id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
16273608|NCT00860262|39487440|FG000|Overall Study|Adverse Event|9|||
16273609|NCT00860262|39487441|FG001|Overall Study|Adverse Event|6|||
16273610|NCT00860262|39487442|FG002|Overall Study|Adverse Event|7|||
16273611|NCT00860262|39487440|FG000|Overall Study|Protocol Violation|0|||
16073831|NCT02001623|38762916|FG000|Overall Study|Disease Progression|2|||
16273612|NCT00860262|39487441|FG001|Overall Study|Protocol Violation|1|||
16273613|NCT00860262|39487442|FG002|Overall Study|Protocol Violation|0|||
16273614|NCT00860262|39487440|FG000|Overall Study|Lost to Follow-up|2|||
16273615|NCT00860262|39487441|FG001|Overall Study|Lost to Follow-up|0|||
16273616|NCT00860262|39487442|FG002|Overall Study|Lost to Follow-up|1|||
16273617|NCT00860262|39487440|FG000|Overall Study|Withdrawal by Subject|4|||
16273618|NCT00860262|39487441|FG001|Overall Study|Withdrawal by Subject|8|||
16273619|NCT00860262|39487442|FG002|Overall Study|Withdrawal by Subject|6|||
16273620|NCT00860262|39487440|FG000|Overall Study|Lack of Efficacy|0|||
16273621|NCT00860262|39487441|FG001|Overall Study|Lack of Efficacy|4|||
16073832|NCT02001623|38762917|FG001|Overall Study|Disease Progression|2|||
16073833|NCT02001623|38762918|FG002|Overall Study|Disease Progression|3|||
16073834|NCT02001623|38762919|FG003|Overall Study|Disease Progression|2|||
16073835|NCT02001623|38762920|FG004|Overall Study|Disease Progression|3|||
16073836|NCT02001623|38762921|FG005|Overall Study|Disease Progression|2|||
16073837|NCT02001623|38762922|FG006|Overall Study|Disease Progression|3|||
16073838|NCT02001623|38762923|FG007|Overall Study|Disease Progression|3|||
16073839|NCT02001623|38762924|FG008|Overall Study|Disease Progression|7|||
16073840|NCT02001623|38762925|FG009|Overall Study|Disease Progression|40|||
16073841|NCT02001623|38762926|FG010|Overall Study|Disease Progression|5|||
16073842|NCT02001623|38762927|FG011|Overall Study|Disease Progression|9|||
16073843|NCT02001623|38762928|FG012|Overall Study|Disease Progression|9|||
16273622|NCT00860262|39487442|FG002|Overall Study|Lack of Efficacy|3|||
16273623|NCT00860262|39487440|FG000|Overall Study|Other|5|||
16273624|NCT00860262|39487441|FG001|Overall Study|Other|3|||
16273625|NCT00860262|39487442|FG002|Overall Study|Other|1|||
16273626|NCT01881737|39487449|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
16273627|NCT01881737|39487449|FG000|Overall Study|Withdrawal by Subject|1|||
16273628|NCT01881737|39487449|FG000|Overall Study|Worsening of baseline behavior|1|||
16273629|NCT02046122|39487450|FG000|Overall Study|Physician Decision|8|||
16273630|NCT02046122|39487450|FG000|Overall Study|Withdrawal by Subject|1|||
16273631|NCT02705716|39487451|FG000|Overall Study|Adverse Event|0|||
16273632|NCT02705716|39487452|FG001|Overall Study|Adverse Event|1|||
16273633|NCT02705716|39487451|FG000|Overall Study|Protocol Violation|3|||
16273634|NCT02705716|39487452|FG001|Overall Study|Protocol Violation|0|||
16273635|NCT02705716|39487451|FG000|Overall Study|Withdrawal of Consent|1|||
16273636|NCT02705716|39487452|FG001|Overall Study|Withdrawal of Consent|1|||
16273637|NCT04473326|39487459|FG000|Overall Study|Death|0|||
16273638|NCT04473326|39487460|FG001|Overall Study|Death|1|||
16273639|NCT04473326|39487459|FG000|Overall Study|Withdrawal by Subject|1|||
16273640|NCT04473326|39487460|FG001|Overall Study|Withdrawal by Subject|2|||
16273641|NCT02161549|39487461|FG000|Overall Study|Physician Decision|6|||
16273642|NCT02161549|39487462|FG001|Overall Study|Physician Decision|2|||
16273643|NCT02119936|39487463|FG000|Overall Study|Lost to Follow-up|10|||
16273644|NCT00379353|39487471|FG000|Overall Study|Hospitalization|3|||
16273645|NCT00379353|39487472|FG001|Overall Study|Hospitalization|3|||
16273646|NCT00379353|39487471|FG000|Overall Study|Withdrawal by Subject|5|||
16273647|NCT00379353|39487472|FG001|Overall Study|Withdrawal by Subject|2|||
16273648|NCT00379353|39487471|FG000|Overall Study|Death|1|||
16273649|NCT00379353|39487472|FG001|Overall Study|Death|0|||
16273650|NCT00379353|39487471|FG000|Overall Study|Cardiac Tamponade|1|||
16273651|NCT00379353|39487472|FG001|Overall Study|Cardiac Tamponade|0|||
16273652|NCT00379353|39487471|FG000|Overall Study|Non-compliance|1|||
16273653|NCT00379353|39487472|FG001|Overall Study|Non-compliance|0|||
16273654|NCT00379353|39487471|FG000|Overall Study|Conflicting drug treatment|0|||
16374121|NCT00489359|39856533|FG000|Overall Study|Death|0|||
16374122|NCT00489359|39856534|FG001|Overall Study|Death|2|||
16374123|NCT00489359|39856533|FG000|Overall Study|Progressive Disease|5|||
16273655|NCT00379353|39487472|FG001|Overall Study|Conflicting drug treatment|1|||
16273656|NCT01923311|39487475|FG000|Overall Study|Pregnancy|1|||
16273657|NCT01923311|39487476|FG001|Overall Study|Pregnancy|0|||
16273658|NCT01923311|39487475|FG000|Overall Study|Investigator's Discretion|1|||
16273659|NCT01923311|39487476|FG001|Overall Study|Investigator's Discretion|0|||
16273660|NCT01923311|39487475|FG000|Overall Study|Non-Compliance with Study Drug|2|||
16273661|NCT01923311|39487476|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16073844|NCT02001623|38762929|FG013|Overall Study|Disease Progression|20|||
16073845|NCT02001623|38762930|FG014|Overall Study|Disease Progression|9|||
16073846|NCT02001623|38762916|FG000|Overall Study|Physician Decision|0|||
16073847|NCT02001623|38762917|FG001|Overall Study|Physician Decision|0|||
16073848|NCT02001623|38762918|FG002|Overall Study|Physician Decision|0|||
16273662|NCT01923311|39487475|FG000|Overall Study|Withdrew Consent|1|||
16273663|NCT01923311|39487476|FG001|Overall Study|Withdrew Consent|0|||
16273664|NCT01923311|39487475|FG000|Overall Study|Study Terminated by Sponsor|12|||
16273665|NCT01923311|39487476|FG001|Overall Study|Study Terminated by Sponsor|0|||
16273666|NCT00450658|39487477|FG000|Overall Study|Adverse Event|24|||
16374124|NCT00489359|39856534|FG001|Overall Study|Progressive Disease|6|||
16374125|NCT00489359|39856533|FG000|Overall Study|Lost to Follow-up|1|||
16374126|NCT00489359|39856534|FG001|Overall Study|Lost to Follow-up|0|||
16374127|NCT00489359|39856533|FG000|Overall Study|Withdrawal by Subject|1|||
16473179|NCT00386607|40214399|FG000|Core|Adverse Event|40|||
16473180|NCT00386607|40214400|FG001|Core|Adverse Event|0|||
16473181|NCT00386607|40214399|FG000|Core|Abnormal laboratory value(s)|3|||
16473182|NCT00386607|40214400|FG001|Core|Abnormal laboratory value(s)|0|||
16473183|NCT00386607|40214399|FG000|Core|Unsatisfactory therapeutic effect|23|||
16473184|NCT00386607|40214400|FG001|Core|Unsatisfactory therapeutic effect|0|||
16473185|NCT00386607|40214399|FG000|Core|Condition no longer requires study drug|4|||
16473186|NCT00386607|40214400|FG001|Core|Condition no longer requires study drug|0|||
16473187|NCT00386607|40214399|FG000|Core|Patient withdrew consent|15|||
16073849|NCT02001623|38762919|FG003|Overall Study|Physician Decision|0|||
16073850|NCT02001623|38762920|FG004|Overall Study|Physician Decision|0|||
16073851|NCT02001623|38762921|FG005|Overall Study|Physician Decision|0|||
16073852|NCT02001623|38762922|FG006|Overall Study|Physician Decision|0|||
16073853|NCT02001623|38762923|FG007|Overall Study|Physician Decision|0|||
16073854|NCT02001623|38762924|FG008|Overall Study|Physician Decision|3|||
16073855|NCT02001623|38762925|FG009|Overall Study|Physician Decision|2|||
16073856|NCT02001623|38762926|FG010|Overall Study|Physician Decision|3|||
16073857|NCT02001623|38762927|FG011|Overall Study|Physician Decision|3|||
16073858|NCT02001623|38762928|FG012|Overall Study|Physician Decision|1|||
16073859|NCT02001623|38762929|FG013|Overall Study|Physician Decision|2|||
16073860|NCT02001623|38762930|FG014|Overall Study|Physician Decision|1|||
16073861|NCT02001623|38762916|FG000|Overall Study|Death|0|||
16073862|NCT02001623|38762917|FG001|Overall Study|Death|1|||
16073863|NCT02001623|38762918|FG002|Overall Study|Death|0|||
16073864|NCT02001623|38762919|FG003|Overall Study|Death|0|||
16073865|NCT02001623|38762920|FG004|Overall Study|Death|0|||
16073866|NCT02001623|38762921|FG005|Overall Study|Death|0|||
16073867|NCT02001623|38762922|FG006|Overall Study|Death|0|||
16073868|NCT02001623|38762923|FG007|Overall Study|Death|0|||
16073869|NCT02001623|38762924|FG008|Overall Study|Death|0|||
16073870|NCT02001623|38762925|FG009|Overall Study|Death|0|||
16073871|NCT02001623|38762926|FG010|Overall Study|Death|0|||
16073872|NCT02001623|38762927|FG011|Overall Study|Death|0|||
16073873|NCT02001623|38762928|FG012|Overall Study|Death|0|||
16073874|NCT02001623|38762929|FG013|Overall Study|Death|0|||
16473188|NCT00386607|40214400|FG001|Core|Patient withdrew consent|0|||
16073875|NCT02001623|38762930|FG014|Overall Study|Death|0|||
16073876|NCT02001623|38762916|FG000|Overall Study|Adverse Event|0|||
16073877|NCT02001623|38762917|FG001|Overall Study|Adverse Event|0|||
16073878|NCT02001623|38762918|FG002|Overall Study|Adverse Event|0|||
16073879|NCT02001623|38762919|FG003|Overall Study|Adverse Event|0|||
16073880|NCT02001623|38762920|FG004|Overall Study|Adverse Event|0|||
16273667|NCT00450658|39487478|FG001|Overall Study|Adverse Event|15|||
16273668|NCT00450658|39487477|FG000|Overall Study|Withdrawal by Subject|43|||
16473189|NCT00386607|40214399|FG000|Core|Lost to Follow-up|23|||
16473190|NCT00386607|40214400|FG001|Core|Lost to Follow-up|0|||
16473191|NCT00386607|40214399|FG000|Core|Administrative problems|1|||
16073881|NCT02001623|38762921|FG005|Overall Study|Adverse Event|1|||
16073882|NCT02001623|38762922|FG006|Overall Study|Adverse Event|0|||
16073883|NCT02001623|38762923|FG007|Overall Study|Adverse Event|3|||
16073884|NCT02001623|38762924|FG008|Overall Study|Adverse Event|4|||
16073885|NCT02001623|38762925|FG009|Overall Study|Adverse Event|6|||
16073886|NCT02001623|38762926|FG010|Overall Study|Adverse Event|4|||
16073887|NCT02001623|38762927|FG011|Overall Study|Adverse Event|0|||
16073888|NCT02001623|38762928|FG012|Overall Study|Adverse Event|3|||
16073889|NCT02001623|38762929|FG013|Overall Study|Adverse Event|5|||
16073890|NCT02001623|38762930|FG014|Overall Study|Adverse Event|6|||
16073891|NCT02001623|38762916|FG000|Overall Study|Other - Miscellaneous|0|||
16073892|NCT02001623|38762917|FG001|Overall Study|Other - Miscellaneous|0|||
16073893|NCT02001623|38762918|FG002|Overall Study|Other - Miscellaneous|0|||
16073894|NCT02001623|38762919|FG003|Overall Study|Other - Miscellaneous|0|||
16073895|NCT02001623|38762920|FG004|Overall Study|Other - Miscellaneous|0|||
16073896|NCT02001623|38762921|FG005|Overall Study|Other - Miscellaneous|0|||
16073897|NCT02001623|38762922|FG006|Overall Study|Other - Miscellaneous|0|||
16073898|NCT02001623|38762923|FG007|Overall Study|Other - Miscellaneous|0|||
16073899|NCT02001623|38762924|FG008|Overall Study|Other - Miscellaneous|0|||
16073900|NCT02001623|38762925|FG009|Overall Study|Other - Miscellaneous|1|||
16374128|NCT00489359|39856534|FG001|Overall Study|Withdrawal by Subject|5|||
16473192|NCT00386607|40214400|FG001|Core|Administrative problems|0|||
16473193|NCT00386607|40214399|FG000|Core|Protocol Deviation|6|||
16073901|NCT02001623|38762926|FG010|Overall Study|Other - Miscellaneous|0|||
16073902|NCT02001623|38762927|FG011|Overall Study|Other - Miscellaneous|0|||
16073903|NCT02001623|38762928|FG012|Overall Study|Other - Miscellaneous|0|||
16073904|NCT02001623|38762929|FG013|Overall Study|Other - Miscellaneous|1|||
16073905|NCT02001623|38762930|FG014|Overall Study|Other - Miscellaneous|0|||
16073906|NCT02001623|38762916|FG000|Overall Study|Withdrawal by Subject|1|||
16273669|NCT00450658|39487478|FG001|Overall Study|Withdrawal by Subject|26|||
16073907|NCT02001623|38762917|FG001|Overall Study|Withdrawal by Subject|0|||
16073908|NCT02001623|38762918|FG002|Overall Study|Withdrawal by Subject|0|||
16073909|NCT02001623|38762919|FG003|Overall Study|Withdrawal by Subject|0|||
16073910|NCT02001623|38762920|FG004|Overall Study|Withdrawal by Subject|0|||
16273670|NCT00450658|39487477|FG000|Overall Study|Lost to Follow-up|22|||
16073911|NCT02001623|38762921|FG005|Overall Study|Withdrawal by Subject|0|||
16073912|NCT02001623|38762922|FG006|Overall Study|Withdrawal by Subject|0|||
16073913|NCT02001623|38762923|FG007|Overall Study|Withdrawal by Subject|0|||
16073914|NCT02001623|38762924|FG008|Overall Study|Withdrawal by Subject|1|||
16073915|NCT02001623|38762925|FG009|Overall Study|Withdrawal by Subject|3|||
16073916|NCT02001623|38762926|FG010|Overall Study|Withdrawal by Subject|2|||
16073917|NCT02001623|38762927|FG011|Overall Study|Withdrawal by Subject|2|||
16073918|NCT02001623|38762928|FG012|Overall Study|Withdrawal by Subject|1|||
16073919|NCT02001623|38762929|FG013|Overall Study|Withdrawal by Subject|5|||
16073920|NCT02001623|38762930|FG014|Overall Study|Withdrawal by Subject|2|||
16073921|NCT02001623|38762916|FG000|Overall Study|Lost to Follow-up|0|||
16073922|NCT02001623|38762917|FG001|Overall Study|Lost to Follow-up|0|||
16073923|NCT02001623|38762918|FG002|Overall Study|Lost to Follow-up|0|||
16073924|NCT02001623|38762919|FG003|Overall Study|Lost to Follow-up|0|||
16273671|NCT00450658|39487478|FG001|Overall Study|Lost to Follow-up|5|||
16273672|NCT00450658|39487477|FG000|Overall Study|UGI ulcer|33|||
16273673|NCT00450658|39487478|FG001|Overall Study|UGI ulcer|34|||
16273674|NCT00450658|39487477|FG000|Overall Study|misc|21|||
16273675|NCT00450658|39487478|FG001|Overall Study|misc|10|||
16273676|NCT00252564|39487479|FG000|Overall Study|Adverse Event|17|||
16273677|NCT00252564|39487480|FG001|Overall Study|Adverse Event|13|||
16273678|NCT00252564|39487479|FG000|Overall Study|Unrelated Complication|2|||
16273679|NCT00252564|39487480|FG001|Overall Study|Unrelated Complication|1|||
16273680|NCT00252564|39487479|FG000|Overall Study|Disease Progression|14|||
16273681|NCT00252564|39487480|FG001|Overall Study|Disease Progression|20|||
16273682|NCT00252564|39487479|FG000|Overall Study|Death|0|||
16273683|NCT00252564|39487480|FG001|Overall Study|Death|3|||
16273684|NCT00252564|39487479|FG000|Overall Study|Physician Decision|1|||
16273685|NCT00252564|39487480|FG001|Overall Study|Physician Decision|0|||
16273686|NCT00252564|39487479|FG000|Overall Study|Lost to Follow-up|1|||
16273687|NCT00252564|39487480|FG001|Overall Study|Lost to Follow-up|0|||
16273688|NCT00252564|39487479|FG000|Overall Study|Patient Request|4|||
16273689|NCT00252564|39487480|FG001|Overall Study|Patient Request|5|||
16273690|NCT00252564|39487479|FG000|Overall Study|Withdrawal by Subject|0|||
16273691|NCT00252564|39487480|FG001|Overall Study|Withdrawal by Subject|2|||
16273692|NCT01726803|39487481|FG000|Overall Study|Lost to Follow-up|6|||
16273693|NCT01726803|39487482|FG001|Overall Study|Lost to Follow-up|1|||
16273694|NCT01726803|39487481|FG000|Overall Study|Withdrawal by Subject|1|||
16473194|NCT00386607|40214400|FG001|Core|Protocol Deviation|0|||
16473195|NCT00386607|40214399|FG000|Extension|Adverse Event|0|||
16073925|NCT02001623|38762920|FG004|Overall Study|Lost to Follow-up|0|||
16473196|NCT00386607|40214400|FG001|Extension|Adverse Event|6|||
16073926|NCT02001623|38762921|FG005|Overall Study|Lost to Follow-up|0|||
16073927|NCT02001623|38762922|FG006|Overall Study|Lost to Follow-up|0|||
16073928|NCT02001623|38762923|FG007|Overall Study|Lost to Follow-up|0|||
16073929|NCT02001623|38762924|FG008|Overall Study|Lost to Follow-up|0|||
16073930|NCT02001623|38762925|FG009|Overall Study|Lost to Follow-up|1|||
16073931|NCT02001623|38762926|FG010|Overall Study|Lost to Follow-up|0|||
16073932|NCT02001623|38762927|FG011|Overall Study|Lost to Follow-up|0|||
16073933|NCT02001623|38762928|FG012|Overall Study|Lost to Follow-up|0|||
16073934|NCT02001623|38762929|FG013|Overall Study|Lost to Follow-up|0|||
16073935|NCT02001623|38762930|FG014|Overall Study|Lost to Follow-up|0|||
16073936|NCT02001623|38762916|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
16073937|NCT02001623|38762917|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
16073938|NCT02001623|38762918|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
16073939|NCT02001623|38762919|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
16073940|NCT02001623|38762920|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
16073941|NCT02001623|38762921|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
16073942|NCT02001623|38762922|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
16073943|NCT02001623|38762923|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
16073944|NCT02001623|38762924|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
16073945|NCT02001623|38762925|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
16073946|NCT02001623|38762926|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
16173684|NCT00781365|39115225|FG000|Overall Study|Withdrawal by Subject|13|||
16273695|NCT01726803|39487482|FG001|Overall Study|Withdrawal by Subject|0|||
16273696|NCT01097694|39487483|FG000|Overall Study|Adverse Event|5|||
16273697|NCT01097694|39487484|FG001|Overall Study|Adverse Event|0|||
16273698|NCT01097694|39487483|FG000|Overall Study|Lost to Follow-up|0|||
16273699|NCT01097694|39487484|FG001|Overall Study|Lost to Follow-up|3|||
16273700|NCT01097694|39487483|FG000|Overall Study|Withdrawal by Subject|3|||
16374129|NCT00489359|39856533|FG000|Overall Study|Adverse Event|0|||
16273701|NCT01097694|39487484|FG001|Overall Study|Withdrawal by Subject|1|||
16273702|NCT01401062|39487485|FG000|Overall Study|Death|9|||
16073947|NCT02001623|38762927|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
16073948|NCT02001623|38762928|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
16073949|NCT02001623|38762929|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
16073950|NCT02001623|38762930|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
16073951|NCT02001623|38762916|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
16073952|NCT02001623|38762917|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
16073953|NCT02001623|38762918|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
16073954|NCT02001623|38762919|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
16073955|NCT02001623|38762920|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
16073956|NCT02001623|38762921|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
16073957|NCT02001623|38762922|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
16073958|NCT02001623|38762923|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
16073959|NCT02001623|38762924|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
16073960|NCT02001623|38762925|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
16273703|NCT01401062|39487486|FG001|Overall Study|Death|7|||
16273704|NCT01401062|39487485|FG000|Overall Study|Physician Decision|1|||
16473197|NCT00386607|40214399|FG000|Extension|Abnormal laboratory value(s)|0|||
16473198|NCT00386607|40214400|FG001|Extension|Abnormal laboratory value(s)|1|||
16273705|NCT01401062|39487486|FG001|Overall Study|Physician Decision|0|||
16273706|NCT01401062|39487485|FG000|Overall Study|Withdrawal by Subject|1|||
16073961|NCT02001623|38762926|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
16073962|NCT02001623|38762927|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
16073963|NCT02001623|38762928|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
16073964|NCT02001623|38762929|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
16073965|NCT02001623|38762930|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
16073966|NCT03439124|38762932|FG000|Overall Study|Adverse Event|2|||
16073967|NCT03439124|38762933|FG001|Overall Study|Adverse Event|0|||
16073968|NCT03439124|38762932|FG000|Overall Study|Lost to Follow-up|1|||
16073969|NCT03439124|38762933|FG001|Overall Study|Lost to Follow-up|0|||
16073970|NCT03439124|38762932|FG000|Overall Study|Other reasons|1|||
16073971|NCT03439124|38762933|FG001|Overall Study|Other reasons|0|||
16073972|NCT01373346|38762934|FG000|Overall Study|Death|1|||
16073973|NCT02145182|38762935|FG000|Overall Study|Adverse Event|4|||
16073974|NCT02145182|38762936|FG001|Overall Study|Adverse Event|1|||
16073975|NCT02145182|38762935|FG000|Overall Study|Death|7|||
16073976|NCT02145182|38762936|FG001|Overall Study|Death|7|||
16073977|NCT02145182|38762935|FG000|Overall Study|Lost to Follow-up|2|||
16073978|NCT02145182|38762936|FG001|Overall Study|Lost to Follow-up|2|||
16073979|NCT02145182|38762935|FG000|Overall Study|Pre-transplant Withdrawal|0|||
16073980|NCT02145182|38762936|FG001|Overall Study|Pre-transplant Withdrawal|2|||
16073981|NCT02145182|38762935|FG000|Overall Study|Withdrawal by Subject|5|||
16073982|NCT02145182|38762936|FG001|Overall Study|Withdrawal by Subject|4|||
16073983|NCT01233050|38762937|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
16073984|NCT01233050|38762938|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
16073985|NCT01281813|38762939|FG000|Overall Study|Adverse Event|0|||
16073986|NCT01281813|38762940|FG001|Overall Study|Adverse Event|0|||
16073987|NCT01281813|38762941|FG002|Overall Study|Adverse Event|10|||
16073988|NCT01281813|38762939|FG000|Overall Study|Lost to Follow-up|0|||
16073989|NCT01281813|38762940|FG001|Overall Study|Lost to Follow-up|0|||
16073990|NCT01281813|38762941|FG002|Overall Study|Lost to Follow-up|31|||
16073991|NCT01281813|38762939|FG000|Overall Study|Withdrawal by Subject|0|||
16073992|NCT01281813|38762940|FG001|Overall Study|Withdrawal by Subject|0|||
16073993|NCT01281813|38762941|FG002|Overall Study|Withdrawal by Subject|13|||
16073994|NCT01281813|38762939|FG000|Overall Study|Subject Non-Compliant|0|||
16073995|NCT01281813|38762940|FG001|Overall Study|Subject Non-Compliant|0|||
16073996|NCT01281813|38762941|FG002|Overall Study|Subject Non-Compliant|6|||
16073997|NCT01281813|38762939|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
16073998|NCT01281813|38762940|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
16073999|NCT01281813|38762941|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
16074000|NCT01281813|38762939|FG000|Overall Study|Sponsor's Decision|4|||
16074001|NCT01281813|38762940|FG001|Overall Study|Sponsor's Decision|3|||
16074002|NCT01281813|38762941|FG002|Overall Study|Sponsor's Decision|7|||
16074003|NCT01281813|38762939|FG000|Overall Study|Switched to Commercially Available Medication|0|||
16074004|NCT01281813|38762940|FG001|Overall Study|Switched to Commercially Available Medication|0|||
16074005|NCT01281813|38762941|FG002|Overall Study|Switched to Commercially Available Medication|26|||
16273707|NCT01401062|39487486|FG001|Overall Study|Withdrawal by Subject|1|||
16273708|NCT00398073|39487488|FG000|Overall Study|Withdrawal by Subject|1|||
16273709|NCT00398073|39487489|FG001|Overall Study|Withdrawal by Subject|0|||
16473199|NCT00386607|40214399|FG000|Extension|Administrative problems|0|||
16074006|NCT01281813|38762939|FG000|Overall Study|Other|0|||
16074007|NCT01281813|38762940|FG001|Overall Study|Other|1|||
16473200|NCT00386607|40214400|FG001|Extension|Administrative problems|1|||
16074008|NCT01281813|38762941|FG002|Overall Study|Other|39|||
16273710|NCT00434590|39487490|FG000|Overall Study|Administrative problems|5|||
16273711|NCT00434590|39487491|FG001|Overall Study|Administrative problems|5|||
16273712|NCT03828539|39487492|FG000|Overall Study|Adverse Event|3|||
16273713|NCT03828539|39487493|FG001|Overall Study|Adverse Event|12|||
16074009|NCT03185819|38762944|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
16074010|NCT03185819|38762945|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
16074011|NCT03185819|38762946|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
16074012|NCT03185819|38762947|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
16074013|NCT03185819|38762944|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
16074014|NCT03185819|38762945|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
16273714|NCT03828539|39487492|FG000|Overall Study|Patient's/guardian's decision|3|||
16273715|NCT03828539|39487493|FG001|Overall Study|Patient's/guardian's decision|5|||
16273716|NCT03828539|39487492|FG000|Overall Study|Lost to Follow-up|4|||
16273717|NCT03828539|39487493|FG001|Overall Study|Lost to Follow-up|2|||
16273718|NCT03828539|39487492|FG000|Overall Study|Protocol Violation|3|||
16273719|NCT03828539|39487493|FG001|Overall Study|Protocol Violation|2|||
16273720|NCT03828539|39487492|FG000|Overall Study|Withdrawal of informed consent|2|||
16273721|NCT03828539|39487493|FG001|Overall Study|Withdrawal of informed consent|1|||
16273722|NCT03828539|39487492|FG000|Overall Study|New therapy for study indication|1|||
16273723|NCT03828539|39487493|FG001|Overall Study|New therapy for study indication|0|||
16273724|NCT01186458|39487496|FG000|Overall Study|Adverse Event|1|||
16273725|NCT00697827|39487499|FG000|Overall Study|enrolled but not treated|2|||
16273726|NCT00697827|39487500|FG001|Overall Study|enrolled but not treated|1|||
16273727|NCT03573544|39487502|FG000|Overall Study|Adverse Event|0|||
16273728|NCT03573544|39487503|FG001|Overall Study|Adverse Event|0|||
16273729|NCT03573544|39487504|FG002|Overall Study|Adverse Event|0|||
16273730|NCT03573544|39487505|FG003|Overall Study|Adverse Event|3|||
16273731|NCT03573544|39487506|FG004|Overall Study|Adverse Event|1|||
16273732|NCT03573544|39487507|FG005|Overall Study|Adverse Event|0|||
16273733|NCT03573544|39487508|FG006|Overall Study|Adverse Event|2|||
16074015|NCT03185819|38762946|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
16074016|NCT03185819|38762947|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
16074017|NCT03185819|38762944|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
16074018|NCT03185819|38762945|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
16074019|NCT03185819|38762946|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
16074020|NCT03185819|38762947|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
16074021|NCT03185819|38762944|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
16074022|NCT03185819|38762945|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
16074023|NCT03185819|38762946|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
16074024|NCT03185819|38762947|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
16074025|NCT03185819|38762944|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
16074026|NCT03185819|38762945|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
16074027|NCT03185819|38762946|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
16074028|NCT03185819|38762947|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
16074029|NCT03185819|38762944|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
16074030|NCT03185819|38762945|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
16074031|NCT03185819|38762946|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
16074032|NCT03185819|38762947|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
16074033|NCT03185819|38762944|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
16074034|NCT03185819|38762945|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
16074035|NCT03185819|38762946|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
16074036|NCT03185819|38762947|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
16074037|NCT03185819|38762944|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
16074038|NCT03185819|38762945|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
16074039|NCT03185819|38762946|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
16074040|NCT03185819|38762947|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
16074041|NCT03185819|38762944|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
16074042|NCT03185819|38762945|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
16074043|NCT03185819|38762946|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
16074044|NCT03185819|38762947|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
16074045|NCT03185819|38762944|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
16074046|NCT03185819|38762945|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
16173685|NCT00781365|39115226|FG001|Overall Study|Withdrawal by Subject|8|||
16173686|NCT00781365|39115225|FG000|Overall Study|Did Not Attend Visit|20|||
16173687|NCT00781365|39115226|FG001|Overall Study|Did Not Attend Visit|28|||
16273734|NCT03573544|39487509|FG007|Overall Study|Adverse Event|0|||
16273735|NCT03573544|39487502|FG000|Overall Study|Physician Decision|0|||
16273736|NCT03573544|39487503|FG001|Overall Study|Physician Decision|0|||
16273737|NCT03573544|39487504|FG002|Overall Study|Physician Decision|0|||
16273738|NCT03573544|39487505|FG003|Overall Study|Physician Decision|0|||
16074047|NCT03185819|38762946|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
16074048|NCT03185819|38762947|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
16074049|NCT03185819|38762944|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
16074050|NCT03185819|38762945|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
16074051|NCT03185819|38762946|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
16074052|NCT03185819|38762947|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
16074053|NCT03185819|38762944|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
16074054|NCT03185819|38762945|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
16074055|NCT03185819|38762946|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
16074056|NCT03185819|38762947|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
16173688|NCT00781365|39115225|FG000|Overall Study|Language barrier|1|||
16273739|NCT03573544|39487506|FG004|Overall Study|Physician Decision|0|||
16273740|NCT03573544|39487507|FG005|Overall Study|Physician Decision|0|||
16273741|NCT03573544|39487508|FG006|Overall Study|Physician Decision|1|||
16273742|NCT03573544|39487509|FG007|Overall Study|Physician Decision|0|||
16273743|NCT03573544|39487502|FG000|Overall Study|Withdrawal by Subject|2|||
16273744|NCT03573544|39487503|FG001|Overall Study|Withdrawal by Subject|0|||
16273745|NCT03573544|39487504|FG002|Overall Study|Withdrawal by Subject|0|||
16273746|NCT03573544|39487505|FG003|Overall Study|Withdrawal by Subject|1|||
16273747|NCT03573544|39487506|FG004|Overall Study|Withdrawal by Subject|1|||
16273748|NCT03573544|39487507|FG005|Overall Study|Withdrawal by Subject|1|||
16273749|NCT03573544|39487508|FG006|Overall Study|Withdrawal by Subject|0|||
16273750|NCT03573544|39487509|FG007|Overall Study|Withdrawal by Subject|1|||
16273751|NCT03573544|39487502|FG000|Overall Study|Disease progression|3|||
16273752|NCT03573544|39487503|FG001|Overall Study|Disease progression|3|||
16273753|NCT03573544|39487504|FG002|Overall Study|Disease progression|6|||
16273754|NCT03573544|39487505|FG003|Overall Study|Disease progression|4|||
16273755|NCT03573544|39487506|FG004|Overall Study|Disease progression|5|||
16273756|NCT03573544|39487507|FG005|Overall Study|Disease progression|7|||
16273757|NCT03573544|39487508|FG006|Overall Study|Disease progression|6|||
16273758|NCT03573544|39487509|FG007|Overall Study|Disease progression|7|||
16273759|NCT02670551|39487510|FG000|Overall Study|Adverse Event|4|||
16273760|NCT02670551|39487511|FG001|Overall Study|Adverse Event|7|||
16273761|NCT02670551|39487512|FG002|Overall Study|Adverse Event|9|||
16273762|NCT02670551|39487510|FG000|Overall Study|Lack of Efficacy|2|||
16273763|NCT02670551|39487511|FG001|Overall Study|Lack of Efficacy|0|||
16273764|NCT02670551|39487512|FG002|Overall Study|Lack of Efficacy|3|||
16273765|NCT02670551|39487510|FG000|Overall Study|Withdrawal of Consent|6|||
16273766|NCT02670551|39487511|FG001|Overall Study|Withdrawal of Consent|3|||
16273767|NCT02670551|39487512|FG002|Overall Study|Withdrawal of Consent|8|||
16273768|NCT02670551|39487510|FG000|Overall Study|Lost to Follow-up|5|||
16273769|NCT02670551|39487511|FG001|Overall Study|Lost to Follow-up|7|||
16273770|NCT02670551|39487512|FG002|Overall Study|Lost to Follow-up|6|||
16273771|NCT02670551|39487510|FG000|Overall Study|Protocol Violation|1|||
16273772|NCT02670551|39487511|FG001|Overall Study|Protocol Violation|0|||
16273773|NCT02670551|39487512|FG002|Overall Study|Protocol Violation|0|||
16273774|NCT02670551|39487510|FG000|Overall Study|Noncompliance with study drug|3|||
16273775|NCT02670551|39487511|FG001|Overall Study|Noncompliance with study drug|3|||
16273776|NCT02670551|39487512|FG002|Overall Study|Noncompliance with study drug|2|||
16273777|NCT02670551|39487510|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16273778|NCT02670551|39487511|FG001|Overall Study|Other Miscellaneous Reasons|3|||
16273779|NCT02670551|39487512|FG002|Overall Study|Other Miscellaneous Reasons|3|||
16273780|NCT02670551|39487510|FG000|Overall Study|Did Not Receive Treatment|5|||
16273781|NCT02670551|39487511|FG001|Overall Study|Did Not Receive Treatment|3|||
16273782|NCT02670551|39487512|FG002|Overall Study|Did Not Receive Treatment|0|||
16273783|NCT01483820|39487513|FG000|Overall Study|Lack of Efficacy|6|||
16273784|NCT01483820|39487513|FG000|Overall Study|Adverse Event|1|||
16273785|NCT01483820|39487513|FG000|Overall Study|Death|1|||
16273786|NCT00396630|39487514|FG000|Overall Study|Lost to Follow-up|1|||
16273787|NCT00396630|39487515|FG001|Overall Study|Lost to Follow-up|1|||
16273788|NCT00396630|39487514|FG000|Overall Study|Withdrawal by Subject|1|||
16273789|NCT00396630|39487515|FG001|Overall Study|Withdrawal by Subject|1|||
16273790|NCT00396630|39487514|FG000|Overall Study|Not vaccinated at Visit 3|3|||
16273791|NCT00396630|39487515|FG001|Overall Study|Not vaccinated at Visit 3|3|||
16273792|NCT03419962|39487516|FG000|Overall Study|Change to other medication|1|||
16273793|NCT03419962|39487516|FG000|Overall Study|Refusal of continuing with trial drug|1|||
16273794|NCT03419962|39487516|FG000|Overall Study|Lost to Follow-up|3|||
16273795|NCT03419962|39487516|FG000|Overall Study|Difficulty in inhaling the doses|1|||
16273796|NCT03419962|39487516|FG000|Overall Study|Missing completion data|31|||
16273797|NCT03185741|39487519|FG000|Baseline|Withdrawal by Subject|1|||
16273798|NCT03185741|39487520|FG001|Baseline|Withdrawal by Subject|3|||
16273799|NCT03185741|39487521|FG002|Baseline|Withdrawal by Subject|2|||
16273800|NCT03185741|39487519|FG000|Baseline|Lost to Follow-up|1|||
16273801|NCT03185741|39487520|FG001|Baseline|Lost to Follow-up|2|||
16273802|NCT03185741|39487521|FG002|Baseline|Lost to Follow-up|3|||
16273803|NCT03185741|39487519|FG000|3Month|Death|1|||
16273804|NCT03185741|39487520|FG001|3Month|Death|1|||
16273805|NCT03185741|39487521|FG002|3Month|Death|2|||
16273806|NCT03185741|39487519|FG000|3Month|Withdrawal by Subject|1|||
16273807|NCT03185741|39487520|FG001|3Month|Withdrawal by Subject|5|||
16273808|NCT03185741|39487521|FG002|3Month|Withdrawal by Subject|1|||
16273809|NCT03185741|39487519|FG000|3Month|Lost to Follow-up|7|||
16273810|NCT03185741|39487520|FG001|3Month|Lost to Follow-up|9|||
16273811|NCT03185741|39487521|FG002|3Month|Lost to Follow-up|8|||
16273812|NCT03185741|39487519|FG000|3Month|Unavailable for 3Month|11|||
16273813|NCT03185741|39487520|FG001|3Month|Unavailable for 3Month|10|||
16273814|NCT03185741|39487521|FG002|3Month|Unavailable for 3Month|11|||
16273815|NCT03185741|39487519|FG000|3Month|Protocol Violation|0|||
16074057|NCT03185819|38762944|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
16473201|NCT00386607|40214399|FG000|Extension|Lost to Follow-up|0|||
16473202|NCT00386607|40214400|FG001|Extension|Lost to Follow-up|3|||
16473203|NCT00386607|40214399|FG000|Extension|Patient withdrew consent|0|||
16273816|NCT03185741|39487520|FG001|3Month|Protocol Violation|0|||
16273817|NCT03185741|39487521|FG002|3Month|Protocol Violation|3|||
16273818|NCT03185741|39487519|FG000|6Month|Death|1|||
16273819|NCT03185741|39487520|FG001|6Month|Death|1|||
16273820|NCT03185741|39487521|FG002|6Month|Death|2|||
16273821|NCT03185741|39487519|FG000|6Month|Withdrawal by Subject|2|||
16273822|NCT03185741|39487520|FG001|6Month|Withdrawal by Subject|3|||
16273823|NCT03185741|39487521|FG002|6Month|Withdrawal by Subject|1|||
16273824|NCT03185741|39487519|FG000|6Month|Lost to Follow-up|16|||
16273825|NCT03185741|39487520|FG001|6Month|Lost to Follow-up|15|||
16273826|NCT03185741|39487521|FG002|6Month|Lost to Follow-up|16|||
16273827|NCT00884390|39487529|FG000|Overall Study|Adverse Event|0|||
16273828|NCT00884390|39487530|FG001|Overall Study|Adverse Event|1|||
16273829|NCT00884390|39487529|FG000|Overall Study|Lost to Follow-up|0|||
16273830|NCT00884390|39487530|FG001|Overall Study|Lost to Follow-up|1|||
16273831|NCT00884390|39487529|FG000|Overall Study|Physician Decision|2|||
16273832|NCT00884390|39487530|FG001|Overall Study|Physician Decision|1|||
16273833|NCT00884390|39487529|FG000|Overall Study|Protocol Violation|4|||
16273834|NCT00884390|39487530|FG001|Overall Study|Protocol Violation|1|||
16273835|NCT00884390|39487529|FG000|Overall Study|Withdrawal by Subject|4|||
16273836|NCT00884390|39487530|FG001|Overall Study|Withdrawal by Subject|1|||
16273837|NCT00884390|39487529|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
16273838|NCT00884390|39487530|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
16273839|NCT00884390|39487529|FG000|Overall Study|Other|11|||
16273840|NCT00884390|39487530|FG001|Overall Study|Other|1|||
16273841|NCT01120691|39487536|FG000|Overall Study|Adverse Event|59|||
16273842|NCT01120691|39487537|FG001|Overall Study|Adverse Event|67|||
16273843|NCT01120691|39487538|FG002|Overall Study|Adverse Event|47|||
16273844|NCT01120691|39487536|FG000|Overall Study|Subject withdrew consent|33|||
16273845|NCT01120691|39487537|FG001|Overall Study|Subject withdrew consent|50|||
16273846|NCT01120691|39487538|FG002|Overall Study|Subject withdrew consent|44|||
16273847|NCT01120691|39487536|FG000|Overall Study|Death|21|||
16273848|NCT01120691|39487537|FG001|Overall Study|Death|22|||
16273849|NCT01120691|39487538|FG002|Overall Study|Death|24|||
16273850|NCT01120691|39487536|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
16273851|NCT01120691|39487537|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
16273852|NCT01120691|39487538|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
16273853|NCT01120691|39487536|FG000|Overall Study|Administrative problems|15|||
16273854|NCT01120691|39487537|FG001|Overall Study|Administrative problems|8|||
16473204|NCT00386607|40214400|FG001|Extension|Patient withdrew consent|5|||
16473205|NCT00386607|40214399|FG000|Extension|Unsatisfactory therapeutic effect|0|||
16473206|NCT00386607|40214400|FG001|Extension|Unsatisfactory therapeutic effect|1|||
16473207|NCT02600351|40214403|FG000|Overall Study|Lack of Efficacy|3|||
16473208|NCT02600351|40214404|FG001|Overall Study|Lack of Efficacy|0|||
16473209|NCT02600351|40214405|FG002|Overall Study|Lack of Efficacy|5|||
16473210|NCT02600351|40214406|FG003|Overall Study|Lack of Efficacy|2|||
16473211|NCT02600351|40214403|FG000|Overall Study|Lost to Follow-up|1|||
16473212|NCT02600351|40214404|FG001|Overall Study|Lost to Follow-up|0|||
16473213|NCT02600351|40214405|FG002|Overall Study|Lost to Follow-up|0|||
16473214|NCT02600351|40214406|FG003|Overall Study|Lost to Follow-up|0|||
16473215|NCT02600351|40214403|FG000|Overall Study|Randomized but Not Treated|1|||
16473216|NCT02600351|40214404|FG001|Overall Study|Randomized but Not Treated|0|||
16074058|NCT03185819|38762945|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
16173689|NCT00781365|39115226|FG001|Overall Study|Language barrier|0|||
16173690|NCT03403192|39115228|FG000|Overall Study|Lost to Follow-up|1|||
16273855|NCT01120691|39487538|FG002|Overall Study|Administrative problems|9|||
16273856|NCT01120691|39487536|FG000|Overall Study|Protocol deviation|13|||
16273857|NCT01120691|39487537|FG001|Overall Study|Protocol deviation|12|||
16273858|NCT01120691|39487538|FG002|Overall Study|Protocol deviation|12|||
16074059|NCT03185819|38762946|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
16273859|NCT01120691|39487536|FG000|Overall Study|Lost to Follow-up|5|||
16273860|NCT01120691|39487537|FG001|Overall Study|Lost to Follow-up|6|||
16273861|NCT01120691|39487538|FG002|Overall Study|Lost to Follow-up|4|||
16273862|NCT01120691|39487536|FG000|Overall Study|Abnormal test procedure result(s)|3|||
16473217|NCT02600351|40214405|FG002|Overall Study|Randomized but Not Treated|1|||
16473218|NCT02600351|40214406|FG003|Overall Study|Randomized but Not Treated|3|||
16473219|NCT03360747|40214407|FG000|Overall Study|Voluntary Withdrawal|1|||
16473220|NCT00853073|40214408|FG000|Overall Study|Withdrawal by Subject|3|||
16473221|NCT00853073|40214409|FG001|Overall Study|Withdrawal by Subject|2|||
16473222|NCT03206073|40214415|FG000|Overall Study|Participant Noncompliance|0|||
16473223|NCT03206073|40214416|FG001|Overall Study|Participant Noncompliance|1|||
16473224|NCT03206073|40214417|FG002|Overall Study|Participant Noncompliance|0|||
16473225|NCT03206073|40214418|FG003|Overall Study|Participant Noncompliance|0|||
16473226|NCT03206073|40214415|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
16473227|NCT03206073|40214416|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
16473228|NCT03206073|40214417|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
16473229|NCT03206073|40214418|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
16473230|NCT03206073|40214415|FG000|Overall Study|Death|0|||
16473231|NCT03206073|40214416|FG001|Overall Study|Death|0|||
16473232|NCT03206073|40214417|FG002|Overall Study|Death|1|||
16273863|NCT01120691|39487537|FG001|Overall Study|Abnormal test procedure result(s)|2|||
16273864|NCT01120691|39487538|FG002|Overall Study|Abnormal test procedure result(s)|1|||
16374130|NCT00489359|39856534|FG001|Overall Study|Adverse Event|16|||
16374131|NCT00079781|39856538|FG000|Pre-implant Period|Withdrawal by Subject|2|||
16374132|NCT00079781|39856539|FG001|Pre-implant Period|Withdrawal by Subject|0|||
16374133|NCT00079781|39856540|FG002|Pre-implant Period|Withdrawal by Subject|0|||
16374134|NCT00079781|39856538|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
16374135|NCT00079781|39856539|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
16374136|NCT00079781|39856540|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
16374137|NCT00079781|39856538|FG000|Follow-up Period|Withdrawal by Subject|3|||
16374138|NCT00079781|39856539|FG001|Follow-up Period|Withdrawal by Subject|0|||
16374139|NCT00079781|39856540|FG002|Follow-up Period|Withdrawal by Subject|1|||
16374140|NCT00079781|39856538|FG000|Follow-up Period|Lost to Follow-up|1|||
16374141|NCT00079781|39856539|FG001|Follow-up Period|Lost to Follow-up|0|||
16374142|NCT00079781|39856540|FG002|Follow-up Period|Lost to Follow-up|0|||
16273865|NCT01120691|39487536|FG000|Overall Study|Patient's inability to use the device|3|||
16273866|NCT01120691|39487537|FG001|Overall Study|Patient's inability to use the device|1|||
16273867|NCT01120691|39487538|FG002|Overall Study|Patient's inability to use the device|0|||
16273868|NCT01120691|39487536|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16273869|NCT01120691|39487537|FG001|Overall Study|Abnormal laboratory value(s)|3|||
16273870|NCT01120691|39487538|FG002|Overall Study|Abnormal laboratory value(s)|4|||
16273871|NCT03183141|39487539|FG000|Overall Study|Withdrawal by Subject|2|||
16273872|NCT03183141|39487540|FG001|Overall Study|Withdrawal by Subject|4|||
16273873|NCT03183141|39487539|FG000|Overall Study|Death|0|||
16273874|NCT03183141|39487540|FG001|Overall Study|Death|8|||
16273875|NCT01971645|39487541|FG000|Overall Study|Adverse Event|1|||
16273876|NCT01971645|39487542|FG001|Overall Study|Adverse Event|0|||
16273877|NCT01971645|39487543|FG002|Overall Study|Adverse Event|0|||
16273878|NCT01971645|39487541|FG000|Overall Study|Lost to Follow-up|1|||
16273879|NCT01971645|39487542|FG001|Overall Study|Lost to Follow-up|0|||
16273880|NCT01971645|39487543|FG002|Overall Study|Lost to Follow-up|1|||
16273881|NCT01971645|39487541|FG000|Overall Study|Protocol Violation|0|||
16273882|NCT01971645|39487542|FG001|Overall Study|Protocol Violation|0|||
16273883|NCT01971645|39487543|FG002|Overall Study|Protocol Violation|1|||
16273884|NCT02260258|39487548|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
16273885|NCT02260258|39487549|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
16273886|NCT01663896|39487552|FG000|Overall Study|Various reasons|43|||
16273887|NCT02028455|39487553|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16273888|NCT02028455|39487554|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16273889|NCT02028455|39487555|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16273890|NCT02028455|39487556|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16273891|NCT02028455|39487557|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16273892|NCT02028455|39487558|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
16273893|NCT02028455|39487559|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
16273894|NCT02028455|39487560|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
16273895|NCT02028455|39487553|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
16374143|NCT00079781|39856538|FG000|Follow-up Period|Death|0|||
16374144|NCT00079781|39856539|FG001|Follow-up Period|Death|0|||
16374145|NCT00079781|39856540|FG002|Follow-up Period|Death|1|||
16374146|NCT02365064|39856541|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
16374147|NCT02365064|39856542|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
16473233|NCT03206073|40214418|FG003|Overall Study|Death|0|||
16273896|NCT02028455|39487554|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
16273897|NCT02028455|39487555|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
16273898|NCT02028455|39487556|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
16273899|NCT02028455|39487557|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
16273900|NCT02028455|39487558|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
16273901|NCT02028455|39487559|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
16273902|NCT02028455|39487560|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
16273903|NCT02028455|39487553|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16273904|NCT02028455|39487554|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16273905|NCT02028455|39487555|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16273906|NCT02028455|39487556|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16273907|NCT02028455|39487557|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16273908|NCT02028455|39487558|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
16273909|NCT02028455|39487559|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
16273910|NCT02028455|39487560|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
16273911|NCT02028455|39487553|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
16273912|NCT02028455|39487554|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
16374148|NCT02365064|39856541|FG000|Overall Study|Withdrawal by Subject|6|||
16273913|NCT02028455|39487555|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
16273914|NCT02028455|39487556|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
16273915|NCT02028455|39487557|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
16273916|NCT02028455|39487558|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
16273917|NCT02028455|39487559|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
16273918|NCT02028455|39487560|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
16273919|NCT03247686|39487562|FG000|Overall Study|Withdrawal by Subject|1|||
16273920|NCT03247686|39487563|FG001|Overall Study|Withdrawal by Subject|2|||
16273921|NCT03868631|39487567|FG000|Baseline to Week 6|Adverse Event|0|||
16273922|NCT03868631|39487568|FG001|Baseline to Week 6|Adverse Event|3|||
16273923|NCT03868631|39487567|FG000|Baseline to Week 6|Protocol Violation|1|||
16273924|NCT03868631|39487568|FG001|Baseline to Week 6|Protocol Violation|1|||
16273925|NCT03868631|39487567|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
16273926|NCT03868631|39487568|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
16273927|NCT03868631|39487567|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
16273928|NCT03868631|39487568|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
16273929|NCT03868631|39487567|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
16273930|NCT03868631|39487568|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
16273931|NCT03868631|39487567|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
16273932|NCT03868631|39487568|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
16273933|NCT01077258|39487571|FG000|Overall Study|Lost to Follow-up|1390|||
16273934|NCT01077258|39487571|FG000|Overall Study|Adverse drug reaction|218|||
16273935|NCT01077258|39487571|FG000|Overall Study|Lack of Efficacy|663|||
16273936|NCT01077258|39487571|FG000|Overall Study|Clinical remission|37|||
16273937|NCT01077258|39487571|FG000|Overall Study|Other reasons|260|||
16273938|NCT01942135|39487574|FG000|Overall Study|Adverse Event|21|||
16273939|NCT01942135|39487575|FG001|Overall Study|Adverse Event|7|||
16273940|NCT01942135|39487574|FG000|Overall Study|Global Deterioration of Health Status|9|||
16273941|NCT01942135|39487575|FG001|Overall Study|Global Deterioration of Health Status|6|||
16273942|NCT01942135|39487574|FG000|Overall Study|Randomized Not Treated|2|||
16273943|NCT01942135|39487575|FG001|Overall Study|Randomized Not Treated|2|||
16273944|NCT01942135|39487574|FG000|Overall Study|Death|2|||
16273945|NCT01942135|39487575|FG001|Overall Study|Death|1|||
16273946|NCT01942135|39487574|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
16273947|NCT01942135|39487575|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
16374149|NCT02365064|39856542|FG001|Overall Study|Withdrawal by Subject|9|||
16374150|NCT02365064|39856541|FG000|Overall Study|Treatment intolerance|2|||
16374151|NCT02365064|39856542|FG001|Overall Study|Treatment intolerance|4|||
16374152|NCT01748552|39856547|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
16374153|NCT01748552|39856548|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
16374154|NCT01748552|39856549|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
16374155|NCT01748552|39856550|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
16374156|NCT01748552|39856551|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
16374157|NCT01748552|39856552|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
16473234|NCT03206073|40214415|FG000|Overall Study|Taken off active treatment|0|||
16273948|NCT01942135|39487574|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
16273949|NCT01942135|39487575|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
16374158|NCT01748552|39856553|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
16273950|NCT01942135|39487574|FG000|Overall Study|Withdrawal by Subject|4|||
16273951|NCT01942135|39487575|FG001|Overall Study|Withdrawal by Subject|3|||
16074060|NCT03185819|38762947|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
16074061|NCT00880048|38762948|FG000|Overall Study|Adverse Event|2|||
16074062|NCT00880048|38762949|FG001|Overall Study|Adverse Event|3|||
16074063|NCT00880048|38762950|FG002|Overall Study|Adverse Event|5|||
16074064|NCT00880048|38762948|FG000|Overall Study|Lack of Efficacy|1|||
16273952|NCT01942135|39487574|FG000|Overall Study|Protocol Violation|1|||
16273953|NCT01942135|39487575|FG001|Overall Study|Protocol Violation|0|||
16273954|NCT01942135|39487574|FG000|Overall Study|Other|19|||
16273955|NCT01942135|39487575|FG001|Overall Study|Other|4|||
16273956|NCT02169336|39487577|FG000|Overall Study|Lack of Efficacy|1|||
16273957|NCT02169336|39487578|FG001|Overall Study|Lack of Efficacy|1|||
16273958|NCT02169336|39487579|FG002|Overall Study|Lack of Efficacy|0|||
16273959|NCT02169336|39487577|FG000|Overall Study|Adverse Event|2|||
16273960|NCT02169336|39487578|FG001|Overall Study|Adverse Event|3|||
16273961|NCT02169336|39487579|FG002|Overall Study|Adverse Event|1|||
16273962|NCT02169336|39487577|FG000|Overall Study|Withdrawal by Subject|1|||
16273963|NCT02169336|39487578|FG001|Overall Study|Withdrawal by Subject|0|||
16273964|NCT02169336|39487579|FG002|Overall Study|Withdrawal by Subject|0|||
16273965|NCT02169336|39487577|FG000|Overall Study|Physician Decision|0|||
16273966|NCT02169336|39487578|FG001|Overall Study|Physician Decision|0|||
16273967|NCT02169336|39487579|FG002|Overall Study|Physician Decision|1|||
16273968|NCT02169336|39487577|FG000|Overall Study|Subject declined to continue dosing|0|||
16273969|NCT02169336|39487578|FG001|Overall Study|Subject declined to continue dosing|0|||
16273970|NCT02169336|39487579|FG002|Overall Study|Subject declined to continue dosing|1|||
16273971|NCT02614898|39487585|FG000|Overall Study|Participated until study termination|10|||
16273972|NCT02614898|39487586|FG001|Overall Study|Participated until study termination|26|||
16273973|NCT02614898|39487585|FG000|Overall Study|Lost to Follow-up|0|||
16273974|NCT02614898|39487586|FG001|Overall Study|Lost to Follow-up|2|||
16273975|NCT02614898|39487585|FG000|Overall Study|Physician Decision|1|||
16273976|NCT02614898|39487586|FG001|Overall Study|Physician Decision|8|||
16273977|NCT02614898|39487585|FG000|Overall Study|Study Terminated by Sponsor|3|||
16273978|NCT02614898|39487586|FG001|Overall Study|Study Terminated by Sponsor|0|||
16273979|NCT02614898|39487585|FG000|Overall Study|Withdrawal by Subject|0|||
16273980|NCT02614898|39487586|FG001|Overall Study|Withdrawal by Subject|2|||
16273981|NCT02614898|39487585|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
16273982|NCT02614898|39487586|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16273983|NCT02614898|39487585|FG000|Overall Study|Other-Additional Information Unavailable|0|||
16273984|NCT02614898|39487586|FG001|Overall Study|Other-Additional Information Unavailable|11|||
16273985|NCT02614898|39487585|FG000|Overall Study|Missing|0|||
16273986|NCT02614898|39487586|FG001|Overall Study|Missing|1|||
16273987|NCT03250117|39487587|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
16273988|NCT03250117|39487588|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
16273989|NCT03250117|39487589|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
16273990|NCT03250117|39487590|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
16273991|NCT02372006|39487592|FG000|Overall Study|Progressive disease|8|||
16273992|NCT02372006|39487593|FG001|Overall Study|Progressive disease|7|||
16273993|NCT02372006|39487594|FG002|Overall Study|Progressive disease|34|||
16273994|NCT02372006|39487592|FG000|Overall Study|Dose limiting toxicity|0|||
16273995|NCT02372006|39487593|FG001|Overall Study|Dose limiting toxicity|1|||
16273996|NCT02372006|39487594|FG002|Overall Study|Dose limiting toxicity|0|||
16273997|NCT02372006|39487592|FG000|Overall Study|Adverse Event|0|||
16273998|NCT02372006|39487593|FG001|Overall Study|Adverse Event|0|||
16273999|NCT02372006|39487594|FG002|Overall Study|Adverse Event|3|||
16074065|NCT00880048|38762949|FG001|Overall Study|Lack of Efficacy|2|||
16074066|NCT00880048|38762950|FG002|Overall Study|Lack of Efficacy|2|||
16074067|NCT00880048|38762948|FG000|Overall Study|Protocol Violation|4|||
16074068|NCT00880048|38762949|FG001|Overall Study|Protocol Violation|6|||
16074069|NCT00880048|38762950|FG002|Overall Study|Protocol Violation|5|||
16074070|NCT00880048|38762948|FG000|Overall Study|Lost to Follow-up|6|||
16074071|NCT00880048|38762949|FG001|Overall Study|Lost to Follow-up|6|||
16074072|NCT00880048|38762950|FG002|Overall Study|Lost to Follow-up|5|||
16074073|NCT00880048|38762948|FG000|Overall Study|Physician Decision|1|||
16074074|NCT00880048|38762949|FG001|Overall Study|Physician Decision|1|||
16074075|NCT00880048|38762950|FG002|Overall Study|Physician Decision|7|||
16074076|NCT00880048|38762948|FG000|Overall Study|Withdrawal by Subject|5|||
16074077|NCT00880048|38762949|FG001|Overall Study|Withdrawal by Subject|8|||
16274000|NCT02372006|39487592|FG000|Overall Study|Withdrawal by Subject|0|||
16274001|NCT02372006|39487593|FG001|Overall Study|Withdrawal by Subject|1|||
16274002|NCT02372006|39487594|FG002|Overall Study|Withdrawal by Subject|1|||
16274003|NCT02372006|39487592|FG000|Overall Study|Other reason for not completing|0|||
16274004|NCT02372006|39487593|FG001|Overall Study|Other reason for not completing|0|||
16274005|NCT02372006|39487594|FG002|Overall Study|Other reason for not completing|1|||
16274006|NCT01050764|39487595|FG000|Overall Study|Death, before HSCT|1|||
16274007|NCT01050764|39487595|FG000|Overall Study|Donor mobilization failure, death|1|||
16074078|NCT00880048|38762950|FG002|Overall Study|Withdrawal by Subject|5|||
16274008|NCT01050764|39487595|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
16274009|NCT02614196|39487601|FG000|Double Blind Treatment Phase|Adverse Event|8|||
16274010|NCT02614196|39487602|FG001|Double Blind Treatment Phase|Adverse Event|5|||
16274011|NCT02614196|39487603|FG002|Double Blind Treatment Phase|Adverse Event|9|||
16274012|NCT02614196|39487604|FG003|Double Blind Treatment Phase|Adverse Event|0|||
16274013|NCT02614196|39487605|FG004|Double Blind Treatment Phase|Adverse Event|0|||
16274014|NCT02614196|39487606|FG005|Double Blind Treatment Phase|Adverse Event|0|||
16274015|NCT02614196|39487601|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
16274016|NCT02614196|39487602|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
16274017|NCT02614196|39487603|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
16274018|NCT02614196|39487604|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
16274019|NCT02614196|39487605|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
16274020|NCT02614196|39487606|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
16274021|NCT02614196|39487601|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
16274022|NCT02614196|39487602|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
16274023|NCT02614196|39487603|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
16274024|NCT02614196|39487604|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
16274025|NCT02614196|39487605|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
16274026|NCT02614196|39487606|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
16274027|NCT02614196|39487601|FG000|Double Blind Treatment Phase|Physician Decision|4|||
16274028|NCT02614196|39487602|FG001|Double Blind Treatment Phase|Physician Decision|0|||
16274029|NCT02614196|39487603|FG002|Double Blind Treatment Phase|Physician Decision|2|||
16274030|NCT02614196|39487604|FG003|Double Blind Treatment Phase|Physician Decision|0|||
16274031|NCT02614196|39487605|FG004|Double Blind Treatment Phase|Physician Decision|0|||
16274032|NCT02614196|39487606|FG005|Double Blind Treatment Phase|Physician Decision|0|||
16274033|NCT02614196|39487601|FG000|Double Blind Treatment Phase|Pregnancy|1|||
16274034|NCT02614196|39487602|FG001|Double Blind Treatment Phase|Pregnancy|2|||
16274035|NCT02614196|39487603|FG002|Double Blind Treatment Phase|Pregnancy|0|||
16274036|NCT02614196|39487604|FG003|Double Blind Treatment Phase|Pregnancy|0|||
16274037|NCT02614196|39487605|FG004|Double Blind Treatment Phase|Pregnancy|0|||
16274038|NCT02614196|39487606|FG005|Double Blind Treatment Phase|Pregnancy|0|||
16274039|NCT02614196|39487601|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
16274040|NCT02614196|39487602|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
16274041|NCT02614196|39487603|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
16274042|NCT02614196|39487604|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
16274043|NCT02614196|39487605|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
16274044|NCT02614196|39487606|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
16274045|NCT02614196|39487601|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
16274046|NCT02614196|39487602|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
16274047|NCT02614196|39487603|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
16274048|NCT02614196|39487604|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
16274049|NCT02614196|39487605|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
16374159|NCT01748552|39856554|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
16374160|NCT01748552|39856555|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
16374161|NCT01748552|39856556|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
16374162|NCT01748552|39856557|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
16374163|NCT01748552|39856558|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
16374164|NCT01748552|39856547|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16374165|NCT01748552|39856548|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16374166|NCT01748552|39856549|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16374167|NCT01748552|39856550|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16374168|NCT01748552|39856551|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16374169|NCT01748552|39856552|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16374170|NCT01748552|39856553|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
16374171|NCT01748552|39856554|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
16274050|NCT02614196|39487606|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
16274051|NCT02614196|39487601|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
16274052|NCT02614196|39487602|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
16274053|NCT02614196|39487603|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
16274054|NCT02614196|39487604|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
16274055|NCT02614196|39487605|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
16274056|NCT02614196|39487606|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
16274057|NCT02614196|39487601|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
16274058|NCT02614196|39487602|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
16274059|NCT02614196|39487603|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
16274060|NCT02614196|39487604|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
16473235|NCT03206073|40214416|FG001|Overall Study|Taken off active treatment|0|||
16473236|NCT03206073|40214417|FG002|Overall Study|Taken off active treatment|3|||
16274061|NCT02614196|39487605|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
16274062|NCT02614196|39487606|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
16274063|NCT02614196|39487601|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
16274064|NCT02614196|39487602|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
16274065|NCT02614196|39487603|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
16274066|NCT02614196|39487604|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
16274067|NCT02614196|39487605|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
16274068|NCT02614196|39487606|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
16274069|NCT02614196|39487601|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
16274070|NCT02614196|39487602|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
16274071|NCT02614196|39487603|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
16274072|NCT02614196|39487604|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
16274073|NCT02614196|39487605|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
16274074|NCT02614196|39487606|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
16274075|NCT02614196|39487601|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
16274076|NCT02614196|39487602|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
16274077|NCT02614196|39487603|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
16274078|NCT02614196|39487604|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
16274079|NCT02614196|39487605|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
16274080|NCT02614196|39487606|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
16274081|NCT02614196|39487601|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
16274082|NCT02614196|39487602|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
16274083|NCT02614196|39487603|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
16374172|NCT01748552|39856555|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
16374173|NCT01748552|39856556|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16274084|NCT02614196|39487604|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
16274085|NCT02614196|39487605|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
16274086|NCT02614196|39487606|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
16274087|NCT02679729|39487608|FG000|Overall Study|Lost to Follow-up|0|||
16274088|NCT02679729|39487609|FG001|Overall Study|Lost to Follow-up|1|||
16274089|NCT02679729|39487610|FG002|Overall Study|Lost to Follow-up|0|||
16274090|NCT02679729|39487611|FG003|Overall Study|Lost to Follow-up|0|||
16274091|NCT02679729|39487612|FG004|Overall Study|Lost to Follow-up|1|||
16274092|NCT02679729|39487613|FG005|Overall Study|Lost to Follow-up|0|||
16274093|NCT02679729|39487614|FG006|Overall Study|Lost to Follow-up|0|||
16274094|NCT02679729|39487615|FG007|Overall Study|Lost to Follow-up|0|||
16274095|NCT02679729|39487616|FG008|Overall Study|Lost to Follow-up|0|||
16274096|NCT02679729|39487608|FG000|Overall Study|Participant decision|0|||
16274097|NCT02679729|39487609|FG001|Overall Study|Participant decision|1|||
16274098|NCT02679729|39487610|FG002|Overall Study|Participant decision|0|||
16274099|NCT02679729|39487611|FG003|Overall Study|Participant decision|0|||
16374174|NCT01748552|39856557|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16274100|NCT02679729|39487612|FG004|Overall Study|Participant decision|0|||
16274101|NCT02679729|39487613|FG005|Overall Study|Participant decision|0|||
16274102|NCT02679729|39487614|FG006|Overall Study|Participant decision|1|||
16274103|NCT02679729|39487615|FG007|Overall Study|Participant decision|0|||
16374175|NCT01748552|39856558|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
16374176|NCT03052608|39856559|FG000|Treatment Phase|Adverse Event|10|||
16374177|NCT03052608|39856560|FG001|Treatment Phase|Adverse Event|12|||
16374178|NCT03052608|39856559|FG000|Treatment Phase|Death|6|||
16374179|NCT03052608|39856560|FG001|Treatment Phase|Death|4|||
16374180|NCT03052608|39856559|FG000|Treatment Phase|Withdrawal by Subject|4|||
16374181|NCT03052608|39856560|FG001|Treatment Phase|Withdrawal by Subject|12|||
16374182|NCT03052608|39856559|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
16374183|NCT03052608|39856560|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
16473237|NCT03206073|40214418|FG003|Overall Study|Taken off active treatment|0|||
16473238|NCT00048061|40214419|FG000|Overall Study|Adverse Event|41|||
16074079|NCT00880048|38762948|FG000|Overall Study|Study closed/terminated|9|||
16074080|NCT00880048|38762949|FG001|Overall Study|Study closed/terminated|7|||
16274104|NCT02679729|39487616|FG008|Overall Study|Participant decision|0|||
16274105|NCT00577655|39487617|FG000|Overall Study|Patient Request|0|||
16274106|NCT00577655|39487618|FG001|Overall Study|Patient Request|2|||
16274107|NCT00577655|39487617|FG000|Overall Study|Protocol Violation|0|||
16274108|NCT00577655|39487618|FG001|Overall Study|Protocol Violation|1|||
16274109|NCT00577655|39487617|FG000|Overall Study|Lost to Follow-up|1|||
16274110|NCT00577655|39487618|FG001|Overall Study|Lost to Follow-up|1|||
16374184|NCT03052608|39856559|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
16274111|NCT03257254|39487619|FG000|Overall Study|Withdrawal by Subject|7|||
16274112|NCT03257254|39487619|FG000|Overall Study|Lost to Follow-up|9|||
16274113|NCT03257254|39487619|FG000|Overall Study|Study discontinued by sponsor|5|||
16274114|NCT00566722|39487620|FG000|Overall Study|Adverse Event|0|||
16274115|NCT00566722|39487621|FG001|Overall Study|Adverse Event|1|||
16274116|NCT00566722|39487622|FG002|Overall Study|Adverse Event|0|||
16374185|NCT03052608|39856560|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
16374186|NCT03052608|39856559|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
16374187|NCT03052608|39856560|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
16374188|NCT03052608|39856559|FG000|Treatment Phase|Ongoing|103|||
16374189|NCT03052608|39856560|FG001|Treatment Phase|Ongoing|31|||
16374190|NCT03052608|39856559|FG000|Long-Term Follow-up Phase|Death|23|||
16374191|NCT03052608|39856560|FG001|Long-Term Follow-up Phase|Death|28|||
16374192|NCT03052608|39856559|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
16374193|NCT03052608|39856560|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
16374194|NCT03052608|39856559|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
16374195|NCT03052608|39856560|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
16374196|NCT03052608|39856559|FG000|Long-Term Follow-up Phase|Ongoing|122|||
16374197|NCT03052608|39856560|FG001|Long-Term Follow-up Phase|Ongoing|99|||
16374198|NCT00976391|39856570|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
16374199|NCT00976391|39856571|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
16374200|NCT00976391|39856570|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
16374201|NCT00976391|39856571|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
16374202|NCT00976391|39856570|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
16374203|NCT00976391|39856571|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
16374204|NCT00976391|39856570|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
16374205|NCT00976391|39856571|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
16074081|NCT00880048|38762950|FG002|Overall Study|Study closed/terminated|6|||
16074082|NCT03993392|38762965|FG000|Overall Study|Withdrawal by Subject|3|||
16274117|NCT00566722|39487620|FG000|Overall Study|Withdrawal by Subject|0|||
16274118|NCT00566722|39487621|FG001|Overall Study|Withdrawal by Subject|0|||
16274119|NCT00566722|39487622|FG002|Overall Study|Withdrawal by Subject|1|||
16274120|NCT00566722|39487620|FG000|Overall Study|Lost to Follow-up|1|||
16274121|NCT00566722|39487621|FG001|Overall Study|Lost to Follow-up|1|||
16274122|NCT00566722|39487622|FG002|Overall Study|Lost to Follow-up|1|||
16274123|NCT00566722|39487620|FG000|Overall Study|Lack of Efficacy|1|||
16274124|NCT00566722|39487621|FG001|Overall Study|Lack of Efficacy|2|||
16274125|NCT00566722|39487622|FG002|Overall Study|Lack of Efficacy|4|||
16274126|NCT00566722|39487620|FG000|Overall Study|Did not meet exclusion criteria|0|||
16274127|NCT00566722|39487621|FG001|Overall Study|Did not meet exclusion criteria|0|||
16274128|NCT00566722|39487622|FG002|Overall Study|Did not meet exclusion criteria|2|||
16274129|NCT00566722|39487620|FG000|Overall Study|Serious adverse event|0|||
16274130|NCT00566722|39487621|FG001|Overall Study|Serious adverse event|1|||
16274131|NCT00566722|39487622|FG002|Overall Study|Serious adverse event|0|||
16274132|NCT00566722|39487620|FG000|Overall Study|Noncompliant with drug administration|0|||
16274133|NCT00566722|39487621|FG001|Overall Study|Noncompliant with drug administration|0|||
16274134|NCT00566722|39487622|FG002|Overall Study|Noncompliant with drug administration|1|||
16274135|NCT02340962|39487623|FG000|Overall Study|Lost to Follow-up|1|||
16274136|NCT02340962|39487624|FG001|Overall Study|Lost to Follow-up|0|||
16274137|NCT03105297|39487625|FG000|Baseline Phase (Day 1)|Other|21|||
16274138|NCT03105297|39487625|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
16274139|NCT03105297|39487625|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
16274140|NCT01253564|39487626|FG000|Overall Study|Disease Progression|22|||
16274141|NCT01253564|39487626|FG000|Overall Study|Withdrawal by Subject|1|||
16274142|NCT01253564|39487626|FG000|Overall Study|Serious Adverse Event|1|||
16274143|NCT05004649|39487627|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
16274144|NCT05004649|39487627|FG000|Overall Study|Lost to Follow-up|1|||
16274145|NCT05004649|39487627|FG000|Overall Study|Withdrawal by Subject|2|||
16074083|NCT03993392|38762965|FG000|Overall Study|Lost to Follow-up|2|||
16074084|NCT03993392|38762965|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
16074085|NCT03070483|38762966|FG000|Overall Study|Lost to Follow-up|2|||
16074086|NCT00723450|38762969|FG000|Open-Label Phase|Adverse Event|26|||
16074087|NCT00723450|38762970|FG001|Open-Label Phase|Adverse Event|0|||
16074088|NCT00723450|38762971|FG002|Open-Label Phase|Adverse Event|0|||
16074089|NCT00723450|38762969|FG000|Open-Label Phase|Lack of Efficacy|18|||
16074090|NCT00723450|38762970|FG001|Open-Label Phase|Lack of Efficacy|0|||
16074091|NCT00723450|38762971|FG002|Open-Label Phase|Lack of Efficacy|0|||
16074092|NCT00723450|38762969|FG000|Open-Label Phase|Protocol Violation|35|||
16074093|NCT00723450|38762970|FG001|Open-Label Phase|Protocol Violation|0|||
16074094|NCT00723450|38762971|FG002|Open-Label Phase|Protocol Violation|0|||
16074095|NCT00723450|38762969|FG000|Open-Label Phase|Lost to Follow-up|7|||
16173691|NCT03403192|39115229|FG001|Overall Study|Lost to Follow-up|2|||
16274146|NCT05004649|39487627|FG000|Overall Study|COVID-19|1|||
16274147|NCT00868998|39487628|FG000|Overall Study|Screen Failure|1|||
16074096|NCT00723450|38762970|FG001|Open-Label Phase|Lost to Follow-up|0|||
16074097|NCT00723450|38762971|FG002|Open-Label Phase|Lost to Follow-up|0|||
16274148|NCT00868998|39487628|FG000|Overall Study|Withdrawal by Subject|1|||
16274149|NCT00868998|39487628|FG000|Overall Study|Progression of disease|2|||
16274150|NCT00868998|39487628|FG000|Overall Study|Death|1|||
16274151|NCT02050321|39487629|FG000|Overall Study|Withdrawal by Subject|1|||
16274152|NCT02050321|39487629|FG000|Overall Study|Adverse Event|1|||
16374206|NCT00976391|39856570|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
16374207|NCT00976391|39856571|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
16374208|NCT00976391|39856570|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
16374209|NCT00976391|39856571|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
16374210|NCT00976391|39856570|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
16374211|NCT00976391|39856571|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
16374212|NCT00976391|39856570|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
16374213|NCT00976391|39856571|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
16374214|NCT00976391|39856570|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
16374215|NCT00976391|39856571|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
16374216|NCT00976391|39856570|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
16374217|NCT00976391|39856571|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
16374218|NCT00976391|39856570|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
16374219|NCT00976391|39856571|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
16374220|NCT00976391|39856570|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
16374221|NCT00976391|39856571|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
16374222|NCT00976391|39856570|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
16374223|NCT00976391|39856571|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
16374224|NCT00976391|39856570|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
16374225|NCT00976391|39856571|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
16374226|NCT00692237|39856573|FG000|Overall Study|Withdrawal by Subject|1|||
16374227|NCT00692237|39856574|FG001|Overall Study|Withdrawal by Subject|3|||
16374228|NCT00692237|39856573|FG000|Overall Study|Adverse Event|0|||
16374229|NCT00692237|39856574|FG001|Overall Study|Adverse Event|1|||
16374230|NCT00663260|39856575|FG000|Overall Study|Lack of Efficacy|2|||
16374231|NCT00663260|39856576|FG001|Overall Study|Lack of Efficacy|0|||
16074098|NCT00723450|38762969|FG000|Open-Label Phase|Physician Decision|2|||
16074099|NCT00723450|38762970|FG001|Open-Label Phase|Physician Decision|0|||
16074100|NCT00723450|38762971|FG002|Open-Label Phase|Physician Decision|0|||
16074101|NCT00723450|38762969|FG000|Open-Label Phase|Withdrawal by Subject|37|||
16074102|NCT00723450|38762970|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16074103|NCT00723450|38762971|FG002|Open-Label Phase|Withdrawal by Subject|0|||
16074104|NCT00723450|38762969|FG000|Randomized Phase|Adverse Event|0|||
16074105|NCT00723450|38762970|FG001|Randomized Phase|Adverse Event|26|||
16074106|NCT00723450|38762971|FG002|Randomized Phase|Adverse Event|17|||
16074107|NCT00723450|38762969|FG000|Randomized Phase|Lack of Efficacy|0|||
16074108|NCT00723450|38762970|FG001|Randomized Phase|Lack of Efficacy|11|||
16074109|NCT00723450|38762971|FG002|Randomized Phase|Lack of Efficacy|11|||
16074110|NCT00723450|38762969|FG000|Randomized Phase|Protocol Violation|0|||
16074111|NCT00723450|38762970|FG001|Randomized Phase|Protocol Violation|9|||
16074112|NCT00723450|38762971|FG002|Randomized Phase|Protocol Violation|13|||
16074113|NCT00723450|38762969|FG000|Randomized Phase|Lost to Follow-up|0|||
16074114|NCT00723450|38762970|FG001|Randomized Phase|Lost to Follow-up|2|||
16074115|NCT00723450|38762971|FG002|Randomized Phase|Lost to Follow-up|3|||
16074116|NCT00723450|38762969|FG000|Randomized Phase|Physician Decision|0|||
16074117|NCT00723450|38762970|FG001|Randomized Phase|Physician Decision|3|||
16074118|NCT00723450|38762971|FG002|Randomized Phase|Physician Decision|1|||
16074119|NCT00723450|38762969|FG000|Randomized Phase|Withdrawal by Subject|0|||
16074120|NCT00723450|38762970|FG001|Randomized Phase|Withdrawal by Subject|14|||
16074121|NCT00723450|38762971|FG002|Randomized Phase|Withdrawal by Subject|22|||
16074122|NCT05257798|38762972|FG000|Follow-up Phase|Lost to Follow-up|1|||
16074123|NCT05257798|38762973|FG001|Follow-up Phase|Lost to Follow-up|0|||
16074124|NCT01490580|38762974|FG000|Overall Study|Parents withdrew consent|0|||
16074125|NCT01490580|38762975|FG001|Overall Study|Parents withdrew consent|2|||
16074126|NCT04493242|38762981|FG000|Overall Study|Death|10|||
16074127|NCT04493242|38762982|FG001|Overall Study|Death|14|||
16074128|NCT04493242|38762983|FG002|Overall Study|Death|16|||
16074129|NCT04493242|38762981|FG000|Overall Study|Lost to Follow-up|1|||
16074130|NCT04493242|38762982|FG001|Overall Study|Lost to Follow-up|1|||
16074131|NCT04493242|38762983|FG002|Overall Study|Lost to Follow-up|0|||
16074132|NCT04493242|38762981|FG000|Overall Study|Withdrawal by Subject|1|||
16074133|NCT04493242|38762982|FG001|Overall Study|Withdrawal by Subject|0|||
16074134|NCT04493242|38762983|FG002|Overall Study|Withdrawal by Subject|0|||
16074135|NCT04493242|38762981|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
16374232|NCT00663260|39856577|FG002|Overall Study|Lack of Efficacy|0|||
16074136|NCT04493242|38762982|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
16074137|NCT04493242|38762983|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
16074138|NCT04493242|38762981|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
16074139|NCT04493242|38762982|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
16074140|NCT04493242|38762983|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
16374233|NCT00663260|39856575|FG000|Overall Study|Adverse Event|12|||
16374234|NCT00663260|39856576|FG001|Overall Study|Adverse Event|7|||
16374235|NCT00663260|39856577|FG002|Overall Study|Adverse Event|6|||
16473239|NCT00048061|40214420|FG001|Overall Study|Adverse Event|32|||
16074141|NCT01069341|38762987|FG000|Overall Study|Lost to Follow-up|1|||
16074142|NCT01353963|38762990|FG000|Overall Study|Adverse Event|2|||
16074143|NCT00414648|38762991|FG000|Overall Study|Adverse Event|5|||
16274153|NCT00757172|39487630|FG000|Overall Study|Withdrawal by Subject|4|||
16274154|NCT00757172|39487630|FG000|Overall Study|Physician Decision|3|||
16274155|NCT00757172|39487630|FG000|Overall Study|Progression|4|||
16274156|NCT00045162|39487636|FG000|Overall Study|Ineligible|12|||
16274157|NCT00045162|39487637|FG001|Overall Study|Ineligible|8|||
16274158|NCT00045162|39487636|FG000|Overall Study|Not treated|7|||
16274159|NCT00045162|39487637|FG001|Overall Study|Not treated|2|||
16274160|NCT00045162|39487636|FG000|Overall Study|Adverse Event|55|||
16274161|NCT00045162|39487637|FG001|Overall Study|Adverse Event|50|||
16274162|NCT00045162|39487636|FG000|Overall Study|Lack of Efficacy|32|||
16274163|NCT00045162|39487637|FG001|Overall Study|Lack of Efficacy|29|||
16274164|NCT00045162|39487636|FG000|Overall Study|Death|10|||
16274165|NCT00045162|39487637|FG001|Overall Study|Death|10|||
16274166|NCT00045162|39487636|FG000|Overall Study|Withdrawal by Subject|5|||
16274167|NCT00045162|39487637|FG001|Overall Study|Withdrawal by Subject|3|||
16274168|NCT00045162|39487636|FG000|Overall Study|Other|21|||
16274169|NCT00045162|39487637|FG001|Overall Study|Other|16|||
16274170|NCT01395017|39487643|FG000|Overall Study|Lost to Follow-up|1|||
16274171|NCT01395017|39487644|FG001|Overall Study|Lost to Follow-up|0|||
16274172|NCT01395017|39487643|FG000|Overall Study|Adverse Event|26|||
16074144|NCT00414648|38762992|FG001|Overall Study|Adverse Event|5|||
16074145|NCT00414648|38762991|FG000|Overall Study|Death|0|||
16274173|NCT01395017|39487644|FG001|Overall Study|Adverse Event|12|||
16274174|NCT01395017|39487643|FG000|Overall Study|Physician Decision|11|||
16274175|NCT01395017|39487644|FG001|Overall Study|Physician Decision|15|||
16274176|NCT01395017|39487643|FG000|Overall Study|Withdrawal by Subject|14|||
16274177|NCT01395017|39487644|FG001|Overall Study|Withdrawal by Subject|8|||
16274178|NCT01395017|39487643|FG000|Overall Study|Protocol deviation|1|||
16274179|NCT01395017|39487644|FG001|Overall Study|Protocol deviation|2|||
16274180|NCT01395017|39487643|FG000|Overall Study|Death|4|||
16274181|NCT01395017|39487644|FG001|Overall Study|Death|3|||
16074146|NCT00414648|38762992|FG001|Overall Study|Death|1|||
16074147|NCT00414648|38762991|FG000|Overall Study|Lack of Efficacy|0|||
16074148|NCT00414648|38762992|FG001|Overall Study|Lack of Efficacy|2|||
16074149|NCT00414648|38762991|FG000|Overall Study|Withdrawal by Subject|0|||
16074150|NCT00414648|38762992|FG001|Overall Study|Withdrawal by Subject|1|||
16074151|NCT02950558|38762993|FG000|Overall Study|Lost to Follow-up|2|||
16074152|NCT02950558|38762994|FG001|Overall Study|Lost to Follow-up|0|||
16074153|NCT00367991|38762995|FG000|Overall Study|Withdrawal by Subject|1|||
16074154|NCT00367991|38762996|FG001|Overall Study|Withdrawal by Subject|1|||
16074155|NCT00367991|38762995|FG000|Overall Study|Adverse Event|1|||
16074156|NCT00367991|38762996|FG001|Overall Study|Adverse Event|1|||
16074157|NCT01897233|38762999|FG000|Part B (24 Weeks)|Adverse Event|1|||
16074158|NCT01897233|38762999|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
16074159|NCT01897233|38762999|FG000|Part B (24 Weeks)|Physician Decision|1|||
16074160|NCT00457691|38763001|FG000|Overall Study|Adverse Event|4|||
16074161|NCT00457691|38763002|FG001|Overall Study|Adverse Event|1|||
16074162|NCT00457691|38763001|FG000|Overall Study|Death|163|||
16074163|NCT00457691|38763002|FG001|Overall Study|Death|148|||
16074164|NCT00457691|38763001|FG000|Overall Study|Protocol Violation|1|||
16074165|NCT00457691|38763002|FG001|Overall Study|Protocol Violation|3|||
16074166|NCT00457691|38763001|FG000|Overall Study|Lost to Follow-up|23|||
16074167|NCT00457691|38763002|FG001|Overall Study|Lost to Follow-up|14|||
16074168|NCT00457691|38763001|FG000|Overall Study|Study terminated by Sponsor|1|||
16074169|NCT00457691|38763002|FG001|Overall Study|Study terminated by Sponsor|1|||
16074170|NCT00457691|38763001|FG000|Overall Study|Subject refused (reason other than AE)|14|||
16074171|NCT00457691|38763002|FG001|Overall Study|Subject refused (reason other than AE)|19|||
16074172|NCT00457691|38763001|FG000|Overall Study|Disease progression, study terminated|180|||
16074173|NCT00457691|38763002|FG001|Overall Study|Disease progression, study terminated|196|||
16074174|NCT02000817|38763003|FG000|Overall Study|Withdrawal by Subject|2|||
16074175|NCT02000817|38763004|FG001|Overall Study|Withdrawal by Subject|0|||
16074176|NCT02000817|38763005|FG002|Overall Study|Withdrawal by Subject|0|||
16074177|NCT02000817|38763006|FG003|Overall Study|Withdrawal by Subject|0|||
16074178|NCT02000817|38763003|FG000|Overall Study|Adverse Event|0|||
16074179|NCT02000817|38763004|FG001|Overall Study|Adverse Event|1|||
16074180|NCT02000817|38763005|FG002|Overall Study|Adverse Event|0|||
16173692|NCT03403192|39115230|FG002|Overall Study|Lost to Follow-up|0|||
16274182|NCT01395017|39487643|FG000|Overall Study|Disease progression|42|||
16074181|NCT02000817|38763006|FG003|Overall Study|Adverse Event|0|||
16274183|NCT01395017|39487644|FG001|Overall Study|Disease progression|58|||
16274184|NCT01395017|39487643|FG000|Overall Study|Sponsor discontinued study|1|||
16274185|NCT01395017|39487644|FG001|Overall Study|Sponsor discontinued study|4|||
16274186|NCT02986139|39487645|FG000|Overall Study|Sponsor Decision|1|||
16274187|NCT02986139|39487646|FG001|Overall Study|Sponsor Decision|2|||
16274188|NCT02986139|39487645|FG000|Overall Study|Withdrawal by Subject|0|||
16274189|NCT02986139|39487646|FG001|Overall Study|Withdrawal by Subject|1|||
16274190|NCT02986139|39487645|FG000|Overall Study|Lost to Follow-up|0|||
16074182|NCT02000817|38763003|FG000|Overall Study|Lost to Follow-up|0|||
16074183|NCT02000817|38763004|FG001|Overall Study|Lost to Follow-up|0|||
16074184|NCT02000817|38763005|FG002|Overall Study|Lost to Follow-up|1|||
16074185|NCT02000817|38763006|FG003|Overall Study|Lost to Follow-up|0|||
16074186|NCT05190419|38763007|FG000|Overall Study|Lack of Efficacy|8|||
16074187|NCT05190419|38763008|FG001|Overall Study|Lack of Efficacy|0|||
16074188|NCT05190419|38763009|FG002|Overall Study|Lack of Efficacy|1|||
16074189|NCT05190419|38763010|FG003|Overall Study|Lack of Efficacy|0|||
16074190|NCT05190419|38763007|FG000|Overall Study|Withdrawal by Subject|7|||
16473240|NCT00048061|40214421|FG002|Overall Study|Adverse Event|44|||
16074191|NCT05190419|38763008|FG001|Overall Study|Withdrawal by Subject|1|||
16074192|NCT05190419|38763009|FG002|Overall Study|Withdrawal by Subject|2|||
16074193|NCT05190419|38763010|FG003|Overall Study|Withdrawal by Subject|2|||
16074194|NCT05190419|38763007|FG000|Overall Study|Adverse Event|2|||
16074195|NCT05190419|38763008|FG001|Overall Study|Adverse Event|10|||
16074196|NCT05190419|38763009|FG002|Overall Study|Adverse Event|11|||
16074197|NCT05190419|38763010|FG003|Overall Study|Adverse Event|21|||
16074198|NCT05190419|38763007|FG000|Overall Study|Lost to Follow-up|1|||
16074199|NCT05190419|38763008|FG001|Overall Study|Lost to Follow-up|2|||
16074200|NCT05190419|38763009|FG002|Overall Study|Lost to Follow-up|3|||
16074201|NCT05190419|38763010|FG003|Overall Study|Lost to Follow-up|1|||
16074202|NCT05190419|38763007|FG000|Overall Study|Other|1|||
16074203|NCT05190419|38763008|FG001|Overall Study|Other|1|||
16074204|NCT05190419|38763009|FG002|Overall Study|Other|0|||
16074205|NCT05190419|38763010|FG003|Overall Study|Other|3|||
16074206|NCT00768651|38763013|FG000|Overall Study|Withdrawal by Subject|1|||
16074207|NCT04246762|38763014|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
16074208|NCT02685033|38763015|FG000|Overall Study|Withdrawal of Consent|0|||
16074209|NCT02685033|38763016|FG001|Overall Study|Withdrawal of Consent|1|||
16074210|NCT02685033|38763015|FG000|Overall Study|Lost to Follow-up|2|||
16274191|NCT02986139|39487646|FG001|Overall Study|Lost to Follow-up|1|||
16274192|NCT04553406|39487647|FG000|Overall Study|Study Discontinuation|0|||
16274193|NCT04553406|39487648|FG001|Overall Study|Study Discontinuation|1|||
16274194|NCT03277248|39487650|FG000|Overall Study|Adverse Event|3|||
16274195|NCT03277248|39487651|FG001|Overall Study|Adverse Event|1|||
16274196|NCT03277248|39487650|FG000|Overall Study|Subject Withdrawal of Consent|6|||
16274197|NCT03277248|39487651|FG001|Overall Study|Subject Withdrawal of Consent|23|||
16274198|NCT03277248|39487650|FG000|Overall Study|Investigator/Sponsor Decision|2|||
16274199|NCT03277248|39487651|FG001|Overall Study|Investigator/Sponsor Decision|2|||
16274200|NCT03277248|39487650|FG000|Overall Study|Pregnancy|4|||
16274201|NCT03277248|39487651|FG001|Overall Study|Pregnancy|1|||
16274202|NCT03277248|39487650|FG000|Overall Study|Lost to Follow-up|0|||
16274203|NCT03277248|39487651|FG001|Overall Study|Lost to Follow-up|2|||
16274204|NCT03277248|39487650|FG000|Overall Study|Lack of Efficacy|0|||
16274205|NCT03277248|39487651|FG001|Overall Study|Lack of Efficacy|2|||
16274206|NCT03277248|39487650|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
16274207|NCT03277248|39487651|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
16274208|NCT01592240|39487656|FG000|Overall Study|Adverse Event|1|||
16274209|NCT01592240|39487657|FG001|Overall Study|Adverse Event|0|||
16274210|NCT01592240|39487658|FG002|Overall Study|Adverse Event|0|||
16274211|NCT01592240|39487659|FG003|Overall Study|Adverse Event|1|||
16274212|NCT01592240|39487660|FG004|Overall Study|Adverse Event|1|||
16274213|NCT01592240|39487661|FG005|Overall Study|Adverse Event|0|||
16274214|NCT01592240|39487662|FG006|Overall Study|Adverse Event|0|||
16274215|NCT01592240|39487656|FG000|Overall Study|Death|0|||
16274216|NCT01592240|39487657|FG001|Overall Study|Death|1|||
16274217|NCT01592240|39487658|FG002|Overall Study|Death|0|||
16274218|NCT01592240|39487659|FG003|Overall Study|Death|0|||
16274219|NCT01592240|39487660|FG004|Overall Study|Death|0|||
16274220|NCT01592240|39487661|FG005|Overall Study|Death|0|||
16274221|NCT01592240|39487662|FG006|Overall Study|Death|0|||
16473241|NCT00048061|40214422|FG003|Overall Study|Adverse Event|37|||
16473242|NCT00048061|40214419|FG000|Overall Study|Lost to Follow-up|3|||
16074211|NCT02685033|38763016|FG001|Overall Study|Lost to Follow-up|1|||
16074212|NCT02685033|38763015|FG000|Overall Study|Adverse Event|1|||
16074213|NCT02685033|38763016|FG001|Overall Study|Adverse Event|0|||
16074214|NCT00636207|38763020|FG000|Overall Study|Adverse Event|1|||
16074215|NCT00636207|38763021|FG001|Overall Study|Adverse Event|0|||
16074216|NCT00636207|38763022|FG002|Overall Study|Adverse Event|0|||
16074217|NCT00636207|38763023|FG003|Overall Study|Adverse Event|0|||
16074218|NCT00636207|38763024|FG004|Overall Study|Adverse Event|0|||
16074219|NCT00636207|38763025|FG005|Overall Study|Adverse Event|0|||
16274222|NCT01592240|39487656|FG000|Overall Study|Lost to Follow-up|1|||
16274223|NCT01592240|39487657|FG001|Overall Study|Lost to Follow-up|3|||
16274224|NCT01592240|39487658|FG002|Overall Study|Lost to Follow-up|1|||
16274225|NCT01592240|39487659|FG003|Overall Study|Lost to Follow-up|0|||
16274226|NCT01592240|39487660|FG004|Overall Study|Lost to Follow-up|3|||
16274227|NCT01592240|39487661|FG005|Overall Study|Lost to Follow-up|2|||
16274228|NCT01592240|39487662|FG006|Overall Study|Lost to Follow-up|0|||
16274229|NCT01592240|39487656|FG000|Overall Study|Protocol Violation|0|||
16074220|NCT00636207|38763026|FG006|Overall Study|Adverse Event|0|||
16074221|NCT00636207|38763020|FG000|Overall Study|Withdrawal by Subject|0|||
16074222|NCT00636207|38763021|FG001|Overall Study|Withdrawal by Subject|1|||
16074223|NCT00636207|38763022|FG002|Overall Study|Withdrawal by Subject|0|||
16074224|NCT00636207|38763023|FG003|Overall Study|Withdrawal by Subject|0|||
16074225|NCT00636207|38763024|FG004|Overall Study|Withdrawal by Subject|1|||
16074226|NCT00636207|38763025|FG005|Overall Study|Withdrawal by Subject|0|||
16074227|NCT00636207|38763026|FG006|Overall Study|Withdrawal by Subject|0|||
16074228|NCT01184508|38763027|FG000|Overall Study|Adverse Event|4|||
16074229|NCT01184508|38763028|FG001|Overall Study|Adverse Event|6|||
16274230|NCT01592240|39487657|FG001|Overall Study|Protocol Violation|0|||
16274231|NCT01592240|39487658|FG002|Overall Study|Protocol Violation|0|||
16274232|NCT01592240|39487659|FG003|Overall Study|Protocol Violation|0|||
16274233|NCT01592240|39487660|FG004|Overall Study|Protocol Violation|0|||
16074230|NCT01184508|38763027|FG000|Overall Study|Lack of Efficacy|1|||
16074231|NCT01184508|38763028|FG001|Overall Study|Lack of Efficacy|1|||
16074232|NCT01184508|38763027|FG000|Overall Study|Lost to Follow-up|1|||
16074233|NCT01184508|38763028|FG001|Overall Study|Lost to Follow-up|1|||
16074234|NCT01184508|38763027|FG000|Overall Study|Physician Decision|1|||
16274234|NCT01592240|39487661|FG005|Overall Study|Protocol Violation|1|||
16274235|NCT01592240|39487662|FG006|Overall Study|Protocol Violation|0|||
16274236|NCT01592240|39487656|FG000|Overall Study|Withdrawal by Subject|0|||
16274237|NCT01592240|39487657|FG001|Overall Study|Withdrawal by Subject|4|||
16274238|NCT01592240|39487658|FG002|Overall Study|Withdrawal by Subject|4|||
16274239|NCT01592240|39487659|FG003|Overall Study|Withdrawal by Subject|1|||
16274240|NCT01592240|39487660|FG004|Overall Study|Withdrawal by Subject|3|||
16274241|NCT01592240|39487661|FG005|Overall Study|Withdrawal by Subject|0|||
16274242|NCT01592240|39487662|FG006|Overall Study|Withdrawal by Subject|2|||
16274243|NCT01592240|39487656|FG000|Overall Study|Other|0|||
16274244|NCT01592240|39487657|FG001|Overall Study|Other|3|||
16274245|NCT01592240|39487658|FG002|Overall Study|Other|1|||
16274246|NCT01592240|39487659|FG003|Overall Study|Other|1|||
16274247|NCT01592240|39487660|FG004|Overall Study|Other|0|||
16274248|NCT01592240|39487661|FG005|Overall Study|Other|0|||
16274249|NCT01592240|39487662|FG006|Overall Study|Other|1|||
16274250|NCT01592240|39487656|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
16274251|NCT01592240|39487657|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
16274252|NCT01592240|39487658|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
16274253|NCT01592240|39487659|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
16274254|NCT01592240|39487660|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
16274255|NCT01592240|39487661|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
16274256|NCT01592240|39487662|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
16274257|NCT02964039|39487667|FG000|Overall Study|Medical reason unrelated to study participation|1|||
16274258|NCT02964039|39487668|FG001|Overall Study|Medical reason unrelated to study participation|0|||
16274259|NCT02964039|39487669|FG002|Overall Study|Medical reason unrelated to study participation|3|||
16274260|NCT02964039|39487667|FG000|Overall Study|Research shutdown due to pandemic|2|||
16274261|NCT02964039|39487668|FG001|Overall Study|Research shutdown due to pandemic|0|||
16274262|NCT02964039|39487669|FG002|Overall Study|Research shutdown due to pandemic|1|||
16274263|NCT02964039|39487667|FG000|Overall Study|Withdrawal by Subject|0|||
16274264|NCT02964039|39487668|FG001|Overall Study|Withdrawal by Subject|1|||
16274265|NCT02964039|39487669|FG002|Overall Study|Withdrawal by Subject|0|||
16274266|NCT02964039|39487667|FG000|Overall Study|Lost to Follow-up|1|||
16274267|NCT02964039|39487668|FG001|Overall Study|Lost to Follow-up|0|||
16274268|NCT02964039|39487669|FG002|Overall Study|Lost to Follow-up|1|||
16274269|NCT00385736|39487670|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
16274270|NCT00385736|39487671|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
16274271|NCT00385736|39487672|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
16274272|NCT00385736|39487670|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
16274273|NCT00385736|39487671|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
16274274|NCT00385736|39487672|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
16074235|NCT01184508|38763028|FG001|Overall Study|Physician Decision|0|||
16074236|NCT01184508|38763027|FG000|Overall Study|Protocol Violation|3|||
16074237|NCT01184508|38763028|FG001|Overall Study|Protocol Violation|1|||
16074238|NCT01184508|38763027|FG000|Overall Study|Sponsor Decision|5|||
16074239|NCT01184508|38763028|FG001|Overall Study|Sponsor Decision|2|||
16074240|NCT01184508|38763027|FG000|Overall Study|Withdrawal by Subject|1|||
16074241|NCT01184508|38763028|FG001|Overall Study|Withdrawal by Subject|3|||
16074242|NCT01184508|38763027|FG000|Overall Study|Randomized, Not Treated|0|||
16274275|NCT00385736|39487670|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
16274276|NCT00385736|39487671|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
16274277|NCT00385736|39487672|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
16274278|NCT00385736|39487670|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
16274279|NCT00385736|39487671|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
16274280|NCT00385736|39487672|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
16274281|NCT00385736|39487670|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
16274282|NCT00385736|39487671|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
16274283|NCT00385736|39487672|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
16274284|NCT00385736|39487670|FG000|Efficacy Analysis Set - Induction|Other|0|||
16274285|NCT00385736|39487671|FG001|Efficacy Analysis Set - Induction|Other|0|||
16274286|NCT00385736|39487672|FG002|Efficacy Analysis Set - Induction|Other|1|||
16274287|NCT00385736|39487670|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
16274288|NCT00385736|39487671|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
16274289|NCT00385736|39487672|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
16274290|NCT00385736|39487670|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
16274291|NCT00385736|39487671|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
16274292|NCT00385736|39487672|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
16274293|NCT00385736|39487670|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
16274294|NCT00385736|39487671|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
16274295|NCT00385736|39487672|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
16274296|NCT00385736|39487670|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
16274297|NCT00385736|39487671|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
16274298|NCT00385736|39487672|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
16274299|NCT00385736|39487670|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
16274300|NCT00385736|39487671|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
16274301|NCT00385736|39487672|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
16274302|NCT00385736|39487670|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
16274303|NCT00385736|39487671|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
16274304|NCT00385736|39487672|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
16274305|NCT00385736|39487670|FG000|Safety Analysis Set|Adverse Event|23|||
16274306|NCT00385736|39487671|FG001|Safety Analysis Set|Adverse Event|15|||
16274307|NCT00385736|39487672|FG002|Safety Analysis Set|Adverse Event|23|||
16274308|NCT00385736|39487670|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
16274309|NCT00385736|39487671|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
16274310|NCT00385736|39487672|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
16274311|NCT00385736|39487670|FG000|Safety Analysis Set|Lost to Follow-up|0|||
16274312|NCT00385736|39487671|FG001|Safety Analysis Set|Lost to Follow-up|2|||
16274313|NCT00385736|39487672|FG002|Safety Analysis Set|Lost to Follow-up|2|||
16274314|NCT00385736|39487670|FG000|Safety Analysis Set|Lack of Efficacy|38|||
16274315|NCT00385736|39487671|FG001|Safety Analysis Set|Lack of Efficacy|16|||
16274316|NCT00385736|39487672|FG002|Safety Analysis Set|Lack of Efficacy|31|||
16274317|NCT00385736|39487670|FG000|Safety Analysis Set|Protocol Violation|2|||
16274318|NCT00385736|39487671|FG001|Safety Analysis Set|Protocol Violation|1|||
16274319|NCT00385736|39487672|FG002|Safety Analysis Set|Protocol Violation|6|||
16274320|NCT00385736|39487670|FG000|Safety Analysis Set|Other|1|||
16274321|NCT00385736|39487671|FG001|Safety Analysis Set|Other|4|||
16274322|NCT00385736|39487672|FG002|Safety Analysis Set|Other|4|||
16274323|NCT01868243|39487673|FG000|Overall Study|Death|0|||
16274324|NCT01868243|39487674|FG001|Overall Study|Death|1|||
16274325|NCT01151280|39487675|FG000|Overall Study|Adverse Event|1|||
16274326|NCT01151280|39487675|FG000|Overall Study|Lack of Efficacy|3|||
16274327|NCT01292837|39487676|FG000|Overall Study|Adverse Event|1|||
16274328|NCT01292837|39487676|FG000|Overall Study|Further treatment determined|1|||
16274329|NCT03498560|39487680|FG000|Overall Study|Found Ineligible|2|||
16274330|NCT03498560|39487680|FG000|Overall Study|Withdrawal by Subject|14|||
16274331|NCT03498560|39487680|FG000|Overall Study|Lost to Follow-up|4|||
16274332|NCT03498560|39487680|FG000|Overall Study|Death|1|||
16274333|NCT00393705|39487682|FG000|Overall Study|Adverse Event|0|||
16274334|NCT00393705|39487683|FG001|Overall Study|Adverse Event|2|||
16274335|NCT00393705|39487682|FG000|Overall Study|Death|0|||
16274336|NCT00393705|39487683|FG001|Overall Study|Death|1|||
16274337|NCT00393705|39487682|FG000|Overall Study|Lost to Follow-up|2|||
16274338|NCT00393705|39487683|FG001|Overall Study|Lost to Follow-up|2|||
16274339|NCT00393705|39487682|FG000|Overall Study|Entry Criteria Not Met|10|||
16274340|NCT00393705|39487683|FG001|Overall Study|Entry Criteria Not Met|10|||
16274341|NCT00393705|39487682|FG000|Overall Study|Protocol Violation|4|||
16274342|NCT00393705|39487683|FG001|Overall Study|Protocol Violation|3|||
16274343|NCT00393705|39487682|FG000|Overall Study|Withdrawal by Subject|5|||
16274344|NCT00393705|39487683|FG001|Overall Study|Withdrawal by Subject|3|||
16274345|NCT00393705|39487682|FG000|Overall Study|Physician Decision|2|||
16274346|NCT00393705|39487683|FG001|Overall Study|Physician Decision|2|||
16274347|NCT00858403|39487690|FG000|Overall Study|Withdrawal by Subject|1|||
16274348|NCT00858403|39487690|FG000|Overall Study|Death|3|||
16274349|NCT00858403|39487690|FG000|Overall Study|Disease Progression|1|||
16274350|NCT03488108|39487691|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
16274351|NCT03488108|39487692|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
16274352|NCT03488108|39487691|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
16274353|NCT03488108|39487692|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
16274354|NCT00909038|39487694|FG000|Overall Study|Protocol Violation|187|||
16274355|NCT00909038|39487694|FG000|Overall Study|Non-evaluable Subjects|230|||
16274356|NCT00105157|39487695|FG000|Double-Blind (DB)|Never Treated|1|||
16274357|NCT00105157|39487696|FG001|Double-Blind (DB)|Never Treated|0|||
16274358|NCT00105157|39487697|FG002|Double-Blind (DB)|Never Treated|0|||
16274359|NCT00105157|39487698|FG003|Double-Blind (DB)|Never Treated|0|||
16274360|NCT00105157|39487695|FG000|Double-Blind (DB)|Adverse Event|2|||
16274361|NCT00105157|39487696|FG001|Double-Blind (DB)|Adverse Event|0|||
16274362|NCT00105157|39487697|FG002|Double-Blind (DB)|Adverse Event|1|||
16274363|NCT00105157|39487698|FG003|Double-Blind (DB)|Adverse Event|1|||
16274364|NCT00105157|39487695|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
16274365|NCT00105157|39487696|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
16274366|NCT00105157|39487697|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
16274367|NCT00105157|39487698|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
16274368|NCT00105157|39487695|FG000|Open-Label Continuation of DB|Adverse Event|3|||
16274369|NCT00105157|39487696|FG001|Open-Label Continuation of DB|Adverse Event|1|||
16274370|NCT00105157|39487697|FG002|Open-Label Continuation of DB|Adverse Event|0|||
16274371|NCT00105157|39487698|FG003|Open-Label Continuation of DB|Adverse Event|0|||
16274372|NCT00105157|39487695|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
16274373|NCT00105157|39487696|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
16374236|NCT00663260|39856575|FG000|Overall Study|Withdrawal by Subject|3|||
16374237|NCT00663260|39856576|FG001|Overall Study|Withdrawal by Subject|1|||
16374238|NCT00663260|39856577|FG002|Overall Study|Withdrawal by Subject|6|||
16374239|NCT00663260|39856575|FG000|Overall Study|Death|1|||
16374240|NCT00663260|39856576|FG001|Overall Study|Death|0|||
16374241|NCT00663260|39856577|FG002|Overall Study|Death|1|||
16374242|NCT00663260|39856575|FG000|Overall Study|Lost to Follow-up|0|||
16274374|NCT00105157|39487697|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
16274375|NCT00105157|39487698|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
16274376|NCT00105157|39487695|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
16274377|NCT00105157|39487696|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
16274378|NCT00105157|39487697|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
16274379|NCT00105157|39487698|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
16274380|NCT00105157|39487695|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
16274381|NCT00105157|39487696|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
16374243|NCT00663260|39856576|FG001|Overall Study|Lost to Follow-up|1|||
16374244|NCT00663260|39856577|FG002|Overall Study|Lost to Follow-up|0|||
16374245|NCT00663260|39856575|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
16374246|NCT00663260|39856576|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
16374247|NCT00663260|39856577|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
16274382|NCT00105157|39487697|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
16274383|NCT00105157|39487698|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
16274384|NCT00105157|39487695|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
16274385|NCT00105157|39487696|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
16274386|NCT00105157|39487697|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
16274387|NCT00105157|39487698|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
16274388|NCT00105157|39487695|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
16274389|NCT00105157|39487696|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
16274390|NCT00105157|39487697|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
16274391|NCT00105157|39487698|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
16274392|NCT00105157|39487695|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
16274393|NCT00105157|39487696|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
16274394|NCT00105157|39487697|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
16374248|NCT04157738|39856583|FG000|Overall Study|Moved out of state|0|||
16374249|NCT04157738|39856584|FG001|Overall Study|Moved out of state|2|||
16374250|NCT04157738|39856583|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
16074243|NCT01184508|38763028|FG001|Overall Study|Randomized, Not Treated|1|||
16374251|NCT04157738|39856584|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
16074244|NCT00754936|38763030|FG000|Overall Study|Lost to Follow-up|3|||
16074245|NCT00754936|38763030|FG000|Overall Study|Physician Decision|1|||
16074246|NCT00754936|38763030|FG000|Overall Study|Withdrawal by Subject|2|||
16074247|NCT00754936|38763030|FG000|Overall Study|Side Effects|3|||
16074248|NCT00754936|38763030|FG000|Overall Study|Inter-current medical events|3|||
16074249|NCT03615924|38763031|FG000|Overall Study|Withdrawal by Subject|2|||
16074250|NCT03615924|38763032|FG001|Overall Study|Withdrawal by Subject|5|||
16074251|NCT03615924|38763031|FG000|Overall Study|Death|3|||
16074252|NCT03615924|38763032|FG001|Overall Study|Death|1|||
16074253|NCT03615924|38763031|FG000|Overall Study|Lost to Follow-up|1|||
16374252|NCT03810365|39856585|FG000|Overall Study|Lost to Follow-up|2|||
16374253|NCT03810365|39856586|FG001|Overall Study|Lost to Follow-up|2|||
16074254|NCT03615924|38763032|FG001|Overall Study|Lost to Follow-up|0|||
16074255|NCT03615924|38763031|FG000|Overall Study|Randomized in error|1|||
16274395|NCT00105157|39487698|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
16274396|NCT00105157|39487695|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
16374254|NCT03810365|39856585|FG000|Overall Study|Withdrawal by Subject|4|||
16274397|NCT00105157|39487696|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
16274398|NCT00105157|39487697|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
16274399|NCT00105157|39487698|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
16274400|NCT00105157|39487695|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
16274401|NCT00105157|39487696|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
16274402|NCT00105157|39487697|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
16274403|NCT00105157|39487698|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
16074256|NCT03615924|38763032|FG001|Overall Study|Randomized in error|0|||
16074257|NCT03615924|38763031|FG000|Overall Study|Study termination by Sponsor|94|||
16074258|NCT03615924|38763032|FG001|Overall Study|Study termination by Sponsor|86|||
16074259|NCT00436644|38763033|FG000|Overall Study|Adverse Event|2|||
16074260|NCT00436644|38763033|FG000|Overall Study|Death|1|||
16074261|NCT00842257|38763034|FG000|Overall Study|Adverse Event|1|||
16074262|NCT01685606|38763036|FG000|Overall Study|Withdrawal by Subject|1|||
16074263|NCT02026258|38763039|FG000|Randomized|Did not start treatment|2|||
16074264|NCT02026258|38763040|FG001|Randomized|Did not start treatment|1|||
16274404|NCT00105157|39487695|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
16274405|NCT00105157|39487696|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
16274406|NCT00105157|39487697|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
16274407|NCT00105157|39487698|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
16274408|NCT00105157|39487695|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
16274409|NCT00105157|39487696|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
16374255|NCT03810365|39856586|FG001|Overall Study|Withdrawal by Subject|5|||
16374256|NCT00311168|39856592|FG000|First Intervention|Withdrawal by Subject|2|||
16374257|NCT00311168|39856593|FG001|First Intervention|Withdrawal by Subject|2|||
16374258|NCT00311168|39856592|FG000|First Intervention|Lost to Follow-up|1|||
16374259|NCT00311168|39856593|FG001|First Intervention|Lost to Follow-up|1|||
16374260|NCT00311168|39856592|FG000|First Intervention|Protocol Violation|1|||
16374261|NCT00311168|39856593|FG001|First Intervention|Protocol Violation|1|||
16374262|NCT00311168|39856592|FG000|First Intervention|Adverse Event|1|||
16374263|NCT00311168|39856593|FG001|First Intervention|Adverse Event|0|||
16374264|NCT00311168|39856592|FG000|First Intervention|Other|2|||
16374265|NCT00311168|39856593|FG001|First Intervention|Other|2|||
16374266|NCT00311168|39856592|FG000|Second Intervention|Lost to Follow-up|9|||
16374267|NCT00311168|39856593|FG001|Second Intervention|Lost to Follow-up|2|||
16374268|NCT00311168|39856592|FG000|Second Intervention|Withdrawal by Subject|0|||
16374269|NCT00311168|39856593|FG001|Second Intervention|Withdrawal by Subject|1|||
16374270|NCT00311168|39856592|FG000|Second Intervention|Other|1|||
16374271|NCT00311168|39856593|FG001|Second Intervention|Other|1|||
16374272|NCT02837952|39856604|FG000|Overall Study|Adverse Event|0|||
16374273|NCT02837952|39856605|FG001|Overall Study|Adverse Event|1|||
16374274|NCT02837952|39856604|FG000|Overall Study|Withdrawal by Subject|4|||
16374275|NCT02837952|39856605|FG001|Overall Study|Withdrawal by Subject|5|||
16374276|NCT02837952|39856604|FG000|Overall Study|Medication Error|1|||
16374277|NCT02837952|39856605|FG001|Overall Study|Medication Error|0|||
16374278|NCT01362530|39856606|FG000|Base Study (Cycle 1)|Adverse Event|2|||
16374279|NCT01362530|39856607|FG001|Base Study (Cycle 1)|Adverse Event|0|||
16374280|NCT01362530|39856606|FG000|Base Study (Cycle 1)|Physician Decision|0|||
16374281|NCT01362530|39856607|FG001|Base Study (Cycle 1)|Physician Decision|1|||
16374282|NCT01362530|39856606|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
16374283|NCT01362530|39856607|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
16374284|NCT01362530|39856606|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
16374285|NCT01362530|39856607|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
16374286|NCT01362530|39856606|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
16074265|NCT02026258|38763039|FG000|Randomized|Change in treatment plan|1|||
16074266|NCT02026258|38763040|FG001|Randomized|Change in treatment plan|0|||
16074267|NCT02026258|38763039|FG000|Randomized|Presence of periodontal disease|1|||
16074268|NCT02026258|38763040|FG001|Randomized|Presence of periodontal disease|1|||
16074269|NCT02026258|38763039|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
16074270|NCT02026258|38763040|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
16074271|NCT02026258|38763039|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
16173693|NCT03403192|39115231|FG003|Overall Study|Lost to Follow-up|0|||
16173694|NCT03403192|39115228|FG000|Overall Study|Unable to respond|0|||
16374287|NCT01362530|39856607|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
16374288|NCT01362530|39856606|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
16374289|NCT01362530|39856607|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
16473243|NCT00048061|40214420|FG001|Overall Study|Lost to Follow-up|2|||
16473244|NCT00048061|40214421|FG002|Overall Study|Lost to Follow-up|4|||
16074272|NCT02026258|38763040|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
16074273|NCT00410124|38763041|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
16074274|NCT00410124|38763042|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
16074275|NCT00410124|38763041|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
16274410|NCT00105157|39487697|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
16274411|NCT00105157|39487698|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
16274412|NCT02034513|39487699|FG000|Overall Study|Adverse Event|11|||
16274413|NCT02034513|39487700|FG001|Overall Study|Adverse Event|10|||
16274414|NCT02034513|39487699|FG000|Overall Study|Lack of Efficacy|0|||
16274415|NCT02034513|39487700|FG001|Overall Study|Lack of Efficacy|1|||
16274416|NCT02034513|39487699|FG000|Overall Study|Lost to Follow-up|6|||
16274417|NCT02034513|39487700|FG001|Overall Study|Lost to Follow-up|7|||
16274418|NCT02034513|39487699|FG000|Overall Study|Pregnancy|0|||
16274419|NCT02034513|39487700|FG001|Overall Study|Pregnancy|3|||
16274420|NCT02034513|39487699|FG000|Overall Study|Protocol Violation|7|||
16274421|NCT02034513|39487700|FG001|Overall Study|Protocol Violation|10|||
16274422|NCT02034513|39487699|FG000|Overall Study|Withdrawal by Subject|25|||
16274423|NCT02034513|39487700|FG001|Overall Study|Withdrawal by Subject|25|||
16274424|NCT02034513|39487699|FG000|Overall Study|Unclassified|0|||
16274425|NCT02034513|39487700|FG001|Overall Study|Unclassified|1|||
16274426|NCT04531527|39487703|FG000|Overall Study|Found to be Ineligible|3|||
16274427|NCT03867760|39487706|FG000|Overall Study|Lost to Follow-up|2|||
16274428|NCT03867760|39487707|FG001|Overall Study|Lost to Follow-up|3|||
16274429|NCT03867760|39487706|FG000|Overall Study|Withdrawal by Subject|1|||
16274430|NCT03867760|39487707|FG001|Overall Study|Withdrawal by Subject|2|||
16274431|NCT03867760|39487706|FG000|Overall Study|subject could not meet study logistics|3|||
16274432|NCT03867760|39487707|FG001|Overall Study|subject could not meet study logistics|3|||
16074276|NCT00410124|38763042|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
16074277|NCT00410124|38763041|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
16274433|NCT00414726|39487709|FG000|Overall Study|Withdrawal by Subject|0|||
16274434|NCT00414726|39487710|FG001|Overall Study|Withdrawal by Subject|1|||
16274435|NCT02227238|39487714|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
16274436|NCT02227238|39487715|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
16274437|NCT02227238|39487716|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
16274438|NCT02227238|39487714|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
16274439|NCT02227238|39487715|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
16274440|NCT02227238|39487716|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
16274441|NCT02227238|39487714|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
16274442|NCT02227238|39487715|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
16274443|NCT02227238|39487716|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
16274444|NCT02227238|39487714|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
16274445|NCT02227238|39487715|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
16274446|NCT02227238|39487716|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
16274447|NCT02227238|39487714|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
16274448|NCT02227238|39487715|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
16274449|NCT02227238|39487716|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
16274450|NCT02227238|39487714|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
16274451|NCT02227238|39487715|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
16274452|NCT02227238|39487716|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
16274453|NCT02227238|39487714|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
16274454|NCT02227238|39487715|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
16274455|NCT02227238|39487716|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
16274456|NCT02227238|39487714|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
16274457|NCT02227238|39487715|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
16274458|NCT02227238|39487716|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
16274459|NCT02227238|39487714|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
16274460|NCT02227238|39487715|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
16274461|NCT02227238|39487716|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
16274462|NCT02227238|39487714|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
16274463|NCT02227238|39487715|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
16274464|NCT02227238|39487716|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
16274465|NCT02227238|39487714|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
16274466|NCT02227238|39487715|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
16274467|NCT02227238|39487716|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
16274468|NCT02227238|39487714|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
16274469|NCT02227238|39487715|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
16274470|NCT02227238|39487716|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
16274471|NCT02227238|39487714|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
16274472|NCT02227238|39487715|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
16274473|NCT02227238|39487716|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
16274474|NCT02227238|39487714|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
16074278|NCT00410124|38763042|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
16074279|NCT00410124|38763041|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
16274475|NCT02227238|39487715|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
16274476|NCT02227238|39487716|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
16274477|NCT00420095|39487721|FG000|Overall Study|Adverse Event|1|||
16274478|NCT00420095|39487722|FG001|Overall Study|Adverse Event|0|||
16274479|NCT00420095|39487721|FG000|Overall Study|Protocol Violation|1|||
16274480|NCT00420095|39487722|FG001|Overall Study|Protocol Violation|1|||
16274481|NCT00420095|39487721|FG000|Overall Study|Lost to Follow-up|1|||
16274482|NCT00420095|39487722|FG001|Overall Study|Lost to Follow-up|0|||
16274483|NCT00856349|39487726|FG000|Overall Study|Death|418|||
16274484|NCT00856349|39487726|FG000|Overall Study|Withdrawal by Subject|116|||
16074280|NCT00410124|38763042|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
16274485|NCT00856349|39487726|FG000|Overall Study|Lost to Follow-up|91|||
16274486|NCT00856349|39487726|FG000|Overall Study|Protocol Violation|38|||
16274487|NCT00856349|39487726|FG000|Overall Study|Physician Decision|13|||
16274488|NCT00856349|39487726|FG000|Overall Study|Subject relocation|104|||
16274489|NCT00856349|39487726|FG000|Overall Study|Device explant|33|||
16274490|NCT00856349|39487726|FG000|Overall Study|Site closure|78|||
16274491|NCT00856349|39487726|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
16274492|NCT01044433|39490013|FG000|Overall Study|Lost to Follow-up|3|||
16274493|NCT01044433|39490013|FG000|Overall Study|Withdrawal by Subject|3|||
16274494|NCT04476277|39490016|FG000|Overall Study|Withdrawal by Subject|0|||
16274495|NCT04476277|39490017|FG001|Overall Study|Withdrawal by Subject|0|||
16274496|NCT04476277|39490018|FG002|Overall Study|Withdrawal by Subject|1|||
16274497|NCT04476277|39490019|FG003|Overall Study|Withdrawal by Subject|0|||
16274498|NCT00090753|39490020|FG000|First Treatment Period|Adverse Event|20|||
16274499|NCT00090753|39490021|FG001|First Treatment Period|Adverse Event|8|||
16274500|NCT00090753|39490020|FG000|First Treatment Period|Death|88|||
16274501|NCT00090753|39490021|FG001|First Treatment Period|Death|62|||
16274502|NCT00090753|39490020|FG000|First Treatment Period|Lack of Efficacy|2|||
16274503|NCT00090753|39490021|FG001|First Treatment Period|Lack of Efficacy|1|||
16274504|NCT00090753|39490020|FG000|First Treatment Period|Refused Treatment|32|||
16274505|NCT00090753|39490021|FG001|First Treatment Period|Refused Treatment|25|||
16074281|NCT00410124|38763041|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
16074282|NCT00410124|38763042|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
16074283|NCT00410124|38763041|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
16074284|NCT00410124|38763042|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
16074285|NCT00410124|38763041|FG000|Core Phase Double Blind (15 Months)|Death|7|||
16074286|NCT00410124|38763042|FG001|Core Phase Double Blind (15 Months)|Death|4|||
16074287|NCT00410124|38763041|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
16074288|NCT00410124|38763042|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
16074289|NCT00410124|38763041|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
16074290|NCT00410124|38763042|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
16074291|NCT00410124|38763041|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
16074292|NCT00410124|38763042|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
16074293|NCT00410124|38763041|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
16074294|NCT00410124|38763042|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
16074295|NCT00410124|38763041|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
16074296|NCT00410124|38763042|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
16074297|NCT00410124|38763041|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
16074298|NCT00410124|38763042|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
16074299|NCT00410124|38763041|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
16074300|NCT00410124|38763042|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
16074301|NCT00410124|38763041|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
16074302|NCT00410124|38763042|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
16074303|NCT00410124|38763041|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
16074304|NCT00410124|38763042|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
16074305|NCT02412748|38763043|FG000|Overall Study|Lost to Follow-up|38|||
16074306|NCT02412748|38763044|FG001|Overall Study|Lost to Follow-up|39|||
16074307|NCT01196429|38763046|FG000|Overall Study|Ineligible - inadequate pathology|1|||
16274506|NCT00090753|39490020|FG000|First Treatment Period|Lost to Follow-up|4|||
16274507|NCT00090753|39490021|FG001|First Treatment Period|Lost to Follow-up|4|||
16274508|NCT00090753|39490020|FG000|First Treatment Period|Renal Transplant|70|||
16274509|NCT00090753|39490021|FG001|First Treatment Period|Renal Transplant|50|||
16274510|NCT00090753|39490020|FG000|First Treatment Period|Mircera Commercialization|1|||
16274511|NCT00090753|39490021|FG001|First Treatment Period|Mircera Commercialization|0|||
16274512|NCT00090753|39490020|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
16274513|NCT00090753|39490021|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
16074308|NCT01196429|38763047|FG001|Overall Study|Ineligible - inadequate pathology|0|||
16274514|NCT00090753|39490020|FG000|Extended Treatment Period|Adverse Event|11|||
16074309|NCT01196429|38763046|FG000|Overall Study|Ineligible - wrong cell type|1|||
16074310|NCT01196429|38763047|FG001|Overall Study|Ineligible - wrong cell type|0|||
16274515|NCT00090753|39490021|FG001|Extended Treatment Period|Adverse Event|0|||
16274516|NCT00090753|39490020|FG000|Extended Treatment Period|Death|58|||
16274517|NCT00090753|39490021|FG001|Extended Treatment Period|Death|30|||
16274518|NCT00090753|39490020|FG000|Extended Treatment Period|Lack of Efficacy|1|||
16274519|NCT00090753|39490021|FG001|Extended Treatment Period|Lack of Efficacy|0|||
16274520|NCT00090753|39490020|FG000|Extended Treatment Period|Refused Treatment|18|||
16274521|NCT00090753|39490021|FG001|Extended Treatment Period|Refused Treatment|12|||
16274522|NCT00090753|39490020|FG000|Extended Treatment Period|Lost to Follow-up|3|||
16074311|NCT01196429|38763046|FG000|Overall Study|Refused - Never Treated|1|||
16074312|NCT01196429|38763047|FG001|Overall Study|Refused - Never Treated|0|||
16074313|NCT03546907|38763048|FG000|Overall Study|Lack of Efficacy|1|||
16074314|NCT03546907|38763049|FG001|Overall Study|Lack of Efficacy|1|||
16074315|NCT03546907|38763048|FG000|Overall Study|Withdrawal by Subject|8|||
16074316|NCT03546907|38763049|FG001|Overall Study|Withdrawal by Subject|9|||
16074317|NCT03546907|38763048|FG000|Overall Study|Adverse events (AEs)|7|||
16074318|NCT03546907|38763049|FG001|Overall Study|Adverse events (AEs)|10|||
16074319|NCT03546907|38763048|FG000|Overall Study|Other-unspecified|1|||
16074320|NCT03546907|38763049|FG001|Overall Study|Other-unspecified|1|||
16074321|NCT02524288|38763054|FG000|Overall Study|Adverse Event|115|||
16074322|NCT02524288|38763054|FG000|Overall Study|Lost to Follow-up|216|||
16074323|NCT02524288|38763054|FG000|Overall Study|Non-Compliance With Protocol|32|||
16074324|NCT02524288|38763054|FG000|Overall Study|Non-Compliance With Study Drug|14|||
16074325|NCT02524288|38763054|FG000|Overall Study|Pregnancy Wish|6|||
16274523|NCT00090753|39490021|FG001|Extended Treatment Period|Lost to Follow-up|1|||
16374290|NCT01362530|39856606|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
16074326|NCT02524288|38763054|FG000|Overall Study|Protocol Violation|6|||
16074327|NCT02524288|38763054|FG000|Overall Study|Screen Failure|2|||
16074328|NCT02524288|38763054|FG000|Overall Study|Site Discontinued Study Participation|1|||
16074329|NCT02524288|38763054|FG000|Overall Study|Study Terminated By Sponsor|1417|||
16074330|NCT02524288|38763054|FG000|Overall Study|Subject Moved|32|||
16374291|NCT01362530|39856607|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
16374292|NCT01362530|39856606|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
16374293|NCT01362530|39856607|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
16374294|NCT01362530|39856606|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
16374295|NCT01362530|39856607|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
16374296|NCT01362530|39856606|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
16374297|NCT01362530|39856607|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
16374298|NCT01362530|39856606|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
16374299|NCT01362530|39856607|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
16374300|NCT01362530|39856606|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
16374301|NCT01362530|39856607|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
16374302|NCT01362530|39856606|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
16374303|NCT01362530|39856607|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
16374304|NCT03211832|39856611|FG000|Overall Study|No longer with agency|32|||
16374305|NCT03211832|39856612|FG001|Overall Study|No longer with agency|49|||
16374306|NCT03211832|39856613|FG002|Overall Study|No longer with agency|30|||
16374307|NCT03211832|39856611|FG000|Overall Study|Declined survey|3|||
16374308|NCT03211832|39856612|FG001|Overall Study|Declined survey|3|||
16374309|NCT03211832|39856613|FG002|Overall Study|Declined survey|2|||
16374310|NCT03211832|39856611|FG000|Overall Study|Not available during data collection|1|||
16374311|NCT03211832|39856612|FG001|Overall Study|Not available during data collection|0|||
16374312|NCT03211832|39856613|FG002|Overall Study|Not available during data collection|2|||
16374313|NCT01341990|39856614|FG000|Overall Study|Adverse Event|0|||
16374314|NCT01341990|39856615|FG001|Overall Study|Adverse Event|1|||
16374315|NCT01341990|39856614|FG000|Overall Study|Torn Study Lens|1|||
16374316|NCT01341990|39856615|FG001|Overall Study|Torn Study Lens|0|||
16374317|NCT01341990|39856614|FG000|Overall Study|Withdrawal by Subject|2|||
16374318|NCT01341990|39856615|FG001|Overall Study|Withdrawal by Subject|0|||
16374319|NCT05122143|39856619|FG000|Overall Study|Adverse Event|1|||
16074331|NCT02524288|38763054|FG000|Overall Study|Withdrawal by Subject|76|||
16074332|NCT02524288|38763054|FG000|Overall Study|Pregnancy|22|||
16074333|NCT02524288|38763054|FG000|Overall Study|Physician Decision|2|||
16274524|NCT00090753|39490020|FG000|Extended Treatment Period|Renal Transplant|15|||
16274525|NCT00090753|39490021|FG001|Extended Treatment Period|Renal Transplant|12|||
16274526|NCT00090753|39490020|FG000|Extended Treatment Period|Mircera Commercialization|188|||
16374320|NCT05122143|39856620|FG001|Overall Study|Adverse Event|0|||
16374321|NCT05122143|39856621|FG002|Overall Study|Adverse Event|0|||
16374322|NCT05122143|39856622|FG003|Overall Study|Adverse Event|0|||
16074334|NCT04567888|38763058|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
16173695|NCT03403192|39115229|FG001|Overall Study|Unable to respond|1|||
16173696|NCT03403192|39115230|FG002|Overall Study|Unable to respond|0|||
16374323|NCT05122143|39856623|FG004|Overall Study|Adverse Event|1|||
16374324|NCT05122143|39856624|FG005|Overall Study|Adverse Event|0|||
16374325|NCT05122143|39856619|FG000|Overall Study|Protocol non-compliance|0|||
16374326|NCT05122143|39856620|FG001|Overall Study|Protocol non-compliance|0|||
16374327|NCT05122143|39856621|FG002|Overall Study|Protocol non-compliance|1|||
16074335|NCT04567888|38763059|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
16074336|NCT04567888|38763058|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
16074337|NCT04567888|38763059|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
16074338|NCT04567888|38763058|FG000|Overall Study|Reported Unusual Birth Year|2|||
16074339|NCT04567888|38763059|FG001|Overall Study|Reported Unusual Birth Year|3|||
16074340|NCT04567888|38763058|FG000|Overall Study|Duplicate Responses|0|||
16074341|NCT04567888|38763059|FG001|Overall Study|Duplicate Responses|1|||
16074342|NCT04480827|38763060|FG000|Overall Study|Adverse Event|0|||
16074343|NCT04480827|38763061|FG001|Overall Study|Adverse Event|0|||
16074344|NCT04480827|38763062|FG002|Overall Study|Adverse Event|0|||
16074345|NCT04480827|38763063|FG003|Overall Study|Adverse Event|0|||
16074346|NCT04480827|38763064|FG004|Overall Study|Adverse Event|0|||
16374328|NCT05122143|39856622|FG003|Overall Study|Protocol non-compliance|0|||
16374329|NCT05122143|39856623|FG004|Overall Study|Protocol non-compliance|0|||
16374330|NCT05122143|39856624|FG005|Overall Study|Protocol non-compliance|0|||
16374331|NCT05122143|39856619|FG000|Overall Study|Covid contact|0|||
16074347|NCT04480827|38763065|FG005|Overall Study|Adverse Event|1|||
16074348|NCT04480827|38763066|FG006|Overall Study|Adverse Event|0|||
16074349|NCT03895034|38763069|FG000|Overall Study|Lost to Follow-up|2|||
16074350|NCT00943735|38763070|FG000|Overall Study|Adverse Event|12|||
16274527|NCT00090753|39490021|FG001|Extended Treatment Period|Mircera Commercialization|93|||
16274528|NCT00090753|39490020|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
16274529|NCT00090753|39490021|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
16074351|NCT00943735|38763070|FG000|Overall Study|Withdrawal by Subject|8|||
16074352|NCT00943735|38763070|FG000|Overall Study|Death|1|||
16074353|NCT00943735|38763070|FG000|Overall Study|Other|8|||
16074354|NCT00943735|38763070|FG000|Overall Study|Other|3|||
16074355|NCT01943799|38763071|FG000|Overall Study|Lost to Follow-up|0|||
16074356|NCT01943799|38763072|FG001|Overall Study|Lost to Follow-up|1|||
16074357|NCT01943799|38763073|FG002|Overall Study|Lost to Follow-up|1|||
16074358|NCT01943799|38763074|FG003|Overall Study|Lost to Follow-up|0|||
16074359|NCT01943799|38763071|FG000|Overall Study|Protocol Violation|1|||
16074360|NCT01943799|38763072|FG001|Overall Study|Protocol Violation|0|||
16074361|NCT01943799|38763073|FG002|Overall Study|Protocol Violation|0|||
16074362|NCT01943799|38763074|FG003|Overall Study|Protocol Violation|0|||
16074363|NCT01943799|38763071|FG000|Overall Study|Withdrawal by Subject|4|||
16074364|NCT01943799|38763072|FG001|Overall Study|Withdrawal by Subject|2|||
16074365|NCT01943799|38763073|FG002|Overall Study|Withdrawal by Subject|1|||
16074366|NCT01943799|38763074|FG003|Overall Study|Withdrawal by Subject|0|||
16074367|NCT00868192|38763079|FG000|Overall Study|Ineligible|4|||
16074368|NCT02955069|38763080|FG000|Overall Study|Adverse Event|7|||
16074369|NCT02955069|38763081|FG001|Overall Study|Adverse Event|2|||
16074370|NCT02955069|38763080|FG000|Overall Study|Death|7|||
16374332|NCT05122143|39856620|FG001|Overall Study|Covid contact|0|||
16274530|NCT01808248|39490022|FG000|Overall Study|Lack of Efficacy|3|||
16274531|NCT01808248|39490022|FG000|Overall Study|Withdrawal by Subject|1|||
16274532|NCT01808248|39490022|FG000|Overall Study|Lost to Follow-up|1|||
16274533|NCT03343639|39490026|FG000|Overall Study|Withdrawal by Subject|10|||
16274534|NCT03343639|39490027|FG001|Overall Study|Withdrawal by Subject|6|||
16274535|NCT03343639|39490026|FG000|Overall Study|Lost to Follow-up|4|||
16274536|NCT03343639|39490027|FG001|Overall Study|Lost to Follow-up|5|||
16274537|NCT03343639|39490026|FG000|Overall Study|Protocol Violation|0|||
16074371|NCT02955069|38763081|FG001|Overall Study|Death|3|||
16274538|NCT03343639|39490027|FG001|Overall Study|Protocol Violation|1|||
16274539|NCT03108820|39490028|FG000|Overall Study|Lost to Follow-up|30|||
16274540|NCT03108820|39490029|FG001|Overall Study|Lost to Follow-up|28|||
16374333|NCT05122143|39856621|FG002|Overall Study|Covid contact|0|||
16074372|NCT02955069|38763080|FG000|Overall Study|Physician Decision|10|||
16074373|NCT02955069|38763081|FG001|Overall Study|Physician Decision|2|||
16074374|NCT02955069|38763080|FG000|Overall Study|Progressive disease|64|||
16074375|NCT02955069|38763081|FG001|Overall Study|Progressive disease|13|||
16074376|NCT02955069|38763080|FG000|Overall Study|Study terminated by sponsor|4|||
16274541|NCT03108820|39490028|FG000|Overall Study|Withdrawal by Subject|32|||
16374334|NCT05122143|39856622|FG003|Overall Study|Covid contact|0|||
16374335|NCT05122143|39856623|FG004|Overall Study|Covid contact|1|||
16374336|NCT05122143|39856624|FG005|Overall Study|Covid contact|0|||
16374337|NCT02715856|39856625|FG000|Overall Study|Software Issues|12|||
16074377|NCT02955069|38763081|FG001|Overall Study|Study terminated by sponsor|0|||
16074378|NCT02955069|38763080|FG000|Overall Study|Subject/Guardian decision|3|||
16074379|NCT02955069|38763081|FG001|Overall Study|Subject/Guardian decision|1|||
16074380|NCT04128319|38763082|FG000|Overall Study|Death|3|||
16274542|NCT03108820|39490029|FG001|Overall Study|Withdrawal by Subject|24|||
16274543|NCT03108820|39490028|FG000|Overall Study|Death|6|||
16274544|NCT03108820|39490029|FG001|Overall Study|Death|11|||
16274545|NCT01928615|39490030|FG000|Overall Study|Study Terminated by Sponsor|2|||
16274546|NCT01256060|39490038|FG000|Overall Study|Lost to Follow-up|0|||
16274547|NCT01256060|39490039|FG001|Overall Study|Lost to Follow-up|1|||
16274548|NCT01256060|39490040|FG002|Overall Study|Lost to Follow-up|0|||
16274549|NCT01256060|39490041|FG003|Overall Study|Lost to Follow-up|0|||
16274550|NCT01949532|39490046|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
16274551|NCT01949532|39490047|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
16274552|NCT02845336|39490053|FG000|Overall Study|Lost to Follow-up|3|||
16274553|NCT02845336|39490054|FG001|Overall Study|Lost to Follow-up|1|||
16274554|NCT02845336|39490053|FG000|Overall Study|Inability to get medication|2|||
16274555|NCT02845336|39490054|FG001|Overall Study|Inability to get medication|0|||
16274556|NCT01968031|39490056|FG000|Overall Study|Adverse Event|13|||
16274557|NCT01968031|39490057|FG001|Overall Study|Adverse Event|10|||
16274558|NCT01968031|39490058|FG002|Overall Study|Adverse Event|22|||
16274559|NCT01968031|39490056|FG000|Overall Study|Withdrawal by Subject|3|||
16274560|NCT01968031|39490057|FG001|Overall Study|Withdrawal by Subject|7|||
16274561|NCT01968031|39490058|FG002|Overall Study|Withdrawal by Subject|3|||
16274562|NCT01968031|39490056|FG000|Overall Study|Did not meet entry criteria|1|||
16074381|NCT02031471|38763083|FG000|24 Week Treatment Period|Adverse Event|6|||
16074382|NCT02031471|38763083|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
16074383|NCT02031471|38763083|FG000|24 Week Treatment Period|Protocol Violation|1|||
16074384|NCT02031471|38763083|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
16074385|NCT02031471|38763083|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
16074386|NCT02031471|38763083|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
16074387|NCT02031471|38763083|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
16074388|NCT03804918|38763086|FG000|Overall Study|Participant did not use the app|1|||
16074389|NCT02020616|38763087|FG000|Overall Study|Adverse Event|0|||
16074390|NCT02020616|38763088|FG001|Overall Study|Adverse Event|0|||
16074391|NCT02020616|38763089|FG002|Overall Study|Adverse Event|0|||
16074392|NCT02020616|38763090|FG003|Overall Study|Adverse Event|0|||
16074393|NCT02020616|38763091|FG004|Overall Study|Adverse Event|0|||
16074394|NCT02020616|38763092|FG005|Overall Study|Adverse Event|1|||
16074395|NCT02020616|38763093|FG006|Overall Study|Adverse Event|1|||
16074396|NCT02020616|38763087|FG000|Overall Study|Physician Decision|0|||
16074397|NCT02020616|38763088|FG001|Overall Study|Physician Decision|0|||
16074398|NCT02020616|38763089|FG002|Overall Study|Physician Decision|0|||
16074399|NCT02020616|38763090|FG003|Overall Study|Physician Decision|0|||
16074400|NCT02020616|38763091|FG004|Overall Study|Physician Decision|0|||
16074401|NCT02020616|38763092|FG005|Overall Study|Physician Decision|1|||
16074402|NCT02020616|38763093|FG006|Overall Study|Physician Decision|2|||
16074403|NCT02020616|38763087|FG000|Overall Study|Withdrawal by Subject|0|||
16074404|NCT02020616|38763088|FG001|Overall Study|Withdrawal by Subject|0|||
16074405|NCT02020616|38763089|FG002|Overall Study|Withdrawal by Subject|1|||
16074406|NCT02020616|38763090|FG003|Overall Study|Withdrawal by Subject|0|||
16074407|NCT02020616|38763091|FG004|Overall Study|Withdrawal by Subject|0|||
16074408|NCT02020616|38763092|FG005|Overall Study|Withdrawal by Subject|1|||
16074409|NCT02020616|38763093|FG006|Overall Study|Withdrawal by Subject|1|||
16074410|NCT02020616|38763087|FG000|Overall Study|Lost to Follow-up|0|||
16074411|NCT02020616|38763088|FG001|Overall Study|Lost to Follow-up|1|||
16074412|NCT02020616|38763089|FG002|Overall Study|Lost to Follow-up|0|||
16074413|NCT02020616|38763090|FG003|Overall Study|Lost to Follow-up|1|||
16074414|NCT02020616|38763091|FG004|Overall Study|Lost to Follow-up|1|||
16074415|NCT02020616|38763092|FG005|Overall Study|Lost to Follow-up|1|||
16074416|NCT02020616|38763093|FG006|Overall Study|Lost to Follow-up|0|||
16074417|NCT02020616|38763087|FG000|Overall Study|Early Termination Criteria Met|0|||
16074418|NCT02020616|38763088|FG001|Overall Study|Early Termination Criteria Met|0|||
16074419|NCT02020616|38763089|FG002|Overall Study|Early Termination Criteria Met|1|||
16074420|NCT02020616|38763090|FG003|Overall Study|Early Termination Criteria Met|0|||
16074421|NCT02020616|38763091|FG004|Overall Study|Early Termination Criteria Met|0|||
16074422|NCT02020616|38763092|FG005|Overall Study|Early Termination Criteria Met|1|||
16074423|NCT02020616|38763093|FG006|Overall Study|Early Termination Criteria Met|0|||
16074424|NCT02020616|38763087|FG000|Overall Study|Randomized in Error|0|||
16074425|NCT02020616|38763088|FG001|Overall Study|Randomized in Error|0|||
16074426|NCT02020616|38763089|FG002|Overall Study|Randomized in Error|0|||
16074427|NCT02020616|38763090|FG003|Overall Study|Randomized in Error|1|||
16074428|NCT02020616|38763091|FG004|Overall Study|Randomized in Error|0|||
16074429|NCT02020616|38763092|FG005|Overall Study|Randomized in Error|0|||
16274563|NCT01968031|39490057|FG001|Overall Study|Did not meet entry criteria|1|||
16274564|NCT01968031|39490058|FG002|Overall Study|Did not meet entry criteria|1|||
16074430|NCT02020616|38763093|FG006|Overall Study|Randomized in Error|0|||
16074431|NCT02020616|38763087|FG000|Overall Study|Lack of Efficacy|0|||
16274565|NCT01968031|39490056|FG000|Overall Study|Noncompliance|0|||
16074432|NCT02020616|38763088|FG001|Overall Study|Lack of Efficacy|0|||
16074433|NCT02020616|38763089|FG002|Overall Study|Lack of Efficacy|0|||
16074434|NCT02020616|38763090|FG003|Overall Study|Lack of Efficacy|0|||
16274566|NCT01968031|39490057|FG001|Overall Study|Noncompliance|0|||
16074435|NCT02020616|38763091|FG004|Overall Study|Lack of Efficacy|1|||
16074436|NCT02020616|38763092|FG005|Overall Study|Lack of Efficacy|0|||
16074437|NCT02020616|38763093|FG006|Overall Study|Lack of Efficacy|0|||
16074438|NCT02045836|38763099|FG000|Overall Study|Adverse Event|4|||
16074439|NCT02045836|38763100|FG001|Overall Study|Adverse Event|4|||
16074440|NCT02045836|38763099|FG000|Overall Study|Withdrawal by Subject|1|||
16074441|NCT02045836|38763100|FG001|Overall Study|Withdrawal by Subject|1|||
16074442|NCT02045836|38763099|FG000|Overall Study|Lost to Follow-up|4|||
16074443|NCT02045836|38763100|FG001|Overall Study|Lost to Follow-up|7|||
16074444|NCT02045836|38763099|FG000|Overall Study|Migrated from study area|0|||
16074445|NCT02045836|38763100|FG001|Overall Study|Migrated from study area|2|||
16074446|NCT03394027|38763105|FG000|Overall Study|Ineligible|3|||
16074447|NCT03394027|38763106|FG001|Overall Study|Ineligible|1|||
16074448|NCT03394027|38763107|FG002|Overall Study|Ineligible|3|||
16074449|NCT03394027|38763105|FG000|Overall Study|Participant declined to participate before treatment started|0|||
16074450|NCT03394027|38763106|FG001|Overall Study|Participant declined to participate before treatment started|0|||
16074451|NCT03394027|38763107|FG002|Overall Study|Participant declined to participate before treatment started|1|||
16074452|NCT01505881|38763108|FG000|Overall Study|Adverse Event|0|||
16074453|NCT01505881|38763109|FG001|Overall Study|Adverse Event|1|||
16374338|NCT02715856|39856626|FG001|Overall Study|Software Issues|7|||
16374339|NCT02715856|39856625|FG000|Overall Study|Death|6|||
16374340|NCT02715856|39856626|FG001|Overall Study|Death|5|||
16074454|NCT01505881|38763108|FG000|Overall Study|Lost to Follow-up|2|||
16074455|NCT01505881|38763109|FG001|Overall Study|Lost to Follow-up|0|||
16074456|NCT01505881|38763108|FG000|Overall Study|Withdrawal by Subject|2|||
16074457|NCT01505881|38763109|FG001|Overall Study|Withdrawal by Subject|0|||
16074458|NCT01121549|38763117|FG000|Overall Study|Adverse Event|10|||
16074459|NCT01121549|38763117|FG000|Overall Study|Lack of Efficacy|11|||
16074460|NCT01121549|38763117|FG000|Overall Study|Lost to Follow-up|12|||
16074461|NCT01121549|38763117|FG000|Overall Study|Did not meet entrance criteria|9|||
16074462|NCT01121549|38763117|FG000|Overall Study|Study terminated by sponsor|197|||
16074463|NCT01121549|38763117|FG000|Overall Study|Pregnancy|1|||
16074464|NCT01121549|38763117|FG000|Overall Study|Protocol Violation|33|||
16374341|NCT02715856|39856625|FG000|Overall Study|Non- Compliant|0|||
16074465|NCT01121549|38763117|FG000|Overall Study|Withdrawal by Subject|16|||
16074466|NCT01121549|38763117|FG000|Overall Study|Other|58|||
16074467|NCT01597258|38763121|FG000|Overall Study|No Drug Administration|1|||
16074468|NCT04594759|38763122|FG000|Overall Study|Lost to Follow-up|3|||
16074469|NCT03008915|38763123|FG000|Treatment 1|Withdrawal by Subject|0|||
16074470|NCT03008915|38763124|FG001|Treatment 1|Withdrawal by Subject|1|||
16074471|NCT01585558|38763125|FG000|Overall Study|Withdrawal by Subject|4|||
16074472|NCT01585558|38763126|FG001|Overall Study|Withdrawal by Subject|5|||
16074473|NCT01585558|38763127|FG002|Overall Study|Withdrawal by Subject|8|||
16074474|NCT01585558|38763125|FG000|Overall Study|Lost to Follow-up|2|||
16074475|NCT01585558|38763126|FG001|Overall Study|Lost to Follow-up|0|||
16074476|NCT01585558|38763127|FG002|Overall Study|Lost to Follow-up|3|||
16074477|NCT01585558|38763125|FG000|Overall Study|Adverse Event|3|||
16074478|NCT01585558|38763126|FG001|Overall Study|Adverse Event|4|||
16074479|NCT01585558|38763127|FG002|Overall Study|Adverse Event|1|||
16074480|NCT01585558|38763125|FG000|Overall Study|Protocol Violation|4|||
16074481|NCT01585558|38763126|FG001|Overall Study|Protocol Violation|3|||
16074482|NCT01585558|38763127|FG002|Overall Study|Protocol Violation|2|||
16074483|NCT01585558|38763125|FG000|Overall Study|Lack of Efficacy|0|||
16074484|NCT01585558|38763126|FG001|Overall Study|Lack of Efficacy|0|||
16074485|NCT01585558|38763127|FG002|Overall Study|Lack of Efficacy|1|||
16074486|NCT02104765|38763131|FG000|Overall Study|Lost to Follow-up|0|||
16074487|NCT02104765|38763132|FG001|Overall Study|Lost to Follow-up|0|||
16074488|NCT02104765|38763133|FG002|Overall Study|Lost to Follow-up|1|||
16074489|NCT02104765|38763134|FG003|Overall Study|Lost to Follow-up|0|||
16074490|NCT02104765|38763135|FG004|Overall Study|Lost to Follow-up|0|||
16074491|NCT02104765|38763136|FG005|Overall Study|Lost to Follow-up|0|||
16374342|NCT02715856|39856626|FG001|Overall Study|Non- Compliant|40|||
16374343|NCT00003907|39856627|FG000|Overall Study|Adverse Event|2|||
16374344|NCT00003907|39856628|FG001|Overall Study|Adverse Event|11|||
16074492|NCT02104765|38763137|FG006|Overall Study|Lost to Follow-up|0|||
16074493|NCT02104765|38763131|FG000|Overall Study|Withdrawal by Subject|0|||
16074494|NCT02104765|38763132|FG001|Overall Study|Withdrawal by Subject|0|||
16074495|NCT02104765|38763133|FG002|Overall Study|Withdrawal by Subject|0|||
16074496|NCT02104765|38763134|FG003|Overall Study|Withdrawal by Subject|1|||
16074497|NCT02104765|38763135|FG004|Overall Study|Withdrawal by Subject|1|||
16074498|NCT02104765|38763136|FG005|Overall Study|Withdrawal by Subject|0|||
16074499|NCT02104765|38763137|FG006|Overall Study|Withdrawal by Subject|1|||
16074500|NCT05274217|38763158|FG000|Overall Study|Study terminated.|11|||
16074501|NCT05274217|38763159|FG001|Overall Study|Study terminated.|0|||
16374345|NCT00003907|39856627|FG000|Overall Study|Death|2|||
16074502|NCT02770248|38763160|FG000|Overall Study|Adverse Event|0|||
16074503|NCT02770248|38763161|FG001|Overall Study|Adverse Event|1|||
16374346|NCT00003907|39856628|FG001|Overall Study|Death|0|||
16374347|NCT00003907|39856627|FG000|Overall Study|Withdrawal by Subject|1|||
16074504|NCT02770248|38763160|FG000|Overall Study|Randomized in error, prior to treatment|0|||
16074505|NCT02770248|38763161|FG001|Overall Study|Randomized in error, prior to treatment|1|||
16074506|NCT04504916|38763162|FG000|Overall Study|Study terminated|7|||
16074507|NCT04504916|38763163|FG001|Overall Study|Study terminated|8|||
16074508|NCT04504916|38763162|FG000|Overall Study|Death|54|||
16074509|NCT04504916|38763163|FG001|Overall Study|Death|18|||
16374348|NCT00003907|39856628|FG001|Overall Study|Withdrawal by Subject|3|||
16374349|NCT00003907|39856627|FG000|Overall Study|Progressive disease|4|||
16374350|NCT00003907|39856628|FG001|Overall Study|Progressive disease|4|||
16374351|NCT00003907|39856627|FG000|Overall Study|Complicating disease|1|||
16374352|NCT00003907|39856628|FG001|Overall Study|Complicating disease|0|||
16374353|NCT00003907|39856627|FG000|Overall Study|Other|1|||
16374354|NCT00003907|39856628|FG001|Overall Study|Other|3|||
16374355|NCT00003907|39856627|FG000|Overall Study|ineligible or not treated|2|||
16274567|NCT01968031|39490058|FG002|Overall Study|Noncompliance|2|||
16274568|NCT01968031|39490056|FG000|Overall Study|Failed inclusion criteria|0|||
16274569|NCT01968031|39490057|FG001|Overall Study|Failed inclusion criteria|2|||
16274570|NCT01968031|39490058|FG002|Overall Study|Failed inclusion criteria|0|||
16274571|NCT01968031|39490056|FG000|Overall Study|Death|0|||
16274572|NCT01968031|39490057|FG001|Overall Study|Death|0|||
16274573|NCT01968031|39490058|FG002|Overall Study|Death|1|||
16274574|NCT01968031|39490056|FG000|Overall Study|Prohibited concomitant medication|1|||
16274575|NCT01968031|39490057|FG001|Overall Study|Prohibited concomitant medication|0|||
16274576|NCT01968031|39490058|FG002|Overall Study|Prohibited concomitant medication|0|||
16274577|NCT01964950|39490059|FG000|Overall Study|Protocol Violation|25|||
16374356|NCT00003907|39856628|FG001|Overall Study|ineligible or not treated|2|||
16274578|NCT05665387|39490060|FG000|Overall Study|Withdrawal by Subject|1|||
16374357|NCT01975285|39856629|FG000|Overall Study|Failed Block and follow up|2|||
16374358|NCT01975285|39856630|FG001|Overall Study|Failed Block and follow up|2|||
16374359|NCT00787800|39856631|FG000|Overall Study|Withdrawal by Subject|3|||
16374360|NCT00787800|39856632|FG001|Overall Study|Withdrawal by Subject|5|||
16374361|NCT00787800|39856631|FG000|Overall Study|Death|0|||
16374362|NCT00787800|39856632|FG001|Overall Study|Death|2|||
16374363|NCT02462057|39856633|FG000|Overall Study|Left Vitality|32|||
16374364|NCT02462057|39856634|FG001|Overall Study|Left Vitality|27|||
16374365|NCT02462057|39856635|FG002|Overall Study|Left Vitality|23|||
16374366|NCT02462057|39856636|FG003|Overall Study|Left Vitality|35|||
16374367|NCT02462057|39856637|FG004|Overall Study|Left Vitality|33|||
16374368|NCT02462057|39856633|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
16374369|NCT02462057|39856634|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
16374370|NCT02462057|39856635|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
16374371|NCT02462057|39856636|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
16274579|NCT05665387|39490061|FG001|Overall Study|Withdrawal by Subject|0|||
16274580|NCT05665387|39490062|FG002|Overall Study|Withdrawal by Subject|1|||
16274581|NCT01198873|39490065|FG000|Overall Study|Adverse Event|4|||
16274582|NCT01198873|39490066|FG001|Overall Study|Adverse Event|7|||
16274583|NCT01198873|39490065|FG000|Overall Study|Study closure|29|||
16274584|NCT01198873|39490066|FG001|Overall Study|Study closure|23|||
16274585|NCT01198873|39490065|FG000|Overall Study|Other than above|4|||
16374372|NCT02462057|39856637|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
16374373|NCT00215657|39856641|FG000|Overall Study|Adverse Event|5|||
16374374|NCT00215657|39856642|FG001|Overall Study|Adverse Event|1|||
16374375|NCT00215657|39856643|FG002|Overall Study|Adverse Event|3|||
16074510|NCT04504916|38763162|FG000|Overall Study|Lost to Follow-up|1|||
16274586|NCT01198873|39490066|FG001|Overall Study|Other than above|2|||
16274587|NCT01507662|39490068|FG000|Overall Study|Death|26|||
16274588|NCT01507662|39490069|FG001|Overall Study|Death|18|||
16274589|NCT01507662|39490068|FG000|Overall Study|Withdrawal by Subject|290|||
16274590|NCT01507662|39490069|FG001|Overall Study|Withdrawal by Subject|287|||
16274591|NCT01507662|39490068|FG000|Overall Study|Lost to Follow-up|498|||
16274592|NCT01507662|39490069|FG001|Overall Study|Lost to Follow-up|523|||
16274593|NCT01507662|39490068|FG000|Overall Study|Proxy interview done|2|||
16274594|NCT01507662|39490069|FG001|Overall Study|Proxy interview done|3|||
16274595|NCT02933060|39490072|FG000|Overall Study|Withdrawal by Subject|0|||
16274596|NCT02933060|39490073|FG001|Overall Study|Withdrawal by Subject|1|||
16074511|NCT04504916|38763163|FG001|Overall Study|Lost to Follow-up|1|||
16274597|NCT04404725|39490074|FG000|First Intervention|Withdrawal by Subject|0|||
16374376|NCT00215657|39856644|FG003|Overall Study|Adverse Event|0|||
16374377|NCT00215657|39856645|FG004|Overall Study|Adverse Event|3|||
16374378|NCT00215657|39856646|FG005|Overall Study|Adverse Event|1|||
16274598|NCT04404725|39490075|FG001|First Intervention|Withdrawal by Subject|2|||
16374379|NCT00215657|39856647|FG006|Overall Study|Adverse Event|0|||
16374380|NCT00215657|39856648|FG007|Overall Study|Adverse Event|3|||
16374381|NCT00215657|39856641|FG000|Overall Study|Withdrawal by Subject|6|||
16274599|NCT04404725|39490074|FG000|Second Intervention|Adverse Event|1|||
16274600|NCT04404725|39490075|FG001|Second Intervention|Adverse Event|1|||
16074512|NCT04504916|38763162|FG000|Overall Study|Withdrawal by Subject|8|||
16274601|NCT04404725|39490074|FG000|Second Intervention|Withdrawal by Subject|0|||
16374382|NCT00215657|39856642|FG001|Overall Study|Withdrawal by Subject|3|||
16374383|NCT00215657|39856643|FG002|Overall Study|Withdrawal by Subject|3|||
16374384|NCT00215657|39856644|FG003|Overall Study|Withdrawal by Subject|1|||
16374385|NCT00215657|39856645|FG004|Overall Study|Withdrawal by Subject|6|||
16374386|NCT00215657|39856646|FG005|Overall Study|Withdrawal by Subject|1|||
16374387|NCT00215657|39856647|FG006|Overall Study|Withdrawal by Subject|10|||
16274602|NCT04404725|39490075|FG001|Second Intervention|Withdrawal by Subject|1|||
16274603|NCT02661022|39490082|FG000|Overall Study|Withdrawal by Subject|3|||
16274604|NCT02661022|39490083|FG001|Overall Study|Withdrawal by Subject|0|||
16274605|NCT02661022|39490082|FG000|Overall Study|Adverse Event|1|||
16274606|NCT02661022|39490083|FG001|Overall Study|Adverse Event|1|||
16274607|NCT02661022|39490082|FG000|Overall Study|Physician Decision|1|||
16274608|NCT02661022|39490083|FG001|Overall Study|Physician Decision|0|||
16274609|NCT02661022|39490082|FG000|Overall Study|Progressive Disease|2|||
16274610|NCT02661022|39490083|FG001|Overall Study|Progressive Disease|1|||
16274611|NCT02369458|39490087|FG000|Overall Study|Determined to be not eligible|1|||
16274612|NCT02369458|39490088|FG001|Overall Study|Determined to be not eligible|0|||
16274613|NCT00021541|39490094|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
16274614|NCT00021541|39490095|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
16374388|NCT00215657|39856648|FG007|Overall Study|Withdrawal by Subject|3|||
16374389|NCT00215657|39856641|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
16374390|NCT00215657|39856642|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
16374391|NCT00215657|39856643|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
16374392|NCT00215657|39856644|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
16374393|NCT00215657|39856645|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
16374394|NCT00215657|39856646|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
16374395|NCT00215657|39856647|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
16374396|NCT00215657|39856648|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
16374397|NCT00215657|39856641|FG000|Overall Study|Insufficient testosterone response|5|||
16374398|NCT00215657|39856642|FG001|Overall Study|Insufficient testosterone response|4|||
16374399|NCT00215657|39856643|FG002|Overall Study|Insufficient testosterone response|1|||
16374400|NCT00215657|39856644|FG003|Overall Study|Insufficient testosterone response|12|||
16374401|NCT00215657|39856645|FG004|Overall Study|Insufficient testosterone response|8|||
16374402|NCT00215657|39856646|FG005|Overall Study|Insufficient testosterone response|12|||
16374403|NCT00215657|39856647|FG006|Overall Study|Insufficient testosterone response|4|||
16374404|NCT00215657|39856648|FG007|Overall Study|Insufficient testosterone response|7|||
16374405|NCT00215657|39856641|FG000|Overall Study|Other|3|||
16374406|NCT00215657|39856642|FG001|Overall Study|Other|1|||
16374407|NCT00215657|39856643|FG002|Overall Study|Other|2|||
16374408|NCT00215657|39856644|FG003|Overall Study|Other|3|||
16374409|NCT00215657|39856645|FG004|Overall Study|Other|5|||
16374410|NCT00215657|39856646|FG005|Overall Study|Other|4|||
16374411|NCT00215657|39856647|FG006|Overall Study|Other|6|||
16374412|NCT00215657|39856648|FG007|Overall Study|Other|1|||
16374413|NCT02244957|39856651|FG000|Overall Study|Lack of Efficacy|1|||
16374414|NCT02244957|39856652|FG001|Overall Study|Lack of Efficacy|0|||
16374415|NCT04191733|39856656|FG000|Overall Study|Withdrawn due to study closure|13|||
16374416|NCT04191733|39856657|FG001|Overall Study|Withdrawn due to study closure|14|||
16374417|NCT04191733|39856656|FG000|Overall Study|Withdrawal by Subject|2|||
16374418|NCT04191733|39856657|FG001|Overall Study|Withdrawal by Subject|4|||
16374419|NCT04191733|39856656|FG000|Overall Study|Physician Decision|1|||
16374420|NCT04191733|39856657|FG001|Overall Study|Physician Decision|1|||
16374421|NCT04191733|39856656|FG000|Overall Study|Lost to Follow-up|5|||
16374422|NCT04191733|39856657|FG001|Overall Study|Lost to Follow-up|6|||
16374423|NCT04191733|39856656|FG000|Overall Study|Death|0|||
16374424|NCT04191733|39856657|FG001|Overall Study|Death|1|||
16274615|NCT00021541|39490094|FG000|Period 1-First Treatment|Adverse Event|2|||
16274616|NCT00021541|39490095|FG001|Period 1-First Treatment|Adverse Event|1|||
16274617|NCT00021541|39490094|FG000|Period 1-First Treatment|non-adherence|3|||
16274618|NCT00021541|39490095|FG001|Period 1-First Treatment|non-adherence|0|||
16274619|NCT00021541|39490094|FG000|Period 1-First Treatment|Death|1|||
16274620|NCT00021541|39490095|FG001|Period 1-First Treatment|Death|0|||
16374425|NCT00576407|39856658|FG000|Overall Study|Death|7|||
16374426|NCT00576407|39856658|FG000|Overall Study|Physician Decision|1|||
16374427|NCT01898130|39856662|FG000|Treatment|Withdrawal by Subject|2|||
16374428|NCT01898130|39856662|FG000|Treatment|Progressive Disease|4|||
16274621|NCT00021541|39490094|FG000|Period 1-First Treatment|Pts that did not progress|2|||
16274622|NCT00021541|39490095|FG001|Period 1-First Treatment|Pts that did not progress|2|||
16274623|NCT00021541|39490094|FG000|Period 1-First Treatment|Ineligible|0|||
16274624|NCT00021541|39490095|FG001|Period 1-First Treatment|Ineligible|2|||
16374429|NCT01898130|39856662|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
16374430|NCT02940223|39856663|FG000|Overall Study|Failed Requirement|2|||
16374431|NCT02940223|39856664|FG001|Overall Study|Failed Requirement|0|||
16374432|NCT01122680|39856677|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
16374433|NCT01122680|39856678|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
16374434|NCT01122680|39856679|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
16374435|NCT01122680|39856680|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
16374436|NCT01122680|39856677|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
16374437|NCT01122680|39856678|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
16074513|NCT04504916|38763163|FG001|Overall Study|Withdrawal by Subject|4|||
16074514|NCT04504916|38763162|FG000|Overall Study|Did not agree to follow-up|0|||
16074515|NCT04504916|38763163|FG001|Overall Study|Did not agree to follow-up|1|||
16074516|NCT02441036|38763167|FG000|Overall Study|No tissue resected|0|||
16074517|NCT02441036|38763168|FG001|Overall Study|No tissue resected|1|||
16074518|NCT02441036|38763169|FG002|Overall Study|No tissue resected|0|||
16074519|NCT02441036|38763170|FG003|Overall Study|No tissue resected|1|||
16074520|NCT02441036|38763171|FG004|Overall Study|No tissue resected|0|||
16074521|NCT00869258|38766259|FG000|Overall Study|Physician Decision|1|||
16374438|NCT01122680|39856679|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
16374439|NCT01122680|39856680|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
16374440|NCT01122680|39856677|FG000|Period 1 (4 Weeks)|Other|1|||
16374441|NCT01122680|39856678|FG001|Period 1 (4 Weeks)|Other|1|||
16074522|NCT00666276|38766260|FG000|Overall Study|Protocol Violation|34|||
16374442|NCT01122680|39856679|FG002|Period 1 (4 Weeks)|Other|0|||
16374443|NCT01122680|39856680|FG003|Period 1 (4 Weeks)|Other|0|||
16374444|NCT01122680|39856677|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
16374445|NCT01122680|39856678|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
16374446|NCT01122680|39856679|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
16374447|NCT01122680|39856680|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
16374448|NCT01122680|39856677|FG000|Period 2 (4 Weeks)|Other|1|||
16374449|NCT01122680|39856678|FG001|Period 2 (4 Weeks)|Other|0|||
16374450|NCT01122680|39856679|FG002|Period 2 (4 Weeks)|Other|0|||
16374451|NCT01122680|39856680|FG003|Period 2 (4 Weeks)|Other|0|||
16374452|NCT01122680|39856677|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
16374453|NCT01122680|39856678|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
16374454|NCT01122680|39856679|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
16374455|NCT01122680|39856680|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
16374456|NCT01122680|39856677|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16374457|NCT01122680|39856678|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
16074523|NCT01157182|38766261|FG000|Washout of 28 Days|Adverse Event|2|||
16074524|NCT01157182|38766262|FG001|Washout of 28 Days|Adverse Event|0|||
16074525|NCT04381494|38766263|FG000|Overall Study|Early termination of trial|19|||
16074526|NCT04381494|38766263|FG000|Overall Study|Investigator's discretion|1|||
16074527|NCT04381494|38766263|FG000|Overall Study|Withdrawal by Subject|9|||
16074528|NCT04381494|38766263|FG000|Overall Study|NSCLC disease progression|4|||
16074529|NCT04381494|38766263|FG000|Overall Study|Device-Related Adverse Event|2|||
16074530|NCT02631148|38766264|FG000|Overall Study|8 were ineligible|8|||
16074531|NCT02631148|38766265|FG001|Overall Study|8 were ineligible|0|||
16074532|NCT02631148|38766264|FG000|Overall Study|Withdrawal by Subject|1|||
16074533|NCT02631148|38766265|FG001|Overall Study|Withdrawal by Subject|0|||
16074534|NCT02631148|38766264|FG000|Overall Study|PAH not available to study participant|1|||
16074535|NCT02631148|38766265|FG001|Overall Study|PAH not available to study participant|0|||
16074536|NCT00739102|38766272|FG000|Overall Study|Death|5|||
16074537|NCT00739102|38766272|FG000|Overall Study|Withdrawal by Subject|10|||
16374458|NCT01122680|39856679|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16374459|NCT01122680|39856680|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16374460|NCT02931539|39856683|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
16374461|NCT02931539|39856684|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
16374462|NCT02931539|39856685|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
16374463|NCT02931539|39856683|FG000|Period 1: Treatment Phase|Adverse Event|5|||
16374464|NCT02931539|39856684|FG001|Period 1: Treatment Phase|Adverse Event|1|||
16374465|NCT02931539|39856685|FG002|Period 1: Treatment Phase|Adverse Event|0|||
16374466|NCT02931539|39856683|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
16374467|NCT02931539|39856684|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
16374468|NCT02931539|39856685|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
16374469|NCT02931539|39856683|FG000|Period 1: Treatment Phase|Death|8|||
16374470|NCT02931539|39856684|FG001|Period 1: Treatment Phase|Death|24|||
16374471|NCT02931539|39856685|FG002|Period 1: Treatment Phase|Death|0|||
16374472|NCT02931539|39856683|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
16374473|NCT02931539|39856684|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
16374474|NCT02931539|39856685|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
16074538|NCT05641311|38766273|FG000|Dosing Period 1|Adverse Event|1|||
16074539|NCT05641311|38766274|FG001|Dosing Period 1|Adverse Event|0|||
16074540|NCT00189202|38766275|FG000|Overall Study|Physician Decision|5|||
16074541|NCT00746330|38766276|FG000|Period 1|Abnormal test procedure result|0|||
16074542|NCT00746330|38766277|FG001|Period 1|Abnormal test procedure result|0|||
16374475|NCT02931539|39856683|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
16374476|NCT02931539|39856684|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
16374477|NCT02931539|39856685|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
16409895|NCT01143051|39981817|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
16074543|NCT00746330|38766278|FG002|Period 1|Abnormal test procedure result|1|||
16074544|NCT00746330|38766279|FG003|Period 1|Abnormal test procedure result|0|||
16173697|NCT03403192|39115231|FG003|Overall Study|Unable to respond|0|||
16074545|NCT01883492|38766282|FG000|Overall Study|Lost to Follow-up|3|||
16074546|NCT01883492|38766283|FG001|Overall Study|Lost to Follow-up|4|||
16374478|NCT02931539|39856683|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
16374479|NCT02931539|39856684|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
16374480|NCT02931539|39856685|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
16374481|NCT02931539|39856683|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
16374482|NCT02931539|39856684|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
16374483|NCT02931539|39856685|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
16374484|NCT02336555|39856697|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16374485|NCT02336555|39856698|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
16374486|NCT02336555|39856697|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
16374487|NCT02336555|39856698|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
16374488|NCT02336555|39856697|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
16374489|NCT02336555|39856698|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
16074547|NCT01883492|38766282|FG000|Overall Study|Surgery on contra-lateral hip|0|||
16074548|NCT01883492|38766283|FG001|Overall Study|Surgery on contra-lateral hip|1|||
16074549|NCT01883492|38766282|FG000|Overall Study|Poor X-ray quality|7|||
16074550|NCT01883492|38766283|FG001|Overall Study|Poor X-ray quality|4|||
16074551|NCT01883492|38766282|FG000|Overall Study|Withdrawal by Subject|1|||
16074552|NCT01883492|38766283|FG001|Overall Study|Withdrawal by Subject|0|||
16074553|NCT01883492|38766282|FG000|Overall Study|inappropriate implant used|1|||
16074554|NCT01883492|38766283|FG001|Overall Study|inappropriate implant used|1|||
16074555|NCT01883492|38766282|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
16074556|NCT01883492|38766283|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
16074557|NCT00980330|38766286|FG000|Overall Study|Adverse Event|0|||
16074558|NCT00980330|38766287|FG001|Overall Study|Adverse Event|0|||
16074559|NCT00980330|38766288|FG002|Overall Study|Adverse Event|0|||
16074560|NCT00980330|38766289|FG003|Overall Study|Adverse Event|1|||
16074561|NCT00980330|38766290|FG004|Overall Study|Adverse Event|0|||
16074562|NCT00980330|38766291|FG005|Overall Study|Adverse Event|0|||
16074563|NCT00980330|38766292|FG006|Overall Study|Adverse Event|0|||
16074564|NCT00980330|38766286|FG000|Overall Study|Lost to Follow-up|1|||
16074565|NCT00980330|38766287|FG001|Overall Study|Lost to Follow-up|1|||
16074566|NCT00980330|38766288|FG002|Overall Study|Lost to Follow-up|4|||
16374490|NCT02942407|39856702|FG000|Overall Study|Lost to Follow-up|3|||
16374491|NCT02942407|39856703|FG001|Overall Study|Lost to Follow-up|2|||
16374492|NCT02942407|39856702|FG000|Overall Study|Withdrawal by Subject|7|||
16374493|NCT02942407|39856703|FG001|Overall Study|Withdrawal by Subject|9|||
16374494|NCT02942407|39856702|FG000|Overall Study|Death|16|||
16374495|NCT02942407|39856703|FG001|Overall Study|Death|13|||
16374496|NCT01687595|39856704|FG000|Overall Study|Withdrawal by Subject|8|||
16374497|NCT01687595|39856705|FG001|Overall Study|Withdrawal by Subject|0|||
16374498|NCT01687595|39856704|FG000|Overall Study|Lost to Follow-up|3|||
16374499|NCT01687595|39856705|FG001|Overall Study|Lost to Follow-up|1|||
16473245|NCT00048061|40214422|FG003|Overall Study|Lost to Follow-up|5|||
16074567|NCT00980330|38766289|FG003|Overall Study|Lost to Follow-up|2|||
16074568|NCT00980330|38766290|FG004|Overall Study|Lost to Follow-up|1|||
16074569|NCT00980330|38766291|FG005|Overall Study|Lost to Follow-up|1|||
16074570|NCT00980330|38766292|FG006|Overall Study|Lost to Follow-up|2|||
16074571|NCT00980330|38766286|FG000|Overall Study|Withdrawal by Subject|2|||
16074572|NCT00980330|38766287|FG001|Overall Study|Withdrawal by Subject|4|||
16074573|NCT00980330|38766288|FG002|Overall Study|Withdrawal by Subject|4|||
16074574|NCT00980330|38766289|FG003|Overall Study|Withdrawal by Subject|1|||
16074575|NCT00980330|38766290|FG004|Overall Study|Withdrawal by Subject|3|||
16074576|NCT00980330|38766291|FG005|Overall Study|Withdrawal by Subject|2|||
16074577|NCT00980330|38766292|FG006|Overall Study|Withdrawal by Subject|5|||
16074578|NCT00980330|38766286|FG000|Overall Study|(not specified)|2|||
16074579|NCT00980330|38766287|FG001|Overall Study|(not specified)|0|||
16074580|NCT00980330|38766288|FG002|Overall Study|(not specified)|0|||
16074581|NCT00980330|38766289|FG003|Overall Study|(not specified)|1|||
16074582|NCT00980330|38766290|FG004|Overall Study|(not specified)|1|||
16074583|NCT00980330|38766291|FG005|Overall Study|(not specified)|1|||
16074584|NCT00980330|38766292|FG006|Overall Study|(not specified)|0|||
16074585|NCT01194154|38766293|FG000|Overall Study|Adverse Event|12|||
16074586|NCT01194154|38766294|FG001|Overall Study|Adverse Event|7|||
16074587|NCT01194154|38766293|FG000|Overall Study|Lost to Follow-up|2|||
16074588|NCT01194154|38766294|FG001|Overall Study|Lost to Follow-up|3|||
16074589|NCT01194154|38766293|FG000|Overall Study|Protocol Violation|0|||
16074590|NCT01194154|38766294|FG001|Overall Study|Protocol Violation|1|||
16074591|NCT01194154|38766293|FG000|Overall Study|Withdrawal by Subject|5|||
16074592|NCT01194154|38766294|FG001|Overall Study|Withdrawal by Subject|6|||
16074593|NCT01194154|38766293|FG000|Overall Study|Blood pressure increase|5|||
16074594|NCT01194154|38766294|FG001|Overall Study|Blood pressure increase|3|||
16074595|NCT01194154|38766293|FG000|Overall Study|Hemoglobin decrease|0|||
16074596|NCT01194154|38766294|FG001|Overall Study|Hemoglobin decrease|1|||
16374500|NCT01687595|39856704|FG000|Overall Study|Investigator's decision|1|||
16074597|NCT01194154|38766293|FG000|Overall Study|Hemoglobin increase|12|||
16074598|NCT01194154|38766294|FG001|Overall Study|Hemoglobin increase|3|||
16074599|NCT01194154|38766293|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
16074600|NCT01194154|38766294|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
16374501|NCT01687595|39856705|FG001|Overall Study|Investigator's decision|0|||
16374502|NCT01687595|39856704|FG000|Overall Study|Sponsor's decision|1|||
16374503|NCT01687595|39856705|FG001|Overall Study|Sponsor's decision|0|||
16374504|NCT01687595|39856704|FG000|Overall Study|Noncompliance|1|||
16374505|NCT01687595|39856705|FG001|Overall Study|Noncompliance|2|||
16374506|NCT01687595|39856704|FG000|Overall Study|Other than specified|56|||
16074601|NCT01194154|38766293|FG000|Overall Study|Treatment with prohibited medication|4|||
16074602|NCT01194154|38766294|FG001|Overall Study|Treatment with prohibited medication|5|||
16074603|NCT01194154|38766293|FG000|Overall Study|Other|4|||
16074604|NCT01194154|38766294|FG001|Overall Study|Other|0|||
16074605|NCT01194154|38766293|FG000|Overall Study|Did not receive study medication|2|||
16074606|NCT01194154|38766294|FG001|Overall Study|Did not receive study medication|4|||
16074607|NCT03053440|38766295|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
16074608|NCT03053440|38766296|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
16074609|NCT03053440|38766295|FG000|Overall Study|Death|18|||
16074610|NCT03053440|38766296|FG001|Overall Study|Death|14|||
16074611|NCT03053440|38766295|FG000|Overall Study|Withdrawal by Subject|9|||
16074612|NCT03053440|38766296|FG001|Overall Study|Withdrawal by Subject|8|||
16074613|NCT03053440|38766295|FG000|Overall Study|Lost to Follow-up|1|||
16074614|NCT03053440|38766296|FG001|Overall Study|Lost to Follow-up|0|||
16074615|NCT03053440|38766295|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
16074616|NCT03053440|38766296|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
16074617|NCT03053440|38766295|FG000|Overall Study|Physician Decision|2|||
16074618|NCT03053440|38766296|FG001|Overall Study|Physician Decision|1|||
16074619|NCT03053440|38766295|FG000|Overall Study|Participant Randomized but died before dosing|1|||
16074620|NCT03053440|38766296|FG001|Overall Study|Participant Randomized but died before dosing|0|||
16074621|NCT00941655|38766297|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
16074622|NCT00941655|38766298|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
16074623|NCT00941655|38766297|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
16074624|NCT00941655|38766298|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
16374507|NCT01687595|39856705|FG001|Overall Study|Other than specified|7|||
16374508|NCT00894647|39856706|FG000|Overall Study|Adverse Event|5|||
16374509|NCT00894647|39856707|FG001|Overall Study|Adverse Event|4|||
16074625|NCT00941655|38766297|FG000|Overall Study|progressed while on chemo|0|||
16074626|NCT00941655|38766298|FG001|Overall Study|progressed while on chemo|2|||
16074627|NCT00941655|38766297|FG000|Overall Study|refused further treatment|0|||
16374510|NCT00894647|39856706|FG000|Overall Study|Withdrawal by Subject|4|||
16374511|NCT00894647|39856707|FG001|Overall Study|Withdrawal by Subject|4|||
16374512|NCT00894647|39856706|FG000|Overall Study|Lost to Follow-up|0|||
16374513|NCT00894647|39856707|FG001|Overall Study|Lost to Follow-up|2|||
16374514|NCT00894647|39856706|FG000|Overall Study|Non-compliance with study procedures|0|||
16374515|NCT00894647|39856707|FG001|Overall Study|Non-compliance with study procedures|2|||
16374516|NCT00894647|39856706|FG000|Overall Study|Other, not due to AE|1|||
16374517|NCT00894647|39856707|FG001|Overall Study|Other, not due to AE|2|||
16374518|NCT01897896|39856712|FG000|Overall Study|Death|1|||
16374519|NCT01897896|39856713|FG001|Overall Study|Death|0|||
16374520|NCT01897896|39856712|FG000|Overall Study|Adverse Event|11|||
16374521|NCT01897896|39856713|FG001|Overall Study|Adverse Event|1|||
16374522|NCT01897896|39856712|FG000|Overall Study|Lost to Follow-up|1|||
16374523|NCT01897896|39856713|FG001|Overall Study|Lost to Follow-up|0|||
16374524|NCT01897896|39856712|FG000|Overall Study|Non-compliance with study drug dosing|1|||
16374525|NCT01897896|39856713|FG001|Overall Study|Non-compliance with study drug dosing|1|||
16374526|NCT01897896|39856712|FG000|Overall Study|Withdrawal by Subject|7|||
16374527|NCT01897896|39856713|FG001|Overall Study|Withdrawal by Subject|1|||
16374528|NCT01897896|39856712|FG000|Overall Study|Require drug that interfere with study|1|||
16374529|NCT01897896|39856713|FG001|Overall Study|Require drug that interfere with study|4|||
16374530|NCT01897896|39856712|FG000|Overall Study|Protocol Violation|1|||
16374531|NCT01897896|39856713|FG001|Overall Study|Protocol Violation|1|||
16074628|NCT00941655|38766298|FG001|Overall Study|refused further treatment|1|||
16074629|NCT00941655|38766297|FG000|Overall Study|withdrew consent|0|||
16074630|NCT00941655|38766298|FG001|Overall Study|withdrew consent|1|||
16074631|NCT00941655|38766297|FG000|Overall Study|non-compliant|0|||
16074632|NCT00941655|38766298|FG001|Overall Study|non-compliant|1|||
16074633|NCT02878330|38766299|FG000|Overall Study|Death|3|||
16074634|NCT02878330|38766300|FG001|Overall Study|Death|2|||
16074635|NCT02878330|38766299|FG000|Overall Study|Lost to Follow-up|11|||
16074636|NCT02878330|38766300|FG001|Overall Study|Lost to Follow-up|26|||
16074637|NCT02878330|38766299|FG000|Overall Study|Withdrawal by Subject|11|||
16374532|NCT01897896|39856712|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
16374533|NCT01897896|39856713|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
16374534|NCT01897896|39856712|FG000|Overall Study|Caregiver can no longer participate|0|||
16374535|NCT01897896|39856713|FG001|Overall Study|Caregiver can no longer participate|2|||
16374536|NCT01897896|39856712|FG000|Overall Study|Other than specified|2|||
16374537|NCT01897896|39856713|FG001|Overall Study|Other than specified|1|||
16374538|NCT00420056|39856714|FG000|Overall Study|Objective progression or relapse|17|||
16374539|NCT01260311|39856715|FG000|Overall Study|Adverse Event|11|||
16374540|NCT01260311|39856715|FG000|Overall Study|Lack of Efficacy|4|||
16374541|NCT01260311|39856715|FG000|Overall Study|Lost to Follow-up|25|||
16374542|NCT01260311|39856715|FG000|Overall Study|Withdrawal by Subject|6|||
16374543|NCT01260311|39856715|FG000|Overall Study|Financial Constraints|77|||
16374544|NCT01260311|39856715|FG000|Overall Study|Gone to Province|2|||
16374545|NCT01260311|39856715|FG000|Overall Study|Medication Stopped|1|||
16374546|NCT01260311|39856715|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
16374547|NCT04146909|39856716|FG000|Overall Study|Withdrawal by Subject|3|||
16374548|NCT04146909|39856716|FG000|Overall Study|Did not qualify after consented|1|||
16374549|NCT02936323|39856717|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16074638|NCT02878330|38766300|FG001|Overall Study|Withdrawal by Subject|21|||
16074639|NCT02878330|38766299|FG000|Overall Study|Other|4|||
16074640|NCT02878330|38766300|FG001|Overall Study|Other|7|||
16074641|NCT00972504|38766301|FG000|Overall Study|Adverse Event|2|||
16374550|NCT02936323|39856718|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
16074642|NCT00972504|38766301|FG000|Overall Study|Investigator discretion|1|||
16074643|NCT00949975|38766302|FG000|Overall Study|Voluntary discontinuation|6|||
16074644|NCT00949975|38766303|FG001|Overall Study|Voluntary discontinuation|5|||
16074645|NCT00949975|38766304|FG002|Overall Study|Voluntary discontinuation|3|||
16074646|NCT00949975|38766305|FG003|Overall Study|Voluntary discontinuation|6|||
16374551|NCT02936323|39856719|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16374552|NCT02936323|39856720|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
16374553|NCT02936323|39856721|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
16374554|NCT02936323|39856722|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
16374555|NCT02936323|39856723|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16374556|NCT02936323|39856724|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16374557|NCT02936323|39856725|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16374558|NCT02936323|39856726|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
16374559|NCT02936323|39856717|FG000|Phase 1 Dose Escalation|Death|2|||
16374560|NCT02936323|39856718|FG001|Phase 1 Dose Escalation|Death|1|||
16374561|NCT02936323|39856719|FG002|Phase 1 Dose Escalation|Death|3|||
16374562|NCT02936323|39856720|FG003|Phase 1 Dose Escalation|Death|1|||
16074647|NCT00949975|38766302|FG000|Overall Study|Adverse Event|11|||
16074648|NCT00949975|38766303|FG001|Overall Study|Adverse Event|11|||
16074649|NCT00949975|38766304|FG002|Overall Study|Adverse Event|10|||
16074650|NCT00949975|38766305|FG003|Overall Study|Adverse Event|10|||
16074651|NCT00949975|38766302|FG000|Overall Study|Safety reason|0|||
16074652|NCT00949975|38766303|FG001|Overall Study|Safety reason|1|||
16074653|NCT00949975|38766304|FG002|Overall Study|Safety reason|0|||
16074654|NCT00949975|38766305|FG003|Overall Study|Safety reason|0|||
16074655|NCT00949975|38766302|FG000|Overall Study|Study-specific criteria|0|||
16074656|NCT00949975|38766303|FG001|Overall Study|Study-specific criteria|1|||
16074657|NCT00949975|38766304|FG002|Overall Study|Study-specific criteria|1|||
16074658|NCT00949975|38766305|FG003|Overall Study|Study-specific criteria|0|||
16074659|NCT00949975|38766302|FG000|Overall Study|Incorrect enrolment|5|||
16074660|NCT00949975|38766303|FG001|Overall Study|Incorrect enrolment|10|||
16074661|NCT00949975|38766304|FG002|Overall Study|Incorrect enrolment|4|||
16074662|NCT00949975|38766305|FG003|Overall Study|Incorrect enrolment|7|||
16074663|NCT00949975|38766302|FG000|Overall Study|Severe non-compliance|3|||
16074664|NCT00949975|38766303|FG001|Overall Study|Severe non-compliance|1|||
16074665|NCT00949975|38766304|FG002|Overall Study|Severe non-compliance|0|||
16074666|NCT00949975|38766305|FG003|Overall Study|Severe non-compliance|2|||
16074667|NCT00949975|38766302|FG000|Overall Study|Lost to Follow-up|1|||
16074668|NCT00949975|38766303|FG001|Overall Study|Lost to Follow-up|0|||
16074669|NCT00949975|38766304|FG002|Overall Study|Lost to Follow-up|1|||
16074670|NCT00949975|38766305|FG003|Overall Study|Lost to Follow-up|3|||
16074671|NCT00949975|38766302|FG000|Overall Study|Other|1|||
16074672|NCT00949975|38766303|FG001|Overall Study|Other|0|||
16074673|NCT00949975|38766304|FG002|Overall Study|Other|0|||
16074674|NCT00949975|38766305|FG003|Overall Study|Other|0|||
16074675|NCT02814643|38766308|FG000|Overall Study|Lost to Follow-up|0|||
16074676|NCT02814643|38766309|FG001|Overall Study|Lost to Follow-up|1|||
16074677|NCT02814643|38766308|FG000|Overall Study|Withdrawal by Subject|1|||
16074678|NCT02814643|38766309|FG001|Overall Study|Withdrawal by Subject|2|||
16074679|NCT00178399|38766312|FG000|Overall Study|Physician Decision|4|||
16074680|NCT00178399|38766312|FG000|Overall Study|Withdrawal by Subject|8|||
16074681|NCT00178399|38766312|FG000|Overall Study|Lost to Follow-up|1|||
16074682|NCT00970307|38766313|FG000|Overall Study|Serious Adverse Event|1|||
16374563|NCT02936323|39856721|FG004|Phase 1 Dose Escalation|Death|2|||
16074683|NCT00970307|38766314|FG001|Overall Study|Serious Adverse Event|0|||
16074684|NCT00970307|38766315|FG002|Overall Study|Serious Adverse Event|0|||
16074685|NCT00970307|38766313|FG000|Overall Study|Withdrawal by Subject|2|||
16074686|NCT00970307|38766314|FG001|Overall Study|Withdrawal by Subject|3|||
16074687|NCT00970307|38766315|FG002|Overall Study|Withdrawal by Subject|2|||
16074688|NCT01259102|38766316|FG000|Overall Study|Adverse Event|1|||
16074689|NCT01259102|38766317|FG001|Overall Study|Adverse Event|0|||
16074690|NCT01259102|38766318|FG002|Overall Study|Adverse Event|1|||
16074691|NCT01259102|38766319|FG003|Overall Study|Adverse Event|1|||
16074692|NCT01259102|38766320|FG004|Overall Study|Adverse Event|0|||
16074693|NCT01259102|38766316|FG000|Overall Study|Other|0|||
16074694|NCT01259102|38766317|FG001|Overall Study|Other|0|||
16274625|NCT00021541|39490094|FG000|Period 2-crossover|refused phase B|2|||
16374564|NCT02936323|39856722|FG005|Phase 1 Dose Escalation|Death|3|||
16374565|NCT02936323|39856723|FG006|Phase 1 Dose Escalation|Death|3|||
16374566|NCT02936323|39856724|FG007|Phase 1 Dose Escalation|Death|0|||
16374567|NCT02936323|39856725|FG008|Phase 1 Dose Escalation|Death|0|||
16374568|NCT02936323|39856726|FG009|Phase 1 Dose Escalation|Death|0|||
16274626|NCT00021541|39490095|FG001|Period 2-crossover|refused phase B|2|||
16274627|NCT00021541|39490094|FG000|Period 2-crossover|Withdrawal by Subject|3|||
16274628|NCT00021541|39490095|FG001|Period 2-crossover|Withdrawal by Subject|4|||
16274629|NCT00021541|39490094|FG000|Period 2-crossover|Adverse Event|2|||
16274630|NCT00021541|39490095|FG001|Period 2-crossover|Adverse Event|2|||
16274631|NCT00021541|39490094|FG000|Period 2-crossover|non-adherence|1|||
16274632|NCT00021541|39490095|FG001|Period 2-crossover|non-adherence|0|||
16274633|NCT00021541|39490094|FG000|Period 2-crossover|Pts that did not progress|2|||
16274634|NCT00021541|39490095|FG001|Period 2-crossover|Pts that did not progress|3|||
16274635|NCT02914457|39490096|FG000|Overall Study|Withdrawal by Subject|1|||
16374569|NCT02936323|39856717|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16374570|NCT02936323|39856718|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16374571|NCT02936323|39856719|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16374572|NCT02936323|39856720|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16374573|NCT02936323|39856721|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16374574|NCT02936323|39856722|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
16374575|NCT02936323|39856723|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16374576|NCT02936323|39856724|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16374577|NCT02936323|39856725|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16374578|NCT02936323|39856726|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
16374579|NCT02936323|39856717|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16374580|NCT02936323|39856718|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16374581|NCT02936323|39856719|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16374582|NCT02936323|39856720|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16374583|NCT02936323|39856721|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16374584|NCT02936323|39856722|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16374585|NCT02936323|39856723|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
16374586|NCT02936323|39856724|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
16374587|NCT02936323|39856725|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
16374588|NCT02936323|39856726|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
16374589|NCT02936323|39856717|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
16374590|NCT02936323|39856718|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
16374591|NCT02936323|39856719|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
16374592|NCT02936323|39856720|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
16374593|NCT02936323|39856721|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
16374594|NCT02936323|39856722|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
16374595|NCT02936323|39856723|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
16374596|NCT02936323|39856724|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
16374597|NCT02936323|39856725|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
16374598|NCT02936323|39856726|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
16374599|NCT02936323|39856717|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16374600|NCT02936323|39856718|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16374601|NCT02936323|39856719|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16374602|NCT02936323|39856720|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16374603|NCT02936323|39856721|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16374604|NCT02936323|39856722|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16374605|NCT02936323|39856723|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16374606|NCT02936323|39856724|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
16374607|NCT02936323|39856725|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
16374608|NCT02936323|39856726|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
16374609|NCT02936323|39856717|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16274636|NCT02914457|39490096|FG000|Overall Study|Physician Decision|1|||
16274637|NCT02914457|39490096|FG000|Overall Study|No veins available for lead placement|1|||
16473246|NCT00048061|40214419|FG000|Overall Study|Withdrawal by Subject|20|||
16074695|NCT01259102|38766318|FG002|Overall Study|Other|1|||
16274638|NCT02914457|39490096|FG000|Overall Study|Electrical instability of patient|1|||
16074696|NCT01259102|38766319|FG003|Overall Study|Other|1|||
16074697|NCT01259102|38766320|FG004|Overall Study|Other|1|||
16074698|NCT01901276|38766321|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
16074699|NCT01901276|38766322|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
16074700|NCT00383188|38766324|FG000|Overall Study|Adverse Event|4|||
16074701|NCT00383188|38766325|FG001|Overall Study|Adverse Event|7|||
16074702|NCT00383188|38766326|FG002|Overall Study|Adverse Event|9|||
16074703|NCT00383188|38766327|FG003|Overall Study|Adverse Event|8|||
16074704|NCT00383188|38766328|FG004|Overall Study|Adverse Event|8|||
16074705|NCT00383188|38766324|FG000|Overall Study|Lack of Efficacy|9|||
16374610|NCT02936323|39856718|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16374611|NCT02936323|39856719|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16374612|NCT02936323|39856720|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16374613|NCT02936323|39856721|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16074706|NCT00383188|38766325|FG001|Overall Study|Lack of Efficacy|3|||
16074707|NCT00383188|38766326|FG002|Overall Study|Lack of Efficacy|3|||
16074708|NCT00383188|38766327|FG003|Overall Study|Lack of Efficacy|2|||
16274639|NCT02914457|39490096|FG000|Overall Study|ECG acquisition error due to sweating|1|||
16274640|NCT02914457|39490096|FG000|Overall Study|Protocol Violation|1|||
16274641|NCT00474188|39490097|FG000|Overall Study|Withdrawal by Subject|1|||
16274642|NCT00474188|39490097|FG000|Overall Study|Study discontinued by sponsor|5|||
16274643|NCT02786953|39490098|FG000|Overall Study|Withdrawal by Subject|3|||
16274644|NCT02786953|39490099|FG001|Overall Study|Withdrawal by Subject|0|||
16274645|NCT02786953|39490098|FG000|Overall Study|Physician Decision|0|||
16274646|NCT02786953|39490099|FG001|Overall Study|Physician Decision|1|||
16274647|NCT01483625|39490104|FG000|Overall Study|Adverse Event|1|||
16274648|NCT01483625|39490105|FG001|Overall Study|Adverse Event|1|||
16374614|NCT02936323|39856722|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16374615|NCT02936323|39856723|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16374616|NCT02936323|39856724|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16374617|NCT02936323|39856725|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
16374618|NCT02936323|39856726|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
16074709|NCT00383188|38766328|FG004|Overall Study|Lack of Efficacy|6|||
16074710|NCT00383188|38766324|FG000|Overall Study|Other|3|||
16374619|NCT02936323|39856717|FG000|Phase 2a Dose Expansion|Death|0|||
16374620|NCT02936323|39856718|FG001|Phase 2a Dose Expansion|Death|0|||
16374621|NCT02936323|39856719|FG002|Phase 2a Dose Expansion|Death|0|||
16374622|NCT02936323|39856720|FG003|Phase 2a Dose Expansion|Death|0|||
16074711|NCT00383188|38766325|FG001|Overall Study|Other|1|||
16074712|NCT00383188|38766326|FG002|Overall Study|Other|0|||
16074713|NCT00383188|38766327|FG003|Overall Study|Other|2|||
16074714|NCT00383188|38766328|FG004|Overall Study|Other|6|||
16074715|NCT00383188|38766324|FG000|Overall Study|No longer willing to participate|1|||
16074716|NCT00383188|38766325|FG001|Overall Study|No longer willing to participate|0|||
16074717|NCT00383188|38766326|FG002|Overall Study|No longer willing to participate|1|||
16074718|NCT00383188|38766327|FG003|Overall Study|No longer willing to participate|0|||
16074719|NCT00383188|38766328|FG004|Overall Study|No longer willing to participate|2|||
16074720|NCT00383188|38766324|FG000|Overall Study|Lost to Follow-up|0|||
16074721|NCT00383188|38766325|FG001|Overall Study|Lost to Follow-up|0|||
16074722|NCT00383188|38766326|FG002|Overall Study|Lost to Follow-up|0|||
16074723|NCT00383188|38766327|FG003|Overall Study|Lost to Follow-up|0|||
16074724|NCT00383188|38766328|FG004|Overall Study|Lost to Follow-up|1|||
16074725|NCT03876457|38766332|FG000|Overall Study|Lost to Follow-up|1|||
16074726|NCT03876457|38766333|FG001|Overall Study|Lost to Follow-up|3|||
16074727|NCT02551055|38766334|FG000|Overall Study|Death|2|||
16074728|NCT02551055|38766335|FG001|Overall Study|Death|4|||
16074729|NCT02551055|38766336|FG002|Overall Study|Death|2|||
16374623|NCT02936323|39856721|FG004|Phase 2a Dose Expansion|Death|0|||
16374624|NCT02936323|39856722|FG005|Phase 2a Dose Expansion|Death|0|||
16374625|NCT02936323|39856723|FG006|Phase 2a Dose Expansion|Death|0|||
16374626|NCT02936323|39856724|FG007|Phase 2a Dose Expansion|Death|4|||
16374627|NCT02936323|39856725|FG008|Phase 2a Dose Expansion|Death|8|||
16374628|NCT02936323|39856726|FG009|Phase 2a Dose Expansion|Death|10|||
16074730|NCT02551055|38766337|FG003|Overall Study|Death|2|||
16074731|NCT02551055|38766338|FG004|Overall Study|Death|2|||
16074732|NCT02551055|38766339|FG005|Overall Study|Death|1|||
16074733|NCT02551055|38766340|FG006|Overall Study|Death|2|||
16374629|NCT01104870|39856745|FG000|Overall Study|Adverse Event|1|||
16074734|NCT02551055|38766341|FG007|Overall Study|Death|0|||
16074735|NCT02551055|38766334|FG000|Overall Study|Study Terminated by Sponsor|1|||
16074736|NCT02551055|38766335|FG001|Overall Study|Study Terminated by Sponsor|1|||
16074737|NCT02551055|38766336|FG002|Overall Study|Study Terminated by Sponsor|0|||
16274649|NCT01483625|39490104|FG000|Overall Study|Refused to continue medication|2|||
16274650|NCT01483625|39490105|FG001|Overall Study|Refused to continue medication|1|||
16074738|NCT02551055|38766337|FG003|Overall Study|Study Terminated by Sponsor|2|||
16074739|NCT02551055|38766338|FG004|Overall Study|Study Terminated by Sponsor|2|||
16074740|NCT02551055|38766339|FG005|Overall Study|Study Terminated by Sponsor|0|||
16074741|NCT02551055|38766340|FG006|Overall Study|Study Terminated by Sponsor|0|||
16074742|NCT02551055|38766341|FG007|Overall Study|Study Terminated by Sponsor|0|||
16074743|NCT02551055|38766334|FG000|Overall Study|Withdrawal by Subject|1|||
16074744|NCT02551055|38766335|FG001|Overall Study|Withdrawal by Subject|1|||
16074745|NCT02551055|38766336|FG002|Overall Study|Withdrawal by Subject|0|||
16074746|NCT02551055|38766337|FG003|Overall Study|Withdrawal by Subject|1|||
16074747|NCT02551055|38766338|FG004|Overall Study|Withdrawal by Subject|2|||
16074748|NCT02551055|38766339|FG005|Overall Study|Withdrawal by Subject|0|||
16074749|NCT02551055|38766340|FG006|Overall Study|Withdrawal by Subject|0|||
16074750|NCT02551055|38766341|FG007|Overall Study|Withdrawal by Subject|0|||
16074751|NCT02551055|38766334|FG000|Overall Study|Reason not specified|0|||
16074752|NCT02551055|38766335|FG001|Overall Study|Reason not specified|0|||
16074753|NCT02551055|38766336|FG002|Overall Study|Reason not specified|0|||
16074754|NCT02551055|38766337|FG003|Overall Study|Reason not specified|0|||
16074755|NCT02551055|38766338|FG004|Overall Study|Reason not specified|1|||
16074756|NCT02551055|38766339|FG005|Overall Study|Reason not specified|0|||
16074757|NCT02551055|38766340|FG006|Overall Study|Reason not specified|1|||
16074758|NCT02551055|38766341|FG007|Overall Study|Reason not specified|0|||
16074759|NCT00813904|38766346|FG000|Overall Study|Death|1|||
16074760|NCT02507752|38766349|FG000|Overall Study|Adverse Event|1|||
16074761|NCT02507752|38766349|FG000|Overall Study|Protocol Violation|6|||
16074762|NCT02507752|38766349|FG000|Overall Study|Lost to Follow-up|7|||
16074763|NCT02507752|38766349|FG000|Overall Study|Infusion reaction at first infusion|1|||
16074764|NCT02507752|38766349|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
16074765|NCT02507752|38766349|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
16074766|NCT02692417|38766350|FG000|Overall Study|Withdrawal by Subject|5|||
16074767|NCT02692417|38766351|FG001|Overall Study|Withdrawal by Subject|1|||
16074768|NCT02692417|38766350|FG000|Overall Study|Adverse Event|1|||
16274651|NCT01483625|39490104|FG000|Overall Study|Due to other reason|1|||
16374630|NCT01104870|39856746|FG001|Overall Study|Adverse Event|1|||
16374631|NCT01104870|39856747|FG002|Overall Study|Adverse Event|0|||
16374632|NCT01104870|39856745|FG000|Overall Study|Death|0|||
16374633|NCT01104870|39856746|FG001|Overall Study|Death|0|||
16374634|NCT01104870|39856747|FG002|Overall Study|Death|1|||
16374635|NCT01104870|39856745|FG000|Overall Study|Withdrawal by Subject|0|||
16374636|NCT01104870|39856746|FG001|Overall Study|Withdrawal by Subject|0|||
16374637|NCT01104870|39856747|FG002|Overall Study|Withdrawal by Subject|1|||
16374638|NCT00159874|39856748|FG000|Overall Study|Adverse Event|2|||
16374639|NCT00159874|39856749|FG001|Overall Study|Adverse Event|2|||
16374640|NCT00159874|39856750|FG002|Overall Study|Adverse Event|5|||
16374641|NCT00159874|39856751|FG003|Overall Study|Adverse Event|1|||
16374642|NCT00159874|39856752|FG004|Overall Study|Adverse Event|1|||
16374643|NCT00159874|39856753|FG005|Overall Study|Adverse Event|2|||
16374644|NCT00159874|39856754|FG006|Overall Study|Adverse Event|0|||
16374645|NCT00159874|39856748|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
16374646|NCT00159874|39856749|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
16274652|NCT01483625|39490105|FG001|Overall Study|Due to other reason|0|||
16274653|NCT01653704|39490107|FG000|Overall Study|Technical failure during recording|1|||
16274654|NCT01653704|39490108|FG001|Overall Study|Technical failure during recording|1|||
16274655|NCT01653704|39490107|FG000|Overall Study|Performance not reflective of training|1|||
16274656|NCT01653704|39490108|FG001|Overall Study|Performance not reflective of training|0|||
16274657|NCT01670097|39490111|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
16274658|NCT01670097|39490112|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
16274659|NCT01670097|39490111|FG000|Overall Study|Study burden|1|||
16274660|NCT01670097|39490112|FG001|Overall Study|Study burden|0|||
16274661|NCT01670097|39490111|FG000|Overall Study|COPD exacerbation|0|||
16274662|NCT01670097|39490112|FG001|Overall Study|COPD exacerbation|1|||
16274663|NCT01670097|39490111|FG000|Overall Study|Neutropenia|0|||
16274664|NCT01670097|39490112|FG001|Overall Study|Neutropenia|1|||
16274665|NCT01670097|39490111|FG000|Overall Study|Clinical deterioration|0|||
16374647|NCT00159874|39856750|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
16374648|NCT00159874|39856751|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
16374649|NCT00159874|39856752|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
16374650|NCT00159874|39856753|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
16274666|NCT01670097|39490112|FG001|Overall Study|Clinical deterioration|1|||
16274667|NCT01670097|39490111|FG000|Overall Study|Disease progression|0|||
16274668|NCT01670097|39490112|FG001|Overall Study|Disease progression|1|||
16274669|NCT00283842|39490113|FG000|Overall Study|Adverse Event|8|||
16274670|NCT00283842|39490114|FG001|Overall Study|Adverse Event|7|||
16274671|NCT00283842|39490115|FG002|Overall Study|Adverse Event|21|||
16274672|NCT00283842|39490116|FG003|Overall Study|Adverse Event|21|||
16274673|NCT00283842|39490117|FG004|Overall Study|Adverse Event|5|||
16274674|NCT00283842|39490113|FG000|Overall Study|Protocol Violation|1|||
16074769|NCT02692417|38766351|FG001|Overall Study|Adverse Event|0|||
16074770|NCT02614560|38766352|FG000|Overall Study|Death|6|||
16074771|NCT02614560|38766353|FG001|Overall Study|Death|2|||
16074772|NCT03058991|38766355|FG000|Overall Study|Lost to Follow-up|17|||
16274675|NCT00283842|39490114|FG001|Overall Study|Protocol Violation|5|||
16274676|NCT00283842|39490115|FG002|Overall Study|Protocol Violation|4|||
16274677|NCT00283842|39490116|FG003|Overall Study|Protocol Violation|0|||
16274678|NCT00283842|39490117|FG004|Overall Study|Protocol Violation|0|||
16274679|NCT00283842|39490113|FG000|Overall Study|Protocol deviation|0|||
16274680|NCT00283842|39490114|FG001|Overall Study|Protocol deviation|0|||
16374651|NCT00159874|39856754|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
16274681|NCT00283842|39490115|FG002|Overall Study|Protocol deviation|0|||
16274682|NCT00283842|39490116|FG003|Overall Study|Protocol deviation|0|||
16274683|NCT00283842|39490117|FG004|Overall Study|Protocol deviation|2|||
16274684|NCT00283842|39490113|FG000|Overall Study|Withdrawal by Subject|2|||
16374652|NCT00159874|39856748|FG000|Overall Study|Lack of Efficacy|2|||
16074773|NCT03058991|38766356|FG001|Overall Study|Lost to Follow-up|12|||
16074774|NCT03058991|38766357|FG002|Overall Study|Lost to Follow-up|12|||
16074775|NCT03058991|38766355|FG000|Overall Study|Withdrawal by Subject|1|||
16074776|NCT03058991|38766356|FG001|Overall Study|Withdrawal by Subject|0|||
16074777|NCT03058991|38766357|FG002|Overall Study|Withdrawal by Subject|0|||
16074778|NCT00430300|38766358|FG000|Overall Study|Adverse Event|0|||
16074779|NCT00430300|38766359|FG001|Overall Study|Adverse Event|2|||
16074780|NCT00430300|38766360|FG002|Overall Study|Adverse Event|1|||
16074781|NCT00430300|38766361|FG003|Overall Study|Adverse Event|1|||
16074782|NCT00430300|38766358|FG000|Overall Study|Withdrawal by Subject|1|||
16074783|NCT00430300|38766359|FG001|Overall Study|Withdrawal by Subject|0|||
16074784|NCT00430300|38766360|FG002|Overall Study|Withdrawal by Subject|5|||
16074785|NCT00430300|38766361|FG003|Overall Study|Withdrawal by Subject|0|||
16074786|NCT00430300|38766358|FG000|Overall Study|Laboratory abnormality|1|||
16074787|NCT00430300|38766359|FG001|Overall Study|Laboratory abnormality|0|||
16074788|NCT00430300|38766360|FG002|Overall Study|Laboratory abnormality|0|||
16074789|NCT00430300|38766361|FG003|Overall Study|Laboratory abnormality|0|||
16074790|NCT00430300|38766358|FG000|Overall Study|Other|0|||
16074791|NCT00430300|38766359|FG001|Overall Study|Other|0|||
16074792|NCT00430300|38766360|FG002|Overall Study|Other|0|||
16074793|NCT00430300|38766361|FG003|Overall Study|Other|1|||
16074794|NCT02027558|38766362|FG000|Overall Study|Death|0|||
16374653|NCT00159874|39856749|FG001|Overall Study|Lack of Efficacy|0|||
16374654|NCT00159874|39856750|FG002|Overall Study|Lack of Efficacy|1|||
16374655|NCT00159874|39856751|FG003|Overall Study|Lack of Efficacy|1|||
16374656|NCT00159874|39856752|FG004|Overall Study|Lack of Efficacy|0|||
16374657|NCT00159874|39856753|FG005|Overall Study|Lack of Efficacy|3|||
16374658|NCT00159874|39856754|FG006|Overall Study|Lack of Efficacy|0|||
16374659|NCT00159874|39856748|FG000|Overall Study|Lost to Follow-up|1|||
16274685|NCT00283842|39490114|FG001|Overall Study|Withdrawal by Subject|1|||
16374660|NCT00159874|39856749|FG001|Overall Study|Lost to Follow-up|0|||
16374661|NCT00159874|39856750|FG002|Overall Study|Lost to Follow-up|3|||
16374662|NCT00159874|39856751|FG003|Overall Study|Lost to Follow-up|0|||
16374663|NCT00159874|39856752|FG004|Overall Study|Lost to Follow-up|1|||
16374664|NCT00159874|39856753|FG005|Overall Study|Lost to Follow-up|2|||
16374665|NCT00159874|39856754|FG006|Overall Study|Lost to Follow-up|1|||
16374666|NCT00159874|39856748|FG000|Overall Study|Other|8|||
16374667|NCT00159874|39856749|FG001|Overall Study|Other|8|||
16374668|NCT00159874|39856750|FG002|Overall Study|Other|8|||
16374669|NCT00159874|39856751|FG003|Overall Study|Other|0|||
16374670|NCT00159874|39856752|FG004|Overall Study|Other|2|||
16374671|NCT00159874|39856753|FG005|Overall Study|Other|1|||
16374672|NCT00159874|39856754|FG006|Overall Study|Other|3|||
16374673|NCT00159874|39856748|FG000|Overall Study|Protocol Violation|0|||
16374674|NCT00159874|39856749|FG001|Overall Study|Protocol Violation|5|||
16374675|NCT00159874|39856750|FG002|Overall Study|Protocol Violation|2|||
16374676|NCT00159874|39856751|FG003|Overall Study|Protocol Violation|0|||
16074795|NCT02027558|38766363|FG001|Overall Study|Death|1|||
16074796|NCT02027558|38766362|FG000|Overall Study|Withdrawal by Subject|2|||
16074797|NCT02027558|38766363|FG001|Overall Study|Withdrawal by Subject|0|||
16074798|NCT02027558|38766362|FG000|Overall Study|Lost to Follow-up|4|||
16074799|NCT02027558|38766363|FG001|Overall Study|Lost to Follow-up|1|||
16173698|NCT03403192|39115228|FG000|Overall Study|Incomplete|3|||
16374677|NCT00159874|39856752|FG004|Overall Study|Protocol Violation|0|||
16374678|NCT00159874|39856753|FG005|Overall Study|Protocol Violation|0|||
16374679|NCT00159874|39856754|FG006|Overall Study|Protocol Violation|0|||
16374680|NCT00159874|39856748|FG000|Overall Study|Death|3|||
16374681|NCT00159874|39856749|FG001|Overall Study|Death|8|||
16374682|NCT00159874|39856750|FG002|Overall Study|Death|15|||
16374683|NCT00159874|39856751|FG003|Overall Study|Death|0|||
16374684|NCT00159874|39856752|FG004|Overall Study|Death|1|||
16374685|NCT00159874|39856753|FG005|Overall Study|Death|2|||
16374686|NCT00159874|39856754|FG006|Overall Study|Death|0|||
16374687|NCT00159874|39856748|FG000|Overall Study|Withdrawal by Subject|2|||
16074800|NCT02027558|38766362|FG000|Overall Study|Refused assessment|3|||
16074801|NCT02027558|38766363|FG001|Overall Study|Refused assessment|0|||
16074802|NCT00976937|38766365|FG000|Overall Study|Adverse Event|4|||
16074803|NCT00976937|38766366|FG001|Overall Study|Adverse Event|5|||
16173699|NCT03403192|39115229|FG001|Overall Study|Incomplete|1|||
16374688|NCT00159874|39856749|FG001|Overall Study|Withdrawal by Subject|6|||
16074804|NCT00976937|38766365|FG000|Overall Study|Lost to Follow-up|2|||
16074805|NCT00976937|38766366|FG001|Overall Study|Lost to Follow-up|1|||
16074806|NCT00976937|38766365|FG000|Overall Study|Withdrawal by Subject|5|||
16074807|NCT00976937|38766366|FG001|Overall Study|Withdrawal by Subject|3|||
16074808|NCT00976937|38766365|FG000|Overall Study|Poor compliance to protocol|3|||
16074809|NCT00976937|38766366|FG001|Overall Study|Poor compliance to protocol|0|||
16074810|NCT00976937|38766365|FG000|Overall Study|Personal and Familial Reason|2|||
16074811|NCT00976937|38766366|FG001|Overall Study|Personal and Familial Reason|2|||
16074812|NCT02041104|38766367|FG000|Overall Study|Lost to Follow-up|1|||
16074813|NCT02041104|38766368|FG001|Overall Study|Lost to Follow-up|4|||
16074814|NCT02041104|38766367|FG000|Overall Study|discomfort during OGTT|0|||
16074815|NCT02041104|38766368|FG001|Overall Study|discomfort during OGTT|3|||
16074816|NCT04054635|38766372|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
16074817|NCT04054635|38766373|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
16274686|NCT00283842|39490115|FG002|Overall Study|Withdrawal by Subject|1|||
16274687|NCT00283842|39490116|FG003|Overall Study|Withdrawal by Subject|5|||
16274688|NCT00283842|39490117|FG004|Overall Study|Withdrawal by Subject|4|||
16274689|NCT00283842|39490113|FG000|Overall Study|Lack of Efficacy|1|||
16274690|NCT00283842|39490114|FG001|Overall Study|Lack of Efficacy|3|||
16274691|NCT00283842|39490115|FG002|Overall Study|Lack of Efficacy|1|||
16274692|NCT00283842|39490116|FG003|Overall Study|Lack of Efficacy|0|||
16274693|NCT00283842|39490117|FG004|Overall Study|Lack of Efficacy|3|||
16274694|NCT00283842|39490113|FG000|Overall Study|Lost to Follow-up|0|||
16274695|NCT00283842|39490114|FG001|Overall Study|Lost to Follow-up|2|||
16274696|NCT00283842|39490115|FG002|Overall Study|Lost to Follow-up|4|||
16274697|NCT00283842|39490116|FG003|Overall Study|Lost to Follow-up|1|||
16274698|NCT00283842|39490117|FG004|Overall Study|Lost to Follow-up|1|||
16274699|NCT00486434|39490122|FG000|Overall Study|Withdrawal by Subject|34|||
16274700|NCT00486434|39490123|FG001|Overall Study|Withdrawal by Subject|39|||
16274701|NCT00486434|39490122|FG000|Overall Study|Adverse Event|118|||
16274702|NCT00486434|39490123|FG001|Overall Study|Adverse Event|44|||
16274703|NCT00486434|39490122|FG000|Overall Study|Protocol Violation|22|||
16274704|NCT00486434|39490123|FG001|Overall Study|Protocol Violation|21|||
16274705|NCT00486434|39490122|FG000|Overall Study|Lack of Efficacy|12|||
16274706|NCT00486434|39490123|FG001|Overall Study|Lack of Efficacy|19|||
16274707|NCT00486434|39490122|FG000|Overall Study|Lost to Follow-up|2|||
16274708|NCT00486434|39490123|FG001|Overall Study|Lost to Follow-up|3|||
16274709|NCT00486434|39490122|FG000|Overall Study|Death|1|||
16274710|NCT00486434|39490123|FG001|Overall Study|Death|2|||
16274711|NCT00486434|39490122|FG000|Overall Study|Personal reasons|5|||
16274712|NCT00486434|39490123|FG001|Overall Study|Personal reasons|6|||
16274713|NCT01559116|39490124|FG000|Overall Study|Adverse Event|10|||
16274714|NCT01559116|39490124|FG000|Overall Study|Lack of Efficacy|1|||
16274715|NCT01559116|39490124|FG000|Overall Study|Lost to Follow-up|1|||
16374689|NCT00159874|39856750|FG002|Overall Study|Withdrawal by Subject|8|||
16374690|NCT00159874|39856751|FG003|Overall Study|Withdrawal by Subject|4|||
16374691|NCT00159874|39856752|FG004|Overall Study|Withdrawal by Subject|3|||
16374692|NCT00159874|39856753|FG005|Overall Study|Withdrawal by Subject|2|||
16374693|NCT00159874|39856754|FG006|Overall Study|Withdrawal by Subject|1|||
16374694|NCT00159874|39856748|FG000|Overall Study|Pregnancy|1|||
16374695|NCT00159874|39856749|FG001|Overall Study|Pregnancy|1|||
16374696|NCT00159874|39856750|FG002|Overall Study|Pregnancy|0|||
16374697|NCT00159874|39856751|FG003|Overall Study|Pregnancy|0|||
16374698|NCT00159874|39856752|FG004|Overall Study|Pregnancy|0|||
16374699|NCT00159874|39856753|FG005|Overall Study|Pregnancy|0|||
16374700|NCT00159874|39856754|FG006|Overall Study|Pregnancy|0|||
16374701|NCT00987935|39856757|FG000|Overall Study|Progressive disease|3|||
16374702|NCT00987935|39856758|FG001|Overall Study|Progressive disease|2|||
16374703|NCT00987935|39856759|FG002|Overall Study|Progressive disease|3|||
16374704|NCT00987935|39856760|FG003|Overall Study|Progressive disease|2|||
16374705|NCT00987935|39856761|FG004|Overall Study|Progressive disease|5|||
16374706|NCT00987935|39856762|FG005|Overall Study|Progressive disease|3|||
16374707|NCT00987935|39856763|FG006|Overall Study|Progressive disease|9|||
16374708|NCT00987935|39856764|FG007|Overall Study|Progressive disease|48|||
16374709|NCT00987935|39856765|FG008|Overall Study|Progressive disease|23|||
16374710|NCT00987935|39856757|FG000|Overall Study|Adverse Event|0|||
16374711|NCT00987935|39856758|FG001|Overall Study|Adverse Event|1|||
16374712|NCT00987935|39856759|FG002|Overall Study|Adverse Event|0|||
16374713|NCT00987935|39856760|FG003|Overall Study|Adverse Event|1|||
16374714|NCT00987935|39856761|FG004|Overall Study|Adverse Event|1|||
16374715|NCT00987935|39856762|FG005|Overall Study|Adverse Event|0|||
16374716|NCT00987935|39856763|FG006|Overall Study|Adverse Event|2|||
16374717|NCT00987935|39856764|FG007|Overall Study|Adverse Event|10|||
16374718|NCT00987935|39856765|FG008|Overall Study|Adverse Event|6|||
16374719|NCT00987935|39856757|FG000|Overall Study|Refused to continue taking trial med.|1|||
16374720|NCT00987935|39856758|FG001|Overall Study|Refused to continue taking trial med.|0|||
16374721|NCT00987935|39856759|FG002|Overall Study|Refused to continue taking trial med.|0|||
16374722|NCT00987935|39856760|FG003|Overall Study|Refused to continue taking trial med.|0|||
16374723|NCT00987935|39856761|FG004|Overall Study|Refused to continue taking trial med.|1|||
16274716|NCT01559116|39490124|FG000|Overall Study|Protocol Violation|1|||
16274717|NCT01559116|39490124|FG000|Overall Study|Withdrawal by Subject|4|||
16274718|NCT01559116|39490124|FG000|Overall Study|other than stated above|9|||
16274719|NCT03480022|39490126|FG000|Overall Study|Pregnancy|2|||
16274720|NCT03480022|39490127|FG001|Overall Study|Pregnancy|0|||
16274721|NCT03480022|39490126|FG000|Overall Study|Adverse Event|6|||
16274722|NCT03480022|39490127|FG001|Overall Study|Adverse Event|0|||
16274723|NCT03480022|39490126|FG000|Overall Study|Lack of Efficacy|0|||
16274724|NCT03480022|39490127|FG001|Overall Study|Lack of Efficacy|2|||
16274725|NCT03480022|39490126|FG000|Overall Study|Physician Decision|0|||
16274726|NCT03480022|39490127|FG001|Overall Study|Physician Decision|1|||
16274727|NCT03480022|39490126|FG000|Overall Study|Withdrawal by Subject|2|||
16274728|NCT03480022|39490127|FG001|Overall Study|Withdrawal by Subject|0|||
16074818|NCT04054635|38766374|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
16074819|NCT04054635|38766372|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
16074820|NCT04054635|38766373|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
16074821|NCT04054635|38766374|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
16074822|NCT03720210|38766375|FG000|Overall Study|Lost to Follow-up|1|||
16074823|NCT00246012|38766378|FG000|Overall Study|Adverse Event|0|||
16274729|NCT03480022|39490126|FG000|Overall Study|Medication concerns|1|||
16274730|NCT03480022|39490127|FG001|Overall Study|Medication concerns|0|||
16274731|NCT03480022|39490126|FG000|Overall Study|Family member COVID exposure|0|||
16274732|NCT03480022|39490127|FG001|Overall Study|Family member COVID exposure|1|||
16074824|NCT00246012|38766379|FG001|Overall Study|Adverse Event|0|||
16274733|NCT03573336|39490128|FG000|Overall Study|Study terminated|2|||
16274734|NCT03573336|39490129|FG001|Overall Study|Study terminated|4|||
16074825|NCT00246012|38766380|FG002|Overall Study|Adverse Event|0|||
16074826|NCT00246012|38766381|FG003|Overall Study|Adverse Event|0|||
16074827|NCT00246012|38766382|FG004|Overall Study|Adverse Event|0|||
16074828|NCT00246012|38766383|FG005|Overall Study|Adverse Event|1|||
16074829|NCT00246012|38766384|FG006|Overall Study|Adverse Event|0|||
16074830|NCT00246012|38766385|FG007|Overall Study|Adverse Event|0|||
16074831|NCT00246012|38766386|FG008|Overall Study|Adverse Event|2|||
16074832|NCT00246012|38766378|FG000|Overall Study|Withdrawal by Subject|0|||
16074833|NCT00246012|38766379|FG001|Overall Study|Withdrawal by Subject|0|||
16074834|NCT00246012|38766380|FG002|Overall Study|Withdrawal by Subject|0|||
16074835|NCT00246012|38766381|FG003|Overall Study|Withdrawal by Subject|0|||
16074836|NCT00246012|38766382|FG004|Overall Study|Withdrawal by Subject|0|||
16074837|NCT00246012|38766383|FG005|Overall Study|Withdrawal by Subject|1|||
16074838|NCT00246012|38766384|FG006|Overall Study|Withdrawal by Subject|0|||
16074839|NCT00246012|38766385|FG007|Overall Study|Withdrawal by Subject|0|||
16074840|NCT00246012|38766386|FG008|Overall Study|Withdrawal by Subject|0|||
16074841|NCT00246012|38766378|FG000|Overall Study|Disease progression|3|||
16074842|NCT00246012|38766379|FG001|Overall Study|Disease progression|1|||
16074843|NCT00246012|38766380|FG002|Overall Study|Disease progression|2|||
16074844|NCT00246012|38766381|FG003|Overall Study|Disease progression|3|||
16074845|NCT00246012|38766382|FG004|Overall Study|Disease progression|3|||
16074846|NCT00246012|38766383|FG005|Overall Study|Disease progression|25|||
16074847|NCT00246012|38766384|FG006|Overall Study|Disease progression|30|||
16074848|NCT00246012|38766385|FG007|Overall Study|Disease progression|27|||
16074849|NCT00246012|38766386|FG008|Overall Study|Disease progression|26|||
16074850|NCT00246012|38766378|FG000|Overall Study|Other|0|||
16074851|NCT00246012|38766379|FG001|Overall Study|Other|0|||
16074852|NCT00246012|38766380|FG002|Overall Study|Other|0|||
16074853|NCT00246012|38766381|FG003|Overall Study|Other|0|||
16074854|NCT00246012|38766382|FG004|Overall Study|Other|0|||
16074855|NCT00246012|38766383|FG005|Overall Study|Other|0|||
16074856|NCT00246012|38766384|FG006|Overall Study|Other|0|||
16074857|NCT00246012|38766385|FG007|Overall Study|Other|1|||
16074858|NCT00246012|38766386|FG008|Overall Study|Other|0|||
16173700|NCT03403192|39115230|FG002|Overall Study|Incomplete|3|||
16173701|NCT03403192|39115231|FG003|Overall Study|Incomplete|6|||
16173702|NCT03124459|39115254|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
16173703|NCT03124459|39115255|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
16173704|NCT03124459|39115256|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
16074859|NCT00246012|38766378|FG000|Overall Study|Randomly assigned but not treated|0|||
16173705|NCT03124459|39115257|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
16173706|NCT03124459|39115258|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
16173707|NCT03124459|39115259|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
16274735|NCT03573336|39490130|FG002|Overall Study|Study terminated|2|||
16274736|NCT00640926|39490134|FG000|Overall Study|Adverse Event|2|||
16274737|NCT00640926|39490135|FG001|Overall Study|Adverse Event|3|||
16274738|NCT00640926|39490136|FG002|Overall Study|Adverse Event|2|||
16074860|NCT00246012|38766379|FG001|Overall Study|Randomly assigned but not treated|0|||
16074861|NCT00246012|38766380|FG002|Overall Study|Randomly assigned but not treated|0|||
16074862|NCT00246012|38766381|FG003|Overall Study|Randomly assigned but not treated|0|||
16074863|NCT00246012|38766382|FG004|Overall Study|Randomly assigned but not treated|0|||
16074864|NCT00246012|38766383|FG005|Overall Study|Randomly assigned but not treated|1|||
16274739|NCT00640926|39490134|FG000|Overall Study|Lack of Efficacy|0|||
16274740|NCT00640926|39490135|FG001|Overall Study|Lack of Efficacy|2|||
16274741|NCT00640926|39490136|FG002|Overall Study|Lack of Efficacy|1|||
16274742|NCT00640926|39490134|FG000|Overall Study|Protocol Violation|2|||
16274743|NCT00640926|39490135|FG001|Overall Study|Protocol Violation|0|||
16274744|NCT00640926|39490136|FG002|Overall Study|Protocol Violation|2|||
16274745|NCT00640926|39490134|FG000|Overall Study|Lost to Follow-up|3|||
16274746|NCT00640926|39490135|FG001|Overall Study|Lost to Follow-up|1|||
16274747|NCT00640926|39490136|FG002|Overall Study|Lost to Follow-up|2|||
16274748|NCT00640926|39490134|FG000|Overall Study|Withdrawal by Subject|1|||
16274749|NCT00640926|39490135|FG001|Overall Study|Withdrawal by Subject|0|||
16274750|NCT00640926|39490136|FG002|Overall Study|Withdrawal by Subject|1|||
16274751|NCT00796328|39490137|FG000|Overall Study|experienced hypotension requiring tx|6|||
16274752|NCT01891357|39490138|FG000|Overall Study|Protocol Violation|3|||
16274753|NCT01598896|39490139|FG000|Overall Study|Withdrawal by Subject|0|||
16274754|NCT01598896|39490140|FG001|Overall Study|Withdrawal by Subject|1|||
16274755|NCT01598896|39490139|FG000|Overall Study|Lack of Efficacy|0|||
16274756|NCT01598896|39490140|FG001|Overall Study|Lack of Efficacy|1|||
16274757|NCT05065619|39490144|FG000|Up to Day 42|Lost to Follow-up|1|||
16274758|NCT05065619|39490145|FG001|Up to Day 42|Lost to Follow-up|0|||
16274759|NCT05065619|39490144|FG000|Up to Day 42|Withdrawal by Subject|1|||
16274760|NCT05065619|39490145|FG001|Up to Day 42|Withdrawal by Subject|0|||
16274761|NCT05065619|39490144|FG000|After Day 43|Lost to Follow-up|1|||
16274762|NCT05065619|39490145|FG001|After Day 43|Lost to Follow-up|0|||
16274763|NCT05065619|39490144|FG000|After Day 43|Physician Decision|3|||
16274764|NCT05065619|39490145|FG001|After Day 43|Physician Decision|0|||
16274765|NCT05065619|39490144|FG000|After Day 43|Withdrawal by Subject|1|||
16274766|NCT05065619|39490145|FG001|After Day 43|Withdrawal by Subject|2|||
16274767|NCT05065619|39490144|FG000|After Day 43|Public vaccination|6|||
16074865|NCT00246012|38766384|FG006|Overall Study|Randomly assigned but not treated|1|||
16274768|NCT05065619|39490145|FG001|After Day 43|Public vaccination|8|||
16274769|NCT05065619|39490144|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
16274770|NCT05065619|39490145|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
16274771|NCT05065619|39490144|FG000|After Day 43|Study Terminated by Sponsor|88|||
16274772|NCT05065619|39490145|FG001|After Day 43|Study Terminated by Sponsor|16|||
16274773|NCT04164758|39490147|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
16274774|NCT04164758|39490148|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
16274775|NCT04164758|39490149|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
16274776|NCT04164758|39490147|FG000|Overall Study|Adverse Event|0|||
16274777|NCT04164758|39490148|FG001|Overall Study|Adverse Event|1|||
16274778|NCT04164758|39490149|FG002|Overall Study|Adverse Event|0|||
16274779|NCT01924364|39490150|FG000|Overall Study|Physician Decision|3|||
16274780|NCT00673660|39490151|FG000|Overall Study|Lost to Follow-up|107|||
16274781|NCT02451696|39490160|FG000|Overall Study|Surgery postponed|1|||
16274782|NCT02451696|39490161|FG001|Overall Study|Surgery postponed|0|||
16274783|NCT01148225|39490162|FG000|Overall Study|Other|185|||
16274784|NCT04668274|39490173|FG000|Part 1 Study Period 1|Adverse Event|3|||
16274785|NCT04668274|39490174|FG001|Part 1 Study Period 1|Adverse Event|0|||
16274786|NCT04668274|39490175|FG002|Part 1 Study Period 1|Adverse Event|0|||
16274787|NCT04668274|39490176|FG003|Part 1 Study Period 1|Adverse Event|0|||
16274788|NCT04668274|39490173|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
16274789|NCT04668274|39490174|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
16274790|NCT04668274|39490175|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
16274791|NCT04668274|39490176|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
16274792|NCT04668274|39490173|FG000|Part 1 Study Period 2|Other|0|||
16274793|NCT04668274|39490174|FG001|Part 1 Study Period 2|Other|1|||
16274794|NCT04668274|39490175|FG002|Part 1 Study Period 2|Other|0|||
16274795|NCT04668274|39490176|FG003|Part 1 Study Period 2|Other|0|||
16274796|NCT04668274|39490173|FG000|Part 1 Study Period 3|Adverse Event|0|||
16374724|NCT00987935|39856762|FG005|Overall Study|Refused to continue taking trial med.|0|||
16374725|NCT00987935|39856763|FG006|Overall Study|Refused to continue taking trial med.|4|||
16274797|NCT04668274|39490174|FG001|Part 1 Study Period 3|Adverse Event|0|||
16274798|NCT04668274|39490175|FG002|Part 1 Study Period 3|Adverse Event|1|||
16274799|NCT04668274|39490176|FG003|Part 1 Study Period 3|Adverse Event|0|||
16274800|NCT04668274|39490173|FG000|Part 1 Study Period 3|Other|0|||
16274801|NCT04668274|39490174|FG001|Part 1 Study Period 3|Other|0|||
16274802|NCT04668274|39490175|FG002|Part 1 Study Period 3|Other|2|||
16274803|NCT04668274|39490176|FG003|Part 1 Study Period 3|Other|0|||
16274804|NCT04668274|39490173|FG000|Part 2 Study Period 4|Other|0|||
16274805|NCT04668274|39490174|FG001|Part 2 Study Period 4|Other|0|||
16274806|NCT04668274|39490175|FG002|Part 2 Study Period 4|Other|0|||
16274807|NCT04668274|39490176|FG003|Part 2 Study Period 4|Other|1|||
16274808|NCT01898598|39490177|FG000|Overall Study|Adverse Event|1|||
16374726|NCT00987935|39856764|FG007|Overall Study|Refused to continue taking trial med.|4|||
16274809|NCT01898598|39490178|FG001|Overall Study|Adverse Event|0|||
16374727|NCT00987935|39856765|FG008|Overall Study|Refused to continue taking trial med.|2|||
16274810|NCT01898598|39490177|FG000|Overall Study|Withdrawal by Subject|3|||
16274811|NCT01898598|39490178|FG001|Overall Study|Withdrawal by Subject|0|||
16274812|NCT01898598|39490177|FG000|Overall Study|Lost to Follow-up|0|||
16274813|NCT01898598|39490178|FG001|Overall Study|Lost to Follow-up|1|||
16274814|NCT01898598|39490177|FG000|Overall Study|Other|0|||
16374728|NCT00987935|39856757|FG000|Overall Study|Reason other than those specified above|0|||
16374729|NCT00987935|39856758|FG001|Overall Study|Reason other than those specified above|0|||
16374730|NCT00987935|39856759|FG002|Overall Study|Reason other than those specified above|0|||
16374731|NCT00987935|39856760|FG003|Overall Study|Reason other than those specified above|0|||
16374732|NCT00987935|39856761|FG004|Overall Study|Reason other than those specified above|0|||
16374733|NCT00987935|39856762|FG005|Overall Study|Reason other than those specified above|0|||
16374734|NCT00987935|39856763|FG006|Overall Study|Reason other than those specified above|0|||
16374735|NCT00987935|39856764|FG007|Overall Study|Reason other than those specified above|0|||
16374736|NCT00987935|39856765|FG008|Overall Study|Reason other than those specified above|1|||
16374737|NCT01346592|39856768|FG000|Overall Study|Lost to Follow-up|62|||
16374738|NCT01346592|39856769|FG001|Overall Study|Lost to Follow-up|29|||
16374739|NCT01346592|39856770|FG002|Overall Study|Lost to Follow-up|29|||
16374740|NCT01346592|39856768|FG000|Overall Study|Protocol Violation|2|||
16374741|NCT01346592|39856769|FG001|Overall Study|Protocol Violation|1|||
16374742|NCT01346592|39856770|FG002|Overall Study|Protocol Violation|0|||
16374743|NCT01346592|39856768|FG000|Overall Study|Death|1|||
16374744|NCT01346592|39856769|FG001|Overall Study|Death|3|||
16374745|NCT01346592|39856770|FG002|Overall Study|Death|4|||
16374746|NCT01346592|39856768|FG000|Overall Study|Adverse Event|0|||
16374747|NCT01346592|39856769|FG001|Overall Study|Adverse Event|1|||
16374748|NCT01346592|39856770|FG002|Overall Study|Adverse Event|0|||
16374749|NCT01346592|39856768|FG000|Overall Study|Withdrawal by Subject|77|||
16374750|NCT01346592|39856769|FG001|Overall Study|Withdrawal by Subject|51|||
16374751|NCT01346592|39856770|FG002|Overall Study|Withdrawal by Subject|38|||
16374752|NCT01346592|39856768|FG000|Overall Study|Inappropriate enrollment|3|||
16374753|NCT01346592|39856769|FG001|Overall Study|Inappropriate enrollment|1|||
16374754|NCT01346592|39856770|FG002|Overall Study|Inappropriate enrollment|1|||
16374755|NCT01346592|39856768|FG000|Overall Study|Administrative reason|1|||
16374756|NCT01346592|39856769|FG001|Overall Study|Administrative reason|0|||
16374757|NCT01346592|39856770|FG002|Overall Study|Administrative reason|0|||
16374758|NCT01346592|39856768|FG000|Overall Study|Unable to Classify|7|||
16374759|NCT01346592|39856769|FG001|Overall Study|Unable to Classify|3|||
16374760|NCT01346592|39856770|FG002|Overall Study|Unable to Classify|6|||
16374761|NCT01210443|39856771|FG000|Overall Study|Study terminated by sponsor|2|||
16374762|NCT00561821|39856772|FG000|Overall Study|Not treated|0|||
16374763|NCT00561821|39856773|FG001|Overall Study|Not treated|0|||
16374764|NCT00561821|39856774|FG002|Overall Study|Not treated|1|||
16374765|NCT00561821|39856775|FG003|Overall Study|Not treated|0|||
16374766|NCT00561821|39856772|FG000|Overall Study|Withdrawal by Subject|0|||
16374767|NCT00561821|39856773|FG001|Overall Study|Withdrawal by Subject|1|||
16374768|NCT00561821|39856774|FG002|Overall Study|Withdrawal by Subject|0|||
16374769|NCT00561821|39856775|FG003|Overall Study|Withdrawal by Subject|2|||
16173708|NCT03124459|39115254|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
16074866|NCT00246012|38766385|FG007|Overall Study|Randomly assigned but not treated|0|||
16074867|NCT00246012|38766386|FG008|Overall Study|Randomly assigned but not treated|0|||
16374770|NCT00561821|39856772|FG000|Overall Study|Reasons not related to trial|2|||
16374771|NCT00561821|39856773|FG001|Overall Study|Reasons not related to trial|1|||
16074868|NCT01251354|38766387|FG000|Overall Study|Adverse Event|1|||
16074869|NCT01251354|38766387|FG000|Overall Study|Investigator's Decision|1|||
16074870|NCT01251354|38766387|FG000|Overall Study|Disease Progression|4|||
16074871|NCT00736853|38766388|FG000|Open-Label Period|Physician Decision|2|||
16074872|NCT00736853|38766389|FG001|Open-Label Period|Physician Decision|0|||
16074873|NCT00736853|38766390|FG002|Open-Label Period|Physician Decision|0|||
16074874|NCT00736853|38766388|FG000|Open-Label Period|Adverse Event|31|||
16074875|NCT00736853|38766389|FG001|Open-Label Period|Adverse Event|0|||
16074876|NCT00736853|38766390|FG002|Open-Label Period|Adverse Event|0|||
16374772|NCT00561821|39856774|FG002|Overall Study|Reasons not related to trial|0|||
16374773|NCT00561821|39856775|FG003|Overall Study|Reasons not related to trial|0|||
16374774|NCT00561821|39856772|FG000|Overall Study|Other (reason not specified)|1|||
16374775|NCT00561821|39856773|FG001|Overall Study|Other (reason not specified)|1|||
16374776|NCT00561821|39856774|FG002|Overall Study|Other (reason not specified)|0|||
16374777|NCT00561821|39856775|FG003|Overall Study|Other (reason not specified)|0|||
16374778|NCT00561821|39856772|FG000|Overall Study|Adverse Event|2|||
16374779|NCT00561821|39856773|FG001|Overall Study|Adverse Event|3|||
16374780|NCT00561821|39856774|FG002|Overall Study|Adverse Event|1|||
16374781|NCT00561821|39856775|FG003|Overall Study|Adverse Event|1|||
16374782|NCT00345592|39856776|FG000|Overall Study|Death|14|||
16374783|NCT00345592|39856777|FG001|Overall Study|Death|16|||
16374784|NCT00345592|39856776|FG000|Overall Study|Withdrawal by Subject|11|||
16074877|NCT00736853|38766388|FG000|Open-Label Period|Withdrawal by Subject|16|||
16074878|NCT00736853|38766389|FG001|Open-Label Period|Withdrawal by Subject|0|||
16274815|NCT01898598|39490178|FG001|Overall Study|Other|1|||
16374785|NCT00345592|39856777|FG001|Overall Study|Withdrawal by Subject|8|||
16374786|NCT03636269|39856780|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
16374787|NCT03636269|39856781|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
16374788|NCT03636269|39856782|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
16374789|NCT03636269|39856780|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
16374790|NCT03636269|39856781|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
16374791|NCT03636269|39856782|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
16074879|NCT00736853|38766390|FG002|Open-Label Period|Withdrawal by Subject|0|||
16074880|NCT00736853|38766388|FG000|Open-Label Period|Started but not treated|42|||
16074881|NCT00736853|38766389|FG001|Open-Label Period|Started but not treated|0|||
16074882|NCT00736853|38766390|FG002|Open-Label Period|Started but not treated|0|||
16074883|NCT00736853|38766388|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
16374792|NCT03636269|39856780|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
16374793|NCT03636269|39856781|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
16074884|NCT00736853|38766389|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
16074885|NCT00736853|38766390|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
16374794|NCT03636269|39856782|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
16374795|NCT03636269|39856780|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
16374796|NCT03636269|39856781|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
16074886|NCT00736853|38766388|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
16074887|NCT00736853|38766389|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
16074888|NCT00736853|38766390|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
16074889|NCT00736853|38766388|FG000|Double-Blind Period|Lack of Efficacy|0|||
16074890|NCT00736853|38766389|FG001|Double-Blind Period|Lack of Efficacy|19|||
16074891|NCT00736853|38766390|FG002|Double-Blind Period|Lack of Efficacy|42|||
16074892|NCT00736853|38766388|FG000|Double-Blind Period|Adverse Event|0|||
16074893|NCT00736853|38766389|FG001|Double-Blind Period|Adverse Event|3|||
16074894|NCT00736853|38766390|FG002|Double-Blind Period|Adverse Event|2|||
16074895|NCT00736853|38766388|FG000|Double-Blind Period|Withdrawal by Subject|0|||
16074896|NCT00736853|38766389|FG001|Double-Blind Period|Withdrawal by Subject|1|||
16074897|NCT00736853|38766390|FG002|Double-Blind Period|Withdrawal by Subject|4|||
16074898|NCT00736853|38766388|FG000|Double-Blind Period|Ineligible to participate the study|0|||
16074899|NCT00736853|38766389|FG001|Double-Blind Period|Ineligible to participate the study|1|||
16074900|NCT00736853|38766390|FG002|Double-Blind Period|Ineligible to participate the study|0|||
16074901|NCT02975934|38766394|FG000|Treatment Phase|Ongoing at data-analysis|33|||
16074902|NCT02975934|38766395|FG001|Treatment Phase|Ongoing at data-analysis|5|||
16074903|NCT02975934|38766394|FG000|Treatment Phase|Discontinued prior to study drug|0|||
16074904|NCT02975934|38766395|FG001|Treatment Phase|Discontinued prior to study drug|5|||
16374797|NCT03636269|39856782|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
16374798|NCT03636269|39856780|FG000|Period 1: Double-blind Phase|Other|6|||
16374799|NCT03636269|39856781|FG001|Period 1: Double-blind Phase|Other|3|||
16374800|NCT03636269|39856782|FG002|Period 1: Double-blind Phase|Other|0|||
16374801|NCT03636269|39856780|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
16374802|NCT03636269|39856781|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
16374803|NCT03636269|39856782|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
16374804|NCT03636269|39856780|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
16374805|NCT03636269|39856781|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
16374806|NCT03636269|39856782|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
16374807|NCT03636269|39856780|FG000|Period 2: Open-label Phase|Adverse Event|0|||
16374808|NCT03636269|39856781|FG001|Period 2: Open-label Phase|Adverse Event|0|||
16374809|NCT03636269|39856782|FG002|Period 2: Open-label Phase|Adverse Event|21|||
16374810|NCT03636269|39856780|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
16374811|NCT03636269|39856781|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
16374812|NCT03636269|39856782|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
16374813|NCT03636269|39856780|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
16374814|NCT03636269|39856781|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
16374815|NCT03636269|39856782|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
16374816|NCT03636269|39856780|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
16374817|NCT03636269|39856781|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
16374818|NCT03636269|39856782|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
16374819|NCT03636269|39856780|FG000|Period 2: Open-label Phase|Administrative|0|||
16374820|NCT03636269|39856781|FG001|Period 2: Open-label Phase|Administrative|0|||
16374821|NCT03636269|39856782|FG002|Period 2: Open-label Phase|Administrative|36|||
16374822|NCT03636269|39856780|FG000|Period 2: Open-label Phase|Other|0|||
16374823|NCT03636269|39856781|FG001|Period 2: Open-label Phase|Other|0|||
16074905|NCT02975934|38766394|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
16074906|NCT02975934|38766395|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
16074907|NCT00082810|38766406|FG000|Overall Study|Adverse Event|3|||
16074908|NCT00082810|38766406|FG000|Overall Study|Progressive disease|24|||
16074909|NCT00082810|38766406|FG000|Overall Study|Withdrawal by Subject|4|||
16374824|NCT03636269|39856782|FG002|Period 2: Open-label Phase|Other|9|||
16374825|NCT03636269|39856780|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
16374826|NCT03636269|39856781|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
16374827|NCT03636269|39856782|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
16374828|NCT03721965|39856783|FG000|Overall Study|Death|1|||
16374829|NCT03721965|39856783|FG000|Overall Study|Study Terminated by Sponsor|1|||
16374830|NCT01681849|39856784|FG000|Overall Study|Protocol Violation|2|||
16374831|NCT01681849|39856785|FG001|Overall Study|Protocol Violation|0|||
16374832|NCT01681849|39856786|FG002|Overall Study|Protocol Violation|0|||
16374833|NCT01681849|39856784|FG000|Overall Study|Withdrawal by Subject|3|||
16374834|NCT01681849|39856785|FG001|Overall Study|Withdrawal by Subject|5|||
16374835|NCT01681849|39856786|FG002|Overall Study|Withdrawal by Subject|33|||
16374836|NCT01681849|39856784|FG000|Overall Study|Lost to Follow-up|3|||
16374837|NCT01681849|39856785|FG001|Overall Study|Lost to Follow-up|2|||
16374838|NCT01681849|39856786|FG002|Overall Study|Lost to Follow-up|6|||
16074910|NCT02057692|38766407|FG000|Overall Study|Adverse Event|1|||
16074911|NCT02057692|38766408|FG001|Overall Study|Adverse Event|0|||
16074912|NCT02057692|38766409|FG002|Overall Study|Adverse Event|0|||
16074913|NCT02057692|38766410|FG003|Overall Study|Adverse Event|0|||
16074914|NCT02057692|38766407|FG000|Overall Study|Lost to Follow-up|0|||
16074915|NCT02057692|38766408|FG001|Overall Study|Lost to Follow-up|0|||
16074916|NCT02057692|38766409|FG002|Overall Study|Lost to Follow-up|0|||
16173709|NCT03124459|39115255|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
16173710|NCT03124459|39115256|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
16173711|NCT03124459|39115257|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
16173712|NCT03124459|39115258|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
16173713|NCT03124459|39115259|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
16173714|NCT03124459|39115254|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
16173715|NCT03124459|39115255|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
16173716|NCT03124459|39115256|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
16173717|NCT03124459|39115257|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
16173718|NCT03124459|39115258|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
16173719|NCT03124459|39115259|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
16173720|NCT03124459|39115254|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
16173721|NCT03124459|39115255|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
16173722|NCT03124459|39115256|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
16173723|NCT03124459|39115257|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
16173724|NCT03124459|39115258|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
16173725|NCT03124459|39115259|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
16173726|NCT03124459|39115254|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
16374839|NCT01133977|39856792|FG000|Overall Study|Adverse Event|0|||
16374840|NCT01133977|39856793|FG001|Overall Study|Adverse Event|0|||
16374841|NCT01133977|39856794|FG002|Overall Study|Adverse Event|1|||
16374842|NCT01133977|39856795|FG003|Overall Study|Adverse Event|0|||
16374843|NCT01133977|39856796|FG004|Overall Study|Adverse Event|0|||
16374844|NCT01133977|39856792|FG000|Overall Study|Death|1|||
16374845|NCT01133977|39856793|FG001|Overall Study|Death|1|||
16374846|NCT01133977|39856794|FG002|Overall Study|Death|1|||
16374847|NCT01133977|39856795|FG003|Overall Study|Death|7|||
16374848|NCT01133977|39856796|FG004|Overall Study|Death|3|||
16374849|NCT01133977|39856792|FG000|Overall Study|Started a New Line of Therapy|2|||
16374850|NCT01133977|39856793|FG001|Overall Study|Started a New Line of Therapy|6|||
16374851|NCT01133977|39856794|FG002|Overall Study|Started a New Line of Therapy|4|||
16374852|NCT01133977|39856795|FG003|Overall Study|Started a New Line of Therapy|25|||
16374853|NCT01133977|39856796|FG004|Overall Study|Started a New Line of Therapy|33|||
16374854|NCT01133977|39856792|FG000|Overall Study|Lost to Follow-up|0|||
16374855|NCT01133977|39856793|FG001|Overall Study|Lost to Follow-up|0|||
16173727|NCT03124459|39115255|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
16173728|NCT03124459|39115256|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
16173729|NCT03124459|39115257|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
16374856|NCT01133977|39856794|FG002|Overall Study|Lost to Follow-up|0|||
16374857|NCT01133977|39856795|FG003|Overall Study|Lost to Follow-up|2|||
16374858|NCT01133977|39856796|FG004|Overall Study|Lost to Follow-up|1|||
16374859|NCT01133977|39856792|FG000|Overall Study|Withdrawal by Subject|0|||
16074917|NCT02057692|38766410|FG003|Overall Study|Lost to Follow-up|1|||
16074918|NCT00468910|38766422|FG000|Overall Study|Lost to Follow-up|2|||
16374860|NCT01133977|39856793|FG001|Overall Study|Withdrawal by Subject|0|||
16374861|NCT01133977|39856794|FG002|Overall Study|Withdrawal by Subject|0|||
16374862|NCT01133977|39856795|FG003|Overall Study|Withdrawal by Subject|5|||
16374863|NCT01133977|39856796|FG004|Overall Study|Withdrawal by Subject|1|||
16374864|NCT00625378|39856797|FG000|Overall Study|Adverse Event|22|||
16374865|NCT00625378|39856798|FG001|Overall Study|Adverse Event|0|||
16074919|NCT00468910|38766423|FG001|Overall Study|Lost to Follow-up|1|||
16074920|NCT00468910|38766422|FG000|Overall Study|Withdrawal by Subject|2|||
16374866|NCT00625378|39856797|FG000|Overall Study|Withdrawal by Subject|16|||
16374867|NCT00625378|39856798|FG001|Overall Study|Withdrawal by Subject|0|||
16374868|NCT00625378|39856797|FG000|Overall Study|Death|38|||
16374869|NCT00625378|39856798|FG001|Overall Study|Death|0|||
16374870|NCT00625378|39856797|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
16374871|NCT00625378|39856798|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
16374872|NCT00625378|39856797|FG000|Overall Study|Lost to Follow-up|17|||
16374873|NCT00625378|39856798|FG001|Overall Study|Lost to Follow-up|0|||
16374874|NCT00625378|39856797|FG000|Overall Study|Non-compliant with study medication|3|||
16374875|NCT00625378|39856798|FG001|Overall Study|Non-compliant with study medication|0|||
16374876|NCT00625378|39856797|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
16374877|NCT00625378|39856798|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
16374878|NCT00625378|39856797|FG000|Overall Study|Medical decision|1|||
16374879|NCT00625378|39856798|FG001|Overall Study|Medical decision|0|||
16374880|NCT00625378|39856797|FG000|Overall Study|Multiple toxicities|1|||
16374881|NCT00625378|39856798|FG001|Overall Study|Multiple toxicities|0|||
16374882|NCT00625378|39856797|FG000|Overall Study|New cancer|1|||
16074921|NCT00468910|38766423|FG001|Overall Study|Withdrawal by Subject|1|||
16074922|NCT00468910|38766422|FG000|Overall Study|Medical Contraindication|0|||
16074923|NCT00468910|38766423|FG001|Overall Study|Medical Contraindication|1|||
16074924|NCT02880241|38766424|FG000|Overall Study|Lack of Efficacy|1|||
16074925|NCT02880241|38766425|FG001|Overall Study|Lack of Efficacy|0|||
16074926|NCT02880241|38766426|FG002|Overall Study|Lack of Efficacy|0|||
16074927|NCT02880241|38766427|FG003|Overall Study|Lack of Efficacy|0|||
16074928|NCT02880241|38766428|FG004|Overall Study|Lack of Efficacy|0|||
16074929|NCT02880241|38766429|FG005|Overall Study|Lack of Efficacy|0|||
16074930|NCT01075217|38766430|FG000|Overall Study|Adverse Event|1|||
16074931|NCT01075217|38766431|FG001|Overall Study|Adverse Event|1|||
16074932|NCT01075217|38766430|FG000|Overall Study|Physician Decision|1|||
16074933|NCT01075217|38766431|FG001|Overall Study|Physician Decision|0|||
16074934|NCT00668863|38766432|FG000|Overall Study|Objective Progression or Relapse|42|||
16074935|NCT00668863|38766432|FG000|Overall Study|Adverse Event|13|||
16074936|NCT00668863|38766432|FG000|Overall Study|Study Terminated by Sponsor|8|||
16074937|NCT00668863|38766432|FG000|Overall Study|Global Deterioration of Health Status|4|||
16074938|NCT00668863|38766432|FG000|Overall Study|Withdrawal by Subject|1|||
16074939|NCT00668863|38766432|FG000|Overall Study|Surgery|1|||
16074940|NCT00668863|38766432|FG000|Overall Study|Subject's work scheduling problem|1|||
16074941|NCT00668863|38766432|FG000|Overall Study|Physician Decision|1|||
16074942|NCT01802632|38766437|FG000|Overall Study|Death|28|||
16074943|NCT01802632|38766438|FG001|Overall Study|Death|1|||
16074944|NCT01802632|38766439|FG002|Overall Study|Death|38|||
16074945|NCT01802632|38766440|FG003|Overall Study|Death|0|||
16074946|NCT01802632|38766441|FG004|Overall Study|Death|2|||
16074947|NCT01802632|38766442|FG005|Overall Study|Death|0|||
16074948|NCT01802632|38766437|FG000|Overall Study|Withdrawal by Subject|4|||
16074949|NCT01802632|38766438|FG001|Overall Study|Withdrawal by Subject|2|||
16074950|NCT01802632|38766439|FG002|Overall Study|Withdrawal by Subject|7|||
16074951|NCT01802632|38766440|FG003|Overall Study|Withdrawal by Subject|3|||
16074952|NCT01802632|38766441|FG004|Overall Study|Withdrawal by Subject|0|||
16074953|NCT01802632|38766442|FG005|Overall Study|Withdrawal by Subject|1|||
16074954|NCT01802632|38766437|FG000|Overall Study|Objective Disease Progression|1|||
16074955|NCT01802632|38766438|FG001|Overall Study|Objective Disease Progression|12|||
16074956|NCT01802632|38766439|FG002|Overall Study|Objective Disease Progression|104|||
16074957|NCT01802632|38766440|FG003|Overall Study|Objective Disease Progression|6|||
16074958|NCT01802632|38766441|FG004|Overall Study|Objective Disease Progression|4|||
16074959|NCT01802632|38766442|FG005|Overall Study|Objective Disease Progression|4|||
16074960|NCT01802632|38766437|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
16074961|NCT01802632|38766438|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
16074962|NCT01802632|38766439|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
16074963|NCT01802632|38766440|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
16074964|NCT01802632|38766441|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
16074965|NCT01802632|38766442|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
16074966|NCT01802632|38766437|FG000|Overall Study|Other (not specified)|0|||
16374883|NCT00625378|39856798|FG001|Overall Study|New cancer|0|||
16374884|NCT00625378|39856797|FG000|Overall Study|PTA program|2|||
16374885|NCT00625378|39856798|FG001|Overall Study|PTA program|0|||
16473247|NCT00048061|40214420|FG001|Overall Study|Withdrawal by Subject|29|||
16074967|NCT01802632|38766438|FG001|Overall Study|Other (not specified)|0|||
16074968|NCT01802632|38766439|FG002|Overall Study|Other (not specified)|7|||
16074969|NCT01802632|38766440|FG003|Overall Study|Other (not specified)|1|||
16074970|NCT01802632|38766441|FG004|Overall Study|Other (not specified)|0|||
16074971|NCT01802632|38766442|FG005|Overall Study|Other (not specified)|1|||
16074972|NCT01039688|38766445|FG000|Overall Study|Adverse Event|38|||
16074973|NCT01039688|38766446|FG001|Overall Study|Adverse Event|39|||
16074974|NCT01039688|38766447|FG002|Overall Study|Adverse Event|24|||
16074975|NCT01039688|38766445|FG000|Overall Study|Lack of Efficacy|20|||
16546445|NCT04704154|40464809|FG004|Overall Study|Physician Decision|1|||
16374886|NCT00625378|39856797|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
16374887|NCT00625378|39856798|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
16374888|NCT00625378|39856797|FG000|Overall Study|Sponsor decision|1|||
16374889|NCT00625378|39856798|FG001|Overall Study|Sponsor decision|0|||
16374890|NCT00625378|39856797|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
16374891|NCT00625378|39856798|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
16374892|NCT00625378|39856797|FG000|Overall Study|Switch to commercial drug|6|||
16374893|NCT00625378|39856798|FG001|Overall Study|Switch to commercial drug|1|||
16374894|NCT00625378|39856797|FG000|Overall Study|Missing|2|||
16374895|NCT00625378|39856798|FG001|Overall Study|Missing|0|||
16374896|NCT00625378|39856797|FG000|Overall Study|End of treatment not available|2|||
16374897|NCT00625378|39856798|FG001|Overall Study|End of treatment not available|0|||
16374898|NCT00625378|39856797|FG000|Overall Study|Never treated|2|||
16374899|NCT00625378|39856798|FG001|Overall Study|Never treated|0|||
16374900|NCT00449787|39856799|FG000|Overall Study|Lost to Follow-up|10|||
16374901|NCT00449787|39856800|FG001|Overall Study|Lost to Follow-up|8|||
16374902|NCT00449787|39856799|FG000|Overall Study|Did not require medication|95|||
16374903|NCT00449787|39856800|FG001|Overall Study|Did not require medication|92|||
16374904|NCT00309946|39856801|FG000|Overall Study|Withdrawal by Subject|1|||
16374905|NCT03757715|39856807|FG000|Overall Study|Lost to Follow-up|4|||
16374906|NCT03757715|39856808|FG001|Overall Study|Lost to Follow-up|9|||
16374907|NCT03757715|39856807|FG000|Overall Study|Withdrawal by Subject|1|||
16374908|NCT03757715|39856808|FG001|Overall Study|Withdrawal by Subject|1|||
16374909|NCT00395447|39856809|FG000|Overall Study|Death|37|||
16374910|NCT00395447|39856810|FG001|Overall Study|Death|32|||
16374911|NCT00395447|39856809|FG000|Overall Study|Lost to Follow-up|52|||
16374912|NCT00395447|39856810|FG001|Overall Study|Lost to Follow-up|43|||
16374913|NCT00395447|39856809|FG000|Overall Study|Withdrawal by Subject|24|||
16374914|NCT00395447|39856810|FG001|Overall Study|Withdrawal by Subject|19|||
16374915|NCT00395447|39856809|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
16374916|NCT00395447|39856810|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
16374917|NCT01248468|39856815|FG000|Overall Study|Administrative problem|1|||
16374918|NCT01248468|39856816|FG001|Overall Study|Administrative problem|0|||
16374919|NCT01248468|39856817|FG002|Overall Study|Administrative problem|0|||
16374920|NCT01248468|39856815|FG000|Overall Study|Lost to Follow-up|9|||
16374921|NCT01248468|39856816|FG001|Overall Study|Lost to Follow-up|12|||
16473248|NCT00048061|40214421|FG002|Overall Study|Withdrawal by Subject|29|||
16074976|NCT01039688|38766446|FG001|Overall Study|Lack of Efficacy|11|||
16074977|NCT01039688|38766447|FG002|Overall Study|Lack of Efficacy|26|||
16074978|NCT01039688|38766445|FG000|Overall Study|Lost to Follow-up|11|||
16074979|NCT01039688|38766446|FG001|Overall Study|Lost to Follow-up|9|||
16074980|NCT01039688|38766447|FG002|Overall Study|Lost to Follow-up|5|||
16074981|NCT01039688|38766445|FG000|Overall Study|Other|13|||
16074982|NCT01039688|38766446|FG001|Overall Study|Other|25|||
16074983|NCT01039688|38766447|FG002|Overall Study|Other|12|||
16074984|NCT01039688|38766445|FG000|Overall Study|Withdrawal by Subject|23|||
16074985|NCT01039688|38766446|FG001|Overall Study|Withdrawal by Subject|27|||
16074986|NCT01039688|38766447|FG002|Overall Study|Withdrawal by Subject|13|||
16074987|NCT01039688|38766445|FG000|Overall Study|Death|2|||
16074988|NCT01039688|38766446|FG001|Overall Study|Death|0|||
16074989|NCT01039688|38766447|FG002|Overall Study|Death|0|||
16074990|NCT00922207|38766448|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
16074991|NCT00922207|38766449|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
16274816|NCT00748566|39490179|FG000|Overall Study|Adverse Event|49|||
16274817|NCT00748566|39490179|FG000|Overall Study|Death|1|||
16374922|NCT01248468|39856817|FG002|Overall Study|Lost to Follow-up|4|||
16374923|NCT01248468|39856815|FG000|Overall Study|Pregnancy|1|||
16374924|NCT01248468|39856816|FG001|Overall Study|Pregnancy|0|||
16374925|NCT01248468|39856817|FG002|Overall Study|Pregnancy|0|||
16374926|NCT01248468|39856815|FG000|Overall Study|Withdrawal by Subject|4|||
16374927|NCT01248468|39856816|FG001|Overall Study|Withdrawal by Subject|2|||
16374928|NCT01248468|39856817|FG002|Overall Study|Withdrawal by Subject|0|||
16374929|NCT02565186|39856818|FG000|Overall Study|Adverse Event|113|||
16374930|NCT02565186|39856819|FG001|Overall Study|Adverse Event|148|||
16374931|NCT02565186|39856818|FG000|Overall Study|Lost to Follow-up|102|||
16374932|NCT02565186|39856819|FG001|Overall Study|Lost to Follow-up|93|||
16374933|NCT02565186|39856818|FG000|Overall Study|Non-Compliance|57|||
16374934|NCT02565186|39856819|FG001|Overall Study|Non-Compliance|55|||
16374935|NCT02565186|39856818|FG000|Overall Study|Withdrawal by Subject|229|||
16374936|NCT02565186|39856819|FG001|Overall Study|Withdrawal by Subject|214|||
16074992|NCT00922207|38766450|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
16074993|NCT00922207|38766448|FG000|Overall Study|Insufficient Therapeutic Response|0|||
16374937|NCT02565186|39856818|FG000|Overall Study|Physician Decision|18|||
16374938|NCT02565186|39856819|FG001|Overall Study|Physician Decision|16|||
16374939|NCT02565186|39856818|FG000|Overall Study|Sponsor Request|5|||
16374940|NCT02565186|39856819|FG001|Overall Study|Sponsor Request|9|||
16374941|NCT02565186|39856818|FG000|Overall Study|Missing|1|||
16546446|NCT04704154|40464810|FG005|Overall Study|Physician Decision|0|||
16074994|NCT00922207|38766449|FG001|Overall Study|Insufficient Therapeutic Response|0|||
16074995|NCT00922207|38766450|FG002|Overall Study|Insufficient Therapeutic Response|1|||
16374942|NCT02565186|39856819|FG001|Overall Study|Missing|0|||
16374943|NCT02565186|39856818|FG000|Overall Study|Did Not Receive Study Drug|55|||
16374944|NCT02565186|39856819|FG001|Overall Study|Did Not Receive Study Drug|86|||
16374945|NCT04223687|39856822|FG000|Overall Study|Missing primary outcome|1|||
16374946|NCT04223687|39856823|FG001|Overall Study|Missing primary outcome|0|||
16374947|NCT02691494|39856824|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
16074996|NCT00922207|38766448|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
16074997|NCT00922207|38766449|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
16074998|NCT00922207|38766450|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
16074999|NCT00922207|38766448|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
16075000|NCT00922207|38766449|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
16075001|NCT00922207|38766450|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
16075002|NCT00922207|38766448|FG000|Overall Study|Withdrew Consent|2|||
16075003|NCT00922207|38766449|FG001|Overall Study|Withdrew Consent|5|||
16075004|NCT00922207|38766450|FG002|Overall Study|Withdrew Consent|2|||
16075005|NCT00922207|38766448|FG000|Overall Study|Abnormality of Laboratory Test|0|||
16075006|NCT00922207|38766449|FG001|Overall Study|Abnormality of Laboratory Test|1|||
16075007|NCT00922207|38766450|FG002|Overall Study|Abnormality of Laboratory Test|1|||
16075008|NCT00442117|38766451|FG000|Overall Study|Adverse Event|3|||
16075009|NCT00442117|38766452|FG001|Overall Study|Adverse Event|2|||
16075010|NCT00442117|38766451|FG000|Overall Study|Lack of Efficacy|2|||
16374948|NCT02691494|39856825|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
16374949|NCT02691494|39856826|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
16374950|NCT02691494|39856824|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
16374951|NCT02691494|39856825|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
16374952|NCT02691494|39856826|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
16374953|NCT02691494|39856824|FG000|Post-Treatment Follow-Up Period|Other|2|||
16374954|NCT02691494|39856825|FG001|Post-Treatment Follow-Up Period|Other|1|||
16075011|NCT00442117|38766452|FG001|Overall Study|Lack of Efficacy|6|||
16075012|NCT00442117|38766451|FG000|Overall Study|Lost to Follow-up|1|||
16075013|NCT00442117|38766452|FG001|Overall Study|Lost to Follow-up|2|||
16075014|NCT00442117|38766451|FG000|Overall Study|Withdrawal by Subject|2|||
16075015|NCT00442117|38766452|FG001|Overall Study|Withdrawal by Subject|2|||
16075016|NCT00442117|38766451|FG000|Overall Study|Major Deviation|25|||
16075017|NCT00442117|38766452|FG001|Overall Study|Major Deviation|20|||
16075018|NCT00442117|38766451|FG000|Overall Study|Non compliance with protocol|3|||
16075019|NCT00442117|38766452|FG001|Overall Study|Non compliance with protocol|5|||
16075020|NCT00442117|38766451|FG000|Overall Study|Met Withdrawal Criteria|2|||
16075021|NCT00442117|38766452|FG001|Overall Study|Met Withdrawal Criteria|1|||
16075022|NCT02537522|38766458|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
16075023|NCT02537522|38766459|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
16075024|NCT02537522|38766460|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
16075025|NCT02537522|38766461|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
16075026|NCT02537522|38766458|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
16075027|NCT02537522|38766459|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
16075028|NCT02537522|38766460|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
16075029|NCT02537522|38766461|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
16075030|NCT02537522|38766458|FG000|Phase I - Contralateral|incorrect randomization|0|||
16075031|NCT02537522|38766459|FG001|Phase I - Contralateral|incorrect randomization|1|||
16075032|NCT02537522|38766460|FG002|Phase I - Contralateral|incorrect randomization|0|||
16075033|NCT02537522|38766461|FG003|Phase I - Contralateral|incorrect randomization|0|||
16075034|NCT02537522|38766458|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
16075035|NCT02537522|38766459|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
16075036|NCT02537522|38766460|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
16075037|NCT02537522|38766461|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
16075038|NCT02537522|38766458|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
16075039|NCT02537522|38766459|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
16075040|NCT02537522|38766460|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
16075041|NCT02537522|38766461|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
16075042|NCT00794118|38766464|FG000|Overall Study|Lost to Follow-up|16|||
16075043|NCT00794118|38766464|FG000|Overall Study|Withdrawal by Subject|9|||
16173730|NCT03124459|39115258|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
16374955|NCT02691494|39856826|FG002|Post-Treatment Follow-Up Period|Other|1|||
16374956|NCT02691494|39856824|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
16374957|NCT02691494|39856825|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
16374958|NCT02691494|39856826|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
16374959|NCT02691494|39856824|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
16075044|NCT00794118|38766464|FG000|Overall Study|Changed hospital center|2|||
16075045|NCT00319436|38766465|FG000|Overall Study|Withdrawal by Subject|6|||
16374960|NCT02691494|39856825|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
16374961|NCT02691494|39856826|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
16374962|NCT01084135|39856827|FG000|20 Week|Physician Decision|0|||
16374963|NCT01084135|39856828|FG001|20 Week|Physician Decision|1|||
16374964|NCT01592747|39856830|FG000|Overall Study|Loss of Therapeutic Response|107|||
16075046|NCT00319436|38766466|FG001|Overall Study|Withdrawal by Subject|7|||
16274818|NCT00748566|39490179|FG000|Overall Study|Lack of Efficacy|12|||
16374965|NCT01592747|39856831|FG001|Overall Study|Loss of Therapeutic Response|108|||
16374966|NCT01592747|39856832|FG002|Overall Study|Loss of Therapeutic Response|100|||
16374967|NCT01592747|39856830|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
16374968|NCT01592747|39856831|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
16374969|NCT01592747|39856832|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
16374970|NCT01592747|39856830|FG000|Overall Study|Adverse Event|1|||
16374971|NCT01592747|39856831|FG001|Overall Study|Adverse Event|0|||
16374972|NCT01592747|39856832|FG002|Overall Study|Adverse Event|0|||
16374973|NCT01592747|39856830|FG000|Overall Study|Protocol Violation|4|||
16374974|NCT01592747|39856831|FG001|Overall Study|Protocol Violation|0|||
16374975|NCT01592747|39856832|FG002|Overall Study|Protocol Violation|4|||
16374976|NCT01592747|39856830|FG000|Overall Study|Lack of Efficacy|0|||
16374977|NCT01592747|39856831|FG001|Overall Study|Lack of Efficacy|1|||
16374978|NCT01592747|39856832|FG002|Overall Study|Lack of Efficacy|0|||
16374979|NCT01592747|39856830|FG000|Overall Study|Withdrawal by Subject|2|||
16374980|NCT01592747|39856831|FG001|Overall Study|Withdrawal by Subject|0|||
16374981|NCT01592747|39856832|FG002|Overall Study|Withdrawal by Subject|2|||
16374982|NCT01592747|39856830|FG000|Overall Study|Lost to Follow-up|1|||
16374983|NCT01592747|39856831|FG001|Overall Study|Lost to Follow-up|0|||
16374984|NCT01592747|39856832|FG002|Overall Study|Lost to Follow-up|1|||
16374985|NCT01592747|39856830|FG000|Overall Study|Other Reasons|1|||
16374986|NCT01592747|39856831|FG001|Overall Study|Other Reasons|1|||
16374987|NCT01592747|39856832|FG002|Overall Study|Other Reasons|0|||
16374988|NCT05346640|39856833|FG000|Overall Study|Lack of Efficacy|2|||
16374989|NCT05346640|39856833|FG000|Overall Study|Lost to Follow-up|14|||
16374990|NCT05346640|39856833|FG000|Overall Study|Protocol Violation|4|||
16374991|NCT05346640|39856833|FG000|Overall Study|Withdrawal by Subject|2|||
16374992|NCT05346640|39856833|FG000|Overall Study|Physiological Complications|3|||
16374993|NCT05346640|39856833|FG000|Overall Study|Other Reason|3|||
16374994|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
16374995|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
16374996|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
16374997|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
16374998|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
16374999|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
16375000|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
16375001|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
16375002|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
16375003|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
16375004|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
16375005|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
16375006|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
16375007|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
16375008|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
16375009|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
16375010|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
16375011|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
16375012|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
16375013|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
16375014|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
16375015|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
16375016|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
16375017|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
16375018|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
16375019|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
16375020|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
16375021|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
16375022|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
16075047|NCT00346151|38766471|FG000|Overall Study|Withdrawal by Subject|3|||
16375023|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
16375024|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
16375025|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
16375026|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
16375027|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
16375028|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
16375029|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
16375030|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
16375031|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
16375032|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
16375033|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
16375034|NCT02596893|39856837|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
16375035|NCT02596893|39856838|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
16375036|NCT02596893|39856839|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
16375037|NCT02596893|39856840|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
16375038|NCT03721107|39856841|FG000|Overall Study|Adverse Event|1|||
16375039|NCT03721107|39856842|FG001|Overall Study|Adverse Event|1|||
16375040|NCT03721107|39856843|FG002|Overall Study|Adverse Event|6|||
16375041|NCT03721107|39856844|FG003|Overall Study|Adverse Event|5|||
16375042|NCT03721107|39856841|FG000|Overall Study|Lost to Follow-up|2|||
16375043|NCT03721107|39856842|FG001|Overall Study|Lost to Follow-up|0|||
16375044|NCT03721107|39856843|FG002|Overall Study|Lost to Follow-up|3|||
16375045|NCT03721107|39856844|FG003|Overall Study|Lost to Follow-up|0|||
16375046|NCT03721107|39856841|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
16375047|NCT03721107|39856842|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
16375048|NCT03721107|39856843|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
16375049|NCT03721107|39856844|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
16375050|NCT03721107|39856841|FG000|Overall Study|Physician Decision|0|||
16375051|NCT03721107|39856842|FG001|Overall Study|Physician Decision|1|||
16375052|NCT03721107|39856843|FG002|Overall Study|Physician Decision|0|||
16375053|NCT03721107|39856844|FG003|Overall Study|Physician Decision|0|||
16375054|NCT03721107|39856841|FG000|Overall Study|Pregnancy|0|||
16375055|NCT03721107|39856842|FG001|Overall Study|Pregnancy|0|||
16375056|NCT03721107|39856843|FG002|Overall Study|Pregnancy|1|||
16375057|NCT03721107|39856844|FG003|Overall Study|Pregnancy|0|||
16375058|NCT03721107|39856841|FG000|Overall Study|Withdrawal by Subject|1|||
16375059|NCT03721107|39856842|FG001|Overall Study|Withdrawal by Subject|1|||
16375060|NCT03721107|39856843|FG002|Overall Study|Withdrawal by Subject|5|||
16375061|NCT03721107|39856844|FG003|Overall Study|Withdrawal by Subject|5|||
16375062|NCT03721107|39856841|FG000|Overall Study|Other|1|||
16375063|NCT03721107|39856842|FG001|Overall Study|Other|0|||
16375064|NCT03721107|39856843|FG002|Overall Study|Other|0|||
16375065|NCT03721107|39856844|FG003|Overall Study|Other|1|||
16375066|NCT04309500|39856847|FG000|Overall Study|Lost to Follow-up|1|||
16375067|NCT04309500|39856848|FG001|Overall Study|Lost to Follow-up|0|||
16375068|NCT04309500|39856849|FG002|Overall Study|Lost to Follow-up|0|||
16375069|NCT04309500|39856850|FG003|Overall Study|Lost to Follow-up|0|||
16375070|NCT01691092|39856851|FG000|Overall Study|Lost to Follow-up|10|||
16375071|NCT01691092|39856851|FG000|Overall Study|Physician Decision|4|||
16375072|NCT01691092|39856851|FG000|Overall Study|Withdrawal by Subject|3|||
16375073|NCT01691092|39856851|FG000|Overall Study|non-compliance|3|||
16375074|NCT01691092|39856851|FG000|Overall Study|used for different study|2|||
16375075|NCT01691092|39856851|FG000|Overall Study|screen fail|19|||
16375076|NCT01832038|39856853|FG000|Overall Study|Death|5|||
16375077|NCT01832038|39856853|FG000|Overall Study|Adverse Event|50|||
16375078|NCT01832038|39856853|FG000|Overall Study|Lack of Efficacy|81|||
16375079|NCT01832038|39856853|FG000|Overall Study|Protocol Violation|7|||
16375080|NCT01832038|39856853|FG000|Overall Study|Lost to Follow-up|10|||
16375081|NCT01832038|39856853|FG000|Overall Study|Withdrawal by Subject|49|||
16375082|NCT01832038|39856853|FG000|Overall Study|Visit non-compliance|2|||
16375083|NCT01832038|39856853|FG000|Overall Study|Subject refused to return visit|2|||
16375084|NCT01832038|39856853|FG000|Overall Study|Not convenient to come back to site|2|||
16375085|NCT01832038|39856853|FG000|Overall Study|Participant was asked to quit|5|||
16375086|NCT01832038|39856853|FG000|Overall Study|Back home|1|||
16375087|NCT01832038|39856853|FG000|Overall Study|Pregnancy|1|||
16375088|NCT01832038|39856853|FG000|Overall Study|Low compliance|3|||
16375089|NCT01832038|39856853|FG000|Overall Study|Prohibit procedure|2|||
16375090|NCT01832038|39856853|FG000|Overall Study|Not possible to visit the hospital|1|||
16375091|NCT01832038|39856853|FG000|Overall Study|Changes of implementation system|3|||
16473249|NCT00048061|40214422|FG003|Overall Study|Withdrawal by Subject|32|||
16375092|NCT01832038|39856853|FG000|Overall Study|Plan to pregnancy|7|||
16375093|NCT01832038|39856853|FG000|Overall Study|Bad mood and has suicidal thought|1|||
16375094|NCT01832038|39856853|FG000|Overall Study|Prohibited concomitant medication|1|||
16375095|NCT01832038|39856853|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
16375096|NCT01832038|39856853|FG000|Overall Study|Subject considered the efficacy was poor|1|||
16375097|NCT04634331|39856854|FG000|Overall Study|Withdrawal by Subject|2|||
16375098|NCT04634331|39856855|FG001|Overall Study|Withdrawal by Subject|2|||
16375099|NCT00420407|39856856|FG000|Overall Study|Lost to Follow-up|0|||
16473250|NCT00048061|40214419|FG000|Overall Study|Did not follow-up|5|||
16473251|NCT00048061|40214420|FG001|Overall Study|Did not follow-up|5|||
16473252|NCT00048061|40214421|FG002|Overall Study|Did not follow-up|4|||
16473253|NCT00048061|40214422|FG003|Overall Study|Did not follow-up|5|||
16473254|NCT00048061|40214419|FG000|Overall Study|Early improvement|6|||
16473255|NCT00048061|40214420|FG001|Overall Study|Early improvement|5|||
16473256|NCT00048061|40214421|FG002|Overall Study|Early improvement|3|||
16473257|NCT00048061|40214422|FG003|Overall Study|Early improvement|0|||
16473258|NCT01024231|40214424|FG000|Overall Study|Other Reasons|1|||
16473259|NCT01024231|40214425|FG001|Overall Study|Other Reasons|2|||
16473260|NCT01024231|40214426|FG002|Overall Study|Other Reasons|0|||
16473261|NCT01024231|40214427|FG003|Overall Study|Other Reasons|0|||
16473262|NCT01024231|40214428|FG004|Overall Study|Other Reasons|2|||
16473263|NCT01024231|40214429|FG005|Overall Study|Other Reasons|0|||
16473264|NCT01024231|40214430|FG006|Overall Study|Other Reasons|1|||
16473265|NCT01024231|40214424|FG000|Overall Study|Maximum Clinical Benefit|1|||
16473266|NCT01024231|40214425|FG001|Overall Study|Maximum Clinical Benefit|2|||
16473267|NCT01024231|40214426|FG002|Overall Study|Maximum Clinical Benefit|0|||
16473268|NCT01024231|40214427|FG003|Overall Study|Maximum Clinical Benefit|1|||
16473269|NCT01024231|40214428|FG004|Overall Study|Maximum Clinical Benefit|1|||
16075048|NCT00356265|38766474|FG000|Overall Study|Withdrawal by Subject|0|||
16075049|NCT00356265|38766475|FG001|Overall Study|Withdrawal by Subject|0|||
16473270|NCT01024231|40214429|FG005|Overall Study|Maximum Clinical Benefit|0|||
16473271|NCT01024231|40214430|FG006|Overall Study|Maximum Clinical Benefit|0|||
16473272|NCT01024231|40214424|FG000|Overall Study|Disease Progression|3|||
16473273|NCT01024231|40214425|FG001|Overall Study|Disease Progression|1|||
16473274|NCT01024231|40214426|FG002|Overall Study|Disease Progression|3|||
16375100|NCT00420407|39856857|FG001|Overall Study|Lost to Follow-up|3|||
16375101|NCT00420407|39856856|FG000|Overall Study|Physician Decision|2|||
16075050|NCT00356265|38766476|FG002|Overall Study|Withdrawal by Subject|1|||
16075051|NCT01063517|38766477|FG000|Overall Study|Consent withdrawal|1|||
16075052|NCT01063517|38766478|FG001|Overall Study|Consent withdrawal|0|||
16075053|NCT01063517|38766477|FG000|Overall Study|Study reached data cut-off|19|||
16075054|NCT01063517|38766478|FG001|Overall Study|Study reached data cut-off|7|||
16075055|NCT01063517|38766477|FG000|Overall Study|Lost to Follow-up|4|||
16075056|NCT01063517|38766478|FG001|Overall Study|Lost to Follow-up|3|||
16075057|NCT01063517|38766477|FG000|Overall Study|Withdrawal by Subject|1|||
16075058|NCT01063517|38766478|FG001|Overall Study|Withdrawal by Subject|2|||
16075059|NCT01063517|38766477|FG000|Overall Study|Death|33|||
16075060|NCT01063517|38766478|FG001|Overall Study|Death|48|||
16075061|NCT01909778|38766480|FG000|Overall Study|failed screening|1|||
16075062|NCT03737240|38766481|FG000|Overall Study|Lost to Follow-up|16|||
16075063|NCT03737240|38766482|FG001|Overall Study|Lost to Follow-up|15|||
16075064|NCT02698241|38766483|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
16375102|NCT00420407|39856857|FG001|Overall Study|Physician Decision|1|||
16375103|NCT00420407|39856856|FG000|Overall Study|subject identified as detainee|1|||
16375104|NCT00420407|39856857|FG001|Overall Study|subject identified as detainee|0|||
16375105|NCT00420407|39856856|FG000|Overall Study|subject identified as Jehovah's witness|1|||
16375106|NCT00420407|39856857|FG001|Overall Study|subject identified as Jehovah's witness|0|||
16375107|NCT00420407|39856856|FG000|Overall Study|Withdrawal by Subject|0|||
16375108|NCT00420407|39856857|FG001|Overall Study|Withdrawal by Subject|2|||
16375109|NCT03627468|39856858|FG000|Overall Study|Adverse Event|5|||
16375110|NCT03627468|39856859|FG001|Overall Study|Adverse Event|33|||
16375111|NCT03627468|39856858|FG000|Overall Study|Withdrawal by Subject|13|||
16375112|NCT03627468|39856859|FG001|Overall Study|Withdrawal by Subject|23|||
16075065|NCT02698241|38766483|FG000|Overall Study|Screening not met|7|||
16075066|NCT02698241|38766483|FG000|Overall Study|Withdrawal by Subject|7|||
16375113|NCT03627468|39856858|FG000|Overall Study|Physician Decision|1|||
16075067|NCT02698241|38766483|FG000|Overall Study|Physician Decision|2|||
16274819|NCT00748566|39490179|FG000|Overall Study|Lost to Follow-up|1|||
16375114|NCT03627468|39856859|FG001|Overall Study|Physician Decision|0|||
16375115|NCT03627468|39856858|FG000|Overall Study|Protocol Violation|0|||
16375116|NCT03627468|39856859|FG001|Overall Study|Protocol Violation|2|||
16375117|NCT03627468|39856858|FG000|Overall Study|Lost to Follow-up|10|||
16375118|NCT03627468|39856859|FG001|Overall Study|Lost to Follow-up|16|||
16375119|NCT03627468|39856858|FG000|Overall Study|Death|1|||
16375120|NCT03627468|39856859|FG001|Overall Study|Death|0|||
16375121|NCT03627468|39856858|FG000|Overall Study|Pregnancy|1|||
16375122|NCT03627468|39856859|FG001|Overall Study|Pregnancy|1|||
16375123|NCT03627468|39856858|FG000|Overall Study|Lack of Efficacy|0|||
16375124|NCT03627468|39856859|FG001|Overall Study|Lack of Efficacy|2|||
16375125|NCT03627468|39856858|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
16375126|NCT03627468|39856859|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
16375127|NCT05029362|39856862|FG000|Overall Study|Lost to Follow-up|9|||
16375128|NCT01259024|39856863|FG000|Overall Study|Physician Decision|1|||
16375129|NCT02741193|39856866|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
16075068|NCT02698241|38766483|FG000|Overall Study|Subject underwent system modification|2|||
16075069|NCT02698241|38766483|FG000|Overall Study|Lost to Follow-up|3|||
16075070|NCT02698241|38766483|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
16473275|NCT01024231|40214427|FG003|Overall Study|Disease Progression|0|||
16473276|NCT01024231|40214428|FG004|Overall Study|Disease Progression|4|||
16473277|NCT01024231|40214429|FG005|Overall Study|Disease Progression|11|||
16473278|NCT01024231|40214430|FG006|Overall Study|Disease Progression|6|||
16473279|NCT01024231|40214424|FG000|Overall Study|AE unrelated to Study Drug|0|||
16473280|NCT01024231|40214425|FG001|Overall Study|AE unrelated to Study Drug|1|||
16473281|NCT01024231|40214426|FG002|Overall Study|AE unrelated to Study Drug|0|||
16473282|NCT01024231|40214427|FG003|Overall Study|AE unrelated to Study Drug|0|||
16473283|NCT01024231|40214428|FG004|Overall Study|AE unrelated to Study Drug|0|||
16473284|NCT01024231|40214429|FG005|Overall Study|AE unrelated to Study Drug|0|||
16473285|NCT01024231|40214430|FG006|Overall Study|AE unrelated to Study Drug|0|||
16473286|NCT01024231|40214424|FG000|Overall Study|No longer meets criteria|0|||
16473287|NCT01024231|40214425|FG001|Overall Study|No longer meets criteria|0|||
16473288|NCT01024231|40214426|FG002|Overall Study|No longer meets criteria|0|||
16473289|NCT01024231|40214427|FG003|Overall Study|No longer meets criteria|0|||
16473290|NCT01024231|40214428|FG004|Overall Study|No longer meets criteria|1|||
16473291|NCT01024231|40214429|FG005|Overall Study|No longer meets criteria|0|||
16075071|NCT02698241|38766483|FG000|Overall Study|geographic and licensing issue|1|||
16075072|NCT02698241|38766483|FG000|Overall Study|Death|2|||
16075073|NCT00373529|38766486|FG000|Overall Study|Physician Decision|19|||
16075074|NCT00373529|38766486|FG000|Overall Study|Withdrawal by Subject|7|||
16075075|NCT00373529|38766486|FG000|Overall Study|Adverse Event|7|||
16075076|NCT00373529|38766486|FG000|Overall Study|Treatment failure|36|||
16075077|NCT00373529|38766486|FG000|Overall Study|Disease recurrence|10|||
16075078|NCT00373529|38766486|FG000|Overall Study|Death|16|||
16075079|NCT00373529|38766486|FG000|Overall Study|Need for treatment prohibited by study|1|||
16075080|NCT00373529|38766486|FG000|Overall Study|Other|8|||
16075081|NCT00373529|38766486|FG000|Overall Study|Failed independent confirmation of AML|3|||
16075082|NCT00373529|38766486|FG000|Overall Study|Consent violation|1|||
16075083|NCT03959241|38766495|FG000|Overall Study|Withdrawal by Subject|7|||
16075084|NCT03959241|38766496|FG001|Overall Study|Withdrawal by Subject|8|||
16075085|NCT03959241|38766495|FG000|Overall Study|Lost to Follow-up|1|||
16075086|NCT03959241|38766496|FG001|Overall Study|Lost to Follow-up|0|||
16075087|NCT03959241|38766495|FG000|Overall Study|Move to Hospice Care|1|||
16075088|NCT03959241|38766496|FG001|Overall Study|Move to Hospice Care|0|||
16075089|NCT03959241|38766495|FG000|Overall Study|Screen Failure|1|||
16075090|NCT03959241|38766496|FG001|Overall Study|Screen Failure|0|||
16075091|NCT03959241|38766495|FG000|Overall Study|Disease Relapse|0|||
16075092|NCT03959241|38766496|FG001|Overall Study|Disease Relapse|1|||
16075093|NCT03959241|38766495|FG000|Overall Study|Off Study|1|||
16075094|NCT03959241|38766496|FG001|Overall Study|Off Study|0|||
16075095|NCT03920215|38766497|FG000|Overall Study|Lost to Follow-up|1|||
16075096|NCT03920215|38766498|FG001|Overall Study|Lost to Follow-up|2|||
16075097|NCT03920215|38766499|FG002|Overall Study|Lost to Follow-up|0|||
16075098|NCT03920215|38766500|FG003|Overall Study|Lost to Follow-up|0|||
16075099|NCT03920215|38766497|FG000|Overall Study|Death|0|||
16075100|NCT03920215|38766498|FG001|Overall Study|Death|0|||
16075101|NCT03920215|38766499|FG002|Overall Study|Death|0|||
16075102|NCT03920215|38766500|FG003|Overall Study|Death|1|||
16075103|NCT01147341|38766501|FG000|Double Blind Period|Lack of Efficacy|1|||
16075104|NCT01147341|38766502|FG001|Double Blind Period|Lack of Efficacy|1|||
16075105|NCT01147341|38766501|FG000|Double Blind Period|Withdrawal by Subject|0|||
16075106|NCT01147341|38766502|FG001|Double Blind Period|Withdrawal by Subject|1|||
16075107|NCT01147341|38766501|FG000|Open Label Period|Lack of Efficacy|3|||
16075108|NCT01147341|38766502|FG001|Open Label Period|Lack of Efficacy|0|||
16173731|NCT03124459|39115259|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
16075109|NCT01147341|38766501|FG000|Open Label Period|Subject moved|1|||
16075110|NCT01147341|38766502|FG001|Open Label Period|Subject moved|0|||
16075111|NCT04353037|38766506|FG000|Overall Study|Lost to Follow-up|0|||
16075112|NCT04353037|38766507|FG001|Overall Study|Lost to Follow-up|1|||
16075113|NCT04353037|38766508|FG002|Overall Study|Lost to Follow-up|2|||
16075114|NCT04353037|38766509|FG003|Overall Study|Lost to Follow-up|3|||
16075115|NCT04353037|38766506|FG000|Overall Study|Withdrawal by Subject|0|||
16075116|NCT04353037|38766507|FG001|Overall Study|Withdrawal by Subject|2|||
16075117|NCT04353037|38766508|FG002|Overall Study|Withdrawal by Subject|3|||
16075118|NCT04353037|38766509|FG003|Overall Study|Withdrawal by Subject|5|||
16075119|NCT04353037|38766506|FG000|Overall Study|Adverse Event|0|||
16274820|NCT00748566|39490179|FG000|Overall Study|Protocol Violation|13|||
16473292|NCT01024231|40214430|FG006|Overall Study|No longer meets criteria|1|||
16473293|NCT01024231|40214424|FG000|Overall Study|Study Drug Toxicity|1|||
16473294|NCT01024231|40214425|FG001|Overall Study|Study Drug Toxicity|6|||
16473295|NCT01024231|40214426|FG002|Overall Study|Study Drug Toxicity|6|||
16473296|NCT01024231|40214427|FG003|Overall Study|Study Drug Toxicity|4|||
16075120|NCT04353037|38766507|FG001|Overall Study|Adverse Event|0|||
16075121|NCT04353037|38766508|FG002|Overall Study|Adverse Event|2|||
16075122|NCT04353037|38766509|FG003|Overall Study|Adverse Event|0|||
16075123|NCT04353037|38766506|FG000|Overall Study|Exposure Change|0|||
16075124|NCT04353037|38766507|FG001|Overall Study|Exposure Change|0|||
16075125|NCT04353037|38766508|FG002|Overall Study|Exposure Change|0|||
16075126|NCT04353037|38766509|FG003|Overall Study|Exposure Change|2|||
16075127|NCT02232178|38766510|FG000|Overall Study|Lost to Follow-up|0|||
16075128|NCT02232178|38766511|FG001|Overall Study|Lost to Follow-up|1|||
16075129|NCT02232178|38766512|FG002|Overall Study|Lost to Follow-up|0|||
16075130|NCT02232178|38766510|FG000|Overall Study|ineligibility|0|||
16075131|NCT02232178|38766511|FG001|Overall Study|ineligibility|0|||
16075132|NCT02232178|38766512|FG002|Overall Study|ineligibility|1|||
16075133|NCT02232178|38766510|FG000|Overall Study|surgical complication|1|||
16075134|NCT02232178|38766511|FG001|Overall Study|surgical complication|0|||
16075135|NCT02232178|38766512|FG002|Overall Study|surgical complication|0|||
16075136|NCT00869323|38766514|FG000|Maintenance Therapy|concurrent illness|1|||
16075137|NCT01241292|38766515|FG000|Overall Study|Administrative Reason by Sponsor|1|||
16075138|NCT01241292|38766516|FG001|Overall Study|Administrative Reason by Sponsor|0|||
16075139|NCT01241292|38766515|FG000|Overall Study|Disease Progression|2|||
16075140|NCT01241292|38766516|FG001|Overall Study|Disease Progression|0|||
16075141|NCT01241292|38766515|FG000|Overall Study|Study Drug Toxicity|0|||
16075142|NCT01241292|38766516|FG001|Overall Study|Study Drug Toxicity|1|||
16075143|NCT01241292|38766515|FG000|Overall Study|Participant Discontinued Treatment|0|||
16075144|NCT01241292|38766516|FG001|Overall Study|Participant Discontinued Treatment|2|||
16075145|NCT02969863|38766522|FG000|Overall Study|Physician Decision|1|||
16075146|NCT02969863|38766523|FG001|Overall Study|Physician Decision|0|||
16075147|NCT02969863|38766524|FG002|Overall Study|Physician Decision|0|||
16075148|NCT02969863|38766525|FG003|Overall Study|Physician Decision|0|||
16075149|NCT02969863|38766526|FG004|Overall Study|Physician Decision|0|||
16075150|NCT02969863|38766527|FG005|Overall Study|Physician Decision|0|||
16075151|NCT05001945|38769643|FG000|Overall Study|Adverse Event|0|||
16075152|NCT05001945|38769644|FG001|Overall Study|Adverse Event|0|||
16075153|NCT05001945|38769645|FG002|Overall Study|Adverse Event|0|||
16075154|NCT05001945|38769646|FG003|Overall Study|Adverse Event|1|||
16075155|NCT05001945|38769647|FG004|Overall Study|Adverse Event|0|||
16075156|NCT05001945|38769648|FG005|Overall Study|Adverse Event|0|||
16173732|NCT03124459|39115254|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
16173733|NCT03124459|39115255|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
16173734|NCT03124459|39115256|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
16075157|NCT05001945|38769649|FG006|Overall Study|Adverse Event|0|||
16075158|NCT05001945|38769650|FG007|Overall Study|Adverse Event|0|||
16075159|NCT05001945|38769643|FG000|Overall Study|Lost to Follow-up|0|||
16075160|NCT05001945|38769644|FG001|Overall Study|Lost to Follow-up|1|||
16075161|NCT05001945|38769645|FG002|Overall Study|Lost to Follow-up|1|||
16075162|NCT05001945|38769646|FG003|Overall Study|Lost to Follow-up|2|||
16075163|NCT05001945|38769647|FG004|Overall Study|Lost to Follow-up|0|||
16075164|NCT05001945|38769648|FG005|Overall Study|Lost to Follow-up|1|||
16075165|NCT05001945|38769649|FG006|Overall Study|Lost to Follow-up|0|||
16075166|NCT05001945|38769650|FG007|Overall Study|Lost to Follow-up|0|||
16075167|NCT05001945|38769643|FG000|Overall Study|Protocol Violation|1|||
16075168|NCT05001945|38769644|FG001|Overall Study|Protocol Violation|0|||
16075169|NCT05001945|38769645|FG002|Overall Study|Protocol Violation|1|||
16075170|NCT05001945|38769646|FG003|Overall Study|Protocol Violation|1|||
16075171|NCT05001945|38769647|FG004|Overall Study|Protocol Violation|0|||
16173735|NCT03124459|39115257|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
16173736|NCT03124459|39115258|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
16173737|NCT03124459|39115259|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
16173738|NCT02013544|39115260|FG000|Overall Study|Adverse Event|5|||
16173739|NCT02013544|39115261|FG001|Overall Study|Adverse Event|5|||
16173740|NCT02013544|39115260|FG000|Overall Study|Lost to Follow-up|2|||
16173741|NCT02013544|39115261|FG001|Overall Study|Lost to Follow-up|3|||
16173742|NCT02013544|39115260|FG000|Overall Study|Withdrawal by Subject|2|||
16173743|NCT02013544|39115261|FG001|Overall Study|Withdrawal by Subject|8|||
16173744|NCT02013544|39115260|FG000|Overall Study|Physician Decision|0|||
16173745|NCT02013544|39115261|FG001|Overall Study|Physician Decision|1|||
16173746|NCT02013544|39115260|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
16173747|NCT02013544|39115261|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
16173748|NCT00768560|39115262|FG000|Intervention Set 1|Adverse Event|0|||
16173749|NCT00768560|39115263|FG001|Intervention Set 1|Adverse Event|1|||
16173750|NCT00768560|39115264|FG002|Intervention Set 1|Adverse Event|0|||
16173751|NCT00768560|39115265|FG003|Intervention Set 1|Adverse Event|0|||
16173752|NCT00768560|39115266|FG004|Intervention Set 1|Adverse Event|0|||
16075172|NCT05001945|38769648|FG005|Overall Study|Protocol Violation|1|||
16075173|NCT05001945|38769649|FG006|Overall Study|Protocol Violation|0|||
16075174|NCT05001945|38769650|FG007|Overall Study|Protocol Violation|0|||
16173753|NCT00768560|39115267|FG005|Intervention Set 1|Adverse Event|0|||
16173754|NCT00140855|39115277|FG000|Overall Study|Progressive disease|2|||
16173755|NCT01662648|39115287|FG000|Overall Study|Death|1|||
16075175|NCT05001945|38769643|FG000|Overall Study|Withdrawal by Subject|0|||
16075176|NCT05001945|38769644|FG001|Overall Study|Withdrawal by Subject|0|||
16075177|NCT05001945|38769645|FG002|Overall Study|Withdrawal by Subject|0|||
16075178|NCT05001945|38769646|FG003|Overall Study|Withdrawal by Subject|1|||
16075179|NCT05001945|38769647|FG004|Overall Study|Withdrawal by Subject|1|||
16075180|NCT05001945|38769648|FG005|Overall Study|Withdrawal by Subject|1|||
16473297|NCT01024231|40214428|FG004|Overall Study|Study Drug Toxicity|2|||
16473298|NCT01024231|40214429|FG005|Overall Study|Study Drug Toxicity|0|||
16473299|NCT01024231|40214430|FG006|Overall Study|Study Drug Toxicity|7|||
16473300|NCT01024231|40214424|FG000|Overall Study|Death|6|||
16473301|NCT01024231|40214425|FG001|Overall Study|Death|2|||
16473302|NCT01024231|40214426|FG002|Overall Study|Death|1|||
16473303|NCT01024231|40214427|FG003|Overall Study|Death|0|||
16473304|NCT01024231|40214428|FG004|Overall Study|Death|4|||
16473305|NCT01024231|40214429|FG005|Overall Study|Death|3|||
16473306|NCT01024231|40214430|FG006|Overall Study|Death|5|||
16473307|NCT01024231|40214424|FG000|Overall Study|Lost to Follow-up|0|||
16473308|NCT01024231|40214425|FG001|Overall Study|Lost to Follow-up|0|||
16473309|NCT01024231|40214426|FG002|Overall Study|Lost to Follow-up|0|||
16173756|NCT01662648|39115288|FG001|Overall Study|Death|3|||
16173757|NCT01662648|39115287|FG000|Overall Study|Adverse Event|40|||
16173758|NCT01662648|39115288|FG001|Overall Study|Adverse Event|37|||
16173759|NCT01662648|39115287|FG000|Overall Study|Lack of Efficacy|17|||
16173760|NCT01662648|39115288|FG001|Overall Study|Lack of Efficacy|16|||
16173761|NCT01662648|39115287|FG000|Overall Study|Participant ineligible to continue trial|1|||
16173762|NCT01662648|39115288|FG001|Overall Study|Participant ineligible to continue trial|1|||
16075181|NCT05001945|38769649|FG006|Overall Study|Withdrawal by Subject|0|||
16173763|NCT01662648|39115287|FG000|Overall Study|Lost to Follow-up|24|||
16173764|NCT01662648|39115288|FG001|Overall Study|Lost to Follow-up|36|||
16173765|NCT01662648|39115287|FG000|Overall Study|Withdrawal by Subject|36|||
16173766|NCT01662648|39115288|FG001|Overall Study|Withdrawal by Subject|53|||
16473310|NCT01024231|40214427|FG003|Overall Study|Lost to Follow-up|0|||
16473311|NCT01024231|40214428|FG004|Overall Study|Lost to Follow-up|0|||
16473312|NCT01024231|40214429|FG005|Overall Study|Lost to Follow-up|0|||
16473313|NCT01024231|40214430|FG006|Overall Study|Lost to Follow-up|1|||
16473314|NCT01024231|40214424|FG000|Overall Study|Withdrew Consent|0|||
16473315|NCT01024231|40214425|FG001|Overall Study|Withdrew Consent|1|||
16473316|NCT01024231|40214426|FG002|Overall Study|Withdrew Consent|0|||
16473317|NCT01024231|40214427|FG003|Overall Study|Withdrew Consent|0|||
16473318|NCT01024231|40214428|FG004|Overall Study|Withdrew Consent|0|||
16473319|NCT01024231|40214429|FG005|Overall Study|Withdrew Consent|0|||
16473320|NCT01024231|40214430|FG006|Overall Study|Withdrew Consent|0|||
16473321|NCT01024231|40214424|FG000|Overall Study|Continuing on Treatment|0|||
16473322|NCT01024231|40214425|FG001|Overall Study|Continuing on Treatment|0|||
16473323|NCT01024231|40214426|FG002|Overall Study|Continuing on Treatment|0|||
16473324|NCT01024231|40214427|FG003|Overall Study|Continuing on Treatment|0|||
16473325|NCT01024231|40214428|FG004|Overall Study|Continuing on Treatment|3|||
16473326|NCT01024231|40214429|FG005|Overall Study|Continuing on Treatment|2|||
16473327|NCT01024231|40214430|FG006|Overall Study|Continuing on Treatment|0|||
16473328|NCT02556203|40214431|FG000|Overall Study|Withdrawal by Subject|21|||
16473329|NCT02556203|40214432|FG001|Overall Study|Withdrawal by Subject|21|||
16473330|NCT02556203|40214431|FG000|Overall Study|Lost to Follow-up|5|||
16473331|NCT02556203|40214432|FG001|Overall Study|Lost to Follow-up|5|||
16473332|NCT02556203|40214431|FG000|Overall Study|Adverse Event|1|||
16473333|NCT02556203|40214432|FG001|Overall Study|Adverse Event|0|||
16473334|NCT01147640|40214436|FG000|Overall Study|Adverse Event|2|||
16473335|NCT01147640|40214437|FG001|Overall Study|Adverse Event|0|||
16473336|NCT01147640|40214436|FG000|Overall Study|Physician Decision|1|||
16473337|NCT01147640|40214437|FG001|Overall Study|Physician Decision|0|||
16473338|NCT01147640|40214436|FG000|Overall Study|Withdrawal by Subject|1|||
16473339|NCT01147640|40214437|FG001|Overall Study|Withdrawal by Subject|0|||
16473340|NCT01147640|40214436|FG000|Overall Study|Lost to Follow-up|0|||
16473341|NCT01147640|40214437|FG001|Overall Study|Lost to Follow-up|1|||
16473342|NCT01147640|40214436|FG000|Overall Study|Didn't meet eligibility criteria|1|||
16473343|NCT01147640|40214437|FG001|Overall Study|Didn't meet eligibility criteria|0|||
16473344|NCT01609231|40214438|FG000|Overall Study|Adverse Event|1|||
16473345|NCT01609231|40214439|FG001|Overall Study|Adverse Event|3|||
16473346|NCT01609231|40214438|FG000|Overall Study|Physician Decision|1|||
16473347|NCT01609231|40214439|FG001|Overall Study|Physician Decision|0|||
16473348|NCT01609231|40214438|FG000|Overall Study|Withdrawal by Subject|1|||
16173767|NCT01662648|39115287|FG000|Overall Study|Participant non-compliant|16|||
16173768|NCT01662648|39115288|FG001|Overall Study|Participant non-compliant|20|||
16473349|NCT01609231|40214439|FG001|Overall Study|Withdrawal by Subject|0|||
16473350|NCT00910988|40214441|FG000|Overall Study|Lost to Follow-up|2|||
16075182|NCT05001945|38769650|FG007|Overall Study|Withdrawal by Subject|1|||
16173769|NCT01662648|39115287|FG000|Overall Study|Other|8|||
16173770|NCT01662648|39115288|FG001|Overall Study|Other|11|||
16173771|NCT01662648|39115287|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
16473351|NCT00910988|40214442|FG001|Overall Study|Lost to Follow-up|4|||
16473352|NCT00910988|40214443|FG002|Overall Study|Lost to Follow-up|3|||
16473353|NCT00910988|40214444|FG003|Overall Study|Lost to Follow-up|0|||
16473354|NCT00937391|40214445|FG000|Stage 2|Withdrawal by Subject|1|||
16473355|NCT01130103|40214447|FG000|Randomized Treatment|Adverse Event|1|||
16473356|NCT01130103|40214448|FG001|Randomized Treatment|Adverse Event|1|||
16473357|NCT01130103|40214447|FG000|Randomized Treatment|Lost to Follow-up|1|||
16473358|NCT01130103|40214448|FG001|Randomized Treatment|Lost to Follow-up|0|||
16473359|NCT01130103|40214447|FG000|Randomized Treatment|Protocol Violation|3|||
16473360|NCT01130103|40214448|FG001|Randomized Treatment|Protocol Violation|2|||
16473361|NCT01130103|40214447|FG000|Randomized Treatment|Withdrawal by Subject|1|||
16473362|NCT01130103|40214448|FG001|Randomized Treatment|Withdrawal by Subject|2|||
16473363|NCT01130103|40214447|FG000|Maintenance Treatment|Lack of Efficacy|0|||
16473364|NCT01130103|40214448|FG001|Maintenance Treatment|Lack of Efficacy|1|||
16473365|NCT01130103|40214447|FG000|Maintenance Treatment|Lost to Follow-up|1|||
16473366|NCT01130103|40214448|FG001|Maintenance Treatment|Lost to Follow-up|1|||
16473367|NCT01130103|40214447|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
16473368|NCT01130103|40214448|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
16473369|NCT00089284|40214450|FG000|Overall Study|Adverse event before starting treatment|0|||
16473370|NCT00089284|40214451|FG001|Overall Study|Adverse event before starting treatment|0|||
16473371|NCT00089284|40214452|FG002|Overall Study|Adverse event before starting treatment|0|||
16473372|NCT00089284|40214453|FG003|Overall Study|Adverse event before starting treatment|0|||
16473373|NCT00089284|40214454|FG004|Overall Study|Adverse event before starting treatment|0|||
16473374|NCT00089284|40214455|FG005|Overall Study|Adverse event before starting treatment|0|||
16473375|NCT00089284|40214456|FG006|Overall Study|Adverse event before starting treatment|1|||
16473376|NCT00747812|40214461|FG000|Overall Study|Research Site Staff Relocation|5|||
16473377|NCT00747812|40214462|FG001|Overall Study|Research Site Staff Relocation|3|||
16075183|NCT05001945|38769643|FG000|Overall Study|Not specified by Investigator|0|||
16473378|NCT01193842|40214463|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
16473379|NCT01193842|40214464|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
16473380|NCT01193842|40214465|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
16473381|NCT01193842|40214466|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
16473382|NCT01193842|40214467|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
16473383|NCT01193842|40214463|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
16473384|NCT01193842|40214464|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
16473385|NCT01193842|40214465|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
16473386|NCT01193842|40214466|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
16473387|NCT01193842|40214467|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
16473388|NCT01193842|40214463|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
16473389|NCT01193842|40214464|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
16473390|NCT01193842|40214465|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
16473391|NCT01193842|40214466|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
16473392|NCT01193842|40214467|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
16473393|NCT01193842|40214463|FG000|Phase II: Randomized Groups|Death|0|||
16473394|NCT01193842|40214464|FG001|Phase II: Randomized Groups|Death|0|||
16473395|NCT01193842|40214465|FG002|Phase II: Randomized Groups|Death|0|||
16473396|NCT01193842|40214466|FG003|Phase II: Randomized Groups|Death|1|||
16473397|NCT01193842|40214467|FG004|Phase II: Randomized Groups|Death|1|||
16473398|NCT01193842|40214463|FG000|Phase II: Randomized Groups|Adverse Event|0|||
16473399|NCT01193842|40214464|FG001|Phase II: Randomized Groups|Adverse Event|0|||
16473400|NCT01193842|40214465|FG002|Phase II: Randomized Groups|Adverse Event|0|||
16473401|NCT01193842|40214466|FG003|Phase II: Randomized Groups|Adverse Event|5|||
16473402|NCT01193842|40214467|FG004|Phase II: Randomized Groups|Adverse Event|3|||
16473403|NCT01193842|40214463|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
16473404|NCT01193842|40214464|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
16473405|NCT01193842|40214465|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
16473406|NCT01193842|40214466|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
16473407|NCT01193842|40214467|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
16473408|NCT01193842|40214463|FG000|Phase II: Randomized Groups|Ineligible|0|||
16473409|NCT01193842|40214464|FG001|Phase II: Randomized Groups|Ineligible|0|||
16473410|NCT01193842|40214465|FG002|Phase II: Randomized Groups|Ineligible|0|||
16473411|NCT01193842|40214466|FG003|Phase II: Randomized Groups|Ineligible|0|||
16473412|NCT01193842|40214467|FG004|Phase II: Randomized Groups|Ineligible|1|||
16473413|NCT01193842|40214463|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
16473414|NCT01193842|40214464|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
16473415|NCT01193842|40214465|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
16473416|NCT01193842|40214466|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
16473417|NCT01193842|40214467|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
16473418|NCT01954342|40214468|FG000|Overall Study|Missing data from 13-16week study visit|0|||
16473419|NCT01954342|40214469|FG001|Overall Study|Missing data from 13-16week study visit|0|||
16473420|NCT01954342|40214470|FG002|Overall Study|Missing data from 13-16week study visit|0|||
16473421|NCT01954342|40214471|FG003|Overall Study|Missing data from 13-16week study visit|1|||
16473422|NCT01954342|40214468|FG000|Overall Study|Miscarriage|0|||
16473423|NCT01954342|40214469|FG001|Overall Study|Miscarriage|0|||
16473424|NCT01954342|40214470|FG002|Overall Study|Miscarriage|0|||
16473425|NCT01954342|40214471|FG003|Overall Study|Miscarriage|3|||
16473426|NCT01954342|40214468|FG000|Overall Study|Lost to Follow-up|0|||
16473427|NCT01954342|40214469|FG001|Overall Study|Lost to Follow-up|0|||
16473428|NCT01954342|40214470|FG002|Overall Study|Lost to Follow-up|0|||
16473429|NCT01954342|40214471|FG003|Overall Study|Lost to Follow-up|5|||
16473430|NCT01954342|40214468|FG000|Overall Study|Preterm delivery|0|||
16473431|NCT01954342|40214469|FG001|Overall Study|Preterm delivery|0|||
16473432|NCT01954342|40214470|FG002|Overall Study|Preterm delivery|0|||
16075184|NCT05001945|38769644|FG001|Overall Study|Not specified by Investigator|3|||
16075185|NCT05001945|38769645|FG002|Overall Study|Not specified by Investigator|0|||
16075186|NCT05001945|38769646|FG003|Overall Study|Not specified by Investigator|0|||
16075187|NCT05001945|38769647|FG004|Overall Study|Not specified by Investigator|1|||
16075188|NCT05001945|38769648|FG005|Overall Study|Not specified by Investigator|0|||
16075189|NCT05001945|38769649|FG006|Overall Study|Not specified by Investigator|0|||
16075190|NCT05001945|38769650|FG007|Overall Study|Not specified by Investigator|0|||
16075191|NCT02705586|38769653|FG000|Overall Study|Health Issues|2|||
16075192|NCT02705586|38769653|FG000|Overall Study|Transportation Difficulties|5|||
16075193|NCT02705586|38769653|FG000|Overall Study|Vacation/Planned Absence|1|||
16075194|NCT00057837|38769654|FG000|Overall Study|Progression/relapse|12|||
16075195|NCT00057837|38769655|FG001|Overall Study|Progression/relapse|14|||
16075196|NCT00057837|38769654|FG000|Overall Study|Adverse Event|2|||
16075197|NCT00057837|38769655|FG001|Overall Study|Adverse Event|12|||
16075198|NCT00057837|38769654|FG000|Overall Study|Death|5|||
16473433|NCT01954342|40214471|FG003|Overall Study|Preterm delivery|3|||
16473434|NCT01954342|40214468|FG000|Overall Study|Pre-eclampsia|0|||
16075199|NCT00057837|38769655|FG001|Overall Study|Death|4|||
16075200|NCT00057837|38769654|FG000|Overall Study|Withdrawal by Subject|5|||
16473435|NCT01954342|40214469|FG001|Overall Study|Pre-eclampsia|0|||
16473436|NCT01954342|40214470|FG002|Overall Study|Pre-eclampsia|0|||
16473437|NCT01954342|40214471|FG003|Overall Study|Pre-eclampsia|4|||
16473438|NCT01954342|40214468|FG000|Overall Study|Unreliable Data|0|||
16075201|NCT00057837|38769655|FG001|Overall Study|Withdrawal by Subject|3|||
16473439|NCT01954342|40214469|FG001|Overall Study|Unreliable Data|0|||
16473440|NCT01954342|40214470|FG002|Overall Study|Unreliable Data|0|||
16473441|NCT01954342|40214471|FG003|Overall Study|Unreliable Data|2|||
16473442|NCT00736879|40214472|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
16473443|NCT00736879|40214473|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
16473444|NCT00736879|40214474|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
16473445|NCT00736879|40214475|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
16075202|NCT00057837|38769654|FG000|Overall Study|Alternative therapy|0|||
16075203|NCT00057837|38769655|FG001|Overall Study|Alternative therapy|1|||
16075204|NCT00057837|38769654|FG000|Overall Study|Other complicating disease|2|||
16075205|NCT00057837|38769655|FG001|Overall Study|Other complicating disease|1|||
16473446|NCT00736879|40214472|FG000|Double Blind Treatment Period|Adverse Event|0|||
16473447|NCT00736879|40214473|FG001|Double Blind Treatment Period|Adverse Event|1|||
16075206|NCT00057837|38769654|FG000|Overall Study|Physician Decision|1|||
16075207|NCT00057837|38769655|FG001|Overall Study|Physician Decision|0|||
16075208|NCT00057837|38769654|FG000|Overall Study|Ineligible|3|||
16075209|NCT00057837|38769655|FG001|Overall Study|Ineligible|3|||
16075210|NCT00057837|38769654|FG000|Overall Study|Never started treatment|1|||
16075211|NCT00057837|38769655|FG001|Overall Study|Never started treatment|1|||
16075212|NCT00545077|38769662|FG000|Overall Study|Treatment not received|5|||
16075213|NCT00545077|38769663|FG001|Overall Study|Treatment not received|1|||
16075214|NCT00545077|38769662|FG000|Overall Study|Disease Progression|131|||
16075215|NCT00545077|38769663|FG001|Overall Study|Disease Progression|98|||
16075216|NCT00545077|38769662|FG000|Overall Study|Withdrawal by Subject|3|||
16075217|NCT00545077|38769663|FG001|Overall Study|Withdrawal by Subject|14|||
16075218|NCT00545077|38769662|FG000|Overall Study|Physician Decision|6|||
16075219|NCT00545077|38769663|FG001|Overall Study|Physician Decision|3|||
16075220|NCT00545077|38769662|FG000|Overall Study|Lost to Follow-up|2|||
16075221|NCT00545077|38769663|FG001|Overall Study|Lost to Follow-up|0|||
16075222|NCT00545077|38769662|FG000|Overall Study|Protocol Violation|1|||
16075223|NCT00545077|38769663|FG001|Overall Study|Protocol Violation|0|||
16075224|NCT00545077|38769662|FG000|Overall Study|Adverse Event|0|||
16173772|NCT01662648|39115288|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
16173773|NCT01662648|39115287|FG000|Overall Study|LOE and other reason unspecified|1|||
16473448|NCT00736879|40214474|FG002|Double Blind Treatment Period|Adverse Event|1|||
16473449|NCT00736879|40214475|FG003|Double Blind Treatment Period|Adverse Event|0|||
16473450|NCT00736879|40214472|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
16173774|NCT01662648|39115288|FG001|Overall Study|LOE and other reason unspecified|0|||
16473451|NCT00736879|40214473|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
16473452|NCT00736879|40214474|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
16473453|NCT00736879|40214475|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
16075225|NCT00545077|38769663|FG001|Overall Study|Adverse Event|31|||
16075226|NCT00545077|38769662|FG000|Overall Study|Death|0|||
16075227|NCT00545077|38769663|FG001|Overall Study|Death|8|||
16473454|NCT00736879|40214472|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
16473455|NCT00736879|40214473|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
16173775|NCT01662648|39115287|FG000|Overall Study|LOE and Participant non-compliant|0|||
16173776|NCT01662648|39115288|FG001|Overall Study|LOE and Participant non-compliant|1|||
16173777|NCT03968419|39115289|FG000|Treatment Period|Adverse Event|0|||
16173778|NCT03968419|39115290|FG001|Treatment Period|Adverse Event|0|||
16173779|NCT03968419|39115291|FG002|Treatment Period|Adverse Event|1|||
16473456|NCT00736879|40214474|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
16473457|NCT00736879|40214475|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
16473458|NCT00736879|40214472|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
16473459|NCT00736879|40214473|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
16473460|NCT00736879|40214474|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
16473461|NCT00736879|40214475|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
16473462|NCT00736879|40214472|FG000|Double Blind Treatment Period|No longer met criteria|0|||
16173780|NCT03968419|39115289|FG000|Safety Follow-up Period|Death|3|||
16173781|NCT03968419|39115290|FG001|Safety Follow-up Period|Death|2|||
16173782|NCT03968419|39115291|FG002|Safety Follow-up Period|Death|1|||
16173783|NCT03968419|39115289|FG000|Safety Follow-up Period|Subject Decision|2|||
16173784|NCT03968419|39115290|FG001|Safety Follow-up Period|Subject Decision|1|||
16173785|NCT03968419|39115291|FG002|Safety Follow-up Period|Subject Decision|0|||
16173786|NCT03304522|39115292|FG000|Overall Study|Adverse Event|0|||
16173787|NCT03304522|39115293|FG001|Overall Study|Adverse Event|4|||
16173788|NCT03304522|39115292|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
16173789|NCT03304522|39115293|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
16173790|NCT03304522|39115292|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
16473463|NCT00736879|40214473|FG001|Double Blind Treatment Period|No longer met criteria|1|||
16075228|NCT02059980|38769664|FG000|Overall Study|Lost to Follow-up|2|||
16075229|NCT02059980|38769665|FG001|Overall Study|Lost to Follow-up|1|||
16075230|NCT00665444|38769668|FG000|Overall Study|Physician Decision|1|||
16075231|NCT00665444|38769668|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
16075232|NCT02139046|38769669|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
16075233|NCT02139046|38769670|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
16075234|NCT02139046|38769671|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
16075235|NCT02139046|38769672|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
16075236|NCT02139046|38769673|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
16075237|NCT02139046|38769669|FG000|Overall Study|Major Protocol Deviation|9|||
16075238|NCT02139046|38769670|FG001|Overall Study|Major Protocol Deviation|10|||
16075239|NCT02139046|38769671|FG002|Overall Study|Major Protocol Deviation|16|||
16075240|NCT02139046|38769672|FG003|Overall Study|Major Protocol Deviation|12|||
16075241|NCT02139046|38769673|FG004|Overall Study|Major Protocol Deviation|6|||
16075242|NCT02139046|38769669|FG000|Overall Study|Lost to Follow-up|13|||
16075243|NCT02139046|38769670|FG001|Overall Study|Lost to Follow-up|16|||
16075244|NCT02139046|38769671|FG002|Overall Study|Lost to Follow-up|16|||
16075245|NCT02139046|38769672|FG003|Overall Study|Lost to Follow-up|18|||
16075246|NCT02139046|38769673|FG004|Overall Study|Lost to Follow-up|13|||
16075247|NCT02139046|38769669|FG000|Overall Study|Voluntary Withdrawal|20|||
16075248|NCT02139046|38769670|FG001|Overall Study|Voluntary Withdrawal|8|||
16075249|NCT02139046|38769671|FG002|Overall Study|Voluntary Withdrawal|10|||
16075250|NCT02139046|38769672|FG003|Overall Study|Voluntary Withdrawal|15|||
16473464|NCT00736879|40214474|FG002|Double Blind Treatment Period|No longer met criteria|0|||
16473465|NCT00736879|40214475|FG003|Double Blind Treatment Period|No longer met criteria|0|||
16473466|NCT00736879|40214472|FG000|Double Blind Treatment Period|non-specified|0|||
16075251|NCT02139046|38769673|FG004|Overall Study|Voluntary Withdrawal|16|||
16473467|NCT00736879|40214473|FG001|Double Blind Treatment Period|non-specified|1|||
16473468|NCT00736879|40214474|FG002|Double Blind Treatment Period|non-specified|0|||
16075252|NCT02139046|38769669|FG000|Overall Study|Lack of Efficacy|0|||
16075253|NCT02139046|38769670|FG001|Overall Study|Lack of Efficacy|1|||
16075254|NCT02139046|38769671|FG002|Overall Study|Lack of Efficacy|2|||
16075255|NCT02139046|38769672|FG003|Overall Study|Lack of Efficacy|1|||
16075256|NCT02139046|38769673|FG004|Overall Study|Lack of Efficacy|2|||
16075257|NCT02139046|38769669|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
16075258|NCT02139046|38769670|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
16075259|NCT02139046|38769671|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
16075260|NCT02139046|38769672|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
16075261|NCT02139046|38769673|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
16075262|NCT02139046|38769669|FG000|Overall Study|Other Miscellaneous Reasons|10|||
16075263|NCT02139046|38769670|FG001|Overall Study|Other Miscellaneous Reasons|9|||
16075264|NCT02139046|38769671|FG002|Overall Study|Other Miscellaneous Reasons|4|||
16075265|NCT02139046|38769672|FG003|Overall Study|Other Miscellaneous Reasons|9|||
16075266|NCT02139046|38769673|FG004|Overall Study|Other Miscellaneous Reasons|12|||
16075267|NCT03520413|38769674|FG000|Overall Study|Lost to Follow-up|1|||
16075268|NCT03520413|38769675|FG001|Overall Study|Lost to Follow-up|1|||
16075269|NCT03520413|38769674|FG000|Overall Study|Withdrawal by Subject|1|||
16075270|NCT03520413|38769675|FG001|Overall Study|Withdrawal by Subject|2|||
16173791|NCT03304522|39115293|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
16173792|NCT03304522|39115292|FG000|Overall Study|Other|0|||
16075271|NCT03520413|38769674|FG000|Overall Study|Death|0|||
16075272|NCT03520413|38769675|FG001|Overall Study|Death|1|||
16473469|NCT00736879|40214475|FG003|Double Blind Treatment Period|non-specified|0|||
16075273|NCT03520413|38769674|FG000|Overall Study|Physician Decision|3|||
16075274|NCT03520413|38769675|FG001|Overall Study|Physician Decision|3|||
16075275|NCT03520413|38769674|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
16075276|NCT03520413|38769675|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
16075277|NCT01692730|38769678|FG000|Overall Study|Lost to Follow-up|225|||
16075278|NCT01692730|38769679|FG001|Overall Study|Lost to Follow-up|227|||
16075279|NCT03299816|38769680|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
16473470|NCT00736879|40214472|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
16473471|NCT00736879|40214473|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
16473472|NCT00736879|40214474|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
16075280|NCT03299816|38769681|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
16075281|NCT03299816|38769680|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
16075282|NCT03299816|38769681|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
16075283|NCT03299816|38769680|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
16075284|NCT03299816|38769681|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
16473473|NCT00736879|40214475|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
16473474|NCT00736879|40214472|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
16473475|NCT00736879|40214473|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
16473476|NCT00736879|40214474|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
16473477|NCT00736879|40214475|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
16473478|NCT03061097|40214476|FG000|Overall Study|Withdrawal by Subject|0|||
16473479|NCT03061097|40214477|FG001|Overall Study|Withdrawal by Subject|3|||
16473480|NCT01032174|40214478|FG000|Overall Study|Adverse Event|0|||
16473481|NCT01032174|40214479|FG001|Overall Study|Adverse Event|1|||
16473482|NCT00760214|40214482|FG000|Overall Study|Adverse Event|8|||
16473483|NCT00760214|40214483|FG001|Overall Study|Adverse Event|9|||
16473484|NCT00760214|40214484|FG002|Overall Study|Adverse Event|12|||
16473485|NCT00760214|40214482|FG000|Overall Study|Protocol Violation|3|||
16473486|NCT00760214|40214483|FG001|Overall Study|Protocol Violation|0|||
16473487|NCT00760214|40214484|FG002|Overall Study|Protocol Violation|3|||
16473488|NCT00760214|40214482|FG000|Overall Study|Lost to Follow-up|0|||
16075285|NCT01117480|38769682|FG000|Overall Study|Protocol Violation|8|||
16075286|NCT01117480|38769682|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
16075287|NCT03844269|38769683|FG000|Overall Study|Withdrawal pre-intervention|1|||
16075288|NCT03844269|38769683|FG000|Overall Study|Did not complete the intervention|2|||
16473489|NCT00760214|40214483|FG001|Overall Study|Lost to Follow-up|0|||
16473490|NCT00760214|40214484|FG002|Overall Study|Lost to Follow-up|1|||
16473491|NCT00760214|40214482|FG000|Overall Study|Withdrawal by Subject|12|||
16473492|NCT00760214|40214483|FG001|Overall Study|Withdrawal by Subject|14|||
16473493|NCT00760214|40214484|FG002|Overall Study|Withdrawal by Subject|13|||
16473494|NCT00760214|40214482|FG000|Overall Study|Lack of Efficacy|3|||
16473495|NCT00760214|40214483|FG001|Overall Study|Lack of Efficacy|2|||
16473496|NCT00760214|40214484|FG002|Overall Study|Lack of Efficacy|4|||
16473497|NCT00760214|40214482|FG000|Overall Study|Pregnancy|0|||
16473498|NCT00760214|40214483|FG001|Overall Study|Pregnancy|0|||
16473499|NCT00760214|40214484|FG002|Overall Study|Pregnancy|1|||
16473500|NCT00760214|40214482|FG000|Overall Study|Physician Decision|1|||
16473501|NCT00760214|40214483|FG001|Overall Study|Physician Decision|1|||
16473502|NCT00760214|40214484|FG002|Overall Study|Physician Decision|1|||
16473503|NCT00760214|40214482|FG000|Overall Study|Other|3|||
16473504|NCT00760214|40214483|FG001|Overall Study|Other|4|||
16473505|NCT00760214|40214484|FG002|Overall Study|Other|6|||
16473506|NCT00915356|40214485|FG000|Overall Study|Withdrawal by Subject|1|||
16473507|NCT00915356|40214486|FG001|Overall Study|Withdrawal by Subject|0|||
16473508|NCT00915356|40214487|FG002|Overall Study|Withdrawal by Subject|0|||
16473509|NCT00915356|40214488|FG003|Overall Study|Withdrawal by Subject|0|||
16473510|NCT00915356|40214489|FG004|Overall Study|Withdrawal by Subject|0|||
16473511|NCT04478123|40214490|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
16473512|NCT04478123|40214490|FG000|Overall Study|NE|1|||
16473513|NCT04889222|40214491|FG000|Overall Study|Did not meet eligibility criteria|8|||
16075289|NCT02808338|38769691|FG000|Screening|Screen Failure|10|||
16075290|NCT02808338|38769691|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
16473514|NCT04889222|40214491|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
16473515|NCT04889222|40214491|FG000|Overall Study|Did not proceed due to time constraints|5|||
16473516|NCT00464269|40214492|FG000|Overall Study|Lack of Efficacy|1|||
16473517|NCT00464269|40214493|FG001|Overall Study|Lack of Efficacy|0|||
16473518|NCT00464269|40214494|FG002|Overall Study|Lack of Efficacy|0|||
16473519|NCT00464269|40214495|FG003|Overall Study|Lack of Efficacy|0|||
16473520|NCT00464269|40214492|FG000|Overall Study|Lost to Follow-up|0|||
16473521|NCT00464269|40214493|FG001|Overall Study|Lost to Follow-up|4|||
16473522|NCT00464269|40214494|FG002|Overall Study|Lost to Follow-up|0|||
16473523|NCT00464269|40214495|FG003|Overall Study|Lost to Follow-up|1|||
16473524|NCT00464269|40214492|FG000|Overall Study|Withdrawal by Subject|0|||
16473525|NCT00464269|40214493|FG001|Overall Study|Withdrawal by Subject|2|||
16473526|NCT00464269|40214494|FG002|Overall Study|Withdrawal by Subject|1|||
16473527|NCT00464269|40214495|FG003|Overall Study|Withdrawal by Subject|1|||
16473528|NCT00464269|40214492|FG000|Overall Study|Other reason|3|||
16473529|NCT00464269|40214493|FG001|Overall Study|Other reason|3|||
16473530|NCT00464269|40214494|FG002|Overall Study|Other reason|1|||
16473531|NCT00464269|40214495|FG003|Overall Study|Other reason|1|||
16473532|NCT00464269|40214492|FG000|Overall Study|AE, serious fatal|0|||
16473533|NCT00464269|40214493|FG001|Overall Study|AE, serious fatal|0|||
16473534|NCT00464269|40214494|FG002|Overall Study|AE, serious fatal|1|||
16473535|NCT00464269|40214495|FG003|Overall Study|AE, serious fatal|1|||
16473536|NCT00464269|40214492|FG000|Overall Study|SAE, non-fatal|0|||
16473537|NCT00464269|40214493|FG001|Overall Study|SAE, non-fatal|0|||
16473538|NCT00464269|40214494|FG002|Overall Study|SAE, non-fatal|0|||
16473539|NCT00464269|40214495|FG003|Overall Study|SAE, non-fatal|1|||
16473540|NCT00464269|40214492|FG000|Overall Study|AE, non-serious non-fatal|2|||
16473541|NCT00464269|40214493|FG001|Overall Study|AE, non-serious non-fatal|8|||
16473542|NCT00464269|40214494|FG002|Overall Study|AE, non-serious non-fatal|3|||
16473543|NCT00464269|40214495|FG003|Overall Study|AE, non-serious non-fatal|4|||
16473544|NCT00464269|40214492|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
16473545|NCT00464269|40214493|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
16473546|NCT00464269|40214494|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
16473547|NCT00464269|40214495|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
16473548|NCT04543409|40214496|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16473549|NCT04543409|40214497|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16473550|NCT04543409|40214496|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
16473551|NCT04543409|40214497|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
16473552|NCT04543409|40214496|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
16473553|NCT04543409|40214497|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
16473554|NCT04543409|40214496|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
16473555|NCT04543409|40214497|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
16473556|NCT04543409|40214496|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
16473557|NCT04543409|40214497|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
16473558|NCT04543409|40214496|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
16473559|NCT04543409|40214497|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
16473560|NCT04543409|40214496|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
16473561|NCT04543409|40214497|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
16473562|NCT04543409|40214496|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
16473563|NCT04543409|40214497|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
16473564|NCT04543409|40214496|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
16473565|NCT04543409|40214497|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
16473566|NCT04543409|40214496|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
16473567|NCT04543409|40214497|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
16473568|NCT04543409|40214496|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
16473569|NCT04543409|40214497|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
16473570|NCT03265665|40214498|FG000|24-week Data Collection|Withdrawal by Subject|2|||
16473571|NCT03265665|40214499|FG001|24-week Data Collection|Withdrawal by Subject|2|||
16473572|NCT03265665|40214498|FG000|24-week Data Collection|Lost to Follow-up|4|||
16473573|NCT03265665|40214499|FG001|24-week Data Collection|Lost to Follow-up|5|||
16473574|NCT03265665|40214498|FG000|36-week Data Collection|Lost to Follow-up|6|||
16473575|NCT03265665|40214499|FG001|36-week Data Collection|Lost to Follow-up|8|||
16473576|NCT04850313|40214500|FG000|Overall Study|Withdrawal by Subject|0|||
16473577|NCT04850313|40214501|FG001|Overall Study|Withdrawal by Subject|1|||
16473578|NCT02035475|40214502|FG000|Overall Study|Withdrawal by Subject|4|||
16473579|NCT02035475|40214502|FG000|Overall Study|Physician Decision|1|||
16473580|NCT02035475|40214502|FG000|Overall Study|Equipment Error|1|||
16473581|NCT02963935|40214505|FG000|Overall Study|Adverse Event|12|||
16473582|NCT02963935|40214506|FG001|Overall Study|Adverse Event|6|||
16473583|NCT02963935|40214505|FG000|Overall Study|Protocol Violation|2|||
16473584|NCT02963935|40214506|FG001|Overall Study|Protocol Violation|1|||
16473585|NCT02963935|40214505|FG000|Overall Study|Lack of Efficacy|0|||
16473586|NCT02963935|40214506|FG001|Overall Study|Lack of Efficacy|2|||
16473587|NCT02963935|40214505|FG000|Overall Study|Lost to Follow-up|1|||
16473588|NCT02963935|40214506|FG001|Overall Study|Lost to Follow-up|6|||
16473589|NCT02963935|40214505|FG000|Overall Study|Unclassified|13|||
16473590|NCT02963935|40214506|FG001|Overall Study|Unclassified|22|||
16473591|NCT01368432|40214507|FG000|Overall Study|Lost to Follow-up|0|||
16473592|NCT01368432|40214508|FG001|Overall Study|Lost to Follow-up|1|||
16473593|NCT03114488|40214509|FG000|Time Period 2|Withdrawal by Subject|1|||
16473594|NCT03114488|40214510|FG001|Time Period 2|Withdrawal by Subject|3|||
16274821|NCT00748566|39490179|FG000|Overall Study|Withdrawal by Subject|22|||
16473595|NCT03816332|40214518|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
16473596|NCT03816332|40214518|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
16473597|NCT02057393|40214522|FG000|Overall Study|Withdrawal by Subject|1|||
16473598|NCT02057393|40214522|FG000|Overall Study|Patient did not meet criteria|1|||
16473599|NCT00986479|40214524|FG000|Period 1|Improved mood|1|||
16473600|NCT00986479|40214525|FG001|Period 1|Improved mood|0|||
16473601|NCT00986479|40214524|FG000|Period 1|Administrative reasons|1|||
16473602|NCT00986479|40214525|FG001|Period 1|Administrative reasons|0|||
16473603|NCT01385371|40214526|FG000|Overall Study|Adverse Event|54|||
16473604|NCT01385371|40214527|FG001|Overall Study|Adverse Event|19|||
16473605|NCT01385371|40214526|FG000|Overall Study|Lost to Follow-up|16|||
16473606|NCT01385371|40214527|FG001|Overall Study|Lost to Follow-up|16|||
16473607|NCT01385371|40214526|FG000|Overall Study|Withdrawal by Subject|52|||
16473608|NCT01385371|40214527|FG001|Overall Study|Withdrawal by Subject|39|||
16473609|NCT01385371|40214526|FG000|Overall Study|Protocol Violation|25|||
16473610|NCT01385371|40214527|FG001|Overall Study|Protocol Violation|21|||
16473611|NCT01385371|40214526|FG000|Overall Study|Administrative|2|||
16473612|NCT01385371|40214527|FG001|Overall Study|Administrative|2|||
16473613|NCT00589290|40214529|FG000|Overall Study|Withdrawal by Subject|1|||
16473614|NCT03131453|40214530|FG000|Overall Study|Study terminated by Sponsor|424|||
16473615|NCT03131453|40214531|FG001|Overall Study|Study terminated by Sponsor|222|||
16473616|NCT03131453|40214532|FG002|Overall Study|Study terminated by Sponsor|438|||
16473617|NCT03131453|40214530|FG000|Overall Study|Withdrawal by Subject|18|||
16473618|NCT03131453|40214531|FG001|Overall Study|Withdrawal by Subject|7|||
16473619|NCT03131453|40214532|FG002|Overall Study|Withdrawal by Subject|13|||
16473620|NCT03131453|40214530|FG000|Overall Study|Adverse Event|10|||
16473621|NCT03131453|40214531|FG001|Overall Study|Adverse Event|3|||
16473622|NCT03131453|40214532|FG002|Overall Study|Adverse Event|3|||
16473623|NCT03131453|40214530|FG000|Overall Study|Lost to Follow-up|1|||
16473624|NCT03131453|40214531|FG001|Overall Study|Lost to Follow-up|0|||
16473625|NCT03131453|40214532|FG002|Overall Study|Lost to Follow-up|1|||
16473626|NCT03131453|40214530|FG000|Overall Study|Physician Decision|1|||
16473627|NCT03131453|40214531|FG001|Overall Study|Physician Decision|0|||
16473628|NCT03131453|40214532|FG002|Overall Study|Physician Decision|1|||
16473629|NCT03131453|40214530|FG000|Overall Study|Non-compliance with study treatment|1|||
16473630|NCT03131453|40214531|FG001|Overall Study|Non-compliance with study treatment|0|||
16473631|NCT03131453|40214532|FG002|Overall Study|Non-compliance with study treatment|0|||
16473632|NCT03131453|40214530|FG000|Overall Study|Technical problems|1|||
16473633|NCT03131453|40214531|FG001|Overall Study|Technical problems|0|||
16473634|NCT03131453|40214532|FG002|Overall Study|Technical problems|0|||
16473635|NCT03131453|40214530|FG000|Overall Study|Protocol deviation|0|||
16473636|NCT03131453|40214531|FG001|Overall Study|Protocol deviation|1|||
16473637|NCT03131453|40214532|FG002|Overall Study|Protocol deviation|0|||
16473638|NCT01977937|40214533|FG000|Overall Study|Withdrawal by Subject|2|||
16473639|NCT01977937|40214534|FG001|Overall Study|Withdrawal by Subject|1|||
16473640|NCT01977937|40214533|FG000|Overall Study|Adverse Event|1|||
16473641|NCT01977937|40214534|FG001|Overall Study|Adverse Event|0|||
16473642|NCT01977937|40214533|FG000|Overall Study|Physician Decision|0|||
16473643|NCT01977937|40214534|FG001|Overall Study|Physician Decision|1|||
16473644|NCT00071396|40214536|FG000|Overall Study|Withdrawal by Subject|1|||
16473645|NCT00071396|40214536|FG000|Overall Study|Physician Decision|2|||
16473646|NCT02484690|40214537|FG000|Overall Study|Adverse Event|1|||
16473647|NCT02484690|40214538|FG001|Overall Study|Adverse Event|3|||
16473648|NCT02484690|40214539|FG002|Overall Study|Adverse Event|0|||
16473649|NCT02484690|40214540|FG003|Overall Study|Adverse Event|0|||
16473650|NCT02484690|40214541|FG004|Overall Study|Adverse Event|5|||
16473651|NCT02484690|40214537|FG000|Overall Study|Death|0|||
16473652|NCT02484690|40214538|FG001|Overall Study|Death|0|||
16473653|NCT02484690|40214539|FG002|Overall Study|Death|0|||
16473654|NCT02484690|40214540|FG003|Overall Study|Death|0|||
16473655|NCT02484690|40214541|FG004|Overall Study|Death|1|||
16473656|NCT02484690|40214537|FG000|Overall Study|Withdrawal by Subject|1|||
16473657|NCT02484690|40214538|FG001|Overall Study|Withdrawal by Subject|3|||
16473658|NCT02484690|40214539|FG002|Overall Study|Withdrawal by Subject|1|||
16473659|NCT02484690|40214540|FG003|Overall Study|Withdrawal by Subject|2|||
16473660|NCT02484690|40214541|FG004|Overall Study|Withdrawal by Subject|0|||
16473661|NCT02484690|40214537|FG000|Overall Study|Physician Decision|2|||
16473662|NCT02484690|40214538|FG001|Overall Study|Physician Decision|0|||
16274822|NCT00748566|39490179|FG000|Overall Study|Study terminated by sponsor|5|||
16274823|NCT00748566|39490179|FG000|Overall Study|Other|9|||
16473663|NCT02484690|40214539|FG002|Overall Study|Physician Decision|1|||
16473664|NCT02484690|40214540|FG003|Overall Study|Physician Decision|0|||
16473665|NCT02484690|40214541|FG004|Overall Study|Physician Decision|0|||
16473666|NCT02484690|40214537|FG000|Overall Study|Lost to Follow-up|0|||
16473667|NCT02484690|40214538|FG001|Overall Study|Lost to Follow-up|0|||
16473668|NCT02484690|40214539|FG002|Overall Study|Lost to Follow-up|1|||
16473669|NCT02484690|40214540|FG003|Overall Study|Lost to Follow-up|0|||
16473670|NCT02484690|40214541|FG004|Overall Study|Lost to Follow-up|0|||
16473671|NCT02360111|40214542|FG000|Overall Study|Death|2|||
16473672|NCT01863953|40214548|FG000|Overall Study|Adverse Event|0|||
16473673|NCT01863953|40214549|FG001|Overall Study|Adverse Event|0|||
16473674|NCT01863953|40214550|FG002|Overall Study|Adverse Event|1|||
16473675|NCT02203071|40214553|FG000|Overall Study|Lost to Follow-up|3|||
16473676|NCT02203071|40214554|FG001|Overall Study|Lost to Follow-up|1|||
16473677|NCT01278160|40214555|FG000|Overall Study|Adverse Event|1|||
16473678|NCT01278160|40214556|FG001|Overall Study|Adverse Event|1|||
16473679|NCT01278160|40214555|FG000|Overall Study|Lost to Follow-up|0|||
16473680|NCT01278160|40214556|FG001|Overall Study|Lost to Follow-up|1|||
16473681|NCT01278160|40214555|FG000|Overall Study|Withdrawal by Subject|3|||
16473682|NCT01278160|40214556|FG001|Overall Study|Withdrawal by Subject|2|||
16473683|NCT01278160|40214555|FG000|Overall Study|Unclassified|1|||
16473684|NCT01278160|40214556|FG001|Overall Study|Unclassified|2|||
16473685|NCT01193660|40214557|FG000|Overall Study|Withdrawal by Subject|2|||
16473686|NCT01193660|40214558|FG001|Overall Study|Withdrawal by Subject|3|||
16473687|NCT01193660|40214559|FG002|Overall Study|Withdrawal by Subject|1|||
16473688|NCT01193660|40214557|FG000|Overall Study|Death|1|||
16473689|NCT01193660|40214558|FG001|Overall Study|Death|0|||
16473690|NCT01193660|40214559|FG002|Overall Study|Death|0|||
16473691|NCT01193660|40214557|FG000|Overall Study|Physician Decision|1|||
16473692|NCT01193660|40214558|FG001|Overall Study|Physician Decision|0|||
16473693|NCT01193660|40214559|FG002|Overall Study|Physician Decision|1|||
16473694|NCT02962765|40214560|FG000|Overall Study|Protocol Violation|9|||
16473695|NCT02962765|40214560|FG000|Overall Study|Withdrawal by Subject|3|||
16473696|NCT02962765|40214560|FG000|Overall Study|Lost to Follow-up|1|||
16473697|NCT02962765|40214560|FG000|Overall Study|Death|1|||
16473698|NCT02962765|40214560|FG000|Overall Study|Limited access to study medication|3|||
16473699|NCT02149875|40214561|FG000|Overall Study|Lost to Follow-up|3|||
16473700|NCT02149875|40214562|FG001|Overall Study|Lost to Follow-up|4|||
16473701|NCT02149875|40214563|FG002|Overall Study|Lost to Follow-up|5|||
16473702|NCT02149875|40214561|FG000|Overall Study|Withdrawal by Subject|3|||
16473703|NCT02149875|40214562|FG001|Overall Study|Withdrawal by Subject|2|||
16473704|NCT02149875|40214563|FG002|Overall Study|Withdrawal by Subject|2|||
16075291|NCT02808338|38769691|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
16075292|NCT02739035|38769692|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
16075293|NCT02739035|38769693|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
16075294|NCT02739035|38769692|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
16075295|NCT02739035|38769693|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
16075296|NCT02739035|38769692|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
16075297|NCT02739035|38769693|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
16075298|NCT02739035|38769692|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
16075299|NCT02739035|38769693|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
16274824|NCT03922750|39490180|FG000|Overall Study|Unclassified|0|||
16473705|NCT02149875|40214561|FG000|Overall Study|Physician Decision|1|||
16473706|NCT02149875|40214562|FG001|Overall Study|Physician Decision|2|||
16473707|NCT02149875|40214563|FG002|Overall Study|Physician Decision|2|||
16473708|NCT04093414|40214564|FG000|3 Month Follow up|Physician Decision|0|||
16473709|NCT04093414|40214565|FG001|3 Month Follow up|Physician Decision|1|||
16473710|NCT04093414|40214564|FG000|6month Follow up|Physician Decision|1|||
16473711|NCT04093414|40214565|FG001|6month Follow up|Physician Decision|3|||
16473712|NCT00737464|40214569|FG000|Overall Study|Adverse Event|1|||
16473713|NCT00737464|40214569|FG000|Overall Study|Death|6|||
16473714|NCT00737464|40214569|FG000|Overall Study|Other - Failure to Return|1|||
16473715|NCT00737464|40214569|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
16473716|NCT00737464|40214569|FG000|Overall Study|Other reasons|4|||
16473717|NCT00471146|40214570|FG000|Overall Study|Adverse Event|32|||
16473718|NCT00471146|40214571|FG001|Overall Study|Adverse Event|33|||
16473719|NCT00471146|40214570|FG000|Overall Study|Withdrawal by Subject|14|||
16473720|NCT00471146|40214571|FG001|Overall Study|Withdrawal by Subject|11|||
16473721|NCT00471146|40214570|FG000|Overall Study|Death|11|||
16473722|NCT00471146|40214571|FG001|Overall Study|Death|12|||
16473723|NCT00471146|40214570|FG000|Overall Study|Lost to Follow-up|4|||
16473724|NCT00471146|40214571|FG001|Overall Study|Lost to Follow-up|2|||
16473725|NCT00471146|40214570|FG000|Overall Study|Protocol Violation|2|||
16473726|NCT00471146|40214571|FG001|Overall Study|Protocol Violation|2|||
16075300|NCT00768664|38769694|FG000|Overall Study|Death|57|||
16075301|NCT00768664|38769694|FG000|Overall Study|Lost to Follow-up|2|||
16473727|NCT00471146|40214570|FG000|Overall Study|Objective progression or relapse|84|||
16473728|NCT00471146|40214571|FG001|Overall Study|Objective progression or relapse|87|||
16473729|NCT00471146|40214570|FG000|Overall Study|Global deterioration of health status|12|||
16473730|NCT00471146|40214571|FG001|Overall Study|Global deterioration of health status|14|||
16473731|NCT00471146|40214570|FG000|Overall Study|Randomized but not treated|9|||
16473732|NCT00471146|40214571|FG001|Overall Study|Randomized but not treated|8|||
16473733|NCT00471146|40214570|FG000|Overall Study|Other|4|||
16473734|NCT00471146|40214571|FG001|Overall Study|Other|5|||
16473735|NCT04535167|40214575|FG000|Treatment|Adverse Event|0|||
16473736|NCT04535167|40214576|FG001|Treatment|Adverse Event|0|||
16473737|NCT04535167|40214577|FG002|Treatment|Adverse Event|0|||
16473738|NCT04535167|40214578|FG003|Treatment|Adverse Event|0|||
16473739|NCT04535167|40214579|FG004|Treatment|Adverse Event|0|||
16473740|NCT04535167|40214580|FG005|Treatment|Adverse Event|0|||
16473741|NCT04535167|40214581|FG006|Treatment|Adverse Event|1|||
16473742|NCT04535167|40214575|FG000|Follow-Up|Death|0|||
16473743|NCT04535167|40214576|FG001|Follow-Up|Death|0|||
16473744|NCT04535167|40214577|FG002|Follow-Up|Death|0|||
16473745|NCT04535167|40214578|FG003|Follow-Up|Death|0|||
16473746|NCT04535167|40214579|FG004|Follow-Up|Death|0|||
16473747|NCT04535167|40214580|FG005|Follow-Up|Death|0|||
16473748|NCT04535167|40214581|FG006|Follow-Up|Death|1|||
16473749|NCT04535167|40214575|FG000|Follow-Up|Lost to Follow-up|0|||
16473750|NCT04535167|40214576|FG001|Follow-Up|Lost to Follow-up|0|||
16473751|NCT04535167|40214577|FG002|Follow-Up|Lost to Follow-up|0|||
16473752|NCT04535167|40214578|FG003|Follow-Up|Lost to Follow-up|1|||
16473753|NCT04535167|40214579|FG004|Follow-Up|Lost to Follow-up|0|||
16473754|NCT04535167|40214580|FG005|Follow-Up|Lost to Follow-up|0|||
16473755|NCT04535167|40214581|FG006|Follow-Up|Lost to Follow-up|0|||
16473756|NCT02478372|40214582|FG000|Overall Study|Protocol Violation|12|||
16473757|NCT02478372|40214583|FG001|Overall Study|Protocol Violation|8|||
16473758|NCT02478372|40214582|FG000|Overall Study|Lost to Follow-up|1|||
16473759|NCT02478372|40214583|FG001|Overall Study|Lost to Follow-up|4|||
16473760|NCT02478372|40214582|FG000|Overall Study|Death|0|||
16473761|NCT02478372|40214583|FG001|Overall Study|Death|2|||
16473762|NCT03282565|40214584|FG000|Overall Study|COVID-19 Research Shutdown|0|||
16473763|NCT03282565|40214585|FG001|Overall Study|COVID-19 Research Shutdown|2|||
16473764|NCT03282565|40214586|FG002|Overall Study|COVID-19 Research Shutdown|2|||
16473765|NCT02806973|40214593|FG000|Period 1|Withdrawal by Subject|0|||
16473766|NCT02806973|40214594|FG001|Period 1|Withdrawal by Subject|2|||
16473767|NCT02806973|40214595|FG002|Period 1|Withdrawal by Subject|1|||
16473768|NCT02806973|40214596|FG003|Period 1|Withdrawal by Subject|1|||
16473769|NCT02806973|40214593|FG000|Period 1|Adverse Event|0|||
16473770|NCT02806973|40214594|FG001|Period 1|Adverse Event|0|||
16473771|NCT02806973|40214595|FG002|Period 1|Adverse Event|0|||
16473772|NCT02806973|40214596|FG003|Period 1|Adverse Event|1|||
16473773|NCT02806973|40214593|FG000|Period 3|Withdrawal by Subject|0|||
16473774|NCT02806973|40214594|FG001|Period 3|Withdrawal by Subject|0|||
16473775|NCT02806973|40214595|FG002|Period 3|Withdrawal by Subject|0|||
16473776|NCT02806973|40214596|FG003|Period 3|Withdrawal by Subject|3|||
16473777|NCT02806973|40214593|FG000|Period 3|Adverse Event|0|||
16473778|NCT02806973|40214594|FG001|Period 3|Adverse Event|0|||
16473779|NCT02806973|40214595|FG002|Period 3|Adverse Event|1|||
16473780|NCT02806973|40214596|FG003|Period 3|Adverse Event|0|||
16473781|NCT02413372|40214597|FG000|Treatment|Lost to Follow-up|0|||
16473782|NCT02413372|40214598|FG001|Treatment|Lost to Follow-up|2|||
16473783|NCT02413372|40214599|FG002|Treatment|Lost to Follow-up|1|||
16473784|NCT02413372|40214597|FG000|Treatment|Withdrawal by Subject|1|||
16473785|NCT02413372|40214598|FG001|Treatment|Withdrawal by Subject|0|||
16473786|NCT02413372|40214599|FG002|Treatment|Withdrawal by Subject|0|||
16473787|NCT02413372|40214597|FG000|Follow-up|Lost to Follow-up|1|||
16473788|NCT02413372|40214598|FG001|Follow-up|Lost to Follow-up|1|||
16473789|NCT02413372|40214599|FG002|Follow-up|Lost to Follow-up|0|||
16473790|NCT02413372|40214597|FG000|Follow-up|Subject Withdrew Consent|1|||
16473791|NCT02413372|40214598|FG001|Follow-up|Subject Withdrew Consent|0|||
16473792|NCT02413372|40214599|FG002|Follow-up|Subject Withdrew Consent|1|||
16473793|NCT02413372|40214597|FG000|Follow-up|Subject unable to return for visit|0|||
16473794|NCT02413372|40214598|FG001|Follow-up|Subject unable to return for visit|0|||
16473795|NCT02413372|40214599|FG002|Follow-up|Subject unable to return for visit|1|||
16473796|NCT01736124|40214600|FG000|Post-intervention Assessment|Death|2|||
16473797|NCT01736124|40214601|FG001|Post-intervention Assessment|Death|2|||
16473798|NCT01736124|40214600|FG000|Post-intervention Assessment|lost computer access|1|||
16473799|NCT01736124|40214601|FG001|Post-intervention Assessment|lost computer access|1|||
16473800|NCT01736124|40214600|FG000|Post-intervention Assessment|Moved away|3|||
16473801|NCT01736124|40214601|FG001|Post-intervention Assessment|Moved away|1|||
16473802|NCT01736124|40214600|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
16473803|NCT01736124|40214601|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
16409896|NCT01143051|39981812|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
16473804|NCT01736124|40214600|FG000|Post-intervention Assessment|Illness|3|||
16473805|NCT01736124|40214601|FG001|Post-intervention Assessment|Illness|2|||
16473806|NCT01736124|40214600|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
16473807|NCT01736124|40214601|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
16473808|NCT01736124|40214600|FG000|Post-intervention Assessment|Temporarily away|3|||
16473809|NCT01736124|40214601|FG001|Post-intervention Assessment|Temporarily away|1|||
16473810|NCT01736124|40214600|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
16473811|NCT01736124|40214601|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
16473812|NCT01736124|40214600|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
16473813|NCT01736124|40214601|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
16473814|NCT01736124|40214600|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
16473815|NCT01736124|40214601|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
16473816|NCT01736124|40214600|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
16473817|NCT01736124|40214601|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
16473818|NCT01736124|40214600|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
16473819|NCT01736124|40214601|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
16473820|NCT01736124|40214600|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
16473821|NCT01736124|40214601|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
16473822|NCT01736124|40214600|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
16075302|NCT00768664|38769694|FG000|Overall Study|Other|9|||
16473823|NCT01736124|40214601|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
16473824|NCT01736124|40214600|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
16473825|NCT01736124|40214601|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
16473826|NCT01736124|40214600|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
16473827|NCT01736124|40214601|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
16473828|NCT03387683|40214606|FG000|Overall Study|In receipt of disallowed medication|1|||
16473829|NCT03387683|40214607|FG001|Overall Study|In receipt of disallowed medication|0|||
16473830|NCT03387683|40214606|FG000|Overall Study|Did not receive treatment|1|||
16473831|NCT03387683|40214607|FG001|Overall Study|Did not receive treatment|0|||
16473832|NCT03711266|40214608|FG000|Overall Study|Lost to Follow-up|10|||
16473833|NCT01856907|40214609|FG000|Overall Study|Pregnancy|0|||
16473834|NCT01856907|40214610|FG001|Overall Study|Pregnancy|1|||
16473835|NCT01856907|40214611|FG002|Overall Study|Pregnancy|0|||
16473836|NCT01856907|40214609|FG000|Overall Study|Pregnancy|0|||
16473837|NCT01856907|40214610|FG001|Overall Study|Pregnancy|1|||
16473838|NCT01856907|40214611|FG002|Overall Study|Pregnancy|0|||
16473839|NCT01856907|40214609|FG000|Overall Study|Withdrawal by Subject|0|||
16473840|NCT01856907|40214610|FG001|Overall Study|Withdrawal by Subject|1|||
16473841|NCT01856907|40214611|FG002|Overall Study|Withdrawal by Subject|0|||
16473842|NCT04087213|40214612|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
16473843|NCT04087213|40214612|FG000|In-Facility Introduction|Adverse Event|1|||
16473844|NCT04087213|40214612|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
16473845|NCT04087213|40214612|FG000|Assisted Evaluable Period|Personal reasons|3|||
16473846|NCT04087213|40214612|FG000|Transition Period B|Renal Transplantation|1|||
16473847|NCT02047227|40214613|FG000|Overall Study|Adverse Event|2|||
16473848|NCT02047227|40214614|FG001|Overall Study|Adverse Event|4|||
16473849|NCT02047227|40214613|FG000|Overall Study|Lost to Follow-up|0|||
16473850|NCT02047227|40214614|FG001|Overall Study|Lost to Follow-up|3|||
16473851|NCT02047227|40214613|FG000|Overall Study|Protocol Violation|1|||
16473852|NCT02047227|40214614|FG001|Overall Study|Protocol Violation|0|||
16473853|NCT02047227|40214613|FG000|Overall Study|Spontaneous pregnancy|1|||
16473854|NCT02047227|40214614|FG001|Overall Study|Spontaneous pregnancy|0|||
16075303|NCT00768664|38769694|FG000|Overall Study|Participant refused|1|||
16075304|NCT01490086|38769696|FG000|Overall Study|Consent withdrawn|4|||
16075305|NCT01490086|38769697|FG001|Overall Study|Consent withdrawn|4|||
16075306|NCT01490086|38769698|FG002|Overall Study|Consent withdrawn|3|||
16075307|NCT01490086|38769699|FG003|Overall Study|Consent withdrawn|0|||
16075308|NCT01490086|38769700|FG004|Overall Study|Consent withdrawn|1|||
16075309|NCT01490086|38769696|FG000|Overall Study|Non-compliance|0|||
16075310|NCT01490086|38769697|FG001|Overall Study|Non-compliance|1|||
16075311|NCT01490086|38769698|FG002|Overall Study|Non-compliance|0|||
16075312|NCT01490086|38769699|FG003|Overall Study|Non-compliance|0|||
16075313|NCT01490086|38769700|FG004|Overall Study|Non-compliance|0|||
16075314|NCT01490086|38769696|FG000|Overall Study|Abnormal laboratory findings|1|||
16075315|NCT01490086|38769697|FG001|Overall Study|Abnormal laboratory findings|0|||
16473855|NCT02047227|40214613|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
16473856|NCT02047227|40214614|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
16473857|NCT02047227|40214613|FG000|Overall Study|No oocytes retrieved|21|||
16473858|NCT02047227|40214614|FG001|Overall Study|No oocytes retrieved|20|||
16473859|NCT02047227|40214613|FG000|Overall Study|No fertilization|61|||
16473860|NCT02047227|40214614|FG001|Overall Study|No fertilization|51|||
16473861|NCT02047227|40214613|FG000|Overall Study|Intention to freeze all embryos|1|||
16473862|NCT02047227|40214614|FG001|Overall Study|Intention to freeze all embryos|0|||
16473863|NCT02047227|40214613|FG000|Overall Study|All embryos discarded|12|||
16473864|NCT02047227|40214614|FG001|Overall Study|All embryos discarded|11|||
16473865|NCT02047227|40214613|FG000|Overall Study|Other|10|||
16473866|NCT02047227|40214614|FG001|Overall Study|Other|9|||
16473867|NCT03898960|40214615|FG000|Overall Study|Death|10|||
16473868|NCT03021304|40214618|FG000|Overall Study|Lack of Efficacy|1|||
16473869|NCT01225887|40214619|FG000|Overall Study|Ineligible:required test not done|2|||
16075316|NCT01490086|38769698|FG002|Overall Study|Abnormal laboratory findings|0|||
16075317|NCT01490086|38769699|FG003|Overall Study|Abnormal laboratory findings|0|||
16274825|NCT03922750|39490181|FG001|Overall Study|Unclassified|0|||
16473870|NCT01225887|40214619|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
16473871|NCT01225887|40214619|FG000|Overall Study|Ineligible:inadequate pathology|2|||
16473872|NCT00336583|40214620|FG000|Overall Study|Lost to Follow-up|1|||
16473873|NCT00336583|40214620|FG000|Overall Study|Death|1|||
16473874|NCT00674973|40214626|FG000|Overall Study|Insufficient Therapeutic Response|77|||
16473875|NCT00674973|40214627|FG001|Overall Study|Insufficient Therapeutic Response|72|||
16473876|NCT00674973|40214626|FG000|Overall Study|Refused Treatment|1|||
16473877|NCT00674973|40214627|FG001|Overall Study|Refused Treatment|5|||
16473878|NCT00674973|40214626|FG000|Overall Study|Failure to Return|1|||
16473879|NCT00674973|40214627|FG001|Overall Study|Failure to Return|0|||
16473880|NCT00674973|40214626|FG000|Overall Study|Adverse Event|2|||
16473881|NCT00674973|40214627|FG001|Overall Study|Adverse Event|9|||
16473882|NCT00674973|40214626|FG000|Overall Study|Death|19|||
16473883|NCT00674973|40214627|FG001|Overall Study|Death|15|||
16473884|NCT00674973|40214626|FG000|Overall Study|Protocol Violation|0|||
16473885|NCT00674973|40214627|FG001|Overall Study|Protocol Violation|1|||
16473886|NCT00629772|40214643|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
16473887|NCT00629772|40214644|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
16473888|NCT00629772|40214643|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
16473889|NCT00629772|40214644|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
16473890|NCT05274165|40214645|FG000|Overall Study|Withdrawal by Subject|3|||
16473891|NCT05274165|40214646|FG001|Overall Study|Withdrawal by Subject|3|||
16473892|NCT00467610|40214647|FG000|Overall Study|Withdrawal by Subject|1|||
16473893|NCT01090973|40214648|FG000|Overall Study|Disease progression|1|||
16473894|NCT03956056|40214649|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
16473895|NCT03956056|40214649|FG000|Overall Study|Lack of Efficacy|1|||
16473896|NCT01721070|40214650|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
16473897|NCT01134315|40214651|FG000|Overall Study|Adverse Event|1|||
16473898|NCT01134315|40214652|FG001|Overall Study|Adverse Event|2|||
16473899|NCT01134315|40214651|FG000|Overall Study|Other Reason|8|||
16075318|NCT01490086|38769700|FG004|Overall Study|Abnormal laboratory findings|0|||
16075319|NCT01490086|38769696|FG000|Overall Study|Lost to Follow-up|0|||
16075320|NCT01490086|38769697|FG001|Overall Study|Lost to Follow-up|0|||
16075321|NCT01490086|38769698|FG002|Overall Study|Lost to Follow-up|0|||
16075322|NCT01490086|38769699|FG003|Overall Study|Lost to Follow-up|0|||
16075323|NCT01490086|38769700|FG004|Overall Study|Lost to Follow-up|1|||
16075324|NCT01490086|38769696|FG000|Overall Study|Physician Decision|3|||
16075325|NCT01490086|38769697|FG001|Overall Study|Physician Decision|4|||
16473900|NCT01134315|40214652|FG001|Overall Study|Other Reason|17|||
16473901|NCT01691898|40214660|FG000|Overall Study|Death|34|||
16473902|NCT01691898|40214661|FG001|Overall Study|Death|32|||
16473903|NCT01691898|40214662|FG002|Overall Study|Death|6|||
16075326|NCT01490086|38769698|FG002|Overall Study|Physician Decision|2|||
16075327|NCT01490086|38769699|FG003|Overall Study|Physician Decision|3|||
16075328|NCT01490086|38769700|FG004|Overall Study|Physician Decision|1|||
16075329|NCT01490086|38769696|FG000|Overall Study|Adverse Event|0|||
16075330|NCT01490086|38769697|FG001|Overall Study|Adverse Event|0|||
16473904|NCT01691898|40214663|FG003|Overall Study|Death|3|||
16473905|NCT01691898|40214664|FG004|Overall Study|Death|8|||
16375130|NCT02741193|39856866|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
16375131|NCT00425854|39856868|FG000|Overall Study|Progressive Disease|19|||
16375132|NCT00425854|39856869|FG001|Overall Study|Progressive Disease|12|||
16375133|NCT00425854|39856868|FG000|Overall Study|Dose reduction toxicity AE|8|||
16375134|NCT00425854|39856869|FG001|Overall Study|Dose reduction toxicity AE|7|||
16375135|NCT00425854|39856868|FG000|Overall Study|Other Adverse Event|2|||
16375136|NCT00425854|39856869|FG001|Overall Study|Other Adverse Event|2|||
16375137|NCT01827943|39856873|FG000|Overall Study|Protocol Violation|8|||
16375138|NCT01827943|39856873|FG000|Overall Study|Never treated because of an rapid progression|1|||
16375139|NCT01385995|39860058|FG000|Period 1, 2 Months|Physician Decision|1|||
16375140|NCT01385995|39860059|FG001|Period 1, 2 Months|Physician Decision|0|||
16375141|NCT00563316|39860060|FG000|Overall Study|Adverse Event|2|||
16473906|NCT01691898|40214665|FG005|Overall Study|Death|31|||
16473907|NCT01691898|40214660|FG000|Overall Study|Adverse Event|0|||
16473908|NCT01691898|40214661|FG001|Overall Study|Adverse Event|1|||
16473909|NCT01691898|40214662|FG002|Overall Study|Adverse Event|0|||
16473910|NCT01691898|40214663|FG003|Overall Study|Adverse Event|1|||
16473911|NCT01691898|40214664|FG004|Overall Study|Adverse Event|1|||
16473912|NCT01691898|40214665|FG005|Overall Study|Adverse Event|0|||
16075331|NCT01490086|38769698|FG002|Overall Study|Adverse Event|1|||
16075332|NCT01490086|38769699|FG003|Overall Study|Adverse Event|2|||
16473913|NCT01691898|40214660|FG000|Overall Study|Progression of Disease|1|||
16473914|NCT01691898|40214661|FG001|Overall Study|Progression of Disease|2|||
16473915|NCT01691898|40214662|FG002|Overall Study|Progression of Disease|1|||
16473916|NCT01691898|40214663|FG003|Overall Study|Progression of Disease|0|||
16473917|NCT01691898|40214664|FG004|Overall Study|Progression of Disease|0|||
16473918|NCT01691898|40214665|FG005|Overall Study|Progression of Disease|1|||
16473919|NCT01691898|40214660|FG000|Overall Study|Lost to Follow-up|3|||
16473920|NCT01691898|40214661|FG001|Overall Study|Lost to Follow-up|1|||
16075333|NCT01490086|38769700|FG004|Overall Study|Adverse Event|0|||
16075334|NCT01490086|38769696|FG000|Overall Study|Lack of Efficacy|0|||
16473921|NCT01691898|40214662|FG002|Overall Study|Lost to Follow-up|0|||
16473922|NCT01691898|40214663|FG003|Overall Study|Lost to Follow-up|0|||
16473923|NCT01691898|40214664|FG004|Overall Study|Lost to Follow-up|1|||
16473924|NCT01691898|40214665|FG005|Overall Study|Lost to Follow-up|0|||
16473925|NCT01691898|40214660|FG000|Overall Study|Withdrawal by Subject|9|||
16473926|NCT01691898|40214661|FG001|Overall Study|Withdrawal by Subject|8|||
16473927|NCT01691898|40214662|FG002|Overall Study|Withdrawal by Subject|2|||
16473928|NCT01691898|40214663|FG003|Overall Study|Withdrawal by Subject|1|||
16473929|NCT01691898|40214664|FG004|Overall Study|Withdrawal by Subject|3|||
16473930|NCT01691898|40214665|FG005|Overall Study|Withdrawal by Subject|3|||
16473931|NCT01691898|40214660|FG000|Overall Study|Non-Compliance|0|||
16473932|NCT01691898|40214661|FG001|Overall Study|Non-Compliance|0|||
16473933|NCT01691898|40214662|FG002|Overall Study|Non-Compliance|0|||
16473934|NCT01691898|40214663|FG003|Overall Study|Non-Compliance|0|||
16473935|NCT01691898|40214664|FG004|Overall Study|Non-Compliance|1|||
16473936|NCT01691898|40214665|FG005|Overall Study|Non-Compliance|0|||
16473937|NCT04521777|40214666|FG000|Overall Study|Death|2|||
16473938|NCT04521777|40214666|FG000|Overall Study|Withdrawal by Subject|2|||
16473939|NCT01858376|40214668|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
16473940|NCT05021081|40214669|FG000|Phase 2|Subject enrolled in error|1|||
16473941|NCT05021081|40214670|FG001|Phase 2|Subject enrolled in error|1|||
16473942|NCT05021081|40214671|FG002|Phase 2|Subject enrolled in error|0|||
16473943|NCT01646073|40214675|FG000|Period A (12 Weeks)|Adverse Event|0|||
16473944|NCT01646073|40214676|FG001|Period A (12 Weeks)|Adverse Event|2|||
16473945|NCT01646073|40214675|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
16473946|NCT01646073|40214676|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
16473947|NCT01646073|40214675|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
16473948|NCT01646073|40214676|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
16473949|NCT01646073|40214675|FG000|Period A (12 Weeks)|Protocol Violation|0|||
16075335|NCT01490086|38769697|FG001|Overall Study|Lack of Efficacy|3|||
16075336|NCT01490086|38769698|FG002|Overall Study|Lack of Efficacy|1|||
16075337|NCT01490086|38769699|FG003|Overall Study|Lack of Efficacy|0|||
16075338|NCT01490086|38769700|FG004|Overall Study|Lack of Efficacy|8|||
16075339|NCT01490086|38769696|FG000|Overall Study|Worsening of symptoms|0|||
16075340|NCT01490086|38769697|FG001|Overall Study|Worsening of symptoms|1|||
16075341|NCT01490086|38769698|FG002|Overall Study|Worsening of symptoms|0|||
16075342|NCT01490086|38769699|FG003|Overall Study|Worsening of symptoms|1|||
16075343|NCT01490086|38769700|FG004|Overall Study|Worsening of symptoms|0|||
16075344|NCT01490086|38769696|FG000|Overall Study|Subject uncontrollable and abusive|0|||
16473950|NCT01646073|40214676|FG001|Period A (12 Weeks)|Protocol Violation|1|||
16473951|NCT01646073|40214675|FG000|Period A (12 Weeks)|Other|0|||
16075345|NCT01490086|38769697|FG001|Overall Study|Subject uncontrollable and abusive|1|||
16075346|NCT01490086|38769698|FG002|Overall Study|Subject uncontrollable and abusive|0|||
16075347|NCT01490086|38769699|FG003|Overall Study|Subject uncontrollable and abusive|0|||
16075348|NCT01490086|38769700|FG004|Overall Study|Subject uncontrollable and abusive|0|||
16473952|NCT01646073|40214676|FG001|Period A (12 Weeks)|Other|1|||
16473953|NCT01646073|40214675|FG000|Period B (12 Weeks)|Adverse Event|0|||
16473954|NCT01646073|40214676|FG001|Period B (12 Weeks)|Adverse Event|7|||
16473955|NCT01646073|40214675|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
16473956|NCT01646073|40214676|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
16473957|NCT01646073|40214675|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
16473958|NCT01646073|40214676|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
16473959|NCT04263454|40214677|FG000|Overall Study|Adverse Event|0|||
16473960|NCT04263454|40214678|FG001|Overall Study|Adverse Event|2|||
16473961|NCT04263454|40214677|FG000|Overall Study|Physician Decision|3|||
16473962|NCT04263454|40214678|FG001|Overall Study|Physician Decision|5|||
16473963|NCT04263454|40214677|FG000|Overall Study|Poor Data Quality|0|||
16473964|NCT04263454|40214678|FG001|Overall Study|Poor Data Quality|1|||
16075349|NCT01490086|38769696|FG000|Overall Study|Subject left hospital|0|||
16075350|NCT01490086|38769697|FG001|Overall Study|Subject left hospital|1|||
16075351|NCT01490086|38769698|FG002|Overall Study|Subject left hospital|0|||
16075352|NCT01490086|38769699|FG003|Overall Study|Subject left hospital|1|||
16075353|NCT01490086|38769700|FG004|Overall Study|Subject left hospital|0|||
16075354|NCT01641198|38769701|FG000|After 12 Months of Function|Lost to Follow-up|3|||
16075355|NCT01641198|38769702|FG001|After 12 Months of Function|Lost to Follow-up|2|||
16473965|NCT00057876|40214679|FG000|Overall Study|Adverse Event|8|||
16473966|NCT00057876|40214680|FG001|Overall Study|Adverse Event|8|||
16473967|NCT00057876|40214679|FG000|Overall Study|Death|2|||
16473968|NCT00057876|40214680|FG001|Overall Study|Death|1|||
16075356|NCT01641198|38769703|FG002|After 12 Months of Function|Lost to Follow-up|2|||
16075357|NCT01641198|38769701|FG000|After 12 Months of Function|Protocol Violation|1|||
16075358|NCT01641198|38769702|FG001|After 12 Months of Function|Protocol Violation|0|||
16075359|NCT01641198|38769703|FG002|After 12 Months of Function|Protocol Violation|0|||
16075360|NCT01641198|38769701|FG000|After 12 Months of Function|Adverse Event|0|||
16473969|NCT00057876|40214679|FG000|Overall Study|Withdrawal by Subject|5|||
16473970|NCT00057876|40214680|FG001|Overall Study|Withdrawal by Subject|6|||
16473971|NCT00057876|40214679|FG000|Overall Study|Lack of Efficacy|10|||
16473972|NCT00057876|40214680|FG001|Overall Study|Lack of Efficacy|8|||
16473973|NCT00057876|40214679|FG000|Overall Study|Ineligible|1|||
16473974|NCT00057876|40214680|FG001|Overall Study|Ineligible|2|||
16075361|NCT01641198|38769702|FG001|After 12 Months of Function|Adverse Event|1|||
16075362|NCT01641198|38769703|FG002|After 12 Months of Function|Adverse Event|0|||
16075363|NCT01641198|38769701|FG000|After 24 Months of Function|Lost to Follow-up|4|||
16075364|NCT01641198|38769702|FG001|After 24 Months of Function|Lost to Follow-up|9|||
16075365|NCT01641198|38769703|FG002|After 24 Months of Function|Lost to Follow-up|6|||
16173793|NCT03304522|39115293|FG001|Overall Study|Other|1|||
16173794|NCT00793793|39115295|FG000|Overall Study|Adverse Event|0|||
16173795|NCT00793793|39115296|FG001|Overall Study|Adverse Event|0|||
16173796|NCT00793793|39115297|FG002|Overall Study|Adverse Event|1|||
16173797|NCT00793793|39115298|FG003|Overall Study|Adverse Event|1|||
16473975|NCT00057876|40214679|FG000|Overall Study|other reason|2|||
16473976|NCT00057876|40214680|FG001|Overall Study|other reason|2|||
16473977|NCT00057876|40214679|FG000|Overall Study|other complicating disease|1|||
16473978|NCT00057876|40214680|FG001|Overall Study|other complicating disease|0|||
16473979|NCT00532155|40214681|FG000|Overall Study|Adverse Event|66|||
16473980|NCT00532155|40214682|FG001|Overall Study|Adverse Event|123|||
16473981|NCT00532155|40214681|FG000|Overall Study|Lack of Efficacy|332|||
16473982|NCT00532155|40214682|FG001|Overall Study|Lack of Efficacy|255|||
16473983|NCT00532155|40214681|FG000|Overall Study|Protocol Violation|1|||
16473984|NCT00532155|40214682|FG001|Overall Study|Protocol Violation|3|||
16473985|NCT00532155|40214681|FG000|Overall Study|Lost to Follow-up|2|||
16473986|NCT00532155|40214682|FG001|Overall Study|Lost to Follow-up|0|||
16473987|NCT00532155|40214681|FG000|Overall Study|Physician Decision|16|||
16473988|NCT00532155|40214682|FG001|Overall Study|Physician Decision|15|||
16473989|NCT00532155|40214681|FG000|Overall Study|Withdrawal by Subject|23|||
16473990|NCT00532155|40214682|FG001|Overall Study|Withdrawal by Subject|44|||
16473991|NCT00532155|40214681|FG000|Overall Study|Consent withdrawn|5|||
16473992|NCT00532155|40214682|FG001|Overall Study|Consent withdrawn|7|||
16473993|NCT00532155|40214681|FG000|Overall Study|Moved|1|||
16473994|NCT00532155|40214682|FG001|Overall Study|Moved|0|||
16473995|NCT00532155|40214681|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
16473996|NCT00532155|40214682|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
16473997|NCT00532155|40214681|FG000|Overall Study|Occurence of a second cancer|0|||
16473998|NCT00532155|40214682|FG001|Overall Study|Occurence of a second cancer|1|||
16473999|NCT00532155|40214681|FG000|Overall Study|Occurence of a secondary cancer|0|||
16474000|NCT00532155|40214682|FG001|Overall Study|Occurence of a secondary cancer|1|||
16474001|NCT00532155|40214681|FG000|Overall Study|Promotor ended study|1|||
16474002|NCT00532155|40214682|FG001|Overall Study|Promotor ended study|0|||
16474003|NCT00532155|40214681|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
16474004|NCT00532155|40214682|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
16474005|NCT00532155|40214681|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
16474006|NCT00532155|40214682|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
16474007|NCT00532155|40214681|FG000|Overall Study|Study stopped|1|||
16474008|NCT00532155|40214682|FG001|Overall Study|Study stopped|0|||
16474009|NCT00532155|40214681|FG000|Overall Study|Study terminated by sponsor|1|||
16474010|NCT00532155|40214682|FG001|Overall Study|Study terminated by sponsor|0|||
16474011|NCT00532155|40214681|FG000|Overall Study|Study termination stop further treatment|4|||
16474012|NCT00532155|40214682|FG001|Overall Study|Study termination stop further treatment|0|||
16474013|NCT00532155|40214681|FG000|Overall Study|Did not receive study medication|2|||
16474014|NCT00532155|40214682|FG001|Overall Study|Did not receive study medication|6|||
16474015|NCT01178073|40214688|FG000|Overall Study|Adverse Event|34|||
16474016|NCT01178073|40214689|FG001|Overall Study|Adverse Event|27|||
16474017|NCT01178073|40214690|FG002|Overall Study|Adverse Event|24|||
16474018|NCT01178073|40214688|FG000|Overall Study|Protocol Violation|1|||
16474019|NCT01178073|40214689|FG001|Overall Study|Protocol Violation|1|||
16474020|NCT01178073|40214690|FG002|Overall Study|Protocol Violation|1|||
16474021|NCT01178073|40214688|FG000|Overall Study|Lost to Follow-up|2|||
16474022|NCT01178073|40214689|FG001|Overall Study|Lost to Follow-up|0|||
16474023|NCT01178073|40214690|FG002|Overall Study|Lost to Follow-up|3|||
16474024|NCT01178073|40214688|FG000|Overall Study|Physician Decision|14|||
16474025|NCT01178073|40214689|FG001|Overall Study|Physician Decision|10|||
16474026|NCT01178073|40214690|FG002|Overall Study|Physician Decision|10|||
16474027|NCT01178073|40214688|FG000|Overall Study|Withdrawal by Subject|10|||
16474028|NCT01178073|40214689|FG001|Overall Study|Withdrawal by Subject|6|||
16474029|NCT01178073|40214690|FG002|Overall Study|Withdrawal by Subject|8|||
16474030|NCT01178073|40214688|FG000|Overall Study|Missing Completion Status|1|||
16474031|NCT01178073|40214689|FG001|Overall Study|Missing Completion Status|0|||
16474032|NCT01178073|40214690|FG002|Overall Study|Missing Completion Status|0|||
16474033|NCT00144027|40214691|FG000|Overall Study|Lost to Follow-up|1|||
16474034|NCT00144027|40214692|FG001|Overall Study|Lost to Follow-up|3|||
16075366|NCT01641198|38769701|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
16173798|NCT00793793|39115299|FG004|Overall Study|Adverse Event|0|||
16173799|NCT00793793|39115300|FG005|Overall Study|Adverse Event|1|||
16173800|NCT00793793|39115301|FG006|Overall Study|Adverse Event|2|||
16173801|NCT00793793|39115302|FG007|Overall Study|Adverse Event|0|||
16474035|NCT00144027|40214691|FG000|Overall Study|Withdrawal by Subject|2|||
16474036|NCT00144027|40214692|FG001|Overall Study|Withdrawal by Subject|2|||
16474037|NCT00144027|40214691|FG000|Overall Study|did not complete baseline assessment|0|||
16474038|NCT00144027|40214692|FG001|Overall Study|did not complete baseline assessment|6|||
16474039|NCT02130024|40214693|FG000|Overall Study|Adverse Event|10|||
16474040|NCT02130024|40214694|FG001|Overall Study|Adverse Event|11|||
16173802|NCT00793793|39115303|FG008|Overall Study|Adverse Event|0|||
16173803|NCT00793793|39115304|FG009|Overall Study|Adverse Event|0|||
16173804|NCT00793793|39115305|FG010|Overall Study|Adverse Event|0|||
16173805|NCT00793793|39115306|FG011|Overall Study|Adverse Event|2|||
16173806|NCT00793793|39115295|FG000|Overall Study|Protocol Violation|0|||
16173807|NCT00793793|39115296|FG001|Overall Study|Protocol Violation|0|||
16173808|NCT00793793|39115297|FG002|Overall Study|Protocol Violation|0|||
16173809|NCT00793793|39115298|FG003|Overall Study|Protocol Violation|1|||
16173810|NCT00793793|39115299|FG004|Overall Study|Protocol Violation|0|||
16173811|NCT00793793|39115300|FG005|Overall Study|Protocol Violation|0|||
16173812|NCT00793793|39115301|FG006|Overall Study|Protocol Violation|0|||
16173813|NCT00793793|39115302|FG007|Overall Study|Protocol Violation|0|||
16173814|NCT00793793|39115303|FG008|Overall Study|Protocol Violation|0|||
16173815|NCT00793793|39115304|FG009|Overall Study|Protocol Violation|0|||
16173816|NCT00793793|39115305|FG010|Overall Study|Protocol Violation|0|||
16173817|NCT00793793|39115306|FG011|Overall Study|Protocol Violation|0|||
16173818|NCT00793793|39115295|FG000|Overall Study|Lost to Follow-up|0|||
16173819|NCT00793793|39115296|FG001|Overall Study|Lost to Follow-up|0|||
16173820|NCT00793793|39115297|FG002|Overall Study|Lost to Follow-up|1|||
16173821|NCT00793793|39115298|FG003|Overall Study|Lost to Follow-up|0|||
16173822|NCT00793793|39115299|FG004|Overall Study|Lost to Follow-up|0|||
16173823|NCT00793793|39115300|FG005|Overall Study|Lost to Follow-up|0|||
16173824|NCT00793793|39115301|FG006|Overall Study|Lost to Follow-up|0|||
16173825|NCT00793793|39115302|FG007|Overall Study|Lost to Follow-up|0|||
16173826|NCT00793793|39115303|FG008|Overall Study|Lost to Follow-up|1|||
16173827|NCT00793793|39115304|FG009|Overall Study|Lost to Follow-up|3|||
16173828|NCT00793793|39115305|FG010|Overall Study|Lost to Follow-up|1|||
16173829|NCT00793793|39115306|FG011|Overall Study|Lost to Follow-up|0|||
16173830|NCT00793793|39115295|FG000|Overall Study|Withdrawal by Subject|0|||
16173831|NCT00793793|39115296|FG001|Overall Study|Withdrawal by Subject|0|||
16173832|NCT00793793|39115297|FG002|Overall Study|Withdrawal by Subject|0|||
16173833|NCT00793793|39115298|FG003|Overall Study|Withdrawal by Subject|0|||
16173834|NCT00793793|39115299|FG004|Overall Study|Withdrawal by Subject|1|||
16173835|NCT00793793|39115300|FG005|Overall Study|Withdrawal by Subject|0|||
16173836|NCT00793793|39115301|FG006|Overall Study|Withdrawal by Subject|0|||
16173837|NCT00793793|39115302|FG007|Overall Study|Withdrawal by Subject|0|||
16173838|NCT00793793|39115303|FG008|Overall Study|Withdrawal by Subject|1|||
16173839|NCT00793793|39115304|FG009|Overall Study|Withdrawal by Subject|0|||
16173840|NCT00793793|39115305|FG010|Overall Study|Withdrawal by Subject|0|||
16173841|NCT00793793|39115306|FG011|Overall Study|Withdrawal by Subject|0|||
16173842|NCT00793793|39115295|FG000|Overall Study|reason not specified|0|||
16173843|NCT00793793|39115296|FG001|Overall Study|reason not specified|1|||
16173844|NCT00793793|39115297|FG002|Overall Study|reason not specified|0|||
16173845|NCT00793793|39115298|FG003|Overall Study|reason not specified|1|||
16173846|NCT00793793|39115299|FG004|Overall Study|reason not specified|1|||
16173847|NCT00793793|39115300|FG005|Overall Study|reason not specified|1|||
16173848|NCT00793793|39115301|FG006|Overall Study|reason not specified|2|||
16173849|NCT00793793|39115302|FG007|Overall Study|reason not specified|0|||
16173850|NCT00793793|39115303|FG008|Overall Study|reason not specified|7|||
16173851|NCT00793793|39115304|FG009|Overall Study|reason not specified|6|||
16173852|NCT00793793|39115305|FG010|Overall Study|reason not specified|2|||
16173853|NCT00793793|39115306|FG011|Overall Study|reason not specified|4|||
16173854|NCT01237951|39115307|FG000|Overall Study|Death|1|||
16173855|NCT02485717|39115308|FG000|Overall Study|Lost to Follow-up|6|||
16173856|NCT02485717|39115309|FG001|Overall Study|Lost to Follow-up|0|||
16173857|NCT02485717|39115310|FG002|Overall Study|Lost to Follow-up|0|||
16173858|NCT02485717|39115308|FG000|Overall Study|Withdrawal by Subject|0|||
16173859|NCT02485717|39115309|FG001|Overall Study|Withdrawal by Subject|0|||
16173860|NCT02485717|39115310|FG002|Overall Study|Withdrawal by Subject|1|||
16173861|NCT02485717|39115308|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
16173862|NCT02485717|39115309|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
16075367|NCT01641198|38769702|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
16173863|NCT02485717|39115310|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
16173864|NCT02485717|39115308|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
16173865|NCT02485717|39115309|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
16173866|NCT02485717|39115310|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
16173867|NCT01244737|39115313|FG000|Overall Study|Physician Decision|2|||
16173868|NCT01244737|39115314|FG001|Overall Study|Physician Decision|18|||
16173869|NCT01244737|39115315|FG002|Overall Study|Physician Decision|5|||
16375142|NCT00563316|39860060|FG000|Overall Study|Physician Decision|1|||
16474041|NCT02130024|40214693|FG000|Overall Study|Death|2|||
16274826|NCT03922750|39490182|FG002|Overall Study|Unclassified|1|||
16474042|NCT02130024|40214694|FG001|Overall Study|Death|2|||
16173870|NCT01244737|39115313|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
16173871|NCT01244737|39115314|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
16173872|NCT01244737|39115315|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
16173873|NCT01244737|39115313|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
16173874|NCT01244737|39115314|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
16173875|NCT01244737|39115315|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
16173876|NCT01244737|39115313|FG000|Overall Study|MIB immunopathology results not available|3|||
16173877|NCT01244737|39115314|FG001|Overall Study|MIB immunopathology results not available|2|||
16173878|NCT01244737|39115315|FG002|Overall Study|MIB immunopathology results not available|0|||
16173879|NCT01244737|39115313|FG000|Overall Study|PET data failure|0|||
16173880|NCT01244737|39115314|FG001|Overall Study|PET data failure|1|||
16173881|NCT01244737|39115315|FG002|Overall Study|PET data failure|0|||
16173882|NCT01244737|39115313|FG000|Overall Study|Withdrawal by Subject|0|||
16173883|NCT01244737|39115314|FG001|Overall Study|Withdrawal by Subject|0|||
16173884|NCT01244737|39115315|FG002|Overall Study|Withdrawal by Subject|1|||
16173885|NCT03502187|39115316|FG000|Overall Study|Withdrawal by Subject|4|||
16173886|NCT03502187|39115317|FG001|Overall Study|Withdrawal by Subject|3|||
16173887|NCT03502187|39115318|FG002|Overall Study|Withdrawal by Subject|3|||
16173888|NCT03502187|39115316|FG000|Overall Study|Lost to Follow-up|5|||
16173889|NCT03502187|39115317|FG001|Overall Study|Lost to Follow-up|4|||
16173890|NCT03502187|39115318|FG002|Overall Study|Lost to Follow-up|5|||
16173891|NCT03715465|39115319|FG000|Overall Study|Withdrawal by Subject|1|||
16173892|NCT03715465|39115320|FG001|Overall Study|Withdrawal by Subject|2|||
16173893|NCT02581995|39115321|FG000|Overall Study|Unspecified other|3|||
16173894|NCT02581995|39115321|FG000|Overall Study|Adverse Event|6|||
16173895|NCT02581995|39115321|FG000|Overall Study|Lost to Follow-up|5|||
16173896|NCT02581995|39115321|FG000|Overall Study|Withdrawal by participant|12|||
16173897|NCT02581995|39115321|FG000|Overall Study|Physician Decision|1|||
16173898|NCT02581995|39115321|FG000|Overall Study|Death|4|||
16173899|NCT01157117|39115322|FG000|Overall Study|Dosing Symptoms|0|||
16173900|NCT01157117|39115323|FG001|Overall Study|Dosing Symptoms|4|||
16173901|NCT01157117|39115324|FG002|Overall Study|Dosing Symptoms|0|||
16173902|NCT01157117|39115322|FG000|Overall Study|Withdrawal by Subject|4|||
16173903|NCT01157117|39115323|FG001|Overall Study|Withdrawal by Subject|1|||
16173904|NCT01157117|39115324|FG002|Overall Study|Withdrawal by Subject|1|||
16173905|NCT01157117|39115322|FG000|Overall Study|Lack of Efficacy|1|||
16173906|NCT01157117|39115323|FG001|Overall Study|Lack of Efficacy|1|||
16173907|NCT01157117|39115324|FG002|Overall Study|Lack of Efficacy|0|||
16173908|NCT01157117|39115322|FG000|Overall Study|Lost to Follow-up|0|||
16173909|NCT01157117|39115323|FG001|Overall Study|Lost to Follow-up|0|||
16173910|NCT01157117|39115324|FG002|Overall Study|Lost to Follow-up|1|||
16173911|NCT01157117|39115322|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
16173912|NCT01157117|39115323|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
16173913|NCT01157117|39115324|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
16173914|NCT00275561|39115326|FG000|Overall Study|Withdrawal by Subject|0|||
16173915|NCT00275561|39115327|FG001|Overall Study|Withdrawal by Subject|1|||
16173916|NCT00275561|39115326|FG000|Overall Study|Travel|1|||
16173917|NCT00275561|39115327|FG001|Overall Study|Travel|1|||
16173918|NCT00275561|39115326|FG000|Overall Study|Scheduling|1|||
16173919|NCT00275561|39115327|FG001|Overall Study|Scheduling|2|||
16173920|NCT00275561|39115326|FG000|Overall Study|Family Issues|0|||
16173921|NCT00275561|39115327|FG001|Overall Study|Family Issues|2|||
16173922|NCT00316264|39115331|FG000|Overall Study|Lost to Follow-up|0|||
16173923|NCT00316264|39115332|FG001|Overall Study|Lost to Follow-up|1|||
16173924|NCT00316264|39115333|FG002|Overall Study|Lost to Follow-up|0|||
16173925|NCT00316264|39115331|FG000|Overall Study|Withdrawal of Consent|3|||
16173926|NCT00316264|39115332|FG001|Overall Study|Withdrawal of Consent|5|||
16173927|NCT00316264|39115333|FG002|Overall Study|Withdrawal of Consent|6|||
16474043|NCT02130024|40214693|FG000|Overall Study|Lost to Follow-up|1|||
16173928|NCT00316264|39115331|FG000|Overall Study|Death|2|||
16173929|NCT00316264|39115332|FG001|Overall Study|Death|0|||
16173930|NCT00316264|39115333|FG002|Overall Study|Death|0|||
16173931|NCT00316264|39115331|FG000|Overall Study|Other|1|||
16173932|NCT00316264|39115332|FG001|Overall Study|Other|1|||
16173933|NCT00316264|39115333|FG002|Overall Study|Other|0|||
16173934|NCT03716726|39115336|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
16173935|NCT03716726|39115337|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
16173936|NCT03716726|39115336|FG000|12 Months Followup|Lost to Follow-up|10|||
16173937|NCT03716726|39115337|FG001|12 Months Followup|Lost to Follow-up|17|||
16173938|NCT02786901|39115340|FG000|Overall Study|Adverse Event|1|||
16173939|NCT02786901|39115341|FG001|Overall Study|Adverse Event|1|||
16274827|NCT03922750|39490180|FG000|Overall Study|Adverse Event|0|||
16173940|NCT02786901|39115342|FG002|Overall Study|Adverse Event|2|||
16474044|NCT02130024|40214694|FG001|Overall Study|Lost to Follow-up|1|||
16474045|NCT02130024|40214693|FG000|Overall Study|Physician Decision|1|||
16173941|NCT02786901|39115340|FG000|Overall Study|Physician Decision|1|||
16173942|NCT02786901|39115341|FG001|Overall Study|Physician Decision|0|||
16474046|NCT02130024|40214694|FG001|Overall Study|Physician Decision|3|||
16474047|NCT02130024|40214693|FG000|Overall Study|Protocol Deviation|4|||
16474048|NCT02130024|40214694|FG001|Overall Study|Protocol Deviation|0|||
16474049|NCT02130024|40214693|FG000|Overall Study|Site Administration Problems|1|||
16474050|NCT02130024|40214694|FG001|Overall Study|Site Administration Problems|0|||
16474051|NCT02130024|40214693|FG000|Overall Study|Subject Withdrew Consent|6|||
16474052|NCT02130024|40214694|FG001|Overall Study|Subject Withdrew Consent|14|||
16474053|NCT02853344|40214695|FG000|Overall Study|Lost to Follow-up|1|||
16474054|NCT02853344|40214696|FG001|Overall Study|Lost to Follow-up|1|||
16474055|NCT02853344|40214695|FG000|Overall Study|Withdrawal by Subject|2|||
16474056|NCT02853344|40214696|FG001|Overall Study|Withdrawal by Subject|4|||
16474057|NCT02853344|40214695|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
16474058|NCT02853344|40214696|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
16474059|NCT02853344|40214695|FG000|Overall Study|Death|70|||
16474060|NCT02853344|40214696|FG001|Overall Study|Death|112|||
16474061|NCT02764697|40214698|FG000|Overall Study|Lack of Efficacy|3|||
16474062|NCT02337738|40214699|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
16474063|NCT02337738|40214700|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
16474064|NCT02337738|40214701|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
16474065|NCT02337738|40214699|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
16474066|NCT02337738|40214700|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
16474067|NCT02337738|40214701|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
16474068|NCT02337738|40214699|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
16474069|NCT02337738|40214700|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
16474070|NCT02337738|40214701|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
16474071|NCT02337738|40214699|FG000|Overall Study|Voluntary Withdrawal|10|||
16474072|NCT02337738|40214700|FG001|Overall Study|Voluntary Withdrawal|5|||
16474073|NCT02337738|40214701|FG002|Overall Study|Voluntary Withdrawal|2|||
16474074|NCT02337738|40214699|FG000|Overall Study|Lack of Efficacy|2|||
16474075|NCT02337738|40214700|FG001|Overall Study|Lack of Efficacy|4|||
16474076|NCT02337738|40214701|FG002|Overall Study|Lack of Efficacy|0|||
16474077|NCT02337738|40214699|FG000|Overall Study|Investigator's Judgment|1|||
16474078|NCT02337738|40214700|FG001|Overall Study|Investigator's Judgment|1|||
16474079|NCT02337738|40214701|FG002|Overall Study|Investigator's Judgment|3|||
16474080|NCT03570697|40214704|FG000|Overall Study|Lost to Follow-up|0|||
16474081|NCT03570697|40214705|FG001|Overall Study|Lost to Follow-up|1|||
16474082|NCT03570697|40214704|FG000|Overall Study|Death|2|||
16474083|NCT03570697|40214705|FG001|Overall Study|Death|0|||
16173943|NCT02786901|39115342|FG002|Overall Study|Physician Decision|0|||
16173944|NCT02786901|39115340|FG000|Overall Study|Rescue Therapy Use|71|||
16173945|NCT02786901|39115341|FG001|Overall Study|Rescue Therapy Use|49|||
16173946|NCT02786901|39115342|FG002|Overall Study|Rescue Therapy Use|33|||
16173947|NCT02786901|39115340|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
16173948|NCT02786901|39115341|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
16173949|NCT02786901|39115342|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
16173950|NCT02786901|39115340|FG000|Overall Study|Disallowed medication|1|||
16173951|NCT02786901|39115341|FG001|Overall Study|Disallowed medication|1|||
16173952|NCT02786901|39115342|FG002|Overall Study|Disallowed medication|0|||
16173953|NCT02786901|39115340|FG000|Overall Study|Randomized in error|2|||
16173954|NCT02786901|39115341|FG001|Overall Study|Randomized in error|0|||
16173955|NCT02786901|39115342|FG002|Overall Study|Randomized in error|1|||
16173956|NCT01535235|39115347|FG000|Overall Study|Adverse Event|1|||
16173957|NCT01535235|39115348|FG001|Overall Study|Adverse Event|0|||
16173958|NCT02443402|39115349|FG000|Overall Study|Withdrawal by Subject|3|||
16173959|NCT02443402|39115350|FG001|Overall Study|Withdrawal by Subject|1|||
16173960|NCT02443402|39115349|FG000|Overall Study|Screen Failure|1|||
16173961|NCT02443402|39115350|FG001|Overall Study|Screen Failure|2|||
16173962|NCT03514914|39115364|FG000|Overall Study|Death|3|||
16173963|NCT03514914|39115365|FG001|Overall Study|Death|3|||
16474084|NCT03570697|40214704|FG000|Overall Study|Withdrawal by Subject|4|||
16474085|NCT03570697|40214705|FG001|Overall Study|Withdrawal by Subject|2|||
16474086|NCT02913612|40214707|FG000|Overall Study|Lost to Follow-up|6|||
16474087|NCT02913612|40214708|FG001|Overall Study|Lost to Follow-up|5|||
16474088|NCT02913612|40214709|FG002|Overall Study|Lost to Follow-up|2|||
16173964|NCT03514914|39115364|FG000|Overall Study|Lost to Follow-up|117|||
16173965|NCT03514914|39115365|FG001|Overall Study|Lost to Follow-up|89|||
16474089|NCT02913612|40214710|FG003|Overall Study|Lost to Follow-up|0|||
16474090|NCT02913612|40214707|FG000|Overall Study|Physician Decision|1|||
16474091|NCT02913612|40214708|FG001|Overall Study|Physician Decision|4|||
16474092|NCT02913612|40214709|FG002|Overall Study|Physician Decision|1|||
16474093|NCT02913612|40214710|FG003|Overall Study|Physician Decision|0|||
16474094|NCT02913612|40214707|FG000|Overall Study|Withdrawal by Subject|2|||
16474095|NCT02913612|40214708|FG001|Overall Study|Withdrawal by Subject|4|||
16474096|NCT02913612|40214709|FG002|Overall Study|Withdrawal by Subject|0|||
16173966|NCT00603239|39115372|FG000|Overall Study|Adverse Event|4|||
16173967|NCT00603239|39115373|FG001|Overall Study|Adverse Event|1|||
16173968|NCT00603239|39115372|FG000|Overall Study|Entry criteria not met|0|||
16173969|NCT00603239|39115373|FG001|Overall Study|Entry criteria not met|1|||
16474097|NCT02913612|40214710|FG003|Overall Study|Withdrawal by Subject|0|||
16474098|NCT02913612|40214707|FG000|Overall Study|Hemangioma resolved|1|||
16474099|NCT02913612|40214708|FG001|Overall Study|Hemangioma resolved|0|||
16474100|NCT02913612|40214709|FG002|Overall Study|Hemangioma resolved|0|||
16474101|NCT02913612|40214710|FG003|Overall Study|Hemangioma resolved|0|||
16474102|NCT02913612|40214707|FG000|Overall Study|Local IRB decision|1|||
16173970|NCT00603239|39115372|FG000|Overall Study|Loss of glucose control|3|||
16173971|NCT00603239|39115373|FG001|Overall Study|Loss of glucose control|0|||
16474103|NCT02913612|40214708|FG001|Overall Study|Local IRB decision|0|||
16474104|NCT02913612|40214709|FG002|Overall Study|Local IRB decision|0|||
16474105|NCT02913612|40214710|FG003|Overall Study|Local IRB decision|0|||
16173972|NCT00603239|39115372|FG000|Overall Study|Lost to Follow-up|2|||
16173973|NCT00603239|39115373|FG001|Overall Study|Lost to Follow-up|1|||
16173974|NCT00603239|39115372|FG000|Overall Study|Physician Decision|2|||
16173975|NCT00603239|39115373|FG001|Overall Study|Physician Decision|0|||
16173976|NCT00603239|39115372|FG000|Overall Study|Protocol Violation|2|||
16173977|NCT00603239|39115373|FG001|Overall Study|Protocol Violation|0|||
16173978|NCT00603239|39115372|FG000|Overall Study|Subject decision|2|||
16173979|NCT00603239|39115373|FG001|Overall Study|Subject decision|1|||
16173980|NCT01238120|39115382|FG000|Overall Study|Withdrawal by Subject|4|||
16474106|NCT02913612|40214707|FG000|Overall Study|Study drug non-compliance|1|||
16474107|NCT02913612|40214708|FG001|Overall Study|Study drug non-compliance|1|||
16474108|NCT02913612|40214709|FG002|Overall Study|Study drug non-compliance|0|||
16474109|NCT02913612|40214710|FG003|Overall Study|Study drug non-compliance|0|||
16474110|NCT02913612|40214707|FG000|Overall Study|Insurance issues|0|||
16474111|NCT02913612|40214708|FG001|Overall Study|Insurance issues|1|||
16474112|NCT02913612|40214709|FG002|Overall Study|Insurance issues|0|||
16474113|NCT02913612|40214710|FG003|Overall Study|Insurance issues|0|||
16474114|NCT02913612|40214707|FG000|Overall Study|Needed to treat second hemangioma|0|||
16474115|NCT02913612|40214708|FG001|Overall Study|Needed to treat second hemangioma|1|||
16173981|NCT01238120|39115383|FG001|Overall Study|Withdrawal by Subject|1|||
16173982|NCT01238120|39115384|FG002|Overall Study|Withdrawal by Subject|2|||
16173983|NCT01238120|39115385|FG003|Overall Study|Withdrawal by Subject|5|||
16173984|NCT01238120|39115382|FG000|Overall Study|Lost to Follow-up|2|||
16173985|NCT01238120|39115383|FG001|Overall Study|Lost to Follow-up|0|||
16173986|NCT01238120|39115384|FG002|Overall Study|Lost to Follow-up|1|||
16173987|NCT01238120|39115385|FG003|Overall Study|Lost to Follow-up|1|||
16173988|NCT01238120|39115382|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
16173989|NCT01238120|39115383|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
16173990|NCT01238120|39115384|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
16173991|NCT01238120|39115385|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
16173992|NCT00480857|39115393|FG000|Overall Study|Lack of Efficacy|2|||
16173993|NCT04343651|39115395|FG000|Overall Study|Physician Decision|2|||
16173994|NCT04343651|39115396|FG001|Overall Study|Physician Decision|1|||
16173995|NCT04343651|39115395|FG000|Overall Study|Lost to Follow-up|2|||
16173996|NCT04343651|39115396|FG001|Overall Study|Lost to Follow-up|1|||
16173997|NCT04343651|39115395|FG000|Overall Study|Protocol Violation|4|||
16173998|NCT04343651|39115396|FG001|Overall Study|Protocol Violation|6|||
16173999|NCT04343651|39115395|FG000|Overall Study|Missing|3|||
16174000|NCT04343651|39115396|FG001|Overall Study|Missing|9|||
16174001|NCT04343651|39115395|FG000|Overall Study|Withdrawal by Subject|0|||
16174002|NCT04343651|39115396|FG001|Overall Study|Withdrawal by Subject|4|||
16174003|NCT04343651|39115395|FG000|Overall Study|Death|0|||
16174004|NCT04343651|39115396|FG001|Overall Study|Death|1|||
16174005|NCT04343651|39115395|FG000|Overall Study|Did not start treatment|1|||
16474116|NCT02913612|40214709|FG002|Overall Study|Needed to treat second hemangioma|0|||
16474117|NCT02913612|40214710|FG003|Overall Study|Needed to treat second hemangioma|0|||
16474118|NCT02913612|40214707|FG000|Overall Study|Study completion criteria not met|0|||
16474119|NCT02913612|40214708|FG001|Overall Study|Study completion criteria not met|1|||
16474120|NCT02913612|40214709|FG002|Overall Study|Study completion criteria not met|0|||
16474121|NCT02913612|40214710|FG003|Overall Study|Study completion criteria not met|0|||
16474122|NCT02913612|40214707|FG000|Overall Study|Ineligible|0|||
16174006|NCT04343651|39115396|FG001|Overall Study|Did not start treatment|1|||
16174007|NCT04343651|39115395|FG000|Overall Study|Patient did not complete visits 3-6|0|||
16174008|NCT04343651|39115396|FG001|Overall Study|Patient did not complete visits 3-6|1|||
16174009|NCT01245673|39115398|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
16174010|NCT01193686|39115403|FG000|Overall Study|Withdrawal by Subject|4|||
16174011|NCT01193686|39115404|FG001|Overall Study|Withdrawal by Subject|1|||
16274828|NCT03922750|39490181|FG001|Overall Study|Adverse Event|1|||
16474123|NCT02913612|40214708|FG001|Overall Study|Ineligible|1|||
16474124|NCT02913612|40214709|FG002|Overall Study|Ineligible|0|||
16474125|NCT02913612|40214710|FG003|Overall Study|Ineligible|0|||
16474126|NCT01226043|40214711|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
16474127|NCT01226043|40214712|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
16474128|NCT01226043|40214713|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
16474129|NCT01226043|40214714|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
16474130|NCT01226043|40214711|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
16474131|NCT01226043|40214712|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
16474132|NCT01226043|40214713|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
16474133|NCT01226043|40214714|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
16474134|NCT01226043|40214711|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
16474135|NCT01226043|40214712|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
16474136|NCT01226043|40214713|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
16174012|NCT01193686|39115403|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
16174013|NCT01193686|39115404|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
16174014|NCT02292849|39115405|FG000|Overall Study|Lost to Follow-up|0|||
16174015|NCT02292849|39115406|FG001|Overall Study|Lost to Follow-up|2|||
16174016|NCT02292849|39115407|FG002|Overall Study|Lost to Follow-up|2|||
16174017|NCT02292849|39115405|FG000|Overall Study|Physician Decision|4|||
16174018|NCT02292849|39115406|FG001|Overall Study|Physician Decision|0|||
16174019|NCT02292849|39115407|FG002|Overall Study|Physician Decision|0|||
16174020|NCT00778830|39115410|FG000|Overall Study|Ongoing at data cut-off|0|||
16174021|NCT00778830|39115411|FG001|Overall Study|Ongoing at data cut-off|1|||
16174022|NCT01700829|39115413|FG000|Overall Study|Withdrawal by Subject|1|||
16174023|NCT01700829|39115414|FG001|Overall Study|Withdrawal by Subject|1|||
16174024|NCT02318784|39115415|FG000|Overall Study|Adverse Event|13|||
16174025|NCT02318784|39115415|FG000|Overall Study|Death|2|||
16174026|NCT02318784|39115415|FG000|Overall Study|Progressive Disease|37|||
16474137|NCT01226043|40214714|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
16474138|NCT01226043|40214711|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
16474139|NCT01226043|40214712|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
16474140|NCT01226043|40214713|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
16174027|NCT02318784|39115415|FG000|Overall Study|Withdrawal by Subject|10|||
16174028|NCT00928070|39115416|FG000|Overall Study|Lost to Follow-up|1|||
16174029|NCT00928070|39115417|FG001|Overall Study|Lost to Follow-up|2|||
16174030|NCT00928070|39115416|FG000|Overall Study|Withdrawal by Subject|10|||
16174031|NCT00928070|39115417|FG001|Overall Study|Withdrawal by Subject|3|||
16174032|NCT00928070|39115416|FG000|Overall Study|Adverse Event|14|||
16474141|NCT01226043|40214714|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
16474142|NCT01226043|40214711|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
16474143|NCT01226043|40214712|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
16474144|NCT01226043|40214713|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
16474145|NCT01226043|40214714|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
16474146|NCT01226043|40214711|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
16474147|NCT01226043|40214712|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
16474148|NCT01226043|40214713|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
16474149|NCT01226043|40214714|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
16474150|NCT01226043|40214711|FG000|6-week Re-randomization Phase|Adverse Event|0|||
16474151|NCT01226043|40214712|FG001|6-week Re-randomization Phase|Adverse Event|0|||
16174033|NCT00928070|39115417|FG001|Overall Study|Adverse Event|26|||
16174034|NCT00928070|39115416|FG000|Overall Study|Lack of Efficacy|9|||
16174035|NCT00928070|39115417|FG001|Overall Study|Lack of Efficacy|5|||
16174036|NCT00928070|39115416|FG000|Overall Study|Did not meet entrance criteria|16|||
16174037|NCT00928070|39115417|FG001|Overall Study|Did not meet entrance criteria|9|||
16174038|NCT00928070|39115416|FG000|Overall Study|Protocol Violation|6|||
16174039|NCT00928070|39115417|FG001|Overall Study|Protocol Violation|5|||
16174040|NCT00928070|39115416|FG000|Overall Study|Randomized but not treated|2|||
16174041|NCT00928070|39115417|FG001|Overall Study|Randomized but not treated|2|||
16174042|NCT00928070|39115416|FG000|Overall Study|Other|5|||
16274829|NCT03922750|39490182|FG002|Overall Study|Adverse Event|0|||
16474152|NCT01226043|40214713|FG002|6-week Re-randomization Phase|Adverse Event|1|||
16474153|NCT01226043|40214714|FG003|6-week Re-randomization Phase|Adverse Event|1|||
16474154|NCT01226043|40214711|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
16474155|NCT01226043|40214712|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
16474156|NCT01226043|40214713|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
16474157|NCT01226043|40214714|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
16474158|NCT01226043|40214711|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
16474159|NCT01226043|40214712|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
16474160|NCT01226043|40214713|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
16474161|NCT01226043|40214714|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
16474162|NCT01226043|40214711|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
16174043|NCT00928070|39115417|FG001|Overall Study|Other|5|||
16174044|NCT00832819|39115418|FG000|Overall Study|Adverse Event|0|||
16174045|NCT00832819|39115419|FG001|Overall Study|Adverse Event|1|||
16174046|NCT00832819|39115420|FG002|Overall Study|Adverse Event|0|||
16174047|NCT00832819|39115418|FG000|Overall Study|Protocol Violation|0|||
16174048|NCT00832819|39115419|FG001|Overall Study|Protocol Violation|0|||
16174049|NCT00832819|39115420|FG002|Overall Study|Protocol Violation|1|||
16174050|NCT01973283|39115421|FG000|Overall Study|Lost to Follow-up|4|||
16174051|NCT01903876|39115422|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
16174052|NCT01903876|39115423|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
16174053|NCT01903876|39115422|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
16174054|NCT01903876|39115423|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
16174055|NCT00260208|39115424|FG000|Overall Study|Subject withdrew consent|11|||
16174056|NCT00260208|39115425|FG001|Overall Study|Subject withdrew consent|7|||
16174057|NCT00260208|39115424|FG000|Overall Study|Lost to Follow-up|6|||
16174058|NCT00260208|39115425|FG001|Overall Study|Lost to Follow-up|1|||
16174059|NCT00260208|39115424|FG000|Overall Study|Death|12|||
16174060|NCT00260208|39115425|FG001|Overall Study|Death|10|||
16174061|NCT00260208|39115424|FG000|Overall Study|Missing|18|||
16174062|NCT00260208|39115425|FG001|Overall Study|Missing|16|||
16174063|NCT00737529|39115430|FG000|Overall Study|Disease Progression|95|||
16174064|NCT00737529|39115430|FG000|Overall Study|Adverse Event|24|||
16174065|NCT00737529|39115430|FG000|Overall Study|Withdrawal by Subject|5|||
16174066|NCT00737529|39115430|FG000|Overall Study|Death|4|||
16174067|NCT00737529|39115430|FG000|Overall Study|Protocol Violation|1|||
16174068|NCT00737529|39115430|FG000|Overall Study|Other|4|||
16174069|NCT00127127|39115439|FG000|Overall Study|Adverse Event|0|||
16174070|NCT00127127|39115440|FG001|Overall Study|Adverse Event|2|||
16174071|NCT00127127|39115441|FG002|Overall Study|Adverse Event|0|||
16474163|NCT01226043|40214712|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
16474164|NCT01226043|40214713|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
16474165|NCT01226043|40214714|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
16474166|NCT01226043|40214711|FG000|6-week Re-randomization Phase|Physician Decision|0|||
16474167|NCT01226043|40214712|FG001|6-week Re-randomization Phase|Physician Decision|0|||
16474168|NCT01226043|40214713|FG002|6-week Re-randomization Phase|Physician Decision|3|||
16474169|NCT01226043|40214714|FG003|6-week Re-randomization Phase|Physician Decision|2|||
16474170|NCT01226043|40214711|FG000|6-week Re-randomization Phase|completed in error|0|||
16474171|NCT01226043|40214712|FG001|6-week Re-randomization Phase|completed in error|0|||
16474172|NCT01226043|40214713|FG002|6-week Re-randomization Phase|completed in error|0|||
16474173|NCT01226043|40214714|FG003|6-week Re-randomization Phase|completed in error|1|||
16474174|NCT01226043|40214711|FG000|30-week Observational Phase|Adverse Event|0|||
16474175|NCT01226043|40214712|FG001|30-week Observational Phase|Adverse Event|0|||
16474176|NCT01226043|40214713|FG002|30-week Observational Phase|Adverse Event|1|||
16474177|NCT01226043|40214714|FG003|30-week Observational Phase|Adverse Event|1|||
16474178|NCT01226043|40214711|FG000|30-week Observational Phase|Protocol Violation|0|||
16474179|NCT01226043|40214712|FG001|30-week Observational Phase|Protocol Violation|0|||
16474180|NCT01226043|40214713|FG002|30-week Observational Phase|Protocol Violation|0|||
16474181|NCT01226043|40214714|FG003|30-week Observational Phase|Protocol Violation|1|||
16474182|NCT01226043|40214711|FG000|30-week Observational Phase|Lost to Follow-up|0|||
16075368|NCT01641198|38769703|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
16075369|NCT01641198|38769701|FG000|At 15-20 Years of Function|Death|1|||
16474183|NCT01226043|40214712|FG001|30-week Observational Phase|Lost to Follow-up|0|||
16474184|NCT01226043|40214713|FG002|30-week Observational Phase|Lost to Follow-up|2|||
16474185|NCT01226043|40214714|FG003|30-week Observational Phase|Lost to Follow-up|2|||
16075370|NCT01641198|38769702|FG001|At 15-20 Years of Function|Death|0|||
16075371|NCT01641198|38769703|FG002|At 15-20 Years of Function|Death|1|||
16474186|NCT01226043|40214711|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
16474187|NCT01226043|40214712|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
16474188|NCT01226043|40214713|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
16474189|NCT01226043|40214714|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
16474190|NCT01226043|40214711|FG000|30-week Observational Phase|Physician Decision|0|||
16474191|NCT01226043|40214712|FG001|30-week Observational Phase|Physician Decision|0|||
16075372|NCT02613364|38769704|FG000|Overall Study|Other|19|||
16075373|NCT02613364|38769705|FG001|Overall Study|Other|29|||
16075374|NCT02613364|38769706|FG002|Overall Study|Other|17|||
16075375|NCT02613364|38769704|FG000|Overall Study|Too time consuming|21|||
16075376|NCT02613364|38769705|FG001|Overall Study|Too time consuming|26|||
16075377|NCT02613364|38769706|FG002|Overall Study|Too time consuming|26|||
16075378|NCT02613364|38769704|FG000|Overall Study|Withdrawal by Subject|13|||
16075379|NCT02613364|38769705|FG001|Overall Study|Withdrawal by Subject|18|||
16174072|NCT00127127|39115442|FG003|Overall Study|Adverse Event|1|||
16174073|NCT00127127|39115439|FG000|Overall Study|Lack of Efficacy|1|||
16174074|NCT00127127|39115440|FG001|Overall Study|Lack of Efficacy|3|||
16174075|NCT00127127|39115441|FG002|Overall Study|Lack of Efficacy|0|||
16174076|NCT00127127|39115442|FG003|Overall Study|Lack of Efficacy|2|||
16075380|NCT02613364|38769706|FG002|Overall Study|Withdrawal by Subject|17|||
16174077|NCT02722044|39115451|FG000|Overall Study|Adverse Event|2|||
16174078|NCT02722044|39115451|FG000|Overall Study|Physician Decision|1|||
16075381|NCT02613364|38769704|FG000|Overall Study|Medical|12|||
16075382|NCT02613364|38769705|FG001|Overall Study|Medical|13|||
16075383|NCT02613364|38769706|FG002|Overall Study|Medical|9|||
16075384|NCT02613364|38769704|FG000|Overall Study|Disliked Study Procedure|1|||
16075385|NCT02613364|38769705|FG001|Overall Study|Disliked Study Procedure|1|||
16075386|NCT02613364|38769706|FG002|Overall Study|Disliked Study Procedure|4|||
16075387|NCT02613364|38769704|FG000|Overall Study|Disliked Intervention|0|||
16075388|NCT02613364|38769705|FG001|Overall Study|Disliked Intervention|3|||
16075389|NCT02613364|38769706|FG002|Overall Study|Disliked Intervention|3|||
16075390|NCT00891930|38769707|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
16075391|NCT00891930|38769707|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
16075392|NCT00891930|38769707|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
16474192|NCT01226043|40214713|FG002|30-week Observational Phase|Physician Decision|2|||
16174079|NCT02722044|39115451|FG000|Overall Study|Withdrawal by Subject|1|||
16174080|NCT02722044|39115451|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
16174081|NCT01262898|39115452|FG000|Overall Study|Protocol Violation|1|||
16174082|NCT01262898|39115453|FG001|Overall Study|Protocol Violation|1|||
16174083|NCT01262898|39115454|FG002|Overall Study|Protocol Violation|0|||
16174084|NCT01262898|39115455|FG003|Overall Study|Protocol Violation|0|||
16174085|NCT01262898|39115452|FG000|Overall Study|Lost to Follow-up|1|||
16474193|NCT01226043|40214714|FG003|30-week Observational Phase|Physician Decision|2|||
16474194|NCT02777333|40214721|FG000|Overall Study|Withdrawal by Subject|0|||
16474195|NCT02777333|40214722|FG001|Overall Study|Withdrawal by Subject|1|||
16474196|NCT02777333|40214721|FG000|Overall Study|Lost to Follow-up|0|||
16474197|NCT02777333|40214722|FG001|Overall Study|Lost to Follow-up|1|||
16474198|NCT00410202|40214723|FG000|On-Treatment|Continuing treatment|69|||
16474199|NCT00410202|40214724|FG001|On-Treatment|Continuing treatment|71|||
16474200|NCT00410202|40214725|FG002|On-Treatment|Continuing treatment|66|||
16474201|NCT00410202|40214723|FG000|On-Treatment|Adverse Event|1|||
16474202|NCT00410202|40214724|FG001|On-Treatment|Adverse Event|3|||
16474203|NCT00410202|40214725|FG002|On-Treatment|Adverse Event|2|||
16474204|NCT00410202|40214723|FG000|On-Treatment|Death|1|||
16474205|NCT00410202|40214724|FG001|On-Treatment|Death|0|||
16474206|NCT00410202|40214725|FG002|On-Treatment|Death|0|||
16474207|NCT00410202|40214723|FG000|On-Treatment|Lost to Follow-up|1|||
16474208|NCT00410202|40214724|FG001|On-Treatment|Lost to Follow-up|0|||
16474209|NCT00410202|40214725|FG002|On-Treatment|Lost to Follow-up|1|||
16474210|NCT00410202|40214723|FG000|On-Treatment|Lack of Efficacy|1|||
16474211|NCT00410202|40214724|FG001|On-Treatment|Lack of Efficacy|4|||
16474212|NCT00410202|40214725|FG002|On-Treatment|Lack of Efficacy|0|||
16474213|NCT00410202|40214723|FG000|On-Treatment|Withdrawal by Subject|2|||
16474214|NCT00410202|40214724|FG001|On-Treatment|Withdrawal by Subject|1|||
16174086|NCT01262898|39115453|FG001|Overall Study|Lost to Follow-up|0|||
16174087|NCT01262898|39115454|FG002|Overall Study|Lost to Follow-up|0|||
16174088|NCT01262898|39115455|FG003|Overall Study|Lost to Follow-up|0|||
16174089|NCT01262898|39115452|FG000|Overall Study|Withdrawal by Subject|1|||
16174090|NCT01262898|39115453|FG001|Overall Study|Withdrawal by Subject|1|||
16174091|NCT01262898|39115454|FG002|Overall Study|Withdrawal by Subject|0|||
16174092|NCT01262898|39115455|FG003|Overall Study|Withdrawal by Subject|0|||
16174093|NCT02665689|39115456|FG000|Overall Study|Adverse Event|1|||
16174094|NCT02665689|39115457|FG001|Overall Study|Adverse Event|0|||
16174095|NCT02665689|39115456|FG000|Overall Study|Trial termination|1|||
16174096|NCT02665689|39115457|FG001|Overall Study|Trial termination|1|||
16174097|NCT02665689|39115456|FG000|Overall Study|Lost to Follow-up|0|||
16174098|NCT02665689|39115457|FG001|Overall Study|Lost to Follow-up|1|||
16174099|NCT03417440|39115458|FG000|Overall Study|Lost to Follow-up|0|||
16174100|NCT03417440|39115459|FG001|Overall Study|Lost to Follow-up|1|||
16174101|NCT03417440|39115460|FG002|Overall Study|Lost to Follow-up|0|||
16174102|NCT03417440|39115461|FG003|Overall Study|Lost to Follow-up|0|||
16174103|NCT03417440|39115462|FG004|Overall Study|Lost to Follow-up|1|||
16174104|NCT03417440|39115463|FG005|Overall Study|Lost to Follow-up|0|||
16474215|NCT00410202|40214725|FG002|On-Treatment|Withdrawal by Subject|1|||
16474216|NCT00410202|40214723|FG000|On-Treatment|Other Reason|0|||
16474217|NCT00410202|40214724|FG001|On-Treatment|Other Reason|0|||
16474218|NCT00410202|40214725|FG002|On-Treatment|Other Reason|1|||
16474219|NCT00410202|40214723|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
16474220|NCT00410202|40214724|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
16474221|NCT00410202|40214725|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
16474222|NCT00410202|40214723|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
16474223|NCT00410202|40214724|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
16474224|NCT00410202|40214725|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
16174105|NCT03417440|39115464|FG006|Overall Study|Lost to Follow-up|0|||
16174106|NCT03417440|39115465|FG007|Overall Study|Lost to Follow-up|0|||
16474225|NCT00410202|40214723|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
16474226|NCT00410202|40214724|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
16174107|NCT03417440|39115458|FG000|Overall Study|Withdrawal by Subject|2|||
16174108|NCT03417440|39115459|FG001|Overall Study|Withdrawal by Subject|0|||
16174109|NCT03417440|39115460|FG002|Overall Study|Withdrawal by Subject|2|||
16474227|NCT00410202|40214725|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
16474228|NCT03347188|40214728|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
16474229|NCT03347188|40214729|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
16474230|NCT03347188|40214728|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
16174110|NCT03417440|39115461|FG003|Overall Study|Withdrawal by Subject|1|||
16174111|NCT03417440|39115462|FG004|Overall Study|Withdrawal by Subject|1|||
16174112|NCT03417440|39115463|FG005|Overall Study|Withdrawal by Subject|0|||
16474231|NCT03347188|40214729|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
16474232|NCT03347188|40214728|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
16474233|NCT03347188|40214729|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
16474234|NCT03347188|40214728|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
16474235|NCT03347188|40214729|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
16474236|NCT03347188|40214728|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
16474237|NCT03347188|40214729|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
16474238|NCT03347188|40214728|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
16474239|NCT03347188|40214729|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
16474240|NCT03347188|40214728|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
16474241|NCT03347188|40214729|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
16174113|NCT03417440|39115464|FG006|Overall Study|Withdrawal by Subject|0|||
16174114|NCT03417440|39115465|FG007|Overall Study|Withdrawal by Subject|1|||
16174115|NCT00870688|39115466|FG000|Overall Study|Lost to Follow-up|2|||
16174116|NCT00870688|39115466|FG000|Overall Study|Death, Unrelated|1|||
16174117|NCT00870688|39115466|FG000|Overall Study|Granules in the Stools|1|||
16174118|NCT00947349|39115467|FG000|Triple Treatment Combination Period|Adverse Event|0|||
16474242|NCT03347188|40214728|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
16174119|NCT00947349|39115468|FG001|Triple Treatment Combination Period|Adverse Event|1|||
16174120|NCT00947349|39115469|FG002|Triple Treatment Combination Period|Adverse Event|0|||
16174121|NCT00947349|39115470|FG003|Triple Treatment Combination Period|Adverse Event|0|||
16174122|NCT00947349|39115467|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
16174123|NCT00947349|39115468|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
16174124|NCT00947349|39115469|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
16474243|NCT03347188|40214729|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
16474244|NCT02106910|40214734|FG000|Overall Study|Lost to Follow-up|1|||
16474245|NCT02106910|40214735|FG001|Overall Study|Lost to Follow-up|1|||
16474246|NCT03693170|40214737|FG000|Overall Study|Disease Progression|48|||
16474247|NCT03693170|40214737|FG000|Overall Study|Adverse Event|16|||
16474248|NCT03693170|40214737|FG000|Overall Study|Physician Decision|6|||
16474249|NCT03693170|40214737|FG000|Overall Study|Protocol Violation|2|||
16474250|NCT03693170|40214737|FG000|Overall Study|Death|1|||
16474251|NCT03693170|40214737|FG000|Overall Study|Non compliance with study drug|1|||
16474252|NCT03693170|40214737|FG000|Overall Study|Withdrawal by Subject|1|||
16474253|NCT01229371|40214738|FG000|Overall Study|Withdrawal by Subject|0|||
16474254|NCT01229371|40214739|FG001|Overall Study|Withdrawal by Subject|1|||
16474255|NCT01229371|40214740|FG002|Overall Study|Withdrawal by Subject|0|||
16474256|NCT01229371|40214741|FG003|Overall Study|Withdrawal by Subject|0|||
16474257|NCT01702571|40214743|FG000|Overall Study|Death|1067|||
16474258|NCT01702571|40214744|FG001|Overall Study|Death|76|||
16474259|NCT01702571|40214743|FG000|Overall Study|Lost to Follow-up|144|||
16474260|NCT01702571|40214744|FG001|Overall Study|Lost to Follow-up|10|||
16474261|NCT01702571|40214743|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
16474262|NCT01702571|40214744|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
16474263|NCT01702571|40214743|FG000|Overall Study|Investigator Decision|5|||
16474264|NCT01702571|40214744|FG001|Overall Study|Investigator Decision|0|||
16474265|NCT01702571|40214743|FG000|Overall Study|Not Classifiable|1|||
16474266|NCT01702571|40214744|FG001|Overall Study|Not Classifiable|0|||
16474267|NCT01702571|40214743|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
16474268|NCT01702571|40214744|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
16474269|NCT01702571|40214743|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
16474270|NCT01702571|40214744|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
16474271|NCT01702571|40214743|FG000|Overall Study|Progressive Disease|3|||
16474272|NCT01702571|40214744|FG001|Overall Study|Progressive Disease|0|||
16474273|NCT01702571|40214743|FG000|Overall Study|Protocol Violation|2|||
16474274|NCT01702571|40214744|FG001|Overall Study|Protocol Violation|0|||
16474275|NCT01702571|40214743|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
16474276|NCT01702571|40214744|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
16474277|NCT01702571|40214743|FG000|Overall Study|Termination By Sponsor|4|||
16474278|NCT01702571|40214744|FG001|Overall Study|Termination By Sponsor|0|||
16474279|NCT01702571|40214743|FG000|Overall Study|Withdrawal by Subject|177|||
16474280|NCT01702571|40214744|FG001|Overall Study|Withdrawal by Subject|29|||
16474281|NCT01614600|40214745|FG000|Overall Study|Unacceptable fit|1|||
16474282|NCT01614600|40214745|FG000|Overall Study|Discomfort|1|||
16174125|NCT00947349|39115470|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
16474283|NCT01614600|40214745|FG000|Overall Study|Unable to remove lens at the end of day|1|||
16474284|NCT01614600|40214745|FG000|Overall Study|Protocol deviation|1|||
16474285|NCT00191646|40217883|FG000|Overall Study|Toxicity|26|||
16474286|NCT00191646|40217884|FG001|Overall Study|Toxicity|37|||
16474287|NCT00191646|40217883|FG000|Overall Study|Disease Progression|5|||
16174126|NCT00947349|39115467|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
16174127|NCT00947349|39115468|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
16174128|NCT00947349|39115469|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
16174129|NCT00947349|39115470|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
16174130|NCT00947349|39115467|FG000|Overall Study Standard of Care|Other|0|||
16174131|NCT00947349|39115468|FG001|Overall Study Standard of Care|Other|0|||
16474288|NCT00191646|40217884|FG001|Overall Study|Disease Progression|6|||
16474289|NCT00191646|40217883|FG000|Overall Study|Physician Decision|20|||
16474290|NCT00191646|40217884|FG001|Overall Study|Physician Decision|11|||
16474291|NCT00191646|40217883|FG000|Overall Study|Withdrawal by Subject|58|||
16474292|NCT00191646|40217884|FG001|Overall Study|Withdrawal by Subject|39|||
16474293|NCT00191646|40217883|FG000|Overall Study|Protocol Violation|5|||
16474294|NCT00191646|40217884|FG001|Overall Study|Protocol Violation|7|||
16474295|NCT00191646|40217883|FG000|Overall Study|Death|6|||
16474296|NCT00191646|40217884|FG001|Overall Study|Death|8|||
16474297|NCT00191646|40217883|FG000|Overall Study|Other|33|||
16474298|NCT00191646|40217884|FG001|Overall Study|Other|34|||
16474299|NCT00191646|40217883|FG000|Overall Study|Missing Data|18|||
16474300|NCT00191646|40217884|FG001|Overall Study|Missing Data|11|||
16474301|NCT04447417|40217891|FG000|Overall Study|Withdrawal by Subject|1|||
16474302|NCT04447417|40217892|FG001|Overall Study|Withdrawal by Subject|0|||
16474303|NCT04447417|40217891|FG000|Overall Study|Failure to meet inclusion criteria|1|||
16474304|NCT04447417|40217892|FG001|Overall Study|Failure to meet inclusion criteria|0|||
16474305|NCT04447417|40217891|FG000|Overall Study|Lost to Follow-up|1|||
16474306|NCT04447417|40217892|FG001|Overall Study|Lost to Follow-up|0|||
16474307|NCT00828854|40217896|FG000|Overall Study|Disease Progression|17|||
16474308|NCT00828854|40217896|FG000|Overall Study|Adverse Event|9|||
16474309|NCT00828854|40217896|FG000|Overall Study|Reason not Specified|1|||
16474310|NCT00702689|40217897|FG000|Overall Study|Withdrawal by Subject|4|||
16474311|NCT00702689|40217897|FG000|Overall Study|Recurrent malignancy|1|||
16474312|NCT00702689|40217897|FG000|Overall Study|Adverse Event|1|||
16474313|NCT00292318|40217898|FG000|Overall Study|Study terminated by officials|2|||
16474314|NCT00292318|40217899|FG001|Overall Study|Study terminated by officials|1|||
16474315|NCT00494299|40217900|FG000|Overall Study|Adverse Event|93|||
16474316|NCT00494299|40217901|FG001|Overall Study|Adverse Event|13|||
16474317|NCT00494299|40217900|FG000|Overall Study|Lost to Follow-up|1|||
16474318|NCT00494299|40217901|FG001|Overall Study|Lost to Follow-up|0|||
16474319|NCT00494299|40217900|FG000|Overall Study|Physician Decision|0|||
16474320|NCT00494299|40217901|FG001|Overall Study|Physician Decision|2|||
16474321|NCT00494299|40217900|FG000|Overall Study|Protocol Violation|1|||
16474322|NCT00494299|40217901|FG001|Overall Study|Protocol Violation|2|||
16474323|NCT00494299|40217900|FG000|Overall Study|Withdrawal by Subject|8|||
16474324|NCT00494299|40217901|FG001|Overall Study|Withdrawal by Subject|3|||
16474325|NCT00494299|40217900|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
16474326|NCT00494299|40217901|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
16474327|NCT00494299|40217900|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
16474328|NCT00494299|40217901|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
16474329|NCT00494299|40217900|FG000|Overall Study|Site Closed by Sponsor|6|||
16474330|NCT00494299|40217901|FG001|Overall Study|Site Closed by Sponsor|0|||
16474331|NCT00494299|40217900|FG000|Overall Study|Protocol Driven Decision Point|11|||
16474332|NCT00494299|40217901|FG001|Overall Study|Protocol Driven Decision Point|22|||
16075393|NCT00891930|38769707|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
16075394|NCT00891930|38769707|FG000|Part 2 Panitumumab + AMG479|Death|30|||
16075395|NCT02013830|38769709|FG000|Overall Study|Adverse Event|3|||
16075396|NCT02013830|38769709|FG000|Overall Study|Death|1|||
16474333|NCT03971071|40217902|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
16474334|NCT03971071|40217903|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
16474335|NCT03971071|40217904|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
16474336|NCT03971071|40217905|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
16474337|NCT03971071|40217906|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
16474338|NCT03971071|40217902|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
16474339|NCT03971071|40217903|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
16474340|NCT03971071|40217904|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
16474341|NCT03971071|40217905|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
16474342|NCT03971071|40217906|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
16474343|NCT03971071|40217902|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
16474344|NCT03971071|40217903|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
16474345|NCT03971071|40217904|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
16075397|NCT02013830|38769709|FG000|Overall Study|Insufficient therapeutic response|25|||
16474346|NCT03971071|40217905|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
16474347|NCT03971071|40217906|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
16474348|NCT03971071|40217902|FG000|Open-label Treatment Period|Sponsor decision|0|||
16474349|NCT03971071|40217903|FG001|Open-label Treatment Period|Sponsor decision|0|||
16474350|NCT03971071|40217904|FG002|Open-label Treatment Period|Sponsor decision|0|||
16474351|NCT03971071|40217905|FG003|Open-label Treatment Period|Sponsor decision|0|||
16474352|NCT03971071|40217906|FG004|Open-label Treatment Period|Sponsor decision|1|||
16474353|NCT03971071|40217902|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
16474354|NCT03971071|40217903|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
16474355|NCT03971071|40217904|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
16474356|NCT03971071|40217905|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
16474357|NCT03971071|40217906|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
16474358|NCT03971071|40217902|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
16474359|NCT03971071|40217903|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
16474360|NCT03971071|40217904|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
16474361|NCT03971071|40217905|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
16474362|NCT03971071|40217906|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
16474363|NCT02395016|40217910|FG000|Overall Study|Adverse Event|4|||
16474364|NCT02395016|40217911|FG001|Overall Study|Adverse Event|3|||
16474365|NCT02395016|40217910|FG000|Overall Study|Withdrawal by Subject|9|||
16474366|NCT02395016|40217911|FG001|Overall Study|Withdrawal by Subject|6|||
16474367|NCT02395016|40217910|FG000|Overall Study|Protocol Violation|2|||
16474368|NCT02395016|40217911|FG001|Overall Study|Protocol Violation|3|||
16474369|NCT02810340|40217915|FG000|Overall Study|Withdrawal by Subject|1|||
16474370|NCT02810340|40217916|FG001|Overall Study|Withdrawal by Subject|0|||
16474371|NCT02810340|40217917|FG002|Overall Study|Withdrawal by Subject|0|||
16474372|NCT02810340|40217915|FG000|Overall Study|Incarceration|0|||
16474373|NCT02810340|40217916|FG001|Overall Study|Incarceration|1|||
16474374|NCT02810340|40217917|FG002|Overall Study|Incarceration|0|||
16474375|NCT02810340|40217915|FG000|Overall Study|Lost to Follow-up|0|||
16474376|NCT02810340|40217916|FG001|Overall Study|Lost to Follow-up|0|||
16474377|NCT02810340|40217917|FG002|Overall Study|Lost to Follow-up|1|||
16474378|NCT02694523|40217918|FG000|Part A|Adverse Event|7|||
16474379|NCT02694523|40217919|FG001|Part A|Adverse Event|3|||
16474380|NCT02694523|40217920|FG002|Part A|Adverse Event|0|||
16474381|NCT02694523|40217921|FG003|Part A|Adverse Event|0|||
16474382|NCT02694523|40217922|FG004|Part A|Adverse Event|0|||
16474383|NCT02694523|40217923|FG005|Part A|Adverse Event|0|||
16474384|NCT02694523|40217924|FG006|Part A|Adverse Event|0|||
16474385|NCT02694523|40217918|FG000|Part A|Protocol Violation|1|||
16474386|NCT02694523|40217919|FG001|Part A|Protocol Violation|0|||
16474387|NCT02694523|40217920|FG002|Part A|Protocol Violation|0|||
16474388|NCT02694523|40217921|FG003|Part A|Protocol Violation|0|||
16474389|NCT02694523|40217922|FG004|Part A|Protocol Violation|0|||
16474390|NCT02694523|40217923|FG005|Part A|Protocol Violation|0|||
16474391|NCT02694523|40217924|FG006|Part A|Protocol Violation|0|||
16474392|NCT02694523|40217918|FG000|Part A|Lost to Follow-up|1|||
16474393|NCT02694523|40217919|FG001|Part A|Lost to Follow-up|2|||
16474394|NCT02694523|40217920|FG002|Part A|Lost to Follow-up|0|||
16474395|NCT02694523|40217921|FG003|Part A|Lost to Follow-up|0|||
16474396|NCT02694523|40217922|FG004|Part A|Lost to Follow-up|0|||
16474397|NCT02694523|40217923|FG005|Part A|Lost to Follow-up|0|||
16474398|NCT02694523|40217924|FG006|Part A|Lost to Follow-up|0|||
16474399|NCT02694523|40217918|FG000|Part A|Withdrawal by Subject|3|||
16474400|NCT02694523|40217919|FG001|Part A|Withdrawal by Subject|1|||
16474401|NCT02694523|40217920|FG002|Part A|Withdrawal by Subject|0|||
16474402|NCT02694523|40217921|FG003|Part A|Withdrawal by Subject|0|||
16474403|NCT02694523|40217922|FG004|Part A|Withdrawal by Subject|0|||
16474404|NCT02694523|40217923|FG005|Part A|Withdrawal by Subject|0|||
16474405|NCT02694523|40217924|FG006|Part A|Withdrawal by Subject|0|||
16474406|NCT02694523|40217918|FG000|Part A|Other|1|||
16474407|NCT02694523|40217919|FG001|Part A|Other|1|||
16474408|NCT02694523|40217920|FG002|Part A|Other|0|||
16474409|NCT02694523|40217921|FG003|Part A|Other|0|||
16474410|NCT02694523|40217922|FG004|Part A|Other|0|||
16474411|NCT02694523|40217923|FG005|Part A|Other|0|||
16474412|NCT02694523|40217924|FG006|Part A|Other|0|||
16474413|NCT02694523|40217918|FG000|Part B|Adverse Event|0|||
16474414|NCT02694523|40217919|FG001|Part B|Adverse Event|0|||
16474415|NCT02694523|40217920|FG002|Part B|Adverse Event|7|||
16474416|NCT02694523|40217921|FG003|Part B|Adverse Event|1|||
16474417|NCT02694523|40217922|FG004|Part B|Adverse Event|1|||
16474418|NCT02694523|40217923|FG005|Part B|Adverse Event|2|||
16474419|NCT02694523|40217924|FG006|Part B|Adverse Event|0|||
16474420|NCT02694523|40217918|FG000|Part B|Protocol Violation|0|||
16474421|NCT02694523|40217919|FG001|Part B|Protocol Violation|0|||
16474422|NCT02694523|40217920|FG002|Part B|Protocol Violation|1|||
16474423|NCT02694523|40217921|FG003|Part B|Protocol Violation|0|||
16474424|NCT02694523|40217922|FG004|Part B|Protocol Violation|0|||
16474425|NCT02694523|40217923|FG005|Part B|Protocol Violation|0|||
16474426|NCT02694523|40217924|FG006|Part B|Protocol Violation|0|||
16474427|NCT02694523|40217918|FG000|Part B|Lost to Follow-up|0|||
16474428|NCT02694523|40217919|FG001|Part B|Lost to Follow-up|0|||
16474429|NCT02694523|40217920|FG002|Part B|Lost to Follow-up|2|||
16474430|NCT02694523|40217921|FG003|Part B|Lost to Follow-up|3|||
16474431|NCT02694523|40217922|FG004|Part B|Lost to Follow-up|2|||
16474432|NCT02694523|40217923|FG005|Part B|Lost to Follow-up|0|||
16474433|NCT02694523|40217924|FG006|Part B|Lost to Follow-up|1|||
16474434|NCT02694523|40217918|FG000|Part B|Withdrawal by Subject|0|||
16474435|NCT02694523|40217919|FG001|Part B|Withdrawal by Subject|0|||
16474436|NCT02694523|40217920|FG002|Part B|Withdrawal by Subject|9|||
16474437|NCT02694523|40217921|FG003|Part B|Withdrawal by Subject|0|||
16474438|NCT02694523|40217922|FG004|Part B|Withdrawal by Subject|1|||
16474439|NCT02694523|40217923|FG005|Part B|Withdrawal by Subject|3|||
16474440|NCT02694523|40217924|FG006|Part B|Withdrawal by Subject|0|||
16474441|NCT02694523|40217918|FG000|Part B|Other|0|||
16474442|NCT02694523|40217919|FG001|Part B|Other|0|||
16474443|NCT02694523|40217920|FG002|Part B|Other|1|||
16474444|NCT02694523|40217921|FG003|Part B|Other|0|||
16174132|NCT00947349|39115469|FG002|Overall Study Standard of Care|Other|0|||
16174133|NCT00947349|39115470|FG003|Overall Study Standard of Care|Other|1|||
16174134|NCT00195650|39115471|FG000|Overall Study|Adverse Event|194|||
16174135|NCT00195650|39115471|FG000|Overall Study|Lack of Efficacy|99|||
16174136|NCT00195650|39115471|FG000|Overall Study|Withdrawal by Subject|67|||
16174137|NCT00195650|39115471|FG000|Overall Study|Lost to Follow-up|44|||
16174138|NCT00195650|39115471|FG000|Overall Study|Death|23|||
16174139|NCT00195650|39115471|FG000|Overall Study|Protocol Violation|15|||
16174140|NCT00195650|39115471|FG000|Overall Study|Administrative reasons|83|||
16174141|NCT04426630|39115472|FG000|Overall Study|Death|4|||
16174142|NCT04426630|39115472|FG000|Overall Study|Lost to Follow-up|2|||
16075398|NCT02013830|38769709|FG000|Overall Study|Refused treatment|1|||
16174143|NCT01070329|39115473|FG000|Overall Study|Adverse Event|13|||
16174144|NCT01070329|39115474|FG001|Overall Study|Adverse Event|10|||
16174145|NCT01070329|39115473|FG000|Overall Study|Lost to Follow-up|22|||
16174146|NCT01070329|39115474|FG001|Overall Study|Lost to Follow-up|12|||
16174147|NCT01070329|39115473|FG000|Overall Study|Withdrawal by Subject|9|||
16474445|NCT02694523|40217922|FG004|Part B|Other|0|||
16174148|NCT01070329|39115474|FG001|Overall Study|Withdrawal by Subject|11|||
16174149|NCT01070329|39115473|FG000|Overall Study|Protocol Violation|3|||
16174150|NCT01070329|39115474|FG001|Overall Study|Protocol Violation|8|||
16174151|NCT01070329|39115473|FG000|Overall Study|Lack of Efficacy|2|||
16174152|NCT01070329|39115474|FG001|Overall Study|Lack of Efficacy|6|||
16174153|NCT01070329|39115473|FG000|Overall Study|Physician Decision|2|||
16174154|NCT01070329|39115474|FG001|Overall Study|Physician Decision|1|||
16174155|NCT01070329|39115473|FG000|Overall Study|Entry Criteria Not Met|1|||
16174156|NCT01070329|39115474|FG001|Overall Study|Entry Criteria Not Met|0|||
16174157|NCT01070329|39115473|FG000|Overall Study|Sponsor Decision|0|||
16174158|NCT01070329|39115474|FG001|Overall Study|Sponsor Decision|1|||
16174159|NCT01591330|39115479|FG000|Period 1|Adverse Event|1|||
16174160|NCT01591330|39115480|FG001|Period 1|Adverse Event|0|||
16174161|NCT01591330|39115481|FG002|Period 1|Adverse Event|0|||
16174162|NCT01591330|39115482|FG003|Period 1|Adverse Event|0|||
16174163|NCT01591330|39115479|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
16174164|NCT01591330|39115480|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
16174165|NCT01591330|39115481|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
16174166|NCT01591330|39115482|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
16174167|NCT01591330|39115479|FG000|Period 2|Adverse Event|1|||
16174168|NCT01591330|39115480|FG001|Period 2|Adverse Event|0|||
16174169|NCT01591330|39115481|FG002|Period 2|Adverse Event|0|||
16174170|NCT01591330|39115482|FG003|Period 2|Adverse Event|0|||
16174171|NCT00811252|39115488|FG000|Overall Study|Adverse Event|6|||
16174172|NCT00811252|39115489|FG001|Overall Study|Adverse Event|10|||
16174173|NCT00811252|39115490|FG002|Overall Study|Adverse Event|15|||
16174174|NCT00811252|39115488|FG000|Overall Study|Lack of Efficacy|7|||
16174175|NCT00811252|39115489|FG001|Overall Study|Lack of Efficacy|2|||
16174176|NCT00811252|39115490|FG002|Overall Study|Lack of Efficacy|0|||
16174177|NCT00811252|39115488|FG000|Overall Study|Protocol Violation|3|||
16174178|NCT00811252|39115489|FG001|Overall Study|Protocol Violation|3|||
16174179|NCT00811252|39115490|FG002|Overall Study|Protocol Violation|2|||
16174180|NCT00811252|39115488|FG000|Overall Study|Withdrawal of Consent|1|||
16174181|NCT00811252|39115489|FG001|Overall Study|Withdrawal of Consent|2|||
16174182|NCT00811252|39115490|FG002|Overall Study|Withdrawal of Consent|2|||
16174183|NCT00811252|39115488|FG000|Overall Study|Lost to Follow-up|0|||
16174184|NCT00811252|39115489|FG001|Overall Study|Lost to Follow-up|0|||
16174185|NCT00811252|39115490|FG002|Overall Study|Lost to Follow-up|2|||
16174186|NCT00811252|39115488|FG000|Overall Study|Administrative or Other Reasons|0|||
16174187|NCT00811252|39115489|FG001|Overall Study|Administrative or Other Reasons|3|||
16174188|NCT00811252|39115490|FG002|Overall Study|Administrative or Other Reasons|2|||
16174189|NCT00925600|39115495|FG000|Overall Study|Withdrawal by Subject|16|||
16174190|NCT00925600|39115496|FG001|Overall Study|Withdrawal by Subject|14|||
16174191|NCT00925600|39115495|FG000|Overall Study|Death|4|||
16174192|NCT00925600|39115496|FG001|Overall Study|Death|3|||
16174193|NCT00925600|39115495|FG000|Overall Study|Lost to Follow-up|2|||
16174194|NCT00925600|39115496|FG001|Overall Study|Lost to Follow-up|2|||
16174195|NCT00925600|39115495|FG000|Overall Study|Disease Progression|1|||
16174196|NCT00925600|39115496|FG001|Overall Study|Disease Progression|3|||
16174197|NCT00925600|39115495|FG000|Overall Study|Administrative Decision|1|||
16174198|NCT00925600|39115496|FG001|Overall Study|Administrative Decision|1|||
16174199|NCT00925600|39115495|FG000|Overall Study|Noncompliance|2|||
16474446|NCT02694523|40217923|FG005|Part B|Other|0|||
16474447|NCT02694523|40217924|FG006|Part B|Other|1|||
16075399|NCT01087762|38769712|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
16174200|NCT00925600|39115496|FG001|Overall Study|Noncompliance|0|||
16174201|NCT00925600|39115495|FG000|Overall Study|Ineligibility Determined|2|||
16174202|NCT00925600|39115496|FG001|Overall Study|Ineligibility Determined|0|||
16174203|NCT00925600|39115495|FG000|Overall Study|Protocol Deviation|0|||
16174204|NCT00925600|39115496|FG001|Overall Study|Protocol Deviation|1|||
16174205|NCT00925600|39115495|FG000|Overall Study|Requirement for Alternative Therapy|0|||
16174206|NCT00925600|39115496|FG001|Overall Study|Requirement for Alternative Therapy|1|||
16174207|NCT00925600|39115495|FG000|Overall Study|Other|3|||
16174208|NCT00925600|39115496|FG001|Overall Study|Other|1|||
16174209|NCT00925600|39115495|FG000|Overall Study|Adverse Event|1|||
16174210|NCT00925600|39115496|FG001|Overall Study|Adverse Event|2|||
16174211|NCT01145560|39115499|FG000|Overall Study|Withdrawal by Subject|2|||
16174212|NCT01145560|39115500|FG001|Overall Study|Withdrawal by Subject|1|||
16174213|NCT01145560|39115501|FG002|Overall Study|Withdrawal by Subject|0|||
16174214|NCT01145560|39115499|FG000|Overall Study|Lost to Follow-up|1|||
16174215|NCT01145560|39115500|FG001|Overall Study|Lost to Follow-up|1|||
16174216|NCT01145560|39115501|FG002|Overall Study|Lost to Follow-up|1|||
16174217|NCT01145560|39115499|FG000|Overall Study|No study drug by 24h after organ failure|1|||
16174218|NCT01145560|39115500|FG001|Overall Study|No study drug by 24h after organ failure|0|||
16174219|NCT01145560|39115501|FG002|Overall Study|No study drug by 24h after organ failure|0|||
16174220|NCT01145560|39115499|FG000|Overall Study|Accidental unblinding of study treatment|0|||
16174221|NCT01145560|39115500|FG001|Overall Study|Accidental unblinding of study treatment|1|||
16174222|NCT01145560|39115501|FG002|Overall Study|Accidental unblinding of study treatment|0|||
16174223|NCT01145560|39115499|FG000|Overall Study|False insurance information|0|||
16174224|NCT01145560|39115500|FG001|Overall Study|False insurance information|1|||
16174225|NCT01145560|39115501|FG002|Overall Study|False insurance information|0|||
16174226|NCT01145560|39115499|FG000|Overall Study|Withdrawal of therapy|0|||
16174227|NCT01145560|39115500|FG001|Overall Study|Withdrawal of therapy|0|||
16174228|NCT01145560|39115501|FG002|Overall Study|Withdrawal of therapy|1|||
16174229|NCT01892722|39115506|FG000|Overall Study|Protocol deviation|0|||
16174230|NCT01892722|39115507|FG001|Overall Study|Protocol deviation|1|||
16174231|NCT01892722|39115506|FG000|Overall Study|Administrative problems|0|||
16174232|NCT01892722|39115507|FG001|Overall Study|Administrative problems|1|||
16174233|NCT01892722|39115506|FG000|Overall Study|Patient/guardian decision|0|||
16174234|NCT01892722|39115507|FG001|Overall Study|Patient/guardian decision|2|||
16174235|NCT01892722|39115506|FG000|Overall Study|Physician Decision|1|||
16174236|NCT01892722|39115507|FG001|Overall Study|Physician Decision|2|||
16174237|NCT01892722|39115506|FG000|Overall Study|Adverse Event|3|||
16174238|NCT01892722|39115507|FG001|Overall Study|Adverse Event|2|||
16174239|NCT01892722|39115506|FG000|Overall Study|Lack of Efficacy|0|||
16075400|NCT01087762|38769713|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
16075401|NCT01087762|38769714|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
16075402|NCT01087762|38769715|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
16075403|NCT01087762|38769716|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
16075404|NCT01087762|38769712|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
16075405|NCT01087762|38769713|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
16075406|NCT01087762|38769714|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
16075407|NCT01087762|38769715|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
16075408|NCT01087762|38769716|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
16174240|NCT01892722|39115507|FG001|Overall Study|Lack of Efficacy|7|||
16174241|NCT01892722|39115506|FG000|Overall Study|Withdrawal by Subject|3|||
16174242|NCT01892722|39115507|FG001|Overall Study|Withdrawal by Subject|5|||
16075409|NCT01087762|38769712|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
16075410|NCT01087762|38769713|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
16075411|NCT01087762|38769714|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
16075412|NCT01087762|38769715|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
16075413|NCT01087762|38769716|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
16075414|NCT01087762|38769712|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
16075415|NCT01087762|38769713|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
16174243|NCT02649634|39115508|FG000|Overall Study|Withdrawal by Subject|3|||
16174244|NCT02649634|39115509|FG001|Overall Study|Withdrawal by Subject|5|||
16075416|NCT01087762|38769714|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
16075417|NCT01087762|38769715|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
16075418|NCT01087762|38769716|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
16075419|NCT01087762|38769712|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
16174245|NCT02649634|39115508|FG000|Overall Study|Lost to Follow-up|0|||
16174246|NCT02649634|39115509|FG001|Overall Study|Lost to Follow-up|1|||
16174247|NCT04800315|39115510|FG000|Randomization|Did not receive study treatment|1|||
16174248|NCT04800315|39115511|FG001|Randomization|Did not receive study treatment|0|||
16174249|NCT04800315|39115512|FG002|Randomization|Did not receive study treatment|0|||
16174250|NCT04800315|39115513|FG003|Randomization|Did not receive study treatment|0|||
16174251|NCT04800315|39115510|FG000|Treatment Period|Adverse Event|4|||
16174252|NCT04800315|39115511|FG001|Treatment Period|Adverse Event|2|||
16174253|NCT04800315|39115512|FG002|Treatment Period|Adverse Event|1|||
16274830|NCT03255980|39490187|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
16274831|NCT03255980|39490188|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
16474448|NCT02160782|40217937|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
16474449|NCT02160782|40217938|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
16174254|NCT04800315|39115513|FG003|Treatment Period|Adverse Event|2|||
16174255|NCT04800315|39115510|FG000|Treatment Period|Lack of Efficacy|1|||
16174256|NCT04800315|39115511|FG001|Treatment Period|Lack of Efficacy|0|||
16174257|NCT04800315|39115512|FG002|Treatment Period|Lack of Efficacy|0|||
16174258|NCT04800315|39115513|FG003|Treatment Period|Lack of Efficacy|3|||
16174259|NCT04800315|39115510|FG000|Treatment Period|Lost to Follow-up|0|||
16174260|NCT04800315|39115511|FG001|Treatment Period|Lost to Follow-up|1|||
16174261|NCT04800315|39115512|FG002|Treatment Period|Lost to Follow-up|2|||
16174262|NCT04800315|39115513|FG003|Treatment Period|Lost to Follow-up|2|||
16174263|NCT04800315|39115510|FG000|Treatment Period|Withdrawal by participant|0|||
16174264|NCT04800315|39115511|FG001|Treatment Period|Withdrawal by participant|0|||
16174265|NCT04800315|39115512|FG002|Treatment Period|Withdrawal by participant|0|||
16174266|NCT04800315|39115513|FG003|Treatment Period|Withdrawal by participant|4|||
16474450|NCT02160782|40217939|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
16174267|NCT04800315|39115510|FG000|Treatment Period|Other Reasons|0|||
16174268|NCT04800315|39115511|FG001|Treatment Period|Other Reasons|2|||
16174269|NCT04800315|39115512|FG002|Treatment Period|Other Reasons|0|||
16474451|NCT02160782|40217940|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
16474452|NCT02160782|40217941|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
16174270|NCT04800315|39115513|FG003|Treatment Period|Other Reasons|1|||
16174271|NCT01390389|39115516|FG000|Overall Study|Withdrawal by Subject|2|||
16174272|NCT01390389|39115517|FG001|Overall Study|Withdrawal by Subject|0|||
16174273|NCT01390389|39115516|FG000|Overall Study|Screen Fail|2|||
16174274|NCT01390389|39115517|FG001|Overall Study|Screen Fail|1|||
16474453|NCT02160782|40217937|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
16474454|NCT02160782|40217938|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
16474455|NCT02160782|40217939|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
16174275|NCT01075178|39115518|FG000|Subject Matching|eligible but not matched|130|||
16174276|NCT01075178|39115519|FG001|Subject Matching|eligible but not matched|403|||
16174277|NCT01075178|39115518|FG000|Subject Chart Review|died before chart review period|0|||
16174278|NCT01075178|39115519|FG001|Subject Chart Review|died before chart review period|2|||
16174279|NCT01075178|39115518|FG000|Subject Chart Review|no data collected due to site closure|3|||
16174280|NCT01075178|39115519|FG001|Subject Chart Review|no data collected due to site closure|4|||
16174281|NCT01075178|39115518|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
16375143|NCT00563316|39860060|FG000|Overall Study|Lost to Follow-up|2|||
16174282|NCT01075178|39115519|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
16174283|NCT00773279|39115520|FG000|Period 1|Adverse Event|2|||
16174284|NCT00773279|39115521|FG001|Period 1|Adverse Event|1|||
16174285|NCT00773279|39115520|FG000|Period 1|Lack of Efficacy|0|||
16174286|NCT00773279|39115521|FG001|Period 1|Lack of Efficacy|2|||
16174287|NCT00773279|39115520|FG000|Period 1|Unclassified|5|||
16174288|NCT00773279|39115521|FG001|Period 1|Unclassified|1|||
16174289|NCT00773279|39115520|FG000|Period 2|Adverse Event|0|||
16174290|NCT00773279|39115521|FG001|Period 2|Adverse Event|1|||
16174291|NCT00773279|39115520|FG000|Period 2|Lack of Efficacy|1|||
16174292|NCT00773279|39115521|FG001|Period 2|Lack of Efficacy|0|||
16174293|NCT00773279|39115520|FG000|Period 2|Protocol Violation|0|||
16174294|NCT00773279|39115521|FG001|Period 2|Protocol Violation|3|||
16174295|NCT00773279|39115520|FG000|Period 2|Unclassified|2|||
16174296|NCT00773279|39115521|FG001|Period 2|Unclassified|2|||
16174297|NCT00469079|39115525|FG000|Overall Study|Lack of Efficacy|3|||
16174298|NCT00469079|39115526|FG001|Overall Study|Lack of Efficacy|8|||
16174299|NCT00469079|39115527|FG002|Overall Study|Lack of Efficacy|5|||
16174300|NCT00469079|39115525|FG000|Overall Study|Adverse Event|1|||
16174301|NCT00469079|39115526|FG001|Overall Study|Adverse Event|3|||
16174302|NCT00469079|39115527|FG002|Overall Study|Adverse Event|2|||
16174303|NCT00469079|39115525|FG000|Overall Study|Lost to Follow-up|4|||
16174304|NCT00469079|39115526|FG001|Overall Study|Lost to Follow-up|8|||
16174305|NCT00469079|39115527|FG002|Overall Study|Lost to Follow-up|10|||
16174306|NCT00469079|39115525|FG000|Overall Study|Withdrawal by Subject|1|||
16174307|NCT00469079|39115526|FG001|Overall Study|Withdrawal by Subject|2|||
16174308|NCT00469079|39115527|FG002|Overall Study|Withdrawal by Subject|2|||
16174309|NCT00469079|39115525|FG000|Overall Study|Ineligible|0|||
16174310|NCT00469079|39115526|FG001|Overall Study|Ineligible|1|||
16174311|NCT00469079|39115527|FG002|Overall Study|Ineligible|0|||
16174312|NCT01120626|39115528|FG000|Overall Study|Withdrawal by Subject|1|||
16174313|NCT01120626|39115529|FG001|Overall Study|Withdrawal by Subject|0|||
16174314|NCT02031679|39115530|FG000|Overall Study|Protocol Violation|0|||
16174315|NCT02031679|39115531|FG001|Overall Study|Protocol Violation|1|||
16174316|NCT02031679|39115530|FG000|Overall Study|Lack of Efficacy|0|||
16174317|NCT02031679|39115531|FG001|Overall Study|Lack of Efficacy|1|||
16174318|NCT00981526|39115532|FG000|Overall Study|Withdrawal by Subject|0|||
16174319|NCT00981526|39115533|FG001|Overall Study|Withdrawal by Subject|2|||
16174320|NCT00981526|39115532|FG000|Overall Study|Physician Decision|4|||
16174321|NCT00981526|39115533|FG001|Overall Study|Physician Decision|4|||
16174322|NCT00684814|39115534|FG000|Washout Period of 7 Days|Adverse Event|1|||
16174323|NCT00684814|39115535|FG001|Washout Period of 7 Days|Adverse Event|2|||
16174324|NCT00684814|39115534|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
16174325|NCT00684814|39115535|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
16174326|NCT00684814|39115534|FG000|Second Intervention|Adverse Event|1|||
16174327|NCT00684814|39115535|FG001|Second Intervention|Adverse Event|0|||
16174328|NCT03301857|39115539|FG000|Overall Study|Death|0|||
16174329|NCT03301857|39115540|FG001|Overall Study|Death|2|||
16174330|NCT03301857|39115539|FG000|Overall Study|Lost to Follow-up|4|||
16174331|NCT03301857|39115540|FG001|Overall Study|Lost to Follow-up|2|||
16174332|NCT03301857|39115539|FG000|Overall Study|Decision by Sponsor|6|||
16174333|NCT03301857|39115540|FG001|Overall Study|Decision by Sponsor|0|||
16174334|NCT03301857|39115539|FG000|Overall Study|Withdrawal by Subject|12|||
16174335|NCT03301857|39115540|FG001|Overall Study|Withdrawal by Subject|4|||
16174336|NCT01021007|39115544|FG000|Overall Study|Lost to Follow-up|1|||
16174337|NCT01021007|39115545|FG001|Overall Study|Lost to Follow-up|1|||
16174338|NCT01021007|39115544|FG000|Overall Study|Adverse Event|1|||
16174339|NCT01021007|39115545|FG001|Overall Study|Adverse Event|3|||
16174340|NCT03195894|39115546|FG000|Overall Study|"An example is Started other treatment."|4|||
16174341|NCT03195894|39115547|FG001|Overall Study|"An example is Started other treatment."|5|||
16174342|NCT03195894|39115546|FG000|Overall Study|Withdrawal by Subject|15|||
16174343|NCT03195894|39115547|FG001|Overall Study|Withdrawal by Subject|4|||
16174344|NCT03195894|39115546|FG000|Overall Study|Lost to Follow-up|14|||
16174345|NCT03195894|39115547|FG001|Overall Study|Lost to Follow-up|19|||
16174346|NCT02338843|39115549|FG000|Overall Study|Adverse Event|2|||
16474456|NCT02160782|40217940|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
16174347|NCT02338843|39115550|FG001|Overall Study|Adverse Event|1|||
16174348|NCT02338843|39115549|FG000|Overall Study|Death|40|||
16174349|NCT02338843|39115550|FG001|Overall Study|Death|53|||
16174350|NCT02338843|39115549|FG000|Overall Study|Physician Decision|1|||
16474457|NCT02160782|40217941|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
16474458|NCT02160782|40217937|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
16474459|NCT02160782|40217938|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
16474460|NCT02160782|40217939|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
16474461|NCT02160782|40217940|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
16474462|NCT02160782|40217941|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
16474463|NCT02160782|40217937|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
16474464|NCT02160782|40217938|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
16474465|NCT02160782|40217939|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
16474466|NCT02160782|40217940|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
16474467|NCT02160782|40217941|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
16474468|NCT02160782|40217937|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
16474469|NCT02160782|40217938|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
16474470|NCT02160782|40217939|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
16474471|NCT02160782|40217940|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
16474472|NCT02160782|40217941|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
16474473|NCT02160782|40217937|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
16474474|NCT02160782|40217938|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
16075420|NCT01087762|38769713|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
16075421|NCT01087762|38769714|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
16075422|NCT01087762|38769715|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
16075423|NCT01087762|38769716|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
16174351|NCT02338843|39115550|FG001|Overall Study|Physician Decision|0|||
16174352|NCT02338843|39115549|FG000|Overall Study|Withdrawal by Subject|0|||
16474475|NCT02160782|40217939|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
16474476|NCT02160782|40217940|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
16474477|NCT02160782|40217941|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
16474478|NCT02160782|40217937|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
16474479|NCT02160782|40217938|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
16474480|NCT02160782|40217939|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
16474481|NCT02160782|40217940|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
16174353|NCT02338843|39115550|FG001|Overall Study|Withdrawal by Subject|2|||
16174354|NCT02338843|39115549|FG000|Overall Study|Subject Recovered|0|||
16174355|NCT02338843|39115550|FG001|Overall Study|Subject Recovered|2|||
16174356|NCT02338843|39115549|FG000|Overall Study|Discontinued prior to randomizat|1|||
16174357|NCT02338843|39115550|FG001|Overall Study|Discontinued prior to randomizat|0|||
16174358|NCT00609609|39119173|FG000|Overall Study|Withdrawal by Subject|2|||
16174359|NCT00609609|39119174|FG001|Overall Study|Withdrawal by Subject|0|||
16174360|NCT00609609|39119173|FG000|Overall Study|Progression|4|||
16174361|NCT00609609|39119174|FG001|Overall Study|Progression|2|||
16174362|NCT00104871|39119176|FG000|Overall Study|Not evaluable|1|||
16174363|NCT00742781|39119177|FG000|Overall Study|Withdrawal by Subject|3|||
16174364|NCT00097539|39119178|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
16174365|NCT00097539|39119179|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
16474482|NCT02160782|40217941|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
16075424|NCT01087762|38769712|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
16075425|NCT01087762|38769713|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
16174366|NCT00097539|39119180|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
16174367|NCT00097539|39119181|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
16174368|NCT00097539|39119182|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
16174369|NCT00097539|39119183|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
16174370|NCT00097539|39119184|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
16174371|NCT00097539|39119178|FG000|Overall Study|Withdrawal by Subject|925|||
16174372|NCT00097539|39119179|FG001|Overall Study|Withdrawal by Subject|323|||
16474483|NCT02204007|40217942|FG000|Overall Study|Surgery Canceled|1|||
16474484|NCT02204007|40217943|FG001|Overall Study|Surgery Canceled|1|||
16474485|NCT00580970|40217944|FG000|Pre-treatment|Non-compliance|1|||
16474486|NCT00580970|40217944|FG000|Treatment (Lovastatin)|Non-compliance|6|||
16474487|NCT00580970|40217944|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
16474488|NCT00580970|40217944|FG000|Treatment (Lovastatin)|Physician Decision|4|||
16474489|NCT00580970|40217944|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
16474490|NCT00580970|40217944|FG000|Treatment (Lovastatin)|Death|1|||
16474491|NCT04545554|40217946|FG000|Overall Study|Withdrawal by Subject|0|||
16474492|NCT04545554|40217947|FG001|Overall Study|Withdrawal by Subject|0|||
16474493|NCT04545554|40217948|FG002|Overall Study|Withdrawal by Subject|0|||
16474494|NCT04545554|40217949|FG003|Overall Study|Withdrawal by Subject|1|||
16474495|NCT04545554|40217950|FG004|Overall Study|Withdrawal by Subject|0|||
16474496|NCT04545554|40217951|FG005|Overall Study|Withdrawal by Subject|0|||
16474497|NCT00406354|40217952|FG000|All Randomized Patients|Protocol Violation|0|||
16474498|NCT00406354|40217953|FG001|All Randomized Patients|Protocol Violation|0|||
16474499|NCT00406354|40217954|FG002|All Randomized Patients|Protocol Violation|1|||
16474500|NCT00406354|40217952|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
16474501|NCT00406354|40217953|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
16474502|NCT00406354|40217954|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
16474503|NCT00406354|40217952|FG000|All Randomized and Treated Patients|Adverse Event|6|||
16474504|NCT00406354|40217953|FG001|All Randomized and Treated Patients|Adverse Event|2|||
16474505|NCT00406354|40217954|FG002|All Randomized and Treated Patients|Adverse Event|1|||
16474506|NCT00406354|40217952|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
16474507|NCT00406354|40217953|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
16474508|NCT00406354|40217954|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
16474509|NCT00406354|40217952|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
16474510|NCT00406354|40217953|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
16474511|NCT00406354|40217954|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
16474512|NCT00406354|40217952|FG000|All Randomized and Treated Patients|Physician Decision|0|||
16474513|NCT00406354|40217953|FG001|All Randomized and Treated Patients|Physician Decision|0|||
16474514|NCT00406354|40217954|FG002|All Randomized and Treated Patients|Physician Decision|1|||
16474515|NCT00721123|40217955|FG000|Overall Study|Adverse Event|96|||
16474516|NCT00721123|40217955|FG000|Overall Study|Death|10|||
16474517|NCT00721123|40217955|FG000|Overall Study|Insufficient Therapeutic Response|21|||
16474518|NCT00721123|40217955|FG000|Overall Study|Protocol Violation|1|||
16474519|NCT00721123|40217955|FG000|Overall Study|Refused Treatment|41|||
16474520|NCT00721123|40217955|FG000|Overall Study|Failure to Return|9|||
16474521|NCT00721123|40217955|FG000|Overall Study|Withdrawal by Subject|5|||
16474522|NCT02448810|40217956|FG000|Overall Study|Adverse Event|0|||
16474523|NCT02448810|40217957|FG001|Overall Study|Adverse Event|0|||
16474524|NCT02448810|40217958|FG002|Overall Study|Adverse Event|1|||
16474525|NCT02448810|40217959|FG003|Overall Study|Adverse Event|0|||
16474526|NCT02448810|40217960|FG004|Overall Study|Adverse Event|0|||
16474527|NCT02448810|40217961|FG005|Overall Study|Adverse Event|0|||
16474528|NCT02448810|40217962|FG006|Overall Study|Adverse Event|0|||
16474529|NCT02448810|40217963|FG007|Overall Study|Adverse Event|0|||
16474530|NCT02448810|40217956|FG000|Overall Study|Withdrawal by Subject|0|||
16474531|NCT02448810|40217957|FG001|Overall Study|Withdrawal by Subject|0|||
16474532|NCT02448810|40217958|FG002|Overall Study|Withdrawal by Subject|1|||
16474533|NCT02448810|40217959|FG003|Overall Study|Withdrawal by Subject|0|||
16474534|NCT02448810|40217960|FG004|Overall Study|Withdrawal by Subject|3|||
16474535|NCT02448810|40217961|FG005|Overall Study|Withdrawal by Subject|5|||
16474536|NCT02448810|40217962|FG006|Overall Study|Withdrawal by Subject|0|||
16474537|NCT02448810|40217963|FG007|Overall Study|Withdrawal by Subject|2|||
16474538|NCT02448810|40217956|FG000|Overall Study|Other (study terminated by sponsor)|0|||
16474539|NCT02448810|40217957|FG001|Overall Study|Other (study terminated by sponsor)|0|||
16474540|NCT02448810|40217958|FG002|Overall Study|Other (study terminated by sponsor)|0|||
16474541|NCT02448810|40217959|FG003|Overall Study|Other (study terminated by sponsor)|0|||
16474542|NCT02448810|40217960|FG004|Overall Study|Other (study terminated by sponsor)|4|||
16474543|NCT02448810|40217961|FG005|Overall Study|Other (study terminated by sponsor)|2|||
16474544|NCT02448810|40217962|FG006|Overall Study|Other (study terminated by sponsor)|2|||
16474545|NCT02448810|40217963|FG007|Overall Study|Other (study terminated by sponsor)|1|||
16474546|NCT02448810|40217956|FG000|Overall Study|Death|1|||
16474547|NCT02448810|40217957|FG001|Overall Study|Death|0|||
16474548|NCT02448810|40217958|FG002|Overall Study|Death|1|||
16474549|NCT02448810|40217959|FG003|Overall Study|Death|0|||
16474550|NCT02448810|40217960|FG004|Overall Study|Death|1|||
16474551|NCT02448810|40217961|FG005|Overall Study|Death|0|||
16474552|NCT02448810|40217962|FG006|Overall Study|Death|0|||
16474553|NCT02448810|40217963|FG007|Overall Study|Death|0|||
16474554|NCT02448810|40217956|FG000|Overall Study|Other (Progressive disease)|2|||
16474555|NCT02448810|40217957|FG001|Overall Study|Other (Progressive disease)|2|||
16474556|NCT02448810|40217958|FG002|Overall Study|Other (Progressive disease)|0|||
16474557|NCT02448810|40217959|FG003|Overall Study|Other (Progressive disease)|3|||
16474558|NCT02448810|40217960|FG004|Overall Study|Other (Progressive disease)|23|||
16474559|NCT02448810|40217961|FG005|Overall Study|Other (Progressive disease)|9|||
16474560|NCT02448810|40217962|FG006|Overall Study|Other (Progressive disease)|14|||
16474561|NCT02448810|40217963|FG007|Overall Study|Other (Progressive disease)|5|||
16474562|NCT02448810|40217956|FG000|Overall Study|Lost to Follow-up|0|||
16474563|NCT02448810|40217957|FG001|Overall Study|Lost to Follow-up|1|||
16474564|NCT02448810|40217958|FG002|Overall Study|Lost to Follow-up|0|||
16474565|NCT02448810|40217959|FG003|Overall Study|Lost to Follow-up|0|||
16474566|NCT02448810|40217960|FG004|Overall Study|Lost to Follow-up|0|||
16474567|NCT02448810|40217961|FG005|Overall Study|Lost to Follow-up|0|||
16474568|NCT02448810|40217962|FG006|Overall Study|Lost to Follow-up|0|||
16474569|NCT02448810|40217963|FG007|Overall Study|Lost to Follow-up|0|||
16474570|NCT02448810|40217956|FG000|Overall Study|Other (unspecified)|0|||
16474571|NCT02448810|40217957|FG001|Overall Study|Other (unspecified)|0|||
16474572|NCT02448810|40217958|FG002|Overall Study|Other (unspecified)|0|||
16474573|NCT02448810|40217959|FG003|Overall Study|Other (unspecified)|0|||
16474574|NCT02448810|40217960|FG004|Overall Study|Other (unspecified)|0|||
16474575|NCT02448810|40217961|FG005|Overall Study|Other (unspecified)|0|||
16474576|NCT02448810|40217962|FG006|Overall Study|Other (unspecified)|2|||
16474577|NCT02448810|40217963|FG007|Overall Study|Other (unspecified)|0|||
16474578|NCT05095454|40217964|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
16474579|NCT05095454|40217965|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
16474580|NCT01281137|40217966|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
16474581|NCT01281137|40217967|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
16474582|NCT01281137|40217966|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
16474583|NCT01281137|40217967|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
16474584|NCT01281137|40217966|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
16474585|NCT01281137|40217967|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
16474586|NCT01281137|40217966|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
16474587|NCT01281137|40217967|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
16474588|NCT01281137|40217966|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
16474589|NCT01281137|40217967|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
16474590|NCT00973674|40217968|FG000|Overall Study|Protocol Violation|2|||
16474591|NCT00973674|40217969|FG001|Overall Study|Protocol Violation|0|||
16474592|NCT02186873|40217970|FG000|Overall Study|Adverse Event|1|||
16474593|NCT02186873|40217971|FG001|Overall Study|Adverse Event|3|||
16174373|NCT00097539|39119180|FG002|Overall Study|Withdrawal by Subject|346|||
16474594|NCT02186873|40217970|FG000|Overall Study|Lack of Efficacy|0|||
16474595|NCT02186873|40217971|FG001|Overall Study|Lack of Efficacy|1|||
16174374|NCT00097539|39119181|FG003|Overall Study|Withdrawal by Subject|217|||
16474596|NCT02186873|40217970|FG000|Overall Study|Lost to Follow-up|1|||
16474597|NCT02186873|40217971|FG001|Overall Study|Lost to Follow-up|2|||
16474598|NCT02186873|40217970|FG000|Overall Study|Withdrawal by Subject|7|||
16474599|NCT02186873|40217971|FG001|Overall Study|Withdrawal by Subject|2|||
16474600|NCT03039192|40217972|FG000|Overall Study|Lost to Follow-up|4|||
16474601|NCT03039192|40217973|FG001|Overall Study|Lost to Follow-up|4|||
16474602|NCT03039192|40217972|FG000|Overall Study|Adverse event, serious fatal|0|||
16474603|NCT03039192|40217973|FG001|Overall Study|Adverse event, serious fatal|1|||
16474604|NCT03039192|40217972|FG000|Overall Study|Adverse event, non-fatal|0|||
16474605|NCT03039192|40217973|FG001|Overall Study|Adverse event, non-fatal|2|||
16474606|NCT03039192|40217972|FG000|Overall Study|Withdrawal by Subject|6|||
16474607|NCT03039192|40217973|FG001|Overall Study|Withdrawal by Subject|9|||
16474608|NCT03039192|40217972|FG000|Overall Study|Discontinued from treatment phase|19|||
16474609|NCT03039192|40217973|FG001|Overall Study|Discontinued from treatment phase|12|||
16474610|NCT03039192|40217972|FG000|Overall Study|Other|3|||
16474611|NCT03039192|40217973|FG001|Overall Study|Other|2|||
16474612|NCT03906461|40217974|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
16474613|NCT03906461|40217974|FG000|Completed 12-month Follow-up|Missed Visit|6|||
16474614|NCT00936611|40217975|FG000|Overall Study|Progressive Disease|3|||
16474615|NCT00936611|40217975|FG000|Overall Study|New Systemic Therapy|22|||
16474616|NCT00936611|40217975|FG000|Overall Study|Lost to Follow-up|1|||
16474617|NCT00936611|40217975|FG000|Overall Study|Withdrawal by Subject|2|||
16474618|NCT00936611|40217975|FG000|Overall Study|Still on Follow-up|1|||
16474619|NCT00936611|40217975|FG000|Overall Study|Still on Active Therapy|7|||
16474620|NCT00936611|40217975|FG000|Overall Study|Ineligible for Study Drug|3|||
16474621|NCT00764504|40217981|FG000|Overall Study|Death|12|||
16474622|NCT00764504|40217982|FG001|Overall Study|Death|6|||
16474623|NCT00764504|40217983|FG002|Overall Study|Death|13|||
16474624|NCT00764504|40217981|FG000|Overall Study|Revision of Device|12|||
16474625|NCT00764504|40217982|FG001|Overall Study|Revision of Device|23|||
16474626|NCT00764504|40217983|FG002|Overall Study|Revision of Device|14|||
16474627|NCT00764504|40217981|FG000|Overall Study|Physician Decision|1|||
16474628|NCT00764504|40217982|FG001|Overall Study|Physician Decision|0|||
16474629|NCT00764504|40217983|FG002|Overall Study|Physician Decision|0|||
16474630|NCT00764504|40217981|FG000|Overall Study|Withdrawal by Subject|1|||
16474631|NCT00764504|40217982|FG001|Overall Study|Withdrawal by Subject|7|||
16474632|NCT00764504|40217983|FG002|Overall Study|Withdrawal by Subject|4|||
16474633|NCT00764504|40217981|FG000|Overall Study|Lost to Follow-up|40|||
16474634|NCT00764504|40217982|FG001|Overall Study|Lost to Follow-up|34|||
16474635|NCT00764504|40217983|FG002|Overall Study|Lost to Follow-up|72|||
16474636|NCT05064735|40217987|FG000|Overall Study|Withdrawal by Subject|7|||
16474637|NCT05064735|40217988|FG001|Overall Study|Withdrawal by Subject|8|||
16474638|NCT05064735|40217987|FG000|Overall Study|Lost to Follow-up|7|||
16474639|NCT05064735|40217988|FG001|Overall Study|Lost to Follow-up|2|||
16474640|NCT05064735|40217987|FG000|Overall Study|Physician Decision|2|||
16474641|NCT05064735|40217988|FG001|Overall Study|Physician Decision|1|||
16474642|NCT05064735|40217987|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
16474643|NCT05064735|40217988|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
16474644|NCT05064735|40217987|FG000|Overall Study|Site Closure|7|||
16474645|NCT05064735|40217988|FG001|Overall Study|Site Closure|2|||
16474646|NCT00976677|40217989|FG000|Overall Study|Adverse Event|1|||
16474647|NCT00976677|40217990|FG001|Overall Study|Adverse Event|0|||
16474648|NCT00976677|40217989|FG000|Overall Study|Withdrawal by Subject|0|||
16474649|NCT00976677|40217990|FG001|Overall Study|Withdrawal by Subject|2|||
16474650|NCT00976677|40217989|FG000|Overall Study|Disease progression|1|||
16474651|NCT00976677|40217990|FG001|Overall Study|Disease progression|1|||
16474652|NCT00976677|40217989|FG000|Overall Study|Trial unblinded|2|||
16474653|NCT00976677|40217990|FG001|Overall Study|Trial unblinded|2|||
16474654|NCT00976677|40217989|FG000|Overall Study|Unknown/Missing|1|||
16474655|NCT00976677|40217990|FG001|Overall Study|Unknown/Missing|0|||
16474656|NCT01845818|40217991|FG000|Overall Study|Withdrawal by Subject|0|||
16474657|NCT01845818|40217992|FG001|Overall Study|Withdrawal by Subject|1|||
16474658|NCT01845818|40217991|FG000|Overall Study|Lost to Follow-up|7|||
16474659|NCT01845818|40217992|FG001|Overall Study|Lost to Follow-up|5|||
16474660|NCT01845818|40217991|FG000|Overall Study|Administrative Reasons|3|||
16474661|NCT01845818|40217992|FG001|Overall Study|Administrative Reasons|1|||
16474662|NCT01845818|40217991|FG000|Overall Study|Serious Adverse Event|1|||
16474663|NCT01845818|40217992|FG001|Overall Study|Serious Adverse Event|1|||
16474664|NCT01845818|40217991|FG000|Overall Study|Other|25|||
16474665|NCT01845818|40217992|FG001|Overall Study|Other|8|||
16474666|NCT01845818|40217991|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
16474667|NCT01845818|40217992|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
16474668|NCT01845818|40217991|FG000|Overall Study|No Follow-Up Data Available|4|||
16474669|NCT01845818|40217992|FG001|Overall Study|No Follow-Up Data Available|1|||
16075426|NCT01087762|38769714|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
16075427|NCT01087762|38769715|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
16075428|NCT01087762|38769716|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
16075429|NCT01087762|38769712|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
16075430|NCT01087762|38769713|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
16075431|NCT01087762|38769714|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
16075432|NCT01087762|38769715|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
16075433|NCT01087762|38769716|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
16075434|NCT01087762|38769712|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
16075435|NCT01087762|38769713|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
16075436|NCT01087762|38769714|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
16075437|NCT01087762|38769715|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
16075438|NCT01087762|38769716|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
16075439|NCT01087762|38769712|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
16075440|NCT01087762|38769713|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
16075441|NCT01087762|38769714|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
16075442|NCT01087762|38769715|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
16075443|NCT01087762|38769716|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
16075444|NCT01087762|38769712|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
16075445|NCT01087762|38769713|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
16075446|NCT01087762|38769714|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
16075447|NCT01087762|38769715|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
16075448|NCT01087762|38769716|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
16075449|NCT01087762|38769712|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
16075450|NCT01087762|38769713|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
16075451|NCT01087762|38769714|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
16075452|NCT01087762|38769715|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
16474670|NCT01297920|40217993|FG000|Overall Study|Adverse Event|42|||
16474671|NCT01297920|40217994|FG001|Overall Study|Adverse Event|10|||
16474672|NCT01297920|40217995|FG002|Overall Study|Adverse Event|38|||
16474673|NCT01297920|40217993|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
16474674|NCT01297920|40217994|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
16474675|NCT01297920|40217995|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
16075453|NCT01087762|38769716|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
16075454|NCT01087762|38769712|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
16075455|NCT01087762|38769713|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
16075456|NCT01087762|38769714|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
16075457|NCT01087762|38769715|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
16075458|NCT01087762|38769716|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
16075459|NCT01087762|38769712|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
16075460|NCT01087762|38769713|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
16075461|NCT01087762|38769714|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
16075462|NCT01087762|38769715|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
16075463|NCT01087762|38769716|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
16474676|NCT01297920|40217993|FG000|Overall Study|Noncompliance|1|||
16474677|NCT01297920|40217994|FG001|Overall Study|Noncompliance|0|||
16474678|NCT01297920|40217995|FG002|Overall Study|Noncompliance|0|||
16474679|NCT01297920|40217993|FG000|Overall Study|Protocol Violation|1|||
16474680|NCT01297920|40217994|FG001|Overall Study|Protocol Violation|3|||
16474681|NCT01297920|40217995|FG002|Overall Study|Protocol Violation|0|||
16075464|NCT00951379|38769717|FG000|Overall Study|Adverse Event|4|||
16075465|NCT00951379|38769718|FG001|Overall Study|Adverse Event|1|||
16075466|NCT00951379|38769717|FG000|Overall Study|Withdrawal by Subject|1|||
16075467|NCT00951379|38769718|FG001|Overall Study|Withdrawal by Subject|0|||
16174375|NCT00097539|39119182|FG004|Overall Study|Withdrawal by Subject|68|||
16075468|NCT00951379|38769717|FG000|Overall Study|Noncompliance|1|||
16075469|NCT00951379|38769718|FG001|Overall Study|Noncompliance|0|||
16075470|NCT00951379|38769717|FG000|Overall Study|Disease Progression|0|||
16075471|NCT00951379|38769718|FG001|Overall Study|Disease Progression|1|||
16075472|NCT04833855|38769725|FG000|Overall Study|Decision by sponsor|0|||
16075473|NCT04833855|38769726|FG001|Overall Study|Decision by sponsor|1|||
16075474|NCT04833855|38769727|FG002|Overall Study|Decision by sponsor|0|||
16075475|NCT04833855|38769728|FG003|Overall Study|Decision by sponsor|0|||
16075476|NCT04833855|38769725|FG000|Overall Study|Withdrawal by Subject|4|||
16075477|NCT04833855|38769726|FG001|Overall Study|Withdrawal by Subject|1|||
16174376|NCT00097539|39119183|FG005|Overall Study|Withdrawal by Subject|229|||
16474682|NCT01297920|40217993|FG000|Overall Study|Inadequate Control of IOP|7|||
16075478|NCT04833855|38769727|FG002|Overall Study|Withdrawal by Subject|3|||
16075479|NCT04833855|38769728|FG003|Overall Study|Withdrawal by Subject|1|||
16075480|NCT04833855|38769725|FG000|Overall Study|Lost to Follow-up|1|||
16075481|NCT04833855|38769726|FG001|Overall Study|Lost to Follow-up|0|||
16075482|NCT04833855|38769727|FG002|Overall Study|Lost to Follow-up|2|||
16075483|NCT04833855|38769728|FG003|Overall Study|Lost to Follow-up|2|||
16075484|NCT04833855|38769725|FG000|Overall Study|Protocol specified criteria|0|||
16075485|NCT04833855|38769726|FG001|Overall Study|Protocol specified criteria|0|||
16075486|NCT04833855|38769727|FG002|Overall Study|Protocol specified criteria|2|||
16075487|NCT04833855|38769728|FG003|Overall Study|Protocol specified criteria|1|||
16075488|NCT02594735|38769729|FG000|Overall Study|Adverse Event|1|||
16075489|NCT02139943|38769733|FG000|Overall Study|Adverse Event|0|||
16075490|NCT02139943|38769734|FG001|Overall Study|Adverse Event|1|||
16075491|NCT02139943|38769735|FG002|Overall Study|Adverse Event|2|||
16075492|NCT02139943|38769733|FG000|Overall Study|Lost to Follow-up|3|||
16174377|NCT00097539|39119184|FG006|Overall Study|Withdrawal by Subject|3|||
16174378|NCT00097539|39119178|FG000|Overall Study|Participant Non-compliant|2140|||
16174379|NCT00097539|39119179|FG001|Overall Study|Participant Non-compliant|567|||
16174380|NCT00097539|39119180|FG002|Overall Study|Participant Non-compliant|1067|||
16174381|NCT00097539|39119181|FG003|Overall Study|Participant Non-compliant|353|||
16174382|NCT00097539|39119182|FG004|Overall Study|Participant Non-compliant|136|||
16174383|NCT00097539|39119183|FG005|Overall Study|Participant Non-compliant|543|||
16174384|NCT00097539|39119184|FG006|Overall Study|Participant Non-compliant|18|||
16174385|NCT00097539|39119178|FG000|Overall Study|Lack of Efficacy|249|||
16174386|NCT00097539|39119179|FG001|Overall Study|Lack of Efficacy|122|||
16174387|NCT00097539|39119180|FG002|Overall Study|Lack of Efficacy|202|||
16174388|NCT00097539|39119181|FG003|Overall Study|Lack of Efficacy|105|||
16174389|NCT00097539|39119182|FG004|Overall Study|Lack of Efficacy|45|||
16174390|NCT00097539|39119183|FG005|Overall Study|Lack of Efficacy|228|||
16174391|NCT00097539|39119184|FG006|Overall Study|Lack of Efficacy|5|||
16174392|NCT00097539|39119178|FG000|Overall Study|Adverse Event|78|||
16174393|NCT00097539|39119179|FG001|Overall Study|Adverse Event|133|||
16174394|NCT00097539|39119180|FG002|Overall Study|Adverse Event|37|||
16174395|NCT00097539|39119181|FG003|Overall Study|Adverse Event|27|||
16174396|NCT00097539|39119182|FG004|Overall Study|Adverse Event|30|||
16075493|NCT02139943|38769734|FG001|Overall Study|Lost to Follow-up|2|||
16075494|NCT02139943|38769735|FG002|Overall Study|Lost to Follow-up|2|||
16075495|NCT02139943|38769733|FG000|Overall Study|Withdrawal by Subject|4|||
16075496|NCT02139943|38769734|FG001|Overall Study|Withdrawal by Subject|3|||
16075497|NCT02139943|38769735|FG002|Overall Study|Withdrawal by Subject|0|||
16075498|NCT02139943|38769733|FG000|Overall Study|Other|0|||
16075499|NCT02139943|38769734|FG001|Overall Study|Other|0|||
16075500|NCT02139943|38769735|FG002|Overall Study|Other|1|||
16174397|NCT00097539|39119183|FG005|Overall Study|Adverse Event|59|||
16174398|NCT00097539|39119184|FG006|Overall Study|Adverse Event|1|||
16174399|NCT00097539|39119178|FG000|Overall Study|Death|2|||
16174400|NCT00097539|39119179|FG001|Overall Study|Death|7|||
16174401|NCT00097539|39119180|FG002|Overall Study|Death|0|||
16174402|NCT00097539|39119181|FG003|Overall Study|Death|0|||
16174403|NCT00097539|39119182|FG004|Overall Study|Death|1|||
16174404|NCT00097539|39119183|FG005|Overall Study|Death|3|||
16174405|NCT00097539|39119184|FG006|Overall Study|Death|0|||
16174406|NCT00097539|39119178|FG000|Overall Study|Reasons Other Than Above|3602|||
16174407|NCT00097539|39119179|FG001|Overall Study|Reasons Other Than Above|1382|||
16174408|NCT00097539|39119180|FG002|Overall Study|Reasons Other Than Above|1757|||
16174409|NCT00097539|39119181|FG003|Overall Study|Reasons Other Than Above|692|||
16174410|NCT00097539|39119182|FG004|Overall Study|Reasons Other Than Above|361|||
16174411|NCT00097539|39119183|FG005|Overall Study|Reasons Other Than Above|1244|||
16174412|NCT00097539|39119184|FG006|Overall Study|Reasons Other Than Above|34|||
16075501|NCT02139943|38769733|FG000|Overall Study|Participant wishes to discontinue|2|||
16174413|NCT00097539|39119178|FG000|Overall Study|Reason not Specified|111|||
16174414|NCT00097539|39119179|FG001|Overall Study|Reason not Specified|49|||
16174415|NCT00097539|39119180|FG002|Overall Study|Reason not Specified|53|||
16174416|NCT00097539|39119181|FG003|Overall Study|Reason not Specified|21|||
16174417|NCT00097539|39119182|FG004|Overall Study|Reason not Specified|11|||
16174418|NCT00097539|39119183|FG005|Overall Study|Reason not Specified|40|||
16174419|NCT00097539|39119184|FG006|Overall Study|Reason not Specified|2|||
16174420|NCT03019549|39119185|FG000|Washout|DId not meet genotype criteria|11|||
16174421|NCT03019549|39119185|FG000|Period 2|Adverse Event|2|||
16174422|NCT03019549|39119185|FG000|Period 2|Physician Decision|2|||
16174423|NCT03019549|39119185|FG000|Period 2|Withdrawal by Subject|1|||
16174424|NCT00270894|39119186|FG000|Overall Study|Adverse Event|1|||
16174425|NCT00270894|39119186|FG000|Overall Study|Withdrawal by Subject|1|||
16174426|NCT01499290|39119187|FG000|Overall Study|Withdrawal by Subject|22|||
16174427|NCT01499290|39119188|FG001|Overall Study|Withdrawal by Subject|15|||
16075502|NCT02139943|38769734|FG001|Overall Study|Participant wishes to discontinue|0|||
16075503|NCT02139943|38769735|FG002|Overall Study|Participant wishes to discontinue|0|||
16075504|NCT02139943|38769733|FG000|Overall Study|Participant in Poor Compliance|1|||
16375144|NCT00563316|39860060|FG000|Overall Study|Death|1|||
16174428|NCT01499290|39119187|FG000|Overall Study|Not specified in study report|11|||
16174429|NCT01499290|39119188|FG001|Overall Study|Not specified in study report|5|||
16174430|NCT01499290|39119187|FG000|Overall Study|Condition improved/subject recovered|1|||
16174431|NCT01499290|39119188|FG001|Overall Study|Condition improved/subject recovered|0|||
16174432|NCT01499290|39119187|FG000|Overall Study|Lack of Efficacy|7|||
16174433|NCT01499290|39119188|FG001|Overall Study|Lack of Efficacy|8|||
16174434|NCT01499290|39119187|FG000|Overall Study|Adverse Event|14|||
16174435|NCT01499290|39119188|FG001|Overall Study|Adverse Event|7|||
16174436|NCT04317690|39119189|FG000|Overall Study|did not have complete information for primary outcome|0|||
16174437|NCT04317690|39119190|FG001|Overall Study|did not have complete information for primary outcome|4|||
16174438|NCT04317690|39119191|FG002|Overall Study|did not have complete information for primary outcome|0|||
16174439|NCT04317690|39119192|FG003|Overall Study|did not have complete information for primary outcome|2|||
16174440|NCT04317690|39119193|FG004|Overall Study|did not have complete information for primary outcome|0|||
16174441|NCT01974817|39119196|FG000|Overall Study|Death|4|||
16174442|NCT01974817|39119196|FG000|Overall Study|Lost to Follow-up|2|||
16174443|NCT01974817|39119196|FG000|Overall Study|Protocol Violation|2|||
16174444|NCT05292755|39119199|FG000|Overall Study|Lost to Follow-up|5|||
16174445|NCT05292755|39119200|FG001|Overall Study|Lost to Follow-up|9|||
16174446|NCT01137435|39119201|FG000|Overall Study|Lost to Follow-up|24|||
16174447|NCT01137435|39119201|FG000|Overall Study|Off label usage|4|||
16174448|NCT01341457|39119202|FG000|Overall Study|Adverse Event|2|||
16174449|NCT01341457|39119203|FG001|Overall Study|Adverse Event|0|||
16174450|NCT02706938|39119205|FG000|First Period, 6 Weeks|Adverse Event|8|||
16174451|NCT02706938|39119206|FG001|First Period, 6 Weeks|Adverse Event|0|||
16174452|NCT02706938|39119205|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
16174453|NCT02706938|39119206|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
16174454|NCT02706938|39119205|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
16174455|NCT02706938|39119206|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
16174456|NCT02706938|39119205|FG000|Second Period, 6 Weeks|Adverse Event|0|||
16174457|NCT02706938|39119206|FG001|Second Period, 6 Weeks|Adverse Event|7|||
16174458|NCT02706938|39119205|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
16174459|NCT02706938|39119206|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
16174460|NCT00484315|39119215|FG000|12-Month Clinical Follow-up|Death|6|||
16075505|NCT02139943|38769734|FG001|Overall Study|Participant in Poor Compliance|0|||
16075506|NCT02139943|38769735|FG002|Overall Study|Participant in Poor Compliance|1|||
16075507|NCT02139943|38769733|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
16075508|NCT02139943|38769734|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
16075509|NCT02139943|38769735|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
16075510|NCT00716144|38769736|FG000|Overall Study|Withdrawal by Subject|4|||
16075511|NCT00716144|38769737|FG001|Overall Study|Withdrawal by Subject|2|||
16075512|NCT00716144|38769738|FG002|Overall Study|Withdrawal by Subject|6|||
16075513|NCT00716144|38769739|FG003|Overall Study|Withdrawal by Subject|6|||
16075514|NCT00716144|38769736|FG000|Overall Study|Lost to Follow-up|2|||
16075515|NCT00716144|38769737|FG001|Overall Study|Lost to Follow-up|2|||
16075516|NCT00716144|38769738|FG002|Overall Study|Lost to Follow-up|1|||
16075517|NCT00716144|38769739|FG003|Overall Study|Lost to Follow-up|2|||
16075518|NCT00716144|38769736|FG000|Overall Study|Adverse Event|0|||
16075519|NCT00716144|38769737|FG001|Overall Study|Adverse Event|0|||
16075520|NCT00716144|38769738|FG002|Overall Study|Adverse Event|0|||
16075521|NCT00716144|38769739|FG003|Overall Study|Adverse Event|2|||
16075522|NCT00716144|38769736|FG000|Overall Study|Non-compliance|1|||
16075523|NCT00716144|38769737|FG001|Overall Study|Non-compliance|0|||
16075524|NCT00716144|38769738|FG002|Overall Study|Non-compliance|0|||
16075525|NCT00716144|38769739|FG003|Overall Study|Non-compliance|0|||
16075526|NCT00716144|38769736|FG000|Overall Study|Protocol Violation|2|||
16075527|NCT00716144|38769737|FG001|Overall Study|Protocol Violation|0|||
16075528|NCT00716144|38769738|FG002|Overall Study|Protocol Violation|1|||
16075529|NCT00716144|38769739|FG003|Overall Study|Protocol Violation|0|||
16075530|NCT00716144|38769736|FG000|Overall Study|Physician Decision|0|||
16075531|NCT00716144|38769737|FG001|Overall Study|Physician Decision|1|||
16075532|NCT00716144|38769738|FG002|Overall Study|Physician Decision|2|||
16075533|NCT00716144|38769739|FG003|Overall Study|Physician Decision|2|||
16075534|NCT00716144|38769736|FG000|Overall Study|Intercurrent illness|0|||
16075535|NCT00716144|38769737|FG001|Overall Study|Intercurrent illness|0|||
16075536|NCT00716144|38769738|FG002|Overall Study|Intercurrent illness|1|||
16075537|NCT00716144|38769739|FG003|Overall Study|Intercurrent illness|0|||
16075538|NCT00716144|38769736|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
16075539|NCT00716144|38769737|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
16075540|NCT00716144|38769738|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
16174461|NCT00484315|39119216|FG001|12-Month Clinical Follow-up|Death|2|||
16075541|NCT00716144|38769739|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
16075542|NCT00716144|38769736|FG000|Overall Study|Adverse event: left foot pain|0|||
16075543|NCT00716144|38769737|FG001|Overall Study|Adverse event: left foot pain|1|||
16075544|NCT00716144|38769738|FG002|Overall Study|Adverse event: left foot pain|0|||
16075545|NCT00716144|38769739|FG003|Overall Study|Adverse event: left foot pain|0|||
16075546|NCT00716144|38769736|FG000|Overall Study|Clinical Depression|0|||
16075547|NCT00716144|38769737|FG001|Overall Study|Clinical Depression|1|||
16075548|NCT00716144|38769738|FG002|Overall Study|Clinical Depression|0|||
16075549|NCT00716144|38769739|FG003|Overall Study|Clinical Depression|0|||
16075550|NCT02754479|38769764|FG000|Overall Study|Lost to Follow-up|1|||
16075551|NCT02471755|38769767|FG000|Overall Study|Withdrawal by Subject|1|||
16075552|NCT02471755|38769768|FG001|Overall Study|Withdrawal by Subject|0|||
16075553|NCT02471755|38769767|FG000|Overall Study|Lost to Follow-up|0|||
16075554|NCT02471755|38769768|FG001|Overall Study|Lost to Follow-up|1|||
16075555|NCT04424641|38769776|FG000|Overall Study|Death|1|||
16075556|NCT04424641|38769777|FG001|Overall Study|Death|2|||
16075557|NCT04424641|38769778|FG002|Overall Study|Death|3|||
16174462|NCT00484315|39119215|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
16174463|NCT00484315|39119216|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
16174464|NCT00484315|39119215|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
16174465|NCT00484315|39119216|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
16174466|NCT00484315|39119215|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
16174467|NCT00484315|39119216|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
16075558|NCT04424641|38769779|FG003|Overall Study|Death|0|||
16174468|NCT00484315|39119215|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
16174469|NCT00484315|39119216|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
16174470|NCT00484315|39119215|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
16174471|NCT00484315|39119216|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
16174472|NCT00484315|39119215|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
16174473|NCT00484315|39119216|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
16174474|NCT03596164|39119217|FG000|Overall Study|Adverse Event|0|||
16174475|NCT03596164|39119218|FG001|Overall Study|Adverse Event|1|||
16174476|NCT03596164|39119217|FG000|Overall Study|Death|1|||
16174477|NCT03596164|39119218|FG001|Overall Study|Death|0|||
16174478|NCT01624194|39119219|FG000|Overall Study|Lost to Follow-up|1|||
16174479|NCT01624194|39119220|FG001|Overall Study|Lost to Follow-up|0|||
16174480|NCT01624194|39119219|FG000|Overall Study|Withdrawal by Subject|1|||
16174481|NCT01624194|39119220|FG001|Overall Study|Withdrawal by Subject|0|||
16174482|NCT02612909|39119221|FG000|Phase 2|Withdrawal by Subject|2|||
16174483|NCT02612909|39119222|FG001|Phase 2|Withdrawal by Subject|5|||
16075559|NCT04424641|38769780|FG004|Overall Study|Death|3|||
16075560|NCT04424641|38769781|FG005|Overall Study|Death|0|||
16075561|NCT04424641|38769782|FG006|Overall Study|Death|1|||
16075562|NCT04424641|38769783|FG007|Overall Study|Death|2|||
16075563|NCT04424641|38769776|FG000|Overall Study|Sponsor decision|0|||
16075564|NCT04424641|38769777|FG001|Overall Study|Sponsor decision|2|||
16075565|NCT04424641|38769778|FG002|Overall Study|Sponsor decision|3|||
16075566|NCT04424641|38769779|FG003|Overall Study|Sponsor decision|7|||
16075567|NCT04424641|38769780|FG004|Overall Study|Sponsor decision|2|||
16075568|NCT04424641|38769781|FG005|Overall Study|Sponsor decision|2|||
16075569|NCT04424641|38769782|FG006|Overall Study|Sponsor decision|3|||
16075570|NCT04424641|38769783|FG007|Overall Study|Sponsor decision|4|||
16075571|NCT04424641|38769776|FG000|Overall Study|Withdrawal by Subject|0|||
16075572|NCT04424641|38769777|FG001|Overall Study|Withdrawal by Subject|0|||
16075573|NCT04424641|38769778|FG002|Overall Study|Withdrawal by Subject|0|||
16075574|NCT04424641|38769779|FG003|Overall Study|Withdrawal by Subject|0|||
16075575|NCT04424641|38769780|FG004|Overall Study|Withdrawal by Subject|1|||
16075576|NCT04424641|38769781|FG005|Overall Study|Withdrawal by Subject|0|||
16075577|NCT04424641|38769782|FG006|Overall Study|Withdrawal by Subject|0|||
16075578|NCT04424641|38769783|FG007|Overall Study|Withdrawal by Subject|0|||
16075579|NCT04424641|38769776|FG000|Overall Study|Other|0|||
16075580|NCT04424641|38769777|FG001|Overall Study|Other|0|||
16075581|NCT04424641|38769778|FG002|Overall Study|Other|1|||
16075582|NCT04424641|38769779|FG003|Overall Study|Other|0|||
16075583|NCT04424641|38769780|FG004|Overall Study|Other|0|||
16075584|NCT04424641|38769781|FG005|Overall Study|Other|0|||
16075585|NCT04424641|38769782|FG006|Overall Study|Other|0|||
16075586|NCT04424641|38769783|FG007|Overall Study|Other|0|||
16075587|NCT02957539|38769784|FG000|Baseline to Week 16|Lost to Follow-up|8|||
16075588|NCT02957539|38769785|FG001|Baseline to Week 16|Lost to Follow-up|10|||
16075589|NCT02957539|38769786|FG002|Baseline to Week 16|Lost to Follow-up|16|||
16075590|NCT02957539|38769784|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
16075591|NCT02957539|38769785|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
16075592|NCT02957539|38769786|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
16174484|NCT02612909|39119223|FG002|Phase 2|Withdrawal by Subject|0|||
16174485|NCT02612909|39119224|FG003|Phase 2|Withdrawal by Subject|0|||
16174486|NCT02612909|39119225|FG004|Phase 2|Withdrawal by Subject|0|||
16174487|NCT02612909|39119221|FG000|Phase 2|Pregnancy|0|||
16174488|NCT02612909|39119222|FG001|Phase 2|Pregnancy|0|||
16075593|NCT02957539|38769784|FG000|Week 16 to 32|Withdrawal by Subject|3|||
16075594|NCT02957539|38769785|FG001|Week 16 to 32|Withdrawal by Subject|3|||
16075595|NCT02957539|38769786|FG002|Week 16 to 32|Withdrawal by Subject|1|||
16174489|NCT02612909|39119223|FG002|Phase 2|Pregnancy|1|||
16174490|NCT02612909|39119224|FG003|Phase 2|Pregnancy|0|||
16174491|NCT02612909|39119225|FG004|Phase 2|Pregnancy|0|||
16174492|NCT02612909|39119221|FG000|Phase 3|Withdrawal by Subject|0|||
16174493|NCT02612909|39119222|FG001|Phase 3|Withdrawal by Subject|0|||
16174494|NCT02612909|39119223|FG002|Phase 3|Withdrawal by Subject|0|||
16075596|NCT02957539|38769784|FG000|Week 16 to 32|Lost to Follow-up|8|||
16075597|NCT02957539|38769785|FG001|Week 16 to 32|Lost to Follow-up|7|||
16075598|NCT02957539|38769786|FG002|Week 16 to 32|Lost to Follow-up|5|||
16075599|NCT02957539|38769784|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
16075600|NCT02957539|38769785|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
16075601|NCT02957539|38769786|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
16075602|NCT02957539|38769784|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
16075603|NCT02957539|38769785|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
16075604|NCT02957539|38769786|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
16174495|NCT02612909|39119224|FG003|Phase 3|Withdrawal by Subject|1|||
16174496|NCT02612909|39119225|FG004|Phase 3|Withdrawal by Subject|0|||
16174497|NCT00466505|39119226|FG000|Overall Study|disease progression|13|||
16174498|NCT00466505|39119226|FG000|Overall Study|Adverse Event|4|||
16174499|NCT00917384|39119227|FG000|Overall Study|Lost to Follow-up|4|||
16174500|NCT00917384|39119228|FG001|Overall Study|Lost to Follow-up|2|||
16174501|NCT00917384|39119227|FG000|Overall Study|Withdrawal by Subject|10|||
16174502|NCT00917384|39119228|FG001|Overall Study|Withdrawal by Subject|2|||
16174503|NCT01028352|39119233|FG000|Overall Study|Ineligible due to baseline average pain|5|||
16174504|NCT01028352|39119233|FG000|Overall Study|Withdrawal by Subject|1|||
16075605|NCT04033432|38769787|FG000|Overall Study|Progressive Disease|8|||
16075606|NCT04033432|38769787|FG000|Overall Study|Adverse Event|4|||
16075607|NCT04033432|38769787|FG000|Overall Study|Death|1|||
16075608|NCT02341625|38769788|FG000|Overall Study|Disease Progression|2|||
16075609|NCT02341625|38769789|FG001|Overall Study|Disease Progression|2|||
16075610|NCT02341625|38769790|FG002|Overall Study|Disease Progression|3|||
16075611|NCT02341625|38769791|FG003|Overall Study|Disease Progression|6|||
16075612|NCT02341625|38769792|FG004|Overall Study|Disease Progression|7|||
16075613|NCT02341625|38769793|FG005|Overall Study|Disease Progression|7|||
16075614|NCT02341625|38769794|FG006|Overall Study|Disease Progression|28|||
16075615|NCT02341625|38769795|FG007|Overall Study|Disease Progression|5|||
16075616|NCT02341625|38769796|FG008|Overall Study|Disease Progression|4|||
16075617|NCT02341625|38769797|FG009|Overall Study|Disease Progression|19|||
16075618|NCT02341625|38769788|FG000|Overall Study|Study Drug Toxicity|0|||
16075619|NCT02341625|38769789|FG001|Overall Study|Study Drug Toxicity|0|||
16075620|NCT02341625|38769790|FG002|Overall Study|Study Drug Toxicity|0|||
16075621|NCT02341625|38769791|FG003|Overall Study|Study Drug Toxicity|1|||
16075622|NCT02341625|38769792|FG004|Overall Study|Study Drug Toxicity|0|||
16075623|NCT02341625|38769793|FG005|Overall Study|Study Drug Toxicity|3|||
16075624|NCT02341625|38769794|FG006|Overall Study|Study Drug Toxicity|10|||
16075625|NCT02341625|38769795|FG007|Overall Study|Study Drug Toxicity|0|||
16075626|NCT02341625|38769796|FG008|Overall Study|Study Drug Toxicity|0|||
16075627|NCT02341625|38769797|FG009|Overall Study|Study Drug Toxicity|3|||
16075628|NCT02341625|38769788|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16075629|NCT02341625|38769789|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16075630|NCT02341625|38769790|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16075631|NCT02341625|38769791|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16075632|NCT02341625|38769792|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16075633|NCT02341625|38769793|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16075634|NCT02341625|38769794|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
16075635|NCT02341625|38769795|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
16075636|NCT02341625|38769796|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16075637|NCT02341625|38769797|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
16075638|NCT02341625|38769788|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16075639|NCT02341625|38769789|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16075640|NCT02341625|38769790|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16075641|NCT02341625|38769791|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16075642|NCT02341625|38769792|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16075643|NCT02341625|38769793|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16075644|NCT02341625|38769794|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
16075645|NCT02341625|38769795|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
16075646|NCT02341625|38769796|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16075647|NCT02341625|38769797|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
16075648|NCT02341625|38769788|FG000|Overall Study|Participant Withdrew Consent|0|||
16075649|NCT02341625|38769789|FG001|Overall Study|Participant Withdrew Consent|0|||
16174505|NCT02318095|39119234|FG000|Overall Study|Adverse Event|1|||
16174506|NCT00847613|39119235|FG000|Overall Study|Ongoing at cut-off date|250|||
16174507|NCT00847613|39119236|FG001|Overall Study|Ongoing at cut-off date|265|||
16174508|NCT00847613|39119237|FG002|Overall Study|Ongoing at cut-off date|64|||
16174509|NCT00847613|39119238|FG003|Overall Study|Ongoing at cut-off date|64|||
16174510|NCT00847613|39119235|FG000|Overall Study|Death|1|||
16174511|NCT00847613|39119236|FG001|Overall Study|Death|1|||
16174512|NCT00847613|39119237|FG002|Overall Study|Death|0|||
16174513|NCT00847613|39119238|FG003|Overall Study|Death|0|||
16174514|NCT00847613|39119235|FG000|Overall Study|Adverse Event|36|||
16174515|NCT00847613|39119236|FG001|Overall Study|Adverse Event|26|||
16174516|NCT00847613|39119237|FG002|Overall Study|Adverse Event|5|||
16174517|NCT00847613|39119238|FG003|Overall Study|Adverse Event|6|||
16075650|NCT02341625|38769790|FG002|Overall Study|Participant Withdrew Consent|0|||
16174518|NCT00847613|39119235|FG000|Overall Study|Lack of Efficacy|7|||
16174519|NCT00847613|39119236|FG001|Overall Study|Lack of Efficacy|3|||
16174520|NCT00847613|39119237|FG002|Overall Study|Lack of Efficacy|3|||
16174521|NCT00847613|39119238|FG003|Overall Study|Lack of Efficacy|1|||
16174522|NCT00847613|39119235|FG000|Overall Study|Study terminated by Sponsor|1|||
16174523|NCT00847613|39119236|FG001|Overall Study|Study terminated by Sponsor|0|||
16174524|NCT00847613|39119237|FG002|Overall Study|Study terminated by Sponsor|2|||
16174525|NCT00847613|39119238|FG003|Overall Study|Study terminated by Sponsor|1|||
16174526|NCT00847613|39119235|FG000|Overall Study|Lost to Follow-up|5|||
16075651|NCT02341625|38769791|FG003|Overall Study|Participant Withdrew Consent|1|||
16075652|NCT02341625|38769792|FG004|Overall Study|Participant Withdrew Consent|0|||
16075653|NCT02341625|38769793|FG005|Overall Study|Participant Withdrew Consent|0|||
16075654|NCT02341625|38769794|FG006|Overall Study|Participant Withdrew Consent|0|||
16075655|NCT02341625|38769795|FG007|Overall Study|Participant Withdrew Consent|0|||
16075656|NCT02341625|38769796|FG008|Overall Study|Participant Withdrew Consent|0|||
16075657|NCT02341625|38769797|FG009|Overall Study|Participant Withdrew Consent|0|||
16075658|NCT02341625|38769788|FG000|Overall Study|Completed Treatment as per Protocol|0|||
16075659|NCT02341625|38769789|FG001|Overall Study|Completed Treatment as per Protocol|0|||
16075660|NCT02341625|38769790|FG002|Overall Study|Completed Treatment as per Protocol|0|||
16075661|NCT02341625|38769791|FG003|Overall Study|Completed Treatment as per Protocol|0|||
16075662|NCT02341625|38769792|FG004|Overall Study|Completed Treatment as per Protocol|0|||
16075663|NCT02341625|38769793|FG005|Overall Study|Completed Treatment as per Protocol|0|||
16075664|NCT02341625|38769794|FG006|Overall Study|Completed Treatment as per Protocol|0|||
16075665|NCT02341625|38769795|FG007|Overall Study|Completed Treatment as per Protocol|0|||
16075666|NCT02341625|38769796|FG008|Overall Study|Completed Treatment as per Protocol|0|||
16075667|NCT02341625|38769797|FG009|Overall Study|Completed Treatment as per Protocol|1|||
16075668|NCT02341625|38769788|FG000|Overall Study|Other Reasons|0|||
16075669|NCT02341625|38769789|FG001|Overall Study|Other Reasons|0|||
16075670|NCT02341625|38769790|FG002|Overall Study|Other Reasons|0|||
16075671|NCT02341625|38769791|FG003|Overall Study|Other Reasons|0|||
16075672|NCT02341625|38769792|FG004|Overall Study|Other Reasons|1|||
16075673|NCT02341625|38769793|FG005|Overall Study|Other Reasons|0|||
16075674|NCT02341625|38769794|FG006|Overall Study|Other Reasons|5|||
16075675|NCT02341625|38769795|FG007|Overall Study|Other Reasons|0|||
16075676|NCT02341625|38769796|FG008|Overall Study|Other Reasons|0|||
16075677|NCT02341625|38769797|FG009|Overall Study|Other Reasons|2|||
16075678|NCT02341625|38769788|FG000|Overall Study|Not Reported|0|||
16075679|NCT02341625|38769789|FG001|Overall Study|Not Reported|0|||
16075680|NCT02341625|38769790|FG002|Overall Study|Not Reported|0|||
16075681|NCT02341625|38769791|FG003|Overall Study|Not Reported|0|||
16075682|NCT02341625|38769792|FG004|Overall Study|Not Reported|0|||
16075683|NCT02341625|38769793|FG005|Overall Study|Not Reported|0|||
16075684|NCT02341625|38769794|FG006|Overall Study|Not Reported|0|||
16075685|NCT02341625|38769795|FG007|Overall Study|Not Reported|0|||
16075686|NCT02341625|38769796|FG008|Overall Study|Not Reported|0|||
16075687|NCT02341625|38769797|FG009|Overall Study|Not Reported|3|||
16075688|NCT00396084|38769801|FG000|Overall Study|Adverse Event|0|||
16075689|NCT00396084|38769802|FG001|Overall Study|Adverse Event|0|||
16075690|NCT00396084|38769803|FG002|Overall Study|Adverse Event|0|||
16075691|NCT00396084|38769804|FG003|Overall Study|Adverse Event|0|||
16075692|NCT00396084|38769805|FG004|Overall Study|Adverse Event|1|||
16075693|NCT00396084|38769806|FG005|Overall Study|Adverse Event|2|||
16075694|NCT00396084|38769801|FG000|Overall Study|Withdrawal by Subject|0|||
16075695|NCT00396084|38769802|FG001|Overall Study|Withdrawal by Subject|0|||
16075696|NCT00396084|38769803|FG002|Overall Study|Withdrawal by Subject|0|||
16075697|NCT00396084|38769804|FG003|Overall Study|Withdrawal by Subject|1|||
16075698|NCT00396084|38769805|FG004|Overall Study|Withdrawal by Subject|0|||
16075699|NCT00396084|38769806|FG005|Overall Study|Withdrawal by Subject|0|||
16075700|NCT00101010|38769809|FG000|Overall Study|Physician Decision|1|||
16075701|NCT00102063|38769810|FG000|Overall Study|Lack of Efficacy|5|||
16075702|NCT00102063|38769811|FG001|Overall Study|Lack of Efficacy|1|||
16075703|NCT00102063|38769812|FG002|Overall Study|Lack of Efficacy|1|||
16174527|NCT00847613|39119236|FG001|Overall Study|Lost to Follow-up|0|||
16174528|NCT00847613|39119237|FG002|Overall Study|Lost to Follow-up|0|||
16075704|NCT00102063|38769810|FG000|Overall Study|Adverse Event|7|||
16174529|NCT00847613|39119238|FG003|Overall Study|Lost to Follow-up|3|||
16174530|NCT00847613|39119235|FG000|Overall Study|Protocol Violation|6|||
16174531|NCT00847613|39119236|FG001|Overall Study|Protocol Violation|6|||
16174532|NCT00847613|39119237|FG002|Overall Study|Protocol Violation|3|||
16075705|NCT00102063|38769811|FG001|Overall Study|Adverse Event|4|||
16075706|NCT00102063|38769812|FG002|Overall Study|Adverse Event|2|||
16075707|NCT00102063|38769810|FG000|Overall Study|Withdrawal by Subject|4|||
16075708|NCT00102063|38769811|FG001|Overall Study|Withdrawal by Subject|12|||
16075709|NCT00102063|38769812|FG002|Overall Study|Withdrawal by Subject|5|||
16075710|NCT00102063|38769810|FG000|Overall Study|Lost to Follow-up|0|||
16075711|NCT00102063|38769811|FG001|Overall Study|Lost to Follow-up|0|||
16075712|NCT00102063|38769812|FG002|Overall Study|Lost to Follow-up|1|||
16075713|NCT00102063|38769810|FG000|Overall Study|Protocol Violation|0|||
16075714|NCT00102063|38769811|FG001|Overall Study|Protocol Violation|1|||
16075715|NCT00102063|38769812|FG002|Overall Study|Protocol Violation|1|||
16075716|NCT02506257|38769813|FG000|Overall Study|Adverse Event|0|||
16075717|NCT02506257|38769814|FG001|Overall Study|Adverse Event|2|||
16075718|NCT02506257|38769815|FG002|Overall Study|Adverse Event|3|||
16075719|NCT02506257|38769816|FG003|Overall Study|Adverse Event|0|||
16075720|NCT02506257|38769813|FG000|Overall Study|Protocol Violation|0|||
16075721|NCT02506257|38769814|FG001|Overall Study|Protocol Violation|0|||
16075722|NCT02506257|38769815|FG002|Overall Study|Protocol Violation|1|||
16075723|NCT02506257|38769816|FG003|Overall Study|Protocol Violation|0|||
16075724|NCT00516386|38769820|FG000|Overall Study|not interested in the study|4|||
16075725|NCT00516386|38769820|FG000|Overall Study|Lost to Follow-up|2|||
16075726|NCT02810080|38769821|FG000|Overall Study|Adverse Event|3|||
16075727|NCT02810080|38769822|FG001|Overall Study|Adverse Event|0|||
16075728|NCT02810080|38769821|FG000|Overall Study|Death|0|||
16075729|NCT02810080|38769822|FG001|Overall Study|Death|2|||
16075730|NCT02810080|38769821|FG000|Overall Study|Physician Decision|4|||
16075731|NCT02810080|38769822|FG001|Overall Study|Physician Decision|0|||
16075732|NCT02810080|38769821|FG000|Overall Study|Withdrawal by Subject|0|||
16075733|NCT02810080|38769822|FG001|Overall Study|Withdrawal by Subject|2|||
16075734|NCT00918957|38769823|FG000|Overall Study|Adverse Event|2|||
16075735|NCT00918957|38769824|FG001|Overall Study|Adverse Event|0|||
16075736|NCT00918957|38769823|FG000|Overall Study|Withdrawal by Subject|1|||
16075737|NCT00918957|38769824|FG001|Overall Study|Withdrawal by Subject|0|||
16075738|NCT00114244|38769826|FG000|Overall Study|Adverse Event|2|||
16075739|NCT00114244|38769827|FG001|Overall Study|Adverse Event|5|||
16075740|NCT00114244|38769826|FG000|Overall Study|Withdrawal by Subject|0|||
16075741|NCT00114244|38769827|FG001|Overall Study|Withdrawal by Subject|2|||
16075742|NCT00703911|38769830|FG000|Overall Study|Death|1|||
16075743|NCT00703911|38769830|FG000|Overall Study|Physician Decision|6|||
16075744|NCT00703911|38769830|FG000|Overall Study|Lost to Follow-up|1|||
16075745|NCT00703911|38769830|FG000|Overall Study|Withdrawal by Subject|2|||
16075746|NCT03593213|38769831|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
16075747|NCT03593213|38769832|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
16075748|NCT03593213|38769833|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
16075749|NCT03593213|38769834|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
16075750|NCT03593213|38769831|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
16075751|NCT03593213|38769832|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
16075752|NCT03593213|38769833|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
16075753|NCT03593213|38769834|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
16075754|NCT03593213|38769831|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
16075755|NCT03593213|38769832|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
16075756|NCT03593213|38769833|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
16075757|NCT03593213|38769834|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
16075758|NCT03593213|38769831|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
16075759|NCT03593213|38769832|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
16075760|NCT03593213|38769833|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
16075761|NCT03593213|38769834|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
16075762|NCT03593213|38769831|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
16075763|NCT03593213|38769832|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
16174533|NCT00847613|39119238|FG003|Overall Study|Protocol Violation|1|||
16174534|NCT00847613|39119235|FG000|Overall Study|Pregnancy|1|||
16174535|NCT00847613|39119236|FG001|Overall Study|Pregnancy|1|||
16174536|NCT00847613|39119237|FG002|Overall Study|Pregnancy|0|||
16174537|NCT00847613|39119238|FG003|Overall Study|Pregnancy|0|||
16075764|NCT03593213|38769833|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
16174538|NCT00847613|39119235|FG000|Overall Study|Site closure|1|||
16174539|NCT00847613|39119236|FG001|Overall Study|Site closure|0|||
16274832|NCT03255980|39490189|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
16274833|NCT03255980|39490190|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
16274834|NCT03255980|39490187|FG000|Overall Study|Adverse Event|1|||
16274835|NCT03255980|39490188|FG001|Overall Study|Adverse Event|1|||
16274836|NCT03255980|39490189|FG002|Overall Study|Adverse Event|0|||
16174540|NCT00847613|39119237|FG002|Overall Study|Site closure|0|||
16274837|NCT03255980|39490190|FG003|Overall Study|Adverse Event|1|||
16274838|NCT03255980|39490187|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
16274839|NCT03255980|39490188|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
16174541|NCT00847613|39119238|FG003|Overall Study|Site closure|1|||
16174542|NCT00847613|39119235|FG000|Overall Study|Withdrawal by Subject|8|||
16174543|NCT00847613|39119236|FG001|Overall Study|Withdrawal by Subject|11|||
16174544|NCT00847613|39119237|FG002|Overall Study|Withdrawal by Subject|2|||
16174545|NCT00847613|39119238|FG003|Overall Study|Withdrawal by Subject|2|||
16174546|NCT00847613|39119235|FG000|Overall Study|Participant moved|4|||
16174547|NCT00847613|39119236|FG001|Overall Study|Participant moved|1|||
16274840|NCT03255980|39490189|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
16274841|NCT03255980|39490190|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
16274842|NCT03255980|39490187|FG000|Overall Study|Lost to Follow-up|1|||
16075765|NCT03593213|38769834|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
16174548|NCT00847613|39119237|FG002|Overall Study|Participant moved|0|||
16174549|NCT00847613|39119238|FG003|Overall Study|Participant moved|0|||
16174550|NCT00847613|39119235|FG000|Overall Study|Sponsor request|0|||
16174551|NCT00847613|39119236|FG001|Overall Study|Sponsor request|1|||
16174552|NCT00847613|39119237|FG002|Overall Study|Sponsor request|0|||
16174553|NCT00847613|39119238|FG003|Overall Study|Sponsor request|0|||
16174554|NCT00847613|39119235|FG000|Overall Study|Randomized, but not treated|0|||
16174555|NCT00847613|39119236|FG001|Overall Study|Randomized, but not treated|3|||
16174556|NCT00847613|39119237|FG002|Overall Study|Randomized, but not treated|0|||
16174557|NCT00847613|39119238|FG003|Overall Study|Randomized, but not treated|0|||
16174558|NCT00847613|39119235|FG000|Overall Study|Other|1|||
16174559|NCT00847613|39119236|FG001|Overall Study|Other|1|||
16174560|NCT00847613|39119237|FG002|Overall Study|Other|2|||
16174561|NCT00847613|39119238|FG003|Overall Study|Other|0|||
16174562|NCT00942409|39119239|FG000|Overall Study|Lack of Efficacy|1|||
16174563|NCT00942409|39119239|FG000|Overall Study|study drug unavailable|2|||
16174564|NCT01355289|39119240|FG000|Core Study|Adverse Event, Non-Fatal|1|||
16174565|NCT01355289|39119241|FG001|Core Study|Adverse Event, Non-Fatal|0|||
16174566|NCT01355289|39119242|FG002|Core Study|Adverse Event, Non-Fatal|0|||
16174567|NCT01355289|39119243|FG003|Core Study|Adverse Event, Non-Fatal|0|||
16174568|NCT01355289|39119244|FG004|Core Study|Adverse Event, Non-Fatal|0|||
16174569|NCT01355289|39119240|FG000|Core Study|Inadequate Therapeutic Effect|0|||
16174570|NCT01355289|39119241|FG001|Core Study|Inadequate Therapeutic Effect|0|||
16174571|NCT01355289|39119242|FG002|Core Study|Inadequate Therapeutic Effect|0|||
16174572|NCT01355289|39119243|FG003|Core Study|Inadequate Therapeutic Effect|1|||
16075766|NCT03593213|38769831|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
16075767|NCT03593213|38769832|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
16075768|NCT03593213|38769833|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
16075769|NCT03593213|38769834|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
16174573|NCT01355289|39119244|FG004|Core Study|Inadequate Therapeutic Effect|0|||
16174574|NCT01355289|39119240|FG000|Core Study|Other|0|||
16174575|NCT01355289|39119241|FG001|Core Study|Other|0|||
16174576|NCT01355289|39119242|FG002|Core Study|Other|0|||
16075770|NCT03593213|38769831|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
16075771|NCT03593213|38769832|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
16075772|NCT03593213|38769833|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
16075773|NCT03593213|38769834|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
16075774|NCT03593213|38769831|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
16075775|NCT03593213|38769832|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
16174577|NCT01355289|39119243|FG003|Core Study|Other|1|||
16075776|NCT03593213|38769833|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
16075777|NCT03593213|38769834|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
16075778|NCT03593213|38769831|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
16075779|NCT03593213|38769832|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
16075780|NCT03593213|38769833|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
16075781|NCT03593213|38769834|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
16075782|NCT03593213|38769831|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
16075783|NCT03593213|38769832|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
16075784|NCT03593213|38769833|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
16075785|NCT03593213|38769834|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
16174578|NCT01355289|39119244|FG004|Core Study|Other|0|||
16174579|NCT01355289|39119240|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
16174580|NCT01355289|39119241|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
16174581|NCT01355289|39119242|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
16174582|NCT01355289|39119243|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
16174583|NCT01355289|39119244|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
16174584|NCT01355289|39119240|FG000|Open Label Extension|Lost to Follow-up|0|||
16174585|NCT01355289|39119241|FG001|Open Label Extension|Lost to Follow-up|0|||
16174586|NCT01355289|39119242|FG002|Open Label Extension|Lost to Follow-up|0|||
16174587|NCT01355289|39119243|FG003|Open Label Extension|Lost to Follow-up|0|||
16274843|NCT03255980|39490188|FG001|Overall Study|Lost to Follow-up|1|||
16075786|NCT03593213|38769831|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
16075787|NCT03593213|38769832|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
16075788|NCT03593213|38769833|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
16075789|NCT03593213|38769834|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
16075790|NCT03593213|38769831|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
16075791|NCT03593213|38769832|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
16075792|NCT03593213|38769833|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
16075793|NCT03593213|38769834|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
16075794|NCT03593213|38769831|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
16075795|NCT03593213|38769832|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
16075796|NCT03593213|38769833|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
16075797|NCT03593213|38769834|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
16075798|NCT03593213|38769831|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
16075799|NCT03593213|38769832|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
16075800|NCT03593213|38769833|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
16075801|NCT03593213|38769834|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
16075802|NCT03593213|38769831|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
16075803|NCT03593213|38769832|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
16075804|NCT03593213|38769833|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
16075805|NCT03593213|38769834|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
16075806|NCT03593213|38769831|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
16075807|NCT03593213|38769832|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
16075808|NCT03593213|38769833|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
16075809|NCT03593213|38769834|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
16075810|NCT03593213|38769831|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
16075811|NCT03593213|38769832|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
16075812|NCT03593213|38769833|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
16075813|NCT03593213|38769834|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
16075814|NCT03593213|38769831|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
16075815|NCT03593213|38769832|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
16075816|NCT03593213|38769833|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
16075817|NCT03593213|38769834|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
16075818|NCT03593213|38769831|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
16075819|NCT03593213|38769832|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
16075820|NCT03593213|38769833|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
16075821|NCT03593213|38769834|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
16075822|NCT00390299|38769835|FG000|Overall Study|Cancellation|1|||
16075823|NCT00390299|38769836|FG001|Overall Study|Cancellation|0|||
16075824|NCT00390299|38769837|FG002|Overall Study|Cancellation|0|||
16075825|NCT00390299|38769838|FG003|Overall Study|Cancellation|0|||
16075826|NCT00390299|38769839|FG004|Overall Study|Cancellation|0|||
16075827|NCT01135511|38769842|FG000|Overall Study|Adverse Event|0|||
16075828|NCT01135511|38769843|FG001|Overall Study|Adverse Event|1|||
16075829|NCT01135511|38769844|FG002|Overall Study|Adverse Event|2|||
16075830|NCT01135511|38769845|FG003|Overall Study|Adverse Event|0|||
16075831|NCT01135511|38769846|FG004|Overall Study|Adverse Event|0|||
16075832|NCT01135511|38769847|FG005|Overall Study|Adverse Event|1|||
16075833|NCT01135511|38769848|FG006|Overall Study|Adverse Event|0|||
16075834|NCT01135511|38769849|FG007|Overall Study|Adverse Event|1|||
16075835|NCT01135511|38769850|FG008|Overall Study|Adverse Event|0|||
16075836|NCT01135511|38769842|FG000|Overall Study|Lack of Efficacy|0|||
16075837|NCT01135511|38769843|FG001|Overall Study|Lack of Efficacy|1|||
16075838|NCT01135511|38769844|FG002|Overall Study|Lack of Efficacy|1|||
16075839|NCT01135511|38769845|FG003|Overall Study|Lack of Efficacy|2|||
16075840|NCT01135511|38769846|FG004|Overall Study|Lack of Efficacy|0|||
16075841|NCT01135511|38769847|FG005|Overall Study|Lack of Efficacy|0|||
16075842|NCT01135511|38769848|FG006|Overall Study|Lack of Efficacy|0|||
16075843|NCT01135511|38769849|FG007|Overall Study|Lack of Efficacy|0|||
16075844|NCT01135511|38769850|FG008|Overall Study|Lack of Efficacy|0|||
16075845|NCT01135511|38769842|FG000|Overall Study|Protocol Violation|0|||
16075846|NCT01135511|38769843|FG001|Overall Study|Protocol Violation|0|||
16075847|NCT01135511|38769844|FG002|Overall Study|Protocol Violation|3|||
16075848|NCT01135511|38769845|FG003|Overall Study|Protocol Violation|0|||
16075849|NCT01135511|38769846|FG004|Overall Study|Protocol Violation|0|||
16174588|NCT01355289|39119244|FG004|Open Label Extension|Lost to Follow-up|1|||
16274844|NCT03255980|39490189|FG002|Overall Study|Lost to Follow-up|0|||
16075850|NCT01135511|38769847|FG005|Overall Study|Protocol Violation|0|||
16075851|NCT01135511|38769848|FG006|Overall Study|Protocol Violation|0|||
16075852|NCT01135511|38769849|FG007|Overall Study|Protocol Violation|0|||
16075853|NCT01135511|38769850|FG008|Overall Study|Protocol Violation|0|||
16075854|NCT01135511|38769842|FG000|Overall Study|Pregnancy|0|||
16075855|NCT01135511|38769843|FG001|Overall Study|Pregnancy|0|||
16075856|NCT01135511|38769844|FG002|Overall Study|Pregnancy|0|||
16075857|NCT01135511|38769845|FG003|Overall Study|Pregnancy|1|||
16075858|NCT01135511|38769846|FG004|Overall Study|Pregnancy|0|||
16075859|NCT01135511|38769847|FG005|Overall Study|Pregnancy|0|||
16075860|NCT01135511|38769848|FG006|Overall Study|Pregnancy|0|||
16075861|NCT01135511|38769849|FG007|Overall Study|Pregnancy|0|||
16075862|NCT01135511|38769850|FG008|Overall Study|Pregnancy|0|||
16075863|NCT01135511|38769842|FG000|Overall Study|could not visit the clinic|0|||
16075864|NCT01135511|38769843|FG001|Overall Study|could not visit the clinic|1|||
16075865|NCT01135511|38769844|FG002|Overall Study|could not visit the clinic|2|||
16075866|NCT01135511|38769845|FG003|Overall Study|could not visit the clinic|0|||
16174589|NCT01355289|39119240|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
16174590|NCT01355289|39119241|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
16075867|NCT01135511|38769846|FG004|Overall Study|could not visit the clinic|0|||
16075868|NCT01135511|38769847|FG005|Overall Study|could not visit the clinic|0|||
16075869|NCT01135511|38769848|FG006|Overall Study|could not visit the clinic|0|||
16075870|NCT01135511|38769849|FG007|Overall Study|could not visit the clinic|0|||
16075871|NCT01135511|38769850|FG008|Overall Study|could not visit the clinic|0|||
16075872|NCT01135511|38769842|FG000|Overall Study|noncompliance with study drug taken|0|||
16075873|NCT01135511|38769843|FG001|Overall Study|noncompliance with study drug taken|0|||
16075874|NCT01135511|38769844|FG002|Overall Study|noncompliance with study drug taken|0|||
16075875|NCT01135511|38769845|FG003|Overall Study|noncompliance with study drug taken|0|||
16075876|NCT01135511|38769846|FG004|Overall Study|noncompliance with study drug taken|1|||
16075877|NCT01135511|38769847|FG005|Overall Study|noncompliance with study drug taken|0|||
16075878|NCT01135511|38769848|FG006|Overall Study|noncompliance with study drug taken|0|||
16075879|NCT01135511|38769849|FG007|Overall Study|noncompliance with study drug taken|0|||
16075880|NCT01135511|38769850|FG008|Overall Study|noncompliance with study drug taken|0|||
16075881|NCT01135511|38769842|FG000|Overall Study|Withdrawal by Subject|0|||
16075882|NCT01135511|38769843|FG001|Overall Study|Withdrawal by Subject|0|||
16075883|NCT01135511|38769844|FG002|Overall Study|Withdrawal by Subject|0|||
16075884|NCT01135511|38769845|FG003|Overall Study|Withdrawal by Subject|0|||
16075885|NCT01135511|38769846|FG004|Overall Study|Withdrawal by Subject|0|||
16075886|NCT01135511|38769847|FG005|Overall Study|Withdrawal by Subject|0|||
16075887|NCT01135511|38769848|FG006|Overall Study|Withdrawal by Subject|1|||
16075888|NCT01135511|38769849|FG007|Overall Study|Withdrawal by Subject|0|||
16075889|NCT01135511|38769850|FG008|Overall Study|Withdrawal by Subject|1|||
16075890|NCT00835380|38769851|FG000|Overall Study|Withdrawal by Subject|2|||
16075891|NCT02534350|38769852|FG000|Overall Study|Randomized But Not Treated|1|||
16075892|NCT02534350|38769853|FG001|Overall Study|Randomized But Not Treated|0|||
16075893|NCT02534350|38769852|FG000|Overall Study|Protocol Violation|1|||
16075894|NCT02534350|38769853|FG001|Overall Study|Protocol Violation|0|||
16075895|NCT02534350|38769852|FG000|Overall Study|Withdrew Consent|2|||
16075896|NCT02534350|38769853|FG001|Overall Study|Withdrew Consent|0|||
16075897|NCT02914522|38769854|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
16075898|NCT02914522|38769855|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
16075899|NCT02914522|38769856|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
16075900|NCT02914522|38769857|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
16075901|NCT02914522|38769858|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
16075902|NCT02914522|38769859|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
16075903|NCT02914522|38769860|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
16075904|NCT02914522|38769861|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
16075905|NCT02914522|38769862|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
16075906|NCT02914522|38769863|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
16075907|NCT02914522|38769864|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
16174591|NCT01355289|39119242|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
16174592|NCT01355289|39119243|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
16174593|NCT01355289|39119244|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
16174594|NCT01355289|39119240|FG000|Open Label Extension|Other|0|||
16075908|NCT02914522|38769854|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
16075909|NCT02914522|38769855|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
16174595|NCT01355289|39119241|FG001|Open Label Extension|Other|0|||
16174596|NCT01355289|39119242|FG002|Open Label Extension|Other|0|||
16174597|NCT01355289|39119243|FG003|Open Label Extension|Other|0|||
16474683|NCT01297920|40217994|FG001|Overall Study|Inadequate Control of IOP|9|||
16075910|NCT02914522|38769856|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
16075911|NCT02914522|38769857|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
16075912|NCT02914522|38769858|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
16075913|NCT02914522|38769859|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
16075914|NCT02914522|38769860|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
16075915|NCT02914522|38769861|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
16075916|NCT02914522|38769862|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
16075917|NCT02914522|38769863|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
16075918|NCT02914522|38769864|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
16075919|NCT02914522|38769854|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
16075920|NCT02914522|38769855|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
16075921|NCT02914522|38769856|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
16075922|NCT02914522|38769857|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
16075923|NCT02914522|38769858|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
16075924|NCT02914522|38769859|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
16075925|NCT02914522|38769860|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
16075926|NCT02914522|38769861|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
16075927|NCT02914522|38769862|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
16075928|NCT02914522|38769863|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
16174598|NCT01355289|39119244|FG004|Open Label Extension|Other|3|||
16174599|NCT01931865|39119245|FG000|Overall Study|Lost to Follow-up|2|||
16174600|NCT01931865|39119245|FG000|Overall Study|Withdrawal by Subject|2|||
16075929|NCT02914522|38769864|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
16075930|NCT02914522|38769854|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
16174601|NCT00098787|39119246|FG000|Overall Study|Never started treatment|3|||
16174602|NCT00098787|39119247|FG001|Overall Study|Never started treatment|2|||
16174603|NCT00098787|39119248|FG002|Overall Study|Never started treatment|1|||
16075931|NCT02914522|38769855|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
16075932|NCT02914522|38769856|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
16075933|NCT02914522|38769857|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
16075934|NCT02914522|38769858|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
16075935|NCT02914522|38769859|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
16075936|NCT02914522|38769860|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
16075937|NCT02914522|38769861|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
16075938|NCT02914522|38769862|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
16075939|NCT02914522|38769863|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
16174604|NCT00098787|39119246|FG000|Overall Study|Ineligible|9|||
16174605|NCT00098787|39119247|FG001|Overall Study|Ineligible|7|||
16174606|NCT00098787|39119248|FG002|Overall Study|Ineligible|3|||
16174607|NCT00098787|39119246|FG000|Overall Study|Disease progression|28|||
16174608|NCT00098787|39119247|FG001|Overall Study|Disease progression|17|||
16174609|NCT00098787|39119248|FG002|Overall Study|Disease progression|23|||
16174610|NCT00098787|39119246|FG000|Overall Study|Adverse Event|8|||
16174611|NCT00098787|39119247|FG001|Overall Study|Adverse Event|17|||
16174612|NCT00098787|39119248|FG002|Overall Study|Adverse Event|8|||
16174613|NCT00098787|39119246|FG000|Overall Study|Death|6|||
16174614|NCT00098787|39119247|FG001|Overall Study|Death|1|||
16174615|NCT00098787|39119248|FG002|Overall Study|Death|0|||
16075940|NCT02914522|38769864|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
16075941|NCT02914522|38769854|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
16075942|NCT02914522|38769855|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
16075943|NCT02914522|38769856|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
16075944|NCT02914522|38769857|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
16075945|NCT02914522|38769858|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
16075946|NCT02914522|38769859|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
16075947|NCT02914522|38769860|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
16174616|NCT00098787|39119246|FG000|Overall Study|Withdrawal by Subject|4|||
16174617|NCT00098787|39119247|FG001|Overall Study|Withdrawal by Subject|12|||
16075948|NCT02914522|38769861|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
16075949|NCT02914522|38769862|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
16075950|NCT02914522|38769863|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
16174618|NCT00098787|39119248|FG002|Overall Study|Withdrawal by Subject|6|||
16174619|NCT00098787|39119246|FG000|Overall Study|Alternative therapy|8|||
16174620|NCT00098787|39119247|FG001|Overall Study|Alternative therapy|13|||
16075951|NCT02914522|38769864|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
16075952|NCT02914522|38769854|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
16075953|NCT02914522|38769855|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16075954|NCT02914522|38769856|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16075955|NCT02914522|38769857|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16075956|NCT02914522|38769858|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16075957|NCT02914522|38769859|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16075958|NCT02914522|38769860|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16075959|NCT02914522|38769861|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16174621|NCT00098787|39119248|FG002|Overall Study|Alternative therapy|13|||
16174622|NCT00098787|39119246|FG000|Overall Study|Other|7|||
16174623|NCT00098787|39119247|FG001|Overall Study|Other|6|||
16174624|NCT00098787|39119248|FG002|Overall Study|Other|9|||
16174625|NCT00075881|39119249|FG000|Overall Study|Lack of Efficacy|18|||
16174626|NCT00075881|39119249|FG000|Overall Study|Adverse Event|7|||
16075960|NCT02914522|38769862|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16075961|NCT02914522|38769863|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16075962|NCT02914522|38769864|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
16075963|NCT02914522|38769854|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
16075964|NCT02914522|38769855|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
16075965|NCT02914522|38769856|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
16075966|NCT02914522|38769857|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
16075967|NCT02914522|38769858|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
16075968|NCT02914522|38769859|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
16075969|NCT02914522|38769860|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
16075970|NCT02914522|38769861|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
16075971|NCT02914522|38769862|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
16075972|NCT02914522|38769863|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
16075973|NCT02914522|38769864|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
16075974|NCT02914522|38769854|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
16075975|NCT02914522|38769855|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
16174627|NCT00075881|39119249|FG000|Overall Study|Death|1|||
16174628|NCT00075881|39119249|FG000|Overall Study|Withdrawal by Subject|2|||
16174629|NCT00075881|39119249|FG000|Overall Study|Protocol Violation|4|||
16174630|NCT00075881|39119249|FG000|Overall Study|other complicating disease|3|||
16174631|NCT00075881|39119249|FG000|Overall Study|other|4|||
16174632|NCT00075881|39119249|FG000|Overall Study|missing data|2|||
16174633|NCT00075881|39119249|FG000|Overall Study|Ineligible|1|||
16174634|NCT00075881|39119249|FG000|Overall Study|never start protocol therapy|1|||
16174635|NCT04439903|39119250|FG000|Overall Study|Withdrawal by Subject|2|||
16174636|NCT04439903|39119250|FG000|Overall Study|Screen Failure|1|||
16174637|NCT03133767|39119253|FG000|Overall Study|Lost to Follow-up|38|||
16174638|NCT03133767|39119254|FG001|Overall Study|Lost to Follow-up|24|||
16174639|NCT03133767|39119253|FG000|Overall Study|Protocol Violation|0|||
16174640|NCT03133767|39119254|FG001|Overall Study|Protocol Violation|1|||
16174641|NCT00629083|39119255|FG000|Overall Study|Adverse Event|0|||
16174642|NCT00629083|39119256|FG001|Overall Study|Adverse Event|2|||
16174643|NCT00629083|39119255|FG000|Overall Study|Lack of Efficacy|3|||
16174644|NCT00629083|39119256|FG001|Overall Study|Lack of Efficacy|1|||
16174645|NCT00629083|39119255|FG000|Overall Study|Withdrawal by Subject|10|||
16174646|NCT00629083|39119256|FG001|Overall Study|Withdrawal by Subject|2|||
16174647|NCT00629083|39119255|FG000|Overall Study|Lost to Follow-up|12|||
16174648|NCT00629083|39119256|FG001|Overall Study|Lost to Follow-up|8|||
16174649|NCT00629083|39119255|FG000|Overall Study|Moved out of country/state|2|||
16174650|NCT00629083|39119256|FG001|Overall Study|Moved out of country/state|1|||
16174651|NCT00629083|39119255|FG000|Overall Study|Refused to return for 12 month visit|1|||
16174652|NCT00629083|39119256|FG001|Overall Study|Refused to return for 12 month visit|0|||
16174653|NCT01085682|39119259|FG000|Overall Study|Withdrawal by Subject|25|||
16174654|NCT01085682|39119260|FG001|Overall Study|Withdrawal by Subject|25|||
16075976|NCT02914522|38769856|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
16075977|NCT02914522|38769857|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
16075978|NCT02914522|38769858|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
16075979|NCT02914522|38769859|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
16075980|NCT02914522|38769860|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
16075981|NCT02914522|38769861|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
16075982|NCT02914522|38769862|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
16075983|NCT02914522|38769863|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
16075984|NCT02914522|38769864|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
16075985|NCT02914522|38769854|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
16075986|NCT02914522|38769855|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
16075987|NCT02914522|38769856|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
16075988|NCT02914522|38769857|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
16075989|NCT02914522|38769858|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
16075990|NCT02914522|38769859|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
16075991|NCT02914522|38769860|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
16075992|NCT02914522|38769861|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
16075993|NCT02914522|38769862|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
16075994|NCT02914522|38769863|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
16075995|NCT02914522|38769864|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
16174655|NCT00891735|39119263|FG000|Overall Study|Adverse Event|2|||
16174656|NCT00891735|39119264|FG001|Overall Study|Adverse Event|0|||
16174657|NCT00891735|39119265|FG002|Overall Study|Adverse Event|2|||
16174658|NCT00891735|39119266|FG003|Overall Study|Adverse Event|0|||
16174659|NCT00891735|39119263|FG000|Overall Study|Death|8|||
16174660|NCT00891735|39119264|FG001|Overall Study|Death|5|||
16174661|NCT00891735|39119265|FG002|Overall Study|Death|4|||
16075996|NCT02914522|38769854|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
16075997|NCT02914522|38769855|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
16075998|NCT02914522|38769856|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
16075999|NCT02914522|38769857|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
16076000|NCT02914522|38769858|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
16076001|NCT02914522|38769859|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
16076002|NCT02914522|38769860|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
16076003|NCT02914522|38769861|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
16076004|NCT02914522|38769862|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
16076005|NCT02914522|38769863|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
16076006|NCT02914522|38769864|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
16076007|NCT02914522|38769854|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
16076008|NCT02914522|38769855|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
16076009|NCT02914522|38769856|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
16076010|NCT02914522|38769857|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
16076011|NCT02914522|38769858|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
16076012|NCT02914522|38769859|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
16076013|NCT02914522|38769860|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
16076014|NCT02914522|38769861|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
16076015|NCT02914522|38769862|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
16076016|NCT02914522|38769863|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
16076017|NCT02914522|38769864|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
16076018|NCT02914522|38769854|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
16076019|NCT02914522|38769855|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
16076020|NCT02914522|38769856|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
16076021|NCT02914522|38769857|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
16076022|NCT02914522|38769858|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
16076023|NCT02914522|38769859|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
16076024|NCT02914522|38769860|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
16076025|NCT02914522|38769861|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
16076026|NCT02914522|38769862|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
16076027|NCT02914522|38769863|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
16076028|NCT02914522|38769864|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
16076029|NCT02914522|38769854|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
16076030|NCT02914522|38769855|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
16076031|NCT02914522|38769856|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
16076032|NCT02914522|38769857|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
16076033|NCT02914522|38769858|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
16076034|NCT02914522|38769859|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
16076035|NCT02914522|38769860|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
16076036|NCT02914522|38769861|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
16076037|NCT02914522|38769862|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
16076038|NCT02914522|38769863|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
16174662|NCT00891735|39119266|FG003|Overall Study|Death|5|||
16174663|NCT00891735|39119263|FG000|Overall Study|Lost to Follow-up|2|||
16174664|NCT00891735|39119264|FG001|Overall Study|Lost to Follow-up|2|||
16174665|NCT00891735|39119265|FG002|Overall Study|Lost to Follow-up|2|||
16174666|NCT00891735|39119266|FG003|Overall Study|Lost to Follow-up|2|||
16174667|NCT00891735|39119263|FG000|Overall Study|Physician's decision to withdraw patient|1|||
16174668|NCT00891735|39119264|FG001|Overall Study|Physician's decision to withdraw patient|0|||
16174669|NCT00891735|39119265|FG002|Overall Study|Physician's decision to withdraw patient|0|||
16174670|NCT00891735|39119266|FG003|Overall Study|Physician's decision to withdraw patient|0|||
16174671|NCT00891735|39119263|FG000|Overall Study|Patient's decision to withdraw|4|||
16174672|NCT00891735|39119264|FG001|Overall Study|Patient's decision to withdraw|9|||
16174673|NCT00891735|39119265|FG002|Overall Study|Patient's decision to withdraw|4|||
16174674|NCT00891735|39119266|FG003|Overall Study|Patient's decision to withdraw|8|||
16174675|NCT02091440|39119267|FG000|Overall Study|Death|2|||
16174676|NCT01307423|39119271|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
16174677|NCT01307423|39119272|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
16174678|NCT01307423|39119273|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
16174679|NCT01307423|39119274|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16174680|NCT01307423|39119275|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16174681|NCT01307423|39119276|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16174682|NCT01307423|39119277|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16174683|NCT01307423|39119278|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16174684|NCT01307423|39119279|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16274845|NCT03255980|39490190|FG003|Overall Study|Lost to Follow-up|3|||
16375145|NCT00563316|39860060|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
16076039|NCT02914522|38769864|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
16076040|NCT02914522|38769854|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
16076041|NCT02914522|38769855|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
16076042|NCT02914522|38769856|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
16076043|NCT02914522|38769857|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
16076044|NCT02914522|38769858|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
16076045|NCT02914522|38769859|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
16076046|NCT02914522|38769860|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
16076047|NCT02914522|38769861|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
16076048|NCT02914522|38769862|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
16076049|NCT02914522|38769863|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
16076050|NCT02914522|38769864|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
16076051|NCT02914522|38769854|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
16076052|NCT02914522|38769855|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
16076053|NCT02914522|38769856|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
16076054|NCT02914522|38769857|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
16076055|NCT02914522|38769858|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
16076056|NCT02914522|38769859|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
16076057|NCT02914522|38769860|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
16076058|NCT02914522|38769861|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
16076059|NCT02914522|38769862|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
16076060|NCT02914522|38769863|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
16076061|NCT02914522|38769864|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
16076062|NCT02914522|38769854|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
16076063|NCT02914522|38769855|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
16076064|NCT02914522|38769856|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
16076065|NCT02914522|38769857|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
16076066|NCT02914522|38769858|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
16076067|NCT02914522|38769859|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
16076068|NCT02914522|38769860|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
16076069|NCT02914522|38769861|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
16076070|NCT02914522|38769862|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
16076071|NCT02914522|38769863|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
16076072|NCT02914522|38769864|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
16076073|NCT02937831|38769871|FG000|Overall Study|Protocol Violation|4|||
16076074|NCT00834834|38769873|FG000|Overall Study|Withdrawal by Subject|4|||
16076075|NCT00834834|38769874|FG001|Overall Study|Withdrawal by Subject|3|||
16076076|NCT00028769|38769881|FG000|Overall Study|Adverse Event|2|||
16076077|NCT00028769|38769881|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
16076078|NCT00028769|38769881|FG000|Overall Study|Progression or Death|31|||
16076079|NCT00028769|38769881|FG000|Overall Study|Other - Not Protocol Specified|1|||
16076080|NCT00028769|38769881|FG000|Overall Study|Ineligible|5|||
16076081|NCT00028769|38769881|FG000|Overall Study|Not Analyzable|1|||
16076082|NCT02299635|38769882|FG000|Overall Study|Adverse Event|2|||
16076083|NCT02299635|38769882|FG000|Overall Study|Death|1|||
16076084|NCT02299635|38769882|FG000|Overall Study|Global deterioration of health status|1|||
16076085|NCT02299635|38769882|FG000|Overall Study|Objective progression or relapse|10|||
16076086|NCT02299635|38769882|FG000|Overall Study|Withdrawal by Subject|2|||
16076087|NCT02299635|38769882|FG000|Overall Study|Other|3|||
16076088|NCT00855465|38769883|FG000|Treatment Period|Adverse Event|4|||
16076089|NCT00855465|38769884|FG001|Treatment Period|Adverse Event|2|||
16076090|NCT00855465|38769883|FG000|Treatment Period|Death|2|||
16076091|NCT00855465|38769884|FG001|Treatment Period|Death|2|||
16076092|NCT00855465|38769883|FG000|Treatment Period|Lack of Efficacy|2|||
16076093|NCT00855465|38769884|FG001|Treatment Period|Lack of Efficacy|1|||
16076094|NCT00855465|38769883|FG000|Treatment Period|Non-compliance|1|||
16076095|NCT00855465|38769884|FG001|Treatment Period|Non-compliance|0|||
16076096|NCT00855465|38769883|FG000|Treatment Period|Protocol Violation|2|||
16076097|NCT00855465|38769884|FG001|Treatment Period|Protocol Violation|0|||
16076098|NCT00855465|38769883|FG000|Treatment Period|Withdrawal by Subject|2|||
16076099|NCT00855465|38769884|FG001|Treatment Period|Withdrawal by Subject|0|||
16076100|NCT00855465|38769883|FG000|Treatment Period|Not treated|1|||
16076101|NCT00855465|38769884|FG001|Treatment Period|Not treated|0|||
16076102|NCT00855465|38769883|FG000|Follow-up Period (FUP)|Adverse Event|0|||
16076103|NCT00855465|38769884|FG001|Follow-up Period (FUP)|Adverse Event|1|||
16174685|NCT01307423|39119271|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
16174686|NCT01307423|39119272|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
16174687|NCT01307423|39119273|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
16174688|NCT01307423|39119274|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16174689|NCT01307423|39119275|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16174690|NCT01307423|39119276|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16174691|NCT01307423|39119277|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16174692|NCT01307423|39119278|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16076104|NCT00855465|38769883|FG000|Follow-up Period (FUP)|Death|0|||
16076105|NCT00855465|38769884|FG001|Follow-up Period (FUP)|Death|1|||
16076106|NCT00855465|38769883|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
16076107|NCT00855465|38769884|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
16076108|NCT00855465|38769883|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
16076109|NCT00855465|38769884|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
16076110|NCT00855465|38769883|FG000|Follow-up Period (FUP)|Missing|1|||
16076111|NCT00855465|38769884|FG001|Follow-up Period (FUP)|Missing|0|||
16076112|NCT00507689|38769885|FG000|Pre-Randomization Period|Adverse Event|1|||
16076113|NCT00507689|38769886|FG001|Pre-Randomization Period|Adverse Event|0|||
16076114|NCT00507689|38769885|FG000|Pre-Randomization Period|Physician Decision|1|||
16076115|NCT00507689|38769886|FG001|Pre-Randomization Period|Physician Decision|0|||
16076116|NCT00507689|38769885|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
16076117|NCT00507689|38769886|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
16076118|NCT00507689|38769885|FG000|Randomized Period|Adverse Event|1|||
16076119|NCT00507689|38769886|FG001|Randomized Period|Adverse Event|1|||
16076120|NCT00507689|38769885|FG000|Randomized Period|Withdrawal by Subject|0|||
16076121|NCT00507689|38769886|FG001|Randomized Period|Withdrawal by Subject|1|||
16076122|NCT00486330|38769887|FG000|Overall Study|Adverse Event|2|||
16076123|NCT00933400|38769891|FG000|Overall Study|Withdrawal by Subject|21|||
16076124|NCT00933400|38769892|FG001|Overall Study|Withdrawal by Subject|1|||
16076125|NCT01104415|38769893|FG000|Core Phase|Consent withdrawn by subjects|1|||
16076126|NCT01104415|38769894|FG001|Core Phase|Consent withdrawn by subjects|0|||
16076127|NCT01104415|38769893|FG000|Extension Period|Progressive disease|0|||
16076128|NCT01104415|38769894|FG001|Extension Period|Progressive disease|4|||
16076129|NCT01104415|38769893|FG000|Extension Period|Death|0|||
16076130|NCT01104415|38769894|FG001|Extension Period|Death|1|||
16076131|NCT01104415|38769893|FG000|Extension Period|Physician Decision|0|||
16076132|NCT01104415|38769894|FG001|Extension Period|Physician Decision|1|||
16076133|NCT01104415|38769893|FG000|Extension Period|Transition to Study LX1606.302|0|||
16076134|NCT01104415|38769894|FG001|Extension Period|Transition to Study LX1606.302|4|||
16076135|NCT01104415|38769893|FG000|Extension Period|Heart surgery/feeling miserable|0|||
16076136|NCT01104415|38769894|FG001|Extension Period|Heart surgery/feeling miserable|1|||
16076137|NCT00711958|38769897|FG000|Overall Study|Withdrawal by Subject|6|||
16076138|NCT00711958|38769898|FG001|Overall Study|Withdrawal by Subject|8|||
16076139|NCT00711958|38769897|FG000|Overall Study|Lack of Efficacy|3|||
16076140|NCT00711958|38769898|FG001|Overall Study|Lack of Efficacy|1|||
16076141|NCT00711958|38769897|FG000|Overall Study|Clinical deterioration|1|||
16076142|NCT00711958|38769898|FG001|Overall Study|Clinical deterioration|0|||
16174693|NCT01307423|39119279|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16174694|NCT01307423|39119271|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
16174695|NCT01307423|39119272|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
16174696|NCT01307423|39119273|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
16174697|NCT01307423|39119274|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16174698|NCT01307423|39119275|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16076143|NCT00711958|38769897|FG000|Overall Study|Adverse Event|9|||
16076144|NCT00711958|38769898|FG001|Overall Study|Adverse Event|7|||
16076145|NCT00711958|38769897|FG000|Overall Study|Protocol Violation|1|||
16076146|NCT00711958|38769898|FG001|Overall Study|Protocol Violation|0|||
16076147|NCT00711958|38769897|FG000|Overall Study|Lost to Follow-up|2|||
16076148|NCT00711958|38769898|FG001|Overall Study|Lost to Follow-up|2|||
16076149|NCT00711958|38769897|FG000|Overall Study|Death|10|||
16076150|NCT00711958|38769898|FG001|Overall Study|Death|5|||
16076151|NCT00711958|38769897|FG000|Overall Study|Progression of disease|1|||
16076152|NCT00711958|38769898|FG001|Overall Study|Progression of disease|0|||
16076153|NCT00585533|38769899|FG000|Overall Study|objective or symptomatic progression|9|||
16076154|NCT03863834|38769900|FG000|Overall Study|Lost to Follow-up|3|||
16076155|NCT02082158|38769901|FG000|Overall Study|Withdrawal by Subject|0|||
16076156|NCT02082158|38769902|FG001|Overall Study|Withdrawal by Subject|0|||
16076157|NCT02082158|38769903|FG002|Overall Study|Withdrawal by Subject|0|||
16076158|NCT02082158|38769904|FG003|Overall Study|Withdrawal by Subject|0|||
16076159|NCT02082158|38769905|FG004|Overall Study|Withdrawal by Subject|1|||
16076160|NCT02082158|38769906|FG005|Overall Study|Withdrawal by Subject|0|||
16076161|NCT02082158|38769901|FG000|Overall Study|Failed Fit-testing|8|||
16076162|NCT02082158|38769902|FG001|Overall Study|Failed Fit-testing|8|||
16076163|NCT02082158|38769903|FG002|Overall Study|Failed Fit-testing|14|||
16076164|NCT02082158|38769904|FG003|Overall Study|Failed Fit-testing|4|||
16076165|NCT02082158|38769905|FG004|Overall Study|Failed Fit-testing|3|||
16076166|NCT02082158|38769906|FG005|Overall Study|Failed Fit-testing|7|||
16174699|NCT01307423|39119276|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16076167|NCT02698891|38769907|FG000|Overall Study|Withdrawal by Subject|2|||
16076168|NCT02698891|38769907|FG000|Overall Study|deemed ineligible|1|||
16076169|NCT02698891|38769907|FG000|Overall Study|Adverse Event|9|||
16076170|NCT00311363|38769908|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
16076171|NCT00311363|38769909|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
16076172|NCT00311363|38769910|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
16076173|NCT00311363|38769908|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
16076174|NCT00311363|38769909|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
16076175|NCT00311363|38769910|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
16076176|NCT00311363|38769908|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
16076177|NCT00311363|38769909|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
16076178|NCT00311363|38769910|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
16076179|NCT00311363|38769908|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
16076180|NCT00311363|38769909|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
16076181|NCT00311363|38769910|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
16076182|NCT00311363|38769908|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
16076183|NCT00311363|38769909|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
16076184|NCT00311363|38769910|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
16076185|NCT00311363|38769908|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
16076186|NCT00311363|38769909|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
16076187|NCT00311363|38769910|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
16174700|NCT01307423|39119277|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16076188|NCT00311363|38769908|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
16076189|NCT00311363|38769909|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
16076190|NCT00311363|38769910|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
16076191|NCT00311363|38769908|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
16076192|NCT00311363|38769909|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
16076193|NCT00311363|38769910|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
16076194|NCT00311363|38769908|FG000|24-Week Single-Blind Treatment Period|Death|1|||
16076195|NCT00311363|38769909|FG001|24-Week Single-Blind Treatment Period|Death|0|||
16076196|NCT00311363|38769910|FG002|24-Week Single-Blind Treatment Period|Death|0|||
16076197|NCT00311363|38769908|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
16076198|NCT00311363|38769909|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
16076199|NCT00311363|38769910|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
16076200|NCT00311363|38769908|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
16076201|NCT00311363|38769909|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
16076202|NCT00311363|38769910|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
16076203|NCT00311363|38769908|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
16076204|NCT00311363|38769909|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
16076205|NCT00311363|38769910|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
16076206|NCT00311363|38769908|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
16076207|NCT00311363|38769909|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
16076208|NCT00311363|38769910|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
16076209|NCT00311363|38769908|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
16076210|NCT00311363|38769909|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
16076211|NCT00311363|38769910|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
16076212|NCT00311363|38769908|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
16076213|NCT00311363|38769909|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
16076214|NCT00311363|38769910|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
16076215|NCT00756730|38769911|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
16076216|NCT00756730|38769912|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
16076217|NCT00756730|38769911|FG000|Overall Study|persistent low-level viremmia|0|||
16076218|NCT00756730|38769912|FG001|Overall Study|persistent low-level viremmia|1|||
16076219|NCT01111526|38769919|FG000|Overall Study|GVHD Disease Progression|0|||
16076220|NCT01111526|38769920|FG001|Overall Study|GVHD Disease Progression|1|||
16076221|NCT01111526|38769921|FG002|Overall Study|GVHD Disease Progression|2|||
16076222|NCT02553460|38769922|FG000|Overall Study|Death|3|||
16076223|NCT02553460|38769922|FG000|Overall Study|Withdrawal by Subject|1|||
16174701|NCT01307423|39119278|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16174702|NCT01307423|39119279|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16174703|NCT01307423|39119271|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16174704|NCT01307423|39119272|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16174705|NCT01307423|39119273|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
16174706|NCT01307423|39119274|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16174707|NCT01307423|39119275|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16174708|NCT01307423|39119276|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16174709|NCT01307423|39119277|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16174710|NCT01307423|39119278|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16174711|NCT01307423|39119279|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16174712|NCT01307423|39119271|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
16174713|NCT01307423|39119272|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
16174714|NCT01307423|39119273|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
16174715|NCT01307423|39119274|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16174716|NCT01307423|39119275|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16174717|NCT01307423|39119276|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16174718|NCT01307423|39119277|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16174719|NCT01307423|39119278|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16174720|NCT01307423|39119279|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16174721|NCT01307423|39119271|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
16174722|NCT01307423|39119272|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16174723|NCT01307423|39119273|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16174724|NCT01307423|39119274|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16174725|NCT01307423|39119275|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16174726|NCT01307423|39119276|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16174727|NCT01307423|39119277|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16174728|NCT01307423|39119278|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16174729|NCT01307423|39119279|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16174730|NCT01307423|39119271|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
16174731|NCT01307423|39119272|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
16174732|NCT01307423|39119273|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16174733|NCT01307423|39119274|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16174734|NCT01307423|39119275|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16174735|NCT01307423|39119276|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16174736|NCT01307423|39119277|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16174737|NCT01307423|39119278|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16174738|NCT01307423|39119279|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16174739|NCT01307423|39119271|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
16174740|NCT01307423|39119272|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
16174741|NCT01307423|39119273|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
16174742|NCT01307423|39119274|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
16174743|NCT01307423|39119275|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
16174744|NCT01307423|39119276|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
16174745|NCT01307423|39119277|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
16174746|NCT01307423|39119278|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
16174747|NCT01307423|39119279|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
16174748|NCT01307423|39119271|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
16174749|NCT01307423|39119272|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
16174750|NCT01307423|39119273|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
16174751|NCT01307423|39119274|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
16274846|NCT03255980|39490187|FG000|Overall Study|Withdrawal by Subject|0|||
16274847|NCT03255980|39490188|FG001|Overall Study|Withdrawal by Subject|1|||
16274848|NCT03255980|39490189|FG002|Overall Study|Withdrawal by Subject|0|||
16274849|NCT03255980|39490190|FG003|Overall Study|Withdrawal by Subject|3|||
16274850|NCT03224624|39490191|FG000|Overall Study|Lost to Follow-up|9|||
16274851|NCT03224624|39490192|FG001|Overall Study|Lost to Follow-up|4|||
16274852|NCT03224624|39490191|FG000|Overall Study|Death|1|||
16274853|NCT03224624|39490192|FG001|Overall Study|Death|0|||
16174752|NCT01307423|39119275|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
16174753|NCT01307423|39119276|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
16174754|NCT01307423|39119277|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
16174755|NCT01307423|39119278|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
16174756|NCT01307423|39119279|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
16174757|NCT01307423|39119271|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
16174758|NCT01307423|39119272|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
16174759|NCT01307423|39119273|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
16174760|NCT01307423|39119274|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
16174761|NCT01307423|39119275|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
16174762|NCT01307423|39119276|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
16274854|NCT01698554|39490194|FG000|Overall Study|Adverse Event|2|||
16274855|NCT01698554|39490195|FG001|Overall Study|Adverse Event|5|||
16274856|NCT01698554|39490196|FG002|Overall Study|Adverse Event|0|||
16274857|NCT01698554|39490197|FG003|Overall Study|Adverse Event|1|||
16274858|NCT01698554|39490194|FG000|Overall Study|Lost to Follow-up|1|||
16274859|NCT01698554|39490195|FG001|Overall Study|Lost to Follow-up|0|||
16174763|NCT01307423|39119277|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
16174764|NCT01307423|39119278|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
16174765|NCT01307423|39119279|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
16174766|NCT01307423|39119271|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
16174767|NCT01307423|39119272|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
16174768|NCT01307423|39119273|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
16174769|NCT01307423|39119274|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
16174770|NCT01307423|39119275|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
16174771|NCT01307423|39119276|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
16174772|NCT01307423|39119277|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
16174773|NCT01307423|39119278|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
16174774|NCT01307423|39119279|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
16174775|NCT01307423|39119271|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
16174776|NCT01307423|39119272|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
16174777|NCT01307423|39119273|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
16174778|NCT01307423|39119274|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
16174779|NCT01307423|39119275|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
16174780|NCT01307423|39119276|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
16174781|NCT01307423|39119277|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
16174782|NCT01307423|39119278|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
16174783|NCT01307423|39119279|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
16174784|NCT01307423|39119271|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
16174785|NCT01307423|39119272|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
16174786|NCT01307423|39119273|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
16174787|NCT01307423|39119274|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
16174788|NCT01307423|39119275|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
16174789|NCT01307423|39119276|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
16174790|NCT01307423|39119277|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
16174791|NCT01307423|39119278|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
16174792|NCT01307423|39119279|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
16174793|NCT01307423|39119271|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
16174794|NCT01307423|39119272|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
16174795|NCT01307423|39119273|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
16174796|NCT01307423|39119274|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
16174797|NCT01307423|39119275|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
16174798|NCT01307423|39119276|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
16174799|NCT01307423|39119277|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
16174800|NCT01307423|39119278|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
16174801|NCT01307423|39119279|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
16174802|NCT01307423|39119271|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
16174803|NCT01307423|39119272|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
16174804|NCT01307423|39119273|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
16174805|NCT01307423|39119274|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
16174806|NCT01307423|39119275|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
16174807|NCT01307423|39119276|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
16174808|NCT01307423|39119277|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
16174809|NCT01307423|39119278|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
16174810|NCT01307423|39119279|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
16174811|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16174812|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
16174813|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
16174814|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16174815|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16174816|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16174817|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16174818|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
16174819|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
16174820|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16174821|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
16174822|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
16174823|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16174824|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16174825|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16274860|NCT01698554|39490196|FG002|Overall Study|Lost to Follow-up|0|||
16274861|NCT01698554|39490197|FG003|Overall Study|Lost to Follow-up|0|||
16274862|NCT01698554|39490194|FG000|Overall Study|Personal Reasons|0|||
16274863|NCT01698554|39490195|FG001|Overall Study|Personal Reasons|5|||
16274864|NCT01698554|39490196|FG002|Overall Study|Personal Reasons|1|||
16274865|NCT01698554|39490197|FG003|Overall Study|Personal Reasons|1|||
16274866|NCT01698554|39490194|FG000|Overall Study|Protocol Violation|2|||
16274867|NCT01698554|39490195|FG001|Overall Study|Protocol Violation|0|||
16274868|NCT01698554|39490196|FG002|Overall Study|Protocol Violation|1|||
16274869|NCT01698554|39490197|FG003|Overall Study|Protocol Violation|0|||
16274870|NCT01698554|39490194|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16274871|NCT01698554|39490195|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16274872|NCT01698554|39490196|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16274873|NCT01698554|39490197|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16174826|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16174827|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
16174828|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
16174829|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
16274874|NCT01206439|39490199|FG000|Overall Study|subject did not meet inclusion criteria|1|||
16274875|NCT03428750|39490200|FG000|Overall Study|Withdrawal by Subject|11|||
16174830|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
16174831|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
16174832|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
16174833|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
16174834|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
16174835|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
16174836|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
16174837|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
16174838|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16174839|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
16174840|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
16174841|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16174842|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16174843|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16174844|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16174845|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
16174846|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
16174847|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16174848|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
16174849|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16174850|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16174851|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16174852|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16174853|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16174854|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
16174855|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
16174856|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16174857|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
16174858|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
16174859|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16174860|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16174861|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16174862|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16174863|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
16174864|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
16174865|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16174866|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
16174867|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
16174868|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16174869|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16174870|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16174871|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16174872|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
16274876|NCT03428750|39490201|FG001|Overall Study|Withdrawal by Subject|10|||
16174873|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
16174874|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
16174875|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
16174876|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
16174877|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
16174878|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
16174879|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
16174880|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
16174881|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
16174882|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
16174883|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16174884|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
16174885|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
16174886|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16174887|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16174888|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16174889|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16174890|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
16174891|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
16174892|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16174893|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
16174894|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
16174895|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16174896|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16174897|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16174898|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16174899|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
16174900|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
16174901|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16174902|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
16174903|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16174904|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16174905|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16174906|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16174907|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16174908|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
16174909|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16174910|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16174911|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
16174912|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16174913|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16174914|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16174915|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16174916|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16174917|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16174918|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16174919|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16174920|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
16174921|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16174922|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16174923|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16174924|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16174925|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16174926|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16174927|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
16174928|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16174929|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
16174930|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
16174931|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16174932|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16174933|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16174934|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16174935|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
16174936|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
16174937|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16174938|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16174939|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
16174940|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16174941|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16174942|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16174943|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16174944|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16174945|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16174946|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16174947|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16174948|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16274877|NCT03428750|39490200|FG000|Overall Study|Lost to Follow-up|3|||
16174949|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16174950|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16174951|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16174952|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16174953|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
16174954|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16174955|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16174956|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
16174957|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
16174958|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16174959|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16174960|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16174961|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16174962|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16174963|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
16174964|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16174965|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
16174966|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
16174967|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16174968|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16174969|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16174970|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16174971|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16174972|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16174973|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16174974|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
16174975|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
16174976|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16174977|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16174978|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16174979|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16174980|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16174981|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
16174982|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
16174983|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
16174984|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
16174985|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
16174986|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
16174987|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
16174988|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
16174989|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
16174990|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
16174991|NCT01307423|39119271|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16174992|NCT01307423|39119272|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16174993|NCT01307423|39119273|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
16174994|NCT01307423|39119274|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16174995|NCT01307423|39119275|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16174996|NCT01307423|39119276|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16174997|NCT01307423|39119277|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16174998|NCT01307423|39119278|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
16174999|NCT01307423|39119279|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
16175000|NCT00693706|39119283|FG000|Overall Study|Protocol Violation|0|||
16175001|NCT00693706|39119284|FG001|Overall Study|Protocol Violation|1|||
16175002|NCT02360098|39119285|FG000|Overall Study|Physician Decision|7|||
16175003|NCT01243268|39119286|FG000|Overall Study|Lost to Follow-up|4|||
16175004|NCT01243268|39119286|FG000|Overall Study|Protocol Violation|51|||
16175005|NCT01243268|39119286|FG000|Overall Study|Deviation with contract date|7|||
16175006|NCT01243268|39119286|FG000|Overall Study|Duplicate subject|2|||
16175007|NCT03427073|39119289|FG000|Overall Study|Disease Progression|1|||
16175008|NCT03427073|39119290|FG001|Overall Study|Disease Progression|1|||
16175009|NCT03427073|39119291|FG002|Overall Study|Disease Progression|1|||
16175010|NCT03427073|39119292|FG003|Overall Study|Disease Progression|3|||
16175011|NCT03427073|39119293|FG004|Overall Study|Disease Progression|3|||
16175012|NCT03427073|39119294|FG005|Overall Study|Disease Progression|4|||
16175013|NCT03427073|39119295|FG006|Overall Study|Disease Progression|2|||
16175014|NCT03427073|39119296|FG007|Overall Study|Disease Progression|3|||
16175015|NCT03427073|39119289|FG000|Overall Study|Physician Decision|0|||
16175016|NCT03427073|39119290|FG001|Overall Study|Physician Decision|0|||
16175017|NCT03427073|39119291|FG002|Overall Study|Physician Decision|0|||
16175018|NCT03427073|39119292|FG003|Overall Study|Physician Decision|0|||
16175019|NCT03427073|39119293|FG004|Overall Study|Physician Decision|0|||
16175020|NCT03427073|39119294|FG005|Overall Study|Physician Decision|0|||
16175021|NCT03427073|39119295|FG006|Overall Study|Physician Decision|1|||
16175022|NCT03427073|39119296|FG007|Overall Study|Physician Decision|1|||
16175023|NCT02048904|39119297|FG000|Overall Study|Withdrawal by Subject|7|||
16175024|NCT02048904|39119297|FG000|Overall Study|Physician Decision|70|||
16175025|NCT01491178|39119298|FG000|Overall Study|Adverse Event|1016|||
16175026|NCT01491178|39119298|FG000|Overall Study|Improvement of NVAF|210|||
16175027|NCT01491178|39119298|FG000|Overall Study|To conduct invasive treatment|59|||
16175028|NCT01491178|39119298|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
16175029|NCT01491178|39119298|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
16175030|NCT01491178|39119298|FG000|Overall Study|To take a contraindication|20|||
16175031|NCT01491178|39119298|FG000|Overall Study|Other than specified above|657|||
16175032|NCT03567187|39119301|FG000|Overall Study|Lost to Follow-up|18|||
16175033|NCT01891643|39119303|FG000|Overall Study|Adverse event unrelated to study drug|2|||
16175034|NCT01891643|39119304|FG001|Overall Study|Adverse event unrelated to study drug|5|||
16175035|NCT01891643|39119303|FG000|Overall Study|Disease Progression|4|||
16175036|NCT01891643|39119304|FG001|Overall Study|Disease Progression|3|||
16175037|NCT01891643|39119303|FG000|Overall Study|Study Drug Toxicity|3|||
16175038|NCT01891643|39119304|FG001|Overall Study|Study Drug Toxicity|0|||
16175039|NCT01891643|39119303|FG000|Overall Study|Maximum Clinical Benefit|0|||
16175040|NCT01891643|39119304|FG001|Overall Study|Maximum Clinical Benefit|1|||
16175041|NCT01891643|39119303|FG000|Overall Study|Poor/Non-compliance|0|||
16175042|NCT01891643|39119304|FG001|Overall Study|Poor/Non-compliance|1|||
16175043|NCT01891643|39119303|FG000|Overall Study|Participant request to discontinue|1|||
16175044|NCT01891643|39119304|FG001|Overall Study|Participant request to discontinue|0|||
16175045|NCT02635204|39119307|FG000|Overall Study|Adverse Event|1|||
16175046|NCT02635204|39119308|FG001|Overall Study|Adverse Event|0|||
16175047|NCT02635204|39119307|FG000|Overall Study|Lost to Follow-up|1|||
16175048|NCT02635204|39119308|FG001|Overall Study|Lost to Follow-up|1|||
16175049|NCT03263806|39119309|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
16175050|NCT03263806|39119310|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
16175051|NCT03263806|39119309|FG000|Overall Study|Withdrawal by Subject|0|||
16175052|NCT03263806|39119310|FG001|Overall Study|Withdrawal by Subject|1|||
16175053|NCT03263806|39119309|FG000|Overall Study|Study Termination|5|||
16175054|NCT03263806|39119310|FG001|Overall Study|Study Termination|6|||
16175055|NCT02240706|39119311|FG000|Overall Study|Lack of Efficacy|2|||
16175056|NCT02240706|39119312|FG001|Overall Study|Lack of Efficacy|2|||
16175057|NCT02240706|39119313|FG002|Overall Study|Lack of Efficacy|2|||
16175058|NCT02240706|39119314|FG003|Overall Study|Lack of Efficacy|2|||
16175059|NCT02240706|39119315|FG004|Overall Study|Lack of Efficacy|5|||
16175060|NCT02240706|39119316|FG005|Overall Study|Lack of Efficacy|0|||
16175061|NCT02240706|39119317|FG006|Overall Study|Lack of Efficacy|0|||
16175062|NCT02240706|39119311|FG000|Overall Study|Adverse Event|1|||
16175063|NCT02240706|39119312|FG001|Overall Study|Adverse Event|0|||
16175064|NCT02240706|39119313|FG002|Overall Study|Adverse Event|1|||
16175065|NCT02240706|39119314|FG003|Overall Study|Adverse Event|0|||
16175066|NCT02240706|39119315|FG004|Overall Study|Adverse Event|2|||
16175067|NCT02240706|39119316|FG005|Overall Study|Adverse Event|0|||
16175068|NCT02240706|39119317|FG006|Overall Study|Adverse Event|0|||
16175069|NCT02240706|39119311|FG000|Overall Study|Progressive disease|0|||
16175070|NCT02240706|39119312|FG001|Overall Study|Progressive disease|0|||
16175071|NCT02240706|39119313|FG002|Overall Study|Progressive disease|0|||
16175072|NCT02240706|39119314|FG003|Overall Study|Progressive disease|0|||
16175073|NCT02240706|39119315|FG004|Overall Study|Progressive disease|1|||
16175074|NCT02240706|39119316|FG005|Overall Study|Progressive disease|0|||
16175075|NCT02240706|39119317|FG006|Overall Study|Progressive disease|0|||
16175076|NCT02240706|39119311|FG000|Overall Study|Dose limiting toxicity|0|||
16175077|NCT02240706|39119312|FG001|Overall Study|Dose limiting toxicity|0|||
16175078|NCT02240706|39119313|FG002|Overall Study|Dose limiting toxicity|0|||
16175079|NCT02240706|39119314|FG003|Overall Study|Dose limiting toxicity|0|||
16175080|NCT02240706|39119315|FG004|Overall Study|Dose limiting toxicity|1|||
16175081|NCT02240706|39119316|FG005|Overall Study|Dose limiting toxicity|0|||
16175082|NCT02240706|39119317|FG006|Overall Study|Dose limiting toxicity|0|||
16175083|NCT02240706|39119311|FG000|Overall Study|Refused to continue taking medication|0|||
16175084|NCT02240706|39119312|FG001|Overall Study|Refused to continue taking medication|1|||
16175085|NCT02240706|39119313|FG002|Overall Study|Refused to continue taking medication|3|||
16175086|NCT02240706|39119314|FG003|Overall Study|Refused to continue taking medication|1|||
16175087|NCT02240706|39119315|FG004|Overall Study|Refused to continue taking medication|2|||
16175088|NCT02240706|39119316|FG005|Overall Study|Refused to continue taking medication|0|||
16175089|NCT02240706|39119317|FG006|Overall Study|Refused to continue taking medication|0|||
16175090|NCT02240706|39119311|FG000|Overall Study|Insurance billing concerns|0|||
16175091|NCT02240706|39119312|FG001|Overall Study|Insurance billing concerns|0|||
16175092|NCT02240706|39119313|FG002|Overall Study|Insurance billing concerns|0|||
16175093|NCT02240706|39119314|FG003|Overall Study|Insurance billing concerns|1|||
16175094|NCT02240706|39119315|FG004|Overall Study|Insurance billing concerns|0|||
16175095|NCT02240706|39119316|FG005|Overall Study|Insurance billing concerns|0|||
16175096|NCT02240706|39119317|FG006|Overall Study|Insurance billing concerns|0|||
16175097|NCT01829048|39119325|FG000|Overall Study|Withdrawal by Subject|0|||
16175098|NCT01829048|39119326|FG001|Overall Study|Withdrawal by Subject|0|||
16175099|NCT01829048|39119327|FG002|Overall Study|Withdrawal by Subject|0|||
16175100|NCT01829048|39119328|FG003|Overall Study|Withdrawal by Subject|2|||
16175101|NCT01829048|39119329|FG004|Overall Study|Withdrawal by Subject|0|||
16175102|NCT01412879|39119332|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
16175103|NCT01412879|39119333|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
16175104|NCT01412879|39119334|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
16175105|NCT01412879|39119332|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
16175106|NCT01412879|39119333|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
16175107|NCT01412879|39119334|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
16175108|NCT01412879|39119332|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
16175109|NCT01412879|39119333|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
16175110|NCT01412879|39119334|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
16175111|NCT01412879|39119332|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
16175112|NCT01412879|39119333|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
16175113|NCT01412879|39119334|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
16175114|NCT01412879|39119332|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
16175115|NCT01412879|39119333|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
16175116|NCT01412879|39119334|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
16175117|NCT02272790|39119337|FG000|Overall Study|Physician Decision|0|||
16175118|NCT02272790|39119338|FG001|Overall Study|Physician Decision|1|||
16175119|NCT02272790|39119339|FG002|Overall Study|Physician Decision|0|||
16175120|NCT02272790|39119340|FG003|Overall Study|Physician Decision|0|||
16175121|NCT02272790|39119341|FG004|Overall Study|Physician Decision|0|||
16175122|NCT02272790|39119342|FG005|Overall Study|Physician Decision|0|||
16175123|NCT01642212|39119343|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
16175124|NCT01642212|39119344|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
16175125|NCT01642212|39119345|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
16175126|NCT01642212|39119346|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
16175127|NCT01642212|39119347|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
16175128|NCT01642212|39119343|FG000|Double-blind Treatment|Other|0|||
16175129|NCT01642212|39119344|FG001|Double-blind Treatment|Other|2|||
16175130|NCT01642212|39119345|FG002|Double-blind Treatment|Other|1|||
16175131|NCT01642212|39119346|FG003|Double-blind Treatment|Other|0|||
16175132|NCT01642212|39119347|FG004|Double-blind Treatment|Other|0|||
16175133|NCT01642212|39119343|FG000|Double-blind Treatment|Non-compliance|0|||
16175134|NCT01642212|39119344|FG001|Double-blind Treatment|Non-compliance|1|||
16175135|NCT01642212|39119345|FG002|Double-blind Treatment|Non-compliance|0|||
16175136|NCT01642212|39119346|FG003|Double-blind Treatment|Non-compliance|0|||
16175137|NCT01642212|39119347|FG004|Double-blind Treatment|Non-compliance|0|||
16175138|NCT01642212|39119343|FG000|Double-blind Treatment|Adverse Event|0|||
16175139|NCT01642212|39119344|FG001|Double-blind Treatment|Adverse Event|0|||
16175140|NCT01642212|39119345|FG002|Double-blind Treatment|Adverse Event|1|||
16175141|NCT01642212|39119346|FG003|Double-blind Treatment|Adverse Event|0|||
16175142|NCT01642212|39119347|FG004|Double-blind Treatment|Adverse Event|0|||
16175143|NCT01642212|39119343|FG000|Open-label Extension|Adverse Event|0|||
16175144|NCT01642212|39119344|FG001|Open-label Extension|Adverse Event|0|||
16175145|NCT01642212|39119345|FG002|Open-label Extension|Adverse Event|0|||
16175146|NCT01642212|39119346|FG003|Open-label Extension|Adverse Event|3|||
16175147|NCT01642212|39119347|FG004|Open-label Extension|Adverse Event|0|||
16175148|NCT01642212|39119343|FG000|Open-label Extension|Sponsor Decision|0|||
16175149|NCT01642212|39119344|FG001|Open-label Extension|Sponsor Decision|0|||
16175150|NCT01642212|39119345|FG002|Open-label Extension|Sponsor Decision|0|||
16175151|NCT01642212|39119346|FG003|Open-label Extension|Sponsor Decision|7|||
16175152|NCT01642212|39119347|FG004|Open-label Extension|Sponsor Decision|4|||
16175153|NCT01642212|39119343|FG000|Open-label Extension|Consent Withdrawn|0|||
16175154|NCT01642212|39119344|FG001|Open-label Extension|Consent Withdrawn|0|||
16175155|NCT01642212|39119345|FG002|Open-label Extension|Consent Withdrawn|0|||
16175156|NCT01642212|39119346|FG003|Open-label Extension|Consent Withdrawn|0|||
16175157|NCT01642212|39119347|FG004|Open-label Extension|Consent Withdrawn|2|||
16175158|NCT01642212|39119343|FG000|Open-label Extension|Lost to Follow-up|0|||
16175159|NCT01642212|39119344|FG001|Open-label Extension|Lost to Follow-up|0|||
16175160|NCT01642212|39119345|FG002|Open-label Extension|Lost to Follow-up|0|||
16175161|NCT01642212|39119346|FG003|Open-label Extension|Lost to Follow-up|0|||
16175162|NCT01642212|39119347|FG004|Open-label Extension|Lost to Follow-up|1|||
16175163|NCT01642212|39119343|FG000|Open-label Extension|Other|0|||
16175164|NCT01642212|39119344|FG001|Open-label Extension|Other|0|||
16175165|NCT01642212|39119345|FG002|Open-label Extension|Other|0|||
16175166|NCT01642212|39119346|FG003|Open-label Extension|Other|0|||
16175167|NCT01642212|39119347|FG004|Open-label Extension|Other|1|||
16175168|NCT01478958|39119348|FG000|Overall Study|Withdrawal by Subject|1|||
16175169|NCT01478958|39119349|FG001|Overall Study|Withdrawal by Subject|1|||
16175170|NCT01478958|39119350|FG002|Overall Study|Withdrawal by Subject|1|||
16175171|NCT01478958|39119348|FG000|Overall Study|Weight loss|1|||
16175172|NCT01478958|39119349|FG001|Overall Study|Weight loss|0|||
16175173|NCT01478958|39119350|FG002|Overall Study|Weight loss|0|||
16175174|NCT01478958|39119348|FG000|Overall Study|Re-located|0|||
16175175|NCT01478958|39119349|FG001|Overall Study|Re-located|1|||
16175176|NCT01478958|39119350|FG002|Overall Study|Re-located|0|||
16175177|NCT01478958|39119348|FG000|Overall Study|Unable to comply|0|||
16175178|NCT01478958|39119349|FG001|Overall Study|Unable to comply|0|||
16175179|NCT01478958|39119350|FG002|Overall Study|Unable to comply|2|||
16175180|NCT01686568|39119353|FG000|Main Study|Withdrawal by Subject|1|||
16175181|NCT01686568|39119354|FG001|Main Study|Withdrawal by Subject|3|||
16175182|NCT01686568|39119353|FG000|Main Study|Noncompliance with protocol|0|||
16175183|NCT01686568|39119354|FG001|Main Study|Noncompliance with protocol|1|||
16175184|NCT01686568|39119353|FG000|Main Study|Liver enzymes above range of exclusion|1|||
16175185|NCT01686568|39119354|FG001|Main Study|Liver enzymes above range of exclusion|0|||
16175186|NCT01686568|39119353|FG000|Sub-Study|Not consented for sub-study|2|||
16175187|NCT01686568|39119354|FG001|Sub-Study|Not consented for sub-study|2|||
16175188|NCT01717638|39119355|FG000|Overall Study|Lost to Follow-up|0|||
16175189|NCT01717638|39119356|FG001|Overall Study|Lost to Follow-up|0|||
16175190|NCT01717638|39119357|FG002|Overall Study|Lost to Follow-up|0|||
16175191|NCT01717638|39119358|FG003|Overall Study|Lost to Follow-up|0|||
16175192|NCT01717638|39119359|FG004|Overall Study|Lost to Follow-up|0|||
16175193|NCT01717638|39119360|FG005|Overall Study|Lost to Follow-up|1|||
16175194|NCT01717638|39119361|FG006|Overall Study|Lost to Follow-up|0|||
16175195|NCT01717638|39119362|FG007|Overall Study|Lost to Follow-up|0|||
16175196|NCT01717638|39119363|FG008|Overall Study|Lost to Follow-up|0|||
16274878|NCT03428750|39490201|FG001|Overall Study|Lost to Follow-up|9|||
16274879|NCT03428750|39490200|FG000|Overall Study|Adverse Event|9|||
16274880|NCT03428750|39490201|FG001|Overall Study|Adverse Event|1|||
16274881|NCT03428750|39490200|FG000|Overall Study|Protocol Violation|1|||
16274882|NCT03428750|39490201|FG001|Overall Study|Protocol Violation|0|||
16274883|NCT03428750|39490200|FG000|Overall Study|Administrative|0|||
16274884|NCT03428750|39490201|FG001|Overall Study|Administrative|1|||
16274885|NCT05412121|39490202|FG000|Overall Study|Withdrawal by Subject|4|||
16274886|NCT05412121|39490202|FG000|Overall Study|Physician Decision|1|||
16274887|NCT05412121|39490202|FG000|Overall Study|Lost to Follow-up|5|||
16274888|NCT05278858|39490203|FG000|Overall Study|Withdrawal by Subject|1|||
16274889|NCT04608448|39490204|FG000|Overall Study|Withdrawal by Subject|1|||
16274890|NCT04608448|39490204|FG000|Overall Study|Adverse Event|1|||
16274891|NCT00440115|39490210|FG000|Overall Study|Death|7|||
16274892|NCT00440115|39490211|FG001|Overall Study|Death|9|||
16274893|NCT00440115|39490212|FG002|Overall Study|Death|5|||
16274894|NCT00440115|39490210|FG000|Overall Study|Incarceration|0|||
16274895|NCT00440115|39490211|FG001|Overall Study|Incarceration|2|||
16274896|NCT00440115|39490212|FG002|Overall Study|Incarceration|1|||
16274897|NCT00570128|39490214|FG000|Overall Study|Adverse Event|1|||
16274898|NCT00570128|39490215|FG001|Overall Study|Adverse Event|0|||
16274899|NCT00570128|39490214|FG000|Overall Study|Lost to Follow-up|1|||
16274900|NCT00570128|39490215|FG001|Overall Study|Lost to Follow-up|0|||
16274901|NCT00570128|39490214|FG000|Overall Study|Withdrawal by Subject|2|||
16274902|NCT00570128|39490215|FG001|Overall Study|Withdrawal by Subject|0|||
16274903|NCT00640341|39490216|FG000|Overall Study|Adverse Event|0|||
16274904|NCT00640341|39490217|FG001|Overall Study|Adverse Event|0|||
16274905|NCT00640341|39490218|FG002|Overall Study|Adverse Event|1|||
16175197|NCT01717638|39119364|FG009|Overall Study|Lost to Follow-up|0|||
16175198|NCT01717638|39119365|FG010|Overall Study|Lost to Follow-up|0|||
16175199|NCT01717638|39119366|FG011|Overall Study|Lost to Follow-up|0|||
16175200|NCT01717638|39119367|FG012|Overall Study|Lost to Follow-up|0|||
16175201|NCT01717638|39119355|FG000|Overall Study|Father in hospital|0|||
16175202|NCT01717638|39119356|FG001|Overall Study|Father in hospital|0|||
16175203|NCT01717638|39119357|FG002|Overall Study|Father in hospital|0|||
16175204|NCT01717638|39119358|FG003|Overall Study|Father in hospital|0|||
16175205|NCT01717638|39119359|FG004|Overall Study|Father in hospital|0|||
16175206|NCT01717638|39119360|FG005|Overall Study|Father in hospital|0|||
16175207|NCT01717638|39119361|FG006|Overall Study|Father in hospital|0|||
16175208|NCT01717638|39119362|FG007|Overall Study|Father in hospital|0|||
16175209|NCT01717638|39119363|FG008|Overall Study|Father in hospital|0|||
16175210|NCT01717638|39119364|FG009|Overall Study|Father in hospital|0|||
16175211|NCT01717638|39119365|FG010|Overall Study|Father in hospital|0|||
16175212|NCT01717638|39119366|FG011|Overall Study|Father in hospital|0|||
16175213|NCT01717638|39119367|FG012|Overall Study|Father in hospital|1|||
16175214|NCT01717638|39119355|FG000|Overall Study|Withdrawal by Subject|0|||
16175215|NCT01717638|39119356|FG001|Overall Study|Withdrawal by Subject|1|||
16274906|NCT00640341|39490216|FG000|Overall Study|Positive Slit Lamp Findings|0|||
16175216|NCT01717638|39119357|FG002|Overall Study|Withdrawal by Subject|1|||
16175217|NCT01717638|39119358|FG003|Overall Study|Withdrawal by Subject|0|||
16274907|NCT00640341|39490217|FG001|Overall Study|Positive Slit Lamp Findings|0|||
16175218|NCT01717638|39119359|FG004|Overall Study|Withdrawal by Subject|1|||
16175219|NCT01717638|39119360|FG005|Overall Study|Withdrawal by Subject|0|||
16175220|NCT01717638|39119361|FG006|Overall Study|Withdrawal by Subject|2|||
16175221|NCT01717638|39119362|FG007|Overall Study|Withdrawal by Subject|1|||
16175222|NCT01717638|39119363|FG008|Overall Study|Withdrawal by Subject|2|||
16175223|NCT01717638|39119364|FG009|Overall Study|Withdrawal by Subject|1|||
16175224|NCT01717638|39119365|FG010|Overall Study|Withdrawal by Subject|0|||
16175225|NCT01717638|39119366|FG011|Overall Study|Withdrawal by Subject|0|||
16175226|NCT01717638|39119367|FG012|Overall Study|Withdrawal by Subject|18|||
16175227|NCT04433117|39119370|FG000|Overall Study|Withdrawal by Subject|1|||
16175228|NCT04433117|39119371|FG001|Overall Study|Withdrawal by Subject|0|||
16175229|NCT00432809|39119372|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
16175230|NCT00432809|39119373|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
16175231|NCT00432809|39119374|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
16175232|NCT00432809|39119372|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
16175233|NCT00432809|39119373|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
16175234|NCT00432809|39119374|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
16175235|NCT05502289|39119377|FG000|Period 1|Out Of Window|1|||
16175236|NCT05502289|39119378|FG001|Period 1|Out Of Window|0|||
16175237|NCT00238264|39119379|FG000|Overall Study|Death|7|||
16175238|NCT00238264|39119379|FG000|Overall Study|Lost to Follow-up|18|||
16175239|NCT00238264|39119379|FG000|Overall Study|Withdrawal by Subject|4|||
16175240|NCT00238264|39119379|FG000|Overall Study|Ineligible|7|||
16175241|NCT01672892|39119380|FG000|Overall Study|Protocol Violation|7|||
16175242|NCT01672892|39119381|FG001|Overall Study|Protocol Violation|3|||
16175243|NCT02318602|39119385|FG000|Overall Study|Adverse Event|0|||
16175244|NCT02318602|39119386|FG001|Overall Study|Adverse Event|1|||
16175245|NCT02318602|39119387|FG002|Overall Study|Adverse Event|1|||
16175246|NCT02318602|39119385|FG000|Overall Study|Withdrawal by Subject|0|||
16175247|NCT02318602|39119386|FG001|Overall Study|Withdrawal by Subject|3|||
16175248|NCT02318602|39119387|FG002|Overall Study|Withdrawal by Subject|0|||
16175249|NCT02318602|39119385|FG000|Overall Study|Death|1|||
16175250|NCT02318602|39119386|FG001|Overall Study|Death|0|||
16175251|NCT02318602|39119387|FG002|Overall Study|Death|0|||
16175252|NCT02318602|39119385|FG000|Overall Study|Guardian decision to withdraw|0|||
16175253|NCT02318602|39119386|FG001|Overall Study|Guardian decision to withdraw|0|||
16175254|NCT02318602|39119387|FG002|Overall Study|Guardian decision to withdraw|1|||
16175255|NCT00658333|39119388|FG000|Overall Study|Adverse Event|2|||
16175256|NCT00658333|39119389|FG001|Overall Study|Adverse Event|1|||
16175257|NCT01287754|39119390|FG000|Overall Study|Death|2|||
16175258|NCT01287754|39119391|FG001|Overall Study|Death|12|||
16175259|NCT01287754|39119390|FG000|Overall Study|Lost to Follow-up|1|||
16175260|NCT01287754|39119391|FG001|Overall Study|Lost to Follow-up|6|||
16175261|NCT01287754|39119390|FG000|Overall Study|Protocol Violation|0|||
16175262|NCT01287754|39119391|FG001|Overall Study|Protocol Violation|3|||
16175263|NCT00283387|39119393|FG000|First Intervention|Subject non-compliant|1|||
16175264|NCT00283387|39119394|FG001|First Intervention|Subject non-compliant|1|||
16175265|NCT00283387|39119393|FG000|First Intervention|Withdrawal by Subject|0|||
16175266|NCT00283387|39119394|FG001|First Intervention|Withdrawal by Subject|1|||
16175267|NCT00851903|39119395|FG000|Overall Study|Withdrawal by Subject|2|||
16175268|NCT05408858|39119396|FG000|Overall Study|no longer met eligibility criteria|1|||
16175269|NCT00935883|39119401|FG000|Treatment Period|Physician Decision|1|||
16175270|NCT00935883|39119402|FG001|Treatment Period|Physician Decision|0|||
16175271|NCT00935883|39119401|FG000|Treatment Period|Withdrawal by Subject|0|||
16175272|NCT00935883|39119402|FG001|Treatment Period|Withdrawal by Subject|2|||
16175273|NCT03584009|39119407|FG000|Overall Study|Death|25|||
16175274|NCT03584009|39119408|FG001|Overall Study|Death|18|||
16175275|NCT03584009|39119407|FG000|Overall Study|Lost to Follow-up|0|||
16175276|NCT03584009|39119408|FG001|Overall Study|Lost to Follow-up|1|||
16175277|NCT03584009|39119407|FG000|Overall Study|Physician Decision|1|||
16175278|NCT03584009|39119408|FG001|Overall Study|Physician Decision|1|||
16175279|NCT03584009|39119407|FG000|Overall Study|Study Terminated by Sponsor|22|||
16175280|NCT03584009|39119408|FG001|Overall Study|Study Terminated by Sponsor|30|||
16175281|NCT03584009|39119407|FG000|Overall Study|Withdrawal by Subject|3|||
16175282|NCT03584009|39119408|FG001|Overall Study|Withdrawal by Subject|2|||
16175283|NCT00752986|39119410|FG000|Overall Study|Withdrawal by Subject|2|||
16175284|NCT00752986|39119411|FG001|Overall Study|Withdrawal by Subject|1|||
16175285|NCT00752986|39119412|FG002|Overall Study|Withdrawal by Subject|2|||
16175286|NCT00752986|39119410|FG000|Overall Study|Protocol Violation|3|||
16175287|NCT00752986|39119411|FG001|Overall Study|Protocol Violation|0|||
16175288|NCT00752986|39119412|FG002|Overall Study|Protocol Violation|0|||
16175289|NCT02909153|39119413|FG000|Overall Study|Withdrawal by Subject|0|||
16175290|NCT02909153|39119414|FG001|Overall Study|Withdrawal by Subject|1|||
16175291|NCT02909153|39119415|FG002|Overall Study|Withdrawal by Subject|0|||
16175292|NCT02909153|39119416|FG003|Overall Study|Withdrawal by Subject|0|||
16175293|NCT02909153|39119417|FG004|Overall Study|Withdrawal by Subject|0|||
16175294|NCT01650805|39119418|FG000|Overall Study|Withdrawal by Subject|1|||
16175295|NCT01650805|39119419|FG001|Overall Study|Withdrawal by Subject|0|||
16175296|NCT04321343|39119420|FG000|Overall Study|Adverse Event|0|||
16175297|NCT04321343|39119421|FG001|Overall Study|Adverse Event|0|||
16175298|NCT04321343|39119422|FG002|Overall Study|Adverse Event|1|||
16175299|NCT04321343|39119423|FG003|Overall Study|Adverse Event|0|||
16175300|NCT04321343|39119420|FG000|Overall Study|Death|0|||
16175301|NCT04321343|39119421|FG001|Overall Study|Death|0|||
16175302|NCT04321343|39119422|FG002|Overall Study|Death|0|||
16175303|NCT04321343|39119423|FG003|Overall Study|Death|1|||
16175304|NCT04321343|39119420|FG000|Overall Study|Pregnancy|1|||
16175305|NCT04321343|39119421|FG001|Overall Study|Pregnancy|0|||
16175306|NCT04321343|39119422|FG002|Overall Study|Pregnancy|0|||
16175307|NCT04321343|39119423|FG003|Overall Study|Pregnancy|0|||
16175308|NCT04321343|39119420|FG000|Overall Study|Protocol Violation|1|||
16175309|NCT04321343|39119421|FG001|Overall Study|Protocol Violation|1|||
16175310|NCT04321343|39119422|FG002|Overall Study|Protocol Violation|1|||
16175311|NCT04321343|39119423|FG003|Overall Study|Protocol Violation|1|||
16175312|NCT04321343|39119420|FG000|Overall Study|Withdrawal by Subject|0|||
16175313|NCT04321343|39119421|FG001|Overall Study|Withdrawal by Subject|6|||
16175314|NCT04321343|39119422|FG002|Overall Study|Withdrawal by Subject|0|||
16175315|NCT04321343|39119423|FG003|Overall Study|Withdrawal by Subject|2|||
16175316|NCT04321343|39119420|FG000|Overall Study|Lost to Follow-up|2|||
16175317|NCT04321343|39119421|FG001|Overall Study|Lost to Follow-up|2|||
16175318|NCT04321343|39119422|FG002|Overall Study|Lost to Follow-up|1|||
16175319|NCT04321343|39119423|FG003|Overall Study|Lost to Follow-up|3|||
16175320|NCT03874234|39119424|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175321|NCT03874234|39119425|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175322|NCT03874234|39119426|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175323|NCT03874234|39119427|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
16175324|NCT03874234|39119428|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175325|NCT03874234|39119429|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175326|NCT03874234|39119430|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175327|NCT03874234|39119431|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175328|NCT03874234|39119432|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175329|NCT03874234|39119433|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175330|NCT03874234|39119434|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175331|NCT03874234|39119435|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175332|NCT03874234|39119436|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
16175333|NCT03874234|39119424|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
16175334|NCT03874234|39119425|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175335|NCT03874234|39119426|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175336|NCT03874234|39119427|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175337|NCT03874234|39119428|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175338|NCT03874234|39119429|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175339|NCT03874234|39119430|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175340|NCT03874234|39119431|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175341|NCT03874234|39119432|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175342|NCT03874234|39119433|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175343|NCT03874234|39119434|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175344|NCT03874234|39119435|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175345|NCT03874234|39119436|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
16175346|NCT03874234|39119424|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175347|NCT03874234|39119425|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175348|NCT03874234|39119426|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175349|NCT03874234|39119427|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
16175350|NCT03874234|39119428|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175351|NCT03874234|39119429|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175352|NCT03874234|39119430|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175353|NCT03874234|39119431|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175354|NCT03874234|39119432|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175355|NCT03874234|39119433|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175356|NCT03874234|39119434|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175357|NCT03874234|39119435|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175358|NCT03874234|39119436|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
16175359|NCT03874234|39119424|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175360|NCT03874234|39119425|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175361|NCT03874234|39119426|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175362|NCT03874234|39119427|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175363|NCT03874234|39119428|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
16175364|NCT03874234|39119429|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175365|NCT03874234|39119430|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175366|NCT03874234|39119431|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175367|NCT03874234|39119432|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175368|NCT03874234|39119433|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175369|NCT03874234|39119434|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175370|NCT03874234|39119435|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175371|NCT03874234|39119436|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
16175372|NCT03874234|39119424|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175373|NCT03874234|39119425|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175374|NCT03874234|39119426|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175375|NCT03874234|39119427|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175376|NCT03874234|39119428|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175377|NCT03874234|39119429|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175378|NCT03874234|39119430|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175379|NCT03874234|39119431|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
16175380|NCT03874234|39119432|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175381|NCT03874234|39119433|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175382|NCT03874234|39119434|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175383|NCT03874234|39119435|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175384|NCT03874234|39119436|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
16175385|NCT03874234|39119424|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175386|NCT03874234|39119425|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175387|NCT03874234|39119426|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175388|NCT03874234|39119427|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175389|NCT03874234|39119428|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
16175390|NCT03874234|39119429|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
16175391|NCT03874234|39119430|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175392|NCT03874234|39119431|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175393|NCT03874234|39119432|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175394|NCT03874234|39119433|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175395|NCT03874234|39119434|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175396|NCT03874234|39119435|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175397|NCT03874234|39119436|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
16175398|NCT03874234|39119424|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175399|NCT03874234|39119425|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175400|NCT03874234|39119426|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175401|NCT03874234|39119427|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175402|NCT03874234|39119428|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175403|NCT03874234|39119429|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175404|NCT03874234|39119430|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
16175405|NCT03874234|39119431|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175406|NCT03874234|39119432|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175407|NCT03874234|39119433|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175408|NCT03874234|39119434|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175409|NCT03874234|39119435|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175410|NCT03874234|39119436|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
16175411|NCT03874234|39119424|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175412|NCT03874234|39119425|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175413|NCT03874234|39119426|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175414|NCT03874234|39119427|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175415|NCT03874234|39119428|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
16175416|NCT03874234|39119429|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175417|NCT03874234|39119430|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175418|NCT03874234|39119431|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175419|NCT03874234|39119432|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175420|NCT03874234|39119433|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175421|NCT03874234|39119434|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175422|NCT03874234|39119435|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175423|NCT03874234|39119436|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
16175424|NCT00332202|39119437|FG000|Overall Study|Adverse Event|72|||
16175425|NCT00332202|39119438|FG001|Overall Study|Adverse Event|28|||
16175426|NCT00332202|39119437|FG000|Overall Study|Lost to Follow-up|2|||
16175427|NCT00332202|39119438|FG001|Overall Study|Lost to Follow-up|1|||
16175428|NCT00332202|39119437|FG000|Overall Study|Physician Decision|6|||
16175429|NCT00332202|39119438|FG001|Overall Study|Physician Decision|8|||
16175430|NCT00332202|39119437|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
16175431|NCT00332202|39119438|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
16175432|NCT00332202|39119437|FG000|Overall Study|Protocol Violation|7|||
16175433|NCT00332202|39119438|FG001|Overall Study|Protocol Violation|2|||
16175434|NCT00332202|39119437|FG000|Overall Study|Sponsor Decision|1|||
16175435|NCT00332202|39119438|FG001|Overall Study|Sponsor Decision|2|||
16175436|NCT00332202|39119437|FG000|Overall Study|Withdrawal by Subject|36|||
16175437|NCT00332202|39119438|FG001|Overall Study|Withdrawal by Subject|17|||
16175438|NCT00332202|39119437|FG000|Overall Study|Progressive Disease|106|||
16175439|NCT00332202|39119438|FG001|Overall Study|Progressive Disease|60|||
16175440|NCT00332202|39119437|FG000|Overall Study|Death|5|||
16175441|NCT00332202|39119438|FG001|Overall Study|Death|2|||
16175442|NCT00768222|39119439|FG000|Overall Study|Lost to Follow-up|1|||
16175443|NCT00768222|39119440|FG001|Overall Study|Lost to Follow-up|1|||
16175444|NCT00768222|39119439|FG000|Overall Study|Withdrawal by Subject|3|||
16175445|NCT00768222|39119440|FG001|Overall Study|Withdrawal by Subject|1|||
16175446|NCT00768222|39119439|FG000|Overall Study|Protocol Violation|0|||
16175447|NCT00768222|39119440|FG001|Overall Study|Protocol Violation|2|||
16175448|NCT03358472|39119441|FG000|Overall Study|Death|6|||
16175449|NCT03358472|39119442|FG001|Overall Study|Death|3|||
16175450|NCT03358472|39119443|FG002|Overall Study|Death|10|||
16175451|NCT03358472|39119441|FG000|Overall Study|Physician Decision|0|||
16175452|NCT03358472|39119442|FG001|Overall Study|Physician Decision|1|||
16175453|NCT03358472|39119443|FG002|Overall Study|Physician Decision|0|||
16175454|NCT03358472|39119441|FG000|Overall Study|Withdrawal by Subject|0|||
16175455|NCT03358472|39119442|FG001|Overall Study|Withdrawal by Subject|0|||
16175456|NCT03358472|39119443|FG002|Overall Study|Withdrawal by Subject|1|||
16175457|NCT03358472|39119441|FG000|Overall Study|On-going at clinical cut off date|9|||
16175458|NCT03358472|39119442|FG001|Overall Study|On-going at clinical cut off date|6|||
16175459|NCT03358472|39119443|FG002|Overall Study|On-going at clinical cut off date|5|||
16175460|NCT00144170|39119446|FG000|Overall Study|Adverse Event|84|||
16175461|NCT00144170|39119447|FG001|Overall Study|Adverse Event|41|||
16175462|NCT00144170|39119446|FG000|Overall Study|Protocol Violation|23|||
16175463|NCT00144170|39119447|FG001|Overall Study|Protocol Violation|16|||
16175464|NCT00144170|39119446|FG000|Overall Study|Lost to Follow-up|5|||
16175465|NCT00144170|39119447|FG001|Overall Study|Lost to Follow-up|10|||
16175466|NCT00144170|39119446|FG000|Overall Study|Withdrawal by Subject|29|||
16175467|NCT00144170|39119447|FG001|Overall Study|Withdrawal by Subject|13|||
16175468|NCT00144170|39119446|FG000|Overall Study|Other reason not defined above|211|||
16175469|NCT00144170|39119447|FG001|Overall Study|Other reason not defined above|316|||
16175470|NCT05369806|39119450|FG000|Overall Study|Lost to Follow-up|1|||
16175471|NCT01748071|39119456|FG000|Overall Study|Adverse Event|2|||
16175472|NCT01748071|39119457|FG001|Overall Study|Adverse Event|2|||
16175473|NCT01748071|39119458|FG002|Overall Study|Adverse Event|0|||
16175474|NCT01948830|39119461|FG000|Overall Study|Physician Decision|1|||
16175475|NCT01948830|39119462|FG001|Overall Study|Physician Decision|3|||
16175476|NCT01948830|39119461|FG000|Overall Study|Protocol deviation|1|||
16175477|NCT01948830|39119462|FG001|Overall Study|Protocol deviation|2|||
16175478|NCT01948830|39119461|FG000|Overall Study|Lost to Follow-up|5|||
16175479|NCT01948830|39119462|FG001|Overall Study|Lost to Follow-up|4|||
16175480|NCT01948830|39119461|FG000|Overall Study|Withdrawal by Subject|14|||
16175481|NCT01948830|39119462|FG001|Overall Study|Withdrawal by Subject|17|||
16175482|NCT01948830|39119461|FG000|Overall Study|Adverse Event|9|||
16175483|NCT01948830|39119462|FG001|Overall Study|Adverse Event|2|||
16175484|NCT01948830|39119461|FG000|Overall Study|Death|3|||
16175485|NCT01948830|39119462|FG001|Overall Study|Death|4|||
16175486|NCT02537678|39119463|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
16175487|NCT02537678|39119464|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
16175488|NCT02537678|39119463|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
16175489|NCT02537678|39119464|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
16175490|NCT02537678|39119463|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
16175491|NCT02537678|39119464|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
16175492|NCT02537678|39119463|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
16175493|NCT02537678|39119464|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
16175494|NCT02537678|39119463|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
16175495|NCT02537678|39119464|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
16175496|NCT02537678|39119463|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
16175497|NCT02537678|39119464|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
16175498|NCT02537678|39119463|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
16175499|NCT02537678|39119464|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
16175500|NCT00376961|39119465|FG000|Initial Registration|Adverse Event|1|||
16175501|NCT00376961|39119466|FG001|Initial Registration|Adverse Event|0|||
16175502|NCT00376961|39119465|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
16175503|NCT00376961|39119466|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
16175504|NCT00376961|39119465|FG000|Initial Registration|Progression/relapse|1|||
16175505|NCT00376961|39119466|FG001|Initial Registration|Progression/relapse|0|||
16175506|NCT00376961|39119465|FG000|Initial Registration|Ineligible|3|||
16175507|NCT00376961|39119466|FG001|Initial Registration|Ineligible|0|||
16175508|NCT00376961|39119465|FG000|Maintenance|Adverse Event|0|||
16175509|NCT00376961|39119466|FG001|Maintenance|Adverse Event|1|||
16175510|NCT00376961|39119465|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
16175511|NCT00376961|39119466|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
16175512|NCT00376961|39119465|FG000|Maintenance|Progression/relapse|0|||
16175513|NCT00376961|39119466|FG001|Maintenance|Progression/relapse|18|||
16175514|NCT00376961|39119465|FG000|Maintenance|Ineligible|0|||
16175515|NCT00376961|39119466|FG001|Maintenance|Ineligible|3|||
16175516|NCT00393718|39119473|FG000|Overall Study|Adverse Event|20|||
16175517|NCT00393718|39119474|FG001|Overall Study|Adverse Event|8|||
16175518|NCT00393718|39119473|FG000|Overall Study|Protocol Violation|1|||
16175519|NCT00393718|39119474|FG001|Overall Study|Protocol Violation|2|||
16175520|NCT00393718|39119473|FG000|Overall Study|Lack of Efficacy|10|||
16175521|NCT00393718|39119474|FG001|Overall Study|Lack of Efficacy|9|||
16175522|NCT00393718|39119473|FG000|Overall Study|Hypoglycaemia|3|||
16175523|NCT00393718|39119474|FG001|Overall Study|Hypoglycaemia|2|||
16175524|NCT00393718|39119473|FG000|Overall Study|Subject decision|5|||
16175525|NCT00393718|39119474|FG001|Overall Study|Subject decision|0|||
16175526|NCT00393718|39119473|FG000|Overall Study|Withdrawal of consent|2|||
16175527|NCT00393718|39119474|FG001|Overall Study|Withdrawal of consent|1|||
16175528|NCT00393718|39119473|FG000|Overall Study|Missed measurement|1|||
16175529|NCT00393718|39119474|FG001|Overall Study|Missed measurement|0|||
16175530|NCT00393718|39119473|FG000|Overall Study|Move|1|||
16175531|NCT00393718|39119474|FG001|Overall Study|Move|0|||
16175532|NCT02041962|39119479|FG000|Overall Study|Lost Aetna Coverage|43|||
16175533|NCT02041962|39119480|FG001|Overall Study|Lost Aetna Coverage|40|||
16175534|NCT02041962|39119479|FG000|Overall Study|Death|1|||
16175535|NCT02041962|39119480|FG001|Overall Study|Death|1|||
16175536|NCT02041962|39119479|FG000|Overall Study|Lost to Follow-up|37|||
16175537|NCT02041962|39119480|FG001|Overall Study|Lost to Follow-up|32|||
16175538|NCT02041962|39119479|FG000|Overall Study|Withdrawal by Subject|0|||
16175539|NCT02041962|39119480|FG001|Overall Study|Withdrawal by Subject|11|||
16175540|NCT04826900|39119481|FG000|Overall Study|Family factor|1|||
16175541|NCT04826900|39119482|FG001|Overall Study|Family factor|1|||
16175542|NCT00541307|39119491|FG000|Overall Study|Death|5|||
16175543|NCT00541307|39119491|FG000|Overall Study|Physician Decision|3|||
16175544|NCT00541307|39119491|FG000|Overall Study|Withdrawal by Subject|6|||
16175545|NCT00541307|39119491|FG000|Overall Study|Lost to Follow-up|4|||
16175546|NCT00541307|39119491|FG000|Overall Study|Subject returned early (outside window)|1|||
16175547|NCT00541307|39119491|FG000|Overall Study|Surgical Bypass|5|||
16175548|NCT03075839|39122640|FG000|Overall Study|Lost to Follow-up|4|||
16175549|NCT01173653|39122641|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
16175550|NCT01173653|39122642|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
16175551|NCT01059448|39122643|FG000|Overall Study|Adverse Event|1|||
16175552|NCT01059448|39122644|FG001|Overall Study|Adverse Event|3|||
16175553|NCT01059448|39122645|FG002|Overall Study|Adverse Event|0|||
16175554|NCT01059448|39122646|FG003|Overall Study|Adverse Event|1|||
16175555|NCT01059448|39122643|FG000|Overall Study|Withdrawal by Subject|2|||
16175556|NCT01059448|39122644|FG001|Overall Study|Withdrawal by Subject|0|||
16175557|NCT01059448|39122645|FG002|Overall Study|Withdrawal by Subject|2|||
16175558|NCT01059448|39122646|FG003|Overall Study|Withdrawal by Subject|4|||
16175559|NCT01059448|39122643|FG000|Overall Study|Disease Progression|2|||
16175560|NCT01059448|39122644|FG001|Overall Study|Disease Progression|1|||
16175561|NCT01059448|39122645|FG002|Overall Study|Disease Progression|4|||
16175562|NCT01059448|39122646|FG003|Overall Study|Disease Progression|2|||
16175563|NCT01059448|39122643|FG000|Overall Study|Administrative Decision|43|||
16175564|NCT01059448|39122644|FG001|Overall Study|Administrative Decision|49|||
16175565|NCT01059448|39122645|FG002|Overall Study|Administrative Decision|45|||
16175566|NCT01059448|39122646|FG003|Overall Study|Administrative Decision|46|||
16175567|NCT01059448|39122643|FG000|Overall Study|Lost to Follow-up|0|||
16175568|NCT01059448|39122644|FG001|Overall Study|Lost to Follow-up|0|||
16175569|NCT01059448|39122645|FG002|Overall Study|Lost to Follow-up|2|||
16175570|NCT01059448|39122646|FG003|Overall Study|Lost to Follow-up|0|||
16175571|NCT01059448|39122643|FG000|Overall Study|Death|0|||
16175572|NCT01059448|39122644|FG001|Overall Study|Death|1|||
16175573|NCT01059448|39122645|FG002|Overall Study|Death|0|||
16175574|NCT01059448|39122646|FG003|Overall Study|Death|0|||
16175575|NCT01059448|39122643|FG000|Overall Study|Other|1|||
16175576|NCT01059448|39122644|FG001|Overall Study|Other|1|||
16175577|NCT01059448|39122645|FG002|Overall Study|Other|0|||
16175578|NCT01059448|39122646|FG003|Overall Study|Other|1|||
16175579|NCT03427814|39122647|FG000|Overall Study|Withdrawal by Subject|4|||
16175580|NCT03427814|39122648|FG001|Overall Study|Withdrawal by Subject|4|||
16175581|NCT03427814|39122647|FG000|Overall Study|Lost to Follow-up|0|||
16175582|NCT03427814|39122648|FG001|Overall Study|Lost to Follow-up|2|||
16175583|NCT03427814|39122647|FG000|Overall Study|Death|42|||
16175584|NCT03427814|39122648|FG001|Overall Study|Death|31|||
16175585|NCT03427814|39122647|FG000|Overall Study|Sponsor's Decision|1|||
16175586|NCT03427814|39122648|FG001|Overall Study|Sponsor's Decision|0|||
16175587|NCT03427814|39122647|FG000|Overall Study|Investigator's Decision|1|||
16175588|NCT03427814|39122648|FG001|Overall Study|Investigator's Decision|2|||
16175589|NCT03427814|39122647|FG000|Overall Study|Disease progression|1|||
16175590|NCT03427814|39122648|FG001|Overall Study|Disease progression|0|||
16175591|NCT03427814|39122647|FG000|Overall Study|Treatment Completed|0|||
16175592|NCT03427814|39122648|FG001|Overall Study|Treatment Completed|1|||
16175593|NCT03427814|39122647|FG000|Overall Study|Sponsor's Decision to End study|21|||
16175594|NCT03427814|39122648|FG001|Overall Study|Sponsor's Decision to End study|25|||
16175595|NCT03427814|39122647|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
16175596|NCT03427814|39122648|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
16175597|NCT03401749|39122649|FG000|Overall Study|Lost to Follow-up|20|||
16175598|NCT03401749|39122650|FG001|Overall Study|Lost to Follow-up|16|||
16175599|NCT03401749|39122651|FG002|Overall Study|Lost to Follow-up|26|||
16175600|NCT00190775|39122652|FG000|Overall Study|Adverse Event|57|||
16175601|NCT00190775|39122653|FG001|Overall Study|Adverse Event|22|||
16175602|NCT00190775|39122652|FG000|Overall Study|Satisfactory Response|1|||
16175603|NCT00190775|39122653|FG001|Overall Study|Satisfactory Response|0|||
16175604|NCT00190775|39122652|FG000|Overall Study|Lack of Efficacy|28|||
16175605|NCT00190775|39122653|FG001|Overall Study|Lack of Efficacy|32|||
16175606|NCT00190775|39122652|FG000|Overall Study|Lost to Follow-up|31|||
16175607|NCT00190775|39122653|FG001|Overall Study|Lost to Follow-up|23|||
16175608|NCT00190775|39122652|FG000|Overall Study|Participant Moved|0|||
16175609|NCT00190775|39122653|FG001|Overall Study|Participant Moved|1|||
16175610|NCT00190775|39122652|FG000|Overall Study|Withdrawal by Subject|24|||
16175611|NCT00190775|39122653|FG001|Overall Study|Withdrawal by Subject|13|||
16175612|NCT00190775|39122652|FG000|Overall Study|Sponsor Decision|1|||
16175613|NCT00190775|39122653|FG001|Overall Study|Sponsor Decision|0|||
16175614|NCT00190775|39122652|FG000|Overall Study|Physician Decision|3|||
16175615|NCT00190775|39122653|FG001|Overall Study|Physician Decision|0|||
16175616|NCT00190775|39122652|FG000|Overall Study|Noncompliance|3|||
16175617|NCT00190775|39122653|FG001|Overall Study|Noncompliance|5|||
16175618|NCT00190775|39122652|FG000|Overall Study|Protocol Violation|0|||
16175619|NCT00190775|39122653|FG001|Overall Study|Protocol Violation|1|||
16175620|NCT00190775|39122652|FG000|Overall Study|Exclusion Criteria Met|1|||
16175621|NCT00190775|39122653|FG001|Overall Study|Exclusion Criteria Met|3|||
16175622|NCT04964258|39122654|FG000|Overall Study|Lost to Follow-up|1|||
16175623|NCT04964258|39122655|FG001|Overall Study|Lost to Follow-up|0|||
16175624|NCT04964258|39122656|FG002|Overall Study|Lost to Follow-up|0|||
16175625|NCT04964258|39122657|FG003|Overall Study|Lost to Follow-up|0|||
16175626|NCT04964258|39122658|FG004|Overall Study|Lost to Follow-up|0|||
16175627|NCT04964258|39122659|FG005|Overall Study|Lost to Follow-up|1|||
16175628|NCT04964258|39122660|FG006|Overall Study|Lost to Follow-up|0|||
16175629|NCT04964258|39122661|FG007|Overall Study|Lost to Follow-up|0|||
16175630|NCT04964258|39122662|FG008|Overall Study|Lost to Follow-up|0|||
16175631|NCT04964258|39122663|FG009|Overall Study|Lost to Follow-up|0|||
16175632|NCT04964258|39122664|FG010|Overall Study|Lost to Follow-up|0|||
16175633|NCT03022422|39122665|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
16175634|NCT03022422|39122666|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
16175635|NCT03022422|39122667|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
16175636|NCT03022422|39122668|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
16175637|NCT03022422|39122669|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
16175638|NCT03022422|39122670|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
16175639|NCT01295125|39122671|FG000|Overall Study|Study stopped prematurely|9|||
16175640|NCT01486264|39122672|FG000|Overall Study|Death|1|||
16175641|NCT01486264|39122673|FG001|Overall Study|Death|1|||
16175642|NCT01486264|39122672|FG000|Overall Study|Adverse Event|3|||
16175643|NCT01486264|39122673|FG001|Overall Study|Adverse Event|3|||
16175644|NCT01486264|39122672|FG000|Overall Study|Lack of Efficacy|6|||
16175645|NCT01486264|39122673|FG001|Overall Study|Lack of Efficacy|10|||
16175646|NCT01486264|39122672|FG000|Overall Study|Withdrawal by Subject|7|||
16175647|NCT01486264|39122673|FG001|Overall Study|Withdrawal by Subject|18|||
16175648|NCT01486264|39122672|FG000|Overall Study|Physician Decision|1|||
16175649|NCT01486264|39122673|FG001|Overall Study|Physician Decision|1|||
16175650|NCT01486264|39122672|FG000|Overall Study|Protocol Violation|3|||
16175651|NCT01486264|39122673|FG001|Overall Study|Protocol Violation|0|||
16175652|NCT01486264|39122672|FG000|Overall Study|Lost to Follow-up|3|||
16175653|NCT01486264|39122673|FG001|Overall Study|Lost to Follow-up|2|||
16175654|NCT01486264|39122672|FG000|Overall Study|Other|5|||
16175655|NCT01486264|39122673|FG001|Overall Study|Other|11|||
16175656|NCT01486264|39122672|FG000|Overall Study|Not treated|0|||
16175657|NCT01486264|39122673|FG001|Overall Study|Not treated|1|||
16175658|NCT00446030|39122676|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
16175659|NCT00446030|39122677|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
16175660|NCT00446030|39122676|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
16175661|NCT00446030|39122677|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
16175662|NCT00446030|39122676|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
16175663|NCT00446030|39122677|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
16175664|NCT00446030|39122676|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
16175665|NCT00446030|39122677|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
16375146|NCT00563316|39860060|FG000|Overall Study|Other|1|||
16175666|NCT00446030|39122676|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
16175667|NCT00446030|39122677|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
16175668|NCT00446030|39122676|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
16175669|NCT00446030|39122677|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
16175670|NCT00446030|39122676|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
16175671|NCT00446030|39122677|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
16175672|NCT00446030|39122676|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
16175673|NCT00446030|39122677|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
16175674|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
16175675|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
16175676|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
16175677|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
16175678|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
16175679|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
16175680|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
16175681|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
16175682|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
16175683|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
16175684|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
16175685|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
16175686|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
16175687|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
16175688|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
16175689|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
16175690|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
16175691|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
16175692|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
16175693|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
16175694|NCT00446030|39122676|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
16175695|NCT00446030|39122677|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
16175696|NCT04429022|39122679|FG000|Overall Study|Protocol Violation|18|||
16175697|NCT04429022|39122680|FG001|Overall Study|Protocol Violation|1|||
16175698|NCT00885365|39122682|FG000|4 Weeks ON Treatment|Adverse Event|2|||
16175699|NCT00885365|39122683|FG001|4 Weeks ON Treatment|Adverse Event|4|||
16175700|NCT00885365|39122682|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
16175701|NCT00885365|39122683|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
16175702|NCT00885365|39122682|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
16175703|NCT00885365|39122683|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
16175704|NCT03487445|39122684|FG000|Randomization|Not treated for administrative reasons|1|||
16175705|NCT03487445|39122685|FG001|Randomization|Not treated for administrative reasons|0|||
16175706|NCT02732951|39122688|FG000|Overall Study|Other than listed|1|||
16175707|NCT02732951|39122689|FG001|Overall Study|Other than listed|0|||
16175708|NCT02732951|39122688|FG000|Overall Study|Lost to Follow-up|0|||
16175709|NCT02732951|39122689|FG001|Overall Study|Lost to Follow-up|1|||
16175710|NCT02732951|39122688|FG000|Overall Study|Adverse Event|4|||
16175711|NCT02732951|39122689|FG001|Overall Study|Adverse Event|4|||
16175712|NCT02732951|39122688|FG000|Overall Study|Protocol Violation|0|||
16175713|NCT02732951|39122689|FG001|Overall Study|Protocol Violation|1|||
16175714|NCT00702143|39122690|FG000|Overall Study|Lost to Follow-up|0|||
16175715|NCT00702143|39122691|FG001|Overall Study|Lost to Follow-up|0|||
16175716|NCT00702143|39122692|FG002|Overall Study|Lost to Follow-up|1|||
16175717|NCT03293654|39122693|FG000|Overall Study|Lost to Follow-up|0|||
16175718|NCT03293654|39122694|FG001|Overall Study|Lost to Follow-up|1|||
16175719|NCT03293654|39122695|FG002|Overall Study|Lost to Follow-up|0|||
16175720|NCT02863848|39122698|FG000|Overall Study|Lost to Follow-up|1|||
16175721|NCT02863848|39122699|FG001|Overall Study|Lost to Follow-up|1|||
16175722|NCT02863848|39122698|FG000|Overall Study|Protocol Violation|1|||
16175723|NCT02863848|39122699|FG001|Overall Study|Protocol Violation|2|||
16175724|NCT01171612|39122702|FG000|Overall Study|Lost to Follow-up|51|||
16175725|NCT00892437|39122706|FG000|Randomized Phase|Randomized but not treated|6|||
16175726|NCT00892437|39122707|FG001|Randomized Phase|Randomized but not treated|0|||
16175727|NCT00892437|39122706|FG000|Randomized Phase|Adverse Event|2|||
16175728|NCT00892437|39122707|FG001|Randomized Phase|Adverse Event|2|||
16175729|NCT00892437|39122706|FG000|Randomized Phase|Lost to Follow-up|1|||
16175730|NCT00892437|39122707|FG001|Randomized Phase|Lost to Follow-up|3|||
16175731|NCT00892437|39122706|FG000|Randomized Phase|Investigator's Discretion|1|||
16175732|NCT00892437|39122707|FG001|Randomized Phase|Investigator's Discretion|0|||
16175733|NCT00892437|39122706|FG000|Randomized Phase|Withdrew Consent|1|||
16175734|NCT00892437|39122707|FG001|Randomized Phase|Withdrew Consent|0|||
16175735|NCT00892437|39122706|FG000|Open-Label Extension Phase|Adverse Event|4|||
16175736|NCT00892437|39122707|FG001|Open-Label Extension Phase|Adverse Event|2|||
16175737|NCT00892437|39122706|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
16175738|NCT00892437|39122707|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
16175739|NCT00892437|39122706|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
16175740|NCT00892437|39122707|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
16175741|NCT00892437|39122706|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
16175742|NCT00892437|39122707|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
16175743|NCT00892437|39122706|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
16175744|NCT00892437|39122707|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
16175745|NCT05029622|39122713|FG000|Overall Study|Lost to Follow-up|1|||
16175746|NCT02966314|39122714|FG000|Overall Study|Lost to Follow-up|1|||
16175747|NCT02966314|39122715|FG001|Overall Study|Lost to Follow-up|0|||
16175748|NCT02224664|39122717|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
16175749|NCT02224664|39122718|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
16175750|NCT02224664|39122719|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
16175751|NCT02224664|39122720|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
16175752|NCT02224664|39122721|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
16175753|NCT02224664|39122717|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
16175754|NCT02224664|39122718|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
16274908|NCT00640341|39490218|FG002|Overall Study|Positive Slit Lamp Findings|1|||
16274909|NCT00640341|39490216|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
16274910|NCT00640341|39490217|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
16274911|NCT00640341|39490218|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
16274912|NCT00640341|39490216|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
16274913|NCT00640341|39490217|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
16274914|NCT00640341|39490218|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
16274915|NCT00640341|39490216|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
16274916|NCT00640341|39490217|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
16274917|NCT00640341|39490218|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
16274918|NCT00640341|39490216|FG000|Overall Study|Lost to Follow-up|2|||
16274919|NCT00640341|39490217|FG001|Overall Study|Lost to Follow-up|0|||
16274920|NCT00640341|39490218|FG002|Overall Study|Lost to Follow-up|0|||
16274921|NCT00640341|39490216|FG000|Overall Study|Withdrawal by Subject|4|||
16274922|NCT00640341|39490217|FG001|Overall Study|Withdrawal by Subject|0|||
16274923|NCT00640341|39490218|FG002|Overall Study|Withdrawal by Subject|1|||
16274924|NCT00640341|39490216|FG000|Overall Study|Unacceptable Lens Movement|1|||
16274925|NCT00640341|39490217|FG001|Overall Study|Unacceptable Lens Movement|0|||
16274926|NCT00640341|39490218|FG002|Overall Study|Unacceptable Lens Movement|0|||
16274927|NCT00640341|39490216|FG000|Overall Study|Poor fit/Uncomfortable|4|||
16274928|NCT00640341|39490217|FG001|Overall Study|Poor fit/Uncomfortable|0|||
16274929|NCT00640341|39490218|FG002|Overall Study|Poor fit/Uncomfortable|0|||
16274930|NCT00640341|39490216|FG000|Overall Study|Ineligable at Baseline|5|||
16274931|NCT00640341|39490217|FG001|Overall Study|Ineligable at Baseline|3|||
16274932|NCT00640341|39490218|FG002|Overall Study|Ineligable at Baseline|2|||
16274933|NCT00640341|39490216|FG000|Overall Study|Adverse event and positive slit lamp|1|||
16274934|NCT00640341|39490217|FG001|Overall Study|Adverse event and positive slit lamp|0|||
16274935|NCT00640341|39490218|FG002|Overall Study|Adverse event and positive slit lamp|0|||
16274936|NCT05889039|39490220|FG000|Overall Study|error in completing survey|0|||
16274937|NCT05889039|39490221|FG001|Overall Study|error in completing survey|2|||
16274938|NCT05889039|39490222|FG002|Overall Study|error in completing survey|0|||
16274939|NCT05889039|39490223|FG003|Overall Study|error in completing survey|0|||
16274940|NCT05889039|39490220|FG000|Overall Study|Lost to Follow-up|4|||
16274941|NCT05889039|39490221|FG001|Overall Study|Lost to Follow-up|0|||
16274942|NCT05889039|39490222|FG002|Overall Study|Lost to Follow-up|0|||
16274943|NCT05889039|39490223|FG003|Overall Study|Lost to Follow-up|0|||
16274944|NCT02957942|39490224|FG000|Overall Study|Withdrawal by Subject|0|||
16474684|NCT01297920|40217995|FG002|Overall Study|Inadequate Control of IOP|17|||
16175755|NCT02224664|39122719|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
16175756|NCT02224664|39122720|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
16175757|NCT02224664|39122721|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
16175758|NCT02224664|39122717|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
16175759|NCT02224664|39122718|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
16175760|NCT02224664|39122719|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
16175761|NCT02224664|39122720|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
16175762|NCT02224664|39122721|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
16175763|NCT01844076|39122722|FG000|Overall Study|Adverse Event|1|||
16175764|NCT01844076|39122723|FG001|Overall Study|Adverse Event|0|||
16175765|NCT01844076|39122724|FG002|Overall Study|Adverse Event|0|||
16175766|NCT01844076|39122725|FG003|Overall Study|Adverse Event|0|||
16175767|NCT01844076|39122722|FG000|Overall Study|Withdrawal by Subject|1|||
16175768|NCT01844076|39122723|FG001|Overall Study|Withdrawal by Subject|0|||
16175769|NCT01844076|39122724|FG002|Overall Study|Withdrawal by Subject|0|||
16175770|NCT01844076|39122725|FG003|Overall Study|Withdrawal by Subject|0|||
16274945|NCT02957942|39490225|FG001|Overall Study|Withdrawal by Subject|1|||
16274946|NCT02957942|39490224|FG000|Overall Study|Practicing experiment protocol|0|||
16175771|NCT00886938|39122726|FG000|Overall Study|Adverse Event|1|||
16175772|NCT00886938|39122726|FG000|Overall Study|Withdrawal by Subject|1|||
16274947|NCT02957942|39490225|FG001|Overall Study|Practicing experiment protocol|6|||
16274948|NCT01119625|39490226|FG000|Overall Study|Lost to Follow-up|1|||
16274949|NCT01119625|39490227|FG001|Overall Study|Lost to Follow-up|2|||
16274950|NCT01119625|39490226|FG000|Overall Study|Withdrawal by Subject|2|||
16274951|NCT01119625|39490227|FG001|Overall Study|Withdrawal by Subject|1|||
16274952|NCT01119625|39490226|FG000|Overall Study|Other|0|||
16274953|NCT01119625|39490227|FG001|Overall Study|Other|1|||
16274954|NCT00377156|39490229|FG000|Overall Study|Death|23|||
16274955|NCT00377156|39490230|FG001|Overall Study|Death|19|||
16274956|NCT00377156|39490229|FG000|Overall Study|Withdrawal by Subject|16|||
16274957|NCT00377156|39490230|FG001|Overall Study|Withdrawal by Subject|24|||
16274958|NCT00377156|39490229|FG000|Overall Study|Had follow-up <90 d|3|||
16274959|NCT00377156|39490230|FG001|Overall Study|Had follow-up <90 d|6|||
16274960|NCT00377156|39490229|FG000|Overall Study|Cancellation|1|||
16274961|NCT00377156|39490230|FG001|Overall Study|Cancellation|0|||
16274962|NCT00377156|39490229|FG000|Overall Study|Refused testing|0|||
16274963|NCT00377156|39490230|FG001|Overall Study|Refused testing|1|||
16274964|NCT00377156|39490229|FG000|Overall Study|Ineligible|0|||
16274965|NCT00377156|39490230|FG001|Overall Study|Ineligible|1|||
16274966|NCT00377156|39490229|FG000|Overall Study|Disability or language problem|0|||
16274967|NCT00377156|39490230|FG001|Overall Study|Disability or language problem|1|||
16274968|NCT00377156|39490229|FG000|Overall Study|Other|5|||
16274969|NCT00377156|39490230|FG001|Overall Study|Other|2|||
16274970|NCT00642811|39490231|FG000|Overall Study|Adverse Event|2|||
16274971|NCT00642811|39490232|FG001|Overall Study|Adverse Event|3|||
16274972|NCT00642811|39490233|FG002|Overall Study|Adverse Event|0|||
16274973|NCT00642811|39490234|FG003|Overall Study|Adverse Event|0|||
16274974|NCT00642811|39490235|FG004|Overall Study|Adverse Event|0|||
16274975|NCT00642811|39490236|FG005|Overall Study|Adverse Event|1|||
16274976|NCT00642811|39490231|FG000|Overall Study|Developement of discontinuation criteria|0|||
16274977|NCT00642811|39490232|FG001|Overall Study|Developement of discontinuation criteria|0|||
16274978|NCT00642811|39490233|FG002|Overall Study|Developement of discontinuation criteria|0|||
16274979|NCT00642811|39490234|FG003|Overall Study|Developement of discontinuation criteria|0|||
16274980|NCT00642811|39490235|FG004|Overall Study|Developement of discontinuation criteria|1|||
16274981|NCT00642811|39490236|FG005|Overall Study|Developement of discontinuation criteria|0|||
16274982|NCT00642811|39490231|FG000|Overall Study|Severe Non-compliance to protocol|1|||
16274983|NCT00642811|39490232|FG001|Overall Study|Severe Non-compliance to protocol|0|||
16274984|NCT00642811|39490233|FG002|Overall Study|Severe Non-compliance to protocol|0|||
16274985|NCT00642811|39490234|FG003|Overall Study|Severe Non-compliance to protocol|0|||
16274986|NCT00642811|39490235|FG004|Overall Study|Severe Non-compliance to protocol|0|||
16274987|NCT00642811|39490236|FG005|Overall Study|Severe Non-compliance to protocol|0|||
16274988|NCT00642811|39490231|FG000|Overall Study|Other|0|||
16274989|NCT00642811|39490232|FG001|Overall Study|Other|1|||
16274990|NCT00642811|39490233|FG002|Overall Study|Other|0|||
16274991|NCT00642811|39490234|FG003|Overall Study|Other|1|||
16274992|NCT00642811|39490235|FG004|Overall Study|Other|0|||
16274993|NCT00642811|39490236|FG005|Overall Study|Other|0|||
16274994|NCT01912807|39490237|FG000|Overall Study|Did not meet elegibility criteria|6|||
16274995|NCT01912807|39490238|FG001|Overall Study|Did not meet elegibility criteria|4|||
16274996|NCT01912807|39490237|FG000|Overall Study|Lost to Follow-up|36|||
16274997|NCT01912807|39490238|FG001|Overall Study|Lost to Follow-up|37|||
16274998|NCT01971554|39490241|FG000|Overall Study|Lost to Follow-up|1|||
16274999|NCT01971554|39490242|FG001|Overall Study|Lost to Follow-up|0|||
16275000|NCT01971554|39490243|FG002|Overall Study|Lost to Follow-up|0|||
16275001|NCT01971554|39490244|FG003|Overall Study|Lost to Follow-up|0|||
16275002|NCT01970592|39490246|FG000|Overall Study|Withdrawal by Subject|4|||
16275003|NCT01970592|39490246|FG000|Overall Study|Physician Decision|1|||
16275004|NCT01970592|39490246|FG000|Overall Study|Adverse Event|1|||
16275005|NCT01344018|39490248|FG000|Overall Study|Death|22|||
16275006|NCT01344018|39490249|FG001|Overall Study|Death|25|||
16275007|NCT01344018|39490248|FG000|Overall Study|Lost to Follow-up|4|||
16275008|NCT01344018|39490249|FG001|Overall Study|Lost to Follow-up|7|||
16275009|NCT02583048|39490252|FG000|Overall Study|Withdrawal by Subject|0|||
16175773|NCT01826214|39122727|FG000|Overall Study|Adverse Event|7|||
16175774|NCT01826214|39122728|FG001|Overall Study|Adverse Event|6|||
16175775|NCT01826214|39122727|FG000|Overall Study|Death|3|||
16175776|NCT01826214|39122728|FG001|Overall Study|Death|1|||
16175777|NCT01826214|39122727|FG000|Overall Study|Lost to Follow-up|1|||
16175778|NCT01826214|39122728|FG001|Overall Study|Lost to Follow-up|0|||
16175779|NCT01826214|39122727|FG000|Overall Study|Physician Decision|0|||
16175780|NCT01826214|39122728|FG001|Overall Study|Physician Decision|2|||
16175781|NCT01826214|39122727|FG000|Overall Study|Progressive disease|22|||
16175782|NCT01826214|39122728|FG001|Overall Study|Progressive disease|21|||
16175783|NCT01826214|39122727|FG000|Overall Study|Study terminated by Sponsor|0|||
16175784|NCT01826214|39122728|FG001|Overall Study|Study terminated by Sponsor|1|||
16175785|NCT01826214|39122727|FG000|Overall Study|Subject/guardian decision|2|||
16175786|NCT01826214|39122728|FG001|Overall Study|Subject/guardian decision|3|||
16175787|NCT01967225|39122734|FG000|Overall Study|Adverse Event|3|||
16175788|NCT01967225|39122735|FG001|Overall Study|Adverse Event|1|||
16275010|NCT02583048|39490253|FG001|Overall Study|Withdrawal by Subject|1|||
16275011|NCT02583048|39490254|FG002|Overall Study|Withdrawal by Subject|0|||
16275012|NCT02583048|39490252|FG000|Overall Study|Failed to meet eligibility criterion|0|||
16275013|NCT02583048|39490253|FG001|Overall Study|Failed to meet eligibility criterion|0|||
16275014|NCT02583048|39490254|FG002|Overall Study|Failed to meet eligibility criterion|1|||
16275015|NCT01211262|39490260|FG000|Overall Study|Progressive Disease|18|||
16275016|NCT01211262|39490261|FG001|Overall Study|Progressive Disease|9|||
16275017|NCT01211262|39490260|FG000|Overall Study|Adverse Event|4|||
16275018|NCT01211262|39490261|FG001|Overall Study|Adverse Event|0|||
16275019|NCT01211262|39490260|FG000|Overall Study|Withdrawal of Consent|1|||
16275020|NCT01211262|39490261|FG001|Overall Study|Withdrawal of Consent|0|||
16275021|NCT01211262|39490260|FG000|Overall Study|Other|0|||
16275022|NCT01211262|39490261|FG001|Overall Study|Other|1|||
16275023|NCT04590027|39490262|FG000|Overall Study|Lost to Follow-up|17|||
16275024|NCT04590027|39490263|FG001|Overall Study|Lost to Follow-up|14|||
16275025|NCT04590027|39490262|FG000|Overall Study|Protocol Violation|0|||
16275026|NCT04590027|39490263|FG001|Overall Study|Protocol Violation|3|||
16275027|NCT02219009|39490264|FG000|Overall Study|Withdrawal by Subject|5|||
16275028|NCT02219009|39490265|FG001|Overall Study|Withdrawal by Subject|1|||
16275029|NCT02219009|39490264|FG000|Overall Study|Adverse Event|2|||
16275030|NCT02219009|39490265|FG001|Overall Study|Adverse Event|4|||
16275031|NCT02219009|39490264|FG000|Overall Study|Lost to Follow-up|2|||
16275032|NCT02219009|39490265|FG001|Overall Study|Lost to Follow-up|2|||
16275033|NCT02219009|39490264|FG000|Overall Study|Protocol deviation|1|||
16275034|NCT02219009|39490265|FG001|Overall Study|Protocol deviation|0|||
16275035|NCT02219009|39490264|FG000|Overall Study|Physician Decision|0|||
16275036|NCT02219009|39490265|FG001|Overall Study|Physician Decision|1|||
16275037|NCT00716625|39493675|FG000|Overall Study|Safety was not Assessable|1|||
16275038|NCT01728116|39493680|FG000|Overall Study|Sponsor Terminated Study|106|||
16275039|NCT01728116|39493681|FG001|Overall Study|Sponsor Terminated Study|35|||
16275040|NCT01728116|39493680|FG000|Overall Study|Withdrawal by Subject|16|||
16275041|NCT01728116|39493681|FG001|Overall Study|Withdrawal by Subject|9|||
16275042|NCT01728116|39493680|FG000|Overall Study|Adverse Event|13|||
16275043|NCT01728116|39493681|FG001|Overall Study|Adverse Event|0|||
16275044|NCT01728116|39493680|FG000|Overall Study|Procedure/device failure|7|||
16275045|NCT01728116|39493681|FG001|Overall Study|Procedure/device failure|0|||
16275046|NCT01728116|39493680|FG000|Overall Study|Lost to Follow-up|9|||
16275047|NCT01728116|39493681|FG001|Overall Study|Lost to Follow-up|2|||
16275048|NCT01728116|39493680|FG000|Overall Study|Physician Decision|2|||
16275049|NCT01728116|39493681|FG001|Overall Study|Physician Decision|0|||
16275050|NCT01728116|39493680|FG000|Overall Study|Subject Non-Compliance|2|||
16275051|NCT01728116|39493681|FG001|Overall Study|Subject Non-Compliance|0|||
16275052|NCT01728116|39493680|FG000|Overall Study|Inter-current finding at procedure|1|||
16275053|NCT01728116|39493681|FG001|Overall Study|Inter-current finding at procedure|0|||
16275054|NCT01728116|39493680|FG000|Overall Study|Incorrectly enrolled in Study|0|||
16275055|NCT01728116|39493681|FG001|Overall Study|Incorrectly enrolled in Study|1|||
16275056|NCT01728116|39493680|FG000|Overall Study|various not noted previously|5|||
16275057|NCT01728116|39493681|FG001|Overall Study|various not noted previously|0|||
16275058|NCT01710358|39493682|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
16275059|NCT01710358|39493683|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
16275060|NCT01710358|39493684|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
16275061|NCT01710358|39493682|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
16275062|NCT01710358|39493683|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
16275063|NCT01710358|39493684|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
16275064|NCT01710358|39493682|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
16275065|NCT01710358|39493683|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
16275066|NCT01710358|39493684|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
16275067|NCT01710358|39493682|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
16275068|NCT01710358|39493683|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
16275069|NCT01710358|39493684|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
16275070|NCT01710358|39493682|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
16275071|NCT01710358|39493683|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
16275072|NCT01710358|39493684|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
16275073|NCT01710358|39493682|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
16275074|NCT01710358|39493683|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
16275075|NCT01710358|39493684|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
16275076|NCT01710358|39493682|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
16275077|NCT01710358|39493683|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
16275078|NCT01710358|39493684|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
16275079|NCT01710358|39493682|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
16275080|NCT01710358|39493683|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
16275081|NCT01710358|39493684|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
16275082|NCT01710358|39493682|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
16275083|NCT01710358|39493683|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
16275084|NCT01710358|39493684|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
16275085|NCT01710358|39493682|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
16275086|NCT01710358|39493683|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
16275087|NCT01710358|39493684|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
16275088|NCT01710358|39493682|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
16275089|NCT01710358|39493683|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
16275090|NCT01710358|39493684|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
16275091|NCT01710358|39493682|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
16275092|NCT01710358|39493683|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
16275093|NCT01710358|39493684|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
16275094|NCT01710358|39493682|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
16275095|NCT01710358|39493683|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
16275096|NCT01710358|39493684|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
16275097|NCT01710358|39493682|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
16275098|NCT01710358|39493683|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
16275099|NCT01710358|39493684|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
16275100|NCT01710358|39493682|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
16275101|NCT01710358|39493683|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
16275102|NCT01710358|39493684|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
16275103|NCT01710358|39493682|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
16275104|NCT01710358|39493683|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
16275105|NCT01710358|39493684|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
16275106|NCT01710358|39493682|FG000|Rescue Period|Adverse Event|0|||
16275107|NCT01710358|39493683|FG001|Rescue Period|Adverse Event|15|||
16175789|NCT01967225|39122734|FG000|Overall Study|Withdrawal by Subject|2|||
16175790|NCT01967225|39122735|FG001|Overall Study|Withdrawal by Subject|1|||
16175791|NCT01967225|39122734|FG000|Overall Study|Lack of Efficacy|1|||
16175792|NCT01967225|39122735|FG001|Overall Study|Lack of Efficacy|1|||
16175793|NCT01967225|39122734|FG000|Overall Study|Switching to other therapy|2|||
16175794|NCT01967225|39122735|FG001|Overall Study|Switching to other therapy|0|||
16175795|NCT01967225|39122734|FG000|Overall Study|Protocol driven decision point|1|||
16175796|NCT01967225|39122735|FG001|Overall Study|Protocol driven decision point|0|||
16275108|NCT01710358|39493684|FG002|Rescue Period|Adverse Event|0|||
16175797|NCT01967225|39122734|FG000|Overall Study|Logistical difficulties|1|||
16175798|NCT01967225|39122735|FG001|Overall Study|Logistical difficulties|0|||
16175799|NCT01967225|39122734|FG000|Overall Study|Protocol Violation|2|||
16175800|NCT01967225|39122735|FG001|Overall Study|Protocol Violation|0|||
16175801|NCT03853694|39122736|FG000|Overall Study|Protocol Violation|3|||
16175802|NCT03853694|39122737|FG001|Overall Study|Protocol Violation|5|||
16175803|NCT03853694|39122738|FG002|Overall Study|Protocol Violation|3|||
16175804|NCT03853694|39122736|FG000|Overall Study|Delivered early|0|||
16175805|NCT03853694|39122737|FG001|Overall Study|Delivered early|1|||
16175806|NCT03853694|39122738|FG002|Overall Study|Delivered early|0|||
16175807|NCT03853694|39122736|FG000|Overall Study|not suitable to proceed|0|||
16175808|NCT03853694|39122737|FG001|Overall Study|not suitable to proceed|1|||
16175809|NCT03853694|39122738|FG002|Overall Study|not suitable to proceed|0|||
16175810|NCT03853694|39122736|FG000|Overall Study|difficult surgery|0|||
16175811|NCT03853694|39122737|FG001|Overall Study|difficult surgery|0|||
16175812|NCT03853694|39122738|FG002|Overall Study|difficult surgery|1|||
16175813|NCT03853694|39122736|FG000|Overall Study|Lost to Follow-up|0|||
16175814|NCT03853694|39122737|FG001|Overall Study|Lost to Follow-up|1|||
16175815|NCT03853694|39122738|FG002|Overall Study|Lost to Follow-up|0|||
16175816|NCT03853694|39122736|FG000|Overall Study|Withdrawal by Subject|0|||
16175817|NCT03853694|39122737|FG001|Overall Study|Withdrawal by Subject|1|||
16175818|NCT03853694|39122738|FG002|Overall Study|Withdrawal by Subject|0|||
16175819|NCT01076179|39122741|FG000|Overall Study|Withdrawal by Subject|1|||
16175820|NCT01773473|39122742|FG000|Overall Study|Adverse Event|3|||
16175821|NCT01773473|39122743|FG001|Overall Study|Adverse Event|2|||
16175822|NCT01773473|39122742|FG000|Overall Study|Protocol Violation|0|||
16175823|NCT01773473|39122743|FG001|Overall Study|Protocol Violation|4|||
16175824|NCT01773473|39122742|FG000|Overall Study|Physician Decision|3|||
16175825|NCT01773473|39122743|FG001|Overall Study|Physician Decision|5|||
16175826|NCT01773473|39122742|FG000|Overall Study|Sponsor Decision|2|||
16175827|NCT01773473|39122743|FG001|Overall Study|Sponsor Decision|0|||
16175828|NCT01773473|39122742|FG000|Overall Study|Lack of Efficacy|0|||
16175829|NCT01773473|39122743|FG001|Overall Study|Lack of Efficacy|1|||
16175830|NCT01773473|39122742|FG000|Overall Study|Non-Compliance with study drug|1|||
16175831|NCT01773473|39122743|FG001|Overall Study|Non-Compliance with study drug|4|||
16175832|NCT01773473|39122742|FG000|Overall Study|Withdrawal by Subject|5|||
16175833|NCT01773473|39122743|FG001|Overall Study|Withdrawal by Subject|3|||
16175834|NCT01773473|39122742|FG000|Overall Study|Lost to Follow-up|2|||
16175835|NCT01773473|39122743|FG001|Overall Study|Lost to Follow-up|0|||
16175836|NCT02111811|39122744|FG000|Treatment Phase|Lost to Follow-up|22|||
16175837|NCT02111811|39122745|FG001|Treatment Phase|Lost to Follow-up|18|||
16175838|NCT02111811|39122744|FG000|Treatment Phase|Death|2|||
16175839|NCT02111811|39122745|FG001|Treatment Phase|Death|0|||
16175840|NCT02111811|39122744|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
16175841|NCT02111811|39122745|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
16175842|NCT02111811|39122744|FG000|Follow up Period (Aim 2)|Death|2|||
16175843|NCT02111811|39122745|FG001|Follow up Period (Aim 2)|Death|0|||
16175844|NCT04938648|39122746|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
16175845|NCT04938648|39122747|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
16175846|NCT04938648|39122746|FG000|Overall Study|Patient too ill|0|||
16175847|NCT04938648|39122747|FG001|Overall Study|Patient too ill|1|||
16175848|NCT04938648|39122746|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
16175849|NCT04938648|39122747|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
16175850|NCT04938648|39122746|FG000|Overall Study|Patient did not have memory problems|1|||
16175851|NCT04938648|39122747|FG001|Overall Study|Patient did not have memory problems|1|||
16175852|NCT04938648|39122746|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
16175853|NCT04938648|39122747|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
16175854|NCT04938648|39122746|FG000|Overall Study|Care partner could not be reached|0|||
16175855|NCT04938648|39122747|FG001|Overall Study|Care partner could not be reached|1|||
16175856|NCT04938648|39122746|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
16175857|NCT04938648|39122747|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
16175858|NCT04938648|39122746|FG000|Overall Study|Withdrawal by Subject|2|||
16275109|NCT01710358|39493682|FG000|Rescue Period|Death|0|||
16275110|NCT01710358|39493683|FG001|Rescue Period|Death|1|||
16275111|NCT01710358|39493684|FG002|Rescue Period|Death|0|||
16275112|NCT01710358|39493682|FG000|Rescue Period|Lack of Efficacy|0|||
16275113|NCT01710358|39493683|FG001|Rescue Period|Lack of Efficacy|7|||
16275114|NCT01710358|39493684|FG002|Rescue Period|Lack of Efficacy|0|||
16275115|NCT01710358|39493682|FG000|Rescue Period|Withdrawal by Subject|0|||
16275116|NCT01710358|39493683|FG001|Rescue Period|Withdrawal by Subject|8|||
16275117|NCT01710358|39493684|FG002|Rescue Period|Withdrawal by Subject|0|||
16275118|NCT00826241|39493688|FG000|Overall Study|Withdrawal from Follow-up|1|||
16275119|NCT00826241|39493688|FG000|Overall Study|Withdrew consent|2|||
16275120|NCT00826241|39493688|FG000|Overall Study|Death|4|||
16275121|NCT00826241|39493688|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
16275122|NCT00826241|39493688|FG000|Overall Study|Non-compliance|1|||
16275123|NCT00826241|39493688|FG000|Overall Study|Progression of disease|1|||
16275124|NCT00826241|39493688|FG000|Overall Study|Patient refused follow-up|3|||
16175859|NCT04938648|39122747|FG001|Overall Study|Withdrawal by Subject|1|||
16175860|NCT00817414|39122748|FG000|Overall Study|Adverse Event|1|||
16175861|NCT00817414|39122749|FG001|Overall Study|Adverse Event|1|||
16175862|NCT00817414|39122750|FG002|Overall Study|Adverse Event|1|||
16175863|NCT00817414|39122751|FG003|Overall Study|Adverse Event|0|||
16175864|NCT00817414|39122752|FG004|Overall Study|Adverse Event|0|||
16175865|NCT00817414|39122748|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
16175866|NCT00817414|39122749|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
16175867|NCT00817414|39122750|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
16175868|NCT00817414|39122751|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
16175869|NCT00817414|39122752|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
16175870|NCT00817414|39122748|FG000|Overall Study|Withdrawal by Subject|1|||
16175871|NCT00817414|39122749|FG001|Overall Study|Withdrawal by Subject|1|||
16175872|NCT00817414|39122750|FG002|Overall Study|Withdrawal by Subject|0|||
16175873|NCT00817414|39122751|FG003|Overall Study|Withdrawal by Subject|0|||
16175874|NCT00817414|39122752|FG004|Overall Study|Withdrawal by Subject|0|||
16175875|NCT00817414|39122748|FG000|Overall Study|Lost to Follow-up|0|||
16175876|NCT00817414|39122749|FG001|Overall Study|Lost to Follow-up|0|||
16175877|NCT00817414|39122750|FG002|Overall Study|Lost to Follow-up|1|||
16275125|NCT00826241|39493688|FG000|Overall Study|Lost to Follow-up|9|||
16275126|NCT00826241|39493688|FG000|Overall Study|Could not obtain records|1|||
16275127|NCT00826241|39493688|FG000|Overall Study|Screen failure|2|||
16175878|NCT00817414|39122751|FG003|Overall Study|Lost to Follow-up|1|||
16175879|NCT00817414|39122752|FG004|Overall Study|Lost to Follow-up|1|||
16175880|NCT00817414|39122748|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
16175881|NCT00817414|39122749|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
16175882|NCT00817414|39122750|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
16175883|NCT00817414|39122751|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
16175884|NCT00817414|39122752|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
16175885|NCT00817414|39122748|FG000|Overall Study|Protocol Violation|0|||
16175886|NCT00817414|39122749|FG001|Overall Study|Protocol Violation|0|||
16175887|NCT00817414|39122750|FG002|Overall Study|Protocol Violation|0|||
16175888|NCT00817414|39122751|FG003|Overall Study|Protocol Violation|0|||
16175889|NCT00817414|39122752|FG004|Overall Study|Protocol Violation|1|||
16175890|NCT00356915|39122753|FG000|Overall Study|Non compliance|1|||
16175891|NCT00356915|39122754|FG001|Overall Study|Non compliance|2|||
16175892|NCT00356915|39122755|FG002|Overall Study|Non compliance|1|||
16175893|NCT00356915|39122753|FG000|Overall Study|Protocol Violation|2|||
16175894|NCT00356915|39122754|FG001|Overall Study|Protocol Violation|3|||
16175895|NCT00356915|39122755|FG002|Overall Study|Protocol Violation|2|||
16175896|NCT00356915|39122753|FG000|Overall Study|Withdrawal by Subject|14|||
16175897|NCT00356915|39122754|FG001|Overall Study|Withdrawal by Subject|14|||
16175898|NCT00356915|39122755|FG002|Overall Study|Withdrawal by Subject|10|||
16175899|NCT00356915|39122753|FG000|Overall Study|Lack of Efficacy|0|||
16175900|NCT00356915|39122754|FG001|Overall Study|Lack of Efficacy|0|||
16175901|NCT00356915|39122755|FG002|Overall Study|Lack of Efficacy|3|||
16175902|NCT00356915|39122753|FG000|Overall Study|Lost to Follow-up|27|||
16175903|NCT00356915|39122754|FG001|Overall Study|Lost to Follow-up|34|||
16175904|NCT00356915|39122755|FG002|Overall Study|Lost to Follow-up|14|||
16175905|NCT00356915|39122753|FG000|Overall Study|Administrative Decision|0|||
16175906|NCT00356915|39122754|FG001|Overall Study|Administrative Decision|0|||
16175907|NCT00356915|39122755|FG002|Overall Study|Administrative Decision|1|||
16175908|NCT00356915|39122753|FG000|Overall Study|Physician Decision|0|||
16175909|NCT00356915|39122754|FG001|Overall Study|Physician Decision|2|||
16175910|NCT00356915|39122755|FG002|Overall Study|Physician Decision|0|||
16175911|NCT00356915|39122753|FG000|Overall Study|Adverse Event|21|||
16175912|NCT00356915|39122754|FG001|Overall Study|Adverse Event|31|||
16175913|NCT00356915|39122755|FG002|Overall Study|Adverse Event|8|||
16175914|NCT00356915|39122753|FG000|Overall Study|Miscellaneous reasons|11|||
16175915|NCT00356915|39122754|FG001|Overall Study|Miscellaneous reasons|8|||
16175916|NCT00356915|39122755|FG002|Overall Study|Miscellaneous reasons|3|||
16175917|NCT00473694|39122756|FG000|Overall Study|Adverse Event|0|||
16175918|NCT00473694|39122757|FG001|Overall Study|Adverse Event|1|||
16175919|NCT00473694|39122758|FG002|Overall Study|Adverse Event|0|||
16175920|NCT00473694|39122759|FG003|Overall Study|Adverse Event|0|||
16175921|NCT00473694|39122756|FG000|Overall Study|Participants did not receive treatment|11|||
16175922|NCT00473694|39122757|FG001|Overall Study|Participants did not receive treatment|3|||
16175923|NCT00473694|39122758|FG002|Overall Study|Participants did not receive treatment|5|||
16175924|NCT00473694|39122759|FG003|Overall Study|Participants did not receive treatment|6|||
16175925|NCT00473694|39122756|FG000|Overall Study|Lost to Follow-up|0|||
16175926|NCT00473694|39122757|FG001|Overall Study|Lost to Follow-up|0|||
16175927|NCT00473694|39122758|FG002|Overall Study|Lost to Follow-up|0|||
16175928|NCT00473694|39122759|FG003|Overall Study|Lost to Follow-up|1|||
16175929|NCT01217606|39122766|FG000|Initial Treatment Phase|Other Reasons|0|||
16175930|NCT01217606|39122767|FG001|Initial Treatment Phase|Other Reasons|2|||
16175931|NCT01217606|39122766|FG000|Initial Treatment Phase|Protocol Violation|3|||
16175932|NCT01217606|39122767|FG001|Initial Treatment Phase|Protocol Violation|2|||
16175933|NCT01217606|39122766|FG000|Initial Treatment Phase|Personal Reasons|0|||
16175934|NCT01217606|39122767|FG001|Initial Treatment Phase|Personal Reasons|2|||
16175935|NCT01217606|39122766|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
16275128|NCT00826241|39493688|FG000|Overall Study|Pt unable to proceed to registration|1|||
16275129|NCT00826241|39493688|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
16275130|NCT01557920|39493689|FG000|Overall Study|Withdrawal by Subject|2|||
16275131|NCT01557920|39493690|FG001|Overall Study|Withdrawal by Subject|3|||
16275132|NCT01557920|39493689|FG000|Overall Study|Lack of Efficacy|1|||
16275133|NCT01557920|39493690|FG001|Overall Study|Lack of Efficacy|0|||
16275134|NCT01596127|39493691|FG000|Overall Study|Patient Ineligible|1|||
16275135|NCT04010227|39493692|FG000|Overall Study|Death|1|||
16275136|NCT04010227|39493693|FG001|Overall Study|Death|2|||
16275137|NCT04010227|39493692|FG000|Overall Study|Medical Reasons|4|||
16275138|NCT04010227|39493693|FG001|Overall Study|Medical Reasons|3|||
16275139|NCT04010227|39493692|FG000|Overall Study|Withdrawal by Subject|2|||
16275140|NCT04010227|39493693|FG001|Overall Study|Withdrawal by Subject|0|||
16275141|NCT04010227|39493692|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
16275142|NCT04010227|39493693|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
16275143|NCT02888756|39493698|FG000|Analytical Treatment Interruption|Physician Decision|10|||
16275144|NCT02888756|39493699|FG001|Analytical Treatment Interruption|Physician Decision|6|||
16275145|NCT02888756|39493700|FG002|Analytical Treatment Interruption|Physician Decision|5|||
16275146|NCT00766493|39493703|FG000|30 Days Post-Procedure|Discontinued|7|||
16275147|NCT00766493|39493703|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
16275148|NCT00766493|39493703|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
16275149|NCT00084864|39493704|FG000|Overall Study|Adverse Event|1|||
16275150|NCT00084864|39493705|FG001|Overall Study|Adverse Event|0|||
16275151|NCT00084864|39493706|FG002|Overall Study|Adverse Event|0|||
16275152|NCT00084864|39493707|FG003|Overall Study|Adverse Event|0|||
16275153|NCT00494013|39493716|FG000|Overall Study|Adverse Event|0|||
16275154|NCT00494013|39493717|FG001|Overall Study|Adverse Event|1|||
16275155|NCT00494013|39493716|FG000|Overall Study|Entry Criteria Not Met|1|||
16275156|NCT00494013|39493717|FG001|Overall Study|Entry Criteria Not Met|4|||
16275157|NCT00494013|39493716|FG000|Overall Study|Lost to Follow-up|5|||
16275158|NCT00494013|39493717|FG001|Overall Study|Lost to Follow-up|6|||
16275159|NCT00494013|39493716|FG000|Overall Study|Physician Decision|3|||
16275160|NCT00494013|39493717|FG001|Overall Study|Physician Decision|5|||
16275161|NCT00494013|39493716|FG000|Overall Study|Protocol Violation|8|||
16275162|NCT00494013|39493717|FG001|Overall Study|Protocol Violation|5|||
16275163|NCT00494013|39493716|FG000|Overall Study|Withdrawal by Subject|13|||
16275164|NCT00494013|39493717|FG001|Overall Study|Withdrawal by Subject|14|||
16275165|NCT00494013|39493716|FG000|Overall Study|Sponsor Decision|0|||
16275166|NCT00494013|39493717|FG001|Overall Study|Sponsor Decision|1|||
16275167|NCT03941834|39493718|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
16275168|NCT03941834|39493719|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
16275169|NCT03941834|39493720|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
16275170|NCT03941834|39493718|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
16275171|NCT03941834|39493719|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
16275172|NCT03941834|39493720|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
16275173|NCT03941834|39493718|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
16275174|NCT03941834|39493719|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
16275175|NCT03941834|39493720|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
16275176|NCT03941834|39493718|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
16275177|NCT03941834|39493719|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
16275178|NCT03941834|39493720|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
16275179|NCT03941834|39493718|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
16275180|NCT03941834|39493719|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
16275181|NCT03941834|39493720|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
16275182|NCT03941834|39493718|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
16275183|NCT03941834|39493719|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
16275184|NCT03941834|39493720|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
16275185|NCT03141151|39493723|FG000|Overall Study|Lost to Follow-up|3|||
16275186|NCT03141151|39493724|FG001|Overall Study|Lost to Follow-up|2|||
16275187|NCT03141151|39493723|FG000|Overall Study|Withdrawal by Subject|3|||
16275188|NCT03141151|39493724|FG001|Overall Study|Withdrawal by Subject|2|||
16275189|NCT01207492|39493725|FG000|Overall Study|Still on study|1|||
16275190|NCT01207492|39493725|FG000|Overall Study|Withdrawal by Subject|9|||
16275191|NCT01207492|39493725|FG000|Overall Study|Physician Decision|1|||
16275192|NCT01207492|39493725|FG000|Overall Study|Progressive disease|3|||
16275193|NCT01207492|39493725|FG000|Overall Study|Toxicity|1|||
16275194|NCT00593827|39493728|FG000|Overall Study|On Active Treatment/Pending|0|||
16275195|NCT00593827|39493729|FG001|Overall Study|On Active Treatment/Pending|2|||
16275196|NCT01151618|39493730|FG000|Overall Study|Adverse Event|2|||
16275197|NCT01151618|39493730|FG000|Overall Study|Withdrawal by Subject|7|||
16275198|NCT02293460|39493731|FG000|Overall Study|Protocol Violation|1|||
16275199|NCT02293460|39493731|FG000|Overall Study|Lack of Efficacy|2|||
16275200|NCT02293460|39493731|FG000|Overall Study|Adverse Event|2|||
16275201|NCT02293460|39493731|FG000|Overall Study|Withdrawal by Subject|1|||
16275202|NCT01435928|39493732|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
16275203|NCT01435928|39493733|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
16275204|NCT01435928|39493734|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
16275205|NCT01435928|39493732|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
16275206|NCT01435928|39493733|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
16275207|NCT01435928|39493734|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
16275208|NCT01435928|39493732|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
16275209|NCT01435928|39493733|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
16275210|NCT01435928|39493734|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
16275211|NCT01435928|39493732|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
16275212|NCT01435928|39493733|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
16275213|NCT01435928|39493734|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
16275214|NCT01435928|39493732|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
16275215|NCT01435928|39493733|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
16275216|NCT01435928|39493734|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
16275217|NCT01435928|39493732|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
16275218|NCT01435928|39493733|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
16275219|NCT01435928|39493734|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
16275220|NCT01435928|39493732|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
16275221|NCT01435928|39493733|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
16275222|NCT01435928|39493734|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
16275223|NCT01435928|39493732|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
16275224|NCT01435928|39493733|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
16275225|NCT01435928|39493734|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
16275226|NCT01435928|39493732|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
16275227|NCT01435928|39493733|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
16275228|NCT01435928|39493734|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
16275229|NCT01435928|39493732|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
16275230|NCT01435928|39493733|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
16275231|NCT01435928|39493734|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
16275232|NCT01435928|39493732|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
16275233|NCT01435928|39493733|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
16275234|NCT01435928|39493734|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
16275235|NCT01435928|39493732|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
16275236|NCT01435928|39493733|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
16275237|NCT01435928|39493734|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
16275238|NCT01435928|39493732|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
16275239|NCT01435928|39493733|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
16275240|NCT01435928|39493734|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
16275241|NCT01435928|39493732|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
16275242|NCT01435928|39493733|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
16275243|NCT01435928|39493734|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
16275244|NCT01435928|39493732|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
16275245|NCT01435928|39493733|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
16275246|NCT01435928|39493734|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
16275247|NCT01435928|39493732|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
16275248|NCT01435928|39493733|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
16275249|NCT01435928|39493734|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
16275250|NCT00413049|39493738|FG000|Overall Study|Adverse Event|10|||
16275251|NCT00413049|39493739|FG001|Overall Study|Adverse Event|8|||
16275252|NCT00413049|39493738|FG000|Overall Study|Withdrawal by Subject|7|||
16275253|NCT00413049|39493739|FG001|Overall Study|Withdrawal by Subject|5|||
16275254|NCT00413049|39493738|FG000|Overall Study|Lost to Follow-up|2|||
16275255|NCT00413049|39493739|FG001|Overall Study|Lost to Follow-up|3|||
16275256|NCT00413049|39493738|FG000|Overall Study|Protocol Violation|3|||
16275257|NCT00413049|39493739|FG001|Overall Study|Protocol Violation|1|||
16275258|NCT00413049|39493738|FG000|Overall Study|Subject no longer requires study drug|0|||
16275259|NCT00413049|39493739|FG001|Overall Study|Subject no longer requires study drug|1|||
16275260|NCT00413049|39493738|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16275261|NCT00413049|39493739|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16275262|NCT00413049|39493738|FG000|Overall Study|Lack of Efficacy|1|||
16275263|NCT00413049|39493739|FG001|Overall Study|Lack of Efficacy|0|||
16275264|NCT00762411|39493742|FG000|Initial Treatment|Death|7|||
16275265|NCT00762411|39493743|FG001|Initial Treatment|Death|6|||
16275266|NCT00762411|39493742|FG000|Initial Treatment|Adverse Event|132|||
16275267|NCT00762411|39493743|FG001|Initial Treatment|Adverse Event|40|||
16275268|NCT00762411|39493742|FG000|Initial Treatment|Protocol Violation|4|||
16275269|NCT00762411|39493743|FG001|Initial Treatment|Protocol Violation|1|||
16275270|NCT00762411|39493742|FG000|Initial Treatment|Withdrawal by Subject|65|||
16275271|NCT00762411|39493743|FG001|Initial Treatment|Withdrawal by Subject|52|||
16275272|NCT00762411|39493742|FG000|Initial Treatment|Physician Decision|1|||
16275273|NCT00762411|39493743|FG001|Initial Treatment|Physician Decision|0|||
16275274|NCT00762411|39493742|FG000|Initial Treatment|Sponsor Decision|293|||
16275275|NCT00762411|39493743|FG001|Initial Treatment|Sponsor Decision|401|||
16275276|NCT00762411|39493742|FG000|Initial Treatment|Lost to Follow-up|5|||
16275277|NCT00762411|39493743|FG001|Initial Treatment|Lost to Follow-up|0|||
16275278|NCT00762411|39493742|FG000|Initial Treatment|Caregiver Decision|21|||
16275279|NCT00762411|39493743|FG001|Initial Treatment|Caregiver Decision|16|||
16275280|NCT00762411|39493742|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
16275281|NCT00762411|39493743|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
16275282|NCT00762411|39493742|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
16275283|NCT00762411|39493743|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
16275284|NCT00762411|39493742|FG000|Delayed Start|Adverse Event|0|||
16275285|NCT00762411|39493743|FG001|Delayed Start|Adverse Event|4|||
16275286|NCT00762411|39493742|FG000|Delayed Start|Protocol Violation|0|||
16275287|NCT00762411|39493743|FG001|Delayed Start|Protocol Violation|1|||
16275288|NCT00762411|39493742|FG000|Delayed Start|Sponsor Decision|16|||
16275289|NCT00762411|39493743|FG001|Delayed Start|Sponsor Decision|20|||
16275290|NCT00762411|39493742|FG000|Delayed Start|Caregiver Decision|1|||
16275291|NCT00762411|39493743|FG001|Delayed Start|Caregiver Decision|1|||
16275292|NCT00762411|39493742|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
16275293|NCT00762411|39493743|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
16275294|NCT00762411|39493742|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
16275295|NCT00762411|39493743|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
16275296|NCT00762411|39493742|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
16275297|NCT00762411|39493743|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
16275298|NCT00762411|39493742|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
16275299|NCT00762411|39493743|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
16275300|NCT00762411|39493742|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
16275301|NCT00762411|39493743|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
16275302|NCT00762411|39493742|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
16275303|NCT00762411|39493743|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
16275304|NCT04801420|39493744|FG000|Overall Study|Other|1|||
16275305|NCT04801420|39493745|FG001|Overall Study|Other|2|||
16275306|NCT04801420|39493746|FG002|Overall Study|Other|1|||
16275307|NCT04801420|39493744|FG000|Overall Study|Lost to Follow-up|7|||
16275308|NCT04801420|39493745|FG001|Overall Study|Lost to Follow-up|9|||
16275309|NCT04801420|39493746|FG002|Overall Study|Lost to Follow-up|10|||
16275310|NCT04801420|39493744|FG000|Overall Study|Moved from study area|0|||
16275311|NCT04801420|39493745|FG001|Overall Study|Moved from study area|1|||
16275312|NCT04801420|39493746|FG002|Overall Study|Moved from study area|1|||
16275313|NCT04801420|39493744|FG000|Overall Study|Withdrawal by Subject|5|||
16275314|NCT04801420|39493745|FG001|Overall Study|Withdrawal by Subject|1|||
16275315|NCT04801420|39493746|FG002|Overall Study|Withdrawal by Subject|4|||
16275316|NCT04801420|39493744|FG000|Overall Study|Individual stopping criteria reached|0|||
16275317|NCT04801420|39493745|FG001|Overall Study|Individual stopping criteria reached|1|||
16275318|NCT04801420|39493746|FG002|Overall Study|Individual stopping criteria reached|0|||
16275319|NCT04801420|39493744|FG000|Overall Study|Ongoing in the study|195|||
16275320|NCT04801420|39493745|FG001|Overall Study|Ongoing in the study|195|||
16275321|NCT04801420|39493746|FG002|Overall Study|Ongoing in the study|192|||
16275322|NCT02151149|39493747|FG000|Treatment Period|Death|2|||
16275323|NCT02151149|39493748|FG001|Treatment Period|Death|3|||
16275324|NCT02151149|39493747|FG000|Treatment Period|Adverse Event|17|||
16275325|NCT02151149|39493748|FG001|Treatment Period|Adverse Event|14|||
16275326|NCT02151149|39493747|FG000|Treatment Period|Progressive Disease|25|||
16275327|NCT02151149|39493748|FG001|Treatment Period|Progressive Disease|24|||
16275328|NCT02151149|39493747|FG000|Treatment Period|Symptomatic Deterioration|2|||
16275329|NCT02151149|39493748|FG001|Treatment Period|Symptomatic Deterioration|10|||
16275330|NCT02151149|39493747|FG000|Treatment Period|Withdrawal by Subject|13|||
16275331|NCT02151149|39493748|FG001|Treatment Period|Withdrawal by Subject|11|||
16275332|NCT02151149|39493747|FG000|Treatment Period|Miscellaneous|8|||
16275333|NCT02151149|39493748|FG001|Treatment Period|Miscellaneous|7|||
16275334|NCT02151149|39493747|FG000|Treatment Period|Participants randomized but not treated|3|||
16275335|NCT02151149|39493748|FG001|Treatment Period|Participants randomized but not treated|2|||
16275336|NCT02151149|39493747|FG000|Follow-Up Period|Lost to Follow-up|2|||
16275337|NCT02151149|39493748|FG001|Follow-Up Period|Lost to Follow-up|3|||
16275338|NCT02151149|39493747|FG000|Follow-Up Period|Death|37|||
16275339|NCT02151149|39493748|FG001|Follow-Up Period|Death|34|||
16275340|NCT01572662|39493749|FG000|Overall Study|Withdrawal by Subject|1|||
16275341|NCT01572662|39493750|FG001|Overall Study|Withdrawal by Subject|0|||
16275342|NCT01572662|39493749|FG000|Overall Study|Physician Decision|0|||
16275343|NCT01572662|39493750|FG001|Overall Study|Physician Decision|1|||
16275344|NCT02259348|39493759|FG000|Overall Study|Donors|6|||
16275345|NCT02259348|39493759|FG000|Overall Study|Death|4|||
16275346|NCT02212457|39493770|FG000|Overall Study|Adverse Event|1|||
16275347|NCT02212457|39493771|FG001|Overall Study|Adverse Event|2|||
16275348|NCT02212457|39493772|FG002|Overall Study|Adverse Event|2|||
16275349|NCT02212457|39493773|FG003|Overall Study|Adverse Event|2|||
16275350|NCT02212457|39493774|FG004|Overall Study|Adverse Event|0|||
16275351|NCT02212457|39493775|FG005|Overall Study|Adverse Event|1|||
16275352|NCT02212457|39493770|FG000|Overall Study|Withdrawal by Subject|8|||
16275353|NCT02212457|39493771|FG001|Overall Study|Withdrawal by Subject|10|||
16275354|NCT02212457|39493772|FG002|Overall Study|Withdrawal by Subject|8|||
16275355|NCT02212457|39493773|FG003|Overall Study|Withdrawal by Subject|6|||
16275356|NCT02212457|39493774|FG004|Overall Study|Withdrawal by Subject|5|||
16275357|NCT02212457|39493775|FG005|Overall Study|Withdrawal by Subject|4|||
16275358|NCT02212457|39493770|FG000|Overall Study|Lost to Follow-up|6|||
16275359|NCT02212457|39493771|FG001|Overall Study|Lost to Follow-up|7|||
16275360|NCT02212457|39493772|FG002|Overall Study|Lost to Follow-up|4|||
16275361|NCT02212457|39493773|FG003|Overall Study|Lost to Follow-up|1|||
16275362|NCT02212457|39493774|FG004|Overall Study|Lost to Follow-up|8|||
16275363|NCT02212457|39493775|FG005|Overall Study|Lost to Follow-up|4|||
16275364|NCT02212457|39493770|FG000|Overall Study|Protocol Violation|2|||
16275365|NCT02212457|39493771|FG001|Overall Study|Protocol Violation|1|||
16275366|NCT02212457|39493772|FG002|Overall Study|Protocol Violation|0|||
16275367|NCT02212457|39493773|FG003|Overall Study|Protocol Violation|1|||
16275368|NCT02212457|39493774|FG004|Overall Study|Protocol Violation|2|||
16275369|NCT02212457|39493775|FG005|Overall Study|Protocol Violation|3|||
16275370|NCT02212457|39493770|FG000|Overall Study|Other|2|||
16275371|NCT02212457|39493771|FG001|Overall Study|Other|1|||
16275372|NCT02212457|39493772|FG002|Overall Study|Other|2|||
16275373|NCT02212457|39493773|FG003|Overall Study|Other|1|||
16275374|NCT02212457|39493774|FG004|Overall Study|Other|0|||
16275375|NCT02212457|39493775|FG005|Overall Study|Other|1|||
16275376|NCT03387462|39493776|FG000|Overall Study|Lost to Follow-up|1|||
16275377|NCT04148287|39493777|FG000|Overall Study|Death|2|||
16275378|NCT00250705|39493789|FG000|Overall Study|Lack of Efficacy|2|||
16275379|NCT02377349|39493790|FG000|Overall Study|Serious Adverse Event|1|||
16275380|NCT02377349|39493791|FG001|Overall Study|Serious Adverse Event|0|||
16275381|NCT02377349|39493790|FG000|Overall Study|Protocol Violation|3|||
16275382|NCT02377349|39493791|FG001|Overall Study|Protocol Violation|2|||
16275383|NCT02377349|39493790|FG000|Overall Study|Withdrawal by Subject|5|||
16275384|NCT02377349|39493791|FG001|Overall Study|Withdrawal by Subject|3|||
16275385|NCT02377349|39493790|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
16275386|NCT02377349|39493791|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
16275387|NCT02377349|39493790|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
16275388|NCT02377349|39493791|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
16275389|NCT02377349|39493790|FG000|Overall Study|Other|0|||
16275390|NCT02377349|39493791|FG001|Overall Study|Other|1|||
16275391|NCT02412722|39493792|FG000|Overall Study|Adverse Event|0|||
16275392|NCT02412722|39493793|FG001|Overall Study|Adverse Event|2|||
16275393|NCT02412722|39493794|FG002|Overall Study|Adverse Event|0|||
16275394|NCT02412722|39493795|FG003|Overall Study|Adverse Event|3|||
16275395|NCT02412722|39493796|FG004|Overall Study|Adverse Event|0|||
16275396|NCT02412722|39493797|FG005|Overall Study|Adverse Event|3|||
16275397|NCT02412722|39493792|FG000|Overall Study|Progressive Disease|6|||
16275398|NCT02412722|39493793|FG001|Overall Study|Progressive Disease|4|||
16275399|NCT02412722|39493794|FG002|Overall Study|Progressive Disease|4|||
16275400|NCT02412722|39493795|FG003|Overall Study|Progressive Disease|9|||
16275401|NCT02412722|39493796|FG004|Overall Study|Progressive Disease|3|||
16275402|NCT02412722|39493797|FG005|Overall Study|Progressive Disease|3|||
16275403|NCT02412722|39493792|FG000|Overall Study|Withdrawal by Subject|2|||
16275404|NCT02412722|39493793|FG001|Overall Study|Withdrawal by Subject|0|||
16275405|NCT02412722|39493794|FG002|Overall Study|Withdrawal by Subject|1|||
16275406|NCT02412722|39493795|FG003|Overall Study|Withdrawal by Subject|2|||
16275407|NCT02412722|39493796|FG004|Overall Study|Withdrawal by Subject|1|||
16275408|NCT02412722|39493797|FG005|Overall Study|Withdrawal by Subject|1|||
16275409|NCT02412722|39493792|FG000|Overall Study|Lost to Follow-up|0|||
16275410|NCT02412722|39493793|FG001|Overall Study|Lost to Follow-up|0|||
16275411|NCT02412722|39493794|FG002|Overall Study|Lost to Follow-up|0|||
16275412|NCT02412722|39493795|FG003|Overall Study|Lost to Follow-up|0|||
16275413|NCT02412722|39493796|FG004|Overall Study|Lost to Follow-up|1|||
16275414|NCT02412722|39493797|FG005|Overall Study|Lost to Follow-up|0|||
16275415|NCT02412722|39493792|FG000|Overall Study|Received drug in run-in and discontinued|0|||
16275416|NCT02412722|39493793|FG001|Overall Study|Received drug in run-in and discontinued|2|||
16275417|NCT02412722|39493794|FG002|Overall Study|Received drug in run-in and discontinued|0|||
16275418|NCT02412722|39493795|FG003|Overall Study|Received drug in run-in and discontinued|0|||
16275419|NCT02412722|39493796|FG004|Overall Study|Received drug in run-in and discontinued|0|||
16275420|NCT02412722|39493797|FG005|Overall Study|Received drug in run-in and discontinued|0|||
16275421|NCT02412722|39493792|FG000|Overall Study|Reason not Specified|3|||
16275422|NCT02412722|39493793|FG001|Overall Study|Reason not Specified|0|||
16275423|NCT02412722|39493794|FG002|Overall Study|Reason not Specified|2|||
16275424|NCT02412722|39493795|FG003|Overall Study|Reason not Specified|1|||
16275425|NCT02412722|39493796|FG004|Overall Study|Reason not Specified|2|||
16275426|NCT02412722|39493797|FG005|Overall Study|Reason not Specified|6|||
16275427|NCT02107196|39493800|FG000|12-week Treatment Period|Adverse Event|6|||
16275428|NCT02107196|39493801|FG001|12-week Treatment Period|Adverse Event|3|||
16275429|NCT02107196|39493800|FG000|12-week Treatment Period|Lack of Efficacy|2|||
16275430|NCT02107196|39493801|FG001|12-week Treatment Period|Lack of Efficacy|1|||
16275431|NCT02107196|39493800|FG000|12-week Treatment Period|Lost to Follow-up|3|||
16275432|NCT02107196|39493801|FG001|12-week Treatment Period|Lost to Follow-up|6|||
16275433|NCT02107196|39493800|FG000|12-week Treatment Period|Physician Decision|0|||
16275434|NCT02107196|39493801|FG001|12-week Treatment Period|Physician Decision|1|||
16275435|NCT02107196|39493800|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
16275436|NCT02107196|39493801|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
16275437|NCT02107196|39493800|FG000|12-week Treatment Period|Protocol Violation|7|||
16275438|NCT02107196|39493801|FG001|12-week Treatment Period|Protocol Violation|8|||
16275439|NCT02107196|39493800|FG000|12-week Treatment Period|Reason Missing|11|||
16275440|NCT02107196|39493801|FG001|12-week Treatment Period|Reason Missing|8|||
16275441|NCT02107196|39493800|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
16275442|NCT02107196|39493801|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
16275443|NCT02107196|39493800|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
16275444|NCT02107196|39493801|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
16275445|NCT02107196|39493800|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
16275446|NCT02107196|39493801|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
16275447|NCT02107196|39493800|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
16275448|NCT02107196|39493801|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
16275449|NCT02416180|39493802|FG000|Overall Study|Withdrawal by Subject|1|||
16275450|NCT02754492|39493805|FG000|Overall Study|Protocol Violation|2|||
16275451|NCT02754492|39493806|FG001|Overall Study|Protocol Violation|2|||
16275452|NCT02754492|39493807|FG002|Overall Study|Protocol Violation|0|||
16275453|NCT02754492|39493808|FG003|Overall Study|Protocol Violation|1|||
16275454|NCT02754492|39493805|FG000|Overall Study|Withdrawal by Subject|2|||
16275455|NCT02754492|39493806|FG001|Overall Study|Withdrawal by Subject|0|||
16275456|NCT02754492|39493807|FG002|Overall Study|Withdrawal by Subject|0|||
16275457|NCT02754492|39493808|FG003|Overall Study|Withdrawal by Subject|0|||
16275458|NCT02754492|39493805|FG000|Overall Study|Equipment malfuntion|0|||
16275459|NCT02754492|39493806|FG001|Overall Study|Equipment malfuntion|0|||
16275460|NCT02754492|39493807|FG002|Overall Study|Equipment malfuntion|2|||
16275461|NCT02754492|39493808|FG003|Overall Study|Equipment malfuntion|5|||
16275462|NCT02754492|39493805|FG000|Overall Study|Adverse Event|0|||
16275463|NCT02754492|39493806|FG001|Overall Study|Adverse Event|0|||
16275464|NCT02754492|39493807|FG002|Overall Study|Adverse Event|0|||
16275465|NCT02754492|39493808|FG003|Overall Study|Adverse Event|13|||
16275466|NCT02754492|39493805|FG000|Overall Study|Venous access issues not resulting in AE|0|||
16275467|NCT02754492|39493806|FG001|Overall Study|Venous access issues not resulting in AE|0|||
16275468|NCT02754492|39493807|FG002|Overall Study|Venous access issues not resulting in AE|0|||
16275469|NCT02754492|39493808|FG003|Overall Study|Venous access issues not resulting in AE|4|||
16275470|NCT01488448|39493809|FG000|Overall Study|Withdrawal by Subject|3|||
16275471|NCT01488448|39493810|FG001|Overall Study|Withdrawal by Subject|1|||
16275472|NCT01488448|39493809|FG000|Overall Study|Adverse Event|9|||
16275473|NCT01488448|39493810|FG001|Overall Study|Adverse Event|4|||
16275474|NCT01488448|39493809|FG000|Overall Study|Physician Decision|4|||
16275475|NCT01488448|39493810|FG001|Overall Study|Physician Decision|9|||
16275476|NCT01488448|39493809|FG000|Overall Study|Protocol Violation|4|||
16275477|NCT01488448|39493810|FG001|Overall Study|Protocol Violation|3|||
16275478|NCT03614728|39493811|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
16275479|NCT03614728|39493812|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
16275480|NCT03614728|39493813|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
16275481|NCT03614728|39493814|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
16275482|NCT03614728|39493811|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
16275483|NCT03614728|39493812|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
16275484|NCT03614728|39493813|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
16275485|NCT03614728|39493814|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
16275486|NCT02197416|39493815|FG000|Overall Study|Other reasons|0|||
16275487|NCT02197416|39493816|FG001|Overall Study|Other reasons|2|||
16275488|NCT02197416|39493817|FG002|Overall Study|Other reasons|5|||
16275489|NCT02197416|39493815|FG000|Overall Study|Withdrawal by Subject|0|||
16275490|NCT02197416|39493816|FG001|Overall Study|Withdrawal by Subject|2|||
16275491|NCT02197416|39493817|FG002|Overall Study|Withdrawal by Subject|1|||
16275492|NCT02197416|39493815|FG000|Overall Study|Protocol Violation|1|||
16275493|NCT02197416|39493816|FG001|Overall Study|Protocol Violation|0|||
16275494|NCT02197416|39493817|FG002|Overall Study|Protocol Violation|1|||
16275495|NCT02197416|39493815|FG000|Overall Study|Adverse Event|0|||
16275496|NCT02197416|39493816|FG001|Overall Study|Adverse Event|0|||
16275497|NCT02197416|39493817|FG002|Overall Study|Adverse Event|1|||
16275498|NCT05263505|39493820|FG000|Overall Study|Adverse Event|0|||
16275499|NCT05263505|39493821|FG001|Overall Study|Adverse Event|1|||
16275500|NCT00089973|39493822|FG000|Overall Study|Adverse Event|3|||
16275501|NCT00089973|39493822|FG000|Overall Study|Withdrawal by Subject|1|||
16275502|NCT00089973|39493822|FG000|Overall Study|Disease progression|45|||
16275503|NCT00089973|39493822|FG000|Overall Study|Death|1|||
16275504|NCT02308241|39493823|FG000|Overall Study|Withdrawal by Subject|3|||
16275505|NCT01896934|39493824|FG000|Overall Study|Adverse Event|1|||
16275506|NCT01896934|39493824|FG000|Overall Study|Withdrawal by Subject|1|||
16275507|NCT04129554|39493825|FG000|Overall Study|Withdrawal by Subject|4|||
16275508|NCT04129554|39493826|FG001|Overall Study|Withdrawal by Subject|3|||
16275509|NCT04129554|39493825|FG000|Overall Study|Other|0|||
16275510|NCT04129554|39493826|FG001|Overall Study|Other|2|||
16275511|NCT02418754|39493830|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
16275512|NCT02418754|39493831|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
16275513|NCT02418754|39493832|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
16275514|NCT02418754|39493833|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
16275515|NCT02418754|39493834|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
16275516|NCT02418754|39493830|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
16275517|NCT02418754|39493831|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
16275518|NCT02418754|39493832|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
16275519|NCT02418754|39493833|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
16275520|NCT02418754|39493834|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
16275521|NCT02418754|39493830|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
16275522|NCT02418754|39493831|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
16275523|NCT02418754|39493832|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
16275524|NCT02418754|39493833|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
16275525|NCT02418754|39493834|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
16275526|NCT02418754|39493830|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
16275527|NCT02418754|39493831|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
16275528|NCT02418754|39493832|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
16275529|NCT02418754|39493833|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
16275530|NCT02418754|39493834|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
16275531|NCT02418754|39493830|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
16275532|NCT02418754|39493831|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
16275533|NCT02418754|39493832|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
16275534|NCT02418754|39493833|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
16275535|NCT02418754|39493834|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
16275536|NCT02418754|39493830|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
16275537|NCT02418754|39493831|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
16275538|NCT02418754|39493832|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
16275539|NCT02418754|39493833|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
16275540|NCT02418754|39493834|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
16275541|NCT02418754|39493830|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
16275542|NCT02418754|39493831|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
16275543|NCT02418754|39493832|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
16375147|NCT00545948|39860064|FG000|Overall Study|Not Treated|1|||
16275544|NCT02418754|39493833|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
16275545|NCT02418754|39493834|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
16275546|NCT02418754|39493830|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
16275547|NCT02418754|39493831|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
16275548|NCT02418754|39493832|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
16275549|NCT02418754|39493833|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
16275550|NCT02418754|39493834|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
16275551|NCT02418754|39493830|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
16275552|NCT02418754|39493831|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
16275553|NCT02418754|39493832|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
16275554|NCT02418754|39493833|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
16275555|NCT02418754|39493834|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
16275556|NCT02418754|39493830|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
16275557|NCT02418754|39493831|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
16275558|NCT02418754|39493832|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
16275559|NCT02418754|39493833|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
16275560|NCT02418754|39493834|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
16275561|NCT02418754|39493830|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
16275562|NCT02418754|39493831|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
16275563|NCT02418754|39493832|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
16275564|NCT02418754|39493833|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
16275565|NCT02418754|39493834|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
16275566|NCT00522041|39493835|FG000|Overall Study|Adverse Event|9|||
16275567|NCT00522041|39493836|FG001|Overall Study|Adverse Event|3|||
16275568|NCT00522041|39493835|FG000|Overall Study|Protocol Violation|2|||
16275569|NCT00522041|39493836|FG001|Overall Study|Protocol Violation|0|||
16275570|NCT00522041|39493835|FG000|Overall Study|Lost to Follow-up|1|||
16275571|NCT00522041|39493836|FG001|Overall Study|Lost to Follow-up|4|||
16275572|NCT00522041|39493835|FG000|Overall Study|Voluntary withdrawal|5|||
16275573|NCT00522041|39493836|FG001|Overall Study|Voluntary withdrawal|4|||
16275574|NCT00522041|39493835|FG000|Overall Study|Did not receive treatment|0|||
16275575|NCT00522041|39493836|FG001|Overall Study|Did not receive treatment|1|||
16275576|NCT01833169|39493837|FG000|Overall Study|Disease Progression|99|||
16275577|NCT01833169|39493837|FG000|Overall Study|Adverse Event|33|||
16275578|NCT01833169|39493837|FG000|Overall Study|Withdrawal by Subject|9|||
16275579|NCT01833169|39493837|FG000|Overall Study|Death|3|||
16275580|NCT01833169|39493837|FG000|Overall Study|Physician Decision|2|||
16275581|NCT04142658|39493838|FG000|Overall Study|Death|2|||
16275582|NCT04142658|39493839|FG001|Overall Study|Death|1|||
16275583|NCT04142658|39493838|FG000|Overall Study|Lost to Follow-up|4|||
16275584|NCT04142658|39493839|FG001|Overall Study|Lost to Follow-up|13|||
16275585|NCT04142658|39493838|FG000|Overall Study|Withdrawal by Subject|9|||
16275586|NCT04142658|39493839|FG001|Overall Study|Withdrawal by Subject|16|||
16275587|NCT00562120|39493840|FG000|First Intervention Period|Adverse Event|1|||
16275588|NCT00562120|39493841|FG001|First Intervention Period|Adverse Event|0|||
16275589|NCT00562120|39493842|FG002|First Intervention Period|Adverse Event|0|||
16275590|NCT00562120|39493843|FG003|First Intervention Period|Adverse Event|0|||
16275591|NCT00562120|39493840|FG000|First Intervention Period|Randomized but not Treated|1|||
16275592|NCT00562120|39493841|FG001|First Intervention Period|Randomized but not Treated|0|||
16275593|NCT00562120|39493842|FG002|First Intervention Period|Randomized but not Treated|0|||
16275594|NCT00562120|39493843|FG003|First Intervention Period|Randomized but not Treated|0|||
16275595|NCT01386125|39493844|FG000|Overall Study|Lost to Follow-up|3|||
16275596|NCT01386125|39493845|FG001|Overall Study|Lost to Follow-up|9|||
16275597|NCT01386125|39493844|FG000|Overall Study|Physician Decision|0|||
16275598|NCT01386125|39493845|FG001|Overall Study|Physician Decision|1|||
16275599|NCT01386125|39493844|FG000|Overall Study|Protocol Violation|5|||
16275600|NCT01386125|39493845|FG001|Overall Study|Protocol Violation|7|||
16275601|NCT01386125|39493844|FG000|Overall Study|Disease Progress|1|||
16275602|NCT01386125|39493845|FG001|Overall Study|Disease Progress|2|||
16275603|NCT01386125|39493844|FG000|Overall Study|Withdrawal by Subject|13|||
16275604|NCT01386125|39493845|FG001|Overall Study|Withdrawal by Subject|12|||
16275605|NCT01386125|39493844|FG000|Overall Study|Adverse Event|2|||
16275606|NCT01386125|39493845|FG001|Overall Study|Adverse Event|5|||
16275607|NCT01386125|39493844|FG000|Overall Study|Lack of Efficacy|0|||
16275608|NCT01386125|39493845|FG001|Overall Study|Lack of Efficacy|1|||
16275609|NCT01386125|39493844|FG000|Overall Study|Participant Leaving Country|1|||
16275610|NCT01386125|39493845|FG001|Overall Study|Participant Leaving Country|0|||
16275611|NCT01067521|39493849|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
16275612|NCT01067521|39493850|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
16275613|NCT01067521|39493849|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
16275614|NCT01067521|39493850|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
16275615|NCT01067521|39493849|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
16275616|NCT01067521|39493850|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
16275617|NCT01067521|39493849|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
16275618|NCT01067521|39493850|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
16275619|NCT01067521|39493849|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
16275620|NCT01067521|39493850|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
16275621|NCT01067521|39493849|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
16275622|NCT01067521|39493850|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
16275623|NCT01067521|39493849|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
16275624|NCT01067521|39493850|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
16275625|NCT01067521|39493849|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
16275626|NCT01067521|39493850|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
16275627|NCT01067521|39493849|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
16275628|NCT01067521|39493850|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
16275629|NCT01067521|39493849|FG000|Open-Label Period|Death|3|||
16275630|NCT01067521|39493850|FG001|Open-Label Period|Death|1|||
16275631|NCT01067521|39493849|FG000|Open-Label Period|Adverse Event|30|||
16275632|NCT01067521|39493850|FG001|Open-Label Period|Adverse Event|28|||
16275633|NCT01067521|39493849|FG000|Open-Label Period|Withdrawal by Subject|160|||
16275634|NCT01067521|39493850|FG001|Open-Label Period|Withdrawal by Subject|88|||
16175936|NCT01217606|39122767|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
16175937|NCT01217606|39122766|FG000|Initial Treatment Phase|Adverse Event|10|||
16175938|NCT01217606|39122767|FG001|Initial Treatment Phase|Adverse Event|6|||
16175939|NCT01217606|39122766|FG000|9-Month Masked Extension|Adverse Event|3|||
16175940|NCT01217606|39122767|FG001|9-Month Masked Extension|Adverse Event|6|||
16175941|NCT01217606|39122766|FG000|9-Month Masked Extension|Other Reasons|4|||
16175942|NCT01217606|39122767|FG001|9-Month Masked Extension|Other Reasons|4|||
16175943|NCT01217606|39122766|FG000|9-Month Masked Extension|Personal Reasons|2|||
16175944|NCT01217606|39122767|FG001|9-Month Masked Extension|Personal Reasons|1|||
16175945|NCT01217606|39122766|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
16175946|NCT01217606|39122767|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
16175947|NCT01217606|39122766|FG000|9-Month Masked Extension|Pregnancy|1|||
16175948|NCT01217606|39122767|FG001|9-Month Masked Extension|Pregnancy|0|||
16175949|NCT01217606|39122766|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
16175950|NCT01217606|39122767|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
16175951|NCT00816036|39122768|FG000|Overall Study|Death|47|||
16175952|NCT00816036|39122769|FG001|Overall Study|Death|28|||
16175953|NCT00816036|39122768|FG000|Overall Study|Lost to Follow-up|75|||
16175954|NCT00816036|39122769|FG001|Overall Study|Lost to Follow-up|57|||
16175955|NCT00816036|39122768|FG000|Overall Study|Withdrawal by Subject|54|||
16175956|NCT00816036|39122769|FG001|Overall Study|Withdrawal by Subject|23|||
16175957|NCT01331161|39122770|FG000|Overall Study|Physician Decision|1|||
16175958|NCT01331161|39122771|FG001|Overall Study|Physician Decision|0|||
16175959|NCT01331161|39122770|FG000|Overall Study|Lost to Follow-up|0|||
16175960|NCT01331161|39122771|FG001|Overall Study|Lost to Follow-up|1|||
16175961|NCT01331161|39122770|FG000|Overall Study|Pregnancy|0|||
16175962|NCT01331161|39122771|FG001|Overall Study|Pregnancy|1|||
16175963|NCT01938625|39122774|FG000|Overall Study|Withdrawal by Subject|0|||
16175964|NCT01938625|39122775|FG001|Overall Study|Withdrawal by Subject|1|||
16175965|NCT01938625|39122774|FG000|Overall Study|Adverse Event|0|||
16175966|NCT01938625|39122775|FG001|Overall Study|Adverse Event|1|||
16175967|NCT02387957|39122776|FG000|Overall Study|The study was discontinued|21|||
16175968|NCT02387957|39122777|FG001|Overall Study|The study was discontinued|21|||
16175969|NCT02387957|39122778|FG002|Overall Study|The study was discontinued|20|||
16175970|NCT01719757|39122783|FG000|Overall Study|Adverse Event|38|||
16175971|NCT01719757|39122783|FG000|Overall Study|Withdrawal by Subject|15|||
16175972|NCT01719757|39122783|FG000|Overall Study|Lost to Follow-up|20|||
16175973|NCT01719757|39122783|FG000|Overall Study|Protocol Violation|1|||
16175974|NCT01719757|39122783|FG000|Overall Study|well controlled pain|27|||
16175975|NCT02835495|39122787|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
16275635|NCT01067521|39493849|FG000|Open-Label Period|Physician Decision|13|||
16275636|NCT01067521|39493850|FG001|Open-Label Period|Physician Decision|11|||
16275637|NCT01067521|39493849|FG000|Open-Label Period|Non-compliance with study drug|5|||
16275638|NCT01067521|39493850|FG001|Open-Label Period|Non-compliance with study drug|0|||
16275639|NCT01067521|39493849|FG000|Open-Label Period|Protocol Violation|3|||
16275640|NCT01067521|39493850|FG001|Open-Label Period|Protocol Violation|0|||
16175976|NCT02835495|39122788|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
16175977|NCT02835495|39122787|FG000|Overall Study|Declined in-person follow-up visit|4|||
16175978|NCT02835495|39122788|FG001|Overall Study|Declined in-person follow-up visit|2|||
16175979|NCT00784758|39122789|FG000|Overall Study|Withdrawal by Subject|3|||
16175980|NCT00784758|39122790|FG001|Overall Study|Withdrawal by Subject|0|||
16175981|NCT00784758|39122789|FG000|Overall Study|Adverse Event|1|||
16175982|NCT00784758|39122790|FG001|Overall Study|Adverse Event|0|||
16175983|NCT00635102|39122792|FG000|Overall Study|Withdrawal by Subject|7|||
16175984|NCT00635102|39122793|FG001|Overall Study|Withdrawal by Subject|8|||
16175985|NCT02333227|39122794|FG000|Overall Study|Lost to Follow-up|137|||
16175986|NCT02333227|39122795|FG001|Overall Study|Lost to Follow-up|106|||
16175987|NCT02333227|39122794|FG000|Overall Study|Pregnancy Interrupted|42|||
16175988|NCT02333227|39122795|FG001|Overall Study|Pregnancy Interrupted|89|||
16175989|NCT02333227|39122794|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
16175990|NCT02333227|39122795|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
16175991|NCT03323749|39122797|FG000|Double-blind Period|Lost to Follow-up|4|||
16175992|NCT03323749|39122798|FG001|Double-blind Period|Lost to Follow-up|5|||
16175993|NCT03323749|39122797|FG000|Double-blind Period|Adverse Event|3|||
16175994|NCT03323749|39122798|FG001|Double-blind Period|Adverse Event|1|||
16175995|NCT03323749|39122797|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
16175996|NCT03323749|39122798|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
16175997|NCT03323749|39122797|FG000|Open-Label Period|Adverse Event|3|||
16175998|NCT03323749|39122798|FG001|Open-Label Period|Adverse Event|10|||
16175999|NCT03323749|39122797|FG000|Open-Label Period|Withdrawal by Subject|7|||
16176000|NCT03323749|39122798|FG001|Open-Label Period|Withdrawal by Subject|5|||
16176001|NCT02580058|39122799|FG000|Overall Study|Adverse Event|16|||
16176002|NCT02580058|39122800|FG001|Overall Study|Adverse Event|30|||
16176003|NCT02580058|39122801|FG002|Overall Study|Adverse Event|20|||
16176004|NCT02580058|39122799|FG000|Overall Study|Death|4|||
16176005|NCT02580058|39122800|FG001|Overall Study|Death|4|||
16176006|NCT02580058|39122801|FG002|Overall Study|Death|5|||
16176007|NCT02580058|39122799|FG000|Overall Study|Physician Decision|1|||
16176008|NCT02580058|39122800|FG001|Overall Study|Physician Decision|3|||
16176009|NCT02580058|39122801|FG002|Overall Study|Physician Decision|11|||
16176010|NCT02580058|39122799|FG000|Overall Study|Other|5|||
16176011|NCT02580058|39122800|FG001|Overall Study|Other|1|||
16176012|NCT02580058|39122801|FG002|Overall Study|Other|3|||
16176013|NCT02580058|39122799|FG000|Overall Study|Withdrawal by Subject|4|||
16176014|NCT02580058|39122800|FG001|Overall Study|Withdrawal by Subject|7|||
16176015|NCT02580058|39122801|FG002|Overall Study|Withdrawal by Subject|31|||
16176016|NCT02580058|39122799|FG000|Overall Study|Global Deterioration of Health Status|19|||
16176017|NCT02580058|39122800|FG001|Overall Study|Global Deterioration of Health Status|18|||
16176018|NCT02580058|39122801|FG002|Overall Study|Global Deterioration of Health Status|24|||
16176019|NCT02580058|39122799|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
16176020|NCT02580058|39122800|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16176021|NCT02580058|39122801|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
16176022|NCT02580058|39122799|FG000|Overall Study|Progressive Disease|137|||
16176023|NCT02580058|39122800|FG001|Overall Study|Progressive Disease|125|||
16176024|NCT02580058|39122801|FG002|Overall Study|Progressive Disease|94|||
16176025|NCT02580058|39122799|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16176026|NCT02580058|39122800|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16176027|NCT02580058|39122801|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16176028|NCT02498652|39122802|FG000|Overall Study|Protocol Violation|0|||
16176029|NCT02498652|39122803|FG001|Overall Study|Protocol Violation|1|||
16176030|NCT02951052|39122804|FG000|Overall Study|Adverse Event|13|||
16176031|NCT02951052|39122805|FG001|Overall Study|Adverse Event|5|||
16176032|NCT02951052|39122804|FG000|Overall Study|Withdrawal by Subject|1|||
16176033|NCT02951052|39122805|FG001|Overall Study|Withdrawal by Subject|5|||
16176034|NCT02951052|39122804|FG000|Overall Study|Physician Decision|2|||
16176035|NCT02951052|39122805|FG001|Overall Study|Physician Decision|0|||
16176036|NCT02951052|39122804|FG000|Overall Study|Lost to Follow-up|1|||
16275641|NCT01067521|39493849|FG000|Open-Label Period|Pregnancy|14|||
16176037|NCT02951052|39122805|FG001|Overall Study|Lost to Follow-up|1|||
16176038|NCT02951052|39122804|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
16176039|NCT02951052|39122805|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
16176040|NCT02951052|39122804|FG000|Overall Study|Protocol Violation|5|||
16176041|NCT02951052|39122805|FG001|Overall Study|Protocol Violation|3|||
16176042|NCT02951052|39122804|FG000|Overall Study|Lack of Efficacy|3|||
16176043|NCT02951052|39122805|FG001|Overall Study|Lack of Efficacy|4|||
16176044|NCT02951052|39122804|FG000|Overall Study|Ongoing|1|||
16176045|NCT02951052|39122805|FG001|Overall Study|Ongoing|0|||
16176046|NCT02468193|39122808|FG000|Overall Study|Adverse Event|4|||
16176047|NCT02468193|39122808|FG000|Overall Study|Subject/ Guardian decision|2|||
16176048|NCT01254344|39122809|FG000|Overall Study|Adverse Event|2|||
16176049|NCT01254344|39122810|FG001|Overall Study|Adverse Event|5|||
16176050|NCT01254344|39122809|FG000|Overall Study|Physician Decision|7|||
16176051|NCT01254344|39122810|FG001|Overall Study|Physician Decision|4|||
16176052|NCT01254344|39122809|FG000|Overall Study|Protocol Violation|1|||
16176053|NCT01254344|39122810|FG001|Overall Study|Protocol Violation|4|||
16176054|NCT01254344|39122809|FG000|Overall Study|Withdrawal by Subject|3|||
16176055|NCT01254344|39122810|FG001|Overall Study|Withdrawal by Subject|6|||
16176056|NCT00222105|39122811|FG000|Overall Study|Removed due to wrong diagnosis|1|||
16176057|NCT00222105|39122811|FG000|Overall Study|Withdrawal by Subject|1|||
16176058|NCT00222105|39122811|FG000|Overall Study|Adverse Event|8|||
16176059|NCT00222105|39122811|FG000|Overall Study|Treatment delays|2|||
16176060|NCT00222105|39122811|FG000|Overall Study|Death|2|||
16176061|NCT03406962|39122812|FG000|Overall Study|Death|2|||
16176062|NCT03406962|39122812|FG000|Overall Study|Adverse Event|1|||
16176063|NCT03185130|39122813|FG000|Overall Study|Withdrawal by Subject|0|||
16176064|NCT03185130|39122814|FG001|Overall Study|Withdrawal by Subject|2|||
16176065|NCT01662999|39122819|FG000|Period 3|Withdrawal by Subject|0|||
16176066|NCT01662999|39122820|FG001|Period 3|Withdrawal by Subject|1|||
16275642|NCT01067521|39493850|FG001|Open-Label Period|Pregnancy|8|||
16275643|NCT01067521|39493849|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
16275644|NCT01067521|39493850|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
16275645|NCT01067521|39493849|FG000|Open-Label Period|Lost to Follow-up|21|||
16275646|NCT01067521|39493850|FG001|Open-Label Period|Lost to Follow-up|20|||
16275647|NCT02896296|39493851|FG000|Overall Study|Adverse Event|1|||
16275648|NCT02896296|39493851|FG000|Overall Study|Lost to Follow-up|19|||
16275649|NCT02896296|39493851|FG000|Overall Study|Pregnancy|1|||
16275650|NCT02896296|39493851|FG000|Overall Study|Physician Decision|2|||
16275651|NCT02896296|39493851|FG000|Overall Study|Withdrawal by Subject|10|||
16275652|NCT02896296|39493851|FG000|Overall Study|Site closing|7|||
16275653|NCT02896296|39493851|FG000|Overall Study|Incarceration|1|||
16275654|NCT02896296|39493851|FG000|Overall Study|Relocation|1|||
16275655|NCT01958476|39493852|FG000|Overall Study|Parent requested exclusion from analysis|1|||
16275656|NCT01958476|39493853|FG001|Overall Study|Parent requested exclusion from analysis|0|||
16275657|NCT00919711|39493855|FG000|Overall Study|Withdrawal by Subject|15|||
16275658|NCT00919711|39493856|FG001|Overall Study|Withdrawal by Subject|7|||
16275659|NCT00919711|39493855|FG000|Overall Study|Adverse Event|13|||
16275660|NCT00919711|39493856|FG001|Overall Study|Adverse Event|3|||
16275661|NCT00919711|39493855|FG000|Overall Study|Other|1|||
16275662|NCT00919711|39493856|FG001|Overall Study|Other|2|||
16275663|NCT00919711|39493855|FG000|Overall Study|Administrative Decision|0|||
16275664|NCT00919711|39493856|FG001|Overall Study|Administrative Decision|1|||
16275665|NCT00919711|39493855|FG000|Overall Study|Lost to Follow-up|2|||
16275666|NCT00919711|39493856|FG001|Overall Study|Lost to Follow-up|0|||
16275667|NCT00919711|39493855|FG000|Overall Study|Death|1|||
16275668|NCT00919711|39493856|FG001|Overall Study|Death|0|||
16275669|NCT00919711|39493855|FG000|Overall Study|Noncompliance|1|||
16275670|NCT00919711|39493856|FG001|Overall Study|Noncompliance|0|||
16275671|NCT04599166|39493857|FG000|Overall Study|Technological failure connecting to study app|80|||
16275672|NCT01835548|39493861|FG000|Dose Optimization Period|Adverse Event|0|||
16275673|NCT01835548|39493862|FG001|Dose Optimization Period|Adverse Event|0|||
16275674|NCT01835548|39493863|FG002|Dose Optimization Period|Adverse Event|1|||
16275675|NCT01835548|39493861|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
16275676|NCT01835548|39493862|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
16275677|NCT01835548|39493863|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
16275678|NCT01835548|39493861|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16275679|NCT01835548|39493862|FG001|Double-Blind Treatment Period|Adverse Event|1|||
16275680|NCT01835548|39493863|FG002|Double-Blind Treatment Period|Adverse Event|0|||
16275681|NCT01835548|39493861|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16275682|NCT01835548|39493862|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16275683|NCT01835548|39493863|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16275684|NCT00757705|39493864|FG000|Overall Study|Adverse Event|19|||
16275685|NCT00757705|39493864|FG000|Overall Study|Lost to Follow-up|16|||
16275686|NCT00757705|39493864|FG000|Overall Study|Withdrawal by Subject|25|||
16275687|NCT00757705|39493864|FG000|Overall Study|Insufficient Response|26|||
16275688|NCT00757705|39493864|FG000|Overall Study|Ineligible to continue|8|||
16275689|NCT00757705|39493864|FG000|Overall Study|Non-compliant|9|||
16275690|NCT00757705|39493864|FG000|Overall Study|Other|18|||
16275691|NCT01086969|39493865|FG000|Overall Study|Withdrawal by Subject|1|||
16275692|NCT01086969|39493866|FG001|Overall Study|Withdrawal by Subject|2|||
16275693|NCT01086969|39493867|FG002|Overall Study|Withdrawal by Subject|0|||
16275694|NCT00396162|39493869|FG000|Overall Study|Withdrawal by Subject|2|||
16275695|NCT00396162|39493870|FG001|Overall Study|Withdrawal by Subject|3|||
16275696|NCT03110380|39493871|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
16275697|NCT03110380|39493872|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
16275698|NCT03110380|39493873|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
16275699|NCT03110380|39493874|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
16275700|NCT03110380|39493871|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
16275701|NCT03110380|39493872|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
16275702|NCT03110380|39493873|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16275703|NCT03110380|39493874|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16275704|NCT03110380|39493871|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
16275705|NCT03110380|39493872|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
16275706|NCT03110380|39493873|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
16275707|NCT03110380|39493874|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
16275708|NCT03110380|39493871|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
16275709|NCT03110380|39493872|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
16275710|NCT03110380|39493873|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
16275711|NCT03110380|39493874|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
16275712|NCT03110380|39493871|FG000|Double-Blind Treatment Phase|Death|2|||
16275713|NCT03110380|39493872|FG001|Double-Blind Treatment Phase|Death|1|||
16275714|NCT03110380|39493873|FG002|Double-Blind Treatment Phase|Death|0|||
16275715|NCT03110380|39493874|FG003|Double-Blind Treatment Phase|Death|0|||
16275716|NCT03110380|39493871|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
16275717|NCT03110380|39493872|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
16275718|NCT03110380|39493873|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
16275719|NCT03110380|39493874|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
16275720|NCT03110380|39493871|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
16275721|NCT03110380|39493872|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
16275722|NCT03110380|39493873|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
16275723|NCT03110380|39493874|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
16275724|NCT03110380|39493871|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
16275725|NCT03110380|39493872|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
16275726|NCT03110380|39493873|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
16275727|NCT03110380|39493874|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
16275728|NCT03110380|39493871|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
16275729|NCT03110380|39493872|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
16275730|NCT03110380|39493873|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
16275731|NCT03110380|39493874|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
16275732|NCT03110380|39493871|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
16275733|NCT03110380|39493872|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
16275734|NCT03110380|39493873|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
16275735|NCT03110380|39493874|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
16275736|NCT03110380|39493871|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
16275737|NCT03110380|39493872|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
16275738|NCT03110380|39493873|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
16275739|NCT03110380|39493874|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
16275740|NCT01142908|39493877|FG000|Overall Study|Lost to Follow-up|19|||
16275741|NCT01142908|39493878|FG001|Overall Study|Lost to Follow-up|13|||
16275742|NCT01142908|39493877|FG000|Overall Study|Death|1|||
16275743|NCT01142908|39493878|FG001|Overall Study|Death|4|||
16275744|NCT01142908|39493877|FG000|Overall Study|Excluded - did not meet criteria|9|||
16275745|NCT01142908|39493878|FG001|Overall Study|Excluded - did not meet criteria|5|||
16275746|NCT01142908|39493877|FG000|Overall Study|Withdrawal by Subject|3|||
16275747|NCT01142908|39493878|FG001|Overall Study|Withdrawal by Subject|0|||
16275748|NCT03555695|39493881|FG000|Overall Study|Withdrawal by Subject|1|||
16275749|NCT03555695|39493881|FG000|Overall Study|Lost to Follow-up|1|||
16275750|NCT03555695|39493881|FG000|Overall Study|appendicitis (unrelated)|1|||
16275751|NCT03555695|39493881|FG000|Overall Study|pre-existing sciatica|1|||
16275752|NCT04660032|39493882|FG000|Overall Study|Protocol Violation|1|||
16275753|NCT04660032|39493883|FG001|Overall Study|Protocol Violation|1|||
16275754|NCT03500094|39493884|FG000|Overall Study|Withdrawal by Subject|1|||
16275755|NCT03500094|39493884|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
16275756|NCT03500094|39493884|FG000|Overall Study|Lost to Follow-up|1|||
16275757|NCT00526162|39493887|FG000|Overall Study|Device not implanted|3|||
16275758|NCT01992094|39493891|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
16275759|NCT01992094|39493892|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
16275760|NCT01992094|39493893|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
16275761|NCT01992094|39493891|FG000|Overall Study|Adverse Event|1|||
16275762|NCT01992094|39493892|FG001|Overall Study|Adverse Event|0|||
16275763|NCT01992094|39493893|FG002|Overall Study|Adverse Event|0|||
16275764|NCT01992094|39493891|FG000|Overall Study|Death|5|||
16275765|NCT01992094|39493892|FG001|Overall Study|Death|5|||
16275766|NCT01992094|39493893|FG002|Overall Study|Death|2|||
16275767|NCT01992094|39493891|FG000|Overall Study|Lost to Follow-up|26|||
16275768|NCT01992094|39493892|FG001|Overall Study|Lost to Follow-up|9|||
16275769|NCT01992094|39493893|FG002|Overall Study|Lost to Follow-up|13|||
16275770|NCT01992094|39493891|FG000|Overall Study|OTHER|4|||
16275771|NCT01992094|39493892|FG001|Overall Study|OTHER|0|||
16275772|NCT01992094|39493893|FG002|Overall Study|OTHER|0|||
16275773|NCT01992094|39493891|FG000|Overall Study|Protocol Violation|1|||
16275774|NCT01992094|39493892|FG001|Overall Study|Protocol Violation|0|||
16275775|NCT01992094|39493893|FG002|Overall Study|Protocol Violation|1|||
16275776|NCT01992094|39493891|FG000|Overall Study|Withdrawal by Subject|7|||
16275777|NCT01992094|39493892|FG001|Overall Study|Withdrawal by Subject|3|||
16275778|NCT01992094|39493893|FG002|Overall Study|Withdrawal by Subject|4|||
16275779|NCT00613730|39493894|FG000|Overall Study|Disease progression|2|||
16275780|NCT00613730|39493894|FG000|Overall Study|Administrative decision|1|||
16275781|NCT01630616|39493895|FG000|Overall Study|Adverse Event|0|||
16275782|NCT01630616|39493896|FG001|Overall Study|Adverse Event|0|||
16275783|NCT01630616|39493897|FG002|Overall Study|Adverse Event|0|||
16275784|NCT01630616|39493898|FG003|Overall Study|Adverse Event|1|||
16275785|NCT01630616|39493899|FG004|Overall Study|Adverse Event|0|||
16275786|NCT01630616|39493900|FG005|Overall Study|Adverse Event|0|||
16275787|NCT01630616|39493895|FG000|Overall Study|Withdrawal by Subject|0|||
16275788|NCT01630616|39493896|FG001|Overall Study|Withdrawal by Subject|0|||
16275789|NCT01630616|39493897|FG002|Overall Study|Withdrawal by Subject|0|||
16275790|NCT01630616|39493898|FG003|Overall Study|Withdrawal by Subject|2|||
16275791|NCT01630616|39493899|FG004|Overall Study|Withdrawal by Subject|0|||
16275792|NCT01630616|39493900|FG005|Overall Study|Withdrawal by Subject|0|||
16275793|NCT04129944|39493901|FG000|Overall Study|Death|0|||
16275794|NCT04129944|39493902|FG001|Overall Study|Death|0|||
16275795|NCT04129944|39493903|FG002|Overall Study|Death|0|||
16275796|NCT04129944|39493904|FG003|Overall Study|Death|1|||
16275797|NCT04129944|39493901|FG000|Overall Study|Lost to Follow-up|1|||
16275798|NCT04129944|39493902|FG001|Overall Study|Lost to Follow-up|0|||
16275799|NCT04129944|39493903|FG002|Overall Study|Lost to Follow-up|0|||
16275800|NCT04129944|39493904|FG003|Overall Study|Lost to Follow-up|0|||
16275801|NCT04129944|39493901|FG000|Overall Study|Withdrawal by Subject|1|||
16275802|NCT04129944|39493902|FG001|Overall Study|Withdrawal by Subject|0|||
16275803|NCT04129944|39493903|FG002|Overall Study|Withdrawal by Subject|1|||
16275804|NCT04129944|39493904|FG003|Overall Study|Withdrawal by Subject|2|||
16275805|NCT00210639|39493905|FG000|Overall Study|Lost to Follow-up|37|||
16275806|NCT00210639|39493906|FG001|Overall Study|Lost to Follow-up|29|||
16275807|NCT00210639|39493905|FG000|Overall Study|Withdrawal by Subject|8|||
16275808|NCT00210639|39493906|FG001|Overall Study|Withdrawal by Subject|1|||
16275809|NCT00210639|39493905|FG000|Overall Study|Other|18|||
16275810|NCT00210639|39493906|FG001|Overall Study|Other|12|||
16275811|NCT00397254|39493907|FG000|Overall Study|Lost to Follow-up|2|||
16275812|NCT00397254|39493908|FG001|Overall Study|Lost to Follow-up|2|||
16275813|NCT00642993|39493909|FG000|Overall Study|Adverse Event|85|||
16275814|NCT00642993|39493910|FG001|Overall Study|Adverse Event|4|||
16275815|NCT00642993|39493909|FG000|Overall Study|Lost to Follow-up|8|||
16275816|NCT00642993|39493910|FG001|Overall Study|Lost to Follow-up|4|||
16275817|NCT00642993|39493909|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
16275818|NCT00642993|39493910|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
16275819|NCT00642993|39493909|FG000|Overall Study|Protocol Violation|1|||
16275820|NCT00642993|39493910|FG001|Overall Study|Protocol Violation|4|||
16275821|NCT00642993|39493909|FG000|Overall Study|Did not meet protocol eligibility|0|||
16275822|NCT00642993|39493910|FG001|Overall Study|Did not meet protocol eligibility|1|||
16275823|NCT00642993|39493909|FG000|Overall Study|Administrative|1|||
16275824|NCT00642993|39493910|FG001|Overall Study|Administrative|0|||
16275825|NCT02941523|39493913|FG000|Monotherapy|Withdrawal by Subject|0|||
16275826|NCT02941523|39493914|FG001|Monotherapy|Withdrawal by Subject|1|||
16275827|NCT02941523|39493913|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
16275828|NCT02941523|39493914|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
16275829|NCT02941523|39493913|FG000|Carboplatin Combination Therapy|Death|1|||
16275830|NCT02941523|39493914|FG001|Carboplatin Combination Therapy|Death|2|||
16275831|NCT02941523|39493913|FG000|Carboplatin Combination Therapy|Disease progression|2|||
16275832|NCT02941523|39493914|FG001|Carboplatin Combination Therapy|Disease progression|0|||
16275833|NCT02941523|39493913|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
16275834|NCT02941523|39493914|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
16275835|NCT01828112|39493915|FG000|Overall Study|Adverse Event|6|||
16275836|NCT01828112|39493916|FG001|Overall Study|Adverse Event|8|||
16275837|NCT01828112|39493915|FG000|Overall Study|Death|9|||
16275838|NCT01828112|39493916|FG001|Overall Study|Death|5|||
16275839|NCT01828112|39493915|FG000|Overall Study|Physician Decision|5|||
16275840|NCT01828112|39493916|FG001|Overall Study|Physician Decision|5|||
16275841|NCT01828112|39493915|FG000|Overall Study|Progressive disease|56|||
16275842|NCT01828112|39493916|FG001|Overall Study|Progressive disease|82|||
16275843|NCT01828112|39493915|FG000|Overall Study|Subject/guardian decision|6|||
16275844|NCT01828112|39493916|FG001|Overall Study|Subject/guardian decision|8|||
16275845|NCT00735696|39493917|FG000|Overall Study|Withdrawal by Subject|1|||
16275846|NCT00735696|39493917|FG000|Overall Study|Enrolled but never Treated|1|||
16275847|NCT00659815|39493918|FG000|Overall Study|Study related symptoms and complaints|2|||
16275848|NCT00659815|39493919|FG001|Overall Study|Study related symptoms and complaints|1|||
16275849|NCT00659815|39493918|FG000|Overall Study|Inability to maintain wearing schedule|1|||
16275850|NCT00659815|39493919|FG001|Overall Study|Inability to maintain wearing schedule|2|||
16275851|NCT00659815|39493918|FG000|Overall Study|Withdrawal by Subject|1|||
16275852|NCT00659815|39493919|FG001|Overall Study|Withdrawal by Subject|1|||
16275853|NCT05061992|39493933|FG000|Overall Study|Excess bowel movements|1|||
16275854|NCT05061992|39493934|FG001|Overall Study|Excess bowel movements|0|||
16275855|NCT05061992|39493933|FG000|Overall Study|Complications of Medical Care|1|||
16275856|NCT05061992|39493934|FG001|Overall Study|Complications of Medical Care|0|||
16275857|NCT05061992|39493933|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
16275858|NCT05061992|39493934|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
16275859|NCT05061992|39493933|FG000|Overall Study|Withdrawal by Subject|0|||
16275860|NCT05061992|39493934|FG001|Overall Study|Withdrawal by Subject|1|||
16275861|NCT00668395|39493943|FG000|Overall Study|Withdrawal by Subject|4|||
16275862|NCT00668395|39493944|FG001|Overall Study|Withdrawal by Subject|4|||
16275863|NCT00668395|39493945|FG002|Overall Study|Withdrawal by Subject|1|||
16275864|NCT00668395|39493943|FG000|Overall Study|Adverse Event|1|||
16275865|NCT00668395|39493944|FG001|Overall Study|Adverse Event|1|||
16275866|NCT00668395|39493945|FG002|Overall Study|Adverse Event|0|||
16275867|NCT00668395|39493943|FG000|Overall Study|Physician Decision|1|||
16275868|NCT00668395|39493944|FG001|Overall Study|Physician Decision|1|||
16275869|NCT00668395|39493945|FG002|Overall Study|Physician Decision|0|||
16275870|NCT03206749|39493946|FG000|Overall Study|Withdrawal of consent|5|||
16275871|NCT03206749|39493947|FG001|Overall Study|Withdrawal of consent|3|||
16275872|NCT03206749|39493948|FG002|Overall Study|Withdrawal of consent|6|||
16275873|NCT03206749|39493946|FG000|Overall Study|Lost to Follow-up|0|||
16275874|NCT03206749|39493947|FG001|Overall Study|Lost to Follow-up|0|||
16275875|NCT03206749|39493948|FG002|Overall Study|Lost to Follow-up|1|||
16275876|NCT00550147|39493949|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
16275877|NCT00550147|39493949|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
16275878|NCT00550147|39493949|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
16275879|NCT00550147|39493949|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
16275880|NCT00550147|39493949|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
16275881|NCT04194151|39493950|FG000|Overall Study|Physician Decision|1|||
16275882|NCT04194151|39493951|FG001|Overall Study|Physician Decision|1|||
16275883|NCT04194151|39493952|FG002|Overall Study|Physician Decision|1|||
16275884|NCT04194151|39493953|FG003|Overall Study|Physician Decision|1|||
16275885|NCT04194151|39493954|FG004|Overall Study|Physician Decision|0|||
16275886|NCT04194151|39493955|FG005|Overall Study|Physician Decision|1|||
16275887|NCT04194151|39493950|FG000|Overall Study|Monitorization problem|0|||
16275888|NCT04194151|39493951|FG001|Overall Study|Monitorization problem|1|||
16275889|NCT04194151|39493952|FG002|Overall Study|Monitorization problem|0|||
16275890|NCT04194151|39493953|FG003|Overall Study|Monitorization problem|0|||
16275891|NCT04194151|39493954|FG004|Overall Study|Monitorization problem|0|||
16275892|NCT04194151|39493955|FG005|Overall Study|Monitorization problem|0|||
16275893|NCT02490800|39493956|FG000|Overall Study|Adverse Event|0|||
16275894|NCT02490800|39493957|FG001|Overall Study|Adverse Event|0|||
16275895|NCT02490800|39493958|FG002|Overall Study|Adverse Event|0|||
16275896|NCT02490800|39493959|FG003|Overall Study|Adverse Event|2|||
16275897|NCT02490800|39493960|FG004|Overall Study|Adverse Event|3|||
16275898|NCT02490800|39493961|FG005|Overall Study|Adverse Event|2|||
16275899|NCT02490800|39493962|FG006|Overall Study|Adverse Event|0|||
16275900|NCT02490800|39493963|FG007|Overall Study|Adverse Event|0|||
16275901|NCT02490800|39493964|FG008|Overall Study|Adverse Event|0|||
16275902|NCT02490800|39493965|FG009|Overall Study|Adverse Event|0|||
16275903|NCT02490800|39493966|FG010|Overall Study|Adverse Event|0|||
16275904|NCT02490800|39493967|FG011|Overall Study|Adverse Event|2|||
16275905|NCT02490800|39493968|FG012|Overall Study|Adverse Event|2|||
16275906|NCT02490800|39493956|FG000|Overall Study|Withdrawal by Subject|0|||
16275907|NCT02490800|39493957|FG001|Overall Study|Withdrawal by Subject|0|||
16275908|NCT02490800|39493958|FG002|Overall Study|Withdrawal by Subject|0|||
16275909|NCT02490800|39493959|FG003|Overall Study|Withdrawal by Subject|1|||
16275910|NCT02490800|39493960|FG004|Overall Study|Withdrawal by Subject|0|||
16275911|NCT02490800|39493961|FG005|Overall Study|Withdrawal by Subject|0|||
16275912|NCT02490800|39493962|FG006|Overall Study|Withdrawal by Subject|0|||
16275913|NCT02490800|39493963|FG007|Overall Study|Withdrawal by Subject|0|||
16275914|NCT02490800|39493964|FG008|Overall Study|Withdrawal by Subject|1|||
16275915|NCT02490800|39493965|FG009|Overall Study|Withdrawal by Subject|0|||
16275916|NCT02490800|39493966|FG010|Overall Study|Withdrawal by Subject|0|||
16275917|NCT02490800|39493967|FG011|Overall Study|Withdrawal by Subject|0|||
16275918|NCT02490800|39493968|FG012|Overall Study|Withdrawal by Subject|0|||
16275919|NCT02490800|39493956|FG000|Overall Study|Progressive disease|3|||
16275920|NCT02490800|39493957|FG001|Overall Study|Progressive disease|3|||
16275921|NCT02490800|39493958|FG002|Overall Study|Progressive disease|3|||
16275922|NCT02490800|39493959|FG003|Overall Study|Progressive disease|4|||
16275923|NCT02490800|39493960|FG004|Overall Study|Progressive disease|4|||
16275924|NCT02490800|39493961|FG005|Overall Study|Progressive disease|1|||
16275925|NCT02490800|39493962|FG006|Overall Study|Progressive disease|4|||
16275926|NCT02490800|39493963|FG007|Overall Study|Progressive disease|3|||
16275927|NCT02490800|39493964|FG008|Overall Study|Progressive disease|6|||
16275928|NCT02490800|39493965|FG009|Overall Study|Progressive disease|2|||
16275929|NCT02490800|39493966|FG010|Overall Study|Progressive disease|7|||
16275930|NCT02490800|39493967|FG011|Overall Study|Progressive disease|1|||
16275931|NCT02490800|39493968|FG012|Overall Study|Progressive disease|10|||
16275932|NCT02490800|39493956|FG000|Overall Study|Patient enrolled in post-trial access|0|||
16275933|NCT02490800|39493957|FG001|Overall Study|Patient enrolled in post-trial access|0|||
16275934|NCT02490800|39493958|FG002|Overall Study|Patient enrolled in post-trial access|0|||
16275935|NCT02490800|39493959|FG003|Overall Study|Patient enrolled in post-trial access|0|||
16275936|NCT02490800|39493960|FG004|Overall Study|Patient enrolled in post-trial access|0|||
16275937|NCT02490800|39493961|FG005|Overall Study|Patient enrolled in post-trial access|0|||
16275938|NCT02490800|39493962|FG006|Overall Study|Patient enrolled in post-trial access|0|||
16275939|NCT02490800|39493963|FG007|Overall Study|Patient enrolled in post-trial access|0|||
16275940|NCT02490800|39493964|FG008|Overall Study|Patient enrolled in post-trial access|0|||
16275941|NCT02490800|39493965|FG009|Overall Study|Patient enrolled in post-trial access|1|||
16275942|NCT02490800|39493966|FG010|Overall Study|Patient enrolled in post-trial access|1|||
16275943|NCT02490800|39493967|FG011|Overall Study|Patient enrolled in post-trial access|0|||
16275944|NCT02490800|39493968|FG012|Overall Study|Patient enrolled in post-trial access|6|||
16275945|NCT04203823|39493969|FG000|Overall Study|Withdrawal by Subject|2|||
16275946|NCT04203823|39493970|FG001|Overall Study|Withdrawal by Subject|2|||
16275947|NCT04203823|39493969|FG000|Overall Study|Adverse Event|1|||
16275948|NCT04203823|39493970|FG001|Overall Study|Adverse Event|1|||
16275949|NCT04203823|39493969|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16275950|NCT04203823|39493970|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
16275951|NCT00960154|39493975|FG000|Overall Study|Study termination|25|||
16275952|NCT00960154|39493976|FG001|Overall Study|Study termination|25|||
16275953|NCT04573309|39493979|FG000|Overall Study|Protocol Violation|1|||
16275954|NCT04573309|39493980|FG001|Overall Study|Protocol Violation|0|||
16275955|NCT01525628|39493981|FG000|Overall Study|Adverse Event|1|||
16275956|NCT01525628|39493982|FG001|Overall Study|Adverse Event|1|||
16275957|NCT01525628|39493983|FG002|Overall Study|Adverse Event|2|||
16275958|NCT01525628|39493984|FG003|Overall Study|Adverse Event|0|||
16275959|NCT01525628|39493985|FG004|Overall Study|Adverse Event|1|||
16275960|NCT01525628|39493981|FG000|Overall Study|Lack of Efficacy|0|||
16275961|NCT01525628|39493982|FG001|Overall Study|Lack of Efficacy|2|||
16275962|NCT01525628|39493983|FG002|Overall Study|Lack of Efficacy|2|||
16275963|NCT01525628|39493984|FG003|Overall Study|Lack of Efficacy|1|||
16275964|NCT01525628|39493985|FG004|Overall Study|Lack of Efficacy|2|||
16275965|NCT01525628|39493981|FG000|Overall Study|Protocol Violation|0|||
16275966|NCT01525628|39493982|FG001|Overall Study|Protocol Violation|0|||
16275967|NCT01525628|39493983|FG002|Overall Study|Protocol Violation|1|||
16275968|NCT01525628|39493984|FG003|Overall Study|Protocol Violation|0|||
16275969|NCT01525628|39493985|FG004|Overall Study|Protocol Violation|0|||
16275970|NCT01525628|39493981|FG000|Overall Study|Lost to Follow-up|1|||
16275971|NCT01525628|39493982|FG001|Overall Study|Lost to Follow-up|1|||
16275972|NCT01525628|39493983|FG002|Overall Study|Lost to Follow-up|0|||
16275973|NCT01525628|39493984|FG003|Overall Study|Lost to Follow-up|0|||
16275974|NCT01525628|39493985|FG004|Overall Study|Lost to Follow-up|0|||
16275975|NCT01525628|39493981|FG000|Overall Study|Withdrawal by Subject|0|||
16275976|NCT01525628|39493982|FG001|Overall Study|Withdrawal by Subject|1|||
16275977|NCT01525628|39493983|FG002|Overall Study|Withdrawal by Subject|0|||
16275978|NCT01525628|39493984|FG003|Overall Study|Withdrawal by Subject|0|||
16275979|NCT01525628|39493985|FG004|Overall Study|Withdrawal by Subject|0|||
16275980|NCT01525628|39493981|FG000|Overall Study|Other reason not defined above|0|||
16275981|NCT01525628|39493982|FG001|Overall Study|Other reason not defined above|0|||
16275982|NCT01525628|39493983|FG002|Overall Study|Other reason not defined above|0|||
16275983|NCT01525628|39493984|FG003|Overall Study|Other reason not defined above|3|||
16275984|NCT01525628|39493985|FG004|Overall Study|Other reason not defined above|0|||
16275985|NCT04408924|39493986|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
16275986|NCT04408924|39493986|FG000|Overall Study|Lost to Follow-up|3|||
16275987|NCT04408924|39493986|FG000|Overall Study|Withdrawal by Subject|5|||
16275988|NCT04408924|39493986|FG000|Overall Study|Sponsor Decision|2|||
16275989|NCT00112437|39493987|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
16275990|NCT00112437|39493988|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
16275991|NCT00112437|39493989|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
16275992|NCT00112437|39493990|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
16275993|NCT00112437|39493991|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
16275994|NCT00112437|39493992|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
16275995|NCT00112437|39493993|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
16275996|NCT00112437|39493994|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
16275997|NCT00112437|39493995|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
16275998|NCT00112437|39493996|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
16275999|NCT00112437|39493997|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276000|NCT00112437|39493998|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276001|NCT00112437|39493999|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276002|NCT00112437|39494000|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276003|NCT00112437|39494001|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276004|NCT00112437|39494002|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276005|NCT00112437|39494003|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276006|NCT00112437|39494004|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276007|NCT00112437|39494005|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276008|NCT00112437|39494006|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276009|NCT00112437|39494007|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276010|NCT00112437|39494008|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276011|NCT00112437|39494009|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276012|NCT00112437|39494010|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276013|NCT00112437|39494011|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276014|NCT00112437|39494012|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
16276015|NCT00112437|39493987|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276016|NCT00112437|39493988|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
16276017|NCT00112437|39493989|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276018|NCT00112437|39493990|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276019|NCT00112437|39493991|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276020|NCT00112437|39493992|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276021|NCT00112437|39493993|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276022|NCT00112437|39493994|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276023|NCT00112437|39493995|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276024|NCT00112437|39493996|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276025|NCT00112437|39493997|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276026|NCT00112437|39493998|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276027|NCT00112437|39493999|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276028|NCT00112437|39494000|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276029|NCT00112437|39494001|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276030|NCT00112437|39494002|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276031|NCT00112437|39494003|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276032|NCT00112437|39494004|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276033|NCT00112437|39494005|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276034|NCT00112437|39494006|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276035|NCT00112437|39494007|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276036|NCT00112437|39494008|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276037|NCT00112437|39494009|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276038|NCT00112437|39494010|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276039|NCT00112437|39494011|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276040|NCT00112437|39494012|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
16276041|NCT00112437|39493987|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276042|NCT00112437|39493988|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
16276043|NCT00112437|39493989|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276044|NCT00112437|39493990|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276045|NCT00112437|39493991|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276046|NCT00112437|39493992|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276047|NCT00112437|39493993|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276048|NCT00112437|39493994|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276049|NCT00112437|39493995|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276050|NCT00112437|39493996|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16111458|NCT00760747|38897274|FG000|Study Period II|Parent/Caregiver Decision|3|||
16276051|NCT00112437|39493997|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276052|NCT00112437|39493998|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276053|NCT00112437|39493999|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276054|NCT00112437|39494000|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276055|NCT00112437|39494001|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276056|NCT00112437|39494002|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276057|NCT00112437|39494003|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276058|NCT00112437|39494004|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276059|NCT00112437|39494005|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276060|NCT00112437|39494006|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276061|NCT00112437|39494007|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276062|NCT00112437|39494008|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276063|NCT00112437|39494009|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276064|NCT00112437|39494010|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276065|NCT00112437|39494011|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276066|NCT00112437|39494012|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
16276067|NCT00112437|39493987|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
16276068|NCT00112437|39493988|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276069|NCT00112437|39493989|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
16276070|NCT00112437|39493990|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
16276071|NCT00112437|39493991|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
16276072|NCT00112437|39493992|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276073|NCT00112437|39493993|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276074|NCT00112437|39493994|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276075|NCT00112437|39493995|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276076|NCT00112437|39493996|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276077|NCT00112437|39493997|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276078|NCT00112437|39493998|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276079|NCT00112437|39493999|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276080|NCT00112437|39494000|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276081|NCT00112437|39494001|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276082|NCT00112437|39494002|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276083|NCT00112437|39494003|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276084|NCT00112437|39494004|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276085|NCT00112437|39494005|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276086|NCT00112437|39494006|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276087|NCT00112437|39494007|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276088|NCT00112437|39494008|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276089|NCT00112437|39494009|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276090|NCT00112437|39494010|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276091|NCT00112437|39494011|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276092|NCT00112437|39494012|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
16276093|NCT00112437|39493987|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
16276094|NCT00112437|39493988|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
16276095|NCT00112437|39493989|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
16276096|NCT00112437|39493990|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
16276097|NCT00112437|39493991|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
16276098|NCT00112437|39493992|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276099|NCT00112437|39493993|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276100|NCT00112437|39493994|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276101|NCT00112437|39493995|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276102|NCT00112437|39493996|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276103|NCT00112437|39493997|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276104|NCT00112437|39493998|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276105|NCT00112437|39493999|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276106|NCT00112437|39494000|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276107|NCT00112437|39494001|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276108|NCT00112437|39494002|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276109|NCT00112437|39494003|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276110|NCT00112437|39494004|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276111|NCT00112437|39494005|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276112|NCT00112437|39494006|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276113|NCT00112437|39494007|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276114|NCT00112437|39494008|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276115|NCT00112437|39494009|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276116|NCT00112437|39494010|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276117|NCT00112437|39494011|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276118|NCT00112437|39494012|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
16276119|NCT00112437|39493987|FG000|Year 1 (12-Month Base Study)|moved|0|||
16276120|NCT00112437|39493988|FG001|Year 1 (12-Month Base Study)|moved|1|||
16276121|NCT00112437|39493989|FG002|Year 1 (12-Month Base Study)|moved|1|||
16276122|NCT00112437|39493990|FG003|Year 1 (12-Month Base Study)|moved|0|||
16276123|NCT00112437|39493991|FG004|Year 1 (12-Month Base Study)|moved|0|||
16276124|NCT00112437|39493992|FG005|Year 1 (12-Month Base Study)|moved|0|||
16276125|NCT00112437|39493993|FG006|Year 1 (12-Month Base Study)|moved|0|||
16276126|NCT00112437|39493994|FG007|Year 1 (12-Month Base Study)|moved|0|||
16276127|NCT00112437|39493995|FG008|Year 1 (12-Month Base Study)|moved|0|||
16276128|NCT00112437|39493996|FG009|Year 1 (12-Month Base Study)|moved|0|||
16276129|NCT00112437|39493997|FG010|Year 1 (12-Month Base Study)|moved|0|||
16276130|NCT00112437|39493998|FG011|Year 1 (12-Month Base Study)|moved|0|||
16276131|NCT00112437|39493999|FG012|Year 1 (12-Month Base Study)|moved|0|||
16276132|NCT00112437|39494000|FG013|Year 1 (12-Month Base Study)|moved|0|||
16276133|NCT00112437|39494001|FG014|Year 1 (12-Month Base Study)|moved|0|||
16276134|NCT00112437|39494002|FG015|Year 1 (12-Month Base Study)|moved|0|||
16276135|NCT00112437|39494003|FG016|Year 1 (12-Month Base Study)|moved|0|||
16276136|NCT00112437|39494004|FG017|Year 1 (12-Month Base Study)|moved|0|||
16276137|NCT00112437|39494005|FG018|Year 1 (12-Month Base Study)|moved|0|||
16276138|NCT00112437|39494006|FG019|Year 1 (12-Month Base Study)|moved|0|||
16276139|NCT00112437|39494007|FG020|Year 1 (12-Month Base Study)|moved|0|||
16276140|NCT00112437|39494008|FG021|Year 1 (12-Month Base Study)|moved|0|||
16276141|NCT00112437|39494009|FG022|Year 1 (12-Month Base Study)|moved|0|||
16276142|NCT00112437|39494010|FG023|Year 1 (12-Month Base Study)|moved|0|||
16276143|NCT00112437|39494011|FG024|Year 1 (12-Month Base Study)|moved|0|||
16276144|NCT00112437|39494012|FG025|Year 1 (12-Month Base Study)|moved|0|||
16276145|NCT00112437|39493987|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276146|NCT00112437|39493988|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276147|NCT00112437|39493989|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276148|NCT00112437|39493990|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
16276149|NCT00112437|39493991|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276150|NCT00112437|39493992|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276151|NCT00112437|39493993|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276152|NCT00112437|39493994|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276153|NCT00112437|39493995|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276154|NCT00112437|39493996|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276155|NCT00112437|39493997|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276156|NCT00112437|39493998|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276157|NCT00112437|39493999|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276158|NCT00112437|39494000|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276159|NCT00112437|39494001|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276160|NCT00112437|39494002|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276161|NCT00112437|39494003|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276162|NCT00112437|39494004|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276163|NCT00112437|39494005|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276164|NCT00112437|39494006|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276165|NCT00112437|39494007|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276166|NCT00112437|39494008|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276167|NCT00112437|39494009|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276168|NCT00112437|39494010|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276169|NCT00112437|39494011|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276170|NCT00112437|39494012|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
16276171|NCT00112437|39493987|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276172|NCT00112437|39493988|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276173|NCT00112437|39493989|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276174|NCT00112437|39493990|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276175|NCT00112437|39493991|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
16276176|NCT00112437|39493992|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276177|NCT00112437|39493993|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276178|NCT00112437|39493994|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276179|NCT00112437|39493995|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276180|NCT00112437|39493996|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276181|NCT00112437|39493997|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276182|NCT00112437|39493998|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276183|NCT00112437|39493999|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276184|NCT00112437|39494000|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276185|NCT00112437|39494001|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276186|NCT00112437|39494002|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276187|NCT00112437|39494003|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276188|NCT00112437|39494004|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276189|NCT00112437|39494005|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276190|NCT00112437|39494006|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276191|NCT00112437|39494007|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276192|NCT00112437|39494008|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276193|NCT00112437|39494009|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276194|NCT00112437|39494010|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276195|NCT00112437|39494011|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276196|NCT00112437|39494012|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
16276197|NCT00112437|39493987|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
16276198|NCT00112437|39493988|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
16276199|NCT00112437|39493989|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
16276200|NCT00112437|39493990|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
16276201|NCT00112437|39493991|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
16276202|NCT00112437|39493992|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
16276203|NCT00112437|39493993|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
16276204|NCT00112437|39493994|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
16276205|NCT00112437|39493995|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
16276206|NCT00112437|39493996|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
16276207|NCT00112437|39493997|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
16276208|NCT00112437|39493998|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
16276209|NCT00112437|39493999|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
16276210|NCT00112437|39494000|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
16276211|NCT00112437|39494001|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
16276212|NCT00112437|39494002|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
16276213|NCT00112437|39494003|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
16276214|NCT00112437|39494004|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
16276215|NCT00112437|39494005|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
16276216|NCT00112437|39494006|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
16276217|NCT00112437|39494007|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
16276218|NCT00112437|39494008|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
16276219|NCT00112437|39494009|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
16276220|NCT00112437|39494010|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
16276221|NCT00112437|39494011|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
16276222|NCT00112437|39494012|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
16276223|NCT00112437|39493987|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276224|NCT00112437|39493988|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276225|NCT00112437|39493989|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276226|NCT00112437|39493990|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276227|NCT00112437|39493991|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276228|NCT00112437|39493992|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
16276229|NCT00112437|39493993|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
16276230|NCT00112437|39493994|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276231|NCT00112437|39493995|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276232|NCT00112437|39493996|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
16276233|NCT00112437|39493997|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276234|NCT00112437|39493998|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276235|NCT00112437|39493999|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276236|NCT00112437|39494000|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276237|NCT00112437|39494001|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276238|NCT00112437|39494002|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276239|NCT00112437|39494003|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276240|NCT00112437|39494004|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276241|NCT00112437|39494005|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276242|NCT00112437|39494006|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276243|NCT00112437|39494007|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276244|NCT00112437|39494008|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276245|NCT00112437|39494009|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276246|NCT00112437|39494010|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276247|NCT00112437|39494011|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276248|NCT00112437|39494012|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
16276249|NCT00112437|39493987|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276250|NCT00112437|39493988|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276251|NCT00112437|39493989|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276252|NCT00112437|39493990|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276253|NCT00112437|39493991|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276254|NCT00112437|39493992|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276255|NCT00112437|39493993|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276256|NCT00112437|39493994|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276257|NCT00112437|39493995|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
16276258|NCT00112437|39493996|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276259|NCT00112437|39493997|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276260|NCT00112437|39493998|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276261|NCT00112437|39493999|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276262|NCT00112437|39494000|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276263|NCT00112437|39494001|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276264|NCT00112437|39494002|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276265|NCT00112437|39494003|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276266|NCT00112437|39494004|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276267|NCT00112437|39494005|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276268|NCT00112437|39494006|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276269|NCT00112437|39494007|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276270|NCT00112437|39494008|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276271|NCT00112437|39494009|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276272|NCT00112437|39494010|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276273|NCT00112437|39494011|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276274|NCT00112437|39494012|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
16276275|NCT00112437|39493987|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276276|NCT00112437|39493988|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276277|NCT00112437|39493989|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276278|NCT00112437|39493990|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276279|NCT00112437|39493991|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276280|NCT00112437|39493992|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276281|NCT00112437|39493993|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276282|NCT00112437|39493994|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276283|NCT00112437|39493995|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
16276284|NCT00112437|39493996|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276285|NCT00112437|39493997|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276286|NCT00112437|39493998|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276287|NCT00112437|39493999|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276288|NCT00112437|39494000|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276289|NCT00112437|39494001|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276290|NCT00112437|39494002|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276291|NCT00112437|39494003|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276292|NCT00112437|39494004|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276293|NCT00112437|39494005|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276294|NCT00112437|39494006|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276295|NCT00112437|39494007|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276296|NCT00112437|39494008|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276297|NCT00112437|39494009|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276298|NCT00112437|39494010|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276299|NCT00112437|39494011|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276300|NCT00112437|39494012|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
16276301|NCT00112437|39493987|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276302|NCT00112437|39493988|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276303|NCT00112437|39493989|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276304|NCT00112437|39493990|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276305|NCT00112437|39493991|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276306|NCT00112437|39493992|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
16276307|NCT00112437|39493993|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
16276308|NCT00112437|39493994|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
16276309|NCT00112437|39493995|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
16276310|NCT00112437|39493996|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
16276311|NCT00112437|39493997|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276312|NCT00112437|39493998|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276313|NCT00112437|39493999|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276314|NCT00112437|39494000|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276315|NCT00112437|39494001|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276316|NCT00112437|39494002|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276317|NCT00112437|39494003|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276318|NCT00112437|39494004|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276319|NCT00112437|39494005|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276320|NCT00112437|39494006|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276321|NCT00112437|39494007|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276322|NCT00112437|39494008|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276323|NCT00112437|39494009|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276324|NCT00112437|39494010|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276325|NCT00112437|39494011|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276326|NCT00112437|39494012|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
16276327|NCT00112437|39493987|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276328|NCT00112437|39493988|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276329|NCT00112437|39493989|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276330|NCT00112437|39493990|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16375148|NCT00545948|39860065|FG001|Overall Study|Not Treated|1|||
16276331|NCT00112437|39493991|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276332|NCT00112437|39493992|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276333|NCT00112437|39493993|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276334|NCT00112437|39493994|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276335|NCT00112437|39493995|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276336|NCT00112437|39493996|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
16276337|NCT00112437|39493997|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276338|NCT00112437|39493998|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276339|NCT00112437|39493999|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276340|NCT00112437|39494000|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276341|NCT00112437|39494001|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276342|NCT00112437|39494002|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276343|NCT00112437|39494003|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276344|NCT00112437|39494004|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276345|NCT00112437|39494005|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276346|NCT00112437|39494006|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276347|NCT00112437|39494007|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276348|NCT00112437|39494008|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276349|NCT00112437|39494009|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276350|NCT00112437|39494010|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276351|NCT00112437|39494011|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276352|NCT00112437|39494012|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
16276353|NCT00112437|39493987|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276354|NCT00112437|39493988|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276355|NCT00112437|39493989|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276356|NCT00112437|39493990|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276357|NCT00112437|39493991|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276358|NCT00112437|39493992|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276359|NCT00112437|39493993|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276360|NCT00112437|39493994|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276361|NCT00112437|39493995|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276362|NCT00112437|39493996|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
16276363|NCT00112437|39493997|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276364|NCT00112437|39493998|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276365|NCT00112437|39493999|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276366|NCT00112437|39494000|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276367|NCT00112437|39494001|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276368|NCT00112437|39494002|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276369|NCT00112437|39494003|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276370|NCT00112437|39494004|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276371|NCT00112437|39494005|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276372|NCT00112437|39494006|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276373|NCT00112437|39494007|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276374|NCT00112437|39494008|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276375|NCT00112437|39494009|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276376|NCT00112437|39494010|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276377|NCT00112437|39494011|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276378|NCT00112437|39494012|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
16276379|NCT00112437|39493987|FG000|Year 2 (12-Month Extension)|Moved|0|||
16276380|NCT00112437|39493988|FG001|Year 2 (12-Month Extension)|Moved|0|||
16276381|NCT00112437|39493989|FG002|Year 2 (12-Month Extension)|Moved|0|||
16276382|NCT00112437|39493990|FG003|Year 2 (12-Month Extension)|Moved|0|||
16276383|NCT00112437|39493991|FG004|Year 2 (12-Month Extension)|Moved|0|||
16276384|NCT00112437|39493992|FG005|Year 2 (12-Month Extension)|Moved|0|||
16276385|NCT00112437|39493993|FG006|Year 2 (12-Month Extension)|Moved|0|||
16276386|NCT00112437|39493994|FG007|Year 2 (12-Month Extension)|Moved|0|||
16276387|NCT00112437|39493995|FG008|Year 2 (12-Month Extension)|Moved|0|||
16276388|NCT00112437|39493996|FG009|Year 2 (12-Month Extension)|Moved|1|||
16276389|NCT00112437|39493997|FG010|Year 2 (12-Month Extension)|Moved|0|||
16276390|NCT00112437|39493998|FG011|Year 2 (12-Month Extension)|Moved|0|||
16276391|NCT00112437|39493999|FG012|Year 2 (12-Month Extension)|Moved|0|||
16276392|NCT00112437|39494000|FG013|Year 2 (12-Month Extension)|Moved|0|||
16276393|NCT00112437|39494001|FG014|Year 2 (12-Month Extension)|Moved|0|||
16276394|NCT00112437|39494002|FG015|Year 2 (12-Month Extension)|Moved|0|||
16276395|NCT00112437|39494003|FG016|Year 2 (12-Month Extension)|Moved|0|||
16276396|NCT00112437|39494004|FG017|Year 2 (12-Month Extension)|Moved|0|||
16276397|NCT00112437|39494005|FG018|Year 2 (12-Month Extension)|Moved|0|||
16276398|NCT00112437|39494006|FG019|Year 2 (12-Month Extension)|Moved|0|||
16276399|NCT00112437|39494007|FG020|Year 2 (12-Month Extension)|Moved|0|||
16276400|NCT00112437|39494008|FG021|Year 2 (12-Month Extension)|Moved|0|||
16276401|NCT00112437|39494009|FG022|Year 2 (12-Month Extension)|Moved|0|||
16276402|NCT00112437|39494010|FG023|Year 2 (12-Month Extension)|Moved|0|||
16276403|NCT00112437|39494011|FG024|Year 2 (12-Month Extension)|Moved|0|||
16276404|NCT00112437|39494012|FG025|Year 2 (12-Month Extension)|Moved|0|||
16276405|NCT00112437|39493987|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
16276406|NCT00112437|39493988|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
16276407|NCT00112437|39493989|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
16276408|NCT00112437|39493990|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
16276409|NCT00112437|39493991|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
16276410|NCT00112437|39493992|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
16276411|NCT00112437|39493993|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
16276412|NCT00112437|39493994|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
16276413|NCT00112437|39493995|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
16276414|NCT00112437|39493996|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
16276415|NCT00112437|39493997|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
16276416|NCT00112437|39493998|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
16276417|NCT00112437|39493999|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
16276418|NCT00112437|39494000|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
16276419|NCT00112437|39494001|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
16276420|NCT00112437|39494002|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
16276421|NCT00112437|39494003|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
16276422|NCT00112437|39494004|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
16276423|NCT00112437|39494005|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
16276424|NCT00112437|39494006|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
16276425|NCT00112437|39494007|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
16276426|NCT00112437|39494008|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
16276427|NCT00112437|39494009|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
16276428|NCT00112437|39494010|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
16276429|NCT00112437|39494011|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
16276430|NCT00112437|39494012|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
16276431|NCT00112437|39493987|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276432|NCT00112437|39493988|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276433|NCT00112437|39493989|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276434|NCT00112437|39493990|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276435|NCT00112437|39493991|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276436|NCT00112437|39493992|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276437|NCT00112437|39493993|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276438|NCT00112437|39493994|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276439|NCT00112437|39493995|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276440|NCT00112437|39493996|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276441|NCT00112437|39493997|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276442|NCT00112437|39493998|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
16276443|NCT00112437|39493999|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276444|NCT00112437|39494000|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
16276445|NCT00112437|39494001|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276446|NCT00112437|39494002|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
16276447|NCT00112437|39494003|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276448|NCT00112437|39494004|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276449|NCT00112437|39494005|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
16276450|NCT00112437|39494006|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276451|NCT00112437|39494007|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276452|NCT00112437|39494008|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276453|NCT00112437|39494009|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276454|NCT00112437|39494010|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276455|NCT00112437|39494011|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276456|NCT00112437|39494012|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
16276457|NCT00112437|39493987|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276458|NCT00112437|39493988|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276459|NCT00112437|39493989|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276460|NCT00112437|39493990|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276461|NCT00112437|39493991|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276462|NCT00112437|39493992|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276463|NCT00112437|39493993|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276464|NCT00112437|39493994|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276465|NCT00112437|39493995|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276466|NCT00112437|39493996|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276467|NCT00112437|39493997|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276468|NCT00112437|39493998|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276469|NCT00112437|39493999|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276470|NCT00112437|39494000|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276471|NCT00112437|39494001|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276472|NCT00112437|39494002|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
16276473|NCT00112437|39494003|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276474|NCT00112437|39494004|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276475|NCT00112437|39494005|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276476|NCT00112437|39494006|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276477|NCT00112437|39494007|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276478|NCT00112437|39494008|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276479|NCT00112437|39494009|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276480|NCT00112437|39494010|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276481|NCT00112437|39494011|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276482|NCT00112437|39494012|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
16276483|NCT00112437|39493987|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276484|NCT00112437|39493988|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276485|NCT00112437|39493989|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276486|NCT00112437|39493990|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276487|NCT00112437|39493991|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276488|NCT00112437|39493992|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276489|NCT00112437|39493993|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276490|NCT00112437|39493994|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276491|NCT00112437|39493995|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276492|NCT00112437|39493996|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276493|NCT00112437|39493997|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276494|NCT00112437|39493998|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276495|NCT00112437|39493999|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276496|NCT00112437|39494000|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276497|NCT00112437|39494001|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276498|NCT00112437|39494002|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
16276499|NCT00112437|39494003|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276500|NCT00112437|39494004|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276501|NCT00112437|39494005|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276502|NCT00112437|39494006|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276503|NCT00112437|39494007|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276504|NCT00112437|39494008|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276505|NCT00112437|39494009|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276506|NCT00112437|39494010|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276507|NCT00112437|39494011|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276508|NCT00112437|39494012|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
16276509|NCT00112437|39493987|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276510|NCT00112437|39493988|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276511|NCT00112437|39493989|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276512|NCT00112437|39493990|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276513|NCT00112437|39493991|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276514|NCT00112437|39493992|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276515|NCT00112437|39493993|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276516|NCT00112437|39493994|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276517|NCT00112437|39493995|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276518|NCT00112437|39493996|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276519|NCT00112437|39493997|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276520|NCT00112437|39493998|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
16276521|NCT00112437|39493999|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276522|NCT00112437|39494000|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276523|NCT00112437|39494001|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
16276524|NCT00112437|39494002|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276525|NCT00112437|39494003|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276526|NCT00112437|39494004|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276527|NCT00112437|39494005|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276528|NCT00112437|39494006|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276529|NCT00112437|39494007|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276530|NCT00112437|39494008|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276531|NCT00112437|39494009|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276532|NCT00112437|39494010|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276533|NCT00112437|39494011|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276534|NCT00112437|39494012|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
16276535|NCT00112437|39493987|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276536|NCT00112437|39493988|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276537|NCT00112437|39493989|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276538|NCT00112437|39493990|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276539|NCT00112437|39493991|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276540|NCT00112437|39493992|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276541|NCT00112437|39493993|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276542|NCT00112437|39493994|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276543|NCT00112437|39493995|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276544|NCT00112437|39493996|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276545|NCT00112437|39493997|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
16276546|NCT00112437|39493998|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
16276547|NCT00112437|39493999|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276548|NCT00112437|39494000|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276549|NCT00112437|39494001|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276550|NCT00112437|39494002|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276551|NCT00112437|39494003|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276552|NCT00112437|39494004|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276553|NCT00112437|39494005|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276554|NCT00112437|39494006|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276555|NCT00112437|39494007|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276556|NCT00112437|39494008|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276557|NCT00112437|39494009|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276558|NCT00112437|39494010|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276559|NCT00112437|39494011|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276560|NCT00112437|39494012|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
16276561|NCT00112437|39493987|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276562|NCT00112437|39493988|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276563|NCT00112437|39493989|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276564|NCT00112437|39493990|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276565|NCT00112437|39493991|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276566|NCT00112437|39493992|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276567|NCT00112437|39493993|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276568|NCT00112437|39493994|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276569|NCT00112437|39493995|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276570|NCT00112437|39493996|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276571|NCT00112437|39493997|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276572|NCT00112437|39493998|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276573|NCT00112437|39493999|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276574|NCT00112437|39494000|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276575|NCT00112437|39494001|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276576|NCT00112437|39494002|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276577|NCT00112437|39494003|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276578|NCT00112437|39494004|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276579|NCT00112437|39494005|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276580|NCT00112437|39494006|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276581|NCT00112437|39494007|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
16276582|NCT00112437|39494008|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
16276583|NCT00112437|39494009|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276584|NCT00112437|39494010|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276585|NCT00112437|39494011|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276586|NCT00112437|39494012|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
16276587|NCT00112437|39493987|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276588|NCT00112437|39493988|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276589|NCT00112437|39493989|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276590|NCT00112437|39493990|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276591|NCT00112437|39493991|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276592|NCT00112437|39493992|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276593|NCT00112437|39493993|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276594|NCT00112437|39493994|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276595|NCT00112437|39493995|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276596|NCT00112437|39493996|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276597|NCT00112437|39493997|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276598|NCT00112437|39493998|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276599|NCT00112437|39493999|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276600|NCT00112437|39494000|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276601|NCT00112437|39494001|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276602|NCT00112437|39494002|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276603|NCT00112437|39494003|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276604|NCT00112437|39494004|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276605|NCT00112437|39494005|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276606|NCT00112437|39494006|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276607|NCT00112437|39494007|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
16276608|NCT00112437|39494008|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276609|NCT00112437|39494009|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276610|NCT00112437|39494010|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276611|NCT00112437|39494011|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276612|NCT00112437|39494012|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
16276613|NCT00112437|39493987|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276614|NCT00112437|39493988|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276615|NCT00112437|39493989|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276616|NCT00112437|39493990|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276617|NCT00112437|39493991|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276618|NCT00112437|39493992|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276619|NCT00112437|39493993|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276620|NCT00112437|39493994|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276621|NCT00112437|39493995|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276622|NCT00112437|39493996|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276623|NCT00112437|39493997|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276624|NCT00112437|39493998|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276625|NCT00112437|39493999|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276626|NCT00112437|39494000|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276627|NCT00112437|39494001|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276628|NCT00112437|39494002|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276629|NCT00112437|39494003|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276630|NCT00112437|39494004|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276631|NCT00112437|39494005|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276632|NCT00112437|39494006|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276633|NCT00112437|39494007|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276634|NCT00112437|39494008|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
16276635|NCT00112437|39494009|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276636|NCT00112437|39494010|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276637|NCT00112437|39494011|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276638|NCT00112437|39494012|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
16276639|NCT00112437|39493987|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276640|NCT00112437|39493988|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276641|NCT00112437|39493989|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276642|NCT00112437|39493990|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276643|NCT00112437|39493991|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276644|NCT00112437|39493992|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276645|NCT00112437|39493993|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276646|NCT00112437|39493994|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276647|NCT00112437|39493995|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276648|NCT00112437|39493996|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276649|NCT00112437|39493997|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276650|NCT00112437|39493998|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276651|NCT00112437|39493999|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276652|NCT00112437|39494000|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276653|NCT00112437|39494001|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276654|NCT00112437|39494002|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276655|NCT00112437|39494003|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276656|NCT00112437|39494004|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276657|NCT00112437|39494005|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276658|NCT00112437|39494006|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276659|NCT00112437|39494007|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276660|NCT00112437|39494008|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
16276661|NCT00112437|39494009|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276662|NCT00112437|39494010|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276663|NCT00112437|39494011|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276664|NCT00112437|39494012|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
16276665|NCT00112437|39493987|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276666|NCT00112437|39493988|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276667|NCT00112437|39493989|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276668|NCT00112437|39493990|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276669|NCT00112437|39493991|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276670|NCT00112437|39493992|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276671|NCT00112437|39493993|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276672|NCT00112437|39493994|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276673|NCT00112437|39493995|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276674|NCT00112437|39493996|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276675|NCT00112437|39493997|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276676|NCT00112437|39493998|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276677|NCT00112437|39493999|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276678|NCT00112437|39494000|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276679|NCT00112437|39494001|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276680|NCT00112437|39494002|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276681|NCT00112437|39494003|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276682|NCT00112437|39494004|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276683|NCT00112437|39494005|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276684|NCT00112437|39494006|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276685|NCT00112437|39494007|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
16276686|NCT00112437|39494008|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
16276687|NCT00112437|39494009|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276688|NCT00112437|39494010|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276689|NCT00112437|39494011|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276690|NCT00112437|39494012|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
16276691|NCT00112437|39493987|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276692|NCT00112437|39493988|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276693|NCT00112437|39493989|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276694|NCT00112437|39493990|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276695|NCT00112437|39493991|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276696|NCT00112437|39493992|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276697|NCT00112437|39493993|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276698|NCT00112437|39493994|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276699|NCT00112437|39493995|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276700|NCT00112437|39493996|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276701|NCT00112437|39493997|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276702|NCT00112437|39493998|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276703|NCT00112437|39493999|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276704|NCT00112437|39494000|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276705|NCT00112437|39494001|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276706|NCT00112437|39494002|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276707|NCT00112437|39494003|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276708|NCT00112437|39494004|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276709|NCT00112437|39494005|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276710|NCT00112437|39494006|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276711|NCT00112437|39494007|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276712|NCT00112437|39494008|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276713|NCT00112437|39494009|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
16276714|NCT00112437|39494010|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
16276715|NCT00112437|39494011|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
16276716|NCT00112437|39494012|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
16276717|NCT00112437|39493987|FG000|Years 6-10 (60-Month Extension)|Death|0|||
16276718|NCT00112437|39493988|FG001|Years 6-10 (60-Month Extension)|Death|0|||
16276719|NCT00112437|39493989|FG002|Years 6-10 (60-Month Extension)|Death|0|||
16276720|NCT00112437|39493990|FG003|Years 6-10 (60-Month Extension)|Death|0|||
16276721|NCT00112437|39493991|FG004|Years 6-10 (60-Month Extension)|Death|0|||
16276722|NCT00112437|39493992|FG005|Years 6-10 (60-Month Extension)|Death|0|||
16276723|NCT00112437|39493993|FG006|Years 6-10 (60-Month Extension)|Death|0|||
16276724|NCT00112437|39493994|FG007|Years 6-10 (60-Month Extension)|Death|0|||
16276725|NCT00112437|39493995|FG008|Years 6-10 (60-Month Extension)|Death|0|||
16276726|NCT00112437|39493996|FG009|Years 6-10 (60-Month Extension)|Death|0|||
16276727|NCT00112437|39493997|FG010|Years 6-10 (60-Month Extension)|Death|0|||
16276728|NCT00112437|39493998|FG011|Years 6-10 (60-Month Extension)|Death|0|||
16276729|NCT00112437|39493999|FG012|Years 6-10 (60-Month Extension)|Death|0|||
16276730|NCT00112437|39494000|FG013|Years 6-10 (60-Month Extension)|Death|0|||
16276731|NCT00112437|39494001|FG014|Years 6-10 (60-Month Extension)|Death|0|||
16276732|NCT00112437|39494002|FG015|Years 6-10 (60-Month Extension)|Death|0|||
16276733|NCT00112437|39494003|FG016|Years 6-10 (60-Month Extension)|Death|0|||
16276734|NCT00112437|39494004|FG017|Years 6-10 (60-Month Extension)|Death|0|||
16276735|NCT00112437|39494005|FG018|Years 6-10 (60-Month Extension)|Death|0|||
16276736|NCT00112437|39494006|FG019|Years 6-10 (60-Month Extension)|Death|0|||
16276737|NCT00112437|39494007|FG020|Years 6-10 (60-Month Extension)|Death|0|||
16276738|NCT00112437|39494008|FG021|Years 6-10 (60-Month Extension)|Death|0|||
16276739|NCT00112437|39494009|FG022|Years 6-10 (60-Month Extension)|Death|0|||
16276740|NCT00112437|39494010|FG023|Years 6-10 (60-Month Extension)|Death|2|||
16276741|NCT00112437|39494011|FG024|Years 6-10 (60-Month Extension)|Death|0|||
16276742|NCT00112437|39494012|FG025|Years 6-10 (60-Month Extension)|Death|0|||
16276743|NCT00112437|39493987|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276744|NCT00112437|39493988|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276745|NCT00112437|39493989|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276746|NCT00112437|39493990|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276747|NCT00112437|39493991|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276748|NCT00112437|39493992|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276749|NCT00112437|39493993|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276750|NCT00112437|39493994|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276751|NCT00112437|39493995|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276752|NCT00112437|39493996|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276753|NCT00112437|39493997|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276754|NCT00112437|39493998|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276755|NCT00112437|39493999|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276756|NCT00112437|39494000|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276757|NCT00112437|39494001|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276758|NCT00112437|39494002|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276759|NCT00112437|39494003|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276760|NCT00112437|39494004|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276761|NCT00112437|39494005|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276762|NCT00112437|39494006|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276763|NCT00112437|39494007|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276764|NCT00112437|39494008|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276765|NCT00112437|39494009|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276766|NCT00112437|39494010|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276767|NCT00112437|39494011|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
16276768|NCT00112437|39494012|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
16276769|NCT00112437|39493987|FG000|Years 6-10 (60-Month Extension)|Other|0|||
16276770|NCT00112437|39493988|FG001|Years 6-10 (60-Month Extension)|Other|0|||
16276771|NCT00112437|39493989|FG002|Years 6-10 (60-Month Extension)|Other|0|||
16276772|NCT00112437|39493990|FG003|Years 6-10 (60-Month Extension)|Other|0|||
16276773|NCT00112437|39493991|FG004|Years 6-10 (60-Month Extension)|Other|0|||
16276774|NCT00112437|39493992|FG005|Years 6-10 (60-Month Extension)|Other|0|||
16276775|NCT00112437|39493993|FG006|Years 6-10 (60-Month Extension)|Other|0|||
16276776|NCT00112437|39493994|FG007|Years 6-10 (60-Month Extension)|Other|0|||
16276777|NCT00112437|39493995|FG008|Years 6-10 (60-Month Extension)|Other|0|||
16276778|NCT00112437|39493996|FG009|Years 6-10 (60-Month Extension)|Other|0|||
16276779|NCT00112437|39493997|FG010|Years 6-10 (60-Month Extension)|Other|0|||
16276780|NCT00112437|39493998|FG011|Years 6-10 (60-Month Extension)|Other|0|||
16276781|NCT00112437|39493999|FG012|Years 6-10 (60-Month Extension)|Other|0|||
16276782|NCT00112437|39494000|FG013|Years 6-10 (60-Month Extension)|Other|0|||
16276783|NCT00112437|39494001|FG014|Years 6-10 (60-Month Extension)|Other|0|||
16276784|NCT00112437|39494002|FG015|Years 6-10 (60-Month Extension)|Other|0|||
16276785|NCT00112437|39494003|FG016|Years 6-10 (60-Month Extension)|Other|0|||
16276786|NCT00112437|39494004|FG017|Years 6-10 (60-Month Extension)|Other|0|||
16276787|NCT00112437|39494005|FG018|Years 6-10 (60-Month Extension)|Other|0|||
16276788|NCT00112437|39494006|FG019|Years 6-10 (60-Month Extension)|Other|0|||
16276789|NCT00112437|39494007|FG020|Years 6-10 (60-Month Extension)|Other|0|||
16276790|NCT00112437|39494008|FG021|Years 6-10 (60-Month Extension)|Other|0|||
16276791|NCT00112437|39494009|FG022|Years 6-10 (60-Month Extension)|Other|0|||
16276792|NCT00112437|39494010|FG023|Years 6-10 (60-Month Extension)|Other|0|||
16276793|NCT00112437|39494011|FG024|Years 6-10 (60-Month Extension)|Other|1|||
16276794|NCT00112437|39494012|FG025|Years 6-10 (60-Month Extension)|Other|0|||
16276795|NCT00112437|39493987|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276796|NCT00112437|39493988|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276797|NCT00112437|39493989|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276798|NCT00112437|39493990|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276799|NCT00112437|39493991|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276800|NCT00112437|39493992|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276801|NCT00112437|39493993|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276802|NCT00112437|39493994|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276803|NCT00112437|39493995|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276804|NCT00112437|39493996|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276805|NCT00112437|39493997|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276806|NCT00112437|39493998|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276807|NCT00112437|39493999|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276808|NCT00112437|39494000|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276809|NCT00112437|39494001|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276810|NCT00112437|39494002|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276811|NCT00112437|39494003|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276812|NCT00112437|39494004|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276813|NCT00112437|39494005|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276814|NCT00112437|39494006|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276815|NCT00112437|39494007|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276816|NCT00112437|39494008|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276817|NCT00112437|39494009|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276818|NCT00112437|39494010|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
16276819|NCT00112437|39494011|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276820|NCT00112437|39494012|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
16276821|NCT00112437|39493987|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276822|NCT00112437|39493988|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276823|NCT00112437|39493989|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276824|NCT00112437|39493990|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276825|NCT00112437|39493991|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276826|NCT00112437|39493992|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276827|NCT00112437|39493993|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276828|NCT00112437|39493994|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276829|NCT00112437|39493995|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276830|NCT00112437|39493996|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276831|NCT00112437|39493997|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276832|NCT00112437|39493998|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276833|NCT00112437|39493999|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276834|NCT00112437|39494000|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276835|NCT00112437|39494001|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276836|NCT00112437|39494002|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276837|NCT00112437|39494003|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276838|NCT00112437|39494004|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276839|NCT00112437|39494005|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276840|NCT00112437|39494006|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276841|NCT00112437|39494007|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276842|NCT00112437|39494008|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276843|NCT00112437|39494009|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
16276844|NCT00112437|39494010|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
16276845|NCT00112437|39494011|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
16276846|NCT00112437|39494012|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
16276847|NCT02888743|39494013|FG000|Overall Study|Withdrawal by Subject|1|||
16276848|NCT02888743|39494014|FG001|Overall Study|Withdrawal by Subject|2|||
16276849|NCT02888743|39494015|FG002|Overall Study|Withdrawal by Subject|2|||
16276850|NCT02888743|39494016|FG003|Overall Study|Withdrawal by Subject|0|||
16276851|NCT02888743|39494017|FG004|Overall Study|Withdrawal by Subject|1|||
16276852|NCT02888743|39494013|FG000|Overall Study|Disease progression before treatment|2|||
16276853|NCT02888743|39494014|FG001|Overall Study|Disease progression before treatment|0|||
16276854|NCT02888743|39494015|FG002|Overall Study|Disease progression before treatment|2|||
16276855|NCT02888743|39494016|FG003|Overall Study|Disease progression before treatment|0|||
16276856|NCT02888743|39494017|FG004|Overall Study|Disease progression before treatment|0|||
16276857|NCT02888743|39494013|FG000|Overall Study|Patient ineligible|1|||
16276858|NCT02888743|39494014|FG001|Overall Study|Patient ineligible|2|||
16276859|NCT02888743|39494015|FG002|Overall Study|Patient ineligible|0|||
16276860|NCT02888743|39494016|FG003|Overall Study|Patient ineligible|0|||
16276861|NCT02888743|39494017|FG004|Overall Study|Patient ineligible|0|||
16276862|NCT02654015|39494018|FG000|Overall Study|Death|12|||
16276863|NCT02654015|39494018|FG000|Overall Study|Lost to Follow-up|3|||
16276864|NCT01824498|39494019|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
16276865|NCT01824498|39494020|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
16276866|NCT01824498|39494021|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
16276867|NCT01824498|39494022|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
16276868|NCT01824498|39494023|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
16276869|NCT01824498|39494024|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
16276870|NCT05497557|39494025|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
16276871|NCT05497557|39494026|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
16276872|NCT05497557|39494027|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
16276873|NCT01426854|39494032|FG000|Overall Study|Adverse Event|1|||
16276874|NCT01426854|39494033|FG001|Overall Study|Adverse Event|5|||
16276875|NCT01426854|39494032|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
16276876|NCT01426854|39494033|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
16276877|NCT01426854|39494032|FG000|Overall Study|Lost to Follow-up|3|||
16276878|NCT01426854|39494033|FG001|Overall Study|Lost to Follow-up|0|||
16276879|NCT01426854|39494032|FG000|Overall Study|Noncompliance|0|||
16276880|NCT01426854|39494033|FG001|Overall Study|Noncompliance|1|||
16276881|NCT01426854|39494032|FG000|Overall Study|Treatment Failure|0|||
16276882|NCT01426854|39494033|FG001|Overall Study|Treatment Failure|16|||
16076224|NCT02553460|38769922|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
16276883|NCT01426854|39494032|FG000|Overall Study|Protocol Deviation|0|||
16276884|NCT01426854|39494033|FG001|Overall Study|Protocol Deviation|1|||
16276885|NCT01426854|39494032|FG000|Overall Study|Other|3|||
16276886|NCT01426854|39494033|FG001|Overall Study|Other|2|||
16276887|NCT00874549|39494034|FG000|Overall Study|Adverse Event|0|||
16276888|NCT00874549|39494035|FG001|Overall Study|Adverse Event|0|||
16276889|NCT00874549|39494036|FG002|Overall Study|Adverse Event|1|||
16276890|NCT00874549|39494037|FG003|Overall Study|Adverse Event|0|||
16276891|NCT00874549|39494034|FG000|Overall Study|Protocol Violation|1|||
16276892|NCT00874549|39494035|FG001|Overall Study|Protocol Violation|0|||
16276893|NCT00874549|39494036|FG002|Overall Study|Protocol Violation|2|||
16276894|NCT00874549|39494037|FG003|Overall Study|Protocol Violation|1|||
16276895|NCT00874549|39494034|FG000|Overall Study|Lost to Follow-up|0|||
16276896|NCT00874549|39494035|FG001|Overall Study|Lost to Follow-up|0|||
16276897|NCT00874549|39494036|FG002|Overall Study|Lost to Follow-up|1|||
16276898|NCT00874549|39494037|FG003|Overall Study|Lost to Follow-up|0|||
16276899|NCT00874549|39494034|FG000|Overall Study|Withdrawal by Subject|0|||
16276900|NCT00874549|39494035|FG001|Overall Study|Withdrawal by Subject|1|||
16276901|NCT00874549|39494036|FG002|Overall Study|Withdrawal by Subject|0|||
16276902|NCT00874549|39494037|FG003|Overall Study|Withdrawal by Subject|1|||
16276903|NCT02834390|39494038|FG000|Induction Phase|Progressive disease|0|||
16276904|NCT02834390|39494039|FG001|Induction Phase|Progressive disease|1|||
16276905|NCT02834390|39494038|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
16276906|NCT02834390|39494039|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
16276907|NCT02834390|39494038|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
16276908|NCT02834390|39494039|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
16276909|NCT02834390|39494038|FG000|Consolidation Phase|Physician Decision|1|||
16276910|NCT02834390|39494039|FG001|Consolidation Phase|Physician Decision|1|||
16276911|NCT02105701|39494040|FG000|Overall Study|Lost to Follow-up|1|||
16276912|NCT02105701|39494041|FG001|Overall Study|Lost to Follow-up|0|||
16276913|NCT02105701|39494042|FG002|Overall Study|Lost to Follow-up|2|||
16276914|NCT02105701|39494043|FG003|Overall Study|Lost to Follow-up|1|||
16276915|NCT02105701|39494040|FG000|Overall Study|Protocol Violation|0|||
16276916|NCT02105701|39494041|FG001|Overall Study|Protocol Violation|0|||
16276917|NCT02105701|39494042|FG002|Overall Study|Protocol Violation|1|||
16276918|NCT02105701|39494043|FG003|Overall Study|Protocol Violation|0|||
16276919|NCT02105701|39494040|FG000|Overall Study|Withdrawal by Subject|2|||
16276920|NCT02105701|39494041|FG001|Overall Study|Withdrawal by Subject|1|||
16276921|NCT02105701|39494042|FG002|Overall Study|Withdrawal by Subject|0|||
16276922|NCT02105701|39494043|FG003|Overall Study|Withdrawal by Subject|1|||
16276923|NCT02105701|39494040|FG000|Overall Study|Death|1|||
16276924|NCT02105701|39494041|FG001|Overall Study|Death|0|||
16276925|NCT02105701|39494042|FG002|Overall Study|Death|0|||
16276926|NCT02105701|39494043|FG003|Overall Study|Death|0|||
16276927|NCT02218541|39494045|FG000|Overall Study|Lost to Follow-up|2|||
16276928|NCT02218541|39494046|FG001|Overall Study|Lost to Follow-up|1|||
16276929|NCT02218541|39494045|FG000|Overall Study|Implant Failure|4|||
16276930|NCT02218541|39494046|FG001|Overall Study|Implant Failure|1|||
16276931|NCT00046839|39494047|FG000|Overall Study|Ineligible / No protocol treatment|0|||
16276932|NCT00046839|39494048|FG001|Overall Study|Ineligible / No protocol treatment|2|||
16276933|NCT00046839|39494047|FG000|Overall Study|Withdrawal of consent|1|||
16276934|NCT00046839|39494048|FG001|Overall Study|Withdrawal of consent|0|||
16276935|NCT03370510|39496955|FG000|Overall Study|COVID-19|2|||
16276936|NCT03370510|39496956|FG001|Overall Study|COVID-19|0|||
16276937|NCT01945580|39496957|FG000|Overall Study|Withdrawal by Subject|13|||
16276938|NCT01945580|39496958|FG001|Overall Study|Withdrawal by Subject|35|||
16276939|NCT01945580|39496957|FG000|Overall Study|Physician Decision|3|||
16276940|NCT01945580|39496958|FG001|Overall Study|Physician Decision|2|||
16276941|NCT01945580|39496957|FG000|Overall Study|Lost to Follow-up|26|||
16276942|NCT01945580|39496958|FG001|Overall Study|Lost to Follow-up|39|||
16276943|NCT01945580|39496957|FG000|Overall Study|Death|7|||
16276944|NCT01945580|39496958|FG001|Overall Study|Death|2|||
16276945|NCT01945580|39496957|FG000|Overall Study|Patient moved out of state|0|||
16276946|NCT01945580|39496958|FG001|Overall Study|Patient moved out of state|1|||
16276947|NCT01945580|39496957|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
16276948|NCT01945580|39496958|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
16276949|NCT01945580|39496957|FG000|Overall Study|Family illness - unable to return|0|||
16276950|NCT01945580|39496958|FG001|Overall Study|Family illness - unable to return|1|||
16276951|NCT01945580|39496957|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
16276952|NCT01945580|39496958|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
16276953|NCT01945580|39496957|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
16276954|NCT01945580|39496958|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
16276955|NCT01945580|39496957|FG000|Overall Study|Noncompliance with 36 month visit|1|||
16276956|NCT01945580|39496958|FG001|Overall Study|Noncompliance with 36 month visit|0|||
16276957|NCT01945580|39496957|FG000|Overall Study|The patient moved.|1|||
16276958|NCT01945580|39496958|FG001|Overall Study|The patient moved.|0|||
16276959|NCT01945580|39496957|FG000|Overall Study|No data available|0|||
16375149|NCT00545948|39860066|FG002|Overall Study|Not Treated|7|||
16375150|NCT04642079|39860067|FG000|Overall Study|Lost to Follow-up|2|||
16375151|NCT04642079|39860068|FG001|Overall Study|Lost to Follow-up|5|||
16375152|NCT04642079|39860069|FG002|Overall Study|Lost to Follow-up|2|||
16375153|NCT04642079|39860070|FG003|Overall Study|Lost to Follow-up|0|||
16375154|NCT04642079|39860067|FG000|Overall Study|Withdrawal by Subject|0|||
16375155|NCT04642079|39860068|FG001|Overall Study|Withdrawal by Subject|4|||
16375156|NCT04642079|39860069|FG002|Overall Study|Withdrawal by Subject|1|||
16375157|NCT04642079|39860070|FG003|Overall Study|Withdrawal by Subject|2|||
16375158|NCT04642079|39860067|FG000|Overall Study|Other|0|||
16375159|NCT04642079|39860068|FG001|Overall Study|Other|0|||
16375160|NCT04642079|39860069|FG002|Overall Study|Other|0|||
16375161|NCT04642079|39860070|FG003|Overall Study|Other|1|||
16375162|NCT04642079|39860067|FG000|Overall Study|No longer met eligibility criteria|1|||
16375163|NCT04642079|39860068|FG001|Overall Study|No longer met eligibility criteria|0|||
16375164|NCT04642079|39860069|FG002|Overall Study|No longer met eligibility criteria|1|||
16375165|NCT04642079|39860070|FG003|Overall Study|No longer met eligibility criteria|1|||
16375166|NCT05451329|39860071|FG000|Overall Study|Adverse Event|1|||
16375167|NCT05451329|39860072|FG001|Overall Study|Adverse Event|1|||
16375168|NCT05451329|39860073|FG002|Overall Study|Adverse Event|0|||
16375169|NCT05451329|39860071|FG000|Overall Study|Withdrawal by Subject|1|||
16375170|NCT05451329|39860072|FG001|Overall Study|Withdrawal by Subject|0|||
16375171|NCT05451329|39860073|FG002|Overall Study|Withdrawal by Subject|0|||
16375172|NCT05451329|39860071|FG000|Overall Study|Investigational Product Lot exchange|1|||
16375173|NCT05451329|39860072|FG001|Overall Study|Investigational Product Lot exchange|1|||
16375174|NCT05451329|39860073|FG002|Overall Study|Investigational Product Lot exchange|0|||
16375175|NCT00752219|39860076|FG000|Overall Study|Clinical failure|0|||
16375176|NCT00752219|39860077|FG001|Overall Study|Clinical failure|1|||
16375177|NCT00752219|39860076|FG000|Overall Study|Adverse Event|5|||
16375178|NCT00752219|39860077|FG001|Overall Study|Adverse Event|3|||
16375179|NCT00752219|39860076|FG000|Overall Study|Protocol deviation|1|||
16375180|NCT00752219|39860077|FG001|Overall Study|Protocol deviation|0|||
16375181|NCT00752219|39860076|FG000|Overall Study|Lost to Follow-up|1|||
16375182|NCT00752219|39860077|FG001|Overall Study|Lost to Follow-up|2|||
16375183|NCT00752219|39860076|FG000|Overall Study|Randomized but not treated|1|||
16375184|NCT00752219|39860077|FG001|Overall Study|Randomized but not treated|0|||
16375185|NCT00752219|39860076|FG000|Overall Study|Other|3|||
16375186|NCT00752219|39860077|FG001|Overall Study|Other|0|||
16375187|NCT02176525|39860078|FG000|Overall Study|Adverse Event|0|||
16375188|NCT02176525|39860079|FG001|Overall Study|Adverse Event|0|||
16375189|NCT02176525|39860080|FG002|Overall Study|Adverse Event|0|||
16375190|NCT02176525|39860081|FG003|Overall Study|Adverse Event|1|||
16375191|NCT02176525|39860082|FG004|Overall Study|Adverse Event|1|||
16375192|NCT02176525|39860083|FG005|Overall Study|Adverse Event|0|||
16375193|NCT02176525|39860084|FG006|Overall Study|Adverse Event|1|||
16375194|NCT02176525|39860085|FG007|Overall Study|Adverse Event|0|||
16375195|NCT02176525|39860078|FG000|Overall Study|not treated|1|||
16375196|NCT02176525|39860079|FG001|Overall Study|not treated|0|||
16375197|NCT02176525|39860080|FG002|Overall Study|not treated|0|||
16375198|NCT02176525|39860081|FG003|Overall Study|not treated|0|||
16375199|NCT02176525|39860082|FG004|Overall Study|not treated|0|||
16375200|NCT02176525|39860083|FG005|Overall Study|not treated|1|||
16375201|NCT02176525|39860084|FG006|Overall Study|not treated|0|||
16375202|NCT02176525|39860085|FG007|Overall Study|not treated|0|||
16375203|NCT00289978|39860088|FG000|Overall Study|Withdrawal by Subject|31|||
16375204|NCT00289978|39860089|FG001|Overall Study|Withdrawal by Subject|17|||
16375205|NCT00289978|39860090|FG002|Overall Study|Withdrawal by Subject|28|||
16375206|NCT00289978|39860088|FG000|Overall Study|Adverse Event|22|||
16375207|NCT00289978|39860089|FG001|Overall Study|Adverse Event|13|||
16375208|NCT00289978|39860090|FG002|Overall Study|Adverse Event|18|||
16375209|NCT00289978|39860088|FG000|Overall Study|Lack of Efficacy|13|||
16375210|NCT00289978|39860089|FG001|Overall Study|Lack of Efficacy|6|||
16375211|NCT00289978|39860090|FG002|Overall Study|Lack of Efficacy|25|||
16375212|NCT00289978|39860088|FG000|Overall Study|Abnormal laboratory value(s)|20|||
16375213|NCT00289978|39860089|FG001|Overall Study|Abnormal laboratory value(s)|9|||
16375214|NCT00289978|39860090|FG002|Overall Study|Abnormal laboratory value(s)|1|||
16375215|NCT00289978|39860088|FG000|Overall Study|Lost to Follow-up|3|||
16375216|NCT00289978|39860089|FG001|Overall Study|Lost to Follow-up|5|||
16375217|NCT00289978|39860090|FG002|Overall Study|Lost to Follow-up|7|||
16375218|NCT00289978|39860088|FG000|Overall Study|Protocol Violation|5|||
16375219|NCT00289978|39860089|FG001|Overall Study|Protocol Violation|5|||
16375220|NCT00289978|39860090|FG002|Overall Study|Protocol Violation|4|||
16375221|NCT00289978|39860088|FG000|Overall Study|Abnormal test procedure result(s)|2|||
16375222|NCT00289978|39860089|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16375223|NCT00289978|39860090|FG002|Overall Study|Abnormal test procedure result(s)|1|||
16375224|NCT00289978|39860088|FG000|Overall Study|Death|1|||
16375225|NCT00289978|39860089|FG001|Overall Study|Death|0|||
16375226|NCT00289978|39860090|FG002|Overall Study|Death|2|||
16375227|NCT01189227|39860091|FG000|Overall Study|Study terminated due to low accrual|6|||
16375228|NCT01189227|39860092|FG001|Overall Study|Study terminated due to low accrual|3|||
16375229|NCT02496156|39860093|FG000|Overall Study|Lost to Follow-up|5|||
16375230|NCT02496156|39860094|FG001|Overall Study|Lost to Follow-up|0|||
16375231|NCT02496156|39860093|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
16375232|NCT02496156|39860094|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
16375233|NCT03345550|39860095|FG000|Overall Study|Withdrawal by Subject|1|||
16375234|NCT03345550|39860096|FG001|Overall Study|Withdrawal by Subject|0|||
16375235|NCT03345550|39860095|FG000|Overall Study|Lost to Follow-up|4|||
16375236|NCT03345550|39860096|FG001|Overall Study|Lost to Follow-up|5|||
16375237|NCT01629563|39860097|FG000|Overall Study|Adverse Event|16|||
16276960|NCT01945580|39496958|FG001|Overall Study|No data available|2|||
16276961|NCT01688882|39496959|FG000|Overall Study|Adverse Event|1|||
16276962|NCT01688882|39496960|FG001|Overall Study|Adverse Event|0|||
16276963|NCT01688882|39496959|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16276964|NCT01688882|39496960|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16276965|NCT01688882|39496959|FG000|Overall Study|Administrative problems|1|||
16276966|NCT01688882|39496960|FG001|Overall Study|Administrative problems|0|||
16276967|NCT00651183|39496961|FG000|Overall Study|Lack of Efficacy|1|||
16276968|NCT00651183|39496962|FG001|Overall Study|Lack of Efficacy|0|||
16276969|NCT00651183|39496961|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
16276970|NCT00651183|39496962|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
16276971|NCT00651183|39496961|FG000|Overall Study|Tolerability insufficient|5|||
16276972|NCT00651183|39496962|FG001|Overall Study|Tolerability insufficient|2|||
16276973|NCT00651183|39496961|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
16276974|NCT00651183|39496962|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
16276975|NCT00651183|39496961|FG000|Overall Study|Withdrawal by Subject|6|||
16276976|NCT00651183|39496962|FG001|Overall Study|Withdrawal by Subject|3|||
16276977|NCT00651183|39496961|FG000|Overall Study|Lost to Follow-up|3|||
16276978|NCT00651183|39496962|FG001|Overall Study|Lost to Follow-up|1|||
16276979|NCT00651183|39496961|FG000|Overall Study|Other reasons|4|||
16276980|NCT00651183|39496962|FG001|Overall Study|Other reasons|2|||
16276981|NCT00651183|39496961|FG000|Overall Study|missing|1|||
16276982|NCT00651183|39496962|FG001|Overall Study|missing|0|||
16276983|NCT04592419|39496963|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
16276984|NCT04592419|39496964|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
16276985|NCT04592419|39496963|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
16276986|NCT04592419|39496964|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
16276987|NCT04592419|39496963|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
16276988|NCT04592419|39496964|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
16276989|NCT04592419|39496963|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
16276990|NCT04592419|39496964|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
16276991|NCT04592419|39496963|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
16276992|NCT04592419|39496964|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
16276993|NCT04592419|39496963|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
16276994|NCT04592419|39496964|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
16276995|NCT04592419|39496963|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
16276996|NCT04592419|39496964|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
16276997|NCT04592419|39496963|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
16276998|NCT04592419|39496964|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
16276999|NCT04592419|39496963|FG000|Open-Label Extension Period|Adverse Event|1|||
16277000|NCT04592419|39496964|FG001|Open-Label Extension Period|Adverse Event|2|||
16277001|NCT04592419|39496963|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
16277002|NCT04592419|39496964|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
16277003|NCT04592419|39496963|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
16277004|NCT04592419|39496964|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
16277005|NCT04592419|39496963|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
16277006|NCT04592419|39496964|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
16277007|NCT04592419|39496963|FG000|Open-Label Extension Period|Sponsor Request|73|||
16277008|NCT04592419|39496964|FG001|Open-Label Extension Period|Sponsor Request|84|||
16277009|NCT00258856|39496970|FG000|Overall Study|Lost to Follow-up|1|||
16277010|NCT00258856|39496971|FG001|Overall Study|Lost to Follow-up|0|||
16277011|NCT00258856|39496972|FG002|Overall Study|Lost to Follow-up|2|||
16277012|NCT00258856|39496973|FG003|Overall Study|Lost to Follow-up|0|||
16277013|NCT00258856|39496970|FG000|Overall Study|Non-compliance|2|||
16277014|NCT00258856|39496971|FG001|Overall Study|Non-compliance|0|||
16277015|NCT00258856|39496972|FG002|Overall Study|Non-compliance|0|||
16277016|NCT00258856|39496973|FG003|Overall Study|Non-compliance|1|||
16277017|NCT00799708|39496974|FG000|Overall Study|non-compliance|1|||
16277018|NCT00799708|39496975|FG001|Overall Study|non-compliance|0|||
16277019|NCT00799708|39496976|FG002|Overall Study|non-compliance|0|||
16277020|NCT01040793|39496977|FG000|Overall Study|Adverse Event|5|||
16277021|NCT01040793|39496978|FG001|Overall Study|Adverse Event|3|||
16277022|NCT01040793|39496979|FG002|Overall Study|Adverse Event|0|||
16277023|NCT01040793|39496980|FG003|Overall Study|Adverse Event|2|||
16277024|NCT01040793|39496981|FG004|Overall Study|Adverse Event|2|||
16277025|NCT01040793|39496982|FG005|Overall Study|Adverse Event|1|||
16277026|NCT01040793|39496977|FG000|Overall Study|Protocol Violation|1|||
16277027|NCT01040793|39496978|FG001|Overall Study|Protocol Violation|1|||
16277028|NCT01040793|39496979|FG002|Overall Study|Protocol Violation|1|||
16277029|NCT01040793|39496980|FG003|Overall Study|Protocol Violation|0|||
16277030|NCT01040793|39496981|FG004|Overall Study|Protocol Violation|1|||
16277031|NCT01040793|39496982|FG005|Overall Study|Protocol Violation|0|||
16277032|NCT01040793|39496977|FG000|Overall Study|Lost to Follow-up|0|||
16277033|NCT01040793|39496978|FG001|Overall Study|Lost to Follow-up|1|||
16277034|NCT01040793|39496979|FG002|Overall Study|Lost to Follow-up|1|||
16277035|NCT01040793|39496980|FG003|Overall Study|Lost to Follow-up|0|||
16277036|NCT01040793|39496981|FG004|Overall Study|Lost to Follow-up|0|||
16277037|NCT01040793|39496982|FG005|Overall Study|Lost to Follow-up|0|||
16277038|NCT01040793|39496977|FG000|Overall Study|Withdrawal by Subject|0|||
16277039|NCT01040793|39496978|FG001|Overall Study|Withdrawal by Subject|0|||
16277040|NCT01040793|39496979|FG002|Overall Study|Withdrawal by Subject|0|||
16277041|NCT01040793|39496980|FG003|Overall Study|Withdrawal by Subject|2|||
16277042|NCT01040793|39496981|FG004|Overall Study|Withdrawal by Subject|0|||
16277043|NCT01040793|39496982|FG005|Overall Study|Withdrawal by Subject|0|||
16277044|NCT01040793|39496977|FG000|Overall Study|Other reasons not listed above|0|||
16277045|NCT01040793|39496978|FG001|Overall Study|Other reasons not listed above|0|||
16277046|NCT01040793|39496979|FG002|Overall Study|Other reasons not listed above|1|||
16277047|NCT01040793|39496980|FG003|Overall Study|Other reasons not listed above|0|||
16277048|NCT01040793|39496981|FG004|Overall Study|Other reasons not listed above|1|||
16277049|NCT01040793|39496982|FG005|Overall Study|Other reasons not listed above|0|||
16277050|NCT00559637|39496985|FG000|Overall Study|Adverse Event|22|||
16277051|NCT00559637|39496985|FG000|Overall Study|Withdrawal by Subject|4|||
16277052|NCT00559637|39496985|FG000|Overall Study|Protocol Violation|6|||
16277053|NCT00559637|39496985|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
16277054|NCT00559637|39496985|FG000|Overall Study|Failure to return|6|||
16277055|NCT00559637|39496985|FG000|Overall Study|Insufficient response|3|||
16277056|NCT00559637|39496985|FG000|Overall Study|Started requiring dialysis after month 7|2|||
16277057|NCT00559637|39496985|FG000|Overall Study|Suspected lung cancer|1|||
16277058|NCT00559637|39496985|FG000|Overall Study|Participation in another study|1|||
16277059|NCT00559637|39496985|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
16277060|NCT00559637|39496985|FG000|Overall Study|Change of center|1|||
16277061|NCT00559637|39496985|FG000|Overall Study|Change of home|1|||
16277062|NCT00559637|39496985|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
16277063|NCT01143337|39496986|FG000|Overall Study|Adverse Event|3|||
16277064|NCT01143337|39496987|FG001|Overall Study|Adverse Event|9|||
16277065|NCT01143337|39496988|FG002|Overall Study|Adverse Event|5|||
16277066|NCT01143337|39496986|FG000|Overall Study|Lack of Efficacy|6|||
16277067|NCT01143337|39496987|FG001|Overall Study|Lack of Efficacy|2|||
16277068|NCT01143337|39496988|FG002|Overall Study|Lack of Efficacy|1|||
16277069|NCT01143337|39496986|FG000|Overall Study|Protocol Violation|1|||
16277070|NCT01143337|39496987|FG001|Overall Study|Protocol Violation|0|||
16277071|NCT01143337|39496988|FG002|Overall Study|Protocol Violation|0|||
16277072|NCT01143337|39496986|FG000|Overall Study|Withdrawal by Subject|0|||
16277073|NCT01143337|39496987|FG001|Overall Study|Withdrawal by Subject|0|||
16277074|NCT01143337|39496988|FG002|Overall Study|Withdrawal by Subject|1|||
16277075|NCT01143337|39496986|FG000|Overall Study|Other reason|0|||
16277076|NCT01143337|39496987|FG001|Overall Study|Other reason|0|||
16277077|NCT01143337|39496988|FG002|Overall Study|Other reason|5|||
16277078|NCT00685334|39496989|FG000|Overall Study|Withdrawal by Subject|5|||
16277079|NCT00685334|39496990|FG001|Overall Study|Withdrawal by Subject|6|||
16277080|NCT00685334|39496989|FG000|Overall Study|Lost to Follow-up|4|||
16277081|NCT00685334|39496990|FG001|Overall Study|Lost to Follow-up|0|||
16277082|NCT00685334|39496989|FG000|Overall Study|Chose to enter hospital|1|||
16277083|NCT00685334|39496990|FG001|Overall Study|Chose to enter hospital|1|||
16277084|NCT04590781|39496991|FG000|Overall Study|Death|0|||
16277085|NCT04590781|39496992|FG001|Overall Study|Death|2|||
16277086|NCT04590781|39496991|FG000|Overall Study|Withdrawal by Subject|2|||
16277087|NCT04590781|39496992|FG001|Overall Study|Withdrawal by Subject|0|||
16277088|NCT03008005|39496995|FG000|Overall Study|Physician Decision|1|||
16277089|NCT03008005|39496996|FG001|Overall Study|Physician Decision|0|||
16277090|NCT03008005|39496997|FG002|Overall Study|Physician Decision|0|||
16277091|NCT03008005|39496995|FG000|Overall Study|Withdrawal by Subject|1|||
16277092|NCT03008005|39496996|FG001|Overall Study|Withdrawal by Subject|0|||
16277093|NCT03008005|39496997|FG002|Overall Study|Withdrawal by Subject|0|||
16277094|NCT03008005|39496995|FG000|Overall Study|Ineligible|0|||
16277095|NCT03008005|39496996|FG001|Overall Study|Ineligible|1|||
16277096|NCT03008005|39496997|FG002|Overall Study|Ineligible|0|||
16277097|NCT02435433|39496998|FG000|Overall Study|Withdrawal by Subject|2|||
16277098|NCT02435433|39496999|FG001|Overall Study|Withdrawal by Subject|3|||
16277099|NCT02435433|39497000|FG002|Overall Study|Withdrawal by Subject|1|||
16277100|NCT02435433|39497001|FG003|Overall Study|Withdrawal by Subject|0|||
16277101|NCT02435433|39497002|FG004|Overall Study|Withdrawal by Subject|0|||
16277102|NCT02435433|39496998|FG000|Overall Study|Lost to Follow-up|2|||
16277103|NCT02435433|39496999|FG001|Overall Study|Lost to Follow-up|2|||
16277104|NCT02435433|39497000|FG002|Overall Study|Lost to Follow-up|4|||
16277105|NCT02435433|39497001|FG003|Overall Study|Lost to Follow-up|1|||
16277106|NCT02435433|39497002|FG004|Overall Study|Lost to Follow-up|0|||
16277107|NCT02448563|39497004|FG000|Overall Study|Lost to Follow-up|16|||
16277108|NCT02448563|39497005|FG001|Overall Study|Lost to Follow-up|10|||
16277109|NCT02448563|39497004|FG000|Overall Study|Withdrawal by Subject|0|||
16277110|NCT02448563|39497005|FG001|Overall Study|Withdrawal by Subject|1|||
16277111|NCT01098539|39497006|FG000|Overall Study|Adverse Event|26|||
16277112|NCT01098539|39497007|FG001|Overall Study|Adverse Event|26|||
16277113|NCT01098539|39497006|FG000|Overall Study|Protocol Violation|1|||
16277114|NCT01098539|39497007|FG001|Overall Study|Protocol Violation|4|||
16277115|NCT01098539|39497006|FG000|Overall Study|Noncompliance|3|||
16277116|NCT01098539|39497007|FG001|Overall Study|Noncompliance|5|||
16277117|NCT01098539|39497006|FG000|Overall Study|Lost to Follow-up|4|||
16277118|NCT01098539|39497007|FG001|Overall Study|Lost to Follow-up|4|||
16277119|NCT01098539|39497006|FG000|Overall Study|Withdrawal by Subject|12|||
16277120|NCT01098539|39497007|FG001|Overall Study|Withdrawal by Subject|26|||
16277121|NCT01098539|39497006|FG000|Overall Study|Physician Decision|5|||
16277122|NCT01098539|39497007|FG001|Overall Study|Physician Decision|3|||
16277123|NCT03942211|39497008|FG000|Overall Study|Death|1|||
16277124|NCT03942211|39497009|FG001|Overall Study|Death|0|||
16277125|NCT03942211|39497008|FG000|Overall Study|Study terminated by sponsor|5|||
16277126|NCT03942211|39497009|FG001|Overall Study|Study terminated by sponsor|3|||
16277127|NCT03942211|39497008|FG000|Overall Study|Adverse Event|0|||
16277128|NCT03942211|39497009|FG001|Overall Study|Adverse Event|1|||
16277129|NCT00530348|39497012|FG000|Overall Study|Adverse Event|5|||
16277130|NCT00530348|39497013|FG001|Overall Study|Adverse Event|1|||
16277131|NCT00530348|39497012|FG000|Overall Study|Death|0|||
16277132|NCT00530348|39497013|FG001|Overall Study|Death|1|||
16277133|NCT00530348|39497012|FG000|Overall Study|Lack of Efficacy|2|||
16277134|NCT00530348|39497013|FG001|Overall Study|Lack of Efficacy|0|||
16277135|NCT00530348|39497012|FG000|Overall Study|Lost to Follow-up|0|||
16277136|NCT00530348|39497013|FG001|Overall Study|Lost to Follow-up|2|||
16277137|NCT00530348|39497012|FG000|Overall Study|Physician Decision|1|||
16277138|NCT00530348|39497013|FG001|Overall Study|Physician Decision|2|||
16277139|NCT00530348|39497012|FG000|Overall Study|Pregnancy|1|||
16277140|NCT00530348|39497013|FG001|Overall Study|Pregnancy|0|||
16277141|NCT00530348|39497012|FG000|Overall Study|Withdrawal by Subject|12|||
16277142|NCT00530348|39497013|FG001|Overall Study|Withdrawal by Subject|12|||
16277143|NCT00530348|39497012|FG000|Overall Study|Randomised in error|1|||
16277144|NCT00530348|39497013|FG001|Overall Study|Randomised in error|0|||
16277145|NCT00530348|39497012|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
16277146|NCT00530348|39497013|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
16277147|NCT02623218|39497015|FG000|Overall Study|Lost to Follow-up|0|||
16277148|NCT02623218|39497016|FG001|Overall Study|Lost to Follow-up|1|||
16277149|NCT02623218|39497017|FG002|Overall Study|Lost to Follow-up|0|||
16277150|NCT02623218|39497018|FG003|Overall Study|Lost to Follow-up|0|||
16277151|NCT02623218|39497019|FG004|Overall Study|Lost to Follow-up|0|||
16277152|NCT01456949|39497020|FG000|Enrollment|PI death- incomplete data|6|||
16277153|NCT01456949|39497020|FG000|Enrollment|Death|1|||
16277154|NCT01456949|39497020|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
16277155|NCT01456949|39497020|FG000|Enrollment|Physician Decision|10|||
16277156|NCT01456949|39497020|FG000|Enrollment|Withdrawal by Subject|7|||
16277157|NCT01456949|39497020|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
16277158|NCT01456949|39497020|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
16277159|NCT01456949|39497020|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
16277160|NCT01456949|39497020|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
16277161|NCT01456949|39497020|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
16277162|NCT01456949|39497020|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
16277163|NCT01456949|39497020|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
16277164|NCT01456949|39497020|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
16277165|NCT01859598|39497025|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
16277166|NCT03885934|39497026|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
16277167|NCT03885934|39497027|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
16277168|NCT03885934|39497028|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
16277169|NCT03885934|39497029|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
16277170|NCT03885934|39497030|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
16277171|NCT03885934|39497031|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
16277172|NCT00265785|39497035|FG000|Overall Study|Adverse Event|4|||
16277173|NCT00265785|39497035|FG000|Overall Study|Withdrawal by Subject|3|||
16277174|NCT00265785|39497035|FG000|Overall Study|Progression/Relapse|15|||
16277175|NCT00265785|39497035|FG000|Overall Study|Not protocol specified|2|||
16277176|NCT00265785|39497035|FG000|Overall Study|Ineligible|1|||
16277177|NCT00265785|39497035|FG000|Overall Study|Did not receive protocol treatment|2|||
16277178|NCT00725764|39497036|FG000|Overall Study|Withdrawal by Subject|2|||
16277179|NCT00725764|39497036|FG000|Overall Study|Physician Decision|1|||
16277180|NCT00725764|39497036|FG000|Overall Study|Progressive Disease|7|||
16277181|NCT00725764|39497036|FG000|Overall Study|Lost to Follow-up|1|||
16277182|NCT00725764|39497036|FG000|Overall Study|Death|1|||
16277183|NCT00725764|39497036|FG000|Overall Study|Participant non compliant with protocol|1|||
16277184|NCT00725764|39497036|FG000|Overall Study|Decline in performance status|1|||
16277185|NCT05070754|39497037|FG000|Overall Study|Withdrawal by Subject|0|||
16277186|NCT05070754|39497038|FG001|Overall Study|Withdrawal by Subject|0|||
16277187|NCT05070754|39497039|FG002|Overall Study|Withdrawal by Subject|0|||
16277188|NCT05070754|39497040|FG003|Overall Study|Withdrawal by Subject|1|||
16277189|NCT05070754|39497037|FG000|Overall Study|Protocol Violation|0|||
16277190|NCT05070754|39497038|FG001|Overall Study|Protocol Violation|0|||
16277191|NCT05070754|39497039|FG002|Overall Study|Protocol Violation|0|||
16277192|NCT05070754|39497040|FG003|Overall Study|Protocol Violation|1|||
16277193|NCT02875028|39497046|FG000|Washout Period|Withdrawal by Subject|0|||
16277194|NCT02875028|39497047|FG001|Washout Period|Withdrawal by Subject|1|||
16277195|NCT01622660|39497048|FG000|Overall Study|Adverse Event|1|||
16277196|NCT00220727|39497051|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
16277197|NCT00220727|39497052|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
16277198|NCT04974580|39497053|FG000|Overall Study|Lost to Follow-up|33|||
16277199|NCT04974580|39497054|FG001|Overall Study|Lost to Follow-up|39|||
16277200|NCT04974580|39497055|FG002|Overall Study|Lost to Follow-up|30|||
16277201|NCT04974580|39497056|FG003|Overall Study|Lost to Follow-up|29|||
16277202|NCT04019054|39497057|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
16277203|NCT04019054|39497058|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
16277204|NCT04019054|39497057|FG000|Overall Study|Withdrawal by Subject|3|||
16277205|NCT04019054|39497058|FG001|Overall Study|Withdrawal by Subject|1|||
16277206|NCT04049097|39497062|FG000|Overall Study|Adverse Event|18|||
16277207|NCT04049097|39497062|FG000|Overall Study|Death|2|||
16277208|NCT04049097|39497062|FG000|Overall Study|Lost to Follow-up|1|||
16277209|NCT04049097|39497062|FG000|Overall Study|Physician Decision|2|||
16277210|NCT04049097|39497062|FG000|Overall Study|Withdrawal by Subject|9|||
16277211|NCT04049097|39497062|FG000|Overall Study|Protocol Violation|2|||
16277212|NCT04049097|39497062|FG000|Overall Study|Other|1|||
16277213|NCT04049097|39497062|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
16277214|NCT01896505|39497063|FG000|Overall Study|Adverse Event|1|||
16277215|NCT01896505|39497064|FG001|Overall Study|Adverse Event|0|||
16277216|NCT01896505|39497065|FG002|Overall Study|Adverse Event|2|||
16277217|NCT01896505|39497066|FG003|Overall Study|Adverse Event|1|||
16277218|NCT01896505|39497067|FG004|Overall Study|Adverse Event|1|||
16277219|NCT01896505|39497068|FG005|Overall Study|Adverse Event|0|||
16277220|NCT01896505|39497063|FG000|Overall Study|Physician Decision|1|||
16277221|NCT01896505|39497064|FG001|Overall Study|Physician Decision|3|||
16277222|NCT01896505|39497065|FG002|Overall Study|Physician Decision|2|||
16277223|NCT01896505|39497066|FG003|Overall Study|Physician Decision|0|||
16277224|NCT01896505|39497067|FG004|Overall Study|Physician Decision|0|||
16277225|NCT01896505|39497068|FG005|Overall Study|Physician Decision|1|||
16277226|NCT01896505|39497063|FG000|Overall Study|Withdrawal by Subject|1|||
16277227|NCT01896505|39497064|FG001|Overall Study|Withdrawal by Subject|0|||
16277228|NCT01896505|39497065|FG002|Overall Study|Withdrawal by Subject|3|||
16277229|NCT01896505|39497066|FG003|Overall Study|Withdrawal by Subject|1|||
16277230|NCT01896505|39497067|FG004|Overall Study|Withdrawal by Subject|0|||
16277231|NCT01896505|39497068|FG005|Overall Study|Withdrawal by Subject|0|||
16277232|NCT01896505|39497063|FG000|Overall Study|Disease Progression|7|||
16277233|NCT01896505|39497064|FG001|Overall Study|Disease Progression|5|||
16277234|NCT01896505|39497065|FG002|Overall Study|Disease Progression|8|||
16277235|NCT01896505|39497066|FG003|Overall Study|Disease Progression|4|||
16277236|NCT01896505|39497067|FG004|Overall Study|Disease Progression|4|||
16277237|NCT01896505|39497068|FG005|Overall Study|Disease Progression|4|||
16277238|NCT01896505|39497063|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
16277239|NCT01896505|39497064|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
16277240|NCT01896505|39497065|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
16277241|NCT01896505|39497066|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
16277242|NCT01896505|39497067|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
16277243|NCT01896505|39497068|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
16277244|NCT01896505|39497063|FG000|Overall Study|Intercurrent illness|0|||
16277245|NCT01896505|39497064|FG001|Overall Study|Intercurrent illness|1|||
16277246|NCT01896505|39497065|FG002|Overall Study|Intercurrent illness|0|||
16277247|NCT01896505|39497066|FG003|Overall Study|Intercurrent illness|0|||
16277248|NCT01896505|39497067|FG004|Overall Study|Intercurrent illness|0|||
16277249|NCT01896505|39497068|FG005|Overall Study|Intercurrent illness|0|||
16277250|NCT01896505|39497063|FG000|Overall Study|Death|0|||
16277251|NCT01896505|39497064|FG001|Overall Study|Death|0|||
16277252|NCT01896505|39497065|FG002|Overall Study|Death|1|||
16277253|NCT01896505|39497066|FG003|Overall Study|Death|1|||
16277254|NCT01896505|39497067|FG004|Overall Study|Death|0|||
16277255|NCT01896505|39497068|FG005|Overall Study|Death|1|||
16277256|NCT03433703|39497069|FG000|Overall Study|Study terminated by Sponsor|2|||
16277257|NCT00508651|39497072|FG000|Overall Study|Lost to Follow-up|3|||
16277258|NCT00508651|39497073|FG001|Overall Study|Lost to Follow-up|1|||
16277259|NCT00508651|39497072|FG000|Overall Study|Withdrawal by Subject|1|||
16277260|NCT00508651|39497073|FG001|Overall Study|Withdrawal by Subject|1|||
16277261|NCT02597049|39497076|FG000|Overall Study|Lost to Follow-up|0|||
16277262|NCT02597049|39497077|FG001|Overall Study|Lost to Follow-up|3|||
16277263|NCT02597049|39497078|FG002|Overall Study|Lost to Follow-up|2|||
16277264|NCT02597049|39497076|FG000|Overall Study|Withdrawal by Subject|2|||
16277265|NCT02597049|39497077|FG001|Overall Study|Withdrawal by Subject|2|||
16277266|NCT02597049|39497078|FG002|Overall Study|Withdrawal by Subject|1|||
16277267|NCT02597049|39497076|FG000|Overall Study|Adverse Event|2|||
16277268|NCT02597049|39497077|FG001|Overall Study|Adverse Event|0|||
16277269|NCT02597049|39497078|FG002|Overall Study|Adverse Event|0|||
16277270|NCT02597049|39497076|FG000|Overall Study|Death|2|||
16277271|NCT02597049|39497077|FG001|Overall Study|Death|0|||
16277272|NCT02597049|39497078|FG002|Overall Study|Death|0|||
16277273|NCT02597049|39497076|FG000|Overall Study|Noncompliant with Study Visits|1|||
16277274|NCT02597049|39497077|FG001|Overall Study|Noncompliant with Study Visits|0|||
16277275|NCT02597049|39497078|FG002|Overall Study|Noncompliant with Study Visits|0|||
16277276|NCT02795676|39497080|FG000|Overall Study|Adverse Event|2|||
16277277|NCT02795676|39497081|FG001|Overall Study|Adverse Event|0|||
16277278|NCT02795676|39497080|FG000|Overall Study|Withdrawal by Subject|3|||
16277279|NCT02795676|39497081|FG001|Overall Study|Withdrawal by Subject|1|||
16277280|NCT03180528|39497082|FG000|Overall Study|Adverse Event|1|||
16277281|NCT03180528|39497082|FG000|Overall Study|Withdrawal by Subject|1|||
16277282|NCT03180528|39497082|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
16277283|NCT02311894|39497084|FG000|Overall Study|Discontinued in error|1|||
16277284|NCT02311894|39497084|FG000|Overall Study|Lost to Follow-up|1|||
16277285|NCT02311894|39497084|FG000|Overall Study|Adverse Event|1|||
16277286|NCT02311894|39497084|FG000|Overall Study|Withdrawal by Subject|1|||
16277287|NCT04232540|39497085|FG000|Overall Study|Lost to Follow-up|1|||
16277288|NCT04232540|39497086|FG001|Overall Study|Lost to Follow-up|0|||
16277289|NCT01899053|39497087|FG000|Overall Study|Progressive Disease|4|||
16277290|NCT01899053|39497088|FG001|Overall Study|Progressive Disease|0|||
16277291|NCT01899053|39497089|FG002|Overall Study|Progressive Disease|3|||
16277292|NCT01899053|39497090|FG003|Overall Study|Progressive Disease|0|||
16277293|NCT01899053|39497091|FG004|Overall Study|Progressive Disease|3|||
16277294|NCT01899053|39497092|FG005|Overall Study|Progressive Disease|1|||
16277295|NCT01899053|39497093|FG006|Overall Study|Progressive Disease|1|||
16277296|NCT01899053|39497094|FG007|Overall Study|Progressive Disease|1|||
16277297|NCT01899053|39497095|FG008|Overall Study|Progressive Disease|4|||
16277298|NCT01899053|39497096|FG009|Overall Study|Progressive Disease|3|||
16277299|NCT01899053|39497097|FG010|Overall Study|Progressive Disease|12|||
16277300|NCT01899053|39497098|FG011|Overall Study|Progressive Disease|5|||
16277301|NCT01899053|39497099|FG012|Overall Study|Progressive Disease|8|||
16277302|NCT01899053|39497100|FG013|Overall Study|Progressive Disease|17|||
16277303|NCT01899053|39497087|FG000|Overall Study|Adverse Event|1|||
16277304|NCT01899053|39497088|FG001|Overall Study|Adverse Event|1|||
16277305|NCT01899053|39497089|FG002|Overall Study|Adverse Event|1|||
16277306|NCT01899053|39497090|FG003|Overall Study|Adverse Event|3|||
16277307|NCT01899053|39497091|FG004|Overall Study|Adverse Event|1|||
16277308|NCT01899053|39497092|FG005|Overall Study|Adverse Event|1|||
16277309|NCT01899053|39497093|FG006|Overall Study|Adverse Event|1|||
16277310|NCT01899053|39497094|FG007|Overall Study|Adverse Event|0|||
16277311|NCT01899053|39497095|FG008|Overall Study|Adverse Event|2|||
16277312|NCT01899053|39497096|FG009|Overall Study|Adverse Event|0|||
16277313|NCT01899053|39497097|FG010|Overall Study|Adverse Event|3|||
16277314|NCT01899053|39497098|FG011|Overall Study|Adverse Event|1|||
16277315|NCT01899053|39497099|FG012|Overall Study|Adverse Event|2|||
16277316|NCT01899053|39497100|FG013|Overall Study|Adverse Event|2|||
16277317|NCT01899053|39497087|FG000|Overall Study|Reason Not Specified|0|||
16277318|NCT01899053|39497088|FG001|Overall Study|Reason Not Specified|0|||
16277319|NCT01899053|39497089|FG002|Overall Study|Reason Not Specified|0|||
16277320|NCT01899053|39497090|FG003|Overall Study|Reason Not Specified|0|||
16277321|NCT01899053|39497091|FG004|Overall Study|Reason Not Specified|0|||
16277322|NCT01899053|39497092|FG005|Overall Study|Reason Not Specified|0|||
16277323|NCT01899053|39497093|FG006|Overall Study|Reason Not Specified|1|||
16277324|NCT01899053|39497094|FG007|Overall Study|Reason Not Specified|0|||
16277325|NCT01899053|39497095|FG008|Overall Study|Reason Not Specified|0|||
16277326|NCT01899053|39497096|FG009|Overall Study|Reason Not Specified|0|||
16277327|NCT01899053|39497097|FG010|Overall Study|Reason Not Specified|0|||
16277328|NCT01899053|39497098|FG011|Overall Study|Reason Not Specified|0|||
16277329|NCT01899053|39497099|FG012|Overall Study|Reason Not Specified|1|||
16277330|NCT01899053|39497100|FG013|Overall Study|Reason Not Specified|0|||
16277331|NCT01899053|39497087|FG000|Overall Study|Withdrawal by Subject|1|||
16277332|NCT01899053|39497088|FG001|Overall Study|Withdrawal by Subject|1|||
16277333|NCT01899053|39497089|FG002|Overall Study|Withdrawal by Subject|2|||
16277334|NCT01899053|39497090|FG003|Overall Study|Withdrawal by Subject|0|||
16277335|NCT01899053|39497091|FG004|Overall Study|Withdrawal by Subject|2|||
16277336|NCT01899053|39497092|FG005|Overall Study|Withdrawal by Subject|0|||
16277337|NCT01899053|39497093|FG006|Overall Study|Withdrawal by Subject|0|||
16277338|NCT01899053|39497094|FG007|Overall Study|Withdrawal by Subject|1|||
16277339|NCT01899053|39497095|FG008|Overall Study|Withdrawal by Subject|0|||
16277340|NCT01899053|39497096|FG009|Overall Study|Withdrawal by Subject|0|||
16277341|NCT01899053|39497097|FG010|Overall Study|Withdrawal by Subject|0|||
16277342|NCT01899053|39497098|FG011|Overall Study|Withdrawal by Subject|0|||
16277343|NCT01899053|39497099|FG012|Overall Study|Withdrawal by Subject|1|||
16277344|NCT01899053|39497100|FG013|Overall Study|Withdrawal by Subject|1|||
16277345|NCT01899053|39497087|FG000|Overall Study|Protocol Violation|0|||
16277346|NCT01899053|39497088|FG001|Overall Study|Protocol Violation|0|||
16277347|NCT01899053|39497089|FG002|Overall Study|Protocol Violation|1|||
16277348|NCT01899053|39497090|FG003|Overall Study|Protocol Violation|0|||
16277349|NCT01899053|39497091|FG004|Overall Study|Protocol Violation|0|||
16277350|NCT01899053|39497092|FG005|Overall Study|Protocol Violation|0|||
16277351|NCT01899053|39497093|FG006|Overall Study|Protocol Violation|0|||
16277352|NCT01899053|39497094|FG007|Overall Study|Protocol Violation|0|||
16277353|NCT01899053|39497095|FG008|Overall Study|Protocol Violation|0|||
16277354|NCT01899053|39497096|FG009|Overall Study|Protocol Violation|0|||
16375238|NCT01629563|39860098|FG001|Overall Study|Adverse Event|16|||
16375239|NCT01629563|39860097|FG000|Overall Study|Death|2|||
16375240|NCT01629563|39860098|FG001|Overall Study|Death|0|||
16375241|NCT01629563|39860097|FG000|Overall Study|Lack of Efficacy|2|||
16375242|NCT01629563|39860098|FG001|Overall Study|Lack of Efficacy|3|||
16375243|NCT01629563|39860097|FG000|Overall Study|Lost to Follow-up|1|||
16375244|NCT01629563|39860098|FG001|Overall Study|Lost to Follow-up|0|||
16375245|NCT01629563|39860097|FG000|Overall Study|Pregnancy|1|||
16375246|NCT01629563|39860098|FG001|Overall Study|Pregnancy|2|||
16375247|NCT01629563|39860097|FG000|Overall Study|Protocol Violation|0|||
16277355|NCT01899053|39497097|FG010|Overall Study|Protocol Violation|0|||
16277356|NCT01899053|39497098|FG011|Overall Study|Protocol Violation|0|||
16277357|NCT01899053|39497099|FG012|Overall Study|Protocol Violation|0|||
16277358|NCT01899053|39497100|FG013|Overall Study|Protocol Violation|0|||
16277359|NCT01899053|39497087|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
16277360|NCT01899053|39497088|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
16277361|NCT01899053|39497089|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
16277362|NCT01899053|39497090|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
16277363|NCT01899053|39497091|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
16277364|NCT01899053|39497092|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
16277365|NCT01899053|39497093|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
16277366|NCT01899053|39497094|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
16277367|NCT01899053|39497095|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
16277368|NCT01899053|39497096|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
16277369|NCT01899053|39497097|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
16277370|NCT01899053|39497098|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
16277371|NCT01899053|39497099|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
16277372|NCT01899053|39497100|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
16375248|NCT01629563|39860098|FG001|Overall Study|Protocol Violation|1|||
16375249|NCT01629563|39860097|FG000|Overall Study|Withdrawal by Subject|27|||
16375250|NCT01629563|39860098|FG001|Overall Study|Withdrawal by Subject|20|||
16375251|NCT01629563|39860097|FG000|Overall Study|surgery|0|||
16277373|NCT01899053|39497087|FG000|Overall Study|Symptomatic Deterioration|0|||
16277374|NCT01899053|39497088|FG001|Overall Study|Symptomatic Deterioration|0|||
16277375|NCT01899053|39497089|FG002|Overall Study|Symptomatic Deterioration|0|||
16277376|NCT01899053|39497090|FG003|Overall Study|Symptomatic Deterioration|0|||
16277377|NCT01899053|39497091|FG004|Overall Study|Symptomatic Deterioration|0|||
16277378|NCT01899053|39497092|FG005|Overall Study|Symptomatic Deterioration|1|||
16277379|NCT01899053|39497093|FG006|Overall Study|Symptomatic Deterioration|0|||
16277380|NCT01899053|39497094|FG007|Overall Study|Symptomatic Deterioration|1|||
16277381|NCT01899053|39497095|FG008|Overall Study|Symptomatic Deterioration|0|||
16277382|NCT01899053|39497096|FG009|Overall Study|Symptomatic Deterioration|0|||
16277383|NCT01899053|39497097|FG010|Overall Study|Symptomatic Deterioration|0|||
16277384|NCT01899053|39497098|FG011|Overall Study|Symptomatic Deterioration|1|||
16277385|NCT01899053|39497099|FG012|Overall Study|Symptomatic Deterioration|2|||
16375252|NCT01629563|39860098|FG001|Overall Study|surgery|3|||
16277386|NCT01899053|39497100|FG013|Overall Study|Symptomatic Deterioration|0|||
16277387|NCT02483416|39497101|FG000|Overall Study|Other reason|0|||
16277388|NCT02483416|39497102|FG001|Overall Study|Other reason|1|||
16277389|NCT02483416|39497101|FG000|Overall Study|Treatment stop|3|||
16277390|NCT02483416|39497102|FG001|Overall Study|Treatment stop|0|||
16375253|NCT01629563|39860097|FG000|Overall Study|Lack of return of menses|12|||
16375254|NCT01629563|39860098|FG001|Overall Study|Lack of return of menses|7|||
16375255|NCT01629563|39860097|FG000|Overall Study|Protocol Violation|0|||
16375256|NCT01629563|39860098|FG001|Overall Study|Protocol Violation|1|||
16277391|NCT01131260|39497103|FG000|Overall Study|Randomization error|5|||
16277392|NCT01131260|39497104|FG001|Overall Study|Randomization error|1|||
16277393|NCT01131260|39497103|FG000|Overall Study|Declined to continue participation|8|||
16277394|NCT01131260|39497104|FG001|Overall Study|Declined to continue participation|13|||
16277395|NCT01131260|39497103|FG000|Overall Study|Physician Decision|22|||
16277396|NCT01131260|39497104|FG001|Overall Study|Physician Decision|24|||
16277397|NCT01131260|39497103|FG000|Overall Study|Technical problems|7|||
16277398|NCT01131260|39497104|FG001|Overall Study|Technical problems|6|||
16277399|NCT01131260|39497103|FG000|Overall Study|Staff error|2|||
16277400|NCT01131260|39497104|FG001|Overall Study|Staff error|1|||
16277401|NCT01131260|39497103|FG000|Overall Study|Ineligible|0|||
16277402|NCT01131260|39497104|FG001|Overall Study|Ineligible|2|||
16277403|NCT01993940|39497105|FG000|Overall Study|Adverse Event|16|||
16277404|NCT01993940|39497106|FG001|Overall Study|Adverse Event|11|||
16277405|NCT01993940|39497105|FG000|Overall Study|Withdrawal by Subject|15|||
16277406|NCT01993940|39497106|FG001|Overall Study|Withdrawal by Subject|19|||
16277407|NCT01993940|39497105|FG000|Overall Study|Lost to Follow-up|2|||
16277408|NCT01993940|39497106|FG001|Overall Study|Lost to Follow-up|5|||
16277409|NCT01993940|39497105|FG000|Overall Study|Protocol Violation|5|||
16277410|NCT01993940|39497106|FG001|Overall Study|Protocol Violation|8|||
16277411|NCT01993940|39497105|FG000|Overall Study|Death|1|||
16277412|NCT01993940|39497106|FG001|Overall Study|Death|0|||
16277413|NCT01993940|39497105|FG000|Overall Study|Other - Miscellaneous|1|||
16277414|NCT01993940|39497106|FG001|Overall Study|Other - Miscellaneous|1|||
16277415|NCT01055886|39497117|FG000|Overall Study|Withdrawal by Subject|4|||
16277416|NCT01055886|39497118|FG001|Overall Study|Withdrawal by Subject|9|||
16277417|NCT01055886|39497117|FG000|Overall Study|Lost to Follow-up|1|||
16277418|NCT01055886|39497118|FG001|Overall Study|Lost to Follow-up|1|||
16277419|NCT01055886|39497117|FG000|Overall Study|Withdrawal by PI|0|||
16277420|NCT01055886|39497118|FG001|Overall Study|Withdrawal by PI|1|||
16277421|NCT00721955|39497119|FG000|Overall Study|Adverse Event|0|||
16277422|NCT00721955|39497120|FG001|Overall Study|Adverse Event|0|||
16277423|NCT00721955|39497121|FG002|Overall Study|Adverse Event|2|||
16277424|NCT04428645|39497124|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
16277425|NCT04167618|39497129|FG000|Overall Study|Trial terminated by sponsor|1|||
16277426|NCT04167618|39497130|FG001|Overall Study|Trial terminated by sponsor|1|||
16277427|NCT04254809|39497138|FG000|Overall Study|Lost to Follow-up|5|||
16277428|NCT04254809|39497139|FG001|Overall Study|Lost to Follow-up|10|||
16277429|NCT01341587|39497140|FG000|Overall Study|Lost to Follow-up|2|||
16277430|NCT01341587|39497141|FG001|Overall Study|Lost to Follow-up|0|||
16277431|NCT01341587|39497140|FG000|Overall Study|stopped using the meters|2|||
16277432|NCT01341587|39497141|FG001|Overall Study|stopped using the meters|10|||
16277433|NCT00688844|39497148|FG000|Overall Study|Lost to Follow-up|10|||
16277434|NCT00301964|39497149|FG000|Overall Study|Second primary|2|||
16277435|NCT00301964|39497149|FG000|Overall Study|Wrong primary|1|||
16277436|NCT00301964|39497149|FG000|Overall Study|Inadequate pathology|1|||
16277437|NCT01451541|39497150|FG000|Overall Study|Adverse Event|4|||
16277438|NCT01451541|39497151|FG001|Overall Study|Adverse Event|3|||
16277439|NCT01451541|39497152|FG002|Overall Study|Adverse Event|6|||
16277440|NCT01451541|39497150|FG000|Overall Study|Lack of Efficacy|2|||
16277441|NCT01451541|39497151|FG001|Overall Study|Lack of Efficacy|0|||
16277442|NCT01451541|39497152|FG002|Overall Study|Lack of Efficacy|0|||
16277443|NCT01451541|39497150|FG000|Overall Study|Lost to Follow-up|4|||
16277444|NCT01451541|39497151|FG001|Overall Study|Lost to Follow-up|4|||
16277445|NCT01451541|39497152|FG002|Overall Study|Lost to Follow-up|7|||
16277446|NCT01451541|39497150|FG000|Overall Study|Withdrawal by Subject|15|||
16277447|NCT01451541|39497151|FG001|Overall Study|Withdrawal by Subject|8|||
16277448|NCT01451541|39497152|FG002|Overall Study|Withdrawal by Subject|6|||
16277449|NCT01451541|39497150|FG000|Overall Study|randomization error, noncompliance|11|||
16277450|NCT01451541|39497151|FG001|Overall Study|randomization error, noncompliance|10|||
16277451|NCT01451541|39497152|FG002|Overall Study|randomization error, noncompliance|8|||
16277452|NCT02462486|39497153|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
16375257|NCT01093573|39860103|FG000|Overall Study|Physician Decision|0|||
16375258|NCT01093573|39860104|FG001|Overall Study|Physician Decision|0|||
16375259|NCT01093573|39860105|FG002|Overall Study|Physician Decision|1|||
16375260|NCT01093573|39860103|FG000|Overall Study|Insurance Denied|0|||
16277453|NCT02462486|39497154|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
16277454|NCT02462486|39497155|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
16277455|NCT02462486|39497153|FG000|Overall Study|Adverse Event|53|||
16277456|NCT02462486|39497154|FG001|Overall Study|Adverse Event|48|||
16277457|NCT02462486|39497155|FG002|Overall Study|Adverse Event|21|||
16277458|NCT02462486|39497153|FG000|Overall Study|Lack of Efficacy|6|||
16277459|NCT02462486|39497154|FG001|Overall Study|Lack of Efficacy|12|||
16277460|NCT02462486|39497155|FG002|Overall Study|Lack of Efficacy|3|||
16277461|NCT02462486|39497153|FG000|Overall Study|Lost to Follow-up|3|||
16375261|NCT01093573|39860104|FG001|Overall Study|Insurance Denied|0|||
16375262|NCT01093573|39860105|FG002|Overall Study|Insurance Denied|1|||
16375263|NCT01529112|39860107|FG000|Overall Study|Adverse Event|2|||
16375264|NCT01529112|39860108|FG001|Overall Study|Adverse Event|0|||
16375265|NCT01529112|39860107|FG000|Overall Study|Death|59|||
16375266|NCT01529112|39860108|FG001|Overall Study|Death|38|||
16375267|NCT01529112|39860107|FG000|Overall Study|Protocol Violation|1|||
16375268|NCT01529112|39860108|FG001|Overall Study|Protocol Violation|0|||
16375269|NCT01529112|39860107|FG000|Overall Study|Withdrawal by Subject|7|||
16375270|NCT01529112|39860108|FG001|Overall Study|Withdrawal by Subject|3|||
16375271|NCT00993473|39860109|FG000|Overall Study|Adverse Event|0|||
16375272|NCT00993473|39860110|FG001|Overall Study|Adverse Event|2|||
16375273|NCT00993473|39860109|FG000|Overall Study|Protocol Violation|1|||
16375274|NCT00993473|39860110|FG001|Overall Study|Protocol Violation|2|||
16375275|NCT00993473|39860109|FG000|Overall Study|Lost to Follow-up|1|||
16375276|NCT00993473|39860110|FG001|Overall Study|Lost to Follow-up|0|||
16375277|NCT00993473|39860109|FG000|Overall Study|Withdrawal by Subject|1|||
16375278|NCT00993473|39860110|FG001|Overall Study|Withdrawal by Subject|5|||
16375279|NCT00993473|39860109|FG000|Overall Study|Technical problem with CGM device|0|||
16375280|NCT00993473|39860110|FG001|Overall Study|Technical problem with CGM device|1|||
16375281|NCT00993473|39860109|FG000|Overall Study|Family event|1|||
16375282|NCT00993473|39860110|FG001|Overall Study|Family event|0|||
16375283|NCT02991859|39860111|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375284|NCT02991859|39860112|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
16375285|NCT02991859|39860113|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375286|NCT02991859|39860114|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375287|NCT02991859|39860115|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
16375288|NCT02991859|39860116|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375289|NCT02991859|39860117|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16277462|NCT02462486|39497154|FG001|Overall Study|Lost to Follow-up|4|||
16277463|NCT02462486|39497155|FG002|Overall Study|Lost to Follow-up|2|||
16277464|NCT02462486|39497153|FG000|Overall Study|Withdrawal by Subject|25|||
16277465|NCT02462486|39497154|FG001|Overall Study|Withdrawal by Subject|22|||
16277466|NCT02462486|39497155|FG002|Overall Study|Withdrawal by Subject|19|||
16277467|NCT02462486|39497153|FG000|Overall Study|Protocol Violation|3|||
16375290|NCT02991859|39860118|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16277468|NCT02462486|39497154|FG001|Overall Study|Protocol Violation|1|||
16277469|NCT02462486|39497155|FG002|Overall Study|Protocol Violation|1|||
16277470|NCT02462486|39497153|FG000|Overall Study|Reason not Specified|3|||
16277471|NCT02462486|39497154|FG001|Overall Study|Reason not Specified|4|||
16277472|NCT02462486|39497155|FG002|Overall Study|Reason not Specified|3|||
16277473|NCT02664415|39497156|FG000|Overall Study|Adverse Event|1|||
16277474|NCT02664415|39497157|FG001|Overall Study|Adverse Event|0|||
16277475|NCT01073631|39497158|FG000|Overall Study|Death|82|||
16277476|NCT01073631|39497158|FG000|Overall Study|Adverse Event|24|||
16277477|NCT01073631|39497158|FG000|Overall Study|Other|63|||
16277478|NCT00089076|39497172|FG000|Overall Study|Alternate Therapy|1|||
16277479|NCT00089076|39497172|FG000|Overall Study|Withdrawal by Subject|2|||
16277480|NCT00089076|39497172|FG000|Overall Study|Progression|7|||
16277481|NCT02727192|39497174|FG000|Overall Study|Lost to Follow-up|1|||
16277482|NCT02727192|39497175|FG001|Overall Study|Lost to Follow-up|0|||
16277483|NCT02727192|39497176|FG002|Overall Study|Lost to Follow-up|0|||
16277484|NCT04449341|39497177|FG000|Overall Study|Protocol Violation|1|||
16277485|NCT04449341|39497178|FG001|Overall Study|Protocol Violation|0|||
16277486|NCT02906917|39497181|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
16277487|NCT02906917|39497182|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
16277488|NCT02906917|39497181|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
16277489|NCT02906917|39497182|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
16277490|NCT02906917|39497181|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
16277491|NCT02906917|39497182|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
16277492|NCT02906917|39497181|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
16277493|NCT02906917|39497182|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
16277494|NCT02906917|39497181|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
16277495|NCT02906917|39497182|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
16277496|NCT02906917|39497181|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
16277497|NCT02906917|39497182|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
16277498|NCT02906917|39497181|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
16277499|NCT02906917|39497182|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
16277500|NCT02906917|39497181|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
16277501|NCT02906917|39497182|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
16277502|NCT04482647|39497183|FG000|Overall Study|Time constraints|2|||
16277503|NCT04482647|39497183|FG000|Overall Study|Health issues|1|||
16277504|NCT04482647|39497183|FG000|Overall Study|Death in the family|1|||
16277505|NCT04482647|39497183|FG000|Overall Study|Disliked the intervention|1|||
16375291|NCT02991859|39860119|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16277506|NCT04482647|39497183|FG000|Overall Study|No reasons specified|7|||
16277507|NCT01824576|39497187|FG000|Overall Study|Device deficiency|2|||
16277508|NCT01023061|39497190|FG000|Overall Study|Withdrawal prior to treatment|2|||
16277509|NCT00683592|39497191|FG000|Overall Study|Adverse Event|12|||
16375292|NCT02991859|39860120|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375293|NCT02991859|39860121|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375294|NCT02991859|39860122|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375295|NCT02991859|39860123|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375296|NCT02991859|39860124|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375297|NCT02991859|39860125|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375298|NCT02991859|39860126|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375299|NCT02991859|39860127|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
16375300|NCT02991859|39860111|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375301|NCT02991859|39860112|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375302|NCT02991859|39860113|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375303|NCT02991859|39860114|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375304|NCT02991859|39860115|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375305|NCT02991859|39860116|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375306|NCT02991859|39860117|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375307|NCT02991859|39860118|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375308|NCT02991859|39860119|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375309|NCT02991859|39860120|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375310|NCT02991859|39860121|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16277510|NCT00683592|39497192|FG001|Overall Study|Adverse Event|4|||
16277511|NCT00683592|39497191|FG000|Overall Study|Withdrawal by Subject|11|||
16277512|NCT00683592|39497192|FG001|Overall Study|Withdrawal by Subject|11|||
16277513|NCT00683592|39497191|FG000|Overall Study|Lost to Follow-up|17|||
16277514|NCT00683592|39497192|FG001|Overall Study|Lost to Follow-up|17|||
16277515|NCT00683592|39497191|FG000|Overall Study|Lack of Efficacy|3|||
16277516|NCT00683592|39497192|FG001|Overall Study|Lack of Efficacy|7|||
16277517|NCT00683592|39497191|FG000|Overall Study|Physician Decision|0|||
16277518|NCT00683592|39497192|FG001|Overall Study|Physician Decision|1|||
16277519|NCT00683592|39497191|FG000|Overall Study|Non-compliance|3|||
16277520|NCT00683592|39497192|FG001|Overall Study|Non-compliance|5|||
16277521|NCT00683592|39497191|FG000|Overall Study|Other|1|||
16277522|NCT00683592|39497192|FG001|Overall Study|Other|1|||
16277523|NCT03496298|39497197|FG000|Overall Study|Adverse Event|49|||
16277524|NCT03496298|39497198|FG001|Overall Study|Adverse Event|68|||
16277525|NCT03496298|39497199|FG002|Overall Study|Adverse Event|79|||
16277526|NCT03496298|39497197|FG000|Overall Study|Study terminated by Sponsor|1050|||
16277527|NCT03496298|39497198|FG001|Overall Study|Study terminated by Sponsor|1063|||
16277528|NCT03496298|39497199|FG002|Overall Study|Study terminated by Sponsor|1071|||
16277529|NCT03496298|39497197|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
16277530|NCT03496298|39497198|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
16277531|NCT03496298|39497199|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
16277532|NCT03496298|39497197|FG000|Overall Study|Withdrawal by Subject|176|||
16277533|NCT03496298|39497198|FG001|Overall Study|Withdrawal by Subject|154|||
16277534|NCT03496298|39497199|FG002|Overall Study|Withdrawal by Subject|151|||
16277535|NCT03496298|39497197|FG000|Overall Study|Other|29|||
16277536|NCT03496298|39497198|FG001|Overall Study|Other|20|||
16277537|NCT03496298|39497199|FG002|Overall Study|Other|23|||
16277538|NCT03496298|39497197|FG000|Overall Study|Randomized and not treated|1|||
16277539|NCT03496298|39497198|FG001|Overall Study|Randomized and not treated|1|||
16277540|NCT03496298|39497199|FG002|Overall Study|Randomized and not treated|1|||
16277541|NCT02805309|39497200|FG000|Overall Study|Lost to Follow-up|2|||
16277542|NCT02805309|39497201|FG001|Overall Study|Lost to Follow-up|2|||
16277543|NCT02805309|39497202|FG002|Overall Study|Lost to Follow-up|2|||
16277544|NCT02805309|39497200|FG000|Overall Study|Post-Randomization Exclusion|0|||
16277545|NCT02805309|39497201|FG001|Overall Study|Post-Randomization Exclusion|2|||
16277546|NCT02805309|39497202|FG002|Overall Study|Post-Randomization Exclusion|1|||
16277547|NCT03303417|39497207|FG000|Overall Study|Withdrawal by Subject|1|||
16277548|NCT03303417|39497208|FG001|Overall Study|Withdrawal by Subject|1|||
16277549|NCT00820599|39497209|FG000|Overall Study|Death|129|||
16277550|NCT00820599|39497209|FG000|Overall Study|Withdrawal by Subject|2|||
16277551|NCT01011335|39497210|FG000|Overall Study|Lost to Follow-up|0|||
16277552|NCT01011335|39497211|FG001|Overall Study|Lost to Follow-up|0|||
16277553|NCT01011335|39497212|FG002|Overall Study|Lost to Follow-up|1|||
16277554|NCT01011335|39497213|FG003|Overall Study|Lost to Follow-up|1|||
16277555|NCT01011335|39497214|FG004|Overall Study|Lost to Follow-up|1|||
16277556|NCT01011335|39497215|FG005|Overall Study|Lost to Follow-up|1|||
16375311|NCT02991859|39860122|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375312|NCT02991859|39860123|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
16375313|NCT02991859|39860124|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
16375314|NCT02991859|39860125|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375315|NCT02991859|39860126|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375316|NCT02991859|39860127|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
16375317|NCT02991859|39860111|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375318|NCT02991859|39860112|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375319|NCT02991859|39860113|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375320|NCT02991859|39860114|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375321|NCT02991859|39860115|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375322|NCT02991859|39860116|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
16375323|NCT02991859|39860117|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375324|NCT02991859|39860118|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375325|NCT02991859|39860119|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375326|NCT02991859|39860120|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375327|NCT02991859|39860121|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375328|NCT02991859|39860122|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375329|NCT02991859|39860123|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375330|NCT02991859|39860124|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375331|NCT02991859|39860125|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375332|NCT02991859|39860126|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375333|NCT02991859|39860127|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
16375334|NCT02991859|39860111|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375335|NCT02991859|39860112|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375336|NCT02991859|39860113|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375337|NCT02991859|39860114|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375338|NCT02991859|39860115|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375339|NCT02991859|39860116|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375340|NCT02991859|39860117|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375341|NCT02991859|39860118|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375342|NCT02991859|39860119|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375343|NCT02991859|39860120|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
16375344|NCT02991859|39860121|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375345|NCT02991859|39860122|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375346|NCT02991859|39860123|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375347|NCT02991859|39860124|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375348|NCT02991859|39860125|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375349|NCT02991859|39860126|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375350|NCT02991859|39860127|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
16375351|NCT02991859|39860111|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375352|NCT02991859|39860112|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375353|NCT02991859|39860113|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375354|NCT02991859|39860114|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375355|NCT02991859|39860115|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375356|NCT02991859|39860116|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375357|NCT02991859|39860117|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375358|NCT02991859|39860118|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375359|NCT02991859|39860119|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
16375360|NCT02991859|39860120|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375361|NCT02991859|39860121|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375362|NCT02991859|39860122|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375363|NCT02991859|39860123|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375364|NCT02991859|39860124|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375365|NCT02991859|39860125|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375366|NCT02991859|39860126|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375367|NCT02991859|39860127|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
16375368|NCT01386645|39860130|FG000|Overall Study|Physician Decision|0|||
16375369|NCT01386645|39860131|FG001|Overall Study|Physician Decision|0|||
16375370|NCT01386645|39860132|FG002|Overall Study|Physician Decision|1|||
16375371|NCT01386645|39860130|FG000|Overall Study|Withdrawal by Subject|0|||
16375372|NCT01386645|39860131|FG001|Overall Study|Withdrawal by Subject|1|||
16375373|NCT01386645|39860132|FG002|Overall Study|Withdrawal by Subject|1|||
16375374|NCT03111108|39860133|FG000|Overall Study|Death|0|||
16375375|NCT03111108|39860134|FG001|Overall Study|Death|1|||
16375376|NCT03111108|39860133|FG000|Overall Study|Withdrawal by Subject|1|||
16375377|NCT03111108|39860134|FG001|Overall Study|Withdrawal by Subject|0|||
16375378|NCT01050218|39860140|FG000|Overall Study|Adverse Event|37|||
16375379|NCT01050218|39860140|FG000|Overall Study|Lack of Efficacy|8|||
16375380|NCT01050218|39860140|FG000|Overall Study|Protocol Violation|3|||
16375381|NCT01050218|39860140|FG000|Overall Study|Withdrawal by Subject|18|||
16375382|NCT01050218|39860140|FG000|Overall Study|Discontinued by sponsor|18|||
16375383|NCT01050218|39860140|FG000|Overall Study|Compliance|2|||
16375384|NCT01050218|39860140|FG000|Overall Study|Failed to return|7|||
16375385|NCT01050218|39860140|FG000|Overall Study|Serious Adverse Event|1|||
16375386|NCT01050218|39860140|FG000|Overall Study|Family emergency|1|||
16375387|NCT00069953|39860141|FG000|Overall Study|Protocol Violation|2|||
16375388|NCT00397046|39860144|FG000|Overall Study|Disease Progression|3|||
16375389|NCT00397046|39860145|FG001|Overall Study|Disease Progression|3|||
16375390|NCT00397046|39860146|FG002|Overall Study|Disease Progression|10|||
16375391|NCT00397046|39860147|FG003|Overall Study|Disease Progression|5|||
16375392|NCT04755231|39860149|FG000|Overall Study|Lost to Follow-up|5|||
16375393|NCT04755231|39860149|FG000|Overall Study|Withdrawal by Subject|5|||
16375394|NCT02489045|39860150|FG000|Overall Study|unable to collect usable data|53|||
16375395|NCT02489045|39860150|FG000|Follow-up|Lost to Follow-up|10|||
16375396|NCT02414841|39860151|FG000|Overall Study|Withdrawal by Subject|7|||
16375397|NCT02414841|39860152|FG001|Overall Study|Withdrawal by Subject|5|||
16375398|NCT02414841|39860151|FG000|Overall Study|Lost to Follow-up|13|||
16375399|NCT02414841|39860152|FG001|Overall Study|Lost to Follow-up|6|||
16375400|NCT02414841|39860151|FG000|Overall Study|Death|17|||
16375401|NCT02414841|39860152|FG001|Overall Study|Death|14|||
16375402|NCT02414841|39860151|FG000|Overall Study|Received a Kidney Transplant|13|||
16375403|NCT02414841|39860152|FG001|Overall Study|Received a Kidney Transplant|4|||
16375404|NCT02414841|39860151|FG000|Overall Study|Randomized But Not Treated|6|||
16375405|NCT02414841|39860152|FG001|Overall Study|Randomized But Not Treated|4|||
16375406|NCT02633527|39860155|FG000|Overall Study|Failed to meet eligibility|0|||
16375407|NCT02633527|39860156|FG001|Overall Study|Failed to meet eligibility|1|||
16375408|NCT02633527|39860157|FG002|Overall Study|Failed to meet eligibility|1|||
16375409|NCT02633527|39860158|FG003|Overall Study|Failed to meet eligibility|0|||
16375410|NCT02633527|39860159|FG004|Overall Study|Failed to meet eligibility|1|||
16375411|NCT02633527|39860155|FG000|Overall Study|Adverse Event|0|||
16375412|NCT02633527|39860156|FG001|Overall Study|Adverse Event|4|||
16375413|NCT02633527|39860157|FG002|Overall Study|Adverse Event|3|||
16375414|NCT02633527|39860158|FG003|Overall Study|Adverse Event|1|||
16375415|NCT02633527|39860159|FG004|Overall Study|Adverse Event|5|||
16375416|NCT02633527|39860155|FG000|Overall Study|Lost to Follow-up|1|||
16375417|NCT02633527|39860156|FG001|Overall Study|Lost to Follow-up|2|||
16375418|NCT02633527|39860157|FG002|Overall Study|Lost to Follow-up|5|||
16375419|NCT02633527|39860158|FG003|Overall Study|Lost to Follow-up|5|||
16375420|NCT02633527|39860159|FG004|Overall Study|Lost to Follow-up|4|||
16375421|NCT02633527|39860155|FG000|Overall Study|Withdrawal by Subject|0|||
16375422|NCT02633527|39860156|FG001|Overall Study|Withdrawal by Subject|3|||
16375423|NCT02633527|39860157|FG002|Overall Study|Withdrawal by Subject|5|||
16375424|NCT02633527|39860158|FG003|Overall Study|Withdrawal by Subject|4|||
16375425|NCT02633527|39860159|FG004|Overall Study|Withdrawal by Subject|4|||
16375426|NCT02633527|39860155|FG000|Overall Study|Protocol Violation|0|||
16375427|NCT02633527|39860156|FG001|Overall Study|Protocol Violation|1|||
16375428|NCT02633527|39860157|FG002|Overall Study|Protocol Violation|1|||
16375429|NCT02633527|39860158|FG003|Overall Study|Protocol Violation|1|||
16375430|NCT02633527|39860159|FG004|Overall Study|Protocol Violation|1|||
16375431|NCT02633527|39860155|FG000|Overall Study|Physician Decision|0|||
16375432|NCT02633527|39860156|FG001|Overall Study|Physician Decision|0|||
16375433|NCT02633527|39860157|FG002|Overall Study|Physician Decision|0|||
16375434|NCT02633527|39860158|FG003|Overall Study|Physician Decision|0|||
16375435|NCT02633527|39860159|FG004|Overall Study|Physician Decision|1|||
16375436|NCT02633527|39860155|FG000|Overall Study|Administrative reason|1|||
16375437|NCT02633527|39860156|FG001|Overall Study|Administrative reason|0|||
16375438|NCT02633527|39860157|FG002|Overall Study|Administrative reason|0|||
16375439|NCT02633527|39860158|FG003|Overall Study|Administrative reason|1|||
16375440|NCT02633527|39860159|FG004|Overall Study|Administrative reason|0|||
16375441|NCT02633527|39860155|FG000|Overall Study|Multiple reasons|1|||
16375442|NCT02633527|39860156|FG001|Overall Study|Multiple reasons|0|||
16375443|NCT02633527|39860157|FG002|Overall Study|Multiple reasons|2|||
16375444|NCT02633527|39860158|FG003|Overall Study|Multiple reasons|2|||
16375445|NCT02633527|39860159|FG004|Overall Study|Multiple reasons|1|||
16375446|NCT00912509|39860163|FG000|Overall Study|Lost to Follow-up|1|||
16375447|NCT00912509|39860164|FG001|Overall Study|Lost to Follow-up|0|||
16375448|NCT00912509|39860163|FG000|Overall Study|Lack of Efficacy|4|||
16375449|NCT00912509|39860164|FG001|Overall Study|Lack of Efficacy|3|||
16375450|NCT01093534|39860165|FG000|Overall Study|Adverse Event|2|||
16375451|NCT01093534|39860166|FG001|Overall Study|Adverse Event|5|||
16375452|NCT01093534|39860167|FG002|Overall Study|Adverse Event|2|||
16375453|NCT01093534|39860165|FG000|Overall Study|Lack of Efficacy|2|||
16375454|NCT01093534|39860166|FG001|Overall Study|Lack of Efficacy|1|||
16375455|NCT01093534|39860167|FG002|Overall Study|Lack of Efficacy|1|||
16375456|NCT01093534|39860165|FG000|Overall Study|Withdrawal by Subject|5|||
16375457|NCT01093534|39860166|FG001|Overall Study|Withdrawal by Subject|7|||
16375458|NCT01093534|39860167|FG002|Overall Study|Withdrawal by Subject|2|||
16375459|NCT01093534|39860165|FG000|Overall Study|Other|1|||
16375460|NCT01093534|39860166|FG001|Overall Study|Other|3|||
16375461|NCT01093534|39860167|FG002|Overall Study|Other|4|||
16375462|NCT00913835|39860168|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
16375463|NCT00913835|39860169|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
16375464|NCT00913835|39860168|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
16375465|NCT00913835|39860169|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
16375466|NCT00913835|39860168|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
16375467|NCT00913835|39860169|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
16375468|NCT00913835|39860168|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
16375469|NCT00913835|39860169|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
16375470|NCT00913835|39860168|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
16375471|NCT00913835|39860169|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
16375472|NCT01959919|39860170|FG000|Overall Study|Did not meet the eligibility criteria|2|||
16375473|NCT00480025|39860171|FG000|Overall Study|Protocol Violation|12|||
16375474|NCT00480025|39860172|FG001|Overall Study|Protocol Violation|7|||
16375475|NCT00480025|39860171|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
16375476|NCT00480025|39860172|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
16375477|NCT00480025|39860171|FG000|Overall Study|Disease Progression / Recurrence|449|||
16375478|NCT00480025|39860172|FG001|Overall Study|Disease Progression / Recurrence|224|||
16375479|NCT00480025|39860171|FG000|Overall Study|Adverse Event|44|||
16375480|NCT00480025|39860172|FG001|Overall Study|Adverse Event|12|||
16375481|NCT00480025|39860171|FG000|Overall Study|Other|70|||
16375482|NCT00480025|39860172|FG001|Overall Study|Other|29|||
16375483|NCT00480025|39860171|FG000|Overall Study|SAE including intercurrent illness|76|||
16375484|NCT00480025|39860172|FG001|Overall Study|SAE including intercurrent illness|42|||
16375485|NCT01217047|39860174|FG000|Overall Study|Lost to Follow-up|0|||
16375486|NCT01217047|39860175|FG001|Overall Study|Lost to Follow-up|1|||
16375487|NCT01217047|39860176|FG002|Overall Study|Lost to Follow-up|0|||
16375488|NCT01335685|39860179|FG000|Overall Study|Study Terminated by Sponsor|2|||
16375489|NCT01335685|39860180|FG001|Overall Study|Study Terminated by Sponsor|1|||
16375490|NCT01335685|39860181|FG002|Overall Study|Study Terminated by Sponsor|1|||
16375491|NCT01335685|39860182|FG003|Overall Study|Study Terminated by Sponsor|10|||
16375492|NCT01335685|39860183|FG004|Overall Study|Study Terminated by Sponsor|0|||
16375493|NCT01335685|39860184|FG005|Overall Study|Study Terminated by Sponsor|4|||
16375494|NCT01335685|39860185|FG006|Overall Study|Study Terminated by Sponsor|2|||
16375495|NCT01335685|39860186|FG007|Overall Study|Study Terminated by Sponsor|3|||
16375496|NCT01335685|39860179|FG000|Overall Study|Withdrawal by Subject|1|||
16375497|NCT01335685|39860180|FG001|Overall Study|Withdrawal by Subject|0|||
16375498|NCT01335685|39860181|FG002|Overall Study|Withdrawal by Subject|0|||
16375499|NCT01335685|39860182|FG003|Overall Study|Withdrawal by Subject|1|||
16375500|NCT01335685|39860183|FG004|Overall Study|Withdrawal by Subject|0|||
16375501|NCT01335685|39860184|FG005|Overall Study|Withdrawal by Subject|0|||
16375502|NCT01335685|39860185|FG006|Overall Study|Withdrawal by Subject|0|||
16375503|NCT01335685|39860186|FG007|Overall Study|Withdrawal by Subject|0|||
16375504|NCT01335685|39860179|FG000|Overall Study|Reason not Specified|0|||
16375505|NCT01335685|39860180|FG001|Overall Study|Reason not Specified|0|||
16375506|NCT01335685|39860181|FG002|Overall Study|Reason not Specified|1|||
16375507|NCT01335685|39860182|FG003|Overall Study|Reason not Specified|0|||
16375508|NCT01335685|39860183|FG004|Overall Study|Reason not Specified|0|||
16375509|NCT01335685|39860184|FG005|Overall Study|Reason not Specified|1|||
16375510|NCT01335685|39860185|FG006|Overall Study|Reason not Specified|0|||
16375511|NCT01335685|39860186|FG007|Overall Study|Reason not Specified|0|||
16375512|NCT04126174|39860192|FG000|Overall Study|Lost to Follow-up|3|||
16375513|NCT04126174|39860193|FG001|Overall Study|Lost to Follow-up|3|||
16375514|NCT04076579|39860194|FG000|Overall Study|Adverse Event|2|||
16375515|NCT04076579|39860195|FG001|Overall Study|Adverse Event|0|||
16375516|NCT04076579|39860194|FG000|Overall Study|discontinued due to toxicity|1|||
16375517|NCT04076579|39860195|FG001|Overall Study|discontinued due to toxicity|0|||
16375518|NCT04076579|39860194|FG000|Overall Study|Physician Decision|1|||
16375519|NCT04076579|39860195|FG001|Overall Study|Physician Decision|0|||
16375520|NCT04076579|39860194|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
16375521|NCT04076579|39860195|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
16375522|NCT04076579|39860194|FG000|Overall Study|Noncompliance|0|||
16375523|NCT04076579|39860195|FG001|Overall Study|Noncompliance|1|||
16375524|NCT04076579|39860194|FG000|Overall Study|Withdrawal by Subject|0|||
16375525|NCT04076579|39860195|FG001|Overall Study|Withdrawal by Subject|2|||
16375526|NCT00617903|39860196|FG000|Overall Study|Withdrawal by Subject|2|||
16375527|NCT00617903|39860197|FG001|Overall Study|Withdrawal by Subject|3|||
16375528|NCT00617903|39860196|FG000|Overall Study|Lost to Follow-up|1|||
16375529|NCT00617903|39860197|FG001|Overall Study|Lost to Follow-up|1|||
16375530|NCT00617903|39860196|FG000|Overall Study|Lack of Efficacy|0|||
16375531|NCT00617903|39860197|FG001|Overall Study|Lack of Efficacy|1|||
16375532|NCT00617903|39860196|FG000|Overall Study|Adverse Event|0|||
16375533|NCT00617903|39860197|FG001|Overall Study|Adverse Event|1|||
16375534|NCT00617903|39860196|FG000|Overall Study|noncompliance|0|||
16375535|NCT00617903|39860197|FG001|Overall Study|noncompliance|1|||
16375536|NCT02402907|39860201|FG000|Overall Study|Delivered vaginally|9|||
16375537|NCT02402907|39860202|FG001|Overall Study|Delivered vaginally|3|||
16375538|NCT02402907|39860201|FG000|Overall Study|Delivered outside of Sinai|1|||
16375539|NCT02402907|39860202|FG001|Overall Study|Delivered outside of Sinai|1|||
16375540|NCT02402907|39860201|FG000|Overall Study|Lost to follow up after C-Section|10|||
16375541|NCT02402907|39860202|FG001|Overall Study|Lost to follow up after C-Section|23|||
16375542|NCT03715829|39860203|FG000|Dose Ranging Period|Adverse Event|2|||
16375543|NCT03715829|39860204|FG001|Dose Ranging Period|Adverse Event|4|||
16375544|NCT03715829|39860205|FG002|Dose Ranging Period|Adverse Event|5|||
16375545|NCT03715829|39860206|FG003|Dose Ranging Period|Adverse Event|2|||
16375546|NCT03715829|39860207|FG004|Dose Ranging Period|Adverse Event|3|||
16375547|NCT03715829|39860208|FG005|Dose Ranging Period|Adverse Event|3|||
16375548|NCT03715829|39860209|FG006|Dose Ranging Period|Adverse Event|0|||
16375549|NCT03715829|39860210|FG007|Dose Ranging Period|Adverse Event|0|||
16375550|NCT03715829|39860211|FG008|Dose Ranging Period|Adverse Event|0|||
16375551|NCT03715829|39860212|FG009|Dose Ranging Period|Adverse Event|0|||
16375552|NCT03715829|39860213|FG010|Dose Ranging Period|Adverse Event|0|||
16375553|NCT03715829|39860203|FG000|Dose Ranging Period|Lack of Efficacy|0|||
16375554|NCT03715829|39860204|FG001|Dose Ranging Period|Lack of Efficacy|1|||
16375555|NCT03715829|39860205|FG002|Dose Ranging Period|Lack of Efficacy|0|||
16375556|NCT03715829|39860206|FG003|Dose Ranging Period|Lack of Efficacy|1|||
16375557|NCT03715829|39860207|FG004|Dose Ranging Period|Lack of Efficacy|0|||
16375558|NCT03715829|39860208|FG005|Dose Ranging Period|Lack of Efficacy|0|||
16375559|NCT03715829|39860209|FG006|Dose Ranging Period|Lack of Efficacy|0|||
16375560|NCT03715829|39860210|FG007|Dose Ranging Period|Lack of Efficacy|0|||
16375561|NCT03715829|39860211|FG008|Dose Ranging Period|Lack of Efficacy|0|||
16375562|NCT03715829|39860212|FG009|Dose Ranging Period|Lack of Efficacy|0|||
16375563|NCT03715829|39860213|FG010|Dose Ranging Period|Lack of Efficacy|0|||
16375564|NCT03715829|39860203|FG000|Dose Ranging Period|Lost to Follow-up|2|||
16375565|NCT03715829|39860204|FG001|Dose Ranging Period|Lost to Follow-up|0|||
16375566|NCT03715829|39860205|FG002|Dose Ranging Period|Lost to Follow-up|1|||
16375567|NCT03715829|39860206|FG003|Dose Ranging Period|Lost to Follow-up|1|||
16375568|NCT03715829|39860207|FG004|Dose Ranging Period|Lost to Follow-up|1|||
16375569|NCT03715829|39860208|FG005|Dose Ranging Period|Lost to Follow-up|2|||
16375570|NCT03715829|39860209|FG006|Dose Ranging Period|Lost to Follow-up|0|||
16375571|NCT03715829|39860210|FG007|Dose Ranging Period|Lost to Follow-up|0|||
16375572|NCT03715829|39860211|FG008|Dose Ranging Period|Lost to Follow-up|0|||
16375573|NCT03715829|39860212|FG009|Dose Ranging Period|Lost to Follow-up|0|||
16375574|NCT03715829|39860213|FG010|Dose Ranging Period|Lost to Follow-up|0|||
16375575|NCT03715829|39860203|FG000|Dose Ranging Period|Protocol Violation|0|||
16375576|NCT03715829|39860204|FG001|Dose Ranging Period|Protocol Violation|0|||
16375577|NCT03715829|39860205|FG002|Dose Ranging Period|Protocol Violation|0|||
16375578|NCT03715829|39860206|FG003|Dose Ranging Period|Protocol Violation|1|||
16375579|NCT03715829|39860207|FG004|Dose Ranging Period|Protocol Violation|0|||
16375580|NCT03715829|39860208|FG005|Dose Ranging Period|Protocol Violation|0|||
16375581|NCT03715829|39860209|FG006|Dose Ranging Period|Protocol Violation|0|||
16375582|NCT03715829|39860210|FG007|Dose Ranging Period|Protocol Violation|0|||
16375583|NCT03715829|39860211|FG008|Dose Ranging Period|Protocol Violation|0|||
16375584|NCT03715829|39860212|FG009|Dose Ranging Period|Protocol Violation|0|||
16375585|NCT03715829|39860213|FG010|Dose Ranging Period|Protocol Violation|0|||
16375586|NCT03715829|39860203|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
16375587|NCT03715829|39860204|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
16375588|NCT03715829|39860205|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
16375589|NCT03715829|39860206|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
16375590|NCT03715829|39860207|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
16375591|NCT03715829|39860208|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
16375592|NCT03715829|39860209|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
16375593|NCT03715829|39860210|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
16375594|NCT03715829|39860211|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
16375595|NCT03715829|39860212|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
16375596|NCT03715829|39860213|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
16375597|NCT03715829|39860203|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16375598|NCT03715829|39860204|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16375599|NCT03715829|39860205|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
16375600|NCT03715829|39860206|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16375601|NCT03715829|39860207|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16375602|NCT03715829|39860208|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16375603|NCT03715829|39860209|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16375604|NCT03715829|39860210|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16375605|NCT03715829|39860211|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16375606|NCT03715829|39860212|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16375607|NCT03715829|39860213|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
16375608|NCT03715829|39860203|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16375609|NCT03715829|39860204|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16375610|NCT03715829|39860205|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
16375611|NCT03715829|39860206|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16375612|NCT03715829|39860207|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
16375613|NCT03715829|39860208|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16375614|NCT03715829|39860209|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16375615|NCT03715829|39860210|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16375616|NCT03715829|39860211|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16375617|NCT03715829|39860212|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16375618|NCT03715829|39860213|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
16375619|NCT03715829|39860203|FG000|Dose Ranging Period|Other|0|||
16375620|NCT03715829|39860204|FG001|Dose Ranging Period|Other|0|||
16375621|NCT03715829|39860205|FG002|Dose Ranging Period|Other|2|||
16375622|NCT03715829|39860206|FG003|Dose Ranging Period|Other|0|||
16375623|NCT03715829|39860207|FG004|Dose Ranging Period|Other|0|||
16375624|NCT03715829|39860208|FG005|Dose Ranging Period|Other|3|||
16375625|NCT03715829|39860209|FG006|Dose Ranging Period|Other|0|||
16375626|NCT03715829|39860210|FG007|Dose Ranging Period|Other|0|||
16375627|NCT03715829|39860211|FG008|Dose Ranging Period|Other|0|||
16375628|NCT03715829|39860212|FG009|Dose Ranging Period|Other|0|||
16375629|NCT03715829|39860213|FG010|Dose Ranging Period|Other|0|||
16375630|NCT03715829|39860203|FG000|Extension Period|Adverse Event|0|||
16375631|NCT03715829|39860204|FG001|Extension Period|Adverse Event|0|||
16375632|NCT03715829|39860205|FG002|Extension Period|Adverse Event|0|||
16375633|NCT03715829|39860206|FG003|Extension Period|Adverse Event|0|||
16375634|NCT03715829|39860207|FG004|Extension Period|Adverse Event|0|||
16375635|NCT03715829|39860208|FG005|Extension Period|Adverse Event|0|||
16375636|NCT03715829|39860209|FG006|Extension Period|Adverse Event|3|||
16375637|NCT03715829|39860210|FG007|Extension Period|Adverse Event|1|||
16375638|NCT03715829|39860211|FG008|Extension Period|Adverse Event|6|||
16375639|NCT03715829|39860212|FG009|Extension Period|Adverse Event|0|||
16375640|NCT03715829|39860213|FG010|Extension Period|Adverse Event|0|||
16375641|NCT03715829|39860203|FG000|Extension Period|Lack of Efficacy|0|||
16375642|NCT03715829|39860204|FG001|Extension Period|Lack of Efficacy|0|||
16375643|NCT03715829|39860205|FG002|Extension Period|Lack of Efficacy|0|||
16375644|NCT03715829|39860206|FG003|Extension Period|Lack of Efficacy|0|||
16375645|NCT03715829|39860207|FG004|Extension Period|Lack of Efficacy|0|||
16375646|NCT03715829|39860208|FG005|Extension Period|Lack of Efficacy|0|||
16375647|NCT03715829|39860209|FG006|Extension Period|Lack of Efficacy|1|||
16375648|NCT03715829|39860210|FG007|Extension Period|Lack of Efficacy|9|||
16375649|NCT03715829|39860211|FG008|Extension Period|Lack of Efficacy|2|||
16375650|NCT03715829|39860212|FG009|Extension Period|Lack of Efficacy|0|||
16375651|NCT03715829|39860213|FG010|Extension Period|Lack of Efficacy|0|||
16375652|NCT03715829|39860203|FG000|Extension Period|Lost to Follow-up|0|||
16375653|NCT03715829|39860204|FG001|Extension Period|Lost to Follow-up|0|||
16375654|NCT03715829|39860205|FG002|Extension Period|Lost to Follow-up|0|||
16375655|NCT03715829|39860206|FG003|Extension Period|Lost to Follow-up|0|||
16375656|NCT03715829|39860207|FG004|Extension Period|Lost to Follow-up|0|||
16375657|NCT03715829|39860208|FG005|Extension Period|Lost to Follow-up|0|||
16375658|NCT03715829|39860209|FG006|Extension Period|Lost to Follow-up|0|||
16375659|NCT03715829|39860210|FG007|Extension Period|Lost to Follow-up|0|||
16375660|NCT03715829|39860211|FG008|Extension Period|Lost to Follow-up|2|||
16375661|NCT03715829|39860212|FG009|Extension Period|Lost to Follow-up|0|||
16375662|NCT03715829|39860213|FG010|Extension Period|Lost to Follow-up|0|||
16375663|NCT03715829|39860203|FG000|Extension Period|Protocol Violation|0|||
16375664|NCT03715829|39860204|FG001|Extension Period|Protocol Violation|0|||
16375665|NCT03715829|39860205|FG002|Extension Period|Protocol Violation|0|||
16375666|NCT03715829|39860206|FG003|Extension Period|Protocol Violation|0|||
16375667|NCT03715829|39860207|FG004|Extension Period|Protocol Violation|0|||
16375668|NCT03715829|39860208|FG005|Extension Period|Protocol Violation|0|||
16375669|NCT03715829|39860209|FG006|Extension Period|Protocol Violation|0|||
16375670|NCT03715829|39860210|FG007|Extension Period|Protocol Violation|0|||
16375671|NCT03715829|39860211|FG008|Extension Period|Protocol Violation|1|||
16375672|NCT03715829|39860212|FG009|Extension Period|Protocol Violation|0|||
16375673|NCT03715829|39860213|FG010|Extension Period|Protocol Violation|0|||
16375674|NCT03715829|39860203|FG000|Extension Period|Withdrawal by Subject|0|||
16375675|NCT03715829|39860204|FG001|Extension Period|Withdrawal by Subject|0|||
16375676|NCT03715829|39860205|FG002|Extension Period|Withdrawal by Subject|0|||
16375677|NCT03715829|39860206|FG003|Extension Period|Withdrawal by Subject|0|||
16375678|NCT03715829|39860207|FG004|Extension Period|Withdrawal by Subject|0|||
16375679|NCT03715829|39860208|FG005|Extension Period|Withdrawal by Subject|0|||
16375680|NCT03715829|39860209|FG006|Extension Period|Withdrawal by Subject|3|||
16375681|NCT03715829|39860210|FG007|Extension Period|Withdrawal by Subject|3|||
16375682|NCT03715829|39860211|FG008|Extension Period|Withdrawal by Subject|12|||
16375683|NCT03715829|39860212|FG009|Extension Period|Withdrawal by Subject|3|||
16375684|NCT03715829|39860213|FG010|Extension Period|Withdrawal by Subject|0|||
16375685|NCT03715829|39860203|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
16375686|NCT03715829|39860204|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
16375687|NCT03715829|39860205|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
16375688|NCT03715829|39860206|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
16375689|NCT03715829|39860207|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
16375690|NCT03715829|39860208|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
16375691|NCT03715829|39860209|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
16375692|NCT03715829|39860210|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
16375693|NCT03715829|39860211|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
16375694|NCT03715829|39860212|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
16375695|NCT03715829|39860213|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
16375696|NCT03715829|39860203|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
16375697|NCT03715829|39860204|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
16375698|NCT03715829|39860205|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
16375699|NCT03715829|39860206|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
16375700|NCT03715829|39860207|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
16375701|NCT03715829|39860208|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
16375702|NCT03715829|39860209|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
16375703|NCT03715829|39860210|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
16375704|NCT03715829|39860211|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
16375705|NCT03715829|39860212|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
16375706|NCT03715829|39860213|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
16375707|NCT03715829|39860203|FG000|Extension Period|Other|0|||
16375708|NCT03715829|39860204|FG001|Extension Period|Other|0|||
16375709|NCT03715829|39860205|FG002|Extension Period|Other|0|||
16375710|NCT03715829|39860206|FG003|Extension Period|Other|0|||
16375711|NCT03715829|39860207|FG004|Extension Period|Other|0|||
16375712|NCT03715829|39860208|FG005|Extension Period|Other|0|||
16375713|NCT03715829|39860209|FG006|Extension Period|Other|1|||
16375714|NCT03715829|39860210|FG007|Extension Period|Other|2|||
16375715|NCT03715829|39860211|FG008|Extension Period|Other|4|||
16375716|NCT03715829|39860212|FG009|Extension Period|Other|0|||
16375717|NCT03715829|39860213|FG010|Extension Period|Other|0|||
16375718|NCT03048019|39860214|FG000|Overall Study|Adverse Event|1|||
16375719|NCT03048019|39860215|FG001|Overall Study|Adverse Event|0|||
16375720|NCT03794544|39860216|FG000|Overall Study|Withdrawal by Subject|1|||
16375721|NCT03794544|39860217|FG001|Overall Study|Withdrawal by Subject|1|||
16375722|NCT03794544|39860218|FG002|Overall Study|Withdrawal by Subject|0|||
16375723|NCT03794544|39860219|FG003|Overall Study|Withdrawal by Subject|0|||
16375724|NCT03794544|39860216|FG000|Overall Study|Death|0|||
16375725|NCT03794544|39860217|FG001|Overall Study|Death|0|||
16375726|NCT03794544|39860218|FG002|Overall Study|Death|0|||
16375727|NCT03794544|39860219|FG003|Overall Study|Death|1|||
16375728|NCT03794544|39860216|FG000|Overall Study|Lost to Follow-up|0|||
16375729|NCT03794544|39860217|FG001|Overall Study|Lost to Follow-up|1|||
16375730|NCT03794544|39860218|FG002|Overall Study|Lost to Follow-up|1|||
16375731|NCT03794544|39860219|FG003|Overall Study|Lost to Follow-up|0|||
16375732|NCT03794544|39860216|FG000|Overall Study|Other|0|||
16375733|NCT03794544|39860217|FG001|Overall Study|Other|1|||
16375734|NCT03794544|39860218|FG002|Overall Study|Other|0|||
16375735|NCT03794544|39860219|FG003|Overall Study|Other|0|||
16375736|NCT01903733|39860220|FG000|Overall Study|Death|23|||
16375737|NCT01903733|39860221|FG001|Overall Study|Death|54|||
16375738|NCT01903733|39860222|FG002|Overall Study|Death|30|||
16375739|NCT01903733|39860223|FG003|Overall Study|Death|98|||
16375740|NCT01903733|39860220|FG000|Overall Study|Participant refused further follow-up|35|||
16375741|NCT01903733|39860221|FG001|Overall Study|Participant refused further follow-up|38|||
16375742|NCT01903733|39860222|FG002|Overall Study|Participant refused further follow-up|13|||
16375743|NCT01903733|39860223|FG003|Overall Study|Participant refused further follow-up|9|||
16375744|NCT01903733|39860220|FG000|Overall Study|Lost to Follow-up|18|||
16375745|NCT01903733|39860221|FG001|Overall Study|Lost to Follow-up|19|||
16375746|NCT01903733|39860222|FG002|Overall Study|Lost to Follow-up|6|||
16375747|NCT01903733|39860223|FG003|Overall Study|Lost to Follow-up|9|||
16375748|NCT01903733|39860220|FG000|Overall Study|Other|10|||
16375749|NCT01903733|39860221|FG001|Overall Study|Other|15|||
16375750|NCT01903733|39860222|FG002|Overall Study|Other|12|||
16375751|NCT01903733|39860223|FG003|Overall Study|Other|3|||
16375752|NCT01903733|39860220|FG000|Overall Study|Missing|2|||
16375753|NCT01903733|39860221|FG001|Overall Study|Missing|0|||
16375754|NCT01903733|39860222|FG002|Overall Study|Missing|0|||
16375755|NCT01903733|39860223|FG003|Overall Study|Missing|0|||
16375756|NCT01903733|39860220|FG000|Overall Study|Investigator request|18|||
16375757|NCT01903733|39860221|FG001|Overall Study|Investigator request|0|||
16375758|NCT01903733|39860222|FG002|Overall Study|Investigator request|0|||
16375759|NCT01903733|39860223|FG003|Overall Study|Investigator request|0|||
16375760|NCT01428713|39860224|FG000|Overall Study|Non-compliance|2|||
16375761|NCT01428713|39860225|FG001|Overall Study|Non-compliance|2|||
16375762|NCT01428713|39860224|FG000|Overall Study|Withdrawal by Subject|1|||
16375763|NCT01428713|39860225|FG001|Overall Study|Withdrawal by Subject|1|||
16375764|NCT01428713|39860224|FG000|Overall Study|Adverse Event|0|||
16375765|NCT01428713|39860225|FG001|Overall Study|Adverse Event|2|||
16375766|NCT00933166|39860226|FG000|Overall Study|Lost to Follow-up|4|||
16375767|NCT00933166|39860226|FG000|Overall Study|Lack of Efficacy|9|||
16375768|NCT00933166|39860226|FG000|Overall Study|Unavailable|4|||
16375769|NCT00933166|39860226|FG000|Overall Study|Withdrawal by Subject|1|||
16375770|NCT05805150|39860228|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
16375771|NCT05805150|39860229|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
16375772|NCT00642759|39860230|FG000|Overall Study|Protocol Violation|1|||
16375773|NCT05333965|39860231|FG000|First Intervention|Adverse Event|0|||
16375774|NCT05333965|39860232|FG001|First Intervention|Adverse Event|1|||
16375775|NCT05333965|39860231|FG000|First Intervention|Withdrawal by Subject|0|||
16375776|NCT05333965|39860232|FG001|First Intervention|Withdrawal by Subject|1|||
16375777|NCT02242903|39860233|FG000|Overall Study|Withdrawal by Subject|1|||
16375778|NCT02242903|39860234|FG001|Overall Study|Withdrawal by Subject|0|||
16375779|NCT02242903|39860235|FG002|Overall Study|Withdrawal by Subject|0|||
16375780|NCT02242903|39860236|FG003|Overall Study|Withdrawal by Subject|0|||
16375781|NCT02242903|39860237|FG004|Overall Study|Withdrawal by Subject|0|||
16375782|NCT02242903|39860238|FG005|Overall Study|Withdrawal by Subject|0|||
16375783|NCT02242903|39860239|FG006|Overall Study|Withdrawal by Subject|0|||
16375784|NCT02829918|39860240|FG000|Overall Study|Death|2|||
16375785|NCT02829918|39860240|FG000|Overall Study|Withdrawal by Subject|4|||
16375786|NCT02829918|39860240|FG000|Overall Study|Adverse Event|1|||
16375787|NCT02829918|39860240|FG000|Overall Study|Progression|1|||
16375788|NCT00890097|39860261|FG000|Overall Study|Adverse Event|21|||
16375789|NCT00890097|39860262|FG001|Overall Study|Adverse Event|32|||
16375790|NCT00890097|39860263|FG002|Overall Study|Adverse Event|28|||
16375791|NCT00890097|39860261|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
16375792|NCT00890097|39860262|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
16375793|NCT00890097|39860263|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
16375794|NCT00890097|39860261|FG000|Overall Study|Withdrew Consent|9|||
16375795|NCT00890097|39860262|FG001|Overall Study|Withdrew Consent|6|||
16375796|NCT00890097|39860263|FG002|Overall Study|Withdrew Consent|9|||
16375797|NCT00890097|39860261|FG000|Overall Study|Lost to Follow-up|5|||
16375798|NCT00890097|39860262|FG001|Overall Study|Lost to Follow-up|5|||
16375799|NCT00890097|39860263|FG002|Overall Study|Lost to Follow-up|5|||
16375800|NCT00890097|39860261|FG000|Overall Study|Noncompliance|0|||
16375801|NCT00890097|39860262|FG001|Overall Study|Noncompliance|4|||
16375802|NCT00890097|39860263|FG002|Overall Study|Noncompliance|4|||
16375803|NCT00890097|39860261|FG000|Overall Study|Sponsor Decision|7|||
16375804|NCT00890097|39860262|FG001|Overall Study|Sponsor Decision|11|||
16375805|NCT00890097|39860263|FG002|Overall Study|Sponsor Decision|7|||
16375806|NCT00890097|39860261|FG000|Overall Study|Did not attend final visit|2|||
16375807|NCT00890097|39860262|FG001|Overall Study|Did not attend final visit|3|||
16375808|NCT00890097|39860263|FG002|Overall Study|Did not attend final visit|0|||
16375809|NCT00890097|39860261|FG000|Overall Study|Subject Decision|3|||
16375810|NCT00890097|39860262|FG001|Overall Study|Subject Decision|2|||
16375811|NCT00890097|39860263|FG002|Overall Study|Subject Decision|6|||
16375812|NCT00890097|39860261|FG000|Overall Study|Randomization Error|2|||
16375813|NCT00890097|39860262|FG001|Overall Study|Randomization Error|0|||
16375814|NCT00890097|39860263|FG002|Overall Study|Randomization Error|0|||
16375815|NCT00890097|39860261|FG000|Overall Study|Failed inclusion criteria|3|||
16375816|NCT00890097|39860262|FG001|Overall Study|Failed inclusion criteria|4|||
16375817|NCT00890097|39860263|FG002|Overall Study|Failed inclusion criteria|0|||
16375818|NCT00890097|39860261|FG000|Overall Study|Transportation|0|||
16375819|NCT00890097|39860262|FG001|Overall Study|Transportation|2|||
16375820|NCT00890097|39860263|FG002|Overall Study|Transportation|0|||
16375821|NCT00890097|39860261|FG000|Overall Study|Subject Moved|0|||
16375822|NCT00890097|39860262|FG001|Overall Study|Subject Moved|4|||
16375823|NCT00890097|39860263|FG002|Overall Study|Subject Moved|0|||
16375824|NCT00890097|39860261|FG000|Overall Study|Protocol Deviation|1|||
16375825|NCT00890097|39860262|FG001|Overall Study|Protocol Deviation|1|||
16375826|NCT00890097|39860263|FG002|Overall Study|Protocol Deviation|1|||
16375827|NCT02298946|39860266|FG000|Overall Study|Did not receive treatment|2|||
16375828|NCT02298946|39860267|FG001|Overall Study|Did not receive treatment|0|||
16375829|NCT02298946|39860266|FG000|Overall Study|Unevaluable|2|||
16375830|NCT02298946|39860267|FG001|Overall Study|Unevaluable|1|||
16375831|NCT00107614|39860270|FG000|Overall Study|Physician Decision|10|||
16375832|NCT00107614|39860270|FG000|Overall Study|Death|2|||
16375833|NCT03301415|39860271|FG000|Overall Study|Lost to Follow-up|2|||
16375834|NCT03301415|39860271|FG000|Overall Study|Unable to comply with visit schedule|2|||
16375835|NCT00903344|39860274|FG000|Overall Study|Pregnancy|2|||
16375836|NCT00903344|39860275|FG001|Overall Study|Pregnancy|3|||
16375837|NCT00903344|39860274|FG000|Overall Study|Lost to Follow-up|3|||
16375838|NCT00903344|39860275|FG001|Overall Study|Lost to Follow-up|0|||
16375839|NCT02951819|39860281|FG000|Overall Study|Death|9|||
16375840|NCT02951819|39860282|FG001|Overall Study|Death|7|||
16375841|NCT02951819|39860281|FG000|Overall Study|Withdrawal by Subject|3|||
16375842|NCT02951819|39860282|FG001|Overall Study|Withdrawal by Subject|0|||
16375843|NCT02951819|39860281|FG000|Overall Study|Adverse Event|1|||
16375844|NCT02951819|39860282|FG001|Overall Study|Adverse Event|0|||
16375845|NCT02951819|39860281|FG000|Overall Study|Lack of Efficacy|4|||
16375846|NCT02951819|39860282|FG001|Overall Study|Lack of Efficacy|0|||
16375847|NCT02951819|39860281|FG000|Overall Study|Lost to Follow-up|1|||
16375848|NCT02951819|39860282|FG001|Overall Study|Lost to Follow-up|0|||
16375849|NCT02951819|39860281|FG000|Overall Study|Progressive Disease|1|||
16375850|NCT02951819|39860282|FG001|Overall Study|Progressive Disease|0|||
16375851|NCT02951819|39860281|FG000|Overall Study|Other|9|||
16375852|NCT02951819|39860282|FG001|Overall Study|Other|0|||
16375853|NCT00023595|39860286|FG000|5 Year Follow up|Lost to Follow-up|2|||
16375854|NCT00023595|39860287|FG001|5 Year Follow up|Lost to Follow-up|2|||
16375855|NCT00023595|39860288|FG002|5 Year Follow up|Lost to Follow-up|1|||
16375856|NCT00023595|39860289|FG003|5 Year Follow up|Lost to Follow-up|7|||
16375857|NCT00023595|39860290|FG004|5 Year Follow up|Lost to Follow-up|3|||
16375858|NCT00023595|39860286|FG000|10 Year Follow up|Lost to Follow-up|12|||
16375859|NCT00023595|39860287|FG001|10 Year Follow up|Lost to Follow-up|10|||
16375860|NCT00023595|39860288|FG002|10 Year Follow up|Lost to Follow-up|3|||
16375861|NCT00023595|39860289|FG003|10 Year Follow up|Lost to Follow-up|0|||
16375862|NCT00023595|39860290|FG004|10 Year Follow up|Lost to Follow-up|0|||
16375863|NCT00680914|39860291|FG000|Overall Study|Consent withdrawal|6|||
16375864|NCT00680914|39860292|FG001|Overall Study|Consent withdrawal|3|||
16375865|NCT00680914|39860291|FG000|Overall Study|Lost to Follow-up|4|||
16375866|NCT00680914|39860292|FG001|Overall Study|Lost to Follow-up|0|||
16375867|NCT00680914|39860291|FG000|Overall Study|serious adverse event (SAE)|0|||
16375868|NCT00680914|39860292|FG001|Overall Study|serious adverse event (SAE)|1|||
16375869|NCT01517178|39860293|FG000|Period 1|Adverse Event|1|||
16375870|NCT01517178|39860294|FG001|Period 1|Adverse Event|2|||
16375871|NCT01517178|39860293|FG000|Period 1|Lack of Efficacy|0|||
16375872|NCT01517178|39860294|FG001|Period 1|Lack of Efficacy|1|||
16375873|NCT01517178|39860293|FG000|Period 1|E.g. study termination|3|||
16375874|NCT01517178|39860294|FG001|Period 1|E.g. study termination|1|||
16375875|NCT01517178|39860293|FG000|Period 1|Withdrawal by Subject|0|||
16375876|NCT01517178|39860294|FG001|Period 1|Withdrawal by Subject|1|||
16375877|NCT01517178|39860293|FG000|Period 2|Adverse Event|1|||
16375878|NCT01517178|39860294|FG001|Period 2|Adverse Event|0|||
16375879|NCT01517178|39860293|FG000|Period 2|Withdrawal by Subject|3|||
16375880|NCT01517178|39860294|FG001|Period 2|Withdrawal by Subject|0|||
16375881|NCT01517178|39860293|FG000|Period 2|E.g. study termination|2|||
16375882|NCT01517178|39860294|FG001|Period 2|E.g. study termination|2|||
16375883|NCT00814983|39860295|FG000|Overall Study|Screen failure|1|||
16375884|NCT00814983|39860296|FG001|Overall Study|Screen failure|0|||
16375885|NCT00814983|39860295|FG000|Overall Study|Withdrawal by Subject|1|||
16375886|NCT00814983|39860296|FG001|Overall Study|Withdrawal by Subject|0|||
16375887|NCT00814983|39860295|FG000|Overall Study|Graft failure|1|||
16375888|NCT00814983|39860296|FG001|Overall Study|Graft failure|0|||
16375889|NCT01371565|39860297|FG000|Overall Study|Withdrawal by Subject|1|||
16375890|NCT01371565|39860297|FG000|Overall Study|Death|1|||
16375891|NCT01371565|39860297|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
16375892|NCT02038647|39860298|FG000|Overall Study|Progressive Disease|50|||
16375893|NCT02038647|39860299|FG001|Overall Study|Progressive Disease|59|||
16375894|NCT02038647|39860298|FG000|Overall Study|Adverse Event|18|||
16375895|NCT02038647|39860299|FG001|Overall Study|Adverse Event|10|||
16375896|NCT02038647|39860298|FG000|Overall Study|Symptomatic Deterioration|7|||
16375897|NCT02038647|39860299|FG001|Overall Study|Symptomatic Deterioration|7|||
16375898|NCT02038647|39860298|FG000|Overall Study|Withdrawal by Subject|5|||
16375899|NCT02038647|39860299|FG001|Overall Study|Withdrawal by Subject|2|||
16375900|NCT02038647|39860298|FG000|Overall Study|Not Reported|0|||
16375901|NCT02038647|39860299|FG001|Overall Study|Not Reported|1|||
16375902|NCT02038647|39860298|FG000|Overall Study|Ongoing at Datacut|9|||
16375903|NCT02038647|39860299|FG001|Overall Study|Ongoing at Datacut|10|||
16375904|NCT02367885|39860300|FG000|Overall Study|Lost to Follow-up|1|||
16375905|NCT02367885|39860301|FG001|Overall Study|Lost to Follow-up|0|||
16375906|NCT02367885|39860302|FG002|Overall Study|Lost to Follow-up|0|||
16375907|NCT02367885|39860300|FG000|Overall Study|Withdrawal by Subject|1|||
16375908|NCT02367885|39860301|FG001|Overall Study|Withdrawal by Subject|0|||
16375909|NCT02367885|39860302|FG002|Overall Study|Withdrawal by Subject|0|||
16375910|NCT00101400|39860303|FG000|Survival Follow-Up|Alive|7|||
16375911|NCT00276380|39860307|FG000|Overall Study|Adverse Event|5|||
16375912|NCT00276380|39860308|FG001|Overall Study|Adverse Event|3|||
16375913|NCT00276380|39860307|FG000|Overall Study|Lost to Follow-up|1|||
16375914|NCT00276380|39860308|FG001|Overall Study|Lost to Follow-up|1|||
16375915|NCT00276380|39860307|FG000|Overall Study|Withdrawal by Subject|3|||
16375916|NCT00276380|39860308|FG001|Overall Study|Withdrawal by Subject|6|||
16375917|NCT00276380|39860307|FG000|Overall Study|Death|5|||
16375918|NCT00276380|39860308|FG001|Overall Study|Death|3|||
16375919|NCT00276380|39860307|FG000|Overall Study|Abnormal aPPT Levels|0|||
16375920|NCT00276380|39860308|FG001|Overall Study|Abnormal aPPT Levels|1|||
16375921|NCT02904096|39860313|FG000|Overall Study|Adverse Event|1|||
16375922|NCT02904096|39860314|FG001|Overall Study|Adverse Event|0|||
16375923|NCT02904096|39860313|FG000|Overall Study|Withdrawal by Subject|4|||
16375924|NCT02904096|39860314|FG001|Overall Study|Withdrawal by Subject|3|||
16375925|NCT02904096|39860313|FG000|Overall Study|Lost to Follow-up|10|||
16375926|NCT02904096|39860314|FG001|Overall Study|Lost to Follow-up|17|||
16375927|NCT02904096|39860313|FG000|Overall Study|Non-compliant|3|||
16375928|NCT02904096|39860314|FG001|Overall Study|Non-compliant|1|||
16375929|NCT02904096|39860313|FG000|Overall Study|Sponsor instructed|1|||
16375930|NCT02904096|39860314|FG001|Overall Study|Sponsor instructed|0|||
16375931|NCT01546987|39860315|FG000|Overall Study|Protocol Violation|3|||
16375932|NCT01546987|39860316|FG001|Overall Study|Protocol Violation|4|||
16375933|NCT00378560|39860319|FG000|Overall Study|Adverse Event|1|||
16375934|NCT00378560|39860320|FG001|Overall Study|Adverse Event|0|||
16375935|NCT00378560|39860319|FG000|Overall Study|Lost to Follow-up|24|||
16375936|NCT00378560|39860320|FG001|Overall Study|Lost to Follow-up|29|||
16375937|NCT00378560|39860319|FG000|Overall Study|Protocol Violation|2|||
16375938|NCT00378560|39860320|FG001|Overall Study|Protocol Violation|0|||
16375939|NCT00378560|39860319|FG000|Overall Study|Withdrawal by Subject|17|||
16375940|NCT00378560|39860320|FG001|Overall Study|Withdrawal by Subject|21|||
16375941|NCT00378560|39860319|FG000|Overall Study|Moved|4|||
16375942|NCT00378560|39860320|FG001|Overall Study|Moved|3|||
16375943|NCT00378560|39860319|FG000|Overall Study|Pregnancy|7|||
16375944|NCT00378560|39860320|FG001|Overall Study|Pregnancy|5|||
16375945|NCT00378560|39860319|FG000|Overall Study|Laboratory test values abnormal|1|||
16375946|NCT00378560|39860320|FG001|Overall Study|Laboratory test values abnormal|0|||
16375947|NCT02100644|39860321|FG000|LTG Escalation Phase|Adverse Event|9|||
16375948|NCT02100644|39860322|FG001|LTG Escalation Phase|Adverse Event|0|||
16375949|NCT02100644|39860323|FG002|LTG Escalation Phase|Adverse Event|0|||
16375950|NCT02100644|39860321|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
16375951|NCT02100644|39860322|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
16375952|NCT02100644|39860323|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
16375953|NCT02100644|39860321|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
16375954|NCT02100644|39860322|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
16375955|NCT02100644|39860323|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
16375956|NCT02363283|39860324|FG000|Overall Study|Withdrawal by Subject|1|||
16375957|NCT02363283|39860324|FG000|Overall Study|Not eligible due to transaminitis|1|||
16375958|NCT01213251|39860325|FG000|Overall Study|Death|2|||
16375959|NCT01213251|39860326|FG001|Overall Study|Death|1|||
16375960|NCT01213251|39860327|FG002|Overall Study|Death|2|||
16375961|NCT01213251|39860325|FG000|Overall Study|Exit|3|||
16375962|NCT01213251|39860326|FG001|Overall Study|Exit|2|||
16375963|NCT01213251|39860327|FG002|Overall Study|Exit|8|||
16375964|NCT01213251|39860325|FG000|Overall Study|Protocol Violation|1|||
16375965|NCT01213251|39860326|FG001|Overall Study|Protocol Violation|1|||
16375966|NCT01213251|39860327|FG002|Overall Study|Protocol Violation|0|||
16375967|NCT01213251|39860325|FG000|Overall Study|Missed 18-Month Follow-up|0|||
16375968|NCT01213251|39860326|FG001|Overall Study|Missed 18-Month Follow-up|0|||
16375969|NCT01213251|39860327|FG002|Overall Study|Missed 18-Month Follow-up|1|||
16375970|NCT02799043|39860329|FG000|Overall Study|Adverse Event|0|||
16375971|NCT02799043|39860330|FG001|Overall Study|Adverse Event|1|||
16375972|NCT02799043|39860329|FG000|Overall Study|Death|1|||
16375973|NCT02799043|39860330|FG001|Overall Study|Death|1|||
16375974|NCT02799043|39860329|FG000|Overall Study|Lost to Follow-up|3|||
16375975|NCT02799043|39860330|FG001|Overall Study|Lost to Follow-up|6|||
16375976|NCT02799043|39860329|FG000|Overall Study|Withdrawal by Subject|4|||
16375977|NCT02799043|39860330|FG001|Overall Study|Withdrawal by Subject|4|||
16375978|NCT02799043|39860329|FG000|Overall Study|Moved to different country|0|||
16375979|NCT02799043|39860330|FG001|Overall Study|Moved to different country|1|||
16375980|NCT02799043|39860329|FG000|Overall Study|Trial Screen Failure|1|||
16375981|NCT02799043|39860330|FG001|Overall Study|Trial Screen Failure|0|||
16375982|NCT02799043|39860329|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
16375983|NCT02799043|39860330|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
16375984|NCT02579759|39860331|FG000|Overall Study|Protocol Violation|2|||
16375985|NCT02579759|39860332|FG001|Overall Study|Protocol Violation|0|||
16375986|NCT02579759|39860333|FG002|Overall Study|Protocol Violation|0|||
16375987|NCT02579759|39860331|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
16375988|NCT02579759|39860332|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
16375989|NCT02579759|39860333|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
16375990|NCT02579759|39860331|FG000|Overall Study|BfArM hold|13|||
16375991|NCT02579759|39860332|FG001|Overall Study|BfArM hold|12|||
16375992|NCT02579759|39860333|FG002|Overall Study|BfArM hold|12|||
16375993|NCT02579759|39860331|FG000|Overall Study|Sponsor stopped Dose 2|0|||
16375994|NCT02579759|39860332|FG001|Overall Study|Sponsor stopped Dose 2|41|||
16375995|NCT02579759|39860333|FG002|Overall Study|Sponsor stopped Dose 2|0|||
16375996|NCT02579759|39860331|FG000|Overall Study|Non compliance|0|||
16375997|NCT02579759|39860332|FG001|Overall Study|Non compliance|1|||
16375998|NCT02579759|39860333|FG002|Overall Study|Non compliance|0|||
16375999|NCT02579759|39860331|FG000|Overall Study|Pregnancy|0|||
16376000|NCT02579759|39860332|FG001|Overall Study|Pregnancy|1|||
16376001|NCT02579759|39860333|FG002|Overall Study|Pregnancy|0|||
16376002|NCT02579759|39860331|FG000|Overall Study|Inclusion/exclusion criteria|0|||
16376003|NCT02579759|39860332|FG001|Overall Study|Inclusion/exclusion criteria|0|||
16376004|NCT02579759|39860333|FG002|Overall Study|Inclusion/exclusion criteria|1|||
16376005|NCT02579759|39860331|FG000|Overall Study|Adverse Event|4|||
16376006|NCT02579759|39860332|FG001|Overall Study|Adverse Event|3|||
16376007|NCT02579759|39860333|FG002|Overall Study|Adverse Event|1|||
16376008|NCT02579759|39860331|FG000|Overall Study|Withdrawal by Subject|3|||
16376009|NCT02579759|39860332|FG001|Overall Study|Withdrawal by Subject|3|||
16376010|NCT02579759|39860333|FG002|Overall Study|Withdrawal by Subject|5|||
16376011|NCT02579759|39860331|FG000|Overall Study|Lost to Follow-up|2|||
16376012|NCT02579759|39860332|FG001|Overall Study|Lost to Follow-up|2|||
16376013|NCT02579759|39860333|FG002|Overall Study|Lost to Follow-up|2|||
16376014|NCT00185614|39860339|FG000|Inter-treatment Period|Physician Decision|1|||
16376015|NCT00185614|39860339|FG000|Inter-treatment Period|Relapse|2|||
16376016|NCT00185614|39860339|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
16376017|NCT01813357|39860340|FG000|Overall Study|Lost to Follow-up|5|||
16376018|NCT01813357|39860341|FG001|Overall Study|Lost to Follow-up|6|||
16376019|NCT02094885|39860342|FG000|Overall Study|Death|1|||
16376020|NCT02094885|39860343|FG001|Overall Study|Death|5|||
16376021|NCT02094885|39860342|FG000|Overall Study|Withdrawn due to age|1|||
16376022|NCT02094885|39860343|FG001|Overall Study|Withdrawn due to age|0|||
16376023|NCT01027754|39860353|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
16376024|NCT01027754|39860354|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
16376025|NCT01027754|39860353|FG000|Overall Study|Withdrawal by Subject|0|||
16376026|NCT01027754|39860354|FG001|Overall Study|Withdrawal by Subject|5|||
16376027|NCT02529488|39860360|FG000|Overall Study|Adverse Event|1|||
16376028|NCT02529488|39860360|FG000|Overall Study|Death|3|||
16376029|NCT03021005|39863182|FG000|Overall Study|Lost to Follow-up|39|||
16376030|NCT03021005|39863183|FG001|Overall Study|Lost to Follow-up|26|||
16376031|NCT01892189|39863186|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
16376032|NCT01892189|39863187|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
16376033|NCT01892189|39863188|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
16376034|NCT01892189|39863189|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
16376035|NCT01892189|39863190|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
16376036|NCT01892189|39863191|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
16376037|NCT01892189|39863192|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
16376038|NCT01892189|39863193|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
16376039|NCT01892189|39863194|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
16376040|NCT01892189|39863186|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16376041|NCT01892189|39863187|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16376042|NCT01892189|39863188|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
16376043|NCT01892189|39863189|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16376044|NCT01892189|39863190|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16376045|NCT01892189|39863191|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16376046|NCT01892189|39863192|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16376047|NCT01892189|39863193|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16376048|NCT01892189|39863194|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16376049|NCT01892189|39863186|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16376050|NCT01892189|39863187|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16376051|NCT01892189|39863188|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16376052|NCT01892189|39863189|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16376053|NCT01892189|39863190|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16376054|NCT01892189|39863191|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
16376055|NCT01892189|39863192|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16376056|NCT01892189|39863193|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16376057|NCT01892189|39863194|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
16376058|NCT01840163|39863197|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
16376059|NCT01840163|39863198|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
16376060|NCT01840163|39863197|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
16376061|NCT01840163|39863198|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
16376062|NCT01840163|39863197|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
16376063|NCT01840163|39863198|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
16376064|NCT02679274|39863203|FG000|Overall Study|Withdrawal by Subject|1|||
16376065|NCT02679274|39863204|FG001|Overall Study|Withdrawal by Subject|0|||
16076225|NCT02553460|38769922|FG000|Overall Study|Relapse or Transplant|14|||
16376066|NCT02661815|39863205|FG000|Overall Study|Withdrawal by Subject|1|||
16376067|NCT02661815|39863206|FG001|Overall Study|Withdrawal by Subject|0|||
16376068|NCT02661815|39863207|FG002|Overall Study|Withdrawal by Subject|0|||
16376069|NCT02661815|39863208|FG003|Overall Study|Withdrawal by Subject|0|||
16376070|NCT02727699|39863209|FG000|Overall Study|Adverse Event|2|||
16376071|NCT02727699|39863210|FG001|Overall Study|Adverse Event|0|||
16376072|NCT02727699|39863209|FG000|Overall Study|Withdrawal by Subject|5|||
16376073|NCT02727699|39863210|FG001|Overall Study|Withdrawal by Subject|3|||
16376074|NCT02727699|39863209|FG000|Overall Study|Protocol Violation|0|||
16376075|NCT02727699|39863210|FG001|Overall Study|Protocol Violation|1|||
16376076|NCT02727699|39863209|FG000|Overall Study|Physician Decision|0|||
16376077|NCT02727699|39863210|FG001|Overall Study|Physician Decision|1|||
16376078|NCT02727699|39863209|FG000|Overall Study|Lost to Follow-up|1|||
16376079|NCT02727699|39863210|FG001|Overall Study|Lost to Follow-up|0|||
16376080|NCT02727699|39863209|FG000|Overall Study|Sponsor Decision|1|||
16376081|NCT02727699|39863210|FG001|Overall Study|Sponsor Decision|0|||
16376082|NCT00773461|39863213|FG000|Overall Study|Adverse Event|1|||
16376083|NCT00773461|39863214|FG001|Overall Study|Adverse Event|3|||
16376084|NCT00773461|39863213|FG000|Overall Study|Withdrawal by Subject|4|||
16376085|NCT00773461|39863214|FG001|Overall Study|Withdrawal by Subject|1|||
16376086|NCT01514422|39863217|FG000|Overall Study|Lost to Follow-up|1|||
16376087|NCT00552279|39863220|FG000|Overall Study|Adverse Event|0|||
16376088|NCT00552279|39863221|FG001|Overall Study|Adverse Event|1|||
16376089|NCT00552279|39863220|FG000|Overall Study|Withdrawal by Subject|12|||
16376090|NCT00552279|39863221|FG001|Overall Study|Withdrawal by Subject|1|||
16376091|NCT00552279|39863220|FG000|Overall Study|Lost to Follow-up|1|||
16376092|NCT00552279|39863221|FG001|Overall Study|Lost to Follow-up|0|||
16376093|NCT00552279|39863220|FG000|Overall Study|Other|1|||
16376094|NCT00552279|39863221|FG001|Overall Study|Other|1|||
16376095|NCT02410200|39863231|FG000|Overall Study|Adverse Event|2|||
16376096|NCT02011542|39863234|FG000|Overall Study|Physician Decision|1|||
16376097|NCT03160573|39863235|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
16376098|NCT03160573|39863236|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
16376099|NCT03160573|39863237|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
16376100|NCT03160573|39863238|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
16376101|NCT02003898|39863243|FG000|Overall Study|Death|3|||
16376102|NCT02003898|39863243|FG000|Overall Study|Lost to Follow-up|12|||
16376103|NCT02003898|39863243|FG000|Overall Study|Withdrawal by Subject|52|||
16376104|NCT02971137|39863244|FG000|Overall Study|Lost to Follow-up|44|||
16376105|NCT02971137|39863245|FG001|Overall Study|Lost to Follow-up|56|||
16376106|NCT02226653|39863246|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
16376107|NCT02226653|39863247|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
16376108|NCT02226653|39863246|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
16376109|NCT02226653|39863247|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
16376110|NCT04985682|39863248|FG000|Overall Study|Withdrawal by Subject|1|||
16376111|NCT00661687|39863255|FG000|Overall Study|Study related symptoms and complaints|5|||
16376112|NCT00661687|39863255|FG000|Overall Study|Positive slit lamp findings|4|||
16376113|NCT00661687|39863255|FG000|Overall Study|Inability to maintain wearing schedule|3|||
16376114|NCT00661687|39863255|FG000|Overall Study|Physician Decision|1|||
16376115|NCT00661687|39863255|FG000|Overall Study|Adverse Event|2|||
16376116|NCT01714063|39863256|FG000|Overall Study|Equipment malfunction|2|||
16376117|NCT03363659|39863257|FG000|Overall Study|Adverse Event|1|||
16376118|NCT03363659|39863257|FG000|Overall Study|Screen fail|1|||
16376119|NCT03363659|39863257|FG000|Overall Study|Withdrawal by Subject|1|||
16376120|NCT05626686|39863260|FG000|Overall Study|Protocol Violation|3|||
16376121|NCT05626686|39863260|FG000|Overall Study|Withdrawal by Subject|3|||
16376122|NCT02771145|39863261|FG000|Overall Study|Adverse Event|3|||
16376123|NCT02771145|39863261|FG000|Overall Study|Lost to Follow-up|1|||
16376124|NCT03186378|39863262|FG000|Overall Study|Lost to Follow-up|1|||
16376125|NCT03186378|39863263|FG001|Overall Study|Lost to Follow-up|0|||
16376126|NCT04537715|39863264|FG000|Overall Study|Completed without enrolling in rollover study EZH-501|9|||
16376127|NCT04537715|39863265|FG001|Overall Study|Completed without enrolling in rollover study EZH-501|15|||
16376128|NCT04537715|39863264|FG000|Overall Study|Withdrawal by Subject|0|||
16376129|NCT04537715|39863265|FG001|Overall Study|Withdrawal by Subject|1|||
16376130|NCT04537715|39863264|FG000|Overall Study|Other|2|||
16376131|NCT04537715|39863265|FG001|Overall Study|Other|2|||
16376132|NCT04537715|39863264|FG000|Overall Study|Death: Progressive disease|9|||
16376133|NCT04537715|39863265|FG001|Overall Study|Death: Progressive disease|2|||
16376134|NCT04537715|39863264|FG000|Overall Study|Death: Adverse event|1|||
16376135|NCT04537715|39863265|FG001|Overall Study|Death: Adverse event|1|||
16376136|NCT05069415|39863271|FG000|Overall Study|Withdrawal by Subject|2|||
16376137|NCT05069415|39863272|FG001|Overall Study|Withdrawal by Subject|0|||
16376138|NCT05069415|39863271|FG000|Overall Study|Adverse Event|2|||
16376139|NCT05069415|39863272|FG001|Overall Study|Adverse Event|0|||
16376140|NCT02757963|39863276|FG000|Overall Study|Adverse Event|3|||
16376141|NCT02757963|39863276|FG000|Overall Study|Reached Stopping Criteria|1054|||
16376142|NCT02757963|39863276|FG000|Overall Study|Lost to Follow-up|5|||
16376143|NCT02757963|39863276|FG000|Overall Study|Physician Decision|1|||
16376144|NCT02757963|39863276|FG000|Overall Study|Withdrawal by Subject|34|||
16376145|NCT00911157|39863281|FG000|Overall Study|Adverse Event|4|||
16376146|NCT00911157|39863282|FG001|Overall Study|Adverse Event|1|||
16376147|NCT00911157|39863281|FG000|Overall Study|Withdrawal by Subject|1|||
16376148|NCT00911157|39863282|FG001|Overall Study|Withdrawal by Subject|1|||
16376149|NCT00911157|39863281|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
16376150|NCT00911157|39863282|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
16376151|NCT00911157|39863281|FG000|Overall Study|Need to treat for lung cancer|1|||
16376152|NCT00911157|39863282|FG001|Overall Study|Need to treat for lung cancer|0|||
16376153|NCT01347086|39863283|FG000|Overall Study|failed screening visit|0|||
16376154|NCT01347086|39863284|FG001|Overall Study|failed screening visit|0|||
16376155|NCT01347086|39863285|FG002|Overall Study|failed screening visit|1|||
16376156|NCT01347086|39863286|FG003|Overall Study|failed screening visit|0|||
16376157|NCT01347086|39863287|FG004|Overall Study|failed screening visit|0|||
16376158|NCT01347086|39863288|FG005|Overall Study|failed screening visit|0|||
16376159|NCT01347086|39863289|FG006|Overall Study|failed screening visit|1|||
16376160|NCT01347086|39863290|FG007|Overall Study|failed screening visit|1|||
16376161|NCT01347086|39863291|FG008|Overall Study|failed screening visit|0|||
16376162|NCT01347086|39863292|FG009|Overall Study|failed screening visit|1|||
16376163|NCT00720083|39863293|FG000|Overall Study|Ineligible|1|||
16376164|NCT00720083|39863294|FG001|Overall Study|Ineligible|2|||
16376165|NCT01848457|39863295|FG000|Overall Study|Death|1|||
16376166|NCT01848457|39863296|FG001|Overall Study|Death|0|||
16376167|NCT01848457|39863297|FG002|Overall Study|Death|0|||
16376168|NCT01848457|39863298|FG003|Overall Study|Death|0|||
16376169|NCT03766906|39863299|FG000|Overall Study|Withdrawal by Subject|6|||
16376170|NCT02144337|39863300|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
16376171|NCT02144337|39863301|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
16376172|NCT02144337|39863300|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
16376173|NCT02144337|39863301|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
16376174|NCT02144337|39863300|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
16376175|NCT02144337|39863301|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
16376176|NCT02144337|39863300|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
16376177|NCT02144337|39863301|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
16376178|NCT02144337|39863300|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
16376179|NCT02144337|39863301|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
16376180|NCT00088881|39863317|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
16376181|NCT00088881|39863317|FG000|Step 1 - R-CHOP|Adverse Event|1|||
16376182|NCT00088881|39863317|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
16376183|NCT00088881|39863317|FG000|Step 1 - R-CHOP|Physician Decision|1|||
16376184|NCT00088881|39863317|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
16376185|NCT00088881|39863317|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
16376186|NCT00088881|39863317|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
16376187|NCT04065841|39863318|FG000|Overall Study|Adverse Event|4|||
16376188|NCT04065841|39863319|FG001|Overall Study|Adverse Event|2|||
16376189|NCT04065841|39863320|FG002|Overall Study|Adverse Event|10|||
16376190|NCT04065841|39863321|FG003|Overall Study|Adverse Event|1|||
16376191|NCT04065841|39863318|FG000|Overall Study|Lost to Follow-up|1|||
16376192|NCT04065841|39863319|FG001|Overall Study|Lost to Follow-up|2|||
16376193|NCT04065841|39863320|FG002|Overall Study|Lost to Follow-up|2|||
16376194|NCT04065841|39863321|FG003|Overall Study|Lost to Follow-up|2|||
16376195|NCT04065841|39863318|FG000|Overall Study|Physician Decision|1|||
16376196|NCT04065841|39863319|FG001|Overall Study|Physician Decision|0|||
16376197|NCT04065841|39863320|FG002|Overall Study|Physician Decision|0|||
16376198|NCT04065841|39863321|FG003|Overall Study|Physician Decision|0|||
16376199|NCT04065841|39863318|FG000|Overall Study|Protocol Violation|0|||
16376200|NCT04065841|39863319|FG001|Overall Study|Protocol Violation|1|||
16376201|NCT04065841|39863320|FG002|Overall Study|Protocol Violation|0|||
16376202|NCT04065841|39863321|FG003|Overall Study|Protocol Violation|0|||
16376203|NCT04065841|39863318|FG000|Overall Study|Study terminated by Sponsor|22|||
16376204|NCT04065841|39863319|FG001|Overall Study|Study terminated by Sponsor|16|||
16376205|NCT04065841|39863320|FG002|Overall Study|Study terminated by Sponsor|28|||
16376206|NCT04065841|39863321|FG003|Overall Study|Study terminated by Sponsor|17|||
16376207|NCT04065841|39863318|FG000|Overall Study|Withdrawal by Subject|1|||
16376208|NCT04065841|39863319|FG001|Overall Study|Withdrawal by Subject|1|||
16376209|NCT04065841|39863320|FG002|Overall Study|Withdrawal by Subject|2|||
16376210|NCT04065841|39863321|FG003|Overall Study|Withdrawal by Subject|0|||
16376211|NCT01755156|39863323|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
16376212|NCT01755156|39863324|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
16376213|NCT01755156|39863323|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
16376214|NCT01755156|39863324|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
16376215|NCT01755156|39863323|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
16376216|NCT01755156|39863324|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
16376217|NCT01755156|39863323|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
16376218|NCT01755156|39863324|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
16376219|NCT01755156|39863323|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
16376220|NCT01755156|39863324|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
16376221|NCT01755156|39863323|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
16376222|NCT01755156|39863324|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
16376223|NCT01755156|39863323|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
16376224|NCT01755156|39863324|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
16376225|NCT01755156|39863323|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
16376226|NCT01755156|39863324|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
16376227|NCT01755156|39863323|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
16376228|NCT01755156|39863324|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
16376229|NCT01755156|39863323|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
16376230|NCT01755156|39863324|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
16376231|NCT01755156|39863323|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
16376232|NCT01755156|39863324|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
16376233|NCT02034565|39863325|FG000|Overall Study|Adverse Event|1|||
16376234|NCT02034565|39863326|FG001|Overall Study|Adverse Event|0|||
16376235|NCT01877278|39863329|FG000|Overall Study|Lost to Follow-up|3|||
16376236|NCT01877278|39863330|FG001|Overall Study|Lost to Follow-up|3|||
16376237|NCT02057666|39863331|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
16376238|NCT02057666|39863332|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
16376239|NCT02057666|39863331|FG000|Double Blind Treatment Period|Poor tolerability|7|||
16376240|NCT02057666|39863332|FG001|Double Blind Treatment Period|Poor tolerability|2|||
16376241|NCT02057666|39863331|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
16376242|NCT02057666|39863332|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
16376243|NCT02057666|39863331|FG000|Double Blind Treatment Period|Physician Decision|1|||
16376244|NCT02057666|39863332|FG001|Double Blind Treatment Period|Physician Decision|0|||
16376245|NCT02057666|39863331|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
16376246|NCT02057666|39863332|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
16376247|NCT02057666|39863331|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
16376248|NCT02057666|39863332|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
16376249|NCT02057666|39863331|FG000|Double Blind Treatment Period|Sponsor's request|70|||
16376250|NCT02057666|39863332|FG001|Double Blind Treatment Period|Sponsor's request|34|||
16376251|NCT02057666|39863331|FG000|Open-Label Treatment Period|Poor tolerability|0|||
16376252|NCT02057666|39863332|FG001|Open-Label Treatment Period|Poor tolerability|1|||
16376253|NCT02057666|39863331|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
16376254|NCT02057666|39863332|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
16376255|NCT02057666|39863331|FG000|Open-Label Treatment Period|Sponsor's request|0|||
16376256|NCT02057666|39863332|FG001|Open-Label Treatment Period|Sponsor's request|4|||
16376257|NCT01299961|39863333|FG000|Overall Study|Adverse Event|3|||
16376258|NCT01299961|39863333|FG000|Overall Study|Lack of Efficacy|2|||
16376259|NCT01299961|39863333|FG000|Overall Study|Lost to Follow-up|1|||
16376260|NCT00392288|39863337|FG000|Overall Study|Adverse Event|17|||
16376261|NCT00392288|39863338|FG001|Overall Study|Adverse Event|7|||
16376262|NCT00392288|39863339|FG002|Overall Study|Adverse Event|8|||
16376263|NCT00392288|39863337|FG000|Overall Study|Lack of Efficacy|8|||
16376264|NCT00392288|39863338|FG001|Overall Study|Lack of Efficacy|5|||
16376265|NCT00392288|39863339|FG002|Overall Study|Lack of Efficacy|3|||
16376266|NCT00392288|39863337|FG000|Overall Study|Protocol Violation|1|||
16376267|NCT00392288|39863338|FG001|Overall Study|Protocol Violation|3|||
16376268|NCT00392288|39863339|FG002|Overall Study|Protocol Violation|1|||
16376269|NCT00392288|39863337|FG000|Overall Study|Lost to Follow-up|1|||
16376270|NCT00392288|39863338|FG001|Overall Study|Lost to Follow-up|1|||
16376271|NCT00392288|39863339|FG002|Overall Study|Lost to Follow-up|1|||
16376272|NCT00392288|39863337|FG000|Overall Study|Withdrawal by Subject|1|||
16376273|NCT00392288|39863338|FG001|Overall Study|Withdrawal by Subject|0|||
16376274|NCT00392288|39863339|FG002|Overall Study|Withdrawal by Subject|2|||
16376275|NCT00392288|39863337|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
16376276|NCT00392288|39863338|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
16376277|NCT00392288|39863339|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
16376278|NCT00392288|39863337|FG000|Overall Study|Other|3|||
16376279|NCT00392288|39863338|FG001|Overall Study|Other|4|||
16376280|NCT00392288|39863339|FG002|Overall Study|Other|1|||
16376281|NCT02502383|39863341|FG000|Overall Study|Lost to Follow-up|130|||
16376282|NCT02502383|39863342|FG001|Overall Study|Lost to Follow-up|131|||
16376283|NCT02502383|39863341|FG000|Overall Study|Withdrawal by Subject|31|||
16376284|NCT02502383|39863342|FG001|Overall Study|Withdrawal by Subject|24|||
16376285|NCT00756444|39863346|FG000|Overall Study|Adverse Event|1|||
16376286|NCT00756444|39863347|FG001|Overall Study|Adverse Event|1|||
16376287|NCT00756444|39863346|FG000|Overall Study|Withdrawal by Subject|6|||
16376288|NCT00756444|39863347|FG001|Overall Study|Withdrawal by Subject|8|||
16376289|NCT00756444|39863346|FG000|Overall Study|Lost to Follow-up|0|||
16376290|NCT00756444|39863347|FG001|Overall Study|Lost to Follow-up|1|||
16376291|NCT00756444|39863346|FG000|Overall Study|Death|5|||
16376292|NCT00756444|39863347|FG001|Overall Study|Death|4|||
16376293|NCT00756444|39863346|FG000|Overall Study|Disease Progression|2|||
16376294|NCT00756444|39863347|FG001|Overall Study|Disease Progression|7|||
16376295|NCT00756444|39863346|FG000|Overall Study|Ineligibility Determined|1|||
16376296|NCT00756444|39863347|FG001|Overall Study|Ineligibility Determined|0|||
16376297|NCT00637156|39863348|FG000|Overall Study|Withdrawal by Subject|0|||
16376298|NCT00637156|39863349|FG001|Overall Study|Withdrawal by Subject|7|||
16376299|NCT00637156|39863348|FG000|Overall Study|Death|0|||
16376300|NCT00637156|39863349|FG001|Overall Study|Death|1|||
16376301|NCT00637156|39863348|FG000|Overall Study|Lost to Follow-up|10|||
16376302|NCT00637156|39863349|FG001|Overall Study|Lost to Follow-up|16|||
16376303|NCT03436732|39863350|FG000|Overall Study|Not treated-enrolled in different study|1|||
16376304|NCT03436732|39863351|FG001|Overall Study|Not treated-enrolled in different study|0|||
16376305|NCT03436732|39863350|FG000|Overall Study|Off study after cycle 1|1|||
16376306|NCT03436732|39863351|FG001|Overall Study|Off study after cycle 1|0|||
16376307|NCT03436732|39863350|FG000|Overall Study|Adverse Event|2|||
16376308|NCT03436732|39863351|FG001|Overall Study|Adverse Event|0|||
16376309|NCT03436732|39863350|FG000|Overall Study|Death|0|||
16376310|NCT03436732|39863351|FG001|Overall Study|Death|1|||
16376311|NCT03579719|39863352|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
16376312|NCT00500331|39863355|FG000|Overall Study|Adverse Event|0|||
16376313|NCT00500331|39863356|FG001|Overall Study|Adverse Event|2|||
16376314|NCT00500331|39863357|FG002|Overall Study|Adverse Event|0|||
16376315|NCT00500331|39863358|FG003|Overall Study|Adverse Event|1|||
16376316|NCT00500331|39863359|FG004|Overall Study|Adverse Event|2|||
16376317|NCT00500331|39863360|FG005|Overall Study|Adverse Event|2|||
16376318|NCT00500331|39863361|FG006|Overall Study|Adverse Event|0|||
16376319|NCT00500331|39863355|FG000|Overall Study|Lost to Follow-up|1|||
16376320|NCT00500331|39863356|FG001|Overall Study|Lost to Follow-up|1|||
16376321|NCT00500331|39863357|FG002|Overall Study|Lost to Follow-up|1|||
16376322|NCT00500331|39863358|FG003|Overall Study|Lost to Follow-up|2|||
16376323|NCT00500331|39863359|FG004|Overall Study|Lost to Follow-up|1|||
16376324|NCT00500331|39863360|FG005|Overall Study|Lost to Follow-up|0|||
16376325|NCT00500331|39863361|FG006|Overall Study|Lost to Follow-up|0|||
16376326|NCT00500331|39863355|FG000|Overall Study|Protocol Violation|3|||
16376327|NCT00500331|39863356|FG001|Overall Study|Protocol Violation|1|||
16376328|NCT00500331|39863357|FG002|Overall Study|Protocol Violation|1|||
16376329|NCT00500331|39863358|FG003|Overall Study|Protocol Violation|0|||
16376330|NCT00500331|39863359|FG004|Overall Study|Protocol Violation|1|||
16376331|NCT00500331|39863360|FG005|Overall Study|Protocol Violation|1|||
16376332|NCT00500331|39863361|FG006|Overall Study|Protocol Violation|1|||
16376333|NCT00500331|39863355|FG000|Overall Study|Withdrawal by Subject|4|||
16376334|NCT00500331|39863356|FG001|Overall Study|Withdrawal by Subject|0|||
16376335|NCT00500331|39863357|FG002|Overall Study|Withdrawal by Subject|1|||
16376336|NCT00500331|39863358|FG003|Overall Study|Withdrawal by Subject|5|||
16376337|NCT00500331|39863359|FG004|Overall Study|Withdrawal by Subject|0|||
16376338|NCT00500331|39863360|FG005|Overall Study|Withdrawal by Subject|1|||
16376339|NCT00500331|39863361|FG006|Overall Study|Withdrawal by Subject|1|||
16376340|NCT00500331|39863355|FG000|Overall Study|Lack of Efficacy|3|||
16376341|NCT00500331|39863356|FG001|Overall Study|Lack of Efficacy|1|||
16376342|NCT00500331|39863357|FG002|Overall Study|Lack of Efficacy|0|||
16376343|NCT00500331|39863358|FG003|Overall Study|Lack of Efficacy|0|||
16376344|NCT00500331|39863359|FG004|Overall Study|Lack of Efficacy|0|||
16376345|NCT00500331|39863360|FG005|Overall Study|Lack of Efficacy|0|||
16376346|NCT00500331|39863361|FG006|Overall Study|Lack of Efficacy|0|||
16376347|NCT00500331|39863355|FG000|Overall Study|Liver function test abnormality|0|||
16376348|NCT00500331|39863356|FG001|Overall Study|Liver function test abnormality|0|||
16376349|NCT00500331|39863357|FG002|Overall Study|Liver function test abnormality|1|||
16376350|NCT00500331|39863358|FG003|Overall Study|Liver function test abnormality|0|||
16376351|NCT00500331|39863359|FG004|Overall Study|Liver function test abnormality|0|||
16376352|NCT00500331|39863360|FG005|Overall Study|Liver function test abnormality|0|||
16376353|NCT00500331|39863361|FG006|Overall Study|Liver function test abnormality|0|||
16376354|NCT00500331|39863355|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
16376355|NCT00500331|39863356|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
16376356|NCT00500331|39863357|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
16376357|NCT00500331|39863358|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
16376358|NCT00500331|39863359|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
16376359|NCT00500331|39863360|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
16376360|NCT00500331|39863361|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
16376361|NCT00500331|39863355|FG000|Overall Study|Didn't return for continuation of study|1|||
16376362|NCT00500331|39863356|FG001|Overall Study|Didn't return for continuation of study|0|||
16376363|NCT00500331|39863357|FG002|Overall Study|Didn't return for continuation of study|0|||
16376364|NCT00500331|39863358|FG003|Overall Study|Didn't return for continuation of study|0|||
16376365|NCT00500331|39863359|FG004|Overall Study|Didn't return for continuation of study|0|||
16376366|NCT00500331|39863360|FG005|Overall Study|Didn't return for continuation of study|0|||
16376367|NCT00500331|39863361|FG006|Overall Study|Didn't return for continuation of study|0|||
16376368|NCT00500331|39863355|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
16376369|NCT00500331|39863356|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
16376370|NCT00500331|39863357|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
16376371|NCT00500331|39863358|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
16376372|NCT00500331|39863359|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
16376373|NCT00500331|39863360|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
16376374|NCT00500331|39863361|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
16376375|NCT00500331|39863355|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
16376376|NCT00500331|39863356|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
16376377|NCT00500331|39863357|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
16376378|NCT00500331|39863358|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
16376379|NCT00500331|39863359|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
16376380|NCT00500331|39863360|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
16376381|NCT00500331|39863361|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
16376382|NCT00500331|39863355|FG000|Overall Study|Participant was randomized by mistake|1|||
16376383|NCT00500331|39863356|FG001|Overall Study|Participant was randomized by mistake|0|||
16376384|NCT00500331|39863357|FG002|Overall Study|Participant was randomized by mistake|0|||
16376385|NCT00500331|39863358|FG003|Overall Study|Participant was randomized by mistake|0|||
16376386|NCT00500331|39863359|FG004|Overall Study|Participant was randomized by mistake|0|||
16376387|NCT00500331|39863360|FG005|Overall Study|Participant was randomized by mistake|0|||
16376388|NCT00500331|39863361|FG006|Overall Study|Participant was randomized by mistake|0|||
16376389|NCT00500331|39863355|FG000|Overall Study|Diabetologist nurse in the study|0|||
16376390|NCT00500331|39863356|FG001|Overall Study|Diabetologist nurse in the study|0|||
16376391|NCT00500331|39863357|FG002|Overall Study|Diabetologist nurse in the study|1|||
16376392|NCT00500331|39863358|FG003|Overall Study|Diabetologist nurse in the study|0|||
16376393|NCT00500331|39863359|FG004|Overall Study|Diabetologist nurse in the study|0|||
16376394|NCT00500331|39863360|FG005|Overall Study|Diabetologist nurse in the study|0|||
16376395|NCT00500331|39863361|FG006|Overall Study|Diabetologist nurse in the study|0|||
16376396|NCT00500331|39863355|FG000|Overall Study|State ban of biological samples export|0|||
16376397|NCT00500331|39863356|FG001|Overall Study|State ban of biological samples export|0|||
16376398|NCT00500331|39863357|FG002|Overall Study|State ban of biological samples export|0|||
16376399|NCT00500331|39863358|FG003|Overall Study|State ban of biological samples export|1|||
16376400|NCT00500331|39863359|FG004|Overall Study|State ban of biological samples export|0|||
16376401|NCT00500331|39863360|FG005|Overall Study|State ban of biological samples export|0|||
16376402|NCT00500331|39863361|FG006|Overall Study|State ban of biological samples export|0|||
16376403|NCT00500331|39863355|FG000|Overall Study|Protocol violated|0|||
16376404|NCT00500331|39863356|FG001|Overall Study|Protocol violated|0|||
16376405|NCT00500331|39863357|FG002|Overall Study|Protocol violated|0|||
16376406|NCT00500331|39863358|FG003|Overall Study|Protocol violated|1|||
16376407|NCT00500331|39863359|FG004|Overall Study|Protocol violated|0|||
16376408|NCT00500331|39863360|FG005|Overall Study|Protocol violated|0|||
16376409|NCT00500331|39863361|FG006|Overall Study|Protocol violated|0|||
16376410|NCT01421459|39863362|FG000|Overall Study|Adverse Event|6|||
16376411|NCT01421459|39863363|FG001|Overall Study|Adverse Event|10|||
16376412|NCT01421459|39863362|FG000|Overall Study|Death|1|||
16376413|NCT01421459|39863363|FG001|Overall Study|Death|1|||
16376414|NCT01421459|39863362|FG000|Overall Study|Lack of Efficacy|1|||
16376415|NCT01421459|39863363|FG001|Overall Study|Lack of Efficacy|2|||
16376416|NCT01421459|39863362|FG000|Overall Study|Lost to Follow-up|8|||
16376417|NCT01421459|39863363|FG001|Overall Study|Lost to Follow-up|9|||
16376418|NCT01421459|39863362|FG000|Overall Study|Physician Decision|9|||
16376419|NCT01421459|39863363|FG001|Overall Study|Physician Decision|9|||
16376420|NCT01421459|39863362|FG000|Overall Study|Protocol Violation|8|||
16376421|NCT01421459|39863363|FG001|Overall Study|Protocol Violation|5|||
16376422|NCT01421459|39863362|FG000|Overall Study|Withdrawal by Subject|12|||
16376423|NCT01421459|39863363|FG001|Overall Study|Withdrawal by Subject|16|||
16376424|NCT03977155|39863364|FG000|Overall Study|Adverse Event|3|||
16376425|NCT03977155|39863365|FG001|Overall Study|Adverse Event|0|||
16376426|NCT03977155|39863366|FG002|Overall Study|Adverse Event|0|||
16376427|NCT03977155|39863364|FG000|Overall Study|Lost to Follow-up|0|||
16376428|NCT03977155|39863365|FG001|Overall Study|Lost to Follow-up|1|||
16376429|NCT03977155|39863366|FG002|Overall Study|Lost to Follow-up|0|||
16376430|NCT03977155|39863364|FG000|Overall Study|Withdrawal by Subject|1|||
16376431|NCT03977155|39863365|FG001|Overall Study|Withdrawal by Subject|1|||
16376432|NCT03977155|39863366|FG002|Overall Study|Withdrawal by Subject|2|||
16376433|NCT03977155|39863364|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
16376434|NCT03977155|39863365|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
16376435|NCT03977155|39863366|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
16376436|NCT04507269|39863367|FG000|Overall Study|Withdrawal by Subject|1|||
16376437|NCT04507269|39863368|FG001|Overall Study|Withdrawal by Subject|1|||
16376438|NCT04507269|39863369|FG002|Overall Study|Withdrawal by Subject|0|||
16176067|NCT01662999|39122821|FG002|Period 3|Withdrawal by Subject|0|||
16376439|NCT04507269|39863370|FG003|Overall Study|Withdrawal by Subject|0|||
16376440|NCT04507269|39863371|FG004|Overall Study|Withdrawal by Subject|0|||
16376441|NCT04507269|39863372|FG005|Overall Study|Withdrawal by Subject|0|||
16376442|NCT04507269|39863367|FG000|Overall Study|Lost to Follow-up|0|||
16376443|NCT04507269|39863368|FG001|Overall Study|Lost to Follow-up|0|||
16376444|NCT04507269|39863369|FG002|Overall Study|Lost to Follow-up|0|||
16376445|NCT04507269|39863370|FG003|Overall Study|Lost to Follow-up|0|||
16376446|NCT04507269|39863371|FG004|Overall Study|Lost to Follow-up|1|||
16376447|NCT04507269|39863372|FG005|Overall Study|Lost to Follow-up|0|||
16376448|NCT03787212|39863373|FG000|Period 1|Study Termination|2|||
16376449|NCT03787212|39863374|FG001|Period 1|Study Termination|2|||
16376450|NCT03510715|39863375|FG000|Overall Study|Adverse Event|1|||
16376451|NCT03510715|39863376|FG001|Overall Study|Adverse Event|0|||
16376452|NCT01111552|39863379|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
16376453|NCT01111552|39863380|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16376454|NCT01111552|39863381|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16376455|NCT01111552|39863382|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16376456|NCT01111552|39863383|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16376457|NCT01111552|39863379|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
16376458|NCT01111552|39863380|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16376459|NCT01111552|39863381|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16376460|NCT01111552|39863382|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16376461|NCT01111552|39863383|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16376462|NCT01111552|39863379|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
16376463|NCT01111552|39863380|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16376464|NCT01111552|39863381|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16376465|NCT01111552|39863382|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16376466|NCT01111552|39863383|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16376467|NCT01111552|39863379|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
16376468|NCT01111552|39863380|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
16376469|NCT01111552|39863381|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
16376470|NCT01111552|39863382|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
16376471|NCT01111552|39863383|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
16376472|NCT01111552|39863379|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
16376473|NCT01111552|39863380|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
16376474|NCT01111552|39863381|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
16376475|NCT01111552|39863382|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
16376476|NCT01111552|39863383|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
16376477|NCT01111552|39863379|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
16376478|NCT01111552|39863380|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
16376479|NCT01111552|39863381|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
16376480|NCT01111552|39863382|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
16376481|NCT01111552|39863383|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
16376482|NCT01111552|39863379|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
16376483|NCT01111552|39863380|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16376484|NCT01111552|39863381|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16376485|NCT01111552|39863382|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16376486|NCT01111552|39863383|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16376487|NCT01111552|39863379|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
16376488|NCT01111552|39863380|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
16376489|NCT01111552|39863381|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
16376490|NCT01111552|39863382|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
16376491|NCT01111552|39863383|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
16376492|NCT01111552|39863379|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16376493|NCT01111552|39863380|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16376494|NCT01111552|39863381|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16376495|NCT01111552|39863382|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
16376496|NCT01111552|39863383|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16376497|NCT01111552|39863379|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
16376498|NCT01111552|39863380|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
16376499|NCT01111552|39863381|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
16376500|NCT01111552|39863382|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
16376501|NCT01111552|39863383|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
16376502|NCT01111552|39863379|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
16376503|NCT01111552|39863380|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
16376504|NCT01111552|39863381|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
16376505|NCT01111552|39863382|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
16376506|NCT01111552|39863383|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
16376507|NCT01111552|39863379|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
16376508|NCT01111552|39863380|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
16376509|NCT01111552|39863381|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
16376510|NCT01111552|39863382|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
16376511|NCT01111552|39863383|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
16376512|NCT01111552|39863379|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
16376513|NCT01111552|39863380|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
16376514|NCT01111552|39863381|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
16376515|NCT01111552|39863382|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
16376516|NCT01111552|39863383|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
16376517|NCT01111552|39863379|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16376518|NCT01111552|39863380|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16376519|NCT01111552|39863381|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
16376520|NCT01111552|39863382|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16376521|NCT01111552|39863383|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16376522|NCT00461812|39863387|FG000|Overall Study|study terminated|10|||
16376523|NCT00468546|39863388|FG000|Week 24 Analysis|Lack of Efficacy|83|||
16376524|NCT00468546|39863389|FG001|Week 24 Analysis|Lack of Efficacy|37|||
16376525|NCT00468546|39863388|FG000|Week 24 Analysis|Refused treatment|5|||
16376526|NCT00468546|39863389|FG001|Week 24 Analysis|Refused treatment|5|||
16376527|NCT00468546|39863388|FG000|Week 24 Analysis|Adverse Event|1|||
16376528|NCT00468546|39863389|FG001|Week 24 Analysis|Adverse Event|8|||
16376529|NCT00468546|39863388|FG000|Week 24 Analysis|Failure to return|3|||
16376530|NCT00468546|39863389|FG001|Week 24 Analysis|Failure to return|4|||
16376531|NCT00468546|39863388|FG000|Week 24 Analysis|Rescue therapy|2|||
16376532|NCT00468546|39863389|FG001|Week 24 Analysis|Rescue therapy|0|||
16376533|NCT00468546|39863388|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
16376534|NCT00468546|39863389|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
16376535|NCT00468546|39863388|FG000|Week 24 Analysis|Due to clinical hold|1|||
16376536|NCT00468546|39863389|FG001|Week 24 Analysis|Due to clinical hold|0|||
16376537|NCT00468546|39863388|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
16376538|NCT00468546|39863389|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
16376539|NCT00468546|39863388|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
16376540|NCT00468546|39863389|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
16376541|NCT00468546|39863388|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
16376542|NCT00468546|39863389|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
16376543|NCT00468546|39863388|FG000|Week 24 to Week 104 Analysis|Death|1|||
16376544|NCT00468546|39863389|FG001|Week 24 to Week 104 Analysis|Death|0|||
16376545|NCT00468546|39863388|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
16376546|NCT00468546|39863389|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
16376547|NCT00468546|39863388|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
16376548|NCT00468546|39863389|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
16376549|NCT00468546|39863388|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
16376550|NCT00468546|39863389|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
16376551|NCT00468546|39863388|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
16376552|NCT00468546|39863389|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
16376553|NCT00468546|39863388|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
16376554|NCT00468546|39863389|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
16376555|NCT00468546|39863388|FG000|Week 24 to Week 104 Analysis|Other|17|||
16376556|NCT00468546|39863389|FG001|Week 24 to Week 104 Analysis|Other|14|||
16376557|NCT03247673|39863390|FG000|Overall Study|Withdrawal by Subject|1|||
16376558|NCT03247673|39863391|FG001|Overall Study|Withdrawal by Subject|0|||
16376559|NCT03247673|39863392|FG002|Overall Study|Withdrawal by Subject|3|||
16376560|NCT03247673|39863390|FG000|Overall Study|Lost to Follow-up|0|||
16376561|NCT03247673|39863391|FG001|Overall Study|Lost to Follow-up|0|||
16376562|NCT03247673|39863392|FG002|Overall Study|Lost to Follow-up|1|||
16376563|NCT00527748|39863394|FG000|Overall Study|Other|3|||
16376564|NCT00908141|39863395|FG000|Overall Study|Withdrawal by Subject|0|||
16376565|NCT00908141|39863396|FG001|Overall Study|Withdrawal by Subject|1|||
16376566|NCT02255656|39863397|FG000|Overall Study|Adverse Event|11|||
16376567|NCT02255656|39863397|FG000|Overall Study|Poor compliance to protocol|3|||
16376568|NCT02255656|39863397|FG000|Overall Study|Lost to Follow-up|30|||
16376569|NCT02255656|39863397|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
16376570|NCT02255656|39863397|FG000|Overall Study|Other|126|||
16376571|NCT01772693|39863398|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
16376572|NCT01772693|39863399|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
16376573|NCT01772693|39863398|FG000|Overall Study|Withdrawal by Subject|2|||
16376574|NCT01772693|39863399|FG001|Overall Study|Withdrawal by Subject|0|||
16376575|NCT01772693|39863398|FG000|Overall Study|Alternative Treatment|2|||
16376576|NCT01772693|39863399|FG001|Overall Study|Alternative Treatment|0|||
16376577|NCT01013870|39863400|FG000|Overall Study|Lost to Follow-up|1|||
16376578|NCT01013870|39863401|FG001|Overall Study|Lost to Follow-up|3|||
16376579|NCT02180672|39863406|FG000|Overall Study|Lost to Follow-up|5|||
16376580|NCT02180672|39863407|FG001|Overall Study|Lost to Follow-up|7|||
16376581|NCT03829683|39863408|FG000|Overall Study|Lost to Follow-up|1|||
16376582|NCT03829683|39863409|FG001|Overall Study|Lost to Follow-up|0|||
16376583|NCT03829683|39863408|FG000|Overall Study|Physician Decision|3|||
16376584|NCT03829683|39863409|FG001|Overall Study|Physician Decision|1|||
16376585|NCT03829683|39863408|FG000|Overall Study|Withdrawal by Subject|0|||
16376586|NCT03829683|39863409|FG001|Overall Study|Withdrawal by Subject|1|||
16376587|NCT03829683|39863408|FG000|Overall Study|Discharge from hospital|1|||
16376588|NCT03829683|39863409|FG001|Overall Study|Discharge from hospital|0|||
16376589|NCT01674062|39863413|FG000|Overall Study|Insufficient Therapeutic Response|56|||
16376590|NCT01674062|39863414|FG001|Overall Study|Insufficient Therapeutic Response|26|||
16376591|NCT01674062|39863413|FG000|Overall Study|Other|8|||
16376592|NCT01674062|39863414|FG001|Overall Study|Other|1|||
16376593|NCT01674062|39863413|FG000|Overall Study|Adverse Event|1|||
16376594|NCT01674062|39863414|FG001|Overall Study|Adverse Event|1|||
16376595|NCT01674062|39863413|FG000|Overall Study|Death|0|||
16376596|NCT01674062|39863414|FG001|Overall Study|Death|1|||
16376597|NCT01674062|39863413|FG000|Overall Study|Programming Error|1|||
16376598|NCT01674062|39863414|FG001|Overall Study|Programming Error|0|||
16376599|NCT03460704|39863416|FG000|Overall Study|Withdrawal by Subject|11|||
16376600|NCT03460704|39863417|FG001|Overall Study|Withdrawal by Subject|14|||
16376601|NCT03460704|39863416|FG000|Overall Study|Study terminated by the Sponsor|29|||
16376602|NCT03460704|39863417|FG001|Overall Study|Study terminated by the Sponsor|19|||
16376603|NCT03460704|39863416|FG000|Overall Study|Adverse Event|10|||
16376604|NCT03460704|39863417|FG001|Overall Study|Adverse Event|5|||
16376605|NCT03460704|39863416|FG000|Overall Study|Death|3|||
16376606|NCT03460704|39863417|FG001|Overall Study|Death|2|||
16376607|NCT03460704|39863416|FG000|Overall Study|Non-Compliance with Study Drug|3|||
16376608|NCT03460704|39863417|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16376609|NCT03460704|39863416|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
16376610|NCT03460704|39863417|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
16376611|NCT03460704|39863416|FG000|Overall Study|Other|2|||
16376612|NCT03460704|39863417|FG001|Overall Study|Other|1|||
16376613|NCT02412436|39863420|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
16376614|NCT02412436|39863420|FG000|Overall Study|Lost to Follow-up|6|||
16376615|NCT02412436|39863420|FG000|Overall Study|Unable to get to clinic|3|||
16376616|NCT02412436|39863420|FG000|Overall Study|Death|1|||
16376617|NCT02412436|39863420|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
16376618|NCT01791205|39863422|FG000|Phase II|Lack of Efficacy|6|||
16376619|NCT01791205|39863423|FG001|Phase II|Lack of Efficacy|0|||
16376620|NCT01791205|39863422|FG000|Phase II|Adverse Event|2|||
16376621|NCT01791205|39863423|FG001|Phase II|Adverse Event|0|||
16376622|NCT01791205|39863422|FG000|Phase II|Safety|1|||
16376623|NCT01791205|39863423|FG001|Phase II|Safety|0|||
16376624|NCT01791205|39863422|FG000|Phase II|Lost to Follow-up|1|||
16376625|NCT01791205|39863423|FG001|Phase II|Lost to Follow-up|0|||
16376626|NCT01791205|39863422|FG000|Phase II|Remission of disease|1|||
16376627|NCT01791205|39863423|FG001|Phase II|Remission of disease|0|||
16376628|NCT01791205|39863422|FG000|Phase II|Physician's decision|1|||
16376629|NCT01791205|39863423|FG001|Phase II|Physician's decision|0|||
16376630|NCT01845974|39863426|FG000|Overall Study|screen failure|1|||
16376631|NCT01845974|39863427|FG001|Overall Study|screen failure|0|||
16376632|NCT00662038|39863428|FG000|Overall Study|Reason not specified|3|||
16376633|NCT00662038|39863428|FG000|Overall Study|Withdrawn consent|22|||
16376634|NCT00662038|39863428|FG000|Overall Study|Withdrawal by Subject|83|||
16376635|NCT00662038|39863428|FG000|Overall Study|Sponsor decision|1|||
16376636|NCT00662038|39863428|FG000|Overall Study|Physician Decision|19|||
16376637|NCT00662038|39863428|FG000|Overall Study|Lung transplantation|44|||
16376638|NCT00662038|39863428|FG000|Overall Study|Lost to Follow-up|1|||
16376639|NCT00662038|39863428|FG000|Overall Study|Death|95|||
16376640|NCT00662038|39863428|FG000|Overall Study|Adverse Event|358|||
16376641|NCT00662038|39863428|FG000|Overall Study|Continued treatment|5|||
16376642|NCT02554474|39863429|FG000|Overall Study|Protocol Violation|1|||
16376643|NCT02554474|39863430|FG001|Overall Study|Protocol Violation|1|||
16376644|NCT02554474|39863429|FG000|Overall Study|Health issue not related to the study|1|||
16076226|NCT02553460|38769922|FG000|Overall Study|No response to treatment|2|||
16076227|NCT02553460|38769922|FG000|Overall Study|Still on therapy|7|||
16376645|NCT02554474|39863430|FG001|Overall Study|Health issue not related to the study|0|||
16376646|NCT02554474|39863429|FG000|Overall Study|Withdrawal by Subject|1|||
16376647|NCT02554474|39863430|FG001|Overall Study|Withdrawal by Subject|1|||
16376648|NCT02965456|39863431|FG000|Overall Study|Lost to Follow-up|40|||
16376649|NCT02965456|39863432|FG001|Overall Study|Lost to Follow-up|18|||
16376650|NCT02965456|39863431|FG000|Overall Study|Subject Request|22|||
16376651|NCT02965456|39863432|FG001|Overall Study|Subject Request|13|||
16376652|NCT02965456|39863431|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
16376653|NCT02965456|39863432|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
16376654|NCT02965456|39863431|FG000|Overall Study|Adverse Event|3|||
16376655|NCT02965456|39863432|FG001|Overall Study|Adverse Event|0|||
16376656|NCT02965456|39863431|FG000|Overall Study|Noncompliance with Study Drug|1|||
16376657|NCT02965456|39863432|FG001|Overall Study|Noncompliance with Study Drug|1|||
16376658|NCT02965456|39863431|FG000|Overall Study|Worsening Condition|0|||
16376659|NCT02965456|39863432|FG001|Overall Study|Worsening Condition|2|||
16376660|NCT02965456|39863431|FG000|Overall Study|Lack of Efficacy|1|||
16376661|NCT02965456|39863432|FG001|Overall Study|Lack of Efficacy|0|||
16376662|NCT02965456|39863431|FG000|Overall Study|Physician Decision|0|||
16376663|NCT02965456|39863432|FG001|Overall Study|Physician Decision|1|||
16376664|NCT02965456|39863431|FG000|Overall Study|Pregnancy|1|||
16376665|NCT02965456|39863432|FG001|Overall Study|Pregnancy|0|||
16376666|NCT02965456|39863431|FG000|Overall Study|Protocol Violation|0|||
16376667|NCT02965456|39863432|FG001|Overall Study|Protocol Violation|1|||
16376668|NCT02965456|39863431|FG000|Overall Study|Participant ran out of study drug|0|||
16376669|NCT02965456|39863432|FG001|Overall Study|Participant ran out of study drug|1|||
16376670|NCT02544763|39863433|FG000|Overall Study|Adverse Event|8|||
16376671|NCT02544763|39863434|FG001|Overall Study|Adverse Event|8|||
16376672|NCT02544763|39863435|FG002|Overall Study|Adverse Event|0|||
16376673|NCT02544763|39863433|FG000|Overall Study|Withdrawn by parent/guardian|1|||
16376674|NCT02544763|39863434|FG001|Overall Study|Withdrawn by parent/guardian|1|||
16376675|NCT02544763|39863435|FG002|Overall Study|Withdrawn by parent/guardian|1|||
16376676|NCT02544763|39863433|FG000|Overall Study|Met withdrawal criteria|0|||
16376677|NCT02544763|39863434|FG001|Overall Study|Met withdrawal criteria|2|||
16376678|NCT02544763|39863435|FG002|Overall Study|Met withdrawal criteria|0|||
16376679|NCT02544763|39863433|FG000|Overall Study|Physician Decision|0|||
16376680|NCT02544763|39863434|FG001|Overall Study|Physician Decision|1|||
16376681|NCT02544763|39863435|FG002|Overall Study|Physician Decision|0|||
16376682|NCT02544763|39863433|FG000|Overall Study|Difficulties taking IMP|1|||
16376683|NCT02544763|39863434|FG001|Overall Study|Difficulties taking IMP|0|||
16376684|NCT02544763|39863435|FG002|Overall Study|Difficulties taking IMP|0|||
16376685|NCT00432991|39863436|FG000|Overall Study|Protocol Violation|7|||
16376686|NCT00432991|39863437|FG001|Overall Study|Protocol Violation|12|||
16376687|NCT02457546|39863438|FG000|Overall Study|Other reasons|4|||
16376688|NCT02457546|39863439|FG001|Overall Study|Other reasons|1|||
16376689|NCT02457546|39863438|FG000|Overall Study|Refused to complete study/procedures|1|||
16376690|NCT02457546|39863439|FG001|Overall Study|Refused to complete study/procedures|1|||
16376691|NCT02457546|39863438|FG000|Overall Study|Lost to Follow-up|4|||
16376692|NCT02457546|39863439|FG001|Overall Study|Lost to Follow-up|1|||
16376693|NCT02457546|39863438|FG000|Overall Study|Adverse Event|0|||
16376694|NCT02457546|39863439|FG001|Overall Study|Adverse Event|1|||
16376695|NCT01767857|39863453|FG000|Overall Study|Adverse Event|27|||
16376696|NCT01767857|39863454|FG001|Overall Study|Adverse Event|7|||
16376697|NCT01767857|39863453|FG000|Overall Study|Death|28|||
16376698|NCT01767857|39863454|FG001|Overall Study|Death|13|||
16376699|NCT01767857|39863453|FG000|Overall Study|Lack of Efficacy|299|||
16376700|NCT01767857|39863454|FG001|Overall Study|Lack of Efficacy|151|||
16376701|NCT01767857|39863453|FG000|Overall Study|Lost to Follow-up|1|||
16376702|NCT01767857|39863454|FG001|Overall Study|Lost to Follow-up|1|||
16376703|NCT01767857|39863453|FG000|Overall Study|Withdrawal by Subject|38|||
16376704|NCT01767857|39863454|FG001|Overall Study|Withdrawal by Subject|18|||
16376705|NCT01767857|39863453|FG000|Overall Study|Physician Decision|17|||
16376706|NCT01767857|39863454|FG001|Overall Study|Physician Decision|10|||
16376707|NCT01767857|39863453|FG000|Overall Study|Protocol Terminated|1|||
16376708|NCT01767857|39863454|FG001|Overall Study|Protocol Terminated|0|||
16376709|NCT01767857|39863453|FG000|Overall Study|Randomized But Never Treated|19|||
16376710|NCT01767857|39863454|FG001|Overall Study|Randomized But Never Treated|13|||
16376711|NCT03382873|39863456|FG000|Overall Study|Lost to Follow-up|9|||
16376712|NCT03382873|39863457|FG001|Overall Study|Lost to Follow-up|10|||
16376713|NCT03382873|39863456|FG000|Overall Study|Withdrawal by Subject|6|||
16376714|NCT03382873|39863457|FG001|Overall Study|Withdrawal by Subject|11|||
16376715|NCT03382873|39863456|FG000|Overall Study|Visit not completed due to pandemic|16|||
16376716|NCT03382873|39863457|FG001|Overall Study|Visit not completed due to pandemic|41|||
16376717|NCT00382863|39863458|FG000|Overall Study|Death|9|||
16376718|NCT00382863|39863459|FG001|Overall Study|Death|9|||
16376719|NCT00382863|39863458|FG000|Overall Study|Lost to Follow-up|1|||
16376720|NCT00382863|39863459|FG001|Overall Study|Lost to Follow-up|2|||
16376721|NCT00382863|39863458|FG000|Overall Study|Withdrawal by Subject|5|||
16376722|NCT00382863|39863459|FG001|Overall Study|Withdrawal by Subject|25|||
16376723|NCT03847519|39863460|FG000|Overall Study|Death|5|||
16376724|NCT03847519|39863461|FG001|Overall Study|Death|8|||
16376725|NCT03847519|39863462|FG002|Overall Study|Death|1|||
16376726|NCT03847519|39863460|FG000|Overall Study|Lost to Follow-up|1|||
16376727|NCT03847519|39863461|FG001|Overall Study|Lost to Follow-up|2|||
16376728|NCT03847519|39863462|FG002|Overall Study|Lost to Follow-up|0|||
16376729|NCT03847519|39863460|FG000|Overall Study|Study Terminated by Sponsor|0|||
16376730|NCT03847519|39863461|FG001|Overall Study|Study Terminated by Sponsor|3|||
16376731|NCT03847519|39863462|FG002|Overall Study|Study Terminated by Sponsor|2|||
16376732|NCT03647137|39863465|FG000|Overall Study|Scan Limitation|2|||
16376733|NCT03647137|39863466|FG001|Overall Study|Scan Limitation|1|||
16376734|NCT03647137|39863467|FG002|Overall Study|Scan Limitation|1|||
16376735|NCT03647137|39863468|FG003|Overall Study|Scan Limitation|2|||
16376736|NCT00539500|39863472|FG000|Overall Study|Disease Progression|1|||
16376737|NCT00539500|39863472|FG000|Overall Study|Lost to Follow-up|2|||
16376738|NCT00489476|39863475|FG000|Overall Study|Lost to Follow-up|0|||
16376739|NCT00489476|39863476|FG001|Overall Study|Lost to Follow-up|1|||
16376740|NCT00489476|39863477|FG002|Overall Study|Lost to Follow-up|0|||
16376741|NCT00489476|39863478|FG003|Overall Study|Lost to Follow-up|0|||
16076228|NCT02553460|38769922|FG000|Overall Study|CAR T cells|1|||
16376742|NCT00456365|39863479|FG000|Overall Study|Lost to Follow-up|1|||
16376743|NCT00456365|39863480|FG001|Overall Study|Lost to Follow-up|3|||
16376744|NCT00456365|39863479|FG000|Overall Study|Withdrawal by Subject|4|||
16376745|NCT00456365|39863480|FG001|Overall Study|Withdrawal by Subject|7|||
16376746|NCT00456365|39863479|FG000|Overall Study|Pregnancy|1|||
16376747|NCT00456365|39863480|FG001|Overall Study|Pregnancy|1|||
16376748|NCT00456365|39863479|FG000|Overall Study|oncologic diagnosis|1|||
16376749|NCT00456365|39863480|FG001|Overall Study|oncologic diagnosis|1|||
16376750|NCT02583477|39863481|FG000|Overall Study|Adverse Event|0|||
16376751|NCT02583477|39863482|FG001|Overall Study|Adverse Event|2|||
16376752|NCT02583477|39863481|FG000|Overall Study|Death|1|||
16376753|NCT02583477|39863482|FG001|Overall Study|Death|16|||
16376754|NCT02583477|39863481|FG000|Overall Study|Study terminated|2|||
16376755|NCT02583477|39863482|FG001|Overall Study|Study terminated|2|||
16376756|NCT02202577|39863483|FG000|Overall Study|Lost to Follow-up|6|||
16376757|NCT02202577|39863484|FG001|Overall Study|Lost to Follow-up|16|||
16376758|NCT02202577|39863483|FG000|Overall Study|Protocol Violation|7|||
16376759|NCT02202577|39863484|FG001|Overall Study|Protocol Violation|3|||
16376760|NCT01027351|39863485|FG000|Overall Study|Withdrawal by Subject|1|||
16376761|NCT01027351|39863486|FG001|Overall Study|Withdrawal by Subject|0|||
16376762|NCT01027351|39863487|FG002|Overall Study|Withdrawal by Subject|1|||
16376763|NCT01027351|39863488|FG003|Overall Study|Withdrawal by Subject|0|||
16376764|NCT01027351|39863489|FG004|Overall Study|Withdrawal by Subject|3|||
16376765|NCT01027351|39863490|FG005|Overall Study|Withdrawal by Subject|5|||
16376766|NCT01027351|39863485|FG000|Overall Study|Lost to Follow-up|1|||
16376767|NCT01027351|39863486|FG001|Overall Study|Lost to Follow-up|1|||
16376768|NCT01027351|39863487|FG002|Overall Study|Lost to Follow-up|0|||
16376769|NCT01027351|39863488|FG003|Overall Study|Lost to Follow-up|1|||
16376770|NCT01027351|39863489|FG004|Overall Study|Lost to Follow-up|6|||
16376771|NCT01027351|39863490|FG005|Overall Study|Lost to Follow-up|0|||
16376772|NCT01027351|39863485|FG000|Overall Study|Inappropriate enrollment|0|||
16376773|NCT01027351|39863486|FG001|Overall Study|Inappropriate enrollment|0|||
16376774|NCT01027351|39863487|FG002|Overall Study|Inappropriate enrollment|0|||
16376775|NCT01027351|39863488|FG003|Overall Study|Inappropriate enrollment|0|||
16376776|NCT01027351|39863489|FG004|Overall Study|Inappropriate enrollment|1|||
16376777|NCT01027351|39863490|FG005|Overall Study|Inappropriate enrollment|0|||
16376778|NCT01027351|39863485|FG000|Overall Study|Protocol Violation|1|||
16376779|NCT01027351|39863486|FG001|Overall Study|Protocol Violation|0|||
16376780|NCT01027351|39863487|FG002|Overall Study|Protocol Violation|0|||
16376781|NCT01027351|39863488|FG003|Overall Study|Protocol Violation|1|||
16376782|NCT01027351|39863489|FG004|Overall Study|Protocol Violation|1|||
16376783|NCT01027351|39863490|FG005|Overall Study|Protocol Violation|0|||
16376784|NCT02773537|39863491|FG000|Overall Study|Lost to Follow-up|0|||
16376785|NCT02773537|39863492|FG001|Overall Study|Lost to Follow-up|1|||
16376786|NCT02773537|39863493|FG002|Overall Study|Lost to Follow-up|4|||
16376787|NCT02284893|39866474|FG000|26 Week (Short Term)|Adverse Event|1|||
16376788|NCT02284893|39866475|FG001|26 Week (Short Term)|Adverse Event|9|||
16376789|NCT02284893|39866474|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
16376790|NCT02284893|39866475|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
16376791|NCT02284893|39866474|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
16376792|NCT02284893|39866475|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
16376793|NCT02284893|39866474|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
16376794|NCT02284893|39866475|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
16376795|NCT02284893|39866474|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
16376796|NCT02284893|39866475|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
16376797|NCT02284893|39866474|FG000|26 Week (Short Term)|Other|1|||
16376798|NCT02284893|39866475|FG001|26 Week (Short Term)|Other|1|||
16376799|NCT02284893|39866474|FG000|52 Week (Long Term)|Adverse Event|3|||
16376800|NCT02284893|39866475|FG001|52 Week (Long Term)|Adverse Event|1|||
16376801|NCT02284893|39866474|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
16376802|NCT02284893|39866475|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
16376803|NCT02284893|39866474|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
16376804|NCT02284893|39866475|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
16376805|NCT02284893|39866474|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
16376806|NCT02284893|39866475|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
16376807|NCT02284893|39866474|FG000|52 Week (Long Term)|Non-Compliance|2|||
16376808|NCT02284893|39866475|FG001|52 Week (Long Term)|Non-Compliance|3|||
16376809|NCT01922895|39866476|FG000|Overall Study|Death|0|||
16376810|NCT01922895|39866477|FG001|Overall Study|Death|1|||
16376811|NCT01922895|39866476|FG000|Overall Study|Withdrawal by Subject|1|||
16376812|NCT01922895|39866477|FG001|Overall Study|Withdrawal by Subject|2|||
16376813|NCT01922895|39866476|FG000|Overall Study|Lost to Follow-up|5|||
16376814|NCT01922895|39866477|FG001|Overall Study|Lost to Follow-up|11|||
16376815|NCT03400787|39866478|FG000|Overall Study|Lost to Follow-up|1|||
16376816|NCT03400787|39866479|FG001|Overall Study|Lost to Follow-up|0|||
16376817|NCT03400787|39866478|FG000|Overall Study|Death|1|||
16376818|NCT03400787|39866479|FG001|Overall Study|Death|0|||
16376819|NCT03400787|39866478|FG000|Overall Study|Protocol Violation|0|||
16376820|NCT03400787|39866479|FG001|Overall Study|Protocol Violation|2|||
16376821|NCT03400787|39866478|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
16376822|NCT03400787|39866479|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
16376823|NCT00530257|39866480|FG000|Overall Study|Lost to Follow-up|1|||
16376824|NCT01926509|39866483|FG000|Overall Study|vital sign met discontinuation criteria|1|||
16376825|NCT01926509|39866484|FG001|Overall Study|vital sign met discontinuation criteria|0|||
16376826|NCT01926509|39866485|FG002|Overall Study|vital sign met discontinuation criteria|0|||
16376827|NCT01926509|39866486|FG003|Overall Study|vital sign met discontinuation criteria|0|||
16376828|NCT03777020|39866489|FG000|Overall Study|Withdrawal by Subject|4|||
16376829|NCT03777020|39866490|FG001|Overall Study|Withdrawal by Subject|4|||
16376830|NCT03777020|39866489|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
16376831|NCT03777020|39866490|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
16376832|NCT03332056|39866491|FG000|Overall Study|Incomplete questionnaires|8|||
16376833|NCT03332056|39866492|FG001|Overall Study|Incomplete questionnaires|9|||
16376834|NCT03332056|39866491|FG000|Overall Study|Passed stone prior to surgery date|1|||
16376835|NCT03332056|39866492|FG001|Overall Study|Passed stone prior to surgery date|0|||
16376836|NCT03332056|39866491|FG000|Overall Study|Did not require a ureteral stent|0|||
16376837|NCT03332056|39866492|FG001|Overall Study|Did not require a ureteral stent|1|||
16376838|NCT02781558|39866493|FG000|Overall Study|Lost to Follow-up|2|||
16376839|NCT02781558|39866494|FG001|Overall Study|Lost to Follow-up|2|||
16376840|NCT02781558|39866493|FG000|Overall Study|Adverse Event|1|||
16376841|NCT02781558|39866494|FG001|Overall Study|Adverse Event|0|||
16376842|NCT00979407|39866499|FG000|Overall Study|Withdrawal by Subject|3|||
16376843|NCT00979407|39866500|FG001|Overall Study|Withdrawal by Subject|4|||
16376844|NCT00979407|39866499|FG000|Overall Study|Lost to Follow-up|3|||
16376845|NCT00979407|39866500|FG001|Overall Study|Lost to Follow-up|3|||
16376846|NCT03895372|39866502|FG000|Investigational Treatment Period|Adverse Event|1|||
16376847|NCT03895372|39866503|FG001|Investigational Treatment Period|Adverse Event|0|||
16376848|NCT03895372|39866504|FG002|Investigational Treatment Period|Adverse Event|0|||
16376849|NCT03895372|39866505|FG003|Investigational Treatment Period|Adverse Event|0|||
16376850|NCT03895372|39866506|FG004|Investigational Treatment Period|Adverse Event|0|||
16376851|NCT03895372|39866507|FG005|Investigational Treatment Period|Adverse Event|0|||
16376852|NCT03895372|39866508|FG006|Investigational Treatment Period|Adverse Event|4|||
16376853|NCT03895372|39866509|FG007|Investigational Treatment Period|Adverse Event|3|||
16376854|NCT03895372|39866502|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
16376855|NCT03895372|39866503|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
16376856|NCT03895372|39866504|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
16376857|NCT03895372|39866505|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
16376858|NCT03895372|39866506|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
16376859|NCT03895372|39866507|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
16376860|NCT03895372|39866508|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
16376861|NCT03895372|39866509|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
16376862|NCT03895372|39866502|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
16376863|NCT03895372|39866503|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
16376864|NCT03895372|39866504|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
16376865|NCT03895372|39866505|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
16376866|NCT03895372|39866506|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
16376867|NCT03895372|39866507|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
16376868|NCT03895372|39866508|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
16376869|NCT03895372|39866509|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
16376870|NCT03895372|39866502|FG000|Investigational Treatment Period|Other|0|||
16376871|NCT03895372|39866503|FG001|Investigational Treatment Period|Other|0|||
16376872|NCT03895372|39866504|FG002|Investigational Treatment Period|Other|0|||
16376873|NCT03895372|39866505|FG003|Investigational Treatment Period|Other|0|||
16376874|NCT03895372|39866506|FG004|Investigational Treatment Period|Other|0|||
16376875|NCT03895372|39866507|FG005|Investigational Treatment Period|Other|1|||
16376876|NCT03895372|39866508|FG006|Investigational Treatment Period|Other|0|||
16376877|NCT03895372|39866509|FG007|Investigational Treatment Period|Other|2|||
16376878|NCT03895372|39866502|FG000|Investigational Treatment Period|Protocol Violation|0|||
16376879|NCT03895372|39866503|FG001|Investigational Treatment Period|Protocol Violation|0|||
16376880|NCT03895372|39866504|FG002|Investigational Treatment Period|Protocol Violation|0|||
16376881|NCT03895372|39866505|FG003|Investigational Treatment Period|Protocol Violation|1|||
16376882|NCT03895372|39866506|FG004|Investigational Treatment Period|Protocol Violation|0|||
16376883|NCT03895372|39866507|FG005|Investigational Treatment Period|Protocol Violation|0|||
16376884|NCT03895372|39866508|FG006|Investigational Treatment Period|Protocol Violation|0|||
16376885|NCT03895372|39866509|FG007|Investigational Treatment Period|Protocol Violation|0|||
16376886|NCT03895372|39866502|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
16376887|NCT03895372|39866503|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
16376888|NCT03895372|39866504|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
16376889|NCT03895372|39866505|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
16376890|NCT03895372|39866506|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
16376891|NCT03895372|39866507|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
16376892|NCT03895372|39866508|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
16376893|NCT03895372|39866509|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
16376894|NCT03895372|39866502|FG000|Extension Treatment Period|Adverse Event|0|||
16376895|NCT03895372|39866503|FG001|Extension Treatment Period|Adverse Event|1|||
16376896|NCT03895372|39866504|FG002|Extension Treatment Period|Adverse Event|0|||
16376897|NCT03895372|39866505|FG003|Extension Treatment Period|Adverse Event|1|||
16376898|NCT03895372|39866506|FG004|Extension Treatment Period|Adverse Event|0|||
16376899|NCT03895372|39866507|FG005|Extension Treatment Period|Adverse Event|0|||
16376900|NCT03895372|39866508|FG006|Extension Treatment Period|Adverse Event|3|||
16376901|NCT03895372|39866509|FG007|Extension Treatment Period|Adverse Event|3|||
16376902|NCT03895372|39866502|FG000|Extension Treatment Period|Other|1|||
16376903|NCT03895372|39866503|FG001|Extension Treatment Period|Other|3|||
16376904|NCT03895372|39866504|FG002|Extension Treatment Period|Other|0|||
16376905|NCT03895372|39866505|FG003|Extension Treatment Period|Other|0|||
16376906|NCT03895372|39866506|FG004|Extension Treatment Period|Other|1|||
16376907|NCT03895372|39866507|FG005|Extension Treatment Period|Other|0|||
16376908|NCT03895372|39866508|FG006|Extension Treatment Period|Other|0|||
16376909|NCT03895372|39866509|FG007|Extension Treatment Period|Other|2|||
16376910|NCT03895372|39866502|FG000|Extension Treatment Period|Pregnancy|0|||
16376911|NCT03895372|39866503|FG001|Extension Treatment Period|Pregnancy|0|||
16376912|NCT03895372|39866504|FG002|Extension Treatment Period|Pregnancy|0|||
16376913|NCT03895372|39866505|FG003|Extension Treatment Period|Pregnancy|0|||
16376914|NCT03895372|39866506|FG004|Extension Treatment Period|Pregnancy|1|||
16376915|NCT03895372|39866507|FG005|Extension Treatment Period|Pregnancy|0|||
16376916|NCT03895372|39866508|FG006|Extension Treatment Period|Pregnancy|0|||
16376917|NCT03895372|39866509|FG007|Extension Treatment Period|Pregnancy|0|||
16376918|NCT03895372|39866502|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
16376919|NCT03895372|39866503|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
16376920|NCT03895372|39866504|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
16376921|NCT03895372|39866505|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
16376922|NCT03895372|39866506|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
16376923|NCT03895372|39866507|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
16376924|NCT03895372|39866508|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
16376925|NCT03895372|39866509|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
16376926|NCT04123704|39866516|FG000|Overall Study|Disease progression|2|||
16376927|NCT00488293|39866520|FG000|Overall Study|Lost to Follow-up|28|||
16376928|NCT00488293|39866521|FG001|Overall Study|Lost to Follow-up|25|||
16376929|NCT00488293|39866520|FG000|Overall Study|Withdrawal by Subject|5|||
16376930|NCT00488293|39866521|FG001|Overall Study|Withdrawal by Subject|3|||
16376931|NCT00488293|39866520|FG000|Overall Study|Death|2|||
16376932|NCT00488293|39866521|FG001|Overall Study|Death|1|||
16376933|NCT00488293|39866520|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
16376934|NCT00488293|39866521|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
16376935|NCT02264821|39866524|FG000|Overall Study|Protocol Violation|1|||
16376936|NCT02264821|39866525|FG001|Overall Study|Protocol Violation|3|||
16376937|NCT02264821|39866526|FG002|Overall Study|Protocol Violation|6|||
16376938|NCT01272219|39866529|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
16376939|NCT01272219|39866530|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
16376940|NCT01272219|39866531|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
16376941|NCT01272219|39866532|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
16376942|NCT01272219|39866533|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
16376943|NCT01272219|39866534|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
16376944|NCT01272219|39866529|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
16376945|NCT01272219|39866530|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
16376946|NCT01272219|39866531|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
16376947|NCT01272219|39866532|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
16376948|NCT01272219|39866533|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
16376949|NCT01272219|39866534|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
16376950|NCT01272219|39866529|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
16376951|NCT01272219|39866530|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
16376952|NCT01272219|39866531|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
16376953|NCT01272219|39866532|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
16376954|NCT01272219|39866533|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
16376955|NCT01272219|39866534|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
16376956|NCT01272219|39866529|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
16376957|NCT01272219|39866530|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
16376958|NCT01272219|39866531|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
16376959|NCT01272219|39866532|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
16376960|NCT01272219|39866533|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
16376961|NCT01272219|39866534|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
16376962|NCT01272219|39866529|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
16376963|NCT01272219|39866530|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
16376964|NCT01272219|39866531|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
16376965|NCT01272219|39866532|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
16376966|NCT01272219|39866533|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
16376967|NCT01272219|39866534|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
16376968|NCT01272219|39866529|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
16376969|NCT01272219|39866530|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
16376970|NCT01272219|39866531|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
16376971|NCT01272219|39866532|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
16376972|NCT01272219|39866533|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
16376973|NCT01272219|39866534|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
16376974|NCT01272219|39866529|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
16376975|NCT01272219|39866530|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
16376976|NCT01272219|39866531|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
16376977|NCT01272219|39866532|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
16376978|NCT01272219|39866533|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
16376979|NCT01272219|39866534|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
16376980|NCT01272219|39866529|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
16376981|NCT01272219|39866530|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
16376982|NCT01272219|39866531|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
16376983|NCT01272219|39866532|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
16376984|NCT01272219|39866533|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
16376985|NCT01272219|39866534|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
16376986|NCT01272219|39866529|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
16376987|NCT01272219|39866530|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
16376988|NCT01272219|39866531|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
16376989|NCT01272219|39866532|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
16376990|NCT01272219|39866533|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
16376991|NCT01272219|39866534|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
16376992|NCT01272219|39866529|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
16376993|NCT01272219|39866530|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
16376994|NCT01272219|39866531|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
16376995|NCT01272219|39866532|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
16376996|NCT01272219|39866533|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
16376997|NCT01272219|39866534|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
16376998|NCT01272219|39866529|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
16376999|NCT01272219|39866530|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
16377000|NCT01272219|39866531|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
16377001|NCT01272219|39866532|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
16377002|NCT01272219|39866533|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
16377003|NCT01272219|39866534|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
16377004|NCT01272219|39866529|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
16377005|NCT01272219|39866530|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
16377006|NCT01272219|39866531|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
16377007|NCT01272219|39866532|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
16377008|NCT01272219|39866533|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
16377009|NCT01272219|39866534|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
16377010|NCT01272219|39866529|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
16377011|NCT01272219|39866530|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
16377012|NCT01272219|39866531|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
16377013|NCT01272219|39866532|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
16377014|NCT01272219|39866533|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
16377015|NCT01272219|39866534|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
16377016|NCT01272219|39866529|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
16377017|NCT01272219|39866530|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
16377018|NCT01272219|39866531|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
16377019|NCT01272219|39866532|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
16377020|NCT01272219|39866533|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
16377021|NCT01272219|39866534|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
16377022|NCT01272219|39866529|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
16377023|NCT01272219|39866530|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
16377024|NCT01272219|39866531|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
16377025|NCT01272219|39866532|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
16377026|NCT01272219|39866533|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
16377027|NCT01272219|39866534|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
16377028|NCT01272219|39866529|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
16377029|NCT01272219|39866530|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
16377030|NCT01272219|39866531|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
16377031|NCT01272219|39866532|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
16377032|NCT01272219|39866533|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
16377033|NCT01272219|39866534|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
16377034|NCT04641975|39866535|FG000|Overall Study|Protocol Violation|1|||
16377035|NCT04641975|39866536|FG001|Overall Study|Protocol Violation|2|||
16377036|NCT04641975|39866537|FG002|Overall Study|Protocol Violation|0|||
16377037|NCT04641975|39866538|FG003|Overall Study|Protocol Violation|0|||
16377038|NCT04641975|39866535|FG000|Overall Study|Adverse Event|0|||
16377039|NCT04641975|39866536|FG001|Overall Study|Adverse Event|0|||
16377040|NCT04641975|39866537|FG002|Overall Study|Adverse Event|1|||
16377041|NCT04641975|39866538|FG003|Overall Study|Adverse Event|1|||
16377042|NCT04641975|39866535|FG000|Overall Study|Withdrawal by Subject|1|||
16377043|NCT04641975|39866536|FG001|Overall Study|Withdrawal by Subject|0|||
16377044|NCT04641975|39866537|FG002|Overall Study|Withdrawal by Subject|0|||
16377045|NCT04641975|39866538|FG003|Overall Study|Withdrawal by Subject|0|||
16377046|NCT01633112|39866539|FG000|Overall Study|Lack of Efficacy|1|||
16377047|NCT01633112|39866540|FG001|Overall Study|Lack of Efficacy|6|||
16377048|NCT01633112|39866541|FG002|Overall Study|Lack of Efficacy|13|||
16377049|NCT01633112|39866539|FG000|Overall Study|Abnormal laboratory value(s)|3|||
16377050|NCT01633112|39866540|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16377051|NCT01633112|39866541|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16377052|NCT01633112|39866539|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16377053|NCT01633112|39866540|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16377054|NCT01633112|39866541|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16377055|NCT01633112|39866539|FG000|Overall Study|Administrative problems|1|||
16377056|NCT01633112|39866540|FG001|Overall Study|Administrative problems|2|||
16377057|NCT01633112|39866541|FG002|Overall Study|Administrative problems|5|||
16377058|NCT01633112|39866539|FG000|Overall Study|Adverse Event|16|||
16377059|NCT01633112|39866540|FG001|Overall Study|Adverse Event|18|||
16377060|NCT01633112|39866541|FG002|Overall Study|Adverse Event|20|||
16377061|NCT01633112|39866539|FG000|Overall Study|Lost to Follow-up|7|||
16377062|NCT01633112|39866540|FG001|Overall Study|Lost to Follow-up|19|||
16377063|NCT01633112|39866541|FG002|Overall Study|Lost to Follow-up|6|||
16377064|NCT01633112|39866539|FG000|Overall Study|Protocol Violation|4|||
16377065|NCT01633112|39866540|FG001|Overall Study|Protocol Violation|0|||
16377066|NCT01633112|39866541|FG002|Overall Study|Protocol Violation|2|||
16377067|NCT01633112|39866539|FG000|Overall Study|Subject no longer requires study drug|0|||
16377068|NCT01633112|39866540|FG001|Overall Study|Subject no longer requires study drug|0|||
16377069|NCT01633112|39866541|FG002|Overall Study|Subject no longer requires study drug|1|||
16377070|NCT01633112|39866539|FG000|Overall Study|Withdrawal by Subject|20|||
16377071|NCT01633112|39866540|FG001|Overall Study|Withdrawal by Subject|12|||
16377072|NCT01633112|39866541|FG002|Overall Study|Withdrawal by Subject|41|||
16377073|NCT01633112|39866539|FG000|Overall Study|missing Study Completion CRF|1|||
16377074|NCT01633112|39866540|FG001|Overall Study|missing Study Completion CRF|1|||
16377075|NCT01633112|39866541|FG002|Overall Study|missing Study Completion CRF|4|||
16377076|NCT01028560|39866542|FG000|Overall Study|Lack of Efficacy|3|||
16377077|NCT01028560|39866543|FG001|Overall Study|Lack of Efficacy|6|||
16377078|NCT01028560|39866542|FG000|Overall Study|Withdrawal by Subject|7|||
16377079|NCT01028560|39866543|FG001|Overall Study|Withdrawal by Subject|12|||
16377080|NCT03766399|39866545|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377081|NCT03766399|39866546|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377082|NCT03766399|39866547|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377083|NCT03766399|39866548|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377084|NCT03766399|39866549|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377085|NCT03766399|39866550|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377086|NCT03766399|39866551|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377087|NCT03766399|39866552|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377088|NCT03766399|39866553|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377089|NCT03766399|39866554|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377090|NCT03766399|39866555|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377091|NCT03766399|39866556|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377092|NCT03766399|39866557|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377093|NCT03766399|39866558|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
16377094|NCT03766399|39866559|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377095|NCT03766399|39866560|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377096|NCT03766399|39866561|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377097|NCT03766399|39866562|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
16377098|NCT03990571|39866566|FG000|Overall Study|Withdrawal by Subject|1|||
16377099|NCT03990571|39866566|FG000|Overall Study|Insurance Issues|3|||
16377100|NCT03990571|39866566|FG000|Overall Study|Covid Restrictions|2|||
16377101|NCT04620668|39866587|FG000|Overall Study|Withdrawal by Subject|2|||
16377102|NCT04620668|39866588|FG001|Overall Study|Withdrawal by Subject|0|||
16377103|NCT04620668|39866587|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
16377104|NCT04620668|39866588|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
16377105|NCT04620668|39866587|FG000|Overall Study|Removed before analysis: missing data|2|||
16377106|NCT04620668|39866588|FG001|Overall Study|Removed before analysis: missing data|0|||
16377107|NCT04620668|39866587|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
16377108|NCT04620668|39866588|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
16377109|NCT04620668|39866587|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
16377110|NCT04620668|39866588|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
16377111|NCT02624687|39866595|FG000|Overall Study|Withdrawal by Subject|1|||
16377112|NCT02624687|39866596|FG001|Overall Study|Withdrawal by Subject|1|||
16377113|NCT02624687|39866595|FG000|Overall Study|medical leave from work|0|||
16377114|NCT02624687|39866596|FG001|Overall Study|medical leave from work|1|||
16377115|NCT00879398|39866597|FG000|Overall Study|Visit Stop|399|||
16377116|NCT00879398|39866597|FG000|Overall Study|Lack of Efficacy|64|||
16377117|NCT00879398|39866597|FG000|Overall Study|Adverse Event|41|||
16377118|NCT00879398|39866597|FG000|Overall Study|Other Reasons|171|||
16377119|NCT01309100|39866598|FG000|Overall Study|Protocol Violation|1|||
16377120|NCT01309100|39866598|FG000|Overall Study|Positive Slit lamp finding|1|||
16377121|NCT04470908|39866603|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
16377122|NCT01443026|39866606|FG000|Overall Study|Physician Decision|1|||
16377123|NCT01443026|39866607|FG001|Overall Study|Physician Decision|0|||
16377124|NCT01443026|39866606|FG000|Overall Study|Death|0|||
16377125|NCT01443026|39866607|FG001|Overall Study|Death|1|||
16377126|NCT01443026|39866606|FG000|Overall Study|Withdrawal by Subject|0|||
16377127|NCT01443026|39866607|FG001|Overall Study|Withdrawal by Subject|3|||
16377128|NCT01443026|39866606|FG000|Overall Study|Lost to Follow-up|2|||
16377129|NCT01443026|39866607|FG001|Overall Study|Lost to Follow-up|1|||
16377130|NCT04887285|39866608|FG000|Overall Study|Lost to Follow-up|0|||
16377131|NCT04887285|39866609|FG001|Overall Study|Lost to Follow-up|2|||
16377132|NCT04887285|39866610|FG002|Overall Study|Lost to Follow-up|3|||
16377133|NCT01730729|39866611|FG000|Overall Study|Adverse Event|1|||
16377134|NCT01730729|39866611|FG000|Overall Study|Death|1|||
16377135|NCT01730729|39866611|FG000|Overall Study|Progressive Disease|12|||
16377136|NCT00553254|39866612|FG000|Overall Study|Death|3|||
16377137|NCT00553254|39866613|FG001|Overall Study|Death|6|||
16377138|NCT00553254|39866614|FG002|Overall Study|Death|25|||
16377139|NCT00553254|39866612|FG000|Overall Study|Lost to Follow-up|0|||
16377140|NCT00553254|39866613|FG001|Overall Study|Lost to Follow-up|0|||
16377141|NCT00553254|39866614|FG002|Overall Study|Lost to Follow-up|2|||
16377142|NCT00553254|39866612|FG000|Overall Study|Withdrawal by Subject|2|||
16377143|NCT00553254|39866613|FG001|Overall Study|Withdrawal by Subject|0|||
16377144|NCT00553254|39866614|FG002|Overall Study|Withdrawal by Subject|2|||
16377145|NCT00553254|39866612|FG000|Overall Study|Study terminated by Sponsor|0|||
16377146|NCT00553254|39866613|FG001|Overall Study|Study terminated by Sponsor|0|||
16377147|NCT00553254|39866614|FG002|Overall Study|Study terminated by Sponsor|1|||
16377148|NCT00553254|39866612|FG000|Overall Study|Other|1|||
16377149|NCT00553254|39866613|FG001|Overall Study|Other|0|||
16377150|NCT00553254|39866614|FG002|Overall Study|Other|13|||
16377151|NCT03633058|39866615|FG000|Overall Study|Adverse Event|0|||
16377152|NCT03633058|39866616|FG001|Overall Study|Adverse Event|0|||
16377153|NCT03633058|39866617|FG002|Overall Study|Adverse Event|1|||
16377154|NCT03633058|39866618|FG003|Overall Study|Adverse Event|0|||
16377155|NCT02852005|39866619|FG000|Overall Study|Lost to Follow-up|0|||
16377156|NCT02852005|39866620|FG001|Overall Study|Lost to Follow-up|0|||
16377157|NCT02852005|39866621|FG002|Overall Study|Lost to Follow-up|0|||
16377158|NCT02852005|39866622|FG003|Overall Study|Lost to Follow-up|0|||
16377159|NCT02852005|39866623|FG004|Overall Study|Lost to Follow-up|1|||
16377160|NCT02852005|39866619|FG000|Overall Study|Withdrawal by Subject|1|||
16377161|NCT02852005|39866620|FG001|Overall Study|Withdrawal by Subject|0|||
16377162|NCT02852005|39866621|FG002|Overall Study|Withdrawal by Subject|0|||
16377163|NCT02852005|39866622|FG003|Overall Study|Withdrawal by Subject|0|||
16377164|NCT02852005|39866623|FG004|Overall Study|Withdrawal by Subject|0|||
16377165|NCT01697501|39866626|FG000|Overall Study|Protocol Violation|2|||
16377166|NCT01916226|39866627|FG000|Overall Study|Adverse Event|1|||
16377167|NCT01916226|39866628|FG001|Overall Study|Adverse Event|0|||
16377168|NCT01916226|39866629|FG002|Overall Study|Adverse Event|1|||
16377169|NCT01916226|39866630|FG003|Overall Study|Adverse Event|1|||
16377170|NCT01916226|39866627|FG000|Overall Study|Lack of Efficacy|0|||
16377171|NCT01916226|39866628|FG001|Overall Study|Lack of Efficacy|0|||
16377172|NCT01916226|39866629|FG002|Overall Study|Lack of Efficacy|2|||
16377173|NCT01916226|39866630|FG003|Overall Study|Lack of Efficacy|1|||
16377174|NCT01916226|39866627|FG000|Overall Study|Protocol Violation|0|||
16377175|NCT01916226|39866628|FG001|Overall Study|Protocol Violation|1|||
16377176|NCT01916226|39866629|FG002|Overall Study|Protocol Violation|0|||
16377177|NCT01916226|39866630|FG003|Overall Study|Protocol Violation|1|||
16377178|NCT01916226|39866627|FG000|Overall Study|Physician Decision|0|||
16377179|NCT01916226|39866628|FG001|Overall Study|Physician Decision|0|||
16377180|NCT01916226|39866629|FG002|Overall Study|Physician Decision|0|||
16377181|NCT01916226|39866630|FG003|Overall Study|Physician Decision|1|||
16377182|NCT03906071|39866631|FG000|Overall Study|Death|180|||
16377183|NCT03906071|39866632|FG001|Overall Study|Death|185|||
16377184|NCT03906071|39866631|FG000|Overall Study|Lost to Follow-up|3|||
16377185|NCT03906071|39866632|FG001|Overall Study|Lost to Follow-up|3|||
16377186|NCT03906071|39866631|FG000|Overall Study|Withdrawal by Subject|15|||
16377187|NCT03906071|39866632|FG001|Overall Study|Withdrawal by Subject|27|||
16377188|NCT03906071|39866631|FG000|Overall Study|Other|2|||
16377189|NCT03906071|39866632|FG001|Overall Study|Other|1|||
16377190|NCT02698787|39866638|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
16377191|NCT02698787|39866639|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
16377192|NCT04650893|39866646|FG000|Overall Study|Lost to Follow-up|11|||
16377193|NCT04650893|39866647|FG001|Overall Study|Lost to Follow-up|10|||
16377194|NCT04650893|39866648|FG002|Overall Study|Lost to Follow-up|11|||
16377195|NCT01557569|39866649|FG000|Overall Study|Adverse Event|2|||
16377196|NCT01557569|39866650|FG001|Overall Study|Adverse Event|0|||
16377197|NCT01557569|39866649|FG000|Overall Study|high blood pressure|0|||
16377198|NCT01557569|39866650|FG001|Overall Study|high blood pressure|1|||
16377199|NCT01557569|39866649|FG000|Overall Study|Withdrawal by Subject|3|||
16377200|NCT01557569|39866650|FG001|Overall Study|Withdrawal by Subject|5|||
16377201|NCT01557569|39866649|FG000|Overall Study|noncompliance with rules of residential|0|||
16377202|NCT01557569|39866650|FG001|Overall Study|noncompliance with rules of residential|1|||
16377203|NCT01661595|39866651|FG000|Phase 1: Week 0-4|Adverse Event|1|||
16377204|NCT01661595|39866652|FG001|Phase 1: Week 0-4|Adverse Event|0|||
16377205|NCT01661595|39866653|FG002|Phase 1: Week 0-4|Adverse Event|0|||
16377206|NCT01661595|39866654|FG003|Phase 1: Week 0-4|Adverse Event|0|||
16377207|NCT01661595|39866651|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
16377208|NCT01661595|39866652|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
16377209|NCT01661595|39866653|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
16377210|NCT01661595|39866654|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
16377211|NCT04535362|39866655|FG000|Overall Study|Lost to Follow-up|3|||
16377212|NCT04535362|39866656|FG001|Overall Study|Lost to Follow-up|1|||
16377213|NCT03131479|39866661|FG000|Overall Study|Adverse Event|0|||
16377214|NCT03131479|39866662|FG001|Overall Study|Adverse Event|0|||
16377215|NCT03131479|39866663|FG002|Overall Study|Adverse Event|1|||
16377216|NCT03131479|39866664|FG003|Overall Study|Adverse Event|1|||
16377217|NCT03131479|39866665|FG004|Overall Study|Adverse Event|0|||
16377218|NCT03131479|39866661|FG000|Overall Study|Subject/Guardian Decision|0|||
16377219|NCT03131479|39866662|FG001|Overall Study|Subject/Guardian Decision|0|||
16377220|NCT03131479|39866663|FG002|Overall Study|Subject/Guardian Decision|0|||
16377221|NCT03131479|39866664|FG003|Overall Study|Subject/Guardian Decision|1|||
16377222|NCT03131479|39866665|FG004|Overall Study|Subject/Guardian Decision|0|||
16377223|NCT00855166|39866668|FG000|Overall Study|Adverse Event|0|||
16377224|NCT00855166|39866669|FG001|Overall Study|Adverse Event|2|||
16377225|NCT00855166|39866668|FG000|Overall Study|Death|0|||
16377226|NCT00855166|39866669|FG001|Overall Study|Death|1|||
16377227|NCT00855166|39866668|FG000|Overall Study|Withdrawal by Subject|1|||
16377228|NCT00855166|39866669|FG001|Overall Study|Withdrawal by Subject|4|||
16377229|NCT00855166|39866668|FG000|Overall Study|Poor/non-compliance|2|||
16377230|NCT00855166|39866669|FG001|Overall Study|Poor/non-compliance|0|||
16377231|NCT00855166|39866668|FG000|Overall Study|Administrative reasons by sponsor|1|||
16377232|NCT00855166|39866669|FG001|Overall Study|Administrative reasons by sponsor|0|||
16377233|NCT00855166|39866668|FG000|Overall Study|Subject no longer meets study criteria|1|||
16377234|NCT00855166|39866669|FG001|Overall Study|Subject no longer meets study criteria|1|||
16377235|NCT03427619|39866670|FG000|Overall Study|Physician Decision|3|||
16377236|NCT03427619|39866670|FG000|Overall Study|Withdrawal by Subject|4|||
16377237|NCT03427619|39866670|FG000|Overall Study|Lost to Follow-up|5|||
16377238|NCT03427619|39866670|FG000|Overall Study|Administrative|4|||
16377239|NCT03427619|39866670|FG000|Overall Study|Other|2|||
16377240|NCT03427619|39866670|FG000|Overall Study|Unknown or Missing Completion Status|48|||
16377241|NCT02093520|39866671|FG000|Overall Study|Not treated|6|||
16377242|NCT02093520|39866672|FG001|Overall Study|Not treated|22|||
16377243|NCT03502200|39866673|FG000|Overall Study|Adverse Event|1|||
16377244|NCT03502200|39866674|FG001|Overall Study|Adverse Event|0|||
16377245|NCT03502200|39866673|FG000|Overall Study|Lost to Follow-up|36|||
16377246|NCT03502200|39866674|FG001|Overall Study|Lost to Follow-up|38|||
16377247|NCT03502200|39866673|FG000|Overall Study|Study Team Decision|1|||
16377248|NCT03502200|39866674|FG001|Overall Study|Study Team Decision|1|||
16377249|NCT03502200|39866673|FG000|Overall Study|Withdrawal by Subject|5|||
16377250|NCT03502200|39866674|FG001|Overall Study|Withdrawal by Subject|7|||
16377251|NCT03502200|39866673|FG000|Overall Study|Death|0|||
16377252|NCT03502200|39866674|FG001|Overall Study|Death|2|||
16377253|NCT00635050|39866675|FG000|Overall Study|Withdrawal by Subject|1|||
16377254|NCT01608308|39866676|FG000|Overall Study|pretreatment medical and billing reasons|0|||
16377255|NCT01608308|39866677|FG001|Overall Study|pretreatment medical and billing reasons|2|||
16377256|NCT02402647|39866678|FG000|Overall Study|Lost to Follow-up|13|||
16377257|NCT02402647|39866679|FG001|Overall Study|Lost to Follow-up|7|||
16377258|NCT02402647|39866678|FG000|Overall Study|Protocol Violation|1|||
16377259|NCT02402647|39866679|FG001|Overall Study|Protocol Violation|1|||
16377260|NCT02402647|39866678|FG000|Overall Study|scheduled and timed out|2|||
16377261|NCT02402647|39866679|FG001|Overall Study|scheduled and timed out|1|||
16377262|NCT02402647|39866678|FG000|Overall Study|medical illness|2|||
16377263|NCT02402647|39866679|FG001|Overall Study|medical illness|4|||
16377264|NCT02402647|39866678|FG000|Overall Study|Moved|2|||
16377265|NCT02402647|39866679|FG001|Overall Study|Moved|0|||
16377266|NCT02402647|39866678|FG000|Overall Study|loved one illness|1|||
16377267|NCT02402647|39866679|FG001|Overall Study|loved one illness|0|||
16377268|NCT02402647|39866678|FG000|Overall Study|deceased preexisting condition|2|||
16377269|NCT02402647|39866679|FG001|Overall Study|deceased preexisting condition|0|||
16377270|NCT02402647|39866678|FG000|Overall Study|Other|2|||
16377271|NCT02402647|39866679|FG001|Overall Study|Other|1|||
16377272|NCT00050011|39866680|FG000|Overall Study|Adverse Event|41|||
16377273|NCT00050011|39866681|FG001|Overall Study|Adverse Event|46|||
16377274|NCT00050011|39866680|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16377275|NCT00050011|39866681|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16377276|NCT00050011|39866680|FG000|Overall Study|Abnormal test procedure results|0|||
16377277|NCT00050011|39866681|FG001|Overall Study|Abnormal test procedure results|1|||
16377278|NCT00050011|39866680|FG000|Overall Study|Lack of Efficacy|16|||
16377279|NCT00050011|39866681|FG001|Overall Study|Lack of Efficacy|21|||
16377280|NCT00050011|39866680|FG000|Overall Study|Participant condition no longer required|1|||
16377281|NCT00050011|39866681|FG001|Overall Study|Participant condition no longer required|0|||
16377282|NCT00050011|39866680|FG000|Overall Study|Protocol Violation|4|||
16377283|NCT00050011|39866681|FG001|Overall Study|Protocol Violation|10|||
16377284|NCT00050011|39866680|FG000|Overall Study|Withdrawal by Subject|34|||
16377285|NCT00050011|39866681|FG001|Overall Study|Withdrawal by Subject|26|||
16377286|NCT00050011|39866680|FG000|Overall Study|Lost to Follow-up|7|||
16377287|NCT00050011|39866681|FG001|Overall Study|Lost to Follow-up|9|||
16377288|NCT00050011|39866680|FG000|Overall Study|Administrative problems|10|||
16377289|NCT00050011|39866681|FG001|Overall Study|Administrative problems|6|||
16377290|NCT00050011|39866680|FG000|Overall Study|Death|7|||
16377291|NCT00050011|39866681|FG001|Overall Study|Death|4|||
16377292|NCT00050011|39866680|FG000|Overall Study|Unknown - Reason is missing|0|||
16377293|NCT00050011|39866681|FG001|Overall Study|Unknown - Reason is missing|2|||
16377294|NCT00980798|39866682|FG000|Overall Study|Adverse Event|7|||
16377295|NCT00980798|39866683|FG001|Overall Study|Adverse Event|36|||
16377296|NCT00980798|39866682|FG000|Overall Study|Lack of Efficacy|16|||
16377297|NCT00980798|39866683|FG001|Overall Study|Lack of Efficacy|5|||
16377298|NCT00980798|39866682|FG000|Overall Study|Lost to Follow-up|0|||
16377299|NCT00980798|39866683|FG001|Overall Study|Lost to Follow-up|1|||
16377300|NCT00980798|39866682|FG000|Overall Study|Physician Decision|2|||
16377301|NCT00980798|39866683|FG001|Overall Study|Physician Decision|1|||
16377302|NCT00980798|39866682|FG000|Overall Study|Withdrawal by Subject|8|||
16377303|NCT00980798|39866683|FG001|Overall Study|Withdrawal by Subject|11|||
16377304|NCT00980798|39866682|FG000|Overall Study|Other|0|||
16377305|NCT00980798|39866683|FG001|Overall Study|Other|1|||
16377306|NCT03449147|39866684|FG000|52-week Treatment Period|Death|0|||
16377307|NCT03449147|39866685|FG001|52-week Treatment Period|Death|1|||
16377308|NCT03449147|39866686|FG002|52-week Treatment Period|Death|0|||
16377309|NCT03449147|39866684|FG000|52-week Treatment Period|Lost to Follow-up|6|||
16377310|NCT03449147|39866685|FG001|52-week Treatment Period|Lost to Follow-up|2|||
16377311|NCT03449147|39866686|FG002|52-week Treatment Period|Lost to Follow-up|5|||
16377312|NCT03449147|39866684|FG000|52-week Treatment Period|Other|0|||
16377313|NCT03449147|39866685|FG001|52-week Treatment Period|Other|1|||
16377314|NCT03449147|39866686|FG002|52-week Treatment Period|Other|2|||
16377315|NCT03449147|39866684|FG000|52-week Treatment Period|Physician Decision|1|||
16377316|NCT03449147|39866685|FG001|52-week Treatment Period|Physician Decision|0|||
16377317|NCT03449147|39866686|FG002|52-week Treatment Period|Physician Decision|3|||
16377318|NCT03449147|39866684|FG000|52-week Treatment Period|Screen Failure|1|||
16377319|NCT03449147|39866685|FG001|52-week Treatment Period|Screen Failure|2|||
16377320|NCT03449147|39866686|FG002|52-week Treatment Period|Screen Failure|0|||
16377321|NCT03449147|39866684|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
16377322|NCT03449147|39866685|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
16377323|NCT03449147|39866686|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
16377324|NCT03449147|39866684|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
16377325|NCT03449147|39866685|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
16377326|NCT03449147|39866686|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
16377327|NCT03449147|39866684|FG000|12-Week Off-Treatment Durability Period|Other|0|||
16377328|NCT03449147|39866685|FG001|12-Week Off-Treatment Durability Period|Other|1|||
16377329|NCT03449147|39866686|FG002|12-Week Off-Treatment Durability Period|Other|0|||
16377330|NCT01946880|39866687|FG000|Overall Study|Lost to Follow-up|1|||
16377331|NCT01946880|39866688|FG001|Overall Study|Lost to Follow-up|0|||
16377332|NCT01946880|39866687|FG000|Overall Study|Physician Decision|1|||
16377333|NCT01946880|39866688|FG001|Overall Study|Physician Decision|1|||
16377334|NCT01946880|39866687|FG000|Overall Study|Withdrawal by Subject|3|||
16377335|NCT01946880|39866688|FG001|Overall Study|Withdrawal by Subject|2|||
16377336|NCT01946880|39866687|FG000|Overall Study|Met Primary Endpoint|1|||
16377337|NCT01946880|39866688|FG001|Overall Study|Met Primary Endpoint|0|||
16377338|NCT01946880|39866687|FG000|Overall Study|Personal and Family Issues|1|||
16377339|NCT01946880|39866688|FG001|Overall Study|Personal and Family Issues|0|||
16377340|NCT02217982|39866689|FG000|Overall Study|Trial discontinued|1|||
16377341|NCT02217982|39866690|FG001|Overall Study|Trial discontinued|0|||
16377342|NCT02217982|39866689|FG000|Overall Study|Adverse Event|0|||
16377343|NCT02217982|39866690|FG001|Overall Study|Adverse Event|1|||
16377344|NCT01682603|39866693|FG000|Overall Study|Lost to Follow-up|3|||
16377345|NCT00581919|39866706|FG000|Overall Study|Adverse Event|8|||
16377346|NCT00581919|39866706|FG000|Overall Study|Death|1|||
16377347|NCT00581919|39866706|FG000|Overall Study|Disease Progression|10|||
16377348|NCT00581919|39866706|FG000|Overall Study|Physician Decision|1|||
16377349|NCT00581919|39866706|FG000|Overall Study|Other Complicating Disease|1|||
16377350|NCT00581919|39866706|FG000|Overall Study|Started Non-Protocol Therapy|2|||
16377351|NCT00581919|39866706|FG000|Overall Study|Withdrawal by Subject|1|||
16377352|NCT01903863|39866707|FG000|Overall Study|Physician Decision|2|||
16377353|NCT01903863|39866708|FG001|Overall Study|Physician Decision|0|||
16377354|NCT01557244|39866710|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
16377355|NCT01557244|39866711|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
16377356|NCT01557244|39866712|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
16377357|NCT01557244|39866713|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
16377358|NCT01557244|39866714|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
16377359|NCT01557244|39866715|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
16377360|NCT01557244|39866716|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
16377361|NCT01557244|39866710|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
16377362|NCT01557244|39866711|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
16377363|NCT01557244|39866712|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
16377364|NCT01557244|39866713|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
16377365|NCT01557244|39866714|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
16377366|NCT01557244|39866715|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
16377367|NCT01557244|39866716|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
16377368|NCT01557244|39866710|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
16377369|NCT01557244|39866711|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16377370|NCT01557244|39866712|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16377371|NCT01557244|39866713|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16377372|NCT01557244|39866714|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16377373|NCT01557244|39866715|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16377374|NCT01557244|39866716|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
16377375|NCT01557244|39866710|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
16377376|NCT01557244|39866711|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
16377377|NCT01557244|39866712|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
16377378|NCT01557244|39866713|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
16377379|NCT01557244|39866714|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
16377380|NCT01557244|39866715|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
16377381|NCT01557244|39866716|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
16377382|NCT01557244|39866710|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16377383|NCT01557244|39866711|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
16377384|NCT01557244|39866712|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16377385|NCT01557244|39866713|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16377386|NCT01557244|39866714|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16377387|NCT01557244|39866715|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16377388|NCT01557244|39866716|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
16377389|NCT01557244|39866710|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
16377390|NCT01557244|39866711|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
16377391|NCT01557244|39866712|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
16377392|NCT01557244|39866713|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
16377393|NCT01557244|39866714|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
16377394|NCT01557244|39866715|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
16377395|NCT01557244|39866716|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
16377396|NCT01557244|39866710|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
16377397|NCT01557244|39866711|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
16377398|NCT01557244|39866712|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
16377399|NCT01557244|39866713|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
16377400|NCT01557244|39866714|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
16377401|NCT01557244|39866715|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
16377402|NCT01557244|39866716|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
16377403|NCT01557244|39866710|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
16377404|NCT01557244|39866711|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
16377405|NCT01557244|39866712|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
16377406|NCT01557244|39866713|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
16377407|NCT01557244|39866714|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
16377408|NCT01557244|39866715|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
16377409|NCT01557244|39866716|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
16377410|NCT01557244|39866710|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
16377411|NCT01557244|39866711|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
16377412|NCT01557244|39866712|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
16377413|NCT01557244|39866713|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
16377414|NCT01557244|39866714|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
16377415|NCT01557244|39866715|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
16377416|NCT01557244|39866716|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
16377417|NCT01557244|39866710|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
16377418|NCT01557244|39866711|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
16377419|NCT01557244|39866712|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
16377420|NCT01557244|39866713|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
16377421|NCT01557244|39866714|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
16377422|NCT01557244|39866715|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
16377423|NCT01557244|39866716|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
16377424|NCT01557244|39866710|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16377425|NCT01557244|39866711|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16377426|NCT01557244|39866712|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16377427|NCT01557244|39866713|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
16377428|NCT01557244|39866714|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16377429|NCT01557244|39866715|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16377430|NCT01557244|39866716|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
16377431|NCT01557244|39866710|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
16377432|NCT01557244|39866711|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
16377433|NCT01557244|39866712|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
16377434|NCT01557244|39866713|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
16377435|NCT01557244|39866714|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
16377436|NCT01557244|39866715|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
16377437|NCT01557244|39866716|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
16377438|NCT04551053|39866719|FG000|Overall Study|Death|9|||
16377439|NCT04551053|39866720|FG001|Overall Study|Death|9|||
16377440|NCT04551053|39866719|FG000|Overall Study|Lost to Follow-up|0|||
16377441|NCT04551053|39866720|FG001|Overall Study|Lost to Follow-up|2|||
16377442|NCT04551053|39866719|FG000|Overall Study|Study Terminated by Sponsor|53|||
16377443|NCT04551053|39866720|FG001|Overall Study|Study Terminated by Sponsor|63|||
16377444|NCT04551053|39866719|FG000|Overall Study|Withdrawal by Subject|12|||
16377445|NCT04551053|39866720|FG001|Overall Study|Withdrawal by Subject|5|||
16377446|NCT04551053|39866719|FG000|Overall Study|Adverse Event|1|||
16377447|NCT04551053|39866720|FG001|Overall Study|Adverse Event|0|||
16377448|NCT04551053|39866719|FG000|Overall Study|Lack of Efficacy|2|||
16377449|NCT04551053|39866720|FG001|Overall Study|Lack of Efficacy|0|||
16377450|NCT04551053|39866719|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
16377451|NCT04551053|39866720|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
16076229|NCT01430611|38769923|FG000|Overall Study|Adverse Event|0|||
16076230|NCT01430611|38769924|FG001|Overall Study|Adverse Event|1|||
16377452|NCT04551053|39866719|FG000|Overall Study|Splenapendectomi|1|||
16377453|NCT04551053|39866720|FG001|Overall Study|Splenapendectomi|0|||
16377454|NCT04551053|39866719|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
16377455|NCT04551053|39866720|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
16377456|NCT04551053|39866719|FG000|Overall Study|Medical Decision|0|||
16377457|NCT04551053|39866720|FG001|Overall Study|Medical Decision|1|||
16377458|NCT04551053|39866719|FG000|Overall Study|Ongoing|6|||
16377459|NCT04551053|39866720|FG001|Overall Study|Ongoing|4|||
16377460|NCT02913326|39866721|FG000|Overall Study|Reason not listed|0|||
16377461|NCT02913326|39866722|FG001|Overall Study|Reason not listed|1|||
16377462|NCT02913326|39866721|FG000|Overall Study|Lost to Follow-up|0|||
16377463|NCT02913326|39866722|FG001|Overall Study|Lost to Follow-up|1|||
16377464|NCT02913326|39866721|FG000|Overall Study|Adverse Event|1|||
16377465|NCT02913326|39866722|FG001|Overall Study|Adverse Event|0|||
16377466|NCT03359395|39866725|FG000|First Intervention A / B|Withdrawal by Subject|1|||
16377467|NCT03359395|39866726|FG001|First Intervention A / B|Withdrawal by Subject|0|||
16377468|NCT03359395|39866725|FG000|First Intervention A / B|Lost to Follow-up|2|||
16377469|NCT03359395|39866726|FG001|First Intervention A / B|Lost to Follow-up|3|||
16377470|NCT03359395|39866725|FG000|Second Intervention B/A|Exclusion criteria|0|||
16377471|NCT03359395|39866726|FG001|Second Intervention B/A|Exclusion criteria|1|||
16377472|NCT03359395|39866725|FG000|Second Intervention B/A|Lost to Follow-up|3|||
16377473|NCT03359395|39866726|FG001|Second Intervention B/A|Lost to Follow-up|2|||
16377474|NCT03078868|39869353|FG000|Overall Study|Physician Decision|3|||
16377475|NCT03312543|39869354|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
16377476|NCT03312543|39869355|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
16377477|NCT03312543|39869354|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
16377478|NCT03312543|39869355|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
16377479|NCT03312543|39869354|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
16377480|NCT03312543|39869355|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
16377481|NCT03312543|39869354|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
16377482|NCT03312543|39869355|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
16377483|NCT03312543|39869354|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
16377484|NCT03312543|39869355|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
16377485|NCT03312543|39869354|FG000|Regression (Week 12 to Week 24)|Death|0|||
16377486|NCT03312543|39869355|FG001|Regression (Week 12 to Week 24)|Death|1|||
16377487|NCT05360784|39869362|FG000|Overall Study|Discontinued|25|||
16377488|NCT05360784|39869363|FG001|Overall Study|Discontinued|11|||
16377489|NCT00564070|39869364|FG000|Overall Study|Lost to Follow-up|9|||
16377490|NCT00564070|39869365|FG001|Overall Study|Lost to Follow-up|7|||
16377491|NCT00564070|39869364|FG000|Overall Study|Worsening depression, referred to care|3|||
16377492|NCT00564070|39869365|FG001|Overall Study|Worsening depression, referred to care|0|||
16377493|NCT02395627|39869368|FG000|Overall Study|Withdrawal by Subject|0|||
16377494|NCT02395627|39869369|FG001|Overall Study|Withdrawal by Subject|2|||
16377495|NCT02395627|39869370|FG002|Overall Study|Withdrawal by Subject|0|||
16377496|NCT02395627|39869368|FG000|Overall Study|Did not receive pembrolizumab|3|||
16377497|NCT02395627|39869369|FG001|Overall Study|Did not receive pembrolizumab|1|||
16377498|NCT02395627|39869370|FG002|Overall Study|Did not receive pembrolizumab|0|||
16377499|NCT02272985|39869371|FG000|Overall Study|Withdrawal by Subject|1|||
16377500|NCT02272985|39869371|FG000|Overall Study|hip fracture|1|||
16377501|NCT02272985|39869371|FG000|Overall Study|kidney transplantation|1|||
16377502|NCT03921528|39869372|FG000|Overall Study|Withdrawal by Subject|0|||
16377503|NCT03921528|39869373|FG001|Overall Study|Withdrawal by Subject|1|||
16377504|NCT03921528|39869374|FG002|Overall Study|Withdrawal by Subject|0|||
16377505|NCT03921528|39869375|FG003|Overall Study|Withdrawal by Subject|0|||
16377506|NCT03921528|39869376|FG004|Overall Study|Withdrawal by Subject|0|||
16377507|NCT01034657|39869377|FG000|Core Phase|Withdrawal by Subject|1|||
16377508|NCT01034657|39869378|FG001|Core Phase|Withdrawal by Subject|0|||
16377509|NCT01034657|39869379|FG002|Core Phase|Withdrawal by Subject|0|||
16377510|NCT01034657|39869377|FG000|Core Phase|Lack of Efficacy|2|||
16377511|NCT01034657|39869378|FG001|Core Phase|Lack of Efficacy|0|||
16377512|NCT01034657|39869379|FG002|Core Phase|Lack of Efficacy|0|||
16377513|NCT01034657|39869377|FG000|Core Phase|Abnormal laboratory value|1|||
16377514|NCT01034657|39869378|FG001|Core Phase|Abnormal laboratory value|0|||
16377515|NCT01034657|39869379|FG002|Core Phase|Abnormal laboratory value|0|||
16377516|NCT01034657|39869377|FG000|Core Phase|Adverse Event|8|||
16377517|NCT01034657|39869378|FG001|Core Phase|Adverse Event|0|||
16377518|NCT01034657|39869379|FG002|Core Phase|Adverse Event|0|||
16377519|NCT01034657|39869377|FG000|Core Phase|Protocol Violation|2|||
16377520|NCT01034657|39869378|FG001|Core Phase|Protocol Violation|0|||
16377521|NCT01034657|39869379|FG002|Core Phase|Protocol Violation|0|||
16377522|NCT01034657|39869377|FG000|Randomized Phase|Withdrawal by Subject|0|||
16377523|NCT01034657|39869378|FG001|Randomized Phase|Withdrawal by Subject|2|||
16377524|NCT01034657|39869379|FG002|Randomized Phase|Withdrawal by Subject|0|||
16377525|NCT01034657|39869377|FG000|Randomized Phase|Lack of Efficacy|5|||
16377526|NCT01034657|39869378|FG001|Randomized Phase|Lack of Efficacy|1|||
16377527|NCT01034657|39869379|FG002|Randomized Phase|Lack of Efficacy|0|||
16377528|NCT01034657|39869377|FG000|Randomized Phase|Abnormal laboratory value|0|||
16377529|NCT01034657|39869378|FG001|Randomized Phase|Abnormal laboratory value|1|||
16377530|NCT01034657|39869379|FG002|Randomized Phase|Abnormal laboratory value|0|||
16377531|NCT01034657|39869377|FG000|Randomized Phase|Adverse Event|0|||
16377532|NCT01034657|39869378|FG001|Randomized Phase|Adverse Event|2|||
16377533|NCT01034657|39869379|FG002|Randomized Phase|Adverse Event|1|||
16377534|NCT01491919|39869381|FG000|Overall Study|Insufficient PK sampling|1|||
16377535|NCT01491919|39869382|FG001|Overall Study|Insufficient PK sampling|2|||
16377536|NCT01491919|39869383|FG002|Overall Study|Insufficient PK sampling|1|||
16377537|NCT00321932|39869384|FG000|Overall Study|Death|3|||
16377538|NCT00321932|39869385|FG001|Overall Study|Death|6|||
16377539|NCT00321932|39869384|FG000|Overall Study|Withdrawal by Subject|3|||
16377540|NCT00321932|39869385|FG001|Overall Study|Withdrawal by Subject|6|||
16377541|NCT00321932|39869384|FG000|Overall Study|Early relapse|2|||
16377542|NCT00321932|39869385|FG001|Overall Study|Early relapse|8|||
16377543|NCT00321932|39869384|FG000|Overall Study|Missing data|2|||
16377544|NCT00321932|39869385|FG001|Overall Study|Missing data|1|||
16377545|NCT01569763|39869392|FG000|Overall Study|Lack of Efficacy|2|||
16377546|NCT01569763|39869393|FG001|Overall Study|Lack of Efficacy|7|||
16377547|NCT01569763|39869392|FG000|Overall Study|Adverse Event|1|||
16377548|NCT01569763|39869393|FG001|Overall Study|Adverse Event|0|||
16377549|NCT03093415|39869394|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
16377550|NCT03093415|39869395|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
16377551|NCT03093415|39869396|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
16377552|NCT03093415|39869394|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
16377553|NCT03093415|39869395|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
16377554|NCT03093415|39869396|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
16377555|NCT03093415|39869394|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
16377556|NCT03093415|39869395|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
16377557|NCT03093415|39869396|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
16377558|NCT03093415|39869394|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
16377559|NCT03093415|39869395|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
16377560|NCT03093415|39869396|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
16377561|NCT03093415|39869394|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
16377562|NCT03093415|39869395|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
16377563|NCT03093415|39869396|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
16377564|NCT03093415|39869394|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
16377565|NCT03093415|39869395|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
16377566|NCT03093415|39869396|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
16377567|NCT03093415|39869394|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
16377568|NCT03093415|39869395|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
16377569|NCT03093415|39869396|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
16377570|NCT03093415|39869394|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
16377571|NCT03093415|39869395|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
16377572|NCT03093415|39869396|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
16377573|NCT03093415|39869394|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
16377574|NCT03093415|39869395|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
16377575|NCT03093415|39869396|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
16377576|NCT03093415|39869394|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
16377577|NCT03093415|39869395|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
16377578|NCT03093415|39869396|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
16377579|NCT03093415|39869394|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
16377580|NCT03093415|39869395|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
16377581|NCT03093415|39869396|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
16377582|NCT01394185|39869397|FG000|Overall Study|Withdrawal by Subject|2|||
16377583|NCT01394185|39869398|FG001|Overall Study|Withdrawal by Subject|0|||
16377584|NCT01394185|39869399|FG002|Overall Study|Withdrawal by Subject|0|||
16377585|NCT01394185|39869400|FG003|Overall Study|Withdrawal by Subject|0|||
16377586|NCT01394185|39869401|FG004|Overall Study|Withdrawal by Subject|1|||
16377587|NCT01394185|39869402|FG005|Overall Study|Withdrawal by Subject|0|||
16377588|NCT01394185|39869397|FG000|Overall Study|Change in protocol|3|||
16377589|NCT01394185|39869398|FG001|Overall Study|Change in protocol|0|||
16377590|NCT01394185|39869399|FG002|Overall Study|Change in protocol|0|||
16377591|NCT01394185|39869400|FG003|Overall Study|Change in protocol|0|||
16377592|NCT01394185|39869401|FG004|Overall Study|Change in protocol|3|||
16377593|NCT01394185|39869402|FG005|Overall Study|Change in protocol|0|||
16377594|NCT01394185|39869397|FG000|Overall Study|Protocol Violation|1|||
16377595|NCT01394185|39869398|FG001|Overall Study|Protocol Violation|0|||
16377596|NCT01394185|39869399|FG002|Overall Study|Protocol Violation|0|||
16377597|NCT01394185|39869400|FG003|Overall Study|Protocol Violation|1|||
16377598|NCT01394185|39869401|FG004|Overall Study|Protocol Violation|0|||
16377599|NCT01394185|39869402|FG005|Overall Study|Protocol Violation|1|||
16377600|NCT01514357|39869403|FG000|Overall Study|Screen failure|2|||
16377601|NCT01514357|39869404|FG001|Overall Study|Screen failure|0|||
16377602|NCT01514357|39869403|FG000|Overall Study|Withdrawal by Subject|2|||
16377603|NCT01514357|39869404|FG001|Overall Study|Withdrawal by Subject|0|||
16377604|NCT01908699|39869410|FG000|Overall Study|Adverse Event|8|||
16377605|NCT01908699|39869411|FG001|Overall Study|Adverse Event|12|||
16377606|NCT01908699|39869410|FG000|Overall Study|Lack of Efficacy|2|||
16377607|NCT01908699|39869411|FG001|Overall Study|Lack of Efficacy|2|||
16377608|NCT01908699|39869410|FG000|Overall Study|Lost to Follow-up|2|||
16377609|NCT01908699|39869411|FG001|Overall Study|Lost to Follow-up|4|||
16377610|NCT01908699|39869410|FG000|Overall Study|Physician Decision|8|||
16377611|NCT01908699|39869411|FG001|Overall Study|Physician Decision|8|||
16377612|NCT01908699|39869410|FG000|Overall Study|Withdrawal by Subject|15|||
16377613|NCT01908699|39869411|FG001|Overall Study|Withdrawal by Subject|10|||
16377614|NCT01908699|39869410|FG000|Overall Study|Pregnancy|0|||
16377615|NCT01908699|39869411|FG001|Overall Study|Pregnancy|1|||
16377616|NCT01908699|39869410|FG000|Overall Study|Randomized in Error|1|||
16377617|NCT01908699|39869411|FG001|Overall Study|Randomized in Error|0|||
16377618|NCT01908699|39869410|FG000|Overall Study|Death|9|||
16377619|NCT01908699|39869411|FG001|Overall Study|Death|12|||
16377620|NCT01908699|39869410|FG000|Overall Study|Progressive Disease|30|||
16377621|NCT01908699|39869411|FG001|Overall Study|Progressive Disease|29|||
16377622|NCT02168439|39869412|FG000|Overall Study|Protocol Violation|0|||
16377623|NCT02168439|39869413|FG001|Overall Study|Protocol Violation|2|||
16377624|NCT03193437|39869414|FG000|Overall Study|Adverse Event|4|||
16377625|NCT03193437|39869414|FG000|Overall Study|Withdrawal by Subject|2|||
16377626|NCT03193437|39869414|FG000|Overall Study|Disease Progression|2|||
16377627|NCT01500135|39869415|FG000|Overall Study|Withdrawal of Consent|4|||
16377628|NCT01500135|39869416|FG001|Overall Study|Withdrawal of Consent|0|||
16377629|NCT01500135|39869415|FG000|Overall Study|Lost to Follow-up|6|||
16377630|NCT01500135|39869416|FG001|Overall Study|Lost to Follow-up|4|||
16377631|NCT01500135|39869415|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
16377632|NCT01500135|39869416|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
16377633|NCT01500135|39869415|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
16377634|NCT01500135|39869416|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
16377635|NCT01500135|39869415|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
16377636|NCT01500135|39869416|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
16377637|NCT01500135|39869415|FG000|Overall Study|Participant was a Safety Concern|1|||
16377638|NCT01500135|39869416|FG001|Overall Study|Participant was a Safety Concern|0|||
16377639|NCT01500135|39869415|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
16377640|NCT01500135|39869416|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
16377641|NCT02958865|39869417|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377642|NCT02958865|39869418|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
16377643|NCT02958865|39869419|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377644|NCT02958865|39869420|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
16377645|NCT02958865|39869421|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
16377646|NCT02958865|39869422|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
16377647|NCT02958865|39869423|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
16377648|NCT02958865|39869424|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377649|NCT02958865|39869425|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377650|NCT02958865|39869426|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377651|NCT02958865|39869427|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377652|NCT02958865|39869428|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377653|NCT02958865|39869429|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377654|NCT02958865|39869430|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377655|NCT02958865|39869431|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377656|NCT02958865|39869432|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
16377657|NCT02958865|39869417|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
16377658|NCT02958865|39869418|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
16377659|NCT02958865|39869419|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
16377660|NCT02958865|39869420|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
16377661|NCT02958865|39869421|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
16076231|NCT01430611|38769923|FG000|Overall Study|Protocol Violation|1|||
16377662|NCT02958865|39869422|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
16377663|NCT02958865|39869423|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
16377664|NCT02958865|39869424|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
16377665|NCT02958865|39869425|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
16377666|NCT02958865|39869426|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
16377667|NCT02958865|39869427|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
16377668|NCT02958865|39869428|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
16377669|NCT02958865|39869429|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
16377670|NCT02958865|39869430|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
16377671|NCT02958865|39869431|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
16377672|NCT02958865|39869432|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
16377673|NCT02958865|39869417|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
16377674|NCT02958865|39869418|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
16377675|NCT02958865|39869419|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377676|NCT02958865|39869420|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377677|NCT02958865|39869421|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377678|NCT02958865|39869422|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377679|NCT02958865|39869423|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377680|NCT02958865|39869424|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377681|NCT02958865|39869425|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377682|NCT02958865|39869426|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377683|NCT02958865|39869427|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377684|NCT02958865|39869428|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377685|NCT02958865|39869429|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377686|NCT02958865|39869430|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377687|NCT02958865|39869431|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377688|NCT02958865|39869432|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
16377689|NCT02958865|39869417|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
16377690|NCT02958865|39869418|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16377691|NCT02958865|39869419|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
16377692|NCT02958865|39869420|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
16377693|NCT02958865|39869421|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
16377694|NCT02958865|39869422|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
16377695|NCT02958865|39869423|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
16377696|NCT02958865|39869424|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16377697|NCT02958865|39869425|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16377698|NCT02958865|39869426|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16377699|NCT02958865|39869427|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16377700|NCT02958865|39869428|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16377701|NCT02958865|39869429|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16377702|NCT02958865|39869430|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16377703|NCT02958865|39869431|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16377704|NCT02958865|39869432|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16377705|NCT02958865|39869417|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377706|NCT02958865|39869418|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377707|NCT02958865|39869419|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377708|NCT02958865|39869420|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
16377709|NCT02958865|39869421|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377710|NCT02958865|39869422|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377711|NCT02958865|39869423|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
16377712|NCT02958865|39869424|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377713|NCT02958865|39869425|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377714|NCT02958865|39869426|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377715|NCT02958865|39869427|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377716|NCT02958865|39869428|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377717|NCT02958865|39869429|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377718|NCT02958865|39869430|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377719|NCT02958865|39869431|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377720|NCT02958865|39869432|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
16377721|NCT02958865|39869417|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377722|NCT02958865|39869418|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377723|NCT02958865|39869419|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
16377724|NCT02958865|39869420|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377725|NCT02958865|39869421|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377726|NCT02958865|39869422|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377727|NCT02958865|39869423|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377728|NCT02958865|39869424|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377729|NCT02958865|39869425|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377730|NCT02958865|39869426|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377731|NCT02958865|39869427|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16076232|NCT01430611|38769924|FG001|Overall Study|Protocol Violation|0|||
16377732|NCT02958865|39869428|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377733|NCT02958865|39869429|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377734|NCT02958865|39869430|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377735|NCT02958865|39869431|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377736|NCT02958865|39869432|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
16377737|NCT02958865|39869417|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
16377738|NCT02958865|39869418|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
16377739|NCT02958865|39869419|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
16377740|NCT02958865|39869420|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377741|NCT02958865|39869421|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377742|NCT02958865|39869422|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377743|NCT02958865|39869423|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377744|NCT02958865|39869424|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377745|NCT02958865|39869425|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377746|NCT02958865|39869426|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377747|NCT02958865|39869427|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377748|NCT02958865|39869428|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377749|NCT02958865|39869429|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377750|NCT02958865|39869430|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377751|NCT02958865|39869431|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377752|NCT02958865|39869432|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16377753|NCT02958865|39869417|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
16377754|NCT02958865|39869418|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
16377755|NCT02958865|39869419|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
16377756|NCT02958865|39869420|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
16176068|NCT01662999|39122822|FG003|Period 3|Withdrawal by Subject|0|||
16176069|NCT01662999|39122823|FG004|Period 3|Withdrawal by Subject|0|||
16176070|NCT01662999|39122824|FG005|Period 3|Withdrawal by Subject|0|||
16176071|NCT02582515|39122825|FG000|Overall Study|Withdrawal by Subject|0|||
16377757|NCT02958865|39869421|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
16377758|NCT02958865|39869422|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
16377759|NCT02958865|39869423|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
16377760|NCT02958865|39869424|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
16377761|NCT02958865|39869425|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
16377762|NCT02958865|39869426|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
16377763|NCT02958865|39869427|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
16377764|NCT02958865|39869428|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
16377765|NCT02958865|39869429|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
16377766|NCT02958865|39869430|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
16377767|NCT02958865|39869431|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
16377768|NCT02958865|39869432|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
16377769|NCT02958865|39869417|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377770|NCT02958865|39869418|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377771|NCT02958865|39869419|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377772|NCT02958865|39869420|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377773|NCT02958865|39869421|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
16377774|NCT02958865|39869422|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377775|NCT02958865|39869423|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377776|NCT02958865|39869424|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377777|NCT02958865|39869425|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377778|NCT02958865|39869426|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377779|NCT02958865|39869427|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377780|NCT02958865|39869428|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377781|NCT02958865|39869429|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377782|NCT02958865|39869430|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377783|NCT02958865|39869431|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377784|NCT02958865|39869432|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16377785|NCT02958865|39869417|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
16377786|NCT02958865|39869418|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
16377787|NCT02958865|39869419|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
16377788|NCT02958865|39869420|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
16377789|NCT02958865|39869421|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
16377790|NCT02958865|39869422|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
16377791|NCT02958865|39869423|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
16377792|NCT02958865|39869424|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
16377793|NCT02958865|39869425|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
16377794|NCT02958865|39869426|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
16377795|NCT02958865|39869427|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
16377796|NCT02958865|39869428|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
16377797|NCT02958865|39869429|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
16377798|NCT02958865|39869430|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
16377799|NCT02958865|39869431|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
16377800|NCT02958865|39869432|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
16377801|NCT02958865|39869417|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377802|NCT02958865|39869418|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377803|NCT02958865|39869419|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377804|NCT02958865|39869420|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377805|NCT02958865|39869421|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377806|NCT02958865|39869422|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377807|NCT02958865|39869423|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377808|NCT02958865|39869424|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377809|NCT02958865|39869425|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
16377810|NCT02958865|39869426|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
16377811|NCT02958865|39869427|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377812|NCT02958865|39869428|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
16377813|NCT02958865|39869429|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377814|NCT02958865|39869430|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
16377815|NCT02958865|39869431|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
16377816|NCT02958865|39869432|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
16377817|NCT02958865|39869417|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377818|NCT02958865|39869418|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377819|NCT02958865|39869419|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377820|NCT02958865|39869420|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377821|NCT02958865|39869421|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377822|NCT02958865|39869422|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377823|NCT02958865|39869423|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377824|NCT02958865|39869424|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377825|NCT02958865|39869425|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377826|NCT02958865|39869426|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
16377827|NCT02958865|39869427|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377828|NCT02958865|39869428|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377829|NCT02958865|39869429|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377830|NCT02958865|39869430|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377831|NCT02958865|39869431|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
16377832|NCT02958865|39869432|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
16377833|NCT02958865|39869417|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377834|NCT02958865|39869418|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377835|NCT02958865|39869419|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377836|NCT02958865|39869420|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377837|NCT02958865|39869421|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377838|NCT02958865|39869422|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377839|NCT02958865|39869423|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377840|NCT02958865|39869424|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377841|NCT02958865|39869425|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377842|NCT02958865|39869426|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377843|NCT02958865|39869427|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
16377844|NCT02958865|39869428|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
16377845|NCT02958865|39869429|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
16377846|NCT02958865|39869430|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
16377847|NCT02958865|39869431|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
16377848|NCT02958865|39869432|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
16377849|NCT02958865|39869417|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
16377850|NCT02958865|39869418|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
16377851|NCT02958865|39869419|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
16377852|NCT02958865|39869420|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
16377853|NCT02958865|39869421|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
16377854|NCT02958865|39869422|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
16377855|NCT02958865|39869423|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
16377856|NCT02958865|39869424|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
16377857|NCT02958865|39869425|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
16377858|NCT02958865|39869426|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
16377859|NCT02958865|39869427|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
16377860|NCT02958865|39869428|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
16377861|NCT02958865|39869429|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
16377862|NCT02958865|39869430|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
16377863|NCT02958865|39869431|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
16377864|NCT02958865|39869432|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
16076233|NCT01430611|38769923|FG000|Overall Study|Lost to Follow-up|1|||
16377865|NCT02958865|39869417|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377866|NCT02958865|39869418|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377867|NCT02958865|39869419|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377868|NCT02958865|39869420|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377869|NCT02958865|39869421|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377870|NCT02958865|39869422|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377871|NCT02958865|39869423|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377872|NCT02958865|39869424|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377873|NCT02958865|39869425|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377874|NCT02958865|39869426|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377875|NCT02958865|39869427|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377876|NCT02958865|39869428|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377877|NCT02958865|39869429|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377878|NCT02958865|39869430|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
16377879|NCT02958865|39869431|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377880|NCT02958865|39869432|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
16377881|NCT02958865|39869417|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377882|NCT02958865|39869418|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377883|NCT02958865|39869419|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377884|NCT02958865|39869420|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377885|NCT02958865|39869421|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377886|NCT02958865|39869422|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377887|NCT02958865|39869423|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377888|NCT02958865|39869424|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377889|NCT02958865|39869425|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377890|NCT02958865|39869426|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377891|NCT02958865|39869427|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377892|NCT02958865|39869428|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377893|NCT02958865|39869429|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377894|NCT02958865|39869430|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
16377895|NCT02958865|39869431|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377896|NCT02958865|39869432|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
16377897|NCT02958865|39869417|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377898|NCT02958865|39869418|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377899|NCT02958865|39869419|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377900|NCT02958865|39869420|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377901|NCT02958865|39869421|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377902|NCT02958865|39869422|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377903|NCT02958865|39869423|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377904|NCT02958865|39869424|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377905|NCT02958865|39869425|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377906|NCT02958865|39869426|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
16377907|NCT02958865|39869427|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377908|NCT02958865|39869428|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377909|NCT02958865|39869429|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377910|NCT02958865|39869430|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377911|NCT02958865|39869431|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377912|NCT02958865|39869432|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
16377913|NCT02231580|39869435|FG000|Overall Study|Adverse Event|5|||
16377914|NCT02231580|39869436|FG001|Overall Study|Adverse Event|0|||
16377915|NCT02251041|39869437|FG000|Overall Study|Did not receive intervention|15|||
16377916|NCT02251041|39869438|FG001|Overall Study|Did not receive intervention|4|||
16377917|NCT03033784|39869439|FG000|Overall Study|Anxiety related to MRI scanner|0|||
16377918|NCT03033784|39869440|FG001|Overall Study|Anxiety related to MRI scanner|1|||
16377919|NCT03033784|39869441|FG002|Overall Study|Anxiety related to MRI scanner|0|||
16377920|NCT03033784|39869442|FG003|Overall Study|Anxiety related to MRI scanner|0|||
16377921|NCT03033784|39869443|FG004|Overall Study|Anxiety related to MRI scanner|0|||
16377922|NCT03033784|39869444|FG005|Overall Study|Anxiety related to MRI scanner|0|||
16377923|NCT03033784|39869445|FG006|Overall Study|Anxiety related to MRI scanner|0|||
16377924|NCT03033784|39869446|FG007|Overall Study|Anxiety related to MRI scanner|0|||
16377925|NCT03033784|39869447|FG008|Overall Study|Anxiety related to MRI scanner|0|||
16377926|NCT03033784|39869448|FG009|Overall Study|Anxiety related to MRI scanner|0|||
16377927|NCT03033784|39869449|FG010|Overall Study|Anxiety related to MRI scanner|0|||
16377928|NCT03033784|39869450|FG011|Overall Study|Anxiety related to MRI scanner|0|||
16377929|NCT03033784|39869451|FG012|Overall Study|Anxiety related to MRI scanner|0|||
16377930|NCT03033784|39869439|FG000|Overall Study|Withdrawal by Subject|0|||
16377931|NCT03033784|39869440|FG001|Overall Study|Withdrawal by Subject|0|||
16377932|NCT03033784|39869441|FG002|Overall Study|Withdrawal by Subject|0|||
16377933|NCT03033784|39869442|FG003|Overall Study|Withdrawal by Subject|0|||
16377934|NCT03033784|39869443|FG004|Overall Study|Withdrawal by Subject|0|||
16377935|NCT03033784|39869444|FG005|Overall Study|Withdrawal by Subject|0|||
16377936|NCT03033784|39869445|FG006|Overall Study|Withdrawal by Subject|0|||
16377937|NCT03033784|39869446|FG007|Overall Study|Withdrawal by Subject|0|||
16377938|NCT03033784|39869447|FG008|Overall Study|Withdrawal by Subject|0|||
16377939|NCT03033784|39869448|FG009|Overall Study|Withdrawal by Subject|0|||
16377940|NCT03033784|39869449|FG010|Overall Study|Withdrawal by Subject|0|||
16377941|NCT03033784|39869450|FG011|Overall Study|Withdrawal by Subject|0|||
16377942|NCT03033784|39869451|FG012|Overall Study|Withdrawal by Subject|2|||
16377943|NCT04629521|39869454|FG000|Overall Study|Death|1|||
16377944|NCT04629521|39869454|FG000|Overall Study|Lost to Follow-up|3|||
16377945|NCT04629521|39869454|FG000|Overall Study|Subject withdrew consent|3|||
16377946|NCT04629521|39869454|FG000|Overall Study|Enrolled in error|1|||
16377947|NCT03163667|39869457|FG000|Overall Study|Death|15|||
16377948|NCT03163667|39869458|FG001|Overall Study|Death|27|||
16377949|NCT03163667|39869457|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
16377950|NCT03163667|39869458|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
16377951|NCT01904279|39869459|FG000|Overall Study|Lack of Efficacy|2|||
16377952|NCT01904279|39869460|FG001|Overall Study|Lack of Efficacy|3|||
16377953|NCT01904279|39869459|FG000|Overall Study|Withdrawal by Subject|1|||
16377954|NCT01904279|39869460|FG001|Overall Study|Withdrawal by Subject|0|||
16377955|NCT03439072|39869461|FG000|Overall Study|Withdrawal by Subject|2|||
16377956|NCT03439072|39869462|FG001|Overall Study|Withdrawal by Subject|3|||
16377957|NCT03439072|39869461|FG000|Overall Study|Physician Decision|0|||
16377958|NCT03439072|39869462|FG001|Overall Study|Physician Decision|1|||
16377959|NCT02150863|39869463|FG000|Overall Study|Lost to Follow-up|0|||
16377960|NCT02150863|39869464|FG001|Overall Study|Lost to Follow-up|1|||
16377961|NCT02150863|39869465|FG002|Overall Study|Lost to Follow-up|0|||
16377962|NCT03559530|39869468|FG000|Overall Study|non-location of medical records|44|||
16377963|NCT03559530|39869469|FG001|Overall Study|non-location of medical records|0|||
16377964|NCT03559530|39869468|FG000|Overall Study|culture results not considered for treat|29|||
16377965|NCT03559530|39869469|FG001|Overall Study|culture results not considered for treat|0|||
16377966|NCT03559530|39869468|FG000|Overall Study|duplicate cases|8|||
16377967|NCT03559530|39869469|FG001|Overall Study|duplicate cases|0|||
16377968|NCT03559530|39869468|FG000|Overall Study|other species of Acinetobacte|7|||
16377969|NCT03559530|39869469|FG001|Overall Study|other species of Acinetobacte|0|||
16377970|NCT03559530|39869468|FG000|Overall Study|contamination / colonization|3|||
16377971|NCT03559530|39869469|FG001|Overall Study|contamination / colonization|0|||
16377972|NCT02496000|39869470|FG000|Overall Study|Withdrawal by Subject|1|||
16377973|NCT02496000|39869471|FG001|Overall Study|Withdrawal by Subject|2|||
16377974|NCT02496000|39869472|FG002|Overall Study|Withdrawal by Subject|0|||
16377975|NCT02496000|39869470|FG000|Overall Study|Lost to Follow-up|1|||
16377976|NCT02496000|39869471|FG001|Overall Study|Lost to Follow-up|0|||
16377977|NCT02496000|39869472|FG002|Overall Study|Lost to Follow-up|1|||
16377978|NCT02496000|39869470|FG000|Overall Study|Protocol Violation|0|||
16377979|NCT02496000|39869471|FG001|Overall Study|Protocol Violation|0|||
16377980|NCT02496000|39869472|FG002|Overall Study|Protocol Violation|1|||
16377981|NCT02496000|39869470|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
16377982|NCT02496000|39869471|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
16377983|NCT02496000|39869472|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
16377984|NCT02496000|39869470|FG000|Overall Study|undetermined|0|||
16377985|NCT02496000|39869471|FG001|Overall Study|undetermined|1|||
16377986|NCT02496000|39869472|FG002|Overall Study|undetermined|0|||
16377987|NCT03773562|39869482|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
16377988|NCT03773562|39869482|FG000|Overall Study|Lost to Follow-up|10|||
16377989|NCT03773562|39869482|FG000|Overall Study|Withdrawal by Subject|1|||
16377990|NCT00458705|39869483|FG000|Overall Study|Adverse Event|4|||
16377991|NCT00458705|39869483|FG000|Overall Study|Not Treated|1|||
16377992|NCT01308788|39869493|FG000|2-year Treatment|medication change by treating physician|4|||
16377993|NCT01308788|39869494|FG001|2-year Treatment|medication change by treating physician|11|||
16377994|NCT01506726|39869495|FG000|Overall Study|Adverse Event|1|||
16377995|NCT01506726|39869496|FG001|Overall Study|Adverse Event|2|||
16377996|NCT05524948|39869504|FG000|Overall Study|Withdrawal by Subject|1|||
16377997|NCT05524948|39869505|FG001|Overall Study|Withdrawal by Subject|0|||
16377998|NCT05524948|39869504|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
16377999|NCT05524948|39869505|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
16378000|NCT01149460|39869511|FG000|Overall Study|Withdrawal by Subject|0|||
16378001|NCT01149460|39869512|FG001|Overall Study|Withdrawal by Subject|2|||
16378002|NCT01882829|39869513|FG000|Overall Study|Adverse Event|4|||
16378003|NCT01882829|39869513|FG000|Overall Study|Protocol Violation|1|||
16378004|NCT01882829|39869513|FG000|Overall Study|Withdrawal by Subject|1|||
16378005|NCT00137449|39869516|FG000|Overall Study|Disease Progression|8|||
16378006|NCT00137449|39869517|FG001|Overall Study|Disease Progression|13|||
16378007|NCT00137449|39869516|FG000|Overall Study|Death|4|||
16378008|NCT00137449|39869517|FG001|Overall Study|Death|3|||
16378009|NCT00137449|39869516|FG000|Overall Study|Adverse Event|3|||
16378010|NCT00137449|39869517|FG001|Overall Study|Adverse Event|1|||
16378011|NCT00137449|39869516|FG000|Overall Study|Withdrawal by Subject|1|||
16378012|NCT00137449|39869517|FG001|Overall Study|Withdrawal by Subject|1|||
16378013|NCT00759395|39869522|FG000|Overall Study|Adverse Event|1|||
16378014|NCT00759395|39869523|FG001|Overall Study|Adverse Event|0|||
16378015|NCT00759395|39869522|FG000|Overall Study|Withdrawal by Subject|1|||
16378016|NCT00759395|39869523|FG001|Overall Study|Withdrawal by Subject|0|||
16378017|NCT00759395|39869522|FG000|Overall Study|Lack of Efficacy|0|||
16378018|NCT00759395|39869523|FG001|Overall Study|Lack of Efficacy|2|||
16378019|NCT03900650|39869530|FG000|Overall Study|Withdrawal by Subject|1|||
16378020|NCT03900650|39869531|FG001|Overall Study|Withdrawal by Subject|1|||
16378021|NCT03900650|39869532|FG002|Overall Study|Withdrawal by Subject|0|||
16378022|NCT03900650|39869533|FG003|Overall Study|Withdrawal by Subject|0|||
16378023|NCT03900650|39869530|FG000|Overall Study|Withdrawn by staff|1|||
16378024|NCT03900650|39869531|FG001|Overall Study|Withdrawn by staff|0|||
16474685|NCT01297920|40217993|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
16474686|NCT01297920|40217994|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
16474687|NCT01297920|40217995|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
16474688|NCT01683019|40217996|FG000|Overall Study|Withdrawal by Subject|2|||
16474689|NCT01683019|40217997|FG001|Overall Study|Withdrawal by Subject|1|||
16378025|NCT03900650|39869532|FG002|Overall Study|Withdrawn by staff|0|||
16378026|NCT03900650|39869533|FG003|Overall Study|Withdrawn by staff|0|||
16378027|NCT01496976|39869534|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
16378028|NCT03701074|39869540|FG000|Overall Study|Physician Decision|1|||
16378029|NCT03701074|39869541|FG001|Overall Study|Physician Decision|0|||
16378030|NCT03360344|39869549|FG000|Overall Study|Withdrawal by Subject|0|||
16378031|NCT03360344|39869550|FG001|Overall Study|Withdrawal by Subject|1|||
16378032|NCT03360344|39869551|FG002|Overall Study|Withdrawal by Subject|1|||
16378033|NCT00645658|39869552|FG000|Overall Study|Withdrawal by Subject|1|||
16378034|NCT00645658|39869553|FG001|Overall Study|Withdrawal by Subject|0|||
16378035|NCT00645658|39869552|FG000|Overall Study|Did not complete all assesments|0|||
16378036|NCT00645658|39869553|FG001|Overall Study|Did not complete all assesments|2|||
16378037|NCT02249949|39869554|FG000|Overall Study|Cancelled prior to treatment|2|||
16378038|NCT01487161|39869555|FG000|Overall Study|Adverse Event|1|||
16378039|NCT01487161|39869556|FG001|Overall Study|Adverse Event|0|||
16378040|NCT01487161|39869557|FG002|Overall Study|Adverse Event|0|||
16378041|NCT01487161|39869558|FG003|Overall Study|Adverse Event|0|||
16378042|NCT01487161|39869555|FG000|Overall Study|Withdrawal by Subject|1|||
16378043|NCT01487161|39869556|FG001|Overall Study|Withdrawal by Subject|1|||
16378044|NCT01487161|39869557|FG002|Overall Study|Withdrawal by Subject|1|||
16378045|NCT01487161|39869558|FG003|Overall Study|Withdrawal by Subject|2|||
16378046|NCT01487161|39869555|FG000|Overall Study|missing data|0|||
16378047|NCT01487161|39869556|FG001|Overall Study|missing data|1|||
16378048|NCT01487161|39869557|FG002|Overall Study|missing data|0|||
16378049|NCT01487161|39869558|FG003|Overall Study|missing data|0|||
16378050|NCT00322218|39869559|FG000|Overall Study|Death|3|||
16378051|NCT00322218|39869560|FG001|Overall Study|Death|6|||
16378052|NCT00855335|39869561|FG000|Overall Study|Lost to Follow-up|0|||
16378053|NCT00855335|39869562|FG001|Overall Study|Lost to Follow-up|0|||
16378054|NCT00855335|39869563|FG002|Overall Study|Lost to Follow-up|3|||
16378055|NCT00855335|39869564|FG003|Overall Study|Lost to Follow-up|1|||
16378056|NCT00855335|39869565|FG004|Overall Study|Lost to Follow-up|0|||
16378057|NCT00855335|39869561|FG000|Overall Study|Withdrawal by Subject|0|||
16378058|NCT00855335|39869562|FG001|Overall Study|Withdrawal by Subject|0|||
16378059|NCT00855335|39869563|FG002|Overall Study|Withdrawal by Subject|0|||
16378060|NCT00855335|39869564|FG003|Overall Study|Withdrawal by Subject|1|||
16378061|NCT00855335|39869565|FG004|Overall Study|Withdrawal by Subject|0|||
16378062|NCT00855335|39869561|FG000|Overall Study|Adverse Event|2|||
16378063|NCT00855335|39869562|FG001|Overall Study|Adverse Event|0|||
16378064|NCT00855335|39869563|FG002|Overall Study|Adverse Event|0|||
16378065|NCT00855335|39869564|FG003|Overall Study|Adverse Event|0|||
16474690|NCT01683019|40217998|FG002|Overall Study|Withdrawal by Subject|4|||
16378066|NCT00855335|39869565|FG004|Overall Study|Adverse Event|0|||
16378067|NCT00855335|39869561|FG000|Overall Study|Physician Decision|1|||
16378068|NCT00855335|39869562|FG001|Overall Study|Physician Decision|1|||
16378069|NCT00855335|39869563|FG002|Overall Study|Physician Decision|0|||
16378070|NCT00855335|39869564|FG003|Overall Study|Physician Decision|0|||
16378071|NCT00855335|39869565|FG004|Overall Study|Physician Decision|0|||
16378072|NCT00855335|39869561|FG000|Overall Study|Other|2|||
16378073|NCT00855335|39869562|FG001|Overall Study|Other|1|||
16378074|NCT00855335|39869563|FG002|Overall Study|Other|2|||
16378075|NCT00855335|39869564|FG003|Overall Study|Other|5|||
16378076|NCT00855335|39869565|FG004|Overall Study|Other|1|||
16378077|NCT01197300|39869568|FG000|Overall Study|Lost to Follow-up|0|||
16378078|NCT01197300|39869569|FG001|Overall Study|Lost to Follow-up|1|||
16378079|NCT01197300|39869568|FG000|Overall Study|Protocol Violation|0|||
16378080|NCT01197300|39869569|FG001|Overall Study|Protocol Violation|1|||
16378081|NCT03456076|39869570|FG000|Overall Study|Withdrawal by Subject|5|||
16378082|NCT03456076|39869571|FG001|Overall Study|Withdrawal by Subject|9|||
16378083|NCT03456076|39869570|FG000|Overall Study|Protocol deviation|0|||
16378084|NCT03456076|39869571|FG001|Overall Study|Protocol deviation|1|||
16378085|NCT03456076|39869570|FG000|Overall Study|Lost to Follow-up|0|||
16378086|NCT03456076|39869571|FG001|Overall Study|Lost to Follow-up|1|||
16378087|NCT03456076|39869570|FG000|Overall Study|Death|2|||
16378088|NCT03456076|39869571|FG001|Overall Study|Death|5|||
16378089|NCT03456076|39869570|FG000|Overall Study|Study ongoing|123|||
16378090|NCT03456076|39869571|FG001|Overall Study|Study ongoing|111|||
16378091|NCT01767987|39869577|FG000|Overall Study|Physician Decision|4|||
16378092|NCT01767987|39869578|FG001|Overall Study|Physician Decision|1|||
16378093|NCT02657343|39869579|FG000|Overall Study|Death|0|||
16378094|NCT02657343|39869580|FG001|Overall Study|Death|2|||
16378095|NCT02657343|39869581|FG002|Overall Study|Death|0|||
16378096|NCT02657343|39869582|FG003|Overall Study|Death|0|||
16378097|NCT02657343|39869583|FG004|Overall Study|Death|0|||
16378098|NCT02657343|39869584|FG005|Overall Study|Death|0|||
16378099|NCT02657343|39869579|FG000|Overall Study|Patient went to hospice|1|||
16378100|NCT02657343|39869580|FG001|Overall Study|Patient went to hospice|0|||
16378101|NCT02657343|39869581|FG002|Overall Study|Patient went to hospice|0|||
16378102|NCT02657343|39869582|FG003|Overall Study|Patient went to hospice|0|||
16378103|NCT02657343|39869583|FG004|Overall Study|Patient went to hospice|0|||
16378104|NCT02657343|39869584|FG005|Overall Study|Patient went to hospice|0|||
16378105|NCT02657343|39869579|FG000|Overall Study|Withdrawal by Subject|0|||
16378106|NCT02657343|39869580|FG001|Overall Study|Withdrawal by Subject|0|||
16378107|NCT02657343|39869581|FG002|Overall Study|Withdrawal by Subject|0|||
16378108|NCT02657343|39869582|FG003|Overall Study|Withdrawal by Subject|0|||
16378109|NCT02657343|39869583|FG004|Overall Study|Withdrawal by Subject|1|||
16378110|NCT02657343|39869584|FG005|Overall Study|Withdrawal by Subject|0|||
16378111|NCT03878602|39869585|FG000|Overall Study|cord blood donation|7|||
16378112|NCT03878602|39869586|FG001|Overall Study|cord blood donation|1|||
16378113|NCT03878602|39869585|FG000|Overall Study|incomplete data collection|2|||
16378114|NCT03878602|39869586|FG001|Overall Study|incomplete data collection|0|||
16378115|NCT02254460|39869593|FG000|Overall Study|Adverse Event|1|||
16378116|NCT02254460|39869594|FG001|Overall Study|Adverse Event|0|||
16378117|NCT02067156|39869596|FG000|Overall Study|Lost to Follow-up|4|||
16378118|NCT00089583|39869597|FG000|Overall Study|Adverse Event|0|||
16378119|NCT00089583|39869598|FG001|Overall Study|Adverse Event|3|||
16076234|NCT01430611|38769924|FG001|Overall Study|Lost to Follow-up|0|||
16076235|NCT01430611|38769923|FG000|Overall Study|Withdrawal by Subject|15|||
16076236|NCT01430611|38769924|FG001|Overall Study|Withdrawal by Subject|14|||
16076237|NCT00172185|38769925|FG000|Overall Study|Adverse Event|0|||
16378120|NCT00089583|39869597|FG000|Overall Study|Insufficient Viral Load Response|5|||
16378121|NCT00089583|39869598|FG001|Overall Study|Insufficient Viral Load Response|5|||
16378122|NCT00089583|39869597|FG000|Overall Study|Withdrawal by Subject|0|||
16378123|NCT00089583|39869598|FG001|Overall Study|Withdrawal by Subject|4|||
16378124|NCT00089583|39869597|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
16378125|NCT00089583|39869598|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
16378126|NCT00089583|39869597|FG000|Overall Study|Participant Refused Study Medication|0|||
16378127|NCT00089583|39869598|FG001|Overall Study|Participant Refused Study Medication|2|||
16378128|NCT00089583|39869597|FG000|Overall Study|Non-Compliance|0|||
16378129|NCT00089583|39869598|FG001|Overall Study|Non-Compliance|4|||
16378130|NCT00089583|39869597|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
16378131|NCT00089583|39869598|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
16378132|NCT00089583|39869597|FG000|Overall Study|Participant Management Criteria Met|0|||
16378133|NCT00089583|39869598|FG001|Overall Study|Participant Management Criteria Met|1|||
16378134|NCT00089583|39869597|FG000|Overall Study|Reason Not Provided|0|||
16378135|NCT00089583|39869598|FG001|Overall Study|Reason Not Provided|1|||
16378136|NCT00089583|39869597|FG000|Overall Study|Protocol Violation|0|||
16378137|NCT00089583|39869598|FG001|Overall Study|Protocol Violation|3|||
16378138|NCT00089583|39869597|FG000|Overall Study|Principal Investigator Decision|0|||
16378139|NCT00089583|39869598|FG001|Overall Study|Principal Investigator Decision|10|||
16378140|NCT00089583|39869597|FG000|Overall Study|Start of Disallowed Medication|0|||
16378141|NCT00089583|39869598|FG001|Overall Study|Start of Disallowed Medication|1|||
16378142|NCT00089583|39869597|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
16378143|NCT00089583|39869598|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
16378144|NCT00089583|39869597|FG000|Overall Study|Participant Incarcerated|0|||
16378145|NCT00089583|39869598|FG001|Overall Study|Participant Incarcerated|1|||
16378146|NCT00936936|39869599|FG000|Overall Study|Adverse Event|7|||
16378147|NCT00936936|39869600|FG001|Overall Study|Adverse Event|1|||
16378148|NCT00936936|39869599|FG000|Overall Study|Disease Progression|2|||
16378149|NCT00936936|39869600|FG001|Overall Study|Disease Progression|2|||
16076238|NCT00172185|38769926|FG001|Overall Study|Adverse Event|1|||
16076239|NCT00172185|38769927|FG002|Overall Study|Adverse Event|3|||
16076240|NCT00172185|38769928|FG003|Overall Study|Adverse Event|4|||
16076241|NCT00172185|38769925|FG000|Overall Study|Physician Decision|0|||
16378150|NCT00936936|39869599|FG000|Overall Study|Unrelated|3|||
16378151|NCT00936936|39869600|FG001|Overall Study|Unrelated|1|||
16378152|NCT03101267|39869603|FG000|Primary Study Period|Withdrawal by Subject|1|||
16378153|NCT03101267|39869604|FG001|Primary Study Period|Withdrawal by Subject|2|||
16378154|NCT03101267|39869605|FG002|Primary Study Period|Withdrawal by Subject|3|||
16378155|NCT03101267|39869603|FG000|Primary Study Period|Miscellaneous|2|||
16378156|NCT03101267|39869604|FG001|Primary Study Period|Miscellaneous|0|||
16378157|NCT03101267|39869605|FG002|Primary Study Period|Miscellaneous|0|||
16378158|NCT00833703|39869610|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
16378159|NCT00833703|39869611|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
16378160|NCT00944645|39869614|FG000|Period 2|Adverse Event|1|||
16378161|NCT00944645|39869615|FG001|Period 2|Adverse Event|0|||
16378162|NCT00944645|39869614|FG000|Period 2|Lost to Follow-up|0|||
16378163|NCT00944645|39869615|FG001|Period 2|Lost to Follow-up|3|||
16378164|NCT00944645|39869614|FG000|Period 2|Withdrawal by Subject|7|||
16378165|NCT00944645|39869615|FG001|Period 2|Withdrawal by Subject|6|||
16378166|NCT00323622|39869616|FG000|Overall Study|Other|30|||
16378167|NCT00323622|39869617|FG001|Overall Study|Other|91|||
16378168|NCT00323622|39869618|FG002|Overall Study|Other|4|||
16378169|NCT00323622|39869619|FG003|Overall Study|Other|12|||
16378170|NCT00323622|39869620|FG004|Overall Study|Other|32|||
16378171|NCT00323622|39869621|FG005|Overall Study|Other|74|||
16378172|NCT00323622|39869622|FG006|Overall Study|Other|5|||
16378173|NCT00323622|39869623|FG007|Overall Study|Other|13|||
16378174|NCT00323622|39869616|FG000|Overall Study|Death|1|||
16378175|NCT00323622|39869617|FG001|Overall Study|Death|1|||
16378176|NCT00323622|39869618|FG002|Overall Study|Death|0|||
16378177|NCT00323622|39869619|FG003|Overall Study|Death|0|||
16378178|NCT00323622|39869620|FG004|Overall Study|Death|7|||
16378179|NCT00323622|39869621|FG005|Overall Study|Death|0|||
16378180|NCT00323622|39869622|FG006|Overall Study|Death|0|||
16378181|NCT00323622|39869623|FG007|Overall Study|Death|2|||
16378182|NCT00605657|39869624|FG000|Overall Study|Adverse Event|1|||
16378183|NCT00605657|39869624|FG000|Overall Study|Protocol Violation|1|||
16378184|NCT01153516|39872009|FG000|Overall Study|Both subjects refused surgery|2|||
16378185|NCT01153516|39872010|FG001|Overall Study|Both subjects refused surgery|0|||
16378186|NCT02014467|39872011|FG000|Overall Study|Adverse Event|4|||
16378187|NCT02014467|39872012|FG001|Overall Study|Adverse Event|0|||
16378188|NCT02014467|39872011|FG000|Overall Study|Protocol Violation|3|||
16378189|NCT02014467|39872012|FG001|Overall Study|Protocol Violation|0|||
16378190|NCT02014467|39872011|FG000|Overall Study|Physician Decision|2|||
16378191|NCT02014467|39872012|FG001|Overall Study|Physician Decision|3|||
16378192|NCT02014467|39872011|FG000|Overall Study|Withdrawal by Subject|16|||
16378193|NCT02014467|39872012|FG001|Overall Study|Withdrawal by Subject|4|||
16378194|NCT04349098|39872016|FG000|Overall Study|Death|16|||
16378195|NCT04349098|39872017|FG001|Overall Study|Death|8|||
16378196|NCT04349098|39872016|FG000|Overall Study|Lost to Follow-up|11|||
16378197|NCT04349098|39872017|FG001|Overall Study|Lost to Follow-up|8|||
16378198|NCT04349098|39872016|FG000|Overall Study|Withdrawal by Subject|8|||
16378199|NCT04349098|39872017|FG001|Overall Study|Withdrawal by Subject|5|||
16378200|NCT04349098|39872016|FG000|Overall Study|Other|3|||
16378201|NCT04349098|39872017|FG001|Overall Study|Other|5|||
16378202|NCT01381679|39872018|FG000|Overall Study|Adverse Event|3|||
16076242|NCT00172185|38769926|FG001|Overall Study|Physician Decision|0|||
16378203|NCT01381679|39872018|FG000|Overall Study|Lost to Follow-up|885|||
16378204|NCT03257657|39872019|FG000|Overall Study|Lost to Follow-up|0|||
16378205|NCT03257657|39872020|FG001|Overall Study|Lost to Follow-up|3|||
16378206|NCT03257657|39872019|FG000|Overall Study|Withdrawn|0|||
16378207|NCT03257657|39872020|FG001|Overall Study|Withdrawn|1|||
16378208|NCT03257657|39872019|FG000|Overall Study|Noted not eligible right after enrolled|0|||
16378209|NCT03257657|39872020|FG001|Overall Study|Noted not eligible right after enrolled|1|||
16378210|NCT00567580|39872021|FG000|Overall Study|Protocol Violation|28|||
16378211|NCT00567580|39872022|FG001|Overall Study|Protocol Violation|24|||
16378212|NCT00567580|39872023|FG002|Overall Study|Protocol Violation|24|||
16378213|NCT03958045|39872029|FG000|Overall Study|Withdrawal by Subject|1|||
16378214|NCT04549454|39872030|FG000|T1 to T2|Lost to Follow-up|22|||
16378215|NCT04549454|39872031|FG001|T1 to T2|Lost to Follow-up|26|||
16378216|NCT04549454|39872030|FG000|T1 to T3|Lost to Follow-up|31|||
16378217|NCT04549454|39872031|FG001|T1 to T3|Lost to Follow-up|36|||
16378218|NCT02730169|39872034|FG000|Overall Study|Protocol Violation|1|||
16378219|NCT02730169|39872035|FG001|Overall Study|Protocol Violation|0|||
16378220|NCT02730169|39872036|FG002|Overall Study|Protocol Violation|0|||
16378221|NCT02730169|39872037|FG003|Overall Study|Protocol Violation|1|||
16378222|NCT02730169|39872034|FG000|Overall Study|Adverse Event|2|||
16378223|NCT02730169|39872035|FG001|Overall Study|Adverse Event|3|||
16378224|NCT02730169|39872036|FG002|Overall Study|Adverse Event|3|||
16378225|NCT02730169|39872037|FG003|Overall Study|Adverse Event|0|||
16378226|NCT02730169|39872034|FG000|Overall Study|Adverse Event of Special Interest|0|||
16378227|NCT02730169|39872035|FG001|Overall Study|Adverse Event of Special Interest|1|||
16378228|NCT02730169|39872036|FG002|Overall Study|Adverse Event of Special Interest|2|||
16378229|NCT02730169|39872037|FG003|Overall Study|Adverse Event of Special Interest|0|||
16378230|NCT02730169|39872034|FG000|Overall Study|Withdrawal by Subject|6|||
16378231|NCT02730169|39872035|FG001|Overall Study|Withdrawal by Subject|11|||
16378232|NCT02730169|39872036|FG002|Overall Study|Withdrawal by Subject|6|||
16378233|NCT02730169|39872037|FG003|Overall Study|Withdrawal by Subject|8|||
16378234|NCT02730169|39872034|FG000|Overall Study|Lost to Follow-up|5|||
16378235|NCT02730169|39872035|FG001|Overall Study|Lost to Follow-up|6|||
16378236|NCT02730169|39872036|FG002|Overall Study|Lost to Follow-up|5|||
16378237|NCT02730169|39872037|FG003|Overall Study|Lost to Follow-up|6|||
16378238|NCT02730169|39872034|FG000|Overall Study|Other|0|||
16378239|NCT02730169|39872035|FG001|Overall Study|Other|0|||
16378240|NCT02730169|39872036|FG002|Overall Study|Other|1|||
16378241|NCT02730169|39872037|FG003|Overall Study|Other|1|||
16378242|NCT02374255|39872038|FG000|Overall Study|Withdrawal by Subject|2|||
16378243|NCT02374255|39872039|FG001|Overall Study|Withdrawal by Subject|0|||
16378244|NCT02374255|39872040|FG002|Overall Study|Withdrawal by Subject|0|||
16378245|NCT02374255|39872041|FG003|Overall Study|Withdrawal by Subject|0|||
16378246|NCT00363298|39872049|FG000|First Study Week|Lack of Efficacy|6|||
16378247|NCT00363298|39872050|FG001|First Study Week|Lack of Efficacy|5|||
16378248|NCT00363298|39872049|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
16378249|NCT00363298|39872050|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
16378250|NCT00787150|39872051|FG000|Overall Study|Adverse Event|4|||
16378251|NCT00787150|39872052|FG001|Overall Study|Adverse Event|4|||
16378252|NCT00787150|39872053|FG002|Overall Study|Adverse Event|4|||
16378253|NCT00787150|39872051|FG000|Overall Study|Physician Decision|1|||
16378254|NCT00787150|39872052|FG001|Overall Study|Physician Decision|2|||
16378255|NCT00787150|39872053|FG002|Overall Study|Physician Decision|1|||
16378256|NCT00787150|39872051|FG000|Overall Study|Withdrawal by Subject|2|||
16378257|NCT00787150|39872052|FG001|Overall Study|Withdrawal by Subject|1|||
16378258|NCT00787150|39872053|FG002|Overall Study|Withdrawal by Subject|0|||
16378259|NCT00787150|39872051|FG000|Overall Study|Dosing incorrect study durg|2|||
16378260|NCT00787150|39872052|FG001|Overall Study|Dosing incorrect study durg|0|||
16378261|NCT00787150|39872053|FG002|Overall Study|Dosing incorrect study durg|0|||
16378262|NCT03368001|39872055|FG000|Allocation|Lost to Pretest|16|||
16378263|NCT03368001|39872056|FG001|Allocation|Lost to Pretest|25|||
16378264|NCT03368001|39872055|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
16378265|NCT03368001|39872056|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
16378266|NCT03368001|39872055|FG000|Posttest|Lost to Posttest|7|||
16378267|NCT03368001|39872056|FG001|Posttest|Lost to Posttest|11|||
16378268|NCT03368001|39872055|FG000|Posttest|Discontinued Intervention|6|||
16378269|NCT03368001|39872056|FG001|Posttest|Discontinued Intervention|19|||
16378270|NCT03368001|39872055|FG000|Follow-up|Lost to Follow-up|6|||
16378271|NCT03368001|39872056|FG001|Follow-up|Lost to Follow-up|3|||
16378272|NCT04976855|39872058|FG000|Part I|Withdrawal by Subject|0|||
16378273|NCT04976855|39872059|FG001|Part I|Withdrawal by Subject|1|||
16378274|NCT04976855|39872060|FG002|Part I|Withdrawal by Subject|0|||
16378275|NCT04976855|39872061|FG003|Part I|Withdrawal by Subject|0|||
16378276|NCT04976855|39872062|FG004|Part I|Withdrawal by Subject|0|||
16076243|NCT00172185|38769927|FG002|Overall Study|Physician Decision|1|||
16076244|NCT00172185|38769928|FG003|Overall Study|Physician Decision|0|||
16378277|NCT04976855|39872063|FG005|Part I|Withdrawal by Subject|0|||
16378278|NCT04976855|39872064|FG006|Part I|Withdrawal by Subject|0|||
16378279|NCT04976855|39872058|FG000|Part II|Adverse Event|0|||
16378280|NCT04976855|39872059|FG001|Part II|Adverse Event|0|||
16378281|NCT04976855|39872060|FG002|Part II|Adverse Event|0|||
16378282|NCT04976855|39872061|FG003|Part II|Adverse Event|1|||
16378283|NCT04976855|39872062|FG004|Part II|Adverse Event|0|||
16378284|NCT04976855|39872063|FG005|Part II|Adverse Event|0|||
16378285|NCT04976855|39872064|FG006|Part II|Adverse Event|0|||
16378286|NCT04976855|39872058|FG000|Part II|Withdrawal by Subject|0|||
16378287|NCT04976855|39872059|FG001|Part II|Withdrawal by Subject|0|||
16378288|NCT04976855|39872060|FG002|Part II|Withdrawal by Subject|0|||
16378289|NCT04976855|39872061|FG003|Part II|Withdrawal by Subject|0|||
16378290|NCT04976855|39872062|FG004|Part II|Withdrawal by Subject|1|||
16378291|NCT04976855|39872063|FG005|Part II|Withdrawal by Subject|0|||
16378292|NCT04976855|39872064|FG006|Part II|Withdrawal by Subject|0|||
16378293|NCT04976855|39872058|FG000|Part II|Lost to Follow-up|0|||
16378294|NCT04976855|39872059|FG001|Part II|Lost to Follow-up|0|||
16378295|NCT04976855|39872060|FG002|Part II|Lost to Follow-up|0|||
16378296|NCT04976855|39872061|FG003|Part II|Lost to Follow-up|0|||
16378297|NCT04976855|39872062|FG004|Part II|Lost to Follow-up|0|||
16378298|NCT04976855|39872063|FG005|Part II|Lost to Follow-up|1|||
16378299|NCT04976855|39872064|FG006|Part II|Lost to Follow-up|0|||
16378300|NCT00133705|39872068|FG000|Overall Study|Withdrawal by Subject|2|||
16076245|NCT00172185|38769925|FG000|Overall Study|SPONSOR Decision|0|||
16378301|NCT00133705|39872069|FG001|Overall Study|Withdrawal by Subject|3|||
16378302|NCT00427700|39872070|FG000|Overall Study|Lost to Follow-up|2|||
16378303|NCT00427700|39872071|FG001|Overall Study|Lost to Follow-up|5|||
16378304|NCT00427700|39872070|FG000|Overall Study|no induction of menses|1|||
16378305|NCT00427700|39872071|FG001|Overall Study|no induction of menses|4|||
16378306|NCT00427700|39872070|FG000|Overall Study|Pregnancy|0|||
16378307|NCT00427700|39872071|FG001|Overall Study|Pregnancy|2|||
16378308|NCT03412591|39872076|FG000|Overall Study|Withdrawal by Subject|1|||
16076246|NCT00172185|38769926|FG001|Overall Study|SPONSOR Decision|1|||
16076247|NCT00172185|38769927|FG002|Overall Study|SPONSOR Decision|0|||
16076248|NCT00172185|38769928|FG003|Overall Study|SPONSOR Decision|0|||
16076249|NCT00172185|38769925|FG000|Overall Study|Withdrawal by Subject|0|||
16076250|NCT00172185|38769926|FG001|Overall Study|Withdrawal by Subject|0|||
16378309|NCT03412591|39872077|FG001|Overall Study|Withdrawal by Subject|8|||
16378310|NCT03412591|39872076|FG000|Overall Study|Adverse Event|0|||
16378311|NCT03412591|39872077|FG001|Overall Study|Adverse Event|1|||
16378312|NCT02081586|39872078|FG000|Overall Study|Lost to Follow-up|0|||
16378313|NCT02081586|39872079|FG001|Overall Study|Lost to Follow-up|1|||
16378314|NCT02081586|39872080|FG002|Overall Study|Lost to Follow-up|0|||
16378315|NCT02081586|39872081|FG003|Overall Study|Lost to Follow-up|1|||
16378316|NCT02081586|39872078|FG000|Overall Study|Head injury not related to study|0|||
16378317|NCT02081586|39872079|FG001|Overall Study|Head injury not related to study|0|||
16378318|NCT02081586|39872080|FG002|Overall Study|Head injury not related to study|1|||
16378319|NCT02081586|39872081|FG003|Overall Study|Head injury not related to study|0|||
16378320|NCT00581100|39872082|FG000|Overall Study|Death|1|||
16378321|NCT00581100|39872083|FG001|Overall Study|Death|0|||
16378322|NCT00581100|39872082|FG000|Overall Study|Adverse Event|2|||
16378323|NCT00581100|39872083|FG001|Overall Study|Adverse Event|1|||
16378324|NCT00581100|39872082|FG000|Overall Study|Withdrawal by Subject|1|||
16378325|NCT00581100|39872083|FG001|Overall Study|Withdrawal by Subject|4|||
16378326|NCT00581100|39872082|FG000|Overall Study|Other|3|||
16378327|NCT00581100|39872083|FG001|Overall Study|Other|0|||
16378328|NCT03682367|39872088|FG000|Overall Study|Protocol Violation|2|||
16378329|NCT03682367|39872089|FG001|Overall Study|Protocol Violation|1|||
16378330|NCT03682367|39872088|FG000|Overall Study|Closed Study Early|0|||
16378331|NCT03682367|39872089|FG001|Overall Study|Closed Study Early|3|||
16378332|NCT02105012|39872091|FG000|Overall Study|Withdrawal by Subject|11|||
16076251|NCT00172185|38769927|FG002|Overall Study|Withdrawal by Subject|1|||
16076252|NCT00172185|38769928|FG003|Overall Study|Withdrawal by Subject|0|||
16076253|NCT00546871|38769929|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
16076254|NCT00546871|38769930|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
16076255|NCT00546871|38769929|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
16076256|NCT00546871|38769930|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
16378333|NCT02105012|39872091|FG000|Overall Study|Protocol Specified Criteria|9|||
16378334|NCT02105012|39872091|FG000|Overall Study|Lost to Follow-up|4|||
16378335|NCT02105012|39872091|FG000|Overall Study|Protocol Violation|4|||
16378336|NCT02105012|39872091|FG000|Overall Study|Physician Decision|3|||
16378337|NCT02105012|39872091|FG000|Overall Study|Adverse Event|1|||
16378338|NCT02105012|39872091|FG000|Overall Study|Lack of Efficacy|1|||
16378339|NCT00618787|39872092|FG000|Overall Study|Adverse Event|0|||
16378340|NCT00618787|39872093|FG001|Overall Study|Adverse Event|1|||
16378341|NCT00618787|39872092|FG000|Overall Study|Withdrawal by Subject|2|||
16378342|NCT00618787|39872093|FG001|Overall Study|Withdrawal by Subject|1|||
16378343|NCT00618787|39872092|FG000|Overall Study|Lost to Follow-up|1|||
16378344|NCT00618787|39872093|FG001|Overall Study|Lost to Follow-up|0|||
16378345|NCT00112385|39872094|FG000|Overall Study|Lost to Follow-up|1|||
16378346|NCT00112385|39872095|FG001|Overall Study|Lost to Follow-up|0|||
16378347|NCT00112385|39872094|FG000|Overall Study|Withdrawal by Subject|0|||
16378348|NCT00112385|39872095|FG001|Overall Study|Withdrawal by Subject|1|||
16378349|NCT01150357|39872096|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
16378350|NCT01150357|39872097|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
16378351|NCT01150357|39872098|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
16378352|NCT01150357|39872096|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
16378353|NCT01150357|39872097|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
16378354|NCT01150357|39872098|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
16378355|NCT01150357|39872096|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
16378356|NCT01150357|39872097|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
16378357|NCT01150357|39872098|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
16378358|NCT01150357|39872096|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
16378359|NCT01150357|39872097|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
16378360|NCT01150357|39872098|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
16378361|NCT01150357|39872096|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
16076257|NCT00546871|38769929|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
16378362|NCT01150357|39872097|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
16378363|NCT01150357|39872098|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
16378364|NCT01150357|39872096|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
16378365|NCT01150357|39872097|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
16378366|NCT01150357|39872098|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
16378367|NCT01150357|39872096|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
16378368|NCT01150357|39872097|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
16378369|NCT01150357|39872098|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
16076258|NCT00546871|38769930|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
16378370|NCT01416831|39872099|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
16378371|NCT01416831|39872100|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
16378372|NCT02082977|39872101|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
16378373|NCT02082977|39872102|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
16076259|NCT00546871|38769929|FG000|Study Extension Period|Protocol Violation|1|||
16076260|NCT00546871|38769930|FG001|Study Extension Period|Protocol Violation|0|||
16076261|NCT00546871|38769929|FG000|Study Extension Period|Withdrawal by Subject|0|||
16076262|NCT00546871|38769930|FG001|Study Extension Period|Withdrawal by Subject|1|||
16076263|NCT00726999|38769931|FG000|Overall Study|Physician Decision|0|||
16076264|NCT00726999|38769932|FG001|Overall Study|Physician Decision|1|||
16076265|NCT00726999|38769931|FG000|Overall Study|Withdrawal by Subject|2|||
16076266|NCT00726999|38769932|FG001|Overall Study|Withdrawal by Subject|0|||
16076267|NCT00726999|38769931|FG000|Overall Study|Protocol Violation|1|||
16076268|NCT00726999|38769932|FG001|Overall Study|Protocol Violation|0|||
16076269|NCT00463788|38769933|FG000|Overall Study|Progressive Disease|86|||
16076270|NCT00463788|38769934|FG001|Overall Study|Progressive Disease|42|||
16076271|NCT00463788|38769933|FG000|Overall Study|Adverse Event|6|||
16076272|NCT00463788|38769934|FG001|Overall Study|Adverse Event|2|||
16076273|NCT00463788|38769933|FG000|Overall Study|Withdrawal by Subject|6|||
16076274|NCT00463788|38769934|FG001|Overall Study|Withdrawal by Subject|2|||
16076275|NCT00463788|38769933|FG000|Overall Study|Death|4|||
16076276|NCT00463788|38769934|FG001|Overall Study|Death|3|||
16076277|NCT00463788|38769933|FG000|Overall Study|Symptomatic Deterioration|2|||
16076278|NCT00463788|38769934|FG001|Overall Study|Symptomatic Deterioration|3|||
16076279|NCT00463788|38769933|FG000|Overall Study|Lost to Follow-up|1|||
16076280|NCT00463788|38769934|FG001|Overall Study|Lost to Follow-up|0|||
16076281|NCT00463788|38769933|FG000|Overall Study|Protocol Violation|0|||
16076282|NCT00463788|38769934|FG001|Overall Study|Protocol Violation|1|||
16076283|NCT00463788|38769933|FG000|Overall Study|Other|3|||
16076284|NCT00463788|38769934|FG001|Overall Study|Other|0|||
16076285|NCT00463788|38769933|FG000|Overall Study|Randomized but not treated|1|||
16076286|NCT00463788|38769934|FG001|Overall Study|Randomized but not treated|1|||
16076287|NCT00955825|38769935|FG000|Overall Study|Adverse Event|15|||
16076288|NCT00955825|38769936|FG001|Overall Study|Adverse Event|2|||
16076289|NCT00955825|38769935|FG000|Overall Study|Withdrawal by Subject|4|||
16076290|NCT00955825|38769936|FG001|Overall Study|Withdrawal by Subject|6|||
16076291|NCT00955825|38769935|FG000|Overall Study|Any other reason not above-mentioned|7|||
16076292|NCT00955825|38769936|FG001|Overall Study|Any other reason not above-mentioned|9|||
16076293|NCT02202499|38769937|FG000|Overall Study|Cancer diagnosis|0|||
16076294|NCT02202499|38769938|FG001|Overall Study|Cancer diagnosis|0|||
16076295|NCT02202499|38769939|FG002|Overall Study|Cancer diagnosis|1|||
16076296|NCT02202499|38769937|FG000|Overall Study|Moved from area|0|||
16076297|NCT02202499|38769938|FG001|Overall Study|Moved from area|0|||
16076298|NCT02202499|38769939|FG002|Overall Study|Moved from area|1|||
16076299|NCT02202499|38769937|FG000|Overall Study|Declined before randomization|1|||
16076300|NCT02202499|38769938|FG001|Overall Study|Declined before randomization|0|||
16076301|NCT02202499|38769939|FG002|Overall Study|Declined before randomization|0|||
16076302|NCT02202499|38769937|FG000|Overall Study|Auto accident|1|||
16378374|NCT02082977|39872103|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
16378375|NCT02082977|39872104|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
16378376|NCT02082977|39872105|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
16378377|NCT02082977|39872106|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
16378378|NCT02082977|39872107|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
16378379|NCT02082977|39872108|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
16378380|NCT02082977|39872109|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
16378381|NCT02082977|39872110|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
16378382|NCT02082977|39872101|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16378383|NCT02082977|39872102|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16378384|NCT02082977|39872103|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16378385|NCT02082977|39872104|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16378386|NCT02082977|39872105|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16378387|NCT02082977|39872106|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16378388|NCT02082977|39872107|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16076303|NCT02202499|38769938|FG001|Overall Study|Auto accident|0|||
16076304|NCT02202499|38769939|FG002|Overall Study|Auto accident|0|||
16076305|NCT02529995|38769945|FG000|Part A|Ongoing Study at Data Cut-off|14|||
16378389|NCT02082977|39872108|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
16378390|NCT02082977|39872109|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16076306|NCT02529995|38769946|FG001|Part A|Ongoing Study at Data Cut-off|16|||
16378391|NCT02082977|39872110|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
16378392|NCT02082977|39872101|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16378393|NCT02082977|39872102|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16378394|NCT02082977|39872103|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16076307|NCT02529995|38769945|FG000|Part A|Discontinued Study|1|||
16076308|NCT02529995|38769946|FG001|Part A|Discontinued Study|0|||
16076309|NCT02529995|38769945|FG000|Part B|Ongoing Study at Data Cut-off|0|||
16076310|NCT02529995|38769946|FG001|Part B|Ongoing Study at Data Cut-off|7|||
16076311|NCT02529995|38769945|FG000|Part B|Discontinued Study|6|||
16076312|NCT02529995|38769946|FG001|Part B|Discontinued Study|5|||
16076313|NCT02918279|38769947|FG000|Overall Study|Lost to Follow-up|3|||
16076314|NCT02918279|38769948|FG001|Overall Study|Lost to Follow-up|6|||
16076315|NCT02918279|38769947|FG000|Overall Study|Withdrawal by Subject|5|||
16076316|NCT02918279|38769948|FG001|Overall Study|Withdrawal by Subject|15|||
16378395|NCT02082977|39872104|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16378396|NCT02082977|39872105|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16378397|NCT02082977|39872106|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
16378398|NCT02082977|39872107|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16378399|NCT02082977|39872108|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16378400|NCT02082977|39872109|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16378401|NCT02082977|39872110|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
16378402|NCT02082977|39872101|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
16378403|NCT02082977|39872102|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
16378404|NCT02082977|39872103|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
16076317|NCT02918279|38769947|FG000|Overall Study|Withdrawal by parent/guardian|2|||
16076318|NCT02918279|38769948|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16378405|NCT02082977|39872104|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
16378406|NCT02082977|39872105|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
16378407|NCT02082977|39872106|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
16378408|NCT02082977|39872107|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
16378409|NCT02082977|39872108|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
16076319|NCT02918279|38769947|FG000|Overall Study|Other|3|||
16076320|NCT02918279|38769948|FG001|Overall Study|Other|1|||
16076321|NCT01290224|38769949|FG000|Overall Study|Adverse Event|1|||
16076322|NCT01290224|38769949|FG000|Overall Study|Refused Further Treatment|4|||
16076323|NCT01415349|38773203|FG000|Treatment Period 1|Adverse Event|0|||
16076324|NCT01415349|38773204|FG001|Treatment Period 1|Adverse Event|1|||
16378410|NCT02082977|39872109|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
16378411|NCT02082977|39872110|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
16378412|NCT02082977|39872101|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16378413|NCT02082977|39872102|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16378414|NCT02082977|39872103|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16378415|NCT02082977|39872104|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16378416|NCT02082977|39872105|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16378417|NCT02082977|39872106|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16378418|NCT02082977|39872107|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16378419|NCT02082977|39872108|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
16378420|NCT02082977|39872109|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16378421|NCT02082977|39872110|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
16378422|NCT00526799|39872111|FG000|Overall Study|Withdrawal by Subject|1|||
16378423|NCT00526799|39872112|FG001|Overall Study|Withdrawal by Subject|0|||
16378424|NCT00526799|39872111|FG000|Overall Study|Intercurrent Complicating Disease|0|||
16378425|NCT00526799|39872112|FG001|Overall Study|Intercurrent Complicating Disease|1|||
16378426|NCT00835042|39872113|FG000|First Intervention|Withdrawal by Subject|3|||
16378427|NCT00835042|39872114|FG001|First Intervention|Withdrawal by Subject|0|||
16378428|NCT00835042|39872113|FG000|First Intervention|Adverse Event|1|||
16378429|NCT00835042|39872114|FG001|First Intervention|Adverse Event|2|||
16378430|NCT00835042|39872113|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
16378431|NCT00835042|39872114|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
16076325|NCT01415349|38773203|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16076326|NCT01415349|38773204|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16378432|NCT04059484|39872116|FG000|Overall Study|Adverse Event|2|||
16378433|NCT04059484|39872117|FG001|Overall Study|Adverse Event|5|||
16378434|NCT04059484|39872116|FG000|Overall Study|Withdrawal by Subject|5|||
16378435|NCT04059484|39872117|FG001|Overall Study|Withdrawal by Subject|3|||
16378436|NCT04059484|39872116|FG000|Overall Study|Progressive disease|112|||
16378437|NCT04059484|39872117|FG001|Overall Study|Progressive disease|112|||
16378438|NCT04059484|39872116|FG000|Overall Study|Other|8|||
16378439|NCT04059484|39872117|FG001|Overall Study|Other|3|||
16378440|NCT04059484|39872116|FG000|Overall Study|Ongoing|20|||
16378441|NCT04059484|39872117|FG001|Overall Study|Ongoing|20|||
16378442|NCT02758626|39872118|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
16076327|NCT03830866|38773205|FG000|Overall Study|Death|90|||
16076328|NCT03830866|38773206|FG001|Overall Study|Death|111|||
16076329|NCT03830866|38773205|FG000|Overall Study|Lost to Follow-up|7|||
16378443|NCT02758626|39872119|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
16378444|NCT02758626|39872118|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
16378445|NCT02758626|39872119|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
16378446|NCT02758626|39872118|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
16378447|NCT02758626|39872119|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
16378448|NCT02758626|39872118|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
16378449|NCT02758626|39872119|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
16378450|NCT01313676|39872122|FG000|Overall Study|Adverse Event|395|||
16378451|NCT01313676|39872123|FG001|Overall Study|Adverse Event|365|||
16378452|NCT01313676|39872124|FG002|Overall Study|Adverse Event|372|||
16378453|NCT01313676|39872125|FG003|Overall Study|Adverse Event|333|||
16378454|NCT01313676|39872122|FG000|Overall Study|Lack of Efficacy|98|||
16378455|NCT01313676|39872123|FG001|Overall Study|Lack of Efficacy|90|||
16378456|NCT01313676|39872124|FG002|Overall Study|Lack of Efficacy|65|||
16378457|NCT01313676|39872125|FG003|Overall Study|Lack of Efficacy|46|||
16378458|NCT01313676|39872122|FG000|Overall Study|Protocol Violation|37|||
16378459|NCT01313676|39872123|FG001|Overall Study|Protocol Violation|44|||
16378460|NCT01313676|39872124|FG002|Overall Study|Protocol Violation|46|||
16378461|NCT01313676|39872125|FG003|Overall Study|Protocol Violation|44|||
16378462|NCT01313676|39872122|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
16378463|NCT01313676|39872123|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
16076330|NCT03830866|38773206|FG001|Overall Study|Lost to Follow-up|7|||
16076331|NCT03830866|38773205|FG000|Overall Study|Withdrawal by Subject|19|||
16378464|NCT01313676|39872124|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
16378465|NCT01313676|39872125|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
16378466|NCT01313676|39872122|FG000|Overall Study|Study Closed/terminated|7|||
16378467|NCT01313676|39872123|FG001|Overall Study|Study Closed/terminated|6|||
16076332|NCT03830866|38773206|FG001|Overall Study|Withdrawal by Subject|16|||
16076333|NCT03830866|38773205|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
16378468|NCT01313676|39872124|FG002|Overall Study|Study Closed/terminated|9|||
16378469|NCT01313676|39872125|FG003|Overall Study|Study Closed/terminated|9|||
16378470|NCT01313676|39872122|FG000|Overall Study|Lost to Follow-up|0|||
16378471|NCT01313676|39872123|FG001|Overall Study|Lost to Follow-up|0|||
16378472|NCT01313676|39872124|FG002|Overall Study|Lost to Follow-up|1|||
16378473|NCT01313676|39872125|FG003|Overall Study|Lost to Follow-up|0|||
16378474|NCT01313676|39872122|FG000|Overall Study|Physician Decision|53|||
16378475|NCT01313676|39872123|FG001|Overall Study|Physician Decision|64|||
16378476|NCT01313676|39872124|FG002|Overall Study|Physician Decision|62|||
16378477|NCT01313676|39872125|FG003|Overall Study|Physician Decision|48|||
16076334|NCT03830866|38773206|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
16076335|NCT03830866|38773205|FG000|Overall Study|Other|1|||
16076336|NCT03830866|38773206|FG001|Overall Study|Other|1|||
16076337|NCT00419094|38773207|FG000|Overall Study|Adverse Event|3|||
16076338|NCT00419094|38773208|FG001|Overall Study|Adverse Event|7|||
16076339|NCT00419094|38773207|FG000|Overall Study|Lack of Efficacy|1|||
16076340|NCT00419094|38773208|FG001|Overall Study|Lack of Efficacy|0|||
16076341|NCT00419094|38773207|FG000|Overall Study|Lost to Follow-up|0|||
16076342|NCT00419094|38773208|FG001|Overall Study|Lost to Follow-up|2|||
16076343|NCT00419094|38773207|FG000|Overall Study|Protocol Violation|1|||
16076344|NCT00419094|38773208|FG001|Overall Study|Protocol Violation|14|||
16076345|NCT00419094|38773207|FG000|Overall Study|Withdrawal of consent|1|||
16076346|NCT00419094|38773208|FG001|Overall Study|Withdrawal of consent|5|||
16076347|NCT00419094|38773207|FG000|Overall Study|Other: Error determining exit criteria|1|||
16076348|NCT00419094|38773208|FG001|Overall Study|Other: Error determining exit criteria|0|||
16076349|NCT00419094|38773207|FG000|Overall Study|Other: Patient non-compliant|0|||
16076350|NCT00419094|38773208|FG001|Overall Study|Other: Patient non-compliant|1|||
16076351|NCT00419094|38773207|FG000|Overall Study|Other: No contact for extended period|0|||
16076352|NCT00419094|38773208|FG001|Overall Study|Other: No contact for extended period|1|||
16076353|NCT00658996|38773214|FG000|First Intervention|Positive slit lamp finding|1|||
16076354|NCT00658996|38773215|FG001|First Intervention|Positive slit lamp finding|0|||
16076355|NCT00658996|38773214|FG000|First Intervention|Lack of lenses|0|||
16076356|NCT00658996|38773215|FG001|First Intervention|Lack of lenses|1|||
16076357|NCT00658996|38773214|FG000|Crossover Period|Physician Decision|1|||
16076358|NCT00658996|38773215|FG001|Crossover Period|Physician Decision|0|||
16076359|NCT00658996|38773214|FG000|Crossover Period|Ineligible|1|||
16076360|NCT00658996|38773215|FG001|Crossover Period|Ineligible|1|||
16076361|NCT00658996|38773214|FG000|Second Intervention|Developed a stye on upper lid|1|||
16378478|NCT01313676|39872122|FG000|Overall Study|Decision by Participant or Proxy|643|||
16378479|NCT01313676|39872123|FG001|Overall Study|Decision by Participant or Proxy|527|||
16378480|NCT01313676|39872124|FG002|Overall Study|Decision by Participant or Proxy|515|||
16378481|NCT01313676|39872125|FG003|Overall Study|Decision by Participant or Proxy|492|||
16378482|NCT01313676|39872122|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
16378483|NCT01313676|39872123|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
16378484|NCT01313676|39872124|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
16076362|NCT00658996|38773215|FG001|Second Intervention|Developed a stye on upper lid|0|||
16378485|NCT01313676|39872125|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
16378486|NCT01313676|39872122|FG000|Overall Study|Investigator Site Closed|12|||
16378487|NCT01313676|39872123|FG001|Overall Study|Investigator Site Closed|11|||
16378488|NCT01313676|39872124|FG002|Overall Study|Investigator Site Closed|15|||
16378489|NCT01313676|39872125|FG003|Overall Study|Investigator Site Closed|10|||
16378490|NCT01313676|39872122|FG000|Overall Study|Missing|1|||
16378491|NCT01313676|39872123|FG001|Overall Study|Missing|1|||
16378492|NCT01313676|39872124|FG002|Overall Study|Missing|1|||
16378493|NCT01313676|39872125|FG003|Overall Study|Missing|0|||
16378494|NCT05185453|39872126|FG000|Overall Study|Lost to Follow-up|13|||
16076363|NCT00658996|38773214|FG000|Second Intervention|Positive slit lamp finding|0|||
16076364|NCT00658996|38773215|FG001|Second Intervention|Positive slit lamp finding|1|||
16076365|NCT02544152|38773220|FG000|Overall Study|Adverse Event|0|||
16378495|NCT05185453|39872127|FG001|Overall Study|Lost to Follow-up|3|||
16378496|NCT02457793|39872128|FG000|Overall Study|Reason not specified|0|||
16076366|NCT02544152|38773221|FG001|Overall Study|Adverse Event|4|||
16076367|NCT02544152|38773220|FG000|Overall Study|Withdrawal by Subject|0|||
16076368|NCT02544152|38773221|FG001|Overall Study|Withdrawal by Subject|3|||
16076369|NCT02544152|38773220|FG000|Overall Study|Other|1|||
16076370|NCT02544152|38773221|FG001|Overall Study|Other|0|||
16076371|NCT00617201|38773222|FG000|Overall Study|Lost to Follow-up|9|||
16076372|NCT00617201|38773223|FG001|Overall Study|Lost to Follow-up|13|||
16076373|NCT01400776|38773225|FG000|Overall Study|Adverse Event|7|||
16076374|NCT01400776|38773226|FG001|Overall Study|Adverse Event|2|||
16076375|NCT01400776|38773227|FG002|Overall Study|Adverse Event|9|||
16076376|NCT01400776|38773228|FG003|Overall Study|Adverse Event|2|||
16076377|NCT01400776|38773225|FG000|Overall Study|Lost to Follow-up|1|||
16076378|NCT01400776|38773226|FG001|Overall Study|Lost to Follow-up|0|||
16076379|NCT01400776|38773227|FG002|Overall Study|Lost to Follow-up|4|||
16076380|NCT01400776|38773228|FG003|Overall Study|Lost to Follow-up|1|||
16076381|NCT01400776|38773225|FG000|Overall Study|Withdrew Consent|4|||
16076382|NCT01400776|38773226|FG001|Overall Study|Withdrew Consent|2|||
16076383|NCT01400776|38773227|FG002|Overall Study|Withdrew Consent|6|||
16076384|NCT01400776|38773228|FG003|Overall Study|Withdrew Consent|1|||
16076385|NCT01400776|38773225|FG000|Overall Study|Protocol Deviation|6|||
16076386|NCT01400776|38773226|FG001|Overall Study|Protocol Deviation|1|||
16076387|NCT01400776|38773227|FG002|Overall Study|Protocol Deviation|5|||
16076388|NCT01400776|38773228|FG003|Overall Study|Protocol Deviation|2|||
16076389|NCT01400776|38773225|FG000|Overall Study|Reason not Specified|3|||
16076390|NCT01400776|38773226|FG001|Overall Study|Reason not Specified|0|||
16076391|NCT01400776|38773227|FG002|Overall Study|Reason not Specified|4|||
16378497|NCT02457793|39872129|FG001|Overall Study|Reason not specified|0|||
16378498|NCT02457793|39872130|FG002|Overall Study|Reason not specified|0|||
16378499|NCT02457793|39872131|FG003|Overall Study|Reason not specified|1|||
16378500|NCT02457793|39872132|FG004|Overall Study|Reason not specified|1|||
16378501|NCT02457793|39872133|FG005|Overall Study|Reason not specified|1|||
16378502|NCT02457793|39872128|FG000|Overall Study|Withdrawal by Subject|0|||
16378503|NCT02457793|39872129|FG001|Overall Study|Withdrawal by Subject|4|||
16378504|NCT02457793|39872130|FG002|Overall Study|Withdrawal by Subject|2|||
16378505|NCT02457793|39872131|FG003|Overall Study|Withdrawal by Subject|2|||
16378506|NCT02457793|39872132|FG004|Overall Study|Withdrawal by Subject|2|||
16378507|NCT02457793|39872133|FG005|Overall Study|Withdrawal by Subject|2|||
16378508|NCT02457793|39872128|FG000|Overall Study|Adverse Event|0|||
16378509|NCT02457793|39872129|FG001|Overall Study|Adverse Event|0|||
16378510|NCT02457793|39872130|FG002|Overall Study|Adverse Event|0|||
16378511|NCT02457793|39872131|FG003|Overall Study|Adverse Event|1|||
16378512|NCT02457793|39872132|FG004|Overall Study|Adverse Event|0|||
16378513|NCT02457793|39872133|FG005|Overall Study|Adverse Event|0|||
16378514|NCT02457793|39872128|FG000|Overall Study|Physician Decision|1|||
16378515|NCT02457793|39872129|FG001|Overall Study|Physician Decision|0|||
16378516|NCT02457793|39872130|FG002|Overall Study|Physician Decision|1|||
16378517|NCT02457793|39872131|FG003|Overall Study|Physician Decision|1|||
16378518|NCT02457793|39872132|FG004|Overall Study|Physician Decision|1|||
16378519|NCT02457793|39872133|FG005|Overall Study|Physician Decision|3|||
16378520|NCT03014089|39872134|FG000|Overall Study|Withdrawal by Subject|0|||
16378521|NCT03014089|39872135|FG001|Overall Study|Withdrawal by Subject|1|||
16378522|NCT03014089|39872136|FG002|Overall Study|Withdrawal by Subject|1|||
16378523|NCT03014089|39872137|FG003|Overall Study|Withdrawal by Subject|1|||
16076392|NCT01400776|38773228|FG003|Overall Study|Reason not Specified|3|||
16076393|NCT04009577|38773229|FG000|Core Study|Adverse Event|1|||
16076394|NCT04009577|38773230|FG001|Core Study|Adverse Event|0|||
16076395|NCT04009577|38773231|FG002|Core Study|Adverse Event|2|||
16378524|NCT03014089|39872134|FG000|Overall Study|Lost to Follow-up|1|||
16378525|NCT03014089|39872135|FG001|Overall Study|Lost to Follow-up|0|||
16378526|NCT03014089|39872136|FG002|Overall Study|Lost to Follow-up|0|||
16076396|NCT04009577|38773232|FG003|Core Study|Adverse Event|4|||
16076397|NCT04009577|38773229|FG000|Core Study|Withdrawal by Subject|0|||
16076398|NCT04009577|38773230|FG001|Core Study|Withdrawal by Subject|0|||
16378527|NCT03014089|39872137|FG003|Overall Study|Lost to Follow-up|0|||
16378528|NCT03014089|39872134|FG000|Overall Study|Adverse Event|1|||
16378529|NCT03014089|39872135|FG001|Overall Study|Adverse Event|0|||
16378530|NCT03014089|39872136|FG002|Overall Study|Adverse Event|1|||
16378531|NCT03014089|39872137|FG003|Overall Study|Adverse Event|0|||
16378532|NCT00836901|39872155|FG000|First Intervention|Withdrawal by Subject|1|||
16378533|NCT00836901|39872156|FG001|First Intervention|Withdrawal by Subject|0|||
16378534|NCT02467270|39872157|FG000|Overall Study|Participants Never Treated|0|||
16378535|NCT02467270|39872158|FG001|Overall Study|Participants Never Treated|1|||
16378536|NCT02467270|39872159|FG002|Overall Study|Participants Never Treated|0|||
16378537|NCT02467270|39872157|FG000|Overall Study|Ongoing|50|||
16378538|NCT02467270|39872158|FG001|Overall Study|Ongoing|41|||
16378539|NCT02467270|39872159|FG002|Overall Study|Ongoing|43|||
16378540|NCT02467270|39872157|FG000|Overall Study|Adverse Event|16|||
16378541|NCT02467270|39872158|FG001|Overall Study|Adverse Event|15|||
16378542|NCT02467270|39872159|FG002|Overall Study|Adverse Event|14|||
16378543|NCT02467270|39872157|FG000|Overall Study|Progressive Disease|7|||
16378544|NCT02467270|39872158|FG001|Overall Study|Progressive Disease|7|||
16378545|NCT02467270|39872159|FG002|Overall Study|Progressive Disease|4|||
16378546|NCT02467270|39872157|FG000|Overall Study|Death|2|||
16378547|NCT02467270|39872158|FG001|Overall Study|Death|0|||
16378548|NCT02467270|39872159|FG002|Overall Study|Death|2|||
16378549|NCT02467270|39872157|FG000|Overall Study|Lack of Efficacy|12|||
16378550|NCT02467270|39872158|FG001|Overall Study|Lack of Efficacy|18|||
16378551|NCT02467270|39872159|FG002|Overall Study|Lack of Efficacy|23|||
16378552|NCT02467270|39872157|FG000|Overall Study|Non-compliance With Study Drug|0|||
16378553|NCT02467270|39872158|FG001|Overall Study|Non-compliance With Study Drug|2|||
16378554|NCT02467270|39872159|FG002|Overall Study|Non-compliance With Study Drug|1|||
16378555|NCT02467270|39872157|FG000|Overall Study|Lost to Follow-up|2|||
16378556|NCT02467270|39872158|FG001|Overall Study|Lost to Follow-up|1|||
16378557|NCT02467270|39872159|FG002|Overall Study|Lost to Follow-up|0|||
16378558|NCT02467270|39872157|FG000|Overall Study|Pregnancy|0|||
16378559|NCT02467270|39872158|FG001|Overall Study|Pregnancy|1|||
16378560|NCT02467270|39872159|FG002|Overall Study|Pregnancy|0|||
16378561|NCT02467270|39872157|FG000|Overall Study|Physician Decision|0|||
16378562|NCT02467270|39872158|FG001|Overall Study|Physician Decision|4|||
16378563|NCT02467270|39872159|FG002|Overall Study|Physician Decision|1|||
16378564|NCT02467270|39872157|FG000|Overall Study|Withdrawal by Subject|4|||
16378565|NCT02467270|39872158|FG001|Overall Study|Withdrawal by Subject|3|||
16378566|NCT02467270|39872159|FG002|Overall Study|Withdrawal by Subject|5|||
16378567|NCT02467270|39872157|FG000|Overall Study|Reason not Specified|1|||
16378568|NCT02467270|39872158|FG001|Overall Study|Reason not Specified|2|||
16378569|NCT02467270|39872159|FG002|Overall Study|Reason not Specified|1|||
16378570|NCT01948427|39872166|FG000|Overall Study|Serious Adverse Event|3|||
16378571|NCT01948427|39872167|FG001|Overall Study|Serious Adverse Event|0|||
16378572|NCT01948427|39872168|FG002|Overall Study|Serious Adverse Event|0|||
16378573|NCT01948427|39872169|FG003|Overall Study|Serious Adverse Event|0|||
16378574|NCT01948427|39872170|FG004|Overall Study|Serious Adverse Event|1|||
16378575|NCT01948427|39872166|FG000|Overall Study|Investigator Request|0|||
16378576|NCT01948427|39872167|FG001|Overall Study|Investigator Request|8|||
16378577|NCT01948427|39872168|FG002|Overall Study|Investigator Request|0|||
16378578|NCT01948427|39872169|FG003|Overall Study|Investigator Request|0|||
16378579|NCT01948427|39872170|FG004|Overall Study|Investigator Request|6|||
16378580|NCT01948427|39872166|FG000|Overall Study|Lost to Follow-up|1|||
16378581|NCT01948427|39872167|FG001|Overall Study|Lost to Follow-up|0|||
16378582|NCT01948427|39872168|FG002|Overall Study|Lost to Follow-up|0|||
16378583|NCT01948427|39872169|FG003|Overall Study|Lost to Follow-up|0|||
16378584|NCT01948427|39872170|FG004|Overall Study|Lost to Follow-up|4|||
16378585|NCT01948427|39872166|FG000|Overall Study|Withdrawal by Subject|2|||
16378586|NCT01948427|39872167|FG001|Overall Study|Withdrawal by Subject|0|||
16378587|NCT01948427|39872168|FG002|Overall Study|Withdrawal by Subject|0|||
16378588|NCT01948427|39872169|FG003|Overall Study|Withdrawal by Subject|0|||
16378589|NCT01948427|39872170|FG004|Overall Study|Withdrawal by Subject|1|||
16378590|NCT01948427|39872166|FG000|Overall Study|Other, Not Specified|1|||
16378591|NCT01948427|39872167|FG001|Overall Study|Other, Not Specified|9|||
16378592|NCT01948427|39872168|FG002|Overall Study|Other, Not Specified|0|||
16378593|NCT01948427|39872169|FG003|Overall Study|Other, Not Specified|0|||
16378594|NCT01948427|39872170|FG004|Overall Study|Other, Not Specified|2|||
16378595|NCT03557931|39872172|FG000|Overall Study|Adverse Event|4|||
16378596|NCT03557931|39872173|FG001|Overall Study|Adverse Event|6|||
16378597|NCT03557931|39872174|FG002|Overall Study|Adverse Event|1|||
16378598|NCT03557931|39872172|FG000|Overall Study|Lost to Follow-up|4|||
16378599|NCT03557931|39872173|FG001|Overall Study|Lost to Follow-up|4|||
16378600|NCT03557931|39872174|FG002|Overall Study|Lost to Follow-up|1|||
16378601|NCT03557931|39872172|FG000|Overall Study|Protocol Violation|1|||
16378602|NCT03557931|39872173|FG001|Overall Study|Protocol Violation|4|||
16378603|NCT03557931|39872174|FG002|Overall Study|Protocol Violation|1|||
16378604|NCT03557931|39872172|FG000|Overall Study|Withdrawal by Subject|14|||
16378605|NCT03557931|39872173|FG001|Overall Study|Withdrawal by Subject|0|||
16378606|NCT03557931|39872174|FG002|Overall Study|Withdrawal by Subject|7|||
16378607|NCT03557931|39872172|FG000|Overall Study|Miscellaneous|8|||
16378608|NCT03557931|39872173|FG001|Overall Study|Miscellaneous|5|||
16378609|NCT03557931|39872174|FG002|Overall Study|Miscellaneous|3|||
16378610|NCT01422382|39872175|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
16378611|NCT00267488|39872177|FG000|Overall Study|Sponsor Terminated Study|9|||
16378612|NCT00267488|39872177|FG000|Overall Study|Protocol Violation|1|||
16378613|NCT00267488|39872177|FG000|Overall Study|Other (Disease Progression)|1|||
16378614|NCT02743221|39872184|FG000|Overall Study|Progressive disease|29|||
16378615|NCT02743221|39872185|FG001|Overall Study|Progressive disease|38|||
16378616|NCT02743221|39872184|FG000|Overall Study|Adverse Event|17|||
16378617|NCT02743221|39872185|FG001|Overall Study|Adverse Event|14|||
16378618|NCT02743221|39872184|FG000|Overall Study|non medical reason|8|||
16378619|NCT02743221|39872185|FG001|Overall Study|non medical reason|2|||
16378620|NCT02743221|39872184|FG000|Overall Study|Physician Decision|2|||
16378621|NCT02743221|39872185|FG001|Overall Study|Physician Decision|5|||
16378622|NCT02743221|39872184|FG000|Overall Study|Patient not eligible, not treated|0|||
16378623|NCT02743221|39872185|FG001|Overall Study|Patient not eligible, not treated|1|||
16378624|NCT02971163|39872186|FG000|Overall Study|Lost to Follow-up|4|||
16378625|NCT02971163|39872187|FG001|Overall Study|Lost to Follow-up|2|||
16378626|NCT01979185|39872188|FG000|Period 2|Other|0|||
16378627|NCT01979185|39872189|FG001|Period 2|Other|1|||
16378628|NCT00265122|39872197|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
16378629|NCT00265122|39872198|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
16378630|NCT00265122|39872199|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
16378631|NCT00265122|39872200|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
16378632|NCT00265122|39872201|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
16378633|NCT00265122|39872202|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
16378634|NCT00265122|39872197|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
16378635|NCT00265122|39872198|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
16378636|NCT00265122|39872199|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
16378637|NCT00265122|39872200|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
16076399|NCT04009577|38773231|FG002|Core Study|Withdrawal by Subject|2|||
16277557|NCT01011335|39497216|FG006|Overall Study|Lost to Follow-up|2|||
16277558|NCT01011335|39497217|FG007|Overall Study|Lost to Follow-up|2|||
16277559|NCT01011335|39497218|FG008|Overall Study|Lost to Follow-up|1|||
16277560|NCT01011335|39497219|FG009|Overall Study|Lost to Follow-up|0|||
16277561|NCT01011335|39497220|FG010|Overall Study|Lost to Follow-up|0|||
16378638|NCT00265122|39872201|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
16378639|NCT00265122|39872202|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
16378640|NCT00265122|39872197|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
16378641|NCT00265122|39872198|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
16378642|NCT00265122|39872199|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
16378643|NCT00265122|39872200|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
16378644|NCT00265122|39872201|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
16378645|NCT00265122|39872202|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
16378646|NCT00265122|39872197|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
16378647|NCT00265122|39872198|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
16378648|NCT00265122|39872199|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
16378649|NCT00265122|39872200|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
16378650|NCT00265122|39872201|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
16378651|NCT00265122|39872202|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
16378652|NCT00265122|39872197|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
16378653|NCT00265122|39872198|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
16378654|NCT00265122|39872199|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
16378655|NCT00265122|39872200|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
16378656|NCT00265122|39872201|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
16378657|NCT00265122|39872202|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
16378658|NCT00265122|39872197|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
16378659|NCT00265122|39872198|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
16378660|NCT00265122|39872199|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
16378661|NCT00265122|39872200|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
16378662|NCT00265122|39872201|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
16378663|NCT00265122|39872202|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
16378664|NCT00679042|39872204|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
16277562|NCT01011335|39497221|FG011|Overall Study|Lost to Follow-up|1|||
16076400|NCT04009577|38773232|FG003|Core Study|Withdrawal by Subject|0|||
16076401|NCT04009577|38773229|FG000|Core Study|Other|0|||
16076402|NCT04009577|38773230|FG001|Core Study|Other|0|||
16277563|NCT01011335|39497222|FG012|Overall Study|Lost to Follow-up|2|||
16076403|NCT04009577|38773231|FG002|Core Study|Other|0|||
16378665|NCT00679042|39872204|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
16378666|NCT00679042|39872204|FG000|5-Year Follow Up|Death|1|||
16378667|NCT00679042|39872204|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
16378668|NCT00679042|39872204|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
16378669|NCT00086515|39872205|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
16378670|NCT00086515|39872206|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
16378671|NCT00086515|39872205|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
16378672|NCT00086515|39872206|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
16378673|NCT00086515|39872205|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
16378674|NCT00086515|39872206|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
16378675|NCT00086515|39872205|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
16378676|NCT00086515|39872206|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
16378677|NCT00086515|39872205|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
16378678|NCT00086515|39872206|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
16378679|NCT00086515|39872205|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
16076404|NCT04009577|38773232|FG003|Core Study|Other|1|||
16076405|NCT04009577|38773229|FG000|Extension Phase|Adverse Event|0|||
16076406|NCT04009577|38773230|FG001|Extension Phase|Adverse Event|0|||
16076407|NCT04009577|38773231|FG002|Extension Phase|Adverse Event|0|||
16076408|NCT04009577|38773232|FG003|Extension Phase|Adverse Event|1|||
16076409|NCT04009577|38773229|FG000|Extension Phase|Inadequate therapeutic effect|0|||
16076410|NCT04009577|38773230|FG001|Extension Phase|Inadequate therapeutic effect|0|||
16076411|NCT04009577|38773231|FG002|Extension Phase|Inadequate therapeutic effect|1|||
16076412|NCT04009577|38773232|FG003|Extension Phase|Inadequate therapeutic effect|0|||
16378680|NCT00086515|39872206|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
16378681|NCT00086515|39872205|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
16378682|NCT00086515|39872206|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
16378683|NCT00086515|39872205|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
16076413|NCT04009577|38773229|FG000|Extension Phase|Withdrawal by Subject|0|||
16076414|NCT04009577|38773230|FG001|Extension Phase|Withdrawal by Subject|0|||
16076415|NCT04009577|38773231|FG002|Extension Phase|Withdrawal by Subject|1|||
16076416|NCT04009577|38773232|FG003|Extension Phase|Withdrawal by Subject|0|||
16076417|NCT04009577|38773229|FG000|Extension Phase|Not Treated|0|||
16076418|NCT04009577|38773230|FG001|Extension Phase|Not Treated|0|||
16076419|NCT04009577|38773231|FG002|Extension Phase|Not Treated|2|||
16076420|NCT04009577|38773232|FG003|Extension Phase|Not Treated|0|||
16076421|NCT02613871|38773241|FG000|Overall Study|Death|2|||
16076422|NCT02613871|38773241|FG000|Overall Study|Withdrew Consent|1|||
16076423|NCT01580293|38773242|FG000|Part A_Main Trial|Adverse Event|0|||
16076424|NCT01580293|38773243|FG001|Part A_Main Trial|Adverse Event|2|||
16076425|NCT01580293|38773244|FG002|Part A_Main Trial|Adverse Event|0|||
16076426|NCT01580293|38773242|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
16076427|NCT01580293|38773243|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
16076428|NCT01580293|38773244|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
16076429|NCT01580293|38773242|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
16076430|NCT01580293|38773243|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
16076431|NCT01580293|38773244|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
16076432|NCT01580293|38773242|FG000|Part A_Extension|Adverse Event|0|||
16076433|NCT01580293|38773243|FG001|Part A_Extension|Adverse Event|2|||
16076434|NCT01580293|38773244|FG002|Part A_Extension|Adverse Event|0|||
16076435|NCT01580293|38773242|FG000|Part A_Extension|Withdrawal by Subject|0|||
16076436|NCT01580293|38773243|FG001|Part A_Extension|Withdrawal by Subject|3|||
16076437|NCT01580293|38773244|FG002|Part A_Extension|Withdrawal by Subject|0|||
16076438|NCT01580293|38773242|FG000|Part A_Extension|Lost to Follow-up|0|||
16076439|NCT01580293|38773243|FG001|Part A_Extension|Lost to Follow-up|1|||
16076440|NCT01580293|38773244|FG002|Part A_Extension|Lost to Follow-up|0|||
16076441|NCT01580293|38773242|FG000|Part A_Extension|Other Reason|0|||
16076442|NCT01580293|38773243|FG001|Part A_Extension|Other Reason|1|||
16076443|NCT01580293|38773244|FG002|Part A_Extension|Other Reason|0|||
16076444|NCT01580293|38773242|FG000|Part A_Extension|Completed Japan only|0|||
16076445|NCT01580293|38773243|FG001|Part A_Extension|Completed Japan only|5|||
16076446|NCT01580293|38773244|FG002|Part A_Extension|Completed Japan only|0|||
16076447|NCT01580293|38773242|FG000|Part B|Withdrawal by Subject|0|||
16076448|NCT01580293|38773243|FG001|Part B|Withdrawal by Subject|0|||
16076449|NCT01580293|38773244|FG002|Part B|Withdrawal by Subject|1|||
16076450|NCT01580293|38773242|FG000|Part B|Other reason|0|||
16378684|NCT00086515|39872206|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
16378685|NCT00086515|39872205|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
16076451|NCT01580293|38773243|FG001|Part B|Other reason|0|||
16076452|NCT01580293|38773244|FG002|Part B|Other reason|1|||
16076453|NCT01713946|38773245|FG000|Overall Study|Death|0|||
16277564|NCT01011335|39497210|FG000|Overall Study|Protocol Violation|0|||
16076454|NCT01713946|38773246|FG001|Overall Study|Death|2|||
16076455|NCT01713946|38773247|FG002|Overall Study|Death|2|||
16076456|NCT01713946|38773245|FG000|Overall Study|Adverse Event|19|||
16076457|NCT01713946|38773246|FG001|Overall Study|Adverse Event|14|||
16076458|NCT01713946|38773247|FG002|Overall Study|Adverse Event|13|||
16076459|NCT01713946|38773245|FG000|Overall Study|Withdrawal by Subject|12|||
16076460|NCT01713946|38773246|FG001|Overall Study|Withdrawal by Subject|12|||
16176072|NCT02582515|39122826|FG001|Overall Study|Withdrawal by Subject|1|||
16176073|NCT01061008|39122828|FG000|Overall Study|Badiocephalic fistula failed|3|||
16176074|NCT01061008|39122829|FG001|Overall Study|Badiocephalic fistula failed|2|||
16176075|NCT01061008|39122828|FG000|Overall Study|Death|1|||
16176076|NCT01061008|39122829|FG001|Overall Study|Death|0|||
16176077|NCT01061008|39122828|FG000|Overall Study|Withdrawal by Subject|1|||
16176078|NCT01061008|39122829|FG001|Overall Study|Withdrawal by Subject|3|||
16176079|NCT01061008|39122828|FG000|Overall Study|Unable to exercise following surgery|1|||
16277565|NCT01011335|39497211|FG001|Overall Study|Protocol Violation|1|||
16277566|NCT01011335|39497212|FG002|Overall Study|Protocol Violation|0|||
16176080|NCT01061008|39122829|FG001|Overall Study|Unable to exercise following surgery|0|||
16176081|NCT01061008|39122828|FG000|Overall Study|Adverse Event|0|||
16176082|NCT01061008|39122829|FG001|Overall Study|Adverse Event|1|||
16176083|NCT05089708|39122830|FG000|Overall Study|Lost to Follow-up|9|||
16176084|NCT05089708|39122831|FG001|Overall Study|Lost to Follow-up|7|||
16176085|NCT05089708|39122830|FG000|Overall Study|Withdrawal by Subject|3|||
16176086|NCT05089708|39122831|FG001|Overall Study|Withdrawal by Subject|1|||
16176087|NCT05089708|39122830|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
16176088|NCT05089708|39122831|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
16176089|NCT05089708|39122830|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
16176090|NCT05089708|39122831|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
16176091|NCT00754390|39122832|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
16176092|NCT00754390|39122832|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
16176093|NCT00754390|39122832|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
16176094|NCT00754390|39122832|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
16176095|NCT00666562|39122833|FG000|Overall Study|Withdrawal by Subject|0|||
16176096|NCT00666562|39122834|FG001|Overall Study|Withdrawal by Subject|1|||
16176097|NCT00666562|39122835|FG002|Overall Study|Withdrawal by Subject|0|||
16176098|NCT00666562|39122833|FG000|Overall Study|Concomitant Medication|0|||
16176099|NCT00666562|39122834|FG001|Overall Study|Concomitant Medication|1|||
16176100|NCT00666562|39122835|FG002|Overall Study|Concomitant Medication|0|||
16176101|NCT03145064|39122839|FG000|Overall Study|Death|24|||
16176102|NCT03145064|39122839|FG000|Overall Study|Lost to Follow-up|3|||
16176103|NCT03145064|39122839|FG000|Overall Study|Withdrawal by Subject|6|||
16176104|NCT03145064|39122839|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
16176105|NCT03145064|39122839|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
16176106|NCT00613626|39122840|FG000|Overall Study|Ineligible|0|||
16176107|NCT00613626|39122841|FG001|Overall Study|Ineligible|1|||
16176108|NCT00613626|39122842|FG002|Overall Study|Ineligible|0|||
16176109|NCT00927485|39122843|FG000|Overall Study|Adverse Event|4|||
16176110|NCT00927485|39122844|FG001|Overall Study|Adverse Event|2|||
16176111|NCT00927485|39122843|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
16176112|NCT00927485|39122844|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
16378686|NCT00086515|39872206|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
16378687|NCT00086515|39872205|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
16378688|NCT00086515|39872206|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
16378689|NCT00086515|39872205|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
16378690|NCT00086515|39872206|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
16378691|NCT00086515|39872205|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
16378692|NCT00086515|39872206|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
16378693|NCT00086515|39872205|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
16378694|NCT00086515|39872206|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
16378695|NCT00086515|39872205|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
16378696|NCT00086515|39872206|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
16378697|NCT00086515|39872205|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
16378698|NCT00086515|39872206|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
16176113|NCT02504541|39122849|FG000|Overall Study|Adverse Event|4|||
16176114|NCT02504541|39122849|FG000|Overall Study|Withdrawal by Subject|4|||
16176115|NCT02504541|39122849|FG000|Overall Study|Lost to Follow-up|1|||
16176116|NCT02504541|39122849|FG000|Overall Study|Met Stopping Criteria|1|||
16176117|NCT02504541|39122849|FG000|Overall Study|Protocol Violation|2|||
16176118|NCT02504541|39122849|FG000|Overall Study|Termination by Sponsor|1|||
16176119|NCT02504541|39122849|FG000|Overall Study|Other|2|||
16176120|NCT02504541|39122849|FG000|Overall Study|Multiple|5|||
16378699|NCT00086515|39872205|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
16176121|NCT00785577|39122852|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
16277567|NCT01011335|39497213|FG003|Overall Study|Protocol Violation|0|||
16378700|NCT00086515|39872206|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
16378701|NCT00086515|39872205|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
16378702|NCT00086515|39872206|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
16378703|NCT00086515|39872205|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
16378704|NCT00086515|39872206|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
16378705|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
16378706|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
16378707|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
16378708|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
16378709|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
16378710|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
16378711|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
16378712|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
16378713|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
16378714|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
16176122|NCT00785577|39122853|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
16176123|NCT00785577|39122854|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
16378715|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
16378716|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
16378717|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
16378718|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
16378719|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
16378720|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
16378721|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
16378722|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
16378723|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
16378724|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
16378725|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
16378726|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
16378727|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
16378728|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
16378729|NCT00086515|39872205|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
16378730|NCT00086515|39872206|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
16378731|NCT01435356|39872215|FG000|Overall Study|Adverse Event|2|||
16378732|NCT01435356|39872216|FG001|Overall Study|Adverse Event|0|||
16378733|NCT01435356|39872215|FG000|Overall Study|Disease progression/recurrence|17|||
16378734|NCT01435356|39872216|FG001|Overall Study|Disease progression/recurrence|10|||
16378735|NCT01435356|39872215|FG000|Overall Study|Protocol Violation|0|||
16378736|NCT01435356|39872216|FG001|Overall Study|Protocol Violation|1|||
16378737|NCT01435356|39872215|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
16378738|NCT01435356|39872216|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
16378739|NCT01435356|39872215|FG000|Overall Study|Withdrawal by Subject|1|||
16474691|NCT01497275|40217999|FG000|Overall Study|Death|1|||
16474692|NCT01497275|40217999|FG000|Overall Study|Adverse Event|1|||
16474693|NCT00697073|40218000|FG000|Overall Study|Withdrawal by Subject|2|||
16176124|NCT00785577|39122855|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
16176125|NCT00785577|39122856|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
16176126|NCT00785577|39122852|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
16176127|NCT00785577|39122853|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
16474694|NCT00697073|40218000|FG000|Overall Study|Pregnancy|1|||
16474695|NCT00697073|40218000|FG000|Overall Study|non compliance and other|6|||
16474696|NCT01565642|40218010|FG000|Overall Study|Withdrawal by Subject|2|||
16474697|NCT01565642|40218011|FG001|Overall Study|Withdrawal by Subject|1|||
16474698|NCT02476422|40218016|FG000|Overall Study|Subject/guardian decision|0|||
16474699|NCT02476422|40218017|FG001|Overall Study|Subject/guardian decision|1|||
16176128|NCT00785577|39122854|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
16176129|NCT00785577|39122855|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
16474700|NCT01346969|40218020|FG000|Overall Study|Withdrawal by Subject|0|||
16474701|NCT01346969|40218021|FG001|Overall Study|Withdrawal by Subject|0|||
16474702|NCT01346969|40218022|FG002|Overall Study|Withdrawal by Subject|1|||
16474703|NCT01346969|40218023|FG003|Overall Study|Withdrawal by Subject|0|||
16474704|NCT01346969|40218020|FG000|Overall Study|Lost to Follow-up|1|||
16474705|NCT01346969|40218021|FG001|Overall Study|Lost to Follow-up|0|||
16474706|NCT01346969|40218022|FG002|Overall Study|Lost to Follow-up|2|||
16176130|NCT00785577|39122856|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
16176131|NCT00785577|39122852|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
16176132|NCT00785577|39122853|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
16176133|NCT00785577|39122854|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
16176134|NCT00785577|39122855|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
16474707|NCT01346969|40218023|FG003|Overall Study|Lost to Follow-up|0|||
16474708|NCT01346969|40218020|FG000|Overall Study|Physician Decision|0|||
16474709|NCT01346969|40218021|FG001|Overall Study|Physician Decision|0|||
16176135|NCT00785577|39122856|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
16176136|NCT00785577|39122852|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
16474710|NCT01346969|40218022|FG002|Overall Study|Physician Decision|0|||
16474711|NCT01346969|40218023|FG003|Overall Study|Physician Decision|1|||
16474712|NCT01346969|40218020|FG000|Overall Study|Randomized but not treated|1|||
16474713|NCT01346969|40218021|FG001|Overall Study|Randomized but not treated|0|||
16474714|NCT01346969|40218022|FG002|Overall Study|Randomized but not treated|0|||
16474715|NCT01346969|40218023|FG003|Overall Study|Randomized but not treated|0|||
16474716|NCT01904058|40218026|FG000|Overall Study|Adverse Event|2|||
16474717|NCT01904058|40218027|FG001|Overall Study|Adverse Event|0|||
16474718|NCT01904058|40218028|FG002|Overall Study|Adverse Event|0|||
16474719|NCT01904058|40218029|FG003|Overall Study|Adverse Event|0|||
16474720|NCT01904058|40218026|FG000|Overall Study|Withdrawal by Subject|1|||
16474721|NCT01904058|40218027|FG001|Overall Study|Withdrawal by Subject|0|||
16474722|NCT01904058|40218028|FG002|Overall Study|Withdrawal by Subject|1|||
16474723|NCT01904058|40218029|FG003|Overall Study|Withdrawal by Subject|0|||
16474724|NCT01904058|40218026|FG000|Overall Study|Pregnancy|0|||
16474725|NCT01904058|40218027|FG001|Overall Study|Pregnancy|0|||
16474726|NCT01904058|40218028|FG002|Overall Study|Pregnancy|0|||
16474727|NCT01904058|40218029|FG003|Overall Study|Pregnancy|1|||
16474728|NCT01669928|40218035|FG000|First Intervention|Withdrawal by Subject|3|||
16474729|NCT01669928|40218036|FG001|First Intervention|Withdrawal by Subject|5|||
16474730|NCT01977651|40218037|FG000|4 Month Treatment Period|Adverse Event|34|||
16176137|NCT00785577|39122853|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
16176138|NCT00785577|39122854|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
16176139|NCT00785577|39122855|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
16474731|NCT01977651|40218037|FG000|4 Month Treatment Period|Death|3|||
16474732|NCT01977651|40218037|FG000|4 Month Treatment Period|Progressive Disease|43|||
16474733|NCT01977651|40218037|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
16474734|NCT01977651|40218037|FG000|4 Month Treatment Period|Physician Decision|4|||
16474735|NCT01977651|40218037|FG000|1 Year Extension Period|Adverse Event|14|||
16474736|NCT01977651|40218037|FG000|1 Year Extension Period|Death|10|||
16474737|NCT01977651|40218037|FG000|1 Year Extension Period|Lost to Follow-up|2|||
16474738|NCT01977651|40218037|FG000|1 Year Extension Period|Progressive Disease|86|||
16474739|NCT01977651|40218037|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
16474740|NCT01977651|40218037|FG000|1 Year Extension Period|Physician Decision|6|||
16474741|NCT01977651|40218037|FG000|1 Year Extension Period|Miscellaneous|1|||
16474742|NCT01977651|40218037|FG000|Post 1 Year Extension Period|Adverse Event|5|||
16474743|NCT01977651|40218037|FG000|Post 1 Year Extension Period|Death|13|||
16474744|NCT01977651|40218037|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
16474745|NCT01977651|40218037|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
16474746|NCT01977651|40218037|FG000|Post 1 Year Extension Period|Physician Decision|4|||
16474747|NCT01977651|40218037|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
16474748|NCT02595970|40218041|FG000|Overall Study|Withdrawal by Subject|2|||
16474749|NCT02595970|40218041|FG000|Overall Study|Physician Decision|2|||
16474750|NCT02595970|40218041|FG000|Overall Study|Protocol Violation|4|||
16474751|NCT02595970|40218041|FG000|Overall Study|Adverse Event|5|||
16474752|NCT02595970|40218041|FG000|Overall Study|Lack of Efficacy|7|||
16474753|NCT02770170|40218044|FG000|Overall Study|Withdrawal by Subject|0|||
16474754|NCT02770170|40218045|FG001|Overall Study|Withdrawal by Subject|0|||
16176140|NCT00785577|39122856|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
16176141|NCT00785577|39122852|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
16176142|NCT00785577|39122853|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
16176143|NCT00785577|39122854|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
16474755|NCT02770170|40218046|FG002|Overall Study|Withdrawal by Subject|0|||
16474756|NCT02770170|40218047|FG003|Overall Study|Withdrawal by Subject|2|||
16474757|NCT02770170|40218044|FG000|Overall Study|due to pregnancy|1|||
16474758|NCT02770170|40218045|FG001|Overall Study|due to pregnancy|0|||
16474759|NCT02770170|40218046|FG002|Overall Study|due to pregnancy|0|||
16474760|NCT02770170|40218047|FG003|Overall Study|due to pregnancy|0|||
16474761|NCT02770170|40218044|FG000|Overall Study|Lack of Efficacy|2|||
16474762|NCT02770170|40218045|FG001|Overall Study|Lack of Efficacy|0|||
16474763|NCT02770170|40218046|FG002|Overall Study|Lack of Efficacy|0|||
16474764|NCT02770170|40218047|FG003|Overall Study|Lack of Efficacy|1|||
16474765|NCT02770170|40218044|FG000|Overall Study|Adverse Event|4|||
16474766|NCT02770170|40218045|FG001|Overall Study|Adverse Event|3|||
16474767|NCT02770170|40218046|FG002|Overall Study|Adverse Event|5|||
16474768|NCT02770170|40218047|FG003|Overall Study|Adverse Event|3|||
16474769|NCT02770170|40218044|FG000|Overall Study|due to disease worsening|0|||
16474770|NCT02770170|40218045|FG001|Overall Study|due to disease worsening|0|||
16474771|NCT02770170|40218046|FG002|Overall Study|due to disease worsening|0|||
16474772|NCT02770170|40218047|FG003|Overall Study|due to disease worsening|1|||
16474773|NCT00107783|40218048|FG000|Overall Study|Adverse Event|0|||
16474774|NCT00107783|40218049|FG001|Overall Study|Adverse Event|2|||
16474775|NCT00107783|40218048|FG000|Overall Study|Death|0|||
16474776|NCT00107783|40218049|FG001|Overall Study|Death|1|||
16474777|NCT00107783|40218048|FG000|Overall Study|Withdrawal by Subject|2|||
16474778|NCT00107783|40218049|FG001|Overall Study|Withdrawal by Subject|0|||
16474779|NCT00107783|40218048|FG000|Overall Study|Second hip replacement|1|||
16474780|NCT00107783|40218049|FG001|Overall Study|Second hip replacement|1|||
16474781|NCT00753766|40218051|FG000|Overall Study|Physician Decision|1|||
16474782|NCT00753766|40218052|FG001|Overall Study|Physician Decision|0|||
16474783|NCT00299182|40218059|FG000|Overall Study|Withdrawal by Subject|0|||
16474784|NCT00299182|40218060|FG001|Overall Study|Withdrawal by Subject|0|||
16474785|NCT00299182|40218061|FG002|Overall Study|Withdrawal by Subject|1|||
16474786|NCT00299182|40218062|FG003|Overall Study|Withdrawal by Subject|0|||
16474787|NCT00299182|40218063|FG004|Overall Study|Withdrawal by Subject|1|||
16474788|NCT00299182|40218064|FG005|Overall Study|Withdrawal by Subject|2|||
16474789|NCT00299182|40218065|FG006|Overall Study|Withdrawal by Subject|0|||
16474790|NCT00299182|40218059|FG000|Overall Study|Chemotherapy Changed|0|||
16474791|NCT00299182|40218060|FG001|Overall Study|Chemotherapy Changed|0|||
16474792|NCT00299182|40218061|FG002|Overall Study|Chemotherapy Changed|1|||
16176144|NCT00785577|39122855|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
16474793|NCT00299182|40218062|FG003|Overall Study|Chemotherapy Changed|0|||
16474794|NCT00299182|40218063|FG004|Overall Study|Chemotherapy Changed|1|||
16474795|NCT00299182|40218064|FG005|Overall Study|Chemotherapy Changed|0|||
16474796|NCT00299182|40218065|FG006|Overall Study|Chemotherapy Changed|1|||
16474797|NCT00299182|40218059|FG000|Overall Study|Adverse Event|0|||
16474798|NCT00299182|40218060|FG001|Overall Study|Adverse Event|0|||
16474799|NCT00299182|40218061|FG002|Overall Study|Adverse Event|0|||
16474800|NCT00299182|40218062|FG003|Overall Study|Adverse Event|0|||
16474801|NCT00299182|40218063|FG004|Overall Study|Adverse Event|0|||
16474802|NCT00299182|40218064|FG005|Overall Study|Adverse Event|1|||
16474803|NCT00299182|40218065|FG006|Overall Study|Adverse Event|0|||
16474804|NCT00299182|40218059|FG000|Overall Study|Not Eligible|0|||
16474805|NCT00299182|40218060|FG001|Overall Study|Not Eligible|0|||
16474806|NCT00299182|40218061|FG002|Overall Study|Not Eligible|0|||
16474807|NCT00299182|40218062|FG003|Overall Study|Not Eligible|0|||
16474808|NCT00299182|40218063|FG004|Overall Study|Not Eligible|1|||
16474809|NCT00299182|40218064|FG005|Overall Study|Not Eligible|0|||
16474810|NCT00299182|40218065|FG006|Overall Study|Not Eligible|0|||
16474811|NCT02437513|40218066|FG000|Overall Study|Withdrawal by Subject|2|||
16474812|NCT02713204|40218067|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
16474813|NCT02713204|40218068|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
16474814|NCT02713204|40218069|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
16474815|NCT02713204|40218070|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
16474816|NCT02713204|40218071|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
16474817|NCT02713204|40218072|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
16474818|NCT02713204|40218073|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
16176145|NCT00785577|39122856|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
16176146|NCT00785577|39122852|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
16176147|NCT00785577|39122853|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
16176148|NCT00785577|39122854|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
16176149|NCT00785577|39122855|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
16176150|NCT00785577|39122856|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
16176151|NCT00785577|39122852|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
16176152|NCT00785577|39122853|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
16176153|NCT00785577|39122854|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
16176154|NCT00785577|39122855|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
16176155|NCT00785577|39122856|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
16176156|NCT00785577|39122852|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
16176157|NCT00785577|39122853|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
16176158|NCT00785577|39122854|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
16176159|NCT00785577|39122855|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
16176160|NCT00785577|39122856|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
16176161|NCT00785577|39122852|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
16176162|NCT00785577|39122853|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
16176163|NCT00785577|39122854|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
16277568|NCT01011335|39497214|FG004|Overall Study|Protocol Violation|0|||
16277569|NCT01011335|39497215|FG005|Overall Study|Protocol Violation|0|||
16277570|NCT01011335|39497216|FG006|Overall Study|Protocol Violation|0|||
16277571|NCT01011335|39497217|FG007|Overall Study|Protocol Violation|0|||
16277572|NCT01011335|39497218|FG008|Overall Study|Protocol Violation|0|||
16277573|NCT01011335|39497219|FG009|Overall Study|Protocol Violation|0|||
16474819|NCT02713204|40218074|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
16474820|NCT02713204|40218067|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16474821|NCT02713204|40218068|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16474822|NCT02713204|40218069|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
16474823|NCT02713204|40218070|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16474824|NCT02713204|40218071|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16474825|NCT02713204|40218072|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16474826|NCT02713204|40218073|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16277574|NCT01011335|39497220|FG010|Overall Study|Protocol Violation|0|||
16277575|NCT01011335|39497221|FG011|Overall Study|Protocol Violation|0|||
16277576|NCT01011335|39497222|FG012|Overall Study|Protocol Violation|0|||
16277577|NCT01011335|39497210|FG000|Overall Study|Moved/deployed or no booster|1|||
16277578|NCT01011335|39497211|FG001|Overall Study|Moved/deployed or no booster|0|||
16277579|NCT01011335|39497212|FG002|Overall Study|Moved/deployed or no booster|0|||
16277580|NCT01011335|39497213|FG003|Overall Study|Moved/deployed or no booster|1|||
16277581|NCT01011335|39497214|FG004|Overall Study|Moved/deployed or no booster|0|||
16277582|NCT01011335|39497215|FG005|Overall Study|Moved/deployed or no booster|0|||
16277583|NCT01011335|39497216|FG006|Overall Study|Moved/deployed or no booster|1|||
16277584|NCT01011335|39497217|FG007|Overall Study|Moved/deployed or no booster|0|||
16277585|NCT01011335|39497218|FG008|Overall Study|Moved/deployed or no booster|1|||
16277586|NCT01011335|39497219|FG009|Overall Study|Moved/deployed or no booster|0|||
16277587|NCT01011335|39497220|FG010|Overall Study|Moved/deployed or no booster|2|||
16277588|NCT01011335|39497221|FG011|Overall Study|Moved/deployed or no booster|0|||
16277589|NCT01011335|39497222|FG012|Overall Study|Moved/deployed or no booster|0|||
16277590|NCT01011335|39497210|FG000|Overall Study|Adverse Event|0|||
16277591|NCT01011335|39497211|FG001|Overall Study|Adverse Event|0|||
16277592|NCT01011335|39497212|FG002|Overall Study|Adverse Event|0|||
16277593|NCT01011335|39497213|FG003|Overall Study|Adverse Event|0|||
16277594|NCT01011335|39497214|FG004|Overall Study|Adverse Event|0|||
16277595|NCT01011335|39497215|FG005|Overall Study|Adverse Event|0|||
16277596|NCT01011335|39497216|FG006|Overall Study|Adverse Event|0|||
16277597|NCT01011335|39497217|FG007|Overall Study|Adverse Event|0|||
16277598|NCT01011335|39497218|FG008|Overall Study|Adverse Event|0|||
16277599|NCT01011335|39497219|FG009|Overall Study|Adverse Event|0|||
16474827|NCT02713204|40218074|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16474828|NCT02713204|40218067|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16474829|NCT02713204|40218068|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
16474830|NCT02713204|40218069|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16474831|NCT02713204|40218070|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16474832|NCT02713204|40218071|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16474833|NCT02713204|40218072|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16474834|NCT02713204|40218073|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16474835|NCT02713204|40218074|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16474836|NCT02713204|40218067|FG000|From Week 12 up to Week 36|Adverse Event|1|||
16474837|NCT02713204|40218068|FG001|From Week 12 up to Week 36|Adverse Event|0|||
16474838|NCT02713204|40218069|FG002|From Week 12 up to Week 36|Adverse Event|0|||
16474839|NCT02713204|40218070|FG003|From Week 12 up to Week 36|Adverse Event|1|||
16474840|NCT02713204|40218071|FG004|From Week 12 up to Week 36|Adverse Event|1|||
16474841|NCT02713204|40218072|FG005|From Week 12 up to Week 36|Adverse Event|0|||
16474842|NCT02713204|40218073|FG006|From Week 12 up to Week 36|Adverse Event|2|||
16474843|NCT02713204|40218074|FG007|From Week 12 up to Week 36|Adverse Event|1|||
16474844|NCT02713204|40218067|FG000|From Week 12 up to Week 36|Death|0|||
16474845|NCT02713204|40218068|FG001|From Week 12 up to Week 36|Death|0|||
16474846|NCT02713204|40218069|FG002|From Week 12 up to Week 36|Death|0|||
16474847|NCT02713204|40218070|FG003|From Week 12 up to Week 36|Death|1|||
16474848|NCT02713204|40218071|FG004|From Week 12 up to Week 36|Death|0|||
16474849|NCT02713204|40218072|FG005|From Week 12 up to Week 36|Death|1|||
16474850|NCT02713204|40218073|FG006|From Week 12 up to Week 36|Death|0|||
16474851|NCT02713204|40218074|FG007|From Week 12 up to Week 36|Death|3|||
16474852|NCT02713204|40218067|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
16474853|NCT02713204|40218068|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
16474854|NCT02713204|40218069|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
16474855|NCT02713204|40218070|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
16474856|NCT02713204|40218071|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
16474857|NCT02713204|40218072|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
16474858|NCT02713204|40218073|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
16474859|NCT02713204|40218074|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
16474860|NCT02713204|40218067|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
16474861|NCT02713204|40218068|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
16474862|NCT02713204|40218069|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
16474863|NCT02713204|40218070|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
16474864|NCT02713204|40218071|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
16474865|NCT02713204|40218072|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
16474866|NCT02713204|40218073|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
16474867|NCT02713204|40218074|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
16474868|NCT01031706|40218075|FG000|Overall Study|Adverse Event|1|||
16474869|NCT01031706|40218076|FG001|Overall Study|Adverse Event|0|||
16474870|NCT01031706|40218075|FG000|Overall Study|Withdrawal by Subject|1|||
16474871|NCT01031706|40218076|FG001|Overall Study|Withdrawal by Subject|1|||
16474872|NCT04251273|40218081|FG000|Overall Study|Lost to Follow-up|331|||
16277600|NCT01011335|39497220|FG010|Overall Study|Adverse Event|4|||
16277601|NCT01011335|39497221|FG011|Overall Study|Adverse Event|0|||
16474873|NCT04251273|40218082|FG001|Overall Study|Lost to Follow-up|290|||
16474874|NCT00195273|40218083|FG000|Overall Study|Adverse Event|9|||
16474875|NCT00195273|40218084|FG001|Overall Study|Adverse Event|9|||
16474876|NCT00195273|40218083|FG000|Overall Study|Protocol deviation|0|||
16474877|NCT00195273|40218084|FG001|Overall Study|Protocol deviation|1|||
16474878|NCT00195273|40218083|FG000|Overall Study|Lack of Efficacy|3|||
16474879|NCT00195273|40218084|FG001|Overall Study|Lack of Efficacy|1|||
16474880|NCT00195273|40218083|FG000|Overall Study|Procedural complications|9|||
16277602|NCT01011335|39497222|FG012|Overall Study|Adverse Event|1|||
16277603|NCT01175473|39497223|FG000|Overall Study|Adverse Event|2|||
16277604|NCT01175473|39497224|FG001|Overall Study|Adverse Event|2|||
16277605|NCT00609154|39497225|FG000|Overall Study|Protocol Violation|1|||
16277606|NCT00609154|39497226|FG001|Overall Study|Protocol Violation|2|||
16277607|NCT00609154|39497225|FG000|Overall Study|Unable to establish IV access|0|||
16277608|NCT00609154|39497226|FG001|Overall Study|Unable to establish IV access|4|||
16277609|NCT00609154|39497225|FG000|Overall Study|Adverse Event|0|||
16277610|NCT00609154|39497226|FG001|Overall Study|Adverse Event|2|||
16277611|NCT00842309|39497227|FG000|Overall Study|Withdrawal by Subject|3|||
16277612|NCT00842309|39497228|FG001|Overall Study|Withdrawal by Subject|1|||
16277613|NCT00939523|39497231|FG000|Overall Study|Lack of Efficacy|1|||
16277614|NCT00939523|39497231|FG000|Overall Study|Physician Decision|2|||
16277615|NCT02328040|39497238|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
16277616|NCT02328040|39497239|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
16277617|NCT01685216|39497240|FG000|Overall Study|Did not receive study drug|1|||
16277618|NCT00274625|39497248|FG000|Overall Study|Lost to Follow-up|46|||
16277619|NCT00274625|39497249|FG001|Overall Study|Lost to Follow-up|54|||
16277620|NCT00274625|39497248|FG000|Overall Study|Excluded from analysis|14|||
16277621|NCT00274625|39497249|FG001|Overall Study|Excluded from analysis|8|||
16277622|NCT01332968|39497252|FG000|Induction Period|Adverse Event|23|||
16277623|NCT01332968|39497253|FG001|Induction Period|Adverse Event|26|||
16277624|NCT01332968|39497254|FG002|Induction Period|Adverse Event|0|||
16277625|NCT01332968|39497255|FG003|Induction Period|Adverse Event|0|||
16277626|NCT01332968|39497256|FG004|Induction Period|Adverse Event|0|||
16277627|NCT01332968|39497257|FG005|Induction Period|Adverse Event|0|||
16277628|NCT01332968|39497258|FG006|Induction Period|Adverse Event|0|||
16277629|NCT01332968|39497259|FG007|Induction Period|Adverse Event|0|||
16277630|NCT01332968|39497252|FG000|Induction Period|Death|1|||
16277631|NCT01332968|39497253|FG001|Induction Period|Death|4|||
16277632|NCT01332968|39497254|FG002|Induction Period|Death|0|||
16277633|NCT01332968|39497255|FG003|Induction Period|Death|0|||
16277634|NCT01332968|39497256|FG004|Induction Period|Death|0|||
16277635|NCT01332968|39497257|FG005|Induction Period|Death|0|||
16277636|NCT01332968|39497258|FG006|Induction Period|Death|0|||
16277637|NCT01332968|39497259|FG007|Induction Period|Death|0|||
16277638|NCT01332968|39497252|FG000|Induction Period|Non-compliance|1|||
16277639|NCT01332968|39497253|FG001|Induction Period|Non-compliance|0|||
16277640|NCT01332968|39497254|FG002|Induction Period|Non-compliance|0|||
16277641|NCT01332968|39497255|FG003|Induction Period|Non-compliance|0|||
16277642|NCT01332968|39497256|FG004|Induction Period|Non-compliance|0|||
16277643|NCT01332968|39497257|FG005|Induction Period|Non-compliance|0|||
16277644|NCT01332968|39497258|FG006|Induction Period|Non-compliance|0|||
16277645|NCT01332968|39497259|FG007|Induction Period|Non-compliance|0|||
16277646|NCT01332968|39497252|FG000|Induction Period|Other|2|||
16277647|NCT01332968|39497253|FG001|Induction Period|Other|2|||
16277648|NCT01332968|39497254|FG002|Induction Period|Other|0|||
16277649|NCT01332968|39497255|FG003|Induction Period|Other|0|||
16277650|NCT01332968|39497256|FG004|Induction Period|Other|0|||
16277651|NCT01332968|39497257|FG005|Induction Period|Other|0|||
16277652|NCT01332968|39497258|FG006|Induction Period|Other|0|||
16277653|NCT01332968|39497259|FG007|Induction Period|Other|0|||
16277654|NCT01332968|39497252|FG000|Induction Period|Physician Decision|6|||
16277655|NCT01332968|39497253|FG001|Induction Period|Physician Decision|1|||
16277656|NCT01332968|39497254|FG002|Induction Period|Physician Decision|0|||
16474881|NCT00195273|40218084|FG001|Overall Study|Procedural complications|3|||
16277657|NCT01332968|39497255|FG003|Induction Period|Physician Decision|0|||
16277658|NCT01332968|39497256|FG004|Induction Period|Physician Decision|0|||
16277659|NCT01332968|39497257|FG005|Induction Period|Physician Decision|0|||
16277660|NCT01332968|39497258|FG006|Induction Period|Physician Decision|0|||
16277661|NCT01332968|39497259|FG007|Induction Period|Physician Decision|0|||
16277662|NCT01332968|39497252|FG000|Induction Period|Progressive Disease|15|||
16277663|NCT01332968|39497253|FG001|Induction Period|Progressive Disease|7|||
16277664|NCT01332968|39497254|FG002|Induction Period|Progressive Disease|0|||
16277665|NCT01332968|39497255|FG003|Induction Period|Progressive Disease|0|||
16277666|NCT01332968|39497256|FG004|Induction Period|Progressive Disease|0|||
16474882|NCT02589405|40218085|FG000|Overall Study|Adverse Event|3|||
16474883|NCT02589405|40218085|FG000|Overall Study|Withdrawal by Subject|1|||
16277667|NCT01332968|39497257|FG005|Induction Period|Progressive Disease|0|||
16277668|NCT01332968|39497258|FG006|Induction Period|Progressive Disease|0|||
16277669|NCT01332968|39497259|FG007|Induction Period|Progressive Disease|0|||
16277670|NCT01332968|39497252|FG000|Induction Period|Protocol Violation|3|||
16277671|NCT01332968|39497253|FG001|Induction Period|Protocol Violation|4|||
16277672|NCT01332968|39497254|FG002|Induction Period|Protocol Violation|0|||
16277673|NCT01332968|39497255|FG003|Induction Period|Protocol Violation|0|||
16277674|NCT01332968|39497256|FG004|Induction Period|Protocol Violation|0|||
16277675|NCT01332968|39497257|FG005|Induction Period|Protocol Violation|0|||
16277676|NCT01332968|39497258|FG006|Induction Period|Protocol Violation|0|||
16277677|NCT01332968|39497259|FG007|Induction Period|Protocol Violation|0|||
16277678|NCT01332968|39497252|FG000|Induction Period|Withdrawal by Subject|3|||
16277679|NCT01332968|39497253|FG001|Induction Period|Withdrawal by Subject|5|||
16277680|NCT01332968|39497254|FG002|Induction Period|Withdrawal by Subject|0|||
16277681|NCT01332968|39497255|FG003|Induction Period|Withdrawal by Subject|0|||
16277682|NCT01332968|39497256|FG004|Induction Period|Withdrawal by Subject|0|||
16474884|NCT01927341|40218086|FG000|Phase 1b|Lost to Follow-up|1|||
16474885|NCT01927341|40218087|FG001|Phase 1b|Lost to Follow-up|0|||
16474886|NCT01927341|40218088|FG002|Phase 1b|Lost to Follow-up|0|||
16474887|NCT01927341|40218089|FG003|Phase 1b|Lost to Follow-up|0|||
16474888|NCT01927341|40218090|FG004|Phase 1b|Lost to Follow-up|0|||
16474889|NCT01927341|40218086|FG000|Phase 1b|Death|2|||
16474890|NCT01927341|40218087|FG001|Phase 1b|Death|0|||
16474891|NCT01927341|40218088|FG002|Phase 1b|Death|0|||
16474892|NCT01927341|40218089|FG003|Phase 1b|Death|0|||
16474893|NCT01927341|40218090|FG004|Phase 1b|Death|0|||
16474894|NCT01927341|40218086|FG000|Phase 1b|Follow-up completed|7|||
16474895|NCT01927341|40218087|FG001|Phase 1b|Follow-up completed|0|||
16474896|NCT01927341|40218088|FG002|Phase 1b|Follow-up completed|0|||
16474897|NCT01927341|40218089|FG003|Phase 1b|Follow-up completed|0|||
16474898|NCT01927341|40218090|FG004|Phase 1b|Follow-up completed|0|||
16474899|NCT01927341|40218086|FG000|Phase 2|Lost to Follow-up|0|||
16474900|NCT01927341|40218087|FG001|Phase 2|Lost to Follow-up|1|||
16474901|NCT01927341|40218088|FG002|Phase 2|Lost to Follow-up|0|||
16474902|NCT01927341|40218089|FG003|Phase 2|Lost to Follow-up|0|||
16474903|NCT01927341|40218090|FG004|Phase 2|Lost to Follow-up|0|||
16474904|NCT01927341|40218086|FG000|Phase 2|Participant withdrew consent|0|||
16474905|NCT01927341|40218087|FG001|Phase 2|Participant withdrew consent|2|||
16474906|NCT01927341|40218088|FG002|Phase 2|Participant withdrew consent|1|||
16474907|NCT01927341|40218089|FG003|Phase 2|Participant withdrew consent|2|||
16474908|NCT01927341|40218090|FG004|Phase 2|Participant withdrew consent|3|||
16474909|NCT01927341|40218086|FG000|Phase 2|Death|0|||
16474910|NCT01927341|40218087|FG001|Phase 2|Death|4|||
16474911|NCT01927341|40218088|FG002|Phase 2|Death|0|||
16474912|NCT01927341|40218089|FG003|Phase 2|Death|3|||
16474913|NCT01927341|40218090|FG004|Phase 2|Death|2|||
16474914|NCT01927341|40218086|FG000|Phase 2|New cancer therapy|0|||
16474915|NCT01927341|40218087|FG001|Phase 2|New cancer therapy|1|||
16474916|NCT01927341|40218088|FG002|Phase 2|New cancer therapy|0|||
16474917|NCT01927341|40218089|FG003|Phase 2|New cancer therapy|4|||
16474918|NCT01927341|40218090|FG004|Phase 2|New cancer therapy|1|||
16474919|NCT01927341|40218086|FG000|Phase 2|Disease progression|0|||
16277683|NCT01332968|39497257|FG005|Induction Period|Withdrawal by Subject|0|||
16277684|NCT01332968|39497258|FG006|Induction Period|Withdrawal by Subject|0|||
16277685|NCT01332968|39497259|FG007|Induction Period|Withdrawal by Subject|0|||
16474920|NCT01927341|40218087|FG001|Phase 2|Disease progression|1|||
16474921|NCT01927341|40218088|FG002|Phase 2|Disease progression|1|||
16474922|NCT01927341|40218089|FG003|Phase 2|Disease progression|1|||
16474923|NCT01927341|40218090|FG004|Phase 2|Disease progression|0|||
16474924|NCT01927341|40218086|FG000|Phase 2|Follow-up completed|0|||
16474925|NCT01927341|40218087|FG001|Phase 2|Follow-up completed|6|||
16474926|NCT01927341|40218088|FG002|Phase 2|Follow-up completed|3|||
16474927|NCT01927341|40218089|FG003|Phase 2|Follow-up completed|5|||
16474928|NCT01927341|40218090|FG004|Phase 2|Follow-up completed|2|||
16474929|NCT02943460|40218091|FG000|Blinded Study Phase|Adverse Event|3|||
16474930|NCT02943460|40218092|FG001|Blinded Study Phase|Adverse Event|0|||
16474931|NCT02943460|40218093|FG002|Blinded Study Phase|Adverse Event|0|||
16474932|NCT02943460|40218091|FG000|Blinded Study Phase|Withdrew Consent|0|||
16474933|NCT02943460|40218092|FG001|Blinded Study Phase|Withdrew Consent|1|||
16474934|NCT02943460|40218093|FG002|Blinded Study Phase|Withdrew Consent|0|||
16474935|NCT02943460|40218091|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
16277686|NCT01332968|39497252|FG000|Induction Period|Randomised but not treated|4|||
16277687|NCT01332968|39497253|FG001|Induction Period|Randomised but not treated|7|||
16277688|NCT01332968|39497254|FG002|Induction Period|Randomised but not treated|0|||
16277689|NCT01332968|39497255|FG003|Induction Period|Randomised but not treated|0|||
16474936|NCT02943460|40218092|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
16474937|NCT02943460|40218093|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
16474938|NCT02943460|40218091|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
16474939|NCT02943460|40218092|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
16474940|NCT02943460|40218093|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
16474941|NCT02943460|40218091|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
16474942|NCT02943460|40218092|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
16474943|NCT02943460|40218093|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
16474944|NCT00943124|40218094|FG000|Period 1|Withdrawal by Subject|1|||
16474945|NCT00943124|40218095|FG001|Period 1|Withdrawal by Subject|1|||
16474946|NCT00943124|40218094|FG000|Period 1|Did Not Follow Study Procedures|1|||
16474947|NCT00943124|40218095|FG001|Period 1|Did Not Follow Study Procedures|0|||
16474948|NCT00943124|40218094|FG000|Period 1|Personal Reasons|0|||
16474949|NCT00943124|40218095|FG001|Period 1|Personal Reasons|1|||
16474950|NCT03923738|40218096|FG000|Period 1|Adverse Event|1|||
16474951|NCT03923738|40218096|FG000|Period 1|Withdrawal by Subject|1|||
16474952|NCT01200524|40218097|FG000|Overall Study|Withdrawal by Subject|1|||
16474953|NCT01200524|40218098|FG001|Overall Study|Withdrawal by Subject|1|||
16474954|NCT01200524|40218099|FG002|Overall Study|Withdrawal by Subject|3|||
16474955|NCT01200524|40218097|FG000|Overall Study|Adverse Event|1|||
16474956|NCT01200524|40218098|FG001|Overall Study|Adverse Event|0|||
16474957|NCT01200524|40218099|FG002|Overall Study|Adverse Event|0|||
16474958|NCT01200524|40218097|FG000|Overall Study|Non availability of study nurse|0|||
16474959|NCT01200524|40218098|FG001|Overall Study|Non availability of study nurse|0|||
16474960|NCT01200524|40218099|FG002|Overall Study|Non availability of study nurse|1|||
16474961|NCT02497612|40218100|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
16474962|NCT02497612|40218101|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
16474963|NCT02497612|40218102|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
16474964|NCT02497612|40218103|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
16474965|NCT02497612|40218100|FG000|Overall Study|Participant's request|2|||
16474966|NCT02497612|40218101|FG001|Overall Study|Participant's request|3|||
16474967|NCT02497612|40218102|FG002|Overall Study|Participant's request|4|||
16474968|NCT02497612|40218103|FG003|Overall Study|Participant's request|1|||
16474969|NCT02497612|40218100|FG000|Overall Study|Investigator's judgement|1|||
16474970|NCT02497612|40218101|FG001|Overall Study|Investigator's judgement|0|||
16474971|NCT02497612|40218102|FG002|Overall Study|Investigator's judgement|0|||
16474972|NCT02497612|40218103|FG003|Overall Study|Investigator's judgement|2|||
16474973|NCT02497612|40218100|FG000|Overall Study|Adverse Event|3|||
16474974|NCT02497612|40218101|FG001|Overall Study|Adverse Event|1|||
16474975|NCT02497612|40218102|FG002|Overall Study|Adverse Event|4|||
16474976|NCT02497612|40218103|FG003|Overall Study|Adverse Event|1|||
16474977|NCT02497612|40218100|FG000|Overall Study|Lost to Follow-up|1|||
16474978|NCT02497612|40218101|FG001|Overall Study|Lost to Follow-up|1|||
16474979|NCT02497612|40218102|FG002|Overall Study|Lost to Follow-up|0|||
16474980|NCT02497612|40218103|FG003|Overall Study|Lost to Follow-up|1|||
16474981|NCT02497612|40218100|FG000|Overall Study|Other unspecified|1|||
16474982|NCT02497612|40218101|FG001|Overall Study|Other unspecified|1|||
16474983|NCT02497612|40218102|FG002|Overall Study|Other unspecified|2|||
16474984|NCT02497612|40218103|FG003|Overall Study|Other unspecified|0|||
16474985|NCT02497612|40218100|FG000|Overall Study|Not eligible|1|||
16474986|NCT02497612|40218101|FG001|Overall Study|Not eligible|0|||
16474987|NCT02497612|40218102|FG002|Overall Study|Not eligible|0|||
16474988|NCT02497612|40218103|FG003|Overall Study|Not eligible|1|||
16474989|NCT00917501|40218104|FG000|Overall Study|Lost to Follow-up|4|||
16474990|NCT00917501|40218105|FG001|Overall Study|Lost to Follow-up|1|||
16474991|NCT00917501|40218104|FG000|Overall Study|Withdrawal by Subject|3|||
16474992|NCT00917501|40218105|FG001|Overall Study|Withdrawal by Subject|1|||
16474993|NCT00917501|40218104|FG000|Overall Study|Lack of Efficacy|1|||
16474994|NCT00917501|40218105|FG001|Overall Study|Lack of Efficacy|2|||
16474995|NCT00917501|40218104|FG000|Overall Study|trouble swollowing capsules|0|||
16176164|NCT00785577|39122855|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
16277690|NCT01332968|39497256|FG004|Induction Period|Randomised but not treated|0|||
16277691|NCT01332968|39497257|FG005|Induction Period|Randomised but not treated|0|||
16277692|NCT01332968|39497258|FG006|Induction Period|Randomised but not treated|0|||
16277693|NCT01332968|39497259|FG007|Induction Period|Randomised but not treated|0|||
16277694|NCT01332968|39497252|FG000|Maintenance/Observation Period|Adverse Event|0|||
16277695|NCT01332968|39497253|FG001|Maintenance/Observation Period|Adverse Event|0|||
16277696|NCT01332968|39497254|FG002|Maintenance/Observation Period|Adverse Event|53|||
16277697|NCT01332968|39497255|FG003|Maintenance/Observation Period|Adverse Event|66|||
16277698|NCT01332968|39497256|FG004|Maintenance/Observation Period|Adverse Event|0|||
16277699|NCT01332968|39497257|FG005|Maintenance/Observation Period|Adverse Event|0|||
16474996|NCT00917501|40218105|FG001|Overall Study|trouble swollowing capsules|1|||
16474997|NCT02869438|40218106|FG000|Overall Study|Lost to Follow-up|1|||
16474998|NCT02869438|40218107|FG001|Overall Study|Lost to Follow-up|0|||
16474999|NCT02869438|40218106|FG000|Overall Study|Adverse Event|1|||
16475000|NCT02869438|40218107|FG001|Overall Study|Adverse Event|0|||
16475001|NCT02869438|40218106|FG000|Overall Study|Withdrawal by Subject|1|||
16475002|NCT02869438|40218107|FG001|Overall Study|Withdrawal by Subject|2|||
16475003|NCT01025154|40218108|FG000|Overall Study|Lost to Follow-up|1|||
16475004|NCT01025154|40218108|FG000|Overall Study|Withdrawal by Subject|1|||
16475005|NCT03643159|40218119|FG000|Overall Study|Adverse Event|1|||
16475006|NCT03643159|40218119|FG000|Overall Study|Withdrawal by Subject|1|||
16475007|NCT04043728|40218128|FG000|Overall Study|Lost to Follow-up|1|||
16475008|NCT04043728|40218129|FG001|Overall Study|Lost to Follow-up|2|||
16475009|NCT04043728|40218130|FG002|Overall Study|Lost to Follow-up|0|||
16475010|NCT04587271|40218133|FG000|Overall Study|Lost to Follow-up|2|||
16475011|NCT04587271|40218134|FG001|Overall Study|Lost to Follow-up|2|||
16475012|NCT04587271|40218135|FG002|Overall Study|Lost to Follow-up|0|||
16475013|NCT04587271|40218136|FG003|Overall Study|Lost to Follow-up|2|||
16475014|NCT04587271|40218137|FG004|Overall Study|Lost to Follow-up|2|||
16475015|NCT04587271|40218138|FG005|Overall Study|Lost to Follow-up|0|||
16475016|NCT04587271|40218133|FG000|Overall Study|Caregiver brought child to visits|0|||
16277700|NCT01332968|39497258|FG006|Maintenance/Observation Period|Adverse Event|0|||
16277701|NCT01332968|39497259|FG007|Maintenance/Observation Period|Adverse Event|0|||
16475017|NCT04587271|40218134|FG001|Overall Study|Caregiver brought child to visits|0|||
16475018|NCT04587271|40218135|FG002|Overall Study|Caregiver brought child to visits|0|||
16475019|NCT04587271|40218136|FG003|Overall Study|Caregiver brought child to visits|1|||
16475020|NCT04587271|40218137|FG004|Overall Study|Caregiver brought child to visits|0|||
16475021|NCT04587271|40218138|FG005|Overall Study|Caregiver brought child to visits|0|||
16475022|NCT02169284|40218140|FG000|Overall Study|Physician Decision|0|||
16475023|NCT02169284|40218141|FG001|Overall Study|Physician Decision|1|||
16475024|NCT01759511|40218142|FG000|Overall Study|Adverse Event|4|||
16475025|NCT01759511|40218142|FG000|Overall Study|Death|2|||
16475026|NCT01759511|40218142|FG000|Overall Study|Lack of Efficacy|2|||
16475027|NCT01759511|40218142|FG000|Overall Study|Physician Decision|1|||
16475028|NCT01759511|40218142|FG000|Overall Study|Progressive Disease|5|||
16475029|NCT01759511|40218142|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
16475030|NCT01759511|40218142|FG000|Overall Study|Study Terminated by Sponsor|13|||
16475031|NCT01759511|40218142|FG000|Overall Study|Withdrawal by Subject|3|||
16475032|NCT00884377|40218145|FG000|Overall Study|Withdrawal by Subject|1|||
16475033|NCT00884377|40218146|FG001|Overall Study|Withdrawal by Subject|0|||
16475034|NCT00884377|40218145|FG000|Overall Study|Could not confirm diagnosis|1|||
16475035|NCT00884377|40218146|FG001|Overall Study|Could not confirm diagnosis|0|||
16475036|NCT00884377|40218145|FG000|Overall Study|Physician Decision|0|||
16475037|NCT00884377|40218146|FG001|Overall Study|Physician Decision|1|||
16475038|NCT02436304|40218152|FG000|Overall Study|Lost to Follow-up|0|||
16475039|NCT02436304|40218153|FG001|Overall Study|Lost to Follow-up|1|||
16475040|NCT02436304|40218154|FG002|Overall Study|Lost to Follow-up|0|||
16277702|NCT01332968|39497252|FG000|Maintenance/Observation Period|Death|0|||
16277703|NCT01332968|39497253|FG001|Maintenance/Observation Period|Death|0|||
16475041|NCT02436304|40218152|FG000|Overall Study|Withdrawal by Subject|0|||
16475042|NCT02436304|40218153|FG001|Overall Study|Withdrawal by Subject|1|||
16475043|NCT02436304|40218154|FG002|Overall Study|Withdrawal by Subject|0|||
16475044|NCT02436304|40218152|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
16475045|NCT02436304|40218153|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
16475046|NCT02436304|40218154|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
16475047|NCT01231347|40218155|FG000|Overall Study|Full Consent withdrawn|19|||
16475048|NCT01231347|40218156|FG001|Overall Study|Full Consent withdrawn|19|||
16475049|NCT01231347|40218157|FG002|Overall Study|Full Consent withdrawn|11|||
16475050|NCT01231347|40218155|FG000|Overall Study|Lost to Follow-up|4|||
16475051|NCT01231347|40218156|FG001|Overall Study|Lost to Follow-up|2|||
16475052|NCT01231347|40218157|FG002|Overall Study|Lost to Follow-up|2|||
16475053|NCT01231347|40218155|FG000|Overall Study|Death|202|||
16475054|NCT01231347|40218156|FG001|Overall Study|Death|210|||
16475055|NCT01231347|40218157|FG002|Overall Study|Death|101|||
16475056|NCT01231347|40218155|FG000|Overall Study|other event|7|||
16475057|NCT01231347|40218156|FG001|Overall Study|other event|9|||
16475058|NCT01231347|40218157|FG002|Overall Study|other event|3|||
16475059|NCT01810432|40218158|FG000|Washout|Protocol Violation|0|||
16475060|NCT01810432|40218159|FG001|Washout|Protocol Violation|1|||
16475061|NCT01810432|40218158|FG000|Washout|Adverse Event|1|||
16475062|NCT01810432|40218159|FG001|Washout|Adverse Event|0|||
16475063|NCT01810432|40218158|FG000|Period 2|Withdrawal by Subject|2|||
16475064|NCT01810432|40218159|FG001|Period 2|Withdrawal by Subject|1|||
16475065|NCT01810432|40218158|FG000|Period 2|Physician Decision|1|||
16475066|NCT01810432|40218159|FG001|Period 2|Physician Decision|0|||
16475067|NCT01810432|40218158|FG000|Period 2|Lost to Follow-up|1|||
16475068|NCT01810432|40218159|FG001|Period 2|Lost to Follow-up|1|||
16475069|NCT00474760|40218164|FG000|Overall Study|Death|0|||
16475070|NCT00474760|40218165|FG001|Overall Study|Death|0|||
16475071|NCT00474760|40218166|FG002|Overall Study|Death|0|||
16475072|NCT00474760|40218167|FG003|Overall Study|Death|0|||
16277704|NCT01332968|39497254|FG002|Maintenance/Observation Period|Death|5|||
16475073|NCT00474760|40218168|FG004|Overall Study|Death|2|||
16475074|NCT00474760|40218169|FG005|Overall Study|Death|0|||
16475075|NCT00474760|40218170|FG006|Overall Study|Death|0|||
16475076|NCT00474760|40218164|FG000|Overall Study|Adverse Event|0|||
16475077|NCT00474760|40218165|FG001|Overall Study|Adverse Event|0|||
16475078|NCT00474760|40218166|FG002|Overall Study|Adverse Event|0|||
16475079|NCT00474760|40218167|FG003|Overall Study|Adverse Event|0|||
16475080|NCT00474760|40218168|FG004|Overall Study|Adverse Event|1|||
16475081|NCT00474760|40218169|FG005|Overall Study|Adverse Event|7|||
16475082|NCT00474760|40218170|FG006|Overall Study|Adverse Event|0|||
16475083|NCT00474760|40218164|FG000|Overall Study|Laboratory abnormality|0|||
16277705|NCT01332968|39497255|FG003|Maintenance/Observation Period|Death|6|||
16277706|NCT01332968|39497256|FG004|Maintenance/Observation Period|Death|0|||
16277707|NCT01332968|39497257|FG005|Maintenance/Observation Period|Death|0|||
16277708|NCT01332968|39497258|FG006|Maintenance/Observation Period|Death|0|||
16277709|NCT01332968|39497259|FG007|Maintenance/Observation Period|Death|0|||
16277710|NCT01332968|39497252|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
16277711|NCT01332968|39497253|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
16277712|NCT01332968|39497254|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
16277713|NCT01332968|39497255|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
16277714|NCT01332968|39497256|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
16277715|NCT01332968|39497257|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
16277716|NCT01332968|39497258|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
16277717|NCT01332968|39497259|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
16277718|NCT01332968|39497252|FG000|Maintenance/Observation Period|Non-compliance|0|||
16277719|NCT01332968|39497253|FG001|Maintenance/Observation Period|Non-compliance|0|||
16277720|NCT01332968|39497254|FG002|Maintenance/Observation Period|Non-compliance|4|||
16277721|NCT01332968|39497255|FG003|Maintenance/Observation Period|Non-compliance|3|||
16277722|NCT01332968|39497256|FG004|Maintenance/Observation Period|Non-compliance|0|||
16277723|NCT01332968|39497257|FG005|Maintenance/Observation Period|Non-compliance|0|||
16277724|NCT01332968|39497258|FG006|Maintenance/Observation Period|Non-compliance|0|||
16277725|NCT01332968|39497259|FG007|Maintenance/Observation Period|Non-compliance|0|||
16475084|NCT00474760|40218165|FG001|Overall Study|Laboratory abnormality|0|||
16475085|NCT00474760|40218166|FG002|Overall Study|Laboratory abnormality|0|||
16475086|NCT00474760|40218167|FG003|Overall Study|Laboratory abnormality|0|||
16475087|NCT00474760|40218168|FG004|Overall Study|Laboratory abnormality|0|||
16475088|NCT00474760|40218169|FG005|Overall Study|Laboratory abnormality|1|||
16475089|NCT00474760|40218170|FG006|Overall Study|Laboratory abnormality|0|||
16475090|NCT00474760|40218164|FG000|Overall Study|Withdrawal by Subject|0|||
16475091|NCT00474760|40218165|FG001|Overall Study|Withdrawal by Subject|0|||
16475092|NCT00474760|40218166|FG002|Overall Study|Withdrawal by Subject|0|||
16475093|NCT00474760|40218167|FG003|Overall Study|Withdrawal by Subject|1|||
16475094|NCT00474760|40218168|FG004|Overall Study|Withdrawal by Subject|0|||
16475095|NCT00474760|40218169|FG005|Overall Study|Withdrawal by Subject|1|||
16475096|NCT00474760|40218170|FG006|Overall Study|Withdrawal by Subject|1|||
16475097|NCT00474760|40218164|FG000|Overall Study|Other|0|||
16475098|NCT00474760|40218165|FG001|Overall Study|Other|1|||
16475099|NCT00474760|40218166|FG002|Overall Study|Other|0|||
16475100|NCT00474760|40218167|FG003|Overall Study|Other|0|||
16475101|NCT00474760|40218168|FG004|Overall Study|Other|1|||
16475102|NCT00474760|40218169|FG005|Overall Study|Other|0|||
16475103|NCT00474760|40218170|FG006|Overall Study|Other|0|||
16475104|NCT00474760|40218164|FG000|Overall Study|Progressive disease|3|||
16475105|NCT00474760|40218165|FG001|Overall Study|Progressive disease|2|||
16475106|NCT00474760|40218166|FG002|Overall Study|Progressive disease|3|||
16475107|NCT00474760|40218167|FG003|Overall Study|Progressive disease|2|||
16475108|NCT00474760|40218168|FG004|Overall Study|Progressive disease|8|||
16475109|NCT00474760|40218169|FG005|Overall Study|Progressive disease|20|||
16475110|NCT00474760|40218170|FG006|Overall Study|Progressive disease|7|||
16475111|NCT00474760|40218164|FG000|Overall Study|Terminated by sponsor|0|||
16475112|NCT00474760|40218165|FG001|Overall Study|Terminated by sponsor|0|||
16475113|NCT00474760|40218166|FG002|Overall Study|Terminated by sponsor|0|||
16475114|NCT00474760|40218167|FG003|Overall Study|Terminated by sponsor|0|||
16475115|NCT00474760|40218168|FG004|Overall Study|Terminated by sponsor|0|||
16475116|NCT00474760|40218169|FG005|Overall Study|Terminated by sponsor|0|||
16475117|NCT00474760|40218170|FG006|Overall Study|Terminated by sponsor|2|||
16475118|NCT03004443|40218173|FG000|Overall Study|Pregnancy|0|||
16475119|NCT03004443|40218174|FG001|Overall Study|Pregnancy|1|||
16475120|NCT03934684|40218186|FG000|Overall Study|Participants continuing in study|11|||
16475121|NCT03934684|40218187|FG001|Overall Study|Participants continuing in study|4|||
16475122|NCT03934684|40218186|FG000|Overall Study|Discontinuation of carfilzomib|20|||
16475123|NCT03934684|40218187|FG001|Overall Study|Discontinuation of carfilzomib|30|||
16475124|NCT03934684|40218186|FG000|Overall Study|Death|2|||
16475125|NCT03934684|40218187|FG001|Overall Study|Death|2|||
16475126|NCT03934684|40218186|FG000|Overall Study|Lost to Follow-up|2|||
16475127|NCT03934684|40218187|FG001|Overall Study|Lost to Follow-up|5|||
16475128|NCT03934684|40218186|FG000|Overall Study|Withdrawal by Subject|7|||
16475129|NCT03934684|40218187|FG001|Overall Study|Withdrawal by Subject|8|||
16475130|NCT01460368|40220605|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16475131|NCT01460368|40220606|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16475132|NCT01460368|40220607|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16475133|NCT01460368|40220608|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16475134|NCT01460368|40220609|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
16475135|NCT01460368|40220610|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16277726|NCT01332968|39497252|FG000|Maintenance/Observation Period|Other|0|||
16277727|NCT01332968|39497253|FG001|Maintenance/Observation Period|Other|0|||
16475136|NCT01460368|40220611|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
16475137|NCT01460368|40220605|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
16475138|NCT01460368|40220606|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
16475139|NCT01460368|40220607|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
16475140|NCT01460368|40220608|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
16475141|NCT01460368|40220609|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
16475142|NCT01460368|40220610|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
16475143|NCT01460368|40220611|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
16475144|NCT01460368|40220605|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16475145|NCT01460368|40220606|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
16475146|NCT01460368|40220607|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16475147|NCT01460368|40220608|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16475148|NCT01460368|40220609|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16475149|NCT01460368|40220610|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16475150|NCT01460368|40220611|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
16475151|NCT01460368|40220605|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16475152|NCT01460368|40220606|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16475153|NCT01460368|40220607|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
16475154|NCT01460368|40220608|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16475155|NCT01460368|40220609|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16475156|NCT01460368|40220610|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16475157|NCT01460368|40220611|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
16475158|NCT01460368|40220605|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
16475159|NCT01460368|40220606|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
16475160|NCT01460368|40220607|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
16475161|NCT01460368|40220608|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
16475162|NCT01460368|40220609|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
16475163|NCT01460368|40220610|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
16475164|NCT01460368|40220611|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
16475165|NCT03082261|40220616|FG000|Overall Study|Death|4|||
16475166|NCT03082261|40220616|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
16475167|NCT03082261|40220616|FG000|Overall Study|Insurance denial|1|||
16475168|NCT03082261|40220616|FG000|Overall Study|Peripheral lead added|1|||
16475169|NCT03082261|40220616|FG000|Overall Study|Withdrawal by Subject|40|||
16475170|NCT03082261|40220616|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
16475171|NCT03082261|40220616|FG000|Overall Study|Subject implanted with device other than study device|1|||
16475172|NCT03082261|40220616|FG000|Overall Study|Lost to Follow-up|14|||
16475173|NCT03082261|40220616|FG000|Overall Study|Subject moved to a different state|1|||
16475174|NCT03082261|40220616|FG000|Overall Study|Subject non-compliance|2|||
16475175|NCT03082261|40220616|FG000|Overall Study|Subject participation terminated by investigator|9|||
16475176|NCT03082261|40220616|FG000|Overall Study|Subject participation terminated by sponsor|4|||
16475177|NCT03082261|40220616|FG000|Overall Study|System explant|19|||
16475178|NCT03082261|40220616|FG000|Overall Study|Unable to place lead(s)|2|||
16475179|NCT03082261|40220616|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
16475180|NCT03063203|40220620|FG000|Overall Study|Chose alternative therapy|3|||
16475181|NCT03063203|40220620|FG000|Overall Study|Death|2|||
16475182|NCT03063203|40220620|FG000|Overall Study|Disease progression|4|||
16475183|NCT03063203|40220620|FG000|Overall Study|Physician Decision|5|||
16475184|NCT00423514|40220622|FG000|Overall Study|Ineligible|1|||
16475185|NCT00423514|40220623|FG001|Overall Study|Ineligible|0|||
16475186|NCT02517866|40220624|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
16475187|NCT02517866|40220625|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
16475188|NCT02517866|40220626|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16475189|NCT02517866|40220624|FG000|Overall Study|Significant Protocol Deviation|4|||
16475190|NCT02517866|40220625|FG001|Overall Study|Significant Protocol Deviation|1|||
16475191|NCT02517866|40220626|FG002|Overall Study|Significant Protocol Deviation|0|||
16475192|NCT02517866|40220624|FG000|Overall Study|Lost to Follow-up|1|||
16475193|NCT02517866|40220625|FG001|Overall Study|Lost to Follow-up|0|||
16475194|NCT02517866|40220626|FG002|Overall Study|Lost to Follow-up|0|||
16475195|NCT02517866|40220624|FG000|Overall Study|Voluntary Withdrawal|2|||
16475196|NCT02517866|40220625|FG001|Overall Study|Voluntary Withdrawal|2|||
16475197|NCT02517866|40220626|FG002|Overall Study|Voluntary Withdrawal|0|||
16475198|NCT02517866|40220624|FG000|Overall Study|Investigator Decision|2|||
16475199|NCT02517866|40220625|FG001|Overall Study|Investigator Decision|1|||
16475200|NCT02517866|40220626|FG002|Overall Study|Investigator Decision|0|||
16475201|NCT02517866|40220624|FG000|Overall Study|Reason not specified|2|||
16475202|NCT02517866|40220625|FG001|Overall Study|Reason not specified|0|||
16475203|NCT02517866|40220626|FG002|Overall Study|Reason not specified|0|||
16475204|NCT01052844|40220627|FG000|Overall Study|Adverse Event|0|||
16475205|NCT01052844|40220628|FG001|Overall Study|Adverse Event|1|||
16475206|NCT00113087|40220631|FG000|Overall Study|Death or Transplant|14|||
16475207|NCT00113087|40220632|FG001|Overall Study|Death or Transplant|16|||
16475208|NCT00113087|40220631|FG000|Overall Study|Family or MD withdrew subject|10|||
16475209|NCT00113087|40220632|FG001|Overall Study|Family or MD withdrew subject|5|||
16475210|NCT03452228|40220636|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
16277728|NCT01332968|39497254|FG002|Maintenance/Observation Period|Other|4|||
16277729|NCT01332968|39497255|FG003|Maintenance/Observation Period|Other|7|||
16277730|NCT01332968|39497256|FG004|Maintenance/Observation Period|Other|0|||
16277731|NCT01332968|39497257|FG005|Maintenance/Observation Period|Other|0|||
16277732|NCT01332968|39497258|FG006|Maintenance/Observation Period|Other|0|||
16277733|NCT01332968|39497259|FG007|Maintenance/Observation Period|Other|0|||
16277734|NCT01332968|39497252|FG000|Maintenance/Observation Period|Physician Decision|0|||
16277735|NCT01332968|39497253|FG001|Maintenance/Observation Period|Physician Decision|0|||
16475211|NCT03452228|40220637|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
16475212|NCT03452228|40220638|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
16475213|NCT03452228|40220636|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
16475214|NCT03452228|40220637|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
16475215|NCT03452228|40220638|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
16475216|NCT03452228|40220636|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
16475217|NCT03452228|40220637|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
16475218|NCT03452228|40220638|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
16475219|NCT03452228|40220636|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
16475220|NCT03452228|40220637|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
16475221|NCT03452228|40220638|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
16475222|NCT01083173|40220642|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
16475223|NCT01083173|40220643|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
16277736|NCT01332968|39497254|FG002|Maintenance/Observation Period|Physician Decision|14|||
16277737|NCT01332968|39497255|FG003|Maintenance/Observation Period|Physician Decision|19|||
16277738|NCT01332968|39497256|FG004|Maintenance/Observation Period|Physician Decision|0|||
16277739|NCT01332968|39497257|FG005|Maintenance/Observation Period|Physician Decision|1|||
16277740|NCT01332968|39497258|FG006|Maintenance/Observation Period|Physician Decision|0|||
16277741|NCT01332968|39497259|FG007|Maintenance/Observation Period|Physician Decision|0|||
16277742|NCT01332968|39497252|FG000|Maintenance/Observation Period|Progressive Disease|0|||
16277743|NCT01332968|39497253|FG001|Maintenance/Observation Period|Progressive Disease|0|||
16277744|NCT01332968|39497254|FG002|Maintenance/Observation Period|Progressive Disease|72|||
16277745|NCT01332968|39497255|FG003|Maintenance/Observation Period|Progressive Disease|40|||
16277746|NCT01332968|39497256|FG004|Maintenance/Observation Period|Progressive Disease|0|||
16277747|NCT01332968|39497257|FG005|Maintenance/Observation Period|Progressive Disease|0|||
16277748|NCT01332968|39497258|FG006|Maintenance/Observation Period|Progressive Disease|0|||
16277749|NCT01332968|39497259|FG007|Maintenance/Observation Period|Progressive Disease|0|||
16277750|NCT01332968|39497252|FG000|Maintenance/Observation Period|Protocol Violation|0|||
16277751|NCT01332968|39497253|FG001|Maintenance/Observation Period|Protocol Violation|0|||
16277752|NCT01332968|39497254|FG002|Maintenance/Observation Period|Protocol Violation|1|||
16277753|NCT01332968|39497255|FG003|Maintenance/Observation Period|Protocol Violation|1|||
16277754|NCT01332968|39497256|FG004|Maintenance/Observation Period|Protocol Violation|0|||
16277755|NCT01332968|39497257|FG005|Maintenance/Observation Period|Protocol Violation|0|||
16277756|NCT01332968|39497258|FG006|Maintenance/Observation Period|Protocol Violation|0|||
16277757|NCT01332968|39497259|FG007|Maintenance/Observation Period|Protocol Violation|0|||
16277758|NCT01332968|39497252|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
16277759|NCT01332968|39497253|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
16277760|NCT01332968|39497254|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
16277761|NCT01332968|39497255|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
16277762|NCT01332968|39497256|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
16277763|NCT01332968|39497257|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
16277764|NCT01332968|39497258|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
16277765|NCT01332968|39497259|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
16475224|NCT01083173|40220642|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
16475225|NCT01083173|40220643|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
16475226|NCT01083173|40220642|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
16475227|NCT01083173|40220643|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
16475228|NCT01083173|40220642|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
16475229|NCT01083173|40220643|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
16475230|NCT01083173|40220642|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
16277766|NCT01332968|39497252|FG000|Follow-Up Period|Adverse Event|0|||
16277767|NCT01332968|39497253|FG001|Follow-Up Period|Adverse Event|0|||
16277768|NCT01332968|39497254|FG002|Follow-Up Period|Adverse Event|0|||
16277769|NCT01332968|39497255|FG003|Follow-Up Period|Adverse Event|0|||
16277770|NCT01332968|39497256|FG004|Follow-Up Period|Adverse Event|0|||
16277771|NCT01332968|39497257|FG005|Follow-Up Period|Adverse Event|0|||
16277772|NCT01332968|39497258|FG006|Follow-Up Period|Adverse Event|0|||
16277773|NCT01332968|39497259|FG007|Follow-Up Period|Adverse Event|4|||
16277774|NCT01332968|39497252|FG000|Follow-Up Period|Death|0|||
16277775|NCT01332968|39497253|FG001|Follow-Up Period|Death|0|||
16277776|NCT01332968|39497254|FG002|Follow-Up Period|Death|0|||
16277777|NCT01332968|39497255|FG003|Follow-Up Period|Death|0|||
16277778|NCT01332968|39497256|FG004|Follow-Up Period|Death|0|||
16277779|NCT01332968|39497257|FG005|Follow-Up Period|Death|0|||
16277780|NCT01332968|39497258|FG006|Follow-Up Period|Death|27|||
16277781|NCT01332968|39497259|FG007|Follow-Up Period|Death|30|||
16277782|NCT01332968|39497252|FG000|Follow-Up Period|Lost to Follow-up|0|||
16277783|NCT01332968|39497253|FG001|Follow-Up Period|Lost to Follow-up|0|||
16277784|NCT01332968|39497254|FG002|Follow-Up Period|Lost to Follow-up|0|||
16277785|NCT01332968|39497255|FG003|Follow-Up Period|Lost to Follow-up|0|||
16277786|NCT01332968|39497256|FG004|Follow-Up Period|Lost to Follow-up|0|||
16277787|NCT01332968|39497257|FG005|Follow-Up Period|Lost to Follow-up|0|||
16277788|NCT01332968|39497258|FG006|Follow-Up Period|Lost to Follow-up|11|||
16475231|NCT01083173|40220643|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
16475232|NCT01083173|40220642|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
16475233|NCT01083173|40220643|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
16475234|NCT01083173|40220642|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
16475235|NCT01083173|40220643|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
16475236|NCT01083173|40220642|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
16475237|NCT01083173|40220643|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
16475238|NCT01083173|40220642|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
16475239|NCT01083173|40220643|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
16277789|NCT01332968|39497259|FG007|Follow-Up Period|Lost to Follow-up|15|||
16277790|NCT01332968|39497252|FG000|Follow-Up Period|Non-compliance|0|||
16277791|NCT01332968|39497253|FG001|Follow-Up Period|Non-compliance|0|||
16277792|NCT01332968|39497254|FG002|Follow-Up Period|Non-compliance|0|||
16277793|NCT01332968|39497255|FG003|Follow-Up Period|Non-compliance|0|||
16277794|NCT01332968|39497256|FG004|Follow-Up Period|Non-compliance|0|||
16378740|NCT01435356|39872216|FG001|Overall Study|Withdrawal by Subject|1|||
16475240|NCT01083173|40220642|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
16475241|NCT01083173|40220643|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
16475242|NCT01083173|40220642|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
16475243|NCT01083173|40220643|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
16475244|NCT03078907|40220644|FG000|Overall Study|Adverse Event|2|||
16475245|NCT03078907|40220645|FG001|Overall Study|Adverse Event|0|||
16475246|NCT03078907|40220644|FG000|Overall Study|Other|1|||
16475247|NCT03078907|40220645|FG001|Overall Study|Other|0|||
16475248|NCT03078907|40220644|FG000|Overall Study|Protocol Violation|0|||
16475249|NCT03078907|40220645|FG001|Overall Study|Protocol Violation|1|||
16475250|NCT02905149|40220646|FG000|Overall Study|Lost to Follow-up|2|||
16475251|NCT02905149|40220647|FG001|Overall Study|Lost to Follow-up|0|||
16475252|NCT03187756|40220651|FG000|Overall Study|Termination of study|4|||
16475253|NCT02128932|40220652|FG000|Overall Study|Withdrawal by Subject|11|||
16475254|NCT02128932|40220653|FG001|Overall Study|Withdrawal by Subject|7|||
16475255|NCT02128932|40220654|FG002|Overall Study|Withdrawal by Subject|8|||
16475256|NCT02128932|40220652|FG000|Overall Study|Death|2|||
16475257|NCT02128932|40220653|FG001|Overall Study|Death|0|||
16475258|NCT02128932|40220654|FG002|Overall Study|Death|2|||
16475259|NCT02128932|40220652|FG000|Overall Study|Lost to Follow-up|2|||
16475260|NCT02128932|40220653|FG001|Overall Study|Lost to Follow-up|1|||
16475261|NCT02128932|40220654|FG002|Overall Study|Lost to Follow-up|1|||
16475262|NCT02128932|40220652|FG000|Overall Study|No reason for withdrawal|12|||
16475263|NCT02128932|40220653|FG001|Overall Study|No reason for withdrawal|11|||
16475264|NCT02128932|40220654|FG002|Overall Study|No reason for withdrawal|7|||
16475265|NCT01298531|40220658|FG000|Overall Study|Lack of Efficacy|0|||
16475266|NCT01298531|40220659|FG001|Overall Study|Lack of Efficacy|1|||
16475267|NCT01298531|40220658|FG000|Overall Study|Lost to Follow-up|2|||
16475268|NCT01298531|40220659|FG001|Overall Study|Lost to Follow-up|0|||
16475269|NCT01298531|40220658|FG000|Overall Study|Protocol Violation|1|||
16475270|NCT01298531|40220659|FG001|Overall Study|Protocol Violation|1|||
16277795|NCT01332968|39497257|FG005|Follow-Up Period|Non-compliance|0|||
16277796|NCT01332968|39497258|FG006|Follow-Up Period|Non-compliance|4|||
16277797|NCT01332968|39497259|FG007|Follow-Up Period|Non-compliance|9|||
16277798|NCT01332968|39497252|FG000|Follow-Up Period|Other|0|||
16277799|NCT01332968|39497253|FG001|Follow-Up Period|Other|0|||
16277800|NCT01332968|39497254|FG002|Follow-Up Period|Other|0|||
16277801|NCT01332968|39497255|FG003|Follow-Up Period|Other|0|||
16277802|NCT01332968|39497256|FG004|Follow-Up Period|Other|0|||
16277803|NCT01332968|39497257|FG005|Follow-Up Period|Other|0|||
16277804|NCT01332968|39497258|FG006|Follow-Up Period|Other|18|||
16277805|NCT01332968|39497259|FG007|Follow-Up Period|Other|21|||
16277806|NCT01332968|39497252|FG000|Follow-Up Period|Physician Decision|0|||
16277807|NCT01332968|39497253|FG001|Follow-Up Period|Physician Decision|0|||
16277808|NCT01332968|39497254|FG002|Follow-Up Period|Physician Decision|0|||
16277809|NCT01332968|39497255|FG003|Follow-Up Period|Physician Decision|0|||
16277810|NCT01332968|39497256|FG004|Follow-Up Period|Physician Decision|0|||
16277811|NCT01332968|39497257|FG005|Follow-Up Period|Physician Decision|0|||
16277812|NCT01332968|39497258|FG006|Follow-Up Period|Physician Decision|12|||
16475271|NCT01298531|40220658|FG000|Overall Study|Adverse Event|4|||
16475272|NCT01298531|40220659|FG001|Overall Study|Adverse Event|3|||
16475273|NCT01298531|40220658|FG000|Overall Study|Does not meet entrance criteria|0|||
16475274|NCT01298531|40220659|FG001|Overall Study|Does not meet entrance criteria|1|||
16475275|NCT01298531|40220658|FG000|Overall Study|Other|2|||
16475276|NCT01298531|40220659|FG001|Overall Study|Other|1|||
16475277|NCT01008150|40220660|FG000|Overall Study|did not receive study drug|1|||
16475278|NCT01008150|40220661|FG001|Overall Study|did not receive study drug|1|||
16475279|NCT01008150|40220662|FG002|Overall Study|did not receive study drug|1|||
16475280|NCT01008150|40220663|FG003|Overall Study|did not receive study drug|0|||
16475281|NCT02003365|40220664|FG000|Overall Study|Lost to Follow-up|0|||
16475282|NCT02003365|40220665|FG001|Overall Study|Lost to Follow-up|0|||
16475283|NCT02003365|40220666|FG002|Overall Study|Lost to Follow-up|1|||
16475284|NCT00750880|40220667|FG000|Overall Study|Adverse Event|76|||
16475285|NCT00750880|40220667|FG000|Overall Study|Death|4|||
16475286|NCT00750880|40220667|FG000|Overall Study|Lack of Efficacy|46|||
16475287|NCT00750880|40220667|FG000|Overall Study|Lost to Follow-up|10|||
16475288|NCT00750880|40220667|FG000|Overall Study|Protocol Violation|15|||
16475289|NCT00750880|40220667|FG000|Overall Study|Withdrawal by Subject|33|||
16475290|NCT00750880|40220667|FG000|Overall Study|Physician Decision|20|||
16475291|NCT00750880|40220667|FG000|Overall Study|Administrative|11|||
16475292|NCT02452697|40220668|FG000|Overall Study|Physician Decision|4|||
16475293|NCT02452697|40220669|FG001|Overall Study|Physician Decision|4|||
16475294|NCT02452697|40220670|FG002|Overall Study|Physician Decision|3|||
16475295|NCT02452697|40220671|FG003|Overall Study|Physician Decision|2|||
16475296|NCT02452697|40220668|FG000|Overall Study|Withdrawal by Subject|1|||
16475297|NCT02452697|40220669|FG001|Overall Study|Withdrawal by Subject|0|||
16475298|NCT02452697|40220670|FG002|Overall Study|Withdrawal by Subject|0|||
16475299|NCT02452697|40220671|FG003|Overall Study|Withdrawal by Subject|0|||
16475300|NCT02452697|40220668|FG000|Overall Study|still in follow-up|2|||
16475301|NCT02452697|40220669|FG001|Overall Study|still in follow-up|2|||
16475302|NCT02452697|40220670|FG002|Overall Study|still in follow-up|1|||
16475303|NCT02452697|40220671|FG003|Overall Study|still in follow-up|3|||
16475304|NCT02846324|40220672|FG000|Overall Study|Other|1|||
16475305|NCT02846324|40220673|FG001|Overall Study|Other|0|||
16475306|NCT02846324|40220674|FG002|Overall Study|Other|0|||
16475307|NCT02846324|40220675|FG003|Overall Study|Other|0|||
16475308|NCT02846324|40220672|FG000|Overall Study|Withdrawal by Subject|1|||
16475309|NCT02846324|40220673|FG001|Overall Study|Withdrawal by Subject|0|||
16475310|NCT02846324|40220674|FG002|Overall Study|Withdrawal by Subject|4|||
16475311|NCT02846324|40220675|FG003|Overall Study|Withdrawal by Subject|0|||
16475312|NCT04327674|40220676|FG000|Overall Study|Protocol Violation|19|||
16475313|NCT03626168|40220677|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
16475314|NCT03626168|40220678|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
16475315|NCT03626168|40220677|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
16475316|NCT03626168|40220678|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
16475317|NCT03626168|40220677|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
16475318|NCT03626168|40220678|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
16277813|NCT01332968|39497259|FG007|Follow-Up Period|Physician Decision|15|||
16277814|NCT01332968|39497252|FG000|Follow-Up Period|Progressive Disease|0|||
16475319|NCT03437512|40220679|FG000|Randomized|Withdrawal by Subject|0|||
16475320|NCT03437512|40220680|FG001|Randomized|Withdrawal by Subject|2|||
16475321|NCT03437512|40220679|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
16475322|NCT03437512|40220680|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
16475323|NCT01642407|40220681|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
16475324|NCT01642407|40220681|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
16475325|NCT01642407|40220681|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
16475326|NCT03228420|40220683|FG000|Overall Study|Lost to Follow-up|5|||
16475327|NCT03228420|40220684|FG001|Overall Study|Lost to Follow-up|3|||
16475328|NCT03228420|40220683|FG000|Overall Study|Withdrawal by Subject|10|||
16475329|NCT03228420|40220684|FG001|Overall Study|Withdrawal by Subject|0|||
16475330|NCT03228420|40220683|FG000|Overall Study|Adverse Event|5|||
16475331|NCT03228420|40220684|FG001|Overall Study|Adverse Event|2|||
16277815|NCT01332968|39497253|FG001|Follow-Up Period|Progressive Disease|0|||
16277816|NCT01332968|39497254|FG002|Follow-Up Period|Progressive Disease|0|||
16475332|NCT01710046|40220685|FG000|Overall Study|Lost to Follow-up|1|||
16475333|NCT01710046|40220686|FG001|Overall Study|Lost to Follow-up|0|||
16475334|NCT02367131|40220688|FG000|Overall Study|Adverse Event|64|||
16475335|NCT02367131|40220688|FG000|Overall Study|No visit since the first visit|3|||
16475336|NCT02367131|40220688|FG000|Overall Study|Request by patient|53|||
16475337|NCT02367131|40220688|FG000|Overall Study|Improvement/remission|2|||
16475338|NCT02367131|40220688|FG000|Overall Study|No change/progressive disease|78|||
16475339|NCT02367131|40220688|FG000|Overall Study|Other than stated above|20|||
16475340|NCT02367131|40220688|FG000|Overall Study|Not treated|2|||
16475341|NCT04697056|40220691|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
16475342|NCT04697056|40220692|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
16475343|NCT01313312|40220694|FG000|Overall Study|Adverse Event|5|||
16475344|NCT01313312|40220694|FG000|Overall Study|Withdrawal by Subject|18|||
16475345|NCT01313312|40220694|FG000|Overall Study|Lack of Efficacy|3|||
16475346|NCT01313312|40220694|FG000|Overall Study|Investigator Decision|1|||
16475347|NCT01313312|40220694|FG000|Overall Study|Observational Phase|1|||
16475348|NCT01313312|40220694|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
16475349|NCT01313312|40220694|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
16475350|NCT00891462|40220695|FG000|Overall Study|Withdrawal by Subject|9|||
16475351|NCT00891462|40220696|FG001|Overall Study|Withdrawal by Subject|6|||
16475352|NCT00891462|40220697|FG002|Overall Study|Withdrawal by Subject|7|||
16475353|NCT00891462|40220695|FG000|Overall Study|Adverse Event|7|||
16475354|NCT00891462|40220696|FG001|Overall Study|Adverse Event|8|||
16475355|NCT00891462|40220697|FG002|Overall Study|Adverse Event|7|||
16475356|NCT00891462|40220695|FG000|Overall Study|Lack of Efficacy|10|||
16475357|NCT00891462|40220696|FG001|Overall Study|Lack of Efficacy|5|||
16475358|NCT00891462|40220697|FG002|Overall Study|Lack of Efficacy|1|||
16475359|NCT00891462|40220695|FG000|Overall Study|COPD exacerbation|7|||
16475360|NCT00891462|40220696|FG001|Overall Study|COPD exacerbation|4|||
16475361|NCT00891462|40220697|FG002|Overall Study|COPD exacerbation|1|||
16475362|NCT00891462|40220695|FG000|Overall Study|Other Reason|2|||
16475363|NCT00891462|40220696|FG001|Overall Study|Other Reason|5|||
16475364|NCT00891462|40220697|FG002|Overall Study|Other Reason|3|||
16475365|NCT00891462|40220695|FG000|Overall Study|Protocol Violation|2|||
16475366|NCT00891462|40220696|FG001|Overall Study|Protocol Violation|1|||
16475367|NCT00891462|40220697|FG002|Overall Study|Protocol Violation|3|||
16475368|NCT00891462|40220695|FG000|Overall Study|Inclusion/exclusion criteria|0|||
16475369|NCT00891462|40220696|FG001|Overall Study|Inclusion/exclusion criteria|2|||
16475370|NCT00891462|40220697|FG002|Overall Study|Inclusion/exclusion criteria|2|||
16475371|NCT00891462|40220695|FG000|Overall Study|Lost to Follow-up|0|||
16475372|NCT00891462|40220696|FG001|Overall Study|Lost to Follow-up|2|||
16475373|NCT00891462|40220697|FG002|Overall Study|Lost to Follow-up|0|||
16475374|NCT01528033|40220701|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
16475375|NCT01528033|40220702|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
16475376|NCT01528033|40220701|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
16475377|NCT01528033|40220702|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
16475378|NCT01528033|40220701|FG000|Primary Endpoint Assessment ITT|Death|2|||
16475379|NCT01528033|40220702|FG001|Primary Endpoint Assessment ITT|Death|2|||
16475380|NCT01528033|40220701|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
16475381|NCT01528033|40220702|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
16475382|NCT01528033|40220701|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
16475383|NCT01528033|40220702|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
16475384|NCT01528033|40220701|FG000|Follow Up|No data available|46|||
16475385|NCT01528033|40220702|FG001|Follow Up|No data available|44|||
16277817|NCT01332968|39497255|FG003|Follow-Up Period|Progressive Disease|0|||
16277818|NCT01332968|39497256|FG004|Follow-Up Period|Progressive Disease|0|||
16277819|NCT01332968|39497257|FG005|Follow-Up Period|Progressive Disease|0|||
16277820|NCT01332968|39497258|FG006|Follow-Up Period|Progressive Disease|126|||
16277821|NCT01332968|39497259|FG007|Follow-Up Period|Progressive Disease|106|||
16277822|NCT01332968|39497252|FG000|Follow-Up Period|Protocol Violation|0|||
16277823|NCT01332968|39497253|FG001|Follow-Up Period|Protocol Violation|0|||
16475386|NCT00302107|40220705|FG000|Overall Study|Lost to Follow-up|6|||
16475387|NCT00302107|40220706|FG001|Overall Study|Lost to Follow-up|5|||
16475388|NCT00302107|40220705|FG000|Overall Study|Protocol Violation|1|||
16475389|NCT00302107|40220706|FG001|Overall Study|Protocol Violation|0|||
16475390|NCT00302107|40220705|FG000|Overall Study|Relocation|0|||
16475391|NCT00302107|40220706|FG001|Overall Study|Relocation|1|||
16475392|NCT00302107|40220705|FG000|Overall Study|Withdrawal by Subject|0|||
16475393|NCT00302107|40220706|FG001|Overall Study|Withdrawal by Subject|3|||
16277824|NCT01332968|39497254|FG002|Follow-Up Period|Protocol Violation|0|||
16475394|NCT00302107|40220705|FG000|Overall Study|Adverse Event|1|||
16475395|NCT00302107|40220706|FG001|Overall Study|Adverse Event|0|||
16475396|NCT00617851|40220709|FG000|Overall Study|Death|0|||
16475397|NCT00617851|40220710|FG001|Overall Study|Death|0|||
16475398|NCT00617851|40220711|FG002|Overall Study|Death|0|||
16475399|NCT00617851|40220712|FG003|Overall Study|Death|1|||
16277825|NCT01332968|39497255|FG003|Follow-Up Period|Protocol Violation|0|||
16277826|NCT01332968|39497256|FG004|Follow-Up Period|Protocol Violation|0|||
16277827|NCT01332968|39497257|FG005|Follow-Up Period|Protocol Violation|0|||
16277828|NCT01332968|39497258|FG006|Follow-Up Period|Protocol Violation|1|||
16277829|NCT01332968|39497259|FG007|Follow-Up Period|Protocol Violation|0|||
16277830|NCT01332968|39497252|FG000|Follow-Up Period|Withdrawal by Subject|0|||
16277831|NCT01332968|39497253|FG001|Follow-Up Period|Withdrawal by Subject|0|||
16277832|NCT01332968|39497254|FG002|Follow-Up Period|Withdrawal by Subject|0|||
16475400|NCT00617851|40220709|FG000|Overall Study|Withdrawal by Subject|14|||
16475401|NCT00617851|40220710|FG001|Overall Study|Withdrawal by Subject|7|||
16475402|NCT00617851|40220711|FG002|Overall Study|Withdrawal by Subject|12|||
16475403|NCT00617851|40220712|FG003|Overall Study|Withdrawal by Subject|4|||
16475404|NCT00617851|40220709|FG000|Overall Study|Lost to Follow-up|27|||
16475405|NCT00617851|40220710|FG001|Overall Study|Lost to Follow-up|29|||
16475406|NCT00617851|40220711|FG002|Overall Study|Lost to Follow-up|31|||
16475407|NCT00617851|40220712|FG003|Overall Study|Lost to Follow-up|19|||
16475408|NCT00617851|40220709|FG000|Overall Study|Inappropriate Enrollment|5|||
16475409|NCT00617851|40220710|FG001|Overall Study|Inappropriate Enrollment|4|||
16475410|NCT00617851|40220711|FG002|Overall Study|Inappropriate Enrollment|1|||
16475411|NCT00617851|40220712|FG003|Overall Study|Inappropriate Enrollment|1|||
16475412|NCT00617851|40220709|FG000|Overall Study|Unable to classify|1|||
16475413|NCT00617851|40220710|FG001|Overall Study|Unable to classify|0|||
16475414|NCT00617851|40220711|FG002|Overall Study|Unable to classify|1|||
16475415|NCT00617851|40220712|FG003|Overall Study|Unable to classify|0|||
16475416|NCT01933217|40220713|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
16475417|NCT01933217|40220714|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
16277833|NCT01332968|39497255|FG003|Follow-Up Period|Withdrawal by Subject|0|||
16277834|NCT01332968|39497256|FG004|Follow-Up Period|Withdrawal by Subject|0|||
16277835|NCT01332968|39497257|FG005|Follow-Up Period|Withdrawal by Subject|0|||
16277836|NCT01332968|39497258|FG006|Follow-Up Period|Withdrawal by Subject|29|||
16277837|NCT01332968|39497259|FG007|Follow-Up Period|Withdrawal by Subject|32|||
16475418|NCT01933217|40220713|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
16277838|NCT01332968|39497252|FG000|Follow-Up Period|No reason provided|0|||
16475419|NCT01933217|40220714|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
16475420|NCT04795622|40220715|FG000|Overall Study|Adverse Event|1|||
16475421|NCT04795622|40220716|FG001|Overall Study|Adverse Event|0|||
16475422|NCT04795622|40220715|FG000|Overall Study|Withdrawal by Subject|3|||
16277839|NCT01332968|39497253|FG001|Follow-Up Period|No reason provided|0|||
16277840|NCT01332968|39497254|FG002|Follow-Up Period|No reason provided|0|||
16277841|NCT01332968|39497255|FG003|Follow-Up Period|No reason provided|0|||
16277842|NCT01332968|39497256|FG004|Follow-Up Period|No reason provided|0|||
16277843|NCT01332968|39497257|FG005|Follow-Up Period|No reason provided|0|||
16277844|NCT01332968|39497258|FG006|Follow-Up Period|No reason provided|2|||
16277845|NCT01332968|39497259|FG007|Follow-Up Period|No reason provided|3|||
16277846|NCT04320745|39497260|FG000|Overall Study|Adverse Event|26|||
16277847|NCT04320745|39497260|FG000|Overall Study|Withdrawal by Subject|4|||
16277848|NCT04320745|39497260|FG000|Overall Study|Lost to Follow-up|12|||
16277849|NCT04320745|39497260|FG000|Overall Study|Protocol Deviation|2|||
16277850|NCT04320745|39497260|FG000|Overall Study|Non-compliance With Study Drug|2|||
16277851|NCT04320745|39497260|FG000|Overall Study|Reason Not Specified|1|||
16277852|NCT03540160|39497261|FG000|Overall Study|Protocol Violation|1|||
16277853|NCT03540160|39497261|FG000|Overall Study|Physician Decision|8|||
16277854|NCT03540160|39497261|FG000|Overall Study|Lack of Efficacy|60|||
16277855|NCT03540160|39497261|FG000|Overall Study|Pregnancy|1|||
16277856|NCT03540160|39497261|FG000|Overall Study|Adverse Event|20|||
16277857|NCT03540160|39497261|FG000|Overall Study|Withdrawal by Subject|68|||
16277858|NCT03540160|39497261|FG000|Overall Study|COVID-19|2|||
16277859|NCT03540160|39497261|FG000|Overall Study|Study Closure|10|||
16277860|NCT03540160|39497261|FG000|Overall Study|Lost to Follow-up|18|||
16277861|NCT03540160|39497261|FG000|Overall Study|Sponsor decision|191|||
16277862|NCT03493919|39497262|FG000|Overall Study|Other|2|||
16277863|NCT03493919|39497263|FG001|Overall Study|Other|0|||
16277864|NCT03493919|39497264|FG002|Overall Study|Other|1|||
16277865|NCT03493919|39497265|FG003|Overall Study|Other|0|||
16277866|NCT03493919|39497262|FG000|Overall Study|Withdrawal by Subject|9|||
16277867|NCT03493919|39497263|FG001|Overall Study|Withdrawal by Subject|3|||
16277868|NCT03493919|39497264|FG002|Overall Study|Withdrawal by Subject|1|||
16277869|NCT03493919|39497265|FG003|Overall Study|Withdrawal by Subject|1|||
16277870|NCT03493919|39497262|FG000|Overall Study|Lost to Follow-up|5|||
16475423|NCT04795622|40220716|FG001|Overall Study|Withdrawal by Subject|3|||
16277871|NCT03493919|39497263|FG001|Overall Study|Lost to Follow-up|0|||
16277872|NCT03493919|39497264|FG002|Overall Study|Lost to Follow-up|0|||
16277873|NCT03493919|39497265|FG003|Overall Study|Lost to Follow-up|3|||
16277874|NCT03493919|39497262|FG000|Overall Study|Adverse Event|0|||
16277875|NCT03493919|39497263|FG001|Overall Study|Adverse Event|1|||
16475424|NCT04795622|40220715|FG000|Overall Study|Protocol Violation|0|||
16475425|NCT04795622|40220716|FG001|Overall Study|Protocol Violation|2|||
16475426|NCT04795622|40220715|FG000|Overall Study|Lost to Follow-up|2|||
16277876|NCT03493919|39497264|FG002|Overall Study|Adverse Event|0|||
16277877|NCT03493919|39497265|FG003|Overall Study|Adverse Event|0|||
16277878|NCT02725515|39497271|FG000|Overall Study|Refused infusion (no study treatment)|1|||
16277879|NCT02725515|39497272|FG001|Overall Study|Refused infusion (no study treatment)|0|||
16475427|NCT04795622|40220716|FG001|Overall Study|Lost to Follow-up|3|||
16475428|NCT04795622|40220715|FG000|Overall Study|Other|7|||
16475429|NCT04795622|40220716|FG001|Overall Study|Other|8|||
16277880|NCT02725515|39497271|FG000|Overall Study|Loss of Improvement per Protocol|14|||
16277881|NCT02725515|39497272|FG001|Overall Study|Loss of Improvement per Protocol|25|||
16277882|NCT02725515|39497271|FG000|Overall Study|Withdrawal by Subject|2|||
16277883|NCT02725515|39497272|FG001|Overall Study|Withdrawal by Subject|1|||
16475430|NCT02634710|40220720|FG000|Overall Study|Death|4|||
16475431|NCT01104701|40220721|FG000|Overall Study|Withdrawal by Subject|0|||
16475432|NCT01104701|40220722|FG001|Overall Study|Withdrawal by Subject|1|||
16475433|NCT01104701|40220723|FG002|Overall Study|Withdrawal by Subject|2|||
16475434|NCT01104701|40220724|FG003|Overall Study|Withdrawal by Subject|1|||
16475435|NCT01104701|40220721|FG000|Overall Study|Adverse Event|0|||
16475436|NCT01104701|40220722|FG001|Overall Study|Adverse Event|0|||
16475437|NCT01104701|40220723|FG002|Overall Study|Adverse Event|0|||
16475438|NCT01104701|40220724|FG003|Overall Study|Adverse Event|1|||
16475439|NCT01104701|40220721|FG000|Overall Study|Physician Decision|0|||
16475440|NCT01104701|40220722|FG001|Overall Study|Physician Decision|2|||
16475441|NCT01104701|40220723|FG002|Overall Study|Physician Decision|0|||
16475442|NCT01104701|40220724|FG003|Overall Study|Physician Decision|0|||
16475443|NCT01347307|40220725|FG000|Overall Study|Death|0|||
16475444|NCT01347307|40220726|FG001|Overall Study|Death|4|||
16277884|NCT02725515|39497271|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16277885|NCT02725515|39497272|FG001|Overall Study|Non-Compliance With Study Drug|3|||
16277886|NCT02725515|39497271|FG000|Overall Study|Lost to Follow-up|1|||
16277887|NCT02725515|39497272|FG001|Overall Study|Lost to Follow-up|1|||
16475445|NCT01347307|40220725|FG000|Overall Study|Physician Decision|0|||
16475446|NCT01347307|40220726|FG001|Overall Study|Physician Decision|1|||
16475447|NCT00736957|40220732|FG000|Overall Study|Adverse Event|43|||
16475448|NCT00736957|40220732|FG000|Overall Study|Withdrawal by Subject|49|||
16475449|NCT00736957|40220732|FG000|Overall Study|violation of eligibility criteria|2|||
16475450|NCT00736957|40220732|FG000|Overall Study|did not attend hospital appointments|1|||
16475451|NCT00736957|40220732|FG000|Overall Study|not eligible for Treatment Period I|22|||
16475452|NCT00736957|40220732|FG000|Overall Study|Physician Decision|5|||
16475453|NCT02507973|40220733|FG000|Overall Study|Adverse Event|1|||
16475454|NCT02001181|40220735|FG000|Overall Study|Adverse Event|0|||
16475455|NCT02001181|40220736|FG001|Overall Study|Adverse Event|2|||
16475456|NCT02001181|40220735|FG000|Overall Study|Lost to Follow-up|1|||
16277888|NCT02725515|39497271|FG000|Overall Study|Adverse Event|7|||
16277889|NCT02725515|39497272|FG001|Overall Study|Adverse Event|2|||
16277890|NCT02725515|39497271|FG000|Overall Study|No Documented Disease Improvement|0|||
16277891|NCT02725515|39497272|FG001|Overall Study|No Documented Disease Improvement|1|||
16277892|NCT02725515|39497271|FG000|Overall Study|Completed Study Under Original Protocol|0|||
16277893|NCT02725515|39497272|FG001|Overall Study|Completed Study Under Original Protocol|1|||
16277894|NCT02725515|39497271|FG000|Overall Study|Lack of Response|0|||
16277895|NCT02725515|39497272|FG001|Overall Study|Lack of Response|1|||
16277896|NCT01721772|39497274|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
16277897|NCT01721772|39497275|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
16277898|NCT01721772|39497274|FG000|Pre-Treatment|Poor/non-compliance|0|||
16277899|NCT01721772|39497275|FG001|Pre-Treatment|Poor/non-compliance|1|||
16277900|NCT01721772|39497274|FG000|Pre-Treatment|Participant withdrew consent|0|||
16277901|NCT01721772|39497275|FG001|Pre-Treatment|Participant withdrew consent|1|||
16277902|NCT01721772|39497274|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
16475457|NCT02001181|40220736|FG001|Overall Study|Lost to Follow-up|0|||
16475458|NCT02001181|40220735|FG000|Overall Study|Withdrawal by Subject|0|||
16475459|NCT02001181|40220736|FG001|Overall Study|Withdrawal by Subject|1|||
16475460|NCT01092507|40220739|FG000|Overall Study|Withdrawal by Subject|2|||
16475461|NCT01092507|40220740|FG001|Overall Study|Withdrawal by Subject|0|||
16475462|NCT03894046|40220743|FG000|Overall Study|Protocol Violation|1|||
16475463|NCT03894046|40220744|FG001|Overall Study|Protocol Violation|0|||
16475464|NCT03894046|40220745|FG002|Overall Study|Protocol Violation|0|||
16475465|NCT03894046|40220743|FG000|Overall Study|Adverse Event|0|||
16475466|NCT03894046|40220744|FG001|Overall Study|Adverse Event|1|||
16475467|NCT03894046|40220745|FG002|Overall Study|Adverse Event|0|||
16475468|NCT03894046|40220743|FG000|Overall Study|Withdrawal by Subject|2|||
16277903|NCT01721772|39497275|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
16475469|NCT03894046|40220744|FG001|Overall Study|Withdrawal by Subject|3|||
16475470|NCT03894046|40220745|FG002|Overall Study|Withdrawal by Subject|1|||
16475471|NCT03894046|40220743|FG000|Overall Study|Death|15|||
16475472|NCT03894046|40220744|FG001|Overall Study|Death|21|||
16475473|NCT03894046|40220745|FG002|Overall Study|Death|4|||
16475474|NCT03894046|40220743|FG000|Overall Study|No growth of ABC|2|||
16475475|NCT03894046|40220744|FG001|Overall Study|No growth of ABC|1|||
16475476|NCT03894046|40220745|FG002|Overall Study|No growth of ABC|0|||
16475477|NCT03894046|40220743|FG000|Overall Study|Physician Decision|1|||
16475478|NCT03894046|40220744|FG001|Overall Study|Physician Decision|1|||
16475479|NCT03894046|40220745|FG002|Overall Study|Physician Decision|1|||
16475480|NCT03894046|40220743|FG000|Overall Study|Prohibited concomitant medication|1|||
16475481|NCT03894046|40220744|FG001|Overall Study|Prohibited concomitant medication|0|||
16475482|NCT03894046|40220745|FG002|Overall Study|Prohibited concomitant medication|0|||
16475483|NCT03894046|40220743|FG000|Overall Study|Transferred to other arm/group|1|||
16475484|NCT03894046|40220744|FG001|Overall Study|Transferred to other arm/group|1|||
16475485|NCT03894046|40220745|FG002|Overall Study|Transferred to other arm/group|0|||
16475486|NCT00333801|40220747|FG000|Overall Study|Moved to another state|5|||
16475487|NCT00333801|40220748|FG001|Overall Study|Moved to another state|3|||
16475488|NCT00333801|40220747|FG000|Overall Study|Lost to Follow-up|2|||
16475489|NCT00333801|40220748|FG001|Overall Study|Lost to Follow-up|0|||
16475490|NCT00333801|40220747|FG000|Overall Study|Incarcerated|1|||
16475491|NCT00333801|40220748|FG001|Overall Study|Incarcerated|2|||
16475492|NCT00333801|40220747|FG000|Overall Study|Withdrawal by Subject|0|||
16475493|NCT00333801|40220748|FG001|Overall Study|Withdrawal by Subject|1|||
16475494|NCT03589469|40220749|FG000|Overall Study|Withdrawal by Subject|8|||
16475495|NCT03589469|40220749|FG000|Overall Study|Physician Decision|20|||
16475496|NCT03589469|40220749|FG000|Overall Study|Death|97|||
16475497|NCT03589469|40220749|FG000|Overall Study|Lost to Follow-up|8|||
16475498|NCT03589469|40220749|FG000|Overall Study|Miscellaneous|1|||
16475499|NCT03917459|40220750|FG000|Overall Study|Adverse Event|1|||
16475500|NCT03917459|40220751|FG001|Overall Study|Adverse Event|0|||
16475501|NCT03917459|40220750|FG000|Overall Study|Withdrawal by Subject|0|||
16475502|NCT03917459|40220751|FG001|Overall Study|Withdrawal by Subject|1|||
16475503|NCT03848065|40220752|FG000|Overall Study|Death|0|||
16475504|NCT03848065|40220753|FG001|Overall Study|Death|1|||
16475505|NCT03848065|40220754|FG002|Overall Study|Death|0|||
16475506|NCT03848065|40220752|FG000|Overall Study|Lost to Follow-up|0|||
16475507|NCT03848065|40220753|FG001|Overall Study|Lost to Follow-up|0|||
16475508|NCT03848065|40220754|FG002|Overall Study|Lost to Follow-up|1|||
16475509|NCT03848065|40220752|FG000|Overall Study|Physician Decision|0|||
16475510|NCT03848065|40220753|FG001|Overall Study|Physician Decision|0|||
16475511|NCT03848065|40220754|FG002|Overall Study|Physician Decision|1|||
16475512|NCT02758171|40220757|FG000|Wash-out|Withdrawal by Subject|1|||
16475513|NCT02758171|40220758|FG001|Wash-out|Withdrawal by Subject|0|||
16475514|NCT02758171|40220757|FG000|Wash-out|Other reason|1|||
16475515|NCT02758171|40220758|FG001|Wash-out|Other reason|0|||
16475516|NCT02027376|40220760|FG000|Overall Study|Death|1|||
16475517|NCT02027376|40220761|FG001|Overall Study|Death|0|||
16475518|NCT02027376|40220762|FG002|Overall Study|Death|0|||
16475519|NCT02322021|40220766|FG000|Core Phase|Adverse Event|1|||
16475520|NCT02322021|40220767|FG001|Core Phase|Adverse Event|3|||
16475521|NCT02322021|40220768|FG002|Core Phase|Adverse Event|4|||
16475522|NCT02322021|40220769|FG003|Core Phase|Adverse Event|2|||
16475523|NCT02322021|40220770|FG004|Core Phase|Adverse Event|0|||
16475524|NCT02322021|40220766|FG000|Core Phase|Participant Choice|4|||
16475525|NCT02322021|40220767|FG001|Core Phase|Participant Choice|5|||
16475526|NCT02322021|40220768|FG002|Core Phase|Participant Choice|4|||
16475527|NCT02322021|40220769|FG003|Core Phase|Participant Choice|2|||
16475528|NCT02322021|40220770|FG004|Core Phase|Participant Choice|0|||
16475529|NCT02322021|40220766|FG000|Core Phase|Lost to Follow-up|0|||
16475530|NCT02322021|40220767|FG001|Core Phase|Lost to Follow-up|0|||
16475531|NCT02322021|40220768|FG002|Core Phase|Lost to Follow-up|0|||
16475532|NCT02322021|40220769|FG003|Core Phase|Lost to Follow-up|1|||
16475533|NCT02322021|40220770|FG004|Core Phase|Lost to Follow-up|0|||
16277904|NCT01721772|39497274|FG000|Treatment|Disease progression|119|||
16277905|NCT01721772|39497275|FG001|Treatment|Disease progression|168|||
16475534|NCT02322021|40220766|FG000|Core Phase|Other|0|||
16475535|NCT02322021|40220767|FG001|Core Phase|Other|0|||
16475536|NCT02322021|40220768|FG002|Core Phase|Other|1|||
16475537|NCT02322021|40220769|FG003|Core Phase|Other|0|||
16475538|NCT02322021|40220770|FG004|Core Phase|Other|0|||
16475539|NCT02322021|40220766|FG000|Extension Phase|Adverse Event|0|||
16475540|NCT02322021|40220767|FG001|Extension Phase|Adverse Event|0|||
16475541|NCT02322021|40220768|FG002|Extension Phase|Adverse Event|0|||
16277906|NCT01721772|39497274|FG000|Treatment|Study drug toxicity|19|||
16475542|NCT02322021|40220769|FG003|Extension Phase|Adverse Event|0|||
16475543|NCT02322021|40220770|FG004|Extension Phase|Adverse Event|3|||
16475544|NCT02322021|40220766|FG000|Extension Phase|Participant Choice|0|||
16475545|NCT02322021|40220767|FG001|Extension Phase|Participant Choice|0|||
16475546|NCT02322021|40220768|FG002|Extension Phase|Participant Choice|0|||
16475547|NCT02322021|40220769|FG003|Extension Phase|Participant Choice|0|||
16475548|NCT02322021|40220770|FG004|Extension Phase|Participant Choice|6|||
16475549|NCT02322021|40220766|FG000|Extension Phase|Other|0|||
16475550|NCT02322021|40220767|FG001|Extension Phase|Other|0|||
16475551|NCT02322021|40220768|FG002|Extension Phase|Other|0|||
16475552|NCT02322021|40220769|FG003|Extension Phase|Other|0|||
16475553|NCT02322021|40220770|FG004|Extension Phase|Other|3|||
16475554|NCT02322021|40220766|FG000|Extension Phase|Lost to Follow-up|0|||
16277907|NCT01721772|39497275|FG001|Treatment|Study drug toxicity|10|||
16277908|NCT01721772|39497274|FG000|Treatment|Adverse event unrelated to study drug|7|||
16277909|NCT01721772|39497275|FG001|Treatment|Adverse event unrelated to study drug|7|||
16277910|NCT01721772|39497274|FG000|Treatment|Maximum clinical benefit|16|||
16277911|NCT01721772|39497275|FG001|Treatment|Maximum clinical benefit|4|||
16277912|NCT01721772|39497274|FG000|Treatment|Other|19|||
16277913|NCT01721772|39497275|FG001|Treatment|Other|2|||
16277914|NCT01721772|39497274|FG000|Treatment|Participant withdrew consent|2|||
16277915|NCT01721772|39497275|FG001|Treatment|Participant withdrew consent|5|||
16277916|NCT01721772|39497274|FG000|Treatment|Participant request to discontinue study treatment|21|||
16277917|NCT01721772|39497275|FG001|Treatment|Participant request to discontinue study treatment|8|||
16277918|NCT01721772|39497274|FG000|Treatment|Death|1|||
16277919|NCT01721772|39497275|FG001|Treatment|Death|0|||
16277920|NCT01721772|39497274|FG000|Treatment|Not reported|1|||
16277921|NCT01721772|39497275|FG001|Treatment|Not reported|0|||
16277922|NCT01721772|39497274|FG000|Treatment|Poor/non-compliance|1|||
16277923|NCT01721772|39497275|FG001|Treatment|Poor/non-compliance|0|||
16277924|NCT01721772|39497274|FG000|Treatment|Lost to Follow-up|0|||
16277925|NCT01721772|39497275|FG001|Treatment|Lost to Follow-up|1|||
16277926|NCT00575380|39497276|FG000|Overall Study|Withdrawal by Subject|1|||
16277927|NCT00575380|39497277|FG001|Overall Study|Withdrawal by Subject|0|||
16277928|NCT00575380|39497276|FG000|Overall Study|Adverse Event|0|||
16277929|NCT00575380|39497277|FG001|Overall Study|Adverse Event|1|||
16277930|NCT00575380|39497276|FG000|Overall Study|Various|0|||
16277931|NCT00575380|39497277|FG001|Overall Study|Various|2|||
16277932|NCT00724958|39497278|FG000|Overall Study|Adverse Event|28|||
16277933|NCT00724958|39497278|FG000|Overall Study|Loss of Response|40|||
16277934|NCT00724958|39497278|FG000|Overall Study|No Response|18|||
16277935|NCT00724958|39497278|FG000|Overall Study|Remission|7|||
16277936|NCT00724958|39497278|FG000|Overall Study|Other Reason|76|||
16277937|NCT00724958|39497278|FG000|Overall Study|No documentation for end of therapy|13|||
16277938|NCT01341405|39500670|FG000|Overall Study|Adverse Event|0|||
16277939|NCT01341405|39500671|FG001|Overall Study|Adverse Event|1|||
16277940|NCT01341405|39500672|FG002|Overall Study|Adverse Event|1|||
16277941|NCT01341405|39500670|FG000|Overall Study|Withdrawal by Subject|3|||
16277942|NCT01341405|39500671|FG001|Overall Study|Withdrawal by Subject|2|||
16277943|NCT01341405|39500672|FG002|Overall Study|Withdrawal by Subject|1|||
16277944|NCT01989676|39500673|FG000|Overall Study|Death|52|||
16277945|NCT01989676|39500674|FG001|Overall Study|Death|60|||
16277946|NCT01989676|39500673|FG000|Overall Study|Protocol Violation|2|||
16277947|NCT01989676|39500674|FG001|Overall Study|Protocol Violation|1|||
16277948|NCT01989676|39500673|FG000|Overall Study|Lost to Follow-up|8|||
16277949|NCT01989676|39500674|FG001|Overall Study|Lost to Follow-up|18|||
16277950|NCT01989676|39500673|FG000|Overall Study|No longer willing to participate in study|26|||
16277951|NCT01989676|39500674|FG001|Overall Study|No longer willing to participate in study|26|||
16277952|NCT01989676|39500673|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
16277953|NCT01989676|39500674|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
16277954|NCT01989676|39500673|FG000|Overall Study|Other|4|||
16277955|NCT01989676|39500674|FG001|Overall Study|Other|3|||
16277956|NCT02289820|39500679|FG000|Overall Study|Withdrawal by Subject|2|||
16277957|NCT02289820|39500680|FG001|Overall Study|Withdrawal by Subject|1|||
16277958|NCT02289820|39500681|FG002|Overall Study|Withdrawal by Subject|2|||
16277959|NCT02289820|39500682|FG003|Overall Study|Withdrawal by Subject|1|||
16277960|NCT02289820|39500683|FG004|Overall Study|Withdrawal by Subject|0|||
16277961|NCT02289820|39500684|FG005|Overall Study|Withdrawal by Subject|0|||
16277962|NCT02289820|39500685|FG006|Overall Study|Withdrawal by Subject|1|||
16277963|NCT02289820|39500679|FG000|Overall Study|Death|0|||
16277964|NCT02289820|39500680|FG001|Overall Study|Death|0|||
16277965|NCT02289820|39500681|FG002|Overall Study|Death|1|||
16277966|NCT02289820|39500682|FG003|Overall Study|Death|0|||
16277967|NCT02289820|39500683|FG004|Overall Study|Death|0|||
16475555|NCT02322021|40220767|FG001|Extension Phase|Lost to Follow-up|0|||
16475556|NCT02322021|40220768|FG002|Extension Phase|Lost to Follow-up|0|||
16475557|NCT02322021|40220769|FG003|Extension Phase|Lost to Follow-up|0|||
16475558|NCT02322021|40220770|FG004|Extension Phase|Lost to Follow-up|1|||
16475559|NCT02322021|40220766|FG000|Extension Phase|Study terminated by sponsor|0|||
16475560|NCT02322021|40220767|FG001|Extension Phase|Study terminated by sponsor|0|||
16475561|NCT02322021|40220768|FG002|Extension Phase|Study terminated by sponsor|0|||
16475562|NCT02322021|40220769|FG003|Extension Phase|Study terminated by sponsor|0|||
16277968|NCT02289820|39500684|FG005|Overall Study|Death|0|||
16475563|NCT02322021|40220770|FG004|Extension Phase|Study terminated by sponsor|28|||
16475564|NCT03800173|40220771|FG000|Overall Study|Lost to Follow-up|0|||
16475565|NCT03800173|40220772|FG001|Overall Study|Lost to Follow-up|0|||
16277969|NCT02289820|39500685|FG006|Overall Study|Death|0|||
16277970|NCT02289820|39500679|FG000|Overall Study|Lost to Follow-up|0|||
16277971|NCT02289820|39500680|FG001|Overall Study|Lost to Follow-up|0|||
16277972|NCT02289820|39500681|FG002|Overall Study|Lost to Follow-up|3|||
16277973|NCT02289820|39500682|FG003|Overall Study|Lost to Follow-up|1|||
16277974|NCT02289820|39500683|FG004|Overall Study|Lost to Follow-up|0|||
16475566|NCT03800173|40220773|FG002|Overall Study|Lost to Follow-up|0|||
16475567|NCT03800173|40220774|FG003|Overall Study|Lost to Follow-up|0|||
16475568|NCT03800173|40220775|FG004|Overall Study|Lost to Follow-up|1|||
16475569|NCT02805972|40220778|FG000|Washout Period|Lost to Follow-up|3|||
16475570|NCT02805972|40220779|FG001|Washout Period|Lost to Follow-up|0|||
16475571|NCT01206166|40220780|FG000|Overall Study|No evaluable data|2|||
16475572|NCT01206166|40220781|FG001|Overall Study|No evaluable data|3|||
16475573|NCT02601027|40220782|FG000|Registration to Surgery|Withdrawal by Subject|20|||
16475574|NCT02601027|40220783|FG001|Registration to Surgery|Withdrawal by Subject|10|||
16475575|NCT00595465|40220784|FG000|Overall Study|Adverse Event|4|||
16475576|NCT00595465|40220785|FG001|Overall Study|Adverse Event|3|||
16475577|NCT00595465|40220786|FG002|Overall Study|Adverse Event|3|||
16475578|NCT00595465|40220784|FG000|Overall Study|Pregnancy|0|||
16475579|NCT00595465|40220785|FG001|Overall Study|Pregnancy|0|||
16277975|NCT02289820|39500684|FG005|Overall Study|Lost to Follow-up|1|||
16277976|NCT02289820|39500685|FG006|Overall Study|Lost to Follow-up|1|||
16277977|NCT02289820|39500679|FG000|Overall Study|withdrawal of consent|0|||
16277978|NCT02289820|39500680|FG001|Overall Study|withdrawal of consent|1|||
16277979|NCT02289820|39500681|FG002|Overall Study|withdrawal of consent|0|||
16277980|NCT02289820|39500682|FG003|Overall Study|withdrawal of consent|0|||
16277981|NCT02289820|39500683|FG004|Overall Study|withdrawal of consent|0|||
16277982|NCT02289820|39500684|FG005|Overall Study|withdrawal of consent|0|||
16277983|NCT02289820|39500685|FG006|Overall Study|withdrawal of consent|0|||
16277984|NCT01466036|39500690|FG000|Overall Study|Death|1|||
16277985|NCT01466036|39500691|FG001|Overall Study|Death|1|||
16277986|NCT01466036|39500690|FG000|Overall Study|Physician Decision|0|||
16277987|NCT01466036|39500691|FG001|Overall Study|Physician Decision|4|||
16475580|NCT00595465|40220786|FG002|Overall Study|Pregnancy|1|||
16475581|NCT00595465|40220784|FG000|Overall Study|Protocol Violation|2|||
16475582|NCT00595465|40220785|FG001|Overall Study|Protocol Violation|1|||
16475583|NCT00595465|40220786|FG002|Overall Study|Protocol Violation|0|||
16475584|NCT00595465|40220784|FG000|Overall Study|Lost to Follow-up|0|||
16475585|NCT00595465|40220785|FG001|Overall Study|Lost to Follow-up|0|||
16475586|NCT00595465|40220786|FG002|Overall Study|Lost to Follow-up|2|||
16475587|NCT00595465|40220784|FG000|Overall Study|administrative reason|0|||
16475588|NCT00595465|40220785|FG001|Overall Study|administrative reason|0|||
16475589|NCT00595465|40220786|FG002|Overall Study|administrative reason|1|||
16475590|NCT01146912|40220787|FG000|Overall Study|Already received influenza vaccination|817|||
16475591|NCT01146912|40220788|FG001|Overall Study|Already received influenza vaccination|822|||
16277988|NCT01466036|39500690|FG000|Overall Study|Adverse Event|2|||
16277989|NCT01466036|39500691|FG001|Overall Study|Adverse Event|6|||
16277990|NCT01466036|39500690|FG000|Overall Study|Withdrawal by Subject|2|||
16475592|NCT01146912|40220789|FG002|Overall Study|Already received influenza vaccination|13|||
16475593|NCT01146912|40220790|FG003|Overall Study|Already received influenza vaccination|15|||
16475594|NCT01146912|40220791|FG004|Overall Study|Already received influenza vaccination|41|||
16475595|NCT01146912|40220792|FG005|Overall Study|Already received influenza vaccination|61|||
16277991|NCT01466036|39500691|FG001|Overall Study|Withdrawal by Subject|8|||
16277992|NCT01466036|39500690|FG000|Overall Study|progression/relapse|14|||
16277993|NCT01466036|39500691|FG001|Overall Study|progression/relapse|21|||
16277994|NCT01466036|39500690|FG000|Overall Study|prolonged treatment delay|1|||
16277995|NCT01466036|39500691|FG001|Overall Study|prolonged treatment delay|1|||
16277996|NCT01691430|39500692|FG000|Overall Study|Death|17|||
16277997|NCT01691430|39500693|FG001|Overall Study|Death|16|||
16475596|NCT01146912|40220793|FG006|Overall Study|Already received influenza vaccination|56|||
16475597|NCT01146912|40220794|FG007|Overall Study|Already received influenza vaccination|0|||
16475598|NCT01146912|40220787|FG000|Overall Study|< 14 weeks gestational age|0|||
16475599|NCT01146912|40220788|FG001|Overall Study|< 14 weeks gestational age|0|||
16475600|NCT01146912|40220789|FG002|Overall Study|< 14 weeks gestational age|3|||
16277998|NCT01691430|39500692|FG000|Overall Study|Withdrawal by Subject|5|||
16475601|NCT01146912|40220790|FG003|Overall Study|< 14 weeks gestational age|2|||
16475602|NCT01146912|40220791|FG004|Overall Study|< 14 weeks gestational age|0|||
16475603|NCT01146912|40220792|FG005|Overall Study|< 14 weeks gestational age|0|||
16475604|NCT01146912|40220793|FG006|Overall Study|< 14 weeks gestational age|0|||
16475605|NCT01146912|40220794|FG007|Overall Study|< 14 weeks gestational age|0|||
16475606|NCT01146912|40220787|FG000|Overall Study|Duplicate patient|0|||
16475607|NCT01146912|40220788|FG001|Overall Study|Duplicate patient|0|||
16475608|NCT01146912|40220789|FG002|Overall Study|Duplicate patient|1|||
16475609|NCT01146912|40220790|FG003|Overall Study|Duplicate patient|0|||
16277999|NCT01691430|39500693|FG001|Overall Study|Withdrawal by Subject|1|||
16278000|NCT01691430|39500692|FG000|Overall Study|Lost to Follow-up|0|||
16278001|NCT01691430|39500693|FG001|Overall Study|Lost to Follow-up|3|||
16475610|NCT01146912|40220791|FG004|Overall Study|Duplicate patient|0|||
16278002|NCT02762994|39500694|FG000|Overall Study|Withdrawal by Subject|0|||
16278003|NCT02762994|39500695|FG001|Overall Study|Withdrawal by Subject|1|||
16278004|NCT02762994|39500696|FG002|Overall Study|Withdrawal by Subject|2|||
16278005|NCT02762994|39500697|FG003|Overall Study|Withdrawal by Subject|0|||
16278006|NCT02762994|39500694|FG000|Overall Study|Protocol Violation|1|||
16475611|NCT01146912|40220792|FG005|Overall Study|Duplicate patient|0|||
16475612|NCT01146912|40220793|FG006|Overall Study|Duplicate patient|0|||
16475613|NCT01146912|40220794|FG007|Overall Study|Duplicate patient|0|||
16475614|NCT02642029|40220795|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
16475615|NCT02642029|40220796|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
16475616|NCT02642029|40220797|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
16475617|NCT02642029|40220798|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
16475618|NCT02642029|40220799|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
16475619|NCT02642029|40220800|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
16475620|NCT02642029|40220795|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
16278007|NCT02762994|39500695|FG001|Overall Study|Protocol Violation|0|||
16278008|NCT02762994|39500696|FG002|Overall Study|Protocol Violation|0|||
16278009|NCT02762994|39500697|FG003|Overall Study|Protocol Violation|2|||
16278010|NCT01908205|39500698|FG000|Overall Study|Lost to Follow-up|2|||
16278011|NCT01908205|39500699|FG001|Overall Study|Lost to Follow-up|0|||
16278012|NCT01908205|39500698|FG000|Overall Study|Withdrawal by Subject|3|||
16278013|NCT01908205|39500699|FG001|Overall Study|Withdrawal by Subject|1|||
16475621|NCT02642029|40220796|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
16475622|NCT02642029|40220797|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
16475623|NCT02642029|40220798|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
16475624|NCT02642029|40220799|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
16475625|NCT02642029|40220800|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
16475626|NCT02642029|40220795|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
16475627|NCT02642029|40220796|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
16475628|NCT02642029|40220797|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
16475629|NCT02642029|40220798|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
16475630|NCT02642029|40220799|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
16475631|NCT02642029|40220800|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
16475632|NCT02642029|40220795|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
16475633|NCT02642029|40220796|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
16475634|NCT02642029|40220797|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
16278014|NCT01264835|39500702|FG000|Overall Study|Lost to Follow-up|1|||
16278015|NCT00880334|39500716|FG000|Randomized Phase|Physician Decision|1|||
16278016|NCT00880334|39500717|FG001|Randomized Phase|Physician Decision|0|||
16278017|NCT00880334|39500716|FG000|Randomized Phase|Withdrawal by Subject|2|||
16475635|NCT02642029|40220798|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
16475636|NCT02642029|40220799|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
16475637|NCT02642029|40220800|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
16475638|NCT02642029|40220795|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
16475639|NCT02642029|40220796|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
16475640|NCT02642029|40220797|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
16475641|NCT02642029|40220798|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
16475642|NCT02642029|40220799|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
16475643|NCT02642029|40220800|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
16475644|NCT02642029|40220795|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
16475645|NCT02642029|40220796|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
16475646|NCT02642029|40220797|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
16475647|NCT02642029|40220798|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
16475648|NCT02642029|40220799|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
16475649|NCT02642029|40220800|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
16475650|NCT01180634|40220802|FG000|Overall Study|Adverse Event|4|||
16475651|NCT01180634|40220803|FG001|Overall Study|Adverse Event|1|||
16475652|NCT01180634|40220802|FG000|Overall Study|Miscellaneous|2|||
16475653|NCT01180634|40220803|FG001|Overall Study|Miscellaneous|0|||
16475654|NCT01180634|40220802|FG000|Overall Study|Withdrawal by Subject|4|||
16475655|NCT01180634|40220803|FG001|Overall Study|Withdrawal by Subject|0|||
16475656|NCT02081183|40220804|FG000|Overall Study|Lost to Follow-up|0|||
16475657|NCT02081183|40220805|FG001|Overall Study|Lost to Follow-up|1|||
16475658|NCT02081183|40220804|FG000|Overall Study|Protocol Violation|1|||
16475659|NCT02081183|40220805|FG001|Overall Study|Protocol Violation|0|||
16475660|NCT02081183|40220804|FG000|Overall Study|Other|3|||
16475661|NCT02081183|40220805|FG001|Overall Study|Other|3|||
16475662|NCT04810481|40220807|FG000|Overall Study|Disqualified data sets|10|||
16475663|NCT04810481|40220808|FG001|Overall Study|Disqualified data sets|28|||
16475664|NCT03270644|40220811|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
16475665|NCT03270644|40220811|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
16475666|NCT01397201|40220812|FG000|Overall Study|Not treated|0|||
16475667|NCT01397201|40220813|FG001|Overall Study|Not treated|0|||
16278018|NCT00880334|39500717|FG001|Randomized Phase|Withdrawal by Subject|1|||
16278019|NCT00880334|39500716|FG000|Randomized Phase|Inadequate Labs|1|||
16278020|NCT00880334|39500717|FG001|Randomized Phase|Inadequate Labs|1|||
16475668|NCT01397201|40220814|FG002|Overall Study|Not treated|1|||
16475669|NCT01397201|40220815|FG003|Overall Study|Not treated|0|||
16475670|NCT01397201|40220816|FG004|Overall Study|Not treated|0|||
16475671|NCT01397201|40220812|FG000|Overall Study|Not yet defined|3|||
16475672|NCT01397201|40220813|FG001|Overall Study|Not yet defined|6|||
16475673|NCT01397201|40220814|FG002|Overall Study|Not yet defined|5|||
16475674|NCT01397201|40220815|FG003|Overall Study|Not yet defined|5|||
16475675|NCT01397201|40220816|FG004|Overall Study|Not yet defined|4|||
16475676|NCT01397201|40220812|FG000|Overall Study|Adverse Event|2|||
16475677|NCT01397201|40220813|FG001|Overall Study|Adverse Event|0|||
16475678|NCT01397201|40220814|FG002|Overall Study|Adverse Event|0|||
16475679|NCT01397201|40220815|FG003|Overall Study|Adverse Event|0|||
16475680|NCT01397201|40220816|FG004|Overall Study|Adverse Event|0|||
16475681|NCT00331422|40220818|FG000|Overall Study|Did not receive entire study regimen|5|||
16475682|NCT01262573|40220819|FG000|Overall Study|Withdrawal by Subject|0|||
16475683|NCT01262573|40220820|FG001|Overall Study|Withdrawal by Subject|1|||
16475684|NCT01066000|40220821|FG000|Overall Study|Protocol Violation|4|||
16475685|NCT01066000|40220821|FG000|Overall Study|Death|3|||
16475686|NCT01066000|40220821|FG000|Overall Study|Withdrawal by Subject|1|||
16475687|NCT01066000|40220821|FG000|Overall Study|Adverse Event|1|||
16475688|NCT01251744|40220822|FG000|Overall Study|Lost to Follow-up|1|||
16475689|NCT01251744|40220823|FG001|Overall Study|Lost to Follow-up|0|||
16475690|NCT01822678|40220824|FG000|Overall Study|Withdrawal by Subject|5|||
16475691|NCT01822678|40220825|FG001|Overall Study|Withdrawal by Subject|4|||
16475692|NCT01822678|40220826|FG002|Overall Study|Withdrawal by Subject|4|||
16475693|NCT01822678|40220824|FG000|Overall Study|Adverse Event|4|||
16475694|NCT01822678|40220825|FG001|Overall Study|Adverse Event|3|||
16475695|NCT01822678|40220826|FG002|Overall Study|Adverse Event|1|||
16475696|NCT01822678|40220824|FG000|Overall Study|Lack of Efficacy|3|||
16475697|NCT01822678|40220825|FG001|Overall Study|Lack of Efficacy|6|||
16475698|NCT01822678|40220826|FG002|Overall Study|Lack of Efficacy|5|||
16475699|NCT01822678|40220824|FG000|Overall Study|Lost to Follow-up|0|||
16475700|NCT01822678|40220825|FG001|Overall Study|Lost to Follow-up|2|||
16475701|NCT01822678|40220826|FG002|Overall Study|Lost to Follow-up|1|||
16475702|NCT03605212|40220827|FG000|Treatment Period|Adverse Event|1|||
16475703|NCT03605212|40220828|FG001|Treatment Period|Adverse Event|0|||
16475704|NCT03605212|40220829|FG002|Treatment Period|Adverse Event|0|||
16475705|NCT03605212|40220830|FG003|Treatment Period|Adverse Event|0|||
16475706|NCT03605212|40220831|FG004|Treatment Period|Adverse Event|0|||
16475707|NCT03605212|40220827|FG000|Treatment Period|Physician Decision|0|||
16475708|NCT03605212|40220828|FG001|Treatment Period|Physician Decision|0|||
16475709|NCT03605212|40220829|FG002|Treatment Period|Physician Decision|0|||
16475710|NCT03605212|40220830|FG003|Treatment Period|Physician Decision|0|||
16475711|NCT03605212|40220831|FG004|Treatment Period|Physician Decision|1|||
16475712|NCT02609828|40220832|FG000|Overall Study|Adverse Event|8|||
16475713|NCT02609828|40220833|FG001|Overall Study|Adverse Event|1|||
16475714|NCT02609828|40220834|FG002|Overall Study|Adverse Event|0|||
16475715|NCT02609828|40220835|FG003|Overall Study|Adverse Event|6|||
16475716|NCT02609828|40220832|FG000|Overall Study|Death|15|||
16475717|NCT02609828|40220833|FG001|Overall Study|Death|1|||
16475718|NCT02609828|40220834|FG002|Overall Study|Death|1|||
16475719|NCT02609828|40220835|FG003|Overall Study|Death|19|||
16475720|NCT02609828|40220832|FG000|Overall Study|Insufficient clinical response|2|||
16475721|NCT02609828|40220833|FG001|Overall Study|Insufficient clinical response|1|||
16475722|NCT02609828|40220834|FG002|Overall Study|Insufficient clinical response|0|||
16475723|NCT02609828|40220835|FG003|Overall Study|Insufficient clinical response|0|||
16475724|NCT02609828|40220832|FG000|Overall Study|Lost to Follow-up|0|||
16475725|NCT02609828|40220833|FG001|Overall Study|Lost to Follow-up|0|||
16475726|NCT02609828|40220834|FG002|Overall Study|Lost to Follow-up|0|||
16475727|NCT02609828|40220835|FG003|Overall Study|Lost to Follow-up|1|||
16475728|NCT02609828|40220832|FG000|Overall Study|Protocol Violation|2|||
16475729|NCT02609828|40220833|FG001|Overall Study|Protocol Violation|0|||
16475730|NCT02609828|40220834|FG002|Overall Study|Protocol Violation|0|||
16475731|NCT02609828|40220835|FG003|Overall Study|Protocol Violation|1|||
16475732|NCT02609828|40220832|FG000|Overall Study|Withdrawal by Subject|12|||
16475733|NCT02609828|40220833|FG001|Overall Study|Withdrawal by Subject|1|||
16475734|NCT02609828|40220834|FG002|Overall Study|Withdrawal by Subject|0|||
16475735|NCT02609828|40220835|FG003|Overall Study|Withdrawal by Subject|10|||
16475736|NCT02609828|40220832|FG000|Overall Study|Other|3|||
16475737|NCT02609828|40220833|FG001|Overall Study|Other|0|||
16475738|NCT02609828|40220834|FG002|Overall Study|Other|0|||
16475739|NCT02609828|40220835|FG003|Overall Study|Other|6|||
16475740|NCT02609828|40220832|FG000|Overall Study|Randomized but not treated|1|||
16475741|NCT02609828|40220833|FG001|Overall Study|Randomized but not treated|0|||
16475742|NCT02609828|40220834|FG002|Overall Study|Randomized but not treated|0|||
16475743|NCT02609828|40220835|FG003|Overall Study|Randomized but not treated|0|||
16475744|NCT00771316|40220836|FG000|Overall Study|Adverse Event|0|||
16475745|NCT00771316|40220837|FG001|Overall Study|Adverse Event|1|||
16475746|NCT00771316|40220836|FG000|Overall Study|Patient withdrew consent|1|||
16475747|NCT00771316|40220837|FG001|Overall Study|Patient withdrew consent|0|||
16475748|NCT00771316|40220836|FG000|Overall Study|Discontinued due to early termination|1|||
16475749|NCT00771316|40220837|FG001|Overall Study|Discontinued due to early termination|0|||
16475750|NCT03575897|40220838|FG000|Overall Study|Lost to Follow-up|12|||
16475751|NCT03575897|40220839|FG001|Overall Study|Lost to Follow-up|13|||
16475752|NCT01051466|40220840|FG000|Overall Study|Adverse Event|1|||
16475753|NCT01051466|40220841|FG001|Overall Study|Adverse Event|0|||
16475754|NCT01051466|40220840|FG000|Overall Study|Lost to Follow-up|1|||
16475755|NCT01051466|40220841|FG001|Overall Study|Lost to Follow-up|1|||
16475756|NCT01051466|40220840|FG000|Overall Study|Withdrawal by Subject|5|||
16475757|NCT01051466|40220841|FG001|Overall Study|Withdrawal by Subject|1|||
16475758|NCT01051466|40220840|FG000|Overall Study|Entry Criteria Not Met|0|||
16475759|NCT01051466|40220841|FG001|Overall Study|Entry Criteria Not Met|3|||
16475760|NCT01051466|40220840|FG000|Overall Study|Physician Decision|1|||
16475761|NCT01051466|40220841|FG001|Overall Study|Physician Decision|0|||
16475762|NCT00354744|40220842|FG000|Overall Study|Adverse Event|2|||
16475763|NCT00354744|40220842|FG000|Overall Study|Death|2|||
16475764|NCT00354744|40220842|FG000|Overall Study|Lack of Efficacy|11|||
16475765|NCT00354744|40220842|FG000|Overall Study|Lost to Follow-up|2|||
16475766|NCT00354744|40220842|FG000|Overall Study|Physician Decision|11|||
16475767|NCT00354744|40220842|FG000|Overall Study|Withdrawal by Subject|14|||
16475768|NCT00467857|40220850|FG000|Overall Study|Adverse Event|1|||
16475769|NCT00467857|40220851|FG001|Overall Study|Adverse Event|0|||
16475770|NCT00467857|40220850|FG000|Overall Study|Withdrew consent|2|||
16475771|NCT00467857|40220851|FG001|Overall Study|Withdrew consent|0|||
16475772|NCT00467857|40220850|FG000|Overall Study|Death|0|||
16475773|NCT00467857|40220851|FG001|Overall Study|Death|1|||
16475774|NCT00467857|40220850|FG000|Overall Study|Discharged from court service|0|||
16475775|NCT00467857|40220851|FG001|Overall Study|Discharged from court service|1|||
16475776|NCT00467857|40220850|FG000|Overall Study|Emergency care required|0|||
16475777|NCT00467857|40220851|FG001|Overall Study|Emergency care required|1|||
16475778|NCT00467857|40220850|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
16475779|NCT00467857|40220851|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
16475780|NCT00467857|40220850|FG000|Overall Study|Discontinuation reason missing|0|||
16475781|NCT00467857|40220851|FG001|Overall Study|Discontinuation reason missing|3|||
16475782|NCT02423109|40223431|FG000|Lens 1|Adverse Event|1|||
16475783|NCT02423109|40223432|FG001|Lens 1|Adverse Event|0|||
16475784|NCT00735254|40223433|FG000|Overall Study|Protocol Violation|1|||
16475785|NCT00735254|40223434|FG001|Overall Study|Protocol Violation|1|||
16475786|NCT00735254|40223435|FG002|Overall Study|Protocol Violation|1|||
16475787|NCT00735254|40223436|FG003|Overall Study|Protocol Violation|0|||
16475788|NCT02639546|40223441|FG000|Overall Study|Death|2|||
16475789|NCT02639546|40223442|FG001|Overall Study|Death|2|||
16475790|NCT02639546|40223443|FG002|Overall Study|Death|1|||
16475791|NCT02639546|40223444|FG003|Overall Study|Death|2|||
16475792|NCT02639546|40223445|FG004|Overall Study|Death|2|||
16475793|NCT02639546|40223446|FG005|Overall Study|Death|2|||
16475794|NCT02639546|40223447|FG006|Overall Study|Death|0|||
16475795|NCT02639546|40223448|FG007|Overall Study|Death|0|||
16475796|NCT02639546|40223441|FG000|Overall Study|Lost to Follow-up|0|||
16475797|NCT02639546|40223442|FG001|Overall Study|Lost to Follow-up|0|||
16475798|NCT02639546|40223443|FG002|Overall Study|Lost to Follow-up|1|||
16475799|NCT02639546|40223444|FG003|Overall Study|Lost to Follow-up|0|||
16475800|NCT02639546|40223445|FG004|Overall Study|Lost to Follow-up|1|||
16475801|NCT02639546|40223446|FG005|Overall Study|Lost to Follow-up|1|||
16475802|NCT02639546|40223447|FG006|Overall Study|Lost to Follow-up|0|||
16475803|NCT02639546|40223448|FG007|Overall Study|Lost to Follow-up|1|||
16475804|NCT02639546|40223441|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
16475805|NCT02639546|40223442|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
16475806|NCT02639546|40223443|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
16475807|NCT02639546|40223444|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
16475808|NCT02639546|40223445|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
16475809|NCT02639546|40223446|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
16475810|NCT02639546|40223447|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
16475811|NCT02639546|40223448|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
16475812|NCT02639546|40223441|FG000|Overall Study|Study Terminated By Sponsor|0|||
16475813|NCT02639546|40223442|FG001|Overall Study|Study Terminated By Sponsor|2|||
16475814|NCT02639546|40223443|FG002|Overall Study|Study Terminated By Sponsor|3|||
16475815|NCT02639546|40223444|FG003|Overall Study|Study Terminated By Sponsor|4|||
16475816|NCT02639546|40223445|FG004|Overall Study|Study Terminated By Sponsor|4|||
16475817|NCT02639546|40223446|FG005|Overall Study|Study Terminated By Sponsor|3|||
16475818|NCT02639546|40223447|FG006|Overall Study|Study Terminated By Sponsor|3|||
16475819|NCT02639546|40223448|FG007|Overall Study|Study Terminated By Sponsor|9|||
16475820|NCT02639546|40223441|FG000|Overall Study|Withdrawal by Subject|2|||
16475821|NCT02639546|40223442|FG001|Overall Study|Withdrawal by Subject|2|||
16475822|NCT02639546|40223443|FG002|Overall Study|Withdrawal by Subject|1|||
16475823|NCT02639546|40223444|FG003|Overall Study|Withdrawal by Subject|0|||
16475824|NCT02639546|40223445|FG004|Overall Study|Withdrawal by Subject|0|||
16475825|NCT02639546|40223446|FG005|Overall Study|Withdrawal by Subject|1|||
16475826|NCT02639546|40223447|FG006|Overall Study|Withdrawal by Subject|2|||
16475827|NCT02639546|40223448|FG007|Overall Study|Withdrawal by Subject|1|||
16475828|NCT02955797|40223449|FG000|Overall Study|Protocol Violation|1|||
16475829|NCT02955797|40223450|FG001|Overall Study|Protocol Violation|0|||
16475830|NCT02955797|40223451|FG002|Overall Study|Protocol Violation|0|||
16475831|NCT02955797|40223452|FG003|Overall Study|Protocol Violation|1|||
16475832|NCT02955797|40223449|FG000|Overall Study|Withdrawal by Subject|2|||
16475833|NCT02955797|40223450|FG001|Overall Study|Withdrawal by Subject|2|||
16475834|NCT02955797|40223451|FG002|Overall Study|Withdrawal by Subject|0|||
16475835|NCT02955797|40223452|FG003|Overall Study|Withdrawal by Subject|1|||
16475836|NCT02955797|40223449|FG000|Overall Study|Lost to Follow-up|0|||
16475837|NCT02955797|40223450|FG001|Overall Study|Lost to Follow-up|1|||
16475838|NCT02955797|40223451|FG002|Overall Study|Lost to Follow-up|0|||
16475839|NCT02955797|40223452|FG003|Overall Study|Lost to Follow-up|0|||
16475840|NCT04357782|40223453|FG000|Overall Study|Discharged from hospital|1|||
16475841|NCT04357782|40223454|FG001|Overall Study|Discharged from hospital|0|||
16475842|NCT04357782|40223453|FG000|Overall Study|Death|0|||
16475843|NCT04357782|40223454|FG001|Overall Study|Death|2|||
16475844|NCT02410551|40223455|FG000|Overall Study|Adverse Event|1|||
16475845|NCT02410551|40223455|FG000|Overall Study|Withdrawal by Subject|1|||
16475846|NCT02410551|40223455|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
16475847|NCT00002651|40223456|FG000|Induction|Adverse Event|44|||
16475848|NCT00002651|40223457|FG001|Induction|Adverse Event|0|||
16475849|NCT00002651|40223458|FG002|Induction|Adverse Event|0|||
16475850|NCT00002651|40223456|FG000|Induction|Refusal unrelated to adverse event|50|||
16475851|NCT00002651|40223457|FG001|Induction|Refusal unrelated to adverse event|0|||
16475852|NCT00002651|40223458|FG002|Induction|Refusal unrelated to adverse event|0|||
16475853|NCT00002651|40223456|FG000|Induction|Progression/relapse|274|||
16475854|NCT00002651|40223457|FG001|Induction|Progression/relapse|0|||
16475855|NCT00002651|40223458|FG002|Induction|Progression/relapse|0|||
16475856|NCT00002651|40223456|FG000|Induction|Death|62|||
16475857|NCT00002651|40223457|FG001|Induction|Death|0|||
16475858|NCT00002651|40223458|FG002|Induction|Death|0|||
16475859|NCT00002651|40223456|FG000|Induction|Other|823|||
16475860|NCT00002651|40223457|FG001|Induction|Other|0|||
16475861|NCT00002651|40223458|FG002|Induction|Other|0|||
16475862|NCT00002651|40223456|FG000|Induction|not eligible|90|||
16475863|NCT00002651|40223457|FG001|Induction|not eligible|0|||
16475864|NCT00002651|40223458|FG002|Induction|not eligible|0|||
16475865|NCT00002651|40223456|FG000|Consolidation and Randomization|Adverse Event|0|||
16475866|NCT00002651|40223457|FG001|Consolidation and Randomization|Adverse Event|36|||
16475867|NCT00002651|40223458|FG002|Consolidation and Randomization|Adverse Event|14|||
16475868|NCT00002651|40223456|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
16475869|NCT00002651|40223457|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
16475870|NCT00002651|40223458|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
16475871|NCT00002651|40223456|FG000|Consolidation and Randomization|Progression/relapse|0|||
16475872|NCT00002651|40223457|FG001|Consolidation and Randomization|Progression/relapse|295|||
16278021|NCT00880334|39500716|FG000|Randomized Phase|Brain Metastasis|0|||
16278022|NCT00880334|39500717|FG001|Randomized Phase|Brain Metastasis|1|||
16278023|NCT00880334|39500716|FG000|Randomized Phase|Crossover Participants|0|||
16278024|NCT00880334|39500717|FG001|Randomized Phase|Crossover Participants|37|||
16278025|NCT04230876|39500718|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
16278026|NCT04230876|39500719|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
16475873|NCT00002651|40223458|FG002|Consolidation and Randomization|Progression/relapse|298|||
16475874|NCT00002651|40223456|FG000|Consolidation and Randomization|Death|0|||
16475875|NCT00002651|40223457|FG001|Consolidation and Randomization|Death|38|||
16475876|NCT00002651|40223458|FG002|Consolidation and Randomization|Death|48|||
16475877|NCT00002651|40223456|FG000|Consolidation and Randomization|Other|0|||
16475878|NCT00002651|40223457|FG001|Consolidation and Randomization|Other|314|||
16475879|NCT00002651|40223458|FG002|Consolidation and Randomization|Other|313|||
16475880|NCT00002651|40223456|FG000|Consolidation and Randomization|not eligible|0|||
16475881|NCT00002651|40223457|FG001|Consolidation and Randomization|not eligible|102|||
16475882|NCT00002651|40223458|FG002|Consolidation and Randomization|not eligible|112|||
16475883|NCT01303861|40223459|FG000|Overall Study|Lost to Follow-up|34|||
16475884|NCT01303861|40223460|FG001|Overall Study|Lost to Follow-up|14|||
16475885|NCT01303861|40223461|FG002|Overall Study|Lost to Follow-up|27|||
16475886|NCT01303861|40223462|FG003|Overall Study|Lost to Follow-up|31|||
16475887|NCT01303861|40223459|FG000|Overall Study|Lack of Efficacy|3|||
16475888|NCT01303861|40223460|FG001|Overall Study|Lack of Efficacy|2|||
16475889|NCT01303861|40223461|FG002|Overall Study|Lack of Efficacy|1|||
16475890|NCT01303861|40223462|FG003|Overall Study|Lack of Efficacy|0|||
16475891|NCT01303861|40223459|FG000|Overall Study|Withdrawal by Subject|16|||
16475892|NCT01303861|40223460|FG001|Overall Study|Withdrawal by Subject|8|||
16475893|NCT01303861|40223461|FG002|Overall Study|Withdrawal by Subject|8|||
16475894|NCT01303861|40223462|FG003|Overall Study|Withdrawal by Subject|23|||
16475895|NCT01303861|40223459|FG000|Overall Study|Adverse Event|4|||
16475896|NCT01303861|40223460|FG001|Overall Study|Adverse Event|1|||
16475897|NCT01303861|40223461|FG002|Overall Study|Adverse Event|0|||
16475898|NCT01303861|40223462|FG003|Overall Study|Adverse Event|5|||
16475899|NCT01303861|40223459|FG000|Overall Study|Pregnancy|1|||
16475900|NCT01303861|40223460|FG001|Overall Study|Pregnancy|0|||
16475901|NCT01303861|40223461|FG002|Overall Study|Pregnancy|0|||
16475902|NCT01303861|40223462|FG003|Overall Study|Pregnancy|0|||
16475903|NCT01555983|40223463|FG000|Overall Study|Withdrawal by Subject|1|||
16475904|NCT01555983|40223464|FG001|Overall Study|Withdrawal by Subject|0|||
16475905|NCT01555983|40223465|FG002|Overall Study|Withdrawal by Subject|0|||
16076461|NCT01713946|38773247|FG002|Overall Study|Withdrawal by Subject|8|||
16475906|NCT01555983|40223466|FG003|Overall Study|Withdrawal by Subject|0|||
16475907|NCT01555983|40223467|FG004|Overall Study|Withdrawal by Subject|1|||
16475908|NCT01555983|40223468|FG005|Overall Study|Withdrawal by Subject|1|||
16475909|NCT01309165|40223471|FG000|Overall Study|Lost to Follow-up|4|||
16475910|NCT01309165|40223472|FG001|Overall Study|Lost to Follow-up|3|||
16475911|NCT01309165|40223471|FG000|Overall Study|Return to work|1|||
16475912|NCT01309165|40223472|FG001|Overall Study|Return to work|2|||
16475913|NCT01309165|40223471|FG000|Overall Study|Left country|0|||
16475914|NCT01309165|40223472|FG001|Overall Study|Left country|1|||
16475915|NCT01309165|40223471|FG000|Overall Study|No transportation|0|||
16475916|NCT01309165|40223472|FG001|Overall Study|No transportation|1|||
16475917|NCT01309165|40223471|FG000|Overall Study|Admitted to hospital for second stroke|1|||
16475918|NCT01309165|40223472|FG001|Overall Study|Admitted to hospital for second stroke|0|||
16475919|NCT03212690|40223473|FG000|Overall Study|Protocol Violation|1|||
16475920|NCT00669396|40223479|FG000|Overall Study|Lost to Follow-up|10|||
16475921|NCT00669396|40223480|FG001|Overall Study|Lost to Follow-up|12|||
16475922|NCT00932126|40223481|FG000|Overall Study|Adverse Event|0|||
16475923|NCT00932126|40223482|FG001|Overall Study|Adverse Event|0|||
16475924|NCT00932126|40223483|FG002|Overall Study|Adverse Event|0|||
16475925|NCT00932126|40223484|FG003|Overall Study|Adverse Event|0|||
16475926|NCT00932126|40223485|FG004|Overall Study|Adverse Event|0|||
16475927|NCT00932126|40223486|FG005|Overall Study|Adverse Event|0|||
16475928|NCT00932126|40223487|FG006|Overall Study|Adverse Event|1|||
16475929|NCT00932126|40223488|FG007|Overall Study|Adverse Event|2|||
16475930|NCT00932126|40223481|FG000|Overall Study|Protocol Violation|0|||
16475931|NCT00932126|40223482|FG001|Overall Study|Protocol Violation|0|||
16475932|NCT00932126|40223483|FG002|Overall Study|Protocol Violation|0|||
16475933|NCT00932126|40223484|FG003|Overall Study|Protocol Violation|0|||
16475934|NCT00932126|40223485|FG004|Overall Study|Protocol Violation|1|||
16475935|NCT00932126|40223486|FG005|Overall Study|Protocol Violation|0|||
16475936|NCT00932126|40223487|FG006|Overall Study|Protocol Violation|0|||
16475937|NCT00932126|40223488|FG007|Overall Study|Protocol Violation|0|||
16475938|NCT00932126|40223481|FG000|Overall Study|Withdrawal by Subject|0|||
16475939|NCT00932126|40223482|FG001|Overall Study|Withdrawal by Subject|0|||
16475940|NCT00932126|40223483|FG002|Overall Study|Withdrawal by Subject|1|||
16475941|NCT00932126|40223484|FG003|Overall Study|Withdrawal by Subject|0|||
16475942|NCT00932126|40223485|FG004|Overall Study|Withdrawal by Subject|0|||
16475943|NCT00932126|40223486|FG005|Overall Study|Withdrawal by Subject|0|||
16475944|NCT00932126|40223487|FG006|Overall Study|Withdrawal by Subject|0|||
16475945|NCT00932126|40223488|FG007|Overall Study|Withdrawal by Subject|1|||
16475946|NCT00932126|40223481|FG000|Overall Study|Objective progression or relapse|3|||
16475947|NCT00932126|40223482|FG001|Overall Study|Objective progression or relapse|3|||
16475948|NCT00932126|40223483|FG002|Overall Study|Objective progression or relapse|2|||
16475949|NCT00932126|40223484|FG003|Overall Study|Objective progression or relapse|3|||
16475950|NCT00932126|40223485|FG004|Overall Study|Objective progression or relapse|3|||
16475951|NCT00932126|40223486|FG005|Overall Study|Objective progression or relapse|3|||
16475952|NCT00932126|40223487|FG006|Overall Study|Objective progression or relapse|3|||
16475953|NCT00932126|40223488|FG007|Overall Study|Objective progression or relapse|5|||
16475954|NCT00932126|40223481|FG000|Overall Study|Other|0|||
16475955|NCT00932126|40223482|FG001|Overall Study|Other|0|||
16475956|NCT00932126|40223483|FG002|Overall Study|Other|0|||
16475957|NCT00932126|40223484|FG003|Overall Study|Other|0|||
16475958|NCT00932126|40223485|FG004|Overall Study|Other|1|||
16475959|NCT00932126|40223486|FG005|Overall Study|Other|0|||
16475960|NCT00932126|40223487|FG006|Overall Study|Other|1|||
16475961|NCT00932126|40223488|FG007|Overall Study|Other|2|||
16475962|NCT00747461|40223489|FG000|Overall Study|study terminated by sponsor|5|||
16475963|NCT04879225|40223490|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
16475964|NCT04879225|40223490|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
16475965|NCT05246397|40223491|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
16475966|NCT01626495|40223493|FG000|Overall Study|Adverse Event|3|||
16475967|NCT01626495|40223493|FG000|Overall Study|Disease progression|27|||
16475968|NCT01626495|40223493|FG000|Overall Study|Withdrawal by Subject|1|||
16475969|NCT01626495|40223493|FG000|Overall Study|Administrative problem|1|||
16475970|NCT01626495|40223493|FG000|Overall Study|Death|2|||
16475971|NCT01626495|40223493|FG000|Overall Study|Physician Decision|1|||
16475972|NCT01626495|40223493|FG000|Overall Study|New cancer therapy|16|||
16475973|NCT01626495|40223493|FG000|Overall Study|Manufacturing failure|1|||
16475974|NCT01123850|40223494|FG000|Overall Study|Slow enrollment|45|||
16475975|NCT01898208|40223498|FG000|Overall Study|Positive blood culture|17|||
16475976|NCT01898208|40223499|FG001|Overall Study|Positive blood culture|23|||
16475977|NCT01898208|40223500|FG002|Overall Study|Positive blood culture|15|||
16475978|NCT01898208|40223498|FG000|Overall Study|Death/comfort care within 24 hours|10|||
16475979|NCT01898208|40223499|FG001|Overall Study|Death/comfort care within 24 hours|9|||
16475980|NCT01898208|40223500|FG002|Overall Study|Death/comfort care within 24 hours|8|||
16475981|NCT01898208|40223498|FG000|Overall Study|Negative Gram Stain|6|||
16475982|NCT01898208|40223499|FG001|Overall Study|Negative Gram Stain|9|||
16475983|NCT01898208|40223500|FG002|Overall Study|Negative Gram Stain|6|||
16475984|NCT01898208|40223498|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
16475985|NCT01898208|40223499|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
16475986|NCT01898208|40223500|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
16475987|NCT01898208|40223498|FG000|Overall Study|System/Technical Error|1|||
16475988|NCT01898208|40223499|FG001|Overall Study|System/Technical Error|2|||
16475989|NCT01898208|40223500|FG002|Overall Study|System/Technical Error|3|||
16475990|NCT01898208|40223498|FG000|Overall Study|Lost to Follow-up|3|||
16475991|NCT01898208|40223499|FG001|Overall Study|Lost to Follow-up|1|||
16475992|NCT01898208|40223500|FG002|Overall Study|Lost to Follow-up|1|||
16475993|NCT01680965|40223502|FG000|Overall Study|Death|0|||
16475994|NCT01680965|40223503|FG001|Overall Study|Death|0|||
16475995|NCT01680965|40223504|FG002|Overall Study|Death|0|||
16475996|NCT01680965|40223505|FG003|Overall Study|Death|6|||
16475997|NCT01986907|40223506|FG000|Overall Study|Adverse Event|11|||
16475998|NCT01986907|40223506|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
16475999|NCT01986907|40223506|FG000|Overall Study|Protocol Violation|4|||
16476000|NCT01986907|40223506|FG000|Overall Study|Withdrawal by Subject|76|||
16476001|NCT01986907|40223506|FG000|Overall Study|Lost to Follow-up|38|||
16476002|NCT01986907|40223506|FG000|Overall Study|Death|9|||
16476003|NCT03403374|40223507|FG000|Overall Study|Lost to Follow-up|1|||
16476004|NCT00066365|40223508|FG000|Overall Study|Adverse Event|1|||
16476005|NCT00066365|40223509|FG001|Overall Study|Adverse Event|0|||
16476006|NCT00066365|40223508|FG000|Overall Study|Lack of Efficacy|15|||
16476007|NCT00066365|40223509|FG001|Overall Study|Lack of Efficacy|12|||
16476008|NCT00066365|40223508|FG000|Overall Study|Physician Decision|1|||
16476009|NCT00066365|40223509|FG001|Overall Study|Physician Decision|0|||
16476010|NCT00066365|40223508|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
16476011|NCT00066365|40223509|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
16476012|NCT00066365|40223508|FG000|Overall Study|Ineligible|4|||
16476013|NCT00066365|40223509|FG001|Overall Study|Ineligible|2|||
16476014|NCT02247531|40223512|FG000|Overall Study|Adverse Event|3|||
16476015|NCT02247531|40223513|FG001|Overall Study|Adverse Event|4|||
16476016|NCT02247531|40223514|FG002|Overall Study|Adverse Event|9|||
16476017|NCT02247531|40223512|FG000|Overall Study|Death|8|||
16476018|NCT02247531|40223513|FG001|Overall Study|Death|9|||
16476019|NCT02247531|40223514|FG002|Overall Study|Death|5|||
16476020|NCT02247531|40223512|FG000|Overall Study|Lost to Follow-up|1|||
16476021|NCT02247531|40223513|FG001|Overall Study|Lost to Follow-up|8|||
16476022|NCT02247531|40223514|FG002|Overall Study|Lost to Follow-up|3|||
16476023|NCT02247531|40223512|FG000|Overall Study|Non-compliance|2|||
16476024|NCT02247531|40223513|FG001|Overall Study|Non-compliance|2|||
16476025|NCT02247531|40223514|FG002|Overall Study|Non-compliance|0|||
16476026|NCT02247531|40223512|FG000|Overall Study|Withdrawal by Subject|26|||
16476027|NCT02247531|40223513|FG001|Overall Study|Withdrawal by Subject|31|||
16476028|NCT02247531|40223514|FG002|Overall Study|Withdrawal by Subject|25|||
16476029|NCT02247531|40223512|FG000|Overall Study|Study Terminated by Sponsor|64|||
16476030|NCT02247531|40223513|FG001|Overall Study|Study Terminated by Sponsor|66|||
16476031|NCT02247531|40223514|FG002|Overall Study|Study Terminated by Sponsor|62|||
16476032|NCT02247531|40223512|FG000|Overall Study|Physician Decision|0|||
16476033|NCT02247531|40223513|FG001|Overall Study|Physician Decision|2|||
16476034|NCT02247531|40223514|FG002|Overall Study|Physician Decision|2|||
16476035|NCT02247531|40223512|FG000|Overall Study|Unspecified Reason|2|||
16476036|NCT02247531|40223513|FG001|Overall Study|Unspecified Reason|3|||
16476037|NCT02247531|40223514|FG002|Overall Study|Unspecified Reason|4|||
16476038|NCT04171765|40223519|FG000|Overall Study|Adverse Event|2|||
16476039|NCT04171765|40223520|FG001|Overall Study|Adverse Event|0|||
16476040|NCT04171765|40223521|FG002|Overall Study|Adverse Event|1|||
16476041|NCT04171765|40223522|FG003|Overall Study|Adverse Event|0|||
16476042|NCT04171765|40223519|FG000|Overall Study|Lost to Follow-up|0|||
16476043|NCT04171765|40223520|FG001|Overall Study|Lost to Follow-up|2|||
16476044|NCT04171765|40223521|FG002|Overall Study|Lost to Follow-up|2|||
16476045|NCT04171765|40223522|FG003|Overall Study|Lost to Follow-up|2|||
16476046|NCT04171765|40223519|FG000|Overall Study|Week 58 visit missed|0|||
16476047|NCT04171765|40223520|FG001|Overall Study|Week 58 visit missed|0|||
16476048|NCT04171765|40223521|FG002|Overall Study|Week 58 visit missed|1|||
16476049|NCT04171765|40223522|FG003|Overall Study|Week 58 visit missed|0|||
16476050|NCT04171765|40223519|FG000|Overall Study|Study terminated by sponsor|2|||
16476051|NCT04171765|40223520|FG001|Overall Study|Study terminated by sponsor|0|||
16476052|NCT04171765|40223521|FG002|Overall Study|Study terminated by sponsor|0|||
16476053|NCT04171765|40223522|FG003|Overall Study|Study terminated by sponsor|0|||
16476054|NCT04171765|40223519|FG000|Overall Study|Withdrawal by Subject|1|||
16476055|NCT04171765|40223520|FG001|Overall Study|Withdrawal by Subject|0|||
16476056|NCT04171765|40223521|FG002|Overall Study|Withdrawal by Subject|0|||
16476057|NCT04171765|40223522|FG003|Overall Study|Withdrawal by Subject|3|||
16476058|NCT02572388|40223523|FG000|Overall Study|Withdrawal by Subject|1|||
16476059|NCT02572388|40223524|FG001|Overall Study|Withdrawal by Subject|1|||
16476060|NCT02572388|40223525|FG002|Overall Study|Withdrawal by Subject|2|||
16476061|NCT02572388|40223526|FG003|Overall Study|Withdrawal by Subject|2|||
16476062|NCT02345226|40223527|FG000|Double-Blind Phase|Adverse Event|5|||
16476063|NCT02345226|40223528|FG001|Double-Blind Phase|Adverse Event|6|||
16476064|NCT02345226|40223527|FG000|Double-Blind Phase|Death|3|||
16476065|NCT02345226|40223528|FG001|Double-Blind Phase|Death|0|||
16476066|NCT02345226|40223527|FG000|Double-Blind Phase|Pregnancy|0|||
16476067|NCT02345226|40223528|FG001|Double-Blind Phase|Pregnancy|1|||
16476068|NCT02345226|40223527|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16476069|NCT02345226|40223528|FG001|Double-Blind Phase|Lack of Efficacy|0|||
16476070|NCT02345226|40223527|FG000|Double-Blind Phase|Investigator's Discretion|4|||
16476071|NCT02345226|40223528|FG001|Double-Blind Phase|Investigator's Discretion|3|||
16476072|NCT02345226|40223527|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
16476073|NCT02345226|40223528|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
16476074|NCT02345226|40223527|FG000|Double-Blind Phase|Withdrew Consent|41|||
16476075|NCT02345226|40223528|FG001|Double-Blind Phase|Withdrew Consent|39|||
16476076|NCT02345226|40223527|FG000|Double-Blind Phase|Lost to Follow-up|12|||
16476077|NCT02345226|40223528|FG001|Double-Blind Phase|Lost to Follow-up|16|||
16476078|NCT02345226|40223527|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
16476079|NCT02345226|40223528|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
16476080|NCT02345226|40223527|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
16476081|NCT02345226|40223528|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
16476082|NCT01461980|40223531|FG000|Overall Study|Other|9|||
16476083|NCT01461980|40223532|FG001|Overall Study|Other|8|||
16476084|NCT01461980|40223533|FG002|Overall Study|Other|6|||
16476085|NCT01461980|40223531|FG000|Overall Study|Medication error|7|||
16476086|NCT01461980|40223532|FG001|Overall Study|Medication error|5|||
16476087|NCT01461980|40223533|FG002|Overall Study|Medication error|6|||
16476088|NCT01461980|40223531|FG000|Overall Study|Adverse Event|12|||
16476089|NCT01461980|40223532|FG001|Overall Study|Adverse Event|5|||
16476090|NCT01461980|40223533|FG002|Overall Study|Adverse Event|6|||
16476091|NCT01461980|40223531|FG000|Overall Study|Protocol Violation|12|||
16476092|NCT01461980|40223532|FG001|Overall Study|Protocol Violation|19|||
16476093|NCT01461980|40223533|FG002|Overall Study|Protocol Violation|16|||
16476094|NCT01461980|40223531|FG000|Overall Study|No longer meets eligibility criteria|18|||
16476095|NCT01461980|40223532|FG001|Overall Study|No longer meets eligibility criteria|9|||
16476096|NCT01461980|40223533|FG002|Overall Study|No longer meets eligibility criteria|19|||
16476097|NCT01461980|40223531|FG000|Overall Study|Lost to Follow-up|52|||
16476098|NCT01461980|40223532|FG001|Overall Study|Lost to Follow-up|53|||
16476099|NCT01461980|40223533|FG002|Overall Study|Lost to Follow-up|51|||
16476100|NCT01461980|40223531|FG000|Overall Study|No longer willing to participate|52|||
16476101|NCT01461980|40223532|FG001|Overall Study|No longer willing to participate|38|||
16476102|NCT01461980|40223533|FG002|Overall Study|No longer willing to participate|54|||
16476103|NCT01461980|40223531|FG000|Overall Study|Randomized but not vaccinated|4|||
16476104|NCT01461980|40223532|FG001|Overall Study|Randomized but not vaccinated|8|||
16476105|NCT01461980|40223533|FG002|Overall Study|Randomized but not vaccinated|7|||
16476106|NCT03277690|40223534|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
16476107|NCT03277690|40223535|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
16476108|NCT03277690|40223534|FG000|Dose Titration and Maintenance|Physician Decision|1|||
16476109|NCT03277690|40223535|FG001|Dose Titration and Maintenance|Physician Decision|0|||
16476110|NCT03277690|40223534|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
16476111|NCT03277690|40223535|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
16476112|NCT03277690|40223534|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
16476113|NCT03277690|40223535|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
16476114|NCT03277690|40223534|FG000|Dose Titration and Maintenance|Adverse Event|15|||
16476115|NCT03277690|40223535|FG001|Dose Titration and Maintenance|Adverse Event|0|||
16476116|NCT03277690|40223534|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
16476117|NCT03277690|40223535|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
16476118|NCT03277690|40223534|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
16476119|NCT03277690|40223535|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
16476120|NCT02231918|40223536|FG000|Overall Study|Withdrawal by Subject|0|||
16476121|NCT02231918|40223537|FG001|Overall Study|Withdrawal by Subject|1|||
16476122|NCT02231918|40223538|FG002|Overall Study|Withdrawal by Subject|0|||
16476123|NCT02231918|40223536|FG000|Overall Study|Adverse Event|0|||
16476124|NCT02231918|40223537|FG001|Overall Study|Adverse Event|0|||
16476125|NCT02231918|40223538|FG002|Overall Study|Adverse Event|1|||
16476126|NCT00057954|40223541|FG000|Overall Study|Death|1|||
16476127|NCT00057954|40223541|FG000|Overall Study|Disease progression|1|||
16476128|NCT04203498|40223542|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
16476129|NCT04203498|40223543|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
16476130|NCT04203498|40223542|FG000|Overall Study|Withdrawal of patient consent|7|||
16476131|NCT04203498|40223543|FG001|Overall Study|Withdrawal of patient consent|2|||
16476132|NCT04203498|40223542|FG000|Overall Study|Adverse Event|4|||
16476133|NCT04203498|40223543|FG001|Overall Study|Adverse Event|1|||
16476134|NCT04203498|40223542|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
16476135|NCT04203498|40223543|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
16476136|NCT04203498|40223542|FG000|Overall Study|Did not receive IMP|2|||
16476137|NCT04203498|40223543|FG001|Overall Study|Did not receive IMP|0|||
16476138|NCT01925274|40223544|FG000|Overall Study|Death|1|||
16476139|NCT01925274|40223545|FG001|Overall Study|Death|0|||
16476140|NCT01925274|40223546|FG002|Overall Study|Death|0|||
16476141|NCT01925274|40223544|FG000|Overall Study|Lost to Follow-up|0|||
16476142|NCT01925274|40223545|FG001|Overall Study|Lost to Follow-up|1|||
16476143|NCT01925274|40223546|FG002|Overall Study|Lost to Follow-up|0|||
16476144|NCT01925274|40223544|FG000|Overall Study|Withdrawal by Subject|1|||
16476145|NCT01925274|40223545|FG001|Overall Study|Withdrawal by Subject|2|||
16476146|NCT01925274|40223546|FG002|Overall Study|Withdrawal by Subject|0|||
16476147|NCT01925274|40223544|FG000|Overall Study|Study terminated by sponsor|4|||
16476148|NCT01925274|40223545|FG001|Overall Study|Study terminated by sponsor|0|||
16476149|NCT01925274|40223546|FG002|Overall Study|Study terminated by sponsor|0|||
16476150|NCT01925274|40223544|FG000|Overall Study|Protocol amendment|1|||
16476151|NCT01925274|40223545|FG001|Overall Study|Protocol amendment|3|||
16476152|NCT01925274|40223546|FG002|Overall Study|Protocol amendment|6|||
16476153|NCT02544074|40223547|FG000|Overall Study|Withdrawal by Subject|0|||
16476154|NCT02544074|40223548|FG001|Overall Study|Withdrawal by Subject|1|||
16476155|NCT02544074|40223549|FG002|Overall Study|Withdrawal by Subject|0|||
16476156|NCT02544074|40223550|FG003|Overall Study|Withdrawal by Subject|0|||
16476157|NCT02544074|40223551|FG004|Overall Study|Withdrawal by Subject|0|||
16476158|NCT02544074|40223552|FG005|Overall Study|Withdrawal by Subject|0|||
16476159|NCT02544074|40223553|FG006|Overall Study|Withdrawal by Subject|0|||
16476160|NCT02544074|40223554|FG007|Overall Study|Withdrawal by Subject|0|||
16476161|NCT02544074|40223555|FG008|Overall Study|Withdrawal by Subject|0|||
16476162|NCT02544074|40223556|FG009|Overall Study|Withdrawal by Subject|0|||
16476163|NCT02544074|40223557|FG010|Overall Study|Withdrawal by Subject|0|||
16476164|NCT02544074|40223558|FG011|Overall Study|Withdrawal by Subject|0|||
16476165|NCT02544074|40223559|FG012|Overall Study|Withdrawal by Subject|0|||
16476166|NCT02544074|40223560|FG013|Overall Study|Withdrawal by Subject|0|||
16476167|NCT02544074|40223561|FG014|Overall Study|Withdrawal by Subject|0|||
16476168|NCT02544074|40223562|FG015|Overall Study|Withdrawal by Subject|0|||
16476169|NCT02544074|40223563|FG016|Overall Study|Withdrawal by Subject|0|||
16476170|NCT02544074|40223564|FG017|Overall Study|Withdrawal by Subject|0|||
16476171|NCT02544074|40223565|FG018|Overall Study|Withdrawal by Subject|0|||
16476172|NCT02544074|40223566|FG019|Overall Study|Withdrawal by Subject|0|||
16476173|NCT02544074|40223567|FG020|Overall Study|Withdrawal by Subject|0|||
16476174|NCT02544074|40223547|FG000|Overall Study|Tablet error|0|||
16476175|NCT02544074|40223548|FG001|Overall Study|Tablet error|0|||
16476176|NCT02544074|40223549|FG002|Overall Study|Tablet error|0|||
16476177|NCT02544074|40223550|FG003|Overall Study|Tablet error|0|||
16476178|NCT02544074|40223551|FG004|Overall Study|Tablet error|0|||
16476179|NCT02544074|40223552|FG005|Overall Study|Tablet error|1|||
16476180|NCT02544074|40223553|FG006|Overall Study|Tablet error|0|||
16476181|NCT02544074|40223554|FG007|Overall Study|Tablet error|0|||
16476182|NCT02544074|40223555|FG008|Overall Study|Tablet error|0|||
16476183|NCT02544074|40223556|FG009|Overall Study|Tablet error|1|||
16476184|NCT02544074|40223557|FG010|Overall Study|Tablet error|0|||
16476185|NCT02544074|40223558|FG011|Overall Study|Tablet error|0|||
16476186|NCT02544074|40223559|FG012|Overall Study|Tablet error|0|||
16476187|NCT02544074|40223560|FG013|Overall Study|Tablet error|0|||
16476188|NCT02544074|40223561|FG014|Overall Study|Tablet error|0|||
16476189|NCT02544074|40223562|FG015|Overall Study|Tablet error|0|||
16476190|NCT02544074|40223563|FG016|Overall Study|Tablet error|0|||
16476191|NCT02544074|40223564|FG017|Overall Study|Tablet error|0|||
16476192|NCT02544074|40223565|FG018|Overall Study|Tablet error|0|||
16476193|NCT02544074|40223566|FG019|Overall Study|Tablet error|0|||
16476194|NCT02544074|40223567|FG020|Overall Study|Tablet error|0|||
16476195|NCT01575548|40223568|FG000|Overall Study|Adverse Event|15|||
16476196|NCT01575548|40223569|FG001|Overall Study|Adverse Event|2|||
16476197|NCT01575548|40223568|FG000|Overall Study|Disease progression|12|||
16476198|NCT01575548|40223569|FG001|Overall Study|Disease progression|25|||
16476199|NCT01575548|40223568|FG000|Overall Study|Death|1|||
16476200|NCT01575548|40223569|FG001|Overall Study|Death|0|||
16476201|NCT01575548|40223568|FG000|Overall Study|Other complicating disease|1|||
16076462|NCT01713946|38773245|FG000|Overall Study|Lack of Efficacy|8|||
16476202|NCT01575548|40223569|FG001|Overall Study|Other complicating disease|0|||
16476203|NCT01575548|40223568|FG000|Overall Study|Withdrawal by Subject|7|||
16476204|NCT01575548|40223569|FG001|Overall Study|Withdrawal by Subject|3|||
16476205|NCT01575548|40223568|FG000|Overall Study|Noncompliance|1|||
16476206|NCT01575548|40223569|FG001|Overall Study|Noncompliance|0|||
16476207|NCT01575548|40223568|FG000|Overall Study|Anticipated surgery|0|||
16476208|NCT01575548|40223569|FG001|Overall Study|Anticipated surgery|1|||
16476209|NCT01575548|40223568|FG000|Overall Study|Never started protocol therapy|3|||
16476210|NCT01575548|40223569|FG001|Overall Study|Never started protocol therapy|2|||
16476211|NCT03954132|40223570|FG000|Overall Study|Adverse Event|2|||
16476212|NCT03954132|40223571|FG001|Overall Study|Adverse Event|0|||
16476213|NCT03954132|40223570|FG000|Overall Study|Patient's wish|5|||
16476214|NCT03954132|40223571|FG001|Overall Study|Patient's wish|0|||
16476215|NCT03954132|40223570|FG000|Overall Study|Lost to Follow-up|10|||
16476216|NCT03954132|40223571|FG001|Overall Study|Lost to Follow-up|0|||
16476217|NCT03954132|40223570|FG000|Overall Study|Screening failure|0|||
16476218|NCT03954132|40223571|FG001|Overall Study|Screening failure|1|||
16476219|NCT03954132|40223570|FG000|Overall Study|No registration after Visit 1|5|||
16476220|NCT03954132|40223571|FG001|Overall Study|No registration after Visit 1|2|||
16476221|NCT03954132|40223570|FG000|Overall Study|Other reason than listed|2|||
16476222|NCT03954132|40223571|FG001|Overall Study|Other reason than listed|2|||
16476223|NCT03954132|40223570|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
16476224|NCT03954132|40223571|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
16476225|NCT03954132|40223570|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
16476226|NCT03954132|40223571|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
16476227|NCT03257371|40223572|FG000|Overall Study|Lost to Follow-up|1|||
16476228|NCT03208127|40223575|FG000|Overall Study|Death|1|||
16476229|NCT00537238|40223580|FG000|Overall Study|Death|1|||
16476230|NCT00537238|40223581|FG001|Overall Study|Death|2|||
16476231|NCT00537238|40223580|FG000|Overall Study|Adverse Event|31|||
16476232|NCT00537238|40223581|FG001|Overall Study|Adverse Event|22|||
16476233|NCT00537238|40223580|FG000|Overall Study|Lack of Efficacy|20|||
16476234|NCT00537238|40223581|FG001|Overall Study|Lack of Efficacy|21|||
16476235|NCT00537238|40223580|FG000|Overall Study|Lost to Follow-up|12|||
16476236|NCT00537238|40223581|FG001|Overall Study|Lost to Follow-up|8|||
16476237|NCT00537238|40223580|FG000|Overall Study|Withdrawal by Subject|51|||
16476238|NCT00537238|40223581|FG001|Overall Study|Withdrawal by Subject|47|||
16476239|NCT00537238|40223580|FG000|Overall Study|Protocol Violation|15|||
16476240|NCT00537238|40223581|FG001|Overall Study|Protocol Violation|19|||
16476241|NCT00537238|40223580|FG000|Overall Study|Does not meet entrance criteria|0|||
16476242|NCT00537238|40223581|FG001|Overall Study|Does not meet entrance criteria|2|||
16476243|NCT00537238|40223580|FG000|Overall Study|Other|44|||
16476244|NCT00537238|40223581|FG001|Overall Study|Other|52|||
16476245|NCT01934972|40223582|FG000|Overall Study|Withdrawal by Subject|9|||
16476246|NCT01934972|40223583|FG001|Overall Study|Withdrawal by Subject|6|||
16476247|NCT03511664|40223592|FG000|Overall Study|Treatment ongoing|49|||
16476248|NCT03511664|40223593|FG001|Overall Study|Treatment ongoing|5|||
16476249|NCT03511664|40223592|FG000|Overall Study|Entered long-term follow-up|140|||
16476250|NCT03511664|40223593|FG001|Overall Study|Entered long-term follow-up|50|||
16476251|NCT03511664|40223592|FG000|Overall Study|Withdrawal by Subject|29|||
16476252|NCT03511664|40223593|FG001|Overall Study|Withdrawal by Subject|53|||
16476253|NCT03511664|40223592|FG000|Overall Study|Lost to Follow-up|4|||
16476254|NCT03511664|40223593|FG001|Overall Study|Lost to Follow-up|4|||
16476255|NCT03511664|40223592|FG000|Overall Study|Physician Decision|0|||
16476256|NCT03511664|40223593|FG001|Overall Study|Physician Decision|1|||
16476257|NCT02395666|40223595|FG000|Overall Study|Physician Decision|3|||
16476258|NCT02395666|40223596|FG001|Overall Study|Physician Decision|0|||
16476259|NCT02395666|40223595|FG000|Overall Study|Lost to Follow-up|1|||
16476260|NCT02395666|40223596|FG001|Overall Study|Lost to Follow-up|0|||
16476261|NCT02395666|40223595|FG000|Overall Study|Withdrawal by Subject|2|||
16476262|NCT02395666|40223596|FG001|Overall Study|Withdrawal by Subject|1|||
16476263|NCT01973569|40223597|FG000|Overall Study|Adverse Event|9|||
16476264|NCT01973569|40223598|FG001|Overall Study|Adverse Event|2|||
16476265|NCT01973569|40223599|FG002|Overall Study|Adverse Event|4|||
16476266|NCT01973569|40223597|FG000|Overall Study|Protocol Violation|2|||
16476267|NCT01973569|40223598|FG001|Overall Study|Protocol Violation|1|||
16476268|NCT01973569|40223599|FG002|Overall Study|Protocol Violation|3|||
16476269|NCT01973569|40223597|FG000|Overall Study|Withdrawal by Subject|7|||
16476270|NCT01973569|40223598|FG001|Overall Study|Withdrawal by Subject|5|||
16476271|NCT01973569|40223599|FG002|Overall Study|Withdrawal by Subject|2|||
16476272|NCT01973569|40223597|FG000|Overall Study|Invasive dental treatment|3|||
16476273|NCT01973569|40223598|FG001|Overall Study|Invasive dental treatment|5|||
16476274|NCT01973569|40223599|FG002|Overall Study|Invasive dental treatment|6|||
16476275|NCT01973569|40223597|FG000|Overall Study|Prohibited concomitant d|1|||
16476276|NCT01973569|40223598|FG001|Overall Study|Prohibited concomitant d|5|||
16476277|NCT01973569|40223599|FG002|Overall Study|Prohibited concomitant d|0|||
16476278|NCT01973569|40223597|FG000|Overall Study|Disease progression|0|||
16476279|NCT01973569|40223598|FG001|Overall Study|Disease progression|3|||
16476280|NCT01973569|40223599|FG002|Overall Study|Disease progression|0|||
16476281|NCT01973569|40223597|FG000|Overall Study|Other|1|||
16476282|NCT01973569|40223598|FG001|Overall Study|Other|1|||
16476283|NCT01973569|40223599|FG002|Overall Study|Other|0|||
16476284|NCT01973569|40223597|FG000|Overall Study|Did not receive study drug|6|||
16476285|NCT01973569|40223598|FG001|Overall Study|Did not receive study drug|3|||
16476286|NCT01973569|40223599|FG002|Overall Study|Did not receive study drug|3|||
16476287|NCT00667602|40223600|FG000|Overall Study|Withdrawal by Subject|4|||
16476288|NCT00667602|40223601|FG001|Overall Study|Withdrawal by Subject|9|||
16476289|NCT00667602|40223602|FG002|Overall Study|Withdrawal by Subject|10|||
16476290|NCT00667602|40223600|FG000|Overall Study|Lost to Follow-up|4|||
16476291|NCT00667602|40223601|FG001|Overall Study|Lost to Follow-up|5|||
16476292|NCT00667602|40223602|FG002|Overall Study|Lost to Follow-up|6|||
16476293|NCT00667602|40223600|FG000|Overall Study|Administrative reason|0|||
16476294|NCT00667602|40223601|FG001|Overall Study|Administrative reason|0|||
16476295|NCT00667602|40223602|FG002|Overall Study|Administrative reason|2|||
16476296|NCT00667602|40223600|FG000|Overall Study|Protocol Violation|0|||
16476297|NCT00667602|40223601|FG001|Overall Study|Protocol Violation|1|||
16476298|NCT00667602|40223602|FG002|Overall Study|Protocol Violation|0|||
16476299|NCT01822496|40223608|FG000|Overall Study|Protocol Violation|2|||
16476300|NCT01822496|40223609|FG001|Overall Study|Protocol Violation|2|||
16476301|NCT01822496|40223610|FG002|Overall Study|Protocol Violation|0|||
16476302|NCT01822496|40223611|FG003|Overall Study|Protocol Violation|1|||
16476303|NCT01822496|40223608|FG000|Overall Study|Withdrawal by Subject|0|||
16476304|NCT01822496|40223609|FG001|Overall Study|Withdrawal by Subject|0|||
16476305|NCT01822496|40223610|FG002|Overall Study|Withdrawal by Subject|0|||
16476306|NCT01822496|40223611|FG003|Overall Study|Withdrawal by Subject|3|||
16476307|NCT04676412|40223612|FG000|Overall Study|Death|17|||
16476308|NCT04676412|40223613|FG001|Overall Study|Death|23|||
16476309|NCT04676412|40223612|FG000|Overall Study|Withdrawal by Subject|0|||
16476310|NCT04676412|40223613|FG001|Overall Study|Withdrawal by Subject|2|||
16476311|NCT04676412|40223612|FG000|Overall Study|Participants ongoing|32|||
16476312|NCT04676412|40223613|FG001|Overall Study|Participants ongoing|33|||
16476313|NCT02360995|40223614|FG000|Overall Study|Lost to Follow-up|2|||
16476314|NCT02360995|40223615|FG001|Overall Study|Lost to Follow-up|0|||
16476315|NCT02360995|40223616|FG002|Overall Study|Lost to Follow-up|2|||
16278027|NCT01557751|39500720|FG000|Overall Study|Physician Decision|3|||
16278028|NCT03732833|39500721|FG000|Overall Study|Adverse Event|0|||
16278029|NCT03732833|39500722|FG001|Overall Study|Adverse Event|3|||
16278030|NCT03732833|39500723|FG002|Overall Study|Adverse Event|1|||
16278031|NCT03732833|39500721|FG000|Overall Study|Withdrawal by Subject|11|||
16278032|NCT03732833|39500722|FG001|Overall Study|Withdrawal by Subject|13|||
16278033|NCT03732833|39500723|FG002|Overall Study|Withdrawal by Subject|8|||
16278034|NCT03732833|39500721|FG000|Overall Study|Lost to Follow-up|3|||
16278035|NCT03732833|39500722|FG001|Overall Study|Lost to Follow-up|5|||
16278036|NCT03732833|39500723|FG002|Overall Study|Lost to Follow-up|4|||
16278037|NCT03732833|39500721|FG000|Overall Study|Pregnancy|0|||
16278038|NCT03732833|39500722|FG001|Overall Study|Pregnancy|2|||
16476316|NCT02360995|40223614|FG000|Overall Study|Withdrawal by Subject|0|||
16476317|NCT02360995|40223615|FG001|Overall Study|Withdrawal by Subject|1|||
16476318|NCT02360995|40223616|FG002|Overall Study|Withdrawal by Subject|0|||
16476319|NCT02147184|40223620|FG000|Overall Study|Lost to Follow-up|28|||
16476320|NCT02147184|40223621|FG001|Overall Study|Lost to Follow-up|15|||
16476321|NCT02147184|40223620|FG000|Overall Study|Study Burden|11|||
16476322|NCT02147184|40223621|FG001|Overall Study|Study Burden|7|||
16476323|NCT02147184|40223620|FG000|Overall Study|Pregnancy|6|||
16476324|NCT02147184|40223621|FG001|Overall Study|Pregnancy|0|||
16476325|NCT02147184|40223620|FG000|Overall Study|Moved out of state|3|||
16476326|NCT02147184|40223621|FG001|Overall Study|Moved out of state|3|||
16476327|NCT02147184|40223620|FG000|Overall Study|Physician Decision|0|||
16476328|NCT02147184|40223621|FG001|Overall Study|Physician Decision|2|||
16476329|NCT02147184|40223620|FG000|Overall Study|Other|1|||
16476330|NCT02147184|40223621|FG001|Overall Study|Other|0|||
16476331|NCT04761822|40223625|FG000|Overall Study|Adverse Event|3|||
16476332|NCT04761822|40223626|FG001|Overall Study|Adverse Event|1|||
16476333|NCT04761822|40223627|FG002|Overall Study|Adverse Event|1|||
16476334|NCT04761822|40223628|FG003|Overall Study|Adverse Event|3|||
16476335|NCT04761822|40223625|FG000|Overall Study|Lost to Follow-up|1|||
16476336|NCT04761822|40223626|FG001|Overall Study|Lost to Follow-up|0|||
16476337|NCT04761822|40223627|FG002|Overall Study|Lost to Follow-up|2|||
16278039|NCT03732833|39500723|FG002|Overall Study|Pregnancy|0|||
16278040|NCT03732833|39500721|FG000|Overall Study|Physician Decision|2|||
16476338|NCT04761822|40223628|FG003|Overall Study|Lost to Follow-up|3|||
16476339|NCT04761822|40223625|FG000|Overall Study|Physician Decision|0|||
16476340|NCT04761822|40223626|FG001|Overall Study|Physician Decision|1|||
16476341|NCT04761822|40223627|FG002|Overall Study|Physician Decision|0|||
16476342|NCT04761822|40223628|FG003|Overall Study|Physician Decision|0|||
16476343|NCT04761822|40223625|FG000|Overall Study|Withdrawal by Subject|3|||
16476344|NCT04761822|40223626|FG001|Overall Study|Withdrawal by Subject|8|||
16476345|NCT04761822|40223627|FG002|Overall Study|Withdrawal by Subject|1|||
16476346|NCT04761822|40223628|FG003|Overall Study|Withdrawal by Subject|11|||
16476347|NCT04761822|40223625|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
16476348|NCT04761822|40223626|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
16476349|NCT04761822|40223627|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
16476350|NCT04761822|40223628|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
16476351|NCT04761822|40223625|FG000|Overall Study|Participant requested unblinding|0|||
16476352|NCT04761822|40223626|FG001|Overall Study|Participant requested unblinding|0|||
16476353|NCT04761822|40223627|FG002|Overall Study|Participant requested unblinding|0|||
16476354|NCT04761822|40223628|FG003|Overall Study|Participant requested unblinding|1|||
16476355|NCT02155881|40223629|FG000|Overall Study|Withdrawal by Subject|0|||
16476356|NCT02155881|40223630|FG001|Overall Study|Withdrawal by Subject|2|||
16476357|NCT02155881|40223629|FG000|Overall Study|Inappropriately randomized|2|||
16476358|NCT02155881|40223630|FG001|Overall Study|Inappropriately randomized|2|||
16476359|NCT01824342|40223631|FG000|Overall Study|Withdrawal by Subject|0|||
16476360|NCT01824342|40223632|FG001|Overall Study|Withdrawal by Subject|3|||
16476361|NCT01824342|40223631|FG000|Overall Study|Adverse Event|1|||
16476362|NCT01824342|40223632|FG001|Overall Study|Adverse Event|1|||
16476363|NCT01824342|40223631|FG000|Overall Study|Disease Progression|1|||
16476364|NCT01824342|40223632|FG001|Overall Study|Disease Progression|1|||
16476365|NCT01824342|40223631|FG000|Overall Study|Physician Decision|5|||
16476366|NCT01824342|40223632|FG001|Overall Study|Physician Decision|0|||
16476367|NCT01824342|40223631|FG000|Overall Study|Death|2|||
16476368|NCT01824342|40223632|FG001|Overall Study|Death|0|||
16476369|NCT00131508|40223639|FG000|Overall Study|Disease progression|0|||
16476370|NCT00131508|40223640|FG001|Overall Study|Disease progression|2|||
16476371|NCT00131508|40223639|FG000|Overall Study|Non-Compliance|2|||
16476372|NCT00131508|40223640|FG001|Overall Study|Non-Compliance|4|||
16476373|NCT00131508|40223639|FG000|Overall Study|Withdrawal by Subject|1|||
16476374|NCT00131508|40223640|FG001|Overall Study|Withdrawal by Subject|2|||
16476375|NCT00147251|40223641|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
16476376|NCT00147251|40223642|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
16476377|NCT02520661|40223647|FG000|Overall Study|Lost to Follow-up|7|||
16476378|NCT02520661|40223648|FG001|Overall Study|Lost to Follow-up|3|||
16476379|NCT02520661|40223647|FG000|Overall Study|Admitted from ED|49|||
16476380|NCT02520661|40223648|FG001|Overall Study|Admitted from ED|48|||
16476381|NCT02520661|40223647|FG000|Overall Study|ED greater than 24 hours|29|||
16476382|NCT02520661|40223648|FG001|Overall Study|ED greater than 24 hours|38|||
16476383|NCT02520661|40223647|FG000|Overall Study|other ineligibility|14|||
16476384|NCT02520661|40223648|FG001|Overall Study|other ineligibility|22|||
16476385|NCT02520661|40223647|FG000|Overall Study|Withdrawal by Subject|7|||
16476386|NCT02520661|40223648|FG001|Overall Study|Withdrawal by Subject|16|||
16476387|NCT04806503|40223649|FG000|Overall Study|Lost to Follow-up|0|||
16476388|NCT04806503|40223650|FG001|Overall Study|Lost to Follow-up|0|||
16476389|NCT04806503|40223651|FG002|Overall Study|Lost to Follow-up|1|||
16476390|NCT04806503|40223652|FG003|Overall Study|Lost to Follow-up|0|||
16476391|NCT04806503|40223653|FG004|Overall Study|Lost to Follow-up|0|||
16476392|NCT04806503|40223649|FG000|Overall Study|Withdrawal by Subject|1|||
16476393|NCT04806503|40223650|FG001|Overall Study|Withdrawal by Subject|0|||
16476394|NCT04806503|40223651|FG002|Overall Study|Withdrawal by Subject|1|||
16476395|NCT04806503|40223652|FG003|Overall Study|Withdrawal by Subject|1|||
16476396|NCT04806503|40223653|FG004|Overall Study|Withdrawal by Subject|1|||
16476397|NCT04806503|40223649|FG000|Overall Study|Adverse Event|1|||
16476398|NCT04806503|40223650|FG001|Overall Study|Adverse Event|1|||
16476399|NCT04806503|40223651|FG002|Overall Study|Adverse Event|0|||
16476400|NCT04806503|40223652|FG003|Overall Study|Adverse Event|1|||
16476401|NCT04806503|40223653|FG004|Overall Study|Adverse Event|0|||
16476402|NCT05061966|40223656|FG000|Overall Study|Lost to Follow-up|13|||
16476403|NCT05061966|40223657|FG001|Overall Study|Lost to Follow-up|13|||
16476404|NCT02180165|40223658|FG000|Overall Study|Not Treated|0|||
16476405|NCT02180165|40223659|FG001|Overall Study|Not Treated|0|||
16476406|NCT02180165|40223660|FG002|Overall Study|Not Treated|1|||
16476407|NCT02180165|40223661|FG003|Overall Study|Not Treated|0|||
16476408|NCT02180165|40223658|FG000|Overall Study|Adverse Event|7|||
16476409|NCT02180165|40223659|FG001|Overall Study|Adverse Event|0|||
16476410|NCT02180165|40223660|FG002|Overall Study|Adverse Event|18|||
16476411|NCT02180165|40223661|FG003|Overall Study|Adverse Event|3|||
16476412|NCT02180165|40223658|FG000|Overall Study|Lack of Efficacy|0|||
16476413|NCT02180165|40223659|FG001|Overall Study|Lack of Efficacy|1|||
16476414|NCT02180165|40223660|FG002|Overall Study|Lack of Efficacy|3|||
16476415|NCT02180165|40223661|FG003|Overall Study|Lack of Efficacy|2|||
16476416|NCT02180165|40223658|FG000|Overall Study|Physician Decision|1|||
16476417|NCT02180165|40223659|FG001|Overall Study|Physician Decision|0|||
16476418|NCT02180165|40223660|FG002|Overall Study|Physician Decision|5|||
16476419|NCT02180165|40223661|FG003|Overall Study|Physician Decision|0|||
16476420|NCT02180165|40223658|FG000|Overall Study|Withdrawal by Subject|3|||
16476421|NCT02180165|40223659|FG001|Overall Study|Withdrawal by Subject|0|||
16476422|NCT02180165|40223660|FG002|Overall Study|Withdrawal by Subject|2|||
16476423|NCT02180165|40223661|FG003|Overall Study|Withdrawal by Subject|1|||
16476424|NCT02024529|40223662|FG000|Overall Study|Withdrawal by Subject|11|||
16476425|NCT02024529|40223663|FG001|Overall Study|Withdrawal by Subject|21|||
16476426|NCT02024529|40223662|FG000|Overall Study|Lost to Follow-up|2|||
16476427|NCT02024529|40223663|FG001|Overall Study|Lost to Follow-up|4|||
16476428|NCT01756053|40223668|FG000|Period 1 (10 Days)|Protocol Violation|1|||
16476429|NCT01756053|40223669|FG001|Period 1 (10 Days)|Protocol Violation|1|||
16476430|NCT01756053|40223668|FG000|Period 2 (10 Days)|Protocol Violation|0|||
16476431|NCT01756053|40223669|FG001|Period 2 (10 Days)|Protocol Violation|2|||
16476432|NCT00004635|40223672|FG000|Period One|refused|2|||
16476433|NCT00004635|40223673|FG001|Period One|refused|1|||
16476434|NCT00004635|40223672|FG000|Period One|Withdrawal by Subject|1|||
16476435|NCT00004635|40223673|FG001|Period One|Withdrawal by Subject|1|||
16476436|NCT00004635|40223672|FG000|Period One|Protocol Violation|1|||
16476437|NCT00004635|40223673|FG001|Period One|Protocol Violation|0|||
16476438|NCT00004635|40223672|FG000|Period One|PSA did not go <5 ng/mL|1|||
16476439|NCT00004635|40223673|FG001|Period One|PSA did not go <5 ng/mL|0|||
16476440|NCT00004635|40223672|FG000|Period One|second malignancy|1|||
16476441|NCT00004635|40223673|FG001|Period One|second malignancy|0|||
16476442|NCT00004635|40223672|FG000|Period One|progressed|0|||
16476443|NCT00004635|40223673|FG001|Period One|progressed|2|||
16476444|NCT00004635|40223672|FG000|Period One|health problem|0|||
16476445|NCT00004635|40223673|FG001|Period One|health problem|1|||
16476446|NCT00004635|40223672|FG000|Period One|discrepancy in data entry|0|||
16476447|NCT00004635|40223673|FG001|Period One|discrepancy in data entry|1|||
16476448|NCT00004635|40223672|FG000|Period Two|progression|2|||
16476449|NCT00004635|40223673|FG001|Period Two|progression|3|||
16476450|NCT00004635|40223672|FG000|Period Two|Adverse Event|1|||
16476451|NCT00004635|40223673|FG001|Period Two|Adverse Event|0|||
16476452|NCT00004635|40223672|FG000|Period Two|refused|0|||
16476453|NCT00004635|40223673|FG001|Period Two|refused|2|||
16476454|NCT00004635|40223672|FG000|Period Two|health problem|1|||
16476455|NCT00004635|40223673|FG001|Period Two|health problem|1|||
16476456|NCT00004635|40223672|FG000|Period Two|travel issues|0|||
16476457|NCT00004635|40223673|FG001|Period Two|travel issues|1|||
16476458|NCT00004635|40223672|FG000|Period Two|secondary malignancy|1|||
16476459|NCT00004635|40223673|FG001|Period Two|secondary malignancy|1|||
16476460|NCT00004635|40223672|FG000|Period Two|Lost to Follow-up|1|||
16476461|NCT00004635|40223673|FG001|Period Two|Lost to Follow-up|0|||
16476462|NCT00004635|40223672|FG000|Period Two|discrepancy in data entry|0|||
16476463|NCT00004635|40223673|FG001|Period Two|discrepancy in data entry|1|||
16476464|NCT00902668|40223678|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
16476465|NCT00839852|40223680|FG000|Overall Study|Adverse Event|10|||
16476466|NCT00839852|40223680|FG000|Overall Study|Insufficient Therapeutic Response|3|||
16476467|NCT00839852|40223680|FG000|Overall Study|Protocol Violation|9|||
16476468|NCT00839852|40223680|FG000|Overall Study|Withdrawal of Consent|16|||
16476469|NCT00839852|40223680|FG000|Overall Study|Lost to Follow-up|7|||
16476470|NCT00839852|40223680|FG000|Overall Study|Lack of Compliance While in Jail|1|||
16476471|NCT00839852|40223680|FG000|Overall Study|Pregnancy|1|||
16476472|NCT01013350|40223681|FG000|Overall Study|Lost to Follow-up|15|||
16476473|NCT01013350|40223682|FG001|Overall Study|Lost to Follow-up|95|||
16476474|NCT01013350|40223681|FG000|Overall Study|Adverse Event|0|||
16476475|NCT01013350|40223682|FG001|Overall Study|Adverse Event|1|||
16476476|NCT01013350|40223681|FG000|Overall Study|Physician Decision|4|||
16476477|NCT01013350|40223682|FG001|Overall Study|Physician Decision|20|||
16476478|NCT01013350|40223681|FG000|Overall Study|Withdrawal by Subject|15|||
16476479|NCT01013350|40223682|FG001|Overall Study|Withdrawal by Subject|38|||
16476480|NCT01013350|40223681|FG000|Overall Study|Death|3|||
16476481|NCT01013350|40223682|FG001|Overall Study|Death|5|||
16476482|NCT01013350|40223681|FG000|Overall Study|Participant entered interventional study|0|||
16476483|NCT01013350|40223682|FG001|Overall Study|Participant entered interventional study|8|||
16476484|NCT01013350|40223681|FG000|Overall Study|Other|1|||
16476485|NCT01013350|40223682|FG001|Overall Study|Other|25|||
16476486|NCT02476201|40223683|FG000|Overall Study|Unable to program MPP|9|||
16476487|NCT02476201|40223683|FG000|Overall Study|Study echo not performed|5|||
16476488|NCT02476201|40223683|FG000|Overall Study|Adverse Event|4|||
16476489|NCT02476201|40223683|FG000|Overall Study|Death|2|||
16476490|NCT02476201|40223683|FG000|Overall Study|Lost to Follow-up|2|||
16476491|NCT02476201|40223683|FG000|Overall Study|MPP programmed to OFF|2|||
16476492|NCT02476201|40223683|FG000|Overall Study|Withdrawal by Subject|1|||
16476493|NCT02476201|40223683|FG000|Overall Study|Unsuccessful implant|1|||
16476494|NCT00447005|40223686|FG000|Overall Study|Adverse Event|1|||
16476495|NCT00447005|40223686|FG000|Overall Study|Lack of Efficacy|11|||
16476496|NCT03650556|40223689|FG000|Overall Study|Death|2|||
16476497|NCT03650556|40223689|FG000|Overall Study|Withdrawal by Subject|20|||
16476498|NCT03650556|40223689|FG000|Overall Study|Physician Decision|2|||
16476499|NCT03650556|40223689|FG000|Overall Study|Lost to Follow-up|8|||
16476500|NCT03650556|40223689|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
16476501|NCT03650556|40223689|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
16476502|NCT01868503|40223690|FG000|Overall Study|Withdrawal by Subject|1|||
16278041|NCT03732833|39500722|FG001|Overall Study|Physician Decision|3|||
16278042|NCT03732833|39500723|FG002|Overall Study|Physician Decision|1|||
16278043|NCT03732833|39500721|FG000|Overall Study|Covid-19 related and other reasons|2|||
16476503|NCT01868503|40223690|FG000|Overall Study|Protocol Violation|1|||
16476504|NCT01967173|40223691|FG000|Overall Study|Lost to Follow-up|5|||
16476505|NCT01967173|40223692|FG001|Overall Study|Lost to Follow-up|3|||
16476506|NCT01967173|40223693|FG002|Overall Study|Lost to Follow-up|2|||
16476507|NCT01967173|40223694|FG003|Overall Study|Lost to Follow-up|4|||
16476508|NCT01967173|40223695|FG004|Overall Study|Lost to Follow-up|8|||
16476509|NCT01967173|40223696|FG005|Overall Study|Lost to Follow-up|12|||
16278044|NCT03732833|39500722|FG001|Overall Study|Covid-19 related and other reasons|7|||
16278045|NCT03732833|39500723|FG002|Overall Study|Covid-19 related and other reasons|3|||
16278046|NCT01609582|39500724|FG000|Overall Study|Adverse Event|20|||
16278047|NCT01609582|39500725|FG001|Overall Study|Adverse Event|18|||
16278048|NCT01609582|39500724|FG000|Overall Study|Lost to Follow-up|10|||
16278049|NCT01609582|39500725|FG001|Overall Study|Lost to Follow-up|10|||
16476510|NCT01967173|40223697|FG006|Overall Study|Lost to Follow-up|6|||
16476511|NCT01967173|40223698|FG007|Overall Study|Lost to Follow-up|8|||
16278050|NCT01609582|39500724|FG000|Overall Study|Withdrawal by Subject|21|||
16278051|NCT01609582|39500725|FG001|Overall Study|Withdrawal by Subject|15|||
16278052|NCT01609582|39500724|FG000|Overall Study|Study Terminated by Sponsor|1543|||
16278053|NCT01609582|39500725|FG001|Overall Study|Study Terminated by Sponsor|1548|||
16278054|NCT01609582|39500724|FG000|Overall Study|Other|9|||
16278055|NCT01609582|39500725|FG001|Overall Study|Other|10|||
16278056|NCT01609582|39500724|FG000|Overall Study|Randomized, but not treated|0|||
16278057|NCT01609582|39500725|FG001|Overall Study|Randomized, but not treated|3|||
16278058|NCT01390948|39500726|FG000|Overall Study|End of Study|1|||
16278059|NCT01390948|39500727|FG001|Overall Study|End of Study|0|||
16278060|NCT01390948|39500728|FG002|Overall Study|End of Study|0|||
16278061|NCT01390948|39500726|FG000|Overall Study|Withdrew consent|2|||
16278062|NCT01390948|39500727|FG001|Overall Study|Withdrew consent|2|||
16278063|NCT01390948|39500728|FG002|Overall Study|Withdrew consent|0|||
16278064|NCT01390948|39500726|FG000|Overall Study|Progressive Disease|2|||
16278065|NCT01390948|39500727|FG001|Overall Study|Progressive Disease|5|||
16278066|NCT01390948|39500728|FG002|Overall Study|Progressive Disease|0|||
16278067|NCT01390948|39500726|FG000|Overall Study|Death during follow-up|10|||
16278068|NCT01390948|39500727|FG001|Overall Study|Death during follow-up|11|||
16278069|NCT01390948|39500728|FG002|Overall Study|Death during follow-up|1|||
16476512|NCT01967173|40223691|FG000|Overall Study|Physician Decision|2|||
16476513|NCT01967173|40223692|FG001|Overall Study|Physician Decision|0|||
16476514|NCT01967173|40223693|FG002|Overall Study|Physician Decision|2|||
16476515|NCT01967173|40223694|FG003|Overall Study|Physician Decision|1|||
16476516|NCT01967173|40223695|FG004|Overall Study|Physician Decision|1|||
16476517|NCT01967173|40223696|FG005|Overall Study|Physician Decision|1|||
16476518|NCT01967173|40223697|FG006|Overall Study|Physician Decision|1|||
16476519|NCT01967173|40223698|FG007|Overall Study|Physician Decision|0|||
16476520|NCT01967173|40223691|FG000|Overall Study|Lack of Efficacy|2|||
16476521|NCT01967173|40223692|FG001|Overall Study|Lack of Efficacy|0|||
16476522|NCT01967173|40223693|FG002|Overall Study|Lack of Efficacy|2|||
16476523|NCT01967173|40223694|FG003|Overall Study|Lack of Efficacy|2|||
16476524|NCT01967173|40223695|FG004|Overall Study|Lack of Efficacy|0|||
16476525|NCT01967173|40223696|FG005|Overall Study|Lack of Efficacy|1|||
16476526|NCT01967173|40223697|FG006|Overall Study|Lack of Efficacy|0|||
16476527|NCT01967173|40223698|FG007|Overall Study|Lack of Efficacy|2|||
16476528|NCT01967173|40223691|FG000|Overall Study|Pregnancy|0|||
16476529|NCT01967173|40223692|FG001|Overall Study|Pregnancy|0|||
16476530|NCT01967173|40223693|FG002|Overall Study|Pregnancy|0|||
16476531|NCT01967173|40223694|FG003|Overall Study|Pregnancy|0|||
16476532|NCT01967173|40223695|FG004|Overall Study|Pregnancy|0|||
16476533|NCT01967173|40223696|FG005|Overall Study|Pregnancy|0|||
16476534|NCT01967173|40223697|FG006|Overall Study|Pregnancy|1|||
16476535|NCT01967173|40223698|FG007|Overall Study|Pregnancy|1|||
16476536|NCT01967173|40223691|FG000|Overall Study|Adverse Event|0|||
16476537|NCT01967173|40223692|FG001|Overall Study|Adverse Event|0|||
16476538|NCT01967173|40223693|FG002|Overall Study|Adverse Event|0|||
16076463|NCT01713946|38773246|FG001|Overall Study|Lack of Efficacy|8|||
16278070|NCT00603512|39500729|FG000|Overall Study|Adverse Event|0|||
16278071|NCT00603512|39500730|FG001|Overall Study|Adverse Event|2|||
16278072|NCT00603512|39500731|FG002|Overall Study|Adverse Event|4|||
16278073|NCT00603512|39500732|FG003|Overall Study|Adverse Event|4|||
16278074|NCT00603512|39500733|FG004|Overall Study|Adverse Event|2|||
16278075|NCT00603512|39500729|FG000|Overall Study|Lack of Efficacy|0|||
16278076|NCT00603512|39500730|FG001|Overall Study|Lack of Efficacy|1|||
16476539|NCT01967173|40223694|FG003|Overall Study|Adverse Event|0|||
16476540|NCT01967173|40223695|FG004|Overall Study|Adverse Event|0|||
16476541|NCT01967173|40223696|FG005|Overall Study|Adverse Event|0|||
16476542|NCT01967173|40223697|FG006|Overall Study|Adverse Event|0|||
16476543|NCT01967173|40223698|FG007|Overall Study|Adverse Event|1|||
16476544|NCT01967173|40223691|FG000|Overall Study|Withdrawal by Subject|15|||
16476545|NCT01967173|40223692|FG001|Overall Study|Withdrawal by Subject|14|||
16476546|NCT01967173|40223693|FG002|Overall Study|Withdrawal by Subject|10|||
16476547|NCT01967173|40223694|FG003|Overall Study|Withdrawal by Subject|7|||
16476548|NCT01967173|40223695|FG004|Overall Study|Withdrawal by Subject|8|||
16476549|NCT01967173|40223696|FG005|Overall Study|Withdrawal by Subject|9|||
16476550|NCT01967173|40223697|FG006|Overall Study|Withdrawal by Subject|10|||
16476551|NCT01967173|40223698|FG007|Overall Study|Withdrawal by Subject|12|||
16476552|NCT01187433|40223699|FG000|Overall Study|Protocol Violation|6|||
16476553|NCT01187433|40223700|FG001|Overall Study|Protocol Violation|2|||
16476554|NCT01187433|40223699|FG000|Overall Study|Withdrawal by Subject|5|||
16476555|NCT01187433|40223700|FG001|Overall Study|Withdrawal by Subject|2|||
16476556|NCT00543543|40223701|FG000|Base Study|Adverse Event|1|||
16476557|NCT00543543|40223702|FG001|Base Study|Adverse Event|11|||
16476558|NCT00543543|40223703|FG002|Base Study|Adverse Event|0|||
16476559|NCT00543543|40223704|FG003|Base Study|Adverse Event|5|||
16476560|NCT00543543|40223701|FG000|Base Study|Lost to Follow-up|12|||
16476561|NCT00543543|40223702|FG001|Base Study|Lost to Follow-up|749|||
16476562|NCT00543543|40223703|FG002|Base Study|Lost to Follow-up|9|||
16476563|NCT00543543|40223704|FG003|Base Study|Lost to Follow-up|701|||
16476564|NCT00543543|40223701|FG000|Base Study|Physician Decision|0|||
16476565|NCT00543543|40223702|FG001|Base Study|Physician Decision|4|||
16476566|NCT00543543|40223703|FG002|Base Study|Physician Decision|0|||
16476567|NCT00543543|40223704|FG003|Base Study|Physician Decision|7|||
16476568|NCT00543543|40223701|FG000|Base Study|Protocol Violation|0|||
16278077|NCT00603512|39500731|FG002|Overall Study|Lack of Efficacy|0|||
16476569|NCT00543543|40223702|FG001|Base Study|Protocol Violation|6|||
16476570|NCT00543543|40223703|FG002|Base Study|Protocol Violation|0|||
16476571|NCT00543543|40223704|FG003|Base Study|Protocol Violation|6|||
16476572|NCT00543543|40223701|FG000|Base Study|Withdrawal by Subject|7|||
16476573|NCT00543543|40223702|FG001|Base Study|Withdrawal by Subject|482|||
16476574|NCT00543543|40223703|FG002|Base Study|Withdrawal by Subject|5|||
16476575|NCT00543543|40223704|FG003|Base Study|Withdrawal by Subject|503|||
16476576|NCT00543543|40223701|FG000|Extension Study|Adverse Event|0|||
16476577|NCT00543543|40223702|FG001|Extension Study|Adverse Event|0|||
16476578|NCT00543543|40223703|FG002|Extension Study|Adverse Event|0|||
16278078|NCT00603512|39500732|FG003|Overall Study|Lack of Efficacy|0|||
16476579|NCT00543543|40223704|FG003|Extension Study|Adverse Event|5|||
16476580|NCT00543543|40223701|FG000|Extension Study|Lost to Follow-up|0|||
16278079|NCT00603512|39500733|FG004|Overall Study|Lack of Efficacy|1|||
16278080|NCT00603512|39500729|FG000|Overall Study|Other|2|||
16278081|NCT00603512|39500730|FG001|Overall Study|Other|1|||
16278082|NCT00603512|39500731|FG002|Overall Study|Other|0|||
16278083|NCT00603512|39500732|FG003|Overall Study|Other|1|||
16278084|NCT00603512|39500733|FG004|Overall Study|Other|1|||
16278085|NCT00603512|39500729|FG000|Overall Study|Withdrawal by Subject|0|||
16278086|NCT00603512|39500730|FG001|Overall Study|Withdrawal by Subject|0|||
16278087|NCT00603512|39500731|FG002|Overall Study|Withdrawal by Subject|0|||
16278088|NCT00603512|39500732|FG003|Overall Study|Withdrawal by Subject|0|||
16278089|NCT00603512|39500733|FG004|Overall Study|Withdrawal by Subject|1|||
16278090|NCT00603512|39500729|FG000|Overall Study|Randomized but not treated|0|||
16278091|NCT00603512|39500730|FG001|Overall Study|Randomized but not treated|1|||
16278092|NCT00603512|39500731|FG002|Overall Study|Randomized but not treated|1|||
16278093|NCT00603512|39500732|FG003|Overall Study|Randomized but not treated|2|||
16476581|NCT00543543|40223702|FG001|Extension Study|Lost to Follow-up|0|||
16476582|NCT00543543|40223703|FG002|Extension Study|Lost to Follow-up|0|||
16476583|NCT00543543|40223704|FG003|Extension Study|Lost to Follow-up|77|||
16476584|NCT00543543|40223701|FG000|Extension Study|Physician Decision|0|||
16476585|NCT00543543|40223702|FG001|Extension Study|Physician Decision|0|||
16476586|NCT00543543|40223703|FG002|Extension Study|Physician Decision|0|||
16476587|NCT00543543|40223704|FG003|Extension Study|Physician Decision|7|||
16476588|NCT00543543|40223701|FG000|Extension Study|Pregnancy|0|||
16476589|NCT00543543|40223702|FG001|Extension Study|Pregnancy|0|||
16476590|NCT00543543|40223703|FG002|Extension Study|Pregnancy|0|||
16476591|NCT00543543|40223704|FG003|Extension Study|Pregnancy|6|||
16476592|NCT00543543|40223701|FG000|Extension Study|Protocol Violation|0|||
16476593|NCT00543543|40223702|FG001|Extension Study|Protocol Violation|0|||
16476594|NCT00543543|40223703|FG002|Extension Study|Protocol Violation|0|||
16278094|NCT00603512|39500733|FG004|Overall Study|Randomized but not treated|0|||
16278095|NCT02427399|39500734|FG000|Overall Study|Protocol Violation|14|||
16476595|NCT00543543|40223704|FG003|Extension Study|Protocol Violation|11|||
16476596|NCT00543543|40223701|FG000|Extension Study|Withdrawal by Subject|0|||
16476597|NCT00543543|40223702|FG001|Extension Study|Withdrawal by Subject|0|||
16476598|NCT00543543|40223703|FG002|Extension Study|Withdrawal by Subject|0|||
16476599|NCT00543543|40223704|FG003|Extension Study|Withdrawal by Subject|120|||
16476600|NCT00338104|40223707|FG000|Overall Study|Protocol Violation|2|||
16476601|NCT00338104|40223708|FG001|Overall Study|Protocol Violation|1|||
16476602|NCT00338104|40223709|FG002|Overall Study|Protocol Violation|3|||
16476603|NCT01739309|40223710|FG000|Overall Study|Adverse Event|1|||
16278096|NCT02427399|39500735|FG001|Overall Study|Protocol Violation|16|||
16476604|NCT01739309|40223710|FG000|Overall Study|Withdrawal by Subject|1|||
16476605|NCT03875768|40223711|FG000|Overall Study|Lost to Follow-up|16|||
16476606|NCT03875768|40223712|FG001|Overall Study|Lost to Follow-up|13|||
16476607|NCT03875768|40223711|FG000|Overall Study|Withdrawal by Subject|10|||
16476608|NCT03875768|40223712|FG001|Overall Study|Withdrawal by Subject|21|||
16476609|NCT03875768|40223711|FG000|Overall Study|Did not complete assessment|21|||
16476610|NCT03875768|40223712|FG001|Overall Study|Did not complete assessment|12|||
16476611|NCT03875768|40223711|FG000|Overall Study|Became ineligible|1|||
16476612|NCT03875768|40223712|FG001|Overall Study|Became ineligible|0|||
16476613|NCT00331864|40223713|FG000|Overall Study|Adverse Event|30|||
16476614|NCT00331864|40223714|FG001|Overall Study|Adverse Event|1|||
16476615|NCT00331864|40223713|FG000|Overall Study|Lack of Efficacy|4|||
16476616|NCT00331864|40223714|FG001|Overall Study|Lack of Efficacy|0|||
16476617|NCT00331864|40223713|FG000|Overall Study|Protocol Violation|3|||
16476618|NCT00331864|40223714|FG001|Overall Study|Protocol Violation|0|||
16476619|NCT00331864|40223713|FG000|Overall Study|Withdrawal by Subject|10|||
16476620|NCT00331864|40223714|FG001|Overall Study|Withdrawal by Subject|0|||
16476621|NCT00331864|40223713|FG000|Overall Study|Lost to Follow-up|4|||
16476622|NCT00331864|40223714|FG001|Overall Study|Lost to Follow-up|3|||
16476623|NCT00331864|40223713|FG000|Overall Study|Administrative Problems|1|||
16476624|NCT00331864|40223714|FG001|Overall Study|Administrative Problems|0|||
16476625|NCT00331864|40223713|FG000|Overall Study|Death|6|||
16476626|NCT00331864|40223714|FG001|Overall Study|Death|0|||
16476627|NCT02020577|40223715|FG000|Overall Study|Progressive disease|3|||
16476628|NCT02020577|40223716|FG001|Overall Study|Progressive disease|38|||
16476629|NCT02020577|40223715|FG000|Overall Study|Other AE or clinical progression|0|||
16476630|NCT02020577|40223716|FG001|Overall Study|Other AE or clinical progression|15|||
16476631|NCT02020577|40223715|FG000|Overall Study|Withdrawal by Subject|0|||
16476632|NCT02020577|40223716|FG001|Overall Study|Withdrawal by Subject|1|||
16476633|NCT02020577|40223715|FG000|Overall Study|Other than stated above|0|||
16476634|NCT02020577|40223716|FG001|Overall Study|Other than stated above|1|||
16476635|NCT02635776|40223717|FG000|Overall Study|Physician Decision|1|||
16476636|NCT02635776|40223718|FG001|Overall Study|Physician Decision|0|||
16476637|NCT02635776|40223717|FG000|Overall Study|Adverse Event|51|||
16476638|NCT02635776|40223718|FG001|Overall Study|Adverse Event|3|||
16476639|NCT02635776|40223717|FG000|Overall Study|Withdrawal by Subject|41|||
16476640|NCT02635776|40223718|FG001|Overall Study|Withdrawal by Subject|7|||
16476641|NCT02635776|40223717|FG000|Overall Study|Lost to Follow-up|4|||
16476642|NCT02635776|40223718|FG001|Overall Study|Lost to Follow-up|0|||
16476643|NCT02635776|40223717|FG000|Overall Study|Other reasons|5|||
16476644|NCT02635776|40223718|FG001|Overall Study|Other reasons|1|||
16476645|NCT02215096|40223721|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
16476646|NCT02215096|40223722|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
16476647|NCT02215096|40223723|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
16476648|NCT02215096|40223724|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
16476649|NCT02215096|40223725|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
16476650|NCT02215096|40223721|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
16476651|NCT02215096|40223722|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
16476652|NCT02215096|40223723|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
16476653|NCT02215096|40223724|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
16476654|NCT02215096|40223725|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
16476655|NCT02215096|40223721|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
16476656|NCT02215096|40223722|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
16476657|NCT02215096|40223723|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
16476658|NCT02215096|40223724|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
16476659|NCT02215096|40223725|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
16476660|NCT02215096|40223721|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
16476661|NCT02215096|40223722|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
16476662|NCT02215096|40223723|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
16476663|NCT02215096|40223724|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
16476664|NCT02215096|40223725|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
16476665|NCT00413244|40223727|FG000|Overall Study|Withdrawal by Subject|10|||
16476666|NCT00413244|40223728|FG001|Overall Study|Withdrawal by Subject|1|||
16476667|NCT04622306|40228003|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
16476668|NCT04622306|40228004|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
16476669|NCT04622306|40228005|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
16476670|NCT04622306|40228006|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
16476671|NCT04622306|40228007|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
16476672|NCT04622306|40228008|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
16476673|NCT04622306|40228003|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
16476674|NCT04622306|40228004|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
16476675|NCT04622306|40228005|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
16476676|NCT04622306|40228006|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
16476677|NCT04622306|40228007|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
16278097|NCT02427399|39500736|FG002|Overall Study|Protocol Violation|12|||
16278098|NCT02427399|39500737|FG003|Overall Study|Protocol Violation|18|||
16278099|NCT02427399|39500738|FG004|Overall Study|Protocol Violation|15|||
16476678|NCT04622306|40228008|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
16476679|NCT03386474|40228009|FG000|Overall Study|Death|1|||
16476680|NCT03386474|40228010|FG001|Overall Study|Death|0|||
16476681|NCT03386474|40228009|FG000|Overall Study|Adverse Event|0|||
16476682|NCT03386474|40228010|FG001|Overall Study|Adverse Event|1|||
16476683|NCT00961649|40228016|FG000|Overall Study|Adverse Event|4|||
16476684|NCT00961649|40228017|FG001|Overall Study|Adverse Event|0|||
16476685|NCT00961649|40228018|FG002|Overall Study|Adverse Event|0|||
16476686|NCT00961649|40228019|FG003|Overall Study|Adverse Event|2|||
16476687|NCT00961649|40228016|FG000|Overall Study|Inadequate control of IOP|0|||
16476688|NCT00961649|40228017|FG001|Overall Study|Inadequate control of IOP|0|||
16476689|NCT00961649|40228018|FG002|Overall Study|Inadequate control of IOP|0|||
16476690|NCT00961649|40228019|FG003|Overall Study|Inadequate control of IOP|1|||
16476691|NCT00961649|40228016|FG000|Overall Study|Patient has travel plans during holidays|0|||
16476692|NCT00961649|40228017|FG001|Overall Study|Patient has travel plans during holidays|0|||
16476693|NCT00961649|40228018|FG002|Overall Study|Patient has travel plans during holidays|1|||
16476694|NCT00961649|40228019|FG003|Overall Study|Patient has travel plans during holidays|0|||
16278100|NCT02166606|39500739|FG000|Overall Study|Adverse Event|3|||
16278101|NCT02166606|39500739|FG000|Overall Study|Death|31|||
16278102|NCT02166606|39500739|FG000|Overall Study|Protocol Violation|7|||
16278103|NCT02166606|39500739|FG000|Overall Study|Lost to Follow-up|30|||
16278104|NCT02166606|39500739|FG000|Overall Study|Withdrawal by Subject|1|||
16278105|NCT02166606|39500739|FG000|Overall Study|Physician Decision|1|||
16278106|NCT02166606|39500739|FG000|Overall Study|Device upgrade|1|||
16278107|NCT02166606|39500739|FG000|Overall Study|Enrolled after End of Enrollment|4|||
16278108|NCT03702049|39500740|FG000|Overall Study|Lost to Follow-up|4|||
16278109|NCT03702049|39500740|FG000|Overall Study|Physician Decision|1|||
16278110|NCT03507686|39500747|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
16476695|NCT00961649|40228016|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
16476696|NCT00961649|40228017|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
16476697|NCT00961649|40228018|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
16476698|NCT00961649|40228019|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
16476699|NCT00961649|40228016|FG000|Overall Study|Study terminated by sponsor|4|||
16476700|NCT00961649|40228017|FG001|Overall Study|Study terminated by sponsor|4|||
16476701|NCT00961649|40228018|FG002|Overall Study|Study terminated by sponsor|4|||
16476702|NCT00961649|40228019|FG003|Overall Study|Study terminated by sponsor|1|||
16476703|NCT00054717|40228020|FG000|Overall Study|Randomized but not treated|2|||
16476704|NCT00054717|40228021|FG001|Overall Study|Randomized but not treated|8|||
16476705|NCT00054717|40228020|FG000|Overall Study|Adverse Event|70|||
16476706|NCT00054717|40228021|FG001|Overall Study|Adverse Event|22|||
16476707|NCT00054717|40228020|FG000|Overall Study|Protocol Violation|18|||
16476708|NCT00054717|40228021|FG001|Overall Study|Protocol Violation|19|||
16476709|NCT00054717|40228020|FG000|Overall Study|Lost to Follow-up|23|||
16476710|NCT00054717|40228021|FG001|Overall Study|Lost to Follow-up|13|||
16476711|NCT00054717|40228020|FG000|Overall Study|Withdrawal by Subject|32|||
16476712|NCT00054717|40228021|FG001|Overall Study|Withdrawal by Subject|20|||
16476713|NCT00054717|40228020|FG000|Overall Study|Other reason not defined above|117|||
16476714|NCT00054717|40228021|FG001|Overall Study|Other reason not defined above|217|||
16476715|NCT00333840|40228024|FG000|First-line Treatment Period|Adverse Event|38|||
16476716|NCT00333840|40228025|FG001|First-line Treatment Period|Adverse Event|37|||
16476717|NCT00333840|40228026|FG002|First-line Treatment Period|Adverse Event|0|||
16476718|NCT00333840|40228027|FG003|First-line Treatment Period|Adverse Event|0|||
16476719|NCT00333840|40228024|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
16476720|NCT00333840|40228025|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
16476721|NCT00333840|40228026|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
16476722|NCT00333840|40228027|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
16476723|NCT00333840|40228024|FG000|First-line Treatment Period|Abnormal procedure|2|||
16476724|NCT00333840|40228025|FG001|First-line Treatment Period|Abnormal procedure|0|||
16476725|NCT00333840|40228026|FG002|First-line Treatment Period|Abnormal procedure|0|||
16476726|NCT00333840|40228027|FG003|First-line Treatment Period|Abnormal procedure|0|||
16476727|NCT00333840|40228024|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
16476728|NCT00333840|40228025|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
16476729|NCT00333840|40228026|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
16278111|NCT03507686|39500748|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
16476730|NCT00333840|40228027|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
16476731|NCT00333840|40228024|FG000|First-line Treatment Period|No longer required study drug|21|||
16476732|NCT00333840|40228025|FG001|First-line Treatment Period|No longer required study drug|8|||
16476733|NCT00333840|40228026|FG002|First-line Treatment Period|No longer required study drug|0|||
16476734|NCT00333840|40228027|FG003|First-line Treatment Period|No longer required study drug|0|||
16476735|NCT00333840|40228024|FG000|First-line Treatment Period|Protocol Violation|17|||
16476736|NCT00333840|40228025|FG001|First-line Treatment Period|Protocol Violation|17|||
16476737|NCT00333840|40228026|FG002|First-line Treatment Period|Protocol Violation|0|||
16476738|NCT00333840|40228027|FG003|First-line Treatment Period|Protocol Violation|0|||
16476739|NCT00333840|40228024|FG000|First-line Treatment Period|Subject withdrew consent|57|||
16476740|NCT00333840|40228025|FG001|First-line Treatment Period|Subject withdrew consent|77|||
16476741|NCT00333840|40228026|FG002|First-line Treatment Period|Subject withdrew consent|0|||
16476742|NCT00333840|40228027|FG003|First-line Treatment Period|Subject withdrew consent|0|||
16476743|NCT00333840|40228024|FG000|First-line Treatment Period|Lost to Follow-up|15|||
16476744|NCT00333840|40228025|FG001|First-line Treatment Period|Lost to Follow-up|6|||
16476745|NCT00333840|40228026|FG002|First-line Treatment Period|Lost to Follow-up|0|||
16476746|NCT00333840|40228027|FG003|First-line Treatment Period|Lost to Follow-up|0|||
16476747|NCT00333840|40228024|FG000|First-line Treatment Period|Administrative problems|12|||
16476748|NCT00333840|40228025|FG001|First-line Treatment Period|Administrative problems|6|||
16476749|NCT00333840|40228026|FG002|First-line Treatment Period|Administrative problems|0|||
16476750|NCT00333840|40228027|FG003|First-line Treatment Period|Administrative problems|0|||
16476751|NCT00333840|40228024|FG000|First-line Treatment Period|Death|19|||
16476752|NCT00333840|40228025|FG001|First-line Treatment Period|Death|2|||
16476753|NCT00333840|40228026|FG002|First-line Treatment Period|Death|0|||
16476754|NCT00333840|40228027|FG003|First-line Treatment Period|Death|0|||
16476755|NCT00333840|40228024|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
16476756|NCT00333840|40228025|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
16476757|NCT00333840|40228026|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
16476758|NCT00333840|40228027|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
16476759|NCT00333840|40228024|FG000|Second-line Treatment Period|Adverse Event|0|||
16476760|NCT00333840|40228025|FG001|Second-line Treatment Period|Adverse Event|0|||
16476761|NCT00333840|40228026|FG002|Second-line Treatment Period|Adverse Event|3|||
16476762|NCT00333840|40228027|FG003|Second-line Treatment Period|Adverse Event|34|||
16476763|NCT00333840|40228024|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
16476764|NCT00333840|40228025|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
16476765|NCT00333840|40228026|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
16476766|NCT00333840|40228027|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
16476767|NCT00333840|40228024|FG000|Second-line Treatment Period|Abnormal procedure|0|||
16476768|NCT00333840|40228025|FG001|Second-line Treatment Period|Abnormal procedure|0|||
16476769|NCT00333840|40228026|FG002|Second-line Treatment Period|Abnormal procedure|0|||
16476770|NCT00333840|40228027|FG003|Second-line Treatment Period|Abnormal procedure|1|||
16476771|NCT00333840|40228024|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
16476772|NCT00333840|40228025|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
16476773|NCT00333840|40228026|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
16476774|NCT00333840|40228027|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
16476775|NCT00333840|40228024|FG000|Second-line Treatment Period|No longer required study drug|0|||
16476776|NCT00333840|40228025|FG001|Second-line Treatment Period|No longer required study drug|0|||
16476777|NCT00333840|40228026|FG002|Second-line Treatment Period|No longer required study drug|1|||
16476778|NCT00333840|40228027|FG003|Second-line Treatment Period|No longer required study drug|14|||
16476779|NCT00333840|40228024|FG000|Second-line Treatment Period|Protocol Violation|0|||
16476780|NCT00333840|40228025|FG001|Second-line Treatment Period|Protocol Violation|0|||
16476781|NCT00333840|40228026|FG002|Second-line Treatment Period|Protocol Violation|1|||
16476782|NCT00333840|40228027|FG003|Second-line Treatment Period|Protocol Violation|10|||
16476783|NCT00333840|40228024|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
16476784|NCT00333840|40228025|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
16476785|NCT00333840|40228026|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
16476786|NCT00333840|40228027|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
16476787|NCT00333840|40228024|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
16476788|NCT00333840|40228025|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
16476789|NCT00333840|40228026|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
16476790|NCT00333840|40228027|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
16476791|NCT00333840|40228024|FG000|Second-line Treatment Period|Administrative problems|0|||
16476792|NCT00333840|40228025|FG001|Second-line Treatment Period|Administrative problems|0|||
16476793|NCT00333840|40228026|FG002|Second-line Treatment Period|Administrative problems|0|||
16476794|NCT00333840|40228027|FG003|Second-line Treatment Period|Administrative problems|7|||
16476795|NCT00333840|40228024|FG000|Second-line Treatment Period|Death|0|||
16476796|NCT00333840|40228025|FG001|Second-line Treatment Period|Death|0|||
16476797|NCT00333840|40228026|FG002|Second-line Treatment Period|Death|0|||
16476798|NCT00333840|40228027|FG003|Second-line Treatment Period|Death|9|||
16476799|NCT02611960|40228030|FG000|Overall Study|Adverse Event|7|||
16476800|NCT02611960|40228031|FG001|Overall Study|Adverse Event|8|||
16476801|NCT02611960|40228030|FG000|Overall Study|Death|98|||
16476802|NCT02611960|40228031|FG001|Overall Study|Death|92|||
16476803|NCT02611960|40228030|FG000|Overall Study|Withdrawal by Subject|1|||
16476804|NCT02611960|40228031|FG001|Overall Study|Withdrawal by Subject|5|||
16278112|NCT03507686|39500747|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
16278113|NCT03507686|39500748|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
16278114|NCT03507686|39500747|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
16278115|NCT03507686|39500748|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
16278116|NCT03507686|39500747|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
16278117|NCT03507686|39500748|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
16278118|NCT03507686|39500747|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
16278119|NCT03507686|39500748|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
16278120|NCT03507686|39500747|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
16278121|NCT03507686|39500748|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
16278122|NCT03431337|39500749|FG000|Overall Study|Lost to Follow-up|21|||
16278123|NCT03431337|39500750|FG001|Overall Study|Lost to Follow-up|19|||
16278124|NCT03431337|39500749|FG000|Overall Study|Withdrawal by Subject|8|||
16278125|NCT03431337|39500750|FG001|Overall Study|Withdrawal by Subject|3|||
16476805|NCT02611960|40228030|FG000|Overall Study|Sponsor Decision|11|||
16476806|NCT02611960|40228031|FG001|Overall Study|Sponsor Decision|11|||
16476807|NCT00354614|40228033|FG000|Overall Study|Lack of Efficacy|28|||
16476808|NCT00397215|40228034|FG000|Month 0 (Day 0)|Adverse Event|0|||
16476809|NCT00397215|40228035|FG001|Month 0 (Day 0)|Adverse Event|1|||
16476810|NCT00397215|40228036|FG002|Month 0 (Day 0)|Adverse Event|0|||
16476811|NCT00397215|40228037|FG003|Month 0 (Day 0)|Adverse Event|0|||
16476812|NCT00397215|40228034|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
16476813|NCT00397215|40228035|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
16476814|NCT00397215|40228036|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
16476815|NCT00397215|40228037|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
16476816|NCT00397215|40228034|FG000|Month 0 (Day 0)|Other|4|||
16476817|NCT00397215|40228035|FG001|Month 0 (Day 0)|Other|1|||
16476818|NCT00397215|40228036|FG002|Month 0 (Day 0)|Other|3|||
16476819|NCT00397215|40228037|FG003|Month 0 (Day 0)|Other|3|||
16476820|NCT00397215|40228034|FG000|Month 6 (Day 180)|Adverse Event|0|||
16476821|NCT00397215|40228035|FG001|Month 6 (Day 180)|Adverse Event|3|||
16476822|NCT00397215|40228036|FG002|Month 6 (Day 180)|Adverse Event|2|||
16476823|NCT00397215|40228037|FG003|Month 6 (Day 180)|Adverse Event|0|||
16476824|NCT00397215|40228034|FG000|Month 6 (Day 180)|Other|2|||
16476825|NCT00397215|40228035|FG001|Month 6 (Day 180)|Other|0|||
16476826|NCT00397215|40228036|FG002|Month 6 (Day 180)|Other|3|||
16476827|NCT00397215|40228037|FG003|Month 6 (Day 180)|Other|0|||
16476828|NCT04607980|40228038|FG000|Overall Study|Adverse Event|3|||
16476829|NCT04607980|40228039|FG001|Overall Study|Adverse Event|4|||
16476830|NCT04607980|40228038|FG000|Overall Study|Death|0|||
16476831|NCT04607980|40228039|FG001|Overall Study|Death|1|||
16476832|NCT04607980|40228038|FG000|Overall Study|Withdrawal by Subject|2|||
16476833|NCT04607980|40228039|FG001|Overall Study|Withdrawal by Subject|5|||
16476834|NCT04607980|40228038|FG000|Overall Study|Lost to Follow-up|4|||
16476835|NCT04607980|40228039|FG001|Overall Study|Lost to Follow-up|8|||
16476836|NCT04607980|40228038|FG000|Overall Study|Protocol Violation|0|||
16476837|NCT04607980|40228039|FG001|Overall Study|Protocol Violation|3|||
16476838|NCT04607980|40228038|FG000|Overall Study|Other|3|||
16476839|NCT04607980|40228039|FG001|Overall Study|Other|0|||
16476840|NCT01823146|40228040|FG000|Overall Study|Withdrawal by Subject|0|||
16476841|NCT01823146|40228041|FG001|Overall Study|Withdrawal by Subject|1|||
16476842|NCT01823146|40228040|FG000|Overall Study|Lost to Follow-up|2|||
16476843|NCT01823146|40228041|FG001|Overall Study|Lost to Follow-up|1|||
16476844|NCT00694707|40228043|FG000|Overall Study|Did Not Receive Treatment|0|||
16476845|NCT00694707|40228044|FG001|Overall Study|Did Not Receive Treatment|0|||
16476846|NCT00694707|40228045|FG002|Overall Study|Did Not Receive Treatment|1|||
16476847|NCT00694707|40228046|FG003|Overall Study|Did Not Receive Treatment|1|||
16476848|NCT00694707|40228047|FG004|Overall Study|Did Not Receive Treatment|1|||
16476849|NCT00694707|40228043|FG000|Overall Study|Adverse Event|22|||
16476850|NCT00694707|40228044|FG001|Overall Study|Adverse Event|14|||
16476851|NCT00694707|40228045|FG002|Overall Study|Adverse Event|8|||
16476852|NCT00694707|40228046|FG003|Overall Study|Adverse Event|12|||
16476853|NCT00694707|40228047|FG004|Overall Study|Adverse Event|13|||
16476854|NCT00694707|40228043|FG000|Overall Study|Insufficient Therapeutic Response|33|||
16476855|NCT00694707|40228044|FG001|Overall Study|Insufficient Therapeutic Response|18|||
16476856|NCT00694707|40228045|FG002|Overall Study|Insufficient Therapeutic Response|17|||
16476857|NCT00694707|40228046|FG003|Overall Study|Insufficient Therapeutic Response|15|||
16476858|NCT00694707|40228047|FG004|Overall Study|Insufficient Therapeutic Response|10|||
16476859|NCT00694707|40228043|FG000|Overall Study|Protocol Violation|1|||
16476860|NCT00694707|40228044|FG001|Overall Study|Protocol Violation|2|||
16476861|NCT00694707|40228045|FG002|Overall Study|Protocol Violation|1|||
16476862|NCT00694707|40228046|FG003|Overall Study|Protocol Violation|3|||
16476863|NCT00694707|40228047|FG004|Overall Study|Protocol Violation|1|||
16476864|NCT00694707|40228043|FG000|Overall Study|Withdrawal of Consent|14|||
16476865|NCT00694707|40228044|FG001|Overall Study|Withdrawal of Consent|18|||
16278126|NCT03448692|39500754|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
16278127|NCT03448692|39500755|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
16278128|NCT03448692|39500754|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
16278129|NCT03448692|39500755|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
16278130|NCT03448692|39500754|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
16278131|NCT03448692|39500755|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
16278132|NCT03448692|39500754|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
16278133|NCT03448692|39500755|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
16278134|NCT03448692|39500754|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
16278135|NCT03448692|39500755|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
16278136|NCT00605176|39500764|FG000|Overall Study|Adverse Event|2|||
16278137|NCT00605176|39500765|FG001|Overall Study|Adverse Event|1|||
16278138|NCT00605176|39500766|FG002|Overall Study|Adverse Event|3|||
16278139|NCT00605176|39500764|FG000|Overall Study|Withdrawal by Subject|4|||
16278140|NCT00605176|39500765|FG001|Overall Study|Withdrawal by Subject|2|||
16278141|NCT00605176|39500766|FG002|Overall Study|Withdrawal by Subject|4|||
16278142|NCT00605176|39500764|FG000|Overall Study|Lost to Follow-up|2|||
16278143|NCT00605176|39500765|FG001|Overall Study|Lost to Follow-up|2|||
16278144|NCT00605176|39500766|FG002|Overall Study|Lost to Follow-up|1|||
16278145|NCT00605176|39500764|FG000|Overall Study|Non-complicance with study procedures|1|||
16278146|NCT00605176|39500765|FG001|Overall Study|Non-complicance with study procedures|0|||
16278147|NCT00605176|39500766|FG002|Overall Study|Non-complicance with study procedures|0|||
16278148|NCT00605176|39500764|FG000|Overall Study|Use of concomitant therapy|1|||
16278149|NCT00605176|39500765|FG001|Overall Study|Use of concomitant therapy|0|||
16278150|NCT00605176|39500766|FG002|Overall Study|Use of concomitant therapy|1|||
16278151|NCT00605176|39500764|FG000|Overall Study|Other (not due to AE)|1|||
16278152|NCT00605176|39500765|FG001|Overall Study|Other (not due to AE)|1|||
16278153|NCT00605176|39500766|FG002|Overall Study|Other (not due to AE)|0|||
16278154|NCT03428945|39500772|FG000|Overall Study|Lost to Follow-up|5|||
16476866|NCT00694707|40228045|FG002|Overall Study|Withdrawal of Consent|22|||
16476867|NCT00694707|40228046|FG003|Overall Study|Withdrawal of Consent|16|||
16476868|NCT00694707|40228047|FG004|Overall Study|Withdrawal of Consent|15|||
16476869|NCT00694707|40228043|FG000|Overall Study|Lost to Follow-up|0|||
16476870|NCT00694707|40228044|FG001|Overall Study|Lost to Follow-up|1|||
16476871|NCT00694707|40228045|FG002|Overall Study|Lost to Follow-up|2|||
16476872|NCT00694707|40228046|FG003|Overall Study|Lost to Follow-up|0|||
16476873|NCT00694707|40228047|FG004|Overall Study|Lost to Follow-up|0|||
16476874|NCT00694707|40228043|FG000|Overall Study|Jeopardizing Parole Status|1|||
16476875|NCT00694707|40228044|FG001|Overall Study|Jeopardizing Parole Status|0|||
16476876|NCT00694707|40228045|FG002|Overall Study|Jeopardizing Parole Status|0|||
16476877|NCT00694707|40228046|FG003|Overall Study|Jeopardizing Parole Status|0|||
16476878|NCT00694707|40228047|FG004|Overall Study|Jeopardizing Parole Status|0|||
16476879|NCT00694707|40228043|FG000|Overall Study|Death in the Family|1|||
16476880|NCT00694707|40228044|FG001|Overall Study|Death in the Family|0|||
16476881|NCT00694707|40228045|FG002|Overall Study|Death in the Family|0|||
16476882|NCT00694707|40228046|FG003|Overall Study|Death in the Family|0|||
16476883|NCT00694707|40228047|FG004|Overall Study|Death in the Family|0|||
16476884|NCT00694707|40228043|FG000|Overall Study|Arrest by Police|0|||
16476885|NCT00694707|40228044|FG001|Overall Study|Arrest by Police|1|||
16476886|NCT00694707|40228045|FG002|Overall Study|Arrest by Police|0|||
16476887|NCT00694707|40228046|FG003|Overall Study|Arrest by Police|0|||
16476888|NCT00694707|40228047|FG004|Overall Study|Arrest by Police|0|||
16476889|NCT00694707|40228043|FG000|Overall Study|Administrative Reasons|0|||
16476890|NCT00694707|40228044|FG001|Overall Study|Administrative Reasons|1|||
16476891|NCT00694707|40228045|FG002|Overall Study|Administrative Reasons|0|||
16476892|NCT00694707|40228046|FG003|Overall Study|Administrative Reasons|2|||
16476893|NCT00694707|40228047|FG004|Overall Study|Administrative Reasons|0|||
16476894|NCT00694707|40228043|FG000|Overall Study|Notification of Past Head Injury|0|||
16476895|NCT00694707|40228044|FG001|Overall Study|Notification of Past Head Injury|0|||
16476896|NCT00694707|40228045|FG002|Overall Study|Notification of Past Head Injury|0|||
16476897|NCT00694707|40228046|FG003|Overall Study|Notification of Past Head Injury|1|||
16476898|NCT00694707|40228047|FG004|Overall Study|Notification of Past Head Injury|0|||
16476899|NCT01033851|40228048|FG000|Overall Study|Withdrawal by Subject|3|||
16476900|NCT01033851|40228049|FG001|Overall Study|Withdrawal by Subject|7|||
16476901|NCT00737438|40228050|FG000|Overall Study|Withdrawal by Subject|2|||
16476902|NCT00737438|40228050|FG000|Overall Study|Patient ineligible|1|||
16476903|NCT04295772|40228051|FG000|Overall Study|Protocol Violation|1|||
16476904|NCT04295772|40228052|FG001|Overall Study|Protocol Violation|0|||
16476905|NCT04295772|40228051|FG000|Overall Study|Ongoing for safety monitoring|14|||
16476906|NCT04295772|40228052|FG001|Overall Study|Ongoing for safety monitoring|1|||
16476907|NCT04295772|40228051|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
16476908|NCT04295772|40228052|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
16476909|NCT03595774|40228053|FG000|Overall Study|Adverse Event|1|||
16476910|NCT03595774|40228054|FG001|Overall Study|Adverse Event|0|||
16278155|NCT03428945|39500773|FG001|Overall Study|Lost to Follow-up|3|||
16278156|NCT03428945|39500772|FG000|Overall Study|Withdrawal by Subject|10|||
16278157|NCT03428945|39500773|FG001|Overall Study|Withdrawal by Subject|10|||
16278158|NCT03201003|39500774|FG000|Overall Study|Adverse Event|14|||
16278159|NCT03201003|39500775|FG001|Overall Study|Adverse Event|1|||
16278160|NCT03201003|39500774|FG000|Overall Study|Other reasons|5|||
16278161|NCT03201003|39500775|FG001|Overall Study|Other reasons|1|||
16278162|NCT03201003|39500774|FG000|Overall Study|Withdrawal by Subject|4|||
16476911|NCT03595774|40228055|FG002|Overall Study|Adverse Event|1|||
16476912|NCT03595774|40228056|FG003|Overall Study|Adverse Event|0|||
16476913|NCT03595774|40228053|FG000|Overall Study|screen failure|0|||
16476914|NCT03595774|40228054|FG001|Overall Study|screen failure|1|||
16476915|NCT03595774|40228055|FG002|Overall Study|screen failure|0|||
16476916|NCT03595774|40228056|FG003|Overall Study|screen failure|1|||
16476917|NCT00445978|40228066|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
16476918|NCT00445978|40228066|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
16476919|NCT00445978|40228066|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
16476920|NCT00445978|40228066|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
16476921|NCT00445978|40228066|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
16476922|NCT00445978|40228066|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
16476923|NCT00445978|40228066|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
16476924|NCT00445978|40228066|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
16476925|NCT00445978|40228066|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
16476926|NCT00910273|40228071|FG000|Overall Study|Lack of Efficacy|6|||
16476927|NCT00910273|40228072|FG001|Overall Study|Lack of Efficacy|9|||
16476928|NCT00910273|40228071|FG000|Overall Study|Adverse Event|1|||
16476929|NCT00910273|40228072|FG001|Overall Study|Adverse Event|1|||
16476930|NCT00910273|40228071|FG000|Overall Study|Withdrawal by Subject|1|||
16476931|NCT00910273|40228072|FG001|Overall Study|Withdrawal by Subject|0|||
16476932|NCT00910273|40228071|FG000|Overall Study|Discontinuation of study by sponsor|8|||
16476933|NCT00910273|40228072|FG001|Overall Study|Discontinuation of study by sponsor|2|||
16476934|NCT00910273|40228071|FG000|Overall Study|Protocol Violation|1|||
16476935|NCT00910273|40228072|FG001|Overall Study|Protocol Violation|0|||
16476936|NCT00910273|40228071|FG000|Overall Study|Lost to Follow-up|1|||
16476937|NCT00910273|40228072|FG001|Overall Study|Lost to Follow-up|1|||
16476938|NCT02038881|40228077|FG000|Overall Study|Withdrawal by Subject|0|||
16476939|NCT02038881|40228078|FG001|Overall Study|Withdrawal by Subject|0|||
16476940|NCT02038881|40228079|FG002|Overall Study|Withdrawal by Subject|1|||
16476941|NCT02038881|40228077|FG000|Overall Study|Lost to Follow-up|2|||
16476942|NCT02038881|40228078|FG001|Overall Study|Lost to Follow-up|0|||
16476943|NCT02038881|40228079|FG002|Overall Study|Lost to Follow-up|0|||
16476944|NCT02038881|40228077|FG000|Overall Study|incarcerated|1|||
16476945|NCT02038881|40228078|FG001|Overall Study|incarcerated|0|||
16476946|NCT02038881|40228079|FG002|Overall Study|incarcerated|0|||
16476947|NCT00423722|40228081|FG000|Overall Study|Death|4|||
16476948|NCT00423722|40228082|FG001|Overall Study|Death|4|||
16476949|NCT00423722|40228081|FG000|Overall Study|Declined to participate|2|||
16476950|NCT00423722|40228082|FG001|Overall Study|Declined to participate|3|||
16476951|NCT00423722|40228081|FG000|Overall Study|Unable to complete questionnaires|4|||
16476952|NCT00423722|40228082|FG001|Overall Study|Unable to complete questionnaires|4|||
16476953|NCT00423722|40228081|FG000|Overall Study|Withdrawal by Subject|4|||
16476954|NCT00423722|40228082|FG001|Overall Study|Withdrawal by Subject|2|||
16476955|NCT00810108|40228089|FG000|Overall Study|Withdrawal by Subject|1|||
16476956|NCT00810108|40228090|FG001|Overall Study|Withdrawal by Subject|0|||
16476957|NCT03633617|40228091|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
16476958|NCT03633617|40228092|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
16476959|NCT03633617|40228093|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
16476960|NCT03633617|40228094|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
16476961|NCT03633617|40228095|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
16476962|NCT03633617|40228096|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
16476963|NCT03633617|40228097|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
16476964|NCT03633617|40228098|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
16476965|NCT03633617|40228099|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
16476966|NCT03633617|40228100|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
16476967|NCT03633617|40228101|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
16278163|NCT03201003|39500775|FG001|Overall Study|Withdrawal by Subject|1|||
16278164|NCT03201003|39500774|FG000|Overall Study|Lost to Follow-up|2|||
16278165|NCT03201003|39500775|FG001|Overall Study|Lost to Follow-up|0|||
16476968|NCT03633617|40228091|FG000|Part A|Unconfirmed early termination visit|1|||
16476969|NCT03633617|40228092|FG001|Part A|Unconfirmed early termination visit|0|||
16476970|NCT03633617|40228093|FG002|Part A|Unconfirmed early termination visit|0|||
16476971|NCT03633617|40228094|FG003|Part A|Unconfirmed early termination visit|0|||
16278166|NCT03201003|39500774|FG000|Overall Study|Protocol Violation|1|||
16476972|NCT03633617|40228095|FG004|Part A|Unconfirmed early termination visit|0|||
16476973|NCT03633617|40228096|FG005|Part A|Unconfirmed early termination visit|0|||
16476974|NCT03633617|40228097|FG006|Part A|Unconfirmed early termination visit|0|||
16476975|NCT03633617|40228098|FG007|Part A|Unconfirmed early termination visit|0|||
16476976|NCT03633617|40228099|FG008|Part A|Unconfirmed early termination visit|0|||
16476977|NCT03633617|40228100|FG009|Part A|Unconfirmed early termination visit|0|||
16476978|NCT03633617|40228101|FG010|Part A|Unconfirmed early termination visit|0|||
16476979|NCT03633617|40228091|FG000|Part A|Adverse Event|0|||
16476980|NCT03633617|40228092|FG001|Part A|Adverse Event|1|||
16476981|NCT03633617|40228093|FG002|Part A|Adverse Event|0|||
16476982|NCT03633617|40228094|FG003|Part A|Adverse Event|0|||
16476983|NCT03633617|40228095|FG004|Part A|Adverse Event|0|||
16476984|NCT03633617|40228096|FG005|Part A|Adverse Event|0|||
16476985|NCT03633617|40228097|FG006|Part A|Adverse Event|0|||
16476986|NCT03633617|40228098|FG007|Part A|Adverse Event|0|||
16476987|NCT03633617|40228099|FG008|Part A|Adverse Event|0|||
16476988|NCT03633617|40228100|FG009|Part A|Adverse Event|0|||
16476989|NCT03633617|40228101|FG010|Part A|Adverse Event|0|||
16476990|NCT03633617|40228091|FG000|Part A|Pregnancy|1|||
16476991|NCT03633617|40228092|FG001|Part A|Pregnancy|0|||
16476992|NCT03633617|40228093|FG002|Part A|Pregnancy|0|||
16476993|NCT03633617|40228094|FG003|Part A|Pregnancy|0|||
16476994|NCT03633617|40228095|FG004|Part A|Pregnancy|0|||
16476995|NCT03633617|40228096|FG005|Part A|Pregnancy|0|||
16476996|NCT03633617|40228097|FG006|Part A|Pregnancy|0|||
16476997|NCT03633617|40228098|FG007|Part A|Pregnancy|0|||
16476998|NCT03633617|40228099|FG008|Part A|Pregnancy|0|||
16278167|NCT03201003|39500775|FG001|Overall Study|Protocol Violation|0|||
16278168|NCT01781234|39500776|FG000|Overall Study|Adverse Event|2|||
16278169|NCT01781234|39500777|FG001|Overall Study|Adverse Event|0|||
16278170|NCT01781234|39500776|FG000|Overall Study|Protocol Violation|3|||
16278171|NCT01781234|39500777|FG001|Overall Study|Protocol Violation|0|||
16278172|NCT01781234|39500776|FG000|Overall Study|Withdrawal by Subject|4|||
16278173|NCT01781234|39500777|FG001|Overall Study|Withdrawal by Subject|3|||
16278174|NCT00874822|39500778|FG000|Overall Study|excluded by criteria|8|||
16278175|NCT01876368|39500779|FG000|Overall Study|Adverse Event|2|||
16278176|NCT01876368|39500780|FG001|Overall Study|Adverse Event|5|||
16278177|NCT01876368|39500779|FG000|Overall Study|Lack of Efficacy|1|||
16278178|NCT01876368|39500780|FG001|Overall Study|Lack of Efficacy|0|||
16278179|NCT01876368|39500779|FG000|Overall Study|Lost to Follow-up|0|||
16278180|NCT01876368|39500780|FG001|Overall Study|Lost to Follow-up|1|||
16278181|NCT01876368|39500779|FG000|Overall Study|Non-compliance with study treatment|0|||
16278182|NCT01876368|39500780|FG001|Overall Study|Non-compliance with study treatment|1|||
16278183|NCT01876368|39500779|FG000|Overall Study|Physician Decision|0|||
16278184|NCT01876368|39500780|FG001|Overall Study|Physician Decision|2|||
16278185|NCT01876368|39500779|FG000|Overall Study|Protocol deviation|3|||
16278186|NCT01876368|39500780|FG001|Overall Study|Protocol deviation|3|||
16278187|NCT01876368|39500779|FG000|Overall Study|Subject/guardian decision|3|||
16278188|NCT01876368|39500780|FG001|Overall Study|Subject/guardian decision|1|||
16278189|NCT02093923|39500783|FG000|Overall Study|Lost to Follow-up|0|||
16278190|NCT02093923|39500784|FG001|Overall Study|Lost to Follow-up|0|||
16278191|NCT02093923|39500785|FG002|Overall Study|Lost to Follow-up|0|||
16278192|NCT02093923|39500786|FG003|Overall Study|Lost to Follow-up|1|||
16278193|NCT02093923|39500787|FG004|Overall Study|Lost to Follow-up|0|||
16278194|NCT02093923|39500783|FG000|Overall Study|Screen failure after randomization|0|||
16278195|NCT02093923|39500784|FG001|Overall Study|Screen failure after randomization|0|||
16278196|NCT02093923|39500785|FG002|Overall Study|Screen failure after randomization|0|||
16278197|NCT02093923|39500786|FG003|Overall Study|Screen failure after randomization|1|||
16278198|NCT02093923|39500787|FG004|Overall Study|Screen failure after randomization|0|||
16278199|NCT00928057|39500788|FG000|Overall Study|Adverse Event|1|||
16278200|NCT00928057|39500789|FG001|Overall Study|Adverse Event|2|||
16476999|NCT03633617|40228100|FG009|Part A|Pregnancy|0|||
16477000|NCT03633617|40228101|FG010|Part A|Pregnancy|0|||
16477001|NCT03633617|40228091|FG000|Part A|Withdrawal by Subject|0|||
16477002|NCT03633617|40228092|FG001|Part A|Withdrawal by Subject|1|||
16278201|NCT00928057|39500788|FG000|Overall Study|Withdrawal by Subject|1|||
16278202|NCT00928057|39500789|FG001|Overall Study|Withdrawal by Subject|0|||
16278203|NCT00928057|39500788|FG000|Overall Study|Lost to Follow-up|0|||
16278204|NCT00928057|39500789|FG001|Overall Study|Lost to Follow-up|1|||
16278205|NCT00928057|39500788|FG000|Overall Study|Protocol Violation|0|||
16278206|NCT00928057|39500789|FG001|Overall Study|Protocol Violation|1|||
16278207|NCT01266603|39500791|FG000|Overall Study|Adverse Event|1|||
16278208|NCT01266603|39500791|FG000|Overall Study|Lack of Efficacy|14|||
16278209|NCT01266603|39500791|FG000|Overall Study|Withdrawal by Subject|1|||
16477003|NCT03633617|40228093|FG002|Part A|Withdrawal by Subject|0|||
16477004|NCT03633617|40228094|FG003|Part A|Withdrawal by Subject|0|||
16477005|NCT03633617|40228095|FG004|Part A|Withdrawal by Subject|0|||
16477006|NCT03633617|40228096|FG005|Part A|Withdrawal by Subject|0|||
16477007|NCT03633617|40228097|FG006|Part A|Withdrawal by Subject|0|||
16477008|NCT03633617|40228098|FG007|Part A|Withdrawal by Subject|0|||
16477009|NCT03633617|40228099|FG008|Part A|Withdrawal by Subject|0|||
16477010|NCT03633617|40228100|FG009|Part A|Withdrawal by Subject|0|||
16477011|NCT03633617|40228101|FG010|Part A|Withdrawal by Subject|0|||
16477012|NCT03633617|40228091|FG000|Part B|Adverse Event|0|||
16477013|NCT03633617|40228092|FG001|Part B|Adverse Event|0|||
16477014|NCT03633617|40228093|FG002|Part B|Adverse Event|2|||
16477015|NCT03633617|40228094|FG003|Part B|Adverse Event|2|||
16477016|NCT03633617|40228095|FG004|Part B|Adverse Event|1|||
16477017|NCT03633617|40228096|FG005|Part B|Adverse Event|0|||
16477018|NCT03633617|40228097|FG006|Part B|Adverse Event|0|||
16477019|NCT03633617|40228098|FG007|Part B|Adverse Event|0|||
16477020|NCT03633617|40228099|FG008|Part B|Adverse Event|0|||
16477021|NCT03633617|40228100|FG009|Part B|Adverse Event|0|||
16278210|NCT01266603|39500791|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
16278211|NCT03365791|39500793|FG000|Overall Study|Adverse Event|5|||
16278212|NCT03365791|39500793|FG000|Overall Study|Death|1|||
16278213|NCT03365791|39500793|FG000|Overall Study|Lost to Follow-up|1|||
16278214|NCT03365791|39500793|FG000|Overall Study|Physician Decision|9|||
16278215|NCT03365791|39500793|FG000|Overall Study|Progressive disease|51|||
16477022|NCT03633617|40228101|FG010|Part B|Adverse Event|0|||
16477023|NCT03633617|40228091|FG000|Part B|Withdrawal by Subject|0|||
16477024|NCT03633617|40228092|FG001|Part B|Withdrawal by Subject|0|||
16477025|NCT03633617|40228093|FG002|Part B|Withdrawal by Subject|1|||
16477026|NCT03633617|40228094|FG003|Part B|Withdrawal by Subject|0|||
16477027|NCT03633617|40228095|FG004|Part B|Withdrawal by Subject|2|||
16477028|NCT03633617|40228096|FG005|Part B|Withdrawal by Subject|0|||
16477029|NCT03633617|40228097|FG006|Part B|Withdrawal by Subject|0|||
16477030|NCT03633617|40228098|FG007|Part B|Withdrawal by Subject|0|||
16477031|NCT03633617|40228099|FG008|Part B|Withdrawal by Subject|0|||
16477032|NCT03633617|40228100|FG009|Part B|Withdrawal by Subject|0|||
16477033|NCT03633617|40228101|FG010|Part B|Withdrawal by Subject|0|||
16477034|NCT03633617|40228091|FG000|Part B|Lost to Follow-up|0|||
16477035|NCT03633617|40228092|FG001|Part B|Lost to Follow-up|0|||
16278216|NCT03365791|39500793|FG000|Overall Study|Subject/guardian decision|5|||
16278217|NCT02000115|39500796|FG000|Overall Study|Death|56|||
16477036|NCT03633617|40228093|FG002|Part B|Lost to Follow-up|0|||
16477037|NCT03633617|40228094|FG003|Part B|Lost to Follow-up|0|||
16477038|NCT03633617|40228095|FG004|Part B|Lost to Follow-up|1|||
16477039|NCT03633617|40228096|FG005|Part B|Lost to Follow-up|0|||
16477040|NCT03633617|40228097|FG006|Part B|Lost to Follow-up|0|||
16477041|NCT03633617|40228098|FG007|Part B|Lost to Follow-up|0|||
16477042|NCT03633617|40228099|FG008|Part B|Lost to Follow-up|0|||
16477043|NCT03633617|40228100|FG009|Part B|Lost to Follow-up|0|||
16477044|NCT03633617|40228101|FG010|Part B|Lost to Follow-up|0|||
16477045|NCT03633617|40228091|FG000|Part B|Physician Decision|0|||
16477046|NCT03633617|40228092|FG001|Part B|Physician Decision|0|||
16477047|NCT03633617|40228093|FG002|Part B|Physician Decision|0|||
16477048|NCT03633617|40228094|FG003|Part B|Physician Decision|0|||
16477049|NCT03633617|40228095|FG004|Part B|Physician Decision|1|||
16477050|NCT03633617|40228096|FG005|Part B|Physician Decision|0|||
16477051|NCT03633617|40228097|FG006|Part B|Physician Decision|0|||
16477052|NCT03633617|40228098|FG007|Part B|Physician Decision|0|||
16477053|NCT03633617|40228099|FG008|Part B|Physician Decision|0|||
16477054|NCT03633617|40228100|FG009|Part B|Physician Decision|0|||
16477055|NCT03633617|40228101|FG010|Part B|Physician Decision|0|||
16477056|NCT03633617|40228091|FG000|Part B|COVID-19 Restrictions|0|||
16477057|NCT03633617|40228092|FG001|Part B|COVID-19 Restrictions|0|||
16477058|NCT03633617|40228093|FG002|Part B|COVID-19 Restrictions|1|||
16477059|NCT03633617|40228094|FG003|Part B|COVID-19 Restrictions|0|||
16477060|NCT03633617|40228095|FG004|Part B|COVID-19 Restrictions|0|||
16477061|NCT03633617|40228096|FG005|Part B|COVID-19 Restrictions|0|||
16477062|NCT03633617|40228097|FG006|Part B|COVID-19 Restrictions|0|||
16477063|NCT03633617|40228098|FG007|Part B|COVID-19 Restrictions|0|||
16477064|NCT03633617|40228099|FG008|Part B|COVID-19 Restrictions|0|||
16477065|NCT03633617|40228100|FG009|Part B|COVID-19 Restrictions|0|||
16477066|NCT03633617|40228101|FG010|Part B|COVID-19 Restrictions|0|||
16477067|NCT03633617|40228091|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
16477068|NCT03633617|40228092|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
16477069|NCT03633617|40228093|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
16278218|NCT02000115|39500797|FG001|Overall Study|Death|45|||
16477070|NCT03633617|40228094|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
16477071|NCT03633617|40228095|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
16477072|NCT03633617|40228096|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
16477073|NCT03633617|40228097|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
16477074|NCT03633617|40228098|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
16477075|NCT03633617|40228099|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
16477076|NCT03633617|40228100|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
16477077|NCT03633617|40228101|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
16278219|NCT02000115|39500798|FG002|Overall Study|Death|0|||
16477078|NCT03633617|40228091|FG000|Part C (& Follow-up)|Adverse Event|0|||
16477079|NCT03633617|40228092|FG001|Part C (& Follow-up)|Adverse Event|0|||
16477080|NCT03633617|40228093|FG002|Part C (& Follow-up)|Adverse Event|0|||
16477081|NCT03633617|40228094|FG003|Part C (& Follow-up)|Adverse Event|0|||
16477082|NCT03633617|40228095|FG004|Part C (& Follow-up)|Adverse Event|0|||
16477083|NCT03633617|40228096|FG005|Part C (& Follow-up)|Adverse Event|1|||
16477084|NCT03633617|40228097|FG006|Part C (& Follow-up)|Adverse Event|0|||
16477085|NCT03633617|40228098|FG007|Part C (& Follow-up)|Adverse Event|1|||
16477086|NCT03633617|40228099|FG008|Part C (& Follow-up)|Adverse Event|0|||
16477087|NCT03633617|40228100|FG009|Part C (& Follow-up)|Adverse Event|0|||
16477088|NCT03633617|40228101|FG010|Part C (& Follow-up)|Adverse Event|0|||
16477089|NCT03633617|40228091|FG000|Part C (& Follow-up)|Pregnancy|0|||
16477090|NCT03633617|40228092|FG001|Part C (& Follow-up)|Pregnancy|0|||
16477091|NCT03633617|40228093|FG002|Part C (& Follow-up)|Pregnancy|0|||
16477092|NCT03633617|40228094|FG003|Part C (& Follow-up)|Pregnancy|0|||
16477093|NCT03633617|40228095|FG004|Part C (& Follow-up)|Pregnancy|0|||
16477094|NCT03633617|40228096|FG005|Part C (& Follow-up)|Pregnancy|0|||
16477095|NCT03633617|40228097|FG006|Part C (& Follow-up)|Pregnancy|0|||
16477096|NCT03633617|40228098|FG007|Part C (& Follow-up)|Pregnancy|0|||
16477097|NCT03633617|40228099|FG008|Part C (& Follow-up)|Pregnancy|0|||
16477098|NCT03633617|40228100|FG009|Part C (& Follow-up)|Pregnancy|1|||
16477099|NCT03633617|40228101|FG010|Part C (& Follow-up)|Pregnancy|0|||
16477100|NCT03633617|40228091|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
16477101|NCT03633617|40228092|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
16477102|NCT03633617|40228093|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
16477103|NCT03633617|40228094|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
16477104|NCT03633617|40228095|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
16278220|NCT02000115|39500799|FG003|Overall Study|Death|0|||
16278221|NCT02000115|39500796|FG000|Overall Study|Missed Visit|6|||
16278222|NCT02000115|39500797|FG001|Overall Study|Missed Visit|8|||
16278223|NCT02000115|39500798|FG002|Overall Study|Missed Visit|1|||
16477105|NCT03633617|40228096|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
16477106|NCT03633617|40228097|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
16278224|NCT02000115|39500799|FG003|Overall Study|Missed Visit|0|||
16278225|NCT02000115|39500796|FG000|Overall Study|Protocol Violation|2|||
16278226|NCT02000115|39500797|FG001|Overall Study|Protocol Violation|1|||
16278227|NCT02000115|39500798|FG002|Overall Study|Protocol Violation|0|||
16278228|NCT02000115|39500799|FG003|Overall Study|Protocol Violation|0|||
16278229|NCT02000115|39500796|FG000|Overall Study|Physician Decision|2|||
16278230|NCT02000115|39500797|FG001|Overall Study|Physician Decision|0|||
16278231|NCT02000115|39500798|FG002|Overall Study|Physician Decision|0|||
16278232|NCT02000115|39500799|FG003|Overall Study|Physician Decision|0|||
16278233|NCT02000115|39500796|FG000|Overall Study|Withdrawal by Subject|11|||
16278234|NCT02000115|39500797|FG001|Overall Study|Withdrawal by Subject|11|||
16278235|NCT02000115|39500798|FG002|Overall Study|Withdrawal by Subject|0|||
16278236|NCT02000115|39500799|FG003|Overall Study|Withdrawal by Subject|0|||
16278237|NCT02000115|39500796|FG000|Overall Study|Lost to Follow-up|0|||
16278238|NCT02000115|39500797|FG001|Overall Study|Lost to Follow-up|1|||
16278239|NCT02000115|39500798|FG002|Overall Study|Lost to Follow-up|0|||
16278240|NCT02000115|39500799|FG003|Overall Study|Lost to Follow-up|0|||
16278241|NCT02000115|39500796|FG000|Overall Study|Non-compliance|2|||
16278242|NCT02000115|39500797|FG001|Overall Study|Non-compliance|1|||
16278243|NCT02000115|39500798|FG002|Overall Study|Non-compliance|0|||
16278244|NCT02000115|39500799|FG003|Overall Study|Non-compliance|0|||
16278245|NCT02000115|39500796|FG000|Overall Study|Withdrawn on day of randomization|0|||
16278246|NCT02000115|39500797|FG001|Overall Study|Withdrawn on day of randomization|1|||
16278247|NCT02000115|39500798|FG002|Overall Study|Withdrawn on day of randomization|0|||
16278248|NCT02000115|39500799|FG003|Overall Study|Withdrawn on day of randomization|0|||
16278249|NCT02000115|39500796|FG000|Overall Study|Still on Study|0|||
16278250|NCT02000115|39500797|FG001|Overall Study|Still on Study|0|||
16278251|NCT02000115|39500798|FG002|Overall Study|Still on Study|0|||
16278252|NCT02000115|39500799|FG003|Overall Study|Still on Study|53|||
16278253|NCT02786927|39500803|FG000|Overall Study|Adverse Event|1|||
16477107|NCT03633617|40228098|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
16477108|NCT03633617|40228099|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
16477109|NCT03633617|40228100|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
16477110|NCT03633617|40228101|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
16477111|NCT03633617|40228091|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
16477112|NCT03633617|40228092|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
16477113|NCT03633617|40228093|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
16477114|NCT03633617|40228094|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
16278254|NCT02786927|39500803|FG000|Overall Study|Protocol Violation|4|||
16278255|NCT01214239|39500804|FG000|Overall Study|Adverse Event|3|||
16278256|NCT01214239|39500805|FG001|Overall Study|Adverse Event|4|||
16278257|NCT01214239|39500804|FG000|Overall Study|Protocol Violation|2|||
16278258|NCT01214239|39500805|FG001|Overall Study|Protocol Violation|1|||
16278259|NCT01214239|39500804|FG000|Overall Study|Lost to Follow-up|1|||
16278260|NCT01214239|39500805|FG001|Overall Study|Lost to Follow-up|1|||
16278261|NCT01214239|39500804|FG000|Overall Study|Withdrawal by Subject|4|||
16477115|NCT03633617|40228095|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
16477116|NCT03633617|40228096|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
16477117|NCT03633617|40228097|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
16477118|NCT03633617|40228098|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
16477119|NCT03633617|40228099|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
16477120|NCT03633617|40228100|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
16477121|NCT03633617|40228101|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
16477122|NCT03633617|40228091|FG000|Part C (& Follow-up)|Physician Decision|0|||
16477123|NCT03633617|40228092|FG001|Part C (& Follow-up)|Physician Decision|0|||
16278262|NCT01214239|39500805|FG001|Overall Study|Withdrawal by Subject|9|||
16278263|NCT01214239|39500804|FG000|Overall Study|Lack of Efficacy|1|||
16278264|NCT01214239|39500805|FG001|Overall Study|Lack of Efficacy|2|||
16278265|NCT01214239|39500804|FG000|Overall Study|patient's private reason|1|||
16477124|NCT03633617|40228093|FG002|Part C (& Follow-up)|Physician Decision|0|||
16477125|NCT03633617|40228094|FG003|Part C (& Follow-up)|Physician Decision|0|||
16477126|NCT03633617|40228095|FG004|Part C (& Follow-up)|Physician Decision|0|||
16477127|NCT03633617|40228096|FG005|Part C (& Follow-up)|Physician Decision|0|||
16477128|NCT03633617|40228097|FG006|Part C (& Follow-up)|Physician Decision|0|||
16477129|NCT03633617|40228098|FG007|Part C (& Follow-up)|Physician Decision|1|||
16477130|NCT03633617|40228099|FG008|Part C (& Follow-up)|Physician Decision|0|||
16477131|NCT03633617|40228100|FG009|Part C (& Follow-up)|Physician Decision|0|||
16477132|NCT03633617|40228101|FG010|Part C (& Follow-up)|Physician Decision|1|||
16477133|NCT03633617|40228091|FG000|Part C (& Follow-up)|COVID-19 related|0|||
16477134|NCT03633617|40228092|FG001|Part C (& Follow-up)|COVID-19 related|0|||
16477135|NCT03633617|40228093|FG002|Part C (& Follow-up)|COVID-19 related|0|||
16477136|NCT03633617|40228094|FG003|Part C (& Follow-up)|COVID-19 related|0|||
16477137|NCT03633617|40228095|FG004|Part C (& Follow-up)|COVID-19 related|0|||
16477138|NCT03633617|40228096|FG005|Part C (& Follow-up)|COVID-19 related|1|||
16477139|NCT03633617|40228097|FG006|Part C (& Follow-up)|COVID-19 related|0|||
16477140|NCT03633617|40228098|FG007|Part C (& Follow-up)|COVID-19 related|0|||
16477141|NCT03633617|40228099|FG008|Part C (& Follow-up)|COVID-19 related|0|||
16477142|NCT03633617|40228100|FG009|Part C (& Follow-up)|COVID-19 related|0|||
16477143|NCT03633617|40228101|FG010|Part C (& Follow-up)|COVID-19 related|0|||
16477144|NCT03633617|40228091|FG000|Part C (& Follow-up)|Protocol Violation|0|||
16477145|NCT03633617|40228092|FG001|Part C (& Follow-up)|Protocol Violation|0|||
16477146|NCT03633617|40228093|FG002|Part C (& Follow-up)|Protocol Violation|0|||
16477147|NCT03633617|40228094|FG003|Part C (& Follow-up)|Protocol Violation|0|||
16477148|NCT03633617|40228095|FG004|Part C (& Follow-up)|Protocol Violation|0|||
16477149|NCT03633617|40228096|FG005|Part C (& Follow-up)|Protocol Violation|0|||
16477150|NCT03633617|40228097|FG006|Part C (& Follow-up)|Protocol Violation|0|||
16477151|NCT03633617|40228098|FG007|Part C (& Follow-up)|Protocol Violation|0|||
16477152|NCT03633617|40228099|FG008|Part C (& Follow-up)|Protocol Violation|0|||
16477153|NCT03633617|40228100|FG009|Part C (& Follow-up)|Protocol Violation|3|||
16477154|NCT03633617|40228101|FG010|Part C (& Follow-up)|Protocol Violation|1|||
16477155|NCT03633617|40228091|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
16477156|NCT03633617|40228092|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
16477157|NCT03633617|40228093|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
16477158|NCT03633617|40228094|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
16477159|NCT03633617|40228095|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
16477160|NCT03633617|40228096|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
16477161|NCT03633617|40228097|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
16477162|NCT03633617|40228098|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
16477163|NCT03633617|40228099|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
16477164|NCT03633617|40228100|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
16477165|NCT03633617|40228101|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
16477166|NCT00369122|40228102|FG000|Overall Study|Ineligible|10|||
16477167|NCT00369122|40228102|FG000|Overall Study|No protocol treatment|1|||
16477168|NCT01907100|40228105|FG000|Overall Study|PD based on modified RECIST criteria|31|||
16477169|NCT01907100|40228106|FG001|Overall Study|PD based on modified RECIST criteria|32|||
16477170|NCT01907100|40228107|FG002|Overall Study|PD based on modified RECIST criteria|95|||
16278266|NCT01214239|39500805|FG001|Overall Study|patient's private reason|1|||
16278267|NCT01664039|39500806|FG000|Overall Study|Adverse Event|3|||
16278268|NCT01664039|39500807|FG001|Overall Study|Adverse Event|4|||
16278269|NCT01664039|39500806|FG000|Overall Study|Lost to Follow-up|1|||
16477171|NCT01907100|40228108|FG003|Overall Study|PD based on modified RECIST criteria|92|||
16477172|NCT01907100|40228105|FG000|Overall Study|Withdrawal by Subject|2|||
16477173|NCT01907100|40228106|FG001|Overall Study|Withdrawal by Subject|5|||
16278270|NCT01664039|39500807|FG001|Overall Study|Lost to Follow-up|1|||
16477174|NCT01907100|40228107|FG002|Overall Study|Withdrawal by Subject|10|||
16477175|NCT01907100|40228108|FG003|Overall Study|Withdrawal by Subject|13|||
16477176|NCT01907100|40228105|FG000|Overall Study|Protocol Violation|0|||
16477177|NCT01907100|40228106|FG001|Overall Study|Protocol Violation|0|||
16477178|NCT01907100|40228107|FG002|Overall Study|Protocol Violation|1|||
16477179|NCT01907100|40228108|FG003|Overall Study|Protocol Violation|1|||
16477180|NCT01907100|40228105|FG000|Overall Study|Lost to Follow-up|0|||
16477181|NCT01907100|40228106|FG001|Overall Study|Lost to Follow-up|0|||
16477182|NCT01907100|40228107|FG002|Overall Study|Lost to Follow-up|0|||
16477183|NCT01907100|40228108|FG003|Overall Study|Lost to Follow-up|1|||
16477184|NCT01907100|40228105|FG000|Overall Study|Not treated|2|||
16477185|NCT01907100|40228106|FG001|Overall Study|Not treated|0|||
16477186|NCT01907100|40228107|FG002|Overall Study|Not treated|1|||
16477187|NCT01907100|40228108|FG003|Overall Study|Not treated|2|||
16477188|NCT01907100|40228105|FG000|Overall Study|Other than reasons specified|1|||
16477189|NCT01907100|40228106|FG001|Overall Study|Other than reasons specified|0|||
16477190|NCT01907100|40228107|FG002|Overall Study|Other than reasons specified|10|||
16477191|NCT01907100|40228108|FG003|Overall Study|Other than reasons specified|6|||
16477192|NCT01907100|40228105|FG000|Overall Study|Adverse event (AE)|6|||
16477193|NCT01907100|40228106|FG001|Overall Study|Adverse event (AE)|3|||
16477194|NCT01907100|40228107|FG002|Overall Study|Adverse event (AE)|22|||
16477195|NCT01907100|40228108|FG003|Overall Study|Adverse event (AE)|23|||
16477196|NCT01907100|40228105|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
16477197|NCT01907100|40228106|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
16477198|NCT01907100|40228107|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
16477199|NCT01907100|40228108|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
16477200|NCT00809354|40228109|FG000|Overall Study|Adverse Event|32|||
16477201|NCT00809354|40228110|FG001|Overall Study|Adverse Event|45|||
16477202|NCT00809354|40228111|FG002|Overall Study|Adverse Event|37|||
16477203|NCT00809354|40228112|FG003|Overall Study|Adverse Event|53|||
16477204|NCT00809354|40228113|FG004|Overall Study|Adverse Event|26|||
16477205|NCT00809354|40228114|FG005|Overall Study|Adverse Event|33|||
16477206|NCT00809354|40228115|FG006|Overall Study|Adverse Event|44|||
16477207|NCT00809354|40228116|FG007|Overall Study|Adverse Event|40|||
16477208|NCT00809354|40228117|FG008|Overall Study|Adverse Event|46|||
16477209|NCT00809354|40228118|FG009|Overall Study|Adverse Event|26|||
16477210|NCT00809354|40228109|FG000|Overall Study|Lack of Efficacy|23|||
16477211|NCT00809354|40228110|FG001|Overall Study|Lack of Efficacy|23|||
16477212|NCT00809354|40228111|FG002|Overall Study|Lack of Efficacy|22|||
16477213|NCT00809354|40228112|FG003|Overall Study|Lack of Efficacy|15|||
16477214|NCT00809354|40228113|FG004|Overall Study|Lack of Efficacy|40|||
16477215|NCT00809354|40228114|FG005|Overall Study|Lack of Efficacy|19|||
16477216|NCT00809354|40228115|FG006|Overall Study|Lack of Efficacy|21|||
16477217|NCT00809354|40228116|FG007|Overall Study|Lack of Efficacy|15|||
16477218|NCT00809354|40228117|FG008|Overall Study|Lack of Efficacy|18|||
16477219|NCT00809354|40228118|FG009|Overall Study|Lack of Efficacy|38|||
16477220|NCT00809354|40228109|FG000|Overall Study|Lost to Follow-up|10|||
16477221|NCT00809354|40228110|FG001|Overall Study|Lost to Follow-up|11|||
16477222|NCT00809354|40228111|FG002|Overall Study|Lost to Follow-up|8|||
16477223|NCT00809354|40228112|FG003|Overall Study|Lost to Follow-up|13|||
16477224|NCT00809354|40228113|FG004|Overall Study|Lost to Follow-up|6|||
16477225|NCT00809354|40228114|FG005|Overall Study|Lost to Follow-up|2|||
16477226|NCT00809354|40228115|FG006|Overall Study|Lost to Follow-up|0|||
16477227|NCT00809354|40228116|FG007|Overall Study|Lost to Follow-up|5|||
16477228|NCT00809354|40228117|FG008|Overall Study|Lost to Follow-up|4|||
16477229|NCT00809354|40228118|FG009|Overall Study|Lost to Follow-up|0|||
16477230|NCT00809354|40228109|FG000|Overall Study|Protocol Violation|7|||
16477231|NCT00809354|40228110|FG001|Overall Study|Protocol Violation|14|||
16477232|NCT00809354|40228111|FG002|Overall Study|Protocol Violation|14|||
16477233|NCT00809354|40228112|FG003|Overall Study|Protocol Violation|12|||
16477234|NCT00809354|40228113|FG004|Overall Study|Protocol Violation|14|||
16477235|NCT00809354|40228114|FG005|Overall Study|Protocol Violation|6|||
16477236|NCT00809354|40228115|FG006|Overall Study|Protocol Violation|4|||
16477237|NCT00809354|40228116|FG007|Overall Study|Protocol Violation|6|||
16477238|NCT00809354|40228117|FG008|Overall Study|Protocol Violation|9|||
16278271|NCT01664039|39500806|FG000|Overall Study|Withdrawal by Subject|1|||
16477239|NCT00809354|40228118|FG009|Overall Study|Protocol Violation|3|||
16477240|NCT00809354|40228109|FG000|Overall Study|Withdrawal by Subject|32|||
16477241|NCT00809354|40228110|FG001|Overall Study|Withdrawal by Subject|27|||
16477242|NCT00809354|40228111|FG002|Overall Study|Withdrawal by Subject|31|||
16477243|NCT00809354|40228112|FG003|Overall Study|Withdrawal by Subject|33|||
16477244|NCT00809354|40228113|FG004|Overall Study|Withdrawal by Subject|34|||
16477245|NCT00809354|40228114|FG005|Overall Study|Withdrawal by Subject|29|||
16477246|NCT00809354|40228115|FG006|Overall Study|Withdrawal by Subject|27|||
16477247|NCT00809354|40228116|FG007|Overall Study|Withdrawal by Subject|19|||
16477248|NCT00809354|40228117|FG008|Overall Study|Withdrawal by Subject|18|||
16477249|NCT00809354|40228118|FG009|Overall Study|Withdrawal by Subject|20|||
16477250|NCT00809354|40228109|FG000|Overall Study|Other|10|||
16477251|NCT00809354|40228110|FG001|Overall Study|Other|2|||
16477252|NCT00809354|40228111|FG002|Overall Study|Other|7|||
16477253|NCT00809354|40228112|FG003|Overall Study|Other|10|||
16477254|NCT00809354|40228113|FG004|Overall Study|Other|5|||
16278272|NCT01664039|39500807|FG001|Overall Study|Withdrawal by Subject|3|||
16477255|NCT00809354|40228114|FG005|Overall Study|Other|3|||
16477256|NCT00809354|40228115|FG006|Overall Study|Other|2|||
16477257|NCT00809354|40228116|FG007|Overall Study|Other|3|||
16477258|NCT00809354|40228117|FG008|Overall Study|Other|4|||
16477259|NCT00809354|40228118|FG009|Overall Study|Other|3|||
16477260|NCT00809354|40228109|FG000|Overall Study|Study terminated by sponsor|138|||
16477261|NCT00809354|40228110|FG001|Overall Study|Study terminated by sponsor|134|||
16477262|NCT00809354|40228111|FG002|Overall Study|Study terminated by sponsor|129|||
16477263|NCT00809354|40228112|FG003|Overall Study|Study terminated by sponsor|120|||
16477264|NCT00809354|40228113|FG004|Overall Study|Study terminated by sponsor|126|||
16477265|NCT00809354|40228114|FG005|Overall Study|Study terminated by sponsor|133|||
16477266|NCT00809354|40228115|FG006|Overall Study|Study terminated by sponsor|124|||
16477267|NCT00809354|40228116|FG007|Overall Study|Study terminated by sponsor|148|||
16477268|NCT00809354|40228117|FG008|Overall Study|Study terminated by sponsor|127|||
16477269|NCT00809354|40228118|FG009|Overall Study|Study terminated by sponsor|135|||
16477270|NCT00809354|40228109|FG000|Overall Study|Withdrawn due to pregnancy|0|||
16477271|NCT00809354|40228110|FG001|Overall Study|Withdrawn due to pregnancy|1|||
16477272|NCT00809354|40228111|FG002|Overall Study|Withdrawn due to pregnancy|0|||
16477273|NCT00809354|40228112|FG003|Overall Study|Withdrawn due to pregnancy|0|||
16477274|NCT00809354|40228113|FG004|Overall Study|Withdrawn due to pregnancy|0|||
16477275|NCT00809354|40228114|FG005|Overall Study|Withdrawn due to pregnancy|0|||
16477276|NCT00809354|40228115|FG006|Overall Study|Withdrawn due to pregnancy|0|||
16477277|NCT00809354|40228116|FG007|Overall Study|Withdrawn due to pregnancy|0|||
16477278|NCT00809354|40228117|FG008|Overall Study|Withdrawn due to pregnancy|0|||
16477279|NCT00809354|40228118|FG009|Overall Study|Withdrawn due to pregnancy|0|||
16477280|NCT00809354|40228109|FG000|Overall Study|Randomized but not Treated|3|||
16477281|NCT00809354|40228110|FG001|Overall Study|Randomized but not Treated|1|||
16477282|NCT00809354|40228111|FG002|Overall Study|Randomized but not Treated|6|||
16477283|NCT00809354|40228112|FG003|Overall Study|Randomized but not Treated|0|||
16477284|NCT00809354|40228113|FG004|Overall Study|Randomized but not Treated|5|||
16477285|NCT00809354|40228114|FG005|Overall Study|Randomized but not Treated|0|||
16477286|NCT00809354|40228115|FG006|Overall Study|Randomized but not Treated|1|||
16477287|NCT00809354|40228116|FG007|Overall Study|Randomized but not Treated|1|||
16477288|NCT00809354|40228117|FG008|Overall Study|Randomized but not Treated|2|||
16477289|NCT00809354|40228118|FG009|Overall Study|Randomized but not Treated|1|||
16278273|NCT01664039|39500806|FG000|Overall Study|Noncompliance|1|||
16278274|NCT01664039|39500807|FG001|Overall Study|Noncompliance|1|||
16278275|NCT02169791|39500824|FG000|Overall Study|Death|6|||
16278276|NCT02169791|39500824|FG000|Overall Study|patient withdrew consent|1|||
16477290|NCT00809354|40228109|FG000|Overall Study|Death|0|||
16477291|NCT00809354|40228110|FG001|Overall Study|Death|0|||
16477292|NCT00809354|40228111|FG002|Overall Study|Death|0|||
16477293|NCT00809354|40228112|FG003|Overall Study|Death|0|||
16477294|NCT00809354|40228113|FG004|Overall Study|Death|0|||
16477295|NCT00809354|40228114|FG005|Overall Study|Death|0|||
16477296|NCT00809354|40228115|FG006|Overall Study|Death|0|||
16477297|NCT00809354|40228116|FG007|Overall Study|Death|1|||
16477298|NCT00809354|40228117|FG008|Overall Study|Death|0|||
16278277|NCT04253236|39500829|FG000|Overall Study|Adverse Event|1|||
16278278|NCT04253236|39500830|FG001|Overall Study|Adverse Event|0|||
16278279|NCT04253236|39500829|FG000|Overall Study|Safety Concerns|1|||
16278280|NCT04253236|39500830|FG001|Overall Study|Safety Concerns|0|||
16278281|NCT04253236|39500829|FG000|Overall Study|Study Terminated by Sponsor|1|||
16477299|NCT00809354|40228118|FG009|Overall Study|Death|0|||
16477300|NCT01601132|40228119|FG000|Overall Study|Patient withdrew consent|1|||
16477301|NCT01601132|40228119|FG000|Overall Study|Protocol deviation|1|||
16477302|NCT03516812|40228120|FG000|Overall Study|Adverse Event|4|||
16477303|NCT03516812|40228120|FG000|Overall Study|Lack of Efficacy|2|||
16477304|NCT03643575|40228138|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
16477305|NCT03643575|40228139|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
16477306|NCT03643575|40228140|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
16477307|NCT03643575|40228141|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
16477308|NCT03643575|40228142|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
16477309|NCT03643575|40228143|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
16477310|NCT03643575|40228138|FG000|Washout: 7 Days|Adverse Event|1|||
16477311|NCT03643575|40228139|FG001|Washout: 7 Days|Adverse Event|0|||
16477312|NCT03643575|40228140|FG002|Washout: 7 Days|Adverse Event|0|||
16477313|NCT03643575|40228141|FG003|Washout: 7 Days|Adverse Event|0|||
16477314|NCT03643575|40228142|FG004|Washout: 7 Days|Adverse Event|0|||
16477315|NCT03643575|40228143|FG005|Washout: 7 Days|Adverse Event|0|||
16477316|NCT03643575|40228138|FG000|Washout: 7 Days|Non compliance check in|0|||
16477317|NCT03643575|40228139|FG001|Washout: 7 Days|Non compliance check in|1|||
16477318|NCT03643575|40228140|FG002|Washout: 7 Days|Non compliance check in|0|||
16278282|NCT04253236|39500830|FG001|Overall Study|Study Terminated by Sponsor|0|||
16278283|NCT03686215|39500831|FG000|Overall Study|Adverse Event|0|||
16477319|NCT03643575|40228141|FG003|Washout: 7 Days|Non compliance check in|0|||
16477320|NCT03643575|40228142|FG004|Washout: 7 Days|Non compliance check in|0|||
16477321|NCT03643575|40228143|FG005|Washout: 7 Days|Non compliance check in|0|||
16477322|NCT00573937|40228144|FG000|Overall Study|Study Terminated|0|||
16477323|NCT00573937|40228145|FG001|Overall Study|Study Terminated|1|||
16477324|NCT00810693|40228146|FG000|Treatment Period|Adverse Event|8|||
16477325|NCT00810693|40228147|FG001|Treatment Period|Adverse Event|1|||
16477326|NCT00810693|40228148|FG002|Treatment Period|Adverse Event|7|||
16477327|NCT00810693|40228146|FG000|Treatment Period|Death|0|||
16477328|NCT00810693|40228147|FG001|Treatment Period|Death|1|||
16477329|NCT00810693|40228148|FG002|Treatment Period|Death|2|||
16477330|NCT00810693|40228146|FG000|Treatment Period|Lack of Efficacy|0|||
16477331|NCT00810693|40228147|FG001|Treatment Period|Lack of Efficacy|0|||
16477332|NCT00810693|40228148|FG002|Treatment Period|Lack of Efficacy|1|||
16477333|NCT00810693|40228146|FG000|Treatment Period|Lost to Follow-up|1|||
16477334|NCT00810693|40228147|FG001|Treatment Period|Lost to Follow-up|0|||
16477335|NCT00810693|40228148|FG002|Treatment Period|Lost to Follow-up|0|||
16477336|NCT00810693|40228146|FG000|Treatment Period|Non-compliance|1|||
16477337|NCT00810693|40228147|FG001|Treatment Period|Non-compliance|0|||
16477338|NCT00810693|40228148|FG002|Treatment Period|Non-compliance|0|||
16477339|NCT00810693|40228146|FG000|Treatment Period|Protocol Violation|1|||
16477340|NCT00810693|40228147|FG001|Treatment Period|Protocol Violation|2|||
16477341|NCT00810693|40228148|FG002|Treatment Period|Protocol Violation|2|||
16477342|NCT00810693|40228146|FG000|Treatment Period|Withdrawal by Subject|6|||
16477343|NCT00810693|40228147|FG001|Treatment Period|Withdrawal by Subject|2|||
16477344|NCT00810693|40228148|FG002|Treatment Period|Withdrawal by Subject|3|||
16477345|NCT00810693|40228146|FG000|Treatment Period|Not treated|0|||
16076464|NCT01713946|38773247|FG002|Overall Study|Lack of Efficacy|14|||
16477346|NCT00810693|40228147|FG001|Treatment Period|Not treated|1|||
16477347|NCT00810693|40228148|FG002|Treatment Period|Not treated|1|||
16477348|NCT00810693|40228146|FG000|Follow-up Period (FUP)|Adverse Event|3|||
16477349|NCT00810693|40228147|FG001|Follow-up Period (FUP)|Adverse Event|1|||
16477350|NCT00810693|40228148|FG002|Follow-up Period (FUP)|Adverse Event|1|||
16477351|NCT00810693|40228146|FG000|Follow-up Period (FUP)|Death|2|||
16477352|NCT00810693|40228147|FG001|Follow-up Period (FUP)|Death|0|||
16477353|NCT00810693|40228148|FG002|Follow-up Period (FUP)|Death|1|||
16477354|NCT00810693|40228146|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
16477355|NCT00810693|40228147|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
16477356|NCT00810693|40228148|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
16477357|NCT00810693|40228146|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
16477358|NCT00810693|40228147|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
16278284|NCT03686215|39500832|FG001|Overall Study|Adverse Event|0|||
16278285|NCT03686215|39500833|FG002|Overall Study|Adverse Event|7|||
16278286|NCT03686215|39500831|FG000|Overall Study|Physician Decision|0|||
16278287|NCT03686215|39500832|FG001|Overall Study|Physician Decision|0|||
16278288|NCT03686215|39500833|FG002|Overall Study|Physician Decision|1|||
16278289|NCT03686215|39500831|FG000|Overall Study|Protocol Violation|0|||
16477359|NCT00810693|40228148|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
16477360|NCT00810693|40228146|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
16477361|NCT00810693|40228147|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
16477362|NCT00810693|40228148|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
16477363|NCT00215683|40228149|FG000|Overall Study|Adverse Event|15|||
16477364|NCT00215683|40228150|FG001|Overall Study|Adverse Event|16|||
16477365|NCT00215683|40228151|FG002|Overall Study|Adverse Event|15|||
16477366|NCT00215683|40228149|FG000|Overall Study|Lack of Efficacy|5|||
16477367|NCT00215683|40228150|FG001|Overall Study|Lack of Efficacy|1|||
16477368|NCT00215683|40228151|FG002|Overall Study|Lack of Efficacy|2|||
16477369|NCT00215683|40228149|FG000|Overall Study|Lost to Follow-up|0|||
16477370|NCT00215683|40228150|FG001|Overall Study|Lost to Follow-up|2|||
16477371|NCT00215683|40228151|FG002|Overall Study|Lost to Follow-up|1|||
16477372|NCT00215683|40228149|FG000|Overall Study|Withdrawal by Subject|9|||
16477373|NCT00215683|40228150|FG001|Overall Study|Withdrawal by Subject|4|||
16477374|NCT00215683|40228151|FG002|Overall Study|Withdrawal by Subject|13|||
16477375|NCT00215683|40228149|FG000|Overall Study|Physician Decision|0|||
16477376|NCT00215683|40228150|FG001|Overall Study|Physician Decision|0|||
16477377|NCT00215683|40228151|FG002|Overall Study|Physician Decision|1|||
16477378|NCT00215683|40228149|FG000|Overall Study|Difficult to attend visits|0|||
16477379|NCT00215683|40228150|FG001|Overall Study|Difficult to attend visits|1|||
16278290|NCT03686215|39500832|FG001|Overall Study|Protocol Violation|0|||
16278291|NCT03686215|39500833|FG002|Overall Study|Protocol Violation|4|||
16477380|NCT00215683|40228151|FG002|Overall Study|Difficult to attend visits|0|||
16477381|NCT00215683|40228149|FG000|Overall Study|No study drug available|0|||
16477382|NCT00215683|40228150|FG001|Overall Study|No study drug available|1|||
16076465|NCT01713946|38773245|FG000|Overall Study|Protocol Violation|2|||
16278292|NCT03686215|39500831|FG000|Overall Study|Device issue|1|||
16278293|NCT03686215|39500832|FG001|Overall Study|Device issue|0|||
16278294|NCT03686215|39500833|FG002|Overall Study|Device issue|2|||
16278295|NCT02587143|39500836|FG000|Overall Study|Adverse Event|1|||
16278296|NCT02587143|39500837|FG001|Overall Study|Adverse Event|0|||
16076466|NCT01713946|38773246|FG001|Overall Study|Protocol Violation|4|||
16378741|NCT01435356|39872215|FG000|Overall Study|Facial palsy|1|||
16076467|NCT01713946|38773247|FG002|Overall Study|Protocol Violation|1|||
16076468|NCT01713946|38773245|FG000|Overall Study|Lost to Follow-up|0|||
16076469|NCT01713946|38773246|FG001|Overall Study|Lost to Follow-up|0|||
16076470|NCT01713946|38773247|FG002|Overall Study|Lost to Follow-up|1|||
16076471|NCT01713946|38773245|FG000|Overall Study|Administrative problems|1|||
16076472|NCT01713946|38773246|FG001|Overall Study|Administrative problems|0|||
16076473|NCT01713946|38773247|FG002|Overall Study|Administrative problems|0|||
16076474|NCT01713946|38773245|FG000|Overall Study|Did not continue in Ext|0|||
16076475|NCT01713946|38773246|FG001|Overall Study|Did not continue in Ext|3|||
16076476|NCT01713946|38773247|FG002|Overall Study|Did not continue in Ext|0|||
16176165|NCT00785577|39122856|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
16076477|NCT01713946|38773245|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
16076478|NCT01713946|38773246|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
16076479|NCT01713946|38773247|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
16076480|NCT01713946|38773245|FG000|Overall Study|Patients never switched to everolimus|0|||
16076481|NCT01713946|38773246|FG001|Overall Study|Patients never switched to everolimus|0|||
16076482|NCT01713946|38773247|FG002|Overall Study|Patients never switched to everolimus|5|||
16076483|NCT00293293|38773248|FG000|Overall Study|Withdrawal by Subject|1|||
16076484|NCT00293293|38773249|FG001|Overall Study|Withdrawal by Subject|1|||
16076485|NCT00293293|38773248|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
16076486|NCT00293293|38773249|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
16076487|NCT00293293|38773248|FG000|Overall Study|Patient discontinued chemotherapy|0|||
16076488|NCT00293293|38773249|FG001|Overall Study|Patient discontinued chemotherapy|1|||
16076489|NCT00979992|38773250|FG000|Overall Study|Ineligible - inadequate pathology|1|||
16076490|NCT00979992|38773250|FG000|Overall Study|Ineligible - wrong cell type|2|||
16076491|NCT00979992|38773250|FG000|Overall Study|Refused - Never Treated|2|||
16076492|NCT00361283|38773255|FG000|Overall Study|Lost to Follow-up|27|||
16076493|NCT02274493|38773258|FG000|Overall Study|Withdrawal by Subject|1|||
16076494|NCT03621696|38773259|FG000|Overall Study|Not eligible|0|||
16076495|NCT03621696|38773260|FG001|Overall Study|Not eligible|0|||
16076496|NCT03621696|38773261|FG002|Overall Study|Not eligible|0|||
16076497|NCT03621696|38773262|FG003|Overall Study|Not eligible|5|||
16076498|NCT03621696|38773259|FG000|Overall Study|Withdrawal by Subject|1|||
16076499|NCT03621696|38773260|FG001|Overall Study|Withdrawal by Subject|1|||
16076500|NCT03621696|38773261|FG002|Overall Study|Withdrawal by Subject|1|||
16076501|NCT03621696|38773262|FG003|Overall Study|Withdrawal by Subject|0|||
16076502|NCT03621696|38773259|FG000|Overall Study|Physician Decision|0|||
16076503|NCT03621696|38773260|FG001|Overall Study|Physician Decision|0|||
16076504|NCT03621696|38773261|FG002|Overall Study|Physician Decision|1|||
16076505|NCT03621696|38773262|FG003|Overall Study|Physician Decision|0|||
16076506|NCT02525796|38773263|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
16076507|NCT02525796|38773264|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
16076508|NCT02525796|38773265|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
16076509|NCT02525796|38773263|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
16076510|NCT02525796|38773264|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
16076511|NCT02525796|38773265|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
16076512|NCT02525796|38773263|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
16076513|NCT02525796|38773264|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
16076514|NCT02525796|38773265|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
16076515|NCT02525796|38773263|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
16076516|NCT02525796|38773264|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
16076517|NCT02525796|38773265|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
16076518|NCT02525796|38773263|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
16278297|NCT03619876|39500842|FG000|Overall Study|Withdrawal by Subject|1|||
16076519|NCT02525796|38773264|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
16076520|NCT02525796|38773265|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
16076521|NCT01061151|38773269|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
16076522|NCT01061151|38773270|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
16076523|NCT01061151|38773271|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
16076524|NCT01061151|38773272|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
16076525|NCT01061151|38773269|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
16076526|NCT01061151|38773270|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
16076527|NCT01061151|38773271|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
16076528|NCT01061151|38773272|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
16076529|NCT01061151|38773269|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
16076530|NCT01061151|38773270|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
16076531|NCT01061151|38773271|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
16076532|NCT01061151|38773272|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
16076533|NCT01061151|38773269|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
16076534|NCT01061151|38773270|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
16076535|NCT01061151|38773271|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
16076536|NCT01061151|38773272|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
16076537|NCT01061151|38773269|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
16076538|NCT01061151|38773270|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
16076539|NCT01061151|38773271|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
16076540|NCT01061151|38773272|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
16076541|NCT01061151|38773269|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
16076542|NCT01061151|38773270|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
16076543|NCT01061151|38773271|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
16076544|NCT01061151|38773272|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
16076545|NCT01061151|38773269|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
16076546|NCT01061151|38773270|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
16076547|NCT01061151|38773271|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
16076548|NCT01061151|38773272|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
16076549|NCT01061151|38773269|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
16076550|NCT01061151|38773270|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
16076551|NCT01061151|38773271|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
16076552|NCT01061151|38773272|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
16076553|NCT01061151|38773269|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
16278298|NCT03619876|39500843|FG001|Overall Study|Withdrawal by Subject|2|||
16076554|NCT01061151|38773270|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
16076555|NCT01061151|38773271|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
16076556|NCT01061151|38773272|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
16076557|NCT01061151|38773269|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
16076558|NCT01061151|38773270|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
16076559|NCT01061151|38773271|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
16076560|NCT01061151|38773272|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
16076561|NCT01061151|38773269|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
16076562|NCT01061151|38773270|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
16076563|NCT01061151|38773271|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
16076564|NCT01061151|38773272|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
16076565|NCT01061151|38773269|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
16076566|NCT01061151|38773270|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
16076567|NCT01061151|38773271|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
16076568|NCT01061151|38773272|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
16076569|NCT01061151|38773269|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
16076570|NCT01061151|38773270|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
16076571|NCT01061151|38773271|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
16076572|NCT01061151|38773272|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
16076573|NCT01061151|38773269|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
16076574|NCT01061151|38773270|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
16076575|NCT01061151|38773271|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
16076576|NCT01061151|38773272|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
16076577|NCT01061151|38773269|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
16076578|NCT01061151|38773270|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
16076579|NCT01061151|38773271|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
16076580|NCT01061151|38773272|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
16076581|NCT00177216|38773276|FG000|Overall Study|Withdrawal by Subject|6|||
16076582|NCT00177216|38773277|FG001|Overall Study|Withdrawal by Subject|3|||
16076583|NCT00177216|38773278|FG002|Overall Study|Withdrawal by Subject|1|||
16076584|NCT03460756|38773281|FG000|Overall Study|Adverse Event|0|||
16076585|NCT03460756|38773282|FG001|Overall Study|Adverse Event|0|||
16076586|NCT03460756|38773283|FG002|Overall Study|Adverse Event|0|||
16076587|NCT03460756|38773284|FG003|Overall Study|Adverse Event|1|||
16076588|NCT03460756|38773281|FG000|Overall Study|Lack of Efficacy|0|||
16076589|NCT03460756|38773282|FG001|Overall Study|Lack of Efficacy|0|||
16076590|NCT03460756|38773283|FG002|Overall Study|Lack of Efficacy|0|||
16076591|NCT03460756|38773284|FG003|Overall Study|Lack of Efficacy|2|||
16076592|NCT03460756|38773281|FG000|Overall Study|Lost to Follow-up|0|||
16076593|NCT03460756|38773282|FG001|Overall Study|Lost to Follow-up|1|||
16076594|NCT03460756|38773283|FG002|Overall Study|Lost to Follow-up|2|||
16076595|NCT03460756|38773284|FG003|Overall Study|Lost to Follow-up|1|||
16076596|NCT03460756|38773281|FG000|Overall Study|Pregnancy|0|||
16076597|NCT03460756|38773282|FG001|Overall Study|Pregnancy|0|||
16076598|NCT03460756|38773283|FG002|Overall Study|Pregnancy|0|||
16076599|NCT03460756|38773284|FG003|Overall Study|Pregnancy|1|||
16076600|NCT03460756|38773281|FG000|Overall Study|Protocol Violation|0|||
16076601|NCT03460756|38773282|FG001|Overall Study|Protocol Violation|0|||
16076602|NCT03460756|38773283|FG002|Overall Study|Protocol Violation|0|||
16076603|NCT03460756|38773284|FG003|Overall Study|Protocol Violation|1|||
16076604|NCT03460756|38773281|FG000|Overall Study|Withdrawal by Subject|0|||
16076605|NCT03460756|38773282|FG001|Overall Study|Withdrawal by Subject|4|||
16076606|NCT03460756|38773283|FG002|Overall Study|Withdrawal by Subject|7|||
16076607|NCT03460756|38773284|FG003|Overall Study|Withdrawal by Subject|3|||
16076608|NCT03557008|38773285|FG000|Overall Study|Withdrawal by Subject|2|||
16076609|NCT03557008|38773286|FG001|Overall Study|Withdrawal by Subject|2|||
16076610|NCT03557008|38773285|FG000|Overall Study|Early termination from study|3|||
16076611|NCT03557008|38773286|FG001|Overall Study|Early termination from study|1|||
16076612|NCT00588666|38773287|FG000|Overall Study|Adverse Event|4|||
16076613|NCT01458210|38773293|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
16076614|NCT01458210|38773293|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
16076615|NCT01458210|38773293|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
16076616|NCT01458210|38773293|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
16076617|NCT04580303|38773294|FG000|Overall Study|Adverse Event|0|||
16076618|NCT04580303|38773295|FG001|Overall Study|Adverse Event|1|||
16076619|NCT04580303|38773296|FG002|Overall Study|Adverse Event|0|||
16076620|NCT04580303|38773297|FG003|Overall Study|Adverse Event|0|||
16076621|NCT04580303|38773294|FG000|Overall Study|Withdrawal by Subject|0|||
16076622|NCT04580303|38773295|FG001|Overall Study|Withdrawal by Subject|0|||
16076623|NCT04580303|38773296|FG002|Overall Study|Withdrawal by Subject|1|||
16076624|NCT04580303|38773297|FG003|Overall Study|Withdrawal by Subject|0|||
16076625|NCT01068743|38773300|FG000|Period 3|Adverse Event|0|||
16076626|NCT01068743|38773301|FG001|Period 3|Adverse Event|1|||
16076627|NCT01068743|38773302|FG002|Period 3|Adverse Event|0|||
16378742|NCT01435356|39872216|FG001|Overall Study|Facial palsy|0|||
16076628|NCT01068743|38773303|FG003|Period 3|Adverse Event|0|||
16076629|NCT01199705|38773304|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
16076630|NCT00988637|38773305|FG000|Overall Study|Lost to Follow-up|2|||
16076631|NCT00988637|38773306|FG001|Overall Study|Lost to Follow-up|1|||
16076632|NCT00988637|38773305|FG000|Overall Study|Withdrawal by Subject|1|||
16076633|NCT00988637|38773306|FG001|Overall Study|Withdrawal by Subject|1|||
16076634|NCT00988637|38773305|FG000|Overall Study|non-compliance with study drug|0|||
16076635|NCT00988637|38773306|FG001|Overall Study|non-compliance with study drug|1|||
16076636|NCT02706717|38773307|FG000|Overall Study|Withdrawal by Subject|1|||
16076637|NCT02706717|38773308|FG001|Overall Study|Withdrawal by Subject|8|||
16076638|NCT02706717|38773307|FG000|Overall Study|Lost to Follow-up|0|||
16076639|NCT02706717|38773308|FG001|Overall Study|Lost to Follow-up|1|||
16076640|NCT02706717|38773307|FG000|Overall Study|Physician Decision|0|||
16076641|NCT02706717|38773308|FG001|Overall Study|Physician Decision|1|||
16076642|NCT02706717|38773307|FG000|Overall Study|Death|0|||
16076643|NCT02706717|38773308|FG001|Overall Study|Death|1|||
16076644|NCT00638963|38773313|FG000|Overall Study|Withdrawal by Subject|1|||
16076645|NCT00638963|38773314|FG001|Overall Study|Withdrawal by Subject|0|||
16076646|NCT02570711|38773315|FG000|Overall Study|Death|1|||
16076647|NCT02570711|38773316|FG001|Overall Study|Death|0|||
16076648|NCT02570711|38773315|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
16076649|NCT02570711|38773316|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
16076650|NCT00940992|38773318|FG000|Overall Study|Adverse Event|2|||
16076651|NCT00940992|38773319|FG001|Overall Study|Adverse Event|0|||
16076652|NCT00940992|38773320|FG002|Overall Study|Adverse Event|1|||
16076653|NCT00940992|38773318|FG000|Overall Study|subject request|2|||
16076654|NCT00940992|38773319|FG001|Overall Study|subject request|1|||
16076655|NCT00940992|38773320|FG002|Overall Study|subject request|0|||
16076656|NCT00940992|38773318|FG000|Overall Study|Lost to Follow-up|0|||
16076657|NCT00940992|38773319|FG001|Overall Study|Lost to Follow-up|1|||
16076658|NCT00940992|38773320|FG002|Overall Study|Lost to Follow-up|1|||
16076659|NCT00835770|38773321|FG000|Overall Study|MS Relapse|17|||
16076660|NCT00835770|38773322|FG001|Overall Study|MS Relapse|23|||
16076661|NCT00835770|38773321|FG000|Overall Study|MS Progression|14|||
16076662|NCT00835770|38773322|FG001|Overall Study|MS Progression|9|||
16076663|NCT00835770|38773321|FG000|Overall Study|Adverse Event|113|||
16076664|NCT00835770|38773322|FG001|Overall Study|Adverse Event|124|||
16076665|NCT00835770|38773321|FG000|Overall Study|Lost to Follow-up|22|||
16076666|NCT00835770|38773322|FG001|Overall Study|Lost to Follow-up|19|||
16076667|NCT00835770|38773321|FG000|Overall Study|Consent Withdrawn|144|||
16076668|NCT00835770|38773322|FG001|Overall Study|Consent Withdrawn|156|||
16076669|NCT00835770|38773321|FG000|Overall Study|Investigator Decision|42|||
16076670|NCT00835770|38773322|FG001|Overall Study|Investigator Decision|42|||
16076671|NCT00835770|38773321|FG000|Overall Study|Participant Non-Compliance|11|||
16076672|NCT00835770|38773322|FG001|Overall Study|Participant Non-Compliance|9|||
16076673|NCT00835770|38773321|FG000|Overall Study|Death|4|||
16076674|NCT00835770|38773322|FG001|Overall Study|Death|6|||
16076675|NCT00835770|38773321|FG000|Overall Study|Other|115|||
16076676|NCT00835770|38773322|FG001|Overall Study|Other|104|||
16076677|NCT00835770|38773321|FG000|Overall Study|Other|2|||
16076678|NCT00835770|38773322|FG001|Overall Study|Other|1|||
16076679|NCT00790790|38773323|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
16076680|NCT00790790|38773324|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
16076681|NCT00790790|38773325|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
16076682|NCT00790790|38773323|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
16076683|NCT00790790|38773324|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
16076684|NCT00790790|38773325|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
16076685|NCT00790790|38773323|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
16076686|NCT00790790|38773324|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
16076687|NCT00790790|38773325|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
16076688|NCT00790790|38773323|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
16076689|NCT00790790|38773324|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
16076690|NCT00790790|38773325|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
16076691|NCT00790790|38773323|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
16076692|NCT00790790|38773324|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
16076693|NCT00790790|38773325|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
16278299|NCT03619876|39500842|FG000|Overall Study|Withdrawal due to incidental finding|0|||
16076694|NCT04464421|38773328|FG000|Overall Study|Lost to Follow-up|2|||
16076695|NCT04464421|38773329|FG001|Overall Study|Lost to Follow-up|2|||
16076696|NCT01253226|38773330|FG000|Overall Study|Adverse Event|0|||
16076697|NCT01253226|38773331|FG001|Overall Study|Adverse Event|0|||
16076698|NCT01253226|38773332|FG002|Overall Study|Adverse Event|1|||
16076699|NCT01253226|38773333|FG003|Overall Study|Adverse Event|0|||
16076700|NCT01253226|38773334|FG004|Overall Study|Adverse Event|0|||
16076701|NCT01253226|38773330|FG000|Overall Study|Death|0|||
16076702|NCT01253226|38773331|FG001|Overall Study|Death|1|||
16076703|NCT01253226|38773332|FG002|Overall Study|Death|0|||
16076704|NCT01253226|38773333|FG003|Overall Study|Death|0|||
16076705|NCT01253226|38773334|FG004|Overall Study|Death|0|||
16076706|NCT01253226|38773330|FG000|Overall Study|Physician Decision|0|||
16076707|NCT01253226|38773331|FG001|Overall Study|Physician Decision|0|||
16076708|NCT01253226|38773332|FG002|Overall Study|Physician Decision|0|||
16076709|NCT01253226|38773333|FG003|Overall Study|Physician Decision|0|||
16076710|NCT01253226|38773334|FG004|Overall Study|Physician Decision|2|||
16076711|NCT01253226|38773330|FG000|Overall Study|Withdrawal by Subject|0|||
16076712|NCT01253226|38773331|FG001|Overall Study|Withdrawal by Subject|0|||
16076713|NCT01253226|38773332|FG002|Overall Study|Withdrawal by Subject|0|||
16076714|NCT01253226|38773333|FG003|Overall Study|Withdrawal by Subject|1|||
16076715|NCT01253226|38773334|FG004|Overall Study|Withdrawal by Subject|0|||
16076716|NCT01171625|38773335|FG000|Overall Study|On-Protocol|67|||
16076717|NCT01171625|38773335|FG000|Overall Study|Death|38|||
16076718|NCT01171625|38773335|FG000|Overall Study|Withdrawal by Subject|31|||
16076719|NCT01171625|38773335|FG000|Overall Study|Explanted|10|||
16076720|NCT01171625|38773335|FG000|Overall Study|Lost to Follow-up|5|||
16076721|NCT01171625|38773335|FG000|Overall Study|Patient received valve-in-valve|3|||
16076722|NCT01171625|38773335|FG000|Overall Study|Other|1|||
16076723|NCT01171625|38773335|FG000|Overall Study|Consented but did not receive device|25|||
16076724|NCT01266265|38773337|FG000|Overall Study|Death|95|||
16076725|NCT01266265|38773338|FG001|Overall Study|Death|73|||
16076726|NCT01266265|38773337|FG000|Overall Study|Lost to Follow-up|23|||
16076727|NCT01266265|38773338|FG001|Overall Study|Lost to Follow-up|28|||
16076728|NCT01266265|38773337|FG000|Overall Study|Withdrawal by Subject|13|||
16076729|NCT01266265|38773338|FG001|Overall Study|Withdrawal by Subject|11|||
16076730|NCT01266265|38773337|FG000|Overall Study|Respiratory-related adverse event|2|||
16076731|NCT01266265|38773338|FG001|Overall Study|Respiratory-related adverse event|1|||
16076732|NCT01266265|38773337|FG000|Overall Study|Transferred care to another provider|22|||
16076733|NCT01266265|38773338|FG001|Overall Study|Transferred care to another provider|28|||
16076734|NCT01266265|38773337|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
16076735|NCT01266265|38773338|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
16076736|NCT01266265|38773337|FG000|Overall Study|Enrolled in another clinical study|15|||
16076737|NCT01266265|38773338|FG001|Overall Study|Enrolled in another clinical study|26|||
16076738|NCT01266265|38773337|FG000|Overall Study|Non-compliance|8|||
16076739|NCT01266265|38773338|FG001|Overall Study|Non-compliance|5|||
16076740|NCT01266265|38773337|FG000|Overall Study|Lung transplant|6|||
16076741|NCT01266265|38773338|FG001|Overall Study|Lung transplant|5|||
16076742|NCT01266265|38773337|FG000|Overall Study|Site closed early|4|||
16076743|NCT01266265|38773338|FG001|Overall Study|Site closed early|3|||
16076744|NCT01266265|38773337|FG000|Overall Study|Clinical worsening|1|||
16076745|NCT01266265|38773338|FG001|Overall Study|Clinical worsening|1|||
16076746|NCT00630786|38773344|FG000|Overall Study|Physician Decision|0|||
16076747|NCT00630786|38773345|FG001|Overall Study|Physician Decision|0|||
16076748|NCT00630786|38773346|FG002|Overall Study|Physician Decision|1|||
16076749|NCT00630786|38773344|FG000|Overall Study|Withdrawal by Subject|0|||
16076750|NCT00630786|38773345|FG001|Overall Study|Withdrawal by Subject|1|||
16076751|NCT00630786|38773346|FG002|Overall Study|Withdrawal by Subject|1|||
16076752|NCT00630786|38773344|FG000|Overall Study|Lost to Follow-up|0|||
16076753|NCT00630786|38773345|FG001|Overall Study|Lost to Follow-up|1|||
16076754|NCT00630786|38773346|FG002|Overall Study|Lost to Follow-up|0|||
16076755|NCT00630786|38773344|FG000|Overall Study|Other|1|||
16076756|NCT00630786|38773345|FG001|Overall Study|Other|0|||
16076757|NCT00630786|38773346|FG002|Overall Study|Other|0|||
16278300|NCT03619876|39500843|FG001|Overall Study|Withdrawal due to incidental finding|2|||
16477383|NCT00215683|40228151|FG002|Overall Study|No study drug available|0|||
16477384|NCT00215683|40228149|FG000|Overall Study|Intermittent therapy required|0|||
16477385|NCT00215683|40228150|FG001|Overall Study|Intermittent therapy required|1|||
16477386|NCT00215683|40228151|FG002|Overall Study|Intermittent therapy required|0|||
16477387|NCT00304239|40228156|FG000|Overall Study|Protocol Deviations/Violations|15|||
16477388|NCT00304239|40228157|FG001|Overall Study|Protocol Deviations/Violations|0|||
16477389|NCT00304239|40228156|FG000|Overall Study|Adverse Event|2|||
16477390|NCT00304239|40228157|FG001|Overall Study|Adverse Event|0|||
16076758|NCT01426269|38773352|FG000|Period 1: 12 Weeks|Adverse Event|5|||
16076759|NCT01426269|38773353|FG001|Period 1: 12 Weeks|Adverse Event|0|||
16076760|NCT01426269|38773354|FG002|Period 1: 12 Weeks|Adverse Event|0|||
16076761|NCT01426269|38773352|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
16076762|NCT01426269|38773353|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
16076763|NCT01426269|38773354|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
16076764|NCT01426269|38773352|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
16076765|NCT01426269|38773353|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
16076766|NCT01426269|38773354|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
16076767|NCT01426269|38773352|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
16076768|NCT01426269|38773353|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
16076769|NCT01426269|38773354|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
16278301|NCT00544167|39500844|FG000|Overall Study|Adverse Event|21|||
16278302|NCT00544167|39500844|FG000|Overall Study|Physician Decision|8|||
16278303|NCT01560819|39500845|FG000|Overall Study|Physician Decision|1|||
16278304|NCT01560819|39500846|FG001|Overall Study|Physician Decision|0|||
16278305|NCT01520987|39500847|FG000|Overall Study|Withdrawal by Subject|1|||
16278306|NCT01520987|39500848|FG001|Overall Study|Withdrawal by Subject|0|||
16278307|NCT01520987|39500849|FG002|Overall Study|Withdrawal by Subject|0|||
16278308|NCT01520987|39500850|FG003|Overall Study|Withdrawal by Subject|0|||
16278309|NCT01520987|39500851|FG004|Overall Study|Withdrawal by Subject|0|||
16278310|NCT01520987|39500852|FG005|Overall Study|Withdrawal by Subject|1|||
16278311|NCT01520987|39500853|FG006|Overall Study|Withdrawal by Subject|0|||
16278312|NCT01520987|39500854|FG007|Overall Study|Withdrawal by Subject|0|||
16278313|NCT01229150|39500855|FG000|Overall Study|Toxicity|2|||
16278314|NCT01229150|39500856|FG001|Overall Study|Toxicity|2|||
16278315|NCT01229150|39500857|FG002|Overall Study|Toxicity|0|||
16278316|NCT01229150|39500858|FG003|Overall Study|Toxicity|0|||
16278317|NCT00749411|39500859|FG000|Overall Study|Adverse Event|0|||
16278318|NCT00749411|39500860|FG001|Overall Study|Adverse Event|2|||
16278319|NCT00749411|39500859|FG000|Overall Study|Lack of Efficacy|0|||
16278320|NCT00749411|39500860|FG001|Overall Study|Lack of Efficacy|1|||
16278321|NCT00749411|39500859|FG000|Overall Study|Protocol Violation|1|||
16278322|NCT00749411|39500860|FG001|Overall Study|Protocol Violation|1|||
16278323|NCT00749411|39500859|FG000|Overall Study|Protocol-defined stopping criteria|0|||
16278324|NCT00749411|39500860|FG001|Overall Study|Protocol-defined stopping criteria|1|||
16278325|NCT00329160|39500863|FG000|Overall Study|Adverse Event|27|||
16278326|NCT00329160|39500863|FG000|Overall Study|Withdrawal by Subject|13|||
16278327|NCT00329160|39500863|FG000|Overall Study|Protocol Violation|2|||
16278328|NCT00329160|39500863|FG000|Overall Study|Did not Receive Study Drug|1|||
16278329|NCT00329160|39500863|FG000|Overall Study|Incomplete IVUS|45|||
16278330|NCT00751023|39500864|FG000|Overall Study|Lost to Follow-up|11|||
16278331|NCT00751023|39500865|FG001|Overall Study|Lost to Follow-up|7|||
16278332|NCT03450629|39500870|FG000|Overall Study|Adverse Event|15|||
16278333|NCT03450629|39500871|FG001|Overall Study|Adverse Event|14|||
16477391|NCT02975882|40228158|FG000|Overall Study|Adverse Event|1|||
16477392|NCT02975882|40228159|FG001|Overall Study|Adverse Event|2|||
16076770|NCT01426269|38773352|FG000|Period 1: 12 Weeks|Pregnancy|1|||
16076771|NCT01426269|38773353|FG001|Period 1: 12 Weeks|Pregnancy|0|||
16278334|NCT03450629|39500870|FG000|Overall Study|Physician Decision|2|||
16278335|NCT03450629|39500871|FG001|Overall Study|Physician Decision|2|||
16278336|NCT03450629|39500870|FG000|Overall Study|Lack of Efficacy|2|||
16278337|NCT03450629|39500871|FG001|Overall Study|Lack of Efficacy|0|||
16278338|NCT03450629|39500870|FG000|Overall Study|Lost to Follow-up|4|||
16278339|NCT03450629|39500871|FG001|Overall Study|Lost to Follow-up|2|||
16278340|NCT03450629|39500870|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16278341|NCT03450629|39500871|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
16076772|NCT01426269|38773354|FG002|Period 1: 12 Weeks|Pregnancy|0|||
16076773|NCT01426269|38773352|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
16076774|NCT01426269|38773353|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
16076775|NCT01426269|38773354|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
16076776|NCT01426269|38773352|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
16076777|NCT01426269|38773353|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
16076778|NCT01426269|38773354|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
16076779|NCT01426269|38773352|FG000|Period 2: 40 Weeks|Adverse Event|0|||
16076780|NCT01426269|38773353|FG001|Period 2: 40 Weeks|Adverse Event|1|||
16076781|NCT01426269|38773354|FG002|Period 2: 40 Weeks|Adverse Event|2|||
16076782|NCT01426269|38773352|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
16076783|NCT01426269|38773353|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
16076784|NCT01426269|38773354|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
16076785|NCT01426269|38773352|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
16076786|NCT01426269|38773353|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
16076787|NCT01426269|38773354|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
16076788|NCT01426269|38773352|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
16076789|NCT01426269|38773353|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
16278342|NCT03450629|39500870|FG000|Overall Study|Non-Compliance With Study Drug|2|||
16278343|NCT03450629|39500871|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16278344|NCT03450629|39500870|FG000|Overall Study|Protocol Violation|11|||
16278345|NCT03450629|39500871|FG001|Overall Study|Protocol Violation|8|||
16278346|NCT03450629|39500870|FG000|Overall Study|Withdrawal by Subject|12|||
16278347|NCT03450629|39500871|FG001|Overall Study|Withdrawal by Subject|6|||
16076790|NCT01426269|38773354|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
16278348|NCT01117987|39500872|FG000|Overall Study|Protocol deviation|0|||
16278349|NCT01117987|39500873|FG001|Overall Study|Protocol deviation|1|||
16278350|NCT01117987|39500872|FG000|Overall Study|Subject no longer requires study drug|1|||
16278351|NCT01117987|39500873|FG001|Overall Study|Subject no longer requires study drug|0|||
16076791|NCT01426269|38773352|FG000|Period 2: 40 Weeks|Site closed|0|||
16278352|NCT01117987|39500872|FG000|Overall Study|Lost to Follow-up|1|||
16477393|NCT02975882|40228160|FG002|Overall Study|Adverse Event|1|||
16278353|NCT01117987|39500873|FG001|Overall Study|Lost to Follow-up|1|||
16278354|NCT01117987|39500872|FG000|Overall Study|Abnormal test procedure result|2|||
16278355|NCT01117987|39500873|FG001|Overall Study|Abnormal test procedure result|0|||
16278356|NCT01117987|39500872|FG000|Overall Study|Lack of Efficacy|3|||
16278357|NCT01117987|39500873|FG001|Overall Study|Lack of Efficacy|4|||
16278358|NCT01117987|39500872|FG000|Overall Study|Death|5|||
16278359|NCT01117987|39500873|FG001|Overall Study|Death|10|||
16278360|NCT01117987|39500872|FG000|Overall Study|Withdrawal by Subject|5|||
16278361|NCT01117987|39500873|FG001|Overall Study|Withdrawal by Subject|10|||
16278362|NCT01117987|39500872|FG000|Overall Study|Adverse Event|19|||
16278363|NCT01117987|39500873|FG001|Overall Study|Adverse Event|26|||
16278364|NCT01117987|39500872|FG000|Overall Study|Administrative problems|25|||
16278365|NCT01117987|39500873|FG001|Overall Study|Administrative problems|22|||
16278366|NCT01634854|39500874|FG000|Overall Study|Cesarean delivery|2|||
16477394|NCT02975882|40228161|FG003|Overall Study|Adverse Event|1|||
16076792|NCT01426269|38773353|FG001|Period 2: 40 Weeks|Site closed|6|||
16076793|NCT01426269|38773354|FG002|Period 2: 40 Weeks|Site closed|5|||
16076794|NCT01426269|38773352|FG000|Period 2: 40 Weeks|Relapsed|0|||
16076795|NCT01426269|38773353|FG001|Period 2: 40 Weeks|Relapsed|9|||
16076796|NCT01426269|38773354|FG002|Period 2: 40 Weeks|Relapsed|18|||
16076797|NCT01499199|38773355|FG000|Overall Study|Adverse Event|1|||
16076798|NCT01499199|38773355|FG000|Overall Study|Lack of Efficacy|1|||
16076799|NCT01064817|38773360|FG000|Study Completion|Physician Decision|1|||
16076800|NCT01064817|38773361|FG001|Study Completion|Physician Decision|0|||
16076801|NCT01064817|38773360|FG000|Study Completion|Withdrawal by Subject|1|||
16076802|NCT01064817|38773361|FG001|Study Completion|Withdrawal by Subject|0|||
16076803|NCT03988023|38773362|FG000|Overall Study|Non-compliance|3|||
16076804|NCT03988023|38773363|FG001|Overall Study|Non-compliance|0|||
16076805|NCT03988023|38773362|FG000|Overall Study|Withdrawal by Subject|39|||
16076806|NCT03988023|38773363|FG001|Overall Study|Withdrawal by Subject|37|||
16076807|NCT03988023|38773362|FG000|Overall Study|Adverse Event|0|||
16076808|NCT03988023|38773363|FG001|Overall Study|Adverse Event|2|||
16076809|NCT03988023|38773362|FG000|Overall Study|Physician Decision|0|||
16076810|NCT03988023|38773363|FG001|Overall Study|Physician Decision|1|||
16076811|NCT03988023|38773362|FG000|Overall Study|Lost to Follow-up|5|||
16076812|NCT03988023|38773363|FG001|Overall Study|Lost to Follow-up|8|||
16076813|NCT03988023|38773362|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
16076814|NCT03988023|38773363|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
16076815|NCT03988023|38773362|FG000|Overall Study|Lack of Efficacy|3|||
16076816|NCT03988023|38773363|FG001|Overall Study|Lack of Efficacy|1|||
16076817|NCT03988023|38773362|FG000|Overall Study|COVID-19 pandemic|225|||
16076818|NCT03988023|38773363|FG001|Overall Study|COVID-19 pandemic|227|||
16076819|NCT00558363|38773364|FG000|Overall Study|Physician Decision|18|||
16076820|NCT00558363|38773365|FG001|Overall Study|Physician Decision|4|||
16076821|NCT00558363|38773364|FG000|Overall Study|Withdrawal by Subject|11|||
16076822|NCT00558363|38773365|FG001|Overall Study|Withdrawal by Subject|4|||
16076823|NCT00558363|38773364|FG000|Overall Study|Adverse Event|5|||
16076824|NCT00558363|38773365|FG001|Overall Study|Adverse Event|5|||
16076825|NCT00558363|38773364|FG000|Overall Study|Lack of Efficacy|2|||
16076826|NCT00558363|38773365|FG001|Overall Study|Lack of Efficacy|2|||
16076827|NCT00558363|38773364|FG000|Overall Study|Protocol Violation|2|||
16076828|NCT00558363|38773365|FG001|Overall Study|Protocol Violation|1|||
16076829|NCT00558363|38773364|FG000|Overall Study|Lost to Follow-up|0|||
16076830|NCT00558363|38773365|FG001|Overall Study|Lost to Follow-up|1|||
16076831|NCT00558363|38773364|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
16278367|NCT01634854|39500875|FG001|Overall Study|Cesarean delivery|7|||
16477395|NCT02975882|40228158|FG000|Overall Study|Death|0|||
16477396|NCT02975882|40228159|FG001|Overall Study|Death|1|||
16477397|NCT02975882|40228160|FG002|Overall Study|Death|0|||
16477398|NCT02975882|40228161|FG003|Overall Study|Death|0|||
16477399|NCT02975882|40228158|FG000|Overall Study|Lack of Efficacy|3|||
16477400|NCT02975882|40228159|FG001|Overall Study|Lack of Efficacy|7|||
16477401|NCT02975882|40228160|FG002|Overall Study|Lack of Efficacy|4|||
16477402|NCT02975882|40228161|FG003|Overall Study|Lack of Efficacy|3|||
16278368|NCT02760433|39500876|FG000|Overall Study|Lost to Follow-up|1|||
16477403|NCT02975882|40228158|FG000|Overall Study|Physician Decision|0|||
16076832|NCT00558363|38773365|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
16076833|NCT00558363|38773364|FG000|Overall Study|Randomized in Error|1|||
16076834|NCT00558363|38773365|FG001|Overall Study|Randomized in Error|2|||
16076835|NCT00558363|38773364|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
16076836|NCT00558363|38773365|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
16076837|NCT00364013|38773366|FG000|Overall Study|Ineligibility determined|4|||
16076838|NCT00364013|38773367|FG001|Overall Study|Ineligibility determined|2|||
16076839|NCT00364013|38773366|FG000|Overall Study|Adverse Event|4|||
16076840|NCT00364013|38773367|FG001|Overall Study|Adverse Event|3|||
16278369|NCT02760433|39500877|FG001|Overall Study|Lost to Follow-up|0|||
16278370|NCT02760433|39500878|FG002|Overall Study|Lost to Follow-up|1|||
16278371|NCT02760433|39500879|FG003|Overall Study|Lost to Follow-up|0|||
16477404|NCT02975882|40228159|FG001|Overall Study|Physician Decision|2|||
16076841|NCT00364013|38773366|FG000|Overall Study|Withdrawal by Subject|13|||
16076842|NCT00364013|38773367|FG001|Overall Study|Withdrawal by Subject|18|||
16076843|NCT00364013|38773366|FG000|Overall Study|Physician Decision|3|||
16076844|NCT00364013|38773367|FG001|Overall Study|Physician Decision|3|||
16076845|NCT00364013|38773366|FG000|Overall Study|Lost to Follow-up|10|||
16076846|NCT00364013|38773367|FG001|Overall Study|Lost to Follow-up|3|||
16076847|NCT00364013|38773366|FG000|Overall Study|Protocol-specified criteria|6|||
16076848|NCT00364013|38773367|FG001|Overall Study|Protocol-specified criteria|6|||
16076849|NCT00364013|38773366|FG000|Overall Study|Other|41|||
16076850|NCT00364013|38773367|FG001|Overall Study|Other|47|||
16076851|NCT00364013|38773366|FG000|Overall Study|Ongoing|20|||
16076852|NCT00364013|38773367|FG001|Overall Study|Ongoing|13|||
16076853|NCT01849055|38773368|FG000|Overall Study|Withdrawal by Subject|0|||
16076854|NCT01849055|38773369|FG001|Overall Study|Withdrawal by Subject|0|||
16076855|NCT01849055|38773370|FG002|Overall Study|Withdrawal by Subject|1|||
16076856|NCT01849055|38773371|FG003|Overall Study|Withdrawal by Subject|0|||
16076857|NCT01849055|38773372|FG004|Overall Study|Withdrawal by Subject|0|||
16076858|NCT01849055|38773373|FG005|Overall Study|Withdrawal by Subject|0|||
16076859|NCT02769858|38773374|FG000|Overall Study|Withdrawal by Subject|2|||
16076860|NCT01185782|38773375|FG000|Overall Study|Adverse Event|0|||
16076861|NCT01185782|38773376|FG001|Overall Study|Adverse Event|1|||
16076862|NCT01185782|38773375|FG000|Overall Study|Protocol Violation|1|||
16076863|NCT01185782|38773376|FG001|Overall Study|Protocol Violation|0|||
16076864|NCT01185782|38773375|FG000|Overall Study|Poor Response to Treatment|3|||
16278372|NCT02760433|39500880|FG004|Overall Study|Lost to Follow-up|0|||
16278373|NCT02760433|39500876|FG000|Overall Study|Withdrawal by Subject|23|||
16278374|NCT02760433|39500877|FG001|Overall Study|Withdrawal by Subject|9|||
16278375|NCT02760433|39500878|FG002|Overall Study|Withdrawal by Subject|0|||
16278376|NCT02760433|39500879|FG003|Overall Study|Withdrawal by Subject|2|||
16278377|NCT02760433|39500880|FG004|Overall Study|Withdrawal by Subject|9|||
16278378|NCT02760433|39500876|FG000|Overall Study|Lack of Response At Week 14|0|||
16278379|NCT02760433|39500877|FG001|Overall Study|Lack of Response At Week 14|0|||
16278380|NCT02760433|39500878|FG002|Overall Study|Lack of Response At Week 14|0|||
16278381|NCT02760433|39500879|FG003|Overall Study|Lack of Response At Week 14|0|||
16278382|NCT02760433|39500880|FG004|Overall Study|Lack of Response At Week 14|1|||
16278383|NCT02760433|39500876|FG000|Overall Study|Subject refused to continue the study|1|||
16278384|NCT02760433|39500877|FG001|Overall Study|Subject refused to continue the study|0|||
16278385|NCT02760433|39500878|FG002|Overall Study|Subject refused to continue the study|0|||
16278386|NCT02760433|39500879|FG003|Overall Study|Subject refused to continue the study|0|||
16278387|NCT02760433|39500880|FG004|Overall Study|Subject refused to continue the study|0|||
16278388|NCT02760433|39500876|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
16278389|NCT02760433|39500877|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
16278390|NCT02760433|39500878|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
16278391|NCT02760433|39500879|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
16278392|NCT02760433|39500880|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
16278393|NCT02760433|39500876|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
16278394|NCT02760433|39500877|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
16278395|NCT02760433|39500878|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
16278396|NCT02760433|39500879|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
16278397|NCT02760433|39500880|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
16278398|NCT01169038|39500882|FG000|Overall Study|Death|1|||
16278399|NCT01169038|39500882|FG000|Overall Study|Adverse Event|5|||
16278400|NCT01169038|39500882|FG000|Overall Study|Required antibiotic administration|1|||
16278401|NCT00569777|39500883|FG000|Overall Study|Withdrawal by Subject|4|||
16278402|NCT00569777|39500884|FG001|Overall Study|Withdrawal by Subject|0|||
16278403|NCT00569777|39500883|FG000|Overall Study|Adverse Event|3|||
16278404|NCT00569777|39500884|FG001|Overall Study|Adverse Event|0|||
16076865|NCT01185782|38773376|FG001|Overall Study|Poor Response to Treatment|1|||
16076866|NCT01185782|38773375|FG000|Overall Study|Other|2|||
16076867|NCT01185782|38773376|FG001|Overall Study|Other|5|||
16076868|NCT01185782|38773375|FG000|Overall Study|Randomized but not treated|0|||
16076869|NCT01185782|38773376|FG001|Overall Study|Randomized but not treated|4|||
16076870|NCT00539292|38773380|FG000|Overall Study|Physician Decision|1|||
16076871|NCT00539292|38773381|FG001|Overall Study|Physician Decision|0|||
16076872|NCT00494780|38773382|FG000|Overall Study|Adverse Event|1|||
16076873|NCT00494780|38773383|FG001|Overall Study|Adverse Event|0|||
16076874|NCT00494780|38773382|FG000|Overall Study|Withdrew before Dosed|0|||
16076875|NCT00494780|38773383|FG001|Overall Study|Withdrew before Dosed|1|||
16076876|NCT00494780|38773382|FG000|Overall Study|Progression of Study Disease|7|||
16076877|NCT00494780|38773383|FG001|Overall Study|Progression of Study Disease|8|||
16076878|NCT00494780|38773382|FG000|Overall Study|New Treatment|2|||
16076879|NCT00494780|38773383|FG001|Overall Study|New Treatment|2|||
16076880|NCT00494780|38773382|FG000|Overall Study|Non-compliance|1|||
16076881|NCT00494780|38773383|FG001|Overall Study|Non-compliance|0|||
16076882|NCT00494780|38773382|FG000|Overall Study|Residual Tumour Mass|0|||
16076883|NCT00494780|38773383|FG001|Overall Study|Residual Tumour Mass|1|||
16076884|NCT00494780|38773382|FG000|Overall Study|Insurance Issues|0|||
16076885|NCT00494780|38773383|FG001|Overall Study|Insurance Issues|1|||
16076886|NCT01321606|38773384|FG000|Overall Study|Lost to Follow-up|0|||
16076887|NCT01321606|38773385|FG001|Overall Study|Lost to Follow-up|0|||
16076888|NCT01321606|38773386|FG002|Overall Study|Lost to Follow-up|0|||
16076889|NCT01321606|38773387|FG003|Overall Study|Lost to Follow-up|1|||
16076890|NCT01239316|38773388|FG000|Overall Study|Progression/Relapse|11|||
16076891|NCT01239316|38773388|FG000|Overall Study|Adverse Event|1|||
16076892|NCT04530747|38773389|FG000|Overall Study|Withdrawal by Subject|1|||
16076893|NCT04530747|38773390|FG001|Overall Study|Withdrawal by Subject|0|||
16076894|NCT00106080|38773393|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
16076895|NCT00106080|38773394|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
16076896|NCT03201562|38773397|FG000|Overall Study|Physician Decision|0|||
16076897|NCT03201562|38773398|FG001|Overall Study|Physician Decision|0|||
16076898|NCT03201562|38773399|FG002|Overall Study|Physician Decision|1|||
16076899|NCT03201562|38773397|FG000|Overall Study|Adverse Event|0|||
16076900|NCT03201562|38773398|FG001|Overall Study|Adverse Event|0|||
16076901|NCT03201562|38773399|FG002|Overall Study|Adverse Event|1|||
16076902|NCT03201562|38773397|FG000|Overall Study|Lost to Follow-up|0|||
16076903|NCT03201562|38773398|FG001|Overall Study|Lost to Follow-up|1|||
16076904|NCT03201562|38773399|FG002|Overall Study|Lost to Follow-up|2|||
16076905|NCT00446550|38773402|FG000|Overall Study|Adverse Event|1|||
16076906|NCT00446550|38773403|FG001|Overall Study|Adverse Event|0|||
16076907|NCT00414544|38773404|FG000|Overall Study|Lost to Follow-up|14|||
16076908|NCT02577835|38773405|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
16076909|NCT00480077|38773406|FG000|Overall Study|Death|19|||
16076910|NCT00480077|38773407|FG001|Overall Study|Death|15|||
16076911|NCT00480077|38773406|FG000|Overall Study|early exit|12|||
16076912|NCT00480077|38773407|FG001|Overall Study|early exit|11|||
16076913|NCT05132478|38773408|FG000|Overall Study|did not complete survey after consent|1|||
16076914|NCT05132478|38773409|FG001|Overall Study|did not complete survey after consent|1|||
16076915|NCT05132478|38773408|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
16076916|NCT05132478|38773409|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
16076917|NCT02238483|38773414|FG000|Overall Study|Withdrawal by Subject|2|||
16076918|NCT02238483|38773415|FG001|Overall Study|Withdrawal by Subject|7|||
16076919|NCT02238483|38773414|FG000|Overall Study|Lost to Follow-up|1|||
16076920|NCT02238483|38773415|FG001|Overall Study|Lost to Follow-up|1|||
16076921|NCT02238483|38773414|FG000|Overall Study|Protocol Violation|1|||
16076922|NCT02238483|38773415|FG001|Overall Study|Protocol Violation|2|||
16076923|NCT02238483|38773414|FG000|Overall Study|Death|1|||
16076924|NCT02238483|38773415|FG001|Overall Study|Death|0|||
16076925|NCT02238483|38773414|FG000|Overall Study|Adverse Event|7|||
16076926|NCT02238483|38773415|FG001|Overall Study|Adverse Event|3|||
16076927|NCT02238483|38773414|FG000|Overall Study|Withdrawn due to physician decision|1|||
16076928|NCT02238483|38773415|FG001|Overall Study|Withdrawn due to physician decision|0|||
16076929|NCT02238483|38773414|FG000|Overall Study|Completion status not recorded|1|||
16076930|NCT02238483|38773415|FG001|Overall Study|Completion status not recorded|1|||
16076931|NCT02238483|38773414|FG000|Overall Study|Illness in family member|1|||
16076932|NCT02238483|38773415|FG001|Overall Study|Illness in family member|0|||
16076933|NCT04056611|38773416|FG000|Overall Study|Physician Decision|1|||
16076934|NCT00639002|38773417|FG000|Overall Study|Death|1|||
16076935|NCT00639002|38773417|FG000|Overall Study|Adverse Event|1|||
16076936|NCT00639002|38773417|FG000|Overall Study|Protocol Violation|1|||
16076937|NCT00639002|38773417|FG000|Overall Study|Disease progression|3|||
16076938|NCT00639002|38773417|FG000|Overall Study|Physician Decision|6|||
16076939|NCT00639002|38773417|FG000|Overall Study|Lack of Efficacy|1|||
16076940|NCT02549170|38773419|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
16076941|NCT02549170|38773420|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
16076942|NCT02549170|38773421|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
16076943|NCT02549170|38773422|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
16076944|NCT02549170|38773423|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
16278405|NCT00569777|39500883|FG000|Overall Study|Lost to Follow-up|1|||
16076945|NCT02549170|38773419|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
16076946|NCT02549170|38773420|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
16076947|NCT02549170|38773421|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
16278406|NCT00569777|39500884|FG001|Overall Study|Lost to Follow-up|0|||
16076948|NCT02549170|38773422|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
16076949|NCT02549170|38773423|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
16278407|NCT00569777|39500883|FG000|Overall Study|scheduled eye surgery|0|||
16076950|NCT02549170|38773419|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
16076951|NCT02549170|38773420|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
16076952|NCT02549170|38773421|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
16076953|NCT02549170|38773422|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
16076954|NCT02549170|38773423|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
16076955|NCT04867902|38773424|FG000|Overall Study|Lost to Follow-up|1|||
16076956|NCT04867902|38773424|FG000|Overall Study|Withdrawal by Subject|2|||
16076957|NCT04867902|38773424|FG000|Overall Study|Protocol Violation|1|||
16076958|NCT01066923|38773426|FG000|Overall Study|Withdrawal by Subject|3|||
16076959|NCT01066923|38773427|FG001|Overall Study|Withdrawal by Subject|3|||
16076960|NCT01066923|38773428|FG002|Overall Study|Withdrawal by Subject|8|||
16076961|NCT01066923|38773429|FG003|Overall Study|Withdrawal by Subject|8|||
16076962|NCT02425111|38773430|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
16076963|NCT02425111|38773430|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
16076964|NCT02425111|38773430|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
16076965|NCT02425111|38773430|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
16076966|NCT02425111|38773430|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
16076967|NCT02425111|38773430|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
16278408|NCT00569777|39500884|FG001|Overall Study|scheduled eye surgery|1|||
16278409|NCT00569777|39500883|FG000|Overall Study|did not meet exclusion criteria|1|||
16076968|NCT02194933|38773432|FG000|Overall Study|Lost to Follow-up|1|||
16076969|NCT02194933|38773433|FG001|Overall Study|Lost to Follow-up|2|||
16076970|NCT02194933|38773432|FG000|Overall Study|Participant met withdrawal criteria|1|||
16076971|NCT02194933|38773433|FG001|Overall Study|Participant met withdrawal criteria|3|||
16076972|NCT02194933|38773432|FG000|Overall Study|Withdrawal by Subject|0|||
16076973|NCT02194933|38773433|FG001|Overall Study|Withdrawal by Subject|2|||
16278410|NCT00569777|39500884|FG001|Overall Study|did not meet exclusion criteria|2|||
16278411|NCT00569777|39500883|FG000|Overall Study|pregnant|1|||
16278412|NCT00569777|39500884|FG001|Overall Study|pregnant|0|||
16278413|NCT01499160|39500889|FG000|Overall Study|Adverse Event|1|||
16278414|NCT01499160|39500889|FG000|Overall Study|Withdrawal by Subject|1|||
16278415|NCT04542694|39500890|FG000|Overall Study|The need for prohibited therapy|2|||
16278416|NCT04542694|39500891|FG001|Overall Study|The need for prohibited therapy|0|||
16278417|NCT04542694|39500890|FG000|Overall Study|Adverse Event|1|||
16278418|NCT04542694|39500891|FG001|Overall Study|Adverse Event|0|||
16278419|NCT04542694|39500890|FG000|Overall Study|Protocol Violation|1|||
16278420|NCT04542694|39500891|FG001|Overall Study|Protocol Violation|0|||
16278421|NCT01109849|39500896|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
16278422|NCT01109849|39500897|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
16278423|NCT01109849|39500898|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
16278424|NCT01109849|39500899|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
16278425|NCT01109849|39500900|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
16278426|NCT01109849|39500896|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
16278427|NCT01109849|39500897|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
16278428|NCT01109849|39500898|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
16076974|NCT02194933|38773432|FG000|Overall Study|Lack of Efficacy|1|||
16076975|NCT02194933|38773433|FG001|Overall Study|Lack of Efficacy|2|||
16076976|NCT03020745|38773434|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
16076977|NCT03020745|38773435|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
16076978|NCT03020745|38773436|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
16076979|NCT03020745|38773437|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
16076980|NCT03020745|38773438|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
16076981|NCT03020745|38773439|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
16076982|NCT03020745|38773440|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
16076983|NCT03020745|38773441|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
16076984|NCT03020745|38773442|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
16076985|NCT03020745|38773443|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
16278429|NCT01109849|39500899|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
16278430|NCT01109849|39500900|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
16278431|NCT01109849|39500896|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
16278432|NCT01109849|39500897|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
16076986|NCT03020745|38773434|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
16076987|NCT03020745|38773435|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
16076988|NCT03020745|38773436|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
16076989|NCT03020745|38773437|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
16076990|NCT03020745|38773438|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
16076991|NCT03020745|38773439|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
16076992|NCT03020745|38773440|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
16076993|NCT03020745|38773441|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
16076994|NCT03020745|38773442|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
16076995|NCT03020745|38773443|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
16076996|NCT03020745|38773434|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
16076997|NCT03020745|38773435|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
16076998|NCT03020745|38773436|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
16076999|NCT03020745|38773437|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
16077000|NCT03020745|38773438|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
16077001|NCT03020745|38773439|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
16077002|NCT03020745|38773440|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
16077003|NCT03020745|38773441|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
16077004|NCT03020745|38773442|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
16077005|NCT03020745|38773443|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
16077006|NCT03020745|38773434|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
16077007|NCT03020745|38773435|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
16077008|NCT03020745|38773436|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
16077009|NCT03020745|38773437|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
16077010|NCT03020745|38773438|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
16077011|NCT03020745|38773439|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
16077012|NCT03020745|38773440|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
16077013|NCT03020745|38773441|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
16077014|NCT03020745|38773442|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
16077015|NCT03020745|38773443|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
16077016|NCT03811574|38773444|FG000|Overall Study|Withdrawal by Subject|2|||
16077017|NCT03811574|38773445|FG001|Overall Study|Withdrawal by Subject|4|||
16077018|NCT03811574|38773446|FG002|Overall Study|Withdrawal by Subject|0|||
16077019|NCT03383146|38773451|FG000|Overall Study|Screen Failure|1|||
16077020|NCT03383146|38773452|FG001|Overall Study|Screen Failure|0|||
16077021|NCT03383146|38773451|FG000|Overall Study|Adverse Event|6|||
16077022|NCT03383146|38773452|FG001|Overall Study|Adverse Event|18|||
16077023|NCT03383146|38773451|FG000|Overall Study|Lack of Efficacy|0|||
16077024|NCT03383146|38773452|FG001|Overall Study|Lack of Efficacy|3|||
16077025|NCT03383146|38773451|FG000|Overall Study|Withdrawal by Subject|20|||
16077026|NCT03383146|38773452|FG001|Overall Study|Withdrawal by Subject|36|||
16077027|NCT03383146|38773451|FG000|Overall Study|Lost to Follow-up|5|||
16077028|NCT03383146|38773452|FG001|Overall Study|Lost to Follow-up|15|||
16077029|NCT03383146|38773451|FG000|Overall Study|Death|0|||
16477405|NCT02975882|40228160|FG002|Overall Study|Physician Decision|4|||
16477406|NCT02975882|40228161|FG003|Overall Study|Physician Decision|2|||
16477407|NCT02975882|40228158|FG000|Overall Study|Ineligible|0|||
16477408|NCT02975882|40228159|FG001|Overall Study|Ineligible|1|||
16477409|NCT02975882|40228160|FG002|Overall Study|Ineligible|0|||
16477410|NCT02975882|40228161|FG003|Overall Study|Ineligible|0|||
16278433|NCT01109849|39500898|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
16278434|NCT01109849|39500899|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
16278435|NCT01109849|39500900|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
16278436|NCT01109849|39500896|FG000|Initial Randomization: ADHD Treatment|move away|2|||
16278437|NCT01109849|39500897|FG001|Initial Randomization: ADHD Treatment|move away|7|||
16278438|NCT01109849|39500898|FG002|Initial Randomization: ADHD Treatment|move away|0|||
16278439|NCT01109849|39500899|FG003|Initial Randomization: ADHD Treatment|move away|0|||
16477411|NCT03198078|40228166|FG000|Overall Study|Adverse Event|0|||
16477412|NCT03198078|40228167|FG001|Overall Study|Adverse Event|1|||
16077030|NCT03383146|38773452|FG001|Overall Study|Death|2|||
16077031|NCT03383146|38773451|FG000|Overall Study|Physician Decision|0|||
16077032|NCT03383146|38773452|FG001|Overall Study|Physician Decision|1|||
16077033|NCT03383146|38773451|FG000|Overall Study|Protocol Deviation|1|||
16077034|NCT03383146|38773452|FG001|Overall Study|Protocol Deviation|8|||
16077035|NCT03383146|38773451|FG000|Overall Study|Study Terminated by the Sponsor|48|||
16077036|NCT03383146|38773452|FG001|Overall Study|Study Terminated by the Sponsor|95|||
16077037|NCT03383146|38773451|FG000|Overall Study|Reason not Specified|4|||
16077038|NCT03383146|38773452|FG001|Overall Study|Reason not Specified|6|||
16077039|NCT01161498|38773453|FG000|Overall Study|Disease Progression|0|||
16077040|NCT01161498|38773454|FG001|Overall Study|Disease Progression|1|||
16477413|NCT03198078|40228168|FG002|Overall Study|Adverse Event|2|||
16477414|NCT03198078|40228166|FG000|Overall Study|Lack of Efficacy|0|||
16477415|NCT03198078|40228167|FG001|Overall Study|Lack of Efficacy|0|||
16077041|NCT00391846|38773455|FG000|Overall Study|Adverse Event|4|||
16077042|NCT00391846|38773456|FG001|Overall Study|Adverse Event|1|||
16077043|NCT00391846|38773455|FG000|Overall Study|Did not meet the required elig. crit|2|||
16077044|NCT00391846|38773456|FG001|Overall Study|Did not meet the required elig. crit|2|||
16077045|NCT00391846|38773455|FG000|Overall Study|Withdrawal by Subject|2|||
16077046|NCT00391846|38773456|FG001|Overall Study|Withdrawal by Subject|3|||
16077047|NCT00391846|38773455|FG000|Overall Study|Developed study specific DC criteria|0|||
16077048|NCT00391846|38773456|FG001|Overall Study|Developed study specific DC criteria|1|||
16077049|NCT00393484|38773459|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
16077050|NCT00393484|38773460|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
16077051|NCT00393484|38773459|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
16077052|NCT00393484|38773460|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
16077053|NCT00393484|38773459|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
16077054|NCT00393484|38773460|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
16077055|NCT00393484|38773459|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
16077056|NCT00393484|38773460|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
16077057|NCT00393484|38773459|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
16077058|NCT00393484|38773460|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
16077059|NCT00393484|38773459|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
16077060|NCT00393484|38773460|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
16077061|NCT00393484|38773459|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
16077062|NCT00393484|38773460|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
16077063|NCT00393484|38773459|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
16077064|NCT00393484|38773460|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
16077065|NCT00393484|38773459|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
16077066|NCT00393484|38773460|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
16077067|NCT00393484|38773459|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
16077068|NCT00393484|38773460|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
16077069|NCT01576484|38773461|FG000|Overall Study|Adverse Event|1|||
16077070|NCT01576484|38773462|FG001|Overall Study|Adverse Event|1|||
16077071|NCT01576484|38773461|FG000|Overall Study|Protocol Violation|0|||
16077072|NCT01576484|38773462|FG001|Overall Study|Protocol Violation|2|||
16077073|NCT01576484|38773461|FG000|Overall Study|Sponsor Decision|2|||
16077074|NCT01576484|38773462|FG001|Overall Study|Sponsor Decision|8|||
16077075|NCT01576484|38773461|FG000|Overall Study|Withdrawal by Subject|0|||
16077076|NCT01576484|38773462|FG001|Overall Study|Withdrawal by Subject|3|||
16077077|NCT01576484|38773461|FG000|Overall Study|Other|2|||
16077078|NCT01576484|38773462|FG001|Overall Study|Other|5|||
16077079|NCT00743444|38773463|FG000|First Intervention|Catheter placement problems|0|||
16077080|NCT00743444|38773464|FG001|First Intervention|Catheter placement problems|1|||
16077081|NCT00743444|38773463|FG000|Washout Period|Adverse Event|0|||
16077082|NCT00743444|38773464|FG001|Washout Period|Adverse Event|1|||
16077083|NCT03069313|38773468|FG000|Overall Study|Adverse Event|5|||
16077084|NCT00223795|38773471|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
16077085|NCT00223795|38773472|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
16077086|NCT00223795|38773471|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
16077087|NCT00223795|38773472|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
16077088|NCT02694978|38773473|FG000|Overall Study|Adverse Event|10|||
16077089|NCT02694978|38773474|FG001|Overall Study|Adverse Event|9|||
16077090|NCT02694978|38773473|FG000|Overall Study|Withdrawal by Subject|22|||
16077091|NCT02694978|38773474|FG001|Overall Study|Withdrawal by Subject|19|||
16077092|NCT02694978|38773473|FG000|Overall Study|Lost to Follow-up|14|||
16077093|NCT02694978|38773474|FG001|Overall Study|Lost to Follow-up|17|||
16077094|NCT02694978|38773473|FG000|Overall Study|Death|4|||
16077095|NCT02694978|38773474|FG001|Overall Study|Death|1|||
16077096|NCT02694978|38773473|FG000|Overall Study|Other-Decision of Participant|6|||
16077097|NCT02694978|38773474|FG001|Overall Study|Other-Decision of Participant|1|||
16077098|NCT02694978|38773473|FG000|Overall Study|Other-Investigator's decision|1|||
16077099|NCT02694978|38773474|FG001|Overall Study|Other-Investigator's decision|0|||
16077100|NCT02694978|38773473|FG000|Overall Study|Other-Unable to be reached|0|||
16077101|NCT02694978|38773474|FG001|Overall Study|Other-Unable to be reached|1|||
16477416|NCT03198078|40228168|FG002|Overall Study|Lack of Efficacy|3|||
16477417|NCT03198078|40228166|FG000|Overall Study|Lost to Follow-up|1|||
16477418|NCT03198078|40228167|FG001|Overall Study|Lost to Follow-up|0|||
16477419|NCT03198078|40228168|FG002|Overall Study|Lost to Follow-up|0|||
16477420|NCT03198078|40228166|FG000|Overall Study|Pregnancy|0|||
16477421|NCT03198078|40228167|FG001|Overall Study|Pregnancy|1|||
16077102|NCT02694978|38773473|FG000|Overall Study|Other-Protocol noncompliant|2|||
16077103|NCT02694978|38773474|FG001|Overall Study|Other-Protocol noncompliant|1|||
16477422|NCT03198078|40228168|FG002|Overall Study|Pregnancy|0|||
16477423|NCT03198078|40228166|FG000|Overall Study|Withdrawal by Subject|1|||
16477424|NCT03198078|40228167|FG001|Overall Study|Withdrawal by Subject|0|||
16477425|NCT03198078|40228168|FG002|Overall Study|Withdrawal by Subject|2|||
16077104|NCT02694978|38773473|FG000|Overall Study|Other-Personal reasons|3|||
16077105|NCT02694978|38773474|FG001|Overall Study|Other-Personal reasons|3|||
16077106|NCT02694978|38773473|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
16077107|NCT02694978|38773474|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
16077108|NCT01081145|38773475|FG000|Open-Label Phase|Lack of Efficacy|56|||
16077109|NCT01081145|38773476|FG001|Open-Label Phase|Lack of Efficacy|0|||
16077110|NCT01081145|38773475|FG000|Open-Label Phase|Response criteria not met|46|||
16077111|NCT01081145|38773476|FG001|Open-Label Phase|Response criteria not met|0|||
16077112|NCT01081145|38773475|FG000|Open-Label Phase|Adverse Event|42|||
16077113|NCT01081145|38773476|FG001|Open-Label Phase|Adverse Event|0|||
16077114|NCT01081145|38773475|FG000|Open-Label Phase|Withdrawal by Subject|41|||
16077115|NCT01081145|38773476|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16077116|NCT01081145|38773475|FG000|Open-Label Phase|Other|12|||
16077117|NCT01081145|38773476|FG001|Open-Label Phase|Other|0|||
16077118|NCT01081145|38773475|FG000|Open-Label Phase|Lost to Follow-up|11|||
16077119|NCT01081145|38773476|FG001|Open-Label Phase|Lost to Follow-up|0|||
16077120|NCT01081145|38773475|FG000|Open-Label Phase|Protocol Violation|4|||
16077121|NCT01081145|38773476|FG001|Open-Label Phase|Protocol Violation|0|||
16077122|NCT01081145|38773475|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
16077123|NCT01081145|38773476|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
16077124|NCT01081145|38773475|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
16077125|NCT01081145|38773476|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
16077126|NCT01081145|38773475|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
16077127|NCT01081145|38773476|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
16077128|NCT01081145|38773475|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
16077129|NCT01081145|38773476|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
16077130|NCT01081145|38773475|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
16077131|NCT01081145|38773476|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
16077132|NCT01081145|38773475|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
16077133|NCT01081145|38773476|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
16077134|NCT01081145|38773475|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
16077135|NCT01081145|38773476|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
16077136|NCT00520546|38776156|FG000|Overall Study|Withdrawal by Subject|1|||
16077137|NCT00520546|38776156|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
16077138|NCT01376089|38776157|FG000|Overall Study|Patient received no contrast media|3|||
16077139|NCT01376089|38776158|FG001|Overall Study|Patient received no contrast media|4|||
16077140|NCT03074331|38776159|FG000|Overall Study|Enrolled but Not Treated|1|||
16077141|NCT03074331|38776159|FG000|Overall Study|Lost to Follow-up|5|||
16077142|NCT03074331|38776159|FG000|Overall Study|Withdrew Consent|1|||
16077143|NCT04489771|38776160|FG000|Overall Study|Death|27|||
16077144|NCT04489771|38776161|FG001|Overall Study|Death|25|||
16077145|NCT04489771|38776160|FG000|Overall Study|Withdrawal by Subject|1|||
16077146|NCT04489771|38776161|FG001|Overall Study|Withdrawal by Subject|0|||
16077147|NCT04489771|38776160|FG000|Overall Study|Participants Ongoing in Study|50|||
16077148|NCT04489771|38776161|FG001|Overall Study|Participants Ongoing in Study|51|||
16077149|NCT00309907|38776163|FG000|Overall Study|Death|4|||
16077150|NCT00309907|38776163|FG000|Overall Study|Physician Decision|1|||
16077151|NCT00309907|38776163|FG000|Overall Study|Ineligible|11|||
16077152|NCT00309907|38776163|FG000|Overall Study|Major infectious event|4|||
16077153|NCT01692938|38776164|FG000|Overall Study|Protocol Deviation|1|||
16077154|NCT01692938|38776165|FG001|Overall Study|Protocol Deviation|1|||
16077155|NCT01692938|38776164|FG000|Overall Study|Study completed prior to site completion|3|||
16077156|NCT01692938|38776165|FG001|Overall Study|Study completed prior to site completion|3|||
16077157|NCT02496702|38776166|FG000|Overall Study|Lost to Follow-up|8|||
16077158|NCT02496702|38776167|FG001|Overall Study|Lost to Follow-up|6|||
16077159|NCT02496702|38776166|FG000|Overall Study|Only partially tested|0|||
16477426|NCT03198078|40228166|FG000|Overall Study|Withdrawal by Caregiver|1|||
16477427|NCT03198078|40228167|FG001|Overall Study|Withdrawal by Caregiver|3|||
16477428|NCT03198078|40228168|FG002|Overall Study|Withdrawal by Caregiver|5|||
16477429|NCT02764333|40228171|FG000|Overall Study|Ineligible|1|||
16477430|NCT00810355|40228177|FG000|Overall Study|Lost to Follow-up|13|||
16477431|NCT00810355|40228178|FG001|Overall Study|Lost to Follow-up|17|||
16477432|NCT00810355|40228179|FG002|Overall Study|Lost to Follow-up|11|||
16477433|NCT00810355|40228177|FG000|Overall Study|Withdrawal by Subject|1|||
16477434|NCT00810355|40228178|FG001|Overall Study|Withdrawal by Subject|0|||
16477435|NCT00810355|40228179|FG002|Overall Study|Withdrawal by Subject|0|||
16477436|NCT02171065|40228181|FG000|Overall Study|Withdrawal by Subject|1|||
16477437|NCT02171065|40228182|FG001|Overall Study|Withdrawal by Subject|0|||
16077160|NCT02496702|38776167|FG001|Overall Study|Only partially tested|2|||
16077161|NCT01350804|38776170|FG000|Core Study|Withdrawal by Subject|11|||
16077162|NCT01350804|38776171|FG001|Core Study|Withdrawal by Subject|17|||
16176166|NCT00785577|39122852|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
16477438|NCT02171065|40228183|FG002|Overall Study|Withdrawal by Subject|0|||
16477439|NCT02171065|40228181|FG000|Overall Study|Lost to Follow-up|0|||
16477440|NCT02171065|40228182|FG001|Overall Study|Lost to Follow-up|0|||
16477441|NCT02171065|40228183|FG002|Overall Study|Lost to Follow-up|1|||
16477442|NCT00590135|40228184|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
16278440|NCT01109849|39500900|FG004|Initial Randomization: ADHD Treatment|move away|0|||
16278441|NCT01109849|39500896|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
16278442|NCT01109849|39500897|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
16278443|NCT01109849|39500898|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
16278444|NCT01109849|39500899|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
16278445|NCT01109849|39500900|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
16278446|NCT01109849|39500896|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
16278447|NCT01109849|39500897|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
16278448|NCT01109849|39500898|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
16278449|NCT01109849|39500899|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
16278450|NCT01109849|39500900|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
16278451|NCT00942734|39500901|FG000|Overall Study|Adverse Event|2|||
16278452|NCT00942734|39500901|FG000|Overall Study|Protocol Violation|3|||
16278453|NCT00942734|39500901|FG000|Overall Study|Disease Progression|2|||
16278454|NCT00942734|39500901|FG000|Overall Study|Physician Decision|1|||
16278455|NCT01041495|39500902|FG000|Overall Study|Withdrawal by Subject|2|||
16278456|NCT01041495|39500903|FG001|Overall Study|Withdrawal by Subject|5|||
16278457|NCT01041495|39500902|FG000|Overall Study|Adverse Event|2|||
16278458|NCT01041495|39500903|FG001|Overall Study|Adverse Event|1|||
16278459|NCT01041495|39500902|FG000|Overall Study|Lost to Follow-up|0|||
16278460|NCT01041495|39500903|FG001|Overall Study|Lost to Follow-up|1|||
16278461|NCT00697619|39500906|FG000|Overall Study|Lack of Efficacy|2|||
16278462|NCT00697619|39500907|FG001|Overall Study|Lack of Efficacy|2|||
16278463|NCT00697619|39500906|FG000|Overall Study|Adverse Event|4|||
16477443|NCT03509467|40228189|FG000|Overall Study|Withdrawal by Subject|5|||
16477444|NCT03509467|40228190|FG001|Overall Study|Withdrawal by Subject|1|||
16477445|NCT03509467|40228191|FG002|Overall Study|Withdrawal by Subject|6|||
16477446|NCT03509467|40228192|FG003|Overall Study|Withdrawal by Subject|7|||
16477447|NCT03509467|40228193|FG004|Overall Study|Withdrawal by Subject|10|||
16477448|NCT03509467|40228194|FG005|Overall Study|Withdrawal by Subject|10|||
16077163|NCT01350804|38776172|FG002|Core Study|Withdrawal by Subject|16|||
16077164|NCT01350804|38776173|FG003|Core Study|Withdrawal by Subject|7|||
16077165|NCT01350804|38776170|FG000|Core Study|Study terminated by Sponsor|0|||
16077166|NCT01350804|38776171|FG001|Core Study|Study terminated by Sponsor|0|||
16077167|NCT01350804|38776172|FG002|Core Study|Study terminated by Sponsor|0|||
16077168|NCT01350804|38776173|FG003|Core Study|Study terminated by Sponsor|2|||
16077169|NCT01350804|38776170|FG000|Core Study|Protocol deviation|1|||
16077170|NCT01350804|38776171|FG001|Core Study|Protocol deviation|0|||
16077171|NCT01350804|38776172|FG002|Core Study|Protocol deviation|1|||
16077172|NCT01350804|38776173|FG003|Core Study|Protocol deviation|0|||
16077173|NCT01350804|38776170|FG000|Core Study|Physician Decision|1|||
16077174|NCT01350804|38776171|FG001|Core Study|Physician Decision|0|||
16077175|NCT01350804|38776172|FG002|Core Study|Physician Decision|1|||
16077176|NCT01350804|38776173|FG003|Core Study|Physician Decision|3|||
16077177|NCT01350804|38776170|FG000|Core Study|Lost to Follow-up|3|||
16077178|NCT01350804|38776171|FG001|Core Study|Lost to Follow-up|0|||
16077179|NCT01350804|38776172|FG002|Core Study|Lost to Follow-up|2|||
16077180|NCT01350804|38776173|FG003|Core Study|Lost to Follow-up|1|||
16077181|NCT01350804|38776170|FG000|Core Study|Lack of Efficacy|16|||
16077182|NCT01350804|38776171|FG001|Core Study|Lack of Efficacy|19|||
16077183|NCT01350804|38776172|FG002|Core Study|Lack of Efficacy|18|||
16077184|NCT01350804|38776173|FG003|Core Study|Lack of Efficacy|5|||
16077185|NCT01350804|38776170|FG000|Core Study|Death|1|||
16077186|NCT01350804|38776171|FG001|Core Study|Death|1|||
16077187|NCT01350804|38776172|FG002|Core Study|Death|1|||
16077188|NCT01350804|38776173|FG003|Core Study|Death|0|||
16077189|NCT01350804|38776170|FG000|Core Study|Adverse Event|8|||
16077190|NCT01350804|38776171|FG001|Core Study|Adverse Event|10|||
16077191|NCT01350804|38776172|FG002|Core Study|Adverse Event|8|||
16077192|NCT01350804|38776173|FG003|Core Study|Adverse Event|8|||
16077193|NCT01350804|38776170|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
16077194|NCT01350804|38776171|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
16077195|NCT01350804|38776172|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
16077196|NCT01350804|38776173|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
16278464|NCT00697619|39500907|FG001|Overall Study|Adverse Event|6|||
16278465|NCT00640393|39500910|FG000|Part 1|Lost to Follow-up|2|||
16278466|NCT00640393|39500911|FG001|Part 1|Lost to Follow-up|0|||
16077197|NCT01350804|38776170|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
16077198|NCT01350804|38776171|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
16077199|NCT01350804|38776172|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
16278467|NCT00640393|39500912|FG002|Part 1|Lost to Follow-up|0|||
16278468|NCT00640393|39500910|FG000|Part 1|Withdrawal by Subject|3|||
16477449|NCT03509467|40228195|FG006|Overall Study|Withdrawal by Subject|10|||
16077200|NCT01350804|38776173|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
16077201|NCT01350804|38776170|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
16077202|NCT01350804|38776171|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
16077203|NCT01350804|38776172|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
16077204|NCT01350804|38776173|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
16077205|NCT01350804|38776170|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
16077206|NCT01350804|38776171|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
16077207|NCT01350804|38776172|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
16077208|NCT01350804|38776173|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
16077209|NCT01350804|38776170|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
16077210|NCT01350804|38776171|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
16077211|NCT01350804|38776172|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
16077212|NCT01350804|38776173|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
16077213|NCT01350804|38776170|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
16077214|NCT01350804|38776171|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
16077215|NCT01350804|38776172|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
16077216|NCT01350804|38776173|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
16077217|NCT01875250|38776174|FG000|Overall Study|Adverse Event|2|||
16077218|NCT01875250|38776175|FG001|Overall Study|Adverse Event|0|||
16077219|NCT00549848|38776176|FG000|Overall Study|Death|1|||
16077220|NCT00549848|38776177|FG001|Overall Study|Death|4|||
16077221|NCT00549848|38776178|FG002|Overall Study|Death|13|||
16077222|NCT00549848|38776176|FG000|Overall Study|Physician Decision|0|||
16077223|NCT00549848|38776177|FG001|Overall Study|Physician Decision|0|||
16077224|NCT00549848|38776178|FG002|Overall Study|Physician Decision|4|||
16077225|NCT00549848|38776176|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
16077226|NCT00549848|38776177|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
16077227|NCT00549848|38776178|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
16077228|NCT00549848|38776176|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
16077229|NCT00549848|38776177|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
16077230|NCT00549848|38776178|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
16077231|NCT00549848|38776176|FG000|Overall Study|Participant/Family Withdraw|2|||
16077232|NCT00549848|38776177|FG001|Overall Study|Participant/Family Withdraw|3|||
16077233|NCT00549848|38776178|FG002|Overall Study|Participant/Family Withdraw|5|||
16077234|NCT00549848|38776176|FG000|Overall Study|Second Malignancy|1|||
16077235|NCT00549848|38776177|FG001|Overall Study|Second Malignancy|0|||
16077236|NCT00549848|38776178|FG002|Overall Study|Second Malignancy|0|||
16077237|NCT00549848|38776176|FG000|Overall Study|Transplant|3|||
16077238|NCT00549848|38776177|FG001|Overall Study|Transplant|3|||
16077239|NCT00549848|38776178|FG002|Overall Study|Transplant|18|||
16077240|NCT00549848|38776176|FG000|Overall Study|Unacceptable Toxicity|1|||
16077241|NCT00549848|38776177|FG001|Overall Study|Unacceptable Toxicity|6|||
16077242|NCT00549848|38776178|FG002|Overall Study|Unacceptable Toxicity|6|||
16077243|NCT00465816|38776179|FG000|Overall Study|Lost to Follow-up|0|||
16077244|NCT00465816|38776180|FG001|Overall Study|Lost to Follow-up|0|||
16077245|NCT00465816|38776181|FG002|Overall Study|Lost to Follow-up|2|||
16077246|NCT00959946|38776191|FG000|Overall Study|Adverse Event|0|||
16077247|NCT00959946|38776192|FG001|Overall Study|Adverse Event|0|||
16077248|NCT00959946|38776193|FG002|Overall Study|Adverse Event|2|||
16077249|NCT00959946|38776194|FG003|Overall Study|Adverse Event|1|||
16077250|NCT00959946|38776195|FG004|Overall Study|Adverse Event|0|||
16077251|NCT00959946|38776196|FG005|Overall Study|Adverse Event|1|||
16077252|NCT00959946|38776197|FG006|Overall Study|Adverse Event|0|||
16077253|NCT00959946|38776198|FG007|Overall Study|Adverse Event|0|||
16077254|NCT00959946|38776191|FG000|Overall Study|Death|0|||
16077255|NCT00959946|38776192|FG001|Overall Study|Death|0|||
16077256|NCT00959946|38776193|FG002|Overall Study|Death|0|||
16077257|NCT00959946|38776194|FG003|Overall Study|Death|0|||
16077258|NCT00959946|38776195|FG004|Overall Study|Death|0|||
16077259|NCT00959946|38776196|FG005|Overall Study|Death|1|||
16077260|NCT00959946|38776197|FG006|Overall Study|Death|0|||
16077261|NCT00959946|38776198|FG007|Overall Study|Death|0|||
16077262|NCT00959946|38776191|FG000|Overall Study|Disease Progression|2|||
16077263|NCT00959946|38776192|FG001|Overall Study|Disease Progression|4|||
16077264|NCT00959946|38776193|FG002|Overall Study|Disease Progression|2|||
16077265|NCT00959946|38776194|FG003|Overall Study|Disease Progression|4|||
16077266|NCT00959946|38776195|FG004|Overall Study|Disease Progression|4|||
16077267|NCT00959946|38776196|FG005|Overall Study|Disease Progression|6|||
16077268|NCT00959946|38776197|FG006|Overall Study|Disease Progression|2|||
16077269|NCT00959946|38776198|FG007|Overall Study|Disease Progression|2|||
16077270|NCT00959946|38776191|FG000|Overall Study|Withdrawal by Subject|0|||
16077271|NCT00959946|38776192|FG001|Overall Study|Withdrawal by Subject|0|||
16077272|NCT00959946|38776193|FG002|Overall Study|Withdrawal by Subject|0|||
16077273|NCT00959946|38776194|FG003|Overall Study|Withdrawal by Subject|0|||
16077274|NCT00959946|38776195|FG004|Overall Study|Withdrawal by Subject|0|||
16278469|NCT00640393|39500911|FG001|Part 1|Withdrawal by Subject|0|||
16077275|NCT00959946|38776196|FG005|Overall Study|Withdrawal by Subject|1|||
16077276|NCT00959946|38776197|FG006|Overall Study|Withdrawal by Subject|0|||
16077277|NCT00959946|38776198|FG007|Overall Study|Withdrawal by Subject|0|||
16077278|NCT00150176|38776199|FG000|Overall Study|Adverse Event|16|||
16077279|NCT00150176|38776200|FG001|Overall Study|Adverse Event|53|||
16077280|NCT00150176|38776199|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
16077281|NCT00150176|38776200|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
16077282|NCT00150176|38776199|FG000|Overall Study|Withdrawal by Subject|19|||
16077283|NCT00150176|38776200|FG001|Overall Study|Withdrawal by Subject|12|||
16077284|NCT00150176|38776199|FG000|Overall Study|Lost to Follow-up|3|||
16077285|NCT00150176|38776200|FG001|Overall Study|Lost to Follow-up|3|||
16077286|NCT00150176|38776199|FG000|Overall Study|OTHER|11|||
16077287|NCT00150176|38776200|FG001|Overall Study|OTHER|13|||
16077288|NCT01395758|38776212|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
16077289|NCT01395758|38776213|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
16077290|NCT01395758|38776214|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
16077291|NCT04035668|38776217|FG000|Overall Study|Adverse Event|3|||
16077292|NCT04035668|38776218|FG001|Overall Study|Adverse Event|4|||
16077293|NCT04035668|38776219|FG002|Overall Study|Adverse Event|2|||
16077294|NCT04035668|38776217|FG000|Overall Study|Lost to Follow-up|0|||
16077295|NCT04035668|38776218|FG001|Overall Study|Lost to Follow-up|1|||
16077296|NCT04035668|38776219|FG002|Overall Study|Lost to Follow-up|0|||
16077297|NCT04035668|38776217|FG000|Overall Study|Physician Decision|2|||
16077298|NCT04035668|38776218|FG001|Overall Study|Physician Decision|1|||
16077299|NCT04035668|38776219|FG002|Overall Study|Physician Decision|1|||
16077300|NCT04035668|38776217|FG000|Overall Study|Subject Decision|2|||
16077301|NCT04035668|38776218|FG001|Overall Study|Subject Decision|2|||
16077302|NCT04035668|38776219|FG002|Overall Study|Subject Decision|0|||
16077303|NCT03997916|38776220|FG000|Overall Study|Protocol Violation|35|||
16077304|NCT02362035|38776222|FG000|Overall Study|Death|67|||
16077305|NCT02362035|38776222|FG000|Overall Study|Lost to Follow-up|3|||
16077306|NCT02362035|38776222|FG000|Overall Study|Adverse Event|1|||
16077307|NCT02362035|38776222|FG000|Overall Study|Physician Decision|1|||
16077308|NCT02362035|38776222|FG000|Overall Study|Subject started another cancer therapy|10|||
16077309|NCT02362035|38776222|FG000|Overall Study|Study terminated by sponsor|45|||
16077310|NCT02362035|38776222|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
16077311|NCT02362035|38776222|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
16077312|NCT02362035|38776222|FG000|Overall Study|Disease progression|11|||
16077313|NCT02362035|38776222|FG000|Overall Study|Withdrawal by Subject|20|||
16278470|NCT00640393|39500912|FG002|Part 1|Withdrawal by Subject|0|||
16278471|NCT00640393|39500910|FG000|Randomization|Withdrawn per protocol|17|||
16077314|NCT02815566|38776223|FG000|Overall Study|Adverse Event|1|||
16077315|NCT02815566|38776224|FG001|Overall Study|Adverse Event|1|||
16077316|NCT02815566|38776223|FG000|Overall Study|Withdrawal by Subject|1|||
16077317|NCT02815566|38776224|FG001|Overall Study|Withdrawal by Subject|0|||
16077318|NCT02815566|38776223|FG000|Overall Study|Lost to Follow-up|0|||
16077319|NCT02815566|38776224|FG001|Overall Study|Lost to Follow-up|1|||
16077320|NCT02708108|38776226|FG000|Overall Study|Death|1|||
16077321|NCT02708108|38776227|FG001|Overall Study|Death|2|||
16077322|NCT02708108|38776226|FG000|Overall Study|Regimen change|1|||
16077323|NCT02708108|38776227|FG001|Overall Study|Regimen change|0|||
16077324|NCT02708108|38776226|FG000|Overall Study|No MRD and no imaging available|0|||
16077325|NCT02708108|38776227|FG001|Overall Study|No MRD and no imaging available|1|||
16077326|NCT03194958|38776228|FG000|Overall Study|Death|0|||
16077327|NCT03194958|38776229|FG001|Overall Study|Death|1|||
16077328|NCT03194958|38776230|FG002|Overall Study|Death|1|||
16077329|NCT03194958|38776231|FG003|Overall Study|Death|1|||
16077330|NCT03194958|38776228|FG000|Overall Study|Withdrawal by Subject|24|||
16077331|NCT03194958|38776229|FG001|Overall Study|Withdrawal by Subject|27|||
16077332|NCT03194958|38776230|FG002|Overall Study|Withdrawal by Subject|7|||
16077333|NCT03194958|38776231|FG003|Overall Study|Withdrawal by Subject|22|||
16077334|NCT03194958|38776228|FG000|Overall Study|Lost to Follow-up|168|||
16077335|NCT03194958|38776229|FG001|Overall Study|Lost to Follow-up|196|||
16077336|NCT03194958|38776230|FG002|Overall Study|Lost to Follow-up|174|||
16077337|NCT03194958|38776231|FG003|Overall Study|Lost to Follow-up|186|||
16077338|NCT02512965|38776232|FG000|Overall Study|Withdrawal by Subject|0|||
16077339|NCT02512965|38776233|FG001|Overall Study|Withdrawal by Subject|4|||
16077340|NCT00589667|38776244|FG000|Overall Study|Adverse Event|2|||
16077341|NCT00589667|38776244|FG000|Overall Study|Withdrawal by Subject|1|||
16077342|NCT04305405|38776247|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16077343|NCT04305405|38776248|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16077344|NCT00716859|38776249|FG000|Overall Study|Adverse Event|4|||
16077345|NCT00716859|38776250|FG001|Overall Study|Adverse Event|1|||
16077346|NCT00716859|38776249|FG000|Overall Study|Lack of Efficacy|3|||
16077347|NCT00716859|38776250|FG001|Overall Study|Lack of Efficacy|0|||
16077348|NCT00716859|38776249|FG000|Overall Study|Withdrawal by Subject|1|||
16077349|NCT00716859|38776250|FG001|Overall Study|Withdrawal by Subject|3|||
16077350|NCT00716859|38776249|FG000|Overall Study|Not treated|1|||
16077351|NCT00716859|38776250|FG001|Overall Study|Not treated|1|||
16278472|NCT00640393|39500911|FG001|Randomization|Withdrawn per protocol|0|||
16278473|NCT00640393|39500912|FG002|Randomization|Withdrawn per protocol|0|||
16278474|NCT00640393|39500910|FG000|Randomization|Never randomized by site|2|||
16278475|NCT00640393|39500911|FG001|Randomization|Never randomized by site|0|||
16278476|NCT00640393|39500912|FG002|Randomization|Never randomized by site|0|||
16278477|NCT00640393|39500910|FG000|Part 2|Lost to Follow-up|0|||
16278478|NCT00640393|39500911|FG001|Part 2|Lost to Follow-up|2|||
16278479|NCT00640393|39500912|FG002|Part 2|Lost to Follow-up|2|||
16278480|NCT00640393|39500910|FG000|Part 2|Withdrawal by Subject|0|||
16278481|NCT00640393|39500911|FG001|Part 2|Withdrawal by Subject|6|||
16477450|NCT03509467|40228196|FG007|Overall Study|Withdrawal by Subject|10|||
16477451|NCT03509467|40228189|FG000|Overall Study|Death|0|||
16077352|NCT05790408|38776253|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
16077353|NCT04218266|38776255|FG000|Overall Study|Death|1|||
16077354|NCT04218266|38776256|FG001|Overall Study|Death|2|||
16077355|NCT04218266|38776257|FG002|Overall Study|Death|3|||
16077356|NCT04218266|38776255|FG000|Overall Study|Adverse Event|13|||
16077357|NCT04218266|38776256|FG001|Overall Study|Adverse Event|14|||
16077358|NCT04218266|38776257|FG002|Overall Study|Adverse Event|11|||
16077359|NCT04218266|38776255|FG000|Overall Study|Other|7|||
16077360|NCT04218266|38776256|FG001|Overall Study|Other|5|||
16077361|NCT04218266|38776257|FG002|Overall Study|Other|14|||
16077362|NCT04218266|38776255|FG000|Overall Study|Physician Decision|1|||
16077363|NCT04218266|38776256|FG001|Overall Study|Physician Decision|3|||
16077364|NCT04218266|38776257|FG002|Overall Study|Physician Decision|2|||
16077365|NCT04218266|38776255|FG000|Overall Study|Non-compliance with study drug|0|||
16077366|NCT04218266|38776256|FG001|Overall Study|Non-compliance with study drug|0|||
16077367|NCT04218266|38776257|FG002|Overall Study|Non-compliance with study drug|1|||
16077368|NCT04218266|38776255|FG000|Overall Study|Withdrawal by Subject|1|||
16077369|NCT04218266|38776256|FG001|Overall Study|Withdrawal by Subject|3|||
16077370|NCT04218266|38776257|FG002|Overall Study|Withdrawal by Subject|1|||
16077371|NCT04218266|38776255|FG000|Overall Study|Study drug never administered|2|||
16077372|NCT04218266|38776256|FG001|Overall Study|Study drug never administered|0|||
16077373|NCT04218266|38776257|FG002|Overall Study|Study drug never administered|0|||
16077374|NCT01563354|38776258|FG000|Core Phase|Adverse Event|5|||
16077375|NCT01563354|38776259|FG001|Core Phase|Adverse Event|15|||
16278482|NCT00640393|39500912|FG002|Part 2|Withdrawal by Subject|1|||
16278483|NCT00640393|39500910|FG000|Part 2|Non-adherence|0|||
16278484|NCT00640393|39500911|FG001|Part 2|Non-adherence|1|||
16477452|NCT03509467|40228190|FG001|Overall Study|Death|0|||
16077376|NCT01563354|38776260|FG002|Core Phase|Adverse Event|13|||
16077377|NCT01563354|38776258|FG000|Core Phase|Withdrawal by Subject|1|||
16077378|NCT01563354|38776259|FG001|Core Phase|Withdrawal by Subject|0|||
16077379|NCT01563354|38776260|FG002|Core Phase|Withdrawal by Subject|3|||
16176167|NCT00785577|39122853|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
16176168|NCT00785577|39122854|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
16278485|NCT00640393|39500912|FG002|Part 2|Non-adherence|0|||
16077380|NCT01563354|38776258|FG000|Core Phase|Lost to Follow-up|1|||
16278486|NCT00640393|39500910|FG000|Part 2|Adverse Event|0|||
16077381|NCT01563354|38776259|FG001|Core Phase|Lost to Follow-up|0|||
16077382|NCT01563354|38776260|FG002|Core Phase|Lost to Follow-up|0|||
16077383|NCT01563354|38776258|FG000|Core Phase|Death|1|||
16077384|NCT01563354|38776259|FG001|Core Phase|Death|5|||
16077385|NCT01563354|38776260|FG002|Core Phase|Death|2|||
16077386|NCT01563354|38776258|FG000|Core Phase|Diseasse progression|18|||
16077387|NCT01563354|38776259|FG001|Core Phase|Diseasse progression|7|||
16077388|NCT01563354|38776260|FG002|Core Phase|Diseasse progression|8|||
16077389|NCT01563354|38776258|FG000|Core Phase|Protocol deviation|2|||
16077390|NCT01563354|38776259|FG001|Core Phase|Protocol deviation|0|||
16077391|NCT01563354|38776260|FG002|Core Phase|Protocol deviation|0|||
16077392|NCT01563354|38776258|FG000|Core Phase|PI decision - did not enter extension|0|||
16077393|NCT01563354|38776259|FG001|Core Phase|PI decision - did not enter extension|1|||
16077394|NCT01563354|38776260|FG002|Core Phase|PI decision - did not enter extension|0|||
16077395|NCT01563354|38776258|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
16077396|NCT01563354|38776259|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
16077397|NCT01563354|38776260|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
16077398|NCT01563354|38776258|FG000|Extension Phase|Adverse Event|0|||
16077399|NCT01563354|38776259|FG001|Extension Phase|Adverse Event|3|||
16077400|NCT01563354|38776260|FG002|Extension Phase|Adverse Event|2|||
16077401|NCT01563354|38776258|FG000|Extension Phase|Withdrawal by Subject|0|||
16077402|NCT01563354|38776259|FG001|Extension Phase|Withdrawal by Subject|1|||
16077403|NCT01563354|38776260|FG002|Extension Phase|Withdrawal by Subject|0|||
16077404|NCT01563354|38776258|FG000|Extension Phase|Administration problems|3|||
16077405|NCT01563354|38776259|FG001|Extension Phase|Administration problems|2|||
16077406|NCT01563354|38776260|FG002|Extension Phase|Administration problems|3|||
16077407|NCT01563354|38776258|FG000|Extension Phase|Disease progression|9|||
16077408|NCT01563354|38776259|FG001|Extension Phase|Disease progression|8|||
16077409|NCT01563354|38776260|FG002|Extension Phase|Disease progression|10|||
16077410|NCT00444600|38776261|FG000|Overall Study|Death|7|||
16077411|NCT00444600|38776262|FG001|Overall Study|Death|5|||
16077412|NCT00444600|38776263|FG002|Overall Study|Death|3|||
16077413|NCT00444600|38776264|FG003|Overall Study|Death|2|||
16077414|NCT00444600|38776261|FG000|Overall Study|Dropped|11|||
16077415|NCT00444600|38776262|FG001|Overall Study|Dropped|11|||
16077416|NCT00444600|38776263|FG002|Overall Study|Dropped|7|||
16077417|NCT00444600|38776264|FG003|Overall Study|Dropped|7|||
16077418|NCT00444600|38776261|FG000|Overall Study|Missed visit|1|||
16077419|NCT00444600|38776262|FG001|Overall Study|Missed visit|0|||
16077420|NCT00444600|38776263|FG002|Overall Study|Missed visit|0|||
16077421|NCT00444600|38776264|FG003|Overall Study|Missed visit|1|||
16077422|NCT00818454|38776270|FG000|Treatment Period 1|Adverse Event|0|||
16077423|NCT00818454|38776271|FG001|Treatment Period 1|Adverse Event|1|||
16077424|NCT00818454|38776272|FG002|Treatment Period 1|Adverse Event|0|||
16077425|NCT00818454|38776273|FG003|Treatment Period 1|Adverse Event|0|||
16077426|NCT00818454|38776270|FG000|Treatment Period 1|Other|3|||
16077427|NCT00818454|38776271|FG001|Treatment Period 1|Other|0|||
16077428|NCT00818454|38776272|FG002|Treatment Period 1|Other|0|||
16077429|NCT00818454|38776273|FG003|Treatment Period 1|Other|0|||
16077430|NCT00818454|38776270|FG000|Washout Period of 1 Week|Adverse Event|1|||
16077431|NCT00818454|38776271|FG001|Washout Period of 1 Week|Adverse Event|1|||
16077432|NCT00818454|38776272|FG002|Washout Period of 1 Week|Adverse Event|0|||
16077433|NCT00818454|38776273|FG003|Washout Period of 1 Week|Adverse Event|0|||
16077434|NCT00818454|38776270|FG000|Washout Period of 1 Week|Protocol Violation|2|||
16077435|NCT00818454|38776271|FG001|Washout Period of 1 Week|Protocol Violation|0|||
16077436|NCT00818454|38776272|FG002|Washout Period of 1 Week|Protocol Violation|0|||
16077437|NCT00818454|38776273|FG003|Washout Period of 1 Week|Protocol Violation|0|||
16077438|NCT00818454|38776270|FG000|Washout Period of 1 Week|Other|1|||
16077439|NCT00818454|38776271|FG001|Washout Period of 1 Week|Other|2|||
16077440|NCT00818454|38776272|FG002|Washout Period of 1 Week|Other|0|||
16077441|NCT00818454|38776273|FG003|Washout Period of 1 Week|Other|0|||
16077442|NCT00818454|38776270|FG000|Treatment Period 2|Other|2|||
16077443|NCT00818454|38776271|FG001|Treatment Period 2|Other|1|||
16077444|NCT00818454|38776272|FG002|Treatment Period 2|Other|0|||
16077445|NCT00818454|38776273|FG003|Treatment Period 2|Other|0|||
16077446|NCT00818454|38776270|FG000|Treatment Period 3|Adverse Event|0|||
16077447|NCT00818454|38776271|FG001|Treatment Period 3|Adverse Event|0|||
16077448|NCT00818454|38776272|FG002|Treatment Period 3|Adverse Event|0|||
16077449|NCT00818454|38776273|FG003|Treatment Period 3|Adverse Event|1|||
16077450|NCT03712930|38776274|FG000|Overall Study|Death|7|||
16077451|NCT03712930|38776274|FG000|Overall Study|Physician Decision|1|||
16077452|NCT03712930|38776274|FG000|Overall Study|Study Terminated by Sponsor|3|||
16077453|NCT03712930|38776274|FG000|Overall Study|Progressive Disease|2|||
16077454|NCT01595061|38776278|FG000|Overall Study|Never Treated|3|||
16077455|NCT01595061|38776278|FG000|Overall Study|Inadequate Pathology|1|||
16077456|NCT01000480|38776279|FG000|Induction Phase|Adverse Event|2|||
16077457|NCT01000480|38776279|FG000|Induction Phase|Lost to Follow-up|1|||
16077458|NCT01000480|38776279|FG000|Induction Phase|Physician Decision|1|||
16077459|NCT01000480|38776279|FG000|Induction Phase|Entry Criteria Not Met|3|||
16077460|NCT01000480|38776279|FG000|Concurrent Therapy Phase|Adverse Event|4|||
16077461|NCT01000480|38776279|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
16077462|NCT01000480|38776279|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
16077463|NCT01000480|38776279|FG000|Concurrent Therapy Phase|Physician Decision|1|||
16077464|NCT00529659|38776283|FG000|Overall Study|Adverse Event|8|||
16077465|NCT00529659|38776284|FG001|Overall Study|Adverse Event|7|||
16077466|NCT00529659|38776283|FG000|Overall Study|Lost to Follow-up|0|||
16077467|NCT00529659|38776284|FG001|Overall Study|Lost to Follow-up|2|||
16077468|NCT00529659|38776283|FG000|Overall Study|Physician Decision|0|||
16077469|NCT00529659|38776284|FG001|Overall Study|Physician Decision|2|||
16077470|NCT00529659|38776283|FG000|Overall Study|Protocol Violation|2|||
16077471|NCT00529659|38776284|FG001|Overall Study|Protocol Violation|6|||
16077472|NCT00529659|38776283|FG000|Overall Study|Withdrawal by Subject|1|||
16077473|NCT00529659|38776284|FG001|Overall Study|Withdrawal by Subject|6|||
16077474|NCT01236001|38776295|FG000|Overall Study|Adverse Event|5|||
16077475|NCT01236001|38776296|FG001|Overall Study|Adverse Event|14|||
16077476|NCT01236001|38776295|FG000|Overall Study|Lack of Efficacy|6|||
16077477|NCT01236001|38776296|FG001|Overall Study|Lack of Efficacy|6|||
16077478|NCT01236001|38776295|FG000|Overall Study|Lost to Follow-up|6|||
16077479|NCT01236001|38776296|FG001|Overall Study|Lost to Follow-up|1|||
16077480|NCT01236001|38776295|FG000|Overall Study|Incompliance|1|||
16077481|NCT01236001|38776296|FG001|Overall Study|Incompliance|0|||
16077482|NCT01236001|38776295|FG000|Overall Study|Planned Visit After End of Study|0|||
16077483|NCT01236001|38776296|FG001|Overall Study|Planned Visit After End of Study|1|||
16077484|NCT04048135|38776297|FG000|Overall Study|Withdrawal by Subject|1|||
16077485|NCT04048135|38776298|FG001|Overall Study|Withdrawal by Subject|1|||
16077486|NCT04048135|38776299|FG002|Overall Study|Withdrawal by Subject|1|||
16077487|NCT04048135|38776300|FG003|Overall Study|Withdrawal by Subject|2|||
16077488|NCT04048135|38776301|FG004|Overall Study|Withdrawal by Subject|0|||
16077489|NCT04048135|38776302|FG005|Overall Study|Withdrawal by Subject|0|||
16077490|NCT04048135|38776303|FG006|Overall Study|Withdrawal by Subject|1|||
16077491|NCT04048135|38776304|FG007|Overall Study|Withdrawal by Subject|1|||
16077492|NCT04048135|38776297|FG000|Overall Study|Adverse Event|0|||
16077493|NCT04048135|38776298|FG001|Overall Study|Adverse Event|0|||
16077494|NCT04048135|38776299|FG002|Overall Study|Adverse Event|0|||
16077495|NCT04048135|38776300|FG003|Overall Study|Adverse Event|1|||
16077496|NCT04048135|38776301|FG004|Overall Study|Adverse Event|1|||
16077497|NCT04048135|38776302|FG005|Overall Study|Adverse Event|0|||
16077498|NCT04048135|38776303|FG006|Overall Study|Adverse Event|0|||
16077499|NCT04048135|38776304|FG007|Overall Study|Adverse Event|0|||
16077500|NCT04048135|38776297|FG000|Overall Study|Protocol Violation|0|||
16077501|NCT04048135|38776298|FG001|Overall Study|Protocol Violation|0|||
16077502|NCT04048135|38776299|FG002|Overall Study|Protocol Violation|0|||
16077503|NCT04048135|38776300|FG003|Overall Study|Protocol Violation|0|||
16077504|NCT04048135|38776301|FG004|Overall Study|Protocol Violation|0|||
16077505|NCT04048135|38776302|FG005|Overall Study|Protocol Violation|1|||
16278487|NCT00640393|39500911|FG001|Part 2|Adverse Event|1|||
16278488|NCT00640393|39500912|FG002|Part 2|Adverse Event|0|||
16278489|NCT04205162|39500916|FG000|Overall Study|Lost to Follow-up|1|||
16278490|NCT04205162|39500917|FG001|Overall Study|Lost to Follow-up|0|||
16477453|NCT03509467|40228191|FG002|Overall Study|Death|2|||
16477454|NCT03509467|40228192|FG003|Overall Study|Death|2|||
16477455|NCT03509467|40228193|FG004|Overall Study|Death|1|||
16077506|NCT04048135|38776303|FG006|Overall Study|Protocol Violation|0|||
16278491|NCT04205162|39500916|FG000|Overall Study|Withdrawal by Subject|2|||
16278492|NCT04205162|39500917|FG001|Overall Study|Withdrawal by Subject|0|||
16278493|NCT04205162|39500916|FG000|Overall Study|University closure due to COVID-19|1|||
16278494|NCT04205162|39500917|FG001|Overall Study|University closure due to COVID-19|0|||
16278495|NCT00645944|39500918|FG000|Randomized|Withdrawal by Subject|1|||
16278496|NCT00645944|39500919|FG001|Randomized|Withdrawal by Subject|2|||
16278497|NCT00645944|39500918|FG000|Received Medication|Adverse Event|2|||
16278498|NCT00645944|39500919|FG001|Received Medication|Adverse Event|1|||
16278499|NCT00645944|39500918|FG000|Received Medication|Withdrawal by Subject|1|||
16278500|NCT00645944|39500919|FG001|Received Medication|Withdrawal by Subject|1|||
16278501|NCT00645944|39500918|FG000|Received Medication|Lost to Follow-up|1|||
16278502|NCT00645944|39500919|FG001|Received Medication|Lost to Follow-up|0|||
16278503|NCT00645944|39500918|FG000|Received Medication|Protocol Violation|2|||
16077507|NCT04048135|38776304|FG007|Overall Study|Protocol Violation|0|||
16077508|NCT03247543|38776305|FG000|Overall Study|Adverse Event|3|||
16278504|NCT00645944|39500919|FG001|Received Medication|Protocol Violation|1|||
16278505|NCT01606228|39500924|FG000|Overall Study|Lost to Follow-up|20|||
16278506|NCT01606228|39500924|FG000|Overall Study|Withdrawal by Subject|3|||
16077509|NCT03247543|38776306|FG001|Overall Study|Adverse Event|6|||
16077510|NCT03247543|38776307|FG002|Overall Study|Adverse Event|4|||
16278507|NCT01606228|39500924|FG000|Overall Study|Non-compliant|3|||
16077511|NCT03247543|38776305|FG000|Overall Study|Lost to Follow-up|10|||
16278508|NCT01606228|39500924|FG000|Overall Study|Lack of Efficacy|2|||
16278509|NCT01606228|39500924|FG000|Overall Study|Adverse Event|1|||
16477456|NCT03509467|40228194|FG005|Overall Study|Death|0|||
16278510|NCT02940522|39500925|FG000|Overall Study|Lost to Follow-up|1|||
16278511|NCT02940522|39500926|FG001|Overall Study|Lost to Follow-up|2|||
16477457|NCT03509467|40228195|FG006|Overall Study|Death|1|||
16077512|NCT03247543|38776306|FG001|Overall Study|Lost to Follow-up|7|||
16477458|NCT03509467|40228196|FG007|Overall Study|Death|0|||
16477459|NCT03509467|40228189|FG000|Overall Study|Proxy Withdrawal|0|||
16477460|NCT03509467|40228190|FG001|Overall Study|Proxy Withdrawal|0|||
16477461|NCT03509467|40228191|FG002|Overall Study|Proxy Withdrawal|0|||
16477462|NCT03509467|40228192|FG003|Overall Study|Proxy Withdrawal|0|||
16477463|NCT03509467|40228193|FG004|Overall Study|Proxy Withdrawal|0|||
16477464|NCT03509467|40228194|FG005|Overall Study|Proxy Withdrawal|0|||
16477465|NCT03509467|40228195|FG006|Overall Study|Proxy Withdrawal|0|||
16477466|NCT03509467|40228196|FG007|Overall Study|Proxy Withdrawal|1|||
16477467|NCT00722423|40228197|FG000|Overall Study|Protocol Violation|0|||
16477468|NCT00722423|40228198|FG001|Overall Study|Protocol Violation|1|||
16477469|NCT01254630|40228199|FG000|Overall Study|Adverse Event|36|||
16477470|NCT01254630|40228200|FG001|Overall Study|Adverse Event|15|||
16477471|NCT01254630|40228201|FG002|Overall Study|Adverse Event|40|||
16477472|NCT01254630|40228202|FG003|Overall Study|Adverse Event|8|||
16077513|NCT03247543|38776307|FG002|Overall Study|Lost to Follow-up|8|||
16077514|NCT03247543|38776305|FG000|Overall Study|Consent withdrawn by caregiver|2|||
16077515|NCT03247543|38776306|FG001|Overall Study|Consent withdrawn by caregiver|2|||
16077516|NCT03247543|38776307|FG002|Overall Study|Consent withdrawn by caregiver|9|||
16077517|NCT03247543|38776305|FG000|Overall Study|Withdrawal by Subject|0|||
16077518|NCT03247543|38776306|FG001|Overall Study|Withdrawal by Subject|0|||
16077519|NCT03247543|38776307|FG002|Overall Study|Withdrawal by Subject|1|||
16077520|NCT03247543|38776305|FG000|Overall Study|Failure to Follow study procedures|1|||
16077521|NCT03247543|38776306|FG001|Overall Study|Failure to Follow study procedures|3|||
16077522|NCT03247543|38776307|FG002|Overall Study|Failure to Follow study procedures|1|||
16077523|NCT03247543|38776305|FG000|Overall Study|Lack of Efficacy|1|||
16077524|NCT03247543|38776306|FG001|Overall Study|Lack of Efficacy|0|||
16077525|NCT03247543|38776307|FG002|Overall Study|Lack of Efficacy|0|||
16077526|NCT03247543|38776305|FG000|Overall Study|Non-compliance with study visits|0|||
16077527|NCT03247543|38776306|FG001|Overall Study|Non-compliance with study visits|1|||
16077528|NCT03247543|38776307|FG002|Overall Study|Non-compliance with study visits|0|||
16477473|NCT01254630|40228199|FG000|Overall Study|Death|461|||
16477474|NCT01254630|40228200|FG001|Overall Study|Death|151|||
16477475|NCT01254630|40228201|FG002|Overall Study|Death|478|||
16477476|NCT01254630|40228202|FG003|Overall Study|Death|139|||
16477477|NCT01254630|40228199|FG000|Overall Study|Lost to Follow-up|80|||
16477478|NCT01254630|40228200|FG001|Overall Study|Lost to Follow-up|26|||
16477479|NCT01254630|40228201|FG002|Overall Study|Lost to Follow-up|89|||
16477480|NCT01254630|40228202|FG003|Overall Study|Lost to Follow-up|32|||
16477481|NCT01254630|40228199|FG000|Overall Study|Physician Decision|24|||
16477482|NCT01254630|40228200|FG001|Overall Study|Physician Decision|8|||
16477483|NCT01254630|40228201|FG002|Overall Study|Physician Decision|16|||
16477484|NCT01254630|40228202|FG003|Overall Study|Physician Decision|7|||
16477485|NCT01254630|40228199|FG000|Overall Study|Withdrawal by Subject|201|||
16477486|NCT01254630|40228200|FG001|Overall Study|Withdrawal by Subject|94|||
16477487|NCT01254630|40228201|FG002|Overall Study|Withdrawal by Subject|188|||
16477488|NCT01254630|40228202|FG003|Overall Study|Withdrawal by Subject|89|||
16477489|NCT01254630|40228199|FG000|Overall Study|Study terminated by sponsor|0|||
16477490|NCT01254630|40228200|FG001|Overall Study|Study terminated by sponsor|994|||
16477491|NCT01254630|40228201|FG002|Overall Study|Study terminated by sponsor|0|||
16477492|NCT01254630|40228202|FG003|Overall Study|Study terminated by sponsor|1010|||
16477493|NCT01254630|40228199|FG000|Overall Study|Status not recorded|0|||
16477494|NCT01254630|40228200|FG001|Overall Study|Status not recorded|0|||
16477495|NCT01254630|40228201|FG002|Overall Study|Status not recorded|1|||
16477496|NCT01254630|40228202|FG003|Overall Study|Status not recorded|0|||
16477497|NCT01903031|40228203|FG000|Overall Study|Not Able to Attend Clinic|1|||
16477498|NCT01903031|40228204|FG001|Overall Study|Not Able to Attend Clinic|1|||
16477499|NCT01903031|40228205|FG002|Overall Study|Not Able to Attend Clinic|0|||
16477500|NCT01903031|40228203|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
16477501|NCT01903031|40228204|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
16477502|NCT01903031|40228205|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
16477503|NCT01903031|40228203|FG000|Overall Study|Adverse Event|0|||
16477504|NCT01903031|40228204|FG001|Overall Study|Adverse Event|1|||
16077529|NCT02448446|38776311|FG000|Overall Study|Withdrawal by Subject|1|||
16077530|NCT02448446|38776312|FG001|Overall Study|Withdrawal by Subject|0|||
16077531|NCT00686855|38776313|FG000|Overall Study|Lost to Follow-up|1|||
16477505|NCT01903031|40228205|FG002|Overall Study|Adverse Event|0|||
16477506|NCT01903031|40228203|FG000|Overall Study|Withdrawal by Subject|0|||
16278512|NCT02940522|39500925|FG000|Overall Study|Withdrawal by Subject|1|||
16477507|NCT01903031|40228204|FG001|Overall Study|Withdrawal by Subject|1|||
16477508|NCT01903031|40228205|FG002|Overall Study|Withdrawal by Subject|1|||
16477509|NCT01903031|40228203|FG000|Overall Study|Protocol Violation|0|||
16477510|NCT01903031|40228204|FG001|Overall Study|Protocol Violation|0|||
16477511|NCT01903031|40228205|FG002|Overall Study|Protocol Violation|2|||
16077532|NCT00686855|38776314|FG001|Overall Study|Lost to Follow-up|0|||
16278513|NCT02940522|39500926|FG001|Overall Study|Withdrawal by Subject|0|||
16278514|NCT01588548|39500927|FG000|Overall Study|Withdrawal by Subject|0|||
16278515|NCT01588548|39500928|FG001|Overall Study|Withdrawal by Subject|1|||
16278516|NCT01588548|39500929|FG002|Overall Study|Withdrawal by Subject|1|||
16278517|NCT01588548|39500930|FG003|Overall Study|Withdrawal by Subject|1|||
16278518|NCT01588548|39500931|FG004|Overall Study|Withdrawal by Subject|2|||
16278519|NCT01588548|39500932|FG005|Overall Study|Withdrawal by Subject|3|||
16278520|NCT01588548|39500927|FG000|Overall Study|Adverse Event|0|||
16278521|NCT01588548|39500928|FG001|Overall Study|Adverse Event|0|||
16278522|NCT01588548|39500929|FG002|Overall Study|Adverse Event|1|||
16278523|NCT01588548|39500930|FG003|Overall Study|Adverse Event|2|||
16278524|NCT01588548|39500931|FG004|Overall Study|Adverse Event|1|||
16278525|NCT01588548|39500932|FG005|Overall Study|Adverse Event|0|||
16278526|NCT01588548|39500927|FG000|Overall Study|Condition Under Investigation Worsened|3|||
16278527|NCT01588548|39500928|FG001|Overall Study|Condition Under Investigation Worsened|6|||
16278528|NCT01588548|39500929|FG002|Overall Study|Condition Under Investigation Worsened|4|||
16077533|NCT00686855|38776313|FG000|Overall Study|Progressive GVHD|0|||
16077534|NCT00686855|38776314|FG001|Overall Study|Progressive GVHD|1|||
16077535|NCT01546753|38776315|FG000|Overall Study|anxiety|1|||
16077536|NCT01546753|38776316|FG001|Overall Study|anxiety|1|||
16077537|NCT01546753|38776315|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
16077538|NCT01546753|38776316|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
16278529|NCT01588548|39500930|FG003|Overall Study|Condition Under Investigation Worsened|4|||
16278530|NCT01588548|39500931|FG004|Overall Study|Condition Under Investigation Worsened|3|||
16278531|NCT01588548|39500932|FG005|Overall Study|Condition Under Investigation Worsened|3|||
16278532|NCT01872715|39500933|FG000|Overall Study|Adverse Event|1|||
16278533|NCT01872715|39500933|FG000|Overall Study|Protocol Violation|1|||
16278534|NCT01872715|39500933|FG000|Overall Study|Withdrawal by Subject|2|||
16477512|NCT01903031|40228203|FG000|Overall Study|Lost to Follow-up|0|||
16477513|NCT01903031|40228204|FG001|Overall Study|Lost to Follow-up|0|||
16077539|NCT00566527|38776324|FG000|Overall Study|Reason not provided|3|||
16077540|NCT00566527|38776325|FG001|Overall Study|Reason not provided|11|||
16077541|NCT00566527|38776326|FG002|Overall Study|Reason not provided|10|||
16077542|NCT00566527|38776324|FG000|Overall Study|Adverse Event|2|||
16077543|NCT00566527|38776325|FG001|Overall Study|Adverse Event|0|||
16077544|NCT00566527|38776326|FG002|Overall Study|Adverse Event|1|||
16077545|NCT00566527|38776324|FG000|Overall Study|Physician Decision|3|||
16077546|NCT00566527|38776325|FG001|Overall Study|Physician Decision|8|||
16077547|NCT00566527|38776326|FG002|Overall Study|Physician Decision|20|||
16077548|NCT00566527|38776324|FG000|Overall Study|Lost to Follow-up|3|||
16077549|NCT00566527|38776325|FG001|Overall Study|Lost to Follow-up|4|||
16077550|NCT00566527|38776326|FG002|Overall Study|Lost to Follow-up|4|||
16077551|NCT00566527|38776324|FG000|Overall Study|Withdrawal by Subject|6|||
16077552|NCT00566527|38776325|FG001|Overall Study|Withdrawal by Subject|43|||
16077553|NCT00566527|38776326|FG002|Overall Study|Withdrawal by Subject|43|||
16077554|NCT01198275|38776332|FG000|Overall Study|Adverse Event|2|||
16077555|NCT01198275|38776333|FG001|Overall Study|Adverse Event|3|||
16077556|NCT01198275|38776332|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
16077557|NCT01198275|38776333|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
16077558|NCT04484935|38776334|FG000|Overall Study|Other|0|||
16077559|NCT04484935|38776335|FG001|Overall Study|Other|1|||
16077560|NCT04484935|38776334|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16077561|NCT04484935|38776335|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16077562|NCT04484935|38776334|FG000|Overall Study|Lost to Follow-up|1|||
16077563|NCT04484935|38776335|FG001|Overall Study|Lost to Follow-up|0|||
16077564|NCT04484935|38776334|FG000|Overall Study|Death|2|||
16077565|NCT04484935|38776335|FG001|Overall Study|Death|1|||
16077566|NCT00089544|38776336|FG000|Overall Study|Ineligible|1|||
16077567|NCT00089544|38776337|FG001|Overall Study|Ineligible|0|||
16077568|NCT00970359|38776338|FG000|Overall Study|Not Treated|4|||
16077569|NCT04358549|38776341|FG000|Overall Study|Adverse Event|0|||
16077570|NCT04358549|38776342|FG001|Overall Study|Adverse Event|1|||
16077571|NCT04358549|38776341|FG000|Overall Study|Death|1|||
16077572|NCT04358549|38776342|FG001|Overall Study|Death|0|||
16077573|NCT04358549|38776341|FG000|Overall Study|Lost to Follow-up|2|||
16077574|NCT04358549|38776342|FG001|Overall Study|Lost to Follow-up|1|||
16077575|NCT04358549|38776341|FG000|Overall Study|Withdrawal by Subject|6|||
16077576|NCT04358549|38776342|FG001|Overall Study|Withdrawal by Subject|6|||
16278535|NCT03969641|39500936|FG000|Overall Study|Lost to Follow-up|5|||
16278536|NCT03969641|39500937|FG001|Overall Study|Lost to Follow-up|3|||
16077577|NCT04358549|38776341|FG000|Overall Study|Start remdesivir|1|||
16077578|NCT04358549|38776342|FG001|Overall Study|Start remdesivir|0|||
16077579|NCT03648762|38776344|FG000|Overall Study|Lost to Follow-up|1|||
16077580|NCT03648762|38776345|FG001|Overall Study|Lost to Follow-up|2|||
16077581|NCT03648762|38776346|FG002|Overall Study|Lost to Follow-up|0|||
16077582|NCT03648762|38776344|FG000|Overall Study|Withdrawal by Subject|5|||
16077583|NCT03648762|38776345|FG001|Overall Study|Withdrawal by Subject|2|||
16077584|NCT03648762|38776346|FG002|Overall Study|Withdrawal by Subject|1|||
16077585|NCT01697969|38776348|FG000|Overall Study|Did not meet inc/exc criteria|3|||
16077586|NCT02886286|38776349|FG000|Overall Study|pump motor stall|0|||
16077587|NCT02886286|38776350|FG001|Overall Study|pump motor stall|1|||
16077588|NCT00457743|38776351|FG000|Overall Study|Adverse Event|0|||
16077589|NCT00457743|38776352|FG001|Overall Study|Adverse Event|4|||
16077590|NCT00457743|38776353|FG002|Overall Study|Adverse Event|0|||
16077591|NCT00457743|38776351|FG000|Overall Study|Lack of Efficacy|3|||
16077592|NCT00457743|38776352|FG001|Overall Study|Lack of Efficacy|23|||
16077593|NCT00457743|38776353|FG002|Overall Study|Lack of Efficacy|3|||
16077594|NCT02960659|38776356|FG000|Overall Study|Withdrawal by Subject|1|||
16077595|NCT02960659|38776357|FG001|Overall Study|Withdrawal by Subject|0|||
16077596|NCT02960659|38776356|FG000|Overall Study|Poor compliance|0|||
16077597|NCT02960659|38776357|FG001|Overall Study|Poor compliance|1|||
16077598|NCT04425629|38776364|FG000|Overall Study|Adverse Event|0|||
16077599|NCT04425629|38776365|FG001|Overall Study|Adverse Event|0|||
16077600|NCT04425629|38776366|FG002|Overall Study|Adverse Event|0|||
16077601|NCT04425629|38776367|FG003|Overall Study|Adverse Event|0|||
16077602|NCT04425629|38776368|FG004|Overall Study|Adverse Event|1|||
16077603|NCT04425629|38776369|FG005|Overall Study|Adverse Event|0|||
16077604|NCT04425629|38776370|FG006|Overall Study|Adverse Event|0|||
16077605|NCT04425629|38776371|FG007|Overall Study|Adverse Event|0|||
16077606|NCT04425629|38776372|FG008|Overall Study|Adverse Event|0|||
16077607|NCT04425629|38776373|FG009|Overall Study|Adverse Event|3|||
16077608|NCT04425629|38776374|FG010|Overall Study|Adverse Event|2|||
16077609|NCT04425629|38776375|FG011|Overall Study|Adverse Event|1|||
16077610|NCT04425629|38776376|FG012|Overall Study|Adverse Event|1|||
16077611|NCT04425629|38776377|FG013|Overall Study|Adverse Event|0|||
16077612|NCT04425629|38776378|FG014|Overall Study|Adverse Event|0|||
16077613|NCT04425629|38776379|FG015|Overall Study|Adverse Event|0|||
16477514|NCT01903031|40228205|FG002|Overall Study|Lost to Follow-up|1|||
16477515|NCT01903031|40228203|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
16477516|NCT01903031|40228204|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
16477517|NCT01903031|40228205|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
16477518|NCT01938573|40228207|FG000|Overall Study|Lack of Efficacy|1|||
16477519|NCT01938573|40228208|FG001|Overall Study|Lack of Efficacy|0|||
16477520|NCT01938573|40228207|FG000|Overall Study|Operation at other hospital|1|||
16477521|NCT01938573|40228208|FG001|Overall Study|Operation at other hospital|0|||
16477522|NCT00631696|40228209|FG000|Overall Study|Entered, not randomized to treatment|1|||
16477523|NCT00631696|40228210|FG001|Overall Study|Entered, not randomized to treatment|1|||
16477524|NCT00631696|40228209|FG000|Overall Study|Discontinued after database release date|1|||
16477525|NCT00631696|40228210|FG001|Overall Study|Discontinued after database release date|0|||
16477526|NCT00631696|40228209|FG000|Overall Study|Follow up after database release date|1|||
16477527|NCT00631696|40228210|FG001|Overall Study|Follow up after database release date|0|||
16477528|NCT00631696|40228209|FG000|Overall Study|Lost to Follow-up|7|||
16477529|NCT00631696|40228210|FG001|Overall Study|Lost to Follow-up|10|||
16477530|NCT00631696|40228209|FG000|Overall Study|Withdrawal by Subject|2|||
16477531|NCT00631696|40228210|FG001|Overall Study|Withdrawal by Subject|9|||
16477532|NCT00631696|40228209|FG000|Overall Study|Other|8|||
16477533|NCT00631696|40228210|FG001|Overall Study|Other|8|||
16077614|NCT04425629|38776380|FG016|Overall Study|Adverse Event|0|||
16077615|NCT04425629|38776381|FG017|Overall Study|Adverse Event|0|||
16077616|NCT04425629|38776382|FG018|Overall Study|Adverse Event|0|||
16077617|NCT04425629|38776364|FG000|Overall Study|Lost to Follow-up|1|||
16077618|NCT04425629|38776365|FG001|Overall Study|Lost to Follow-up|3|||
16077619|NCT04425629|38776366|FG002|Overall Study|Lost to Follow-up|1|||
16077620|NCT04425629|38776367|FG003|Overall Study|Lost to Follow-up|7|||
16077621|NCT04425629|38776368|FG004|Overall Study|Lost to Follow-up|1|||
16077622|NCT04425629|38776369|FG005|Overall Study|Lost to Follow-up|2|||
16077623|NCT04425629|38776370|FG006|Overall Study|Lost to Follow-up|1|||
16077624|NCT04425629|38776371|FG007|Overall Study|Lost to Follow-up|0|||
16077625|NCT04425629|38776372|FG008|Overall Study|Lost to Follow-up|1|||
16077626|NCT04425629|38776373|FG009|Overall Study|Lost to Follow-up|64|||
16077627|NCT04425629|38776374|FG010|Overall Study|Lost to Follow-up|70|||
16077628|NCT04425629|38776375|FG011|Overall Study|Lost to Follow-up|98|||
16077629|NCT04425629|38776376|FG012|Overall Study|Lost to Follow-up|30|||
16077630|NCT04425629|38776377|FG013|Overall Study|Lost to Follow-up|0|||
16077631|NCT04425629|38776378|FG014|Overall Study|Lost to Follow-up|5|||
16077632|NCT04425629|38776379|FG015|Overall Study|Lost to Follow-up|4|||
16077633|NCT04425629|38776380|FG016|Overall Study|Lost to Follow-up|0|||
16477534|NCT00631696|40228209|FG000|Overall Study|Protocol Violation|9|||
16477535|NCT00631696|40228210|FG001|Overall Study|Protocol Violation|9|||
16077634|NCT04425629|38776381|FG017|Overall Study|Lost to Follow-up|3|||
16077635|NCT04425629|38776382|FG018|Overall Study|Lost to Follow-up|1|||
16077636|NCT04425629|38776364|FG000|Overall Study|Subject Decision|0|||
16077637|NCT04425629|38776365|FG001|Overall Study|Subject Decision|2|||
16077638|NCT04425629|38776366|FG002|Overall Study|Subject Decision|1|||
16077639|NCT04425629|38776367|FG003|Overall Study|Subject Decision|3|||
16077640|NCT04425629|38776368|FG004|Overall Study|Subject Decision|6|||
16077641|NCT04425629|38776369|FG005|Overall Study|Subject Decision|6|||
16077642|NCT04425629|38776370|FG006|Overall Study|Subject Decision|3|||
16077643|NCT04425629|38776371|FG007|Overall Study|Subject Decision|3|||
16077644|NCT04425629|38776372|FG008|Overall Study|Subject Decision|1|||
16077645|NCT04425629|38776373|FG009|Overall Study|Subject Decision|70|||
16077646|NCT04425629|38776374|FG010|Overall Study|Subject Decision|95|||
16077647|NCT04425629|38776375|FG011|Overall Study|Subject Decision|124|||
16077648|NCT04425629|38776376|FG012|Overall Study|Subject Decision|25|||
16477536|NCT00631696|40228209|FG000|Overall Study|Study terminated by sponsor|3|||
16477537|NCT00631696|40228210|FG001|Overall Study|Study terminated by sponsor|3|||
16477538|NCT00631696|40228209|FG000|Overall Study|Adverse Event|5|||
16477539|NCT00631696|40228210|FG001|Overall Study|Adverse Event|0|||
16477540|NCT02428608|40228215|FG000|Overall Study|Pregnancy|2|||
16477541|NCT02428608|40228215|FG000|Overall Study|Lost to Follow-up|37|||
16477542|NCT02428608|40228215|FG000|Overall Study|Withdrawal by Subject|2|||
16477543|NCT02428608|40228215|FG000|Overall Study|scheduling conflicts|15|||
16477544|NCT02428608|40228215|FG000|Overall Study|moved away|10|||
16477545|NCT02428608|40228215|FG000|Overall Study|Death|1|||
16477546|NCT02428608|40228215|FG000|Overall Study|various|16|||
16477547|NCT01752985|40228216|FG000|Treatment Period|Subject request to discontinue treatment|1|||
16477548|NCT01752985|40228217|FG001|Treatment Period|Subject request to discontinue treatment|0|||
16077649|NCT04425629|38776377|FG013|Overall Study|Subject Decision|0|||
16077650|NCT04425629|38776378|FG014|Overall Study|Subject Decision|1|||
16077651|NCT04425629|38776379|FG015|Overall Study|Subject Decision|4|||
16077652|NCT04425629|38776380|FG016|Overall Study|Subject Decision|1|||
16077653|NCT04425629|38776381|FG017|Overall Study|Subject Decision|0|||
16077654|NCT04425629|38776382|FG018|Overall Study|Subject Decision|2|||
16077655|NCT04425629|38776364|FG000|Overall Study|Death|0|||
16077656|NCT04425629|38776365|FG001|Overall Study|Death|0|||
16077657|NCT04425629|38776366|FG002|Overall Study|Death|0|||
16077658|NCT04425629|38776367|FG003|Overall Study|Death|0|||
16077659|NCT04425629|38776368|FG004|Overall Study|Death|0|||
16077660|NCT04425629|38776369|FG005|Overall Study|Death|0|||
16077661|NCT04425629|38776370|FG006|Overall Study|Death|0|||
16077662|NCT04425629|38776371|FG007|Overall Study|Death|0|||
16077663|NCT04425629|38776372|FG008|Overall Study|Death|0|||
16077664|NCT04425629|38776373|FG009|Overall Study|Death|11|||
16077665|NCT04425629|38776374|FG010|Overall Study|Death|2|||
16077666|NCT04425629|38776375|FG011|Overall Study|Death|4|||
16077667|NCT04425629|38776376|FG012|Overall Study|Death|0|||
16077668|NCT04425629|38776377|FG013|Overall Study|Death|0|||
16077669|NCT04425629|38776378|FG014|Overall Study|Death|0|||
16077670|NCT04425629|38776379|FG015|Overall Study|Death|0|||
16077671|NCT04425629|38776380|FG016|Overall Study|Death|0|||
16077672|NCT04425629|38776381|FG017|Overall Study|Death|0|||
16077673|NCT04425629|38776382|FG018|Overall Study|Death|0|||
16278537|NCT03969641|39500936|FG000|Overall Study|Withdrawal by Subject|1|||
16278538|NCT03969641|39500937|FG001|Overall Study|Withdrawal by Subject|2|||
16077674|NCT04425629|38776364|FG000|Overall Study|Sponsor Request|0|||
16077675|NCT04425629|38776365|FG001|Overall Study|Sponsor Request|0|||
16077676|NCT04425629|38776366|FG002|Overall Study|Sponsor Request|0|||
16077677|NCT04425629|38776367|FG003|Overall Study|Sponsor Request|2|||
16077678|NCT04425629|38776368|FG004|Overall Study|Sponsor Request|2|||
16077679|NCT04425629|38776369|FG005|Overall Study|Sponsor Request|2|||
16077680|NCT04425629|38776370|FG006|Overall Study|Sponsor Request|1|||
16077681|NCT04425629|38776371|FG007|Overall Study|Sponsor Request|0|||
16077682|NCT04425629|38776372|FG008|Overall Study|Sponsor Request|0|||
16077683|NCT04425629|38776373|FG009|Overall Study|Sponsor Request|9|||
16077684|NCT04425629|38776374|FG010|Overall Study|Sponsor Request|9|||
16278539|NCT03969641|39500936|FG000|Overall Study|Found to be ineligible|1|||
16278540|NCT03969641|39500937|FG001|Overall Study|Found to be ineligible|1|||
16278541|NCT03969641|39500936|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
16477549|NCT01752985|40228218|FG002|Treatment Period|Subject request to discontinue treatment|1|||
16477550|NCT01752985|40228216|FG000|Treatment Period|Subject no longer meets study criteria|0|||
16077685|NCT04425629|38776375|FG011|Overall Study|Sponsor Request|10|||
16077686|NCT04425629|38776376|FG012|Overall Study|Sponsor Request|8|||
16077687|NCT04425629|38776377|FG013|Overall Study|Sponsor Request|0|||
16077688|NCT04425629|38776378|FG014|Overall Study|Sponsor Request|0|||
16077689|NCT04425629|38776379|FG015|Overall Study|Sponsor Request|1|||
16077690|NCT04425629|38776380|FG016|Overall Study|Sponsor Request|0|||
16077691|NCT04425629|38776381|FG017|Overall Study|Sponsor Request|0|||
16077692|NCT04425629|38776382|FG018|Overall Study|Sponsor Request|0|||
16077693|NCT04425629|38776364|FG000|Overall Study|Physician Decision|0|||
16077694|NCT04425629|38776365|FG001|Overall Study|Physician Decision|0|||
16077695|NCT04425629|38776366|FG002|Overall Study|Physician Decision|0|||
16077696|NCT04425629|38776367|FG003|Overall Study|Physician Decision|0|||
16077697|NCT04425629|38776368|FG004|Overall Study|Physician Decision|0|||
16077698|NCT04425629|38776369|FG005|Overall Study|Physician Decision|0|||
16077699|NCT04425629|38776370|FG006|Overall Study|Physician Decision|0|||
16077700|NCT04425629|38776371|FG007|Overall Study|Physician Decision|0|||
16077701|NCT04425629|38776372|FG008|Overall Study|Physician Decision|0|||
16077702|NCT04425629|38776373|FG009|Overall Study|Physician Decision|4|||
16077703|NCT04425629|38776374|FG010|Overall Study|Physician Decision|3|||
16077704|NCT04425629|38776375|FG011|Overall Study|Physician Decision|5|||
16077705|NCT04425629|38776376|FG012|Overall Study|Physician Decision|1|||
16077706|NCT04425629|38776377|FG013|Overall Study|Physician Decision|0|||
16077707|NCT04425629|38776378|FG014|Overall Study|Physician Decision|0|||
16077708|NCT04425629|38776379|FG015|Overall Study|Physician Decision|1|||
16077709|NCT04425629|38776380|FG016|Overall Study|Physician Decision|0|||
16077710|NCT04425629|38776381|FG017|Overall Study|Physician Decision|0|||
16077711|NCT04425629|38776382|FG018|Overall Study|Physician Decision|0|||
16077712|NCT04425629|38776364|FG000|Overall Study|Lack of Efficacy|0|||
16077713|NCT04425629|38776365|FG001|Overall Study|Lack of Efficacy|0|||
16077714|NCT04425629|38776366|FG002|Overall Study|Lack of Efficacy|0|||
16077715|NCT04425629|38776367|FG003|Overall Study|Lack of Efficacy|0|||
16077716|NCT04425629|38776368|FG004|Overall Study|Lack of Efficacy|0|||
16077717|NCT04425629|38776369|FG005|Overall Study|Lack of Efficacy|0|||
16077718|NCT04425629|38776370|FG006|Overall Study|Lack of Efficacy|0|||
16077719|NCT04425629|38776371|FG007|Overall Study|Lack of Efficacy|0|||
16077720|NCT04425629|38776372|FG008|Overall Study|Lack of Efficacy|0|||
16077721|NCT04425629|38776373|FG009|Overall Study|Lack of Efficacy|0|||
16077722|NCT04425629|38776374|FG010|Overall Study|Lack of Efficacy|1|||
16077723|NCT04425629|38776375|FG011|Overall Study|Lack of Efficacy|0|||
16077724|NCT04425629|38776376|FG012|Overall Study|Lack of Efficacy|0|||
16278542|NCT03969641|39500937|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
16278543|NCT03969641|39500936|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
16278544|NCT03969641|39500937|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
16278545|NCT03969641|39500936|FG000|Overall Study|Elective termination|0|||
16278546|NCT03969641|39500937|FG001|Overall Study|Elective termination|1|||
16278547|NCT00057941|39500938|FG000|Overall Study|Death|1|||
16278548|NCT00057941|39500939|FG001|Overall Study|Death|2|||
16278549|NCT00057941|39500938|FG000|Overall Study|Adverse Event|7|||
16278550|NCT00057941|39500939|FG001|Overall Study|Adverse Event|9|||
16278551|NCT00057941|39500938|FG000|Overall Study|Lack of Efficacy|54|||
16278552|NCT00057941|39500939|FG001|Overall Study|Lack of Efficacy|53|||
16278553|NCT00057941|39500938|FG000|Overall Study|Withdrawal by Subject|6|||
16278554|NCT00057941|39500939|FG001|Overall Study|Withdrawal by Subject|1|||
16278555|NCT00057941|39500938|FG000|Overall Study|still on treatment|3|||
16278556|NCT00057941|39500939|FG001|Overall Study|still on treatment|1|||
16278557|NCT00057941|39500938|FG000|Overall Study|insurance, symptomatic deterioration|1|||
16278558|NCT00057941|39500939|FG001|Overall Study|insurance, symptomatic deterioration|3|||
16278559|NCT00057941|39500938|FG000|Overall Study|Ineligible|2|||
16278560|NCT00057941|39500939|FG001|Overall Study|Ineligible|5|||
16278561|NCT02832167|39500940|FG000|Treatment Period 1|Disease progression|90|||
16278562|NCT02832167|39500940|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
16278563|NCT02832167|39500940|FG000|Treatment Period 1|Death|2|||
16278564|NCT02832167|39500940|FG000|Treatment Period 1|Study Drug Toxicity|6|||
16278565|NCT02832167|39500940|FG000|Treatment Period 1|Participant request to discontinue|9|||
16278566|NCT02832167|39500940|FG000|Treatment Period 1|No longer meet study criteria|1|||
16278567|NCT02832167|39500940|FG000|Treatment Period 1|Participant withdrew consent|3|||
16278568|NCT02832167|39500940|FG000|Treatment Period 1|Other reasons|6|||
16278569|NCT02832167|39500940|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
16077725|NCT04425629|38776377|FG013|Overall Study|Lack of Efficacy|0|||
16278570|NCT02832167|39500940|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
16278571|NCT02832167|39500940|FG000|Transition From Period 1 to Period 2|Death|2|||
16278572|NCT02832167|39500940|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
16278573|NCT02832167|39500940|FG000|Treatment Period 2|Disease progression|69|||
16278574|NCT02832167|39500940|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
16278575|NCT02832167|39500940|FG000|Treatment Period 2|Maximum clinical benefit|1|||
16077726|NCT04425629|38776378|FG014|Overall Study|Lack of Efficacy|0|||
16077727|NCT04425629|38776379|FG015|Overall Study|Lack of Efficacy|0|||
16278576|NCT02832167|39500940|FG000|Treatment Period 2|Study Drug Toxicity|5|||
16278577|NCT02832167|39500940|FG000|Treatment Period 2|Participant request to discontinue|2|||
16278578|NCT02832167|39500940|FG000|Treatment Period 2|Participant withdrew consent|3|||
16278579|NCT02832167|39500940|FG000|Treatment Period 2|Other reasons|3|||
16278580|NCT00152516|39500941|FG000|Overall Study|Adverse Event|18|||
16278581|NCT00152516|39500941|FG000|Overall Study|Lack and Loss of Efficacy|30|||
16278582|NCT00152516|39500941|FG000|Overall Study|Lost to Follow-up|5|||
16278583|NCT00152516|39500941|FG000|Overall Study|Withdrawal by Subject|8|||
16278584|NCT00152516|39500941|FG000|Overall Study|Protocol Violation|3|||
16077728|NCT04425629|38776380|FG016|Overall Study|Lack of Efficacy|0|||
16077729|NCT04425629|38776381|FG017|Overall Study|Lack of Efficacy|0|||
16077730|NCT04425629|38776382|FG018|Overall Study|Lack of Efficacy|0|||
16077731|NCT04600752|38776383|FG000|Overall Study|Physician Decision|0|||
16077732|NCT04600752|38776384|FG001|Overall Study|Physician Decision|0|||
16278585|NCT00152516|39500941|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
16278586|NCT00152516|39500941|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
16278587|NCT00152516|39500941|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
16278588|NCT00152516|39500941|FG000|Overall Study|Other: Non-Compliance|2|||
16278589|NCT00152516|39500941|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
16278590|NCT00152516|39500941|FG000|Overall Study|Other: Moved Out Of State|1|||
16278591|NCT00152516|39500941|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
16278592|NCT00152516|39500941|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
16278593|NCT00381849|39500942|FG000|Wash Out|Withdrawal by Subject|0|||
16278594|NCT00381849|39500943|FG001|Wash Out|Withdrawal by Subject|1|||
16278595|NCT01496118|39500944|FG000|Overall Study|Disease progression|3|||
16278596|NCT01496118|39500945|FG001|Overall Study|Disease progression|2|||
16278597|NCT01496118|39500946|FG002|Overall Study|Disease progression|3|||
16278598|NCT01496118|39500947|FG003|Overall Study|Disease progression|1|||
16077733|NCT04600752|38776385|FG002|Overall Study|Physician Decision|1|||
16077734|NCT04600752|38776383|FG000|Overall Study|Adverse Event|0|||
16077735|NCT04600752|38776384|FG001|Overall Study|Adverse Event|1|||
16077736|NCT04600752|38776385|FG002|Overall Study|Adverse Event|0|||
16077737|NCT04600752|38776383|FG000|Overall Study|Withdrawal by Subject|2|||
16077738|NCT04600752|38776384|FG001|Overall Study|Withdrawal by Subject|1|||
16077739|NCT04600752|38776385|FG002|Overall Study|Withdrawal by Subject|0|||
16077740|NCT04600752|38776383|FG000|Overall Study|Lack of Efficacy|1|||
16077741|NCT04600752|38776384|FG001|Overall Study|Lack of Efficacy|0|||
16077742|NCT04600752|38776385|FG002|Overall Study|Lack of Efficacy|0|||
16077743|NCT02547922|38776386|FG000|Overall Study|Withdrawal by Subject|9|||
16077744|NCT02547922|38776387|FG001|Overall Study|Withdrawal by Subject|6|||
16077745|NCT02547922|38776388|FG002|Overall Study|Withdrawal by Subject|10|||
16077746|NCT02547922|38776386|FG000|Overall Study|Adverse Event|3|||
16077747|NCT02547922|38776387|FG001|Overall Study|Adverse Event|1|||
16077748|NCT02547922|38776388|FG002|Overall Study|Adverse Event|2|||
16077749|NCT02547922|38776386|FG000|Overall Study|Lost to Follow-up|1|||
16077750|NCT02547922|38776387|FG001|Overall Study|Lost to Follow-up|0|||
16077751|NCT02547922|38776388|FG002|Overall Study|Lost to Follow-up|0|||
16077752|NCT02547922|38776386|FG000|Overall Study|Lack of Efficacy|5|||
16077753|NCT02547922|38776387|FG001|Overall Study|Lack of Efficacy|7|||
16077754|NCT02547922|38776388|FG002|Overall Study|Lack of Efficacy|4|||
16077755|NCT02547922|38776386|FG000|Overall Study|Death|1|||
16077756|NCT02547922|38776387|FG001|Overall Study|Death|0|||
16077757|NCT02547922|38776388|FG002|Overall Study|Death|0|||
16077758|NCT02547922|38776386|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
16077759|NCT02547922|38776387|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
16077760|NCT02547922|38776388|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
16077761|NCT02547922|38776386|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
16077762|NCT02547922|38776387|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
16077763|NCT02547922|38776388|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
16077764|NCT02547922|38776386|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
16077765|NCT02547922|38776387|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
16077766|NCT02547922|38776388|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
16077767|NCT02547922|38776386|FG000|Overall Study|Physician Decision|2|||
16077768|NCT02547922|38776387|FG001|Overall Study|Physician Decision|1|||
16077769|NCT02547922|38776388|FG002|Overall Study|Physician Decision|2|||
16077770|NCT02547922|38776386|FG000|Overall Study|Patients did not receive IP|1|||
16077771|NCT02547922|38776387|FG001|Overall Study|Patients did not receive IP|1|||
16077772|NCT02547922|38776388|FG002|Overall Study|Patients did not receive IP|0|||
16077773|NCT00841035|38776390|FG000|Phase 1 Overall Study|Physician Decision|13|||
16077774|NCT01369498|38776391|FG000|Overall Study|Lack of Efficacy|9|||
16077775|NCT01369498|38776392|FG001|Overall Study|Lack of Efficacy|9|||
16077776|NCT01369498|38776393|FG002|Overall Study|Lack of Efficacy|1|||
16077777|NCT01369498|38776394|FG003|Overall Study|Lack of Efficacy|3|||
16077778|NCT01369498|38776391|FG000|Overall Study|Adverse Event|1|||
16077779|NCT01369498|38776392|FG001|Overall Study|Adverse Event|2|||
16077780|NCT01369498|38776393|FG002|Overall Study|Adverse Event|0|||
16077781|NCT01369498|38776394|FG003|Overall Study|Adverse Event|1|||
16077782|NCT01369498|38776391|FG000|Overall Study|Withdrawal of Consent|0|||
16077783|NCT01369498|38776392|FG001|Overall Study|Withdrawal of Consent|1|||
16077784|NCT01369498|38776393|FG002|Overall Study|Withdrawal of Consent|1|||
16077785|NCT01369498|38776394|FG003|Overall Study|Withdrawal of Consent|1|||
16077786|NCT01369498|38776391|FG000|Overall Study|Death|0|||
16077787|NCT01369498|38776392|FG001|Overall Study|Death|0|||
16278599|NCT01496118|39500948|FG004|Overall Study|Disease progression|2|||
16278600|NCT01496118|39500949|FG005|Overall Study|Disease progression|2|||
16278601|NCT01496118|39500950|FG006|Overall Study|Disease progression|14|||
16278602|NCT01496118|39500951|FG007|Overall Study|Disease progression|10|||
16077788|NCT01369498|38776393|FG002|Overall Study|Death|1|||
16077789|NCT01369498|38776394|FG003|Overall Study|Death|0|||
16077790|NCT01369498|38776391|FG000|Overall Study|Investigator's Discretion|1|||
16278603|NCT01496118|39500944|FG000|Overall Study|Physician Decision|0|||
16278604|NCT01496118|39500945|FG001|Overall Study|Physician Decision|0|||
16278605|NCT01496118|39500946|FG002|Overall Study|Physician Decision|0|||
16278606|NCT01496118|39500947|FG003|Overall Study|Physician Decision|0|||
16278607|NCT01496118|39500948|FG004|Overall Study|Physician Decision|1|||
16278608|NCT01496118|39500949|FG005|Overall Study|Physician Decision|0|||
16278609|NCT01496118|39500950|FG006|Overall Study|Physician Decision|3|||
16278610|NCT01496118|39500951|FG007|Overall Study|Physician Decision|6|||
16278611|NCT01496118|39500944|FG000|Overall Study|Adverse Event|1|||
16278612|NCT01496118|39500945|FG001|Overall Study|Adverse Event|1|||
16278613|NCT01496118|39500946|FG002|Overall Study|Adverse Event|0|||
16278614|NCT01496118|39500947|FG003|Overall Study|Adverse Event|0|||
16278615|NCT01496118|39500948|FG004|Overall Study|Adverse Event|0|||
16278616|NCT01496118|39500949|FG005|Overall Study|Adverse Event|0|||
16278617|NCT01496118|39500950|FG006|Overall Study|Adverse Event|6|||
16278618|NCT01496118|39500951|FG007|Overall Study|Adverse Event|10|||
16278619|NCT01496118|39500944|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
16278620|NCT01496118|39500945|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
16278621|NCT01496118|39500946|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
16278622|NCT01496118|39500947|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
16278623|NCT01496118|39500948|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
16278624|NCT01496118|39500949|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
16278625|NCT01496118|39500950|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
16278626|NCT01496118|39500951|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
16278627|NCT01496118|39500944|FG000|Overall Study|Death|0|||
16278628|NCT01496118|39500945|FG001|Overall Study|Death|0|||
16278629|NCT01496118|39500946|FG002|Overall Study|Death|0|||
16278630|NCT01496118|39500947|FG003|Overall Study|Death|0|||
16278631|NCT01496118|39500948|FG004|Overall Study|Death|0|||
16278632|NCT01496118|39500949|FG005|Overall Study|Death|0|||
16278633|NCT01496118|39500950|FG006|Overall Study|Death|1|||
16278634|NCT01496118|39500951|FG007|Overall Study|Death|1|||
16278635|NCT01496118|39500944|FG000|Overall Study|Withdrawal by Subject|0|||
16278636|NCT01496118|39500945|FG001|Overall Study|Withdrawal by Subject|0|||
16278637|NCT01496118|39500946|FG002|Overall Study|Withdrawal by Subject|0|||
16278638|NCT01496118|39500947|FG003|Overall Study|Withdrawal by Subject|2|||
16077791|NCT01369498|38776392|FG001|Overall Study|Investigator's Discretion|0|||
16077792|NCT01369498|38776393|FG002|Overall Study|Investigator's Discretion|1|||
16077793|NCT01369498|38776394|FG003|Overall Study|Investigator's Discretion|3|||
16077794|NCT01369498|38776391|FG000|Overall Study|Unknown Reason|1|||
16077795|NCT01369498|38776392|FG001|Overall Study|Unknown Reason|0|||
16077796|NCT01369498|38776393|FG002|Overall Study|Unknown Reason|11|||
16077797|NCT01369498|38776394|FG003|Overall Study|Unknown Reason|6|||
16077798|NCT01369498|38776391|FG000|Overall Study|Disease Progression|0|||
16077799|NCT01369498|38776392|FG001|Overall Study|Disease Progression|0|||
16077800|NCT01369498|38776393|FG002|Overall Study|Disease Progression|0|||
16077801|NCT01369498|38776394|FG003|Overall Study|Disease Progression|1|||
16077802|NCT01599104|38776397|FG000|Overall Study|Withdrawal by Subject|1|||
16077803|NCT01599104|38776398|FG001|Overall Study|Withdrawal by Subject|1|||
16077804|NCT01599104|38776399|FG002|Overall Study|Withdrawal by Subject|2|||
16077805|NCT01599104|38776397|FG000|Overall Study|Technical Problems|1|||
16077806|NCT01599104|38776398|FG001|Overall Study|Technical Problems|0|||
16077807|NCT01599104|38776399|FG002|Overall Study|Technical Problems|0|||
16077808|NCT01599104|38776397|FG000|Overall Study|Physician Decision|3|||
16077809|NCT01599104|38776398|FG001|Overall Study|Physician Decision|2|||
16077810|NCT01599104|38776399|FG002|Overall Study|Physician Decision|2|||
16077811|NCT01599104|38776397|FG000|Overall Study|Non-compliance with study treatment|0|||
16077812|NCT01599104|38776398|FG001|Overall Study|Non-compliance with study treatment|1|||
16077813|NCT01599104|38776399|FG002|Overall Study|Non-compliance with study treatment|0|||
16077814|NCT01599104|38776397|FG000|Overall Study|Lack of Efficacy|4|||
16077815|NCT01599104|38776398|FG001|Overall Study|Lack of Efficacy|4|||
16077816|NCT01599104|38776399|FG002|Overall Study|Lack of Efficacy|10|||
16077817|NCT01599104|38776397|FG000|Overall Study|Adverse Event|7|||
16077818|NCT01599104|38776398|FG001|Overall Study|Adverse Event|6|||
16077819|NCT01599104|38776399|FG002|Overall Study|Adverse Event|12|||
16278639|NCT01496118|39500948|FG004|Overall Study|Withdrawal by Subject|0|||
16278640|NCT01496118|39500949|FG005|Overall Study|Withdrawal by Subject|1|||
16278641|NCT01496118|39500950|FG006|Overall Study|Withdrawal by Subject|6|||
16278642|NCT01496118|39500951|FG007|Overall Study|Withdrawal by Subject|3|||
16278643|NCT01745094|39500952|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
16077820|NCT01803555|38776400|FG000|Overall Study|Adverse Event|3|||
16077821|NCT01803555|38776401|FG001|Overall Study|Adverse Event|2|||
16077822|NCT01803555|38776400|FG000|Overall Study|Withdrawal by Subject|3|||
16077823|NCT01803555|38776401|FG001|Overall Study|Withdrawal by Subject|3|||
16278644|NCT01745094|39500953|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
16278645|NCT01745094|39500954|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
16077824|NCT01803555|38776400|FG000|Overall Study|Non-compliance|1|||
16077825|NCT01803555|38776401|FG001|Overall Study|Non-compliance|1|||
16077826|NCT01803555|38776400|FG000|Overall Study|Protocol Violation|3|||
16077827|NCT01803555|38776401|FG001|Overall Study|Protocol Violation|5|||
16077828|NCT01803555|38776400|FG000|Overall Study|Lost to Follow-up|0|||
16077829|NCT01803555|38776401|FG001|Overall Study|Lost to Follow-up|2|||
16077830|NCT01803555|38776400|FG000|Overall Study|Other than specified|3|||
16077831|NCT01803555|38776401|FG001|Overall Study|Other than specified|5|||
16077832|NCT01968226|38776404|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
16077833|NCT02731755|38776408|FG000|First Intervention|Withdrawal by Subject|0|||
16077834|NCT02731755|38776409|FG001|First Intervention|Withdrawal by Subject|2|||
16077835|NCT00554788|38776415|FG000|Overall Study|Adverse Event|0|||
16077836|NCT00554788|38776416|FG001|Overall Study|Adverse Event|1|||
16077837|NCT00554788|38776417|FG002|Overall Study|Adverse Event|2|||
16077838|NCT00554788|38776415|FG000|Overall Study|Lost to Follow-up|4|||
16077839|NCT00554788|38776416|FG001|Overall Study|Lost to Follow-up|3|||
16077840|NCT00554788|38776417|FG002|Overall Study|Lost to Follow-up|3|||
16077841|NCT00554788|38776415|FG000|Overall Study|Physician Decision|1|||
16077842|NCT00554788|38776416|FG001|Overall Study|Physician Decision|1|||
16077843|NCT00554788|38776417|FG002|Overall Study|Physician Decision|3|||
16077844|NCT00554788|38776415|FG000|Overall Study|Withdrawal by Subject|0|||
16077845|NCT00554788|38776416|FG001|Overall Study|Withdrawal by Subject|0|||
16077846|NCT00554788|38776417|FG002|Overall Study|Withdrawal by Subject|1|||
16077847|NCT00554788|38776415|FG000|Overall Study|Refusal of further protocol therapy|0|||
16077848|NCT00554788|38776416|FG001|Overall Study|Refusal of further protocol therapy|1|||
16077849|NCT00554788|38776417|FG002|Overall Study|Refusal of further protocol therapy|1|||
16077850|NCT00554788|38776415|FG000|Overall Study|Progressive disease|0|||
16077851|NCT00554788|38776416|FG001|Overall Study|Progressive disease|0|||
16077852|NCT00554788|38776417|FG002|Overall Study|Progressive disease|3|||
16077853|NCT00554788|38776415|FG000|Overall Study|Ineligible|2|||
16077854|NCT00554788|38776416|FG001|Overall Study|Ineligible|0|||
16077855|NCT00554788|38776417|FG002|Overall Study|Ineligible|1|||
16077856|NCT03452189|38776420|FG000|First Intervention (3 Months)|Adverse Event|1|||
16077857|NCT03452189|38776421|FG001|First Intervention (3 Months)|Adverse Event|0|||
16077858|NCT03452189|38776420|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
16077859|NCT03452189|38776421|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
16077860|NCT01832480|38776422|FG000|Overall Study|Lost to Follow-up|33|||
16077861|NCT01832480|38776423|FG001|Overall Study|Lost to Follow-up|30|||
16077862|NCT01832480|38776422|FG000|Overall Study|Withdrawal by Subject|0|||
16077863|NCT01832480|38776423|FG001|Overall Study|Withdrawal by Subject|2|||
16077864|NCT01832480|38776422|FG000|Overall Study|post randomization ineligible|8|||
16077865|NCT01832480|38776423|FG001|Overall Study|post randomization ineligible|10|||
16077866|NCT02685488|38776427|FG000|Overall Study|Withdrawal by Subject|0|||
16077867|NCT02685488|38776428|FG001|Overall Study|Withdrawal by Subject|1|||
16077868|NCT01199575|38776433|FG000|Overall Study|Withdrawal by Subject|5|||
16077869|NCT01677936|38776434|FG000|Overall Study|Lost to Follow-up|4|||
16077870|NCT01677936|38776435|FG001|Overall Study|Lost to Follow-up|1|||
16077871|NCT01677936|38776434|FG000|Overall Study|Protocol Violation|3|||
16278646|NCT01745094|39500955|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
16077872|NCT01677936|38776435|FG001|Overall Study|Protocol Violation|0|||
16077873|NCT01677936|38776434|FG000|Overall Study|Adverse Event|1|||
16077874|NCT01677936|38776435|FG001|Overall Study|Adverse Event|0|||
16077875|NCT01677936|38776434|FG000|Overall Study|Lost to Follow-up|1|||
16077876|NCT01677936|38776435|FG001|Overall Study|Lost to Follow-up|0|||
16077877|NCT01677936|38776434|FG000|Overall Study|Protocol Violation|0|||
16077878|NCT01677936|38776435|FG001|Overall Study|Protocol Violation|4|||
16077879|NCT01493778|38776436|FG000|Overall Study|Withdrawal by Subject|8|||
16077880|NCT00186186|38779617|FG000|Overall Study|Lack of Efficacy|3|||
16077881|NCT00186186|38779617|FG000|Overall Study|Withdrawal by Subject|3|||
16077882|NCT00186186|38779617|FG000|Overall Study|Not reported as to reason|2|||
16278647|NCT01745094|39500952|FG000|Overall Study|Adverse Event|0|||
16477551|NCT01752985|40228217|FG001|Treatment Period|Subject no longer meets study criteria|1|||
16477552|NCT01752985|40228218|FG002|Treatment Period|Subject no longer meets study criteria|1|||
16077883|NCT01444417|38779618|FG000|Overall Study|Ineligibility Determined|0|||
16077884|NCT01444417|38779619|FG001|Overall Study|Ineligibility Determined|1|||
16077885|NCT01444417|38779618|FG000|Overall Study|Withdrawal by Subject|2|||
16077886|NCT01444417|38779619|FG001|Overall Study|Withdrawal by Subject|0|||
16077887|NCT00632424|38779620|FG000|Overall Study|Disease Progression|17|||
16077888|NCT00632424|38779620|FG000|Overall Study|Study Drug Toxicity|1|||
16077889|NCT02738840|38779621|FG000|Overall Study|MRI Scan not Performed|5|||
16077890|NCT02738840|38779621|FG000|Overall Study|Lost to Follow-up|1|||
16077891|NCT02738840|38779621|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
16077892|NCT02738840|38779621|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
16278648|NCT01745094|39500953|FG001|Overall Study|Adverse Event|0|||
16077893|NCT01041417|38779622|FG000|Overall Study|Adverse Event|5|||
16278649|NCT01745094|39500954|FG002|Overall Study|Adverse Event|3|||
16077894|NCT01041417|38779623|FG001|Overall Study|Adverse Event|2|||
16077895|NCT01041417|38779622|FG000|Overall Study|Lost to Follow-up|1|||
16077896|NCT01041417|38779623|FG001|Overall Study|Lost to Follow-up|1|||
16077897|NCT01041417|38779622|FG000|Overall Study|Death|1|||
16077898|NCT01041417|38779623|FG001|Overall Study|Death|0|||
16077899|NCT00661778|38779626|FG000|Overall Study|Disease Progression|23|||
16077900|NCT00661778|38779626|FG000|Overall Study|Adverse Event|18|||
16077901|NCT00661778|38779626|FG000|Overall Study|Reason not Specified|6|||
16077902|NCT00661778|38779626|FG000|Overall Study|Protocol Violation|2|||
16077903|NCT00661778|38779626|FG000|Overall Study|Withdrawal of Consent|1|||
16077904|NCT03432858|38779627|FG000|Overall Study|Protocol Violation|2|||
16077905|NCT03432858|38779628|FG001|Overall Study|Protocol Violation|1|||
16077906|NCT03432858|38779629|FG002|Overall Study|Protocol Violation|9|||
16077907|NCT03432858|38779627|FG000|Overall Study|Withdrawal by Subject|0|||
16077908|NCT03432858|38779628|FG001|Overall Study|Withdrawal by Subject|1|||
16077909|NCT03432858|38779629|FG002|Overall Study|Withdrawal by Subject|1|||
16077910|NCT03432858|38779627|FG000|Overall Study|Procedure canceled/rescheduled|0|||
16077911|NCT03432858|38779628|FG001|Overall Study|Procedure canceled/rescheduled|9|||
16077912|NCT03432858|38779629|FG002|Overall Study|Procedure canceled/rescheduled|6|||
16077913|NCT03432858|38779627|FG000|Overall Study|Required postop mobilization with splinting|0|||
16077914|NCT03432858|38779628|FG001|Overall Study|Required postop mobilization with splinting|0|||
16077915|NCT03432858|38779629|FG002|Overall Study|Required postop mobilization with splinting|1|||
16077916|NCT02372253|38779635|FG000|Overall Study|Non Compliance|2|||
16077917|NCT02372253|38779636|FG001|Overall Study|Non Compliance|0|||
16077918|NCT00423098|38779637|FG000|Overall Study|Adverse Event|1|||
16077919|NCT00423098|38779638|FG001|Overall Study|Adverse Event|2|||
16077920|NCT00423098|38779637|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16077921|NCT00423098|38779638|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16077922|NCT00423098|38779637|FG000|Overall Study|Administrative problems|0|||
16077923|NCT00423098|38779638|FG001|Overall Study|Administrative problems|1|||
16077924|NCT00423098|38779637|FG000|Overall Study|Death|2|||
16077925|NCT00423098|38779638|FG001|Overall Study|Death|0|||
16077926|NCT03684044|38779639|FG000|Overall Study|Adverse Event|3|||
16077927|NCT03684044|38779640|FG001|Overall Study|Adverse Event|0|||
16077928|NCT03684044|38779639|FG000|Overall Study|Death|4|||
16077929|NCT03684044|38779640|FG001|Overall Study|Death|7|||
16077930|NCT03684044|38779639|FG000|Overall Study|Lost to Follow-up|3|||
16077931|NCT03684044|38779640|FG001|Overall Study|Lost to Follow-up|2|||
16077932|NCT03684044|38779639|FG000|Overall Study|Patient Not Available|0|||
16077933|NCT03684044|38779640|FG001|Overall Study|Patient Not Available|2|||
16077934|NCT03684044|38779639|FG000|Overall Study|Physician Decision|1|||
16077935|NCT03684044|38779640|FG001|Overall Study|Physician Decision|0|||
16077936|NCT03684044|38779639|FG000|Overall Study|Withdrawal by Subject|11|||
16077937|NCT03684044|38779640|FG001|Overall Study|Withdrawal by Subject|9|||
16077938|NCT00393848|38779644|FG000|Overall Study|Surgical schedule|0|||
16077939|NCT00393848|38779645|FG001|Overall Study|Surgical schedule|0|||
16077940|NCT00393848|38779646|FG002|Overall Study|Surgical schedule|0|||
16077941|NCT00393848|38779647|FG003|Overall Study|Surgical schedule|1|||
16077942|NCT00393848|38779644|FG000|Overall Study|Personal reasons|0|||
16077943|NCT00393848|38779645|FG001|Overall Study|Personal reasons|0|||
16077944|NCT00393848|38779646|FG002|Overall Study|Personal reasons|2|||
16077945|NCT00393848|38779647|FG003|Overall Study|Personal reasons|0|||
16077946|NCT02320123|38779648|FG000|Overall Study|Lost to Follow-up|4|||
16077947|NCT02320123|38779649|FG001|Overall Study|Lost to Follow-up|6|||
16077948|NCT02320123|38779648|FG000|Overall Study|Death|6|||
16077949|NCT02320123|38779649|FG001|Overall Study|Death|5|||
16077950|NCT01318382|38779650|FG000|Overall Study|Physician Decision|2|||
16077951|NCT01318382|38779650|FG000|Overall Study|Device Malfunction|10|||
16077952|NCT01318382|38779650|FG000|Overall Study|Protocol Violation|1|||
16077953|NCT01460446|38779654|FG000|Overall Study|Non-compliance|2|||
16077954|NCT01460446|38779655|FG001|Overall Study|Non-compliance|9|||
16077955|NCT01460446|38779654|FG000|Overall Study|Consent Withdrawn|0|||
16077956|NCT01460446|38779655|FG001|Overall Study|Consent Withdrawn|4|||
16077957|NCT01460446|38779654|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
16077958|NCT01460446|38779655|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
16077959|NCT01460446|38779654|FG000|Overall Study|Surgery/Illness|1|||
16077960|NCT01460446|38779655|FG001|Overall Study|Surgery/Illness|1|||
16077961|NCT01460446|38779654|FG000|Overall Study|Pregnancy|1|||
16077962|NCT01460446|38779655|FG001|Overall Study|Pregnancy|0|||
16077963|NCT01460446|38779654|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
16077964|NCT01460446|38779655|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
16077965|NCT02983617|38779656|FG000|Overall Study|Adverse Event|0|||
16077966|NCT02983617|38779657|FG001|Overall Study|Adverse Event|7|||
16077967|NCT02983617|38779656|FG000|Overall Study|Death|0|||
16077968|NCT02983617|38779657|FG001|Overall Study|Death|1|||
16077969|NCT02983617|38779656|FG000|Overall Study|Investigator's Discretion|0|||
16077970|NCT02983617|38779657|FG001|Overall Study|Investigator's Discretion|1|||
16077971|NCT01144468|38779662|FG000|Overall Study|Lost to Follow-up|4|||
16077972|NCT01144468|38779663|FG001|Overall Study|Lost to Follow-up|7|||
16077973|NCT01144468|38779662|FG000|Overall Study|Adverse Event|3|||
16077974|NCT01144468|38779663|FG001|Overall Study|Adverse Event|2|||
16077975|NCT01144468|38779662|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
16077976|NCT01144468|38779663|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
16077977|NCT03024606|38779664|FG000|Overall Study|Withdrawal by Subject|9|||
16077978|NCT03024606|38779665|FG001|Overall Study|Withdrawal by Subject|10|||
16077979|NCT02423291|38779666|FG000|Overall Study|Lack of Efficacy|14|||
16077980|NCT02423291|38779666|FG000|Overall Study|Adverse Event|1|||
16077981|NCT02988817|38779667|FG000|Overall Study|Withdrawal by Subject|1|||
16077982|NCT02988817|38779668|FG001|Overall Study|Withdrawal by Subject|0|||
16278650|NCT01745094|39500955|FG003|Overall Study|Adverse Event|0|||
16077983|NCT02988817|38779669|FG002|Overall Study|Withdrawal by Subject|0|||
16077984|NCT02988817|38779670|FG003|Overall Study|Withdrawal by Subject|1|||
16077985|NCT02988817|38779671|FG004|Overall Study|Withdrawal by Subject|3|||
16077986|NCT02988817|38779672|FG005|Overall Study|Withdrawal by Subject|1|||
16077987|NCT02988817|38779673|FG006|Overall Study|Withdrawal by Subject|2|||
16077988|NCT02988817|38779674|FG007|Overall Study|Withdrawal by Subject|1|||
16077989|NCT02988817|38779675|FG008|Overall Study|Withdrawal by Subject|1|||
16077990|NCT02988817|38779676|FG009|Overall Study|Withdrawal by Subject|1|||
16077991|NCT02988817|38779677|FG010|Overall Study|Withdrawal by Subject|1|||
16077992|NCT02988817|38779678|FG011|Overall Study|Withdrawal by Subject|12|||
16077993|NCT02988817|38779679|FG012|Overall Study|Withdrawal by Subject|6|||
16077994|NCT02988817|38779680|FG013|Overall Study|Withdrawal by Subject|6|||
16077995|NCT02988817|38779681|FG014|Overall Study|Withdrawal by Subject|4|||
16077996|NCT02988817|38779682|FG015|Overall Study|Withdrawal by Subject|5|||
16077997|NCT02988817|38779683|FG016|Overall Study|Withdrawal by Subject|4|||
16077998|NCT02988817|38779684|FG017|Overall Study|Withdrawal by Subject|11|||
16077999|NCT02988817|38779685|FG018|Overall Study|Withdrawal by Subject|4|||
16078000|NCT02988817|38779686|FG019|Overall Study|Withdrawal by Subject|2|||
16078001|NCT02988817|38779667|FG000|Overall Study|Death|0|||
16078002|NCT02988817|38779668|FG001|Overall Study|Death|1|||
16078003|NCT02988817|38779669|FG002|Overall Study|Death|3|||
16078004|NCT02988817|38779670|FG003|Overall Study|Death|1|||
16078005|NCT02988817|38779671|FG004|Overall Study|Death|6|||
16078006|NCT02988817|38779672|FG005|Overall Study|Death|10|||
16278651|NCT01745094|39500952|FG000|Overall Study|Withdrawal by Subject|2|||
16078007|NCT02988817|38779673|FG006|Overall Study|Death|1|||
16078008|NCT02988817|38779674|FG007|Overall Study|Death|2|||
16078009|NCT02988817|38779675|FG008|Overall Study|Death|1|||
16078010|NCT02988817|38779676|FG009|Overall Study|Death|5|||
16078011|NCT02988817|38779677|FG010|Overall Study|Death|1|||
16078012|NCT02988817|38779678|FG011|Overall Study|Death|8|||
16078013|NCT02988817|38779679|FG012|Overall Study|Death|9|||
16078014|NCT02988817|38779680|FG013|Overall Study|Death|17|||
16078015|NCT02988817|38779681|FG014|Overall Study|Death|18|||
16078016|NCT02988817|38779682|FG015|Overall Study|Death|30|||
16078017|NCT02988817|38779683|FG016|Overall Study|Death|17|||
16078018|NCT02988817|38779684|FG017|Overall Study|Death|38|||
16078019|NCT02988817|38779685|FG018|Overall Study|Death|14|||
16078020|NCT02988817|38779686|FG019|Overall Study|Death|16|||
16078021|NCT02988817|38779667|FG000|Overall Study|Other|0|||
16078022|NCT02988817|38779668|FG001|Overall Study|Other|0|||
16078023|NCT02988817|38779669|FG002|Overall Study|Other|0|||
16078024|NCT02988817|38779670|FG003|Overall Study|Other|1|||
16078025|NCT02988817|38779671|FG004|Overall Study|Other|1|||
16078026|NCT02988817|38779672|FG005|Overall Study|Other|0|||
16078027|NCT02988817|38779673|FG006|Overall Study|Other|0|||
16078028|NCT02988817|38779674|FG007|Overall Study|Other|0|||
16078029|NCT02988817|38779675|FG008|Overall Study|Other|0|||
16078030|NCT02988817|38779676|FG009|Overall Study|Other|0|||
16078031|NCT02988817|38779677|FG010|Overall Study|Other|0|||
16078032|NCT02988817|38779678|FG011|Overall Study|Other|0|||
16078033|NCT02988817|38779679|FG012|Overall Study|Other|0|||
16078034|NCT02988817|38779680|FG013|Overall Study|Other|0|||
16078035|NCT02988817|38779681|FG014|Overall Study|Other|0|||
16078036|NCT02988817|38779682|FG015|Overall Study|Other|1|||
16078037|NCT02988817|38779683|FG016|Overall Study|Other|0|||
16078038|NCT02988817|38779684|FG017|Overall Study|Other|0|||
16078039|NCT02988817|38779685|FG018|Overall Study|Other|0|||
16078040|NCT02988817|38779686|FG019|Overall Study|Other|0|||
16078041|NCT02988817|38779667|FG000|Overall Study|Lost to Follow-up|0|||
16078042|NCT02988817|38779668|FG001|Overall Study|Lost to Follow-up|0|||
16078043|NCT02988817|38779669|FG002|Overall Study|Lost to Follow-up|0|||
16078044|NCT02988817|38779670|FG003|Overall Study|Lost to Follow-up|0|||
16078045|NCT02988817|38779671|FG004|Overall Study|Lost to Follow-up|0|||
16078046|NCT02988817|38779672|FG005|Overall Study|Lost to Follow-up|0|||
16078047|NCT02988817|38779673|FG006|Overall Study|Lost to Follow-up|0|||
16078048|NCT02988817|38779674|FG007|Overall Study|Lost to Follow-up|0|||
16078049|NCT02988817|38779675|FG008|Overall Study|Lost to Follow-up|1|||
16078050|NCT02988817|38779676|FG009|Overall Study|Lost to Follow-up|0|||
16078051|NCT02988817|38779677|FG010|Overall Study|Lost to Follow-up|1|||
16278652|NCT01745094|39500953|FG001|Overall Study|Withdrawal by Subject|0|||
16078052|NCT02988817|38779678|FG011|Overall Study|Lost to Follow-up|1|||
16078053|NCT02988817|38779679|FG012|Overall Study|Lost to Follow-up|0|||
16078054|NCT02988817|38779680|FG013|Overall Study|Lost to Follow-up|0|||
16078055|NCT02988817|38779681|FG014|Overall Study|Lost to Follow-up|1|||
16078056|NCT02988817|38779682|FG015|Overall Study|Lost to Follow-up|1|||
16078057|NCT02988817|38779683|FG016|Overall Study|Lost to Follow-up|2|||
16078058|NCT02988817|38779684|FG017|Overall Study|Lost to Follow-up|3|||
16078059|NCT02988817|38779685|FG018|Overall Study|Lost to Follow-up|0|||
16078060|NCT02988817|38779686|FG019|Overall Study|Lost to Follow-up|0|||
16078061|NCT02988817|38779667|FG000|Overall Study|Sponsor decision|0|||
16078062|NCT02988817|38779668|FG001|Overall Study|Sponsor decision|0|||
16078063|NCT02988817|38779669|FG002|Overall Study|Sponsor decision|0|||
16078064|NCT02988817|38779670|FG003|Overall Study|Sponsor decision|0|||
16078065|NCT02988817|38779671|FG004|Overall Study|Sponsor decision|0|||
16078066|NCT02988817|38779672|FG005|Overall Study|Sponsor decision|0|||
16078067|NCT02988817|38779673|FG006|Overall Study|Sponsor decision|0|||
16078068|NCT02988817|38779674|FG007|Overall Study|Sponsor decision|0|||
16078069|NCT02988817|38779675|FG008|Overall Study|Sponsor decision|0|||
16078070|NCT02988817|38779676|FG009|Overall Study|Sponsor decision|0|||
16078071|NCT02988817|38779677|FG010|Overall Study|Sponsor decision|0|||
16078072|NCT02988817|38779678|FG011|Overall Study|Sponsor decision|1|||
16078073|NCT02988817|38779679|FG012|Overall Study|Sponsor decision|1|||
16078074|NCT02988817|38779680|FG013|Overall Study|Sponsor decision|2|||
16078075|NCT02988817|38779681|FG014|Overall Study|Sponsor decision|2|||
16078076|NCT02988817|38779682|FG015|Overall Study|Sponsor decision|6|||
16078077|NCT02988817|38779683|FG016|Overall Study|Sponsor decision|2|||
16078078|NCT02988817|38779684|FG017|Overall Study|Sponsor decision|3|||
16078079|NCT02988817|38779685|FG018|Overall Study|Sponsor decision|2|||
16078080|NCT02988817|38779686|FG019|Overall Study|Sponsor decision|7|||
16078081|NCT02988817|38779667|FG000|Overall Study|Physician Decision|0|||
16078082|NCT02988817|38779668|FG001|Overall Study|Physician Decision|0|||
16078083|NCT02988817|38779669|FG002|Overall Study|Physician Decision|0|||
16078084|NCT02988817|38779670|FG003|Overall Study|Physician Decision|0|||
16078085|NCT02988817|38779671|FG004|Overall Study|Physician Decision|0|||
16078086|NCT02988817|38779672|FG005|Overall Study|Physician Decision|0|||
16078087|NCT02988817|38779673|FG006|Overall Study|Physician Decision|0|||
16078088|NCT02988817|38779674|FG007|Overall Study|Physician Decision|0|||
16078089|NCT02988817|38779675|FG008|Overall Study|Physician Decision|0|||
16078090|NCT02988817|38779676|FG009|Overall Study|Physician Decision|0|||
16078091|NCT02988817|38779677|FG010|Overall Study|Physician Decision|0|||
16078092|NCT02988817|38779678|FG011|Overall Study|Physician Decision|0|||
16078093|NCT02988817|38779679|FG012|Overall Study|Physician Decision|0|||
16078094|NCT02988817|38779680|FG013|Overall Study|Physician Decision|0|||
16078095|NCT02988817|38779681|FG014|Overall Study|Physician Decision|0|||
16078096|NCT02988817|38779682|FG015|Overall Study|Physician Decision|1|||
16078097|NCT02988817|38779683|FG016|Overall Study|Physician Decision|0|||
16078098|NCT02988817|38779684|FG017|Overall Study|Physician Decision|0|||
16078099|NCT02988817|38779685|FG018|Overall Study|Physician Decision|1|||
16078100|NCT02988817|38779686|FG019|Overall Study|Physician Decision|1|||
16078101|NCT01662336|38779687|FG000|Overall Study|Adverse Event|1|||
16078102|NCT01662336|38779687|FG000|Overall Study|No longer on LPV/r|30|||
16078103|NCT01662336|38779687|FG000|Overall Study|Other|29|||
16078104|NCT01662336|38779687|FG000|Overall Study|Withdrawal by Subject|6|||
16078105|NCT06136897|38779695|FG000|Overall Study|Ineligible|3|||
16078106|NCT06136897|38779695|FG000|Overall Study|Mutation status not confirmed|7|||
16078107|NCT06136897|38779695|FG000|Overall Study|Adverse Event|2|||
16078108|NCT06136897|38779695|FG000|Overall Study|Death|1|||
16078109|NCT06136897|38779695|FG000|Overall Study|Disease progression|18|||
16078110|NCT06136897|38779695|FG000|Overall Study|Other complicating disease|1|||
16078111|NCT06136897|38779695|FG000|Overall Study|Withdrawal by Subject|1|||
16078112|NCT06136897|38779695|FG000|Overall Study|Still on treatment|1|||
16078113|NCT06136897|38779695|FG000|Overall Study|Lost to Follow-up|1|||
16078114|NCT02957136|38779696|FG000|Overall Study|Withdrawal by Subject|2|||
16078115|NCT02957136|38779697|FG001|Overall Study|Withdrawal by Subject|1|||
16278653|NCT01745094|39500954|FG002|Overall Study|Withdrawal by Subject|1|||
16078116|NCT05082935|38779702|FG000|Overall Study|Lost to Follow-up|549|||
16078117|NCT05082935|38779703|FG001|Overall Study|Lost to Follow-up|631|||
16078118|NCT05082935|38779702|FG000|Overall Study|Withdrawal by Subject|27|||
16078119|NCT05082935|38779703|FG001|Overall Study|Withdrawal by Subject|58|||
16078120|NCT03740009|38779704|FG000|Overall Study|Physician Decision|9|||
16078121|NCT03740009|38779704|FG000|Overall Study|Lost to Follow-up|1|||
16078122|NCT03102710|38779707|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
16078123|NCT03102710|38779708|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
16078124|NCT03102710|38779709|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
16078125|NCT03102710|38779707|FG000|Overall Study|Technical issues during final MRI scan|0|||
16078126|NCT03102710|38779708|FG001|Overall Study|Technical issues during final MRI scan|1|||
16078127|NCT03102710|38779709|FG002|Overall Study|Technical issues during final MRI scan|0|||
16078128|NCT03102710|38779707|FG000|Overall Study|Nausea during MRI scan|0|||
16078129|NCT03102710|38779708|FG001|Overall Study|Nausea during MRI scan|1|||
16078130|NCT03102710|38779709|FG002|Overall Study|Nausea during MRI scan|0|||
16078131|NCT03102710|38779707|FG000|Overall Study|Subject unable to attend final session|0|||
16078132|NCT03102710|38779708|FG001|Overall Study|Subject unable to attend final session|1|||
16078133|NCT03102710|38779709|FG002|Overall Study|Subject unable to attend final session|0|||
16078134|NCT00001277|38779712|FG000|Overall Study|Adverse Event|0|||
16078135|NCT00001277|38779713|FG001|Overall Study|Adverse Event|0|||
16078136|NCT00001277|38779714|FG002|Overall Study|Adverse Event|1|||
16078137|NCT00001277|38779712|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
16078138|NCT00001277|38779713|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
16078139|NCT00001277|38779714|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
16078140|NCT01561989|38779723|FG000|Overall Study|accural target not met.|5|||
16078141|NCT01561989|38779724|FG001|Overall Study|accural target not met.|6|||
16078142|NCT02965846|38779725|FG000|Overall Study|Lost to Follow-up|1|||
16078143|NCT02965846|38779726|FG001|Overall Study|Lost to Follow-up|0|||
16078144|NCT02965846|38779727|FG002|Overall Study|Lost to Follow-up|0|||
16078145|NCT02965846|38779725|FG000|Overall Study|Withdrawal by Subject|0|||
16078146|NCT02965846|38779726|FG001|Overall Study|Withdrawal by Subject|1|||
16078147|NCT02965846|38779727|FG002|Overall Study|Withdrawal by Subject|0|||
16078148|NCT02965846|38779725|FG000|Overall Study|Study Terminated By Sponsor|4|||
16078149|NCT02965846|38779726|FG001|Overall Study|Study Terminated By Sponsor|4|||
16078150|NCT02965846|38779727|FG002|Overall Study|Study Terminated By Sponsor|0|||
16078151|NCT02965846|38779725|FG000|Overall Study|Participants not randomized|0|||
16078152|NCT02965846|38779726|FG001|Overall Study|Participants not randomized|0|||
16078153|NCT02965846|38779727|FG002|Overall Study|Participants not randomized|33|||
16078154|NCT02477670|38779728|FG000|Stage 1|Adverse Event|2|||
16078155|NCT02477670|38779729|FG001|Stage 1|Adverse Event|7|||
16078156|NCT02477670|38779730|FG002|Stage 1|Adverse Event|0|||
16078157|NCT02477670|38779731|FG003|Stage 1|Adverse Event|0|||
16078158|NCT02477670|38779732|FG004|Stage 1|Adverse Event|0|||
16078159|NCT02477670|38779733|FG005|Stage 1|Adverse Event|0|||
16078160|NCT02477670|38779734|FG006|Stage 1|Adverse Event|0|||
16078161|NCT02477670|38779728|FG000|Stage 1|Lost to Follow-up|0|||
16078162|NCT02477670|38779729|FG001|Stage 1|Lost to Follow-up|2|||
16078163|NCT02477670|38779730|FG002|Stage 1|Lost to Follow-up|0|||
16078164|NCT02477670|38779731|FG003|Stage 1|Lost to Follow-up|0|||
16078165|NCT02477670|38779732|FG004|Stage 1|Lost to Follow-up|0|||
16078166|NCT02477670|38779733|FG005|Stage 1|Lost to Follow-up|0|||
16078167|NCT02477670|38779734|FG006|Stage 1|Lost to Follow-up|0|||
16078168|NCT02477670|38779728|FG000|Stage 1|Withdrawal by Subject|1|||
16078169|NCT02477670|38779729|FG001|Stage 1|Withdrawal by Subject|2|||
16078170|NCT02477670|38779730|FG002|Stage 1|Withdrawal by Subject|0|||
16078171|NCT02477670|38779731|FG003|Stage 1|Withdrawal by Subject|0|||
16078172|NCT02477670|38779732|FG004|Stage 1|Withdrawal by Subject|0|||
16078173|NCT02477670|38779733|FG005|Stage 1|Withdrawal by Subject|0|||
16078174|NCT02477670|38779734|FG006|Stage 1|Withdrawal by Subject|0|||
16078175|NCT02477670|38779728|FG000|Stage 1|Non-compliance with Study Drug|1|||
16078176|NCT02477670|38779729|FG001|Stage 1|Non-compliance with Study Drug|2|||
16078177|NCT02477670|38779730|FG002|Stage 1|Non-compliance with Study Drug|0|||
16078178|NCT02477670|38779731|FG003|Stage 1|Non-compliance with Study Drug|0|||
16078179|NCT02477670|38779732|FG004|Stage 1|Non-compliance with Study Drug|0|||
16078180|NCT02477670|38779733|FG005|Stage 1|Non-compliance with Study Drug|0|||
16278654|NCT01745094|39500955|FG003|Overall Study|Withdrawal by Subject|2|||
16278655|NCT01745094|39500952|FG000|Overall Study|Protocol Violation|1|||
16278656|NCT01745094|39500953|FG001|Overall Study|Protocol Violation|0|||
16278657|NCT01745094|39500954|FG002|Overall Study|Protocol Violation|3|||
16078181|NCT02477670|38779734|FG006|Stage 1|Non-compliance with Study Drug|0|||
16078182|NCT02477670|38779728|FG000|Stage 2|Adverse Event|0|||
16078183|NCT02477670|38779729|FG001|Stage 2|Adverse Event|0|||
16078184|NCT02477670|38779730|FG002|Stage 2|Adverse Event|1|||
16078185|NCT02477670|38779731|FG003|Stage 2|Adverse Event|0|||
16078186|NCT02477670|38779732|FG004|Stage 2|Adverse Event|0|||
16078187|NCT02477670|38779733|FG005|Stage 2|Adverse Event|0|||
16078188|NCT02477670|38779734|FG006|Stage 2|Adverse Event|0|||
16078189|NCT02477670|38779728|FG000|Stage 2|Antipsychotic Medication Changed|0|||
16078190|NCT02477670|38779729|FG001|Stage 2|Antipsychotic Medication Changed|0|||
16078191|NCT02477670|38779730|FG002|Stage 2|Antipsychotic Medication Changed|1|||
16078192|NCT02477670|38779731|FG003|Stage 2|Antipsychotic Medication Changed|0|||
16078193|NCT02477670|38779732|FG004|Stage 2|Antipsychotic Medication Changed|0|||
16078194|NCT02477670|38779733|FG005|Stage 2|Antipsychotic Medication Changed|0|||
16078195|NCT02477670|38779734|FG006|Stage 2|Antipsychotic Medication Changed|0|||
16078196|NCT02477670|38779728|FG000|Stage 2|Withdrawal by Subject|0|||
16078197|NCT02477670|38779729|FG001|Stage 2|Withdrawal by Subject|0|||
16078198|NCT02477670|38779730|FG002|Stage 2|Withdrawal by Subject|0|||
16078199|NCT02477670|38779731|FG003|Stage 2|Withdrawal by Subject|1|||
16078200|NCT02477670|38779732|FG004|Stage 2|Withdrawal by Subject|0|||
16078201|NCT02477670|38779733|FG005|Stage 2|Withdrawal by Subject|0|||
16078202|NCT02477670|38779734|FG006|Stage 2|Withdrawal by Subject|0|||
16078203|NCT02798835|38779735|FG000|Overall Study|Protocol Violation|0|||
16278658|NCT01745094|39500955|FG003|Overall Study|Protocol Violation|1|||
16078204|NCT02798835|38779736|FG001|Overall Study|Protocol Violation|0|||
16078205|NCT02798835|38779737|FG002|Overall Study|Protocol Violation|3|||
16078206|NCT01198028|38779742|FG000|Overall Study|Adverse Event|5|||
16078207|NCT01198028|38779742|FG000|Overall Study|Death|3|||
16078208|NCT01198028|38779742|FG000|Overall Study|Physician Decision|2|||
16078209|NCT01188655|38779743|FG000|Overall Study|Lack of Efficacy|1|||
16078210|NCT01188655|38779743|FG000|Overall Study|Lost to Follow-up|1|||
16078211|NCT01188655|38779743|FG000|Overall Study|Other|11|||
16078212|NCT00206375|38779744|FG000|Overall Study|Lost to Follow-up|1|||
16078213|NCT00206375|38779745|FG001|Overall Study|Lost to Follow-up|0|||
16078214|NCT00206375|38779746|FG002|Overall Study|Lost to Follow-up|0|||
16078215|NCT00206375|38779744|FG000|Overall Study|Withdrawal by Subject|2|||
16078216|NCT00206375|38779745|FG001|Overall Study|Withdrawal by Subject|1|||
16078217|NCT00206375|38779746|FG002|Overall Study|Withdrawal by Subject|3|||
16078218|NCT00206375|38779744|FG000|Overall Study|Study terminated due to lack of funds|0|||
16078219|NCT00206375|38779745|FG001|Overall Study|Study terminated due to lack of funds|1|||
16078220|NCT00206375|38779746|FG002|Overall Study|Study terminated due to lack of funds|1|||
16078221|NCT00535145|38779747|FG000|Phase I|Adverse Event|3|||
16078222|NCT00535145|38779747|FG000|Phase I|Lost to Follow-up|7|||
16078223|NCT00535145|38779747|FG000|Phase I|Withdrawal by Subject|6|||
16078224|NCT00535145|38779747|FG000|Phase I|(eligibility)|8|||
16078225|NCT00535145|38779747|FG000|Phase I|(protocol violation)|1|||
16078226|NCT00535145|38779747|FG000|Phase I|(PI decision)|1|||
16078227|NCT00535145|38779747|FG000|Phase I|(diagnosis)|3|||
16078228|NCT00535145|38779747|FG000|Phase II|Adverse Event|2|||
16078229|NCT00535145|38779747|FG000|Phase II|Lack of Efficacy|1|||
16078230|NCT00535145|38779747|FG000|Phase II|Lost to Follow-up|5|||
16078231|NCT00535145|38779747|FG000|Phase II|Withdrawal by Subject|5|||
16078232|NCT00535145|38779747|FG000|Phase II|Subject non-compliance|2|||
16078233|NCT01759264|38779748|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
16078234|NCT01759264|38779748|FG000|Overall Study|Adverse Event|1|||
16078235|NCT01759264|38779748|FG000|Overall Study|Other|2|||
16078236|NCT01759264|38779748|FG000|Overall Study|Lost to Follow-up|2|||
16078237|NCT01759264|38779748|FG000|Overall Study|Withdrawal by Subject|3|||
16078238|NCT01759264|38779748|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
16078239|NCT03380390|38779750|FG000|Overall Study|Adverse Event|3|||
16078240|NCT00360698|38779754|FG000|Run-In|Physician Decision|0|||
16078241|NCT00360698|38779755|FG001|Run-In|Physician Decision|1|||
16078242|NCT00360698|38779754|FG000|Run-In|Withdrawal by Subject|0|||
16078243|NCT00360698|38779755|FG001|Run-In|Withdrawal by Subject|2|||
16078244|NCT00360698|38779754|FG000|Run-In|Non compliance with treatment procedure|0|||
16078245|NCT00360698|38779755|FG001|Run-In|Non compliance with treatment procedure|1|||
16078246|NCT00360698|38779754|FG000|Run-In|Sponsor request|0|||
16078247|NCT00360698|38779755|FG001|Run-In|Sponsor request|2|||
16078248|NCT00360698|38779754|FG000|Run-In|Patient did not meet inclusion criteria|0|||
16078249|NCT00360698|38779755|FG001|Run-In|Patient did not meet inclusion criteria|1|||
16078250|NCT00360698|38779754|FG000|Run-In|Patient personal reasons|0|||
16078251|NCT00360698|38779755|FG001|Run-In|Patient personal reasons|2|||
16078252|NCT00360698|38779754|FG000|Run-In|Need of insulin with meals|0|||
16078253|NCT00360698|38779755|FG001|Run-In|Need of insulin with meals|1|||
16078254|NCT00360698|38779754|FG000|Treatment Period|Non compliance with treatment procedure|1|||
16078255|NCT00360698|38779755|FG001|Treatment Period|Non compliance with treatment procedure|0|||
16078256|NCT00360698|38779754|FG000|Treatment Period|Early termination by error|0|||
16278659|NCT01745094|39500952|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
16278660|NCT01745094|39500953|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
16078257|NCT00360698|38779755|FG001|Treatment Period|Early termination by error|1|||
16078258|NCT00510887|38779756|FG000|Overall Study|Lost to Follow-up|1|||
16078259|NCT03050814|38779757|FG000|Overall Study|Screen failures|0|||
16078260|NCT03050814|38779758|FG001|Overall Study|Screen failures|0|||
16078261|NCT03050814|38779759|FG002|Overall Study|Screen failures|4|||
16078262|NCT04732338|38779762|FG000|Overall Study|Lost to Follow-up|3|||
16078263|NCT04732338|38779763|FG001|Overall Study|Lost to Follow-up|3|||
16078264|NCT02568683|38779764|FG000|Overall Study|Death|0|||
16278661|NCT01745094|39500954|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
16378743|NCT01435356|39872215|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
16078265|NCT02568683|38779765|FG001|Overall Study|Death|2|||
16078266|NCT02568683|38779764|FG000|Overall Study|Withdrew Consent|1|||
16078267|NCT02568683|38779765|FG001|Overall Study|Withdrew Consent|0|||
16078268|NCT02568683|38779764|FG000|Overall Study|Study Terminated By Sponsor|5|||
16078269|NCT02568683|38779765|FG001|Overall Study|Study Terminated By Sponsor|2|||
16078270|NCT02566902|38779766|FG000|Overall Study|Protocol Violation|2|||
16078271|NCT02566902|38779767|FG001|Overall Study|Protocol Violation|1|||
16378744|NCT01435356|39872216|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
16378745|NCT01435356|39872215|FG000|Overall Study|Physician Decision|1|||
16378746|NCT01435356|39872216|FG001|Overall Study|Physician Decision|0|||
16378747|NCT01435356|39872215|FG000|Overall Study|Patient decision|3|||
16378748|NCT01435356|39872216|FG001|Overall Study|Patient decision|0|||
16378749|NCT01435356|39872215|FG000|Overall Study|Patient moved to another city|1|||
16378750|NCT01435356|39872216|FG001|Overall Study|Patient moved to another city|1|||
16378751|NCT00862940|39872217|FG000|Overall Study|Adverse Event|15|||
16378752|NCT00862940|39872218|FG001|Overall Study|Adverse Event|12|||
16378753|NCT00862940|39872217|FG000|Overall Study|Lack of Efficacy|1|||
16378754|NCT00862940|39872218|FG001|Overall Study|Lack of Efficacy|3|||
16078284|NCT04057196|38779775|FG000|Overall Study|Withdrawal by Subject|3|||
16078285|NCT04057196|38779775|FG000|Overall Study|Death|3|||
16078286|NCT00738699|38779776|FG000|Overall Study|Withdrawal by Subject|5|||
16078287|NCT00738699|38779777|FG001|Overall Study|Withdrawal by Subject|0|||
16278662|NCT01745094|39500955|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
16278663|NCT01745094|39500952|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
16278664|NCT01745094|39500953|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
16278665|NCT01745094|39500954|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
16278666|NCT01745094|39500955|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
16477553|NCT01752985|40228216|FG000|Treatment Period|Adverse Event|2|||
16078288|NCT00738699|38779776|FG000|Overall Study|Lost to Follow-up|1|||
16078289|NCT00738699|38779777|FG001|Overall Study|Lost to Follow-up|0|||
16477554|NCT01752985|40228217|FG001|Treatment Period|Adverse Event|1|||
16477555|NCT01752985|40228218|FG002|Treatment Period|Adverse Event|2|||
16477556|NCT01752985|40228216|FG000|Treatment Period|Withdrawal by Subject|1|||
16477557|NCT01752985|40228217|FG001|Treatment Period|Withdrawal by Subject|1|||
16477558|NCT01752985|40228218|FG002|Treatment Period|Withdrawal by Subject|0|||
16477559|NCT01752985|40228216|FG000|Treatment Period|Lost to Follow-up|0|||
16078290|NCT00738699|38779776|FG000|Overall Study|Death|144|||
16078291|NCT00738699|38779777|FG001|Overall Study|Death|68|||
16078292|NCT00738699|38779776|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
16078293|NCT00738699|38779777|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
16078294|NCT00738699|38779776|FG000|Overall Study|Other|2|||
16078295|NCT00738699|38779777|FG001|Overall Study|Other|0|||
16078296|NCT01254188|38779778|FG000|Overall Study|Disease Progression|6|||
16078297|NCT01254188|38779778|FG000|Overall Study|Protocol Violation|6|||
16078298|NCT01254188|38779778|FG000|Overall Study|Pregnancy|2|||
16078299|NCT01254188|38779778|FG000|Overall Study|Death|4|||
16078300|NCT01254188|38779778|FG000|Overall Study|Lost to Follow-up|5|||
16278667|NCT01745094|39500952|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
16278668|NCT01745094|39500953|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
16278669|NCT01745094|39500954|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
16278670|NCT01745094|39500955|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
16278671|NCT01801917|39500956|FG000|Period 1 - Randomized|Adverse Event|1|||
16278672|NCT01801917|39500957|FG001|Period 1 - Randomized|Adverse Event|0|||
16278673|NCT01801917|39500958|FG002|Period 1 - Randomized|Adverse Event|1|||
16278674|NCT01801917|39500959|FG003|Period 1 - Randomized|Adverse Event|0|||
16278675|NCT04158687|39500960|FG000|Overall Study|Adverse Event|2|||
16278676|NCT04158687|39500961|FG001|Overall Study|Adverse Event|3|||
16278677|NCT04158687|39500962|FG002|Overall Study|Adverse Event|0|||
16278678|NCT04158687|39500963|FG003|Overall Study|Adverse Event|3|||
16278679|NCT04158687|39500960|FG000|Overall Study|Lost to Follow-up|5|||
16278680|NCT04158687|39500961|FG001|Overall Study|Lost to Follow-up|12|||
16278681|NCT04158687|39500962|FG002|Overall Study|Lost to Follow-up|4|||
16278682|NCT04158687|39500963|FG003|Overall Study|Lost to Follow-up|5|||
16278683|NCT04158687|39500960|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
16078301|NCT01254188|38779778|FG000|Overall Study|Withdrawal by Subject|7|||
16078302|NCT01254188|38779778|FG000|Overall Study|Adverse Event|43|||
16078303|NCT01254188|38779778|FG000|Overall Study|per investigator discretion|20|||
16078304|NCT02192606|38779779|FG000|Overall Study|surgery type was changed|1|||
16078305|NCT02192606|38779780|FG001|Overall Study|surgery type was changed|1|||
16078306|NCT02192606|38779779|FG000|Overall Study|Physician Decision|1|||
16078307|NCT02192606|38779780|FG001|Overall Study|Physician Decision|2|||
16078308|NCT02192606|38779779|FG000|Overall Study|3D equipment rep unable to join|0|||
16078309|NCT02192606|38779780|FG001|Overall Study|3D equipment rep unable to join|1|||
16078310|NCT01759771|38779781|FG000|Overall Study|Withdrawal by Subject|1|||
16078311|NCT01759771|38779782|FG001|Overall Study|Withdrawal by Subject|1|||
16078312|NCT01202955|38779783|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
16078313|NCT01202955|38779784|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
16078314|NCT02742519|38779785|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
16078315|NCT02742519|38779786|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
16078316|NCT02742519|38779787|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
16078317|NCT02742519|38779785|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
16078318|NCT02742519|38779786|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
16078319|NCT02742519|38779787|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
16078320|NCT02742519|38779785|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
16078321|NCT02742519|38779786|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
16078322|NCT02742519|38779787|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
16078323|NCT02178098|38779788|FG000|Overall Study|Withdrawal by Subject|0|||
16078324|NCT02178098|38779789|FG001|Overall Study|Withdrawal by Subject|6|||
16078325|NCT02178098|38779788|FG000|Overall Study|Adverse Event|1|||
16078326|NCT02178098|38779789|FG001|Overall Study|Adverse Event|2|||
16078327|NCT02178098|38779788|FG000|Overall Study|Protocol Violation|1|||
16078328|NCT02178098|38779789|FG001|Overall Study|Protocol Violation|1|||
16078329|NCT02178098|38779788|FG000|Overall Study|Lost to Follow-up|0|||
16078330|NCT02178098|38779789|FG001|Overall Study|Lost to Follow-up|1|||
16078331|NCT02178098|38779788|FG000|Overall Study|Sponsor Request|1|||
16078332|NCT02178098|38779789|FG001|Overall Study|Sponsor Request|0|||
16078333|NCT02178098|38779788|FG000|Overall Study|Other|2|||
16078334|NCT02178098|38779789|FG001|Overall Study|Other|2|||
16078335|NCT03403413|38779791|FG000|Overall Study|Lack of Efficacy|2|||
16078336|NCT01044303|38779792|FG000|Overall Study|Lost to Follow-up|2|||
16078337|NCT01170962|38779802|FG000|Treatment Period|Lack of Efficacy|96|||
16078338|NCT01170962|38779803|FG001|Treatment Period|Lack of Efficacy|91|||
16278684|NCT04158687|39500961|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
16078339|NCT01170962|38779804|FG002|Treatment Period|Lack of Efficacy|7|||
16078340|NCT01170962|38779802|FG000|Treatment Period|Adverse Event|11|||
16078341|NCT01170962|38779803|FG001|Treatment Period|Adverse Event|12|||
16078342|NCT01170962|38779804|FG002|Treatment Period|Adverse Event|3|||
16278685|NCT04158687|39500962|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
16078343|NCT01170962|38779802|FG000|Treatment Period|Withdrawal by Subject|2|||
16078344|NCT01170962|38779803|FG001|Treatment Period|Withdrawal by Subject|1|||
16078345|NCT01170962|38779804|FG002|Treatment Period|Withdrawal by Subject|0|||
16078346|NCT01170962|38779802|FG000|Treatment Period|Lost to Follow-up|1|||
16078347|NCT01170962|38779803|FG001|Treatment Period|Lost to Follow-up|1|||
16078348|NCT01170962|38779804|FG002|Treatment Period|Lost to Follow-up|1|||
16078349|NCT01170962|38779802|FG000|Treatment Period|Participant no longer meets criteria|0|||
16078350|NCT01170962|38779803|FG001|Treatment Period|Participant no longer meets criteria|1|||
16078351|NCT01170962|38779804|FG002|Treatment Period|Participant no longer meets criteria|0|||
16078352|NCT01170962|38779802|FG000|Treatment Period|Request to discontinue treatment|7|||
16078353|NCT01170962|38779803|FG001|Treatment Period|Request to discontinue treatment|3|||
16078354|NCT01170962|38779804|FG002|Treatment Period|Request to discontinue treatment|1|||
16078355|NCT01170962|38779802|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
16078356|NCT01170962|38779803|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
16078357|NCT01170962|38779804|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
16078358|NCT01170962|38779802|FG000|Follow up Period|Withdrawal by Subject|14|||
16078359|NCT01170962|38779803|FG001|Follow up Period|Withdrawal by Subject|10|||
16078360|NCT01170962|38779804|FG002|Follow up Period|Withdrawal by Subject|2|||
16078361|NCT01170962|38779802|FG000|Follow up Period|Lost to Follow-up|13|||
16078362|NCT01170962|38779803|FG001|Follow up Period|Lost to Follow-up|8|||
16078363|NCT01170962|38779804|FG002|Follow up Period|Lost to Follow-up|1|||
16078364|NCT01170962|38779802|FG000|Follow up Period|Death|2|||
16078365|NCT01170962|38779803|FG001|Follow up Period|Death|2|||
16078366|NCT01170962|38779804|FG002|Follow up Period|Death|0|||
16078367|NCT01170962|38779802|FG000|Follow up Period|Others|10|||
16078368|NCT01170962|38779803|FG001|Follow up Period|Others|7|||
16078369|NCT01170962|38779804|FG002|Follow up Period|Others|3|||
16078370|NCT01227278|38779826|FG000|Overall Study|Withdrawal by Subject|4|||
16078371|NCT01227278|38779827|FG001|Overall Study|Withdrawal by Subject|4|||
16078372|NCT01227278|38779826|FG000|Overall Study|Death|0|||
16078373|NCT01227278|38779827|FG001|Overall Study|Death|2|||
16078374|NCT01227278|38779826|FG000|Overall Study|Other|1|||
16078375|NCT01227278|38779827|FG001|Overall Study|Other|2|||
16078376|NCT02528188|38779828|FG000|Overall Study|Adverse Event|23|||
16078377|NCT02528188|38779829|FG001|Overall Study|Adverse Event|22|||
16078378|NCT02528188|38779830|FG002|Overall Study|Adverse Event|8|||
16078379|NCT02528188|38779828|FG000|Overall Study|Protocol Violation|4|||
16078380|NCT02528188|38779829|FG001|Overall Study|Protocol Violation|6|||
16078381|NCT02528188|38779830|FG002|Overall Study|Protocol Violation|4|||
16078382|NCT02528188|38779828|FG000|Overall Study|Lack of Efficacy|19|||
16078383|NCT02528188|38779829|FG001|Overall Study|Lack of Efficacy|21|||
16078384|NCT02528188|38779830|FG002|Overall Study|Lack of Efficacy|22|||
16078385|NCT02528188|38779828|FG000|Overall Study|Withdrawal by Subject|97|||
16078386|NCT02528188|38779829|FG001|Overall Study|Withdrawal by Subject|104|||
16078387|NCT02528188|38779830|FG002|Overall Study|Withdrawal by Subject|100|||
16078388|NCT02528188|38779828|FG000|Overall Study|Lost to Follow-up|25|||
16078389|NCT02528188|38779829|FG001|Overall Study|Lost to Follow-up|21|||
16078390|NCT02528188|38779830|FG002|Overall Study|Lost to Follow-up|31|||
16078391|NCT02528188|38779828|FG000|Overall Study|Death|4|||
16078392|NCT02528188|38779829|FG001|Overall Study|Death|4|||
16078393|NCT02528188|38779830|FG002|Overall Study|Death|0|||
16078394|NCT02528188|38779828|FG000|Overall Study|Other|89|||
16078395|NCT02528188|38779829|FG001|Overall Study|Other|91|||
16078396|NCT02528188|38779830|FG002|Overall Study|Other|74|||
16078397|NCT02528188|38779828|FG000|Overall Study|Randomized but not treated|6|||
16078398|NCT02528188|38779829|FG001|Overall Study|Randomized but not treated|7|||
16078399|NCT02528188|38779830|FG002|Overall Study|Randomized but not treated|12|||
16078400|NCT00174382|38779831|FG000|Overall Study|Death|2|||
16078401|NCT00174382|38779831|FG000|Overall Study|Adverse Event|19|||
16078402|NCT00174382|38779831|FG000|Overall Study|Withdrawal by Subject|6|||
16078403|NCT00174382|38779831|FG000|Overall Study|Protocol Violation|3|||
16078404|NCT00174382|38779831|FG000|Overall Study|Arrived early for last visit in error|1|||
16078405|NCT00174382|38779831|FG000|Overall Study|Subject felt pill not effective enough|1|||
16078406|NCT00174382|38779831|FG000|Overall Study|Lost to Follow-up|1|||
16078407|NCT00704184|38779847|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
16078408|NCT00704184|38779848|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
16078409|NCT00704184|38779849|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
16078410|NCT00704184|38779850|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
16078411|NCT00704184|38779851|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
16078412|NCT00704184|38779847|FG000|Open-Label Treatment|Adverse Event|0|||
16078413|NCT00704184|38779848|FG001|Open-Label Treatment|Adverse Event|0|||
16078414|NCT00704184|38779849|FG002|Open-Label Treatment|Adverse Event|2|||
16078415|NCT00704184|38779850|FG003|Open-Label Treatment|Adverse Event|0|||
16078416|NCT00704184|38779851|FG004|Open-Label Treatment|Adverse Event|1|||
16078417|NCT00704184|38779847|FG000|Open-Label Treatment|Lack of Efficacy|0|||
16078418|NCT00704184|38779848|FG001|Open-Label Treatment|Lack of Efficacy|2|||
16078419|NCT00704184|38779849|FG002|Open-Label Treatment|Lack of Efficacy|2|||
16078420|NCT00704184|38779850|FG003|Open-Label Treatment|Lack of Efficacy|2|||
16078421|NCT00704184|38779851|FG004|Open-Label Treatment|Lack of Efficacy|1|||
16078422|NCT00704184|38779847|FG000|Open-Label Treatment|Physician Decision|0|||
16078423|NCT00704184|38779848|FG001|Open-Label Treatment|Physician Decision|0|||
16078424|NCT00704184|38779849|FG002|Open-Label Treatment|Physician Decision|0|||
16078425|NCT00704184|38779850|FG003|Open-Label Treatment|Physician Decision|0|||
16078426|NCT00704184|38779851|FG004|Open-Label Treatment|Physician Decision|1|||
16078427|NCT00704184|38779847|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
16078428|NCT00704184|38779848|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
16078429|NCT00704184|38779849|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
16078430|NCT00704184|38779850|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
16078431|NCT00704184|38779851|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
16078432|NCT03990649|38779854|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
16078433|NCT03990649|38779855|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
16078434|NCT03990649|38779856|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
16078435|NCT03990649|38779854|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
16078436|NCT03990649|38779855|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
16078437|NCT03990649|38779856|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
16078438|NCT03990649|38779854|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
16078439|NCT03990649|38779855|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
16078440|NCT03990649|38779856|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
16078441|NCT03990649|38779854|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
16078442|NCT03990649|38779855|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
16078443|NCT03990649|38779856|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
16078444|NCT03990649|38779854|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
16078445|NCT03990649|38779855|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
16078446|NCT03990649|38779856|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
16078447|NCT03990649|38779854|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
16078448|NCT03990649|38779855|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
16078449|NCT03990649|38779856|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
16078450|NCT03990649|38779854|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
16078451|NCT03990649|38779855|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
16078452|NCT03990649|38779856|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
16078453|NCT03183518|38779857|FG000|Overall Study|Other (Not specified)|2|||
16477560|NCT01752985|40228217|FG001|Treatment Period|Lost to Follow-up|0|||
16078454|NCT03183518|38779857|FG000|Overall Study|Other (Withdrawal of consent)|1|||
16078455|NCT01359592|38779858|FG000|Initial Registration|Adverse Event|1|||
16278686|NCT04158687|39500963|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
16477561|NCT01752985|40228218|FG002|Treatment Period|Lost to Follow-up|1|||
16477562|NCT02436681|40228219|FG000|Overall Study|Lost to Follow-up|10|||
16477563|NCT02436681|40228219|FG000|Overall Study|Withdrawal by Subject|2|||
16477564|NCT02436681|40228219|FG000|Overall Study|Death|2|||
16477565|NCT03583164|40228226|FG000|Overall Study|Death in Main Phase|35|||
16477566|NCT03583164|40228226|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
16477567|NCT03583164|40228226|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
16477568|NCT03583164|40228226|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
16477569|NCT03583164|40228226|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
16477570|NCT03583164|40228226|FG000|Overall Study|Physician decision in Main Phase|1|||
16477571|NCT03583164|40228226|FG000|Overall Study|Physician decision in Extended Phase|2|||
16477572|NCT03583164|40228226|FG000|Overall Study|Death in Extended Phase|13|||
16477573|NCT03583164|40228226|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
16477574|NCT03583164|40228226|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
16477575|NCT03583164|40228226|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
16477576|NCT03583164|40228226|FG000|Overall Study|Treatment failure in Main Phase|2|||
16477577|NCT03583164|40228226|FG000|Overall Study|Treatment failure in Extended Phase|4|||
16477578|NCT03583164|40228226|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
16477579|NCT03583164|40228226|FG000|Overall Study|Other not specified reason in Main Phase|2|||
16477580|NCT03438383|40228227|FG000|Overall Study|Protocol Violation|9|||
16477581|NCT03438383|40228228|FG001|Overall Study|Protocol Violation|3|||
16477582|NCT04402060|40228229|FG000|Overall Study|Death|1|||
16477583|NCT04402060|40228230|FG001|Overall Study|Death|12|||
16477584|NCT04402060|40228231|FG002|Overall Study|Death|7|||
16477585|NCT04402060|40228229|FG000|Overall Study|Adverse Event|0|||
16477586|NCT04402060|40228230|FG001|Overall Study|Adverse Event|0|||
16477587|NCT04402060|40228231|FG002|Overall Study|Adverse Event|1|||
16477588|NCT04402060|40228229|FG000|Overall Study|Withdrawal by Subject|0|||
16477589|NCT04402060|40228230|FG001|Overall Study|Withdrawal by Subject|1|||
16477590|NCT04402060|40228231|FG002|Overall Study|Withdrawal by Subject|2|||
16477591|NCT04402060|40228229|FG000|Overall Study|Sponsor Request|0|||
16078456|NCT01359592|38779859|FG001|Initial Registration|Adverse Event|0|||
16078457|NCT01359592|38779860|FG002|Initial Registration|Adverse Event|0|||
16078458|NCT01359592|38779861|FG003|Initial Registration|Adverse Event|0|||
16078459|NCT01359592|38779858|FG000|Initial Registration|Death|1|||
16078460|NCT01359592|38779859|FG001|Initial Registration|Death|0|||
16078461|NCT01359592|38779860|FG002|Initial Registration|Death|0|||
16078462|NCT01359592|38779861|FG003|Initial Registration|Death|0|||
16078463|NCT01359592|38779858|FG000|Initial Registration|Other reason not protocol specified|1|||
16078464|NCT01359592|38779859|FG001|Initial Registration|Other reason not protocol specified|0|||
16078465|NCT01359592|38779860|FG002|Initial Registration|Other reason not protocol specified|0|||
16078466|NCT01359592|38779861|FG003|Initial Registration|Other reason not protocol specified|0|||
16078467|NCT01359592|38779858|FG000|Initial Registration|Ineligible|26|||
16078468|NCT01359592|38779859|FG001|Initial Registration|Ineligible|0|||
16078469|NCT01359592|38779860|FG002|Initial Registration|Ineligible|0|||
16078470|NCT01359592|38779861|FG003|Initial Registration|Ineligible|0|||
16078471|NCT01359592|38779858|FG000|PET-Directed Therapy|Adverse Event|0|||
16078472|NCT01359592|38779859|FG001|PET-Directed Therapy|Adverse Event|0|||
16078473|NCT01359592|38779860|FG002|PET-Directed Therapy|Adverse Event|1|||
16078474|NCT01359592|38779861|FG003|PET-Directed Therapy|Adverse Event|0|||
16078475|NCT01359592|38779858|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
16078476|NCT01359592|38779859|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
16078477|NCT01359592|38779860|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
16078478|NCT01359592|38779861|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
16078479|NCT01359592|38779858|FG000|PET-Directed Therapy|Ineligible|0|||
16078480|NCT01359592|38779859|FG001|PET-Directed Therapy|Ineligible|0|||
16078481|NCT01359592|38779860|FG002|PET-Directed Therapy|Ineligible|24|||
16078482|NCT01359592|38779861|FG003|PET-Directed Therapy|Ineligible|0|||
16078483|NCT01551355|38779862|FG000|Overall Study|Lost to Follow-up|51|||
16078484|NCT01551355|38779863|FG001|Overall Study|Lost to Follow-up|49|||
16078485|NCT01551355|38779864|FG002|Overall Study|Lost to Follow-up|34|||
16078486|NCT01551355|38779865|FG003|Overall Study|Lost to Follow-up|24|||
16078487|NCT01551355|38779866|FG004|Overall Study|Lost to Follow-up|9|||
16078488|NCT01551355|38779867|FG005|Overall Study|Lost to Follow-up|6|||
16078489|NCT02299375|38779868|FG000|Overall Study|Adverse Event, serious fatal|1|||
16078490|NCT02299375|38779869|FG001|Overall Study|Adverse Event, serious fatal|3|||
16078491|NCT02299375|38779868|FG000|Overall Study|Adverse Event, non-fatal|8|||
16078492|NCT02299375|38779869|FG001|Overall Study|Adverse Event, non-fatal|9|||
16078493|NCT02299375|38779868|FG000|Overall Study|Lack of Efficacy|1|||
16078494|NCT02299375|38779869|FG001|Overall Study|Lack of Efficacy|3|||
16078495|NCT02299375|38779868|FG000|Overall Study|Protocol Violation|1|||
16078496|NCT02299375|38779869|FG001|Overall Study|Protocol Violation|3|||
16078497|NCT02299375|38779868|FG000|Overall Study|Other: Met stopping criteria|1|||
16078498|NCT02299375|38779869|FG001|Overall Study|Other: Met stopping criteria|0|||
16078499|NCT02299375|38779868|FG000|Overall Study|Other: Study closed/terminated|66|||
16078500|NCT02299375|38779869|FG001|Overall Study|Other: Study closed/terminated|55|||
16078501|NCT02299375|38779868|FG000|Overall Study|Lost to Follow-up|0|||
16078502|NCT02299375|38779869|FG001|Overall Study|Lost to Follow-up|2|||
16078503|NCT02299375|38779868|FG000|Overall Study|Physician Decision|1|||
16078504|NCT02299375|38779869|FG001|Overall Study|Physician Decision|1|||
16078505|NCT02299375|38779868|FG000|Overall Study|Withdrawal by Subject|1|||
16078506|NCT02299375|38779869|FG001|Overall Study|Withdrawal by Subject|4|||
16078507|NCT00482729|38779870|FG000|Overall Study|Adverse Event|29|||
16078508|NCT00482729|38779871|FG001|Overall Study|Adverse Event|33|||
16078509|NCT00482729|38779870|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
16078510|NCT00482729|38779871|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
16078511|NCT00482729|38779870|FG000|Overall Study|Hyperglycemia Criteria|7|||
16078512|NCT00482729|38779871|FG001|Overall Study|Hyperglycemia Criteria|5|||
16078513|NCT00482729|38779870|FG000|Overall Study|Lack of Efficacy|4|||
16078514|NCT00482729|38779871|FG001|Overall Study|Lack of Efficacy|16|||
16078515|NCT00482729|38779870|FG000|Overall Study|Lost to Follow-up|86|||
16078516|NCT00482729|38779871|FG001|Overall Study|Lost to Follow-up|66|||
16078517|NCT00482729|38779870|FG000|Overall Study|Physician Decision|10|||
16078518|NCT00482729|38779871|FG001|Overall Study|Physician Decision|7|||
16477592|NCT04402060|40228230|FG001|Overall Study|Sponsor Request|2|||
16078519|NCT00482729|38779870|FG000|Overall Study|Pregnancy|4|||
16078520|NCT00482729|38779871|FG001|Overall Study|Pregnancy|2|||
16078521|NCT00482729|38779870|FG000|Overall Study|Protocol Violation|10|||
16078522|NCT00482729|38779871|FG001|Overall Study|Protocol Violation|18|||
16078523|NCT00482729|38779870|FG000|Overall Study|Withdrawal by Subject|67|||
16078524|NCT00482729|38779871|FG001|Overall Study|Withdrawal by Subject|69|||
16078525|NCT01764464|38779872|FG000|First Intervention|Withdrawal by Subject|1|||
16078526|NCT01764464|38779873|FG001|First Intervention|Withdrawal by Subject|0|||
16078527|NCT01764464|38779872|FG000|First Intervention|Lost to Follow-up|1|||
16078528|NCT01764464|38779873|FG001|First Intervention|Lost to Follow-up|0|||
16078529|NCT01764464|38779872|FG000|First Intervention|Adverse Event|0|||
16078530|NCT01764464|38779873|FG001|First Intervention|Adverse Event|2|||
16078531|NCT01764464|38779872|FG000|First Intervention|did not receive study drug|0|||
16078532|NCT01764464|38779873|FG001|First Intervention|did not receive study drug|1|||
16078533|NCT01764464|38779872|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
16078534|NCT01764464|38779873|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
16078535|NCT00159783|38779874|FG000|Overall Study|Adverse Event|5|||
16078536|NCT00159783|38779875|FG001|Overall Study|Adverse Event|7|||
16078537|NCT00159783|38779876|FG002|Overall Study|Adverse Event|9|||
16078538|NCT00159783|38779874|FG000|Overall Study|Lack of Efficacy|1|||
16078539|NCT00159783|38779875|FG001|Overall Study|Lack of Efficacy|2|||
16078540|NCT00159783|38779876|FG002|Overall Study|Lack of Efficacy|3|||
16078541|NCT00159783|38779874|FG000|Overall Study|Withdrawal by Subject|7|||
16078542|NCT00159783|38779875|FG001|Overall Study|Withdrawal by Subject|11|||
16078543|NCT00159783|38779876|FG002|Overall Study|Withdrawal by Subject|12|||
16078544|NCT00159783|38779874|FG000|Overall Study|Lost to Follow-up|6|||
16078545|NCT00159783|38779875|FG001|Overall Study|Lost to Follow-up|5|||
16278687|NCT04158687|39500960|FG000|Overall Study|Non-Compliance with Study Medication|2|||
16278688|NCT04158687|39500961|FG001|Overall Study|Non-Compliance with Study Medication|2|||
16078546|NCT00159783|38779876|FG002|Overall Study|Lost to Follow-up|11|||
16078547|NCT00159783|38779874|FG000|Overall Study|Other|0|||
16078548|NCT00159783|38779875|FG001|Overall Study|Other|2|||
16078549|NCT00159783|38779876|FG002|Overall Study|Other|4|||
16078550|NCT05283395|38779877|FG000|Overall Study|Adverse Event|4|||
16078551|NCT05283395|38779878|FG001|Overall Study|Adverse Event|4|||
16078552|NCT05283395|38779879|FG002|Overall Study|Adverse Event|0|||
16078553|NCT05283395|38779877|FG000|Overall Study|Patient Lost to Follow-Up|0|||
16078554|NCT05283395|38779878|FG001|Overall Study|Patient Lost to Follow-Up|0|||
16078555|NCT05283395|38779879|FG002|Overall Study|Patient Lost to Follow-Up|1|||
16078556|NCT05283395|38779877|FG000|Overall Study|Patient Withdrawal|2|||
16078557|NCT05283395|38779878|FG001|Overall Study|Patient Withdrawal|4|||
16078558|NCT05283395|38779879|FG002|Overall Study|Patient Withdrawal|2|||
16078559|NCT05283395|38779877|FG000|Overall Study|Investigator Decision|1|||
16078560|NCT05283395|38779878|FG001|Overall Study|Investigator Decision|0|||
16078561|NCT05283395|38779879|FG002|Overall Study|Investigator Decision|1|||
16078562|NCT05283395|38779877|FG000|Overall Study|Enrolled in error|0|||
16078563|NCT05283395|38779878|FG001|Overall Study|Enrolled in error|0|||
16078564|NCT05283395|38779879|FG002|Overall Study|Enrolled in error|1|||
16078565|NCT02101281|38779880|FG000|Overall Study|Adverse Event|0|||
16078566|NCT02101281|38779881|FG001|Overall Study|Adverse Event|1|||
16078567|NCT02271854|38782544|FG000|Overall Study|Withdrawal by Subject|2|||
16078568|NCT02271854|38782544|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
16078569|NCT02271854|38782544|FG000|Overall Study|Lost to Follow-up|1|||
16078570|NCT03482635|38782545|FG000|Overall Study|Lack of Efficacy|0|||
16078571|NCT03482635|38782546|FG001|Overall Study|Lack of Efficacy|0|||
16078572|NCT03482635|38782547|FG002|Overall Study|Lack of Efficacy|1|||
16078573|NCT03482635|38782548|FG003|Overall Study|Lack of Efficacy|3|||
16078574|NCT03482635|38782545|FG000|Overall Study|Adverse Event|2|||
16078575|NCT03482635|38782546|FG001|Overall Study|Adverse Event|2|||
16078576|NCT03482635|38782547|FG002|Overall Study|Adverse Event|0|||
16078577|NCT03482635|38782548|FG003|Overall Study|Adverse Event|3|||
16078578|NCT03482635|38782545|FG000|Overall Study|Withdrawal by Subject|2|||
16078579|NCT03482635|38782546|FG001|Overall Study|Withdrawal by Subject|1|||
16078580|NCT03482635|38782547|FG002|Overall Study|Withdrawal by Subject|0|||
16078581|NCT03482635|38782548|FG003|Overall Study|Withdrawal by Subject|1|||
16078582|NCT03482635|38782545|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
16078583|NCT03482635|38782546|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
16078584|NCT03482635|38782547|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
16078585|NCT03482635|38782548|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
16078586|NCT03482635|38782545|FG000|Overall Study|Not treated|0|||
16078587|NCT03482635|38782546|FG001|Overall Study|Not treated|0|||
16078588|NCT03482635|38782547|FG002|Overall Study|Not treated|0|||
16078589|NCT03482635|38782548|FG003|Overall Study|Not treated|1|||
16078590|NCT01062126|38782550|FG000|Overall Study|Death|209|||
16078591|NCT01062126|38782550|FG000|Overall Study|All Withdrawals|324|||
16078592|NCT01278394|38782551|FG000|Overall Study|Lost to Follow-up|1|||
16078593|NCT04252586|38782552|FG000|Overall Study|Withdrawal by parent/guardian|3|||
16078594|NCT04252586|38782552|FG000|Overall Study|Adverse Event|1|||
16078595|NCT04252586|38782552|FG000|Overall Study|Death|2|||
16078596|NCT04252586|38782552|FG000|Overall Study|Study terminated by sponsor|4|||
16078597|NCT04252586|38782552|FG000|Overall Study|Sponsor request|10|||
16078598|NCT04252586|38782552|FG000|Overall Study|Did not complete treatment period|1|||
16078599|NCT02709655|38782557|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
16078600|NCT02709655|38782558|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
16078601|NCT02709655|38782559|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
16078602|NCT02709655|38782560|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
16078603|NCT02709655|38782561|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
16078604|NCT02709655|38782557|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
16078605|NCT02709655|38782558|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
16078606|NCT02709655|38782559|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
16078607|NCT02709655|38782560|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
16078608|NCT02709655|38782561|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
16078609|NCT02709655|38782557|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
16078610|NCT02709655|38782558|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
16078611|NCT02709655|38782559|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
16078612|NCT02709655|38782560|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
16078613|NCT02709655|38782561|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
16078614|NCT02709655|38782557|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
16078615|NCT02709655|38782558|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
16078616|NCT02709655|38782559|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
16078617|NCT02709655|38782560|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
16078618|NCT02709655|38782561|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
16078619|NCT02709655|38782557|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
16078620|NCT02709655|38782558|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
16078621|NCT02709655|38782559|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
16078622|NCT02709655|38782560|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
16078623|NCT02709655|38782561|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
16078624|NCT02709655|38782557|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
16477593|NCT04402060|40228231|FG002|Overall Study|Sponsor Request|0|||
16477594|NCT04402060|40228229|FG000|Overall Study|Physician Decision|0|||
16477595|NCT04402060|40228230|FG001|Overall Study|Physician Decision|0|||
16078625|NCT02709655|38782558|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
16078626|NCT02709655|38782559|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
16078627|NCT02709655|38782560|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
16078628|NCT02709655|38782561|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
16078629|NCT02709655|38782557|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
16078630|NCT02709655|38782558|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
16078631|NCT02709655|38782559|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
16078632|NCT02709655|38782560|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
16078633|NCT02709655|38782561|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
16078634|NCT02709655|38782557|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
16078635|NCT02709655|38782558|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
16078636|NCT02709655|38782559|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
16078637|NCT02709655|38782560|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
16078638|NCT02709655|38782561|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
16078639|NCT02709655|38782557|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
16078640|NCT02709655|38782558|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
16078641|NCT02709655|38782559|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
16078642|NCT02709655|38782560|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
16078643|NCT02709655|38782561|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
16078644|NCT02709655|38782557|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
16078645|NCT02709655|38782558|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
16078646|NCT02709655|38782559|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
16078647|NCT02709655|38782560|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
16078648|NCT02709655|38782561|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
16078649|NCT02709655|38782557|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
16078650|NCT02709655|38782558|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
16078651|NCT02709655|38782559|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
16078652|NCT02709655|38782560|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
16078653|NCT02709655|38782561|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
16078654|NCT02709655|38782557|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
16078655|NCT02709655|38782558|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
16078656|NCT02709655|38782559|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
16078657|NCT02709655|38782560|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
16477596|NCT04402060|40228231|FG002|Overall Study|Physician Decision|1|||
16477597|NCT04402060|40228229|FG000|Overall Study|Other|0|||
16078658|NCT02709655|38782561|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
16078659|NCT02709655|38782557|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
16078660|NCT02709655|38782558|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
16078661|NCT02709655|38782559|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
16078662|NCT02709655|38782560|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
16078663|NCT02709655|38782561|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
16078664|NCT02709655|38782557|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
16078665|NCT02709655|38782558|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
16078666|NCT02709655|38782559|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
16078667|NCT02709655|38782560|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
16078668|NCT02709655|38782561|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
16078669|NCT02709655|38782557|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
16078670|NCT02709655|38782558|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
16078671|NCT02709655|38782559|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
16078672|NCT02709655|38782560|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
16078673|NCT02709655|38782561|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
16078674|NCT02709655|38782557|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
16078675|NCT02709655|38782558|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
16078676|NCT02709655|38782559|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
16078677|NCT02709655|38782560|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
16078678|NCT02709655|38782561|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
16078679|NCT04093752|38782564|FG000|Overall Study|Adverse Event|7|||
16078680|NCT04093752|38782565|FG001|Overall Study|Adverse Event|19|||
16078681|NCT04093752|38782566|FG002|Overall Study|Adverse Event|18|||
16078682|NCT04093752|38782567|FG003|Overall Study|Adverse Event|4|||
16078683|NCT04093752|38782564|FG000|Overall Study|Withdrawal by Subject|6|||
16078684|NCT04093752|38782565|FG001|Overall Study|Withdrawal by Subject|6|||
16078685|NCT04093752|38782566|FG002|Overall Study|Withdrawal by Subject|8|||
16078686|NCT04093752|38782567|FG003|Overall Study|Withdrawal by Subject|20|||
16078687|NCT04093752|38782564|FG000|Overall Study|Lost to Follow-up|2|||
16078688|NCT04093752|38782565|FG001|Overall Study|Lost to Follow-up|1|||
16078689|NCT04093752|38782566|FG002|Overall Study|Lost to Follow-up|1|||
16078690|NCT04093752|38782567|FG003|Overall Study|Lost to Follow-up|1|||
16078691|NCT04093752|38782564|FG000|Overall Study|Death|0|||
16078692|NCT04093752|38782565|FG001|Overall Study|Death|0|||
16078693|NCT04093752|38782566|FG002|Overall Study|Death|1|||
16078694|NCT04093752|38782567|FG003|Overall Study|Death|2|||
16078695|NCT04093752|38782564|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
16078696|NCT04093752|38782565|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
16078697|NCT04093752|38782566|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
16078698|NCT04093752|38782567|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
16078699|NCT04093752|38782564|FG000|Overall Study|Covid 19|0|||
16078700|NCT04093752|38782565|FG001|Overall Study|Covid 19|0|||
16078701|NCT04093752|38782566|FG002|Overall Study|Covid 19|0|||
16078702|NCT04093752|38782567|FG003|Overall Study|Covid 19|1|||
16078703|NCT04093752|38782564|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
16078704|NCT04093752|38782565|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
16078705|NCT04093752|38782566|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
16078706|NCT04093752|38782567|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
16078707|NCT04093752|38782564|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
16078708|NCT04093752|38782565|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
16078709|NCT04093752|38782566|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
16078710|NCT04093752|38782567|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
16078711|NCT04093752|38782564|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
16078712|NCT04093752|38782565|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
16078713|NCT04093752|38782566|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
16078714|NCT04093752|38782567|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
16078715|NCT01875848|38782568|FG000|Overall Study|Withdrawal by Subject|2|||
16078716|NCT01875848|38782569|FG001|Overall Study|Withdrawal by Subject|0|||
16078717|NCT01610297|38782578|FG000|Overall Study|Lost to Follow-up|1|||
16078718|NCT00433199|38782581|FG000|Double-Blind Period|Adverse Event|0|||
16078719|NCT00433199|38782582|FG001|Double-Blind Period|Adverse Event|25|||
16078720|NCT00433199|38782581|FG000|Double-Blind Period|Lack of Efficacy|0|||
16078721|NCT00433199|38782582|FG001|Double-Blind Period|Lack of Efficacy|2|||
16078722|NCT00433199|38782581|FG000|Double-Blind Period|Lost to Follow-up|2|||
16078723|NCT00433199|38782582|FG001|Double-Blind Period|Lost to Follow-up|5|||
16078724|NCT00433199|38782581|FG000|Double-Blind Period|Withdrawal by Subject|8|||
16078725|NCT00433199|38782582|FG001|Double-Blind Period|Withdrawal by Subject|19|||
16078726|NCT00433199|38782581|FG000|Double-Blind Period|Protocol Violation|1|||
16078727|NCT00433199|38782582|FG001|Double-Blind Period|Protocol Violation|10|||
16078728|NCT00433199|38782581|FG000|Double-Blind Period|Administrative|1|||
16078729|NCT00433199|38782582|FG001|Double-Blind Period|Administrative|5|||
16078730|NCT00433199|38782581|FG000|Open-Label Period|Adverse Event|0|||
16078731|NCT00433199|38782582|FG001|Open-Label Period|Adverse Event|19|||
16078732|NCT00433199|38782581|FG000|Open-Label Period|Lack of Efficacy|0|||
16078733|NCT00433199|38782582|FG001|Open-Label Period|Lack of Efficacy|2|||
16078734|NCT00433199|38782581|FG000|Open-Label Period|Lost to Follow-up|0|||
16078735|NCT00433199|38782582|FG001|Open-Label Period|Lost to Follow-up|3|||
16078736|NCT00433199|38782581|FG000|Open-Label Period|Withdrawal by Subject|0|||
16078737|NCT00433199|38782582|FG001|Open-Label Period|Withdrawal by Subject|7|||
16078738|NCT00433199|38782581|FG000|Open-Label Period|Protocol Violation|0|||
16078739|NCT00433199|38782582|FG001|Open-Label Period|Protocol Violation|2|||
16078740|NCT00433199|38782581|FG000|Open-Label Period|Administrative|0|||
16078741|NCT00433199|38782582|FG001|Open-Label Period|Administrative|1|||
16078742|NCT00539734|38782583|FG000|Overall Study|Protocol Violation|1|||
16078743|NCT00296036|38782584|FG000|Overall Study|Withdrawal by Subject|1|||
16078744|NCT00296036|38782585|FG001|Overall Study|Withdrawal by Subject|0|||
16078745|NCT00296036|38782586|FG002|Overall Study|Withdrawal by Subject|2|||
16078746|NCT00296036|38782587|FG003|Overall Study|Withdrawal by Subject|1|||
16078747|NCT00296036|38782588|FG004|Overall Study|Withdrawal by Subject|2|||
16078748|NCT00296036|38782589|FG005|Overall Study|Withdrawal by Subject|1|||
16078749|NCT00296036|38782584|FG000|Overall Study|Protocol Violation|0|||
16078750|NCT00296036|38782585|FG001|Overall Study|Protocol Violation|0|||
16078751|NCT00296036|38782586|FG002|Overall Study|Protocol Violation|0|||
16078752|NCT00296036|38782587|FG003|Overall Study|Protocol Violation|0|||
16078753|NCT00296036|38782588|FG004|Overall Study|Protocol Violation|0|||
16078754|NCT00296036|38782589|FG005|Overall Study|Protocol Violation|3|||
16078755|NCT00726596|38782591|FG000|Overall Study|Adverse Event|2|||
16078756|NCT00726596|38782592|FG001|Overall Study|Adverse Event|1|||
16078757|NCT00726596|38782591|FG000|Overall Study|Withdrawal by Subject|3|||
16078758|NCT00726596|38782592|FG001|Overall Study|Withdrawal by Subject|3|||
16078759|NCT00712335|38782595|FG000|Overall Study|Withdrawal by Subject|0|||
16078760|NCT00712335|38782596|FG001|Overall Study|Withdrawal by Subject|7|||
16078761|NCT00712335|38782597|FG002|Overall Study|Withdrawal by Subject|2|||
16078762|NCT00712335|38782598|FG003|Overall Study|Withdrawal by Subject|3|||
16078763|NCT00712335|38782599|FG004|Overall Study|Withdrawal by Subject|0|||
16078764|NCT00712335|38782595|FG000|Overall Study|Lost to Follow-up|2|||
16078765|NCT00712335|38782596|FG001|Overall Study|Lost to Follow-up|5|||
16078766|NCT00712335|38782597|FG002|Overall Study|Lost to Follow-up|0|||
16078767|NCT00712335|38782598|FG003|Overall Study|Lost to Follow-up|1|||
16078768|NCT00712335|38782599|FG004|Overall Study|Lost to Follow-up|0|||
16278689|NCT04158687|39500962|FG002|Overall Study|Non-Compliance with Study Medication|3|||
16278690|NCT04158687|39500963|FG003|Overall Study|Non-Compliance with Study Medication|0|||
16278691|NCT04158687|39500960|FG000|Overall Study|Investigator Decision|0|||
16278692|NCT04158687|39500961|FG001|Overall Study|Investigator Decision|0|||
16278693|NCT04158687|39500962|FG002|Overall Study|Investigator Decision|2|||
16278694|NCT04158687|39500963|FG003|Overall Study|Investigator Decision|0|||
16278695|NCT04158687|39500960|FG000|Overall Study|Protocol Violation|0|||
16278696|NCT04158687|39500961|FG001|Overall Study|Protocol Violation|2|||
16278697|NCT04158687|39500962|FG002|Overall Study|Protocol Violation|1|||
16278698|NCT04158687|39500963|FG003|Overall Study|Protocol Violation|0|||
16278699|NCT04158687|39500960|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
16278700|NCT04158687|39500961|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
16278701|NCT04158687|39500962|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
16278702|NCT04158687|39500963|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
16278703|NCT04158687|39500960|FG000|Overall Study|Reason not Specified|3|||
16278704|NCT04158687|39500961|FG001|Overall Study|Reason not Specified|2|||
16278705|NCT04158687|39500962|FG002|Overall Study|Reason not Specified|4|||
16278706|NCT04158687|39500963|FG003|Overall Study|Reason not Specified|4|||
16278707|NCT02310763|39500964|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
16278708|NCT02310763|39500965|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
16278709|NCT02310763|39500966|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
16278710|NCT02310763|39500964|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
16278711|NCT02310763|39500965|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
16278712|NCT02310763|39500966|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
16278713|NCT02310763|39500964|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
16078769|NCT00712335|38782595|FG000|Overall Study|Protocol Violation|1|||
16278714|NCT02310763|39500965|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
16278715|NCT02310763|39500966|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
16278716|NCT02310763|39500964|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
16078770|NCT00712335|38782596|FG001|Overall Study|Protocol Violation|2|||
16078771|NCT00712335|38782597|FG002|Overall Study|Protocol Violation|1|||
16078772|NCT00712335|38782598|FG003|Overall Study|Protocol Violation|0|||
16078773|NCT00712335|38782599|FG004|Overall Study|Protocol Violation|0|||
16078774|NCT00712335|38782595|FG000|Overall Study|Lack of Efficacy|0|||
16078775|NCT00712335|38782596|FG001|Overall Study|Lack of Efficacy|0|||
16078776|NCT00712335|38782597|FG002|Overall Study|Lack of Efficacy|1|||
16078777|NCT00712335|38782598|FG003|Overall Study|Lack of Efficacy|1|||
16078778|NCT00712335|38782599|FG004|Overall Study|Lack of Efficacy|0|||
16078779|NCT00712335|38782595|FG000|Overall Study|Other Reason|0|||
16078780|NCT00712335|38782596|FG001|Overall Study|Other Reason|3|||
16078781|NCT00712335|38782597|FG002|Overall Study|Other Reason|1|||
16078782|NCT00712335|38782598|FG003|Overall Study|Other Reason|0|||
16078783|NCT00712335|38782599|FG004|Overall Study|Other Reason|0|||
16078784|NCT00529516|38782600|FG000|Overall Study|Adverse Event|2|||
16078785|NCT00529516|38782601|FG001|Overall Study|Adverse Event|1|||
16078786|NCT00529516|38782602|FG002|Overall Study|Adverse Event|0|||
16078787|NCT00529516|38782600|FG000|Overall Study|Withdrawal by Subject|1|||
16078788|NCT00529516|38782601|FG001|Overall Study|Withdrawal by Subject|1|||
16078789|NCT00529516|38782602|FG002|Overall Study|Withdrawal by Subject|0|||
16078790|NCT00529516|38782600|FG000|Overall Study|Lost to Follow-up|0|||
16078791|NCT00529516|38782601|FG001|Overall Study|Lost to Follow-up|0|||
16078792|NCT00529516|38782602|FG002|Overall Study|Lost to Follow-up|1|||
16078793|NCT01867216|38782603|FG000|Overall Study|Withdrawal by Subject|2|||
16078794|NCT01867216|38782604|FG001|Overall Study|Withdrawal by Subject|0|||
16078795|NCT01867216|38782605|FG002|Overall Study|Withdrawal by Subject|0|||
16078796|NCT01867216|38782606|FG003|Overall Study|Withdrawal by Subject|0|||
16078797|NCT01867216|38782607|FG004|Overall Study|Withdrawal by Subject|1|||
16078798|NCT01867216|38782608|FG005|Overall Study|Withdrawal by Subject|0|||
16078799|NCT01867216|38782609|FG006|Overall Study|Withdrawal by Subject|1|||
16078800|NCT01867216|38782603|FG000|Overall Study|Physician Decision|1|||
16078801|NCT01867216|38782604|FG001|Overall Study|Physician Decision|0|||
16078802|NCT01867216|38782605|FG002|Overall Study|Physician Decision|0|||
16078803|NCT01867216|38782606|FG003|Overall Study|Physician Decision|0|||
16078804|NCT01867216|38782607|FG004|Overall Study|Physician Decision|0|||
16078805|NCT01867216|38782608|FG005|Overall Study|Physician Decision|0|||
16078806|NCT01867216|38782609|FG006|Overall Study|Physician Decision|0|||
16078807|NCT01867216|38782603|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
16078808|NCT01867216|38782604|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16078809|NCT01867216|38782605|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16078810|NCT01867216|38782606|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16078811|NCT01867216|38782607|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16078812|NCT01867216|38782608|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16078813|NCT01867216|38782609|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
16078814|NCT01124734|38782610|FG000|Overall Study|Disease progression|13|||
16078815|NCT01124734|38782610|FG000|Overall Study|Adverse Event|1|||
16078816|NCT01124734|38782610|FG000|Overall Study|Withdrawal by Subject|1|||
16078817|NCT01124734|38782610|FG000|Overall Study|Elected for alternative treatment|2|||
16078818|NCT03887650|38782613|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
16078819|NCT03887650|38782614|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
16078820|NCT03887650|38782613|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
16078821|NCT03887650|38782614|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
16078822|NCT03887650|38782613|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
16078823|NCT03887650|38782614|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
16078824|NCT03703336|38782615|FG000|Overall Study|Parent withdrew consent|29|||
16078825|NCT03703336|38782616|FG001|Overall Study|Parent withdrew consent|8|||
16078826|NCT03703336|38782615|FG000|Overall Study|Migration|3|||
16078827|NCT03703336|38782616|FG001|Overall Study|Migration|3|||
16078828|NCT03703336|38782615|FG000|Overall Study|Protocol Violation|3|||
16078829|NCT03703336|38782616|FG001|Overall Study|Protocol Violation|1|||
16078830|NCT03703336|38782615|FG000|Overall Study|Physician Decision|2|||
16078831|NCT03703336|38782616|FG001|Overall Study|Physician Decision|0|||
16078832|NCT03703336|38782615|FG000|Overall Study|Adverse Event|0|||
16078833|NCT03703336|38782616|FG001|Overall Study|Adverse Event|2|||
16078834|NCT03703336|38782615|FG000|Overall Study|Lost to Follow-up|1|||
16078835|NCT03703336|38782616|FG001|Overall Study|Lost to Follow-up|0|||
16278717|NCT02310763|39500965|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
16278718|NCT02310763|39500966|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
16278719|NCT02310763|39500964|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
16477598|NCT04402060|40228230|FG001|Overall Study|Other|1|||
16477599|NCT04402060|40228231|FG002|Overall Study|Other|0|||
16477600|NCT03576495|40228232|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
16477601|NCT03576495|40228233|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
16477602|NCT01811225|40228234|FG000|Treatment Period 1|Adverse Event|2|||
16477603|NCT01811225|40228235|FG001|Treatment Period 1|Adverse Event|3|||
16477604|NCT01811225|40228234|FG000|Treatment Period 1|Lost to Follow-up|12|||
16477605|NCT01811225|40228235|FG001|Treatment Period 1|Lost to Follow-up|8|||
16477606|NCT01811225|40228234|FG000|Treatment Period 1|transporation|1|||
16477607|NCT01811225|40228235|FG001|Treatment Period 1|transporation|0|||
16078836|NCT04218110|38782617|FG000|Overall Study|Withdrawal by Subject|0|||
16078837|NCT04218110|38782618|FG001|Overall Study|Withdrawal by Subject|0|||
16078838|NCT04218110|38782619|FG002|Overall Study|Withdrawal by Subject|0|||
16378755|NCT00862940|39872217|FG000|Overall Study|Protocol Violation|2|||
16078839|NCT04218110|38782620|FG003|Overall Study|Withdrawal by Subject|1|||
16078840|NCT01070069|38782623|FG000|Overall Study|Death|1|||
16078841|NCT01070069|38782624|FG001|Overall Study|Death|0|||
16078842|NCT01070069|38782625|FG002|Overall Study|Death|2|||
16078843|NCT01070069|38782626|FG003|Overall Study|Death|0|||
16078844|NCT01070069|38782627|FG004|Overall Study|Death|1|||
16078845|NCT01070069|38782623|FG000|Overall Study|Withdrawal by Subject|1|||
16078846|NCT01070069|38782624|FG001|Overall Study|Withdrawal by Subject|1|||
16078847|NCT01070069|38782625|FG002|Overall Study|Withdrawal by Subject|4|||
16078848|NCT01070069|38782626|FG003|Overall Study|Withdrawal by Subject|0|||
16078849|NCT01070069|38782627|FG004|Overall Study|Withdrawal by Subject|0|||
16078850|NCT01070069|38782623|FG000|Overall Study|Lost to Follow-up|4|||
16078851|NCT01070069|38782624|FG001|Overall Study|Lost to Follow-up|1|||
16078852|NCT01070069|38782625|FG002|Overall Study|Lost to Follow-up|0|||
16078853|NCT01070069|38782626|FG003|Overall Study|Lost to Follow-up|0|||
16078854|NCT01070069|38782627|FG004|Overall Study|Lost to Follow-up|3|||
16078855|NCT00002842|38782628|FG000|Overall Study|ineligible for surgical resection|27|||
16078856|NCT03169244|38782632|FG000|Overall Study|Lost to Follow-up|1|||
16078857|NCT03169244|38782633|FG001|Overall Study|Lost to Follow-up|2|||
16078858|NCT03169244|38782632|FG000|Overall Study|Adverse Event|1|||
16078859|NCT03169244|38782633|FG001|Overall Study|Adverse Event|0|||
16078860|NCT03169244|38782632|FG000|Overall Study|Withdrawal by Subject|2|||
16078861|NCT03169244|38782633|FG001|Overall Study|Withdrawal by Subject|2|||
16078862|NCT03169244|38782632|FG000|Overall Study|Physician Decision|1|||
16078863|NCT03169244|38782633|FG001|Overall Study|Physician Decision|0|||
16078864|NCT01565148|38782639|FG000|Overall Study|Withdrawal by Subject|1|||
16078865|NCT01565148|38782640|FG001|Overall Study|Withdrawal by Subject|1|||
16078866|NCT01565148|38782641|FG002|Overall Study|Withdrawal by Subject|1|||
16078867|NCT01565148|38782642|FG003|Overall Study|Withdrawal by Subject|2|||
16078868|NCT01565148|38782639|FG000|Overall Study|Lost to Follow-up|4|||
16078869|NCT01565148|38782640|FG001|Overall Study|Lost to Follow-up|4|||
16078870|NCT01565148|38782641|FG002|Overall Study|Lost to Follow-up|0|||
16078871|NCT01565148|38782642|FG003|Overall Study|Lost to Follow-up|3|||
16078872|NCT01565148|38782639|FG000|Overall Study|Rescue Therapy|8|||
16078873|NCT01565148|38782640|FG001|Overall Study|Rescue Therapy|5|||
16078874|NCT01565148|38782641|FG002|Overall Study|Rescue Therapy|5|||
16078875|NCT01565148|38782642|FG003|Overall Study|Rescue Therapy|8|||
16078876|NCT01565148|38782639|FG000|Overall Study|Death|0|||
16078877|NCT01565148|38782640|FG001|Overall Study|Death|0|||
16078878|NCT01565148|38782641|FG002|Overall Study|Death|1|||
16078879|NCT01565148|38782642|FG003|Overall Study|Death|0|||
16078880|NCT01565148|38782639|FG000|Overall Study|Physician Decision|2|||
16078881|NCT01565148|38782640|FG001|Overall Study|Physician Decision|5|||
16078882|NCT01565148|38782641|FG002|Overall Study|Physician Decision|0|||
16078883|NCT01565148|38782642|FG003|Overall Study|Physician Decision|0|||
16078884|NCT01736215|38782643|FG000|Overall Study|Early termination of erythropoietin use|1|||
16078885|NCT01736215|38782643|FG000|Overall Study|Adverse Event|4|||
16078886|NCT01736215|38782643|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
16078887|NCT01736215|38782643|FG000|Overall Study|Insufficient data to perform analysis|8|||
16078888|NCT00925899|38782650|FG000|Part 1|Death|1|||
16078889|NCT00925899|38782651|FG001|Part 1|Death|2|||
16078890|NCT00925899|38782650|FG000|Part 1|Withdrawal by Subject|10|||
16078891|NCT00925899|38782651|FG001|Part 1|Withdrawal by Subject|9|||
16078892|NCT05382104|38782654|FG000|Period 2 (2 Days)|Adverse Event|0|||
16078893|NCT05382104|38782655|FG001|Period 2 (2 Days)|Adverse Event|1|||
16078894|NCT05382104|38782656|FG002|Period 2 (2 Days)|Adverse Event|0|||
16078895|NCT05382104|38782657|FG003|Period 2 (2 Days)|Adverse Event|0|||
16078896|NCT05382104|38782658|FG004|Period 2 (2 Days)|Adverse Event|0|||
16078897|NCT05382104|38782659|FG005|Period 2 (2 Days)|Adverse Event|0|||
16078898|NCT00357097|38782661|FG000|Overall Study|Did not meet inclusion criteria|5|||
16078899|NCT00357097|38782662|FG001|Overall Study|Did not meet inclusion criteria|3|||
16078900|NCT00357097|38782661|FG000|Overall Study|Adverse Event|34|||
16078901|NCT00357097|38782662|FG001|Overall Study|Adverse Event|6|||
16078902|NCT00357097|38782661|FG000|Overall Study|Withdrawal by Subject|8|||
16078903|NCT00357097|38782662|FG001|Overall Study|Withdrawal by Subject|7|||
16078904|NCT00357097|38782661|FG000|Overall Study|Non-compliance|1|||
16078905|NCT00357097|38782662|FG001|Overall Study|Non-compliance|2|||
16078906|NCT00357097|38782661|FG000|Overall Study|Lack of Efficacy|2|||
16078907|NCT00357097|38782662|FG001|Overall Study|Lack of Efficacy|8|||
16078908|NCT00357097|38782661|FG000|Overall Study|Met Exclusion Criteria|3|||
16078909|NCT00357097|38782662|FG001|Overall Study|Met Exclusion Criteria|1|||
16078910|NCT00357097|38782661|FG000|Overall Study|Other|1|||
16078911|NCT00357097|38782662|FG001|Overall Study|Other|1|||
16378756|NCT00862940|39872218|FG001|Overall Study|Protocol Violation|5|||
16078912|NCT00357097|38782661|FG000|Overall Study|Increase of RLS Symptoms|0|||
16078913|NCT00357097|38782662|FG001|Overall Study|Increase of RLS Symptoms|1|||
16078914|NCT00610649|38782664|FG000|Overall Study|Adverse Event|1|||
16078915|NCT00610649|38782665|FG001|Overall Study|Adverse Event|0|||
16078916|NCT00610649|38782666|FG002|Overall Study|Adverse Event|0|||
16078917|NCT00610649|38782667|FG003|Overall Study|Adverse Event|0|||
16078918|NCT00610649|38782668|FG004|Overall Study|Adverse Event|0|||
16078919|NCT00610649|38782669|FG005|Overall Study|Adverse Event|0|||
16078920|NCT00610649|38782670|FG006|Overall Study|Adverse Event|0|||
16078921|NCT00610649|38782671|FG007|Overall Study|Adverse Event|0|||
16078922|NCT00610649|38782672|FG008|Overall Study|Adverse Event|0|||
16078923|NCT00610649|38782673|FG009|Overall Study|Adverse Event|0|||
16078924|NCT00610649|38782674|FG010|Overall Study|Adverse Event|1|||
16078925|NCT00610649|38782664|FG000|Overall Study|Family Emergency|0|||
16078926|NCT00610649|38782665|FG001|Overall Study|Family Emergency|1|||
16078927|NCT00610649|38782666|FG002|Overall Study|Family Emergency|0|||
16078928|NCT00610649|38782667|FG003|Overall Study|Family Emergency|0|||
16078929|NCT00610649|38782668|FG004|Overall Study|Family Emergency|0|||
16278720|NCT02310763|39500965|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
16278721|NCT02310763|39500966|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
16278722|NCT03727139|39500967|FG000|Overall Study|Protocol Violation|60|||
16278723|NCT01475786|39500968|FG000|Overall Study|Adverse Event|0|||
16278724|NCT01475786|39500969|FG001|Overall Study|Adverse Event|1|||
16278725|NCT01475786|39500970|FG002|Overall Study|Adverse Event|0|||
16278726|NCT01475786|39500968|FG000|Overall Study|Lost to Follow-up|1|||
16278727|NCT01475786|39500969|FG001|Overall Study|Lost to Follow-up|2|||
16278728|NCT01475786|39500970|FG002|Overall Study|Lost to Follow-up|1|||
16278729|NCT01475786|39500968|FG000|Overall Study|Withdrawal by Subject|0|||
16278730|NCT01475786|39500969|FG001|Overall Study|Withdrawal by Subject|1|||
16278731|NCT01475786|39500970|FG002|Overall Study|Withdrawal by Subject|1|||
16477608|NCT01811225|40228234|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
16477609|NCT01811225|40228235|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
16078930|NCT00610649|38782669|FG005|Overall Study|Family Emergency|0|||
16078931|NCT00610649|38782670|FG006|Overall Study|Family Emergency|0|||
16078932|NCT00610649|38782671|FG007|Overall Study|Family Emergency|0|||
16078933|NCT00610649|38782672|FG008|Overall Study|Family Emergency|0|||
16078934|NCT00610649|38782673|FG009|Overall Study|Family Emergency|0|||
16078935|NCT00610649|38782674|FG010|Overall Study|Family Emergency|0|||
16078936|NCT00610649|38782664|FG000|Overall Study|Withdrawal by Subject|0|||
16078937|NCT00610649|38782665|FG001|Overall Study|Withdrawal by Subject|0|||
16078938|NCT00610649|38782666|FG002|Overall Study|Withdrawal by Subject|0|||
16078939|NCT00610649|38782667|FG003|Overall Study|Withdrawal by Subject|0|||
16078940|NCT00610649|38782668|FG004|Overall Study|Withdrawal by Subject|0|||
16078941|NCT00610649|38782669|FG005|Overall Study|Withdrawal by Subject|0|||
16078942|NCT00610649|38782670|FG006|Overall Study|Withdrawal by Subject|0|||
16078943|NCT00610649|38782671|FG007|Overall Study|Withdrawal by Subject|0|||
16078944|NCT00610649|38782672|FG008|Overall Study|Withdrawal by Subject|0|||
16078945|NCT00610649|38782673|FG009|Overall Study|Withdrawal by Subject|1|||
16078946|NCT00610649|38782674|FG010|Overall Study|Withdrawal by Subject|0|||
16078947|NCT00094575|38782678|FG000|Overall Study|Death|146|||
16078948|NCT00094575|38782679|FG001|Overall Study|Death|146|||
16078949|NCT02539225|38782688|FG000|Part A|Adverse Event|13|||
16078950|NCT02539225|38782689|FG001|Part A|Adverse Event|4|||
16078951|NCT02539225|38782688|FG000|Part A|Withdrawal by Subject|2|||
16078952|NCT02539225|38782689|FG001|Part A|Withdrawal by Subject|4|||
16078953|NCT02539225|38782688|FG000|Part A|Physician Decision|4|||
16477610|NCT01811225|40228234|FG000|Treatment Period 2|Lost to Follow-up|1|||
16477611|NCT01811225|40228235|FG001|Treatment Period 2|Lost to Follow-up|2|||
16477612|NCT01811225|40228234|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
16477613|NCT01811225|40228235|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
16477614|NCT01264016|40228236|FG000|Overall Study|Withdrawal by Subject|1|||
16477615|NCT01264016|40228236|FG000|Overall Study|Felt faint at sight of blood|1|||
16477616|NCT03343067|40228238|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
16477617|NCT03343067|40228239|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
16477618|NCT03343067|40228240|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
16477619|NCT00437320|40228241|FG000|Overall Study|Participant request|2|||
16477620|NCT00437320|40228242|FG001|Overall Study|Participant request|1|||
16477621|NCT00437320|40228243|FG002|Overall Study|Participant request|4|||
16477622|NCT00451451|40228244|FG000|Overall Study|Adverse Event|11|||
16477623|NCT00451451|40228245|FG001|Overall Study|Adverse Event|21|||
16477624|NCT00451451|40228246|FG002|Overall Study|Adverse Event|26|||
16477625|NCT00451451|40228247|FG003|Overall Study|Adverse Event|10|||
16477626|NCT00451451|40228244|FG000|Overall Study|Lost to Follow-up|11|||
16477627|NCT00451451|40228245|FG001|Overall Study|Lost to Follow-up|9|||
16477628|NCT00451451|40228246|FG002|Overall Study|Lost to Follow-up|8|||
16477629|NCT00451451|40228247|FG003|Overall Study|Lost to Follow-up|11|||
16477630|NCT00451451|40228244|FG000|Overall Study|Consent Withdrawn|14|||
16078954|NCT02539225|38782689|FG001|Part A|Physician Decision|7|||
16078955|NCT02539225|38782688|FG000|Part A|Did Not Receive study Drug|1|||
16078956|NCT02539225|38782689|FG001|Part A|Did Not Receive study Drug|1|||
16278732|NCT01475786|39500968|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
16278733|NCT01475786|39500969|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
16278734|NCT01475786|39500970|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
16477631|NCT00451451|40228245|FG001|Overall Study|Consent Withdrawn|9|||
16078957|NCT02539225|38782688|FG000|Pre Treatment for Part B|Progressive disease|1|||
16078958|NCT02539225|38782689|FG001|Pre Treatment for Part B|Progressive disease|1|||
16078959|NCT02539225|38782688|FG000|Pre Treatment for Part B|Adverse Event|1|||
16078960|NCT02539225|38782689|FG001|Pre Treatment for Part B|Adverse Event|1|||
16078961|NCT02539225|38782688|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
16078962|NCT02539225|38782689|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
16078963|NCT02539225|38782688|FG000|Pre Treatment for Part B|Physician Decision|2|||
16078964|NCT02539225|38782689|FG001|Pre Treatment for Part B|Physician Decision|0|||
16078965|NCT02539225|38782688|FG000|Part B|Adverse Event|4|||
16078966|NCT02539225|38782689|FG001|Part B|Adverse Event|4|||
16078967|NCT02539225|38782688|FG000|Part B|Withdrawal by Subject|0|||
16078968|NCT02539225|38782689|FG001|Part B|Withdrawal by Subject|3|||
16078969|NCT02539225|38782688|FG000|Part B|Physician Decision|0|||
16078970|NCT02539225|38782689|FG001|Part B|Physician Decision|9|||
16078971|NCT01443845|38782690|FG000|Overall Study|Protocol Violation|43|||
16078972|NCT01443845|38782691|FG001|Overall Study|Protocol Violation|45|||
16078973|NCT01443845|38782690|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
16078974|NCT01443845|38782691|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
16078975|NCT01443845|38782690|FG000|Overall Study|Deterioration in pulmonary function|1|||
16078976|NCT01443845|38782691|FG001|Overall Study|Deterioration in pulmonary function|4|||
16078977|NCT01443845|38782690|FG000|Overall Study|Lack of Efficacy|10|||
16078978|NCT01443845|38782691|FG001|Overall Study|Lack of Efficacy|5|||
16078979|NCT01443845|38782690|FG000|Overall Study|Adverse Event|64|||
16078980|NCT01443845|38782691|FG001|Overall Study|Adverse Event|138|||
16078981|NCT01443845|38782690|FG000|Overall Study|Withdrawal by Subject|63|||
16078982|NCT01443845|38782691|FG001|Overall Study|Withdrawal by Subject|67|||
16078983|NCT01443845|38782690|FG000|Overall Study|Military Conflict - Site Terminated|20|||
16078984|NCT01443845|38782691|FG001|Overall Study|Military Conflict - Site Terminated|21|||
16078985|NCT01443845|38782690|FG000|Overall Study|Lost to Follow-up|9|||
16078986|NCT01443845|38782691|FG001|Overall Study|Lost to Follow-up|13|||
16078987|NCT01061671|38782692|FG000|Overall Study|Withdrawal by Subject|16|||
16078988|NCT01061671|38782693|FG001|Overall Study|Withdrawal by Subject|20|||
16078989|NCT01061671|38782692|FG000|Overall Study|Lost to Follow-up|3|||
16078990|NCT01061671|38782693|FG001|Overall Study|Lost to Follow-up|5|||
16078991|NCT01061671|38782692|FG000|Overall Study|Death|28|||
16078992|NCT01061671|38782693|FG001|Overall Study|Death|30|||
16078993|NCT01118377|38782698|FG000|Overall Study|Did Not Receive Study Medication|1|||
16078994|NCT01118377|38782698|FG000|Overall Study|Death|38|||
16078995|NCT01118377|38782698|FG000|Overall Study|Failure to Return|3|||
16078996|NCT03544515|38782699|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
16078997|NCT03544515|38782700|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
16078998|NCT03544515|38782699|FG000|Overall Study|Lost to Follow-up|2|||
16078999|NCT03544515|38782700|FG001|Overall Study|Lost to Follow-up|0|||
16079000|NCT02383472|38782701|FG000|Overall Study|Withdrawal by Subject|1|||
16079001|NCT02383472|38782702|FG001|Overall Study|Withdrawal by Subject|1|||
16079002|NCT00068601|38782712|FG000|Overall Study|Ineligible|11|||
16079003|NCT00068601|38782713|FG001|Overall Study|Ineligible|13|||
16079004|NCT00068601|38782712|FG000|Overall Study|Not evaluable: withdrew consent|5|||
16079005|NCT00068601|38782713|FG001|Overall Study|Not evaluable: withdrew consent|4|||
16079006|NCT00068601|38782712|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
16079007|NCT00068601|38782713|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
16079008|NCT00068601|38782712|FG000|Overall Study|Death|11|||
16079009|NCT00068601|38782713|FG001|Overall Study|Death|3|||
16079010|NCT00068601|38782712|FG000|Overall Study|Lost to Follow-up|3|||
16079011|NCT00068601|38782713|FG001|Overall Study|Lost to Follow-up|2|||
16079012|NCT00068601|38782712|FG000|Overall Study|Missing primary outcome data|30|||
16079013|NCT00068601|38782713|FG001|Overall Study|Missing primary outcome data|34|||
16278735|NCT03407729|39500971|FG000|Overall Study|Lost to Follow-up|2|||
16079014|NCT03750968|38782715|FG000|Overall Study|Adverse Event|2|||
16079015|NCT03750968|38782716|FG001|Overall Study|Adverse Event|0|||
16079016|NCT03750968|38782715|FG000|Overall Study|Lost to Follow-up|1|||
16079017|NCT03750968|38782716|FG001|Overall Study|Lost to Follow-up|3|||
16079018|NCT01049503|38782717|FG000|Overall Study|Lost to Follow-up|11|||
16079019|NCT01049503|38782718|FG001|Overall Study|Lost to Follow-up|12|||
16079020|NCT01049503|38782719|FG002|Overall Study|Lost to Follow-up|24|||
16079021|NCT01049503|38782720|FG003|Overall Study|Lost to Follow-up|26|||
16278736|NCT03407729|39500972|FG001|Overall Study|Lost to Follow-up|0|||
16278737|NCT03407729|39500971|FG000|Overall Study|Unable to schedule|0|||
16079022|NCT01049503|38782721|FG004|Overall Study|Lost to Follow-up|27|||
16079023|NCT01049503|38782722|FG005|Overall Study|Lost to Follow-up|8|||
16079024|NCT00205179|38782725|FG000|Overall Study|Death|0|||
16278738|NCT03407729|39500972|FG001|Overall Study|Unable to schedule|3|||
16079025|NCT00205179|38782726|FG001|Overall Study|Death|2|||
16079026|NCT00205179|38782725|FG000|Overall Study|Physician Decision|1|||
16079027|NCT00205179|38782726|FG001|Overall Study|Physician Decision|1|||
16079028|NCT00205179|38782725|FG000|Overall Study|Adverse Event|1|||
16079029|NCT00205179|38782726|FG001|Overall Study|Adverse Event|1|||
16079030|NCT00997386|38782730|FG000|Overall Study|Death|7|||
16079031|NCT00495677|38782731|FG000|Stage 1 (25 Days)|Adverse Event|0|||
16079032|NCT00495677|38782732|FG001|Stage 1 (25 Days)|Adverse Event|0|||
16079033|NCT00495677|38782733|FG002|Stage 1 (25 Days)|Adverse Event|1|||
16079034|NCT00495677|38782734|FG003|Stage 1 (25 Days)|Adverse Event|0|||
16477632|NCT00451451|40228246|FG002|Overall Study|Consent Withdrawn|17|||
16477633|NCT00451451|40228247|FG003|Overall Study|Consent Withdrawn|17|||
16477634|NCT00451451|40228244|FG000|Overall Study|Investigator Decision|6|||
16278739|NCT00926367|39500973|FG000|Overall Study|Withdrawal by Subject|0|||
16278740|NCT00926367|39500974|FG001|Overall Study|Withdrawal by Subject|1|||
16278741|NCT00926367|39500973|FG000|Overall Study|Lost to Follow-up|1|||
16278742|NCT00926367|39500974|FG001|Overall Study|Lost to Follow-up|0|||
16278743|NCT00926367|39500973|FG000|Overall Study|Skin Irritation|1|||
16278744|NCT00926367|39500974|FG001|Overall Study|Skin Irritation|2|||
16278745|NCT04100096|39500977|FG000|Overall Study|Adverse Event|19|||
16278746|NCT04100096|39500978|FG001|Overall Study|Adverse Event|7|||
16278747|NCT04100096|39500977|FG000|Overall Study|Lack of Efficacy|0|||
16278748|NCT04100096|39500978|FG001|Overall Study|Lack of Efficacy|1|||
16278749|NCT04100096|39500977|FG000|Overall Study|Lost to Follow-up|13|||
16278750|NCT04100096|39500978|FG001|Overall Study|Lost to Follow-up|11|||
16278751|NCT04100096|39500977|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16477635|NCT00451451|40228245|FG001|Overall Study|Investigator Decision|2|||
16477636|NCT00451451|40228246|FG002|Overall Study|Investigator Decision|1|||
16477637|NCT00451451|40228247|FG003|Overall Study|Investigator Decision|2|||
16477638|NCT00451451|40228244|FG000|Overall Study|Subject Non-Compliance|8|||
16477639|NCT00451451|40228245|FG001|Overall Study|Subject Non-Compliance|4|||
16477640|NCT00451451|40228246|FG002|Overall Study|Subject Non-Compliance|3|||
16477641|NCT00451451|40228247|FG003|Overall Study|Subject Non-Compliance|3|||
16477642|NCT00451451|40228244|FG000|Overall Study|Death|1|||
16477643|NCT00451451|40228245|FG001|Overall Study|Death|0|||
16477644|NCT00451451|40228246|FG002|Overall Study|Death|0|||
16477645|NCT00451451|40228247|FG003|Overall Study|Death|1|||
16278752|NCT04100096|39500978|FG001|Overall Study|Non-Compliance With Study Drug|3|||
16278753|NCT04100096|39500977|FG000|Overall Study|Protocol Deviation|1|||
16278754|NCT04100096|39500978|FG001|Overall Study|Protocol Deviation|1|||
16278755|NCT04100096|39500977|FG000|Overall Study|Withdrawal by Participant|13|||
16278756|NCT04100096|39500978|FG001|Overall Study|Withdrawal by Participant|15|||
16278757|NCT03139240|39500979|FG000|Overall Study|Lost to Follow-up|0|||
16278758|NCT03139240|39500980|FG001|Overall Study|Lost to Follow-up|1|||
16278759|NCT03139240|39500981|FG002|Overall Study|Lost to Follow-up|1|||
16278760|NCT03139240|39500982|FG003|Overall Study|Lost to Follow-up|0|||
16278761|NCT02075840|39500983|FG000|Overall Study|Withdrawal by Subject|13|||
16278762|NCT02075840|39500984|FG001|Overall Study|Withdrawal by Subject|22|||
16278763|NCT02075840|39500983|FG000|Overall Study|Reason not specified|1|||
16278764|NCT02075840|39500984|FG001|Overall Study|Reason not specified|0|||
16278765|NCT02075840|39500983|FG000|Overall Study|Adverse Event|0|||
16278766|NCT02075840|39500984|FG001|Overall Study|Adverse Event|2|||
16278767|NCT02075840|39500983|FG000|Overall Study|Death|35|||
16278768|NCT02075840|39500984|FG001|Overall Study|Death|40|||
16278769|NCT02075840|39500983|FG000|Overall Study|Lost to Follow-up|3|||
16278770|NCT02075840|39500984|FG001|Overall Study|Lost to Follow-up|2|||
16278771|NCT02075840|39500983|FG000|Overall Study|Physician Decision|1|||
16278772|NCT02075840|39500984|FG001|Overall Study|Physician Decision|3|||
16278773|NCT02075840|39500983|FG000|Overall Study|Ongoing at CCOD|99|||
16278774|NCT02075840|39500984|FG001|Overall Study|Ongoing at CCOD|82|||
16278775|NCT02611323|39500985|FG000|Overall Study|Death|3|||
16278776|NCT02611323|39500986|FG001|Overall Study|Death|1|||
16278777|NCT02611323|39500987|FG002|Overall Study|Death|0|||
16278778|NCT02611323|39500988|FG003|Overall Study|Death|0|||
16278779|NCT02611323|39500989|FG004|Overall Study|Death|1|||
16278780|NCT02611323|39500990|FG005|Overall Study|Death|1|||
16278781|NCT02611323|39500991|FG006|Overall Study|Death|8|||
16278782|NCT02611323|39500992|FG007|Overall Study|Death|0|||
16278783|NCT02611323|39500993|FG008|Overall Study|Death|4|||
16278784|NCT02611323|39500994|FG009|Overall Study|Death|6|||
16278785|NCT02611323|39500995|FG010|Overall Study|Death|26|||
16278786|NCT02611323|39500985|FG000|Overall Study|Lost to Follow-up|1|||
16278787|NCT02611323|39500986|FG001|Overall Study|Lost to Follow-up|0|||
16278788|NCT02611323|39500987|FG002|Overall Study|Lost to Follow-up|0|||
16477646|NCT00451451|40228244|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
16278789|NCT02611323|39500988|FG003|Overall Study|Lost to Follow-up|0|||
16278790|NCT02611323|39500989|FG004|Overall Study|Lost to Follow-up|0|||
16278791|NCT02611323|39500990|FG005|Overall Study|Lost to Follow-up|0|||
16278792|NCT02611323|39500991|FG006|Overall Study|Lost to Follow-up|3|||
16278793|NCT02611323|39500992|FG007|Overall Study|Lost to Follow-up|0|||
16278794|NCT02611323|39500993|FG008|Overall Study|Lost to Follow-up|0|||
16278795|NCT02611323|39500994|FG009|Overall Study|Lost to Follow-up|0|||
16278796|NCT02611323|39500995|FG010|Overall Study|Lost to Follow-up|2|||
16278797|NCT02611323|39500985|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
16079035|NCT00495677|38782735|FG004|Stage 1 (25 Days)|Adverse Event|0|||
16079036|NCT00495677|38782736|FG005|Stage 1 (25 Days)|Adverse Event|0|||
16079037|NCT00495677|38782737|FG006|Stage 1 (25 Days)|Adverse Event|0|||
16079038|NCT01331824|38782738|FG000|Overall Study|Adverse Event|2|||
16079039|NCT01331824|38782738|FG000|Overall Study|Death|1|||
16079040|NCT01331824|38782738|FG000|Overall Study|Disease Progression|9|||
16079041|NCT01331824|38782738|FG000|Overall Study|Withdrawal by Subject|1|||
16079042|NCT02794480|38782741|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
16079043|NCT02794480|38782742|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
16079044|NCT02794480|38782743|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
16079045|NCT02794480|38782744|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
16079046|NCT02794480|38782741|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
16079047|NCT02794480|38782742|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
16079048|NCT02794480|38782743|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
16079049|NCT02794480|38782744|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
16079050|NCT02794480|38782741|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16079051|NCT02794480|38782742|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16079052|NCT02794480|38782743|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16079053|NCT02794480|38782744|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
16079054|NCT02794480|38782741|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16079055|NCT02794480|38782742|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
16079056|NCT02794480|38782743|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16079057|NCT02794480|38782744|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
16079058|NCT02794480|38782741|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
16079059|NCT02794480|38782742|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16079060|NCT02794480|38782743|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16079061|NCT02794480|38782744|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
16079062|NCT00683696|38782746|FG000|Overall Study|Withdrawn due to study closure|337|||
16079063|NCT00683696|38782747|FG001|Overall Study|Withdrawn due to study closure|338|||
16079064|NCT00683696|38782746|FG000|Overall Study|Withdrawn prior to study closure|13|||
16079065|NCT00683696|38782747|FG001|Overall Study|Withdrawn prior to study closure|28|||
16079066|NCT00683696|38782746|FG000|Overall Study|Lost to Follow-up|5|||
16079067|NCT00683696|38782747|FG001|Overall Study|Lost to Follow-up|6|||
16079068|NCT00683696|38782746|FG000|Overall Study|Vital status follow-up only|3|||
16079069|NCT00683696|38782747|FG001|Overall Study|Vital status follow-up only|3|||
16079070|NCT00683696|38782746|FG000|Overall Study|Death|46|||
16079071|NCT00683696|38782747|FG001|Overall Study|Death|30|||
16079072|NCT05368831|38782751|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
16079073|NCT02974634|38782753|FG000|Overall Study|Advanced disease|12|||
16079074|NCT02974634|38782754|FG001|Overall Study|Advanced disease|3|||
16079075|NCT02974634|38782753|FG000|Overall Study|Noncompliance|3|||
16079076|NCT02974634|38782754|FG001|Overall Study|Noncompliance|7|||
16079077|NCT02974634|38782753|FG000|Overall Study|intervention technology related issues|5|||
16079078|NCT02974634|38782754|FG001|Overall Study|intervention technology related issues|0|||
16278798|NCT02611323|39500986|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
16278799|NCT02611323|39500987|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
16278800|NCT02611323|39500988|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
16278801|NCT02611323|39500989|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
16278802|NCT02611323|39500990|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
16278803|NCT02611323|39500991|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
16278804|NCT02611323|39500992|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
16278805|NCT02611323|39500993|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
16278806|NCT02611323|39500994|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
16278807|NCT02611323|39500995|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
16278808|NCT02611323|39500985|FG000|Overall Study|Progressive Disease|0|||
16278809|NCT02611323|39500986|FG001|Overall Study|Progressive Disease|0|||
16278810|NCT02611323|39500987|FG002|Overall Study|Progressive Disease|0|||
16278811|NCT02611323|39500988|FG003|Overall Study|Progressive Disease|0|||
16278812|NCT02611323|39500989|FG004|Overall Study|Progressive Disease|0|||
16278813|NCT02611323|39500990|FG005|Overall Study|Progressive Disease|0|||
16278814|NCT02611323|39500991|FG006|Overall Study|Progressive Disease|0|||
16278815|NCT02611323|39500992|FG007|Overall Study|Progressive Disease|0|||
16278816|NCT02611323|39500993|FG008|Overall Study|Progressive Disease|0|||
16278817|NCT02611323|39500994|FG009|Overall Study|Progressive Disease|0|||
16278818|NCT02611323|39500995|FG010|Overall Study|Progressive Disease|1|||
16278819|NCT02611323|39500985|FG000|Overall Study|Withdrawal by Subject|1|||
16278820|NCT02611323|39500986|FG001|Overall Study|Withdrawal by Subject|0|||
16278821|NCT02611323|39500987|FG002|Overall Study|Withdrawal by Subject|0|||
16278822|NCT02611323|39500988|FG003|Overall Study|Withdrawal by Subject|0|||
16278823|NCT02611323|39500989|FG004|Overall Study|Withdrawal by Subject|0|||
16278824|NCT02611323|39500990|FG005|Overall Study|Withdrawal by Subject|0|||
16278825|NCT02611323|39500991|FG006|Overall Study|Withdrawal by Subject|0|||
16278826|NCT02611323|39500992|FG007|Overall Study|Withdrawal by Subject|1|||
16278827|NCT02611323|39500993|FG008|Overall Study|Withdrawal by Subject|0|||
16278828|NCT02611323|39500994|FG009|Overall Study|Withdrawal by Subject|1|||
16278829|NCT02611323|39500995|FG010|Overall Study|Withdrawal by Subject|0|||
16278830|NCT01853176|39500996|FG000|Overall Study|Study terminated|4|||
16278831|NCT01853176|39500997|FG001|Overall Study|Study terminated|0|||
16278832|NCT02943096|39500998|FG000|Overall Study|Lack of Efficacy|0|||
16278833|NCT02943096|39500999|FG001|Overall Study|Lack of Efficacy|1|||
16278834|NCT01315028|39504104|FG000|Overall Study|Lost to Follow-up|1|||
16278835|NCT01315028|39504105|FG001|Overall Study|Lost to Follow-up|0|||
16278836|NCT01315028|39504104|FG000|Overall Study|Death|0|||
16278837|NCT01315028|39504105|FG001|Overall Study|Death|1|||
16278838|NCT01408888|39504111|FG000|First Intervention|Adverse Event|0|||
16278839|NCT01408888|39504112|FG001|First Intervention|Adverse Event|1|||
16079079|NCT02974634|38782753|FG000|Overall Study|Death|8|||
16079080|NCT02974634|38782754|FG001|Overall Study|Death|11|||
16079081|NCT02928224|38782756|FG000|Overall Study|Lost to Follow-up|1|||
16079082|NCT02928224|38782757|FG001|Overall Study|Lost to Follow-up|1|||
16079083|NCT02928224|38782758|FG002|Overall Study|Lost to Follow-up|3|||
16079084|NCT02928224|38782759|FG003|Overall Study|Lost to Follow-up|0|||
16079085|NCT02928224|38782756|FG000|Overall Study|Death|30|||
16079086|NCT02928224|38782757|FG001|Overall Study|Death|209|||
16079087|NCT02928224|38782758|FG002|Overall Study|Death|193|||
16079088|NCT02928224|38782759|FG003|Overall Study|Death|198|||
16079089|NCT02928224|38782756|FG000|Overall Study|Withdrawal by Subject|0|||
16079090|NCT02928224|38782757|FG001|Overall Study|Withdrawal by Subject|3|||
16079091|NCT02928224|38782758|FG002|Overall Study|Withdrawal by Subject|7|||
16079092|NCT02928224|38782759|FG003|Overall Study|Withdrawal by Subject|20|||
16079093|NCT02928224|38782756|FG000|Overall Study|Study participation terminated by sponsor|3|||
16079094|NCT02928224|38782757|FG001|Overall Study|Study participation terminated by sponsor|8|||
16079095|NCT02928224|38782758|FG002|Overall Study|Study participation terminated by sponsor|12|||
16079096|NCT02928224|38782759|FG003|Overall Study|Study participation terminated by sponsor|3|||
16079097|NCT02928224|38782756|FG000|Overall Study|Other|3|||
16079098|NCT02928224|38782757|FG001|Overall Study|Other|3|||
16079099|NCT02928224|38782758|FG002|Overall Study|Other|5|||
16079100|NCT02928224|38782759|FG003|Overall Study|Other|0|||
16079101|NCT01887600|38782766|FG000|Overall Study|Death|39|||
16079102|NCT01887600|38782767|FG001|Overall Study|Death|16|||
16079103|NCT01887600|38782766|FG000|Overall Study|Lack of Efficacy|3|||
16079104|NCT01887600|38782767|FG001|Overall Study|Lack of Efficacy|26|||
16079105|NCT01887600|38782766|FG000|Overall Study|Lost to Follow-up|5|||
16079106|NCT01887600|38782767|FG001|Overall Study|Lost to Follow-up|1|||
16079107|NCT01887600|38782766|FG000|Overall Study|Physician Decision|7|||
16079108|NCT01887600|38782767|FG001|Overall Study|Physician Decision|8|||
16079109|NCT01887600|38782766|FG000|Overall Study|Protocol Deviation|3|||
16079110|NCT01887600|38782767|FG001|Overall Study|Protocol Deviation|0|||
16079111|NCT01887600|38782766|FG000|Overall Study|Withdrawal by Subject|58|||
16079112|NCT01887600|38782767|FG001|Overall Study|Withdrawal by Subject|52|||
16079113|NCT01887600|38782766|FG000|Overall Study|Adverse Event|21|||
16079114|NCT01887600|38782767|FG001|Overall Study|Adverse Event|9|||
16079115|NCT01887600|38782766|FG000|Overall Study|Non-compliance with study drug|3|||
16079116|NCT01887600|38782767|FG001|Overall Study|Non-compliance with study drug|0|||
16176169|NCT00785577|39122855|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
16176170|NCT00785577|39122856|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
16176171|NCT03116113|39122857|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
16176172|NCT03116113|39122858|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
16176173|NCT03116113|39122859|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
16176174|NCT03116113|39122860|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
16176175|NCT03116113|39122861|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
16176176|NCT03116113|39122862|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
16176177|NCT03116113|39122863|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
16176178|NCT03116113|39122864|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
16176179|NCT03116113|39122865|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
16176180|NCT01445171|39122867|FG000|Overall Study|Lost to Follow-up|11|||
16176181|NCT01445171|39122867|FG000|Overall Study|Withdrawal by Subject|16|||
16176182|NCT01445171|39122867|FG000|Overall Study|Death|51|||
16176183|NCT01445171|39122867|FG000|Overall Study|Subjects declined to return for followup|9|||
16176184|NCT01445171|39122867|FG000|Overall Study|Consented but did not receive device|8|||
16176185|NCT00924703|39122868|FG000|Overall Study|Withdrawal by Subject|11|||
16176186|NCT00924703|39122868|FG000|Overall Study|Physician Decision|5|||
16176187|NCT00924703|39122868|FG000|Overall Study|Lost to Follow-up|3|||
16176188|NCT00924703|39122868|FG000|Overall Study|Adverse Event|2|||
16278840|NCT01408888|39504111|FG000|First Intervention|Withdrawal by Subject|0|||
16278841|NCT01408888|39504112|FG001|First Intervention|Withdrawal by Subject|2|||
16278842|NCT01408888|39504111|FG000|Second Intervention|Withdrawal by Subject|1|||
16278843|NCT01408888|39504112|FG001|Second Intervention|Withdrawal by Subject|0|||
16278844|NCT01408888|39504111|FG000|Second Intervention|Adverse Event|1|||
16278845|NCT01408888|39504112|FG001|Second Intervention|Adverse Event|0|||
16278846|NCT03712124|39504113|FG000|Overall Study|Protocol Violation|1|||
16278847|NCT03712124|39504114|FG001|Overall Study|Protocol Violation|0|||
16278848|NCT04139317|39504115|FG000|Overall Study|Adverse Event|10|||
16278849|NCT04139317|39504116|FG001|Overall Study|Adverse Event|2|||
16278850|NCT04139317|39504115|FG000|Overall Study|Death|6|||
16278851|NCT04139317|39504116|FG001|Overall Study|Death|4|||
16278852|NCT04139317|39504115|FG000|Overall Study|Lost to Follow-up|1|||
16278853|NCT04139317|39504116|FG001|Overall Study|Lost to Follow-up|0|||
16278854|NCT04139317|39504115|FG000|Overall Study|Physician Decision|3|||
16278855|NCT04139317|39504116|FG001|Overall Study|Physician Decision|1|||
16278856|NCT04139317|39504115|FG000|Overall Study|Progressive Disease|19|||
16278857|NCT04139317|39504116|FG001|Overall Study|Progressive Disease|9|||
16278858|NCT04139317|39504115|FG000|Overall Study|Subject Decision|2|||
16278859|NCT04139317|39504116|FG001|Overall Study|Subject Decision|2|||
16278860|NCT00360490|39504119|FG000|Overall Study|Adverse Event|4|||
16278861|NCT00360490|39504120|FG001|Overall Study|Adverse Event|2|||
16278862|NCT00360490|39504119|FG000|Overall Study|Lost to Follow-up|2|||
16278863|NCT00360490|39504120|FG001|Overall Study|Lost to Follow-up|1|||
16278864|NCT00360490|39504119|FG000|Overall Study|Physician Decision|2|||
16278865|NCT00360490|39504120|FG001|Overall Study|Physician Decision|1|||
16278866|NCT00360490|39504119|FG000|Overall Study|Protocol Violation|0|||
16278867|NCT00360490|39504120|FG001|Overall Study|Protocol Violation|4|||
16079117|NCT01887600|38782766|FG000|Overall Study|Miscellaneous|6|||
16079118|NCT01887600|38782767|FG001|Overall Study|Miscellaneous|2|||
16079119|NCT01887600|38782766|FG000|Overall Study|Progressive Disease|1|||
16079120|NCT01887600|38782767|FG001|Overall Study|Progressive Disease|0|||
16278868|NCT00360490|39504119|FG000|Overall Study|Withdrawal by Subject|1|||
16278869|NCT00360490|39504120|FG001|Overall Study|Withdrawal by Subject|3|||
16278870|NCT00480324|39504121|FG000|Overall Study|Adverse Event|1|||
16278871|NCT00480324|39504122|FG001|Overall Study|Adverse Event|1|||
16278872|NCT00480324|39504121|FG000|Overall Study|Protocol Violation|0|||
16278873|NCT00480324|39504122|FG001|Overall Study|Protocol Violation|1|||
16278874|NCT00480324|39504121|FG000|Overall Study|Withdrawal by Subject|14|||
16278875|NCT00480324|39504122|FG001|Overall Study|Withdrawal by Subject|5|||
16278876|NCT00480324|39504121|FG000|Overall Study|Lost to Follow-up|17|||
16278877|NCT00480324|39504122|FG001|Overall Study|Lost to Follow-up|8|||
16278878|NCT00480324|39504121|FG000|Overall Study|Subject's mother pregnant|0|||
16278879|NCT00480324|39504122|FG001|Overall Study|Subject's mother pregnant|1|||
16278880|NCT01098851|39504123|FG000|Overall Study|Equipment failure|1|||
16278881|NCT01098851|39504124|FG001|Overall Study|Equipment failure|0|||
16278882|NCT02058160|39504125|FG000|Overall Study|Randomized but not treated|2|||
16278883|NCT02058160|39504126|FG001|Overall Study|Randomized but not treated|4|||
16278884|NCT02058160|39504125|FG000|Overall Study|Poor compliance to protocol|4|||
16278885|NCT02058160|39504126|FG001|Overall Study|Poor compliance to protocol|1|||
16278886|NCT02058160|39504125|FG000|Overall Study|Adverse Event|12|||
16278887|NCT02058160|39504126|FG001|Overall Study|Adverse Event|3|||
16278888|NCT02058160|39504125|FG000|Overall Study|Lost to Follow-up|1|||
16278889|NCT02058160|39504126|FG001|Overall Study|Lost to Follow-up|0|||
16477647|NCT00451451|40228245|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
16278890|NCT02058160|39504125|FG000|Overall Study|Other than specified above|12|||
16079121|NCT00802464|38782772|FG000|Month 0 - Month 8|Adverse Event|0|||
16079122|NCT00802464|38782773|FG001|Month 0 - Month 8|Adverse Event|1|||
16079123|NCT00802464|38782774|FG002|Month 0 - Month 8|Adverse Event|1|||
16079124|NCT00802464|38782775|FG003|Month 0 - Month 8|Adverse Event|2|||
16079125|NCT00802464|38782772|FG000|Month 0 - Month 8|Protocol Violation|0|||
16079126|NCT00802464|38782773|FG001|Month 0 - Month 8|Protocol Violation|0|||
16079127|NCT00802464|38782774|FG002|Month 0 - Month 8|Protocol Violation|1|||
16079128|NCT00802464|38782775|FG003|Month 0 - Month 8|Protocol Violation|0|||
16079129|NCT00802464|38782772|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
16079130|NCT00802464|38782773|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
16079131|NCT00802464|38782774|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
16278891|NCT02058160|39504126|FG001|Overall Study|Other than specified above|6|||
16278892|NCT02005562|39504128|FG000|Overall Study|Death|2|||
16278893|NCT02005562|39504129|FG001|Overall Study|Death|2|||
16278894|NCT02005562|39504128|FG000|Overall Study|Graft loss|7|||
16278895|NCT02005562|39504129|FG001|Overall Study|Graft loss|6|||
16278896|NCT02005562|39504128|FG000|Overall Study|Withdrawal by Subject|2|||
16278897|NCT02005562|39504129|FG001|Overall Study|Withdrawal by Subject|2|||
16079132|NCT00802464|38782775|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
16278898|NCT02005562|39504128|FG000|Overall Study|No transplant|1|||
16079133|NCT00802464|38782772|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
16278899|NCT02005562|39504129|FG001|Overall Study|No transplant|4|||
16278900|NCT02005562|39504128|FG000|Overall Study|Physician Decision|0|||
16278901|NCT02005562|39504129|FG001|Overall Study|Physician Decision|1|||
16278902|NCT01632306|39504130|FG000|Overall Study|Protocol Violation|1|||
16079134|NCT00802464|38782773|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
16079135|NCT00802464|38782774|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
16079136|NCT00802464|38782775|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
16079137|NCT00802464|38782772|FG000|Month 0 - Month 8|Other|0|||
16477648|NCT00451451|40228246|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
16477649|NCT00451451|40228247|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
16477650|NCT03330288|40228248|FG000|Overall Study|Other reason|1|||
16477651|NCT03330288|40228249|FG001|Overall Study|Other reason|1|||
16477652|NCT03330288|40228248|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
16477653|NCT03330288|40228249|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
16477654|NCT03330288|40228248|FG000|Overall Study|Adverse Event|1|||
16477655|NCT03330288|40228249|FG001|Overall Study|Adverse Event|0|||
16477656|NCT03330288|40228248|FG000|Overall Study|Withdrawal by Subject|1|||
16477657|NCT03330288|40228249|FG001|Overall Study|Withdrawal by Subject|0|||
16477658|NCT03330288|40228248|FG000|Overall Study|Lost to Follow-up|26|||
16477659|NCT03330288|40228249|FG001|Overall Study|Lost to Follow-up|7|||
16477660|NCT02633501|40228250|FG000|Overall Study|Adverse Event|0|||
16477661|NCT02633501|40228251|FG001|Overall Study|Adverse Event|0|||
16477662|NCT02633501|40228252|FG002|Overall Study|Adverse Event|1|||
16477663|NCT02633501|40228253|FG003|Overall Study|Adverse Event|0|||
16477664|NCT02633501|40228254|FG004|Overall Study|Adverse Event|1|||
16477665|NCT02633501|40228255|FG005|Overall Study|Adverse Event|1|||
16477666|NCT02633501|40228250|FG000|Overall Study|Withdrawal by Subject|2|||
16477667|NCT02633501|40228251|FG001|Overall Study|Withdrawal by Subject|1|||
16477668|NCT02633501|40228252|FG002|Overall Study|Withdrawal by Subject|2|||
16477669|NCT02633501|40228253|FG003|Overall Study|Withdrawal by Subject|2|||
16477670|NCT02633501|40228254|FG004|Overall Study|Withdrawal by Subject|1|||
16477671|NCT02633501|40228255|FG005|Overall Study|Withdrawal by Subject|3|||
16477672|NCT02633501|40228250|FG000|Overall Study|Various other reasons|0|||
16477673|NCT02633501|40228251|FG001|Overall Study|Various other reasons|2|||
16477674|NCT02633501|40228252|FG002|Overall Study|Various other reasons|4|||
16477675|NCT02633501|40228253|FG003|Overall Study|Various other reasons|1|||
16477676|NCT02633501|40228254|FG004|Overall Study|Various other reasons|7|||
16477677|NCT02633501|40228255|FG005|Overall Study|Various other reasons|11|||
16477678|NCT02633501|40228250|FG000|Overall Study|Lost to Follow-up|0|||
16477679|NCT02633501|40228251|FG001|Overall Study|Lost to Follow-up|0|||
16477680|NCT02633501|40228252|FG002|Overall Study|Lost to Follow-up|0|||
16477681|NCT02633501|40228253|FG003|Overall Study|Lost to Follow-up|1|||
16477682|NCT02633501|40228254|FG004|Overall Study|Lost to Follow-up|2|||
16477683|NCT02633501|40228255|FG005|Overall Study|Lost to Follow-up|0|||
16477684|NCT02282358|40228256|FG000|Overall Study|Nonevaluable|1|||
16477685|NCT03468985|40228257|FG000|Overall Study|Adverse Event|0|||
16477686|NCT03468985|40228258|FG001|Overall Study|Adverse Event|2|||
16477687|NCT03468985|40228259|FG002|Overall Study|Adverse Event|0|||
16477688|NCT03468985|40228260|FG003|Overall Study|Adverse Event|0|||
16079138|NCT00802464|38782773|FG001|Month 0 - Month 8|Other|0|||
16079139|NCT00802464|38782774|FG002|Month 0 - Month 8|Other|1|||
16079140|NCT00802464|38782775|FG003|Month 0 - Month 8|Other|0|||
16079141|NCT00802464|38782772|FG000|Month 8 - Month 14|Adverse Event|0|||
16079142|NCT00802464|38782773|FG001|Month 8 - Month 14|Adverse Event|1|||
16079143|NCT00802464|38782774|FG002|Month 8 - Month 14|Adverse Event|0|||
16079144|NCT00802464|38782775|FG003|Month 8 - Month 14|Adverse Event|0|||
16079145|NCT00802464|38782772|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
16079146|NCT00802464|38782773|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
16079147|NCT00802464|38782774|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
16079148|NCT00802464|38782775|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
16079149|NCT00802464|38782772|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
16079150|NCT00802464|38782773|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
16079151|NCT00802464|38782774|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
16079152|NCT00802464|38782775|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
16477689|NCT03468985|40228257|FG000|Overall Study|Withdrawal by Subject|0|||
16477690|NCT03468985|40228258|FG001|Overall Study|Withdrawal by Subject|0|||
16477691|NCT03468985|40228259|FG002|Overall Study|Withdrawal by Subject|0|||
16477692|NCT03468985|40228260|FG003|Overall Study|Withdrawal by Subject|1|||
16477693|NCT00191906|40228261|FG000|Study Period II|Adverse Event|0|||
16079153|NCT02755116|38782780|FG000|Overall Study|surgery converted to open, pt admitted|3|||
16079154|NCT02755116|38782781|FG001|Overall Study|surgery converted to open, pt admitted|1|||
16477694|NCT00191906|40228262|FG001|Study Period II|Adverse Event|1|||
16477695|NCT00191906|40228263|FG002|Study Period II|Adverse Event|0|||
16079155|NCT03482011|38782783|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
16079156|NCT03482011|38782784|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
16079157|NCT03482011|38782785|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
16079158|NCT03482011|38782786|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
16079159|NCT03482011|38782787|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
16079160|NCT03482011|38782788|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
16079161|NCT03482011|38782789|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
16079162|NCT03482011|38782790|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
16079163|NCT03482011|38782783|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
16079164|NCT03482011|38782784|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
16079165|NCT03482011|38782785|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16079166|NCT03482011|38782786|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16079167|NCT03482011|38782787|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16079168|NCT03482011|38782788|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16079169|NCT03482011|38782789|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16079170|NCT03482011|38782790|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16079171|NCT03482011|38782783|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
16079172|NCT03482011|38782784|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
16079173|NCT03482011|38782785|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
16079174|NCT03482011|38782786|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
16079175|NCT03482011|38782787|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
16079176|NCT03482011|38782788|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
16079177|NCT03482011|38782789|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
16079178|NCT03482011|38782790|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
16079179|NCT03482011|38782783|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
16079180|NCT03482011|38782784|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
16079181|NCT03482011|38782785|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
16079182|NCT03482011|38782786|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
16079183|NCT03482011|38782787|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
16079184|NCT03482011|38782788|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
16079185|NCT03482011|38782789|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
16079186|NCT03482011|38782790|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
16079187|NCT03482011|38782783|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
16079188|NCT03482011|38782784|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
16278903|NCT01632306|39504131|FG001|Overall Study|Protocol Violation|0|||
16278904|NCT01632306|39504132|FG002|Overall Study|Protocol Violation|0|||
16278905|NCT04499482|39504133|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
16278906|NCT00271024|39504138|FG000|Overall Study|Lost Interest|3|||
16079189|NCT03482011|38782785|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16079190|NCT03482011|38782786|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16079191|NCT03482011|38782787|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16079192|NCT03482011|38782788|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16079193|NCT03482011|38782789|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16079194|NCT03482011|38782790|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16079195|NCT03482011|38782783|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
16079196|NCT03482011|38782784|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
16079197|NCT03482011|38782785|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
16079198|NCT03482011|38782786|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
16079199|NCT03482011|38782787|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
16079200|NCT03482011|38782788|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
16079201|NCT03482011|38782789|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
16079202|NCT03482011|38782790|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
16079203|NCT03482011|38782783|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
16079204|NCT03482011|38782784|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
16079205|NCT03482011|38782785|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
16079206|NCT03482011|38782786|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
16079207|NCT03482011|38782787|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
16079208|NCT03482011|38782788|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
16079209|NCT03482011|38782789|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
16079210|NCT03482011|38782790|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
16079211|NCT03482011|38782783|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16079212|NCT03482011|38782784|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16079213|NCT03482011|38782785|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16079214|NCT03482011|38782786|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16278907|NCT00271024|39504139|FG001|Overall Study|Lost Interest|4|||
16278908|NCT00271024|39504140|FG002|Overall Study|Lost Interest|2|||
16079215|NCT03482011|38782787|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
16079216|NCT03482011|38782788|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16079217|NCT03482011|38782789|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16278909|NCT00271024|39504141|FG003|Overall Study|Lost Interest|3|||
16278910|NCT00271024|39504138|FG000|Overall Study|Unknown/Unspecified|11|||
16079218|NCT03482011|38782790|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
16079219|NCT03482011|38782783|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
16079220|NCT03482011|38782784|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
16278911|NCT00271024|39504139|FG001|Overall Study|Unknown/Unspecified|11|||
16278912|NCT00271024|39504140|FG002|Overall Study|Unknown/Unspecified|8|||
16278913|NCT00271024|39504141|FG003|Overall Study|Unknown/Unspecified|4|||
16278914|NCT00271024|39504138|FG000|Overall Study|Protocol Violation|1|||
16079221|NCT03482011|38782785|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
16079222|NCT03482011|38782786|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
16079223|NCT03482011|38782787|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
16079224|NCT03482011|38782788|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
16079225|NCT03482011|38782789|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
16079226|NCT03482011|38782790|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
16079227|NCT03482011|38782783|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16079228|NCT03482011|38782784|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16079229|NCT03482011|38782785|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16079230|NCT03482011|38782786|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
16079231|NCT03482011|38782787|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
16079232|NCT03482011|38782788|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
16278915|NCT00271024|39504139|FG001|Overall Study|Protocol Violation|6|||
16278916|NCT00271024|39504140|FG002|Overall Study|Protocol Violation|5|||
16278917|NCT00271024|39504141|FG003|Overall Study|Protocol Violation|11|||
16079233|NCT03482011|38782789|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
16079234|NCT03482011|38782790|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
16079235|NCT03482011|38782783|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16079236|NCT03482011|38782784|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16079237|NCT03482011|38782785|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16079238|NCT03482011|38782786|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
16079239|NCT03482011|38782787|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16079240|NCT03482011|38782788|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
16079241|NCT03482011|38782789|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
16079242|NCT03482011|38782790|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
16079243|NCT03482011|38782783|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
16079244|NCT03482011|38782784|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
16079245|NCT03482011|38782785|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
16079246|NCT03482011|38782786|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
16079247|NCT03482011|38782787|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
16079248|NCT03482011|38782788|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
16079249|NCT03482011|38782789|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
16079250|NCT03482011|38782790|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
16079251|NCT03482011|38782783|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
16079252|NCT03482011|38782784|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
16079253|NCT03482011|38782785|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
16079254|NCT03482011|38782786|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
16079255|NCT03482011|38782787|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
16079256|NCT03482011|38782788|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
16079257|NCT03482011|38782789|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
16079258|NCT03482011|38782790|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
16079259|NCT03482011|38782783|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
16079260|NCT03482011|38782784|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
16079261|NCT03482011|38782785|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
16079262|NCT03482011|38782786|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
16079263|NCT03482011|38782787|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
16079264|NCT03482011|38782788|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
16079265|NCT03482011|38782789|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
16079266|NCT03482011|38782790|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
16079267|NCT03482011|38782783|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
16079268|NCT03482011|38782784|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
16079269|NCT03482011|38782785|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
16079270|NCT03482011|38782786|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
16079271|NCT03482011|38782787|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
16079272|NCT03482011|38782788|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
16079273|NCT03482011|38782789|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
16079274|NCT03482011|38782790|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
16079275|NCT01538719|38782791|FG000|Overall Study|Lost to Follow-up|2|||
16079276|NCT01538719|38782792|FG001|Overall Study|Lost to Follow-up|0|||
16079277|NCT02759016|38782793|FG000|Overall Study|Not treated with BI 836826|1|||
16079278|NCT02759016|38782794|FG001|Overall Study|Not treated with BI 836826|0|||
16079279|NCT02759016|38782793|FG000|Overall Study|Progressive disease|1|||
16278918|NCT00271024|39504138|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
16278919|NCT00271024|39504139|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
16477696|NCT00191906|40228264|FG003|Study Period II|Adverse Event|0|||
16079280|NCT02759016|38782794|FG001|Overall Study|Progressive disease|0|||
16079281|NCT02759016|38782793|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
16079282|NCT02759016|38782794|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
16079283|NCT02759016|38782793|FG000|Overall Study|Other not defined above|2|||
16079284|NCT02759016|38782794|FG001|Overall Study|Other not defined above|1|||
16079285|NCT01337635|38782797|FG000|Overall Study|Lost to Follow-up|0|||
16079286|NCT01337635|38782798|FG001|Overall Study|Lost to Follow-up|1|||
16079287|NCT01823536|38782801|FG000|Overall Study|Lost to Follow-up|1|||
16079288|NCT01823536|38782802|FG001|Overall Study|Lost to Follow-up|0|||
16079289|NCT01823536|38782803|FG002|Overall Study|Lost to Follow-up|0|||
16079290|NCT01823536|38782804|FG003|Overall Study|Lost to Follow-up|1|||
16079291|NCT01823536|38782805|FG004|Overall Study|Lost to Follow-up|1|||
16079292|NCT01823536|38782806|FG005|Overall Study|Lost to Follow-up|0|||
16079293|NCT01823536|38782801|FG000|Overall Study|Protocol Violation|0|||
16079294|NCT01823536|38782802|FG001|Overall Study|Protocol Violation|1|||
16079295|NCT01823536|38782803|FG002|Overall Study|Protocol Violation|0|||
16079296|NCT01823536|38782804|FG003|Overall Study|Protocol Violation|0|||
16079297|NCT01823536|38782805|FG004|Overall Study|Protocol Violation|0|||
16079298|NCT01823536|38782806|FG005|Overall Study|Protocol Violation|0|||
16079299|NCT01823536|38782801|FG000|Overall Study|Withdrawal by Subject|1|||
16079300|NCT01823536|38782802|FG001|Overall Study|Withdrawal by Subject|1|||
16079301|NCT01823536|38782803|FG002|Overall Study|Withdrawal by Subject|0|||
16079302|NCT01823536|38782804|FG003|Overall Study|Withdrawal by Subject|0|||
16079303|NCT01823536|38782805|FG004|Overall Study|Withdrawal by Subject|0|||
16079304|NCT01823536|38782806|FG005|Overall Study|Withdrawal by Subject|0|||
16079305|NCT01823536|38782801|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
16079306|NCT01823536|38782802|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
16079307|NCT01823536|38782803|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
16079308|NCT01823536|38782804|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
16079309|NCT01823536|38782805|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
16079310|NCT01823536|38782806|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
16079311|NCT01823536|38782801|FG000|Overall Study|Met exclusion criterion No 6|0|||
16079312|NCT01823536|38782802|FG001|Overall Study|Met exclusion criterion No 6|0|||
16079313|NCT01823536|38782803|FG002|Overall Study|Met exclusion criterion No 6|0|||
16079314|NCT01823536|38782804|FG003|Overall Study|Met exclusion criterion No 6|1|||
16079315|NCT01823536|38782805|FG004|Overall Study|Met exclusion criterion No 6|0|||
16079316|NCT01823536|38782806|FG005|Overall Study|Met exclusion criterion No 6|0|||
16079317|NCT01823536|38782801|FG000|Overall Study|Subject moved out of the state|0|||
16079318|NCT01823536|38782802|FG001|Overall Study|Subject moved out of the state|0|||
16079319|NCT01823536|38782803|FG002|Overall Study|Subject moved out of the state|0|||
16079320|NCT01823536|38782804|FG003|Overall Study|Subject moved out of the state|0|||
16079321|NCT01823536|38782805|FG004|Overall Study|Subject moved out of the state|1|||
16079322|NCT01823536|38782806|FG005|Overall Study|Subject moved out of the state|0|||
16079323|NCT00031694|38782807|FG000|Overall Study|Adverse Event|12|||
16079324|NCT00031694|38782807|FG000|Overall Study|Death|2|||
16079325|NCT00031694|38782807|FG000|Overall Study|Withdrawal by Subject|5|||
16079326|NCT01925339|38782812|FG000|Overall Study|Adverse Event|2|||
16079327|NCT01925339|38782813|FG001|Overall Study|Adverse Event|0|||
16079328|NCT02296424|38782816|FG000|Part 1|New therapy for study indication|0|||
16079329|NCT02296424|38782817|FG001|Part 1|New therapy for study indication|1|||
16079330|NCT02296424|38782818|FG002|Part 1|New therapy for study indication|0|||
16079331|NCT02296424|38782819|FG003|Part 1|New therapy for study indication|0|||
16079332|NCT02296424|38782816|FG000|Part 1|Protocol Violation|0|||
16079333|NCT02296424|38782817|FG001|Part 1|Protocol Violation|1|||
16079334|NCT02296424|38782818|FG002|Part 1|Protocol Violation|0|||
16079335|NCT02296424|38782819|FG003|Part 1|Protocol Violation|0|||
16079336|NCT02296424|38782816|FG000|Part 1|Withdrawal by Subject|0|||
16079337|NCT02296424|38782817|FG001|Part 1|Withdrawal by Subject|2|||
16079338|NCT02296424|38782818|FG002|Part 1|Withdrawal by Subject|0|||
16079339|NCT02296424|38782819|FG003|Part 1|Withdrawal by Subject|0|||
16079340|NCT02296424|38782816|FG000|Part 1|Study terminated by sponsor|0|||
16079341|NCT02296424|38782817|FG001|Part 1|Study terminated by sponsor|1|||
16079342|NCT02296424|38782818|FG002|Part 1|Study terminated by sponsor|0|||
16079343|NCT02296424|38782819|FG003|Part 1|Study terminated by sponsor|0|||
16079344|NCT02296424|38782816|FG000|Part 1|Adverse Event|2|||
16079345|NCT02296424|38782817|FG001|Part 1|Adverse Event|11|||
16079346|NCT02296424|38782818|FG002|Part 1|Adverse Event|0|||
16079347|NCT02296424|38782819|FG003|Part 1|Adverse Event|0|||
16079348|NCT02296424|38782816|FG000|Part 1|Lack of Efficacy|5|||
16079349|NCT02296424|38782817|FG001|Part 1|Lack of Efficacy|17|||
16079350|NCT02296424|38782818|FG002|Part 1|Lack of Efficacy|0|||
16079351|NCT02296424|38782819|FG003|Part 1|Lack of Efficacy|0|||
16079352|NCT02296424|38782816|FG000|Part 1|16 directly started part II|16|||
16079353|NCT02296424|38782817|FG001|Part 1|16 directly started part II|0|||
16079354|NCT02296424|38782818|FG002|Part 1|16 directly started part II|0|||
16079355|NCT02296424|38782819|FG003|Part 1|16 directly started part II|0|||
16079356|NCT02296424|38782816|FG000|Part 2|Lack of Efficacy|0|||
16079357|NCT02296424|38782817|FG001|Part 2|Lack of Efficacy|0|||
16079358|NCT02296424|38782818|FG002|Part 2|Lack of Efficacy|1|||
16079359|NCT02296424|38782819|FG003|Part 2|Lack of Efficacy|0|||
16079360|NCT02296424|38782816|FG000|Part 2|Adverse Event|0|||
16079361|NCT02296424|38782817|FG001|Part 2|Adverse Event|0|||
16079362|NCT02296424|38782818|FG002|Part 2|Adverse Event|1|||
16079363|NCT02296424|38782819|FG003|Part 2|Adverse Event|0|||
16079364|NCT02296424|38782816|FG000|Part 2|Lost to Follow-up|0|||
16079365|NCT02296424|38782817|FG001|Part 2|Lost to Follow-up|0|||
16079366|NCT02296424|38782818|FG002|Part 2|Lost to Follow-up|1|||
16079367|NCT02296424|38782819|FG003|Part 2|Lost to Follow-up|0|||
16079368|NCT03981822|38782824|FG000|Overall Study|Lost to Follow-up|0|||
16079369|NCT03981822|38782825|FG001|Overall Study|Lost to Follow-up|1|||
16079370|NCT03981822|38782826|FG002|Overall Study|Lost to Follow-up|1|||
16079371|NCT03981822|38782827|FG003|Overall Study|Lost to Follow-up|0|||
16079372|NCT03981822|38782828|FG004|Overall Study|Lost to Follow-up|6|||
16079373|NCT03981822|38782829|FG005|Overall Study|Lost to Follow-up|4|||
16079374|NCT03981822|38782830|FG006|Overall Study|Lost to Follow-up|4|||
16079375|NCT03981822|38782831|FG007|Overall Study|Lost to Follow-up|2|||
16079376|NCT03981822|38782824|FG000|Overall Study|Withdrawal by Subject|0|||
16079377|NCT03981822|38782825|FG001|Overall Study|Withdrawal by Subject|1|||
16079378|NCT03981822|38782826|FG002|Overall Study|Withdrawal by Subject|0|||
16079379|NCT03981822|38782827|FG003|Overall Study|Withdrawal by Subject|0|||
16079380|NCT03981822|38782828|FG004|Overall Study|Withdrawal by Subject|0|||
16079381|NCT03981822|38782829|FG005|Overall Study|Withdrawal by Subject|1|||
16079382|NCT03981822|38782830|FG006|Overall Study|Withdrawal by Subject|0|||
16079383|NCT03981822|38782831|FG007|Overall Study|Withdrawal by Subject|2|||
16079384|NCT03981822|38782824|FG000|Overall Study|COVID-19 Related|0|||
16079385|NCT03981822|38782825|FG001|Overall Study|COVID-19 Related|0|||
16079386|NCT03981822|38782826|FG002|Overall Study|COVID-19 Related|0|||
16079387|NCT03981822|38782827|FG003|Overall Study|COVID-19 Related|0|||
16079388|NCT03981822|38782828|FG004|Overall Study|COVID-19 Related|2|||
16079389|NCT03981822|38782829|FG005|Overall Study|COVID-19 Related|1|||
16079390|NCT03981822|38782830|FG006|Overall Study|COVID-19 Related|2|||
16079391|NCT03981822|38782831|FG007|Overall Study|COVID-19 Related|1|||
16079392|NCT02807493|38782832|FG000|Overall Study|Adverse Event|5|||
16079393|NCT02807493|38782833|FG001|Overall Study|Adverse Event|2|||
16079394|NCT02807493|38782832|FG000|Overall Study|Lost to Follow-up|6|||
16079395|NCT02807493|38782833|FG001|Overall Study|Lost to Follow-up|0|||
16079396|NCT02807493|38782832|FG000|Overall Study|Physician Decision|4|||
16079397|NCT02807493|38782833|FG001|Overall Study|Physician Decision|1|||
16079398|NCT02807493|38782832|FG000|Overall Study|Protocol Violation|7|||
16079399|NCT02807493|38782833|FG001|Overall Study|Protocol Violation|0|||
16079400|NCT02807493|38782832|FG000|Overall Study|Withdrawal by Subject|17|||
16079401|NCT02807493|38782833|FG001|Overall Study|Withdrawal by Subject|10|||
16079402|NCT02807493|38782832|FG000|Overall Study|Other withdrawal|17|||
16079403|NCT02807493|38782833|FG001|Overall Study|Other withdrawal|0|||
16079404|NCT02807493|38782832|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
16079405|NCT02807493|38782833|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
16079406|NCT01266122|38782834|FG000|Overall Study|Lost to Follow-up|6|||
16079407|NCT01266122|38782835|FG001|Overall Study|Lost to Follow-up|6|||
16079408|NCT01136876|38782836|FG000|Overall Study|Lost to Follow-up|0|||
16079409|NCT01136876|38782837|FG001|Overall Study|Lost to Follow-up|1|||
16079410|NCT01136876|38782836|FG000|Overall Study|Physician Decision|3|||
16079411|NCT01136876|38782837|FG001|Overall Study|Physician Decision|5|||
16079412|NCT01136876|38782836|FG000|Overall Study|Missing NGAL measurement|2|||
16079413|NCT01136876|38782837|FG001|Overall Study|Missing NGAL measurement|5|||
16079414|NCT00065260|38782840|FG000|Overall Study|Death|0|||
16079415|NCT00065260|38782841|FG001|Overall Study|Death|1|||
16079416|NCT03262935|38782842|FG000|Overall Study|Withdrawal by Subject|6|||
16079417|NCT03262935|38782843|FG001|Overall Study|Withdrawal by Subject|7|||
16079418|NCT03262935|38782842|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
16079419|NCT03262935|38782843|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
16079420|NCT03262935|38782842|FG000|Overall Study|Death|181|||
16079421|NCT03262935|38782843|FG001|Overall Study|Death|94|||
16079422|NCT03262935|38782842|FG000|Overall Study|Lost to Follow-up|9|||
16079423|NCT03262935|38782843|FG001|Overall Study|Lost to Follow-up|4|||
16079424|NCT03262935|38782842|FG000|Overall Study|Other reason|5|||
16079425|NCT03262935|38782843|FG001|Overall Study|Other reason|0|||
16079426|NCT03101930|38782844|FG000|Overall Study|Withdrawal by Subject|2|||
16079427|NCT03101930|38782845|FG001|Overall Study|Withdrawal by Subject|1|||
16079428|NCT03101930|38782846|FG002|Overall Study|Withdrawal by Subject|2|||
16079429|NCT01084707|38786565|FG000|Overall Study|Withdrawal by Subject|6|||
16079430|NCT01534494|38786571|FG000|Overall Study|Withdrawal by Subject|1|||
16079431|NCT01308567|38786572|FG000|Overall Study|Lost to Follow-up|2|||
16079432|NCT01308567|38786573|FG001|Overall Study|Lost to Follow-up|4|||
16079433|NCT01308567|38786574|FG002|Overall Study|Lost to Follow-up|4|||
16079434|NCT00232180|38786575|FG000|Double-blind (DB) Phase|Death|186|||
16079435|NCT00232180|38786576|FG001|Double-blind (DB) Phase|Death|222|||
16079436|NCT00232180|38786577|FG002|Double-blind (DB) Phase|Death|0|||
16079437|NCT00232180|38786575|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
16079438|NCT00232180|38786576|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
16079439|NCT00232180|38786577|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
16079440|NCT00232180|38786575|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
16477697|NCT00191906|40228261|FG000|Study Period II|Withdrawal by Subject|0|||
16079441|NCT00232180|38786576|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
16079442|NCT00232180|38786577|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
16079443|NCT00232180|38786575|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
16079444|NCT00232180|38786576|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
16079445|NCT00232180|38786577|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
16079446|NCT00232180|38786575|FG000|Double-blind (DB) Phase|Adverse Event|83|||
16079447|NCT00232180|38786576|FG001|Double-blind (DB) Phase|Adverse Event|100|||
16079448|NCT00232180|38786577|FG002|Double-blind (DB) Phase|Adverse Event|0|||
16079449|NCT00232180|38786575|FG000|Double-blind (DB) Phase|Other|70|||
16079450|NCT00232180|38786576|FG001|Double-blind (DB) Phase|Other|75|||
16079451|NCT00232180|38786577|FG002|Double-blind (DB) Phase|Other|0|||
16079452|NCT00232180|38786575|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
16079453|NCT00232180|38786576|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
16079454|NCT00232180|38786577|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
16079455|NCT00232180|38786575|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
16079456|NCT00232180|38786576|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
16079457|NCT00232180|38786577|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
16079458|NCT00232180|38786575|FG000|Open Label Phase|Death|0|||
16079459|NCT00232180|38786576|FG001|Open Label Phase|Death|0|||
16079460|NCT00232180|38786577|FG002|Open Label Phase|Death|48|||
16079461|NCT00232180|38786575|FG000|Open Label Phase|Lost to Follow-up|0|||
16079462|NCT00232180|38786576|FG001|Open Label Phase|Lost to Follow-up|0|||
16079463|NCT00232180|38786577|FG002|Open Label Phase|Lost to Follow-up|5|||
16079464|NCT00232180|38786575|FG000|Open Label Phase|Protocol Violation|0|||
16079465|NCT00232180|38786576|FG001|Open Label Phase|Protocol Violation|0|||
16079466|NCT00232180|38786577|FG002|Open Label Phase|Protocol Violation|3|||
16079467|NCT00232180|38786575|FG000|Open Label Phase|Study terminated by sponsor|0|||
16079468|NCT00232180|38786576|FG001|Open Label Phase|Study terminated by sponsor|0|||
16079469|NCT00232180|38786577|FG002|Open Label Phase|Study terminated by sponsor|3|||
16079470|NCT00232180|38786575|FG000|Open Label Phase|Withdrawal by Subject|0|||
16079471|NCT00232180|38786576|FG001|Open Label Phase|Withdrawal by Subject|0|||
16079472|NCT00232180|38786577|FG002|Open Label Phase|Withdrawal by Subject|37|||
16079473|NCT00232180|38786575|FG000|Open Label Phase|Other|0|||
16079474|NCT00232180|38786576|FG001|Open Label Phase|Other|0|||
16079475|NCT00232180|38786577|FG002|Open Label Phase|Other|16|||
16079476|NCT00232180|38786575|FG000|Open Label Phase|Adverse Event|0|||
16079477|NCT00232180|38786576|FG001|Open Label Phase|Adverse Event|0|||
16079478|NCT00232180|38786577|FG002|Open Label Phase|Adverse Event|25|||
16079479|NCT00232180|38786575|FG000|Open Label Phase|Laboratory abnormality|0|||
16079480|NCT00232180|38786576|FG001|Open Label Phase|Laboratory abnormality|0|||
16079481|NCT00232180|38786577|FG002|Open Label Phase|Laboratory abnormality|10|||
16079482|NCT00232180|38786575|FG000|Open Label Phase|Randomized but not treated|0|||
16079483|NCT00232180|38786576|FG001|Open Label Phase|Randomized but not treated|0|||
16079484|NCT00232180|38786577|FG002|Open Label Phase|Randomized but not treated|1|||
16079485|NCT02422615|38786579|FG000|Treatment Period|Progressive disease|314|||
16079486|NCT02422615|38786580|FG001|Treatment Period|Progressive disease|200|||
16079487|NCT02422615|38786579|FG000|Treatment Period|Adverse Event|51|||
16079488|NCT02422615|38786580|FG001|Treatment Period|Adverse Event|9|||
16079489|NCT02422615|38786579|FG000|Treatment Period|Physician Decision|32|||
16079490|NCT02422615|38786580|FG001|Treatment Period|Physician Decision|8|||
16079491|NCT02422615|38786579|FG000|Treatment Period|Subject/guardian decision|38|||
16079492|NCT02422615|38786580|FG001|Treatment Period|Subject/guardian decision|8|||
16079493|NCT02422615|38786579|FG000|Treatment Period|Death|2|||
16079494|NCT02422615|38786580|FG001|Treatment Period|Death|1|||
16079495|NCT02422615|38786579|FG000|Treatment Period|Technical problems|0|||
16079496|NCT02422615|38786580|FG001|Treatment Period|Technical problems|1|||
16079497|NCT02422615|38786579|FG000|Treatment Period|Protocol deviation|1|||
16079498|NCT02422615|38786580|FG001|Treatment Period|Protocol deviation|1|||
16079499|NCT02422615|38786579|FG000|Treatment Period|Study terminated as per protocol|46|||
16079500|NCT02422615|38786580|FG001|Treatment Period|Study terminated as per protocol|14|||
16079501|NCT02422615|38786579|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
16079502|NCT02422615|38786580|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
16079503|NCT02422615|38786579|FG000|Post-treatment Efficacy Follow-up|Death|2|||
16079504|NCT02422615|38786580|FG001|Post-treatment Efficacy Follow-up|Death|1|||
16079505|NCT02422615|38786579|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
16079506|NCT02422615|38786580|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
16079507|NCT02422615|38786579|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
16079508|NCT02422615|38786580|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
16079509|NCT02422615|38786579|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
16079510|NCT02422615|38786580|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
16079511|NCT02422615|38786579|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
16079512|NCT02422615|38786580|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
16079513|NCT01613716|38786581|FG000|Overall Study|screen failures|3|||
16079514|NCT01613716|38786581|FG000|Overall Study|Lost to Follow-up|4|||
16079515|NCT00439569|38786582|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
16079516|NCT00439569|38786582|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
16079517|NCT00439569|38786582|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
16079518|NCT02538107|38786587|FG000|Overall Study|Did not receive any Mircera dose|11|||
16079519|NCT02538107|38786587|FG000|Overall Study|Missing|5|||
16079520|NCT02538107|38786587|FG000|Overall Study|Necessity of dialysis|20|||
16079521|NCT02538107|38786587|FG000|Overall Study|Administration of other ESA|11|||
16079522|NCT02538107|38786587|FG000|Overall Study|No further treatment necessary|18|||
16079523|NCT02538107|38786587|FG000|Overall Study|Withdrawal by Subject|17|||
16079524|NCT02538107|38786587|FG000|Overall Study|Death|4|||
16079525|NCT02538107|38786587|FG000|Overall Study|Administrative reason|5|||
16079526|NCT02538107|38786587|FG000|Overall Study|Adverse Event|4|||
16079527|NCT02538107|38786587|FG000|Overall Study|Surgery|1|||
16079528|NCT02538107|38786587|FG000|Overall Study|Other|7|||
16079529|NCT02538107|38786587|FG000|Overall Study|Not recorded|7|||
16079530|NCT02200770|38786588|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
16079531|NCT02200770|38786589|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
16079532|NCT02200770|38786588|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
16079533|NCT02200770|38786589|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
16079534|NCT02200770|38786588|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
16079535|NCT02200770|38786589|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
16079536|NCT02200770|38786588|FG000|Randomized-controlled Period (RCP)|Other|1|||
16079537|NCT02200770|38786589|FG001|Randomized-controlled Period (RCP)|Other|2|||
16079538|NCT02200770|38786588|FG000|Open-label Period (OLP)|Adverse Event|1|||
16079539|NCT02200770|38786589|FG001|Open-label Period (OLP)|Adverse Event|2|||
16079540|NCT02200770|38786588|FG000|Open-label Period (OLP)|Death|1|||
16079541|NCT02200770|38786589|FG001|Open-label Period (OLP)|Death|2|||
16079542|NCT02200770|38786588|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
16079543|NCT02200770|38786589|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
16079544|NCT02200770|38786588|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
16079545|NCT02200770|38786589|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
16079546|NCT02200770|38786588|FG000|Open-label Period (OLP)|Other|6|||
16079547|NCT02200770|38786589|FG001|Open-label Period (OLP)|Other|15|||
16079548|NCT03762668|38786590|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
16079549|NCT03762668|38786591|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
16079550|NCT01017146|38786593|FG000|Overall Study|Adverse Event|11|||
16079551|NCT01017146|38786594|FG001|Overall Study|Adverse Event|1|||
16079552|NCT01017146|38786593|FG000|Overall Study|Lost to Follow-up|14|||
16079553|NCT01017146|38786594|FG001|Overall Study|Lost to Follow-up|14|||
16079554|NCT01017146|38786593|FG000|Overall Study|Noncompliance with Study Product|1|||
16079555|NCT01017146|38786594|FG001|Overall Study|Noncompliance with Study Product|1|||
16079556|NCT01017146|38786593|FG000|Overall Study|Withdrawal by Subject|32|||
16079557|NCT01017146|38786594|FG001|Overall Study|Withdrawal by Subject|16|||
16079558|NCT01017146|38786593|FG000|Overall Study|Relocation|0|||
16079559|NCT01017146|38786594|FG001|Overall Study|Relocation|4|||
16079560|NCT01017146|38786593|FG000|Overall Study|Pregnancy|2|||
16079561|NCT01017146|38786594|FG001|Overall Study|Pregnancy|1|||
16079562|NCT01017146|38786593|FG000|Overall Study|Protocol Violation|2|||
16079563|NCT01017146|38786594|FG001|Overall Study|Protocol Violation|0|||
16079564|NCT01017146|38786593|FG000|Overall Study|Took Excluded Medication|2|||
16079565|NCT01017146|38786594|FG001|Overall Study|Took Excluded Medication|0|||
16079566|NCT01017146|38786593|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
16079567|NCT01017146|38786594|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
16079568|NCT01017146|38786593|FG000|Overall Study|Change in Work Situation|1|||
16079569|NCT01017146|38786594|FG001|Overall Study|Change in Work Situation|0|||
16079570|NCT00978042|38786595|FG000|Initial Treatment Period|Treated in Error|0|||
16079571|NCT00978042|38786596|FG001|Initial Treatment Period|Treated in Error|3|||
16079572|NCT00978042|38786595|FG000|Initial Treatment Period|Ineligibility|1|||
16079573|NCT00978042|38786596|FG001|Initial Treatment Period|Ineligibility|0|||
16079574|NCT00978042|38786595|FG000|Initial Treatment Period|Lost to Follow-up|21|||
16079575|NCT00978042|38786596|FG001|Initial Treatment Period|Lost to Follow-up|3|||
16079576|NCT00978042|38786595|FG000|Initial Treatment Period|Adverse Event|2|||
16278920|NCT00271024|39504140|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
16079577|NCT00978042|38786596|FG001|Initial Treatment Period|Adverse Event|0|||
16079578|NCT00978042|38786595|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
16278921|NCT00271024|39504141|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
16079579|NCT00978042|38786596|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
16079580|NCT00978042|38786595|FG000|Initial Treatment Period|Consent withdrawn|22|||
16079581|NCT00978042|38786596|FG001|Initial Treatment Period|Consent withdrawn|9|||
16079582|NCT00978042|38786595|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
16079583|NCT00978042|38786596|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
16079584|NCT01747486|38786598|FG000|Stage 1|Physician Decision|3|||
16079585|NCT01747486|38786599|FG001|Stage 1|Physician Decision|0|||
16079586|NCT01747486|38786598|FG000|Stage 1|Withdrawal by Subject|4|||
16079587|NCT01747486|38786599|FG001|Stage 1|Withdrawal by Subject|3|||
16079588|NCT01747486|38786598|FG000|Stage 1|Disease progression|4|||
16079589|NCT01747486|38786599|FG001|Stage 1|Disease progression|9|||
16079590|NCT01747486|38786598|FG000|Stage 1|Death|1|||
16079591|NCT01747486|38786599|FG001|Stage 1|Death|1|||
16079592|NCT01747486|38786598|FG000|Stage 2|Physician Decision|2|||
16079593|NCT01747486|38786599|FG001|Stage 2|Physician Decision|0|||
16079594|NCT01747486|38786598|FG000|Stage 2|Withdrawal by Subject|1|||
16079595|NCT01747486|38786599|FG001|Stage 2|Withdrawal by Subject|0|||
16079596|NCT01747486|38786598|FG000|Stage 2|New Cancer Therapy|3|||
16079597|NCT01747486|38786599|FG001|Stage 2|New Cancer Therapy|0|||
16079598|NCT01747486|38786598|FG000|Stage 2|Disease Progression|3|||
16079599|NCT01747486|38786599|FG001|Stage 2|Disease Progression|0|||
16079600|NCT03950622|38786600|FG000|Overall Study|Withdrawal by Subject|1|||
16079601|NCT03950622|38786601|FG001|Overall Study|Withdrawal by Subject|0|||
16079602|NCT03950622|38786600|FG000|Overall Study|Protocol Deviation|0|||
16079603|NCT03950622|38786601|FG001|Overall Study|Protocol Deviation|1|||
16079604|NCT03950622|38786600|FG000|Overall Study|Physician Decision|1|||
16079605|NCT03950622|38786601|FG001|Overall Study|Physician Decision|0|||
16079606|NCT03950622|38786600|FG000|Overall Study|Lost to Follow-up|5|||
16079607|NCT03950622|38786601|FG001|Overall Study|Lost to Follow-up|5|||
16079608|NCT03950622|38786600|FG000|Overall Study|Death|1|||
16079609|NCT03950622|38786601|FG001|Overall Study|Death|1|||
16079610|NCT00505934|38786602|FG000|Overall Study|Adverse Event|1|||
16079611|NCT00505934|38786602|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
16079612|NCT00505934|38786602|FG000|Overall Study|Other: IV dose needed to be changed|1|||
16079613|NCT01811706|38786603|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
16079614|NCT01811706|38786604|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
16079615|NCT02748317|38786606|FG000|Overall Study|Withdrawal by Subject|14|||
16079616|NCT02748317|38786606|FG000|Overall Study|Lost to Follow-up|8|||
16079617|NCT02748317|38786606|FG000|Overall Study|Death|1|||
16079618|NCT00111813|38786607|FG000|Overall Study|Adverse Event|1|||
16079619|NCT00111813|38786608|FG001|Overall Study|Adverse Event|2|||
16079620|NCT00111813|38786609|FG002|Overall Study|Adverse Event|4|||
16079621|NCT00111813|38786610|FG003|Overall Study|Adverse Event|2|||
16079622|NCT00111813|38786611|FG004|Overall Study|Adverse Event|2|||
16079623|NCT00111813|38786612|FG005|Overall Study|Adverse Event|2|||
16079624|NCT00111813|38786607|FG000|Overall Study|Progressive disease|2|||
16079625|NCT00111813|38786608|FG001|Overall Study|Progressive disease|1|||
16079626|NCT00111813|38786609|FG002|Overall Study|Progressive disease|5|||
16079627|NCT00111813|38786610|FG003|Overall Study|Progressive disease|3|||
16079628|NCT00111813|38786611|FG004|Overall Study|Progressive disease|4|||
16079629|NCT00111813|38786612|FG005|Overall Study|Progressive disease|3|||
16079630|NCT00111813|38786607|FG000|Overall Study|Lack of Efficacy|0|||
16079631|NCT00111813|38786608|FG001|Overall Study|Lack of Efficacy|0|||
16079632|NCT00111813|38786609|FG002|Overall Study|Lack of Efficacy|0|||
16079633|NCT00111813|38786610|FG003|Overall Study|Lack of Efficacy|0|||
16079634|NCT00111813|38786611|FG004|Overall Study|Lack of Efficacy|0|||
16079635|NCT00111813|38786612|FG005|Overall Study|Lack of Efficacy|1|||
16079636|NCT00111813|38786607|FG000|Overall Study|Other|0|||
16079637|NCT00111813|38786608|FG001|Overall Study|Other|0|||
16079638|NCT00111813|38786609|FG002|Overall Study|Other|1|||
16079639|NCT00111813|38786610|FG003|Overall Study|Other|0|||
16079640|NCT00111813|38786611|FG004|Overall Study|Other|0|||
16079641|NCT00111813|38786612|FG005|Overall Study|Other|0|||
16079642|NCT02374307|38786613|FG000|3-months Follow-up|Lost to Follow-up|1|||
16079643|NCT02374307|38786614|FG001|3-months Follow-up|Lost to Follow-up|2|||
16079644|NCT02374307|38786613|FG000|3-months Follow-up|Withdrawal by Subject|1|||
16079645|NCT02374307|38786614|FG001|3-months Follow-up|Withdrawal by Subject|4|||
16079646|NCT02374307|38786613|FG000|3-months Follow-up|Death|1|||
16079647|NCT02374307|38786614|FG001|3-months Follow-up|Death|2|||
16079648|NCT02374307|38786613|FG000|3-months Follow-up|Missed first follow-up|5|||
16079649|NCT02374307|38786614|FG001|3-months Follow-up|Missed first follow-up|1|||
16079650|NCT02374307|38786613|FG000|6-months Follow-up|Lost to Follow-up|1|||
16278922|NCT00271024|39504138|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
16079651|NCT02374307|38786614|FG001|6-months Follow-up|Lost to Follow-up|2|||
16079652|NCT02374307|38786613|FG000|6-months Follow-up|Death|2|||
16079653|NCT02374307|38786614|FG001|6-months Follow-up|Death|1|||
16079654|NCT02374307|38786613|FG000|6-months Follow-up|Withdrawal by Subject|0|||
16079655|NCT02374307|38786614|FG001|6-months Follow-up|Withdrawal by Subject|3|||
16079656|NCT01264679|38786615|FG000|Overall Study|Participation in Another Clinical Trial|1|||
16079657|NCT01264679|38786615|FG000|Overall Study|Physician Decision|1|||
16079658|NCT01264679|38786615|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
16079659|NCT01264679|38786615|FG000|Overall Study|Withdrawal by Subject|1|||
16079660|NCT00493649|38786628|FG000|Overall Study|Adverse Event|44|||
16079661|NCT00493649|38786628|FG000|Overall Study|Patient Request|21|||
16079662|NCT00493649|38786628|FG000|Overall Study|Investigator Request|2|||
16079663|NCT00493649|38786628|FG000|Overall Study|Disease Progression|1|||
16079664|NCT00493649|38786628|FG000|Overall Study|Lost to Follow-up|1|||
16079665|NCT00493649|38786628|FG000|Overall Study|Other|13|||
16079666|NCT03771352|38786635|FG000|Overall Study|Screen failure|2|||
16079667|NCT03771352|38786635|FG000|Overall Study|Withdrawal by Subject|2|||
16079668|NCT00714714|38786636|FG000|Overall Study|Adverse Event|1|||
16079669|NCT04452318|38786643|FG000|Overall Study|Physician Decision|1|||
16079670|NCT04452318|38786644|FG001|Overall Study|Physician Decision|2|||
16079671|NCT04452318|38786645|FG002|Overall Study|Physician Decision|0|||
16079672|NCT04452318|38786646|FG003|Overall Study|Physician Decision|2|||
16079673|NCT04452318|38786647|FG004|Overall Study|Physician Decision|0|||
16079674|NCT04452318|38786648|FG005|Overall Study|Physician Decision|2|||
16079675|NCT04452318|38786649|FG006|Overall Study|Physician Decision|5|||
16079676|NCT04452318|38786643|FG000|Overall Study|Death|2|||
16079677|NCT04452318|38786644|FG001|Overall Study|Death|3|||
16079678|NCT04452318|38786645|FG002|Overall Study|Death|0|||
16278923|NCT00271024|39504139|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
16278924|NCT00271024|39504140|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
16278925|NCT00271024|39504141|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
16278926|NCT02488109|39504142|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
16278927|NCT02488109|39504143|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
16278928|NCT02488109|39504142|FG000|12-month Follow-Up|Lost to Follow-up|4|||
16278929|NCT02488109|39504143|FG001|12-month Follow-Up|Lost to Follow-up|7|||
16278930|NCT00109850|39504147|FG000|Overall Study|Adverse Event|1|||
16278931|NCT00109850|39504147|FG000|Overall Study|Death|2|||
16278932|NCT00109850|39504147|FG000|Overall Study|Ineligible|1|||
16278933|NCT01439724|39504148|FG000|Overall Study|missing consultation|9|||
16278934|NCT01439724|39504149|FG001|Overall Study|missing consultation|8|||
16079679|NCT04452318|38786646|FG003|Overall Study|Death|0|||
16079680|NCT04452318|38786647|FG004|Overall Study|Death|0|||
16079681|NCT04452318|38786648|FG005|Overall Study|Death|0|||
16079682|NCT04452318|38786649|FG006|Overall Study|Death|0|||
16079683|NCT04452318|38786643|FG000|Overall Study|Lost to Follow-up|38|||
16079684|NCT04452318|38786644|FG001|Overall Study|Lost to Follow-up|28|||
16079685|NCT04452318|38786645|FG002|Overall Study|Lost to Follow-up|0|||
16079686|NCT04452318|38786646|FG003|Overall Study|Lost to Follow-up|3|||
16079687|NCT04452318|38786647|FG004|Overall Study|Lost to Follow-up|3|||
16079688|NCT04452318|38786648|FG005|Overall Study|Lost to Follow-up|2|||
16079689|NCT04452318|38786649|FG006|Overall Study|Lost to Follow-up|1|||
16079690|NCT04452318|38786643|FG000|Overall Study|Withdrawal by Subject|46|||
16079691|NCT04452318|38786644|FG001|Overall Study|Withdrawal by Subject|40|||
16079692|NCT04452318|38786645|FG002|Overall Study|Withdrawal by Subject|0|||
16079693|NCT04452318|38786646|FG003|Overall Study|Withdrawal by Subject|18|||
16079694|NCT04452318|38786647|FG004|Overall Study|Withdrawal by Subject|6|||
16079695|NCT04452318|38786648|FG005|Overall Study|Withdrawal by Subject|8|||
16079696|NCT04452318|38786649|FG006|Overall Study|Withdrawal by Subject|6|||
16079697|NCT03803475|38786651|FG000|Overall Study|Physician Decision|1|||
16079698|NCT00968149|38786652|FG000|Overall Study|Adverse Event|5|||
16079699|NCT00968149|38786653|FG001|Overall Study|Adverse Event|1|||
16079700|NCT00968149|38786652|FG000|Overall Study|Lack of Efficacy|0|||
16079701|NCT00968149|38786653|FG001|Overall Study|Lack of Efficacy|4|||
16079702|NCT00968149|38786652|FG000|Overall Study|Lost to Follow-up|0|||
16079703|NCT00968149|38786653|FG001|Overall Study|Lost to Follow-up|1|||
16079704|NCT00968149|38786652|FG000|Overall Study|Protocol Violation|4|||
16079705|NCT00968149|38786653|FG001|Overall Study|Protocol Violation|0|||
16079706|NCT00968149|38786652|FG000|Overall Study|Withdrawal by Subject|2|||
16079707|NCT00968149|38786653|FG001|Overall Study|Withdrawal by Subject|0|||
16079708|NCT02115139|38786654|FG000|Overall Study|Protocol Violation|1|||
16079709|NCT02115139|38786654|FG000|Overall Study|treatment discontinuation|6|||
16079710|NCT02960893|38786657|FG000|Randomization Phase (8-week)|Adverse Event|5|||
16079711|NCT02960893|38786658|FG001|Randomization Phase (8-week)|Adverse Event|0|||
16278935|NCT01719562|39504152|FG000|Overall Study|Lost to Follow-up|1|||
16278936|NCT01719562|39504153|FG001|Overall Study|Lost to Follow-up|0|||
16079712|NCT02960893|38786657|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
16079713|NCT02960893|38786658|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
16079714|NCT02960893|38786657|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
16079715|NCT02960893|38786658|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
16079716|NCT02960893|38786657|FG000|Extension Phase (48-week)|Adverse Event|2|||
16079717|NCT02960893|38786658|FG001|Extension Phase (48-week)|Adverse Event|3|||
16079718|NCT02960893|38786657|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
16079719|NCT02960893|38786658|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
16079720|NCT02960893|38786657|FG000|Extension Phase (48-week)|Other Reason|2|||
16079721|NCT02960893|38786658|FG001|Extension Phase (48-week)|Other Reason|1|||
16079722|NCT02960893|38786657|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
16278937|NCT01719562|39504152|FG000|Overall Study|Death|1|||
16278938|NCT01719562|39504153|FG001|Overall Study|Death|0|||
16278939|NCT01719562|39504152|FG000|Overall Study|New cancer diagnosis|1|||
16278940|NCT01719562|39504153|FG001|Overall Study|New cancer diagnosis|0|||
16278941|NCT01398787|39504156|FG000|Overall Study|Adverse Event|1|||
16278942|NCT01863433|39504161|FG000|Overall Study|Protocol Violation|1|||
16278943|NCT01911429|39504162|FG000|Overall Study|Adverse Event|5|||
16278944|NCT01911429|39504163|FG001|Overall Study|Adverse Event|3|||
16278945|NCT01911429|39504164|FG002|Overall Study|Adverse Event|9|||
16278946|NCT01911429|39504162|FG000|Overall Study|Lack of Efficacy|1|||
16278947|NCT01911429|39504163|FG001|Overall Study|Lack of Efficacy|2|||
16278948|NCT01911429|39504164|FG002|Overall Study|Lack of Efficacy|4|||
16278949|NCT01911429|39504162|FG000|Overall Study|Lost to Follow-up|0|||
16278950|NCT01911429|39504163|FG001|Overall Study|Lost to Follow-up|0|||
16278951|NCT01911429|39504164|FG002|Overall Study|Lost to Follow-up|1|||
16278952|NCT01911429|39504162|FG000|Overall Study|Protocol Violation|0|||
16079723|NCT02960893|38786658|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
16079724|NCT02960893|38786657|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
16079725|NCT02960893|38786658|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
16079726|NCT02396316|38786659|FG000|Overall Study|Physician Decision|1|||
16079727|NCT02396316|38786660|FG001|Overall Study|Physician Decision|0|||
16079728|NCT02396316|38786659|FG000|Overall Study|Progressive disease|6|||
16079729|NCT02396316|38786660|FG001|Overall Study|Progressive disease|3|||
16079730|NCT02396316|38786659|FG000|Overall Study|Protocol Violation|0|||
16079731|NCT02396316|38786660|FG001|Overall Study|Protocol Violation|1|||
16079732|NCT02396316|38786659|FG000|Overall Study|Treatment unblinded|0|||
16079733|NCT02396316|38786660|FG001|Overall Study|Treatment unblinded|1|||
16079734|NCT01127373|38786661|FG000|Overall Study|Not Treated|3|||
16079735|NCT01127373|38786661|FG000|Overall Study|Lost to Follow-up|7|||
16079736|NCT01127373|38786661|FG000|Overall Study|Withdrawal by Subject|1|||
16079737|NCT01127373|38786661|FG000|Overall Study|Disease progression|1|||
16079738|NCT01839331|38786662|FG000|Overall Study|Early Termination|3|||
16079739|NCT01839331|38786663|FG001|Overall Study|Early Termination|0|||
16079740|NCT01839331|38786664|FG002|Overall Study|Early Termination|1|||
16079741|NCT01839331|38786665|FG003|Overall Study|Early Termination|2|||
16079742|NCT01839331|38786662|FG000|Overall Study|Protocol Violation|1|||
16079743|NCT01839331|38786663|FG001|Overall Study|Protocol Violation|6|||
16079744|NCT01839331|38786664|FG002|Overall Study|Protocol Violation|4|||
16079745|NCT01839331|38786665|FG003|Overall Study|Protocol Violation|3|||
16079746|NCT01953692|38786666|FG000|Overall Study|Adverse Event|5|||
16079747|NCT01953692|38786667|FG001|Overall Study|Adverse Event|2|||
16079748|NCT01953692|38786668|FG002|Overall Study|Adverse Event|4|||
16079749|NCT01953692|38786669|FG003|Overall Study|Adverse Event|2|||
16079750|NCT01953692|38786670|FG004|Overall Study|Adverse Event|1|||
16079751|NCT01953692|38786671|FG005|Overall Study|Adverse Event|2|||
16176189|NCT00924703|39122868|FG000|Overall Study|Withdrawal by Sponsor|1|||
16176190|NCT01526148|39122869|FG000|Overall Study|Adverse Event|6|||
16176191|NCT01526148|39122870|FG001|Overall Study|Adverse Event|5|||
16176192|NCT01526148|39122869|FG000|Overall Study|Lost to Follow-up|3|||
16176193|NCT01526148|39122870|FG001|Overall Study|Lost to Follow-up|6|||
16176194|NCT01526148|39122869|FG000|Overall Study|Withdrawal by Subject|2|||
16176195|NCT01526148|39122870|FG001|Overall Study|Withdrawal by Subject|0|||
16176196|NCT01526148|39122869|FG000|Overall Study|Unstable Medical Condition|1|||
16176197|NCT01526148|39122870|FG001|Overall Study|Unstable Medical Condition|0|||
16176198|NCT01526148|39122869|FG000|Overall Study|Unable to discontinue concomitant med|1|||
16176199|NCT01526148|39122870|FG001|Overall Study|Unable to discontinue concomitant med|0|||
16278953|NCT01911429|39504163|FG001|Overall Study|Protocol Violation|0|||
16278954|NCT01911429|39504164|FG002|Overall Study|Protocol Violation|1|||
16278955|NCT01911429|39504162|FG000|Overall Study|Withdrawal by Subject|5|||
16176200|NCT01526148|39122869|FG000|Overall Study|Moved out of state|1|||
16176201|NCT01526148|39122870|FG001|Overall Study|Moved out of state|0|||
16278956|NCT01911429|39504163|FG001|Overall Study|Withdrawal by Subject|5|||
16278957|NCT01911429|39504164|FG002|Overall Study|Withdrawal by Subject|4|||
16278958|NCT01911429|39504162|FG000|Overall Study|Accidental randomization|0|||
16278959|NCT01911429|39504163|FG001|Overall Study|Accidental randomization|0|||
16278960|NCT01911429|39504164|FG002|Overall Study|Accidental randomization|1|||
16079752|NCT01953692|38786672|FG006|Overall Study|Adverse Event|0|||
16079753|NCT01953692|38786673|FG007|Overall Study|Adverse Event|0|||
16079754|NCT01953692|38786674|FG008|Overall Study|Adverse Event|0|||
16079755|NCT01953692|38786666|FG000|Overall Study|Clinical Progression|0|||
16079756|NCT01953692|38786667|FG001|Overall Study|Clinical Progression|15|||
16278961|NCT01911429|39504162|FG000|Overall Study|subject left study|1|||
16278962|NCT01911429|39504163|FG001|Overall Study|subject left study|0|||
16278963|NCT01911429|39504164|FG002|Overall Study|subject left study|0|||
16278964|NCT00024258|39504166|FG000|Overall Study|Withdrawal by Subject|1|||
16176202|NCT01526148|39122869|FG000|Overall Study|Incarcerated|0|||
16176203|NCT01526148|39122870|FG001|Overall Study|Incarcerated|2|||
16176204|NCT02088034|39122872|FG000|Overall Study|Lost to Follow-up|1|||
16176205|NCT02088034|39122873|FG001|Overall Study|Lost to Follow-up|1|||
16176206|NCT02088034|39122874|FG002|Overall Study|Lost to Follow-up|0|||
16176207|NCT02088034|39122872|FG000|Overall Study|Pregnancy|2|||
16176208|NCT02088034|39122873|FG001|Overall Study|Pregnancy|1|||
16176209|NCT02088034|39122874|FG002|Overall Study|Pregnancy|2|||
16176210|NCT03180736|39122878|FG000|Overall Study|Adverse Event|3|||
16176211|NCT03180736|39122879|FG001|Overall Study|Adverse Event|4|||
16278965|NCT00024258|39504166|FG000|Overall Study|Disease Progression|8|||
16278966|NCT02148445|39504167|FG000|Overall Study|Death|1|||
16278967|NCT02148445|39504168|FG001|Overall Study|Death|3|||
16278968|NCT02751424|39504169|FG000|Part 2|Adverse Event|0|||
16278969|NCT02751424|39504170|FG001|Part 2|Adverse Event|0|||
16278970|NCT02751424|39504171|FG002|Part 2|Adverse Event|0|||
16278971|NCT02751424|39504172|FG003|Part 2|Adverse Event|0|||
16278972|NCT02751424|39504173|FG004|Part 2|Adverse Event|0|||
16278973|NCT02751424|39504174|FG005|Part 2|Adverse Event|0|||
16278974|NCT02751424|39504175|FG006|Part 2|Adverse Event|0|||
16278975|NCT02751424|39504176|FG007|Part 2|Adverse Event|5|||
16176212|NCT03180736|39122878|FG000|Overall Study|Death|10|||
16176213|NCT03180736|39122879|FG001|Overall Study|Death|7|||
16176214|NCT03180736|39122878|FG000|Overall Study|Withdrawal by Subject|5|||
16176215|NCT03180736|39122879|FG001|Overall Study|Withdrawal by Subject|12|||
16176216|NCT03180736|39122878|FG000|Overall Study|Lost to Follow-up|1|||
16176217|NCT03180736|39122879|FG001|Overall Study|Lost to Follow-up|0|||
16176218|NCT03180736|39122878|FG000|Overall Study|Lack of Efficacy|66|||
16176219|NCT03180736|39122879|FG001|Overall Study|Lack of Efficacy|87|||
16176220|NCT03180736|39122878|FG000|Overall Study|Physician Decision|4|||
16176221|NCT03180736|39122879|FG001|Overall Study|Physician Decision|7|||
16176222|NCT03180736|39122878|FG000|Overall Study|randomized but not treated|2|||
16176223|NCT03180736|39122879|FG001|Overall Study|randomized but not treated|3|||
16176224|NCT03258814|39122886|FG000|Overall Study|Early Termination|4|||
16176225|NCT03258814|39122887|FG001|Overall Study|Early Termination|3|||
16176226|NCT03258814|39122888|FG002|Overall Study|Early Termination|10|||
16176227|NCT00278629|39122891|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
16176228|NCT00476086|39122892|FG000|Overall Study|Alternative therapy|1|||
16176229|NCT00476086|39122892|FG000|Overall Study|Progressive Disease|4|||
16176230|NCT00826514|39122895|FG000|Overall Study|Adverse Event|1|||
16176231|NCT00826514|39122896|FG001|Overall Study|Adverse Event|1|||
16176232|NCT00826514|39122895|FG000|Overall Study|Lack of Efficacy|0|||
16176233|NCT00826514|39122896|FG001|Overall Study|Lack of Efficacy|1|||
16176234|NCT00826514|39122895|FG000|Overall Study|Withdrawal by Subject|2|||
16176235|NCT00826514|39122896|FG001|Overall Study|Withdrawal by Subject|3|||
16176236|NCT02658448|39122899|FG000|Overall Study|Lost to Follow-up|1|||
16176237|NCT00686127|39122906|FG000|Overall Study|Withdrawal by Subject|14|||
16176238|NCT00686127|39122907|FG001|Overall Study|Withdrawal by Subject|6|||
16176239|NCT02978222|39122908|FG000|Overall Study|Withdrawal by Subject|2|||
16176240|NCT02978222|39122909|FG001|Overall Study|Withdrawal by Subject|2|||
16176241|NCT02978222|39122908|FG000|Overall Study|Physician Decision|2|||
16176242|NCT02978222|39122909|FG001|Overall Study|Physician Decision|0|||
16176243|NCT02978222|39122908|FG000|Overall Study|Adverse Event|0|||
16278976|NCT02751424|39504177|FG008|Part 2|Adverse Event|0|||
16278977|NCT02488824|39504178|FG000|Overall Study|Adverse Event|1|||
16278978|NCT02488824|39504179|FG001|Overall Study|Adverse Event|1|||
16278979|NCT01142661|39504180|FG000|Overall Study|Adverse Event|2|||
16278980|NCT01142661|39504180|FG000|Overall Study|Withdrawal by Subject|1|||
16278981|NCT01142661|39504180|FG000|Overall Study|Physician Decision|1|||
16278982|NCT01436643|39504183|FG000|2-week Pre-treatment|Abnormal test result|0|||
16278983|NCT01436643|39504184|FG001|2-week Pre-treatment|Abnormal test result|0|||
16278984|NCT01436643|39504185|FG002|2-week Pre-treatment|Abnormal test result|0|||
16278985|NCT01436643|39504186|FG003|2-week Pre-treatment|Abnormal test result|1|||
16278986|NCT01436643|39504183|FG000|2-week Pre-treatment|Adverse Event|0|||
16278987|NCT01436643|39504184|FG001|2-week Pre-treatment|Adverse Event|0|||
16278988|NCT01436643|39504185|FG002|2-week Pre-treatment|Adverse Event|0|||
16278989|NCT01436643|39504186|FG003|2-week Pre-treatment|Adverse Event|5|||
16176244|NCT02978222|39122909|FG001|Overall Study|Adverse Event|1|||
16176245|NCT02978222|39122908|FG000|Overall Study|Death|1|||
16176246|NCT02978222|39122909|FG001|Overall Study|Death|0|||
16176247|NCT02978222|39122908|FG000|Overall Study|Disease Progression|32|||
16176248|NCT02978222|39122909|FG001|Overall Study|Disease Progression|32|||
16176249|NCT02978222|39122908|FG000|Overall Study|Early Study Termination|24|||
16176250|NCT02978222|39122909|FG001|Overall Study|Early Study Termination|21|||
16278990|NCT01436643|39504183|FG000|2-week Pre-treatment|Protocol Violation|0|||
16278991|NCT01436643|39504184|FG001|2-week Pre-treatment|Protocol Violation|0|||
16176251|NCT01009294|39122910|FG000|Overall Study|Study discontinued by Sponsor|6|||
16176252|NCT00488631|39122911|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
16176253|NCT00488631|39122912|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
16176254|NCT00488631|39122913|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
16079757|NCT01953692|38786668|FG002|Overall Study|Clinical Progression|7|||
16079758|NCT01953692|38786669|FG003|Overall Study|Clinical Progression|5|||
16079759|NCT01953692|38786670|FG004|Overall Study|Clinical Progression|0|||
16079760|NCT01953692|38786671|FG005|Overall Study|Clinical Progression|7|||
16079761|NCT01953692|38786672|FG006|Overall Study|Clinical Progression|20|||
16176255|NCT00488631|39122914|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
16176256|NCT00488631|39122915|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
16176257|NCT00488631|39122916|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
16176258|NCT00488631|39122917|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
16176259|NCT00488631|39122918|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
16176260|NCT00488631|39122919|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
16176261|NCT00488631|39122920|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
16176262|NCT00488631|39122911|FG000|Double Blind Period (Week 0-54)|Death|0|||
16176263|NCT00488631|39122912|FG001|Double Blind Period (Week 0-54)|Death|0|||
16176264|NCT00488631|39122913|FG002|Double Blind Period (Week 0-54)|Death|0|||
16176265|NCT00488631|39122914|FG003|Double Blind Period (Week 0-54)|Death|0|||
16176266|NCT00488631|39122915|FG004|Double Blind Period (Week 0-54)|Death|0|||
16176267|NCT00488631|39122916|FG005|Double Blind Period (Week 0-54)|Death|1|||
16176268|NCT00488631|39122917|FG006|Double Blind Period (Week 0-54)|Death|0|||
16176269|NCT00488631|39122918|FG007|Double Blind Period (Week 0-54)|Death|0|||
16176270|NCT00488631|39122919|FG008|Double Blind Period (Week 0-54)|Death|0|||
16176271|NCT00488631|39122920|FG009|Double Blind Period (Week 0-54)|Death|0|||
16176272|NCT00488631|39122911|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
16176273|NCT00488631|39122912|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
16176274|NCT00488631|39122913|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
16176275|NCT00488631|39122914|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
16176276|NCT00488631|39122915|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
16079762|NCT01953692|38786673|FG007|Overall Study|Clinical Progression|3|||
16079763|NCT01953692|38786674|FG008|Overall Study|Clinical Progression|3|||
16079764|NCT01953692|38786666|FG000|Overall Study|Death|5|||
16079765|NCT01953692|38786667|FG001|Overall Study|Death|0|||
16079766|NCT01953692|38786668|FG002|Overall Study|Death|2|||
16079767|NCT01953692|38786669|FG003|Overall Study|Death|2|||
16176277|NCT00488631|39122916|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
16176278|NCT00488631|39122917|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
16176279|NCT00488631|39122918|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
16176280|NCT00488631|39122919|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
16176281|NCT00488631|39122920|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
16176282|NCT00488631|39122911|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
16176283|NCT00488631|39122912|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
16176284|NCT00488631|39122913|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
16176285|NCT00488631|39122914|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
16176286|NCT00488631|39122915|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
16176287|NCT00488631|39122916|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
16176288|NCT00488631|39122917|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
16176289|NCT00488631|39122918|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
16176290|NCT00488631|39122919|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
16176291|NCT00488631|39122920|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
16176292|NCT00488631|39122911|FG000|Double Blind Period (Week 0-54)|Other|6|||
16176293|NCT00488631|39122912|FG001|Double Blind Period (Week 0-54)|Other|12|||
16176294|NCT00488631|39122913|FG002|Double Blind Period (Week 0-54)|Other|10|||
16176295|NCT00488631|39122914|FG003|Double Blind Period (Week 0-54)|Other|11|||
16176296|NCT00488631|39122915|FG004|Double Blind Period (Week 0-54)|Other|14|||
16176297|NCT00488631|39122916|FG005|Double Blind Period (Week 0-54)|Other|34|||
16176298|NCT00488631|39122917|FG006|Double Blind Period (Week 0-54)|Other|0|||
16176299|NCT00488631|39122918|FG007|Double Blind Period (Week 0-54)|Other|0|||
16176300|NCT00488631|39122919|FG008|Double Blind Period (Week 0-54)|Other|0|||
16176301|NCT00488631|39122920|FG009|Double Blind Period (Week 0-54)|Other|0|||
16176302|NCT00488631|39122911|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
16176303|NCT00488631|39122912|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
16176304|NCT00488631|39122913|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
16176305|NCT00488631|39122914|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
16176306|NCT00488631|39122915|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
16176307|NCT00488631|39122916|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
16176308|NCT00488631|39122917|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
16278992|NCT01436643|39504185|FG002|2-week Pre-treatment|Protocol Violation|0|||
16176309|NCT00488631|39122918|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
16176310|NCT00488631|39122919|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
16176311|NCT00488631|39122920|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
16176312|NCT00488631|39122911|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
16176313|NCT00488631|39122912|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
16176314|NCT00488631|39122913|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
16176315|NCT00488631|39122914|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
16176316|NCT00488631|39122915|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
16176317|NCT00488631|39122916|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
16176318|NCT00488631|39122917|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
16176319|NCT00488631|39122918|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
16176320|NCT00488631|39122919|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
16278993|NCT01436643|39504186|FG003|2-week Pre-treatment|Protocol Violation|4|||
16278994|NCT01436643|39504183|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
16278995|NCT01436643|39504184|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
16278996|NCT01436643|39504185|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
16176321|NCT00488631|39122920|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
16176322|NCT00488631|39122911|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
16176323|NCT00488631|39122912|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
16176324|NCT00488631|39122913|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
16176325|NCT00488631|39122914|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
16176326|NCT00488631|39122915|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
16176327|NCT00488631|39122916|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
16176328|NCT00488631|39122917|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
16176329|NCT00488631|39122918|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
16176330|NCT00488631|39122919|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
16176331|NCT00488631|39122920|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
16176332|NCT00488631|39122911|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
16176333|NCT00488631|39122912|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
16176334|NCT00488631|39122913|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
16176335|NCT00488631|39122914|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
16176336|NCT00488631|39122915|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
16176337|NCT00488631|39122916|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
16176338|NCT00488631|39122917|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
16176339|NCT00488631|39122918|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
16176340|NCT00488631|39122919|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
16176341|NCT00488631|39122920|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
16176342|NCT00488631|39122911|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
16176343|NCT00488631|39122912|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
16176344|NCT00488631|39122913|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
16176345|NCT00488631|39122914|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
16176346|NCT00488631|39122915|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
16176347|NCT00488631|39122916|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
16176348|NCT00488631|39122917|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
16176349|NCT00488631|39122918|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
16176350|NCT00488631|39122919|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
16176351|NCT00488631|39122920|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
16176352|NCT03926143|39122927|FG000|Overall Study|Physician Decision|3|||
16176353|NCT03926143|39122927|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
16176354|NCT03926143|39122927|FG000|Overall Study|Adverse Event|2|||
16176355|NCT03926143|39122927|FG000|Overall Study|Progressive disease|3|||
16176356|NCT03593915|39122928|FG000|Overall Study|Adverse Event|0|||
16176357|NCT03593915|39122929|FG001|Overall Study|Adverse Event|0|||
16176358|NCT03593915|39122930|FG002|Overall Study|Adverse Event|0|||
16176359|NCT03593915|39122931|FG003|Overall Study|Adverse Event|1|||
16176360|NCT03593915|39122932|FG004|Overall Study|Adverse Event|0|||
16176361|NCT03593915|39122933|FG005|Overall Study|Adverse Event|0|||
16176362|NCT03593915|39122928|FG000|Overall Study|Physician Decision|0|||
16176363|NCT03593915|39122929|FG001|Overall Study|Physician Decision|0|||
16278997|NCT01436643|39504186|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
16278998|NCT01436643|39504183|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
16278999|NCT01436643|39504184|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
16279000|NCT01436643|39504185|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
16079768|NCT01953692|38786670|FG004|Overall Study|Death|1|||
16176364|NCT03593915|39122930|FG002|Overall Study|Physician Decision|0|||
16176365|NCT03593915|39122931|FG003|Overall Study|Physician Decision|0|||
16176366|NCT03593915|39122932|FG004|Overall Study|Physician Decision|0|||
16176367|NCT03593915|39122933|FG005|Overall Study|Physician Decision|1|||
16176368|NCT00200057|39122934|FG000|Overall Study|Lack of Efficacy|3|||
16176369|NCT00200057|39122934|FG000|Overall Study|Exited due to terminal illness of PI|2|||
16176370|NCT00200057|39122934|FG000|Overall Study|Withdrawal by Subject|1|||
16176371|NCT00200057|39122934|FG000|Overall Study|Change in medical condition|1|||
16176372|NCT00200057|39122934|FG000|Overall Study|Infection|1|||
16176373|NCT00200057|39122934|FG000|Overall Study|Death|1|||
16176374|NCT00504257|39122935|FG000|Overall Study|Withdrawal by Subject|2|||
16176375|NCT00504257|39122935|FG000|Overall Study|ineligible histology|2|||
16176376|NCT01450137|39126049|FG000|Up to Week 12|Adverse Event|2|||
16176377|NCT01450137|39126050|FG001|Up to Week 12|Adverse Event|1|||
16176378|NCT01450137|39126049|FG000|Up to Week 12|Withdrawal by Subject|0|||
16176379|NCT01450137|39126050|FG001|Up to Week 12|Withdrawal by Subject|2|||
16176380|NCT01450137|39126049|FG000|Week 12 to Study End|Death|0|||
16176381|NCT01450137|39126050|FG001|Week 12 to Study End|Death|1|||
16176382|NCT01450137|39126049|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
16176383|NCT01450137|39126050|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
16176384|NCT00995371|39126053|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
16176385|NCT00995371|39126054|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
16176386|NCT01624142|39126055|FG000|Overall Study|Withdrawal by Subject|14|||
16176387|NCT01624142|39126056|FG001|Overall Study|Withdrawal by Subject|4|||
16176388|NCT01624142|39126055|FG000|Overall Study|Death|3|||
16176389|NCT01624142|39126056|FG001|Overall Study|Death|6|||
16176390|NCT01624142|39126055|FG000|Overall Study|Study Closure|12|||
16176391|NCT01624142|39126056|FG001|Overall Study|Study Closure|6|||
16176392|NCT01624142|39126055|FG000|Overall Study|Lost to Follow-up|2|||
16176393|NCT01624142|39126056|FG001|Overall Study|Lost to Follow-up|0|||
16176394|NCT01624142|39126055|FG000|Overall Study|Other|1|||
16176395|NCT01624142|39126056|FG001|Overall Study|Other|0|||
16176396|NCT01697345|39126057|FG000|Overall Study|Withdrawal by Subject|1|||
16176397|NCT00957853|39126058|FG000|Overall Study|Withdrawal by Subject|1|||
16176398|NCT00957853|39126059|FG001|Overall Study|Withdrawal by Subject|0|||
16176399|NCT00957853|39126060|FG002|Overall Study|Withdrawal by Subject|0|||
16176400|NCT00813995|39126070|FG000|Overall Study|Clinical adverse event|9|||
16176401|NCT00813995|39126071|FG001|Overall Study|Clinical adverse event|3|||
16176402|NCT00813995|39126070|FG000|Overall Study|Laboratory adverse event|0|||
16176403|NCT00813995|39126071|FG001|Overall Study|Laboratory adverse event|2|||
16176404|NCT00813995|39126070|FG000|Overall Study|Lack of Efficacy|1|||
16176405|NCT00813995|39126071|FG001|Overall Study|Lack of Efficacy|0|||
16176406|NCT00813995|39126070|FG000|Overall Study|Lost to Follow-up|4|||
16176407|NCT00813995|39126071|FG001|Overall Study|Lost to Follow-up|2|||
16176408|NCT00813995|39126070|FG000|Overall Study|Other reason|2|||
16176409|NCT00813995|39126071|FG001|Overall Study|Other reason|2|||
16176410|NCT00813995|39126070|FG000|Overall Study|Protocol Violation|3|||
16176411|NCT00813995|39126071|FG001|Overall Study|Protocol Violation|2|||
16176412|NCT00813995|39126070|FG000|Overall Study|Subject moved|4|||
16176413|NCT00813995|39126071|FG001|Overall Study|Subject moved|0|||
16176414|NCT00813995|39126070|FG000|Overall Study|Withdrawal by Subject|0|||
16176415|NCT00813995|39126071|FG001|Overall Study|Withdrawal by Subject|5|||
16176416|NCT02561156|39126072|FG000|Part 2|Adverse Event|0|||
16176417|NCT02561156|39126073|FG001|Part 2|Adverse Event|0|||
16176418|NCT02561156|39126074|FG002|Part 2|Adverse Event|0|||
16176419|NCT02561156|39126075|FG003|Part 2|Adverse Event|0|||
16176420|NCT02561156|39126076|FG004|Part 2|Adverse Event|0|||
16176421|NCT02561156|39126077|FG005|Part 2|Adverse Event|0|||
16176422|NCT02561156|39126078|FG006|Part 2|Adverse Event|0|||
16176423|NCT02561156|39126079|FG007|Part 2|Adverse Event|0|||
16176424|NCT02561156|39126080|FG008|Part 2|Adverse Event|0|||
16176425|NCT02561156|39126081|FG009|Part 2|Adverse Event|0|||
16176426|NCT02561156|39126082|FG010|Part 2|Adverse Event|0|||
16176427|NCT02561156|39126083|FG011|Part 2|Adverse Event|1|||
16176428|NCT02561156|39126084|FG012|Part 2|Adverse Event|0|||
16176429|NCT00847561|39126089|FG000|Overall Study|Withdrawal by Subject|4|||
16176430|NCT00847561|39126090|FG001|Overall Study|Withdrawal by Subject|3|||
16176431|NCT00847561|39126089|FG000|Overall Study|Unable to schedule|9|||
16176432|NCT00847561|39126090|FG001|Overall Study|Unable to schedule|1|||
16176433|NCT00440401|39126098|FG000|Overall Study|Adverse Event|2|||
16176434|NCT00440401|39126099|FG001|Overall Study|Adverse Event|1|||
16176435|NCT00440401|39126098|FG000|Overall Study|Other|2|||
16176436|NCT00440401|39126099|FG001|Overall Study|Other|5|||
16176437|NCT03022461|39126100|FG000|Overall Study|Death|3|||
16176438|NCT00002850|39126101|FG000|Overall Study|Death|4|||
16176439|NCT00002850|39126102|FG001|Overall Study|Death|1|||
16176440|NCT00002850|39126103|FG002|Overall Study|Death|3|||
16176441|NCT00002850|39126101|FG000|Overall Study|Protocol Violation|1|||
16176442|NCT00002850|39126102|FG001|Overall Study|Protocol Violation|0|||
16176443|NCT00002850|39126103|FG002|Overall Study|Protocol Violation|1|||
16176444|NCT00002850|39126101|FG000|Overall Study|Withdrawal by Subject|0|||
16176445|NCT00002850|39126102|FG001|Overall Study|Withdrawal by Subject|1|||
16176446|NCT00002850|39126103|FG002|Overall Study|Withdrawal by Subject|0|||
16176447|NCT04538950|39126105|FG000|Overall Study|Pulmonary Issues|2|||
16176448|NCT04538950|39126105|FG000|Overall Study|illness|2|||
16176449|NCT00813748|39126111|FG000|Skin Test Substudy|Physician Decision|0|||
16176450|NCT00813748|39126112|FG001|Skin Test Substudy|Physician Decision|1|||
16176451|NCT00162773|39126122|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
16176452|NCT04030195|39126123|FG000|Overall Study|Withdrawal by Subject|2|||
16176453|NCT04030195|39126124|FG001|Overall Study|Withdrawal by Subject|0|||
16176454|NCT04030195|39126125|FG002|Overall Study|Withdrawal by Subject|0|||
16176455|NCT01925703|39126126|FG000|Overall Study|Physician Decision|1|||
16176456|NCT01925703|39126126|FG000|Overall Study|Lost to Follow-up|2|||
16176457|NCT01925703|39126126|FG000|Overall Study|Discharge prior to full iron repletion|1|||
16176458|NCT01006356|39126127|FG000|Overall Study|Adverse Event|6|||
16176459|NCT01006356|39126127|FG000|Overall Study|Physician Decision|1|||
16176460|NCT01006356|39126127|FG000|Overall Study|Paticipants did not cooperate|6|||
16176461|NCT01006356|39126127|FG000|Overall Study|Withdrawal by Subject|1|||
16176462|NCT01006356|39126127|FG000|Overall Study|Choice by participants|2|||
16176463|NCT01006356|39126127|FG000|Overall Study|Protocol Violation|3|||
16176464|NCT01006356|39126127|FG000|Overall Study|Other|23|||
16176465|NCT02015819|39126128|FG000|Overall Study|Rickham catheter was misaligned|0|||
16176466|NCT02015819|39126129|FG001|Overall Study|Rickham catheter was misaligned|0|||
16176467|NCT02015819|39126130|FG002|Overall Study|Rickham catheter was misaligned|0|||
16176468|NCT02015819|39126131|FG003|Overall Study|Rickham catheter was misaligned|1|||
16176469|NCT00110305|39126145|FG000|Overall Study|Adverse Event|46|||
16176470|NCT00110305|39126146|FG001|Overall Study|Adverse Event|13|||
16176471|NCT00110305|39126145|FG000|Overall Study|Sponsors Decision|1|||
16176472|NCT00110305|39126146|FG001|Overall Study|Sponsors Decision|0|||
16176473|NCT00110305|39126145|FG000|Overall Study|Subject Non-Compliant|9|||
16176474|NCT00110305|39126146|FG001|Overall Study|Subject Non-Compliant|2|||
16477698|NCT00191906|40228262|FG001|Study Period II|Withdrawal by Subject|3|||
16477699|NCT00191906|40228263|FG002|Study Period II|Withdrawal by Subject|0|||
16477700|NCT00191906|40228264|FG003|Study Period II|Withdrawal by Subject|0|||
16477701|NCT00191906|40228261|FG000|Study Period II|Parent/Caregiver Decision|0|||
16477702|NCT00191906|40228262|FG001|Study Period II|Parent/Caregiver Decision|1|||
16477703|NCT00191906|40228263|FG002|Study Period II|Parent/Caregiver Decision|0|||
16477704|NCT00191906|40228264|FG003|Study Period II|Parent/Caregiver Decision|0|||
16477705|NCT00191906|40228261|FG000|Study Period II|Entry Criteria Exclusion|0|||
16477706|NCT00191906|40228262|FG001|Study Period II|Entry Criteria Exclusion|0|||
16477707|NCT00191906|40228263|FG002|Study Period II|Entry Criteria Exclusion|1|||
16477708|NCT00191906|40228264|FG003|Study Period II|Entry Criteria Exclusion|0|||
16477709|NCT00191906|40228261|FG000|Study Period III|Adverse Event|1|||
16477710|NCT00191906|40228262|FG001|Study Period III|Adverse Event|0|||
16477711|NCT00191906|40228263|FG002|Study Period III|Adverse Event|0|||
16477712|NCT00191906|40228264|FG003|Study Period III|Adverse Event|0|||
16477713|NCT00191906|40228261|FG000|Study Period III|Lost to Follow-up|0|||
16477714|NCT00191906|40228262|FG001|Study Period III|Lost to Follow-up|1|||
16477715|NCT00191906|40228263|FG002|Study Period III|Lost to Follow-up|0|||
16477716|NCT00191906|40228264|FG003|Study Period III|Lost to Follow-up|0|||
16477717|NCT00191906|40228261|FG000|Study Period III|Parent/Caregiver Decision|1|||
16477718|NCT00191906|40228262|FG001|Study Period III|Parent/Caregiver Decision|0|||
16477719|NCT00191906|40228263|FG002|Study Period III|Parent/Caregiver Decision|0|||
16477720|NCT00191906|40228264|FG003|Study Period III|Parent/Caregiver Decision|0|||
16477721|NCT00191906|40228261|FG000|Study Period III|Lack of Efficacy|3|||
16477722|NCT00191906|40228262|FG001|Study Period III|Lack of Efficacy|3|||
16477723|NCT00191906|40228263|FG002|Study Period III|Lack of Efficacy|0|||
16477724|NCT00191906|40228264|FG003|Study Period III|Lack of Efficacy|0|||
16477725|NCT00691301|40228269|FG000|Overall Study|Adverse Event|10|||
16477726|NCT00691301|40228269|FG000|Overall Study|Death|2|||
16477727|NCT00691301|40228269|FG000|Overall Study|Lack of Efficacy|32|||
16477728|NCT00691301|40228269|FG000|Overall Study|Withdrawal by Subject|4|||
16079769|NCT01953692|38786671|FG005|Overall Study|Death|3|||
16477729|NCT00691301|40228269|FG000|Overall Study|Concurrent illness|2|||
16477730|NCT00691301|40228269|FG000|Overall Study|other reason|3|||
16477731|NCT00691301|40228269|FG000|Overall Study|Did not initiate study treatment|1|||
16477732|NCT02030938|40228270|FG000|Overall Study|Lost to Follow-up|4|||
16477733|NCT02030938|40228270|FG000|Overall Study|Withdrawal by Subject|1|||
16477734|NCT05447897|40228273|FG000|Overall Study|Did not participate in survey|2|||
16477735|NCT02651467|40228274|FG000|Overall Study|Withdrawal by Subject|0|||
16477736|NCT02651467|40228275|FG001|Overall Study|Withdrawal by Subject|0|||
16477737|NCT02651467|40228276|FG002|Overall Study|Withdrawal by Subject|2|||
16477738|NCT02651467|40228274|FG000|Overall Study|Other (Not specified)|1|||
16477739|NCT02651467|40228275|FG001|Overall Study|Other (Not specified)|0|||
16477740|NCT02651467|40228276|FG002|Overall Study|Other (Not specified)|2|||
16477741|NCT01927627|40228287|FG000|Overall Study|Adverse Event|3|||
16477742|NCT01927627|40228287|FG000|Overall Study|Lack of Efficacy|1|||
16477743|NCT01927627|40228287|FG000|Overall Study|Financial Concerns|1|||
16477744|NCT01897714|40228288|FG000|Phase I (Dose Escalation)|Disease progression|3|||
16477745|NCT01897714|40228289|FG001|Phase I (Dose Escalation)|Disease progression|5|||
16477746|NCT01897714|40228290|FG002|Phase I (Dose Escalation)|Disease progression|1|||
16477747|NCT01897714|40228291|FG003|Phase I (Dose Escalation)|Disease progression|3|||
16477748|NCT01897714|40228292|FG004|Phase I (Dose Escalation)|Disease progression|0|||
16279001|NCT01436643|39504186|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
16279002|NCT01436643|39504183|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
16279003|NCT01436643|39504184|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
16279004|NCT01436643|39504185|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
16279005|NCT01436643|39504186|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
16279006|NCT03223909|39504196|FG000|Overall Study|Protocol Violation|48|||
16279007|NCT03223909|39504197|FG001|Overall Study|Protocol Violation|45|||
16477749|NCT01897714|40228293|FG005|Phase I (Dose Escalation)|Disease progression|0|||
16477750|NCT01897714|40228288|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
16477751|NCT01897714|40228289|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
16477752|NCT01897714|40228290|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
16477753|NCT01897714|40228291|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
16477754|NCT01897714|40228292|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
16477755|NCT01897714|40228293|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
16477756|NCT01897714|40228288|FG000|Phase I (Dose Escalation)|Other|0|||
16477757|NCT01897714|40228289|FG001|Phase I (Dose Escalation)|Other|1|||
16477758|NCT01897714|40228290|FG002|Phase I (Dose Escalation)|Other|0|||
16477759|NCT01897714|40228291|FG003|Phase I (Dose Escalation)|Other|0|||
16477760|NCT01897714|40228292|FG004|Phase I (Dose Escalation)|Other|0|||
16079770|NCT01953692|38786672|FG006|Overall Study|Death|6|||
16079771|NCT01953692|38786673|FG007|Overall Study|Death|2|||
16079772|NCT01953692|38786674|FG008|Overall Study|Death|1|||
16079773|NCT01953692|38786666|FG000|Overall Study|Excluded Medication|1|||
16079774|NCT01953692|38786667|FG001|Overall Study|Excluded Medication|0|||
16079775|NCT01953692|38786668|FG002|Overall Study|Excluded Medication|0|||
16079776|NCT01953692|38786669|FG003|Overall Study|Excluded Medication|0|||
16176475|NCT00110305|39126145|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
16176476|NCT00110305|39126146|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
16176477|NCT00110305|39126145|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
16176478|NCT00110305|39126146|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
16176479|NCT00110305|39126145|FG000|Overall Study|Protocol Violation|0|||
16176480|NCT00110305|39126146|FG001|Overall Study|Protocol Violation|1|||
16079777|NCT01953692|38786670|FG004|Overall Study|Excluded Medication|0|||
16079778|NCT01953692|38786671|FG005|Overall Study|Excluded Medication|0|||
16079779|NCT01953692|38786672|FG006|Overall Study|Excluded Medication|0|||
16079780|NCT01953692|38786673|FG007|Overall Study|Excluded Medication|0|||
16079781|NCT01953692|38786674|FG008|Overall Study|Excluded Medication|0|||
16079782|NCT01953692|38786666|FG000|Overall Study|Lost to Follow-up|1|||
16079783|NCT01953692|38786667|FG001|Overall Study|Lost to Follow-up|0|||
16079784|NCT01953692|38786668|FG002|Overall Study|Lost to Follow-up|3|||
16079785|NCT01953692|38786669|FG003|Overall Study|Lost to Follow-up|1|||
16079786|NCT01953692|38786670|FG004|Overall Study|Lost to Follow-up|0|||
16079787|NCT01953692|38786671|FG005|Overall Study|Lost to Follow-up|1|||
16079788|NCT01953692|38786672|FG006|Overall Study|Lost to Follow-up|0|||
16079789|NCT01953692|38786673|FG007|Overall Study|Lost to Follow-up|0|||
16079790|NCT01953692|38786674|FG008|Overall Study|Lost to Follow-up|0|||
16079791|NCT01953692|38786666|FG000|Overall Study|Physician Decision|11|||
16279008|NCT03223909|39504198|FG002|Overall Study|Protocol Violation|16|||
16279009|NCT02129062|39504199|FG000|Overall Study|Death|1|||
16477761|NCT01897714|40228293|FG005|Phase I (Dose Escalation)|Other|0|||
16477762|NCT01897714|40228288|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
16477763|NCT01897714|40228289|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
16477764|NCT01897714|40228290|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
16477765|NCT01897714|40228291|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
16477766|NCT01897714|40228292|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
16477767|NCT01897714|40228293|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
16477768|NCT01897714|40228288|FG000|Phase II (MTD)|Lost to Follow-up|0|||
16477769|NCT01897714|40228289|FG001|Phase II (MTD)|Lost to Follow-up|0|||
16477770|NCT01897714|40228290|FG002|Phase II (MTD)|Lost to Follow-up|0|||
16477771|NCT01897714|40228291|FG003|Phase II (MTD)|Lost to Follow-up|0|||
16477772|NCT01897714|40228292|FG004|Phase II (MTD)|Lost to Follow-up|1|||
16477773|NCT01897714|40228293|FG005|Phase II (MTD)|Lost to Follow-up|0|||
16079792|NCT01953692|38786667|FG001|Overall Study|Physician Decision|4|||
16079793|NCT01953692|38786668|FG002|Overall Study|Physician Decision|2|||
16079794|NCT01953692|38786669|FG003|Overall Study|Physician Decision|2|||
16477774|NCT01897714|40228288|FG000|Phase II (MTD)|Death|0|||
16477775|NCT01897714|40228289|FG001|Phase II (MTD)|Death|0|||
16477776|NCT01897714|40228290|FG002|Phase II (MTD)|Death|0|||
16477777|NCT01897714|40228291|FG003|Phase II (MTD)|Death|0|||
16477778|NCT01897714|40228292|FG004|Phase II (MTD)|Death|25|||
16477779|NCT01897714|40228293|FG005|Phase II (MTD)|Death|10|||
16477780|NCT01897714|40228288|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
16477781|NCT01897714|40228289|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
16477782|NCT01897714|40228290|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
16477783|NCT01897714|40228291|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
16477784|NCT01897714|40228292|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
16477785|NCT01897714|40228293|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
16477786|NCT01897714|40228288|FG000|Phase II (MTD)|Other|0|||
16477787|NCT01897714|40228289|FG001|Phase II (MTD)|Other|0|||
16477788|NCT01897714|40228290|FG002|Phase II (MTD)|Other|0|||
16477789|NCT01897714|40228291|FG003|Phase II (MTD)|Other|0|||
16477790|NCT01897714|40228292|FG004|Phase II (MTD)|Other|3|||
16477791|NCT01897714|40228293|FG005|Phase II (MTD)|Other|0|||
16477792|NCT00559754|40228304|FG000|Overall Study|Disease progression|1|||
16477793|NCT00559754|40228304|FG000|Overall Study|Adverse Event|5|||
16477794|NCT00559754|40228304|FG000|Overall Study|Protocol Violation|1|||
16477795|NCT00559754|40228304|FG000|Overall Study|Investigator criteria|2|||
16477796|NCT00559754|40228304|FG000|Overall Study|Withdrawal by Subject|2|||
16079795|NCT01953692|38786670|FG004|Overall Study|Physician Decision|1|||
16079796|NCT01953692|38786671|FG005|Overall Study|Physician Decision|2|||
16079797|NCT01953692|38786672|FG006|Overall Study|Physician Decision|4|||
16477797|NCT00808483|40228308|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
16079798|NCT01953692|38786673|FG007|Overall Study|Physician Decision|1|||
16079799|NCT01953692|38786674|FG008|Overall Study|Physician Decision|0|||
16079800|NCT01953692|38786666|FG000|Overall Study|Protocol Violation|0|||
16079801|NCT01953692|38786667|FG001|Overall Study|Protocol Violation|2|||
16079802|NCT01953692|38786668|FG002|Overall Study|Protocol Violation|1|||
16079803|NCT01953692|38786669|FG003|Overall Study|Protocol Violation|0|||
16079804|NCT01953692|38786670|FG004|Overall Study|Protocol Violation|0|||
16079805|NCT01953692|38786671|FG005|Overall Study|Protocol Violation|0|||
16079806|NCT01953692|38786672|FG006|Overall Study|Protocol Violation|0|||
16079807|NCT01953692|38786673|FG007|Overall Study|Protocol Violation|1|||
16079808|NCT01953692|38786674|FG008|Overall Study|Protocol Violation|0|||
16079809|NCT01953692|38786666|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16079810|NCT01953692|38786667|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16079811|NCT01953692|38786668|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16079812|NCT01953692|38786669|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16079813|NCT01953692|38786670|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16079814|NCT01953692|38786671|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16079815|NCT01953692|38786672|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16079816|NCT01953692|38786673|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
16079817|NCT01953692|38786674|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
16079818|NCT01953692|38786666|FG000|Overall Study|Withdrawal by Subject|4|||
16079819|NCT01953692|38786667|FG001|Overall Study|Withdrawal by Subject|2|||
16079820|NCT01953692|38786668|FG002|Overall Study|Withdrawal by Subject|1|||
16079821|NCT01953692|38786669|FG003|Overall Study|Withdrawal by Subject|2|||
16079822|NCT01953692|38786670|FG004|Overall Study|Withdrawal by Subject|0|||
16079823|NCT01953692|38786671|FG005|Overall Study|Withdrawal by Subject|3|||
16079824|NCT01953692|38786672|FG006|Overall Study|Withdrawal by Subject|2|||
16079825|NCT01953692|38786673|FG007|Overall Study|Withdrawal by Subject|1|||
16079826|NCT01953692|38786674|FG008|Overall Study|Withdrawal by Subject|1|||
16079827|NCT00402246|38786675|FG000|Overall Study|Death|62|||
16079828|NCT00402246|38786676|FG001|Overall Study|Death|58|||
16079829|NCT00402246|38786675|FG000|Overall Study|Lost to Follow-up|20|||
16079830|NCT00402246|38786676|FG001|Overall Study|Lost to Follow-up|28|||
16176481|NCT00110305|39126145|FG000|Overall Study|Withdrawal by Subject|7|||
16176482|NCT00110305|39126146|FG001|Overall Study|Withdrawal by Subject|7|||
16176483|NCT00110305|39126145|FG000|Overall Study|Lost to Follow-up|20|||
16176484|NCT00110305|39126146|FG001|Overall Study|Lost to Follow-up|3|||
16176485|NCT00110305|39126145|FG000|Overall Study|Other|8|||
16477798|NCT00808483|40228309|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
16477799|NCT00808483|40228308|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
16477800|NCT00808483|40228309|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
16477801|NCT00808483|40228308|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
16477802|NCT00808483|40228309|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
16477803|NCT00573248|40228312|FG000|Overall Study|scheduling conflicts|15|||
16176486|NCT00110305|39126146|FG001|Overall Study|Other|2|||
16176487|NCT01645930|39126147|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
16176488|NCT01645930|39126147|FG000|Overall Study|Progressive Disease|12|||
16176489|NCT01645930|39126147|FG000|Overall Study|Adverse Event|4|||
16176490|NCT01645930|39126147|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
16477804|NCT00573248|40228313|FG001|Overall Study|scheduling conflicts|11|||
16176491|NCT01645930|39126147|FG000|Overall Study|Withdrawal by Participant|2|||
16176492|NCT01645930|39126147|FG000|Overall Study|Reason not Defined|1|||
16176493|NCT01051739|39126148|FG000|Overall Study|Death|3|||
16176494|NCT01051739|39126149|FG001|Overall Study|Death|3|||
16176495|NCT01051739|39126148|FG000|Overall Study|Withdrawal by Subject|25|||
16176496|NCT01051739|39126149|FG001|Overall Study|Withdrawal by Subject|10|||
16176497|NCT01573442|39126150|FG000|Overall Study|Cancels|9|||
16176498|NCT01573442|39126151|FG001|Overall Study|Cancels|10|||
16176499|NCT00730236|39126155|FG000|Overall Study|Adverse Event|4|||
16176500|NCT00730236|39126155|FG000|Overall Study|Withdrawal by Subject|1|||
16176501|NCT00730236|39126155|FG000|Overall Study|Non-compliance|1|||
16176502|NCT00844883|39126156|FG000|Overall Study|Bridged to liver transplant|3|||
16176503|NCT00844883|39126156|FG000|Overall Study|Bridged to resection|1|||
16176504|NCT02120417|39126157|FG000|Overall Study|Death|5|||
16176505|NCT02120417|39126158|FG001|Overall Study|Death|1|||
16176506|NCT02120417|39126157|FG000|Overall Study|Adverse Event|3|||
16176507|NCT02120417|39126158|FG001|Overall Study|Adverse Event|9|||
16176508|NCT02120417|39126157|FG000|Overall Study|Participant decision|4|||
16176509|NCT02120417|39126158|FG001|Overall Study|Participant decision|4|||
16176510|NCT02120417|39126157|FG000|Overall Study|Disease progression|41|||
16176511|NCT02120417|39126158|FG001|Overall Study|Disease progression|45|||
16176512|NCT02120417|39126157|FG000|Overall Study|Noncompliance with study treatment|0|||
16176513|NCT02120417|39126158|FG001|Overall Study|Noncompliance with study treatment|2|||
16176514|NCT02120417|39126157|FG000|Overall Study|Physician Decision|2|||
16176515|NCT02120417|39126158|FG001|Overall Study|Physician Decision|3|||
16176516|NCT02120417|39126157|FG000|Overall Study|Other unspecified|5|||
16176517|NCT02120417|39126158|FG001|Overall Study|Other unspecified|4|||
16176518|NCT04725682|39126160|FG000|Overall Study|Withdrawal by Subject|7|||
16176519|NCT04725682|39126161|FG001|Overall Study|Withdrawal by Subject|5|||
16176520|NCT04725682|39126160|FG000|Overall Study|Failed to comply with the requirements|2|||
16176521|NCT04725682|39126161|FG001|Overall Study|Failed to comply with the requirements|1|||
16176522|NCT04725682|39126160|FG000|Overall Study|Adverse Event|1|||
16176523|NCT04725682|39126161|FG001|Overall Study|Adverse Event|1|||
16176524|NCT04725682|39126160|FG000|Overall Study|Death|0|||
16176525|NCT04725682|39126161|FG001|Overall Study|Death|1|||
16176526|NCT00317044|39126162|FG000|Overall Study|Protocol Violation|28|||
16176527|NCT00317044|39126163|FG001|Overall Study|Protocol Violation|22|||
16176528|NCT00317044|39126164|FG002|Overall Study|Protocol Violation|20|||
16176529|NCT00317044|39126162|FG000|Overall Study|Adverse Event|4|||
16176530|NCT00317044|39126163|FG001|Overall Study|Adverse Event|7|||
16176531|NCT00317044|39126164|FG002|Overall Study|Adverse Event|4|||
16176532|NCT00317044|39126162|FG000|Overall Study|Withdrawal by Subject|10|||
16176533|NCT00317044|39126163|FG001|Overall Study|Withdrawal by Subject|7|||
16477805|NCT03096483|40228315|FG000|Overall Study|Withdrawal by site|1|||
16477806|NCT00422097|40228324|FG000|Dose Level 2|Still on treatment|0|||
16477807|NCT00422097|40228325|FG001|Dose Level 2|Still on treatment|1|||
16477808|NCT00422097|40228326|FG002|Dose Level 2|Still on treatment|0|||
16477809|NCT00422097|40228327|FG003|Dose Level 2|Still on treatment|0|||
16477810|NCT00422097|40228328|FG004|Dose Level 2|Still on treatment|0|||
16176534|NCT00317044|39126164|FG002|Overall Study|Withdrawal by Subject|12|||
16176535|NCT00317044|39126162|FG000|Overall Study|Lost to Follow-up|0|||
16176536|NCT00317044|39126163|FG001|Overall Study|Lost to Follow-up|2|||
16176537|NCT00317044|39126164|FG002|Overall Study|Lost to Follow-up|3|||
16176538|NCT00317044|39126162|FG000|Overall Study|Multiple Reasons|6|||
16176539|NCT00317044|39126163|FG001|Overall Study|Multiple Reasons|2|||
16176540|NCT00317044|39126164|FG002|Overall Study|Multiple Reasons|6|||
16176541|NCT01360996|39126165|FG000|Overall Study|Withdrawal by Subject|4|||
16176542|NCT01360996|39126166|FG001|Overall Study|Withdrawal by Subject|3|||
16176543|NCT01360996|39126167|FG002|Overall Study|Withdrawal by Subject|2|||
16176544|NCT01360996|39126165|FG000|Overall Study|Noncompliant|2|||
16176545|NCT01360996|39126166|FG001|Overall Study|Noncompliant|0|||
16176546|NCT01360996|39126167|FG002|Overall Study|Noncompliant|0|||
16176547|NCT03459040|39126170|FG000|Overall Study|Death|8|||
16176548|NCT03459040|39126170|FG000|Overall Study|Withdrawal by Subject|1|||
16176549|NCT00509106|39126177|FG000|Overall Study|Adverse Event|3|||
16176550|NCT00509106|39126178|FG001|Overall Study|Adverse Event|2|||
16176551|NCT00509106|39126177|FG000|Overall Study|Noncompliance|0|||
16477811|NCT00422097|40228329|FG005|Dose Level 2|Still on treatment|0|||
16176552|NCT00509106|39126178|FG001|Overall Study|Noncompliance|1|||
16176553|NCT00509106|39126177|FG000|Overall Study|At the request of sponsor/investigator|1|||
16477812|NCT00422097|40228330|FG006|Dose Level 2|Still on treatment|0|||
16176554|NCT00509106|39126178|FG001|Overall Study|At the request of sponsor/investigator|2|||
16176555|NCT00509106|39126177|FG000|Overall Study|Withdrew consent|4|||
16176556|NCT00509106|39126178|FG001|Overall Study|Withdrew consent|8|||
16176557|NCT00509106|39126177|FG000|Overall Study|Lost to Follow-up|16|||
16176558|NCT00509106|39126178|FG001|Overall Study|Lost to Follow-up|10|||
16176559|NCT00509106|39126177|FG000|Overall Study|Other|1|||
16176560|NCT00509106|39126178|FG001|Overall Study|Other|0|||
16176561|NCT00509106|39126177|FG000|Overall Study|Death|6|||
16176562|NCT00509106|39126178|FG001|Overall Study|Death|6|||
16176563|NCT00195351|39126181|FG000|Overall Study|Lost to Follow-up|9|||
16079831|NCT00402246|38786675|FG000|Overall Study|Withdrawal by Subject|72|||
16079832|NCT00402246|38786676|FG001|Overall Study|Withdrawal by Subject|87|||
16079833|NCT00402246|38786675|FG000|Overall Study|Physician Decision|24|||
16477813|NCT00422097|40228331|FG007|Dose Level 2|Still on treatment|0|||
16477814|NCT01786148|40228332|FG000|Overall Study|Lost to Follow-up|21|||
16477815|NCT01786148|40228333|FG001|Overall Study|Lost to Follow-up|13|||
16477816|NCT01786148|40228332|FG000|Overall Study|Death|0|||
16477817|NCT01786148|40228333|FG001|Overall Study|Death|1|||
16477818|NCT01786148|40228332|FG000|Overall Study|Withdrawal by Subject|0|||
16477819|NCT01786148|40228333|FG001|Overall Study|Withdrawal by Subject|7|||
16477820|NCT01786148|40228332|FG000|Overall Study|Incarceration|1|||
16477821|NCT01786148|40228333|FG001|Overall Study|Incarceration|1|||
16477822|NCT01011738|40228339|FG000|Overall Study|Death|12|||
16477823|NCT01011738|40228340|FG001|Overall Study|Death|3|||
16079834|NCT00402246|38786676|FG001|Overall Study|Physician Decision|26|||
16079835|NCT00402246|38786675|FG000|Overall Study|Protocol Violation|25|||
16079836|NCT00402246|38786676|FG001|Overall Study|Protocol Violation|24|||
16079837|NCT00402246|38786675|FG000|Overall Study|Missed Final Visit|1|||
16079838|NCT00402246|38786676|FG001|Overall Study|Missed Final Visit|2|||
16079839|NCT00402246|38786675|FG000|Overall Study|Insurance Issues|2|||
16079840|NCT00402246|38786676|FG001|Overall Study|Insurance Issues|1|||
16176564|NCT00195351|39126182|FG001|Overall Study|Lost to Follow-up|9|||
16176565|NCT00195351|39126181|FG000|Overall Study|Withdrawal by Subject|6|||
16176566|NCT00195351|39126182|FG001|Overall Study|Withdrawal by Subject|3|||
16176567|NCT00195351|39126181|FG000|Overall Study|Protocol Deviation|3|||
16176568|NCT00195351|39126182|FG001|Overall Study|Protocol Deviation|2|||
16176569|NCT00195351|39126181|FG000|Overall Study|Death|3|||
16176570|NCT00195351|39126182|FG001|Overall Study|Death|1|||
16176571|NCT00195351|39126181|FG000|Overall Study|Lack of Efficacy|0|||
16176572|NCT00195351|39126182|FG001|Overall Study|Lack of Efficacy|1|||
16176573|NCT03633331|39126183|FG000|Overall Study|Withdrawal by Subject|1|||
16176574|NCT02273973|39126184|FG000|Overall Study|Adverse Event|4|||
16176575|NCT02273973|39126185|FG001|Overall Study|Adverse Event|0|||
16176576|NCT02273973|39126184|FG000|Overall Study|Withdrawal by Subject|2|||
16176577|NCT02273973|39126185|FG001|Overall Study|Withdrawal by Subject|3|||
16176578|NCT02273973|39126184|FG000|Overall Study|Death|1|||
16176579|NCT02273973|39126185|FG001|Overall Study|Death|0|||
16176580|NCT02273973|39126184|FG000|Overall Study|Non-compliance|1|||
16176581|NCT02273973|39126185|FG001|Overall Study|Non-compliance|0|||
16176582|NCT02273973|39126184|FG000|Overall Study|Protocol Violation|1|||
16176583|NCT02273973|39126185|FG001|Overall Study|Protocol Violation|0|||
16176584|NCT02273973|39126184|FG000|Overall Study|Progression of disease|0|||
16176585|NCT02273973|39126185|FG001|Overall Study|Progression of disease|2|||
16176586|NCT02273973|39126184|FG000|Overall Study|Lost to Follow-up|0|||
16176587|NCT02273973|39126185|FG001|Overall Study|Lost to Follow-up|1|||
16176588|NCT02273973|39126184|FG000|Overall Study|Physician Decision|0|||
16176589|NCT02273973|39126185|FG001|Overall Study|Physician Decision|1|||
16176590|NCT02273973|39126184|FG000|Overall Study|Reason not specified|0|||
16176591|NCT02273973|39126185|FG001|Overall Study|Reason not specified|1|||
16176592|NCT01564784|39126191|FG000|Overall Study|Other|1|||
16176593|NCT01564784|39126192|FG001|Overall Study|Other|0|||
16176594|NCT01564784|39126191|FG000|Overall Study|Subject refused further follow-up|1|||
16477824|NCT01011738|40228341|FG002|Overall Study|Death|0|||
16477825|NCT01011738|40228339|FG000|Overall Study|Unknown reasons|312|||
16477826|NCT01011738|40228340|FG001|Overall Study|Unknown reasons|291|||
16477827|NCT01011738|40228341|FG002|Overall Study|Unknown reasons|17|||
16477828|NCT02213042|40228342|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
16477829|NCT02213042|40228343|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
16176595|NCT01564784|39126192|FG001|Overall Study|Subject refused further follow-up|6|||
16176596|NCT01564784|39126191|FG000|Overall Study|Lost to Follow-up|1|||
16176597|NCT01564784|39126192|FG001|Overall Study|Lost to Follow-up|1|||
16176598|NCT01564784|39126191|FG000|Overall Study|Death|131|||
16176599|NCT01564784|39126192|FG001|Overall Study|Death|126|||
16176600|NCT03263091|39126193|FG000|OL Component|Withdrawal by Subject|1|||
16176601|NCT03263091|39126194|FG001|OL Component|Withdrawal by Subject|1|||
16176602|NCT03263091|39126195|FG002|OL Component|Withdrawal by Subject|0|||
16176603|NCT03263091|39126196|FG003|OL Component|Withdrawal by Subject|0|||
16477830|NCT02213042|40228344|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
16079841|NCT00402246|38786675|FG000|Overall Study|Heart Transplant|0|||
16176604|NCT03263091|39126197|FG004|OL Component|Withdrawal by Subject|0|||
16176605|NCT03263091|39126198|FG005|OL Component|Withdrawal by Subject|0|||
16176606|NCT03263091|39126193|FG000|OL Component|Physician Decision|0|||
16176607|NCT03263091|39126194|FG001|OL Component|Physician Decision|1|||
16176608|NCT03263091|39126195|FG002|OL Component|Physician Decision|2|||
16176609|NCT03263091|39126196|FG003|OL Component|Physician Decision|0|||
16176610|NCT03263091|39126197|FG004|OL Component|Physician Decision|0|||
16176611|NCT03263091|39126198|FG005|OL Component|Physician Decision|0|||
16176612|NCT03263091|39126193|FG000|OL Component|Death|1|||
16176613|NCT03263091|39126194|FG001|OL Component|Death|0|||
16176614|NCT03263091|39126195|FG002|OL Component|Death|0|||
16176615|NCT03263091|39126196|FG003|OL Component|Death|0|||
16176616|NCT03263091|39126197|FG004|OL Component|Death|0|||
16176617|NCT03263091|39126198|FG005|OL Component|Death|0|||
16477831|NCT02213042|40228342|FG000|Overall Study|Adverse Event|2|||
16477832|NCT02213042|40228343|FG001|Overall Study|Adverse Event|1|||
16477833|NCT02213042|40228344|FG002|Overall Study|Adverse Event|0|||
16176618|NCT03263091|39126193|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
16176619|NCT03263091|39126194|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
16176620|NCT03263091|39126195|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
16176621|NCT03263091|39126196|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
16176622|NCT03263091|39126197|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
16176623|NCT03263091|39126198|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
16176624|NCT03263091|39126193|FG000|OL High-EPO Component|Physician Decision|0|||
16176625|NCT03263091|39126194|FG001|OL High-EPO Component|Physician Decision|0|||
16176626|NCT03263091|39126195|FG002|OL High-EPO Component|Physician Decision|0|||
16176627|NCT03263091|39126196|FG003|OL High-EPO Component|Physician Decision|1|||
16176628|NCT03263091|39126197|FG004|OL High-EPO Component|Physician Decision|0|||
16176629|NCT03263091|39126198|FG005|OL High-EPO Component|Physician Decision|0|||
16176630|NCT03263091|39126193|FG000|OL High-EPO Component|Death|0|||
16176631|NCT03263091|39126194|FG001|OL High-EPO Component|Death|0|||
16176632|NCT03263091|39126195|FG002|OL High-EPO Component|Death|0|||
16176633|NCT03263091|39126196|FG003|OL High-EPO Component|Death|3|||
16176634|NCT03263091|39126197|FG004|OL High-EPO Component|Death|0|||
16176635|NCT03263091|39126198|FG005|OL High-EPO Component|Death|0|||
16176636|NCT03263091|39126193|FG000|DB Component|Withdrawal by Subject|0|||
16176637|NCT03263091|39126194|FG001|DB Component|Withdrawal by Subject|0|||
16176638|NCT03263091|39126195|FG002|DB Component|Withdrawal by Subject|0|||
16176639|NCT03263091|39126196|FG003|DB Component|Withdrawal by Subject|0|||
16176640|NCT03263091|39126197|FG004|DB Component|Withdrawal by Subject|22|||
16176641|NCT03263091|39126198|FG005|DB Component|Withdrawal by Subject|8|||
16176642|NCT03263091|39126193|FG000|DB Component|Physician Decision|0|||
16176643|NCT03263091|39126194|FG001|DB Component|Physician Decision|0|||
16176644|NCT03263091|39126195|FG002|DB Component|Physician Decision|0|||
16176645|NCT03263091|39126196|FG003|DB Component|Physician Decision|0|||
16176646|NCT03263091|39126197|FG004|DB Component|Physician Decision|3|||
16176647|NCT03263091|39126198|FG005|DB Component|Physician Decision|1|||
16176648|NCT03263091|39126193|FG000|DB Component|Adverse Event|0|||
16176649|NCT03263091|39126194|FG001|DB Component|Adverse Event|0|||
16176650|NCT03263091|39126195|FG002|DB Component|Adverse Event|0|||
16176651|NCT03263091|39126196|FG003|DB Component|Adverse Event|0|||
16176652|NCT03263091|39126197|FG004|DB Component|Adverse Event|2|||
16176653|NCT03263091|39126198|FG005|DB Component|Adverse Event|1|||
16176654|NCT03263091|39126193|FG000|DB Component|Lost to Follow-up|0|||
16176655|NCT03263091|39126194|FG001|DB Component|Lost to Follow-up|0|||
16176656|NCT03263091|39126195|FG002|DB Component|Lost to Follow-up|0|||
16176657|NCT03263091|39126196|FG003|DB Component|Lost to Follow-up|0|||
16176658|NCT03263091|39126197|FG004|DB Component|Lost to Follow-up|2|||
16176659|NCT03263091|39126198|FG005|DB Component|Lost to Follow-up|1|||
16176660|NCT03263091|39126193|FG000|DB Component|Death|0|||
16176661|NCT03263091|39126194|FG001|DB Component|Death|0|||
16176662|NCT03263091|39126195|FG002|DB Component|Death|0|||
16176663|NCT03263091|39126196|FG003|DB Component|Death|0|||
16176664|NCT03263091|39126197|FG004|DB Component|Death|7|||
16176665|NCT03263091|39126198|FG005|DB Component|Death|4|||
16176666|NCT03263091|39126193|FG000|DB Component|Other than specified|0|||
16176667|NCT03263091|39126194|FG001|DB Component|Other than specified|0|||
16176668|NCT03263091|39126195|FG002|DB Component|Other than specified|0|||
16176669|NCT03263091|39126196|FG003|DB Component|Other than specified|0|||
16176670|NCT03263091|39126197|FG004|DB Component|Other than specified|8|||
16176671|NCT03263091|39126198|FG005|DB Component|Other than specified|6|||
16176672|NCT00004980|39126199|FG000|Overall Study|Withdrawal by Subject|1|||
16176673|NCT00004980|39126200|FG001|Overall Study|Withdrawal by Subject|0|||
16176674|NCT00004980|39126199|FG000|Overall Study|memory difficulties|1|||
16176675|NCT00004980|39126200|FG001|Overall Study|memory difficulties|1|||
16176676|NCT00004980|39126199|FG000|Overall Study|Physician Decision|0|||
16176677|NCT00004980|39126200|FG001|Overall Study|Physician Decision|1|||
16176678|NCT01380080|39126201|FG000|Overall Study|Death|36|||
16176679|NCT01380080|39126202|FG001|Overall Study|Death|44|||
16176680|NCT01380080|39126201|FG000|Overall Study|Site is closing|28|||
16176681|NCT01380080|39126202|FG001|Overall Study|Site is closing|31|||
16176682|NCT01380080|39126201|FG000|Overall Study|Not able to get to clinic|7|||
16176683|NCT01380080|39126202|FG001|Overall Study|Not able to get to clinic|1|||
16176684|NCT01380080|39126201|FG000|Overall Study|Not willing to adhere to requirements|6|||
16176685|NCT01380080|39126202|FG001|Overall Study|Not willing to adhere to requirements|2|||
16176686|NCT01380080|39126201|FG000|Overall Study|Withdrawal by Subject|5|||
16477834|NCT02213042|40228342|FG000|Overall Study|Withdrawal by Subject|0|||
16477835|NCT02213042|40228343|FG001|Overall Study|Withdrawal by Subject|1|||
16477836|NCT02213042|40228344|FG002|Overall Study|Withdrawal by Subject|1|||
16477837|NCT02213042|40228342|FG000|Overall Study|Protocol Violation|1|||
16477838|NCT02213042|40228343|FG001|Overall Study|Protocol Violation|0|||
16477839|NCT02213042|40228344|FG002|Overall Study|Protocol Violation|0|||
16477840|NCT02213042|40228342|FG000|Overall Study|Investigator discretion|0|||
16477841|NCT02213042|40228343|FG001|Overall Study|Investigator discretion|0|||
16477842|NCT02213042|40228344|FG002|Overall Study|Investigator discretion|1|||
16477843|NCT02979197|40228345|FG000|Overall Study|Adverse Event|4|||
16477844|NCT02979197|40228346|FG001|Overall Study|Adverse Event|2|||
16477845|NCT02979197|40228347|FG002|Overall Study|Adverse Event|0|||
16477846|NCT02979197|40228345|FG000|Overall Study|Protocol Violation|0|||
16477847|NCT02979197|40228346|FG001|Overall Study|Protocol Violation|1|||
16477848|NCT02979197|40228347|FG002|Overall Study|Protocol Violation|0|||
16477849|NCT02979197|40228345|FG000|Overall Study|Subject unable to commit to study dates|0|||
16477850|NCT02979197|40228346|FG001|Overall Study|Subject unable to commit to study dates|1|||
16176687|NCT01380080|39126202|FG001|Overall Study|Withdrawal by Subject|2|||
16176688|NCT01380080|39126201|FG000|Overall Study|Lost to Follow-up|3|||
16176689|NCT01380080|39126202|FG001|Overall Study|Lost to Follow-up|3|||
16176690|NCT03040024|39126203|FG000|Overall Study|Adverse Event|0|||
16176691|NCT03040024|39126204|FG001|Overall Study|Adverse Event|1|||
16176692|NCT03040024|39126205|FG002|Overall Study|Adverse Event|0|||
16176693|NCT03040024|39126203|FG000|Overall Study|Death|0|||
16176694|NCT03040024|39126204|FG001|Overall Study|Death|1|||
16176695|NCT03040024|39126205|FG002|Overall Study|Death|0|||
16176696|NCT03040024|39126203|FG000|Overall Study|Physician Decision|0|||
16176697|NCT03040024|39126204|FG001|Overall Study|Physician Decision|0|||
16176698|NCT03040024|39126205|FG002|Overall Study|Physician Decision|1|||
16176699|NCT04052139|39126206|FG000|Overall Study|Lost to Follow-up|2|||
16176700|NCT04052139|39126207|FG001|Overall Study|Lost to Follow-up|0|||
16176701|NCT04052139|39126208|FG002|Overall Study|Lost to Follow-up|0|||
16176702|NCT04052139|39126206|FG000|Overall Study|Withdrawal by Subject|1|||
16176703|NCT04052139|39126207|FG001|Overall Study|Withdrawal by Subject|0|||
16176704|NCT04052139|39126208|FG002|Overall Study|Withdrawal by Subject|0|||
16176705|NCT01856673|39126209|FG000|Overall Study|Withdrawal by Subject|44|||
16176706|NCT01856673|39126210|FG001|Overall Study|Withdrawal by Subject|50|||
16176707|NCT01856673|39126211|FG002|Overall Study|Withdrawal by Subject|33|||
16176708|NCT01856673|39126209|FG000|Overall Study|Lost to Follow-up|31|||
16176709|NCT01856673|39126210|FG001|Overall Study|Lost to Follow-up|34|||
16176710|NCT01856673|39126211|FG002|Overall Study|Lost to Follow-up|0|||
16176711|NCT01856673|39126209|FG000|Overall Study|Unknown reasons|9|||
16176712|NCT01856673|39126210|FG001|Overall Study|Unknown reasons|0|||
16176713|NCT01856673|39126211|FG002|Overall Study|Unknown reasons|0|||
16176714|NCT01856673|39126209|FG000|Overall Study|Psychologist decision|1|||
16176715|NCT01856673|39126210|FG001|Overall Study|Psychologist decision|0|||
16176716|NCT01856673|39126211|FG002|Overall Study|Psychologist decision|0|||
16176717|NCT01856673|39126209|FG000|Overall Study|Paperwork errors|8|||
16176718|NCT01856673|39126210|FG001|Overall Study|Paperwork errors|0|||
16176719|NCT01856673|39126211|FG002|Overall Study|Paperwork errors|0|||
16176720|NCT01856673|39126209|FG000|Overall Study|Death|1|||
16176721|NCT01856673|39126210|FG001|Overall Study|Death|1|||
16477851|NCT02979197|40228347|FG002|Overall Study|Subject unable to commit to study dates|0|||
16477852|NCT02761733|40228349|FG000|Overall Study|Death|3|||
16477853|NCT02761733|40228350|FG001|Overall Study|Death|5|||
16477854|NCT02761733|40228351|FG002|Overall Study|Death|1|||
16477855|NCT02761733|40228352|FG003|Overall Study|Death|1|||
16176722|NCT01856673|39126211|FG002|Overall Study|Death|0|||
16176723|NCT01856673|39126209|FG000|Overall Study|Protocol Violation|1|||
16176724|NCT01856673|39126210|FG001|Overall Study|Protocol Violation|0|||
16176725|NCT01856673|39126211|FG002|Overall Study|Protocol Violation|1|||
16176726|NCT03443024|39126214|FG000|Overall Study|Adverse Event|2|||
16176727|NCT03443024|39126215|FG001|Overall Study|Adverse Event|4|||
16176728|NCT03443024|39126216|FG002|Overall Study|Adverse Event|3|||
16477856|NCT02761733|40228349|FG000|Overall Study|Lost to Follow-up|6|||
16477857|NCT02761733|40228350|FG001|Overall Study|Lost to Follow-up|7|||
16477858|NCT02761733|40228351|FG002|Overall Study|Lost to Follow-up|0|||
16477859|NCT02761733|40228352|FG003|Overall Study|Lost to Follow-up|3|||
16477860|NCT02761733|40228349|FG000|Overall Study|Physician Decision|4|||
16477861|NCT02761733|40228350|FG001|Overall Study|Physician Decision|0|||
16176729|NCT03443024|39126217|FG003|Overall Study|Adverse Event|1|||
16176730|NCT03443024|39126214|FG000|Overall Study|Lost to Follow-up|9|||
16176731|NCT03443024|39126215|FG001|Overall Study|Lost to Follow-up|9|||
16176732|NCT03443024|39126216|FG002|Overall Study|Lost to Follow-up|7|||
16176733|NCT03443024|39126217|FG003|Overall Study|Lost to Follow-up|5|||
16176734|NCT03443024|39126214|FG000|Overall Study|Withdrawal by Subject|8|||
16176735|NCT03443024|39126215|FG001|Overall Study|Withdrawal by Subject|15|||
16176736|NCT03443024|39126216|FG002|Overall Study|Withdrawal by Subject|9|||
16176737|NCT03443024|39126217|FG003|Overall Study|Withdrawal by Subject|23|||
16176738|NCT03443024|39126214|FG000|Overall Study|Physician Decision|1|||
16176739|NCT03443024|39126215|FG001|Overall Study|Physician Decision|2|||
16176740|NCT03443024|39126216|FG002|Overall Study|Physician Decision|0|||
16176741|NCT03443024|39126217|FG003|Overall Study|Physician Decision|1|||
16176742|NCT03443024|39126214|FG000|Overall Study|Sponsor Decision|1|||
16176743|NCT03443024|39126215|FG001|Overall Study|Sponsor Decision|1|||
16176744|NCT03443024|39126216|FG002|Overall Study|Sponsor Decision|0|||
16176745|NCT03443024|39126217|FG003|Overall Study|Sponsor Decision|0|||
16176746|NCT03443024|39126214|FG000|Overall Study|Protocol Deviation|0|||
16176747|NCT03443024|39126215|FG001|Overall Study|Protocol Deviation|0|||
16176748|NCT03443024|39126216|FG002|Overall Study|Protocol Deviation|0|||
16176749|NCT03443024|39126217|FG003|Overall Study|Protocol Deviation|2|||
16176750|NCT00942162|39126218|FG000|Overall Study|Death|45|||
16176751|NCT00942162|39126219|FG001|Overall Study|Death|35|||
16176752|NCT00942162|39126220|FG002|Overall Study|Death|0|||
16176753|NCT00942162|39126218|FG000|Overall Study|Withdrawal by Subject|7|||
16176754|NCT00942162|39126219|FG001|Overall Study|Withdrawal by Subject|2|||
16176755|NCT00942162|39126220|FG002|Overall Study|Withdrawal by Subject|0|||
16176756|NCT00942162|39126218|FG000|Overall Study|Lost to Follow-up|4|||
16176757|NCT00942162|39126219|FG001|Overall Study|Lost to Follow-up|0|||
16176758|NCT00942162|39126220|FG002|Overall Study|Lost to Follow-up|0|||
16176759|NCT00942162|39126218|FG000|Overall Study|Other|14|||
16176760|NCT00942162|39126219|FG001|Overall Study|Other|13|||
16477862|NCT02761733|40228351|FG002|Overall Study|Physician Decision|0|||
16477863|NCT02761733|40228352|FG003|Overall Study|Physician Decision|0|||
16477864|NCT02761733|40228349|FG000|Overall Study|Withdrawal by Subject|2|||
16477865|NCT02761733|40228350|FG001|Overall Study|Withdrawal by Subject|0|||
16477866|NCT02761733|40228351|FG002|Overall Study|Withdrawal by Subject|0|||
16477867|NCT02761733|40228352|FG003|Overall Study|Withdrawal by Subject|0|||
16477868|NCT02761733|40228349|FG000|Overall Study|Discharged from Study Site|10|||
16477869|NCT02761733|40228350|FG001|Overall Study|Discharged from Study Site|9|||
16477870|NCT02761733|40228351|FG002|Overall Study|Discharged from Study Site|25|||
16477871|NCT02761733|40228352|FG003|Overall Study|Discharged from Study Site|11|||
16477872|NCT02761733|40228349|FG000|Overall Study|Cognitive Impairment|5|||
16477873|NCT02761733|40228350|FG001|Overall Study|Cognitive Impairment|0|||
16176761|NCT00942162|39126220|FG002|Overall Study|Other|2|||
16176762|NCT00824564|39126222|FG000|Overall Study|Lost to Follow-up|5|||
16176763|NCT00824564|39126223|FG001|Overall Study|Lost to Follow-up|7|||
16176764|NCT00824564|39126222|FG000|Overall Study|Withdrawal by Subject|1|||
16176765|NCT00824564|39126223|FG001|Overall Study|Withdrawal by Subject|1|||
16176766|NCT00824564|39126222|FG000|Overall Study|Other|1|||
16176767|NCT00824564|39126223|FG001|Overall Study|Other|2|||
16176768|NCT00824564|39126222|FG000|Overall Study|Randomized, but not treated|1|||
16176769|NCT00824564|39126223|FG001|Overall Study|Randomized, but not treated|0|||
16176770|NCT02579603|39126224|FG000|Overall Study|Not treated|1|||
16176771|NCT02579603|39126225|FG001|Overall Study|Not treated|0|||
16176772|NCT02579603|39126224|FG000|Overall Study|Adverse Event|2|||
16176773|NCT02579603|39126225|FG001|Overall Study|Adverse Event|2|||
16176774|NCT02579603|39126224|FG000|Overall Study|Other than stated|1|||
16176775|NCT02579603|39126225|FG001|Overall Study|Other than stated|0|||
16176776|NCT02489630|39126226|FG000|Overall Study|Oversedation|1|||
16176777|NCT02489630|39126227|FG001|Overall Study|Oversedation|1|||
16176778|NCT02489630|39126226|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
16176779|NCT02489630|39126227|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
16279010|NCT02129062|39504199|FG000|Overall Study|Disease Progression|2|||
16477874|NCT02761733|40228351|FG002|Overall Study|Cognitive Impairment|1|||
16176780|NCT04655586|39126230|FG000|Overall Study|Physician Decision|1|||
16176781|NCT04655586|39126231|FG001|Overall Study|Physician Decision|3|||
16176782|NCT04655586|39126232|FG002|Overall Study|Physician Decision|4|||
16176783|NCT04655586|39126230|FG000|Overall Study|Withdrawal by Subject|1|||
16176784|NCT04655586|39126231|FG001|Overall Study|Withdrawal by Subject|3|||
16176785|NCT04655586|39126232|FG002|Overall Study|Withdrawal by Subject|1|||
16176786|NCT02452359|39126235|FG000|Overall Study|Adverse Event|1|||
16176787|NCT02452359|39126235|FG000|Overall Study|Lost to Follow-up|15|||
16176788|NCT02452359|39126235|FG000|Overall Study|Pregnancy|1|||
16279011|NCT02308696|39504200|FG000|Overall Study|Lost to Follow-up|28|||
16477875|NCT02761733|40228352|FG003|Overall Study|Cognitive Impairment|0|||
16477876|NCT02846545|40228353|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
16477877|NCT02846545|40228354|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
16477878|NCT02846545|40228353|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
16176789|NCT02452359|39126235|FG000|Overall Study|Withdrawal by Subject|4|||
16176790|NCT02286960|39126236|FG000|Overall Study|Lost to Follow-up|3|||
16176791|NCT02286960|39126237|FG001|Overall Study|Lost to Follow-up|3|||
16176792|NCT02424149|39126239|FG000|Overall Study|surgery cancelled|2|||
16176793|NCT02424149|39126240|FG001|Overall Study|surgery cancelled|0|||
16176794|NCT02424149|39126239|FG000|Overall Study|Withdrawal by Subject|0|||
16176795|NCT02424149|39126240|FG001|Overall Study|Withdrawal by Subject|1|||
16176796|NCT01325493|39126241|FG000|Overall Study|Protocol Violation|0|||
16176797|NCT01325493|39126242|FG001|Overall Study|Protocol Violation|1|||
16176798|NCT01325493|39126241|FG000|Overall Study|loss of neuromonitoring signals|0|||
16176799|NCT01325493|39126242|FG001|Overall Study|loss of neuromonitoring signals|2|||
16176800|NCT01325493|39126241|FG000|Overall Study|Allergy|1|||
16176801|NCT01325493|39126242|FG001|Overall Study|Allergy|0|||
16176802|NCT01794780|39126243|FG000|Overall Study|Adverse Event|0|||
16176803|NCT01794780|39126244|FG001|Overall Study|Adverse Event|1|||
16176804|NCT01794780|39126245|FG002|Overall Study|Adverse Event|2|||
16176805|NCT01794780|39126246|FG003|Overall Study|Adverse Event|0|||
16176806|NCT01794780|39126247|FG004|Overall Study|Adverse Event|0|||
16176807|NCT01794780|39126248|FG005|Overall Study|Adverse Event|0|||
16176808|NCT01794780|39126249|FG006|Overall Study|Adverse Event|0|||
16176809|NCT01794780|39126250|FG007|Overall Study|Adverse Event|0|||
16176810|NCT01794780|39126243|FG000|Overall Study|Death|0|||
16176811|NCT01794780|39126244|FG001|Overall Study|Death|2|||
16176812|NCT01794780|39126245|FG002|Overall Study|Death|14|||
16176813|NCT01794780|39126246|FG003|Overall Study|Death|1|||
16176814|NCT01794780|39126247|FG004|Overall Study|Death|0|||
16176815|NCT01794780|39126248|FG005|Overall Study|Death|9|||
16176816|NCT01794780|39126249|FG006|Overall Study|Death|4|||
16176817|NCT01794780|39126250|FG007|Overall Study|Death|0|||
16176818|NCT01794780|39126243|FG000|Overall Study|Lost to Follow-up|10|||
16176819|NCT01794780|39126244|FG001|Overall Study|Lost to Follow-up|64|||
16176820|NCT01794780|39126245|FG002|Overall Study|Lost to Follow-up|165|||
16176821|NCT01794780|39126246|FG003|Overall Study|Lost to Follow-up|53|||
16176822|NCT01794780|39126247|FG004|Overall Study|Lost to Follow-up|2|||
16176823|NCT01794780|39126248|FG005|Overall Study|Lost to Follow-up|99|||
16176824|NCT01794780|39126249|FG006|Overall Study|Lost to Follow-up|30|||
16176825|NCT01794780|39126250|FG007|Overall Study|Lost to Follow-up|5|||
16176826|NCT01794780|39126243|FG000|Overall Study|Withdrew informed consent|7|||
16176827|NCT01794780|39126244|FG001|Overall Study|Withdrew informed consent|17|||
16176828|NCT01794780|39126245|FG002|Overall Study|Withdrew informed consent|36|||
16176829|NCT01794780|39126246|FG003|Overall Study|Withdrew informed consent|9|||
16176830|NCT01794780|39126247|FG004|Overall Study|Withdrew informed consent|0|||
16176831|NCT01794780|39126248|FG005|Overall Study|Withdrew informed consent|48|||
16176832|NCT01794780|39126249|FG006|Overall Study|Withdrew informed consent|4|||
16176833|NCT01794780|39126250|FG007|Overall Study|Withdrew informed consent|3|||
16176834|NCT01794780|39126243|FG000|Overall Study|Other|0|||
16176835|NCT01794780|39126244|FG001|Overall Study|Other|12|||
16176836|NCT01794780|39126245|FG002|Overall Study|Other|25|||
16176837|NCT01794780|39126246|FG003|Overall Study|Other|20|||
16176838|NCT01794780|39126247|FG004|Overall Study|Other|1|||
16176839|NCT01794780|39126248|FG005|Overall Study|Other|24|||
16176840|NCT01794780|39126249|FG006|Overall Study|Other|4|||
16176841|NCT01794780|39126250|FG007|Overall Study|Other|1|||
16176842|NCT04112914|39126256|FG000|Overall Study|Lost to Follow-up|13|||
16176843|NCT04112914|39126257|FG001|Overall Study|Lost to Follow-up|9|||
16176844|NCT04112914|39126256|FG000|Overall Study|Withdrawal by Subject|1|||
16176845|NCT04112914|39126257|FG001|Overall Study|Withdrawal by Subject|0|||
16176846|NCT01157169|39126258|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
16176847|NCT01157169|39126259|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
16176848|NCT01157169|39126258|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
16176849|NCT01157169|39126259|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
16176850|NCT01299025|39126260|FG000|Overall Study|Withdrawal by Subject|2|||
16176851|NCT01299025|39126261|FG001|Overall Study|Withdrawal by Subject|1|||
16176852|NCT01299025|39126260|FG000|Overall Study|Lost to Follow-up|1|||
16176853|NCT01299025|39126261|FG001|Overall Study|Lost to Follow-up|0|||
16176854|NCT01318902|39126262|FG000|Overall Study|Symptomatic Deterioration|0|||
16176855|NCT01318902|39126263|FG001|Overall Study|Symptomatic Deterioration|1|||
16176856|NCT01318902|39126264|FG002|Overall Study|Symptomatic Deterioration|1|||
16176857|NCT01318902|39126265|FG003|Overall Study|Symptomatic Deterioration|2|||
16176858|NCT01318902|39126262|FG000|Overall Study|Withdrawal by Patient|0|||
16176859|NCT01318902|39126263|FG001|Overall Study|Withdrawal by Patient|1|||
16176860|NCT01318902|39126264|FG002|Overall Study|Withdrawal by Patient|0|||
16176861|NCT01318902|39126265|FG003|Overall Study|Withdrawal by Patient|3|||
16176862|NCT01318902|39126262|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
16176863|NCT01318902|39126263|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
16176864|NCT01318902|39126264|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
16176865|NCT01318902|39126265|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
16176866|NCT01318902|39126262|FG000|Overall Study|Adverse Event|0|||
16176867|NCT01318902|39126263|FG001|Overall Study|Adverse Event|1|||
16176868|NCT01318902|39126264|FG002|Overall Study|Adverse Event|0|||
16176869|NCT01318902|39126265|FG003|Overall Study|Adverse Event|0|||
16176870|NCT01318902|39126262|FG000|Overall Study|Terminated by Sponsor|0|||
16176871|NCT01318902|39126263|FG001|Overall Study|Terminated by Sponsor|0|||
16176872|NCT01318902|39126264|FG002|Overall Study|Terminated by Sponsor|1|||
16176873|NCT01318902|39126265|FG003|Overall Study|Terminated by Sponsor|0|||
16176874|NCT01739595|39126270|FG000|Overall Study|Adverse Event|3|||
16176875|NCT01739595|39126271|FG001|Overall Study|Adverse Event|0|||
16176876|NCT01739595|39126272|FG002|Overall Study|Adverse Event|0|||
16176877|NCT01739595|39126270|FG000|Overall Study|Lost to Follow-up|2|||
16176878|NCT01739595|39126271|FG001|Overall Study|Lost to Follow-up|0|||
16176879|NCT01739595|39126272|FG002|Overall Study|Lost to Follow-up|0|||
16176880|NCT01739595|39126270|FG000|Overall Study|Withdrawal by Subject|2|||
16176881|NCT01739595|39126271|FG001|Overall Study|Withdrawal by Subject|1|||
16176882|NCT01739595|39126272|FG002|Overall Study|Withdrawal by Subject|2|||
16176883|NCT01739595|39126270|FG000|Overall Study|Eligibility issue|3|||
16176884|NCT01739595|39126271|FG001|Overall Study|Eligibility issue|0|||
16477879|NCT02846545|40228354|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
16477880|NCT02846545|40228353|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
16477881|NCT02846545|40228354|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
16477882|NCT02846545|40228353|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
16477883|NCT02846545|40228354|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
16477884|NCT02846545|40228353|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
16176885|NCT01739595|39126272|FG002|Overall Study|Eligibility issue|0|||
16176886|NCT01739595|39126270|FG000|Overall Study|Protocol Violation|1|||
16176887|NCT01739595|39126271|FG001|Overall Study|Protocol Violation|0|||
16176888|NCT01739595|39126272|FG002|Overall Study|Protocol Violation|0|||
16176889|NCT01739595|39126270|FG000|Overall Study|Lab assessment|1|||
16176890|NCT01739595|39126271|FG001|Overall Study|Lab assessment|0|||
16176891|NCT01739595|39126272|FG002|Overall Study|Lab assessment|0|||
16176892|NCT01739595|39126270|FG000|Overall Study|Drug discrepancy|1|||
16176893|NCT01739595|39126271|FG001|Overall Study|Drug discrepancy|0|||
16176894|NCT01739595|39126272|FG002|Overall Study|Drug discrepancy|0|||
16176895|NCT03455543|39126273|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
16477885|NCT02846545|40228354|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
16477886|NCT01254331|40228356|FG000|Initial Phase|Adverse Event|3|||
16477887|NCT01254331|40228356|FG000|Initial Phase|Withdrawal by Subject|1|||
16477888|NCT01254331|40228356|FG000|Initial Phase|Pregnancy|1|||
16176896|NCT03455543|39126274|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
16176897|NCT03455543|39126275|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
16176898|NCT03455543|39126273|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
16176899|NCT03455543|39126274|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
16176900|NCT03455543|39126275|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
16176901|NCT03455543|39126273|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
16176902|NCT03455543|39126274|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
16176903|NCT03455543|39126275|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
16176904|NCT03455543|39126273|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
16176905|NCT03455543|39126274|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
16176906|NCT03455543|39126275|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
16176907|NCT03455543|39126273|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
16477889|NCT01254331|40228356|FG000|Extension Phase|Lack of Efficacy|1|||
16477890|NCT01254331|40228356|FG000|Extension Phase|Lost to Follow-up|3|||
16477891|NCT03000569|40228359|FG000|Overall Study|Withdrawal by Subject|1|||
16477892|NCT03000569|40228360|FG001|Overall Study|Withdrawal by Subject|0|||
16477893|NCT04308304|40228361|FG000|Overall Study|Withdrawal by Subject|4|||
16477894|NCT04308304|40228362|FG001|Overall Study|Withdrawal by Subject|0|||
16477895|NCT04308304|40228361|FG000|Overall Study|Protocol Violation|1|||
16176908|NCT03455543|39126274|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
16176909|NCT03455543|39126275|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
16176910|NCT03455543|39126273|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
16176911|NCT03455543|39126274|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
16176912|NCT03455543|39126275|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
16176913|NCT03455543|39126273|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
16176914|NCT03455543|39126274|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
16176915|NCT03455543|39126275|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
16176916|NCT03455543|39126273|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
16176917|NCT03455543|39126274|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
16477896|NCT04308304|40228362|FG001|Overall Study|Protocol Violation|0|||
16477897|NCT00434954|40228365|FG000|Overall Study|Adverse Event|17|||
16477898|NCT00434954|40228366|FG001|Overall Study|Adverse Event|2|||
16477899|NCT00434954|40228365|FG000|Overall Study|Entry criteria not met|14|||
16477900|NCT00434954|40228366|FG001|Overall Study|Entry criteria not met|16|||
16477901|NCT00434954|40228365|FG000|Overall Study|Lost to Follow-up|0|||
16477902|NCT00434954|40228366|FG001|Overall Study|Lost to Follow-up|1|||
16477903|NCT00434954|40228365|FG000|Overall Study|Physician Decision|6|||
16477904|NCT00434954|40228366|FG001|Overall Study|Physician Decision|3|||
16477905|NCT00434954|40228365|FG000|Overall Study|Protocol Violation|36|||
16477906|NCT00434954|40228366|FG001|Overall Study|Protocol Violation|27|||
16477907|NCT00434954|40228365|FG000|Overall Study|Sponsor decision|1|||
16477908|NCT00434954|40228366|FG001|Overall Study|Sponsor decision|0|||
16477909|NCT00434954|40228365|FG000|Overall Study|Subject decision|8|||
16477910|NCT00434954|40228366|FG001|Overall Study|Subject decision|22|||
16477911|NCT00660673|40230968|FG000|Overall Study|Adverse Event|84|||
16477912|NCT00660673|40230968|FG000|Overall Study|Lack of Efficacy|7|||
16477913|NCT00660673|40230968|FG000|Overall Study|Withdrawal by Subject|22|||
16477914|NCT00660673|40230968|FG000|Overall Study|Administrative|2|||
16477915|NCT00660673|40230968|FG000|Overall Study|Protocol Violation|2|||
16477916|NCT00788073|40230971|FG000|STX209 Then Placebo|Adverse Event|1|||
16477917|NCT00788073|40230972|FG001|STX209 Then Placebo|Adverse Event|0|||
16477918|NCT00788073|40230971|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
16477919|NCT00788073|40230972|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
16477920|NCT00788073|40230971|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
16477921|NCT00788073|40230972|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
16477922|NCT00788073|40230971|FG000|STX209 Then Placebo|unable to return due to travel|0|||
16477923|NCT00788073|40230972|FG001|STX209 Then Placebo|unable to return due to travel|1|||
16477924|NCT00788073|40230971|FG000|Placebo Then STX209|Adverse Event|2|||
16477925|NCT00788073|40230972|FG001|Placebo Then STX209|Adverse Event|0|||
16477926|NCT00788073|40230971|FG000|Placebo Then STX209|Protocol Violation|0|||
16477927|NCT00788073|40230972|FG001|Placebo Then STX209|Protocol Violation|1|||
16477928|NCT01361568|40230974|FG000|Overall Study|Adverse Event|0|||
16477929|NCT01361568|40230975|FG001|Overall Study|Adverse Event|0|||
16477930|NCT01361568|40230976|FG002|Overall Study|Adverse Event|0|||
16477931|NCT01361568|40230977|FG003|Overall Study|Adverse Event|0|||
16477932|NCT01361568|40230978|FG004|Overall Study|Adverse Event|1|||
16477933|NCT01361568|40230979|FG005|Overall Study|Adverse Event|0|||
16477934|NCT01361568|40230974|FG000|Overall Study|Physician Decision|0|||
16477935|NCT01361568|40230975|FG001|Overall Study|Physician Decision|0|||
16477936|NCT01361568|40230976|FG002|Overall Study|Physician Decision|0|||
16477937|NCT01361568|40230977|FG003|Overall Study|Physician Decision|0|||
16477938|NCT01361568|40230978|FG004|Overall Study|Physician Decision|0|||
16477939|NCT01361568|40230979|FG005|Overall Study|Physician Decision|1|||
16477940|NCT01361568|40230974|FG000|Overall Study|Withdrawal by Subject|2|||
16477941|NCT01361568|40230975|FG001|Overall Study|Withdrawal by Subject|1|||
16477942|NCT01361568|40230976|FG002|Overall Study|Withdrawal by Subject|0|||
16477943|NCT01361568|40230977|FG003|Overall Study|Withdrawal by Subject|0|||
16477944|NCT01361568|40230978|FG004|Overall Study|Withdrawal by Subject|0|||
16477945|NCT01361568|40230979|FG005|Overall Study|Withdrawal by Subject|1|||
16477946|NCT00939640|40230980|FG000|Overall Study|Physician Decision|1|||
16477947|NCT00668707|40230984|FG000|Overall Study|Cancer Recurrence|58|||
16477948|NCT00668707|40230985|FG001|Overall Study|Cancer Recurrence|58|||
16176918|NCT03455543|39126275|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
16176919|NCT03455543|39126273|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
16176920|NCT03455543|39126274|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
16279012|NCT02308696|39504201|FG001|Overall Study|Lost to Follow-up|21|||
16477949|NCT00668707|40230984|FG000|Overall Study|Withdrawal by Subject|117|||
16477950|NCT00668707|40230985|FG001|Overall Study|Withdrawal by Subject|100|||
16477951|NCT00668707|40230984|FG000|Overall Study|Lost to Follow-up|3|||
16477952|NCT00668707|40230985|FG001|Overall Study|Lost to Follow-up|6|||
16477953|NCT00668707|40230984|FG000|Overall Study|Protocol Violation|10|||
16477954|NCT00668707|40230985|FG001|Overall Study|Protocol Violation|12|||
16477955|NCT00668707|40230984|FG000|Overall Study|Death|11|||
16477956|NCT00668707|40230985|FG001|Overall Study|Death|4|||
16477957|NCT01068652|40230987|FG000|Overall Study|Adverse Event|4|||
16477958|NCT01068652|40230988|FG001|Overall Study|Adverse Event|0|||
16477959|NCT01068652|40230987|FG000|Overall Study|Lack of Efficacy|0|||
16477960|NCT01068652|40230988|FG001|Overall Study|Lack of Efficacy|2|||
16477961|NCT01068652|40230987|FG000|Overall Study|Lost to Follow-up|2|||
16477962|NCT01068652|40230988|FG001|Overall Study|Lost to Follow-up|1|||
16477963|NCT01068652|40230987|FG000|Overall Study|Protocol Violation|3|||
16477964|NCT01068652|40230988|FG001|Overall Study|Protocol Violation|6|||
16477965|NCT01068652|40230987|FG000|Overall Study|Withdrawal criteria|1|||
16477966|NCT01068652|40230988|FG001|Overall Study|Withdrawal criteria|2|||
16477967|NCT01068652|40230987|FG000|Overall Study|Patient was not eligible|1|||
16477968|NCT01068652|40230988|FG001|Overall Study|Patient was not eligible|0|||
16477969|NCT01068652|40230987|FG000|Overall Study|Unclassified|7|||
16477970|NCT01068652|40230988|FG001|Overall Study|Unclassified|4|||
16477971|NCT00408629|40230989|FG000|Overall Study|Adverse Event|13|||
16477972|NCT00408629|40230990|FG001|Overall Study|Adverse Event|27|||
16477973|NCT00408629|40230989|FG000|Overall Study|Withdrawal by Subject|8|||
16477974|NCT00408629|40230990|FG001|Overall Study|Withdrawal by Subject|4|||
16477975|NCT00408629|40230989|FG000|Overall Study|Lost to Follow-up|1|||
16477976|NCT00408629|40230990|FG001|Overall Study|Lost to Follow-up|1|||
16477977|NCT00408629|40230989|FG000|Overall Study|Lack of Efficacy|63|||
16477978|NCT00408629|40230990|FG001|Overall Study|Lack of Efficacy|73|||
16477979|NCT00408629|40230989|FG000|Overall Study|Protocol Violation|1|||
16477980|NCT00408629|40230990|FG001|Overall Study|Protocol Violation|5|||
16477981|NCT00408629|40230989|FG000|Overall Study|Miscellaneous|11|||
16477982|NCT00408629|40230990|FG001|Overall Study|Miscellaneous|15|||
16477983|NCT04729621|40230992|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
16477984|NCT04729621|40230993|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
16477985|NCT04729621|40230994|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
16477986|NCT04729621|40230995|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
16477987|NCT04729621|40230996|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
16477988|NCT04729621|40230992|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
16477989|NCT04729621|40230993|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
16477990|NCT04729621|40230994|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
16477991|NCT04729621|40230995|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
16477992|NCT04729621|40230996|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
16477993|NCT04729621|40230992|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
16477994|NCT04729621|40230993|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
16477995|NCT04729621|40230994|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
16477996|NCT04729621|40230995|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
16477997|NCT04729621|40230996|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
16477998|NCT04729621|40230992|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
16477999|NCT04729621|40230993|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
16478000|NCT04729621|40230994|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
16478001|NCT04729621|40230995|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
16478002|NCT04729621|40230996|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
16478003|NCT04729621|40230992|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
16478004|NCT04729621|40230993|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
16478005|NCT04729621|40230994|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
16478006|NCT04729621|40230995|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
16478007|NCT04729621|40230996|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
16478008|NCT04729621|40230992|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
16478009|NCT04729621|40230993|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
16478010|NCT04729621|40230994|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
16478011|NCT04729621|40230995|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
16478012|NCT04729621|40230996|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
16478013|NCT00074984|40230997|FG000|Overall Study|Death|1|||
16478014|NCT00074984|40230998|FG001|Overall Study|Death|2|||
16478015|NCT00074984|40230997|FG000|Overall Study|Withdrawal by Subject|2|||
16478016|NCT00074984|40230998|FG001|Overall Study|Withdrawal by Subject|3|||
16478017|NCT00074984|40230997|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
16478018|NCT00074984|40230998|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
16478019|NCT02298023|40230999|FG000|Overall Study|Withdrawal by Subject|1|||
16478020|NCT02298023|40231000|FG001|Overall Study|Withdrawal by Subject|0|||
16478021|NCT02298023|40231001|FG002|Overall Study|Withdrawal by Subject|0|||
16478022|NCT01419626|40231002|FG000|Overall Study|Protocol Violation|3|||
16478023|NCT01419626|40231003|FG001|Overall Study|Protocol Violation|2|||
16478024|NCT01419626|40231004|FG002|Overall Study|Protocol Violation|2|||
16478025|NCT01419626|40231002|FG000|Overall Study|Withdrawal by Subject|1|||
16478026|NCT01419626|40231003|FG001|Overall Study|Withdrawal by Subject|0|||
16478027|NCT01419626|40231004|FG002|Overall Study|Withdrawal by Subject|0|||
16478028|NCT01419626|40231002|FG000|Overall Study|Lost to Follow-up|0|||
16478029|NCT01419626|40231003|FG001|Overall Study|Lost to Follow-up|1|||
16478030|NCT01419626|40231004|FG002|Overall Study|Lost to Follow-up|1|||
16478031|NCT00066729|40231010|FG000|Overall Study|Lost to Follow-up|1|||
16478032|NCT00066729|40231010|FG000|Overall Study|Disease progression|1|||
16478033|NCT00621959|40231012|FG000|Overall Study|Adverse Event|4|||
16478034|NCT00621959|40231013|FG001|Overall Study|Adverse Event|2|||
16478035|NCT00621959|40231012|FG000|Overall Study|Lack of Efficacy|1|||
16478036|NCT00621959|40231013|FG001|Overall Study|Lack of Efficacy|1|||
16478037|NCT00621959|40231012|FG000|Overall Study|Lost to Follow-up|0|||
16478038|NCT00621959|40231013|FG001|Overall Study|Lost to Follow-up|2|||
16478039|NCT00621959|40231012|FG000|Overall Study|Withdrawal by Subject|1|||
16478040|NCT00621959|40231013|FG001|Overall Study|Withdrawal by Subject|1|||
16478041|NCT00621959|40231012|FG000|Overall Study|Other|1|||
16478042|NCT00621959|40231013|FG001|Overall Study|Other|3|||
16478043|NCT02716805|40231016|FG000|Overall Study|Progressive disease|2|||
16478044|NCT02716805|40231017|FG001|Overall Study|Progressive disease|0|||
16478045|NCT02716805|40231018|FG002|Overall Study|Progressive disease|0|||
16478046|NCT02716805|40231019|FG003|Overall Study|Progressive disease|0|||
16478047|NCT02281773|40231025|FG000|Overall Study|Adverse Event|6|||
16478048|NCT02281773|40231026|FG001|Overall Study|Adverse Event|1|||
16478049|NCT02281773|40231027|FG002|Overall Study|Adverse Event|4|||
16478050|NCT02281773|40231028|FG003|Overall Study|Adverse Event|8|||
16478051|NCT02281773|40231029|FG004|Overall Study|Adverse Event|9|||
16478052|NCT02281773|40231025|FG000|Overall Study|Protocol Violation|1|||
16478053|NCT02281773|40231026|FG001|Overall Study|Protocol Violation|0|||
16478054|NCT02281773|40231027|FG002|Overall Study|Protocol Violation|0|||
16478055|NCT02281773|40231028|FG003|Overall Study|Protocol Violation|2|||
16478056|NCT02281773|40231029|FG004|Overall Study|Protocol Violation|2|||
16478057|NCT02281773|40231025|FG000|Overall Study|Lost to Follow-up|2|||
16478058|NCT02281773|40231026|FG001|Overall Study|Lost to Follow-up|2|||
16478059|NCT02281773|40231027|FG002|Overall Study|Lost to Follow-up|6|||
16478060|NCT02281773|40231028|FG003|Overall Study|Lost to Follow-up|2|||
16478061|NCT02281773|40231029|FG004|Overall Study|Lost to Follow-up|10|||
16478062|NCT02281773|40231025|FG000|Overall Study|Withdrawal by Subject|2|||
16478063|NCT02281773|40231026|FG001|Overall Study|Withdrawal by Subject|8|||
16478064|NCT02281773|40231027|FG002|Overall Study|Withdrawal by Subject|6|||
16176921|NCT03455543|39126275|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
16176922|NCT00023322|39126276|FG000|Overall Study|Lost to Follow-up|1|||
16176923|NCT02209766|39126280|FG000|Overall Study|Withdrawal by Subject|0|||
16176924|NCT02209766|39126281|FG001|Overall Study|Withdrawal by Subject|0|||
16176925|NCT02209766|39126282|FG002|Overall Study|Withdrawal by Subject|0|||
16176926|NCT02209766|39126283|FG003|Overall Study|Withdrawal by Subject|1|||
16176927|NCT02209766|39126284|FG004|Overall Study|Withdrawal by Subject|0|||
16176928|NCT02886715|39126285|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16176929|NCT02886715|39126286|FG001|Overall Study|Non-Compliance With Study Drug|2|||
16176930|NCT02886715|39126287|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16176931|NCT02886715|39126285|FG000|Overall Study|Adverse Event|4|||
16176932|NCT02886715|39126286|FG001|Overall Study|Adverse Event|2|||
16176933|NCT02886715|39126287|FG002|Overall Study|Adverse Event|0|||
16176934|NCT02886715|39126285|FG000|Overall Study|Lack of Efficacy|0|||
16176935|NCT02886715|39126286|FG001|Overall Study|Lack of Efficacy|2|||
16176936|NCT02886715|39126287|FG002|Overall Study|Lack of Efficacy|1|||
16176937|NCT02886715|39126285|FG000|Overall Study|Lost to Follow-up|29|||
16176938|NCT02886715|39126286|FG001|Overall Study|Lost to Follow-up|26|||
16176939|NCT02886715|39126287|FG002|Overall Study|Lost to Follow-up|10|||
16176940|NCT02886715|39126285|FG000|Overall Study|Pregnancy|1|||
16176941|NCT02886715|39126286|FG001|Overall Study|Pregnancy|1|||
16176942|NCT02886715|39126287|FG002|Overall Study|Pregnancy|1|||
16176943|NCT02886715|39126285|FG000|Overall Study|Protocol Violation|3|||
16176944|NCT02886715|39126286|FG001|Overall Study|Protocol Violation|2|||
16176945|NCT02886715|39126287|FG002|Overall Study|Protocol Violation|1|||
16176946|NCT02886715|39126285|FG000|Overall Study|Withdrawal by Subject|20|||
16176947|NCT02886715|39126286|FG001|Overall Study|Withdrawal by Subject|18|||
16176948|NCT02886715|39126287|FG002|Overall Study|Withdrawal by Subject|5|||
16176949|NCT02886715|39126285|FG000|Overall Study|missing|7|||
16176950|NCT02886715|39126286|FG001|Overall Study|missing|2|||
16176951|NCT02886715|39126287|FG002|Overall Study|missing|2|||
16176952|NCT01750918|39126290|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
16176953|NCT01750918|39126291|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
16176954|NCT01750918|39126292|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
16176955|NCT01750918|39126293|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
16176956|NCT01750918|39126294|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
16176957|NCT01750918|39126295|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
16176958|NCT01750918|39126296|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
16176959|NCT01750918|39126297|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
16176960|NCT01750918|39126290|FG000|Overall Study|Lost to Follow-up|0|||
16176961|NCT01750918|39126291|FG001|Overall Study|Lost to Follow-up|0|||
16176962|NCT01750918|39126292|FG002|Overall Study|Lost to Follow-up|2|||
16176963|NCT01750918|39126293|FG003|Overall Study|Lost to Follow-up|2|||
16176964|NCT01750918|39126294|FG004|Overall Study|Lost to Follow-up|0|||
16279013|NCT02308696|39504200|FG000|Overall Study|Death|8|||
16176965|NCT01750918|39126295|FG005|Overall Study|Lost to Follow-up|0|||
16478065|NCT02281773|40231028|FG003|Overall Study|Withdrawal by Subject|6|||
16478066|NCT02281773|40231029|FG004|Overall Study|Withdrawal by Subject|8|||
16478067|NCT02281773|40231025|FG000|Overall Study|Other Reason|0|||
16478068|NCT02281773|40231026|FG001|Overall Study|Other Reason|4|||
16478069|NCT02281773|40231027|FG002|Overall Study|Other Reason|2|||
16478070|NCT02281773|40231028|FG003|Overall Study|Other Reason|3|||
16279014|NCT02308696|39504201|FG001|Overall Study|Death|4|||
16079842|NCT00402246|38786676|FG001|Overall Study|Heart Transplant|1|||
16079843|NCT00402246|38786675|FG000|Overall Study|Patient's device explanted|6|||
16079844|NCT00402246|38786676|FG001|Overall Study|Patient's device explanted|2|||
16079845|NCT00402246|38786675|FG000|Overall Study|Center Closure|5|||
16079846|NCT00402246|38786676|FG001|Overall Study|Center Closure|3|||
16079847|NCT00402246|38786675|FG000|Overall Study|Deterioriating Condition|3|||
16079848|NCT00402246|38786676|FG001|Overall Study|Deterioriating Condition|2|||
16079849|NCT01184326|38786677|FG000|Overall Study|Adverse Event|1|||
16079850|NCT01184326|38786678|FG001|Overall Study|Adverse Event|2|||
16079851|NCT01184326|38786679|FG002|Overall Study|Adverse Event|0|||
16079852|NCT01184326|38786677|FG000|Overall Study|Death|0|||
16079853|NCT01184326|38786678|FG001|Overall Study|Death|0|||
16079854|NCT01184326|38786679|FG002|Overall Study|Death|1|||
16079855|NCT01184326|38786677|FG000|Overall Study|Withdrawal by Subject|0|||
16079856|NCT01184326|38786678|FG001|Overall Study|Withdrawal by Subject|0|||
16079857|NCT01184326|38786679|FG002|Overall Study|Withdrawal by Subject|1|||
16079858|NCT01184326|38786677|FG000|Overall Study|Physician Decision|1|||
16079859|NCT01184326|38786678|FG001|Overall Study|Physician Decision|1|||
16079860|NCT01184326|38786679|FG002|Overall Study|Physician Decision|0|||
16079861|NCT01184326|38786677|FG000|Overall Study|Disease Progression|1|||
16079862|NCT01184326|38786678|FG001|Overall Study|Disease Progression|3|||
16079863|NCT01184326|38786679|FG002|Overall Study|Disease Progression|12|||
16079864|NCT02463448|38786680|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
16079865|NCT02463448|38786680|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
16079866|NCT02463448|38786680|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
16079867|NCT02463448|38786680|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
16079868|NCT04377308|38786681|FG000|Overall Study|Withdrawal by Subject|0|||
16079869|NCT04377308|38786682|FG001|Overall Study|Withdrawal by Subject|1|||
16079870|NCT00088413|38786688|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
16079871|NCT00088413|38786689|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
16079872|NCT00088413|38786690|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
16079873|NCT00088413|38786691|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
16079874|NCT00088413|38786688|FG000|Overall Study|Adverse Events/Side Effects|0|||
16079875|NCT00088413|38786689|FG001|Overall Study|Adverse Events/Side Effects|1|||
16079876|NCT00088413|38786690|FG002|Overall Study|Adverse Events/Side Effects|1|||
16079877|NCT00088413|38786691|FG003|Overall Study|Adverse Events/Side Effects|0|||
16079878|NCT00088413|38786688|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
16079879|NCT00088413|38786689|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
16079880|NCT00088413|38786690|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
16079881|NCT00088413|38786691|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
16079882|NCT00088413|38786688|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
16079883|NCT00088413|38786689|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
16079884|NCT00088413|38786690|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
16079885|NCT00088413|38786691|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
16079886|NCT00088413|38786688|FG000|Overall Study|Death|0|||
16079887|NCT00088413|38786689|FG001|Overall Study|Death|1|||
16079888|NCT00088413|38786690|FG002|Overall Study|Death|0|||
16079889|NCT00088413|38786691|FG003|Overall Study|Death|0|||
16079890|NCT00088413|38786688|FG000|Overall Study|Progressive disease|9|||
16079891|NCT00088413|38786689|FG001|Overall Study|Progressive disease|11|||
16079892|NCT00088413|38786690|FG002|Overall Study|Progressive disease|8|||
16079893|NCT00088413|38786691|FG003|Overall Study|Progressive disease|14|||
16079894|NCT00088413|38786688|FG000|Overall Study|Other|0|||
16079895|NCT00088413|38786689|FG001|Overall Study|Other|1|||
16079896|NCT00088413|38786690|FG002|Overall Study|Other|0|||
16079897|NCT00088413|38786691|FG003|Overall Study|Other|0|||
16079898|NCT00088413|38786688|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
16079899|NCT00088413|38786689|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
16079900|NCT00088413|38786690|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
16079901|NCT00088413|38786691|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
16079902|NCT02584829|38786694|FG000|Overall Study|Physician Decision|1|||
16079903|NCT02584829|38786695|FG001|Overall Study|Physician Decision|0|||
16079904|NCT02584829|38786694|FG000|Overall Study|Withdrawal by Subject|0|||
16079905|NCT02584829|38786695|FG001|Overall Study|Withdrawal by Subject|1|||
16079906|NCT02584829|38786694|FG000|Overall Study|Progressive Disease|0|||
16079907|NCT02584829|38786695|FG001|Overall Study|Progressive Disease|3|||
16079908|NCT00516321|38786696|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
16079909|NCT00516321|38786697|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
16079910|NCT00516321|38786698|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
16079911|NCT00516321|38786696|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
16079912|NCT00516321|38786697|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
16079913|NCT00516321|38786698|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
16079914|NCT00516321|38786696|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
16279015|NCT02308696|39504200|FG000|Overall Study|Moved to a Higher Level of Care|17|||
16176966|NCT01750918|39126296|FG006|Overall Study|Lost to Follow-up|0|||
16176967|NCT01750918|39126297|FG007|Overall Study|Lost to Follow-up|1|||
16176968|NCT01750918|39126290|FG000|Overall Study|Withdrawal by Subject|0|||
16176969|NCT01750918|39126291|FG001|Overall Study|Withdrawal by Subject|0|||
16176970|NCT01750918|39126292|FG002|Overall Study|Withdrawal by Subject|1|||
16176971|NCT01750918|39126293|FG003|Overall Study|Withdrawal by Subject|2|||
16176972|NCT01750918|39126294|FG004|Overall Study|Withdrawal by Subject|1|||
16176973|NCT01750918|39126295|FG005|Overall Study|Withdrawal by Subject|1|||
16176974|NCT01750918|39126296|FG006|Overall Study|Withdrawal by Subject|2|||
16176975|NCT01750918|39126297|FG007|Overall Study|Withdrawal by Subject|2|||
16176976|NCT02517515|39126300|FG000|Overall Study|Adverse Event|0|||
16176977|NCT02517515|39126301|FG001|Overall Study|Adverse Event|1|||
16176978|NCT02517515|39126300|FG000|Overall Study|Withdrew Consent|0|||
16176979|NCT02517515|39126301|FG001|Overall Study|Withdrew Consent|1|||
16176980|NCT02517515|39126300|FG000|Overall Study|Lost to Follow-up|1|||
16176981|NCT02517515|39126301|FG001|Overall Study|Lost to Follow-up|0|||
16176982|NCT02517515|39126300|FG000|Overall Study|Other|1|||
16176983|NCT02517515|39126301|FG001|Overall Study|Other|0|||
16176984|NCT04375878|39126304|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
16176985|NCT04375878|39126305|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
16176986|NCT04375878|39126306|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
16176987|NCT04375878|39126307|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
16176988|NCT04375878|39126308|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
16176989|NCT04375878|39126309|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
16176990|NCT04375878|39126304|FG000|Crossover First and Second Interventions|Adverse Event|0|||
16176991|NCT04375878|39126305|FG001|Crossover First and Second Interventions|Adverse Event|0|||
16176992|NCT04375878|39126306|FG002|Crossover First and Second Interventions|Adverse Event|1|||
16176993|NCT04375878|39126307|FG003|Crossover First and Second Interventions|Adverse Event|0|||
16176994|NCT04375878|39126308|FG004|Crossover First and Second Interventions|Adverse Event|0|||
16176995|NCT04375878|39126309|FG005|Crossover First and Second Interventions|Adverse Event|0|||
16176996|NCT04375878|39126304|FG000|Extension Phase|Withdrawal by Subject|0|||
16176997|NCT04375878|39126305|FG001|Extension Phase|Withdrawal by Subject|0|||
16176998|NCT04375878|39126306|FG002|Extension Phase|Withdrawal by Subject|0|||
16176999|NCT04375878|39126307|FG003|Extension Phase|Withdrawal by Subject|0|||
16177000|NCT04375878|39126308|FG004|Extension Phase|Withdrawal by Subject|1|||
16177001|NCT04375878|39126309|FG005|Extension Phase|Withdrawal by Subject|0|||
16177002|NCT00503399|39126310|FG000|Overall Study|Death|2|||
16177003|NCT00503399|39126311|FG001|Overall Study|Death|1|||
16177004|NCT00503399|39126310|FG000|Overall Study|Protocol Violation|1|||
16177005|NCT00503399|39126311|FG001|Overall Study|Protocol Violation|0|||
16177006|NCT00503399|39126310|FG000|Overall Study|Withdrawal by Subject|4|||
16177007|NCT00503399|39126311|FG001|Overall Study|Withdrawal by Subject|2|||
16177008|NCT00503399|39126310|FG000|Overall Study|Adverse Event|0|||
16177009|NCT00503399|39126311|FG001|Overall Study|Adverse Event|3|||
16177010|NCT00503399|39126310|FG000|Overall Study|Lost to Follow-up|0|||
16177011|NCT00503399|39126311|FG001|Overall Study|Lost to Follow-up|2|||
16177012|NCT02286102|39126312|FG000|Overall Study|Screen Failure|1|||
16177013|NCT02286102|39126313|FG001|Overall Study|Screen Failure|1|||
16177014|NCT03015532|39126314|FG000|Overall Study|Adverse Event|0|||
16177015|NCT03015532|39126315|FG001|Overall Study|Adverse Event|0|||
16177016|NCT03015532|39126316|FG002|Overall Study|Adverse Event|0|||
16177017|NCT03015532|39126317|FG003|Overall Study|Adverse Event|0|||
16177018|NCT03015532|39126318|FG004|Overall Study|Adverse Event|0|||
16177019|NCT03015532|39126319|FG005|Overall Study|Adverse Event|2|||
16177020|NCT03015532|39126320|FG006|Overall Study|Adverse Event|1|||
16177021|NCT03015532|39126321|FG007|Overall Study|Adverse Event|0|||
16177022|NCT03015532|39126314|FG000|Overall Study|Withdrawal by Subject|0|||
16177023|NCT03015532|39126315|FG001|Overall Study|Withdrawal by Subject|0|||
16177024|NCT03015532|39126316|FG002|Overall Study|Withdrawal by Subject|0|||
16177025|NCT03015532|39126317|FG003|Overall Study|Withdrawal by Subject|0|||
16177026|NCT03015532|39126318|FG004|Overall Study|Withdrawal by Subject|0|||
16177027|NCT03015532|39126319|FG005|Overall Study|Withdrawal by Subject|0|||
16177028|NCT03015532|39126320|FG006|Overall Study|Withdrawal by Subject|1|||
16177029|NCT03015532|39126321|FG007|Overall Study|Withdrawal by Subject|0|||
16177030|NCT02868892|39126323|FG000|Overall Study|Investigator left site and no follow-up|6|||
16177031|NCT00215150|39126327|FG000|Open Label Phase|Lost to Follow-up|7|||
16177032|NCT00215150|39126327|FG000|Open Label Phase|Withdrawal by Subject|1|||
16177033|NCT00215150|39126327|FG000|Open Label Phase|Did not complete a post base visit|13|||
16177034|NCT00215150|39126327|FG000|Open Label Phase|Did not meet randomization criteria|9|||
16177035|NCT00215150|39126327|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
16177036|NCT00215150|39126327|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
16177037|NCT00215150|39126327|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
16177038|NCT02770807|39126328|FG000|Overall Study|Adverse Event|3|||
16177039|NCT02770807|39126329|FG001|Overall Study|Adverse Event|3|||
16177040|NCT02770807|39126330|FG002|Overall Study|Adverse Event|1|||
16177041|NCT02770807|39126328|FG000|Overall Study|Withdrawal by Subject|7|||
16177042|NCT02770807|39126329|FG001|Overall Study|Withdrawal by Subject|3|||
16177043|NCT02770807|39126330|FG002|Overall Study|Withdrawal by Subject|4|||
16177044|NCT02770807|39126328|FG000|Overall Study|Other|0|||
16177045|NCT02770807|39126329|FG001|Overall Study|Other|1|||
16177046|NCT02770807|39126330|FG002|Overall Study|Other|0|||
16177047|NCT02770807|39126328|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
16177048|NCT02770807|39126329|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
16177049|NCT02770807|39126330|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
16177050|NCT02770807|39126328|FG000|Overall Study|Physician Decision|0|||
16177051|NCT02770807|39126329|FG001|Overall Study|Physician Decision|0|||
16177052|NCT02770807|39126330|FG002|Overall Study|Physician Decision|1|||
16177053|NCT00688688|39126331|FG000|Overall Study|Eligibility criterion not met|7|||
16177054|NCT00688688|39126332|FG001|Overall Study|Eligibility criterion not met|7|||
16177055|NCT00688688|39126333|FG002|Overall Study|Eligibility criterion not met|10|||
16177056|NCT00688688|39126331|FG000|Overall Study|Adverse Event|52|||
16177057|NCT00688688|39126332|FG001|Overall Study|Adverse Event|51|||
16177058|NCT00688688|39126333|FG002|Overall Study|Adverse Event|50|||
16177059|NCT00688688|39126331|FG000|Overall Study|Lack of Efficacy|34|||
16177060|NCT00688688|39126332|FG001|Overall Study|Lack of Efficacy|25|||
16177061|NCT00688688|39126333|FG002|Overall Study|Lack of Efficacy|45|||
16177062|NCT00688688|39126331|FG000|Overall Study|Withdrawal by Subject|66|||
16177063|NCT00688688|39126332|FG001|Overall Study|Withdrawal by Subject|75|||
16177064|NCT00688688|39126333|FG002|Overall Study|Withdrawal by Subject|65|||
16177065|NCT00688688|39126331|FG000|Overall Study|Lost to Follow-up|14|||
16177066|NCT00688688|39126332|FG001|Overall Study|Lost to Follow-up|7|||
16177067|NCT00688688|39126333|FG002|Overall Study|Lost to Follow-up|7|||
16177068|NCT00688688|39126331|FG000|Overall Study|Protocol Violation|6|||
16177069|NCT00688688|39126332|FG001|Overall Study|Protocol Violation|9|||
16177070|NCT00688688|39126333|FG002|Overall Study|Protocol Violation|11|||
16177071|NCT00688688|39126331|FG000|Overall Study|Randomized but never received study drug|1|||
16177072|NCT00688688|39126332|FG001|Overall Study|Randomized but never received study drug|0|||
16177073|NCT00688688|39126333|FG002|Overall Study|Randomized but never received study drug|0|||
16177074|NCT00688688|39126331|FG000|Overall Study|Non-compliance with study procedures|5|||
16177075|NCT00688688|39126332|FG001|Overall Study|Non-compliance with study procedures|3|||
16177076|NCT00688688|39126333|FG002|Overall Study|Non-compliance with study procedures|4|||
16177077|NCT00688688|39126331|FG000|Overall Study|Taking exclusionary medications|1|||
16177078|NCT00688688|39126332|FG001|Overall Study|Taking exclusionary medications|0|||
16177079|NCT00688688|39126333|FG002|Overall Study|Taking exclusionary medications|0|||
16177080|NCT00688688|39126331|FG000|Overall Study|Site closure|0|||
16177081|NCT00688688|39126332|FG001|Overall Study|Site closure|1|||
16177082|NCT00688688|39126333|FG002|Overall Study|Site closure|0|||
16177083|NCT00688688|39126331|FG000|Overall Study|Violation of exclusion criterion|0|||
16177084|NCT00688688|39126332|FG001|Overall Study|Violation of exclusion criterion|1|||
16177085|NCT00688688|39126333|FG002|Overall Study|Violation of exclusion criterion|0|||
16177086|NCT01503021|39126334|FG000|Overall Study|Adverse Event|7|||
16177087|NCT01503021|39126335|FG001|Overall Study|Adverse Event|6|||
16177088|NCT01503021|39126334|FG000|Overall Study|Death|0|||
16177089|NCT01503021|39126335|FG001|Overall Study|Death|2|||
16177090|NCT01503021|39126334|FG000|Overall Study|Lost to Follow-up|2|||
16177091|NCT01503021|39126335|FG001|Overall Study|Lost to Follow-up|0|||
16177092|NCT01503021|39126334|FG000|Overall Study|Physician Decision|3|||
16177093|NCT01503021|39126335|FG001|Overall Study|Physician Decision|0|||
16177094|NCT01503021|39126334|FG000|Overall Study|Protocol Violation|1|||
16177095|NCT01503021|39126335|FG001|Overall Study|Protocol Violation|3|||
16177096|NCT01503021|39126334|FG000|Overall Study|Withdrawal by Subject|9|||
16177097|NCT01503021|39126335|FG001|Overall Study|Withdrawal by Subject|8|||
16177098|NCT01503021|39126334|FG000|Overall Study|Moved, received transplant, etc.|5|||
16177099|NCT01503021|39126335|FG001|Overall Study|Moved, received transplant, etc.|7|||
16177100|NCT01748760|39126336|FG000|Overall Study|Withdrawal by Subject|1|||
16177101|NCT01748760|39126337|FG001|Overall Study|Withdrawal by Subject|1|||
16177102|NCT01748760|39126336|FG000|Overall Study|Lost to Follow-up|5|||
16177103|NCT01748760|39126337|FG001|Overall Study|Lost to Follow-up|1|||
16177104|NCT01059812|39126340|FG000|Overall Study|Adverse Event|9|||
16177105|NCT01059812|39126341|FG001|Overall Study|Adverse Event|5|||
16177106|NCT01059812|39126340|FG000|Overall Study|Lack of Efficacy|2|||
16177107|NCT01059812|39126341|FG001|Overall Study|Lack of Efficacy|2|||
16177108|NCT01059812|39126340|FG000|Overall Study|Protocol Violation|3|||
16177109|NCT01059812|39126341|FG001|Overall Study|Protocol Violation|1|||
16177110|NCT01059812|39126340|FG000|Overall Study|Withdrawal Criteria|9|||
16177111|NCT01059812|39126341|FG001|Overall Study|Withdrawal Criteria|4|||
16177112|NCT01059812|39126340|FG000|Overall Study|Unclassified|14|||
16177113|NCT01059812|39126341|FG001|Overall Study|Unclassified|4|||
16177114|NCT02453841|39126343|FG000|Overall Study|Protocol Violation|1|||
16177115|NCT02453841|39126343|FG000|Overall Study|Unable to obtain blood samples|2|||
16177116|NCT04927312|39126347|FG000|Overall Study|Adverse Event|1|||
16177117|NCT04927312|39126347|FG000|Overall Study|Death|1|||
16177118|NCT04927312|39126347|FG000|Overall Study|Withdrawal by Subject|1|||
16177119|NCT04927312|39126347|FG000|Overall Study|Other|1|||
16177120|NCT01982630|39126348|FG000|Overall Study|Adverse Event|2|||
16177121|NCT01982630|39126349|FG001|Overall Study|Adverse Event|0|||
16177122|NCT01982630|39126350|FG002|Overall Study|Adverse Event|1|||
16177123|NCT01982630|39126351|FG003|Overall Study|Adverse Event|0|||
16478071|NCT02281773|40231029|FG004|Overall Study|Other Reason|1|||
16177124|NCT01982630|39126352|FG004|Overall Study|Adverse Event|1|||
16177125|NCT01982630|39126353|FG005|Overall Study|Adverse Event|2|||
16177126|NCT01982630|39126354|FG006|Overall Study|Adverse Event|1|||
16177127|NCT01982630|39126355|FG007|Overall Study|Adverse Event|0|||
16177128|NCT01982630|39126348|FG000|Overall Study|Physician Decision|1|||
16177129|NCT01982630|39126349|FG001|Overall Study|Physician Decision|0|||
16177130|NCT01982630|39126350|FG002|Overall Study|Physician Decision|2|||
16177131|NCT01982630|39126351|FG003|Overall Study|Physician Decision|1|||
16177132|NCT01982630|39126352|FG004|Overall Study|Physician Decision|2|||
16177133|NCT01982630|39126353|FG005|Overall Study|Physician Decision|0|||
16177134|NCT01982630|39126354|FG006|Overall Study|Physician Decision|0|||
16177135|NCT01982630|39126355|FG007|Overall Study|Physician Decision|0|||
16177136|NCT01982630|39126348|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16177137|NCT01982630|39126349|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16177138|NCT01982630|39126350|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
16177139|NCT01982630|39126351|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16177140|NCT01982630|39126352|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16177141|NCT01982630|39126353|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16177142|NCT01982630|39126354|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16177143|NCT01982630|39126355|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
16177144|NCT01982630|39126348|FG000|Overall Study|Withdrawal by Subject|0|||
16177145|NCT01982630|39126349|FG001|Overall Study|Withdrawal by Subject|0|||
16177146|NCT01982630|39126350|FG002|Overall Study|Withdrawal by Subject|0|||
16177147|NCT01982630|39126351|FG003|Overall Study|Withdrawal by Subject|0|||
16177148|NCT01982630|39126352|FG004|Overall Study|Withdrawal by Subject|0|||
16177149|NCT01982630|39126353|FG005|Overall Study|Withdrawal by Subject|1|||
16177150|NCT01982630|39126354|FG006|Overall Study|Withdrawal by Subject|0|||
16177151|NCT01982630|39126355|FG007|Overall Study|Withdrawal by Subject|0|||
16177152|NCT00826748|39126358|FG000|Overall Study|Withdrawal by Subject|0|||
16177153|NCT00826748|39126359|FG001|Overall Study|Withdrawal by Subject|0|||
16177154|NCT00826748|39126360|FG002|Overall Study|Withdrawal by Subject|2|||
16177155|NCT00826748|39126358|FG000|Overall Study|Physician Decision|0|||
16177156|NCT00826748|39126359|FG001|Overall Study|Physician Decision|0|||
16177157|NCT00826748|39126360|FG002|Overall Study|Physician Decision|1|||
16177158|NCT00826748|39126358|FG000|Overall Study|Samples Did Not pass QC|0|||
16177159|NCT00826748|39126359|FG001|Overall Study|Samples Did Not pass QC|0|||
16177160|NCT00826748|39126360|FG002|Overall Study|Samples Did Not pass QC|1|||
16177161|NCT00845429|39126365|FG000|Overall Study|Protocol Violation|5|||
16177162|NCT00845429|39126366|FG001|Overall Study|Protocol Violation|4|||
16177163|NCT00845429|39126367|FG002|Overall Study|Protocol Violation|7|||
16177164|NCT00845429|39126365|FG000|Overall Study|Lost to Follow-up|7|||
16177165|NCT00845429|39126366|FG001|Overall Study|Lost to Follow-up|9|||
16177166|NCT00845429|39126367|FG002|Overall Study|Lost to Follow-up|10|||
16177167|NCT00845429|39126365|FG000|Overall Study|Withdrawal by Subject|2|||
16177168|NCT00845429|39126366|FG001|Overall Study|Withdrawal by Subject|2|||
16177169|NCT00845429|39126367|FG002|Overall Study|Withdrawal by Subject|2|||
16177170|NCT00845429|39126365|FG000|Overall Study|Serious adverse event|0|||
16177171|NCT00845429|39126366|FG001|Overall Study|Serious adverse event|0|||
16177172|NCT00845429|39126367|FG002|Overall Study|Serious adverse event|1|||
16177173|NCT00095121|39126368|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
16177174|NCT00095121|39126369|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
16177175|NCT00095121|39126368|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
16177176|NCT00095121|39126369|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
16177177|NCT01071070|39126370|FG000|Overall Study|Adverse Event|0|||
16177178|NCT01071070|39126371|FG001|Overall Study|Adverse Event|3|||
16177179|NCT01071070|39126370|FG000|Overall Study|Withdrawal by Subject|1|||
16177180|NCT01071070|39126371|FG001|Overall Study|Withdrawal by Subject|0|||
16177181|NCT01071070|39126370|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
16177182|NCT01071070|39126371|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
16177183|NCT01071070|39126370|FG000|Overall Study|Hypercalcemia|1|||
16177184|NCT01071070|39126371|FG001|Overall Study|Hypercalcemia|0|||
16177185|NCT00793585|39126372|FG000|Overall Study|Adverse Event|1|||
16177186|NCT00793585|39126373|FG001|Overall Study|Adverse Event|1|||
16478072|NCT00569270|40231030|FG000|Period: First Intervention|Protocol Violation|0|||
16177187|NCT00793585|39126372|FG000|Overall Study|Protocol Violation|1|||
16177188|NCT00793585|39126373|FG001|Overall Study|Protocol Violation|2|||
16177189|NCT05480514|39126374|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
16478073|NCT00569270|40231031|FG001|Period: First Intervention|Protocol Violation|1|||
16177190|NCT05480514|39126375|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
16177191|NCT05480514|39126374|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
16177192|NCT05480514|39126375|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
16177193|NCT05480514|39126374|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
16177194|NCT05480514|39126375|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
16478074|NCT01560403|40231032|FG000|Overall Study|Lost to Follow-up|0|||
16478075|NCT01560403|40231033|FG001|Overall Study|Lost to Follow-up|1|||
16079915|NCT00516321|38786697|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
16079916|NCT00516321|38786698|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
16079917|NCT00516321|38786696|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
16079918|NCT00516321|38786697|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
16079919|NCT00516321|38786698|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
16079920|NCT00516321|38786696|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
16079921|NCT00516321|38786697|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
16079922|NCT00516321|38786698|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
16079923|NCT00516321|38786696|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
16079924|NCT00516321|38786697|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
16079925|NCT00516321|38786698|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
16079926|NCT00516321|38786696|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
16079927|NCT00516321|38786697|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
16079928|NCT00516321|38786698|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
16079929|NCT00516321|38786696|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
16079930|NCT00516321|38786697|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
16079931|NCT00516321|38786698|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
16079932|NCT00516321|38786696|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
16079933|NCT00516321|38786697|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
16079934|NCT00516321|38786698|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
16079935|NCT00516321|38786696|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
16079936|NCT00516321|38786697|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
16079937|NCT00516321|38786698|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
16079938|NCT00516321|38786696|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
16079939|NCT00516321|38786697|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
16079940|NCT00516321|38786698|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
16079941|NCT03565315|38786699|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
16079942|NCT03565315|38786700|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
16079943|NCT03565315|38786701|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
16079944|NCT03565315|38786702|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
16079945|NCT01837966|38786703|FG000|Overall Study|Withdrawal by Subject|2|||
16079946|NCT01837966|38786704|FG001|Overall Study|Withdrawal by Subject|1|||
16079947|NCT02015546|38786705|FG000|Overall Study|Withdrawal by Subject|1|||
16079948|NCT02015546|38786706|FG001|Overall Study|Withdrawal by Subject|1|||
16079949|NCT02015546|38786707|FG002|Overall Study|Withdrawal by Subject|1|||
16079950|NCT02015546|38786705|FG000|Overall Study|Screem Failure|2|||
16079951|NCT02015546|38786706|FG001|Overall Study|Screem Failure|1|||
16079952|NCT02015546|38786707|FG002|Overall Study|Screem Failure|3|||
16079953|NCT03086369|38786708|FG000|Overall Study|Lost to Follow-up|1|||
16079954|NCT03086369|38786709|FG001|Overall Study|Lost to Follow-up|0|||
16079955|NCT03086369|38786710|FG002|Overall Study|Lost to Follow-up|0|||
16079956|NCT03086369|38786711|FG003|Overall Study|Lost to Follow-up|2|||
16079957|NCT03086369|38786712|FG004|Overall Study|Lost to Follow-up|1|||
16079958|NCT03086369|38786708|FG000|Overall Study|Physician Decision|0|||
16079959|NCT03086369|38786709|FG001|Overall Study|Physician Decision|0|||
16079960|NCT03086369|38786710|FG002|Overall Study|Physician Decision|0|||
16079961|NCT03086369|38786711|FG003|Overall Study|Physician Decision|1|||
16079962|NCT03086369|38786712|FG004|Overall Study|Physician Decision|2|||
16079963|NCT03086369|38786708|FG000|Overall Study|Withdrawal by Subject|0|||
16079964|NCT03086369|38786709|FG001|Overall Study|Withdrawal by Subject|0|||
16279016|NCT02308696|39504201|FG001|Overall Study|Moved to a Higher Level of Care|6|||
16279017|NCT05562011|39504208|FG000|Overall Study|Withdrawal by Subject|3|||
16177195|NCT05480514|39126374|FG000|Period 1|Covid-19 Related|1|||
16177196|NCT05480514|39126375|FG001|Period 1|Covid-19 Related|0|||
16177197|NCT05480514|39126374|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
16177198|NCT05480514|39126375|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
16177199|NCT01158950|39129373|FG000|1st Intervention (1 Day)|Physician Decision|1|||
16177200|NCT01158950|39129374|FG001|1st Intervention (1 Day)|Physician Decision|2|||
16177201|NCT00377962|39129375|FG000|Core Study: 0-12 Months|Adverse Event|18|||
16177202|NCT00377962|39129376|FG001|Core Study: 0-12 Months|Adverse Event|2|||
16177203|NCT00377962|39129375|FG000|Core Study: 0-12 Months|Death|3|||
16177204|NCT00377962|39129376|FG001|Core Study: 0-12 Months|Death|0|||
16177205|NCT00377962|39129375|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
16177206|NCT00377962|39129376|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
16177207|NCT00377962|39129375|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
16177208|NCT00377962|39129376|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
16177209|NCT00377962|39129375|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
16177210|NCT00377962|39129376|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
16177211|NCT00377962|39129375|FG000|Extension Study: 12-24 Months|Death|1|||
16177212|NCT00377962|39129376|FG001|Extension Study: 12-24 Months|Death|1|||
16177213|NCT00377962|39129375|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
16177214|NCT00377962|39129376|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
16177215|NCT00377962|39129375|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
16177216|NCT00377962|39129376|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
16177217|NCT00377962|39129375|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
16177218|NCT00377962|39129376|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
16177219|NCT00149214|39129377|FG000|Overall Study|Adverse Event|12|||
16177220|NCT00149214|39129378|FG001|Overall Study|Adverse Event|9|||
16177221|NCT00149214|39129377|FG000|Overall Study|Withdrawal by Subject|4|||
16177222|NCT00149214|39129378|FG001|Overall Study|Withdrawal by Subject|1|||
16177223|NCT00149214|39129377|FG000|Overall Study|Physician Decision|3|||
16177224|NCT00149214|39129378|FG001|Overall Study|Physician Decision|3|||
16177225|NCT00149214|39129377|FG000|Overall Study|Sponsor Decision|0|||
16177226|NCT00149214|39129378|FG001|Overall Study|Sponsor Decision|1|||
16177227|NCT00149214|39129377|FG000|Overall Study|Progressive Disease|7|||
16177228|NCT00149214|39129378|FG001|Overall Study|Progressive Disease|3|||
16177229|NCT02201940|39129379|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
16177230|NCT02201940|39129380|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
16177231|NCT02201940|39129379|FG000|Overall Study|Lack of Efficacy|2|||
16177232|NCT02201940|39129380|FG001|Overall Study|Lack of Efficacy|113|||
16177233|NCT02201940|39129379|FG000|Overall Study|Lost to Follow-up|5|||
16177234|NCT02201940|39129380|FG001|Overall Study|Lost to Follow-up|0|||
16177235|NCT02201940|39129379|FG000|Overall Study|Withdrew Consent|2|||
16177236|NCT02201940|39129380|FG001|Overall Study|Withdrew Consent|1|||
16177237|NCT02201940|39129379|FG000|Overall Study|Investigator's Discretion|1|||
16177238|NCT02201940|39129380|FG001|Overall Study|Investigator's Discretion|1|||
16177239|NCT02201940|39129379|FG000|Overall Study|Death|1|||
16177240|NCT02201940|39129380|FG001|Overall Study|Death|0|||
16177241|NCT02201940|39129379|FG000|Overall Study|Adverse Event|0|||
16177242|NCT02201940|39129380|FG001|Overall Study|Adverse Event|1|||
16177243|NCT01531725|39129386|FG000|Overall Study|Protocol Violation|5|||
16177244|NCT01389128|39129387|FG000|Overall Study|Fetal distress|1|||
16177245|NCT01389128|39129388|FG001|Overall Study|Fetal distress|0|||
16177246|NCT01389128|39129387|FG000|Overall Study|Cervix dilation stop|1|||
16177247|NCT01389128|39129388|FG001|Overall Study|Cervix dilation stop|2|||
16177248|NCT01389128|39129387|FG000|Overall Study|Rapid labor evolution|3|||
16177249|NCT01389128|39129388|FG001|Overall Study|Rapid labor evolution|2|||
16177250|NCT01389128|39129387|FG000|Overall Study|Intolerance to procedure|0|||
16177251|NCT01389128|39129388|FG001|Overall Study|Intolerance to procedure|2|||
16177252|NCT00546351|39129389|FG000|Overall Study|Adverse Event|76|||
16177253|NCT00546351|39129389|FG000|Overall Study|Lack of Efficacy|15|||
16177254|NCT00546351|39129389|FG000|Overall Study|Withdrawal by Subject|109|||
16177255|NCT00546351|39129389|FG000|Overall Study|Lost to Follow-up|9|||
16177256|NCT00546351|39129389|FG000|Overall Study|Protocol Deviation|1|||
16177257|NCT00546351|39129389|FG000|Overall Study|Unsatisfactory compliance|9|||
16177258|NCT00546351|39129389|FG000|Overall Study|Other reasons for premature termination|17|||
16177259|NCT03635489|39129390|FG000|Overall Study|Death|6|||
16177260|NCT03635489|39129391|FG001|Overall Study|Death|3|||
16177261|NCT03635489|39129390|FG000|Overall Study|Lost to Follow-up|0|||
16177262|NCT03635489|39129391|FG001|Overall Study|Lost to Follow-up|1|||
16177263|NCT03635489|39129390|FG000|Overall Study|Withdrawal by Subject|1|||
16177264|NCT03635489|39129391|FG001|Overall Study|Withdrawal by Subject|2|||
16279018|NCT05562011|39504208|FG000|Overall Study|Lost to Follow-up|1|||
16177265|NCT00670111|39129392|FG000|Enrollment to One Month|Testing Failure|0|||
16177266|NCT00670111|39129393|FG001|Enrollment to One Month|Testing Failure|0|||
16177267|NCT00670111|39129394|FG002|Enrollment to One Month|Testing Failure|13|||
16177268|NCT00670111|39129392|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
16177269|NCT00670111|39129393|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
16177270|NCT00670111|39129394|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
16177271|NCT00670111|39129392|FG000|Enrollment to One Month|Physician Decision|1|||
16177272|NCT00670111|39129393|FG001|Enrollment to One Month|Physician Decision|0|||
16177273|NCT00670111|39129394|FG002|Enrollment to One Month|Physician Decision|0|||
16177274|NCT00467649|39129395|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
16177275|NCT00467649|39129396|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
16177276|NCT00467649|39129397|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
16177277|NCT00467649|39129398|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
16177278|NCT00467649|39129399|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
16177279|NCT00467649|39129400|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
16177280|NCT00467649|39129395|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
16177281|NCT00467649|39129396|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
16177282|NCT00467649|39129397|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
16177283|NCT00467649|39129398|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
16177284|NCT00467649|39129399|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
16177285|NCT00467649|39129400|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
16177286|NCT00467649|39129395|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
16177287|NCT00467649|39129396|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
16177288|NCT00467649|39129397|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
16177289|NCT00467649|39129398|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
16177290|NCT00467649|39129399|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
16177291|NCT00467649|39129400|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
16177292|NCT00467649|39129395|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
16177293|NCT00467649|39129396|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
16177294|NCT00467649|39129397|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
16177295|NCT00467649|39129398|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
16177296|NCT00467649|39129399|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
16177297|NCT00467649|39129400|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
16177298|NCT00467649|39129395|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
16177299|NCT00467649|39129396|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
16177300|NCT00467649|39129397|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
16177301|NCT00467649|39129398|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
16177302|NCT00467649|39129399|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
16177303|NCT00467649|39129400|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
16177304|NCT00467649|39129395|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
16177305|NCT00467649|39129396|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
16177306|NCT00467649|39129397|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
16177307|NCT00467649|39129398|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
16177308|NCT00467649|39129399|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
16177309|NCT00467649|39129400|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
16177310|NCT00467649|39129395|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
16177311|NCT00467649|39129396|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
16177312|NCT00467649|39129397|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
16177313|NCT00467649|39129398|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
16177314|NCT00467649|39129399|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
16177315|NCT00467649|39129400|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
16177316|NCT00986349|39129403|FG000|Overall Study|Unsuccessful implant procedure|3|||
16177317|NCT00986349|39129403|FG000|Overall Study|Adverse Event|2|||
16177318|NCT00986349|39129403|FG000|Overall Study|Physician Decision|1|||
16177319|NCT00986349|39129403|FG000|Overall Study|device migration|1|||
16177320|NCT01073943|39129404|FG000|Overall Study|Withdrawal by Subject|8|||
16177321|NCT01073943|39129405|FG001|Overall Study|Withdrawal by Subject|2|||
16177322|NCT01073943|39129404|FG000|Overall Study|Protocol Violation|2|||
16177323|NCT01073943|39129405|FG001|Overall Study|Protocol Violation|1|||
16177324|NCT01073943|39129404|FG000|Overall Study|Adverse Event|1|||
16177325|NCT01073943|39129405|FG001|Overall Study|Adverse Event|1|||
16177326|NCT01073943|39129404|FG000|Overall Study|Lost to Follow-up|0|||
16177327|NCT01073943|39129405|FG001|Overall Study|Lost to Follow-up|2|||
16177328|NCT01073943|39129404|FG000|Overall Study|Power outage; colonoscopy not done|1|||
16177329|NCT01073943|39129405|FG001|Overall Study|Power outage; colonoscopy not done|0|||
16177330|NCT01073943|39129404|FG000|Overall Study|Subject forgot|0|||
16177331|NCT01073943|39129405|FG001|Overall Study|Subject forgot|1|||
16177332|NCT01073943|39129404|FG000|Overall Study|Unable to return for follow-up|0|||
16177333|NCT01073943|39129405|FG001|Overall Study|Unable to return for follow-up|1|||
16177334|NCT01073943|39129404|FG000|Overall Study|Could not tolerate prep|1|||
16177335|NCT01073943|39129405|FG001|Overall Study|Could not tolerate prep|0|||
16177336|NCT00049127|39129409|FG000|Overall Study|Withdrawal by Subject|0|||
16177337|NCT00049127|39129410|FG001|Overall Study|Withdrawal by Subject|0|||
16177338|NCT00049127|39129411|FG002|Overall Study|Withdrawal by Subject|1|||
16177339|NCT00049127|39129412|FG003|Overall Study|Withdrawal by Subject|0|||
16177340|NCT00049127|39129413|FG004|Overall Study|Withdrawal by Subject|0|||
16177341|NCT00561353|39129416|FG000|Overall Study|Subject reached a virologic endpoint|2|||
16177342|NCT00561353|39129417|FG001|Overall Study|Subject reached a virologic endpoint|1|||
16177343|NCT00561353|39129418|FG002|Overall Study|Subject reached a virologic endpoint|1|||
16177344|NCT00561353|39129419|FG003|Overall Study|Subject reached a virologic endpoint|4|||
16177345|NCT00561353|39129420|FG004|Overall Study|Subject reached a virologic endpoint|1|||
16177346|NCT00561353|39129421|FG005|Overall Study|Subject reached a virologic endpoint|3|||
16177347|NCT00561353|39129422|FG006|Overall Study|Subject reached a virologic endpoint|4|||
16177348|NCT00561353|39129423|FG007|Overall Study|Subject reached a virologic endpoint|4|||
16177349|NCT00561353|39129424|FG008|Overall Study|Subject reached a virologic endpoint|5|||
16177350|NCT00561353|39129425|FG009|Overall Study|Subject reached a virologic endpoint|0|||
16177351|NCT00561353|39129416|FG000|Overall Study|Subject ineligible to continue the trial|0|||
16177352|NCT00561353|39129417|FG001|Overall Study|Subject ineligible to continue the trial|0|||
16177353|NCT00561353|39129418|FG002|Overall Study|Subject ineligible to continue the trial|0|||
16177354|NCT00561353|39129419|FG003|Overall Study|Subject ineligible to continue the trial|0|||
16177355|NCT00561353|39129420|FG004|Overall Study|Subject ineligible to continue the trial|0|||
16177356|NCT00561353|39129421|FG005|Overall Study|Subject ineligible to continue the trial|1|||
16177357|NCT00561353|39129422|FG006|Overall Study|Subject ineligible to continue the trial|1|||
16177358|NCT00561353|39129423|FG007|Overall Study|Subject ineligible to continue the trial|0|||
16177359|NCT00561353|39129424|FG008|Overall Study|Subject ineligible to continue the trial|2|||
16177360|NCT00561353|39129425|FG009|Overall Study|Subject ineligible to continue the trial|1|||
16177361|NCT00561353|39129416|FG000|Overall Study|Other|1|||
16177362|NCT00561353|39129417|FG001|Overall Study|Other|0|||
16177363|NCT00561353|39129418|FG002|Overall Study|Other|1|||
16177364|NCT00561353|39129419|FG003|Overall Study|Other|0|||
16177365|NCT00561353|39129420|FG004|Overall Study|Other|0|||
16177366|NCT00561353|39129421|FG005|Overall Study|Other|2|||
16177367|NCT00561353|39129422|FG006|Overall Study|Other|0|||
16177368|NCT00561353|39129423|FG007|Overall Study|Other|0|||
16177369|NCT00561353|39129424|FG008|Overall Study|Other|0|||
16177370|NCT00561353|39129425|FG009|Overall Study|Other|0|||
16177371|NCT00561353|39129416|FG000|Overall Study|Adverse Event|0|||
16177372|NCT00561353|39129417|FG001|Overall Study|Adverse Event|0|||
16177373|NCT00561353|39129418|FG002|Overall Study|Adverse Event|0|||
16177374|NCT00561353|39129419|FG003|Overall Study|Adverse Event|2|||
16177375|NCT00561353|39129420|FG004|Overall Study|Adverse Event|0|||
16177376|NCT00561353|39129421|FG005|Overall Study|Adverse Event|0|||
16177377|NCT00561353|39129422|FG006|Overall Study|Adverse Event|1|||
16177378|NCT00561353|39129423|FG007|Overall Study|Adverse Event|0|||
16177379|NCT00561353|39129424|FG008|Overall Study|Adverse Event|0|||
16177380|NCT00561353|39129425|FG009|Overall Study|Adverse Event|1|||
16177381|NCT00561353|39129416|FG000|Overall Study|Lost to Follow-up|2|||
16177382|NCT00561353|39129417|FG001|Overall Study|Lost to Follow-up|0|||
16177383|NCT00561353|39129418|FG002|Overall Study|Lost to Follow-up|1|||
16177384|NCT00561353|39129419|FG003|Overall Study|Lost to Follow-up|0|||
16177385|NCT00561353|39129420|FG004|Overall Study|Lost to Follow-up|0|||
16177386|NCT00561353|39129421|FG005|Overall Study|Lost to Follow-up|0|||
16177387|NCT00561353|39129422|FG006|Overall Study|Lost to Follow-up|0|||
16177388|NCT00561353|39129423|FG007|Overall Study|Lost to Follow-up|0|||
16177389|NCT00561353|39129424|FG008|Overall Study|Lost to Follow-up|0|||
16177390|NCT00561353|39129425|FG009|Overall Study|Lost to Follow-up|0|||
16177391|NCT00561353|39129416|FG000|Overall Study|Withdrawal by Subject|0|||
16177392|NCT00561353|39129417|FG001|Overall Study|Withdrawal by Subject|2|||
16177393|NCT00561353|39129418|FG002|Overall Study|Withdrawal by Subject|0|||
16177394|NCT00561353|39129419|FG003|Overall Study|Withdrawal by Subject|0|||
16177395|NCT00561353|39129420|FG004|Overall Study|Withdrawal by Subject|0|||
16177396|NCT00561353|39129421|FG005|Overall Study|Withdrawal by Subject|0|||
16177397|NCT00561353|39129422|FG006|Overall Study|Withdrawal by Subject|0|||
16177398|NCT00561353|39129423|FG007|Overall Study|Withdrawal by Subject|0|||
16177399|NCT00561353|39129424|FG008|Overall Study|Withdrawal by Subject|0|||
16177400|NCT00561353|39129425|FG009|Overall Study|Withdrawal by Subject|0|||
16177401|NCT00613314|39129432|FG000|Overall Study|Adverse Event|5|||
16177402|NCT00613314|39129432|FG000|Overall Study|Protocol Violation|14|||
16177403|NCT00613314|39129432|FG000|Overall Study|Lost to Follow-up|46|||
16177404|NCT00613314|39129432|FG000|Overall Study|Other reason not defined above|90|||
16177405|NCT02873221|39129433|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
16177406|NCT02873221|39129434|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
16177407|NCT02873221|39129435|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
16478076|NCT01034631|40231034|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
16177408|NCT02873221|39129433|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
16177409|NCT02873221|39129434|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
16177410|NCT02873221|39129435|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
16177411|NCT02873221|39129433|FG000|Treatment Period|Protocol Violation|2|||
16177412|NCT02873221|39129434|FG001|Treatment Period|Protocol Violation|5|||
16177413|NCT02873221|39129435|FG002|Treatment Period|Protocol Violation|8|||
16177414|NCT02873221|39129433|FG000|Treatment Period|Pregnancy|4|||
16177415|NCT02873221|39129434|FG001|Treatment Period|Pregnancy|6|||
16177416|NCT02873221|39129435|FG002|Treatment Period|Pregnancy|3|||
16177417|NCT02873221|39129433|FG000|Treatment Period|Lack of Qualifying Event|0|||
16177418|NCT02873221|39129434|FG001|Treatment Period|Lack of Qualifying Event|3|||
16177419|NCT02873221|39129435|FG002|Treatment Period|Lack of Qualifying Event|1|||
16177420|NCT02873221|39129433|FG000|Treatment Period|Withdrawal of Consent|52|||
16177421|NCT02873221|39129434|FG001|Treatment Period|Withdrawal of Consent|51|||
16177422|NCT02873221|39129435|FG002|Treatment Period|Withdrawal of Consent|41|||
16177423|NCT02873221|39129433|FG000|Treatment Period|Lack of Efficacy|0|||
16177424|NCT02873221|39129434|FG001|Treatment Period|Lack of Efficacy|17|||
16177425|NCT02873221|39129435|FG002|Treatment Period|Lack of Efficacy|12|||
16177426|NCT02873221|39129433|FG000|Treatment Period|Adverse Event|4|||
16177427|NCT02873221|39129434|FG001|Treatment Period|Adverse Event|9|||
16177428|NCT02873221|39129435|FG002|Treatment Period|Adverse Event|11|||
16177429|NCT02873221|39129433|FG000|Treatment Period|Lost to Follow-up|26|||
16177430|NCT02873221|39129434|FG001|Treatment Period|Lost to Follow-up|30|||
16177431|NCT02873221|39129435|FG002|Treatment Period|Lost to Follow-up|26|||
16177432|NCT02873221|39129433|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
16177433|NCT02873221|39129434|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
16177434|NCT02873221|39129435|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
16177435|NCT02873221|39129433|FG000|Safety Follow-up Period|Protocol Violation|0|||
16177436|NCT02873221|39129434|FG001|Safety Follow-up Period|Protocol Violation|0|||
16177437|NCT02873221|39129435|FG002|Safety Follow-up Period|Protocol Violation|1|||
16177438|NCT02873221|39129433|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
16177439|NCT02873221|39129434|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
16177440|NCT02873221|39129435|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
16177441|NCT02873221|39129433|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
16177442|NCT02873221|39129434|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
16177443|NCT02873221|39129435|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
16177444|NCT00761215|39129436|FG000|Overall Study|Randomized but didn't receive drug|1|||
16177445|NCT00761215|39129437|FG001|Overall Study|Randomized but didn't receive drug|1|||
16177446|NCT00761215|39129438|FG002|Overall Study|Randomized but didn't receive drug|2|||
16177447|NCT00761215|39129436|FG000|Overall Study|Lost to Follow-up|6|||
16177448|NCT00761215|39129437|FG001|Overall Study|Lost to Follow-up|3|||
16177449|NCT00761215|39129438|FG002|Overall Study|Lost to Follow-up|6|||
16177450|NCT00761215|39129436|FG000|Overall Study|Withdrawal by Subject|1|||
16177451|NCT00761215|39129437|FG001|Overall Study|Withdrawal by Subject|0|||
16177452|NCT00761215|39129438|FG002|Overall Study|Withdrawal by Subject|0|||
16177453|NCT00761215|39129436|FG000|Overall Study|Bacteremia|1|||
16177454|NCT00761215|39129437|FG001|Overall Study|Bacteremia|0|||
16177455|NCT00761215|39129438|FG002|Overall Study|Bacteremia|0|||
16177456|NCT01121406|39129439|FG000|Overall Study|Progressive disease RECIST|44|||
16177457|NCT01121406|39129440|FG001|Overall Study|Progressive disease RECIST|28|||
16177458|NCT01121406|39129439|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
16177459|NCT01121406|39129440|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
16177460|NCT01121406|39129439|FG000|Overall Study|Other AE|3|||
16177461|NCT01121406|39129440|FG001|Overall Study|Other AE|10|||
16177462|NCT01121406|39129439|FG000|Overall Study|Non-compliant with protocol|0|||
16177463|NCT01121406|39129440|FG001|Overall Study|Non-compliant with protocol|2|||
16177464|NCT01121406|39129439|FG000|Overall Study|Lost to Follow-up|0|||
16177465|NCT01121406|39129440|FG001|Overall Study|Lost to Follow-up|1|||
16177466|NCT01121406|39129439|FG000|Overall Study|Refused continuation of study med.|1|||
16177467|NCT01121406|39129440|FG001|Overall Study|Refused continuation of study med.|2|||
16177468|NCT01121406|39129439|FG000|Overall Study|Reason other than specified above|2|||
16177469|NCT01121406|39129440|FG001|Overall Study|Reason other than specified above|6|||
16177470|NCT01121406|39129439|FG000|Overall Study|Not treated|1|||
16177471|NCT01121406|39129440|FG001|Overall Study|Not treated|0|||
16177472|NCT01440101|39129444|FG000|Overall Study|Adverse Event|2|||
16177473|NCT01440101|39129445|FG001|Overall Study|Adverse Event|0|||
16177474|NCT01440101|39129446|FG002|Overall Study|Adverse Event|0|||
16478077|NCT01034631|40231035|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
16177475|NCT01440101|39129444|FG000|Overall Study|Withdrawal by Subject|0|||
16177476|NCT01440101|39129445|FG001|Overall Study|Withdrawal by Subject|3|||
16177477|NCT01440101|39129446|FG002|Overall Study|Withdrawal by Subject|1|||
16177478|NCT01440101|39129444|FG000|Overall Study|Other|0|||
16177479|NCT01440101|39129445|FG001|Overall Study|Other|1|||
16177480|NCT01440101|39129446|FG002|Overall Study|Other|0|||
16177481|NCT00308620|39129448|FG000|Overall Study|Death|1|||
16177482|NCT00308620|39129449|FG001|Overall Study|Death|1|||
16177483|NCT00308620|39129450|FG002|Overall Study|Death|0|||
16177484|NCT00308620|39129448|FG000|Overall Study|Lost to Follow-up|0|||
16177485|NCT00308620|39129449|FG001|Overall Study|Lost to Follow-up|0|||
16177486|NCT00308620|39129450|FG002|Overall Study|Lost to Follow-up|1|||
16177487|NCT00592683|39129451|FG000|Overall Study|Found ineligible|0|||
16177488|NCT00592683|39129452|FG001|Overall Study|Found ineligible|1|||
16177489|NCT00592683|39129451|FG000|Overall Study|Withdrawal by Subject|1|||
16177490|NCT00592683|39129452|FG001|Overall Study|Withdrawal by Subject|0|||
16177491|NCT00592683|39129451|FG000|Overall Study|Adverse Event|0|||
16177492|NCT00592683|39129452|FG001|Overall Study|Adverse Event|2|||
16177493|NCT00592683|39129451|FG000|Overall Study|Protocol Violation|1|||
16177494|NCT00592683|39129452|FG001|Overall Study|Protocol Violation|0|||
16177495|NCT00592683|39129451|FG000|Overall Study|Study drug expired|1|||
16177496|NCT00592683|39129452|FG001|Overall Study|Study drug expired|0|||
16177497|NCT00592683|39129451|FG000|Overall Study|Other|1|||
16177498|NCT00592683|39129452|FG001|Overall Study|Other|0|||
16177499|NCT00592683|39129451|FG000|Overall Study|Lost to Follow-up|0|||
16177500|NCT00592683|39129452|FG001|Overall Study|Lost to Follow-up|1|||
16177501|NCT03952650|39129453|FG000|Overall Study|TRAVEL|0|||
16177502|NCT03952650|39129454|FG001|Overall Study|TRAVEL|4|||
16177503|NCT03952650|39129455|FG002|Overall Study|TRAVEL|0|||
16177504|NCT03952650|39129456|FG003|Overall Study|TRAVEL|4|||
16177505|NCT03952650|39129457|FG004|Overall Study|TRAVEL|0|||
16177506|NCT03952650|39129458|FG005|Overall Study|TRAVEL|3|||
16177507|NCT03952650|39129459|FG006|Overall Study|TRAVEL|2|||
16177508|NCT03952650|39129453|FG000|Overall Study|Withdrawal by Subject|0|||
16177509|NCT03952650|39129454|FG001|Overall Study|Withdrawal by Subject|2|||
16177510|NCT03952650|39129455|FG002|Overall Study|Withdrawal by Subject|0|||
16177511|NCT03952650|39129456|FG003|Overall Study|Withdrawal by Subject|3|||
16177512|NCT03952650|39129457|FG004|Overall Study|Withdrawal by Subject|0|||
16177513|NCT03952650|39129458|FG005|Overall Study|Withdrawal by Subject|1|||
16177514|NCT03952650|39129459|FG006|Overall Study|Withdrawal by Subject|1|||
16177515|NCT03952650|39129453|FG000|Overall Study|Lost to Follow-up|0|||
16177516|NCT03952650|39129454|FG001|Overall Study|Lost to Follow-up|1|||
16177517|NCT03952650|39129455|FG002|Overall Study|Lost to Follow-up|0|||
16177518|NCT03952650|39129456|FG003|Overall Study|Lost to Follow-up|0|||
16177519|NCT03952650|39129457|FG004|Overall Study|Lost to Follow-up|0|||
16177520|NCT03952650|39129458|FG005|Overall Study|Lost to Follow-up|1|||
16177521|NCT03952650|39129459|FG006|Overall Study|Lost to Follow-up|1|||
16177522|NCT03952650|39129453|FG000|Overall Study|Received wrong vaccine and travelled|0|||
16177523|NCT03952650|39129454|FG001|Overall Study|Received wrong vaccine and travelled|0|||
16177524|NCT03952650|39129455|FG002|Overall Study|Received wrong vaccine and travelled|0|||
16177525|NCT03952650|39129456|FG003|Overall Study|Received wrong vaccine and travelled|0|||
16177526|NCT03952650|39129457|FG004|Overall Study|Received wrong vaccine and travelled|0|||
16177527|NCT03952650|39129458|FG005|Overall Study|Received wrong vaccine and travelled|1|||
16177528|NCT03952650|39129459|FG006|Overall Study|Received wrong vaccine and travelled|0|||
16177529|NCT03952650|39129453|FG000|Overall Study|Unable to make study visit|0|||
16177530|NCT03952650|39129454|FG001|Overall Study|Unable to make study visit|0|||
16177531|NCT03952650|39129455|FG002|Overall Study|Unable to make study visit|0|||
16177532|NCT03952650|39129456|FG003|Overall Study|Unable to make study visit|0|||
16177533|NCT03952650|39129457|FG004|Overall Study|Unable to make study visit|0|||
16177534|NCT03952650|39129458|FG005|Overall Study|Unable to make study visit|1|||
16177535|NCT03952650|39129459|FG006|Overall Study|Unable to make study visit|0|||
16177536|NCT00364793|39129460|FG000|Overall Study|Adverse Event|2|||
16177537|NCT00364793|39129461|FG001|Overall Study|Adverse Event|0|||
16177538|NCT00364793|39129462|FG002|Overall Study|Adverse Event|0|||
16177539|NCT00364793|39129463|FG003|Overall Study|Adverse Event|0|||
16177540|NCT00364793|39129460|FG000|Overall Study|Death|1|||
16177541|NCT00364793|39129461|FG001|Overall Study|Death|0|||
16177542|NCT00364793|39129462|FG002|Overall Study|Death|1|||
16177543|NCT00364793|39129463|FG003|Overall Study|Death|0|||
16177544|NCT00364793|39129460|FG000|Overall Study|Lack of Efficacy|3|||
16177545|NCT00364793|39129461|FG001|Overall Study|Lack of Efficacy|3|||
16177546|NCT00364793|39129462|FG002|Overall Study|Lack of Efficacy|1|||
16079965|NCT03086369|38786710|FG002|Overall Study|Withdrawal by Subject|0|||
16177547|NCT00364793|39129463|FG003|Overall Study|Lack of Efficacy|1|||
16177548|NCT00364793|39129460|FG000|Overall Study|Lost to Follow-up|1|||
16177549|NCT00364793|39129461|FG001|Overall Study|Lost to Follow-up|0|||
16177550|NCT00364793|39129462|FG002|Overall Study|Lost to Follow-up|2|||
16177551|NCT00364793|39129463|FG003|Overall Study|Lost to Follow-up|0|||
16177552|NCT00364793|39129460|FG000|Overall Study|Poor or non-compliance|1|||
16177553|NCT00364793|39129461|FG001|Overall Study|Poor or non-compliance|1|||
16177554|NCT00364793|39129462|FG002|Overall Study|Poor or non-compliance|0|||
16177555|NCT00364793|39129463|FG003|Overall Study|Poor or non-compliance|1|||
16177556|NCT00364793|39129460|FG000|Overall Study|No longer meets criteria|0|||
16177557|NCT00364793|39129461|FG001|Overall Study|No longer meets criteria|0|||
16177558|NCT00364793|39129462|FG002|Overall Study|No longer meets criteria|0|||
16177559|NCT00364793|39129463|FG003|Overall Study|No longer meets criteria|1|||
16177560|NCT00364793|39129460|FG000|Overall Study|Withdrawal by Subject|0|||
16177561|NCT00364793|39129461|FG001|Overall Study|Withdrawal by Subject|1|||
16177562|NCT00364793|39129462|FG002|Overall Study|Withdrawal by Subject|0|||
16177563|NCT00364793|39129463|FG003|Overall Study|Withdrawal by Subject|0|||
16177564|NCT02522377|39129466|FG000|Overall Study|Withdrawal by Subject|1|||
16177565|NCT02522377|39129467|FG001|Overall Study|Withdrawal by Subject|0|||
16177566|NCT02522377|39129466|FG000|Overall Study|Remission Achieved|3|||
16177567|NCT02522377|39129467|FG001|Overall Study|Remission Achieved|0|||
16177568|NCT02498821|39129468|FG000|Overall Study|Screen failure|3|||
16177569|NCT02498821|39129469|FG001|Overall Study|Screen failure|5|||
16177570|NCT03312218|39129470|FG000|Overall Study|Never signed in to access the app|54|||
16177571|NCT03312218|39129471|FG001|Overall Study|Never signed in to access the app|58|||
16177572|NCT02704429|39129472|FG000|Part A: 24 Weeks|Adverse Event|3|||
16177573|NCT02704429|39129473|FG001|Part A: 24 Weeks|Adverse Event|0|||
16177574|NCT02704429|39129472|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
16177575|NCT02704429|39129473|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
16177576|NCT01676116|39129474|FG000|Overall Study|Withdrawal criteria|2|||
16177577|NCT01676116|39129475|FG001|Overall Study|Withdrawal criteria|14|||
16177578|NCT01676116|39129474|FG000|Overall Study|Adverse Event|1|||
16177579|NCT01676116|39129475|FG001|Overall Study|Adverse Event|2|||
16177580|NCT01676116|39129474|FG000|Overall Study|Unclassified|4|||
16177581|NCT01676116|39129475|FG001|Overall Study|Unclassified|10|||
16177582|NCT01676116|39129474|FG000|Overall Study|Protocol Violation|9|||
16177583|NCT01676116|39129475|FG001|Overall Study|Protocol Violation|3|||
16177584|NCT03227861|39129476|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
16177585|NCT03227861|39129476|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
16177586|NCT03227861|39129476|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
16177587|NCT03227861|39129476|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
16177588|NCT03227861|39129476|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
16177589|NCT03227861|39129476|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
16177590|NCT03227861|39129476|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
16177591|NCT03227861|39129476|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
16177592|NCT03227861|39129476|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
16177593|NCT03227861|39129476|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
16177594|NCT02397655|39129477|FG000|Overall Study|data not completed|1301|||
16177595|NCT03212261|39129478|FG000|Overall Study|Became ineligible d/t tech|2|||
16177596|NCT03212261|39129478|FG000|Overall Study|Tech Trouble- No first study visit|1|||
16177597|NCT03212261|39129478|FG000|Overall Study|Lost to Follow-up|7|||
16177598|NCT03212261|39129478|FG000|Overall Study|Family Emergency|1|||
16177599|NCT03212261|39129478|FG000|Overall Study|Too busy/ No time|5|||
16177600|NCT01937312|39129482|FG000|Overall Study|Adverse Event|10|||
16177601|NCT01937312|39129483|FG001|Overall Study|Adverse Event|1|||
16177602|NCT01937312|39129482|FG000|Overall Study|Lack of Efficacy|0|||
16177603|NCT01937312|39129483|FG001|Overall Study|Lack of Efficacy|1|||
16177604|NCT01937312|39129482|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
16177605|NCT01937312|39129483|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
16177606|NCT00963807|39129486|FG000|Overall Study|Physician Decision|2|||
16177607|NCT00963807|39129486|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
16177608|NCT00963807|39129486|FG000|Overall Study|Disease progression|15|||
16177609|NCT01926886|39129487|FG000|Overall Study|Administrative/other|1|||
16177610|NCT01926886|39129488|FG001|Overall Study|Administrative/other|0|||
16177611|NCT01926886|39129487|FG000|Overall Study|Adverse event/intercurrent illness|4|||
16177612|NCT01926886|39129488|FG001|Overall Study|Adverse event/intercurrent illness|0|||
16177613|NCT01926886|39129487|FG000|Overall Study|Disease progression/recurrence|4|||
16177614|NCT01926886|39129488|FG001|Overall Study|Disease progression/recurrence|0|||
16177615|NCT01926886|39129487|FG000|Overall Study|Withdrawal by Subject|15|||
16177616|NCT01926886|39129488|FG001|Overall Study|Withdrawal by Subject|0|||
16177617|NCT01926886|39129487|FG000|Overall Study|Failure to return|3|||
16177618|NCT01926886|39129488|FG001|Overall Study|Failure to return|0|||
16177619|NCT01926886|39129487|FG000|Overall Study|Recurrence of disease|1|||
16177620|NCT01926886|39129488|FG001|Overall Study|Recurrence of disease|0|||
16177621|NCT01926886|39129487|FG000|Overall Study|Progression of disease|2|||
16177622|NCT01926886|39129488|FG001|Overall Study|Progression of disease|0|||
16177623|NCT01926886|39129487|FG000|Overall Study|Death|1|||
16177624|NCT01926886|39129488|FG001|Overall Study|Death|0|||
16177625|NCT01926886|39129487|FG000|Overall Study|Did not cooperate|1|||
16177626|NCT01926886|39129488|FG001|Overall Study|Did not cooperate|0|||
16177627|NCT04435366|39129489|FG000|Overall Study|Adverse Event|3|||
16177628|NCT04435366|39129490|FG001|Overall Study|Adverse Event|2|||
16177629|NCT04435366|39129489|FG000|Overall Study|Death|2|||
16177630|NCT04435366|39129490|FG001|Overall Study|Death|1|||
16177631|NCT04435366|39129489|FG000|Overall Study|Lost to Follow-up|2|||
16177632|NCT04435366|39129490|FG001|Overall Study|Lost to Follow-up|1|||
16177633|NCT04435366|39129489|FG000|Overall Study|Withdrawal by Subject|17|||
16177634|NCT04435366|39129490|FG001|Overall Study|Withdrawal by Subject|13|||
16177635|NCT04435366|39129489|FG000|Overall Study|Patient non-compliance|1|||
16177636|NCT04435366|39129490|FG001|Overall Study|Patient non-compliance|0|||
16177637|NCT02782715|39129491|FG000|Overall Study|Withdrawal by Subject|1|||
16177638|NCT00860470|39129492|FG000|Overall Study|Death|6|||
16177639|NCT00860470|39129493|FG001|Overall Study|Death|10|||
16177640|NCT00860470|39129492|FG000|Overall Study|Moved away|8|||
16177641|NCT00860470|39129493|FG001|Overall Study|Moved away|10|||
16177642|NCT00860470|39129492|FG000|Overall Study|Lost to Follow-up|34|||
16177643|NCT00860470|39129493|FG001|Overall Study|Lost to Follow-up|39|||
16177644|NCT02981472|39129494|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
16177645|NCT02981472|39129495|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
16177646|NCT02981472|39129494|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16177647|NCT02981472|39129495|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16177648|NCT02981472|39129494|FG000|Treatment Period|Adverse Event|6|||
16177649|NCT02981472|39129495|FG001|Treatment Period|Adverse Event|1|||
16177650|NCT02981472|39129494|FG000|Treatment Period|Participant withdrew consent|1|||
16177651|NCT02981472|39129495|FG001|Treatment Period|Participant withdrew consent|0|||
16177652|NCT02981472|39129494|FG000|Treatment Period|Lost to Follow-up|0|||
16177653|NCT02981472|39129495|FG001|Treatment Period|Lost to Follow-up|1|||
16177654|NCT01282814|39129499|FG000|First Intervention|Emesis During Dosing Interval|0|||
16177655|NCT01282814|39129500|FG001|First Intervention|Emesis During Dosing Interval|3|||
16177656|NCT01282814|39129499|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
16177657|NCT01282814|39129500|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16177658|NCT04285723|39129503|FG000|Overall Study|Subject decision|1|||
16177659|NCT04285723|39129504|FG001|Overall Study|Subject decision|2|||
16177660|NCT04285723|39129503|FG000|Overall Study|Physician Decision|1|||
16177661|NCT04285723|39129504|FG001|Overall Study|Physician Decision|0|||
16177662|NCT04285723|39129503|FG000|Overall Study|No efficiency|1|||
16177663|NCT04285723|39129504|FG001|Overall Study|No efficiency|0|||
16177664|NCT00840463|39129505|FG000|Overall Study|Adverse Event|1|||
16177665|NCT00840463|39129506|FG001|Overall Study|Adverse Event|0|||
16177666|NCT03941548|39129510|FG000|Overall Study|Adverse Event|0|||
16177667|NCT03941548|39129511|FG001|Overall Study|Adverse Event|1|||
16177668|NCT03941548|39129510|FG000|Overall Study|Lost to Follow-up|0|||
16177669|NCT03941548|39129511|FG001|Overall Study|Lost to Follow-up|1|||
16177670|NCT03941548|39129510|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
16177671|NCT03941548|39129511|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
16177672|NCT00327444|39129518|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
16177673|NCT00327444|39129519|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
16177674|NCT00327444|39129518|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
16478078|NCT01034631|40231036|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
16478079|NCT01034631|40231034|FG000|Phase II|Not Evaluable per protocol|0|||
16478080|NCT01034631|40231035|FG001|Phase II|Not Evaluable per protocol|0|||
16478081|NCT01034631|40231036|FG002|Phase II|Not Evaluable per protocol|2|||
16478082|NCT01034631|40231034|FG000|Phase II|Determined Ineligible per protocol|0|||
16478083|NCT01034631|40231035|FG001|Phase II|Determined Ineligible per protocol|1|||
16478084|NCT01034631|40231036|FG002|Phase II|Determined Ineligible per protocol|0|||
16478085|NCT02121522|40231037|FG000|Overall Study|Adverse Event|1|||
16478086|NCT00633750|40231038|FG000|Overall Study|Adverse Event|2|||
16478087|NCT00633750|40231038|FG000|Overall Study|Withdrawal by Subject|3|||
16478088|NCT00484094|40231040|FG000|Overall Study|Discontinued|39|||
16478089|NCT00484094|40231040|FG000|Overall Study|Other|3|||
16478090|NCT00492531|40231041|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
16478091|NCT00492531|40231042|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
16478092|NCT02202837|40231043|FG000|Overall Study|Enbrel treatment discontinued|36|||
16478093|NCT02202837|40231044|FG001|Overall Study|Enbrel treatment discontinued|4|||
16478094|NCT02202837|40231043|FG000|Overall Study|Other|10|||
16478095|NCT02202837|40231044|FG001|Overall Study|Other|0|||
16478096|NCT02202837|40231043|FG000|Overall Study|Lost to Follow-up|7|||
16478097|NCT02202837|40231044|FG001|Overall Study|Lost to Follow-up|1|||
16177675|NCT00327444|39129519|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
16177676|NCT00327444|39129518|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
16177677|NCT00327444|39129519|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
16177678|NCT00327444|39129518|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
16478098|NCT00470847|40231046|FG000|Overall Study|Pt still receiving treatment|1|||
16478099|NCT04553679|40231047|FG000|Overall Study|Withdrawal by Subject|2|||
16177679|NCT00327444|39129519|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
16177680|NCT00327444|39129518|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
16177681|NCT00327444|39129519|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
16177682|NCT00327444|39129518|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
16177683|NCT00327444|39129519|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
16177684|NCT00327444|39129518|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
16177685|NCT00327444|39129519|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
16177686|NCT00327444|39129518|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
16177687|NCT00327444|39129519|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
16177688|NCT02499952|39129522|FG000|Overall Study|Lost to Follow-up|1|||
16177689|NCT02499952|39129522|FG000|Overall Study|Death|9|||
16177690|NCT02104180|39129525|FG000|Overall Study|Protocol Violation|1|||
16177691|NCT02104180|39129526|FG001|Overall Study|Protocol Violation|0|||
16177692|NCT01633060|39129527|FG000|Randomization Phase|Protocol deviation|1|||
16177693|NCT01633060|39129528|FG001|Randomization Phase|Protocol deviation|2|||
16177694|NCT01633060|39129527|FG000|Randomization Phase|Technical problem|0|||
16177695|NCT01633060|39129528|FG001|Randomization Phase|Technical problem|1|||
16177696|NCT01633060|39129527|FG000|Treatment Phase|Adverse Event|24|||
16177697|NCT01633060|39129528|FG001|Treatment Phase|Adverse Event|3|||
16177698|NCT01633060|39129527|FG000|Treatment Phase|Lost to Follow-up|1|||
16177699|NCT01633060|39129528|FG001|Treatment Phase|Lost to Follow-up|0|||
16177700|NCT01633060|39129527|FG000|Treatment Phase|Physician Decision|16|||
16177701|NCT01633060|39129528|FG001|Treatment Phase|Physician Decision|7|||
16177702|NCT01633060|39129527|FG000|Treatment Phase|Progressive Disease|210|||
16177703|NCT01633060|39129528|FG001|Treatment Phase|Progressive Disease|120|||
16177704|NCT01633060|39129527|FG000|Treatment Phase|Protocol Deviation|1|||
16177705|NCT01633060|39129528|FG001|Treatment Phase|Protocol Deviation|0|||
16177706|NCT01633060|39129527|FG000|Treatment Phase|Study Terminated by sponsor|7|||
16177707|NCT01633060|39129528|FG001|Treatment Phase|Study Terminated by sponsor|3|||
16177708|NCT01633060|39129527|FG000|Treatment Phase|Subject/guardian decision|25|||
16177709|NCT01633060|39129528|FG001|Treatment Phase|Subject/guardian decision|4|||
16177710|NCT01633060|39129527|FG000|Treatment Phase|Death|4|||
16177711|NCT01633060|39129528|FG001|Treatment Phase|Death|3|||
16177712|NCT01633060|39129527|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
16177713|NCT01633060|39129528|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16177714|NCT01633060|39129527|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
16177715|NCT01633060|39129528|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
16177716|NCT01633060|39129527|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
16177717|NCT01633060|39129528|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
16177718|NCT01633060|39129527|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
16177719|NCT01633060|39129528|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
16177720|NCT01633060|39129527|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
16177721|NCT01633060|39129528|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
16177722|NCT01633060|39129527|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
16177723|NCT01633060|39129528|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
16177724|NCT02300129|39129542|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
16177725|NCT02300129|39129543|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
16177726|NCT02300129|39129544|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
16177727|NCT02300129|39129545|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
16177728|NCT02300129|39129542|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
16177729|NCT02300129|39129543|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
16177730|NCT02300129|39129544|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
16177731|NCT02300129|39129545|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
16177732|NCT02300129|39129542|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
16177733|NCT02300129|39129543|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
16177734|NCT02300129|39129544|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
16177735|NCT02300129|39129545|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
16177736|NCT02032524|39129546|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
16177737|NCT02032524|39129547|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
16177738|NCT02032524|39129548|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
16177739|NCT02032524|39129549|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
16177740|NCT02032524|39129550|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
16177741|NCT02032524|39129551|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
16177742|NCT02032524|39129546|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
16177743|NCT02032524|39129547|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
16177744|NCT02032524|39129548|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
16279019|NCT05562011|39504208|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
16177745|NCT02032524|39129549|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
16177746|NCT02032524|39129550|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
16177747|NCT02032524|39129551|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
16177748|NCT02032524|39129546|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
16177749|NCT02032524|39129547|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
16177750|NCT02032524|39129548|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
16177751|NCT02032524|39129549|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
16177752|NCT02032524|39129550|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
16177753|NCT02032524|39129551|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
16177754|NCT02032524|39129546|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
16177755|NCT02032524|39129547|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
16177756|NCT02032524|39129548|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
16177757|NCT02032524|39129549|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
16177758|NCT02032524|39129550|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
16177759|NCT02032524|39129551|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
16177760|NCT02032524|39129546|FG000|Period 2: LTS13769 Study|Other|0|||
16177761|NCT02032524|39129547|FG001|Period 2: LTS13769 Study|Other|0|||
16177762|NCT02032524|39129548|FG002|Period 2: LTS13769 Study|Other|0|||
16177763|NCT02032524|39129549|FG003|Period 2: LTS13769 Study|Other|0|||
16177764|NCT02032524|39129550|FG004|Period 2: LTS13769 Study|Other|0|||
16177765|NCT02032524|39129551|FG005|Period 2: LTS13769 Study|Other|1|||
16177766|NCT05127486|39129552|FG000|Overall Study|Adverse Event|2|||
16177767|NCT05127486|39129553|FG001|Overall Study|Adverse Event|4|||
16177768|NCT05127486|39129552|FG000|Overall Study|Lack of Efficacy|1|||
16177769|NCT05127486|39129553|FG001|Overall Study|Lack of Efficacy|0|||
16177770|NCT05127486|39129552|FG000|Overall Study|Pregnancy|0|||
16177771|NCT05127486|39129553|FG001|Overall Study|Pregnancy|1|||
16177772|NCT05127486|39129552|FG000|Overall Study|Physician Decision|4|||
16177773|NCT05127486|39129553|FG001|Overall Study|Physician Decision|1|||
16177774|NCT05127486|39129552|FG000|Overall Study|Withdrawal by Subject|14|||
16177775|NCT05127486|39129553|FG001|Overall Study|Withdrawal by Subject|13|||
16177776|NCT05127486|39129552|FG000|Overall Study|Lost to Follow-up|5|||
16177777|NCT05127486|39129553|FG001|Overall Study|Lost to Follow-up|8|||
16177778|NCT01966731|39129554|FG000|Overall Study|Death|2|||
16177779|NCT01966731|39129554|FG000|Overall Study|Lost to Follow-up|1|||
16177780|NCT01966731|39129554|FG000|Overall Study|Physician Decision|2|||
16177781|NCT01966731|39129554|FG000|Overall Study|Follow up is not complete|600|||
16177782|NCT01966731|39129554|FG000|Overall Study|Screening Failure|29|||
16177783|NCT01966731|39129554|FG000|Overall Study|Found to be ineligible|1|||
16177784|NCT02902809|39129558|FG000|Overall Study|Discontinuation of asthma program|28|||
16177785|NCT01682044|39129559|FG000|Overall Study|Death|1|||
16177786|NCT01682044|39129559|FG000|Overall Study|Progression|3|||
16177787|NCT03545282|39129562|FG000|Overall Study|Lost to Follow-up|15|||
16177788|NCT03545282|39129563|FG001|Overall Study|Lost to Follow-up|10|||
16177789|NCT03545282|39129562|FG000|Overall Study|Withdrawal by Subject|2|||
16177790|NCT03545282|39129563|FG001|Overall Study|Withdrawal by Subject|2|||
16177791|NCT01584024|39129567|FG000|Overall Study|Lost to Follow-up|10|||
16177792|NCT01584024|39129567|FG000|Overall Study|Withdrawal by Subject|3|||
16177793|NCT01287117|39129570|FG000|Overall Study|Adverse Event|2|||
16177794|NCT01287117|39129571|FG001|Overall Study|Adverse Event|1|||
16177795|NCT01287117|39129572|FG002|Overall Study|Adverse Event|1|||
16177796|NCT01287117|39129573|FG003|Overall Study|Adverse Event|1|||
16177797|NCT01287117|39129570|FG000|Overall Study|Lost to Follow-up|1|||
16177798|NCT01287117|39129571|FG001|Overall Study|Lost to Follow-up|1|||
16177799|NCT01287117|39129572|FG002|Overall Study|Lost to Follow-up|0|||
16177800|NCT01287117|39129573|FG003|Overall Study|Lost to Follow-up|0|||
16177801|NCT01287117|39129570|FG000|Overall Study|Physician Decision|0|||
16177802|NCT01287117|39129571|FG001|Overall Study|Physician Decision|1|||
16177803|NCT01287117|39129572|FG002|Overall Study|Physician Decision|1|||
16177804|NCT01287117|39129573|FG003|Overall Study|Physician Decision|1|||
16177805|NCT01287117|39129570|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
16177806|NCT01287117|39129571|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
16177807|NCT01287117|39129572|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
16177808|NCT01287117|39129573|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
16177809|NCT01287117|39129570|FG000|Overall Study|Disease Progression|10|||
16177810|NCT01287117|39129571|FG001|Overall Study|Disease Progression|5|||
16177811|NCT01287117|39129572|FG002|Overall Study|Disease Progression|6|||
16177812|NCT01287117|39129573|FG003|Overall Study|Disease Progression|5|||
16177813|NCT01896232|39129574|FG000|Overall Study|Death|6|||
16177814|NCT01896232|39129575|FG001|Overall Study|Death|10|||
16177815|NCT01896232|39129574|FG000|Overall Study|Withdrawal by Subject|32|||
16177816|NCT01896232|39129575|FG001|Overall Study|Withdrawal by Subject|31|||
16177817|NCT01896232|39129574|FG000|Overall Study|Sponsor Decision|2|||
16177818|NCT01896232|39129575|FG001|Overall Study|Sponsor Decision|0|||
16177819|NCT01896232|39129574|FG000|Overall Study|Lost to Follow-up|9|||
16177820|NCT01896232|39129575|FG001|Overall Study|Lost to Follow-up|12|||
16177821|NCT02017444|39129576|FG000|Overall Study|Physician Decision|1|||
16177822|NCT02017444|39129577|FG001|Overall Study|Physician Decision|0|||
16177823|NCT02017444|39129576|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
16177824|NCT02017444|39129577|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
16177825|NCT02109029|39129578|FG000|Part B|Adverse Event|0|||
16177826|NCT02109029|39129579|FG001|Part B|Adverse Event|0|||
16177827|NCT02109029|39129580|FG002|Part B|Adverse Event|0|||
16177828|NCT02109029|39129581|FG003|Part B|Adverse Event|0|||
16177829|NCT02109029|39129582|FG004|Part B|Adverse Event|1|||
16177830|NCT02109029|39129583|FG005|Part B|Adverse Event|1|||
16177831|NCT02900092|39129584|FG000|Overall Study|Adverse Event|1|||
16177832|NCT01821963|39129588|FG000|Overall Study|Adverse Event|1|||
16177833|NCT04329949|39129589|FG000|Overall Study|Death|36|||
16177834|NCT04329949|39129589|FG000|Overall Study|Withdrawal by Subject|4|||
16177835|NCT04329949|39129589|FG000|Overall Study|Termination of study by sponsor|3|||
16177836|NCT00538681|39129590|FG000|Overall Study|Progressive Disease|7|||
16177837|NCT00538681|39129591|FG001|Overall Study|Progressive Disease|0|||
16177838|NCT00538681|39129592|FG002|Overall Study|Progressive Disease|1|||
16177839|NCT00538681|39129593|FG003|Overall Study|Progressive Disease|0|||
16177840|NCT00538681|39129590|FG000|Overall Study|Sponsor Decision|1|||
16177841|NCT00538681|39129591|FG001|Overall Study|Sponsor Decision|3|||
16177842|NCT00538681|39129592|FG002|Overall Study|Sponsor Decision|8|||
16177843|NCT00538681|39129593|FG003|Overall Study|Sponsor Decision|9|||
16177844|NCT00538681|39129590|FG000|Overall Study|Adverse Event|1|||
16177845|NCT00538681|39129591|FG001|Overall Study|Adverse Event|1|||
16177846|NCT00538681|39129592|FG002|Overall Study|Adverse Event|1|||
16177847|NCT00538681|39129593|FG003|Overall Study|Adverse Event|0|||
16177848|NCT00538681|39129590|FG000|Overall Study|Death|0|||
16177849|NCT00538681|39129591|FG001|Overall Study|Death|0|||
16177850|NCT00538681|39129592|FG002|Overall Study|Death|1|||
16177851|NCT00538681|39129593|FG003|Overall Study|Death|1|||
16177852|NCT00538681|39129590|FG000|Overall Study|Investigator Decision|0|||
16177853|NCT00538681|39129591|FG001|Overall Study|Investigator Decision|0|||
16177854|NCT00538681|39129592|FG002|Overall Study|Investigator Decision|0|||
16177855|NCT00538681|39129593|FG003|Overall Study|Investigator Decision|1|||
16177856|NCT01480180|39129594|FG000|Main Phase|Withdrawal criteria|12|||
16177857|NCT01480180|39129595|FG001|Main Phase|Withdrawal criteria|1|||
16177858|NCT01480180|39129596|FG002|Main Phase|Withdrawal criteria|0|||
16177859|NCT01480180|39129597|FG003|Main Phase|Withdrawal criteria|0|||
16177860|NCT01480180|39129598|FG004|Main Phase|Withdrawal criteria|0|||
16177861|NCT01480180|39129599|FG005|Main Phase|Withdrawal criteria|0|||
16177862|NCT01480180|39129594|FG000|Main Phase|Lack of Efficacy|1|||
16177863|NCT01480180|39129595|FG001|Main Phase|Lack of Efficacy|0|||
16177864|NCT01480180|39129596|FG002|Main Phase|Lack of Efficacy|0|||
16177865|NCT01480180|39129597|FG003|Main Phase|Lack of Efficacy|0|||
16177866|NCT01480180|39129598|FG004|Main Phase|Lack of Efficacy|0|||
16177867|NCT01480180|39129599|FG005|Main Phase|Lack of Efficacy|0|||
16177868|NCT01480180|39129594|FG000|Main Phase|Non-compliance|3|||
16177869|NCT01480180|39129595|FG001|Main Phase|Non-compliance|0|||
16177870|NCT01480180|39129596|FG002|Main Phase|Non-compliance|0|||
16177871|NCT01480180|39129597|FG003|Main Phase|Non-compliance|0|||
16177872|NCT01480180|39129598|FG004|Main Phase|Non-compliance|0|||
16177873|NCT01480180|39129599|FG005|Main Phase|Non-compliance|0|||
16177874|NCT01480180|39129594|FG000|Main Phase|Unclassified|3|||
16177875|NCT01480180|39129595|FG001|Main Phase|Unclassified|0|||
16177876|NCT01480180|39129596|FG002|Main Phase|Unclassified|0|||
16177877|NCT01480180|39129597|FG003|Main Phase|Unclassified|0|||
16177878|NCT01480180|39129598|FG004|Main Phase|Unclassified|0|||
16177879|NCT01480180|39129599|FG005|Main Phase|Unclassified|0|||
16177880|NCT01480180|39129594|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
16177881|NCT01480180|39129595|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
16177882|NCT01480180|39129596|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
16177883|NCT01480180|39129597|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
16177884|NCT01480180|39129598|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
16177885|NCT01480180|39129599|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
16177886|NCT01480180|39129594|FG000|Extension Phase, Part 1|Unclassified|0|||
16177887|NCT01480180|39129595|FG001|Extension Phase, Part 1|Unclassified|0|||
16177888|NCT01480180|39129596|FG002|Extension Phase, Part 1|Unclassified|1|||
16177889|NCT01480180|39129597|FG003|Extension Phase, Part 1|Unclassified|0|||
16177890|NCT01480180|39129598|FG004|Extension Phase, Part 1|Unclassified|0|||
16177891|NCT01480180|39129599|FG005|Extension Phase, Part 1|Unclassified|0|||
16177892|NCT01480180|39129594|FG000|Extension Phase, Part 1|Adverse Event|0|||
16177893|NCT01480180|39129595|FG001|Extension Phase, Part 1|Adverse Event|0|||
16177894|NCT01480180|39129596|FG002|Extension Phase, Part 1|Adverse Event|4|||
16177895|NCT01480180|39129597|FG003|Extension Phase, Part 1|Adverse Event|1|||
16177896|NCT01480180|39129598|FG004|Extension Phase, Part 1|Adverse Event|0|||
16177897|NCT01480180|39129599|FG005|Extension Phase, Part 1|Adverse Event|0|||
16177898|NCT01480180|39129594|FG000|Extension Phase, Part 1|Change of treatment|0|||
16177899|NCT01480180|39129595|FG001|Extension Phase, Part 1|Change of treatment|0|||
16177900|NCT01480180|39129596|FG002|Extension Phase, Part 1|Change of treatment|0|||
16177901|NCT01480180|39129597|FG003|Extension Phase, Part 1|Change of treatment|9|||
16177902|NCT01480180|39129598|FG004|Extension Phase, Part 1|Change of treatment|0|||
16177903|NCT01480180|39129599|FG005|Extension Phase, Part 1|Change of treatment|0|||
16177904|NCT01480180|39129594|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
16177905|NCT01480180|39129595|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
16177906|NCT01480180|39129596|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
16177907|NCT01480180|39129597|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
16177908|NCT01480180|39129598|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
16177909|NCT01480180|39129599|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
16177910|NCT01480180|39129594|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
16177911|NCT01480180|39129595|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
16177912|NCT01480180|39129596|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
16177913|NCT01480180|39129597|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
16177914|NCT01480180|39129598|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
16177915|NCT01480180|39129599|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
16177916|NCT01480180|39129594|FG000|Extension Phase, Part 2|Unclassified|0|||
16177917|NCT01480180|39129595|FG001|Extension Phase, Part 2|Unclassified|0|||
16177918|NCT01480180|39129596|FG002|Extension Phase, Part 2|Unclassified|3|||
16177919|NCT01480180|39129597|FG003|Extension Phase, Part 2|Unclassified|1|||
16177920|NCT01480180|39129598|FG004|Extension Phase, Part 2|Unclassified|1|||
16177921|NCT01480180|39129599|FG005|Extension Phase, Part 2|Unclassified|0|||
16478100|NCT04553679|40231048|FG001|Overall Study|Withdrawal by Subject|0|||
16478101|NCT04553679|40231047|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
16546302|NCT02237508|40464776|FG003|Overall Study|Withdrawal by Subject|1|||
16177922|NCT04840667|39129600|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
16177923|NCT03233048|39129606|FG000|Overall Study|Withdrawal by Subject|1|||
16177924|NCT02179398|39129607|FG000|Overall Study|Lack of obligatory data|3|||
16177925|NCT02179398|39129608|FG001|Overall Study|Lack of obligatory data|3|||
16177926|NCT02179398|39129607|FG000|Overall Study|Lost to Follow-up|0|||
16177927|NCT02179398|39129608|FG001|Overall Study|Lost to Follow-up|1|||
16177928|NCT03717922|39129611|FG000|Overall Study|Lost to Follow-up|2|||
16177929|NCT03717922|39129612|FG001|Overall Study|Lost to Follow-up|2|||
16177930|NCT01333189|39129617|FG000|Overall Study|Time constraints|1|||
16177931|NCT01333189|39129618|FG001|Overall Study|Time constraints|0|||
16177932|NCT01333189|39129617|FG000|Overall Study|Adverse Event|1|||
16177933|NCT01333189|39129618|FG001|Overall Study|Adverse Event|0|||
16177934|NCT01333189|39129617|FG000|Overall Study|Transportation difficulties|0|||
16177935|NCT01333189|39129618|FG001|Overall Study|Transportation difficulties|1|||
16177936|NCT01333189|39129617|FG000|Overall Study|Moved from region|0|||
16177937|NCT01333189|39129618|FG001|Overall Study|Moved from region|1|||
16177938|NCT02698410|39129619|FG000|Overall Study|Adverse Event|2|||
16177939|NCT02698410|39129619|FG000|Overall Study|Withdrawal by Subject|1|||
16177940|NCT02698410|39129619|FG000|Overall Study|Other|1|||
16177941|NCT00465569|39129620|FG000|Overall Study|persistent eczema during dose escalation|1|||
16177942|NCT00465569|39129621|FG001|Overall Study|persistent eczema during dose escalation|0|||
16177943|NCT01524289|39129622|FG000|Overall Study|Lost to Follow-up|0|||
16177944|NCT01524289|39129623|FG001|Overall Study|Lost to Follow-up|1|||
16177945|NCT01524289|39129622|FG000|Overall Study|Physician Decision|1|||
16177946|NCT01524289|39129623|FG001|Overall Study|Physician Decision|0|||
16177947|NCT01524289|39129622|FG000|Overall Study|Protocol Violation|5|||
16177948|NCT01524289|39129623|FG001|Overall Study|Protocol Violation|1|||
16177949|NCT01524289|39129622|FG000|Overall Study|Withdrawal by Subject|11|||
16177950|NCT01524289|39129623|FG001|Overall Study|Withdrawal by Subject|7|||
16177951|NCT01524289|39129622|FG000|Overall Study|Adverse Event|12|||
16177952|NCT01524289|39129623|FG001|Overall Study|Adverse Event|5|||
16177953|NCT01524289|39129622|FG000|Overall Study|Did not take study medication|1|||
16177954|NCT01524289|39129623|FG001|Overall Study|Did not take study medication|0|||
16177955|NCT00947154|39129627|FG000|Overall Study|Lost to Follow-up|1|||
16177956|NCT00659438|39129628|FG000|Overall Study|Withdrawal by Subject|2|||
16177957|NCT00659438|39129629|FG001|Overall Study|Withdrawal by Subject|2|||
16177958|NCT00659438|39129628|FG000|Overall Study|Death|11|||
16177959|NCT00659438|39129629|FG001|Overall Study|Death|6|||
16177960|NCT00659438|39129628|FG000|Overall Study|Lost to Follow-up|1|||
16177961|NCT00659438|39129629|FG001|Overall Study|Lost to Follow-up|0|||
16177962|NCT03478683|39129636|FG000|Overall Study|Adverse Event|5|||
16177963|NCT03478683|39129637|FG001|Overall Study|Adverse Event|3|||
16177964|NCT03478683|39129636|FG000|Overall Study|Lost to Follow-up|0|||
16177965|NCT03478683|39129637|FG001|Overall Study|Lost to Follow-up|5|||
16177966|NCT03478683|39129636|FG000|Overall Study|Physician Decision|1|||
16177967|NCT03478683|39129637|FG001|Overall Study|Physician Decision|3|||
16177968|NCT03478683|39129636|FG000|Overall Study|Withdrawal by Subject|7|||
16177969|NCT03478683|39129637|FG001|Overall Study|Withdrawal by Subject|7|||
16177970|NCT02707757|39129638|FG000|Overall Study|Protocol Violation|3|||
16177971|NCT02707757|39129639|FG001|Overall Study|Protocol Violation|2|||
16177972|NCT02707757|39129638|FG000|Overall Study|Withdrawal by Subject|2|||
16177973|NCT02707757|39129639|FG001|Overall Study|Withdrawal by Subject|0|||
16177974|NCT02707757|39129638|FG000|Overall Study|Death|0|||
16177975|NCT02707757|39129639|FG001|Overall Study|Death|1|||
16177976|NCT02707757|39129638|FG000|Overall Study|Adverse Event|6|||
16177977|NCT02707757|39129639|FG001|Overall Study|Adverse Event|4|||
16177978|NCT02707757|39129638|FG000|Overall Study|Renal transplant/elective operation|1|||
16177979|NCT02707757|39129639|FG001|Overall Study|Renal transplant/elective operation|5|||
16177980|NCT00996840|39129640|FG000|Overall Study|Adverse Event|0|||
16177981|NCT00996840|39129641|FG001|Overall Study|Adverse Event|1|||
16478102|NCT04553679|40231048|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
16478103|NCT02024555|40231049|FG000|Overall Study|Lost to Follow-up|1|||
16478104|NCT02024555|40231050|FG001|Overall Study|Lost to Follow-up|1|||
16478105|NCT02024555|40231049|FG000|Overall Study|Withdrawal by Subject|5|||
16478106|NCT02024555|40231050|FG001|Overall Study|Withdrawal by Subject|1|||
16478107|NCT04638660|40231051|FG000|Overall Study|Withdrawal by Subject|2|||
16478108|NCT04638660|40231052|FG001|Overall Study|Withdrawal by Subject|0|||
16177982|NCT00996840|39129642|FG002|Overall Study|Adverse Event|0|||
16177983|NCT00996840|39129643|FG003|Overall Study|Adverse Event|0|||
16177984|NCT00996840|39129644|FG004|Overall Study|Adverse Event|0|||
16177985|NCT00996840|39129640|FG000|Overall Study|Physician Decision|0|||
16177986|NCT00996840|39129641|FG001|Overall Study|Physician Decision|0|||
16177987|NCT00996840|39129642|FG002|Overall Study|Physician Decision|1|||
16177988|NCT00996840|39129643|FG003|Overall Study|Physician Decision|1|||
16177989|NCT00996840|39129644|FG004|Overall Study|Physician Decision|2|||
16177990|NCT00996840|39129640|FG000|Overall Study|Withdrawal by Subject|1|||
16177991|NCT00996840|39129641|FG001|Overall Study|Withdrawal by Subject|1|||
16177992|NCT00996840|39129642|FG002|Overall Study|Withdrawal by Subject|0|||
16177993|NCT00996840|39129643|FG003|Overall Study|Withdrawal by Subject|0|||
16177994|NCT00996840|39129644|FG004|Overall Study|Withdrawal by Subject|0|||
16177995|NCT01154101|39129645|FG000|Overall Study|Adverse Event|0|||
16177996|NCT01154101|39129646|FG001|Overall Study|Adverse Event|2|||
16177997|NCT01154101|39129647|FG002|Overall Study|Adverse Event|1|||
16177998|NCT01154101|39129648|FG003|Overall Study|Adverse Event|1|||
16177999|NCT01154101|39129649|FG004|Overall Study|Adverse Event|0|||
16178000|NCT01154101|39129645|FG000|Overall Study|Lost to Follow-up|0|||
16178001|NCT01154101|39129646|FG001|Overall Study|Lost to Follow-up|1|||
16178002|NCT01154101|39129647|FG002|Overall Study|Lost to Follow-up|0|||
16178003|NCT01154101|39129648|FG003|Overall Study|Lost to Follow-up|1|||
16178004|NCT01154101|39129649|FG004|Overall Study|Lost to Follow-up|0|||
16178005|NCT01154101|39129645|FG000|Overall Study|Withdrawal by Subject|0|||
16178006|NCT01154101|39129646|FG001|Overall Study|Withdrawal by Subject|1|||
16178007|NCT01154101|39129647|FG002|Overall Study|Withdrawal by Subject|2|||
16178008|NCT01154101|39129648|FG003|Overall Study|Withdrawal by Subject|0|||
16178009|NCT01154101|39129649|FG004|Overall Study|Withdrawal by Subject|1|||
16178010|NCT02609399|39129650|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
16178011|NCT02609399|39129651|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
16178012|NCT02609399|39129650|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
16178013|NCT02609399|39129651|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
16178014|NCT02609399|39129650|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
16478109|NCT04638660|40231051|FG000|Overall Study|Lost to Follow-up|1|||
16478110|NCT04638660|40231052|FG001|Overall Study|Lost to Follow-up|0|||
16478111|NCT03822182|40231057|FG000|Overall Study|Protocol Violation|0|||
16079966|NCT03086369|38786711|FG003|Overall Study|Withdrawal by Subject|5|||
16079967|NCT03086369|38786712|FG004|Overall Study|Withdrawal by Subject|3|||
16079968|NCT03086369|38786708|FG000|Overall Study|Progressive Disease|0|||
16079969|NCT03086369|38786709|FG001|Overall Study|Progressive Disease|0|||
16079970|NCT03086369|38786710|FG002|Overall Study|Progressive Disease|0|||
16079971|NCT03086369|38786711|FG003|Overall Study|Progressive Disease|1|||
16079972|NCT03086369|38786712|FG004|Overall Study|Progressive Disease|1|||
16079973|NCT01102231|38786713|FG000|Overall Study|Protocol Violation|3|||
16079974|NCT01102231|38786713|FG000|Overall Study|Lack of Efficacy|2|||
16079975|NCT01102231|38786713|FG000|Overall Study|Death|2|||
16178015|NCT02609399|39129651|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
16178016|NCT02500550|39129659|FG000|Overall Study|Death|7|||
16178017|NCT03577990|39129662|FG000|Overall Study|Lost to Follow-up|4|||
16178018|NCT03577990|39129663|FG001|Overall Study|Lost to Follow-up|6|||
16178019|NCT03577990|39129662|FG000|Overall Study|Withdrawal by Subject|4|||
16178020|NCT03577990|39129663|FG001|Overall Study|Withdrawal by Subject|7|||
16178021|NCT02251743|39129664|FG000|Overall Study|Withdrawal by Subject|1|||
16178022|NCT02251743|39129665|FG001|Overall Study|Withdrawal by Subject|1|||
16178023|NCT03429556|39129666|FG000|Overall Study|Lost to Follow-up|0|||
16178024|NCT03429556|39129667|FG001|Overall Study|Lost to Follow-up|1|||
16178025|NCT03429556|39129668|FG002|Overall Study|Lost to Follow-up|0|||
16178026|NCT03429556|39129669|FG003|Overall Study|Lost to Follow-up|0|||
16178027|NCT01273818|39132586|FG000|Overall Study|Physician Decision|13|||
16478112|NCT03822182|40231058|FG001|Overall Study|Protocol Violation|1|||
16478113|NCT03822182|40231059|FG002|Overall Study|Protocol Violation|1|||
16178028|NCT01273818|39132587|FG001|Overall Study|Physician Decision|2|||
16178029|NCT01273818|39132588|FG002|Overall Study|Physician Decision|9|||
16178030|NCT03830281|39132590|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
16178031|NCT03830281|39132591|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
16178032|NCT03830281|39132590|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
16178033|NCT03830281|39132591|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
16178034|NCT03830281|39132590|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
16178035|NCT03830281|39132591|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
16178036|NCT03830281|39132590|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
16178037|NCT03830281|39132591|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
16178038|NCT03830281|39132590|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
16178039|NCT03830281|39132591|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
16178040|NCT03830281|39132590|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
16178041|NCT03830281|39132591|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
16178042|NCT03830281|39132590|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
16178043|NCT03830281|39132591|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
16178044|NCT03830281|39132590|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
16178045|NCT03830281|39132591|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
16178046|NCT03830281|39132590|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
16178047|NCT03830281|39132591|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
16178048|NCT05421754|39132592|FG000|Overall Study|Technical issue with sensor|1|||
16178049|NCT00824421|39132593|FG000|Overall Study|Adverse Event|6|||
16178050|NCT00824421|39132594|FG001|Overall Study|Adverse Event|6|||
16178051|NCT00824421|39132595|FG002|Overall Study|Adverse Event|6|||
16178052|NCT00824421|39132593|FG000|Overall Study|Death|0|||
16178053|NCT00824421|39132594|FG001|Overall Study|Death|1|||
16178054|NCT00824421|39132595|FG002|Overall Study|Death|0|||
16178055|NCT00824421|39132593|FG000|Overall Study|Lack of Efficacy|5|||
16178056|NCT00824421|39132594|FG001|Overall Study|Lack of Efficacy|7|||
16478114|NCT03308786|40231061|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
16478115|NCT04195906|40231067|FG000|Part 1|Adverse Event|3|||
16178057|NCT00824421|39132595|FG002|Overall Study|Lack of Efficacy|4|||
16178058|NCT00824421|39132593|FG000|Overall Study|Lost to Follow-up|2|||
16178059|NCT00824421|39132594|FG001|Overall Study|Lost to Follow-up|3|||
16178060|NCT00824421|39132595|FG002|Overall Study|Lost to Follow-up|0|||
16178061|NCT00824421|39132593|FG000|Overall Study|Pregnancy|1|||
16178062|NCT00824421|39132594|FG001|Overall Study|Pregnancy|0|||
16178063|NCT00824421|39132595|FG002|Overall Study|Pregnancy|1|||
16178064|NCT00824421|39132593|FG000|Overall Study|Withdrawal by Subject|2|||
16178065|NCT00824421|39132594|FG001|Overall Study|Withdrawal by Subject|3|||
16178066|NCT00824421|39132595|FG002|Overall Study|Withdrawal by Subject|3|||
16178067|NCT00824421|39132593|FG000|Overall Study|Randomized but not Treated|1|||
16178068|NCT00824421|39132594|FG001|Overall Study|Randomized but not Treated|1|||
16178069|NCT00824421|39132595|FG002|Overall Study|Randomized but not Treated|0|||
16178070|NCT00824421|39132593|FG000|Overall Study|Other|0|||
16178071|NCT00824421|39132594|FG001|Overall Study|Other|1|||
16178072|NCT00824421|39132595|FG002|Overall Study|Other|0|||
16178073|NCT01025336|39132596|FG000|Overall Study|Protocol Violation|0|||
16178074|NCT01025336|39132597|FG001|Overall Study|Protocol Violation|0|||
16178075|NCT01025336|39132598|FG002|Overall Study|Protocol Violation|0|||
16178076|NCT01025336|39132599|FG003|Overall Study|Protocol Violation|2|||
16178077|NCT01025336|39132600|FG004|Overall Study|Protocol Violation|0|||
16178078|NCT00206518|39132601|FG000|Overall Study|Lack of Efficacy|6|||
16178079|NCT00206518|39132602|FG001|Overall Study|Lack of Efficacy|4|||
16178080|NCT00206518|39132601|FG000|Overall Study|Adverse Event|2|||
16178081|NCT00206518|39132602|FG001|Overall Study|Adverse Event|1|||
16178082|NCT00206518|39132601|FG000|Overall Study|Physician Decision|1|||
16178083|NCT00206518|39132602|FG001|Overall Study|Physician Decision|0|||
16178084|NCT00206518|39132601|FG000|Overall Study|Protocol Violation|1|||
16178085|NCT00206518|39132602|FG001|Overall Study|Protocol Violation|1|||
16178086|NCT00363415|39132607|FG000|Overall Study|Progressive Disease|196|||
16178087|NCT00363415|39132608|FG001|Overall Study|Progressive Disease|107|||
16178088|NCT00363415|39132607|FG000|Overall Study|Sponsor Decision|67|||
16178089|NCT00363415|39132608|FG001|Overall Study|Sponsor Decision|31|||
16178090|NCT00363415|39132607|FG000|Overall Study|Death|32|||
16178091|NCT00363415|39132608|FG001|Overall Study|Death|29|||
16178092|NCT00363415|39132607|FG000|Overall Study|Adverse Event|24|||
16178093|NCT00363415|39132608|FG001|Overall Study|Adverse Event|15|||
16178094|NCT00363415|39132607|FG000|Overall Study|Physician Decision|18|||
16178095|NCT00363415|39132608|FG001|Overall Study|Physician Decision|35|||
16178096|NCT00363415|39132607|FG000|Overall Study|Entry Criteria Not Met|11|||
16178097|NCT00363415|39132608|FG001|Overall Study|Entry Criteria Not Met|10|||
16178098|NCT00363415|39132607|FG000|Overall Study|Withdrawal by Subject|9|||
16178099|NCT00363415|39132608|FG001|Overall Study|Withdrawal by Subject|15|||
16178100|NCT00363415|39132607|FG000|Overall Study|Lost to Follow-up|3|||
16178101|NCT00363415|39132608|FG001|Overall Study|Lost to Follow-up|3|||
16178102|NCT00363415|39132607|FG000|Overall Study|Protocol Violation|1|||
16178103|NCT00363415|39132608|FG001|Overall Study|Protocol Violation|4|||
16178104|NCT00638846|39132612|FG000|Overall Study|Adverse Event|0|||
16178105|NCT00638846|39132613|FG001|Overall Study|Adverse Event|1|||
16178106|NCT00638846|39132612|FG000|Overall Study|Lost to Follow-up|3|||
16178107|NCT00638846|39132613|FG001|Overall Study|Lost to Follow-up|2|||
16178108|NCT00638846|39132612|FG000|Overall Study|lens issue|1|||
16178109|NCT00638846|39132613|FG001|Overall Study|lens issue|3|||
16178110|NCT00447421|39132614|FG000|Overall Study|Lack of Efficacy|1|||
16178111|NCT00447421|39132614|FG000|Overall Study|Adverse Event|3|||
16478116|NCT04195906|40231068|FG001|Part 1|Adverse Event|7|||
16478117|NCT04195906|40231067|FG000|Part 1|Withdrawal by Subject|0|||
16478118|NCT04195906|40231068|FG001|Part 1|Withdrawal by Subject|1|||
16478119|NCT04195906|40231067|FG000|Part 2|Adverse Event|1|||
16478120|NCT04195906|40231068|FG001|Part 2|Adverse Event|1|||
16478121|NCT04195906|40231067|FG000|Part 2|Withdrawal by Subject|0|||
16478122|NCT04195906|40231068|FG001|Part 2|Withdrawal by Subject|3|||
16478123|NCT04195906|40231067|FG000|Part 2|Other|1|||
16478124|NCT04195906|40231068|FG001|Part 2|Other|3|||
16478125|NCT05306977|40231069|FG000|Overall Study|Withdrawal by Subject|1|||
16478126|NCT00406718|40231072|FG000|Overall Study|Withdrawal by Subject|2|||
16478127|NCT00406718|40231073|FG001|Overall Study|Withdrawal by Subject|9|||
16478128|NCT00406718|40231074|FG002|Overall Study|Withdrawal by Subject|4|||
16478129|NCT00406718|40231072|FG000|Overall Study|Lost to Follow-up|2|||
16478130|NCT00406718|40231073|FG001|Overall Study|Lost to Follow-up|5|||
16178112|NCT00447421|39132614|FG000|Overall Study|Sponsor Decision|2|||
16178113|NCT02626338|39132620|FG000|Overall Study|Lack of Efficacy|3|||
16178114|NCT02626338|39132621|FG001|Overall Study|Lack of Efficacy|2|||
16178115|NCT02626338|39132622|FG002|Overall Study|Lack of Efficacy|0|||
16178116|NCT02750410|39132625|FG000|Double-Blind Treatment Period|Adverse Event|2|||
16178117|NCT02750410|39132626|FG001|Double-Blind Treatment Period|Adverse Event|2|||
16178118|NCT02750410|39132625|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16178119|NCT02750410|39132626|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16178120|NCT02750410|39132625|FG000|Open-Label Extension Period|Adverse Event|5|||
16178121|NCT02750410|39132626|FG001|Open-Label Extension Period|Adverse Event|3|||
16178122|NCT02750410|39132625|FG000|Open-Label Extension Period|Protocol Violation|0|||
16178123|NCT02750410|39132626|FG001|Open-Label Extension Period|Protocol Violation|1|||
16178124|NCT02750410|39132625|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
16178125|NCT02750410|39132626|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
16178126|NCT01733329|39132630|FG000|Overall Study|Protocol Violation|1|||
16178127|NCT01733329|39132631|FG001|Overall Study|Protocol Violation|1|||
16178128|NCT01733329|39132630|FG000|Overall Study|Uterine artery injury|1|||
16178129|NCT01733329|39132631|FG001|Overall Study|Uterine artery injury|0|||
16178130|NCT04272606|39132638|FG000|Overall Study|Protocol Violation|1|||
16178131|NCT04272606|39132639|FG001|Overall Study|Protocol Violation|1|||
16178132|NCT04272606|39132638|FG000|Overall Study|Physician Decision|0|||
16178133|NCT04272606|39132639|FG001|Overall Study|Physician Decision|1|||
16178134|NCT01040832|39132644|FG000|Overall Study|Adverse Event|4|||
16178135|NCT01040832|39132645|FG001|Overall Study|Adverse Event|5|||
16178136|NCT01040832|39132644|FG000|Overall Study|Death|4|||
16178137|NCT01040832|39132645|FG001|Overall Study|Death|6|||
16178138|NCT01040832|39132644|FG000|Overall Study|Withdrawal by Subject|2|||
16178139|NCT01040832|39132645|FG001|Overall Study|Withdrawal by Subject|3|||
16178140|NCT01040832|39132644|FG000|Overall Study|Progressive disease|32|||
16178141|NCT01040832|39132645|FG001|Overall Study|Progressive disease|17|||
16178142|NCT01040832|39132644|FG000|Overall Study|Symptomatic deterioration|2|||
16178143|NCT01040832|39132645|FG001|Overall Study|Symptomatic deterioration|5|||
16178144|NCT01040832|39132644|FG000|Overall Study|Other|2|||
16178145|NCT01040832|39132645|FG001|Overall Study|Other|1|||
16178146|NCT04178590|39132646|FG000|Overall Study|Pregnancy|1|||
16178147|NCT04178590|39132646|FG000|Overall Study|Lost to Follow-up|1|||
16178148|NCT03088605|39132647|FG000|Overall Study|Withdrawal by Subject|1|||
16178149|NCT03088605|39132648|FG001|Overall Study|Withdrawal by Subject|0|||
16178150|NCT02717507|39132649|FG000|Overall Study|Lost to Follow-up|5|||
16178151|NCT02717507|39132650|FG001|Overall Study|Lost to Follow-up|8|||
16178152|NCT02717507|39132649|FG000|Overall Study|Pregnancy|1|||
16178153|NCT02717507|39132650|FG001|Overall Study|Pregnancy|1|||
16478131|NCT00406718|40231074|FG002|Overall Study|Lost to Follow-up|4|||
16478132|NCT00864721|40231075|FG000|Overall Study|Patient request|11|||
16478133|NCT00864721|40231075|FG000|Overall Study|Hospitalized|1|||
16478134|NCT00864721|40231075|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
16478135|NCT00864721|40231075|FG000|Overall Study|Adverse Event|21|||
16079976|NCT01102231|38786713|FG000|Overall Study|Adverse Event|3|||
16178154|NCT02717507|39132649|FG000|Overall Study|Protocol Violation|2|||
16178155|NCT02717507|39132650|FG001|Overall Study|Protocol Violation|2|||
16178156|NCT02717507|39132649|FG000|Overall Study|Withdrawal by Subject|20|||
16178157|NCT02717507|39132650|FG001|Overall Study|Withdrawal by Subject|20|||
16178158|NCT02717507|39132649|FG000|Overall Study|Relapse|1|||
16178159|NCT02717507|39132650|FG001|Overall Study|Relapse|1|||
16178160|NCT02717507|39132649|FG000|Overall Study|Cardiac Event|2|||
16178161|NCT02717507|39132650|FG001|Overall Study|Cardiac Event|6|||
16478136|NCT00566111|40231076|FG000|Overall Study|Adverse Event|0|||
16178162|NCT00117338|39132651|FG000|Overall Study|Adverse Event|0|||
16178163|NCT00117338|39132652|FG001|Overall Study|Adverse Event|1|||
16178164|NCT00117338|39132651|FG000|Overall Study|Protocol Violation|3|||
16178165|NCT00117338|39132652|FG001|Overall Study|Protocol Violation|2|||
16178166|NCT00117338|39132651|FG000|Overall Study|Withdrawal by Subject|1|||
16178167|NCT00117338|39132652|FG001|Overall Study|Withdrawal by Subject|0|||
16178168|NCT00117338|39132651|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
16178169|NCT00117338|39132652|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
16178170|NCT00117338|39132651|FG000|Overall Study|Lack of Efficacy|0|||
16178171|NCT00117338|39132652|FG001|Overall Study|Lack of Efficacy|1|||
16178172|NCT02629393|39132653|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
16178173|NCT02629393|39132653|FG000|Overall Study|Physician Decision|1|||
16178174|NCT01451515|39132654|FG000|Overall Study|Death|0|||
16178175|NCT01451515|39132655|FG001|Overall Study|Death|1|||
16178176|NCT01451515|39132656|FG002|Overall Study|Death|0|||
16178177|NCT01451515|39132654|FG000|Overall Study|Withdrawal by Subject|0|||
16178178|NCT01451515|39132655|FG001|Overall Study|Withdrawal by Subject|1|||
16178179|NCT01451515|39132656|FG002|Overall Study|Withdrawal by Subject|0|||
16178180|NCT01451515|39132654|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
16178181|NCT01451515|39132655|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
16178182|NCT01451515|39132656|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
16178183|NCT01451515|39132654|FG000|Overall Study|Relapse (except CNS)|1|||
16178184|NCT01451515|39132655|FG001|Overall Study|Relapse (except CNS)|1|||
16178185|NCT01451515|39132656|FG002|Overall Study|Relapse (except CNS)|0|||
16178186|NCT03167619|39132659|FG000|Overall Study|Death|11|||
16178187|NCT03167619|39132660|FG001|Overall Study|Death|8|||
16178188|NCT03167619|39132659|FG000|Overall Study|Withdrawal by Subject|1|||
16178189|NCT03167619|39132660|FG001|Overall Study|Withdrawal by Subject|2|||
16178190|NCT03167619|39132659|FG000|Overall Study|Physician Decision|0|||
16178191|NCT03167619|39132660|FG001|Overall Study|Physician Decision|1|||
16178192|NCT00998738|39132661|FG000|Overall Study|Uknown|1|||
16178193|NCT01380093|39132662|FG000|Naloxone Challenge Phase|Screen failures|21|||
16178194|NCT01380093|39132663|FG001|Naloxone Challenge Phase|Screen failures|0|||
16178195|NCT01380093|39132664|FG002|Naloxone Challenge Phase|Screen failures|0|||
16178196|NCT01380093|39132665|FG003|Naloxone Challenge Phase|Screen failures|0|||
16178197|NCT01380093|39132666|FG004|Naloxone Challenge Phase|Screen failures|0|||
16178198|NCT01380093|39132667|FG005|Naloxone Challenge Phase|Screen failures|0|||
16178199|NCT01380093|39132668|FG006|Naloxone Challenge Phase|Screen failures|0|||
16178200|NCT01380093|39132669|FG007|Naloxone Challenge Phase|Screen failures|0|||
16178201|NCT01380093|39132670|FG008|Naloxone Challenge Phase|Screen failures|0|||
16178202|NCT01380093|39132662|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16178203|NCT01380093|39132663|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
16178204|NCT01380093|39132664|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16178205|NCT01380093|39132665|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16178206|NCT01380093|39132666|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16178207|NCT01380093|39132667|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16178208|NCT01380093|39132668|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16178209|NCT01380093|39132669|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16178210|NCT01380093|39132670|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
16178211|NCT01380093|39132662|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16178212|NCT01380093|39132663|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
16178213|NCT01380093|39132664|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
16178214|NCT01380093|39132665|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16178215|NCT01380093|39132666|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16178216|NCT01380093|39132667|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16178217|NCT01380093|39132668|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16178218|NCT01380093|39132669|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16178219|NCT01380093|39132670|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
16178220|NCT01380093|39132662|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16178221|NCT01380093|39132663|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
16178222|NCT01380093|39132664|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16178223|NCT01380093|39132665|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16178224|NCT01380093|39132666|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16178225|NCT01380093|39132667|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16178226|NCT01380093|39132668|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16178227|NCT01380093|39132669|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16178228|NCT01380093|39132670|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
16178229|NCT01380093|39132662|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16178230|NCT01380093|39132663|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
16178231|NCT01380093|39132664|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
16178232|NCT01380093|39132665|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16178233|NCT01380093|39132666|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16178234|NCT01380093|39132667|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16178235|NCT01380093|39132668|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16178236|NCT01380093|39132669|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16178237|NCT01380093|39132670|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
16178238|NCT01380093|39132662|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16178239|NCT01380093|39132663|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
16178240|NCT01380093|39132664|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
16178241|NCT01380093|39132665|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16178242|NCT01380093|39132666|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16178243|NCT01380093|39132667|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16178244|NCT01380093|39132668|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16178245|NCT01380093|39132669|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16178246|NCT01380093|39132670|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
16178247|NCT01380093|39132662|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
16178248|NCT01380093|39132663|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
16178249|NCT01380093|39132664|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
16178250|NCT01380093|39132665|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
16178251|NCT01380093|39132666|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
16178252|NCT01380093|39132667|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
16178253|NCT01380093|39132668|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
16178254|NCT01380093|39132669|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
16178255|NCT01380093|39132670|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
16178256|NCT01380093|39132662|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16178257|NCT01380093|39132663|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16178258|NCT01380093|39132664|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
16178259|NCT01380093|39132665|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16178260|NCT01380093|39132666|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16178261|NCT01380093|39132667|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16178262|NCT01380093|39132668|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16178263|NCT01380093|39132669|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16178264|NCT01380093|39132670|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
16178265|NCT01380093|39132662|FG000|Treatment Phase: Second Intervention|Other|0|||
16178266|NCT01380093|39132663|FG001|Treatment Phase: Second Intervention|Other|0|||
16178267|NCT01380093|39132664|FG002|Treatment Phase: Second Intervention|Other|0|||
16178268|NCT01380093|39132665|FG003|Treatment Phase: Second Intervention|Other|1|||
16178269|NCT01380093|39132666|FG004|Treatment Phase: Second Intervention|Other|0|||
16178270|NCT01380093|39132667|FG005|Treatment Phase: Second Intervention|Other|0|||
16178271|NCT01380093|39132668|FG006|Treatment Phase: Second Intervention|Other|0|||
16178272|NCT01380093|39132669|FG007|Treatment Phase: Second Intervention|Other|0|||
16178273|NCT01380093|39132670|FG008|Treatment Phase: Second Intervention|Other|0|||
16178274|NCT01380093|39132662|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
16178275|NCT01380093|39132663|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
16178276|NCT01380093|39132664|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
16178277|NCT01380093|39132665|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
16178278|NCT01380093|39132666|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
16178279|NCT01380093|39132667|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
16178280|NCT01380093|39132668|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
16178281|NCT01380093|39132669|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
16178282|NCT01380093|39132670|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
16178283|NCT01380093|39132662|FG000|Treatment Phase: Third Intervention|Other|0|||
16178284|NCT01380093|39132663|FG001|Treatment Phase: Third Intervention|Other|0|||
16178285|NCT01380093|39132664|FG002|Treatment Phase: Third Intervention|Other|0|||
16178286|NCT01380093|39132665|FG003|Treatment Phase: Third Intervention|Other|0|||
16178287|NCT01380093|39132666|FG004|Treatment Phase: Third Intervention|Other|0|||
16178288|NCT01380093|39132667|FG005|Treatment Phase: Third Intervention|Other|0|||
16478137|NCT00566111|40231077|FG001|Overall Study|Adverse Event|2|||
16478138|NCT01484275|40231080|FG000|Overall Study|Study terminated by sponsor|28|||
16478139|NCT01484275|40231081|FG001|Overall Study|Study terminated by sponsor|32|||
16478140|NCT01484275|40231080|FG000|Overall Study|Other|10|||
16478141|NCT01484275|40231081|FG001|Overall Study|Other|0|||
16478142|NCT01484275|40231080|FG000|Overall Study|Death|3|||
16478143|NCT01484275|40231081|FG001|Overall Study|Death|4|||
16478144|NCT01484275|40231080|FG000|Overall Study|Withdrawal by Subject|1|||
16478145|NCT01484275|40231081|FG001|Overall Study|Withdrawal by Subject|5|||
16478146|NCT01484275|40231080|FG000|Overall Study|Lost to Follow-up|1|||
16478147|NCT01484275|40231081|FG001|Overall Study|Lost to Follow-up|1|||
16478148|NCT00100178|40231082|FG000|Overall Study|Lost to Follow-up|0|||
16478149|NCT00100178|40231083|FG001|Overall Study|Lost to Follow-up|6|||
16178289|NCT01380093|39132668|FG006|Treatment Phase: Third Intervention|Other|0|||
16178290|NCT01380093|39132669|FG007|Treatment Phase: Third Intervention|Other|0|||
16178291|NCT01380093|39132670|FG008|Treatment Phase: Third Intervention|Other|1|||
16178292|NCT00391976|39132673|FG000|Overall Study|Adverse Event|0|||
16178293|NCT00391976|39132674|FG001|Overall Study|Adverse Event|0|||
16178294|NCT00391976|39132675|FG002|Overall Study|Adverse Event|1|||
16178295|NCT00391976|39132673|FG000|Overall Study|Withdrawal of consent|0|||
16178296|NCT00391976|39132674|FG001|Overall Study|Withdrawal of consent|1|||
16178297|NCT00391976|39132675|FG002|Overall Study|Withdrawal of consent|1|||
16178298|NCT00391976|39132673|FG000|Overall Study|Lost to Follow-up|1|||
16178299|NCT00391976|39132674|FG001|Overall Study|Lost to Follow-up|2|||
16178300|NCT00391976|39132675|FG002|Overall Study|Lost to Follow-up|0|||
16178301|NCT00391976|39132673|FG000|Overall Study|Inappropriate enrollment|1|||
16178302|NCT00391976|39132674|FG001|Overall Study|Inappropriate enrollment|1|||
16178303|NCT00391976|39132675|FG002|Overall Study|Inappropriate enrollment|0|||
16478150|NCT00100178|40231084|FG002|Overall Study|Lost to Follow-up|5|||
16478151|NCT00100178|40231082|FG000|Overall Study|Adverse Event|2|||
16478152|NCT00100178|40231083|FG001|Overall Study|Adverse Event|2|||
16478153|NCT00100178|40231084|FG002|Overall Study|Adverse Event|1|||
16478154|NCT00100178|40231082|FG000|Overall Study|Withdrawal by Subject|1|||
16478155|NCT00100178|40231083|FG001|Overall Study|Withdrawal by Subject|1|||
16478156|NCT00100178|40231084|FG002|Overall Study|Withdrawal by Subject|1|||
16478157|NCT00100178|40231082|FG000|Overall Study|Physician Decision|6|||
16478158|NCT00100178|40231083|FG001|Overall Study|Physician Decision|1|||
16478159|NCT00100178|40231084|FG002|Overall Study|Physician Decision|3|||
16478160|NCT03398200|40231085|FG000|Overall Study|Withdrawal by Subject|0|||
16478161|NCT03398200|40231086|FG001|Overall Study|Withdrawal by Subject|1|||
16478162|NCT00657358|40231087|FG000|Overall Study|Lack of Efficacy|6|||
16478163|NCT01453725|40231088|FG000|Overall Study|Adverse Event|3|||
16478164|NCT01453725|40231089|FG001|Overall Study|Adverse Event|3|||
16478165|NCT01453725|40231088|FG000|Overall Study|Lost to Follow-up|4|||
16478166|NCT01453725|40231089|FG001|Overall Study|Lost to Follow-up|0|||
16478167|NCT01453725|40231088|FG000|Overall Study|Non-compliance With Protocol|1|||
16478168|NCT01453725|40231089|FG001|Overall Study|Non-compliance With Protocol|2|||
16478169|NCT01453725|40231088|FG000|Overall Study|Protocol Violation|1|||
16478170|NCT01453725|40231089|FG001|Overall Study|Protocol Violation|0|||
16478171|NCT01453725|40231088|FG000|Overall Study|Withdrawal by Subject|2|||
16478172|NCT01453725|40231089|FG001|Overall Study|Withdrawal by Subject|3|||
16478173|NCT01453725|40231088|FG000|Overall Study|Pregnancy Wish|0|||
16478174|NCT01453725|40231089|FG001|Overall Study|Pregnancy Wish|2|||
16478175|NCT01453725|40231088|FG000|Overall Study|Pregnancy|1|||
16478176|NCT01453725|40231089|FG001|Overall Study|Pregnancy|0|||
16478177|NCT01453725|40231088|FG000|Overall Study|Physician Decision|1|||
16478178|NCT01453725|40231089|FG001|Overall Study|Physician Decision|1|||
16478179|NCT01050543|40231092|FG000|Overall Study|Withdrawal by Subject|0|||
16478180|NCT01050543|40231093|FG001|Overall Study|Withdrawal by Subject|2|||
16478181|NCT01050543|40231092|FG000|Overall Study|Protocol Violation|0|||
16478182|NCT01050543|40231093|FG001|Overall Study|Protocol Violation|1|||
16478183|NCT01050543|40231092|FG000|Overall Study|Administrative|4|||
16178304|NCT00391976|39132673|FG000|Overall Study|Protocol deviation/violation|4|||
16178305|NCT00391976|39132674|FG001|Overall Study|Protocol deviation/violation|2|||
16178306|NCT00391976|39132675|FG002|Overall Study|Protocol deviation/violation|1|||
16178307|NCT00391976|39132673|FG000|Overall Study|Recurrence/no eradication of infection|21|||
16178308|NCT00391976|39132674|FG001|Overall Study|Recurrence/no eradication of infection|19|||
16178309|NCT00391976|39132675|FG002|Overall Study|Recurrence/no eradication of infection|0|||
16178310|NCT00391976|39132673|FG000|Overall Study|Unable to classify|0|||
16178311|NCT00391976|39132674|FG001|Overall Study|Unable to classify|0|||
16178312|NCT00391976|39132675|FG002|Overall Study|Unable to classify|1|||
16178313|NCT00391976|39132673|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
16178314|NCT00391976|39132674|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
16178315|NCT00391976|39132675|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
16178316|NCT01772134|39132676|FG000|Overall Study|Adverse Event|6|||
16178317|NCT01772134|39132677|FG001|Overall Study|Adverse Event|5|||
16178318|NCT01772134|39132678|FG002|Overall Study|Adverse Event|10|||
16178319|NCT01772134|39132676|FG000|Overall Study|Withdrew Consent|3|||
16178320|NCT01772134|39132677|FG001|Overall Study|Withdrew Consent|1|||
16478184|NCT01050543|40231093|FG001|Overall Study|Administrative|1|||
16478185|NCT01495975|40231094|FG000|Overall Study|Lost to Follow-up|1|||
16478186|NCT01495975|40231095|FG001|Overall Study|Lost to Follow-up|0|||
16478187|NCT00723398|40231096|FG000|Overall Study|Withdrawal by Subject|2|||
16478188|NCT00723398|40231097|FG001|Overall Study|Withdrawal by Subject|6|||
16478189|NCT00723398|40231098|FG002|Overall Study|Withdrawal by Subject|4|||
16178321|NCT01772134|39132678|FG002|Overall Study|Withdrew Consent|5|||
16178322|NCT01772134|39132676|FG000|Overall Study|Lost to Follow-up|2|||
16478190|NCT00723398|40231099|FG003|Overall Study|Withdrawal by Subject|4|||
16478191|NCT00723398|40231100|FG004|Overall Study|Withdrawal by Subject|4|||
16478192|NCT00723398|40231096|FG000|Overall Study|Protocol Violation|2|||
16178323|NCT01772134|39132677|FG001|Overall Study|Lost to Follow-up|0|||
16178324|NCT01772134|39132678|FG002|Overall Study|Lost to Follow-up|0|||
16178325|NCT01772134|39132676|FG000|Overall Study|Protocol Deviation|4|||
16178326|NCT01772134|39132677|FG001|Overall Study|Protocol Deviation|3|||
16178327|NCT01772134|39132678|FG002|Overall Study|Protocol Deviation|3|||
16178328|NCT01772134|39132676|FG000|Overall Study|Lack of Efficacy|11|||
16178329|NCT01772134|39132677|FG001|Overall Study|Lack of Efficacy|5|||
16178330|NCT01772134|39132678|FG002|Overall Study|Lack of Efficacy|3|||
16178331|NCT01772134|39132676|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
16178332|NCT01772134|39132677|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
16178333|NCT01772134|39132678|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
16178334|NCT01772134|39132676|FG000|Overall Study|Randomized Study Medication Not Received|2|||
16178335|NCT01772134|39132677|FG001|Overall Study|Randomized Study Medication Not Received|0|||
16178336|NCT01772134|39132678|FG002|Overall Study|Randomized Study Medication Not Received|1|||
16178337|NCT03794986|39132679|FG000|Overall Study|0 Sessions Attended|34|||
16178338|NCT03794986|39132680|FG001|Overall Study|0 Sessions Attended|37|||
16178339|NCT03794986|39132679|FG000|Overall Study|Withdrawal by Subject|4|||
16178340|NCT03794986|39132680|FG001|Overall Study|Withdrawal by Subject|6|||
16178341|NCT03794986|39132679|FG000|Overall Study|Protocol Violation|1|||
16178342|NCT03794986|39132680|FG001|Overall Study|Protocol Violation|0|||
16178343|NCT01845077|39132683|FG000|Washout Period|Lost to Follow-up|0|||
16178344|NCT01845077|39132684|FG001|Washout Period|Lost to Follow-up|1|||
16178345|NCT01845077|39132685|FG002|Washout Period|Lost to Follow-up|0|||
16178346|NCT01845077|39132686|FG003|Washout Period|Lost to Follow-up|1|||
16178347|NCT01845077|39132687|FG004|Washout Period|Lost to Follow-up|0|||
16178348|NCT01845077|39132688|FG005|Washout Period|Lost to Follow-up|1|||
16178349|NCT01845077|39132683|FG000|Washout Period|Adverse Event|1|||
16178350|NCT01845077|39132684|FG001|Washout Period|Adverse Event|0|||
16178351|NCT01845077|39132685|FG002|Washout Period|Adverse Event|0|||
16178352|NCT01845077|39132686|FG003|Washout Period|Adverse Event|0|||
16178353|NCT01845077|39132687|FG004|Washout Period|Adverse Event|0|||
16178354|NCT01845077|39132688|FG005|Washout Period|Adverse Event|0|||
16178355|NCT01845077|39132683|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
16178356|NCT01845077|39132684|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
16178357|NCT01845077|39132685|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
16178358|NCT01845077|39132686|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
16178359|NCT01845077|39132687|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
16178360|NCT01845077|39132688|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
16178361|NCT01845077|39132683|FG000|Washout Period|Protocol Violation|0|||
16178362|NCT01845077|39132684|FG001|Washout Period|Protocol Violation|0|||
16178363|NCT01845077|39132685|FG002|Washout Period|Protocol Violation|0|||
16178364|NCT01845077|39132686|FG003|Washout Period|Protocol Violation|1|||
16178365|NCT01845077|39132687|FG004|Washout Period|Protocol Violation|1|||
16178366|NCT01845077|39132688|FG005|Washout Period|Protocol Violation|0|||
16178367|NCT00815308|39132692|FG000|Overall Study|Adverse Event|4|||
16178368|NCT00815308|39132692|FG000|Overall Study|Withdrawal by Subject|0|||
16178369|NCT00815308|39132692|FG000|Overall Study|Protocol Violation|6|||
16178370|NCT01919307|39132693|FG000|Overall Study|Withdrawal by Subject|9|||
16178371|NCT00586690|39132694|FG000|Overall Study|Death|2|||
16178372|NCT00586690|39132695|FG001|Overall Study|Death|0|||
16178373|NCT00586690|39132694|FG000|Overall Study|Disease Progression|10|||
16478193|NCT00723398|40231097|FG001|Overall Study|Protocol Violation|1|||
16178374|NCT00586690|39132695|FG001|Overall Study|Disease Progression|0|||
16178375|NCT00586690|39132694|FG000|Overall Study|Adverse Event|1|||
16178376|NCT00586690|39132695|FG001|Overall Study|Adverse Event|0|||
16178377|NCT00586690|39132694|FG000|Overall Study|Lack of Efficacy|2|||
16178378|NCT00586690|39132695|FG001|Overall Study|Lack of Efficacy|0|||
16178379|NCT00586690|39132694|FG000|Overall Study|Lab can't accommodate|1|||
16178380|NCT00586690|39132695|FG001|Overall Study|Lab can't accommodate|0|||
16178381|NCT00775021|39132698|FG000|First Intervention|Lost to Follow-up|1|||
16178382|NCT00775021|39132699|FG001|First Intervention|Lost to Follow-up|0|||
16178383|NCT00775021|39132698|FG000|Second Intervention|Adverse Event|0|||
16178384|NCT00775021|39132699|FG001|Second Intervention|Adverse Event|1|||
16279020|NCT05562011|39504208|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
16178385|NCT02623361|39132700|FG000|Overall Study|Protocol Violation|0|||
16178386|NCT02623361|39132701|FG001|Overall Study|Protocol Violation|1|||
16178387|NCT02623361|39132700|FG000|Overall Study|Withdrawal by Subject|0|||
16178388|NCT02623361|39132701|FG001|Overall Study|Withdrawal by Subject|1|||
16178389|NCT04919564|39132708|FG000|Overall Study|Lost to Follow-up|1|||
16178390|NCT04919564|39132709|FG001|Overall Study|Lost to Follow-up|0|||
16178391|NCT04919564|39132708|FG000|Overall Study|Physician Decision|1|||
16178392|NCT04919564|39132709|FG001|Overall Study|Physician Decision|1|||
16178393|NCT01416181|39132710|FG000|Part 1|Other|10|||
16178394|NCT01416181|39132711|FG001|Part 1|Other|24|||
16178395|NCT01416181|39132710|FG000|Part 1|Death|0|||
16178396|NCT01416181|39132711|FG001|Part 1|Death|1|||
16178397|NCT01416181|39132710|FG000|Part 1|Investigator Decision|7|||
16178398|NCT01416181|39132711|FG001|Part 1|Investigator Decision|6|||
16178399|NCT01416181|39132710|FG000|Part 1|Withdrawal by Subject|74|||
16178400|NCT01416181|39132711|FG001|Part 1|Withdrawal by Subject|48|||
16178401|NCT01416181|39132710|FG000|Part 1|Lack of Efficacy|16|||
16178402|NCT01416181|39132711|FG001|Part 1|Lack of Efficacy|8|||
16178403|NCT01416181|39132710|FG000|Part 1|Lost to Follow-up|1|||
16178404|NCT01416181|39132711|FG001|Part 1|Lost to Follow-up|1|||
16178405|NCT01416181|39132710|FG000|Part 1|Adverse Event|15|||
16178406|NCT01416181|39132711|FG001|Part 1|Adverse Event|18|||
16178407|NCT01416181|39132710|FG000|Part 1|Ongoing in Follow-Up|14|||
16178408|NCT01416181|39132711|FG001|Part 1|Ongoing in Follow-Up|8|||
16178409|NCT01416181|39132710|FG000|Part 2|Adverse Event|11|||
16178410|NCT01416181|39132711|FG001|Part 2|Adverse Event|4|||
16178411|NCT01416181|39132710|FG000|Part 2|Other|234|||
16178412|NCT01416181|39132711|FG001|Part 2|Other|267|||
16178413|NCT01416181|39132710|FG000|Part 2|Investigator Decision|6|||
16178414|NCT01416181|39132711|FG001|Part 2|Investigator Decision|7|||
16178415|NCT01416181|39132710|FG000|Part 2|Withdrawal by Subject|14|||
16178416|NCT01416181|39132711|FG001|Part 2|Withdrawal by Subject|5|||
16178417|NCT01416181|39132710|FG000|Part 2|Lack of Efficacy|4|||
16178418|NCT01416181|39132711|FG001|Part 2|Lack of Efficacy|1|||
16178419|NCT01416181|39132710|FG000|Part 2|Lost to Follow-up|2|||
16178420|NCT01416181|39132711|FG001|Part 2|Lost to Follow-up|2|||
16178421|NCT02986373|39132712|FG000|Overall Study|Adverse Event|4|||
16178422|NCT02986373|39132712|FG000|Overall Study|Lost to Follow-up|1|||
16178423|NCT02986373|39132712|FG000|Overall Study|Withdrawal by Subject|10|||
16178424|NCT02986373|39132712|FG000|Overall Study|Other|24|||
16178425|NCT04734873|39132714|FG000|Overall Study|Lost to Follow-up|1|||
16178426|NCT04734873|39132715|FG001|Overall Study|Lost to Follow-up|3|||
16178427|NCT04734873|39132716|FG002|Overall Study|Lost to Follow-up|2|||
16178428|NCT04734873|39132714|FG000|Overall Study|Randomized but not dosed|1|||
16178429|NCT04734873|39132715|FG001|Overall Study|Randomized but not dosed|0|||
16178430|NCT04734873|39132716|FG002|Overall Study|Randomized but not dosed|1|||
16178431|NCT00891657|39132717|FG000|Overall Study|Withdrawal by Subject|1|||
16178432|NCT00891657|39132718|FG001|Overall Study|Withdrawal by Subject|1|||
16178433|NCT01025635|39132724|FG000|Overall Study|Withdrawal by Subject|6|||
16178434|NCT01025635|39132725|FG001|Overall Study|Withdrawal by Subject|7|||
16178435|NCT01025635|39132724|FG000|Overall Study|Protocol Violation|4|||
16178436|NCT01025635|39132725|FG001|Overall Study|Protocol Violation|2|||
16178437|NCT01025635|39132724|FG000|Overall Study|Lack of Efficacy|0|||
16178438|NCT01025635|39132725|FG001|Overall Study|Lack of Efficacy|1|||
16178439|NCT01025635|39132724|FG000|Overall Study|Lost to Follow-up|9|||
16178440|NCT01025635|39132725|FG001|Overall Study|Lost to Follow-up|13|||
16178441|NCT01025635|39132724|FG000|Overall Study|Reason not known|4|||
16178442|NCT01025635|39132725|FG001|Overall Study|Reason not known|2|||
16178443|NCT00957372|39132728|FG000|PART I|Lost to Follow-up|0|||
16178444|NCT00957372|39132729|FG001|PART I|Lost to Follow-up|0|||
16178445|NCT00957372|39132730|FG002|PART I|Lost to Follow-up|1|||
16178446|NCT00957372|39132731|FG003|PART I|Lost to Follow-up|0|||
16178447|NCT00957372|39132728|FG000|PART II|Withdrawal by Subject|0|||
16178448|NCT00957372|39132729|FG001|PART II|Withdrawal by Subject|0|||
16178449|NCT00957372|39132730|FG002|PART II|Withdrawal by Subject|0|||
16178450|NCT00957372|39132731|FG003|PART II|Withdrawal by Subject|8|||
16178451|NCT00957372|39132728|FG000|PART II|Physician Decision|0|||
16178452|NCT00957372|39132729|FG001|PART II|Physician Decision|0|||
16178453|NCT00957372|39132730|FG002|PART II|Physician Decision|0|||
16178454|NCT00957372|39132731|FG003|PART II|Physician Decision|1|||
16178455|NCT00957372|39132728|FG000|PART II|Pregnancy|0|||
16178456|NCT00957372|39132729|FG001|PART II|Pregnancy|0|||
16178457|NCT00957372|39132730|FG002|PART II|Pregnancy|0|||
16178458|NCT00957372|39132731|FG003|PART II|Pregnancy|1|||
16178459|NCT00957372|39132728|FG000|PART II|Not Know|0|||
16178460|NCT00957372|39132729|FG001|PART II|Not Know|0|||
16178461|NCT00957372|39132730|FG002|PART II|Not Know|0|||
16178462|NCT00957372|39132731|FG003|PART II|Not Know|20|||
16178463|NCT00957372|39132728|FG000|PART II|Adverse Event|0|||
16178464|NCT00957372|39132729|FG001|PART II|Adverse Event|0|||
16178465|NCT00957372|39132730|FG002|PART II|Adverse Event|0|||
16178466|NCT00957372|39132731|FG003|PART II|Adverse Event|10|||
16178467|NCT00957372|39132728|FG000|PART II|Patient non-compliance|0|||
16178468|NCT00957372|39132729|FG001|PART II|Patient non-compliance|0|||
16178469|NCT00957372|39132730|FG002|PART II|Patient non-compliance|0|||
16178470|NCT00957372|39132731|FG003|PART II|Patient non-compliance|4|||
16178471|NCT01096667|39132732|FG000|Overall Study|Lost to Follow-up|1|||
16178472|NCT01096667|39132733|FG001|Overall Study|Lost to Follow-up|1|||
16178473|NCT01096667|39132734|FG002|Overall Study|Lost to Follow-up|1|||
16178474|NCT01096667|39132735|FG003|Overall Study|Lost to Follow-up|0|||
16178475|NCT01096667|39132736|FG004|Overall Study|Lost to Follow-up|0|||
16178476|NCT01096667|39132732|FG000|Overall Study|Withdrawal by Subject|1|||
16178477|NCT01096667|39132733|FG001|Overall Study|Withdrawal by Subject|0|||
16178478|NCT01096667|39132734|FG002|Overall Study|Withdrawal by Subject|0|||
16178479|NCT01096667|39132735|FG003|Overall Study|Withdrawal by Subject|1|||
16178480|NCT01096667|39132736|FG004|Overall Study|Withdrawal by Subject|0|||
16178481|NCT01096667|39132732|FG000|Overall Study|Reason not available|0|||
16178482|NCT01096667|39132733|FG001|Overall Study|Reason not available|1|||
16178483|NCT01096667|39132734|FG002|Overall Study|Reason not available|1|||
16178484|NCT01096667|39132735|FG003|Overall Study|Reason not available|1|||
16178485|NCT01096667|39132736|FG004|Overall Study|Reason not available|0|||
16178486|NCT01096667|39132732|FG000|Overall Study|Protocol Violation|0|||
16178487|NCT01096667|39132733|FG001|Overall Study|Protocol Violation|0|||
16178488|NCT01096667|39132734|FG002|Overall Study|Protocol Violation|0|||
16178489|NCT01096667|39132735|FG003|Overall Study|Protocol Violation|1|||
16178490|NCT01096667|39132736|FG004|Overall Study|Protocol Violation|0|||
16178491|NCT01096667|39132732|FG000|Overall Study|Not treated|1|||
16178492|NCT01096667|39132733|FG001|Overall Study|Not treated|0|||
16178493|NCT01096667|39132734|FG002|Overall Study|Not treated|0|||
16178494|NCT01096667|39132735|FG003|Overall Study|Not treated|0|||
16178495|NCT01096667|39132736|FG004|Overall Study|Not treated|0|||
16178496|NCT00524303|39132737|FG000|Overall Study|Lost to Follow-up|6|||
16178497|NCT00524303|39132738|FG001|Overall Study|Lost to Follow-up|0|||
16178498|NCT00524303|39132739|FG002|Overall Study|Lost to Follow-up|3|||
16178499|NCT00524303|39132737|FG000|Overall Study|Protocol Violation|0|||
16178500|NCT00524303|39132738|FG001|Overall Study|Protocol Violation|1|||
16178501|NCT00524303|39132739|FG002|Overall Study|Protocol Violation|1|||
16178502|NCT00524303|39132737|FG000|Overall Study|Withdrawal by Subject|3|||
16178503|NCT00524303|39132738|FG001|Overall Study|Withdrawal by Subject|0|||
16178504|NCT00524303|39132739|FG002|Overall Study|Withdrawal by Subject|4|||
16178505|NCT00524303|39132737|FG000|Overall Study|Death|0|||
16178506|NCT00524303|39132738|FG001|Overall Study|Death|2|||
16178507|NCT00524303|39132739|FG002|Overall Study|Death|3|||
16178508|NCT00524303|39132737|FG000|Overall Study|Adverse Event|1|||
16178509|NCT00524303|39132738|FG001|Overall Study|Adverse Event|2|||
16178510|NCT00524303|39132739|FG002|Overall Study|Adverse Event|3|||
16178511|NCT00524303|39132737|FG000|Overall Study|Did not Complete Study Dosing|1|||
16178512|NCT00524303|39132738|FG001|Overall Study|Did not Complete Study Dosing|0|||
16178513|NCT00524303|39132739|FG002|Overall Study|Did not Complete Study Dosing|0|||
16178514|NCT00524303|39132737|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
16178515|NCT00524303|39132738|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
16178516|NCT00524303|39132739|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
16178517|NCT00524303|39132737|FG000|Overall Study|Disease Progression|0|||
16178518|NCT00524303|39132738|FG001|Overall Study|Disease Progression|4|||
16178519|NCT00524303|39132739|FG002|Overall Study|Disease Progression|1|||
16178520|NCT00524303|39132737|FG000|Overall Study|Disease Recurrence|0|||
16178521|NCT00524303|39132738|FG001|Overall Study|Disease Recurrence|1|||
16178522|NCT00524303|39132739|FG002|Overall Study|Disease Recurrence|0|||
16178523|NCT00524303|39132737|FG000|Overall Study|Sponsor Request|0|||
16178524|NCT00524303|39132738|FG001|Overall Study|Sponsor Request|0|||
16178525|NCT00524303|39132739|FG002|Overall Study|Sponsor Request|1|||
16178526|NCT00524303|39132737|FG000|Overall Study|Physician Decision|0|||
16178527|NCT00524303|39132738|FG001|Overall Study|Physician Decision|0|||
16178528|NCT00524303|39132739|FG002|Overall Study|Physician Decision|1|||
16178529|NCT00524303|39132737|FG000|Overall Study|Completed 5 years|0|||
16178530|NCT00524303|39132738|FG001|Overall Study|Completed 5 years|0|||
16178531|NCT00524303|39132739|FG002|Overall Study|Completed 5 years|1|||
16178532|NCT00805207|39132740|FG000|Overall Study|Protocol Violation|0|||
16178533|NCT00805207|39132741|FG001|Overall Study|Protocol Violation|0|||
16178534|NCT00805207|39132742|FG002|Overall Study|Protocol Violation|1|||
16178535|NCT00805207|39132743|FG003|Overall Study|Protocol Violation|0|||
16178536|NCT00805207|39132744|FG004|Overall Study|Protocol Violation|0|||
16178537|NCT00805207|39132745|FG005|Overall Study|Protocol Violation|0|||
16178538|NCT00805207|39132746|FG006|Overall Study|Protocol Violation|0|||
16178539|NCT00805207|39132747|FG007|Overall Study|Protocol Violation|0|||
16178540|NCT00805207|39132748|FG008|Overall Study|Protocol Violation|0|||
16178541|NCT00805207|39132740|FG000|Overall Study|Physician Decision|0|||
16178542|NCT00805207|39132741|FG001|Overall Study|Physician Decision|1|||
16178543|NCT00805207|39132742|FG002|Overall Study|Physician Decision|0|||
16178544|NCT00805207|39132743|FG003|Overall Study|Physician Decision|0|||
16178545|NCT00805207|39132744|FG004|Overall Study|Physician Decision|0|||
16178546|NCT00805207|39132745|FG005|Overall Study|Physician Decision|1|||
16178547|NCT00805207|39132746|FG006|Overall Study|Physician Decision|0|||
16178548|NCT00805207|39132747|FG007|Overall Study|Physician Decision|0|||
16178549|NCT00805207|39132748|FG008|Overall Study|Physician Decision|0|||
16178550|NCT00805207|39132740|FG000|Overall Study|Withdrawal by Subject|0|||
16178551|NCT00805207|39132741|FG001|Overall Study|Withdrawal by Subject|1|||
16178552|NCT00805207|39132742|FG002|Overall Study|Withdrawal by Subject|0|||
16279021|NCT05562011|39504208|FG000|Overall Study|Device malfunction|13|||
16178553|NCT00805207|39132743|FG003|Overall Study|Withdrawal by Subject|0|||
16178554|NCT00805207|39132744|FG004|Overall Study|Withdrawal by Subject|1|||
16178555|NCT00805207|39132745|FG005|Overall Study|Withdrawal by Subject|2|||
16178556|NCT00805207|39132746|FG006|Overall Study|Withdrawal by Subject|0|||
16178557|NCT00805207|39132747|FG007|Overall Study|Withdrawal by Subject|0|||
16178558|NCT00805207|39132748|FG008|Overall Study|Withdrawal by Subject|0|||
16178559|NCT01981187|39132749|FG000|Overall Study|Participant/guardian decision|2|||
16178560|NCT01981187|39132749|FG000|Overall Study|Physician Decision|1|||
16178561|NCT01981187|39132749|FG000|Overall Study|Disease progression|2|||
16178562|NCT01981187|39132749|FG000|Overall Study|Adverse Event|7|||
16178563|NCT02299934|39132753|FG000|Overall Study|Termination of study|13|||
16178564|NCT02111369|39132756|FG000|Overall Study|Lost to Follow-up|2|||
16178565|NCT02111369|39132756|FG000|Overall Study|Withdrawal by Subject|1|||
16178566|NCT03240081|39132757|FG000|Overall Study|Withdrawal by Subject|0|||
16178567|NCT03240081|39132758|FG001|Overall Study|Withdrawal by Subject|2|||
16178568|NCT03240081|39132757|FG000|Overall Study|Lost to Follow-up|0|||
16178569|NCT03240081|39132758|FG001|Overall Study|Lost to Follow-up|1|||
16178570|NCT01241786|39132762|FG000|Overall Study|Lack of Efficacy|5|||
16178571|NCT03065530|39132763|FG000|Overall Study|Lack of Efficacy|1|||
16178572|NCT03065530|39132764|FG001|Overall Study|Lack of Efficacy|1|||
16178573|NCT03065530|39132765|FG002|Overall Study|Lack of Efficacy|0|||
16178574|NCT03065530|39132766|FG003|Overall Study|Lack of Efficacy|1|||
16178575|NCT03065530|39132763|FG000|Overall Study|Protocol Violation|1|||
16178576|NCT03065530|39132764|FG001|Overall Study|Protocol Violation|0|||
16178577|NCT03065530|39132765|FG002|Overall Study|Protocol Violation|1|||
16178578|NCT03065530|39132766|FG003|Overall Study|Protocol Violation|1|||
16178579|NCT00636818|39132777|FG000|Overall Study|Adverse Event|1|||
16178580|NCT00636818|39132777|FG000|Overall Study|Lost to Follow-up|2|||
16178581|NCT00636818|39132777|FG000|Overall Study|Entry Criteria Exclusion|3|||
16178582|NCT00636818|39132777|FG000|Overall Study|Protocol Violation|1|||
16178583|NCT00636818|39132777|FG000|Overall Study|Withdrawal by Subject|4|||
16178584|NCT00853905|39132778|FG000|Overall Study|Lost to Follow-up|1|||
16178585|NCT00853905|39132779|FG001|Overall Study|Lost to Follow-up|3|||
16178586|NCT00853905|39132778|FG000|Overall Study|Withdrawal by Subject|0|||
16178587|NCT00853905|39132779|FG001|Overall Study|Withdrawal by Subject|1|||
16178588|NCT00853905|39132778|FG000|Overall Study|never had surgery|1|||
16178589|NCT00853905|39132779|FG001|Overall Study|never had surgery|0|||
16178590|NCT01676961|39132780|FG000|Overall Study|Death|3|||
16178591|NCT01676961|39132780|FG000|Overall Study|Lost to Follow-up|1|||
16178592|NCT01676961|39132780|FG000|Overall Study|Withdrawal by Subject|1|||
16178593|NCT02053246|39132781|FG000|Overall Study|Withdrawal by Subject|3|||
16178594|NCT02053246|39132781|FG000|Overall Study|Physician Decision|1|||
16178595|NCT00104104|39132784|FG000|Overall Study|Adverse Event|8|||
16178596|NCT00104104|39132785|FG001|Overall Study|Adverse Event|8|||
16178597|NCT00104104|39132784|FG000|Overall Study|Abnormal laboratory value(s)|20|||
16178598|NCT00104104|39132785|FG001|Overall Study|Abnormal laboratory value(s)|14|||
16178599|NCT00104104|39132784|FG000|Overall Study|Lack of Efficacy|0|||
16178600|NCT00104104|39132785|FG001|Overall Study|Lack of Efficacy|3|||
16178601|NCT00104104|39132784|FG000|Overall Study|Condition no longer requires study drug|7|||
16178602|NCT00104104|39132785|FG001|Overall Study|Condition no longer requires study drug|4|||
16178603|NCT00104104|39132784|FG000|Overall Study|Protocol Violation|5|||
16178604|NCT00104104|39132785|FG001|Overall Study|Protocol Violation|2|||
16178605|NCT00104104|39132784|FG000|Overall Study|Withdrawal by Subject|11|||
16178606|NCT00104104|39132785|FG001|Overall Study|Withdrawal by Subject|15|||
16178607|NCT00104104|39132784|FG000|Overall Study|Lost to Follow-up|3|||
16178608|NCT00104104|39132785|FG001|Overall Study|Lost to Follow-up|7|||
16178609|NCT00104104|39132784|FG000|Overall Study|Administrative problems|12|||
16178610|NCT00104104|39132785|FG001|Overall Study|Administrative problems|13|||
16178611|NCT00104104|39132784|FG000|Overall Study|Death|9|||
16178612|NCT00104104|39132785|FG001|Overall Study|Death|6|||
16178613|NCT02317510|39132786|FG000|Overall Study|Adverse Event|0|||
16178614|NCT02317510|39132787|FG001|Overall Study|Adverse Event|1|||
16178615|NCT00553787|39132788|FG000|Overall Study|Adverse Event|34|||
16178616|NCT00553787|39132789|FG001|Overall Study|Adverse Event|21|||
16178617|NCT00553787|39132790|FG002|Overall Study|Adverse Event|67|||
16178618|NCT00553787|39132788|FG000|Overall Study|Lost to Follow-up|132|||
16178619|NCT00553787|39132789|FG001|Overall Study|Lost to Follow-up|44|||
16178620|NCT00553787|39132790|FG002|Overall Study|Lost to Follow-up|78|||
16178621|NCT00553787|39132788|FG000|Overall Study|Withdrawal by Subject|151|||
16178622|NCT00553787|39132789|FG001|Overall Study|Withdrawal by Subject|40|||
16178623|NCT00553787|39132790|FG002|Overall Study|Withdrawal by Subject|83|||
16178624|NCT00553787|39132788|FG000|Overall Study|Lack of Efficacy|31|||
16178625|NCT00553787|39132789|FG001|Overall Study|Lack of Efficacy|1|||
16178626|NCT00553787|39132790|FG002|Overall Study|Lack of Efficacy|3|||
16178627|NCT00553787|39132788|FG000|Overall Study|Pregnancy|0|||
16178628|NCT00553787|39132789|FG001|Overall Study|Pregnancy|1|||
16279022|NCT02578641|39504209|FG000|Overall Study|Adverse Event|5|||
16178629|NCT00553787|39132790|FG002|Overall Study|Pregnancy|2|||
16178630|NCT00553787|39132788|FG000|Overall Study|non compliance|4|||
16178631|NCT00553787|39132789|FG001|Overall Study|non compliance|0|||
16178632|NCT00553787|39132790|FG002|Overall Study|non compliance|11|||
16178633|NCT00553787|39132788|FG000|Overall Study|Requirement for restricted medication|8|||
16178634|NCT00553787|39132789|FG001|Overall Study|Requirement for restricted medication|7|||
16178635|NCT00553787|39132790|FG002|Overall Study|Requirement for restricted medication|5|||
16178636|NCT00553787|39132788|FG000|Overall Study|Other|18|||
16178637|NCT00553787|39132789|FG001|Overall Study|Other|10|||
16178638|NCT00553787|39132790|FG002|Overall Study|Other|13|||
16178639|NCT01193335|39132791|FG000|After Infant Series|Lost to Follow-up|1|||
16178640|NCT01193335|39132792|FG001|After Infant Series|Lost to Follow-up|2|||
16178641|NCT01193335|39132791|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
16178642|NCT01193335|39132792|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
16178643|NCT01193335|39132791|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
16178644|NCT01193335|39132792|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
16178645|NCT01193335|39132791|FG000|1-Year Follow-up|Lost to Follow-up|4|||
16178646|NCT01193335|39132792|FG001|1-Year Follow-up|Lost to Follow-up|0|||
16178647|NCT01193335|39132791|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
16178648|NCT01193335|39132792|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
16178649|NCT01193335|39132791|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
16178650|NCT01193335|39132792|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
16178651|NCT03497689|39132793|FG000|Overall Study|Adverse Event|2|||
16178652|NCT03497689|39132793|FG000|Overall Study|Death|1|||
16178653|NCT03497689|39132793|FG000|Overall Study|Physician Decision|1|||
16178654|NCT03497689|39132793|FG000|Overall Study|Withdrawal by Subject|1|||
16178655|NCT03497689|39132793|FG000|Overall Study|Protocol Violation|2|||
16178656|NCT01357239|39132796|FG000|Stratum: All Patients|Adverse Event|0|||
16178657|NCT01357239|39132797|FG001|Stratum: All Patients|Adverse Event|0|||
16178658|NCT01357239|39132798|FG002|Stratum: All Patients|Adverse Event|1|||
16178659|NCT01357239|39132799|FG003|Stratum: All Patients|Adverse Event|1|||
16178660|NCT01357239|39132796|FG000|Stratum: All Patients|Subject withdrew consent|0|||
16178661|NCT01357239|39132797|FG001|Stratum: All Patients|Subject withdrew consent|0|||
16178662|NCT01357239|39132798|FG002|Stratum: All Patients|Subject withdrew consent|1|||
16178663|NCT01357239|39132799|FG003|Stratum: All Patients|Subject withdrew consent|1|||
16178664|NCT01357239|39132796|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
16178665|NCT01357239|39132797|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
16178666|NCT01357239|39132798|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
16178667|NCT01357239|39132799|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
16178668|NCT01357239|39132796|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
16178669|NCT01357239|39132797|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
16178670|NCT01357239|39132798|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
16178671|NCT01357239|39132799|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
16178672|NCT01357239|39132796|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
16178673|NCT01357239|39132797|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
16178674|NCT01357239|39132798|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
16178675|NCT01357239|39132799|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
16178676|NCT01122927|39132802|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
16178677|NCT01122927|39132803|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
16178678|NCT01122927|39132802|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
16178679|NCT01122927|39132803|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
16178680|NCT01122927|39132802|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
16178681|NCT01122927|39132803|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
16178682|NCT01122927|39132802|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
16178683|NCT01122927|39132803|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
16178684|NCT01122927|39132802|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
16178685|NCT01122927|39132803|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
16178686|NCT01122927|39132802|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
16178687|NCT01122927|39132803|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
16178688|NCT01122927|39132802|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
16178689|NCT01122927|39132803|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
16178690|NCT01122927|39132802|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
16178691|NCT01122927|39132803|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
16178692|NCT01122927|39132802|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
16178693|NCT01122927|39132803|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
16178694|NCT01122927|39132802|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
16178695|NCT01122927|39132803|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
16178696|NCT01122927|39132802|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
16178697|NCT01122927|39132803|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
16178698|NCT01122927|39132802|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
16178699|NCT01122927|39132803|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
16178700|NCT03368859|39132804|FG000|Overall Study|Withdrew Consent|5|||
16178701|NCT03368859|39132805|FG001|Overall Study|Withdrew Consent|4|||
16178702|NCT03368859|39132804|FG000|Overall Study|Death|12|||
16178703|NCT03368859|39132805|FG001|Overall Study|Death|6|||
16178704|NCT03368859|39132804|FG000|Overall Study|Study terminated by Sponsor|18|||
16178705|NCT03368859|39132805|FG001|Overall Study|Study terminated by Sponsor|23|||
16178706|NCT03368859|39132804|FG000|Overall Study|Other|1|||
16178707|NCT03368859|39132805|FG001|Overall Study|Other|1|||
16178708|NCT03658889|39132806|FG000|Overall Study|Protocol Violation|2|||
16178709|NCT03658889|39132807|FG001|Overall Study|Protocol Violation|0|||
16178710|NCT01123889|39132808|FG000|Overall Study|Lost to Follow-up|3|||
16178711|NCT01123889|39132809|FG001|Overall Study|Lost to Follow-up|1|||
16178712|NCT01450540|39132814|FG000|Overall Study|Withdrawal by Subject|19|||
16178713|NCT01450540|39132815|FG001|Overall Study|Withdrawal by Subject|13|||
16178714|NCT01450540|39132814|FG000|Overall Study|protocol deviation|3|||
16178715|NCT01450540|39132815|FG001|Overall Study|protocol deviation|23|||
16178716|NCT01901224|39132816|FG000|Overall Study|study was not funded and terminated|2|||
16178717|NCT00964795|39132817|FG000|Overall Study|Withdrawal by Subject|79|||
16178718|NCT00964795|39132817|FG000|Overall Study|Adverse Event|12|||
16178719|NCT00964795|39132817|FG000|Overall Study|Death|14|||
16178720|NCT00964795|39132817|FG000|Overall Study|Lost to Follow-up|7|||
16178721|NCT00964795|39132817|FG000|Overall Study|Termination of Study by Sponsor|169|||
16178722|NCT00964795|39132817|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
16178723|NCT00964795|39132817|FG000|Overall Study|Other|23|||
16178724|NCT02403206|39132819|FG000|Overall Study|Lost to Follow-up|4|||
16178725|NCT02403206|39132820|FG001|Overall Study|Lost to Follow-up|3|||
16178726|NCT02403206|39132819|FG000|Overall Study|Physician Decision|2|||
16178727|NCT02403206|39132820|FG001|Overall Study|Physician Decision|0|||
16178728|NCT02403206|39132819|FG000|Overall Study|Withdrawal by Subject|3|||
16178729|NCT02403206|39132820|FG001|Overall Study|Withdrawal by Subject|3|||
16178730|NCT02403206|39132819|FG000|Overall Study|Reason not given|2|||
16178731|NCT02403206|39132820|FG001|Overall Study|Reason not given|4|||
16178732|NCT00500071|39132821|FG000|Screening and Washout Phase|Protocol Violation|1|||
16178733|NCT00500071|39132821|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
16178734|NCT00500071|39132821|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
16178735|NCT00500071|39132821|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
16178736|NCT00500071|39132821|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
16178737|NCT00500071|39132821|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
16178738|NCT00500071|39132821|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
16178739|NCT05309083|39132822|FG000|Overall Study|Withdrawal by Subject|2|||
16178740|NCT02919306|39132826|FG000|Overall Study|Withdrawal by Subject|1|||
16178741|NCT02919306|39132827|FG001|Overall Study|Withdrawal by Subject|0|||
16178742|NCT02919306|39132826|FG000|Overall Study|Protocol Violation|1|||
16178743|NCT02919306|39132827|FG001|Overall Study|Protocol Violation|0|||
16178744|NCT02723630|39132838|FG000|Intervention Period 1|Adverse Event|1|||
16178745|NCT02723630|39132839|FG001|Intervention Period 1|Adverse Event|0|||
16178746|NCT02723630|39132840|FG002|Intervention Period 1|Adverse Event|0|||
16178747|NCT02723630|39132841|FG003|Intervention Period 1|Adverse Event|0|||
16178748|NCT02723630|39132842|FG004|Intervention Period 1|Adverse Event|0|||
16178749|NCT02723630|39132843|FG005|Intervention Period 1|Adverse Event|0|||
16178750|NCT02723630|39132838|FG000|Intervention Period 3|consumption of restricted item|0|||
16178751|NCT02723630|39132839|FG001|Intervention Period 3|consumption of restricted item|1|||
16178752|NCT02723630|39132840|FG002|Intervention Period 3|consumption of restricted item|0|||
16178753|NCT02723630|39132841|FG003|Intervention Period 3|consumption of restricted item|0|||
16178754|NCT02723630|39132842|FG004|Intervention Period 3|consumption of restricted item|0|||
16178755|NCT02723630|39132843|FG005|Intervention Period 3|consumption of restricted item|0|||
16178756|NCT03215277|39132846|FG000|Overall Study|Adverse Event|2|||
16178757|NCT03215277|39132847|FG001|Overall Study|Adverse Event|3|||
16178758|NCT03215277|39132846|FG000|Overall Study|Death|1|||
16178759|NCT03215277|39132847|FG001|Overall Study|Death|0|||
16178760|NCT03215277|39132846|FG000|Overall Study|Lost to Follow-up|0|||
16178761|NCT03215277|39132847|FG001|Overall Study|Lost to Follow-up|1|||
16178762|NCT03215277|39132846|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
16178763|NCT03215277|39132847|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
16178764|NCT02240628|39132848|FG000|Overall Study|Physician Decision|6|||
16178765|NCT02240628|39132849|FG001|Overall Study|Physician Decision|5|||
16178766|NCT00376688|39132854|FG000|Overall Study|Adverse Event|3|||
16178767|NCT00376688|39132854|FG000|Overall Study|Death|1|||
16178768|NCT03825042|39132855|FG000|Overall Study|Adverse Event|1|||
16178769|NCT03825042|39132856|FG001|Overall Study|Adverse Event|0|||
16178770|NCT03825042|39132855|FG000|Overall Study|Withdrawal by Subject|1|||
16178771|NCT03825042|39132856|FG001|Overall Study|Withdrawal by Subject|0|||
16178772|NCT00519077|39132858|FG000|Overall Study|Death|6|||
16178773|NCT00519077|39132858|FG000|Overall Study|Other|2|||
16178774|NCT03486314|39132861|FG000|Part A|Adverse Event|1|||
16178775|NCT03486314|39132862|FG001|Part A|Adverse Event|0|||
16178776|NCT03486314|39132863|FG002|Part A|Adverse Event|0|||
16178777|NCT03486314|39132861|FG000|Part A|Symptomatic Deterioration|2|||
16178778|NCT03486314|39132862|FG001|Part A|Symptomatic Deterioration|0|||
16178779|NCT03486314|39132863|FG002|Part A|Symptomatic Deterioration|0|||
16178780|NCT00501852|39132864|FG000|Overall Study|Adverse Event|3|||
16178781|NCT00501852|39132864|FG000|Overall Study|Withdrawal by Subject|2|||
16178782|NCT00492921|39135704|FG000|Overall Study|Death|1|||
16178783|NCT00492921|39135705|FG001|Overall Study|Death|0|||
16178784|NCT00492921|39135706|FG002|Overall Study|Death|1|||
16178785|NCT00491530|39135707|FG000|Overall Study|Adverse Event|6|||
16178786|NCT00491530|39135708|FG001|Overall Study|Adverse Event|1|||
16178787|NCT00491530|39135709|FG002|Overall Study|Adverse Event|2|||
16178788|NCT00491530|39135707|FG000|Overall Study|Withdrawal by Subject|3|||
16178789|NCT00491530|39135708|FG001|Overall Study|Withdrawal by Subject|0|||
16178790|NCT00491530|39135709|FG002|Overall Study|Withdrawal by Subject|0|||
16178791|NCT00491530|39135707|FG000|Overall Study|Lost to Follow-up|3|||
16178792|NCT00491530|39135708|FG001|Overall Study|Lost to Follow-up|2|||
16178793|NCT00491530|39135709|FG002|Overall Study|Lost to Follow-up|2|||
16178794|NCT00491530|39135707|FG000|Overall Study|Lack of Efficacy|0|||
16178795|NCT00491530|39135708|FG001|Overall Study|Lack of Efficacy|1|||
16178796|NCT00491530|39135709|FG002|Overall Study|Lack of Efficacy|0|||
16178797|NCT00491530|39135707|FG000|Overall Study|Investigator Discretion|0|||
16178798|NCT00491530|39135708|FG001|Overall Study|Investigator Discretion|1|||
16178799|NCT00491530|39135709|FG002|Overall Study|Investigator Discretion|0|||
16178800|NCT00491530|39135707|FG000|Overall Study|Patient Request|0|||
16178801|NCT00491530|39135708|FG001|Overall Study|Patient Request|1|||
16178802|NCT00491530|39135709|FG002|Overall Study|Patient Request|0|||
16178803|NCT00491530|39135707|FG000|Overall Study|Use of Prohibited Medication|0|||
16178804|NCT00491530|39135708|FG001|Overall Study|Use of Prohibited Medication|0|||
16178805|NCT00491530|39135709|FG002|Overall Study|Use of Prohibited Medication|1|||
16178806|NCT00542815|39135710|FG000|Overall Study|Adverse Event|19|||
16178807|NCT00542815|39135711|FG001|Overall Study|Adverse Event|6|||
16178808|NCT00542815|39135712|FG002|Overall Study|Adverse Event|9|||
16178809|NCT00542815|39135710|FG000|Overall Study|Death|10|||
16178810|NCT00542815|39135711|FG001|Overall Study|Death|7|||
16178811|NCT00542815|39135712|FG002|Overall Study|Death|3|||
16178812|NCT00542815|39135710|FG000|Overall Study|Lack of Efficacy|9|||
16178813|NCT00542815|39135711|FG001|Overall Study|Lack of Efficacy|2|||
16178814|NCT00542815|39135712|FG002|Overall Study|Lack of Efficacy|0|||
16178815|NCT00542815|39135710|FG000|Overall Study|Physician Decision|2|||
16178816|NCT00542815|39135711|FG001|Overall Study|Physician Decision|1|||
16178817|NCT00542815|39135712|FG002|Overall Study|Physician Decision|0|||
16178818|NCT00542815|39135710|FG000|Overall Study|Protocol Violation|1|||
16178819|NCT00542815|39135711|FG001|Overall Study|Protocol Violation|1|||
16178820|NCT00542815|39135712|FG002|Overall Study|Protocol Violation|2|||
16178821|NCT00542815|39135710|FG000|Overall Study|Withdrawal by Subject|41|||
16178822|NCT00542815|39135711|FG001|Overall Study|Withdrawal by Subject|5|||
16178823|NCT00542815|39135712|FG002|Overall Study|Withdrawal by Subject|8|||
16178824|NCT00542815|39135710|FG000|Overall Study|Other reasons|24|||
16178825|NCT00542815|39135711|FG001|Overall Study|Other reasons|10|||
16178826|NCT00542815|39135712|FG002|Overall Study|Other reasons|10|||
16178827|NCT03952130|39135713|FG000|Overall Study|Adverse Event|0|||
16178828|NCT03952130|39135714|FG001|Overall Study|Adverse Event|1|||
16178829|NCT03952130|39135713|FG000|Overall Study|Lost to Follow-up|1|||
16178830|NCT03952130|39135714|FG001|Overall Study|Lost to Follow-up|0|||
16178831|NCT03952130|39135713|FG000|Overall Study|Withdrawal by Subject|1|||
16178832|NCT03952130|39135714|FG001|Overall Study|Withdrawal by Subject|5|||
16178833|NCT00852930|39135715|FG000|Overall Study|Withdrawal by Subject|1|||
16178834|NCT00852930|39135716|FG001|Overall Study|Withdrawal by Subject|1|||
16178835|NCT00852930|39135717|FG002|Overall Study|Withdrawal by Subject|1|||
16178836|NCT00852930|39135715|FG000|Overall Study|Physician Decision|0|||
16178837|NCT00852930|39135716|FG001|Overall Study|Physician Decision|0|||
16178838|NCT00852930|39135717|FG002|Overall Study|Physician Decision|1|||
16178839|NCT05299892|39135720|FG000|Overall Study|Withdrawal by Subject|2|||
16178840|NCT02522481|39135721|FG000|Overall Study|discontinued|1|||
16178841|NCT02522481|39135721|FG000|Overall Study|Not dosed|2|||
16178842|NCT01165229|39135724|FG000|Overall Study|Serious Adverse Event|456|||
16178843|NCT01165229|39135725|FG001|Overall Study|Serious Adverse Event|487|||
16178844|NCT01165229|39135724|FG000|Overall Study|Non-Serious Adverse Event|47|||
16178845|NCT01165229|39135725|FG001|Overall Study|Non-Serious Adverse Event|15|||
16178846|NCT01165229|39135724|FG000|Overall Study|Protocol Violation|6|||
16178847|NCT01165229|39135725|FG001|Overall Study|Protocol Violation|8|||
16178848|NCT01165229|39135724|FG000|Overall Study|Withdrawal by Subject|387|||
16178849|NCT01165229|39135725|FG001|Overall Study|Withdrawal by Subject|396|||
16178850|NCT01165229|39135724|FG000|Overall Study|Migrated/moved from study area|51|||
16178851|NCT01165229|39135725|FG001|Overall Study|Migrated/moved from study area|46|||
16178852|NCT01165229|39135724|FG000|Overall Study|Lost to Follow-up|123|||
16178853|NCT01165229|39135725|FG001|Overall Study|Lost to Follow-up|133|||
16178854|NCT01165229|39135724|FG000|Overall Study|Suspected HZ Episode|2|||
16178855|NCT01165229|39135725|FG001|Overall Study|Suspected HZ Episode|2|||
16178856|NCT01165229|39135724|FG000|Overall Study|No reason from the subject|108|||
16178857|NCT01165229|39135725|FG001|Overall Study|No reason from the subject|102|||
16178858|NCT01165229|39135724|FG000|Overall Study|Unknown completion status|0|||
16178859|NCT01165229|39135725|FG001|Overall Study|Unknown completion status|1|||
16178860|NCT01416610|39135728|FG000|Overall Study|Adverse Event|4|||
16178861|NCT01416610|39135728|FG000|Overall Study|Adverse Event -Patient decision|3|||
16178862|NCT01416610|39135728|FG000|Overall Study|Lack of Efficacy|4|||
16178863|NCT01416610|39135728|FG000|Overall Study|No reason given|5|||
16178864|NCT01416610|39135728|FG000|Overall Study|Withdrawal by Subject|13|||
16178865|NCT01416610|39135728|FG000|Overall Study|Lost to Follow-up|7|||
16178866|NCT01416610|39135728|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
16178867|NCT00064701|39135729|FG000|One Year Post-transplant|Did not receive study drug|7|||
16178868|NCT00064701|39135730|FG001|One Year Post-transplant|Did not receive study drug|12|||
16178869|NCT00064701|39135731|FG002|One Year Post-transplant|Did not receive study drug|11|||
16178870|NCT00064701|39135729|FG000|One Year Post-transplant|Adverse Event|23|||
16178871|NCT00064701|39135730|FG001|One Year Post-transplant|Adverse Event|19|||
16178872|NCT00064701|39135731|FG002|One Year Post-transplant|Adverse Event|37|||
16178873|NCT00064701|39135729|FG000|One Year Post-transplant|Rejection|0|||
16178874|NCT00064701|39135730|FG001|One Year Post-transplant|Rejection|1|||
16178875|NCT00064701|39135731|FG002|One Year Post-transplant|Rejection|16|||
16178876|NCT00064701|39135729|FG000|One Year Post-transplant|Non-compliance|4|||
16178877|NCT00064701|39135730|FG001|One Year Post-transplant|Non-compliance|2|||
16178878|NCT00064701|39135731|FG002|One Year Post-transplant|Non-compliance|5|||
16178879|NCT00064701|39135729|FG000|One Year Post-transplant|Graft Failure|3|||
16178880|NCT00064701|39135730|FG001|One Year Post-transplant|Graft Failure|2|||
16178881|NCT00064701|39135731|FG002|One Year Post-transplant|Graft Failure|1|||
16178882|NCT00064701|39135729|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
16178883|NCT00064701|39135730|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
16178884|NCT00064701|39135731|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
16178885|NCT00064701|39135729|FG000|One Year Post-transplant|Lost to Follow-up|1|||
16178886|NCT00064701|39135730|FG001|One Year Post-transplant|Lost to Follow-up|0|||
16178887|NCT00064701|39135731|FG002|One Year Post-transplant|Lost to Follow-up|0|||
16178888|NCT00064701|39135729|FG000|One Year Post-transplant|Converted to rapamycin|1|||
16178889|NCT00064701|39135730|FG001|One Year Post-transplant|Converted to rapamycin|0|||
16178890|NCT00064701|39135731|FG002|One Year Post-transplant|Converted to rapamycin|0|||
16178891|NCT00064701|39135729|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
16178892|NCT00064701|39135730|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
16178893|NCT00064701|39135731|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
16178894|NCT00064701|39135729|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
16178895|NCT00064701|39135730|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
16178896|NCT00064701|39135731|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
16178897|NCT00064701|39135729|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
16178898|NCT00064701|39135730|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
16178899|NCT00064701|39135731|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
16178900|NCT00064701|39135729|FG000|One Year Post-transplant|Poor absorption|0|||
16178901|NCT00064701|39135730|FG001|One Year Post-transplant|Poor absorption|1|||
16178902|NCT00064701|39135731|FG002|One Year Post-transplant|Poor absorption|0|||
16178903|NCT00064701|39135729|FG000|One Year Post-transplant|Pancreas transplant|0|||
16178904|NCT00064701|39135730|FG001|One Year Post-transplant|Pancreas transplant|0|||
16178905|NCT00064701|39135731|FG002|One Year Post-transplant|Pancreas transplant|1|||
16178906|NCT00064701|39135729|FG000|Clinical Continuation Phase|Adverse Event|12|||
16178907|NCT00064701|39135730|FG001|Clinical Continuation Phase|Adverse Event|21|||
16178908|NCT00064701|39135731|FG002|Clinical Continuation Phase|Adverse Event|14|||
16178909|NCT00064701|39135729|FG000|Clinical Continuation Phase|Non-compliance|8|||
16178910|NCT00064701|39135730|FG001|Clinical Continuation Phase|Non-compliance|6|||
16178911|NCT00064701|39135731|FG002|Clinical Continuation Phase|Non-compliance|7|||
16178912|NCT00064701|39135729|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
16178913|NCT00064701|39135730|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
16178914|NCT00064701|39135731|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
16178915|NCT00064701|39135729|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
16178916|NCT00064701|39135730|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
16178917|NCT00064701|39135731|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
16178918|NCT00064701|39135729|FG000|Clinical Continuation Phase|Graft Failure|5|||
16178919|NCT00064701|39135730|FG001|Clinical Continuation Phase|Graft Failure|5|||
16178920|NCT00064701|39135731|FG002|Clinical Continuation Phase|Graft Failure|2|||
16079977|NCT01102231|38786713|FG000|Overall Study|Withdrawal by Subject|1|||
16079978|NCT01102231|38786713|FG000|Overall Study|Did not received the treatment|4|||
16079979|NCT00421889|38786716|FG000|Overall Study|Adverse Event|1|||
16079980|NCT00421889|38786717|FG001|Overall Study|Adverse Event|0|||
16079981|NCT00421889|38786718|FG002|Overall Study|Adverse Event|1|||
16079982|NCT00421889|38786719|FG003|Overall Study|Adverse Event|1|||
16079983|NCT00421889|38786720|FG004|Overall Study|Adverse Event|1|||
16178921|NCT00064701|39135729|FG000|Clinical Continuation Phase|Rejection|1|||
16178922|NCT00064701|39135730|FG001|Clinical Continuation Phase|Rejection|2|||
16178923|NCT00064701|39135731|FG002|Clinical Continuation Phase|Rejection|2|||
16178924|NCT00064701|39135729|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
16178925|NCT00064701|39135730|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
16178926|NCT00064701|39135731|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
16079984|NCT00421889|38786721|FG005|Overall Study|Adverse Event|4|||
16178927|NCT00064701|39135729|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
16178928|NCT00064701|39135730|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
16178929|NCT00064701|39135731|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
16178930|NCT00064701|39135729|FG000|Clinical Continuation Phase|Physician Decision|1|||
16178931|NCT00064701|39135730|FG001|Clinical Continuation Phase|Physician Decision|3|||
16178932|NCT00064701|39135731|FG002|Clinical Continuation Phase|Physician Decision|0|||
16178933|NCT00064701|39135729|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
16178934|NCT00064701|39135730|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
16178935|NCT00064701|39135731|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
16178936|NCT00064701|39135729|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
16178937|NCT00064701|39135730|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
16178938|NCT00064701|39135731|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
16178939|NCT00064701|39135729|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
16178940|NCT00064701|39135730|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
16178941|NCT00064701|39135731|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
16178942|NCT00064701|39135729|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
16178943|NCT00064701|39135730|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
16178944|NCT00064701|39135731|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
16178945|NCT00064701|39135729|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
16178946|NCT00064701|39135730|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
16178947|NCT00064701|39135731|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
16178948|NCT00064701|39135729|FG000|Clinical Continuation Phase|Patient opted out|0|||
16178949|NCT00064701|39135730|FG001|Clinical Continuation Phase|Patient opted out|0|||
16178950|NCT00064701|39135731|FG002|Clinical Continuation Phase|Patient opted out|1|||
16178951|NCT00408681|39135737|FG000|Overall Study|Lack of Efficacy|2|||
16178952|NCT00408681|39135737|FG000|Overall Study|Adverse Event|7|||
16178953|NCT03067311|39135741|FG000|Overall Study|Lost to Follow-up|1|||
16178954|NCT03067311|39135742|FG001|Overall Study|Lost to Follow-up|1|||
16178955|NCT03067311|39135741|FG000|Overall Study|Moved away|1|||
16178956|NCT03067311|39135742|FG001|Overall Study|Moved away|1|||
16178957|NCT00472303|39135743|FG000|Titration Phase|Adverse Event|22|||
16178958|NCT00472303|39135744|FG001|Titration Phase|Adverse Event|12|||
16178959|NCT00472303|39135745|FG002|Titration Phase|Adverse Event|0|||
16478194|NCT00723398|40231098|FG002|Overall Study|Protocol Violation|5|||
16478195|NCT00723398|40231099|FG003|Overall Study|Protocol Violation|0|||
16478196|NCT00723398|40231100|FG004|Overall Study|Protocol Violation|0|||
16478197|NCT00723398|40231096|FG000|Overall Study|Physician Decision|2|||
16478198|NCT00723398|40231097|FG001|Overall Study|Physician Decision|2|||
16178960|NCT00472303|39135743|FG000|Titration Phase|Death|4|||
16178961|NCT00472303|39135744|FG001|Titration Phase|Death|2|||
16178962|NCT00472303|39135745|FG002|Titration Phase|Death|0|||
16478199|NCT00723398|40231098|FG002|Overall Study|Physician Decision|5|||
16478200|NCT00723398|40231099|FG003|Overall Study|Physician Decision|0|||
16478201|NCT00723398|40231100|FG004|Overall Study|Physician Decision|1|||
16478202|NCT00723398|40231096|FG000|Overall Study|Adverse Event|0|||
16478203|NCT00723398|40231097|FG001|Overall Study|Adverse Event|5|||
16478204|NCT00723398|40231098|FG002|Overall Study|Adverse Event|3|||
16478205|NCT00723398|40231099|FG003|Overall Study|Adverse Event|1|||
16478206|NCT00723398|40231100|FG004|Overall Study|Adverse Event|4|||
16478207|NCT00723398|40231096|FG000|Overall Study|Lost to Follow-up|0|||
16478208|NCT00723398|40231097|FG001|Overall Study|Lost to Follow-up|1|||
16478209|NCT00723398|40231098|FG002|Overall Study|Lost to Follow-up|0|||
16478210|NCT00723398|40231099|FG003|Overall Study|Lost to Follow-up|0|||
16478211|NCT00723398|40231100|FG004|Overall Study|Lost to Follow-up|0|||
16478212|NCT00395733|40231101|FG000|Period 2|Withdrawal by Subject|1|||
16478213|NCT00395733|40231102|FG001|Period 2|Withdrawal by Subject|2|||
16478214|NCT00395733|40231101|FG000|Period 2|Protocol Violation|0|||
16478215|NCT00395733|40231102|FG001|Period 2|Protocol Violation|1|||
16478216|NCT00395733|40231101|FG000|Period 2|Adverse Event|0|||
16478217|NCT00395733|40231102|FG001|Period 2|Adverse Event|2|||
16478218|NCT00395733|40231101|FG000|Period 2|Technical problems|1|||
16478219|NCT00395733|40231102|FG001|Period 2|Technical problems|0|||
16478220|NCT00722800|40231107|FG000|Overall Study|Withdrawal by Subject|1|||
16478221|NCT00722800|40231108|FG001|Overall Study|Withdrawal by Subject|0|||
16478222|NCT00722800|40231107|FG000|Overall Study|Physician Decision|1|||
16478223|NCT00722800|40231108|FG001|Overall Study|Physician Decision|0|||
16478224|NCT00122109|40231110|FG000|Overall Study|Did not meet criteria|6|||
16178963|NCT00472303|39135743|FG000|Titration Phase|Lack of Efficacy|10|||
16478225|NCT00122109|40231111|FG001|Overall Study|Did not meet criteria|7|||
16478226|NCT01328431|40231112|FG000|Baseline|Protocol Violation|0|||
16478227|NCT01328431|40231113|FG001|Baseline|Protocol Violation|2|||
16478228|NCT01328431|40231112|FG000|1 Month (1M)|Lost to Follow-up|55|||
16478229|NCT01328431|40231113|FG001|1 Month (1M)|Lost to Follow-up|58|||
16478230|NCT01328431|40231112|FG000|3 Month (3M)|Death|2|||
16478231|NCT01328431|40231113|FG001|3 Month (3M)|Death|2|||
16178964|NCT00472303|39135744|FG001|Titration Phase|Lack of Efficacy|0|||
16178965|NCT00472303|39135745|FG002|Titration Phase|Lack of Efficacy|0|||
16178966|NCT00472303|39135743|FG000|Titration Phase|Withdrawal by Subject|16|||
16178967|NCT00472303|39135744|FG001|Titration Phase|Withdrawal by Subject|13|||
16178968|NCT00472303|39135745|FG002|Titration Phase|Withdrawal by Subject|0|||
16178969|NCT00472303|39135743|FG000|Titration Phase|Trial Medication non-compliant|4|||
16178970|NCT00472303|39135744|FG001|Titration Phase|Trial Medication non-compliant|1|||
16178971|NCT00472303|39135745|FG002|Titration Phase|Trial Medication non-compliant|0|||
16178972|NCT00472303|39135743|FG000|Titration Phase|Other|3|||
16178973|NCT00472303|39135744|FG001|Titration Phase|Other|1|||
16178974|NCT00472303|39135745|FG002|Titration Phase|Other|0|||
16178975|NCT00472303|39135743|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
16178976|NCT00472303|39135744|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
16178977|NCT00472303|39135745|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
16178978|NCT00472303|39135743|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
16178979|NCT00472303|39135744|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
16178980|NCT00472303|39135745|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
16178981|NCT00472303|39135743|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
16178982|NCT00472303|39135744|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
16178983|NCT00472303|39135745|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
16178984|NCT00472303|39135743|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
16178985|NCT00472303|39135744|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
16178986|NCT00472303|39135745|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
16178987|NCT00472303|39135743|FG000|Discontinuations After Titration Phase|Other|5|||
16178988|NCT00472303|39135744|FG001|Discontinuations After Titration Phase|Other|0|||
16178989|NCT00472303|39135745|FG002|Discontinuations After Titration Phase|Other|0|||
16178990|NCT00472303|39135743|FG000|Maintenance Phase|Adverse Event|5|||
16178991|NCT00472303|39135744|FG001|Maintenance Phase|Adverse Event|6|||
16178992|NCT00472303|39135745|FG002|Maintenance Phase|Adverse Event|6|||
16178993|NCT00472303|39135743|FG000|Maintenance Phase|Death|3|||
16178994|NCT00472303|39135744|FG001|Maintenance Phase|Death|0|||
16178995|NCT00472303|39135745|FG002|Maintenance Phase|Death|2|||
16178996|NCT00472303|39135743|FG000|Maintenance Phase|Lack of Efficacy|2|||
16478232|NCT01328431|40231112|FG000|3 Month (3M)|Lost to Follow-up|75|||
16478233|NCT01328431|40231113|FG001|3 Month (3M)|Lost to Follow-up|70|||
16478234|NCT01328431|40231112|FG000|12 Month (12M)|Death|2|||
16478235|NCT01328431|40231113|FG001|12 Month (12M)|Death|6|||
16478236|NCT01328431|40231112|FG000|12 Month (12M)|Lost to Follow-up|82|||
16478237|NCT01328431|40231113|FG001|12 Month (12M)|Lost to Follow-up|91|||
16478238|NCT02357979|40231114|FG000|Overall Study|Lost to Follow-up|5|||
16478239|NCT02357979|40231115|FG001|Overall Study|Lost to Follow-up|5|||
16478240|NCT03555435|40231117|FG000|Overall Study|Lost to Follow-up|17|||
16478241|NCT03555435|40231118|FG001|Overall Study|Lost to Follow-up|19|||
16478242|NCT03555435|40231119|FG002|Overall Study|Lost to Follow-up|8|||
16478243|NCT02477839|40231120|FG000|Overall Study|Adverse Event|0|||
16478244|NCT02477839|40231121|FG001|Overall Study|Adverse Event|1|||
16478245|NCT02477839|40231120|FG000|Overall Study|Protocol Violation|0|||
16478246|NCT02477839|40231121|FG001|Overall Study|Protocol Violation|2|||
16178997|NCT00472303|39135744|FG001|Maintenance Phase|Lack of Efficacy|2|||
16178998|NCT00472303|39135745|FG002|Maintenance Phase|Lack of Efficacy|4|||
16178999|NCT00472303|39135743|FG000|Maintenance Phase|Withdrawal by Subject|6|||
16179000|NCT00472303|39135744|FG001|Maintenance Phase|Withdrawal by Subject|7|||
16179001|NCT00472303|39135745|FG002|Maintenance Phase|Withdrawal by Subject|3|||
16179002|NCT00472303|39135743|FG000|Maintenance Phase|Trial medication non-compliant|0|||
16179003|NCT00472303|39135744|FG001|Maintenance Phase|Trial medication non-compliant|0|||
16179004|NCT00472303|39135745|FG002|Maintenance Phase|Trial medication non-compliant|1|||
16179005|NCT00472303|39135743|FG000|Maintenance Phase|Resolution of pain|0|||
16179006|NCT00472303|39135744|FG001|Maintenance Phase|Resolution of pain|0|||
16179007|NCT00472303|39135745|FG002|Maintenance Phase|Resolution of pain|1|||
16179008|NCT00472303|39135743|FG000|Maintenance Phase|Other|1|||
16179009|NCT00472303|39135744|FG001|Maintenance Phase|Other|1|||
16179010|NCT00472303|39135745|FG002|Maintenance Phase|Other|0|||
16179011|NCT00117312|39135750|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
16179012|NCT00117312|39135751|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
16179013|NCT00117312|39135752|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
16179014|NCT00117312|39135753|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
16179015|NCT00117312|39135750|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
16179016|NCT00117312|39135751|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
16179017|NCT00117312|39135752|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
16478247|NCT02477839|40231120|FG000|Overall Study|Withdrawal by Subject|3|||
16478248|NCT02477839|40231121|FG001|Overall Study|Withdrawal by Subject|3|||
16478249|NCT02477839|40231120|FG000|Overall Study|Participant had PGS during V6|0|||
16179018|NCT00117312|39135753|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
16179019|NCT00117312|39135750|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
16179020|NCT00117312|39135751|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
16179021|NCT00117312|39135752|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
16179022|NCT00117312|39135753|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
16179023|NCT00117312|39135750|FG000|Overall Study|Other|0|||
16179024|NCT00117312|39135751|FG001|Overall Study|Other|1|||
16179025|NCT00117312|39135752|FG002|Overall Study|Other|3|||
16179026|NCT00117312|39135753|FG003|Overall Study|Other|1|||
16179027|NCT00117312|39135750|FG000|Overall Study|Patient choice|0|||
16179028|NCT00117312|39135751|FG001|Overall Study|Patient choice|0|||
16179029|NCT00117312|39135752|FG002|Overall Study|Patient choice|2|||
16179030|NCT00117312|39135753|FG003|Overall Study|Patient choice|1|||
16179031|NCT00117312|39135750|FG000|Overall Study|Adverse Event|0|||
16179032|NCT00117312|39135751|FG001|Overall Study|Adverse Event|2|||
16179033|NCT00117312|39135752|FG002|Overall Study|Adverse Event|0|||
16179034|NCT00117312|39135753|FG003|Overall Study|Adverse Event|0|||
16179035|NCT00117312|39135750|FG000|Overall Study|Protocol Violation|0|||
16179036|NCT00117312|39135751|FG001|Overall Study|Protocol Violation|1|||
16179037|NCT00117312|39135752|FG002|Overall Study|Protocol Violation|3|||
16179038|NCT00117312|39135753|FG003|Overall Study|Protocol Violation|0|||
16179039|NCT00117312|39135750|FG000|Overall Study|PSA decrease <=50%|0|||
16179040|NCT00117312|39135751|FG001|Overall Study|PSA decrease <=50%|2|||
16179041|NCT00117312|39135752|FG002|Overall Study|PSA decrease <=50%|2|||
16179042|NCT00117312|39135753|FG003|Overall Study|PSA decrease <=50%|4|||
16179043|NCT00117312|39135750|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
16179044|NCT00117312|39135751|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
16179045|NCT00117312|39135752|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
16179046|NCT00117312|39135753|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
16179047|NCT00117312|39135750|FG000|Overall Study|Hepatic abnormality|0|||
16179048|NCT00117312|39135751|FG001|Overall Study|Hepatic abnormality|1|||
16179049|NCT00117312|39135752|FG002|Overall Study|Hepatic abnormality|0|||
16179050|NCT00117312|39135753|FG003|Overall Study|Hepatic abnormality|1|||
16179051|NCT00117312|39135750|FG000|Overall Study|Withdrawal by Subject|0|||
16179052|NCT00117312|39135751|FG001|Overall Study|Withdrawal by Subject|2|||
16179053|NCT00117312|39135752|FG002|Overall Study|Withdrawal by Subject|0|||
16179054|NCT00117312|39135753|FG003|Overall Study|Withdrawal by Subject|0|||
16179055|NCT01845025|39135754|FG000|Overall Study|Adverse Event|6|||
16179056|NCT01845025|39135755|FG001|Overall Study|Adverse Event|3|||
16179057|NCT01845025|39135754|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16179058|NCT01845025|39135755|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16179059|NCT01845025|39135754|FG000|Overall Study|Withdrawal by Subject|48|||
16179060|NCT01845025|39135755|FG001|Overall Study|Withdrawal by Subject|44|||
16179061|NCT01845025|39135754|FG000|Overall Study|Lost to Follow-up|13|||
16179062|NCT01845025|39135755|FG001|Overall Study|Lost to Follow-up|13|||
16279023|NCT02578641|39504210|FG001|Overall Study|Adverse Event|15|||
16279024|NCT02578641|39504209|FG000|Overall Study|Death|16|||
16279025|NCT02578641|39504210|FG001|Overall Study|Death|8|||
16079985|NCT00421889|38786722|FG006|Overall Study|Adverse Event|1|||
16179063|NCT01845025|39135754|FG000|Overall Study|Administrative problems|8|||
16179064|NCT01845025|39135755|FG001|Overall Study|Administrative problems|8|||
16179065|NCT01845025|39135754|FG000|Overall Study|Death|2|||
16179066|NCT01845025|39135755|FG001|Overall Study|Death|0|||
16179067|NCT01845025|39135754|FG000|Overall Study|Protocol deviation|3|||
16179068|NCT01845025|39135755|FG001|Overall Study|Protocol deviation|6|||
16179069|NCT01845025|39135754|FG000|Overall Study|Missing|1|||
16179070|NCT01845025|39135755|FG001|Overall Study|Missing|1|||
16179071|NCT02786537|39135756|FG000|As Randomized|Adverse Event|0|||
16179072|NCT02786537|39135757|FG001|As Randomized|Adverse Event|11|||
16179073|NCT02786537|39135758|FG002|As Randomized|Adverse Event|0|||
16179074|NCT02786537|39135759|FG003|As Randomized|Adverse Event|4|||
16179075|NCT02786537|39135760|FG004|As Randomized|Adverse Event|6|||
16179076|NCT02786537|39135761|FG005|As Randomized|Adverse Event|2|||
16179077|NCT02786537|39135756|FG000|As Randomized|Lack of Efficacy|0|||
16179078|NCT02786537|39135757|FG001|As Randomized|Lack of Efficacy|0|||
16179079|NCT02786537|39135758|FG002|As Randomized|Lack of Efficacy|0|||
16179080|NCT02786537|39135759|FG003|As Randomized|Lack of Efficacy|1|||
16179081|NCT02786537|39135760|FG004|As Randomized|Lack of Efficacy|0|||
16179082|NCT02786537|39135761|FG005|As Randomized|Lack of Efficacy|0|||
16179083|NCT02786537|39135756|FG000|As Randomized|Withdrawal by Subject|1|||
16179084|NCT02786537|39135757|FG001|As Randomized|Withdrawal by Subject|2|||
16179085|NCT02786537|39135758|FG002|As Randomized|Withdrawal by Subject|0|||
16179086|NCT02786537|39135759|FG003|As Randomized|Withdrawal by Subject|1|||
16179087|NCT02786537|39135760|FG004|As Randomized|Withdrawal by Subject|1|||
16179088|NCT02786537|39135761|FG005|As Randomized|Withdrawal by Subject|0|||
16179089|NCT02786537|39135756|FG000|As Randomized|Death|0|||
16179090|NCT02786537|39135757|FG001|As Randomized|Death|2|||
16179091|NCT02786537|39135758|FG002|As Randomized|Death|0|||
16179092|NCT02786537|39135759|FG003|As Randomized|Death|3|||
16179093|NCT02786537|39135760|FG004|As Randomized|Death|1|||
16179094|NCT02786537|39135761|FG005|As Randomized|Death|0|||
16279026|NCT02578641|39504209|FG000|Overall Study|Lost to Follow-up|0|||
16179095|NCT02786537|39135756|FG000|As Randomized|Non-compliance with study drug|1|||
16179096|NCT02786537|39135757|FG001|As Randomized|Non-compliance with study drug|11|||
16179097|NCT02786537|39135758|FG002|As Randomized|Non-compliance with study drug|0|||
16179098|NCT02786537|39135759|FG003|As Randomized|Non-compliance with study drug|1|||
16179099|NCT02786537|39135760|FG004|As Randomized|Non-compliance with study drug|0|||
16179100|NCT02786537|39135761|FG005|As Randomized|Non-compliance with study drug|1|||
16179101|NCT02786537|39135756|FG000|As Randomized|Lost to treatment follow-up|4|||
16179102|NCT02786537|39135757|FG001|As Randomized|Lost to treatment follow-up|32|||
16179103|NCT02786537|39135758|FG002|As Randomized|Lost to treatment follow-up|0|||
16179104|NCT02786537|39135759|FG003|As Randomized|Lost to treatment follow-up|24|||
16179105|NCT02786537|39135760|FG004|As Randomized|Lost to treatment follow-up|4|||
16179106|NCT02786537|39135761|FG005|As Randomized|Lost to treatment follow-up|4|||
16179107|NCT02786537|39135756|FG000|As Randomized|Incarceration|0|||
16179108|NCT02786537|39135757|FG001|As Randomized|Incarceration|1|||
16179109|NCT02786537|39135758|FG002|As Randomized|Incarceration|0|||
16179110|NCT02786537|39135759|FG003|As Randomized|Incarceration|0|||
16179111|NCT02786537|39135760|FG004|As Randomized|Incarceration|0|||
16179112|NCT02786537|39135761|FG005|As Randomized|Incarceration|0|||
16179113|NCT02786537|39135756|FG000|As Randomized|Opiate Dependency Relapse|0|||
16179114|NCT02786537|39135757|FG001|As Randomized|Opiate Dependency Relapse|1|||
16179115|NCT02786537|39135758|FG002|As Randomized|Opiate Dependency Relapse|0|||
16179116|NCT02786537|39135759|FG003|As Randomized|Opiate Dependency Relapse|0|||
16179117|NCT02786537|39135760|FG004|As Randomized|Opiate Dependency Relapse|0|||
16179118|NCT02786537|39135761|FG005|As Randomized|Opiate Dependency Relapse|0|||
16179119|NCT02786537|39135756|FG000|As Randomized|HCV drugs stolen from pt|0|||
16179120|NCT02786537|39135757|FG001|As Randomized|HCV drugs stolen from pt|1|||
16179121|NCT02786537|39135758|FG002|As Randomized|HCV drugs stolen from pt|0|||
16179122|NCT02786537|39135759|FG003|As Randomized|HCV drugs stolen from pt|0|||
16179123|NCT02786537|39135760|FG004|As Randomized|HCV drugs stolen from pt|0|||
16179124|NCT02786537|39135761|FG005|As Randomized|HCV drugs stolen from pt|0|||
16179125|NCT02786537|39135756|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
16179126|NCT02786537|39135757|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
16179127|NCT02786537|39135758|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
16179128|NCT02786537|39135759|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
16179129|NCT02786537|39135760|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
16179130|NCT02786537|39135761|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
16179131|NCT02786537|39135756|FG000|As Randomized|Subject lost insurance|0|||
16179132|NCT02786537|39135757|FG001|As Randomized|Subject lost insurance|0|||
16179133|NCT02786537|39135758|FG002|As Randomized|Subject lost insurance|0|||
16179134|NCT02786537|39135759|FG003|As Randomized|Subject lost insurance|1|||
16478250|NCT02477839|40231121|FG001|Overall Study|Participant had PGS during V6|1|||
16478251|NCT02477839|40231120|FG000|Overall Study|Parents decided to stop medication|0|||
16478252|NCT02477839|40231121|FG001|Overall Study|Parents decided to stop medication|1|||
16478253|NCT02477839|40231120|FG000|Overall Study|Lack of tolerability|0|||
16478254|NCT02477839|40231121|FG001|Overall Study|Lack of tolerability|1|||
16179135|NCT02786537|39135760|FG004|As Randomized|Subject lost insurance|0|||
16179136|NCT02786537|39135761|FG005|As Randomized|Subject lost insurance|0|||
16179137|NCT02786537|39135756|FG000|As Treated|Adverse Event|0|||
16179138|NCT02786537|39135757|FG001|As Treated|Adverse Event|11|||
16179139|NCT02786537|39135758|FG002|As Treated|Adverse Event|0|||
16179140|NCT02786537|39135759|FG003|As Treated|Adverse Event|4|||
16179141|NCT02786537|39135760|FG004|As Treated|Adverse Event|6|||
16179142|NCT02786537|39135761|FG005|As Treated|Adverse Event|2|||
16179143|NCT02786537|39135756|FG000|As Treated|Death|0|||
16179144|NCT02786537|39135757|FG001|As Treated|Death|2|||
16478255|NCT02477839|40231120|FG000|Overall Study|Exclusion criterion|0|||
16478256|NCT02477839|40231121|FG001|Overall Study|Exclusion criterion|1|||
16478257|NCT01758523|40231122|FG000|Overall Study|Adverse Event|2|||
16478258|NCT01758523|40231123|FG001|Overall Study|Adverse Event|1|||
16478259|NCT01758523|40231122|FG000|Overall Study|Lack of Efficacy|4|||
16478260|NCT01758523|40231123|FG001|Overall Study|Lack of Efficacy|2|||
16179145|NCT02786537|39135758|FG002|As Treated|Death|0|||
16179146|NCT02786537|39135759|FG003|As Treated|Death|3|||
16179147|NCT02786537|39135760|FG004|As Treated|Death|1|||
16179148|NCT02786537|39135761|FG005|As Treated|Death|0|||
16179149|NCT02786537|39135756|FG000|As Treated|Lack of Efficacy|0|||
16179150|NCT02786537|39135757|FG001|As Treated|Lack of Efficacy|0|||
16179151|NCT02786537|39135758|FG002|As Treated|Lack of Efficacy|0|||
16179152|NCT02786537|39135759|FG003|As Treated|Lack of Efficacy|1|||
16179153|NCT02786537|39135760|FG004|As Treated|Lack of Efficacy|0|||
16179154|NCT02786537|39135761|FG005|As Treated|Lack of Efficacy|0|||
16179155|NCT02786537|39135756|FG000|As Treated|Lost to Follow-up|4|||
16179156|NCT02786537|39135757|FG001|As Treated|Lost to Follow-up|32|||
16179157|NCT02786537|39135758|FG002|As Treated|Lost to Follow-up|0|||
16179158|NCT02786537|39135759|FG003|As Treated|Lost to Follow-up|25|||
16279027|NCT02578641|39504210|FG001|Overall Study|Lost to Follow-up|1|||
16478261|NCT01758523|40231122|FG000|Overall Study|Lost to Follow-up|3|||
16478262|NCT01758523|40231123|FG001|Overall Study|Lost to Follow-up|4|||
16179159|NCT02786537|39135760|FG004|As Treated|Lost to Follow-up|4|||
16179160|NCT02786537|39135761|FG005|As Treated|Lost to Follow-up|4|||
16179161|NCT02786537|39135756|FG000|As Treated|Non-compliance with study drug|1|||
16179162|NCT02786537|39135757|FG001|As Treated|Non-compliance with study drug|11|||
16179163|NCT02786537|39135758|FG002|As Treated|Non-compliance with study drug|0|||
16179164|NCT02786537|39135759|FG003|As Treated|Non-compliance with study drug|1|||
16179165|NCT02786537|39135760|FG004|As Treated|Non-compliance with study drug|0|||
16179166|NCT02786537|39135761|FG005|As Treated|Non-compliance with study drug|1|||
16179167|NCT02786537|39135756|FG000|As Treated|Lost insurance|0|||
16179168|NCT02786537|39135757|FG001|As Treated|Lost insurance|0|||
16179169|NCT02786537|39135758|FG002|As Treated|Lost insurance|0|||
16179170|NCT02786537|39135759|FG003|As Treated|Lost insurance|1|||
16179171|NCT02786537|39135760|FG004|As Treated|Lost insurance|0|||
16179172|NCT02786537|39135761|FG005|As Treated|Lost insurance|0|||
16179173|NCT02786537|39135756|FG000|As Treated|Withdrawal by Subject|1|||
16079986|NCT00421889|38786723|FG007|Overall Study|Adverse Event|0|||
16079987|NCT00421889|38786724|FG008|Overall Study|Adverse Event|2|||
16079988|NCT00421889|38786716|FG000|Overall Study|Withdrawal by Subject|1|||
16079989|NCT00421889|38786717|FG001|Overall Study|Withdrawal by Subject|3|||
16079990|NCT00421889|38786718|FG002|Overall Study|Withdrawal by Subject|0|||
16079991|NCT00421889|38786719|FG003|Overall Study|Withdrawal by Subject|0|||
16079992|NCT00421889|38786720|FG004|Overall Study|Withdrawal by Subject|2|||
16079993|NCT00421889|38786721|FG005|Overall Study|Withdrawal by Subject|0|||
16079994|NCT00421889|38786722|FG006|Overall Study|Withdrawal by Subject|0|||
16079995|NCT00421889|38786723|FG007|Overall Study|Withdrawal by Subject|0|||
16079996|NCT00421889|38786724|FG008|Overall Study|Withdrawal by Subject|0|||
16079997|NCT00421889|38786716|FG000|Overall Study|Death|0|||
16079998|NCT00421889|38786717|FG001|Overall Study|Death|0|||
16079999|NCT00421889|38786718|FG002|Overall Study|Death|0|||
16080000|NCT00421889|38786719|FG003|Overall Study|Death|0|||
16080001|NCT00421889|38786720|FG004|Overall Study|Death|1|||
16080002|NCT00421889|38786721|FG005|Overall Study|Death|1|||
16080003|NCT00421889|38786722|FG006|Overall Study|Death|0|||
16080004|NCT00421889|38786723|FG007|Overall Study|Death|0|||
16080005|NCT00421889|38786724|FG008|Overall Study|Death|0|||
16080006|NCT00421889|38786716|FG000|Overall Study|Progressive disease|3|||
16080007|NCT00421889|38786717|FG001|Overall Study|Progressive disease|2|||
16080008|NCT00421889|38786718|FG002|Overall Study|Progressive disease|2|||
16080009|NCT00421889|38786719|FG003|Overall Study|Progressive disease|3|||
16080010|NCT00421889|38786720|FG004|Overall Study|Progressive disease|2|||
16080011|NCT00421889|38786721|FG005|Overall Study|Progressive disease|21|||
16080012|NCT00421889|38786722|FG006|Overall Study|Progressive disease|3|||
16080013|NCT00421889|38786723|FG007|Overall Study|Progressive disease|1|||
16080014|NCT00421889|38786724|FG008|Overall Study|Progressive disease|5|||
16080015|NCT00421889|38786716|FG000|Overall Study|Patient/Investigator request|0|||
16080016|NCT00421889|38786717|FG001|Overall Study|Patient/Investigator request|0|||
16080017|NCT00421889|38786718|FG002|Overall Study|Patient/Investigator request|0|||
16080018|NCT00421889|38786719|FG003|Overall Study|Patient/Investigator request|0|||
16080019|NCT00421889|38786720|FG004|Overall Study|Patient/Investigator request|0|||
16080020|NCT00421889|38786721|FG005|Overall Study|Patient/Investigator request|9|||
16080021|NCT00421889|38786722|FG006|Overall Study|Patient/Investigator request|0|||
16080022|NCT00421889|38786723|FG007|Overall Study|Patient/Investigator request|1|||
16080023|NCT00421889|38786724|FG008|Overall Study|Patient/Investigator request|3|||
16080024|NCT00421889|38786716|FG000|Overall Study|Lost to Follow-up|0|||
16080025|NCT00421889|38786717|FG001|Overall Study|Lost to Follow-up|0|||
16080026|NCT00421889|38786718|FG002|Overall Study|Lost to Follow-up|0|||
16080027|NCT00421889|38786719|FG003|Overall Study|Lost to Follow-up|0|||
16080028|NCT00421889|38786720|FG004|Overall Study|Lost to Follow-up|0|||
16080029|NCT00421889|38786721|FG005|Overall Study|Lost to Follow-up|0|||
16080030|NCT00421889|38786722|FG006|Overall Study|Lost to Follow-up|0|||
16080031|NCT00421889|38786723|FG007|Overall Study|Lost to Follow-up|0|||
16080032|NCT00421889|38786724|FG008|Overall Study|Lost to Follow-up|1|||
16080033|NCT00812461|38786725|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
16080034|NCT00812461|38786726|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
16080035|NCT00812461|38786725|FG000|All Treated Patients|Adverse Event|8|||
16080036|NCT00812461|38786726|FG001|All Treated Patients|Adverse Event|15|||
16080037|NCT00812461|38786725|FG000|All Treated Patients|Lack of Efficacy|13|||
16080038|NCT00812461|38786726|FG001|All Treated Patients|Lack of Efficacy|7|||
16080039|NCT00812461|38786725|FG000|All Treated Patients|Non-compliance|6|||
16080040|NCT00812461|38786726|FG001|All Treated Patients|Non-compliance|9|||
16080041|NCT00812461|38786725|FG000|All Treated Patients|Protocol Violation|36|||
16080042|NCT00812461|38786726|FG001|All Treated Patients|Protocol Violation|27|||
16080043|NCT00812461|38786725|FG000|All Treated Patients|Withdrawal by Subject|45|||
16179174|NCT02786537|39135757|FG001|As Treated|Withdrawal by Subject|2|||
16179175|NCT02786537|39135758|FG002|As Treated|Withdrawal by Subject|0|||
16179176|NCT02786537|39135759|FG003|As Treated|Withdrawal by Subject|0|||
16179177|NCT02786537|39135760|FG004|As Treated|Withdrawal by Subject|1|||
16179178|NCT02786537|39135761|FG005|As Treated|Withdrawal by Subject|0|||
16179179|NCT02786537|39135756|FG000|As Treated|Incarceration|0|||
16179180|NCT02786537|39135757|FG001|As Treated|Incarceration|1|||
16179181|NCT02786537|39135758|FG002|As Treated|Incarceration|0|||
16179182|NCT02786537|39135759|FG003|As Treated|Incarceration|0|||
16179183|NCT02786537|39135760|FG004|As Treated|Incarceration|0|||
16179184|NCT02786537|39135761|FG005|As Treated|Incarceration|0|||
16179185|NCT02786537|39135756|FG000|As Treated|Opiate dependency relapse|0|||
16179186|NCT02786537|39135757|FG001|As Treated|Opiate dependency relapse|1|||
16179187|NCT02786537|39135758|FG002|As Treated|Opiate dependency relapse|0|||
16179188|NCT02786537|39135759|FG003|As Treated|Opiate dependency relapse|0|||
16179189|NCT02786537|39135760|FG004|As Treated|Opiate dependency relapse|0|||
16179190|NCT02786537|39135761|FG005|As Treated|Opiate dependency relapse|0|||
16179191|NCT02786537|39135756|FG000|As Treated|Drugs stolen from patient|0|||
16179192|NCT02786537|39135757|FG001|As Treated|Drugs stolen from patient|1|||
16179193|NCT02786537|39135758|FG002|As Treated|Drugs stolen from patient|0|||
16179194|NCT02786537|39135759|FG003|As Treated|Drugs stolen from patient|0|||
16179195|NCT02786537|39135760|FG004|As Treated|Drugs stolen from patient|0|||
16179196|NCT02786537|39135761|FG005|As Treated|Drugs stolen from patient|0|||
16179197|NCT02786537|39135756|FG000|As Treated|Advised to stop tx after loss of meds|0|||
16179198|NCT02786537|39135757|FG001|As Treated|Advised to stop tx after loss of meds|1|||
16179199|NCT02786537|39135758|FG002|As Treated|Advised to stop tx after loss of meds|0|||
16179200|NCT02786537|39135759|FG003|As Treated|Advised to stop tx after loss of meds|0|||
16179201|NCT02786537|39135760|FG004|As Treated|Advised to stop tx after loss of meds|0|||
16179202|NCT02786537|39135761|FG005|As Treated|Advised to stop tx after loss of meds|0|||
16179203|NCT00871858|39135762|FG000|Overall Study|Protocol Violation|3|||
16179204|NCT00871858|39135763|FG001|Overall Study|Protocol Violation|4|||
16179205|NCT00871858|39135762|FG000|Overall Study|Adverse Event|1|||
16179206|NCT00871858|39135763|FG001|Overall Study|Adverse Event|1|||
16179207|NCT00871858|39135762|FG000|Overall Study|Withdrawal by Subject|1|||
16179208|NCT00871858|39135763|FG001|Overall Study|Withdrawal by Subject|1|||
16179209|NCT00871858|39135762|FG000|Overall Study|Lost to Follow-up|0|||
16179210|NCT00871858|39135763|FG001|Overall Study|Lost to Follow-up|1|||
16179211|NCT02263365|39135764|FG000|Overall Study|Physician Decision|22|||
16179212|NCT02263365|39135765|FG001|Overall Study|Physician Decision|18|||
16179213|NCT02519231|39135766|FG000|Overall Study|Lost to Follow-up|2|||
16179214|NCT02519231|39135767|FG001|Overall Study|Lost to Follow-up|5|||
16179215|NCT02519231|39135766|FG000|Overall Study|Withdrawal by Subject|0|||
16179216|NCT02519231|39135767|FG001|Overall Study|Withdrawal by Subject|1|||
16179217|NCT00685178|39135769|FG000|Overall Study|Adverse Event|1|||
16179218|NCT00685178|39135770|FG001|Overall Study|Adverse Event|5|||
16179219|NCT00685178|39135771|FG002|Overall Study|Adverse Event|2|||
16179220|NCT00685178|39135772|FG003|Overall Study|Adverse Event|4|||
16179221|NCT00685178|39135769|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
16179222|NCT00685178|39135770|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
16179223|NCT00685178|39135771|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
16179224|NCT00685178|39135772|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
16179225|NCT00685178|39135769|FG000|Overall Study|voluntary study discharge|4|||
16179226|NCT00685178|39135770|FG001|Overall Study|voluntary study discharge|5|||
16179227|NCT00685178|39135771|FG002|Overall Study|voluntary study discharge|1|||
16179228|NCT00685178|39135772|FG003|Overall Study|voluntary study discharge|1|||
16179229|NCT00685178|39135769|FG000|Overall Study|incarcerated|1|||
16179230|NCT00685178|39135770|FG001|Overall Study|incarcerated|3|||
16179231|NCT00685178|39135771|FG002|Overall Study|incarcerated|7|||
16179232|NCT00685178|39135772|FG003|Overall Study|incarcerated|0|||
16179233|NCT00685178|39135769|FG000|Overall Study|administrative (disciplinary) discharge|0|||
16179234|NCT00685178|39135770|FG001|Overall Study|administrative (disciplinary) discharge|1|||
16179235|NCT00685178|39135771|FG002|Overall Study|administrative (disciplinary) discharge|0|||
16179236|NCT00685178|39135772|FG003|Overall Study|administrative (disciplinary) discharge|2|||
16179237|NCT00685178|39135769|FG000|Overall Study|Pregnancy|0|||
16179238|NCT00685178|39135770|FG001|Overall Study|Pregnancy|0|||
16478263|NCT01758523|40231122|FG000|Overall Study|Withdrawal by Subject|12|||
16478264|NCT01758523|40231123|FG001|Overall Study|Withdrawal by Subject|7|||
16478265|NCT03608254|40231124|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
16179239|NCT00685178|39135771|FG002|Overall Study|Pregnancy|0|||
16179240|NCT00685178|39135772|FG003|Overall Study|Pregnancy|1|||
16179241|NCT00594399|39135773|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
16179242|NCT00594399|39135774|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
16179243|NCT00594399|39135775|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
16179244|NCT00594399|39135773|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
16179245|NCT00594399|39135774|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
16179246|NCT00594399|39135775|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
16179247|NCT00594399|39135773|FG000|Initial 3 Month Counseling|Personal issues|2|||
16179248|NCT00594399|39135774|FG001|Initial 3 Month Counseling|Personal issues|0|||
16179249|NCT00594399|39135775|FG002|Initial 3 Month Counseling|Personal issues|0|||
16179250|NCT00594399|39135773|FG000|Initial 3 Month Counseling|Too busy|7|||
16179251|NCT00594399|39135774|FG001|Initial 3 Month Counseling|Too busy|1|||
16179252|NCT00594399|39135775|FG002|Initial 3 Month Counseling|Too busy|0|||
16179253|NCT00594399|39135773|FG000|Initial 3 Month Counseling|Pain|2|||
16179254|NCT00594399|39135774|FG001|Initial 3 Month Counseling|Pain|0|||
16179255|NCT00594399|39135775|FG002|Initial 3 Month Counseling|Pain|0|||
16179256|NCT00594399|39135773|FG000|Initial 3 Month Counseling|Moved|1|||
16179257|NCT00594399|39135774|FG001|Initial 3 Month Counseling|Moved|0|||
16179258|NCT00594399|39135775|FG002|Initial 3 Month Counseling|Moved|0|||
16179259|NCT00594399|39135773|FG000|Initial 3 Month Counseling|Family illness|1|||
16179260|NCT00594399|39135774|FG001|Initial 3 Month Counseling|Family illness|0|||
16179261|NCT00594399|39135775|FG002|Initial 3 Month Counseling|Family illness|0|||
16179262|NCT00594399|39135773|FG000|Rerandomization Arm 1 Only|Death|2|||
16179263|NCT00594399|39135774|FG001|Rerandomization Arm 1 Only|Death|1|||
16179264|NCT00594399|39135775|FG002|Rerandomization Arm 1 Only|Death|0|||
16179265|NCT00594399|39135773|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
16179266|NCT00594399|39135774|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
16179267|NCT00594399|39135775|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
16179268|NCT02285010|39135776|FG000|Overall Study|not abdominal hysterectomy|2|||
16179269|NCT02285010|39135777|FG001|Overall Study|not abdominal hysterectomy|0|||
16179270|NCT02285010|39135776|FG000|Overall Study|Not spinal anesthesia|3|||
16179271|NCT02285010|39135777|FG001|Overall Study|Not spinal anesthesia|1|||
16179272|NCT00587223|39135778|FG000|Overall Study|Adverse Event|1|||
16179273|NCT00201201|39135779|FG000|Overall Study|Death|0|||
16179274|NCT00201201|39135780|FG001|Overall Study|Death|2|||
16179275|NCT00201201|39135779|FG000|Overall Study|Withdrawal by Subject|5|||
16179276|NCT00201201|39135780|FG001|Overall Study|Withdrawal by Subject|5|||
16179277|NCT00756002|39135781|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
16179278|NCT00756002|39135782|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
16179279|NCT00756002|39135781|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16179280|NCT00756002|39135782|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
16179281|NCT00756002|39135781|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
16179282|NCT00756002|39135782|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
16179283|NCT00756002|39135781|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
16179284|NCT00756002|39135782|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
16179285|NCT00756002|39135781|FG000|Double-Blind Treatment Period|Other|2|||
16179286|NCT00756002|39135782|FG001|Double-Blind Treatment Period|Other|2|||
16179287|NCT00003641|39135784|FG000|Overall Study|Withdrawal by Subject|0|||
16179288|NCT00003641|39135785|FG001|Overall Study|Withdrawal by Subject|100|||
16179289|NCT00003641|39135784|FG000|Overall Study|Adverse Event|0|||
16179290|NCT00003641|39135785|FG001|Overall Study|Adverse Event|38|||
16179291|NCT00003641|39135784|FG000|Overall Study|Disease progression|0|||
16179292|NCT00003641|39135785|FG001|Overall Study|Disease progression|2|||
16179293|NCT00003641|39135784|FG000|Overall Study|Unknown/missing|0|||
16179294|NCT00003641|39135785|FG001|Overall Study|Unknown/missing|22|||
16179295|NCT00003641|39135784|FG000|Overall Study|Should not receive interferon therapy|2|||
16179296|NCT00003641|39135785|FG001|Overall Study|Should not receive interferon therapy|0|||
16179297|NCT00003641|39135784|FG000|Overall Study|Never started interferon|567|||
16179298|NCT00003641|39135785|FG001|Overall Study|Never started interferon|12|||
16478266|NCT03608254|40231124|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
16478267|NCT01193530|40231125|FG000|Overall Study|Withdrawal by Subject|2|||
16478268|NCT01193530|40231126|FG001|Overall Study|Withdrawal by Subject|2|||
16478269|NCT01193530|40231125|FG000|Overall Study|Began Contraindicated Therapy|1|||
16478270|NCT01193530|40231126|FG001|Overall Study|Began Contraindicated Therapy|0|||
16478271|NCT01193530|40231125|FG000|Overall Study|Lost Light Box|0|||
16478272|NCT01193530|40231126|FG001|Overall Study|Lost Light Box|1|||
16478273|NCT01193530|40231125|FG000|Overall Study|Returned home - out of state|0|||
16478274|NCT01193530|40231126|FG001|Overall Study|Returned home - out of state|1|||
16478275|NCT01193530|40231125|FG000|Overall Study|Non-Compliance|0|||
16478276|NCT01193530|40231126|FG001|Overall Study|Non-Compliance|1|||
16478277|NCT03841448|40231127|FG000|Double-blind Treatment (DBT) Period|Death|1|||
16478278|NCT03841448|40231128|FG001|Double-blind Treatment (DBT) Period|Death|1|||
16179299|NCT00532259|39135786|FG000|Overall Study|Withdrawal by Subject|2|||
16179300|NCT00532259|39135786|FG000|Overall Study|Adverse Event|1|||
16179301|NCT00532259|39135786|FG000|Overall Study|Death|1|||
16179302|NCT00532259|39135786|FG000|Overall Study|Lack of Efficacy|21|||
16179303|NCT00532259|39135786|FG000|Overall Study|Lost to Follow-up|3|||
16478279|NCT03841448|40231129|FG002|Double-blind Treatment (DBT) Period|Death|0|||
16478280|NCT03841448|40231130|FG003|Double-blind Treatment (DBT) Period|Death|0|||
16478281|NCT03841448|40231127|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
16478282|NCT03841448|40231128|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
16478283|NCT03841448|40231129|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
16478284|NCT03841448|40231130|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
16478285|NCT03841448|40231127|FG000|Open-Label Extension (OLE) Period|Death|0|||
16478286|NCT03841448|40231128|FG001|Open-Label Extension (OLE) Period|Death|0|||
16478287|NCT03841448|40231129|FG002|Open-Label Extension (OLE) Period|Death|0|||
16478288|NCT03841448|40231130|FG003|Open-Label Extension (OLE) Period|Death|1|||
16478289|NCT03841448|40231127|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
16478290|NCT03841448|40231128|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
16478291|NCT03841448|40231129|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
16478292|NCT03841448|40231130|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
16478293|NCT03841448|40231127|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
16478294|NCT03841448|40231128|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
16478295|NCT03841448|40231129|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
16478296|NCT03841448|40231130|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
16478297|NCT03841448|40231127|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
16179304|NCT00532259|39135786|FG000|Overall Study|Physician Decision|3|||
16179305|NCT00532259|39135786|FG000|Overall Study|Protocol Violation|1|||
16179306|NCT01174784|39135787|FG000|Overall Study|Screen fails|4|||
16179307|NCT01618656|39135791|FG000|Overall Study|Withdrawal by Subject|7|||
16179308|NCT01618656|39135792|FG001|Overall Study|Withdrawal by Subject|3|||
16179309|NCT01618656|39135791|FG000|Overall Study|Physician Decision|1|||
16179310|NCT01618656|39135792|FG001|Overall Study|Physician Decision|1|||
16179311|NCT02591615|39135793|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
16179312|NCT02591615|39135794|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
16179313|NCT02591615|39135795|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
16179314|NCT02591615|39135796|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
16179315|NCT02591615|39135793|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
16179316|NCT02591615|39135794|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
16179317|NCT02591615|39135795|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
16179318|NCT02591615|39135796|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
16179319|NCT02591615|39135793|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
16179320|NCT02591615|39135794|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
16179321|NCT02591615|39135795|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
16179322|NCT02591615|39135796|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
16179323|NCT02591615|39135793|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
16179324|NCT02591615|39135794|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
16179325|NCT02591615|39135795|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
16179326|NCT02591615|39135796|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
16179327|NCT02591615|39135793|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
16179328|NCT02591615|39135794|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
16179329|NCT02591615|39135795|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
16080044|NCT00812461|38786726|FG001|All Treated Patients|Withdrawal by Subject|54|||
16080045|NCT00812461|38786725|FG000|All Treated Patients|Lost to Follow-up|11|||
16080046|NCT00812461|38786726|FG001|All Treated Patients|Lost to Follow-up|14|||
16080047|NCT00812461|38786725|FG000|All Treated Patients|Other Reason|13|||
16080048|NCT00812461|38786726|FG001|All Treated Patients|Other Reason|21|||
16080049|NCT03175172|38786736|FG000|Overall Study|Death|3|||
16080050|NCT03175172|38786736|FG000|Overall Study|Withdrawal by Subject|3|||
16080051|NCT03175172|38786736|FG000|Overall Study|Lost to Follow-up|1|||
16179330|NCT02591615|39135796|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
16478298|NCT03841448|40231128|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
16478299|NCT03841448|40231129|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
16478300|NCT03841448|40231130|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
16478301|NCT03540030|40231134|FG000|Overall Study|Withdrawal by Subject|2|||
16478302|NCT03540030|40231135|FG001|Overall Study|Withdrawal by Subject|1|||
16478303|NCT03540030|40231134|FG000|Overall Study|screen fail|7|||
16080052|NCT03175172|38786736|FG000|Overall Study|Study Terminated by Sponsor|3|||
16179331|NCT02591615|39135793|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
16179332|NCT02591615|39135794|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
16179333|NCT02591615|39135795|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
16179334|NCT02591615|39135796|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
16179335|NCT02591615|39135793|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
16179336|NCT02591615|39135794|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
16179337|NCT02591615|39135795|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
16179338|NCT02591615|39135796|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
16179339|NCT02591615|39135793|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
16179340|NCT02591615|39135794|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
16179341|NCT02591615|39135795|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
16179342|NCT02591615|39135796|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
16179343|NCT02591615|39135793|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
16179344|NCT02591615|39135794|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
16179345|NCT02591615|39135795|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
16179346|NCT02591615|39135796|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
16179347|NCT02591615|39135793|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
16179348|NCT02591615|39135794|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
16179349|NCT02591615|39135795|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
16179350|NCT02591615|39135796|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
16179351|NCT02591615|39135793|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
16179352|NCT02591615|39135794|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
16179353|NCT02591615|39135795|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
16179354|NCT02591615|39135796|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
16179355|NCT02591615|39135793|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
16179356|NCT02591615|39135794|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
16179357|NCT02591615|39135795|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
16179358|NCT02591615|39135796|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
16179359|NCT02591615|39135793|FG000|Maintenance MK-3475|Adverse Event|0|||
16179360|NCT02591615|39135794|FG001|Maintenance MK-3475|Adverse Event|3|||
16179361|NCT02591615|39135795|FG002|Maintenance MK-3475|Adverse Event|1|||
16179362|NCT02591615|39135796|FG003|Maintenance MK-3475|Adverse Event|2|||
16179363|NCT02591615|39135793|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
16179364|NCT02591615|39135794|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
16179365|NCT02591615|39135795|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
16179366|NCT02591615|39135796|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
16179367|NCT02591615|39135793|FG000|Maintenance MK-3475|Death|0|||
16179368|NCT02591615|39135794|FG001|Maintenance MK-3475|Death|1|||
16179369|NCT02591615|39135795|FG002|Maintenance MK-3475|Death|1|||
16179370|NCT02591615|39135796|FG003|Maintenance MK-3475|Death|0|||
16179371|NCT02591615|39135793|FG000|Maintenance MK-3475|Physician discretion|0|||
16179372|NCT02591615|39135794|FG001|Maintenance MK-3475|Physician discretion|0|||
16179373|NCT02591615|39135795|FG002|Maintenance MK-3475|Physician discretion|1|||
16179374|NCT02591615|39135796|FG003|Maintenance MK-3475|Physician discretion|0|||
16179375|NCT02591615|39135793|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
16179376|NCT02591615|39135794|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
16179377|NCT02591615|39135795|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
16179378|NCT02591615|39135796|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
16179379|NCT02591615|39135793|FG000|Maintenance MK-3475|In active treatment|2|||
16179380|NCT02591615|39135794|FG001|Maintenance MK-3475|In active treatment|0|||
16179381|NCT02591615|39135795|FG002|Maintenance MK-3475|In active treatment|0|||
16179382|NCT02591615|39135796|FG003|Maintenance MK-3475|In active treatment|1|||
16179383|NCT00641147|39135799|FG000|Completed 4 Months.|Physician Decision|1|||
16179384|NCT00641147|39135800|FG001|Completed 4 Months.|Physician Decision|0|||
16179385|NCT00641147|39135799|FG000|Completed 4 Months.|Adverse Event|1|||
16179386|NCT00641147|39135800|FG001|Completed 4 Months.|Adverse Event|0|||
16179387|NCT00641147|39135799|FG000|Completed 8 Months.|Physician Decision|2|||
16179388|NCT00641147|39135800|FG001|Completed 8 Months.|Physician Decision|1|||
16179389|NCT00641147|39135799|FG000|Completed 8 Months.|non compliance|1|||
16179390|NCT00641147|39135800|FG001|Completed 8 Months.|non compliance|0|||
16179391|NCT00641147|39135799|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
16179392|NCT00641147|39135800|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
16179393|NCT00641147|39135799|FG000|Completed 12 Months.|Physician Decision|1|||
16179394|NCT00641147|39135800|FG001|Completed 12 Months.|Physician Decision|1|||
16179395|NCT00641147|39135799|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
16179396|NCT00641147|39135800|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
16179397|NCT00641147|39135799|FG000|Completed 16 Months.|Physician Decision|1|||
16179398|NCT00641147|39135800|FG001|Completed 16 Months.|Physician Decision|0|||
16179399|NCT00641147|39135799|FG000|Completed 16 Months.|Lost to Follow-up|1|||
16179400|NCT00641147|39135800|FG001|Completed 16 Months.|Lost to Follow-up|0|||
16179401|NCT01687673|39135804|FG000|Overall Study|Physician Decision|1|||
16179402|NCT01736683|39135809|FG000|Overall Study|Disease Relapse|0|||
16179403|NCT01736683|39135810|FG001|Overall Study|Disease Relapse|0|||
16179404|NCT01736683|39135811|FG002|Overall Study|Disease Relapse|2|||
16179405|NCT01736683|39135812|FG003|Overall Study|Disease Relapse|1|||
16179406|NCT01736683|39135813|FG004|Overall Study|Disease Relapse|0|||
16179407|NCT01736683|39135809|FG000|Overall Study|Adverse Event|0|||
16179408|NCT01736683|39135810|FG001|Overall Study|Adverse Event|2|||
16179409|NCT01736683|39135811|FG002|Overall Study|Adverse Event|2|||
16179410|NCT01736683|39135812|FG003|Overall Study|Adverse Event|3|||
16179411|NCT01736683|39135813|FG004|Overall Study|Adverse Event|2|||
16279028|NCT02578641|39504209|FG000|Overall Study|Withdrawal by Subject|14|||
16279029|NCT02578641|39504210|FG001|Overall Study|Withdrawal by Subject|7|||
16179412|NCT01736683|39135809|FG000|Overall Study|Withdrawal by Subject|0|||
16179413|NCT01736683|39135810|FG001|Overall Study|Withdrawal by Subject|0|||
16179414|NCT01736683|39135811|FG002|Overall Study|Withdrawal by Subject|3|||
16179415|NCT01736683|39135812|FG003|Overall Study|Withdrawal by Subject|1|||
16179416|NCT01736683|39135813|FG004|Overall Study|Withdrawal by Subject|1|||
16179417|NCT01736683|39135809|FG000|Overall Study|Lack of Therapeutic Effect|7|||
16179418|NCT01736683|39135810|FG001|Overall Study|Lack of Therapeutic Effect|4|||
16179419|NCT01736683|39135811|FG002|Overall Study|Lack of Therapeutic Effect|13|||
16179420|NCT01736683|39135812|FG003|Overall Study|Lack of Therapeutic Effect|20|||
16179421|NCT01736683|39135813|FG004|Overall Study|Lack of Therapeutic Effect|1|||
16179422|NCT01736683|39135809|FG000|Overall Study|Progressive Disease|0|||
16478304|NCT03540030|40231135|FG001|Overall Study|screen fail|1|||
16478305|NCT03540030|40231134|FG000|Overall Study|never had surgery after signing consent|9|||
16478306|NCT03540030|40231135|FG001|Overall Study|never had surgery after signing consent|1|||
16478307|NCT00137631|40231138|FG000|Overall Study|Lost to Follow-up|37|||
16478308|NCT00137631|40231139|FG001|Overall Study|Lost to Follow-up|41|||
16478309|NCT04154930|40231140|FG000|Overall Study|Withdrawal by Subject|15|||
16080053|NCT02466516|38786737|FG000|Overall Study|Adverse Event|1|||
16080054|NCT02466516|38786738|FG001|Overall Study|Adverse Event|1|||
16080055|NCT02466516|38786739|FG002|Overall Study|Adverse Event|0|||
16080056|NCT02466516|38786740|FG003|Overall Study|Adverse Event|0|||
16080057|NCT02466516|38786741|FG004|Overall Study|Adverse Event|0|||
16080058|NCT02466516|38786737|FG000|Overall Study|Withdrew Consent|1|||
16080059|NCT02466516|38786738|FG001|Overall Study|Withdrew Consent|0|||
16080060|NCT02466516|38786739|FG002|Overall Study|Withdrew Consent|0|||
16080061|NCT02466516|38786740|FG003|Overall Study|Withdrew Consent|0|||
16080062|NCT02466516|38786741|FG004|Overall Study|Withdrew Consent|0|||
16080063|NCT02466516|38786737|FG000|Overall Study|Lost to Follow-up|2|||
16080064|NCT02466516|38786738|FG001|Overall Study|Lost to Follow-up|0|||
16080065|NCT02466516|38786739|FG002|Overall Study|Lost to Follow-up|1|||
16080066|NCT02466516|38786740|FG003|Overall Study|Lost to Follow-up|0|||
16080067|NCT02466516|38786741|FG004|Overall Study|Lost to Follow-up|0|||
16080068|NCT02531113|38786742|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
16080069|NCT02531113|38786742|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
16080070|NCT02531113|38786742|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
16080071|NCT02531113|38786742|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
16080072|NCT02531113|38786742|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
16080073|NCT02531113|38786742|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
16080074|NCT02531113|38786742|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
16080075|NCT02531113|38786742|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
16080076|NCT01765543|38786743|FG000|Overall Study|Death|1|||
16080077|NCT01765543|38786743|FG000|Overall Study|Withdrawal by Subject|2|||
16080078|NCT03260140|38786751|FG000|Overall Study|Death|4|||
16080079|NCT03260140|38786752|FG001|Overall Study|Death|1|||
16080080|NCT03260140|38786751|FG000|Overall Study|Withdrawal by Subject|1|||
16080081|NCT03260140|38786752|FG001|Overall Study|Withdrawal by Subject|4|||
16080082|NCT01872078|38786756|FG000|Overall Study|Adverse Event|0|||
16080083|NCT01872078|38786757|FG001|Overall Study|Adverse Event|0|||
16080084|NCT01872078|38786758|FG002|Overall Study|Adverse Event|1|||
16080085|NCT01872078|38786759|FG003|Overall Study|Adverse Event|0|||
16080086|NCT01872078|38786756|FG000|Overall Study|Dose administration non-compliance|0|||
16080087|NCT01872078|38786757|FG001|Overall Study|Dose administration non-compliance|0|||
16080088|NCT01872078|38786758|FG002|Overall Study|Dose administration non-compliance|0|||
16080089|NCT01872078|38786759|FG003|Overall Study|Dose administration non-compliance|1|||
16080090|NCT01872078|38786756|FG000|Overall Study|Protocol Violation|0|||
16080091|NCT01872078|38786757|FG001|Overall Study|Protocol Violation|0|||
16080092|NCT01872078|38786758|FG002|Overall Study|Protocol Violation|1|||
16080093|NCT01872078|38786759|FG003|Overall Study|Protocol Violation|0|||
16080094|NCT01872078|38786756|FG000|Overall Study|Withdrawal by Subject|0|||
16080095|NCT01872078|38786757|FG001|Overall Study|Withdrawal by Subject|0|||
16179423|NCT01736683|39135810|FG001|Overall Study|Progressive Disease|0|||
16478310|NCT04154930|40231141|FG001|Overall Study|Withdrawal by Subject|6|||
16478311|NCT04154930|40231140|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
16478312|NCT04154930|40231141|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
16179424|NCT01736683|39135811|FG002|Overall Study|Progressive Disease|0|||
16179425|NCT01736683|39135812|FG003|Overall Study|Progressive Disease|1|||
16179426|NCT01736683|39135813|FG004|Overall Study|Progressive Disease|0|||
16179427|NCT01736683|39135809|FG000|Overall Study|Other|0|||
16179428|NCT01736683|39135810|FG001|Overall Study|Other|0|||
16179429|NCT01736683|39135811|FG002|Overall Study|Other|1|||
16179430|NCT01736683|39135812|FG003|Overall Study|Other|9|||
16179431|NCT01736683|39135813|FG004|Overall Study|Other|1|||
16179432|NCT03846947|39135814|FG000|Overall Study|technical issues with imaging sequence|2|||
16179433|NCT00072189|39135817|FG000|Overall Study|Withdrawal by Subject|1|||
16179434|NCT01088412|39135818|FG000|Overall Study|Adverse Event|38|||
16179435|NCT01088412|39135819|FG001|Overall Study|Adverse Event|0|||
16179436|NCT01088412|39135820|FG002|Overall Study|Adverse Event|0|||
16179437|NCT01088412|39135818|FG000|Overall Study|Death|42|||
16179438|NCT01088412|39135819|FG001|Overall Study|Death|6|||
16179439|NCT01088412|39135820|FG002|Overall Study|Death|0|||
16179440|NCT01088412|39135818|FG000|Overall Study|Other Reason per Case Report Form|2089|||
16179441|NCT01088412|39135819|FG001|Overall Study|Other Reason per Case Report Form|103|||
16179442|NCT01088412|39135820|FG002|Overall Study|Other Reason per Case Report Form|9|||
16179443|NCT01088412|39135818|FG000|Overall Study|Withdrawal by Subject|1761|||
16179444|NCT01088412|39135819|FG001|Overall Study|Withdrawal by Subject|25|||
16179445|NCT01088412|39135820|FG002|Overall Study|Withdrawal by Subject|1|||
16179446|NCT01088412|39135818|FG000|Overall Study|Received Another GH Product|79|||
16179447|NCT01088412|39135819|FG001|Overall Study|Received Another GH Product|0|||
16179448|NCT01088412|39135820|FG002|Overall Study|Received Another GH Product|0|||
16179449|NCT01088412|39135818|FG000|Overall Study|Participant Moved|601|||
16179450|NCT01088412|39135819|FG001|Overall Study|Participant Moved|21|||
16179451|NCT01088412|39135820|FG002|Overall Study|Participant Moved|2|||
16179452|NCT01088412|39135818|FG000|Overall Study|Physician Decision|1041|||
16179453|NCT01088412|39135819|FG001|Overall Study|Physician Decision|8|||
16179454|NCT01088412|39135820|FG002|Overall Study|Physician Decision|4|||
16179455|NCT01088412|39135818|FG000|Overall Study|Sponsor Decision|4467|||
16179456|NCT01088412|39135819|FG001|Overall Study|Sponsor Decision|79|||
16179457|NCT01088412|39135820|FG002|Overall Study|Sponsor Decision|23|||
16179458|NCT01088412|39135818|FG000|Overall Study|Third Party Required to Change Brand|487|||
16179459|NCT01088412|39135819|FG001|Overall Study|Third Party Required to Change Brand|0|||
16179460|NCT01088412|39135820|FG002|Overall Study|Third Party Required to Change Brand|0|||
16179461|NCT01088412|39135818|FG000|Overall Study|Lost to Follow-up|3052|||
16179462|NCT01088412|39135819|FG001|Overall Study|Lost to Follow-up|130|||
16179463|NCT01088412|39135820|FG002|Overall Study|Lost to Follow-up|11|||
16179464|NCT01088412|39135818|FG000|Overall Study|Study Summary Not Completed|4360|||
16179465|NCT01088412|39135819|FG001|Overall Study|Study Summary Not Completed|64|||
16179466|NCT01088412|39135820|FG002|Overall Study|Study Summary Not Completed|22|||
16179467|NCT00091793|39135823|FG000|Overall Study|Adverse Event|1|||
16179468|NCT00091793|39135824|FG001|Overall Study|Adverse Event|2|||
16179469|NCT00091793|39135823|FG000|Overall Study|Withdrawal by Subject|10|||
16478313|NCT04154930|40231140|FG000|Overall Study|Lost to Follow-up|14|||
16179470|NCT00091793|39135824|FG001|Overall Study|Withdrawal by Subject|15|||
16179471|NCT00091793|39135823|FG000|Overall Study|Ineligibility determined|2|||
16179472|NCT00091793|39135824|FG001|Overall Study|Ineligibility determined|0|||
16179473|NCT00091793|39135823|FG000|Overall Study|Lost to Follow-up|7|||
16179474|NCT00091793|39135824|FG001|Overall Study|Lost to Follow-up|5|||
16179475|NCT00091793|39135823|FG000|Overall Study|Noncompliance|2|||
16179476|NCT00091793|39135824|FG001|Overall Study|Noncompliance|0|||
16179477|NCT00091793|39135823|FG000|Overall Study|Other|2|||
16179478|NCT00091793|39135824|FG001|Overall Study|Other|0|||
16179479|NCT02836236|39135825|FG000|Overall Study|Randomized but Never Treated|1|||
16179480|NCT02836236|39135826|FG001|Overall Study|Randomized but Never Treated|0|||
16179481|NCT02836236|39135825|FG000|Overall Study|Withdrew Consent|2|||
16179482|NCT02836236|39135826|FG001|Overall Study|Withdrew Consent|0|||
16179483|NCT02836236|39135825|FG000|Overall Study|Adverse Event|0|||
16179484|NCT02836236|39135826|FG001|Overall Study|Adverse Event|1|||
16179485|NCT02836236|39135825|FG000|Overall Study|Investigator's Discretion|1|||
16179486|NCT02836236|39135826|FG001|Overall Study|Investigator's Discretion|0|||
16179487|NCT02836236|39135825|FG000|Overall Study|Still on Study|101|||
16179488|NCT02836236|39135826|FG001|Overall Study|Still on Study|49|||
16179489|NCT01635933|39135837|FG000|Overall Study|Adverse Event|1|||
16179490|NCT01635933|39135838|FG001|Overall Study|Adverse Event|0|||
16179491|NCT01635933|39135837|FG000|Overall Study|Lost to Follow-up|0|||
16179492|NCT01635933|39135838|FG001|Overall Study|Lost to Follow-up|5|||
16179493|NCT01635933|39135837|FG000|Overall Study|Subject decision|1|||
16179494|NCT01635933|39135838|FG001|Overall Study|Subject decision|1|||
16179495|NCT01635933|39135837|FG000|Overall Study|Noncompliance|0|||
16179496|NCT01635933|39135838|FG001|Overall Study|Noncompliance|1|||
16179497|NCT01635933|39135837|FG000|Overall Study|No longer had transportation|0|||
16478314|NCT04154930|40231141|FG001|Overall Study|Lost to Follow-up|6|||
16478315|NCT04154930|40231140|FG000|Overall Study|Other|6|||
16179498|NCT01635933|39135838|FG001|Overall Study|No longer had transportation|1|||
16179499|NCT01024244|39135839|FG000|Overall Study|Adverse Event|1|||
16179500|NCT01024244|39135840|FG001|Overall Study|Adverse Event|2|||
16179501|NCT01024244|39135841|FG002|Overall Study|Adverse Event|0|||
16179502|NCT01024244|39135842|FG003|Overall Study|Adverse Event|1|||
16179503|NCT01024244|39135843|FG004|Overall Study|Adverse Event|2|||
16179504|NCT01024244|39135839|FG000|Overall Study|Entry Criteria Not Met|0|||
16179505|NCT01024244|39135840|FG001|Overall Study|Entry Criteria Not Met|1|||
16179506|NCT01024244|39135841|FG002|Overall Study|Entry Criteria Not Met|0|||
16179507|NCT01024244|39135842|FG003|Overall Study|Entry Criteria Not Met|0|||
16478316|NCT04154930|40231141|FG001|Overall Study|Other|0|||
16478317|NCT02486302|40231142|FG000|Overall Study|Discontinued prematurely|410|||
16478318|NCT02486302|40231142|FG000|Overall Study|Documentation not completed|255|||
16478319|NCT02486302|40231142|FG000|Overall Study|Excluded due to legal reasons|8|||
16478320|NCT02486302|40231142|FG000|Overall Study|Not treated|3|||
16478321|NCT00754065|40231143|FG000|Overall Study|Never received treatment|12|||
16478322|NCT00754065|40231144|FG001|Overall Study|Never received treatment|2|||
16478323|NCT00754065|40231143|FG000|Overall Study|Adverse Event|19|||
16478324|NCT00754065|40231144|FG001|Overall Study|Adverse Event|25|||
16478325|NCT00754065|40231143|FG000|Overall Study|Lost to Follow-up|7|||
16478326|NCT00754065|40231144|FG001|Overall Study|Lost to Follow-up|11|||
16478327|NCT00754065|40231143|FG000|Overall Study|Protocol Violation|12|||
16478328|NCT00754065|40231144|FG001|Overall Study|Protocol Violation|10|||
16478329|NCT00754065|40231143|FG000|Overall Study|Withdrawal by Subject|4|||
16478330|NCT00754065|40231144|FG001|Overall Study|Withdrawal by Subject|5|||
16478331|NCT00754065|40231143|FG000|Overall Study|Pregnancy|6|||
16478332|NCT00754065|40231144|FG001|Overall Study|Pregnancy|0|||
16478333|NCT00754065|40231143|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
16478334|NCT00754065|40231144|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
16478335|NCT02349542|40231145|FG000|Overall Study|Withdrawal by Subject|5|||
16478336|NCT04203797|40231151|FG000|Overall Study|Adverse Event|1|||
16478337|NCT04203797|40231152|FG001|Overall Study|Adverse Event|0|||
16478338|NCT04203797|40231151|FG000|Overall Study|Did not complete End of Study follow-up|1|||
16478339|NCT04203797|40231152|FG001|Overall Study|Did not complete End of Study follow-up|0|||
16478340|NCT01058655|40231154|FG000|Overall Study|Withdrawal by Subject|1|||
16478341|NCT01058655|40231155|FG001|Overall Study|Withdrawal by Subject|0|||
16478342|NCT01058655|40231156|FG002|Overall Study|Withdrawal by Subject|3|||
16478343|NCT01058655|40231157|FG003|Overall Study|Withdrawal by Subject|4|||
16478344|NCT01058655|40231154|FG000|Overall Study|Prolonged Treatment Delay|0|||
16478345|NCT01058655|40231155|FG001|Overall Study|Prolonged Treatment Delay|0|||
16478346|NCT01058655|40231156|FG002|Overall Study|Prolonged Treatment Delay|0|||
16478347|NCT01058655|40231157|FG003|Overall Study|Prolonged Treatment Delay|2|||
16478348|NCT01058655|40231154|FG000|Overall Study|Symptomatic Deterioration|0|||
16478349|NCT01058655|40231155|FG001|Overall Study|Symptomatic Deterioration|0|||
16478350|NCT01058655|40231156|FG002|Overall Study|Symptomatic Deterioration|0|||
16478351|NCT01058655|40231157|FG003|Overall Study|Symptomatic Deterioration|1|||
16478352|NCT01058655|40231154|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
16478353|NCT01058655|40231155|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
16478354|NCT01058655|40231156|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
16478355|NCT01058655|40231157|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
16478356|NCT01058655|40231154|FG000|Overall Study|Death|0|||
16478357|NCT01058655|40231155|FG001|Overall Study|Death|1|||
16478358|NCT01058655|40231156|FG002|Overall Study|Death|1|||
16478359|NCT01058655|40231157|FG003|Overall Study|Death|0|||
16478360|NCT01058655|40231154|FG000|Overall Study|Disease Progression|1|||
16478361|NCT01058655|40231155|FG001|Overall Study|Disease Progression|2|||
16478362|NCT01058655|40231156|FG002|Overall Study|Disease Progression|4|||
16478363|NCT01058655|40231157|FG003|Overall Study|Disease Progression|24|||
16478364|NCT01058655|40231154|FG000|Overall Study|Other|0|||
16478365|NCT01058655|40231155|FG001|Overall Study|Other|0|||
16478366|NCT01058655|40231156|FG002|Overall Study|Other|0|||
16478367|NCT01058655|40231157|FG003|Overall Study|Other|4|||
16478368|NCT00983437|40231163|FG000|Overall Study|Adverse Event|9|||
16179508|NCT01024244|39135843|FG004|Overall Study|Entry Criteria Not Met|0|||
16179509|NCT01024244|39135839|FG000|Overall Study|Lack of Efficacy|1|||
16179510|NCT01024244|39135840|FG001|Overall Study|Lack of Efficacy|0|||
16179511|NCT01024244|39135841|FG002|Overall Study|Lack of Efficacy|0|||
16179512|NCT01024244|39135842|FG003|Overall Study|Lack of Efficacy|0|||
16179513|NCT01024244|39135843|FG004|Overall Study|Lack of Efficacy|0|||
16179514|NCT01024244|39135839|FG000|Overall Study|Protocol Violation|1|||
16179515|NCT01024244|39135840|FG001|Overall Study|Protocol Violation|0|||
16478369|NCT00983437|40231163|FG000|Overall Study|Lack of Efficacy|1|||
16478370|NCT00983437|40231163|FG000|Overall Study|Withdrawal by Subject|8|||
16478371|NCT00983437|40231163|FG000|Overall Study|Noncompliance to Study Procedures|1|||
16478372|NCT00983437|40231163|FG000|Overall Study|Lost to Follow-up|2|||
16478373|NCT00983437|40231163|FG000|Overall Study|Other Reason|26|||
16478374|NCT04122534|40231173|FG000|Overall Study|Lost to Follow-up|4|||
16478375|NCT00968864|40231174|FG000|Overall Study|Protocol exception/ not evaluable|1|||
16179516|NCT01024244|39135841|FG002|Overall Study|Protocol Violation|0|||
16179517|NCT01024244|39135842|FG003|Overall Study|Protocol Violation|0|||
16179518|NCT01024244|39135843|FG004|Overall Study|Protocol Violation|2|||
16179519|NCT01024244|39135839|FG000|Overall Study|Sponsor Decision|14|||
16179520|NCT01024244|39135840|FG001|Overall Study|Sponsor Decision|7|||
16179521|NCT01024244|39135841|FG002|Overall Study|Sponsor Decision|14|||
16179522|NCT01024244|39135842|FG003|Overall Study|Sponsor Decision|12|||
16179523|NCT01024244|39135843|FG004|Overall Study|Sponsor Decision|10|||
16179524|NCT01024244|39135839|FG000|Overall Study|Withdrawal by Subject|0|||
16179525|NCT01024244|39135840|FG001|Overall Study|Withdrawal by Subject|1|||
16179526|NCT01024244|39135841|FG002|Overall Study|Withdrawal by Subject|0|||
16179527|NCT01024244|39135842|FG003|Overall Study|Withdrawal by Subject|0|||
16179528|NCT01024244|39135843|FG004|Overall Study|Withdrawal by Subject|0|||
16179529|NCT02795156|39135844|FG000|Overall Study|Progressive Disease|22|||
16179530|NCT02795156|39135845|FG001|Overall Study|Progressive Disease|7|||
16179531|NCT02795156|39135846|FG002|Overall Study|Progressive Disease|34|||
16179532|NCT02795156|39135847|FG003|Overall Study|Progressive Disease|7|||
16179533|NCT02795156|39135844|FG000|Overall Study|Adverse Event|13|||
16179534|NCT02795156|39135845|FG001|Overall Study|Adverse Event|2|||
16179535|NCT02795156|39135846|FG002|Overall Study|Adverse Event|3|||
16179536|NCT02795156|39135847|FG003|Overall Study|Adverse Event|2|||
16179537|NCT02795156|39135844|FG000|Overall Study|Death|1|||
16179538|NCT02795156|39135845|FG001|Overall Study|Death|1|||
16179539|NCT02795156|39135846|FG002|Overall Study|Death|1|||
16179540|NCT02795156|39135847|FG003|Overall Study|Death|0|||
16179541|NCT02795156|39135844|FG000|Overall Study|Physician Decision|1|||
16179542|NCT02795156|39135845|FG001|Overall Study|Physician Decision|0|||
16179543|NCT02795156|39135846|FG002|Overall Study|Physician Decision|1|||
16179544|NCT02795156|39135847|FG003|Overall Study|Physician Decision|0|||
16179545|NCT02795156|39135844|FG000|Overall Study|Withdrawal by Subject|2|||
16179546|NCT02795156|39135845|FG001|Overall Study|Withdrawal by Subject|0|||
16179547|NCT02795156|39135846|FG002|Overall Study|Withdrawal by Subject|3|||
16179548|NCT02795156|39135847|FG003|Overall Study|Withdrawal by Subject|0|||
16179549|NCT04172831|39135848|FG000|Overall Study|Adverse Event|21|||
16179550|NCT04172831|39135849|FG001|Overall Study|Adverse Event|9|||
16179551|NCT04172831|39135848|FG000|Overall Study|Lack of Efficacy|2|||
16179552|NCT04172831|39135849|FG001|Overall Study|Lack of Efficacy|8|||
16179553|NCT04172831|39135848|FG000|Overall Study|Physician Decision|0|||
16179554|NCT04172831|39135849|FG001|Overall Study|Physician Decision|1|||
16179555|NCT04172831|39135848|FG000|Overall Study|Withdrawal by Subject|12|||
16478376|NCT01145625|40231175|FG000|Overall Study|Lost to Follow-up|8|||
16478377|NCT01145625|40231176|FG001|Overall Study|Lost to Follow-up|9|||
16478378|NCT01145625|40231175|FG000|Overall Study|Adverse Event|6|||
16478379|NCT01145625|40231176|FG001|Overall Study|Adverse Event|4|||
16478380|NCT01145625|40231175|FG000|Overall Study|Protocol Violation|3|||
16478381|NCT01145625|40231176|FG001|Overall Study|Protocol Violation|1|||
16179556|NCT04172831|39135849|FG001|Overall Study|Withdrawal by Subject|11|||
16179557|NCT04172831|39135848|FG000|Overall Study|Lost to Follow-up|4|||
16179558|NCT04172831|39135849|FG001|Overall Study|Lost to Follow-up|9|||
16179559|NCT04172831|39135848|FG000|Overall Study|COVID-19 related crisis|3|||
16179560|NCT04172831|39135849|FG001|Overall Study|COVID-19 related crisis|3|||
16179561|NCT04172831|39135848|FG000|Overall Study|Subject non-compliance|1|||
16179562|NCT04172831|39135849|FG001|Overall Study|Subject non-compliance|1|||
16179563|NCT04172831|39135848|FG000|Overall Study|Family emergency|1|||
16179564|NCT04172831|39135849|FG001|Overall Study|Family emergency|0|||
16179565|NCT02082184|39135856|FG000|Overall Study|Adverse Event|1|||
16179566|NCT02082184|39135857|FG001|Overall Study|Adverse Event|0|||
16179567|NCT02082184|39135856|FG000|Overall Study|Medical diagnosis|1|||
16179568|NCT02082184|39135857|FG001|Overall Study|Medical diagnosis|2|||
16179569|NCT02082184|39135856|FG000|Overall Study|Device associated symptoms|5|||
16478382|NCT01145625|40231175|FG000|Overall Study|Withdrawal by Subject|7|||
16478383|NCT01145625|40231176|FG001|Overall Study|Withdrawal by Subject|16|||
16478384|NCT01145625|40231175|FG000|Overall Study|Pregnancy|0|||
16478385|NCT01145625|40231176|FG001|Overall Study|Pregnancy|1|||
16478386|NCT01426438|40231177|FG000|Overall Study|Lost to Follow-up|1|||
16478387|NCT01426438|40231178|FG001|Overall Study|Lost to Follow-up|3|||
16179570|NCT02082184|39135857|FG001|Overall Study|Device associated symptoms|0|||
16179571|NCT02082184|39135856|FG000|Overall Study|Withdrawal by Subject|3|||
16179572|NCT02082184|39135857|FG001|Overall Study|Withdrawal by Subject|2|||
16179573|NCT02082184|39135856|FG000|Overall Study|Protocol Violation|0|||
16179574|NCT02082184|39135857|FG001|Overall Study|Protocol Violation|6|||
16179575|NCT02082184|39135856|FG000|Overall Study|Lost to Follow-up|0|||
16179576|NCT02082184|39135857|FG001|Overall Study|Lost to Follow-up|2|||
16179577|NCT02082184|39135856|FG000|Overall Study|Subject non-compliance|0|||
16179578|NCT02082184|39135857|FG001|Overall Study|Subject non-compliance|1|||
16279030|NCT02578641|39504209|FG000|Overall Study|Progressive Disease|69|||
16478388|NCT01426438|40231177|FG000|Overall Study|Off study Treatment|9|||
16478389|NCT01426438|40231178|FG001|Overall Study|Off study Treatment|3|||
16179579|NCT02515669|39135858|FG000|228 Week Open-Label Phase|Other|0|||
16179580|NCT02515669|39135859|FG001|228 Week Open-Label Phase|Other|0|||
16478390|NCT01426438|40231177|FG000|Overall Study|Poor scan quality|3|||
16478391|NCT01426438|40231178|FG001|Overall Study|Poor scan quality|2|||
16478392|NCT01426438|40231177|FG000|Overall Study|Missed Scan|2|||
16478393|NCT01426438|40231178|FG001|Overall Study|Missed Scan|2|||
16478394|NCT00579098|40231179|FG000|Overall Study|Lost to Follow-up|2|||
16478395|NCT00579098|40231180|FG001|Overall Study|Lost to Follow-up|0|||
16478396|NCT00579098|40231179|FG000|Overall Study|Adverse Event|2|||
16478397|NCT00579098|40231180|FG001|Overall Study|Adverse Event|3|||
16478398|NCT00579098|40231179|FG000|Overall Study|Withdrawal by Subject|2|||
16478399|NCT00579098|40231180|FG001|Overall Study|Withdrawal by Subject|3|||
16478400|NCT00579098|40231179|FG000|Overall Study|AF returned after ablation|3|||
16478401|NCT00579098|40231180|FG001|Overall Study|AF returned after ablation|2|||
16478402|NCT02106975|40231181|FG000|Overall Study|Death|25|||
16478403|NCT02106975|40231182|FG001|Overall Study|Death|39|||
16478404|NCT01436396|40231187|FG000|Overall Study|Protocol Violation|7|||
16478405|NCT01436396|40231188|FG001|Overall Study|Protocol Violation|5|||
16478406|NCT01436396|40231187|FG000|Overall Study|Adverse Event|1|||
16478407|NCT01436396|40231188|FG001|Overall Study|Adverse Event|2|||
16478408|NCT01436396|40231187|FG000|Overall Study|Withdrawal by Subject|19|||
16179581|NCT02515669|39135860|FG002|228 Week Open-Label Phase|Other|1|||
16179582|NCT02515669|39135861|FG003|228 Week Open-Label Phase|Other|4|||
16179583|NCT02515669|39135858|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
16179584|NCT02515669|39135859|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
16179585|NCT02515669|39135860|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
16179586|NCT02515669|39135861|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
16179587|NCT02515669|39135858|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
16179588|NCT02515669|39135859|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
16179589|NCT02515669|39135860|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
16179590|NCT02515669|39135861|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
16179591|NCT02515669|39135858|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
16179592|NCT02515669|39135859|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
16179593|NCT02515669|39135860|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
16179594|NCT02515669|39135861|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
16179595|NCT02515669|39135858|FG000|228 Week Open-Label Phase|Missing|0|||
16179596|NCT02515669|39135859|FG001|228 Week Open-Label Phase|Missing|2|||
16179597|NCT02515669|39135860|FG002|228 Week Open-Label Phase|Missing|2|||
16179598|NCT02515669|39135861|FG003|228 Week Open-Label Phase|Missing|2|||
16179599|NCT00514449|39135868|FG000|Overall Study|Withdrawal by Subject|1|||
16179600|NCT00514449|39135869|FG001|Overall Study|Withdrawal by Subject|2|||
16179601|NCT00514449|39135868|FG000|Overall Study|Protocol Violation|1|||
16179602|NCT00514449|39135869|FG001|Overall Study|Protocol Violation|2|||
16179603|NCT00514449|39135868|FG000|Overall Study|Lost to Follow-up|1|||
16179604|NCT00514449|39135869|FG001|Overall Study|Lost to Follow-up|0|||
16179605|NCT00630032|39135871|FG000|Overall Study|Death|55|||
16179606|NCT00630032|39135872|FG001|Overall Study|Death|49|||
16179607|NCT00630032|39135871|FG000|Overall Study|Withdrawal by Subject|3|||
16179608|NCT00630032|39135872|FG001|Overall Study|Withdrawal by Subject|2|||
16179609|NCT00630032|39135871|FG000|Overall Study|Lost to Follow-up|18|||
16179610|NCT00630032|39135872|FG001|Overall Study|Lost to Follow-up|31|||
16179611|NCT00630032|39135871|FG000|Overall Study|Protocol Violation|1|||
16179612|NCT00630032|39135872|FG001|Overall Study|Protocol Violation|0|||
16179613|NCT00630032|39135871|FG000|Overall Study|Patient has moved|1|||
16179614|NCT00630032|39135872|FG001|Overall Study|Patient has moved|1|||
16179615|NCT00630032|39135871|FG000|Overall Study|Disease progression|1|||
16179616|NCT00630032|39135872|FG001|Overall Study|Disease progression|1|||
16179617|NCT00630032|39135871|FG000|Overall Study|End of monitoring in US centers|11|||
16179618|NCT00630032|39135872|FG001|Overall Study|End of monitoring in US centers|11|||
16179619|NCT02190591|39135875|FG000|Overall Study|Withdrawal by Subject|1|||
16179620|NCT02190591|39135876|FG001|Overall Study|Withdrawal by Subject|8|||
16179621|NCT02190591|39135875|FG000|Overall Study|Protocol Violation|1|||
16179622|NCT02190591|39135876|FG001|Overall Study|Protocol Violation|0|||
16179623|NCT02190591|39135875|FG000|Overall Study|did not use peanut ball as instructed|0|||
16179624|NCT02190591|39135876|FG001|Overall Study|did not use peanut ball as instructed|2|||
16179625|NCT02190591|39135875|FG000|Overall Study|face presentation so she was ineligible|0|||
16478409|NCT01436396|40231188|FG001|Overall Study|Withdrawal by Subject|29|||
16478410|NCT01436396|40231187|FG000|Overall Study|Serious adverse event|2|||
16478411|NCT01436396|40231188|FG001|Overall Study|Serious adverse event|3|||
16179626|NCT02190591|39135876|FG001|Overall Study|face presentation so she was ineligible|1|||
16179627|NCT01899144|39135879|FG000|Treatment Period 2|Other|1|||
16179628|NCT01899144|39135879|FG000|Treatment Period 3|Other|2|||
16179629|NCT01899144|39135879|FG000|Treatment Period 5|Other|1|||
16179630|NCT02124798|39135880|FG000|Overall Study|Adverse Event|3|||
16179631|NCT02124798|39135880|FG000|Overall Study|Lost to Follow-up|1|||
16478412|NCT01436396|40231187|FG000|Overall Study|Lost to Follow-up|3|||
16179632|NCT03461289|39135881|FG000|Overall Study|Death|1|||
16179633|NCT00479466|39135882|FG000|Overall Study|Adverse Event|5|||
16179634|NCT00479466|39135883|FG001|Overall Study|Adverse Event|1|||
16179635|NCT00479466|39135884|FG002|Overall Study|Adverse Event|0|||
16179636|NCT00479466|39135885|FG003|Overall Study|Adverse Event|1|||
16179637|NCT00479466|39135886|FG004|Overall Study|Adverse Event|2|||
16179638|NCT00479466|39135887|FG005|Overall Study|Adverse Event|0|||
16179639|NCT00479466|39135882|FG000|Overall Study|Hyperglycemia|0|||
16179640|NCT00479466|39135883|FG001|Overall Study|Hyperglycemia|0|||
16179641|NCT00479466|39135884|FG002|Overall Study|Hyperglycemia|0|||
16179642|NCT00479466|39135885|FG003|Overall Study|Hyperglycemia|0|||
16179643|NCT00479466|39135886|FG004|Overall Study|Hyperglycemia|0|||
16179644|NCT00479466|39135887|FG005|Overall Study|Hyperglycemia|1|||
16179645|NCT00479466|39135882|FG000|Overall Study|Lack of Efficacy|2|||
16179646|NCT00479466|39135883|FG001|Overall Study|Lack of Efficacy|0|||
16179647|NCT00479466|39135884|FG002|Overall Study|Lack of Efficacy|1|||
16179648|NCT00479466|39135885|FG003|Overall Study|Lack of Efficacy|0|||
16179649|NCT00479466|39135886|FG004|Overall Study|Lack of Efficacy|0|||
16179650|NCT00479466|39135887|FG005|Overall Study|Lack of Efficacy|0|||
16179651|NCT00479466|39135882|FG000|Overall Study|Lost to Follow-up|0|||
16179652|NCT00479466|39135883|FG001|Overall Study|Lost to Follow-up|1|||
16179653|NCT00479466|39135884|FG002|Overall Study|Lost to Follow-up|1|||
16179654|NCT00479466|39135885|FG003|Overall Study|Lost to Follow-up|0|||
16179655|NCT00479466|39135886|FG004|Overall Study|Lost to Follow-up|2|||
16179656|NCT00479466|39135887|FG005|Overall Study|Lost to Follow-up|2|||
16179657|NCT00479466|39135882|FG000|Overall Study|Physician Decision|2|||
16179658|NCT00479466|39135883|FG001|Overall Study|Physician Decision|1|||
16179659|NCT00479466|39135884|FG002|Overall Study|Physician Decision|1|||
16179660|NCT00479466|39135885|FG003|Overall Study|Physician Decision|0|||
16179661|NCT00479466|39135886|FG004|Overall Study|Physician Decision|0|||
16179662|NCT00479466|39135887|FG005|Overall Study|Physician Decision|0|||
16478413|NCT01436396|40231188|FG001|Overall Study|Lost to Follow-up|3|||
16478414|NCT00257608|40231189|FG000|Chemotherapy Phase|Adverse Event|138|||
16478415|NCT00257608|40231190|FG001|Chemotherapy Phase|Adverse Event|0|||
16478416|NCT00257608|40231191|FG002|Chemotherapy Phase|Adverse Event|0|||
16478417|NCT00257608|40231189|FG000|Chemotherapy Phase|Disease progression|139|||
16478418|NCT00257608|40231190|FG001|Chemotherapy Phase|Disease progression|0|||
16478419|NCT00257608|40231191|FG002|Chemotherapy Phase|Disease progression|0|||
16478420|NCT00257608|40231189|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
16478421|NCT00257608|40231190|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
16478422|NCT00257608|40231191|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
16478423|NCT00257608|40231189|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
16478424|NCT00257608|40231190|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
16478425|NCT00257608|40231191|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
16478426|NCT00257608|40231189|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
16478427|NCT00257608|40231190|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
16478428|NCT00257608|40231191|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
16478429|NCT00257608|40231189|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
16179663|NCT00479466|39135882|FG000|Overall Study|Pregnancy|0|||
16179664|NCT00479466|39135883|FG001|Overall Study|Pregnancy|0|||
16179665|NCT00479466|39135884|FG002|Overall Study|Pregnancy|0|||
16179666|NCT00479466|39135885|FG003|Overall Study|Pregnancy|0|||
16179667|NCT00479466|39135886|FG004|Overall Study|Pregnancy|1|||
16179668|NCT00479466|39135887|FG005|Overall Study|Pregnancy|0|||
16179669|NCT00479466|39135882|FG000|Overall Study|Protocol Violation|1|||
16179670|NCT00479466|39135883|FG001|Overall Study|Protocol Violation|0|||
16179671|NCT00479466|39135884|FG002|Overall Study|Protocol Violation|0|||
16179672|NCT00479466|39135885|FG003|Overall Study|Protocol Violation|0|||
16179673|NCT00479466|39135886|FG004|Overall Study|Protocol Violation|0|||
16179674|NCT00479466|39135887|FG005|Overall Study|Protocol Violation|0|||
16179675|NCT00479466|39135882|FG000|Overall Study|Withdrawal by Subject|3|||
16478430|NCT00257608|40231190|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
16478431|NCT00257608|40231191|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
16179676|NCT00479466|39135883|FG001|Overall Study|Withdrawal by Subject|5|||
16179677|NCT00479466|39135884|FG002|Overall Study|Withdrawal by Subject|0|||
16179678|NCT00479466|39135885|FG003|Overall Study|Withdrawal by Subject|2|||
16179679|NCT00479466|39135886|FG004|Overall Study|Withdrawal by Subject|3|||
16179680|NCT00479466|39135887|FG005|Overall Study|Withdrawal by Subject|1|||
16179681|NCT03815175|39135888|FG000|Overall Study|Subject Lost to Follow-up|6|||
16179682|NCT03815175|39135888|FG000|Overall Study|Subject Withdrew Consent|48|||
16179683|NCT03815175|39135888|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
16179684|NCT03815175|39135888|FG000|Overall Study|Death|86|||
16179685|NCT03815175|39135888|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
16179686|NCT03815175|39135888|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
16179687|NCT03815175|39135888|FG000|Overall Study|Other Status Change Reason|1|||
16179688|NCT03815175|39135888|FG000|Overall Study|Missed Visit|12|||
16179689|NCT04651777|39135899|FG000|Overall Study|Adverse Event|1|||
16179690|NCT04651777|39135899|FG000|Overall Study|Withdrawal by Subject|2|||
16179691|NCT00907738|39135902|FG000|Overall Study|Adverse Event|2|||
16179692|NCT00907738|39135903|FG001|Overall Study|Adverse Event|0|||
16478432|NCT00257608|40231189|FG000|Chemotherapy Phase|Physician Decision|28|||
16478433|NCT00257608|40231190|FG001|Chemotherapy Phase|Physician Decision|0|||
16478434|NCT00257608|40231191|FG002|Chemotherapy Phase|Physician Decision|0|||
16478435|NCT00257608|40231189|FG000|Post Chemotherapy Phase|Adverse Event|0|||
16478436|NCT00257608|40231190|FG001|Post Chemotherapy Phase|Adverse Event|34|||
16478437|NCT00257608|40231191|FG002|Post Chemotherapy Phase|Adverse Event|38|||
16478438|NCT00257608|40231189|FG000|Post Chemotherapy Phase|Disease progression|0|||
16478439|NCT00257608|40231190|FG001|Post Chemotherapy Phase|Disease progression|204|||
16478440|NCT00257608|40231191|FG002|Post Chemotherapy Phase|Disease progression|168|||
16478441|NCT00257608|40231189|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
16478442|NCT00257608|40231190|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
16179693|NCT00907738|39135904|FG002|Overall Study|Adverse Event|1|||
16179694|NCT00907738|39135905|FG003|Overall Study|Adverse Event|0|||
16179695|NCT00907738|39135906|FG004|Overall Study|Adverse Event|0|||
16179696|NCT00907738|39135902|FG000|Overall Study|not specified or withdrew consent|3|||
16478443|NCT00257608|40231191|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
16478444|NCT00257608|40231189|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
16478445|NCT00257608|40231190|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
16478446|NCT00257608|40231191|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
16478447|NCT00257608|40231189|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
16478448|NCT00257608|40231190|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
16478449|NCT00257608|40231191|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
16478450|NCT00257608|40231189|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
16478451|NCT00257608|40231190|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
16478452|NCT00257608|40231191|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
16478453|NCT00257608|40231189|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
16478454|NCT00257608|40231190|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
16478455|NCT00257608|40231191|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
16478456|NCT00257608|40231189|FG000|Post Chemotherapy Phase|Physician Decision|0|||
16478457|NCT00257608|40231190|FG001|Post Chemotherapy Phase|Physician Decision|8|||
16478458|NCT00257608|40231191|FG002|Post Chemotherapy Phase|Physician Decision|11|||
16179697|NCT00907738|39135903|FG001|Overall Study|not specified or withdrew consent|0|||
16179698|NCT00907738|39135904|FG002|Overall Study|not specified or withdrew consent|0|||
16179699|NCT00907738|39135905|FG003|Overall Study|not specified or withdrew consent|0|||
16179700|NCT00907738|39135906|FG004|Overall Study|not specified or withdrew consent|0|||
16179701|NCT00907738|39135902|FG000|Overall Study|Disease progression|8|||
16179702|NCT00907738|39135903|FG001|Overall Study|Disease progression|1|||
16179703|NCT00907738|39135904|FG002|Overall Study|Disease progression|6|||
16179704|NCT00907738|39135905|FG003|Overall Study|Disease progression|4|||
16179705|NCT00907738|39135906|FG004|Overall Study|Disease progression|2|||
16179706|NCT00624338|39135907|FG000|Overall Study|Adverse Event|14|||
16179707|NCT00624338|39135908|FG001|Overall Study|Adverse Event|14|||
16179708|NCT00624338|39135909|FG002|Overall Study|Adverse Event|18|||
16179709|NCT00624338|39135907|FG000|Overall Study|Lost to Follow-up|1|||
16179710|NCT00624338|39135908|FG001|Overall Study|Lost to Follow-up|0|||
16179711|NCT00624338|39135909|FG002|Overall Study|Lost to Follow-up|0|||
16179712|NCT00624338|39135907|FG000|Overall Study|Lack of Efficacy|11|||
16179713|NCT00624338|39135908|FG001|Overall Study|Lack of Efficacy|3|||
16179714|NCT00624338|39135909|FG002|Overall Study|Lack of Efficacy|14|||
16179715|NCT00624338|39135907|FG000|Overall Study|Protocol Violation|3|||
16179716|NCT00624338|39135908|FG001|Overall Study|Protocol Violation|3|||
16179717|NCT00624338|39135909|FG002|Overall Study|Protocol Violation|2|||
16179718|NCT00624338|39135907|FG000|Overall Study|Death|0|||
16179719|NCT00624338|39135908|FG001|Overall Study|Death|2|||
16179720|NCT00624338|39135909|FG002|Overall Study|Death|0|||
16478459|NCT00257608|40231189|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
16179721|NCT00624338|39135907|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
16179722|NCT00624338|39135908|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
16179723|NCT00624338|39135909|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
16179724|NCT00624338|39135907|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
16179725|NCT00624338|39135908|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
16179726|NCT00624338|39135909|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
16179727|NCT00624338|39135907|FG000|Overall Study|Other|15|||
16179728|NCT00624338|39135908|FG001|Overall Study|Other|5|||
16179729|NCT00624338|39135909|FG002|Overall Study|Other|9|||
16179730|NCT00624338|39135907|FG000|Overall Study|Randomized but not treated|2|||
16179731|NCT00624338|39135908|FG001|Overall Study|Randomized but not treated|1|||
16279031|NCT02578641|39504210|FG001|Overall Study|Progressive Disease|21|||
16478460|NCT00257608|40231190|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
16478461|NCT00257608|40231191|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
16478462|NCT00257608|40231189|FG000|Post Chemotherapy Phase|Not treated|0|||
16478463|NCT00257608|40231190|FG001|Post Chemotherapy Phase|Not treated|4|||
16478464|NCT00257608|40231191|FG002|Post Chemotherapy Phase|Not treated|7|||
16478465|NCT03685123|40231195|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
16478466|NCT03685123|40231196|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
16478467|NCT03685123|40231197|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
16478468|NCT03685123|40231195|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
16478469|NCT03685123|40231196|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
16478470|NCT03685123|40231197|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
16478471|NCT03685123|40231195|FG000|Weight Loss Phase|Lost to Follow-up|1|||
16478472|NCT03685123|40231196|FG001|Weight Loss Phase|Lost to Follow-up|0|||
16478473|NCT03685123|40231197|FG002|Weight Loss Phase|Lost to Follow-up|0|||
16478474|NCT03685123|40231195|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
16478475|NCT03685123|40231196|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
16478476|NCT03685123|40231197|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
16478477|NCT03685123|40231195|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
16478478|NCT03685123|40231196|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
16478479|NCT03685123|40231197|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
16478480|NCT03685123|40231195|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
16478481|NCT03685123|40231196|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
16478482|NCT03685123|40231197|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
16478483|NCT00516074|40231198|FG000|Overall Study|Adverse Event|0|||
16478484|NCT00516074|40231199|FG001|Overall Study|Adverse Event|1|||
16478485|NCT00516074|40231198|FG000|Overall Study|Subject Decision|4|||
16478486|NCT00516074|40231199|FG001|Overall Study|Subject Decision|2|||
16478487|NCT00516074|40231198|FG000|Overall Study|Loss of Glucose Control|2|||
16478488|NCT00516074|40231199|FG001|Overall Study|Loss of Glucose Control|0|||
16478489|NCT00892047|40231200|FG000|Overall Study|Adverse Event|2|||
16478490|NCT00892047|40231201|FG001|Overall Study|Adverse Event|2|||
16478491|NCT00892047|40231200|FG000|Overall Study|subject burden|2|||
16478492|NCT00892047|40231201|FG001|Overall Study|subject burden|3|||
16478493|NCT00892047|40231200|FG000|Overall Study|Lack of Efficacy|0|||
16478494|NCT00892047|40231201|FG001|Overall Study|Lack of Efficacy|2|||
16478495|NCT04696055|40231202|FG000|Overall Study|Adverse Event|10|||
16080096|NCT01872078|38786758|FG002|Overall Study|Withdrawal by Subject|1|||
16080097|NCT01872078|38786759|FG003|Overall Study|Withdrawal by Subject|0|||
16080098|NCT01872078|38786756|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
16080099|NCT01872078|38786757|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
16080100|NCT01872078|38786758|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
16080101|NCT01872078|38786759|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
16080102|NCT02214160|38786762|FG000|Overall Study|Withdrawal by Subject|1|||
16080103|NCT02214160|38786763|FG001|Overall Study|Withdrawal by Subject|0|||
16080104|NCT02214160|38786764|FG002|Overall Study|Withdrawal by Subject|6|||
16080105|NCT02214160|38786762|FG000|Overall Study|Death|2|||
16080106|NCT02214160|38786763|FG001|Overall Study|Death|2|||
16080107|NCT02214160|38786764|FG002|Overall Study|Death|1|||
16080108|NCT02214160|38786762|FG000|Overall Study|Subject Non-Compliance|0|||
16080109|NCT02214160|38786763|FG001|Overall Study|Subject Non-Compliance|3|||
16080110|NCT02214160|38786764|FG002|Overall Study|Subject Non-Compliance|1|||
16080111|NCT02214160|38786762|FG000|Overall Study|Adverse Event|0|||
16080112|NCT02214160|38786763|FG001|Overall Study|Adverse Event|1|||
16080113|NCT02214160|38786764|FG002|Overall Study|Adverse Event|1|||
16080114|NCT02214160|38786762|FG000|Overall Study|Sponsor Decision|0|||
16080115|NCT02214160|38786763|FG001|Overall Study|Sponsor Decision|2|||
16080116|NCT02214160|38786764|FG002|Overall Study|Sponsor Decision|0|||
16080117|NCT02214160|38786762|FG000|Overall Study|Protocol Violation|1|||
16080118|NCT02214160|38786763|FG001|Overall Study|Protocol Violation|0|||
16080119|NCT02214160|38786764|FG002|Overall Study|Protocol Violation|0|||
16080120|NCT02214160|38786762|FG000|Overall Study|Physician Decision|0|||
16080121|NCT02214160|38786763|FG001|Overall Study|Physician Decision|0|||
16080122|NCT02214160|38786764|FG002|Overall Study|Physician Decision|1|||
16080123|NCT00304031|38786765|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
16080124|NCT00304031|38786766|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
16080125|NCT00304031|38786767|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
16080126|NCT00304031|38786765|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
16080127|NCT00304031|38786766|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
16080128|NCT00304031|38786767|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
16279032|NCT02578641|39504209|FG000|Overall Study|No Study Drug|2|||
16478496|NCT04696055|40231203|FG001|Overall Study|Adverse Event|0|||
16478497|NCT04696055|40231202|FG000|Overall Study|Death|2|||
16478498|NCT04696055|40231203|FG001|Overall Study|Death|1|||
16478499|NCT04696055|40231202|FG000|Overall Study|Other|4|||
16478500|NCT04696055|40231203|FG001|Overall Study|Other|0|||
16478501|NCT04696055|40231202|FG000|Overall Study|Physician Decision|1|||
16478502|NCT04696055|40231203|FG001|Overall Study|Physician Decision|0|||
16478503|NCT04696055|40231202|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
16478504|NCT04696055|40231203|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
16478505|NCT04696055|40231202|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
16478506|NCT04696055|40231203|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
16478507|NCT04696055|40231202|FG000|Overall Study|Subject Decision|1|||
16478508|NCT04696055|40231203|FG001|Overall Study|Subject Decision|2|||
16478509|NCT04696055|40231202|FG000|Overall Study|Ongoing with study treatment|13|||
16478510|NCT04696055|40231203|FG001|Overall Study|Ongoing with study treatment|10|||
16478511|NCT01788046|40231204|FG000|Overall Study|Withdrawal by Subject|12|||
16478512|NCT01788046|40231205|FG001|Overall Study|Withdrawal by Subject|12|||
16478513|NCT01788046|40231204|FG000|Overall Study|Lost to Follow-up|12|||
16478514|NCT01788046|40231205|FG001|Overall Study|Lost to Follow-up|19|||
16478515|NCT01788046|40231204|FG000|Overall Study|Death|7|||
16478516|NCT01788046|40231205|FG001|Overall Study|Death|5|||
16478517|NCT01788046|40231204|FG000|Overall Study|Protocol Specified Criteria|25|||
16478518|NCT01788046|40231205|FG001|Overall Study|Protocol Specified Criteria|1|||
16478519|NCT05350410|40231206|FG000|Overall Study|Withdrawal by Subject|1|||
16478520|NCT01914757|40231207|FG000|Overall Study|Severe non-compliance to protocol|3|||
16478521|NCT01914757|40231208|FG001|Overall Study|Severe non-compliance to protocol|1|||
16478522|NCT01914757|40231209|FG002|Overall Study|Severe non-compliance to protocol|2|||
16478523|NCT01914757|40231207|FG000|Overall Study|Lost to Follow-up|5|||
16478524|NCT01914757|40231208|FG001|Overall Study|Lost to Follow-up|8|||
16478525|NCT01914757|40231209|FG002|Overall Study|Lost to Follow-up|6|||
16478526|NCT01914757|40231207|FG000|Overall Study|Withdrawal by Subject|15|||
16478527|NCT01914757|40231208|FG001|Overall Study|Withdrawal by Subject|27|||
16478528|NCT01914757|40231209|FG002|Overall Study|Withdrawal by Subject|19|||
16478529|NCT01914757|40231207|FG000|Overall Study|Death|2|||
16478530|NCT01914757|40231208|FG001|Overall Study|Death|2|||
16478531|NCT01914757|40231209|FG002|Overall Study|Death|1|||
16478532|NCT01914757|40231207|FG000|Overall Study|Adverse Event|4|||
16478533|NCT01914757|40231208|FG001|Overall Study|Adverse Event|3|||
16478534|NCT01914757|40231209|FG002|Overall Study|Adverse Event|4|||
16478535|NCT01914757|40231207|FG000|Overall Study|Study specific withdrawal criteria|0|||
16478536|NCT01914757|40231208|FG001|Overall Study|Study specific withdrawal criteria|1|||
16478537|NCT01914757|40231209|FG002|Overall Study|Study specific withdrawal criteria|0|||
16478538|NCT01914757|40231207|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16478539|NCT01914757|40231208|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16478540|NCT01914757|40231209|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
16478541|NCT01914757|40231207|FG000|Overall Study|Other reasons|5|||
16179732|NCT00624338|39135909|FG002|Overall Study|Randomized but not treated|3|||
16179733|NCT03976401|39135921|FG000|Overall Study|Adverse Event|2|||
16179734|NCT03976401|39135922|FG001|Overall Study|Adverse Event|0|||
16179735|NCT03976401|39135923|FG002|Overall Study|Adverse Event|4|||
16179736|NCT03976401|39135924|FG003|Overall Study|Adverse Event|1|||
16179737|NCT03976401|39135925|FG004|Overall Study|Adverse Event|1|||
16179738|NCT03976401|39135926|FG005|Overall Study|Adverse Event|0|||
16179739|NCT03976401|39135921|FG000|Overall Study|Withdrawal by Subject|0|||
16179740|NCT03976401|39135922|FG001|Overall Study|Withdrawal by Subject|1|||
16179741|NCT03976401|39135923|FG002|Overall Study|Withdrawal by Subject|0|||
16179742|NCT03976401|39135924|FG003|Overall Study|Withdrawal by Subject|0|||
16179743|NCT03976401|39135925|FG004|Overall Study|Withdrawal by Subject|0|||
16179744|NCT03976401|39135926|FG005|Overall Study|Withdrawal by Subject|1|||
16179745|NCT03976401|39135921|FG000|Overall Study|Physician Decision|0|||
16179746|NCT03976401|39135922|FG001|Overall Study|Physician Decision|0|||
16179747|NCT03976401|39135923|FG002|Overall Study|Physician Decision|1|||
16179748|NCT03976401|39135924|FG003|Overall Study|Physician Decision|0|||
16179749|NCT03976401|39135925|FG004|Overall Study|Physician Decision|0|||
16179750|NCT03976401|39135926|FG005|Overall Study|Physician Decision|0|||
16179751|NCT03976401|39135921|FG000|Overall Study|Lost to Follow-up|1|||
16179752|NCT03976401|39135922|FG001|Overall Study|Lost to Follow-up|2|||
16179753|NCT03976401|39135923|FG002|Overall Study|Lost to Follow-up|0|||
16179754|NCT03976401|39135924|FG003|Overall Study|Lost to Follow-up|0|||
16478542|NCT01914757|40231208|FG001|Overall Study|Other reasons|9|||
16478543|NCT01914757|40231209|FG002|Overall Study|Other reasons|4|||
16478544|NCT01268150|40234178|FG000|Treatment Phase|Progression of disease|18|||
16179755|NCT03976401|39135925|FG004|Overall Study|Lost to Follow-up|0|||
16179756|NCT03976401|39135926|FG005|Overall Study|Lost to Follow-up|0|||
16179757|NCT03976401|39135921|FG000|Overall Study|Protocol Violation|0|||
16179758|NCT03976401|39135922|FG001|Overall Study|Protocol Violation|1|||
16179759|NCT03976401|39135923|FG002|Overall Study|Protocol Violation|0|||
16179760|NCT03976401|39135924|FG003|Overall Study|Protocol Violation|0|||
16478545|NCT01268150|40234178|FG000|Treatment Phase|Adverse Event|3|||
16179761|NCT03976401|39135925|FG004|Overall Study|Protocol Violation|0|||
16179762|NCT03976401|39135926|FG005|Overall Study|Protocol Violation|0|||
16179763|NCT03976401|39135921|FG000|Overall Study|Withdrew Consent|0|||
16179764|NCT03976401|39135922|FG001|Overall Study|Withdrew Consent|0|||
16179765|NCT03976401|39135923|FG002|Overall Study|Withdrew Consent|0|||
16179766|NCT03976401|39135924|FG003|Overall Study|Withdrew Consent|1|||
16179767|NCT03976401|39135925|FG004|Overall Study|Withdrew Consent|0|||
16179768|NCT03976401|39135926|FG005|Overall Study|Withdrew Consent|0|||
16179769|NCT00545818|39135927|FG000|Overall Study|Protocol Violation|1|||
16179770|NCT00545818|39135928|FG001|Overall Study|Protocol Violation|0|||
16179771|NCT00545818|39135927|FG000|Overall Study|Adverse Event|1|||
16179772|NCT00545818|39135928|FG001|Overall Study|Adverse Event|1|||
16179773|NCT00545818|39135927|FG000|Overall Study|Lost to Follow-up|1|||
16179774|NCT00545818|39135928|FG001|Overall Study|Lost to Follow-up|6|||
16179775|NCT00201851|39135929|FG000|Overall Study|Lost to Follow-up|2|||
16478546|NCT01268150|40234178|FG000|Treatment Phase|Withdrawal by Subject|3|||
16478547|NCT01268150|40234178|FG000|Treatment Phase|Other|4|||
16478548|NCT01268150|40234178|FG000|Extension Phase|Adverse Event|3|||
16478549|NCT01268150|40234178|FG000|Extension Phase|Disease progression|18|||
16478550|NCT01268150|40234178|FG000|Extension Phase|Other|6|||
16478551|NCT00957580|40234180|FG000|Overall Study|Ongoing at data cut-off|0|||
16478552|NCT00957580|40234181|FG001|Overall Study|Ongoing at data cut-off|1|||
16478553|NCT00957580|40234182|FG002|Overall Study|Ongoing at data cut-off|0|||
16478554|NCT00957580|40234180|FG000|Overall Study|Enrolled but not treated|0|||
16478555|NCT00957580|40234181|FG001|Overall Study|Enrolled but not treated|1|||
16478556|NCT00957580|40234182|FG002|Overall Study|Enrolled but not treated|0|||
16478557|NCT01651039|40234185|FG000|Overall Study|Non-evaluables|5|||
16478558|NCT01651039|40234185|FG000|Overall Study|Physician Decision|2|||
16478559|NCT01651039|40234185|FG000|Overall Study|Withdrawal by Subject|1|||
16478560|NCT01651039|40234185|FG000|Overall Study|Progressive Disease|22|||
16478561|NCT02362269|40234189|FG000|Overall Study|Moved|1|||
16478562|NCT02362269|40234190|FG001|Overall Study|Moved|0|||
16478563|NCT02362269|40234189|FG000|Overall Study|Lost to Follow-up|0|||
16478564|NCT02362269|40234190|FG001|Overall Study|Lost to Follow-up|6|||
16478565|NCT00806351|40234191|FG000|Overall Study|Death|5|||
16478566|NCT00806351|40234192|FG001|Overall Study|Death|4|||
16478567|NCT05085730|40234193|FG000|Overall Study|Withdrawal by Subject|4|||
16478568|NCT05085730|40234193|FG000|Overall Study|Physician Decision|1|||
16478569|NCT02002091|40234196|FG000|Screening|Lost to Follow-up|10|||
16179776|NCT00201851|39135930|FG001|Overall Study|Lost to Follow-up|1|||
16179777|NCT00201851|39135931|FG002|Overall Study|Lost to Follow-up|0|||
16179778|NCT00201851|39135929|FG000|Overall Study|Ineligible post enrollment|6|||
16179779|NCT00201851|39135930|FG001|Overall Study|Ineligible post enrollment|1|||
16179780|NCT00201851|39135931|FG002|Overall Study|Ineligible post enrollment|1|||
16179781|NCT00673673|39135932|FG000|Overall Study|Progressive disease|27|||
16478570|NCT02002091|40234197|FG001|Screening|Lost to Follow-up|12|||
16478571|NCT02002091|40234196|FG000|Screening|Death|3|||
16179782|NCT00673673|39135932|FG000|Overall Study|Adverse Event|4|||
16179783|NCT00673673|39135932|FG000|Overall Study|Withdrawal by Subject|3|||
16179784|NCT00673673|39135932|FG000|Overall Study|Investigators' discretion|2|||
16179785|NCT00144300|39135933|FG000|Overall Study|Adverse Event|18|||
16179786|NCT00144300|39135934|FG001|Overall Study|Adverse Event|16|||
16179787|NCT00144300|39135933|FG000|Overall Study|Protocol Violation|1|||
16179788|NCT00144300|39135934|FG001|Overall Study|Protocol Violation|3|||
16179789|NCT00144300|39135933|FG000|Overall Study|Lost to Follow-up|3|||
16179790|NCT00144300|39135934|FG001|Overall Study|Lost to Follow-up|0|||
16179791|NCT00144300|39135933|FG000|Overall Study|Withdrawal by Subject|6|||
16179792|NCT00144300|39135934|FG001|Overall Study|Withdrawal by Subject|6|||
16179793|NCT00144300|39135933|FG000|Overall Study|Other reason (not specified)|1|||
16179794|NCT00144300|39135934|FG001|Overall Study|Other reason (not specified)|3|||
16179795|NCT01444391|39135935|FG000|Overall Study|Death|1|||
16179796|NCT01919411|39135939|FG000|Overall Study|Lost to Follow-up|2|||
16179797|NCT01919411|39135940|FG001|Overall Study|Lost to Follow-up|4|||
16179798|NCT01919411|39135939|FG000|Overall Study|Physician Decision|1|||
16179799|NCT01919411|39135940|FG001|Overall Study|Physician Decision|0|||
16179800|NCT01919411|39135939|FG000|Overall Study|Protocol Violation|2|||
16179801|NCT01919411|39135940|FG001|Overall Study|Protocol Violation|1|||
16179802|NCT04090164|39135941|FG000|Overall Study|incomplete data on file|245|||
16179803|NCT04090164|39135942|FG001|Overall Study|incomplete data on file|0|||
16179804|NCT00465738|39135943|FG000|Overall Study|Lost to Follow-up|2|||
16179805|NCT00465738|39135944|FG001|Overall Study|Lost to Follow-up|0|||
16179806|NCT00465738|39135943|FG000|Overall Study|Adverse Event|0|||
16179807|NCT00465738|39135944|FG001|Overall Study|Adverse Event|1|||
16179808|NCT00465738|39135943|FG000|Overall Study|Withdrawal by Subject|2|||
16179809|NCT00465738|39135944|FG001|Overall Study|Withdrawal by Subject|0|||
16179810|NCT00465738|39135943|FG000|Overall Study|Other|2|||
16179811|NCT00465738|39135944|FG001|Overall Study|Other|5|||
16179812|NCT01259466|39135945|FG000|Overall Study|Withdrawal by Subject|1|||
16179813|NCT01259466|39135946|FG001|Overall Study|Withdrawal by Subject|9|||
16179814|NCT00820040|39135949|FG000|Overall Study|Death|1|||
16179815|NCT00820040|39135949|FG000|Overall Study|Sponsor terminated study|1|||
16179816|NCT00820040|39135949|FG000|Overall Study|Screen failure|1|||
16179817|NCT00538733|39135951|FG000|Overall Study|Adverse Event|8|||
16179818|NCT00538733|39135951|FG000|Overall Study|Death|1|||
16478572|NCT02002091|40234197|FG001|Screening|Death|2|||
16478573|NCT02980783|40234203|FG000|Overall Study|Lost to Follow-up|1|||
16478574|NCT00615108|40234204|FG000|Overall Study|Adverse Event|122|||
16478575|NCT00615108|40234204|FG000|Overall Study|Other|370|||
16478576|NCT00615108|40234204|FG000|Overall Study|Lost to Follow-up|15|||
16478577|NCT01254292|40234205|FG000|Comparative Phase|Adverse Event|25|||
16478578|NCT01254292|40234206|FG001|Comparative Phase|Adverse Event|25|||
16478579|NCT01254292|40234205|FG000|Comparative Phase|Lost to Follow-up|3|||
16478580|NCT01254292|40234206|FG001|Comparative Phase|Lost to Follow-up|21|||
16478581|NCT01254292|40234205|FG000|Comparative Phase|Pregnancy|2|||
16478582|NCT01254292|40234206|FG001|Comparative Phase|Pregnancy|6|||
16179819|NCT00538733|39135951|FG000|Overall Study|declined to participate|2|||
16179820|NCT00538733|39135951|FG000|Overall Study|still on therapy|1|||
16179821|NCT01609933|39135952|FG000|Overall Study|Adverse Event|1|||
16179822|NCT01609933|39135952|FG000|Overall Study|Withdrawal by Subject|3|||
16179823|NCT00231478|39135956|FG000|Overall Study|Protocol Violation|3|||
16179824|NCT00231478|39135957|FG001|Overall Study|Protocol Violation|2|||
16179825|NCT00231478|39135956|FG000|Overall Study|Refused Treatment|1|||
16179826|NCT00231478|39135957|FG001|Overall Study|Refused Treatment|1|||
16179827|NCT00231478|39135956|FG000|Overall Study|Withdrawal by Subject|1|||
16179828|NCT00231478|39135957|FG001|Overall Study|Withdrawal by Subject|0|||
16179829|NCT00231478|39135956|FG000|Overall Study|Adverse Event|0|||
16179830|NCT00231478|39135957|FG001|Overall Study|Adverse Event|1|||
16179831|NCT00231478|39135956|FG000|Overall Study|Administrative|3|||
16179832|NCT00231478|39135957|FG001|Overall Study|Administrative|2|||
16179833|NCT03750838|39135961|FG000|Overall Study|Lost to Follow-up|10|||
16179834|NCT03750838|39135962|FG001|Overall Study|Lost to Follow-up|6|||
16179835|NCT03575468|39135963|FG000|Overall Study|Withdrawal by Subject|3|||
16179836|NCT03575468|39135964|FG001|Overall Study|Withdrawal by Subject|0|||
16179837|NCT03575468|39135963|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
16179838|NCT03575468|39135964|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
16179839|NCT03575468|39135963|FG000|Overall Study|Lost to Follow-up|13|||
16179840|NCT03575468|39135964|FG001|Overall Study|Lost to Follow-up|17|||
16179841|NCT01242111|39135966|FG000|Overall Study|Adverse Event|1|||
16179842|NCT01242111|39135966|FG000|Overall Study|Withdrawal by Subject|1|||
16179843|NCT01242111|39135966|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
16179844|NCT02469246|39135971|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
16179845|NCT02469246|39135972|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
16179846|NCT02469246|39135971|FG000|Double-Blind Phase|Adverse Event|12|||
16179847|NCT02469246|39135972|FG001|Double-Blind Phase|Adverse Event|9|||
16179848|NCT02469246|39135971|FG000|Double-Blind Phase|Death|2|||
16179849|NCT02469246|39135972|FG001|Double-Blind Phase|Death|0|||
16179850|NCT02469246|39135971|FG000|Double-Blind Phase|Lack of Efficacy|2|||
16179851|NCT02469246|39135972|FG001|Double-Blind Phase|Lack of Efficacy|1|||
16179852|NCT02469246|39135971|FG000|Double-Blind Phase|Investigator's Discretion|8|||
16179853|NCT02469246|39135972|FG001|Double-Blind Phase|Investigator's Discretion|8|||
16179854|NCT02469246|39135971|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
16179855|NCT02469246|39135972|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
16179856|NCT02469246|39135971|FG000|Double-Blind Phase|Protocol Violation|1|||
16179857|NCT02469246|39135972|FG001|Double-Blind Phase|Protocol Violation|1|||
16478583|NCT01254292|40234205|FG000|Comparative Phase|Withdrawal by Subject|20|||
16478584|NCT01254292|40234206|FG001|Comparative Phase|Withdrawal by Subject|21|||
16179858|NCT02469246|39135971|FG000|Double-Blind Phase|Withdrew Consent|25|||
16179859|NCT02469246|39135972|FG001|Double-Blind Phase|Withdrew Consent|25|||
16179860|NCT02469246|39135971|FG000|Double-Blind Phase|Lost to Follow-up|9|||
16179861|NCT02469246|39135972|FG001|Double-Blind Phase|Lost to Follow-up|5|||
16179862|NCT02638012|39138401|FG000|Overall Study|Lost to Follow-up|1|||
16179863|NCT00474253|39138406|FG000|Overall Study|Withdrew consent|2|||
16478585|NCT01254292|40234205|FG000|Comparative Phase|Protocol Violation|1|||
16478586|NCT01254292|40234206|FG001|Comparative Phase|Protocol Violation|2|||
16179864|NCT00474253|39138407|FG001|Overall Study|Withdrew consent|0|||
16179865|NCT00474253|39138406|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
16179866|NCT00474253|39138407|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
16179867|NCT00474253|39138406|FG000|Overall Study|Lost to Follow-up|1|||
16179868|NCT00474253|39138407|FG001|Overall Study|Lost to Follow-up|0|||
16179869|NCT00474253|39138406|FG000|Overall Study|Discharged prior to study completion|0|||
16179870|NCT00474253|39138407|FG001|Overall Study|Discharged prior to study completion|1|||
16179871|NCT01342640|39138408|FG000|Overall Study|Adverse Event|3|||
16179872|NCT01342640|39138408|FG000|Overall Study|Protocol Violation|16|||
16179873|NCT01342640|39138408|FG000|Overall Study|Lost to Follow-up|21|||
16179874|NCT01342640|39138408|FG000|Overall Study|Other|1|||
16179875|NCT02493751|39138415|FG000|Overall Study|Withdrawal by Subject|2|||
16179876|NCT02493751|39138416|FG001|Overall Study|Withdrawal by Subject|8|||
16179877|NCT02493751|39138415|FG000|Overall Study|Death|6|||
16179878|NCT02493751|39138416|FG001|Overall Study|Death|13|||
16179879|NCT02493751|39138415|FG000|Overall Study|Lost to Follow-up|2|||
16179880|NCT02493751|39138416|FG001|Overall Study|Lost to Follow-up|3|||
16179881|NCT02493751|39138415|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
16179882|NCT02493751|39138416|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
16179883|NCT03826914|39138417|FG000|Overall Study|Withdrawal by Subject|1|||
16179884|NCT03826914|39138418|FG001|Overall Study|Withdrawal by Subject|1|||
16179885|NCT01507246|39138432|FG000|Overall Study|Required different surgical procedures|2|||
16179886|NCT01507246|39138433|FG001|Overall Study|Required different surgical procedures|1|||
16179887|NCT00069121|39138436|FG000|Overall Study|Death|286|||
16179888|NCT00069121|39138437|FG001|Overall Study|Death|242|||
16179889|NCT00069121|39138436|FG000|Overall Study|Withdrawal by Subject|18|||
16179890|NCT00069121|39138437|FG001|Overall Study|Withdrawal by Subject|20|||
16179891|NCT00069121|39138436|FG000|Overall Study|Lost to Follow-up|63|||
16179892|NCT00069121|39138437|FG001|Overall Study|Lost to Follow-up|63|||
16179893|NCT02128490|39138440|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16179894|NCT02128490|39138441|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
16179895|NCT02128490|39138442|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
16179896|NCT02128490|39138443|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
16179897|NCT02128490|39138444|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
16179898|NCT02128490|39138440|FG000|Overall Study|Major Protocol Deviation|1|||
16179899|NCT02128490|39138441|FG001|Overall Study|Major Protocol Deviation|2|||
16179900|NCT02128490|39138442|FG002|Overall Study|Major Protocol Deviation|0|||
16179901|NCT02128490|39138443|FG003|Overall Study|Major Protocol Deviation|2|||
16179902|NCT02128490|39138444|FG004|Overall Study|Major Protocol Deviation|2|||
16179903|NCT02128490|39138440|FG000|Overall Study|Lost to Follow-up|0|||
16179904|NCT02128490|39138441|FG001|Overall Study|Lost to Follow-up|0|||
16179905|NCT02128490|39138442|FG002|Overall Study|Lost to Follow-up|1|||
16179906|NCT02128490|39138443|FG003|Overall Study|Lost to Follow-up|1|||
16179907|NCT02128490|39138444|FG004|Overall Study|Lost to Follow-up|1|||
16179908|NCT02128490|39138440|FG000|Overall Study|Voluntary Withdrawal|3|||
16179909|NCT02128490|39138441|FG001|Overall Study|Voluntary Withdrawal|3|||
16179910|NCT02128490|39138442|FG002|Overall Study|Voluntary Withdrawal|1|||
16179911|NCT02128490|39138443|FG003|Overall Study|Voluntary Withdrawal|1|||
16179912|NCT02128490|39138444|FG004|Overall Study|Voluntary Withdrawal|2|||
16179913|NCT02128490|39138440|FG000|Overall Study|Lack of Efficacy|0|||
16179914|NCT02128490|39138441|FG001|Overall Study|Lack of Efficacy|1|||
16179915|NCT02128490|39138442|FG002|Overall Study|Lack of Efficacy|0|||
16179916|NCT02128490|39138443|FG003|Overall Study|Lack of Efficacy|0|||
16179917|NCT02128490|39138444|FG004|Overall Study|Lack of Efficacy|0|||
16179918|NCT02128490|39138440|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
16179919|NCT02128490|39138441|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
16279033|NCT02578641|39504210|FG001|Overall Study|No Study Drug|0|||
16279034|NCT02578641|39504209|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
16279035|NCT02578641|39504210|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
16279036|NCT02578641|39504209|FG000|Overall Study|Non-compliance with Study Schedule|1|||
16279037|NCT02578641|39504210|FG001|Overall Study|Non-compliance with Study Schedule|0|||
16279038|NCT02578641|39504209|FG000|Overall Study|Other|1|||
16279039|NCT02578641|39504210|FG001|Overall Study|Other|10|||
16279040|NCT02578641|39504209|FG000|Overall Study|Not treated|1|||
16279041|NCT02578641|39504210|FG001|Overall Study|Not treated|4|||
16279042|NCT03635983|39504211|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
16279043|NCT03635983|39504212|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
16179920|NCT02128490|39138442|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
16179921|NCT02128490|39138443|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
16179922|NCT02128490|39138444|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
16179923|NCT02128490|39138440|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16179924|NCT02128490|39138441|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16179925|NCT02128490|39138442|FG002|Overall Study|Other Miscellaneous Reasons|2|||
16179926|NCT02128490|39138443|FG003|Overall Study|Other Miscellaneous Reasons|1|||
16478587|NCT01254292|40234205|FG000|Comparative Phase|Wish for pregnancy|4|||
16478588|NCT01254292|40234206|FG001|Comparative Phase|Wish for pregnancy|6|||
16478589|NCT01254292|40234205|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
16478590|NCT01254292|40234206|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
16478591|NCT01254292|40234205|FG000|LCS12 Extension Phase|Adverse Event|9|||
16179927|NCT02128490|39138444|FG004|Overall Study|Other Miscellaneous Reasons|1|||
16478592|NCT01254292|40234206|FG001|LCS12 Extension Phase|Adverse Event|0|||
16478593|NCT01254292|40234205|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
16478594|NCT01254292|40234206|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
16478595|NCT01254292|40234205|FG000|LCS12 Extension Phase|Other unknown|4|||
16478596|NCT01254292|40234206|FG001|LCS12 Extension Phase|Other unknown|0|||
16478597|NCT01254292|40234205|FG000|LCS12 Extension Phase|Pregnancy|2|||
16478598|NCT01254292|40234206|FG001|LCS12 Extension Phase|Pregnancy|0|||
16478599|NCT01254292|40234205|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
16478600|NCT01254292|40234206|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
16478601|NCT03439657|40234207|FG000|Overall Study|Adverse Event|2|||
16478602|NCT03439657|40234208|FG001|Overall Study|Adverse Event|3|||
16179928|NCT04331899|39138450|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
16179929|NCT04331899|39138451|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
16179930|NCT04024228|39138459|FG000|Overall Study|Adverse Event|1|||
16179931|NCT04024228|39138460|FG001|Overall Study|Adverse Event|0|||
16179932|NCT04024228|39138459|FG000|Overall Study|Protocol Deviation|0|||
16179933|NCT04024228|39138460|FG001|Overall Study|Protocol Deviation|2|||
16179934|NCT04024228|39138459|FG000|Overall Study|Withdrawal by Subject|3|||
16179935|NCT04024228|39138460|FG001|Overall Study|Withdrawal by Subject|4|||
16179936|NCT05372315|39138461|FG000|Overall Study|Withdrawal by Subject|1|||
16179937|NCT05372315|39138462|FG001|Overall Study|Withdrawal by Subject|0|||
16179938|NCT03937986|39138464|FG000|Overall Study|COVID-19 Pandemic|1|||
16179939|NCT05370157|39138465|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
16179940|NCT05370157|39138466|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
16179941|NCT05370157|39138465|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
16179942|NCT05370157|39138466|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
16179943|NCT03964415|39138469|FG000|Overall Study|Sponsor's decision|1563|||
16179944|NCT03964415|39138470|FG001|Overall Study|Sponsor's decision|1528|||
16179945|NCT03964415|39138469|FG000|Overall Study|Lost to Follow-up|139|||
16179946|NCT03964415|39138470|FG001|Overall Study|Lost to Follow-up|146|||
16179947|NCT03964415|39138469|FG000|Overall Study|Withdrawal by Subject|68|||
16179948|NCT03964415|39138470|FG001|Overall Study|Withdrawal by Subject|72|||
16179949|NCT03964415|39138469|FG000|Overall Study|Physician Decision|34|||
16179950|NCT03964415|39138470|FG001|Overall Study|Physician Decision|48|||
16179951|NCT03964415|39138469|FG000|Overall Study|Adverse Event|3|||
16179952|NCT03964415|39138470|FG001|Overall Study|Adverse Event|0|||
16179953|NCT03964415|39138469|FG000|Overall Study|Death|4|||
16179954|NCT03964415|39138470|FG001|Overall Study|Death|6|||
16179955|NCT03964415|39138469|FG000|Overall Study|Protocol Violation|1|||
16179956|NCT03964415|39138470|FG001|Overall Study|Protocol Violation|4|||
16179957|NCT03964415|39138469|FG000|Overall Study|Other|35|||
16179958|NCT03964415|39138470|FG001|Overall Study|Other|38|||
16179959|NCT03964415|39138469|FG000|Overall Study|Randomized but not treated|6|||
16179960|NCT03964415|39138470|FG001|Overall Study|Randomized but not treated|7|||
16179961|NCT00883753|39138472|FG000|Overall Study|Adverse Event|37|||
16179962|NCT00883753|39138472|FG000|Overall Study|Death|2|||
16179963|NCT00883753|39138472|FG000|Overall Study|Insufficient therapeutic response|16|||
16179964|NCT00883753|39138472|FG000|Overall Study|Lost to Follow-up|4|||
16179965|NCT00883753|39138472|FG000|Overall Study|Violation of selection criteria at entry|7|||
16179966|NCT00883753|39138472|FG000|Overall Study|Protocol Violation|2|||
16179967|NCT00883753|39138472|FG000|Overall Study|Refused treatment|4|||
16179968|NCT00883753|39138472|FG000|Overall Study|Withdrew consent|10|||
16179969|NCT00883753|39138472|FG000|Overall Study|Investigator's decision|17|||
16179970|NCT00883753|39138472|FG000|Overall Study|Administrative/Other|8|||
16179971|NCT00728416|39138473|FG000|Overall Study|Adverse Event|1|||
16179972|NCT00728416|39138474|FG001|Overall Study|Adverse Event|1|||
16179973|NCT00728416|39138473|FG000|Overall Study|Treatment Failure|0|||
16179974|NCT00728416|39138474|FG001|Overall Study|Treatment Failure|1|||
16179975|NCT00728416|39138473|FG000|Overall Study|Withdrawal by Subject|1|||
16179976|NCT00728416|39138474|FG001|Overall Study|Withdrawal by Subject|0|||
16179977|NCT00866294|39138475|FG000|Overall Study|Adverse Event|12|||
16179978|NCT00866294|39138476|FG001|Overall Study|Adverse Event|13|||
16179979|NCT00866294|39138477|FG002|Overall Study|Adverse Event|9|||
16179980|NCT00866294|39138475|FG000|Overall Study|Lack of Efficacy|7|||
16478603|NCT03439657|40234207|FG000|Overall Study|Lost to Follow-up|1|||
16478604|NCT03439657|40234208|FG001|Overall Study|Lost to Follow-up|0|||
16179981|NCT00866294|39138476|FG001|Overall Study|Lack of Efficacy|1|||
16179982|NCT00866294|39138477|FG002|Overall Study|Lack of Efficacy|0|||
16179983|NCT00866294|39138475|FG000|Overall Study|Protocol Violation|2|||
16179984|NCT00866294|39138476|FG001|Overall Study|Protocol Violation|0|||
16478605|NCT03439657|40234207|FG000|Overall Study|Protocol Violation|1|||
16179985|NCT00866294|39138477|FG002|Overall Study|Protocol Violation|0|||
16179986|NCT00866294|39138475|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
16179987|NCT00866294|39138476|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16179988|NCT00866294|39138477|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16179989|NCT00866294|39138475|FG000|Overall Study|Lost to Follow-up|1|||
16179990|NCT00866294|39138476|FG001|Overall Study|Lost to Follow-up|3|||
16179991|NCT00866294|39138477|FG002|Overall Study|Lost to Follow-up|0|||
16179992|NCT00866294|39138475|FG000|Overall Study|Physician Decision|6|||
16179993|NCT00866294|39138476|FG001|Overall Study|Physician Decision|2|||
16179994|NCT00866294|39138477|FG002|Overall Study|Physician Decision|1|||
16179995|NCT00035815|39138482|FG000|Overall Study|Withdrawal by Subject|17|||
16179996|NCT00035815|39138483|FG001|Overall Study|Withdrawal by Subject|11|||
16179997|NCT02158533|39138487|FG000|Stage 1|Adverse Event|6|||
16478606|NCT03439657|40234208|FG001|Overall Study|Protocol Violation|1|||
16478607|NCT03439657|40234207|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
16478608|NCT03439657|40234208|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
16478609|NCT05213481|40234209|FG000|Overall Study|Adverse Event|3|||
16478610|NCT05213481|40234209|FG000|Overall Study|Lost to Follow-up|1|||
16478611|NCT01443078|40234213|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
16478612|NCT01443078|40234213|FG000|Overall Study|Withdrawal by Subject|1|||
16478613|NCT01443078|40234213|FG000|Overall Study|Patient had brain mets|1|||
16478614|NCT01031381|40234218|FG000|Overall Study|Physician Decision|3|||
16478615|NCT01031381|40234218|FG000|Overall Study|Withdrawal by Subject|6|||
16478616|NCT00370071|40234219|FG000|Overall Study|Withdrawal by Subject|2|||
16478617|NCT02104752|40234222|FG000|Overall Study|Withdrawal by Subject|1|||
16478618|NCT02104752|40234223|FG001|Overall Study|Withdrawal by Subject|0|||
16478619|NCT02104752|40234222|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
16478620|NCT02104752|40234223|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
16478621|NCT03113916|40234225|FG000|Overall Study|Withdrawal by Subject|9|||
16478622|NCT03113916|40234226|FG001|Overall Study|Withdrawal by Subject|7|||
16478623|NCT03113916|40234225|FG000|Overall Study|Pregnancy|1|||
16478624|NCT03113916|40234226|FG001|Overall Study|Pregnancy|3|||
16478625|NCT03113916|40234225|FG000|Overall Study|Lost to Follow-up|1|||
16478626|NCT03113916|40234226|FG001|Overall Study|Lost to Follow-up|2|||
16478627|NCT01772160|40234229|FG000|Overall Study|Death|3|||
16478628|NCT01772160|40234229|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
16478629|NCT01772160|40234229|FG000|Overall Study|Consent withdrawal|3|||
16478630|NCT01772160|40234229|FG000|Overall Study|Migrated / moved from the study area|4|||
16478631|NCT01772160|40234229|FG000|Overall Study|Lost to Follow-up|30|||
16478632|NCT01772160|40234229|FG000|Overall Study|Other|5|||
16478633|NCT03945214|40234232|FG000|Overall Study|Lost to Follow-up|3|||
16478634|NCT03945214|40234233|FG001|Overall Study|Lost to Follow-up|4|||
16478635|NCT03945214|40234234|FG002|Overall Study|Lost to Follow-up|7|||
16478636|NCT03945214|40234235|FG003|Overall Study|Lost to Follow-up|4|||
16478637|NCT02019277|40234244|FG000|Overall Study|Withdrawal by Subject|3|||
16478638|NCT02019277|40234244|FG000|Overall Study|Death|7|||
16478639|NCT02019277|40234244|FG000|Overall Study|Did no Cooperate|1|||
16478640|NCT02019277|40234244|FG000|Overall Study|Adverse Event|1|||
16478641|NCT02607930|40234245|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
16478642|NCT02607930|40234246|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
16478643|NCT02607930|40234247|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
16478644|NCT02607930|40234248|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
16478645|NCT02607930|40234245|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
16478646|NCT02607930|40234246|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
16478647|NCT02607930|40234247|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
16478648|NCT02607930|40234248|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
16478649|NCT02607930|40234245|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
16478650|NCT02607930|40234246|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
16478651|NCT02607930|40234247|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
16478652|NCT02607930|40234248|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
16478653|NCT02607930|40234245|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
16478654|NCT02607930|40234246|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
16179998|NCT02158533|39138488|FG001|Stage 1|Adverse Event|4|||
16179999|NCT02158533|39138489|FG002|Stage 1|Adverse Event|7|||
16180000|NCT02158533|39138490|FG003|Stage 1|Adverse Event|0|||
16180001|NCT02158533|39138491|FG004|Stage 1|Adverse Event|0|||
16478655|NCT02607930|40234247|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
16478656|NCT02607930|40234248|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
16478657|NCT02607930|40234245|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
16478658|NCT02607930|40234246|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
16478659|NCT02607930|40234247|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
16478660|NCT02607930|40234248|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
16478661|NCT02607930|40234245|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
16478662|NCT02607930|40234246|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
16478663|NCT02607930|40234247|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
16478664|NCT02607930|40234248|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
16478665|NCT02607930|40234245|FG000|Double-Blinded Treatment Phase|Death|2|||
16478666|NCT02607930|40234246|FG001|Double-Blinded Treatment Phase|Death|1|||
16478667|NCT02607930|40234247|FG002|Double-Blinded Treatment Phase|Death|0|||
16478668|NCT02607930|40234248|FG003|Double-Blinded Treatment Phase|Death|0|||
16180002|NCT02158533|39138492|FG005|Stage 1|Adverse Event|0|||
16180003|NCT02158533|39138487|FG000|Stage 1|Withdrawal by Subject|3|||
16180004|NCT02158533|39138488|FG001|Stage 1|Withdrawal by Subject|2|||
16180005|NCT02158533|39138489|FG002|Stage 1|Withdrawal by Subject|1|||
16180006|NCT02158533|39138490|FG003|Stage 1|Withdrawal by Subject|0|||
16180007|NCT02158533|39138491|FG004|Stage 1|Withdrawal by Subject|0|||
16180008|NCT02158533|39138492|FG005|Stage 1|Withdrawal by Subject|0|||
16180009|NCT02158533|39138487|FG000|Stage 1|Lack of Efficacy|1|||
16180010|NCT02158533|39138488|FG001|Stage 1|Lack of Efficacy|0|||
16180011|NCT02158533|39138489|FG002|Stage 1|Lack of Efficacy|0|||
16180012|NCT02158533|39138490|FG003|Stage 1|Lack of Efficacy|0|||
16180013|NCT02158533|39138491|FG004|Stage 1|Lack of Efficacy|0|||
16180014|NCT02158533|39138492|FG005|Stage 1|Lack of Efficacy|0|||
16180015|NCT02158533|39138487|FG000|Stage 1|Lost to Follow-up|3|||
16180016|NCT02158533|39138488|FG001|Stage 1|Lost to Follow-up|1|||
16180017|NCT02158533|39138489|FG002|Stage 1|Lost to Follow-up|0|||
16180018|NCT02158533|39138490|FG003|Stage 1|Lost to Follow-up|0|||
16180019|NCT02158533|39138491|FG004|Stage 1|Lost to Follow-up|0|||
16180020|NCT02158533|39138492|FG005|Stage 1|Lost to Follow-up|0|||
16180021|NCT02158533|39138487|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
16180022|NCT02158533|39138488|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
16180023|NCT02158533|39138489|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
16180024|NCT02158533|39138490|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
16180025|NCT02158533|39138491|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
16180026|NCT02158533|39138492|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
16180027|NCT02158533|39138487|FG000|Stage 1|Non-compliance with study visits|1|||
16180028|NCT02158533|39138488|FG001|Stage 1|Non-compliance with study visits|0|||
16180029|NCT02158533|39138489|FG002|Stage 1|Non-compliance with study visits|0|||
16180030|NCT02158533|39138490|FG003|Stage 1|Non-compliance with study visits|0|||
16180031|NCT02158533|39138491|FG004|Stage 1|Non-compliance with study visits|0|||
16180032|NCT02158533|39138492|FG005|Stage 1|Non-compliance with study visits|0|||
16180033|NCT02158533|39138487|FG000|Stage 2|Adverse Event|0|||
16180034|NCT02158533|39138488|FG001|Stage 2|Adverse Event|0|||
16180035|NCT02158533|39138489|FG002|Stage 2|Adverse Event|0|||
16180036|NCT02158533|39138490|FG003|Stage 2|Adverse Event|0|||
16180037|NCT02158533|39138491|FG004|Stage 2|Adverse Event|0|||
16180038|NCT02158533|39138492|FG005|Stage 2|Adverse Event|1|||
16180039|NCT02158533|39138487|FG000|Stage 2|Lack of Efficacy|0|||
16180040|NCT02158533|39138488|FG001|Stage 2|Lack of Efficacy|0|||
16180041|NCT02158533|39138489|FG002|Stage 2|Lack of Efficacy|0|||
16180042|NCT02158533|39138490|FG003|Stage 2|Lack of Efficacy|0|||
16180043|NCT02158533|39138491|FG004|Stage 2|Lack of Efficacy|1|||
16180044|NCT02158533|39138492|FG005|Stage 2|Lack of Efficacy|0|||
16180045|NCT02158533|39138487|FG000|Stage 2|Lost to Follow-up|0|||
16180046|NCT02158533|39138488|FG001|Stage 2|Lost to Follow-up|0|||
16180047|NCT02158533|39138489|FG002|Stage 2|Lost to Follow-up|0|||
16180048|NCT02158533|39138490|FG003|Stage 2|Lost to Follow-up|1|||
16180049|NCT02158533|39138491|FG004|Stage 2|Lost to Follow-up|1|||
16180050|NCT02158533|39138492|FG005|Stage 2|Lost to Follow-up|2|||
16180051|NCT02158533|39138487|FG000|Stage 2|Withdrawal by Subject|0|||
16180052|NCT02158533|39138488|FG001|Stage 2|Withdrawal by Subject|0|||
16180053|NCT02158533|39138489|FG002|Stage 2|Withdrawal by Subject|0|||
16180054|NCT02158533|39138490|FG003|Stage 2|Withdrawal by Subject|0|||
16180055|NCT02158533|39138491|FG004|Stage 2|Withdrawal by Subject|1|||
16180056|NCT02158533|39138492|FG005|Stage 2|Withdrawal by Subject|2|||
16180057|NCT02158533|39138487|FG000|Stage 2|Physician Decision|0|||
16180058|NCT02158533|39138488|FG001|Stage 2|Physician Decision|0|||
16180059|NCT02158533|39138489|FG002|Stage 2|Physician Decision|0|||
16180060|NCT02158533|39138490|FG003|Stage 2|Physician Decision|0|||
16478669|NCT02607930|40234245|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
16180061|NCT02158533|39138491|FG004|Stage 2|Physician Decision|1|||
16180062|NCT02158533|39138492|FG005|Stage 2|Physician Decision|0|||
16180063|NCT02158533|39138487|FG000|Stage 2|Pregnancy|0|||
16180064|NCT02158533|39138488|FG001|Stage 2|Pregnancy|0|||
16180065|NCT02158533|39138489|FG002|Stage 2|Pregnancy|0|||
16180066|NCT02158533|39138490|FG003|Stage 2|Pregnancy|1|||
16180067|NCT02158533|39138491|FG004|Stage 2|Pregnancy|0|||
16180068|NCT02158533|39138492|FG005|Stage 2|Pregnancy|0|||
16180069|NCT02158533|39138487|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
16180070|NCT02158533|39138488|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
16180071|NCT02158533|39138489|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
16180072|NCT02158533|39138490|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
16180073|NCT02158533|39138491|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
16180074|NCT02158533|39138492|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
16478670|NCT02607930|40234246|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
16180075|NCT02158533|39138487|FG000|Stage 2|Non-adherence with study visits|0|||
16180076|NCT02158533|39138488|FG001|Stage 2|Non-adherence with study visits|0|||
16180077|NCT02158533|39138489|FG002|Stage 2|Non-adherence with study visits|0|||
16180078|NCT02158533|39138490|FG003|Stage 2|Non-adherence with study visits|0|||
16180079|NCT02158533|39138491|FG004|Stage 2|Non-adherence with study visits|0|||
16180080|NCT02158533|39138492|FG005|Stage 2|Non-adherence with study visits|1|||
16180081|NCT02955186|39138493|FG000|Overall Study|Withdrawal by Subject|6|||
16180082|NCT02955186|39138494|FG001|Overall Study|Withdrawal by Subject|2|||
16180083|NCT02955186|39138493|FG000|Overall Study|Protocol Violation|1|||
16180084|NCT02955186|39138494|FG001|Overall Study|Protocol Violation|0|||
16180085|NCT02767570|39138505|FG000|Overall Study|Lost to Follow-up|3|||
16180086|NCT02767570|39138506|FG001|Overall Study|Lost to Follow-up|0|||
16180087|NCT02767570|39138505|FG000|Overall Study|COVID shutdown|2|||
16180088|NCT02767570|39138506|FG001|Overall Study|COVID shutdown|5|||
16180089|NCT02767570|39138505|FG000|Overall Study|Increased pain|2|||
16180090|NCT02767570|39138506|FG001|Overall Study|Increased pain|0|||
16180091|NCT02767570|39138505|FG000|Overall Study|Withdrawal by Subject|1|||
16180092|NCT02767570|39138506|FG001|Overall Study|Withdrawal by Subject|3|||
16180093|NCT02767570|39138505|FG000|Overall Study|Unrelated medical issue|1|||
16180094|NCT02767570|39138506|FG001|Overall Study|Unrelated medical issue|1|||
16180095|NCT02767570|39138505|FG000|Overall Study|Received intra-articular injection|0|||
16180096|NCT02767570|39138506|FG001|Overall Study|Received intra-articular injection|1|||
16180097|NCT01326962|39138511|FG000|Overall Study|Adverse Event|1|||
16180098|NCT01326962|39138511|FG000|Overall Study|Withdrawal by Subject|1|||
16180099|NCT01326962|39138511|FG000|Overall Study|Lost to Follow-up|3|||
16180100|NCT01326962|39138511|FG000|Overall Study|Other|2|||
16180101|NCT02903511|39138512|FG000|Overall Study|Withdrawal by Subject|1|||
16180102|NCT02903511|39138513|FG001|Overall Study|Withdrawal by Subject|0|||
16180103|NCT02903511|39138512|FG000|Overall Study|Lost to Follow-up|3|||
16180104|NCT02903511|39138513|FG001|Overall Study|Lost to Follow-up|2|||
16180105|NCT00783289|39138514|FG000|Overall Study|Protocol Violation|0|||
16180106|NCT00783289|39138515|FG001|Overall Study|Protocol Violation|1|||
16180107|NCT00783289|39138516|FG002|Overall Study|Protocol Violation|0|||
16180108|NCT00783289|39138517|FG003|Overall Study|Protocol Violation|0|||
16180109|NCT03518840|39138518|FG000|Overall Study|Lost to Follow-up|6|||
16180110|NCT00650585|39138519|FG000|Overall Study|Lost to Follow-up|505|||
16180111|NCT00650585|39138520|FG001|Overall Study|Lost to Follow-up|482|||
16180112|NCT00650585|39138519|FG000|Overall Study|No parental consent|935|||
16180113|NCT00650585|39138520|FG001|Overall Study|No parental consent|866|||
16180114|NCT00650585|39138519|FG000|Overall Study|Excluded/ruled ineligible|357|||
16180115|NCT00650585|39138520|FG001|Overall Study|Excluded/ruled ineligible|129|||
16180116|NCT04786210|39138521|FG000|Overall Study|Lost to Follow-up|2|||
16180117|NCT04786210|39138521|FG000|Overall Study|Withdrawal by Subject|4|||
16180118|NCT01716169|39138524|FG000|Overall Study|Adverse Event|1|||
16180119|NCT01716169|39138524|FG000|Overall Study|Lost to Follow-up|1|||
16180120|NCT01716169|39138524|FG000|Overall Study|Withdrawal by Subject|1|||
16180121|NCT01716169|39138524|FG000|Overall Study|inconsistent dressing application|1|||
16180122|NCT00506389|39138525|FG000|In-treatment Period|Other|3|||
16180123|NCT00506389|39138526|FG001|In-treatment Period|Other|3|||
16180124|NCT00506389|39138527|FG002|In-treatment Period|Other|4|||
16180125|NCT00506389|39138525|FG000|In-treatment Period|Lost to Follow-up|0|||
16180126|NCT00506389|39138526|FG001|In-treatment Period|Lost to Follow-up|0|||
16180127|NCT00506389|39138527|FG002|In-treatment Period|Lost to Follow-up|1|||
16180128|NCT00506389|39138525|FG000|In-treatment Period|Lack of compliance|1|||
16180129|NCT00506389|39138526|FG001|In-treatment Period|Lack of compliance|0|||
16180130|NCT00506389|39138527|FG002|In-treatment Period|Lack of compliance|0|||
16180131|NCT00506389|39138525|FG000|In-treatment Period|Reasons not related to trial|4|||
16180132|NCT00506389|39138526|FG001|In-treatment Period|Reasons not related to trial|1|||
16180133|NCT00506389|39138527|FG002|In-treatment Period|Reasons not related to trial|0|||
16180134|NCT00506389|39138525|FG000|In-treatment Period|Withdrawal by Subject|3|||
16180135|NCT00506389|39138526|FG001|In-treatment Period|Withdrawal by Subject|3|||
16180136|NCT00506389|39138527|FG002|In-treatment Period|Withdrawal by Subject|4|||
16180137|NCT00506389|39138525|FG000|In-treatment Period|Lack of Efficacy|0|||
16180138|NCT00506389|39138526|FG001|In-treatment Period|Lack of Efficacy|2|||
16180139|NCT00506389|39138527|FG002|In-treatment Period|Lack of Efficacy|0|||
16180140|NCT00506389|39138525|FG000|In-treatment Period|Adverse Event|11|||
16180141|NCT00506389|39138526|FG001|In-treatment Period|Adverse Event|5|||
16180142|NCT00506389|39138527|FG002|In-treatment Period|Adverse Event|2|||
16180143|NCT00506389|39138525|FG000|In-treatment Period|Randomized but not treated|4|||
16180144|NCT00506389|39138526|FG001|In-treatment Period|Randomized but not treated|1|||
16180145|NCT00506389|39138527|FG002|In-treatment Period|Randomized but not treated|1|||
16180146|NCT01508676|39138528|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
16180147|NCT01508676|39138529|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
16180148|NCT01508676|39138528|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
16180149|NCT01508676|39138529|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
16180150|NCT01508676|39138528|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
16180151|NCT01508676|39138529|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
16180152|NCT01508676|39138528|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
16180153|NCT01508676|39138529|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
16180154|NCT01508676|39138528|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
16180155|NCT01508676|39138529|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
16180156|NCT01348919|39138532|FG000|Overall Study|Adverse Event|3|||
16180157|NCT01348919|39138533|FG001|Overall Study|Adverse Event|1|||
16180158|NCT01348919|39138534|FG002|Overall Study|Adverse Event|0|||
16180159|NCT01348919|39138532|FG000|Overall Study|Withdrawal by Subject|0|||
16180160|NCT01348919|39138533|FG001|Overall Study|Withdrawal by Subject|1|||
16180161|NCT01348919|39138534|FG002|Overall Study|Withdrawal by Subject|0|||
16180162|NCT01348919|39138532|FG000|Overall Study|Disease progression|0|||
16180163|NCT01348919|39138533|FG001|Overall Study|Disease progression|1|||
16180164|NCT01348919|39138534|FG002|Overall Study|Disease progression|1|||
16180165|NCT02675517|39138535|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
16180166|NCT02675517|39138535|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
16180167|NCT01943539|39138536|FG000|Overall Study|Non-compliance with at-home intervention|4|||
16180168|NCT01943539|39138537|FG001|Overall Study|Non-compliance with at-home intervention|0|||
16180169|NCT01041573|39138541|FG000|Overall Study|Withdrawal by Subject|2|||
16180170|NCT01041573|39138542|FG001|Overall Study|Withdrawal by Subject|5|||
16180171|NCT01041573|39138543|FG002|Overall Study|Withdrawal by Subject|2|||
16180172|NCT01041573|39138544|FG003|Overall Study|Withdrawal by Subject|0|||
16180173|NCT01041573|39138541|FG000|Overall Study|Death|1|||
16180174|NCT01041573|39138542|FG001|Overall Study|Death|0|||
16180175|NCT01041573|39138543|FG002|Overall Study|Death|0|||
16180176|NCT01041573|39138544|FG003|Overall Study|Death|0|||
16180177|NCT01041573|39138541|FG000|Overall Study|Lost to Follow-up|0|||
16180178|NCT01041573|39138542|FG001|Overall Study|Lost to Follow-up|1|||
16180179|NCT01041573|39138543|FG002|Overall Study|Lost to Follow-up|2|||
16180180|NCT01041573|39138544|FG003|Overall Study|Lost to Follow-up|1|||
16180181|NCT01041573|39138541|FG000|Overall Study|Adverse Event|0|||
16180182|NCT01041573|39138542|FG001|Overall Study|Adverse Event|2|||
16180183|NCT01041573|39138543|FG002|Overall Study|Adverse Event|0|||
16180184|NCT01041573|39138544|FG003|Overall Study|Adverse Event|0|||
16180185|NCT01041573|39138541|FG000|Overall Study|relocation|1|||
16180186|NCT01041573|39138542|FG001|Overall Study|relocation|4|||
16180187|NCT01041573|39138543|FG002|Overall Study|relocation|3|||
16180188|NCT01041573|39138544|FG003|Overall Study|relocation|1|||
16180189|NCT01041573|39138541|FG000|Overall Study|further blood extraction|0|||
16180190|NCT01041573|39138542|FG001|Overall Study|further blood extraction|1|||
16180191|NCT01041573|39138543|FG002|Overall Study|further blood extraction|0|||
16180192|NCT01041573|39138544|FG003|Overall Study|further blood extraction|0|||
16180193|NCT01041573|39138541|FG000|Overall Study|positive to anti-HCV|1|||
16180194|NCT01041573|39138542|FG001|Overall Study|positive to anti-HCV|0|||
16180195|NCT01041573|39138543|FG002|Overall Study|positive to anti-HCV|0|||
16180196|NCT01041573|39138544|FG003|Overall Study|positive to anti-HCV|0|||
16180197|NCT02714205|39138545|FG000|Overall Study|Cannot tolerate medication|1|||
16180198|NCT02714205|39138546|FG001|Overall Study|Cannot tolerate medication|0|||
16180199|NCT02714205|39138545|FG000|Overall Study|Adverse Event|2|||
16180200|NCT02714205|39138546|FG001|Overall Study|Adverse Event|0|||
16180201|NCT02714205|39138545|FG000|Overall Study|Too busy|1|||
16180202|NCT02714205|39138546|FG001|Overall Study|Too busy|0|||
16180203|NCT02714205|39138545|FG000|Overall Study|Incomplete outcome data|0|||
16180204|NCT02714205|39138546|FG001|Overall Study|Incomplete outcome data|1|||
16180205|NCT04332419|39138547|FG000|Overall Study|Withdrawal by Subject|1|||
16180206|NCT02259231|39138548|FG000|Overall Study|Adverse Event|1|||
16180207|NCT02259231|39138549|FG001|Overall Study|Adverse Event|1|||
16180208|NCT02259231|39138550|FG002|Overall Study|Adverse Event|2|||
16180209|NCT02259231|39138551|FG003|Overall Study|Adverse Event|0|||
16180210|NCT02259231|39138552|FG004|Overall Study|Adverse Event|0|||
16180211|NCT02259231|39138553|FG005|Overall Study|Adverse Event|0|||
16180212|NCT02259231|39138554|FG006|Overall Study|Adverse Event|0|||
16180213|NCT02259231|39138548|FG000|Overall Study|Progressive Disease|4|||
16180214|NCT02259231|39138549|FG001|Overall Study|Progressive Disease|5|||
16180215|NCT02259231|39138550|FG002|Overall Study|Progressive Disease|4|||
16279044|NCT03635983|39504211|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
16279045|NCT03635983|39504212|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
16180216|NCT02259231|39138551|FG003|Overall Study|Progressive Disease|5|||
16180217|NCT02259231|39138552|FG004|Overall Study|Progressive Disease|4|||
16180218|NCT02259231|39138553|FG005|Overall Study|Progressive Disease|5|||
16180219|NCT02259231|39138554|FG006|Overall Study|Progressive Disease|4|||
16180220|NCT02259231|39138548|FG000|Overall Study|Sponsor termination of study|1|||
16180221|NCT02259231|39138549|FG001|Overall Study|Sponsor termination of study|0|||
16180222|NCT02259231|39138550|FG002|Overall Study|Sponsor termination of study|0|||
16180223|NCT02259231|39138551|FG003|Overall Study|Sponsor termination of study|1|||
16180224|NCT02259231|39138552|FG004|Overall Study|Sponsor termination of study|2|||
16180225|NCT02259231|39138553|FG005|Overall Study|Sponsor termination of study|1|||
16180226|NCT02259231|39138554|FG006|Overall Study|Sponsor termination of study|1|||
16180227|NCT00393458|39138559|FG000|Overall Study|Adverse Event|35|||
16180228|NCT00393458|39138560|FG001|Overall Study|Adverse Event|24|||
16180229|NCT00393458|39138561|FG002|Overall Study|Adverse Event|40|||
16180230|NCT00393458|39138562|FG003|Overall Study|Adverse Event|35|||
16180231|NCT00393458|39138559|FG000|Overall Study|Subject withdrew consent|27|||
16180232|NCT00393458|39138560|FG001|Overall Study|Subject withdrew consent|40|||
16180233|NCT00393458|39138561|FG002|Overall Study|Subject withdrew consent|33|||
16180234|NCT00393458|39138562|FG003|Overall Study|Subject withdrew consent|50|||
16180235|NCT00393458|39138559|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
16180236|NCT00393458|39138560|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
16180237|NCT00393458|39138561|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
16180238|NCT00393458|39138562|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
16180239|NCT00393458|39138559|FG000|Overall Study|Protocol deviation|11|||
16180240|NCT00393458|39138560|FG001|Overall Study|Protocol deviation|11|||
16180241|NCT00393458|39138561|FG002|Overall Study|Protocol deviation|11|||
16180242|NCT00393458|39138562|FG003|Overall Study|Protocol deviation|10|||
16180243|NCT00393458|39138559|FG000|Overall Study|Administrative problems|7|||
16180244|NCT00393458|39138560|FG001|Overall Study|Administrative problems|8|||
16180245|NCT00393458|39138561|FG002|Overall Study|Administrative problems|5|||
16180246|NCT00393458|39138562|FG003|Overall Study|Administrative problems|2|||
16180247|NCT00393458|39138559|FG000|Overall Study|Lost to Follow-up|5|||
16180248|NCT00393458|39138560|FG001|Overall Study|Lost to Follow-up|6|||
16180249|NCT00393458|39138561|FG002|Overall Study|Lost to Follow-up|5|||
16180250|NCT00393458|39138562|FG003|Overall Study|Lost to Follow-up|3|||
16180251|NCT00393458|39138559|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16180252|NCT00393458|39138560|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16180253|NCT00393458|39138561|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16180254|NCT00393458|39138562|FG003|Overall Study|Abnormal laboratory value(s)|0|||
16180255|NCT00393458|39138559|FG000|Overall Study|Death|1|||
16180256|NCT00393458|39138560|FG001|Overall Study|Death|1|||
16180257|NCT00393458|39138561|FG002|Overall Study|Death|5|||
16180258|NCT00393458|39138562|FG003|Overall Study|Death|5|||
16180259|NCT00393458|39138559|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16180260|NCT00393458|39138560|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16180261|NCT00393458|39138561|FG002|Overall Study|Abnormal test procedure result(s)|1|||
16180262|NCT00393458|39138562|FG003|Overall Study|Abnormal test procedure result(s)|2|||
16180263|NCT00393458|39138559|FG000|Overall Study|Subject no longer requires study drug|0|||
16180264|NCT00393458|39138560|FG001|Overall Study|Subject no longer requires study drug|1|||
16180265|NCT00393458|39138561|FG002|Overall Study|Subject no longer requires study drug|0|||
16180266|NCT00393458|39138562|FG003|Overall Study|Subject no longer requires study drug|0|||
16180267|NCT00283712|39138563|FG000|Overall Study|Death|0|||
16180268|NCT00283712|39138564|FG001|Overall Study|Death|1|||
16180269|NCT00942708|39138567|FG000|Overall Study|Withdrawal by Subject|1|||
16180270|NCT01522651|39138573|FG000|Overall Study|Adverse Event|3|||
16180271|NCT01522651|39138574|FG001|Overall Study|Adverse Event|4|||
16180272|NCT01522651|39138575|FG002|Overall Study|Adverse Event|4|||
16180273|NCT01522651|39138576|FG003|Overall Study|Adverse Event|5|||
16180274|NCT01522651|39138577|FG004|Overall Study|Adverse Event|4|||
16180275|NCT01522651|39138573|FG000|Overall Study|Cardioversion|1|||
16180276|NCT01522651|39138574|FG001|Overall Study|Cardioversion|0|||
16180277|NCT01522651|39138575|FG002|Overall Study|Cardioversion|0|||
16180278|NCT01522651|39138576|FG003|Overall Study|Cardioversion|0|||
16180279|NCT01522651|39138577|FG004|Overall Study|Cardioversion|0|||
16180280|NCT01522651|39138573|FG000|Overall Study|Device Malfunction|0|||
16180281|NCT01522651|39138574|FG001|Overall Study|Device Malfunction|1|||
16180282|NCT01522651|39138575|FG002|Overall Study|Device Malfunction|0|||
16180283|NCT01522651|39138576|FG003|Overall Study|Device Malfunction|0|||
16180284|NCT01522651|39138577|FG004|Overall Study|Device Malfunction|0|||
16180285|NCT01522651|39138573|FG000|Overall Study|Investigator's Discretion|0|||
16180286|NCT01522651|39138574|FG001|Overall Study|Investigator's Discretion|1|||
16180287|NCT01522651|39138575|FG002|Overall Study|Investigator's Discretion|0|||
16180288|NCT01522651|39138576|FG003|Overall Study|Investigator's Discretion|0|||
16180289|NCT01522651|39138577|FG004|Overall Study|Investigator's Discretion|0|||
16180290|NCT01522651|39138573|FG000|Overall Study|Protocol Violation|3|||
16180291|NCT01522651|39138574|FG001|Overall Study|Protocol Violation|0|||
16180292|NCT01522651|39138575|FG002|Overall Study|Protocol Violation|0|||
16180293|NCT01522651|39138576|FG003|Overall Study|Protocol Violation|0|||
16180294|NCT01522651|39138577|FG004|Overall Study|Protocol Violation|0|||
16180295|NCT01522651|39138573|FG000|Overall Study|Reason Not Specified|0|||
16180296|NCT01522651|39138574|FG001|Overall Study|Reason Not Specified|0|||
16180297|NCT01522651|39138575|FG002|Overall Study|Reason Not Specified|0|||
16180298|NCT01522651|39138576|FG003|Overall Study|Reason Not Specified|1|||
16180299|NCT01522651|39138577|FG004|Overall Study|Reason Not Specified|0|||
16279046|NCT03635983|39504211|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16180300|NCT01522651|39138573|FG000|Overall Study|Participant Non-Compliance|1|||
16180301|NCT01522651|39138574|FG001|Overall Study|Participant Non-Compliance|0|||
16180302|NCT01522651|39138575|FG002|Overall Study|Participant Non-Compliance|0|||
16180303|NCT01522651|39138576|FG003|Overall Study|Participant Non-Compliance|0|||
16180304|NCT01522651|39138577|FG004|Overall Study|Participant Non-Compliance|0|||
16180305|NCT01522651|39138573|FG000|Overall Study|Withdrew Consent|1|||
16180306|NCT01522651|39138574|FG001|Overall Study|Withdrew Consent|1|||
16180307|NCT01522651|39138575|FG002|Overall Study|Withdrew Consent|0|||
16180308|NCT01522651|39138576|FG003|Overall Study|Withdrew Consent|1|||
16180309|NCT01522651|39138577|FG004|Overall Study|Withdrew Consent|1|||
16180310|NCT01522651|39138573|FG000|Overall Study|Randomized but Never Treated|0|||
16180311|NCT01522651|39138574|FG001|Overall Study|Randomized but Never Treated|1|||
16180312|NCT01522651|39138575|FG002|Overall Study|Randomized but Never Treated|0|||
16180313|NCT01522651|39138576|FG003|Overall Study|Randomized but Never Treated|1|||
16180314|NCT01522651|39138577|FG004|Overall Study|Randomized but Never Treated|1|||
16180315|NCT01570491|39138578|FG000|Overall Study|Lost to Follow-up|3|||
16180316|NCT01570491|39138579|FG001|Overall Study|Lost to Follow-up|1|||
16180317|NCT01570491|39138578|FG000|Overall Study|treatment: not given or discontinued|2|||
16180318|NCT01570491|39138579|FG001|Overall Study|treatment: not given or discontinued|0|||
16180319|NCT03241173|39138593|FG000|Overall Study|Death|3|||
16180320|NCT03241173|39138594|FG001|Overall Study|Death|2|||
16180321|NCT03241173|39138595|FG002|Overall Study|Death|4|||
16180322|NCT03241173|39138596|FG003|Overall Study|Death|4|||
16180323|NCT03241173|39138597|FG004|Overall Study|Death|2|||
16180324|NCT03241173|39138598|FG005|Overall Study|Death|2|||
16180325|NCT03241173|39138599|FG006|Overall Study|Death|3|||
16180326|NCT03241173|39138600|FG007|Overall Study|Death|1|||
16180327|NCT03241173|39138601|FG008|Overall Study|Death|0|||
16180328|NCT03241173|39138602|FG009|Overall Study|Death|5|||
16180329|NCT03241173|39138603|FG010|Overall Study|Death|4|||
16180330|NCT03241173|39138604|FG011|Overall Study|Death|3|||
16180331|NCT03241173|39138605|FG012|Overall Study|Death|0|||
16180332|NCT03241173|39138606|FG013|Overall Study|Death|0|||
16180333|NCT03241173|39138607|FG014|Overall Study|Death|0|||
16180334|NCT03241173|39138593|FG000|Overall Study|Withdrawal by Subject|0|||
16180335|NCT03241173|39138594|FG001|Overall Study|Withdrawal by Subject|0|||
16180336|NCT03241173|39138595|FG002|Overall Study|Withdrawal by Subject|1|||
16180337|NCT03241173|39138596|FG003|Overall Study|Withdrawal by Subject|0|||
16180338|NCT03241173|39138597|FG004|Overall Study|Withdrawal by Subject|0|||
16180339|NCT03241173|39138598|FG005|Overall Study|Withdrawal by Subject|1|||
16180340|NCT03241173|39138599|FG006|Overall Study|Withdrawal by Subject|0|||
16180341|NCT03241173|39138600|FG007|Overall Study|Withdrawal by Subject|0|||
16180342|NCT03241173|39138601|FG008|Overall Study|Withdrawal by Subject|0|||
16180343|NCT03241173|39138602|FG009|Overall Study|Withdrawal by Subject|0|||
16180344|NCT03241173|39138603|FG010|Overall Study|Withdrawal by Subject|0|||
16180345|NCT03241173|39138604|FG011|Overall Study|Withdrawal by Subject|0|||
16180346|NCT03241173|39138605|FG012|Overall Study|Withdrawal by Subject|0|||
16180347|NCT03241173|39138606|FG013|Overall Study|Withdrawal by Subject|0|||
16180348|NCT03241173|39138607|FG014|Overall Study|Withdrawal by Subject|0|||
16180349|NCT03241173|39138593|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
16180350|NCT03241173|39138594|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
16180351|NCT03241173|39138595|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
16180352|NCT03241173|39138596|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
16180353|NCT03241173|39138597|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
16180354|NCT03241173|39138598|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
16180355|NCT03241173|39138599|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
16180356|NCT03241173|39138600|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
16180357|NCT03241173|39138601|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
16180358|NCT03241173|39138602|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
16180359|NCT03241173|39138603|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
16180360|NCT03241173|39138604|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
16180361|NCT03241173|39138605|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
16180362|NCT03241173|39138606|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
16180363|NCT03241173|39138607|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
16180364|NCT03241173|39138593|FG000|Overall Study|Lost to Follow-up|0|||
16180365|NCT03241173|39138594|FG001|Overall Study|Lost to Follow-up|0|||
16180366|NCT03241173|39138595|FG002|Overall Study|Lost to Follow-up|0|||
16180367|NCT03241173|39138596|FG003|Overall Study|Lost to Follow-up|0|||
16180368|NCT03241173|39138597|FG004|Overall Study|Lost to Follow-up|1|||
16180369|NCT03241173|39138598|FG005|Overall Study|Lost to Follow-up|0|||
16180370|NCT03241173|39138599|FG006|Overall Study|Lost to Follow-up|0|||
16180371|NCT03241173|39138600|FG007|Overall Study|Lost to Follow-up|0|||
16180372|NCT03241173|39138601|FG008|Overall Study|Lost to Follow-up|0|||
16180373|NCT03241173|39138602|FG009|Overall Study|Lost to Follow-up|1|||
16180374|NCT03241173|39138603|FG010|Overall Study|Lost to Follow-up|0|||
16180375|NCT03241173|39138604|FG011|Overall Study|Lost to Follow-up|0|||
16180376|NCT03241173|39138605|FG012|Overall Study|Lost to Follow-up|0|||
16180377|NCT03241173|39138606|FG013|Overall Study|Lost to Follow-up|0|||
16180378|NCT03241173|39138607|FG014|Overall Study|Lost to Follow-up|0|||
16180379|NCT00618956|39138608|FG000|Overall Study|Adverse Event|10|||
16180380|NCT00618956|39138609|FG001|Overall Study|Adverse Event|34|||
16180381|NCT00618956|39138608|FG000|Overall Study|Lack of Efficacy|2|||
16180382|NCT00618956|39138609|FG001|Overall Study|Lack of Efficacy|1|||
16180383|NCT00618956|39138608|FG000|Overall Study|Withdrawal by Subject|5|||
16180384|NCT00618956|39138609|FG001|Overall Study|Withdrawal by Subject|7|||
16180385|NCT00618956|39138608|FG000|Overall Study|Lost to Follow-up|4|||
16180386|NCT00618956|39138609|FG001|Overall Study|Lost to Follow-up|5|||
16180387|NCT00618956|39138608|FG000|Overall Study|Protocol Violation|2|||
16180388|NCT00618956|39138609|FG001|Overall Study|Protocol Violation|2|||
16180389|NCT00618956|39138608|FG000|Overall Study|did not meet criteria, non-compliance|2|||
16180390|NCT00618956|39138609|FG001|Overall Study|did not meet criteria, non-compliance|1|||
16180391|NCT00550238|39138610|FG000|Overall Study|Adverse Event|88|||
16180392|NCT00550238|39138610|FG000|Overall Study|Death|34|||
16180393|NCT00550238|39138610|FG000|Overall Study|Disease progression|46|||
16180394|NCT00550238|39138610|FG000|Overall Study|Withdrawal by Subject|167|||
16180395|NCT00550238|39138610|FG000|Overall Study|Physician Decision|31|||
16180396|NCT00550238|39138610|FG000|Overall Study|Patient noncompliance|25|||
16180397|NCT00550238|39138610|FG000|Overall Study|Lost to Follow-up|13|||
16180398|NCT00550238|39138610|FG000|Overall Study|Sponsor decision|55|||
16180399|NCT02032875|39138616|FG000|Treatment Period|Adverse Event|1|||
16180400|NCT02032875|39138617|FG001|Treatment Period|Adverse Event|0|||
16180401|NCT02032875|39138616|FG000|Treatment Period|Liver transplant, No extension needed|0|||
16180402|NCT02032875|39138617|FG001|Treatment Period|Liver transplant, No extension needed|1|||
16180403|NCT02032875|39138616|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
16180404|NCT02032875|39138617|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
16180405|NCT02032875|39138616|FG000|Follow-up Period|Death|0|||
16180406|NCT02032875|39138617|FG001|Follow-up Period|Death|1|||
16180407|NCT02032875|39138616|FG000|Follow-up Period|Virologic Relapse|3|||
16180408|NCT02032875|39138617|FG001|Follow-up Period|Virologic Relapse|10|||
16180409|NCT01252966|39138618|FG000|Overall Study|Lost to Follow-up|16|||
16180410|NCT01252966|39138619|FG001|Overall Study|Lost to Follow-up|10|||
16180411|NCT01252966|39138618|FG000|Overall Study|Withdrawal by Subject|7|||
16180412|NCT01252966|39138619|FG001|Overall Study|Withdrawal by Subject|3|||
16180413|NCT00174941|39138620|FG000|Overall Study|Adverse Event|1|||
16180414|NCT00174941|39138621|FG001|Overall Study|Adverse Event|10|||
16180415|NCT00174941|39138622|FG002|Overall Study|Adverse Event|2|||
16180416|NCT00174941|39138623|FG003|Overall Study|Adverse Event|13|||
16180417|NCT00174941|39138620|FG000|Overall Study|Protocol Violation|0|||
16180418|NCT00174941|39138621|FG001|Overall Study|Protocol Violation|1|||
16180419|NCT00174941|39138622|FG002|Overall Study|Protocol Violation|0|||
16180420|NCT00174941|39138623|FG003|Overall Study|Protocol Violation|1|||
16180421|NCT00174941|39138620|FG000|Overall Study|Lost to Follow-up|0|||
16180422|NCT00174941|39138621|FG001|Overall Study|Lost to Follow-up|3|||
16180423|NCT00174941|39138622|FG002|Overall Study|Lost to Follow-up|2|||
16180424|NCT00174941|39138623|FG003|Overall Study|Lost to Follow-up|5|||
16180425|NCT00174941|39138620|FG000|Overall Study|Personal Reason(s)|0|||
16180426|NCT00174941|39138621|FG001|Overall Study|Personal Reason(s)|14|||
16180427|NCT00174941|39138622|FG002|Overall Study|Personal Reason(s)|8|||
16180428|NCT00174941|39138623|FG003|Overall Study|Personal Reason(s)|22|||
16180429|NCT00174941|39138620|FG000|Overall Study|Gout Flare|0|||
16180430|NCT00174941|39138621|FG001|Overall Study|Gout Flare|4|||
16180431|NCT00174941|39138622|FG002|Overall Study|Gout Flare|4|||
16180432|NCT00174941|39138623|FG003|Overall Study|Gout Flare|8|||
16180433|NCT00174941|39138620|FG000|Overall Study|Reason Not Specified|1|||
16180434|NCT00174941|39138621|FG001|Overall Study|Reason Not Specified|6|||
16180435|NCT00174941|39138622|FG002|Overall Study|Reason Not Specified|2|||
16180436|NCT00174941|39138623|FG003|Overall Study|Reason Not Specified|9|||
16180437|NCT01208181|39138624|FG000|Part 1|Withdrawal by Subject|11|||
16279047|NCT03635983|39504212|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16279048|NCT03635983|39504211|FG000|Pre-Treatment Period|Other reasons|1|||
16279049|NCT03635983|39504212|FG001|Pre-Treatment Period|Other reasons|2|||
16279050|NCT03635983|39504211|FG000|Pre-Treatment Period|Disease Progression|0|||
16279051|NCT03635983|39504212|FG001|Pre-Treatment Period|Disease Progression|1|||
16279052|NCT03635983|39504211|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
16180438|NCT01208181|39138625|FG001|Part 1|Withdrawal by Subject|10|||
16180439|NCT01208181|39138626|FG002|Part 1|Withdrawal by Subject|0|||
16180440|NCT01208181|39138627|FG003|Part 1|Withdrawal by Subject|0|||
16180441|NCT01208181|39138628|FG004|Part 1|Withdrawal by Subject|0|||
16180442|NCT01208181|39138624|FG000|Part 1|Technical problem|5|||
16180443|NCT01208181|39138625|FG001|Part 1|Technical problem|0|||
16180444|NCT01208181|39138626|FG002|Part 1|Technical problem|0|||
16180445|NCT01208181|39138627|FG003|Part 1|Technical problem|0|||
16180446|NCT01208181|39138628|FG004|Part 1|Technical problem|0|||
16180447|NCT01208181|39138624|FG000|Part 1|Protocol Violation|10|||
16180448|NCT01208181|39138625|FG001|Part 1|Protocol Violation|5|||
16180449|NCT01208181|39138626|FG002|Part 1|Protocol Violation|0|||
16180450|NCT01208181|39138627|FG003|Part 1|Protocol Violation|0|||
16180451|NCT01208181|39138628|FG004|Part 1|Protocol Violation|0|||
16180452|NCT01208181|39138624|FG000|Part 1|Physician Decision|4|||
16180453|NCT01208181|39138625|FG001|Part 1|Physician Decision|0|||
16180454|NCT01208181|39138626|FG002|Part 1|Physician Decision|0|||
16180455|NCT01208181|39138627|FG003|Part 1|Physician Decision|0|||
16180456|NCT01208181|39138628|FG004|Part 1|Physician Decision|0|||
16180457|NCT01208181|39138624|FG000|Part 1|Non-compliance with study drug|1|||
16180458|NCT01208181|39138625|FG001|Part 1|Non-compliance with study drug|1|||
16180459|NCT01208181|39138626|FG002|Part 1|Non-compliance with study drug|0|||
16180460|NCT01208181|39138627|FG003|Part 1|Non-compliance with study drug|0|||
16180461|NCT01208181|39138628|FG004|Part 1|Non-compliance with study drug|0|||
16180462|NCT01208181|39138624|FG000|Part 1|Lost to Follow-up|5|||
16180463|NCT01208181|39138625|FG001|Part 1|Lost to Follow-up|3|||
16180464|NCT01208181|39138626|FG002|Part 1|Lost to Follow-up|0|||
16180465|NCT01208181|39138627|FG003|Part 1|Lost to Follow-up|0|||
16180466|NCT01208181|39138628|FG004|Part 1|Lost to Follow-up|1|||
16180467|NCT01208181|39138624|FG000|Part 1|Lack of Efficacy|37|||
16180468|NCT01208181|39138625|FG001|Part 1|Lack of Efficacy|12|||
16180469|NCT01208181|39138626|FG002|Part 1|Lack of Efficacy|0|||
16180470|NCT01208181|39138627|FG003|Part 1|Lack of Efficacy|0|||
16180471|NCT01208181|39138628|FG004|Part 1|Lack of Efficacy|17|||
16180472|NCT01208181|39138624|FG000|Part 1|Adverse Event|26|||
16180473|NCT01208181|39138625|FG001|Part 1|Adverse Event|24|||
16180474|NCT01208181|39138626|FG002|Part 1|Adverse Event|0|||
16180475|NCT01208181|39138627|FG003|Part 1|Adverse Event|0|||
16180476|NCT01208181|39138628|FG004|Part 1|Adverse Event|4|||
16180477|NCT01208181|39138624|FG000|Part 2|Adverse Event|0|||
16180478|NCT01208181|39138625|FG001|Part 2|Adverse Event|0|||
16180479|NCT01208181|39138626|FG002|Part 2|Adverse Event|6|||
16180480|NCT01208181|39138627|FG003|Part 2|Adverse Event|7|||
16180481|NCT01208181|39138628|FG004|Part 2|Adverse Event|0|||
16180482|NCT01208181|39138624|FG000|Part 2|Withdrawal by Subject|0|||
16180483|NCT01208181|39138625|FG001|Part 2|Withdrawal by Subject|0|||
16180484|NCT01208181|39138626|FG002|Part 2|Withdrawal by Subject|1|||
16180485|NCT01208181|39138627|FG003|Part 2|Withdrawal by Subject|1|||
16180486|NCT01208181|39138628|FG004|Part 2|Withdrawal by Subject|0|||
16279053|NCT03635983|39504212|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
16279054|NCT03635983|39504211|FG000|Treatment Period|Completed treatment period|13|||
16279055|NCT03635983|39504212|FG001|Treatment Period|Completed treatment period|20|||
16279056|NCT03635983|39504211|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
16279057|NCT03635983|39504212|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
16279058|NCT03635983|39504211|FG000|Treatment Period|Withdrawal by Subject|2|||
16279059|NCT03635983|39504212|FG001|Treatment Period|Withdrawal by Subject|4|||
16279060|NCT03635983|39504211|FG000|Treatment Period|Death|3|||
16279061|NCT03635983|39504212|FG001|Treatment Period|Death|4|||
16279062|NCT03635983|39504211|FG000|Treatment Period|Poor/Non-compliance|1|||
16279063|NCT03635983|39504212|FG001|Treatment Period|Poor/Non-compliance|0|||
16279064|NCT03635983|39504211|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
16279065|NCT03635983|39504212|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
16279066|NCT03635983|39504211|FG000|Treatment Period|Other reasons|5|||
16279067|NCT03635983|39504212|FG001|Treatment Period|Other reasons|2|||
16279068|NCT03635983|39504211|FG000|Treatment Period|Disease progression|184|||
16279069|NCT03635983|39504212|FG001|Treatment Period|Disease progression|168|||
16279070|NCT03635983|39504211|FG000|Treatment Period|Study drug toxicity|26|||
16279071|NCT03635983|39504212|FG001|Treatment Period|Study drug toxicity|29|||
16279072|NCT03635983|39504211|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
16279073|NCT03635983|39504212|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
16279074|NCT03635983|39504211|FG000|Treatment Period|Maximum clinical benefit|3|||
16279075|NCT03635983|39504212|FG001|Treatment Period|Maximum clinical benefit|2|||
16279076|NCT04102345|39504215|FG000|Overall Study|Withdrawal by Subject|1|||
16279077|NCT04102345|39504216|FG001|Overall Study|Withdrawal by Subject|0|||
16279078|NCT00401245|39504217|FG000|Double Blind Titration Phase|Adverse Event|3|||
16279079|NCT00401245|39504218|FG001|Double Blind Titration Phase|Adverse Event|2|||
16180487|NCT01208181|39138624|FG000|Part 2|Protocol Violation|0|||
16279080|NCT00401245|39504219|FG002|Double Blind Titration Phase|Adverse Event|5|||
16279081|NCT00401245|39504220|FG003|Double Blind Titration Phase|Adverse Event|12|||
16180488|NCT01208181|39138625|FG001|Part 2|Protocol Violation|0|||
16279082|NCT00401245|39504221|FG004|Double Blind Titration Phase|Adverse Event|0|||
16180489|NCT01208181|39138626|FG002|Part 2|Protocol Violation|1|||
16180490|NCT01208181|39138627|FG003|Part 2|Protocol Violation|0|||
16180491|NCT01208181|39138628|FG004|Part 2|Protocol Violation|0|||
16180492|NCT01208181|39138624|FG000|Part 2|Physician Decision|0|||
16180493|NCT01208181|39138625|FG001|Part 2|Physician Decision|0|||
16180494|NCT01208181|39138626|FG002|Part 2|Physician Decision|1|||
16180495|NCT01208181|39138627|FG003|Part 2|Physician Decision|2|||
16279083|NCT00401245|39504222|FG005|Double Blind Titration Phase|Adverse Event|0|||
16279084|NCT00401245|39504223|FG006|Double Blind Titration Phase|Adverse Event|0|||
16279085|NCT00401245|39504224|FG007|Double Blind Titration Phase|Adverse Event|0|||
16279086|NCT00401245|39504217|FG000|Double Blind Titration Phase|Other|0|||
16279087|NCT00401245|39504218|FG001|Double Blind Titration Phase|Other|0|||
16279088|NCT00401245|39504219|FG002|Double Blind Titration Phase|Other|1|||
16279089|NCT00401245|39504220|FG003|Double Blind Titration Phase|Other|0|||
16279090|NCT00401245|39504221|FG004|Double Blind Titration Phase|Other|0|||
16279091|NCT00401245|39504222|FG005|Double Blind Titration Phase|Other|0|||
16279092|NCT00401245|39504223|FG006|Double Blind Titration Phase|Other|0|||
16279093|NCT00401245|39504224|FG007|Double Blind Titration Phase|Other|0|||
16279094|NCT00401245|39504217|FG000|Double Blind Titration Phase|Protocol Violation|0|||
16279095|NCT00401245|39504218|FG001|Double Blind Titration Phase|Protocol Violation|0|||
16279096|NCT00401245|39504219|FG002|Double Blind Titration Phase|Protocol Violation|0|||
16279097|NCT00401245|39504220|FG003|Double Blind Titration Phase|Protocol Violation|1|||
16279098|NCT00401245|39504221|FG004|Double Blind Titration Phase|Protocol Violation|0|||
16279099|NCT00401245|39504222|FG005|Double Blind Titration Phase|Protocol Violation|0|||
16279100|NCT00401245|39504223|FG006|Double Blind Titration Phase|Protocol Violation|0|||
16279101|NCT00401245|39504224|FG007|Double Blind Titration Phase|Protocol Violation|0|||
16279102|NCT00401245|39504217|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
16279103|NCT00401245|39504218|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
16279104|NCT00401245|39504219|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
16279105|NCT00401245|39504220|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
16279106|NCT00401245|39504221|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
16279107|NCT00401245|39504222|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
16279108|NCT00401245|39504223|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
16279109|NCT00401245|39504224|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
16279110|NCT00401245|39504217|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
16279111|NCT00401245|39504218|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
16279112|NCT00401245|39504219|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
16279113|NCT00401245|39504220|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
16279114|NCT00401245|39504221|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
16279115|NCT00401245|39504222|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
16279116|NCT00401245|39504223|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
16279117|NCT00401245|39504224|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
16279118|NCT00401245|39504217|FG000|Open Label Phase|Adverse Event|5|||
16279119|NCT00401245|39504218|FG001|Open Label Phase|Adverse Event|14|||
16279120|NCT00401245|39504219|FG002|Open Label Phase|Adverse Event|6|||
16279121|NCT00401245|39504220|FG003|Open Label Phase|Adverse Event|7|||
16279122|NCT00401245|39504221|FG004|Open Label Phase|Adverse Event|0|||
16279123|NCT00401245|39504222|FG005|Open Label Phase|Adverse Event|0|||
16279124|NCT00401245|39504223|FG006|Open Label Phase|Adverse Event|0|||
16279125|NCT00401245|39504224|FG007|Open Label Phase|Adverse Event|0|||
16279126|NCT00401245|39504217|FG000|Open Label Phase|Lost to Follow-up|5|||
16279127|NCT00401245|39504218|FG001|Open Label Phase|Lost to Follow-up|7|||
16279128|NCT00401245|39504219|FG002|Open Label Phase|Lost to Follow-up|5|||
16279129|NCT00401245|39504220|FG003|Open Label Phase|Lost to Follow-up|4|||
16279130|NCT00401245|39504221|FG004|Open Label Phase|Lost to Follow-up|0|||
16279131|NCT00401245|39504222|FG005|Open Label Phase|Lost to Follow-up|0|||
16279132|NCT00401245|39504223|FG006|Open Label Phase|Lost to Follow-up|0|||
16279133|NCT00401245|39504224|FG007|Open Label Phase|Lost to Follow-up|0|||
16279134|NCT00401245|39504217|FG000|Open Label Phase|Other|4|||
16279135|NCT00401245|39504218|FG001|Open Label Phase|Other|8|||
16279136|NCT00401245|39504219|FG002|Open Label Phase|Other|7|||
16279137|NCT00401245|39504220|FG003|Open Label Phase|Other|8|||
16279138|NCT00401245|39504221|FG004|Open Label Phase|Other|0|||
16279139|NCT00401245|39504222|FG005|Open Label Phase|Other|0|||
16279140|NCT00401245|39504223|FG006|Open Label Phase|Other|0|||
16279141|NCT00401245|39504224|FG007|Open Label Phase|Other|0|||
16279142|NCT00401245|39504217|FG000|Open Label Phase|Protocol Violation|0|||
16279143|NCT00401245|39504218|FG001|Open Label Phase|Protocol Violation|1|||
16279144|NCT00401245|39504219|FG002|Open Label Phase|Protocol Violation|0|||
16279145|NCT00401245|39504220|FG003|Open Label Phase|Protocol Violation|1|||
16279146|NCT00401245|39504221|FG004|Open Label Phase|Protocol Violation|0|||
16279147|NCT00401245|39504222|FG005|Open Label Phase|Protocol Violation|0|||
16279148|NCT00401245|39504223|FG006|Open Label Phase|Protocol Violation|0|||
16279149|NCT00401245|39504224|FG007|Open Label Phase|Protocol Violation|0|||
16279150|NCT00401245|39504217|FG000|Open Label Phase|Withdrawal by Subject|3|||
16279151|NCT00401245|39504218|FG001|Open Label Phase|Withdrawal by Subject|3|||
16279152|NCT00401245|39504219|FG002|Open Label Phase|Withdrawal by Subject|2|||
16279153|NCT00401245|39504220|FG003|Open Label Phase|Withdrawal by Subject|1|||
16279154|NCT00401245|39504221|FG004|Open Label Phase|Withdrawal by Subject|0|||
16279155|NCT00401245|39504222|FG005|Open Label Phase|Withdrawal by Subject|0|||
16279156|NCT00401245|39504223|FG006|Open Label Phase|Withdrawal by Subject|0|||
16279157|NCT00401245|39504224|FG007|Open Label Phase|Withdrawal by Subject|0|||
16279158|NCT00401245|39504217|FG000|Open Label Phase|Lack of Efficacy|4|||
16279159|NCT00401245|39504218|FG001|Open Label Phase|Lack of Efficacy|2|||
16279160|NCT00401245|39504219|FG002|Open Label Phase|Lack of Efficacy|3|||
16279161|NCT00401245|39504220|FG003|Open Label Phase|Lack of Efficacy|0|||
16279162|NCT00401245|39504221|FG004|Open Label Phase|Lack of Efficacy|0|||
16279163|NCT00401245|39504222|FG005|Open Label Phase|Lack of Efficacy|0|||
16279164|NCT00401245|39504223|FG006|Open Label Phase|Lack of Efficacy|0|||
16279165|NCT00401245|39504224|FG007|Open Label Phase|Lack of Efficacy|0|||
16279166|NCT00401245|39504217|FG000|Double Blind Tapering Phase|Adverse Event|0|||
16279167|NCT00401245|39504218|FG001|Double Blind Tapering Phase|Adverse Event|0|||
16180496|NCT01208181|39138628|FG004|Part 2|Physician Decision|0|||
16180497|NCT01208181|39138624|FG000|Part 2|Non-compliance with study drug|0|||
16180498|NCT01208181|39138625|FG001|Part 2|Non-compliance with study drug|0|||
16180499|NCT01208181|39138626|FG002|Part 2|Non-compliance with study drug|1|||
16180500|NCT01208181|39138627|FG003|Part 2|Non-compliance with study drug|1|||
16180501|NCT01208181|39138628|FG004|Part 2|Non-compliance with study drug|0|||
16180502|NCT01208181|39138624|FG000|Part 2|Lost to Follow-up|0|||
16180503|NCT01208181|39138625|FG001|Part 2|Lost to Follow-up|0|||
16180504|NCT01208181|39138626|FG002|Part 2|Lost to Follow-up|1|||
16180505|NCT01208181|39138627|FG003|Part 2|Lost to Follow-up|2|||
16180506|NCT01208181|39138628|FG004|Part 2|Lost to Follow-up|0|||
16180507|NCT01208181|39138624|FG000|Part 2|Lack of Efficacy|0|||
16180508|NCT01208181|39138625|FG001|Part 2|Lack of Efficacy|0|||
16180509|NCT01208181|39138626|FG002|Part 2|Lack of Efficacy|5|||
16180510|NCT01208181|39138627|FG003|Part 2|Lack of Efficacy|7|||
16180511|NCT01208181|39138628|FG004|Part 2|Lack of Efficacy|0|||
16180512|NCT01713348|39138629|FG000|Overall Study|Withdrawal by Subject|3|||
16180513|NCT01713348|39138630|FG001|Overall Study|Withdrawal by Subject|2|||
16180514|NCT01713348|39138631|FG002|Overall Study|Withdrawal by Subject|2|||
16180515|NCT01713348|39138632|FG003|Overall Study|Withdrawal by Subject|0|||
16180516|NCT01713348|39138629|FG000|Overall Study|Lost to Follow-up|1|||
16180517|NCT01713348|39138630|FG001|Overall Study|Lost to Follow-up|0|||
16180518|NCT01713348|39138631|FG002|Overall Study|Lost to Follow-up|0|||
16180519|NCT01713348|39138632|FG003|Overall Study|Lost to Follow-up|0|||
16180520|NCT02436239|39138633|FG000|Open-Lable Treatment Period|Adverse Event|12|||
16180521|NCT02436239|39138634|FG001|Open-Lable Treatment Period|Adverse Event|3|||
16180522|NCT02436239|39138635|FG002|Open-Lable Treatment Period|Adverse Event|4|||
16180523|NCT02436239|39138636|FG003|Open-Lable Treatment Period|Adverse Event|2|||
16180524|NCT02436239|39138633|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
16180525|NCT02436239|39138634|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
16180526|NCT02436239|39138635|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
16180527|NCT02436239|39138636|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
16180528|NCT02436239|39138633|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
16180529|NCT02436239|39138634|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
16180530|NCT02436239|39138635|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
16180531|NCT02436239|39138636|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
16180532|NCT02436239|39138633|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
16180533|NCT02436239|39138634|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
16180534|NCT02436239|39138635|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
16180535|NCT02436239|39138636|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
16180536|NCT02436239|39138633|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
16180537|NCT02436239|39138634|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
16180538|NCT02436239|39138635|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
16180539|NCT02436239|39138636|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
16180540|NCT02436239|39138633|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
16180541|NCT02436239|39138634|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
16180542|NCT02436239|39138635|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
16180543|NCT02436239|39138636|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
16180544|NCT02436239|39138633|FG000|Open-Lable Treatment Period|Other Reason|1|||
16180545|NCT02436239|39138634|FG001|Open-Lable Treatment Period|Other Reason|1|||
16180546|NCT02436239|39138635|FG002|Open-Lable Treatment Period|Other Reason|0|||
16180547|NCT02436239|39138636|FG003|Open-Lable Treatment Period|Other Reason|0|||
16180548|NCT02436239|39138633|FG000|Down-Taper Period|Withdrawal by Subject|4|||
16180549|NCT02436239|39138634|FG001|Down-Taper Period|Withdrawal by Subject|4|||
16180550|NCT02436239|39138635|FG002|Down-Taper Period|Withdrawal by Subject|1|||
16180551|NCT02436239|39138636|FG003|Down-Taper Period|Withdrawal by Subject|2|||
16180552|NCT03414359|39138637|FG000|Overall Study|Lack of Efficacy|1|||
16180553|NCT03414359|39138638|FG001|Overall Study|Lack of Efficacy|1|||
16279168|NCT00401245|39504219|FG002|Double Blind Tapering Phase|Adverse Event|0|||
16279169|NCT00401245|39504220|FG003|Double Blind Tapering Phase|Adverse Event|0|||
16279170|NCT00401245|39504221|FG004|Double Blind Tapering Phase|Adverse Event|1|||
16279171|NCT00401245|39504222|FG005|Double Blind Tapering Phase|Adverse Event|1|||
16180554|NCT03414359|39138637|FG000|Overall Study|Protocol Violation|0|||
16180555|NCT03414359|39138638|FG001|Overall Study|Protocol Violation|1|||
16180556|NCT00510692|39138639|FG000|Overall Study|Adverse Event|1|||
16180557|NCT00510692|39138640|FG001|Overall Study|Adverse Event|3|||
16180558|NCT00510692|39138639|FG000|Overall Study|Withdrawal by Subject|1|||
16180559|NCT00510692|39138640|FG001|Overall Study|Withdrawal by Subject|0|||
16180560|NCT03060577|39138643|FG000|Overall Study|Withdrawal by Subject|25|||
16180561|NCT03060577|39138644|FG001|Overall Study|Withdrawal by Subject|5|||
16180562|NCT03060577|39138643|FG000|Overall Study|Physician Decision|4|||
16180563|NCT03060577|39138644|FG001|Overall Study|Physician Decision|3|||
16180564|NCT03060577|39138643|FG000|Overall Study|Lost to Follow-up|3|||
16180565|NCT03060577|39138644|FG001|Overall Study|Lost to Follow-up|0|||
16180566|NCT03060577|39138643|FG000|Overall Study|Death|7|||
16180567|NCT03060577|39138644|FG001|Overall Study|Death|1|||
16180568|NCT03060577|39138643|FG000|Overall Study|Adverse Event|9|||
16180569|NCT03060577|39138644|FG001|Overall Study|Adverse Event|1|||
16180570|NCT03060577|39138643|FG000|Overall Study|Inclusion/Exclusion|1|||
16180571|NCT03060577|39138644|FG001|Overall Study|Inclusion/Exclusion|0|||
16180572|NCT03060577|39138643|FG000|Overall Study|Other|8|||
16180573|NCT03060577|39138644|FG001|Overall Study|Other|2|||
16180574|NCT04083222|39138646|FG000|Overall Study|Voluntary Withdrawal|0|||
16180575|NCT04083222|39138647|FG001|Overall Study|Voluntary Withdrawal|1|||
16180576|NCT04083222|39138646|FG000|Overall Study|Reason not Specified|0|||
16180577|NCT04083222|39138647|FG001|Overall Study|Reason not Specified|1|||
16180578|NCT02243176|39138648|FG000|Overall Study|Other reason|1|||
16180579|NCT02243176|39138649|FG001|Overall Study|Other reason|2|||
16180580|NCT02243176|39138648|FG000|Overall Study|protocol specified withdrawal critera|1|||
16180581|NCT02243176|39138649|FG001|Overall Study|protocol specified withdrawal critera|3|||
16180582|NCT02243176|39138648|FG000|Overall Study|Protocol Violation|2|||
16180583|NCT02243176|39138649|FG001|Overall Study|Protocol Violation|1|||
16180584|NCT02243176|39138648|FG000|Overall Study|Withdrawal by Subject|8|||
16180585|NCT02243176|39138649|FG001|Overall Study|Withdrawal by Subject|7|||
16180586|NCT02243176|39138648|FG000|Overall Study|Adverse Event|2|||
16180587|NCT02243176|39138649|FG001|Overall Study|Adverse Event|2|||
16180588|NCT04430348|39138650|FG000|Overall Study|Death|3|||
16180589|NCT04430348|39138651|FG001|Overall Study|Death|2|||
16180590|NCT04430348|39138652|FG002|Overall Study|Death|2|||
16180591|NCT04430348|39138653|FG003|Overall Study|Death|2|||
16180592|NCT04430348|39138654|FG004|Overall Study|Death|2|||
16180593|NCT04430348|39138655|FG005|Overall Study|Death|3|||
16180594|NCT04430348|39138650|FG000|Overall Study|Lost to Follow-up|0|||
16180595|NCT04430348|39138651|FG001|Overall Study|Lost to Follow-up|0|||
16180596|NCT04430348|39138652|FG002|Overall Study|Lost to Follow-up|0|||
16180597|NCT04430348|39138653|FG003|Overall Study|Lost to Follow-up|1|||
16180598|NCT04430348|39138654|FG004|Overall Study|Lost to Follow-up|0|||
16180599|NCT04430348|39138655|FG005|Overall Study|Lost to Follow-up|0|||
16180600|NCT04430348|39138650|FG000|Overall Study|Adverse Event|0|||
16180601|NCT04430348|39138651|FG001|Overall Study|Adverse Event|0|||
16180602|NCT04430348|39138652|FG002|Overall Study|Adverse Event|0|||
16180603|NCT04430348|39138653|FG003|Overall Study|Adverse Event|0|||
16180604|NCT04430348|39138654|FG004|Overall Study|Adverse Event|0|||
16180605|NCT04430348|39138655|FG005|Overall Study|Adverse Event|1|||
16180606|NCT04430348|39138650|FG000|Overall Study|Withdrawal by Subject|0|||
16180607|NCT04430348|39138651|FG001|Overall Study|Withdrawal by Subject|1|||
16180608|NCT04430348|39138652|FG002|Overall Study|Withdrawal by Subject|0|||
16180609|NCT04430348|39138653|FG003|Overall Study|Withdrawal by Subject|0|||
16180610|NCT04430348|39138654|FG004|Overall Study|Withdrawal by Subject|0|||
16180611|NCT04430348|39138655|FG005|Overall Study|Withdrawal by Subject|1|||
16180612|NCT04430348|39138650|FG000|Overall Study|Study Terminated by Sponsor|0|||
16180613|NCT04430348|39138651|FG001|Overall Study|Study Terminated by Sponsor|0|||
16180614|NCT04430348|39138652|FG002|Overall Study|Study Terminated by Sponsor|2|||
16180615|NCT04430348|39138653|FG003|Overall Study|Study Terminated by Sponsor|0|||
16180616|NCT04430348|39138654|FG004|Overall Study|Study Terminated by Sponsor|1|||
16180617|NCT04430348|39138655|FG005|Overall Study|Study Terminated by Sponsor|1|||
16180618|NCT00404768|39138656|FG000|Part A and B|Withdrawn due to labor progression|1|||
16180619|NCT00404768|39138657|FG001|Part A and B|Withdrawn due to labor progression|0|||
16180620|NCT00404768|39138658|FG002|Part A and B|Withdrawn due to labor progression|0|||
16180621|NCT00404768|39138659|FG003|Part A and B|Withdrawn due to labor progression|0|||
16180622|NCT00404768|39138656|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
16180623|NCT00404768|39138657|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
16180624|NCT00404768|39138658|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
16180625|NCT00404768|39138659|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
16180626|NCT00404768|39138656|FG000|Part C|Adverse Event|0|||
16180627|NCT00404768|39138657|FG001|Part C|Adverse Event|0|||
16180628|NCT00404768|39138658|FG002|Part C|Adverse Event|0|||
16180629|NCT00404768|39138659|FG003|Part C|Adverse Event|3|||
16180630|NCT00404768|39138656|FG000|Part C|Lost to Follow-up|0|||
16180631|NCT00404768|39138657|FG001|Part C|Lost to Follow-up|0|||
16180632|NCT00404768|39138658|FG002|Part C|Lost to Follow-up|3|||
16180633|NCT00404768|39138659|FG003|Part C|Lost to Follow-up|1|||
16180634|NCT00404768|39138656|FG000|Part C|Withdrawal by Subject|0|||
16180635|NCT00404768|39138657|FG001|Part C|Withdrawal by Subject|0|||
16180636|NCT00404768|39138658|FG002|Part C|Withdrawal by Subject|2|||
16180637|NCT00404768|39138659|FG003|Part C|Withdrawal by Subject|1|||
16180638|NCT00404768|39138656|FG000|Part C|Early withdrawal from study medication|0|||
16180639|NCT00404768|39138657|FG001|Part C|Early withdrawal from study medication|0|||
16180640|NCT00404768|39138658|FG002|Part C|Early withdrawal from study medication|1|||
16180641|NCT00404768|39138659|FG003|Part C|Early withdrawal from study medication|0|||
16180642|NCT00404768|39138656|FG000|Part C|Participant did not respond to therapy|0|||
16180643|NCT00404768|39138657|FG001|Part C|Participant did not respond to therapy|0|||
16180644|NCT00404768|39138658|FG002|Part C|Participant did not respond to therapy|1|||
16180645|NCT00404768|39138659|FG003|Part C|Participant did not respond to therapy|1|||
16180646|NCT00404768|39138656|FG000|Part C|Physician withdrew the study medication|0|||
16180647|NCT00404768|39138657|FG001|Part C|Physician withdrew the study medication|0|||
16180648|NCT00404768|39138658|FG002|Part C|Physician withdrew the study medication|1|||
16180649|NCT00404768|39138659|FG003|Part C|Physician withdrew the study medication|0|||
16180650|NCT00404768|39138656|FG000|Part C|Participant delivered baby|0|||
16180651|NCT00404768|39138657|FG001|Part C|Participant delivered baby|0|||
16180652|NCT00404768|39138658|FG002|Part C|Participant delivered baby|0|||
16180653|NCT00404768|39138659|FG003|Part C|Participant delivered baby|1|||
16180654|NCT00404768|39138656|FG000|Part C|Unsatisfactory uterine response to IP|0|||
16180655|NCT00404768|39138657|FG001|Part C|Unsatisfactory uterine response to IP|0|||
16180656|NCT00404768|39138658|FG002|Part C|Unsatisfactory uterine response to IP|0|||
16180657|NCT00404768|39138659|FG003|Part C|Unsatisfactory uterine response to IP|1|||
16180658|NCT00404768|39138656|FG000|Part C|Active labor|0|||
16180659|NCT00404768|39138657|FG001|Part C|Active labor|0|||
16180660|NCT00404768|39138658|FG002|Part C|Active labor|0|||
16180661|NCT00404768|39138659|FG003|Part C|Active labor|1|||
16180662|NCT00404768|39138656|FG000|Part C|Lack of Efficacy|0|||
16180663|NCT00404768|39138657|FG001|Part C|Lack of Efficacy|0|||
16180664|NCT00404768|39138658|FG002|Part C|Lack of Efficacy|0|||
16180665|NCT00404768|39138659|FG003|Part C|Lack of Efficacy|2|||
16180666|NCT00404768|39138656|FG000|Part C|Treatment failure|0|||
16180667|NCT00404768|39138657|FG001|Part C|Treatment failure|0|||
16180668|NCT00404768|39138658|FG002|Part C|Treatment failure|0|||
16180669|NCT00404768|39138659|FG003|Part C|Treatment failure|1|||
16180670|NCT00404768|39138656|FG000|Part C|Investigator discretion|0|||
16180671|NCT00404768|39138657|FG001|Part C|Investigator discretion|0|||
16180672|NCT00404768|39138658|FG002|Part C|Investigator discretion|0|||
16180673|NCT00404768|39138659|FG003|Part C|Investigator discretion|1|||
16180674|NCT00404768|39138656|FG000|Part C|Researcher suspended study medication|0|||
16180675|NCT00404768|39138657|FG001|Part C|Researcher suspended study medication|0|||
16180676|NCT00404768|39138658|FG002|Part C|Researcher suspended study medication|0|||
16180677|NCT00404768|39138659|FG003|Part C|Researcher suspended study medication|1|||
16180678|NCT01457339|39138660|FG000|Period 3 (100 mg)|Adverse Event|0|||
16180679|NCT01457339|39138661|FG001|Period 3 (100 mg)|Adverse Event|1|||
16180680|NCT01457339|39138660|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
16180681|NCT01457339|39138661|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
16180682|NCT01457339|39138660|FG000|Period 6 (250 mg)|Family Emergency|1|||
16180683|NCT01457339|39138661|FG001|Period 6 (250 mg)|Family Emergency|0|||
16180684|NCT01457339|39138660|FG000|Period 6 (250 mg)|Personal appointment|0|||
16180685|NCT01457339|39138661|FG001|Period 6 (250 mg)|Personal appointment|1|||
16180686|NCT02345161|39138662|FG000|Overall Study|Withdrawal by Subject|25|||
16478671|NCT02607930|40234247|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
16478672|NCT02607930|40234248|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
16180687|NCT02345161|39138663|FG001|Overall Study|Withdrawal by Subject|33|||
16180688|NCT02345161|39138662|FG000|Overall Study|Adverse Event|16|||
16180689|NCT02345161|39138663|FG001|Overall Study|Adverse Event|19|||
16180690|NCT02345161|39138662|FG000|Overall Study|Physician Decision|4|||
16180691|NCT02345161|39138663|FG001|Overall Study|Physician Decision|4|||
16180692|NCT02345161|39138662|FG000|Overall Study|Lost to Follow-up|0|||
16180693|NCT02345161|39138663|FG001|Overall Study|Lost to Follow-up|1|||
16180694|NCT00095303|39138665|FG000|Main Study|Lost to Follow-up|91|||
16180695|NCT00095303|39138666|FG001|Main Study|Lost to Follow-up|87|||
16180696|NCT00095303|39138665|FG000|Follow Up Study|Lost to Follow-up|59|||
16180697|NCT00095303|39138666|FG001|Follow Up Study|Lost to Follow-up|58|||
16478673|NCT02607930|40234245|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
16478674|NCT02607930|40234246|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
16478675|NCT02607930|40234247|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
16180698|NCT00443560|39138667|FG000|Overall Study|No intrathecal dose|58|||
16180699|NCT00443560|39138668|FG001|Overall Study|No intrathecal dose|26|||
16180700|NCT00443560|39138667|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
16180701|NCT00443560|39138668|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
16180702|NCT02024464|39138669|FG000|Overall Study|Discontinued|5|||
16180703|NCT02024464|39138670|FG001|Overall Study|Discontinued|4|||
16180704|NCT02024464|39138669|FG000|Overall Study|Missed Visits|1|||
16180705|NCT02024464|39138670|FG001|Overall Study|Missed Visits|0|||
16180706|NCT02024464|39138669|FG000|Overall Study|Lost to Follow-up|4|||
16180707|NCT02024464|39138670|FG001|Overall Study|Lost to Follow-up|7|||
16180708|NCT00707577|39138671|FG000|Overall Study|Withdrawal by Subject|3|||
16180709|NCT00707577|39138672|FG001|Overall Study|Withdrawal by Subject|2|||
16180710|NCT00707577|39138671|FG000|Overall Study|Lost to Follow-up|34|||
16180711|NCT00707577|39138672|FG001|Overall Study|Lost to Follow-up|25|||
16180712|NCT00707577|39138671|FG000|Overall Study|Left employment|13|||
16180713|NCT00707577|39138672|FG001|Overall Study|Left employment|10|||
16180714|NCT00707577|39138671|FG000|Overall Study|Pregnancy|4|||
16180715|NCT00707577|39138672|FG001|Overall Study|Pregnancy|1|||
16180716|NCT02369510|39138674|FG000|Overall Study|Spilled Medication|1|||
16180717|NCT02369510|39138675|FG001|Overall Study|Spilled Medication|2|||
16180718|NCT02369510|39138676|FG002|Overall Study|Spilled Medication|1|||
16180719|NCT02369510|39138674|FG000|Overall Study|Epidural Activation|1|||
16180720|NCT02369510|39138675|FG001|Overall Study|Epidural Activation|1|||
16180721|NCT02369510|39138676|FG002|Overall Study|Epidural Activation|5|||
16180722|NCT01707147|39138677|FG000|Overall Study|Administered Trajenta prior to contract|5|||
16180723|NCT01707147|39138677|FG000|Overall Study|Patients who have not taken Trajenta|1|||
16180724|NCT01707147|39138677|FG000|Overall Study|Follow-up failure|17|||
16180725|NCT01707147|39138677|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
16180726|NCT00850499|39138678|FG000|Overall Study|Adverse Event|3|||
16180727|NCT00850499|39138679|FG001|Overall Study|Adverse Event|1|||
16180728|NCT00850499|39138678|FG000|Overall Study|Lack of Efficacy|0|||
16180729|NCT00850499|39138679|FG001|Overall Study|Lack of Efficacy|1|||
16180730|NCT01548638|39138681|FG000|Overall Study|Protocol Violation|3|||
16180731|NCT01548638|39138681|FG000|Overall Study|Withdrawal by Subject|1|||
16180732|NCT02371629|39138682|FG000|Overall Study|Patient decision|14|||
16180733|NCT02371629|39138683|FG001|Overall Study|Patient decision|10|||
16180734|NCT02371629|39138682|FG000|Overall Study|Adverse Event|8|||
16180735|NCT02371629|39138683|FG001|Overall Study|Adverse Event|8|||
16180736|NCT02371629|39138682|FG000|Overall Study|Physician Decision|2|||
16180737|NCT02371629|39138683|FG001|Overall Study|Physician Decision|3|||
16180738|NCT02371629|39138682|FG000|Overall Study|Death|1|||
16180739|NCT02371629|39138683|FG001|Overall Study|Death|1|||
16180740|NCT02371629|39138682|FG000|Overall Study|Noncompliance with study treatment|1|||
16180741|NCT02371629|39138683|FG001|Overall Study|Noncompliance with study treatment|0|||
16180742|NCT02371629|39138682|FG000|Overall Study|Lack of Efficacy|0|||
16180743|NCT02371629|39138683|FG001|Overall Study|Lack of Efficacy|2|||
16180744|NCT02371629|39138682|FG000|Overall Study|Protocol deviation|0|||
16180745|NCT02371629|39138683|FG001|Overall Study|Protocol deviation|1|||
16180746|NCT03114969|39142021|FG000|Overall Study|Lost to Follow-up|0|||
16180747|NCT03114969|39142022|FG001|Overall Study|Lost to Follow-up|0|||
16180748|NCT03114969|39142023|FG002|Overall Study|Lost to Follow-up|3|||
16180749|NCT03114969|39142024|FG003|Overall Study|Lost to Follow-up|2|||
16180750|NCT03114969|39142025|FG004|Overall Study|Lost to Follow-up|0|||
16180751|NCT03114969|39142026|FG005|Overall Study|Lost to Follow-up|0|||
16180752|NCT03114969|39142027|FG006|Overall Study|Lost to Follow-up|0|||
16180753|NCT03114969|39142028|FG007|Overall Study|Lost to Follow-up|0|||
16180754|NCT03114969|39142029|FG008|Overall Study|Lost to Follow-up|0|||
16180755|NCT03114969|39142021|FG000|Overall Study|Adverse Event|0|||
16180756|NCT03114969|39142022|FG001|Overall Study|Adverse Event|0|||
16180757|NCT03114969|39142023|FG002|Overall Study|Adverse Event|1|||
16180758|NCT03114969|39142024|FG003|Overall Study|Adverse Event|0|||
16180759|NCT03114969|39142025|FG004|Overall Study|Adverse Event|0|||
16180760|NCT03114969|39142026|FG005|Overall Study|Adverse Event|1|||
16180761|NCT03114969|39142027|FG006|Overall Study|Adverse Event|1|||
16180762|NCT03114969|39142028|FG007|Overall Study|Adverse Event|0|||
16180763|NCT03114969|39142029|FG008|Overall Study|Adverse Event|2|||
16180764|NCT04723537|39142030|FG000|Overall Study|Withdrawal by Subject|3|||
16180765|NCT04723537|39142031|FG001|Overall Study|Withdrawal by Subject|0|||
16180766|NCT04723537|39142032|FG002|Overall Study|Withdrawal by Subject|0|||
16180767|NCT04723537|39142030|FG000|Overall Study|Physician Decision|0|||
16180768|NCT04723537|39142031|FG001|Overall Study|Physician Decision|0|||
16180769|NCT04723537|39142032|FG002|Overall Study|Physician Decision|1|||
16180770|NCT04723537|39142030|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
16180771|NCT04723537|39142031|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
16180772|NCT04723537|39142032|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
16180773|NCT00875420|39142035|FG000|Overall Study|Adverse Event|0|||
16180774|NCT00875420|39142036|FG001|Overall Study|Adverse Event|1|||
16180775|NCT00875420|39142037|FG002|Overall Study|Adverse Event|1|||
16180776|NCT00875420|39142038|FG003|Overall Study|Adverse Event|0|||
16180777|NCT00875420|39142039|FG004|Overall Study|Adverse Event|0|||
16180778|NCT00875420|39142035|FG000|Overall Study|Inability to complete study procedures|1|||
16180779|NCT00875420|39142036|FG001|Overall Study|Inability to complete study procedures|0|||
16180780|NCT00875420|39142037|FG002|Overall Study|Inability to complete study procedures|1|||
16180781|NCT00875420|39142038|FG003|Overall Study|Inability to complete study procedures|1|||
16180782|NCT00875420|39142039|FG004|Overall Study|Inability to complete study procedures|1|||
16180783|NCT00875420|39142035|FG000|Overall Study|Lost to Follow-up|1|||
16180784|NCT00875420|39142036|FG001|Overall Study|Lost to Follow-up|0|||
16180785|NCT00875420|39142037|FG002|Overall Study|Lost to Follow-up|0|||
16180786|NCT00875420|39142038|FG003|Overall Study|Lost to Follow-up|0|||
16180787|NCT00875420|39142039|FG004|Overall Study|Lost to Follow-up|0|||
16180788|NCT00875420|39142035|FG000|Overall Study|Personal reason|0|||
16180789|NCT00875420|39142036|FG001|Overall Study|Personal reason|0|||
16180790|NCT00875420|39142037|FG002|Overall Study|Personal reason|0|||
16478676|NCT02607930|40234248|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
16478677|NCT02607930|40234245|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
16478678|NCT02607930|40234246|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
16478679|NCT02607930|40234247|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
16478680|NCT02607930|40234248|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
16478681|NCT02607930|40234245|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
16478682|NCT02607930|40234246|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
16478683|NCT02607930|40234247|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
16478684|NCT02607930|40234248|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
16478685|NCT02607930|40234245|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
16180791|NCT00875420|39142038|FG003|Overall Study|Personal reason|0|||
16180792|NCT00875420|39142039|FG004|Overall Study|Personal reason|1|||
16180793|NCT00875420|39142035|FG000|Overall Study|Prohibited medication|0|||
16180794|NCT00875420|39142036|FG001|Overall Study|Prohibited medication|0|||
16180795|NCT00875420|39142037|FG002|Overall Study|Prohibited medication|0|||
16180796|NCT00875420|39142038|FG003|Overall Study|Prohibited medication|1|||
16180797|NCT00875420|39142039|FG004|Overall Study|Prohibited medication|0|||
16180798|NCT00875420|39142035|FG000|Overall Study|Sponsor decision|0|||
16180799|NCT00875420|39142036|FG001|Overall Study|Sponsor decision|1|||
16180800|NCT00875420|39142037|FG002|Overall Study|Sponsor decision|0|||
16180801|NCT00875420|39142038|FG003|Overall Study|Sponsor decision|0|||
16180802|NCT00875420|39142039|FG004|Overall Study|Sponsor decision|0|||
16180803|NCT00875420|39142035|FG000|Overall Study|Withdrawal by Subject|0|||
16180804|NCT00875420|39142036|FG001|Overall Study|Withdrawal by Subject|0|||
16180805|NCT00875420|39142037|FG002|Overall Study|Withdrawal by Subject|1|||
16180806|NCT00875420|39142038|FG003|Overall Study|Withdrawal by Subject|0|||
16180807|NCT00875420|39142039|FG004|Overall Study|Withdrawal by Subject|0|||
16180808|NCT04542291|39142040|FG000|Overall Study|Adverse Event|1|||
16180809|NCT04542291|39142040|FG000|Overall Study|Physician Decision|2|||
16180810|NCT02725177|39142043|FG000|Overall Study|Physician Decision|4|||
16180811|NCT02725177|39142043|FG000|Overall Study|Adverse Event|1|||
16180812|NCT01756157|39142047|FG000|First Intervention Period|Withdrawal by Subject|1|||
16180813|NCT01756157|39142048|FG001|First Intervention Period|Withdrawal by Subject|0|||
16180814|NCT01756157|39142047|FG000|First Intervention Period|Lost to Follow-up|0|||
16180815|NCT01756157|39142048|FG001|First Intervention Period|Lost to Follow-up|2|||
16180816|NCT00872898|39142050|FG000|Part Two - Double Blind|Adverse Event|4|||
16478686|NCT02607930|40234246|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
16478687|NCT02607930|40234247|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
16478688|NCT02607930|40234248|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
16478689|NCT02607930|40234245|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
16478690|NCT02607930|40234246|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
16478691|NCT02607930|40234247|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
16478692|NCT02607930|40234248|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
16478693|NCT02607930|40234245|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
16478694|NCT02607930|40234246|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
16478695|NCT02607930|40234247|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
16478696|NCT02607930|40234248|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
16478697|NCT02607930|40234245|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
16478698|NCT02607930|40234246|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
16478699|NCT02607930|40234247|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
16478700|NCT02607930|40234248|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
16478701|NCT02607930|40234245|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
16478702|NCT02607930|40234246|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
16478703|NCT02607930|40234247|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
16478704|NCT02607930|40234248|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
16478705|NCT01160211|40234249|FG000|Overall Study|ongoing|90|||
16180817|NCT00872898|39142051|FG001|Part Two - Double Blind|Adverse Event|3|||
16180818|NCT00872898|39142050|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
16180819|NCT00872898|39142051|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
16180820|NCT00872898|39142050|FG000|Part Two - Double Blind|Protocol Violation|1|||
16180821|NCT00872898|39142051|FG001|Part Two - Double Blind|Protocol Violation|0|||
16180822|NCT00872898|39142050|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
16180823|NCT00872898|39142051|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
16180824|NCT00872898|39142050|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
16478706|NCT01160211|40234250|FG001|Overall Study|ongoing|75|||
16478707|NCT01160211|40234251|FG002|Overall Study|ongoing|79|||
16478708|NCT01160211|40234249|FG000|Overall Study|Withdrawal by Subject|3|||
16478709|NCT01160211|40234250|FG001|Overall Study|Withdrawal by Subject|5|||
16478710|NCT01160211|40234251|FG002|Overall Study|Withdrawal by Subject|3|||
16478711|NCT01160211|40234249|FG000|Overall Study|Physician Decision|2|||
16478712|NCT01160211|40234250|FG001|Overall Study|Physician Decision|0|||
16478713|NCT01160211|40234251|FG002|Overall Study|Physician Decision|0|||
16478714|NCT01160211|40234249|FG000|Overall Study|Lost to Follow-up|4|||
16478715|NCT01160211|40234250|FG001|Overall Study|Lost to Follow-up|7|||
16478716|NCT01160211|40234251|FG002|Overall Study|Lost to Follow-up|5|||
16478717|NCT00142935|40234252|FG000|Overall Study|Other reason|1|||
16180825|NCT00872898|39142051|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
16180826|NCT00872898|39142050|FG000|Part Two - Double Blind|Other reasons|2|||
16180827|NCT00872898|39142051|FG001|Part Two - Double Blind|Other reasons|0|||
16180828|NCT03894540|39142052|FG000|Overall Study|Adverse Event|0|||
16180829|NCT03894540|39142053|FG001|Overall Study|Adverse Event|0|||
16180830|NCT03894540|39142054|FG002|Overall Study|Adverse Event|0|||
16180831|NCT03894540|39142055|FG003|Overall Study|Adverse Event|0|||
16180832|NCT03894540|39142056|FG004|Overall Study|Adverse Event|1|||
16180833|NCT03894540|39142057|FG005|Overall Study|Adverse Event|0|||
16180834|NCT03894540|39142052|FG000|Overall Study|Withdrawal by Subject|0|||
16180835|NCT03894540|39142053|FG001|Overall Study|Withdrawal by Subject|0|||
16180836|NCT03894540|39142054|FG002|Overall Study|Withdrawal by Subject|0|||
16180837|NCT03894540|39142055|FG003|Overall Study|Withdrawal by Subject|0|||
16180838|NCT03894540|39142056|FG004|Overall Study|Withdrawal by Subject|1|||
16180839|NCT03894540|39142057|FG005|Overall Study|Withdrawal by Subject|0|||
16180840|NCT03894540|39142052|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
16180841|NCT03894540|39142053|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
16180842|NCT03894540|39142054|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
16180843|NCT03894540|39142055|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
16180844|NCT03894540|39142056|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
16180845|NCT03894540|39142057|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
16180846|NCT03894540|39142052|FG000|Overall Study|Progressive Disease Clinical|1|||
16180847|NCT03894540|39142053|FG001|Overall Study|Progressive Disease Clinical|1|||
16180848|NCT03894540|39142054|FG002|Overall Study|Progressive Disease Clinical|0|||
16180849|NCT03894540|39142055|FG003|Overall Study|Progressive Disease Clinical|1|||
16180850|NCT03894540|39142056|FG004|Overall Study|Progressive Disease Clinical|5|||
16180851|NCT03894540|39142057|FG005|Overall Study|Progressive Disease Clinical|1|||
16180852|NCT03894540|39142052|FG000|Overall Study|Study termination by sponsor|0|||
16180853|NCT03894540|39142053|FG001|Overall Study|Study termination by sponsor|0|||
16180854|NCT03894540|39142054|FG002|Overall Study|Study termination by sponsor|0|||
16180855|NCT03894540|39142055|FG003|Overall Study|Study termination by sponsor|0|||
16180856|NCT03894540|39142056|FG004|Overall Study|Study termination by sponsor|2|||
16180857|NCT03894540|39142057|FG005|Overall Study|Study termination by sponsor|0|||
16180858|NCT03894904|39142060|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
16180859|NCT03894904|39142061|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
16180860|NCT03894904|39142060|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
16180861|NCT03894904|39142061|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
16180862|NCT03476239|39142062|FG000|Overall Study|Withdrawal by Subject|10|||
16180863|NCT03476239|39142062|FG000|Overall Study|Death|80|||
16180864|NCT03476239|39142062|FG000|Overall Study|Lost to Follow-up|8|||
16180865|NCT02795767|39142063|FG000|Overall Study|Received Commercial Emicizumab|1|||
16180866|NCT02795767|39142064|FG001|Overall Study|Received Commercial Emicizumab|0|||
16180867|NCT02795767|39142065|FG002|Overall Study|Received Commercial Emicizumab|0|||
16180868|NCT01172288|39142067|FG000|Overall Study|Adverse Event|1|||
16180869|NCT01172288|39142068|FG001|Overall Study|Adverse Event|0|||
16180870|NCT01172288|39142067|FG000|Overall Study|Protocol Violation|0|||
16180871|NCT01172288|39142068|FG001|Overall Study|Protocol Violation|1|||
16180872|NCT00621023|39142071|FG000|Overall Study|Death|5|||
16180873|NCT00621023|39142071|FG000|Overall Study|Follow up discontinued|1|||
16180874|NCT02859415|39142076|FG000|Overall Study|Physician Decision|1|||
16180875|NCT02859415|39142077|FG001|Overall Study|Physician Decision|0|||
16180876|NCT02859415|39142076|FG000|Overall Study|Off treatment due to cardiac event|0|||
16180877|NCT02859415|39142077|FG001|Overall Study|Off treatment due to cardiac event|1|||
16180878|NCT00857246|39142078|FG000|Induction Regimen|Adverse Event|1|||
16180879|NCT00857246|39142078|FG000|Induction Regimen|disease-related complications|1|||
16180880|NCT00857246|39142078|FG000|Induction Regimen|Withdrawal by Subject|1|||
16478718|NCT00142935|40234253|FG001|Overall Study|Other reason|1|||
16478719|NCT00142935|40234254|FG002|Overall Study|Other reason|1|||
16478720|NCT00142935|40234252|FG000|Overall Study|Lost to Follow-up|2|||
16180881|NCT00857246|39142078|FG000|Surgery (Curative)|disease progression|6|||
16180882|NCT00857246|39142078|FG000|ChemoRT|Withdrawal by Subject|1|||
16180883|NCT00857246|39142078|FG000|ChemoRT|Adverse Event|2|||
16180884|NCT00814710|39142079|FG000|Overall Study|Adverse Event|1|||
16180885|NCT00814710|39142080|FG001|Overall Study|Adverse Event|0|||
16180886|NCT00814710|39142079|FG000|Overall Study|Lost to Follow-up|7|||
16180887|NCT00814710|39142080|FG001|Overall Study|Lost to Follow-up|3|||
16180888|NCT02749370|39142083|FG000|Overall Study|Withdrawal by Subject|11|||
16180889|NCT02749370|39142083|FG000|Overall Study|Lost to Follow-up|3|||
16180890|NCT04021862|39142084|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
16180891|NCT04021862|39142085|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
16180892|NCT04021862|39142086|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
16180893|NCT04021862|39142087|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
16180894|NCT04021862|39142088|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
16180895|NCT04021862|39142089|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
16180896|NCT04021862|39142084|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
16180897|NCT04021862|39142085|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
16180898|NCT04021862|39142086|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
16180899|NCT04021862|39142087|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
16180900|NCT04021862|39142088|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
16180901|NCT04021862|39142089|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
16180902|NCT04021862|39142084|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
16180903|NCT04021862|39142085|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
16180904|NCT04021862|39142086|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
16180905|NCT04021862|39142087|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
16180906|NCT04021862|39142088|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
16180907|NCT04021862|39142089|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
16180908|NCT04021862|39142084|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
16180909|NCT04021862|39142085|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
16180910|NCT04021862|39142086|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
16180911|NCT04021862|39142087|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
16180912|NCT04021862|39142088|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
16180913|NCT04021862|39142089|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
16180914|NCT04021862|39142084|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
16180915|NCT04021862|39142085|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
16180916|NCT04021862|39142086|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
16180917|NCT04021862|39142087|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
16478721|NCT00142935|40234253|FG001|Overall Study|Lost to Follow-up|5|||
16478722|NCT00142935|40234254|FG002|Overall Study|Lost to Follow-up|5|||
16478723|NCT00142935|40234252|FG000|Overall Study|Death|0|||
16478724|NCT00142935|40234253|FG001|Overall Study|Death|2|||
16478725|NCT00142935|40234254|FG002|Overall Study|Death|1|||
16478726|NCT01578330|40234255|FG000|Overall Study|Adverse Event|2|||
16478727|NCT01578330|40234255|FG000|Overall Study|Protocol Violation|5|||
16478728|NCT03519178|40234256|FG000|PF-06873600 Treatment|Adverse Event|0|||
16478729|NCT03519178|40234257|FG001|PF-06873600 Treatment|Adverse Event|0|||
16478730|NCT03519178|40234258|FG002|PF-06873600 Treatment|Adverse Event|0|||
16478731|NCT03519178|40234259|FG003|PF-06873600 Treatment|Adverse Event|0|||
16478732|NCT03519178|40234260|FG004|PF-06873600 Treatment|Adverse Event|0|||
16478733|NCT03519178|40234261|FG005|PF-06873600 Treatment|Adverse Event|0|||
16478734|NCT03519178|40234262|FG006|PF-06873600 Treatment|Adverse Event|0|||
16478735|NCT03519178|40234263|FG007|PF-06873600 Treatment|Adverse Event|2|||
16478736|NCT03519178|40234264|FG008|PF-06873600 Treatment|Adverse Event|1|||
16478737|NCT03519178|40234265|FG009|PF-06873600 Treatment|Adverse Event|0|||
16478738|NCT03519178|40234266|FG010|PF-06873600 Treatment|Adverse Event|0|||
16478739|NCT03519178|40234267|FG011|PF-06873600 Treatment|Adverse Event|0|||
16478740|NCT03519178|40234268|FG012|PF-06873600 Treatment|Adverse Event|1|||
16478741|NCT03519178|40234269|FG013|PF-06873600 Treatment|Adverse Event|3|||
16478742|NCT03519178|40234270|FG014|PF-06873600 Treatment|Adverse Event|2|||
16180918|NCT04021862|39142088|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
16180919|NCT04021862|39142089|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
16180920|NCT02333331|39142099|FG000|Overall Study|Adverse Event|1|||
16478743|NCT03519178|40234256|FG000|PF-06873600 Treatment|Death|0|||
16478744|NCT03519178|40234257|FG001|PF-06873600 Treatment|Death|0|||
16478745|NCT03519178|40234258|FG002|PF-06873600 Treatment|Death|0|||
16478746|NCT03519178|40234259|FG003|PF-06873600 Treatment|Death|0|||
16478747|NCT03519178|40234260|FG004|PF-06873600 Treatment|Death|0|||
16478748|NCT03519178|40234261|FG005|PF-06873600 Treatment|Death|0|||
16478749|NCT03519178|40234262|FG006|PF-06873600 Treatment|Death|0|||
16478750|NCT03519178|40234263|FG007|PF-06873600 Treatment|Death|0|||
16180921|NCT02333331|39142100|FG001|Overall Study|Adverse Event|0|||
16180922|NCT02333331|39142101|FG002|Overall Study|Adverse Event|4|||
16180923|NCT02333331|39142102|FG003|Overall Study|Adverse Event|1|||
16180924|NCT02333331|39142099|FG000|Overall Study|Death|0|||
16180925|NCT02333331|39142100|FG001|Overall Study|Death|0|||
16180926|NCT02333331|39142101|FG002|Overall Study|Death|2|||
16180927|NCT02333331|39142102|FG003|Overall Study|Death|0|||
16180928|NCT02333331|39142099|FG000|Overall Study|Lost to Follow-up|0|||
16180929|NCT02333331|39142100|FG001|Overall Study|Lost to Follow-up|0|||
16180930|NCT02333331|39142101|FG002|Overall Study|Lost to Follow-up|1|||
16180931|NCT02333331|39142102|FG003|Overall Study|Lost to Follow-up|0|||
16180932|NCT02333331|39142099|FG000|Overall Study|Physician Decision|0|||
16180933|NCT02333331|39142100|FG001|Overall Study|Physician Decision|1|||
16180934|NCT02333331|39142101|FG002|Overall Study|Physician Decision|0|||
16180935|NCT02333331|39142102|FG003|Overall Study|Physician Decision|0|||
16180936|NCT02333331|39142099|FG000|Overall Study|Protocol Deviation|0|||
16180937|NCT02333331|39142100|FG001|Overall Study|Protocol Deviation|3|||
16180938|NCT02333331|39142101|FG002|Overall Study|Protocol Deviation|2|||
16180939|NCT02333331|39142102|FG003|Overall Study|Protocol Deviation|1|||
16180940|NCT02333331|39142099|FG000|Overall Study|Patient/Guardian Decision|1|||
16180941|NCT02333331|39142100|FG001|Overall Study|Patient/Guardian Decision|2|||
16180942|NCT02333331|39142101|FG002|Overall Study|Patient/Guardian Decision|9|||
16180943|NCT02333331|39142102|FG003|Overall Study|Patient/Guardian Decision|1|||
16180944|NCT00949650|39142103|FG000|Overall Study|Progressive disease|188|||
16180945|NCT00949650|39142104|FG001|Overall Study|Progressive disease|19|||
16180946|NCT00949650|39142103|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
16180947|NCT00949650|39142104|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
16180948|NCT00949650|39142103|FG000|Overall Study|Other Adverse Event (AE)|28|||
16180949|NCT00949650|39142104|FG001|Overall Study|Other Adverse Event (AE)|17|||
16180950|NCT00949650|39142103|FG000|Overall Study|Protocol Violation|1|||
16180951|NCT00949650|39142104|FG001|Overall Study|Protocol Violation|4|||
16180952|NCT00949650|39142103|FG000|Overall Study|Refusal to continue medication|7|||
16180953|NCT00949650|39142104|FG001|Overall Study|Refusal to continue medication|11|||
16180954|NCT00949650|39142103|FG000|Overall Study|Not treated|1|||
16180955|NCT00949650|39142104|FG001|Overall Study|Not treated|4|||
16180956|NCT00949650|39142103|FG000|Overall Study|Other not specified above|5|||
16180957|NCT00949650|39142104|FG001|Overall Study|Other not specified above|0|||
16180958|NCT04275310|39142105|FG000|Overall Study|Non-randomized due to running out of funding|4|||
16180959|NCT04275310|39142106|FG001|Overall Study|Non-randomized due to running out of funding|0|||
16180960|NCT01927562|39142107|FG000|Overall Study|Lost to Follow-up|30|||
16180961|NCT01927562|39142107|FG000|Overall Study|Withdrawal by Subject|3|||
16180962|NCT01927562|39142107|FG000|Overall Study|Physician Decision|5|||
16180963|NCT01985321|39142110|FG000|Overall Study|Protocol Violation|4|||
16478751|NCT03519178|40234264|FG008|PF-06873600 Treatment|Death|1|||
16478752|NCT03519178|40234265|FG009|PF-06873600 Treatment|Death|1|||
16478753|NCT03519178|40234266|FG010|PF-06873600 Treatment|Death|0|||
16478754|NCT03519178|40234267|FG011|PF-06873600 Treatment|Death|0|||
16478755|NCT03519178|40234268|FG012|PF-06873600 Treatment|Death|0|||
16478756|NCT03519178|40234269|FG013|PF-06873600 Treatment|Death|0|||
16478757|NCT03519178|40234270|FG014|PF-06873600 Treatment|Death|1|||
16478758|NCT03519178|40234256|FG000|PF-06873600 Treatment|Physician Decision|0|||
16478759|NCT03519178|40234257|FG001|PF-06873600 Treatment|Physician Decision|0|||
16478760|NCT03519178|40234258|FG002|PF-06873600 Treatment|Physician Decision|0|||
16478761|NCT03519178|40234259|FG003|PF-06873600 Treatment|Physician Decision|0|||
16478762|NCT03519178|40234260|FG004|PF-06873600 Treatment|Physician Decision|0|||
16478763|NCT03519178|40234261|FG005|PF-06873600 Treatment|Physician Decision|0|||
16478764|NCT03519178|40234262|FG006|PF-06873600 Treatment|Physician Decision|0|||
16478765|NCT03519178|40234263|FG007|PF-06873600 Treatment|Physician Decision|1|||
16478766|NCT03519178|40234264|FG008|PF-06873600 Treatment|Physician Decision|0|||
16478767|NCT03519178|40234265|FG009|PF-06873600 Treatment|Physician Decision|0|||
16180964|NCT01985321|39142111|FG001|Overall Study|Protocol Violation|3|||
16180965|NCT01985321|39142110|FG000|Overall Study|Withdrawal by Subject|1|||
16180966|NCT01985321|39142111|FG001|Overall Study|Withdrawal by Subject|0|||
16180967|NCT01985321|39142110|FG000|Overall Study|Lost to Follow-up|5|||
16180968|NCT01985321|39142111|FG001|Overall Study|Lost to Follow-up|2|||
16180969|NCT01985321|39142110|FG000|Overall Study|Subject treated wrong type of sore|1|||
16180970|NCT01985321|39142111|FG001|Overall Study|Subject treated wrong type of sore|0|||
16180971|NCT00611130|39142114|FG000|Overall Study|Lost to Follow-up|25|||
16180972|NCT00611130|39142115|FG001|Overall Study|Lost to Follow-up|29|||
16180973|NCT00611130|39142114|FG000|Overall Study|Protocol noncompliance|7|||
16478768|NCT03519178|40234266|FG010|PF-06873600 Treatment|Physician Decision|1|||
16478769|NCT03519178|40234267|FG011|PF-06873600 Treatment|Physician Decision|0|||
16478770|NCT03519178|40234268|FG012|PF-06873600 Treatment|Physician Decision|0|||
16180974|NCT00611130|39142115|FG001|Overall Study|Protocol noncompliance|6|||
16180975|NCT00611130|39142114|FG000|Overall Study|Withdrawal by Subject|6|||
16180976|NCT00611130|39142115|FG001|Overall Study|Withdrawal by Subject|5|||
16180977|NCT00611130|39142114|FG000|Overall Study|Other|5|||
16180978|NCT00611130|39142115|FG001|Overall Study|Other|4|||
16180979|NCT00611130|39142114|FG000|Overall Study|Incarceration|3|||
16180980|NCT00611130|39142115|FG001|Overall Study|Incarceration|2|||
16180981|NCT00611130|39142114|FG000|Overall Study|Administrative|1|||
16180982|NCT00611130|39142115|FG001|Overall Study|Administrative|1|||
16180983|NCT00611130|39142114|FG000|Overall Study|Adverse Event|1|||
16180984|NCT00611130|39142115|FG001|Overall Study|Adverse Event|0|||
16180985|NCT00611130|39142114|FG000|Overall Study|Death|1|||
16180986|NCT00611130|39142115|FG001|Overall Study|Death|0|||
16180987|NCT01009463|39142116|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
16180988|NCT01009463|39142117|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16180989|NCT01009463|39142118|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16180990|NCT01009463|39142119|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16180991|NCT01009463|39142120|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16180992|NCT01009463|39142116|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
16180993|NCT01009463|39142117|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
16180994|NCT01009463|39142118|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
16180995|NCT01009463|39142119|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
16180996|NCT01009463|39142120|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
16180997|NCT01009463|39142116|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
16478771|NCT03519178|40234269|FG013|PF-06873600 Treatment|Physician Decision|4|||
16478772|NCT03519178|40234270|FG014|PF-06873600 Treatment|Physician Decision|1|||
16478773|NCT03519178|40234256|FG000|PF-06873600 Treatment|Progressive disease|1|||
16478774|NCT03519178|40234257|FG001|PF-06873600 Treatment|Progressive disease|1|||
16478775|NCT03519178|40234258|FG002|PF-06873600 Treatment|Progressive disease|1|||
16478776|NCT03519178|40234259|FG003|PF-06873600 Treatment|Progressive disease|1|||
16478777|NCT03519178|40234260|FG004|PF-06873600 Treatment|Progressive disease|6|||
16478778|NCT03519178|40234261|FG005|PF-06873600 Treatment|Progressive disease|7|||
16478779|NCT03519178|40234262|FG006|PF-06873600 Treatment|Progressive disease|3|||
16478780|NCT03519178|40234263|FG007|PF-06873600 Treatment|Progressive disease|7|||
16478781|NCT03519178|40234264|FG008|PF-06873600 Treatment|Progressive disease|3|||
16180998|NCT01009463|39142117|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16180999|NCT01009463|39142118|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16181000|NCT01009463|39142119|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16478782|NCT03519178|40234265|FG009|PF-06873600 Treatment|Progressive disease|5|||
16478783|NCT03519178|40234266|FG010|PF-06873600 Treatment|Progressive disease|4|||
16181001|NCT01009463|39142120|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16181002|NCT01009463|39142116|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
16181003|NCT01009463|39142117|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
16181004|NCT01009463|39142118|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
16181005|NCT01009463|39142119|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
16181006|NCT01009463|39142120|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
16181007|NCT01009463|39142116|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
16181008|NCT01009463|39142117|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16181009|NCT01009463|39142118|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16181010|NCT01009463|39142119|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16181011|NCT01009463|39142120|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16181012|NCT01009463|39142116|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
16181013|NCT01009463|39142117|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
16181014|NCT01009463|39142118|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
16181015|NCT01009463|39142119|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
16181016|NCT01009463|39142120|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
16181017|NCT01009463|39142116|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16181018|NCT01009463|39142117|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
16181019|NCT01009463|39142118|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
16181020|NCT01009463|39142119|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
16181021|NCT01009463|39142120|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
16181022|NCT01009463|39142116|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
16181023|NCT01009463|39142117|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
16181024|NCT01009463|39142118|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
16181025|NCT01009463|39142119|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
16181026|NCT01009463|39142120|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
16181027|NCT01009463|39142116|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
16181028|NCT01009463|39142117|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
16181029|NCT01009463|39142118|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
16181030|NCT01009463|39142119|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
16181031|NCT01009463|39142120|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
16181032|NCT01009463|39142116|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
16181033|NCT01009463|39142117|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
16181034|NCT01009463|39142118|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
16181035|NCT01009463|39142119|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
16181036|NCT01009463|39142120|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
16181037|NCT01009463|39142116|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16181038|NCT01009463|39142117|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
16181039|NCT01009463|39142118|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16181040|NCT01009463|39142119|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
16181041|NCT01009463|39142120|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16181042|NCT01009463|39142116|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16181043|NCT01009463|39142117|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
16181044|NCT01009463|39142118|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
16478784|NCT03519178|40234267|FG011|PF-06873600 Treatment|Progressive disease|3|||
16478785|NCT03519178|40234268|FG012|PF-06873600 Treatment|Progressive disease|4|||
16478786|NCT03519178|40234269|FG013|PF-06873600 Treatment|Progressive disease|28|||
16478787|NCT03519178|40234270|FG014|PF-06873600 Treatment|Progressive disease|7|||
16478788|NCT03519178|40234256|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
16478789|NCT03519178|40234257|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
16478790|NCT03519178|40234258|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
16478791|NCT03519178|40234259|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
16478792|NCT03519178|40234260|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
16478793|NCT03519178|40234261|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
16478794|NCT03519178|40234262|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
16478795|NCT03519178|40234263|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
16478796|NCT03519178|40234264|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
16478797|NCT03519178|40234265|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
16478798|NCT03519178|40234266|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
16478799|NCT03519178|40234267|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
16478800|NCT03519178|40234268|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
16478801|NCT03519178|40234269|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
16478802|NCT03519178|40234270|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
16478803|NCT03519178|40234256|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
16478804|NCT03519178|40234257|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
16279172|NCT00401245|39504223|FG006|Double Blind Tapering Phase|Adverse Event|2|||
16279173|NCT00401245|39504224|FG007|Double Blind Tapering Phase|Adverse Event|4|||
16279174|NCT00401245|39504217|FG000|Double Blind Tapering Phase|Investigator request|0|||
16279175|NCT00401245|39504218|FG001|Double Blind Tapering Phase|Investigator request|0|||
16279176|NCT00401245|39504219|FG002|Double Blind Tapering Phase|Investigator request|0|||
16279177|NCT00401245|39504220|FG003|Double Blind Tapering Phase|Investigator request|0|||
16279178|NCT00401245|39504221|FG004|Double Blind Tapering Phase|Investigator request|0|||
16279179|NCT00401245|39504222|FG005|Double Blind Tapering Phase|Investigator request|0|||
16279180|NCT00401245|39504223|FG006|Double Blind Tapering Phase|Investigator request|0|||
16279181|NCT00401245|39504224|FG007|Double Blind Tapering Phase|Investigator request|1|||
16279182|NCT00401245|39504217|FG000|Double Blind Tapering Phase|Other|0|||
16279183|NCT00401245|39504218|FG001|Double Blind Tapering Phase|Other|0|||
16279184|NCT00401245|39504219|FG002|Double Blind Tapering Phase|Other|0|||
16279185|NCT00401245|39504220|FG003|Double Blind Tapering Phase|Other|0|||
16279186|NCT00401245|39504221|FG004|Double Blind Tapering Phase|Other|1|||
16279187|NCT00401245|39504222|FG005|Double Blind Tapering Phase|Other|0|||
16279188|NCT00401245|39504223|FG006|Double Blind Tapering Phase|Other|2|||
16279189|NCT00401245|39504224|FG007|Double Blind Tapering Phase|Other|2|||
16279190|NCT00401245|39504217|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
16279191|NCT00401245|39504218|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
16279192|NCT00401245|39504219|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
16279193|NCT00401245|39504220|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
16279194|NCT00401245|39504221|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
16279195|NCT00401245|39504222|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
16279196|NCT00401245|39504223|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
16279197|NCT00401245|39504224|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
16279198|NCT00401245|39504217|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
16279199|NCT00401245|39504218|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
16279200|NCT00401245|39504219|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
16279201|NCT00401245|39504220|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
16279202|NCT00401245|39504221|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
16279203|NCT00401245|39504222|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
16279204|NCT00401245|39504223|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
16181045|NCT01009463|39142119|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
16181046|NCT01009463|39142120|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
16181047|NCT01009463|39142116|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
16181048|NCT01009463|39142117|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
16181049|NCT01009463|39142118|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
16181050|NCT01009463|39142119|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
16181051|NCT01009463|39142120|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
16181052|NCT01269125|39142133|FG000|Overall Study|Adverse Event|3|||
16181053|NCT01269125|39142134|FG001|Overall Study|Adverse Event|5|||
16181054|NCT01269125|39142135|FG002|Overall Study|Adverse Event|0|||
16181055|NCT01269125|39142133|FG000|Overall Study|Lost to Follow-up|4|||
16181056|NCT01269125|39142134|FG001|Overall Study|Lost to Follow-up|0|||
16181057|NCT01269125|39142135|FG002|Overall Study|Lost to Follow-up|0|||
16181058|NCT00916721|39142139|FG000|Overall Study|Lost to Follow-up|0|||
16181059|NCT00916721|39142140|FG001|Overall Study|Lost to Follow-up|1|||
16181060|NCT00916721|39142139|FG000|Overall Study|Adverse Event|6|||
16181061|NCT00916721|39142140|FG001|Overall Study|Adverse Event|3|||
16181062|NCT00916721|39142139|FG000|Overall Study|Withdrawal by Subject|2|||
16181063|NCT00916721|39142140|FG001|Overall Study|Withdrawal by Subject|2|||
16181064|NCT00916721|39142139|FG000|Overall Study|Protocol Violation|2|||
16181065|NCT00916721|39142140|FG001|Overall Study|Protocol Violation|4|||
16181066|NCT03090737|39142141|FG000|Overall Study|Other reasons|1|||
16181067|NCT03090737|39142141|FG000|Overall Study|Completed treatment as per protocol|17|||
16181068|NCT03090737|39142141|FG000|Overall Study|Maximum clinical benefit|2|||
16181069|NCT03090737|39142141|FG000|Overall Study|Adverse event unrelated to study drug|7|||
16181070|NCT03090737|39142141|FG000|Overall Study|Study drug toxicity|4|||
16181071|NCT03090737|39142141|FG000|Overall Study|Disease progression|98|||
16181072|NCT01901328|39142142|FG000|Overall Study|Lost to Follow-up|1|||
16181073|NCT01901328|39142143|FG001|Overall Study|Lost to Follow-up|0|||
16181074|NCT01901328|39142142|FG000|Overall Study|Physician Decision|0|||
16181075|NCT01901328|39142143|FG001|Overall Study|Physician Decision|1|||
16181076|NCT01901328|39142142|FG000|Overall Study|Protocol Violation|1|||
16181077|NCT01901328|39142143|FG001|Overall Study|Protocol Violation|1|||
16279205|NCT00401245|39504224|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
16279206|NCT01952691|39504225|FG000|Overall Study|Lost to Follow-up|2|||
16181078|NCT01901328|39142142|FG000|Overall Study|Study Terminated by Sponsor|19|||
16181079|NCT01901328|39142143|FG001|Overall Study|Study Terminated by Sponsor|16|||
16181080|NCT01901328|39142142|FG000|Overall Study|Withdrawal by Subject|1|||
16181081|NCT01901328|39142143|FG001|Overall Study|Withdrawal by Subject|2|||
16181082|NCT01901328|39142142|FG000|Overall Study|Lack of Efficacy|0|||
16181083|NCT01901328|39142143|FG001|Overall Study|Lack of Efficacy|1|||
16181084|NCT04770155|39142144|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
16181085|NCT04770155|39142145|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
16181086|NCT04770155|39142146|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
16181087|NCT04770155|39142147|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
16181088|NCT04770155|39142148|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
16181089|NCT04770155|39142149|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
16181090|NCT04770155|39142150|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
16181091|NCT04770155|39142151|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
16181092|NCT04334148|39142155|FG000|Overall Study|positive nasal swab at baseline|0|||
16181093|NCT04334148|39142156|FG001|Overall Study|positive nasal swab at baseline|1|||
16181094|NCT03242759|39142160|FG000|Overall Study|Adverse Event|5|||
16181095|NCT03242759|39142161|FG001|Overall Study|Adverse Event|1|||
16181096|NCT03242759|39142160|FG000|Overall Study|Withdrawal by Subject|4|||
16181097|NCT03242759|39142161|FG001|Overall Study|Withdrawal by Subject|3|||
16181098|NCT03242759|39142160|FG000|Overall Study|Lost to Follow-up|3|||
16181099|NCT03242759|39142161|FG001|Overall Study|Lost to Follow-up|1|||
16181100|NCT03242759|39142160|FG000|Overall Study|Administrative problems|1|||
16181101|NCT03242759|39142161|FG001|Overall Study|Administrative problems|1|||
16181102|NCT03242759|39142160|FG000|Overall Study|Death|22|||
16181103|NCT03242759|39142161|FG001|Overall Study|Death|0|||
16181104|NCT03242759|39142160|FG000|Overall Study|Change visit schedule|0|||
16181105|NCT03242759|39142161|FG001|Overall Study|Change visit schedule|1|||
16181106|NCT00091390|39142163|FG000|Overall Study|Protocol Violation|1|||
16181107|NCT00091390|39142163|FG000|Overall Study|No protocol treatment|3|||
16181108|NCT02799381|39142164|FG000|Overall Study|Withdrew consent|3|||
16181109|NCT02799381|39142165|FG001|Overall Study|Withdrew consent|2|||
16181110|NCT02799381|39142164|FG000|Overall Study|Adverse Event|0|||
16181111|NCT02799381|39142165|FG001|Overall Study|Adverse Event|1|||
16181112|NCT02799381|39142164|FG000|Overall Study|Participant did not take any study drug|1|||
16181113|NCT02799381|39142165|FG001|Overall Study|Participant did not take any study drug|0|||
16181114|NCT00772967|39142173|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
16181115|NCT00772967|39142174|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
16181116|NCT00772967|39142175|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
16181117|NCT00772967|39142176|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
16181118|NCT00772967|39142177|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
16181119|NCT00772967|39142178|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
16181120|NCT00772967|39142173|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
16181121|NCT00772967|39142174|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
16181122|NCT00772967|39142175|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
16181123|NCT00772967|39142176|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
16181124|NCT00772967|39142177|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
16181125|NCT00772967|39142178|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
16181126|NCT00772967|39142173|FG000|Crossover Treatment 3|Adverse Event|0|||
16181127|NCT00772967|39142174|FG001|Crossover Treatment 3|Adverse Event|0|||
16181128|NCT00772967|39142175|FG002|Crossover Treatment 3|Adverse Event|0|||
16279207|NCT00707434|39504228|FG000|Overall Study|Adverse Event|1|||
16279208|NCT00743145|39504229|FG000|Overall Study|Withdrawal by Subject|1|||
16279209|NCT00743145|39504229|FG000|Overall Study|Adverse Event|2|||
16279210|NCT00743145|39504229|FG000|Overall Study|Pregnancy|1|||
16279211|NCT04640194|39504230|FG000|Overall Study|Adverse Event|3|||
16279212|NCT04640194|39504231|FG001|Overall Study|Adverse Event|7|||
16279213|NCT04640194|39504232|FG002|Overall Study|Adverse Event|0|||
16279214|NCT04640194|39504233|FG003|Overall Study|Adverse Event|5|||
16279215|NCT04640194|39504234|FG004|Overall Study|Adverse Event|0|||
16279216|NCT04640194|39504235|FG005|Overall Study|Adverse Event|4|||
16279217|NCT04640194|39504236|FG006|Overall Study|Adverse Event|0|||
16279218|NCT04640194|39504230|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
16279219|NCT04640194|39504231|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
16279220|NCT04640194|39504232|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
16279221|NCT04640194|39504233|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
16279222|NCT04640194|39504234|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
16279223|NCT04640194|39504235|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
16279224|NCT04640194|39504236|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
16279225|NCT04640194|39504230|FG000|Overall Study|fibrinogen level too low|0|||
16279226|NCT04640194|39504231|FG001|Overall Study|fibrinogen level too low|0|||
16181129|NCT00772967|39142176|FG003|Crossover Treatment 3|Adverse Event|0|||
16279227|NCT04640194|39504232|FG002|Overall Study|fibrinogen level too low|0|||
16279228|NCT04640194|39504233|FG003|Overall Study|fibrinogen level too low|1|||
16279229|NCT04640194|39504234|FG004|Overall Study|fibrinogen level too low|0|||
16279230|NCT04640194|39504235|FG005|Overall Study|fibrinogen level too low|0|||
16279231|NCT04640194|39504236|FG006|Overall Study|fibrinogen level too low|0|||
16279232|NCT04640194|39504230|FG000|Overall Study|mild bleeding|0|||
16279233|NCT04640194|39504231|FG001|Overall Study|mild bleeding|0|||
16279234|NCT04640194|39504232|FG002|Overall Study|mild bleeding|0|||
16279235|NCT04640194|39504233|FG003|Overall Study|mild bleeding|1|||
16279236|NCT04640194|39504234|FG004|Overall Study|mild bleeding|0|||
16279237|NCT04640194|39504235|FG005|Overall Study|mild bleeding|0|||
16279238|NCT04640194|39504236|FG006|Overall Study|mild bleeding|0|||
16279239|NCT04640194|39504230|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
16279240|NCT04640194|39504231|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
16279241|NCT04640194|39504232|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
16279242|NCT04640194|39504233|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
16279243|NCT04640194|39504234|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
16279244|NCT04640194|39504235|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
16279245|NCT04640194|39504236|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
16279246|NCT01937117|39504237|FG000|Overall Study|Disease Progression|7|||
16279247|NCT01937117|39504237|FG000|Overall Study|Physician Decision|4|||
16279248|NCT01937117|39504237|FG000|Overall Study|Adverse Event|2|||
16279249|NCT02820740|39504240|FG000|Overall Study|Did not have procedure|2|||
16279250|NCT02329431|39504244|FG000|Overall Study|Lost to Follow-up|20|||
16181130|NCT00772967|39142177|FG004|Crossover Treatment 3|Adverse Event|1|||
16181131|NCT00772967|39142178|FG005|Crossover Treatment 3|Adverse Event|0|||
16279251|NCT02329431|39504245|FG001|Overall Study|Lost to Follow-up|13|||
16279252|NCT02327325|39504249|FG000|Overall Study|Withdrawal by Subject|1|||
16279253|NCT02327325|39504250|FG001|Overall Study|Withdrawal by Subject|4|||
16279254|NCT02327325|39504251|FG002|Overall Study|Withdrawal by Subject|4|||
16279255|NCT02327325|39504249|FG000|Overall Study|Excluded by Study Team|0|||
16279256|NCT02327325|39504250|FG001|Overall Study|Excluded by Study Team|0|||
16279257|NCT02327325|39504251|FG002|Overall Study|Excluded by Study Team|1|||
16279258|NCT02416934|39504261|FG000|Overall Study|given steroids|1|||
16279259|NCT02416934|39504262|FG001|Overall Study|given steroids|2|||
16279260|NCT02416934|39504261|FG000|Overall Study|Lost to Follow-up|0|||
16279261|NCT02416934|39504262|FG001|Overall Study|Lost to Follow-up|2|||
16279262|NCT02416934|39504261|FG000|Overall Study|Withdrawal by Subject|1|||
16279263|NCT02416934|39504262|FG001|Overall Study|Withdrawal by Subject|0|||
16279264|NCT02416934|39504261|FG000|Overall Study|recruited during continuing renewal proc|0|||
16279265|NCT02416934|39504262|FG001|Overall Study|recruited during continuing renewal proc|1|||
16279266|NCT02416934|39504261|FG000|Overall Study|Protocol Violation|0|||
16279267|NCT02416934|39504262|FG001|Overall Study|Protocol Violation|1|||
16181132|NCT00336492|39142179|FG000|Overall Study|Adverse Event|4|||
16181133|NCT00336492|39142180|FG001|Overall Study|Adverse Event|3|||
16181134|NCT00336492|39142181|FG002|Overall Study|Adverse Event|6|||
16181135|NCT00336492|39142179|FG000|Overall Study|Lack of Efficacy|6|||
16181136|NCT00336492|39142180|FG001|Overall Study|Lack of Efficacy|1|||
16181137|NCT00336492|39142181|FG002|Overall Study|Lack of Efficacy|4|||
16181138|NCT00336492|39142179|FG000|Overall Study|Other|5|||
16181139|NCT00336492|39142180|FG001|Overall Study|Other|0|||
16181140|NCT00336492|39142181|FG002|Overall Study|Other|1|||
16181141|NCT01595646|39142185|FG000|Overall Study|Withdrawal by Subject|1|||
16181142|NCT01595646|39142186|FG001|Overall Study|Withdrawal by Subject|0|||
16181143|NCT01595646|39142187|FG002|Overall Study|Withdrawal by Subject|0|||
16181144|NCT00663858|39142188|FG000|Overall Study|Adverse Event|9|||
16181145|NCT00663858|39142189|FG001|Overall Study|Adverse Event|1|||
16181146|NCT00663858|39142190|FG002|Overall Study|Adverse Event|6|||
16181147|NCT00663858|39142188|FG000|Overall Study|Lack of Efficacy|5|||
16181148|NCT00663858|39142189|FG001|Overall Study|Lack of Efficacy|1|||
16181149|NCT00663858|39142190|FG002|Overall Study|Lack of Efficacy|3|||
16181150|NCT00663858|39142188|FG000|Overall Study|Withdrawal by Subject|7|||
16181151|NCT00663858|39142189|FG001|Overall Study|Withdrawal by Subject|3|||
16181152|NCT00663858|39142190|FG002|Overall Study|Withdrawal by Subject|3|||
16181153|NCT00663858|39142188|FG000|Overall Study|Protocol Violation|5|||
16181154|NCT00663858|39142189|FG001|Overall Study|Protocol Violation|3|||
16181155|NCT00663858|39142190|FG002|Overall Study|Protocol Violation|4|||
16181156|NCT00663858|39142188|FG000|Overall Study|Other|8|||
16181157|NCT00663858|39142189|FG001|Overall Study|Other|2|||
16181158|NCT00663858|39142190|FG002|Overall Study|Other|4|||
16181159|NCT00969618|39142191|FG000|Overall Study|Adverse Event|29|||
16279268|NCT02416934|39504261|FG000|Overall Study|surgery started late|0|||
16279269|NCT02416934|39504262|FG001|Overall Study|surgery started late|1|||
16181160|NCT00969618|39142191|FG000|Overall Study|Entry Criteria Not Met|3|||
16181161|NCT00969618|39142191|FG000|Overall Study|Lack of Efficacy|2|||
16181162|NCT00969618|39142191|FG000|Overall Study|Lost to Follow-up|7|||
16181163|NCT00969618|39142191|FG000|Overall Study|Physician Decision|1|||
16181164|NCT00969618|39142191|FG000|Overall Study|Protocol Violation|9|||
16181165|NCT00969618|39142191|FG000|Overall Study|Withdrawal by Subject|27|||
16181166|NCT00858832|39142192|FG000|Overall Study|became ineligible: delivered vaginally|1|||
16181167|NCT00858832|39142193|FG001|Overall Study|became ineligible: delivered vaginally|0|||
16181168|NCT00858832|39142192|FG000|Overall Study|Adverse Event|0|||
16181169|NCT00858832|39142193|FG001|Overall Study|Adverse Event|1|||
16181170|NCT01272180|39142201|FG000|Overall Study|Adverse Event|0|||
16181171|NCT01272180|39142202|FG001|Overall Study|Adverse Event|0|||
16181172|NCT01272180|39142203|FG002|Overall Study|Adverse Event|1|||
16181173|NCT01272180|39142204|FG003|Overall Study|Adverse Event|0|||
16181174|NCT01272180|39142201|FG000|Overall Study|Withdrawal by Subject|2|||
16181175|NCT01272180|39142202|FG001|Overall Study|Withdrawal by Subject|6|||
16181176|NCT01272180|39142203|FG002|Overall Study|Withdrawal by Subject|3|||
16181177|NCT01272180|39142204|FG003|Overall Study|Withdrawal by Subject|2|||
16181178|NCT01272180|39142201|FG000|Overall Study|Lost to Follow-up|15|||
16181179|NCT01272180|39142202|FG001|Overall Study|Lost to Follow-up|14|||
16181180|NCT01272180|39142203|FG002|Overall Study|Lost to Follow-up|8|||
16181181|NCT01272180|39142204|FG003|Overall Study|Lost to Follow-up|10|||
16181182|NCT01272180|39142201|FG000|Overall Study|Inappropriate enrollment|0|||
16181183|NCT01272180|39142202|FG001|Overall Study|Inappropriate enrollment|0|||
16181184|NCT01272180|39142203|FG002|Overall Study|Inappropriate enrollment|1|||
16181185|NCT01272180|39142204|FG003|Overall Study|Inappropriate enrollment|1|||
16181186|NCT01272180|39142201|FG000|Overall Study|Protocol Violation|0|||
16181187|NCT01272180|39142202|FG001|Overall Study|Protocol Violation|1|||
16181188|NCT01272180|39142203|FG002|Overall Study|Protocol Violation|0|||
16181189|NCT01272180|39142204|FG003|Overall Study|Protocol Violation|1|||
16181190|NCT00686205|39142207|FG000|Overall Study|Protocol Violation|127|||
16181191|NCT00686205|39142208|FG001|Overall Study|Protocol Violation|0|||
16181192|NCT00686205|39142207|FG000|Overall Study|Withdrawal by Subject|2|||
16181193|NCT00686205|39142208|FG001|Overall Study|Withdrawal by Subject|0|||
16181194|NCT00686205|39142207|FG000|Overall Study|Specimen handling procedure altered|5878|||
16181195|NCT00686205|39142208|FG001|Overall Study|Specimen handling procedure altered|0|||
16181196|NCT00686205|39142207|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
16181197|NCT00686205|39142208|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
16181198|NCT00945191|39142222|FG000|Overall Study|Did not achieve a complete response|18|||
16279270|NCT02416934|39504261|FG000|Overall Study|re-operation|1|||
16181199|NCT00945191|39142222|FG000|Overall Study|Participant relocated to another state|1|||
16181200|NCT00945191|39142222|FG000|Overall Study|Disease progression|3|||
16181201|NCT00945191|39142222|FG000|Overall Study|Serious adverse event or adverse event|1|||
16181202|NCT00945191|39142222|FG000|Overall Study|Investigator's discretion|1|||
16181203|NCT00971321|39142223|FG000|Up to Month 7|Withdrawal by Subject|1|||
16181204|NCT00971321|39142224|FG001|Up to Month 7|Withdrawal by Subject|0|||
16181205|NCT00971321|39142223|FG000|Up to Month 7|Migrated/moved from study area|3|||
16181206|NCT00971321|39142224|FG001|Up to Month 7|Migrated/moved from study area|2|||
16181207|NCT00971321|39142223|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
16181208|NCT00971321|39142224|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
16181209|NCT00971321|39142223|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
16181210|NCT00971321|39142224|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
16181211|NCT00971321|39142223|FG000|Up to Month 11-12|Lost to Follow-up|1|||
16181212|NCT00971321|39142224|FG001|Up to Month 11-12|Lost to Follow-up|0|||
16181213|NCT01821677|39142225|FG000|Overall Study|Adverse Event|4|||
16181214|NCT01821677|39142226|FG001|Overall Study|Adverse Event|6|||
16181215|NCT01821677|39142227|FG002|Overall Study|Adverse Event|5|||
16181216|NCT01821677|39142225|FG000|Overall Study|Physician Decision|1|||
16181217|NCT01821677|39142226|FG001|Overall Study|Physician Decision|4|||
16181218|NCT01821677|39142227|FG002|Overall Study|Physician Decision|1|||
16181219|NCT01821677|39142225|FG000|Overall Study|Non-compliance|0|||
16181220|NCT01821677|39142226|FG001|Overall Study|Non-compliance|1|||
16181221|NCT01821677|39142227|FG002|Overall Study|Non-compliance|2|||
16181222|NCT01821677|39142225|FG000|Overall Study|Lost to Follow-up|2|||
16181223|NCT01821677|39142226|FG001|Overall Study|Lost to Follow-up|1|||
16181224|NCT01821677|39142227|FG002|Overall Study|Lost to Follow-up|3|||
16181225|NCT01821677|39142225|FG000|Overall Study|Protocol Violation|0|||
16181226|NCT01821677|39142226|FG001|Overall Study|Protocol Violation|0|||
16181227|NCT01821677|39142227|FG002|Overall Study|Protocol Violation|2|||
16181228|NCT01821677|39142225|FG000|Overall Study|Withdrawal by Subject|7|||
16279271|NCT02416934|39504262|FG001|Overall Study|re-operation|0|||
16279272|NCT03168906|39504265|FG000|Overall Study|Lack of Efficacy|6|||
16279273|NCT03168906|39504266|FG001|Overall Study|Lack of Efficacy|6|||
16279274|NCT03366194|39504267|FG000|Overall Study|Lost to Follow-up|2|||
16279275|NCT00772148|39504276|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
16279276|NCT00772148|39504277|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
16279277|NCT00772148|39504276|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
16279278|NCT00772148|39504277|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
16279279|NCT00772148|39504276|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
16279280|NCT00772148|39504277|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
16181229|NCT01821677|39142226|FG001|Overall Study|Withdrawal by Subject|3|||
16181230|NCT01821677|39142227|FG002|Overall Study|Withdrawal by Subject|2|||
16279281|NCT00772148|39504276|FG000|Maintenance Phase (Week 52)|Death|2|||
16181231|NCT01821677|39142225|FG000|Overall Study|Other|9|||
16181232|NCT01821677|39142226|FG001|Overall Study|Other|0|||
16181233|NCT01821677|39142227|FG002|Overall Study|Other|0|||
16279282|NCT00772148|39504277|FG001|Maintenance Phase (Week 52)|Death|2|||
16181234|NCT01024465|39142228|FG000|Overall Study|Adverse Event|2|||
16181235|NCT01024465|39142228|FG000|Overall Study|Physician Decision|1|||
16181236|NCT01632878|39142229|FG000|Screening|Physician Decision|268|||
16181237|NCT01632878|39142229|FG000|Treatment|Lost to Follow-up|41|||
16279283|NCT00772148|39504276|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
16279284|NCT00772148|39504277|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
16279285|NCT00772148|39504276|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
16279286|NCT00772148|39504277|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
16279287|NCT00772148|39504276|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
16279288|NCT00772148|39504277|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
16478805|NCT03519178|40234258|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
16478806|NCT03519178|40234259|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
16478807|NCT03519178|40234260|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
16478808|NCT03519178|40234261|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
16478809|NCT03519178|40234262|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
16478810|NCT03519178|40234263|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
16478811|NCT03519178|40234264|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
16478812|NCT03519178|40234265|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
16478813|NCT03519178|40234266|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
16478814|NCT03519178|40234267|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
16478815|NCT03519178|40234268|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
16478816|NCT03519178|40234269|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
16478817|NCT03519178|40234270|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
16181238|NCT01632878|39142229|FG000|Treatment|Withdrawal by Subject|36|||
16181239|NCT01632878|39142229|FG000|Treatment|Physician Decision|34|||
16181240|NCT01632878|39142229|FG000|Treatment|missing information|4|||
16181241|NCT01632878|39142229|FG000|Treatment|no information on study completion|43|||
16181242|NCT01952015|39142230|FG000|Induction|Protocol Violation|1|||
16181243|NCT01952015|39142230|FG000|Maintenance|Adverse Event|2|||
16181244|NCT01952015|39142230|FG000|Treatment Period 3|Physician Decision|9|||
16181245|NCT00530712|39142231|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
16181246|NCT00530712|39142231|FG000|30 Day Follow-up Visit|Missed Visit|5|||
16181247|NCT00530712|39142231|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
16181248|NCT00530712|39142231|FG000|6 Month Follow-up Visit|Missed Visit|3|||
16181249|NCT00530712|39142231|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
16181250|NCT00530712|39142231|FG000|6 Month Follow-up Visit|Death|2|||
16181251|NCT00530712|39142231|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
16181252|NCT00530712|39142231|FG000|12 Month Follow-up Visit|Missed Visit|3|||
16181253|NCT00530712|39142231|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
16181254|NCT00530712|39142231|FG000|12 Month Follow-up Visit|Death|9|||
16181255|NCT00224016|39142232|FG000|Titration Period|Withdrawal by Subject|0|||
16181256|NCT00224016|39142233|FG001|Titration Period|Withdrawal by Subject|1|||
16181257|NCT00224016|39142232|FG000|Titration Period|Lost to Follow-up|1|||
16279289|NCT02966340|39504278|FG000|Overall Study|Adverse Event|0|||
16279290|NCT02966340|39504279|FG001|Overall Study|Adverse Event|1|||
16279291|NCT02966340|39504278|FG000|Overall Study|Lost to Follow-up|0|||
16279292|NCT02966340|39504279|FG001|Overall Study|Lost to Follow-up|1|||
16279293|NCT02966340|39504278|FG000|Overall Study|Withdrawal by Subject|1|||
16279294|NCT02966340|39504279|FG001|Overall Study|Withdrawal by Subject|0|||
16279295|NCT02966340|39504278|FG000|Overall Study|data acquisition error|1|||
16279296|NCT02966340|39504279|FG001|Overall Study|data acquisition error|0|||
16279297|NCT02966340|39504278|FG000|Overall Study|startle non-responder|1|||
16279298|NCT02966340|39504279|FG001|Overall Study|startle non-responder|1|||
16279299|NCT02998541|39504281|FG000|Overall Study|Adverse Event|4|||
16279300|NCT02998541|39504282|FG001|Overall Study|Adverse Event|5|||
16279301|NCT02998541|39504283|FG002|Overall Study|Adverse Event|1|||
16279302|NCT02998541|39504281|FG000|Overall Study|Protocol Violation|1|||
16279303|NCT02998541|39504282|FG001|Overall Study|Protocol Violation|0|||
16279304|NCT02998541|39504283|FG002|Overall Study|Protocol Violation|0|||
16279305|NCT02998541|39504281|FG000|Overall Study|Withdrawal by Subject|3|||
16279306|NCT02998541|39504282|FG001|Overall Study|Withdrawal by Subject|1|||
16279307|NCT02998541|39504283|FG002|Overall Study|Withdrawal by Subject|0|||
16279308|NCT02998541|39504281|FG000|Overall Study|Lost to Follow-up|0|||
16279309|NCT02998541|39504282|FG001|Overall Study|Lost to Follow-up|3|||
16279310|NCT02998541|39504283|FG002|Overall Study|Lost to Follow-up|1|||
16279311|NCT02998541|39504281|FG000|Overall Study|Physician Decision|0|||
16279312|NCT02998541|39504282|FG001|Overall Study|Physician Decision|0|||
16181258|NCT00224016|39142233|FG001|Titration Period|Lost to Follow-up|0|||
16181259|NCT00224016|39142232|FG000|Maintenance Period|Withdrawal by Subject|2|||
16181260|NCT00224016|39142233|FG001|Maintenance Period|Withdrawal by Subject|0|||
16279313|NCT02998541|39504283|FG002|Overall Study|Physician Decision|3|||
16279314|NCT02998541|39504281|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16279315|NCT02998541|39504282|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16279316|NCT02998541|39504283|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
16279317|NCT03847974|39504288|FG000|Overall Study|relocated out of region|3|||
16279318|NCT03847974|39504288|FG000|Overall Study|Withdrawal by Subject|2|||
16279319|NCT03847974|39504288|FG000|Overall Study|Adverse Event|1|||
16181261|NCT00224016|39142232|FG000|Maintenance Period|Lost to Follow-up|0|||
16181262|NCT00224016|39142233|FG001|Maintenance Period|Lost to Follow-up|1|||
16181263|NCT01720667|39142234|FG000|Overall Study|Adverse Event|1|||
16181264|NCT01720667|39142235|FG001|Overall Study|Adverse Event|1|||
16181265|NCT01720667|39142234|FG000|Overall Study|Withdrawal by Subject|3|||
16181266|NCT01720667|39142235|FG001|Overall Study|Withdrawal by Subject|0|||
16181267|NCT02908477|39142238|FG000|Overall Study|Withdrawal by Subject|8|||
16181268|NCT02908477|39142239|FG001|Overall Study|Withdrawal by Subject|28|||
16181269|NCT02362412|39142240|FG000|Treatment Period III|Lost to Follow-up|0|||
16181270|NCT02362412|39142241|FG001|Treatment Period III|Lost to Follow-up|1|||
16181271|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Adverse Event|37|||
16181272|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Adverse Event|0|||
16181273|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Adverse Event|0|||
16181274|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Adverse Event|0|||
16181275|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Death|2|||
16181276|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Death|0|||
16181277|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Death|0|||
16181278|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Death|0|||
16181279|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
16181280|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
16181281|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
16181282|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
16181283|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
16181284|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
16181285|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
16181286|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
16181287|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
16181288|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
16181289|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
16181290|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
16181291|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
16181292|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
16181293|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
16181294|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
16181295|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Physician Decision|4|||
16181296|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Physician Decision|0|||
16181297|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Physician Decision|0|||
16181298|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Physician Decision|0|||
16181299|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Pregnancy|1|||
16181300|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Pregnancy|0|||
16181301|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Pregnancy|0|||
16181302|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Pregnancy|0|||
16181303|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
16181304|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
16181305|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
16181306|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
16181307|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
16181308|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
16181309|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
16279320|NCT02725411|39504289|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
16279321|NCT02725411|39504290|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
16279322|NCT02725411|39504291|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
16279323|NCT02725411|39504289|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
16279324|NCT02725411|39504290|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
16279325|NCT02725411|39504291|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
16279326|NCT02725411|39504289|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
16279327|NCT02725411|39504290|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
16279328|NCT02725411|39504291|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
16279329|NCT02725411|39504289|FG000|Treatment Period (56 Weeks)|Other|1|||
16279330|NCT02725411|39504290|FG001|Treatment Period (56 Weeks)|Other|4|||
16279331|NCT02725411|39504291|FG002|Treatment Period (56 Weeks)|Other|5|||
16279332|NCT02725411|39504289|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
16279333|NCT02725411|39504290|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
16279334|NCT02725411|39504291|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
16279335|NCT02725411|39504289|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
16181310|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
16181311|NCT01855789|39142245|FG000|1) Baseline up to Week 24|Other|4|||
16181312|NCT01855789|39142246|FG001|1) Baseline up to Week 24|Other|0|||
16181313|NCT01855789|39142247|FG002|1) Baseline up to Week 24|Other|0|||
16181314|NCT01855789|39142248|FG003|1) Baseline up to Week 24|Other|0|||
16181315|NCT01855789|39142245|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
16279336|NCT02725411|39504290|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
16181316|NCT01855789|39142246|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
16181317|NCT01855789|39142247|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
16181318|NCT01855789|39142248|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
16181319|NCT01855789|39142245|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
16181320|NCT01855789|39142246|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
16181321|NCT01855789|39142247|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
16181322|NCT01855789|39142248|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
16181323|NCT01855789|39142245|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
16181324|NCT01855789|39142246|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
16181325|NCT01855789|39142247|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
16181326|NCT01855789|39142248|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
16181327|NCT01855789|39142245|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
16181328|NCT01855789|39142246|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
16181329|NCT01855789|39142247|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
16181330|NCT01855789|39142248|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
16181331|NCT01855789|39142245|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
16181332|NCT01855789|39142246|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
16181333|NCT01855789|39142247|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
16181334|NCT01855789|39142248|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
16181335|NCT01855789|39142245|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
16181336|NCT01855789|39142246|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
16181337|NCT01855789|39142247|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
16181338|NCT01855789|39142248|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
16181339|NCT01855789|39142245|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
16181340|NCT01855789|39142246|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
16181341|NCT01855789|39142247|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
16181342|NCT01855789|39142248|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
16181343|NCT01855789|39142245|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
16181344|NCT01855789|39142246|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
16181345|NCT01855789|39142247|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
16181346|NCT01855789|39142248|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
16181347|NCT01855789|39142245|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
16181348|NCT01855789|39142246|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
16181349|NCT01855789|39142247|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
16181350|NCT01855789|39142248|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
16181351|NCT01855789|39142245|FG000|2) Week 24 up to End of Study|Other|0|||
16181352|NCT01855789|39142246|FG001|2) Week 24 up to End of Study|Other|0|||
16181353|NCT01855789|39142247|FG002|2) Week 24 up to End of Study|Other|0|||
16181354|NCT01855789|39142248|FG003|2) Week 24 up to End of Study|Other|1|||
16181355|NCT02805907|39142251|FG000|Overall Study|Lost to Follow-up|3|||
16181356|NCT02805907|39142252|FG001|Overall Study|Lost to Follow-up|3|||
16181357|NCT03517722|39142253|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
16181358|NCT03517722|39142254|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
16181359|NCT03517722|39142253|FG000|Double Blind Period: Week 0-52|Death|0|||
16181360|NCT03517722|39142254|FG001|Double Blind Period: Week 0-52|Death|4|||
16181361|NCT03517722|39142253|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
16181362|NCT03517722|39142254|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
16181363|NCT03517722|39142253|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
16181364|NCT03517722|39142254|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
16181365|NCT03517722|39142253|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
16181366|NCT03517722|39142254|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
16181367|NCT03517722|39142253|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
16181368|NCT03517722|39142254|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
16181369|NCT03517722|39142253|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
16181370|NCT03517722|39142254|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
16181371|NCT03517722|39142253|FG000|Double Blind Period: Week 0-52|Other|4|||
16181372|NCT03517722|39142254|FG001|Double Blind Period: Week 0-52|Other|3|||
16181373|NCT03517722|39142253|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
16181374|NCT03517722|39142254|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
16181375|NCT03517722|39142253|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
16181376|NCT03517722|39142254|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
16181377|NCT03517722|39142253|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
16181378|NCT03517722|39142254|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
16181379|NCT03517722|39142253|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
16181380|NCT03517722|39142254|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
16181381|NCT03517722|39142253|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
16181382|NCT03517722|39142254|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
16181383|NCT00570739|39142263|FG000|Overall Study|Adverse Event|8|||
16181384|NCT00570739|39142264|FG001|Overall Study|Adverse Event|6|||
16181385|NCT00570739|39142265|FG002|Overall Study|Adverse Event|2|||
16181386|NCT00570739|39142266|FG003|Overall Study|Adverse Event|2|||
16181387|NCT00570739|39142263|FG000|Overall Study|Lost to Follow-up|4|||
16181388|NCT00570739|39142264|FG001|Overall Study|Lost to Follow-up|5|||
16181389|NCT00570739|39142265|FG002|Overall Study|Lost to Follow-up|4|||
16181390|NCT00570739|39142266|FG003|Overall Study|Lost to Follow-up|1|||
16181391|NCT00570739|39142263|FG000|Overall Study|Physician Decision|1|||
16181392|NCT00570739|39142264|FG001|Overall Study|Physician Decision|1|||
16181393|NCT00570739|39142265|FG002|Overall Study|Physician Decision|0|||
16181394|NCT00570739|39142266|FG003|Overall Study|Physician Decision|0|||
16181395|NCT00570739|39142263|FG000|Overall Study|Withdrawal by Subject|7|||
16181396|NCT00570739|39142264|FG001|Overall Study|Withdrawal by Subject|7|||
16181397|NCT00570739|39142265|FG002|Overall Study|Withdrawal by Subject|3|||
16181398|NCT00570739|39142266|FG003|Overall Study|Withdrawal by Subject|5|||
16181399|NCT00570739|39142263|FG000|Overall Study|Required restricted medication|0|||
16181400|NCT00570739|39142264|FG001|Overall Study|Required restricted medication|0|||
16181401|NCT00570739|39142265|FG002|Overall Study|Required restricted medication|1|||
16181402|NCT00570739|39142266|FG003|Overall Study|Required restricted medication|0|||
16181403|NCT00570739|39142263|FG000|Overall Study|Met discontinuation criteria|1|||
16181404|NCT00570739|39142264|FG001|Overall Study|Met discontinuation criteria|0|||
16181405|NCT00570739|39142265|FG002|Overall Study|Met discontinuation criteria|1|||
16181406|NCT00570739|39142266|FG003|Overall Study|Met discontinuation criteria|1|||
16181407|NCT00570739|39142263|FG000|Overall Study|Other|0|||
16181408|NCT00570739|39142264|FG001|Overall Study|Other|2|||
16181409|NCT00570739|39142265|FG002|Overall Study|Other|5|||
16181410|NCT00570739|39142266|FG003|Overall Study|Other|3|||
16181411|NCT01396525|39142267|FG000|Overall Study|Withdrawal by Subject|8|||
16181412|NCT01396525|39142267|FG000|Overall Study|Death|14|||
16181413|NCT01396525|39142267|FG000|Overall Study|Lost to Follow-up|4|||
16181414|NCT02640612|39142268|FG000|Overall Study|Adverse Event|6|||
16181415|NCT02640612|39142269|FG001|Overall Study|Adverse Event|7|||
16181416|NCT02640612|39142270|FG002|Overall Study|Adverse Event|2|||
16181417|NCT02640612|39142268|FG000|Overall Study|Death|1|||
16181418|NCT02640612|39142269|FG001|Overall Study|Death|0|||
16181419|NCT02640612|39142270|FG002|Overall Study|Death|0|||
16181420|NCT02640612|39142268|FG000|Overall Study|Withdrawal by Subject|10|||
16181421|NCT02640612|39142269|FG001|Overall Study|Withdrawal by Subject|3|||
16181422|NCT02640612|39142270|FG002|Overall Study|Withdrawal by Subject|3|||
16181423|NCT02640612|39142268|FG000|Overall Study|Lost to Follow-up|4|||
16181424|NCT02640612|39142269|FG001|Overall Study|Lost to Follow-up|1|||
16181425|NCT02640612|39142270|FG002|Overall Study|Lost to Follow-up|1|||
16181426|NCT02640612|39142268|FG000|Overall Study|Protocol Violation|0|||
16181427|NCT02640612|39142269|FG001|Overall Study|Protocol Violation|2|||
16181428|NCT02640612|39142270|FG002|Overall Study|Protocol Violation|0|||
16181429|NCT02640612|39142268|FG000|Overall Study|Lack of Efficacy|1|||
16181430|NCT02640612|39142269|FG001|Overall Study|Lack of Efficacy|1|||
16181431|NCT02640612|39142270|FG002|Overall Study|Lack of Efficacy|0|||
16181432|NCT00652093|39142272|FG000|Overall Study|Withdrawal by Subject|0|||
16181433|NCT00652093|39142273|FG001|Overall Study|Withdrawal by Subject|0|||
16181434|NCT00652093|39142274|FG002|Overall Study|Withdrawal by Subject|1|||
16181435|NCT00652093|39142275|FG003|Overall Study|Withdrawal by Subject|0|||
16181436|NCT00652093|39142276|FG004|Overall Study|Withdrawal by Subject|1|||
16181437|NCT00652093|39142277|FG005|Overall Study|Withdrawal by Subject|0|||
16181438|NCT00652093|39142272|FG000|Overall Study|Physician Decision|0|||
16181439|NCT00652093|39142273|FG001|Overall Study|Physician Decision|0|||
16181440|NCT00652093|39142274|FG002|Overall Study|Physician Decision|0|||
16181441|NCT00652093|39142275|FG003|Overall Study|Physician Decision|0|||
16181442|NCT00652093|39142276|FG004|Overall Study|Physician Decision|1|||
16181443|NCT00652093|39142277|FG005|Overall Study|Physician Decision|0|||
16181444|NCT02138110|39142278|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
16181445|NCT02138110|39142278|FG000|Overall Scaffold Implantation|Death|3|||
16181446|NCT01520922|39142280|FG000|Treatment Phase|Physician Decision|2|||
16181447|NCT01520922|39142281|FG001|Treatment Phase|Physician Decision|1|||
16181448|NCT01520922|39142280|FG000|Treatment Phase|Progression|0|||
16181449|NCT01520922|39142281|FG001|Treatment Phase|Progression|2|||
16181450|NCT01520922|39142280|FG000|Treatment Phase|Adverse Event|3|||
16181451|NCT01520922|39142281|FG001|Treatment Phase|Adverse Event|5|||
16181452|NCT01520922|39142280|FG000|Follow up|Lost to Follow-up|0|||
16181453|NCT01520922|39142281|FG001|Follow up|Lost to Follow-up|1|||
16181454|NCT01520922|39142280|FG000|Survival Follow-up|Withdrawal by Subject|1|||
16181455|NCT01520922|39142281|FG001|Survival Follow-up|Withdrawal by Subject|0|||
16181456|NCT01824602|39142282|FG000|Overall Study|Withdrawal by Subject|0|||
16181457|NCT01824602|39142283|FG001|Overall Study|Withdrawal by Subject|0|||
16181458|NCT01824602|39142284|FG002|Overall Study|Withdrawal by Subject|1|||
16181459|NCT01824602|39142285|FG003|Overall Study|Withdrawal by Subject|2|||
16181460|NCT01824602|39142282|FG000|Overall Study|Patient non-compliance|0|||
16181461|NCT01824602|39142283|FG001|Overall Study|Patient non-compliance|0|||
16181462|NCT01824602|39142284|FG002|Overall Study|Patient non-compliance|1|||
16181463|NCT01824602|39142285|FG003|Overall Study|Patient non-compliance|0|||
16181464|NCT01824602|39142282|FG000|Overall Study|Adverse Event|1|||
16080129|NCT00304031|38786765|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
16080130|NCT00304031|38786766|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
16181465|NCT01824602|39142283|FG001|Overall Study|Adverse Event|0|||
16181466|NCT01824602|39142284|FG002|Overall Study|Adverse Event|2|||
16181467|NCT01824602|39142285|FG003|Overall Study|Adverse Event|2|||
16181468|NCT01824602|39142282|FG000|Overall Study|Treatment failure|0|||
16181469|NCT01824602|39142283|FG001|Overall Study|Treatment failure|0|||
16478818|NCT03519178|40234256|FG000|PF-06873600 Treatment|Refused further treatment|0|||
16478819|NCT03519178|40234257|FG001|PF-06873600 Treatment|Refused further treatment|1|||
16478820|NCT03519178|40234258|FG002|PF-06873600 Treatment|Refused further treatment|0|||
16478821|NCT03519178|40234259|FG003|PF-06873600 Treatment|Refused further treatment|0|||
16478822|NCT03519178|40234260|FG004|PF-06873600 Treatment|Refused further treatment|1|||
16080131|NCT00304031|38786767|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
16080132|NCT00304031|38786765|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
16080133|NCT00304031|38786766|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
16080134|NCT00304031|38786767|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
16080135|NCT00304031|38786765|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
16080136|NCT00304031|38786766|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
16080137|NCT00304031|38786767|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
16080138|NCT00304031|38786765|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
16080139|NCT00304031|38786766|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
16080140|NCT00304031|38786767|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
16080141|NCT00304031|38786765|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
16080142|NCT00304031|38786766|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
16080143|NCT00304031|38786767|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
16080144|NCT00304031|38786765|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
16080145|NCT00304031|38786766|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
16080146|NCT00304031|38786767|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
16080147|NCT00304031|38786765|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
16080148|NCT00304031|38786766|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
16080149|NCT00304031|38786767|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
16080150|NCT04048382|38786768|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
16080151|NCT04048382|38786769|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
16080152|NCT04048382|38786768|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
16080153|NCT04048382|38786769|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
16080154|NCT04048382|38786768|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
16080155|NCT04048382|38786769|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
16080156|NCT00761605|38786772|FG000|Overall Study|Adverse Event|26|||
16080157|NCT00761605|38786772|FG000|Overall Study|Death|2|||
16080158|NCT00761605|38786772|FG000|Overall Study|Lack of Efficacy|26|||
16080159|NCT00761605|38786772|FG000|Overall Study|Lost to Follow-up|29|||
16080160|NCT00761605|38786772|FG000|Overall Study|Withdrawal by Subject|37|||
16080161|NCT00761605|38786772|FG000|Overall Study|Other|21|||
16080162|NCT03051165|38786773|FG000|Overall Study|Withdrawal by Subject|1|||
16080163|NCT03051165|38786773|FG000|Overall Study|Early termination of study|12|||
16080164|NCT00785512|38786775|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
16080165|NCT00785512|38786776|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
16080166|NCT00785512|38786775|FG000|Overall Study|Adverse Event|0|||
16080167|NCT00785512|38786776|FG001|Overall Study|Adverse Event|0|||
16080168|NCT00785512|38786775|FG000|Overall Study|Lack of Efficacy|0|||
16080169|NCT00785512|38786776|FG001|Overall Study|Lack of Efficacy|2|||
16080170|NCT00785512|38786775|FG000|Overall Study|Withdrawal by Subject|0|||
16080171|NCT00785512|38786776|FG001|Overall Study|Withdrawal by Subject|1|||
16080172|NCT00785512|38786775|FG000|Overall Study|Lost to Follow-up|3|||
16080173|NCT00785512|38786776|FG001|Overall Study|Lost to Follow-up|0|||
16080174|NCT00785512|38786775|FG000|Overall Study|Precedure Refused|0|||
16080175|NCT00785512|38786776|FG001|Overall Study|Precedure Refused|0|||
16080176|NCT00785512|38786775|FG000|Overall Study|IVRS Programing Error|0|||
16080177|NCT00785512|38786776|FG001|Overall Study|IVRS Programing Error|0|||
16080178|NCT00785512|38786775|FG000|Overall Study|Physician Decision|0|||
16080179|NCT00785512|38786776|FG001|Overall Study|Physician Decision|0|||
16080180|NCT00785512|38786775|FG000|Overall Study|Lack of compliance|0|||
16080181|NCT00785512|38786776|FG001|Overall Study|Lack of compliance|1|||
16080182|NCT03531840|38786777|FG000|Overall Study|Death on study|3|||
16080183|NCT03531840|38786778|FG001|Overall Study|Death on study|2|||
16080184|NCT03531840|38786779|FG002|Overall Study|Death on study|1|||
16080185|NCT03531840|38786780|FG003|Overall Study|Death on study|2|||
16181470|NCT01824602|39142284|FG002|Overall Study|Treatment failure|0|||
16181471|NCT01824602|39142285|FG003|Overall Study|Treatment failure|1|||
16181472|NCT04075604|39142286|FG000|Overall Study|Adverse Event|0|||
16181473|NCT04075604|39142287|FG001|Overall Study|Adverse Event|0|||
16181474|NCT04075604|39142288|FG002|Overall Study|Adverse Event|3|||
16181475|NCT04075604|39142286|FG000|Overall Study|Participant request to discontinue study treatment|0|||
16181476|NCT04075604|39142287|FG001|Overall Study|Participant request to discontinue study treatment|0|||
16181477|NCT04075604|39142288|FG002|Overall Study|Participant request to discontinue study treatment|1|||
16181478|NCT04075604|39142286|FG000|Overall Study|Participant withdrew consent|0|||
16181479|NCT04075604|39142287|FG001|Overall Study|Participant withdrew consent|0|||
16181480|NCT04075604|39142288|FG002|Overall Study|Participant withdrew consent|1|||
16181481|NCT04075604|39142286|FG000|Overall Study|Other reasons|1|||
16181482|NCT04075604|39142287|FG001|Overall Study|Other reasons|0|||
16181483|NCT04075604|39142288|FG002|Overall Study|Other reasons|0|||
16181484|NCT04075604|39142286|FG000|Overall Study|Disease progression|0|||
16181485|NCT04075604|39142287|FG001|Overall Study|Disease progression|1|||
16181486|NCT04075604|39142288|FG002|Overall Study|Disease progression|0|||
16181487|NCT04075604|39142286|FG000|Overall Study|Study drug toxicity|0|||
16181488|NCT04075604|39142287|FG001|Overall Study|Study drug toxicity|5|||
16181489|NCT04075604|39142288|FG002|Overall Study|Study drug toxicity|1|||
16181490|NCT01200511|39142289|FG000|Overall Study|Lost to Follow-up|3|||
16181491|NCT01200511|39142289|FG000|Overall Study|Withdrawal by Subject|1|||
16181492|NCT01200511|39142289|FG000|Overall Study|Adverse Event|1|||
16181493|NCT01362322|39142290|FG000|Overall Study|Withdrawal by Subject|3|||
16181494|NCT01362322|39142291|FG001|Overall Study|Withdrawal by Subject|1|||
16181495|NCT01362322|39142290|FG000|Overall Study|Lost to Follow-up|2|||
16181496|NCT01362322|39142291|FG001|Overall Study|Lost to Follow-up|6|||
16181497|NCT03634072|39142295|FG000|Overall Study|Early termination of overall study|1|||
16181498|NCT03634072|39142296|FG001|Overall Study|Early termination of overall study|0|||
16181499|NCT01887210|39142301|FG000|Overall Study|Withdrawal by Subject|1|||
16181500|NCT01887210|39142302|FG001|Overall Study|Withdrawal by Subject|3|||
16181501|NCT01887210|39142301|FG000|Overall Study|Lost to Follow-up|0|||
16181502|NCT01887210|39142302|FG001|Overall Study|Lost to Follow-up|1|||
16181503|NCT00744055|39142303|FG000|Overall Study|Withdrawal by Subject|6|||
16181504|NCT00744055|39142304|FG001|Overall Study|Withdrawal by Subject|9|||
16181505|NCT00744055|39142303|FG000|Overall Study|Lack of Efficacy|0|||
16181506|NCT00744055|39142304|FG001|Overall Study|Lack of Efficacy|1|||
16181507|NCT00744055|39142303|FG000|Overall Study|Physician Decision|0|||
16181508|NCT00744055|39142304|FG001|Overall Study|Physician Decision|2|||
16181509|NCT00744055|39142303|FG000|Overall Study|Protocol Violation|1|||
16181510|NCT00744055|39142304|FG001|Overall Study|Protocol Violation|1|||
16181511|NCT00744055|39142303|FG000|Overall Study|Lost to Follow-up|0|||
16181512|NCT00744055|39142304|FG001|Overall Study|Lost to Follow-up|1|||
16181513|NCT02424539|39142305|FG000|Overall Study|Adverse Event|0|||
16181514|NCT02424539|39142306|FG001|Overall Study|Adverse Event|0|||
16181515|NCT02424539|39142307|FG002|Overall Study|Adverse Event|1|||
16181516|NCT02424539|39142305|FG000|Overall Study|Physician Decision|0|||
16181517|NCT02424539|39142306|FG001|Overall Study|Physician Decision|0|||
16181518|NCT02424539|39142307|FG002|Overall Study|Physician Decision|1|||
16181519|NCT02424539|39142305|FG000|Overall Study|Withdrawal by Subject|3|||
16181520|NCT02424539|39142306|FG001|Overall Study|Withdrawal by Subject|1|||
16181521|NCT02424539|39142307|FG002|Overall Study|Withdrawal by Subject|0|||
16181522|NCT02424539|39142305|FG000|Overall Study|Other: Reached stopping criteria|11|||
16181523|NCT02424539|39142306|FG001|Overall Study|Other: Reached stopping criteria|7|||
16181524|NCT02424539|39142307|FG002|Overall Study|Other: Reached stopping criteria|6|||
16181525|NCT00564629|39142310|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
16181526|NCT00564629|39142311|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
16181527|NCT01415440|39142316|FG000|Overall Study|Lost to Follow-up|0|||
16181528|NCT01415440|39142317|FG001|Overall Study|Lost to Follow-up|1|||
16181529|NCT01415440|39142318|FG002|Overall Study|Lost to Follow-up|2|||
16181530|NCT01415440|39142316|FG000|Overall Study|Physician Decision|3|||
16181531|NCT01415440|39142317|FG001|Overall Study|Physician Decision|0|||
16181532|NCT01415440|39142318|FG002|Overall Study|Physician Decision|0|||
16181533|NCT01415440|39142316|FG000|Overall Study|Withdrawal by Subject|1|||
16181534|NCT01415440|39142317|FG001|Overall Study|Withdrawal by Subject|0|||
16181535|NCT01415440|39142318|FG002|Overall Study|Withdrawal by Subject|0|||
16181536|NCT03494725|39142319|FG000|Overall Study|Withdrawal by Subject|0|||
16181537|NCT03494725|39142320|FG001|Overall Study|Withdrawal by Subject|2|||
16181538|NCT03494725|39142319|FG000|Overall Study|Antibiotic use|1|||
16181539|NCT03494725|39142320|FG001|Overall Study|Antibiotic use|0|||
16181540|NCT00519532|39142321|FG000|Overall Study|Adverse Event|11|||
16181541|NCT00519532|39142321|FG000|Overall Study|Withdrawal by Subject|5|||
16181542|NCT00519532|39142321|FG000|Overall Study|Lost to Follow-up|2|||
16181543|NCT00482001|39142325|FG000|Overall Study|Protocol Violation|1|||
16181544|NCT00482001|39142326|FG001|Overall Study|Protocol Violation|1|||
16181545|NCT03280550|39142330|FG000|Overall Study|Withdrawal by Subject|2|||
16181546|NCT03280550|39142331|FG001|Overall Study|Withdrawal by Subject|2|||
16181547|NCT03280550|39142330|FG000|Overall Study|Physician Decision|0|||
16181548|NCT03280550|39142331|FG001|Overall Study|Physician Decision|1|||
16181549|NCT00881205|39142332|FG000|Overall Study|Adverse Event|8|||
16181550|NCT00881205|39142333|FG001|Overall Study|Adverse Event|3|||
16181551|NCT00881205|39142332|FG000|Overall Study|Withdrawal by Subject|1|||
16181552|NCT00881205|39142333|FG001|Overall Study|Withdrawal by Subject|2|||
16181553|NCT00881205|39142332|FG000|Overall Study|Lost to Follow-up|0|||
16181554|NCT00881205|39142333|FG001|Overall Study|Lost to Follow-up|1|||
16181555|NCT00881205|39142332|FG000|Overall Study|Administrative problems|1|||
16181556|NCT00881205|39142333|FG001|Overall Study|Administrative problems|1|||
16181557|NCT00881205|39142332|FG000|Overall Study|Condition no longer requires drug|1|||
16181558|NCT00881205|39142333|FG001|Overall Study|Condition no longer requires drug|0|||
16181559|NCT02616029|39142334|FG000|Overall Study|Adverse Event|1|||
16181560|NCT02616029|39142335|FG001|Overall Study|Adverse Event|0|||
16181561|NCT02616029|39142334|FG000|Overall Study|Death|0|||
16181562|NCT02616029|39142335|FG001|Overall Study|Death|1|||
16181563|NCT02616029|39142334|FG000|Overall Study|Protocol Violation|1|||
16181564|NCT02616029|39142335|FG001|Overall Study|Protocol Violation|0|||
16181565|NCT02616029|39142334|FG000|Overall Study|Withdrew Consent|1|||
16181566|NCT02616029|39142335|FG001|Overall Study|Withdrew Consent|0|||
16181567|NCT02616029|39142334|FG000|Overall Study|Enrolled and Never Treated|1|||
16181568|NCT02616029|39142335|FG001|Overall Study|Enrolled and Never Treated|1|||
16181569|NCT02613572|39142336|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
16181570|NCT02613572|39142337|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
16181571|NCT02613572|39142338|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
16181572|NCT02613572|39142336|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
16181573|NCT02613572|39142337|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
16478823|NCT03519178|40234261|FG005|PF-06873600 Treatment|Refused further treatment|0|||
16478824|NCT03519178|40234262|FG006|PF-06873600 Treatment|Refused further treatment|0|||
16478825|NCT03519178|40234263|FG007|PF-06873600 Treatment|Refused further treatment|0|||
16478826|NCT03519178|40234264|FG008|PF-06873600 Treatment|Refused further treatment|0|||
16478827|NCT03519178|40234265|FG009|PF-06873600 Treatment|Refused further treatment|0|||
16478828|NCT03519178|40234266|FG010|PF-06873600 Treatment|Refused further treatment|0|||
16478829|NCT03519178|40234267|FG011|PF-06873600 Treatment|Refused further treatment|0|||
16181574|NCT02613572|39142338|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
16181575|NCT03133481|39142339|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
16181576|NCT03133481|39142340|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
16181577|NCT01499576|39142345|FG000|Overall Study|Physician Decision|12|||
16181578|NCT01499576|39142345|FG000|Overall Study|Withdrawal by Subject|9|||
16181579|NCT00425438|39145291|FG000|Overall Study|Termination by Sponsor|25|||
16181580|NCT00425438|39145292|FG001|Overall Study|Termination by Sponsor|27|||
16181581|NCT05590403|39145293|FG000|Overall Study|Lost to Follow-up|3|||
16181582|NCT05590403|39145294|FG001|Overall Study|Lost to Follow-up|0|||
16181583|NCT05590403|39145295|FG002|Overall Study|Lost to Follow-up|2|||
16181584|NCT05590403|39145296|FG003|Overall Study|Lost to Follow-up|0|||
16181585|NCT05590403|39145297|FG004|Overall Study|Lost to Follow-up|0|||
16181586|NCT05590403|39145293|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
16181587|NCT05590403|39145294|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
16181588|NCT05590403|39145295|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
16181589|NCT05590403|39145296|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
16181590|NCT05590403|39145297|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
16181591|NCT02021812|39145298|FG000|Overall Study|Death|8|||
16181592|NCT02021812|39145298|FG000|Overall Study|Withdrawal by Subject|3|||
16181593|NCT02021812|39145298|FG000|Overall Study|Lost to Follow-up|2|||
16181594|NCT02021812|39145298|FG000|Overall Study|Refuse to return, COVD 19|2|||
16181595|NCT01330381|39145306|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
16181596|NCT01330381|39145307|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
16181597|NCT01330381|39145308|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
16181598|NCT01330381|39145306|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
16181599|NCT01330381|39145307|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
16181600|NCT01330381|39145308|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
16181601|NCT01330381|39145306|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
16181602|NCT01330381|39145307|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
16181603|NCT01330381|39145308|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
16181604|NCT01330381|39145306|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
16181605|NCT01330381|39145307|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
16181606|NCT01330381|39145308|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
16181607|NCT01330381|39145306|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
16181608|NCT01330381|39145307|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
16273262|NCT01541215|39484476|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
16478830|NCT03519178|40234268|FG012|PF-06873600 Treatment|Refused further treatment|0|||
16181609|NCT01330381|39145308|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
16181610|NCT01330381|39145306|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
16181611|NCT01330381|39145307|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
16181612|NCT01330381|39145308|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
16181613|NCT01330381|39145306|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
16181614|NCT01330381|39145307|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
16181615|NCT01330381|39145308|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
16181616|NCT01330381|39145306|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
16181617|NCT01330381|39145307|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
16181618|NCT01330381|39145308|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
16181619|NCT01330381|39145306|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
16181620|NCT01330381|39145307|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
16181621|NCT01330381|39145308|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
16181622|NCT01330381|39145306|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
16181623|NCT01330381|39145307|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
16181624|NCT01330381|39145308|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
16181625|NCT03103750|39145311|FG000|Overall Study|Adverse Event|1|||
16181626|NCT03103750|39145312|FG001|Overall Study|Adverse Event|0|||
16181627|NCT03103750|39145311|FG000|Overall Study|Lost to Follow-up|1|||
16181628|NCT03103750|39145312|FG001|Overall Study|Lost to Follow-up|0|||
16181629|NCT03103750|39145311|FG000|Overall Study|PET Equipment Related|2|||
16181630|NCT03103750|39145312|FG001|Overall Study|PET Equipment Related|2|||
16181631|NCT00637728|39145313|FG000|Double-blind Phase|Adverse Event|1|||
16181632|NCT00637728|39145314|FG001|Double-blind Phase|Adverse Event|0|||
16181633|NCT00637728|39145315|FG002|Double-blind Phase|Adverse Event|0|||
16181634|NCT00637728|39145313|FG000|Double-blind Phase|Non-compliance|2|||
16181635|NCT00637728|39145314|FG001|Double-blind Phase|Non-compliance|0|||
16181636|NCT00637728|39145315|FG002|Double-blind Phase|Non-compliance|0|||
16181637|NCT00637728|39145313|FG000|Double-blind Phase|Study Discontinued|1|||
16181638|NCT00637728|39145314|FG001|Double-blind Phase|Study Discontinued|1|||
16181639|NCT00637728|39145315|FG002|Double-blind Phase|Study Discontinued|0|||
16181640|NCT02388776|39145324|FG000|Overall Study|Death|1|||
16181641|NCT02388776|39145324|FG000|Overall Study|Lost to Follow-up|1|||
16181642|NCT00414440|39145325|FG000|Core Period|Withdrawal by Subject|70|||
16181643|NCT00414440|39145326|FG001|Core Period|Withdrawal by Subject|32|||
16181644|NCT00414440|39145325|FG000|Extension Period|Lost to Follow-up|44|||
16181645|NCT00414440|39145326|FG001|Extension Period|Lost to Follow-up|52|||
16181646|NCT00414440|39145325|FG000|Extension Period|Did not consent to continue follow up|61|||
16181647|NCT00414440|39145326|FG001|Extension Period|Did not consent to continue follow up|54|||
16181648|NCT00414440|39145325|FG000|Extension Period|Other|1|||
16181649|NCT00414440|39145326|FG001|Extension Period|Other|1|||
16181650|NCT00414440|39145325|FG000|Extension Period|Administrative|16|||
16181651|NCT00414440|39145326|FG001|Extension Period|Administrative|16|||
16181652|NCT00414440|39145325|FG000|Extension Period|Death|1|||
16181653|NCT00414440|39145326|FG001|Extension Period|Death|2|||
16181654|NCT00414440|39145325|FG000|Extension Period|Withdrawal by Subject|9|||
16181655|NCT00414440|39145326|FG001|Extension Period|Withdrawal by Subject|7|||
16181656|NCT00414440|39145325|FG000|Extension Period|Not included in follow up period|18|||
16181657|NCT00414440|39145326|FG001|Extension Period|Not included in follow up period|8|||
16181658|NCT01426386|39145327|FG000|Overall Study|Adverse Event|0|||
16181659|NCT01426386|39145328|FG001|Overall Study|Adverse Event|1|||
16181660|NCT01426386|39145329|FG002|Overall Study|Adverse Event|0|||
16181661|NCT01426386|39145330|FG003|Overall Study|Adverse Event|0|||
16181662|NCT01426386|39145331|FG004|Overall Study|Adverse Event|0|||
16181663|NCT01426386|39145332|FG005|Overall Study|Adverse Event|0|||
16181664|NCT01426386|39145327|FG000|Overall Study|Did not attend scheduled visit|1|||
16181665|NCT01426386|39145328|FG001|Overall Study|Did not attend scheduled visit|4|||
16181666|NCT01426386|39145329|FG002|Overall Study|Did not attend scheduled visit|0|||
16181667|NCT01426386|39145330|FG003|Overall Study|Did not attend scheduled visit|0|||
16181668|NCT01426386|39145331|FG004|Overall Study|Did not attend scheduled visit|2|||
16279337|NCT02725411|39504291|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
16279338|NCT02725411|39504289|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
16279339|NCT02725411|39504290|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
16279340|NCT02725411|39504291|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
16279341|NCT02725411|39504289|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
16279342|NCT02725411|39504290|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
16279343|NCT02725411|39504291|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
16279344|NCT02725411|39504289|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
16279345|NCT02725411|39504290|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
16279346|NCT02725411|39504291|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
16181669|NCT01426386|39145332|FG005|Overall Study|Did not attend scheduled visit|1|||
16181670|NCT01426386|39145327|FG000|Overall Study|Poor response|2|||
16279347|NCT02725411|39504289|FG000|Follow-up Period (24 Weeks)|Other|1|||
16279348|NCT02725411|39504290|FG001|Follow-up Period (24 Weeks)|Other|4|||
16279349|NCT02725411|39504291|FG002|Follow-up Period (24 Weeks)|Other|2|||
16279350|NCT02725411|39504289|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
16279351|NCT02725411|39504290|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
16279352|NCT02725411|39504291|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
16279353|NCT04661202|39504295|FG000|Overall Study|Withdrawal by Subject|1|||
16279354|NCT04661202|39504296|FG001|Overall Study|Withdrawal by Subject|1|||
16279355|NCT04661202|39504295|FG000|Overall Study|Lack of Efficacy|2|||
16279356|NCT04661202|39504296|FG001|Overall Study|Lack of Efficacy|0|||
16279357|NCT01362296|39504305|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
16279358|NCT01362296|39504306|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
16279359|NCT01362296|39504307|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
16378757|NCT00862940|39872217|FG000|Overall Study|Withdrawal by Subject|4|||
16378758|NCT00862940|39872218|FG001|Overall Study|Withdrawal by Subject|6|||
16378759|NCT00862940|39872217|FG000|Overall Study|Non-compliance|4|||
16378760|NCT00862940|39872218|FG001|Overall Study|Non-compliance|0|||
16378761|NCT00862940|39872217|FG000|Overall Study|Lost to Follow-up|0|||
16378762|NCT00862940|39872218|FG001|Overall Study|Lost to Follow-up|1|||
16378763|NCT00862940|39872217|FG000|Overall Study|Administrative or other reason(s)|4|||
16378764|NCT00862940|39872218|FG001|Overall Study|Administrative or other reason(s)|3|||
16378765|NCT04988087|39872223|FG000|Overall Study|Adverse Event|4|||
16378766|NCT04988087|39872224|FG001|Overall Study|Adverse Event|0|||
16378767|NCT04988087|39872225|FG002|Overall Study|Adverse Event|0|||
16378768|NCT04988087|39872226|FG003|Overall Study|Adverse Event|0|||
16378769|NCT04988087|39872223|FG000|Overall Study|Withdrawal by Subject|1|||
16378770|NCT04988087|39872224|FG001|Overall Study|Withdrawal by Subject|1|||
16378771|NCT04988087|39872225|FG002|Overall Study|Withdrawal by Subject|0|||
16378772|NCT04988087|39872226|FG003|Overall Study|Withdrawal by Subject|0|||
16378773|NCT04988087|39872223|FG000|Overall Study|Technical problems|7|||
16378774|NCT04988087|39872224|FG001|Overall Study|Technical problems|9|||
16378775|NCT04988087|39872225|FG002|Overall Study|Technical problems|1|||
16378776|NCT04988087|39872226|FG003|Overall Study|Technical problems|2|||
16378777|NCT04164901|39872227|FG000|Overall Study|Withdrawal by Subject|4|||
16378778|NCT04164901|39872228|FG001|Overall Study|Withdrawal by Subject|4|||
16478831|NCT03519178|40234269|FG013|PF-06873600 Treatment|Refused further treatment|0|||
16478832|NCT03519178|40234270|FG014|PF-06873600 Treatment|Refused further treatment|1|||
16478833|NCT03519178|40234256|FG000|PF-06873600 Treatment|Other|0|||
16478834|NCT03519178|40234257|FG001|PF-06873600 Treatment|Other|0|||
16478835|NCT03519178|40234258|FG002|PF-06873600 Treatment|Other|0|||
16478836|NCT03519178|40234259|FG003|PF-06873600 Treatment|Other|0|||
16478837|NCT03519178|40234260|FG004|PF-06873600 Treatment|Other|0|||
16181671|NCT01426386|39145328|FG001|Overall Study|Poor response|1|||
16181672|NCT01426386|39145329|FG002|Overall Study|Poor response|2|||
16181673|NCT01426386|39145330|FG003|Overall Study|Poor response|0|||
16181674|NCT01426386|39145331|FG004|Overall Study|Poor response|1|||
16181675|NCT01426386|39145332|FG005|Overall Study|Poor response|0|||
16181676|NCT01426386|39145327|FG000|Overall Study|Personal reasons|0|||
16181677|NCT01426386|39145328|FG001|Overall Study|Personal reasons|0|||
16181678|NCT01426386|39145329|FG002|Overall Study|Personal reasons|0|||
16181679|NCT01426386|39145330|FG003|Overall Study|Personal reasons|0|||
16181680|NCT01426386|39145331|FG004|Overall Study|Personal reasons|1|||
16181681|NCT01426386|39145332|FG005|Overall Study|Personal reasons|0|||
16181682|NCT05253807|39145333|FG000|Overall Study|Death|1|||
16478838|NCT03519178|40234261|FG005|PF-06873600 Treatment|Other|0|||
16478839|NCT03519178|40234262|FG006|PF-06873600 Treatment|Other|0|||
16478840|NCT03519178|40234263|FG007|PF-06873600 Treatment|Other|0|||
16181683|NCT05253807|39145334|FG001|Overall Study|Death|4|||
16181684|NCT05253807|39145333|FG000|Overall Study|Withdrawal by Subject|1|||
16181685|NCT05253807|39145334|FG001|Overall Study|Withdrawal by Subject|0|||
16181686|NCT05253807|39145333|FG000|Overall Study|Study Terminated by Sponsor|1|||
16181687|NCT05253807|39145334|FG001|Overall Study|Study Terminated by Sponsor|1|||
16181688|NCT01164501|39145335|FG000|Overall Study|Not treated|2|||
16181689|NCT01164501|39145336|FG001|Overall Study|Not treated|0|||
16181690|NCT01164501|39145337|FG002|Overall Study|Not treated|1|||
16181691|NCT01164501|39145335|FG000|Overall Study|Adverse Event|18|||
16181692|NCT01164501|39145336|FG001|Overall Study|Adverse Event|4|||
16181693|NCT01164501|39145337|FG002|Overall Study|Adverse Event|21|||
16181694|NCT01164501|39145335|FG000|Overall Study|Lack of Efficacy|0|||
16181695|NCT01164501|39145336|FG001|Overall Study|Lack of Efficacy|0|||
16378779|NCT03232567|39872229|FG000|Overall Study|Withdrawal by Subject|0|||
16378780|NCT03232567|39872230|FG001|Overall Study|Withdrawal by Subject|1|||
16378781|NCT03232567|39872231|FG002|Overall Study|Withdrawal by Subject|0|||
16478841|NCT03519178|40234264|FG008|PF-06873600 Treatment|Other|1|||
16181696|NCT01164501|39145337|FG002|Overall Study|Lack of Efficacy|1|||
16279360|NCT01362296|39504308|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
16478842|NCT03519178|40234265|FG009|PF-06873600 Treatment|Other|0|||
16478843|NCT03519178|40234266|FG010|PF-06873600 Treatment|Other|0|||
16478844|NCT03519178|40234267|FG011|PF-06873600 Treatment|Other|0|||
16478845|NCT03519178|40234268|FG012|PF-06873600 Treatment|Other|0|||
16478846|NCT03519178|40234269|FG013|PF-06873600 Treatment|Other|1|||
16478847|NCT03519178|40234270|FG014|PF-06873600 Treatment|Other|3|||
16478848|NCT03519178|40234256|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
16478849|NCT03519178|40234257|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
16478850|NCT03519178|40234258|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
16478851|NCT03519178|40234259|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
16478852|NCT03519178|40234260|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
16181697|NCT01164501|39145335|FG000|Overall Study|Non compliant with protocol|1|||
16181698|NCT01164501|39145336|FG001|Overall Study|Non compliant with protocol|1|||
16181699|NCT01164501|39145337|FG002|Overall Study|Non compliant with protocol|4|||
16181700|NCT01164501|39145335|FG000|Overall Study|Lost to Follow-up|3|||
16181701|NCT01164501|39145336|FG001|Overall Study|Lost to Follow-up|0|||
16181702|NCT01164501|39145337|FG002|Overall Study|Lost to Follow-up|3|||
16181703|NCT01164501|39145335|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
16181704|NCT01164501|39145336|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
16181705|NCT01164501|39145337|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
16181706|NCT01164501|39145335|FG000|Overall Study|Other reason not defined above|9|||
16181707|NCT01164501|39145336|FG001|Overall Study|Other reason not defined above|1|||
16181708|NCT01164501|39145337|FG002|Overall Study|Other reason not defined above|4|||
16181709|NCT02203838|39145338|FG000|Overall Study|Lack of Efficacy|7|||
16181710|NCT02203838|39145339|FG001|Overall Study|Lack of Efficacy|0|||
16181711|NCT02203838|39145340|FG002|Overall Study|Lack of Efficacy|1|||
16181712|NCT02203838|39145341|FG003|Overall Study|Lack of Efficacy|1|||
16181713|NCT02203838|39145338|FG000|Overall Study|Adverse Event|46|||
16181714|NCT02203838|39145339|FG001|Overall Study|Adverse Event|6|||
16181715|NCT02203838|39145340|FG002|Overall Study|Adverse Event|3|||
16181716|NCT02203838|39145341|FG003|Overall Study|Adverse Event|2|||
16181717|NCT02203838|39145338|FG000|Overall Study|Lost to Follow-up|39|||
16181718|NCT02203838|39145339|FG001|Overall Study|Lost to Follow-up|3|||
16181719|NCT02203838|39145340|FG002|Overall Study|Lost to Follow-up|2|||
16181720|NCT02203838|39145341|FG003|Overall Study|Lost to Follow-up|1|||
16181721|NCT02203838|39145338|FG000|Overall Study|Protocol Violation|7|||
16181722|NCT02203838|39145339|FG001|Overall Study|Protocol Violation|3|||
16181723|NCT02203838|39145340|FG002|Overall Study|Protocol Violation|0|||
16181724|NCT02203838|39145341|FG003|Overall Study|Protocol Violation|0|||
16181725|NCT02203838|39145338|FG000|Overall Study|Withdrawal by Subject|83|||
16181726|NCT02203838|39145339|FG001|Overall Study|Withdrawal by Subject|10|||
16181727|NCT02203838|39145340|FG002|Overall Study|Withdrawal by Subject|8|||
16478853|NCT03519178|40234261|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
16478854|NCT03519178|40234262|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
16181728|NCT02203838|39145341|FG003|Overall Study|Withdrawal by Subject|11|||
16181729|NCT02203838|39145338|FG000|Overall Study|Physician Decision|27|||
16181730|NCT02203838|39145339|FG001|Overall Study|Physician Decision|0|||
16181731|NCT02203838|39145340|FG002|Overall Study|Physician Decision|2|||
16181732|NCT02203838|39145341|FG003|Overall Study|Physician Decision|3|||
16181733|NCT02203838|39145338|FG000|Overall Study|Other|1|||
16181734|NCT02203838|39145339|FG001|Overall Study|Other|0|||
16181735|NCT02203838|39145340|FG002|Overall Study|Other|0|||
16181736|NCT02203838|39145341|FG003|Overall Study|Other|0|||
16181737|NCT00642616|39145343|FG000|Overall Study|Adverse Event|2|||
16181738|NCT00642616|39145344|FG001|Overall Study|Adverse Event|0|||
16181739|NCT00642616|39145345|FG002|Overall Study|Adverse Event|1|||
16181740|NCT00642616|39145346|FG003|Overall Study|Adverse Event|0|||
16181741|NCT00642616|39145343|FG000|Overall Study|Study Terminated by Sponsor|7|||
16181742|NCT00642616|39145344|FG001|Overall Study|Study Terminated by Sponsor|6|||
16181743|NCT00642616|39145345|FG002|Overall Study|Study Terminated by Sponsor|4|||
16181744|NCT00642616|39145346|FG003|Overall Study|Study Terminated by Sponsor|5|||
16181745|NCT00642616|39145343|FG000|Overall Study|Withdrawal by Subject|0|||
16181746|NCT00642616|39145344|FG001|Overall Study|Withdrawal by Subject|1|||
16478855|NCT03519178|40234263|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
16181747|NCT00642616|39145345|FG002|Overall Study|Withdrawal by Subject|1|||
16181748|NCT00642616|39145346|FG003|Overall Study|Withdrawal by Subject|1|||
16181749|NCT00642616|39145343|FG000|Overall Study|Protocol Violation|0|||
16181750|NCT00642616|39145344|FG001|Overall Study|Protocol Violation|0|||
16181751|NCT00642616|39145345|FG002|Overall Study|Protocol Violation|2|||
16181752|NCT00642616|39145346|FG003|Overall Study|Protocol Violation|0|||
16181753|NCT00642616|39145343|FG000|Overall Study|Physician Decision|0|||
16181754|NCT00642616|39145344|FG001|Overall Study|Physician Decision|0|||
16181755|NCT00642616|39145345|FG002|Overall Study|Physician Decision|1|||
16181756|NCT00642616|39145346|FG003|Overall Study|Physician Decision|1|||
16181757|NCT01873950|39145347|FG000|Period 5|Withdrawal by Subject|0|||
16181758|NCT01873950|39145348|FG001|Period 5|Withdrawal by Subject|0|||
16478856|NCT03519178|40234264|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
16478857|NCT03519178|40234265|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
16478858|NCT03519178|40234266|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
16478859|NCT03519178|40234267|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
16181759|NCT01873950|39145349|FG002|Period 5|Withdrawal by Subject|0|||
16181760|NCT01873950|39145350|FG003|Period 5|Withdrawal by Subject|1|||
16181761|NCT01873950|39145351|FG004|Period 5|Withdrawal by Subject|0|||
16181762|NCT00922935|39145354|FG000|Overall Study|Protocol Violation|0|||
16181763|NCT00922935|39145355|FG001|Overall Study|Protocol Violation|3|||
16181764|NCT00922935|39145356|FG002|Overall Study|Protocol Violation|0|||
16181765|NCT00922935|39145354|FG000|Overall Study|Physician Decision|1|||
16181766|NCT00922935|39145355|FG001|Overall Study|Physician Decision|1|||
16181767|NCT00922935|39145356|FG002|Overall Study|Physician Decision|0|||
16181768|NCT00922935|39145354|FG000|Overall Study|Lost to Follow-up|0|||
16181769|NCT00922935|39145355|FG001|Overall Study|Lost to Follow-up|1|||
16181770|NCT00922935|39145356|FG002|Overall Study|Lost to Follow-up|0|||
16181771|NCT04382651|39145357|FG000|Overall Study|Death|26|||
16181772|NCT04382651|39145358|FG001|Overall Study|Death|23|||
16181773|NCT04382651|39145357|FG000|Overall Study|Lost to Follow-up|3|||
16181774|NCT04382651|39145358|FG001|Overall Study|Lost to Follow-up|4|||
16181775|NCT04382651|39145357|FG000|Overall Study|Withdrawal by Subject|2|||
16181776|NCT04382651|39145358|FG001|Overall Study|Withdrawal by Subject|0|||
16181777|NCT04382651|39145357|FG000|Overall Study|Physician Decision|0|||
16181778|NCT04382651|39145358|FG001|Overall Study|Physician Decision|1|||
16181779|NCT02224846|39145359|FG000|Period 1 (Month 3)|Adverse Event|2|||
16181780|NCT02224846|39145360|FG001|Period 1 (Month 3)|Adverse Event|1|||
16181781|NCT02224846|39145359|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
16181782|NCT02224846|39145360|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
16181783|NCT02224846|39145359|FG000|Period 1 (Month 3)|Protocol Violation|4|||
16181784|NCT02224846|39145360|FG001|Period 1 (Month 3)|Protocol Violation|8|||
16181785|NCT02224846|39145359|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
16181786|NCT02224846|39145360|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
16181787|NCT02224846|39145359|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
16181788|NCT02224846|39145360|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
16181789|NCT02224846|39145359|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
16181790|NCT02224846|39145360|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
16181791|NCT02224846|39145359|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
16181792|NCT02224846|39145360|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
16181793|NCT02224846|39145359|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
16181794|NCT02224846|39145360|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
16181795|NCT02224846|39145359|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
16181796|NCT02224846|39145360|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
16181797|NCT02224846|39145359|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
16181798|NCT02224846|39145360|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
16181799|NCT02224846|39145359|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
16181800|NCT02224846|39145360|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
16181801|NCT02224846|39145359|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
16181802|NCT02224846|39145360|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
16181803|NCT02224846|39145359|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
16181804|NCT02224846|39145360|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
16181805|NCT02224846|39145359|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
16181806|NCT02224846|39145360|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
16181807|NCT02224846|39145359|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
16181808|NCT02224846|39145360|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
16181809|NCT02224846|39145359|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
16181810|NCT02224846|39145360|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
16181811|NCT02224846|39145359|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
16181812|NCT02224846|39145360|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
16181813|NCT01458340|39145361|FG000|Overall Study|Adverse Event|5|||
16181814|NCT01458340|39145362|FG001|Overall Study|Adverse Event|4|||
16181815|NCT01458340|39145363|FG002|Overall Study|Adverse Event|2|||
16181816|NCT01458340|39145361|FG000|Overall Study|Lost to Follow-up|3|||
16181817|NCT01458340|39145362|FG001|Overall Study|Lost to Follow-up|3|||
16181818|NCT01458340|39145363|FG002|Overall Study|Lost to Follow-up|10|||
16181819|NCT01458340|39145361|FG000|Overall Study|Miscellaneous|0|||
16181820|NCT01458340|39145362|FG001|Overall Study|Miscellaneous|1|||
16181821|NCT01458340|39145363|FG002|Overall Study|Miscellaneous|0|||
16181822|NCT01458340|39145361|FG000|Overall Study|Physician Decision|1|||
16181823|NCT01458340|39145362|FG001|Overall Study|Physician Decision|1|||
16181824|NCT01458340|39145363|FG002|Overall Study|Physician Decision|2|||
16181825|NCT01458340|39145361|FG000|Overall Study|Protocol Violation|6|||
16181826|NCT01458340|39145362|FG001|Overall Study|Protocol Violation|6|||
16181827|NCT01458340|39145363|FG002|Overall Study|Protocol Violation|5|||
16181828|NCT01458340|39145361|FG000|Overall Study|Withdrawal by Subject|12|||
16181829|NCT01458340|39145362|FG001|Overall Study|Withdrawal by Subject|6|||
16181830|NCT01458340|39145363|FG002|Overall Study|Withdrawal by Subject|4|||
16181831|NCT00933335|39145364|FG000|Overall Study|Lost to Follow-up|1|||
16181832|NCT00933335|39145365|FG001|Overall Study|Lost to Follow-up|3|||
16181833|NCT00933335|39145364|FG000|Overall Study|Withdrawal by Subject|0|||
16181834|NCT00933335|39145365|FG001|Overall Study|Withdrawal by Subject|1|||
16181835|NCT00933335|39145364|FG000|Overall Study|Progressive Disease|0|||
16181836|NCT00933335|39145365|FG001|Overall Study|Progressive Disease|11|||
16181837|NCT00933335|39145364|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
16181838|NCT00933335|39145365|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
16181839|NCT00933335|39145364|FG000|Overall Study|Co-morbid Illness|1|||
16181840|NCT00933335|39145365|FG001|Overall Study|Co-morbid Illness|0|||
16181841|NCT04101422|39145370|FG000|Overall Study|Ineligible|1|||
16181842|NCT04101422|39145371|FG001|Overall Study|Ineligible|0|||
16181843|NCT04101422|39145372|FG002|Overall Study|Ineligible|9|||
16181844|NCT04101422|39145373|FG003|Overall Study|Ineligible|0|||
16181845|NCT04101422|39145370|FG000|Overall Study|Withdrawal by Subject|0|||
16181846|NCT04101422|39145371|FG001|Overall Study|Withdrawal by Subject|0|||
16181847|NCT04101422|39145372|FG002|Overall Study|Withdrawal by Subject|1|||
16181848|NCT04101422|39145373|FG003|Overall Study|Withdrawal by Subject|0|||
16181849|NCT04101422|39145370|FG000|Overall Study|Not attending to the stimuli|0|||
16181850|NCT04101422|39145371|FG001|Overall Study|Not attending to the stimuli|0|||
16181851|NCT04101422|39145372|FG002|Overall Study|Not attending to the stimuli|4|||
16181852|NCT04101422|39145373|FG003|Overall Study|Not attending to the stimuli|0|||
16181853|NCT04101422|39145370|FG000|Overall Study|Did not download app|0|||
16181854|NCT04101422|39145371|FG001|Overall Study|Did not download app|0|||
16181855|NCT04101422|39145372|FG002|Overall Study|Did not download app|0|||
16181856|NCT04101422|39145373|FG003|Overall Study|Did not download app|17|||
16181857|NCT04101422|39145370|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
16181858|NCT04101422|39145371|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
16181859|NCT04101422|39145372|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
16181860|NCT04101422|39145373|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
16181861|NCT02760602|39145374|FG000|Overall Study|Withdrawal by Subject|1|||
16181862|NCT02760602|39145375|FG001|Overall Study|Withdrawal by Subject|0|||
16181863|NCT02760602|39145374|FG000|Overall Study|Terminated by sponsor|12|||
16181864|NCT02760602|39145375|FG001|Overall Study|Terminated by sponsor|13|||
16181865|NCT00849212|39145378|FG000|Overall Study|Lack of Efficacy|1|||
16181866|NCT00849212|39145378|FG000|Overall Study|Withdrawal by Subject|3|||
16181867|NCT00849212|39145378|FG000|Overall Study|Adverse Event|2|||
16181868|NCT00849212|39145378|FG000|Overall Study|Miscellaneous|1|||
16181869|NCT03228186|39145379|FG000|Overall Study|Patient never started treatment|1|||
16181870|NCT01887912|39145384|FG000|Overall Study|Serious adverse event|400|||
16181871|NCT01887912|39145385|FG001|Overall Study|Serious adverse event|198|||
16181872|NCT01887912|39145384|FG000|Overall Study|Other Adverse Event|34|||
16181873|NCT01887912|39145385|FG001|Overall Study|Other Adverse Event|15|||
16181874|NCT01887912|39145384|FG000|Overall Study|Protocol Violation|67|||
16181875|NCT01887912|39145385|FG001|Overall Study|Protocol Violation|37|||
16181876|NCT01887912|39145384|FG000|Overall Study|Lost to Follow-up|163|||
16181877|NCT01887912|39145385|FG001|Overall Study|Lost to Follow-up|74|||
16181878|NCT01887912|39145384|FG000|Overall Study|Withdrawal by Subject|606|||
16181879|NCT01887912|39145385|FG001|Overall Study|Withdrawal by Subject|349|||
16181880|NCT01887912|39145384|FG000|Overall Study|Other|122|||
16181881|NCT01887912|39145385|FG001|Overall Study|Other|58|||
16181882|NCT00098345|39145387|FG000|Overall Study|Adverse Event|7|||
16181883|NCT00098345|39145387|FG000|Overall Study|Withdrawal by Subject|2|||
16181884|NCT00098345|39145387|FG000|Overall Study|progression|4|||
16181885|NCT01056107|39145388|FG000|Overall Study|Withdrawal by Subject|0|||
16181886|NCT01056107|39145389|FG001|Overall Study|Withdrawal by Subject|1|||
16181887|NCT01056107|39145390|FG002|Overall Study|Withdrawal by Subject|3|||
16181888|NCT01056107|39145391|FG003|Overall Study|Withdrawal by Subject|0|||
16181889|NCT03598777|39145397|FG000|Overall Study|Study Terminated by Sponsor|3|||
16181890|NCT03598777|39145398|FG001|Overall Study|Study Terminated by Sponsor|0|||
16181891|NCT03598777|39145399|FG002|Overall Study|Study Terminated by Sponsor|0|||
16181892|NCT03598777|39145400|FG003|Overall Study|Study Terminated by Sponsor|0|||
16181893|NCT03598777|39145401|FG004|Overall Study|Study Terminated by Sponsor|15|||
16181894|NCT03598777|39145397|FG000|Overall Study|Withdrawal by Subject|1|||
16181895|NCT03598777|39145398|FG001|Overall Study|Withdrawal by Subject|1|||
16181896|NCT03598777|39145399|FG002|Overall Study|Withdrawal by Subject|0|||
16181897|NCT03598777|39145400|FG003|Overall Study|Withdrawal by Subject|0|||
16181898|NCT03598777|39145401|FG004|Overall Study|Withdrawal by Subject|0|||
16181899|NCT03598777|39145397|FG000|Overall Study|Adverse Event|1|||
16181900|NCT03598777|39145398|FG001|Overall Study|Adverse Event|0|||
16279361|NCT01362296|39504305|FG000|Randomized Phase (RP)|Physician Decision|1|||
16181901|NCT03598777|39145399|FG002|Overall Study|Adverse Event|0|||
16181902|NCT03598777|39145400|FG003|Overall Study|Adverse Event|0|||
16181903|NCT03598777|39145401|FG004|Overall Study|Adverse Event|0|||
16181904|NCT03598777|39145397|FG000|Overall Study|Lost to Follow-up|1|||
16181905|NCT03598777|39145398|FG001|Overall Study|Lost to Follow-up|0|||
16181906|NCT03598777|39145399|FG002|Overall Study|Lost to Follow-up|0|||
16181907|NCT03598777|39145400|FG003|Overall Study|Lost to Follow-up|0|||
16181908|NCT03598777|39145401|FG004|Overall Study|Lost to Follow-up|0|||
16181909|NCT01651260|39145403|FG000|Overall Study|unable to apply product|3|||
16181910|NCT00090285|39145406|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
16181911|NCT00090285|39145407|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
16181912|NCT00090285|39145408|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
16181913|NCT00090285|39145409|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
16181914|NCT00090285|39145410|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
16181915|NCT00090285|39145411|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
16181916|NCT00090285|39145406|FG000|Base Study Vaccination Period|Adverse Event|2|||
16181917|NCT00090285|39145407|FG001|Base Study Vaccination Period|Adverse Event|4|||
16181918|NCT00090285|39145408|FG002|Base Study Vaccination Period|Adverse Event|0|||
16181919|NCT00090285|39145409|FG003|Base Study Vaccination Period|Adverse Event|0|||
16181920|NCT00090285|39145410|FG004|Base Study Vaccination Period|Adverse Event|0|||
16181921|NCT00090285|39145411|FG005|Base Study Vaccination Period|Adverse Event|0|||
16181922|NCT00090285|39145406|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
16181923|NCT00090285|39145407|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
16181924|NCT00090285|39145408|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
16181925|NCT00090285|39145409|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
16181926|NCT00090285|39145410|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
16181927|NCT00090285|39145411|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
16181928|NCT00090285|39145406|FG000|Base Study Vaccination Period|Protocol Violation|2|||
16181929|NCT00090285|39145407|FG001|Base Study Vaccination Period|Protocol Violation|3|||
16181930|NCT00090285|39145408|FG002|Base Study Vaccination Period|Protocol Violation|0|||
16181931|NCT00090285|39145409|FG003|Base Study Vaccination Period|Protocol Violation|0|||
16181932|NCT00090285|39145410|FG004|Base Study Vaccination Period|Protocol Violation|0|||
16181933|NCT00090285|39145411|FG005|Base Study Vaccination Period|Protocol Violation|0|||
16181934|NCT00090285|39145406|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
16478860|NCT03519178|40234268|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
16478861|NCT03519178|40234269|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
16181935|NCT00090285|39145407|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
16181936|NCT00090285|39145408|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
16181937|NCT00090285|39145409|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
16181938|NCT00090285|39145410|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
16181939|NCT00090285|39145411|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
16181940|NCT00090285|39145406|FG000|Base Study Vaccination Period|Uncooperative|2|||
16181941|NCT00090285|39145407|FG001|Base Study Vaccination Period|Uncooperative|2|||
16181942|NCT00090285|39145408|FG002|Base Study Vaccination Period|Uncooperative|0|||
16181943|NCT00090285|39145409|FG003|Base Study Vaccination Period|Uncooperative|0|||
16181944|NCT00090285|39145410|FG004|Base Study Vaccination Period|Uncooperative|0|||
16181945|NCT00090285|39145411|FG005|Base Study Vaccination Period|Uncooperative|0|||
16181946|NCT00090285|39145406|FG000|Base Study Vaccination Period|Moved|20|||
16181947|NCT00090285|39145407|FG001|Base Study Vaccination Period|Moved|21|||
16181948|NCT00090285|39145408|FG002|Base Study Vaccination Period|Moved|0|||
16181949|NCT00090285|39145409|FG003|Base Study Vaccination Period|Moved|0|||
16478862|NCT03519178|40234270|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
16478863|NCT03519178|40234256|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478864|NCT03519178|40234257|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478865|NCT03519178|40234258|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478866|NCT03519178|40234259|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478867|NCT03519178|40234260|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478868|NCT03519178|40234261|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478869|NCT03519178|40234262|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478870|NCT03519178|40234263|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478871|NCT03519178|40234264|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478872|NCT03519178|40234265|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478873|NCT03519178|40234266|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478874|NCT03519178|40234267|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478875|NCT03519178|40234268|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
16478876|NCT03519178|40234269|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
16478877|NCT03519178|40234270|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
16478878|NCT03519178|40234256|FG000|PF-06873600 Treatment|Ongoing|0|||
16478879|NCT03519178|40234257|FG001|PF-06873600 Treatment|Ongoing|0|||
16478880|NCT03519178|40234258|FG002|PF-06873600 Treatment|Ongoing|0|||
16478881|NCT03519178|40234259|FG003|PF-06873600 Treatment|Ongoing|0|||
16478882|NCT03519178|40234260|FG004|PF-06873600 Treatment|Ongoing|0|||
16478883|NCT03519178|40234261|FG005|PF-06873600 Treatment|Ongoing|0|||
16478884|NCT03519178|40234262|FG006|PF-06873600 Treatment|Ongoing|0|||
16478885|NCT03519178|40234263|FG007|PF-06873600 Treatment|Ongoing|0|||
16181950|NCT00090285|39145410|FG004|Base Study Vaccination Period|Moved|0|||
16181951|NCT00090285|39145411|FG005|Base Study Vaccination Period|Moved|0|||
16181952|NCT00090285|39145406|FG000|Base Study Vaccination Period|Site Terminated|1|||
16181953|NCT00090285|39145407|FG001|Base Study Vaccination Period|Site Terminated|0|||
16181954|NCT00090285|39145408|FG002|Base Study Vaccination Period|Site Terminated|0|||
16181955|NCT00090285|39145409|FG003|Base Study Vaccination Period|Site Terminated|0|||
16181956|NCT00090285|39145410|FG004|Base Study Vaccination Period|Site Terminated|0|||
16181957|NCT00090285|39145411|FG005|Base Study Vaccination Period|Site Terminated|0|||
16181958|NCT00090285|39145406|FG000|Base Study Vaccination Period|Other|2|||
16181959|NCT00090285|39145407|FG001|Base Study Vaccination Period|Other|2|||
16181960|NCT00090285|39145408|FG002|Base Study Vaccination Period|Other|0|||
16181961|NCT00090285|39145409|FG003|Base Study Vaccination Period|Other|0|||
16478886|NCT03519178|40234264|FG008|PF-06873600 Treatment|Ongoing|0|||
16478887|NCT03519178|40234265|FG009|PF-06873600 Treatment|Ongoing|0|||
16478888|NCT03519178|40234266|FG010|PF-06873600 Treatment|Ongoing|0|||
16478889|NCT03519178|40234267|FG011|PF-06873600 Treatment|Ongoing|0|||
16478890|NCT03519178|40234268|FG012|PF-06873600 Treatment|Ongoing|0|||
16478891|NCT03519178|40234269|FG013|PF-06873600 Treatment|Ongoing|1|||
16478892|NCT03519178|40234270|FG014|PF-06873600 Treatment|Ongoing|6|||
16478893|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16378782|NCT03232567|39872232|FG003|Overall Study|Withdrawal by Subject|0|||
16378783|NCT02213926|39872237|FG000|Overall Study|Death|59|||
16378784|NCT02213926|39872237|FG000|Overall Study|Withdrawal by Subject|10|||
16378785|NCT02213926|39872237|FG000|Overall Study|study terminated by sponsor|51|||
16378786|NCT02213926|39872237|FG000|Overall Study|Lost to Follow-up|3|||
16378787|NCT02213926|39872237|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
16378788|NCT05261126|39872239|FG000|Overall Study|Death|0|||
16378789|NCT05261126|39872240|FG001|Overall Study|Death|0|||
16378790|NCT05261126|39872241|FG002|Overall Study|Death|1|||
16378791|NCT05261126|39872242|FG003|Overall Study|Death|0|||
16378792|NCT05261126|39872243|FG004|Overall Study|Death|0|||
16378793|NCT05261126|39872239|FG000|Overall Study|Lost to Follow-up|0|||
16378794|NCT05261126|39872240|FG001|Overall Study|Lost to Follow-up|0|||
16378795|NCT05261126|39872241|FG002|Overall Study|Lost to Follow-up|0|||
16378796|NCT05261126|39872242|FG003|Overall Study|Lost to Follow-up|0|||
16378797|NCT05261126|39872243|FG004|Overall Study|Lost to Follow-up|1|||
16378798|NCT05261126|39872239|FG000|Overall Study|Physician Decision|1|||
16378799|NCT05261126|39872240|FG001|Overall Study|Physician Decision|0|||
16378800|NCT05261126|39872241|FG002|Overall Study|Physician Decision|0|||
16378801|NCT05261126|39872242|FG003|Overall Study|Physician Decision|0|||
16378802|NCT05261126|39872243|FG004|Overall Study|Physician Decision|0|||
16378803|NCT05261126|39872239|FG000|Overall Study|Screen Failure|0|||
16378804|NCT05261126|39872240|FG001|Overall Study|Screen Failure|0|||
16378805|NCT05261126|39872241|FG002|Overall Study|Screen Failure|0|||
16378806|NCT05261126|39872242|FG003|Overall Study|Screen Failure|0|||
16378807|NCT05261126|39872243|FG004|Overall Study|Screen Failure|1|||
16378808|NCT05261126|39872239|FG000|Overall Study|Withdrawal by Subject|1|||
16378809|NCT05261126|39872240|FG001|Overall Study|Withdrawal by Subject|0|||
16478894|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16478895|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16478896|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16478897|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16478898|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16478899|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16478900|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16181962|NCT00090285|39145410|FG004|Base Study Vaccination Period|Other|0|||
16181963|NCT00090285|39145411|FG005|Base Study Vaccination Period|Other|0|||
16181964|NCT00090285|39145406|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
16181965|NCT00090285|39145407|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
16279362|NCT01362296|39504306|FG001|Randomized Phase (RP)|Physician Decision|9|||
16279363|NCT01362296|39504307|FG002|Randomized Phase (RP)|Physician Decision|0|||
16279364|NCT01362296|39504308|FG003|Randomized Phase (RP)|Physician Decision|0|||
16279365|NCT01362296|39504305|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
16279366|NCT01362296|39504306|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
16279367|NCT01362296|39504307|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
16279368|NCT01362296|39504308|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
16279369|NCT01362296|39504305|FG000|Randomized Phase (RP)|Adverse Event|20|||
16279370|NCT01362296|39504306|FG001|Randomized Phase (RP)|Adverse Event|4|||
16279371|NCT01362296|39504307|FG002|Randomized Phase (RP)|Adverse Event|0|||
16279372|NCT01362296|39504308|FG003|Randomized Phase (RP)|Adverse Event|0|||
16279373|NCT01362296|39504305|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
16279374|NCT01362296|39504306|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
16279375|NCT01362296|39504307|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
16279376|NCT01362296|39504308|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
16279377|NCT01362296|39504305|FG000|Crossover Phase|PD including Death due to PD|0|||
16378810|NCT05261126|39872241|FG002|Overall Study|Withdrawal by Subject|1|||
16378811|NCT05261126|39872242|FG003|Overall Study|Withdrawal by Subject|1|||
16378812|NCT05261126|39872243|FG004|Overall Study|Withdrawal by Subject|0|||
16181966|NCT00090285|39145408|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
16181967|NCT00090285|39145409|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
16181968|NCT00090285|39145410|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
16181969|NCT00090285|39145411|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
16181970|NCT00090285|39145406|FG000|Base Study Vaccination Period|HIV positive|1|||
16181971|NCT00090285|39145407|FG001|Base Study Vaccination Period|HIV positive|1|||
16181972|NCT00090285|39145408|FG002|Base Study Vaccination Period|HIV positive|0|||
16181973|NCT00090285|39145409|FG003|Base Study Vaccination Period|HIV positive|0|||
16181974|NCT00090285|39145410|FG004|Base Study Vaccination Period|HIV positive|0|||
16181975|NCT00090285|39145411|FG005|Base Study Vaccination Period|HIV positive|0|||
16181976|NCT00090285|39145406|FG000|Base Study Follow-up Period|Adverse Event|3|||
16181977|NCT00090285|39145407|FG001|Base Study Follow-up Period|Adverse Event|10|||
16181978|NCT00090285|39145408|FG002|Base Study Follow-up Period|Adverse Event|0|||
16181979|NCT00090285|39145409|FG003|Base Study Follow-up Period|Adverse Event|0|||
16181980|NCT00090285|39145410|FG004|Base Study Follow-up Period|Adverse Event|0|||
16181981|NCT00090285|39145411|FG005|Base Study Follow-up Period|Adverse Event|0|||
16181982|NCT00090285|39145406|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
16181983|NCT00090285|39145407|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
16181984|NCT00090285|39145408|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
16181985|NCT00090285|39145409|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
16181986|NCT00090285|39145410|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
16181987|NCT00090285|39145411|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
16181988|NCT00090285|39145406|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
16181989|NCT00090285|39145407|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
16181990|NCT00090285|39145408|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
16181991|NCT00090285|39145409|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
16181992|NCT00090285|39145410|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
16181993|NCT00090285|39145411|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
16181994|NCT00090285|39145406|FG000|Base Study Follow-up Period|Moved|41|||
16181995|NCT00090285|39145407|FG001|Base Study Follow-up Period|Moved|36|||
16181996|NCT00090285|39145408|FG002|Base Study Follow-up Period|Moved|0|||
16181997|NCT00090285|39145409|FG003|Base Study Follow-up Period|Moved|0|||
16378813|NCT05261126|39872239|FG000|Overall Study|Not Recorded|0|||
16378814|NCT05261126|39872240|FG001|Overall Study|Not Recorded|0|||
16378815|NCT05261126|39872241|FG002|Overall Study|Not Recorded|0|||
16378816|NCT05261126|39872242|FG003|Overall Study|Not Recorded|1|||
16378817|NCT05261126|39872243|FG004|Overall Study|Not Recorded|0|||
16378818|NCT04691115|39872244|FG000|Overall Study|Withdrawal by Subject|0|||
16378819|NCT04691115|39872245|FG001|Overall Study|Withdrawal by Subject|0|||
16378820|NCT04691115|39872246|FG002|Overall Study|Withdrawal by Subject|0|||
16378821|NCT04691115|39872247|FG003|Overall Study|Withdrawal by Subject|0|||
16378822|NCT04691115|39872248|FG004|Overall Study|Withdrawal by Subject|0|||
16378823|NCT04691115|39872249|FG005|Overall Study|Withdrawal by Subject|1|||
16378824|NCT04691115|39872250|FG006|Overall Study|Withdrawal by Subject|0|||
16378825|NCT04691115|39872251|FG007|Overall Study|Withdrawal by Subject|0|||
16378826|NCT04691115|39872252|FG008|Overall Study|Withdrawal by Subject|0|||
16181998|NCT00090285|39145410|FG004|Base Study Follow-up Period|Moved|0|||
16181999|NCT00090285|39145411|FG005|Base Study Follow-up Period|Moved|0|||
16182000|NCT00090285|39145406|FG000|Base Study Follow-up Period|Other|2|||
16182001|NCT00090285|39145407|FG001|Base Study Follow-up Period|Other|0|||
16182002|NCT00090285|39145408|FG002|Base Study Follow-up Period|Other|0|||
16182003|NCT00090285|39145409|FG003|Base Study Follow-up Period|Other|0|||
16182004|NCT00090285|39145410|FG004|Base Study Follow-up Period|Other|0|||
16182005|NCT00090285|39145411|FG005|Base Study Follow-up Period|Other|0|||
16182006|NCT00090285|39145406|FG000|Base Study Follow-up Period|Protocol Violation|1|||
16182007|NCT00090285|39145407|FG001|Base Study Follow-up Period|Protocol Violation|0|||
16182008|NCT00090285|39145408|FG002|Base Study Follow-up Period|Protocol Violation|0|||
16182009|NCT00090285|39145409|FG003|Base Study Follow-up Period|Protocol Violation|0|||
16182010|NCT00090285|39145410|FG004|Base Study Follow-up Period|Protocol Violation|0|||
16182011|NCT00090285|39145411|FG005|Base Study Follow-up Period|Protocol Violation|0|||
16182012|NCT00090285|39145406|FG000|Base Study Follow-up Period|Uncooperative|3|||
16182013|NCT00090285|39145407|FG001|Base Study Follow-up Period|Uncooperative|4|||
16182014|NCT00090285|39145408|FG002|Base Study Follow-up Period|Uncooperative|0|||
16182015|NCT00090285|39145409|FG003|Base Study Follow-up Period|Uncooperative|0|||
16182016|NCT00090285|39145410|FG004|Base Study Follow-up Period|Uncooperative|0|||
16378827|NCT04691115|39872253|FG009|Overall Study|Withdrawal by Subject|0|||
16182017|NCT00090285|39145411|FG005|Base Study Follow-up Period|Uncooperative|0|||
16378828|NCT04691115|39872254|FG010|Overall Study|Withdrawal by Subject|0|||
16478901|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16182018|NCT00090285|39145406|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
16182019|NCT00090285|39145407|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
16378829|NCT04691115|39872255|FG011|Overall Study|Withdrawal by Subject|0|||
16378830|NCT04691115|39872256|FG012|Overall Study|Withdrawal by Subject|0|||
16378831|NCT04691115|39872257|FG013|Overall Study|Withdrawal by Subject|0|||
16378832|NCT02801578|39874628|FG000|Overall Study|Adverse Event|2|||
16378833|NCT02552225|39874629|FG000|Overall Study|Withdrawal by Subject|1|||
16378834|NCT02552225|39874630|FG001|Overall Study|Withdrawal by Subject|0|||
16378835|NCT00721110|39874636|FG000|Overall Study|Ultram use|1|||
16378836|NCT00721110|39874637|FG001|Overall Study|Ultram use|0|||
16378837|NCT00721110|39874638|FG002|Overall Study|Ultram use|0|||
16378838|NCT00721110|39874639|FG003|Overall Study|Ultram use|0|||
16378839|NCT00721110|39874636|FG000|Overall Study|vertical incision|0|||
16378840|NCT00721110|39874637|FG001|Overall Study|vertical incision|0|||
16378841|NCT00721110|39874638|FG002|Overall Study|vertical incision|1|||
16378842|NCT00721110|39874639|FG003|Overall Study|vertical incision|0|||
16378843|NCT00959049|39874640|FG000|Overall Study|Adverse Event|1|||
16378844|NCT00959049|39874641|FG001|Overall Study|Adverse Event|0|||
16378845|NCT00959049|39874642|FG002|Overall Study|Adverse Event|0|||
16378846|NCT00959049|39874643|FG003|Overall Study|Adverse Event|0|||
16378847|NCT00959049|39874644|FG004|Overall Study|Adverse Event|0|||
16378848|NCT00959049|39874645|FG005|Overall Study|Adverse Event|0|||
16378849|NCT00959049|39874640|FG000|Overall Study|Lost to Follow-up|17|||
16378850|NCT00959049|39874641|FG001|Overall Study|Lost to Follow-up|5|||
16378851|NCT00959049|39874642|FG002|Overall Study|Lost to Follow-up|1|||
16378852|NCT00959049|39874643|FG003|Overall Study|Lost to Follow-up|10|||
16378853|NCT00959049|39874644|FG004|Overall Study|Lost to Follow-up|9|||
16378854|NCT00959049|39874645|FG005|Overall Study|Lost to Follow-up|1|||
16378855|NCT00959049|39874640|FG000|Overall Study|Contraindicated medication|0|||
16378856|NCT00959049|39874641|FG001|Overall Study|Contraindicated medication|0|||
16378857|NCT00959049|39874642|FG002|Overall Study|Contraindicated medication|0|||
16378858|NCT00959049|39874643|FG003|Overall Study|Contraindicated medication|1|||
16378859|NCT00959049|39874644|FG004|Overall Study|Contraindicated medication|0|||
16378860|NCT00959049|39874645|FG005|Overall Study|Contraindicated medication|0|||
16378861|NCT00959049|39874640|FG000|Overall Study|Withdrawal by Subject|0|||
16378862|NCT00959049|39874641|FG001|Overall Study|Withdrawal by Subject|2|||
16378863|NCT00959049|39874642|FG002|Overall Study|Withdrawal by Subject|0|||
16378864|NCT00959049|39874643|FG003|Overall Study|Withdrawal by Subject|0|||
16378865|NCT00959049|39874644|FG004|Overall Study|Withdrawal by Subject|0|||
16378866|NCT00959049|39874645|FG005|Overall Study|Withdrawal by Subject|0|||
16378867|NCT03552029|39874646|FG000|Overall Study|Death|3|||
16378868|NCT03552029|39874647|FG001|Overall Study|Death|0|||
16378869|NCT03552029|39874646|FG000|Overall Study|Adverse Event|1|||
16378870|NCT03552029|39874647|FG001|Overall Study|Adverse Event|0|||
16378871|NCT03552029|39874646|FG000|Overall Study|Lack of Efficacy|0|||
16378872|NCT03552029|39874647|FG001|Overall Study|Lack of Efficacy|2|||
16378873|NCT03552029|39874646|FG000|Overall Study|Physician Decision|0|||
16378874|NCT03552029|39874647|FG001|Overall Study|Physician Decision|1|||
16378875|NCT03552029|39874646|FG000|Overall Study|Study terminated by Sponsor|0|||
16378876|NCT03552029|39874647|FG001|Overall Study|Study terminated by Sponsor|1|||
16378877|NCT03552029|39874646|FG000|Overall Study|Other|0|||
16378878|NCT03552029|39874647|FG001|Overall Study|Other|2|||
16378879|NCT00113373|39874650|FG000|Overall Study|Ineligible: wrong primary|1|||
16378880|NCT00113373|39874650|FG000|Overall Study|Ineligible: second primary|1|||
16378881|NCT00113373|39874650|FG000|Overall Study|Never Treated|1|||
16378882|NCT04380142|39874651|FG000|LD/CD Stabilization Period|Adverse Event|3|||
16182020|NCT00090285|39145408|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
16182021|NCT00090285|39145409|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
16182022|NCT00090285|39145410|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
16182023|NCT00090285|39145411|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
16182024|NCT00090285|39145406|FG000|Extension 1|Adverse Event|0|||
16182025|NCT00090285|39145407|FG001|Extension 1|Adverse Event|0|||
16182026|NCT00090285|39145408|FG002|Extension 1|Adverse Event|2|||
16182027|NCT00090285|39145409|FG003|Extension 1|Adverse Event|0|||
16182028|NCT00090285|39145410|FG004|Extension 1|Adverse Event|0|||
16182029|NCT00090285|39145411|FG005|Extension 1|Adverse Event|0|||
16182030|NCT00090285|39145406|FG000|Extension 1|Lost to Follow-up|0|||
16182031|NCT00090285|39145407|FG001|Extension 1|Lost to Follow-up|0|||
16182032|NCT00090285|39145408|FG002|Extension 1|Lost to Follow-up|35|||
16182033|NCT00090285|39145409|FG003|Extension 1|Lost to Follow-up|0|||
16182034|NCT00090285|39145410|FG004|Extension 1|Lost to Follow-up|0|||
16182035|NCT00090285|39145411|FG005|Extension 1|Lost to Follow-up|0|||
16182036|NCT00090285|39145406|FG000|Extension 1|Withdrawal by Subject|0|||
16182037|NCT00090285|39145407|FG001|Extension 1|Withdrawal by Subject|0|||
16378883|NCT04380142|39874652|FG001|LD/CD Stabilization Period|Adverse Event|0|||
16378884|NCT04380142|39874653|FG002|LD/CD Stabilization Period|Adverse Event|0|||
16478902|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16182038|NCT00090285|39145408|FG002|Extension 1|Withdrawal by Subject|13|||
16182039|NCT00090285|39145409|FG003|Extension 1|Withdrawal by Subject|1|||
16182040|NCT00090285|39145410|FG004|Extension 1|Withdrawal by Subject|0|||
16182041|NCT00090285|39145411|FG005|Extension 1|Withdrawal by Subject|0|||
16378885|NCT04380142|39874651|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
16378886|NCT04380142|39874652|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
16182042|NCT00090285|39145406|FG000|Extension 1|Other|0|||
16182043|NCT00090285|39145407|FG001|Extension 1|Other|0|||
16182044|NCT00090285|39145408|FG002|Extension 1|Other|4|||
16182045|NCT00090285|39145409|FG003|Extension 1|Other|0|||
16182046|NCT00090285|39145410|FG004|Extension 1|Other|0|||
16182047|NCT00090285|39145411|FG005|Extension 1|Other|0|||
16182048|NCT00090285|39145406|FG000|Extension 1|Moved|0|||
16182049|NCT00090285|39145407|FG001|Extension 1|Moved|0|||
16182050|NCT00090285|39145408|FG002|Extension 1|Moved|3|||
16182051|NCT00090285|39145409|FG003|Extension 1|Moved|0|||
16182052|NCT00090285|39145410|FG004|Extension 1|Moved|0|||
16182053|NCT00090285|39145411|FG005|Extension 1|Moved|0|||
16182054|NCT00090285|39145406|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
16182055|NCT00090285|39145407|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
16182056|NCT00090285|39145408|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
16182057|NCT00090285|39145409|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
16182058|NCT00090285|39145410|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
16182059|NCT00090285|39145411|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
16182060|NCT00090285|39145406|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
16182061|NCT00090285|39145407|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
16182062|NCT00090285|39145408|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
16182063|NCT00090285|39145409|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
16182064|NCT00090285|39145410|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
16182065|NCT00090285|39145411|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
16182066|NCT00090285|39145406|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
16182067|NCT00090285|39145407|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
16182068|NCT00090285|39145408|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
16182069|NCT00090285|39145409|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
16182070|NCT00090285|39145410|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
16182071|NCT00090285|39145411|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
16182072|NCT00090285|39145406|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
16182073|NCT00090285|39145407|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
16182074|NCT00090285|39145408|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
16182075|NCT00090285|39145409|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
16182076|NCT00090285|39145410|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
16182077|NCT00090285|39145411|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
16182078|NCT00955110|39145421|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
16182079|NCT00955110|39145421|FG000|Treatment Phase|Adverse Event|2|||
16182080|NCT00955110|39145421|FG000|Treatment Phase|Administrative reasons|2|||
16182081|NCT00955110|39145421|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
16182082|NCT00955110|39145421|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
16182083|NCT04814823|39145422|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
16182084|NCT01486238|39145432|FG000|Overall Study|Death|0|||
16182085|NCT01486238|39145433|FG001|Overall Study|Death|2|||
16182086|NCT01486238|39145432|FG000|Overall Study|Withdrawal by Subject|2|||
16182087|NCT01486238|39145433|FG001|Overall Study|Withdrawal by Subject|1|||
16182088|NCT01486238|39145432|FG000|Overall Study|Lost to Follow-up|0|||
16182089|NCT01486238|39145433|FG001|Overall Study|Lost to Follow-up|3|||
16182090|NCT04329923|39145435|FG000|Overall Study|Withdrawal by Subject|1|||
16182091|NCT04329923|39145436|FG001|Overall Study|Withdrawal by Subject|4|||
16182092|NCT04329923|39145437|FG002|Overall Study|Withdrawal by Subject|1|||
16182093|NCT04329923|39145438|FG003|Overall Study|Withdrawal by Subject|1|||
16182094|NCT04329923|39145439|FG004|Overall Study|Withdrawal by Subject|1|||
16182095|NCT04329923|39145440|FG005|Overall Study|Withdrawal by Subject|1|||
16182096|NCT04329923|39145435|FG000|Overall Study|early termination of study|0|||
16182097|NCT04329923|39145436|FG001|Overall Study|early termination of study|0|||
16182098|NCT04329923|39145437|FG002|Overall Study|early termination of study|0|||
16182099|NCT04329923|39145438|FG003|Overall Study|early termination of study|0|||
16182100|NCT04329923|39145439|FG004|Overall Study|early termination of study|1|||
16182101|NCT04329923|39145440|FG005|Overall Study|early termination of study|2|||
16182102|NCT04329923|39145435|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
16182103|NCT04329923|39145436|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
16182104|NCT04329923|39145437|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
16182105|NCT04329923|39145438|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
16182106|NCT04329923|39145439|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
16182107|NCT04329923|39145440|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
16182108|NCT01770353|39145451|FG000|Overall Study|Progressive disease|2|||
16182109|NCT01770353|39145452|FG001|Overall Study|Progressive disease|1|||
16182110|NCT01770353|39145451|FG000|Overall Study|Adverse Event|0|||
16182111|NCT01770353|39145452|FG001|Overall Study|Adverse Event|1|||
16182112|NCT01770353|39145451|FG000|Overall Study|Protocol Violation|1|||
16182113|NCT01770353|39145452|FG001|Overall Study|Protocol Violation|0|||
16182114|NCT01770353|39145451|FG000|Overall Study|Physician Decision|0|||
16182115|NCT01770353|39145452|FG001|Overall Study|Physician Decision|3|||
16182116|NCT01770353|39145451|FG000|Overall Study|Clinical deterioration|3|||
16182117|NCT01770353|39145452|FG001|Overall Study|Clinical deterioration|6|||
16182118|NCT01770353|39145451|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
16182119|NCT01770353|39145452|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
16182120|NCT02213198|39145453|FG000|Baseline|No show for intake|7|||
16182121|NCT02213198|39145454|FG001|Baseline|No show for intake|9|||
16182122|NCT02213198|39145453|FG000|Baseline|Withdrawal by Subject|34|||
16182123|NCT02213198|39145454|FG001|Baseline|Withdrawal by Subject|11|||
16182124|NCT02213198|39145453|FG000|Baseline|transferred out of clinic|7|||
16182125|NCT02213198|39145454|FG001|Baseline|transferred out of clinic|9|||
16378887|NCT04380142|39874653|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
16378888|NCT04380142|39874651|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
16378889|NCT04380142|39874652|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
16378890|NCT04380142|39874653|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
16378891|NCT04380142|39874651|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
16182126|NCT02213198|39145453|FG000|Baseline|Lost to Follow-up|40|||
16182127|NCT02213198|39145454|FG001|Baseline|Lost to Follow-up|21|||
16279378|NCT01362296|39504306|FG001|Crossover Phase|PD including Death due to PD|0|||
16279379|NCT01362296|39504307|FG002|Crossover Phase|PD including Death due to PD|16|||
16279380|NCT01362296|39504308|FG003|Crossover Phase|PD including Death due to PD|1|||
16279381|NCT01362296|39504305|FG000|Crossover Phase|Withdrawal by Subject|0|||
16279382|NCT01362296|39504306|FG001|Crossover Phase|Withdrawal by Subject|0|||
16182128|NCT02213198|39145453|FG000|Baseline|incarcerated,violent|0|||
16182129|NCT02213198|39145454|FG001|Baseline|incarcerated,violent|1|||
16182130|NCT02213198|39145453|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
16182131|NCT02213198|39145454|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
16182132|NCT02213198|39145453|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
16182133|NCT02213198|39145454|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
16182134|NCT02213198|39145453|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
16182135|NCT02213198|39145454|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
16182136|NCT02213198|39145453|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
16182137|NCT02213198|39145454|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
16182138|NCT02213198|39145453|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
16182139|NCT02213198|39145454|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
16182140|NCT02213198|39145453|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
16182141|NCT02213198|39145454|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
16182142|NCT01787591|39145455|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
16182143|NCT01787591|39145456|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
16182144|NCT01787591|39145457|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
16182145|NCT01787591|39145458|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
16182146|NCT03270085|39145459|FG000|Overall Study|Withdrawal by Subject|1|||
16182147|NCT03270085|39145460|FG001|Overall Study|Withdrawal by Subject|0|||
16182148|NCT00312377|39145461|FG000|Overall Study|Death|403|||
16182149|NCT00312377|39145462|FG001|Overall Study|Death|418|||
16182150|NCT00312377|39145461|FG000|Overall Study|Withdrawal by Subject|23|||
16182151|NCT00312377|39145462|FG001|Overall Study|Withdrawal by Subject|30|||
16182152|NCT00312377|39145461|FG000|Overall Study|Lost to Follow-up|9|||
16182153|NCT00312377|39145462|FG001|Overall Study|Lost to Follow-up|12|||
16182154|NCT00312377|39145461|FG000|Overall Study|Non-compliance|0|||
16182155|NCT00312377|39145462|FG001|Overall Study|Non-compliance|2|||
16182156|NCT00312377|39145461|FG000|Overall Study|Randomised but never received treatment|6|||
16182157|NCT00312377|39145462|FG001|Overall Study|Randomised but never received treatment|6|||
16182158|NCT00312377|39145461|FG000|Overall Study|Discontinue treatment survival follow up|202|||
16182159|NCT00312377|39145462|FG001|Overall Study|Discontinue treatment survival follow up|200|||
16182160|NCT00312377|39145461|FG000|Overall Study|Site ended participation in study|1|||
16182161|NCT00312377|39145462|FG001|Overall Study|Site ended participation in study|0|||
16182162|NCT01188798|39145466|FG000|Overall Study|Death|0|||
16182163|NCT01188798|39145467|FG001|Overall Study|Death|1|||
16182164|NCT01188798|39145466|FG000|Overall Study|Required additional transplant|1|||
16182165|NCT01188798|39145467|FG001|Overall Study|Required additional transplant|1|||
16182166|NCT01188798|39145466|FG000|Overall Study|Protocol closure|1|||
16182167|NCT01188798|39145467|FG001|Overall Study|Protocol closure|1|||
16182168|NCT04799782|39145470|FG000|Washout|Physician Decision|2|||
16182169|NCT04799782|39145471|FG001|Washout|Physician Decision|0|||
16182170|NCT04799782|39145470|FG000|Washout|Withdrawal by Subject|0|||
16182171|NCT04799782|39145471|FG001|Washout|Withdrawal by Subject|2|||
16182172|NCT04799782|39145470|FG000|Washout|Lost to Follow-up|0|||
16182173|NCT04799782|39145471|FG001|Washout|Lost to Follow-up|1|||
16182174|NCT01903434|39145472|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
16182175|NCT01903434|39145473|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
16182176|NCT01903434|39145472|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
16182177|NCT01903434|39145473|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
16182178|NCT01062399|39145474|FG000|Overall Study|Protocol Violation|0|||
16279383|NCT01362296|39504307|FG002|Crossover Phase|Withdrawal by Subject|2|||
16182179|NCT01062399|39145475|FG001|Overall Study|Protocol Violation|1|||
16182180|NCT01062399|39145476|FG002|Overall Study|Protocol Violation|0|||
16182181|NCT01062399|39145477|FG003|Overall Study|Protocol Violation|6|||
16182182|NCT01062399|39145478|FG004|Overall Study|Protocol Violation|4|||
16182183|NCT00552305|39145479|FG000|Overall Study|Adverse Event|43|||
16182184|NCT00552305|39145479|FG000|Overall Study|Lack of Efficacy|120|||
16182185|NCT00552305|39145479|FG000|Overall Study|Lost to Follow-up|4|||
16182186|NCT00552305|39145479|FG000|Overall Study|Protocol Violation|3|||
16182187|NCT00552305|39145479|FG000|Overall Study|Withdrawal by Subject|44|||
16182188|NCT00552305|39145479|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
16182189|NCT00552305|39145479|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
16182190|NCT00552305|39145479|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
16182191|NCT00552305|39145479|FG000|Overall Study|Unsatisfactory compliance|11|||
16182192|NCT00552305|39145479|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
16182193|NCT00552305|39145479|FG000|Overall Study|AE/Other: prohibited drug required|1|||
16182194|NCT00552305|39145479|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
16182195|NCT00552305|39145479|FG000|Overall Study|Other: Site closed|4|||
16182196|NCT00552305|39145479|FG000|Overall Study|Other: Personal problems|1|||
16182197|NCT00552305|39145479|FG000|Overall Study|Other: Unable to attend visits|1|||
16182198|NCT00552305|39145479|FG000|Overall Study|Other: Subject underwent surgery|4|||
16182199|NCT00552305|39145479|FG000|Overall Study|Other: Subject became pregnant|1|||
16182200|NCT00552305|39145479|FG000|Overall Study|Other: Health problems, not drug related|1|||
16182201|NCT00552305|39145479|FG000|Overall Study|Other: Subject moved from area|2|||
16182202|NCT00552305|39145479|FG000|Overall Study|Other: Subject incarcerated|1|||
16182203|NCT00552305|39145479|FG000|Overall Study|Other: Subject went to rehab|1|||
16182204|NCT01260181|39145482|FG000|Overall Study|Decision of Investigator|1|||
16182205|NCT03141307|39145483|FG000|In-Hospital|Withdrawal by Subject|0|||
16182206|NCT03141307|39145484|FG001|In-Hospital|Withdrawal by Subject|2|||
16182207|NCT03141307|39145483|FG000|In-Hospital|Protocol Violation|4|||
16182208|NCT03141307|39145484|FG001|In-Hospital|Protocol Violation|0|||
16182209|NCT03141307|39145483|FG000|Follow-Up|Lost to Follow-up|97|||
16182210|NCT03141307|39145484|FG001|Follow-Up|Lost to Follow-up|54|||
16182211|NCT01302769|39145492|FG000|Overall Study|Lost to Follow-up|1|||
16182212|NCT01302769|39145493|FG001|Overall Study|Lost to Follow-up|1|||
16182213|NCT00231062|39145494|FG000|Overall Study|Physician Decision|6|||
16182214|NCT01491945|39145495|FG000|Overall Study|Death|30|||
16182215|NCT01491945|39145495|FG000|Overall Study|Withdrwan/LTF|16|||
16182216|NCT01491945|39145495|FG000|Overall Study|Conversion|4|||
16182217|NCT01491945|39145495|FG000|Overall Study|Missed Visit|1|||
16279384|NCT01362296|39504308|FG003|Crossover Phase|Withdrawal by Subject|1|||
16279385|NCT01362296|39504305|FG000|Crossover Phase|Adverse Event|0|||
16279386|NCT01362296|39504306|FG001|Crossover Phase|Adverse Event|0|||
16279387|NCT01362296|39504307|FG002|Crossover Phase|Adverse Event|4|||
16279388|NCT01362296|39504308|FG003|Crossover Phase|Adverse Event|0|||
16279389|NCT01362296|39504305|FG000|Crossover Phase|Study Closed/Terminated|0|||
16378892|NCT04380142|39874652|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
16378893|NCT04380142|39874653|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
16378894|NCT04380142|39874651|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
16378895|NCT04380142|39874652|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
16378896|NCT04380142|39874653|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
16378897|NCT04380142|39874651|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
16378898|NCT04380142|39874652|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
16378899|NCT04380142|39874653|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
16378900|NCT04380142|39874651|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16378901|NCT04380142|39874652|FG001|Double-Blind Treatment Period|Adverse Event|1|||
16378902|NCT04380142|39874653|FG002|Double-Blind Treatment Period|Adverse Event|14|||
16378903|NCT04380142|39874651|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
16378904|NCT04380142|39874652|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
16378905|NCT04380142|39874653|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
16182218|NCT03607682|39145497|FG000|Overall Study|Withdrawal by Subject|1|||
16182219|NCT03607682|39145497|FG000|Overall Study|Disease progression|1|||
16182220|NCT01663740|39145500|FG000|Overall Study|Lost to Follow-up|1|||
16478903|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16182221|NCT01663740|39145501|FG001|Overall Study|Lost to Follow-up|4|||
16182222|NCT01663740|39145500|FG000|Overall Study|Other|9|||
16182223|NCT01663740|39145501|FG001|Overall Study|Other|2|||
16182224|NCT01663740|39145500|FG000|Overall Study|Inclusion/Exclusion not met|1|||
16182225|NCT01663740|39145501|FG001|Overall Study|Inclusion/Exclusion not met|0|||
16182226|NCT01663740|39145500|FG000|Overall Study|Death|0|||
16182227|NCT01663740|39145501|FG001|Overall Study|Death|1|||
16182228|NCT01663740|39145500|FG000|Overall Study|Withdrawal by Subject|2|||
16182229|NCT01663740|39145501|FG001|Overall Study|Withdrawal by Subject|1|||
16182230|NCT01663740|39145500|FG000|Overall Study|No end of study status|3|||
16182231|NCT01663740|39145501|FG001|Overall Study|No end of study status|0|||
16279390|NCT01362296|39504306|FG001|Crossover Phase|Study Closed/Terminated|0|||
16279391|NCT01362296|39504307|FG002|Crossover Phase|Study Closed/Terminated|1|||
16279392|NCT01362296|39504308|FG003|Crossover Phase|Study Closed/Terminated|0|||
16279393|NCT00537017|39504315|FG000|Treatment Phase|Adverse Event|19|||
16182232|NCT00882713|39145504|FG000|Overall Study|Adverse Event|2|||
16182233|NCT00882713|39145504|FG000|Overall Study|Death|3|||
16182234|NCT00882713|39145504|FG000|Overall Study|Administrative reasons|4|||
16182235|NCT00882713|39145504|FG000|Overall Study|refused treatment/withdrew consent|4|||
16182236|NCT00882713|39145504|FG000|Overall Study|Blood transfusion|2|||
16182237|NCT00882713|39145504|FG000|Overall Study|Insufficient therapeutic response|3|||
16182238|NCT00882713|39145504|FG000|Overall Study|Failure to return|2|||
16182239|NCT00882713|39145504|FG000|Overall Study|Other - Reasons|2|||
16182240|NCT02241512|39145505|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
16182241|NCT02241512|39145506|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
16182242|NCT03334214|39145511|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
16182243|NCT03334214|39145512|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
16182244|NCT03334214|39145511|FG000|Overall Study|Withdrawal by Subject|0|||
16182245|NCT03334214|39145512|FG001|Overall Study|Withdrawal by Subject|1|||
16182246|NCT03334214|39145511|FG000|Overall Study|Other|1|||
16182247|NCT03334214|39145512|FG001|Overall Study|Other|0|||
16182248|NCT03090191|39145513|FG000|Overall Study|Adverse Event|90|||
16182249|NCT03090191|39145514|FG001|Overall Study|Adverse Event|72|||
16182250|NCT03090191|39145513|FG000|Overall Study|Death|365|||
16182251|NCT03090191|39145514|FG001|Overall Study|Death|358|||
16182252|NCT03090191|39145513|FG000|Overall Study|Lost to Follow-up|382|||
16182253|NCT03090191|39145514|FG001|Overall Study|Lost to Follow-up|394|||
16182254|NCT03090191|39145513|FG000|Overall Study|Physician Decision|77|||
16182255|NCT03090191|39145514|FG001|Overall Study|Physician Decision|66|||
16182256|NCT03090191|39145513|FG000|Overall Study|Protocol Violation|43|||
16182257|NCT03090191|39145514|FG001|Overall Study|Protocol Violation|52|||
16182258|NCT03090191|39145513|FG000|Overall Study|Withdrawal by Subject|2160|||
16182259|NCT03090191|39145514|FG001|Overall Study|Withdrawal by Subject|2133|||
16182260|NCT03090191|39145513|FG000|Overall Study|Site terminated|7|||
16182261|NCT03090191|39145514|FG001|Overall Study|Site terminated|8|||
16182262|NCT03090191|39145513|FG000|Overall Study|Other|66|||
16182263|NCT03090191|39145514|FG001|Overall Study|Other|60|||
16182264|NCT03090191|39145513|FG000|Overall Study|Withdrawn before any study vaccination|43|||
16182265|NCT03090191|39145514|FG001|Overall Study|Withdrawn before any study vaccination|52|||
16182266|NCT01614457|39145520|FG000|Overall Study|Non-Compliance|1|||
16182267|NCT01614457|39145521|FG001|Overall Study|Non-Compliance|0|||
16182268|NCT01614457|39145520|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
16182269|NCT01614457|39145521|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
16182270|NCT00592501|39145522|FG000|Overall Study|Withdrawal by Subject|1|||
16182271|NCT00592501|39145522|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
16182272|NCT01165203|39145523|FG000|Active Phase|Serious Adverse Event|1|||
16182273|NCT01165203|39145524|FG001|Active Phase|Serious Adverse Event|0|||
16182274|NCT01165203|39145523|FG000|Active Phase|Withdrawal by Subject|2|||
16182275|NCT01165203|39145524|FG001|Active Phase|Withdrawal by Subject|1|||
16182276|NCT01165203|39145523|FG000|Active Phase|Migrated/moved from study area|0|||
16182277|NCT01165203|39145524|FG001|Active Phase|Migrated/moved from study area|1|||
16182278|NCT01165203|39145523|FG000|Active Phase|Lost to Follow-up|2|||
16182279|NCT01165203|39145524|FG001|Active Phase|Lost to Follow-up|0|||
16182280|NCT01165203|39145523|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
16182281|NCT01165203|39145524|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
16182282|NCT01165203|39145523|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
16182283|NCT01165203|39145524|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
16182284|NCT01165203|39145523|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
16182285|NCT01165203|39145524|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
16182286|NCT01165203|39145523|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
16182287|NCT01165203|39145524|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
16182288|NCT01165203|39145523|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
16182289|NCT01165203|39145524|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
16182290|NCT00375934|39145529|FG000|Overall Study|Adverse Event|1|||
16182291|NCT00375934|39145530|FG001|Overall Study|Adverse Event|1|||
16182292|NCT00375934|39145529|FG000|Overall Study|Withdrawal by Subject|2|||
16182293|NCT00375934|39145530|FG001|Overall Study|Withdrawal by Subject|2|||
16182294|NCT00375934|39145529|FG000|Overall Study|Lack of Efficacy|0|||
16182295|NCT00375934|39145530|FG001|Overall Study|Lack of Efficacy|2|||
16182296|NCT00375934|39145529|FG000|Overall Study|Physician Decision|0|||
16182297|NCT00375934|39145530|FG001|Overall Study|Physician Decision|1|||
16182298|NCT02614794|39145532|FG000|Overall Study|Death|258|||
16182299|NCT02614794|39145533|FG001|Overall Study|Death|151|||
16478904|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16182300|NCT02614794|39145532|FG000|Overall Study|Study closure by Sponsor|119|||
16182301|NCT02614794|39145533|FG001|Overall Study|Study closure by Sponsor|45|||
16182302|NCT02614794|39145532|FG000|Overall Study|Withdrawal by Subject|24|||
16182303|NCT02614794|39145533|FG001|Overall Study|Withdrawal by Subject|5|||
16182304|NCT02614794|39145532|FG000|Overall Study|Lost to Follow-up|7|||
16182305|NCT02614794|39145533|FG001|Overall Study|Lost to Follow-up|0|||
16182306|NCT02614794|39145532|FG000|Overall Study|Physician Decision|1|||
16182307|NCT02614794|39145533|FG001|Overall Study|Physician Decision|1|||
16182308|NCT02614794|39145532|FG000|Overall Study|Hospital closure|1|||
16182309|NCT02614794|39145533|FG001|Overall Study|Hospital closure|0|||
16182310|NCT00537823|39145536|FG000|Overall Study|Adverse Event|2|||
16182311|NCT00537823|39145537|FG001|Overall Study|Adverse Event|0|||
16182312|NCT02400346|39145538|FG000|Overall Study|Adverse Event|24|||
16182313|NCT02400346|39145538|FG000|Overall Study|Lack of Efficacy|9|||
16182314|NCT02400346|39145538|FG000|Overall Study|Non-compliance with IMP|1|||
16182315|NCT02400346|39145538|FG000|Overall Study|Withdrawal by Subject|7|||
16182316|NCT02400346|39145538|FG000|Overall Study|Administrative or other reason(s)|2|||
16182317|NCT02400346|39145538|FG000|Overall Study|Lost to Follow-up|1|||
16182318|NCT04530825|39145542|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
16182319|NCT04530825|39145543|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
16182320|NCT04530825|39145544|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
16182321|NCT04530825|39145545|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
16182322|NCT04530825|39145542|FG000|Overall Study|Did not complete follow-up|3|||
16182323|NCT04530825|39145543|FG001|Overall Study|Did not complete follow-up|0|||
16182324|NCT04530825|39145544|FG002|Overall Study|Did not complete follow-up|0|||
16182325|NCT04530825|39145545|FG003|Overall Study|Did not complete follow-up|0|||
16182326|NCT00519623|39145546|FG000|Overall Study|Adverse Event|1|||
16182327|NCT02119104|39145547|FG000|Overall Study|Protocol Violation|16|||
16182328|NCT04419506|39145556|FG000|Overall Study|Adverse Event|0|||
16182329|NCT04419506|39145557|FG001|Overall Study|Adverse Event|10|||
16182330|NCT04419506|39145558|FG002|Overall Study|Adverse Event|0|||
16182331|NCT04419506|39145559|FG003|Overall Study|Adverse Event|3|||
16182332|NCT04419506|39145556|FG000|Overall Study|Withdrawal by Subject|0|||
16182333|NCT04419506|39145557|FG001|Overall Study|Withdrawal by Subject|0|||
16182334|NCT04419506|39145558|FG002|Overall Study|Withdrawal by Subject|0|||
16182335|NCT04419506|39145559|FG003|Overall Study|Withdrawal by Subject|1|||
16182336|NCT04419506|39145556|FG000|Overall Study|poor-compliance|0|||
16182337|NCT04419506|39145557|FG001|Overall Study|poor-compliance|0|||
16182338|NCT04419506|39145558|FG002|Overall Study|poor-compliance|0|||
16182339|NCT04419506|39145559|FG003|Overall Study|poor-compliance|1|||
16182340|NCT02144220|39145560|FG000|Overall Study|technology incompatibility|9|||
16182341|NCT02144220|39145560|FG000|Overall Study|Lack of Efficacy|4|||
16182342|NCT02144220|39145560|FG000|Overall Study|Physician Decision|3|||
16182343|NCT02144220|39145560|FG000|Overall Study|Withdrawal by Subject|2|||
16182344|NCT02144220|39145560|FG000|Overall Study|Protocol Violation|1|||
16182345|NCT00793104|39145561|FG000|Overall Study|Lost to Follow-up|1|||
16182346|NCT02332915|39145562|FG000|Overall Study|Moved out of region|3|||
16182347|NCT02332915|39145563|FG001|Overall Study|Moved out of region|0|||
16182348|NCT02332915|39145562|FG000|Overall Study|Unrelated illness|1|||
16182349|NCT02332915|39145563|FG001|Overall Study|Unrelated illness|1|||
16182350|NCT02332915|39145562|FG000|Overall Study|Travel distance prohibitive|0|||
16182351|NCT02332915|39145563|FG001|Overall Study|Travel distance prohibitive|1|||
16182352|NCT02332915|39145562|FG000|Overall Study|did not meet inclusion criteria|2|||
16182353|NCT02332915|39145563|FG001|Overall Study|did not meet inclusion criteria|4|||
16182354|NCT01300286|39145564|FG000|Overall Study|did not get dosed|1|||
16182355|NCT01001494|39145566|FG000|Overall Study|Adverse Event|8|||
16182356|NCT01001494|39145567|FG001|Overall Study|Adverse Event|4|||
16182357|NCT01001494|39145568|FG002|Overall Study|Adverse Event|6|||
16182358|NCT01001494|39145566|FG000|Overall Study|Protocol Violation|0|||
16182359|NCT01001494|39145567|FG001|Overall Study|Protocol Violation|1|||
16182360|NCT01001494|39145568|FG002|Overall Study|Protocol Violation|1|||
16182361|NCT01001494|39145566|FG000|Overall Study|Lost to Follow-up|2|||
16182362|NCT01001494|39145567|FG001|Overall Study|Lost to Follow-up|0|||
16182363|NCT01001494|39145568|FG002|Overall Study|Lost to Follow-up|1|||
16182364|NCT01001494|39145566|FG000|Overall Study|Withdrawal by Subject|9|||
16182365|NCT01001494|39145567|FG001|Overall Study|Withdrawal by Subject|7|||
16182366|NCT01001494|39145568|FG002|Overall Study|Withdrawal by Subject|17|||
16182367|NCT01001494|39145566|FG000|Overall Study|COPD exacerbation|3|||
16182368|NCT01001494|39145567|FG001|Overall Study|COPD exacerbation|4|||
16182369|NCT01001494|39145568|FG002|Overall Study|COPD exacerbation|5|||
16182370|NCT01001494|39145566|FG000|Overall Study|Lack of Efficacy|2|||
16182371|NCT01001494|39145567|FG001|Overall Study|Lack of Efficacy|0|||
16182372|NCT01001494|39145568|FG002|Overall Study|Lack of Efficacy|8|||
16182373|NCT01001494|39145566|FG000|Overall Study|Other|0|||
16182374|NCT01001494|39145567|FG001|Overall Study|Other|1|||
16182375|NCT01001494|39145568|FG002|Overall Study|Other|3|||
16182376|NCT00751881|39145569|FG000|Core Treatment Period|Not treated|1|||
16182377|NCT00751881|39145570|FG001|Core Treatment Period|Not treated|1|||
16182378|NCT00751881|39145571|FG002|Core Treatment Period|Not treated|2|||
16182379|NCT00751881|39145569|FG000|Core Treatment Period|Adverse Event|26|||
16182380|NCT00751881|39145570|FG001|Core Treatment Period|Adverse Event|54|||
16182381|NCT00751881|39145571|FG002|Core Treatment Period|Adverse Event|58|||
16182382|NCT00751881|39145569|FG000|Core Treatment Period|Lack of Efficacy|37|||
16182383|NCT00751881|39145570|FG001|Core Treatment Period|Lack of Efficacy|30|||
16182384|NCT00751881|39145571|FG002|Core Treatment Period|Lack of Efficacy|20|||
16182385|NCT00751881|39145569|FG000|Core Treatment Period|Poor compliance to protocol|15|||
16182386|NCT00751881|39145570|FG001|Core Treatment Period|Poor compliance to protocol|3|||
16182387|NCT00751881|39145571|FG002|Core Treatment Period|Poor compliance to protocol|4|||
16182388|NCT00751881|39145569|FG000|Core Treatment Period|Lost to Follow-up|6|||
16182389|NCT00751881|39145570|FG001|Core Treatment Period|Lost to Follow-up|4|||
16182390|NCT00751881|39145571|FG002|Core Treatment Period|Lost to Follow-up|3|||
16182391|NCT00751881|39145569|FG000|Core Treatment Period|Other: protocol deviation|3|||
16182392|NCT00751881|39145570|FG001|Core Treatment Period|Other: protocol deviation|3|||
16182393|NCT00751881|39145571|FG002|Core Treatment Period|Other: protocol deviation|7|||
16182394|NCT00751881|39145569|FG000|Core Treatment Period|Other: wish to parent|5|||
16182395|NCT00751881|39145570|FG001|Core Treatment Period|Other: wish to parent|7|||
16182396|NCT00751881|39145571|FG002|Core Treatment Period|Other: wish to parent|4|||
16182397|NCT00751881|39145569|FG000|Core Treatment Period|Other: personal/family constraints|6|||
16182398|NCT00751881|39145570|FG001|Core Treatment Period|Other: personal/family constraints|7|||
16182399|NCT00751881|39145571|FG002|Core Treatment Period|Other: personal/family constraints|10|||
16182400|NCT00751881|39145569|FG000|Core Treatment Period|Other: MS treatment change|6|||
16182401|NCT00751881|39145570|FG001|Core Treatment Period|Other: MS treatment change|4|||
16182402|NCT00751881|39145571|FG002|Core Treatment Period|Other: MS treatment change|4|||
16182403|NCT00751881|39145569|FG000|Core Treatment Period|Other: tolerability complaints|2|||
16182404|NCT00751881|39145570|FG001|Core Treatment Period|Other: tolerability complaints|0|||
16182405|NCT00751881|39145571|FG002|Core Treatment Period|Other: tolerability complaints|0|||
16182406|NCT00751881|39145569|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
16182407|NCT00751881|39145570|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
16182408|NCT00751881|39145571|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
16182409|NCT00751881|39145569|FG000|Extension Study Period|Adverse Event|18|||
16182410|NCT00751881|39145570|FG001|Extension Study Period|Adverse Event|20|||
16182411|NCT00751881|39145571|FG002|Extension Study Period|Adverse Event|21|||
16182412|NCT00751881|39145569|FG000|Extension Study Period|Lack of Efficacy|14|||
16182413|NCT00751881|39145570|FG001|Extension Study Period|Lack of Efficacy|10|||
16182414|NCT00751881|39145571|FG002|Extension Study Period|Lack of Efficacy|20|||
16182415|NCT00751881|39145569|FG000|Extension Study Period|Lost to Follow-up|4|||
16182416|NCT00751881|39145570|FG001|Extension Study Period|Lost to Follow-up|9|||
16182417|NCT00751881|39145571|FG002|Extension Study Period|Lost to Follow-up|6|||
16182418|NCT00751881|39145569|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
16182419|NCT00751881|39145570|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
16182420|NCT00751881|39145571|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
16080186|NCT03531840|38786777|FG000|Overall Study|Death during follow up|2|||
16080187|NCT03531840|38786778|FG001|Overall Study|Death during follow up|3|||
16080188|NCT03531840|38786779|FG002|Overall Study|Death during follow up|4|||
16080189|NCT03531840|38786780|FG003|Overall Study|Death during follow up|1|||
16080190|NCT01307267|38786781|FG000|Overall Study|Death|4|||
16080191|NCT01307267|38786782|FG001|Overall Study|Death|3|||
16080192|NCT01307267|38786783|FG002|Overall Study|Death|5|||
16080193|NCT01307267|38786784|FG003|Overall Study|Death|3|||
16080194|NCT01307267|38786785|FG004|Overall Study|Death|1|||
16080195|NCT01307267|38786786|FG005|Overall Study|Death|26|||
16080196|NCT01307267|38786787|FG006|Overall Study|Death|2|||
16182421|NCT00751881|39145569|FG000|Extension Study Period|Other than specified above|26|||
16182422|NCT00751881|39145570|FG001|Extension Study Period|Other than specified above|30|||
16182423|NCT00751881|39145571|FG002|Extension Study Period|Other than specified above|18|||
16182424|NCT01364467|39145572|FG000|Overall Study|Lost to Follow-up|1|||
16182425|NCT01364467|39145573|FG001|Overall Study|Lost to Follow-up|2|||
16182426|NCT04238663|39145574|FG000|Overall Study|Lost to Follow-up|0|||
16182427|NCT04238663|39145575|FG001|Overall Study|Lost to Follow-up|1|||
16182428|NCT04238663|39145576|FG002|Overall Study|Lost to Follow-up|0|||
16182429|NCT04579393|39145577|FG000|Overall Study|Withdrawal by Subject|2|||
16182430|NCT04579393|39145578|FG001|Overall Study|Withdrawal by Subject|2|||
16182431|NCT04579393|39145577|FG000|Overall Study|Death|1|||
16182432|NCT04579393|39145578|FG001|Overall Study|Death|3|||
16182433|NCT00539591|39145583|FG000|Overall Study|Toxicity|3|||
16182434|NCT00539591|39145584|FG001|Overall Study|Toxicity|0|||
16182435|NCT00539591|39145585|FG002|Overall Study|Toxicity|0|||
16182436|NCT00539591|39145583|FG000|Overall Study|Disease progression|2|||
16182437|NCT00539591|39145584|FG001|Overall Study|Disease progression|2|||
16182438|NCT00539591|39145585|FG002|Overall Study|Disease progression|3|||
16182439|NCT01171521|39145586|FG000|Overall Study|Lost to Follow-up|5|||
16182440|NCT01171521|39145586|FG000|Overall Study|screen failure|1|||
16080197|NCT01307267|38786788|FG007|Overall Study|Death|2|||
16182441|NCT03321929|39145588|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
16182442|NCT00306891|39145589|FG000|Part A|Withdrawal by Subject|1|||
16182443|NCT00306891|39145590|FG001|Part A|Withdrawal by Subject|1|||
16080198|NCT01307267|38786789|FG008|Overall Study|Death|21|||
16080199|NCT01307267|38786790|FG009|Overall Study|Death|2|||
16182444|NCT00306891|39145591|FG002|Part A|Withdrawal by Subject|0|||
16182445|NCT00306891|39145592|FG003|Part A|Withdrawal by Subject|0|||
16182446|NCT00306891|39145589|FG000|Part A|Condition under investigation worsened|2|||
16182447|NCT00306891|39145590|FG001|Part A|Condition under investigation worsened|2|||
16182448|NCT00306891|39145591|FG002|Part A|Condition under investigation worsened|0|||
16182449|NCT00306891|39145592|FG003|Part A|Condition under investigation worsened|0|||
16182450|NCT00306891|39145589|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
16182451|NCT00306891|39145590|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
16182452|NCT00306891|39145591|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
16182453|NCT00306891|39145592|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
16182454|NCT00306891|39145589|FG000|Part A|Partial bowel obstruction|1|||
16182455|NCT00306891|39145590|FG001|Part A|Partial bowel obstruction|0|||
16182456|NCT00306891|39145591|FG002|Part A|Partial bowel obstruction|0|||
16182457|NCT00306891|39145592|FG003|Part A|Partial bowel obstruction|0|||
16182458|NCT00306891|39145589|FG000|Part A|Reaccumul. of ascites following drainage|0|||
16182459|NCT00306891|39145590|FG001|Part A|Reaccumul. of ascites following drainage|1|||
16182460|NCT00306891|39145591|FG002|Part A|Reaccumul. of ascites following drainage|0|||
16182461|NCT00306891|39145592|FG003|Part A|Reaccumul. of ascites following drainage|0|||
16182462|NCT00306891|39145589|FG000|Part A|Suspicion of second malignancy|0|||
16182463|NCT00306891|39145590|FG001|Part A|Suspicion of second malignancy|1|||
16182464|NCT00306891|39145591|FG002|Part A|Suspicion of second malignancy|0|||
16182465|NCT00306891|39145592|FG003|Part A|Suspicion of second malignancy|0|||
16182466|NCT00306891|39145589|FG000|Part A|QTC interval outwith elig. criteria|1|||
16182467|NCT00306891|39145590|FG001|Part A|QTC interval outwith elig. criteria|0|||
16182468|NCT00306891|39145591|FG002|Part A|QTC interval outwith elig. criteria|0|||
16182469|NCT00306891|39145592|FG003|Part A|QTC interval outwith elig. criteria|0|||
16182470|NCT00306891|39145589|FG000|Part B|Death|0|||
16182471|NCT00306891|39145590|FG001|Part B|Death|0|||
16182472|NCT00306891|39145591|FG002|Part B|Death|1|||
16182473|NCT00306891|39145592|FG003|Part B|Death|2|||
16182474|NCT00306891|39145589|FG000|Part B|Adverse Event|0|||
16182475|NCT00306891|39145590|FG001|Part B|Adverse Event|0|||
16182476|NCT00306891|39145591|FG002|Part B|Adverse Event|5|||
16182477|NCT00306891|39145592|FG003|Part B|Adverse Event|5|||
16182478|NCT00306891|39145589|FG000|Part B|Withdrawal by Subject|0|||
16182479|NCT00306891|39145590|FG001|Part B|Withdrawal by Subject|0|||
16182480|NCT00306891|39145591|FG002|Part B|Withdrawal by Subject|3|||
16182481|NCT00306891|39145592|FG003|Part B|Withdrawal by Subject|1|||
16182482|NCT00306891|39145589|FG000|Part B|Condition under investigation worsened|0|||
16182483|NCT00306891|39145590|FG001|Part B|Condition under investigation worsened|0|||
16182484|NCT00306891|39145591|FG002|Part B|Condition under investigation worsened|2|||
16182485|NCT00306891|39145592|FG003|Part B|Condition under investigation worsened|8|||
16182486|NCT00306891|39145589|FG000|Part B|Development of study specific disc crit.|0|||
16182487|NCT00306891|39145590|FG001|Part B|Development of study specific disc crit.|0|||
16182488|NCT00306891|39145591|FG002|Part B|Development of study specific disc crit.|0|||
16182489|NCT00306891|39145592|FG003|Part B|Development of study specific disc crit.|1|||
16182490|NCT01988012|39145595|FG000|Overall Study|Adverse Event|5|||
16182491|NCT01988012|39145595|FG000|Overall Study|Insufficient Therapeutic Response|3|||
16182492|NCT01988012|39145595|FG000|Overall Study|Patient Withdrawal of Consent|4|||
16182493|NCT01988012|39145595|FG000|Overall Study|Lost to Follow-up|1|||
16182494|NCT01988012|39145595|FG000|Overall Study|Physician Decision|1|||
16182495|NCT01988012|39145595|FG000|Overall Study|Protocol Violation|1|||
16182496|NCT01089725|39145596|FG000|Overall Study|Adverse Event|1|||
16182497|NCT01089725|39145597|FG001|Overall Study|Adverse Event|1|||
16182498|NCT01089725|39145598|FG002|Overall Study|Adverse Event|0|||
16182499|NCT01089725|39145599|FG003|Overall Study|Adverse Event|0|||
16182500|NCT01089725|39145600|FG004|Overall Study|Adverse Event|2|||
16182501|NCT01089725|39145596|FG000|Overall Study|Lack of Efficacy|4|||
16182502|NCT01089725|39145597|FG001|Overall Study|Lack of Efficacy|3|||
16182503|NCT01089725|39145598|FG002|Overall Study|Lack of Efficacy|1|||
16080200|NCT01307267|38786791|FG010|Overall Study|Death|3|||
16182504|NCT01089725|39145599|FG003|Overall Study|Lack of Efficacy|0|||
16182505|NCT01089725|39145600|FG004|Overall Study|Lack of Efficacy|4|||
16182506|NCT01089725|39145596|FG000|Overall Study|Lost to Follow-up|2|||
16182507|NCT01089725|39145597|FG001|Overall Study|Lost to Follow-up|2|||
16182508|NCT01089725|39145598|FG002|Overall Study|Lost to Follow-up|0|||
16182509|NCT01089725|39145599|FG003|Overall Study|Lost to Follow-up|3|||
16182510|NCT01089725|39145600|FG004|Overall Study|Lost to Follow-up|0|||
16182511|NCT01089725|39145596|FG000|Overall Study|Protocol Violation|0|||
16182512|NCT01089725|39145597|FG001|Overall Study|Protocol Violation|0|||
16182513|NCT01089725|39145598|FG002|Overall Study|Protocol Violation|1|||
16182514|NCT01089725|39145599|FG003|Overall Study|Protocol Violation|1|||
16182515|NCT01089725|39145600|FG004|Overall Study|Protocol Violation|0|||
16182516|NCT01089725|39145596|FG000|Overall Study|Withdrawal by Subject|5|||
16182517|NCT01089725|39145597|FG001|Overall Study|Withdrawal by Subject|5|||
16182518|NCT01089725|39145598|FG002|Overall Study|Withdrawal by Subject|4|||
16182519|NCT01089725|39145599|FG003|Overall Study|Withdrawal by Subject|5|||
16182520|NCT01089725|39145600|FG004|Overall Study|Withdrawal by Subject|4|||
16182521|NCT01089725|39145596|FG000|Overall Study|Study Terminated by Sponsor|51|||
16182522|NCT01089725|39145597|FG001|Overall Study|Study Terminated by Sponsor|56|||
16182523|NCT01089725|39145598|FG002|Overall Study|Study Terminated by Sponsor|53|||
16182524|NCT01089725|39145599|FG003|Overall Study|Study Terminated by Sponsor|68|||
16182525|NCT01089725|39145600|FG004|Overall Study|Study Terminated by Sponsor|68|||
16182526|NCT01089725|39145596|FG000|Overall Study|Randomized, but not treated|0|||
16182527|NCT01089725|39145597|FG001|Overall Study|Randomized, but not treated|1|||
16182528|NCT01089725|39145598|FG002|Overall Study|Randomized, but not treated|2|||
16182529|NCT01089725|39145599|FG003|Overall Study|Randomized, but not treated|1|||
16182530|NCT01089725|39145600|FG004|Overall Study|Randomized, but not treated|2|||
16182531|NCT01089725|39145596|FG000|Overall Study|Other|3|||
16182532|NCT01089725|39145597|FG001|Overall Study|Other|0|||
16182533|NCT01089725|39145598|FG002|Overall Study|Other|0|||
16182534|NCT01089725|39145599|FG003|Overall Study|Other|1|||
16182535|NCT01089725|39145600|FG004|Overall Study|Other|0|||
16182536|NCT00417612|39148782|FG000|Overall Study|Errant diagnosis|0|||
16182537|NCT00417612|39148783|FG001|Overall Study|Errant diagnosis|1|||
16182538|NCT00417612|39148782|FG000|Overall Study|Adverse Event|2|||
16182539|NCT00417612|39148783|FG001|Overall Study|Adverse Event|0|||
16182540|NCT00417612|39148782|FG000|Overall Study|Protocol Violation|0|||
16182541|NCT00417612|39148783|FG001|Overall Study|Protocol Violation|2|||
16182542|NCT00417612|39148782|FG000|Overall Study|Lost to Follow-up|1|||
16182543|NCT00417612|39148783|FG001|Overall Study|Lost to Follow-up|0|||
16182544|NCT00984659|39148784|FG000|2-week Run-in Period|Adverse Event|8|||
16182545|NCT00984659|39148785|FG001|2-week Run-in Period|Adverse Event|0|||
16182546|NCT00984659|39148786|FG002|2-week Run-in Period|Adverse Event|0|||
16182547|NCT00984659|39148787|FG003|2-week Run-in Period|Adverse Event|0|||
16182548|NCT00984659|39148784|FG000|2-week Run-in Period|Protocol Violation|5|||
16182549|NCT00984659|39148785|FG001|2-week Run-in Period|Protocol Violation|0|||
16182550|NCT00984659|39148786|FG002|2-week Run-in Period|Protocol Violation|0|||
16182551|NCT00984659|39148787|FG003|2-week Run-in Period|Protocol Violation|0|||
16182552|NCT00984659|39148784|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
16182553|NCT00984659|39148785|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
16182554|NCT00984659|39148786|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
16182555|NCT00984659|39148787|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
16182556|NCT00984659|39148784|FG000|2-week Run-in Period|Lost to Follow-up|3|||
16182557|NCT00984659|39148785|FG001|2-week Run-in Period|Lost to Follow-up|0|||
16478905|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16478906|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
16478907|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
16478908|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Death|0|||
16478909|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Death|0|||
16478910|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Death|0|||
16182558|NCT00984659|39148786|FG002|2-week Run-in Period|Lost to Follow-up|0|||
16182559|NCT00984659|39148787|FG003|2-week Run-in Period|Lost to Follow-up|0|||
16182560|NCT00984659|39148784|FG000|2-week Run-in Period|Physician Decision|10|||
16182561|NCT00984659|39148785|FG001|2-week Run-in Period|Physician Decision|0|||
16182562|NCT00984659|39148786|FG002|2-week Run-in Period|Physician Decision|0|||
16182563|NCT00984659|39148787|FG003|2-week Run-in Period|Physician Decision|0|||
16378906|NCT04380142|39874651|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
16378907|NCT04380142|39874652|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
16378908|NCT04380142|39874653|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
16378909|NCT04380142|39874651|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
16378910|NCT04380142|39874652|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
16378911|NCT04380142|39874653|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
16378912|NCT04380142|39874651|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
16378913|NCT04380142|39874652|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
16378914|NCT04380142|39874653|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
16378915|NCT04380142|39874651|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
16378916|NCT04380142|39874652|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
16378917|NCT04380142|39874653|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
16478911|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Death|0|||
16182564|NCT00984659|39148784|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
16182565|NCT00984659|39148785|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16182566|NCT00984659|39148786|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16182567|NCT00984659|39148787|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
16182568|NCT00984659|39148784|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
16182569|NCT00984659|39148785|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16182570|NCT00984659|39148786|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16182571|NCT00984659|39148787|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16182572|NCT00984659|39148784|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
16182573|NCT00984659|39148785|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
16182574|NCT00984659|39148786|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
16182575|NCT00984659|39148787|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
16182576|NCT00984659|39148784|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
16182577|NCT00984659|39148785|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
16182578|NCT00984659|39148786|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
16182579|NCT00984659|39148787|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
16182580|NCT00984659|39148784|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
16182581|NCT00984659|39148785|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
16182582|NCT00984659|39148786|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
16182583|NCT00984659|39148787|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
16182584|NCT00984659|39148784|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
16182585|NCT00984659|39148785|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
16182586|NCT00984659|39148786|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
16182587|NCT00984659|39148787|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
16182588|NCT00984659|39148784|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16182589|NCT00984659|39148785|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
16182590|NCT00984659|39148786|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
16182591|NCT00984659|39148787|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
16182592|NCT02532543|39148788|FG000|Overall Study|Lost to Follow-up|0|||
16182593|NCT02532543|39148789|FG001|Overall Study|Lost to Follow-up|0|||
16182594|NCT02532543|39148790|FG002|Overall Study|Lost to Follow-up|1|||
16182595|NCT02532543|39148791|FG003|Overall Study|Lost to Follow-up|0|||
16182596|NCT02601001|39148796|FG000|Dosing Period 2|Adverse Event|0|||
16182597|NCT02601001|39148797|FG001|Dosing Period 2|Adverse Event|0|||
16182598|NCT02601001|39148798|FG002|Dosing Period 2|Adverse Event|0|||
16378918|NCT04442269|39874656|FG000|Overall Study|Adverse Event|1|||
16378919|NCT04442269|39874657|FG001|Overall Study|Adverse Event|0|||
16378920|NCT04442269|39874656|FG000|Overall Study|Death|0|||
16378921|NCT04442269|39874657|FG001|Overall Study|Death|1|||
16378922|NCT04442269|39874656|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
16378923|NCT04442269|39874657|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
16182599|NCT02601001|39148799|FG003|Dosing Period 2|Adverse Event|0|||
16182600|NCT02601001|39148800|FG004|Dosing Period 2|Adverse Event|0|||
16182601|NCT02601001|39148801|FG005|Dosing Period 2|Adverse Event|0|||
16182602|NCT02601001|39148802|FG006|Dosing Period 2|Adverse Event|1|||
16182603|NCT02275026|39148804|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
16182604|NCT02275026|39148804|FG000|Overall Study|Withdrawal by Subject|4|||
16378924|NCT04442269|39874656|FG000|Overall Study|Lost to Follow-up|1|||
16378925|NCT04442269|39874657|FG001|Overall Study|Lost to Follow-up|0|||
16378926|NCT04442269|39874656|FG000|Overall Study|Withdrawal by Subject|3|||
16378927|NCT04442269|39874657|FG001|Overall Study|Withdrawal by Subject|2|||
16378928|NCT04442269|39874656|FG000|Overall Study|Protocol Deviation|0|||
16182605|NCT02275026|39148804|FG000|Overall Study|Ineligible due to medical history|13|||
16182606|NCT02275026|39148804|FG000|Overall Study|MRI malfunction precluded testing|1|||
16378929|NCT04442269|39874657|FG001|Overall Study|Protocol Deviation|1|||
16378930|NCT04442269|39874656|FG000|Overall Study|Travel Limitations|1|||
16378931|NCT04442269|39874657|FG001|Overall Study|Travel Limitations|1|||
16378932|NCT01585025|39874658|FG000|Overall Study|Withdrawal by Subject|0|||
16378933|NCT01585025|39874659|FG001|Overall Study|Withdrawal by Subject|3|||
16378934|NCT01585025|39874660|FG002|Overall Study|Withdrawal by Subject|4|||
16378935|NCT02883049|39874661|FG000|Induction|Adverse Event|52|||
16378936|NCT02883049|39874662|FG001|Induction|Adverse Event|2|||
16182607|NCT02275026|39148804|FG000|Overall Study|Ineligible after MRI findings|1|||
16182608|NCT02275026|39148804|FG000|Overall Study|Lost to Follow-up|2|||
16182609|NCT02275026|39148804|FG000|Overall Study|Scanner failure|1|||
16182610|NCT00222729|39148805|FG000|Overall Study|Adverse Event|3|||
16182611|NCT03635190|39148806|FG000|Overall Study|Lost to Follow-up|4|||
16182612|NCT03635190|39148806|FG000|Overall Study|Death|3|||
16182613|NCT03635190|39148806|FG000|Overall Study|Withdrawal by Subject|1|||
16182614|NCT03635190|39148806|FG000|Overall Study|Patient moved and did not return for follow up|1|||
16182615|NCT00542828|39148807|FG000|Overall Study|Physician Decision|1|||
16182616|NCT00542828|39148807|FG000|Overall Study|Need for Prohibited Treatment|3|||
16182617|NCT00542828|39148807|FG000|Overall Study|Study Prematurely Discontinued|7|||
16182618|NCT00542828|39148807|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
16182619|NCT04333433|39148810|FG000|Overall Study|Withdrawal by Subject|6|||
16182620|NCT04333433|39148811|FG001|Overall Study|Withdrawal by Subject|3|||
16182621|NCT04333433|39148810|FG000|Overall Study|Death|3|||
16182622|NCT04333433|39148811|FG001|Overall Study|Death|0|||
16182623|NCT04333433|39148810|FG000|Overall Study|Lost to Follow-up|6|||
16182624|NCT04333433|39148811|FG001|Overall Study|Lost to Follow-up|1|||
16182625|NCT04333433|39148810|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
16182626|NCT04333433|39148811|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
16182627|NCT02335450|39148812|FG000|Overall Study|Pregnancy|1|||
16182628|NCT02116972|39148820|FG000|Overall Study|Adverse Event|4|||
16182629|NCT02116972|39148821|FG001|Overall Study|Adverse Event|4|||
16182630|NCT02116972|39148822|FG002|Overall Study|Adverse Event|1|||
16182631|NCT02116972|39148820|FG000|Overall Study|Withdrawal by Subject|1|||
16182632|NCT02116972|39148821|FG001|Overall Study|Withdrawal by Subject|1|||
16182633|NCT02116972|39148822|FG002|Overall Study|Withdrawal by Subject|5|||
16182634|NCT02116972|39148820|FG000|Overall Study|Protocol Violation|1|||
16182635|NCT02116972|39148821|FG001|Overall Study|Protocol Violation|0|||
16182636|NCT02116972|39148822|FG002|Overall Study|Protocol Violation|1|||
16182637|NCT02116972|39148820|FG000|Overall Study|Lost to Follow-up|4|||
16182638|NCT02116972|39148821|FG001|Overall Study|Lost to Follow-up|3|||
16182639|NCT02116972|39148822|FG002|Overall Study|Lost to Follow-up|1|||
16182640|NCT02116972|39148820|FG000|Overall Study|Lack of Efficacy|6|||
16378937|NCT02883049|39874663|FG002|Induction|Adverse Event|0|||
16378938|NCT02883049|39874664|FG003|Induction|Adverse Event|0|||
16182641|NCT02116972|39148821|FG001|Overall Study|Lack of Efficacy|6|||
16182642|NCT02116972|39148822|FG002|Overall Study|Lack of Efficacy|5|||
16182643|NCT02116972|39148820|FG000|Overall Study|scheduling conflicts and relocation|3|||
16182644|NCT02116972|39148821|FG001|Overall Study|scheduling conflicts and relocation|3|||
16182645|NCT02116972|39148822|FG002|Overall Study|scheduling conflicts and relocation|6|||
16182646|NCT03396471|39148829|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
16182647|NCT03396471|39148829|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
16182648|NCT03396471|39148829|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
16182649|NCT03396471|39148829|FG000|Study Treatment - Up to 22 Months|Death|2|||
16182650|NCT03396471|39148829|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
16182651|NCT03396471|39148829|FG000|Follow up - Up to 2 Years|Death|9|||
16182652|NCT03396471|39148829|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
16182653|NCT03396471|39148829|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
16182654|NCT03396471|39148829|FG000|Follow up - Up to 2 Years|study terminated|1|||
16182655|NCT03396471|39148829|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
16182656|NCT03396471|39148829|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
16182657|NCT02114203|39148830|FG000|Overall Study|Adverse Event|0|||
16182658|NCT02114203|39148831|FG001|Overall Study|Adverse Event|1|||
16182659|NCT02114203|39148832|FG002|Overall Study|Adverse Event|0|||
16182660|NCT02114203|39148830|FG000|Overall Study|Withdrawal by Subject|0|||
16182661|NCT02114203|39148831|FG001|Overall Study|Withdrawal by Subject|1|||
16182662|NCT02114203|39148832|FG002|Overall Study|Withdrawal by Subject|0|||
16182663|NCT02385123|39148833|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
16182664|NCT00593112|39148836|FG000|Overall Study|Scan Anxiety|3|||
16182665|NCT00593112|39148837|FG001|Overall Study|Scan Anxiety|0|||
16182666|NCT00593112|39148836|FG000|Overall Study|Abnormal Scan|1|||
16182667|NCT00593112|39148837|FG001|Overall Study|Abnormal Scan|0|||
16182668|NCT00593112|39148836|FG000|Overall Study|Unreadable Scan|1|||
16182669|NCT00593112|39148837|FG001|Overall Study|Unreadable Scan|0|||
16182670|NCT00593112|39148836|FG000|Overall Study|Withdrawal by Subject|5|||
16182671|NCT00593112|39148837|FG001|Overall Study|Withdrawal by Subject|0|||
16182672|NCT01050062|39148838|FG000|Overall Study|Adverse Event|75|||
16182673|NCT01050062|39148839|FG001|Overall Study|Adverse Event|22|||
16378939|NCT02883049|39874665|FG004|Induction|Adverse Event|0|||
16378940|NCT02883049|39874666|FG005|Induction|Adverse Event|0|||
16182674|NCT01050062|39148838|FG000|Overall Study|Lost to Follow-up|83|||
16378941|NCT02883049|39874667|FG006|Induction|Adverse Event|0|||
16182675|NCT01050062|39148839|FG001|Overall Study|Lost to Follow-up|35|||
16182676|NCT01050062|39148838|FG000|Overall Study|Lack of Efficacy|22|||
16182677|NCT01050062|39148839|FG001|Overall Study|Lack of Efficacy|35|||
16182678|NCT01050062|39148838|FG000|Overall Study|Physician Decision|74|||
16182679|NCT01050062|39148839|FG001|Overall Study|Physician Decision|9|||
16182680|NCT01050062|39148838|FG000|Overall Study|Others|17|||
16182681|NCT01050062|39148839|FG001|Overall Study|Others|11|||
16182682|NCT00667277|39148840|FG000|Overall Study|Withdrawal by Subject|2|||
16182683|NCT02586207|39148843|FG000|Overall Study|Physician Decision|1|||
16182684|NCT02586207|39148843|FG000|Overall Study|Withdrawal by Subject|1|||
16182685|NCT00590681|39148845|FG000|Overall Study|Withdrawal by Subject|7|||
16182686|NCT00590681|39148845|FG000|Overall Study|Adverse Event|8|||
16182687|NCT00590681|39148845|FG000|Overall Study|Death|3|||
16182688|NCT00590681|39148845|FG000|Overall Study|Lost to Follow-up|1|||
16182689|NCT00590681|39148845|FG000|Overall Study|disease progression|1|||
16182690|NCT02990338|39148852|FG000|Overall Study|Ongoing|30|||
16182691|NCT02990338|39148853|FG001|Overall Study|Ongoing|36|||
16182692|NCT03043365|39148856|FG000|Weeks 0 to Week 8|Adverse Event|1|||
16182693|NCT03043365|39148857|FG001|Weeks 0 to Week 8|Adverse Event|3|||
16182694|NCT03043365|39148856|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
16182695|NCT03043365|39148857|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
16182696|NCT03043365|39148856|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
16182697|NCT03043365|39148857|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
16182698|NCT01712438|39148862|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
16182699|NCT01712438|39148862|FG000|Overall Study|Ongoing ITI treatment|6|||
16182700|NCT01712438|39148862|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
16182701|NCT01712438|39148862|FG000|Overall Study|Prematurely Discontinued|25|||
16182702|NCT00576693|39148863|FG000|Overall Study|Lost to Follow-up|7|||
16182703|NCT00576693|39148864|FG001|Overall Study|Lost to Follow-up|11|||
16182704|NCT00576693|39148863|FG000|Overall Study|Withdrawal by Subject|3|||
16182705|NCT00576693|39148864|FG001|Overall Study|Withdrawal by Subject|13|||
16182706|NCT03199911|39148865|FG000|Overall Study|Lost to Follow-up|5|||
16182707|NCT03199911|39148866|FG001|Overall Study|Lost to Follow-up|5|||
16182708|NCT03199911|39148865|FG000|Overall Study|Did not proceed with surgery|2|||
16182709|NCT03199911|39148866|FG001|Overall Study|Did not proceed with surgery|1|||
16182710|NCT00734929|39148869|FG000|Overall Study|Lost to Follow-up|1|||
16182711|NCT00734929|39148870|FG001|Overall Study|Lost to Follow-up|2|||
16182712|NCT00734929|39148869|FG000|Overall Study|No intervention/ screen fail|5|||
16182713|NCT00734929|39148870|FG001|Overall Study|No intervention/ screen fail|3|||
16182714|NCT03126227|39148871|FG000|Overall Study|Adverse Event|43|||
16182715|NCT03126227|39148872|FG001|Overall Study|Adverse Event|4|||
16182716|NCT03126227|39148871|FG000|Overall Study|Death|0|||
16182717|NCT03126227|39148872|FG001|Overall Study|Death|1|||
16182718|NCT03126227|39148871|FG000|Overall Study|Lost to Follow-up|0|||
16182719|NCT03126227|39148872|FG001|Overall Study|Lost to Follow-up|1|||
16182720|NCT03126227|39148871|FG000|Overall Study|Physician Decision|2|||
16182721|NCT03126227|39148872|FG001|Overall Study|Physician Decision|0|||
16182722|NCT03126227|39148871|FG000|Overall Study|Protocol Violation|1|||
16182723|NCT03126227|39148872|FG001|Overall Study|Protocol Violation|0|||
16182724|NCT03126227|39148871|FG000|Overall Study|Withdrawal by Subject|19|||
16182725|NCT03126227|39148872|FG001|Overall Study|Withdrawal by Subject|3|||
16182726|NCT03126227|39148871|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
16182727|NCT03126227|39148872|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
16182728|NCT03126227|39148871|FG000|Overall Study|Lack of dosing compliance|2|||
16182729|NCT03126227|39148872|FG001|Overall Study|Lack of dosing compliance|0|||
16182730|NCT03126227|39148871|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
16182731|NCT03126227|39148872|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
16182732|NCT03126227|39148871|FG000|Overall Study|Scheduling conflict|1|||
16182733|NCT03126227|39148872|FG001|Overall Study|Scheduling conflict|0|||
16182734|NCT00839098|39148874|FG000|Overall Study|Withdrawal by Subject|2|||
16182735|NCT00839098|39148875|FG001|Overall Study|Withdrawal by Subject|1|||
16182736|NCT00839098|39148876|FG002|Overall Study|Withdrawal by Subject|7|||
16182737|NCT00184054|39148877|FG000|Overall Study|Adverse Event|1|||
16182738|NCT00227877|39148882|FG000|Pre-visit Assessment|Technical difficulties|7|||
16182739|NCT00227877|39148883|FG001|Pre-visit Assessment|Technical difficulties|3|||
16182740|NCT00227877|39148884|FG002|Pre-visit Assessment|Technical difficulties|0|||
16182741|NCT00227877|39148885|FG003|Pre-visit Assessment|Technical difficulties|0|||
16182742|NCT00227877|39148882|FG000|Post-visit Checklist|Lost to Follow-up|24|||
16182743|NCT00227877|39148883|FG001|Post-visit Checklist|Lost to Follow-up|13|||
16182744|NCT00227877|39148884|FG002|Post-visit Checklist|Lost to Follow-up|1|||
16182745|NCT00227877|39148885|FG003|Post-visit Checklist|Lost to Follow-up|0|||
16182746|NCT00227877|39148882|FG000|3-months Follow-up|Completed late|135|||
16182747|NCT00227877|39148883|FG001|3-months Follow-up|Completed late|128|||
16182748|NCT00227877|39148884|FG002|3-months Follow-up|Completed late|34|||
16182749|NCT00227877|39148885|FG003|3-months Follow-up|Completed late|8|||
16182750|NCT00227877|39148882|FG000|3-months Follow-up|Lost to Follow-up|178|||
16182751|NCT00227877|39148883|FG001|3-months Follow-up|Lost to Follow-up|139|||
16182752|NCT00227877|39148884|FG002|3-months Follow-up|Lost to Follow-up|18|||
16182753|NCT00227877|39148885|FG003|3-months Follow-up|Lost to Follow-up|13|||
16182754|NCT00227877|39148882|FG000|12-months Follow-up|Completed late|78|||
16182755|NCT00227877|39148883|FG001|12-months Follow-up|Completed late|74|||
16182756|NCT00227877|39148884|FG002|12-months Follow-up|Completed late|1|||
16182757|NCT00227877|39148885|FG003|12-months Follow-up|Completed late|0|||
16080201|NCT01307267|38786792|FG011|Overall Study|Death|9|||
16478912|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Death|0|||
16478913|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Death|0|||
16478914|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Death|0|||
16182758|NCT00227877|39148882|FG000|12-months Follow-up|Lost to Follow-up|232|||
16182759|NCT00227877|39148883|FG001|12-months Follow-up|Lost to Follow-up|189|||
16182760|NCT00227877|39148884|FG002|12-months Follow-up|Lost to Follow-up|30|||
16182761|NCT00227877|39148885|FG003|12-months Follow-up|Lost to Follow-up|26|||
16182762|NCT01588197|39148886|FG000|Overall Study|Lack of Efficacy|0|||
16182763|NCT01588197|39148887|FG001|Overall Study|Lack of Efficacy|1|||
16182764|NCT01588197|39148886|FG000|Overall Study|No MRI|1|||
16182765|NCT01588197|39148887|FG001|Overall Study|No MRI|0|||
16182766|NCT00521339|39148888|FG000|Treatment Phase|Adverse Event|2|||
16182767|NCT00521339|39148889|FG001|Treatment Phase|Adverse Event|0|||
16182768|NCT00521339|39148890|FG002|Treatment Phase|Adverse Event|0|||
16182769|NCT00521339|39148888|FG000|Treatment Phase|Intolerability to study drug|2|||
16182770|NCT00521339|39148889|FG001|Treatment Phase|Intolerability to study drug|0|||
16182771|NCT00521339|39148890|FG002|Treatment Phase|Intolerability to study drug|0|||
16182772|NCT00521339|39148888|FG000|Treatment Phase|Lack of Efficacy|3|||
16182773|NCT00521339|39148889|FG001|Treatment Phase|Lack of Efficacy|0|||
16182774|NCT00521339|39148890|FG002|Treatment Phase|Lack of Efficacy|0|||
16182775|NCT00521339|39148888|FG000|Treatment Phase|Withdrawal by Subject|3|||
16182776|NCT00521339|39148889|FG001|Treatment Phase|Withdrawal by Subject|0|||
16182777|NCT00521339|39148890|FG002|Treatment Phase|Withdrawal by Subject|0|||
16182778|NCT00521339|39148888|FG000|Treatment Phase|Lost to Follow-up|1|||
16182779|NCT00521339|39148889|FG001|Treatment Phase|Lost to Follow-up|0|||
16182780|NCT00521339|39148890|FG002|Treatment Phase|Lost to Follow-up|0|||
16182781|NCT00521339|39148888|FG000|Treatment Phase|Protocol Violation|1|||
16182782|NCT00521339|39148889|FG001|Treatment Phase|Protocol Violation|0|||
16182783|NCT00521339|39148890|FG002|Treatment Phase|Protocol Violation|0|||
16182784|NCT00521339|39148888|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
16182785|NCT00521339|39148889|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
16182786|NCT00521339|39148890|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
16182787|NCT00521339|39148888|FG000|Treatment Extension Phase|Death|0|||
16182788|NCT00521339|39148889|FG001|Treatment Extension Phase|Death|0|||
16182789|NCT00521339|39148890|FG002|Treatment Extension Phase|Death|1|||
16182790|NCT01277289|39148891|FG000|Overall Study|fragile vein|1|||
16182791|NCT01277289|39148892|FG001|Overall Study|fragile vein|0|||
16182792|NCT01277289|39148891|FG000|Overall Study|Physician Decision|1|||
16182793|NCT01277289|39148892|FG001|Overall Study|Physician Decision|0|||
16182794|NCT01277289|39148891|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
16182795|NCT01277289|39148892|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
16182796|NCT01277289|39148891|FG000|Overall Study|Protocol Violation|1|||
16182797|NCT01277289|39148892|FG001|Overall Study|Protocol Violation|1|||
16182798|NCT01277289|39148891|FG000|Overall Study|Adverse Event|2|||
16182799|NCT01277289|39148892|FG001|Overall Study|Adverse Event|1|||
16182800|NCT01277289|39148891|FG000|Overall Study|consent withdrawn|1|||
16182801|NCT01277289|39148892|FG001|Overall Study|consent withdrawn|1|||
16182802|NCT01277289|39148891|FG000|Overall Study|premature closure of the study|4|||
16182803|NCT01277289|39148892|FG001|Overall Study|premature closure of the study|2|||
16182804|NCT00500149|39148895|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
16182805|NCT00500149|39148896|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
16182806|NCT00500149|39148895|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
16182807|NCT00500149|39148896|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
16182808|NCT00500149|39148895|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
16182809|NCT00500149|39148896|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
16182810|NCT00500149|39148895|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
16182811|NCT00500149|39148896|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
16182812|NCT00500149|39148895|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
16182813|NCT00500149|39148896|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
16182814|NCT00500149|39148895|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
16182815|NCT00500149|39148896|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
16182816|NCT00500149|39148895|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
16182817|NCT00500149|39148896|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
16182818|NCT01413178|39148897|FG000|Overall Study|Toxicity|1|||
16182819|NCT01413178|39148898|FG001|Overall Study|Toxicity|0|||
16182820|NCT01413178|39148897|FG000|Overall Study|Ineligible|0|||
16182821|NCT01413178|39148898|FG001|Overall Study|Ineligible|2|||
16182822|NCT03176966|39148899|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
16182823|NCT03176966|39148900|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
16182824|NCT03176966|39148899|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
16182825|NCT03176966|39148900|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
16182826|NCT03176966|39148899|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
16182827|NCT03176966|39148900|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
16182828|NCT03176966|39148899|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
16182829|NCT03176966|39148900|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
16182830|NCT03176966|39148899|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
16182831|NCT03176966|39148900|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
16182832|NCT03176966|39148899|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
16182833|NCT03176966|39148900|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
16182834|NCT03176966|39148899|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
16182835|NCT03176966|39148900|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
16182836|NCT03184701|39148901|FG000|Overall Study|Death|3|||
16182837|NCT03184701|39148901|FG000|Overall Study|Physician Decision|3|||
16182838|NCT03184701|39148901|FG000|Overall Study|Withdrawal by Subject|6|||
16182839|NCT03184701|39148901|FG000|Overall Study|Lost to Follow-up|5|||
16182840|NCT02732912|39148902|FG000|Overall Study|Discharged before night|2|||
16182841|NCT02732912|39148903|FG001|Overall Study|Discharged before night|6|||
16182842|NCT02732912|39148902|FG000|Overall Study|Incomplete completion of questionnaire|2|||
16182843|NCT02732912|39148903|FG001|Overall Study|Incomplete completion of questionnaire|3|||
16182844|NCT02732912|39148902|FG000|Overall Study|No outcome; discharged or refused|6|||
16182845|NCT02732912|39148903|FG001|Overall Study|No outcome; discharged or refused|9|||
16182846|NCT01863758|39148904|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
16182847|NCT01863758|39148904|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
16182848|NCT03694522|39148907|FG000|Overall Study|Withdrawal by Subject|8|||
16182849|NCT03694522|39148908|FG001|Overall Study|Withdrawal by Subject|10|||
16182850|NCT03694522|39148907|FG000|Overall Study|Physician Decision|53|||
16182851|NCT03694522|39148908|FG001|Overall Study|Physician Decision|54|||
16182852|NCT03694522|39148907|FG000|Overall Study|Other|1|||
16182853|NCT03694522|39148908|FG001|Overall Study|Other|1|||
16182854|NCT03694522|39148907|FG000|Overall Study|Lost to Follow-up|0|||
16182855|NCT03694522|39148908|FG001|Overall Study|Lost to Follow-up|1|||
16182856|NCT01853228|39148909|FG000|Phase 1|Lack of Efficacy|8|||
16182857|NCT01853228|39148910|FG001|Phase 1|Lack of Efficacy|0|||
16182858|NCT01853228|39148909|FG000|Phase 1|Other|1|||
16182859|NCT01853228|39148910|FG001|Phase 1|Other|0|||
16182860|NCT01853228|39148909|FG000|Phase 2|Physician Decision|0|||
16182861|NCT01853228|39148910|FG001|Phase 2|Physician Decision|1|||
16182862|NCT01853228|39148909|FG000|Phase 2|Proceed To Transplant|0|||
16182863|NCT01853228|39148910|FG001|Phase 2|Proceed To Transplant|3|||
16182864|NCT01853228|39148909|FG000|Phase 2|Lack of Efficacy|0|||
16182865|NCT01853228|39148910|FG001|Phase 2|Lack of Efficacy|4|||
16182866|NCT02234622|39148911|FG000|Overall Study|Withdrawal by Subject|16|||
16182867|NCT02234622|39148912|FG001|Overall Study|Withdrawal by Subject|22|||
16182868|NCT02234622|39148911|FG000|Overall Study|Lost to Follow-up|27|||
16182869|NCT02234622|39148912|FG001|Overall Study|Lost to Follow-up|14|||
16182870|NCT00893789|39148919|FG000|Overall Study|Withdrawal by Subject|3|||
16182871|NCT00893789|39148920|FG001|Overall Study|Withdrawal by Subject|1|||
16378942|NCT02883049|39874668|FG007|Induction|Adverse Event|0|||
16378943|NCT02883049|39874669|FG008|Induction|Adverse Event|0|||
16378944|NCT02883049|39874670|FG009|Induction|Adverse Event|0|||
16378945|NCT02883049|39874671|FG010|Induction|Adverse Event|0|||
16182872|NCT00893789|39148921|FG002|Overall Study|Withdrawal by Subject|3|||
16182873|NCT00893789|39148922|FG003|Overall Study|Withdrawal by Subject|1|||
16182874|NCT00893789|39148919|FG000|Overall Study|Noncompliance With Study Drug|1|||
16182875|NCT00893789|39148920|FG001|Overall Study|Noncompliance With Study Drug|0|||
16182876|NCT00893789|39148921|FG002|Overall Study|Noncompliance With Study Drug|1|||
16182877|NCT00893789|39148922|FG003|Overall Study|Noncompliance With Study Drug|2|||
16182878|NCT00893789|39148919|FG000|Overall Study|Noncompliance With Study Procedures|1|||
16182879|NCT00893789|39148920|FG001|Overall Study|Noncompliance With Study Procedures|0|||
16182880|NCT00893789|39148921|FG002|Overall Study|Noncompliance With Study Procedures|0|||
16182881|NCT00893789|39148922|FG003|Overall Study|Noncompliance With Study Procedures|0|||
16182882|NCT00893789|39148919|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
16378946|NCT02883049|39874672|FG011|Induction|Adverse Event|0|||
16378947|NCT02883049|39874673|FG012|Induction|Adverse Event|0|||
16182883|NCT00893789|39148920|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
16182884|NCT00893789|39148921|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
16182885|NCT00893789|39148922|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
16182886|NCT00893789|39148919|FG000|Overall Study|Adverse Event|0|||
16182887|NCT00893789|39148920|FG001|Overall Study|Adverse Event|2|||
16378948|NCT02883049|39874674|FG013|Induction|Adverse Event|0|||
16378949|NCT02883049|39874675|FG014|Induction|Adverse Event|0|||
16182888|NCT00893789|39148921|FG002|Overall Study|Adverse Event|1|||
16478915|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Death|0|||
16378950|NCT02883049|39874676|FG015|Induction|Adverse Event|0|||
16378951|NCT02883049|39874661|FG000|Induction|Death|76|||
16378952|NCT02883049|39874662|FG001|Induction|Death|8|||
16378953|NCT02883049|39874663|FG002|Induction|Death|0|||
16378954|NCT02883049|39874664|FG003|Induction|Death|0|||
16378955|NCT02883049|39874665|FG004|Induction|Death|0|||
16378956|NCT02883049|39874666|FG005|Induction|Death|0|||
16378957|NCT02883049|39874667|FG006|Induction|Death|0|||
16378958|NCT02883049|39874668|FG007|Induction|Death|0|||
16378959|NCT02883049|39874669|FG008|Induction|Death|0|||
16378960|NCT02883049|39874670|FG009|Induction|Death|0|||
16378961|NCT02883049|39874671|FG010|Induction|Death|0|||
16378962|NCT02883049|39874672|FG011|Induction|Death|0|||
16378963|NCT02883049|39874673|FG012|Induction|Death|0|||
16378964|NCT02883049|39874674|FG013|Induction|Death|0|||
16478916|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Death|0|||
16478917|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Death|1|||
16478918|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Death|0|||
16182889|NCT00893789|39148922|FG003|Overall Study|Adverse Event|5|||
16182890|NCT00893789|39148919|FG000|Overall Study|Protocol Violation|0|||
16182891|NCT00893789|39148920|FG001|Overall Study|Protocol Violation|1|||
16182892|NCT00893789|39148921|FG002|Overall Study|Protocol Violation|1|||
16182893|NCT00893789|39148922|FG003|Overall Study|Protocol Violation|4|||
16182894|NCT00893789|39148919|FG000|Overall Study|Lost to Follow-up|0|||
16182895|NCT00893789|39148920|FG001|Overall Study|Lost to Follow-up|0|||
16182896|NCT00893789|39148921|FG002|Overall Study|Lost to Follow-up|0|||
16378965|NCT02883049|39874675|FG014|Induction|Death|0|||
16378966|NCT02883049|39874676|FG015|Induction|Death|0|||
16378967|NCT02883049|39874661|FG000|Induction|Lost to Follow-up|2|||
16378968|NCT02883049|39874662|FG001|Induction|Lost to Follow-up|0|||
16378969|NCT02883049|39874663|FG002|Induction|Lost to Follow-up|0|||
16378970|NCT02883049|39874664|FG003|Induction|Lost to Follow-up|0|||
16378971|NCT02883049|39874665|FG004|Induction|Lost to Follow-up|0|||
16378972|NCT02883049|39874666|FG005|Induction|Lost to Follow-up|0|||
16378973|NCT02883049|39874667|FG006|Induction|Lost to Follow-up|0|||
16378974|NCT02883049|39874668|FG007|Induction|Lost to Follow-up|0|||
16378975|NCT02883049|39874669|FG008|Induction|Lost to Follow-up|0|||
16378976|NCT02883049|39874670|FG009|Induction|Lost to Follow-up|0|||
16378977|NCT02883049|39874671|FG010|Induction|Lost to Follow-up|0|||
16378978|NCT02883049|39874672|FG011|Induction|Lost to Follow-up|0|||
16378979|NCT02883049|39874673|FG012|Induction|Lost to Follow-up|0|||
16378980|NCT02883049|39874674|FG013|Induction|Lost to Follow-up|0|||
16378981|NCT02883049|39874675|FG014|Induction|Lost to Follow-up|0|||
16378982|NCT02883049|39874676|FG015|Induction|Lost to Follow-up|0|||
16378983|NCT02883049|39874661|FG000|Induction|Physician Decision|1407|||
16378984|NCT02883049|39874662|FG001|Induction|Physician Decision|8|||
16378985|NCT02883049|39874663|FG002|Induction|Physician Decision|0|||
16378986|NCT02883049|39874664|FG003|Induction|Physician Decision|0|||
16378987|NCT02883049|39874665|FG004|Induction|Physician Decision|0|||
16378988|NCT02883049|39874666|FG005|Induction|Physician Decision|0|||
16378989|NCT02883049|39874667|FG006|Induction|Physician Decision|0|||
16378990|NCT02883049|39874668|FG007|Induction|Physician Decision|0|||
16378991|NCT02883049|39874669|FG008|Induction|Physician Decision|0|||
16378992|NCT02883049|39874670|FG009|Induction|Physician Decision|0|||
16378993|NCT02883049|39874671|FG010|Induction|Physician Decision|0|||
16378994|NCT02883049|39874672|FG011|Induction|Physician Decision|0|||
16378995|NCT02883049|39874673|FG012|Induction|Physician Decision|0|||
16378996|NCT02883049|39874674|FG013|Induction|Physician Decision|0|||
16182897|NCT00893789|39148922|FG003|Overall Study|Lost to Follow-up|1|||
16378997|NCT02883049|39874675|FG014|Induction|Physician Decision|0|||
16378998|NCT02883049|39874676|FG015|Induction|Physician Decision|0|||
16378999|NCT02883049|39874661|FG000|Induction|Protocol Violation|6|||
16379000|NCT02883049|39874662|FG001|Induction|Protocol Violation|0|||
16379001|NCT02883049|39874663|FG002|Induction|Protocol Violation|0|||
16379002|NCT02883049|39874664|FG003|Induction|Protocol Violation|0|||
16379003|NCT02883049|39874665|FG004|Induction|Protocol Violation|0|||
16379004|NCT02883049|39874666|FG005|Induction|Protocol Violation|0|||
16379005|NCT02883049|39874667|FG006|Induction|Protocol Violation|0|||
16379006|NCT02883049|39874668|FG007|Induction|Protocol Violation|0|||
16379007|NCT02883049|39874669|FG008|Induction|Protocol Violation|0|||
16379008|NCT02883049|39874670|FG009|Induction|Protocol Violation|0|||
16182898|NCT02441803|39148923|FG000|Overall Study|Physician Decision|0|||
16182899|NCT02441803|39148924|FG001|Overall Study|Physician Decision|2|||
16182900|NCT02441803|39148925|FG002|Overall Study|Physician Decision|2|||
16379009|NCT02883049|39874671|FG010|Induction|Protocol Violation|0|||
16379010|NCT02883049|39874672|FG011|Induction|Protocol Violation|0|||
16379011|NCT02883049|39874673|FG012|Induction|Protocol Violation|0|||
16379012|NCT02883049|39874674|FG013|Induction|Protocol Violation|0|||
16379013|NCT02883049|39874675|FG014|Induction|Protocol Violation|0|||
16379014|NCT02883049|39874676|FG015|Induction|Protocol Violation|0|||
16379015|NCT02883049|39874661|FG000|Induction|Withdrawal by Subject|6|||
16379016|NCT02883049|39874662|FG001|Induction|Withdrawal by Subject|0|||
16379017|NCT02883049|39874663|FG002|Induction|Withdrawal by Subject|0|||
16379018|NCT02883049|39874664|FG003|Induction|Withdrawal by Subject|0|||
16379019|NCT02883049|39874665|FG004|Induction|Withdrawal by Subject|0|||
16379020|NCT02883049|39874666|FG005|Induction|Withdrawal by Subject|0|||
16379021|NCT02883049|39874667|FG006|Induction|Withdrawal by Subject|0|||
16379022|NCT02883049|39874668|FG007|Induction|Withdrawal by Subject|0|||
16379023|NCT02883049|39874669|FG008|Induction|Withdrawal by Subject|0|||
16379024|NCT02883049|39874670|FG009|Induction|Withdrawal by Subject|0|||
16379025|NCT02883049|39874671|FG010|Induction|Withdrawal by Subject|0|||
16379026|NCT02883049|39874672|FG011|Induction|Withdrawal by Subject|0|||
16379027|NCT02883049|39874673|FG012|Induction|Withdrawal by Subject|0|||
16379028|NCT02883049|39874674|FG013|Induction|Withdrawal by Subject|0|||
16379029|NCT02883049|39874675|FG014|Induction|Withdrawal by Subject|0|||
16379030|NCT02883049|39874676|FG015|Induction|Withdrawal by Subject|0|||
16379031|NCT02883049|39874661|FG000|Induction|Ineligible|35|||
16379032|NCT02883049|39874662|FG001|Induction|Ineligible|1|||
16379033|NCT02883049|39874663|FG002|Induction|Ineligible|0|||
16379034|NCT02883049|39874664|FG003|Induction|Ineligible|0|||
16379035|NCT02883049|39874665|FG004|Induction|Ineligible|0|||
16379036|NCT02883049|39874666|FG005|Induction|Ineligible|0|||
16379037|NCT02883049|39874667|FG006|Induction|Ineligible|0|||
16379038|NCT02883049|39874668|FG007|Induction|Ineligible|0|||
16379039|NCT02883049|39874669|FG008|Induction|Ineligible|0|||
16379040|NCT02883049|39874670|FG009|Induction|Ineligible|0|||
16379041|NCT02883049|39874671|FG010|Induction|Ineligible|0|||
16379042|NCT02883049|39874672|FG011|Induction|Ineligible|0|||
16379043|NCT02883049|39874673|FG012|Induction|Ineligible|0|||
16379044|NCT02883049|39874674|FG013|Induction|Ineligible|0|||
16379045|NCT02883049|39874675|FG014|Induction|Ineligible|0|||
16379046|NCT02883049|39874676|FG015|Induction|Ineligible|0|||
16379047|NCT02883049|39874661|FG000|Induction|Refusal of further protocol therapy|466|||
16379048|NCT02883049|39874662|FG001|Induction|Refusal of further protocol therapy|2|||
16379049|NCT02883049|39874663|FG002|Induction|Refusal of further protocol therapy|0|||
16379050|NCT02883049|39874664|FG003|Induction|Refusal of further protocol therapy|0|||
16379051|NCT02883049|39874665|FG004|Induction|Refusal of further protocol therapy|0|||
16379052|NCT02883049|39874666|FG005|Induction|Refusal of further protocol therapy|0|||
16379053|NCT02883049|39874667|FG006|Induction|Refusal of further protocol therapy|0|||
16379054|NCT02883049|39874668|FG007|Induction|Refusal of further protocol therapy|0|||
16379055|NCT02883049|39874669|FG008|Induction|Refusal of further protocol therapy|0|||
16379056|NCT02883049|39874670|FG009|Induction|Refusal of further protocol therapy|0|||
16379057|NCT02883049|39874671|FG010|Induction|Refusal of further protocol therapy|0|||
16379058|NCT02883049|39874672|FG011|Induction|Refusal of further protocol therapy|0|||
16379059|NCT02883049|39874673|FG012|Induction|Refusal of further protocol therapy|0|||
16379060|NCT02883049|39874674|FG013|Induction|Refusal of further protocol therapy|0|||
16379061|NCT02883049|39874675|FG014|Induction|Refusal of further protocol therapy|0|||
16379062|NCT02883049|39874676|FG015|Induction|Refusal of further protocol therapy|0|||
16379063|NCT02883049|39874661|FG000|Induction|Identified as Ph+ patients|279|||
16379064|NCT02883049|39874662|FG001|Induction|Identified as Ph+ patients|1|||
16379065|NCT02883049|39874663|FG002|Induction|Identified as Ph+ patients|0|||
16379066|NCT02883049|39874664|FG003|Induction|Identified as Ph+ patients|0|||
16379067|NCT02883049|39874665|FG004|Induction|Identified as Ph+ patients|0|||
16379068|NCT02883049|39874666|FG005|Induction|Identified as Ph+ patients|0|||
16182901|NCT02413255|39148926|FG000|Overall Study|Voluntary Withdrawal|0|||
16182902|NCT02413255|39148927|FG001|Overall Study|Voluntary Withdrawal|0|||
16182903|NCT02413255|39148928|FG002|Overall Study|Voluntary Withdrawal|0|||
16182904|NCT02413255|39148929|FG003|Overall Study|Voluntary Withdrawal|0|||
16182905|NCT02413255|39148930|FG004|Overall Study|Voluntary Withdrawal|0|||
16182906|NCT02413255|39148931|FG005|Overall Study|Voluntary Withdrawal|0|||
16379069|NCT02883049|39874667|FG006|Induction|Identified as Ph+ patients|0|||
16379070|NCT02883049|39874668|FG007|Induction|Identified as Ph+ patients|0|||
16379071|NCT02883049|39874669|FG008|Induction|Identified as Ph+ patients|0|||
16379072|NCT02883049|39874670|FG009|Induction|Identified as Ph+ patients|0|||
16379073|NCT02883049|39874671|FG010|Induction|Identified as Ph+ patients|0|||
16379074|NCT02883049|39874672|FG011|Induction|Identified as Ph+ patients|0|||
16379075|NCT02883049|39874673|FG012|Induction|Identified as Ph+ patients|0|||
16379076|NCT02883049|39874674|FG013|Induction|Identified as Ph+ patients|0|||
16379077|NCT02883049|39874675|FG014|Induction|Identified as Ph+ patients|0|||
16379078|NCT02883049|39874676|FG015|Induction|Identified as Ph+ patients|0|||
16379079|NCT02883049|39874661|FG000|Induction|M3 Marrow at Day29|8|||
16379080|NCT02883049|39874662|FG001|Induction|M3 Marrow at Day29|1|||
16379081|NCT02883049|39874663|FG002|Induction|M3 Marrow at Day29|0|||
16379082|NCT02883049|39874664|FG003|Induction|M3 Marrow at Day29|0|||
16182907|NCT02413255|39148932|FG006|Overall Study|Voluntary Withdrawal|0|||
16379083|NCT02883049|39874665|FG004|Induction|M3 Marrow at Day29|0|||
16379084|NCT02883049|39874666|FG005|Induction|M3 Marrow at Day29|0|||
16379085|NCT02883049|39874667|FG006|Induction|M3 Marrow at Day29|0|||
16182908|NCT02413255|39148933|FG007|Overall Study|Voluntary Withdrawal|0|||
16182909|NCT02413255|39148934|FG008|Overall Study|Voluntary Withdrawal|0|||
16182910|NCT02413255|39148935|FG009|Overall Study|Voluntary Withdrawal|0|||
16379086|NCT02883049|39874668|FG007|Induction|M3 Marrow at Day29|0|||
16379087|NCT02883049|39874669|FG008|Induction|M3 Marrow at Day29|0|||
16379088|NCT02883049|39874670|FG009|Induction|M3 Marrow at Day29|0|||
16379089|NCT02883049|39874671|FG010|Induction|M3 Marrow at Day29|0|||
16379090|NCT02883049|39874672|FG011|Induction|M3 Marrow at Day29|0|||
16379091|NCT02883049|39874673|FG012|Induction|M3 Marrow at Day29|0|||
16379092|NCT02883049|39874674|FG013|Induction|M3 Marrow at Day29|0|||
16379093|NCT02883049|39874675|FG014|Induction|M3 Marrow at Day29|0|||
16379094|NCT02883049|39874676|FG015|Induction|M3 Marrow at Day29|0|||
16182911|NCT02413255|39148936|FG010|Overall Study|Voluntary Withdrawal|0|||
16182912|NCT02413255|39148937|FG011|Overall Study|Voluntary Withdrawal|0|||
16182913|NCT02413255|39148938|FG012|Overall Study|Voluntary Withdrawal|0|||
16182914|NCT02413255|39148939|FG013|Overall Study|Voluntary Withdrawal|0|||
16182915|NCT02413255|39148940|FG014|Overall Study|Voluntary Withdrawal|1|||
16182916|NCT02413255|39148941|FG015|Overall Study|Voluntary Withdrawal|0|||
16182917|NCT02413255|39148942|FG016|Overall Study|Voluntary Withdrawal|0|||
16182918|NCT01849848|39148943|FG000|Overall Study|Physician Decision|1|||
16182919|NCT01849848|39148943|FG000|Overall Study|Progression of the primary disease|3|||
16182920|NCT03671369|39148944|FG000|Overall Study|Other|1|||
16182921|NCT03671369|39148944|FG000|Overall Study|Withdrawal by Subject|289|||
16182922|NCT03671369|39148944|FG000|Overall Study|Not willing to be vaccinated|1|||
16182923|NCT01541254|39148954|FG000|Overall Study|Withdrawal by Subject|1|||
16182924|NCT01541254|39148954|FG000|Overall Study|excluded - metal allergy|1|||
16182925|NCT01541254|39148954|FG000|Overall Study|enrolled after study closed|1|||
16182926|NCT01541254|39148954|FG000|Overall Study|GI bleed prior to procedure|1|||
16182927|NCT01541254|39148954|FG000|Overall Study|stent not required|1|||
16182928|NCT01541254|39148954|FG000|Overall Study|alternate stent used|1|||
16182929|NCT03000452|39148955|FG000|Treatment Period|Death|1|||
16182930|NCT03000452|39148955|FG000|Treatment Period|Progressive Disease (PD)|14|||
16182931|NCT03000452|39148955|FG000|Treatment Period|Physician Decision|1|||
16182932|NCT03000452|39148955|FG000|Treatment Period|Miscellaneous|2|||
16182933|NCT03000452|39148955|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
16182934|NCT03000452|39148955|FG000|Follow-Up Period|Death|3|||
16182935|NCT03000452|39148955|FG000|Follow-Up Period|Withdrawal by Subject|3|||
16182936|NCT03472534|39148956|FG000|Overall Study|Withdrawal by Subject|9|||
16182937|NCT03472534|39148956|FG000|Overall Study|Adverse Event|2|||
16182938|NCT01264965|39148957|FG000|Overall Study|Withdrawal by Subject|10|||
16182939|NCT04601272|39148958|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
16182940|NCT04601272|39148959|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
16182941|NCT04601272|39148960|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
16182942|NCT02031146|39148961|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
16182943|NCT02031146|39148962|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
16182944|NCT02031146|39148963|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
16182945|NCT02031146|39148964|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
16182946|NCT02031146|39148965|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
16182947|NCT02031146|39148966|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
16182948|NCT02031146|39148967|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
16182949|NCT02973815|39148970|FG000|Post Intervention|Death|1|||
16182950|NCT02973815|39148971|FG001|Post Intervention|Death|0|||
16182951|NCT02973815|39148970|FG000|Post Intervention|Lost to Follow-up|7|||
16182952|NCT02973815|39148971|FG001|Post Intervention|Lost to Follow-up|24|||
16182953|NCT02973815|39148970|FG000|Follow-up|Lost to Follow-up|2|||
16182954|NCT02973815|39148971|FG001|Follow-up|Lost to Follow-up|0|||
16182955|NCT02940886|39148976|FG000|Overall Study|Adverse Event|7|||
16182956|NCT02940886|39148977|FG001|Overall Study|Adverse Event|3|||
16182957|NCT02940886|39148976|FG000|Overall Study|Protocol Violation|0|||
16182958|NCT02940886|39148977|FG001|Overall Study|Protocol Violation|2|||
16182959|NCT02940886|39148976|FG000|Overall Study|Withdrawal by Subject|28|||
16182960|NCT02940886|39148977|FG001|Overall Study|Withdrawal by Subject|20|||
16379095|NCT02883049|39874661|FG000|Induction|Inevaluable|33|||
16379096|NCT02883049|39874662|FG001|Induction|Inevaluable|1|||
16379097|NCT02883049|39874663|FG002|Induction|Inevaluable|0|||
16379098|NCT02883049|39874664|FG003|Induction|Inevaluable|0|||
16182961|NCT02940886|39148976|FG000|Overall Study|Death|1|||
16182962|NCT02940886|39148977|FG001|Overall Study|Death|0|||
16182963|NCT02940886|39148976|FG000|Overall Study|Lack of Efficacy|1|||
16182964|NCT02940886|39148977|FG001|Overall Study|Lack of Efficacy|0|||
16182965|NCT02940886|39148976|FG000|Overall Study|Lost to Follow-up|49|||
16182966|NCT02940886|39148977|FG001|Overall Study|Lost to Follow-up|21|||
16182967|NCT02940886|39148976|FG000|Overall Study|Physician Decision|9|||
16182968|NCT02940886|39148977|FG001|Overall Study|Physician Decision|4|||
16379099|NCT02883049|39874665|FG004|Induction|Inevaluable|0|||
16379100|NCT02883049|39874666|FG005|Induction|Inevaluable|0|||
16379101|NCT02883049|39874667|FG006|Induction|Inevaluable|0|||
16379102|NCT02883049|39874668|FG007|Induction|Inevaluable|0|||
16379103|NCT02883049|39874669|FG008|Induction|Inevaluable|0|||
16379104|NCT02883049|39874670|FG009|Induction|Inevaluable|0|||
16182969|NCT02940886|39148976|FG000|Overall Study|Sponsor decision|0|||
16182970|NCT02940886|39148977|FG001|Overall Study|Sponsor decision|1|||
16182971|NCT02940886|39148976|FG000|Overall Study|No treatment|7|||
16182972|NCT02940886|39148977|FG001|Overall Study|No treatment|2|||
16182973|NCT02940886|39148976|FG000|Overall Study|Enrolment error|0|||
16182974|NCT02940886|39148977|FG001|Overall Study|Enrolment error|1|||
16182975|NCT04590937|39148979|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
16182976|NCT00370149|39148982|FG000|Overall Study|Physician Decision|16|||
16182977|NCT00370149|39148983|FG001|Overall Study|Physician Decision|16|||
16182978|NCT00370149|39148982|FG000|Overall Study|Protocol Violation|1|||
16182979|NCT00370149|39148983|FG001|Overall Study|Protocol Violation|0|||
16182980|NCT00370149|39148982|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
16182981|NCT00370149|39148983|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
16182982|NCT00370149|39148982|FG000|Overall Study|Pre-existing infection|0|||
16182983|NCT00370149|39148983|FG001|Overall Study|Pre-existing infection|1|||
16182984|NCT00370149|39148982|FG000|Overall Study|Antibiotic coated dressing placed|0|||
16182985|NCT00370149|39148983|FG001|Overall Study|Antibiotic coated dressing placed|1|||
16182986|NCT02746679|39148984|FG000|Overall Study|Lost to Follow-up|4|||
16182987|NCT02746679|39148985|FG001|Overall Study|Lost to Follow-up|6|||
16182988|NCT03705494|39148989|FG000|Overall Study|Lost to Follow-up|2|||
16182989|NCT03705494|39148990|FG001|Overall Study|Lost to Follow-up|1|||
16182990|NCT03705494|39148989|FG000|Overall Study|Withdrawal by Subject|5|||
16182991|NCT03705494|39148990|FG001|Overall Study|Withdrawal by Subject|2|||
16182992|NCT01422304|39148991|FG000|Overall Study|Adverse Event|0|||
16182993|NCT01422304|39148992|FG001|Overall Study|Adverse Event|1|||
16182994|NCT01422304|39148991|FG000|Overall Study|Lost to Follow-up|14|||
16182995|NCT01422304|39148992|FG001|Overall Study|Lost to Follow-up|20|||
16182996|NCT01422304|39148991|FG000|Overall Study|Never Entered Follow-up|2|||
16182997|NCT01422304|39148992|FG001|Overall Study|Never Entered Follow-up|1|||
16182998|NCT01422304|39148991|FG000|Overall Study|Protocol Violation|1|||
16182999|NCT01422304|39148992|FG001|Overall Study|Protocol Violation|0|||
16183000|NCT01422304|39148991|FG000|Overall Study|Withdrawal by Subject|4|||
16183001|NCT01422304|39148992|FG001|Overall Study|Withdrawal by Subject|2|||
16183002|NCT01422304|39148991|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
16183003|NCT01422304|39148992|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
16183004|NCT01422304|39148991|FG000|Overall Study|Not Treated|3|||
16183005|NCT01422304|39148992|FG001|Overall Study|Not Treated|11|||
16183006|NCT05091060|39148995|FG000|Overall Study|Lost to Follow-up|1|||
16183007|NCT01052012|39149006|FG000|Overall Study|Not treated|2|||
16183008|NCT01052012|39149007|FG001|Overall Study|Not treated|5|||
16183009|NCT01052012|39149008|FG002|Overall Study|Not treated|0|||
16183010|NCT01052012|39149009|FG003|Overall Study|Not treated|0|||
16183011|NCT01052012|39149010|FG004|Overall Study|Not treated|11|||
16183012|NCT01052012|39149011|FG005|Overall Study|Not treated|8|||
16183013|NCT01052012|39149006|FG000|Overall Study|Adverse Event|1|||
16183014|NCT01052012|39149007|FG001|Overall Study|Adverse Event|0|||
16183015|NCT01052012|39149008|FG002|Overall Study|Adverse Event|0|||
16183016|NCT01052012|39149009|FG003|Overall Study|Adverse Event|1|||
16183017|NCT01052012|39149010|FG004|Overall Study|Adverse Event|0|||
16183018|NCT01052012|39149011|FG005|Overall Study|Adverse Event|0|||
16183019|NCT01052012|39149006|FG000|Overall Study|Lost to Follow-up|0|||
16183020|NCT01052012|39149007|FG001|Overall Study|Lost to Follow-up|0|||
16183021|NCT01052012|39149008|FG002|Overall Study|Lost to Follow-up|0|||
16183022|NCT01052012|39149009|FG003|Overall Study|Lost to Follow-up|0|||
16183023|NCT01052012|39149010|FG004|Overall Study|Lost to Follow-up|1|||
16183024|NCT01052012|39149011|FG005|Overall Study|Lost to Follow-up|0|||
16183025|NCT01052012|39149006|FG000|Overall Study|Withdrawal by Subject|1|||
16379105|NCT02883049|39874671|FG010|Induction|Inevaluable|0|||
16183026|NCT01052012|39149007|FG001|Overall Study|Withdrawal by Subject|1|||
16183027|NCT01052012|39149008|FG002|Overall Study|Withdrawal by Subject|0|||
16183028|NCT01052012|39149009|FG003|Overall Study|Withdrawal by Subject|0|||
16183029|NCT01052012|39149010|FG004|Overall Study|Withdrawal by Subject|3|||
16183030|NCT01052012|39149011|FG005|Overall Study|Withdrawal by Subject|1|||
16183031|NCT01052012|39149006|FG000|Overall Study|Physician Decision|0|||
16183032|NCT01052012|39149007|FG001|Overall Study|Physician Decision|0|||
16183033|NCT01052012|39149008|FG002|Overall Study|Physician Decision|0|||
16183034|NCT01052012|39149009|FG003|Overall Study|Physician Decision|0|||
16183035|NCT01052012|39149010|FG004|Overall Study|Physician Decision|0|||
16183036|NCT01052012|39149011|FG005|Overall Study|Physician Decision|1|||
16183037|NCT01052012|39149006|FG000|Overall Study|Other|0|||
16183038|NCT01052012|39149007|FG001|Overall Study|Other|0|||
16183039|NCT01052012|39149008|FG002|Overall Study|Other|0|||
16183040|NCT01052012|39149009|FG003|Overall Study|Other|0|||
16183041|NCT01052012|39149010|FG004|Overall Study|Other|1|||
16183042|NCT01052012|39149011|FG005|Overall Study|Other|0|||
16183043|NCT00487279|39149012|FG000|Overall Study|Death|1|||
16183044|NCT00487279|39149013|FG001|Overall Study|Death|0|||
16183045|NCT00487279|39149012|FG000|Overall Study|Withdrawal by Subject|0|||
16183046|NCT00487279|39149013|FG001|Overall Study|Withdrawal by Subject|2|||
16183047|NCT01937130|39149014|FG000|Overall Study|Withdrawal by Subject|0|||
16183048|NCT01937130|39149015|FG001|Overall Study|Withdrawal by Subject|0|||
16183049|NCT01937130|39149016|FG002|Overall Study|Withdrawal by Subject|0|||
16183050|NCT01937130|39149017|FG003|Overall Study|Withdrawal by Subject|1|||
16183051|NCT01937130|39149014|FG000|Overall Study|Adverse Event|0|||
16183052|NCT01937130|39149015|FG001|Overall Study|Adverse Event|1|||
16183053|NCT01937130|39149016|FG002|Overall Study|Adverse Event|0|||
16183054|NCT01937130|39149017|FG003|Overall Study|Adverse Event|1|||
16183055|NCT01937130|39149014|FG000|Overall Study|Death|1|||
16183056|NCT01937130|39149015|FG001|Overall Study|Death|1|||
16183057|NCT01937130|39149016|FG002|Overall Study|Death|1|||
16183058|NCT01937130|39149017|FG003|Overall Study|Death|0|||
16183059|NCT01937130|39149014|FG000|Overall Study|Lost to Follow-up|2|||
16183060|NCT01937130|39149015|FG001|Overall Study|Lost to Follow-up|0|||
16183061|NCT01937130|39149016|FG002|Overall Study|Lost to Follow-up|2|||
16183062|NCT01937130|39149017|FG003|Overall Study|Lost to Follow-up|0|||
16183063|NCT01937130|39149014|FG000|Overall Study|Physician Decision|0|||
16183064|NCT01937130|39149015|FG001|Overall Study|Physician Decision|1|||
16183065|NCT01937130|39149016|FG002|Overall Study|Physician Decision|0|||
16183066|NCT01937130|39149017|FG003|Overall Study|Physician Decision|0|||
16183067|NCT01937130|39149014|FG000|Overall Study|Patients unable to swallow|0|||
16183068|NCT01937130|39149015|FG001|Overall Study|Patients unable to swallow|1|||
16183069|NCT01937130|39149016|FG002|Overall Study|Patients unable to swallow|0|||
16183070|NCT01937130|39149017|FG003|Overall Study|Patients unable to swallow|0|||
16080202|NCT01307267|38786793|FG012|Overall Study|Death|0|||
16183071|NCT01937130|39149014|FG000|Overall Study|Patient lost to FU due to death|2|||
16183072|NCT01937130|39149015|FG001|Overall Study|Patient lost to FU due to death|0|||
16183073|NCT01937130|39149016|FG002|Overall Study|Patient lost to FU due to death|0|||
16183074|NCT01937130|39149017|FG003|Overall Study|Patient lost to FU due to death|0|||
16183075|NCT02239094|39149020|FG000|Overall Study|Withdrawal by Subject|1|||
16183076|NCT02239094|39149020|FG000|Overall Study|Remitted before started|1|||
16183077|NCT00081289|39149021|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
16183078|NCT00081289|39149022|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
16183079|NCT00081289|39149021|FG000|Overall Study|Ineligible / no protocol treatment|3|||
16183080|NCT00081289|39149022|FG001|Overall Study|Ineligible / no protocol treatment|4|||
16183081|NCT02559505|39149023|FG000|Overall Study|Lost to Follow-up|23|||
16183082|NCT02559505|39149024|FG001|Overall Study|Lost to Follow-up|20|||
16183083|NCT02559505|39149023|FG000|Overall Study|Withdrawal by Subject|4|||
16183084|NCT02559505|39149024|FG001|Overall Study|Withdrawal by Subject|2|||
16183085|NCT01161524|39149025|FG000|Core Study (23 Weeks)|Adverse Event|3|||
16183086|NCT01161524|39149026|FG001|Core Study (23 Weeks)|Adverse Event|0|||
16183087|NCT01161524|39149027|FG002|Core Study (23 Weeks)|Adverse Event|0|||
16183088|NCT01161524|39149025|FG000|Core Study (23 Weeks)|Other|1|||
16183089|NCT01161524|39149026|FG001|Core Study (23 Weeks)|Other|0|||
16183090|NCT01161524|39149027|FG002|Core Study (23 Weeks)|Other|0|||
16183091|NCT01161524|39149025|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
16183092|NCT01161524|39149026|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
16183093|NCT01161524|39149027|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
16183094|NCT01161524|39149025|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
16183095|NCT01161524|39149026|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
16183096|NCT01161524|39149027|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
16183097|NCT01161524|39149025|FG000|Core Study (23 Weeks)|Subject Choice|3|||
16183098|NCT01161524|39149026|FG001|Core Study (23 Weeks)|Subject Choice|2|||
16183099|NCT01161524|39149027|FG002|Core Study (23 Weeks)|Subject Choice|0|||
16183100|NCT01161524|39149025|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
16183101|NCT01161524|39149026|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
16183102|NCT01161524|39149027|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
16183103|NCT01161524|39149025|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
16183104|NCT01161524|39149026|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
16183105|NCT01161524|39149027|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
16183106|NCT01161524|39149025|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
16183107|NCT01161524|39149026|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
16183108|NCT01161524|39149027|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
16183109|NCT01161524|39149025|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
16183110|NCT01161524|39149026|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
16183111|NCT01161524|39149027|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
16183112|NCT01161524|39149025|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
16183113|NCT01161524|39149026|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
16183114|NCT01161524|39149027|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
16183115|NCT01963117|39149028|FG000|Overall Study|Death|1|||
16183116|NCT02873715|39149029|FG000|Overall Study|Lost to Follow-up|84|||
16183117|NCT02873715|39149030|FG001|Overall Study|Lost to Follow-up|94|||
16183118|NCT02873715|39149029|FG000|Overall Study|Withdrawal by Subject|7|||
16183119|NCT02873715|39149030|FG001|Overall Study|Withdrawal by Subject|26|||
16183120|NCT00418886|39149031|FG000|Overall Study|discontinue treatment survival follow up|90|||
16183121|NCT00418886|39149032|FG001|Overall Study|discontinue treatment survival follow up|91|||
16183122|NCT00418886|39149031|FG000|Overall Study|Death|122|||
16183123|NCT00418886|39149032|FG001|Overall Study|Death|147|||
16183124|NCT00418886|39149031|FG000|Overall Study|Withdrawal by Subject|9|||
16183125|NCT00418886|39149032|FG001|Overall Study|Withdrawal by Subject|10|||
16183126|NCT00418886|39149031|FG000|Overall Study|Lost to Follow-up|4|||
16183127|NCT00418886|39149032|FG001|Overall Study|Lost to Follow-up|6|||
16183128|NCT00418886|39149031|FG000|Overall Study|withdrawn due to other reason|1|||
16183129|NCT00418886|39149032|FG001|Overall Study|withdrawn due to other reason|0|||
16183130|NCT00418886|39149031|FG000|Overall Study|randomised but no treatment received|0|||
16183131|NCT00418886|39149032|FG001|Overall Study|randomised but no treatment received|1|||
16183132|NCT02698423|39149033|FG000|Overall Study|Lost to Follow-up|19|||
16183133|NCT02698423|39149034|FG001|Overall Study|Lost to Follow-up|24|||
16183134|NCT01183858|39149035|FG000|Overall Study|Death not related to Progressive Disease|5|||
16183135|NCT01183858|39149036|FG001|Overall Study|Death not related to Progressive Disease|6|||
16183136|NCT01183858|39149035|FG000|Overall Study|Adverse Event|14|||
16183137|NCT01183858|39149036|FG001|Overall Study|Adverse Event|11|||
16183138|NCT01183858|39149035|FG000|Overall Study|Investigator's Decision|0|||
16183139|NCT01183858|39149036|FG001|Overall Study|Investigator's Decision|3|||
16183140|NCT01183858|39149035|FG000|Overall Study|Insufficient Therapeutic Response|2|||
16183141|NCT01183858|39149036|FG001|Overall Study|Insufficient Therapeutic Response|0|||
16183142|NCT01183858|39149035|FG000|Overall Study|Refused Treatment|1|||
16183143|NCT01183858|39149036|FG001|Overall Study|Refused Treatment|4|||
16478919|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Death|0|||
16478920|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Death|0|||
16478921|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Death|0|||
16478922|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Death|1|||
16478923|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478924|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478925|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478926|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478927|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16183144|NCT01183858|39149035|FG000|Overall Study|Withdrew Consent|4|||
16183145|NCT01183858|39149036|FG001|Overall Study|Withdrew Consent|4|||
16183146|NCT01183858|39149035|FG000|Overall Study|Discontinued Smoking|3|||
16183147|NCT01183858|39149036|FG001|Overall Study|Discontinued Smoking|1|||
16183148|NCT01183858|39149035|FG000|Overall Study|Protocol Violation|1|||
16183149|NCT01183858|39149036|FG001|Overall Study|Protocol Violation|0|||
16183150|NCT01183858|39149035|FG000|Overall Study|Administrative/Other|6|||
16183151|NCT01183858|39149036|FG001|Overall Study|Administrative/Other|6|||
16183152|NCT01183858|39149035|FG000|Overall Study|Progressive Disease|112|||
16183153|NCT01183858|39149036|FG001|Overall Study|Progressive Disease|115|||
16183154|NCT01183858|39149035|FG000|Overall Study|Death related to Progressive Disease|4|||
16183155|NCT01183858|39149036|FG001|Overall Study|Death related to Progressive Disease|5|||
16183156|NCT01183858|39149035|FG000|Overall Study|Lost to Follow-up|1|||
16183157|NCT01183858|39149036|FG001|Overall Study|Lost to Follow-up|1|||
16183158|NCT01478347|39149037|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
16183159|NCT01478347|39149037|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
16183160|NCT01478347|39149037|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
16183161|NCT00790296|39149038|FG000|Overall Study|Did not meet study eligibility criteria|1|||
16183162|NCT00790296|39149039|FG001|Overall Study|Did not meet study eligibility criteria|1|||
16183163|NCT00790296|39149038|FG000|Overall Study|Adverse Event|0|||
16183164|NCT00790296|39149039|FG001|Overall Study|Adverse Event|1|||
16183165|NCT01100307|39149042|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
16183166|NCT01100307|39149043|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
16183167|NCT01100307|39149042|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
16183168|NCT01100307|39149043|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
16183169|NCT01100307|39149042|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
16183170|NCT01100307|39149043|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
16183171|NCT01100307|39149042|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
16183172|NCT01100307|39149043|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
16183173|NCT01100307|39149042|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
16183174|NCT01100307|39149043|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
16183175|NCT01100307|39149042|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
16183176|NCT01100307|39149043|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
16183177|NCT00196937|39149047|FG000|Overall Study|Serious Adverse Event|1|||
16183178|NCT00196937|39149048|FG001|Overall Study|Serious Adverse Event|0|||
16183179|NCT00196937|39149049|FG002|Overall Study|Serious Adverse Event|0|||
16183180|NCT00196937|39149047|FG000|Overall Study|Non-serious adverse event|1|||
16183181|NCT00196937|39149048|FG001|Overall Study|Non-serious adverse event|1|||
16183182|NCT00196937|39149049|FG002|Overall Study|Non-serious adverse event|1|||
16183183|NCT00196937|39149047|FG000|Overall Study|Withdrawal by Subject|0|||
16183184|NCT00196937|39149048|FG001|Overall Study|Withdrawal by Subject|0|||
16183185|NCT00196937|39149049|FG002|Overall Study|Withdrawal by Subject|2|||
16183186|NCT00196937|39149047|FG000|Overall Study|Lost to Follow-up|4|||
16183187|NCT00196937|39149048|FG001|Overall Study|Lost to Follow-up|3|||
16183188|NCT00196937|39149049|FG002|Overall Study|Lost to Follow-up|3|||
16183189|NCT00196937|39149047|FG000|Overall Study|Other|3|||
16183190|NCT00196937|39149048|FG001|Overall Study|Other|1|||
16183191|NCT00196937|39149049|FG002|Overall Study|Other|1|||
16183192|NCT05165394|39149051|FG000|Overall Study|Withdrawal by Subject|5|||
16183193|NCT05165394|39149052|FG001|Overall Study|Withdrawal by Subject|1|||
16183194|NCT05165394|39149051|FG000|Overall Study|Lost to Follow-up|1|||
16183195|NCT05165394|39149052|FG001|Overall Study|Lost to Follow-up|2|||
16183196|NCT05165394|39149051|FG000|Overall Study|Other Than Specified|0|||
16183197|NCT05165394|39149052|FG001|Overall Study|Other Than Specified|1|||
16183198|NCT02760407|39149060|FG000|Overall Study|Death|2|||
16183199|NCT02760407|39149061|FG001|Overall Study|Death|3|||
16183200|NCT02760407|39149062|FG002|Overall Study|Death|1|||
16183201|NCT02760407|39149063|FG003|Overall Study|Death|1|||
16183202|NCT02760407|39149060|FG000|Overall Study|Lost to Follow-up|1|||
16183203|NCT02760407|39149061|FG001|Overall Study|Lost to Follow-up|7|||
16183204|NCT02760407|39149062|FG002|Overall Study|Lost to Follow-up|4|||
16183205|NCT02760407|39149063|FG003|Overall Study|Lost to Follow-up|6|||
16183206|NCT02760407|39149060|FG000|Overall Study|Withdrawal by Subject|25|||
16183207|NCT02760407|39149061|FG001|Overall Study|Withdrawal by Subject|31|||
16183208|NCT02760407|39149062|FG002|Overall Study|Withdrawal by Subject|37|||
16183209|NCT02760407|39149063|FG003|Overall Study|Withdrawal by Subject|25|||
16183210|NCT02760407|39149060|FG000|Overall Study|Violation of Eligibility criteria|0|||
16183211|NCT02760407|39149061|FG001|Overall Study|Violation of Eligibility criteria|0|||
16183212|NCT02760407|39149062|FG002|Overall Study|Violation of Eligibility criteria|1|||
16183213|NCT02760407|39149063|FG003|Overall Study|Violation of Eligibility criteria|1|||
16183214|NCT02760407|39149060|FG000|Overall Study|Personal reasons|0|||
16183215|NCT02760407|39149061|FG001|Overall Study|Personal reasons|0|||
16183216|NCT02760407|39149062|FG002|Overall Study|Personal reasons|0|||
16183217|NCT02760407|39149063|FG003|Overall Study|Personal reasons|1|||
16183218|NCT02760407|39149060|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
16183219|NCT02760407|39149061|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
16183220|NCT02760407|39149062|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
16183221|NCT02760407|39149063|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
16183222|NCT02760407|39149060|FG000|Overall Study|Use of prohibited Medication|0|||
16183223|NCT02760407|39149061|FG001|Overall Study|Use of prohibited Medication|0|||
16183224|NCT02760407|39149062|FG002|Overall Study|Use of prohibited Medication|1|||
16183225|NCT02760407|39149063|FG003|Overall Study|Use of prohibited Medication|0|||
16183226|NCT02760407|39149060|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
16183227|NCT02760407|39149061|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
16183228|NCT02760407|39149062|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
16183229|NCT02760407|39149063|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
16183230|NCT02760407|39149060|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
16183231|NCT02760407|39149061|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
16183232|NCT02760407|39149062|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
16183233|NCT02760407|39149063|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
16183234|NCT02760407|39149060|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
16183235|NCT02760407|39149061|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
16183236|NCT02760407|39149062|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
16478928|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16183237|NCT02760407|39149063|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
16183238|NCT02760407|39149060|FG000|Overall Study|Inadequately Enrolled|0|||
16183239|NCT02760407|39149061|FG001|Overall Study|Inadequately Enrolled|0|||
16183240|NCT02760407|39149062|FG002|Overall Study|Inadequately Enrolled|0|||
16183241|NCT02760407|39149063|FG003|Overall Study|Inadequately Enrolled|1|||
16183242|NCT02760407|39149060|FG000|Overall Study|Withdrawal By PI's Decision|0|||
16183243|NCT02760407|39149061|FG001|Overall Study|Withdrawal By PI's Decision|1|||
16183244|NCT02760407|39149062|FG002|Overall Study|Withdrawal By PI's Decision|0|||
16183245|NCT02760407|39149063|FG003|Overall Study|Withdrawal By PI's Decision|0|||
16183246|NCT02760407|39149060|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
16183247|NCT02760407|39149061|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
16183248|NCT02760407|39149062|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
16478929|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16183249|NCT02760407|39149063|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
16183250|NCT02760407|39149060|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
16183251|NCT02760407|39149061|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
16183252|NCT02760407|39149062|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
16183253|NCT02760407|39149063|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
16183254|NCT02760407|39149060|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
16183255|NCT02760407|39149061|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
16183256|NCT02760407|39149062|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
16478930|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478931|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478932|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478933|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478934|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478935|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478936|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
16478937|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
16478938|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478939|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478940|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478941|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478942|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478943|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478944|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16183257|NCT02760407|39149063|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
16183258|NCT02760407|39149060|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
16183259|NCT02760407|39149061|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
16183260|NCT02760407|39149062|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
16183261|NCT02760407|39149063|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
16183262|NCT02760407|39149060|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
16183263|NCT02760407|39149061|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
16183264|NCT02760407|39149062|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
16183265|NCT02760407|39149063|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
16183266|NCT02760407|39149060|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
16183267|NCT02760407|39149061|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
16183268|NCT02760407|39149062|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
16183269|NCT02760407|39149063|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
16183270|NCT02760407|39149060|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
16183271|NCT02760407|39149061|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
16183272|NCT02760407|39149062|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
16183273|NCT02760407|39149063|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
16183274|NCT02760407|39149060|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
16183275|NCT02760407|39149061|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
16183276|NCT02760407|39149062|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
16183277|NCT02760407|39149063|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
16183278|NCT02760407|39149060|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
16183279|NCT02760407|39149061|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
16183280|NCT02760407|39149062|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
16183281|NCT02760407|39149063|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
16183282|NCT00265941|39149068|FG000|Overall Study|Protocol Violation|22|||
16183283|NCT00265941|39149069|FG001|Overall Study|Protocol Violation|25|||
16183284|NCT00265941|39149068|FG000|Overall Study|Lost to Follow-up|1|||
16183285|NCT00265941|39149069|FG001|Overall Study|Lost to Follow-up|1|||
16183286|NCT01749735|39149070|FG000|Overall Study|Withdrawal by Subject|1|||
16183287|NCT01749735|39149071|FG001|Overall Study|Withdrawal by Subject|0|||
16183288|NCT02927171|39149077|FG000|Overall Study|Lost to Follow-up|0|||
16183289|NCT02927171|39149078|FG001|Overall Study|Lost to Follow-up|1|||
16183290|NCT02341014|39149079|FG000|Overall Study|Adverse Event|0|||
16183291|NCT02341014|39149080|FG001|Overall Study|Adverse Event|1|||
16183292|NCT02341014|39149081|FG002|Overall Study|Adverse Event|0|||
16183293|NCT02341014|39149082|FG003|Overall Study|Adverse Event|0|||
16183294|NCT02341014|39149083|FG004|Overall Study|Adverse Event|2|||
16183295|NCT00829166|39149086|FG000|Overall Study|Death|305|||
16183296|NCT00829166|39149087|FG001|Overall Study|Death|333|||
16183297|NCT00829166|39149086|FG000|Overall Study|Lost to Follow-up|5|||
16183298|NCT00829166|39149087|FG001|Overall Study|Lost to Follow-up|4|||
16183299|NCT00829166|39149086|FG000|Overall Study|Physician's Decision|4|||
16183300|NCT00829166|39149087|FG001|Overall Study|Physician's Decision|3|||
16183301|NCT00829166|39149086|FG000|Overall Study|Subject's Decision|41|||
16183302|NCT00829166|39149087|FG001|Overall Study|Subject's Decision|55|||
16183303|NCT00829166|39149086|FG000|Overall Study|Sponsor's Decision|137|||
16183304|NCT00829166|39149087|FG001|Overall Study|Sponsor's Decision|98|||
16183305|NCT00829166|39149086|FG000|Overall Study|Reason Not Specified|3|||
16183306|NCT00829166|39149087|FG001|Overall Study|Reason Not Specified|3|||
16183307|NCT01634243|39149091|FG000|Overall Study|Adverse Event|5|||
16183308|NCT01634243|39149092|FG001|Overall Study|Adverse Event|5|||
16183309|NCT01634243|39149091|FG000|Overall Study|Lack of Efficacy|1|||
16183310|NCT01634243|39149092|FG001|Overall Study|Lack of Efficacy|0|||
16183311|NCT02342171|39149093|FG000|Overall Study|Death|4|||
16183312|NCT02342171|39149094|FG001|Overall Study|Death|87|||
16183313|NCT02342171|39149093|FG000|Overall Study|Received favipiravir|10|||
16183314|NCT02342171|39149094|FG001|Overall Study|Received favipiravir|0|||
16183315|NCT02342171|39149093|FG000|Overall Study|Missing cycle treshold value|1|||
16183316|NCT02342171|39149094|FG001|Overall Study|Missing cycle treshold value|0|||
16183317|NCT02342171|39149093|FG000|Overall Study|Unknown outcome|0|||
16183318|NCT02342171|39149094|FG001|Overall Study|Unknown outcome|1|||
16183319|NCT02342171|39149093|FG000|Overall Study|Missing age data|0|||
16183320|NCT02342171|39149094|FG001|Overall Study|Missing age data|1|||
16183321|NCT00751101|39149098|FG000|Overall Study|Withdrawal by Subject|1|||
16183322|NCT00751101|39149099|FG001|Overall Study|Withdrawal by Subject|0|||
16183323|NCT00751101|39149098|FG000|Overall Study|No HFS / Never Started Patch/|0|||
16183324|NCT00751101|39149099|FG001|Overall Study|No HFS / Never Started Patch/|4|||
16183325|NCT00751101|39149098|FG000|Overall Study|Never began capecitabine|1|||
16183326|NCT00751101|39149099|FG001|Overall Study|Never began capecitabine|0|||
16183327|NCT00751101|39149098|FG000|Overall Study|Physician Decision|0|||
16183328|NCT00751101|39149099|FG001|Overall Study|Physician Decision|1|||
16183329|NCT04436822|39149102|FG000|Overall Study|Physician Decision|2|||
16183330|NCT04436822|39149103|FG001|Overall Study|Physician Decision|0|||
16183331|NCT04436822|39149102|FG000|Overall Study|Sponsor request|1|||
16183332|NCT04436822|39149103|FG001|Overall Study|Sponsor request|0|||
16183333|NCT04436822|39149102|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16183334|NCT04436822|39149103|FG001|Overall Study|Withdrawal by parent/guardian|3|||
16183335|NCT04436822|39149102|FG000|Overall Study|Unsuccessful procedure|0|||
16183336|NCT04436822|39149103|FG001|Overall Study|Unsuccessful procedure|1|||
16183337|NCT04436822|39149102|FG000|Overall Study|Withdrawal due to Covid-19|8|||
16183338|NCT04436822|39149103|FG001|Overall Study|Withdrawal due to Covid-19|1|||
16183339|NCT04436822|39149102|FG000|Overall Study|Withdrawal by Subject|1|||
16183340|NCT04436822|39149103|FG001|Overall Study|Withdrawal by Subject|0|||
16183341|NCT04436822|39149102|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
16183342|NCT04436822|39149103|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
16183343|NCT00616239|39152127|FG000|Overall Study|Withdrawal by Subject|2|||
16183344|NCT03288779|39152133|FG000|Overall Study|Withdrawal by Subject|3|||
16183345|NCT00878072|39152135|FG000|Overall Study|Withdrew consent|2|||
16183346|NCT00077623|39152138|FG000|Overall Study|Adverse Event|1|||
16183347|NCT00077623|39152139|FG001|Overall Study|Adverse Event|0|||
16183348|NCT00077623|39152140|FG002|Overall Study|Adverse Event|1|||
16183349|NCT00077623|39152138|FG000|Overall Study|Withdrawal by Subject|2|||
16183350|NCT00077623|39152139|FG001|Overall Study|Withdrawal by Subject|10|||
16183351|NCT00077623|39152140|FG002|Overall Study|Withdrawal by Subject|1|||
16183352|NCT00077623|39152138|FG000|Overall Study|Other-Non safety reason|18|||
16183353|NCT00077623|39152139|FG001|Overall Study|Other-Non safety reason|15|||
16183354|NCT00077623|39152140|FG002|Overall Study|Other-Non safety reason|19|||
16183355|NCT00077623|39152138|FG000|Overall Study|Insufficient therapeutic response|2|||
16183356|NCT00077623|39152139|FG001|Overall Study|Insufficient therapeutic response|0|||
16183357|NCT00077623|39152140|FG002|Overall Study|Insufficient therapeutic response|0|||
16478945|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16183358|NCT00077623|39152138|FG000|Overall Study|Death|12|||
16183359|NCT00077623|39152139|FG001|Overall Study|Death|18|||
16183360|NCT00077623|39152140|FG002|Overall Study|Death|11|||
16183361|NCT00077623|39152138|FG000|Overall Study|Failure to return|1|||
16183362|NCT00077623|39152139|FG001|Overall Study|Failure to return|0|||
16183363|NCT00077623|39152140|FG002|Overall Study|Failure to return|0|||
16183364|NCT02717546|39152151|FG000|Overall Study|Lost to Follow-up|12|||
16183365|NCT00436215|39152158|FG000|Overall Study|Refused further treatment|3|||
16183366|NCT00436215|39152158|FG000|Overall Study|Small bowel obstruction|1|||
16183367|NCT01558089|39152161|FG000|Overall Study|Adverse Event|1|||
16183368|NCT01558089|39152161|FG000|Overall Study|Lack of Efficacy|1|||
16183369|NCT01558089|39152161|FG000|Overall Study|Lost to Follow-up|5|||
16183370|NCT01558089|39152161|FG000|Overall Study|Withdrawal by Subject|6|||
16183371|NCT03196297|39152162|FG000|Main Period|Withdrawal by Subject|4|||
16183372|NCT03196297|39152162|FG000|Extension Period|Withdrawal by Subject|1|||
16183373|NCT03196297|39152162|FG000|Extension Period|Lack of Efficacy|2|||
16183374|NCT00443430|39152166|FG000|Overall Study|Lack of Efficacy|3|||
16183375|NCT00443430|39152167|FG001|Overall Study|Lack of Efficacy|3|||
16183376|NCT00443430|39152166|FG000|Overall Study|Adverse Event|1|||
16183377|NCT00443430|39152167|FG001|Overall Study|Adverse Event|1|||
16183378|NCT00273858|39152168|FG000|Overall Study|Not completed 24 month observation time|334|||
16183379|NCT00273858|39152168|FG000|Overall Study|Lost to Follow-up|101|||
16183380|NCT00273858|39152168|FG000|Overall Study|Withdrawal by Subject|21|||
16183381|NCT00273858|39152168|FG000|Overall Study|Adverse Event|81|||
16183382|NCT00931892|39152169|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
16183383|NCT00931892|39152170|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
16183384|NCT01334125|39152171|FG000|Overall Study|Lost to Follow-up|3|||
16183385|NCT01334125|39152172|FG001|Overall Study|Lost to Follow-up|3|||
16183386|NCT01933672|39152179|FG000|Metformin Run-in Period|Adverse Event|1|||
16183387|NCT01933672|39152180|FG001|Metformin Run-in Period|Adverse Event|0|||
16183388|NCT01933672|39152181|FG002|Metformin Run-in Period|Adverse Event|0|||
16183389|NCT01933672|39152182|FG003|Metformin Run-in Period|Adverse Event|0|||
16183390|NCT01933672|39152183|FG004|Metformin Run-in Period|Adverse Event|0|||
16183391|NCT01933672|39152184|FG005|Metformin Run-in Period|Adverse Event|0|||
16183392|NCT01933672|39152185|FG006|Metformin Run-in Period|Adverse Event|0|||
16183393|NCT01933672|39152179|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
16183394|NCT01933672|39152180|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16183395|NCT01933672|39152181|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16183396|NCT01933672|39152182|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16183397|NCT01933672|39152183|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16183398|NCT01933672|39152184|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16183399|NCT01933672|39152185|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
16183400|NCT01933672|39152179|FG000|Metformin Run-in Period|Other|5|||
16183401|NCT01933672|39152180|FG001|Metformin Run-in Period|Other|0|||
16183402|NCT01933672|39152181|FG002|Metformin Run-in Period|Other|0|||
16183403|NCT01933672|39152182|FG003|Metformin Run-in Period|Other|0|||
16183404|NCT01933672|39152183|FG004|Metformin Run-in Period|Other|0|||
16183405|NCT01933672|39152184|FG005|Metformin Run-in Period|Other|0|||
16183406|NCT01933672|39152185|FG006|Metformin Run-in Period|Other|0|||
16183407|NCT01933672|39152179|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183408|NCT01933672|39152180|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183409|NCT01933672|39152181|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183410|NCT01933672|39152182|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183411|NCT01933672|39152183|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
16183412|NCT01933672|39152184|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183413|NCT01933672|39152185|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183414|NCT01933672|39152179|FG000|First Intervention Period (12-16 Days)|Other|0|||
16183415|NCT01933672|39152180|FG001|First Intervention Period (12-16 Days)|Other|0|||
16183416|NCT01933672|39152181|FG002|First Intervention Period (12-16 Days)|Other|1|||
16183417|NCT01933672|39152182|FG003|First Intervention Period (12-16 Days)|Other|0|||
16183418|NCT01933672|39152183|FG004|First Intervention Period (12-16 Days)|Other|0|||
16183419|NCT01933672|39152184|FG005|First Intervention Period (12-16 Days)|Other|1|||
16183420|NCT01933672|39152185|FG006|First Intervention Period (12-16 Days)|Other|0|||
16183421|NCT01933672|39152179|FG000|Second Intervention Period (12-16 Days)|Other|0|||
16183422|NCT01933672|39152180|FG001|Second Intervention Period (12-16 Days)|Other|1|||
16183423|NCT01933672|39152181|FG002|Second Intervention Period (12-16 Days)|Other|1|||
16183424|NCT01933672|39152182|FG003|Second Intervention Period (12-16 Days)|Other|0|||
16183425|NCT01933672|39152183|FG004|Second Intervention Period (12-16 Days)|Other|0|||
16183426|NCT01933672|39152184|FG005|Second Intervention Period (12-16 Days)|Other|0|||
16183427|NCT01933672|39152185|FG006|Second Intervention Period (12-16 Days)|Other|0|||
16183428|NCT01933672|39152179|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183429|NCT01933672|39152180|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183430|NCT01933672|39152181|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183431|NCT01933672|39152182|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
16183432|NCT01933672|39152183|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183433|NCT01933672|39152184|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183434|NCT01933672|39152185|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
16183435|NCT01933672|39152179|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16183436|NCT01933672|39152180|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
16183437|NCT01933672|39152181|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16183438|NCT01933672|39152182|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16183439|NCT01933672|39152183|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16183440|NCT01933672|39152184|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16183441|NCT01933672|39152185|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
16183442|NCT02209597|39152196|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
16183443|NCT02209597|39152196|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
16183444|NCT02209597|39152196|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
16183445|NCT02209597|39152196|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
16183446|NCT02089737|39152200|FG000|Overall Study|Survey form not completed|5|||
16183447|NCT02089737|39152200|FG000|Overall Study|Not treated|1|||
16183448|NCT00753922|39152202|FG000|Overall Study|Lost to Follow-up|155|||
16183449|NCT00753922|39152203|FG001|Overall Study|Lost to Follow-up|24|||
16183450|NCT00753922|39152204|FG002|Overall Study|Lost to Follow-up|28|||
16183451|NCT00753922|39152205|FG003|Overall Study|Lost to Follow-up|5|||
16183452|NCT00753922|39152202|FG000|Overall Study|Withdrawal by Subject|9|||
16183453|NCT00753922|39152203|FG001|Overall Study|Withdrawal by Subject|11|||
16183454|NCT00753922|39152204|FG002|Overall Study|Withdrawal by Subject|4|||
16183455|NCT00753922|39152205|FG003|Overall Study|Withdrawal by Subject|2|||
16183456|NCT00753922|39152202|FG000|Overall Study|Patient Non-compliance|55|||
16183457|NCT00753922|39152203|FG001|Overall Study|Patient Non-compliance|22|||
16183458|NCT00753922|39152204|FG002|Overall Study|Patient Non-compliance|14|||
16183459|NCT00753922|39152205|FG003|Overall Study|Patient Non-compliance|11|||
16183460|NCT00753922|39152202|FG000|Overall Study|Patients Not Completing Visit|11|||
16183461|NCT00753922|39152203|FG001|Overall Study|Patients Not Completing Visit|0|||
16478946|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478947|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478948|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478949|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478950|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
16478951|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
16478952|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
16478953|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478954|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478955|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478956|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478957|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478958|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478959|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478960|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478961|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478962|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
16183462|NCT00753922|39152204|FG002|Overall Study|Patients Not Completing Visit|1|||
16183463|NCT00753922|39152205|FG003|Overall Study|Patients Not Completing Visit|0|||
16183464|NCT00753922|39152202|FG000|Overall Study|Death|2|||
16183465|NCT00753922|39152203|FG001|Overall Study|Death|23|||
16183466|NCT00753922|39152204|FG002|Overall Study|Death|2|||
16183467|NCT00753922|39152205|FG003|Overall Study|Death|1|||
16183468|NCT00753922|39152202|FG000|Overall Study|Discontinuation Due to Explantation|14|||
16183469|NCT00753922|39152203|FG001|Overall Study|Discontinuation Due to Explantation|14|||
16183470|NCT00753922|39152204|FG002|Overall Study|Discontinuation Due to Explantation|14|||
16183471|NCT00753922|39152205|FG003|Overall Study|Discontinuation Due to Explantation|4|||
16183472|NCT01594476|39152207|FG000|Overall Study|Protocol Violation|1|||
16183473|NCT01594476|39152208|FG001|Overall Study|Protocol Violation|3|||
16183474|NCT00719732|39152210|FG000|Overall Study|Lost to Follow-up|20|||
16183475|NCT00719732|39152210|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
16183476|NCT00719732|39152210|FG000|Overall Study|Illness not associated with device|1|||
16183477|NCT00719810|39152211|FG000|Overall Study|Adverse Event|0|||
16183478|NCT00719810|39152212|FG001|Overall Study|Adverse Event|2|||
16183479|NCT00719810|39152213|FG002|Overall Study|Adverse Event|3|||
16183480|NCT00719810|39152211|FG000|Overall Study|Lost to Follow-up|2|||
16183481|NCT00719810|39152212|FG001|Overall Study|Lost to Follow-up|0|||
16183482|NCT00719810|39152213|FG002|Overall Study|Lost to Follow-up|3|||
16183483|NCT00719810|39152211|FG000|Overall Study|Physician Decision|0|||
16183484|NCT00719810|39152212|FG001|Overall Study|Physician Decision|1|||
16183485|NCT00719810|39152213|FG002|Overall Study|Physician Decision|0|||
16183486|NCT00719810|39152211|FG000|Overall Study|Withdrawal by Subject|1|||
16183487|NCT00719810|39152212|FG001|Overall Study|Withdrawal by Subject|1|||
16183488|NCT00719810|39152213|FG002|Overall Study|Withdrawal by Subject|2|||
16183489|NCT02792777|39152214|FG000|Overall Study|Withdrawal by Subject|2|||
16183490|NCT02792777|39152215|FG001|Overall Study|Withdrawal by Subject|0|||
16183491|NCT02792777|39152214|FG000|Overall Study|Recording malfunction|2|||
16183492|NCT02792777|39152215|FG001|Overall Study|Recording malfunction|0|||
16183493|NCT02792777|39152214|FG000|Overall Study|Later determined to be ineligible|2|||
16183494|NCT02792777|39152215|FG001|Overall Study|Later determined to be ineligible|0|||
16183495|NCT02792777|39152214|FG000|Overall Study|Participant interviewed twice|1|||
16183496|NCT02792777|39152215|FG001|Overall Study|Participant interviewed twice|0|||
16183497|NCT03988751|39152220|FG000|Overall Study|Withdrawal by Subject|1|||
16183498|NCT03988751|39152221|FG001|Overall Study|Withdrawal by Subject|0|||
16183499|NCT03988751|39152220|FG000|Overall Study|Protocol Violation|0|||
16183500|NCT03988751|39152221|FG001|Overall Study|Protocol Violation|1|||
16183501|NCT02839746|39152224|FG000|Overall Study|Not met selection criteria|12|||
16183502|NCT03216265|39152225|FG000|Overall Study|Adverse Event|2|||
16183503|NCT03216265|39152226|FG001|Overall Study|Adverse Event|0|||
16183504|NCT03216265|39152227|FG002|Overall Study|Adverse Event|2|||
16183505|NCT03216265|39152225|FG000|Overall Study|Lost to Follow-up|0|||
16183506|NCT03216265|39152226|FG001|Overall Study|Lost to Follow-up|1|||
16183507|NCT03216265|39152227|FG002|Overall Study|Lost to Follow-up|0|||
16183508|NCT03216265|39152225|FG000|Overall Study|Withdrawal by Subject|0|||
16183509|NCT03216265|39152226|FG001|Overall Study|Withdrawal by Subject|0|||
16183510|NCT03216265|39152227|FG002|Overall Study|Withdrawal by Subject|1|||
16183511|NCT01095250|39152231|FG000|Overall Study|administrative reasons|8|||
16183512|NCT01095250|39152232|FG001|Overall Study|administrative reasons|10|||
16183513|NCT01095250|39152233|FG002|Overall Study|administrative reasons|7|||
16183514|NCT01095250|39152234|FG003|Overall Study|administrative reasons|5|||
16183515|NCT01095250|39152231|FG000|Overall Study|Withdrawal by Subject|0|||
16183516|NCT01095250|39152232|FG001|Overall Study|Withdrawal by Subject|0|||
16183517|NCT01095250|39152233|FG002|Overall Study|Withdrawal by Subject|1|||
16183518|NCT01095250|39152234|FG003|Overall Study|Withdrawal by Subject|0|||
16183519|NCT04952389|39152235|FG000|Overall Study|Withdrawal by Subject|8|||
16183520|NCT04952389|39152236|FG001|Overall Study|Withdrawal by Subject|4|||
16183521|NCT01158534|39152237|FG000|Overall Study|Withdrawal by Subject|1|||
16183522|NCT01158534|39152237|FG000|Overall Study|Death|1|||
16183523|NCT01158534|39152237|FG000|Overall Study|Other|1|||
16183524|NCT03408873|39152240|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
16183525|NCT03408873|39152240|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
16183526|NCT03408873|39152240|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
16183527|NCT03408873|39152240|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
16183528|NCT03408873|39152240|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
16183529|NCT03408873|39152240|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
16183530|NCT00778999|39152241|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
16183531|NCT00778999|39152242|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
16183532|NCT00778999|39152241|FG000|Overall Study|Did not receive recFSH|14|||
16183533|NCT00778999|39152242|FG001|Overall Study|Did not receive recFSH|20|||
16183534|NCT01469052|39152243|FG000|Overall Study|Adverse Event|2|||
16183535|NCT01469052|39152244|FG001|Overall Study|Adverse Event|3|||
16183536|NCT01469052|39152245|FG002|Overall Study|Adverse Event|0|||
16183537|NCT01469052|39152246|FG003|Overall Study|Adverse Event|2|||
16183538|NCT01469052|39152247|FG004|Overall Study|Adverse Event|0|||
16183539|NCT01469052|39152248|FG005|Overall Study|Adverse Event|1|||
16183540|NCT01469052|39152243|FG000|Overall Study|Progressive disease|3|||
16183541|NCT01469052|39152244|FG001|Overall Study|Progressive disease|0|||
16478963|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478964|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16183542|NCT01469052|39152245|FG002|Overall Study|Progressive disease|5|||
16183543|NCT01469052|39152246|FG003|Overall Study|Progressive disease|3|||
16183544|NCT01469052|39152247|FG004|Overall Study|Progressive disease|7|||
16183545|NCT01469052|39152248|FG005|Overall Study|Progressive disease|2|||
16183546|NCT01469052|39152243|FG000|Overall Study|Lack of Efficacy|0|||
16183547|NCT01469052|39152244|FG001|Overall Study|Lack of Efficacy|0|||
16183548|NCT01469052|39152245|FG002|Overall Study|Lack of Efficacy|0|||
16183549|NCT01469052|39152246|FG003|Overall Study|Lack of Efficacy|0|||
16183550|NCT01469052|39152247|FG004|Overall Study|Lack of Efficacy|0|||
16183551|NCT01469052|39152248|FG005|Overall Study|Lack of Efficacy|2|||
16183552|NCT01469052|39152243|FG000|Overall Study|Moved to rollover protocol|1|||
16183553|NCT01469052|39152244|FG001|Overall Study|Moved to rollover protocol|0|||
16183554|NCT01469052|39152245|FG002|Overall Study|Moved to rollover protocol|1|||
16183555|NCT01469052|39152246|FG003|Overall Study|Moved to rollover protocol|0|||
16183556|NCT01469052|39152247|FG004|Overall Study|Moved to rollover protocol|0|||
16183557|NCT01469052|39152248|FG005|Overall Study|Moved to rollover protocol|1|||
16183558|NCT01469052|39152243|FG000|Overall Study|Other|0|||
16183559|NCT01469052|39152244|FG001|Overall Study|Other|1|||
16183560|NCT01469052|39152245|FG002|Overall Study|Other|0|||
16183561|NCT01469052|39152246|FG003|Overall Study|Other|0|||
16183562|NCT01469052|39152247|FG004|Overall Study|Other|1|||
16183563|NCT01469052|39152248|FG005|Overall Study|Other|0|||
16183564|NCT02807454|39152249|FG000|Overall Study|Adverse Event|1|||
16183565|NCT02807454|39152250|FG001|Overall Study|Adverse Event|0|||
16183566|NCT02807454|39152249|FG000|Overall Study|Withdrawal by Subject|0|||
16183567|NCT02807454|39152250|FG001|Overall Study|Withdrawal by Subject|1|||
16183568|NCT02807454|39152249|FG000|Overall Study|Progressive Disease|30|||
16183569|NCT02807454|39152250|FG001|Overall Study|Progressive Disease|3|||
16183570|NCT02807454|39152249|FG000|Overall Study|Other Reasons|1|||
16183571|NCT02807454|39152250|FG001|Overall Study|Other Reasons|1|||
16183572|NCT05301322|39152251|FG000|Overall Study|Adverse Event|7|||
16183573|NCT05301322|39152252|FG001|Overall Study|Adverse Event|3|||
16183574|NCT05301322|39152251|FG000|Overall Study|Death|0|||
16183575|NCT05301322|39152252|FG001|Overall Study|Death|1|||
16183576|NCT05301322|39152251|FG000|Overall Study|Lost to Follow-up|2|||
16183577|NCT05301322|39152252|FG001|Overall Study|Lost to Follow-up|1|||
16183578|NCT05301322|39152251|FG000|Overall Study|Protocol Violation|3|||
16183579|NCT05301322|39152252|FG001|Overall Study|Protocol Violation|1|||
16183580|NCT05301322|39152251|FG000|Overall Study|Withdrawal by Subject|3|||
16183581|NCT05301322|39152252|FG001|Overall Study|Withdrawal by Subject|0|||
16183582|NCT05301322|39152251|FG000|Overall Study|Other|4|||
16183583|NCT05301322|39152252|FG001|Overall Study|Other|0|||
16183584|NCT04156646|39152253|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
16183585|NCT04156646|39152254|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
16183586|NCT01582282|39152255|FG000|Overall Study|Adverse Event|1|||
16183587|NCT01582282|39152256|FG001|Overall Study|Adverse Event|1|||
16183588|NCT01582282|39152257|FG002|Overall Study|Adverse Event|0|||
16183589|NCT01582282|39152255|FG000|Overall Study|Lost to Follow-up|1|||
16183590|NCT01582282|39152256|FG001|Overall Study|Lost to Follow-up|0|||
16183591|NCT01582282|39152257|FG002|Overall Study|Lost to Follow-up|0|||
16183592|NCT01582282|39152255|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
16183593|NCT01582282|39152256|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
16183594|NCT01582282|39152257|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
16183595|NCT03880227|39152258|FG000|First Visit|Withdrawal by Subject|1|||
16183596|NCT03880227|39152259|FG001|First Visit|Withdrawal by Subject|0|||
16183597|NCT03880227|39152260|FG002|First Visit|Withdrawal by Subject|0|||
16183598|NCT03880227|39152261|FG003|First Visit|Withdrawal by Subject|0|||
16183599|NCT03880227|39152258|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
16183600|NCT03880227|39152259|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
16183601|NCT03880227|39152260|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
16183602|NCT03880227|39152261|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
16183603|NCT03880227|39152258|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
16183604|NCT03880227|39152259|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
16183605|NCT03880227|39152260|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
16183606|NCT03880227|39152261|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
16183607|NCT03880227|39152258|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
16183608|NCT03880227|39152259|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
16183609|NCT03880227|39152260|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
16183610|NCT03880227|39152261|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
16183611|NCT01645280|39152262|FG000|Overall Study|Death|0|||
16183612|NCT01645280|39152263|FG001|Overall Study|Death|1|||
16183613|NCT01645280|39152264|FG002|Overall Study|Death|0|||
16183614|NCT01645280|39152265|FG003|Overall Study|Death|0|||
16183615|NCT01645280|39152266|FG004|Overall Study|Death|0|||
16183616|NCT01645280|39152262|FG000|Overall Study|Withdrawal by Subject|4|||
16183617|NCT01645280|39152263|FG001|Overall Study|Withdrawal by Subject|0|||
16183618|NCT01645280|39152264|FG002|Overall Study|Withdrawal by Subject|2|||
16183619|NCT01645280|39152265|FG003|Overall Study|Withdrawal by Subject|4|||
16183620|NCT01645280|39152266|FG004|Overall Study|Withdrawal by Subject|5|||
16183621|NCT01645280|39152262|FG000|Overall Study|Lost to Follow-up|0|||
16183622|NCT01645280|39152263|FG001|Overall Study|Lost to Follow-up|0|||
16183623|NCT01645280|39152264|FG002|Overall Study|Lost to Follow-up|0|||
16183624|NCT01645280|39152265|FG003|Overall Study|Lost to Follow-up|2|||
16183625|NCT01645280|39152266|FG004|Overall Study|Lost to Follow-up|1|||
16183626|NCT01645280|39152262|FG000|Overall Study|Other|1|||
16183627|NCT01645280|39152263|FG001|Overall Study|Other|1|||
16183628|NCT01645280|39152264|FG002|Overall Study|Other|2|||
16183629|NCT01645280|39152265|FG003|Overall Study|Other|0|||
16183630|NCT01645280|39152266|FG004|Overall Study|Other|0|||
16183631|NCT01645280|39152262|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
16183632|NCT01645280|39152263|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
16183633|NCT01645280|39152264|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
16183634|NCT01645280|39152265|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
16183635|NCT01645280|39152266|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
16183636|NCT01507545|39152267|FG000|Overall Study|Withdrawal by Subject|6|||
16183637|NCT01507545|39152268|FG001|Overall Study|Withdrawal by Subject|2|||
16183638|NCT01507545|39152267|FG000|Overall Study|Lost to Follow-up|1|||
16183639|NCT01507545|39152268|FG001|Overall Study|Lost to Follow-up|0|||
16183640|NCT01507545|39152267|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
16183641|NCT01507545|39152268|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
16183642|NCT01507545|39152267|FG000|Overall Study|Progressive disease|60|||
16183643|NCT01507545|39152268|FG001|Overall Study|Progressive disease|27|||
16183644|NCT01507545|39152267|FG000|Overall Study|Other|6|||
16183645|NCT01507545|39152268|FG001|Overall Study|Other|4|||
16183646|NCT01276847|39152272|FG000|Overall Study|Withdrawal by Subject|1|||
16183647|NCT01276847|39152273|FG001|Overall Study|Withdrawal by Subject|0|||
16183648|NCT01276847|39152274|FG002|Overall Study|Withdrawal by Subject|0|||
16183649|NCT02399475|39152277|FG000|Overall Study|Physician Decision|1|||
16183650|NCT02399475|39152278|FG001|Overall Study|Physician Decision|0|||
16183651|NCT03237845|39152282|FG000|Overall Study|Adverse Event|0|||
16183652|NCT03237845|39152283|FG001|Overall Study|Adverse Event|1|||
16183653|NCT03237845|39152282|FG000|Overall Study|Lost to Follow-up|13|||
16183654|NCT03237845|39152283|FG001|Overall Study|Lost to Follow-up|10|||
16183655|NCT03237845|39152282|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
16183656|NCT03237845|39152283|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
16183657|NCT03237845|39152282|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
16183658|NCT03237845|39152283|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
16183659|NCT03237845|39152282|FG000|Overall Study|Physician Decision|1|||
16183660|NCT03237845|39152283|FG001|Overall Study|Physician Decision|2|||
16183661|NCT03237845|39152282|FG000|Overall Study|Pregnancy|1|||
16183662|NCT03237845|39152283|FG001|Overall Study|Pregnancy|0|||
16183663|NCT03237845|39152282|FG000|Overall Study|Protocol Deviation|0|||
16183664|NCT03237845|39152283|FG001|Overall Study|Protocol Deviation|1|||
16183665|NCT03237845|39152282|FG000|Overall Study|Technical Problems|8|||
16183666|NCT03237845|39152283|FG001|Overall Study|Technical Problems|1|||
16183667|NCT03237845|39152282|FG000|Overall Study|Withdrawal by Subject|3|||
16183668|NCT03237845|39152283|FG001|Overall Study|Withdrawal by Subject|3|||
16183669|NCT03237845|39152282|FG000|Overall Study|Other Reasons|4|||
16183670|NCT03237845|39152283|FG001|Overall Study|Other Reasons|0|||
16183671|NCT01781026|39152284|FG000|Overall Study|Lack of Efficacy|2|||
16183672|NCT04070378|39152288|FG000|Overall Study|Withdrawal by Subject|2|||
16183673|NCT04070378|39152288|FG000|Overall Study|Screen Failure|6|||
16183674|NCT04070378|39152288|FG000|Overall Study|Physician Decision|1|||
16183675|NCT04070378|39152288|FG000|Overall Study|Adverse Event|1|||
16183676|NCT00474630|39152295|FG000|Overall Study|Adverse Event|98|||
16183677|NCT00474630|39152296|FG001|Overall Study|Adverse Event|26|||
16183678|NCT00474630|39152295|FG000|Overall Study|Lost to Follow-up|22|||
16183679|NCT00474630|39152296|FG001|Overall Study|Lost to Follow-up|15|||
16183680|NCT00474630|39152295|FG000|Overall Study|Withdrawal by Subject|21|||
16183681|NCT00474630|39152296|FG001|Overall Study|Withdrawal by Subject|15|||
16183682|NCT00474630|39152295|FG000|Overall Study|Protocol Violation|3|||
16183683|NCT00474630|39152296|FG001|Overall Study|Protocol Violation|4|||
16183684|NCT00474630|39152295|FG000|Overall Study|Lack of Efficacy|5|||
16183685|NCT00474630|39152296|FG001|Overall Study|Lack of Efficacy|6|||
16183686|NCT00474630|39152295|FG000|Overall Study|Drug noncompliance, other|11|||
16183687|NCT00474630|39152296|FG001|Overall Study|Drug noncompliance, other|4|||
16183688|NCT00863928|39152297|FG000|Overall Study|Protocol Violation|26|||
16183689|NCT00863928|39152298|FG001|Overall Study|Protocol Violation|0|||
16183690|NCT00863928|39152297|FG000|Overall Study|Withdrawal by Subject|3|||
16183691|NCT00863928|39152298|FG001|Overall Study|Withdrawal by Subject|0|||
16183692|NCT00863928|39152297|FG000|Overall Study|surgery cancellation|4|||
16183693|NCT00863928|39152298|FG001|Overall Study|surgery cancellation|0|||
16183694|NCT00863928|39152297|FG000|Overall Study|medication allergy|3|||
16183695|NCT00863928|39152298|FG001|Overall Study|medication allergy|0|||
16183696|NCT00390780|39152300|FG000|Overall Study|Not completed|10|||
16183697|NCT00390780|39152301|FG001|Overall Study|Not completed|4|||
16183698|NCT00390780|39152300|FG000|Overall Study|Protocol Violation|6|||
16183699|NCT00390780|39152301|FG001|Overall Study|Protocol Violation|4|||
16183700|NCT00390780|39152300|FG000|Overall Study|Lost to Follow-up|3|||
16183701|NCT00390780|39152301|FG001|Overall Study|Lost to Follow-up|6|||
16183702|NCT00390780|39152300|FG000|Overall Study|Adverse Event|2|||
16183703|NCT00390780|39152301|FG001|Overall Study|Adverse Event|3|||
16183704|NCT00390780|39152300|FG000|Overall Study|Death|1|||
16183705|NCT00390780|39152301|FG001|Overall Study|Death|3|||
16183706|NCT00390780|39152300|FG000|Overall Study|Withdrawal by Subject|1|||
16183707|NCT00390780|39152301|FG001|Overall Study|Withdrawal by Subject|2|||
16183708|NCT00390780|39152300|FG000|Overall Study|Inclusion criteria not satisfied|0|||
16183709|NCT00390780|39152301|FG001|Overall Study|Inclusion criteria not satisfied|2|||
16183710|NCT00390780|39152300|FG000|Overall Study|Lost to follow up and other reasons|0|||
16183711|NCT00390780|39152301|FG001|Overall Study|Lost to follow up and other reasons|1|||
16183712|NCT00390780|39152300|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
16183713|NCT00390780|39152301|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
16183714|NCT00390780|39152300|FG000|Overall Study|SAE, death|0|||
16183715|NCT00390780|39152301|FG001|Overall Study|SAE, death|1|||
16183716|NCT01671488|39152303|FG000|Overall Study|Withdrawal by Subject|1|||
16183717|NCT01096550|39152304|FG000|Overall Study|discontinued site|10|||
16478965|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
16478966|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
16478967|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
16478968|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16183718|NCT01096550|39152305|FG001|Overall Study|discontinued site|11|||
16183719|NCT01096550|39152304|FG000|Overall Study|non-regular treatment track at clinic|1|||
16183720|NCT01096550|39152305|FG001|Overall Study|non-regular treatment track at clinic|1|||
16183721|NCT01096550|39152304|FG000|Overall Study|clinic readmission|1|||
16183722|NCT01096550|39152305|FG001|Overall Study|clinic readmission|1|||
16183723|NCT01096550|39152304|FG000|Overall Study|Withdrawal by Subject|0|||
16183724|NCT01096550|39152305|FG001|Overall Study|Withdrawal by Subject|1|||
16183725|NCT01096550|39152304|FG000|Overall Study|non-African American participant|13|||
16183726|NCT01096550|39152305|FG001|Overall Study|non-African American participant|6|||
16183727|NCT01096550|39152304|FG000|Overall Study|Lost to Follow-up|12|||
16183728|NCT01096550|39152305|FG001|Overall Study|Lost to Follow-up|9|||
16183729|NCT02492711|39152310|FG000|Overall Study|Adverse Event|9|||
16183730|NCT02492711|39152311|FG001|Overall Study|Adverse Event|9|||
16183731|NCT02492711|39152312|FG002|Overall Study|Adverse Event|2|||
16183732|NCT02492711|39152310|FG000|Overall Study|Death|3|||
16183733|NCT02492711|39152311|FG001|Overall Study|Death|3|||
16183734|NCT02492711|39152312|FG002|Overall Study|Death|0|||
16183735|NCT02492711|39152310|FG000|Overall Study|Withdrawal by Subject|10|||
16183736|NCT02492711|39152311|FG001|Overall Study|Withdrawal by Subject|16|||
16183737|NCT02492711|39152312|FG002|Overall Study|Withdrawal by Subject|5|||
16183738|NCT02492711|39152310|FG000|Overall Study|Physician Decision|10|||
16183739|NCT02492711|39152311|FG001|Overall Study|Physician Decision|6|||
16183740|NCT02492711|39152312|FG002|Overall Study|Physician Decision|4|||
16183741|NCT02492711|39152310|FG000|Overall Study|Lost to Follow-up|0|||
16183742|NCT02492711|39152311|FG001|Overall Study|Lost to Follow-up|0|||
16183743|NCT02492711|39152312|FG002|Overall Study|Lost to Follow-up|1|||
16183744|NCT02492711|39152310|FG000|Overall Study|study treatment delay|2|||
16183745|NCT02492711|39152311|FG001|Overall Study|study treatment delay|1|||
16183746|NCT02492711|39152312|FG002|Overall Study|study treatment delay|0|||
16183747|NCT02492711|39152310|FG000|Overall Study|change in chemotherapy|0|||
16183748|NCT02492711|39152311|FG001|Overall Study|change in chemotherapy|1|||
16183749|NCT02492711|39152312|FG002|Overall Study|change in chemotherapy|0|||
16183750|NCT02492711|39152310|FG000|Overall Study|never treated|2|||
16183751|NCT02492711|39152311|FG001|Overall Study|never treated|4|||
16183752|NCT02492711|39152312|FG002|Overall Study|never treated|0|||
16183753|NCT02492711|39152310|FG000|Overall Study|Other|0|||
16183754|NCT02492711|39152311|FG001|Overall Study|Other|0|||
16183755|NCT02492711|39152312|FG002|Overall Study|Other|1|||
16183756|NCT01004146|39152316|FG000|Overall Study|Withdrawal by Subject|4|||
16183757|NCT01004146|39152317|FG001|Overall Study|Withdrawal by Subject|5|||
16183758|NCT01797432|39152323|FG000|Overall Study|Lost to Follow-up|1|||
16183759|NCT01797432|39152323|FG000|Overall Study|Adverse Event|1|||
16183760|NCT01797432|39152323|FG000|Overall Study|Withdrawal by Subject|1|||
16183761|NCT01797432|39152323|FG000|Overall Study|lived too far from study site|1|||
16183762|NCT02401256|39152324|FG000|Overall Study|Adverse Event|5|||
16183763|NCT02401256|39152324|FG000|Overall Study|Withdrawal by Subject|12|||
16183764|NCT00739297|39152333|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
16183765|NCT00739297|39152334|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
16183766|NCT00739297|39152335|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
16183767|NCT00739297|39152336|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
16183768|NCT00739297|39152337|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
16183769|NCT00739297|39152338|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
16183770|NCT00739297|39152339|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
16183771|NCT00739297|39152333|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
16183772|NCT00739297|39152334|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
16183773|NCT00739297|39152335|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
16183774|NCT00739297|39152336|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
16183775|NCT00739297|39152337|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
16183776|NCT00739297|39152338|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
16183777|NCT00739297|39152339|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
16183778|NCT00537745|39152341|FG000|Overall Study|Did not meet eligibility criteria|2|||
16183779|NCT00537745|39152341|FG000|Overall Study|Withdrawal by Subject|2|||
16183780|NCT00537745|39152341|FG000|Overall Study|Subject unable to provide Interlock info|1|||
16183781|NCT04407507|39152342|FG000|Overall Study|Withdrawal by Subject|0|||
16183782|NCT04407507|39152343|FG001|Overall Study|Withdrawal by Subject|1|||
16183783|NCT05372575|39152351|FG000|Overall Study|Protocol Violation|7|||
16183784|NCT05372575|39152352|FG001|Overall Study|Protocol Violation|16|||
16183785|NCT01013883|39152353|FG000|Overall Study|Lost to Follow-up|2|||
16183786|NCT01013883|39152354|FG001|Overall Study|Lost to Follow-up|2|||
16183787|NCT00377299|39152355|FG000|Overall Study|Lost to Follow-up|14|||
16183788|NCT00377299|39152356|FG001|Overall Study|Lost to Follow-up|19|||
16183789|NCT00377299|39152355|FG000|Overall Study|Adverse Event|0|||
16183790|NCT00377299|39152356|FG001|Overall Study|Adverse Event|1|||
16183791|NCT00377299|39152355|FG000|Overall Study|Withdrawal by Subject|5|||
16183792|NCT00377299|39152356|FG001|Overall Study|Withdrawal by Subject|4|||
16183793|NCT01650779|39152359|FG000|Overall Study|Withdrawal by Subject|1|||
16183794|NCT04498910|39152370|FG000|Overall Study|Lost to Follow-up|0|||
16183795|NCT04498910|39152371|FG001|Overall Study|Lost to Follow-up|1|||
16183796|NCT04498910|39152370|FG000|Overall Study|Withdrawal by Subject|2|||
16183797|NCT04498910|39152371|FG001|Overall Study|Withdrawal by Subject|1|||
16183798|NCT04498910|39152370|FG000|Overall Study|Adverse Event|1|||
16183799|NCT04498910|39152371|FG001|Overall Study|Adverse Event|0|||
16183800|NCT00001259|39152372|FG000|Study 2|Adverse Event|0|||
16183801|NCT00001259|39152373|FG001|Study 2|Adverse Event|0|||
16183802|NCT00001259|39152374|FG002|Study 2|Adverse Event|0|||
16183803|NCT00001259|39152375|FG003|Study 2|Adverse Event|0|||
16183804|NCT00001259|39152376|FG004|Study 2|Adverse Event|2|||
16183805|NCT00001259|39152377|FG005|Study 2|Adverse Event|0|||
16183806|NCT00001259|39152378|FG006|Study 2|Adverse Event|0|||
16183807|NCT02284906|39152382|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16183808|NCT02284906|39152383|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
16183809|NCT02284906|39152384|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16183810|NCT02284906|39152382|FG000|Overall Study|Major Protocol Deviation|0|||
16183811|NCT02284906|39152383|FG001|Overall Study|Major Protocol Deviation|1|||
16183812|NCT02284906|39152384|FG002|Overall Study|Major Protocol Deviation|0|||
16183813|NCT02284906|39152382|FG000|Overall Study|Voluntary Withdrawal|2|||
16183814|NCT02284906|39152383|FG001|Overall Study|Voluntary Withdrawal|4|||
16183815|NCT02284906|39152384|FG002|Overall Study|Voluntary Withdrawal|5|||
16183816|NCT02284906|39152382|FG000|Overall Study|Study Termination|0|||
16183817|NCT02284906|39152383|FG001|Overall Study|Study Termination|11|||
16183818|NCT02284906|39152384|FG002|Overall Study|Study Termination|14|||
16183819|NCT02284906|39152382|FG000|Overall Study|Reason not Specified|1|||
16183820|NCT02284906|39152383|FG001|Overall Study|Reason not Specified|1|||
16183821|NCT02284906|39152384|FG002|Overall Study|Reason not Specified|0|||
16183822|NCT02225223|39152385|FG000|Overall Study|Death|10|||
16183823|NCT02225223|39152386|FG001|Overall Study|Death|1|||
16183824|NCT02225223|39152385|FG000|Overall Study|Lost to Follow-up|5|||
16183825|NCT02225223|39152386|FG001|Overall Study|Lost to Follow-up|0|||
16183826|NCT02225223|39152385|FG000|Overall Study|Other|1|||
16183827|NCT02225223|39152386|FG001|Overall Study|Other|2|||
16183828|NCT02225223|39152385|FG000|Overall Study|Physician Decision|1|||
16183829|NCT02225223|39152386|FG001|Overall Study|Physician Decision|0|||
16183830|NCT02225223|39152385|FG000|Overall Study|Withdrawal by Subject|2|||
16183831|NCT02225223|39152386|FG001|Overall Study|Withdrawal by Subject|2|||
16478969|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478970|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478971|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478972|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478973|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478974|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478975|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478976|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478977|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478978|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478979|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16183832|NCT01070550|39152387|FG000|Overall Study|Adverse Event|43|||
16080203|NCT01307267|38786794|FG013|Overall Study|Death|0|||
16183833|NCT01070550|39152388|FG001|Overall Study|Adverse Event|1|||
16183834|NCT01070550|39152389|FG002|Overall Study|Adverse Event|3|||
16183835|NCT01070550|39152390|FG003|Overall Study|Adverse Event|0|||
16183836|NCT01070550|39152391|FG004|Overall Study|Adverse Event|0|||
16183837|NCT01070550|39152392|FG005|Overall Study|Adverse Event|0|||
16183838|NCT01070550|39152387|FG000|Overall Study|Death|20|||
16183839|NCT01070550|39152388|FG001|Overall Study|Death|4|||
16183840|NCT01070550|39152389|FG002|Overall Study|Death|3|||
16183841|NCT01070550|39152390|FG003|Overall Study|Death|0|||
16183842|NCT01070550|39152391|FG004|Overall Study|Death|0|||
16183843|NCT01070550|39152392|FG005|Overall Study|Death|0|||
16379106|NCT02883049|39874672|FG011|Induction|Inevaluable|0|||
16478980|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
16478981|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
16478982|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
16478983|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478984|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478985|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478986|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478987|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478988|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478989|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478990|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478991|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478992|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
16478993|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478994|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478995|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
16478996|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
16478997|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
16478998|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16183844|NCT01070550|39152387|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
16183845|NCT01070550|39152388|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
16183846|NCT01070550|39152389|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
16183847|NCT01070550|39152390|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
16183848|NCT01070550|39152391|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
16183849|NCT01070550|39152392|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
16183850|NCT01070550|39152387|FG000|Overall Study|Early termination|3|||
16183851|NCT01070550|39152388|FG001|Overall Study|Early termination|0|||
16183852|NCT01070550|39152389|FG002|Overall Study|Early termination|0|||
16183853|NCT01070550|39152390|FG003|Overall Study|Early termination|0|||
16183854|NCT01070550|39152391|FG004|Overall Study|Early termination|0|||
16183855|NCT01070550|39152392|FG005|Overall Study|Early termination|0|||
16183856|NCT01070550|39152387|FG000|Overall Study|Failed to return|450|||
16379107|NCT02883049|39874673|FG012|Induction|Inevaluable|0|||
16379108|NCT02883049|39874674|FG013|Induction|Inevaluable|0|||
16379109|NCT02883049|39874675|FG014|Induction|Inevaluable|0|||
16379110|NCT02883049|39874676|FG015|Induction|Inevaluable|0|||
16379111|NCT02883049|39874661|FG000|Induction|Identified as VHR at end of Induction|244|||
16379112|NCT02883049|39874662|FG001|Induction|Identified as VHR at end of Induction|0|||
16379113|NCT02883049|39874663|FG002|Induction|Identified as VHR at end of Induction|0|||
16379114|NCT02883049|39874664|FG003|Induction|Identified as VHR at end of Induction|0|||
16379115|NCT02883049|39874665|FG004|Induction|Identified as VHR at end of Induction|0|||
16379116|NCT02883049|39874666|FG005|Induction|Identified as VHR at end of Induction|0|||
16379117|NCT02883049|39874667|FG006|Induction|Identified as VHR at end of Induction|0|||
16379118|NCT02883049|39874668|FG007|Induction|Identified as VHR at end of Induction|0|||
16379119|NCT02883049|39874669|FG008|Induction|Identified as VHR at end of Induction|0|||
16379120|NCT02883049|39874670|FG009|Induction|Identified as VHR at end of Induction|0|||
16379121|NCT02883049|39874671|FG010|Induction|Identified as VHR at end of Induction|0|||
16379122|NCT02883049|39874672|FG011|Induction|Identified as VHR at end of Induction|0|||
16379123|NCT02883049|39874673|FG012|Induction|Identified as VHR at end of Induction|0|||
16379124|NCT02883049|39874674|FG013|Induction|Identified as VHR at end of Induction|0|||
16379125|NCT02883049|39874675|FG014|Induction|Identified as VHR at end of Induction|0|||
16379126|NCT02883049|39874676|FG015|Induction|Identified as VHR at end of Induction|0|||
16379127|NCT02883049|39874661|FG000|Induction|Moved to another non-COG institution|3|||
16379128|NCT02883049|39874662|FG001|Induction|Moved to another non-COG institution|0|||
16379129|NCT02883049|39874663|FG002|Induction|Moved to another non-COG institution|0|||
16379130|NCT02883049|39874664|FG003|Induction|Moved to another non-COG institution|0|||
16379131|NCT02883049|39874665|FG004|Induction|Moved to another non-COG institution|0|||
16379132|NCT02883049|39874666|FG005|Induction|Moved to another non-COG institution|0|||
16379133|NCT02883049|39874667|FG006|Induction|Moved to another non-COG institution|0|||
16379134|NCT02883049|39874668|FG007|Induction|Moved to another non-COG institution|0|||
16379135|NCT02883049|39874669|FG008|Induction|Moved to another non-COG institution|0|||
16379136|NCT02883049|39874670|FG009|Induction|Moved to another non-COG institution|0|||
16379137|NCT02883049|39874671|FG010|Induction|Moved to another non-COG institution|0|||
16379138|NCT02883049|39874672|FG011|Induction|Moved to another non-COG institution|0|||
16379139|NCT02883049|39874673|FG012|Induction|Moved to another non-COG institution|0|||
16379140|NCT02883049|39874674|FG013|Induction|Moved to another non-COG institution|0|||
16183857|NCT01070550|39152388|FG001|Overall Study|Failed to return|33|||
16183858|NCT01070550|39152389|FG002|Overall Study|Failed to return|144|||
16183859|NCT01070550|39152390|FG003|Overall Study|Failed to return|40|||
16183860|NCT01070550|39152391|FG004|Overall Study|Failed to return|1|||
16183861|NCT01070550|39152392|FG005|Overall Study|Failed to return|2|||
16183862|NCT01070550|39152387|FG000|Overall Study|Incomplete treatment|2|||
16183863|NCT01070550|39152388|FG001|Overall Study|Incomplete treatment|0|||
16183864|NCT01070550|39152389|FG002|Overall Study|Incomplete treatment|0|||
16183865|NCT01070550|39152390|FG003|Overall Study|Incomplete treatment|0|||
16183866|NCT01070550|39152391|FG004|Overall Study|Incomplete treatment|0|||
16183867|NCT01070550|39152392|FG005|Overall Study|Incomplete treatment|0|||
16183868|NCT01070550|39152387|FG000|Overall Study|Lab test not done|22|||
16183869|NCT01070550|39152388|FG001|Overall Study|Lab test not done|3|||
16183870|NCT01070550|39152389|FG002|Overall Study|Lab test not done|4|||
16183871|NCT01070550|39152390|FG003|Overall Study|Lab test not done|1|||
16183872|NCT01070550|39152391|FG004|Overall Study|Lab test not done|0|||
16183873|NCT01070550|39152392|FG005|Overall Study|Lab test not done|1|||
16183874|NCT01070550|39152387|FG000|Overall Study|Lack of Efficacy|65|||
16183875|NCT01070550|39152388|FG001|Overall Study|Lack of Efficacy|1|||
16183876|NCT01070550|39152389|FG002|Overall Study|Lack of Efficacy|5|||
16183877|NCT01070550|39152390|FG003|Overall Study|Lack of Efficacy|5|||
16183878|NCT01070550|39152391|FG004|Overall Study|Lack of Efficacy|0|||
16183879|NCT01070550|39152392|FG005|Overall Study|Lack of Efficacy|1|||
16183880|NCT01070550|39152387|FG000|Overall Study|Miscellaneous|12|||
16183881|NCT01070550|39152388|FG001|Overall Study|Miscellaneous|2|||
16183882|NCT01070550|39152389|FG002|Overall Study|Miscellaneous|3|||
16183883|NCT01070550|39152390|FG003|Overall Study|Miscellaneous|1|||
16183884|NCT01070550|39152391|FG004|Overall Study|Miscellaneous|0|||
16183885|NCT01070550|39152392|FG005|Overall Study|Miscellaneous|0|||
16183886|NCT01070550|39152387|FG000|Overall Study|New treatment started|3|||
16183887|NCT01070550|39152388|FG001|Overall Study|New treatment started|1|||
16183888|NCT01070550|39152389|FG002|Overall Study|New treatment started|0|||
16183889|NCT01070550|39152390|FG003|Overall Study|New treatment started|2|||
16183890|NCT01070550|39152391|FG004|Overall Study|New treatment started|0|||
16183891|NCT01070550|39152392|FG005|Overall Study|New treatment started|0|||
16183892|NCT01070550|39152387|FG000|Overall Study|Non-responders|493|||
16183893|NCT01070550|39152388|FG001|Overall Study|Non-responders|4|||
16183894|NCT01070550|39152389|FG002|Overall Study|Non-responders|21|||
16183895|NCT01070550|39152390|FG003|Overall Study|Non-responders|20|||
16183896|NCT01070550|39152391|FG004|Overall Study|Non-responders|0|||
16183897|NCT01070550|39152392|FG005|Overall Study|Non-responders|2|||
16183898|NCT01070550|39152387|FG000|Overall Study|Not categorized|33|||
16183899|NCT01070550|39152388|FG001|Overall Study|Not categorized|2|||
16183900|NCT01070550|39152389|FG002|Overall Study|Not categorized|6|||
16183901|NCT01070550|39152390|FG003|Overall Study|Not categorized|1|||
16183902|NCT01070550|39152391|FG004|Overall Study|Not categorized|0|||
16183903|NCT01070550|39152392|FG005|Overall Study|Not categorized|1|||
16183904|NCT01070550|39152387|FG000|Overall Study|Protocol Violation|15|||
16183905|NCT01070550|39152388|FG001|Overall Study|Protocol Violation|1|||
16183906|NCT01070550|39152389|FG002|Overall Study|Protocol Violation|1|||
16183907|NCT01070550|39152390|FG003|Overall Study|Protocol Violation|1|||
16183908|NCT01070550|39152391|FG004|Overall Study|Protocol Violation|0|||
16183909|NCT01070550|39152392|FG005|Overall Study|Protocol Violation|0|||
16183910|NCT01070550|39152387|FG000|Overall Study|Relapse|44|||
16183911|NCT01070550|39152388|FG001|Overall Study|Relapse|5|||
16183912|NCT01070550|39152389|FG002|Overall Study|Relapse|14|||
16183913|NCT01070550|39152390|FG003|Overall Study|Relapse|4|||
16183914|NCT01070550|39152391|FG004|Overall Study|Relapse|0|||
16183915|NCT01070550|39152392|FG005|Overall Study|Relapse|0|||
16183916|NCT01070550|39152387|FG000|Overall Study|Result not available|3|||
16183917|NCT01070550|39152388|FG001|Overall Study|Result not available|1|||
16183918|NCT01070550|39152389|FG002|Overall Study|Result not available|3|||
16183919|NCT01070550|39152390|FG003|Overall Study|Result not available|0|||
16183920|NCT01070550|39152391|FG004|Overall Study|Result not available|0|||
16183921|NCT01070550|39152392|FG005|Overall Study|Result not available|0|||
16183922|NCT01070550|39152387|FG000|Overall Study|Screen failure|1|||
16183923|NCT01070550|39152388|FG001|Overall Study|Screen failure|0|||
16183924|NCT01070550|39152389|FG002|Overall Study|Screen failure|0|||
16183925|NCT01070550|39152390|FG003|Overall Study|Screen failure|0|||
16183926|NCT01070550|39152391|FG004|Overall Study|Screen failure|0|||
16183927|NCT01070550|39152392|FG005|Overall Study|Screen failure|0|||
16183928|NCT01070550|39152387|FG000|Overall Study|Sponsor decision|1|||
16183929|NCT01070550|39152388|FG001|Overall Study|Sponsor decision|0|||
16183930|NCT01070550|39152389|FG002|Overall Study|Sponsor decision|0|||
16183931|NCT01070550|39152390|FG003|Overall Study|Sponsor decision|0|||
16183932|NCT01070550|39152391|FG004|Overall Study|Sponsor decision|0|||
16183933|NCT01070550|39152392|FG005|Overall Study|Sponsor decision|0|||
16183934|NCT01070550|39152387|FG000|Overall Study|Treatment duration shortened|1|||
16183935|NCT01070550|39152388|FG001|Overall Study|Treatment duration shortened|0|||
16183936|NCT01070550|39152389|FG002|Overall Study|Treatment duration shortened|0|||
16183937|NCT01070550|39152390|FG003|Overall Study|Treatment duration shortened|0|||
16183938|NCT01070550|39152391|FG004|Overall Study|Treatment duration shortened|0|||
16183939|NCT01070550|39152392|FG005|Overall Study|Treatment duration shortened|0|||
16183940|NCT01070550|39152387|FG000|Overall Study|Treatment interrupted|7|||
16183941|NCT01070550|39152388|FG001|Overall Study|Treatment interrupted|0|||
16183942|NCT01070550|39152389|FG002|Overall Study|Treatment interrupted|1|||
16183943|NCT01070550|39152390|FG003|Overall Study|Treatment interrupted|1|||
16183944|NCT01070550|39152391|FG004|Overall Study|Treatment interrupted|0|||
16183945|NCT01070550|39152392|FG005|Overall Study|Treatment interrupted|0|||
16183946|NCT01070550|39152387|FG000|Overall Study|Treatment not started|14|||
16183947|NCT01070550|39152388|FG001|Overall Study|Treatment not started|2|||
16183948|NCT01070550|39152389|FG002|Overall Study|Treatment not started|4|||
16183949|NCT01070550|39152390|FG003|Overall Study|Treatment not started|0|||
16183950|NCT01070550|39152391|FG004|Overall Study|Treatment not started|0|||
16183951|NCT01070550|39152392|FG005|Overall Study|Treatment not started|0|||
16183952|NCT01070550|39152387|FG000|Overall Study|Treatment restarted|0|||
16183953|NCT01070550|39152388|FG001|Overall Study|Treatment restarted|1|||
16183954|NCT01070550|39152389|FG002|Overall Study|Treatment restarted|0|||
16183955|NCT01070550|39152390|FG003|Overall Study|Treatment restarted|0|||
16183956|NCT01070550|39152391|FG004|Overall Study|Treatment restarted|0|||
16183957|NCT01070550|39152392|FG005|Overall Study|Treatment restarted|0|||
16183958|NCT01070550|39152387|FG000|Overall Study|Treatment stopped|3|||
16183959|NCT01070550|39152388|FG001|Overall Study|Treatment stopped|0|||
16183960|NCT01070550|39152389|FG002|Overall Study|Treatment stopped|0|||
16379141|NCT02883049|39874675|FG014|Induction|Moved to another non-COG institution|0|||
16379142|NCT02883049|39874676|FG015|Induction|Moved to another non-COG institution|0|||
16379143|NCT02883049|39874661|FG000|Induction|Randomization closed|41|||
16379144|NCT02883049|39874662|FG001|Induction|Randomization closed|0|||
16379145|NCT02883049|39874663|FG002|Induction|Randomization closed|0|||
16379146|NCT02883049|39874664|FG003|Induction|Randomization closed|0|||
16379147|NCT02883049|39874665|FG004|Induction|Randomization closed|0|||
16379148|NCT02883049|39874666|FG005|Induction|Randomization closed|0|||
16379149|NCT02883049|39874667|FG006|Induction|Randomization closed|0|||
16379150|NCT02883049|39874668|FG007|Induction|Randomization closed|0|||
16183961|NCT01070550|39152390|FG003|Overall Study|Treatment stopped|0|||
16183962|NCT01070550|39152391|FG004|Overall Study|Treatment stopped|0|||
16183963|NCT01070550|39152392|FG005|Overall Study|Treatment stopped|0|||
16183964|NCT01070550|39152387|FG000|Overall Study|Treatment unavailable|1|||
16183965|NCT01070550|39152388|FG001|Overall Study|Treatment unavailable|0|||
16183966|NCT01070550|39152389|FG002|Overall Study|Treatment unavailable|0|||
16183967|NCT01070550|39152390|FG003|Overall Study|Treatment unavailable|0|||
16183968|NCT01070550|39152391|FG004|Overall Study|Treatment unavailable|0|||
16183969|NCT01070550|39152392|FG005|Overall Study|Treatment unavailable|0|||
16183970|NCT01070550|39152387|FG000|Overall Study|Treatment was stopped early|7|||
16183971|NCT01070550|39152388|FG001|Overall Study|Treatment was stopped early|0|||
16183972|NCT01070550|39152389|FG002|Overall Study|Treatment was stopped early|0|||
16183973|NCT01070550|39152390|FG003|Overall Study|Treatment was stopped early|0|||
16183974|NCT01070550|39152391|FG004|Overall Study|Treatment was stopped early|0|||
16183975|NCT01070550|39152392|FG005|Overall Study|Treatment was stopped early|0|||
16183976|NCT01070550|39152387|FG000|Overall Study|Other|5|||
16183977|NCT01070550|39152388|FG001|Overall Study|Other|0|||
16183978|NCT01070550|39152389|FG002|Overall Study|Other|0|||
16183979|NCT01070550|39152390|FG003|Overall Study|Other|1|||
16183980|NCT01070550|39152391|FG004|Overall Study|Other|0|||
16183981|NCT01070550|39152392|FG005|Overall Study|Other|0|||
16183982|NCT01070550|39152387|FG000|Overall Study|Withdrawal by Subject|35|||
16183983|NCT01070550|39152388|FG001|Overall Study|Withdrawal by Subject|0|||
16183984|NCT01070550|39152389|FG002|Overall Study|Withdrawal by Subject|3|||
16183985|NCT01070550|39152390|FG003|Overall Study|Withdrawal by Subject|0|||
16379151|NCT02883049|39874669|FG008|Induction|Randomization closed|0|||
16379152|NCT02883049|39874670|FG009|Induction|Randomization closed|0|||
16379153|NCT02883049|39874671|FG010|Induction|Randomization closed|0|||
16183986|NCT01070550|39152391|FG004|Overall Study|Withdrawal by Subject|0|||
16183987|NCT01070550|39152392|FG005|Overall Study|Withdrawal by Subject|0|||
16183988|NCT00726323|39152396|FG000|Overall Study|Withdrawal by Subject|3|||
16183989|NCT00726323|39152397|FG001|Overall Study|Withdrawal by Subject|1|||
16183990|NCT00726323|39152396|FG000|Overall Study|Physician Decision|1|||
16183991|NCT00726323|39152397|FG001|Overall Study|Physician Decision|0|||
16183992|NCT00726323|39152396|FG000|Overall Study|Progressive disease|23|||
16183993|NCT00726323|39152397|FG001|Overall Study|Progressive disease|16|||
16183994|NCT00726323|39152396|FG000|Overall Study|Clinical progression|0|||
16183995|NCT00726323|39152397|FG001|Overall Study|Clinical progression|3|||
16183996|NCT00726323|39152396|FG000|Overall Study|Adverse Event|9|||
16379154|NCT02883049|39874672|FG011|Induction|Randomization closed|0|||
16183997|NCT00726323|39152397|FG001|Overall Study|Adverse Event|9|||
16183998|NCT00726323|39152396|FG000|Overall Study|Death|1|||
16183999|NCT00726323|39152397|FG001|Overall Study|Death|0|||
16184000|NCT00726323|39152396|FG000|Overall Study|Participant wished to discontinue|0|||
16379155|NCT02883049|39874673|FG012|Induction|Randomization closed|0|||
16184001|NCT00726323|39152397|FG001|Overall Study|Participant wished to discontinue|1|||
16184002|NCT00726323|39152396|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
16184003|NCT00726323|39152397|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
16184004|NCT02961764|39152398|FG000|Overall Study|Protocol Violation|0|||
16184005|NCT02961764|39152399|FG001|Overall Study|Protocol Violation|1|||
16184006|NCT02961764|39152398|FG000|Overall Study|Death|2|||
16184007|NCT02961764|39152399|FG001|Overall Study|Death|0|||
16184008|NCT02961764|39152398|FG000|Overall Study|Lost to Follow-up|35|||
16184009|NCT02961764|39152399|FG001|Overall Study|Lost to Follow-up|24|||
16184010|NCT02961764|39152398|FG000|Overall Study|Withdrawal by Subject|2|||
16184011|NCT02961764|39152399|FG001|Overall Study|Withdrawal by Subject|0|||
16184012|NCT00784784|39152400|FG000|Overall Study|Withdrawal by Subject|2|||
16184013|NCT00784784|39152401|FG001|Overall Study|Withdrawal by Subject|2|||
16184014|NCT01894516|39155348|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
16184015|NCT01894516|39155349|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
16184016|NCT01894516|39155350|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
16184017|NCT01894516|39155351|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
16184018|NCT01894516|39155348|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
16184019|NCT01894516|39155349|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16184020|NCT01894516|39155350|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16184021|NCT01894516|39155351|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16184022|NCT01894516|39155348|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
16184023|NCT01894516|39155349|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
16184024|NCT01894516|39155350|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
16184025|NCT01894516|39155351|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
16184026|NCT01894516|39155348|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
16184027|NCT01894516|39155349|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
16184028|NCT01894516|39155350|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
16184029|NCT01894516|39155351|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
16184030|NCT01894516|39155348|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
16184031|NCT01894516|39155349|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
16184032|NCT01894516|39155350|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
16184033|NCT01894516|39155351|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
16184034|NCT01894516|39155348|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
16184035|NCT01894516|39155349|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
16184036|NCT01894516|39155350|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
16184037|NCT01894516|39155351|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
16379156|NCT02883049|39874674|FG013|Induction|Randomization closed|0|||
16379157|NCT02883049|39874675|FG014|Induction|Randomization closed|0|||
16379158|NCT02883049|39874676|FG015|Induction|Randomization closed|0|||
16379159|NCT02883049|39874661|FG000|Induction|MRD negative|36|||
16379160|NCT02883049|39874662|FG001|Induction|MRD negative|0|||
16379161|NCT02883049|39874663|FG002|Induction|MRD negative|0|||
16379162|NCT02883049|39874664|FG003|Induction|MRD negative|0|||
16379163|NCT02883049|39874665|FG004|Induction|MRD negative|0|||
16379164|NCT02883049|39874666|FG005|Induction|MRD negative|0|||
16379165|NCT02883049|39874667|FG006|Induction|MRD negative|0|||
16379166|NCT02883049|39874668|FG007|Induction|MRD negative|0|||
16379167|NCT02883049|39874669|FG008|Induction|MRD negative|0|||
16379168|NCT02883049|39874670|FG009|Induction|MRD negative|0|||
16379169|NCT02883049|39874671|FG010|Induction|MRD negative|0|||
16379170|NCT02883049|39874672|FG011|Induction|MRD negative|0|||
16379171|NCT02883049|39874673|FG012|Induction|MRD negative|0|||
16379172|NCT02883049|39874674|FG013|Induction|MRD negative|0|||
16379173|NCT02883049|39874675|FG014|Induction|MRD negative|0|||
16379174|NCT02883049|39874676|FG015|Induction|MRD negative|0|||
16379175|NCT02883049|39874661|FG000|Induction|Identified as HR patients|165|||
16184038|NCT01894516|39155348|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
16184039|NCT01894516|39155349|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
16184040|NCT01894516|39155350|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
16184041|NCT01894516|39155351|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
16184042|NCT01894516|39155348|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16184043|NCT01894516|39155349|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16379176|NCT02883049|39874662|FG001|Induction|Identified as HR patients|0|||
16379177|NCT02883049|39874663|FG002|Induction|Identified as HR patients|0|||
16379178|NCT02883049|39874664|FG003|Induction|Identified as HR patients|0|||
16379179|NCT02883049|39874665|FG004|Induction|Identified as HR patients|0|||
16379180|NCT02883049|39874666|FG005|Induction|Identified as HR patients|0|||
16379181|NCT02883049|39874667|FG006|Induction|Identified as HR patients|0|||
16379182|NCT02883049|39874668|FG007|Induction|Identified as HR patients|0|||
16379183|NCT02883049|39874669|FG008|Induction|Identified as HR patients|0|||
16379184|NCT02883049|39874670|FG009|Induction|Identified as HR patients|0|||
16379185|NCT02883049|39874671|FG010|Induction|Identified as HR patients|0|||
16184044|NCT01894516|39155350|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
16184045|NCT01894516|39155351|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16184046|NCT01518192|39155352|FG000|Overall Study|Lost to Follow-up|29|||
16184047|NCT01518192|39155353|FG001|Overall Study|Lost to Follow-up|26|||
16184048|NCT01518192|39155354|FG002|Overall Study|Lost to Follow-up|35|||
16184049|NCT03153111|39155355|FG000|Overall Study|Death|2|||
16184050|NCT03153111|39155356|FG001|Overall Study|Death|5|||
16184051|NCT03153111|39155355|FG000|Overall Study|Lost to Follow-up|1|||
16184052|NCT03153111|39155356|FG001|Overall Study|Lost to Follow-up|0|||
16184053|NCT03153111|39155355|FG000|Overall Study|Physician Decision|5|||
16184054|NCT03153111|39155356|FG001|Overall Study|Physician Decision|1|||
16184055|NCT03153111|39155355|FG000|Overall Study|Withdrawal by Subject|3|||
16184056|NCT03153111|39155356|FG001|Overall Study|Withdrawal by Subject|3|||
16184057|NCT01070303|39155357|FG000|Overall Study|Adverse Event|39|||
16184058|NCT01070303|39155357|FG000|Overall Study|Withdrawal by Subject|20|||
16379186|NCT02883049|39874672|FG011|Induction|Identified as HR patients|0|||
16379187|NCT02883049|39874673|FG012|Induction|Identified as HR patients|0|||
16379188|NCT02883049|39874674|FG013|Induction|Identified as HR patients|0|||
16379189|NCT02883049|39874675|FG014|Induction|Identified as HR patients|0|||
16379190|NCT02883049|39874676|FG015|Induction|Identified as HR patients|0|||
16379191|NCT02883049|39874661|FG000|Induction|Developed SMN|0|||
16379192|NCT02883049|39874662|FG001|Induction|Developed SMN|1|||
16379193|NCT02883049|39874663|FG002|Induction|Developed SMN|0|||
16184059|NCT01070303|39155357|FG000|Overall Study|Lost to Follow-up|9|||
16184060|NCT01070303|39155357|FG000|Overall Study|Protocol Violation|0|||
16184061|NCT01070303|39155357|FG000|Overall Study|Lack of Efficacy|2|||
16184062|NCT01070303|39155357|FG000|Overall Study|Administrative Reason|1|||
16184063|NCT01070303|39155357|FG000|Overall Study|Other|18|||
16184064|NCT00864227|39155358|FG000|Overall Study|Withdrawal by Subject|1|||
16184065|NCT00864227|39155358|FG000|Overall Study|Disease Relapse/Progression|3|||
16184066|NCT02465034|39155359|FG000|Overall Study|Withdrawal by Subject|1|||
16184067|NCT02465034|39155360|FG001|Overall Study|Withdrawal by Subject|1|||
16184068|NCT02465034|39155359|FG000|Overall Study|Screen fail|2|||
16184069|NCT02465034|39155360|FG001|Overall Study|Screen fail|0|||
16184070|NCT02465034|39155359|FG000|Overall Study|Could not be scheduled for study visit|0|||
16184071|NCT02465034|39155360|FG001|Overall Study|Could not be scheduled for study visit|5|||
16184072|NCT01696877|39155361|FG000|Overall Study|Adverse Event|0|||
16184073|NCT01696877|39155362|FG001|Overall Study|Adverse Event|1|||
16184074|NCT01743027|39155363|FG000|Overall Study|Adverse Event|2|||
16184075|NCT01743027|39155364|FG001|Overall Study|Adverse Event|0|||
16184076|NCT01743027|39155365|FG002|Overall Study|Adverse Event|0|||
16184077|NCT01743027|39155366|FG003|Overall Study|Adverse Event|0|||
16184078|NCT01743027|39155363|FG000|Overall Study|Lost to Follow-up|0|||
16184079|NCT01743027|39155364|FG001|Overall Study|Lost to Follow-up|0|||
16184080|NCT01743027|39155365|FG002|Overall Study|Lost to Follow-up|2|||
16184081|NCT01743027|39155366|FG003|Overall Study|Lost to Follow-up|0|||
16184082|NCT01743027|39155363|FG000|Overall Study|Progressive Disease|1|||
16184083|NCT01743027|39155364|FG001|Overall Study|Progressive Disease|4|||
16184084|NCT01743027|39155365|FG002|Overall Study|Progressive Disease|3|||
16379194|NCT02883049|39874664|FG003|Induction|Developed SMN|0|||
16379195|NCT02883049|39874665|FG004|Induction|Developed SMN|0|||
16379196|NCT02883049|39874666|FG005|Induction|Developed SMN|0|||
16379197|NCT02883049|39874667|FG006|Induction|Developed SMN|0|||
16379198|NCT02883049|39874668|FG007|Induction|Developed SMN|0|||
16379199|NCT02883049|39874669|FG008|Induction|Developed SMN|0|||
16379200|NCT02883049|39874670|FG009|Induction|Developed SMN|0|||
16379201|NCT02883049|39874671|FG010|Induction|Developed SMN|0|||
16379202|NCT02883049|39874672|FG011|Induction|Developed SMN|0|||
16379203|NCT02883049|39874673|FG012|Induction|Developed SMN|0|||
16184085|NCT01743027|39155366|FG003|Overall Study|Progressive Disease|0|||
16184086|NCT01743027|39155363|FG000|Overall Study|Protocol Violation|1|||
16184087|NCT01743027|39155364|FG001|Overall Study|Protocol Violation|1|||
16184088|NCT01743027|39155365|FG002|Overall Study|Protocol Violation|1|||
16184089|NCT01743027|39155366|FG003|Overall Study|Protocol Violation|0|||
16184090|NCT01743027|39155363|FG000|Overall Study|Withdrawal by Subject|1|||
16184091|NCT01743027|39155364|FG001|Overall Study|Withdrawal by Subject|0|||
16184092|NCT01743027|39155365|FG002|Overall Study|Withdrawal by Subject|3|||
16184093|NCT01743027|39155366|FG003|Overall Study|Withdrawal by Subject|1|||
16379204|NCT02883049|39874674|FG013|Induction|Developed SMN|0|||
16379205|NCT02883049|39874675|FG014|Induction|Developed SMN|0|||
16379206|NCT02883049|39874676|FG015|Induction|Developed SMN|0|||
16379207|NCT02883049|39874661|FG000|Induction|Enrolled onto another COG study|72|||
16379208|NCT02883049|39874662|FG001|Induction|Enrolled onto another COG study|0|||
16184094|NCT00394914|39155367|FG000|Treatment Period|Adverse Event|0|||
16184095|NCT00394914|39155368|FG001|Treatment Period|Adverse Event|3|||
16184096|NCT00394914|39155369|FG002|Treatment Period|Adverse Event|1|||
16184097|NCT00394914|39155367|FG000|Treatment Period|Lost to Follow-up|0|||
16184098|NCT00394914|39155368|FG001|Treatment Period|Lost to Follow-up|1|||
16379209|NCT02883049|39874663|FG002|Induction|Enrolled onto another COG study|0|||
16184099|NCT00394914|39155369|FG002|Treatment Period|Lost to Follow-up|0|||
16184100|NCT00394914|39155367|FG000|Treatment Period|Withdrawal by Subject|0|||
16184101|NCT00394914|39155368|FG001|Treatment Period|Withdrawal by Subject|2|||
16184102|NCT00394914|39155369|FG002|Treatment Period|Withdrawal by Subject|2|||
16184103|NCT00394914|39155367|FG000|Treatment Period|Noncompliance with protocol|0|||
16184104|NCT00394914|39155368|FG001|Treatment Period|Noncompliance with protocol|3|||
16184105|NCT00394914|39155369|FG002|Treatment Period|Noncompliance with protocol|2|||
16184106|NCT00394914|39155367|FG000|Treatment Period|Did not meet protocol eligibility|0|||
16184107|NCT00394914|39155368|FG001|Treatment Period|Did not meet protocol eligibility|1|||
16184108|NCT00394914|39155369|FG002|Treatment Period|Did not meet protocol eligibility|1|||
16184109|NCT00637273|39155371|FG000|Overall Study|Adverse Event|11|||
16184110|NCT00637273|39155372|FG001|Overall Study|Adverse Event|5|||
16184111|NCT00637273|39155373|FG002|Overall Study|Adverse Event|7|||
16184112|NCT00637273|39155371|FG000|Overall Study|Lost to Follow-up|8|||
16184113|NCT00637273|39155372|FG001|Overall Study|Lost to Follow-up|9|||
16184114|NCT00637273|39155373|FG002|Overall Study|Lost to Follow-up|13|||
16184115|NCT00637273|39155371|FG000|Overall Study|Protocol Violation|2|||
16184116|NCT00637273|39155372|FG001|Overall Study|Protocol Violation|4|||
16184117|NCT00637273|39155373|FG002|Overall Study|Protocol Violation|1|||
16184118|NCT00637273|39155371|FG000|Overall Study|Withdrawal of Consent|18|||
16184119|NCT00637273|39155372|FG001|Overall Study|Withdrawal of Consent|6|||
16184120|NCT00637273|39155373|FG002|Overall Study|Withdrawal of Consent|18|||
16184121|NCT00637273|39155371|FG000|Overall Study|Investigator Decision|1|||
16184122|NCT00637273|39155372|FG001|Overall Study|Investigator Decision|3|||
16184123|NCT00637273|39155373|FG002|Overall Study|Investigator Decision|1|||
16184124|NCT00637273|39155371|FG000|Overall Study|Administrative|2|||
16184125|NCT00637273|39155372|FG001|Overall Study|Administrative|0|||
16184126|NCT00637273|39155373|FG002|Overall Study|Administrative|0|||
16184127|NCT00637273|39155371|FG000|Overall Study|Loss of Glucose Control|1|||
16184128|NCT00637273|39155372|FG001|Overall Study|Loss of Glucose Control|1|||
16184129|NCT00637273|39155373|FG002|Overall Study|Loss of Glucose Control|1|||
16184130|NCT04983940|39155379|FG000|Overall Study|Lost to Follow-up|14|||
16184131|NCT04983940|39155379|FG000|Overall Study|Lack of Efficacy|2|||
16184132|NCT01671085|39155380|FG000|Overall Study|Withdrawal by Subject|1|||
16184133|NCT01671085|39155381|FG001|Overall Study|Withdrawal by Subject|0|||
16184134|NCT03042611|39155385|FG000|Core Phase|Withdrawal by Subject|13|||
16184135|NCT03042611|39155386|FG001|Core Phase|Withdrawal by Subject|4|||
16184136|NCT03042611|39155387|FG002|Core Phase|Withdrawal by Subject|0|||
16184137|NCT03042611|39155388|FG003|Core Phase|Withdrawal by Subject|0|||
16184138|NCT03042611|39155385|FG000|Core Phase|Death|232|||
16184139|NCT03042611|39155386|FG001|Core Phase|Death|110|||
16184140|NCT03042611|39155387|FG002|Core Phase|Death|0|||
16184141|NCT03042611|39155388|FG003|Core Phase|Death|0|||
16184142|NCT03042611|39155385|FG000|Core Phase|Lost to Follow-up|4|||
16184143|NCT03042611|39155386|FG001|Core Phase|Lost to Follow-up|7|||
16379210|NCT02883049|39874664|FG003|Induction|Enrolled onto another COG study|0|||
16379211|NCT02883049|39874665|FG004|Induction|Enrolled onto another COG study|0|||
16379212|NCT02883049|39874666|FG005|Induction|Enrolled onto another COG study|0|||
16379213|NCT02883049|39874667|FG006|Induction|Enrolled onto another COG study|0|||
16379214|NCT02883049|39874668|FG007|Induction|Enrolled onto another COG study|0|||
16379215|NCT02883049|39874669|FG008|Induction|Enrolled onto another COG study|0|||
16379216|NCT02883049|39874670|FG009|Induction|Enrolled onto another COG study|0|||
16184144|NCT03042611|39155387|FG002|Core Phase|Lost to Follow-up|0|||
16379217|NCT02883049|39874671|FG010|Induction|Enrolled onto another COG study|0|||
16379218|NCT02883049|39874672|FG011|Induction|Enrolled onto another COG study|0|||
16379219|NCT02883049|39874673|FG012|Induction|Enrolled onto another COG study|0|||
16379220|NCT02883049|39874674|FG013|Induction|Enrolled onto another COG study|0|||
16379221|NCT02883049|39874675|FG014|Induction|Enrolled onto another COG study|0|||
16379222|NCT02883049|39874676|FG015|Induction|Enrolled onto another COG study|0|||
16379223|NCT02883049|39874661|FG000|Induction|Incomplete induction data|17|||
16379224|NCT02883049|39874662|FG001|Induction|Incomplete induction data|0|||
16379225|NCT02883049|39874663|FG002|Induction|Incomplete induction data|0|||
16379226|NCT02883049|39874664|FG003|Induction|Incomplete induction data|0|||
16184145|NCT03042611|39155388|FG003|Core Phase|Lost to Follow-up|0|||
16184146|NCT03042611|39155385|FG000|Core Phase|Physician Decision|7|||
16184147|NCT03042611|39155386|FG001|Core Phase|Physician Decision|2|||
16184148|NCT03042611|39155387|FG002|Core Phase|Physician Decision|0|||
16379227|NCT02883049|39874665|FG004|Induction|Incomplete induction data|0|||
16184149|NCT03042611|39155388|FG003|Core Phase|Physician Decision|0|||
16184150|NCT03042611|39155385|FG000|Core Phase|Study Closed|0|||
16184151|NCT03042611|39155386|FG001|Core Phase|Study Closed|1|||
16184152|NCT03042611|39155387|FG002|Core Phase|Study Closed|0|||
16184153|NCT03042611|39155388|FG003|Core Phase|Study Closed|0|||
16379228|NCT02883049|39874666|FG005|Induction|Incomplete induction data|0|||
16379229|NCT02883049|39874667|FG006|Induction|Incomplete induction data|0|||
16379230|NCT02883049|39874668|FG007|Induction|Incomplete induction data|0|||
16379231|NCT02883049|39874669|FG008|Induction|Incomplete induction data|0|||
16379232|NCT02883049|39874670|FG009|Induction|Incomplete induction data|0|||
16379233|NCT02883049|39874671|FG010|Induction|Incomplete induction data|0|||
16184154|NCT03042611|39155385|FG000|Extension Phase|Death|0|||
16184155|NCT03042611|39155386|FG001|Extension Phase|Death|0|||
16184156|NCT03042611|39155387|FG002|Extension Phase|Death|34|||
16184157|NCT03042611|39155388|FG003|Extension Phase|Death|16|||
16184158|NCT03042611|39155385|FG000|Extension Phase|Lost to Follow-up|0|||
16184159|NCT03042611|39155386|FG001|Extension Phase|Lost to Follow-up|0|||
16184160|NCT03042611|39155387|FG002|Extension Phase|Lost to Follow-up|1|||
16184161|NCT03042611|39155388|FG003|Extension Phase|Lost to Follow-up|1|||
16184162|NCT03042611|39155385|FG000|Extension Phase|Study Closed|0|||
16184163|NCT03042611|39155386|FG001|Extension Phase|Study Closed|0|||
16184164|NCT03042611|39155387|FG002|Extension Phase|Study Closed|17|||
16184165|NCT03042611|39155388|FG003|Extension Phase|Study Closed|11|||
16184166|NCT00923091|39155392|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
16184167|NCT00923091|39155393|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
16184168|NCT00923091|39155394|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
16184169|NCT00923091|39155395|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
16184170|NCT00923091|39155396|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
16184171|NCT00923091|39155397|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
16184172|NCT00923091|39155398|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
16184173|NCT00923091|39155399|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
16184174|NCT00923091|39155400|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
16184175|NCT00923091|39155401|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
16184176|NCT00923091|39155402|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
16184177|NCT00923091|39155403|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
16184178|NCT00923091|39155404|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
16184179|NCT00923091|39155392|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
16184180|NCT00923091|39155393|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
16184181|NCT00923091|39155394|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
16184182|NCT00923091|39155395|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
16184183|NCT00923091|39155396|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
16184184|NCT00923091|39155397|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
16184185|NCT00923091|39155398|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
16184186|NCT00923091|39155399|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
16184187|NCT00923091|39155400|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
16184188|NCT00923091|39155401|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
16184189|NCT00923091|39155402|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
16184190|NCT00923091|39155403|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
16184191|NCT00923091|39155404|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
16184192|NCT00923091|39155392|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
16184193|NCT00923091|39155393|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
16184194|NCT00923091|39155394|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
16184195|NCT00923091|39155395|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
16184196|NCT00923091|39155396|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
16184197|NCT00923091|39155397|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
16184198|NCT00923091|39155398|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
16184199|NCT00923091|39155399|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
16184200|NCT00923091|39155400|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
16184201|NCT00923091|39155401|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
16184202|NCT00923091|39155402|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
16184203|NCT00923091|39155403|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
16184204|NCT00923091|39155404|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
16184205|NCT00923091|39155392|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184206|NCT00923091|39155393|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184207|NCT00923091|39155394|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184208|NCT00923091|39155395|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184209|NCT00923091|39155396|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184210|NCT00923091|39155397|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
16184211|NCT00923091|39155398|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184212|NCT00923091|39155399|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184213|NCT00923091|39155400|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184214|NCT00923091|39155401|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184215|NCT00923091|39155402|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184216|NCT00923091|39155403|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184217|NCT00923091|39155404|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
16184218|NCT00923091|39155392|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16184219|NCT00923091|39155393|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
16184220|NCT00923091|39155394|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16184221|NCT00923091|39155395|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
16184222|NCT00923091|39155396|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16184223|NCT00923091|39155397|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
16184224|NCT00923091|39155398|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16184225|NCT00923091|39155399|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16184226|NCT00923091|39155400|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16184227|NCT00923091|39155401|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16184228|NCT00923091|39155402|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16184229|NCT00923091|39155403|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16184230|NCT00923091|39155404|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
16184231|NCT00923091|39155392|FG000|Period III (Single-Blind)|Adverse Event|5|||
16184232|NCT00923091|39155393|FG001|Period III (Single-Blind)|Adverse Event|0|||
16184233|NCT00923091|39155394|FG002|Period III (Single-Blind)|Adverse Event|0|||
16184234|NCT00923091|39155395|FG003|Period III (Single-Blind)|Adverse Event|0|||
16184235|NCT00923091|39155396|FG004|Period III (Single-Blind)|Adverse Event|0|||
16184236|NCT00923091|39155397|FG005|Period III (Single-Blind)|Adverse Event|0|||
16184237|NCT00923091|39155398|FG006|Period III (Single-Blind)|Adverse Event|0|||
16184238|NCT00923091|39155399|FG007|Period III (Single-Blind)|Adverse Event|0|||
16184239|NCT00923091|39155400|FG008|Period III (Single-Blind)|Adverse Event|0|||
16184240|NCT00923091|39155401|FG009|Period III (Single-Blind)|Adverse Event|0|||
16184241|NCT00923091|39155402|FG010|Period III (Single-Blind)|Adverse Event|0|||
16184242|NCT00923091|39155403|FG011|Period III (Single-Blind)|Adverse Event|0|||
16184243|NCT00923091|39155404|FG012|Period III (Single-Blind)|Adverse Event|0|||
16184244|NCT00923091|39155392|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
16184245|NCT00923091|39155393|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184246|NCT00923091|39155394|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184247|NCT00923091|39155395|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184248|NCT00923091|39155396|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184249|NCT00923091|39155397|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184250|NCT00923091|39155398|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184251|NCT00923091|39155399|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184252|NCT00923091|39155400|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184253|NCT00923091|39155401|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184254|NCT00923091|39155402|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184255|NCT00923091|39155403|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184256|NCT00923091|39155404|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
16184257|NCT00923091|39155392|FG000|Period III (Single-Blind)|Protocol Violation|3|||
16184258|NCT00923091|39155393|FG001|Period III (Single-Blind)|Protocol Violation|0|||
16184259|NCT00923091|39155394|FG002|Period III (Single-Blind)|Protocol Violation|0|||
16184260|NCT00923091|39155395|FG003|Period III (Single-Blind)|Protocol Violation|0|||
16184261|NCT00923091|39155396|FG004|Period III (Single-Blind)|Protocol Violation|0|||
16184262|NCT00923091|39155397|FG005|Period III (Single-Blind)|Protocol Violation|0|||
16184263|NCT00923091|39155398|FG006|Period III (Single-Blind)|Protocol Violation|0|||
16184264|NCT00923091|39155399|FG007|Period III (Single-Blind)|Protocol Violation|0|||
16184265|NCT00923091|39155400|FG008|Period III (Single-Blind)|Protocol Violation|0|||
16184266|NCT00923091|39155401|FG009|Period III (Single-Blind)|Protocol Violation|0|||
16184267|NCT00923091|39155402|FG010|Period III (Single-Blind)|Protocol Violation|0|||
16184268|NCT00923091|39155403|FG011|Period III (Single-Blind)|Protocol Violation|0|||
16184269|NCT00923091|39155404|FG012|Period III (Single-Blind)|Protocol Violation|0|||
16184270|NCT00923091|39155392|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
16184271|NCT00923091|39155393|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
16184272|NCT00923091|39155394|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
16184273|NCT00923091|39155395|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
16184274|NCT00923091|39155396|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
16379234|NCT02883049|39874672|FG011|Induction|Incomplete induction data|0|||
16379235|NCT02883049|39874673|FG012|Induction|Incomplete induction data|0|||
16379236|NCT02883049|39874674|FG013|Induction|Incomplete induction data|0|||
16379237|NCT02883049|39874675|FG014|Induction|Incomplete induction data|0|||
16546303|NCT02237508|40464777|FG004|Overall Study|Withdrawal by Subject|0|||
16184275|NCT00923091|39155397|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
16184276|NCT00923091|39155398|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
16379238|NCT02883049|39874676|FG015|Induction|Incomplete induction data|0|||
16184277|NCT00923091|39155399|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
16184278|NCT00923091|39155400|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
16184279|NCT00923091|39155401|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
16184280|NCT00923091|39155402|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
16184281|NCT00923091|39155403|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
16184282|NCT00923091|39155404|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
16184283|NCT00923091|39155392|FG000|Period IV (Double-Blind)|Adverse Event|2|||
16184284|NCT00923091|39155393|FG001|Period IV (Double-Blind)|Adverse Event|0|||
16184285|NCT00923091|39155394|FG002|Period IV (Double-Blind)|Adverse Event|0|||
16184286|NCT00923091|39155395|FG003|Period IV (Double-Blind)|Adverse Event|0|||
16379239|NCT02883049|39874661|FG000|Post Induction|Adverse Event|0|||
16379240|NCT02883049|39874662|FG001|Post Induction|Adverse Event|0|||
16478999|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16184287|NCT00923091|39155396|FG004|Period IV (Double-Blind)|Adverse Event|0|||
16184288|NCT00923091|39155397|FG005|Period IV (Double-Blind)|Adverse Event|0|||
16184289|NCT00923091|39155398|FG006|Period IV (Double-Blind)|Adverse Event|0|||
16184290|NCT00923091|39155399|FG007|Period IV (Double-Blind)|Adverse Event|0|||
16184291|NCT00923091|39155400|FG008|Period IV (Double-Blind)|Adverse Event|0|||
16184292|NCT00923091|39155401|FG009|Period IV (Double-Blind)|Adverse Event|0|||
16184293|NCT00923091|39155402|FG010|Period IV (Double-Blind)|Adverse Event|0|||
16184294|NCT00923091|39155403|FG011|Period IV (Double-Blind)|Adverse Event|0|||
16184295|NCT00923091|39155404|FG012|Period IV (Double-Blind)|Adverse Event|0|||
16184296|NCT00923091|39155392|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184297|NCT00923091|39155393|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
16184298|NCT00923091|39155394|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184299|NCT00923091|39155395|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184300|NCT00923091|39155396|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184301|NCT00923091|39155397|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184302|NCT00923091|39155398|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184303|NCT00923091|39155399|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184304|NCT00923091|39155400|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184305|NCT00923091|39155401|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184306|NCT00923091|39155402|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184307|NCT00923091|39155403|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184308|NCT00923091|39155404|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
16184309|NCT00923091|39155392|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
16184310|NCT00923091|39155393|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
16184311|NCT00923091|39155394|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
16184312|NCT00923091|39155395|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
16184313|NCT00923091|39155396|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
16184314|NCT00923091|39155397|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
16184315|NCT00923091|39155398|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
16184316|NCT00923091|39155399|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
16184317|NCT00923091|39155400|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
16184318|NCT00923091|39155401|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
16184319|NCT00923091|39155402|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
16184320|NCT00923091|39155403|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
16184321|NCT00923091|39155404|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
16184322|NCT00923091|39155392|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184323|NCT00923091|39155393|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184324|NCT00923091|39155394|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184325|NCT00923091|39155395|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184326|NCT00923091|39155396|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184327|NCT00923091|39155397|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184328|NCT00923091|39155398|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184329|NCT00923091|39155399|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184330|NCT00923091|39155400|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
16184331|NCT00923091|39155401|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184332|NCT00923091|39155402|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184333|NCT00923091|39155403|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
16184334|NCT00923091|39155404|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
16184335|NCT00923091|39155392|FG000|Period V (Double -Blind)|Protocol Violation|0|||
16184336|NCT00923091|39155393|FG001|Period V (Double -Blind)|Protocol Violation|0|||
16184337|NCT00923091|39155394|FG002|Period V (Double -Blind)|Protocol Violation|0|||
16184338|NCT00923091|39155395|FG003|Period V (Double -Blind)|Protocol Violation|0|||
16184339|NCT00923091|39155396|FG004|Period V (Double -Blind)|Protocol Violation|0|||
16184340|NCT00923091|39155397|FG005|Period V (Double -Blind)|Protocol Violation|0|||
16184341|NCT00923091|39155398|FG006|Period V (Double -Blind)|Protocol Violation|0|||
16184342|NCT00923091|39155399|FG007|Period V (Double -Blind)|Protocol Violation|0|||
16184343|NCT00923091|39155400|FG008|Period V (Double -Blind)|Protocol Violation|0|||
16184344|NCT00923091|39155401|FG009|Period V (Double -Blind)|Protocol Violation|0|||
16184345|NCT00923091|39155402|FG010|Period V (Double -Blind)|Protocol Violation|0|||
16184346|NCT00923091|39155403|FG011|Period V (Double -Blind)|Protocol Violation|0|||
16184347|NCT00923091|39155404|FG012|Period V (Double -Blind)|Protocol Violation|1|||
16184348|NCT00923091|39155392|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
16184349|NCT00923091|39155393|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
16184350|NCT00923091|39155394|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
16184351|NCT00923091|39155395|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
16184352|NCT00923091|39155396|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
16184353|NCT00923091|39155397|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
16184354|NCT00923091|39155398|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
16184355|NCT00923091|39155399|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
16184356|NCT00923091|39155400|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
16184357|NCT00923091|39155401|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
16184358|NCT00923091|39155402|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
16184359|NCT00923091|39155403|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
16184360|NCT00923091|39155404|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
16184361|NCT00923091|39155392|FG000|Period VI (Open-Label)|Adverse Event|17|||
16184362|NCT00923091|39155393|FG001|Period VI (Open-Label)|Adverse Event|0|||
16184363|NCT00923091|39155394|FG002|Period VI (Open-Label)|Adverse Event|4|||
16184364|NCT00923091|39155395|FG003|Period VI (Open-Label)|Adverse Event|1|||
16184365|NCT00923091|39155396|FG004|Period VI (Open-Label)|Adverse Event|1|||
16184366|NCT00923091|39155397|FG005|Period VI (Open-Label)|Adverse Event|0|||
16184367|NCT00923091|39155398|FG006|Period VI (Open-Label)|Adverse Event|0|||
16184368|NCT00923091|39155399|FG007|Period VI (Open-Label)|Adverse Event|0|||
16184369|NCT00923091|39155400|FG008|Period VI (Open-Label)|Adverse Event|0|||
16184370|NCT00923091|39155401|FG009|Period VI (Open-Label)|Adverse Event|0|||
16184371|NCT00923091|39155402|FG010|Period VI (Open-Label)|Adverse Event|0|||
16184372|NCT00923091|39155403|FG011|Period VI (Open-Label)|Adverse Event|0|||
16184373|NCT00923091|39155404|FG012|Period VI (Open-Label)|Adverse Event|0|||
16184374|NCT00923091|39155392|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
16184375|NCT00923091|39155393|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
16184376|NCT00923091|39155394|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
16184377|NCT00923091|39155395|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
16184378|NCT00923091|39155396|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
16184379|NCT00923091|39155397|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
16184380|NCT00923091|39155398|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
16184381|NCT00923091|39155399|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
16184382|NCT00923091|39155400|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
16184383|NCT00923091|39155401|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
16184384|NCT00923091|39155402|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
16184385|NCT00923091|39155403|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
16184386|NCT00923091|39155404|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
16184387|NCT00923091|39155392|FG000|Period VI (Open-Label)|Protocol Violation|6|||
16184388|NCT00923091|39155393|FG001|Period VI (Open-Label)|Protocol Violation|1|||
16184389|NCT00923091|39155394|FG002|Period VI (Open-Label)|Protocol Violation|3|||
16184390|NCT00923091|39155395|FG003|Period VI (Open-Label)|Protocol Violation|1|||
16184391|NCT00923091|39155396|FG004|Period VI (Open-Label)|Protocol Violation|4|||
16184392|NCT00923091|39155397|FG005|Period VI (Open-Label)|Protocol Violation|0|||
16184393|NCT00923091|39155398|FG006|Period VI (Open-Label)|Protocol Violation|0|||
16184394|NCT00923091|39155399|FG007|Period VI (Open-Label)|Protocol Violation|0|||
16184395|NCT00923091|39155400|FG008|Period VI (Open-Label)|Protocol Violation|0|||
16184396|NCT00923091|39155401|FG009|Period VI (Open-Label)|Protocol Violation|0|||
16184397|NCT00923091|39155402|FG010|Period VI (Open-Label)|Protocol Violation|0|||
16184398|NCT00923091|39155403|FG011|Period VI (Open-Label)|Protocol Violation|0|||
16184399|NCT00923091|39155404|FG012|Period VI (Open-Label)|Protocol Violation|0|||
16184400|NCT00923091|39155392|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
16184401|NCT00923091|39155393|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
16184402|NCT00923091|39155394|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
16184403|NCT00923091|39155395|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
16184404|NCT00923091|39155396|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
16184405|NCT00923091|39155397|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
16184406|NCT00923091|39155398|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
16184407|NCT00923091|39155399|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
16184408|NCT00923091|39155400|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
16184409|NCT00923091|39155401|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
16184410|NCT00923091|39155402|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
16184411|NCT00923091|39155403|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
16184412|NCT00923091|39155404|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
16184413|NCT00923091|39155392|FG000|Period VI (Open-Label)|Other Reason|0|||
16184414|NCT00923091|39155393|FG001|Period VI (Open-Label)|Other Reason|0|||
16184415|NCT00923091|39155394|FG002|Period VI (Open-Label)|Other Reason|0|||
16184416|NCT00923091|39155395|FG003|Period VI (Open-Label)|Other Reason|1|||
16184417|NCT00923091|39155396|FG004|Period VI (Open-Label)|Other Reason|1|||
16379241|NCT02883049|39874663|FG002|Post Induction|Adverse Event|0|||
16379242|NCT02883049|39874664|FG003|Post Induction|Adverse Event|7|||
16379243|NCT02883049|39874665|FG004|Post Induction|Adverse Event|8|||
16379244|NCT02883049|39874666|FG005|Post Induction|Adverse Event|3|||
16379245|NCT02883049|39874667|FG006|Post Induction|Adverse Event|4|||
16379246|NCT02883049|39874668|FG007|Post Induction|Adverse Event|5|||
16379247|NCT02883049|39874669|FG008|Post Induction|Adverse Event|6|||
16379248|NCT02883049|39874670|FG009|Post Induction|Adverse Event|7|||
16379249|NCT02883049|39874671|FG010|Post Induction|Adverse Event|2|||
16379250|NCT02883049|39874672|FG011|Post Induction|Adverse Event|2|||
16379251|NCT02883049|39874673|FG012|Post Induction|Adverse Event|0|||
16379252|NCT02883049|39874674|FG013|Post Induction|Adverse Event|0|||
16379253|NCT02883049|39874675|FG014|Post Induction|Adverse Event|5|||
16379254|NCT02883049|39874676|FG015|Post Induction|Adverse Event|2|||
16184418|NCT00923091|39155397|FG005|Period VI (Open-Label)|Other Reason|0|||
16184419|NCT00923091|39155398|FG006|Period VI (Open-Label)|Other Reason|0|||
16184420|NCT00923091|39155399|FG007|Period VI (Open-Label)|Other Reason|0|||
16184421|NCT00923091|39155400|FG008|Period VI (Open-Label)|Other Reason|0|||
16184422|NCT00923091|39155401|FG009|Period VI (Open-Label)|Other Reason|0|||
16184423|NCT00923091|39155402|FG010|Period VI (Open-Label)|Other Reason|0|||
16184424|NCT00923091|39155403|FG011|Period VI (Open-Label)|Other Reason|0|||
16184425|NCT00923091|39155404|FG012|Period VI (Open-Label)|Other Reason|0|||
16184426|NCT00515463|39155405|FG000|Overall Study|Physician Decision|4|||
16184427|NCT00515463|39155406|FG001|Overall Study|Physician Decision|2|||
16184428|NCT00515463|39155405|FG000|Overall Study|Adverse Event|1|||
16184429|NCT00515463|39155406|FG001|Overall Study|Adverse Event|2|||
16184430|NCT00515463|39155405|FG000|Overall Study|Withdrawal by Subject|3|||
16184431|NCT00515463|39155406|FG001|Overall Study|Withdrawal by Subject|4|||
16184432|NCT00515463|39155405|FG000|Overall Study|Lost to Follow-up|6|||
16184433|NCT00515463|39155406|FG001|Overall Study|Lost to Follow-up|5|||
16184434|NCT00515463|39155405|FG000|Overall Study|Other|0|||
16184435|NCT00515463|39155406|FG001|Overall Study|Other|1|||
16184436|NCT04743635|39155410|FG000|Overall Study|Lost to Follow-up|2|||
16184437|NCT04743635|39155411|FG001|Overall Study|Lost to Follow-up|0|||
16184438|NCT02452970|39155412|FG000|Overall Study|Adverse Event|1|||
16184439|NCT02160977|39155413|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
16184440|NCT02160977|39155414|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
16184441|NCT02160977|39155413|FG000|Three Months After Surgery|Lost to Follow-up|0|||
16184442|NCT02160977|39155414|FG001|Three Months After Surgery|Lost to Follow-up|2|||
16184443|NCT02160977|39155413|FG000|Six Months After Surgery|Lost to Follow-up|2|||
16184444|NCT02160977|39155414|FG001|Six Months After Surgery|Lost to Follow-up|1|||
16184445|NCT01678807|39155415|FG000|Overall Study|Adverse Event|4|||
16184446|NCT01678807|39155416|FG001|Overall Study|Adverse Event|4|||
16184447|NCT01678807|39155417|FG002|Overall Study|Adverse Event|0|||
16184448|NCT01678807|39155415|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
16184449|NCT01678807|39155416|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
16184450|NCT01678807|39155417|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
16184451|NCT01734993|39155418|FG000|Overall Study|Adverse Event|1|||
16184452|NCT01734993|39155418|FG000|Overall Study|Lack of Efficacy|1|||
16184453|NCT03662334|39155420|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
16184454|NCT03662334|39155421|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
16184455|NCT03135028|39155434|FG000|Overall Study|Death|6|||
16184456|NCT03135028|39155434|FG000|Overall Study|Study Terminated by Sponsor|2|||
16184457|NCT03135028|39155434|FG000|Overall Study|Withdrew Consent|1|||
16184458|NCT02815397|39155435|FG000|Overall Study|Physician Decision|2|||
16184459|NCT00779038|39155436|FG000|Overall Study|Study Prematurely Terminated|13|||
16184460|NCT02062151|39155439|FG000|Overall Study|screen failure|1|||
16184461|NCT01214616|39155440|FG000|Overall Study|Progressive disease|2|||
16184462|NCT01214616|39155441|FG001|Overall Study|Progressive disease|2|||
16184463|NCT01214616|39155442|FG002|Overall Study|Progressive disease|2|||
16184464|NCT01214616|39155443|FG003|Overall Study|Progressive disease|4|||
16184465|NCT01214616|39155440|FG000|Overall Study|Dose limiting toxicity|0|||
16184466|NCT01214616|39155441|FG001|Overall Study|Dose limiting toxicity|2|||
16184467|NCT01214616|39155442|FG002|Overall Study|Dose limiting toxicity|0|||
16184468|NCT01214616|39155443|FG003|Overall Study|Dose limiting toxicity|0|||
16379255|NCT02883049|39874661|FG000|Post Induction|Death|0|||
16379256|NCT02883049|39874662|FG001|Post Induction|Death|0|||
16379257|NCT02883049|39874663|FG002|Post Induction|Death|0|||
16184469|NCT01214616|39155440|FG000|Overall Study|Other adverse events|0|||
16184470|NCT01214616|39155441|FG001|Overall Study|Other adverse events|1|||
16184471|NCT01214616|39155442|FG002|Overall Study|Other adverse events|1|||
16184472|NCT01214616|39155443|FG003|Overall Study|Other adverse events|1|||
16184473|NCT01214616|39155440|FG000|Overall Study|Withdrawal by Subject|1|||
16184474|NCT01214616|39155441|FG001|Overall Study|Withdrawal by Subject|0|||
16184475|NCT01214616|39155442|FG002|Overall Study|Withdrawal by Subject|0|||
16184476|NCT01214616|39155443|FG003|Overall Study|Withdrawal by Subject|1|||
16379258|NCT02883049|39874664|FG003|Post Induction|Death|9|||
16379259|NCT02883049|39874665|FG004|Post Induction|Death|9|||
16184477|NCT00399802|39155446|FG000|Overall Study|Adverse Event|0|||
16184478|NCT00399802|39155447|FG001|Overall Study|Adverse Event|2|||
16184479|NCT00399802|39155446|FG000|Overall Study|Participant discontinued by mistake|0|||
16184480|NCT00399802|39155447|FG001|Overall Study|Participant discontinued by mistake|1|||
16184481|NCT03123939|39155451|FG000|Overall Study|Lack of Efficacy|6|||
16184482|NCT03123939|39155451|FG000|Overall Study|Death|5|||
16184483|NCT03123939|39155451|FG000|Overall Study|Physician Decision|2|||
16184484|NCT03123939|39155451|FG000|Overall Study|Subject/guardian decision|2|||
16184485|NCT03123939|39155451|FG000|Overall Study|Lost to Follow-up|1|||
16184486|NCT03123939|39155451|FG000|Overall Study|New therapy for study indication|1|||
16184487|NCT03123939|39155451|FG000|Overall Study|Protocol deviation|1|||
16184488|NCT03123939|39155451|FG000|Overall Study|Progressive disease|18|||
16184489|NCT03123939|39155451|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
16184490|NCT03123939|39155451|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
16184491|NCT02229864|39155458|FG000|Overall Study|Death|2|||
16184492|NCT02229864|39155458|FG000|Overall Study|Lost to Follow-up|1|||
16184493|NCT02504892|39155461|FG000|Overall Study|Adverse event-pneumonitis|2|||
16184494|NCT01486316|39155465|FG000|Overall Study|Device explanted with/without re-implant|3|||
16184495|NCT01486316|39155466|FG001|Overall Study|Device explanted with/without re-implant|2|||
16184496|NCT01486316|39155467|FG002|Overall Study|Device explanted with/without re-implant|0|||
16184497|NCT01486316|39155468|FG003|Overall Study|Device explanted with/without re-implant|2|||
16184498|NCT01486316|39155465|FG000|Overall Study|Not meeting eligibility criteria|0|||
16184499|NCT01486316|39155466|FG001|Overall Study|Not meeting eligibility criteria|0|||
16184500|NCT01486316|39155467|FG002|Overall Study|Not meeting eligibility criteria|1|||
16184501|NCT01486316|39155468|FG003|Overall Study|Not meeting eligibility criteria|0|||
16184502|NCT01486316|39155465|FG000|Overall Study|Withdrawal by Subject|1|||
16184503|NCT01486316|39155466|FG001|Overall Study|Withdrawal by Subject|0|||
16184504|NCT01486316|39155467|FG002|Overall Study|Withdrawal by Subject|3|||
16184505|NCT01486316|39155468|FG003|Overall Study|Withdrawal by Subject|0|||
16184506|NCT01486316|39155465|FG000|Overall Study|Physician Decision|0|||
16184507|NCT01486316|39155466|FG001|Overall Study|Physician Decision|0|||
16184508|NCT01486316|39155467|FG002|Overall Study|Physician Decision|1|||
16184509|NCT01486316|39155468|FG003|Overall Study|Physician Decision|0|||
16184510|NCT01486316|39155465|FG000|Overall Study|Death|0|||
16184511|NCT01486316|39155466|FG001|Overall Study|Death|1|||
16184512|NCT01486316|39155467|FG002|Overall Study|Death|0|||
16184513|NCT01486316|39155468|FG003|Overall Study|Death|0|||
16184514|NCT01318083|39155471|FG000|Overall Study|Adverse Event|4|||
16184515|NCT01318083|39155472|FG001|Overall Study|Adverse Event|1|||
16184516|NCT01318083|39155473|FG002|Overall Study|Adverse Event|2|||
16184517|NCT01318083|39155471|FG000|Overall Study|Withdrawal by Subject|1|||
16184518|NCT01318083|39155472|FG001|Overall Study|Withdrawal by Subject|0|||
16184519|NCT01318083|39155473|FG002|Overall Study|Withdrawal by Subject|2|||
16184520|NCT01318083|39155471|FG000|Overall Study|Lack of Efficacy|0|||
16184521|NCT01318083|39155472|FG001|Overall Study|Lack of Efficacy|0|||
16184522|NCT01318083|39155473|FG002|Overall Study|Lack of Efficacy|1|||
16379260|NCT02883049|39874666|FG005|Post Induction|Death|0|||
16379261|NCT02883049|39874667|FG006|Post Induction|Death|1|||
16379262|NCT02883049|39874668|FG007|Post Induction|Death|6|||
16379263|NCT02883049|39874669|FG008|Post Induction|Death|5|||
16379264|NCT02883049|39874670|FG009|Post Induction|Death|3|||
16379265|NCT02883049|39874671|FG010|Post Induction|Death|1|||
16379266|NCT02883049|39874672|FG011|Post Induction|Death|0|||
16379267|NCT02883049|39874673|FG012|Post Induction|Death|1|||
16379268|NCT02883049|39874674|FG013|Post Induction|Death|1|||
16379269|NCT02883049|39874675|FG014|Post Induction|Death|10|||
16379270|NCT02883049|39874676|FG015|Post Induction|Death|2|||
16379271|NCT02883049|39874661|FG000|Post Induction|Lost to Follow-up|0|||
16379272|NCT02883049|39874662|FG001|Post Induction|Lost to Follow-up|0|||
16379273|NCT02883049|39874663|FG002|Post Induction|Lost to Follow-up|0|||
16379274|NCT02883049|39874664|FG003|Post Induction|Lost to Follow-up|0|||
16379275|NCT02883049|39874665|FG004|Post Induction|Lost to Follow-up|1|||
16379276|NCT02883049|39874666|FG005|Post Induction|Lost to Follow-up|1|||
16184523|NCT01318083|39155471|FG000|Overall Study|Treatment Complications|1|||
16184524|NCT01318083|39155472|FG001|Overall Study|Treatment Complications|0|||
16184525|NCT01318083|39155473|FG002|Overall Study|Treatment Complications|0|||
16184526|NCT01318083|39155471|FG000|Overall Study|Lack of Study Medication Compliance|0|||
16184527|NCT01318083|39155472|FG001|Overall Study|Lack of Study Medication Compliance|1|||
16184528|NCT01318083|39155473|FG002|Overall Study|Lack of Study Medication Compliance|0|||
16184529|NCT00053846|39155474|FG000|Overall Study|Changed mind|8|||
16184530|NCT00053846|39155475|FG001|Overall Study|Changed mind|13|||
16184531|NCT00053846|39155474|FG000|Overall Study|Became too ill|8|||
16184532|NCT00053846|39155475|FG001|Overall Study|Became too ill|7|||
16184533|NCT00053846|39155474|FG000|Overall Study|Expired|5|||
16184534|NCT00053846|39155475|FG001|Overall Study|Expired|0|||
16184535|NCT00053846|39155474|FG000|Overall Study|Became ineligible|3|||
16379277|NCT02883049|39874667|FG006|Post Induction|Lost to Follow-up|0|||
16379278|NCT02883049|39874668|FG007|Post Induction|Lost to Follow-up|0|||
16184536|NCT00053846|39155475|FG001|Overall Study|Became ineligible|1|||
16184537|NCT00053846|39155474|FG000|Overall Study|Did not return data|1|||
16184538|NCT00053846|39155475|FG001|Overall Study|Did not return data|2|||
16184539|NCT00053846|39155474|FG000|Overall Study|Quit due to side effects|1|||
16184540|NCT00053846|39155475|FG001|Overall Study|Quit due to side effects|3|||
16184541|NCT00053846|39155474|FG000|Overall Study|Pills too large|0|||
16184542|NCT00053846|39155475|FG001|Overall Study|Pills too large|1|||
16184543|NCT00450866|39155480|FG000|Overall Study|Adverse Event|0|||
16184544|NCT00450866|39155481|FG001|Overall Study|Adverse Event|1|||
16184545|NCT00450866|39155480|FG000|Overall Study|Withdrawal by Subject|5|||
16184546|NCT00450866|39155481|FG001|Overall Study|Withdrawal by Subject|2|||
16184547|NCT00450866|39155480|FG000|Overall Study|Death|1|||
16184548|NCT00450866|39155481|FG001|Overall Study|Death|0|||
16184549|NCT00450866|39155480|FG000|Overall Study|Physician Decision|1|||
16184550|NCT00450866|39155481|FG001|Overall Study|Physician Decision|0|||
16184551|NCT00309777|39155483|FG000|Overall Study|Adverse Event|13|||
16184552|NCT00309777|39155484|FG001|Overall Study|Adverse Event|2|||
16184553|NCT00309777|39155485|FG002|Overall Study|Adverse Event|8|||
16184554|NCT00309777|39155486|FG003|Overall Study|Adverse Event|1|||
16184555|NCT00309777|39155483|FG000|Overall Study|Protocol Violation|4|||
16184556|NCT00309777|39155484|FG001|Overall Study|Protocol Violation|1|||
16184557|NCT00309777|39155485|FG002|Overall Study|Protocol Violation|3|||
16184558|NCT00309777|39155486|FG003|Overall Study|Protocol Violation|1|||
16184559|NCT00309777|39155483|FG000|Overall Study|Withdrawal by Subject|6|||
16379279|NCT02883049|39874669|FG008|Post Induction|Lost to Follow-up|3|||
16379280|NCT02883049|39874670|FG009|Post Induction|Lost to Follow-up|0|||
16379281|NCT02883049|39874671|FG010|Post Induction|Lost to Follow-up|1|||
16379282|NCT02883049|39874672|FG011|Post Induction|Lost to Follow-up|0|||
16379283|NCT02883049|39874673|FG012|Post Induction|Lost to Follow-up|0|||
16379284|NCT02883049|39874674|FG013|Post Induction|Lost to Follow-up|0|||
16379285|NCT02883049|39874675|FG014|Post Induction|Lost to Follow-up|0|||
16184560|NCT00309777|39155484|FG001|Overall Study|Withdrawal by Subject|5|||
16184561|NCT00309777|39155485|FG002|Overall Study|Withdrawal by Subject|7|||
16184562|NCT00309777|39155486|FG003|Overall Study|Withdrawal by Subject|2|||
16184563|NCT00309777|39155483|FG000|Overall Study|Lost to Follow-up|0|||
16379286|NCT02883049|39874676|FG015|Post Induction|Lost to Follow-up|0|||
16379287|NCT02883049|39874661|FG000|Post Induction|Physician Decision|0|||
16379288|NCT02883049|39874662|FG001|Post Induction|Physician Decision|0|||
16379289|NCT02883049|39874663|FG002|Post Induction|Physician Decision|0|||
16379290|NCT02883049|39874664|FG003|Post Induction|Physician Decision|27|||
16379291|NCT02883049|39874665|FG004|Post Induction|Physician Decision|27|||
16379292|NCT02883049|39874666|FG005|Post Induction|Physician Decision|23|||
16379293|NCT02883049|39874667|FG006|Post Induction|Physician Decision|30|||
16379294|NCT02883049|39874668|FG007|Post Induction|Physician Decision|56|||
16379295|NCT02883049|39874669|FG008|Post Induction|Physician Decision|85|||
16379296|NCT02883049|39874670|FG009|Post Induction|Physician Decision|12|||
16379297|NCT02883049|39874671|FG010|Post Induction|Physician Decision|5|||
16379298|NCT02883049|39874672|FG011|Post Induction|Physician Decision|14|||
16379299|NCT02883049|39874673|FG012|Post Induction|Physician Decision|1|||
16379300|NCT02883049|39874674|FG013|Post Induction|Physician Decision|11|||
16184564|NCT00309777|39155484|FG001|Overall Study|Lost to Follow-up|0|||
16184565|NCT00309777|39155485|FG002|Overall Study|Lost to Follow-up|1|||
16184566|NCT00309777|39155486|FG003|Overall Study|Lost to Follow-up|0|||
16184567|NCT00309777|39155483|FG000|Overall Study|Death|0|||
16184568|NCT00309777|39155484|FG001|Overall Study|Death|1|||
16184569|NCT00309777|39155485|FG002|Overall Study|Death|0|||
16184570|NCT00309777|39155486|FG003|Overall Study|Death|0|||
16184571|NCT01753115|39155492|FG000|Overall Study|Lost to Follow-up|3|||
16184572|NCT01753115|39155493|FG001|Overall Study|Lost to Follow-up|6|||
16184573|NCT01753115|39155494|FG002|Overall Study|Lost to Follow-up|8|||
16184574|NCT01753115|39155492|FG000|Overall Study|Withdrawal by Subject|6|||
16379301|NCT02883049|39874675|FG014|Post Induction|Physician Decision|19|||
16184575|NCT01753115|39155493|FG001|Overall Study|Withdrawal by Subject|5|||
16184576|NCT01753115|39155494|FG002|Overall Study|Withdrawal by Subject|6|||
16184577|NCT01753115|39155492|FG000|Overall Study|Subject non-compliant|3|||
16184578|NCT01753115|39155493|FG001|Overall Study|Subject non-compliant|3|||
16184579|NCT01753115|39155494|FG002|Overall Study|Subject non-compliant|0|||
16184580|NCT01753115|39155492|FG000|Overall Study|Used excluded drug|0|||
16184581|NCT01753115|39155493|FG001|Overall Study|Used excluded drug|1|||
16184582|NCT01753115|39155494|FG002|Overall Study|Used excluded drug|0|||
16184583|NCT01780389|39155500|FG000|Overall Study|Adverse Event|1|||
16184584|NCT00257192|39155503|FG000|Overall Study|Adverse Event|21|||
16184585|NCT00257192|39155504|FG001|Overall Study|Adverse Event|10|||
16184586|NCT00257192|39155503|FG000|Overall Study|Laboratory abnormality|1|||
16184587|NCT00257192|39155504|FG001|Overall Study|Laboratory abnormality|1|||
16184588|NCT00257192|39155503|FG000|Overall Study|Lost to Follow-up|3|||
16184589|NCT00257192|39155504|FG001|Overall Study|Lost to Follow-up|3|||
16184590|NCT00257192|39155503|FG000|Overall Study|Insufficient clinical response|18|||
16184591|NCT00257192|39155504|FG001|Overall Study|Insufficient clinical response|18|||
16184592|NCT00257192|39155503|FG000|Overall Study|Withdrawal by Subject|14|||
16184593|NCT00257192|39155504|FG001|Overall Study|Withdrawal by Subject|2|||
16184594|NCT00257192|39155503|FG000|Overall Study|Randomized but not treated|0|||
16184595|NCT00257192|39155504|FG001|Overall Study|Randomized but not treated|1|||
16184596|NCT00257192|39155503|FG000|Overall Study|Study terminated by sponsor|1|||
16184597|NCT00257192|39155504|FG001|Overall Study|Study terminated by sponsor|0|||
16184598|NCT00257192|39155503|FG000|Overall Study|Miscellaneous|0|||
16184599|NCT00257192|39155504|FG001|Overall Study|Miscellaneous|4|||
16184600|NCT02874794|39155507|FG000|Overall Study|Physician Decision|3|||
16184601|NCT02874794|39155508|FG001|Overall Study|Physician Decision|2|||
16184602|NCT02874794|39155507|FG000|Overall Study|Withdrawal by Subject|2|||
16184603|NCT02874794|39155508|FG001|Overall Study|Withdrawal by Subject|8|||
16379302|NCT02883049|39874676|FG015|Post Induction|Physician Decision|5|||
16379303|NCT02883049|39874661|FG000|Post Induction|Protocol Violation|0|||
16184604|NCT02874794|39155507|FG000|Overall Study|Death|2|||
16184605|NCT02874794|39155508|FG001|Overall Study|Death|1|||
16184606|NCT01769404|39155509|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
16184607|NCT01769404|39155510|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
16184608|NCT01769404|39155509|FG000|Treatment Period 1|Withdrawal by Subject|3|||
16184609|NCT01769404|39155510|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16184610|NCT01769404|39155509|FG000|Treatment Period 1|Sponsor decision|1|||
16379304|NCT02883049|39874662|FG001|Post Induction|Protocol Violation|0|||
16184611|NCT01769404|39155510|FG001|Treatment Period 1|Sponsor decision|0|||
16184612|NCT01769404|39155509|FG000|Treatment Period 2|Sponsor decision|7|||
16184613|NCT01769404|39155510|FG001|Treatment Period 2|Sponsor decision|0|||
16184614|NCT01022853|39155513|FG000|Overall Study|Progressive disease|2|||
16184615|NCT01022853|39155514|FG001|Overall Study|Progressive disease|3|||
16184616|NCT01022853|39155515|FG002|Overall Study|Progressive disease|11|||
16184617|NCT01022853|39155516|FG003|Overall Study|Progressive disease|7|||
16184618|NCT01022853|39155517|FG004|Overall Study|Progressive disease|1|||
16184619|NCT01022853|39155513|FG000|Overall Study|Dose-limiting toxicity|0|||
16184620|NCT01022853|39155514|FG001|Overall Study|Dose-limiting toxicity|0|||
16184621|NCT01022853|39155515|FG002|Overall Study|Dose-limiting toxicity|0|||
16184622|NCT01022853|39155516|FG003|Overall Study|Dose-limiting toxicity|0|||
16184623|NCT01022853|39155517|FG004|Overall Study|Dose-limiting toxicity|1|||
16184624|NCT01022853|39155513|FG000|Overall Study|Withdrawal by Subject|0|||
16184625|NCT01022853|39155514|FG001|Overall Study|Withdrawal by Subject|1|||
16184626|NCT01022853|39155515|FG002|Overall Study|Withdrawal by Subject|1|||
16184627|NCT01022853|39155516|FG003|Overall Study|Withdrawal by Subject|1|||
16184628|NCT01022853|39155517|FG004|Overall Study|Withdrawal by Subject|0|||
16184629|NCT01022853|39155513|FG000|Overall Study|Other not stated above|1|||
16184630|NCT01022853|39155514|FG001|Overall Study|Other not stated above|0|||
16184631|NCT01022853|39155515|FG002|Overall Study|Other not stated above|1|||
16184632|NCT01022853|39155516|FG003|Overall Study|Other not stated above|0|||
16184633|NCT01022853|39155517|FG004|Overall Study|Other not stated above|0|||
16184634|NCT01319929|39155518|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
16184635|NCT01319929|39155519|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
16184636|NCT01319929|39155518|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
16184637|NCT01319929|39155519|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
16184638|NCT01319929|39155518|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
16184639|NCT01319929|39155519|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
16184640|NCT01319929|39155518|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
16184641|NCT01319929|39155519|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
16184642|NCT01319929|39155518|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
16184643|NCT01319929|39155519|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
16184644|NCT00803244|39155520|FG000|Overall Study|Adverse Event|1|||
16184645|NCT00803244|39155521|FG001|Overall Study|Adverse Event|2|||
16184646|NCT00803244|39155520|FG000|Overall Study|Withdrawal by Subject|2|||
16184647|NCT00803244|39155521|FG001|Overall Study|Withdrawal by Subject|3|||
16184648|NCT00803244|39155520|FG000|Overall Study|Any other reason not above-mentioned|4|||
16184649|NCT00803244|39155521|FG001|Overall Study|Any other reason not above-mentioned|10|||
16184650|NCT03268746|39155523|FG000|Overall Study|Withdrawal by Subject|1|||
16184651|NCT00515008|39155524|FG000|Overall Study|Lost to Follow-up|1|||
16184652|NCT00515008|39155525|FG001|Overall Study|Lost to Follow-up|0|||
16184653|NCT00515008|39155524|FG000|Overall Study|Declined|0|||
16379305|NCT02883049|39874663|FG002|Post Induction|Protocol Violation|0|||
16184654|NCT00515008|39155525|FG001|Overall Study|Declined|3|||
16184655|NCT00515008|39155524|FG000|Overall Study|Left the Boston Area|1|||
16184656|NCT00515008|39155525|FG001|Overall Study|Left the Boston Area|1|||
16184657|NCT00515008|39155524|FG000|Overall Study|Scheduling conflict|1|||
16184658|NCT00515008|39155525|FG001|Overall Study|Scheduling conflict|0|||
16184689|NCT01809262|39155538|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
16184690|NCT01809262|39155539|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
16184691|NCT01809262|39155540|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
16184692|NCT01809262|39155541|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
16184693|NCT01809262|39155542|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
16184694|NCT01809262|39155543|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
16184695|NCT01809262|39155544|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
16184696|NCT01809262|39155545|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
16184697|NCT01809262|39155546|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
16184698|NCT01809262|39155547|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
16184699|NCT01809262|39155538|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16184700|NCT01809262|39155539|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
16184701|NCT01809262|39155540|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16184702|NCT01809262|39155541|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16184703|NCT01809262|39155542|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16184704|NCT01809262|39155543|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16184705|NCT01809262|39155544|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16184706|NCT01809262|39155545|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16184707|NCT01809262|39155546|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16184708|NCT01809262|39155547|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
16184709|NCT02028338|39155555|FG000|Overall Study|Withdrawal by Subject|3|||
16184710|NCT02028338|39155556|FG001|Overall Study|Withdrawal by Subject|1|||
16184711|NCT02028338|39155555|FG000|Overall Study|Unable to contact participant|1|||
16184712|NCT02028338|39155556|FG001|Overall Study|Unable to contact participant|0|||
16184713|NCT02260193|39155557|FG000|Overall Study|Lack of Efficacy|0|||
16184714|NCT02260193|39155558|FG001|Overall Study|Lack of Efficacy|1|||
16080204|NCT01307267|38786795|FG014|Overall Study|Death|0|||
16184715|NCT02260193|39155559|FG002|Overall Study|Lack of Efficacy|6|||
16184716|NCT02260193|39155557|FG000|Overall Study|Adverse Event|3|||
16184717|NCT02260193|39155558|FG001|Overall Study|Adverse Event|4|||
16184718|NCT02260193|39155559|FG002|Overall Study|Adverse Event|1|||
16184719|NCT02260193|39155557|FG000|Overall Study|Protocol Violation|0|||
16184720|NCT02260193|39155558|FG001|Overall Study|Protocol Violation|4|||
16184721|NCT02260193|39155559|FG002|Overall Study|Protocol Violation|0|||
16379306|NCT02883049|39874664|FG003|Post Induction|Protocol Violation|0|||
16184722|NCT02260193|39155557|FG000|Overall Study|Withdrawal by Subject|3|||
16184723|NCT02260193|39155558|FG001|Overall Study|Withdrawal by Subject|0|||
16184724|NCT02260193|39155559|FG002|Overall Study|Withdrawal by Subject|2|||
16379307|NCT02883049|39874665|FG004|Post Induction|Protocol Violation|0|||
16184725|NCT02260193|39155557|FG000|Overall Study|Kidney Transplantation|0|||
16184726|NCT02260193|39155558|FG001|Overall Study|Kidney Transplantation|0|||
16184727|NCT02260193|39155559|FG002|Overall Study|Kidney Transplantation|1|||
16379308|NCT02883049|39874666|FG005|Post Induction|Protocol Violation|0|||
16379309|NCT02883049|39874667|FG006|Post Induction|Protocol Violation|0|||
16379310|NCT02883049|39874668|FG007|Post Induction|Protocol Violation|1|||
16379311|NCT02883049|39874669|FG008|Post Induction|Protocol Violation|0|||
16379312|NCT02883049|39874670|FG009|Post Induction|Protocol Violation|0|||
16379313|NCT02883049|39874671|FG010|Post Induction|Protocol Violation|0|||
16379314|NCT02883049|39874672|FG011|Post Induction|Protocol Violation|0|||
16379315|NCT02883049|39874673|FG012|Post Induction|Protocol Violation|0|||
16379316|NCT02883049|39874674|FG013|Post Induction|Protocol Violation|0|||
16379317|NCT02883049|39874675|FG014|Post Induction|Protocol Violation|0|||
16379318|NCT02883049|39874676|FG015|Post Induction|Protocol Violation|0|||
16379319|NCT02883049|39874661|FG000|Post Induction|Withdrawal by Subject|0|||
16379320|NCT02883049|39874662|FG001|Post Induction|Withdrawal by Subject|0|||
16379321|NCT02883049|39874663|FG002|Post Induction|Withdrawal by Subject|0|||
16379322|NCT02883049|39874664|FG003|Post Induction|Withdrawal by Subject|5|||
16379323|NCT02883049|39874665|FG004|Post Induction|Withdrawal by Subject|2|||
16379324|NCT02883049|39874666|FG005|Post Induction|Withdrawal by Subject|1|||
16379325|NCT02883049|39874667|FG006|Post Induction|Withdrawal by Subject|0|||
16379326|NCT02883049|39874668|FG007|Post Induction|Withdrawal by Subject|0|||
16379327|NCT02883049|39874669|FG008|Post Induction|Withdrawal by Subject|2|||
16379328|NCT02883049|39874670|FG009|Post Induction|Withdrawal by Subject|0|||
16379329|NCT02883049|39874671|FG010|Post Induction|Withdrawal by Subject|1|||
16379330|NCT02883049|39874672|FG011|Post Induction|Withdrawal by Subject|1|||
16379331|NCT02883049|39874673|FG012|Post Induction|Withdrawal by Subject|0|||
16379332|NCT02883049|39874674|FG013|Post Induction|Withdrawal by Subject|0|||
16379333|NCT02883049|39874675|FG014|Post Induction|Withdrawal by Subject|1|||
16379334|NCT02883049|39874676|FG015|Post Induction|Withdrawal by Subject|0|||
16379335|NCT02883049|39874661|FG000|Post Induction|Ineligible|0|||
16379336|NCT02883049|39874662|FG001|Post Induction|Ineligible|0|||
16379337|NCT02883049|39874663|FG002|Post Induction|Ineligible|2|||
16379338|NCT02883049|39874664|FG003|Post Induction|Ineligible|0|||
16379339|NCT02883049|39874665|FG004|Post Induction|Ineligible|0|||
16379340|NCT02883049|39874666|FG005|Post Induction|Ineligible|0|||
16379341|NCT02883049|39874667|FG006|Post Induction|Ineligible|1|||
16379342|NCT02883049|39874668|FG007|Post Induction|Ineligible|0|||
16379343|NCT02883049|39874669|FG008|Post Induction|Ineligible|0|||
16379344|NCT02883049|39874670|FG009|Post Induction|Ineligible|0|||
16379345|NCT02883049|39874671|FG010|Post Induction|Ineligible|1|||
16379346|NCT02883049|39874672|FG011|Post Induction|Ineligible|0|||
16379347|NCT02883049|39874673|FG012|Post Induction|Ineligible|0|||
16379348|NCT02883049|39874674|FG013|Post Induction|Ineligible|0|||
16379349|NCT02883049|39874675|FG014|Post Induction|Ineligible|0|||
16379350|NCT02883049|39874676|FG015|Post Induction|Ineligible|1|||
16184728|NCT01327339|39155560|FG000|Overall Study|Protocol Violation|8|||
16184729|NCT01733316|39155561|FG000|RP103 Phase|Non-compliance|1|||
16184730|NCT01733316|39155561|FG000|Long Term Extension Phase|Adverse Event|1|||
16184731|NCT01733316|39155561|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
16184732|NCT01733316|39155561|FG000|Long Term Extension Phase|Sponsor Decision|2|||
16184733|NCT01605396|39155567|FG000|Overall Study|Adverse Event|5|||
16184734|NCT01605396|39155568|FG001|Overall Study|Adverse Event|3|||
16184735|NCT01605396|39155567|FG000|Overall Study|Lost to Follow-up|1|||
16184736|NCT01605396|39155568|FG001|Overall Study|Lost to Follow-up|0|||
16184737|NCT01605396|39155567|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16184738|NCT01605396|39155568|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16184739|NCT01605396|39155567|FG000|Overall Study|Physician Decision|2|||
16184740|NCT01605396|39155568|FG001|Overall Study|Physician Decision|2|||
16184741|NCT01605396|39155567|FG000|Overall Study|Progressive Disease|23|||
16379351|NCT02883049|39874661|FG000|Post Induction|Refusal of further protocol therapy|0|||
16379352|NCT02883049|39874662|FG001|Post Induction|Refusal of further protocol therapy|0|||
16379353|NCT02883049|39874663|FG002|Post Induction|Refusal of further protocol therapy|0|||
16379354|NCT02883049|39874664|FG003|Post Induction|Refusal of further protocol therapy|11|||
16379355|NCT02883049|39874665|FG004|Post Induction|Refusal of further protocol therapy|15|||
16184742|NCT01605396|39155568|FG001|Overall Study|Progressive Disease|27|||
16184743|NCT01605396|39155567|FG000|Overall Study|Withdrawal by Subject|4|||
16184744|NCT01605396|39155568|FG001|Overall Study|Withdrawal by Subject|2|||
16184745|NCT01605396|39155567|FG000|Overall Study|Transfer Off Study|4|||
16379356|NCT02883049|39874666|FG005|Post Induction|Refusal of further protocol therapy|9|||
16184746|NCT01605396|39155568|FG001|Overall Study|Transfer Off Study|5|||
16184747|NCT00486226|39155569|FG000|Overall Study|Death|3|||
16184748|NCT00486226|39155569|FG000|Overall Study|Adverse Event|1|||
16184749|NCT00486226|39155569|FG000|Overall Study|Withdrawal by Subject|1|||
16184750|NCT00486226|39155569|FG000|Overall Study|Lost to Follow-up|8|||
16184751|NCT01981122|39155574|FG000|Overall Study|Withdrawal by Subject|0|||
16184752|NCT01981122|39155575|FG001|Overall Study|Withdrawal by Subject|2|||
16184753|NCT01981122|39155574|FG000|Overall Study|Protocol Violation|0|||
16184754|NCT01981122|39155575|FG001|Overall Study|Protocol Violation|1|||
16184755|NCT01981122|39155574|FG000|Overall Study|Lost to Follow-up|0|||
16184756|NCT01981122|39155575|FG001|Overall Study|Lost to Follow-up|1|||
16184757|NCT01981122|39155574|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
16184758|NCT01981122|39155575|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
16184759|NCT01981122|39155574|FG000|Overall Study|Death|14|||
16184760|NCT01981122|39155575|FG001|Overall Study|Death|15|||
16184761|NCT00430781|39155578|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
16184762|NCT00430781|39155579|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
16184763|NCT00430781|39155580|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
16184764|NCT00430781|39155578|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
16184765|NCT00430781|39155579|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
16184766|NCT00430781|39155580|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
16184767|NCT00430781|39155578|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
16184768|NCT00430781|39155579|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
16184769|NCT00430781|39155580|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
16184770|NCT00430781|39155578|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
16184771|NCT00430781|39155579|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
16184772|NCT00430781|39155580|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
16184773|NCT00430781|39155578|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
16184774|NCT00430781|39155579|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
16184775|NCT00430781|39155580|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
16379357|NCT02883049|39874667|FG006|Post Induction|Refusal of further protocol therapy|13|||
16379358|NCT02883049|39874668|FG007|Post Induction|Refusal of further protocol therapy|5|||
16279394|NCT00537017|39504315|FG000|Treatment Phase|Withdrawal by Subject|13|||
16279395|NCT00537017|39504315|FG000|Treatment Phase|Protocol Violation|2|||
16379359|NCT02883049|39874669|FG008|Post Induction|Refusal of further protocol therapy|21|||
16379360|NCT02883049|39874670|FG009|Post Induction|Refusal of further protocol therapy|7|||
16379361|NCT02883049|39874671|FG010|Post Induction|Refusal of further protocol therapy|0|||
16379362|NCT02883049|39874672|FG011|Post Induction|Refusal of further protocol therapy|7|||
16379363|NCT02883049|39874673|FG012|Post Induction|Refusal of further protocol therapy|3|||
16379364|NCT02883049|39874674|FG013|Post Induction|Refusal of further protocol therapy|0|||
16379365|NCT02883049|39874675|FG014|Post Induction|Refusal of further protocol therapy|4|||
16379366|NCT02883049|39874676|FG015|Post Induction|Refusal of further protocol therapy|1|||
16379367|NCT02883049|39874661|FG000|Post Induction|Inevaluable|0|||
16379368|NCT02883049|39874662|FG001|Post Induction|Inevaluable|0|||
16379369|NCT02883049|39874663|FG002|Post Induction|Inevaluable|0|||
16379370|NCT02883049|39874664|FG003|Post Induction|Inevaluable|1|||
16379371|NCT02883049|39874665|FG004|Post Induction|Inevaluable|1|||
16379372|NCT02883049|39874666|FG005|Post Induction|Inevaluable|2|||
16379373|NCT02883049|39874667|FG006|Post Induction|Inevaluable|7|||
16379374|NCT02883049|39874668|FG007|Post Induction|Inevaluable|6|||
16379375|NCT02883049|39874669|FG008|Post Induction|Inevaluable|4|||
16379376|NCT02883049|39874670|FG009|Post Induction|Inevaluable|4|||
16379377|NCT02883049|39874671|FG010|Post Induction|Inevaluable|1|||
16379378|NCT02883049|39874672|FG011|Post Induction|Inevaluable|1|||
16379379|NCT02883049|39874673|FG012|Post Induction|Inevaluable|2|||
16184776|NCT00430781|39155578|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
16184777|NCT00430781|39155579|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
16184778|NCT00430781|39155580|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
16184779|NCT00430781|39155578|FG000|Interim Analysis; 11 February 2008|Death|0|||
16279396|NCT00537017|39504315|FG000|Follow-up Phase|Withdrawal by Subject|9|||
16279397|NCT01849458|39504316|FG000|Overall Study|Lost to Follow-up|4|||
16279398|NCT03847194|39504317|FG000|Overall Study|Lost to Follow-up|2|||
16279399|NCT03847194|39504318|FG001|Overall Study|Lost to Follow-up|5|||
16184780|NCT00430781|39155579|FG001|Interim Analysis; 11 February 2008|Death|1|||
16184781|NCT00430781|39155580|FG002|Interim Analysis; 11 February 2008|Death|0|||
16184782|NCT00430781|39155578|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
16279400|NCT03847194|39504317|FG000|Overall Study|Withdrawal by Subject|1|||
16379380|NCT02883049|39874674|FG013|Post Induction|Inevaluable|0|||
16379381|NCT02883049|39874675|FG014|Post Induction|Inevaluable|0|||
16379382|NCT02883049|39874676|FG015|Post Induction|Inevaluable|1|||
16184783|NCT00430781|39155579|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
16279401|NCT03847194|39504318|FG001|Overall Study|Withdrawal by Subject|2|||
16184784|NCT00430781|39155580|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
16184785|NCT00430781|39155578|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
16184786|NCT00430781|39155579|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
16184787|NCT00430781|39155580|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
16184788|NCT00430781|39155578|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
16184789|NCT00430781|39155579|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
16184790|NCT00430781|39155580|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
16184791|NCT00430781|39155578|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
16184792|NCT00430781|39155579|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
16184793|NCT00430781|39155580|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
16184794|NCT00430781|39155578|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
16184795|NCT00430781|39155579|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
16184796|NCT00430781|39155580|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
16184797|NCT00430781|39155578|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
16184798|NCT00430781|39155579|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
16184799|NCT00430781|39155580|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
16184800|NCT00430781|39155578|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
16184801|NCT00430781|39155579|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
16184802|NCT00430781|39155580|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
16184803|NCT00430781|39155578|FG000|Final Analysis; 31 July 2008|Other|0|||
16184804|NCT00430781|39155579|FG001|Final Analysis; 31 July 2008|Other|1|||
16184805|NCT00430781|39155580|FG002|Final Analysis; 31 July 2008|Other|0|||
16184806|NCT00430781|39155578|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
16184807|NCT00430781|39155579|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
16184808|NCT00430781|39155580|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
16184809|NCT00430781|39155578|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
16184810|NCT00430781|39155579|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
16184811|NCT00430781|39155580|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
16184812|NCT00430781|39155578|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
16184813|NCT00430781|39155579|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
16184814|NCT00430781|39155580|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
16184815|NCT00430781|39155578|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
16184816|NCT00430781|39155579|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
16184817|NCT00430781|39155580|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
16184818|NCT00430781|39155578|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
16184819|NCT00430781|39155579|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
16184820|NCT00430781|39155580|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
16184821|NCT00430781|39155578|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
16184822|NCT00430781|39155579|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
16184823|NCT00430781|39155580|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
16184824|NCT00430781|39155578|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
16184825|NCT00430781|39155579|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
16184826|NCT00430781|39155580|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
16184827|NCT00909090|39155581|FG000|Overall Study|Lost to Follow-up|17|||
16184828|NCT00909090|39155582|FG001|Overall Study|Lost to Follow-up|17|||
16184829|NCT04220866|39155583|FG000|Overall Study|Death|4|||
16184830|NCT04220866|39155584|FG001|Overall Study|Death|5|||
16184831|NCT04220866|39155583|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
16184832|NCT04220866|39155584|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
16184833|NCT04220866|39155583|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
16184834|NCT04220866|39155584|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
16184835|NCT04220866|39155583|FG000|Overall Study|Withdrawal by Subject|0|||
16184836|NCT04220866|39155584|FG001|Overall Study|Withdrawal by Subject|1|||
16184837|NCT00151411|39155585|FG000|Overall Study|Lost to Follow-up|15|||
16184838|NCT00151411|39155586|FG001|Overall Study|Lost to Follow-up|19|||
16184839|NCT00151411|39155585|FG000|Overall Study|Withdrawal by Subject|12|||
16184840|NCT00151411|39155586|FG001|Overall Study|Withdrawal by Subject|20|||
16184841|NCT00151411|39155585|FG000|Overall Study|Adverse Event|6|||
16184842|NCT00151411|39155586|FG001|Overall Study|Adverse Event|0|||
16184843|NCT00151411|39155585|FG000|Overall Study|Pregnancy|0|||
16184844|NCT00151411|39155586|FG001|Overall Study|Pregnancy|4|||
16184845|NCT00783705|39155587|FG000|Overall Study|Adverse Event|2|||
16184846|NCT00783705|39155588|FG001|Overall Study|Adverse Event|0|||
16184847|NCT00783705|39155587|FG000|Overall Study|Withdrawal by Subject|3|||
16184848|NCT00783705|39155588|FG001|Overall Study|Withdrawal by Subject|2|||
16184849|NCT00783705|39155587|FG000|Overall Study|Lost to Follow-up|1|||
16184850|NCT00783705|39155588|FG001|Overall Study|Lost to Follow-up|3|||
16184851|NCT02606877|39155591|FG000|Overall Study|Adverse Event|3|||
16184852|NCT02606877|39155592|FG001|Overall Study|Adverse Event|0|||
16184853|NCT02606877|39155591|FG000|Overall Study|Non-compliance with protocol|0|||
16184854|NCT02606877|39155592|FG001|Overall Study|Non-compliance with protocol|1|||
16184855|NCT02606877|39155591|FG000|Overall Study|Other than listed above|1|||
16184856|NCT02606877|39155592|FG001|Overall Study|Other than listed above|0|||
16184857|NCT02413398|39155596|FG000|Overall Study|Lost to Follow-up|2|||
16184858|NCT02413398|39155597|FG001|Overall Study|Lost to Follow-up|4|||
16184859|NCT02413398|39155596|FG000|Overall Study|Withdrawal by Subject|1|||
16184860|NCT02413398|39155597|FG001|Overall Study|Withdrawal by Subject|1|||
16184861|NCT02413398|39155596|FG000|Overall Study|Other Eligibility criteria|1|||
16184862|NCT02413398|39155597|FG001|Overall Study|Other Eligibility criteria|2|||
16184863|NCT01589094|39155598|FG000|Overall Study|Did not receive treatment|2|||
16184864|NCT01494038|39155602|FG000|Overall Study|Protocol Violation|1|||
16184865|NCT01494038|39155603|FG001|Overall Study|Protocol Violation|1|||
16184866|NCT01494038|39155602|FG000|Overall Study|Lost to Follow-up|18|||
16184867|NCT01494038|39155603|FG001|Overall Study|Lost to Follow-up|20|||
16184868|NCT01494038|39155602|FG000|Overall Study|Withdrawal by Subject|44|||
16184869|NCT01494038|39155603|FG001|Overall Study|Withdrawal by Subject|34|||
16184870|NCT01494038|39155602|FG000|Overall Study|Not able to get to clinic|21|||
16184871|NCT01494038|39155603|FG001|Overall Study|Not able to get to clinic|15|||
16184872|NCT01494038|39155602|FG000|Overall Study|Not willing to adhere to reqs|2|||
16184873|NCT01494038|39155603|FG001|Overall Study|Not willing to adhere to reqs|9|||
16184874|NCT01494038|39155602|FG000|Overall Study|Death|2|||
16184875|NCT01494038|39155603|FG001|Overall Study|Death|4|||
16184876|NCT02518620|39155607|FG000|Overall Study|Adverse Event|23|||
16184877|NCT02518620|39155608|FG001|Overall Study|Adverse Event|11|||
16184878|NCT02518620|39155607|FG000|Overall Study|Lack of Efficacy|2|||
16184879|NCT02518620|39155608|FG001|Overall Study|Lack of Efficacy|0|||
16184880|NCT02518620|39155607|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16184881|NCT02518620|39155608|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16184882|NCT02518620|39155607|FG000|Overall Study|Physician Decision|1|||
16184883|NCT02518620|39155608|FG001|Overall Study|Physician Decision|1|||
16184884|NCT02518620|39155607|FG000|Overall Study|Sponsor's Decision|0|||
16184885|NCT02518620|39155608|FG001|Overall Study|Sponsor's Decision|3|||
16184886|NCT02518620|39155607|FG000|Overall Study|Lost to Follow-up|1|||
16184887|NCT02518620|39155608|FG001|Overall Study|Lost to Follow-up|1|||
16184888|NCT02518620|39155607|FG000|Overall Study|Withdrawal by Subject|17|||
16184889|NCT02518620|39155608|FG001|Overall Study|Withdrawal by Subject|9|||
16184890|NCT02518620|39155607|FG000|Overall Study|Death|1|||
16184891|NCT02518620|39155608|FG001|Overall Study|Death|0|||
16184892|NCT02518620|39155607|FG000|Overall Study|Pregnancy Wish|3|||
16184893|NCT02518620|39155608|FG001|Overall Study|Pregnancy Wish|0|||
16184894|NCT02518620|39155607|FG000|Overall Study|Pregnancy|1|||
16184895|NCT02518620|39155608|FG001|Overall Study|Pregnancy|0|||
16184896|NCT02518620|39155607|FG000|Overall Study|Relocation|2|||
16184897|NCT02518620|39155608|FG001|Overall Study|Relocation|1|||
16184898|NCT01754922|39155611|FG000|Overall Study|Adverse Event|0|||
16184899|NCT01754922|39155612|FG001|Overall Study|Adverse Event|1|||
16184900|NCT02749721|39155613|FG000|Screening|Withdrawal by Subject|1|||
16184901|NCT02749721|39155613|FG000|Screening|Lost to Follow-up|2|||
16184902|NCT02749721|39155613|FG000|Screening|Protocol Violation|3|||
16184903|NCT02749721|39155613|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
16279402|NCT03847194|39504317|FG000|Overall Study|Death|0|||
16279403|NCT03847194|39504318|FG001|Overall Study|Death|1|||
16279404|NCT01579006|39504321|FG000|Overall Study|Lack of Efficacy|10|||
16279405|NCT01579006|39504321|FG000|Overall Study|Adverse Event|13|||
16279406|NCT01579006|39504321|FG000|Overall Study|Withdrawal by Subject|5|||
16279407|NCT01579006|39504321|FG000|Overall Study|Non-compliance|3|||
16279408|NCT01579006|39504321|FG000|Overall Study|Due to participant's health fund|1|||
16279409|NCT01579006|39504321|FG000|Overall Study|Scheduled surgery|1|||
16279410|NCT01958060|39504332|FG000|Overall Study|Not treated|2|||
16279411|NCT01958060|39504333|FG001|Overall Study|Not treated|0|||
16279412|NCT01958060|39504334|FG002|Overall Study|Not treated|0|||
16279413|NCT01958060|39504335|FG003|Overall Study|Not treated|0|||
16279414|NCT01958060|39504336|FG004|Overall Study|Not treated|1|||
16279415|NCT01958060|39504337|FG005|Overall Study|Not treated|0|||
16279416|NCT00108628|39504340|FG000|Overall Study|Withdrawal by Subject|17|||
16279417|NCT00108628|39504341|FG001|Overall Study|Withdrawal by Subject|9|||
16279418|NCT00108628|39504340|FG000|Overall Study|Lack of Efficacy|2|||
16279419|NCT00108628|39504341|FG001|Overall Study|Lack of Efficacy|1|||
16279420|NCT00108628|39504340|FG000|Overall Study|Death|1|||
16279421|NCT00108628|39504341|FG001|Overall Study|Death|0|||
16279422|NCT02654587|39504346|FG000|Overall Study|patient alive at end of study|22|||
16279423|NCT02654587|39504347|FG001|Overall Study|patient alive at end of study|8|||
16279424|NCT02654587|39504346|FG000|Overall Study|Withdrawal by Subject|1|||
16279425|NCT02654587|39504347|FG001|Overall Study|Withdrawal by Subject|7|||
16279426|NCT01263561|39504348|FG000|Overall Study|Death|1|||
16279427|NCT01263561|39504349|FG001|Overall Study|Death|2|||
16279428|NCT03843125|39504352|FG000|Overall Study|Adverse Event|17|||
16279429|NCT03843125|39504353|FG001|Overall Study|Adverse Event|13|||
16279430|NCT03843125|39504354|FG002|Overall Study|Adverse Event|5|||
16184904|NCT02749721|39155613|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
16184905|NCT03191396|39155614|FG000|Overall Study|Lost to Follow-up|0|||
16184906|NCT03191396|39155615|FG001|Overall Study|Lost to Follow-up|3|||
16184907|NCT03191396|39155614|FG000|Overall Study|Withdrawal by Subject|3|||
16184908|NCT03191396|39155615|FG001|Overall Study|Withdrawal by Subject|2|||
16184909|NCT02582749|39155616|FG000|Overall Study|Study terminated by funder|5|||
16184910|NCT02582749|39155617|FG001|Overall Study|Study terminated by funder|10|||
16184911|NCT02582749|39155616|FG000|Overall Study|Withdrawal by Subject|0|||
16184912|NCT02582749|39155617|FG001|Overall Study|Withdrawal by Subject|1|||
16184913|NCT02065869|39155622|FG000|Overall Study|Death|7|||
16184914|NCT02065869|39155622|FG000|Overall Study|Disease relapse|16|||
16279431|NCT03843125|39504355|FG003|Overall Study|Adverse Event|9|||
16184915|NCT02065869|39155622|FG000|Overall Study|Lost to Follow-up|4|||
16279432|NCT03843125|39504352|FG000|Overall Study|Death|0|||
16279433|NCT03843125|39504353|FG001|Overall Study|Death|6|||
16279434|NCT03843125|39504354|FG002|Overall Study|Death|2|||
16279435|NCT03843125|39504355|FG003|Overall Study|Death|0|||
16279436|NCT03843125|39504352|FG000|Overall Study|Lack of Efficacy|14|||
16279437|NCT03843125|39504353|FG001|Overall Study|Lack of Efficacy|11|||
16279438|NCT03843125|39504354|FG002|Overall Study|Lack of Efficacy|9|||
16279439|NCT03843125|39504355|FG003|Overall Study|Lack of Efficacy|4|||
16279440|NCT03843125|39504352|FG000|Overall Study|Lost to Follow-up|3|||
16279441|NCT03843125|39504353|FG001|Overall Study|Lost to Follow-up|4|||
16279442|NCT03843125|39504354|FG002|Overall Study|Lost to Follow-up|0|||
16279443|NCT03843125|39504355|FG003|Overall Study|Lost to Follow-up|2|||
16279444|NCT03843125|39504352|FG000|Overall Study|Other|12|||
16279445|NCT03843125|39504353|FG001|Overall Study|Other|14|||
16279446|NCT03843125|39504354|FG002|Overall Study|Other|3|||
16279447|NCT03843125|39504355|FG003|Overall Study|Other|4|||
16279448|NCT03843125|39504352|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
16279449|NCT03843125|39504353|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
16279450|NCT03843125|39504354|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
16279451|NCT03843125|39504355|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
16279452|NCT03843125|39504352|FG000|Overall Study|Study Terminated by Sponsor|318|||
16279453|NCT03843125|39504353|FG001|Overall Study|Study Terminated by Sponsor|318|||
16279454|NCT03843125|39504354|FG002|Overall Study|Study Terminated by Sponsor|163|||
16279455|NCT03843125|39504355|FG003|Overall Study|Study Terminated by Sponsor|163|||
16279456|NCT03843125|39504352|FG000|Overall Study|Withdrawal by Subject|23|||
16279457|NCT03843125|39504353|FG001|Overall Study|Withdrawal by Subject|12|||
16279458|NCT03843125|39504354|FG002|Overall Study|Withdrawal by Subject|6|||
16279459|NCT03843125|39504355|FG003|Overall Study|Withdrawal by Subject|9|||
16279460|NCT03843125|39504352|FG000|Overall Study|Missing data|0|||
16279461|NCT03843125|39504353|FG001|Overall Study|Missing data|1|||
16279462|NCT03843125|39504354|FG002|Overall Study|Missing data|1|||
16279463|NCT03843125|39504355|FG003|Overall Study|Missing data|0|||
16279464|NCT01680016|39504356|FG000|Overall Study|Adverse Event|0|||
16279465|NCT01680016|39504357|FG001|Overall Study|Adverse Event|0|||
16279466|NCT01680016|39504358|FG002|Overall Study|Adverse Event|1|||
16279467|NCT01680016|39504359|FG003|Overall Study|Adverse Event|4|||
16279468|NCT01680016|39504356|FG000|Overall Study|The Subject went out of The Trial|1|||
16279469|NCT01680016|39504357|FG001|Overall Study|The Subject went out of The Trial|0|||
16279470|NCT01680016|39504358|FG002|Overall Study|The Subject went out of The Trial|3|||
16279471|NCT01680016|39504359|FG003|Overall Study|The Subject went out of The Trial|0|||
16279472|NCT01680016|39504356|FG000|Overall Study|Protocol Violation|0|||
16279473|NCT01680016|39504357|FG001|Overall Study|Protocol Violation|1|||
16279474|NCT01680016|39504358|FG002|Overall Study|Protocol Violation|0|||
16279475|NCT01680016|39504359|FG003|Overall Study|Protocol Violation|0|||
16279476|NCT01680016|39504356|FG000|Overall Study|Withdrawal by Subject|5|||
16279477|NCT01680016|39504357|FG001|Overall Study|Withdrawal by Subject|7|||
16279478|NCT01680016|39504358|FG002|Overall Study|Withdrawal by Subject|1|||
16279479|NCT01680016|39504359|FG003|Overall Study|Withdrawal by Subject|1|||
16279480|NCT00407745|39504360|FG000|Overall Study|Lack of Efficacy|1|||
16279481|NCT00407745|39504361|FG001|Overall Study|Lack of Efficacy|2|||
16279482|NCT00407745|39504360|FG000|Overall Study|Withdrawal by Subject|3|||
16279483|NCT00407745|39504361|FG001|Overall Study|Withdrawal by Subject|3|||
16279484|NCT00407745|39504360|FG000|Overall Study|Protocol Violation|5|||
16279485|NCT00407745|39504361|FG001|Overall Study|Protocol Violation|3|||
16279486|NCT00407745|39504360|FG000|Overall Study|Adverse Event|8|||
16279487|NCT00407745|39504361|FG001|Overall Study|Adverse Event|8|||
16279488|NCT00407745|39504360|FG000|Overall Study|Other|2|||
16279489|NCT00407745|39504361|FG001|Overall Study|Other|0|||
16279490|NCT00407745|39504360|FG000|Overall Study|Randomized, unknown if treated|0|||
16279491|NCT00407745|39504361|FG001|Overall Study|Randomized, unknown if treated|1|||
16279492|NCT00654641|39504362|FG000|Overall Study|Lost to Follow-up|2|||
16184916|NCT02065869|39155622|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
16184917|NCT02065869|39155622|FG000|Overall Study|Withdrawal by Subject|1|||
16184918|NCT02426086|39155623|FG000|Overall Study|Death|33|||
16184919|NCT02426086|39155624|FG001|Overall Study|Death|36|||
16184920|NCT02426086|39155623|FG000|Overall Study|Lost to Follow-up|2|||
16184921|NCT02426086|39155624|FG001|Overall Study|Lost to Follow-up|0|||
16184922|NCT02426086|39155623|FG000|Overall Study|Study Terminated by Sponsor|5|||
16184923|NCT02426086|39155624|FG001|Overall Study|Study Terminated by Sponsor|14|||
16184924|NCT02426086|39155623|FG000|Overall Study|Withdrawal by Subject|8|||
16184925|NCT02426086|39155624|FG001|Overall Study|Withdrawal by Subject|9|||
16184926|NCT00718861|39155626|FG000|Overall Study|Withdrawal by Subject|15|||
16184927|NCT00718861|39155627|FG001|Overall Study|Withdrawal by Subject|10|||
16279493|NCT00654641|39504363|FG001|Overall Study|Lost to Follow-up|3|||
16279494|NCT01475487|39504364|FG000|Overall Study|had to leave early for personal reasons|2|||
16279495|NCT01475487|39504365|FG001|Overall Study|had to leave early for personal reasons|1|||
16279496|NCT00756717|39504368|FG000|Overall Study|Withdrawal by Subject|2|||
16279497|NCT01802216|39504369|FG000|4 Month Visit|Participant did not show to visit|3|||
16279498|NCT01802216|39504370|FG001|4 Month Visit|Participant did not show to visit|4|||
16184928|NCT00718861|39155626|FG000|Overall Study|Adverse Event|2|||
16184929|NCT00718861|39155627|FG001|Overall Study|Adverse Event|1|||
16184930|NCT00718861|39155626|FG000|Overall Study|Lost to Follow-up|2|||
16184931|NCT00718861|39155627|FG001|Overall Study|Lost to Follow-up|1|||
16184932|NCT00718861|39155626|FG000|Overall Study|Administrative Problems|1|||
16184933|NCT00718861|39155627|FG001|Overall Study|Administrative Problems|1|||
16184934|NCT00718861|39155626|FG000|Overall Study|Death|1|||
16184935|NCT00718861|39155627|FG001|Overall Study|Death|5|||
16184936|NCT04222725|39155628|FG000|Overall Study|Adverse Event|0|||
16184937|NCT04222725|39155629|FG001|Overall Study|Adverse Event|1|||
16184938|NCT04222725|39155630|FG002|Overall Study|Adverse Event|0|||
16184939|NCT04222725|39155631|FG003|Overall Study|Adverse Event|0|||
16184940|NCT01056523|39155634|FG000|Overall Study|Death|1|||
16184941|NCT01056523|39155635|FG001|Overall Study|Death|0|||
16184942|NCT01056523|39155636|FG002|Overall Study|Death|2|||
16279499|NCT01802216|39504369|FG000|8 Month Visit|Participant did not show to visit|3|||
16279500|NCT01802216|39504370|FG001|8 Month Visit|Participant did not show to visit|5|||
16279501|NCT01802216|39504369|FG000|12 Month Visit|Participant did not show to visit|3|||
16279502|NCT01802216|39504370|FG001|12 Month Visit|Participant did not show to visit|4|||
16279503|NCT04405739|39504371|FG000|Overall Study|Adverse Event|0|||
16279504|NCT04405739|39504372|FG001|Overall Study|Adverse Event|1|||
16279505|NCT04405739|39504373|FG002|Overall Study|Adverse Event|0|||
16279506|NCT04405739|39504374|FG003|Overall Study|Adverse Event|0|||
16279507|NCT04405739|39504371|FG000|Overall Study|Lost to Follow-up|0|||
16279508|NCT04405739|39504372|FG001|Overall Study|Lost to Follow-up|2|||
16279509|NCT04405739|39504373|FG002|Overall Study|Lost to Follow-up|1|||
16279510|NCT04405739|39504374|FG003|Overall Study|Lost to Follow-up|3|||
16279511|NCT04405739|39504371|FG000|Overall Study|Withdrawal by Subject|0|||
16279512|NCT04405739|39504372|FG001|Overall Study|Withdrawal by Subject|2|||
16279513|NCT04405739|39504373|FG002|Overall Study|Withdrawal by Subject|1|||
16279514|NCT04405739|39504374|FG003|Overall Study|Withdrawal by Subject|1|||
16279515|NCT04405739|39504371|FG000|Overall Study|Death|0|||
16279516|NCT04405739|39504372|FG001|Overall Study|Death|0|||
16279517|NCT04405739|39504373|FG002|Overall Study|Death|1|||
16279518|NCT04405739|39504374|FG003|Overall Study|Death|0|||
16279519|NCT04405739|39504371|FG000|Overall Study|Transferred to rehab|0|||
16279520|NCT04405739|39504372|FG001|Overall Study|Transferred to rehab|0|||
16279521|NCT04405739|39504373|FG002|Overall Study|Transferred to rehab|0|||
16279522|NCT04405739|39504374|FG003|Overall Study|Transferred to rehab|1|||
16279523|NCT04405739|39504371|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
16279524|NCT04405739|39504372|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
16279525|NCT04405739|39504373|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
16279526|NCT04405739|39504374|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
16279527|NCT04703855|39504375|FG000|Overall Study|Heart Transplant|1|||
16279528|NCT03578809|39504376|FG000|Overall Study|Death|0|||
16279529|NCT03578809|39504377|FG001|Overall Study|Death|2|||
16279530|NCT03578809|39504378|FG002|Overall Study|Death|0|||
16279531|NCT03578809|39504379|FG003|Overall Study|Death|1|||
16279532|NCT03578809|39504376|FG000|Overall Study|Lost to Follow-up|0|||
16279533|NCT03578809|39504377|FG001|Overall Study|Lost to Follow-up|1|||
16279534|NCT03578809|39504378|FG002|Overall Study|Lost to Follow-up|0|||
16279535|NCT03578809|39504379|FG003|Overall Study|Lost to Follow-up|0|||
16279536|NCT03578809|39504376|FG000|Overall Study|Withdrawal by Subject|3|||
16279537|NCT03578809|39504377|FG001|Overall Study|Withdrawal by Subject|5|||
16279538|NCT03578809|39504378|FG002|Overall Study|Withdrawal by Subject|2|||
16279539|NCT03578809|39504379|FG003|Overall Study|Withdrawal by Subject|0|||
16279540|NCT03578809|39504376|FG000|Overall Study|Other|3|||
16279541|NCT03578809|39504377|FG001|Overall Study|Other|6|||
16279542|NCT03578809|39504378|FG002|Overall Study|Other|2|||
16279543|NCT03578809|39504379|FG003|Overall Study|Other|8|||
16279544|NCT00263887|39504380|FG000|Overall Study|Withdrawal by Subject|1|||
16279545|NCT00263887|39504381|FG001|Overall Study|Withdrawal by Subject|1|||
16279546|NCT00263887|39504380|FG000|Overall Study|Lung transplantation|1|||
16279547|NCT00263887|39504381|FG001|Overall Study|Lung transplantation|2|||
16279548|NCT00263887|39504380|FG000|Overall Study|Too ill to attend visit|1|||
16279549|NCT00263887|39504381|FG001|Overall Study|Too ill to attend visit|0|||
16279550|NCT00263887|39504380|FG000|Overall Study|Adverse Event|0|||
16279551|NCT00263887|39504381|FG001|Overall Study|Adverse Event|2|||
16279552|NCT00263887|39504380|FG000|Overall Study|Disease progression|0|||
16279553|NCT00263887|39504381|FG001|Overall Study|Disease progression|1|||
16279554|NCT00263887|39504380|FG000|Overall Study|Lack of Efficacy|0|||
16279555|NCT00263887|39504381|FG001|Overall Study|Lack of Efficacy|1|||
16279556|NCT04979858|39504382|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
16184943|NCT01056523|39155637|FG003|Overall Study|Death|3|||
16184944|NCT01056523|39155638|FG004|Overall Study|Death|0|||
16184945|NCT01056523|39155639|FG005|Overall Study|Death|0|||
16279557|NCT04979858|39504383|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
16279558|NCT03294317|39504395|FG000|Overall Study|Physician Decision|1|||
16279559|NCT03294317|39504395|FG000|Overall Study|Withdrawal by Subject|6|||
16279560|NCT03294317|39504395|FG000|Overall Study|Lost to Follow-up|1|||
16279561|NCT03294317|39504395|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
16279562|NCT03294317|39504395|FG000|Overall Study|Failed HB lead implant|8|||
16279563|NCT03294317|39504395|FG000|Overall Study|Received CRT instead|1|||
16279564|NCT03294317|39504395|FG000|Overall Study|Exited after lead revision|2|||
16279565|NCT01917084|39504396|FG000|Overall Study|Withdrawal by Subject|1|||
16279566|NCT01235715|39504397|FG000|Overall Study|Physician Decision|0|||
16279567|NCT01235715|39504398|FG001|Overall Study|Physician Decision|2|||
16279568|NCT00958724|39504399|FG000|Overall Study|Disease Progression|6|||
16279569|NCT02300987|39504401|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
16279570|NCT02300987|39504402|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
16279571|NCT02300987|39504401|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
16279572|NCT02300987|39504402|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
16279573|NCT02300987|39504401|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
16279574|NCT02300987|39504402|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
16184946|NCT01056523|39155640|FG006|Overall Study|Death|1|||
16184947|NCT00328198|39155646|FG000|Treatment|Adverse Event|21|||
16184948|NCT00328198|39155646|FG000|Treatment|Death|1|||
16279575|NCT02300987|39504401|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
16279576|NCT02300987|39504402|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
16279577|NCT02300987|39504401|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
16279578|NCT02300987|39504402|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
16279579|NCT00894933|39504403|FG000|Overall Study|Lost to Follow-up|2|||
16279580|NCT00894933|39504403|FG000|Overall Study|Cancelled Procedure|1|||
16279581|NCT00894933|39504403|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
16279582|NCT01115933|39504406|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
16279583|NCT02616380|39504407|FG000|Overall Study|Lost to Follow-up|1|||
16279584|NCT02616380|39504407|FG000|Overall Study|Other|2|||
16279585|NCT00442351|39504408|FG000|Overall Study|Administrative|6|||
16279586|NCT00442351|39504409|FG001|Overall Study|Administrative|5|||
16279587|NCT00442351|39504408|FG000|Overall Study|Did not meet protocol eligibility|1|||
16279588|NCT00442351|39504409|FG001|Overall Study|Did not meet protocol eligibility|0|||
16184949|NCT00328198|39155646|FG000|Treatment|Physician Decision|5|||
16184950|NCT00328198|39155646|FG000|Treatment|Withdrawal by Subject|5|||
16184951|NCT00328198|39155646|FG000|Treatment|Evidence of disease progression|2|||
16184952|NCT00328198|39155646|FG000|Treatment|Non-compliance|1|||
16184953|NCT00328198|39155646|FG000|Treatment|Confirmed complete response, MRD -|3|||
16184954|NCT00328198|39155646|FG000|Follow-up|Lost to Follow-up|4|||
16184955|NCT00328198|39155646|FG000|Follow-up|Death|31|||
16184956|NCT02168946|39155647|FG000|Overall Study|Adverse Event|8|||
16184957|NCT02168946|39155648|FG001|Overall Study|Adverse Event|5|||
16184958|NCT02168946|39155647|FG000|Overall Study|Lost to Follow-up|3|||
16184959|NCT02168946|39155648|FG001|Overall Study|Lost to Follow-up|0|||
16184960|NCT02168946|39155647|FG000|Overall Study|Subject unable to come back for visits|1|||
16184961|NCT02168946|39155648|FG001|Overall Study|Subject unable to come back for visits|0|||
16184962|NCT01197378|39155649|FG000|Overall Study|Adverse Event|3|||
16184963|NCT01197378|39155649|FG000|Overall Study|Withdrawal by Subject|1|||
16184964|NCT01197378|39155649|FG000|Overall Study|Physician Decision|1|||
16184965|NCT01197378|39155649|FG000|Overall Study|Other|2|||
16184966|NCT02702193|39155650|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
16184967|NCT02702193|39155651|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
16184968|NCT02702193|39155650|FG000|4 Month Follow up|Withdrawal by Subject|1|||
16184969|NCT02702193|39155651|FG001|4 Month Follow up|Withdrawal by Subject|0|||
16184970|NCT02702193|39155650|FG000|4 Month Follow up|Lost to Follow-up|17|||
16184971|NCT02702193|39155651|FG001|4 Month Follow up|Lost to Follow-up|18|||
16184972|NCT02702193|39155650|FG000|8 Month Follow up|Withdrawal by Subject|1|||
16184973|NCT02702193|39155651|FG001|8 Month Follow up|Withdrawal by Subject|0|||
16184974|NCT02702193|39155650|FG000|8 Month Follow up|Lost to Follow-up|14|||
16184975|NCT02702193|39155651|FG001|8 Month Follow up|Lost to Follow-up|18|||
16184976|NCT02702193|39155650|FG000|12 Month Follow up|Withdrawal by Subject|1|||
16184977|NCT02702193|39155651|FG001|12 Month Follow up|Withdrawal by Subject|0|||
16184978|NCT02702193|39155650|FG000|12 Month Follow up|Lost to Follow-up|16|||
16184979|NCT02702193|39155651|FG001|12 Month Follow up|Lost to Follow-up|18|||
16184980|NCT01753518|39159115|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
16184981|NCT01753518|39159116|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
16184982|NCT01753518|39159115|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
16184983|NCT01753518|39159116|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
16184984|NCT01753518|39159115|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
16184985|NCT01753518|39159116|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
16184986|NCT01753518|39159115|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
16184987|NCT01753518|39159116|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
16184988|NCT00633139|39159121|FG000|Overall Study|Non compliance|0|||
16184989|NCT00633139|39159122|FG001|Overall Study|Non compliance|0|||
16184990|NCT00633139|39159123|FG002|Overall Study|Non compliance|1|||
16184991|NCT00633139|39159121|FG000|Overall Study|Withdrawal by Subject|0|||
16279589|NCT00442351|39504408|FG000|Overall Study|Other|0|||
16279590|NCT00442351|39504409|FG001|Overall Study|Other|1|||
16279591|NCT00585312|39504411|FG000|Overall Study|Adverse Event|3|||
16279592|NCT00585312|39504412|FG001|Overall Study|Adverse Event|0|||
16279593|NCT00585312|39504411|FG000|Overall Study|Lack of Efficacy|6|||
16279594|NCT00585312|39504412|FG001|Overall Study|Lack of Efficacy|11|||
16279595|NCT00585312|39504411|FG000|Overall Study|Lost to Follow-up|1|||
16279596|NCT00585312|39504412|FG001|Overall Study|Lost to Follow-up|1|||
16279597|NCT00585312|39504411|FG000|Overall Study|Reason not specified|2|||
16279598|NCT00585312|39504412|FG001|Overall Study|Reason not specified|0|||
16279599|NCT00585312|39504411|FG000|Overall Study|Withdrawal by Subject|5|||
16279600|NCT00585312|39504412|FG001|Overall Study|Withdrawal by Subject|1|||
16279601|NCT00585312|39504411|FG000|Overall Study|Study terminated by the sponsor|34|||
16279602|NCT00585312|39504412|FG001|Overall Study|Study terminated by the sponsor|31|||
16279603|NCT01261624|39504413|FG000|Week 0 to Week 12|Disease Progression|1|||
16279604|NCT01261624|39504414|FG001|Week 0 to Week 12|Disease Progression|1|||
16279605|NCT01261624|39504413|FG000|Week 0 to Week 12|Insufficient Response|0|||
16279606|NCT01261624|39504414|FG001|Week 0 to Week 12|Insufficient Response|2|||
16279607|NCT01261624|39504413|FG000|Week 13 to Week 24|Insufficient Response|0|||
16279608|NCT01261624|39504414|FG001|Week 13 to Week 24|Insufficient Response|1|||
16279609|NCT00979212|39504417|FG000|Overall Study|Protocol Violation|1|||
16279610|NCT00979212|39504418|FG001|Overall Study|Protocol Violation|8|||
16279611|NCT00979212|39504417|FG000|Overall Study|No protocol therapy received|1|||
16279612|NCT00979212|39504418|FG001|Overall Study|No protocol therapy received|0|||
16279613|NCT00685035|39507093|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
16279614|NCT00685035|39507094|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
16279615|NCT02846883|39507105|FG000|Overall Study|Death|0|||
16279616|NCT02846883|39507106|FG001|Overall Study|Death|1|||
16279617|NCT02846883|39507107|FG002|Overall Study|Death|1|||
16379383|NCT02883049|39874661|FG000|Post Induction|Moved to another non-COG institution|0|||
16379384|NCT02883049|39874662|FG001|Post Induction|Moved to another non-COG institution|0|||
16379385|NCT02883049|39874663|FG002|Post Induction|Moved to another non-COG institution|0|||
16379386|NCT02883049|39874664|FG003|Post Induction|Moved to another non-COG institution|0|||
16379387|NCT02883049|39874665|FG004|Post Induction|Moved to another non-COG institution|0|||
16379388|NCT02883049|39874666|FG005|Post Induction|Moved to another non-COG institution|0|||
16379389|NCT02883049|39874667|FG006|Post Induction|Moved to another non-COG institution|0|||
16379390|NCT02883049|39874668|FG007|Post Induction|Moved to another non-COG institution|2|||
16379391|NCT02883049|39874669|FG008|Post Induction|Moved to another non-COG institution|2|||
16379392|NCT02883049|39874670|FG009|Post Induction|Moved to another non-COG institution|0|||
16379393|NCT02883049|39874671|FG010|Post Induction|Moved to another non-COG institution|0|||
16379394|NCT02883049|39874672|FG011|Post Induction|Moved to another non-COG institution|1|||
16379395|NCT02883049|39874673|FG012|Post Induction|Moved to another non-COG institution|0|||
16379396|NCT02883049|39874674|FG013|Post Induction|Moved to another non-COG institution|0|||
16379397|NCT02883049|39874675|FG014|Post Induction|Moved to another non-COG institution|0|||
16379398|NCT02883049|39874676|FG015|Post Induction|Moved to another non-COG institution|0|||
16379399|NCT02883049|39874661|FG000|Post Induction|Randomization closed|0|||
16379400|NCT02883049|39874662|FG001|Post Induction|Randomization closed|0|||
16379401|NCT02883049|39874663|FG002|Post Induction|Randomization closed|0|||
16379402|NCT02883049|39874664|FG003|Post Induction|Randomization closed|0|||
16379403|NCT02883049|39874665|FG004|Post Induction|Randomization closed|0|||
16379404|NCT02883049|39874666|FG005|Post Induction|Randomization closed|0|||
16379405|NCT02883049|39874667|FG006|Post Induction|Randomization closed|0|||
16379406|NCT02883049|39874668|FG007|Post Induction|Randomization closed|20|||
16379407|NCT02883049|39874669|FG008|Post Induction|Randomization closed|0|||
16379408|NCT02883049|39874670|FG009|Post Induction|Randomization closed|0|||
16379409|NCT02883049|39874671|FG010|Post Induction|Randomization closed|0|||
16379410|NCT02883049|39874672|FG011|Post Induction|Randomization closed|0|||
16379411|NCT02883049|39874673|FG012|Post Induction|Randomization closed|0|||
16379412|NCT02883049|39874674|FG013|Post Induction|Randomization closed|0|||
16379413|NCT02883049|39874675|FG014|Post Induction|Randomization closed|0|||
16479000|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16279618|NCT02846883|39507105|FG000|Overall Study|Lost to Follow-up|0|||
16279619|NCT02846883|39507106|FG001|Overall Study|Lost to Follow-up|0|||
16279620|NCT02846883|39507107|FG002|Overall Study|Lost to Follow-up|1|||
16279621|NCT02846883|39507105|FG000|Overall Study|Withdrawal by Subject|1|||
16279622|NCT02846883|39507106|FG001|Overall Study|Withdrawal by Subject|0|||
16279623|NCT02846883|39507107|FG002|Overall Study|Withdrawal by Subject|0|||
16279624|NCT02846883|39507105|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
16279625|NCT02846883|39507106|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
16279626|NCT02846883|39507107|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
16279627|NCT02846883|39507105|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
16479001|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16279628|NCT02846883|39507106|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
16279629|NCT02846883|39507107|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
16279630|NCT00104247|39507108|FG000|Overall Study|Withdrawal by Subject|1|||
16379414|NCT02883049|39874676|FG015|Post Induction|Randomization closed|0|||
16379415|NCT02883049|39874661|FG000|Post Induction|MRD negative|0|||
16379416|NCT02883049|39874662|FG001|Post Induction|MRD negative|0|||
16379417|NCT02883049|39874663|FG002|Post Induction|MRD negative|0|||
16379418|NCT02883049|39874664|FG003|Post Induction|MRD negative|0|||
16379419|NCT02883049|39874665|FG004|Post Induction|MRD negative|0|||
16379420|NCT02883049|39874666|FG005|Post Induction|MRD negative|0|||
16379421|NCT02883049|39874667|FG006|Post Induction|MRD negative|0|||
16379422|NCT02883049|39874668|FG007|Post Induction|MRD negative|11|||
16379423|NCT02883049|39874669|FG008|Post Induction|MRD negative|0|||
16379424|NCT02883049|39874670|FG009|Post Induction|MRD negative|0|||
16379425|NCT02883049|39874671|FG010|Post Induction|MRD negative|0|||
16184992|NCT00633139|39159122|FG001|Overall Study|Withdrawal by Subject|1|||
16184993|NCT00633139|39159123|FG002|Overall Study|Withdrawal by Subject|0|||
16184994|NCT01152450|39159124|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
16184995|NCT01152450|39159125|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
16184996|NCT01152450|39159126|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
16184997|NCT01152450|39159127|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
16279631|NCT00104247|39507109|FG001|Overall Study|Withdrawal by Subject|0|||
16279632|NCT00104247|39507108|FG000|Overall Study|Noncompliant with dosing|0|||
16279633|NCT00104247|39507109|FG001|Overall Study|Noncompliant with dosing|1|||
16379426|NCT02883049|39874672|FG011|Post Induction|MRD negative|0|||
16379427|NCT02883049|39874673|FG012|Post Induction|MRD negative|0|||
16379428|NCT02883049|39874674|FG013|Post Induction|MRD negative|0|||
16379429|NCT02883049|39874675|FG014|Post Induction|MRD negative|0|||
16379430|NCT02883049|39874676|FG015|Post Induction|MRD negative|0|||
16379431|NCT02883049|39874661|FG000|Post Induction|Developed SMN|0|||
16379432|NCT02883049|39874662|FG001|Post Induction|Developed SMN|0|||
16379433|NCT02883049|39874663|FG002|Post Induction|Developed SMN|0|||
16379434|NCT02883049|39874664|FG003|Post Induction|Developed SMN|0|||
16379435|NCT02883049|39874665|FG004|Post Induction|Developed SMN|1|||
16379436|NCT02883049|39874666|FG005|Post Induction|Developed SMN|0|||
16379437|NCT02883049|39874667|FG006|Post Induction|Developed SMN|1|||
16379438|NCT02883049|39874668|FG007|Post Induction|Developed SMN|0|||
16379439|NCT02883049|39874669|FG008|Post Induction|Developed SMN|0|||
16379440|NCT02883049|39874670|FG009|Post Induction|Developed SMN|0|||
16379441|NCT02883049|39874671|FG010|Post Induction|Developed SMN|1|||
16379442|NCT02883049|39874672|FG011|Post Induction|Developed SMN|1|||
16379443|NCT02883049|39874673|FG012|Post Induction|Developed SMN|0|||
16184998|NCT01152450|39159128|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
16279634|NCT00676494|39507121|FG000|Overall Study|Missed Visit|8|||
16184999|NCT01152450|39159129|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
16185000|NCT01152450|39159124|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
16185001|NCT01152450|39159125|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
16185002|NCT01152450|39159126|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
16185003|NCT01152450|39159127|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
16185004|NCT01152450|39159128|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
16185005|NCT01152450|39159129|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
16185006|NCT01152450|39159124|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16185007|NCT01152450|39159125|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
16185008|NCT01152450|39159126|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
16185009|NCT01152450|39159127|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16185010|NCT01152450|39159128|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16185011|NCT01152450|39159129|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16185012|NCT00791128|39159135|FG000|Overall Study|Adverse Event|4|||
16185013|NCT00791128|39159135|FG000|Overall Study|Device migration|2|||
16185014|NCT00791128|39159135|FG000|Overall Study|non-compliance by subject|2|||
16185015|NCT00791128|39159135|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
16185016|NCT03692910|39159141|FG000|Overall Study|Lost to Follow-up|4|||
16185017|NCT03692910|39159142|FG001|Overall Study|Lost to Follow-up|0|||
16185018|NCT03692910|39159143|FG002|Overall Study|Lost to Follow-up|0|||
16185019|NCT03692910|39159141|FG000|Overall Study|Withdrawal by Subject|2|||
16185020|NCT03692910|39159142|FG001|Overall Study|Withdrawal by Subject|0|||
16185021|NCT03692910|39159143|FG002|Overall Study|Withdrawal by Subject|0|||
16185022|NCT00914628|39159148|FG000|Overall Study|Death|35|||
16185023|NCT00914628|39159149|FG001|Overall Study|Death|17|||
16185024|NCT00914628|39159148|FG000|Overall Study|Medical decision|4|||
16279635|NCT00676494|39507121|FG000|Overall Study|Withdrawal by Subject|6|||
16279636|NCT00183196|39507122|FG000|Overall Study|Withdrawal by Subject|18|||
16379444|NCT02883049|39874674|FG013|Post Induction|Developed SMN|0|||
16379445|NCT02883049|39874675|FG014|Post Induction|Developed SMN|1|||
16379446|NCT02883049|39874676|FG015|Post Induction|Developed SMN|0|||
16279637|NCT00183196|39507123|FG001|Overall Study|Withdrawal by Subject|11|||
16279638|NCT00183196|39507124|FG002|Overall Study|Withdrawal by Subject|13|||
16279639|NCT00183196|39507122|FG000|Overall Study|Adverse Event|1|||
16279640|NCT00183196|39507123|FG001|Overall Study|Adverse Event|2|||
16279641|NCT00183196|39507124|FG002|Overall Study|Adverse Event|2|||
16279642|NCT00183196|39507122|FG000|Overall Study|Legal event|1|||
16279643|NCT00183196|39507123|FG001|Overall Study|Legal event|1|||
16279644|NCT00183196|39507124|FG002|Overall Study|Legal event|1|||
16279645|NCT00183196|39507122|FG000|Overall Study|Required more intensive care|0|||
16279646|NCT00183196|39507123|FG001|Overall Study|Required more intensive care|1|||
16279647|NCT00183196|39507124|FG002|Overall Study|Required more intensive care|2|||
16279648|NCT03438006|39507125|FG000|Overall Study|Adverse Event|1|||
16279649|NCT03438006|39507125|FG000|Overall Study|Lost to Follow-up|67|||
16279650|NCT03438006|39507125|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
16279651|NCT03438006|39507125|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
16279652|NCT02124902|39507126|FG000|Overall Study|Adverse Event|7|||
16279653|NCT02124902|39507127|FG001|Overall Study|Adverse Event|2|||
16279654|NCT02124902|39507126|FG000|Overall Study|Went to alternative treatment|4|||
16279655|NCT02124902|39507127|FG001|Overall Study|Went to alternative treatment|0|||
16279656|NCT02124902|39507126|FG000|Overall Study|Withdrawal by Subject|2|||
16279657|NCT02124902|39507127|FG001|Overall Study|Withdrawal by Subject|1|||
16279658|NCT02124902|39507126|FG000|Overall Study|Physician Decision|2|||
16279659|NCT02124902|39507127|FG001|Overall Study|Physician Decision|0|||
16279660|NCT02124902|39507126|FG000|Overall Study|Not eligible|1|||
16279661|NCT02124902|39507127|FG001|Overall Study|Not eligible|0|||
16279662|NCT02124902|39507126|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
16279663|NCT02124902|39507127|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
16379447|NCT02883049|39874661|FG000|Post Induction|Enrolled onto another COG study|0|||
16379448|NCT02883049|39874662|FG001|Post Induction|Enrolled onto another COG study|0|||
16379449|NCT02883049|39874663|FG002|Post Induction|Enrolled onto another COG study|0|||
16379450|NCT02883049|39874664|FG003|Post Induction|Enrolled onto another COG study|1|||
16379451|NCT02883049|39874665|FG004|Post Induction|Enrolled onto another COG study|1|||
16379452|NCT02883049|39874666|FG005|Post Induction|Enrolled onto another COG study|0|||
16379453|NCT02883049|39874667|FG006|Post Induction|Enrolled onto another COG study|0|||
16279664|NCT00784134|39507130|FG000|Overall Study|Lost to Follow-up|3|||
16279665|NCT00784134|39507131|FG001|Overall Study|Lost to Follow-up|6|||
16379454|NCT02883049|39874668|FG007|Post Induction|Enrolled onto another COG study|4|||
16379455|NCT02883049|39874669|FG008|Post Induction|Enrolled onto another COG study|0|||
16379456|NCT02883049|39874670|FG009|Post Induction|Enrolled onto another COG study|0|||
16379457|NCT02883049|39874671|FG010|Post Induction|Enrolled onto another COG study|0|||
16279666|NCT01186016|39507132|FG000|Overall Study|Withdrawal by Subject|46|||
16279667|NCT01186016|39507133|FG001|Overall Study|Withdrawal by Subject|29|||
16279668|NCT02415387|39507134|FG000|Overall Study|Withdrawal by Subject|6|||
16279669|NCT02415387|39507135|FG001|Overall Study|Withdrawal by Subject|1|||
16279670|NCT02415387|39507134|FG000|Overall Study|blood draw problem|0|||
16279671|NCT02415387|39507135|FG001|Overall Study|blood draw problem|1|||
16279672|NCT02415387|39507134|FG000|Overall Study|Protocol Violation|1|||
16279673|NCT02415387|39507135|FG001|Overall Study|Protocol Violation|0|||
16279674|NCT03259789|39507136|FG000|Overall Study|Adverse Event|3|||
16279675|NCT03259789|39507137|FG001|Overall Study|Adverse Event|2|||
16279676|NCT03259789|39507138|FG002|Overall Study|Adverse Event|1|||
16279677|NCT03259789|39507136|FG000|Overall Study|Withdrawal by Subject|9|||
16279678|NCT03259789|39507137|FG001|Overall Study|Withdrawal by Subject|5|||
16279679|NCT03259789|39507138|FG002|Overall Study|Withdrawal by Subject|1|||
16279680|NCT03259789|39507136|FG000|Overall Study|Lost to Follow-up|5|||
16279681|NCT03259789|39507137|FG001|Overall Study|Lost to Follow-up|9|||
16279682|NCT03259789|39507138|FG002|Overall Study|Lost to Follow-up|4|||
16279683|NCT03259789|39507136|FG000|Overall Study|Physician Decision|0|||
16279684|NCT03259789|39507137|FG001|Overall Study|Physician Decision|1|||
16279685|NCT03259789|39507138|FG002|Overall Study|Physician Decision|0|||
16279686|NCT04154787|39507141|FG000|Overall Study|Adverse Event|0|||
16279687|NCT04154787|39507142|FG001|Overall Study|Adverse Event|1|||
16279688|NCT04154787|39507143|FG002|Overall Study|Adverse Event|0|||
16279689|NCT04154787|39507141|FG000|Overall Study|Patient Requires Other Treatment|0|||
16279690|NCT04154787|39507142|FG001|Overall Study|Patient Requires Other Treatment|1|||
16279691|NCT04154787|39507143|FG002|Overall Study|Patient Requires Other Treatment|0|||
16279692|NCT04154787|39507141|FG000|Overall Study|Study Terminated By Sponsor|0|||
16279693|NCT04154787|39507142|FG001|Overall Study|Study Terminated By Sponsor|6|||
16379458|NCT02883049|39874672|FG011|Post Induction|Enrolled onto another COG study|2|||
16279694|NCT04154787|39507143|FG002|Overall Study|Study Terminated By Sponsor|1|||
16279695|NCT04154787|39507141|FG000|Overall Study|Subject Decision|0|||
16279696|NCT04154787|39507142|FG001|Overall Study|Subject Decision|1|||
16279697|NCT04154787|39507143|FG002|Overall Study|Subject Decision|0|||
16279698|NCT04154787|39507141|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
16279699|NCT04154787|39507142|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
16279700|NCT04154787|39507143|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
16279701|NCT02655224|39507146|FG000|Overall Study|Adverse Event|1|||
16279702|NCT02655224|39507147|FG001|Overall Study|Adverse Event|1|||
16279703|NCT02001051|39507148|FG000|Overall Study|Deemed not eligible following enrollment|0|||
16279704|NCT02001051|39507149|FG001|Overall Study|Deemed not eligible following enrollment|1|||
16279705|NCT01213836|39507153|FG000|Period 1, First Intervention|Adverse Event|2|||
16279706|NCT01213836|39507154|FG001|Period 1, First Intervention|Adverse Event|1|||
16279707|NCT01213836|39507153|FG000|Period 1, First Intervention|Protocol Violation|0|||
16279708|NCT01213836|39507154|FG001|Period 1, First Intervention|Protocol Violation|1|||
16279709|NCT01213836|39507153|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
16279710|NCT01213836|39507154|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
16279711|NCT04729101|39507155|FG000|Overall Study|Adverse Event|1|||
16279712|NCT04729101|39507156|FG001|Overall Study|Adverse Event|0|||
16379459|NCT02883049|39874673|FG012|Post Induction|Enrolled onto another COG study|0|||
16379460|NCT02883049|39874674|FG013|Post Induction|Enrolled onto another COG study|1|||
16379461|NCT02883049|39874675|FG014|Post Induction|Enrolled onto another COG study|0|||
16379462|NCT02883049|39874676|FG015|Post Induction|Enrolled onto another COG study|0|||
16379463|NCT02883049|39874661|FG000|Post Induction|Recurrent leukemia|0|||
16379464|NCT02883049|39874662|FG001|Post Induction|Recurrent leukemia|0|||
16379465|NCT02883049|39874663|FG002|Post Induction|Recurrent leukemia|0|||
16379466|NCT02883049|39874664|FG003|Post Induction|Recurrent leukemia|17|||
16379467|NCT02883049|39874665|FG004|Post Induction|Recurrent leukemia|12|||
16379468|NCT02883049|39874666|FG005|Post Induction|Recurrent leukemia|4|||
16379469|NCT02883049|39874667|FG006|Post Induction|Recurrent leukemia|1|||
16379470|NCT02883049|39874668|FG007|Post Induction|Recurrent leukemia|13|||
16379471|NCT02883049|39874669|FG008|Post Induction|Recurrent leukemia|27|||
16379472|NCT02883049|39874670|FG009|Post Induction|Recurrent leukemia|5|||
16379473|NCT02883049|39874671|FG010|Post Induction|Recurrent leukemia|3|||
16379474|NCT02883049|39874672|FG011|Post Induction|Recurrent leukemia|12|||
16379475|NCT02883049|39874673|FG012|Post Induction|Recurrent leukemia|1|||
16379476|NCT02883049|39874674|FG013|Post Induction|Recurrent leukemia|1|||
16379477|NCT02883049|39874675|FG014|Post Induction|Recurrent leukemia|9|||
16379478|NCT02883049|39874676|FG015|Post Induction|Recurrent leukemia|3|||
16379479|NCT02883049|39874661|FG000|Post Induction|Induction Failure|0|||
16379480|NCT02883049|39874662|FG001|Post Induction|Induction Failure|0|||
16379481|NCT02883049|39874663|FG002|Post Induction|Induction Failure|0|||
16379482|NCT02883049|39874664|FG003|Post Induction|Induction Failure|0|||
16379483|NCT02883049|39874665|FG004|Post Induction|Induction Failure|0|||
16379484|NCT02883049|39874666|FG005|Post Induction|Induction Failure|0|||
16379485|NCT02883049|39874667|FG006|Post Induction|Induction Failure|0|||
16379486|NCT02883049|39874668|FG007|Post Induction|Induction Failure|2|||
16379487|NCT02883049|39874669|FG008|Post Induction|Induction Failure|2|||
16379488|NCT02883049|39874670|FG009|Post Induction|Induction Failure|0|||
16379489|NCT02883049|39874671|FG010|Post Induction|Induction Failure|0|||
16379490|NCT02883049|39874672|FG011|Post Induction|Induction Failure|0|||
16379491|NCT02883049|39874673|FG012|Post Induction|Induction Failure|0|||
16379492|NCT02883049|39874674|FG013|Post Induction|Induction Failure|2|||
16379493|NCT02883049|39874675|FG014|Post Induction|Induction Failure|0|||
16379494|NCT02883049|39874676|FG015|Post Induction|Induction Failure|0|||
16379495|NCT00505687|39874677|FG000|Overall Study|Important protocol violation|2|||
16379496|NCT00505687|39874677|FG000|Overall Study|Lack of Efficacy|15|||
16379497|NCT00505687|39874677|FG000|Overall Study|Adverse Event|48|||
16379498|NCT00505687|39874677|FG000|Overall Study|Subject withdrew consent|15|||
16379499|NCT00505687|39874677|FG000|Overall Study|Lost to Follow-up|1|||
16379500|NCT00505687|39874677|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
16379501|NCT00505687|39874677|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
16379502|NCT00505687|39874677|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
16379503|NCT00505687|39874677|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
16279713|NCT04729101|39507155|FG000|Overall Study|Physician Decision|1|||
16279714|NCT04729101|39507156|FG001|Overall Study|Physician Decision|0|||
16279715|NCT04729101|39507155|FG000|Overall Study|Withdrawal by Subject|1|||
16279716|NCT04729101|39507156|FG001|Overall Study|Withdrawal by Subject|0|||
16279717|NCT01999894|39507157|FG000|Overall Study|Adverse Event|9|||
16279718|NCT01999894|39507157|FG000|Overall Study|Lack of Efficacy|5|||
16279719|NCT01999894|39507157|FG000|Overall Study|Protocol Violation|1|||
16379504|NCT00505687|39874677|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
16379505|NCT00505687|39874677|FG000|Overall Study|Other: Disease Progression|1|||
16379506|NCT00505687|39874677|FG000|Overall Study|Other: As Per Sponsor|8|||
16379507|NCT00835367|39874678|FG000|Washout|Adverse Event|2|||
16379508|NCT00835367|39874679|FG001|Washout|Adverse Event|0|||
16379509|NCT00835367|39874678|FG000|Washout|Withdrawal by Subject|1|||
16379510|NCT00835367|39874679|FG001|Washout|Withdrawal by Subject|0|||
16379511|NCT00835367|39874678|FG000|Second Intervention|Adverse Event|1|||
16279720|NCT01999894|39507157|FG000|Overall Study|Withdrawal by Subject|7|||
16379512|NCT00835367|39874679|FG001|Second Intervention|Adverse Event|1|||
16379513|NCT04016714|39874682|FG000|Overall Study|Death|1|||
16379514|NCT04016714|39874683|FG001|Overall Study|Death|0|||
16279721|NCT01999894|39507157|FG000|Overall Study|Lost to Follow-up|10|||
16379515|NCT04016714|39874682|FG000|Overall Study|Lost to Follow-up|3|||
16279722|NCT01999894|39507157|FG000|Overall Study|Other Reason|3|||
16279723|NCT01999894|39507157|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
16279724|NCT04501094|39507158|FG000|Overall Study|Death (unrelated to research)|1|||
16279725|NCT04501094|39507159|FG001|Overall Study|Death (unrelated to research)|0|||
16279726|NCT01470417|39507160|FG000|Overall Study|Disease progression|0|||
16279727|NCT01470417|39507161|FG001|Overall Study|Disease progression|2|||
16279728|NCT00035555|39507162|FG000|Overall Study|Adverse Event|5|||
16279729|NCT00035555|39507163|FG001|Overall Study|Adverse Event|8|||
16279730|NCT00035555|39507164|FG002|Overall Study|Adverse Event|9|||
16279731|NCT00035555|39507162|FG000|Overall Study|Allograft loss|1|||
16279732|NCT00035555|39507163|FG001|Overall Study|Allograft loss|1|||
16279733|NCT00035555|39507164|FG002|Overall Study|Allograft loss|2|||
16279734|NCT00035555|39507162|FG000|Overall Study|Death|0|||
16279735|NCT00035555|39507163|FG001|Overall Study|Death|0|||
16279736|NCT00035555|39507164|FG002|Overall Study|Death|2|||
16279737|NCT00035555|39507162|FG000|Overall Study|Lost to Follow-up|0|||
16279738|NCT00035555|39507163|FG001|Overall Study|Lost to Follow-up|0|||
16185025|NCT00914628|39159149|FG001|Overall Study|Medical decision|0|||
16185026|NCT00914628|39159148|FG000|Overall Study|Protocol Violation|1|||
16185027|NCT00914628|39159149|FG001|Overall Study|Protocol Violation|0|||
16379516|NCT04016714|39874683|FG001|Overall Study|Lost to Follow-up|1|||
16185028|NCT00914628|39159148|FG000|Overall Study|Lack of Efficacy|1|||
16185029|NCT00914628|39159149|FG001|Overall Study|Lack of Efficacy|0|||
16185030|NCT00914628|39159148|FG000|Overall Study|non-randomized|1|||
16185031|NCT00914628|39159149|FG001|Overall Study|non-randomized|0|||
16185032|NCT00914628|39159148|FG000|Overall Study|Relapse|1|||
16185033|NCT00914628|39159149|FG001|Overall Study|Relapse|2|||
16185034|NCT00914628|39159148|FG000|Overall Study|Study terminated by Sponsor|14|||
16185035|NCT00914628|39159149|FG001|Overall Study|Study terminated by Sponsor|8|||
16185036|NCT00914628|39159148|FG000|Overall Study|Patients who did not receive a single dose|7|||
16185037|NCT00914628|39159149|FG001|Overall Study|Patients who did not receive a single dose|1|||
16185038|NCT05258058|39159150|FG000|Overall Study|Withdrawal by Subject|2|||
16185039|NCT00958568|39159151|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
16185040|NCT00958568|39159152|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
16185041|NCT00958568|39159153|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
16185042|NCT00958568|39159154|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
16185043|NCT00958568|39159151|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
16185044|NCT00958568|39159152|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
16185045|NCT00958568|39159153|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
16185046|NCT00958568|39159154|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
16185047|NCT00958568|39159151|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
16185048|NCT00958568|39159152|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
16185049|NCT00958568|39159153|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
16185050|NCT00958568|39159154|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
16185051|NCT00958568|39159151|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
16185052|NCT00958568|39159152|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
16185053|NCT00958568|39159153|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
16185054|NCT00958568|39159154|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
16185055|NCT00958568|39159151|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
16185056|NCT00958568|39159152|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
16185057|NCT00958568|39159153|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
16185058|NCT00958568|39159154|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
16185059|NCT00958568|39159151|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
16185060|NCT00958568|39159152|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
16185061|NCT00958568|39159153|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
16185062|NCT00958568|39159154|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
16185063|NCT00958568|39159151|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
16185064|NCT00958568|39159152|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
16279739|NCT00035555|39507164|FG002|Overall Study|Lost to Follow-up|1|||
16279740|NCT00035555|39507162|FG000|Overall Study|Noncompliance|0|||
16279741|NCT00035555|39507163|FG001|Overall Study|Noncompliance|1|||
16279742|NCT00035555|39507164|FG002|Overall Study|Noncompliance|1|||
16279743|NCT00035555|39507162|FG000|Overall Study|Prohibited medication|1|||
16279744|NCT00035555|39507163|FG001|Overall Study|Prohibited medication|1|||
16379517|NCT04016714|39874682|FG000|Overall Study|Physician Decision|3|||
16185065|NCT00958568|39159153|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
16279745|NCT00035555|39507164|FG002|Overall Study|Prohibited medication|0|||
16279746|NCT00035555|39507162|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
16279747|NCT00035555|39507163|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
16279748|NCT00035555|39507164|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
16279749|NCT00035555|39507162|FG000|Overall Study|Withdrawal by Subject|2|||
16185066|NCT00958568|39159154|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
16279750|NCT00035555|39507163|FG001|Overall Study|Withdrawal by Subject|0|||
16379518|NCT04016714|39874683|FG001|Overall Study|Physician Decision|3|||
16379519|NCT04016714|39874682|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
16379520|NCT04016714|39874683|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
16379521|NCT00567502|39874688|FG000|Overall Study|Lost to Follow-up|91|||
16379522|NCT00567502|39874689|FG001|Overall Study|Lost to Follow-up|14|||
16379523|NCT00567502|39874690|FG002|Overall Study|Lost to Follow-up|351|||
16379524|NCT00567502|39874691|FG003|Overall Study|Lost to Follow-up|2|||
16379525|NCT00567502|39874688|FG000|Overall Study|Death|65|||
16379526|NCT00567502|39874689|FG001|Overall Study|Death|16|||
16379527|NCT00567502|39874690|FG002|Overall Study|Death|360|||
16379528|NCT00567502|39874691|FG003|Overall Study|Death|5|||
16379529|NCT00567502|39874688|FG000|Overall Study|Other|64|||
16379530|NCT00567502|39874689|FG001|Overall Study|Other|2|||
16379531|NCT00567502|39874690|FG002|Overall Study|Other|134|||
16379532|NCT00567502|39874691|FG003|Overall Study|Other|6|||
16379533|NCT00567502|39874688|FG000|Overall Study|Participant request|12|||
16379534|NCT00567502|39874689|FG001|Overall Study|Participant request|1|||
16379535|NCT00567502|39874690|FG002|Overall Study|Participant request|33|||
16379536|NCT00567502|39874691|FG003|Overall Study|Participant request|1|||
16379537|NCT00567502|39874688|FG000|Overall Study|Sponsor request|9|||
16379538|NCT00567502|39874689|FG001|Overall Study|Sponsor request|0|||
16379539|NCT00567502|39874690|FG002|Overall Study|Sponsor request|30|||
16379540|NCT00567502|39874691|FG003|Overall Study|Sponsor request|1|||
16379541|NCT00567502|39874688|FG000|Overall Study|Never Initiated Treatment|0|||
16379542|NCT00567502|39874689|FG001|Overall Study|Never Initiated Treatment|0|||
16379543|NCT00567502|39874690|FG002|Overall Study|Never Initiated Treatment|0|||
16379544|NCT00567502|39874691|FG003|Overall Study|Never Initiated Treatment|72|||
16379545|NCT03685149|39874692|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
16379546|NCT03685149|39874693|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
16379547|NCT03685149|39874692|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
16379548|NCT03685149|39874693|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
16379549|NCT03685149|39874692|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
16379550|NCT03685149|39874693|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
16379551|NCT02106832|39874695|FG000|Overall Study|Adverse Event|1|||
16379552|NCT02106832|39874696|FG001|Overall Study|Adverse Event|2|||
16379553|NCT02106832|39874697|FG002|Overall Study|Adverse Event|3|||
16379554|NCT02106832|39874698|FG003|Overall Study|Adverse Event|0|||
16379555|NCT02106832|39874695|FG000|Overall Study|Death|4|||
16379556|NCT02106832|39874696|FG001|Overall Study|Death|4|||
16185067|NCT00958568|39159151|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
16185068|NCT00958568|39159152|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
16185069|NCT00958568|39159153|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
16185070|NCT00958568|39159154|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
16185071|NCT00958568|39159151|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
16185072|NCT00958568|39159152|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
16185073|NCT00958568|39159153|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
16185074|NCT00958568|39159154|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
16185075|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
16185076|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
16185077|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
16185078|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
16185079|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
16185080|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
16185081|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
16185082|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
16185083|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
16185084|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
16185085|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
16185086|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
16185087|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
16185088|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
16185089|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
16185090|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
16185091|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
16185092|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
16185093|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
16379557|NCT02106832|39874697|FG002|Overall Study|Death|1|||
16379558|NCT02106832|39874698|FG003|Overall Study|Death|4|||
16379559|NCT02106832|39874695|FG000|Overall Study|Deterioration of general conditions|0|||
16379560|NCT02106832|39874696|FG001|Overall Study|Deterioration of general conditions|0|||
16379561|NCT02106832|39874697|FG002|Overall Study|Deterioration of general conditions|1|||
16379562|NCT02106832|39874698|FG003|Overall Study|Deterioration of general conditions|0|||
16379563|NCT02106832|39874695|FG000|Overall Study|Lost to Follow-up|0|||
16379564|NCT02106832|39874696|FG001|Overall Study|Lost to Follow-up|1|||
16379565|NCT02106832|39874697|FG002|Overall Study|Lost to Follow-up|1|||
16379566|NCT02106832|39874698|FG003|Overall Study|Lost to Follow-up|3|||
16379567|NCT02106832|39874695|FG000|Overall Study|Physician Decision|1|||
16379568|NCT02106832|39874696|FG001|Overall Study|Physician Decision|0|||
16379569|NCT02106832|39874697|FG002|Overall Study|Physician Decision|0|||
16379570|NCT02106832|39874698|FG003|Overall Study|Physician Decision|0|||
16379571|NCT02106832|39874695|FG000|Overall Study|Protocol Violation|0|||
16379572|NCT02106832|39874696|FG001|Overall Study|Protocol Violation|0|||
16379573|NCT02106832|39874697|FG002|Overall Study|Protocol Violation|0|||
16379574|NCT02106832|39874698|FG003|Overall Study|Protocol Violation|1|||
16379575|NCT02106832|39874695|FG000|Overall Study|Withdrawal by Subject|17|||
16379576|NCT02106832|39874696|FG001|Overall Study|Withdrawal by Subject|17|||
16379577|NCT02106832|39874697|FG002|Overall Study|Withdrawal by Subject|10|||
16479002|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16479003|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16479004|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16479005|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16479006|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16479007|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
16479008|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16479009|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16479010|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16479011|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
16479012|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
16479013|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479014|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479015|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16279751|NCT00035555|39507164|FG002|Overall Study|Withdrawal by Subject|2|||
16279752|NCT00035555|39507162|FG000|Overall Study|Investigator deemed not a good candidate|0|||
16279753|NCT00035555|39507163|FG001|Overall Study|Investigator deemed not a good candidate|0|||
16279754|NCT00035555|39507164|FG002|Overall Study|Investigator deemed not a good candidate|1|||
16279755|NCT00035555|39507162|FG000|Overall Study|Received cyclosporin in error|0|||
16379578|NCT02106832|39874698|FG003|Overall Study|Withdrawal by Subject|7|||
16279756|NCT00035555|39507163|FG001|Overall Study|Received cyclosporin in error|0|||
16279757|NCT00035555|39507164|FG002|Overall Study|Received cyclosporin in error|1|||
16279758|NCT01321697|39507167|FG000|Overall Study|Study Terminated|7|||
16279759|NCT00983528|39507174|FG000|Overall Study|Death|4|||
16279760|NCT00983528|39507174|FG000|Overall Study|Lost to Follow-up|1|||
16279761|NCT00983528|39507174|FG000|Overall Study|Study Terminated|1|||
16279762|NCT01181531|39507175|FG000|Overall Study|Other|17|||
16279763|NCT01181531|39507176|FG001|Overall Study|Other|12|||
16279764|NCT01181531|39507175|FG000|Overall Study|Partial consent by subject withdrawn|0|||
16279765|NCT01181531|39507176|FG001|Overall Study|Partial consent by subject withdrawn|1|||
16279766|NCT01181531|39507175|FG000|Overall Study|Physician Decision|3|||
16279767|NCT01181531|39507176|FG001|Overall Study|Physician Decision|1|||
16279768|NCT01181531|39507175|FG000|Overall Study|Noncompliance|2|||
16279769|NCT01181531|39507176|FG001|Overall Study|Noncompliance|2|||
16279770|NCT01181531|39507175|FG000|Overall Study|Ineligibility determined|1|||
16279771|NCT01181531|39507176|FG001|Overall Study|Ineligibility determined|2|||
16279772|NCT01181531|39507175|FG000|Overall Study|Protocol Specified Criteria|15|||
16279773|NCT01181531|39507176|FG001|Overall Study|Protocol Specified Criteria|8|||
16279774|NCT01181531|39507175|FG000|Overall Study|Pregnancy|0|||
16279775|NCT01181531|39507176|FG001|Overall Study|Pregnancy|1|||
16279776|NCT01181531|39507175|FG000|Overall Study|Withdrawal by Subject|8|||
16279777|NCT01181531|39507176|FG001|Overall Study|Withdrawal by Subject|7|||
16279778|NCT01181531|39507175|FG000|Overall Study|Protocol Violation|6|||
16279779|NCT01181531|39507176|FG001|Overall Study|Protocol Violation|6|||
16279780|NCT01181531|39507175|FG000|Overall Study|Death|9|||
16279781|NCT01181531|39507176|FG001|Overall Study|Death|12|||
16279782|NCT01181531|39507175|FG000|Overall Study|Adverse Event|0|||
16279783|NCT01181531|39507176|FG001|Overall Study|Adverse Event|1|||
16279784|NCT01144403|39507177|FG000|Overall Study|Lost to Follow-up|3|||
16279785|NCT01144403|39507177|FG000|Overall Study|Death|1|||
16279786|NCT01144403|39507177|FG000|Overall Study|Adverse Event|1|||
16279787|NCT02190279|39507178|FG000|Overall Study|Withdrawal consent|1|||
16279788|NCT02190279|39507179|FG001|Overall Study|Withdrawal consent|0|||
16279789|NCT02190279|39507180|FG002|Overall Study|Withdrawal consent|1|||
16279790|NCT02190279|39507178|FG000|Overall Study|Lost to Follow-up|2|||
16379579|NCT02106832|39874695|FG000|Overall Study|Technical problems|0|||
16379580|NCT02106832|39874696|FG001|Overall Study|Technical problems|1|||
16379581|NCT02106832|39874697|FG002|Overall Study|Technical problems|0|||
16379582|NCT02106832|39874698|FG003|Overall Study|Technical problems|0|||
16379583|NCT01107886|39874704|FG000|Overall Study|Lost to Follow-up|15|||
16379584|NCT01107886|39874705|FG001|Overall Study|Lost to Follow-up|13|||
16379585|NCT01107886|39874704|FG000|Overall Study|Withdrawal by Subject|180|||
16379586|NCT01107886|39874705|FG001|Overall Study|Withdrawal by Subject|196|||
16379587|NCT01107886|39874704|FG000|Overall Study|Administrative withdrawal of consent|7|||
16479016|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479017|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479018|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479019|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479020|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479021|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479022|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479023|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479024|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479025|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479026|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
16479027|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
16479028|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Other|0|||
16479029|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Other|0|||
16479030|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Other|0|||
16479031|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Other|0|||
16479032|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Other|0|||
16479033|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Other|0|||
16479034|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Other|0|||
16479035|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Other|0|||
16479036|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Other|0|||
16479037|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Other|0|||
16479038|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Other|0|||
16479039|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Other|0|||
16479040|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Other|0|||
16479041|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Other|1|||
16479042|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Other|3|||
16479043|NCT03519178|40234256|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479044|NCT03519178|40234257|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479045|NCT03519178|40234258|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479046|NCT03519178|40234259|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479047|NCT03519178|40234260|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479048|NCT03519178|40234261|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479049|NCT03519178|40234262|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479050|NCT03519178|40234263|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479051|NCT03519178|40234264|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479052|NCT03519178|40234265|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479053|NCT03519178|40234266|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479054|NCT03519178|40234267|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479055|NCT03519178|40234268|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
16479056|NCT03519178|40234269|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
16479057|NCT03519178|40234270|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
16479058|NCT03519178|40234256|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
16479059|NCT03519178|40234257|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
16479060|NCT03519178|40234258|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
16479061|NCT03519178|40234259|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
16479062|NCT03519178|40234260|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
16479063|NCT03519178|40234261|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
16479064|NCT03519178|40234262|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
16479065|NCT03519178|40234263|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
16479066|NCT03519178|40234264|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
16080205|NCT01307267|38786796|FG015|Overall Study|Death|0|||
16279791|NCT02190279|39507179|FG001|Overall Study|Lost to Follow-up|0|||
16279792|NCT02190279|39507180|FG002|Overall Study|Lost to Follow-up|0|||
16279793|NCT02190279|39507178|FG000|Overall Study|Refused further treatment|0|||
16279794|NCT02190279|39507179|FG001|Overall Study|Refused further treatment|0|||
16080206|NCT01307267|38786797|FG016|Overall Study|Death|1|||
16080207|NCT01307267|38786798|FG017|Overall Study|Death|1|||
16080208|NCT01307267|38786799|FG018|Overall Study|Death|2|||
16080209|NCT01307267|38786800|FG019|Overall Study|Death|8|||
16479067|NCT03519178|40234265|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
16479068|NCT03519178|40234266|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
16479069|NCT03519178|40234267|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
16479070|NCT03519178|40234268|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
16479071|NCT03519178|40234269|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
16479072|NCT03519178|40234270|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
16479073|NCT03519178|40234256|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
16479074|NCT03519178|40234257|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
16479075|NCT03519178|40234258|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
16479076|NCT03519178|40234259|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
16479077|NCT03519178|40234260|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
16479078|NCT03519178|40234261|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
16479079|NCT03519178|40234262|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
16479080|NCT03519178|40234263|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
16479081|NCT03519178|40234264|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
16479082|NCT03519178|40234265|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
16479083|NCT03519178|40234266|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
16479084|NCT03519178|40234267|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
16479085|NCT03519178|40234268|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
16479086|NCT03519178|40234269|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
16479087|NCT03519178|40234270|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
16479088|NCT03519178|40234256|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479089|NCT03519178|40234257|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479090|NCT03519178|40234258|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479091|NCT03519178|40234259|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479092|NCT03519178|40234260|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479093|NCT03519178|40234261|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479094|NCT03519178|40234262|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479095|NCT03519178|40234263|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479096|NCT03519178|40234264|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479097|NCT03519178|40234265|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479098|NCT03519178|40234266|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
16479099|NCT03519178|40234267|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479100|NCT03519178|40234268|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479101|NCT03519178|40234269|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479102|NCT03519178|40234270|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
16479103|NCT03519178|40234256|FG000|Follow-Up|Death|0|||
16479104|NCT03519178|40234257|FG001|Follow-Up|Death|0|||
16479105|NCT03519178|40234258|FG002|Follow-Up|Death|1|||
16479106|NCT03519178|40234259|FG003|Follow-Up|Death|0|||
16479107|NCT03519178|40234260|FG004|Follow-Up|Death|0|||
16479108|NCT03519178|40234261|FG005|Follow-Up|Death|0|||
16479109|NCT03519178|40234262|FG006|Follow-Up|Death|0|||
16479110|NCT03519178|40234263|FG007|Follow-Up|Death|0|||
16479111|NCT03519178|40234264|FG008|Follow-Up|Death|3|||
16479112|NCT03519178|40234265|FG009|Follow-Up|Death|1|||
16479113|NCT03519178|40234266|FG010|Follow-Up|Death|0|||
16479114|NCT03519178|40234267|FG011|Follow-Up|Death|0|||
16479115|NCT03519178|40234268|FG012|Follow-Up|Death|2|||
16479116|NCT03519178|40234269|FG013|Follow-Up|Death|0|||
16479117|NCT03519178|40234270|FG014|Follow-Up|Death|0|||
16479118|NCT03519178|40234256|FG000|Follow-Up|Lost to Follow-up|0|||
16479119|NCT03519178|40234257|FG001|Follow-Up|Lost to Follow-up|0|||
16479120|NCT03519178|40234258|FG002|Follow-Up|Lost to Follow-up|0|||
16479121|NCT03519178|40234259|FG003|Follow-Up|Lost to Follow-up|0|||
16479122|NCT03519178|40234260|FG004|Follow-Up|Lost to Follow-up|0|||
16479123|NCT03519178|40234261|FG005|Follow-Up|Lost to Follow-up|3|||
16479124|NCT03519178|40234262|FG006|Follow-Up|Lost to Follow-up|1|||
16479125|NCT03519178|40234263|FG007|Follow-Up|Lost to Follow-up|4|||
16479126|NCT03519178|40234264|FG008|Follow-Up|Lost to Follow-up|1|||
16479127|NCT03519178|40234265|FG009|Follow-Up|Lost to Follow-up|0|||
16479128|NCT03519178|40234266|FG010|Follow-Up|Lost to Follow-up|0|||
16479129|NCT03519178|40234267|FG011|Follow-Up|Lost to Follow-up|0|||
16479130|NCT03519178|40234268|FG012|Follow-Up|Lost to Follow-up|0|||
16479131|NCT03519178|40234269|FG013|Follow-Up|Lost to Follow-up|0|||
16479132|NCT03519178|40234270|FG014|Follow-Up|Lost to Follow-up|0|||
16479133|NCT03519178|40234256|FG000|Follow-Up|Withdrawal by Subject|1|||
16479134|NCT03519178|40234257|FG001|Follow-Up|Withdrawal by Subject|2|||
16479135|NCT03519178|40234258|FG002|Follow-Up|Withdrawal by Subject|2|||
16479136|NCT03519178|40234259|FG003|Follow-Up|Withdrawal by Subject|3|||
16479137|NCT03519178|40234260|FG004|Follow-Up|Withdrawal by Subject|5|||
16479138|NCT03519178|40234261|FG005|Follow-Up|Withdrawal by Subject|1|||
16479139|NCT03519178|40234262|FG006|Follow-Up|Withdrawal by Subject|2|||
16479140|NCT03519178|40234263|FG007|Follow-Up|Withdrawal by Subject|6|||
16479141|NCT03519178|40234264|FG008|Follow-Up|Withdrawal by Subject|5|||
16479142|NCT03519178|40234265|FG009|Follow-Up|Withdrawal by Subject|2|||
16479143|NCT03519178|40234266|FG010|Follow-Up|Withdrawal by Subject|3|||
16479144|NCT03519178|40234267|FG011|Follow-Up|Withdrawal by Subject|5|||
16279795|NCT02190279|39507180|FG002|Overall Study|Refused further treatment|1|||
16279796|NCT02190279|39507178|FG000|Overall Study|Screening failure|0|||
16279797|NCT02190279|39507179|FG001|Overall Study|Screening failure|0|||
16279798|NCT02190279|39507180|FG002|Overall Study|Screening failure|1|||
16279799|NCT03566238|39507187|FG000|Overall Study|Adverse Event|0|||
16279800|NCT03566238|39507188|FG001|Overall Study|Adverse Event|1|||
16279801|NCT03566238|39507189|FG002|Overall Study|Adverse Event|0|||
16279802|NCT03566238|39507187|FG000|Overall Study|Lack of Efficacy|4|||
16279803|NCT03566238|39507188|FG001|Overall Study|Lack of Efficacy|2|||
16279804|NCT03566238|39507189|FG002|Overall Study|Lack of Efficacy|5|||
16279805|NCT03566238|39507187|FG000|Overall Study|Other|1|||
16279806|NCT03566238|39507188|FG001|Overall Study|Other|0|||
16279807|NCT03566238|39507189|FG002|Overall Study|Other|0|||
16279808|NCT01188226|39507190|FG000|Overall Study|Withdrawal by Subject|4|||
16279809|NCT02674633|39507191|FG000|Overall Study|Lost to Follow-up|3|||
16279810|NCT02674633|39507192|FG001|Overall Study|Lost to Follow-up|2|||
16279811|NCT02674633|39507191|FG000|Overall Study|Physician Decision|1|||
16279812|NCT02674633|39507192|FG001|Overall Study|Physician Decision|0|||
16279813|NCT02674633|39507191|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
16279814|NCT02674633|39507192|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
16279815|NCT02658019|39507193|FG000|Overall Study|Adverse Event|1|||
16279816|NCT01004510|39507194|FG000|Overall Study|Adverse Event|1|||
16279817|NCT00761176|39507195|FG000|Overall Study|Death|1|||
16279818|NCT00761176|39507196|FG001|Overall Study|Death|0|||
16279819|NCT00761176|39507195|FG000|Overall Study|Withdrawal by Subject|1|||
16279820|NCT00761176|39507196|FG001|Overall Study|Withdrawal by Subject|1|||
16279821|NCT03546647|39507199|FG000|Overall Study|Adverse Event|1|||
16279822|NCT03546647|39507200|FG001|Overall Study|Adverse Event|0|||
16279823|NCT02510261|39507201|FG000|Overall Study|Adverse Event|5|||
16279824|NCT02510261|39507202|FG001|Overall Study|Adverse Event|8|||
16279825|NCT02510261|39507203|FG002|Overall Study|Adverse Event|0|||
16279826|NCT02510261|39507201|FG000|Overall Study|Physician Decision|1|||
16279827|NCT02510261|39507202|FG001|Overall Study|Physician Decision|5|||
16279828|NCT02510261|39507203|FG002|Overall Study|Physician Decision|0|||
16279829|NCT02510261|39507201|FG000|Overall Study|Death|19|||
16279830|NCT02510261|39507202|FG001|Overall Study|Death|19|||
16279831|NCT02510261|39507203|FG002|Overall Study|Death|0|||
16279832|NCT02510261|39507201|FG000|Overall Study|Withdrawal by Subject|3|||
16279833|NCT02510261|39507202|FG001|Overall Study|Withdrawal by Subject|10|||
16279834|NCT02510261|39507203|FG002|Overall Study|Withdrawal by Subject|3|||
16279835|NCT00819767|39507204|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16279836|NCT00819767|39507205|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16279837|NCT00831233|39507206|FG000|Overall Study|Adverse Event|0|||
16279838|NCT00831233|39507207|FG001|Overall Study|Adverse Event|1|||
16279839|NCT00831233|39507206|FG000|Overall Study|Protocol Violation|1|||
16279840|NCT00831233|39507207|FG001|Overall Study|Protocol Violation|0|||
16279841|NCT00831233|39507206|FG000|Overall Study|Selection Criteria Not Met|2|||
16279842|NCT00831233|39507207|FG001|Overall Study|Selection Criteria Not Met|0|||
16279843|NCT00097786|39507212|FG000|Overall Study|lost to follow-up for all-cause death|296|||
16279844|NCT00097786|39507213|FG001|Overall Study|lost to follow-up for all-cause death|292|||
16279845|NCT00097786|39507214|FG002|Overall Study|lost to follow-up for all-cause death|313|||
16279846|NCT00097786|39507215|FG003|Overall Study|lost to follow-up for all-cause death|310|||
16279847|NCT01463982|39507216|FG000|Overall Study|Withdrawal by Subject|0|||
16379588|NCT01107886|39874705|FG001|Overall Study|Administrative withdrawal of consent|5|||
16379589|NCT02989857|39874709|FG000|Randomization Phase|Not Treated|3|||
16379590|NCT02989857|39874710|FG001|Randomization Phase|Not Treated|2|||
16479145|NCT03519178|40234268|FG012|Follow-Up|Withdrawal by Subject|2|||
16279848|NCT01463982|39507217|FG001|Overall Study|Withdrawal by Subject|1|||
16279849|NCT01463982|39507218|FG002|Overall Study|Withdrawal by Subject|1|||
16279850|NCT01463982|39507219|FG003|Overall Study|Withdrawal by Subject|0|||
16279851|NCT01463982|39507216|FG000|Overall Study|Treatment delay over 5 week|0|||
16279852|NCT01463982|39507217|FG001|Overall Study|Treatment delay over 5 week|0|||
16279853|NCT01463982|39507218|FG002|Overall Study|Treatment delay over 5 week|1|||
16279854|NCT01463982|39507219|FG003|Overall Study|Treatment delay over 5 week|0|||
16279855|NCT04252287|39507220|FG000|Overall Study|Death|5|||
16279856|NCT04252287|39507221|FG001|Overall Study|Death|3|||
16279857|NCT04252287|39507220|FG000|Overall Study|Lost to Follow-up|4|||
16479146|NCT03519178|40234269|FG013|Follow-Up|Withdrawal by Subject|0|||
16479147|NCT03519178|40234270|FG014|Follow-Up|Withdrawal by Subject|0|||
16279858|NCT04252287|39507221|FG001|Overall Study|Lost to Follow-up|6|||
16479148|NCT03519178|40234256|FG000|Follow-Up|Other|0|||
16479149|NCT03519178|40234257|FG001|Follow-Up|Other|0|||
16479150|NCT03519178|40234258|FG002|Follow-Up|Other|0|||
16479151|NCT03519178|40234259|FG003|Follow-Up|Other|0|||
16279859|NCT04252287|39507220|FG000|Overall Study|Withdrawal by Subject|19|||
16279860|NCT04252287|39507221|FG001|Overall Study|Withdrawal by Subject|16|||
16279861|NCT04252287|39507220|FG000|Overall Study|Protocol Violation|3|||
16279862|NCT04252287|39507221|FG001|Overall Study|Protocol Violation|4|||
16279863|NCT02726386|39507222|FG000|Overall Study|Adverse Event|17|||
16279864|NCT02726386|39507223|FG001|Overall Study|Adverse Event|20|||
16279865|NCT02726386|39507222|FG000|Overall Study|Withdrawal by Subject|14|||
16279866|NCT02726386|39507223|FG001|Overall Study|Withdrawal by Subject|28|||
16279867|NCT02726386|39507222|FG000|Overall Study|Other reasons|7|||
16279868|NCT02726386|39507223|FG001|Overall Study|Other reasons|8|||
16279869|NCT01647711|39507231|FG000|Overall Study|Progressive disease|6|||
16279870|NCT01647711|39507232|FG001|Overall Study|Progressive disease|2|||
16279871|NCT01647711|39507233|FG002|Overall Study|Progressive disease|6|||
16279872|NCT01647711|39507234|FG003|Overall Study|Progressive disease|8|||
16279873|NCT01647711|39507235|FG004|Overall Study|Progressive disease|2|||
16279874|NCT01647711|39507231|FG000|Overall Study|Other adverse event|0|||
16279875|NCT01647711|39507232|FG001|Overall Study|Other adverse event|0|||
16279876|NCT01647711|39507233|FG002|Overall Study|Other adverse event|2|||
16279877|NCT01647711|39507234|FG003|Overall Study|Other adverse event|0|||
16279878|NCT01647711|39507235|FG004|Overall Study|Other adverse event|2|||
16279879|NCT01647711|39507231|FG000|Overall Study|Protocol Violation|0|||
16279880|NCT01647711|39507232|FG001|Overall Study|Protocol Violation|0|||
16279881|NCT01647711|39507233|FG002|Overall Study|Protocol Violation|0|||
16279882|NCT01647711|39507234|FG003|Overall Study|Protocol Violation|0|||
16279883|NCT01647711|39507235|FG004|Overall Study|Protocol Violation|1|||
16279884|NCT01647711|39507231|FG000|Overall Study|Refused to continue taking medication|0|||
16279885|NCT01647711|39507232|FG001|Overall Study|Refused to continue taking medication|0|||
16279886|NCT01647711|39507233|FG002|Overall Study|Refused to continue taking medication|0|||
16279887|NCT01647711|39507234|FG003|Overall Study|Refused to continue taking medication|2|||
16279888|NCT01647711|39507235|FG004|Overall Study|Refused to continue taking medication|1|||
16279889|NCT01647711|39507231|FG000|Overall Study|Other reason not defined|0|||
16279890|NCT01647711|39507232|FG001|Overall Study|Other reason not defined|1|||
16279891|NCT01647711|39507233|FG002|Overall Study|Other reason not defined|1|||
16279892|NCT01647711|39507234|FG003|Overall Study|Other reason not defined|1|||
16279893|NCT01647711|39507235|FG004|Overall Study|Other reason not defined|0|||
16279894|NCT00529217|39507236|FG000|Overall Study|Lack of Efficacy|2|||
16279895|NCT00529217|39507236|FG000|Overall Study|Unable to adhere to study schedule|2|||
16279896|NCT04823130|39507237|FG000|Overall Study|Withdrawal by Subject|2|||
16279897|NCT04823130|39507238|FG001|Overall Study|Withdrawal by Subject|3|||
16279898|NCT04823130|39507237|FG000|Overall Study|Failure to meet inclusion criteria|6|||
16279899|NCT04823130|39507238|FG001|Overall Study|Failure to meet inclusion criteria|4|||
16279900|NCT04823130|39507237|FG000|Overall Study|Other-unspecified|1|||
16279901|NCT04823130|39507238|FG001|Overall Study|Other-unspecified|0|||
16279902|NCT00559364|39507241|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
16279903|NCT00559364|39507242|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
16279904|NCT01644149|39507243|FG000|Overall Study|Withdrawal by Subject|1|||
16279905|NCT01644149|39507244|FG001|Overall Study|Withdrawal by Subject|0|||
16279906|NCT01644149|39507243|FG000|Overall Study|Lost to Follow-up|3|||
16279907|NCT01644149|39507244|FG001|Overall Study|Lost to Follow-up|1|||
16279908|NCT02363439|39507245|FG000|Overall Study|Lack of Efficacy|4|||
16279909|NCT03877926|39507248|FG000|Overall Study|Adverse Event|1|||
16279910|NCT03877926|39507249|FG001|Overall Study|Adverse Event|0|||
16279911|NCT03877926|39507250|FG002|Overall Study|Adverse Event|0|||
16279912|NCT03877926|39507251|FG003|Overall Study|Adverse Event|0|||
16279913|NCT03877926|39507248|FG000|Overall Study|Death|2|||
16379591|NCT02989857|39874711|FG002|Randomization Phase|Not Treated|0|||
16379592|NCT04456699|39874712|FG000|Overall Study|Withdrawal by Subject|8|||
16379593|NCT04456699|39874713|FG001|Overall Study|Withdrawal by Subject|4|||
16379594|NCT04456699|39874714|FG002|Overall Study|Withdrawal by Subject|4|||
16379595|NCT04456699|39874712|FG000|Overall Study|Sponsor Decision|1|||
16379596|NCT04456699|39874713|FG001|Overall Study|Sponsor Decision|4|||
16379597|NCT04456699|39874714|FG002|Overall Study|Sponsor Decision|1|||
16379598|NCT04456699|39874712|FG000|Overall Study|Death|47|||
16379599|NCT04456699|39874713|FG001|Overall Study|Death|48|||
16379600|NCT04456699|39874714|FG002|Overall Study|Death|51|||
16379601|NCT04456699|39874712|FG000|Overall Study|Participants Ongoing in Study|55|||
16379602|NCT04456699|39874713|FG001|Overall Study|Participants Ongoing in Study|59|||
16379603|NCT04456699|39874714|FG002|Overall Study|Participants Ongoing in Study|53|||
16379604|NCT04129398|39874720|FG000|Overall Study|Physician Decision|2|||
16479152|NCT03519178|40234260|FG004|Follow-Up|Other|0|||
16279914|NCT03877926|39507249|FG001|Overall Study|Death|2|||
16279915|NCT03877926|39507250|FG002|Overall Study|Death|2|||
16279916|NCT03877926|39507251|FG003|Overall Study|Death|0|||
16279917|NCT03877926|39507248|FG000|Overall Study|Lost to Follow-up|41|||
16279918|NCT03877926|39507249|FG001|Overall Study|Lost to Follow-up|52|||
16279919|NCT03877926|39507250|FG002|Overall Study|Lost to Follow-up|45|||
16279920|NCT03877926|39507251|FG003|Overall Study|Lost to Follow-up|17|||
16279921|NCT03877926|39507248|FG000|Overall Study|Physician Decision|2|||
16279922|NCT03877926|39507249|FG001|Overall Study|Physician Decision|0|||
16279923|NCT03877926|39507250|FG002|Overall Study|Physician Decision|2|||
16279924|NCT03877926|39507251|FG003|Overall Study|Physician Decision|0|||
16279925|NCT03877926|39507248|FG000|Overall Study|Withdrawal by Subject|18|||
16279926|NCT03877926|39507249|FG001|Overall Study|Withdrawal by Subject|21|||
16279927|NCT03877926|39507250|FG002|Overall Study|Withdrawal by Subject|12|||
16279928|NCT03877926|39507251|FG003|Overall Study|Withdrawal by Subject|4|||
16279929|NCT03877926|39507248|FG000|Overall Study|Other - Various|4|||
16279930|NCT03877926|39507249|FG001|Overall Study|Other - Various|1|||
16279931|NCT03877926|39507250|FG002|Overall Study|Other - Various|1|||
16279932|NCT03877926|39507251|FG003|Overall Study|Other - Various|0|||
16279933|NCT03877926|39507248|FG000|Overall Study|Not Treated|3|||
16279934|NCT03877926|39507249|FG001|Overall Study|Not Treated|1|||
16279935|NCT03877926|39507250|FG002|Overall Study|Not Treated|1|||
16279936|NCT03877926|39507251|FG003|Overall Study|Not Treated|0|||
16279937|NCT00388037|39507252|FG000|Overall Study|Protocol Violation|1|||
16279938|NCT02618382|39507253|FG000|Overall Study|Physician Decision|1|||
16279939|NCT02618382|39507253|FG000|Overall Study|Withdrawal by Subject|1|||
16279940|NCT02618382|39507253|FG000|Overall Study|Protocol Violation|1|||
16279941|NCT04099641|39507255|FG000|Overall Study|Death|46|||
16279942|NCT04099641|39507256|FG001|Overall Study|Death|12|||
16279943|NCT04099641|39507255|FG000|Overall Study|Lost to Follow-up|1|||
16279944|NCT04099641|39507256|FG001|Overall Study|Lost to Follow-up|0|||
16279945|NCT04099641|39507255|FG000|Overall Study|Withdrawal by Subject|2|||
16279946|NCT04099641|39507256|FG001|Overall Study|Withdrawal by Subject|0|||
16279947|NCT00983476|39507263|FG000|Overall Study|Did not receive intervention|17|||
16279948|NCT00983476|39507264|FG001|Overall Study|Did not receive intervention|22|||
16279949|NCT00983476|39507265|FG002|Overall Study|Did not receive intervention|0|||
16279950|NCT02466386|39507266|FG000|Overall Study|Adverse Event|5|||
16279951|NCT02466386|39507266|FG000|Overall Study|Protocol Violation|2|||
16279952|NCT02466386|39507266|FG000|Overall Study|Withdrawal by Subject|14|||
16279953|NCT02466386|39507266|FG000|Overall Study|Lost to Follow-up|5|||
16279954|NCT02466386|39507266|FG000|Overall Study|Lack of Efficacy|8|||
16279955|NCT02466386|39507266|FG000|Overall Study|Other|10|||
16279956|NCT00676650|39507271|FG000|Overall Study|Death|45|||
16279957|NCT00676650|39507272|FG001|Overall Study|Death|14|||
16279958|NCT00676650|39507271|FG000|Overall Study|Adverse Event|159|||
16279959|NCT00676650|39507272|FG001|Overall Study|Adverse Event|21|||
16279960|NCT00676650|39507271|FG000|Overall Study|Global deterioration of health status|66|||
16279961|NCT00676650|39507272|FG001|Overall Study|Global deterioration of health status|31|||
16279962|NCT00676650|39507271|FG000|Overall Study|Lost to Follow-up|0|||
16279963|NCT00676650|39507272|FG001|Overall Study|Lost to Follow-up|1|||
16279964|NCT00676650|39507271|FG000|Overall Study|Objective progression or relapse|189|||
16279965|NCT00676650|39507272|FG001|Overall Study|Objective progression or relapse|140|||
16279966|NCT00676650|39507271|FG000|Overall Study|Other|14|||
16279967|NCT00676650|39507272|FG001|Overall Study|Other|10|||
16279968|NCT00676650|39507271|FG000|Overall Study|Protocol Violation|3|||
16279969|NCT00676650|39507272|FG001|Overall Study|Protocol Violation|1|||
16279970|NCT00676650|39507271|FG000|Overall Study|Study terminated by sponsor|57|||
16279971|NCT00676650|39507272|FG001|Overall Study|Study terminated by sponsor|43|||
16279972|NCT00676650|39507271|FG000|Overall Study|Withdrawal by Subject|48|||
16279973|NCT00676650|39507272|FG001|Overall Study|Withdrawal by Subject|24|||
16279974|NCT00676650|39507271|FG000|Overall Study|Randomized but not treated|3|||
16279975|NCT00676650|39507272|FG001|Overall Study|Randomized but not treated|4|||
16279976|NCT01203917|39507273|FG000|Overall Study|Death|29|||
16279977|NCT01203917|39507273|FG000|Overall Study|Lost to Follow-up|2|||
16279978|NCT01203917|39507273|FG000|Overall Study|Withdrawal by Subject|3|||
16279979|NCT01203917|39507273|FG000|Overall Study|Due to objective disease progression|1|||
16080210|NCT01307267|38786801|FG020|Overall Study|Death|1|||
16080211|NCT01307267|38786802|FG021|Overall Study|Death|2|||
16279980|NCT01203917|39507273|FG000|Overall Study|Due to EGFR M+I patient|1|||
16279981|NCT00939627|39507274|FG000|Overall Study|Disease Progression|16|||
16279982|NCT00939627|39507275|FG001|Overall Study|Disease Progression|12|||
16279983|NCT00939627|39507276|FG002|Overall Study|Disease Progression|0|||
16279984|NCT00939627|39507274|FG000|Overall Study|Adverse Event|6|||
16279985|NCT00939627|39507275|FG001|Overall Study|Adverse Event|7|||
16279986|NCT00939627|39507276|FG002|Overall Study|Adverse Event|0|||
16279987|NCT00939627|39507274|FG000|Overall Study|Death|0|||
16279988|NCT00939627|39507275|FG001|Overall Study|Death|2|||
16279989|NCT00939627|39507276|FG002|Overall Study|Death|0|||
16279990|NCT00939627|39507274|FG000|Overall Study|Withdrawal by Subject|2|||
16279991|NCT00939627|39507275|FG001|Overall Study|Withdrawal by Subject|4|||
16279992|NCT00939627|39507276|FG002|Overall Study|Withdrawal by Subject|0|||
16279993|NCT00939627|39507274|FG000|Overall Study|Other complicating disease|1|||
16279994|NCT00939627|39507275|FG001|Overall Study|Other complicating disease|1|||
16279995|NCT00939627|39507276|FG002|Overall Study|Other complicating disease|0|||
16279996|NCT00939627|39507274|FG000|Overall Study|Not compliant|2|||
16279997|NCT00939627|39507275|FG001|Overall Study|Not compliant|0|||
16279998|NCT00939627|39507276|FG002|Overall Study|Not compliant|0|||
16279999|NCT00939627|39507274|FG000|Overall Study|No off-tx reason given|0|||
16280000|NCT00939627|39507275|FG001|Overall Study|No off-tx reason given|2|||
16280001|NCT00939627|39507276|FG002|Overall Study|No off-tx reason given|0|||
16280002|NCT00927251|39507277|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
16280003|NCT02020967|39507278|FG000|Overall Study|Withdrawal by Subject|51|||
16280004|NCT01376037|39507279|FG000|Overall Study|Lost to Follow-up|0|||
16280005|NCT01376037|39507280|FG001|Overall Study|Lost to Follow-up|2|||
16280006|NCT03823287|39507281|FG000|Overall Study|Withdrawal by Subject|25|||
16280007|NCT03823287|39507282|FG001|Overall Study|Withdrawal by Subject|17|||
16280008|NCT03823287|39507281|FG000|Overall Study|Death|13|||
16280009|NCT03823287|39507282|FG001|Overall Study|Death|7|||
16280010|NCT03823287|39507281|FG000|Overall Study|Lost to Follow-up|7|||
16280011|NCT03823287|39507282|FG001|Overall Study|Lost to Follow-up|8|||
16280012|NCT03823287|39507281|FG000|Overall Study|Adverse Event|6|||
16280013|NCT03823287|39507282|FG001|Overall Study|Adverse Event|8|||
16280014|NCT03823287|39507281|FG000|Overall Study|Physician Decision|5|||
16280015|NCT03823287|39507282|FG001|Overall Study|Physician Decision|2|||
16280016|NCT03823287|39507281|FG000|Overall Study|Lack of Efficacy|2|||
16479153|NCT03519178|40234261|FG005|Follow-Up|Other|0|||
16479154|NCT03519178|40234262|FG006|Follow-Up|Other|0|||
16479155|NCT03519178|40234263|FG007|Follow-Up|Other|1|||
16479156|NCT03519178|40234264|FG008|Follow-Up|Other|0|||
16479157|NCT03519178|40234265|FG009|Follow-Up|Other|0|||
16479158|NCT03519178|40234266|FG010|Follow-Up|Other|0|||
16479159|NCT03519178|40234267|FG011|Follow-Up|Other|0|||
16479160|NCT03519178|40234268|FG012|Follow-Up|Other|0|||
16479161|NCT03519178|40234269|FG013|Follow-Up|Other|0|||
16479162|NCT03519178|40234270|FG014|Follow-Up|Other|0|||
16479163|NCT03519178|40234256|FG000|Long-term Follow-up|Death|0|||
16479164|NCT03519178|40234257|FG001|Long-term Follow-up|Death|0|||
16280017|NCT03823287|39507282|FG001|Overall Study|Lack of Efficacy|0|||
16280018|NCT03823287|39507281|FG000|Overall Study|Other|2|||
16280019|NCT03823287|39507282|FG001|Overall Study|Other|4|||
16280020|NCT02426541|39507283|FG000|Overall Study|Protocol Violation|1|||
16280021|NCT02426541|39507284|FG001|Overall Study|Protocol Violation|0|||
16479165|NCT03519178|40234258|FG002|Long-term Follow-up|Death|0|||
16479166|NCT03519178|40234259|FG003|Long-term Follow-up|Death|0|||
16479167|NCT03519178|40234260|FG004|Long-term Follow-up|Death|0|||
16280022|NCT01337596|39507285|FG000|Overall Study|Withdrawal by Subject|0|||
16280023|NCT01337596|39507286|FG001|Overall Study|Withdrawal by Subject|0|||
16280024|NCT01337596|39507287|FG002|Overall Study|Withdrawal by Subject|0|||
16280025|NCT01337596|39507288|FG003|Overall Study|Withdrawal by Subject|0|||
16280026|NCT01337596|39507289|FG004|Overall Study|Withdrawal by Subject|2|||
16280027|NCT01337596|39507290|FG005|Overall Study|Withdrawal by Subject|0|||
16280028|NCT01337596|39507291|FG006|Overall Study|Withdrawal by Subject|0|||
16280029|NCT01337596|39507292|FG007|Overall Study|Withdrawal by Subject|0|||
16280030|NCT01337596|39507293|FG008|Overall Study|Withdrawal by Subject|0|||
16280031|NCT03023137|39507294|FG000|Overall Study|Multiple pregnancy|2|||
16280032|NCT03023137|39507295|FG001|Overall Study|Multiple pregnancy|4|||
16280033|NCT03023137|39507294|FG000|Overall Study|Lost to Follow-up|1|||
16280034|NCT03023137|39507295|FG001|Overall Study|Lost to Follow-up|1|||
16280035|NCT03023137|39507294|FG000|Overall Study|Protocol Violation|0|||
16280036|NCT03023137|39507295|FG001|Overall Study|Protocol Violation|4|||
16280037|NCT03023137|39507294|FG000|Overall Study|Lost the baby in a car accident|1|||
16280038|NCT03023137|39507295|FG001|Overall Study|Lost the baby in a car accident|0|||
16280039|NCT03358147|39507296|FG000|Overall Study|Withdrawal by Subject|13|||
16280040|NCT03358147|39507297|FG001|Overall Study|Withdrawal by Subject|19|||
16479168|NCT03519178|40234261|FG005|Long-term Follow-up|Death|0|||
16479169|NCT03519178|40234262|FG006|Long-term Follow-up|Death|0|||
16479170|NCT03519178|40234263|FG007|Long-term Follow-up|Death|0|||
16479171|NCT03519178|40234264|FG008|Long-term Follow-up|Death|0|||
16479172|NCT03519178|40234265|FG009|Long-term Follow-up|Death|0|||
16479173|NCT03519178|40234266|FG010|Long-term Follow-up|Death|0|||
16479174|NCT03519178|40234267|FG011|Long-term Follow-up|Death|0|||
16479175|NCT03519178|40234268|FG012|Long-term Follow-up|Death|0|||
16479176|NCT03519178|40234269|FG013|Long-term Follow-up|Death|4|||
16479177|NCT03519178|40234270|FG014|Long-term Follow-up|Death|4|||
16479178|NCT03519178|40234256|FG000|Long-term Follow-up|Lost to Follow-up|0|||
16479179|NCT03519178|40234257|FG001|Long-term Follow-up|Lost to Follow-up|0|||
16479180|NCT03519178|40234258|FG002|Long-term Follow-up|Lost to Follow-up|0|||
16479181|NCT03519178|40234259|FG003|Long-term Follow-up|Lost to Follow-up|0|||
16479182|NCT03519178|40234260|FG004|Long-term Follow-up|Lost to Follow-up|0|||
16479183|NCT03519178|40234261|FG005|Long-term Follow-up|Lost to Follow-up|0|||
16479184|NCT03519178|40234262|FG006|Long-term Follow-up|Lost to Follow-up|0|||
16479185|NCT03519178|40234263|FG007|Long-term Follow-up|Lost to Follow-up|0|||
16479186|NCT03519178|40234264|FG008|Long-term Follow-up|Lost to Follow-up|0|||
16479187|NCT03519178|40234265|FG009|Long-term Follow-up|Lost to Follow-up|0|||
16479188|NCT03519178|40234266|FG010|Long-term Follow-up|Lost to Follow-up|0|||
16479189|NCT03519178|40234267|FG011|Long-term Follow-up|Lost to Follow-up|0|||
16479190|NCT03519178|40234268|FG012|Long-term Follow-up|Lost to Follow-up|0|||
16479191|NCT03519178|40234269|FG013|Long-term Follow-up|Lost to Follow-up|1|||
16479192|NCT03519178|40234270|FG014|Long-term Follow-up|Lost to Follow-up|1|||
16479193|NCT03519178|40234256|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
16479194|NCT03519178|40234257|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
16280041|NCT03358147|39507298|FG002|Overall Study|Withdrawal by Subject|16|||
16280042|NCT03358147|39507299|FG003|Overall Study|Withdrawal by Subject|10|||
16280043|NCT03358147|39507300|FG004|Overall Study|Withdrawal by Subject|5|||
16280044|NCT03358147|39507296|FG000|Overall Study|Adverse Event|3|||
16280045|NCT03358147|39507297|FG001|Overall Study|Adverse Event|9|||
16280046|NCT03358147|39507298|FG002|Overall Study|Adverse Event|7|||
16280047|NCT03358147|39507299|FG003|Overall Study|Adverse Event|5|||
16280048|NCT03358147|39507300|FG004|Overall Study|Adverse Event|2|||
16280049|NCT03358147|39507296|FG000|Overall Study|Lost to Follow-up|4|||
16280050|NCT03358147|39507297|FG001|Overall Study|Lost to Follow-up|3|||
16280051|NCT03358147|39507298|FG002|Overall Study|Lost to Follow-up|7|||
16280052|NCT03358147|39507299|FG003|Overall Study|Lost to Follow-up|6|||
16280053|NCT03358147|39507300|FG004|Overall Study|Lost to Follow-up|4|||
16280054|NCT03358147|39507296|FG000|Overall Study|Major Protocol Deviation|11|||
16280055|NCT03358147|39507297|FG001|Overall Study|Major Protocol Deviation|3|||
16280056|NCT03358147|39507298|FG002|Overall Study|Major Protocol Deviation|2|||
16479195|NCT03519178|40234258|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
16479196|NCT03519178|40234259|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
16479197|NCT03519178|40234260|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
16479198|NCT03519178|40234261|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
16479199|NCT03519178|40234262|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
16479200|NCT03519178|40234263|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
16280057|NCT03358147|39507299|FG003|Overall Study|Major Protocol Deviation|3|||
16280058|NCT03358147|39507300|FG004|Overall Study|Major Protocol Deviation|1|||
16280059|NCT03358147|39507296|FG000|Overall Study|Protocol specified criteria|2|||
16280060|NCT03358147|39507297|FG001|Overall Study|Protocol specified criteria|3|||
16280061|NCT03358147|39507298|FG002|Overall Study|Protocol specified criteria|0|||
16280062|NCT03358147|39507299|FG003|Overall Study|Protocol specified criteria|3|||
16280063|NCT03358147|39507300|FG004|Overall Study|Protocol specified criteria|1|||
16280064|NCT03358147|39507296|FG000|Overall Study|Physician Decision|1|||
16280065|NCT03358147|39507297|FG001|Overall Study|Physician Decision|0|||
16280066|NCT03358147|39507298|FG002|Overall Study|Physician Decision|1|||
16280067|NCT03358147|39507299|FG003|Overall Study|Physician Decision|6|||
16280068|NCT03358147|39507300|FG004|Overall Study|Physician Decision|1|||
16280069|NCT03358147|39507296|FG000|Overall Study|Administrative reasons|0|||
16280070|NCT03358147|39507297|FG001|Overall Study|Administrative reasons|1|||
16280071|NCT03358147|39507298|FG002|Overall Study|Administrative reasons|0|||
16280072|NCT03358147|39507299|FG003|Overall Study|Administrative reasons|3|||
16280073|NCT03358147|39507300|FG004|Overall Study|Administrative reasons|0|||
16280074|NCT03358147|39507296|FG000|Overall Study|Lack of Efficacy|0|||
16280075|NCT03358147|39507297|FG001|Overall Study|Lack of Efficacy|1|||
16280076|NCT03358147|39507298|FG002|Overall Study|Lack of Efficacy|1|||
16280077|NCT03358147|39507299|FG003|Overall Study|Lack of Efficacy|0|||
16280078|NCT03358147|39507300|FG004|Overall Study|Lack of Efficacy|0|||
16280079|NCT01294449|39507303|FG000|Overall Study|Death|11|||
16280080|NCT01294449|39507304|FG001|Overall Study|Death|12|||
16280081|NCT01294449|39507303|FG000|Overall Study|Withdrawal by Subject|1|||
16280082|NCT01294449|39507304|FG001|Overall Study|Withdrawal by Subject|3|||
16280083|NCT03693950|39507306|FG000|Overall Study|Withdrawal by Subject|1|||
16280084|NCT03693950|39507307|FG001|Overall Study|Withdrawal by Subject|0|||
16280085|NCT00726895|39507317|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
16280086|NCT00726895|39507318|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16280087|NCT01691612|39507319|FG000|Overall Study|deemed ineligible after 1st visit|6|||
16280088|NCT01691612|39507319|FG000|Overall Study|Adverse Event|1|||
16280089|NCT04980456|39507320|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
16280090|NCT04980456|39507321|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
16280091|NCT04980456|39507320|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
16280092|NCT04980456|39507321|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
16280093|NCT04980456|39507320|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
16280094|NCT04980456|39507321|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
16280095|NCT04980456|39507320|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
16280096|NCT04980456|39507321|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
16280097|NCT01523587|39507322|FG000|Overall Study|Other than listed|5|||
16280098|NCT01523587|39507323|FG001|Overall Study|Other than listed|5|||
16280099|NCT01523587|39507322|FG000|Overall Study|Worsening of underlying cancer disease|19|||
16280100|NCT01523587|39507323|FG001|Overall Study|Worsening of underlying cancer disease|34|||
16280101|NCT01523587|39507322|FG000|Overall Study|Adverse Event|68|||
16280102|NCT01523587|39507323|FG001|Overall Study|Adverse Event|52|||
16280103|NCT01523587|39507322|FG000|Overall Study|Protocol Violation|5|||
16280104|NCT01523587|39507323|FG001|Overall Study|Protocol Violation|3|||
16280105|NCT01523587|39507322|FG000|Overall Study|Lost to Follow-up|2|||
16280106|NCT01523587|39507323|FG001|Overall Study|Lost to Follow-up|2|||
16280107|NCT01523587|39507322|FG000|Overall Study|Withdrawal by Subject|28|||
16280108|NCT01523587|39507323|FG001|Overall Study|Withdrawal by Subject|20|||
16280109|NCT01523587|39507322|FG000|Overall Study|Withdrew due to Progressive disease|265|||
16280110|NCT01523587|39507323|FG001|Overall Study|Withdrew due to Progressive disease|279|||
16280111|NCT01523587|39507322|FG000|Overall Study|Randomised but bot treated|6|||
16280112|NCT01523587|39507323|FG001|Overall Study|Randomised but bot treated|2|||
16280113|NCT01192399|39507324|FG000|Overall Study|Lack of Efficacy|2|||
16280114|NCT01636934|39507327|FG000|Overall Study|Withdrawal by Subject|3|||
16280115|NCT01636934|39507328|FG001|Overall Study|Withdrawal by Subject|2|||
16280116|NCT01636934|39507327|FG000|Overall Study|Chemo cancel|1|||
16280117|NCT01636934|39507328|FG001|Overall Study|Chemo cancel|0|||
16280118|NCT01636934|39507327|FG000|Overall Study|Too ill to continue|1|||
16280119|NCT01636934|39507328|FG001|Overall Study|Too ill to continue|0|||
16280120|NCT01636934|39507327|FG000|Overall Study|Never started study medication|1|||
16280121|NCT01636934|39507328|FG001|Overall Study|Never started study medication|1|||
16280122|NCT03389477|39507329|FG000|Step 1|Withdrawal by Subject|1|||
16280123|NCT03389477|39507330|FG001|Step 1|Withdrawal by Subject|0|||
16280124|NCT03389477|39507329|FG000|Step 2|Withdrawal by Subject|1|||
16280125|NCT03389477|39507330|FG001|Step 2|Withdrawal by Subject|2|||
16280126|NCT03389477|39507329|FG000|Step 2|Disease progression|1|||
16280127|NCT03389477|39507330|FG001|Step 2|Disease progression|0|||
16280128|NCT03389477|39507329|FG000|Step 2|Death|0|||
16280129|NCT03389477|39507330|FG001|Step 2|Death|1|||
16280130|NCT03389477|39507329|FG000|Step 2|Poor performance status and nutrition|0|||
16280131|NCT03389477|39507330|FG001|Step 2|Poor performance status and nutrition|1|||
16280132|NCT03389477|39507329|FG000|Step 3|Withdrawal after 3 cycles|0|||
16280133|NCT03389477|39507330|FG001|Step 3|Withdrawal after 3 cycles|1|||
16280134|NCT03389477|39507329|FG000|Step 3|Still receiving active treatment|4|||
16280135|NCT03389477|39507330|FG001|Step 3|Still receiving active treatment|0|||
16280136|NCT03389477|39507329|FG000|Step 3|Progressive disease after 2 cycles|1|||
16280137|NCT03389477|39507330|FG001|Step 3|Progressive disease after 2 cycles|0|||
16280138|NCT00380588|39507334|FG000|Overall Study|Unequivocal Disease Progression|25|||
16280139|NCT00380588|39507335|FG001|Overall Study|Unequivocal Disease Progression|34|||
16280140|NCT00380588|39507334|FG000|Overall Study|Next Cycle Not Started|4|||
16280141|NCT00380588|39507335|FG001|Overall Study|Next Cycle Not Started|0|||
16185094|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
16185095|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
16185096|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
16185097|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
16185098|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
16185099|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
16185100|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
16185101|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
16185102|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
16185103|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
16185104|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
16185105|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
16185106|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
16185107|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
16185108|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
16185109|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
16185110|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
16185111|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
16185112|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
16185113|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
16185114|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
16185115|NCT00958568|39159151|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
16185116|NCT00958568|39159152|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
16185117|NCT00958568|39159153|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
16185118|NCT00958568|39159154|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
16185119|NCT00958568|39159151|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
16185120|NCT00958568|39159152|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
16185121|NCT00958568|39159153|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
16185122|NCT00958568|39159154|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
16185123|NCT00958568|39159151|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
16185124|NCT00958568|39159152|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
16185125|NCT00958568|39159153|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
16185126|NCT00958568|39159154|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
16280142|NCT00380588|39507334|FG000|Overall Study|Adverse Event|7|||
16280143|NCT00380588|39507335|FG001|Overall Study|Adverse Event|3|||
16280144|NCT00380588|39507334|FG000|Overall Study|Withdrawal by Subject|1|||
16280145|NCT00380588|39507335|FG001|Overall Study|Withdrawal by Subject|3|||
16185127|NCT00958568|39159151|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
16185128|NCT00958568|39159152|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
16185129|NCT00958568|39159153|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
16185130|NCT00958568|39159154|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
16185131|NCT00958568|39159151|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
16185132|NCT00958568|39159152|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
16185133|NCT00958568|39159153|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
16185134|NCT00958568|39159154|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
16185135|NCT00958568|39159151|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
16185136|NCT00958568|39159152|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
16185137|NCT00958568|39159153|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
16185138|NCT00958568|39159154|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
16185139|NCT00958568|39159151|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
16185140|NCT00958568|39159152|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
16185141|NCT00958568|39159153|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
16185142|NCT00958568|39159154|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
16185143|NCT00958568|39159151|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
16185144|NCT00958568|39159152|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
16185145|NCT00958568|39159153|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
16185146|NCT00958568|39159154|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
16185147|NCT00958568|39159151|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
16185148|NCT00958568|39159152|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
16185149|NCT00958568|39159153|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
16185150|NCT00958568|39159154|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
16185151|NCT00958568|39159151|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
16185152|NCT00958568|39159152|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
16185153|NCT00958568|39159153|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
16185154|NCT00958568|39159154|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
16185155|NCT01912872|39159155|FG000|Overall Study|Lost to Follow-up|2|||
16185156|NCT01912872|39159156|FG001|Overall Study|Lost to Follow-up|3|||
16185157|NCT01912872|39159157|FG002|Overall Study|Lost to Follow-up|5|||
16185158|NCT01912872|39159158|FG003|Overall Study|Lost to Follow-up|5|||
16185159|NCT01912872|39159155|FG000|Overall Study|Other unspecified|3|||
16185160|NCT01912872|39159156|FG001|Overall Study|Other unspecified|1|||
16185161|NCT01912872|39159157|FG002|Overall Study|Other unspecified|3|||
16185162|NCT01912872|39159158|FG003|Overall Study|Other unspecified|0|||
16185163|NCT01912872|39159155|FG000|Overall Study|Informed consent withdrawn|0|||
16185164|NCT01912872|39159156|FG001|Overall Study|Informed consent withdrawn|0|||
16185165|NCT01912872|39159157|FG002|Overall Study|Informed consent withdrawn|1|||
16185166|NCT01912872|39159158|FG003|Overall Study|Informed consent withdrawn|1|||
16185167|NCT01912872|39159155|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
16185168|NCT01912872|39159156|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
16185169|NCT01912872|39159157|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
16185170|NCT01912872|39159158|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
16185171|NCT01912872|39159155|FG000|Overall Study|Protocol Violation|0|||
16185172|NCT01912872|39159156|FG001|Overall Study|Protocol Violation|0|||
16185173|NCT01912872|39159157|FG002|Overall Study|Protocol Violation|1|||
16185174|NCT01912872|39159158|FG003|Overall Study|Protocol Violation|0|||
16185175|NCT01912872|39159155|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16185176|NCT01912872|39159156|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16185177|NCT01912872|39159157|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16185178|NCT01912872|39159158|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
16185179|NCT01912872|39159155|FG000|Overall Study|Withdrawal of study medication|0|||
16185180|NCT01912872|39159156|FG001|Overall Study|Withdrawal of study medication|0|||
16185181|NCT01912872|39159157|FG002|Overall Study|Withdrawal of study medication|0|||
16185182|NCT01912872|39159158|FG003|Overall Study|Withdrawal of study medication|2|||
16185183|NCT01912872|39159155|FG000|Overall Study|Missing|0|||
16185184|NCT01912872|39159156|FG001|Overall Study|Missing|0|||
16185185|NCT01912872|39159157|FG002|Overall Study|Missing|0|||
16185186|NCT01912872|39159158|FG003|Overall Study|Missing|1|||
16185187|NCT03283163|39159161|FG000|Overall Study|Lost to Follow-up|1|||
16185188|NCT03283163|39159161|FG000|Overall Study|other life commitments|6|||
16185189|NCT03283163|39159161|FG000|Overall Study|COVID-19 institution wide halting|1|||
16185190|NCT03283163|39159161|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
16280146|NCT00380588|39507334|FG000|Overall Study|Physician Decision|2|||
16280147|NCT00380588|39507335|FG001|Overall Study|Physician Decision|0|||
16280148|NCT01857973|39507336|FG000|Overall Study|Subject did not meet required BG range|3|||
16280149|NCT01857973|39507336|FG000|Overall Study|drop out after 3 failed attempts|1|||
16280150|NCT01857973|39507336|FG000|Overall Study|Physician Decision|1|||
16280151|NCT00982228|39507344|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
16280152|NCT00982228|39507345|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
16280153|NCT00982228|39507344|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
16280154|NCT00982228|39507345|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
16280155|NCT00982228|39507344|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
16280156|NCT00982228|39507345|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
16280157|NCT00982228|39507344|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
16280158|NCT00982228|39507345|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
16280159|NCT00982228|39507344|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
16280160|NCT00982228|39507345|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
16280161|NCT00982228|39507344|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
16280162|NCT00982228|39507345|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
16280163|NCT00982228|39507344|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
16280164|NCT00982228|39507345|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
16280165|NCT00982228|39507344|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
16280166|NCT00982228|39507345|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
16280167|NCT00982228|39507344|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
16280168|NCT00982228|39507345|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
16280169|NCT00982228|39507344|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
16280170|NCT00982228|39507345|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
16280171|NCT00351351|39507346|FG000|Overall Study|surgical access pbs; device issues|9|||
16280172|NCT00351351|39507347|FG001|Overall Study|surgical access pbs; device issues|4|||
16280173|NCT01501110|39507348|FG000|Overall Study|Death|0|||
16280174|NCT01501110|39507349|FG001|Overall Study|Death|1|||
16280175|NCT04106817|39507350|FG000|Overall Study|Lost to Follow-up|1|||
16280176|NCT04106817|39507351|FG001|Overall Study|Lost to Follow-up|0|||
16280177|NCT04106817|39507352|FG002|Overall Study|Lost to Follow-up|0|||
16280178|NCT05692154|39507355|FG000|Overall Study|Adverse Event|0|||
16280179|NCT05692154|39507356|FG001|Overall Study|Adverse Event|1|||
16280180|NCT01915940|39507357|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
16280181|NCT01915940|39507358|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
16280182|NCT01915940|39507359|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
16479201|NCT03519178|40234264|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
16479202|NCT03519178|40234265|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
16479203|NCT03519178|40234266|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
16479204|NCT03519178|40234267|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
16479205|NCT03519178|40234268|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
16479206|NCT03519178|40234269|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
16479207|NCT03519178|40234270|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
16479208|NCT03519178|40234256|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
16479209|NCT03519178|40234257|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
16479210|NCT03519178|40234258|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
16479211|NCT03519178|40234259|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
16479212|NCT03519178|40234260|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
16479213|NCT03519178|40234261|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
16479214|NCT03519178|40234262|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
16479215|NCT03519178|40234263|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
16479216|NCT03519178|40234264|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
16479217|NCT03519178|40234265|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
16479218|NCT03519178|40234266|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
16479219|NCT03519178|40234267|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
16479220|NCT03519178|40234268|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
16479221|NCT03519178|40234269|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
16479222|NCT03519178|40234270|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
16479223|NCT03519178|40234256|FG000|Long-term Follow-up|Other|0|||
16479224|NCT03519178|40234257|FG001|Long-term Follow-up|Other|0|||
16479225|NCT03519178|40234258|FG002|Long-term Follow-up|Other|0|||
16479226|NCT03519178|40234259|FG003|Long-term Follow-up|Other|0|||
16479227|NCT03519178|40234260|FG004|Long-term Follow-up|Other|0|||
16479228|NCT03519178|40234261|FG005|Long-term Follow-up|Other|0|||
16479229|NCT03519178|40234262|FG006|Long-term Follow-up|Other|0|||
16479230|NCT03519178|40234263|FG007|Long-term Follow-up|Other|0|||
16280183|NCT01915940|39507357|FG000|Treatment Period|Decision of Participant|0|||
16280184|NCT01915940|39507358|FG001|Treatment Period|Decision of Participant|1|||
16280185|NCT01915940|39507359|FG002|Treatment Period|Decision of Participant|3|||
16280186|NCT01915940|39507357|FG000|Treatment Period|Adverse Event|0|||
16479231|NCT03519178|40234264|FG008|Long-term Follow-up|Other|0|||
16479232|NCT03519178|40234265|FG009|Long-term Follow-up|Other|0|||
16479233|NCT03519178|40234266|FG010|Long-term Follow-up|Other|0|||
16479234|NCT03519178|40234267|FG011|Long-term Follow-up|Other|0|||
16479235|NCT03519178|40234268|FG012|Long-term Follow-up|Other|0|||
16479236|NCT03519178|40234269|FG013|Long-term Follow-up|Other|0|||
16479237|NCT03519178|40234270|FG014|Long-term Follow-up|Other|1|||
16479238|NCT03519178|40234256|FG000|Long-term Follow-up|Ongoing|0|||
16479239|NCT03519178|40234257|FG001|Long-term Follow-up|Ongoing|0|||
16479240|NCT03519178|40234258|FG002|Long-term Follow-up|Ongoing|0|||
16479241|NCT03519178|40234259|FG003|Long-term Follow-up|Ongoing|0|||
16479242|NCT03519178|40234260|FG004|Long-term Follow-up|Ongoing|0|||
16479243|NCT03519178|40234261|FG005|Long-term Follow-up|Ongoing|0|||
16479244|NCT03519178|40234262|FG006|Long-term Follow-up|Ongoing|0|||
16479245|NCT03519178|40234263|FG007|Long-term Follow-up|Ongoing|0|||
16479246|NCT03519178|40234264|FG008|Long-term Follow-up|Ongoing|0|||
16479247|NCT03519178|40234265|FG009|Long-term Follow-up|Ongoing|0|||
16479248|NCT03519178|40234266|FG010|Long-term Follow-up|Ongoing|0|||
16479249|NCT03519178|40234267|FG011|Long-term Follow-up|Ongoing|0|||
16479250|NCT03519178|40234268|FG012|Long-term Follow-up|Ongoing|0|||
16479251|NCT03519178|40234269|FG013|Long-term Follow-up|Ongoing|1|||
16479252|NCT03519178|40234270|FG014|Long-term Follow-up|Ongoing|0|||
16479253|NCT03001882|40234271|FG000|Overall Study|Death|1|||
16479254|NCT03001882|40234272|FG001|Overall Study|Death|0|||
16479255|NCT03001882|40234273|FG002|Overall Study|Death|0|||
16479256|NCT03001882|40234274|FG003|Overall Study|Death|3|||
16479257|NCT03001882|40234271|FG000|Overall Study|Participant withdrew consent|0|||
16479258|NCT03001882|40234272|FG001|Overall Study|Participant withdrew consent|1|||
16479259|NCT03001882|40234273|FG002|Overall Study|Participant withdrew consent|0|||
16479260|NCT03001882|40234274|FG003|Overall Study|Participant withdrew consent|5|||
16479261|NCT03001882|40234271|FG000|Overall Study|Other reasons|1|||
16479262|NCT03001882|40234272|FG001|Overall Study|Other reasons|2|||
16479263|NCT03001882|40234273|FG002|Overall Study|Other reasons|0|||
16479264|NCT03001882|40234274|FG003|Overall Study|Other reasons|5|||
16479265|NCT03001882|40234271|FG000|Overall Study|Administrative reason by sponsor|0|||
16479266|NCT03001882|40234272|FG001|Overall Study|Administrative reason by sponsor|0|||
16479267|NCT03001882|40234273|FG002|Overall Study|Administrative reason by sponsor|0|||
16479268|NCT03001882|40234274|FG003|Overall Study|Administrative reason by sponsor|1|||
16280187|NCT01915940|39507358|FG001|Treatment Period|Adverse Event|9|||
16280188|NCT01915940|39507359|FG002|Treatment Period|Adverse Event|1|||
16280189|NCT01915940|39507357|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
16280190|NCT01915940|39507358|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
16280191|NCT01915940|39507359|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
16280192|NCT02010255|39507362|FG000|Overall Study|Death|0|||
16280193|NCT02010255|39507363|FG001|Overall Study|Death|1|||
16280194|NCT02010255|39507364|FG002|Overall Study|Death|4|||
16280195|NCT02010255|39507365|FG003|Overall Study|Death|4|||
16280196|NCT02010255|39507366|FG004|Overall Study|Death|2|||
16280197|NCT02010255|39507367|FG005|Overall Study|Death|0|||
16280198|NCT02010255|39507368|FG006|Overall Study|Death|1|||
16280199|NCT02010255|39507369|FG007|Overall Study|Death|1|||
16280200|NCT02010255|39507370|FG008|Overall Study|Death|1|||
16280201|NCT02010255|39507371|FG009|Overall Study|Death|0|||
16280202|NCT02010255|39507372|FG010|Overall Study|Death|1|||
16280203|NCT02010255|39507373|FG011|Overall Study|Death|1|||
16280204|NCT02010255|39507374|FG012|Overall Study|Death|0|||
16280205|NCT02010255|39507375|FG013|Overall Study|Death|0|||
16280206|NCT02010255|39507362|FG000|Overall Study|Lack of Efficacy|4|||
16280207|NCT02010255|39507363|FG001|Overall Study|Lack of Efficacy|1|||
16280208|NCT02010255|39507364|FG002|Overall Study|Lack of Efficacy|2|||
16280209|NCT02010255|39507365|FG003|Overall Study|Lack of Efficacy|1|||
16280210|NCT02010255|39507366|FG004|Overall Study|Lack of Efficacy|1|||
16280211|NCT02010255|39507367|FG005|Overall Study|Lack of Efficacy|0|||
16280212|NCT02010255|39507368|FG006|Overall Study|Lack of Efficacy|0|||
16280213|NCT02010255|39507369|FG007|Overall Study|Lack of Efficacy|0|||
16280214|NCT02010255|39507370|FG008|Overall Study|Lack of Efficacy|0|||
16280215|NCT02010255|39507371|FG009|Overall Study|Lack of Efficacy|0|||
16280216|NCT02010255|39507372|FG010|Overall Study|Lack of Efficacy|1|||
16280217|NCT02010255|39507373|FG011|Overall Study|Lack of Efficacy|0|||
16479269|NCT03001882|40234271|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
16479270|NCT03001882|40234272|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
16479271|NCT03001882|40234273|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
16479272|NCT03001882|40234274|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
16479273|NCT03001882|40234271|FG000|Overall Study|Not reported|0|||
16280218|NCT02010255|39507374|FG012|Overall Study|Lack of Efficacy|0|||
16280219|NCT02010255|39507375|FG013|Overall Study|Lack of Efficacy|0|||
16280220|NCT02010255|39507362|FG000|Overall Study|Withdrew Consent|1|||
16280221|NCT02010255|39507363|FG001|Overall Study|Withdrew Consent|0|||
16280222|NCT02010255|39507364|FG002|Overall Study|Withdrew Consent|0|||
16280223|NCT02010255|39507365|FG003|Overall Study|Withdrew Consent|1|||
16280224|NCT02010255|39507366|FG004|Overall Study|Withdrew Consent|0|||
16479274|NCT03001882|40234272|FG001|Overall Study|Not reported|0|||
16479275|NCT03001882|40234273|FG002|Overall Study|Not reported|0|||
16280225|NCT02010255|39507367|FG005|Overall Study|Withdrew Consent|0|||
16280226|NCT02010255|39507368|FG006|Overall Study|Withdrew Consent|0|||
16280227|NCT02010255|39507369|FG007|Overall Study|Withdrew Consent|0|||
16280228|NCT02010255|39507370|FG008|Overall Study|Withdrew Consent|0|||
16280229|NCT02010255|39507371|FG009|Overall Study|Withdrew Consent|0|||
16280230|NCT02010255|39507372|FG010|Overall Study|Withdrew Consent|0|||
16280231|NCT02010255|39507373|FG011|Overall Study|Withdrew Consent|0|||
16280232|NCT02010255|39507374|FG012|Overall Study|Withdrew Consent|0|||
16280233|NCT02010255|39507375|FG013|Overall Study|Withdrew Consent|0|||
16280234|NCT02010255|39507362|FG000|Overall Study|Adverse Event|1|||
16280235|NCT02010255|39507363|FG001|Overall Study|Adverse Event|0|||
16280236|NCT02010255|39507364|FG002|Overall Study|Adverse Event|0|||
16280237|NCT02010255|39507365|FG003|Overall Study|Adverse Event|0|||
16280238|NCT02010255|39507366|FG004|Overall Study|Adverse Event|0|||
16280239|NCT02010255|39507367|FG005|Overall Study|Adverse Event|0|||
16280240|NCT02010255|39507368|FG006|Overall Study|Adverse Event|0|||
16280241|NCT02010255|39507369|FG007|Overall Study|Adverse Event|0|||
16280242|NCT02010255|39507370|FG008|Overall Study|Adverse Event|0|||
16185191|NCT03283163|39159161|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
16185192|NCT05836818|39159162|FG000|Overall Study|Physician Decision|1|||
16185193|NCT05836818|39159163|FG001|Overall Study|Physician Decision|1|||
16185194|NCT05836818|39159164|FG002|Overall Study|Physician Decision|0|||
16185195|NCT05836818|39159162|FG000|Overall Study|Withdrawal by Subject|0|||
16185196|NCT05836818|39159163|FG001|Overall Study|Withdrawal by Subject|0|||
16185197|NCT05836818|39159164|FG002|Overall Study|Withdrawal by Subject|1|||
16185198|NCT05836818|39159162|FG000|Overall Study|Later found to be previously vaccinated|0|||
16185199|NCT05836818|39159163|FG001|Overall Study|Later found to be previously vaccinated|1|||
16185200|NCT05836818|39159164|FG002|Overall Study|Later found to be previously vaccinated|3|||
16185201|NCT05836818|39159162|FG000|Overall Study|Pregnancy|0|||
16185202|NCT05836818|39159163|FG001|Overall Study|Pregnancy|1|||
16185203|NCT05836818|39159164|FG002|Overall Study|Pregnancy|0|||
16185204|NCT05836818|39159162|FG000|Overall Study|Allergic to vaccines|0|||
16185205|NCT05836818|39159163|FG001|Overall Study|Allergic to vaccines|1|||
16185206|NCT05836818|39159164|FG002|Overall Study|Allergic to vaccines|0|||
16185207|NCT00085540|39159165|FG000|Overall Study|Withdrawal by Subject|0|||
16185208|NCT00085540|39159166|FG001|Overall Study|Withdrawal by Subject|1|||
16185209|NCT00085540|39159165|FG000|Overall Study|Protocol Violation|0|||
16185210|NCT00085540|39159166|FG001|Overall Study|Protocol Violation|1|||
16185211|NCT01454401|39159170|FG000|Overall Study|Death|1|||
16185212|NCT01454401|39159170|FG000|Overall Study|hospitalised|1|||
16185213|NCT01454401|39159170|FG000|Overall Study|osteomyelitis|2|||
16185214|NCT01454401|39159170|FG000|Overall Study|non-adherence|1|||
16185215|NCT02574312|39159171|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
16185216|NCT02574312|39159172|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
16185217|NCT02546856|39159173|FG000|4 Months Evaluation|Death|2|||
16185218|NCT02546856|39159174|FG001|4 Months Evaluation|Death|3|||
16185219|NCT02546856|39159173|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
16185220|NCT02546856|39159174|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
16185221|NCT02546856|39159173|FG000|4 Months Evaluation|Lost to Follow-up|3|||
16185222|NCT02546856|39159174|FG001|4 Months Evaluation|Lost to Follow-up|3|||
16185223|NCT02546856|39159173|FG000|4 Months Evaluation|Physician Decision|3|||
16185224|NCT02546856|39159174|FG001|4 Months Evaluation|Physician Decision|0|||
16185225|NCT02546856|39159173|FG000|4 Months Evaluation|Working or living abroad|5|||
16185226|NCT02546856|39159174|FG001|4 Months Evaluation|Working or living abroad|1|||
16185227|NCT02546856|39159173|FG000|4 Months Evaluation|reasons not due to titration|4|||
16185228|NCT02546856|39159174|FG001|4 Months Evaluation|reasons not due to titration|1|||
16185229|NCT02546856|39159173|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
16185230|NCT02546856|39159174|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
16185231|NCT02546856|39159173|FG000|6 Months Evaluation|Death|1|||
16185232|NCT02546856|39159174|FG001|6 Months Evaluation|Death|1|||
16185233|NCT02546856|39159173|FG000|6 Months Evaluation|Lost to Follow-up|1|||
16185234|NCT02546856|39159174|FG001|6 Months Evaluation|Lost to Follow-up|1|||
16185235|NCT02546856|39159173|FG000|6 Months Evaluation|Working or living abroad|6|||
16185236|NCT02546856|39159174|FG001|6 Months Evaluation|Working or living abroad|4|||
16280243|NCT02010255|39507371|FG009|Overall Study|Adverse Event|0|||
16280244|NCT02010255|39507372|FG010|Overall Study|Adverse Event|0|||
16280245|NCT02010255|39507373|FG011|Overall Study|Adverse Event|0|||
16280246|NCT02010255|39507374|FG012|Overall Study|Adverse Event|0|||
16185237|NCT02546856|39159173|FG000|6 Months Evaluation|reasons not due to titration|0|||
16479276|NCT03001882|40234274|FG003|Overall Study|Not reported|6|||
16479277|NCT03001882|40234271|FG000|Overall Study|Maximum clinical benefit|2|||
16479278|NCT03001882|40234272|FG001|Overall Study|Maximum clinical benefit|3|||
16479279|NCT03001882|40234273|FG002|Overall Study|Maximum clinical benefit|0|||
16479280|NCT03001882|40234274|FG003|Overall Study|Maximum clinical benefit|10|||
16479281|NCT03001882|40234271|FG000|Overall Study|AE unrelated to study drug|3|||
16479282|NCT03001882|40234272|FG001|Overall Study|AE unrelated to study drug|3|||
16479283|NCT03001882|40234273|FG002|Overall Study|AE unrelated to study drug|0|||
16479284|NCT03001882|40234274|FG003|Overall Study|AE unrelated to study drug|11|||
16479285|NCT03001882|40234271|FG000|Overall Study|Study Drug Toxicity|8|||
16479286|NCT03001882|40234272|FG001|Overall Study|Study Drug Toxicity|5|||
16479287|NCT03001882|40234273|FG002|Overall Study|Study Drug Toxicity|0|||
16479288|NCT03001882|40234274|FG003|Overall Study|Study Drug Toxicity|37|||
16479289|NCT03001882|40234271|FG000|Overall Study|Disease progression|16|||
16479290|NCT03001882|40234272|FG001|Overall Study|Disease progression|14|||
16479291|NCT03001882|40234273|FG002|Overall Study|Disease progression|1|||
16479292|NCT03001882|40234274|FG003|Overall Study|Disease progression|90|||
16479293|NCT02925117|40234275|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
16479294|NCT02925117|40234276|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
16479295|NCT02925117|40234277|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
16479296|NCT02925117|40234278|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
16479297|NCT02925117|40234279|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
16479298|NCT02925117|40234280|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
16479299|NCT02925117|40234281|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
16479300|NCT02925117|40234282|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
16479301|NCT02925117|40234283|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
16479302|NCT02925117|40234284|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
16479303|NCT02925117|40234285|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
16185238|NCT02546856|39159174|FG001|6 Months Evaluation|reasons not due to titration|1|||
16185239|NCT03844633|39159175|FG000|1 Week FU|Lost to Follow-up|0|||
16185240|NCT03844633|39159176|FG001|1 Week FU|Lost to Follow-up|1|||
16185241|NCT03844633|39159177|FG002|1 Week FU|Lost to Follow-up|4|||
16185242|NCT03844633|39159175|FG000|12-month Follow-up|Lost to Follow-up|7|||
16185243|NCT03844633|39159176|FG001|12-month Follow-up|Lost to Follow-up|5|||
16185244|NCT03844633|39159177|FG002|12-month Follow-up|Lost to Follow-up|8|||
16185245|NCT01512368|39159184|FG000|Overall Study|Protocol Violation|3|||
16479304|NCT02925117|40234286|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
16479305|NCT02925117|40234275|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
16479306|NCT02925117|40234276|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
16185246|NCT01070784|39159185|FG000|Overall Study|Withdrawal by Subject|6|||
16185247|NCT01070784|39159186|FG001|Overall Study|Withdrawal by Subject|9|||
16185248|NCT01070784|39159185|FG000|Overall Study|Adverse Event|14|||
16185249|NCT01070784|39159186|FG001|Overall Study|Adverse Event|9|||
16185250|NCT02429427|39159192|FG000|Overall Study|Adverse Event|220|||
16185251|NCT02429427|39159193|FG001|Overall Study|Adverse Event|92|||
16185252|NCT02429427|39159192|FG000|Overall Study|Protocol Violation|10|||
16185253|NCT02429427|39159193|FG001|Overall Study|Protocol Violation|6|||
16185254|NCT02429427|39159192|FG000|Overall Study|Lost to Follow-up|15|||
16185255|NCT02429427|39159193|FG001|Overall Study|Lost to Follow-up|6|||
16185256|NCT02429427|39159192|FG000|Overall Study|Withdrawal by Subject|64|||
16185257|NCT02429427|39159193|FG001|Overall Study|Withdrawal by Subject|34|||
16185258|NCT02429427|39159192|FG000|Overall Study|Other|62|||
16185259|NCT02429427|39159193|FG001|Overall Study|Other|41|||
16185260|NCT02433210|39159197|FG000|Overall Study|Physician Decision|1|||
16185261|NCT02433210|39159198|FG001|Overall Study|Physician Decision|0|||
16185262|NCT02433210|39159199|FG002|Overall Study|Physician Decision|0|||
16185263|NCT02552355|39159200|FG000|Overall Study|Adverse Event|0|||
16185264|NCT02552355|39159201|FG001|Overall Study|Adverse Event|2|||
16185265|NCT02552355|39159202|FG002|Overall Study|Adverse Event|2|||
16185266|NCT02552355|39159203|FG003|Overall Study|Adverse Event|0|||
16185267|NCT02552355|39159200|FG000|Overall Study|Withdrawal by Subject|0|||
16185268|NCT02552355|39159201|FG001|Overall Study|Withdrawal by Subject|0|||
16185269|NCT02552355|39159202|FG002|Overall Study|Withdrawal by Subject|0|||
16280247|NCT02010255|39507375|FG013|Overall Study|Adverse Event|0|||
16280248|NCT02010255|39507362|FG000|Overall Study|Lost to Follow-up|0|||
16280249|NCT02010255|39507363|FG001|Overall Study|Lost to Follow-up|0|||
16280250|NCT02010255|39507364|FG002|Overall Study|Lost to Follow-up|1|||
16280251|NCT02010255|39507365|FG003|Overall Study|Lost to Follow-up|0|||
16280252|NCT02010255|39507366|FG004|Overall Study|Lost to Follow-up|1|||
16280253|NCT02010255|39507367|FG005|Overall Study|Lost to Follow-up|0|||
16185270|NCT02552355|39159203|FG003|Overall Study|Withdrawal by Subject|1|||
16280254|NCT02010255|39507368|FG006|Overall Study|Lost to Follow-up|0|||
16280255|NCT02010255|39507369|FG007|Overall Study|Lost to Follow-up|0|||
16479307|NCT02925117|40234277|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
16479308|NCT02925117|40234278|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
16479309|NCT02925117|40234279|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
16280256|NCT02010255|39507370|FG008|Overall Study|Lost to Follow-up|0|||
16280257|NCT02010255|39507371|FG009|Overall Study|Lost to Follow-up|0|||
16280258|NCT02010255|39507372|FG010|Overall Study|Lost to Follow-up|0|||
16280259|NCT02010255|39507373|FG011|Overall Study|Lost to Follow-up|0|||
16280260|NCT02010255|39507374|FG012|Overall Study|Lost to Follow-up|0|||
16280261|NCT02010255|39507375|FG013|Overall Study|Lost to Follow-up|0|||
16280262|NCT02010255|39507362|FG000|Overall Study|Randomized but Not Treated|0|||
16280263|NCT02010255|39507363|FG001|Overall Study|Randomized but Not Treated|0|||
16280264|NCT02010255|39507364|FG002|Overall Study|Randomized but Not Treated|0|||
16280265|NCT02010255|39507365|FG003|Overall Study|Randomized but Not Treated|0|||
16280266|NCT02010255|39507366|FG004|Overall Study|Randomized but Not Treated|0|||
16280267|NCT02010255|39507367|FG005|Overall Study|Randomized but Not Treated|0|||
16280268|NCT02010255|39507368|FG006|Overall Study|Randomized but Not Treated|0|||
16280269|NCT02010255|39507369|FG007|Overall Study|Randomized but Not Treated|0|||
16280270|NCT02010255|39507370|FG008|Overall Study|Randomized but Not Treated|0|||
16280271|NCT02010255|39507371|FG009|Overall Study|Randomized but Not Treated|0|||
16280272|NCT02010255|39507372|FG010|Overall Study|Randomized but Not Treated|0|||
16280273|NCT02010255|39507373|FG011|Overall Study|Randomized but Not Treated|0|||
16280274|NCT02010255|39507374|FG012|Overall Study|Randomized but Not Treated|0|||
16280275|NCT02010255|39507375|FG013|Overall Study|Randomized but Not Treated|1|||
16280276|NCT01563237|39507378|FG000|Overall Study|Lost to Follow-up|6|||
16280277|NCT01563237|39507379|FG001|Overall Study|Lost to Follow-up|0|||
16479310|NCT02925117|40234280|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
16479311|NCT02925117|40234281|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
16479312|NCT02925117|40234282|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
16479313|NCT02925117|40234283|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
16479314|NCT02925117|40234284|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
16479315|NCT02925117|40234285|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
16479316|NCT02925117|40234286|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
16479317|NCT02925117|40234275|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
16479318|NCT02925117|40234276|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
16479319|NCT02925117|40234277|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
16479320|NCT02925117|40234278|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
16479321|NCT02925117|40234279|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
16479322|NCT02925117|40234280|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
16479323|NCT02925117|40234281|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
16479324|NCT02925117|40234282|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
16479325|NCT02925117|40234283|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
16479326|NCT02925117|40234284|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
16479327|NCT02925117|40234285|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
16479328|NCT02925117|40234286|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
16479329|NCT02925117|40234275|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
16280278|NCT01563237|39507378|FG000|Overall Study|Withdrawal by Subject|1|||
16280279|NCT01563237|39507379|FG001|Overall Study|Withdrawal by Subject|0|||
16280280|NCT01563237|39507378|FG000|Overall Study|Adverse Event|1|||
16280281|NCT01563237|39507379|FG001|Overall Study|Adverse Event|0|||
16280282|NCT01563237|39507378|FG000|Overall Study|Medical Reasons|1|||
16280283|NCT01563237|39507379|FG001|Overall Study|Medical Reasons|0|||
16280284|NCT01563237|39507378|FG000|Overall Study|Death|1|||
16280285|NCT01563237|39507379|FG001|Overall Study|Death|0|||
16280286|NCT01803269|39507380|FG000|Overall Study|Withdrawal by Subject|3|||
16280287|NCT01803269|39507381|FG001|Overall Study|Withdrawal by Subject|0|||
16280288|NCT01803269|39507382|FG002|Overall Study|Withdrawal by Subject|0|||
16280289|NCT00546910|39507383|FG000|Overall Study|Adverse Event|2|||
16280290|NCT00546910|39507384|FG001|Overall Study|Adverse Event|3|||
16280291|NCT00546910|39507383|FG000|Overall Study|Lack of Efficacy|5|||
16280292|NCT00546910|39507384|FG001|Overall Study|Lack of Efficacy|7|||
16280293|NCT00546910|39507383|FG000|Overall Study|Physician Decision|0|||
16280294|NCT00546910|39507384|FG001|Overall Study|Physician Decision|1|||
16280295|NCT00546910|39507383|FG000|Overall Study|Withdrawal by Subject|2|||
16280296|NCT00546910|39507384|FG001|Overall Study|Withdrawal by Subject|0|||
16280297|NCT03442569|39510303|FG000|Overall Study|Subject was ineligible after enrollment|1|||
16280298|NCT00823199|39510306|FG000|Overall Study|Withdrawal by Subject|2|||
16280299|NCT04556734|39510307|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
16280300|NCT04556734|39510308|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
16280301|NCT04556734|39510309|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
16280302|NCT04556734|39510310|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16280303|NCT04556734|39510311|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16280304|NCT04556734|39510312|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16280305|NCT04556734|39510313|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16479330|NCT02925117|40234276|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
16280306|NCT04556734|39510314|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16280307|NCT04556734|39510307|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
16479331|NCT02925117|40234277|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
16280308|NCT04556734|39510308|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
16280309|NCT04556734|39510309|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
16280310|NCT04556734|39510310|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
16280311|NCT04556734|39510311|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
16280312|NCT04556734|39510312|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
16280313|NCT04556734|39510313|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
16280314|NCT04556734|39510314|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
16080212|NCT01307267|38786803|FG022|Overall Study|Death|2|||
16280315|NCT04556734|39510307|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
16280316|NCT04556734|39510308|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16280317|NCT04556734|39510309|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
16280318|NCT04556734|39510310|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16280319|NCT04556734|39510311|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16280320|NCT04556734|39510312|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16280321|NCT04556734|39510313|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16280322|NCT04556734|39510314|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16280323|NCT04556734|39510307|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
16280324|NCT04556734|39510308|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
16280325|NCT04556734|39510309|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
16280326|NCT04556734|39510310|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
16280327|NCT04556734|39510311|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
16280328|NCT04556734|39510312|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
16280329|NCT04556734|39510313|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
16280330|NCT04556734|39510314|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
16280331|NCT04556734|39510307|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
16280332|NCT04556734|39510308|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
16280333|NCT04556734|39510309|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
16280334|NCT04556734|39510310|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
16280335|NCT04556734|39510311|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
16280336|NCT04556734|39510312|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
16280337|NCT04556734|39510313|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
16280338|NCT04556734|39510314|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
16280339|NCT04556734|39510307|FG000|OLE Period (28 Weeks)|Not reported|0|||
16280340|NCT04556734|39510308|FG001|OLE Period (28 Weeks)|Not reported|0|||
16280341|NCT04556734|39510309|FG002|OLE Period (28 Weeks)|Not reported|0|||
16280342|NCT04556734|39510310|FG003|OLE Period (28 Weeks)|Not reported|0|||
16280343|NCT04556734|39510311|FG004|OLE Period (28 Weeks)|Not reported|0|||
16280344|NCT04556734|39510312|FG005|OLE Period (28 Weeks)|Not reported|1|||
16280345|NCT04556734|39510313|FG006|OLE Period (28 Weeks)|Not reported|0|||
16280346|NCT04556734|39510314|FG007|OLE Period (28 Weeks)|Not reported|0|||
16280347|NCT04556734|39510307|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
16280348|NCT04556734|39510308|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
16280349|NCT04556734|39510309|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
16280350|NCT04556734|39510310|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
16280351|NCT04556734|39510311|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
16280352|NCT04556734|39510312|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
16280353|NCT04556734|39510313|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
16280354|NCT04556734|39510314|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
16280355|NCT04556734|39510307|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
16280356|NCT04556734|39510308|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
16280357|NCT04556734|39510309|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
16280358|NCT04556734|39510310|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
16280359|NCT04556734|39510311|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
16280360|NCT04556734|39510312|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
16280361|NCT04556734|39510313|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
16280362|NCT04556734|39510314|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
16280363|NCT04556734|39510307|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
16280364|NCT04556734|39510308|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
16280365|NCT04556734|39510309|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
16280366|NCT04556734|39510310|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
16280367|NCT04556734|39510311|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
16280368|NCT04556734|39510312|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
16280369|NCT04556734|39510313|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
16479332|NCT02925117|40234278|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
16280370|NCT04556734|39510314|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
16280371|NCT02408120|39510320|FG000|Overall Study|Withdrawal by Subject|0|||
16280372|NCT02408120|39510321|FG001|Overall Study|Withdrawal by Subject|1|||
16280373|NCT02408120|39510320|FG000|Overall Study|Treatment Refusal|1|||
16280374|NCT02408120|39510321|FG001|Overall Study|Treatment Refusal|0|||
16280375|NCT02408120|39510320|FG000|Overall Study|Received Steroids|1|||
16280376|NCT02408120|39510321|FG001|Overall Study|Received Steroids|1|||
16280377|NCT02408120|39510320|FG000|Overall Study|Discharged same day|1|||
16280378|NCT02408120|39510321|FG001|Overall Study|Discharged same day|1|||
16280379|NCT02408120|39510320|FG000|Overall Study|Did not receive insulin|1|||
16280380|NCT02408120|39510321|FG001|Overall Study|Did not receive insulin|2|||
16280381|NCT01467479|39510322|FG000|Overall Study|No Study Medication|1|||
16280382|NCT01467479|39510323|FG001|Overall Study|No Study Medication|0|||
16280383|NCT01467479|39510324|FG002|Overall Study|No Study Medication|2|||
16280384|NCT01467479|39510322|FG000|Overall Study|Adverse Event|1|||
16280385|NCT01467479|39510323|FG001|Overall Study|Adverse Event|2|||
16280386|NCT01467479|39510324|FG002|Overall Study|Adverse Event|0|||
16280387|NCT01467479|39510322|FG000|Overall Study|Death|0|||
16280388|NCT01467479|39510323|FG001|Overall Study|Death|0|||
16280389|NCT01467479|39510324|FG002|Overall Study|Death|1|||
16280390|NCT01467479|39510322|FG000|Overall Study|Lost to Follow-up|2|||
16280391|NCT01467479|39510323|FG001|Overall Study|Lost to Follow-up|5|||
16280392|NCT01467479|39510324|FG002|Overall Study|Lost to Follow-up|3|||
16280393|NCT01467479|39510322|FG000|Overall Study|Withdrawal of Consent|3|||
16280394|NCT01467479|39510323|FG001|Overall Study|Withdrawal of Consent|7|||
16280395|NCT01467479|39510324|FG002|Overall Study|Withdrawal of Consent|7|||
16280396|NCT01467479|39510322|FG000|Overall Study|Study Terminated by Sponsor|1|||
16280397|NCT01467479|39510323|FG001|Overall Study|Study Terminated by Sponsor|3|||
16280398|NCT01467479|39510324|FG002|Overall Study|Study Terminated by Sponsor|3|||
16280399|NCT01467479|39510322|FG000|Overall Study|Other|1|||
16280400|NCT01467479|39510323|FG001|Overall Study|Other|0|||
16280401|NCT01467479|39510324|FG002|Overall Study|Other|0|||
16280402|NCT00224484|39510325|FG000|Overall Study|Serious Adverse Event|1|||
16280403|NCT00224484|39510326|FG001|Overall Study|Serious Adverse Event|1|||
16280404|NCT00224484|39510327|FG002|Overall Study|Serious Adverse Event|0|||
16280405|NCT00224484|39510325|FG000|Overall Study|Non-Serious Adverse Event|5|||
16280406|NCT00224484|39510326|FG001|Overall Study|Non-Serious Adverse Event|7|||
16280407|NCT00224484|39510327|FG002|Overall Study|Non-Serious Adverse Event|3|||
16280408|NCT00224484|39510325|FG000|Overall Study|Protocol Violation|2|||
16280409|NCT00224484|39510326|FG001|Overall Study|Protocol Violation|2|||
16280410|NCT00224484|39510327|FG002|Overall Study|Protocol Violation|0|||
16280411|NCT00224484|39510325|FG000|Overall Study|Withdrawal by Subject|49|||
16280412|NCT00224484|39510326|FG001|Overall Study|Withdrawal by Subject|18|||
16280413|NCT00224484|39510327|FG002|Overall Study|Withdrawal by Subject|16|||
16280414|NCT00224484|39510325|FG000|Overall Study|Migrated/moved from study area|18|||
16280415|NCT00224484|39510326|FG001|Overall Study|Migrated/moved from study area|5|||
16280416|NCT00224484|39510327|FG002|Overall Study|Migrated/moved from study area|5|||
16280417|NCT00224484|39510325|FG000|Overall Study|Lost to Follow-up|66|||
16280418|NCT00224484|39510326|FG001|Overall Study|Lost to Follow-up|28|||
16280419|NCT00224484|39510327|FG002|Overall Study|Lost to Follow-up|36|||
16280420|NCT00224484|39510325|FG000|Overall Study|Reason not specified|5|||
16280421|NCT00224484|39510326|FG001|Overall Study|Reason not specified|4|||
16280422|NCT00224484|39510327|FG002|Overall Study|Reason not specified|2|||
16280423|NCT00869440|39510330|FG000|Overall Study|Withdrawal by Subject|1|||
16280424|NCT00869440|39510331|FG001|Overall Study|Withdrawal by Subject|0|||
16280425|NCT00869440|39510332|FG002|Overall Study|Withdrawal by Subject|0|||
16280426|NCT00869440|39510333|FG003|Overall Study|Withdrawal by Subject|0|||
16280427|NCT00869440|39510330|FG000|Overall Study|Physician Decision|1|||
16280428|NCT00869440|39510331|FG001|Overall Study|Physician Decision|1|||
16280429|NCT00869440|39510332|FG002|Overall Study|Physician Decision|0|||
16280430|NCT00869440|39510333|FG003|Overall Study|Physician Decision|0|||
16280431|NCT02031237|39510334|FG000|Overall Study|Death|1|||
16280432|NCT02031237|39510335|FG001|Overall Study|Death|5|||
16280433|NCT02031237|39510336|FG002|Overall Study|Death|0|||
16280434|NCT02031237|39510334|FG000|Overall Study|Physician Decision|0|||
16280435|NCT02031237|39510335|FG001|Overall Study|Physician Decision|1|||
16280436|NCT02031237|39510336|FG002|Overall Study|Physician Decision|0|||
16280437|NCT02031237|39510334|FG000|Overall Study|Withdrawal by Subject|2|||
16280438|NCT02031237|39510335|FG001|Overall Study|Withdrawal by Subject|2|||
16280439|NCT02031237|39510336|FG002|Overall Study|Withdrawal by Subject|0|||
16280440|NCT02031237|39510334|FG000|Overall Study|Protocol Violation|2|||
16280441|NCT02031237|39510335|FG001|Overall Study|Protocol Violation|6|||
16280442|NCT02031237|39510336|FG002|Overall Study|Protocol Violation|0|||
16280443|NCT02031237|39510334|FG000|Overall Study|Alternate Treatment Given|0|||
16280444|NCT02031237|39510335|FG001|Overall Study|Alternate Treatment Given|0|||
16280445|NCT02031237|39510336|FG002|Overall Study|Alternate Treatment Given|3|||
16280446|NCT00476593|39510338|FG000|Overall Study|Lost to Follow-up|10|||
16280447|NCT00476593|39510339|FG001|Overall Study|Lost to Follow-up|2|||
16280448|NCT00476593|39510340|FG002|Overall Study|Lost to Follow-up|8|||
16280449|NCT00476593|39510341|FG003|Overall Study|Lost to Follow-up|22|||
16479333|NCT02925117|40234279|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
16479334|NCT02925117|40234280|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
16479335|NCT02925117|40234281|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
16479336|NCT02925117|40234282|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
16479337|NCT02925117|40234283|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
16479338|NCT02925117|40234284|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
16479339|NCT02925117|40234285|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
16479340|NCT02925117|40234286|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
16479341|NCT02925117|40234275|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
16479342|NCT02925117|40234276|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
16185271|NCT01757704|39159204|FG000|Overall Study|Protocol Violation|1|||
16185272|NCT01757704|39159205|FG001|Overall Study|Protocol Violation|3|||
16185273|NCT01520324|39159206|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
16185274|NCT01266148|39159207|FG000|Overall Study|Adverse Event|2|||
16185275|NCT01266148|39159208|FG001|Overall Study|Adverse Event|0|||
16185276|NCT01266148|39159207|FG000|Overall Study|Ongoing rejection|1|||
16185277|NCT01266148|39159208|FG001|Overall Study|Ongoing rejection|0|||
16185278|NCT01266148|39159207|FG000|Overall Study|2 2R rejections|1|||
16185279|NCT01266148|39159208|FG001|Overall Study|2 2R rejections|0|||
16185280|NCT01266148|39159207|FG000|Overall Study|Death|2|||
16185281|NCT01266148|39159208|FG001|Overall Study|Death|3|||
16185282|NCT01266148|39159207|FG000|Overall Study|missing mGFR value + AE|1|||
16185283|NCT01266148|39159208|FG001|Overall Study|missing mGFR value + AE|0|||
16185284|NCT02375698|39159209|FG000|Overall Study|Withdrawal by Subject|0|||
16185285|NCT02375698|39159210|FG001|Overall Study|Withdrawal by Subject|2|||
16185286|NCT02375698|39159209|FG000|Overall Study|Physician Decision|2|||
16185287|NCT02375698|39159210|FG001|Overall Study|Physician Decision|0|||
16185288|NCT01408537|39159213|FG000|Overall Study|Withdrawal by Subject|2|||
16185289|NCT01408537|39159213|FG000|Overall Study|Protocol Violation|3|||
16185290|NCT01408537|39159213|FG000|Overall Study|Lost to Follow-up|3|||
16185291|NCT00769704|39159221|FG000|Overall Study|Lost to Follow-up|3|||
16185292|NCT00769704|39159222|FG001|Overall Study|Lost to Follow-up|2|||
16185293|NCT00769704|39159221|FG000|Overall Study|Death|95|||
16185294|NCT00769704|39159222|FG001|Overall Study|Death|190|||
16185295|NCT00769704|39159221|FG000|Overall Study|Withdrawal by Subject|12|||
16185296|NCT00769704|39159222|FG001|Overall Study|Withdrawal by Subject|5|||
16185297|NCT00769704|39159221|FG000|Overall Study|Other|1|||
16185298|NCT00769704|39159222|FG001|Overall Study|Other|2|||
16185299|NCT01978912|39159223|FG000|Overall Study|Adverse Event|0|||
16185300|NCT01978912|39159224|FG001|Overall Study|Adverse Event|1|||
16185301|NCT01978912|39159225|FG002|Overall Study|Adverse Event|0|||
16185302|NCT01978912|39159226|FG003|Overall Study|Adverse Event|0|||
16185303|NCT01978912|39159223|FG000|Overall Study|Lost to Follow-up|1|||
16185304|NCT01978912|39159224|FG001|Overall Study|Lost to Follow-up|1|||
16185305|NCT01978912|39159225|FG002|Overall Study|Lost to Follow-up|0|||
16185306|NCT01978912|39159226|FG003|Overall Study|Lost to Follow-up|1|||
16185307|NCT01978912|39159223|FG000|Overall Study|Withdrawal by Subject|1|||
16185308|NCT01978912|39159224|FG001|Overall Study|Withdrawal by Subject|0|||
16185309|NCT01978912|39159225|FG002|Overall Study|Withdrawal by Subject|2|||
16185310|NCT01978912|39159226|FG003|Overall Study|Withdrawal by Subject|2|||
16185311|NCT01978912|39159223|FG000|Overall Study|Lumbar Surgery|1|||
16185312|NCT01978912|39159224|FG001|Overall Study|Lumbar Surgery|0|||
16185313|NCT01978912|39159225|FG002|Overall Study|Lumbar Surgery|1|||
16185314|NCT01978912|39159226|FG003|Overall Study|Lumbar Surgery|0|||
16185315|NCT01978912|39159223|FG000|Overall Study|Intradiscal Steroid Injection|0|||
16185316|NCT01978912|39159224|FG001|Overall Study|Intradiscal Steroid Injection|1|||
16185317|NCT01978912|39159225|FG002|Overall Study|Intradiscal Steroid Injection|0|||
16185318|NCT01978912|39159226|FG003|Overall Study|Intradiscal Steroid Injection|0|||
16185319|NCT01905397|39159227|FG000|Overall Study|Death|0|||
16185320|NCT01905397|39159228|FG001|Overall Study|Death|1|||
16185321|NCT01905397|39159227|FG000|Overall Study|Withdrawal by Subject|2|||
16185322|NCT01905397|39159228|FG001|Overall Study|Withdrawal by Subject|0|||
16185323|NCT01905397|39159227|FG000|Overall Study|Surgery canceled/aborted|9|||
16185324|NCT01905397|39159228|FG001|Overall Study|Surgery canceled/aborted|5|||
16185325|NCT01905397|39159227|FG000|Overall Study|Incision < 7 cm|2|||
16185326|NCT01905397|39159228|FG001|Overall Study|Incision < 7 cm|0|||
16185327|NCT01905397|39159227|FG000|Overall Study|Wrong treatment|1|||
16185328|NCT01905397|39159228|FG001|Overall Study|Wrong treatment|1|||
16185329|NCT01905397|39159227|FG000|Overall Study|Device not applied|3|||
16185330|NCT01905397|39159228|FG001|Overall Study|Device not applied|0|||
16185331|NCT01905397|39159227|FG000|Overall Study|Dressing not applied in operating room|1|||
16280450|NCT03086135|39510343|FG000|Overall Study|Adverse Event|1|||
16280451|NCT03086135|39510343|FG000|Overall Study|Lost to Follow-up|2|||
16479343|NCT02925117|40234277|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
16479344|NCT02925117|40234278|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
16280452|NCT01740427|39510344|FG000|Overall Study|Ongoing|45|||
16280453|NCT01740427|39510345|FG001|Overall Study|Ongoing|5|||
16280454|NCT01740427|39510344|FG000|Overall Study|Objective Progression or Relapse|281|||
16280455|NCT01740427|39510345|FG001|Overall Study|Objective Progression or Relapse|171|||
16280456|NCT01740427|39510344|FG000|Overall Study|Adverse Event|31|||
16280457|NCT01740427|39510345|FG001|Overall Study|Adverse Event|9|||
16280458|NCT01740427|39510344|FG000|Overall Study|Global Deterioration of Health Status|28|||
16280459|NCT01740427|39510345|FG001|Overall Study|Global Deterioration of Health Status|12|||
16479345|NCT02925117|40234279|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
16479346|NCT02925117|40234280|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
16479347|NCT02925117|40234281|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
16479348|NCT02925117|40234282|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
16479349|NCT02925117|40234283|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
16479350|NCT02925117|40234284|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
16479351|NCT02925117|40234285|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
16479352|NCT02925117|40234286|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
16280460|NCT01740427|39510344|FG000|Overall Study|Participant Refused Continued Treatment|26|||
16280461|NCT01740427|39510345|FG001|Overall Study|Participant Refused Continued Treatment|15|||
16280462|NCT01740427|39510344|FG000|Overall Study|Unspecified reasons|15|||
16479353|NCT02925117|40234275|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
16479354|NCT02925117|40234276|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
16479355|NCT02925117|40234277|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
16479356|NCT02925117|40234278|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
16479357|NCT02925117|40234279|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
16479358|NCT02925117|40234280|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
16479359|NCT02925117|40234281|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
16479360|NCT02925117|40234282|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
16479361|NCT02925117|40234283|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
16479362|NCT02925117|40234284|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
16479363|NCT02925117|40234285|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
16479364|NCT02925117|40234286|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
16479365|NCT02925117|40234275|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
16479366|NCT02925117|40234276|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
16080213|NCT01307267|38786781|FG000|Overall Study|Lost to Follow-up|0|||
16280463|NCT01740427|39510345|FG001|Overall Study|Unspecified reasons|4|||
16280464|NCT01740427|39510344|FG000|Overall Study|Death|10|||
16479367|NCT02925117|40234277|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
16479368|NCT02925117|40234278|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
16479369|NCT02925117|40234279|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
16479370|NCT02925117|40234280|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
16479371|NCT02925117|40234281|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
16479372|NCT02925117|40234282|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
16479373|NCT02925117|40234283|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
16479374|NCT02925117|40234284|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
16479375|NCT02925117|40234285|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
16479376|NCT02925117|40234286|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
16479377|NCT02925117|40234275|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
16479378|NCT02925117|40234276|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
16280465|NCT01740427|39510345|FG001|Overall Study|Death|3|||
16280466|NCT01740427|39510344|FG000|Overall Study|Protocol Violation|5|||
16280467|NCT01740427|39510345|FG001|Overall Study|Protocol Violation|3|||
16280468|NCT01740427|39510344|FG000|Overall Study|Lost to Follow-up|2|||
16280469|NCT01740427|39510345|FG001|Overall Study|Lost to Follow-up|0|||
16280470|NCT01740427|39510344|FG000|Overall Study|Site Terminated by Sponsor|1|||
16280471|NCT01740427|39510345|FG001|Overall Study|Site Terminated by Sponsor|0|||
16280472|NCT00551616|39510346|FG000|Overall Study|Lost to Follow-up|48|||
16280473|NCT00551616|39510347|FG001|Overall Study|Lost to Follow-up|40|||
16280474|NCT01949116|39510351|FG000|Overall Study|Death|2|||
16280475|NCT01949116|39510352|FG001|Overall Study|Death|0|||
16280476|NCT01949116|39510351|FG000|Overall Study|Lost to Follow-up|1|||
16280477|NCT01949116|39510352|FG001|Overall Study|Lost to Follow-up|3|||
16280478|NCT01949116|39510351|FG000|Overall Study|Withdrawal by Subject|5|||
16280479|NCT01949116|39510352|FG001|Overall Study|Withdrawal by Subject|3|||
16280480|NCT01785615|39510355|FG000|Dietary Phase|Lost to Follow-up|0|||
16280481|NCT01785615|39510356|FG001|Dietary Phase|Lost to Follow-up|0|||
16280482|NCT01785615|39510357|FG002|Dietary Phase|Lost to Follow-up|0|||
16280483|NCT01785615|39510358|FG003|Dietary Phase|Lost to Follow-up|24|||
16280484|NCT02539368|39510359|FG000|Overall Study|Death|4|||
16280485|NCT02539368|39510360|FG001|Overall Study|Death|2|||
16280486|NCT02539368|39510361|FG002|Overall Study|Death|1|||
16280487|NCT02539368|39510362|FG003|Overall Study|Death|0|||
16280488|NCT02539368|39510363|FG004|Overall Study|Death|0|||
16280489|NCT02539368|39510359|FG000|Overall Study|Withdrawal by Subject|44|||
16280490|NCT02539368|39510360|FG001|Overall Study|Withdrawal by Subject|35|||
16280491|NCT02539368|39510361|FG002|Overall Study|Withdrawal by Subject|9|||
16280492|NCT02539368|39510362|FG003|Overall Study|Withdrawal by Subject|1|||
16280493|NCT02539368|39510363|FG004|Overall Study|Withdrawal by Subject|3|||
16280494|NCT02539368|39510359|FG000|Overall Study|Physician Decision|49|||
16479379|NCT02925117|40234277|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
16479380|NCT02925117|40234278|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
16479381|NCT02925117|40234279|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
16479382|NCT02925117|40234280|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
16479383|NCT02925117|40234281|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
16479384|NCT02925117|40234282|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
16479385|NCT02925117|40234283|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
16479386|NCT02925117|40234284|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
16479387|NCT02925117|40234285|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
16479388|NCT02925117|40234286|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
16479389|NCT01871142|40234289|FG000|Overall Study|Adverse Event|1|||
16479390|NCT00697788|40234290|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
16479391|NCT00697788|40234291|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
16479392|NCT00697788|40234292|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
16479393|NCT00697788|40234293|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
16280495|NCT02539368|39510360|FG001|Overall Study|Physician Decision|15|||
16280496|NCT02539368|39510361|FG002|Overall Study|Physician Decision|7|||
16280497|NCT02539368|39510362|FG003|Overall Study|Physician Decision|0|||
16479394|NCT00697788|40234294|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
16479395|NCT00697788|40234295|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
16479396|NCT00697788|40234296|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
16479397|NCT00697788|40234297|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
16479398|NCT00697788|40234290|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
16479399|NCT00697788|40234291|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
16280498|NCT02539368|39510363|FG004|Overall Study|Physician Decision|2|||
16280499|NCT02539368|39510359|FG000|Overall Study|Lost to Follow-up|96|||
16280500|NCT02539368|39510360|FG001|Overall Study|Lost to Follow-up|21|||
16280501|NCT02539368|39510361|FG002|Overall Study|Lost to Follow-up|16|||
16280502|NCT02539368|39510362|FG003|Overall Study|Lost to Follow-up|4|||
16280503|NCT02539368|39510363|FG004|Overall Study|Lost to Follow-up|3|||
16280504|NCT02539368|39510359|FG000|Overall Study|Adverse Event|44|||
16280505|NCT02539368|39510360|FG001|Overall Study|Adverse Event|5|||
16280506|NCT02539368|39510361|FG002|Overall Study|Adverse Event|9|||
16280507|NCT02539368|39510362|FG003|Overall Study|Adverse Event|0|||
16280508|NCT02539368|39510363|FG004|Overall Study|Adverse Event|3|||
16479400|NCT00697788|40234292|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
16479401|NCT00697788|40234293|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
16479402|NCT00697788|40234294|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
16479403|NCT00697788|40234295|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
16479404|NCT00697788|40234296|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
16479405|NCT00697788|40234297|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
16479406|NCT04744831|40234298|FG000|Overall Study|Progressive Disease|31|||
16479407|NCT04744831|40234299|FG001|Overall Study|Progressive Disease|27|||
16479408|NCT04744831|40234300|FG002|Overall Study|Progressive Disease|25|||
16479409|NCT04744831|40234298|FG000|Overall Study|Adverse Event|3|||
16479410|NCT04744831|40234299|FG001|Overall Study|Adverse Event|3|||
16479411|NCT04744831|40234300|FG002|Overall Study|Adverse Event|3|||
16479412|NCT04744831|40234298|FG000|Overall Study|Clinical Progression|3|||
16479413|NCT04744831|40234299|FG001|Overall Study|Clinical Progression|2|||
16479414|NCT04744831|40234300|FG002|Overall Study|Clinical Progression|5|||
16479415|NCT04744831|40234298|FG000|Overall Study|Other|0|||
16479416|NCT04744831|40234299|FG001|Overall Study|Other|2|||
16080214|NCT01307267|38786782|FG001|Overall Study|Lost to Follow-up|0|||
16280509|NCT02539368|39510359|FG000|Overall Study|Participant Non-compliant|13|||
16280510|NCT02539368|39510360|FG001|Overall Study|Participant Non-compliant|2|||
16280511|NCT02539368|39510361|FG002|Overall Study|Participant Non-compliant|1|||
16280512|NCT02539368|39510362|FG003|Overall Study|Participant Non-compliant|1|||
16280513|NCT02539368|39510363|FG004|Overall Study|Participant Non-compliant|0|||
16280514|NCT02539368|39510359|FG000|Overall Study|Other|145|||
16280515|NCT02539368|39510360|FG001|Overall Study|Other|18|||
16280516|NCT02539368|39510361|FG002|Overall Study|Other|24|||
16280517|NCT02539368|39510362|FG003|Overall Study|Other|1|||
16280518|NCT02539368|39510363|FG004|Overall Study|Other|3|||
16280519|NCT02539368|39510359|FG000|Overall Study|Missing|10|||
16280520|NCT02539368|39510360|FG001|Overall Study|Missing|3|||
16280521|NCT02539368|39510361|FG002|Overall Study|Missing|0|||
16280522|NCT02539368|39510362|FG003|Overall Study|Missing|0|||
16280523|NCT02539368|39510363|FG004|Overall Study|Missing|0|||
16280524|NCT04330157|39510364|FG000|Overall Study|Protocol Violation|4|||
16280525|NCT04330157|39510364|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
16280526|NCT02012452|39510365|FG000|Overall Study|Lost to Follow-up|2|||
16280527|NCT02012452|39510366|FG001|Overall Study|Lost to Follow-up|1|||
16280528|NCT02012452|39510365|FG000|Overall Study|Withdrawal by Subject|4|||
16280529|NCT02012452|39510366|FG001|Overall Study|Withdrawal by Subject|0|||
16280530|NCT03689894|39510368|FG000|Overall Study|Adverse Event|1|||
16280531|NCT01134627|39510371|FG000|Overall Study|Adverse Event|47|||
16280532|NCT01134627|39510372|FG001|Overall Study|Adverse Event|31|||
16280533|NCT01134627|39510371|FG000|Overall Study|Lost to Follow-up|1|||
16280534|NCT01134627|39510372|FG001|Overall Study|Lost to Follow-up|2|||
16280535|NCT01134627|39510371|FG000|Overall Study|Protocol Violation|3|||
16280536|NCT01134627|39510372|FG001|Overall Study|Protocol Violation|5|||
16280537|NCT01134627|39510371|FG000|Overall Study|Lack of Efficacy|2|||
16280538|NCT01134627|39510372|FG001|Overall Study|Lack of Efficacy|12|||
16280539|NCT01134627|39510371|FG000|Overall Study|Withdrawal by Subject|4|||
16280540|NCT01134627|39510372|FG001|Overall Study|Withdrawal by Subject|3|||
16280541|NCT01134627|39510371|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
16280542|NCT01134627|39510372|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
16280543|NCT01134627|39510371|FG000|Overall Study|Other|11|||
16280544|NCT01134627|39510372|FG001|Overall Study|Other|14|||
16280545|NCT01270620|39510373|FG000|Overall Study|Withdrawal by Subject|1|||
16280546|NCT01270620|39510374|FG001|Overall Study|Withdrawal by Subject|3|||
16280547|NCT03761056|39510376|FG000|Overall Study|Still on Study|34|||
16280548|NCT03761056|39510376|FG000|Overall Study|Death|6|||
16280549|NCT03761056|39510376|FG000|Overall Study|Investigator Decision|1|||
16280550|NCT03761056|39510376|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
16280551|NCT00469898|39510377|FG000|Overall Study|Adverse Event|7|||
16280552|NCT00469898|39510377|FG000|Overall Study|Withdrawal by Subject|4|||
16280553|NCT00469898|39510377|FG000|Overall Study|Death|4|||
16280554|NCT00469898|39510377|FG000|Overall Study|Disease progression|9|||
16280555|NCT00469898|39510377|FG000|Overall Study|Decreased performance status|1|||
16280556|NCT01074008|39510378|FG000|Overall Study|Adverse Event|0|||
16280557|NCT01074008|39510379|FG001|Overall Study|Adverse Event|1|||
16280558|NCT01074008|39510380|FG002|Overall Study|Adverse Event|0|||
16280559|NCT01074008|39510381|FG003|Overall Study|Adverse Event|0|||
16280560|NCT01074008|39510382|FG004|Overall Study|Adverse Event|0|||
16280561|NCT01074008|39510383|FG005|Overall Study|Adverse Event|0|||
16479417|NCT04744831|40234300|FG002|Overall Study|Other|1|||
16479418|NCT04744831|40234298|FG000|Overall Study|Death|0|||
16280562|NCT01074008|39510384|FG006|Overall Study|Adverse Event|0|||
16280563|NCT01074008|39510385|FG007|Overall Study|Adverse Event|0|||
16280564|NCT01074008|39510386|FG008|Overall Study|Adverse Event|0|||
16479419|NCT04744831|40234299|FG001|Overall Study|Death|2|||
16479420|NCT04744831|40234300|FG002|Overall Study|Death|1|||
16479421|NCT02058693|40234301|FG000|Phase 1|Withdrawal by Subject|3|||
16280565|NCT01074008|39510378|FG000|Overall Study|Withdrawal by Subject|1|||
16280566|NCT01074008|39510379|FG001|Overall Study|Withdrawal by Subject|1|||
16280567|NCT01074008|39510380|FG002|Overall Study|Withdrawal by Subject|1|||
16280568|NCT01074008|39510381|FG003|Overall Study|Withdrawal by Subject|0|||
16280569|NCT01074008|39510382|FG004|Overall Study|Withdrawal by Subject|1|||
16280570|NCT01074008|39510383|FG005|Overall Study|Withdrawal by Subject|0|||
16280571|NCT01074008|39510384|FG006|Overall Study|Withdrawal by Subject|0|||
16280572|NCT01074008|39510385|FG007|Overall Study|Withdrawal by Subject|0|||
16280573|NCT01074008|39510386|FG008|Overall Study|Withdrawal by Subject|0|||
16280574|NCT01074008|39510378|FG000|Overall Study|Lost to Follow-up|0|||
16280575|NCT01074008|39510379|FG001|Overall Study|Lost to Follow-up|1|||
16280576|NCT01074008|39510380|FG002|Overall Study|Lost to Follow-up|1|||
16280577|NCT01074008|39510381|FG003|Overall Study|Lost to Follow-up|1|||
16280578|NCT01074008|39510382|FG004|Overall Study|Lost to Follow-up|1|||
16280579|NCT01074008|39510383|FG005|Overall Study|Lost to Follow-up|0|||
16280580|NCT01074008|39510384|FG006|Overall Study|Lost to Follow-up|1|||
16280581|NCT01074008|39510385|FG007|Overall Study|Lost to Follow-up|0|||
16280582|NCT01074008|39510386|FG008|Overall Study|Lost to Follow-up|4|||
16280583|NCT01546519|39510387|FG000|Overall Study|Adverse Event|0|||
16280584|NCT01546519|39510388|FG001|Overall Study|Adverse Event|0|||
16280585|NCT01546519|39510389|FG002|Overall Study|Adverse Event|1|||
16280586|NCT01546519|39510390|FG003|Overall Study|Adverse Event|1|||
16280587|NCT01546519|39510387|FG000|Overall Study|Death|0|||
16280588|NCT01546519|39510388|FG001|Overall Study|Death|1|||
16280589|NCT01546519|39510389|FG002|Overall Study|Death|3|||
16280590|NCT01546519|39510390|FG003|Overall Study|Death|1|||
16280591|NCT01546519|39510387|FG000|Overall Study|related to disease progression|2|||
16280592|NCT01546519|39510388|FG001|Overall Study|related to disease progression|2|||
16280593|NCT01546519|39510389|FG002|Overall Study|related to disease progression|2|||
16280594|NCT01546519|39510390|FG003|Overall Study|related to disease progression|1|||
16280595|NCT01546519|39510387|FG000|Overall Study|Physician Decision|6|||
16280596|NCT01546519|39510388|FG001|Overall Study|Physician Decision|5|||
16280597|NCT01546519|39510389|FG002|Overall Study|Physician Decision|2|||
16280598|NCT01546519|39510390|FG003|Overall Study|Physician Decision|3|||
16280599|NCT01546519|39510387|FG000|Overall Study|Withdrawal by Subject|1|||
16280600|NCT01546519|39510388|FG001|Overall Study|Withdrawal by Subject|0|||
16280601|NCT01546519|39510389|FG002|Overall Study|Withdrawal by Subject|0|||
16280602|NCT01546519|39510390|FG003|Overall Study|Withdrawal by Subject|0|||
16280603|NCT00587431|39510395|FG000|Overall Study|Adverse Event|1|||
16280604|NCT00587431|39510396|FG001|Overall Study|Adverse Event|0|||
16280605|NCT00587431|39510395|FG000|Overall Study|Withdrawal by Subject|0|||
16280606|NCT00587431|39510396|FG001|Overall Study|Withdrawal by Subject|1|||
16280607|NCT02808819|39510398|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
16280608|NCT02808819|39510399|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
16280609|NCT02808819|39510398|FG000|Overall Study|Withdrawal by Subject|10|||
16280610|NCT02808819|39510399|FG001|Overall Study|Withdrawal by Subject|13|||
16280611|NCT02808819|39510398|FG000|Overall Study|Site terminated by sponsor|2|||
16280612|NCT02808819|39510399|FG001|Overall Study|Site terminated by sponsor|0|||
16280613|NCT02808819|39510398|FG000|Overall Study|Pregnancy|1|||
16280614|NCT02808819|39510399|FG001|Overall Study|Pregnancy|0|||
16280615|NCT02808819|39510398|FG000|Overall Study|Lost to Follow-up|1|||
16280616|NCT02808819|39510399|FG001|Overall Study|Lost to Follow-up|6|||
16280617|NCT02808819|39510398|FG000|Overall Study|Protocol Violation|0|||
16280618|NCT02808819|39510399|FG001|Overall Study|Protocol Violation|1|||
16280619|NCT02808819|39510398|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
16280620|NCT02808819|39510399|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
16280621|NCT02808819|39510398|FG000|Overall Study|Death|1|||
16280622|NCT02808819|39510399|FG001|Overall Study|Death|0|||
16280623|NCT02808819|39510398|FG000|Overall Study|Adverse Event|3|||
16280624|NCT02808819|39510399|FG001|Overall Study|Adverse Event|4|||
16280625|NCT01517867|39510402|FG000|Overall Study|never started treatment|29|||
16280626|NCT01517867|39510403|FG001|Overall Study|never started treatment|32|||
16280627|NCT01517867|39510402|FG000|Overall Study|Withdrawal by Subject|34|||
16280628|NCT01517867|39510403|FG001|Overall Study|Withdrawal by Subject|30|||
16280629|NCT01517867|39510402|FG000|Overall Study|Still in treatment at study end|0|||
16280630|NCT01517867|39510403|FG001|Overall Study|Still in treatment at study end|3|||
16280631|NCT01118117|39510406|FG000|Overall Study|Death|8|||
16280632|NCT01118117|39510407|FG001|Overall Study|Death|0|||
16280633|NCT01118117|39510406|FG000|Overall Study|Lost to Follow-up|6|||
16280634|NCT01118117|39510407|FG001|Overall Study|Lost to Follow-up|0|||
16280635|NCT01118117|39510406|FG000|Overall Study|Missed 12 Month Visit|7|||
16280636|NCT01118117|39510407|FG001|Overall Study|Missed 12 Month Visit|0|||
16280637|NCT01899326|39510408|FG000|Overall Study|Withdrawal by Subject|1|||
16280638|NCT01899326|39510408|FG000|Overall Study|Adverse Event|2|||
16280639|NCT01899326|39510408|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
16280640|NCT02280187|39510409|FG000|Overall Study|Lost to Follow-up|218|||
16280641|NCT01867606|39510413|FG000|Overall Study|Withdrawal by Subject|10|||
16280642|NCT01867606|39510414|FG001|Overall Study|Withdrawal by Subject|14|||
16280643|NCT01867606|39510413|FG000|Overall Study|Protocol Violation|0|||
16280644|NCT01867606|39510414|FG001|Overall Study|Protocol Violation|1|||
16280645|NCT01029392|39510415|FG000|Overall Study|Withdrawal by Subject|18|||
16280646|NCT01029392|39510416|FG001|Overall Study|Withdrawal by Subject|11|||
16280647|NCT01029392|39510415|FG000|Overall Study|Physician Decision|2|||
16280648|NCT01029392|39510416|FG001|Overall Study|Physician Decision|0|||
16280649|NCT02302716|39510417|FG000|Overall Study|Adverse Event|1|||
16280650|NCT02302716|39510418|FG001|Overall Study|Adverse Event|1|||
16280651|NCT02302716|39510417|FG000|Overall Study|Death|0|||
16280652|NCT02302716|39510418|FG001|Overall Study|Death|1|||
16280653|NCT02302716|39510417|FG000|Overall Study|Lack of Efficacy|0|||
16280654|NCT02302716|39510418|FG001|Overall Study|Lack of Efficacy|1|||
16280655|NCT02302716|39510417|FG000|Overall Study|Lost to Follow-up|2|||
16280656|NCT02302716|39510418|FG001|Overall Study|Lost to Follow-up|4|||
16280657|NCT02302716|39510417|FG000|Overall Study|Physician Decision|3|||
16280658|NCT02302716|39510418|FG001|Overall Study|Physician Decision|4|||
16280659|NCT02302716|39510417|FG000|Overall Study|Withdrawal by Subject|13|||
16280660|NCT02302716|39510418|FG001|Overall Study|Withdrawal by Subject|7|||
16280661|NCT02302716|39510417|FG000|Overall Study|Protocol Violation|0|||
16280662|NCT02302716|39510418|FG001|Overall Study|Protocol Violation|1|||
16280663|NCT02457611|39510422|FG000|Overall Study|Lost to Follow-up|3|||
16280664|NCT02224053|39510423|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
16280665|NCT02224053|39510423|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
16280666|NCT02224053|39510423|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
16280667|NCT02224053|39510423|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
16280668|NCT02224053|39510423|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
16280669|NCT00595335|39510424|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
16280670|NCT00595335|39510425|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
16280671|NCT00595335|39510424|FG000|Baseline to Six Months|Disease Progression|1|||
16280672|NCT00595335|39510425|FG001|Baseline to Six Months|Disease Progression|1|||
16280673|NCT00595335|39510424|FG000|Baseline to Six Months|Adverse Event|1|||
16280674|NCT00595335|39510425|FG001|Baseline to Six Months|Adverse Event|0|||
16280675|NCT00595335|39510424|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
16280676|NCT00595335|39510425|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
16280677|NCT00595335|39510424|FG000|Six Months to Twelve Months|Disease Progression|1|||
16280678|NCT00595335|39510425|FG001|Six Months to Twelve Months|Disease Progression|0|||
16280679|NCT01363011|39510426|FG000|Main Study|Adverse Event|2|||
16280680|NCT01363011|39510427|FG001|Main Study|Adverse Event|3|||
16280681|NCT01363011|39510426|FG000|Main Study|Investigator's Discretion|1|||
16280682|NCT01363011|39510427|FG001|Main Study|Investigator's Discretion|1|||
16280683|NCT01363011|39510426|FG000|Main Study|Withdrew Consent|1|||
16280684|NCT01363011|39510427|FG001|Main Study|Withdrew Consent|4|||
16280685|NCT01363011|39510426|FG000|Main Study|Protocol Violation|0|||
16280686|NCT01363011|39510427|FG001|Main Study|Protocol Violation|1|||
16280687|NCT01363011|39510426|FG000|Extension Phase|Adverse Event|1|||
16280688|NCT01363011|39510427|FG001|Extension Phase|Adverse Event|1|||
16280689|NCT01363011|39510426|FG000|Extension Phase|Lack of Efficacy|0|||
16280690|NCT01363011|39510427|FG001|Extension Phase|Lack of Efficacy|1|||
16280691|NCT01363011|39510426|FG000|Extension Phase|Investigator's Discretion|2|||
16280692|NCT01363011|39510427|FG001|Extension Phase|Investigator's Discretion|2|||
16280693|NCT01363011|39510426|FG000|Extension Phase|Withdrew Consent|0|||
16280694|NCT01363011|39510427|FG001|Extension Phase|Withdrew Consent|1|||
16280695|NCT01363011|39510426|FG000|Extension Phase|Lost to Follow-up|0|||
16280696|NCT01363011|39510427|FG001|Extension Phase|Lost to Follow-up|2|||
16280697|NCT01363011|39510426|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
16280698|NCT01363011|39510427|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
16280699|NCT02443545|39510428|FG000|Overall Study|Adverse Event|1|||
16280700|NCT02443545|39510429|FG001|Overall Study|Adverse Event|1|||
16280701|NCT02443545|39510428|FG000|Overall Study|Lost to Follow-up|0|||
16280702|NCT02443545|39510429|FG001|Overall Study|Lost to Follow-up|2|||
16280703|NCT02443545|39510428|FG000|Overall Study|Physician Decision|3|||
16280704|NCT02443545|39510429|FG001|Overall Study|Physician Decision|0|||
16280705|NCT02443545|39510428|FG000|Overall Study|Protocol Violation|8|||
16280706|NCT02443545|39510429|FG001|Overall Study|Protocol Violation|1|||
16280707|NCT02443545|39510428|FG000|Overall Study|Pregnancy|1|||
16280708|NCT02443545|39510429|FG001|Overall Study|Pregnancy|1|||
16280709|NCT02443545|39510428|FG000|Overall Study|Withdrawal by Subject|6|||
16280710|NCT02443545|39510429|FG001|Overall Study|Withdrawal by Subject|3|||
16280711|NCT02443545|39510428|FG000|Overall Study|Termination of study|20|||
16280712|NCT02443545|39510429|FG001|Overall Study|Termination of study|11|||
16280713|NCT02418455|39510430|FG000|48-Week Treatment Period|Other- Not Specified|1|||
16280714|NCT02418455|39510430|FG000|Continuation Period|Sponsor Decision|7|||
16280715|NCT01841073|39510433|FG000|Overall Study|Adverse Event|1|||
16280716|NCT01841073|39510434|FG001|Overall Study|Adverse Event|1|||
16280717|NCT01841073|39510433|FG000|Overall Study|Physician Decision|1|||
16280718|NCT01841073|39510434|FG001|Overall Study|Physician Decision|0|||
16280719|NCT01841073|39510433|FG000|Overall Study|Lost to Follow-up|0|||
16280720|NCT01841073|39510434|FG001|Overall Study|Lost to Follow-up|2|||
16280721|NCT04149535|39510435|FG000|Overall Study|Death|11|||
16280722|NCT04149535|39510436|FG001|Overall Study|Death|7|||
16280723|NCT04149535|39510435|FG000|Overall Study|Physician Decision|10|||
16280724|NCT04149535|39510436|FG001|Overall Study|Physician Decision|4|||
16280725|NCT04149535|39510435|FG000|Overall Study|Withdrawal by Subject|6|||
16280726|NCT04149535|39510436|FG001|Overall Study|Withdrawal by Subject|7|||
16280727|NCT04149535|39510435|FG000|Overall Study|Not described|2|||
16280728|NCT04149535|39510436|FG001|Overall Study|Not described|0|||
16280729|NCT02697617|39510438|FG000|Overall Study|Withdrawal by Subject|0|||
16280730|NCT02697617|39510439|FG001|Overall Study|Withdrawal by Subject|2|||
16280731|NCT02697617|39510438|FG000|Overall Study|Pregnancy|1|||
16280732|NCT02697617|39510439|FG001|Overall Study|Pregnancy|0|||
16280733|NCT02853331|39510440|FG000|Overall Study|Death|59|||
16280734|NCT02853331|39510441|FG001|Overall Study|Death|95|||
16280735|NCT02853331|39510440|FG000|Overall Study|Withdrawal by Subject|5|||
16280736|NCT02853331|39510441|FG001|Overall Study|Withdrawal by Subject|9|||
16280737|NCT02853331|39510440|FG000|Overall Study|Ongoing in study|368|||
16280738|NCT02853331|39510441|FG001|Overall Study|Ongoing in study|325|||
16280739|NCT02063217|39510446|FG000|Overall Study|Withdrawal by Subject|1|||
16280740|NCT02063217|39510447|FG001|Overall Study|Withdrawal by Subject|0|||
16280741|NCT02063217|39510448|FG002|Overall Study|Withdrawal by Subject|0|||
16280742|NCT02722616|39510449|FG000|Overall Study|Sponsor closed study after one month|2|||
16280743|NCT02722616|39510450|FG001|Overall Study|Sponsor closed study after one month|0|||
16280744|NCT02722616|39510451|FG002|Overall Study|Sponsor closed study after one month|0|||
16280745|NCT00889252|39510452|FG000|Overall Study|Adverse Event|2|||
16280746|NCT00889252|39510453|FG001|Overall Study|Adverse Event|4|||
16280747|NCT00889252|39510452|FG000|Overall Study|Withdrawal by Subject|3|||
16280748|NCT00889252|39510453|FG001|Overall Study|Withdrawal by Subject|0|||
16280749|NCT00889252|39510452|FG000|Overall Study|Protocol Violation|2|||
16280750|NCT00889252|39510453|FG001|Overall Study|Protocol Violation|0|||
16280751|NCT01055834|39510454|FG000|Treatment Period I|Adverse Event|1|||
16280752|NCT01055834|39510455|FG001|Treatment Period I|Adverse Event|0|||
16280753|NCT05135273|39510458|FG000|Overall Study|Recruited into the army|0|||
16280754|NCT05135273|39510459|FG001|Overall Study|Recruited into the army|0|||
16280755|NCT05135273|39510460|FG002|Overall Study|Recruited into the army|0|||
16280756|NCT05135273|39510461|FG003|Overall Study|Recruited into the army|0|||
16280757|NCT05135273|39510462|FG004|Overall Study|Recruited into the army|1|||
16280758|NCT05135273|39510463|FG005|Overall Study|Recruited into the army|0|||
16280759|NCT05135273|39510464|FG006|Overall Study|Recruited into the army|0|||
16280760|NCT05135273|39510465|FG007|Overall Study|Recruited into the army|0|||
16280761|NCT05135273|39510458|FG000|Overall Study|Moved away from study site|0|||
16280762|NCT05135273|39510459|FG001|Overall Study|Moved away from study site|0|||
16280763|NCT05135273|39510460|FG002|Overall Study|Moved away from study site|0|||
16280764|NCT05135273|39510461|FG003|Overall Study|Moved away from study site|0|||
16280765|NCT05135273|39510462|FG004|Overall Study|Moved away from study site|0|||
16280766|NCT05135273|39510463|FG005|Overall Study|Moved away from study site|1|||
16280767|NCT05135273|39510464|FG006|Overall Study|Moved away from study site|1|||
16280768|NCT05135273|39510465|FG007|Overall Study|Moved away from study site|0|||
16280769|NCT05135273|39510458|FG000|Overall Study|Travel|0|||
16280770|NCT05135273|39510459|FG001|Overall Study|Travel|0|||
16280771|NCT05135273|39510460|FG002|Overall Study|Travel|0|||
16280772|NCT05135273|39510461|FG003|Overall Study|Travel|0|||
16280773|NCT05135273|39510462|FG004|Overall Study|Travel|0|||
16280774|NCT05135273|39510463|FG005|Overall Study|Travel|0|||
16280775|NCT05135273|39510464|FG006|Overall Study|Travel|0|||
16280776|NCT05135273|39510465|FG007|Overall Study|Travel|1|||
16280777|NCT01015287|39510466|FG000|Overall Study|Death|21|||
16280778|NCT01015287|39510467|FG001|Overall Study|Death|16|||
16280779|NCT01015287|39510466|FG000|Overall Study|Adverse Event|1|||
16280780|NCT01015287|39510467|FG001|Overall Study|Adverse Event|0|||
16280781|NCT01015287|39510466|FG000|Overall Study|Sponsor Decision|3|||
16280782|NCT01015287|39510467|FG001|Overall Study|Sponsor Decision|7|||
16280783|NCT01015287|39510466|FG000|Overall Study|Physician Decision|19|||
16280784|NCT01015287|39510467|FG001|Overall Study|Physician Decision|21|||
16280785|NCT01015287|39510466|FG000|Overall Study|Withdrawal by Subject|14|||
16280786|NCT01015287|39510467|FG001|Overall Study|Withdrawal by Subject|19|||
16280787|NCT01015287|39510466|FG000|Overall Study|Entry Criteria not Met|11|||
16280788|NCT01015287|39510467|FG001|Overall Study|Entry Criteria not Met|14|||
16280789|NCT01015287|39510466|FG000|Overall Study|Lost to Follow-up|2|||
16280790|NCT01015287|39510467|FG001|Overall Study|Lost to Follow-up|1|||
16280791|NCT01015287|39510466|FG000|Overall Study|Protocol Violation|1|||
16280792|NCT01015287|39510467|FG001|Overall Study|Protocol Violation|1|||
16280793|NCT02174276|39510472|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
16280794|NCT02174276|39510473|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
16280795|NCT02174276|39510474|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
16280796|NCT02174276|39510475|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
16280797|NCT02174276|39510472|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
16280798|NCT02174276|39510473|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
16280799|NCT02174276|39510474|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
16280800|NCT02174276|39510475|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
16280801|NCT02174276|39510472|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
16280802|NCT02174276|39510473|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
16280803|NCT02174276|39510474|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
16280804|NCT02174276|39510475|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
16280805|NCT02174276|39510472|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
16280806|NCT02174276|39510473|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
16280807|NCT02174276|39510474|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
16280808|NCT02174276|39510475|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
16280809|NCT02174276|39510472|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
16280810|NCT02174276|39510473|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
16280811|NCT02174276|39510474|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
16280812|NCT02174276|39510475|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
16280813|NCT02174276|39510472|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
16280814|NCT02174276|39510473|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
16280815|NCT02174276|39510474|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
16280816|NCT02174276|39510475|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
16280817|NCT02310789|39510481|FG000|Overall Study|Adverse Event|1|||
16280818|NCT01083680|39510482|FG000|Overall Study|Lost to Follow-up|2758|||
16280819|NCT01083680|39510482|FG000|Overall Study|Withdrawal by Subject|1086|||
16280820|NCT01355302|39510483|FG000|Phase 1b|Death|4|||
16280821|NCT01355302|39510484|FG001|Phase 1b|Death|0|||
16280822|NCT01355302|39510485|FG002|Phase 1b|Death|0|||
16280823|NCT01355302|39510483|FG000|Phase 1b|Study terminated by sponsor|2|||
16280824|NCT01355302|39510484|FG001|Phase 1b|Study terminated by sponsor|0|||
16280825|NCT01355302|39510485|FG002|Phase 1b|Study terminated by sponsor|0|||
16280826|NCT01740791|39510486|FG000|Overall Study|Randomized but never treated|5|||
16280827|NCT01740791|39510487|FG001|Overall Study|Randomized but never treated|3|||
16280828|NCT01740791|39510488|FG002|Overall Study|Randomized but never treated|2|||
16280829|NCT01740791|39510489|FG003|Overall Study|Randomized but never treated|2|||
16280830|NCT01740791|39510490|FG004|Overall Study|Randomized but never treated|1|||
16280831|NCT01740791|39510491|FG005|Overall Study|Randomized but never treated|3|||
16280832|NCT01740791|39510486|FG000|Overall Study|Lost to Follow-up|2|||
16280833|NCT01740791|39510487|FG001|Overall Study|Lost to Follow-up|0|||
16280834|NCT01740791|39510488|FG002|Overall Study|Lost to Follow-up|2|||
16280835|NCT01740791|39510489|FG003|Overall Study|Lost to Follow-up|3|||
16280836|NCT01740791|39510490|FG004|Overall Study|Lost to Follow-up|2|||
16280837|NCT01740791|39510491|FG005|Overall Study|Lost to Follow-up|3|||
16280838|NCT01740791|39510486|FG000|Overall Study|Withdrew Consent|4|||
16280839|NCT01740791|39510487|FG001|Overall Study|Withdrew Consent|0|||
16280840|NCT01740791|39510488|FG002|Overall Study|Withdrew Consent|1|||
16280841|NCT01740791|39510489|FG003|Overall Study|Withdrew Consent|2|||
16280842|NCT01740791|39510490|FG004|Overall Study|Withdrew Consent|0|||
16280843|NCT01740791|39510491|FG005|Overall Study|Withdrew Consent|3|||
16280844|NCT01740791|39510486|FG000|Overall Study|Investigator's discretion|1|||
16280845|NCT01740791|39510487|FG001|Overall Study|Investigator's discretion|0|||
16280846|NCT01740791|39510488|FG002|Overall Study|Investigator's discretion|1|||
16280847|NCT01740791|39510489|FG003|Overall Study|Investigator's discretion|0|||
16280848|NCT01740791|39510490|FG004|Overall Study|Investigator's discretion|0|||
16280849|NCT01740791|39510491|FG005|Overall Study|Investigator's discretion|1|||
16280850|NCT01740791|39510486|FG000|Overall Study|Adverse Event|0|||
16280851|NCT01740791|39510487|FG001|Overall Study|Adverse Event|0|||
16280852|NCT01740791|39510488|FG002|Overall Study|Adverse Event|0|||
16280853|NCT01740791|39510489|FG003|Overall Study|Adverse Event|0|||
16280854|NCT01740791|39510490|FG004|Overall Study|Adverse Event|0|||
16280855|NCT01740791|39510491|FG005|Overall Study|Adverse Event|1|||
16280856|NCT02419573|39510492|FG000|Overall Study|Lost to Follow-up|3|||
16280857|NCT02419573|39510493|FG001|Overall Study|Lost to Follow-up|0|||
16280858|NCT02419573|39510492|FG000|Overall Study|Withdrawal by Subject|1|||
16280859|NCT02419573|39510493|FG001|Overall Study|Withdrawal by Subject|0|||
16280860|NCT03203642|39510494|FG000|Overall Study|Adverse Event|3|||
16280861|NCT03203642|39510495|FG001|Overall Study|Adverse Event|1|||
16280862|NCT03203642|39510494|FG000|Overall Study|Withdrawal by Subject|6|||
16280863|NCT03203642|39510495|FG001|Overall Study|Withdrawal by Subject|6|||
16280864|NCT03203642|39510494|FG000|Overall Study|Lost to Follow-up|2|||
16280865|NCT03203642|39510495|FG001|Overall Study|Lost to Follow-up|1|||
16280866|NCT03203642|39510494|FG000|Overall Study|Termination of the study by sponsor|1|||
16280867|NCT03203642|39510495|FG001|Overall Study|Termination of the study by sponsor|1|||
16280868|NCT03203642|39510494|FG000|Overall Study|Participant moved|0|||
16280869|NCT03203642|39510495|FG001|Overall Study|Participant moved|1|||
16280870|NCT03203642|39510494|FG000|Overall Study|Investigator's decision|3|||
16280871|NCT03203642|39510495|FG001|Overall Study|Investigator's decision|0|||
16280872|NCT03203642|39510494|FG000|Overall Study|Other than above specified|0|||
16280873|NCT03203642|39510495|FG001|Overall Study|Other than above specified|1|||
16280874|NCT02522780|39510496|FG000|Overall Study|Consent withdrawn by subject|5|||
16280875|NCT02522780|39510497|FG001|Overall Study|Consent withdrawn by subject|7|||
16280876|NCT02522780|39510496|FG000|Overall Study|Protocol deviation|1|||
16280877|NCT02522780|39510497|FG001|Overall Study|Protocol deviation|3|||
16280878|NCT02522780|39510496|FG000|Overall Study|Subject refused endoscopic procedure|0|||
16280879|NCT02522780|39510497|FG001|Overall Study|Subject refused endoscopic procedure|1|||
16280880|NCT02522780|39510496|FG000|Overall Study|Adverse event, non-fatal|11|||
16280881|NCT02522780|39510497|FG001|Overall Study|Adverse event, non-fatal|16|||
16280882|NCT00732160|39510498|FG000|Overall Study|Adverse Event|1|||
16280883|NCT00732160|39510499|FG001|Overall Study|Adverse Event|0|||
16280884|NCT00732160|39510500|FG002|Overall Study|Adverse Event|1|||
16280885|NCT00732160|39510501|FG003|Overall Study|Adverse Event|1|||
16280886|NCT00732160|39510498|FG000|Overall Study|scheduling|4|||
16280887|NCT00732160|39510499|FG001|Overall Study|scheduling|4|||
16280888|NCT00732160|39510500|FG002|Overall Study|scheduling|2|||
16280889|NCT00732160|39510501|FG003|Overall Study|scheduling|1|||
16280890|NCT01011556|39510504|FG000|Overall Study|Adverse Event|1|||
16280891|NCT01011556|39510505|FG001|Overall Study|Adverse Event|3|||
16280892|NCT01011556|39510506|FG002|Overall Study|Adverse Event|2|||
16280893|NCT01011556|39510507|FG003|Overall Study|Adverse Event|1|||
16280894|NCT01011556|39510504|FG000|Overall Study|Lost to Follow-up|1|||
16280895|NCT01011556|39510505|FG001|Overall Study|Lost to Follow-up|0|||
16280896|NCT01011556|39510506|FG002|Overall Study|Lost to Follow-up|0|||
16280897|NCT01011556|39510507|FG003|Overall Study|Lost to Follow-up|0|||
16280898|NCT01011556|39510504|FG000|Overall Study|Physician Decision|1|||
16280899|NCT01011556|39510505|FG001|Overall Study|Physician Decision|0|||
16280900|NCT01011556|39510506|FG002|Overall Study|Physician Decision|0|||
16280901|NCT01011556|39510507|FG003|Overall Study|Physician Decision|1|||
16280902|NCT01011556|39510504|FG000|Overall Study|Protocol Violation|0|||
16280903|NCT01011556|39510505|FG001|Overall Study|Protocol Violation|1|||
16280904|NCT01011556|39510506|FG002|Overall Study|Protocol Violation|0|||
16280905|NCT01011556|39510507|FG003|Overall Study|Protocol Violation|0|||
16280906|NCT01011556|39510504|FG000|Overall Study|Withdrawal by Subject|1|||
16280907|NCT01011556|39510505|FG001|Overall Study|Withdrawal by Subject|2|||
16280908|NCT01011556|39510506|FG002|Overall Study|Withdrawal by Subject|4|||
16280909|NCT01011556|39510507|FG003|Overall Study|Withdrawal by Subject|4|||
16280910|NCT01011556|39510504|FG000|Overall Study|Sponsor decision|0|||
16280911|NCT01011556|39510505|FG001|Overall Study|Sponsor decision|1|||
16280912|NCT01011556|39510506|FG002|Overall Study|Sponsor decision|1|||
16280913|NCT01011556|39510507|FG003|Overall Study|Sponsor decision|2|||
16280914|NCT01011556|39510504|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
16280915|NCT01011556|39510505|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
16280916|NCT01011556|39510506|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
16280917|NCT01011556|39510507|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
16280918|NCT01120899|39510508|FG000|Overall Study|Withdrawal by Subject|3|||
16280919|NCT02756637|39510509|FG000|Overall Study|Not eligible for initial SWOG study|10|||
16280920|NCT02756637|39510510|FG001|Overall Study|Not eligible for initial SWOG study|10|||
16280921|NCT02756637|39510509|FG000|Overall Study|No available NLR value|44|||
16280922|NCT02756637|39510510|FG001|Overall Study|No available NLR value|44|||
16280923|NCT02756637|39510509|FG000|Overall Study|Did not complete curative therapy|33|||
16280924|NCT02756637|39510510|FG001|Overall Study|Did not complete curative therapy|0|||
16280925|NCT02013531|39510513|FG000|Overall Study|Lost to Follow-up|3|||
16280926|NCT02013531|39510513|FG000|Overall Study|Met Withdrawal Criteria|1|||
16280927|NCT02013531|39510513|FG000|Overall Study|Withdrawal by Subject|1|||
16280928|NCT02608476|39510526|FG000|Overall Study|Withdrawal by Subject|30|||
16280929|NCT02608476|39510527|FG001|Overall Study|Withdrawal by Subject|37|||
16280930|NCT02608476|39510526|FG000|Overall Study|Lost to Follow-up|24|||
16280931|NCT02608476|39510527|FG001|Overall Study|Lost to Follow-up|24|||
16280932|NCT02608476|39510526|FG000|Overall Study|Adverse Event|2|||
16280933|NCT02608476|39510527|FG001|Overall Study|Adverse Event|8|||
16280934|NCT02608476|39510526|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
16280935|NCT02608476|39510527|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
16280936|NCT02608476|39510526|FG000|Overall Study|Noncompliance with treatment|1|||
16280937|NCT02608476|39510527|FG001|Overall Study|Noncompliance with treatment|5|||
16280938|NCT02608476|39510526|FG000|Overall Study|Lack of Efficacy|3|||
16280939|NCT02608476|39510527|FG001|Overall Study|Lack of Efficacy|1|||
16280940|NCT02608476|39510526|FG000|Overall Study|Other|0|||
16280941|NCT02608476|39510527|FG001|Overall Study|Other|1|||
16280942|NCT02608476|39510526|FG000|Overall Study|Physician Decision|1|||
16280943|NCT02608476|39510527|FG001|Overall Study|Physician Decision|0|||
16280944|NCT02608476|39510526|FG000|Overall Study|Pregnancy|0|||
16280945|NCT02608476|39510527|FG001|Overall Study|Pregnancy|1|||
16280946|NCT02608476|39510526|FG000|Overall Study|Progressive disease|1|||
16280947|NCT02608476|39510527|FG001|Overall Study|Progressive disease|0|||
16280948|NCT03449199|39510528|FG000|Overall Study|Lost to Follow-up|1|||
16280949|NCT03449199|39510529|FG001|Overall Study|Lost to Follow-up|1|||
16280950|NCT03449199|39510530|FG002|Overall Study|Lost to Follow-up|0|||
16280951|NCT03449199|39510528|FG000|Overall Study|Protocol Deviation|0|||
16280952|NCT03449199|39510529|FG001|Overall Study|Protocol Deviation|0|||
16280953|NCT03449199|39510530|FG002|Overall Study|Protocol Deviation|1|||
16280954|NCT03449199|39510528|FG000|Overall Study|Withdrawal by Subject|0|||
16280955|NCT03449199|39510529|FG001|Overall Study|Withdrawal by Subject|0|||
16280956|NCT03449199|39510530|FG002|Overall Study|Withdrawal by Subject|1|||
16280957|NCT01955044|39510531|FG000|Overall Study|Death|1|||
16280958|NCT01955044|39510532|FG001|Overall Study|Death|1|||
16280959|NCT01955044|39510533|FG002|Overall Study|Death|0|||
16280960|NCT02260635|39510536|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
16280961|NCT02260635|39510537|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
16280962|NCT02260635|39510536|FG000|Open-Label Extension|Study Termination|25|||
16280963|NCT02260635|39510537|FG001|Open-Label Extension|Study Termination|25|||
16280964|NCT02260635|39510536|FG000|Open-Label Extension|Withdrawal by Subject|1|||
16280965|NCT02260635|39510537|FG001|Open-Label Extension|Withdrawal by Subject|0|||
16280966|NCT00199901|39510539|FG000|Overall Study|Protocol Violation|2|||
16280967|NCT00199901|39510540|FG001|Overall Study|Protocol Violation|0|||
16280968|NCT00199901|39510539|FG000|Overall Study|Withdrawal by Subject|1|||
16280969|NCT00199901|39510540|FG001|Overall Study|Withdrawal by Subject|0|||
16280970|NCT00199901|39510539|FG000|Overall Study|Progressive Disease|24|||
16280971|NCT00199901|39510540|FG001|Overall Study|Progressive Disease|24|||
16280972|NCT00063258|39510544|FG000|Overall Study|Physician Decision|2|||
16280973|NCT00063258|39510545|FG001|Overall Study|Physician Decision|0|||
16280974|NCT00063258|39510544|FG000|Overall Study|Lack of Efficacy|2|||
16280975|NCT00063258|39510545|FG001|Overall Study|Lack of Efficacy|0|||
16280976|NCT02004691|39510550|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
16280977|NCT02004691|39510551|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
16280978|NCT02004691|39510550|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
16280979|NCT02004691|39510551|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
16280980|NCT02004691|39510550|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
16280981|NCT02004691|39510551|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
16280982|NCT02004691|39510550|FG000|ETP: Ongoing From Week 52|Other|0|||
16280983|NCT02004691|39510551|FG001|ETP: Ongoing From Week 52|Other|1|||
16280984|NCT02004691|39510550|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
16280985|NCT02004691|39510551|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
16280986|NCT00413218|39510552|FG000|Overall Study|Randomized but didn't receive study drug|2|||
16280987|NCT00413218|39510553|FG001|Overall Study|Randomized but didn't receive study drug|8|||
16280988|NCT00413218|39510552|FG000|Overall Study|Death|57|||
16280989|NCT00413218|39510553|FG001|Overall Study|Death|56|||
16280990|NCT00413218|39510552|FG000|Overall Study|Lost to Follow-up|14|||
16280991|NCT00413218|39510553|FG001|Overall Study|Lost to Follow-up|17|||
16280992|NCT00413218|39510552|FG000|Overall Study|Admin|20|||
16280993|NCT00413218|39510553|FG001|Overall Study|Admin|14|||
16280994|NCT00413218|39510552|FG000|Overall Study|Missing|1|||
16280995|NCT00413218|39510553|FG001|Overall Study|Missing|0|||
16280996|NCT00413218|39510552|FG000|Overall Study|Withdrawal by Subject|9|||
16280997|NCT00413218|39510553|FG001|Overall Study|Withdrawal by Subject|1|||
16280998|NCT03069417|39510556|FG000|Overall Study|Lost to Follow-up|2|||
16280999|NCT03069417|39510557|FG001|Overall Study|Lost to Follow-up|0|||
16281000|NCT03069417|39510556|FG000|Overall Study|Reason Unknown|4|||
16281001|NCT03069417|39510557|FG001|Overall Study|Reason Unknown|7|||
16281002|NCT00683787|39510558|FG000|Overall Study|Progression|3|||
16281003|NCT00683787|39510559|FG001|Overall Study|Progression|3|||
16281004|NCT00683787|39510560|FG002|Overall Study|Progression|0|||
16281005|NCT00683787|39510558|FG000|Overall Study|Adverse Event|0|||
16281006|NCT00683787|39510559|FG001|Overall Study|Adverse Event|0|||
16281007|NCT00683787|39510560|FG002|Overall Study|Adverse Event|2|||
16281008|NCT04276935|39510561|FG000|Overall Study|Lost to Follow-up|3|||
16281009|NCT00794417|39510562|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
16281010|NCT00794417|39510563|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
16281011|NCT00794417|39510564|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
16281012|NCT00794417|39510565|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
16281013|NCT00794417|39510562|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
16281014|NCT00794417|39510563|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
16281015|NCT00794417|39510564|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
16281016|NCT00794417|39510565|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
16281017|NCT00794417|39510562|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
16281018|NCT00794417|39510563|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
16281019|NCT00794417|39510564|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
16281020|NCT00794417|39510565|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
16281021|NCT00794417|39510562|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
16281022|NCT00794417|39510563|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
16281023|NCT00794417|39510564|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
16281024|NCT00794417|39510565|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
16281025|NCT00794417|39510562|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
16281026|NCT00794417|39510563|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
16281027|NCT00794417|39510564|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
16281028|NCT00794417|39510565|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
16281029|NCT00794417|39510562|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
16281030|NCT00794417|39510563|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
16281031|NCT00794417|39510564|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
16281032|NCT00794417|39510565|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
16281033|NCT01813435|39510570|FG000|Overall Study|did not finish experimental regimen|1902|||
16281034|NCT01813435|39510571|FG001|Overall Study|did not finish experimental regimen|770|||
16281035|NCT01813435|39510570|FG000|Overall Study|Lost to Follow-up|268|||
16281036|NCT01813435|39510571|FG001|Overall Study|Lost to Follow-up|237|||
16281037|NCT00545688|39510574|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
16281038|NCT00545688|39510575|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
16281039|NCT00545688|39510576|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
16281040|NCT00545688|39510577|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
16281041|NCT00545688|39510574|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
16281042|NCT00545688|39510575|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
16281043|NCT00545688|39510576|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
16281044|NCT00545688|39510577|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
16281045|NCT00545688|39510574|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
16281046|NCT00545688|39510575|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
16281047|NCT00545688|39510576|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
16281048|NCT00545688|39510577|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
16281049|NCT00545688|39510574|FG000|Neo-Adjuvant Treatment Period|Death|0|||
16281050|NCT00545688|39510575|FG001|Neo-Adjuvant Treatment Period|Death|1|||
16281051|NCT00545688|39510576|FG002|Neo-Adjuvant Treatment Period|Death|0|||
16281052|NCT00545688|39510577|FG003|Neo-Adjuvant Treatment Period|Death|0|||
16281053|NCT00545688|39510574|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
16281054|NCT00545688|39510575|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
16281055|NCT00545688|39510576|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
16281056|NCT00545688|39510577|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
16281057|NCT00545688|39510574|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
16281058|NCT00545688|39510575|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
16281059|NCT00545688|39510576|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
16281060|NCT00545688|39510577|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
16281061|NCT00545688|39510574|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
16281062|NCT00545688|39510575|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
16281063|NCT00545688|39510576|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
16281064|NCT00545688|39510577|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
16281065|NCT00545688|39510574|FG000|Adjuvant Treatment Period|Disease Progression|3|||
16281066|NCT00545688|39510575|FG001|Adjuvant Treatment Period|Disease Progression|3|||
16281067|NCT00545688|39510576|FG002|Adjuvant Treatment Period|Disease Progression|0|||
16281068|NCT00545688|39510577|FG003|Adjuvant Treatment Period|Disease Progression|7|||
16281069|NCT00545688|39510574|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
16281070|NCT00545688|39510575|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
16281071|NCT00545688|39510576|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
16281072|NCT00545688|39510577|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
16281073|NCT00545688|39510574|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
16281074|NCT00545688|39510575|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
16281075|NCT00545688|39510576|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
16281076|NCT00545688|39510577|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
16281077|NCT00545688|39510574|FG000|Adjuvant Treatment Period|Adverse Event|0|||
16281078|NCT00545688|39510575|FG001|Adjuvant Treatment Period|Adverse Event|3|||
16281079|NCT00545688|39510576|FG002|Adjuvant Treatment Period|Adverse Event|2|||
16281080|NCT00545688|39510577|FG003|Adjuvant Treatment Period|Adverse Event|2|||
16281081|NCT00545688|39510574|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
16281082|NCT00545688|39510575|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
16281083|NCT00545688|39510576|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
16281084|NCT00545688|39510577|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
16281085|NCT00545688|39510574|FG000|Follow-Up Period|Death|4|||
16281086|NCT00545688|39510575|FG001|Follow-Up Period|Death|2|||
16281087|NCT00545688|39510576|FG002|Follow-Up Period|Death|2|||
16281088|NCT00545688|39510577|FG003|Follow-Up Period|Death|6|||
16281089|NCT00545688|39510574|FG000|Follow-Up Period|Disease Progression|6|||
16281090|NCT00545688|39510575|FG001|Follow-Up Period|Disease Progression|5|||
16281091|NCT00545688|39510576|FG002|Follow-Up Period|Disease Progression|9|||
16281092|NCT00545688|39510577|FG003|Follow-Up Period|Disease Progression|9|||
16281093|NCT00545688|39510574|FG000|Follow-Up Period|Refused Treatment|6|||
16281094|NCT00545688|39510575|FG001|Follow-Up Period|Refused Treatment|2|||
16281095|NCT00545688|39510576|FG002|Follow-Up Period|Refused Treatment|0|||
16281096|NCT00545688|39510577|FG003|Follow-Up Period|Refused Treatment|2|||
16281097|NCT00545688|39510574|FG000|Follow-Up Period|Lost to Follow-up|3|||
16281098|NCT00545688|39510575|FG001|Follow-Up Period|Lost to Follow-up|3|||
16281099|NCT00545688|39510576|FG002|Follow-Up Period|Lost to Follow-up|3|||
16281100|NCT00545688|39510577|FG003|Follow-Up Period|Lost to Follow-up|1|||
16281101|NCT00545688|39510574|FG000|Follow-Up Period|Unspecified Reason|2|||
16281102|NCT00545688|39510575|FG001|Follow-Up Period|Unspecified Reason|5|||
16281103|NCT00545688|39510576|FG002|Follow-Up Period|Unspecified Reason|6|||
16281104|NCT00545688|39510577|FG003|Follow-Up Period|Unspecified Reason|8|||
16281105|NCT00545688|39510574|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
16281106|NCT00545688|39510575|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
16281107|NCT00545688|39510576|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
16281108|NCT00545688|39510577|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
16281109|NCT01223027|39510578|FG000|Overall Study|Adverse Event|20|||
16281110|NCT01223027|39510579|FG001|Overall Study|Adverse Event|10|||
16281111|NCT01223027|39510578|FG000|Overall Study|Death|42|||
16281112|NCT01223027|39510579|FG001|Overall Study|Death|42|||
16281113|NCT01223027|39510578|FG000|Overall Study|Lost to Follow-up|2|||
16281114|NCT01223027|39510579|FG001|Overall Study|Lost to Follow-up|1|||
16281115|NCT01223027|39510578|FG000|Overall Study|Physician Decision|4|||
16281116|NCT01223027|39510579|FG001|Overall Study|Physician Decision|8|||
16281117|NCT01223027|39510578|FG000|Overall Study|Progressive Disease|167|||
16281118|NCT01223027|39510579|FG001|Overall Study|Progressive Disease|183|||
16281119|NCT01223027|39510578|FG000|Overall Study|Protocol Violation|2|||
16281120|NCT01223027|39510579|FG001|Overall Study|Protocol Violation|1|||
16281121|NCT01223027|39510578|FG000|Overall Study|Subject/guardian decicion|18|||
16281122|NCT01223027|39510579|FG001|Overall Study|Subject/guardian decicion|16|||
16281123|NCT01223027|39510578|FG000|Overall Study|New therapy for study indication|17|||
16281124|NCT01223027|39510579|FG001|Overall Study|New therapy for study indication|8|||
16281125|NCT01223027|39510578|FG000|Overall Study|Study terminated by sponsor|2|||
16281126|NCT01223027|39510579|FG001|Overall Study|Study terminated by sponsor|8|||
16281127|NCT01522950|39514077|FG000|Overall Study|Withdrawal by Subject|3|||
16281128|NCT01522950|39514078|FG001|Overall Study|Withdrawal by Subject|2|||
16281129|NCT01522950|39514079|FG002|Overall Study|Withdrawal by Subject|1|||
16281130|NCT01522950|39514077|FG000|Overall Study|Adverse Event|3|||
16281131|NCT01522950|39514078|FG001|Overall Study|Adverse Event|1|||
16281132|NCT01522950|39514079|FG002|Overall Study|Adverse Event|1|||
16281133|NCT01522950|39514077|FG000|Overall Study|Protocol Violation|0|||
16281134|NCT01522950|39514078|FG001|Overall Study|Protocol Violation|0|||
16281135|NCT01522950|39514079|FG002|Overall Study|Protocol Violation|2|||
16281136|NCT01522950|39514077|FG000|Overall Study|Death|0|||
16281137|NCT01522950|39514078|FG001|Overall Study|Death|1|||
16281138|NCT01522950|39514079|FG002|Overall Study|Death|1|||
16281139|NCT01522950|39514077|FG000|Overall Study|Study Medication Sensitivity|0|||
16281140|NCT01522950|39514078|FG001|Overall Study|Study Medication Sensitivity|1|||
16281141|NCT01522950|39514079|FG002|Overall Study|Study Medication Sensitivity|0|||
16281142|NCT01223235|39514080|FG000|Overall Study|Withdrawal by Subject|1|||
16281143|NCT03395639|39514081|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
16281144|NCT03395639|39514082|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
16281145|NCT03395639|39514083|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
16281146|NCT03395639|39514081|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
16281147|NCT03395639|39514082|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
16281148|NCT03395639|39514083|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
16281149|NCT03395639|39514081|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
16281150|NCT03395639|39514082|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
16281151|NCT03395639|39514083|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
16281152|NCT03395639|39514081|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
16281153|NCT03395639|39514082|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
16281154|NCT03395639|39514083|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
16281155|NCT03395639|39514081|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
16281156|NCT03395639|39514082|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
16281157|NCT03395639|39514083|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
16281158|NCT03701763|39514084|FG000|Placebo-controlled Phase|Adverse Event|1|||
16281159|NCT03701763|39514085|FG001|Placebo-controlled Phase|Adverse Event|5|||
16281160|NCT03701763|39514086|FG002|Placebo-controlled Phase|Adverse Event|0|||
16281161|NCT03701763|39514087|FG003|Placebo-controlled Phase|Adverse Event|0|||
16281162|NCT03701763|39514084|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
16281163|NCT03701763|39514085|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
16281164|NCT03701763|39514086|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
16281165|NCT03701763|39514087|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
16281166|NCT03701763|39514084|FG000|Placebo-controlled Phase|Miscellaneous|2|||
16281167|NCT03701763|39514085|FG001|Placebo-controlled Phase|Miscellaneous|0|||
16281168|NCT03701763|39514086|FG002|Placebo-controlled Phase|Miscellaneous|0|||
16281169|NCT03701763|39514087|FG003|Placebo-controlled Phase|Miscellaneous|0|||
16281170|NCT03701763|39514084|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
16281171|NCT03701763|39514085|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
16281172|NCT03701763|39514086|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
16281173|NCT03701763|39514087|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
16281174|NCT03701763|39514084|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
16281175|NCT03701763|39514085|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
16281176|NCT03701763|39514086|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
16281177|NCT03701763|39514087|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
16281178|NCT03701763|39514084|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
16281179|NCT03701763|39514085|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
16281180|NCT03701763|39514086|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
16281181|NCT03701763|39514087|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
16281182|NCT03701763|39514084|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
16281183|NCT03701763|39514085|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
16281184|NCT03701763|39514086|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
16281185|NCT03701763|39514087|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
16281186|NCT03701763|39514084|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
16281187|NCT03701763|39514085|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
16281188|NCT03701763|39514086|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
16281189|NCT03701763|39514087|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
16281190|NCT03701763|39514084|FG000|Apremilast Extension Phase|Adverse Event|0|||
16281191|NCT03701763|39514085|FG001|Apremilast Extension Phase|Adverse Event|0|||
16281192|NCT03701763|39514086|FG002|Apremilast Extension Phase|Adverse Event|3|||
16281193|NCT03701763|39514087|FG003|Apremilast Extension Phase|Adverse Event|1|||
16281194|NCT03701763|39514084|FG000|Apremilast Extension Phase|Miscellaneous|0|||
16281195|NCT03701763|39514085|FG001|Apremilast Extension Phase|Miscellaneous|0|||
16281196|NCT03701763|39514086|FG002|Apremilast Extension Phase|Miscellaneous|2|||
16281197|NCT03701763|39514087|FG003|Apremilast Extension Phase|Miscellaneous|1|||
16281198|NCT03701763|39514084|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
16281199|NCT03701763|39514085|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
16281200|NCT03701763|39514086|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
16281201|NCT03701763|39514087|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
16281202|NCT03701763|39514084|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
16281203|NCT03701763|39514085|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
16281204|NCT03701763|39514086|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
16281205|NCT03701763|39514087|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
16281206|NCT03701763|39514084|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
16281207|NCT03701763|39514085|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
16281208|NCT03701763|39514086|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
16281209|NCT03701763|39514087|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
16281210|NCT03701763|39514084|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
16281211|NCT03701763|39514085|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
16281212|NCT03701763|39514086|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
16281213|NCT03701763|39514087|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
16281214|NCT03701763|39514084|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
16281215|NCT03701763|39514085|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
16281216|NCT03701763|39514086|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
16281217|NCT03701763|39514087|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
16281218|NCT03701763|39514084|FG000|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
16281219|NCT03701763|39514085|FG001|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
16281220|NCT03701763|39514086|FG002|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|1|||
16281221|NCT03701763|39514087|FG003|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
16281222|NCT03701763|39514084|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
16281223|NCT03701763|39514085|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
16281224|NCT03701763|39514086|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
16281225|NCT03701763|39514087|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
16281226|NCT03701763|39514084|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
16281227|NCT03701763|39514085|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
16281228|NCT03701763|39514086|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
16281229|NCT03701763|39514087|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
16281230|NCT00739973|39514088|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
16281231|NCT00739973|39514089|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
16281232|NCT00739973|39514090|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
16281233|NCT00739973|39514091|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
16281234|NCT00739973|39514092|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
16281235|NCT00739973|39514093|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
16281236|NCT00739973|39514094|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
16281237|NCT00739973|39514095|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
16281238|NCT00739973|39514096|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
16281239|NCT00739973|39514088|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
16281240|NCT00739973|39514089|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
16281241|NCT00739973|39514090|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
16281242|NCT00739973|39514091|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
16281243|NCT00739973|39514092|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
16281244|NCT00739973|39514093|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
16281245|NCT00739973|39514094|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
16281246|NCT00739973|39514095|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
16281247|NCT00739973|39514096|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
16281248|NCT00739973|39514088|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
16281249|NCT00739973|39514089|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
16281250|NCT00739973|39514090|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
16281251|NCT00739973|39514091|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
16281252|NCT00739973|39514092|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
16281253|NCT00739973|39514093|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
16281254|NCT00739973|39514094|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
16281255|NCT00739973|39514095|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
16281256|NCT00739973|39514096|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
16281257|NCT00739973|39514088|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
16281258|NCT00739973|39514089|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
16281259|NCT00739973|39514090|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
16281260|NCT00739973|39514091|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
16281261|NCT00739973|39514092|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
16281262|NCT00739973|39514093|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
16281263|NCT00739973|39514094|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
16281264|NCT00739973|39514095|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
16281265|NCT00739973|39514096|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
16281266|NCT00739973|39514088|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
16281267|NCT00739973|39514089|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
16281268|NCT00739973|39514090|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
16281269|NCT00739973|39514091|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
16281270|NCT00739973|39514092|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
16281271|NCT00739973|39514093|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
16281272|NCT00739973|39514094|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
16281273|NCT00739973|39514095|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
16281274|NCT00739973|39514096|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
16281275|NCT00739973|39514088|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
16281276|NCT00739973|39514089|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
16281277|NCT00739973|39514090|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
16281278|NCT00739973|39514091|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
16281279|NCT00739973|39514092|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
16281280|NCT00739973|39514093|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
16281281|NCT00739973|39514094|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
16281282|NCT00739973|39514095|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
16281283|NCT00739973|39514096|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
16281284|NCT00739973|39514088|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
16281285|NCT00739973|39514089|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
16281286|NCT00739973|39514090|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
16281287|NCT00739973|39514091|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
16281288|NCT00739973|39514092|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
16281289|NCT00739973|39514093|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
16281290|NCT00739973|39514094|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
16281291|NCT00739973|39514095|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
16281292|NCT00739973|39514096|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
16281293|NCT00739973|39514088|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
16281294|NCT00739973|39514089|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
16281295|NCT00739973|39514090|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
16281296|NCT00739973|39514091|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
16281297|NCT00739973|39514092|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
16281298|NCT00739973|39514093|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
16281299|NCT00739973|39514094|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
16281300|NCT00739973|39514095|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
16281301|NCT00739973|39514096|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
16281302|NCT00739973|39514088|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
16281303|NCT00739973|39514089|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
16281304|NCT00739973|39514090|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
16281305|NCT00739973|39514091|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
16281306|NCT00739973|39514092|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
16281307|NCT00739973|39514093|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
16281308|NCT00739973|39514094|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
16281309|NCT00739973|39514095|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
16281310|NCT00739973|39514096|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
16281311|NCT00739973|39514088|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
16281312|NCT00739973|39514089|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
16281313|NCT00739973|39514090|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
16281314|NCT00739973|39514091|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
16281315|NCT00739973|39514092|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
16281316|NCT00739973|39514093|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
16281317|NCT00739973|39514094|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
16281318|NCT00739973|39514095|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
16281319|NCT00739973|39514096|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
16281320|NCT00739973|39514088|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
16281321|NCT00739973|39514089|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
16281322|NCT00739973|39514090|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
16281323|NCT00739973|39514091|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
16281324|NCT00739973|39514092|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
16281325|NCT00739973|39514093|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
16281326|NCT00739973|39514094|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
16281327|NCT00739973|39514095|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
16281328|NCT00739973|39514096|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
16281329|NCT00739973|39514088|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
16281330|NCT00739973|39514089|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
16281331|NCT00739973|39514090|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
16281332|NCT00739973|39514091|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
16281333|NCT00739973|39514092|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
16281334|NCT00739973|39514093|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
16281335|NCT00739973|39514094|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
16281336|NCT00739973|39514095|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
16281337|NCT00739973|39514096|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
16281338|NCT00739973|39514088|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
16281339|NCT00739973|39514089|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
16281340|NCT00739973|39514090|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
16281341|NCT00739973|39514091|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
16281342|NCT00739973|39514092|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
16281343|NCT00739973|39514093|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
16281344|NCT00739973|39514094|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
16281345|NCT00739973|39514095|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
16281346|NCT00739973|39514096|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
16281347|NCT00739973|39514088|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
16281348|NCT00739973|39514089|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
16281349|NCT00739973|39514090|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
16281350|NCT00739973|39514091|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
16281351|NCT00739973|39514092|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
16281352|NCT00739973|39514093|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
16281353|NCT00739973|39514094|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
16281354|NCT00739973|39514095|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
16281355|NCT00739973|39514096|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
16281356|NCT00739973|39514088|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
16281357|NCT00739973|39514089|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
16281358|NCT00739973|39514090|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
16281359|NCT00739973|39514091|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
16281360|NCT00739973|39514092|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
16281361|NCT00739973|39514093|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
16281362|NCT00739973|39514094|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
16281363|NCT00739973|39514095|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
16281364|NCT00739973|39514096|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
16281365|NCT00739973|39514088|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
16281366|NCT00739973|39514089|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
16281367|NCT00739973|39514090|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
16281368|NCT00739973|39514091|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
16281369|NCT00739973|39514092|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
16281370|NCT00739973|39514093|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
16281371|NCT00739973|39514094|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
16281372|NCT00739973|39514095|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
16281373|NCT00739973|39514096|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
16281374|NCT00739973|39514088|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
16281375|NCT00739973|39514089|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
16281376|NCT00739973|39514090|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
16281377|NCT00739973|39514091|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
16281378|NCT00739973|39514092|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
16281379|NCT00739973|39514093|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
16281380|NCT00739973|39514094|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
16281381|NCT00739973|39514095|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
16281382|NCT00739973|39514096|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
16281383|NCT00860743|39514097|FG000|Overall Study|Withdrawal by Subject|3|||
16281384|NCT00860743|39514098|FG001|Overall Study|Withdrawal by Subject|0|||
16281385|NCT03573817|39514099|FG000|Overall Study|Adverse Event|0|||
16281386|NCT03573817|39514100|FG001|Overall Study|Adverse Event|2|||
16281387|NCT03573817|39514099|FG000|Overall Study|Protocol Violation|0|||
16281388|NCT03573817|39514100|FG001|Overall Study|Protocol Violation|1|||
16281389|NCT03573817|39514099|FG000|Overall Study|Withdrawal by Subject|1|||
16281390|NCT03573817|39514100|FG001|Overall Study|Withdrawal by Subject|1|||
16281391|NCT05766787|39514101|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
16281392|NCT05766787|39514102|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
16281393|NCT05766787|39514101|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
16281394|NCT05766787|39514102|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
16379671|NCT01356940|39874724|FG000|First Intervention (28 Days)|Adverse Event|1|||
16379672|NCT01356940|39874725|FG001|First Intervention (28 Days)|Adverse Event|0|||
16379673|NCT01356940|39874724|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
16379674|NCT01356940|39874725|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
16080215|NCT01307267|38786783|FG002|Overall Study|Lost to Follow-up|0|||
16281395|NCT05766787|39514101|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
16281396|NCT05766787|39514102|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
16281397|NCT01684215|39514111|FG000|Phase 1, Part 1|Adverse Event|1|||
16281398|NCT01684215|39514112|FG001|Phase 1, Part 1|Adverse Event|0|||
16281399|NCT01684215|39514113|FG002|Phase 1, Part 1|Adverse Event|0|||
16281400|NCT01684215|39514114|FG003|Phase 1, Part 1|Adverse Event|0|||
16281401|NCT01684215|39514111|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
16281402|NCT01684215|39514112|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
16281403|NCT01684215|39514113|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
16281404|NCT01684215|39514114|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
16281405|NCT01684215|39514111|FG000|Phase 1, Part 2|Adverse Event|0|||
16281406|NCT01684215|39514112|FG001|Phase 1, Part 2|Adverse Event|0|||
16281407|NCT01684215|39514113|FG002|Phase 1, Part 2|Adverse Event|1|||
16281408|NCT01684215|39514114|FG003|Phase 1, Part 2|Adverse Event|0|||
16281409|NCT01684215|39514111|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
16281410|NCT01684215|39514112|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
16281411|NCT01684215|39514113|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
16281412|NCT01684215|39514114|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
16281413|NCT01684215|39514111|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
16281414|NCT01684215|39514112|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
16281415|NCT01684215|39514113|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
16281416|NCT01684215|39514114|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
16281417|NCT01684215|39514111|FG000|Phase 2|Death|0|||
16281418|NCT01684215|39514112|FG001|Phase 2|Death|0|||
16281419|NCT01684215|39514113|FG002|Phase 2|Death|0|||
16281420|NCT01684215|39514114|FG003|Phase 2|Death|8|||
16281421|NCT01684215|39514111|FG000|Phase 2|Study terminated by sponsor|0|||
16281422|NCT01684215|39514112|FG001|Phase 2|Study terminated by sponsor|0|||
16281423|NCT01684215|39514113|FG002|Phase 2|Study terminated by sponsor|0|||
16281424|NCT01684215|39514114|FG003|Phase 2|Study terminated by sponsor|30|||
16281425|NCT01684215|39514111|FG000|Phase 2|Enrolled but not treated|0|||
16281426|NCT01684215|39514112|FG001|Phase 2|Enrolled but not treated|0|||
16281427|NCT01684215|39514113|FG002|Phase 2|Enrolled but not treated|0|||
16281428|NCT01684215|39514114|FG003|Phase 2|Enrolled but not treated|1|||
16281429|NCT01684215|39514111|FG000|Phase 2|Lost to Follow-up|0|||
16281430|NCT01684215|39514112|FG001|Phase 2|Lost to Follow-up|0|||
16281431|NCT01684215|39514113|FG002|Phase 2|Lost to Follow-up|0|||
16281432|NCT01684215|39514114|FG003|Phase 2|Lost to Follow-up|4|||
16281433|NCT04314843|39514115|FG000|Overall Study|Death|2|||
16281434|NCT04314843|39514116|FG001|Overall Study|Death|2|||
16281435|NCT04314843|39514115|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
16281436|NCT04314843|39514116|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
16281437|NCT01619579|39514117|FG000|Overall Study|Withdrawal by Subject|0|||
16281438|NCT01619579|39514118|FG001|Overall Study|Withdrawal by Subject|3|||
16281439|NCT02911935|39514119|FG000|Overall Study|Lost to Follow-up|5|||
16281440|NCT02911935|39514120|FG001|Overall Study|Lost to Follow-up|7|||
16281441|NCT02688387|39514121|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281442|NCT02688387|39514122|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281443|NCT02688387|39514123|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
16281444|NCT02688387|39514124|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281445|NCT02688387|39514125|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281446|NCT02688387|39514126|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281447|NCT02688387|39514127|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281448|NCT02688387|39514128|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281449|NCT02688387|39514129|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281450|NCT02688387|39514130|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281451|NCT02688387|39514131|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281452|NCT02688387|39514132|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281453|NCT02688387|39514133|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281454|NCT02688387|39514134|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281455|NCT02688387|39514135|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281456|NCT02688387|39514136|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281457|NCT02688387|39514137|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281458|NCT02688387|39514138|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281459|NCT02688387|39514139|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281460|NCT02688387|39514140|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16479422|NCT02058693|40234302|FG001|Phase 1|Withdrawal by Subject|2|||
16281461|NCT02688387|39514141|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16479423|NCT02058693|40234301|FG000|Phase 1|Adverse Event|0|||
16479424|NCT02058693|40234302|FG001|Phase 1|Adverse Event|1|||
16281462|NCT02688387|39514142|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
16281463|NCT02688387|39514121|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281464|NCT02688387|39514122|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281465|NCT02688387|39514123|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16479425|NCT02058693|40234301|FG000|Phase 1|Lack of Efficacy|1|||
16479426|NCT02058693|40234302|FG001|Phase 1|Lack of Efficacy|0|||
16479427|NCT02058693|40234301|FG000|Phase 1|Physician Decision|1|||
16479428|NCT02058693|40234302|FG001|Phase 1|Physician Decision|1|||
16479429|NCT02058693|40234301|FG000|Phase 2|Withdrawal by Subject|0|||
16080216|NCT01307267|38786784|FG003|Overall Study|Lost to Follow-up|0|||
16281466|NCT02688387|39514124|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
16281467|NCT02688387|39514125|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281468|NCT02688387|39514126|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281469|NCT02688387|39514127|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281470|NCT02688387|39514128|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281471|NCT02688387|39514129|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281472|NCT02688387|39514130|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281473|NCT02688387|39514131|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281474|NCT02688387|39514132|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281475|NCT02688387|39514133|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281476|NCT02688387|39514134|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281477|NCT02688387|39514135|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281478|NCT02688387|39514136|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281479|NCT02688387|39514137|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281480|NCT02688387|39514138|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281481|NCT02688387|39514139|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281482|NCT02688387|39514140|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281483|NCT02688387|39514141|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281484|NCT02688387|39514142|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281485|NCT02688387|39514121|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281486|NCT02688387|39514122|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
16281487|NCT02688387|39514123|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281488|NCT02688387|39514124|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281489|NCT02688387|39514125|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281490|NCT02688387|39514126|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281491|NCT02688387|39514127|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281492|NCT02688387|39514128|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281493|NCT02688387|39514129|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281494|NCT02688387|39514130|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281495|NCT02688387|39514131|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16379675|NCT00982280|39874726|FG000|Observation Period|Not eligible to be dosed|19|||
16379676|NCT00982280|39874726|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
16379677|NCT00982280|39874726|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
16379678|NCT00982280|39874726|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
16379679|NCT00982280|39874726|FG000|Maintenance Period|Adverse Event|1|||
16379680|NCT01911260|39874731|FG000|Supplementation Period|transference or evasion of school|7|||
16379681|NCT01911260|39874732|FG001|Supplementation Period|transference or evasion of school|9|||
16379682|NCT01911260|39874733|FG002|Supplementation Period|transference or evasion of school|7|||
16379683|NCT01911260|39874734|FG003|Supplementation Period|transference or evasion of school|6|||
16379684|NCT01911260|39874731|FG000|Supplementation Period|Adverse Event|2|||
16379685|NCT01911260|39874732|FG001|Supplementation Period|Adverse Event|0|||
16379686|NCT01911260|39874733|FG002|Supplementation Period|Adverse Event|1|||
16379687|NCT01911260|39874734|FG003|Supplementation Period|Adverse Event|0|||
16379688|NCT01911260|39874731|FG000|Supplementation Period|refused to receive supplement|1|||
16379689|NCT01911260|39874732|FG001|Supplementation Period|refused to receive supplement|0|||
16379690|NCT01911260|39874733|FG002|Supplementation Period|refused to receive supplement|1|||
16379691|NCT01911260|39874734|FG003|Supplementation Period|refused to receive supplement|0|||
16379692|NCT01911260|39874731|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
16379693|NCT01911260|39874732|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
16379694|NCT01911260|39874733|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
16379695|NCT01911260|39874734|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
16379696|NCT01911260|39874731|FG000|Follow-up Period|transference or evasion of school|13|||
16379697|NCT01911260|39874732|FG001|Follow-up Period|transference or evasion of school|20|||
16379698|NCT01911260|39874733|FG002|Follow-up Period|transference or evasion of school|15|||
16379699|NCT01911260|39874734|FG003|Follow-up Period|transference or evasion of school|12|||
16379700|NCT00493285|39874737|FG000|Overall Study|Lost to Follow-up|0|||
16379701|NCT00493285|39874738|FG001|Overall Study|Lost to Follow-up|0|||
16379702|NCT00493285|39874739|FG002|Overall Study|Lost to Follow-up|0|||
16379703|NCT00493285|39874740|FG003|Overall Study|Lost to Follow-up|0|||
16379704|NCT00493285|39874741|FG004|Overall Study|Lost to Follow-up|1|||
16479430|NCT02058693|40234302|FG001|Phase 2|Withdrawal by Subject|2|||
16479431|NCT03896165|40234303|FG000|Overall Study|Withdrawal by Subject|2|||
16281496|NCT02688387|39514132|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281497|NCT02688387|39514133|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281498|NCT02688387|39514134|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281499|NCT02688387|39514135|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281500|NCT02688387|39514136|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281501|NCT02688387|39514137|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281502|NCT02688387|39514138|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281503|NCT02688387|39514139|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281504|NCT02688387|39514140|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281505|NCT02688387|39514141|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281506|NCT02688387|39514142|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
16281507|NCT02688387|39514121|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281508|NCT02688387|39514122|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281509|NCT02688387|39514123|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
16281510|NCT02688387|39514124|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281511|NCT02688387|39514125|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
16281512|NCT02688387|39514126|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281513|NCT02688387|39514127|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281514|NCT02688387|39514128|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281515|NCT02688387|39514129|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281516|NCT02688387|39514130|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281517|NCT02688387|39514131|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281518|NCT02688387|39514132|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281519|NCT02688387|39514133|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281520|NCT02688387|39514134|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281521|NCT02688387|39514135|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281522|NCT02688387|39514136|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281523|NCT02688387|39514137|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281524|NCT02688387|39514138|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281525|NCT02688387|39514139|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281526|NCT02688387|39514140|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281527|NCT02688387|39514141|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281528|NCT02688387|39514142|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
16281529|NCT02688387|39514121|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
16281530|NCT02688387|39514122|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281531|NCT02688387|39514123|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281532|NCT02688387|39514124|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281533|NCT02688387|39514125|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281534|NCT02688387|39514126|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281535|NCT02688387|39514127|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281536|NCT02688387|39514128|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281537|NCT02688387|39514129|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281538|NCT02688387|39514130|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281539|NCT02688387|39514131|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281540|NCT02688387|39514132|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281541|NCT02688387|39514133|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281542|NCT02688387|39514134|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281543|NCT02688387|39514135|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281544|NCT02688387|39514136|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281545|NCT02688387|39514137|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281546|NCT02688387|39514138|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281547|NCT02688387|39514139|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281548|NCT02688387|39514140|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281549|NCT02688387|39514141|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281550|NCT02688387|39514142|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
16281551|NCT02688387|39514121|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281552|NCT02688387|39514122|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16379705|NCT00493285|39874742|FG005|Overall Study|Lost to Follow-up|0|||
16379706|NCT03142334|39874744|FG000|Overall Study|Death|18|||
16479432|NCT03080454|40234304|FG000|Baseline|Adverse Event|2|||
16080217|NCT01307267|38786785|FG004|Overall Study|Lost to Follow-up|0|||
16281553|NCT02688387|39514123|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281554|NCT02688387|39514124|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281555|NCT02688387|39514125|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281556|NCT02688387|39514126|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281557|NCT02688387|39514127|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281558|NCT02688387|39514128|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281559|NCT02688387|39514129|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281560|NCT02688387|39514130|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281561|NCT02688387|39514131|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
16281562|NCT02688387|39514132|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281563|NCT02688387|39514133|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281564|NCT02688387|39514134|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281565|NCT02688387|39514135|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281566|NCT02688387|39514136|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281567|NCT02688387|39514137|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281568|NCT02688387|39514138|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281569|NCT02688387|39514139|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281570|NCT02688387|39514140|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281571|NCT02688387|39514141|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281572|NCT02688387|39514142|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
16281573|NCT02688387|39514121|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281574|NCT02688387|39514122|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281575|NCT02688387|39514123|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281576|NCT02688387|39514124|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281577|NCT02688387|39514125|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281578|NCT02688387|39514126|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281579|NCT02688387|39514127|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281580|NCT02688387|39514128|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281581|NCT02688387|39514129|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281582|NCT02688387|39514130|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281583|NCT02688387|39514131|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281584|NCT02688387|39514132|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281585|NCT02688387|39514133|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281586|NCT02688387|39514134|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281587|NCT02688387|39514135|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
16281588|NCT02688387|39514136|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281589|NCT02688387|39514137|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281590|NCT02688387|39514138|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281591|NCT02688387|39514139|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281592|NCT02688387|39514140|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281593|NCT02688387|39514141|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281594|NCT02688387|39514142|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
16281595|NCT02688387|39514121|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281596|NCT02688387|39514122|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281597|NCT02688387|39514123|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281598|NCT02688387|39514124|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281599|NCT02688387|39514125|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281600|NCT02688387|39514126|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281601|NCT02688387|39514127|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281602|NCT02688387|39514128|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281603|NCT02688387|39514129|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281604|NCT02688387|39514130|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281605|NCT02688387|39514131|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281606|NCT02688387|39514132|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281607|NCT02688387|39514133|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281608|NCT02688387|39514134|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281609|NCT02688387|39514135|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281610|NCT02688387|39514136|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281611|NCT02688387|39514137|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281612|NCT02688387|39514138|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281613|NCT02688387|39514139|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281614|NCT02688387|39514140|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281615|NCT02688387|39514141|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
16281616|NCT02688387|39514142|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
16281617|NCT02688387|39514121|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281618|NCT02688387|39514122|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281619|NCT02688387|39514123|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281620|NCT02688387|39514124|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281621|NCT02688387|39514125|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281622|NCT02688387|39514126|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281623|NCT02688387|39514127|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281624|NCT02688387|39514128|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281625|NCT02688387|39514129|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281626|NCT02688387|39514130|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281627|NCT02688387|39514131|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281628|NCT02688387|39514132|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281629|NCT02688387|39514133|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16379707|NCT03142334|39874745|FG001|Overall Study|Death|33|||
16379708|NCT03142334|39874744|FG000|Overall Study|Withdrawal by Subject|15|||
16379709|NCT03142334|39874745|FG001|Overall Study|Withdrawal by Subject|11|||
16185332|NCT01905397|39159228|FG001|Overall Study|Dressing not applied in operating room|0|||
16185333|NCT01905397|39159227|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
16185334|NCT01905397|39159228|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
16185335|NCT00537940|39159229|FG000|Overall Study|Adverse Event|20|||
16185336|NCT00537940|39159230|FG001|Overall Study|Adverse Event|19|||
16185337|NCT00537940|39159229|FG000|Overall Study|Lack of Efficacy|8|||
16185338|NCT00537940|39159230|FG001|Overall Study|Lack of Efficacy|16|||
16185339|NCT00537940|39159229|FG000|Overall Study|Lost to Follow-up|23|||
16185340|NCT00537940|39159230|FG001|Overall Study|Lost to Follow-up|29|||
16185341|NCT00537940|39159229|FG000|Overall Study|Withdrawal by Subject|113|||
16185342|NCT00537940|39159230|FG001|Overall Study|Withdrawal by Subject|95|||
16185343|NCT00537940|39159229|FG000|Overall Study|Protocol Violation|6|||
16185344|NCT00537940|39159230|FG001|Overall Study|Protocol Violation|4|||
16185345|NCT00537940|39159229|FG000|Overall Study|Pregnancy|1|||
16185346|NCT00537940|39159230|FG001|Overall Study|Pregnancy|1|||
16185347|NCT00537940|39159229|FG000|Overall Study|Study terminated by sponsor|2|||
16185348|NCT00537940|39159230|FG001|Overall Study|Study terminated by sponsor|3|||
16185349|NCT00537940|39159229|FG000|Overall Study|Other|10|||
16185350|NCT00537940|39159230|FG001|Overall Study|Other|12|||
16185351|NCT00970294|39159231|FG000|Overall Study|Physician Decision|4|||
16185352|NCT00970294|39159231|FG000|Overall Study|Withdrawal by Subject|1|||
16185353|NCT01345786|39159232|FG000|Overall Study|Adverse Event|0|||
16185354|NCT01345786|39159233|FG001|Overall Study|Adverse Event|1|||
16185355|NCT01345786|39159234|FG002|Overall Study|Adverse Event|3|||
16185356|NCT01345786|39159235|FG003|Overall Study|Adverse Event|1|||
16185357|NCT01345786|39159232|FG000|Overall Study|Subject withdrew consent|2|||
16185358|NCT01345786|39159233|FG001|Overall Study|Subject withdrew consent|2|||
16185359|NCT01345786|39159234|FG002|Overall Study|Subject withdrew consent|1|||
16185360|NCT01345786|39159235|FG003|Overall Study|Subject withdrew consent|0|||
16185361|NCT01345786|39159232|FG000|Overall Study|Noncompliance with protocol|1|||
16185362|NCT01345786|39159233|FG001|Overall Study|Noncompliance with protocol|0|||
16185363|NCT01345786|39159234|FG002|Overall Study|Noncompliance with protocol|1|||
16185364|NCT01345786|39159235|FG003|Overall Study|Noncompliance with protocol|0|||
16185365|NCT01345786|39159232|FG000|Overall Study|Administrative|3|||
16185366|NCT01345786|39159233|FG001|Overall Study|Administrative|5|||
16185367|NCT01345786|39159234|FG002|Overall Study|Administrative|0|||
16185368|NCT01345786|39159235|FG003|Overall Study|Administrative|0|||
16185369|NCT01345786|39159232|FG000|Overall Study|Lost to Follow-up|0|||
16185370|NCT01345786|39159233|FG001|Overall Study|Lost to Follow-up|0|||
16185371|NCT01345786|39159234|FG002|Overall Study|Lost to Follow-up|0|||
16185372|NCT01345786|39159235|FG003|Overall Study|Lost to Follow-up|2|||
16185373|NCT00064662|39159236|FG000|Overall Study|Death|1|||
16185374|NCT00064662|39159237|FG001|Overall Study|Death|1|||
16185375|NCT00064662|39159236|FG000|Overall Study|Lost to Follow-up|57|||
16185376|NCT00064662|39159237|FG001|Overall Study|Lost to Follow-up|44|||
16185377|NCT00064662|39159236|FG000|Overall Study|Withdrawal by Subject|14|||
16185378|NCT00064662|39159237|FG001|Overall Study|Withdrawal by Subject|14|||
16185379|NCT00064662|39159236|FG000|Overall Study|Administratively withdrawn|2|||
16185380|NCT00064662|39159237|FG001|Overall Study|Administratively withdrawn|2|||
16185381|NCT03290300|39159238|FG000|Overall Study|Lost to Follow-up|3|||
16185382|NCT00723840|39159239|FG000|Overall Study|Lost to Follow-up|2|||
16185383|NCT00723840|39159239|FG000|Overall Study|Failure to return|18|||
16281630|NCT02688387|39514134|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281631|NCT02688387|39514135|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16185384|NCT00723840|39159239|FG000|Overall Study|Withdrawal by Subject|55|||
16185385|NCT00723840|39159239|FG000|Overall Study|Serious Adverse Events|3|||
16185386|NCT00723840|39159239|FG000|Overall Study|Other Medical Event|2|||
16185387|NCT00723840|39159239|FG000|Overall Study|Unspecified reason|2|||
16185388|NCT01544595|39159240|FG000|Status at Week 68|Adverse Event|3|||
16185389|NCT01544595|39159241|FG001|Status at Week 68|Adverse Event|2|||
16185390|NCT01544595|39159242|FG002|Status at Week 68|Adverse Event|1|||
16185391|NCT01544595|39159243|FG003|Status at Week 68|Adverse Event|0|||
16281632|NCT02688387|39514136|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281633|NCT02688387|39514137|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281634|NCT02688387|39514138|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281635|NCT02688387|39514139|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
16281636|NCT02688387|39514140|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281637|NCT02688387|39514141|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
16281638|NCT02688387|39514142|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
16281639|NCT02688387|39514121|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281640|NCT02688387|39514122|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281641|NCT02688387|39514123|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281642|NCT02688387|39514124|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281643|NCT02688387|39514125|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281644|NCT02688387|39514126|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281645|NCT02688387|39514127|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16479433|NCT03080454|40234304|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
16479434|NCT03080454|40234304|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
16479435|NCT02919696|40234306|FG000|Overall Study|Adverse Event|1|||
16479436|NCT02919696|40234307|FG001|Overall Study|Adverse Event|2|||
16479437|NCT02919696|40234306|FG000|Overall Study|Withdrawal by Subject|2|||
16479438|NCT02919696|40234307|FG001|Overall Study|Withdrawal by Subject|1|||
16479439|NCT02919696|40234306|FG000|Overall Study|Sponsor Decision|1|||
16479440|NCT02919696|40234307|FG001|Overall Study|Sponsor Decision|1|||
16479441|NCT02919696|40234306|FG000|Overall Study|Never Treated|0|||
16479442|NCT02919696|40234307|FG001|Overall Study|Never Treated|1|||
16479443|NCT02264639|40234308|FG000|Overall Study|Death (after completing single-dose phase)|1|||
16479444|NCT02264639|40234309|FG001|Overall Study|Death (after completing single-dose phase)|0|||
16080218|NCT01307267|38786786|FG005|Overall Study|Lost to Follow-up|7|||
16080219|NCT01307267|38786787|FG006|Overall Study|Lost to Follow-up|0|||
16281646|NCT02688387|39514128|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281647|NCT02688387|39514129|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281648|NCT02688387|39514130|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281649|NCT02688387|39514131|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281650|NCT02688387|39514132|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281651|NCT02688387|39514133|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281652|NCT02688387|39514134|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281653|NCT02688387|39514135|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281654|NCT02688387|39514136|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281655|NCT02688387|39514137|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281656|NCT02688387|39514138|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281657|NCT02688387|39514139|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281658|NCT02688387|39514140|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
16281659|NCT02688387|39514141|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281660|NCT02688387|39514142|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
16281661|NCT03310619|39514143|FG000|Pre-Treatment Period|Death|1|||
16281662|NCT03310619|39514144|FG001|Pre-Treatment Period|Death|0|||
16281663|NCT03310619|39514145|FG002|Pre-Treatment Period|Death|0|||
16281664|NCT03310619|39514146|FG003|Pre-Treatment Period|Death|0|||
16281665|NCT03310619|39514147|FG004|Pre-Treatment Period|Death|1|||
16281666|NCT03310619|39514148|FG005|Pre-Treatment Period|Death|0|||
16281667|NCT03310619|39514149|FG006|Pre-Treatment Period|Death|0|||
16281668|NCT03310619|39514150|FG007|Pre-Treatment Period|Death|0|||
16281669|NCT03310619|39514143|FG000|Pre-Treatment Period|Other reasons|2|||
16281670|NCT03310619|39514144|FG001|Pre-Treatment Period|Other reasons|1|||
16281671|NCT03310619|39514145|FG002|Pre-Treatment Period|Other reasons|2|||
16281672|NCT03310619|39514146|FG003|Pre-Treatment Period|Other reasons|0|||
16281673|NCT03310619|39514147|FG004|Pre-Treatment Period|Other reasons|0|||
16281674|NCT03310619|39514148|FG005|Pre-Treatment Period|Other reasons|0|||
16281675|NCT03310619|39514149|FG006|Pre-Treatment Period|Other reasons|2|||
16281676|NCT03310619|39514150|FG007|Pre-Treatment Period|Other reasons|0|||
16281677|NCT03310619|39514143|FG000|Treatment Period|Death|1|||
16281678|NCT03310619|39514144|FG001|Treatment Period|Death|2|||
16281679|NCT03310619|39514145|FG002|Treatment Period|Death|0|||
16281680|NCT03310619|39514146|FG003|Treatment Period|Death|0|||
16281681|NCT03310619|39514147|FG004|Treatment Period|Death|1|||
16281682|NCT03310619|39514148|FG005|Treatment Period|Death|0|||
16281683|NCT03310619|39514149|FG006|Treatment Period|Death|2|||
16281684|NCT03310619|39514150|FG007|Treatment Period|Death|0|||
16281685|NCT03310619|39514143|FG000|Treatment Period|Adverse Event|0|||
16281686|NCT03310619|39514144|FG001|Treatment Period|Adverse Event|1|||
16281687|NCT03310619|39514145|FG002|Treatment Period|Adverse Event|4|||
16281688|NCT03310619|39514146|FG003|Treatment Period|Adverse Event|1|||
16281689|NCT03310619|39514147|FG004|Treatment Period|Adverse Event|0|||
16479445|NCT02264639|40234310|FG002|Overall Study|Death (after completing single-dose phase)|0|||
16479446|NCT02264639|40234311|FG003|Overall Study|Death (after completing single-dose phase)|0|||
16281690|NCT03310619|39514148|FG005|Treatment Period|Adverse Event|0|||
16281691|NCT03310619|39514149|FG006|Treatment Period|Adverse Event|0|||
16281692|NCT03310619|39514150|FG007|Treatment Period|Adverse Event|0|||
16281693|NCT03310619|39514143|FG000|Treatment Period|Withdrawal by participant|0|||
16281694|NCT03310619|39514144|FG001|Treatment Period|Withdrawal by participant|0|||
16281695|NCT03310619|39514145|FG002|Treatment Period|Withdrawal by participant|1|||
16281696|NCT03310619|39514146|FG003|Treatment Period|Withdrawal by participant|0|||
16281697|NCT03310619|39514147|FG004|Treatment Period|Withdrawal by participant|0|||
16281698|NCT03310619|39514148|FG005|Treatment Period|Withdrawal by participant|0|||
16281699|NCT03310619|39514149|FG006|Treatment Period|Withdrawal by participant|0|||
16281700|NCT03310619|39514150|FG007|Treatment Period|Withdrawal by participant|0|||
16281701|NCT03310619|39514143|FG000|Treatment Period|Lost to Follow-up|0|||
16281702|NCT03310619|39514144|FG001|Treatment Period|Lost to Follow-up|0|||
16281703|NCT03310619|39514145|FG002|Treatment Period|Lost to Follow-up|0|||
16281704|NCT03310619|39514146|FG003|Treatment Period|Lost to Follow-up|0|||
16281705|NCT03310619|39514147|FG004|Treatment Period|Lost to Follow-up|0|||
16281706|NCT03310619|39514148|FG005|Treatment Period|Lost to Follow-up|0|||
16281707|NCT03310619|39514149|FG006|Treatment Period|Lost to Follow-up|0|||
16281708|NCT03310619|39514150|FG007|Treatment Period|Lost to Follow-up|1|||
16281709|NCT03310619|39514143|FG000|Treatment Period|Study terminated by sponsor|0|||
16281710|NCT03310619|39514144|FG001|Treatment Period|Study terminated by sponsor|0|||
16281711|NCT03310619|39514145|FG002|Treatment Period|Study terminated by sponsor|0|||
16281712|NCT03310619|39514146|FG003|Treatment Period|Study terminated by sponsor|0|||
16281713|NCT03310619|39514147|FG004|Treatment Period|Study terminated by sponsor|0|||
16281714|NCT03310619|39514148|FG005|Treatment Period|Study terminated by sponsor|0|||
16281715|NCT03310619|39514149|FG006|Treatment Period|Study terminated by sponsor|0|||
16281716|NCT03310619|39514150|FG007|Treatment Period|Study terminated by sponsor|1|||
16281717|NCT03310619|39514143|FG000|Treatment Period|Physician Decision|0|||
16281718|NCT03310619|39514144|FG001|Treatment Period|Physician Decision|0|||
16281719|NCT03310619|39514145|FG002|Treatment Period|Physician Decision|0|||
16281720|NCT03310619|39514146|FG003|Treatment Period|Physician Decision|0|||
16281721|NCT03310619|39514147|FG004|Treatment Period|Physician Decision|3|||
16281722|NCT03310619|39514148|FG005|Treatment Period|Physician Decision|0|||
16281723|NCT03310619|39514149|FG006|Treatment Period|Physician Decision|0|||
16281724|NCT03310619|39514150|FG007|Treatment Period|Physician Decision|0|||
16281725|NCT03310619|39514143|FG000|Treatment Period|Other reasons|1|||
16281726|NCT03310619|39514144|FG001|Treatment Period|Other reasons|0|||
16281727|NCT03310619|39514145|FG002|Treatment Period|Other reasons|2|||
16281728|NCT03310619|39514146|FG003|Treatment Period|Other reasons|0|||
16281729|NCT03310619|39514147|FG004|Treatment Period|Other reasons|0|||
16281730|NCT03310619|39514148|FG005|Treatment Period|Other reasons|0|||
16281731|NCT03310619|39514149|FG006|Treatment Period|Other reasons|0|||
16281732|NCT03310619|39514150|FG007|Treatment Period|Other reasons|0|||
16379710|NCT03142334|39874744|FG000|Overall Study|Ongoing on trial follow up|463|||
16479447|NCT02264639|40234312|FG004|Overall Study|Death (after completing single-dose phase)|0|||
16479448|NCT02264639|40234308|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
16479449|NCT02264639|40234309|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
16479450|NCT02264639|40234310|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
16479451|NCT02264639|40234311|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
16479452|NCT02264639|40234312|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
16479453|NCT02264639|40234308|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
16479454|NCT02264639|40234309|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
16479455|NCT02264639|40234310|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
16479456|NCT02264639|40234311|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
16479457|NCT02264639|40234312|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
16479458|NCT02264639|40234308|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
16479459|NCT02264639|40234309|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
16479460|NCT02264639|40234310|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
16479461|NCT02264639|40234311|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
16479462|NCT02264639|40234312|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
16479463|NCT00622284|40234313|FG000|Overall Study|Lack of Efficacy|45|||
16479464|NCT00622284|40234314|FG001|Overall Study|Lack of Efficacy|15|||
16479465|NCT00622284|40234313|FG000|Overall Study|Adverse Event|61|||
16479466|NCT00622284|40234314|FG001|Overall Study|Adverse Event|90|||
16281733|NCT03417830|39514152|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
16281734|NCT03417830|39514153|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
16281735|NCT00808509|39514154|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
16281736|NCT00808509|39514155|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
16281737|NCT00808509|39514154|FG000|Randomized Phase|Reduced methotrexate dose|1|||
16281738|NCT00808509|39514155|FG001|Randomized Phase|Reduced methotrexate dose|2|||
16281739|NCT00808509|39514154|FG000|Randomized Phase|Patient refused rescue therapy|0|||
16479467|NCT00622284|40234313|FG000|Overall Study|Protocol Violation|12|||
16479468|NCT00622284|40234314|FG001|Overall Study|Protocol Violation|5|||
16479469|NCT00622284|40234313|FG000|Overall Study|Lost to Follow-up|11|||
16479470|NCT00622284|40234314|FG001|Overall Study|Lost to Follow-up|13|||
16479471|NCT00622284|40234313|FG000|Overall Study|Withdrawal by Subject|27|||
16281740|NCT00808509|39514155|FG001|Randomized Phase|Patient refused rescue therapy|3|||
16281741|NCT01009515|39514156|FG000|Overall Study|Withdrawal by Subject|3|||
16281742|NCT02147587|39514157|FG000|Overall Study|Adverse Event|9|||
16281743|NCT02147587|39514158|FG001|Overall Study|Adverse Event|4|||
16281744|NCT02147587|39514157|FG000|Overall Study|Lack of Efficacy|2|||
16281745|NCT02147587|39514158|FG001|Overall Study|Lack of Efficacy|1|||
16281746|NCT01610063|39514159|FG000|Overall Study|Lost to Follow-up|42|||
16281747|NCT01610063|39514160|FG001|Overall Study|Lost to Follow-up|20|||
16281748|NCT01961687|39514161|FG000|Overall Study|Lost to Follow-up|19|||
16281749|NCT01961687|39514161|FG000|Overall Study|Re-operation|17|||
16281750|NCT01961687|39514161|FG000|Overall Study|Death|7|||
16281751|NCT01961687|39514161|FG000|Overall Study|Withdrawal by Subject|6|||
16281752|NCT01961687|39514161|FG000|Overall Study|Adverse Event|6|||
16281753|NCT01961687|39514161|FG000|Overall Study|Moved to area without study site|2|||
16281754|NCT01961687|39514161|FG000|Overall Study|Sponsor decision|2|||
16281755|NCT01961687|39514161|FG000|Overall Study|Physician Decision|1|||
16281756|NCT01961687|39514161|FG000|Overall Study|Unable to meet follow-up requirements|1|||
16281757|NCT00255151|39514162|FG000|Overall Study|Adverse Event|10|||
16281758|NCT00255151|39514163|FG001|Overall Study|Adverse Event|6|||
16281759|NCT00255151|39514164|FG002|Overall Study|Adverse Event|9|||
16281760|NCT00255151|39514162|FG000|Overall Study|Lost to Follow-up|4|||
16281761|NCT00255151|39514163|FG001|Overall Study|Lost to Follow-up|3|||
16281762|NCT00255151|39514164|FG002|Overall Study|Lost to Follow-up|4|||
16281763|NCT00255151|39514162|FG000|Overall Study|Withdrawal by Subject|18|||
16281764|NCT00255151|39514163|FG001|Overall Study|Withdrawal by Subject|17|||
16281765|NCT00255151|39514164|FG002|Overall Study|Withdrawal by Subject|8|||
16281766|NCT00255151|39514162|FG000|Overall Study|Noncompliance|0|||
16281767|NCT00255151|39514163|FG001|Overall Study|Noncompliance|1|||
16281768|NCT00255151|39514164|FG002|Overall Study|Noncompliance|2|||
16281769|NCT00255151|39514162|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
16281770|NCT00255151|39514163|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
16281771|NCT00255151|39514164|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
16281772|NCT00255151|39514162|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
16281773|NCT00255151|39514163|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
16281774|NCT00255151|39514164|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
16281775|NCT00255151|39514162|FG000|Overall Study|Possible Barrett's Esophagus|1|||
16281776|NCT00255151|39514163|FG001|Overall Study|Possible Barrett's Esophagus|3|||
16281777|NCT00255151|39514164|FG002|Overall Study|Possible Barrett's Esophagus|8|||
16281778|NCT00255151|39514162|FG000|Overall Study|Esophageal Stricture|0|||
16281779|NCT00255151|39514163|FG001|Overall Study|Esophageal Stricture|0|||
16281780|NCT00255151|39514164|FG002|Overall Study|Esophageal Stricture|1|||
16281781|NCT00255151|39514162|FG000|Overall Study|Therapeutic Failure|11|||
16281782|NCT00255151|39514163|FG001|Overall Study|Therapeutic Failure|2|||
16281783|NCT00255151|39514164|FG002|Overall Study|Therapeutic Failure|3|||
16281784|NCT00631007|39514165|FG000|Overall Study|Adverse Event|0|||
16281785|NCT00631007|39514166|FG001|Overall Study|Adverse Event|2|||
16281786|NCT00631007|39514167|FG002|Overall Study|Adverse Event|0|||
16281787|NCT00631007|39514168|FG003|Overall Study|Adverse Event|2|||
16281788|NCT00631007|39514169|FG004|Overall Study|Adverse Event|3|||
16281789|NCT00631007|39514170|FG005|Overall Study|Adverse Event|2|||
16281790|NCT00631007|39514165|FG000|Overall Study|Lost to Follow-up|2|||
16281791|NCT00631007|39514166|FG001|Overall Study|Lost to Follow-up|1|||
16281792|NCT00631007|39514167|FG002|Overall Study|Lost to Follow-up|2|||
16281793|NCT00631007|39514168|FG003|Overall Study|Lost to Follow-up|4|||
16281794|NCT00631007|39514169|FG004|Overall Study|Lost to Follow-up|5|||
16281795|NCT00631007|39514170|FG005|Overall Study|Lost to Follow-up|3|||
16281796|NCT00631007|39514165|FG000|Overall Study|Physician Decision|1|||
16281797|NCT00631007|39514166|FG001|Overall Study|Physician Decision|0|||
16281798|NCT00631007|39514167|FG002|Overall Study|Physician Decision|1|||
16281799|NCT00631007|39514168|FG003|Overall Study|Physician Decision|0|||
16281800|NCT00631007|39514169|FG004|Overall Study|Physician Decision|0|||
16281801|NCT00631007|39514170|FG005|Overall Study|Physician Decision|2|||
16281802|NCT00631007|39514165|FG000|Overall Study|Persistent Hyperglycemia|2|||
16281803|NCT00631007|39514166|FG001|Overall Study|Persistent Hyperglycemia|2|||
16281804|NCT00631007|39514167|FG002|Overall Study|Persistent Hyperglycemia|5|||
16479472|NCT00622284|40234314|FG001|Overall Study|Withdrawal by Subject|24|||
16281805|NCT00631007|39514168|FG003|Overall Study|Persistent Hyperglycemia|1|||
16281806|NCT00631007|39514169|FG004|Overall Study|Persistent Hyperglycemia|2|||
16281807|NCT00631007|39514170|FG005|Overall Study|Persistent Hyperglycemia|5|||
16281808|NCT00631007|39514165|FG000|Overall Study|Withdrawal by Subject|4|||
16281809|NCT00631007|39514166|FG001|Overall Study|Withdrawal by Subject|5|||
16281810|NCT00631007|39514167|FG002|Overall Study|Withdrawal by Subject|2|||
16281811|NCT00631007|39514168|FG003|Overall Study|Withdrawal by Subject|2|||
16281812|NCT00631007|39514169|FG004|Overall Study|Withdrawal by Subject|1|||
16281813|NCT00631007|39514170|FG005|Overall Study|Withdrawal by Subject|3|||
16281814|NCT00631007|39514165|FG000|Overall Study|Other|2|||
16281815|NCT00631007|39514166|FG001|Overall Study|Other|1|||
16281816|NCT00631007|39514167|FG002|Overall Study|Other|0|||
16281817|NCT00631007|39514168|FG003|Overall Study|Other|0|||
16281818|NCT00631007|39514169|FG004|Overall Study|Other|1|||
16281819|NCT00631007|39514170|FG005|Overall Study|Other|0|||
16281820|NCT04126343|39514172|FG000|Overall Study|Adverse Event|0|||
16281821|NCT04126343|39514173|FG001|Overall Study|Adverse Event|0|||
16281822|NCT04126343|39514174|FG002|Overall Study|Adverse Event|0|||
16281823|NCT04126343|39514175|FG003|Overall Study|Adverse Event|0|||
16281824|NCT04126343|39514176|FG004|Overall Study|Adverse Event|0|||
16281825|NCT04126343|39514177|FG005|Overall Study|Adverse Event|1|||
16281826|NCT04126343|39514172|FG000|Overall Study|Withdrawal by Subject|0|||
16281827|NCT04126343|39514173|FG001|Overall Study|Withdrawal by Subject|0|||
16281828|NCT04126343|39514174|FG002|Overall Study|Withdrawal by Subject|0|||
16281829|NCT04126343|39514175|FG003|Overall Study|Withdrawal by Subject|1|||
16281830|NCT04126343|39514176|FG004|Overall Study|Withdrawal by Subject|0|||
16281831|NCT04126343|39514177|FG005|Overall Study|Withdrawal by Subject|0|||
16281832|NCT04126343|39514172|FG000|Overall Study|Related to COVID-19 pandemic|3|||
16281833|NCT04126343|39514173|FG001|Overall Study|Related to COVID-19 pandemic|4|||
16281834|NCT04126343|39514174|FG002|Overall Study|Related to COVID-19 pandemic|3|||
16281835|NCT04126343|39514175|FG003|Overall Study|Related to COVID-19 pandemic|3|||
16281836|NCT04126343|39514176|FG004|Overall Study|Related to COVID-19 pandemic|3|||
16281837|NCT04126343|39514177|FG005|Overall Study|Related to COVID-19 pandemic|3|||
16281838|NCT01937351|39514179|FG000|Overall Study|Withdrawal by Subject|4|||
16281839|NCT01937351|39514180|FG001|Overall Study|Withdrawal by Subject|2|||
16281840|NCT01937351|39514179|FG000|Overall Study|Death|1|||
16281841|NCT01937351|39514180|FG001|Overall Study|Death|0|||
16281842|NCT01937351|39514179|FG000|Overall Study|Not treated w device, per protocol fail|4|||
16281843|NCT01937351|39514180|FG001|Overall Study|Not treated w device, per protocol fail|0|||
16281844|NCT03785145|39514183|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
16281845|NCT03785145|39514184|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
16281846|NCT03785145|39514183|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
16281847|NCT03785145|39514184|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
16281848|NCT03785145|39514183|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
16281849|NCT03785145|39514184|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
16281850|NCT03785145|39514183|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
16281851|NCT03785145|39514184|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
16281852|NCT03785145|39514183|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
16281853|NCT03785145|39514184|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
16281854|NCT03785145|39514183|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
16281855|NCT03785145|39514184|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
16281856|NCT03785145|39514183|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
16281857|NCT03785145|39514184|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
16281858|NCT03785145|39514183|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
16281859|NCT03785145|39514184|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
16281860|NCT03785145|39514183|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
16281861|NCT03785145|39514184|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
16281862|NCT03785145|39514183|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
16281863|NCT03785145|39514184|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
16281864|NCT03785145|39514183|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
16281865|NCT03785145|39514184|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
16281866|NCT03166124|39514185|FG000|Treatment Period 1|Adverse Event|0|||
16281867|NCT03166124|39514186|FG001|Treatment Period 1|Adverse Event|0|||
16281868|NCT03166124|39514187|FG002|Treatment Period 1|Adverse Event|1|||
16281869|NCT03166124|39514188|FG003|Treatment Period 1|Adverse Event|0|||
16281870|NCT03166124|39514185|FG000|Wash-out Period|Withdrawal by Subject|0|||
16281871|NCT03166124|39514186|FG001|Wash-out Period|Withdrawal by Subject|1|||
16281872|NCT03166124|39514187|FG002|Wash-out Period|Withdrawal by Subject|0|||
16281873|NCT03166124|39514188|FG003|Wash-out Period|Withdrawal by Subject|1|||
16281874|NCT03166124|39514185|FG000|Wash-out Period|Adverse Event|0|||
16281875|NCT03166124|39514186|FG001|Wash-out Period|Adverse Event|1|||
16281876|NCT03166124|39514187|FG002|Wash-out Period|Adverse Event|1|||
16379711|NCT03142334|39874745|FG001|Overall Study|Ongoing on trial follow up|454|||
16281877|NCT03166124|39514188|FG003|Wash-out Period|Adverse Event|0|||
16281878|NCT00099268|39514193|FG000|Overall Study|Withdrawal by Subject|46|||
16281879|NCT00099268|39514194|FG001|Overall Study|Withdrawal by Subject|28|||
16379712|NCT02278003|39874746|FG000|Overall Study|Withdrawal by Subject|11|||
16379713|NCT02278003|39874747|FG001|Overall Study|Withdrawal by Subject|0|||
16281880|NCT00099268|39514193|FG000|Overall Study|Adverse Event|19|||
16281881|NCT00099268|39514194|FG001|Overall Study|Adverse Event|19|||
16281882|NCT00099268|39514193|FG000|Overall Study|Protocol Violation|9|||
16281883|NCT00099268|39514194|FG001|Overall Study|Protocol Violation|8|||
16281884|NCT00099268|39514193|FG000|Overall Study|Lost to Follow-up|6|||
16281885|NCT00099268|39514194|FG001|Overall Study|Lost to Follow-up|4|||
16281886|NCT00099268|39514193|FG000|Overall Study|Lack of Efficacy|5|||
16281887|NCT00099268|39514194|FG001|Overall Study|Lack of Efficacy|18|||
16281888|NCT00099268|39514193|FG000|Overall Study|Administrative problems|4|||
16281889|NCT00099268|39514194|FG001|Overall Study|Administrative problems|4|||
16281890|NCT00099268|39514193|FG000|Overall Study|Death|3|||
16281891|NCT00099268|39514194|FG001|Overall Study|Death|1|||
16281892|NCT00865098|39514197|FG000|Overall Study|Progressive disease|1|||
16281893|NCT01894230|39514202|FG000|Overall Study|Lost to Follow-up|2|||
16281894|NCT01894230|39514203|FG001|Overall Study|Lost to Follow-up|2|||
16281895|NCT01894230|39514202|FG000|Overall Study|Withdrawal by Subject|4|||
16281896|NCT01894230|39514203|FG001|Overall Study|Withdrawal by Subject|4|||
16281897|NCT01894230|39514202|FG000|Overall Study|Non-adherent|0|||
16281898|NCT01894230|39514203|FG001|Overall Study|Non-adherent|1|||
16281899|NCT01894230|39514202|FG000|Overall Study|Death|1|||
16281900|NCT01894230|39514203|FG001|Overall Study|Death|0|||
16281901|NCT00115934|39514204|FG000|Overall Study|Lost to Follow-up|1|||
16281902|NCT00115934|39514205|FG001|Overall Study|Lost to Follow-up|0|||
16281903|NCT00115934|39514204|FG000|Overall Study|Did not receive intervention|3|||
16281904|NCT00115934|39514205|FG001|Overall Study|Did not receive intervention|2|||
16281905|NCT00754052|39514206|FG000|Overall Study|Study terminated by Sponsor|5|||
16281906|NCT00754052|39514207|FG001|Overall Study|Study terminated by Sponsor|3|||
16281907|NCT01552369|39514215|FG000|Overall Study|Did not consent to extended follow up|8|||
16281908|NCT01552369|39514216|FG001|Overall Study|Did not consent to extended follow up|9|||
16281909|NCT02274948|39514219|FG000|Overall Study|Lost to Follow-up|28|||
16281910|NCT02274948|39514220|FG001|Overall Study|Lost to Follow-up|25|||
16281911|NCT02274948|39514219|FG000|Overall Study|Withdrawal by Subject|64|||
16281912|NCT02274948|39514220|FG001|Overall Study|Withdrawal by Subject|58|||
16281913|NCT02274948|39514219|FG000|Overall Study|Stopped on family Practitioner advice|2|||
16281914|NCT02274948|39514220|FG001|Overall Study|Stopped on family Practitioner advice|5|||
16281915|NCT02274948|39514219|FG000|Overall Study|Left the area|4|||
16479473|NCT00622284|40234313|FG000|Overall Study|Other reason (not specified)|33|||
16479474|NCT00622284|40234314|FG001|Overall Study|Other reason (not specified)|24|||
16479475|NCT02008318|40234315|FG000|Overall Study|Adverse Event|4|||
16479476|NCT02008318|40234316|FG001|Overall Study|Adverse Event|0|||
16479477|NCT02008318|40234315|FG000|Overall Study|Physician Decision|2|||
16479478|NCT02008318|40234316|FG001|Overall Study|Physician Decision|0|||
16479479|NCT02008318|40234315|FG000|Overall Study|Progressive Disease|2|||
16479480|NCT02008318|40234316|FG001|Overall Study|Progressive Disease|0|||
16479481|NCT02008318|40234315|FG000|Overall Study|Protocol Violation|1|||
16479482|NCT02008318|40234316|FG001|Overall Study|Protocol Violation|1|||
16479483|NCT02008318|40234315|FG000|Overall Study|Withdrawal by Subject|3|||
16479484|NCT02008318|40234316|FG001|Overall Study|Withdrawal by Subject|0|||
16479485|NCT01390649|40234327|FG000|Overall Study|Physician Decision|1|||
16479486|NCT01042678|40234328|FG000|Overall Study|Physician Decision|1|||
16479487|NCT01042678|40234329|FG001|Overall Study|Physician Decision|0|||
16479488|NCT01042678|40234330|FG002|Overall Study|Physician Decision|0|||
16479489|NCT01042678|40234331|FG003|Overall Study|Physician Decision|0|||
16281916|NCT02274948|39514220|FG001|Overall Study|Left the area|3|||
16281917|NCT01103479|39514221|FG000|Overall Study|Up to date with CRC screening|1|||
16281918|NCT01103479|39514222|FG001|Overall Study|Up to date with CRC screening|9|||
16281919|NCT01103479|39514223|FG002|Overall Study|Up to date with CRC screening|12|||
16281920|NCT01103479|39514221|FG000|Overall Study|Family history of CRC|1|||
16281921|NCT01103479|39514222|FG001|Overall Study|Family history of CRC|0|||
16281922|NCT01103479|39514223|FG002|Overall Study|Family history of CRC|2|||
16281923|NCT01103479|39514221|FG000|Overall Study|Active cancer|1|||
16281924|NCT01103479|39514222|FG001|Overall Study|Active cancer|0|||
16281925|NCT01103479|39514223|FG002|Overall Study|Active cancer|0|||
16281926|NCT01103479|39514221|FG000|Overall Study|Saw non-study physician|2|||
16281927|NCT01103479|39514222|FG001|Overall Study|Saw non-study physician|0|||
16281928|NCT01103479|39514223|FG002|Overall Study|Saw non-study physician|0|||
16281929|NCT02413294|39514228|FG000|Overall Study|Withdrawal by Subject|1|||
16281930|NCT00124462|39514229|FG000|Overall Study|Lost to Follow-up|3|||
16479490|NCT01042678|40234332|FG004|Overall Study|Physician Decision|0|||
16479491|NCT01042678|40234333|FG005|Overall Study|Physician Decision|0|||
16479492|NCT01386008|40234334|FG000|Overall Study|exited w/o incident /study discontinued|17|||
16281931|NCT00124462|39514230|FG001|Overall Study|Lost to Follow-up|3|||
16281932|NCT00124462|39514229|FG000|Overall Study|Physician Decision|3|||
16281933|NCT00124462|39514230|FG001|Overall Study|Physician Decision|4|||
16281934|NCT00124462|39514229|FG000|Overall Study|Withdrawal by Subject|4|||
16281935|NCT00124462|39514230|FG001|Overall Study|Withdrawal by Subject|5|||
16479493|NCT01386008|40234334|FG000|Overall Study|Adverse Event|3|||
16479494|NCT02663908|40234335|FG000|Overall Study|Withdrawal by Subject|8|||
16281936|NCT00124462|39514229|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
16281937|NCT00124462|39514230|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
16281938|NCT01662362|39514233|FG000|Overall Study|Lost to Follow-up|38|||
16281939|NCT02443324|39514234|FG000|Overall Study|Death|4|||
16281940|NCT02443324|39514235|FG001|Overall Study|Death|1|||
16281941|NCT02443324|39514236|FG002|Overall Study|Death|0|||
16281942|NCT02443324|39514237|FG003|Overall Study|Death|3|||
16281943|NCT02443324|39514238|FG004|Overall Study|Death|1|||
16281944|NCT02443324|39514239|FG005|Overall Study|Death|3|||
16281945|NCT02443324|39514240|FG006|Overall Study|Death|2|||
16281946|NCT02443324|39514234|FG000|Overall Study|Lost to Follow-up|0|||
16281947|NCT02443324|39514235|FG001|Overall Study|Lost to Follow-up|0|||
16281948|NCT02443324|39514236|FG002|Overall Study|Lost to Follow-up|0|||
16281949|NCT02443324|39514237|FG003|Overall Study|Lost to Follow-up|1|||
16281950|NCT02443324|39514238|FG004|Overall Study|Lost to Follow-up|0|||
16281951|NCT02443324|39514239|FG005|Overall Study|Lost to Follow-up|1|||
16281952|NCT02443324|39514240|FG006|Overall Study|Lost to Follow-up|0|||
16281953|NCT02443324|39514234|FG000|Overall Study|Physician Decision|0|||
16281954|NCT02443324|39514235|FG001|Overall Study|Physician Decision|3|||
16281955|NCT02443324|39514236|FG002|Overall Study|Physician Decision|5|||
16281956|NCT02443324|39514237|FG003|Overall Study|Physician Decision|1|||
16281957|NCT02443324|39514238|FG004|Overall Study|Physician Decision|1|||
16281958|NCT02443324|39514239|FG005|Overall Study|Physician Decision|0|||
16281959|NCT02443324|39514240|FG006|Overall Study|Physician Decision|2|||
16281960|NCT02443324|39514234|FG000|Overall Study|Progressive Disease|20|||
16281961|NCT02443324|39514235|FG001|Overall Study|Progressive Disease|20|||
16281962|NCT02443324|39514236|FG002|Overall Study|Progressive Disease|13|||
16281963|NCT02443324|39514237|FG003|Overall Study|Progressive Disease|10|||
16281964|NCT02443324|39514238|FG004|Overall Study|Progressive Disease|13|||
16281965|NCT02443324|39514239|FG005|Overall Study|Progressive Disease|17|||
16281966|NCT02443324|39514240|FG006|Overall Study|Progressive Disease|10|||
16281967|NCT02443324|39514234|FG000|Overall Study|Withdrawal by Subject|0|||
16281968|NCT02443324|39514235|FG001|Overall Study|Withdrawal by Subject|0|||
16281969|NCT02443324|39514236|FG002|Overall Study|Withdrawal by Subject|3|||
16281970|NCT02443324|39514237|FG003|Overall Study|Withdrawal by Subject|1|||
16479495|NCT02663908|40234336|FG001|Overall Study|Withdrawal by Subject|5|||
16479496|NCT02663908|40234335|FG000|Overall Study|Lost to Follow-up|1|||
16479497|NCT02663908|40234336|FG001|Overall Study|Lost to Follow-up|5|||
16479498|NCT02663908|40234335|FG000|Overall Study|Adverse Event|13|||
16479499|NCT02663908|40234336|FG001|Overall Study|Adverse Event|11|||
16479500|NCT02663908|40234335|FG000|Overall Study|Protocol Violation|1|||
16479501|NCT02663908|40234336|FG001|Overall Study|Protocol Violation|2|||
16479502|NCT02663908|40234335|FG000|Overall Study|Lack of therapeutic response|2|||
16479503|NCT02663908|40234336|FG001|Overall Study|Lack of therapeutic response|0|||
16479504|NCT02663908|40234335|FG000|Overall Study|COVID-19|1|||
16479505|NCT02663908|40234336|FG001|Overall Study|COVID-19|0|||
16479506|NCT02663908|40234335|FG000|Overall Study|Site closed|1|||
16479507|NCT02663908|40234336|FG001|Overall Study|Site closed|0|||
16479508|NCT02663908|40234335|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
16479509|NCT02663908|40234336|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
16479510|NCT02663908|40234335|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
16479511|NCT02663908|40234336|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
16479512|NCT02663908|40234335|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
16479513|NCT02663908|40234336|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
16479514|NCT02663908|40234335|FG000|Overall Study|Death|1|||
16479515|NCT02663908|40234336|FG001|Overall Study|Death|0|||
16281971|NCT02443324|39514238|FG004|Overall Study|Withdrawal by Subject|1|||
16281972|NCT02443324|39514239|FG005|Overall Study|Withdrawal by Subject|0|||
16281973|NCT02443324|39514240|FG006|Overall Study|Withdrawal by Subject|1|||
16281974|NCT02443324|39514234|FG000|Overall Study|Adverse Event|0|||
16281975|NCT02443324|39514235|FG001|Overall Study|Adverse Event|1|||
16281976|NCT02443324|39514236|FG002|Overall Study|Adverse Event|3|||
16479516|NCT02663908|40234335|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
16479517|NCT02663908|40234336|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
16479518|NCT02663908|40234335|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
16479519|NCT02663908|40234336|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
16479520|NCT03307785|40234337|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
16281977|NCT02443324|39514237|FG003|Overall Study|Adverse Event|0|||
16281978|NCT02443324|39514238|FG004|Overall Study|Adverse Event|4|||
16281979|NCT02443324|39514239|FG005|Overall Study|Adverse Event|3|||
16281980|NCT02443324|39514240|FG006|Overall Study|Adverse Event|3|||
16281981|NCT02443324|39514234|FG000|Overall Study|Enrolled but Never Treated|0|||
16281982|NCT02443324|39514235|FG001|Overall Study|Enrolled but Never Treated|0|||
16281983|NCT02443324|39514236|FG002|Overall Study|Enrolled but Never Treated|1|||
16281984|NCT02443324|39514237|FG003|Overall Study|Enrolled but Never Treated|0|||
16281985|NCT02443324|39514238|FG004|Overall Study|Enrolled but Never Treated|1|||
16281986|NCT02443324|39514239|FG005|Overall Study|Enrolled but Never Treated|0|||
16281987|NCT02443324|39514240|FG006|Overall Study|Enrolled but Never Treated|1|||
16281988|NCT00775528|39514243|FG000|Overall Study|Protocol Violation|1|||
16281989|NCT00763555|39514244|FG000|Overall Study|Adverse Event|2|||
16281990|NCT00763555|39514245|FG001|Overall Study|Adverse Event|1|||
16479521|NCT03307785|40234338|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
16479522|NCT03307785|40234339|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
16281991|NCT00763555|39514244|FG000|Overall Study|Withdrawal by Subject|2|||
16281992|NCT00763555|39514245|FG001|Overall Study|Withdrawal by Subject|6|||
16281993|NCT00763555|39514244|FG000|Overall Study|Lost to Follow-up|0|||
16281994|NCT00763555|39514245|FG001|Overall Study|Lost to Follow-up|3|||
16281995|NCT01717040|39514246|FG000|Overall Study|Lost to Follow-up|2|||
16281996|NCT01717040|39514247|FG001|Overall Study|Lost to Follow-up|3|||
16281997|NCT01717040|39514246|FG000|Overall Study|Lack of Efficacy|1|||
16281998|NCT01717040|39514247|FG001|Overall Study|Lack of Efficacy|1|||
16281999|NCT01717040|39514246|FG000|Overall Study|Adverse Event|1|||
16282000|NCT01717040|39514247|FG001|Overall Study|Adverse Event|0|||
16282001|NCT01717040|39514246|FG000|Overall Study|Required Medication Change|0|||
16282002|NCT01717040|39514247|FG001|Overall Study|Required Medication Change|1|||
16282003|NCT01717040|39514246|FG000|Overall Study|New Substance Use Disorder|1|||
16282004|NCT01717040|39514247|FG001|Overall Study|New Substance Use Disorder|0|||
16282005|NCT05069155|39514248|FG000|Overall Study|Withdrawal by Subject|1|||
16282006|NCT05069155|39514249|FG001|Overall Study|Withdrawal by Subject|3|||
16282007|NCT00460109|39514250|FG000|Overall Study|Death|1|||
16282008|NCT03078478|39514253|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
16282009|NCT03078478|39514254|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
16282010|NCT03078478|39514253|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
16282011|NCT03078478|39514254|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
16282012|NCT03078478|39514253|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
16282013|NCT03078478|39514254|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
16282014|NCT03078478|39514253|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
16282015|NCT03078478|39514254|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
16282016|NCT03078478|39514253|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
16282017|NCT03078478|39514254|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
16282018|NCT03078478|39514253|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
16282019|NCT03078478|39514254|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
16282020|NCT03078478|39514253|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
16282021|NCT03078478|39514254|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
16282022|NCT03078478|39514253|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
16282023|NCT03078478|39514254|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
16282024|NCT03401073|39514260|FG000|Overall Study|Lost to Follow-up|1|||
16282025|NCT03401073|39514261|FG001|Overall Study|Lost to Follow-up|2|||
16282026|NCT03170869|39514262|FG000|Overall Study|Protocol Violation|5|||
16282027|NCT03170869|39514262|FG000|Overall Study|Early study termination|3|||
16282028|NCT01253317|39514266|FG000|Overall Study|Adverse Event|2|||
16282029|NCT00977431|39514268|FG000|Overall Study|Other than listed|1|||
16282030|NCT00977431|39514269|FG001|Overall Study|Other than listed|0|||
16282031|NCT00977431|39514270|FG002|Overall Study|Other than listed|0|||
16282032|NCT00977431|39514271|FG003|Overall Study|Other than listed|0|||
16282033|NCT00977431|39514272|FG004|Overall Study|Other than listed|2|||
16282034|NCT00977431|39514268|FG000|Overall Study|Protocol Violation|0|||
16282035|NCT00977431|39514269|FG001|Overall Study|Protocol Violation|0|||
16282036|NCT00977431|39514270|FG002|Overall Study|Protocol Violation|1|||
16282037|NCT00977431|39514271|FG003|Overall Study|Protocol Violation|0|||
16282038|NCT00977431|39514272|FG004|Overall Study|Protocol Violation|0|||
16282039|NCT00977431|39514268|FG000|Overall Study|Adverse Event|3|||
16479523|NCT03307785|40234340|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
16479524|NCT03307785|40234341|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
16479525|NCT03307785|40234342|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
16479526|NCT03307785|40234343|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
16479527|NCT03307785|40234344|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
16479528|NCT03307785|40234345|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
16479529|NCT03307785|40234346|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
16282040|NCT00977431|39514269|FG001|Overall Study|Adverse Event|0|||
16282041|NCT00977431|39514270|FG002|Overall Study|Adverse Event|4|||
16282042|NCT00977431|39514271|FG003|Overall Study|Adverse Event|0|||
16282043|NCT00977431|39514272|FG004|Overall Study|Adverse Event|6|||
16282044|NCT00977431|39514268|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
16282045|NCT00977431|39514269|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
16282046|NCT00977431|39514270|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
16379714|NCT02278003|39874746|FG000|Overall Study|Not Treated|1|||
16479530|NCT03307785|40234347|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
16479531|NCT03307785|40234337|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
16282047|NCT00977431|39514271|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
16282048|NCT00977431|39514272|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
16282049|NCT00977431|39514268|FG000|Overall Study|Progressive disease|2|||
16282050|NCT00977431|39514269|FG001|Overall Study|Progressive disease|6|||
16282051|NCT00977431|39514270|FG002|Overall Study|Progressive disease|1|||
16282052|NCT00977431|39514271|FG003|Overall Study|Progressive disease|3|||
16282053|NCT00977431|39514272|FG004|Overall Study|Progressive disease|5|||
16282054|NCT02972515|39514273|FG000|Overall Study|Lost to Follow-up|78|||
16282055|NCT00784979|39514274|FG000|Overall Study|incomplete data|6|||
16282056|NCT00399893|39514275|FG000|Overall Study|Withdrawal by Subject|1|||
16282057|NCT00399893|39514276|FG001|Overall Study|Withdrawal by Subject|0|||
16282058|NCT03554317|39514278|FG000|Overall Study|Withdrawal by Subject|1|||
16282059|NCT03554317|39514278|FG000|Overall Study|PSA Progression|3|||
16282060|NCT03554317|39514278|FG000|Overall Study|Radiographic Progression|4|||
16282061|NCT00830167|39514284|FG000|Overall Study|Lack of Efficacy|26|||
16282062|NCT00830167|39514285|FG001|Overall Study|Lack of Efficacy|10|||
16282063|NCT00830167|39514284|FG000|Overall Study|Adverse Event|8|||
16282064|NCT00830167|39514285|FG001|Overall Study|Adverse Event|24|||
16282065|NCT00830167|39514284|FG000|Overall Study|Not meeting entrance criteria|2|||
16282066|NCT00830167|39514285|FG001|Overall Study|Not meeting entrance criteria|5|||
16282067|NCT00830167|39514284|FG000|Overall Study|Withdrawal by Subject|2|||
16282068|NCT00830167|39514285|FG001|Overall Study|Withdrawal by Subject|0|||
16282069|NCT00830167|39514284|FG000|Overall Study|Lost to Follow-up|0|||
16282070|NCT00830167|39514285|FG001|Overall Study|Lost to Follow-up|1|||
16282071|NCT00830167|39514284|FG000|Overall Study|Protocol Violation|0|||
16282072|NCT00830167|39514285|FG001|Overall Study|Protocol Violation|1|||
16282073|NCT00830167|39514284|FG000|Overall Study|Other|2|||
16282074|NCT00830167|39514285|FG001|Overall Study|Other|2|||
16282075|NCT02563769|39514286|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
16282076|NCT02563769|39514287|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
16282077|NCT02563769|39514288|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
16282078|NCT00508027|39514289|FG000|Dose Level 1|Lost to Follow-up|4|||
16282079|NCT00508027|39514289|FG000|Dose Level 1|Withdrawal by Subject|2|||
16282080|NCT00508027|39514289|FG000|Dose Level 1|Physician Decision|2|||
16282081|NCT00508027|39514289|FG000|Dose Level 2|Lost to Follow-up|2|||
16282082|NCT00508027|39514289|FG000|Dose Level 2|Withdrawal by Subject|2|||
16282083|NCT00857818|39514290|FG000|Overall Study|Lack of Efficacy|1|||
16282084|NCT00857818|39514291|FG001|Overall Study|Lack of Efficacy|0|||
16282085|NCT00857818|39514290|FG000|Overall Study|Adverse Event|3|||
16282086|NCT00857818|39514291|FG001|Overall Study|Adverse Event|0|||
16282087|NCT00857818|39514290|FG000|Overall Study|Withdrawal by Subject|0|||
16282088|NCT00857818|39514291|FG001|Overall Study|Withdrawal by Subject|4|||
16282089|NCT00857818|39514290|FG000|Overall Study|Sponsor terminated study|6|||
16282090|NCT00857818|39514291|FG001|Overall Study|Sponsor terminated study|4|||
16282091|NCT00857818|39514290|FG000|Overall Study|Investigator decision|1|||
16282092|NCT00857818|39514291|FG001|Overall Study|Investigator decision|0|||
16282093|NCT02985398|39514292|FG000|Overall Study|Adverse Event|1|||
16282094|NCT02985398|39514292|FG000|Overall Study|Lost to Follow-up|4|||
16479532|NCT03307785|40234338|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
16479533|NCT03307785|40234339|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
16479534|NCT03307785|40234340|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
16479535|NCT03307785|40234341|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
16479536|NCT03307785|40234342|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
16479537|NCT03307785|40234343|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
16479538|NCT03307785|40234344|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
16479539|NCT03307785|40234345|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
16479540|NCT03307785|40234346|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
16479541|NCT03307785|40234347|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
16479542|NCT03307785|40234337|FG000|Part A: Up to 28.5 Months|Death|4|||
16479543|NCT03307785|40234338|FG001|Part A: Up to 28.5 Months|Death|4|||
16479544|NCT03307785|40234339|FG002|Part A: Up to 28.5 Months|Death|0|||
16479545|NCT03307785|40234340|FG003|Part A: Up to 28.5 Months|Death|0|||
16479546|NCT03307785|40234341|FG004|Part A: Up to 28.5 Months|Death|0|||
16479547|NCT03307785|40234342|FG005|Part A: Up to 28.5 Months|Death|0|||
16479548|NCT03307785|40234343|FG006|Part A: Up to 28.5 Months|Death|0|||
16479549|NCT03307785|40234344|FG007|Part A: Up to 28.5 Months|Death|0|||
16479550|NCT03307785|40234345|FG008|Part A: Up to 28.5 Months|Death|0|||
16479551|NCT03307785|40234346|FG009|Part A: Up to 28.5 Months|Death|0|||
16479552|NCT03307785|40234347|FG010|Part A: Up to 28.5 Months|Death|0|||
16479553|NCT03307785|40234337|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
16479554|NCT03307785|40234338|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
16479555|NCT03307785|40234339|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
16479556|NCT03307785|40234340|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
16282095|NCT02985398|39514292|FG000|Overall Study|Withdrawal by Subject|8|||
16282096|NCT02985398|39514292|FG000|Overall Study|Study Burden|9|||
16282097|NCT02096588|39514293|FG000|Overall Study|Lack of Efficacy|2|||
16282098|NCT02096588|39514294|FG001|Overall Study|Lack of Efficacy|0|||
16479557|NCT03307785|40234341|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
16479558|NCT03307785|40234342|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
16479559|NCT03307785|40234343|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
16479560|NCT03307785|40234344|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
16479561|NCT03307785|40234345|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
16479562|NCT03307785|40234346|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
16479563|NCT03307785|40234347|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
16479564|NCT03307785|40234337|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
16479565|NCT03307785|40234338|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
16479566|NCT03307785|40234339|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
16479567|NCT03307785|40234340|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
16479568|NCT03307785|40234341|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
16479569|NCT03307785|40234342|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
16479570|NCT03307785|40234343|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
16479571|NCT03307785|40234344|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
16479572|NCT03307785|40234345|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
16479573|NCT03307785|40234346|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
16479574|NCT03307785|40234347|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
16479575|NCT03307785|40234337|FG000|Part B: Up to Approx. 66 Months|Death|0|||
16479576|NCT03307785|40234338|FG001|Part B: Up to Approx. 66 Months|Death|0|||
16479577|NCT03307785|40234339|FG002|Part B: Up to Approx. 66 Months|Death|7|||
16479578|NCT03307785|40234340|FG003|Part B: Up to Approx. 66 Months|Death|0|||
16479579|NCT03307785|40234341|FG004|Part B: Up to Approx. 66 Months|Death|0|||
16479580|NCT03307785|40234342|FG005|Part B: Up to Approx. 66 Months|Death|0|||
16479581|NCT03307785|40234343|FG006|Part B: Up to Approx. 66 Months|Death|0|||
16479582|NCT03307785|40234344|FG007|Part B: Up to Approx. 66 Months|Death|0|||
16479583|NCT03307785|40234345|FG008|Part B: Up to Approx. 66 Months|Death|0|||
16479584|NCT03307785|40234346|FG009|Part B: Up to Approx. 66 Months|Death|0|||
16479585|NCT03307785|40234347|FG010|Part B: Up to Approx. 66 Months|Death|0|||
16479586|NCT03307785|40234337|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
16479587|NCT03307785|40234338|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
16479588|NCT03307785|40234339|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
16479589|NCT03307785|40234340|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
16479590|NCT03307785|40234341|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
16479591|NCT03307785|40234342|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
16479592|NCT03307785|40234343|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
16479593|NCT03307785|40234344|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
16479594|NCT03307785|40234345|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
16479595|NCT03307785|40234346|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
16479596|NCT03307785|40234347|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
16479597|NCT03307785|40234337|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
16479598|NCT03307785|40234338|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
16479599|NCT03307785|40234339|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
16479600|NCT03307785|40234340|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
16479601|NCT03307785|40234341|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
16479602|NCT03307785|40234342|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
16479603|NCT03307785|40234343|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
16479604|NCT03307785|40234344|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
16479605|NCT03307785|40234345|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
16479606|NCT03307785|40234346|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
16479607|NCT03307785|40234347|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
16479608|NCT03307785|40234337|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
16479609|NCT03307785|40234338|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
16479610|NCT03307785|40234339|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
16479611|NCT03307785|40234340|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
16479612|NCT03307785|40234341|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
16479613|NCT03307785|40234342|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
16479614|NCT03307785|40234343|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
16479615|NCT03307785|40234344|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
16479616|NCT03307785|40234345|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
16479617|NCT03307785|40234346|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
16479618|NCT03307785|40234347|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
16479619|NCT03307785|40234337|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
16479620|NCT03307785|40234338|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
16479621|NCT03307785|40234339|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
16479622|NCT03307785|40234340|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
16479623|NCT03307785|40234341|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
16479624|NCT03307785|40234342|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
16282099|NCT02096588|39514293|FG000|Overall Study|Withdrawal by Subject|0|||
16282100|NCT02096588|39514294|FG001|Overall Study|Withdrawal by Subject|1|||
16282101|NCT00298740|39514296|FG000|Overall Study|Lack of Efficacy|6|||
16282102|NCT00298740|39514296|FG000|Overall Study|Withdrawal by Subject|3|||
16282103|NCT01754376|39514297|FG000|Overall Study|Adverse Event|1|||
16282104|NCT01754376|39514297|FG000|Overall Study|Lack of Efficacy|2|||
16282105|NCT01231373|39514300|FG000|Overall Study|Withdrew consent prior to randomization|2|||
16282106|NCT01231373|39514301|FG001|Overall Study|Withdrew consent prior to randomization|1|||
16282107|NCT01231373|39514302|FG002|Overall Study|Withdrew consent prior to randomization|0|||
16282108|NCT01231373|39514303|FG003|Overall Study|Withdrew consent prior to randomization|0|||
16282109|NCT01231373|39514300|FG000|Overall Study|Lost to Follow-up|0|||
16282110|NCT01231373|39514301|FG001|Overall Study|Lost to Follow-up|0|||
16282111|NCT01231373|39514302|FG002|Overall Study|Lost to Follow-up|0|||
16282112|NCT01231373|39514303|FG003|Overall Study|Lost to Follow-up|1|||
16282113|NCT01231373|39514300|FG000|Overall Study|Withdrew Consent|1|||
16282114|NCT01231373|39514301|FG001|Overall Study|Withdrew Consent|0|||
16282115|NCT01231373|39514302|FG002|Overall Study|Withdrew Consent|0|||
16282116|NCT01231373|39514303|FG003|Overall Study|Withdrew Consent|0|||
16282117|NCT02246764|39514304|FG000|Overall Study|Adverse Event|15|||
16282118|NCT02246764|39514305|FG001|Overall Study|Adverse Event|29|||
16282119|NCT02246764|39514306|FG002|Overall Study|Adverse Event|1|||
16282120|NCT02246764|39514304|FG000|Overall Study|Withdrawal by Subject|0|||
16282121|NCT02246764|39514305|FG001|Overall Study|Withdrawal by Subject|0|||
16282122|NCT02246764|39514306|FG002|Overall Study|Withdrawal by Subject|1|||
16282123|NCT02246764|39514304|FG000|Overall Study|Disallowed Concomitant Medication|1|||
16282124|NCT02246764|39514305|FG001|Overall Study|Disallowed Concomitant Medication|0|||
16282125|NCT02246764|39514306|FG002|Overall Study|Disallowed Concomitant Medication|0|||
16282126|NCT02246764|39514304|FG000|Overall Study|Physician Decision|0|||
16282127|NCT02246764|39514305|FG001|Overall Study|Physician Decision|2|||
16282128|NCT02246764|39514306|FG002|Overall Study|Physician Decision|1|||
16282129|NCT02246764|39514304|FG000|Overall Study|Protocol Violation|2|||
16282130|NCT02246764|39514305|FG001|Overall Study|Protocol Violation|1|||
16282131|NCT02246764|39514306|FG002|Overall Study|Protocol Violation|1|||
16282132|NCT02039063|39514307|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
16282133|NCT02039063|39514308|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
16282134|NCT02039063|39514309|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
16282135|NCT02039063|39514310|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
16282136|NCT02039063|39514307|FG000|Treatment Phase|Progression of disease|0|||
16282137|NCT02039063|39514308|FG001|Treatment Phase|Progression of disease|0|||
16282138|NCT02039063|39514309|FG002|Treatment Phase|Progression of disease|1|||
16282139|NCT02039063|39514310|FG003|Treatment Phase|Progression of disease|1|||
16282140|NCT02039063|39514307|FG000|Extension Phase|Inadequate therapeutic effect|0|||
16282141|NCT02039063|39514308|FG001|Extension Phase|Inadequate therapeutic effect|1|||
16282142|NCT02039063|39514309|FG002|Extension Phase|Inadequate therapeutic effect|2|||
16282143|NCT02039063|39514310|FG003|Extension Phase|Inadequate therapeutic effect|0|||
16282144|NCT02039063|39514307|FG000|Extension Phase|Progression of disease|0|||
16282145|NCT02039063|39514308|FG001|Extension Phase|Progression of disease|0|||
16282146|NCT02039063|39514309|FG002|Extension Phase|Progression of disease|0|||
16282147|NCT02039063|39514310|FG003|Extension Phase|Progression of disease|1|||
16282148|NCT02039063|39514307|FG000|Extension Phase|Adverse Event|0|||
16282149|NCT02039063|39514308|FG001|Extension Phase|Adverse Event|0|||
16282150|NCT02039063|39514309|FG002|Extension Phase|Adverse Event|1|||
16282151|NCT02039063|39514310|FG003|Extension Phase|Adverse Event|0|||
16282152|NCT03648879|39514311|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
16282153|NCT01478828|39514312|FG000|Overall Study|Adverse Event|1|||
16282154|NCT01115855|39514313|FG000|Overall Study|Adverse Event|16|||
16282155|NCT01115855|39514314|FG001|Overall Study|Adverse Event|18|||
16282156|NCT01115855|39514313|FG000|Overall Study|Death|6|||
16282157|NCT01115855|39514314|FG001|Overall Study|Death|5|||
16282158|NCT01115855|39514313|FG000|Overall Study|Lab Abnormality|1|||
16282159|NCT01115855|39514314|FG001|Overall Study|Lab Abnormality|1|||
16282160|NCT01115855|39514313|FG000|Overall Study|Protocol Violation|0|||
16282161|NCT01115855|39514314|FG001|Overall Study|Protocol Violation|1|||
16282162|NCT01115855|39514313|FG000|Overall Study|Withdrawal by Subject|5|||
16282163|NCT01115855|39514314|FG001|Overall Study|Withdrawal by Subject|5|||
16282164|NCT01115855|39514313|FG000|Overall Study|Other|8|||
16379715|NCT02278003|39874747|FG001|Overall Study|Not Treated|0|||
16282165|NCT01115855|39514314|FG001|Overall Study|Other|6|||
16282166|NCT03840382|39514317|FG000|Overall Study|Lost to Follow-up|11|||
16282167|NCT03381196|39514319|FG000|Overall Study|Withdrawal by Subject|7|||
16282168|NCT03381196|39514320|FG001|Overall Study|Withdrawal by Subject|7|||
16282169|NCT03381196|39514319|FG000|Overall Study|Other|0|||
16282170|NCT03381196|39514320|FG001|Overall Study|Other|1|||
16282171|NCT03381196|39514319|FG000|Overall Study|Lost to Follow-up|5|||
16282172|NCT03381196|39514320|FG001|Overall Study|Lost to Follow-up|4|||
16282173|NCT03381196|39514319|FG000|Overall Study|Death|0|||
16282174|NCT03381196|39514320|FG001|Overall Study|Death|1|||
16282175|NCT03381196|39514319|FG000|Overall Study|Adverse Event|1|||
16282176|NCT03381196|39514320|FG001|Overall Study|Adverse Event|0|||
16282177|NCT03381196|39514319|FG000|Overall Study|Randomized, not treated|3|||
16282178|NCT03381196|39514320|FG001|Overall Study|Randomized, not treated|6|||
16282179|NCT00685750|39514321|FG000|Overall Study|Tumor sampling failure|0|||
16282180|NCT00685750|39514322|FG001|Overall Study|Tumor sampling failure|0|||
16282181|NCT00685750|39514323|FG002|Overall Study|Tumor sampling failure|1|||
16282182|NCT00685750|39514324|FG003|Overall Study|Tumor sampling failure|0|||
16282183|NCT00685750|39514325|FG004|Overall Study|Tumor sampling failure|0|||
16282184|NCT00685750|39514326|FG005|Overall Study|Tumor sampling failure|0|||
16282185|NCT00685750|39514327|FG006|Overall Study|Tumor sampling failure|0|||
16282186|NCT00685750|39514321|FG000|Overall Study|Patient didn't receive the treatment|0|||
16282187|NCT00685750|39514322|FG001|Overall Study|Patient didn't receive the treatment|0|||
16282188|NCT00685750|39514323|FG002|Overall Study|Patient didn't receive the treatment|0|||
16282189|NCT00685750|39514324|FG003|Overall Study|Patient didn't receive the treatment|0|||
16282190|NCT00685750|39514325|FG004|Overall Study|Patient didn't receive the treatment|0|||
16282191|NCT00685750|39514326|FG005|Overall Study|Patient didn't receive the treatment|0|||
16282192|NCT00685750|39514327|FG006|Overall Study|Patient didn't receive the treatment|1|||
16282193|NCT00685750|39514321|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16282194|NCT00685750|39514322|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16282195|NCT00685750|39514323|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
16282196|NCT00685750|39514324|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
16282197|NCT00685750|39514325|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
16282198|NCT00685750|39514326|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
16282199|NCT00685750|39514327|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
16282200|NCT00981799|39514328|FG000|Overall Study|Adverse Event|1|||
16282201|NCT00981799|39514329|FG001|Overall Study|Adverse Event|1|||
16282202|NCT00981799|39514330|FG002|Overall Study|Adverse Event|0|||
16282203|NCT00981799|39514331|FG003|Overall Study|Adverse Event|0|||
16282204|NCT00348816|39514343|FG000|Overall Study|Noncompliance with radiation treatment|1|||
16282205|NCT01848210|39514344|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
16282206|NCT01848210|39514345|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
16282207|NCT01848210|39514344|FG000|Overall Study|Lost to Follow-up|24|||
16282208|NCT01848210|39514345|FG001|Overall Study|Lost to Follow-up|12|||
16282209|NCT01848210|39514344|FG000|Overall Study|Protocol Violation|3|||
16282210|NCT01848210|39514345|FG001|Overall Study|Protocol Violation|5|||
16282211|NCT01848210|39514344|FG000|Overall Study|Use of Forbidden Drugs|9|||
16282212|NCT01848210|39514345|FG001|Overall Study|Use of Forbidden Drugs|10|||
16282213|NCT01848210|39514344|FG000|Overall Study|Impedition Condition|5|||
16282214|NCT01848210|39514345|FG001|Overall Study|Impedition Condition|9|||
16282215|NCT01848210|39514344|FG000|Overall Study|Adverse Event|7|||
16282216|NCT01848210|39514345|FG001|Overall Study|Adverse Event|9|||
16282217|NCT01848210|39514344|FG000|Overall Study|Discontinuation Criterion|5|||
16282218|NCT01848210|39514345|FG001|Overall Study|Discontinuation Criterion|7|||
16282219|NCT01848210|39514344|FG000|Overall Study|Hypesensitivity|1|||
16282220|NCT01848210|39514345|FG001|Overall Study|Hypesensitivity|0|||
16282221|NCT01848210|39514344|FG000|Overall Study|Hepatic Function Alteration|4|||
16282222|NCT01848210|39514345|FG001|Overall Study|Hepatic Function Alteration|0|||
16282223|NCT01848210|39514344|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
16282224|NCT01848210|39514345|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
16282225|NCT01848210|39514344|FG000|Overall Study|Administrative|1|||
16282226|NCT01848210|39514345|FG001|Overall Study|Administrative|0|||
16282227|NCT02056652|39514346|FG000|Overall Study|Withdrawal by Subject|1|||
16282228|NCT02056652|39514347|FG001|Overall Study|Withdrawal by Subject|0|||
16282229|NCT02056652|39514346|FG000|Overall Study|Lost to Follow-up|0|||
16282230|NCT02056652|39514347|FG001|Overall Study|Lost to Follow-up|3|||
16282231|NCT02297841|39514352|FG000|Overall Study|Withdrawal by Subject|1|||
16282232|NCT02297841|39514352|FG000|Overall Study|Protocol Violation|7|||
16282233|NCT01592721|39514353|FG000|Long-term Follow-up|Death|1|||
16282234|NCT01235442|39514354|FG000|Overall Study|Lost to Follow-up|12|||
16282235|NCT01235442|39514355|FG001|Overall Study|Lost to Follow-up|10|||
16282236|NCT01235442|39514354|FG000|Overall Study|Death|0|||
16282237|NCT01235442|39514355|FG001|Overall Study|Death|2|||
16282238|NCT01235442|39514354|FG000|Overall Study|Pregnancy|1|||
16282239|NCT01235442|39514355|FG001|Overall Study|Pregnancy|1|||
16282240|NCT01235442|39514354|FG000|Overall Study|Ineligibility determined|5|||
16282241|NCT01235442|39514355|FG001|Overall Study|Ineligibility determined|4|||
16282242|NCT01235442|39514354|FG000|Overall Study|Protocol Violation|3|||
16282243|NCT01235442|39514355|FG001|Overall Study|Protocol Violation|3|||
16282244|NCT01235442|39514354|FG000|Overall Study|Adverse Event|4|||
16282245|NCT01235442|39514355|FG001|Overall Study|Adverse Event|6|||
16282246|NCT01235442|39514354|FG000|Overall Study|Withdrawal by Subject|15|||
16282247|NCT01235442|39514355|FG001|Overall Study|Withdrawal by Subject|9|||
16282248|NCT01235442|39514354|FG000|Overall Study|Lack of Efficacy|1|||
16282249|NCT01235442|39514355|FG001|Overall Study|Lack of Efficacy|3|||
16282250|NCT01235442|39514354|FG000|Overall Study|Noncompliance|1|||
16282251|NCT01235442|39514355|FG001|Overall Study|Noncompliance|2|||
16282252|NCT01235442|39514354|FG000|Overall Study|Administrative decision|1|||
16282253|NCT01235442|39514355|FG001|Overall Study|Administrative decision|2|||
16282254|NCT01235442|39514354|FG000|Overall Study|Other unspecified|1|||
16282255|NCT01235442|39514355|FG001|Overall Study|Other unspecified|2|||
16282256|NCT00602537|39514356|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
16282257|NCT00602537|39514357|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
16282258|NCT00602537|39514356|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
16282259|NCT00602537|39514357|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
16282260|NCT00602537|39514356|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
16282261|NCT00602537|39514357|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
16282262|NCT00602537|39514356|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
16282263|NCT00602537|39514357|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
16282264|NCT00602537|39514356|FG000|Follow Up Study Comparison|Adverse Event|1|||
16282265|NCT00602537|39514357|FG001|Follow Up Study Comparison|Adverse Event|0|||
16282266|NCT00602537|39514356|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
16282267|NCT00602537|39514357|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
16282268|NCT00602537|39514356|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
16282269|NCT00602537|39514357|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
16282270|NCT00708682|39514358|FG000|Infant Series|Adverse Event|1|||
16282271|NCT00708682|39514358|FG000|Infant Series|Lost to Follow-up|4|||
16282272|NCT00708682|39514358|FG000|Infant Series|Protocol Violation|1|||
16282273|NCT00708682|39514358|FG000|Infant Series|Parent/legal guardian request|6|||
16282274|NCT00708682|39514358|FG000|Infant Series|Failed to return|2|||
16282275|NCT00708682|39514358|FG000|Infant Series|Other|19|||
16282276|NCT00708682|39514358|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
16282277|NCT00708682|39514358|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
16282278|NCT00708682|39514358|FG000|Toddler Dose|Lost to Follow-up|3|||
16282279|NCT00708682|39514358|FG000|Toddler Dose|Failed to Return|4|||
16282280|NCT02460835|39514359|FG000|Overall Study|Disease progression prior to treatment|3|||
16282281|NCT02460835|39514359|FG000|Overall Study|Unable to complete planning scans|2|||
16282282|NCT02460835|39514359|FG000|Overall Study|Decrease in performance status|1|||
16282283|NCT02460835|39514359|FG000|Overall Study|Withdrawal by Subject|3|||
16282284|NCT02460835|39514359|FG000|Overall Study|Underwent fractionated RT|10|||
16282285|NCT02460835|39514359|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
16282286|NCT02485158|39514360|FG000|Overall Study|Withdrawal by Subject|3|||
16282287|NCT02485158|39514360|FG000|Overall Study|expected drug side effect|1|||
16282288|NCT01662024|39514361|FG000|Overall Study|Pregnancy|2|||
16282289|NCT01662024|39514361|FG000|Overall Study|Withdrawal by Subject|3|||
16282290|NCT00544817|39514362|FG000|Combined Modality|Lack of Efficacy|2|||
16282291|NCT00544817|39514362|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
16282292|NCT00544817|39514362|FG000|Combined Modality|Adverse Event|2|||
16282293|NCT00544817|39514362|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
16282294|NCT00544817|39514362|FG000|No Treatment Interval|Lack of Efficacy|8|||
16282295|NCT00544817|39514362|FG000|No Treatment Interval|Physician Decision|3|||
16282296|NCT00544817|39514362|FG000|No Treatment Interval|Adverse Event|1|||
16282297|NCT00544817|39514362|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
16282298|NCT00544817|39514362|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
16282299|NCT00544817|39514362|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
16282300|NCT02662582|39514365|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
16282301|NCT02662582|39514366|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
16282302|NCT02662582|39514365|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
16282303|NCT02662582|39514366|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
16282304|NCT02662582|39514365|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
16282305|NCT02662582|39514366|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
16282306|NCT02662582|39514365|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16282307|NCT02662582|39514366|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16282308|NCT01350934|39514369|FG000|Base Study|Adverse Event|6|||
16282309|NCT01350934|39514370|FG001|Base Study|Adverse Event|0|||
16282310|NCT01350934|39514369|FG000|Base Study|Lost to Follow-up|1|||
16282311|NCT01350934|39514370|FG001|Base Study|Lost to Follow-up|0|||
16282312|NCT01350934|39514369|FG000|Base Study|Protocol Violation|1|||
16282313|NCT01350934|39514370|FG001|Base Study|Protocol Violation|1|||
16282314|NCT01350934|39514369|FG000|Base Study|Withdrawal by Subject|1|||
16282315|NCT01350934|39514370|FG001|Base Study|Withdrawal by Subject|2|||
16282316|NCT01350934|39514369|FG000|Base Study|Non-Compliance With Study Drug|2|||
16282317|NCT01350934|39514370|FG001|Base Study|Non-Compliance With Study Drug|0|||
16282318|NCT01350934|39514369|FG000|Extension Study|Adverse Event|2|||
16282319|NCT01350934|39514370|FG001|Extension Study|Adverse Event|1|||
16282320|NCT01350934|39514369|FG000|Extension Study|Lost to Follow-up|2|||
16282321|NCT01350934|39514370|FG001|Extension Study|Lost to Follow-up|0|||
16479625|NCT03307785|40234343|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
16479626|NCT03307785|40234344|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
16479627|NCT03307785|40234345|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
16479628|NCT03307785|40234346|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
16479629|NCT03307785|40234347|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
16479630|NCT03307785|40234337|FG000|Part C: Up to Approx. 60 Months|Death|0|||
16479631|NCT03307785|40234338|FG001|Part C: Up to Approx. 60 Months|Death|0|||
16479632|NCT03307785|40234339|FG002|Part C: Up to Approx. 60 Months|Death|0|||
16479633|NCT03307785|40234340|FG003|Part C: Up to Approx. 60 Months|Death|2|||
16479634|NCT03307785|40234341|FG004|Part C: Up to Approx. 60 Months|Death|5|||
16479635|NCT03307785|40234342|FG005|Part C: Up to Approx. 60 Months|Death|0|||
16479636|NCT03307785|40234343|FG006|Part C: Up to Approx. 60 Months|Death|0|||
16479637|NCT03307785|40234344|FG007|Part C: Up to Approx. 60 Months|Death|0|||
16479638|NCT03307785|40234345|FG008|Part C: Up to Approx. 60 Months|Death|0|||
16479639|NCT03307785|40234346|FG009|Part C: Up to Approx. 60 Months|Death|0|||
16479640|NCT03307785|40234347|FG010|Part C: Up to Approx. 60 Months|Death|0|||
16479641|NCT03307785|40234337|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
16479642|NCT03307785|40234338|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
16479643|NCT03307785|40234339|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
16479644|NCT03307785|40234340|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
16479645|NCT03307785|40234341|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
16479646|NCT03307785|40234342|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
16479647|NCT03307785|40234343|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
16479648|NCT03307785|40234344|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
16479649|NCT03307785|40234345|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
16479650|NCT03307785|40234346|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
16479651|NCT03307785|40234347|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
16479652|NCT03307785|40234337|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
16479653|NCT03307785|40234338|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
16479654|NCT03307785|40234339|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
16479655|NCT03307785|40234340|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
16479656|NCT03307785|40234341|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
16479657|NCT03307785|40234342|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
16479658|NCT03307785|40234343|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
16479659|NCT03307785|40234344|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
16479660|NCT03307785|40234345|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
16479661|NCT03307785|40234346|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
16479662|NCT03307785|40234347|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
16479663|NCT03307785|40234337|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
16479664|NCT03307785|40234338|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
16479665|NCT03307785|40234339|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
16479666|NCT03307785|40234340|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
16479667|NCT03307785|40234341|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
16479668|NCT03307785|40234342|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
16479669|NCT03307785|40234343|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
16479670|NCT03307785|40234344|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
16479671|NCT03307785|40234345|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
16479672|NCT03307785|40234346|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
16479673|NCT03307785|40234347|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
16479674|NCT03307785|40234337|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
16479675|NCT03307785|40234338|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
16479676|NCT03307785|40234339|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
16479677|NCT03307785|40234340|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
16479678|NCT03307785|40234341|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
16479679|NCT03307785|40234342|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
16479680|NCT03307785|40234343|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
16479681|NCT03307785|40234344|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
16479682|NCT03307785|40234345|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
16479683|NCT03307785|40234346|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
16479684|NCT03307785|40234347|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
16479685|NCT03307785|40234337|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
16479686|NCT03307785|40234338|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
16479687|NCT03307785|40234339|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
16479688|NCT03307785|40234340|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
16479689|NCT03307785|40234341|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
16479690|NCT03307785|40234342|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
16479691|NCT03307785|40234343|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
16479692|NCT03307785|40234344|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
16479693|NCT03307785|40234345|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
16479694|NCT03307785|40234346|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
16479695|NCT03307785|40234347|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
16282322|NCT01350934|39514369|FG000|Extension Study|Protocol Violation|1|||
16282323|NCT01350934|39514370|FG001|Extension Study|Protocol Violation|1|||
16282324|NCT01350934|39514369|FG000|Extension Study|Lack of Efficacy|0|||
16282325|NCT01350934|39514370|FG001|Extension Study|Lack of Efficacy|1|||
16282326|NCT01350934|39514369|FG000|Extension Study|Withdrawal by Subject|0|||
16282327|NCT01350934|39514370|FG001|Extension Study|Withdrawal by Subject|1|||
16282328|NCT00879684|39514374|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
16282329|NCT00879684|39514375|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
16282330|NCT00879684|39514376|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
16282331|NCT00879684|39514377|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
16282332|NCT00879684|39514378|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
16282333|NCT00879684|39514379|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
16282334|NCT00879684|39514380|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
16282335|NCT00879684|39514374|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
16282336|NCT00879684|39514375|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
16282337|NCT00879684|39514376|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
16282338|NCT00879684|39514377|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
16282339|NCT00879684|39514378|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
16282340|NCT00879684|39514379|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
16282341|NCT00879684|39514380|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
16282342|NCT00879684|39514374|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
16282343|NCT00879684|39514375|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
16282344|NCT00879684|39514376|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
16282345|NCT00879684|39514377|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
16282346|NCT00879684|39514378|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
16282347|NCT00879684|39514379|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
16282348|NCT00879684|39514380|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
16282349|NCT00879684|39514374|FG000|Stage 1: Dose Escalation|Death|0|||
16282350|NCT00879684|39514375|FG001|Stage 1: Dose Escalation|Death|0|||
16282351|NCT00879684|39514376|FG002|Stage 1: Dose Escalation|Death|1|||
16282352|NCT00879684|39514377|FG003|Stage 1: Dose Escalation|Death|0|||
16479696|NCT03307785|40234337|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
16479697|NCT03307785|40234338|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
16479698|NCT03307785|40234339|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
16479699|NCT03307785|40234340|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
16479700|NCT03307785|40234341|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
16479701|NCT03307785|40234342|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
16479702|NCT03307785|40234343|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
16479703|NCT03307785|40234344|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
16479704|NCT03307785|40234345|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
16479705|NCT03307785|40234346|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
16479706|NCT03307785|40234347|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
16479707|NCT03307785|40234337|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
16479708|NCT03307785|40234338|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
16479709|NCT03307785|40234339|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
16479710|NCT03307785|40234340|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
16479711|NCT03307785|40234341|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
16479712|NCT03307785|40234342|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
16479713|NCT03307785|40234343|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
16479714|NCT03307785|40234344|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
16479715|NCT03307785|40234345|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
16479716|NCT03307785|40234346|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
16479717|NCT03307785|40234347|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
16479718|NCT03307785|40234337|FG000|Part E: Up to 4.4 Months|Death|0|||
16479719|NCT03307785|40234338|FG001|Part E: Up to 4.4 Months|Death|0|||
16282353|NCT00879684|39514378|FG004|Stage 1: Dose Escalation|Death|0|||
16282354|NCT00879684|39514379|FG005|Stage 1: Dose Escalation|Death|0|||
16479720|NCT03307785|40234339|FG002|Part E: Up to 4.4 Months|Death|0|||
16479721|NCT03307785|40234340|FG003|Part E: Up to 4.4 Months|Death|0|||
16479722|NCT03307785|40234341|FG004|Part E: Up to 4.4 Months|Death|0|||
16479723|NCT03307785|40234342|FG005|Part E: Up to 4.4 Months|Death|0|||
16479724|NCT03307785|40234343|FG006|Part E: Up to 4.4 Months|Death|1|||
16479725|NCT03307785|40234344|FG007|Part E: Up to 4.4 Months|Death|0|||
16479726|NCT03307785|40234345|FG008|Part E: Up to 4.4 Months|Death|0|||
16479727|NCT03307785|40234346|FG009|Part E: Up to 4.4 Months|Death|0|||
16479728|NCT03307785|40234347|FG010|Part E: Up to 4.4 Months|Death|0|||
16479729|NCT03307785|40234337|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
16479730|NCT03307785|40234338|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
16479731|NCT03307785|40234339|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
16479732|NCT03307785|40234340|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
16479733|NCT03307785|40234341|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
16479734|NCT03307785|40234342|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
16479735|NCT03307785|40234343|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
16479736|NCT03307785|40234344|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
16479737|NCT03307785|40234345|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
16479738|NCT03307785|40234346|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
16479739|NCT03307785|40234347|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
16479740|NCT03307785|40234337|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
16479741|NCT03307785|40234338|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
16479742|NCT03307785|40234339|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
16479743|NCT03307785|40234340|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
16479744|NCT03307785|40234341|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
16479745|NCT03307785|40234342|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
16479746|NCT03307785|40234343|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
16479747|NCT03307785|40234344|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
16479748|NCT03307785|40234345|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
16479749|NCT03307785|40234346|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
16479750|NCT03307785|40234347|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
16479751|NCT02187744|40234348|FG000|Study|Participant refused further follow-up|1|||
16479752|NCT02187744|40234349|FG001|Study|Participant refused further follow-up|0|||
16479753|NCT02187744|40234348|FG000|Study|Other|2|||
16479754|NCT02187744|40234349|FG001|Study|Other|1|||
16479755|NCT02187744|40234348|FG000|Study|Lost to Follow-up|0|||
16479756|NCT02187744|40234349|FG001|Study|Lost to Follow-up|2|||
16479757|NCT02187744|40234348|FG000|Study|Related adverse event, not serious|0|||
16479758|NCT02187744|40234349|FG001|Study|Related adverse event, not serious|2|||
16479759|NCT02187744|40234348|FG000|Study|Death|1|||
16479760|NCT02187744|40234349|FG001|Study|Death|0|||
16479761|NCT02187744|40234348|FG000|Study|Related adverse event, serious non-fatal|0|||
16479762|NCT02187744|40234349|FG001|Study|Related adverse event, serious non-fatal|1|||
16479763|NCT02187744|40234348|FG000|Treatment|Death|1|||
16479764|NCT02187744|40234349|FG001|Treatment|Death|0|||
16479765|NCT02187744|40234348|FG000|Treatment|Related adverse event, serious non-fatal|0|||
16479766|NCT02187744|40234349|FG001|Treatment|Related adverse event, serious non-fatal|1|||
16479767|NCT02187744|40234348|FG000|Treatment|Related adverse event, not serious|0|||
16479768|NCT02187744|40234349|FG001|Treatment|Related adverse event, not serious|2|||
16479769|NCT02187744|40234348|FG000|Treatment|Lost to Follow-up|0|||
16479770|NCT02187744|40234349|FG001|Treatment|Lost to Follow-up|1|||
16479771|NCT02187744|40234348|FG000|Treatment|Other|2|||
16282355|NCT00879684|39514380|FG006|Stage 1: Dose Escalation|Death|0|||
16282356|NCT00879684|39514374|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
16282357|NCT00879684|39514375|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
16282358|NCT00879684|39514376|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
16282359|NCT00879684|39514377|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
16282360|NCT00879684|39514378|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
16282361|NCT00879684|39514379|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
16282362|NCT00879684|39514380|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
16282363|NCT00879684|39514374|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
16282364|NCT00879684|39514375|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
16282365|NCT00879684|39514376|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
16282366|NCT00879684|39514377|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
16282367|NCT00879684|39514378|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
16479772|NCT02187744|40234349|FG001|Treatment|Other|0|||
16479773|NCT02187744|40234348|FG000|Treatment|Participant refused continued treatment|1|||
16479774|NCT02187744|40234349|FG001|Treatment|Participant refused continued treatment|1|||
16479775|NCT02158975|40234350|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
16479776|NCT04223973|40234353|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
16282368|NCT00879684|39514379|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
16282369|NCT00879684|39514380|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
16282370|NCT00879684|39514374|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
16282371|NCT00879684|39514375|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
16282372|NCT00879684|39514376|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
16282373|NCT00879684|39514377|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
16282374|NCT00879684|39514378|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
16282375|NCT00879684|39514379|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
16282376|NCT00879684|39514380|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
16282377|NCT03136406|39514381|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
16282378|NCT01957150|39514382|FG000|Overall Study|Adverse Event|23|||
16282379|NCT01957150|39514383|FG001|Overall Study|Adverse Event|20|||
16282380|NCT01957150|39514382|FG000|Overall Study|Withdrawal by Subject|13|||
16282381|NCT01957150|39514383|FG001|Overall Study|Withdrawal by Subject|17|||
16282382|NCT01957150|39514382|FG000|Overall Study|Physician Decision|3|||
16282383|NCT01957150|39514383|FG001|Overall Study|Physician Decision|6|||
16282384|NCT01957150|39514382|FG000|Overall Study|Lost to Follow-up|4|||
16282385|NCT01957150|39514383|FG001|Overall Study|Lost to Follow-up|4|||
16282386|NCT01957150|39514382|FG000|Overall Study|Protocol Violation|1|||
16282387|NCT01957150|39514383|FG001|Overall Study|Protocol Violation|0|||
16282388|NCT01957150|39514382|FG000|Overall Study|Lack of Efficacy|11|||
16282389|NCT01957150|39514383|FG001|Overall Study|Lack of Efficacy|11|||
16282390|NCT01049412|39514384|FG000|Period I|Withdrawal by Subject|4|||
16282391|NCT01049412|39514385|FG001|Period I|Withdrawal by Subject|6|||
16282392|NCT01049412|39514384|FG000|Period I|Lost to Follow-up|2|||
16282393|NCT01049412|39514385|FG001|Period I|Lost to Follow-up|2|||
16282394|NCT01049412|39514384|FG000|Period I|Physician Decision|0|||
16282395|NCT01049412|39514385|FG001|Period I|Physician Decision|3|||
16282396|NCT01049412|39514384|FG000|Period I|Protocol Violation|1|||
16282397|NCT01049412|39514385|FG001|Period I|Protocol Violation|2|||
16282398|NCT01049412|39514384|FG000|Period I|Adverse Event|1|||
16282399|NCT01049412|39514385|FG001|Period I|Adverse Event|0|||
16282400|NCT01049412|39514384|FG000|Period II|Withdrawal by Subject|2|||
16282401|NCT01049412|39514385|FG001|Period II|Withdrawal by Subject|3|||
16282402|NCT01049412|39514384|FG000|Period II|Adverse Event|1|||
16379716|NCT02278003|39874746|FG000|Overall Study|Recognition task improperly completed|7|||
16379717|NCT02278003|39874747|FG001|Overall Study|Recognition task improperly completed|0|||
16379718|NCT01174563|39874748|FG000|Overall Study|Progressive Disease|45|||
16379719|NCT01174563|39874748|FG000|Overall Study|Death|5|||
16379720|NCT01174563|39874748|FG000|Overall Study|Investigator's Discretion|5|||
16379721|NCT01174563|39874748|FG000|Overall Study|Participant Withdrew Consent|3|||
16379722|NCT01174563|39874748|FG000|Overall Study|Rash Adverse Event|1|||
16379723|NCT01174563|39874748|FG000|Overall Study|Sponsor's decision|1|||
16379724|NCT03312114|39874749|FG000|Overall Study|All the five enrolled dropped out of the|5|||
16379725|NCT00095576|39874756|FG000|Overall Study|Adverse Event|5|||
16379726|NCT00095576|39874757|FG001|Overall Study|Adverse Event|3|||
16379727|NCT00095576|39874756|FG000|Overall Study|Lost to Follow-up|233|||
16379728|NCT00095576|39874757|FG001|Overall Study|Lost to Follow-up|229|||
16379729|NCT00095576|39874756|FG000|Overall Study|Protocol Violation|1|||
16379730|NCT00095576|39874757|FG001|Overall Study|Protocol Violation|0|||
16379731|NCT00095576|39874756|FG000|Overall Study|Withdrawal by Subject|34|||
16379732|NCT00095576|39874757|FG001|Overall Study|Withdrawal by Subject|47|||
16379733|NCT00095576|39874756|FG000|Overall Study|Option to switch to a rollover study|1097|||
16379734|NCT00095576|39874757|FG001|Overall Study|Option to switch to a rollover study|1099|||
16379735|NCT00095576|39874756|FG000|Overall Study|Site terminated|75|||
16379736|NCT00095576|39874757|FG001|Overall Study|Site terminated|67|||
16379737|NCT00095576|39874756|FG000|Overall Study|Subject moved|30|||
16379738|NCT00095576|39874757|FG001|Overall Study|Subject moved|36|||
16379739|NCT00105066|39874758|FG000|Overall Study|Adverse Event|2|||
16379740|NCT00105066|39874759|FG001|Overall Study|Adverse Event|5|||
16379741|NCT01651208|39874760|FG000|Overall Study|Lost to Follow-up|14|||
16379742|NCT01651208|39874761|FG001|Overall Study|Lost to Follow-up|16|||
16379743|NCT03814746|39874762|FG000|Overall Study|Participant decision|9|||
16379744|NCT03814746|39874763|FG001|Overall Study|Participant decision|6|||
16379745|NCT03814746|39874764|FG002|Overall Study|Participant decision|15|||
16282403|NCT01049412|39514385|FG001|Period II|Adverse Event|0|||
16282404|NCT01049412|39514384|FG000|Period II|Lost to Follow-up|1|||
16282405|NCT01049412|39514385|FG001|Period II|Lost to Follow-up|0|||
16282406|NCT00194792|39514386|FG000|Overall Study|Withdrawal by Subject|1|||
16379746|NCT03814746|39874762|FG000|Overall Study|Physician Decision|2|||
16379747|NCT03814746|39874763|FG001|Overall Study|Physician Decision|2|||
16379748|NCT03814746|39874764|FG002|Overall Study|Physician Decision|4|||
16379749|NCT03814746|39874762|FG000|Overall Study|Death|2|||
16379750|NCT03814746|39874763|FG001|Overall Study|Death|2|||
16379751|NCT03814746|39874764|FG002|Overall Study|Death|2|||
16379752|NCT03814746|39874762|FG000|Overall Study|Adverse Event|2|||
16282407|NCT00996437|39514387|FG000|Overall Study|Death|1|||
16282408|NCT00996437|39514388|FG001|Overall Study|Death|0|||
16282409|NCT00996437|39514387|FG000|Overall Study|Dropped|2|||
16282410|NCT00996437|39514388|FG001|Overall Study|Dropped|2|||
16282411|NCT00996437|39514387|FG000|Overall Study|Missed|2|||
16282412|NCT00996437|39514388|FG001|Overall Study|Missed|5|||
16282413|NCT02274558|39514395|FG000|Overall Study|Adverse Event|2|||
16282414|NCT02274558|39514396|FG001|Overall Study|Adverse Event|4|||
16282415|NCT02274558|39514397|FG002|Overall Study|Adverse Event|2|||
16282416|NCT02274558|39514395|FG000|Overall Study|Non-compliance|2|||
16282417|NCT02274558|39514396|FG001|Overall Study|Non-compliance|1|||
16282418|NCT02274558|39514397|FG002|Overall Study|Non-compliance|0|||
16282419|NCT02274558|39514395|FG000|Overall Study|Withdrawal by Subject|1|||
16282420|NCT02274558|39514396|FG001|Overall Study|Withdrawal by Subject|5|||
16282421|NCT02274558|39514397|FG002|Overall Study|Withdrawal by Subject|4|||
16282422|NCT02274558|39514395|FG000|Overall Study|Death|0|||
16282423|NCT02274558|39514396|FG001|Overall Study|Death|0|||
16282424|NCT02274558|39514397|FG002|Overall Study|Death|1|||
16282425|NCT02274558|39514395|FG000|Overall Study|Lost to Follow-up|2|||
16282426|NCT02274558|39514396|FG001|Overall Study|Lost to Follow-up|1|||
16282427|NCT02274558|39514397|FG002|Overall Study|Lost to Follow-up|1|||
16282428|NCT02274558|39514395|FG000|Overall Study|Physician Decision|0|||
16282429|NCT02274558|39514396|FG001|Overall Study|Physician Decision|2|||
16282430|NCT02274558|39514397|FG002|Overall Study|Physician Decision|1|||
16282431|NCT00557245|39514398|FG000|Overall Study|Lost to Follow-up|7|||
16282432|NCT00557245|39514399|FG001|Overall Study|Lost to Follow-up|8|||
16282433|NCT00557245|39514400|FG002|Overall Study|Lost to Follow-up|10|||
16282434|NCT00557245|39514398|FG000|Overall Study|Ineligible|5|||
16282435|NCT00557245|39514399|FG001|Overall Study|Ineligible|4|||
16282436|NCT00557245|39514400|FG002|Overall Study|Ineligible|2|||
16282437|NCT00179673|39514402|FG000|Overall Study|Adverse Event|7|||
16282438|NCT00179673|39514402|FG000|Overall Study|Lack of Efficacy|15|||
16282439|NCT00179673|39514402|FG000|Overall Study|Withdrawal by Subject|3|||
16282440|NCT00179673|39514402|FG000|Overall Study|Death|4|||
16282441|NCT00179673|39514402|FG000|Overall Study|Other Observations and options|14|||
16282442|NCT02576717|39514403|FG000|Overall Study|Other Reasons|16|||
16282443|NCT02576717|39514404|FG001|Overall Study|Other Reasons|18|||
16282444|NCT02576717|39514405|FG002|Overall Study|Other Reasons|15|||
16282445|NCT02576717|39514403|FG000|Overall Study|Covid-19 Pandemic|0|||
16282446|NCT02576717|39514404|FG001|Overall Study|Covid-19 Pandemic|1|||
16282447|NCT02576717|39514405|FG002|Overall Study|Covid-19 Pandemic|1|||
16282448|NCT02576717|39514403|FG000|Overall Study|Sponsor Decision|0|||
16282449|NCT02576717|39514404|FG001|Overall Study|Sponsor Decision|0|||
16282450|NCT02576717|39514405|FG002|Overall Study|Sponsor Decision|1|||
16282451|NCT02576717|39514403|FG000|Overall Study|Physician Decision|3|||
16282452|NCT02576717|39514404|FG001|Overall Study|Physician Decision|8|||
16282453|NCT02576717|39514405|FG002|Overall Study|Physician Decision|9|||
16282454|NCT02576717|39514403|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
16282455|NCT02576717|39514404|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
16282456|NCT02576717|39514405|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
16282457|NCT02576717|39514403|FG000|Overall Study|Death|3|||
16479777|NCT04223973|40234354|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
16479778|NCT04223973|40234353|FG000|Overall Study|Adverse Event|4|||
16479779|NCT04223973|40234354|FG001|Overall Study|Adverse Event|0|||
16479780|NCT04223973|40234353|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
16479781|NCT04223973|40234354|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
16479782|NCT04223973|40234353|FG000|Overall Study|Physician Decision|1|||
16479783|NCT04223973|40234354|FG001|Overall Study|Physician Decision|1|||
16479784|NCT04223973|40234353|FG000|Overall Study|Withdrawal by Subject|0|||
16282458|NCT02576717|39514404|FG001|Overall Study|Death|5|||
16282459|NCT02576717|39514405|FG002|Overall Study|Death|3|||
16282460|NCT02576717|39514403|FG000|Overall Study|Lost to Follow-up|9|||
16282461|NCT02576717|39514404|FG001|Overall Study|Lost to Follow-up|10|||
16282462|NCT02576717|39514405|FG002|Overall Study|Lost to Follow-up|19|||
16282463|NCT02576717|39514403|FG000|Overall Study|Protocol Violation|4|||
16282464|NCT02576717|39514404|FG001|Overall Study|Protocol Violation|0|||
16282465|NCT02576717|39514405|FG002|Overall Study|Protocol Violation|5|||
16282466|NCT02576717|39514403|FG000|Overall Study|Lack of Efficacy|24|||
16282467|NCT02576717|39514404|FG001|Overall Study|Lack of Efficacy|28|||
16282468|NCT02576717|39514405|FG002|Overall Study|Lack of Efficacy|20|||
16282469|NCT02576717|39514403|FG000|Overall Study|Adverse Event|26|||
16282470|NCT02576717|39514404|FG001|Overall Study|Adverse Event|32|||
16282471|NCT02576717|39514405|FG002|Overall Study|Adverse Event|26|||
16282472|NCT00612677|39517401|FG000|Overall Study|study closed before treatment started|1|||
16282473|NCT04523480|39517403|FG000|Overall Study|Lost to Follow-up|30|||
16282474|NCT04523480|39517404|FG001|Overall Study|Lost to Follow-up|35|||
16282475|NCT04523480|39517405|FG002|Overall Study|Lost to Follow-up|0|||
16282476|NCT02695719|39517408|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
16282477|NCT02695719|39517409|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
16282478|NCT02695719|39517408|FG000|Overall Study|Significant Protocol Deviation|0|||
16282479|NCT02695719|39517409|FG001|Overall Study|Significant Protocol Deviation|1|||
16282480|NCT02695719|39517408|FG000|Overall Study|Voluntary Withdrawal|1|||
16282481|NCT02695719|39517409|FG001|Overall Study|Voluntary Withdrawal|0|||
16282482|NCT00436917|39517410|FG000|Overall Study|Withdrawal by Subject|13|||
16282483|NCT00436917|39517410|FG000|Overall Study|Adverse Event|2|||
16282484|NCT00436917|39517410|FG000|Overall Study|Physician Decision|1|||
16282485|NCT00436917|39517410|FG000|Overall Study|Death|1|||
16282486|NCT00436917|39517410|FG000|Overall Study|Lost to Follow-up|1|||
16282487|NCT00436917|39517410|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
16282488|NCT00436917|39517410|FG000|Overall Study|Increased creatinine|1|||
16282489|NCT00436917|39517410|FG000|Overall Study|Personal conflicts of patient|1|||
16282490|NCT00766831|39517414|FG000|Overall Study|Withdrawal by Subject|4|||
16282491|NCT00766831|39517414|FG000|Overall Study|Lost to Follow-up|3|||
16282492|NCT00766831|39517414|FG000|Overall Study|Adverse Event|20|||
16282493|NCT00766831|39517414|FG000|Overall Study|Protocol Violation|15|||
16282494|NCT00766831|39517414|FG000|Overall Study|Physician Decision|5|||
16282495|NCT00766831|39517414|FG000|Overall Study|Withdrawal of consent|26|||
16282496|NCT00766831|39517414|FG000|Overall Study|Non cooperation by participants|14|||
16282497|NCT00766831|39517414|FG000|Overall Study|Other|28|||
16282498|NCT04034355|39517419|FG000|Overall Study|Study terminated by Sponsor|10|||
16282499|NCT04034355|39517420|FG001|Overall Study|Study terminated by Sponsor|17|||
16282500|NCT04034355|39517419|FG000|Overall Study|Withdrawal by Subject|12|||
16282501|NCT04034355|39517420|FG001|Overall Study|Withdrawal by Subject|11|||
16282502|NCT04034355|39517419|FG000|Overall Study|Site terminated by Sponsor|4|||
16282503|NCT04034355|39517420|FG001|Overall Study|Site terminated by Sponsor|5|||
16282504|NCT04034355|39517419|FG000|Overall Study|Adverse Event|2|||
16282505|NCT04034355|39517420|FG001|Overall Study|Adverse Event|0|||
16282506|NCT04034355|39517419|FG000|Overall Study|Death|1|||
16282507|NCT04034355|39517420|FG001|Overall Study|Death|1|||
16282508|NCT04034355|39517419|FG000|Overall Study|Not reported|2|||
16282509|NCT04034355|39517420|FG001|Overall Study|Not reported|0|||
16282510|NCT04034355|39517419|FG000|Overall Study|Lost to Follow-up|1|||
16282511|NCT04034355|39517420|FG001|Overall Study|Lost to Follow-up|0|||
16282512|NCT04034355|39517419|FG000|Overall Study|Physician Decision|1|||
16282513|NCT04034355|39517420|FG001|Overall Study|Physician Decision|0|||
16282514|NCT04034355|39517419|FG000|Overall Study|Protocol Violation|0|||
16282515|NCT04034355|39517420|FG001|Overall Study|Protocol Violation|1|||
16282516|NCT04034355|39517419|FG000|Overall Study|Progressive disease|1|||
16282517|NCT04034355|39517420|FG001|Overall Study|Progressive disease|0|||
16282518|NCT02339090|39517425|FG000|Overall Study|Adverse Event|1|||
16282519|NCT02339090|39517426|FG001|Overall Study|Adverse Event|0|||
16282520|NCT02339090|39517425|FG000|Overall Study|Lost to Follow-up|0|||
16282521|NCT02339090|39517426|FG001|Overall Study|Lost to Follow-up|1|||
16282522|NCT02339090|39517425|FG000|Overall Study|Non-compliance With Study Drug|0|||
16282523|NCT02339090|39517426|FG001|Overall Study|Non-compliance With Study Drug|1|||
16282524|NCT02339090|39517425|FG000|Overall Study|Withdrawal by Subject|2|||
16282525|NCT02339090|39517426|FG001|Overall Study|Withdrawal by Subject|1|||
16282526|NCT02339090|39517425|FG000|Overall Study|Poor Growth|3|||
16282527|NCT02339090|39517426|FG001|Overall Study|Poor Growth|0|||
16282528|NCT02339090|39517425|FG000|Overall Study|Randomized but not treated|0|||
16282529|NCT02339090|39517426|FG001|Overall Study|Randomized but not treated|2|||
16282530|NCT02351167|39517427|FG000|Overall Study|Withdrawal by Subject|19|||
16282531|NCT02351167|39517428|FG001|Overall Study|Withdrawal by Subject|18|||
16282532|NCT02351167|39517429|FG002|Overall Study|Withdrawal by Subject|21|||
16282533|NCT00412737|39517430|FG000|Overall Study|Death|1|||
16282534|NCT00412737|39517431|FG001|Overall Study|Death|0|||
16282535|NCT00412737|39517430|FG000|Overall Study|Adverse Event|3|||
16282536|NCT00412737|39517431|FG001|Overall Study|Adverse Event|2|||
16282537|NCT00412737|39517430|FG000|Overall Study|Refused Treatment|6|||
16282538|NCT00412737|39517431|FG001|Overall Study|Refused Treatment|2|||
16282539|NCT00412737|39517430|FG000|Overall Study|Failure to Return|6|||
16282540|NCT00412737|39517431|FG001|Overall Study|Failure to Return|2|||
16282541|NCT01220609|39517433|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
16282542|NCT01220609|39517433|FG000|Overall Study|Ineligible- Wrong cell type|1|||
16282543|NCT01220609|39517433|FG000|Overall Study|Ineligible-Never treated|1|||
16282544|NCT03558139|39517436|FG000|Overall Study|Consent Withdrawn|1|||
16282545|NCT03558139|39517437|FG001|Overall Study|Consent Withdrawn|1|||
16282546|NCT03558139|39517438|FG002|Overall Study|Consent Withdrawn|4|||
16282547|NCT03558139|39517436|FG000|Overall Study|Death|5|||
16282548|NCT03558139|39517437|FG001|Overall Study|Death|3|||
16282549|NCT03558139|39517438|FG002|Overall Study|Death|8|||
16282550|NCT03558139|39517436|FG000|Overall Study|Lost to Follow-up|0|||
16282551|NCT03558139|39517437|FG001|Overall Study|Lost to Follow-up|0|||
16282552|NCT03558139|39517438|FG002|Overall Study|Lost to Follow-up|3|||
16282553|NCT03558139|39517436|FG000|Overall Study|Study Ended Per Protocol|0|||
16282554|NCT03558139|39517437|FG001|Overall Study|Study Ended Per Protocol|3|||
16282555|NCT03558139|39517438|FG002|Overall Study|Study Ended Per Protocol|6|||
16282556|NCT02083926|39517444|FG000|Overall Study|Withdrawal by Subject|1|||
16282557|NCT02083926|39517445|FG001|Overall Study|Withdrawal by Subject|0|||
16282558|NCT01258101|39517446|FG000|Overall Study|Adverse Event|5|||
16282559|NCT01258101|39517447|FG001|Overall Study|Adverse Event|6|||
16282560|NCT01258101|39517448|FG002|Overall Study|Adverse Event|0|||
16282561|NCT01258101|39517449|FG003|Overall Study|Adverse Event|0|||
16282562|NCT01258101|39517446|FG000|Overall Study|Extra exclusion criterion amended|2|||
16282563|NCT01258101|39517447|FG001|Overall Study|Extra exclusion criterion amended|1|||
16282564|NCT01258101|39517448|FG002|Overall Study|Extra exclusion criterion amended|1|||
16282565|NCT01258101|39517449|FG003|Overall Study|Extra exclusion criterion amended|1|||
16282566|NCT01258101|39517446|FG000|Overall Study|Informed consent has been withdrawn|2|||
16282567|NCT01258101|39517447|FG001|Overall Study|Informed consent has been withdrawn|2|||
16282568|NCT01258101|39517448|FG002|Overall Study|Informed consent has been withdrawn|1|||
16282569|NCT01258101|39517449|FG003|Overall Study|Informed consent has been withdrawn|1|||
16282570|NCT01258101|39517446|FG000|Overall Study|Patient is not able to attend visits|8|||
16282571|NCT01258101|39517447|FG001|Overall Study|Patient is not able to attend visits|9|||
16282572|NCT01258101|39517448|FG002|Overall Study|Patient is not able to attend visits|7|||
16282573|NCT01258101|39517449|FG003|Overall Study|Patient is not able to attend visits|6|||
16282574|NCT01258101|39517446|FG000|Overall Study|Patient´s compliance|4|||
16282575|NCT01258101|39517447|FG001|Overall Study|Patient´s compliance|3|||
16282576|NCT01258101|39517448|FG002|Overall Study|Patient´s compliance|1|||
16282577|NCT01258101|39517449|FG003|Overall Study|Patient´s compliance|2|||
16282578|NCT01258101|39517446|FG000|Overall Study|Lost to Follow-up|5|||
16282579|NCT01258101|39517447|FG001|Overall Study|Lost to Follow-up|5|||
16282580|NCT01258101|39517448|FG002|Overall Study|Lost to Follow-up|0|||
16282581|NCT01258101|39517449|FG003|Overall Study|Lost to Follow-up|6|||
16282582|NCT01258101|39517446|FG000|Overall Study|PCR positive at week 24|0|||
16282583|NCT01258101|39517447|FG001|Overall Study|PCR positive at week 24|0|||
16282584|NCT01258101|39517448|FG002|Overall Study|PCR positive at week 24|0|||
16282585|NCT01258101|39517449|FG003|Overall Study|PCR positive at week 24|1|||
16282586|NCT01258101|39517446|FG000|Overall Study|Other reason|7|||
16282587|NCT01258101|39517447|FG001|Overall Study|Other reason|8|||
16282588|NCT01258101|39517448|FG002|Overall Study|Other reason|1|||
16282589|NCT01258101|39517449|FG003|Overall Study|Other reason|8|||
16282590|NCT00605917|39517450|FG000|Overall Study|Protocol Violation|79|||
16282591|NCT00303667|39517456|FG000|Overall Study|Death|0|||
16282592|NCT00303667|39517457|FG001|Overall Study|Death|4|||
16282593|NCT02000531|39517458|FG000|Overall Study|Lost to Follow-up|1|||
16282594|NCT02000531|39517459|FG001|Overall Study|Lost to Follow-up|0|||
16282595|NCT02000531|39517458|FG000|Overall Study|Discontinued due to data cut-off|3|||
16479785|NCT04223973|40234354|FG001|Overall Study|Withdrawal by Subject|1|||
16479786|NCT00702923|40234358|FG000|Overall Study|Adverse Event|1|||
16479787|NCT00085709|40234364|FG000|Overall Study|Adverse Event|8|||
16479788|NCT00085709|40234365|FG001|Overall Study|Adverse Event|0|||
16479789|NCT00085709|40234364|FG000|Overall Study|Death|8|||
16479790|NCT00085709|40234365|FG001|Overall Study|Death|2|||
16479791|NCT00085709|40234364|FG000|Overall Study|Refusal unrelated to adverse events|1|||
16479792|NCT00085709|40234365|FG001|Overall Study|Refusal unrelated to adverse events|2|||
16479793|NCT00085709|40234364|FG000|Overall Study|Progression|3|||
16479794|NCT00085709|40234365|FG001|Overall Study|Progression|4|||
16479795|NCT00085709|40234364|FG000|Overall Study|Not protocol specified|12|||
16479796|NCT00085709|40234365|FG001|Overall Study|Not protocol specified|22|||
16479797|NCT00085709|40234364|FG000|Overall Study|Not eligible|19|||
16479798|NCT00085709|40234365|FG001|Overall Study|Not eligible|19|||
16282596|NCT02000531|39517459|FG001|Overall Study|Discontinued due to data cut-off|8|||
16282597|NCT00129116|39517464|FG000|Primary Phase|Lost to Follow-up|1|||
16282598|NCT00129116|39517465|FG001|Primary Phase|Lost to Follow-up|1|||
16282599|NCT00129116|39517466|FG002|Primary Phase|Lost to Follow-up|0|||
16282600|NCT00129116|39517467|FG003|Primary Phase|Lost to Follow-up|1|||
16282601|NCT00129116|39517468|FG004|Primary Phase|Lost to Follow-up|1|||
16282602|NCT00129116|39517464|FG000|Primary Phase|Protocol Violation|0|||
16282603|NCT00129116|39517465|FG001|Primary Phase|Protocol Violation|1|||
16282604|NCT00129116|39517466|FG002|Primary Phase|Protocol Violation|0|||
16282605|NCT00129116|39517467|FG003|Primary Phase|Protocol Violation|0|||
16282606|NCT00129116|39517468|FG004|Primary Phase|Protocol Violation|0|||
16282607|NCT00129116|39517464|FG000|Primary Phase|Adverse Event|1|||
16282608|NCT00129116|39517465|FG001|Primary Phase|Adverse Event|1|||
16282609|NCT00129116|39517466|FG002|Primary Phase|Adverse Event|0|||
16479799|NCT00085709|40234364|FG000|Overall Study|Withdrawal by Subject|2|||
16479800|NCT00085709|40234365|FG001|Overall Study|Withdrawal by Subject|1|||
16479801|NCT01612858|40234366|FG000|Overall Study|Withdrawal by Subject|5|||
16479802|NCT01612858|40234367|FG001|Overall Study|Withdrawal by Subject|1|||
16282610|NCT00129116|39517467|FG003|Primary Phase|Adverse Event|0|||
16282611|NCT00129116|39517468|FG004|Primary Phase|Adverse Event|0|||
16282612|NCT00129116|39517464|FG000|Primary Phase|Withdrawal by Subject|0|||
16282613|NCT00129116|39517465|FG001|Primary Phase|Withdrawal by Subject|1|||
16282614|NCT00129116|39517466|FG002|Primary Phase|Withdrawal by Subject|0|||
16282615|NCT00129116|39517467|FG003|Primary Phase|Withdrawal by Subject|0|||
16282616|NCT00129116|39517468|FG004|Primary Phase|Withdrawal by Subject|0|||
16282617|NCT00129116|39517464|FG000|Primary Phase|Other|0|||
16282618|NCT00129116|39517465|FG001|Primary Phase|Other|0|||
16282619|NCT00129116|39517466|FG002|Primary Phase|Other|1|||
16282620|NCT00129116|39517467|FG003|Primary Phase|Other|0|||
16282621|NCT00129116|39517468|FG004|Primary Phase|Other|0|||
16282622|NCT00129116|39517464|FG000|Booster Phase|Lost to Follow-up|2|||
16282623|NCT00129116|39517465|FG001|Booster Phase|Lost to Follow-up|0|||
16282624|NCT00129116|39517466|FG002|Booster Phase|Lost to Follow-up|0|||
16282625|NCT00129116|39517467|FG003|Booster Phase|Lost to Follow-up|0|||
16282626|NCT00129116|39517468|FG004|Booster Phase|Lost to Follow-up|1|||
16282627|NCT02400476|39517472|FG000|Overall Study|Adverse Event|57|||
16282628|NCT02400476|39517473|FG001|Overall Study|Adverse Event|10|||
16282629|NCT02400476|39517474|FG002|Overall Study|Adverse Event|22|||
16282630|NCT02400476|39517475|FG003|Overall Study|Adverse Event|19|||
16282631|NCT02400476|39517476|FG004|Overall Study|Adverse Event|5|||
16282632|NCT02400476|39517477|FG005|Overall Study|Adverse Event|8|||
16282633|NCT02400476|39517472|FG000|Overall Study|Withdrawal by Subject|4|||
16282634|NCT02400476|39517473|FG001|Overall Study|Withdrawal by Subject|1|||
16282635|NCT02400476|39517474|FG002|Overall Study|Withdrawal by Subject|12|||
16282636|NCT02400476|39517475|FG003|Overall Study|Withdrawal by Subject|7|||
16282637|NCT02400476|39517476|FG004|Overall Study|Withdrawal by Subject|5|||
16282638|NCT02400476|39517477|FG005|Overall Study|Withdrawal by Subject|5|||
16282639|NCT02400476|39517472|FG000|Overall Study|Lost to Follow-up|0|||
16282640|NCT02400476|39517473|FG001|Overall Study|Lost to Follow-up|0|||
16282641|NCT02400476|39517474|FG002|Overall Study|Lost to Follow-up|0|||
16282642|NCT02400476|39517475|FG003|Overall Study|Lost to Follow-up|1|||
16282643|NCT02400476|39517476|FG004|Overall Study|Lost to Follow-up|3|||
16282644|NCT02400476|39517477|FG005|Overall Study|Lost to Follow-up|1|||
16282645|NCT02400476|39517472|FG000|Overall Study|Physician Decision|0|||
16282646|NCT02400476|39517473|FG001|Overall Study|Physician Decision|0|||
16282647|NCT02400476|39517474|FG002|Overall Study|Physician Decision|1|||
16282648|NCT02400476|39517475|FG003|Overall Study|Physician Decision|1|||
16282649|NCT02400476|39517476|FG004|Overall Study|Physician Decision|0|||
16282650|NCT02400476|39517477|FG005|Overall Study|Physician Decision|1|||
16282651|NCT02400476|39517472|FG000|Overall Study|Other, Disease Progression|0|||
16282652|NCT02400476|39517473|FG001|Overall Study|Other, Disease Progression|1|||
16282653|NCT02400476|39517474|FG002|Overall Study|Other, Disease Progression|2|||
16282654|NCT02400476|39517475|FG003|Overall Study|Other, Disease Progression|1|||
16282655|NCT02400476|39517476|FG004|Overall Study|Other, Disease Progression|2|||
16282656|NCT02400476|39517477|FG005|Overall Study|Other, Disease Progression|1|||
16282657|NCT02400476|39517472|FG000|Overall Study|Other, Decreased Quality of Life|0|||
16282658|NCT02400476|39517473|FG001|Overall Study|Other, Decreased Quality of Life|0|||
16282659|NCT02400476|39517474|FG002|Overall Study|Other, Decreased Quality of Life|2|||
16282660|NCT02400476|39517475|FG003|Overall Study|Other, Decreased Quality of Life|0|||
16282661|NCT02400476|39517476|FG004|Overall Study|Other, Decreased Quality of Life|0|||
16282662|NCT02400476|39517477|FG005|Overall Study|Other, Decreased Quality of Life|0|||
16282663|NCT02400476|39517472|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
16282664|NCT02400476|39517473|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
16282665|NCT02400476|39517474|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
16282666|NCT02400476|39517475|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
16282667|NCT02400476|39517476|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
16282668|NCT02400476|39517477|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
16282669|NCT02021318|39517492|FG000|Overall Study|Adverse Event|2|||
16282670|NCT02021318|39517493|FG001|Overall Study|Adverse Event|1|||
16282671|NCT02021318|39517492|FG000|Overall Study|Death|33|||
16282672|NCT02021318|39517493|FG001|Overall Study|Death|34|||
16282673|NCT02021318|39517492|FG000|Overall Study|Lost to Follow-up|3|||
16282674|NCT02021318|39517493|FG001|Overall Study|Lost to Follow-up|3|||
16282675|NCT02021318|39517492|FG000|Overall Study|Progressive Disease|0|||
16282676|NCT02021318|39517493|FG001|Overall Study|Progressive Disease|1|||
16282677|NCT02021318|39517492|FG000|Overall Study|Withdrawal by Subject|30|||
16282678|NCT02021318|39517493|FG001|Overall Study|Withdrawal by Subject|18|||
16282679|NCT02021318|39517492|FG000|Overall Study|Physician Decision|3|||
16282680|NCT02021318|39517493|FG001|Overall Study|Physician Decision|3|||
16282681|NCT02021318|39517492|FG000|Overall Study|Miscellaneous|2|||
16282682|NCT02021318|39517493|FG001|Overall Study|Miscellaneous|3|||
16080220|NCT01307267|38786788|FG007|Overall Study|Lost to Follow-up|0|||
16282683|NCT00576303|39517501|FG000|Dose Titration Period|Early withdrawal|17|||
16282684|NCT00576303|39517501|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
16282685|NCT00576303|39517501|FG000|Long Term Safety Period|Early withdrawal|16|||
16282686|NCT02999984|39517505|FG000|Overall Study|Treatment Failure|1|||
16282687|NCT04798482|39517511|FG000|Overall Study|Physician Decision|1|||
16282688|NCT04798482|39517511|FG000|Overall Study|Lost eligibility|1|||
16282689|NCT03043872|39517514|FG000|Overall Study|Withdrawal by Subject|6|||
16282690|NCT03043872|39517515|FG001|Overall Study|Withdrawal by Subject|6|||
16282691|NCT03043872|39517516|FG002|Overall Study|Withdrawal by Subject|15|||
16282692|NCT03043872|39517514|FG000|Overall Study|Lost to Follow-up|2|||
16282693|NCT03043872|39517515|FG001|Overall Study|Lost to Follow-up|1|||
16282694|NCT03043872|39517516|FG002|Overall Study|Lost to Follow-up|1|||
16282695|NCT03043872|39517514|FG000|Overall Study|Death|270|||
16282696|NCT03043872|39517515|FG001|Overall Study|Death|269|||
16282697|NCT03043872|39517516|FG002|Overall Study|Death|296|||
16282698|NCT03430011|39517517|FG000|Pre-Treatment|Death|1|||
16282699|NCT03430011|39517518|FG001|Pre-Treatment|Death|0|||
16282700|NCT03430011|39517519|FG002|Pre-Treatment|Death|0|||
16282701|NCT03430011|39517520|FG003|Pre-Treatment|Death|0|||
16282702|NCT03430011|39517521|FG004|Pre-Treatment|Death|1|||
16282703|NCT03430011|39517522|FG005|Pre-Treatment|Death|0|||
16282704|NCT03430011|39517523|FG006|Pre-Treatment|Death|1|||
16282705|NCT03430011|39517524|FG007|Pre-Treatment|Death|0|||
16282706|NCT03430011|39517517|FG000|Pre-Treatment|Screen Fail|0|||
16282707|NCT03430011|39517518|FG001|Pre-Treatment|Screen Fail|0|||
16282708|NCT03430011|39517519|FG002|Pre-Treatment|Screen Fail|0|||
16282709|NCT03430011|39517520|FG003|Pre-Treatment|Screen Fail|0|||
16282710|NCT03430011|39517521|FG004|Pre-Treatment|Screen Fail|1|||
16282711|NCT03430011|39517522|FG005|Pre-Treatment|Screen Fail|0|||
16282712|NCT03430011|39517523|FG006|Pre-Treatment|Screen Fail|0|||
16282713|NCT03430011|39517524|FG007|Pre-Treatment|Screen Fail|0|||
16282714|NCT03430011|39517517|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
16282715|NCT03430011|39517518|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
16282716|NCT03430011|39517519|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
16282717|NCT03430011|39517520|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
16282718|NCT03430011|39517521|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
16282719|NCT03430011|39517522|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
16282720|NCT03430011|39517523|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
16282721|NCT03430011|39517524|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
16282722|NCT03430011|39517517|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
16282723|NCT03430011|39517518|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
16282724|NCT03430011|39517519|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
16282725|NCT03430011|39517520|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
16282726|NCT03430011|39517521|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
16282727|NCT03430011|39517522|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
16282728|NCT03430011|39517523|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
16282729|NCT03430011|39517524|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
16282730|NCT03430011|39517517|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
16282731|NCT03430011|39517518|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
16282732|NCT03430011|39517519|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
16282733|NCT03430011|39517520|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
16282734|NCT03430011|39517521|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
16282735|NCT03430011|39517522|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
16282736|NCT03430011|39517523|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
16282737|NCT03430011|39517524|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
16282738|NCT03430011|39517517|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
16282739|NCT03430011|39517518|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
16282740|NCT03430011|39517519|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
16479803|NCT00851630|40234377|FG000|Overall Study|Death|2|||
16479804|NCT00851630|40234378|FG001|Overall Study|Death|1|||
16282741|NCT03430011|39517520|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
16282742|NCT03430011|39517521|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
16282743|NCT03430011|39517522|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
16282744|NCT03430011|39517523|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
16282745|NCT03430011|39517524|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
16282746|NCT03430011|39517517|FG000|JCARH125 Treatment|Death|4|||
16282747|NCT03430011|39517518|FG001|JCARH125 Treatment|Death|19|||
16282748|NCT03430011|39517519|FG002|JCARH125 Treatment|Death|10|||
16282749|NCT03430011|39517520|FG003|JCARH125 Treatment|Death|8|||
16379753|NCT03814746|39874763|FG001|Overall Study|Adverse Event|2|||
16379754|NCT03814746|39874764|FG002|Overall Study|Adverse Event|1|||
16379755|NCT03814746|39874762|FG000|Overall Study|Lost to Follow-up|2|||
16379756|NCT03814746|39874763|FG001|Overall Study|Lost to Follow-up|1|||
16379757|NCT03814746|39874764|FG002|Overall Study|Lost to Follow-up|2|||
16379758|NCT03814746|39874762|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16479805|NCT00851630|40234377|FG000|Overall Study|Clinical failure|0|||
16080221|NCT01307267|38786789|FG008|Overall Study|Lost to Follow-up|1|||
16282750|NCT03430011|39517521|FG004|JCARH125 Treatment|Death|5|||
16282751|NCT03430011|39517522|FG005|JCARH125 Treatment|Death|3|||
16282752|NCT03430011|39517523|FG006|JCARH125 Treatment|Death|4|||
16379759|NCT03814746|39874763|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16479806|NCT00851630|40234378|FG001|Overall Study|Clinical failure|1|||
16479807|NCT03953820|40234379|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
16282753|NCT03430011|39517524|FG007|JCARH125 Treatment|Death|2|||
16282754|NCT03430011|39517517|FG000|JCARH125 Treatment|Other reasons|1|||
16282755|NCT03430011|39517518|FG001|JCARH125 Treatment|Other reasons|0|||
16282756|NCT03430011|39517519|FG002|JCARH125 Treatment|Other reasons|4|||
16282757|NCT03430011|39517520|FG003|JCARH125 Treatment|Other reasons|2|||
16282758|NCT03430011|39517521|FG004|JCARH125 Treatment|Other reasons|2|||
16282759|NCT03430011|39517522|FG005|JCARH125 Treatment|Other reasons|1|||
16282760|NCT03430011|39517523|FG006|JCARH125 Treatment|Other reasons|3|||
16282761|NCT03430011|39517524|FG007|JCARH125 Treatment|Other reasons|2|||
16282762|NCT02839798|39517525|FG000|Overall Study|Withdrawal by Subject|2|||
16282763|NCT00517192|39517526|FG000|Overall Study|Adverse Event|1|||
16282764|NCT00517192|39517527|FG001|Overall Study|Adverse Event|1|||
16282765|NCT00517192|39517526|FG000|Overall Study|Lost to Follow-up|1|||
16282766|NCT00517192|39517527|FG001|Overall Study|Lost to Follow-up|1|||
16282767|NCT00517192|39517526|FG000|Overall Study|Withdrawal by Subject|1|||
16282768|NCT00517192|39517527|FG001|Overall Study|Withdrawal by Subject|0|||
16282769|NCT00517192|39517526|FG000|Overall Study|Early termination of the trial|16|||
16282770|NCT00517192|39517527|FG001|Overall Study|Early termination of the trial|18|||
16282771|NCT03547635|39517528|FG000|Overall Study|Adverse Event|5|||
16282772|NCT03547635|39517529|FG001|Overall Study|Adverse Event|2|||
16282773|NCT03547635|39517530|FG002|Overall Study|Adverse Event|3|||
16282774|NCT03547635|39517528|FG000|Overall Study|Lost to Follow-up|1|||
16282775|NCT03547635|39517529|FG001|Overall Study|Lost to Follow-up|3|||
16282776|NCT03547635|39517530|FG002|Overall Study|Lost to Follow-up|4|||
16282777|NCT03547635|39517528|FG000|Overall Study|Withdrawal by Subject|1|||
16282778|NCT03547635|39517529|FG001|Overall Study|Withdrawal by Subject|0|||
16282779|NCT03547635|39517530|FG002|Overall Study|Withdrawal by Subject|0|||
16282780|NCT03547635|39517528|FG000|Overall Study|Withdrawal By PI|0|||
16282781|NCT03547635|39517529|FG001|Overall Study|Withdrawal By PI|1|||
16282782|NCT03547635|39517530|FG002|Overall Study|Withdrawal By PI|0|||
16282783|NCT03547635|39517528|FG000|Overall Study|Withdrawal by Sponsor|0|||
16282784|NCT03547635|39517529|FG001|Overall Study|Withdrawal by Sponsor|0|||
16282785|NCT03547635|39517530|FG002|Overall Study|Withdrawal by Sponsor|1|||
16282786|NCT03547635|39517528|FG000|Overall Study|Errant Randomization before Treatment|0|||
16282787|NCT03547635|39517529|FG001|Overall Study|Errant Randomization before Treatment|1|||
16282788|NCT03547635|39517530|FG002|Overall Study|Errant Randomization before Treatment|0|||
16282789|NCT03547635|39517528|FG000|Overall Study|Withdrawal by Subject|1|||
16282790|NCT03547635|39517529|FG001|Overall Study|Withdrawal by Subject|0|||
16282791|NCT03547635|39517530|FG002|Overall Study|Withdrawal by Subject|0|||
16282792|NCT02994394|39517531|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
16282793|NCT02994394|39517532|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
16282794|NCT02994394|39517533|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
16282795|NCT02994394|39517534|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
16282796|NCT02994394|39517535|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
16282797|NCT02994394|39517536|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
16282798|NCT02994394|39517531|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
16282799|NCT02994394|39517532|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
16282800|NCT02994394|39517533|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
16282801|NCT02994394|39517534|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
16282802|NCT02994394|39517535|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
16282803|NCT02994394|39517536|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
16282804|NCT00588731|39517537|FG000|Overall Study|Withdrawal by Subject|3|||
16282805|NCT00588731|39517538|FG001|Overall Study|Withdrawal by Subject|2|||
16282806|NCT03629028|39517547|FG000|Overall Study|Lost to Follow-up|26|||
16282807|NCT03629028|39517548|FG001|Overall Study|Lost to Follow-up|23|||
16282808|NCT03629028|39517547|FG000|Overall Study|Pregnancy|4|||
16282809|NCT03629028|39517548|FG001|Overall Study|Pregnancy|2|||
16282810|NCT03629028|39517547|FG000|Overall Study|intolerance to examination|2|||
16282811|NCT03629028|39517548|FG001|Overall Study|intolerance to examination|0|||
16282812|NCT01731886|39517555|FG000|Overall Study|Death|1|||
16379760|NCT03814746|39874764|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
16379761|NCT03814746|39874762|FG000|Overall Study|Pregnancy|0|||
16379762|NCT03814746|39874763|FG001|Overall Study|Pregnancy|1|||
16379763|NCT03814746|39874764|FG002|Overall Study|Pregnancy|1|||
16379764|NCT03814746|39874762|FG000|Overall Study|Protocol Violation|1|||
16379765|NCT03814746|39874763|FG001|Overall Study|Protocol Violation|0|||
16379766|NCT03814746|39874764|FG002|Overall Study|Protocol Violation|0|||
16379767|NCT04938427|39874765|FG000|Overall Study|Adverse Event|5|||
16379768|NCT04938427|39874766|FG001|Overall Study|Adverse Event|19|||
16379769|NCT04938427|39874765|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
16282813|NCT01731886|39517556|FG001|Overall Study|Death|0|||
16282814|NCT01731886|39517555|FG000|Overall Study|Never started treatment|0|||
16282815|NCT01731886|39517556|FG001|Overall Study|Never started treatment|1|||
16282816|NCT01731886|39517555|FG000|Overall Study|Non-compliant|1|||
16282817|NCT01731886|39517556|FG001|Overall Study|Non-compliant|0|||
16282818|NCT00987831|39517557|FG000|Overall Study|Never flared in 12 months|1|||
16379770|NCT04938427|39874766|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16080222|NCT01307267|38786790|FG009|Overall Study|Lost to Follow-up|2|||
16282819|NCT00987831|39517558|FG001|Overall Study|Never flared in 12 months|0|||
16282820|NCT00987831|39517559|FG002|Overall Study|Never flared in 12 months|0|||
16282821|NCT00987831|39517557|FG000|Overall Study|Lost to Follow-up|0|||
16282822|NCT00987831|39517558|FG001|Overall Study|Lost to Follow-up|3|||
16282823|NCT00987831|39517559|FG002|Overall Study|Lost to Follow-up|0|||
16282824|NCT03062358|39517564|FG000|Overall Study|Death|220|||
16282825|NCT03062358|39517565|FG001|Overall Study|Death|127|||
16282826|NCT03062358|39517564|FG000|Overall Study|Withdrawal by Subject|2|||
16282827|NCT03062358|39517565|FG001|Overall Study|Withdrawal by Subject|1|||
16282828|NCT03062358|39517564|FG000|Overall Study|Ongoing in Trial|78|||
16282829|NCT03062358|39517565|FG001|Overall Study|Ongoing in Trial|25|||
16282830|NCT00985231|39517573|FG000|Overall Study|ineligible|1|||
16282831|NCT00985231|39517574|FG001|Overall Study|ineligible|0|||
16282832|NCT00985231|39517573|FG000|Overall Study|Protocol Violation|1|||
16282833|NCT00985231|39517574|FG001|Overall Study|Protocol Violation|0|||
16282834|NCT00985231|39517573|FG000|Overall Study|Withdrawal by Subject|1|||
16282835|NCT00985231|39517574|FG001|Overall Study|Withdrawal by Subject|0|||
16282836|NCT00985231|39517573|FG000|Overall Study|Lost to Follow-up|0|||
16282837|NCT00985231|39517574|FG001|Overall Study|Lost to Follow-up|1|||
16282838|NCT00985231|39517573|FG000|Overall Study|Study related symptoms & complaints|0|||
16282839|NCT00985231|39517574|FG001|Overall Study|Study related symptoms & complaints|2|||
16282840|NCT03545191|39517577|FG000|Overall Study|Death|1|||
16282841|NCT03545191|39517578|FG001|Overall Study|Death|0|||
16282842|NCT03545191|39517579|FG002|Overall Study|Death|0|||
16282843|NCT03545191|39517577|FG000|Overall Study|Adverse Event|4|||
16282844|NCT03545191|39517578|FG001|Overall Study|Adverse Event|2|||
16282845|NCT03545191|39517579|FG002|Overall Study|Adverse Event|7|||
16282846|NCT03545191|39517577|FG000|Overall Study|Other reasons|3|||
16282847|NCT03545191|39517578|FG001|Overall Study|Other reasons|11|||
16282848|NCT03545191|39517579|FG002|Overall Study|Other reasons|8|||
16282849|NCT03545191|39517577|FG000|Overall Study|Withdrawal by Subject|13|||
16282850|NCT03545191|39517578|FG001|Overall Study|Withdrawal by Subject|10|||
16479808|NCT03953820|40234380|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
16479809|NCT03953820|40234381|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
16479810|NCT03953820|40234379|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
16479811|NCT03953820|40234380|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
16479812|NCT03953820|40234381|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
16479813|NCT00285818|40234382|FG000|Overall Study|Withdrawal by Subject|3|||
16479814|NCT00285818|40234383|FG001|Overall Study|Withdrawal by Subject|2|||
16479815|NCT00285818|40234382|FG000|Overall Study|Lost to Follow-up|1|||
16479816|NCT00285818|40234383|FG001|Overall Study|Lost to Follow-up|0|||
16282851|NCT03545191|39517579|FG002|Overall Study|Withdrawal by Subject|12|||
16282852|NCT03545191|39517577|FG000|Overall Study|Lost to Follow-up|1|||
16282853|NCT03545191|39517578|FG001|Overall Study|Lost to Follow-up|2|||
16282854|NCT03545191|39517579|FG002|Overall Study|Lost to Follow-up|3|||
16282855|NCT01230892|39517580|FG000|Overall Study|Withdrawal by Subject|1|||
16282856|NCT01230892|39517581|FG001|Overall Study|Withdrawal by Subject|1|||
16282857|NCT01230892|39517580|FG000|Overall Study|Lost to Follow-up|2|||
16282858|NCT01230892|39517581|FG001|Overall Study|Lost to Follow-up|0|||
16282859|NCT00171340|39517582|FG000|Overall Study|Adverse Event|46|||
16282860|NCT00171340|39517583|FG001|Overall Study|Adverse Event|42|||
16282861|NCT00171340|39517582|FG000|Overall Study|Lack of Efficacy|29|||
16282862|NCT00171340|39517583|FG001|Overall Study|Lack of Efficacy|41|||
16282863|NCT00171340|39517582|FG000|Overall Study|Protocol Violation|7|||
16282864|NCT00171340|39517583|FG001|Overall Study|Protocol Violation|8|||
16282865|NCT00171340|39517582|FG000|Overall Study|Withdrawal by Subject|22|||
16282866|NCT00171340|39517583|FG001|Overall Study|Withdrawal by Subject|19|||
16282867|NCT00171340|39517582|FG000|Overall Study|Lost to Follow-up|0|||
16282868|NCT00171340|39517583|FG001|Overall Study|Lost to Follow-up|5|||
16282869|NCT00171340|39517582|FG000|Overall Study|Abnormal Laboratory Results|2|||
16282870|NCT00171340|39517583|FG001|Overall Study|Abnormal Laboratory Results|0|||
16282871|NCT00171340|39517582|FG000|Overall Study|Abnormal Test Procedure Results|6|||
16282872|NCT00171340|39517583|FG001|Overall Study|Abnormal Test Procedure Results|11|||
16282873|NCT00171340|39517582|FG000|Overall Study|No Longer Required Study Drug|1|||
16282874|NCT00171340|39517583|FG001|Overall Study|No Longer Required Study Drug|1|||
16282875|NCT00171340|39517582|FG000|Overall Study|Administrative Problems|5|||
16282876|NCT00171340|39517583|FG001|Overall Study|Administrative Problems|2|||
16282877|NCT00171340|39517582|FG000|Overall Study|Death|6|||
16282878|NCT00171340|39517583|FG001|Overall Study|Death|6|||
16282879|NCT02737592|39517588|FG000|Overall Study|Withdrawal by Subject|1|||
16282880|NCT02927834|39517589|FG000|Overall Study|Lost to Follow-up|1|||
16282881|NCT02927834|39517590|FG001|Overall Study|Lost to Follow-up|2|||
16282882|NCT02927834|39517591|FG002|Overall Study|Lost to Follow-up|2|||
16282883|NCT03135899|39517596|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
16479817|NCT00115739|40234384|FG000|Overall Study|Lost to Follow-up|3|||
16080223|NCT01307267|38786791|FG010|Overall Study|Lost to Follow-up|1|||
16282884|NCT03135899|39517597|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
16282885|NCT03135899|39517598|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
16282886|NCT03135899|39517599|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
16282887|NCT03135899|39517600|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
16282888|NCT03135899|39517601|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
16282889|NCT03135899|39517602|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
16282890|NCT03135899|39517603|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
16282891|NCT03135899|39517596|FG000|Overall Study|Withdrawal by Subject|0|||
16282892|NCT03135899|39517597|FG001|Overall Study|Withdrawal by Subject|0|||
16282893|NCT03135899|39517598|FG002|Overall Study|Withdrawal by Subject|0|||
16282894|NCT03135899|39517599|FG003|Overall Study|Withdrawal by Subject|0|||
16282895|NCT03135899|39517600|FG004|Overall Study|Withdrawal by Subject|0|||
16282896|NCT03135899|39517601|FG005|Overall Study|Withdrawal by Subject|2|||
16282897|NCT03135899|39517602|FG006|Overall Study|Withdrawal by Subject|0|||
16282898|NCT03135899|39517603|FG007|Overall Study|Withdrawal by Subject|0|||
16282899|NCT02710214|39517607|FG000|Overall Study|Lost to Follow-up|1|||
16282900|NCT02710214|39517608|FG001|Overall Study|Lost to Follow-up|0|||
16282901|NCT02710214|39517607|FG000|Overall Study|Lack of Efficacy|0|||
16282902|NCT02710214|39517608|FG001|Overall Study|Lack of Efficacy|1|||
16282903|NCT02710214|39517607|FG000|Overall Study|Death|0|||
16282904|NCT02710214|39517608|FG001|Overall Study|Death|1|||
16282905|NCT01714739|39517612|FG000|Overall Study|Disease progression|3|||
16282906|NCT01714739|39517613|FG001|Overall Study|Disease progression|5|||
16282907|NCT01714739|39517614|FG002|Overall Study|Disease progression|5|||
16282908|NCT01714739|39517615|FG003|Overall Study|Disease progression|204|||
16282909|NCT01714739|39517616|FG004|Overall Study|Disease progression|1|||
16282910|NCT01714739|39517617|FG005|Overall Study|Disease progression|3|||
16282911|NCT01714739|39517618|FG006|Overall Study|Disease progression|5|||
16282912|NCT01714739|39517612|FG000|Overall Study|Study drug toxicity|1|||
16282913|NCT01714739|39517613|FG001|Overall Study|Study drug toxicity|1|||
16282914|NCT01714739|39517614|FG002|Overall Study|Study drug toxicity|1|||
16282915|NCT01714739|39517615|FG003|Overall Study|Study drug toxicity|15|||
16282916|NCT01714739|39517616|FG004|Overall Study|Study drug toxicity|0|||
16282917|NCT01714739|39517617|FG005|Overall Study|Study drug toxicity|0|||
16282918|NCT01714739|39517618|FG006|Overall Study|Study drug toxicity|5|||
16282919|NCT01714739|39517612|FG000|Overall Study|Death|0|||
16282920|NCT01714739|39517613|FG001|Overall Study|Death|0|||
16282921|NCT01714739|39517614|FG002|Overall Study|Death|0|||
16282922|NCT01714739|39517615|FG003|Overall Study|Death|1|||
16282923|NCT01714739|39517616|FG004|Overall Study|Death|0|||
16282924|NCT01714739|39517617|FG005|Overall Study|Death|0|||
16282925|NCT01714739|39517618|FG006|Overall Study|Death|0|||
16282926|NCT01714739|39517612|FG000|Overall Study|Adverse Event unrelated to drug|0|||
16282927|NCT01714739|39517613|FG001|Overall Study|Adverse Event unrelated to drug|0|||
16282928|NCT01714739|39517614|FG002|Overall Study|Adverse Event unrelated to drug|3|||
16282929|NCT01714739|39517615|FG003|Overall Study|Adverse Event unrelated to drug|21|||
16282930|NCT01714739|39517616|FG004|Overall Study|Adverse Event unrelated to drug|0|||
16282931|NCT01714739|39517617|FG005|Overall Study|Adverse Event unrelated to drug|0|||
16282932|NCT01714739|39517618|FG006|Overall Study|Adverse Event unrelated to drug|0|||
16282933|NCT01714739|39517612|FG000|Overall Study|Participant request to stop therapy|0|||
16282934|NCT01714739|39517613|FG001|Overall Study|Participant request to stop therapy|1|||
16282935|NCT01714739|39517614|FG002|Overall Study|Participant request to stop therapy|0|||
16282936|NCT01714739|39517615|FG003|Overall Study|Participant request to stop therapy|6|||
16282937|NCT01714739|39517616|FG004|Overall Study|Participant request to stop therapy|0|||
16282938|NCT01714739|39517617|FG005|Overall Study|Participant request to stop therapy|0|||
16282939|NCT01714739|39517618|FG006|Overall Study|Participant request to stop therapy|0|||
16282940|NCT01714739|39517612|FG000|Overall Study|Participant withdrew consent|0|||
16282941|NCT01714739|39517613|FG001|Overall Study|Participant withdrew consent|1|||
16282942|NCT01714739|39517614|FG002|Overall Study|Participant withdrew consent|0|||
16282943|NCT01714739|39517615|FG003|Overall Study|Participant withdrew consent|8|||
16282944|NCT01714739|39517616|FG004|Overall Study|Participant withdrew consent|0|||
16282945|NCT01714739|39517617|FG005|Overall Study|Participant withdrew consent|0|||
16282946|NCT01714739|39517618|FG006|Overall Study|Participant withdrew consent|0|||
16282947|NCT01714739|39517612|FG000|Overall Study|Lost to Follow-up|0|||
16282948|NCT01714739|39517613|FG001|Overall Study|Lost to Follow-up|0|||
16282949|NCT01714739|39517614|FG002|Overall Study|Lost to Follow-up|0|||
16379771|NCT04938427|39874765|FG000|Overall Study|Withdrawal by Subject|1|||
16379772|NCT04938427|39874766|FG001|Overall Study|Withdrawal by Subject|0|||
16282950|NCT01714739|39517615|FG003|Overall Study|Lost to Follow-up|1|||
16282951|NCT01714739|39517616|FG004|Overall Study|Lost to Follow-up|0|||
16282952|NCT01714739|39517617|FG005|Overall Study|Lost to Follow-up|0|||
16282953|NCT01714739|39517618|FG006|Overall Study|Lost to Follow-up|0|||
16282954|NCT01714739|39517612|FG000|Overall Study|Maximum clinical benefit|0|||
16282955|NCT01714739|39517613|FG001|Overall Study|Maximum clinical benefit|1|||
16282956|NCT01714739|39517614|FG002|Overall Study|Maximum clinical benefit|1|||
16282957|NCT01714739|39517615|FG003|Overall Study|Maximum clinical benefit|3|||
16282958|NCT01714739|39517616|FG004|Overall Study|Maximum clinical benefit|0|||
16282959|NCT01714739|39517617|FG005|Overall Study|Maximum clinical benefit|0|||
16282960|NCT01714739|39517618|FG006|Overall Study|Maximum clinical benefit|0|||
16282961|NCT01714739|39517612|FG000|Overall Study|Poor/non-comliance|0|||
16282962|NCT01714739|39517613|FG001|Overall Study|Poor/non-comliance|1|||
16282963|NCT01714739|39517614|FG002|Overall Study|Poor/non-comliance|0|||
16282964|NCT01714739|39517615|FG003|Overall Study|Poor/non-comliance|1|||
16282965|NCT01714739|39517616|FG004|Overall Study|Poor/non-comliance|0|||
16282966|NCT01714739|39517617|FG005|Overall Study|Poor/non-comliance|0|||
16282967|NCT01714739|39517618|FG006|Overall Study|Poor/non-comliance|0|||
16282968|NCT01714739|39517612|FG000|Overall Study|No longer meets study criteria|0|||
16282969|NCT01714739|39517613|FG001|Overall Study|No longer meets study criteria|0|||
16282970|NCT01714739|39517614|FG002|Overall Study|No longer meets study criteria|0|||
16282971|NCT01714739|39517615|FG003|Overall Study|No longer meets study criteria|1|||
16282972|NCT01714739|39517616|FG004|Overall Study|No longer meets study criteria|0|||
16282973|NCT01714739|39517617|FG005|Overall Study|No longer meets study criteria|0|||
16282974|NCT01714739|39517618|FG006|Overall Study|No longer meets study criteria|0|||
16282975|NCT01714739|39517612|FG000|Overall Study|Other reason|0|||
16282976|NCT01714739|39517613|FG001|Overall Study|Other reason|0|||
16282977|NCT01714739|39517614|FG002|Overall Study|Other reason|0|||
16282978|NCT01714739|39517615|FG003|Overall Study|Other reason|3|||
16282979|NCT01714739|39517616|FG004|Overall Study|Other reason|1|||
16282980|NCT01714739|39517617|FG005|Overall Study|Other reason|0|||
16282981|NCT01714739|39517618|FG006|Overall Study|Other reason|0|||
16282982|NCT00251316|39517619|FG000|Overall Study|Physician Decision|2|||
16282983|NCT00251316|39517620|FG001|Overall Study|Physician Decision|3|||
16282984|NCT01020526|39517621|FG000|Overall Study|Withdrawal by Subject|5|||
16282985|NCT01020526|39517621|FG000|Overall Study|Other reasons|3|||
16282986|NCT01020526|39517621|FG000|Overall Study|Insufficient clinical response|3|||
16282987|NCT01020526|39517621|FG000|Overall Study|Lost to Follow-up|1|||
16282988|NCT01020526|39517621|FG000|Overall Study|Adverse Event|2|||
16282989|NCT03297294|39517622|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
16282990|NCT03297294|39517623|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
16282991|NCT03297294|39517624|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
16282992|NCT03297294|39517625|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
16282993|NCT03297294|39517626|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
16282994|NCT03297294|39517622|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
16282995|NCT03297294|39517623|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
16282996|NCT03297294|39517624|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
16282997|NCT03297294|39517625|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
16282998|NCT03297294|39517626|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
16282999|NCT03297294|39517622|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
16283000|NCT03297294|39517623|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
16283001|NCT03297294|39517624|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
16283002|NCT03297294|39517625|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
16283003|NCT03297294|39517626|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
16283004|NCT03297294|39517622|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
16283005|NCT03297294|39517623|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
16283006|NCT03297294|39517624|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
16283007|NCT03297294|39517625|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
16283008|NCT03297294|39517626|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
16283009|NCT03297294|39517622|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
16283010|NCT03297294|39517623|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
16283011|NCT03297294|39517624|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
16283012|NCT03297294|39517625|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
16283013|NCT03297294|39517626|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
16479818|NCT03673046|40234387|FG000|Overall Study|Adverse Event|1|||
16479819|NCT03673046|40234388|FG001|Overall Study|Adverse Event|1|||
16479820|NCT03673046|40234387|FG000|Overall Study|Withdrawal by Subject|8|||
16479821|NCT03673046|40234388|FG001|Overall Study|Withdrawal by Subject|2|||
16479822|NCT00392015|40234391|FG000|Overall Study|Lost to Follow-up|2|||
16479823|NCT00392015|40234392|FG001|Overall Study|Lost to Follow-up|0|||
16479824|NCT00392015|40234393|FG002|Overall Study|Lost to Follow-up|2|||
16283014|NCT01301482|39517627|FG000|Overall Study|Withdrawal by Subject|1|||
16283015|NCT02447887|39517630|FG000|Overall Study|Study was terminated|3|||
16283016|NCT00931463|39517634|FG000|Overall Study|Death|8|||
16283017|NCT00931463|39517635|FG001|Overall Study|Death|4|||
16283018|NCT00931463|39517634|FG000|Overall Study|Withdrawal by Subject|5|||
16283019|NCT00931463|39517635|FG001|Overall Study|Withdrawal by Subject|0|||
16283020|NCT00931463|39517634|FG000|Overall Study|Lost to Follow-up|4|||
16283021|NCT00931463|39517635|FG001|Overall Study|Lost to Follow-up|1|||
16283022|NCT00895037|39517642|FG000|Overall Study|Death|0|||
16479825|NCT00392015|40234394|FG003|Overall Study|Lost to Follow-up|1|||
16479826|NCT00392015|40234395|FG004|Overall Study|Lost to Follow-up|1|||
16479827|NCT00392015|40234396|FG005|Overall Study|Lost to Follow-up|0|||
16283023|NCT00895037|39517643|FG001|Overall Study|Death|2|||
16479828|NCT00392015|40234391|FG000|Overall Study|Withdrawal by Subject|0|||
16479829|NCT00392015|40234392|FG001|Overall Study|Withdrawal by Subject|0|||
16479830|NCT00392015|40234393|FG002|Overall Study|Withdrawal by Subject|2|||
16479831|NCT00392015|40234394|FG003|Overall Study|Withdrawal by Subject|0|||
16479832|NCT00392015|40234395|FG004|Overall Study|Withdrawal by Subject|0|||
16479833|NCT00392015|40234396|FG005|Overall Study|Withdrawal by Subject|0|||
16479834|NCT00392015|40234391|FG000|Overall Study|Adverse Event|0|||
16479835|NCT00392015|40234392|FG001|Overall Study|Adverse Event|0|||
16479836|NCT00392015|40234393|FG002|Overall Study|Adverse Event|0|||
16479837|NCT00392015|40234394|FG003|Overall Study|Adverse Event|0|||
16479838|NCT00392015|40234395|FG004|Overall Study|Adverse Event|1|||
16479839|NCT00392015|40234396|FG005|Overall Study|Adverse Event|0|||
16479840|NCT00392015|40234391|FG000|Overall Study|Previous trial recipient|0|||
16479841|NCT00392015|40234392|FG001|Overall Study|Previous trial recipient|0|||
16479842|NCT00392015|40234393|FG002|Overall Study|Previous trial recipient|0|||
16479843|NCT00392015|40234394|FG003|Overall Study|Previous trial recipient|0|||
16479844|NCT00392015|40234395|FG004|Overall Study|Previous trial recipient|1|||
16283024|NCT00895037|39517644|FG002|Overall Study|Death|1|||
16283025|NCT01765270|39517645|FG000|Overall Study|Physician Decision|1|||
16283026|NCT01765270|39517646|FG001|Overall Study|Physician Decision|0|||
16283027|NCT01765270|39517645|FG000|Overall Study|Withdrawal by Subject|0|||
16283028|NCT01765270|39517646|FG001|Overall Study|Withdrawal by Subject|1|||
16283029|NCT04406194|39517647|FG000|Period 1|Withdrawal by Subject|0|||
16283030|NCT04406194|39517648|FG001|Period 1|Withdrawal by Subject|1|||
16283031|NCT05467982|39517649|FG000|Overall Study|Death|0|||
16283032|NCT05467982|39517650|FG001|Overall Study|Death|1|||
16283033|NCT05467982|39517649|FG000|Overall Study|Lost to Follow-up|3|||
16283034|NCT05467982|39517650|FG001|Overall Study|Lost to Follow-up|1|||
16283035|NCT01239472|39517651|FG000|Overall Study|Withdrawal by Subject|5|||
16283036|NCT01239472|39517652|FG001|Overall Study|Withdrawal by Subject|1|||
16283037|NCT01239472|39517651|FG000|Overall Study|Adverse Event|0|||
16283038|NCT01239472|39517652|FG001|Overall Study|Adverse Event|1|||
16283039|NCT01239472|39517651|FG000|Overall Study|Lack of Efficacy|0|||
16283040|NCT01239472|39517652|FG001|Overall Study|Lack of Efficacy|1|||
16283041|NCT03429049|39517655|FG000|Overall Study|Adverse Event|2|||
16283042|NCT03429049|39517656|FG001|Overall Study|Adverse Event|3|||
16283043|NCT03429049|39517655|FG000|Overall Study|Death|0|||
16283044|NCT03429049|39517656|FG001|Overall Study|Death|1|||
16283045|NCT03429049|39517655|FG000|Overall Study|Lack of Efficacy|4|||
16283046|NCT03429049|39517656|FG001|Overall Study|Lack of Efficacy|2|||
16283047|NCT03429049|39517655|FG000|Overall Study|Lost to Follow-up|9|||
16283048|NCT03429049|39517656|FG001|Overall Study|Lost to Follow-up|8|||
16283049|NCT03429049|39517655|FG000|Overall Study|Physician Decision|1|||
16283050|NCT03429049|39517656|FG001|Overall Study|Physician Decision|0|||
16283051|NCT03429049|39517655|FG000|Overall Study|Protocol Violation|3|||
16283052|NCT03429049|39517656|FG001|Overall Study|Protocol Violation|0|||
16283053|NCT03429049|39517655|FG000|Overall Study|Sponsor Decision|2|||
16283054|NCT03429049|39517656|FG001|Overall Study|Sponsor Decision|0|||
16283055|NCT03429049|39517655|FG000|Overall Study|Withdrawal by Subject|4|||
16283056|NCT03429049|39517656|FG001|Overall Study|Withdrawal by Subject|20|||
16283057|NCT03429049|39517655|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
16283058|NCT03429049|39517656|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
16283059|NCT01628549|39517657|FG000|Overall Study|Adverse Event|1|||
16283060|NCT01628549|39517658|FG001|Overall Study|Adverse Event|1|||
16283061|NCT01628549|39517659|FG002|Overall Study|Adverse Event|0|||
16283062|NCT01628549|39517660|FG003|Overall Study|Adverse Event|4|||
16283063|NCT01628549|39517657|FG000|Overall Study|Lost to Follow-up|3|||
16283064|NCT01628549|39517658|FG001|Overall Study|Lost to Follow-up|4|||
16283065|NCT01628549|39517659|FG002|Overall Study|Lost to Follow-up|3|||
16283066|NCT01628549|39517660|FG003|Overall Study|Lost to Follow-up|3|||
16283067|NCT01628549|39517657|FG000|Overall Study|Withdrawal by Subject|3|||
16283068|NCT01628549|39517658|FG001|Overall Study|Withdrawal by Subject|4|||
16283069|NCT01628549|39517659|FG002|Overall Study|Withdrawal by Subject|4|||
16283070|NCT01628549|39517660|FG003|Overall Study|Withdrawal by Subject|1|||
16283071|NCT01628549|39517657|FG000|Overall Study|Protocol Violation|2|||
16283072|NCT01628549|39517658|FG001|Overall Study|Protocol Violation|1|||
16283073|NCT01628549|39517659|FG002|Overall Study|Protocol Violation|1|||
16283074|NCT01628549|39517660|FG003|Overall Study|Protocol Violation|0|||
16283075|NCT01628549|39517657|FG000|Overall Study|withdrawn for noncompliance|0|||
16283076|NCT01628549|39517658|FG001|Overall Study|withdrawn for noncompliance|2|||
16283077|NCT01628549|39517659|FG002|Overall Study|withdrawn for noncompliance|1|||
16283078|NCT01628549|39517660|FG003|Overall Study|withdrawn for noncompliance|0|||
16283079|NCT01628549|39517657|FG000|Overall Study|abnormal laboratory test results|0|||
16283080|NCT01628549|39517658|FG001|Overall Study|abnormal laboratory test results|0|||
16283081|NCT01628549|39517659|FG002|Overall Study|abnormal laboratory test results|1|||
16283082|NCT01628549|39517660|FG003|Overall Study|abnormal laboratory test results|0|||
16479845|NCT00392015|40234396|FG005|Overall Study|Previous trial recipient|0|||
16283083|NCT01628549|39517657|FG000|Overall Study|positive pregnancy test|0|||
16283084|NCT01628549|39517658|FG001|Overall Study|positive pregnancy test|0|||
16283085|NCT01628549|39517659|FG002|Overall Study|positive pregnancy test|0|||
16283086|NCT01628549|39517660|FG003|Overall Study|positive pregnancy test|1|||
16283087|NCT01682148|39517667|FG000|Overall Study|Withdrawal by Subject|2|||
16283088|NCT01682148|39517668|FG001|Overall Study|Withdrawal by Subject|0|||
16283089|NCT01682148|39517667|FG000|Overall Study|Lost to Follow-up|1|||
16283090|NCT01682148|39517668|FG001|Overall Study|Lost to Follow-up|2|||
16283091|NCT01682148|39517667|FG000|Overall Study|Protocol Violation|1|||
16283092|NCT01682148|39517668|FG001|Overall Study|Protocol Violation|1|||
16283093|NCT02733627|39517673|FG000|Overall Study|Adverse Event|0|||
16283094|NCT02733627|39517674|FG001|Overall Study|Adverse Event|1|||
16283095|NCT02733627|39517675|FG002|Overall Study|Adverse Event|1|||
16283096|NCT02733627|39517676|FG003|Overall Study|Adverse Event|0|||
16283097|NCT02733627|39517673|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
16283098|NCT02733627|39517674|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
16283099|NCT02733627|39517675|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
16283100|NCT02733627|39517676|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
16283101|NCT00500318|39517677|FG000|Overall Study|Adverse Event|3|||
16283102|NCT00500318|39517678|FG001|Overall Study|Adverse Event|8|||
16283103|NCT00500318|39517677|FG000|Overall Study|Protocol Violation|1|||
16283104|NCT00500318|39517678|FG001|Overall Study|Protocol Violation|3|||
16283105|NCT00500318|39517677|FG000|Overall Study|Withdrawal by Subject|1|||
16283106|NCT00500318|39517678|FG001|Overall Study|Withdrawal by Subject|2|||
16283107|NCT00500318|39517677|FG000|Overall Study|Lack of Efficacy|0|||
16283108|NCT00500318|39517678|FG001|Overall Study|Lack of Efficacy|3|||
16283109|NCT00500318|39517677|FG000|Overall Study|Other Reason|0|||
16283110|NCT00500318|39517678|FG001|Overall Study|Other Reason|1|||
16283111|NCT01825837|39517679|FG000|PART I|Withdrawal by Subject|0|||
16283112|NCT01825837|39517680|FG001|PART I|Withdrawal by Subject|0|||
16283113|NCT01825837|39517681|FG002|PART I|Withdrawal by Subject|0|||
16283114|NCT01825837|39517682|FG003|PART I|Withdrawal by Subject|6|||
16283115|NCT01825837|39517679|FG000|PART I|Patient non-compliance|0|||
16283116|NCT01825837|39517680|FG001|PART I|Patient non-compliance|0|||
16283117|NCT01825837|39517681|FG002|PART I|Patient non-compliance|0|||
16283118|NCT01825837|39517682|FG003|PART I|Patient non-compliance|1|||
16283119|NCT01825837|39517679|FG000|PART I|Treatment failure|0|||
16283120|NCT01825837|39517680|FG001|PART I|Treatment failure|0|||
16283121|NCT01825837|39517681|FG002|PART I|Treatment failure|0|||
16283122|NCT01825837|39517682|FG003|PART I|Treatment failure|7|||
16283123|NCT01825837|39517679|FG000|PART I|reason unspecified|0|||
16283124|NCT01825837|39517680|FG001|PART I|reason unspecified|0|||
16283125|NCT01825837|39517681|FG002|PART I|reason unspecified|0|||
16283126|NCT01825837|39517682|FG003|PART I|reason unspecified|3|||
16283127|NCT01825837|39517679|FG000|PART II|Withdrawal by Subject|3|||
16283128|NCT01825837|39517680|FG001|PART II|Withdrawal by Subject|3|||
16283129|NCT01825837|39517681|FG002|PART II|Withdrawal by Subject|7|||
16283130|NCT01825837|39517682|FG003|PART II|Withdrawal by Subject|0|||
16283131|NCT01825837|39517679|FG000|PART II|Patient non-compliance|5|||
16283132|NCT01825837|39517680|FG001|PART II|Patient non-compliance|2|||
16283133|NCT01825837|39517681|FG002|PART II|Patient non-compliance|4|||
16283134|NCT01825837|39517682|FG003|PART II|Patient non-compliance|0|||
16283135|NCT01825837|39517679|FG000|PART II|Adverse Event|3|||
16283136|NCT01825837|39517680|FG001|PART II|Adverse Event|3|||
16379773|NCT04938427|39874765|FG000|Overall Study|Reason Not Specified|2|||
16379774|NCT04938427|39874766|FG001|Overall Study|Reason Not Specified|1|||
16379775|NCT02014376|39874767|FG000|Overall Study|Adverse Event|1|||
16379776|NCT02014376|39874768|FG001|Overall Study|Adverse Event|1|||
16379777|NCT02014376|39874769|FG002|Overall Study|Adverse Event|0|||
16379778|NCT02014376|39874767|FG000|Overall Study|Lost to Follow-up|2|||
16379779|NCT02014376|39874768|FG001|Overall Study|Lost to Follow-up|0|||
16379780|NCT02014376|39874769|FG002|Overall Study|Lost to Follow-up|0|||
16379781|NCT04103450|39874772|FG000|Overall Study|Adverse Event|4|||
16379782|NCT04103450|39874773|FG001|Overall Study|Adverse Event|2|||
16379783|NCT04103450|39874772|FG000|Overall Study|Lack of Efficacy|3|||
16379784|NCT04103450|39874773|FG001|Overall Study|Lack of Efficacy|0|||
16283137|NCT01825837|39517681|FG002|PART II|Adverse Event|1|||
16283138|NCT01825837|39517682|FG003|PART II|Adverse Event|0|||
16283139|NCT01825837|39517679|FG000|PART II|Treatment failure|6|||
16283140|NCT01825837|39517680|FG001|PART II|Treatment failure|4|||
16283141|NCT01825837|39517681|FG002|PART II|Treatment failure|5|||
16283142|NCT01825837|39517682|FG003|PART II|Treatment failure|0|||
16283143|NCT01825837|39517679|FG000|PART II|reason unspecified|2|||
16283144|NCT01825837|39517680|FG001|PART II|reason unspecified|2|||
16283145|NCT01825837|39517681|FG002|PART II|reason unspecified|2|||
16283146|NCT01825837|39517682|FG003|PART II|reason unspecified|0|||
16379785|NCT04103450|39874772|FG000|Overall Study|Withdrawal by Subject|5|||
16379786|NCT04103450|39874773|FG001|Overall Study|Withdrawal by Subject|3|||
16283147|NCT03321526|39517686|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
16479846|NCT01387932|40234400|FG000|Randomized and Treated|Physician Decision|3|||
16479847|NCT01387932|40234401|FG001|Randomized and Treated|Physician Decision|2|||
16479848|NCT01387932|40234400|FG000|Randomized and Treated|Withdrawal by Subject|4|||
16479849|NCT01387932|40234401|FG001|Randomized and Treated|Withdrawal by Subject|2|||
16479850|NCT01387932|40234400|FG000|Survival Follow-up|Liver Transplant|24|||
16479851|NCT01387932|40234401|FG001|Survival Follow-up|Liver Transplant|28|||
16479852|NCT01387932|40234400|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
16479853|NCT01387932|40234401|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
16479854|NCT01387932|40234400|FG000|Survival Follow-up|Withdrawal by Subject|2|||
16479855|NCT01387932|40234401|FG001|Survival Follow-up|Withdrawal by Subject|4|||
16283148|NCT03321526|39517687|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
16283149|NCT03321526|39517686|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
16283150|NCT03321526|39517687|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
16283151|NCT03321526|39517686|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
16283152|NCT03321526|39517687|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
16283153|NCT03321526|39517686|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
16283154|NCT03321526|39517687|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
16283155|NCT03321526|39517686|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
16283156|NCT03321526|39517687|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
16283157|NCT03321526|39517686|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
16283158|NCT03321526|39517687|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
16283159|NCT03321526|39517686|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
16283160|NCT03321526|39517687|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
16283161|NCT03321526|39517686|FG000|Follow-up Phase (2 Weeks)|Other|24|||
16283162|NCT03321526|39517687|FG001|Follow-up Phase (2 Weeks)|Other|24|||
16283163|NCT02985879|39517691|FG000|Overall Study|Adverse Event|7|||
16283164|NCT02985879|39517692|FG001|Overall Study|Adverse Event|9|||
16283165|NCT02985879|39517693|FG002|Overall Study|Adverse Event|7|||
16283166|NCT02985879|39517691|FG000|Overall Study|Withdrew consent|6|||
16479856|NCT01387932|40234400|FG000|Survival Follow-up|Lost to Follow-up|6|||
16479857|NCT01387932|40234401|FG001|Survival Follow-up|Lost to Follow-up|5|||
16479858|NCT02840721|40234403|FG000|Treatment Period|Adverse Event|1|||
16479859|NCT02840721|40234403|FG000|Follow-Up|Lack of Efficacy|1|||
16479860|NCT02840721|40234403|FG000|Follow-Up|Withdrawal by Subject|4|||
16479861|NCT02840721|40234403|FG000|Follow-Up|Withdrawal of Consent|2|||
16479862|NCT00415168|40234408|FG000|Overall Study|Death|26|||
16479863|NCT00415168|40234408|FG000|Overall Study|Lost to Follow-up|3|||
16479864|NCT00415168|40234408|FG000|Overall Study|Physician Decision|13|||
16283167|NCT02985879|39517692|FG001|Overall Study|Withdrew consent|8|||
16283168|NCT02985879|39517693|FG002|Overall Study|Withdrew consent|10|||
16283169|NCT02985879|39517691|FG000|Overall Study|Lost to Follow-up|1|||
16283170|NCT02985879|39517692|FG001|Overall Study|Lost to Follow-up|0|||
16283171|NCT02985879|39517693|FG002|Overall Study|Lost to Follow-up|2|||
16283172|NCT02985879|39517691|FG000|Overall Study|Other, not specified|62|||
16283173|NCT02985879|39517692|FG001|Overall Study|Other, not specified|58|||
16283174|NCT02985879|39517693|FG002|Overall Study|Other, not specified|58|||
16283175|NCT00112294|39517694|FG000|Overall Study|Still on study|5|||
16283176|NCT00112294|39517695|FG001|Overall Study|Still on study|0|||
16283177|NCT04569786|39517699|FG000|Overall Study|Lost to Follow-up|1|||
16283178|NCT04569786|39517700|FG001|Overall Study|Lost to Follow-up|0|||
16283179|NCT04569786|39517701|FG002|Overall Study|Lost to Follow-up|4|||
16283180|NCT04569786|39517702|FG003|Overall Study|Lost to Follow-up|1|||
16283181|NCT04569786|39517703|FG004|Overall Study|Lost to Follow-up|0|||
16283182|NCT04569786|39517699|FG000|Overall Study|Withdrawal by Subject|0|||
16283183|NCT04569786|39517700|FG001|Overall Study|Withdrawal by Subject|0|||
16283184|NCT04569786|39517701|FG002|Overall Study|Withdrawal by Subject|0|||
16283185|NCT04569786|39517702|FG003|Overall Study|Withdrawal by Subject|5|||
16283186|NCT04569786|39517703|FG004|Overall Study|Withdrawal by Subject|1|||
16479865|NCT00415168|40234408|FG000|Overall Study|Sponsor Decision|4|||
16479866|NCT00415168|40234408|FG000|Overall Study|Withdrawal by Subject|6|||
16479867|NCT00676338|40234411|FG000|Overall Study|Adverse Event|6|||
16479868|NCT00676338|40234412|FG001|Overall Study|Adverse Event|6|||
16283187|NCT04569786|39517699|FG000|Overall Study|Physician Decision|0|||
16283188|NCT04569786|39517700|FG001|Overall Study|Physician Decision|0|||
16283189|NCT04569786|39517701|FG002|Overall Study|Physician Decision|0|||
16283190|NCT04569786|39517702|FG003|Overall Study|Physician Decision|1|||
16283191|NCT04569786|39517703|FG004|Overall Study|Physician Decision|0|||
16283192|NCT00767520|39517704|FG000|Overall Study|Participants still on treatment|11|||
16283193|NCT00767520|39517705|FG001|Overall Study|Participants still on treatment|15|||
16479869|NCT00676338|40234413|FG002|Overall Study|Adverse Event|5|||
16283194|NCT00767520|39517704|FG000|Overall Study|Randomized in error and Never treated|0|||
16283195|NCT00767520|39517705|FG001|Overall Study|Randomized in error and Never treated|2|||
16283196|NCT03756883|39517708|FG000|Overall Study|Adverse Event|2|||
16283197|NCT03756883|39517709|FG001|Overall Study|Adverse Event|2|||
16283198|NCT03756883|39517710|FG002|Overall Study|Adverse Event|2|||
16283199|NCT03756883|39517708|FG000|Overall Study|Lack of Efficacy|0|||
16283200|NCT03756883|39517709|FG001|Overall Study|Lack of Efficacy|1|||
16283201|NCT03756883|39517710|FG002|Overall Study|Lack of Efficacy|2|||
16283202|NCT03756883|39517708|FG000|Overall Study|Lost to Follow-up|3|||
16283203|NCT03756883|39517709|FG001|Overall Study|Lost to Follow-up|3|||
16283204|NCT03756883|39517710|FG002|Overall Study|Lost to Follow-up|0|||
16283205|NCT03756883|39517708|FG000|Overall Study|Protocol Violation|2|||
16283206|NCT03756883|39517709|FG001|Overall Study|Protocol Violation|0|||
16283207|NCT03756883|39517710|FG002|Overall Study|Protocol Violation|1|||
16283208|NCT03756883|39517708|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
16283209|NCT03756883|39517709|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
16283210|NCT03756883|39517710|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
16283211|NCT03756883|39517708|FG000|Overall Study|Withdrawal by Subject|4|||
16283212|NCT03756883|39517709|FG001|Overall Study|Withdrawal by Subject|1|||
16283213|NCT03756883|39517710|FG002|Overall Study|Withdrawal by Subject|0|||
16283214|NCT03756883|39517708|FG000|Overall Study|Other Reasons|2|||
16283215|NCT03756883|39517709|FG001|Overall Study|Other Reasons|4|||
16283216|NCT03756883|39517710|FG002|Overall Study|Other Reasons|0|||
16283217|NCT02751827|39517712|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
16283218|NCT02751827|39517713|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
16283219|NCT02751827|39517714|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
16283220|NCT00743509|39517718|FG000|Overall Study|Withdrawal by Subject|2|||
16283221|NCT00918463|39517719|FG000|Overall Study|Death|1|||
16283222|NCT00918463|39517719|FG000|Overall Study|Lack of Efficacy|1|||
16283223|NCT01730040|39521910|FG000|Overall Study|Randomized but not treated|0|||
16283224|NCT01730040|39521911|FG001|Overall Study|Randomized but not treated|0|||
16283225|NCT01730040|39521912|FG002|Overall Study|Randomized but not treated|0|||
16283226|NCT01730040|39521913|FG003|Overall Study|Randomized but not treated|0|||
16283227|NCT01730040|39521914|FG004|Overall Study|Randomized but not treated|0|||
16283228|NCT01730040|39521915|FG005|Overall Study|Randomized but not treated|1|||
16283229|NCT01730040|39521916|FG006|Overall Study|Randomized but not treated|0|||
16283230|NCT01730040|39521910|FG000|Overall Study|Subject moved|0|||
16283231|NCT01730040|39521911|FG001|Overall Study|Subject moved|0|||
16283232|NCT01730040|39521912|FG002|Overall Study|Subject moved|1|||
16283233|NCT01730040|39521913|FG003|Overall Study|Subject moved|0|||
16283234|NCT01730040|39521914|FG004|Overall Study|Subject moved|0|||
16283235|NCT01730040|39521915|FG005|Overall Study|Subject moved|0|||
16283236|NCT01730040|39521916|FG006|Overall Study|Subject moved|1|||
16283237|NCT01730040|39521910|FG000|Overall Study|Physician Decision|0|||
16283238|NCT01730040|39521911|FG001|Overall Study|Physician Decision|0|||
16283239|NCT01730040|39521912|FG002|Overall Study|Physician Decision|0|||
16283240|NCT01730040|39521913|FG003|Overall Study|Physician Decision|0|||
16283241|NCT01730040|39521914|FG004|Overall Study|Physician Decision|0|||
16283242|NCT01730040|39521915|FG005|Overall Study|Physician Decision|1|||
16283243|NCT01730040|39521916|FG006|Overall Study|Physician Decision|1|||
16283244|NCT01730040|39521910|FG000|Overall Study|Other than specified|7|||
16283245|NCT01730040|39521911|FG001|Overall Study|Other than specified|8|||
16283246|NCT01730040|39521912|FG002|Overall Study|Other than specified|5|||
16283247|NCT01730040|39521913|FG003|Overall Study|Other than specified|5|||
16283248|NCT01730040|39521914|FG004|Overall Study|Other than specified|5|||
16283249|NCT01730040|39521915|FG005|Overall Study|Other than specified|4|||
16283250|NCT01730040|39521916|FG006|Overall Study|Other than specified|4|||
16283251|NCT01730040|39521910|FG000|Overall Study|Adverse Event|4|||
16283252|NCT01730040|39521911|FG001|Overall Study|Adverse Event|3|||
16283253|NCT01730040|39521912|FG002|Overall Study|Adverse Event|5|||
16283254|NCT01730040|39521913|FG003|Overall Study|Adverse Event|3|||
16283255|NCT01730040|39521914|FG004|Overall Study|Adverse Event|1|||
16283256|NCT01730040|39521915|FG005|Overall Study|Adverse Event|1|||
16283257|NCT01730040|39521916|FG006|Overall Study|Adverse Event|2|||
16283258|NCT01730040|39521910|FG000|Overall Study|Poor compliance to protocol|2|||
16283259|NCT01730040|39521911|FG001|Overall Study|Poor compliance to protocol|4|||
16283260|NCT01730040|39521912|FG002|Overall Study|Poor compliance to protocol|0|||
16283261|NCT01730040|39521913|FG003|Overall Study|Poor compliance to protocol|0|||
16283262|NCT01730040|39521914|FG004|Overall Study|Poor compliance to protocol|0|||
16283263|NCT01730040|39521915|FG005|Overall Study|Poor compliance to protocol|0|||
16283264|NCT01730040|39521916|FG006|Overall Study|Poor compliance to protocol|1|||
16283265|NCT01567826|39521930|FG000|Overall Study|Lost to Follow-up|3|||
16283266|NCT01567826|39521931|FG001|Overall Study|Lost to Follow-up|2|||
16283267|NCT02631876|39521937|FG000|Overall Study|Death|96|||
16379787|NCT04103450|39874772|FG000|Overall Study|Lost to Follow-up|1|||
16283268|NCT02631876|39521938|FG001|Overall Study|Death|50|||
16283269|NCT02631876|39521937|FG000|Overall Study|Investigator's discretion|1|||
16283270|NCT02631876|39521938|FG001|Overall Study|Investigator's discretion|0|||
16283271|NCT02631876|39521937|FG000|Overall Study|Lost to Follow-up|2|||
16283272|NCT02631876|39521938|FG001|Overall Study|Lost to Follow-up|0|||
16283273|NCT02631876|39521937|FG000|Overall Study|Withdrawal by Subject|16|||
16283274|NCT02631876|39521938|FG001|Overall Study|Withdrawal by Subject|9|||
16283275|NCT02631876|39521937|FG000|Overall Study|Other than specified|4|||
16283276|NCT02631876|39521938|FG001|Overall Study|Other than specified|4|||
16283277|NCT01844531|39521939|FG000|Overall Study|Withdrawal by Subject|0|||
16283278|NCT01844531|39521940|FG001|Overall Study|Withdrawal by Subject|1|||
16283279|NCT01844531|39521941|FG002|Overall Study|Withdrawal by Subject|0|||
16283280|NCT01844531|39521942|FG003|Overall Study|Withdrawal by Subject|0|||
16283281|NCT03165955|39521943|FG000|Treatment|Withdrawal by Subject|3|||
16283282|NCT03165955|39521943|FG000|Treatment|Death|1|||
16283283|NCT03165955|39521943|FG000|Treatment|Adverse Event|1|||
16283284|NCT03165955|39521943|FG000|Treatment|Progressive disease|3|||
16283285|NCT02752802|39521951|FG000|Overall Study|Contrast Volume Not Collected|1|||
16283286|NCT02752802|39521952|FG001|Overall Study|Contrast Volume Not Collected|0|||
16283287|NCT00319046|39521953|FG000|Overall Study|withdrawal of subject's consent|7|||
16283288|NCT00319046|39521953|FG000|Overall Study|administrative reason|1|||
16283289|NCT02487082|39521955|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
16283290|NCT02487082|39521956|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
16283291|NCT02487082|39521955|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
16283292|NCT02487082|39521956|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
16283293|NCT02696031|39521957|FG000|Up to Week 24|Adverse Event|2|||
16283294|NCT02696031|39521958|FG001|Up to Week 24|Adverse Event|4|||
16479870|NCT00676338|40234414|FG003|Overall Study|Adverse Event|1|||
16479871|NCT00676338|40234411|FG000|Overall Study|Lost to Follow-up|4|||
16479872|NCT00676338|40234412|FG001|Overall Study|Lost to Follow-up|1|||
16479873|NCT00676338|40234413|FG002|Overall Study|Lost to Follow-up|3|||
16479874|NCT00676338|40234414|FG003|Overall Study|Lost to Follow-up|4|||
16479875|NCT00676338|40234411|FG000|Overall Study|Physician Decision|3|||
16479876|NCT00676338|40234412|FG001|Overall Study|Physician Decision|3|||
16479877|NCT00676338|40234413|FG002|Overall Study|Physician Decision|2|||
16479878|NCT00676338|40234414|FG003|Overall Study|Physician Decision|3|||
16283295|NCT02696031|39521959|FG002|Up to Week 24|Adverse Event|2|||
16283296|NCT02696031|39521960|FG003|Up to Week 24|Adverse Event|0|||
16283297|NCT02696031|39521961|FG004|Up to Week 24|Adverse Event|0|||
16283298|NCT02696031|39521962|FG005|Up to Week 24|Adverse Event|0|||
16283299|NCT02696031|39521957|FG000|Up to Week 24|Lack of Efficacy|2|||
16283300|NCT02696031|39521958|FG001|Up to Week 24|Lack of Efficacy|1|||
16283301|NCT02696031|39521959|FG002|Up to Week 24|Lack of Efficacy|2|||
16283302|NCT02696031|39521960|FG003|Up to Week 24|Lack of Efficacy|0|||
16283303|NCT02696031|39521961|FG004|Up to Week 24|Lack of Efficacy|0|||
16283304|NCT02696031|39521962|FG005|Up to Week 24|Lack of Efficacy|0|||
16283305|NCT02696031|39521957|FG000|Up to Week 24|Lost to Follow-up|0|||
16283306|NCT02696031|39521958|FG001|Up to Week 24|Lost to Follow-up|1|||
16283307|NCT02696031|39521959|FG002|Up to Week 24|Lost to Follow-up|1|||
16283308|NCT02696031|39521960|FG003|Up to Week 24|Lost to Follow-up|0|||
16283309|NCT02696031|39521961|FG004|Up to Week 24|Lost to Follow-up|0|||
16283310|NCT02696031|39521962|FG005|Up to Week 24|Lost to Follow-up|0|||
16283311|NCT02696031|39521957|FG000|Up to Week 24|Physician Decision|1|||
16283312|NCT02696031|39521958|FG001|Up to Week 24|Physician Decision|0|||
16283313|NCT02696031|39521959|FG002|Up to Week 24|Physician Decision|1|||
16283314|NCT02696031|39521960|FG003|Up to Week 24|Physician Decision|0|||
16283315|NCT02696031|39521961|FG004|Up to Week 24|Physician Decision|0|||
16283316|NCT02696031|39521962|FG005|Up to Week 24|Physician Decision|0|||
16283317|NCT02696031|39521957|FG000|Up to Week 24|Protocol Violation|1|||
16283318|NCT02696031|39521958|FG001|Up to Week 24|Protocol Violation|0|||
16283319|NCT02696031|39521959|FG002|Up to Week 24|Protocol Violation|0|||
16283320|NCT02696031|39521960|FG003|Up to Week 24|Protocol Violation|0|||
16283321|NCT02696031|39521961|FG004|Up to Week 24|Protocol Violation|0|||
16283322|NCT02696031|39521962|FG005|Up to Week 24|Protocol Violation|0|||
16283323|NCT02696031|39521957|FG000|Up to Week 24|Withdrawal by Subject|4|||
16283324|NCT02696031|39521958|FG001|Up to Week 24|Withdrawal by Subject|1|||
16283325|NCT02696031|39521959|FG002|Up to Week 24|Withdrawal by Subject|5|||
16283326|NCT02696031|39521960|FG003|Up to Week 24|Withdrawal by Subject|0|||
16479879|NCT00676338|40234411|FG000|Overall Study|Protocol Violation|5|||
16479880|NCT00676338|40234412|FG001|Overall Study|Protocol Violation|9|||
16479881|NCT00676338|40234413|FG002|Overall Study|Protocol Violation|2|||
16479882|NCT00676338|40234414|FG003|Overall Study|Protocol Violation|5|||
16283327|NCT02696031|39521961|FG004|Up to Week 24|Withdrawal by Subject|0|||
16283328|NCT02696031|39521962|FG005|Up to Week 24|Withdrawal by Subject|0|||
16283329|NCT02696031|39521957|FG000|Up to Week 52|Adverse Event|4|||
16283330|NCT02696031|39521958|FG001|Up to Week 52|Adverse Event|5|||
16283331|NCT02696031|39521959|FG002|Up to Week 52|Adverse Event|3|||
16283332|NCT02696031|39521960|FG003|Up to Week 52|Adverse Event|0|||
16283333|NCT02696031|39521961|FG004|Up to Week 52|Adverse Event|0|||
16283334|NCT02696031|39521962|FG005|Up to Week 52|Adverse Event|0|||
16283335|NCT02696031|39521957|FG000|Up to Week 52|Lack of Efficacy|10|||
16283336|NCT02696031|39521958|FG001|Up to Week 52|Lack of Efficacy|7|||
16283337|NCT02696031|39521959|FG002|Up to Week 52|Lack of Efficacy|11|||
16283338|NCT02696031|39521960|FG003|Up to Week 52|Lack of Efficacy|0|||
16283339|NCT02696031|39521961|FG004|Up to Week 52|Lack of Efficacy|0|||
16283340|NCT02696031|39521962|FG005|Up to Week 52|Lack of Efficacy|0|||
16283341|NCT02696031|39521957|FG000|Up to Week 52|Lost to Follow-up|1|||
16283342|NCT02696031|39521958|FG001|Up to Week 52|Lost to Follow-up|1|||
16283343|NCT02696031|39521959|FG002|Up to Week 52|Lost to Follow-up|1|||
16283344|NCT02696031|39521960|FG003|Up to Week 52|Lost to Follow-up|0|||
16283345|NCT02696031|39521961|FG004|Up to Week 52|Lost to Follow-up|0|||
16283346|NCT02696031|39521962|FG005|Up to Week 52|Lost to Follow-up|0|||
16283347|NCT02696031|39521957|FG000|Up to Week 52|Physician Decision|1|||
16283348|NCT02696031|39521958|FG001|Up to Week 52|Physician Decision|1|||
16283349|NCT02696031|39521959|FG002|Up to Week 52|Physician Decision|2|||
16283350|NCT02696031|39521960|FG003|Up to Week 52|Physician Decision|0|||
16283351|NCT02696031|39521961|FG004|Up to Week 52|Physician Decision|0|||
16283352|NCT02696031|39521962|FG005|Up to Week 52|Physician Decision|0|||
16283353|NCT02696031|39521957|FG000|Up to Week 52|Pregnancy|0|||
16283354|NCT02696031|39521958|FG001|Up to Week 52|Pregnancy|2|||
16283355|NCT02696031|39521959|FG002|Up to Week 52|Pregnancy|0|||
16283356|NCT02696031|39521960|FG003|Up to Week 52|Pregnancy|0|||
16283357|NCT02696031|39521961|FG004|Up to Week 52|Pregnancy|0|||
16283358|NCT02696031|39521962|FG005|Up to Week 52|Pregnancy|0|||
16283359|NCT02696031|39521957|FG000|Up to Week 52|Protocol Violation|1|||
16283360|NCT02696031|39521958|FG001|Up to Week 52|Protocol Violation|0|||
16283361|NCT02696031|39521959|FG002|Up to Week 52|Protocol Violation|0|||
16283362|NCT02696031|39521960|FG003|Up to Week 52|Protocol Violation|0|||
16283363|NCT02696031|39521961|FG004|Up to Week 52|Protocol Violation|0|||
16283364|NCT02696031|39521962|FG005|Up to Week 52|Protocol Violation|0|||
16283365|NCT02696031|39521957|FG000|Up to Week 52|Withdrawal by Subject|12|||
16283366|NCT02696031|39521958|FG001|Up to Week 52|Withdrawal by Subject|3|||
16283367|NCT02696031|39521959|FG002|Up to Week 52|Withdrawal by Subject|9|||
16283368|NCT02696031|39521960|FG003|Up to Week 52|Withdrawal by Subject|0|||
16283369|NCT02696031|39521961|FG004|Up to Week 52|Withdrawal by Subject|0|||
16283370|NCT02696031|39521962|FG005|Up to Week 52|Withdrawal by Subject|0|||
16283371|NCT02696031|39521957|FG000|Up to Week 104|Pregnancy|0|||
16283372|NCT02696031|39521958|FG001|Up to Week 104|Pregnancy|2|||
16283373|NCT02696031|39521959|FG002|Up to Week 104|Pregnancy|1|||
16283374|NCT02696031|39521960|FG003|Up to Week 104|Pregnancy|0|||
16283375|NCT02696031|39521961|FG004|Up to Week 104|Pregnancy|0|||
16283376|NCT02696031|39521962|FG005|Up to Week 104|Pregnancy|0|||
16283377|NCT02696031|39521957|FG000|Up to Week 104|Withdrawal by Subject|15|||
16283378|NCT02696031|39521958|FG001|Up to Week 104|Withdrawal by Subject|10|||
16283379|NCT02696031|39521959|FG002|Up to Week 104|Withdrawal by Subject|16|||
16283380|NCT02696031|39521960|FG003|Up to Week 104|Withdrawal by Subject|0|||
16283381|NCT02696031|39521961|FG004|Up to Week 104|Withdrawal by Subject|0|||
16283382|NCT02696031|39521962|FG005|Up to Week 104|Withdrawal by Subject|0|||
16283383|NCT02696031|39521957|FG000|Up to Week 104|Protocol Violation|1|||
16283384|NCT02696031|39521958|FG001|Up to Week 104|Protocol Violation|0|||
16283385|NCT02696031|39521959|FG002|Up to Week 104|Protocol Violation|0|||
16283386|NCT02696031|39521960|FG003|Up to Week 104|Protocol Violation|0|||
16283387|NCT02696031|39521961|FG004|Up to Week 104|Protocol Violation|0|||
16283388|NCT02696031|39521962|FG005|Up to Week 104|Protocol Violation|0|||
16283389|NCT02696031|39521957|FG000|Up to Week 104|Physician Decision|1|||
16283390|NCT02696031|39521958|FG001|Up to Week 104|Physician Decision|2|||
16283391|NCT02696031|39521959|FG002|Up to Week 104|Physician Decision|3|||
16283392|NCT02696031|39521960|FG003|Up to Week 104|Physician Decision|0|||
16283393|NCT02696031|39521961|FG004|Up to Week 104|Physician Decision|0|||
16283394|NCT02696031|39521962|FG005|Up to Week 104|Physician Decision|0|||
16283395|NCT02696031|39521957|FG000|Up to Week 104|Lost to Follow-up|2|||
16283396|NCT02696031|39521958|FG001|Up to Week 104|Lost to Follow-up|3|||
16283397|NCT02696031|39521959|FG002|Up to Week 104|Lost to Follow-up|1|||
16283398|NCT02696031|39521960|FG003|Up to Week 104|Lost to Follow-up|0|||
16283399|NCT02696031|39521961|FG004|Up to Week 104|Lost to Follow-up|0|||
16283400|NCT02696031|39521962|FG005|Up to Week 104|Lost to Follow-up|0|||
16283401|NCT02696031|39521957|FG000|Up to Week 104|Lack of Efficacy|13|||
16283402|NCT02696031|39521958|FG001|Up to Week 104|Lack of Efficacy|12|||
16283403|NCT02696031|39521959|FG002|Up to Week 104|Lack of Efficacy|11|||
16283404|NCT02696031|39521960|FG003|Up to Week 104|Lack of Efficacy|0|||
16283405|NCT02696031|39521961|FG004|Up to Week 104|Lack of Efficacy|0|||
16283406|NCT02696031|39521962|FG005|Up to Week 104|Lack of Efficacy|0|||
16283407|NCT02696031|39521957|FG000|Up to Week 104|Adverse Event|7|||
16283408|NCT02696031|39521958|FG001|Up to Week 104|Adverse Event|11|||
16283409|NCT02696031|39521959|FG002|Up to Week 104|Adverse Event|5|||
16283410|NCT02696031|39521960|FG003|Up to Week 104|Adverse Event|0|||
16283411|NCT02696031|39521961|FG004|Up to Week 104|Adverse Event|0|||
16283412|NCT02696031|39521962|FG005|Up to Week 104|Adverse Event|0|||
16283413|NCT02696031|39521957|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
16379788|NCT04103450|39874773|FG001|Overall Study|Lost to Follow-up|2|||
16283414|NCT02696031|39521958|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
16283415|NCT02696031|39521959|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
16283416|NCT02696031|39521960|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
16283417|NCT02696031|39521961|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
16283418|NCT02696031|39521962|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
16283419|NCT02696031|39521957|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
16283420|NCT02696031|39521958|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
16283421|NCT02696031|39521959|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
16283422|NCT02696031|39521960|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
16283423|NCT02696031|39521961|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
16283424|NCT02696031|39521962|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
16283425|NCT02696031|39521957|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
16283426|NCT02696031|39521958|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
16283427|NCT02696031|39521959|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
16283428|NCT02696031|39521960|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
16283429|NCT02696031|39521961|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
16283430|NCT02696031|39521962|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
16283431|NCT02696031|39521957|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
16283432|NCT02696031|39521958|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
16283433|NCT02696031|39521959|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
16283434|NCT02696031|39521960|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
16283435|NCT02696031|39521961|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
16283436|NCT02696031|39521962|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
16283437|NCT02696031|39521957|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
16283438|NCT02696031|39521958|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
16283439|NCT02696031|39521959|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
16283440|NCT02696031|39521960|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
16283441|NCT02696031|39521961|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
16283442|NCT02696031|39521962|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
16283443|NCT02696031|39521957|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
16283444|NCT02696031|39521958|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
16283445|NCT02696031|39521959|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
16283446|NCT02696031|39521960|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
16283447|NCT02696031|39521961|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
16283448|NCT02696031|39521962|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
16283449|NCT02696031|39521957|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
16283450|NCT02696031|39521958|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
16283451|NCT02696031|39521959|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
16283452|NCT02696031|39521960|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
16283453|NCT02696031|39521961|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
16283454|NCT02696031|39521962|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
16283455|NCT02104817|39521963|FG000|Overall Study|Death|363|||
16283456|NCT02104817|39521964|FG001|Overall Study|Death|330|||
16283457|NCT02104817|39521963|FG000|Overall Study|Lost to Follow-up|3|||
16283458|NCT02104817|39521964|FG001|Overall Study|Lost to Follow-up|2|||
16283459|NCT02104817|39521963|FG000|Overall Study|Protocol Violation|0|||
16283460|NCT02104817|39521964|FG001|Overall Study|Protocol Violation|1|||
16283461|NCT02104817|39521963|FG000|Overall Study|Study terminated by sponsor|5854|||
16283462|NCT02104817|39521964|FG001|Overall Study|Study terminated by sponsor|5901|||
16283463|NCT02104817|39521963|FG000|Overall Study|Withdrawal by Subject|111|||
16283464|NCT02104817|39521964|FG001|Overall Study|Withdrawal by Subject|78|||
16283465|NCT02104817|39521963|FG000|Overall Study|Other reasons|128|||
16283466|NCT02104817|39521964|FG001|Overall Study|Other reasons|135|||
16283467|NCT02220725|39521965|FG000|Overall Study|Lost to Follow-up|0|||
16283468|NCT02220725|39521966|FG001|Overall Study|Lost to Follow-up|0|||
16283469|NCT02220725|39521967|FG002|Overall Study|Lost to Follow-up|0|||
16283470|NCT02220725|39521968|FG003|Overall Study|Lost to Follow-up|1|||
16283471|NCT02220725|39521965|FG000|Overall Study|Withdrawal by Subject|0|||
16283472|NCT02220725|39521966|FG001|Overall Study|Withdrawal by Subject|0|||
16283473|NCT02220725|39521967|FG002|Overall Study|Withdrawal by Subject|0|||
16283474|NCT02220725|39521968|FG003|Overall Study|Withdrawal by Subject|1|||
16283475|NCT00456495|39521969|FG000|Overall Study|Physician Decision|2|||
16283476|NCT01705717|39521970|FG000|Overall Study|Adverse Event|2|||
16283477|NCT01705717|39521971|FG001|Overall Study|Adverse Event|2|||
16283478|NCT01705717|39521970|FG000|Overall Study|Lack of Efficacy|0|||
16283479|NCT01705717|39521971|FG001|Overall Study|Lack of Efficacy|1|||
16283480|NCT01705717|39521970|FG000|Overall Study|Other|0|||
16080224|NCT01307267|38786792|FG011|Overall Study|Lost to Follow-up|0|||
16080225|NCT01307267|38786793|FG012|Overall Study|Lost to Follow-up|0|||
16283481|NCT01705717|39521971|FG001|Overall Study|Other|2|||
16283482|NCT03686150|39521974|FG000|Overall Study|Withdrawal by Subject|1|||
16283483|NCT03686150|39521975|FG001|Overall Study|Withdrawal by Subject|1|||
16283484|NCT03686150|39521976|FG002|Overall Study|Withdrawal by Subject|1|||
16283485|NCT03686150|39521977|FG003|Overall Study|Withdrawal by Subject|0|||
16283486|NCT03686150|39521978|FG004|Overall Study|Withdrawal by Subject|1|||
16283487|NCT03686150|39521979|FG005|Overall Study|Withdrawal by Subject|2|||
16283488|NCT03686150|39521974|FG000|Overall Study|Physician Decision|1|||
16283489|NCT03686150|39521975|FG001|Overall Study|Physician Decision|0|||
16283490|NCT03686150|39521976|FG002|Overall Study|Physician Decision|0|||
16283491|NCT03686150|39521977|FG003|Overall Study|Physician Decision|0|||
16283492|NCT03686150|39521978|FG004|Overall Study|Physician Decision|0|||
16283493|NCT03686150|39521979|FG005|Overall Study|Physician Decision|1|||
16283494|NCT03686150|39521974|FG000|Overall Study|Lost to Follow-up|0|||
16283495|NCT03686150|39521975|FG001|Overall Study|Lost to Follow-up|1|||
16283496|NCT03686150|39521976|FG002|Overall Study|Lost to Follow-up|0|||
16283497|NCT03686150|39521977|FG003|Overall Study|Lost to Follow-up|0|||
16283498|NCT03686150|39521978|FG004|Overall Study|Lost to Follow-up|0|||
16283499|NCT03686150|39521979|FG005|Overall Study|Lost to Follow-up|0|||
16283500|NCT02326974|39521981|FG000|Overall Study|Withdrawal by Subject|2|||
16283501|NCT02326974|39521981|FG000|Overall Study|failed heterogenity evaluation|5|||
16283502|NCT01138826|39521984|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
16283503|NCT01138826|39521985|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
16283504|NCT01138826|39521986|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
16283505|NCT01138826|39521987|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
16283506|NCT01138826|39521988|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
16283507|NCT01138826|39521989|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
16283508|NCT01546922|39521991|FG000|First Period of 10 Weeks|Protocol Violation|3|||
16283509|NCT01546922|39521992|FG001|First Period of 10 Weeks|Protocol Violation|1|||
16283510|NCT01546922|39521991|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
16283511|NCT01546922|39521992|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
16283512|NCT01546922|39521991|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
16283513|NCT01546922|39521992|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
16283514|NCT01546922|39521991|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
16283515|NCT01546922|39521992|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
16283516|NCT01546922|39521991|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
16283517|NCT01546922|39521992|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
16283518|NCT02133001|39521993|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
16283519|NCT02133001|39521994|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
16283520|NCT02133001|39521993|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
16283521|NCT02133001|39521994|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
16283522|NCT02133001|39521993|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
16283523|NCT02133001|39521994|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
16283524|NCT02133001|39521993|FG000|Double Blind (Day 1-25)|Other|2|||
16283525|NCT02133001|39521994|FG001|Double Blind (Day 1-25)|Other|2|||
16479883|NCT00676338|40234411|FG000|Overall Study|Withdrawal by Subject|17|||
16479884|NCT00676338|40234412|FG001|Overall Study|Withdrawal by Subject|9|||
16479885|NCT00676338|40234413|FG002|Overall Study|Withdrawal by Subject|12|||
16479886|NCT00676338|40234414|FG003|Overall Study|Withdrawal by Subject|6|||
16479887|NCT00676338|40234411|FG000|Overall Study|Entry Criteria Not Met|0|||
16479888|NCT00676338|40234412|FG001|Overall Study|Entry Criteria Not Met|2|||
16479889|NCT00676338|40234413|FG002|Overall Study|Entry Criteria Not Met|1|||
16479890|NCT00676338|40234414|FG003|Overall Study|Entry Criteria Not Met|1|||
16479891|NCT00676338|40234411|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
16479892|NCT00676338|40234412|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
16479893|NCT00676338|40234413|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
16479894|NCT00676338|40234414|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
16479895|NCT00369824|40234422|FG000|Overall Study|Adverse Event|0|||
16479896|NCT00369824|40234423|FG001|Overall Study|Adverse Event|2|||
16479897|NCT00369824|40234424|FG002|Overall Study|Adverse Event|0|||
16479898|NCT00369824|40234425|FG003|Overall Study|Adverse Event|0|||
16080226|NCT01307267|38786794|FG013|Overall Study|Lost to Follow-up|0|||
16283526|NCT02133001|39521993|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
16283527|NCT02133001|39521994|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
16283528|NCT02133001|39521993|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
16283529|NCT02133001|39521994|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
16283530|NCT02133001|39521993|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
16283531|NCT02133001|39521994|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
16283532|NCT02133001|39521993|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
16283533|NCT02133001|39521994|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
16283534|NCT00369382|39521995|FG000|Overall Study|Death|0|||
16283535|NCT00369382|39521996|FG001|Overall Study|Death|2|||
16283536|NCT00369382|39521995|FG000|Overall Study|Physician Decision|2|||
16080227|NCT01307267|38786795|FG014|Overall Study|Lost to Follow-up|0|||
16283537|NCT00369382|39521996|FG001|Overall Study|Physician Decision|1|||
16283538|NCT00369382|39521995|FG000|Overall Study|Withdrawal by Subject|5|||
16283539|NCT00369382|39521996|FG001|Overall Study|Withdrawal by Subject|0|||
16283540|NCT00369382|39521995|FG000|Overall Study|Randomized, not treated|2|||
16283541|NCT00369382|39521996|FG001|Overall Study|Randomized, not treated|0|||
16283542|NCT00369382|39521995|FG000|Overall Study|Other|1|||
16479899|NCT00369824|40234426|FG004|Overall Study|Adverse Event|1|||
16479900|NCT00369824|40234427|FG005|Overall Study|Adverse Event|0|||
16479901|NCT00369824|40234422|FG000|Overall Study|Protocol Violation|0|||
16479902|NCT00369824|40234423|FG001|Overall Study|Protocol Violation|1|||
16479903|NCT00369824|40234424|FG002|Overall Study|Protocol Violation|0|||
16479904|NCT00369824|40234425|FG003|Overall Study|Protocol Violation|1|||
16479905|NCT00369824|40234426|FG004|Overall Study|Protocol Violation|1|||
16479906|NCT00369824|40234427|FG005|Overall Study|Protocol Violation|0|||
16283543|NCT00369382|39521996|FG001|Overall Study|Other|0|||
16283544|NCT01885182|39522000|FG000|Overall Study|Adverse Event|11|||
16283545|NCT01885182|39522001|FG001|Overall Study|Adverse Event|13|||
16283546|NCT01885182|39522000|FG000|Overall Study|Withdrawal by Subject|13|||
16283547|NCT01885182|39522001|FG001|Overall Study|Withdrawal by Subject|6|||
16283548|NCT01885182|39522000|FG000|Overall Study|Lost to Follow-up|2|||
16283549|NCT01885182|39522001|FG001|Overall Study|Lost to Follow-up|2|||
16283550|NCT01885182|39522000|FG000|Overall Study|Lack of Efficacy|8|||
16283551|NCT01885182|39522001|FG001|Overall Study|Lack of Efficacy|1|||
16283552|NCT02315066|39522015|FG000|Overall Study|Lost to Follow-up|0|||
16283553|NCT02315066|39522016|FG001|Overall Study|Lost to Follow-up|1|||
16283554|NCT02315066|39522017|FG002|Overall Study|Lost to Follow-up|1|||
16283555|NCT02315066|39522018|FG003|Overall Study|Lost to Follow-up|0|||
16283556|NCT02315066|39522019|FG004|Overall Study|Lost to Follow-up|1|||
16283557|NCT02315066|39522020|FG005|Overall Study|Lost to Follow-up|0|||
16283558|NCT02315066|39522021|FG006|Overall Study|Lost to Follow-up|2|||
16283559|NCT02315066|39522022|FG007|Overall Study|Lost to Follow-up|1|||
16283560|NCT02315066|39522023|FG008|Overall Study|Lost to Follow-up|0|||
16283561|NCT02315066|39522024|FG009|Overall Study|Lost to Follow-up|0|||
16283562|NCT02315066|39522025|FG010|Overall Study|Lost to Follow-up|1|||
16283563|NCT02315066|39522026|FG011|Overall Study|Lost to Follow-up|2|||
16283564|NCT02315066|39522027|FG012|Overall Study|Lost to Follow-up|0|||
16283565|NCT02315066|39522028|FG013|Overall Study|Lost to Follow-up|4|||
16283566|NCT02315066|39522015|FG000|Overall Study|Death|2|||
16283567|NCT02315066|39522016|FG001|Overall Study|Death|7|||
16283568|NCT02315066|39522017|FG002|Overall Study|Death|6|||
16283569|NCT02315066|39522018|FG003|Overall Study|Death|11|||
16479907|NCT00369824|40234422|FG000|Overall Study|Withdrawal by Subject|9|||
16479908|NCT00369824|40234423|FG001|Overall Study|Withdrawal by Subject|5|||
16479909|NCT00369824|40234424|FG002|Overall Study|Withdrawal by Subject|5|||
16479910|NCT00369824|40234425|FG003|Overall Study|Withdrawal by Subject|4|||
16479911|NCT00369824|40234426|FG004|Overall Study|Withdrawal by Subject|6|||
16479912|NCT00369824|40234427|FG005|Overall Study|Withdrawal by Subject|2|||
16479913|NCT00369824|40234422|FG000|Overall Study|Lost to Follow-up|6|||
16479914|NCT00369824|40234423|FG001|Overall Study|Lost to Follow-up|11|||
16479915|NCT00369824|40234424|FG002|Overall Study|Lost to Follow-up|7|||
16479916|NCT00369824|40234425|FG003|Overall Study|Lost to Follow-up|8|||
16479917|NCT00369824|40234426|FG004|Overall Study|Lost to Follow-up|9|||
16479918|NCT00369824|40234427|FG005|Overall Study|Lost to Follow-up|6|||
16479919|NCT00369824|40234422|FG000|Overall Study|Other|0|||
16479920|NCT00369824|40234423|FG001|Overall Study|Other|0|||
16479921|NCT00369824|40234424|FG002|Overall Study|Other|0|||
16479922|NCT00369824|40234425|FG003|Overall Study|Other|2|||
16479923|NCT00369824|40234426|FG004|Overall Study|Other|1|||
16479924|NCT00369824|40234427|FG005|Overall Study|Other|3|||
16479925|NCT01083485|40234430|FG000|Overall Study|Adverse Event|0|||
16479926|NCT01083485|40234431|FG001|Overall Study|Adverse Event|1|||
16479927|NCT01083485|40234430|FG000|Overall Study|Protocol Violation|1|||
16479928|NCT01083485|40234431|FG001|Overall Study|Protocol Violation|0|||
16479929|NCT01083485|40234430|FG000|Overall Study|Withdrawal by Subject|5|||
16080228|NCT01307267|38786796|FG015|Overall Study|Lost to Follow-up|0|||
16283570|NCT02315066|39522019|FG004|Overall Study|Death|10|||
16283571|NCT02315066|39522020|FG005|Overall Study|Death|3|||
16283572|NCT02315066|39522021|FG006|Overall Study|Death|9|||
16080229|NCT01307267|38786797|FG016|Overall Study|Lost to Follow-up|0|||
16283573|NCT02315066|39522022|FG007|Overall Study|Death|9|||
16283574|NCT02315066|39522023|FG008|Overall Study|Death|10|||
16283575|NCT02315066|39522024|FG009|Overall Study|Death|8|||
16283576|NCT02315066|39522025|FG010|Overall Study|Death|10|||
16479930|NCT01083485|40234431|FG001|Overall Study|Withdrawal by Subject|2|||
16479931|NCT01083485|40234430|FG000|Overall Study|Other|1|||
16479932|NCT01083485|40234431|FG001|Overall Study|Other|0|||
16479933|NCT03750955|40234434|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
16283577|NCT02315066|39522026|FG011|Overall Study|Death|7|||
16283578|NCT02315066|39522027|FG012|Overall Study|Death|8|||
16283579|NCT02315066|39522028|FG013|Overall Study|Death|21|||
16283580|NCT02315066|39522015|FG000|Overall Study|Other|0|||
16283581|NCT02315066|39522016|FG001|Overall Study|Other|0|||
16479934|NCT03750955|40234435|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
16479935|NCT03750955|40234434|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
16479936|NCT03750955|40234435|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
16479937|NCT02877134|40234438|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
16479938|NCT02877134|40234439|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
16479939|NCT02877134|40234440|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
16479940|NCT02877134|40234441|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
16479941|NCT02877134|40234442|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
16479942|NCT02877134|40234443|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
16479943|NCT02877134|40234444|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
16479944|NCT02877134|40234445|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
16479945|NCT02877134|40234446|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
16479946|NCT02877134|40234447|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
16479947|NCT02877134|40234448|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
16479948|NCT02877134|40234449|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
16479949|NCT02877134|40234438|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
16479950|NCT02877134|40234439|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
16479951|NCT02877134|40234440|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
16479952|NCT02877134|40234441|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
16479953|NCT02877134|40234442|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
16479954|NCT02877134|40234443|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
16479955|NCT02877134|40234444|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
16479956|NCT02877134|40234445|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
16479957|NCT02877134|40234446|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
16479958|NCT02877134|40234447|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
16479959|NCT02877134|40234448|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
16479960|NCT02877134|40234449|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
16479961|NCT02877134|40234438|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
16479962|NCT02877134|40234439|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
16283582|NCT02315066|39522017|FG002|Overall Study|Other|0|||
16283583|NCT02315066|39522018|FG003|Overall Study|Other|0|||
16283584|NCT02315066|39522019|FG004|Overall Study|Other|0|||
16283585|NCT02315066|39522020|FG005|Overall Study|Other|0|||
16283586|NCT02315066|39522021|FG006|Overall Study|Other|0|||
16283587|NCT02315066|39522022|FG007|Overall Study|Other|1|||
16283588|NCT02315066|39522023|FG008|Overall Study|Other|1|||
16283589|NCT02315066|39522024|FG009|Overall Study|Other|2|||
16283590|NCT02315066|39522025|FG010|Overall Study|Other|0|||
16283591|NCT02315066|39522026|FG011|Overall Study|Other|0|||
16283592|NCT02315066|39522027|FG012|Overall Study|Other|0|||
16283593|NCT02315066|39522028|FG013|Overall Study|Other|0|||
16283594|NCT02315066|39522015|FG000|Overall Study|Subject refused further follow-up|0|||
16283595|NCT02315066|39522016|FG001|Overall Study|Subject refused further follow-up|2|||
16283596|NCT02315066|39522017|FG002|Overall Study|Subject refused further follow-up|2|||
16283597|NCT02315066|39522018|FG003|Overall Study|Subject refused further follow-up|0|||
16283598|NCT02315066|39522019|FG004|Overall Study|Subject refused further follow-up|0|||
16283599|NCT02315066|39522020|FG005|Overall Study|Subject refused further follow-up|0|||
16283600|NCT02315066|39522021|FG006|Overall Study|Subject refused further follow-up|2|||
16283601|NCT02315066|39522022|FG007|Overall Study|Subject refused further follow-up|3|||
16283602|NCT02315066|39522023|FG008|Overall Study|Subject refused further follow-up|0|||
16283603|NCT02315066|39522024|FG009|Overall Study|Subject refused further follow-up|1|||
16283604|NCT02315066|39522025|FG010|Overall Study|Subject refused further follow-up|1|||
16283605|NCT02315066|39522026|FG011|Overall Study|Subject refused further follow-up|2|||
16283606|NCT02315066|39522027|FG012|Overall Study|Subject refused further follow-up|2|||
16283607|NCT02315066|39522028|FG013|Overall Study|Subject refused further follow-up|4|||
16283608|NCT02315066|39522015|FG000|Overall Study|Study ongoing at date of cut-off|0|||
16283609|NCT02315066|39522016|FG001|Overall Study|Study ongoing at date of cut-off|0|||
16283610|NCT02315066|39522017|FG002|Overall Study|Study ongoing at date of cut-off|0|||
16283611|NCT02315066|39522018|FG003|Overall Study|Study ongoing at date of cut-off|0|||
16283612|NCT02315066|39522019|FG004|Overall Study|Study ongoing at date of cut-off|0|||
16283613|NCT02315066|39522020|FG005|Overall Study|Study ongoing at date of cut-off|0|||
16283614|NCT02315066|39522021|FG006|Overall Study|Study ongoing at date of cut-off|0|||
16283615|NCT02315066|39522022|FG007|Overall Study|Study ongoing at date of cut-off|0|||
16283616|NCT02315066|39522023|FG008|Overall Study|Study ongoing at date of cut-off|0|||
16283617|NCT02315066|39522024|FG009|Overall Study|Study ongoing at date of cut-off|0|||
16283618|NCT02315066|39522025|FG010|Overall Study|Study ongoing at date of cut-off|0|||
16283619|NCT02315066|39522026|FG011|Overall Study|Study ongoing at date of cut-off|0|||
16479963|NCT02877134|40234440|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
16283620|NCT02315066|39522027|FG012|Overall Study|Study ongoing at date of cut-off|0|||
16283621|NCT02315066|39522028|FG013|Overall Study|Study ongoing at date of cut-off|1|||
16283622|NCT01857206|39522029|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
16283623|NCT01857206|39522030|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
16283624|NCT01857206|39522029|FG000|Overall Study|Lost to Follow-up|9|||
16283625|NCT01857206|39522030|FG001|Overall Study|Lost to Follow-up|6|||
16283626|NCT01857206|39522029|FG000|Overall Study|Unclassified|3|||
16283627|NCT01857206|39522030|FG001|Overall Study|Unclassified|3|||
16283628|NCT01857206|39522029|FG000|Overall Study|Withdrawal by Subject|1|||
16283629|NCT01857206|39522030|FG001|Overall Study|Withdrawal by Subject|0|||
16283630|NCT01438476|39522031|FG000|Overall Study|Protocol Violation|1|||
16283631|NCT01438476|39522032|FG001|Overall Study|Protocol Violation|0|||
16283632|NCT01438476|39522031|FG000|Overall Study|Withdrawal by Subject|1|||
16283633|NCT01438476|39522032|FG001|Overall Study|Withdrawal by Subject|0|||
16283634|NCT01438476|39522031|FG000|Overall Study|No Surgery- Disease|8|||
16283635|NCT01438476|39522032|FG001|Overall Study|No Surgery- Disease|10|||
16283636|NCT01438476|39522031|FG000|Overall Study|Communication barrier|0|||
16283637|NCT01438476|39522032|FG001|Overall Study|Communication barrier|1|||
16283638|NCT02792218|39522035|FG000|Overall Study|Patient/guardian decision|15|||
16283639|NCT02792218|39522036|FG001|Overall Study|Patient/guardian decision|42|||
16283640|NCT02792218|39522035|FG000|Overall Study|Adverse Event|15|||
16283641|NCT02792218|39522036|FG001|Overall Study|Adverse Event|14|||
16283642|NCT02792218|39522035|FG000|Overall Study|Lost to Follow-up|10|||
16283643|NCT02792218|39522036|FG001|Overall Study|Lost to Follow-up|5|||
16283644|NCT02792218|39522035|FG000|Overall Study|Lack of Efficacy|1|||
16283645|NCT02792218|39522036|FG001|Overall Study|Lack of Efficacy|12|||
16283646|NCT02792218|39522035|FG000|Overall Study|Physician Decision|4|||
16283647|NCT02792218|39522036|FG001|Overall Study|Physician Decision|4|||
16283648|NCT02792218|39522035|FG000|Overall Study|Protocol deviation|3|||
16283649|NCT02792218|39522036|FG001|Overall Study|Protocol deviation|2|||
16283650|NCT02792218|39522035|FG000|Overall Study|New therapy for study indication|0|||
16283651|NCT02792218|39522036|FG001|Overall Study|New therapy for study indication|1|||
16283652|NCT02792218|39522035|FG000|Overall Study|Non-compliance with study treatment|0|||
16283653|NCT02792218|39522036|FG001|Overall Study|Non-compliance with study treatment|1|||
16283654|NCT02792218|39522035|FG000|Overall Study|Pregnancy|1|||
16283655|NCT02792218|39522036|FG001|Overall Study|Pregnancy|0|||
16283656|NCT00293202|39522037|FG000|Overall Study|Withdrawal by Subject|1|||
16283657|NCT00293202|39522038|FG001|Overall Study|Withdrawal by Subject|2|||
16283658|NCT00293202|39522037|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
16283659|NCT00293202|39522038|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
16283660|NCT00293202|39522037|FG000|Overall Study|on-hold due to fistula maturation time|1|||
16283661|NCT00293202|39522038|FG001|Overall Study|on-hold due to fistula maturation time|0|||
16283662|NCT00880087|39522039|FG000|Overall Study|Lost to Follow-up|0|||
16283663|NCT00880087|39522040|FG001|Overall Study|Lost to Follow-up|2|||
16283664|NCT00949988|39522043|FG000|Overall Study|Withdrawal by Subject|3|||
16283665|NCT03451006|39522047|FG000|Overall Study|Withdrawal by Subject|2|||
16283666|NCT03451006|39522048|FG001|Overall Study|Withdrawal by Subject|2|||
16283667|NCT02747004|39522053|FG000|Overall Study|Withdrawal by Subject|8|||
16283668|NCT02747004|39522054|FG001|Overall Study|Withdrawal by Subject|5|||
16283669|NCT02747004|39522055|FG002|Overall Study|Withdrawal by Subject|4|||
16283670|NCT02747004|39522053|FG000|Overall Study|Lost to Follow-up|1|||
16283671|NCT02747004|39522054|FG001|Overall Study|Lost to Follow-up|2|||
16283672|NCT02747004|39522055|FG002|Overall Study|Lost to Follow-up|2|||
16283673|NCT02747004|39522053|FG000|Overall Study|on study treatment/follow-up|48|||
16283674|NCT02747004|39522054|FG001|Overall Study|on study treatment/follow-up|42|||
16283675|NCT02747004|39522055|FG002|Overall Study|on study treatment/follow-up|41|||
16283676|NCT00700817|39522058|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
16283677|NCT00700817|39522059|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
16283678|NCT00700817|39522060|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
16283679|NCT00700817|39522061|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
16283680|NCT00700817|39522062|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
16283681|NCT00700817|39522058|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
16283682|NCT00700817|39522059|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
16283683|NCT00700817|39522060|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
16283684|NCT00700817|39522061|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
16283685|NCT00700817|39522062|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
16283686|NCT00700817|39522058|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
16283687|NCT00700817|39522059|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
16080230|NCT01307267|38786798|FG017|Overall Study|Lost to Follow-up|0|||
16283688|NCT00700817|39522060|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
16283689|NCT00700817|39522061|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
16283690|NCT00700817|39522062|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
16283691|NCT00700817|39522058|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
16283692|NCT00700817|39522059|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
16283693|NCT00700817|39522060|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
16283694|NCT00700817|39522061|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
16283695|NCT00700817|39522062|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
16283696|NCT00700817|39522058|FG000|Week 0-26 (Main Period)|Unclassified|14|||
16283697|NCT00700817|39522059|FG001|Week 0-26 (Main Period)|Unclassified|4|||
16283698|NCT00700817|39522060|FG002|Week 0-26 (Main Period)|Unclassified|8|||
16283699|NCT00700817|39522061|FG003|Week 0-26 (Main Period)|Unclassified|0|||
16283700|NCT00700817|39522062|FG004|Week 0-26 (Main Period)|Unclassified|0|||
16283701|NCT00700817|39522058|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
16283702|NCT00700817|39522059|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
16283703|NCT00700817|39522060|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
16283704|NCT00700817|39522061|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
16283705|NCT00700817|39522062|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
16283706|NCT00700817|39522058|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
16283707|NCT00700817|39522059|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
16283708|NCT00700817|39522060|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
16283709|NCT00700817|39522061|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
16283710|NCT00700817|39522062|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
16283711|NCT00700817|39522058|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
16283712|NCT00700817|39522059|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
16283713|NCT00700817|39522060|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
16283714|NCT00700817|39522061|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
16283715|NCT00700817|39522062|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
16283716|NCT00700817|39522058|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
16283717|NCT00700817|39522059|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
16283718|NCT00700817|39522060|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
16283719|NCT00700817|39522061|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
16283720|NCT00700817|39522062|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
16283721|NCT00700817|39522058|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
16283722|NCT00700817|39522059|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
16283723|NCT00700817|39522060|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
16283724|NCT00700817|39522061|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
16283725|NCT00700817|39522062|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
16283726|NCT00700817|39522058|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
16283727|NCT00700817|39522059|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
16283728|NCT00700817|39522060|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
16283729|NCT00700817|39522061|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
16283730|NCT00700817|39522062|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
16283731|NCT00700817|39522058|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
16283732|NCT00700817|39522059|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
16283733|NCT00700817|39522060|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
16283734|NCT00700817|39522061|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
16283735|NCT00700817|39522062|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
16283736|NCT00700817|39522058|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
16283737|NCT00700817|39522059|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
16283738|NCT00700817|39522060|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
16283739|NCT00700817|39522061|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
16283740|NCT00700817|39522062|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
16283741|NCT00700817|39522058|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
16283742|NCT00700817|39522059|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
16283743|NCT00700817|39522060|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
16283744|NCT00700817|39522061|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
16283745|NCT00700817|39522062|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
16283746|NCT00700817|39522058|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
16283747|NCT00700817|39522059|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
16283748|NCT00700817|39522060|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
16283749|NCT00700817|39522061|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
16283750|NCT00700817|39522062|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
16283751|NCT01045707|39522064|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
16283752|NCT01045707|39522065|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
16283753|NCT01045707|39522064|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
16283754|NCT01045707|39522065|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
16283755|NCT01045707|39522064|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
16283756|NCT01045707|39522065|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
16283757|NCT01045707|39522064|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
16283758|NCT01045707|39522065|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
16283759|NCT01045707|39522064|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
16283760|NCT01045707|39522065|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
16283761|NCT01045707|39522064|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
16283762|NCT01045707|39522065|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
16283763|NCT01045707|39522064|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
16283764|NCT01045707|39522065|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
16283765|NCT01045707|39522064|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
16283766|NCT01045707|39522065|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
16283767|NCT01045707|39522064|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
16283768|NCT01045707|39522065|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
16283769|NCT00892281|39522070|FG000|Overall Study|Adverse Event|65|||
16283770|NCT00892281|39522071|FG001|Overall Study|Adverse Event|8|||
16283771|NCT00892281|39522070|FG000|Overall Study|Lost to Follow-up|81|||
16283772|NCT00892281|39522071|FG001|Overall Study|Lost to Follow-up|8|||
16283773|NCT00892281|39522070|FG000|Overall Study|Pregnancy|1|||
16283774|NCT00892281|39522071|FG001|Overall Study|Pregnancy|0|||
16283775|NCT00892281|39522070|FG000|Overall Study|Protocol Violation|7|||
16283776|NCT00892281|39522071|FG001|Overall Study|Protocol Violation|2|||
16283777|NCT00892281|39522070|FG000|Overall Study|Withdrawal by Subject|86|||
16283778|NCT00892281|39522071|FG001|Overall Study|Withdrawal by Subject|14|||
16283779|NCT00892281|39522070|FG000|Overall Study|Subject failed to return for final visit|2|||
16283780|NCT00892281|39522071|FG001|Overall Study|Subject failed to return for final visit|0|||
16283781|NCT00892281|39522070|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
16283782|NCT00892281|39522071|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
16283783|NCT00892281|39522070|FG000|Overall Study|Final visit completed 4 weeks late|0|||
16283784|NCT00892281|39522071|FG001|Overall Study|Final visit completed 4 weeks late|1|||
16283785|NCT00892281|39522070|FG000|Overall Study|Subject completed day after study closed|1|||
16283786|NCT00892281|39522071|FG001|Overall Study|Subject completed day after study closed|0|||
16283787|NCT00892281|39522070|FG000|Overall Study|Family emergency|1|||
16283788|NCT00892281|39522071|FG001|Overall Study|Family emergency|0|||
16283789|NCT00892281|39522070|FG000|Overall Study|Last visit not done - death in family|1|||
16283790|NCT00892281|39522071|FG001|Overall Study|Last visit not done - death in family|0|||
16283791|NCT00892281|39522070|FG000|Overall Study|Did not meet incl/excl criteria|1|||
16283792|NCT00892281|39522071|FG001|Overall Study|Did not meet incl/excl criteria|0|||
16283793|NCT00892281|39522070|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
16283794|NCT00892281|39522071|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
16283795|NCT00892281|39522070|FG000|Overall Study|Unable to redeem the drug voucher|1|||
16283796|NCT00892281|39522071|FG001|Overall Study|Unable to redeem the drug voucher|0|||
16283797|NCT00892281|39522070|FG000|Overall Study|Subject not good candidate for study|1|||
16283798|NCT00892281|39522071|FG001|Overall Study|Subject not good candidate for study|0|||
16283799|NCT00892281|39522070|FG000|Overall Study|Subject did not return for any visits|1|||
16283800|NCT00892281|39522071|FG001|Overall Study|Subject did not return for any visits|0|||
16283801|NCT00892281|39522070|FG000|Overall Study|Subject missed several visits/lost meds|1|||
16283802|NCT00892281|39522071|FG001|Overall Study|Subject missed several visits/lost meds|0|||
16283803|NCT00892281|39522070|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
16283804|NCT00892281|39522071|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
16283805|NCT00892281|39522070|FG000|Overall Study|Scheduled for knee replacement|0|||
16283806|NCT00892281|39522071|FG001|Overall Study|Scheduled for knee replacement|1|||
16283807|NCT00892281|39522070|FG000|Overall Study|PI complained of inadequate compensation|3|||
16283808|NCT00892281|39522071|FG001|Overall Study|PI complained of inadequate compensation|0|||
16479964|NCT02877134|40234441|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
16479965|NCT02877134|40234442|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
16479966|NCT02877134|40234443|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
16479967|NCT02877134|40234444|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
16479968|NCT02877134|40234445|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
16283809|NCT00892281|39522070|FG000|Overall Study|Subject lost interest in program|0|||
16283810|NCT00892281|39522071|FG001|Overall Study|Subject lost interest in program|1|||
16283811|NCT00892281|39522070|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
16283812|NCT00892281|39522071|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
16283813|NCT00892281|39522070|FG000|Overall Study|Death in family|1|||
16283814|NCT00892281|39522071|FG001|Overall Study|Death in family|0|||
16283815|NCT00892281|39522070|FG000|Overall Study|Lack of efficacy of study product|2|||
16283816|NCT00892281|39522071|FG001|Overall Study|Lack of efficacy of study product|0|||
16283817|NCT00892281|39522070|FG000|Overall Study|Subject not seen by PI at final visit|1|||
16283818|NCT00892281|39522071|FG001|Overall Study|Subject not seen by PI at final visit|0|||
16283819|NCT00892281|39522070|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
16283820|NCT00892281|39522071|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
16283821|NCT00892281|39522070|FG000|Overall Study|Missed multiple visits|1|||
16283822|NCT00892281|39522071|FG001|Overall Study|Missed multiple visits|0|||
16283823|NCT00892281|39522070|FG000|Overall Study|Missed visits rescheduled out of window|1|||
16283824|NCT00892281|39522071|FG001|Overall Study|Missed visits rescheduled out of window|0|||
16283825|NCT00892281|39522070|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
16283826|NCT00892281|39522071|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
16283827|NCT00892281|39522070|FG000|Overall Study|Subject had history of drug abuse|1|||
16283828|NCT00892281|39522071|FG001|Overall Study|Subject had history of drug abuse|0|||
16283829|NCT00892281|39522070|FG000|Overall Study|Rash on hand|1|||
16283830|NCT00892281|39522071|FG001|Overall Study|Rash on hand|0|||
16283831|NCT00892281|39522070|FG000|Overall Study|Visit 4 date out of window|1|||
16283832|NCT00892281|39522071|FG001|Overall Study|Visit 4 date out of window|0|||
16283833|NCT02954159|39522072|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
16283834|NCT02954159|39522073|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
16283835|NCT02954159|39522072|FG000|Overall Study|Withdrawal by Subject|0|||
16283836|NCT02954159|39522073|FG001|Overall Study|Withdrawal by Subject|1|||
16283837|NCT03433755|39522074|FG000|Overall Study|Lost to Follow-up|1|||
16283838|NCT03433755|39522075|FG001|Overall Study|Lost to Follow-up|0|||
16283839|NCT03433755|39522076|FG002|Overall Study|Lost to Follow-up|0|||
16283840|NCT03433755|39522077|FG003|Overall Study|Lost to Follow-up|0|||
16283841|NCT03433755|39522074|FG000|Overall Study|Decision by Sponsor|1|||
16283842|NCT03433755|39522075|FG001|Overall Study|Decision by Sponsor|0|||
16283843|NCT03433755|39522076|FG002|Overall Study|Decision by Sponsor|0|||
16283844|NCT03433755|39522077|FG003|Overall Study|Decision by Sponsor|0|||
16283845|NCT00493779|39522078|FG000|Overall Study|Logistical issue at site|1|||
16283846|NCT05158140|39522080|FG000|Overall Study|Death|0|||
16283847|NCT05158140|39522081|FG001|Overall Study|Death|0|||
16283848|NCT05158140|39522082|FG002|Overall Study|Death|0|||
16283849|NCT05158140|39522083|FG003|Overall Study|Death|1|||
16283850|NCT05158140|39522080|FG000|Overall Study|Lost to Follow-up|3|||
16283851|NCT05158140|39522081|FG001|Overall Study|Lost to Follow-up|6|||
16283852|NCT05158140|39522082|FG002|Overall Study|Lost to Follow-up|4|||
16283853|NCT05158140|39522083|FG003|Overall Study|Lost to Follow-up|3|||
16283854|NCT05158140|39522080|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16283855|NCT05158140|39522081|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16283856|NCT05158140|39522082|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
16283857|NCT05158140|39522083|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
16283858|NCT05158140|39522080|FG000|Overall Study|Withdrawal by Subject|3|||
16283859|NCT05158140|39522081|FG001|Overall Study|Withdrawal by Subject|7|||
16283860|NCT05158140|39522082|FG002|Overall Study|Withdrawal by Subject|3|||
16283861|NCT05158140|39522083|FG003|Overall Study|Withdrawal by Subject|7|||
16283862|NCT00307931|39522085|FG000|Overall Study|Adverse Event|1|||
16283863|NCT00484419|39522086|FG000|Overall Study|Adverse Event|3|||
16283864|NCT00484419|39522087|FG001|Overall Study|Adverse Event|0|||
16283865|NCT00484419|39522088|FG002|Overall Study|Adverse Event|0|||
16283866|NCT00484419|39522086|FG000|Overall Study|Lost to Follow-up|1|||
16283867|NCT00484419|39522087|FG001|Overall Study|Lost to Follow-up|0|||
16283868|NCT00484419|39522088|FG002|Overall Study|Lost to Follow-up|2|||
16283869|NCT00484419|39522086|FG000|Overall Study|Withdrawal by Subject|3|||
16283870|NCT00484419|39522087|FG001|Overall Study|Withdrawal by Subject|1|||
16283871|NCT00484419|39522088|FG002|Overall Study|Withdrawal by Subject|1|||
16283872|NCT00484419|39522086|FG000|Overall Study|subject met discontinuation criteria|2|||
16283873|NCT00484419|39522087|FG001|Overall Study|subject met discontinuation criteria|2|||
16283874|NCT00484419|39522088|FG002|Overall Study|subject met discontinuation criteria|4|||
16283875|NCT00484419|39522086|FG000|Overall Study|required restricted medication|1|||
16283876|NCT00484419|39522087|FG001|Overall Study|required restricted medication|0|||
16283877|NCT00484419|39522088|FG002|Overall Study|required restricted medication|1|||
16283878|NCT00484419|39522086|FG000|Overall Study|Physician Decision|1|||
16283879|NCT00484419|39522087|FG001|Overall Study|Physician Decision|1|||
16283880|NCT00484419|39522088|FG002|Overall Study|Physician Decision|1|||
16283881|NCT00484419|39522086|FG000|Overall Study|subject unable to receive medication|1|||
16283882|NCT00484419|39522087|FG001|Overall Study|subject unable to receive medication|0|||
16283883|NCT00484419|39522088|FG002|Overall Study|subject unable to receive medication|0|||
16283884|NCT00484419|39522086|FG000|Overall Study|subject relocated|0|||
16283885|NCT00484419|39522087|FG001|Overall Study|subject relocated|1|||
16283886|NCT00484419|39522088|FG002|Overall Study|subject relocated|0|||
16283887|NCT00484419|39522086|FG000|Overall Study|sponsor decision, randomized in error|0|||
16283888|NCT00484419|39522087|FG001|Overall Study|sponsor decision, randomized in error|0|||
16283889|NCT00484419|39522088|FG002|Overall Study|sponsor decision, randomized in error|2|||
16283890|NCT01396421|39522089|FG000|Overall Study|Lost to Follow-up|0|||
16283891|NCT01396421|39522090|FG001|Overall Study|Lost to Follow-up|0|||
16283892|NCT01396421|39522091|FG002|Overall Study|Lost to Follow-up|0|||
16283893|NCT01396421|39522092|FG003|Overall Study|Lost to Follow-up|1|||
16283894|NCT01396421|39522089|FG000|Overall Study|Adverse Event|17|||
16283895|NCT01396421|39522090|FG001|Overall Study|Adverse Event|15|||
16283896|NCT01396421|39522091|FG002|Overall Study|Adverse Event|12|||
16283897|NCT01396421|39522092|FG003|Overall Study|Adverse Event|32|||
16283898|NCT01396421|39522089|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
16283899|NCT01396421|39522090|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
16283900|NCT01396421|39522091|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
16283901|NCT01396421|39522092|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
16080231|NCT01307267|38786799|FG018|Overall Study|Lost to Follow-up|0|||
16283902|NCT01396421|39522089|FG000|Overall Study|Physician Decision|1|||
16283903|NCT01396421|39522090|FG001|Overall Study|Physician Decision|1|||
16283904|NCT01396421|39522091|FG002|Overall Study|Physician Decision|0|||
16283905|NCT01396421|39522092|FG003|Overall Study|Physician Decision|3|||
16283906|NCT01396421|39522089|FG000|Overall Study|Withdrawal by Subject|31|||
16283907|NCT01396421|39522090|FG001|Overall Study|Withdrawal by Subject|24|||
16283908|NCT01396421|39522091|FG002|Overall Study|Withdrawal by Subject|13|||
16283909|NCT01396421|39522092|FG003|Overall Study|Withdrawal by Subject|21|||
16283910|NCT01396421|39522089|FG000|Overall Study|Protocol Deviation|2|||
16283911|NCT01396421|39522090|FG001|Overall Study|Protocol Deviation|1|||
16479969|NCT02877134|40234446|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
16479970|NCT02877134|40234447|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
16479971|NCT02877134|40234448|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
16479972|NCT02877134|40234449|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
16479973|NCT02877134|40234438|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
16479974|NCT02877134|40234439|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
16479975|NCT02877134|40234440|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
16479976|NCT02877134|40234441|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
16479977|NCT02877134|40234442|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
16185392|NCT01544595|39159244|FG004|Status at Week 68|Adverse Event|0|||
16185393|NCT01544595|39159245|FG005|Status at Week 68|Adverse Event|0|||
16185394|NCT01544595|39159240|FG000|Status at Week 68|Lack of Efficacy|1|||
16185395|NCT01544595|39159241|FG001|Status at Week 68|Lack of Efficacy|0|||
16185396|NCT01544595|39159242|FG002|Status at Week 68|Lack of Efficacy|0|||
16185397|NCT01544595|39159243|FG003|Status at Week 68|Lack of Efficacy|0|||
16185398|NCT01544595|39159244|FG004|Status at Week 68|Lack of Efficacy|0|||
16185399|NCT01544595|39159245|FG005|Status at Week 68|Lack of Efficacy|0|||
16185400|NCT01544595|39159240|FG000|Status at Week 68|Lost to Follow-up|1|||
16185401|NCT01544595|39159241|FG001|Status at Week 68|Lost to Follow-up|1|||
16185402|NCT01544595|39159242|FG002|Status at Week 68|Lost to Follow-up|0|||
16185403|NCT01544595|39159243|FG003|Status at Week 68|Lost to Follow-up|0|||
16185404|NCT01544595|39159244|FG004|Status at Week 68|Lost to Follow-up|0|||
16185405|NCT01544595|39159245|FG005|Status at Week 68|Lost to Follow-up|0|||
16185406|NCT01544595|39159240|FG000|Status at Week 68|Non-compliance with study treatment|1|||
16185407|NCT01544595|39159241|FG001|Status at Week 68|Non-compliance with study treatment|0|||
16185408|NCT01544595|39159242|FG002|Status at Week 68|Non-compliance with study treatment|0|||
16185409|NCT01544595|39159243|FG003|Status at Week 68|Non-compliance with study treatment|1|||
16185410|NCT01544595|39159244|FG004|Status at Week 68|Non-compliance with study treatment|0|||
16185411|NCT01544595|39159245|FG005|Status at Week 68|Non-compliance with study treatment|0|||
16185412|NCT01544595|39159240|FG000|Status at Week 68|Protocol Violation|2|||
16185413|NCT01544595|39159241|FG001|Status at Week 68|Protocol Violation|0|||
16185414|NCT01544595|39159242|FG002|Status at Week 68|Protocol Violation|1|||
16185415|NCT01544595|39159243|FG003|Status at Week 68|Protocol Violation|1|||
16185416|NCT01544595|39159244|FG004|Status at Week 68|Protocol Violation|0|||
16185417|NCT01544595|39159245|FG005|Status at Week 68|Protocol Violation|0|||
16185418|NCT01544595|39159240|FG000|Status at Week 68|Technical problems|1|||
16185419|NCT01544595|39159241|FG001|Status at Week 68|Technical problems|0|||
16185420|NCT01544595|39159242|FG002|Status at Week 68|Technical problems|0|||
16185421|NCT01544595|39159243|FG003|Status at Week 68|Technical problems|1|||
16185422|NCT01544595|39159244|FG004|Status at Week 68|Technical problems|0|||
16185423|NCT01544595|39159245|FG005|Status at Week 68|Technical problems|0|||
16185424|NCT01544595|39159240|FG000|Status at Week 68|Withdrawal by Subject|0|||
16185425|NCT01544595|39159241|FG001|Status at Week 68|Withdrawal by Subject|1|||
16185426|NCT01544595|39159242|FG002|Status at Week 68|Withdrawal by Subject|1|||
16185427|NCT01544595|39159243|FG003|Status at Week 68|Withdrawal by Subject|2|||
16185428|NCT01544595|39159244|FG004|Status at Week 68|Withdrawal by Subject|0|||
16185429|NCT01544595|39159245|FG005|Status at Week 68|Withdrawal by Subject|0|||
16185430|NCT01544595|39159240|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
16185431|NCT01544595|39159241|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
16185432|NCT01544595|39159242|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
16185433|NCT01544595|39159243|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
16185434|NCT01544595|39159244|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
16185435|NCT01544595|39159245|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
16185436|NCT01544595|39159240|FG000|Status at Week 156|Withdrawal by Subject|9|||
16185437|NCT01544595|39159241|FG001|Status at Week 156|Withdrawal by Subject|10|||
16185438|NCT01544595|39159242|FG002|Status at Week 156|Withdrawal by Subject|4|||
16185439|NCT01544595|39159243|FG003|Status at Week 156|Withdrawal by Subject|9|||
16185440|NCT01544595|39159244|FG004|Status at Week 156|Withdrawal by Subject|20|||
16185441|NCT01544595|39159245|FG005|Status at Week 156|Withdrawal by Subject|6|||
16185442|NCT01544595|39159240|FG000|Status at Week 156|Adverse Event|9|||
16185443|NCT01544595|39159241|FG001|Status at Week 156|Adverse Event|11|||
16185444|NCT01544595|39159242|FG002|Status at Week 156|Adverse Event|1|||
16185445|NCT01544595|39159243|FG003|Status at Week 156|Adverse Event|3|||
16185446|NCT01544595|39159244|FG004|Status at Week 156|Adverse Event|4|||
16283912|NCT01396421|39522091|FG002|Overall Study|Protocol Deviation|1|||
16283913|NCT01396421|39522092|FG003|Overall Study|Protocol Deviation|0|||
16283914|NCT01396421|39522089|FG000|Overall Study|Lack of Efficacy|7|||
16283915|NCT01396421|39522090|FG001|Overall Study|Lack of Efficacy|17|||
16283916|NCT01396421|39522091|FG002|Overall Study|Lack of Efficacy|7|||
16283917|NCT01396421|39522092|FG003|Overall Study|Lack of Efficacy|18|||
16283918|NCT01507090|39522098|FG000|Overall Study|incomplete dataset|18|||
16283919|NCT03253094|39522099|FG000|Overall Study|Adverse Event|2|||
16283920|NCT03253094|39522100|FG001|Overall Study|Adverse Event|0|||
16283921|NCT03253094|39522101|FG002|Overall Study|Adverse Event|0|||
16283922|NCT03253094|39522102|FG003|Overall Study|Adverse Event|0|||
16283923|NCT03253094|39522103|FG004|Overall Study|Adverse Event|0|||
16283924|NCT03253094|39522104|FG005|Overall Study|Adverse Event|0|||
16283925|NCT03253094|39522099|FG000|Overall Study|Lack of Efficacy|0|||
16283926|NCT03253094|39522100|FG001|Overall Study|Lack of Efficacy|0|||
16283927|NCT03253094|39522101|FG002|Overall Study|Lack of Efficacy|2|||
16283928|NCT03253094|39522102|FG003|Overall Study|Lack of Efficacy|1|||
16283929|NCT03253094|39522103|FG004|Overall Study|Lack of Efficacy|2|||
16283930|NCT03253094|39522104|FG005|Overall Study|Lack of Efficacy|1|||
16283931|NCT03253094|39522099|FG000|Overall Study|Lost to Follow-up|0|||
16283932|NCT03253094|39522100|FG001|Overall Study|Lost to Follow-up|0|||
16283933|NCT03253094|39522101|FG002|Overall Study|Lost to Follow-up|1|||
16283934|NCT03253094|39522102|FG003|Overall Study|Lost to Follow-up|1|||
16283935|NCT03253094|39522103|FG004|Overall Study|Lost to Follow-up|0|||
16283936|NCT03253094|39522104|FG005|Overall Study|Lost to Follow-up|1|||
16283937|NCT03253094|39522099|FG000|Overall Study|Physician Decision|1|||
16283938|NCT03253094|39522100|FG001|Overall Study|Physician Decision|0|||
16283939|NCT03253094|39522101|FG002|Overall Study|Physician Decision|0|||
16283940|NCT03253094|39522102|FG003|Overall Study|Physician Decision|1|||
16283941|NCT03253094|39522103|FG004|Overall Study|Physician Decision|0|||
16283942|NCT03253094|39522104|FG005|Overall Study|Physician Decision|2|||
16283943|NCT03253094|39522099|FG000|Overall Study|Withdrawal by Subject|1|||
16283944|NCT03253094|39522100|FG001|Overall Study|Withdrawal by Subject|2|||
16283945|NCT03253094|39522101|FG002|Overall Study|Withdrawal by Subject|1|||
16283946|NCT03253094|39522102|FG003|Overall Study|Withdrawal by Subject|0|||
16283947|NCT03253094|39522103|FG004|Overall Study|Withdrawal by Subject|3|||
16283948|NCT03253094|39522104|FG005|Overall Study|Withdrawal by Subject|0|||
16283949|NCT03253094|39522099|FG000|Overall Study|Other|0|||
16283950|NCT03253094|39522100|FG001|Overall Study|Other|1|||
16283951|NCT03253094|39522101|FG002|Overall Study|Other|2|||
16283952|NCT03253094|39522102|FG003|Overall Study|Other|1|||
16283953|NCT03253094|39522103|FG004|Overall Study|Other|0|||
16283954|NCT03253094|39522104|FG005|Overall Study|Other|0|||
16283955|NCT02459418|39522105|FG000|Overall Study|Exclusion Criteria|4|||
16283956|NCT02459418|39522106|FG001|Overall Study|Exclusion Criteria|0|||
16283957|NCT02459418|39522105|FG000|Overall Study|Protocol Violation|0|||
16283958|NCT02459418|39522106|FG001|Overall Study|Protocol Violation|2|||
16283959|NCT02459418|39522105|FG000|Overall Study|Physician Decision|0|||
16283960|NCT02459418|39522106|FG001|Overall Study|Physician Decision|2|||
16283961|NCT02459418|39522105|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
16283962|NCT02459418|39522106|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
16283963|NCT02459418|39522105|FG000|Overall Study|Adverse Event|0|||
16283964|NCT02459418|39522106|FG001|Overall Study|Adverse Event|1|||
16283965|NCT02459418|39522105|FG000|Overall Study|Withdrawal by Subject|1|||
16283966|NCT02459418|39522106|FG001|Overall Study|Withdrawal by Subject|1|||
16283967|NCT02459418|39522105|FG000|Overall Study|Elevated Creatine Kinase|1|||
16283968|NCT02459418|39522106|FG001|Overall Study|Elevated Creatine Kinase|0|||
16283969|NCT02459418|39522105|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
16479978|NCT02877134|40234443|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
16479979|NCT02877134|40234444|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
16479980|NCT02877134|40234445|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
16479981|NCT02877134|40234446|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
16479982|NCT02877134|40234447|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
16479983|NCT02877134|40234448|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
16479984|NCT02877134|40234449|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
16479985|NCT02877134|40234438|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16283970|NCT02459418|39522106|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
16283971|NCT00942331|39522107|FG000|Overall Study|Did not start treatment|15|||
16283972|NCT00942331|39522108|FG001|Overall Study|Did not start treatment|22|||
16479986|NCT02877134|40234439|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16283973|NCT04046549|39522109|FG000|Overall Study|Adverse Event|1|||
16283974|NCT04046549|39522109|FG000|Overall Study|Physician Decision|1|||
16283975|NCT04046549|39522109|FG000|Overall Study|Withdrawal by Subject|3|||
16283976|NCT04046549|39522109|FG000|Overall Study|Other, Not Specified|5|||
16283977|NCT02619682|39522110|FG000|Overall Study|Withdrawal by Subject|3|||
16283978|NCT02619682|39522110|FG000|Overall Study|Lack of Efficacy|8|||
16283979|NCT02619682|39522110|FG000|Overall Study|new secondary cancer|1|||
16283980|NCT02619682|39522110|FG000|Overall Study|post surgery complications|2|||
16283981|NCT01640873|39522111|FG000|Overall Study|Protocol Violation|2|||
16283982|NCT01640873|39522112|FG001|Overall Study|Protocol Violation|1|||
16283983|NCT00685802|39522113|FG000|Washout Period of 7 Days|Protocol Violation|2|||
16283984|NCT00685802|39522114|FG001|Washout Period of 7 Days|Protocol Violation|0|||
16283985|NCT00685802|39522113|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
16283986|NCT00685802|39522114|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16283987|NCT04403763|39522115|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
16283988|NCT04403763|39522116|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
16283989|NCT04403763|39522117|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
16283990|NCT04403763|39522118|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
16283991|NCT04403763|39522119|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
16283992|NCT04403763|39522120|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
16283993|NCT04403763|39522121|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
16283994|NCT04403763|39522115|FG000|Stage 1|Early termination due to PK tube failure|0|||
16283995|NCT04403763|39522116|FG001|Stage 1|Early termination due to PK tube failure|0|||
16283996|NCT04403763|39522117|FG002|Stage 1|Early termination due to PK tube failure|1|||
16283997|NCT04403763|39522118|FG003|Stage 1|Early termination due to PK tube failure|0|||
16283998|NCT04403763|39522119|FG004|Stage 1|Early termination due to PK tube failure|0|||
16283999|NCT04403763|39522120|FG005|Stage 1|Early termination due to PK tube failure|0|||
16284000|NCT04403763|39522121|FG006|Stage 1|Early termination due to PK tube failure|0|||
16284001|NCT04403763|39522115|FG000|Stage 2A|Adverse Event|0|||
16284002|NCT04403763|39522116|FG001|Stage 2A|Adverse Event|0|||
16284003|NCT04403763|39522117|FG002|Stage 2A|Adverse Event|0|||
16284004|NCT04403763|39522118|FG003|Stage 2A|Adverse Event|0|||
16284005|NCT04403763|39522119|FG004|Stage 2A|Adverse Event|0|||
16284006|NCT04403763|39522120|FG005|Stage 2A|Adverse Event|0|||
16284007|NCT04403763|39522121|FG006|Stage 2A|Adverse Event|1|||
16284008|NCT03176784|39522122|FG000|Overall Study|Lost to Follow-up|77|||
16284009|NCT03176784|39522123|FG001|Overall Study|Lost to Follow-up|79|||
16284010|NCT03176784|39522124|FG002|Overall Study|Lost to Follow-up|79|||
16284011|NCT03176784|39522125|FG003|Overall Study|Lost to Follow-up|49|||
16284012|NCT03176784|39522122|FG000|Overall Study|Withdrawal by Subject|28|||
16284013|NCT03176784|39522123|FG001|Overall Study|Withdrawal by Subject|34|||
16284014|NCT03176784|39522124|FG002|Overall Study|Withdrawal by Subject|34|||
16284015|NCT03176784|39522125|FG003|Overall Study|Withdrawal by Subject|21|||
16284016|NCT02744755|39522126|FG000|Study Period 1|Protocol Violation|2|||
16284017|NCT02744755|39522127|FG001|Study Period 1|Protocol Violation|1|||
16284018|NCT02744755|39522126|FG000|Study Period 1|not defined|0|||
16284019|NCT02744755|39522127|FG001|Study Period 1|not defined|1|||
16284020|NCT02744755|39522126|FG000|Study Period 1|Pregnancy|1|||
16284021|NCT02744755|39522127|FG001|Study Period 1|Pregnancy|0|||
16284022|NCT02744755|39522126|FG000|Study Period 1|Adverse Event|1|||
16284023|NCT02744755|39522127|FG001|Study Period 1|Adverse Event|1|||
16284024|NCT02744755|39522126|FG000|Study Period 1|Lost to Follow-up|1|||
16284025|NCT02744755|39522127|FG001|Study Period 1|Lost to Follow-up|1|||
16284026|NCT02744755|39522126|FG000|Study Period 1|Lack of Efficacy|1|||
16284027|NCT02744755|39522127|FG001|Study Period 1|Lack of Efficacy|0|||
16284028|NCT02744755|39522126|FG000|Study Period 1|Withdrawal by Subject|8|||
16284029|NCT02744755|39522127|FG001|Study Period 1|Withdrawal by Subject|4|||
16284030|NCT02744755|39522126|FG000|Study Period 2|Adverse Event|5|||
16284031|NCT02744755|39522127|FG001|Study Period 2|Adverse Event|0|||
16284032|NCT02744755|39522126|FG000|Study Period 2|Protocol Violation|1|||
16284033|NCT02744755|39522127|FG001|Study Period 2|Protocol Violation|0|||
16284034|NCT02744755|39522126|FG000|Study Period 2|not defined|3|||
16284035|NCT02744755|39522127|FG001|Study Period 2|not defined|2|||
16284036|NCT02744755|39522126|FG000|Study Period 2|Lost to Follow-up|0|||
16284037|NCT02744755|39522127|FG001|Study Period 2|Lost to Follow-up|2|||
16284038|NCT02744755|39522126|FG000|Study Period 2|Withdrawal by Subject|2|||
16284039|NCT02744755|39522127|FG001|Study Period 2|Withdrawal by Subject|2|||
16284040|NCT02744755|39522126|FG000|Study Period 2|Lack of Efficacy|3|||
16284041|NCT02744755|39522127|FG001|Study Period 2|Lack of Efficacy|2|||
16284042|NCT02960438|39522128|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
16284043|NCT02960438|39522129|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
16284044|NCT02960438|39522130|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
16284045|NCT02960438|39522131|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
16284046|NCT02960438|39522128|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
16284047|NCT02960438|39522129|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
16284048|NCT02960438|39522130|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
16284049|NCT02960438|39522131|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
16284050|NCT02960438|39522128|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
16284051|NCT02960438|39522129|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
16284052|NCT02960438|39522130|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
16284053|NCT02960438|39522131|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
16284054|NCT02960438|39522128|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
16284055|NCT02960438|39522129|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
16284056|NCT02960438|39522130|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
16284057|NCT02960438|39522131|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
16284058|NCT02960438|39522128|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
16284059|NCT02960438|39522129|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
16284060|NCT02960438|39522130|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
16284061|NCT02960438|39522131|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
16284062|NCT02960438|39522128|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
16284063|NCT02960438|39522129|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
16284064|NCT02960438|39522130|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
16284065|NCT02960438|39522131|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
16284066|NCT02960438|39522128|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
16284067|NCT02960438|39522129|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
16284068|NCT02960438|39522130|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
16284069|NCT02960438|39522131|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
16284070|NCT02960438|39522128|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
16284071|NCT02960438|39522129|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
16284072|NCT02960438|39522130|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
16284073|NCT02960438|39522131|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
16284074|NCT02960438|39522128|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
16284075|NCT02960438|39522129|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
16284076|NCT02960438|39522130|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
16284077|NCT02960438|39522131|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
16284078|NCT02960438|39522128|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
16284079|NCT02960438|39522129|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
16284080|NCT02960438|39522130|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
16284081|NCT02960438|39522131|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
16284082|NCT02960438|39522128|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
16284083|NCT02960438|39522129|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
16284084|NCT02960438|39522130|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
16284085|NCT02960438|39522131|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
16284086|NCT02960438|39522128|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
16284087|NCT02960438|39522129|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
16284088|NCT02960438|39522130|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
16284089|NCT02960438|39522131|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
16284090|NCT00854373|39522134|FG000|Overall Study|Withdrawal by Subject|1|||
16284091|NCT00854373|39522135|FG001|Overall Study|Withdrawal by Subject|3|||
16284092|NCT00854373|39522134|FG000|Overall Study|Forgot to take study drug|1|||
16284093|NCT00854373|39522135|FG001|Overall Study|Forgot to take study drug|1|||
16284094|NCT03201211|39522138|FG000|Overall Study|Adverse Event|1|||
16284095|NCT03201211|39522139|FG001|Overall Study|Adverse Event|0|||
16284096|NCT03201211|39522140|FG002|Overall Study|Adverse Event|0|||
16284097|NCT03201211|39522138|FG000|Overall Study|Protocol Violation|1|||
16284098|NCT03201211|39522139|FG001|Overall Study|Protocol Violation|0|||
16284099|NCT03201211|39522140|FG002|Overall Study|Protocol Violation|0|||
16284100|NCT03201211|39522138|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
16284101|NCT03201211|39522139|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
16284102|NCT03201211|39522140|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
16284103|NCT03201211|39522138|FG000|Overall Study|OTHER unknown reasons|0|||
16284104|NCT03201211|39522139|FG001|Overall Study|OTHER unknown reasons|1|||
16284105|NCT03201211|39522140|FG002|Overall Study|OTHER unknown reasons|0|||
16284106|NCT04287868|39522141|FG000|Overall Study|Screening fail|1|||
16284107|NCT04287868|39522142|FG001|Overall Study|Screening fail|0|||
16284108|NCT01647958|39522145|FG000|Initial Study|Lost to Follow-up|2|||
16284109|NCT01647958|39522146|FG001|Initial Study|Lost to Follow-up|3|||
16284110|NCT01647958|39522145|FG000|Continuation Phase|treatment received during Overall Study|39|||
16284111|NCT01647958|39522146|FG001|Continuation Phase|treatment received during Overall Study|0|||
16284112|NCT01647958|39522145|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
16284113|NCT01647958|39522146|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
16284114|NCT00706992|39522147|FG000|Overall Study|Study termination|5|||
16284115|NCT00706992|39522148|FG001|Overall Study|Study termination|5|||
16284116|NCT00706992|39522149|FG002|Overall Study|Study termination|6|||
16284117|NCT00706992|39522150|FG003|Overall Study|Study termination|2|||
16284118|NCT00706992|39522151|FG004|Overall Study|Study termination|3|||
16284119|NCT00706992|39522152|FG005|Overall Study|Study termination|2|||
16284120|NCT00706992|39522153|FG006|Overall Study|Study termination|3|||
16284121|NCT00706992|39522147|FG000|Overall Study|Disease progression before treatment|0|||
16284122|NCT00706992|39522148|FG001|Overall Study|Disease progression before treatment|0|||
16284123|NCT00706992|39522149|FG002|Overall Study|Disease progression before treatment|0|||
16284124|NCT00706992|39522150|FG003|Overall Study|Disease progression before treatment|0|||
16284125|NCT00706992|39522151|FG004|Overall Study|Disease progression before treatment|1|||
16284126|NCT00706992|39522152|FG005|Overall Study|Disease progression before treatment|0|||
16284127|NCT00706992|39522153|FG006|Overall Study|Disease progression before treatment|0|||
16284128|NCT00684567|39522154|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
16284129|NCT00684567|39522154|FG000|Monotherapy Period|Adverse Event|2|||
16284130|NCT00684567|39522154|FG000|Monotherapy Period|Death|1|||
16284131|NCT00684567|39522154|FG000|Monotherapy Period|Progression of primary disease|11|||
16284132|NCT00802178|39522157|FG000|Overall Study|Lack of Efficacy|36|||
16284133|NCT00802178|39522157|FG000|Overall Study|Insufficient tolerability (IT)|17|||
16284134|NCT00802178|39522157|FG000|Overall Study|Withdrawal by Subject|18|||
16284135|NCT00802178|39522157|FG000|Overall Study|Other|32|||
16284136|NCT00802178|39522157|FG000|Overall Study|Lack of efficacy and patient wish|1|||
16284137|NCT00802178|39522157|FG000|Overall Study|IT and patient wish|8|||
16284138|NCT00802178|39522157|FG000|Overall Study|Patients wish and other reason|1|||
16284139|NCT00710749|39522159|FG000|First Intervention|Withdrawal by Subject|1|||
16284140|NCT00710749|39522160|FG001|First Intervention|Withdrawal by Subject|0|||
16284141|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
16284142|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
16284143|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
16284144|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
16284145|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
16284146|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
16284147|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
16284148|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
16284149|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
16284150|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
16284151|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Subject decision|1|||
16284152|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Subject decision|1|||
16284153|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
16284154|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
16284155|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
16284156|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
16284157|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
16284158|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
16284159|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
16284160|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
16284161|NCT00518882|39522163|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
16284162|NCT00518882|39522164|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
16284163|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
16284164|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
16284165|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
16284166|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
16284167|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
16479987|NCT02877134|40234440|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16479988|NCT02877134|40234441|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16479989|NCT02877134|40234442|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16479990|NCT02877134|40234443|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16479991|NCT02877134|40234444|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16479992|NCT02877134|40234445|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16479993|NCT02877134|40234446|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
16479994|NCT02877134|40234447|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16479995|NCT02877134|40234448|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16479996|NCT02877134|40234449|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
16479997|NCT02877134|40234438|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
16479998|NCT02877134|40234439|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
16479999|NCT02877134|40234440|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
16480000|NCT02877134|40234441|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
16480001|NCT02877134|40234442|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
16480002|NCT02877134|40234443|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
16480003|NCT02877134|40234444|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
16480004|NCT02877134|40234445|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
16480005|NCT02877134|40234446|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
16480006|NCT02877134|40234447|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
16480007|NCT02877134|40234448|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
16480008|NCT02877134|40234449|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
16480009|NCT02877134|40234438|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
16080232|NCT01307267|38786800|FG019|Overall Study|Lost to Follow-up|2|||
16080233|NCT01307267|38786801|FG020|Overall Study|Lost to Follow-up|0|||
16480010|NCT02877134|40234439|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
16284168|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
16284169|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
16284170|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
16284171|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
16284172|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
16284173|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
16284174|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
16284175|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
16284176|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
16284177|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
16284178|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
16284179|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
16284180|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
16284181|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
16284182|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
16284183|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
16284184|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
16284185|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
16284186|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
16284187|NCT00518882|39522163|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
16284188|NCT00518882|39522164|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
16284189|NCT03952559|39522174|FG000|Double Blind Treatment Period|Adverse Event|0|||
16284190|NCT03952559|39522175|FG001|Double Blind Treatment Period|Adverse Event|2|||
16284191|NCT03952559|39522176|FG002|Double Blind Treatment Period|Adverse Event|1|||
16284192|NCT03952559|39522177|FG003|Double Blind Treatment Period|Adverse Event|0|||
16284193|NCT03952559|39522178|FG004|Double Blind Treatment Period|Adverse Event|1|||
16284194|NCT03952559|39522174|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
16284195|NCT03952559|39522175|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
16284196|NCT03952559|39522176|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
16379789|NCT04103450|39874772|FG000|Overall Study|Physician Decision|1|||
16379790|NCT04103450|39874773|FG001|Overall Study|Physician Decision|2|||
16379791|NCT04103450|39874772|FG000|Overall Study|Protocol Violation|1|||
16379792|NCT04103450|39874773|FG001|Overall Study|Protocol Violation|0|||
16284197|NCT03952559|39522177|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
16284198|NCT03952559|39522178|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
16284199|NCT03952559|39522174|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
16284200|NCT03952559|39522175|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
16284201|NCT03952559|39522176|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
16284202|NCT03952559|39522177|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
16284203|NCT03952559|39522178|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
16284204|NCT03952559|39522174|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
16284205|NCT03952559|39522175|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
16284206|NCT03952559|39522176|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
16284207|NCT03952559|39522177|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
16284208|NCT03952559|39522178|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
16284209|NCT03005067|39522179|FG000|Overall Study|Withdrawal by Subject|3|||
16284210|NCT03005067|39522180|FG001|Overall Study|Withdrawal by Subject|2|||
16284211|NCT03005067|39522179|FG000|Overall Study|Adverse Event|4|||
16284212|NCT03005067|39522180|FG001|Overall Study|Adverse Event|3|||
16284213|NCT03005067|39522179|FG000|Overall Study|Other (reason not specified)|3|||
16284214|NCT03005067|39522180|FG001|Overall Study|Other (reason not specified)|1|||
16284215|NCT03005067|39522179|FG000|Overall Study|Protocol Violation|0|||
16284216|NCT03005067|39522180|FG001|Overall Study|Protocol Violation|1|||
16284217|NCT00063882|39522181|FG000|Overall Study|Protocol Violation|3|||
16284218|NCT00063882|39522182|FG001|Overall Study|Protocol Violation|3|||
16284219|NCT00063882|39522181|FG000|Overall Study|Withdrawal by Subject|2|||
16284220|NCT00063882|39522182|FG001|Overall Study|Withdrawal by Subject|1|||
16284221|NCT00438659|39522185|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
16284222|NCT00438659|39522186|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
16284223|NCT00438659|39522185|FG000|Overall Study|Cancel|5|||
16480011|NCT02877134|40234440|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
16480012|NCT02877134|40234441|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
16480013|NCT02877134|40234442|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
16480014|NCT02877134|40234443|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
16284224|NCT00438659|39522186|FG001|Overall Study|Cancel|2|||
16284225|NCT02148913|39522187|FG000|Overall Study|Death|0|||
16284226|NCT02148913|39522188|FG001|Overall Study|Death|1|||
16284227|NCT02148913|39522189|FG002|Overall Study|Death|0|||
16284228|NCT02148913|39522190|FG003|Overall Study|Death|0|||
16284229|NCT01286558|39522191|FG000|Overall Study|Adverse Event|1|||
16284230|NCT01286558|39522192|FG001|Overall Study|Adverse Event|1|||
16284231|NCT01286558|39522191|FG000|Overall Study|Withdrawal by Subject|0|||
16284232|NCT01286558|39522192|FG001|Overall Study|Withdrawal by Subject|1|||
16284233|NCT01684878|39522193|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
16284234|NCT01684878|39522194|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
16284235|NCT01684878|39522195|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
16284236|NCT01684878|39522196|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
16284237|NCT01684878|39522193|FG000|Part 1: Safety Run in Phase|Death|15|||
16480015|NCT02877134|40234444|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
16480016|NCT02877134|40234445|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
16480017|NCT02877134|40234446|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
16480018|NCT02877134|40234447|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
16480019|NCT02877134|40234448|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
16480020|NCT02877134|40234449|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
16480021|NCT02877134|40234438|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
16480022|NCT02877134|40234439|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
16480023|NCT02877134|40234440|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
16480024|NCT02877134|40234441|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
16480025|NCT02877134|40234442|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
16480026|NCT02877134|40234443|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
16480027|NCT02877134|40234444|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
16480028|NCT02877134|40234445|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
16480029|NCT02877134|40234446|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
16480030|NCT02877134|40234447|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
16480031|NCT02877134|40234448|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
16480032|NCT02877134|40234449|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
16480033|NCT04447794|40234450|FG000|Overall Study|Lost to Follow-up|2|||
16480034|NCT04447794|40234451|FG001|Overall Study|Lost to Follow-up|3|||
16480035|NCT04447794|40234452|FG002|Overall Study|Lost to Follow-up|8|||
16480036|NCT04447794|40234450|FG000|Overall Study|Withdrawal by Subject|1|||
16480037|NCT04447794|40234451|FG001|Overall Study|Withdrawal by Subject|1|||
16480038|NCT04447794|40234452|FG002|Overall Study|Withdrawal by Subject|0|||
16480039|NCT00287365|40234454|FG000|Overall Study|sample not acquired|13|||
16480040|NCT00216476|40234455|FG000|Overall Study|Withdrawal by Subject|59|||
16480041|NCT00216476|40234456|FG001|Overall Study|Withdrawal by Subject|72|||
16480042|NCT00216476|40234457|FG002|Overall Study|Withdrawal by Subject|9|||
16480043|NCT00216476|40234455|FG000|Overall Study|Lost to Follow-up|10|||
16480044|NCT00216476|40234456|FG001|Overall Study|Lost to Follow-up|9|||
16480045|NCT00216476|40234457|FG002|Overall Study|Lost to Follow-up|1|||
16480046|NCT00216476|40234455|FG000|Overall Study|Adverse Event|6|||
16480047|NCT00216476|40234456|FG001|Overall Study|Adverse Event|10|||
16480048|NCT00216476|40234457|FG002|Overall Study|Adverse Event|1|||
16480049|NCT00216476|40234455|FG000|Overall Study|Lack of Efficacy|4|||
16480050|NCT00216476|40234456|FG001|Overall Study|Lack of Efficacy|3|||
16480051|NCT00216476|40234457|FG002|Overall Study|Lack of Efficacy|0|||
16480052|NCT00216476|40234455|FG000|Overall Study|Death|2|||
16480053|NCT00216476|40234456|FG001|Overall Study|Death|0|||
16480054|NCT00216476|40234457|FG002|Overall Study|Death|0|||
16480055|NCT00216476|40234455|FG000|Overall Study|Pregnancy|0|||
16480056|NCT00216476|40234456|FG001|Overall Study|Pregnancy|1|||
16480057|NCT00216476|40234457|FG002|Overall Study|Pregnancy|1|||
16480058|NCT00216476|40234455|FG000|Overall Study|Other|0|||
16480059|NCT00216476|40234456|FG001|Overall Study|Other|0|||
16480060|NCT00216476|40234457|FG002|Overall Study|Other|1|||
16480061|NCT00216476|40234455|FG000|Overall Study|Refuses Injection|11|||
16480062|NCT00216476|40234456|FG001|Overall Study|Refuses Injection|0|||
16480063|NCT00216476|40234457|FG002|Overall Study|Refuses Injection|0|||
16480064|NCT00216476|40234455|FG000|Overall Study|No Further Need for Treatment|3|||
16480065|NCT00216476|40234456|FG001|Overall Study|No Further Need for Treatment|4|||
16480066|NCT00216476|40234457|FG002|Overall Study|No Further Need for Treatment|1|||
16480067|NCT00216476|40234455|FG000|Overall Study|Non-compliance|0|||
16480068|NCT00216476|40234456|FG001|Overall Study|Non-compliance|4|||
16480069|NCT00216476|40234457|FG002|Overall Study|Non-compliance|1|||
16480070|NCT00216476|40234455|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
16480071|NCT00216476|40234456|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
16480072|NCT00216476|40234457|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
16480073|NCT00216476|40234455|FG000|Overall Study|Administrative Reasons|1|||
16480074|NCT00216476|40234456|FG001|Overall Study|Administrative Reasons|1|||
16480075|NCT00216476|40234457|FG002|Overall Study|Administrative Reasons|0|||
16480076|NCT00216476|40234455|FG000|Overall Study|Protocol Deviation|5|||
16480077|NCT00216476|40234456|FG001|Overall Study|Protocol Deviation|1|||
16480078|NCT00216476|40234457|FG002|Overall Study|Protocol Deviation|0|||
16480079|NCT00216476|40234455|FG000|Overall Study|Patient Moved|2|||
16480080|NCT00216476|40234456|FG001|Overall Study|Patient Moved|2|||
16480081|NCT00216476|40234457|FG002|Overall Study|Patient Moved|0|||
16480082|NCT00880542|40238142|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
16480083|NCT00880542|40238142|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
16480084|NCT00880542|40238142|FG000|REP: Surgical Resection|progressive disease|1|||
16480085|NCT03546062|40238143|FG000|Overall Study|Adverse Event|6|||
16480086|NCT03546062|40238144|FG001|Overall Study|Adverse Event|5|||
16480087|NCT03546062|40238145|FG002|Overall Study|Adverse Event|8|||
16480088|NCT03334630|40238146|FG000|Overall Study|Withdrawal by Subject|7|||
16480089|NCT03334630|40238147|FG001|Overall Study|Withdrawal by Subject|7|||
16480090|NCT03334630|40238146|FG000|Overall Study|Lost to Follow-up|3|||
16480091|NCT03334630|40238147|FG001|Overall Study|Lost to Follow-up|1|||
16480092|NCT03334630|40238146|FG000|Overall Study|Adverse Event|0|||
16480093|NCT03334630|40238147|FG001|Overall Study|Adverse Event|1|||
16480094|NCT03334630|40238146|FG000|Overall Study|Physician Decision|1|||
16480095|NCT03334630|40238147|FG001|Overall Study|Physician Decision|1|||
16480096|NCT03334630|40238146|FG000|Overall Study|Enrollment closed|2|||
16480097|NCT03334630|40238147|FG001|Overall Study|Enrollment closed|1|||
16480098|NCT03334630|40238146|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
16480099|NCT03334630|40238147|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
16480100|NCT03334630|40238146|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
16480101|NCT03334630|40238147|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
16480102|NCT00736944|40238148|FG000|Induction|Death|1|||
16284238|NCT01684878|39522194|FG001|Part 1: Safety Run in Phase|Death|20|||
16284239|NCT01684878|39522195|FG002|Part 1: Safety Run in Phase|Death|0|||
16284240|NCT01684878|39522196|FG003|Part 1: Safety Run in Phase|Death|0|||
16284241|NCT01684878|39522193|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
16284242|NCT01684878|39522194|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
16480103|NCT00736944|40238148|FG000|Definitive Treatment|Physician Decision|1|||
16480104|NCT00241358|40238149|FG000|Overall Study|Determined to be not ineligible|0|||
16480105|NCT00241358|40238150|FG001|Overall Study|Determined to be not ineligible|1|||
16480106|NCT00241358|40238151|FG002|Overall Study|Determined to be not ineligible|1|||
16480107|NCT00239590|40238152|FG000|Randomized|Lost to Follow-up|0|||
16480108|NCT00239590|40238153|FG001|Randomized|Lost to Follow-up|1|||
16480109|NCT00239590|40238152|FG000|Randomized|Withdrawal by Subject|0|||
16480110|NCT00239590|40238153|FG001|Randomized|Withdrawal by Subject|1|||
16480111|NCT00239590|40238152|FG000|Completed Study Protocol|Adverse Event|1|||
16480112|NCT00239590|40238153|FG001|Completed Study Protocol|Adverse Event|1|||
16480113|NCT00239590|40238152|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
16284243|NCT01684878|39522195|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
16284244|NCT01684878|39522196|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
16284245|NCT01684878|39522193|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
16284246|NCT01684878|39522194|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
16284247|NCT01684878|39522195|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
16284248|NCT01684878|39522196|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
16284249|NCT01684878|39522193|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
16284250|NCT01684878|39522194|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
16284251|NCT01684878|39522195|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
16284252|NCT01684878|39522196|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
16284253|NCT01684878|39522193|FG000|Part 2: Randomized Phase|Death|0|||
16284254|NCT01684878|39522194|FG001|Part 2: Randomized Phase|Death|0|||
16284255|NCT01684878|39522195|FG002|Part 2: Randomized Phase|Death|62|||
16284256|NCT01684878|39522196|FG003|Part 2: Randomized Phase|Death|68|||
16284257|NCT01684878|39522193|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
16284258|NCT01684878|39522194|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
16284259|NCT01684878|39522195|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
16284260|NCT01684878|39522196|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
16284261|NCT01684878|39522193|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
16284262|NCT01684878|39522194|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
16284263|NCT01684878|39522195|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
16284264|NCT01684878|39522196|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
16284265|NCT02508116|39522197|FG000|Overall Study|Lost to Follow-up|2|||
16284266|NCT02508116|39522198|FG001|Overall Study|Lost to Follow-up|3|||
16284267|NCT02508116|39522197|FG000|Overall Study|Withdrawal by Subject|3|||
16284268|NCT02508116|39522198|FG001|Overall Study|Withdrawal by Subject|2|||
16284269|NCT02508116|39522197|FG000|Overall Study|Protocol Violation|1|||
16284270|NCT02508116|39522198|FG001|Overall Study|Protocol Violation|2|||
16284271|NCT02508116|39522197|FG000|Overall Study|Physician Decision|2|||
16284272|NCT02508116|39522198|FG001|Overall Study|Physician Decision|0|||
16284273|NCT01257581|39522206|FG000|Overall Study|Early Termination|3|||
16284274|NCT01257581|39522207|FG001|Overall Study|Early Termination|1|||
16284275|NCT01257581|39522208|FG002|Overall Study|Early Termination|2|||
16284276|NCT01257581|39522206|FG000|Overall Study|Death|2|||
16284277|NCT01257581|39522207|FG001|Overall Study|Death|2|||
16284278|NCT01257581|39522208|FG002|Overall Study|Death|4|||
16284279|NCT00114231|39522211|FG000|Overall Study|No consent|2|||
16284280|NCT00114231|39522212|FG001|Overall Study|No consent|0|||
16284281|NCT00114231|39522211|FG000|Overall Study|QARC requirement not met|1|||
16284282|NCT00114231|39522212|FG001|Overall Study|QARC requirement not met|0|||
16284283|NCT00114231|39522211|FG000|Overall Study|Suspected metastatic disease|1|||
16284284|NCT00114231|39522212|FG001|Overall Study|Suspected metastatic disease|0|||
16284285|NCT00114231|39522211|FG000|Overall Study|No adenocarcinoma|1|||
16284286|NCT00114231|39522212|FG001|Overall Study|No adenocarcinoma|0|||
16284287|NCT00114231|39522211|FG000|Overall Study|Low creatinine clearance|0|||
16284288|NCT00114231|39522212|FG001|Overall Study|Low creatinine clearance|1|||
16284289|NCT00114231|39522211|FG000|Overall Study|Tumor size > 4cm|1|||
16284290|NCT00114231|39522212|FG001|Overall Study|Tumor size > 4cm|0|||
16284291|NCT00114231|39522211|FG000|Overall Study|Tumor fixed on digital exam|0|||
16284292|NCT00114231|39522212|FG001|Overall Study|Tumor fixed on digital exam|1|||
16284293|NCT00114231|39522211|FG000|Overall Study|No Absolute Neutrophil Count|2|||
16284294|NCT00114231|39522212|FG001|Overall Study|No Absolute Neutrophil Count|0|||
16284295|NCT00114231|39522211|FG000|Overall Study|Biopsy done after registration|1|||
16284296|NCT00114231|39522212|FG001|Overall Study|Biopsy done after registration|0|||
16284297|NCT03870477|39522218|FG000|Overall Study|Early Study Termination|1|||
16284298|NCT00941720|39522219|FG000|Overall Study|Withdrawal by Subject|1|||
16284299|NCT00941720|39522219|FG000|Overall Study|Insurance denied participation|11|||
16284300|NCT00941720|39522219|FG000|Overall Study|ineligible|2|||
16284301|NCT00296491|39522225|FG000|Overall Study|Low Pollen Counts|18|||
16284302|NCT00296491|39522226|FG001|Overall Study|Low Pollen Counts|26|||
16284303|NCT00296491|39522227|FG002|Overall Study|Low Pollen Counts|25|||
16284304|NCT00296491|39522228|FG003|Overall Study|Low Pollen Counts|16|||
16284305|NCT00296491|39522225|FG000|Overall Study|Protocol Violation|4|||
16284306|NCT00296491|39522226|FG001|Overall Study|Protocol Violation|6|||
16284307|NCT00296491|39522227|FG002|Overall Study|Protocol Violation|2|||
16284308|NCT00296491|39522228|FG003|Overall Study|Protocol Violation|3|||
16284309|NCT00296491|39522225|FG000|Overall Study|Adverse Event|1|||
16284310|NCT00296491|39522226|FG001|Overall Study|Adverse Event|3|||
16284311|NCT00296491|39522227|FG002|Overall Study|Adverse Event|1|||
16284312|NCT00296491|39522228|FG003|Overall Study|Adverse Event|4|||
16284313|NCT00296491|39522225|FG000|Overall Study|Withdrawn due to Asthma|0|||
16284314|NCT00296491|39522226|FG001|Overall Study|Withdrawn due to Asthma|0|||
16284315|NCT00296491|39522227|FG002|Overall Study|Withdrawn due to Asthma|0|||
16284316|NCT00296491|39522228|FG003|Overall Study|Withdrawn due to Asthma|4|||
16284317|NCT00296491|39522225|FG000|Overall Study|Withdrawal by Subject|7|||
16284318|NCT00296491|39522226|FG001|Overall Study|Withdrawal by Subject|3|||
16284319|NCT00296491|39522227|FG002|Overall Study|Withdrawal by Subject|3|||
16284320|NCT00296491|39522228|FG003|Overall Study|Withdrawal by Subject|2|||
16284321|NCT00296491|39522225|FG000|Overall Study|Non-Compliance|12|||
16284322|NCT00296491|39522226|FG001|Overall Study|Non-Compliance|13|||
16284323|NCT00296491|39522227|FG002|Overall Study|Non-Compliance|10|||
16284324|NCT00296491|39522228|FG003|Overall Study|Non-Compliance|14|||
16284325|NCT00296491|39522225|FG000|Overall Study|Lost to Follow-up|0|||
16284326|NCT00296491|39522226|FG001|Overall Study|Lost to Follow-up|2|||
16284327|NCT00296491|39522227|FG002|Overall Study|Lost to Follow-up|2|||
16284328|NCT00296491|39522228|FG003|Overall Study|Lost to Follow-up|0|||
16284329|NCT02575339|39522229|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
16284330|NCT02575339|39522230|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
16284331|NCT02575339|39522231|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
16284332|NCT02575339|39522229|FG000|Study Treatment|Disease Progression|5|||
16284333|NCT02575339|39522230|FG001|Study Treatment|Disease Progression|2|||
16284334|NCT02575339|39522231|FG002|Study Treatment|Disease Progression|0|||
16480114|NCT00239590|40238153|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
16480115|NCT00875979|40238154|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
16480116|NCT00875979|40238155|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
16284335|NCT02575339|39522229|FG000|Study Treatment|Adverse Event|1|||
16284336|NCT02575339|39522230|FG001|Study Treatment|Adverse Event|2|||
16284337|NCT02575339|39522231|FG002|Study Treatment|Adverse Event|0|||
16284338|NCT02575339|39522229|FG000|Follow up|Death|6|||
16284339|NCT02575339|39522230|FG001|Follow up|Death|2|||
16284340|NCT02575339|39522231|FG002|Follow up|Death|0|||
16284341|NCT02575339|39522229|FG000|Follow up|Study Terminated|0|||
16284342|NCT02575339|39522230|FG001|Follow up|Study Terminated|2|||
16284343|NCT02575339|39522231|FG002|Follow up|Study Terminated|0|||
16284344|NCT02575339|39522229|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
16284345|NCT02575339|39522230|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
16284346|NCT02575339|39522231|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
16284347|NCT02427984|39522232|FG000|Overall Study|Lost to Follow-up|13|||
16284348|NCT02427984|39522233|FG001|Overall Study|Lost to Follow-up|5|||
16284349|NCT02427984|39522234|FG002|Overall Study|Lost to Follow-up|18|||
16284350|NCT00977548|39522237|FG000|Overall Study|Ineligible|4|||
16284351|NCT00977548|39522237|FG000|Overall Study|Adverse Event|8|||
16284352|NCT00977548|39522237|FG000|Overall Study|Withdrawal by Subject|1|||
16284353|NCT01098110|39522238|FG000|Overall Study|Withdrawal by Subject|14|||
16284354|NCT01098110|39522239|FG001|Overall Study|Withdrawal by Subject|24|||
16284355|NCT01098110|39522240|FG002|Overall Study|Withdrawal by Subject|19|||
16284356|NCT01098110|39522238|FG000|Overall Study|Adverse Event|30|||
16284357|NCT01098110|39522239|FG001|Overall Study|Adverse Event|32|||
16284358|NCT01098110|39522240|FG002|Overall Study|Adverse Event|43|||
16284359|NCT01098110|39522238|FG000|Overall Study|Lack of Efficacy|13|||
16284360|NCT01098110|39522239|FG001|Overall Study|Lack of Efficacy|9|||
16284361|NCT01098110|39522240|FG002|Overall Study|Lack of Efficacy|27|||
16284362|NCT01098110|39522238|FG000|Overall Study|Other|4|||
16284363|NCT01098110|39522239|FG001|Overall Study|Other|7|||
16284364|NCT01098110|39522240|FG002|Overall Study|Other|5|||
16284365|NCT01098110|39522238|FG000|Overall Study|Untreated|1|||
16284366|NCT01098110|39522239|FG001|Overall Study|Untreated|1|||
16284367|NCT01098110|39522240|FG002|Overall Study|Untreated|0|||
16284368|NCT02776553|39522243|FG000|Overall Study|Lost to Follow-up|1|||
16284369|NCT02776553|39522244|FG001|Overall Study|Lost to Follow-up|0|||
16284370|NCT02776553|39522243|FG000|Overall Study|got liver transplant|1|||
16284371|NCT02776553|39522244|FG001|Overall Study|got liver transplant|2|||
16284372|NCT02776553|39522243|FG000|Overall Study|had other surgery|1|||
16284373|NCT02776553|39522244|FG001|Overall Study|had other surgery|0|||
16284374|NCT02776553|39522243|FG000|Overall Study|Protocol Violation|0|||
16284375|NCT02776553|39522244|FG001|Overall Study|Protocol Violation|1|||
16284376|NCT02344745|39522245|FG000|Overall Study|Data collection sheets were lost|2|||
16379793|NCT04103450|39874772|FG000|Overall Study|Other|1|||
16379794|NCT04103450|39874773|FG001|Overall Study|Other|1|||
16284377|NCT02344745|39522246|FG001|Overall Study|Data collection sheets were lost|0|||
16284378|NCT00233987|39526112|FG000|Overall Study|Withdrawal by Subject|1|||
16284379|NCT00233987|39526112|FG000|Overall Study|Lack of Efficacy|2|||
16284380|NCT00233987|39526112|FG000|Overall Study|Reason Under Review|1|||
16284381|NCT00233987|39526112|FG000|Overall Study|Other - Not Protocol Specified|5|||
16284382|NCT00233987|39526112|FG000|Overall Study|Eligible but No Treatment Received|2|||
16284383|NCT00233987|39526112|FG000|Overall Study|Ineligible|4|||
16284384|NCT00442546|39526114|FG000|Overall Study|Adverse Event|11|||
16284385|NCT00442546|39526115|FG001|Overall Study|Adverse Event|17|||
16284386|NCT00442546|39526116|FG002|Overall Study|Adverse Event|13|||
16284387|NCT00442546|39526114|FG000|Overall Study|Lost to Follow-up|1|||
16284388|NCT00442546|39526115|FG001|Overall Study|Lost to Follow-up|2|||
16284389|NCT00442546|39526116|FG002|Overall Study|Lost to Follow-up|1|||
16480117|NCT00875979|40238154|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
16379795|NCT02257684|39874774|FG000|Overall Study|Adverse Event|2|||
16480118|NCT00875979|40238155|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
16480119|NCT00875979|40238154|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
16480120|NCT00875979|40238155|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
16480121|NCT00875979|40238154|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
16480122|NCT00875979|40238155|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
16480123|NCT00875979|40238154|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
16480124|NCT00875979|40238155|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
16480125|NCT00875979|40238154|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
16480126|NCT00875979|40238155|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
16480127|NCT00875979|40238154|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
16480128|NCT00875979|40238155|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
16480129|NCT00875979|40238154|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
16480130|NCT00875979|40238155|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
16480131|NCT00875979|40238154|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
16480132|NCT00875979|40238155|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
16480133|NCT02586064|40238158|FG000|Overall Study|Other Obligations|6|||
16480134|NCT02586064|40238159|FG001|Overall Study|Other Obligations|6|||
16480135|NCT02586064|40238158|FG000|Overall Study|Other|3|||
16480136|NCT02586064|40238159|FG001|Overall Study|Other|7|||
16480137|NCT02586064|40238158|FG000|Overall Study|Never Started|3|||
16480138|NCT02586064|40238159|FG001|Overall Study|Never Started|3|||
16480139|NCT02586064|40238158|FG000|Overall Study|Lost Interest|1|||
16480140|NCT02586064|40238159|FG001|Overall Study|Lost Interest|4|||
16480141|NCT02586064|40238158|FG000|Overall Study|Miscellaneous Life Issues|0|||
16480142|NCT02586064|40238159|FG001|Overall Study|Miscellaneous Life Issues|5|||
16480143|NCT02586064|40238158|FG000|Overall Study|Infrequent Attendance|2|||
16480144|NCT02586064|40238159|FG001|Overall Study|Infrequent Attendance|1|||
16480145|NCT02586064|40238158|FG000|Overall Study|Timed Out|2|||
16480146|NCT02586064|40238159|FG001|Overall Study|Timed Out|0|||
16480147|NCT02586064|40238158|FG000|Overall Study|AUD relapse|0|||
16480148|NCT02586064|40238159|FG001|Overall Study|AUD relapse|2|||
16480149|NCT02586064|40238158|FG000|Overall Study|Legal Issue|1|||
16480150|NCT02586064|40238159|FG001|Overall Study|Legal Issue|0|||
16480151|NCT01893203|40238164|FG000|Overall Study|Withdrawal by Subject|1|||
16480152|NCT03166735|40238165|FG000|Overall Study|Not Treated|1|||
16480153|NCT03166735|40238166|FG001|Overall Study|Not Treated|0|||
16480154|NCT03166735|40238167|FG002|Overall Study|Not Treated|0|||
16480155|NCT03166735|40238168|FG003|Overall Study|Not Treated|0|||
16480156|NCT03166735|40238169|FG004|Overall Study|Not Treated|0|||
16284390|NCT00442546|39526114|FG000|Overall Study|Other|4|||
16284391|NCT00442546|39526115|FG001|Overall Study|Other|9|||
16284392|NCT00442546|39526116|FG002|Overall Study|Other|6|||
16284393|NCT00442546|39526114|FG000|Overall Study|Withdrawal by Subject|5|||
16284394|NCT00442546|39526115|FG001|Overall Study|Withdrawal by Subject|5|||
16284395|NCT00442546|39526116|FG002|Overall Study|Withdrawal by Subject|7|||
16284396|NCT00442546|39526114|FG000|Overall Study|Randomized But Not Treated|5|||
16284397|NCT00442546|39526115|FG001|Overall Study|Randomized But Not Treated|4|||
16284398|NCT00442546|39526116|FG002|Overall Study|Randomized But Not Treated|6|||
16284399|NCT00418522|39526124|FG000|Overall Study|Adverse Event|7|||
16284400|NCT00418522|39526125|FG001|Overall Study|Adverse Event|1|||
16284401|NCT00418522|39526124|FG000|Overall Study|Lack of Efficacy|1|||
16284402|NCT00418522|39526125|FG001|Overall Study|Lack of Efficacy|3|||
16284403|NCT00418522|39526124|FG000|Overall Study|Lost to Follow-up|10|||
16284404|NCT00418522|39526125|FG001|Overall Study|Lost to Follow-up|4|||
16284405|NCT00418522|39526124|FG000|Overall Study|Withdrawal by Subject|31|||
16284406|NCT00418522|39526125|FG001|Overall Study|Withdrawal by Subject|7|||
16284407|NCT00418522|39526124|FG000|Overall Study|Other|27|||
16284408|NCT00418522|39526125|FG001|Overall Study|Other|23|||
16284409|NCT00418522|39526124|FG000|Overall Study|Randomized but did not receive treatment|7|||
16284410|NCT00418522|39526125|FG001|Overall Study|Randomized but did not receive treatment|4|||
16284411|NCT03438227|39526126|FG000|Overall Study|Withdrawal by Subject|10|||
16284412|NCT03438227|39526127|FG001|Overall Study|Withdrawal by Subject|5|||
16284413|NCT00810602|39526128|FG000|Overall Study|Withdrawal by Subject|8|||
16284414|NCT00810602|39526129|FG001|Overall Study|Withdrawal by Subject|3|||
16284415|NCT01376310|39526130|FG000|Overall Study|Study closed/terminated|1|||
16284416|NCT01376310|39526131|FG001|Overall Study|Study closed/terminated|2|||
16284417|NCT01376310|39526130|FG000|Overall Study|Withdrawal by Subject|8|||
16284418|NCT01376310|39526131|FG001|Overall Study|Withdrawal by Subject|2|||
16284419|NCT01376310|39526130|FG000|Overall Study|Physician Decision|26|||
16284420|NCT01376310|39526131|FG001|Overall Study|Physician Decision|7|||
16480157|NCT03166735|40238165|FG000|Overall Study|follow-up not completed as planned|0|||
16480158|NCT03166735|40238166|FG001|Overall Study|follow-up not completed as planned|1|||
16480159|NCT03166735|40238167|FG002|Overall Study|follow-up not completed as planned|1|||
16480160|NCT03166735|40238168|FG003|Overall Study|follow-up not completed as planned|0|||
16480161|NCT03166735|40238169|FG004|Overall Study|follow-up not completed as planned|1|||
16284421|NCT01376310|39526130|FG000|Overall Study|Lost to Follow-up|1|||
16284422|NCT01376310|39526131|FG001|Overall Study|Lost to Follow-up|0|||
16284423|NCT01615263|39526132|FG000|Overall Study|Post-randomization exclusion|0|||
16284424|NCT01615263|39526133|FG001|Overall Study|Post-randomization exclusion|2|||
16284425|NCT01729026|39526134|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
16284426|NCT01729026|39526135|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
16284427|NCT01729026|39526134|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
16284428|NCT01729026|39526135|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
16284429|NCT01961882|39526136|FG000|Overall Study|Adverse Event|3|||
16284430|NCT01961882|39526137|FG001|Overall Study|Adverse Event|2|||
16284431|NCT01961882|39526136|FG000|Overall Study|Physician Decision|1|||
16284432|NCT01961882|39526137|FG001|Overall Study|Physician Decision|0|||
16284433|NCT01961882|39526136|FG000|Overall Study|Withdrawal by Subject|4|||
16284434|NCT01961882|39526137|FG001|Overall Study|Withdrawal by Subject|1|||
16284435|NCT01961882|39526136|FG000|Overall Study|Relapse of AML|39|||
16284436|NCT01961882|39526137|FG001|Overall Study|Relapse of AML|37|||
16284437|NCT01961882|39526136|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
16284438|NCT01961882|39526137|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
16284439|NCT01961882|39526136|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
16284440|NCT01961882|39526137|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
16284441|NCT00897949|39526143|FG000|Overall Study|Adverse Event|1|||
16284442|NCT00897949|39526144|FG001|Overall Study|Adverse Event|1|||
16284443|NCT00897949|39526145|FG002|Overall Study|Adverse Event|0|||
16284444|NCT00897949|39526143|FG000|Overall Study|Lost to Follow-up|0|||
16284445|NCT00897949|39526144|FG001|Overall Study|Lost to Follow-up|2|||
16480162|NCT03166735|40238165|FG000|Overall Study|Withdrawal by Subject|0|||
16480163|NCT03166735|40238166|FG001|Overall Study|Withdrawal by Subject|0|||
16480164|NCT03166735|40238167|FG002|Overall Study|Withdrawal by Subject|1|||
16480165|NCT03166735|40238168|FG003|Overall Study|Withdrawal by Subject|1|||
16480166|NCT03166735|40238169|FG004|Overall Study|Withdrawal by Subject|2|||
16480167|NCT03166735|40238165|FG000|Overall Study|Lost to Follow-up|0|||
16480168|NCT03166735|40238166|FG001|Overall Study|Lost to Follow-up|2|||
16480169|NCT03166735|40238167|FG002|Overall Study|Lost to Follow-up|1|||
16480170|NCT03166735|40238168|FG003|Overall Study|Lost to Follow-up|0|||
16480171|NCT03166735|40238169|FG004|Overall Study|Lost to Follow-up|1|||
16480172|NCT02217878|40238170|FG000|Overall Study|required morphine due to chest pain|1|||
16480173|NCT02217878|40238171|FG001|Overall Study|required morphine due to chest pain|2|||
16480174|NCT02217878|40238170|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
16480175|NCT02217878|40238171|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
16480176|NCT02083965|40238173|FG000|Treatment Period|Other|1|||
16480177|NCT02083965|40238174|FG001|Treatment Period|Other|0|||
16480178|NCT01890746|40238179|FG000|Overall Study|Death|39|||
16480179|NCT01890746|40238180|FG001|Overall Study|Death|30|||
16480180|NCT01890746|40238179|FG000|Overall Study|Adverse Event|1|||
16480181|NCT01890746|40238180|FG001|Overall Study|Adverse Event|0|||
16480182|NCT01890746|40238179|FG000|Overall Study|Lost to Follow-up|4|||
16480183|NCT01890746|40238180|FG001|Overall Study|Lost to Follow-up|1|||
16480184|NCT01890746|40238179|FG000|Overall Study|Physician Decision|3|||
16480185|NCT01890746|40238180|FG001|Overall Study|Physician Decision|2|||
16480186|NCT01890746|40238179|FG000|Overall Study|Withdrawal by Subject|5|||
16480187|NCT01890746|40238180|FG001|Overall Study|Withdrawal by Subject|8|||
16480188|NCT01976338|40238185|FG000|Overall Study|Physician Decision|0|||
16480189|NCT01976338|40238186|FG001|Overall Study|Physician Decision|1|||
16284446|NCT00897949|39526145|FG002|Overall Study|Lost to Follow-up|1|||
16284447|NCT00897949|39526143|FG000|Overall Study|Protocol Violation|6|||
16284448|NCT00897949|39526144|FG001|Overall Study|Protocol Violation|3|||
16284449|NCT00897949|39526145|FG002|Overall Study|Protocol Violation|1|||
16284450|NCT00897949|39526143|FG000|Overall Study|Withdrawal by Subject|1|||
16284451|NCT00897949|39526144|FG001|Overall Study|Withdrawal by Subject|2|||
16284452|NCT00897949|39526145|FG002|Overall Study|Withdrawal by Subject|0|||
16284453|NCT00897949|39526143|FG000|Overall Study|Patient Uncoorperative|0|||
16284454|NCT00897949|39526144|FG001|Overall Study|Patient Uncoorperative|2|||
16284455|NCT00897949|39526145|FG002|Overall Study|Patient Uncoorperative|1|||
16284456|NCT00897949|39526143|FG000|Overall Study|Lost to Follow-up|30|||
16284457|NCT00897949|39526144|FG001|Overall Study|Lost to Follow-up|23|||
16284458|NCT00897949|39526145|FG002|Overall Study|Lost to Follow-up|17|||
16284459|NCT00897949|39526143|FG000|Overall Study|Withdrawal by Subject|24|||
16284460|NCT00897949|39526144|FG001|Overall Study|Withdrawal by Subject|31|||
16284461|NCT00897949|39526145|FG002|Overall Study|Withdrawal by Subject|17|||
16480190|NCT01976338|40238185|FG000|Overall Study|Lost to Follow-up|3|||
16480191|NCT01976338|40238186|FG001|Overall Study|Lost to Follow-up|0|||
16480192|NCT01976338|40238185|FG000|Overall Study|Withdrawal by Subject|5|||
16284462|NCT00897949|39526143|FG000|Overall Study|Abnormal Prestudy Labs|2|||
16284463|NCT00897949|39526144|FG001|Overall Study|Abnormal Prestudy Labs|3|||
16284464|NCT00897949|39526145|FG002|Overall Study|Abnormal Prestudy Labs|4|||
16284465|NCT00897949|39526143|FG000|Overall Study|Abnormal Baseline ECG|2|||
16284466|NCT00897949|39526144|FG001|Overall Study|Abnormal Baseline ECG|2|||
16284467|NCT00897949|39526145|FG002|Overall Study|Abnormal Baseline ECG|4|||
16284468|NCT00897949|39526143|FG000|Overall Study|Need for Concom. Med.|0|||
16284469|NCT00897949|39526144|FG001|Overall Study|Need for Concom. Med.|1|||
16284470|NCT00897949|39526145|FG002|Overall Study|Need for Concom. Med.|1|||
16284471|NCT00897949|39526143|FG000|Overall Study|Lack of Migraine Attack|29|||
16284472|NCT00897949|39526144|FG001|Overall Study|Lack of Migraine Attack|30|||
16284473|NCT00897949|39526145|FG002|Overall Study|Lack of Migraine Attack|19|||
16284474|NCT00897949|39526143|FG000|Overall Study|Did not take study drug|9|||
16284475|NCT00897949|39526144|FG001|Overall Study|Did not take study drug|3|||
16284476|NCT00897949|39526145|FG002|Overall Study|Did not take study drug|4|||
16284477|NCT00003531|39526150|FG000|Overall Study|Not evaluable|10|||
16284478|NCT02788513|39526151|FG000|Overall Study|Withdrawal by Subject|3|||
16284479|NCT02788513|39526152|FG001|Overall Study|Withdrawal by Subject|0|||
16284480|NCT02788513|39526153|FG002|Overall Study|Withdrawal by Subject|2|||
16284481|NCT02788513|39526154|FG003|Overall Study|Withdrawal by Subject|3|||
16284482|NCT02788513|39526155|FG004|Overall Study|Withdrawal by Subject|1|||
16480193|NCT01976338|40238186|FG001|Overall Study|Withdrawal by Subject|2|||
16480194|NCT01976338|40238185|FG000|Overall Study|Adverse Event|5|||
16480195|NCT01976338|40238186|FG001|Overall Study|Adverse Event|1|||
16480196|NCT00894166|40238187|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
16480197|NCT00894166|40238188|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
16480198|NCT00894166|40238189|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
16480199|NCT00894166|40238190|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
16480200|NCT00894166|40238191|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
16480201|NCT00894166|40238192|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
16480202|NCT00894166|40238193|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
16480203|NCT00894166|40238194|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
16480204|NCT00894166|40238187|FG000|Overall Study|Death|0|||
16480205|NCT00894166|40238188|FG001|Overall Study|Death|0|||
16480206|NCT00894166|40238189|FG002|Overall Study|Death|0|||
16480207|NCT00894166|40238190|FG003|Overall Study|Death|1|||
16480208|NCT00894166|40238191|FG004|Overall Study|Death|0|||
16480209|NCT00894166|40238192|FG005|Overall Study|Death|0|||
16480210|NCT00894166|40238193|FG006|Overall Study|Death|0|||
16480211|NCT00894166|40238194|FG007|Overall Study|Death|0|||
16480212|NCT02059408|40238196|FG000|Overall Study|Did not get tested|0|||
16480213|NCT02059408|40238197|FG001|Overall Study|Did not get tested|330|||
16480214|NCT02059408|40238198|FG002|Overall Study|Did not get tested|358|||
16480215|NCT01539083|40238199|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
16284483|NCT02788513|39526151|FG000|Overall Study|Lost to Follow-up|1|||
16284484|NCT02788513|39526152|FG001|Overall Study|Lost to Follow-up|0|||
16284485|NCT02788513|39526153|FG002|Overall Study|Lost to Follow-up|0|||
16284486|NCT02788513|39526154|FG003|Overall Study|Lost to Follow-up|0|||
16284487|NCT02788513|39526155|FG004|Overall Study|Lost to Follow-up|1|||
16284488|NCT02788513|39526151|FG000|Overall Study|Adverse Event|5|||
16284489|NCT02788513|39526152|FG001|Overall Study|Adverse Event|8|||
16284490|NCT02788513|39526153|FG002|Overall Study|Adverse Event|4|||
16284491|NCT02788513|39526154|FG003|Overall Study|Adverse Event|2|||
16284492|NCT02788513|39526155|FG004|Overall Study|Adverse Event|2|||
16284493|NCT02788513|39526151|FG000|Overall Study|Protocol Violation|0|||
16284494|NCT02788513|39526152|FG001|Overall Study|Protocol Violation|0|||
16284495|NCT02788513|39526153|FG002|Overall Study|Protocol Violation|1|||
16284496|NCT02788513|39526154|FG003|Overall Study|Protocol Violation|1|||
16284497|NCT02788513|39526155|FG004|Overall Study|Protocol Violation|0|||
16284498|NCT02788513|39526151|FG000|Overall Study|Subject decided to stop taking treatment|0|||
16284499|NCT02788513|39526152|FG001|Overall Study|Subject decided to stop taking treatment|0|||
16284500|NCT02788513|39526153|FG002|Overall Study|Subject decided to stop taking treatment|1|||
16284501|NCT02788513|39526154|FG003|Overall Study|Subject decided to stop taking treatment|0|||
16284502|NCT02788513|39526155|FG004|Overall Study|Subject decided to stop taking treatment|0|||
16284503|NCT02788513|39526151|FG000|Overall Study|Decision by the study team|0|||
16284504|NCT02788513|39526152|FG001|Overall Study|Decision by the study team|0|||
16284505|NCT02788513|39526153|FG002|Overall Study|Decision by the study team|0|||
16284506|NCT02788513|39526154|FG003|Overall Study|Decision by the study team|0|||
16284507|NCT02788513|39526155|FG004|Overall Study|Decision by the study team|1|||
16284508|NCT00466726|39526156|FG000|Overall Study|Not evaluable for response|14|||
16284509|NCT01807117|39526157|FG000|Overall Study|Physician Decision|2|||
16284510|NCT01807117|39526157|FG000|Overall Study|Disease diagnosis not a study disease|1|||
16480216|NCT01539083|40238200|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
16480217|NCT01539083|40238201|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
16284511|NCT00991510|39526158|FG000|Period I (Days 1-14)|Adverse Event|1|||
16284512|NCT00991510|39526159|FG001|Period I (Days 1-14)|Adverse Event|0|||
16284513|NCT00991510|39526158|FG000|Period III (Days 29-112)|Adverse Event|1|||
16284514|NCT00991510|39526159|FG001|Period III (Days 29-112)|Adverse Event|1|||
16480218|NCT01539083|40238199|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
16284515|NCT02663882|39526160|FG000|Overall Study|Lost to Follow-up|4|||
16284516|NCT02663882|39526161|FG001|Overall Study|Lost to Follow-up|2|||
16284517|NCT02039414|39526162|FG000|Overall Study|Delivered|1|||
16284518|NCT02039414|39526163|FG001|Overall Study|Delivered|1|||
16284519|NCT02039414|39526162|FG000|Overall Study|Lost to Follow-up|2|||
16284520|NCT02039414|39526163|FG001|Overall Study|Lost to Follow-up|0|||
16284521|NCT02039414|39526162|FG000|Overall Study|Protocol Violation|3|||
16284522|NCT02039414|39526163|FG001|Overall Study|Protocol Violation|1|||
16284523|NCT03832738|39526164|FG000|Overall Study|Withdrawal by Subject|6|||
16284524|NCT03832738|39526165|FG001|Overall Study|Withdrawal by Subject|7|||
16284525|NCT03832738|39526166|FG002|Overall Study|Withdrawal by Subject|16|||
16284526|NCT03832738|39526164|FG000|Overall Study|Physician Decision|0|||
16284527|NCT03832738|39526165|FG001|Overall Study|Physician Decision|1|||
16284528|NCT03832738|39526166|FG002|Overall Study|Physician Decision|2|||
16284529|NCT03832738|39526164|FG000|Overall Study|Adverse Event|2|||
16284530|NCT03832738|39526165|FG001|Overall Study|Adverse Event|3|||
16284531|NCT03832738|39526166|FG002|Overall Study|Adverse Event|1|||
16284532|NCT03832738|39526164|FG000|Overall Study|Pregnancy|0|||
16480219|NCT01539083|40238200|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
16480220|NCT01539083|40238201|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
16480221|NCT01539083|40238199|FG000|Before Randomization (VCD Induction)|Death|6|||
16480222|NCT01539083|40238200|FG001|Before Randomization (VCD Induction)|Death|0|||
16480223|NCT01539083|40238201|FG002|Before Randomization (VCD Induction)|Death|0|||
16480224|NCT01539083|40238199|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
16480225|NCT01539083|40238200|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
16284533|NCT03832738|39526165|FG001|Overall Study|Pregnancy|1|||
16284534|NCT03832738|39526166|FG002|Overall Study|Pregnancy|0|||
16284535|NCT00611884|39526167|FG000|Overall Study|Adverse Event|1|||
16284536|NCT00611884|39526168|FG001|Overall Study|Adverse Event|0|||
16284537|NCT00611884|39526169|FG002|Overall Study|Adverse Event|0|||
16284538|NCT00611884|39526170|FG003|Overall Study|Adverse Event|1|||
16284539|NCT00611884|39526167|FG000|Overall Study|Non-Compliance|1|||
16284540|NCT00611884|39526168|FG001|Overall Study|Non-Compliance|4|||
16284541|NCT00611884|39526169|FG002|Overall Study|Non-Compliance|2|||
16284542|NCT00611884|39526170|FG003|Overall Study|Non-Compliance|2|||
16284543|NCT00611884|39526167|FG000|Overall Study|Lack of Efficacy|0|||
16284544|NCT00611884|39526168|FG001|Overall Study|Lack of Efficacy|1|||
16284545|NCT00611884|39526169|FG002|Overall Study|Lack of Efficacy|0|||
16284546|NCT00611884|39526170|FG003|Overall Study|Lack of Efficacy|0|||
16284547|NCT00611884|39526167|FG000|Overall Study|Unclassified|7|||
16284548|NCT00611884|39526168|FG001|Overall Study|Unclassified|4|||
16284549|NCT00611884|39526169|FG002|Overall Study|Unclassified|2|||
16284550|NCT00611884|39526170|FG003|Overall Study|Unclassified|3|||
16284551|NCT00202839|39526171|FG000|Overall Study|Adverse Event|1|||
16284552|NCT00202839|39526172|FG001|Overall Study|Adverse Event|5|||
16284553|NCT00202839|39526171|FG000|Overall Study|Physician Decision|12|||
16284554|NCT00202839|39526172|FG001|Overall Study|Physician Decision|0|||
16284555|NCT00202839|39526171|FG000|Overall Study|Withdrawal by Subject|6|||
16284556|NCT00202839|39526172|FG001|Overall Study|Withdrawal by Subject|2|||
16284557|NCT00202839|39526171|FG000|Overall Study|Protocol Violation|2|||
16284558|NCT00202839|39526172|FG001|Overall Study|Protocol Violation|1|||
16284559|NCT00202839|39526171|FG000|Overall Study|Lost to Follow-up|3|||
16284560|NCT00202839|39526172|FG001|Overall Study|Lost to Follow-up|2|||
16284561|NCT02219308|39526174|FG000|Overall Study|Withdrawal by Subject|1|||
16284562|NCT02219308|39526175|FG001|Overall Study|Withdrawal by Subject|2|||
16284563|NCT01453153|39526182|FG000|Overall Study|Physician Decision|0|||
16284564|NCT01453153|39526183|FG001|Overall Study|Physician Decision|0|||
16284565|NCT01453153|39526184|FG002|Overall Study|Physician Decision|1|||
16284566|NCT01453153|39526182|FG000|Overall Study|Progressive Disease|3|||
16284567|NCT01453153|39526183|FG001|Overall Study|Progressive Disease|2|||
16284568|NCT01453153|39526184|FG002|Overall Study|Progressive Disease|16|||
16284569|NCT01453153|39526182|FG000|Overall Study|Withdrawal by Subject|0|||
16284570|NCT01453153|39526183|FG001|Overall Study|Withdrawal by Subject|1|||
16284571|NCT01453153|39526184|FG002|Overall Study|Withdrawal by Subject|2|||
16284572|NCT01453153|39526182|FG000|Overall Study|Adverse Event|1|||
16284573|NCT01453153|39526183|FG001|Overall Study|Adverse Event|1|||
16284574|NCT01453153|39526184|FG002|Overall Study|Adverse Event|1|||
16284575|NCT04059549|39526185|FG000|Overall Study|Withdrawal by Subject|2|||
16284576|NCT04059549|39526186|FG001|Overall Study|Withdrawal by Subject|0|||
16284577|NCT00824369|39526187|FG000|Overall Study|Nolonger willing to participate in study|1|||
16284578|NCT00824369|39526188|FG001|Overall Study|Nolonger willing to participate in study|0|||
16284579|NCT00824369|39526189|FG002|Overall Study|Nolonger willing to participate in study|1|||
16284580|NCT00824369|39526190|FG003|Overall Study|Nolonger willing to participate in study|2|||
16284581|NCT00824369|39526191|FG004|Overall Study|Nolonger willing to participate in study|0|||
16284582|NCT00824369|39526192|FG005|Overall Study|Nolonger willing to participate in study|1|||
16284583|NCT00824369|39526187|FG000|Overall Study|Lost to Follow-up|0|||
16284584|NCT00824369|39526188|FG001|Overall Study|Lost to Follow-up|0|||
16284585|NCT00824369|39526189|FG002|Overall Study|Lost to Follow-up|0|||
16284586|NCT00824369|39526190|FG003|Overall Study|Lost to Follow-up|0|||
16284587|NCT00824369|39526191|FG004|Overall Study|Lost to Follow-up|1|||
16284588|NCT00824369|39526192|FG005|Overall Study|Lost to Follow-up|0|||
16284589|NCT00330460|39526194|FG000|Overall Study|Physician Decision|1|||
16284590|NCT00330460|39526195|FG001|Overall Study|Physician Decision|0|||
16284591|NCT00330460|39526194|FG000|Overall Study|Adverse Event|10|||
16284592|NCT00330460|39526195|FG001|Overall Study|Adverse Event|8|||
16284593|NCT00330460|39526194|FG000|Overall Study|Withdrawal by Subject|18|||
16284594|NCT00330460|39526195|FG001|Overall Study|Withdrawal by Subject|17|||
16284595|NCT00330460|39526194|FG000|Overall Study|Death|1|||
16284596|NCT00330460|39526195|FG001|Overall Study|Death|1|||
16284597|NCT00330460|39526194|FG000|Overall Study|Ineligibility determined|1|||
16284598|NCT00330460|39526195|FG001|Overall Study|Ineligibility determined|3|||
16284599|NCT00330460|39526194|FG000|Overall Study|Lost to Follow-up|8|||
16284600|NCT00330460|39526195|FG001|Overall Study|Lost to Follow-up|3|||
16284601|NCT00330460|39526194|FG000|Overall Study|Noncompliance|2|||
16284602|NCT00330460|39526195|FG001|Overall Study|Noncompliance|1|||
16284603|NCT00330460|39526194|FG000|Overall Study|Other|1|||
16284604|NCT00330460|39526195|FG001|Overall Study|Other|0|||
16284605|NCT01534637|39526201|FG000|Overall Study|Physician Decision|3|||
16284606|NCT01534637|39526201|FG000|Overall Study|Lack of Efficacy|3|||
16284607|NCT01534637|39526201|FG000|Overall Study|Withdrawal by Subject|1|||
16284608|NCT01534637|39526201|FG000|Overall Study|Adverse Event|1|||
16284609|NCT01534637|39526201|FG000|Overall Study|Liver Mets before treatment|1|||
16284610|NCT01042535|39526202|FG000|Overall Study|disease progression prior to treatment|3|||
16284611|NCT01042535|39526202|FG000|Overall Study|disease progression during treatment|3|||
16284612|NCT01042535|39526202|FG000|Overall Study|complications from other disease|2|||
16284613|NCT00613834|39526205|FG000|Overall Study|Withdrawal by Subject|0|||
16284614|NCT00613834|39526206|FG001|Overall Study|Withdrawal by Subject|3|||
16284615|NCT02457819|39526209|FG000|Overall Study|reason not given|8|||
16284616|NCT02457819|39526209|FG000|Overall Study|Withdrawal by Subject|24|||
16284617|NCT02457819|39526209|FG000|Overall Study|Protocol Violation|1|||
16284618|NCT02457819|39526209|FG000|Overall Study|non compliance with study drug|4|||
16284619|NCT02457819|39526209|FG000|Overall Study|Lost to Follow-up|10|||
16284620|NCT02457819|39526209|FG000|Overall Study|Lack of Efficacy|19|||
16284621|NCT02457819|39526209|FG000|Overall Study|Adverse Event|33|||
16284622|NCT03487848|39526210|FG000|Overall Study|Lost to Follow-up|1|||
16284623|NCT00988208|39526213|FG000|Overall Study|Adverse Event|71|||
16284624|NCT00988208|39526214|FG001|Overall Study|Adverse Event|122|||
16284625|NCT00988208|39526213|FG000|Overall Study|Disease Progression|103|||
16284626|NCT00988208|39526214|FG001|Overall Study|Disease Progression|89|||
16284627|NCT00988208|39526213|FG000|Overall Study|Withdrawal by Subject|50|||
16284628|NCT00988208|39526214|FG001|Overall Study|Withdrawal by Subject|57|||
16284629|NCT00988208|39526213|FG000|Overall Study|Death|9|||
16284630|NCT00988208|39526214|FG001|Overall Study|Death|15|||
16284631|NCT00988208|39526213|FG000|Overall Study|Lost to Follow-up|2|||
16284632|NCT00988208|39526214|FG001|Overall Study|Lost to Follow-up|3|||
16284633|NCT00988208|39526213|FG000|Overall Study|Protocol Violation|9|||
16284634|NCT00988208|39526214|FG001|Overall Study|Protocol Violation|2|||
16284635|NCT00988208|39526213|FG000|Overall Study|Sponsor Decision|102|||
16284636|NCT00988208|39526214|FG001|Overall Study|Sponsor Decision|78|||
16379796|NCT02257684|39874774|FG000|Overall Study|Lack of Efficacy|1|||
16379797|NCT02257684|39874774|FG000|Overall Study|Sponsor's Decision|1|||
16080234|NCT01307267|38786802|FG021|Overall Study|Lost to Follow-up|0|||
16080235|NCT01307267|38786803|FG022|Overall Study|Lost to Follow-up|0|||
16284637|NCT00988208|39526213|FG000|Overall Study|Clinical Progression|17|||
16284638|NCT00988208|39526214|FG001|Overall Study|Clinical Progression|16|||
16284639|NCT00988208|39526213|FG000|Overall Study|Biochemical Progression|21|||
16284640|NCT00988208|39526214|FG001|Overall Study|Biochemical Progression|7|||
16080236|NCT01307267|38786781|FG000|Overall Study|Withdrawal by Subject|0|||
16284641|NCT00988208|39526213|FG000|Overall Study|Clinical Deterioration|7|||
16284642|NCT00988208|39526214|FG001|Overall Study|Clinical Deterioration|14|||
16284643|NCT00988208|39526213|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
16284644|NCT00988208|39526214|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
16284645|NCT00988208|39526213|FG000|Overall Study|Other|8|||
16284646|NCT00988208|39526214|FG001|Overall Study|Other|3|||
16284647|NCT00969124|39526215|FG000|Overall Study|Protocol Violation|2|||
16284648|NCT00969124|39526215|FG000|Overall Study|Inadequate bowel preparation|15|||
16284649|NCT00969124|39526215|FG000|Overall Study|Inability to reach cecum|9|||
16284650|NCT00969124|39526215|FG000|Overall Study|Previously unrecognized disease|3|||
16409897|NCT01143051|39981813|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
16284651|NCT00969124|39526215|FG000|Overall Study|Technical error|1|||
16480226|NCT01539083|40238201|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
16480227|NCT01539083|40238199|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
16480228|NCT01539083|40238200|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
16480229|NCT01539083|40238201|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
16480230|NCT01539083|40238199|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
16480231|NCT01539083|40238200|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
16480232|NCT01539083|40238201|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
16480233|NCT01539083|40238199|FG000|Before Randomization (VCD Induction)|Other|5|||
16480234|NCT01539083|40238200|FG001|Before Randomization (VCD Induction)|Other|0|||
16480235|NCT01539083|40238201|FG002|Before Randomization (VCD Induction)|Other|0|||
16480236|NCT01539083|40238199|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
16480237|NCT01539083|40238200|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
16480238|NCT01539083|40238201|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
16480239|NCT01539083|40238199|FG000|After Randomization (TP and VTP)|Other|0|||
16480240|NCT01539083|40238200|FG001|After Randomization (TP and VTP)|Other|1|||
16480241|NCT01539083|40238201|FG002|After Randomization (TP and VTP)|Other|1|||
16480242|NCT01539083|40238199|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
16480243|NCT01539083|40238200|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
16480244|NCT01539083|40238201|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
16480245|NCT01539083|40238199|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
16284652|NCT00955721|39526216|FG000|Overall Study|Physician Decision|1|||
16284653|NCT00955721|39526217|FG001|Overall Study|Physician Decision|0|||
16284654|NCT00955721|39526216|FG000|Overall Study|Death|1|||
16284655|NCT00955721|39526217|FG001|Overall Study|Death|0|||
16284656|NCT00955721|39526216|FG000|Overall Study|Withdrawal by Subject|1|||
16284657|NCT00955721|39526217|FG001|Overall Study|Withdrawal by Subject|0|||
16284658|NCT01813071|39526218|FG000|Overall Study|Protocol Violation|0|||
16284659|NCT01813071|39526219|FG001|Overall Study|Protocol Violation|0|||
16284660|NCT01813071|39526220|FG002|Overall Study|Protocol Violation|0|||
16284661|NCT01813071|39526221|FG003|Overall Study|Protocol Violation|0|||
16284662|NCT01813071|39526222|FG004|Overall Study|Protocol Violation|1|||
16284663|NCT01813071|39526223|FG005|Overall Study|Protocol Violation|4|||
16284664|NCT01813071|39526224|FG006|Overall Study|Protocol Violation|2|||
16284665|NCT01813071|39526225|FG007|Overall Study|Protocol Violation|4|||
16284666|NCT01813071|39526226|FG008|Overall Study|Protocol Violation|2|||
16284667|NCT01813071|39526218|FG000|Overall Study|Withdrawal by Subject|0|||
16284668|NCT01813071|39526219|FG001|Overall Study|Withdrawal by Subject|0|||
16284669|NCT01813071|39526220|FG002|Overall Study|Withdrawal by Subject|0|||
16284670|NCT01813071|39526221|FG003|Overall Study|Withdrawal by Subject|0|||
16284671|NCT01813071|39526222|FG004|Overall Study|Withdrawal by Subject|0|||
16284672|NCT01813071|39526223|FG005|Overall Study|Withdrawal by Subject|1|||
16284673|NCT01813071|39526224|FG006|Overall Study|Withdrawal by Subject|0|||
16284674|NCT01813071|39526225|FG007|Overall Study|Withdrawal by Subject|0|||
16284675|NCT01813071|39526226|FG008|Overall Study|Withdrawal by Subject|0|||
16284676|NCT01813071|39526218|FG000|Overall Study|Adverse Event|0|||
16284677|NCT01813071|39526219|FG001|Overall Study|Adverse Event|0|||
16284678|NCT01813071|39526220|FG002|Overall Study|Adverse Event|0|||
16284679|NCT01813071|39526221|FG003|Overall Study|Adverse Event|0|||
16284680|NCT01813071|39526222|FG004|Overall Study|Adverse Event|0|||
16284681|NCT01813071|39526223|FG005|Overall Study|Adverse Event|1|||
16284682|NCT01813071|39526224|FG006|Overall Study|Adverse Event|0|||
16284683|NCT01813071|39526225|FG007|Overall Study|Adverse Event|0|||
16284684|NCT01813071|39526226|FG008|Overall Study|Adverse Event|0|||
16284685|NCT01813071|39526218|FG000|Overall Study|Physician Decision|0|||
16284686|NCT01813071|39526219|FG001|Overall Study|Physician Decision|0|||
16284687|NCT01813071|39526220|FG002|Overall Study|Physician Decision|0|||
16284688|NCT01813071|39526221|FG003|Overall Study|Physician Decision|0|||
16284689|NCT01813071|39526222|FG004|Overall Study|Physician Decision|0|||
16284690|NCT01813071|39526223|FG005|Overall Study|Physician Decision|0|||
16284691|NCT01813071|39526224|FG006|Overall Study|Physician Decision|1|||
16284692|NCT01813071|39526225|FG007|Overall Study|Physician Decision|0|||
16284693|NCT01813071|39526226|FG008|Overall Study|Physician Decision|0|||
16284694|NCT01813071|39526218|FG000|Overall Study|Met inc/exc criteria|0|||
16480246|NCT01539083|40238200|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
16284695|NCT01813071|39526219|FG001|Overall Study|Met inc/exc criteria|0|||
16284696|NCT01813071|39526220|FG002|Overall Study|Met inc/exc criteria|0|||
16284697|NCT01813071|39526221|FG003|Overall Study|Met inc/exc criteria|0|||
16284698|NCT01813071|39526222|FG004|Overall Study|Met inc/exc criteria|0|||
16284699|NCT01813071|39526223|FG005|Overall Study|Met inc/exc criteria|1|||
16284700|NCT01813071|39526224|FG006|Overall Study|Met inc/exc criteria|0|||
16284701|NCT01813071|39526225|FG007|Overall Study|Met inc/exc criteria|1|||
16284702|NCT01813071|39526226|FG008|Overall Study|Met inc/exc criteria|1|||
16284703|NCT00652028|39526227|FG000|Overall Study|Adverse Event|1|||
16284704|NCT00652028|39526228|FG001|Overall Study|Adverse Event|0|||
16284705|NCT00652028|39526229|FG002|Overall Study|Adverse Event|0|||
16284706|NCT00652028|39526230|FG003|Overall Study|Adverse Event|0|||
16284707|NCT00652028|39526227|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
16284708|NCT00652028|39526228|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
16284709|NCT00652028|39526229|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
16284710|NCT00652028|39526230|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
16284711|NCT00652028|39526227|FG000|Overall Study|Physician Decision|0|||
16284712|NCT00652028|39526228|FG001|Overall Study|Physician Decision|0|||
16284713|NCT00652028|39526229|FG002|Overall Study|Physician Decision|1|||
16284714|NCT00652028|39526230|FG003|Overall Study|Physician Decision|0|||
16284715|NCT00779402|39526231|FG000|Treatment Phase 1|Disease Progression|1|||
16284716|NCT00779402|39526232|FG001|Treatment Phase 1|Disease Progression|0|||
16284717|NCT00779402|39526231|FG000|Treatment Phase 1|Adverse Event|2|||
16284718|NCT00779402|39526232|FG001|Treatment Phase 1|Adverse Event|0|||
16284719|NCT00779402|39526231|FG000|Treatment Phase 1|Protocol Violation|1|||
16284720|NCT00779402|39526232|FG001|Treatment Phase 1|Protocol Violation|0|||
16284721|NCT00779402|39526231|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
16284722|NCT00779402|39526232|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
16284723|NCT00779402|39526231|FG000|Treatment Phase 1|Lost to Follow-up|0|||
16284724|NCT00779402|39526232|FG001|Treatment Phase 1|Lost to Follow-up|1|||
16284725|NCT00779402|39526231|FG000|Treatment Phase 1|Death|0|||
16284726|NCT00779402|39526232|FG001|Treatment Phase 1|Death|1|||
16284727|NCT00779402|39526231|FG000|Treatment Phase 1|Intercurrent Illness|1|||
16284728|NCT00779402|39526232|FG001|Treatment Phase 1|Intercurrent Illness|1|||
16284729|NCT00779402|39526231|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
16284730|NCT00779402|39526232|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
16284731|NCT00779402|39526231|FG000|Treatment Phase 1|Other|4|||
16284732|NCT00779402|39526232|FG001|Treatment Phase 1|Other|2|||
16284733|NCT00779402|39526231|FG000|Treatment Phase 1|Closure of Study|3|||
16284734|NCT00779402|39526232|FG001|Treatment Phase 1|Closure of Study|2|||
16284735|NCT00779402|39526231|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
16284736|NCT00779402|39526232|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
16284737|NCT00779402|39526231|FG000|Surveillance Phase|Protocol Violation|0|||
16284738|NCT00779402|39526232|FG001|Surveillance Phase|Protocol Violation|1|||
16284739|NCT00779402|39526231|FG000|Surveillance Phase|Patient refused to continue|22|||
16284740|NCT00779402|39526232|FG001|Surveillance Phase|Patient refused to continue|14|||
16284741|NCT00779402|39526231|FG000|Surveillance Phase|Lost to Follow-up|2|||
16284742|NCT00779402|39526232|FG001|Surveillance Phase|Lost to Follow-up|1|||
16284743|NCT00779402|39526231|FG000|Surveillance Phase|Death|0|||
16284744|NCT00779402|39526232|FG001|Surveillance Phase|Death|1|||
16284745|NCT00779402|39526231|FG000|Surveillance Phase|Intercurrent Illness|2|||
16284746|NCT00779402|39526232|FG001|Surveillance Phase|Intercurrent Illness|0|||
16284747|NCT00779402|39526231|FG000|Surveillance Phase|Other|5|||
16284748|NCT00779402|39526232|FG001|Surveillance Phase|Other|5|||
16284749|NCT00779402|39526231|FG000|Surveillance Phase|Withdrawal by Subject|4|||
16284750|NCT00779402|39526232|FG001|Surveillance Phase|Withdrawal by Subject|1|||
16284751|NCT00779402|39526231|FG000|Surveillance Phase|Closure of study|5|||
16284752|NCT00779402|39526232|FG001|Surveillance Phase|Closure of study|6|||
16284753|NCT00779402|39526231|FG000|Surveillance Phase|Completed Protocol Visits|3|||
16284754|NCT00779402|39526232|FG001|Surveillance Phase|Completed Protocol Visits|2|||
16284755|NCT00779402|39526231|FG000|Long-term Follow-up|Patient refused to continue|2|||
16284756|NCT00779402|39526232|FG001|Long-term Follow-up|Patient refused to continue|0|||
16284757|NCT00779402|39526231|FG000|Long-term Follow-up|Other|5|||
16284758|NCT00779402|39526232|FG001|Long-term Follow-up|Other|0|||
16284759|NCT00779402|39526231|FG000|Long-term Follow-up|Closure of Study|8|||
16284760|NCT00779402|39526232|FG001|Long-term Follow-up|Closure of Study|4|||
16284761|NCT00779402|39526231|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
16284762|NCT00779402|39526232|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
16284763|NCT04403399|39526237|FG000|Period 2|Physician Decision|0|||
16284764|NCT04403399|39526238|FG001|Period 2|Physician Decision|1|||
16284765|NCT01221090|39526239|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
16284766|NCT01221090|39526240|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
16284767|NCT01221090|39526241|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
16284768|NCT01221090|39526242|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
16409898|NCT01143051|39981814|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
16284769|NCT01221090|39526239|FG000|Overall Study|Withdrawal by Subject|0|||
16284770|NCT01221090|39526240|FG001|Overall Study|Withdrawal by Subject|22|||
16284771|NCT01221090|39526241|FG002|Overall Study|Withdrawal by Subject|27|||
16284772|NCT01221090|39526242|FG003|Overall Study|Withdrawal by Subject|2|||
16284773|NCT00706355|39526244|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
16284774|NCT00706355|39526245|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
16284775|NCT00706355|39526246|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
16284776|NCT00706355|39526247|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
16284777|NCT00706355|39526244|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
16284778|NCT00706355|39526245|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
16284779|NCT00706355|39526246|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
16284780|NCT00706355|39526247|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
16284781|NCT00706355|39526244|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
16480247|NCT01539083|40238201|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
16480248|NCT01539083|40238199|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
16480249|NCT01539083|40238200|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
16480250|NCT01539083|40238201|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
16480251|NCT01539083|40238199|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
16480252|NCT01539083|40238200|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
16480253|NCT01539083|40238201|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
16480254|NCT01539083|40238199|FG000|After Randomization (TP and VTP)|Death|0|||
16480255|NCT01539083|40238200|FG001|After Randomization (TP and VTP)|Death|6|||
16480256|NCT01539083|40238201|FG002|After Randomization (TP and VTP)|Death|11|||
16480257|NCT04478266|40238204|FG000|Overall Study|Adverse Event|20|||
16480258|NCT04478266|40238205|FG001|Overall Study|Adverse Event|21|||
16480259|NCT04478266|40238204|FG000|Overall Study|Progressive disease|146|||
16480260|NCT04478266|40238205|FG001|Overall Study|Progressive disease|168|||
16480261|NCT04478266|40238204|FG000|Overall Study|Poor compliance to protocol|1|||
16080237|NCT01307267|38786782|FG001|Overall Study|Withdrawal by Subject|0|||
16284782|NCT00706355|39526245|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
16284783|NCT00706355|39526246|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
16284784|NCT00706355|39526247|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
16284785|NCT00706355|39526244|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
16284786|NCT00706355|39526245|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
16284787|NCT00706355|39526246|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
16284788|NCT00706355|39526247|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
16284789|NCT00706355|39526244|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
16284790|NCT00706355|39526245|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
16284791|NCT00706355|39526246|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
16284792|NCT00706355|39526247|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
16284793|NCT00706355|39526244|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
16284794|NCT00706355|39526245|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
16284795|NCT00706355|39526246|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
16284796|NCT00706355|39526247|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
16284797|NCT00706355|39526244|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
16284798|NCT00706355|39526245|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
16284799|NCT00706355|39526246|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
16284800|NCT00706355|39526247|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
16284801|NCT00706355|39526244|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
16284802|NCT00706355|39526245|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
16284803|NCT00706355|39526246|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
16284804|NCT00706355|39526247|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
16284805|NCT00706355|39526244|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
16284806|NCT00706355|39526245|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
16284807|NCT00706355|39526246|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
16284808|NCT00706355|39526247|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
16284809|NCT00690482|39526249|FG000|Overall Study|Adverse Event|2|||
16284810|NCT00690482|39526250|FG001|Overall Study|Adverse Event|1|||
16284811|NCT00690482|39526249|FG000|Overall Study|Incorrect enrolment|0|||
16284812|NCT00690482|39526250|FG001|Overall Study|Incorrect enrolment|1|||
16480262|NCT04478266|40238205|FG001|Overall Study|Poor compliance to protocol|0|||
16480263|NCT04478266|40238204|FG000|Overall Study|Withdrawal by Subject|19|||
16480264|NCT04478266|40238205|FG001|Overall Study|Withdrawal by Subject|16|||
16284813|NCT00690482|39526249|FG000|Overall Study|Study-specific discontinuation criteria|1|||
16284814|NCT00690482|39526250|FG001|Overall Study|Study-specific discontinuation criteria|0|||
16284815|NCT00690482|39526249|FG000|Overall Study|Intake of prohibited medicine|1|||
16284816|NCT00690482|39526250|FG001|Overall Study|Intake of prohibited medicine|0|||
16284817|NCT00690482|39526249|FG000|Overall Study|withdrew consent at rand.day|0|||
16284818|NCT00690482|39526250|FG001|Overall Study|withdrew consent at rand.day|1|||
16284819|NCT00359632|39526255|FG000|Overall Study|Death|2|||
16284820|NCT00359632|39526256|FG001|Overall Study|Death|0|||
16284821|NCT00359632|39526255|FG000|Overall Study|Adverse Event|1|||
16284822|NCT00359632|39526256|FG001|Overall Study|Adverse Event|0|||
16284823|NCT00359632|39526255|FG000|Overall Study|Non-compliance with visit schedule|1|||
16284824|NCT00359632|39526256|FG001|Overall Study|Non-compliance with visit schedule|0|||
16284825|NCT03227224|39526257|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
16284826|NCT03227224|39526258|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
16284827|NCT03227224|39526259|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
16284828|NCT03227224|39526260|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
16284829|NCT03227224|39526257|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
16284830|NCT03227224|39526258|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
16284831|NCT03227224|39526259|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
16284832|NCT03227224|39526260|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
16284833|NCT03227224|39526257|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
16284834|NCT03227224|39526258|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
16284835|NCT03227224|39526259|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
16284836|NCT03227224|39526260|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
16284837|NCT03227224|39526257|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
16284838|NCT03227224|39526258|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
16284839|NCT03227224|39526259|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
16284840|NCT03227224|39526260|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
16284841|NCT03227224|39526257|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
16284842|NCT03227224|39526258|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
16284843|NCT03227224|39526259|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
16284844|NCT03227224|39526260|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
16284845|NCT03227224|39526257|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
16284846|NCT03227224|39526258|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
16284847|NCT03227224|39526259|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
16284848|NCT03227224|39526260|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
16284849|NCT03227224|39526257|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
16284850|NCT03227224|39526258|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
16284851|NCT03227224|39526259|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
16284852|NCT03227224|39526260|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
16284853|NCT03227224|39526257|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
16284854|NCT03227224|39526258|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
16284855|NCT03227224|39526259|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
16284856|NCT03227224|39526260|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
16284857|NCT03227224|39526257|FG000|Follow-up Phase (2 Weeks)|Other|4|||
16284858|NCT03227224|39526258|FG001|Follow-up Phase (2 Weeks)|Other|4|||
16546304|NCT02237508|40464778|FG005|Overall Study|Withdrawal by Subject|1|||
16284859|NCT03227224|39526259|FG002|Follow-up Phase (2 Weeks)|Other|6|||
16284860|NCT03227224|39526260|FG003|Follow-up Phase (2 Weeks)|Other|3|||
16284861|NCT04364737|39526261|FG000|Overall Study|Withdrawal by Subject|4|||
16284862|NCT04364737|39526262|FG001|Overall Study|Withdrawal by Subject|9|||
16284863|NCT04364737|39526261|FG000|Overall Study|Lost to Follow-up|1|||
16284864|NCT04364737|39526262|FG001|Overall Study|Lost to Follow-up|1|||
16284865|NCT00890552|39526263|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
16284866|NCT00890552|39526263|FG000|On-treatment|Early prog disease/ death|10|||
16284867|NCT01194973|39526267|FG000|Screening Period|Screen Failure|3|||
16284868|NCT01194973|39526267|FG000|26 Week Treatment Period|Adverse Event|1|||
16284869|NCT01194973|39526267|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
16284870|NCT01194973|39526267|FG000|26 Week Treatment Period|Pregnancy|1|||
16284871|NCT01701973|39526268|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16284872|NCT01701973|39526269|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
16284873|NCT01701973|39526270|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16284874|NCT01701973|39526271|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16284875|NCT01701973|39526272|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16284876|NCT01701973|39526273|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16284877|NCT01701973|39526274|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16284878|NCT01701973|39526275|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
16409899|NCT01143051|39981815|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
16284879|NCT05816200|39526276|FG000|Overall Study|Lost to Follow-up|2|||
16284880|NCT05816200|39526277|FG001|Overall Study|Lost to Follow-up|1|||
16284881|NCT02244424|39526278|FG000|Overall Study|Lost to Follow-up|20|||
16480265|NCT04478266|40238204|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
16480266|NCT04478266|40238205|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
16480267|NCT04478266|40238204|FG000|Overall Study|Study terminated by sponsor|33|||
16480268|NCT04478266|40238205|FG001|Overall Study|Study terminated by sponsor|35|||
16480269|NCT04478266|40238204|FG000|Overall Study|Other: unspecified|5|||
16480270|NCT04478266|40238205|FG001|Overall Study|Other: unspecified|7|||
16480271|NCT04478266|40238204|FG000|Overall Study|Randomized but not treated|1|||
16480272|NCT04478266|40238205|FG001|Overall Study|Randomized but not treated|1|||
16480273|NCT04515394|40238211|FG000|Overall Study|Participant did not receive treatment|1|||
16480274|NCT04502433|40238212|FG000|Overall Study|Death|2|||
16480275|NCT04502433|40238213|FG001|Overall Study|Death|4|||
16480276|NCT04502433|40238212|FG000|Overall Study|Lost to Follow-up|1|||
16480277|NCT04502433|40238213|FG001|Overall Study|Lost to Follow-up|0|||
16480278|NCT04502433|40238212|FG000|Overall Study|Physician Decision|0|||
16480279|NCT04502433|40238213|FG001|Overall Study|Physician Decision|1|||
16480280|NCT00044083|40238214|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
16480281|NCT00044083|40238215|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
16480282|NCT00044083|40238214|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
16480283|NCT00044083|40238215|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
16480284|NCT00044083|40238214|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
16480285|NCT00044083|40238215|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
16480286|NCT00044083|40238214|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
16284882|NCT02244424|39526279|FG001|Overall Study|Lost to Follow-up|10|||
16284883|NCT00094094|39526280|FG000|Overall Study|Death|2|||
16480287|NCT00044083|40238215|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
16480288|NCT00044083|40238214|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
16480289|NCT00044083|40238215|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
16480290|NCT00044083|40238214|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
16284884|NCT00094094|39526280|FG000|Overall Study|Lack of Efficacy|23|||
16284885|NCT00094094|39526280|FG000|Overall Study|Adverse Event|7|||
16284886|NCT04412057|39526281|FG000|Overall Study|Death|3|||
16284887|NCT04412057|39526282|FG001|Overall Study|Death|7|||
16284888|NCT04412057|39526281|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
16284889|NCT04412057|39526282|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
16284890|NCT02075606|39526283|FG000|Overall Study|Adverse Event|5|||
16284891|NCT02075606|39526283|FG000|Overall Study|Withdrawal by Subject|1|||
16284892|NCT02075606|39526283|FG000|Overall Study|Death|1|||
16284893|NCT02075606|39526283|FG000|Overall Study|Investigator's decision|1|||
16284894|NCT02075606|39526283|FG000|Overall Study|Symptom management|1|||
16284895|NCT02075606|39526283|FG000|Overall Study|Increasing Symptoms|1|||
16284896|NCT01132664|39526284|FG000|Phase lb|Adverse Event|0|||
16284897|NCT01132664|39526285|FG001|Phase lb|Adverse Event|1|||
16284898|NCT01132664|39526286|FG002|Phase lb|Adverse Event|0|||
16284899|NCT01132664|39526287|FG003|Phase lb|Adverse Event|0|||
16284900|NCT01132664|39526288|FG004|Phase lb|Adverse Event|0|||
16284901|NCT01132664|39526284|FG000|Phase lb|Withdrawal by Subject|1|||
16284902|NCT01132664|39526285|FG001|Phase lb|Withdrawal by Subject|2|||
16284903|NCT01132664|39526286|FG002|Phase lb|Withdrawal by Subject|0|||
16284904|NCT01132664|39526287|FG003|Phase lb|Withdrawal by Subject|0|||
16284905|NCT01132664|39526288|FG004|Phase lb|Withdrawal by Subject|0|||
16284906|NCT01132664|39526284|FG000|Phase lb|Disease Progression|4|||
16284907|NCT01132664|39526285|FG001|Phase lb|Disease Progression|9|||
16284908|NCT01132664|39526286|FG002|Phase lb|Disease Progression|0|||
16284909|NCT01132664|39526287|FG003|Phase lb|Disease Progression|0|||
16284910|NCT01132664|39526288|FG004|Phase lb|Disease Progression|0|||
16284911|NCT01132664|39526284|FG000|Phase ll|Death|0|||
16284912|NCT01132664|39526285|FG001|Phase ll|Death|0|||
16284913|NCT01132664|39526286|FG002|Phase ll|Death|2|||
16284914|NCT01132664|39526287|FG003|Phase ll|Death|0|||
16284915|NCT01132664|39526288|FG004|Phase ll|Death|0|||
16284916|NCT01132664|39526284|FG000|Phase ll|Adverse Event|0|||
16284917|NCT01132664|39526285|FG001|Phase ll|Adverse Event|0|||
16284918|NCT01132664|39526286|FG002|Phase ll|Adverse Event|10|||
16284919|NCT01132664|39526287|FG003|Phase ll|Adverse Event|0|||
16284920|NCT01132664|39526288|FG004|Phase ll|Adverse Event|0|||
16284921|NCT01132664|39526284|FG000|Phase ll|Withdrawal by Subject|0|||
16284922|NCT01132664|39526285|FG001|Phase ll|Withdrawal by Subject|0|||
16284923|NCT01132664|39526286|FG002|Phase ll|Withdrawal by Subject|3|||
16480291|NCT00044083|40238215|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
16480292|NCT00044083|40238214|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
16480293|NCT00044083|40238215|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
16284924|NCT01132664|39526287|FG003|Phase ll|Withdrawal by Subject|0|||
16284925|NCT01132664|39526288|FG004|Phase ll|Withdrawal by Subject|0|||
16284926|NCT01132664|39526284|FG000|Phase ll|Disease progression|0|||
16284927|NCT01132664|39526285|FG001|Phase ll|Disease progression|0|||
16284928|NCT01132664|39526286|FG002|Phase ll|Disease progression|35|||
16284929|NCT01132664|39526287|FG003|Phase ll|Disease progression|0|||
16284930|NCT01132664|39526288|FG004|Phase ll|Disease progression|0|||
16480294|NCT00044083|40238214|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
16480295|NCT00044083|40238215|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
16480296|NCT00044083|40238214|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
16480297|NCT00044083|40238215|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
16480298|NCT00044083|40238214|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
16480299|NCT00044083|40238215|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
16480300|NCT00181155|40238219|FG000|Overall Study|Physician Decision|1|||
16480301|NCT00181155|40238220|FG001|Overall Study|Physician Decision|0|||
16480302|NCT00181155|40238219|FG000|Overall Study|Withdrawal by Subject|1|||
16480303|NCT00181155|40238220|FG001|Overall Study|Withdrawal by Subject|0|||
16284931|NCT01132664|39526284|FG000|BM Cohort|Disease progression|0|||
16284932|NCT01132664|39526285|FG001|BM Cohort|Disease progression|0|||
16284933|NCT01132664|39526286|FG002|BM Cohort|Disease progression|0|||
16284934|NCT01132664|39526287|FG003|BM Cohort|Disease progression|3|||
16284935|NCT01132664|39526288|FG004|BM Cohort|Disease progression|4|||
16284936|NCT01132664|39526284|FG000|BM Cohort|Adverse Event|0|||
16284937|NCT01132664|39526285|FG001|BM Cohort|Adverse Event|0|||
16284938|NCT01132664|39526286|FG002|BM Cohort|Adverse Event|0|||
16284939|NCT01132664|39526287|FG003|BM Cohort|Adverse Event|0|||
16284940|NCT01132664|39526288|FG004|BM Cohort|Adverse Event|1|||
16284941|NCT01132664|39526284|FG000|BM Cohort|Withdrawal by Subject|0|||
16284942|NCT01132664|39526285|FG001|BM Cohort|Withdrawal by Subject|0|||
16284943|NCT01132664|39526286|FG002|BM Cohort|Withdrawal by Subject|0|||
16284944|NCT01132664|39526287|FG003|BM Cohort|Withdrawal by Subject|0|||
16284945|NCT01132664|39526288|FG004|BM Cohort|Withdrawal by Subject|1|||
16284946|NCT02470091|39526296|FG000|Overall Study|Withdrawal by Subject|1|||
16284947|NCT02470091|39526297|FG001|Overall Study|Withdrawal by Subject|0|||
16284948|NCT02470091|39526296|FG000|Overall Study|Ineligible|0|||
16284949|NCT02470091|39526297|FG001|Overall Study|Ineligible|2|||
16284950|NCT01048502|39526301|FG000|Overall Study|Lost to Follow-up|2|||
16284951|NCT01048502|39526302|FG001|Overall Study|Lost to Follow-up|0|||
16284952|NCT01048502|39526303|FG002|Overall Study|Lost to Follow-up|0|||
16284953|NCT01048502|39526304|FG003|Overall Study|Lost to Follow-up|0|||
16284954|NCT01048502|39526301|FG000|Overall Study|Adverse Event|1|||
16480304|NCT01235689|40238225|FG000|Overall Study|Adverse Event|12|||
16480305|NCT01235689|40238226|FG001|Overall Study|Adverse Event|16|||
16480306|NCT01235689|40238225|FG000|Overall Study|Lack of Efficacy|12|||
16480307|NCT01235689|40238226|FG001|Overall Study|Lack of Efficacy|5|||
16480308|NCT01235689|40238225|FG000|Overall Study|Withdrawal by Subject|3|||
16480309|NCT01235689|40238226|FG001|Overall Study|Withdrawal by Subject|4|||
16185447|NCT01544595|39159245|FG005|Status at Week 156|Adverse Event|2|||
16284955|NCT01048502|39526302|FG001|Overall Study|Adverse Event|0|||
16480310|NCT01235689|40238225|FG000|Overall Study|Lost to Follow-up|1|||
16480311|NCT01235689|40238226|FG001|Overall Study|Lost to Follow-up|2|||
16480312|NCT01235689|40238225|FG000|Overall Study|Miscellaneous|1|||
16284956|NCT01048502|39526303|FG002|Overall Study|Adverse Event|0|||
16284957|NCT01048502|39526304|FG003|Overall Study|Adverse Event|0|||
16284958|NCT01048502|39526301|FG000|Overall Study|Withdrawal by Subject|1|||
16284959|NCT01048502|39526302|FG001|Overall Study|Withdrawal by Subject|4|||
16284960|NCT01048502|39526303|FG002|Overall Study|Withdrawal by Subject|5|||
16284961|NCT01048502|39526304|FG003|Overall Study|Withdrawal by Subject|3|||
16284962|NCT01048502|39526301|FG000|Overall Study|Physician Decision|0|||
16284963|NCT01048502|39526302|FG001|Overall Study|Physician Decision|3|||
16284964|NCT01048502|39526303|FG002|Overall Study|Physician Decision|0|||
16284965|NCT01048502|39526304|FG003|Overall Study|Physician Decision|1|||
16284966|NCT02924376|39526307|FG000|Overall Study|Progressive Disease|4|||
16284967|NCT02924376|39526308|FG001|Overall Study|Progressive Disease|0|||
16284968|NCT02924376|39526309|FG002|Overall Study|Progressive Disease|1|||
16284969|NCT02924376|39526310|FG003|Overall Study|Progressive Disease|0|||
16284970|NCT02924376|39526307|FG000|Overall Study|Death|73|||
16284971|NCT02924376|39526308|FG001|Overall Study|Death|18|||
16284972|NCT02924376|39526309|FG002|Overall Study|Death|15|||
16284973|NCT02924376|39526310|FG003|Overall Study|Death|2|||
16284974|NCT02924376|39526307|FG000|Overall Study|Lost to Follow-up|3|||
16284975|NCT02924376|39526308|FG001|Overall Study|Lost to Follow-up|0|||
16284976|NCT02924376|39526309|FG002|Overall Study|Lost to Follow-up|0|||
16284977|NCT02924376|39526310|FG003|Overall Study|Lost to Follow-up|0|||
16284978|NCT02924376|39526307|FG000|Overall Study|Study Terminated by Sponsor|19|||
16284979|NCT02924376|39526308|FG001|Overall Study|Study Terminated by Sponsor|0|||
16284980|NCT02924376|39526309|FG002|Overall Study|Study Terminated by Sponsor|0|||
16284981|NCT02924376|39526310|FG003|Overall Study|Study Terminated by Sponsor|0|||
16284982|NCT02924376|39526307|FG000|Overall Study|Physician Decision|1|||
16284983|NCT02924376|39526308|FG001|Overall Study|Physician Decision|0|||
16284984|NCT02924376|39526309|FG002|Overall Study|Physician Decision|0|||
16284985|NCT02924376|39526310|FG003|Overall Study|Physician Decision|0|||
16284986|NCT02924376|39526307|FG000|Overall Study|Withdrawal by Subject|7|||
16284987|NCT02924376|39526308|FG001|Overall Study|Withdrawal by Subject|2|||
16284988|NCT02924376|39526309|FG002|Overall Study|Withdrawal by Subject|1|||
16284989|NCT02924376|39526310|FG003|Overall Study|Withdrawal by Subject|0|||
16284990|NCT02924376|39526307|FG000|Overall Study|Rolled Over to Another Study|1|||
16284991|NCT02924376|39526308|FG001|Overall Study|Rolled Over to Another Study|0|||
16284992|NCT02924376|39526309|FG002|Overall Study|Rolled Over to Another Study|0|||
16284993|NCT02924376|39526310|FG003|Overall Study|Rolled Over to Another Study|0|||
16284994|NCT02181296|39526315|FG000|Overall Study|Lost to Follow-up|7|||
16284995|NCT02181296|39526316|FG001|Overall Study|Lost to Follow-up|6|||
16284996|NCT02284347|39526317|FG000|Overall Study|Lost to Follow-up|2|||
16379798|NCT03773484|39874775|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
16379799|NCT00939185|39874778|FG000|Overall Study|Adverse Event|3|||
16379800|NCT00939185|39874778|FG000|Overall Study|Lack of Efficacy|1|||
16379801|NCT00939185|39874778|FG000|Overall Study|Lost to Follow-up|6|||
16379802|NCT00939185|39874778|FG000|Overall Study|Other|3|||
16379803|NCT00939185|39874778|FG000|Overall Study|Withdrawal by Subject|2|||
16379804|NCT00939185|39874778|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
16379805|NCT01344356|39874779|FG000|Overall Study|Physician Decision|0|||
16379806|NCT01344356|39874780|FG001|Overall Study|Physician Decision|3|||
16379807|NCT01344356|39874779|FG000|Overall Study|Lost to Follow-up|0|||
16379808|NCT01344356|39874780|FG001|Overall Study|Lost to Follow-up|6|||
16379809|NCT04581395|39874781|FG000|Overall Study|Protocol Violation|4|||
16480313|NCT01235689|40238226|FG001|Overall Study|Miscellaneous|5|||
16480314|NCT00385762|40238227|FG000|Overall Study|Adverse Event|1|||
16480315|NCT00385762|40238227|FG000|Overall Study|Lost to Follow-up|1|||
16480316|NCT01548287|40238228|FG000|Screening|No reason provided|0|||
16284997|NCT02284347|39526317|FG000|Overall Study|Withdrawn prior to treatment|1|||
16379810|NCT04581395|39874782|FG001|Overall Study|Protocol Violation|3|||
16379811|NCT04581395|39874783|FG002|Overall Study|Protocol Violation|2|||
16379812|NCT04581395|39874781|FG000|Overall Study|Physician Decision|0|||
16379813|NCT04581395|39874782|FG001|Overall Study|Physician Decision|1|||
16379814|NCT04581395|39874783|FG002|Overall Study|Physician Decision|0|||
16379815|NCT00829244|39874788|FG000|Overall Study|Adverse Event|1|||
16379816|NCT00829244|39874789|FG001|Overall Study|Adverse Event|3|||
16379817|NCT00829244|39874788|FG000|Overall Study|Protocol Violation|1|||
16379818|NCT00829244|39874789|FG001|Overall Study|Protocol Violation|0|||
16379819|NCT00829244|39874788|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
16379820|NCT00829244|39874789|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
16379821|NCT00829244|39874788|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
16379822|NCT00829244|39874789|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
16379823|NCT00829244|39874788|FG000|Overall Study|No fertilization|2|||
16480317|NCT01548287|40238229|FG001|Screening|No reason provided|0|||
16480318|NCT01548287|40238230|FG002|Screening|No reason provided|0|||
16284998|NCT00873119|39526319|FG000|Overall Study|Patient request|4|||
16284999|NCT00873119|39526320|FG001|Overall Study|Patient request|2|||
16285000|NCT00873119|39526319|FG000|Overall Study|Adverse Event|8|||
16285001|NCT00873119|39526320|FG001|Overall Study|Adverse Event|0|||
16285002|NCT00873119|39526319|FG000|Overall Study|Progressive disease|26|||
16285003|NCT00873119|39526320|FG001|Overall Study|Progressive disease|18|||
16285004|NCT00873119|39526319|FG000|Overall Study|Death|2|||
16379824|NCT00829244|39874789|FG001|Overall Study|No fertilization|2|||
16379825|NCT00829244|39874788|FG000|Overall Study|All embryos discarded|0|||
16379826|NCT00829244|39874789|FG001|Overall Study|All embryos discarded|3|||
16379827|NCT00829244|39874788|FG000|Overall Study|No embryo cleavage|0|||
16379828|NCT00829244|39874789|FG001|Overall Study|No embryo cleavage|2|||
16379829|NCT03384966|39874791|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
16379830|NCT03384966|39874792|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
16379831|NCT03384966|39874793|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
16379832|NCT03384966|39874791|FG000|Follow-up Period|Adverse Event|1|||
16379833|NCT03384966|39874792|FG001|Follow-up Period|Adverse Event|0|||
16379834|NCT03384966|39874793|FG002|Follow-up Period|Adverse Event|0|||
16379835|NCT03553836|39874794|FG000|Overall Study|Ongoing in Study|460|||
16379836|NCT03553836|39874795|FG001|Overall Study|Ongoing in Study|459|||
16379837|NCT03553836|39874794|FG000|Overall Study|Withdrawal by Subject|9|||
16379838|NCT03553836|39874795|FG001|Overall Study|Withdrawal by Subject|10|||
16379839|NCT03553836|39874794|FG000|Overall Study|Lost to Follow-up|1|||
16379840|NCT03553836|39874795|FG001|Overall Study|Lost to Follow-up|3|||
16379841|NCT03553836|39874794|FG000|Overall Study|Death|17|||
16379842|NCT03553836|39874795|FG001|Overall Study|Death|17|||
16379843|NCT02495883|39874801|FG000|Overall Study|Excessive head motion|1|||
16379844|NCT02495883|39874802|FG001|Overall Study|Excessive head motion|0|||
16379845|NCT04100018|39874803|FG000|Pre-Treatment Period|Not Reported|0|||
16379846|NCT04100018|39874804|FG001|Pre-Treatment Period|Not Reported|4|||
16379847|NCT04100018|39874803|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
16379848|NCT04100018|39874804|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
16379849|NCT04100018|39874803|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
16379850|NCT04100018|39874804|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
16379851|NCT04100018|39874803|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
16379852|NCT04100018|39874804|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
16379853|NCT04100018|39874803|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
16379854|NCT04100018|39874804|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
16379855|NCT04100018|39874803|FG000|Treatment Period|Ongoing Treatment as of clinical cut off date|58|||
16379856|NCT04100018|39874804|FG001|Treatment Period|Ongoing Treatment as of clinical cut off date|52|||
16379857|NCT04100018|39874803|FG000|Treatment Period|Other Reason|18|||
16379858|NCT04100018|39874804|FG001|Treatment Period|Other Reason|29|||
16379859|NCT04100018|39874803|FG000|Treatment Period|Completed treatment as per protocol|0|||
16379860|NCT04100018|39874804|FG001|Treatment Period|Completed treatment as per protocol|1|||
16379861|NCT04100018|39874803|FG000|Treatment Period|Maximum clinical benefit|3|||
16379862|NCT04100018|39874804|FG001|Treatment Period|Maximum clinical benefit|0|||
16379863|NCT04100018|39874803|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
16379864|NCT04100018|39874804|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
16379865|NCT04100018|39874803|FG000|Treatment Period|Study drug toxicity|67|||
16379866|NCT04100018|39874804|FG001|Treatment Period|Study drug toxicity|28|||
16379867|NCT04100018|39874803|FG000|Treatment Period|Disease Progression|269|||
16379868|NCT04100018|39874804|FG001|Treatment Period|Disease Progression|318|||
16379869|NCT04100018|39874803|FG000|Treatment Period|Administrative reasons by sponsor|1|||
16379870|NCT04100018|39874804|FG001|Treatment Period|Administrative reasons by sponsor|1|||
16379871|NCT04100018|39874803|FG000|Treatment Period|Poor/Non-Compliance|1|||
16379872|NCT04100018|39874804|FG001|Treatment Period|Poor/Non-Compliance|0|||
16379873|NCT04100018|39874803|FG000|Treatment Period|Lost to Follow-up|2|||
16379874|NCT04100018|39874804|FG001|Treatment Period|Lost to Follow-up|2|||
16379875|NCT04100018|39874803|FG000|Treatment Period|Death|14|||
16379876|NCT04100018|39874804|FG001|Treatment Period|Death|11|||
16379877|NCT04100018|39874803|FG000|Treatment Period|Participant withdrew consent|8|||
16379878|NCT04100018|39874804|FG001|Treatment Period|Participant withdrew consent|10|||
16379879|NCT04100018|39874803|FG000|Treatment Period|Participant request to discontinue study treatment|32|||
16379880|NCT04100018|39874804|FG001|Treatment Period|Participant request to discontinue study treatment|31|||
16379881|NCT04100018|39874803|FG000|Treatment Period|Adverse Event|12|||
16379882|NCT04100018|39874804|FG001|Treatment Period|Adverse Event|6|||
16379883|NCT04100018|39874803|FG000|Treatment Period|Lack of Efficacy|4|||
16379884|NCT04100018|39874804|FG001|Treatment Period|Lack of Efficacy|2|||
16379885|NCT02743962|39874807|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
16379886|NCT02743962|39874808|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
16379887|NCT00668642|39874809|FG000|First Off-cycle|Cancer progression|1|||
16379888|NCT00668642|39874810|FG001|First Off-cycle|Cancer progression|0|||
16379889|NCT00668642|39874809|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
16379890|NCT00668642|39874810|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
16379891|NCT03331354|39874812|FG000|Overall Study|Withdrawal by Subject|1|||
16379892|NCT03331354|39874813|FG001|Overall Study|Withdrawal by Subject|3|||
16379893|NCT03331354|39874812|FG000|Overall Study|Lost to Follow-up|3|||
16379894|NCT03331354|39874813|FG001|Overall Study|Lost to Follow-up|3|||
16379895|NCT03331354|39874812|FG000|Overall Study|Found employment before initiated active intervention|0|||
16379896|NCT03331354|39874813|FG001|Overall Study|Found employment before initiated active intervention|4|||
16480319|NCT01548287|40238231|FG003|Screening|No reason provided|0|||
16480320|NCT01548287|40238232|FG004|Screening|No reason provided|9|||
16480321|NCT01548287|40238228|FG000|Screening|Did not meet eligibility criteria|0|||
16480322|NCT01548287|40238229|FG001|Screening|Did not meet eligibility criteria|0|||
16480323|NCT01548287|40238230|FG002|Screening|Did not meet eligibility criteria|0|||
16480324|NCT01548287|40238231|FG003|Screening|Did not meet eligibility criteria|0|||
16480325|NCT01548287|40238232|FG004|Screening|Did not meet eligibility criteria|74|||
16480326|NCT01548287|40238228|FG000|Randomized Period|Did not meet inclusion criteria|0|||
16480327|NCT01548287|40238229|FG001|Randomized Period|Did not meet inclusion criteria|0|||
16480328|NCT01548287|40238230|FG002|Randomized Period|Did not meet inclusion criteria|2|||
16480329|NCT01548287|40238231|FG003|Randomized Period|Did not meet inclusion criteria|0|||
16480330|NCT01548287|40238232|FG004|Randomized Period|Did not meet inclusion criteria|0|||
16480331|NCT01548287|40238228|FG000|Randomized Period|Adverse Event|0|||
16480332|NCT01548287|40238229|FG001|Randomized Period|Adverse Event|2|||
16480333|NCT01548287|40238230|FG002|Randomized Period|Adverse Event|5|||
16480334|NCT01548287|40238231|FG003|Randomized Period|Adverse Event|0|||
16480335|NCT01548287|40238232|FG004|Randomized Period|Adverse Event|0|||
16480336|NCT00369707|40238238|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
16480337|NCT00369707|40238238|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
16480338|NCT00369707|40238238|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
16480339|NCT00369707|40238238|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
16480340|NCT00369707|40238238|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
16480341|NCT00369707|40238238|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
16480342|NCT00369707|40238238|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
16480343|NCT00369707|40238238|FG000|Follow up for 2 Years After Treatment|Death|1|||
16480344|NCT00369707|40238238|FG000|Follow up for 2 Years After Treatment|Other|2|||
16480345|NCT03780543|40238239|FG000|Overall Study|Adverse Event|1|||
16480346|NCT03780543|40238240|FG001|Overall Study|Adverse Event|0|||
16480347|NCT03780543|40238241|FG002|Overall Study|Adverse Event|2|||
16480348|NCT03780543|40238239|FG000|Overall Study|Lost to Follow-up|2|||
16480349|NCT03780543|40238240|FG001|Overall Study|Lost to Follow-up|0|||
16480350|NCT03780543|40238241|FG002|Overall Study|Lost to Follow-up|1|||
16480351|NCT03780543|40238239|FG000|Overall Study|Study terminated by Sponsor|8|||
16480352|NCT03780543|40238240|FG001|Overall Study|Study terminated by Sponsor|7|||
16480353|NCT03780543|40238241|FG002|Overall Study|Study terminated by Sponsor|13|||
16480354|NCT03780543|40238239|FG000|Overall Study|Withdrawal by Subject|1|||
16480355|NCT03780543|40238240|FG001|Overall Study|Withdrawal by Subject|8|||
16480356|NCT03780543|40238241|FG002|Overall Study|Withdrawal by Subject|1|||
16480357|NCT03780543|40238239|FG000|Overall Study|Noncompliance with study drug|1|||
16480358|NCT03780543|40238240|FG001|Overall Study|Noncompliance with study drug|0|||
16480359|NCT03780543|40238241|FG002|Overall Study|Noncompliance with study drug|0|||
16480360|NCT01539538|40238243|FG000|Overall Study|Adverse Event|13|||
16480361|NCT01539538|40238244|FG001|Overall Study|Adverse Event|18|||
16480362|NCT01539538|40238243|FG000|Overall Study|Lack of Efficacy|13|||
16480363|NCT01539538|40238244|FG001|Overall Study|Lack of Efficacy|16|||
16480364|NCT01539538|40238243|FG000|Overall Study|Withdrawal by Subject|2|||
16480365|NCT01539538|40238244|FG001|Overall Study|Withdrawal by Subject|3|||
16480366|NCT01539538|40238243|FG000|Overall Study|PCA no longer required or PCA problem|3|||
16480367|NCT01539538|40238244|FG001|Overall Study|PCA no longer required or PCA problem|7|||
16480368|NCT02762578|40238245|FG000|Overall Study|Adverse Event|1|||
16480369|NCT02762578|40238246|FG001|Overall Study|Adverse Event|6|||
16480370|NCT02762578|40238245|FG000|Overall Study|Protocol Violation|4|||
16480371|NCT02762578|40238246|FG001|Overall Study|Protocol Violation|2|||
16480372|NCT02762578|40238245|FG000|Overall Study|Withdrawal by Subject|4|||
16480373|NCT02762578|40238246|FG001|Overall Study|Withdrawal by Subject|2|||
16480374|NCT02762578|40238245|FG000|Overall Study|Unclassified|6|||
16480375|NCT02762578|40238246|FG001|Overall Study|Unclassified|0|||
16480376|NCT00400764|40238247|FG000|Phase Ib|Adverse Event|1|||
16480377|NCT00400764|40238248|FG001|Phase Ib|Adverse Event|0|||
16480378|NCT00400764|40238249|FG002|Phase Ib|Adverse Event|0|||
16480379|NCT00400764|40238250|FG003|Phase Ib|Adverse Event|0|||
16480380|NCT00400764|40238251|FG004|Phase Ib|Adverse Event|0|||
16480381|NCT00400764|40238247|FG000|Phase Ib|Death|1|||
16480382|NCT00400764|40238248|FG001|Phase Ib|Death|0|||
16480383|NCT00400764|40238249|FG002|Phase Ib|Death|0|||
16480384|NCT00400764|40238250|FG003|Phase Ib|Death|0|||
16480385|NCT00400764|40238251|FG004|Phase Ib|Death|0|||
16480386|NCT00400764|40238247|FG000|Phase Ib|Disease Progression|4|||
16480387|NCT00400764|40238248|FG001|Phase Ib|Disease Progression|4|||
16480388|NCT00400764|40238249|FG002|Phase Ib|Disease Progression|0|||
16480389|NCT00400764|40238250|FG003|Phase Ib|Disease Progression|0|||
16480390|NCT00400764|40238251|FG004|Phase Ib|Disease Progression|0|||
16480391|NCT00400764|40238247|FG000|Phase II|Death|0|||
16185448|NCT01544595|39159240|FG000|Status at Week 156|Lost to Follow-up|4|||
16480392|NCT00400764|40238248|FG001|Phase II|Death|0|||
16480393|NCT00400764|40238249|FG002|Phase II|Death|1|||
16480394|NCT00400764|40238250|FG003|Phase II|Death|2|||
16480395|NCT00400764|40238251|FG004|Phase II|Death|0|||
16480396|NCT00400764|40238247|FG000|Phase II|Lost to Follow-up|0|||
16480397|NCT00400764|40238248|FG001|Phase II|Lost to Follow-up|0|||
16480398|NCT00400764|40238249|FG002|Phase II|Lost to Follow-up|1|||
16480399|NCT00400764|40238250|FG003|Phase II|Lost to Follow-up|0|||
16480400|NCT00400764|40238251|FG004|Phase II|Lost to Follow-up|0|||
16480401|NCT00400764|40238247|FG000|Phase II|Physician Decision|0|||
16480402|NCT00400764|40238248|FG001|Phase II|Physician Decision|0|||
16480403|NCT00400764|40238249|FG002|Phase II|Physician Decision|1|||
16480404|NCT00400764|40238250|FG003|Phase II|Physician Decision|1|||
16480405|NCT00400764|40238251|FG004|Phase II|Physician Decision|0|||
16480406|NCT00400764|40238247|FG000|Phase II|Sponsor's decision to terminate|0|||
16480407|NCT00400764|40238248|FG001|Phase II|Sponsor's decision to terminate|0|||
16480408|NCT00400764|40238249|FG002|Phase II|Sponsor's decision to terminate|18|||
16480409|NCT00400764|40238250|FG003|Phase II|Sponsor's decision to terminate|22|||
16480410|NCT00400764|40238251|FG004|Phase II|Sponsor's decision to terminate|11|||
16480411|NCT00400764|40238247|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
16480412|NCT00400764|40238248|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
16480413|NCT00400764|40238249|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
16480414|NCT00400764|40238250|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
16480415|NCT00400764|40238251|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
16480416|NCT00400764|40238247|FG000|Phase II|Withdrawal by Subject|0|||
16480417|NCT00400764|40238248|FG001|Phase II|Withdrawal by Subject|0|||
16480418|NCT00400764|40238249|FG002|Phase II|Withdrawal by Subject|1|||
16480419|NCT00400764|40238250|FG003|Phase II|Withdrawal by Subject|1|||
16480420|NCT00400764|40238251|FG004|Phase II|Withdrawal by Subject|0|||
16480421|NCT03793556|40238254|FG000|Overall Study|Withdrawal by Subject|12|||
16480422|NCT03793556|40238255|FG001|Overall Study|Withdrawal by Subject|1|||
16480423|NCT03793556|40238254|FG000|Overall Study|Lost to Follow-up|1|||
16480424|NCT03793556|40238255|FG001|Overall Study|Lost to Follow-up|1|||
16480425|NCT02405780|40238258|FG000|Period I|Adverse Event|8|||
16480426|NCT02405780|40238259|FG001|Period I|Adverse Event|0|||
16480427|NCT02405780|40238260|FG002|Period I|Adverse Event|3|||
16480428|NCT02405780|40238261|FG003|Period I|Adverse Event|7|||
16480429|NCT02405780|40238258|FG000|Period I|Medical reasons|1|||
16480430|NCT02405780|40238259|FG001|Period I|Medical reasons|1|||
16480431|NCT02405780|40238260|FG002|Period I|Medical reasons|0|||
16480432|NCT02405780|40238261|FG003|Period I|Medical reasons|1|||
16480433|NCT02405780|40238258|FG000|Period I|Screening Failure|1|||
16480434|NCT02405780|40238259|FG001|Period I|Screening Failure|0|||
16480435|NCT02405780|40238260|FG002|Period I|Screening Failure|1|||
16480436|NCT02405780|40238261|FG003|Period I|Screening Failure|0|||
16480437|NCT02405780|40238258|FG000|Period I|Withdrawal by Subject|9|||
16480438|NCT02405780|40238259|FG001|Period I|Withdrawal by Subject|1|||
16480439|NCT02405780|40238260|FG002|Period I|Withdrawal by Subject|3|||
16480440|NCT02405780|40238261|FG003|Period I|Withdrawal by Subject|4|||
16480441|NCT02405780|40238258|FG000|Period I|Non-compliance with study procedures|8|||
16480442|NCT02405780|40238259|FG001|Period I|Non-compliance with study procedures|6|||
16480443|NCT02405780|40238260|FG002|Period I|Non-compliance with study procedures|8|||
16285005|NCT00873119|39526320|FG001|Overall Study|Death|1|||
16285006|NCT00873119|39526319|FG000|Overall Study|Other|2|||
16285007|NCT00873119|39526320|FG001|Overall Study|Other|5|||
16285008|NCT00873119|39526319|FG000|Overall Study|Not treated|2|||
16285009|NCT00873119|39526320|FG001|Overall Study|Not treated|0|||
16285010|NCT02610816|39526323|FG000|Phase 1|Withdrawal by Subject|2|||
16285011|NCT02610816|39526324|FG001|Phase 1|Withdrawal by Subject|6|||
16285012|NCT02610816|39526325|FG002|Phase 1|Withdrawal by Subject|0|||
16285013|NCT02610816|39526326|FG003|Phase 1|Withdrawal by Subject|0|||
16285014|NCT02610816|39526323|FG000|Phase 1|Lost to Follow-up|2|||
16285015|NCT02610816|39526324|FG001|Phase 1|Lost to Follow-up|1|||
16285016|NCT02610816|39526325|FG002|Phase 1|Lost to Follow-up|0|||
16285017|NCT02610816|39526326|FG003|Phase 1|Lost to Follow-up|0|||
16285018|NCT02610816|39526323|FG000|Phase 1|Physician Decision|0|||
16285019|NCT02610816|39526324|FG001|Phase 1|Physician Decision|1|||
16285020|NCT02610816|39526325|FG002|Phase 1|Physician Decision|0|||
16285021|NCT02610816|39526326|FG003|Phase 1|Physician Decision|0|||
16285022|NCT02610816|39526323|FG000|Phase 2|Withdrawal by Subject|0|||
16480444|NCT02405780|40238261|FG003|Period I|Non-compliance with study procedures|11|||
16480445|NCT02405780|40238258|FG000|Period II|Adverse Event|3|||
16480446|NCT02405780|40238259|FG001|Period II|Adverse Event|5|||
16285023|NCT02610816|39526324|FG001|Phase 2|Withdrawal by Subject|0|||
16285024|NCT02610816|39526325|FG002|Phase 2|Withdrawal by Subject|9|||
16285025|NCT02610816|39526326|FG003|Phase 2|Withdrawal by Subject|3|||
16480447|NCT02405780|40238260|FG002|Period II|Adverse Event|4|||
16480448|NCT02405780|40238261|FG003|Period II|Adverse Event|11|||
16480449|NCT02405780|40238258|FG000|Period II|Medical reason|0|||
16480450|NCT02405780|40238259|FG001|Period II|Medical reason|1|||
16480451|NCT02405780|40238260|FG002|Period II|Medical reason|0|||
16285026|NCT02610816|39526323|FG000|Phase 2|Lost to Follow-up|0|||
16285027|NCT02610816|39526324|FG001|Phase 2|Lost to Follow-up|0|||
16480452|NCT02405780|40238261|FG003|Period II|Medical reason|0|||
16480453|NCT02405780|40238258|FG000|Period II|Pregnancy|0|||
16480454|NCT02405780|40238259|FG001|Period II|Pregnancy|0|||
16285028|NCT02610816|39526325|FG002|Phase 2|Lost to Follow-up|2|||
16285029|NCT02610816|39526326|FG003|Phase 2|Lost to Follow-up|0|||
16285030|NCT02610816|39526323|FG000|Phase 2|Physician Decision|0|||
16285031|NCT02610816|39526324|FG001|Phase 2|Physician Decision|0|||
16285032|NCT02610816|39526325|FG002|Phase 2|Physician Decision|0|||
16285033|NCT02610816|39526326|FG003|Phase 2|Physician Decision|2|||
16285034|NCT02610816|39526323|FG000|Phase 2|Pregnancy|0|||
16285035|NCT02610816|39526324|FG001|Phase 2|Pregnancy|0|||
16285036|NCT02610816|39526325|FG002|Phase 2|Pregnancy|0|||
16285037|NCT02610816|39526326|FG003|Phase 2|Pregnancy|1|||
16285038|NCT00084799|39526327|FG000|Overall Study|Disease Progression|1|||
16285039|NCT00084799|39526328|FG001|Overall Study|Disease Progression|0|||
16285040|NCT01796964|39526329|FG000|Overall Study|Adverse Event|1|||
16285041|NCT01796964|39526330|FG001|Overall Study|Adverse Event|1|||
16285042|NCT01796964|39526329|FG000|Overall Study|Death|1|||
16285043|NCT01796964|39526330|FG001|Overall Study|Death|0|||
16285044|NCT01796964|39526329|FG000|Overall Study|Protocol Violation|0|||
16285045|NCT01796964|39526330|FG001|Overall Study|Protocol Violation|1|||
16285046|NCT01796964|39526329|FG000|Overall Study|Withdrawal by Subject|1|||
16285047|NCT01796964|39526330|FG001|Overall Study|Withdrawal by Subject|1|||
16285048|NCT00868296|39526331|FG000|Overall Study|Adverse Event|0|||
16285049|NCT00868296|39526332|FG001|Overall Study|Adverse Event|2|||
16285050|NCT00868296|39526331|FG000|Overall Study|Withdrawal by Subject|0|||
16285051|NCT00868296|39526332|FG001|Overall Study|Withdrawal by Subject|1|||
16285052|NCT01534078|39526342|FG000|Overall Study|Death|1|||
16285053|NCT01534078|39526342|FG000|Overall Study|Withdrawal by Subject|1|||
16285054|NCT01998243|39526343|FG000|Overall Study|Pregnancy|0|||
16285055|NCT01998243|39526344|FG001|Overall Study|Pregnancy|1|||
16285056|NCT01998243|39526343|FG000|Overall Study|Protocol Violation|5|||
16285057|NCT01998243|39526344|FG001|Overall Study|Protocol Violation|2|||
16285058|NCT01998243|39526343|FG000|Overall Study|Withdrawal by Subject|3|||
16285059|NCT01998243|39526344|FG001|Overall Study|Withdrawal by Subject|4|||
16285060|NCT01765751|39526345|FG000|Overall Study|Lost to Follow-up|0|||
16285061|NCT01765751|39526346|FG001|Overall Study|Lost to Follow-up|2|||
16285062|NCT01765751|39526347|FG002|Overall Study|Lost to Follow-up|1|||
16285063|NCT00355472|39526348|FG000|Overall Study|Physician Decision|1|||
16285064|NCT01201759|39526349|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
16285065|NCT01201759|39526350|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
16285066|NCT01201759|39526349|FG000|Visit 3 - Washout|Adverse Event|0|||
16285067|NCT01201759|39526350|FG001|Visit 3 - Washout|Adverse Event|3|||
16285068|NCT01201759|39526349|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
16285069|NCT01201759|39526350|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
16285070|NCT01201759|39526349|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
16285071|NCT01201759|39526350|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
16285072|NCT00493246|39526355|FG000|Overall Study|Withdrawal by Subject|0|||
16285073|NCT00493246|39526356|FG001|Overall Study|Withdrawal by Subject|0|||
16285074|NCT00493246|39526357|FG002|Overall Study|Withdrawal by Subject|0|||
16285075|NCT00493246|39526358|FG003|Overall Study|Withdrawal by Subject|0|||
16285076|NCT00493246|39526359|FG004|Overall Study|Withdrawal by Subject|1|||
16285077|NCT00493246|39526360|FG005|Overall Study|Withdrawal by Subject|0|||
16285078|NCT00493246|39526361|FG006|Overall Study|Withdrawal by Subject|0|||
16285079|NCT00493246|39526362|FG007|Overall Study|Withdrawal by Subject|0|||
16285080|NCT00493246|39526355|FG000|Overall Study|No access to draw blood|0|||
16285081|NCT00493246|39526356|FG001|Overall Study|No access to draw blood|0|||
16285082|NCT00493246|39526357|FG002|Overall Study|No access to draw blood|0|||
16285083|NCT00493246|39526358|FG003|Overall Study|No access to draw blood|0|||
16285084|NCT00493246|39526359|FG004|Overall Study|No access to draw blood|0|||
16285085|NCT00493246|39526360|FG005|Overall Study|No access to draw blood|1|||
16285086|NCT00493246|39526361|FG006|Overall Study|No access to draw blood|0|||
16285087|NCT00493246|39526362|FG007|Overall Study|No access to draw blood|0|||
16285088|NCT00493246|39526355|FG000|Overall Study|Lost to Follow-up|0|||
16285089|NCT00493246|39526356|FG001|Overall Study|Lost to Follow-up|0|||
16285090|NCT00493246|39526357|FG002|Overall Study|Lost to Follow-up|0|||
16285091|NCT00493246|39526358|FG003|Overall Study|Lost to Follow-up|0|||
16285092|NCT00493246|39526359|FG004|Overall Study|Lost to Follow-up|0|||
16285093|NCT00493246|39526360|FG005|Overall Study|Lost to Follow-up|0|||
16285094|NCT00493246|39526361|FG006|Overall Study|Lost to Follow-up|1|||
16285095|NCT00493246|39526362|FG007|Overall Study|Lost to Follow-up|0|||
16285096|NCT01976728|39526363|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
16285097|NCT01976728|39526364|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
16480455|NCT02405780|40238260|FG002|Period II|Pregnancy|1|||
16285098|NCT01976728|39526365|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
16285099|NCT01976728|39526366|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
16285100|NCT00515034|39526367|FG000|Overall Study|Adverse Event|2|||
16285101|NCT00515034|39526368|FG001|Overall Study|Adverse Event|0|||
16285102|NCT00515034|39526369|FG002|Overall Study|Adverse Event|1|||
16285103|NCT00515034|39526370|FG003|Overall Study|Adverse Event|0|||
16285104|NCT00515034|39526367|FG000|Overall Study|Death|4|||
16285105|NCT00515034|39526368|FG001|Overall Study|Death|2|||
16285106|NCT00515034|39526369|FG002|Overall Study|Death|1|||
16285107|NCT00515034|39526370|FG003|Overall Study|Death|3|||
16285108|NCT00515034|39526367|FG000|Overall Study|Withdrawal by Subject|1|||
16285109|NCT00515034|39526368|FG001|Overall Study|Withdrawal by Subject|0|||
16285110|NCT00515034|39526369|FG002|Overall Study|Withdrawal by Subject|3|||
16285111|NCT00515034|39526370|FG003|Overall Study|Withdrawal by Subject|0|||
16285112|NCT00515034|39526367|FG000|Overall Study|Physician Decision|0|||
16285113|NCT00515034|39526368|FG001|Overall Study|Physician Decision|0|||
16285114|NCT00515034|39526369|FG002|Overall Study|Physician Decision|1|||
16285115|NCT00515034|39526370|FG003|Overall Study|Physician Decision|1|||
16285116|NCT00515034|39526367|FG000|Overall Study|Other|1|||
16285117|NCT00515034|39526368|FG001|Overall Study|Other|0|||
16285118|NCT00515034|39526369|FG002|Overall Study|Other|2|||
16285119|NCT00515034|39526370|FG003|Overall Study|Other|1|||
16285120|NCT00359788|39526371|FG000|Overall Study|Adverse Event|11|||
16285121|NCT00359788|39526372|FG001|Overall Study|Adverse Event|10|||
16285122|NCT00359788|39526371|FG000|Overall Study|Lack of Efficacy|1|||
16285123|NCT00359788|39526372|FG001|Overall Study|Lack of Efficacy|2|||
16285124|NCT00359788|39526371|FG000|Overall Study|Lost to Follow-up|3|||
16285125|NCT00359788|39526372|FG001|Overall Study|Lost to Follow-up|2|||
16285126|NCT00359788|39526371|FG000|Overall Study|Withdrawal by Subject|4|||
16285127|NCT00359788|39526372|FG001|Overall Study|Withdrawal by Subject|1|||
16285128|NCT00359788|39526371|FG000|Overall Study|Protocol Violation|4|||
16285129|NCT00359788|39526372|FG001|Overall Study|Protocol Violation|2|||
16285130|NCT01302847|39526373|FG000|Overall Study|Ongoing|0|||
16285131|NCT01302847|39526374|FG001|Overall Study|Ongoing|0|||
16285132|NCT01302847|39526375|FG002|Overall Study|Ongoing|0|||
16285133|NCT01302847|39526376|FG003|Overall Study|Ongoing|0|||
16285134|NCT01302847|39526377|FG004|Overall Study|Ongoing|0|||
16285135|NCT01302847|39526378|FG005|Overall Study|Ongoing|27|||
16285136|NCT01302847|39526379|FG006|Overall Study|Ongoing|22|||
16285137|NCT01302847|39526380|FG007|Overall Study|Ongoing|17|||
16285138|NCT01302847|39526373|FG000|Overall Study|Death|0|||
16285139|NCT01302847|39526374|FG001|Overall Study|Death|1|||
16285140|NCT01302847|39526375|FG002|Overall Study|Death|0|||
16285141|NCT01302847|39526376|FG003|Overall Study|Death|0|||
16285142|NCT01302847|39526377|FG004|Overall Study|Death|0|||
16285143|NCT01302847|39526378|FG005|Overall Study|Death|1|||
16285144|NCT01302847|39526379|FG006|Overall Study|Death|1|||
16285145|NCT01302847|39526380|FG007|Overall Study|Death|0|||
16285146|NCT01302847|39526373|FG000|Overall Study|Pregnancy|2|||
16285147|NCT01302847|39526374|FG001|Overall Study|Pregnancy|0|||
16285148|NCT01302847|39526375|FG002|Overall Study|Pregnancy|0|||
16285149|NCT01302847|39526376|FG003|Overall Study|Pregnancy|0|||
16285150|NCT01302847|39526377|FG004|Overall Study|Pregnancy|0|||
16285151|NCT01302847|39526378|FG005|Overall Study|Pregnancy|0|||
16285152|NCT01302847|39526379|FG006|Overall Study|Pregnancy|0|||
16285153|NCT01302847|39526380|FG007|Overall Study|Pregnancy|0|||
16285154|NCT01302847|39526373|FG000|Overall Study|Virologic failure|0|||
16285155|NCT01302847|39526374|FG001|Overall Study|Virologic failure|2|||
16285156|NCT01302847|39526375|FG002|Overall Study|Virologic failure|2|||
16285157|NCT01302847|39526376|FG003|Overall Study|Virologic failure|0|||
16285158|NCT01302847|39526377|FG004|Overall Study|Virologic failure|1|||
16285159|NCT01302847|39526378|FG005|Overall Study|Virologic failure|1|||
16285160|NCT01302847|39526379|FG006|Overall Study|Virologic failure|0|||
16285161|NCT01302847|39526380|FG007|Overall Study|Virologic failure|2|||
16285162|NCT01302847|39526373|FG000|Overall Study|Severe debilitation, unable to continue|0|||
16285163|NCT01302847|39526374|FG001|Overall Study|Severe debilitation, unable to continue|0|||
16285164|NCT01302847|39526375|FG002|Overall Study|Severe debilitation, unable to continue|0|||
16285165|NCT01302847|39526376|FG003|Overall Study|Severe debilitation, unable to continue|0|||
16285166|NCT01302847|39526377|FG004|Overall Study|Severe debilitation, unable to continue|0|||
16285167|NCT01302847|39526378|FG005|Overall Study|Severe debilitation, unable to continue|1|||
16285168|NCT01302847|39526379|FG006|Overall Study|Severe debilitation, unable to continue|1|||
16285169|NCT01302847|39526380|FG007|Overall Study|Severe debilitation, unable to continue|0|||
16285170|NCT01302847|39526373|FG000|Overall Study|Not able to get to clinic|1|||
16285171|NCT01302847|39526374|FG001|Overall Study|Not able to get to clinic|1|||
16285172|NCT01302847|39526375|FG002|Overall Study|Not able to get to clinic|0|||
16285173|NCT01302847|39526376|FG003|Overall Study|Not able to get to clinic|0|||
16285174|NCT01302847|39526377|FG004|Overall Study|Not able to get to clinic|0|||
16285175|NCT01302847|39526378|FG005|Overall Study|Not able to get to clinic|0|||
16285176|NCT01302847|39526379|FG006|Overall Study|Not able to get to clinic|0|||
16285177|NCT01302847|39526380|FG007|Overall Study|Not able to get to clinic|0|||
16285178|NCT01302847|39526373|FG000|Overall Study|Site closing|2|||
16285179|NCT01302847|39526374|FG001|Overall Study|Site closing|2|||
16285180|NCT01302847|39526375|FG002|Overall Study|Site closing|0|||
16285181|NCT01302847|39526376|FG003|Overall Study|Site closing|0|||
16285182|NCT01302847|39526377|FG004|Overall Study|Site closing|0|||
16285183|NCT01302847|39526378|FG005|Overall Study|Site closing|0|||
16285184|NCT01302847|39526379|FG006|Overall Study|Site closing|0|||
16285185|NCT01302847|39526380|FG007|Overall Study|Site closing|0|||
16480456|NCT02405780|40238261|FG003|Period II|Pregnancy|0|||
16285186|NCT01302847|39526373|FG000|Overall Study|Withdrawal by Subject|1|||
16285187|NCT01302847|39526374|FG001|Overall Study|Withdrawal by Subject|0|||
16285188|NCT01302847|39526375|FG002|Overall Study|Withdrawal by Subject|0|||
16285189|NCT01302847|39526376|FG003|Overall Study|Withdrawal by Subject|0|||
16285190|NCT01302847|39526377|FG004|Overall Study|Withdrawal by Subject|1|||
16285191|NCT01302847|39526378|FG005|Overall Study|Withdrawal by Subject|0|||
16285192|NCT01302847|39526379|FG006|Overall Study|Withdrawal by Subject|0|||
16285193|NCT01302847|39526380|FG007|Overall Study|Withdrawal by Subject|1|||
16285194|NCT01302847|39526373|FG000|Overall Study|Not willing to adhere to requirements|5|||
16285195|NCT01302847|39526374|FG001|Overall Study|Not willing to adhere to requirements|0|||
16285196|NCT01302847|39526375|FG002|Overall Study|Not willing to adhere to requirements|0|||
16285197|NCT01302847|39526376|FG003|Overall Study|Not willing to adhere to requirements|1|||
16285198|NCT01302847|39526377|FG004|Overall Study|Not willing to adhere to requirements|0|||
16285199|NCT01302847|39526378|FG005|Overall Study|Not willing to adhere to requirements|0|||
16285200|NCT01302847|39526379|FG006|Overall Study|Not willing to adhere to requirements|0|||
16285201|NCT01302847|39526380|FG007|Overall Study|Not willing to adhere to requirements|2|||
16285202|NCT01302847|39526373|FG000|Overall Study|Site unable to contact participant|2|||
16285203|NCT01302847|39526374|FG001|Overall Study|Site unable to contact participant|1|||
16285204|NCT01302847|39526375|FG002|Overall Study|Site unable to contact participant|0|||
16285205|NCT01302847|39526376|FG003|Overall Study|Site unable to contact participant|0|||
16285206|NCT01302847|39526377|FG004|Overall Study|Site unable to contact participant|0|||
16285207|NCT01302847|39526378|FG005|Overall Study|Site unable to contact participant|0|||
16285208|NCT01302847|39526379|FG006|Overall Study|Site unable to contact participant|2|||
16285209|NCT01302847|39526380|FG007|Overall Study|Site unable to contact participant|0|||
16285210|NCT04241133|39526381|FG000|Overall Study|COVID19 Precautions|14|||
16285211|NCT04241133|39526382|FG001|Overall Study|COVID19 Precautions|34|||
16285212|NCT02843659|39526383|FG000|Overall Study|Subject Withdrew Consent|0|||
16285213|NCT02843659|39526384|FG001|Overall Study|Subject Withdrew Consent|0|||
16285214|NCT02843659|39526385|FG002|Overall Study|Subject Withdrew Consent|1|||
16285215|NCT02843659|39526383|FG000|Overall Study|Administrative Reason by Sponsor|4|||
16285216|NCT02843659|39526384|FG001|Overall Study|Administrative Reason by Sponsor|5|||
16285217|NCT02843659|39526385|FG002|Overall Study|Administrative Reason by Sponsor|4|||
16285218|NCT02843659|39526383|FG000|Overall Study|Adverse Event|0|||
16285219|NCT02843659|39526384|FG001|Overall Study|Adverse Event|1|||
16285220|NCT02843659|39526385|FG002|Overall Study|Adverse Event|0|||
16285221|NCT02087176|39526386|FG000|Overall Study|Withdrawal by Subject|1|||
16285222|NCT02087176|39526386|FG000|Overall Study|Death|10|||
16285223|NCT02087176|39526386|FG000|Overall Study|Censored|19|||
16285224|NCT02087176|39526386|FG000|Overall Study|Study Terminated by Sponsor|2|||
16285225|NCT02858726|39526388|FG000|Overall Study|Adverse Event|4|||
16285226|NCT02858726|39526389|FG001|Overall Study|Adverse Event|4|||
16285227|NCT02858726|39526390|FG002|Overall Study|Adverse Event|9|||
16285228|NCT02858726|39526391|FG003|Overall Study|Adverse Event|1|||
16285229|NCT02858726|39526388|FG000|Overall Study|Physician Decision|0|||
16285230|NCT02858726|39526389|FG001|Overall Study|Physician Decision|0|||
16285231|NCT02858726|39526390|FG002|Overall Study|Physician Decision|1|||
16285232|NCT02858726|39526391|FG003|Overall Study|Physician Decision|0|||
16285233|NCT02858726|39526388|FG000|Overall Study|Protocol Violation|0|||
16285234|NCT02858726|39526389|FG001|Overall Study|Protocol Violation|0|||
16285235|NCT02858726|39526390|FG002|Overall Study|Protocol Violation|0|||
16285236|NCT02858726|39526391|FG003|Overall Study|Protocol Violation|1|||
16285237|NCT02858726|39526388|FG000|Overall Study|Study Terminated by Sponsor|0|||
16285238|NCT02858726|39526389|FG001|Overall Study|Study Terminated by Sponsor|0|||
16285239|NCT02858726|39526390|FG002|Overall Study|Study Terminated by Sponsor|0|||
16285240|NCT02858726|39526391|FG003|Overall Study|Study Terminated by Sponsor|1|||
16285241|NCT02858726|39526388|FG000|Overall Study|Withdrawal by Subject|1|||
16285242|NCT02858726|39526389|FG001|Overall Study|Withdrawal by Subject|2|||
16285243|NCT02858726|39526390|FG002|Overall Study|Withdrawal by Subject|1|||
16285244|NCT02858726|39526391|FG003|Overall Study|Withdrawal by Subject|0|||
16285245|NCT02858726|39526388|FG000|Overall Study|Noncompliance|0|||
16285246|NCT02858726|39526389|FG001|Overall Study|Noncompliance|1|||
16285247|NCT02858726|39526390|FG002|Overall Study|Noncompliance|0|||
16285248|NCT02858726|39526391|FG003|Overall Study|Noncompliance|0|||
16285249|NCT02070757|39526392|FG000|Overall Study|Adverse Event|107|||
16285250|NCT02070757|39526393|FG001|Overall Study|Adverse Event|99|||
16285251|NCT02070757|39526392|FG000|Overall Study|Lost to Follow-up|7|||
16285252|NCT02070757|39526393|FG001|Overall Study|Lost to Follow-up|4|||
16285253|NCT02070757|39526392|FG000|Overall Study|Protocol Violation|0|||
16285254|NCT02070757|39526393|FG001|Overall Study|Protocol Violation|4|||
16285255|NCT02070757|39526392|FG000|Overall Study|Withdrawal by Subject|1|||
16285256|NCT02070757|39526393|FG001|Overall Study|Withdrawal by Subject|3|||
16285257|NCT02070757|39526392|FG000|Overall Study|Investigator Decision|0|||
16285258|NCT02070757|39526393|FG001|Overall Study|Investigator Decision|2|||
16285259|NCT02070757|39526392|FG000|Overall Study|Discharged from Study Hospital|2|||
16285260|NCT02070757|39526393|FG001|Overall Study|Discharged from Study Hospital|2|||
16285261|NCT02701413|39526394|FG000|Overall Study|Withdrawal by Subject|7|||
16285262|NCT02701413|39526395|FG001|Overall Study|Withdrawal by Subject|11|||
16285263|NCT05016622|39526399|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
16285264|NCT05016622|39526399|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
16285265|NCT03903159|39526402|FG000|Overall Study|Discharged with Staff Approval|2|||
16285266|NCT03903159|39526402|FG000|Overall Study|Discharged at Staff Request|2|||
16285267|NCT03903159|39526402|FG000|Overall Study|Discharged Against Staff Advice|1|||
16285268|NCT00708708|39526403|FG000|Overall Study|Another therapy instead of Enbrel|141|||
16285269|NCT00708708|39526403|FG000|Overall Study|Lost to Follow-up|52|||
16285270|NCT00708708|39526403|FG000|Overall Study|Withdrawal by Subject|51|||
16285271|NCT00708708|39526403|FG000|Overall Study|Intolerance|42|||
16285272|NCT00708708|39526403|FG000|Overall Study|Another therapy along with Enbrel|15|||
16285273|NCT00708708|39526403|FG000|Overall Study|Other unspecified|11|||
16285274|NCT00708708|39526403|FG000|Overall Study|Good effectiveness|9|||
16285275|NCT00708708|39526403|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
16285276|NCT00708708|39526403|FG000|Overall Study|Administrative reasons|7|||
16285277|NCT00708708|39526403|FG000|Overall Study|Lack of effectiveness|4|||
16285278|NCT00708708|39526403|FG000|Overall Study|Lack of compliance|3|||
16285279|NCT00708708|39526403|FG000|Overall Study|Pregnancy|3|||
16285280|NCT00708708|39526403|FG000|Overall Study|Adverse Event|3|||
16285281|NCT00708708|39526403|FG000|Overall Study|Missing values|392|||
16285282|NCT03978091|39526406|FG000|Overall Study|Lost to Follow-up|0|||
16285283|NCT03978091|39526407|FG001|Overall Study|Lost to Follow-up|0|||
16285284|NCT03978091|39526408|FG002|Overall Study|Lost to Follow-up|1|||
16285285|NCT03978091|39526409|FG003|Overall Study|Lost to Follow-up|0|||
16285286|NCT03978091|39526410|FG004|Overall Study|Lost to Follow-up|0|||
16285287|NCT03978091|39526411|FG005|Overall Study|Lost to Follow-up|0|||
16285288|NCT03978091|39526406|FG000|Overall Study|Withdrawal by Subject|0|||
16285289|NCT03978091|39526407|FG001|Overall Study|Withdrawal by Subject|0|||
16285290|NCT03978091|39526408|FG002|Overall Study|Withdrawal by Subject|0|||
16285291|NCT03978091|39526409|FG003|Overall Study|Withdrawal by Subject|1|||
16285292|NCT03978091|39526410|FG004|Overall Study|Withdrawal by Subject|1|||
16285293|NCT03978091|39526411|FG005|Overall Study|Withdrawal by Subject|0|||
16285294|NCT01546142|39526412|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
16285295|NCT01546142|39526413|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
16285296|NCT01546142|39526412|FG000|Overall Study|Subject Noncompliance|1|||
16285297|NCT01546142|39526413|FG001|Overall Study|Subject Noncompliance|1|||
16285298|NCT01546142|39526412|FG000|Overall Study|Adverse Event|6|||
16285299|NCT01546142|39526413|FG001|Overall Study|Adverse Event|3|||
16285300|NCT01546142|39526412|FG000|Overall Study|Lost to Follow-up|20|||
16285301|NCT01546142|39526413|FG001|Overall Study|Lost to Follow-up|15|||
16285302|NCT01546142|39526412|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
16285303|NCT01546142|39526413|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
16285304|NCT01546142|39526412|FG000|Overall Study|Subject Randomized but Not Treated|1|||
16285305|NCT01546142|39526413|FG001|Overall Study|Subject Randomized but Not Treated|0|||
16285306|NCT00852917|39526416|FG000|Overall Study|Adverse Event|13|||
16285307|NCT00852917|39526417|FG001|Overall Study|Adverse Event|20|||
16285308|NCT00852917|39526418|FG002|Overall Study|Adverse Event|35|||
16285309|NCT00852917|39526419|FG003|Overall Study|Adverse Event|17|||
16285310|NCT00852917|39526416|FG000|Overall Study|Lack of Efficacy|21|||
16285311|NCT00852917|39526417|FG001|Overall Study|Lack of Efficacy|11|||
16285312|NCT00852917|39526418|FG002|Overall Study|Lack of Efficacy|11|||
16285313|NCT00852917|39526419|FG003|Overall Study|Lack of Efficacy|47|||
16285314|NCT00852917|39526416|FG000|Overall Study|Withdrawal by Subject|4|||
16285315|NCT00852917|39526417|FG001|Overall Study|Withdrawal by Subject|8|||
16285316|NCT00852917|39526418|FG002|Overall Study|Withdrawal by Subject|10|||
16285317|NCT00852917|39526419|FG003|Overall Study|Withdrawal by Subject|9|||
16285318|NCT00852917|39526416|FG000|Overall Study|Physician Decision|6|||
16285319|NCT00852917|39526417|FG001|Overall Study|Physician Decision|7|||
16285320|NCT00852917|39526418|FG002|Overall Study|Physician Decision|2|||
16285321|NCT00852917|39526419|FG003|Overall Study|Physician Decision|19|||
16285322|NCT00852917|39526416|FG000|Overall Study|Death|0|||
16285323|NCT00852917|39526417|FG001|Overall Study|Death|0|||
16285324|NCT00852917|39526418|FG002|Overall Study|Death|0|||
16285325|NCT00852917|39526419|FG003|Overall Study|Death|1|||
16285326|NCT01640184|39526420|FG000|Overall Study|Death|1|||
16285327|NCT01640184|39526421|FG001|Overall Study|Death|0|||
16285328|NCT01640184|39526422|FG002|Overall Study|Death|0|||
16285329|NCT01640184|39526420|FG000|Overall Study|Lost to Follow-up|4|||
16285330|NCT01640184|39526421|FG001|Overall Study|Lost to Follow-up|1|||
16285331|NCT01640184|39526422|FG002|Overall Study|Lost to Follow-up|0|||
16285332|NCT01640184|39526420|FG000|Overall Study|Physician Decision|3|||
16285333|NCT01640184|39526421|FG001|Overall Study|Physician Decision|0|||
16285334|NCT01640184|39526422|FG002|Overall Study|Physician Decision|0|||
16480457|NCT02405780|40238258|FG000|Period II|Withdrawal by Subject|7|||
16285335|NCT01640184|39526420|FG000|Overall Study|Withdrawal by Subject|0|||
16285336|NCT01640184|39526421|FG001|Overall Study|Withdrawal by Subject|1|||
16480458|NCT02405780|40238259|FG001|Period II|Withdrawal by Subject|4|||
16285337|NCT01640184|39526422|FG002|Overall Study|Withdrawal by Subject|1|||
16285338|NCT01640184|39526420|FG000|Overall Study|Protocol Violation|0|||
16285339|NCT01640184|39526421|FG001|Overall Study|Protocol Violation|0|||
16285340|NCT01640184|39526422|FG002|Overall Study|Protocol Violation|1|||
16285341|NCT01553747|39526423|FG000|Overall Study|Protocol Violation|0|||
16285342|NCT01553747|39526424|FG001|Overall Study|Protocol Violation|2|||
16285343|NCT01553747|39526425|FG002|Overall Study|Protocol Violation|0|||
16285344|NCT01553747|39526423|FG000|Overall Study|Voluntarily withdrew|70|||
16285345|NCT01553747|39526424|FG001|Overall Study|Voluntarily withdrew|66|||
16285346|NCT01553747|39526425|FG002|Overall Study|Voluntarily withdrew|74|||
16285347|NCT01553747|39526423|FG000|Overall Study|Adverse event or SAE|32|||
16285348|NCT01553747|39526424|FG001|Overall Study|Adverse event or SAE|28|||
16285349|NCT01553747|39526425|FG002|Overall Study|Adverse event or SAE|19|||
16285350|NCT01553747|39526423|FG000|Overall Study|Physician decision: other|10|||
16285351|NCT01553747|39526424|FG001|Overall Study|Physician decision: other|8|||
16285352|NCT01553747|39526425|FG002|Overall Study|Physician decision: other|7|||
16285353|NCT01553747|39526423|FG000|Overall Study|Lost to Follow-up|11|||
16285354|NCT01553747|39526424|FG001|Overall Study|Lost to Follow-up|5|||
16285355|NCT01553747|39526425|FG002|Overall Study|Lost to Follow-up|6|||
16285356|NCT01553747|39526423|FG000|Overall Study|Sponsor decision, specify|7|||
16285357|NCT01553747|39526424|FG001|Overall Study|Sponsor decision, specify|5|||
16285358|NCT01553747|39526425|FG002|Overall Study|Sponsor decision, specify|0|||
16285359|NCT01553747|39526423|FG000|Overall Study|Physician decision: lack of efficacy|1|||
16285360|NCT01553747|39526424|FG001|Overall Study|Physician decision: lack of efficacy|5|||
16285361|NCT01553747|39526425|FG002|Overall Study|Physician decision: lack of efficacy|3|||
16285362|NCT01933919|39526426|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
16285363|NCT01933919|39526427|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
16285364|NCT01933919|39526426|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
16285365|NCT01933919|39526427|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
16285366|NCT01933919|39526426|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
16285367|NCT01933919|39526427|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
16285368|NCT01933919|39526426|FG000|Open-label Long-term Phase|Adverse Event|2|||
16285369|NCT01933919|39526427|FG001|Open-label Long-term Phase|Adverse Event|0|||
16285370|NCT01933919|39526426|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
16285371|NCT01933919|39526427|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
16285372|NCT01933919|39526426|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
16285373|NCT01933919|39526427|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
16285374|NCT01933919|39526426|FG000|Open-label Long-term Phase|Other|1|||
16285375|NCT01933919|39526427|FG001|Open-label Long-term Phase|Other|2|||
16285376|NCT02429934|39526428|FG000|Overall Study|Withdrawal by Subject|0|||
16285377|NCT02429934|39526429|FG001|Overall Study|Withdrawal by Subject|2|||
16285378|NCT02429934|39526428|FG000|Overall Study|Adverse Event|2|||
16285379|NCT02429934|39526429|FG001|Overall Study|Adverse Event|0|||
16285380|NCT02429934|39526428|FG000|Overall Study|Lost to Follow-up|1|||
16285381|NCT02429934|39526429|FG001|Overall Study|Lost to Follow-up|1|||
16285382|NCT02429934|39526428|FG000|Overall Study|Physician Decision|1|||
16285383|NCT02429934|39526429|FG001|Overall Study|Physician Decision|0|||
16285384|NCT04932941|39529777|FG000|Overall Study|Lost to Follow-up|3|||
16285385|NCT04932941|39529778|FG001|Overall Study|Lost to Follow-up|1|||
16285386|NCT04932941|39529777|FG000|Overall Study|Withdrawal by Subject|7|||
16285387|NCT04932941|39529778|FG001|Overall Study|Withdrawal by Subject|4|||
16285388|NCT04932941|39529777|FG000|Overall Study|Other|4|||
16480459|NCT02405780|40238260|FG002|Period II|Withdrawal by Subject|0|||
16480460|NCT02405780|40238261|FG003|Period II|Withdrawal by Subject|3|||
16480461|NCT02405780|40238258|FG000|Period II|Non-compliance with study procedures|5|||
16480462|NCT02405780|40238259|FG001|Period II|Non-compliance with study procedures|2|||
16480463|NCT02405780|40238260|FG002|Period II|Non-compliance with study procedures|7|||
16285389|NCT04932941|39529778|FG001|Overall Study|Other|2|||
16285390|NCT02492841|39529779|FG000|Overall Study|Lost to Follow-up|34|||
16285391|NCT02492841|39529780|FG001|Overall Study|Lost to Follow-up|31|||
16285392|NCT02492841|39529781|FG002|Overall Study|Lost to Follow-up|35|||
16285393|NCT01371994|39529782|FG000|Overall Study|Adverse Event|3|||
16285394|NCT01371994|39529783|FG001|Overall Study|Adverse Event|6|||
16285395|NCT01371994|39529782|FG000|Overall Study|Lack of Efficacy|3|||
16480464|NCT02405780|40238261|FG003|Period II|Non-compliance with study procedures|4|||
16480465|NCT04289623|40238264|FG000|Wave 1 Emails|Email was not delivered|268|||
16285396|NCT01371994|39529783|FG001|Overall Study|Lack of Efficacy|0|||
16285397|NCT01371994|39529782|FG000|Overall Study|Withdrawal by Subject|13|||
16285398|NCT01371994|39529783|FG001|Overall Study|Withdrawal by Subject|7|||
16285399|NCT01371994|39529782|FG000|Overall Study|Lost to Follow-up|1|||
16285400|NCT01371994|39529783|FG001|Overall Study|Lost to Follow-up|1|||
16285401|NCT01371994|39529782|FG000|Overall Study|Protocol Violation|24|||
16285402|NCT01371994|39529783|FG001|Overall Study|Protocol Violation|17|||
16285403|NCT01371994|39529782|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
16285404|NCT01371994|39529783|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
16285405|NCT01371994|39529782|FG000|Overall Study|Physician Decision|1|||
16285406|NCT01371994|39529783|FG001|Overall Study|Physician Decision|1|||
16285407|NCT01371994|39529782|FG000|Overall Study|Miscellaneous Reasons|6|||
16285408|NCT01371994|39529783|FG001|Overall Study|Miscellaneous Reasons|4|||
16285409|NCT02502734|39529787|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
16285410|NCT02502734|39529788|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
16285411|NCT02502734|39529787|FG000|Washout Period|Adverse Event|1|||
16285412|NCT02502734|39529788|FG001|Washout Period|Adverse Event|0|||
16285413|NCT04025684|39529791|FG000|Overall Study|Withdrawal by Subject|1|||
16285414|NCT04025684|39529792|FG001|Overall Study|Withdrawal by Subject|1|||
16285415|NCT04025684|39529793|FG002|Overall Study|Withdrawal by Subject|0|||
16285416|NCT04025684|39529794|FG003|Overall Study|Withdrawal by Subject|0|||
16285417|NCT04025684|39529791|FG000|Overall Study|Multiple reasons|1|||
16285418|NCT04025684|39529792|FG001|Overall Study|Multiple reasons|3|||
16285419|NCT04025684|39529793|FG002|Overall Study|Multiple reasons|0|||
16285420|NCT04025684|39529794|FG003|Overall Study|Multiple reasons|1|||
16285421|NCT02674386|39529796|FG000|Overall Study|Lost to Follow-up|0|||
16285422|NCT02674386|39529797|FG001|Overall Study|Lost to Follow-up|1|||
16285423|NCT02674386|39529798|FG002|Overall Study|Lost to Follow-up|1|||
16285424|NCT02674386|39529796|FG000|Overall Study|Withdrawal by Subject|0|||
16285425|NCT02674386|39529797|FG001|Overall Study|Withdrawal by Subject|4|||
16285426|NCT02674386|39529798|FG002|Overall Study|Withdrawal by Subject|0|||
16285427|NCT02674386|39529796|FG000|Overall Study|Other|0|||
16285428|NCT02674386|39529797|FG001|Overall Study|Other|1|||
16285429|NCT02674386|39529798|FG002|Overall Study|Other|0|||
16285430|NCT02674386|39529796|FG000|Overall Study|Enrolled but not evaluated|0|||
16285431|NCT02674386|39529797|FG001|Overall Study|Enrolled but not evaluated|4|||
16285432|NCT02674386|39529798|FG002|Overall Study|Enrolled but not evaluated|0|||
16285433|NCT03827018|39529799|FG000|Overall Study|Adverse Event|1|||
16285434|NCT03827018|39529800|FG001|Overall Study|Adverse Event|0|||
16285435|NCT03827018|39529799|FG000|Overall Study|Withdrawal by Subject|2|||
16285436|NCT03827018|39529800|FG001|Overall Study|Withdrawal by Subject|2|||
16285437|NCT03827018|39529799|FG000|Overall Study|Lack of Efficacy|0|||
16285438|NCT03827018|39529800|FG001|Overall Study|Lack of Efficacy|1|||
16285439|NCT00493454|39529803|FG000|Overall Study|Withdrawal by Subject|1|||
16285440|NCT05855616|39529804|FG000|Overall Study|Lost to Follow-up|1|||
16285441|NCT05855616|39529805|FG001|Overall Study|Lost to Follow-up|2|||
16285442|NCT01435031|39529808|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
16285443|NCT01435031|39529808|FG000|ITT at 1 Month|Death|1|||
16285444|NCT01435031|39529808|FG000|ITT at 1 Month|Lost to Follow-up|4|||
16285445|NCT01435031|39529808|FG000|ITT at 6 Months|Death|2|||
16285446|NCT01435031|39529808|FG000|ITT at 6 Months|Lost to Follow-up|3|||
16285447|NCT01435031|39529808|FG000|ITT at 1 Year|Death|1|||
16285448|NCT01435031|39529808|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
16285449|NCT01435031|39529808|FG000|ITT at 1 Year|Lost to Follow-up|6|||
16285450|NCT01435031|39529808|FG000|ITT at 2 Years|Death|7|||
16285451|NCT01435031|39529808|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
16285452|NCT01435031|39529808|FG000|ITT at 2 Years|Lost to Follow-up|4|||
16285453|NCT01435031|39529808|FG000|ITT at 3 Years|Death|5|||
16285454|NCT01435031|39529808|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
16285455|NCT01435031|39529808|FG000|ITT at 3 Years|Lost to Follow-up|4|||
16285456|NCT01435031|39529808|FG000|ITT at 4 Years|Death|4|||
16285457|NCT01435031|39529808|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
16285458|NCT01435031|39529808|FG000|ITT at 4 Years|Lost to Follow-up|1|||
16285459|NCT03336242|39529810|FG000|Overall Study|Adverse Event|0|||
16285460|NCT03336242|39529811|FG001|Overall Study|Adverse Event|1|||
16285461|NCT02356211|39529812|FG000|Overall Study|Withdrawal by Subject|2|||
16285462|NCT02356211|39529813|FG001|Overall Study|Withdrawal by Subject|2|||
16285463|NCT02356211|39529812|FG000|Overall Study|ineligible|1|||
16285464|NCT02356211|39529813|FG001|Overall Study|ineligible|8|||
16285465|NCT01546649|39529816|FG000|Overall Study|Adverse Event|4|||
16285466|NCT01546649|39529817|FG001|Overall Study|Adverse Event|5|||
16285467|NCT01546649|39529816|FG000|Overall Study|Protocol Violation|1|||
16285468|NCT01546649|39529817|FG001|Overall Study|Protocol Violation|0|||
16285469|NCT01546649|39529816|FG000|Overall Study|Lack of Efficacy|1|||
16285470|NCT01546649|39529817|FG001|Overall Study|Lack of Efficacy|0|||
16285471|NCT01546649|39529816|FG000|Overall Study|Recurrence|1|||
16285472|NCT01546649|39529817|FG001|Overall Study|Recurrence|1|||
16285473|NCT01546649|39529816|FG000|Overall Study|Discovery of secondary cancer|0|||
16285474|NCT01546649|39529817|FG001|Overall Study|Discovery of secondary cancer|1|||
16285475|NCT01546649|39529816|FG000|Overall Study|Withdrawal by Subject|1|||
16285476|NCT01546649|39529817|FG001|Overall Study|Withdrawal by Subject|2|||
16285477|NCT00702208|39529818|FG000|Overall Study|Lost to Follow-up|28|||
16285478|NCT00702208|39529818|FG000|Overall Study|Did not self-lavage|1|||
16285479|NCT00702208|39529818|FG000|Overall Study|Unsatisfactory colposcopy|2|||
16285480|NCT03653026|39529826|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
16285481|NCT03653026|39529827|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
16285482|NCT03653026|39529828|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
16285483|NCT03653026|39529829|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
16285484|NCT03653026|39529826|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
16285485|NCT03653026|39529827|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
16285486|NCT03653026|39529828|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
16285487|NCT03653026|39529829|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
16285488|NCT03653026|39529826|FG000|Part 1: Placebo-controlled Period|Other|0|||
16285489|NCT03653026|39529827|FG001|Part 1: Placebo-controlled Period|Other|3|||
16285490|NCT03653026|39529828|FG002|Part 1: Placebo-controlled Period|Other|0|||
16285491|NCT03653026|39529829|FG003|Part 1: Placebo-controlled Period|Other|0|||
16285492|NCT03653026|39529826|FG000|Part 2: Open-label Extension|Adverse Event|0|||
16285493|NCT03653026|39529827|FG001|Part 2: Open-label Extension|Adverse Event|0|||
16285494|NCT03653026|39529828|FG002|Part 2: Open-label Extension|Adverse Event|1|||
16285495|NCT03653026|39529829|FG003|Part 2: Open-label Extension|Adverse Event|1|||
16285496|NCT03653026|39529826|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
16285497|NCT03653026|39529827|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
16285498|NCT03653026|39529828|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
16285499|NCT03653026|39529829|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
16285500|NCT03653026|39529826|FG000|Part 2: Open-label Extension|Other|0|||
16285501|NCT03653026|39529827|FG001|Part 2: Open-label Extension|Other|0|||
16285502|NCT03653026|39529828|FG002|Part 2: Open-label Extension|Other|1|||
16285503|NCT03653026|39529829|FG003|Part 2: Open-label Extension|Other|2|||
16285504|NCT01583218|39529830|FG000|Overall Study|Withdrawal by Subject|43|||
16285505|NCT01583218|39529831|FG001|Overall Study|Withdrawal by Subject|29|||
16285506|NCT01583218|39529830|FG000|Overall Study|Death|206|||
16285507|NCT01583218|39529831|FG001|Overall Study|Death|211|||
16285508|NCT01583218|39529830|FG000|Overall Study|Lost to Follow-up|11|||
16285509|NCT01583218|39529831|FG001|Overall Study|Lost to Follow-up|17|||
16285510|NCT01583218|39529830|FG000|Overall Study|Adverse event or serious adverse event|3|||
16285511|NCT01583218|39529831|FG001|Overall Study|Adverse event or serious adverse event|3|||
16285512|NCT01583218|39529830|FG000|Overall Study|Patient /Family decision|3|||
16285513|NCT01583218|39529831|FG001|Overall Study|Patient /Family decision|0|||
16285514|NCT01583218|39529830|FG000|Overall Study|Cannot contact patient directly|1|||
16285515|NCT01583218|39529831|FG001|Overall Study|Cannot contact patient directly|2|||
16285516|NCT01583218|39529830|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
16285517|NCT01583218|39529831|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
16285518|NCT01583218|39529830|FG000|Overall Study|Patient did not wish to attend visits|0|||
16285519|NCT01583218|39529831|FG001|Overall Study|Patient did not wish to attend visits|1|||
16285520|NCT01583218|39529830|FG000|Overall Study|Patient randomized but not dosed|17|||
16285521|NCT01583218|39529831|FG001|Overall Study|Patient randomized but not dosed|16|||
16285522|NCT01583218|39529830|FG000|Overall Study|Patient was assessed via phone in person|1|||
16285523|NCT01583218|39529831|FG001|Overall Study|Patient was assessed via phone in person|0|||
16285524|NCT01583218|39529830|FG000|Overall Study|Patient deemed ineligible after random|2|||
16285525|NCT01583218|39529831|FG001|Overall Study|Patient deemed ineligible after random|0|||
16285526|NCT01583218|39529830|FG000|Overall Study|Patient was early terminated from study|0|||
16285527|NCT01583218|39529831|FG001|Overall Study|Patient was early terminated from study|1|||
16285528|NCT01583218|39529830|FG000|Overall Study|Patient was randomized due to mistake|1|||
16285529|NCT01583218|39529831|FG001|Overall Study|Patient was randomized due to mistake|0|||
16285530|NCT01583218|39529830|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
16285531|NCT01583218|39529831|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
16285532|NCT01583218|39529830|FG000|Overall Study|Withdraw of consent on day of random|1|||
16285533|NCT01583218|39529831|FG001|Overall Study|Withdraw of consent on day of random|0|||
16285534|NCT02953678|39529832|FG000|Overall Study|Adverse Event|20|||
16285535|NCT02953678|39529832|FG000|Overall Study|Death|7|||
16285536|NCT02953678|39529832|FG000|Overall Study|Physician Decision|23|||
16285537|NCT02953678|39529832|FG000|Overall Study|Progressive Disease of GVHD|7|||
16285538|NCT02953678|39529832|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
16285539|NCT02953678|39529832|FG000|Overall Study|Withdrawal by participant|3|||
16285540|NCT02953678|39529832|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
16285541|NCT02953678|39529832|FG000|Overall Study|Participants were transferred to commercial product.|3|||
16285542|NCT03919448|39529833|FG000|Overall Study|Withdrawal by Subject|1|||
16285543|NCT03919448|39529834|FG001|Overall Study|Withdrawal by Subject|0|||
16285544|NCT03919448|39529835|FG002|Overall Study|Withdrawal by Subject|0|||
16285545|NCT02450526|39529836|FG000|DB Period (Cycle 1)|Adverse Event|0|||
16285546|NCT02450526|39529837|FG001|DB Period (Cycle 1)|Adverse Event|0|||
16285547|NCT02450526|39529838|FG002|DB Period (Cycle 1)|Adverse Event|2|||
16285548|NCT02450526|39529839|FG003|DB Period (Cycle 1)|Adverse Event|0|||
16285549|NCT02450526|39529840|FG004|DB Period (Cycle 1)|Adverse Event|0|||
16285550|NCT02450526|39529836|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
16285551|NCT02450526|39529837|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
16285552|NCT02450526|39529838|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
16285553|NCT02450526|39529839|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
16285554|NCT02450526|39529840|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
16285555|NCT02450526|39529836|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
16285556|NCT02450526|39529837|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
16285557|NCT02450526|39529838|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
16285558|NCT02450526|39529839|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
16285559|NCT02450526|39529840|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
16285560|NCT02450526|39529836|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
16285561|NCT02450526|39529837|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
16285562|NCT02450526|39529838|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
16285563|NCT02450526|39529839|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
16285564|NCT02450526|39529840|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
16285565|NCT02450526|39529836|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
16285566|NCT02450526|39529837|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
16285567|NCT02450526|39529838|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
16285568|NCT02450526|39529839|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
16285569|NCT02450526|39529840|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
16285570|NCT02450526|39529836|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
16285571|NCT02450526|39529837|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
16285572|NCT02450526|39529838|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
16285573|NCT02450526|39529839|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
16285574|NCT02450526|39529840|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
16285575|NCT02450526|39529836|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
16285576|NCT02450526|39529837|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
16285577|NCT02450526|39529838|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
16285578|NCT02450526|39529839|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
16285579|NCT02450526|39529840|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
16285580|NCT02450526|39529836|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
16285581|NCT02450526|39529837|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
16285582|NCT02450526|39529838|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
16285583|NCT02450526|39529839|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
16285584|NCT02450526|39529840|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
16285585|NCT01020799|39529842|FG000|Overall Study|Adverse Event|4|||
16285586|NCT01020799|39529843|FG001|Overall Study|Adverse Event|3|||
16285587|NCT01020799|39529844|FG002|Overall Study|Adverse Event|2|||
16285588|NCT01020799|39529842|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
16285589|NCT01020799|39529843|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
16285590|NCT01020799|39529844|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
16285591|NCT01020799|39529842|FG000|Overall Study|Protocol Violation|3|||
16285592|NCT01020799|39529843|FG001|Overall Study|Protocol Violation|2|||
16285593|NCT01020799|39529844|FG002|Overall Study|Protocol Violation|0|||
16285594|NCT01020799|39529842|FG000|Overall Study|Withdrawal by Subject|2|||
16285595|NCT01020799|39529843|FG001|Overall Study|Withdrawal by Subject|2|||
16285596|NCT01020799|39529844|FG002|Overall Study|Withdrawal by Subject|3|||
16285597|NCT01020799|39529842|FG000|Overall Study|Lost to Follow-up|6|||
16285598|NCT01020799|39529843|FG001|Overall Study|Lost to Follow-up|4|||
16285599|NCT01020799|39529844|FG002|Overall Study|Lost to Follow-up|2|||
16285600|NCT00248170|39529845|FG000|Overall Study|Withdrawal by Subject|71|||
16285601|NCT00248170|39529846|FG001|Overall Study|Withdrawal by Subject|79|||
16285602|NCT00248170|39529845|FG000|Overall Study|Protocol Violation|35|||
16285603|NCT00248170|39529846|FG001|Overall Study|Protocol Violation|30|||
16285604|NCT00248170|39529845|FG000|Overall Study|Lost to Follow-up|28|||
16285605|NCT00248170|39529846|FG001|Overall Study|Lost to Follow-up|35|||
16285606|NCT00248170|39529845|FG000|Overall Study|Disease progression|196|||
16285607|NCT00248170|39529846|FG001|Overall Study|Disease progression|216|||
16285608|NCT00248170|39529845|FG000|Overall Study|Death|28|||
16285609|NCT00248170|39529846|FG001|Overall Study|Death|47|||
16285610|NCT00248170|39529845|FG000|Overall Study|Adverse Event|311|||
16285611|NCT00248170|39529846|FG001|Overall Study|Adverse Event|296|||
16285612|NCT00248170|39529845|FG000|Overall Study|Administrative problems|22|||
16285613|NCT00248170|39529846|FG001|Overall Study|Administrative problems|25|||
16285614|NCT00248170|39529845|FG000|Overall Study|Abnormal test procedure(s) result|49|||
16285615|NCT00248170|39529846|FG001|Overall Study|Abnormal test procedure(s) result|61|||
16285616|NCT00248170|39529845|FG000|Overall Study|Abnormal laboratory values|4|||
16285617|NCT00248170|39529846|FG001|Overall Study|Abnormal laboratory values|0|||
16285618|NCT00248170|39529845|FG000|Overall Study|Protocol deviation|17|||
16285619|NCT00248170|39529846|FG001|Overall Study|Protocol deviation|19|||
16285620|NCT01010750|39529848|FG000|Second Intervention|Adverse Event|0|||
16285621|NCT01010750|39529849|FG001|Second Intervention|Adverse Event|1|||
16285622|NCT01010750|39529850|FG002|Second Intervention|Adverse Event|0|||
16285623|NCT01010750|39529851|FG003|Second Intervention|Adverse Event|0|||
16285624|NCT01010750|39529852|FG004|Second Intervention|Adverse Event|0|||
16285625|NCT01010750|39529853|FG005|Second Intervention|Adverse Event|0|||
16285626|NCT03212794|39529854|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
16285627|NCT03212794|39529855|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
16285628|NCT03212794|39529854|FG000|Overall Study|Lost to Follow-up|5|||
16285629|NCT03212794|39529855|FG001|Overall Study|Lost to Follow-up|6|||
16285630|NCT03212794|39529854|FG000|Overall Study|Incarcerated; unable to participate|2|||
16285631|NCT03212794|39529855|FG001|Overall Study|Incarcerated; unable to participate|0|||
16285632|NCT03212794|39529854|FG000|Overall Study|Withdrawal by Subject|1|||
16285633|NCT03212794|39529855|FG001|Overall Study|Withdrawal by Subject|0|||
16285634|NCT03212794|39529854|FG000|Overall Study|Death|0|||
16285635|NCT03212794|39529855|FG001|Overall Study|Death|1|||
16285636|NCT03212794|39529854|FG000|Overall Study|Found to be ineligible after allocation|0|||
16285637|NCT03212794|39529855|FG001|Overall Study|Found to be ineligible after allocation|1|||
16285638|NCT03212794|39529854|FG000|Overall Study|Relocated out of area|2|||
16285639|NCT03212794|39529855|FG001|Overall Study|Relocated out of area|0|||
16285640|NCT01232491|39529859|FG000|Overall Study|Adverse Event|13|||
16285641|NCT01232491|39529860|FG001|Overall Study|Adverse Event|8|||
16285642|NCT01232491|39529859|FG000|Overall Study|Lack of Efficacy|1|||
16285643|NCT01232491|39529860|FG001|Overall Study|Lack of Efficacy|5|||
16285644|NCT01232491|39529859|FG000|Overall Study|Protocol Violation|13|||
16285645|NCT01232491|39529860|FG001|Overall Study|Protocol Violation|11|||
16285646|NCT01232491|39529859|FG000|Overall Study|Withdrawal Criteria|12|||
16285647|NCT01232491|39529860|FG001|Overall Study|Withdrawal Criteria|21|||
16285648|NCT01232491|39529859|FG000|Overall Study|Other|21|||
16285649|NCT01232491|39529860|FG001|Overall Study|Other|18|||
16285650|NCT04675775|39529863|FG000|Overall Study|Withdrawal by Subject|7|||
16285651|NCT00518622|39529864|FG000|Overall Study|Lost to Follow-up|0|||
16285652|NCT00518622|39529865|FG001|Overall Study|Lost to Follow-up|0|||
16285653|NCT00518622|39529866|FG002|Overall Study|Lost to Follow-up|1|||
16285654|NCT00518622|39529867|FG003|Overall Study|Lost to Follow-up|0|||
16285655|NCT00518622|39529868|FG004|Overall Study|Lost to Follow-up|0|||
16285656|NCT00518622|39529869|FG005|Overall Study|Lost to Follow-up|0|||
16285657|NCT00518622|39529870|FG006|Overall Study|Lost to Follow-up|0|||
16285658|NCT00518622|39529871|FG007|Overall Study|Lost to Follow-up|0|||
16285659|NCT00518622|39529864|FG000|Overall Study|Study medication taken incorrectly|0|||
16285660|NCT00518622|39529865|FG001|Overall Study|Study medication taken incorrectly|1|||
16285661|NCT00518622|39529866|FG002|Overall Study|Study medication taken incorrectly|0|||
16285662|NCT00518622|39529867|FG003|Overall Study|Study medication taken incorrectly|0|||
16285663|NCT00518622|39529868|FG004|Overall Study|Study medication taken incorrectly|0|||
16285664|NCT00518622|39529869|FG005|Overall Study|Study medication taken incorrectly|0|||
16285665|NCT00518622|39529870|FG006|Overall Study|Study medication taken incorrectly|0|||
16285666|NCT00518622|39529871|FG007|Overall Study|Study medication taken incorrectly|0|||
16285667|NCT02458092|39529872|FG000|Overall Study|Withdrawal by Subject|1|||
16285668|NCT02458092|39529873|FG001|Overall Study|Withdrawal by Subject|0|||
16285669|NCT00483548|39529874|FG000|Overall Study|Randomized; not treated with study drug|1|||
16285670|NCT00483548|39529875|FG001|Overall Study|Randomized; not treated with study drug|3|||
16285671|NCT00483548|39529874|FG000|Overall Study|Adverse Event|25|||
16285672|NCT00483548|39529875|FG001|Overall Study|Adverse Event|14|||
16285673|NCT00483548|39529874|FG000|Overall Study|Laboratory abnormality|1|||
16285674|NCT00483548|39529875|FG001|Overall Study|Laboratory abnormality|2|||
16285675|NCT00483548|39529874|FG000|Overall Study|Lack of Efficacy|4|||
16285676|NCT00483548|39529875|FG001|Overall Study|Lack of Efficacy|8|||
16285677|NCT00483548|39529874|FG000|Overall Study|Protocol Violation|11|||
16285678|NCT00483548|39529875|FG001|Overall Study|Protocol Violation|7|||
16285679|NCT00483548|39529874|FG000|Overall Study|Pregnancy|1|||
16285680|NCT00483548|39529875|FG001|Overall Study|Pregnancy|0|||
16285681|NCT00483548|39529874|FG000|Overall Study|Protocol required discontinuation|6|||
16285682|NCT00483548|39529875|FG001|Overall Study|Protocol required discontinuation|6|||
16285683|NCT00483548|39529874|FG000|Overall Study|Unable to comply with protocol schedule|1|||
16285684|NCT00483548|39529875|FG001|Overall Study|Unable to comply with protocol schedule|0|||
16285685|NCT00483548|39529874|FG000|Overall Study|Non-compliance with medication|2|||
16285686|NCT00483548|39529875|FG001|Overall Study|Non-compliance with medication|0|||
16285687|NCT00483548|39529874|FG000|Overall Study|Lost to Follow-up|3|||
16285688|NCT00483548|39529875|FG001|Overall Study|Lost to Follow-up|4|||
16285689|NCT00483548|39529874|FG000|Overall Study|Withdrawal by Subject|5|||
16285690|NCT00483548|39529875|FG001|Overall Study|Withdrawal by Subject|2|||
16285691|NCT01557582|39529876|FG000|Overall Study|Protocol Violation|4|||
16285692|NCT01557582|39529876|FG000|Overall Study|Operator error|2|||
16285693|NCT00608517|39529877|FG000|Overall Study|Death|1|||
16285694|NCT00608517|39529878|FG001|Overall Study|Death|0|||
16285695|NCT00608517|39529879|FG002|Overall Study|Death|0|||
16285696|NCT04633642|39529880|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
16285697|NCT04633642|39529881|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
16285698|NCT01506908|39529882|FG000|Overall Study|Adverse Event|1|||
16285699|NCT01506908|39529883|FG001|Overall Study|Adverse Event|0|||
16285700|NCT03330236|39529884|FG000|Overall Study|Death|2|||
16285701|NCT03330236|39529885|FG001|Overall Study|Death|1|||
16285702|NCT03330236|39529884|FG000|Overall Study|Withdrawal by Subject|2|||
16285703|NCT03330236|39529885|FG001|Overall Study|Withdrawal by Subject|4|||
16285704|NCT03330236|39529884|FG000|Overall Study|Lost to Follow-up|0|||
16285705|NCT03330236|39529885|FG001|Overall Study|Lost to Follow-up|2|||
16285706|NCT03330236|39529884|FG000|Overall Study|Physician Decision|2|||
16285707|NCT03330236|39529885|FG001|Overall Study|Physician Decision|0|||
16285708|NCT03330236|39529884|FG000|Overall Study|Protocol Violation|4|||
16285709|NCT03330236|39529885|FG001|Overall Study|Protocol Violation|3|||
16285710|NCT03330236|39529884|FG000|Overall Study|SedLine malfunction/blinding|19|||
16285711|NCT03330236|39529885|FG001|Overall Study|SedLine malfunction/blinding|14|||
16285712|NCT03330236|39529884|FG000|Overall Study|Volatile anesthetics used|11|||
16285713|NCT03330236|39529885|FG001|Overall Study|Volatile anesthetics used|8|||
16285714|NCT03330236|39529884|FG000|Overall Study|Surgery aborted/converted to open|60|||
16285715|NCT03330236|39529885|FG001|Overall Study|Surgery aborted/converted to open|52|||
16285716|NCT01846273|39529886|FG000|Overall Study|Adverse Event|9|||
16285717|NCT01846273|39529887|FG001|Overall Study|Adverse Event|7|||
16285718|NCT01846273|39529888|FG002|Overall Study|Adverse Event|0|||
16285719|NCT01846273|39529886|FG000|Overall Study|Subject withdrew consent|5|||
16285720|NCT01846273|39529887|FG001|Overall Study|Subject withdrew consent|8|||
16285721|NCT01846273|39529888|FG002|Overall Study|Subject withdrew consent|0|||
16285722|NCT01846273|39529886|FG000|Overall Study|Lost to Follow-up|2|||
16285723|NCT01846273|39529887|FG001|Overall Study|Lost to Follow-up|1|||
16285724|NCT01846273|39529888|FG002|Overall Study|Lost to Follow-up|0|||
16285725|NCT01846273|39529886|FG000|Overall Study|Administrative problems|1|||
16285726|NCT01846273|39529887|FG001|Overall Study|Administrative problems|0|||
16285727|NCT01846273|39529888|FG002|Overall Study|Administrative problems|0|||
16285728|NCT01846273|39529886|FG000|Overall Study|Death|2|||
16285729|NCT01846273|39529887|FG001|Overall Study|Death|1|||
16285730|NCT01846273|39529888|FG002|Overall Study|Death|0|||
16285731|NCT01846273|39529886|FG000|Overall Study|Disease Progression|0|||
16285732|NCT01846273|39529887|FG001|Overall Study|Disease Progression|4|||
16285733|NCT01846273|39529888|FG002|Overall Study|Disease Progression|0|||
16285734|NCT01846273|39529886|FG000|Overall Study|Protocol Deviation|2|||
16285735|NCT01846273|39529887|FG001|Overall Study|Protocol Deviation|3|||
16285736|NCT01846273|39529888|FG002|Overall Study|Protocol Deviation|0|||
16285737|NCT01846273|39529886|FG000|Overall Study|Physician Decision|1|||
16285738|NCT01846273|39529887|FG001|Overall Study|Physician Decision|2|||
16285739|NCT01846273|39529888|FG002|Overall Study|Physician Decision|0|||
16285740|NCT00262041|39529889|FG000|Overall Study|Withdrawal by Subject|0|||
16285741|NCT00262041|39529890|FG001|Overall Study|Withdrawal by Subject|3|||
16285742|NCT00262041|39529891|FG002|Overall Study|Withdrawal by Subject|1|||
16285743|NCT00262041|39529889|FG000|Overall Study|Lost to Follow-up|1|||
16285744|NCT00262041|39529890|FG001|Overall Study|Lost to Follow-up|1|||
16285745|NCT00262041|39529891|FG002|Overall Study|Lost to Follow-up|5|||
16285746|NCT00262041|39529889|FG000|Overall Study|Unable to classify|1|||
16285747|NCT00262041|39529890|FG001|Overall Study|Unable to classify|0|||
16285748|NCT00262041|39529891|FG002|Overall Study|Unable to classify|0|||
16285749|NCT02709486|39529894|FG000|Overall Study|Adverse Event|2|||
16285750|NCT02709486|39529895|FG001|Overall Study|Adverse Event|5|||
16285751|NCT02709486|39529896|FG002|Overall Study|Adverse Event|3|||
16285752|NCT02709486|39529894|FG000|Overall Study|Death|0|||
16285753|NCT02709486|39529895|FG001|Overall Study|Death|0|||
16285754|NCT02709486|39529896|FG002|Overall Study|Death|2|||
16285755|NCT02709486|39529894|FG000|Overall Study|Insufficient clinical response|7|||
16285756|NCT02709486|39529895|FG001|Overall Study|Insufficient clinical response|3|||
16285757|NCT02709486|39529896|FG002|Overall Study|Insufficient clinical response|3|||
16285758|NCT02709486|39529894|FG000|Overall Study|Lost to Follow-up|3|||
16285759|NCT02709486|39529895|FG001|Overall Study|Lost to Follow-up|2|||
16285760|NCT02709486|39529896|FG002|Overall Study|Lost to Follow-up|2|||
16285761|NCT02709486|39529894|FG000|Overall Study|Other|0|||
16285762|NCT02709486|39529895|FG001|Overall Study|Other|2|||
16285763|NCT02709486|39529896|FG002|Overall Study|Other|3|||
16285764|NCT02709486|39529894|FG000|Overall Study|Withdrawal by Subject|32|||
16285765|NCT02709486|39529895|FG001|Overall Study|Withdrawal by Subject|22|||
16285766|NCT02709486|39529896|FG002|Overall Study|Withdrawal by Subject|32|||
16285767|NCT00396331|39529897|FG000|Overall Study|Failed to mobilize - no transplant|8|||
16285768|NCT00396331|39529897|FG000|Overall Study|Did not go on to transplant|5|||
16285769|NCT00396331|39529897|FG000|Overall Study|Lost to Follow-up|3|||
16285770|NCT00396331|39529897|FG000|Overall Study|Death|16|||
16285771|NCT02556307|39529899|FG000|Overall Study|Premature treatment interruption|11|||
16285772|NCT02556307|39529899|FG000|Overall Study|Lost to Follow-up|36|||
16285773|NCT02556307|39529899|FG000|Overall Study|Change to triple therapy|4|||
16285774|NCT02556307|39529899|FG000|Overall Study|Enrolled but not treated|2|||
16285775|NCT00733369|39529900|FG000|Overall Study|Lost to Follow-up|2|||
16285776|NCT00733369|39529901|FG001|Overall Study|Lost to Follow-up|1|||
16285777|NCT00733369|39529900|FG000|Overall Study|Adverse Event|4|||
16285778|NCT00733369|39529901|FG001|Overall Study|Adverse Event|4|||
16285779|NCT00733369|39529900|FG000|Overall Study|Protocol Violation|4|||
16285780|NCT00733369|39529901|FG001|Overall Study|Protocol Violation|4|||
16285781|NCT02037165|39529902|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
16285782|NCT02037165|39529903|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
16285783|NCT02037165|39529904|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
16285784|NCT02037165|39529905|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
16285785|NCT02037165|39529906|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
16285786|NCT01660022|39529907|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
16285787|NCT01660022|39529908|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
16285788|NCT01660022|39529909|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
16285789|NCT01660022|39529910|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
16285790|NCT01660022|39529911|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
16285791|NCT01660022|39529912|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
16285792|NCT01660022|39529907|FG000|First Sequence (7 Days)|Adverse Event|0|||
16285793|NCT01660022|39529908|FG001|First Sequence (7 Days)|Adverse Event|0|||
16285794|NCT01660022|39529909|FG002|First Sequence (7 Days)|Adverse Event|0|||
16285795|NCT01660022|39529910|FG003|First Sequence (7 Days)|Adverse Event|0|||
16285796|NCT01660022|39529911|FG004|First Sequence (7 Days)|Adverse Event|1|||
16285797|NCT01660022|39529912|FG005|First Sequence (7 Days)|Adverse Event|3|||
16285798|NCT01660022|39529907|FG000|First Sequence (7 Days)|Protocol Violation|0|||
16285799|NCT01660022|39529908|FG001|First Sequence (7 Days)|Protocol Violation|0|||
16285800|NCT01660022|39529909|FG002|First Sequence (7 Days)|Protocol Violation|0|||
16285801|NCT01660022|39529910|FG003|First Sequence (7 Days)|Protocol Violation|0|||
16285802|NCT01660022|39529911|FG004|First Sequence (7 Days)|Protocol Violation|0|||
16285803|NCT01660022|39529912|FG005|First Sequence (7 Days)|Protocol Violation|1|||
16285804|NCT00653159|39529915|FG000|Overall Study|Adverse Event|4|||
16285805|NCT00653159|39529916|FG001|Overall Study|Adverse Event|1|||
16285806|NCT00653159|39529915|FG000|Overall Study|Lost to Follow-up|1|||
16285807|NCT00653159|39529916|FG001|Overall Study|Lost to Follow-up|2|||
16285808|NCT01131299|39529917|FG000|Overall Study|Withdrawal by Subject|4|||
16285809|NCT01131299|39529918|FG001|Overall Study|Withdrawal by Subject|7|||
16285810|NCT04234464|39529919|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
16285811|NCT04234464|39529920|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
16285812|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
16285813|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
16285814|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
16285815|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
16285816|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
16285817|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
16285818|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
16285819|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
16285820|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
16285821|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
16285822|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
16285823|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
16285824|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16285825|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16285826|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
16285827|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
16285828|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
16285829|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
16285830|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
16285831|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
16285832|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
16285833|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
16285834|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
16285835|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
16285836|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
16285837|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
16285838|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
16285839|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
16285840|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Death|0|||
16285841|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Death|1|||
16285842|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Death|0|||
16285843|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Death|0|||
16285844|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
16285845|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
16285846|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
16285847|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
16285848|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
16285849|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
16285850|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
16285851|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
16285852|NCT02990806|39529921|FG000|Stage 1 (22 Weeks)|Other|1|||
16285853|NCT02990806|39529922|FG001|Stage 1 (22 Weeks)|Other|3|||
16285854|NCT02990806|39529923|FG002|Stage 1 (22 Weeks)|Other|0|||
16285855|NCT02990806|39529924|FG003|Stage 1 (22 Weeks)|Other|0|||
16285856|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
16480466|NCT04289623|40238265|FG001|Wave 1 Emails|Email was not delivered|257|||
16480467|NCT04289623|40238266|FG002|Wave 1 Emails|Email was not delivered|0|||
16480468|NCT04289623|40238267|FG003|Wave 1 Emails|Email was not delivered|0|||
16480469|NCT04289623|40238268|FG004|Wave 1 Emails|Email was not delivered|0|||
16480470|NCT04289623|40238269|FG005|Wave 1 Emails|Email was not delivered|0|||
16480471|NCT00734474|40238270|FG000|Overall Study|Entry Criteria Not Met|0|||
16285857|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
16285858|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
16480472|NCT00734474|40238271|FG001|Overall Study|Entry Criteria Not Met|0|||
16480473|NCT00734474|40238272|FG002|Overall Study|Entry Criteria Not Met|5|||
16480474|NCT00734474|40238273|FG003|Overall Study|Entry Criteria Not Met|0|||
16480475|NCT00734474|40238274|FG004|Overall Study|Entry Criteria Not Met|3|||
16480476|NCT00734474|40238275|FG005|Overall Study|Entry Criteria Not Met|1|||
16480477|NCT00734474|40238276|FG006|Overall Study|Entry Criteria Not Met|0|||
16480478|NCT00734474|40238277|FG007|Overall Study|Entry Criteria Not Met|1|||
16480479|NCT00734474|40238278|FG008|Overall Study|Entry Criteria Not Met|1|||
16480480|NCT00734474|40238270|FG000|Overall Study|Lost to Follow-up|1|||
16480481|NCT00734474|40238271|FG001|Overall Study|Lost to Follow-up|0|||
16480482|NCT00734474|40238272|FG002|Overall Study|Lost to Follow-up|13|||
16480483|NCT00734474|40238273|FG003|Overall Study|Lost to Follow-up|0|||
16480484|NCT00734474|40238274|FG004|Overall Study|Lost to Follow-up|11|||
16480485|NCT00734474|40238275|FG005|Overall Study|Lost to Follow-up|1|||
16480486|NCT00734474|40238276|FG006|Overall Study|Lost to Follow-up|0|||
16480487|NCT00734474|40238277|FG007|Overall Study|Lost to Follow-up|9|||
16480488|NCT00734474|40238278|FG008|Overall Study|Lost to Follow-up|4|||
16480489|NCT00734474|40238270|FG000|Overall Study|Withdrawal by Subject|2|||
16480490|NCT00734474|40238271|FG001|Overall Study|Withdrawal by Subject|1|||
16480491|NCT00734474|40238272|FG002|Overall Study|Withdrawal by Subject|18|||
16480492|NCT00734474|40238273|FG003|Overall Study|Withdrawal by Subject|0|||
16480493|NCT00734474|40238274|FG004|Overall Study|Withdrawal by Subject|24|||
16480494|NCT00734474|40238275|FG005|Overall Study|Withdrawal by Subject|2|||
16480495|NCT00734474|40238276|FG006|Overall Study|Withdrawal by Subject|0|||
16480496|NCT00734474|40238277|FG007|Overall Study|Withdrawal by Subject|36|||
16480497|NCT00734474|40238278|FG008|Overall Study|Withdrawal by Subject|21|||
16480498|NCT00734474|40238270|FG000|Overall Study|Physician Decision|0|||
16480499|NCT00734474|40238271|FG001|Overall Study|Physician Decision|0|||
16480500|NCT00734474|40238272|FG002|Overall Study|Physician Decision|4|||
16480501|NCT00734474|40238273|FG003|Overall Study|Physician Decision|1|||
16480502|NCT00734474|40238274|FG004|Overall Study|Physician Decision|11|||
16480503|NCT00734474|40238275|FG005|Overall Study|Physician Decision|0|||
16480504|NCT00734474|40238276|FG006|Overall Study|Physician Decision|0|||
16480505|NCT00734474|40238277|FG007|Overall Study|Physician Decision|9|||
16480506|NCT00734474|40238278|FG008|Overall Study|Physician Decision|9|||
16480507|NCT00734474|40238270|FG000|Overall Study|Adverse Event|4|||
16480508|NCT00734474|40238271|FG001|Overall Study|Adverse Event|4|||
16480509|NCT00734474|40238272|FG002|Overall Study|Adverse Event|63|||
16480510|NCT00734474|40238273|FG003|Overall Study|Adverse Event|1|||
16480511|NCT00734474|40238274|FG004|Overall Study|Adverse Event|64|||
16480512|NCT00734474|40238275|FG005|Overall Study|Adverse Event|0|||
16480513|NCT00734474|40238276|FG006|Overall Study|Adverse Event|1|||
16480514|NCT00734474|40238277|FG007|Overall Study|Adverse Event|65|||
16480515|NCT00734474|40238278|FG008|Overall Study|Adverse Event|39|||
16080238|NCT01307267|38786783|FG002|Overall Study|Withdrawal by Subject|0|||
16080239|NCT01307267|38786784|FG003|Overall Study|Withdrawal by Subject|0|||
16285859|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
16285860|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Death|1|||
16480516|NCT00734474|40238270|FG000|Overall Study|Protocol Violation|0|||
16480517|NCT00734474|40238271|FG001|Overall Study|Protocol Violation|0|||
16480518|NCT00734474|40238272|FG002|Overall Study|Protocol Violation|4|||
16480519|NCT00734474|40238273|FG003|Overall Study|Protocol Violation|0|||
16480520|NCT00734474|40238274|FG004|Overall Study|Protocol Violation|3|||
16480521|NCT00734474|40238275|FG005|Overall Study|Protocol Violation|0|||
16480522|NCT00734474|40238276|FG006|Overall Study|Protocol Violation|0|||
16480523|NCT00734474|40238277|FG007|Overall Study|Protocol Violation|3|||
16480524|NCT00734474|40238278|FG008|Overall Study|Protocol Violation|1|||
16480525|NCT00734474|40238270|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
16480526|NCT00734474|40238271|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
16480527|NCT00734474|40238272|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
16480528|NCT00734474|40238273|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
16480529|NCT00734474|40238274|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
16480530|NCT00734474|40238275|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
16480531|NCT00734474|40238276|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
16480532|NCT00734474|40238277|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
16480533|NCT00734474|40238278|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
16480534|NCT00734474|40238270|FG000|Overall Study|Sponsor Decision|0|||
16480535|NCT00734474|40238271|FG001|Overall Study|Sponsor Decision|0|||
16480536|NCT00734474|40238272|FG002|Overall Study|Sponsor Decision|0|||
16480537|NCT00734474|40238273|FG003|Overall Study|Sponsor Decision|0|||
16480538|NCT00734474|40238274|FG004|Overall Study|Sponsor Decision|2|||
16480539|NCT00734474|40238275|FG005|Overall Study|Sponsor Decision|0|||
16480540|NCT00734474|40238276|FG006|Overall Study|Sponsor Decision|0|||
16480541|NCT00734474|40238277|FG007|Overall Study|Sponsor Decision|0|||
16480542|NCT00734474|40238278|FG008|Overall Study|Sponsor Decision|0|||
16480543|NCT00734474|40238270|FG000|Overall Study|Death|0|||
16480544|NCT00734474|40238271|FG001|Overall Study|Death|0|||
16480545|NCT00734474|40238272|FG002|Overall Study|Death|1|||
16480546|NCT00734474|40238273|FG003|Overall Study|Death|0|||
16480547|NCT00734474|40238274|FG004|Overall Study|Death|0|||
16480548|NCT00734474|40238275|FG005|Overall Study|Death|0|||
16480549|NCT00734474|40238276|FG006|Overall Study|Death|0|||
16480550|NCT00734474|40238277|FG007|Overall Study|Death|2|||
16480551|NCT00734474|40238278|FG008|Overall Study|Death|1|||
16480552|NCT00734474|40238270|FG000|Overall Study|Lack of Efficacy|0|||
16480553|NCT00734474|40238271|FG001|Overall Study|Lack of Efficacy|0|||
16480554|NCT00734474|40238272|FG002|Overall Study|Lack of Efficacy|4|||
16480555|NCT00734474|40238273|FG003|Overall Study|Lack of Efficacy|0|||
16480556|NCT00734474|40238274|FG004|Overall Study|Lack of Efficacy|0|||
16480557|NCT00734474|40238275|FG005|Overall Study|Lack of Efficacy|0|||
16480558|NCT00734474|40238276|FG006|Overall Study|Lack of Efficacy|0|||
16480559|NCT00734474|40238277|FG007|Overall Study|Lack of Efficacy|4|||
16480560|NCT00734474|40238278|FG008|Overall Study|Lack of Efficacy|6|||
16480561|NCT00850070|40238280|FG000|Overall Study|Lack of Efficacy|1|||
16480562|NCT00850070|40238281|FG001|Overall Study|Lack of Efficacy|1|||
16480563|NCT00850070|40238280|FG000|Overall Study|Adverse Event|2|||
16480564|NCT00850070|40238281|FG001|Overall Study|Adverse Event|0|||
16480565|NCT04431453|40238282|FG000|Overall Study|Withdrew Consent|0|||
16480566|NCT04431453|40238283|FG001|Overall Study|Withdrew Consent|1|||
16480567|NCT04431453|40238284|FG002|Overall Study|Withdrew Consent|0|||
16480568|NCT04431453|40238285|FG003|Overall Study|Withdrew Consent|2|||
16480569|NCT04431453|40238286|FG004|Overall Study|Withdrew Consent|0|||
16480570|NCT04431453|40238287|FG005|Overall Study|Withdrew Consent|0|||
16480571|NCT04431453|40238288|FG006|Overall Study|Withdrew Consent|0|||
16480572|NCT04431453|40238289|FG007|Overall Study|Withdrew Consent|0|||
16480573|NCT04431453|40238282|FG000|Overall Study|Death|1|||
16480574|NCT04431453|40238283|FG001|Overall Study|Death|0|||
16480575|NCT04431453|40238284|FG002|Overall Study|Death|0|||
16480576|NCT04431453|40238285|FG003|Overall Study|Death|0|||
16480577|NCT04431453|40238286|FG004|Overall Study|Death|0|||
16480578|NCT04431453|40238287|FG005|Overall Study|Death|0|||
16480579|NCT04431453|40238288|FG006|Overall Study|Death|0|||
16480580|NCT04431453|40238289|FG007|Overall Study|Death|1|||
16480581|NCT04431453|40238282|FG000|Overall Study|Lost to Follow-up|0|||
16480582|NCT04431453|40238283|FG001|Overall Study|Lost to Follow-up|0|||
16480583|NCT04431453|40238284|FG002|Overall Study|Lost to Follow-up|1|||
16480584|NCT04431453|40238285|FG003|Overall Study|Lost to Follow-up|1|||
16480585|NCT04431453|40238286|FG004|Overall Study|Lost to Follow-up|0|||
16480586|NCT04431453|40238287|FG005|Overall Study|Lost to Follow-up|0|||
16480587|NCT04431453|40238288|FG006|Overall Study|Lost to Follow-up|0|||
16480588|NCT04431453|40238289|FG007|Overall Study|Lost to Follow-up|0|||
16480589|NCT04431453|40238282|FG000|Overall Study|Enrolled but Never Treated|0|||
16480590|NCT04431453|40238283|FG001|Overall Study|Enrolled but Never Treated|0|||
16480591|NCT04431453|40238284|FG002|Overall Study|Enrolled but Never Treated|0|||
16480592|NCT04431453|40238285|FG003|Overall Study|Enrolled but Never Treated|0|||
16480593|NCT04431453|40238286|FG004|Overall Study|Enrolled but Never Treated|1|||
16480594|NCT04431453|40238287|FG005|Overall Study|Enrolled but Never Treated|0|||
16480595|NCT04431453|40238288|FG006|Overall Study|Enrolled but Never Treated|0|||
16480596|NCT04431453|40238289|FG007|Overall Study|Enrolled but Never Treated|0|||
16480597|NCT01500031|40238290|FG000|Overall Study|Death|1|||
16480598|NCT01500031|40238290|FG000|Overall Study|Withdrawal by Subject|4|||
16480599|NCT02935842|40238291|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
16480600|NCT02935842|40238292|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
16285861|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Death|0|||
16480601|NCT02935842|40238293|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
16480602|NCT02935842|40238294|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
16480603|NCT02935842|40238291|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
16480604|NCT02935842|40238292|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
16480605|NCT02935842|40238293|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
16480606|NCT02935842|40238294|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
16480607|NCT02935842|40238291|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
16480608|NCT02935842|40238292|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
16480609|NCT02935842|40238293|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
16480610|NCT02935842|40238294|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
16480611|NCT02935842|40238291|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
16480612|NCT02935842|40238292|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
16480613|NCT02935842|40238293|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
16480614|NCT02935842|40238294|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
16480615|NCT02935842|40238291|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
16480616|NCT02935842|40238292|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
16480617|NCT02935842|40238293|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
16480618|NCT02935842|40238294|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
16480619|NCT00674362|40238302|FG000|Double Blind|Adverse Event|6|||
16480620|NCT00674362|40238303|FG001|Double Blind|Adverse Event|6|||
16480621|NCT00674362|40238302|FG000|Double Blind|Lack of Efficacy|2|||
16480622|NCT00674362|40238303|FG001|Double Blind|Lack of Efficacy|6|||
16480623|NCT00674362|40238302|FG000|Double Blind|Loss of efficacy|0|||
16480624|NCT00674362|40238303|FG001|Double Blind|Loss of efficacy|1|||
16480625|NCT00674362|40238302|FG000|Double Blind|Withdrawal by Subject|4|||
16480626|NCT00674362|40238303|FG001|Double Blind|Withdrawal by Subject|3|||
16480627|NCT00674362|40238302|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
16480628|NCT00674362|40238303|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
16480629|NCT00674362|40238302|FG000|Double Blind|Other: Surgery|0|||
16480630|NCT00674362|40238303|FG001|Double Blind|Other: Surgery|1|||
16480631|NCT00674362|40238302|FG000|Open Label|Adverse Event|1|||
16480632|NCT00674362|40238303|FG001|Open Label|Adverse Event|0|||
16480633|NCT00674362|40238302|FG000|Open Label|Other: Subject moved to extension study|1|||
16480634|NCT00674362|40238303|FG001|Open Label|Other: Subject moved to extension study|0|||
16480635|NCT01773733|40238304|FG000|Overall Study|Adverse Event|3286|||
16480636|NCT01773733|40238305|FG001|Overall Study|Adverse Event|540|||
16480637|NCT01773733|40238304|FG000|Overall Study|Pregnancy|28|||
16480638|NCT01773733|40238305|FG001|Overall Study|Pregnancy|0|||
16480639|NCT01773733|40238304|FG000|Overall Study|Other different categories of not compl|55415|||
16480640|NCT01773733|40238305|FG001|Overall Study|Other different categories of not compl|7781|||
16480641|NCT02959983|40238310|FG000|Overall Study|Protocol Violation|0|||
16480642|NCT02959983|40238311|FG001|Overall Study|Protocol Violation|1|||
16480643|NCT02959983|40238310|FG000|Overall Study|Lack of Efficacy|0|||
16480644|NCT02959983|40238311|FG001|Overall Study|Lack of Efficacy|1|||
16480645|NCT02959983|40238310|FG000|Overall Study|Lost to Follow-up|12|||
16480646|NCT02959983|40238311|FG001|Overall Study|Lost to Follow-up|9|||
16480647|NCT02959983|40238310|FG000|Overall Study|Other|1|||
16480648|NCT02959983|40238311|FG001|Overall Study|Other|1|||
16480649|NCT02959983|40238310|FG000|Overall Study|Physician Decision|1|||
16480650|NCT02959983|40238311|FG001|Overall Study|Physician Decision|0|||
16480651|NCT02959983|40238310|FG000|Overall Study|Adverse Event|5|||
16480652|NCT02959983|40238311|FG001|Overall Study|Adverse Event|1|||
16480653|NCT02959983|40238310|FG000|Overall Study|Withdrawal by Subject|7|||
16480654|NCT02959983|40238311|FG001|Overall Study|Withdrawal by Subject|12|||
16480655|NCT01522248|40238312|FG000|Overall Study|Lost to Follow-up|1|||
16480656|NCT01522248|40238313|FG001|Overall Study|Lost to Follow-up|0|||
16480657|NCT00491764|40238314|FG000|Overall Study|Adverse Event|1|||
16480658|NCT00491764|40238315|FG001|Overall Study|Adverse Event|2|||
16480659|NCT00491764|40238316|FG002|Overall Study|Adverse Event|4|||
16480660|NCT00491764|40238317|FG003|Overall Study|Adverse Event|4|||
16480661|NCT00491764|40238318|FG004|Overall Study|Adverse Event|0|||
16480662|NCT00491764|40238319|FG005|Overall Study|Adverse Event|1|||
16480663|NCT00491764|40238314|FG000|Overall Study|Lost to Follow-up|0|||
16480664|NCT00491764|40238315|FG001|Overall Study|Lost to Follow-up|1|||
16480665|NCT00491764|40238316|FG002|Overall Study|Lost to Follow-up|0|||
16480666|NCT00491764|40238317|FG003|Overall Study|Lost to Follow-up|1|||
16480667|NCT00491764|40238318|FG004|Overall Study|Lost to Follow-up|0|||
16480668|NCT00491764|40238319|FG005|Overall Study|Lost to Follow-up|3|||
16480669|NCT00491764|40238314|FG000|Overall Study|Withdrawal by Subject|2|||
16480670|NCT00491764|40238315|FG001|Overall Study|Withdrawal by Subject|3|||
16480671|NCT00491764|40238316|FG002|Overall Study|Withdrawal by Subject|1|||
16480672|NCT00491764|40238317|FG003|Overall Study|Withdrawal by Subject|2|||
16480673|NCT00491764|40238318|FG004|Overall Study|Withdrawal by Subject|2|||
16480674|NCT00491764|40238319|FG005|Overall Study|Withdrawal by Subject|4|||
16480675|NCT00491764|40238314|FG000|Overall Study|Non Compliance with the Protocol|1|||
16480676|NCT00491764|40238315|FG001|Overall Study|Non Compliance with the Protocol|0|||
16480677|NCT00491764|40238316|FG002|Overall Study|Non Compliance with the Protocol|0|||
16480678|NCT00491764|40238317|FG003|Overall Study|Non Compliance with the Protocol|0|||
16480679|NCT00491764|40238318|FG004|Overall Study|Non Compliance with the Protocol|0|||
16480680|NCT00491764|40238319|FG005|Overall Study|Non Compliance with the Protocol|0|||
16480681|NCT00491764|40238314|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
16480682|NCT00491764|40238315|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
16480683|NCT00491764|40238316|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
16480684|NCT00491764|40238317|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
16480685|NCT00491764|40238318|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
16480686|NCT00491764|40238319|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
16480687|NCT00491764|40238314|FG000|Overall Study|Administrative|1|||
16480688|NCT00491764|40238315|FG001|Overall Study|Administrative|0|||
16480689|NCT00491764|40238316|FG002|Overall Study|Administrative|2|||
16480690|NCT00491764|40238317|FG003|Overall Study|Administrative|1|||
16480691|NCT00491764|40238318|FG004|Overall Study|Administrative|0|||
16480692|NCT00491764|40238319|FG005|Overall Study|Administrative|0|||
16480693|NCT01696071|40238320|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
16480694|NCT01696071|40238321|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
16480695|NCT01849783|40238328|FG000|Overall Study|Adverse Event|5|||
16480696|NCT01849783|40238328|FG000|Overall Study|Death|2|||
16480697|NCT01849783|40238328|FG000|Overall Study|Physician Decision|1|||
16480698|NCT01849783|40238328|FG000|Overall Study|Withdrawal by Subject|1|||
16480699|NCT01849783|40238328|FG000|Overall Study|Unable to comply|2|||
16480700|NCT01849783|40238328|FG000|Overall Study|Disease progression|11|||
16480701|NCT03817879|40238330|FG000|Overall Study|Drop out|5|||
16480702|NCT03817879|40238331|FG001|Overall Study|Drop out|12|||
16480703|NCT03817879|40238330|FG000|Overall Study|Withdrawal by Subject|0|||
16480704|NCT03817879|40238331|FG001|Overall Study|Withdrawal by Subject|1|||
16480705|NCT04218695|40238336|FG000|Overall Study|Adverse Event|1|||
16480706|NCT04218695|40238337|FG001|Overall Study|Adverse Event|0|||
16480707|NCT01543958|40238342|FG000|Overall Study|Loss to follow-up|3|||
16480708|NCT01543958|40238342|FG000|Overall Study|ART initiation|1|||
16480709|NCT00389597|40238343|FG000|Overall Study|Lost to Follow-up|8|||
16480710|NCT00389597|40238344|FG001|Overall Study|Lost to Follow-up|6|||
16480711|NCT00389597|40238345|FG002|Overall Study|Lost to Follow-up|4|||
16480712|NCT00389597|40238346|FG003|Overall Study|Lost to Follow-up|6|||
16480713|NCT02761057|40238347|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
16379897|NCT00867035|39874814|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
16379898|NCT00867035|39874815|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
16379899|NCT00867035|39874814|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
16379900|NCT00867035|39874815|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
16379901|NCT01849276|39874818|FG000|Followed for Survival for 5 Years|Death|1|||
16379902|NCT01849276|39874818|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
16379903|NCT00425555|39874820|FG000|Overall Study|Withdrawal by Subject|11|||
16379904|NCT00425555|39874821|FG001|Overall Study|Withdrawal by Subject|8|||
16379905|NCT00425555|39874820|FG000|Overall Study|Lost to Follow-up|0|||
16379906|NCT00425555|39874821|FG001|Overall Study|Lost to Follow-up|1|||
16379907|NCT00425555|39874820|FG000|Overall Study|Administrative problems|3|||
16379908|NCT00425555|39874821|FG001|Overall Study|Administrative problems|0|||
16379909|NCT00425555|39874820|FG000|Overall Study|Death|1|||
16379910|NCT00425555|39874821|FG001|Overall Study|Death|2|||
16379911|NCT00425555|39874820|FG000|Overall Study|New cancer therapy|2|||
16379912|NCT00425555|39874821|FG001|Overall Study|New cancer therapy|1|||
16379913|NCT00425555|39874820|FG000|Overall Study|Disease progression|36|||
16480714|NCT02761057|40238348|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
16480715|NCT02761057|40238349|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
16480716|NCT02761057|40238350|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
16480717|NCT02761057|40238347|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
16480718|NCT02761057|40238348|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
16480719|NCT02761057|40238349|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
16480720|NCT02761057|40238350|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
16480721|NCT02761057|40238347|FG000|Overall Study|Currently On Study Treatment|0|||
16480722|NCT02761057|40238348|FG001|Overall Study|Currently On Study Treatment|3|||
16480723|NCT02761057|40238349|FG002|Overall Study|Currently On Study Treatment|0|||
16480724|NCT02761057|40238350|FG003|Overall Study|Currently On Study Treatment|0|||
16480725|NCT02761057|40238347|FG000|Overall Study|Adverse Event|11|||
16480726|NCT02761057|40238348|FG001|Overall Study|Adverse Event|9|||
16379914|NCT00425555|39874821|FG001|Overall Study|Disease progression|33|||
16379915|NCT00425555|39874820|FG000|Overall Study|Adverse Event|25|||
16379916|NCT00425555|39874821|FG001|Overall Study|Adverse Event|15|||
16379917|NCT00425555|39874820|FG000|Overall Study|Protocol Violation|1|||
16379918|NCT00425555|39874821|FG001|Overall Study|Protocol Violation|0|||
16480727|NCT02761057|40238349|FG002|Overall Study|Adverse Event|5|||
16480728|NCT02761057|40238350|FG003|Overall Study|Adverse Event|3|||
16480729|NCT02761057|40238347|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
16480730|NCT02761057|40238348|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
16480731|NCT02761057|40238349|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
16480732|NCT02761057|40238350|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
16480733|NCT02761057|40238347|FG000|Overall Study|Progression/Relapse|29|||
16480734|NCT02761057|40238348|FG001|Overall Study|Progression/Relapse|27|||
16480735|NCT02761057|40238349|FG002|Overall Study|Progression/Relapse|20|||
16480736|NCT02761057|40238350|FG003|Overall Study|Progression/Relapse|23|||
16480737|NCT02761057|40238347|FG000|Overall Study|Death|2|||
16480738|NCT02761057|40238348|FG001|Overall Study|Death|2|||
16480739|NCT02761057|40238349|FG002|Overall Study|Death|1|||
16480740|NCT02761057|40238350|FG003|Overall Study|Death|1|||
16480741|NCT02761057|40238347|FG000|Overall Study|Other - Not Protocol Specified|2|||
16480742|NCT02761057|40238348|FG001|Overall Study|Other - Not Protocol Specified|1|||
16480743|NCT02761057|40238349|FG002|Overall Study|Other - Not Protocol Specified|2|||
16480744|NCT02761057|40238350|FG003|Overall Study|Other - Not Protocol Specified|0|||
16480745|NCT01649804|40238355|FG000|Overall Study|Administrative/Other|8|||
16480746|NCT02906332|40238358|FG000|Overall Study|Withdrawal by Subject|1|||
16480747|NCT01218243|40238362|FG000|Overall Study|Lack of Efficacy|1|||
16480748|NCT01218243|40238363|FG001|Overall Study|Lack of Efficacy|1|||
16480749|NCT01218243|40238362|FG000|Overall Study|Lost to Follow-up|3|||
16480750|NCT01218243|40238363|FG001|Overall Study|Lost to Follow-up|3|||
16480751|NCT01218243|40238362|FG000|Overall Study|Protocol Violation|5|||
16480752|NCT01218243|40238363|FG001|Overall Study|Protocol Violation|10|||
16480753|NCT01611155|40238364|FG000|Overall Study|Adverse Event|1|||
16480754|NCT01611155|40238365|FG001|Overall Study|Adverse Event|1|||
16480755|NCT01611155|40238364|FG000|Overall Study|Refused further treatment|6|||
16480756|NCT01611155|40238365|FG001|Overall Study|Refused further treatment|4|||
16480757|NCT01611155|40238364|FG000|Overall Study|Disease progression|1|||
16480758|NCT01611155|40238365|FG001|Overall Study|Disease progression|0|||
16480759|NCT01611155|40238364|FG000|Overall Study|Withdrawal by Subject|1|||
16480760|NCT01611155|40238365|FG001|Overall Study|Withdrawal by Subject|0|||
16480761|NCT01611155|40238364|FG000|Overall Study|Alternative treatment|0|||
16480762|NCT01611155|40238365|FG001|Overall Study|Alternative treatment|1|||
16480763|NCT01611155|40238364|FG000|Overall Study|Ineligible patient|0|||
16480764|NCT01611155|40238365|FG001|Overall Study|Ineligible patient|1|||
16480765|NCT03320057|40238369|FG000|Overall Study|Lost to Follow-up|4|||
16480766|NCT03320057|40238370|FG001|Overall Study|Lost to Follow-up|17|||
16480767|NCT03320057|40238369|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
16480768|NCT03320057|40238370|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
16480769|NCT01846104|40238371|FG000|Overall Study|Withdrawal by Subject|1|||
16480770|NCT01890473|40238372|FG000|Overall Study|Lost to Follow-up|1|||
16480771|NCT01890473|40238373|FG001|Overall Study|Lost to Follow-up|0|||
16480772|NCT01890473|40238372|FG000|Overall Study|Poor/non-compliance|1|||
16480773|NCT01890473|40238373|FG001|Overall Study|Poor/non-compliance|0|||
16480774|NCT01980940|40238378|FG000|Overall Study|Protocol Violation|0|||
16480775|NCT01980940|40238379|FG001|Overall Study|Protocol Violation|0|||
16480776|NCT01980940|40238380|FG002|Overall Study|Protocol Violation|0|||
16480777|NCT01980940|40238381|FG003|Overall Study|Protocol Violation|0|||
16480778|NCT01980940|40238382|FG004|Overall Study|Protocol Violation|0|||
16480779|NCT01980940|40238383|FG005|Overall Study|Protocol Violation|2|||
16480780|NCT01980940|40238384|FG006|Overall Study|Protocol Violation|0|||
16480781|NCT01980940|40238385|FG007|Overall Study|Protocol Violation|0|||
16480782|NCT02202980|40238387|FG000|Overall Study|Lack of Efficacy|1|||
16480783|NCT02202980|40238388|FG001|Overall Study|Lack of Efficacy|0|||
16185449|NCT01544595|39159241|FG001|Status at Week 156|Lost to Follow-up|4|||
16185450|NCT01544595|39159242|FG002|Status at Week 156|Lost to Follow-up|0|||
16185451|NCT01544595|39159243|FG003|Status at Week 156|Lost to Follow-up|1|||
16185452|NCT01544595|39159244|FG004|Status at Week 156|Lost to Follow-up|4|||
16185453|NCT01544595|39159245|FG005|Status at Week 156|Lost to Follow-up|1|||
16185454|NCT01544595|39159240|FG000|Status at Week 156|Non-compliance with study treatement|0|||
16185455|NCT01544595|39159241|FG001|Status at Week 156|Non-compliance with study treatement|1|||
16185456|NCT01544595|39159242|FG002|Status at Week 156|Non-compliance with study treatement|0|||
16185457|NCT01544595|39159243|FG003|Status at Week 156|Non-compliance with study treatement|1|||
16185458|NCT01544595|39159244|FG004|Status at Week 156|Non-compliance with study treatement|0|||
16185459|NCT01544595|39159245|FG005|Status at Week 156|Non-compliance with study treatement|1|||
16185460|NCT01544595|39159240|FG000|Status at Week 156|Physician Decision|0|||
16480784|NCT02202980|40238389|FG002|Overall Study|Lack of Efficacy|7|||
16480785|NCT02202980|40238390|FG003|Overall Study|Lack of Efficacy|0|||
16480786|NCT02202980|40238391|FG004|Overall Study|Lack of Efficacy|3|||
16480787|NCT02202980|40238392|FG005|Overall Study|Lack of Efficacy|1|||
16480788|NCT02202980|40238393|FG006|Overall Study|Lack of Efficacy|11|||
16480789|NCT02202980|40238394|FG007|Overall Study|Lack of Efficacy|2|||
16480790|NCT02202980|40238395|FG008|Overall Study|Lack of Efficacy|2|||
16480791|NCT02202980|40238396|FG009|Overall Study|Lack of Efficacy|0|||
16480792|NCT02202980|40238397|FG010|Overall Study|Lack of Efficacy|0|||
16480793|NCT02202980|40238398|FG011|Overall Study|Lack of Efficacy|3|||
16480794|NCT02202980|40238399|FG012|Overall Study|Lack of Efficacy|10|||
16480795|NCT02202980|40238400|FG013|Overall Study|Lack of Efficacy|0|||
16285862|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Death|0|||
16285863|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Death|0|||
16285864|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
16285865|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
16285866|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
16285867|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
16285868|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
16285869|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
16285870|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
16285871|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
16285872|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
16285873|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
16285874|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
16285875|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
16285876|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
16285877|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
16285878|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
16285879|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
16285880|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16285881|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
16285882|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
16285883|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
16285884|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
16285885|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
16285886|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
16285887|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
16285888|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
16285889|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
16285890|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
16285891|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
16285892|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
16285893|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
16285894|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
16480796|NCT02202980|40238387|FG000|Overall Study|Protocol Violation|0|||
16480797|NCT02202980|40238388|FG001|Overall Study|Protocol Violation|0|||
16480798|NCT02202980|40238389|FG002|Overall Study|Protocol Violation|0|||
16480799|NCT02202980|40238390|FG003|Overall Study|Protocol Violation|3|||
16480800|NCT02202980|40238391|FG004|Overall Study|Protocol Violation|3|||
16480801|NCT02202980|40238392|FG005|Overall Study|Protocol Violation|0|||
16480802|NCT02202980|40238393|FG006|Overall Study|Protocol Violation|0|||
16480803|NCT02202980|40238394|FG007|Overall Study|Protocol Violation|0|||
16285895|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
16285896|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
16285897|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
16285898|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
16285899|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
16285900|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Other|3|||
16285901|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Other|0|||
16285902|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Other|4|||
16285903|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Other|1|||
16285904|NCT02990806|39529921|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
16285905|NCT02990806|39529922|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
16379919|NCT02296125|39874822|FG000|Overall Study|Withdrawal by Subject|18|||
16480804|NCT02202980|40238395|FG008|Overall Study|Protocol Violation|0|||
16480805|NCT02202980|40238396|FG009|Overall Study|Protocol Violation|0|||
16480806|NCT02202980|40238397|FG010|Overall Study|Protocol Violation|0|||
16480807|NCT02202980|40238398|FG011|Overall Study|Protocol Violation|0|||
16480808|NCT02202980|40238399|FG012|Overall Study|Protocol Violation|0|||
16480809|NCT02202980|40238400|FG013|Overall Study|Protocol Violation|0|||
16480810|NCT02202980|40238387|FG000|Overall Study|Lost to Follow-up|0|||
16480811|NCT02202980|40238388|FG001|Overall Study|Lost to Follow-up|1|||
16480812|NCT02202980|40238389|FG002|Overall Study|Lost to Follow-up|1|||
16480813|NCT02202980|40238390|FG003|Overall Study|Lost to Follow-up|1|||
16480814|NCT02202980|40238391|FG004|Overall Study|Lost to Follow-up|0|||
16480815|NCT02202980|40238392|FG005|Overall Study|Lost to Follow-up|0|||
16285906|NCT02990806|39529923|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
16285907|NCT02990806|39529924|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
16480816|NCT02202980|40238393|FG006|Overall Study|Lost to Follow-up|0|||
16480817|NCT02202980|40238394|FG007|Overall Study|Lost to Follow-up|1|||
16480818|NCT02202980|40238395|FG008|Overall Study|Lost to Follow-up|1|||
16480819|NCT02202980|40238396|FG009|Overall Study|Lost to Follow-up|0|||
16480820|NCT02202980|40238397|FG010|Overall Study|Lost to Follow-up|0|||
16480821|NCT02202980|40238398|FG011|Overall Study|Lost to Follow-up|0|||
16480822|NCT02202980|40238399|FG012|Overall Study|Lost to Follow-up|1|||
16480823|NCT02202980|40238400|FG013|Overall Study|Lost to Follow-up|0|||
16480824|NCT02202980|40238387|FG000|Overall Study|Withdrew Consent|0|||
16480825|NCT02202980|40238388|FG001|Overall Study|Withdrew Consent|1|||
16480826|NCT02202980|40238389|FG002|Overall Study|Withdrew Consent|2|||
16480827|NCT02202980|40238390|FG003|Overall Study|Withdrew Consent|0|||
16480828|NCT02202980|40238391|FG004|Overall Study|Withdrew Consent|0|||
16480829|NCT02202980|40238392|FG005|Overall Study|Withdrew Consent|0|||
16480830|NCT02202980|40238393|FG006|Overall Study|Withdrew Consent|0|||
16480831|NCT02202980|40238394|FG007|Overall Study|Withdrew Consent|0|||
16480832|NCT02202980|40238395|FG008|Overall Study|Withdrew Consent|1|||
16480833|NCT02202980|40238396|FG009|Overall Study|Withdrew Consent|0|||
16480834|NCT02202980|40238397|FG010|Overall Study|Withdrew Consent|0|||
16480835|NCT02202980|40238398|FG011|Overall Study|Withdrew Consent|0|||
16480836|NCT02202980|40238399|FG012|Overall Study|Withdrew Consent|0|||
16480837|NCT02202980|40238400|FG013|Overall Study|Withdrew Consent|0|||
16480838|NCT03988088|40238401|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
16480839|NCT03988088|40238402|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
16480840|NCT03988088|40238403|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
16480841|NCT03988088|40238404|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
16480842|NCT03988088|40238401|FG000|Open-Label Addendum|Lost to Follow-up|0|||
16285908|NCT02990806|39529921|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
16285909|NCT02990806|39529922|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
16285910|NCT02990806|39529923|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
16285911|NCT02990806|39529924|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
16285912|NCT02990806|39529921|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
16285913|NCT02990806|39529922|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
16285914|NCT02990806|39529923|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
16285915|NCT02990806|39529924|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
16285916|NCT02990806|39529921|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16285917|NCT02990806|39529922|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
16285918|NCT02990806|39529923|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16285919|NCT02990806|39529924|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
16285920|NCT02990806|39529921|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
16285921|NCT02990806|39529922|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
16285922|NCT02990806|39529923|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
16285923|NCT02990806|39529924|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
16285924|NCT02990806|39529921|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
16285925|NCT02990806|39529922|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
16285926|NCT02990806|39529923|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
16285927|NCT02990806|39529924|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
16285928|NCT02990806|39529921|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
16285929|NCT02990806|39529922|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
16285930|NCT02990806|39529923|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
16285931|NCT02990806|39529924|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
16285932|NCT02990806|39529921|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
16285933|NCT02990806|39529922|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
16285934|NCT02990806|39529923|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
16285935|NCT02990806|39529924|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
16285936|NCT02990806|39529921|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
16285937|NCT02990806|39529922|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
16285938|NCT02990806|39529923|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
16285939|NCT02990806|39529924|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
16285940|NCT01613378|39529925|FG000|Overall Study|Lack of Efficacy|13|||
16285941|NCT01613378|39529925|FG000|Overall Study|Adverse Event|11|||
16285942|NCT01613378|39529925|FG000|Overall Study|Withdrawal by Subject|8|||
16285943|NCT01613378|39529925|FG000|Overall Study|Death|2|||
16285944|NCT01613378|39529925|FG000|Overall Study|Lost to Follow-up|1|||
16285945|NCT01613378|39529925|FG000|Overall Study|Other Reason|4|||
16285946|NCT04974619|39529936|FG000|Overall Study|Lost to Follow-up|0|||
16285947|NCT04974619|39529937|FG001|Overall Study|Lost to Follow-up|0|||
16285948|NCT04974619|39529938|FG002|Overall Study|Lost to Follow-up|1|||
16379920|NCT02296125|39874823|FG001|Overall Study|Withdrawal by Subject|8|||
16379921|NCT02296125|39874824|FG002|Overall Study|Withdrawal by Subject|6|||
16480843|NCT03988088|40238402|FG001|Open-Label Addendum|Lost to Follow-up|0|||
16480844|NCT03988088|40238403|FG002|Open-Label Addendum|Lost to Follow-up|1|||
16480845|NCT03988088|40238404|FG003|Open-Label Addendum|Lost to Follow-up|0|||
16480846|NCT03417219|40238405|FG000|Overall Study|Lost to Follow-up|0|||
16480847|NCT03417219|40238406|FG001|Overall Study|Lost to Follow-up|3|||
16480848|NCT00934089|40238414|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
16285949|NCT04974619|39529936|FG000|Overall Study|Withdrawal by Subject|0|||
16285950|NCT04974619|39529937|FG001|Overall Study|Withdrawal by Subject|0|||
16285951|NCT04974619|39529938|FG002|Overall Study|Withdrawal by Subject|1|||
16285952|NCT04974619|39529936|FG000|Overall Study|Protocol Violation|0|||
16285953|NCT04974619|39529937|FG001|Overall Study|Protocol Violation|1|||
16285954|NCT04974619|39529938|FG002|Overall Study|Protocol Violation|0|||
16285955|NCT01345318|39529941|FG000|Overall Study|Adverse Event|16|||
16285956|NCT01345318|39529941|FG000|Overall Study|Lack of Efficacy|17|||
16285957|NCT01345318|39529941|FG000|Overall Study|Lost to Follow-up|2|||
16480849|NCT00934089|40238415|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
16480850|NCT00934089|40238414|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
16285958|NCT01345318|39529941|FG000|Overall Study|Protocol Violation|1|||
16285959|NCT01345318|39529941|FG000|Overall Study|Withdrawal by Subject|41|||
16285960|NCT01345318|39529941|FG000|Overall Study|Other|3|||
16285961|NCT01475253|39529942|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
16285962|NCT01475253|39529943|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
16285963|NCT01475253|39529944|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
16285964|NCT01475253|39529945|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
16285965|NCT01475253|39529942|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
16285966|NCT01475253|39529943|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
16285967|NCT01475253|39529944|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
16285968|NCT01475253|39529945|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
16285969|NCT02100319|39529947|FG000|Overall Study|Case Report Forms Uncollected|11|||
16285970|NCT02100319|39529947|FG000|Overall Study|Protocol Deviation|5|||
16285971|NCT01688726|39529949|FG000|Overall Study|Adverse Event|1|||
16285972|NCT01688726|39529950|FG001|Overall Study|Adverse Event|0|||
16285973|NCT01688726|39529949|FG000|Overall Study|Relocated abroad|0|||
16285974|NCT01688726|39529950|FG001|Overall Study|Relocated abroad|1|||
16285975|NCT01189500|39529951|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
16285976|NCT01189500|39529951|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
16285977|NCT04740931|39529957|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
16285978|NCT04740931|39529958|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
16285979|NCT04740931|39529957|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
16285980|NCT04740931|39529958|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
16285981|NCT04740931|39529957|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
16285982|NCT04740931|39529958|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
16285983|NCT04740931|39529957|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
16285984|NCT04740931|39529958|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
16285985|NCT04740931|39529957|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
16285986|NCT04740931|39529958|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
16285987|NCT04740931|39529957|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
16285988|NCT04740931|39529958|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
16379922|NCT02296125|39874825|FG003|Overall Study|Withdrawal by Subject|2|||
16480851|NCT00934089|40238415|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
16480852|NCT01889238|40238417|FG000|Overall Study|Treatment ongoing|9|||
16285989|NCT04740931|39529957|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
16285990|NCT04740931|39529958|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
16285991|NCT04740931|39529957|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
16285992|NCT04740931|39529958|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
16285993|NCT04740931|39529957|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
16379923|NCT02296125|39874822|FG000|Overall Study|Adverse Event|41|||
16379924|NCT02296125|39874823|FG001|Overall Study|Adverse Event|52|||
16379925|NCT02296125|39874824|FG002|Overall Study|Adverse Event|9|||
16379926|NCT02296125|39874825|FG003|Overall Study|Adverse Event|4|||
16379927|NCT02296125|39874822|FG000|Overall Study|Severe non-compliance to protocol|0|||
16379928|NCT02296125|39874823|FG001|Overall Study|Severe non-compliance to protocol|1|||
16379929|NCT02296125|39874824|FG002|Overall Study|Severe non-compliance to protocol|0|||
16379930|NCT02296125|39874825|FG003|Overall Study|Severe non-compliance to protocol|0|||
16379931|NCT02296125|39874822|FG000|Overall Study|Condition under investigation worsened|153|||
16379932|NCT02296125|39874823|FG001|Overall Study|Condition under investigation worsened|199|||
16379933|NCT02296125|39874824|FG002|Overall Study|Condition under investigation worsened|39|||
16379934|NCT02296125|39874825|FG003|Overall Study|Condition under investigation worsened|56|||
16379935|NCT02296125|39874822|FG000|Overall Study|Any reason not specifically recorded|6|||
16379936|NCT02296125|39874823|FG001|Overall Study|Any reason not specifically recorded|4|||
16379937|NCT02296125|39874824|FG002|Overall Study|Any reason not specifically recorded|2|||
16379938|NCT02296125|39874825|FG003|Overall Study|Any reason not specifically recorded|0|||
16379939|NCT00835549|39874826|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
16379940|NCT00835549|39874827|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16379941|NCT02546323|39874841|FG000|Overall Study|Withdrawal by Subject|36|||
16379942|NCT02546323|39874842|FG001|Overall Study|Withdrawal by Subject|33|||
16480853|NCT00108433|40238418|FG000|Overall Study|Lack of Efficacy|1|||
16480854|NCT00108433|40238419|FG001|Overall Study|Lack of Efficacy|2|||
16480855|NCT00108433|40238418|FG000|Overall Study|Death|3|||
16480856|NCT00108433|40238419|FG001|Overall Study|Death|0|||
16480857|NCT00108433|40238418|FG000|Overall Study|Adverse Event|3|||
16480858|NCT00108433|40238419|FG001|Overall Study|Adverse Event|1|||
16480859|NCT00108433|40238418|FG000|Overall Study|Other|14|||
16480860|NCT00108433|40238419|FG001|Overall Study|Other|14|||
16480861|NCT00334958|40238420|FG000|Overall Study|Medication Noncompliance|0|||
16480862|NCT00334958|40238421|FG001|Overall Study|Medication Noncompliance|3|||
16480863|NCT00334958|40238420|FG000|Overall Study|Protocol Violation|2|||
16480864|NCT00334958|40238421|FG001|Overall Study|Protocol Violation|2|||
16480865|NCT00334958|40238420|FG000|Overall Study|Request of the investigator or sponsor|0|||
16480866|NCT00334958|40238421|FG001|Overall Study|Request of the investigator or sponsor|1|||
16480867|NCT00334958|40238420|FG000|Overall Study|Withdrawal by Subject|7|||
16480868|NCT00334958|40238421|FG001|Overall Study|Withdrawal by Subject|4|||
16285994|NCT04740931|39529958|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
16285995|NCT04740931|39529957|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
16285996|NCT04740931|39529958|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
16285997|NCT04740931|39529957|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
16285998|NCT04740931|39529958|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
16285999|NCT04740931|39529957|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
16286000|NCT04740931|39529958|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
16286001|NCT04740931|39529957|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
16286002|NCT04740931|39529958|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
16286003|NCT04740931|39529957|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
16286004|NCT04740931|39529958|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
16286005|NCT04740931|39529957|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
16286006|NCT04740931|39529958|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
16286007|NCT01316419|39529959|FG000|Overall Study|Not treated|103|||
16286008|NCT01316419|39529959|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
16286009|NCT01316419|39529959|FG000|Overall Study|Lost to Follow-up|19|||
16286010|NCT01832402|39529960|FG000|Overall Study|Lost to Follow-up|2|||
16286011|NCT01832402|39529961|FG001|Overall Study|Lost to Follow-up|0|||
16286012|NCT01832402|39529960|FG000|Overall Study|Withdrawal by Subject|3|||
16286013|NCT01832402|39529961|FG001|Overall Study|Withdrawal by Subject|3|||
16286014|NCT01832402|39529960|FG000|Overall Study|Declining Performance status|2|||
16286015|NCT01832402|39529961|FG001|Overall Study|Declining Performance status|1|||
16286016|NCT00966381|39529962|FG000|Overall Study|Withdrawal by Subject|2|||
16286017|NCT00966381|39529963|FG001|Overall Study|Withdrawal by Subject|2|||
16286018|NCT00537199|39529964|FG000|Overall Study|Study Terminated|1|||
16286019|NCT00346164|39529965|FG000|Overall Study|Adverse Event|0|||
16286020|NCT00346164|39529966|FG001|Overall Study|Adverse Event|0|||
16286021|NCT00346164|39529967|FG002|Overall Study|Adverse Event|0|||
16286022|NCT00346164|39529968|FG003|Overall Study|Adverse Event|1|||
16286023|NCT00346164|39529965|FG000|Overall Study|Lack of Efficacy|0|||
16286024|NCT00346164|39529966|FG001|Overall Study|Lack of Efficacy|1|||
16286025|NCT00346164|39529967|FG002|Overall Study|Lack of Efficacy|7|||
16286026|NCT00346164|39529968|FG003|Overall Study|Lack of Efficacy|25|||
16286027|NCT00346164|39529965|FG000|Overall Study|Physician Decision|0|||
16286028|NCT00346164|39529966|FG001|Overall Study|Physician Decision|1|||
16286029|NCT00346164|39529967|FG002|Overall Study|Physician Decision|2|||
16286030|NCT00346164|39529968|FG003|Overall Study|Physician Decision|27|||
16286031|NCT00346164|39529965|FG000|Overall Study|Protocol Violation|6|||
16286032|NCT00346164|39529966|FG001|Overall Study|Protocol Violation|2|||
16286033|NCT00346164|39529967|FG002|Overall Study|Protocol Violation|10|||
16480869|NCT00334958|40238420|FG000|Overall Study|Adverse Event|27|||
16480870|NCT00334958|40238421|FG001|Overall Study|Adverse Event|12|||
16480871|NCT00334958|40238420|FG000|Overall Study|Other|1|||
16480872|NCT00334958|40238421|FG001|Overall Study|Other|2|||
16480873|NCT02124161|40238423|FG000|Overall Study|Other unspecified|0|||
16480874|NCT02124161|40238424|FG001|Overall Study|Other unspecified|1|||
16480875|NCT02124161|40238423|FG000|Overall Study|Death|1|||
16480876|NCT02124161|40238424|FG001|Overall Study|Death|0|||
16480877|NCT02124161|40238423|FG000|Overall Study|Protocol Violation|2|||
16286034|NCT00346164|39529968|FG003|Overall Study|Protocol Violation|4|||
16286035|NCT00346164|39529965|FG000|Overall Study|Withdrawal by Subject|0|||
16480878|NCT02124161|40238424|FG001|Overall Study|Protocol Violation|1|||
16480879|NCT02124161|40238423|FG000|Overall Study|Withdrawal by Subject|1|||
16480880|NCT02124161|40238424|FG001|Overall Study|Withdrawal by Subject|2|||
16480881|NCT02124161|40238423|FG000|Overall Study|Adverse Event|2|||
16286036|NCT00346164|39529966|FG001|Overall Study|Withdrawal by Subject|0|||
16286037|NCT00346164|39529967|FG002|Overall Study|Withdrawal by Subject|2|||
16286038|NCT00346164|39529968|FG003|Overall Study|Withdrawal by Subject|0|||
16480882|NCT02124161|40238424|FG001|Overall Study|Adverse Event|0|||
16480883|NCT02124161|40238423|FG000|Overall Study|Does not meet entrance criteria|2|||
16480884|NCT02124161|40238424|FG001|Overall Study|Does not meet entrance criteria|3|||
16480885|NCT02124161|40238423|FG000|Overall Study|No longer meets eligibility criteria|5|||
16480886|NCT02124161|40238424|FG001|Overall Study|No longer meets eligibility criteria|4|||
16480887|NCT02124161|40238423|FG000|Overall Study|Lost to Follow-up|3|||
16480888|NCT02124161|40238424|FG001|Overall Study|Lost to Follow-up|4|||
16480889|NCT00586625|40238427|FG000|Overall Study|Adverse Event|6|||
16480890|NCT00586625|40238428|FG001|Overall Study|Adverse Event|6|||
16480891|NCT00586625|40238427|FG000|Overall Study|Protocol Violation|3|||
16480892|NCT00586625|40238428|FG001|Overall Study|Protocol Violation|0|||
16480893|NCT00586625|40238427|FG000|Overall Study|Withdrawal by Subject|32|||
16480894|NCT00586625|40238428|FG001|Overall Study|Withdrawal by Subject|10|||
16480895|NCT00586625|40238427|FG000|Overall Study|Subject non-compliance|0|||
16480896|NCT00586625|40238428|FG001|Overall Study|Subject non-compliance|1|||
16480897|NCT00586625|40238427|FG000|Overall Study|Subject unable to return for visit|2|||
16480898|NCT00586625|40238428|FG001|Overall Study|Subject unable to return for visit|0|||
16480899|NCT00621582|40238429|FG000|Overall Study|Adverse Event|7|||
16480900|NCT00621582|40238429|FG000|Overall Study|Protocol Violation|57|||
16480901|NCT00621582|40238429|FG000|Overall Study|Lost to Follow-up|24|||
16480902|NCT00621582|40238429|FG000|Overall Study|issues not identified by investigators|18|||
16480903|NCT02699593|40238430|FG000|Period 1|Unsatisfactory Visual Response|0|||
16480904|NCT02699593|40238431|FG001|Period 1|Unsatisfactory Visual Response|1|||
16480905|NCT02699593|40238430|FG000|Period 1|Torn Contact Len|4|||
16480906|NCT02699593|40238431|FG001|Period 1|Torn Contact Len|3|||
16480907|NCT02699593|40238430|FG000|Period 1|Protocol Violation|0|||
16480908|NCT02699593|40238431|FG001|Period 1|Protocol Violation|1|||
16480909|NCT02699593|40238430|FG000|Period 1|Withdrawal by Subject|0|||
16480910|NCT02699593|40238431|FG001|Period 1|Withdrawal by Subject|1|||
16480911|NCT02699593|40238430|FG000|Period 1|Adverse Event|1|||
16480912|NCT02699593|40238431|FG001|Period 1|Adverse Event|1|||
16480913|NCT02699593|40238430|FG000|Period 2|Adverse Event|1|||
16480914|NCT02699593|40238431|FG001|Period 2|Adverse Event|1|||
16480915|NCT02699593|40238430|FG000|Period 2|Lost Contact Lens|0|||
16480916|NCT02699593|40238431|FG001|Period 2|Lost Contact Lens|1|||
16480917|NCT02699593|40238430|FG000|Period 2|Torn Contact Lens|1|||
16480918|NCT02699593|40238431|FG001|Period 2|Torn Contact Lens|0|||
16480919|NCT00531934|40238432|FG000|Overall Study|Adverse Event|4|||
16480920|NCT00531934|40238433|FG001|Overall Study|Adverse Event|8|||
16480921|NCT00531934|40238432|FG000|Overall Study|Progression|52|||
16480922|NCT00531934|40238433|FG001|Overall Study|Progression|42|||
16480923|NCT00531934|40238432|FG000|Overall Study|Death|7|||
16286039|NCT00346164|39529965|FG000|Overall Study|Ineligible|11|||
16286040|NCT00346164|39529966|FG001|Overall Study|Ineligible|2|||
16286041|NCT00346164|39529967|FG002|Overall Study|Ineligible|2|||
16286042|NCT00346164|39529968|FG003|Overall Study|Ineligible|23|||
16286043|NCT00346164|39529965|FG000|Overall Study|Refusal of further protocol therapy|0|||
16286044|NCT00346164|39529966|FG001|Overall Study|Refusal of further protocol therapy|1|||
16286045|NCT00346164|39529967|FG002|Overall Study|Refusal of further protocol therapy|3|||
16286046|NCT00346164|39529968|FG003|Overall Study|Refusal of further protocol therapy|15|||
16286047|NCT00346164|39529965|FG000|Overall Study|Inability to start week 16 tx on time|0|||
16286048|NCT00346164|39529966|FG001|Overall Study|Inability to start week 16 tx on time|0|||
16286049|NCT00346164|39529967|FG002|Overall Study|Inability to start week 16 tx on time|0|||
16286050|NCT00346164|39529968|FG003|Overall Study|Inability to start week 16 tx on time|11|||
16286051|NCT01056640|39529969|FG000|Overall Study|Withdrawal by Subject|11|||
16286052|NCT01056640|39529970|FG001|Overall Study|Withdrawal by Subject|8|||
16286053|NCT01056640|39529969|FG000|Overall Study|Death|15|||
16286054|NCT01056640|39529970|FG001|Overall Study|Death|4|||
16286055|NCT01297322|39529972|FG000|Overall Study|Lost to Follow-up|1|||
16286056|NCT01297322|39529973|FG001|Overall Study|Lost to Follow-up|0|||
16286057|NCT01297322|39529972|FG000|Overall Study|Withdrawal by Subject|0|||
16286058|NCT01297322|39529973|FG001|Overall Study|Withdrawal by Subject|1|||
16286059|NCT01297322|39529972|FG000|Overall Study|Protocol Violation|0|||
16286060|NCT01297322|39529973|FG001|Overall Study|Protocol Violation|3|||
16286061|NCT00567476|39529977|FG000|Overall Study|Adverse Event|2|||
16286062|NCT00567476|39529978|FG001|Overall Study|Adverse Event|0|||
16286063|NCT00567476|39529977|FG000|Overall Study|Pregnancy|1|||
16286064|NCT00567476|39529978|FG001|Overall Study|Pregnancy|0|||
16286065|NCT00567476|39529977|FG000|Overall Study|Protocol Violation|4|||
16286066|NCT00567476|39529978|FG001|Overall Study|Protocol Violation|1|||
16286067|NCT00567476|39529977|FG000|Overall Study|Lost to Follow-up|0|||
16286068|NCT00567476|39529978|FG001|Overall Study|Lost to Follow-up|1|||
16286069|NCT00567476|39529977|FG000|Overall Study|Administrative issues|1|||
16286070|NCT00567476|39529978|FG001|Overall Study|Administrative issues|0|||
16286071|NCT00567476|39529977|FG000|Overall Study|Medical Decision|0|||
16480924|NCT00531934|40238433|FG001|Overall Study|Death|10|||
16286072|NCT00567476|39529978|FG001|Overall Study|Medical Decision|1|||
16480925|NCT00531934|40238432|FG000|Overall Study|Withdrawal by Subject|1|||
16480926|NCT00531934|40238433|FG001|Overall Study|Withdrawal by Subject|1|||
16480927|NCT00531934|40238432|FG000|Overall Study|Other|2|||
16480928|NCT00531934|40238433|FG001|Overall Study|Other|2|||
16480929|NCT00319501|40238434|FG000|Double-blind Period|Withdrawal by Subject|0|||
16480930|NCT00319501|40238435|FG001|Double-blind Period|Withdrawal by Subject|3|||
16286073|NCT00567476|39529977|FG000|Overall Study|Non-adherence to protocol|0|||
16286074|NCT00567476|39529978|FG001|Overall Study|Non-adherence to protocol|1|||
16286075|NCT01929395|39529979|FG000|Overall Study|Did not complete - non-related toxicity|1|||
16286076|NCT01929395|39529980|FG001|Overall Study|Did not complete - non-related toxicity|0|||
16286077|NCT01929395|39529981|FG002|Overall Study|Did not complete - non-related toxicity|0|||
16286078|NCT01929395|39529979|FG000|Overall Study|Withdrawal by Subject|0|||
16286079|NCT01929395|39529980|FG001|Overall Study|Withdrawal by Subject|1|||
16286080|NCT01929395|39529981|FG002|Overall Study|Withdrawal by Subject|0|||
16286081|NCT01929395|39529979|FG000|Overall Study|Screen Fail|0|||
16286082|NCT01929395|39529980|FG001|Overall Study|Screen Fail|0|||
16286083|NCT01929395|39529981|FG002|Overall Study|Screen Fail|1|||
16286084|NCT03087786|39529982|FG000|Overall Study|Withdrawal by Subject|2|||
16286085|NCT03087786|39529983|FG001|Overall Study|Withdrawal by Subject|0|||
16286086|NCT02510014|39529986|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
16286087|NCT02510014|39529987|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
16286088|NCT02510014|39529986|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
16286089|NCT02510014|39529987|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
16286090|NCT02510014|39529986|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
16286091|NCT02510014|39529987|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
16286092|NCT02510014|39529986|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
16286093|NCT02510014|39529987|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
16286094|NCT02510014|39529986|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
16286095|NCT02510014|39529987|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
16286096|NCT02510014|39529986|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
16286097|NCT02510014|39529987|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
16286098|NCT02510014|39529986|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
16286099|NCT02510014|39529987|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
16286100|NCT02510014|39529986|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
16286101|NCT02510014|39529987|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
16286102|NCT02510014|39529986|FG000|Treatment Period|Adverse Event|11|||
16286103|NCT02510014|39529987|FG001|Treatment Period|Adverse Event|4|||
16286104|NCT02510014|39529986|FG000|Treatment Period|Withdrawal symptoms|3|||
16286105|NCT02510014|39529987|FG001|Treatment Period|Withdrawal symptoms|0|||
16286106|NCT02510014|39529986|FG000|Treatment Period|Lost to Follow-up|80|||
16286107|NCT02510014|39529987|FG001|Treatment Period|Lost to Follow-up|19|||
16286108|NCT02510014|39529986|FG000|Treatment Period|Physician Decision|5|||
16286109|NCT02510014|39529987|FG001|Treatment Period|Physician Decision|0|||
16286110|NCT02510014|39529986|FG000|Treatment Period|Withdrawal by Subject|67|||
16286111|NCT02510014|39529987|FG001|Treatment Period|Withdrawal by Subject|24|||
16286112|NCT02510014|39529986|FG000|Treatment Period|Withdrawn by the investigator|7|||
16286113|NCT02510014|39529987|FG001|Treatment Period|Withdrawn by the investigator|1|||
16286114|NCT02510014|39529986|FG000|Treatment Period|Protocol Violation|4|||
16286115|NCT02510014|39529987|FG001|Treatment Period|Protocol Violation|4|||
16286116|NCT02510014|39529986|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
16286117|NCT02510014|39529987|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
16286118|NCT02384850|39529989|FG000|Overall Study|Withdrawal by Subject|2|||
16286119|NCT02384850|39529990|FG001|Overall Study|Withdrawal by Subject|2|||
16286120|NCT01392326|39529991|FG000|Overall Study|Death|2|||
16286121|NCT01392326|39529992|FG001|Overall Study|Death|0|||
16286122|NCT01392326|39529993|FG002|Overall Study|Death|0|||
16286123|NCT01392326|39529991|FG000|Overall Study|Withdrawal by Subject|12|||
16286124|NCT01392326|39529992|FG001|Overall Study|Withdrawal by Subject|11|||
16286125|NCT01392326|39529993|FG002|Overall Study|Withdrawal by Subject|15|||
16286126|NCT01392326|39529991|FG000|Overall Study|Protocol Violation|2|||
16286127|NCT01392326|39529992|FG001|Overall Study|Protocol Violation|0|||
16286128|NCT01392326|39529993|FG002|Overall Study|Protocol Violation|0|||
16286129|NCT01392326|39529991|FG000|Overall Study|Pregnancy|0|||
16286130|NCT01392326|39529992|FG001|Overall Study|Pregnancy|0|||
16286131|NCT01392326|39529993|FG002|Overall Study|Pregnancy|1|||
16286132|NCT01392326|39529991|FG000|Overall Study|Physician Decision|7|||
16286133|NCT01392326|39529992|FG001|Overall Study|Physician Decision|5|||
16286134|NCT01392326|39529993|FG002|Overall Study|Physician Decision|2|||
16286135|NCT01392326|39529991|FG000|Overall Study|Lost to Follow-up|1|||
16286136|NCT01392326|39529992|FG001|Overall Study|Lost to Follow-up|3|||
16286137|NCT01392326|39529993|FG002|Overall Study|Lost to Follow-up|4|||
16286138|NCT01392326|39529991|FG000|Overall Study|Lack of Efficacy|14|||
16286139|NCT01392326|39529992|FG001|Overall Study|Lack of Efficacy|10|||
16286140|NCT01392326|39529993|FG002|Overall Study|Lack of Efficacy|15|||
16286141|NCT01392326|39529991|FG000|Overall Study|Adverse Event|9|||
16286142|NCT01392326|39529992|FG001|Overall Study|Adverse Event|6|||
16286143|NCT01392326|39529993|FG002|Overall Study|Adverse Event|11|||
16286144|NCT02014441|39529994|FG000|Overall Study|Withdrawal by Subject|12|||
16286145|NCT04233879|39529997|FG000|Overall Study|Death|2|||
16286146|NCT04233879|39529998|FG001|Overall Study|Death|0|||
16286147|NCT04233879|39529997|FG000|Overall Study|Lost to Follow-up|3|||
16286148|NCT04233879|39529998|FG001|Overall Study|Lost to Follow-up|8|||
16286149|NCT04233879|39529997|FG000|Overall Study|Physician Decision|4|||
16286150|NCT04233879|39529998|FG001|Overall Study|Physician Decision|4|||
16286151|NCT04233879|39529997|FG000|Overall Study|Withdrawal by Subject|7|||
16286152|NCT04233879|39529998|FG001|Overall Study|Withdrawal by Subject|10|||
16286153|NCT04233879|39529997|FG000|Overall Study|Other|281|||
16286154|NCT04233879|39529998|FG001|Overall Study|Other|279|||
16480931|NCT00319501|40238434|FG000|Double-blind Period|Sponsor Request|1|||
16480932|NCT00319501|40238435|FG001|Double-blind Period|Sponsor Request|0|||
16480933|NCT00319501|40238434|FG000|Double-blind Period|Did not receive treatment|42|||
16480934|NCT00319501|40238435|FG001|Double-blind Period|Did not receive treatment|29|||
16480935|NCT00319501|40238434|FG000|Open-label Period|Adverse Event|5|||
16480936|NCT00319501|40238435|FG001|Open-label Period|Adverse Event|0|||
16480937|NCT00319501|40238434|FG000|Open-label Period|Protocol Violation|6|||
16480938|NCT00319501|40238435|FG001|Open-label Period|Protocol Violation|0|||
16480939|NCT00319501|40238434|FG000|Open-label Period|Withdrawal by Subject|38|||
16480940|NCT00319501|40238435|FG001|Open-label Period|Withdrawal by Subject|0|||
16480941|NCT00319501|40238434|FG000|Open-label Period|Principal Investigator decision|6|||
16480942|NCT00319501|40238435|FG001|Open-label Period|Principal Investigator decision|0|||
16480943|NCT00319501|40238434|FG000|Open-label Period|Sponsor request|12|||
16480944|NCT00319501|40238435|FG001|Open-label Period|Sponsor request|0|||
16480945|NCT00319501|40238434|FG000|Open-label Period|Lost to Follow-up|5|||
16480946|NCT00319501|40238435|FG001|Open-label Period|Lost to Follow-up|0|||
16480947|NCT00319501|40238434|FG000|Open-label Period|Did not receive treatment|33|||
16480948|NCT00319501|40238435|FG001|Open-label Period|Did not receive treatment|0|||
16480949|NCT00319501|40238434|FG000|Open-label Period|Other|11|||
16480950|NCT00319501|40238435|FG001|Open-label Period|Other|0|||
16480951|NCT00319501|40238434|FG000|Open-label Extension Period|Adverse Event|2|||
16480952|NCT00319501|40238435|FG001|Open-label Extension Period|Adverse Event|0|||
16480953|NCT00319501|40238434|FG000|Open-label Extension Period|Did not receive treatment|18|||
16480954|NCT00319501|40238435|FG001|Open-label Extension Period|Did not receive treatment|0|||
16480955|NCT00319501|40238434|FG000|Open-label Extension Period|Other|1|||
16480956|NCT00319501|40238435|FG001|Open-label Extension Period|Other|0|||
16480957|NCT00319501|40238434|FG000|Open-label Extension Period|Principal investigator decision|2|||
16480958|NCT00319501|40238435|FG001|Open-label Extension Period|Principal investigator decision|0|||
16480959|NCT00319501|40238434|FG000|Open-label Extension Period|Sponsor request|26|||
16480960|NCT00319501|40238435|FG001|Open-label Extension Period|Sponsor request|0|||
16480961|NCT00319501|40238434|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
16480962|NCT00319501|40238435|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
16480963|NCT03758443|40238436|FG000|Induction Period|Adverse Event|2|||
16480964|NCT03758443|40238437|FG001|Induction Period|Adverse Event|4|||
16480965|NCT03758443|40238438|FG002|Induction Period|Adverse Event|2|||
16480966|NCT03758443|40238439|FG003|Induction Period|Adverse Event|3|||
16480967|NCT03758443|40238436|FG000|Induction Period|Physician Decision|1|||
16480968|NCT03758443|40238437|FG001|Induction Period|Physician Decision|1|||
16480969|NCT03758443|40238438|FG002|Induction Period|Physician Decision|3|||
16480970|NCT03758443|40238439|FG003|Induction Period|Physician Decision|0|||
16480971|NCT03758443|40238436|FG000|Induction Period|Protocol Violation|0|||
16480972|NCT03758443|40238437|FG001|Induction Period|Protocol Violation|0|||
16480973|NCT03758443|40238438|FG002|Induction Period|Protocol Violation|0|||
16480974|NCT03758443|40238439|FG003|Induction Period|Protocol Violation|1|||
16480975|NCT03758443|40238436|FG000|Induction Period|Withdrawal by Subject|3|||
16480976|NCT03758443|40238437|FG001|Induction Period|Withdrawal by Subject|2|||
16480977|NCT03758443|40238438|FG002|Induction Period|Withdrawal by Subject|2|||
16480978|NCT03758443|40238439|FG003|Induction Period|Withdrawal by Subject|4|||
16480979|NCT03758443|40238436|FG000|Extended Induction Period|Adverse Event|1|||
16480980|NCT03758443|40238437|FG001|Extended Induction Period|Adverse Event|1|||
16480981|NCT03758443|40238438|FG002|Extended Induction Period|Adverse Event|0|||
16480982|NCT03758443|40238439|FG003|Extended Induction Period|Adverse Event|1|||
16480983|NCT03758443|40238436|FG000|Extended Induction Period|Lost to Follow-up|1|||
16480984|NCT03758443|40238437|FG001|Extended Induction Period|Lost to Follow-up|0|||
16286155|NCT00885677|39529999|FG000|Overall Study|Death|40|||
16286156|NCT00885677|39530000|FG001|Overall Study|Death|34|||
16286157|NCT00885677|39529999|FG000|Overall Study|Lost to Follow-up|15|||
16480985|NCT03758443|40238438|FG002|Extended Induction Period|Lost to Follow-up|0|||
16480986|NCT03758443|40238439|FG003|Extended Induction Period|Lost to Follow-up|0|||
16480987|NCT03758443|40238436|FG000|Extended Induction Period|Physician Decision|2|||
16480988|NCT03758443|40238437|FG001|Extended Induction Period|Physician Decision|1|||
16480989|NCT03758443|40238438|FG002|Extended Induction Period|Physician Decision|2|||
16480990|NCT03758443|40238439|FG003|Extended Induction Period|Physician Decision|2|||
16480991|NCT03758443|40238436|FG000|Extended Induction Period|Protocol Violation|0|||
16480992|NCT03758443|40238437|FG001|Extended Induction Period|Protocol Violation|0|||
16480993|NCT03758443|40238438|FG002|Extended Induction Period|Protocol Violation|0|||
16480994|NCT03758443|40238439|FG003|Extended Induction Period|Protocol Violation|1|||
16480995|NCT03758443|40238436|FG000|Extended Induction Period|Withdrawal by Subject|8|||
16480996|NCT03758443|40238437|FG001|Extended Induction Period|Withdrawal by Subject|1|||
16480997|NCT03758443|40238438|FG002|Extended Induction Period|Withdrawal by Subject|7|||
16480998|NCT03758443|40238439|FG003|Extended Induction Period|Withdrawal by Subject|3|||
16480999|NCT03758443|40238436|FG000|Extended Induction Period|Miscellaneous|1|||
16481000|NCT03758443|40238437|FG001|Extended Induction Period|Miscellaneous|0|||
16481001|NCT03758443|40238438|FG002|Extended Induction Period|Miscellaneous|0|||
16481002|NCT03758443|40238439|FG003|Extended Induction Period|Miscellaneous|0|||
16481003|NCT03758443|40238436|FG000|Maintenance Period|Adverse Event|1|||
16481004|NCT03758443|40238437|FG001|Maintenance Period|Adverse Event|2|||
16481005|NCT03758443|40238438|FG002|Maintenance Period|Adverse Event|0|||
16481006|NCT03758443|40238439|FG003|Maintenance Period|Adverse Event|0|||
16481007|NCT03758443|40238436|FG000|Maintenance Period|Lost to Follow-up|0|||
16481008|NCT03758443|40238437|FG001|Maintenance Period|Lost to Follow-up|0|||
16481009|NCT03758443|40238438|FG002|Maintenance Period|Lost to Follow-up|0|||
16481010|NCT03758443|40238439|FG003|Maintenance Period|Lost to Follow-up|1|||
16481011|NCT03758443|40238436|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
16481012|NCT03758443|40238437|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
16286158|NCT00885677|39530000|FG001|Overall Study|Lost to Follow-up|13|||
16286159|NCT00885677|39529999|FG000|Overall Study|Protocol Violation|54|||
16286160|NCT00885677|39530000|FG001|Overall Study|Protocol Violation|54|||
16286161|NCT00885677|39529999|FG000|Overall Study|premature study closure|41|||
16286162|NCT00885677|39530000|FG001|Overall Study|premature study closure|44|||
16286163|NCT00885677|39529999|FG000|Overall Study|device/lead revision or replacement|7|||
16286164|NCT00885677|39530000|FG001|Overall Study|device/lead revision or replacement|6|||
16286165|NCT00885677|39529999|FG000|Overall Study|Heart transplantation|1|||
16481013|NCT03758443|40238438|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
16481014|NCT03758443|40238439|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
16481015|NCT03758443|40238436|FG000|Maintenance Period|Protocol Violation|0|||
16481016|NCT03758443|40238437|FG001|Maintenance Period|Protocol Violation|1|||
16481017|NCT03758443|40238438|FG002|Maintenance Period|Protocol Violation|0|||
16481018|NCT03758443|40238439|FG003|Maintenance Period|Protocol Violation|0|||
16481019|NCT03758443|40238436|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
16481020|NCT03758443|40238437|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
16481021|NCT03758443|40238438|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
16286166|NCT00885677|39530000|FG001|Overall Study|Heart transplantation|0|||
16286167|NCT00885677|39529999|FG000|Overall Study|Inclusion/exclusion not met|25|||
16286168|NCT00885677|39530000|FG001|Overall Study|Inclusion/exclusion not met|27|||
16286169|NCT01787279|39530003|FG000|Overall Study|Lost to Follow-up|2|||
16286170|NCT01787279|39530003|FG000|Overall Study|Lack of Efficacy|1|||
16286171|NCT02221037|39530004|FG000|Overall Study|Physician Decision|0|||
16286172|NCT02221037|39530005|FG001|Overall Study|Physician Decision|0|||
16286173|NCT02221037|39530006|FG002|Overall Study|Physician Decision|1|||
16286174|NCT02221037|39530007|FG003|Overall Study|Physician Decision|0|||
16286175|NCT01652729|39530008|FG000|Overall Study|Withdrawal by Subject|14|||
16286176|NCT01652729|39530009|FG001|Overall Study|Withdrawal by Subject|7|||
16286177|NCT01652729|39530010|FG002|Overall Study|Withdrawal by Subject|7|||
16286178|NCT01652729|39530008|FG000|Overall Study|Adverse Event|4|||
16286179|NCT01652729|39530009|FG001|Overall Study|Adverse Event|0|||
16286180|NCT01652729|39530010|FG002|Overall Study|Adverse Event|3|||
16286181|NCT01652729|39530008|FG000|Overall Study|Physician Decision|1|||
16286182|NCT01652729|39530009|FG001|Overall Study|Physician Decision|0|||
16286183|NCT01652729|39530010|FG002|Overall Study|Physician Decision|1|||
16286184|NCT01652729|39530008|FG000|Overall Study|Protocol Violation|1|||
16286185|NCT01652729|39530009|FG001|Overall Study|Protocol Violation|0|||
16286186|NCT01652729|39530010|FG002|Overall Study|Protocol Violation|0|||
16286187|NCT01652729|39530008|FG000|Overall Study|Lost to Follow-up|6|||
16286188|NCT01652729|39530009|FG001|Overall Study|Lost to Follow-up|6|||
16286189|NCT01652729|39530010|FG002|Overall Study|Lost to Follow-up|3|||
16286190|NCT01652729|39530008|FG000|Overall Study|Administrative|1|||
16286191|NCT01652729|39530009|FG001|Overall Study|Administrative|0|||
16286192|NCT01652729|39530010|FG002|Overall Study|Administrative|0|||
16286193|NCT02224573|39530015|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
16286194|NCT02224573|39530016|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
16286195|NCT02224573|39530015|FG000|Treatment Phase|Started on Other IMP|1|||
16286196|NCT02224573|39530016|FG001|Treatment Phase|Started on Other IMP|0|||
16286197|NCT02224573|39530015|FG000|Treatment Phase|Participant Discontinued IMP|0|||
16286198|NCT02224573|39530016|FG001|Treatment Phase|Participant Discontinued IMP|1|||
16286199|NCT02224573|39530015|FG000|Treatment Phase|Lack of Efficacy|15|||
16286200|NCT02224573|39530016|FG001|Treatment Phase|Lack of Efficacy|8|||
16286201|NCT02224573|39530015|FG000|Treatment Phase|Began Commercial Product|1|||
16286202|NCT02224573|39530016|FG001|Treatment Phase|Began Commercial Product|0|||
16286203|NCT02224573|39530015|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
16286204|NCT02224573|39530016|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
16286205|NCT02224573|39530015|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
16286206|NCT02224573|39530016|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
16286207|NCT02224573|39530015|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
16286208|NCT02224573|39530016|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
16286209|NCT02224573|39530015|FG000|Treatment Phase|Continued Compassionate Use|1|||
16286210|NCT02224573|39530016|FG001|Treatment Phase|Continued Compassionate Use|0|||
16286211|NCT02224573|39530015|FG000|Treatment Phase|Lack of Efficiency|2|||
16286212|NCT02224573|39530016|FG001|Treatment Phase|Lack of Efficiency|1|||
16286213|NCT02224573|39530015|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
16286214|NCT02224573|39530016|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
16286215|NCT02224573|39530015|FG000|Treatment Phase|Participant Moved|2|||
16286216|NCT02224573|39530016|FG001|Treatment Phase|Participant Moved|0|||
16286217|NCT02224573|39530015|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
16286218|NCT02224573|39530016|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
16286219|NCT02224573|39530015|FG000|Treatment Phase|Refused Medication|1|||
16286220|NCT02224573|39530016|FG001|Treatment Phase|Refused Medication|1|||
16286221|NCT02224573|39530015|FG000|Treatment Phase|Adverse Event|26|||
16286222|NCT02224573|39530016|FG001|Treatment Phase|Adverse Event|38|||
16286223|NCT02224573|39530015|FG000|Treatment Phase|Placed in Group Home|0|||
16286224|NCT02224573|39530016|FG001|Treatment Phase|Placed in Group Home|1|||
16286225|NCT02224573|39530015|FG000|Treatment Phase|Pursued Other Trials|1|||
16286226|NCT02224573|39530016|FG001|Treatment Phase|Pursued Other Trials|0|||
16286227|NCT02224573|39530015|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
16286228|NCT02224573|39530016|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
16286229|NCT02224573|39530015|FG000|Treatment Phase|Lost to Follow-up|2|||
16286230|NCT02224573|39530016|FG001|Treatment Phase|Lost to Follow-up|1|||
16286231|NCT02224573|39530015|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
16286232|NCT02224573|39530016|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
16286233|NCT02224573|39530015|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
16286234|NCT02224573|39530016|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
16286235|NCT02224573|39530015|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
16286236|NCT02224573|39530016|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
16286237|NCT02224573|39530015|FG000|Taper Phase|Adverse Event|1|||
16286238|NCT02224573|39530016|FG001|Taper Phase|Adverse Event|1|||
16286239|NCT01460901|39530017|FG000|Overall Study|Withdrawal by Subject|2|||
16286240|NCT03710590|39530018|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
16286241|NCT03710590|39530019|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
16286242|NCT02017860|39530030|FG000|Overall Study|Adverse Event|1|||
16286243|NCT02017860|39530030|FG000|Overall Study|Withdrawal by Subject|1|||
16286244|NCT01674647|39530031|FG000|Treatment Period|Death|4|||
16286245|NCT01674647|39530032|FG001|Treatment Period|Death|1|||
16286246|NCT01674647|39530031|FG000|Treatment Period|Efficacy outcome reached|0|||
16286247|NCT01674647|39530032|FG001|Treatment Period|Efficacy outcome reached|1|||
16286248|NCT01674647|39530031|FG000|Treatment Period|Physician Decision|3|||
16286249|NCT01674647|39530032|FG001|Treatment Period|Physician Decision|1|||
16286250|NCT01674647|39530031|FG000|Treatment Period|Adverse Event|60|||
16286251|NCT01674647|39530032|FG001|Treatment Period|Adverse Event|22|||
16286252|NCT01674647|39530031|FG000|Treatment Period|Non-compliance with study drug|3|||
16286253|NCT01674647|39530032|FG001|Treatment Period|Non-compliance with study drug|0|||
16286254|NCT01674647|39530031|FG000|Treatment Period|Lost to Follow-up|1|||
16286255|NCT01674647|39530032|FG001|Treatment Period|Lost to Follow-up|1|||
16286256|NCT01674647|39530031|FG000|Treatment Period|Withdrawal by Subject|19|||
16286257|NCT01674647|39530032|FG001|Treatment Period|Withdrawal by Subject|16|||
16286258|NCT01674647|39530031|FG000|Treatment Period|Switching to other therapy|5|||
16286259|NCT01674647|39530032|FG001|Treatment Period|Switching to other therapy|2|||
16286260|NCT01674647|39530031|FG000|Treatment Period|Logistical difficulties|5|||
16286261|NCT01674647|39530032|FG001|Treatment Period|Logistical difficulties|8|||
16286262|NCT01674647|39530031|FG000|Treatment Period|Treatment failure|0|||
16286263|NCT01674647|39530032|FG001|Treatment Period|Treatment failure|14|||
16286264|NCT01674647|39530031|FG000|Treatment Period|Protocol Violation|56|||
16286265|NCT01674647|39530032|FG001|Treatment Period|Protocol Violation|36|||
16286266|NCT01674647|39530031|FG000|30-day Safety Follow-up Period|Death|3|||
16286267|NCT01674647|39530032|FG001|30-day Safety Follow-up Period|Death|2|||
16286268|NCT01674647|39530031|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
16286269|NCT01674647|39530032|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
16286270|NCT01674647|39530031|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
16286271|NCT01674647|39530032|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
16286272|NCT01674647|39530031|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
16286273|NCT01674647|39530032|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
16286274|NCT01674647|39530031|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
16286275|NCT01674647|39530032|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
16286276|NCT01674647|39530031|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
16286277|NCT01674647|39530032|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
16286278|NCT00513682|39530033|FG000|Washout Phase|Adverse Event|2|||
16286279|NCT00754442|39530034|FG000|Overall Study|Withdrawal by Subject|5|||
16286280|NCT00754442|39530035|FG001|Overall Study|Withdrawal by Subject|3|||
16286281|NCT01663727|39530036|FG000|Overall Study|Death|161|||
16286282|NCT01663727|39530037|FG001|Overall Study|Death|155|||
16286283|NCT01663727|39530036|FG000|Overall Study|Lost to Follow-up|10|||
16286284|NCT01663727|39530037|FG001|Overall Study|Lost to Follow-up|8|||
16286285|NCT01663727|39530036|FG000|Overall Study|Withdrawal by Subject|18|||
16286286|NCT01663727|39530037|FG001|Overall Study|Withdrawal by Subject|25|||
16286287|NCT01663727|39530036|FG000|Overall Study|Study Terminated|51|||
16286288|NCT01663727|39530037|FG001|Overall Study|Study Terminated|50|||
16286289|NCT01663727|39530036|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
16286290|NCT01663727|39530037|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
16286291|NCT01663727|39530036|FG000|Overall Study|Withdrawal prior to dosing.|1|||
16286292|NCT01663727|39530037|FG001|Overall Study|Withdrawal prior to dosing.|0|||
16286293|NCT01272921|39533065|FG000|Overall Study|Protocol Violation|2|||
16286294|NCT01272921|39533066|FG001|Overall Study|Protocol Violation|1|||
16286295|NCT00384293|39533070|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
16286296|NCT00384293|39533071|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
16286297|NCT00384293|39533072|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
16286298|NCT00384293|39533070|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
16286299|NCT00384293|39533071|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
16286300|NCT00384293|39533072|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
16286301|NCT00384293|39533070|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
16286302|NCT00384293|39533071|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
16286303|NCT00384293|39533072|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
16286304|NCT00384293|39533070|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
16286305|NCT00384293|39533071|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
16286306|NCT00384293|39533072|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
16286307|NCT00384293|39533070|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
16286308|NCT00384293|39533071|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
16286309|NCT00384293|39533072|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
16286310|NCT00384293|39533070|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
16286311|NCT00384293|39533071|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
16481022|NCT03758443|40238439|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
16481023|NCT03758443|40238436|FG000|Maintenance Period|Withdrawal by Subject|1|||
16481024|NCT03758443|40238437|FG001|Maintenance Period|Withdrawal by Subject|0|||
16481025|NCT03758443|40238438|FG002|Maintenance Period|Withdrawal by Subject|1|||
16481026|NCT03758443|40238439|FG003|Maintenance Period|Withdrawal by Subject|1|||
16481027|NCT03758443|40238436|FG000|Maintenance Period|Miscellaneous|0|||
16481028|NCT03758443|40238437|FG001|Maintenance Period|Miscellaneous|0|||
16481029|NCT03758443|40238438|FG002|Maintenance Period|Miscellaneous|1|||
16481030|NCT03758443|40238439|FG003|Maintenance Period|Miscellaneous|0|||
16481031|NCT03948581|40238446|FG000|Overall Study|Lost to Follow-up|0|||
16481032|NCT03948581|40238447|FG001|Overall Study|Lost to Follow-up|1|||
16286312|NCT00384293|39533072|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
16286313|NCT00384293|39533070|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
16286314|NCT00384293|39533071|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
16286315|NCT00384293|39533072|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
16286316|NCT00384293|39533070|FG000|Post-randomization Period|Adverse Event|0|||
16286317|NCT00384293|39533071|FG001|Post-randomization Period|Adverse Event|23|||
16286318|NCT00384293|39533072|FG002|Post-randomization Period|Adverse Event|7|||
16286319|NCT00384293|39533070|FG000|Post-randomization Period|Lost to Follow-up|0|||
16286320|NCT00384293|39533071|FG001|Post-randomization Period|Lost to Follow-up|2|||
16286321|NCT00384293|39533072|FG002|Post-randomization Period|Lost to Follow-up|1|||
16286322|NCT00384293|39533070|FG000|Post-randomization Period|Protocol Violation|0|||
16286323|NCT00384293|39533071|FG001|Post-randomization Period|Protocol Violation|1|||
16286324|NCT00384293|39533072|FG002|Post-randomization Period|Protocol Violation|0|||
16286325|NCT00384293|39533070|FG000|Post-randomization Period|Withdrawal by Subject|0|||
16286326|NCT00384293|39533071|FG001|Post-randomization Period|Withdrawal by Subject|8|||
16286327|NCT00384293|39533072|FG002|Post-randomization Period|Withdrawal by Subject|6|||
16286328|NCT00384293|39533070|FG000|Post-randomization Period|Trial Termination|0|||
16286329|NCT00384293|39533071|FG001|Post-randomization Period|Trial Termination|180|||
16286330|NCT00384293|39533072|FG002|Post-randomization Period|Trial Termination|204|||
16286331|NCT00384293|39533070|FG000|Post-randomization Period|Patient Randomized in Error|0|||
16286332|NCT00384293|39533071|FG001|Post-randomization Period|Patient Randomized in Error|0|||
16286333|NCT00384293|39533072|FG002|Post-randomization Period|Patient Randomized in Error|1|||
16286334|NCT00792623|39533073|FG000|Overall Study|Adverse Event|2|||
16286335|NCT00792623|39533073|FG000|Overall Study|Withdrawal by Subject|5|||
16286336|NCT01010126|39533074|FG000|Overall Study|Withdrawal by Subject|1|||
16286337|NCT01010126|39533075|FG001|Overall Study|Withdrawal by Subject|0|||
16286338|NCT01010126|39533076|FG002|Overall Study|Withdrawal by Subject|1|||
16286339|NCT01010126|39533077|FG003|Overall Study|Withdrawal by Subject|0|||
16286340|NCT01010126|39533078|FG004|Overall Study|Withdrawal by Subject|3|||
16286341|NCT01010126|39533079|FG005|Overall Study|Withdrawal by Subject|0|||
16286342|NCT00389831|39533086|FG000|Overall Study|Lack of Efficacy|0|||
16286343|NCT00389831|39533087|FG001|Overall Study|Lack of Efficacy|2|||
16286344|NCT00389831|39533086|FG000|Overall Study|Did not receive treatment.|0|||
16286345|NCT00389831|39533087|FG001|Overall Study|Did not receive treatment.|2|||
16286346|NCT00389831|39533086|FG000|Overall Study|Other reasons|0|||
16286347|NCT00389831|39533087|FG001|Overall Study|Other reasons|2|||
16286348|NCT00389831|39533086|FG000|Overall Study|Lost to Follow-up|0|||
16286349|NCT00389831|39533087|FG001|Overall Study|Lost to Follow-up|1|||
16286350|NCT00594646|39533088|FG000|Overall Study|Withdrawal by Subject|1|||
16481033|NCT02122458|40238451|FG000|Overall Study|Withdrawal by Subject|0|||
16481034|NCT02122458|40238452|FG001|Overall Study|Withdrawal by Subject|0|||
16286351|NCT00594646|39533088|FG000|Overall Study|Lost to Follow-up|15|||
16286352|NCT00058214|39533089|FG000|Overall Study|Adverse Event|1|||
16286353|NCT01215513|39533093|FG000|Overall Study|Not completed CS42|9|||
16286354|NCT01215513|39533093|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
16286355|NCT01215513|39533093|FG000|Overall Study|Adverse event (CS42A)|2|||
16286356|NCT01215513|39533093|FG000|Overall Study|Physician decision (CS42A)|6|||
16286357|NCT01215513|39533093|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
16286358|NCT01215513|39533093|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
16286359|NCT03064438|39533096|FG000|Overall Study|Lost to Follow-up|1|||
16286360|NCT03064438|39533097|FG001|Overall Study|Lost to Follow-up|0|||
16286361|NCT03064438|39533096|FG000|Overall Study|Withdrawal by Subject|0|||
16286362|NCT03064438|39533097|FG001|Overall Study|Withdrawal by Subject|1|||
16286363|NCT03827564|39533098|FG000|Overall Study|Discontinued due to Study Termination|1|||
16286364|NCT03827564|39533099|FG001|Overall Study|Discontinued due to Study Termination|0|||
16286365|NCT02211014|39533100|FG000|Overall Study|Adverse Event|0|||
16286366|NCT02211014|39533101|FG001|Overall Study|Adverse Event|2|||
16286367|NCT02211014|39533100|FG000|Overall Study|Physician Decision|1|||
16286368|NCT02211014|39533101|FG001|Overall Study|Physician Decision|2|||
16286369|NCT02211014|39533100|FG000|Overall Study|Started another cancer therapy|1|||
16286370|NCT02211014|39533101|FG001|Overall Study|Started another cancer therapy|0|||
16286371|NCT02211014|39533100|FG000|Overall Study|Withdrawal by Subject|0|||
16286372|NCT02211014|39533101|FG001|Overall Study|Withdrawal by Subject|1|||
16286373|NCT02211014|39533100|FG000|Overall Study|In agreement with patient, no benefit|0|||
16286374|NCT02211014|39533101|FG001|Overall Study|In agreement with patient, no benefit|1|||
16286375|NCT02777918|39533102|FG000|Overall Study|Medical reasons|1|||
16286376|NCT02777918|39533103|FG001|Overall Study|Medical reasons|2|||
16286377|NCT02777918|39533102|FG000|Overall Study|Too busy / stressed|1|||
16286378|NCT02777918|39533103|FG001|Overall Study|Too busy / stressed|1|||
16286379|NCT02777918|39533102|FG000|Overall Study|Withdrawal by Subject|1|||
16286380|NCT02777918|39533103|FG001|Overall Study|Withdrawal by Subject|1|||
16286381|NCT00307034|39533104|FG000|Overall Study|Adverse Event|1|||
16185461|NCT01544595|39159241|FG001|Status at Week 156|Physician Decision|3|||
16185462|NCT01544595|39159242|FG002|Status at Week 156|Physician Decision|1|||
16185463|NCT01544595|39159243|FG003|Status at Week 156|Physician Decision|0|||
16185464|NCT01544595|39159244|FG004|Status at Week 156|Physician Decision|0|||
16185465|NCT01544595|39159245|FG005|Status at Week 156|Physician Decision|0|||
16286382|NCT00307034|39533105|FG001|Overall Study|Adverse Event|2|||
16286383|NCT00307034|39533104|FG000|Overall Study|Withdrawal by Subject|1|||
16286384|NCT00307034|39533105|FG001|Overall Study|Withdrawal by Subject|2|||
16286385|NCT00307034|39533104|FG000|Overall Study|Lost to Follow-up|0|||
16286386|NCT00307034|39533105|FG001|Overall Study|Lost to Follow-up|3|||
16286387|NCT03852459|39533106|FG000|Overall Study|Adverse Event|2|||
16286388|NCT03852459|39533107|FG001|Overall Study|Adverse Event|2|||
16286389|NCT03852459|39533106|FG000|Overall Study|Withdrawal by Subject|1|||
16286390|NCT03852459|39533107|FG001|Overall Study|Withdrawal by Subject|1|||
16286391|NCT00731549|39533109|FG000|Overall Study|Lost to Follow-up|19|||
16286392|NCT00731549|39533109|FG000|Overall Study|Met withdrawal criteria|24|||
16286393|NCT00731549|39533109|FG000|Overall Study|Physician Decision|16|||
16379943|NCT02546323|39874841|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
16185466|NCT01544595|39159240|FG000|Status at Week 156|Pregnancy|2|||
16185467|NCT01544595|39159241|FG001|Status at Week 156|Pregnancy|3|||
16185468|NCT01544595|39159242|FG002|Status at Week 156|Pregnancy|0|||
16185469|NCT01544595|39159243|FG003|Status at Week 156|Pregnancy|0|||
16185470|NCT01544595|39159244|FG004|Status at Week 156|Pregnancy|0|||
16185471|NCT01544595|39159245|FG005|Status at Week 156|Pregnancy|0|||
16185472|NCT01544595|39159240|FG000|Status at Week 156|Protocol Violation|3|||
16185473|NCT01544595|39159241|FG001|Status at Week 156|Protocol Violation|1|||
16185474|NCT01544595|39159242|FG002|Status at Week 156|Protocol Violation|2|||
16286394|NCT00731549|39533109|FG000|Overall Study|Withdrawal by Subject|89|||
16286395|NCT00731549|39533109|FG000|Overall Study|Protocol deviation|1|||
16286396|NCT00731549|39533109|FG000|Overall Study|Adverse Event|31|||
16286397|NCT00731549|39533109|FG000|Overall Study|Lack of efficacy with AE|37|||
16286398|NCT00731549|39533109|FG000|Overall Study|Lack of efficacy without AE|6|||
16286399|NCT01333072|39533110|FG000|Overall Study|Lost to Follow-up|3|||
16286400|NCT01333072|39533111|FG001|Overall Study|Lost to Follow-up|0|||
16286401|NCT01333072|39533110|FG000|Overall Study|Adverse Event|2|||
16185475|NCT01544595|39159243|FG003|Status at Week 156|Protocol Violation|2|||
16185476|NCT01544595|39159244|FG004|Status at Week 156|Protocol Violation|0|||
16185477|NCT01544595|39159245|FG005|Status at Week 156|Protocol Violation|0|||
16286402|NCT01333072|39533111|FG001|Overall Study|Adverse Event|4|||
16286403|NCT01333072|39533110|FG000|Overall Study|Physician Decision|1|||
16286404|NCT01333072|39533111|FG001|Overall Study|Physician Decision|0|||
16286405|NCT01355159|39533112|FG000|Overall Study|Withdrew consent|39|||
16286406|NCT01355159|39533113|FG001|Overall Study|Withdrew consent|47|||
16286407|NCT01355159|39533112|FG000|Overall Study|No primary outcome data|17|||
16286408|NCT01355159|39533113|FG001|Overall Study|No primary outcome data|11|||
16286409|NCT01355159|39533112|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
16286410|NCT01355159|39533113|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
16481035|NCT02122458|40238453|FG002|Overall Study|Withdrawal by Subject|0|||
16481036|NCT02122458|40238454|FG003|Overall Study|Withdrawal by Subject|4|||
16481037|NCT02122458|40238455|FG004|Overall Study|Withdrawal by Subject|4|||
16481038|NCT02122458|40238456|FG005|Overall Study|Withdrawal by Subject|4|||
16481039|NCT02122458|40238457|FG006|Overall Study|Withdrawal by Subject|0|||
16481040|NCT02122458|40238451|FG000|Overall Study|Lost to Follow-up|1|||
16481041|NCT02122458|40238452|FG001|Overall Study|Lost to Follow-up|3|||
16481042|NCT02122458|40238453|FG002|Overall Study|Lost to Follow-up|0|||
16481043|NCT02122458|40238454|FG003|Overall Study|Lost to Follow-up|7|||
16481044|NCT02122458|40238455|FG004|Overall Study|Lost to Follow-up|5|||
16481045|NCT02122458|40238456|FG005|Overall Study|Lost to Follow-up|15|||
16481046|NCT02122458|40238457|FG006|Overall Study|Lost to Follow-up|1|||
16481047|NCT02122458|40238451|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
16481048|NCT02122458|40238452|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
16481049|NCT02122458|40238453|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
16481050|NCT02122458|40238454|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
16481051|NCT02122458|40238455|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
16481052|NCT02122458|40238456|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
16481053|NCT02122458|40238457|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
16481054|NCT02122458|40238451|FG000|Overall Study|Adverse Event|1|||
16481055|NCT02122458|40238452|FG001|Overall Study|Adverse Event|0|||
16481056|NCT02122458|40238453|FG002|Overall Study|Adverse Event|0|||
16481057|NCT02122458|40238454|FG003|Overall Study|Adverse Event|0|||
16481058|NCT02122458|40238455|FG004|Overall Study|Adverse Event|0|||
16481059|NCT02122458|40238456|FG005|Overall Study|Adverse Event|0|||
16481060|NCT02122458|40238457|FG006|Overall Study|Adverse Event|0|||
16481061|NCT02122458|40238451|FG000|Overall Study|Experimental Error|0|||
16481062|NCT02122458|40238452|FG001|Overall Study|Experimental Error|0|||
16481063|NCT02122458|40238453|FG002|Overall Study|Experimental Error|0|||
16481064|NCT02122458|40238454|FG003|Overall Study|Experimental Error|0|||
16481065|NCT02122458|40238455|FG004|Overall Study|Experimental Error|3|||
16481066|NCT02122458|40238456|FG005|Overall Study|Experimental Error|0|||
16481067|NCT02122458|40238457|FG006|Overall Study|Experimental Error|0|||
16481068|NCT02122458|40238451|FG000|Overall Study|Deployed or Moved|0|||
16481069|NCT02122458|40238452|FG001|Overall Study|Deployed or Moved|0|||
16481070|NCT02122458|40238453|FG002|Overall Study|Deployed or Moved|0|||
16481071|NCT02122458|40238454|FG003|Overall Study|Deployed or Moved|0|||
16481072|NCT02122458|40238455|FG004|Overall Study|Deployed or Moved|1|||
16481073|NCT02122458|40238456|FG005|Overall Study|Deployed or Moved|0|||
16481074|NCT02122458|40238457|FG006|Overall Study|Deployed or Moved|0|||
16481075|NCT02122458|40238451|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
16481076|NCT02122458|40238452|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
16481077|NCT02122458|40238453|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
16481078|NCT02122458|40238454|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
16481079|NCT02122458|40238455|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
16481080|NCT02122458|40238456|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
16481081|NCT02122458|40238457|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
16481082|NCT02122458|40238451|FG000|Overall Study|Noncompliance|0|||
16481083|NCT02122458|40238452|FG001|Overall Study|Noncompliance|1|||
16481084|NCT02122458|40238453|FG002|Overall Study|Noncompliance|0|||
16481085|NCT02122458|40238454|FG003|Overall Study|Noncompliance|0|||
16481086|NCT02122458|40238455|FG004|Overall Study|Noncompliance|0|||
16481087|NCT02122458|40238456|FG005|Overall Study|Noncompliance|0|||
16481088|NCT02122458|40238457|FG006|Overall Study|Noncompliance|0|||
16481089|NCT01816074|40238458|FG000|Phase 1|Time commitment issues|0|||
16481090|NCT01816074|40238459|FG001|Phase 1|Time commitment issues|0|||
16481091|NCT01816074|40238460|FG002|Phase 1|Time commitment issues|1|||
16481092|NCT01816074|40238461|FG003|Phase 1|Time commitment issues|0|||
16481093|NCT01816074|40238458|FG000|Phase 2|Time commitment Issues|0|||
16286411|NCT01355159|39533112|FG000|Overall Study|Early intrauterine fetal death|6|||
16481094|NCT01816074|40238459|FG001|Phase 2|Time commitment Issues|2|||
16481095|NCT01816074|40238460|FG002|Phase 2|Time commitment Issues|0|||
16481096|NCT01816074|40238461|FG003|Phase 2|Time commitment Issues|0|||
16481097|NCT01816074|40238458|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
16481098|NCT01816074|40238459|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
16286412|NCT01355159|39533113|FG001|Overall Study|Early intrauterine fetal death|6|||
16286413|NCT00103402|39533121|FG000|Overall Study|Adverse Event|3|||
16481099|NCT01816074|40238460|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
16481100|NCT01816074|40238461|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
16481101|NCT01816074|40238458|FG000|Phase 2|Physician Decision|0|||
16481102|NCT01816074|40238459|FG001|Phase 2|Physician Decision|0|||
16481103|NCT01816074|40238460|FG002|Phase 2|Physician Decision|0|||
16481104|NCT01816074|40238461|FG003|Phase 2|Physician Decision|1|||
16286414|NCT00103402|39533122|FG001|Overall Study|Adverse Event|4|||
16286415|NCT00103402|39533121|FG000|Overall Study|Lost to Follow-up|8|||
16286416|NCT00103402|39533122|FG001|Overall Study|Lost to Follow-up|7|||
16286417|NCT00103402|39533121|FG000|Overall Study|Dissatisfied/No longer interested|6|||
16286418|NCT00103402|39533122|FG001|Overall Study|Dissatisfied/No longer interested|6|||
16286419|NCT00103402|39533121|FG000|Overall Study|Personal constraints/Other|5|||
16286420|NCT00103402|39533122|FG001|Overall Study|Personal constraints/Other|0|||
16286421|NCT03581188|39533129|FG000|Overall Study|Inclusion criteria not met|3|||
16286422|NCT03581188|39533130|FG001|Overall Study|Inclusion criteria not met|2|||
16286423|NCT03581188|39533129|FG000|Overall Study|Lost to Follow-up|5|||
16286424|NCT03581188|39533130|FG001|Overall Study|Lost to Follow-up|5|||
16286425|NCT03581188|39533129|FG000|Overall Study|Discontinued intervention|11|||
16286426|NCT03581188|39533130|FG001|Overall Study|Discontinued intervention|8|||
16286427|NCT03407118|39533131|FG000|Period 2|Withdrawal by Subject|1|||
16286428|NCT03407118|39533132|FG001|Period 2|Withdrawal by Subject|0|||
16286429|NCT03499119|39533135|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
16286430|NCT03499119|39533136|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
16286431|NCT03499119|39533137|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
16286432|NCT03499119|39533138|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
16286433|NCT03499119|39533135|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
16286434|NCT03499119|39533136|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
16286435|NCT03499119|39533137|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
16286436|NCT03499119|39533138|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
16286437|NCT03499119|39533135|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
16286438|NCT03499119|39533136|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
16286439|NCT03499119|39533137|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
16286440|NCT03499119|39533138|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
16286441|NCT03499119|39533135|FG000|Optional Extension Phase|Lost to Follow-up|0|||
16286442|NCT03499119|39533136|FG001|Optional Extension Phase|Lost to Follow-up|0|||
16286443|NCT03499119|39533137|FG002|Optional Extension Phase|Lost to Follow-up|0|||
16286444|NCT03499119|39533138|FG003|Optional Extension Phase|Lost to Follow-up|1|||
16286445|NCT03499119|39533135|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
16286446|NCT03499119|39533136|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
16286447|NCT03499119|39533137|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
16286448|NCT03499119|39533138|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
16286449|NCT03499119|39533135|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
16286450|NCT03499119|39533136|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
16286451|NCT03499119|39533137|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
16286452|NCT03499119|39533138|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
16286453|NCT02357342|39533141|FG000|First 6 Months|Death|2|||
16286454|NCT02357342|39533142|FG001|First 6 Months|Death|0|||
16286455|NCT02562482|39533143|FG000|Overall Study|Enrolled, but did not receive product|4|||
16286456|NCT02562482|39533144|FG001|Overall Study|Enrolled, but did not receive product|0|||
16286457|NCT02562482|39533143|FG000|Overall Study|Lost to Follow-up|9|||
16286458|NCT02562482|39533144|FG001|Overall Study|Lost to Follow-up|6|||
16286459|NCT02562482|39533143|FG000|Overall Study|Moved from area|2|||
16286460|NCT02562482|39533144|FG001|Overall Study|Moved from area|3|||
16286461|NCT02562482|39533143|FG000|Overall Study|Withdrawal by Subject|5|||
16286462|NCT02562482|39533144|FG001|Overall Study|Withdrawal by Subject|3|||
16286463|NCT02562482|39533143|FG000|Overall Study|Physician Decision|1|||
16286464|NCT02562482|39533144|FG001|Overall Study|Physician Decision|3|||
16286465|NCT02562482|39533143|FG000|Overall Study|Illness/Injury unrelated to product|0|||
16286466|NCT02562482|39533144|FG001|Overall Study|Illness/Injury unrelated to product|1|||
16286467|NCT03604341|39533145|FG000|Overall Study|Withdrawal by Subject|1|||
16286468|NCT03604341|39533146|FG001|Overall Study|Withdrawal by Subject|1|||
16286469|NCT03604341|39533145|FG000|Overall Study|Adverse Event|1|||
16286470|NCT03604341|39533146|FG001|Overall Study|Adverse Event|0|||
16286471|NCT03604341|39533145|FG000|Overall Study|Protocol Violation|0|||
16286472|NCT03604341|39533146|FG001|Overall Study|Protocol Violation|1|||
16286473|NCT01673698|39533147|FG000|Overall Study|Lost to Follow-up|51|||
16286474|NCT01673698|39533148|FG001|Overall Study|Lost to Follow-up|13|||
16481105|NCT01816074|40238458|FG000|Phase 2|Withdrawal by Subject|1|||
16481106|NCT01816074|40238459|FG001|Phase 2|Withdrawal by Subject|0|||
16080240|NCT01307267|38786785|FG004|Overall Study|Withdrawal by Subject|0|||
16286475|NCT03921151|39533149|FG000|Overall Study|Withdrawal by Subject|11|||
16286476|NCT03921151|39533150|FG001|Overall Study|Withdrawal by Subject|16|||
16286477|NCT00841906|39533151|FG000|Overall Study|Withdrawal by Subject|2|||
16286478|NCT00841906|39533152|FG001|Overall Study|Withdrawal by Subject|0|||
16286479|NCT02938520|39533159|FG000|Overall Study|On-going at the time of analysis|258|||
16286480|NCT02938520|39533160|FG001|Overall Study|On-going at the time of analysis|261|||
16286481|NCT02938520|39533159|FG000|Overall Study|Physician Decision|2|||
16481107|NCT01816074|40238460|FG002|Phase 2|Withdrawal by Subject|0|||
16481108|NCT01816074|40238461|FG003|Phase 2|Withdrawal by Subject|0|||
16481109|NCT00866788|40238462|FG000|Overall Study|Adverse Event|0|||
16481110|NCT00866788|40238463|FG001|Overall Study|Adverse Event|2|||
16481111|NCT00866788|40238464|FG002|Overall Study|Adverse Event|0|||
16481112|NCT00866788|40238465|FG003|Overall Study|Adverse Event|1|||
16481113|NCT00866788|40238462|FG000|Overall Study|Lost to Follow-up|1|||
16481114|NCT00866788|40238463|FG001|Overall Study|Lost to Follow-up|1|||
16481115|NCT00866788|40238464|FG002|Overall Study|Lost to Follow-up|0|||
16481116|NCT00866788|40238465|FG003|Overall Study|Lost to Follow-up|2|||
16481117|NCT00866788|40238462|FG000|Overall Study|Withdrawal by Subject|2|||
16481118|NCT00866788|40238463|FG001|Overall Study|Withdrawal by Subject|1|||
16286482|NCT02938520|39533160|FG001|Overall Study|Physician Decision|5|||
16286483|NCT02938520|39533159|FG000|Overall Study|Lost to Follow-up|2|||
16286484|NCT02938520|39533160|FG001|Overall Study|Lost to Follow-up|2|||
16286485|NCT02938520|39533159|FG000|Overall Study|Withdrawal by Subject|7|||
16286486|NCT02938520|39533160|FG001|Overall Study|Withdrawal by Subject|7|||
16286487|NCT02938520|39533159|FG000|Overall Study|Protocol Violation|0|||
16286488|NCT02938520|39533160|FG001|Overall Study|Protocol Violation|1|||
16286489|NCT02938520|39533159|FG000|Overall Study|Lack of Efficacy|5|||
16286490|NCT02938520|39533160|FG001|Overall Study|Lack of Efficacy|3|||
16286491|NCT02938520|39533159|FG000|Overall Study|Adverse Event|9|||
16286492|NCT02938520|39533160|FG001|Overall Study|Adverse Event|4|||
16286493|NCT00725621|39533162|FG000|Overall Study|Adverse Event|25|||
16286494|NCT00725621|39533162|FG000|Overall Study|Lack of Efficacy|46|||
16286495|NCT00725621|39533162|FG000|Overall Study|Withdrawal by Subject|57|||
16286496|NCT00725621|39533162|FG000|Overall Study|Physician Decision|19|||
16286497|NCT00725621|39533162|FG000|Overall Study|Lost to Follow-up|52|||
16286498|NCT00725621|39533162|FG000|Overall Study|Non-compliance|8|||
16286499|NCT00725621|39533162|FG000|Overall Study|Continued treatment by other physician|6|||
16286500|NCT00725621|39533162|FG000|Overall Study|Switched to other study|1|||
16286501|NCT00725621|39533162|FG000|Overall Study|Switched to other drug|1|||
16286502|NCT00725621|39533162|FG000|Overall Study|Prepared for elective surgery|1|||
16286503|NCT00725621|39533162|FG000|Overall Study|Reason not specified|55|||
16286504|NCT00597116|39533163|FG000|Overall Study|Adverse Event|2|||
16286505|NCT00597116|39533164|FG001|Overall Study|Adverse Event|1|||
16286506|NCT00597116|39533163|FG000|Overall Study|Withdrawal by Subject|0|||
16286507|NCT00597116|39533164|FG001|Overall Study|Withdrawal by Subject|2|||
16286508|NCT00597116|39533163|FG000|Overall Study|Physician Decision|0|||
16286509|NCT00597116|39533164|FG001|Overall Study|Physician Decision|1|||
16286510|NCT00597116|39533163|FG000|Overall Study|Death|0|||
16286511|NCT00597116|39533164|FG001|Overall Study|Death|1|||
16286512|NCT00597116|39533163|FG000|Overall Study|Lost to Follow-up|1|||
16286513|NCT00597116|39533164|FG001|Overall Study|Lost to Follow-up|0|||
16286514|NCT00597116|39533163|FG000|Overall Study|Progressive disease|11|||
16286515|NCT00597116|39533164|FG001|Overall Study|Progressive disease|6|||
16286516|NCT00619359|39533165|FG000|Overall Study|Adverse Event|32|||
16286517|NCT00619359|39533166|FG001|Overall Study|Adverse Event|36|||
16286518|NCT00619359|39533165|FG000|Overall Study|Lost to Follow-up|12|||
16286519|NCT00619359|39533166|FG001|Overall Study|Lost to Follow-up|16|||
16286520|NCT00619359|39533165|FG000|Overall Study|Physician Decision|0|||
16286521|NCT00619359|39533166|FG001|Overall Study|Physician Decision|7|||
16286522|NCT00619359|39533165|FG000|Overall Study|Protocol Violation|1|||
16286523|NCT00619359|39533166|FG001|Overall Study|Protocol Violation|1|||
16286524|NCT00619359|39533165|FG000|Overall Study|Withdrawal by Subject|19|||
16286525|NCT00619359|39533166|FG001|Overall Study|Withdrawal by Subject|20|||
16286526|NCT00619359|39533165|FG000|Overall Study|Progressive Disease|3|||
16286527|NCT00619359|39533166|FG001|Overall Study|Progressive Disease|1|||
16286528|NCT00831623|39533167|FG000|Overall Study|Withdrawal by Subject|9|||
16286529|NCT00831623|39533167|FG000|Overall Study|Lost to Follow-up|1|||
16286530|NCT00831623|39533167|FG000|Overall Study|Not 2 years post-treatment|12|||
16286531|NCT00804141|39533168|FG000|Overall Study|Adverse Event|157|||
16286532|NCT00804141|39533168|FG000|Overall Study|Death|4|||
16286533|NCT00804141|39533168|FG000|Overall Study|Failed to return|96|||
16286534|NCT00804141|39533168|FG000|Overall Study|Investigator request|8|||
16286535|NCT00804141|39533168|FG000|Overall Study|Protocol Violation|85|||
16286536|NCT00804141|39533168|FG000|Overall Study|Withdrawal by Subject|131|||
16481119|NCT00866788|40238464|FG002|Overall Study|Withdrawal by Subject|0|||
16286537|NCT00804141|39533168|FG000|Overall Study|Lack of Efficacy|46|||
16481120|NCT00866788|40238465|FG003|Overall Study|Withdrawal by Subject|1|||
16481121|NCT00866788|40238462|FG000|Overall Study|Pregnancy|0|||
16481122|NCT00866788|40238463|FG001|Overall Study|Pregnancy|1|||
16286538|NCT00804141|39533168|FG000|Overall Study|Other than specified|30|||
16286539|NCT00804141|39533168|FG000|Overall Study|Enrolled but not treated|6|||
16286540|NCT02694549|39533169|FG000|Overall Study|screen failures|2|||
16286541|NCT01202877|39533170|FG000|Overall Study|Disease Progression|0|||
16286542|NCT01202877|39533171|FG001|Overall Study|Disease Progression|1|||
16481123|NCT00866788|40238464|FG002|Overall Study|Pregnancy|0|||
16481124|NCT00866788|40238465|FG003|Overall Study|Pregnancy|0|||
16481125|NCT00866788|40238462|FG000|Overall Study|Disease progression|3|||
16481126|NCT00866788|40238463|FG001|Overall Study|Disease progression|1|||
16481127|NCT00866788|40238464|FG002|Overall Study|Disease progression|1|||
16481128|NCT00866788|40238465|FG003|Overall Study|Disease progression|0|||
16481129|NCT00866788|40238462|FG000|Overall Study|Physician Decision|0|||
16481130|NCT00866788|40238463|FG001|Overall Study|Physician Decision|0|||
16481131|NCT00866788|40238464|FG002|Overall Study|Physician Decision|1|||
16481132|NCT00866788|40238465|FG003|Overall Study|Physician Decision|1|||
16481133|NCT05047770|40238468|FG000|Overall Study|Withdrawal by Subject|15|||
16481134|NCT05047770|40238469|FG001|Overall Study|Withdrawal by Subject|10|||
16481135|NCT05047770|40238470|FG002|Overall Study|Withdrawal by Subject|6|||
16481136|NCT05047770|40238471|FG003|Overall Study|Withdrawal by Subject|12|||
16481137|NCT05047770|40238468|FG000|Overall Study|Lost to Follow-up|7|||
16481138|NCT05047770|40238469|FG001|Overall Study|Lost to Follow-up|5|||
16481139|NCT05047770|40238470|FG002|Overall Study|Lost to Follow-up|12|||
16481140|NCT05047770|40238471|FG003|Overall Study|Lost to Follow-up|13|||
16481141|NCT05047770|40238468|FG000|Overall Study|Other|1|||
16481142|NCT05047770|40238469|FG001|Overall Study|Other|0|||
16481143|NCT05047770|40238470|FG002|Overall Study|Other|1|||
16481144|NCT05047770|40238471|FG003|Overall Study|Other|0|||
16481145|NCT01201785|40238474|FG000|Overall Study|Lost to Follow-up|16|||
16481146|NCT02083081|40238475|FG000|Overall Study|Lost to Follow-up|31|||
16481147|NCT02083081|40238476|FG001|Overall Study|Lost to Follow-up|9|||
16481148|NCT01972568|40238477|FG000|Overall Study|Other events|3|||
16481149|NCT01972568|40238478|FG001|Overall Study|Other events|0|||
16481150|NCT01972568|40238479|FG002|Overall Study|Other events|0|||
16286543|NCT01202877|39533172|FG002|Overall Study|Disease Progression|2|||
16286544|NCT01202877|39533170|FG000|Overall Study|Adverse Event|0|||
16286545|NCT01202877|39533171|FG001|Overall Study|Adverse Event|0|||
16286546|NCT01202877|39533172|FG002|Overall Study|Adverse Event|2|||
16286547|NCT01202877|39533170|FG000|Overall Study|Withdrawal by Subject|0|||
16286548|NCT01202877|39533171|FG001|Overall Study|Withdrawal by Subject|0|||
16286549|NCT01202877|39533172|FG002|Overall Study|Withdrawal by Subject|1|||
16286550|NCT01202877|39533170|FG000|Overall Study|Death|0|||
16286551|NCT01202877|39533171|FG001|Overall Study|Death|0|||
16286552|NCT01202877|39533172|FG002|Overall Study|Death|1|||
16286553|NCT00532935|39533173|FG000|Overall Study|Adverse Event|11|||
16286554|NCT00532935|39533174|FG001|Overall Study|Adverse Event|12|||
16286555|NCT00532935|39533173|FG000|Overall Study|Lack of Efficacy|0|||
16286556|NCT00532935|39533174|FG001|Overall Study|Lack of Efficacy|3|||
16286557|NCT00532935|39533173|FG000|Overall Study|Lost to Follow-up|10|||
16286558|NCT00532935|39533174|FG001|Overall Study|Lost to Follow-up|6|||
16286559|NCT00532935|39533173|FG000|Overall Study|Physician Decision|4|||
16286560|NCT00532935|39533174|FG001|Overall Study|Physician Decision|5|||
16286561|NCT00532935|39533173|FG000|Overall Study|Pregnancy|1|||
16286562|NCT00532935|39533174|FG001|Overall Study|Pregnancy|0|||
16286563|NCT00532935|39533173|FG000|Overall Study|Protocol Violation|4|||
16286564|NCT00532935|39533174|FG001|Overall Study|Protocol Violation|2|||
16286565|NCT00532935|39533173|FG000|Overall Study|Withdrawal by Subject|10|||
16286566|NCT00532935|39533174|FG001|Overall Study|Withdrawal by Subject|9|||
16286567|NCT00532935|39533173|FG000|Overall Study|Protocol Specific Criteria|11|||
16286568|NCT00532935|39533174|FG001|Overall Study|Protocol Specific Criteria|15|||
16286569|NCT03185013|39533177|FG000|Overall Study|Withdrawal by Subject|5|||
16286570|NCT03185013|39533178|FG001|Overall Study|Withdrawal by Subject|3|||
16286571|NCT03185013|39533177|FG000|Overall Study|Adverse Event|1|||
16286572|NCT03185013|39533178|FG001|Overall Study|Adverse Event|0|||
16286573|NCT03185013|39533177|FG000|Overall Study|Progressive Disease|1|||
16286574|NCT03185013|39533178|FG001|Overall Study|Progressive Disease|0|||
16286575|NCT03185013|39533177|FG000|Overall Study|Lost to Follow-up|8|||
16481151|NCT01972568|40238477|FG000|Overall Study|Lack of Efficacy|0|||
16481152|NCT01972568|40238478|FG001|Overall Study|Lack of Efficacy|1|||
16286576|NCT03185013|39533178|FG001|Overall Study|Lost to Follow-up|2|||
16286577|NCT03185013|39533177|FG000|Overall Study|Physician Decision|1|||
16286578|NCT03185013|39533178|FG001|Overall Study|Physician Decision|0|||
16286579|NCT03185013|39533177|FG000|Overall Study|Protocol Deviation|2|||
16286580|NCT03185013|39533178|FG001|Overall Study|Protocol Deviation|0|||
16286581|NCT03185013|39533177|FG000|Overall Study|Reason not Specified|3|||
16286582|NCT03185013|39533178|FG001|Overall Study|Reason not Specified|2|||
16286583|NCT03185013|39533177|FG000|Overall Study|Death|1|||
16481153|NCT01972568|40238479|FG002|Overall Study|Lack of Efficacy|2|||
16481154|NCT01972568|40238477|FG000|Overall Study|Protocol Violation|1|||
16286584|NCT03185013|39533178|FG001|Overall Study|Death|0|||
16286585|NCT00865514|39533179|FG000|Overall Study|Infusion cost exceeded funding|2|||
16286586|NCT02746627|39533180|FG000|Overall Study|Withdrawal by Subject|1|||
16286587|NCT02746627|39533181|FG001|Overall Study|Withdrawal by Subject|1|||
16481155|NCT01972568|40238478|FG001|Overall Study|Protocol Violation|2|||
16481156|NCT01972568|40238479|FG002|Overall Study|Protocol Violation|2|||
16481157|NCT01972568|40238477|FG000|Overall Study|Withdrawal by Subject|6|||
16481158|NCT01972568|40238478|FG001|Overall Study|Withdrawal by Subject|3|||
16286588|NCT02746627|39533182|FG002|Overall Study|Withdrawal by Subject|1|||
16286589|NCT00479388|39533183|FG000|Overall Study|Adverse Event|90|||
16286590|NCT00479388|39533184|FG001|Overall Study|Adverse Event|45|||
16286591|NCT00479388|39533183|FG000|Overall Study|Lost to Follow-up|0|||
16286592|NCT00479388|39533184|FG001|Overall Study|Lost to Follow-up|2|||
16286593|NCT00479388|39533183|FG000|Overall Study|Protocol Violation|10|||
16286594|NCT00479388|39533184|FG001|Overall Study|Protocol Violation|9|||
16286595|NCT00479388|39533183|FG000|Overall Study|Withdrawal by Subject|32|||
16286596|NCT00479388|39533184|FG001|Overall Study|Withdrawal by Subject|17|||
16286597|NCT00446199|39533185|FG000|Overall Study|Adverse Event|7|||
16286598|NCT00446199|39533186|FG001|Overall Study|Adverse Event|4|||
16286599|NCT00446199|39533187|FG002|Overall Study|Adverse Event|6|||
16286600|NCT00446199|39533188|FG003|Overall Study|Adverse Event|4|||
16286601|NCT00446199|39533185|FG000|Overall Study|Lost to Follow-up|4|||
16286602|NCT00446199|39533186|FG001|Overall Study|Lost to Follow-up|5|||
16286603|NCT00446199|39533187|FG002|Overall Study|Lost to Follow-up|2|||
16286604|NCT00446199|39533188|FG003|Overall Study|Lost to Follow-up|6|||
16286605|NCT00446199|39533185|FG000|Overall Study|Protocol Violation|1|||
16286606|NCT00446199|39533186|FG001|Overall Study|Protocol Violation|2|||
16286607|NCT00446199|39533187|FG002|Overall Study|Protocol Violation|1|||
16286608|NCT00446199|39533188|FG003|Overall Study|Protocol Violation|3|||
16286609|NCT00446199|39533185|FG000|Overall Study|Withdrawal by Subject|2|||
16286610|NCT00446199|39533186|FG001|Overall Study|Withdrawal by Subject|5|||
16286611|NCT00446199|39533187|FG002|Overall Study|Withdrawal by Subject|9|||
16286612|NCT00446199|39533188|FG003|Overall Study|Withdrawal by Subject|10|||
16286613|NCT00446199|39533185|FG000|Overall Study|Site termination|2|||
16286614|NCT00446199|39533186|FG001|Overall Study|Site termination|0|||
16286615|NCT00446199|39533187|FG002|Overall Study|Site termination|0|||
16286616|NCT00446199|39533188|FG003|Overall Study|Site termination|1|||
16286617|NCT00446199|39533185|FG000|Overall Study|Randomization in Error|2|||
16286618|NCT00446199|39533186|FG001|Overall Study|Randomization in Error|0|||
16286619|NCT00446199|39533187|FG002|Overall Study|Randomization in Error|1|||
16286620|NCT00446199|39533188|FG003|Overall Study|Randomization in Error|1|||
16286621|NCT00446199|39533185|FG000|Overall Study|Lack of Efficacy|1|||
16286622|NCT00446199|39533186|FG001|Overall Study|Lack of Efficacy|0|||
16286623|NCT00446199|39533187|FG002|Overall Study|Lack of Efficacy|0|||
16286624|NCT00446199|39533188|FG003|Overall Study|Lack of Efficacy|1|||
16286625|NCT00446199|39533185|FG000|Overall Study|Non-compliant with study drug|1|||
16286626|NCT00446199|39533186|FG001|Overall Study|Non-compliant with study drug|0|||
16286627|NCT00446199|39533187|FG002|Overall Study|Non-compliant with study drug|5|||
16286628|NCT00446199|39533188|FG003|Overall Study|Non-compliant with study drug|0|||
16286629|NCT00446199|39533185|FG000|Overall Study|Non-compliant with visit schedule|1|||
16286630|NCT00446199|39533186|FG001|Overall Study|Non-compliant with visit schedule|1|||
16286631|NCT00446199|39533187|FG002|Overall Study|Non-compliant with visit schedule|1|||
16286632|NCT00446199|39533188|FG003|Overall Study|Non-compliant with visit schedule|2|||
16481159|NCT01972568|40238479|FG002|Overall Study|Withdrawal by Subject|7|||
16481160|NCT01972568|40238477|FG000|Overall Study|Lost to Follow-up|1|||
16481161|NCT01972568|40238478|FG001|Overall Study|Lost to Follow-up|0|||
16481162|NCT01972568|40238479|FG002|Overall Study|Lost to Follow-up|0|||
16481163|NCT01972568|40238477|FG000|Overall Study|Adverse Event|5|||
16481164|NCT01972568|40238478|FG001|Overall Study|Adverse Event|6|||
16481165|NCT01972568|40238479|FG002|Overall Study|Adverse Event|5|||
16481166|NCT04032652|40238480|FG000|Overall Study|The study was terminated and the PI has|1|||
16481167|NCT04032652|40238481|FG001|Overall Study|The study was terminated and the PI has|1|||
16481168|NCT02243696|40238482|FG000|Overall Study|Death|282|||
16481169|NCT02243696|40238482|FG000|Overall Study|Withdrawal by Subject|79|||
16481170|NCT02243696|40238482|FG000|Overall Study|Lost to Follow-up|57|||
16481171|NCT02243696|40238482|FG000|Overall Study|Subject No Longer has Study System|42|||
16481172|NCT02243696|40238482|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
16481173|NCT02243696|40238482|FG000|Overall Study|Study Terminated for EP PASSION|961|||
16481174|NCT01705730|40238483|FG000|Overall Study|Lack of Efficacy|1|||
16481175|NCT01705730|40238483|FG000|Overall Study|Adverse Event|3|||
16481176|NCT01705730|40238483|FG000|Overall Study|Lost to Follow-up|1|||
16481177|NCT01705730|40238483|FG000|Overall Study|Reason not Specified|4|||
16481178|NCT02728596|40238484|FG000|Overall Study|Refusal unrelated to adverse event|3|||
16481179|NCT02728596|40238485|FG001|Overall Study|Refusal unrelated to adverse event|6|||
16286633|NCT00446199|39533185|FG000|Overall Study|Hormone fear|0|||
16481180|NCT02728596|40238486|FG002|Overall Study|Refusal unrelated to adverse event|7|||
16481181|NCT02728596|40238487|FG003|Overall Study|Refusal unrelated to adverse event|7|||
16481182|NCT02728596|40238484|FG000|Overall Study|Death|44|||
16481183|NCT02728596|40238485|FG001|Overall Study|Death|42|||
16286634|NCT00446199|39533186|FG001|Overall Study|Hormone fear|0|||
16286635|NCT00446199|39533187|FG002|Overall Study|Hormone fear|0|||
16286636|NCT00446199|39533188|FG003|Overall Study|Hormone fear|1|||
16080241|NCT01307267|38786786|FG005|Overall Study|Withdrawal by Subject|1|||
16286637|NCT00446199|39533185|FG000|Overall Study|Lost interest in study participation|0|||
16286638|NCT00446199|39533186|FG001|Overall Study|Lost interest in study participation|1|||
16481184|NCT02728596|40238486|FG002|Overall Study|Death|123|||
16481185|NCT02728596|40238487|FG003|Overall Study|Death|68|||
16481186|NCT01952145|40238494|FG000|Overall Study|Protocol Violation|2|||
16481187|NCT01952145|40238495|FG001|Overall Study|Protocol Violation|1|||
16481188|NCT01952145|40238494|FG000|Overall Study|Death|0|||
16481189|NCT01952145|40238495|FG001|Overall Study|Death|1|||
16481190|NCT01952145|40238494|FG000|Overall Study|Adverse Event|9|||
16481191|NCT01952145|40238495|FG001|Overall Study|Adverse Event|0|||
16481192|NCT01952145|40238494|FG000|Overall Study|Withdrawal Criteria|16|||
16481193|NCT01952145|40238495|FG001|Overall Study|Withdrawal Criteria|11|||
16481194|NCT01952145|40238494|FG000|Overall Study|Unclassified|1|||
16481195|NCT01952145|40238495|FG001|Overall Study|Unclassified|1|||
16481196|NCT00412542|40238496|FG000|Overall Study|Withdrawal by Subject|0|||
16481197|NCT00412542|40238497|FG001|Overall Study|Withdrawal by Subject|2|||
16481198|NCT00412542|40238496|FG000|Overall Study|Not Eligible|0|||
16481199|NCT00412542|40238497|FG001|Overall Study|Not Eligible|1|||
16481200|NCT00395304|40238498|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16481201|NCT00395304|40238499|FG001|Treatment Period 1|Withdrawal by Subject|3|||
16481202|NCT00395304|40238500|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16481203|NCT00395304|40238501|FG003|Treatment Period 1|Withdrawal by Subject|2|||
16481204|NCT00395304|40238502|FG004|Treatment Period 1|Withdrawal by Subject|1|||
16481205|NCT00395304|40238503|FG005|Treatment Period 1|Withdrawal by Subject|1|||
16481206|NCT00395304|40238498|FG000|Treatment Period 1|Lost to Follow-up|1|||
16481207|NCT00395304|40238499|FG001|Treatment Period 1|Lost to Follow-up|0|||
16481208|NCT00395304|40238500|FG002|Treatment Period 1|Lost to Follow-up|0|||
16286639|NCT00446199|39533187|FG002|Overall Study|Lost interest in study participation|0|||
16286640|NCT00446199|39533188|FG003|Overall Study|Lost interest in study participation|0|||
16286641|NCT00446199|39533185|FG000|Overall Study|In-/Exclusion criterion violated|2|||
16286642|NCT00446199|39533186|FG001|Overall Study|In-/Exclusion criterion violated|1|||
16286643|NCT00446199|39533187|FG002|Overall Study|In-/Exclusion criterion violated|2|||
16286644|NCT00446199|39533188|FG003|Overall Study|In-/Exclusion criterion violated|1|||
16286645|NCT00446199|39533185|FG000|Overall Study|Move|0|||
16286646|NCT00446199|39533186|FG001|Overall Study|Move|1|||
16286647|NCT00446199|39533187|FG002|Overall Study|Move|0|||
16286648|NCT00446199|39533188|FG003|Overall Study|Move|0|||
16286649|NCT03235479|39533189|FG000|Overall Study|Lost to Follow-up|8|||
16286650|NCT03235479|39533190|FG001|Overall Study|Lost to Follow-up|11|||
16286651|NCT03235479|39533189|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
16286652|NCT03235479|39533190|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
16286653|NCT03235479|39533189|FG000|Overall Study|Pregnancy|1|||
16286654|NCT03235479|39533190|FG001|Overall Study|Pregnancy|0|||
16481209|NCT00395304|40238501|FG003|Treatment Period 1|Lost to Follow-up|1|||
16481210|NCT00395304|40238502|FG004|Treatment Period 1|Lost to Follow-up|0|||
16481211|NCT00395304|40238503|FG005|Treatment Period 1|Lost to Follow-up|1|||
16481212|NCT00395304|40238498|FG000|Treatment Period 1|Physician Decision|0|||
16481213|NCT00395304|40238499|FG001|Treatment Period 1|Physician Decision|1|||
16481214|NCT00395304|40238500|FG002|Treatment Period 1|Physician Decision|0|||
16481215|NCT00395304|40238501|FG003|Treatment Period 1|Physician Decision|0|||
16481216|NCT00395304|40238502|FG004|Treatment Period 1|Physician Decision|0|||
16481217|NCT00395304|40238503|FG005|Treatment Period 1|Physician Decision|0|||
16481218|NCT00395304|40238498|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16481219|NCT00395304|40238499|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16481220|NCT00395304|40238500|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16481221|NCT00395304|40238501|FG003|Treatment Period 2|Withdrawal by Subject|1|||
16481222|NCT00395304|40238502|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16481223|NCT00395304|40238503|FG005|Treatment Period 2|Withdrawal by Subject|2|||
16481224|NCT00395304|40238498|FG000|Treatment Period 2|Lost to Follow-up|0|||
16481225|NCT00395304|40238499|FG001|Treatment Period 2|Lost to Follow-up|3|||
16481226|NCT00395304|40238500|FG002|Treatment Period 2|Lost to Follow-up|0|||
16481227|NCT00395304|40238501|FG003|Treatment Period 2|Lost to Follow-up|0|||
16481228|NCT00395304|40238502|FG004|Treatment Period 2|Lost to Follow-up|0|||
16481229|NCT00395304|40238503|FG005|Treatment Period 2|Lost to Follow-up|0|||
16481230|NCT00395304|40238498|FG000|Treatment Period 2|Physician Decision|0|||
16481231|NCT00395304|40238499|FG001|Treatment Period 2|Physician Decision|0|||
16286655|NCT03235479|39533189|FG000|Overall Study|Protocol Deviation|1|||
16286656|NCT03235479|39533190|FG001|Overall Study|Protocol Deviation|3|||
16481232|NCT00395304|40238500|FG002|Treatment Period 2|Physician Decision|1|||
16481233|NCT00395304|40238501|FG003|Treatment Period 2|Physician Decision|0|||
16481234|NCT00395304|40238502|FG004|Treatment Period 2|Physician Decision|0|||
16481235|NCT00395304|40238503|FG005|Treatment Period 2|Physician Decision|0|||
16286657|NCT03235479|39533189|FG000|Overall Study|Technical Problems|3|||
16286658|NCT03235479|39533190|FG001|Overall Study|Technical Problems|2|||
16286659|NCT03235479|39533189|FG000|Overall Study|Withdrawal by Subject|2|||
16286660|NCT03235479|39533190|FG001|Overall Study|Withdrawal by Subject|2|||
16481236|NCT00395304|40238498|FG000|Treatment Period 2|Other|0|||
16481237|NCT00395304|40238499|FG001|Treatment Period 2|Other|1|||
16481238|NCT00395304|40238500|FG002|Treatment Period 2|Other|0|||
16481239|NCT00395304|40238501|FG003|Treatment Period 2|Other|0|||
16286661|NCT03235479|39533189|FG000|Overall Study|Other Reasons|3|||
16286662|NCT03235479|39533190|FG001|Overall Study|Other Reasons|5|||
16286663|NCT00952276|39533191|FG000|Overall Study|Withdrawal by Subject|1|||
16286664|NCT00952276|39533192|FG001|Overall Study|Withdrawal by Subject|0|||
16286665|NCT00952276|39533193|FG002|Overall Study|Withdrawal by Subject|0|||
16286666|NCT00952276|39533194|FG003|Overall Study|Withdrawal by Subject|1|||
16286667|NCT00952276|39533195|FG004|Overall Study|Withdrawal by Subject|0|||
16286668|NCT01884688|39533196|FG000|Overall Study|Screen Failure|2|||
16286669|NCT00679913|39533200|FG000|Overall Study|Protocol Violation|18|||
16286670|NCT00679913|39533201|FG001|Overall Study|Protocol Violation|13|||
16286671|NCT01206816|39533202|FG000|Overall Study|Protocol Violation|0|||
16286672|NCT01206816|39533203|FG001|Overall Study|Protocol Violation|0|||
16286673|NCT01206816|39533204|FG002|Overall Study|Protocol Violation|1|||
16286674|NCT01206816|39533205|FG003|Overall Study|Protocol Violation|0|||
16286675|NCT01206816|39533206|FG004|Overall Study|Protocol Violation|0|||
16286676|NCT01206816|39533207|FG005|Overall Study|Protocol Violation|0|||
16286677|NCT01206816|39533208|FG006|Overall Study|Protocol Violation|0|||
16286678|NCT01206816|39533202|FG000|Overall Study|Withdrawal by Subject|0|||
16286679|NCT01206816|39533203|FG001|Overall Study|Withdrawal by Subject|0|||
16286680|NCT01206816|39533204|FG002|Overall Study|Withdrawal by Subject|1|||
16286681|NCT01206816|39533205|FG003|Overall Study|Withdrawal by Subject|0|||
16286682|NCT01206816|39533206|FG004|Overall Study|Withdrawal by Subject|0|||
16286683|NCT01206816|39533207|FG005|Overall Study|Withdrawal by Subject|0|||
16286684|NCT01206816|39533208|FG006|Overall Study|Withdrawal by Subject|0|||
16286685|NCT01206816|39533202|FG000|Overall Study|Progressive disease|3|||
16286686|NCT01206816|39533203|FG001|Overall Study|Progressive disease|3|||
16286687|NCT01206816|39533204|FG002|Overall Study|Progressive disease|13|||
16286688|NCT01206816|39533205|FG003|Overall Study|Progressive disease|3|||
16286689|NCT01206816|39533206|FG004|Overall Study|Progressive disease|3|||
16286690|NCT01206816|39533207|FG005|Overall Study|Progressive disease|16|||
16286691|NCT01206816|39533208|FG006|Overall Study|Progressive disease|3|||
16286692|NCT01206816|39533202|FG000|Overall Study|Other AE|0|||
16286693|NCT01206816|39533203|FG001|Overall Study|Other AE|0|||
16286694|NCT01206816|39533204|FG002|Overall Study|Other AE|4|||
16286695|NCT01206816|39533205|FG003|Overall Study|Other AE|0|||
16286696|NCT01206816|39533206|FG004|Overall Study|Other AE|0|||
16286697|NCT01206816|39533207|FG005|Overall Study|Other AE|3|||
16286698|NCT01206816|39533208|FG006|Overall Study|Other AE|2|||
16286699|NCT01206816|39533202|FG000|Overall Study|other than stated above|0|||
16286700|NCT01206816|39533203|FG001|Overall Study|other than stated above|0|||
16286701|NCT01206816|39533204|FG002|Overall Study|other than stated above|1|||
16286702|NCT01206816|39533205|FG003|Overall Study|other than stated above|0|||
16286703|NCT01206816|39533206|FG004|Overall Study|other than stated above|0|||
16286704|NCT01206816|39533207|FG005|Overall Study|other than stated above|0|||
16286705|NCT01206816|39533208|FG006|Overall Study|other than stated above|1|||
16286706|NCT01207440|39533209|FG000|Overall Study|Adverse Event|46|||
16286707|NCT01207440|39533210|FG001|Overall Study|Adverse Event|11|||
16286708|NCT01207440|39533211|FG002|Overall Study|Adverse Event|7|||
16286709|NCT01207440|39533212|FG003|Overall Study|Adverse Event|2|||
16286710|NCT01207440|39533213|FG004|Overall Study|Adverse Event|6|||
16286711|NCT01207440|39533214|FG005|Overall Study|Adverse Event|6|||
16286712|NCT01207440|39533215|FG006|Overall Study|Adverse Event|2|||
16286713|NCT01207440|39533209|FG000|Overall Study|Death|6|||
16286714|NCT01207440|39533210|FG001|Overall Study|Death|3|||
16286715|NCT01207440|39533211|FG002|Overall Study|Death|2|||
16286716|NCT01207440|39533212|FG003|Overall Study|Death|2|||
16286717|NCT01207440|39533213|FG004|Overall Study|Death|7|||
16286718|NCT01207440|39533214|FG005|Overall Study|Death|5|||
16286719|NCT01207440|39533215|FG006|Overall Study|Death|1|||
16286720|NCT01207440|39533209|FG000|Overall Study|Lack of Efficacy|13|||
16286721|NCT01207440|39533210|FG001|Overall Study|Lack of Efficacy|2|||
16286722|NCT01207440|39533211|FG002|Overall Study|Lack of Efficacy|5|||
16286723|NCT01207440|39533212|FG003|Overall Study|Lack of Efficacy|1|||
16286724|NCT01207440|39533213|FG004|Overall Study|Lack of Efficacy|2|||
16286725|NCT01207440|39533214|FG005|Overall Study|Lack of Efficacy|3|||
16286726|NCT01207440|39533215|FG006|Overall Study|Lack of Efficacy|0|||
16286727|NCT01207440|39533209|FG000|Overall Study|Lost to Follow-up|0|||
16481240|NCT00395304|40238502|FG004|Treatment Period 2|Other|0|||
16286728|NCT01207440|39533210|FG001|Overall Study|Lost to Follow-up|0|||
16286729|NCT01207440|39533211|FG002|Overall Study|Lost to Follow-up|2|||
16286730|NCT01207440|39533212|FG003|Overall Study|Lost to Follow-up|1|||
16286731|NCT01207440|39533213|FG004|Overall Study|Lost to Follow-up|0|||
16286732|NCT01207440|39533214|FG005|Overall Study|Lost to Follow-up|0|||
16286733|NCT01207440|39533215|FG006|Overall Study|Lost to Follow-up|0|||
16286734|NCT01207440|39533209|FG000|Overall Study|Non-compliance with Study Drug|3|||
16286735|NCT01207440|39533210|FG001|Overall Study|Non-compliance with Study Drug|0|||
16286736|NCT01207440|39533211|FG002|Overall Study|Non-compliance with Study Drug|1|||
16286737|NCT01207440|39533212|FG003|Overall Study|Non-compliance with Study Drug|0|||
16286738|NCT01207440|39533213|FG004|Overall Study|Non-compliance with Study Drug|0|||
16286739|NCT01207440|39533214|FG005|Overall Study|Non-compliance with Study Drug|0|||
16286740|NCT01207440|39533215|FG006|Overall Study|Non-compliance with Study Drug|0|||
16286741|NCT01207440|39533209|FG000|Overall Study|Physician Decision|6|||
16286742|NCT01207440|39533210|FG001|Overall Study|Physician Decision|5|||
16286743|NCT01207440|39533211|FG002|Overall Study|Physician Decision|5|||
16286744|NCT01207440|39533212|FG003|Overall Study|Physician Decision|0|||
16286745|NCT01207440|39533213|FG004|Overall Study|Physician Decision|1|||
16286746|NCT01207440|39533214|FG005|Overall Study|Physician Decision|0|||
16286747|NCT01207440|39533215|FG006|Overall Study|Physician Decision|0|||
16286748|NCT01207440|39533209|FG000|Overall Study|Progressive Disease|19|||
16286749|NCT01207440|39533210|FG001|Overall Study|Progressive Disease|10|||
16286750|NCT01207440|39533211|FG002|Overall Study|Progressive Disease|19|||
16286751|NCT01207440|39533212|FG003|Overall Study|Progressive Disease|7|||
16286752|NCT01207440|39533213|FG004|Overall Study|Progressive Disease|23|||
16286753|NCT01207440|39533214|FG005|Overall Study|Progressive Disease|27|||
16286754|NCT01207440|39533215|FG006|Overall Study|Progressive Disease|0|||
16286755|NCT01207440|39533209|FG000|Overall Study|Protocol Violation|2|||
16286756|NCT01207440|39533210|FG001|Overall Study|Protocol Violation|0|||
16286757|NCT01207440|39533211|FG002|Overall Study|Protocol Violation|0|||
16286758|NCT01207440|39533212|FG003|Overall Study|Protocol Violation|0|||
16286759|NCT01207440|39533213|FG004|Overall Study|Protocol Violation|0|||
16286760|NCT01207440|39533214|FG005|Overall Study|Protocol Violation|0|||
16286761|NCT01207440|39533215|FG006|Overall Study|Protocol Violation|0|||
16286762|NCT01207440|39533209|FG000|Overall Study|Site Terminated by Sponsor|69|||
16286763|NCT01207440|39533210|FG001|Overall Study|Site Terminated by Sponsor|19|||
16286764|NCT01207440|39533211|FG002|Overall Study|Site Terminated by Sponsor|12|||
16286765|NCT01207440|39533212|FG003|Overall Study|Site Terminated by Sponsor|2|||
16286766|NCT01207440|39533213|FG004|Overall Study|Site Terminated by Sponsor|3|||
16286767|NCT01207440|39533214|FG005|Overall Study|Site Terminated by Sponsor|0|||
16286768|NCT01207440|39533215|FG006|Overall Study|Site Terminated by Sponsor|2|||
16286769|NCT01207440|39533209|FG000|Overall Study|Withdrawal by Subject|29|||
16286770|NCT01207440|39533210|FG001|Overall Study|Withdrawal by Subject|4|||
16286771|NCT01207440|39533211|FG002|Overall Study|Withdrawal by Subject|5|||
16286772|NCT01207440|39533212|FG003|Overall Study|Withdrawal by Subject|3|||
16481241|NCT00395304|40238503|FG005|Treatment Period 2|Other|0|||
16481242|NCT00395304|40238498|FG000|Treatment Period 3|Withdrawal by Subject|0|||
16481243|NCT00395304|40238499|FG001|Treatment Period 3|Withdrawal by Subject|0|||
16481244|NCT00395304|40238500|FG002|Treatment Period 3|Withdrawal by Subject|0|||
16481245|NCT00395304|40238501|FG003|Treatment Period 3|Withdrawal by Subject|1|||
16481246|NCT00395304|40238502|FG004|Treatment Period 3|Withdrawal by Subject|0|||
16481247|NCT00395304|40238503|FG005|Treatment Period 3|Withdrawal by Subject|1|||
16481248|NCT00395304|40238498|FG000|Treatment Period 3|Lost to Follow-up|1|||
16481249|NCT00395304|40238499|FG001|Treatment Period 3|Lost to Follow-up|1|||
16286773|NCT01207440|39533213|FG004|Overall Study|Withdrawal by Subject|2|||
16286774|NCT01207440|39533214|FG005|Overall Study|Withdrawal by Subject|2|||
16286775|NCT01207440|39533215|FG006|Overall Study|Withdrawal by Subject|0|||
16286776|NCT01207440|39533209|FG000|Overall Study|Reason Not Specified|10|||
16286777|NCT01207440|39533210|FG001|Overall Study|Reason Not Specified|10|||
16286778|NCT01207440|39533211|FG002|Overall Study|Reason Not Specified|7|||
16286779|NCT01207440|39533212|FG003|Overall Study|Reason Not Specified|0|||
16286780|NCT01207440|39533213|FG004|Overall Study|Reason Not Specified|4|||
16286781|NCT01207440|39533214|FG005|Overall Study|Reason Not Specified|3|||
16481250|NCT00395304|40238500|FG002|Treatment Period 3|Lost to Follow-up|0|||
16481251|NCT00395304|40238501|FG003|Treatment Period 3|Lost to Follow-up|0|||
16481252|NCT00395304|40238502|FG004|Treatment Period 3|Lost to Follow-up|0|||
16286782|NCT01207440|39533215|FG006|Overall Study|Reason Not Specified|0|||
16286783|NCT00502801|39533218|FG000|Treatment Period|Withdrawal by Subject|3|||
16286784|NCT00502801|39533218|FG000|Treatment Period|Adverse Event|7|||
16286785|NCT00502801|39533218|FG000|Treatment Period|Death|14|||
16286786|NCT00502801|39533218|FG000|Treatment Period|OTHER|30|||
16286787|NCT00502801|39533218|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
16286788|NCT00502801|39533218|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
16286789|NCT00502801|39533218|FG000|End of Therapy to Test of Cure|Death|3|||
16286790|NCT00502801|39533218|FG000|End of Therapy to Test of Cure|OTHER|2|||
16286791|NCT05506358|39533219|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
16286792|NCT05506358|39533220|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
16286793|NCT05506358|39533221|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
16286794|NCT05506358|39533222|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
16286795|NCT05506358|39533223|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
16286796|NCT05506358|39533219|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
16286797|NCT05506358|39533220|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
16286798|NCT05506358|39533221|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
16286799|NCT05506358|39533222|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
16286800|NCT05506358|39533223|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
16286801|NCT05506358|39533219|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
16286802|NCT05506358|39533220|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
16286803|NCT05506358|39533221|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
16286804|NCT05506358|39533222|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
16286805|NCT05506358|39533223|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
16286806|NCT05506358|39533219|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
16286807|NCT05506358|39533220|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
16286808|NCT05506358|39533221|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
16286809|NCT05506358|39533222|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
16286810|NCT05506358|39533223|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
16286811|NCT05506358|39533219|FG000|Overall Study|HbE trait|0|||
16286812|NCT05506358|39533220|FG001|Overall Study|HbE trait|0|||
16286813|NCT05506358|39533221|FG002|Overall Study|HbE trait|0|||
16286814|NCT05506358|39533222|FG003|Overall Study|HbE trait|1|||
16286815|NCT05506358|39533223|FG004|Overall Study|HbE trait|0|||
16286816|NCT00373425|39533224|FG000|Overall Study|Relapse of NSCLC|116|||
16286817|NCT00373425|39533225|FG001|Overall Study|Relapse of NSCLC|104|||
16286818|NCT00373425|39533226|FG002|Overall Study|Relapse of NSCLC|19|||
16286819|NCT00373425|39533227|FG003|Overall Study|Relapse of NSCLC|2|||
16286820|NCT00373425|39533228|FG004|Overall Study|Relapse of NSCLC|26|||
16286821|NCT00373425|39533224|FG000|Overall Study|Adverse Event|191|||
16286822|NCT00373425|39533225|FG001|Overall Study|Adverse Event|22|||
16286823|NCT00373425|39533226|FG002|Overall Study|Adverse Event|59|||
16286824|NCT00373425|39533227|FG003|Overall Study|Adverse Event|0|||
16286825|NCT00373425|39533228|FG004|Overall Study|Adverse Event|34|||
16481253|NCT00395304|40238503|FG005|Treatment Period 3|Lost to Follow-up|0|||
16481254|NCT00395304|40238498|FG000|Treatment Period 3|Physician Decision|0|||
16481255|NCT00395304|40238499|FG001|Treatment Period 3|Physician Decision|1|||
16481256|NCT00395304|40238500|FG002|Treatment Period 3|Physician Decision|0|||
16481257|NCT00395304|40238501|FG003|Treatment Period 3|Physician Decision|0|||
16481258|NCT00395304|40238502|FG004|Treatment Period 3|Physician Decision|0|||
16481259|NCT00395304|40238503|FG005|Treatment Period 3|Physician Decision|0|||
16481260|NCT00395304|40238498|FG000|Treatment Period 3|Other|0|||
16481261|NCT00395304|40238499|FG001|Treatment Period 3|Other|0|||
16481262|NCT00395304|40238500|FG002|Treatment Period 3|Other|0|||
16286826|NCT00373425|39533224|FG000|Overall Study|Patient request|35|||
16286827|NCT00373425|39533225|FG001|Overall Study|Patient request|18|||
16286828|NCT00373425|39533226|FG002|Overall Study|Patient request|43|||
16481263|NCT00395304|40238501|FG003|Treatment Period 3|Other|1|||
16481264|NCT00395304|40238502|FG004|Treatment Period 3|Other|0|||
16481265|NCT00395304|40238503|FG005|Treatment Period 3|Other|0|||
16286829|NCT00373425|39533227|FG003|Overall Study|Patient request|6|||
16286830|NCT00373425|39533228|FG004|Overall Study|Patient request|7|||
16286831|NCT00373425|39533224|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
16286832|NCT00373425|39533225|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
16286833|NCT00373425|39533226|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
16286834|NCT00373425|39533227|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
16286835|NCT00373425|39533228|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
16286836|NCT00373425|39533224|FG000|Overall Study|Death|7|||
16286837|NCT00373425|39533225|FG001|Overall Study|Death|0|||
16286838|NCT00373425|39533226|FG002|Overall Study|Death|3|||
16286839|NCT00373425|39533227|FG003|Overall Study|Death|1|||
16286840|NCT00373425|39533228|FG004|Overall Study|Death|0|||
16286841|NCT00430950|39533231|FG000|Overall Study|Adverse Event|7|||
16286842|NCT00430950|39533232|FG001|Overall Study|Adverse Event|6|||
16286843|NCT00430950|39533231|FG000|Overall Study|Withdrawal by Subject|1|||
16286844|NCT00430950|39533232|FG001|Overall Study|Withdrawal by Subject|0|||
16286845|NCT00430950|39533231|FG000|Overall Study|concomitant medication,etc.|5|||
16286846|NCT00430950|39533232|FG001|Overall Study|concomitant medication,etc.|7|||
16286847|NCT01351350|39533236|FG000|Overall Study|Disease Progression|5|||
16286848|NCT01351350|39533237|FG001|Overall Study|Disease Progression|13|||
16286849|NCT01351350|39533238|FG002|Overall Study|Disease Progression|6|||
16286850|NCT01351350|39533239|FG003|Overall Study|Disease Progression|8|||
16286851|NCT01351350|39533240|FG004|Overall Study|Disease Progression|5|||
16286852|NCT01351350|39533236|FG000|Overall Study|Adverse Event|1|||
16286853|NCT01351350|39533237|FG001|Overall Study|Adverse Event|10|||
16286854|NCT01351350|39533238|FG002|Overall Study|Adverse Event|1|||
16286855|NCT01351350|39533239|FG003|Overall Study|Adverse Event|2|||
16286856|NCT01351350|39533240|FG004|Overall Study|Adverse Event|0|||
16286857|NCT01351350|39533236|FG000|Overall Study|Participant Decision|2|||
16286858|NCT01351350|39533237|FG001|Overall Study|Participant Decision|6|||
16286859|NCT01351350|39533238|FG002|Overall Study|Participant Decision|3|||
16286860|NCT01351350|39533239|FG003|Overall Study|Participant Decision|3|||
16286861|NCT01351350|39533240|FG004|Overall Study|Participant Decision|2|||
16286862|NCT01351350|39533236|FG000|Overall Study|Enrolled but not Treated|0|||
16286863|NCT01351350|39533237|FG001|Overall Study|Enrolled but not Treated|0|||
16286864|NCT01351350|39533238|FG002|Overall Study|Enrolled but not Treated|1|||
16286865|NCT01351350|39533239|FG003|Overall Study|Enrolled but not Treated|0|||
16481266|NCT02110238|40238504|FG000|12 Week Pivotal Phase|Adverse Event|3|||
16481267|NCT02110238|40238505|FG001|12 Week Pivotal Phase|Adverse Event|0|||
16481268|NCT02110238|40238504|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
16481269|NCT02110238|40238505|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
16481270|NCT02110238|40238504|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
16481271|NCT02110238|40238505|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
16481272|NCT02110238|40238504|FG000|12 Week Pivotal Phase|Physician Decision|0|||
16481273|NCT02110238|40238505|FG001|12 Week Pivotal Phase|Physician Decision|2|||
16481274|NCT02110238|40238504|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
16481275|NCT02110238|40238505|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
16481276|NCT02110238|40238504|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
16481277|NCT02110238|40238505|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
16481278|NCT02110238|40238504|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
16481279|NCT02110238|40238505|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
16481280|NCT02110238|40238504|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
16481281|NCT02110238|40238505|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
16481282|NCT02110238|40238504|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
16481283|NCT02110238|40238505|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
16481284|NCT02110238|40238504|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
16481285|NCT02110238|40238505|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
16481286|NCT02110238|40238504|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
16481287|NCT02110238|40238505|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
16481288|NCT02833350|40238506|FG000|Overall Study|Adverse Event|0|||
16481289|NCT02833350|40238507|FG001|Overall Study|Adverse Event|3|||
16481290|NCT02833350|40238508|FG002|Overall Study|Adverse Event|4|||
16481291|NCT02833350|40238509|FG003|Overall Study|Adverse Event|4|||
16481292|NCT02833350|40238510|FG004|Overall Study|Adverse Event|1|||
16481293|NCT02833350|40238511|FG005|Overall Study|Adverse Event|0|||
16481294|NCT02833350|40238512|FG006|Overall Study|Adverse Event|1|||
16481295|NCT02833350|40238506|FG000|Overall Study|Death|0|||
16481296|NCT02833350|40238507|FG001|Overall Study|Death|0|||
16286866|NCT01351350|39533240|FG004|Overall Study|Enrolled but not Treated|0|||
16286867|NCT04086641|39533241|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
16286868|NCT04086641|39533242|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
16481297|NCT02833350|40238508|FG002|Overall Study|Death|1|||
16481298|NCT02833350|40238509|FG003|Overall Study|Death|0|||
16481299|NCT02833350|40238510|FG004|Overall Study|Death|0|||
16286869|NCT01782482|39533245|FG000|Overall Study|Adverse Event|2|||
16481300|NCT02833350|40238511|FG005|Overall Study|Death|0|||
16481301|NCT02833350|40238512|FG006|Overall Study|Death|0|||
16481302|NCT02833350|40238506|FG000|Overall Study|Lack of Efficacy|0|||
16481303|NCT02833350|40238507|FG001|Overall Study|Lack of Efficacy|2|||
16481304|NCT02833350|40238508|FG002|Overall Study|Lack of Efficacy|1|||
16481305|NCT02833350|40238509|FG003|Overall Study|Lack of Efficacy|4|||
16481306|NCT02833350|40238510|FG004|Overall Study|Lack of Efficacy|0|||
16481307|NCT02833350|40238511|FG005|Overall Study|Lack of Efficacy|1|||
16286870|NCT01782482|39533246|FG001|Overall Study|Adverse Event|1|||
16286871|NCT01782482|39533245|FG000|Overall Study|Lost to Follow-up|2|||
16286872|NCT01782482|39533246|FG001|Overall Study|Lost to Follow-up|3|||
16286873|NCT01782482|39533245|FG000|Overall Study|Physician Decision|1|||
16286874|NCT01782482|39533246|FG001|Overall Study|Physician Decision|0|||
16286875|NCT01782482|39533245|FG000|Overall Study|Protocol Violation|1|||
16286876|NCT01782482|39533246|FG001|Overall Study|Protocol Violation|0|||
16286877|NCT01782482|39533245|FG000|Overall Study|Withdrawal by Subject|2|||
16481308|NCT02833350|40238512|FG006|Overall Study|Lack of Efficacy|1|||
16481309|NCT02833350|40238506|FG000|Overall Study|Lost to Follow-up|0|||
16286878|NCT01782482|39533246|FG001|Overall Study|Withdrawal by Subject|3|||
16286879|NCT01782482|39533245|FG000|Overall Study|Randomized in Error|2|||
16286880|NCT01782482|39533246|FG001|Overall Study|Randomized in Error|2|||
16286881|NCT01782482|39533245|FG000|Overall Study|Habitually wearing toric lens OS|0|||
16286882|NCT01782482|39533246|FG001|Overall Study|Habitually wearing toric lens OS|1|||
16286883|NCT00402025|39533247|FG000|Overall Study|Adverse Event|0|||
16286884|NCT00402025|39533248|FG001|Overall Study|Adverse Event|0|||
16286885|NCT00402025|39533249|FG002|Overall Study|Adverse Event|2|||
16286886|NCT00402025|39533247|FG000|Overall Study|Death|0|||
16286887|NCT00402025|39533248|FG001|Overall Study|Death|1|||
16286888|NCT00402025|39533249|FG002|Overall Study|Death|5|||
16286889|NCT00402025|39533247|FG000|Overall Study|Disease Progression|1|||
16286890|NCT00402025|39533248|FG001|Overall Study|Disease Progression|1|||
16286891|NCT00402025|39533249|FG002|Overall Study|Disease Progression|2|||
16286892|NCT00402025|39533247|FG000|Overall Study|Physician Decision|1|||
16286893|NCT00402025|39533248|FG001|Overall Study|Physician Decision|1|||
16286894|NCT00402025|39533249|FG002|Overall Study|Physician Decision|0|||
16286895|NCT00402025|39533247|FG000|Overall Study|Participant Decision|0|||
16286896|NCT00402025|39533248|FG001|Overall Study|Participant Decision|0|||
16286897|NCT00402025|39533249|FG002|Overall Study|Participant Decision|1|||
16286898|NCT00268892|39533257|FG000|Overall Study|Adverse Event|14|||
16286899|NCT00268892|39533258|FG001|Overall Study|Adverse Event|17|||
16286900|NCT00268892|39533259|FG002|Overall Study|Adverse Event|20|||
16286901|NCT00268892|39533257|FG000|Overall Study|Lack of Efficacy|1|||
16286902|NCT00268892|39533258|FG001|Overall Study|Lack of Efficacy|3|||
16286903|NCT00268892|39533259|FG002|Overall Study|Lack of Efficacy|0|||
16286904|NCT00268892|39533257|FG000|Overall Study|Withdrawal by Subject|14|||
16286905|NCT00268892|39533258|FG001|Overall Study|Withdrawal by Subject|15|||
16286906|NCT00268892|39533259|FG002|Overall Study|Withdrawal by Subject|13|||
16286907|NCT00268892|39533257|FG000|Overall Study|Physician Decision|0|||
16286908|NCT00268892|39533258|FG001|Overall Study|Physician Decision|1|||
16286909|NCT00268892|39533259|FG002|Overall Study|Physician Decision|0|||
16286910|NCT00268892|39533257|FG000|Overall Study|Lost to Follow-up|5|||
16286911|NCT00268892|39533258|FG001|Overall Study|Lost to Follow-up|2|||
16286912|NCT00268892|39533259|FG002|Overall Study|Lost to Follow-up|4|||
16286913|NCT00268892|39533257|FG000|Overall Study|Protocol Violation|0|||
16286914|NCT00268892|39533258|FG001|Overall Study|Protocol Violation|1|||
16286915|NCT00268892|39533259|FG002|Overall Study|Protocol Violation|0|||
16286916|NCT00268892|39533257|FG000|Overall Study|Disease Progression|1|||
16286917|NCT00268892|39533258|FG001|Overall Study|Disease Progression|1|||
16286918|NCT00268892|39533259|FG002|Overall Study|Disease Progression|0|||
16286919|NCT00268892|39533257|FG000|Overall Study|Trial Site Closed|4|||
16286920|NCT00268892|39533258|FG001|Overall Study|Trial Site Closed|2|||
16286921|NCT00268892|39533259|FG002|Overall Study|Trial Site Closed|2|||
16286922|NCT01843348|39533261|FG000|Overall Study|Withdrawal by Subject|4|||
16286923|NCT01843348|39533262|FG001|Overall Study|Withdrawal by Subject|16|||
16286924|NCT01843348|39533263|FG002|Overall Study|Withdrawal by Subject|18|||
16286925|NCT01843348|39533261|FG000|Overall Study|Lost to Follow-up|5|||
16286926|NCT01843348|39533262|FG001|Overall Study|Lost to Follow-up|4|||
16286927|NCT01843348|39533263|FG002|Overall Study|Lost to Follow-up|2|||
16286928|NCT01843348|39533261|FG000|Overall Study|Death|5|||
16286929|NCT01843348|39533262|FG001|Overall Study|Death|3|||
16286930|NCT01843348|39533263|FG002|Overall Study|Death|4|||
16286931|NCT01843348|39533261|FG000|Overall Study|Graft loss/retransplantation|5|||
16286932|NCT01843348|39533262|FG001|Overall Study|Graft loss/retransplantation|8|||
16481310|NCT02833350|40238507|FG001|Overall Study|Lost to Follow-up|1|||
16481311|NCT02833350|40238508|FG002|Overall Study|Lost to Follow-up|0|||
16481312|NCT02833350|40238509|FG003|Overall Study|Lost to Follow-up|0|||
16286933|NCT01843348|39533263|FG002|Overall Study|Graft loss/retransplantation|11|||
16286934|NCT01843348|39533261|FG000|Overall Study|Various reasons|4|||
16286935|NCT01843348|39533262|FG001|Overall Study|Various reasons|9|||
16286936|NCT01843348|39533263|FG002|Overall Study|Various reasons|6|||
16286937|NCT04920916|39533269|FG000|Phase IIa 60 Day Study|Death|2|||
16286938|NCT04920916|39533270|FG001|Phase IIa 60 Day Study|Death|5|||
16286939|NCT04920916|39533269|FG000|1 Year Follow up (Phone Call)|Death|1|||
16286940|NCT04920916|39533270|FG001|1 Year Follow up (Phone Call)|Death|3|||
16286941|NCT04920916|39533269|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
16286942|NCT04920916|39533270|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
16286943|NCT02340221|39533275|FG000|Overall Study|Death|100|||
16286944|NCT02340221|39533276|FG001|Overall Study|Death|197|||
16286945|NCT02340221|39533275|FG000|Overall Study|Withdrawal by Participant|24|||
16286946|NCT02340221|39533276|FG001|Overall Study|Withdrawal by Participant|37|||
16286947|NCT02340221|39533275|FG000|Overall Study|Lost to Follow-up|4|||
16286948|NCT02340221|39533276|FG001|Overall Study|Lost to Follow-up|15|||
16286949|NCT02340221|39533275|FG000|Overall Study|Reason Not Specified|85|||
16286950|NCT02340221|39533276|FG001|Overall Study|Reason Not Specified|165|||
16286951|NCT02340221|39533275|FG000|Overall Study|Study Terminated by Sponsor|1|||
16286952|NCT02340221|39533276|FG001|Overall Study|Study Terminated by Sponsor|3|||
16286953|NCT00848042|39533277|FG000|Overall Study|Death|1|||
16286954|NCT00848042|39533278|FG001|Overall Study|Death|2|||
16286955|NCT00848042|39533279|FG002|Overall Study|Death|0|||
16286956|NCT00848042|39533277|FG000|Overall Study|Other Therapy|3|||
16286957|NCT00848042|39533278|FG001|Overall Study|Other Therapy|0|||
16286958|NCT00848042|39533279|FG002|Overall Study|Other Therapy|0|||
16286959|NCT00049842|39533280|FG000|Treatment Phase|Adverse Event|47|||
16286960|NCT00049842|39533281|FG001|Treatment Phase|Adverse Event|12|||
16286961|NCT00049842|39533280|FG000|Treatment Phase|Withdrawal by Subject|35|||
16286962|NCT00049842|39533281|FG001|Treatment Phase|Withdrawal by Subject|46|||
16286963|NCT00049842|39533280|FG000|Treatment Phase|Non-compliance with protocol|7|||
16286964|NCT00049842|39533281|FG001|Treatment Phase|Non-compliance with protocol|8|||
16286965|NCT00049842|39533280|FG000|Treatment Phase|Lost to Follow-up|4|||
16286966|NCT00049842|39533281|FG001|Treatment Phase|Lost to Follow-up|8|||
16286967|NCT00049842|39533280|FG000|Treatment Phase|Administrative|0|||
16286968|NCT00049842|39533281|FG001|Treatment Phase|Administrative|3|||
16286969|NCT00049842|39533280|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
16286970|NCT00049842|39533281|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
16286971|NCT00049842|39533280|FG000|Follow-up Phase|Adverse Event|6|||
16286972|NCT00049842|39533281|FG001|Follow-up Phase|Adverse Event|1|||
16286973|NCT00049842|39533280|FG000|Follow-up Phase|Other|1|||
16286974|NCT00049842|39533281|FG001|Follow-up Phase|Other|4|||
16286975|NCT00108082|39533283|FG000|Overall Study|Adverse Event|14|||
16286976|NCT00108082|39533284|FG001|Overall Study|Adverse Event|12|||
16286977|NCT00108082|39533285|FG002|Overall Study|Adverse Event|17|||
16286978|NCT00108082|39533283|FG000|Overall Study|Lost to Follow-up|6|||
16286979|NCT00108082|39533284|FG001|Overall Study|Lost to Follow-up|3|||
16286980|NCT00108082|39533285|FG002|Overall Study|Lost to Follow-up|7|||
16286981|NCT00108082|39533283|FG000|Overall Study|Consent Withdrawn|3|||
16286982|NCT00108082|39533284|FG001|Overall Study|Consent Withdrawn|3|||
16286983|NCT00108082|39533285|FG002|Overall Study|Consent Withdrawn|5|||
16286984|NCT00108082|39533283|FG000|Overall Study|Protocol Violation|1|||
16286985|NCT00108082|39533284|FG001|Overall Study|Protocol Violation|2|||
16286986|NCT00108082|39533285|FG002|Overall Study|Protocol Violation|0|||
16286987|NCT00108082|39533283|FG000|Overall Study|Lack of Efficacy|3|||
16481313|NCT02833350|40238510|FG004|Overall Study|Lost to Follow-up|0|||
16481314|NCT02833350|40238511|FG005|Overall Study|Lost to Follow-up|0|||
16481315|NCT02833350|40238512|FG006|Overall Study|Lost to Follow-up|1|||
16481316|NCT02833350|40238506|FG000|Overall Study|Withdrawal by Subject|3|||
16481317|NCT02833350|40238507|FG001|Overall Study|Withdrawal by Subject|3|||
16481318|NCT02833350|40238508|FG002|Overall Study|Withdrawal by Subject|2|||
16481319|NCT02833350|40238509|FG003|Overall Study|Withdrawal by Subject|0|||
16481320|NCT02833350|40238510|FG004|Overall Study|Withdrawal by Subject|2|||
16481321|NCT02833350|40238511|FG005|Overall Study|Withdrawal by Subject|0|||
16481322|NCT02833350|40238512|FG006|Overall Study|Withdrawal by Subject|2|||
16481323|NCT00246753|40238513|FG000|Overall Study|Withdrawal by Subject|2|||
16481324|NCT00246753|40238513|FG000|Overall Study|Physician Decision|2|||
16481325|NCT00246753|40238513|FG000|Overall Study|Adverse Event|2|||
16481326|NCT00246753|40238513|FG000|Overall Study|Unacceptable toxicity|2|||
16286988|NCT00108082|39533284|FG001|Overall Study|Lack of Efficacy|1|||
16286989|NCT00108082|39533285|FG002|Overall Study|Lack of Efficacy|2|||
16286990|NCT00108082|39533283|FG000|Overall Study|Amendment 4: > Month 12|5|||
16286991|NCT00108082|39533284|FG001|Overall Study|Amendment 4: > Month 12|7|||
16286992|NCT00108082|39533285|FG002|Overall Study|Amendment 4: > Month 12|5|||
16286993|NCT00108082|39533283|FG000|Overall Study|Woman of Child-bearing Potential|2|||
16286994|NCT00108082|39533284|FG001|Overall Study|Woman of Child-bearing Potential|0|||
16286995|NCT00108082|39533285|FG002|Overall Study|Woman of Child-bearing Potential|2|||
16286996|NCT00108082|39533283|FG000|Overall Study|Incorrectly Randomized|0|||
16286997|NCT00108082|39533284|FG001|Overall Study|Incorrectly Randomized|0|||
16286998|NCT00108082|39533285|FG002|Overall Study|Incorrectly Randomized|2|||
16286999|NCT00108082|39533283|FG000|Overall Study|Non-compliance|1|||
16287000|NCT00108082|39533284|FG001|Overall Study|Non-compliance|0|||
16287001|NCT00108082|39533285|FG002|Overall Study|Non-compliance|2|||
16287002|NCT00108082|39533283|FG000|Overall Study|Stopped Study Medication|0|||
16287003|NCT00108082|39533284|FG001|Overall Study|Stopped Study Medication|0|||
16287004|NCT00108082|39533285|FG002|Overall Study|Stopped Study Medication|1|||
16287005|NCT00108082|39533283|FG000|Overall Study|Site Closed Study|0|||
16287006|NCT00108082|39533284|FG001|Overall Study|Site Closed Study|2|||
16287007|NCT00108082|39533285|FG002|Overall Study|Site Closed Study|0|||
16287008|NCT00108082|39533283|FG000|Overall Study|Protocol Amendment|0|||
16287009|NCT00108082|39533284|FG001|Overall Study|Protocol Amendment|1|||
16287010|NCT00108082|39533285|FG002|Overall Study|Protocol Amendment|0|||
16287011|NCT00108082|39533283|FG000|Overall Study|Study Medication Not Tapered|0|||
16481327|NCT00150709|40242198|FG000|Overall Study|Protocol Violation|7|||
16481328|NCT00150709|40242199|FG001|Overall Study|Protocol Violation|8|||
16481329|NCT00150709|40242200|FG002|Overall Study|Protocol Violation|3|||
16481330|NCT00150709|40242201|FG003|Overall Study|Protocol Violation|1|||
16481331|NCT00150709|40242198|FG000|Overall Study|Adverse Event|8|||
16481332|NCT00150709|40242199|FG001|Overall Study|Adverse Event|2|||
16481333|NCT00150709|40242200|FG002|Overall Study|Adverse Event|2|||
16481334|NCT00150709|40242201|FG003|Overall Study|Adverse Event|3|||
16481335|NCT00150709|40242198|FG000|Overall Study|Lack of Efficacy|6|||
16481336|NCT00150709|40242199|FG001|Overall Study|Lack of Efficacy|11|||
16481337|NCT00150709|40242200|FG002|Overall Study|Lack of Efficacy|9|||
16481338|NCT00150709|40242201|FG003|Overall Study|Lack of Efficacy|0|||
16481339|NCT00150709|40242198|FG000|Overall Study|Withdrawal by Subject|7|||
16481340|NCT00150709|40242199|FG001|Overall Study|Withdrawal by Subject|10|||
16481341|NCT00150709|40242200|FG002|Overall Study|Withdrawal by Subject|5|||
16481342|NCT00150709|40242201|FG003|Overall Study|Withdrawal by Subject|0|||
16481343|NCT00150709|40242198|FG000|Overall Study|Lost to Follow-up|3|||
16481344|NCT00150709|40242199|FG001|Overall Study|Lost to Follow-up|2|||
16481345|NCT00150709|40242200|FG002|Overall Study|Lost to Follow-up|0|||
16481346|NCT00150709|40242201|FG003|Overall Study|Lost to Follow-up|0|||
16481347|NCT00150709|40242198|FG000|Overall Study|Sponsor decision|0|||
16481348|NCT00150709|40242199|FG001|Overall Study|Sponsor decision|0|||
16481349|NCT00150709|40242200|FG002|Overall Study|Sponsor decision|0|||
16481350|NCT00150709|40242201|FG003|Overall Study|Sponsor decision|1|||
16481351|NCT00150709|40242198|FG000|Overall Study|Site/Investigator discontinued the study|5|||
16481352|NCT00150709|40242199|FG001|Overall Study|Site/Investigator discontinued the study|5|||
16481353|NCT00150709|40242200|FG002|Overall Study|Site/Investigator discontinued the study|2|||
16481354|NCT00150709|40242201|FG003|Overall Study|Site/Investigator discontinued the study|0|||
16481355|NCT00150709|40242198|FG000|Overall Study|Decision of parent(s)|1|||
16481356|NCT00150709|40242199|FG001|Overall Study|Decision of parent(s)|2|||
16481357|NCT00150709|40242200|FG002|Overall Study|Decision of parent(s)|0|||
16481358|NCT00150709|40242201|FG003|Overall Study|Decision of parent(s)|0|||
16481359|NCT00150709|40242198|FG000|Overall Study|Decision of parent(s) and investigator|3|||
16481360|NCT00150709|40242199|FG001|Overall Study|Decision of parent(s) and investigator|0|||
16287012|NCT00108082|39533284|FG001|Overall Study|Study Medication Not Tapered|1|||
16287013|NCT00108082|39533285|FG002|Overall Study|Study Medication Not Tapered|0|||
16287014|NCT00108082|39533283|FG000|Overall Study|Subject Left Site Location|1|||
16287015|NCT00108082|39533284|FG001|Overall Study|Subject Left Site Location|0|||
16287016|NCT00108082|39533285|FG002|Overall Study|Subject Left Site Location|0|||
16287017|NCT00108082|39533283|FG000|Overall Study|Investigator Not at Site|1|||
16287018|NCT00108082|39533284|FG001|Overall Study|Investigator Not at Site|0|||
16287019|NCT00108082|39533285|FG002|Overall Study|Investigator Not at Site|0|||
16287020|NCT00108082|39533283|FG000|Overall Study|Blood Pressure Not Controlled|1|||
16287021|NCT00108082|39533284|FG001|Overall Study|Blood Pressure Not Controlled|0|||
16287022|NCT00108082|39533285|FG002|Overall Study|Blood Pressure Not Controlled|0|||
16287023|NCT02531594|39533286|FG000|Overall Study|Withdrawal by Subject|7|||
16287024|NCT02531594|39533287|FG001|Overall Study|Withdrawal by Subject|8|||
16287025|NCT00536484|39533290|FG000|Overall Study|Adverse Event|21|||
16287026|NCT00536484|39533291|FG001|Overall Study|Adverse Event|34|||
16287027|NCT00536484|39533290|FG000|Overall Study|Withdrawal by Subject|11|||
16287028|NCT00536484|39533291|FG001|Overall Study|Withdrawal by Subject|11|||
16287029|NCT00536484|39533290|FG000|Overall Study|Lost to Follow-up|8|||
16287030|NCT00536484|39533291|FG001|Overall Study|Lost to Follow-up|6|||
16287031|NCT00536484|39533290|FG000|Overall Study|Lack of Efficacy|16|||
16287032|NCT00536484|39533291|FG001|Overall Study|Lack of Efficacy|5|||
16287033|NCT00536484|39533290|FG000|Overall Study|Other|4|||
16481361|NCT00150709|40242200|FG002|Overall Study|Decision of parent(s) and investigator|0|||
16287034|NCT00536484|39533291|FG001|Overall Study|Other|0|||
16287035|NCT03401450|39533292|FG000|Overall Study|Lost to Follow-up|4|||
16287036|NCT03401450|39533293|FG001|Overall Study|Lost to Follow-up|6|||
16287037|NCT03401450|39533292|FG000|Overall Study|Anesthesia plan changed|2|||
16287038|NCT03401450|39533293|FG001|Overall Study|Anesthesia plan changed|2|||
16287039|NCT03401450|39533292|FG000|Overall Study|Did not complete medication diary|4|||
16287040|NCT03401450|39533293|FG001|Overall Study|Did not complete medication diary|2|||
16287041|NCT03401450|39533292|FG000|Overall Study|post surgery medication change|2|||
16287042|NCT03401450|39533293|FG001|Overall Study|post surgery medication change|1|||
16287043|NCT03401450|39533292|FG000|Overall Study|Cancelled surgery|0|||
16287044|NCT03401450|39533293|FG001|Overall Study|Cancelled surgery|2|||
16287045|NCT00206102|39533294|FG000|Overall Study|Adverse Event|119|||
16481362|NCT00150709|40242201|FG003|Overall Study|Decision of parent(s) and investigator|0|||
16481363|NCT00150709|40242198|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
16481364|NCT00150709|40242199|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
16481365|NCT00150709|40242200|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
16481366|NCT00150709|40242201|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
16481367|NCT00150709|40242198|FG000|Overall Study|Investigator decision|1|||
16481368|NCT00150709|40242199|FG001|Overall Study|Investigator decision|0|||
16481369|NCT00150709|40242200|FG002|Overall Study|Investigator decision|0|||
16481370|NCT00150709|40242201|FG003|Overall Study|Investigator decision|1|||
16481371|NCT00150709|40242198|FG000|Overall Study|Subject relocated|2|||
16481372|NCT00150709|40242199|FG001|Overall Study|Subject relocated|2|||
16481373|NCT00150709|40242200|FG002|Overall Study|Subject relocated|1|||
16481374|NCT00150709|40242201|FG003|Overall Study|Subject relocated|0|||
16481375|NCT00150709|40242198|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
16481376|NCT00150709|40242199|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
16481377|NCT00150709|40242200|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
16481378|NCT00150709|40242201|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
16481379|NCT00150709|40242198|FG000|Overall Study|Convenience|0|||
16287046|NCT00206102|39533295|FG001|Overall Study|Adverse Event|82|||
16287047|NCT00206102|39533294|FG000|Overall Study|Protocol Violation|0|||
16287048|NCT00206102|39533295|FG001|Overall Study|Protocol Violation|2|||
16287049|NCT00206102|39533294|FG000|Overall Study|Lack of therapeutic response|16|||
16287050|NCT00206102|39533295|FG001|Overall Study|Lack of therapeutic response|11|||
16287051|NCT00206102|39533294|FG000|Overall Study|Lost to Follow-up|95|||
16287052|NCT00206102|39533295|FG001|Overall Study|Lost to Follow-up|66|||
16287053|NCT00206102|39533294|FG000|Overall Study|Withdrawal by Subject|118|||
16287054|NCT00206102|39533295|FG001|Overall Study|Withdrawal by Subject|101|||
16287055|NCT00206102|39533294|FG000|Overall Study|Study-specific discontinuation criteria|18|||
16287056|NCT00206102|39533295|FG001|Overall Study|Study-specific discontinuation criteria|17|||
16287057|NCT00206102|39533294|FG000|Overall Study|None of those categories|42|||
16287058|NCT00206102|39533295|FG001|Overall Study|None of those categories|36|||
16287059|NCT00467831|39533299|FG000|Overall Study|Death|2|||
16287060|NCT00467831|39533299|FG000|Overall Study|Withdrawal by Subject|1|||
16287061|NCT00834899|39533300|FG000|Overall Study|Withdrawal by Subject|1|||
16287062|NCT00834899|39533301|FG001|Overall Study|Withdrawal by Subject|1|||
16287063|NCT01014624|39533302|FG000|Overall Study|Adverse Event|0|||
16287064|NCT01014624|39533303|FG001|Overall Study|Adverse Event|1|||
16287065|NCT01014624|39533302|FG000|Overall Study|Protocol Violation|1|||
16287066|NCT01014624|39533303|FG001|Overall Study|Protocol Violation|0|||
16287067|NCT01014624|39533302|FG000|Overall Study|Withdrawal by Subject|1|||
16287068|NCT01014624|39533303|FG001|Overall Study|Withdrawal by Subject|0|||
16287069|NCT00995085|39533310|FG000|Overall Study|Withdrawal by Subject|5|||
16287070|NCT00869024|39533311|FG000|Overall Study|Death|2|||
16287071|NCT00869024|39533312|FG001|Overall Study|Death|3|||
16287072|NCT00869024|39533311|FG000|Overall Study|Lost to Follow-up|0|||
16287073|NCT00869024|39533312|FG001|Overall Study|Lost to Follow-up|1|||
16481380|NCT00150709|40242199|FG001|Overall Study|Convenience|1|||
16481381|NCT00150709|40242200|FG002|Overall Study|Convenience|0|||
16481382|NCT00150709|40242201|FG003|Overall Study|Convenience|0|||
16481383|NCT00150709|40242198|FG000|Overall Study|Subject entered new drug study|0|||
16481384|NCT00150709|40242199|FG001|Overall Study|Subject entered new drug study|1|||
16379944|NCT02546323|39874842|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
16379945|NCT02546323|39874841|FG000|Overall Study|Adverse Event|17|||
16379946|NCT02546323|39874842|FG001|Overall Study|Adverse Event|11|||
16379947|NCT02546323|39874841|FG000|Overall Study|Patient Specific Reasons|1|||
16379948|NCT02546323|39874842|FG001|Overall Study|Patient Specific Reasons|2|||
16379949|NCT02546323|39874841|FG000|Overall Study|Lost to Follow-up|2|||
16379950|NCT02546323|39874842|FG001|Overall Study|Lost to Follow-up|3|||
16379951|NCT02546323|39874841|FG000|Overall Study|Non-compliance with Study Drug|2|||
16379952|NCT02546323|39874842|FG001|Overall Study|Non-compliance with Study Drug|2|||
16287074|NCT00869024|39533311|FG000|Overall Study|Protocol Violation|0|||
16287075|NCT00869024|39533312|FG001|Overall Study|Protocol Violation|1|||
16287076|NCT02903238|39533313|FG000|Overall Study|Lost to Follow-up|4|||
16287077|NCT02333487|39533314|FG000|Overall Study|Adverse Event|0|||
16287078|NCT02333487|39533315|FG001|Overall Study|Adverse Event|2|||
16287079|NCT02333487|39533316|FG002|Overall Study|Adverse Event|0|||
16287080|NCT00573170|39533321|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
16287081|NCT00573170|39533322|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
16287082|NCT00573170|39533323|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
16287083|NCT00573170|39533324|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
16287084|NCT00573170|39533325|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
16379953|NCT02546323|39874841|FG000|Overall Study|Met Withdrawal Criteria|2|||
16379954|NCT02546323|39874842|FG001|Overall Study|Met Withdrawal Criteria|14|||
16379955|NCT03468998|39874843|FG000|Overall Study|Withdrawal by Subject|1|||
16379956|NCT03468998|39874844|FG001|Overall Study|Withdrawal by Subject|1|||
16379957|NCT03468998|39874845|FG002|Overall Study|Withdrawal by Subject|0|||
16379958|NCT03468998|39874846|FG003|Overall Study|Withdrawal by Subject|4|||
16379959|NCT03468998|39874847|FG004|Overall Study|Withdrawal by Subject|1|||
16379960|NCT03468998|39874848|FG005|Overall Study|Withdrawal by Subject|0|||
16379961|NCT03729609|39874849|FG000|Overall Study|Protocol Violation|1|||
16481385|NCT00150709|40242200|FG002|Overall Study|Subject entered new drug study|0|||
16481386|NCT00150709|40242201|FG003|Overall Study|Subject entered new drug study|0|||
16481387|NCT00150709|40242198|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
16287085|NCT00573170|39533326|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
16287086|NCT00573170|39533321|FG000|First Washout Period|Adverse Event|1|||
16287087|NCT00573170|39533322|FG001|First Washout Period|Adverse Event|1|||
16287088|NCT00573170|39533323|FG002|First Washout Period|Adverse Event|0|||
16287089|NCT00573170|39533324|FG003|First Washout Period|Adverse Event|0|||
16287090|NCT00573170|39533325|FG004|First Washout Period|Adverse Event|0|||
16287091|NCT00573170|39533326|FG005|First Washout Period|Adverse Event|1|||
16287092|NCT00573170|39533321|FG000|First Washout Period|Lack of Efficacy|0|||
16287093|NCT00573170|39533322|FG001|First Washout Period|Lack of Efficacy|0|||
16287094|NCT00573170|39533323|FG002|First Washout Period|Lack of Efficacy|0|||
16287095|NCT00573170|39533324|FG003|First Washout Period|Lack of Efficacy|0|||
16287096|NCT00573170|39533325|FG004|First Washout Period|Lack of Efficacy|0|||
16287097|NCT00573170|39533326|FG005|First Washout Period|Lack of Efficacy|1|||
16287098|NCT00573170|39533321|FG000|First Washout Period|Lost to Follow-up|1|||
16287099|NCT00573170|39533322|FG001|First Washout Period|Lost to Follow-up|1|||
16287100|NCT00573170|39533323|FG002|First Washout Period|Lost to Follow-up|0|||
16287101|NCT00573170|39533324|FG003|First Washout Period|Lost to Follow-up|2|||
16287102|NCT00573170|39533325|FG004|First Washout Period|Lost to Follow-up|0|||
16287103|NCT00573170|39533326|FG005|First Washout Period|Lost to Follow-up|2|||
16287104|NCT00573170|39533321|FG000|First Washout Period|Withdrawal by Subject|2|||
16287105|NCT00573170|39533322|FG001|First Washout Period|Withdrawal by Subject|0|||
16287106|NCT00573170|39533323|FG002|First Washout Period|Withdrawal by Subject|0|||
16287107|NCT00573170|39533324|FG003|First Washout Period|Withdrawal by Subject|2|||
16287108|NCT00573170|39533325|FG004|First Washout Period|Withdrawal by Subject|3|||
16287109|NCT00573170|39533326|FG005|First Washout Period|Withdrawal by Subject|3|||
16287110|NCT00573170|39533321|FG000|First Washout Period|Other|4|||
16287111|NCT00573170|39533322|FG001|First Washout Period|Other|0|||
16287112|NCT00573170|39533323|FG002|First Washout Period|Other|1|||
16287113|NCT00573170|39533324|FG003|First Washout Period|Other|1|||
16287114|NCT00573170|39533325|FG004|First Washout Period|Other|0|||
16287115|NCT00573170|39533326|FG005|First Washout Period|Other|0|||
16287116|NCT00573170|39533321|FG000|Second Washout Period|Adverse Event|1|||
16287117|NCT00573170|39533322|FG001|Second Washout Period|Adverse Event|0|||
16287118|NCT00573170|39533323|FG002|Second Washout Period|Adverse Event|0|||
16287119|NCT00573170|39533324|FG003|Second Washout Period|Adverse Event|0|||
16287120|NCT00573170|39533325|FG004|Second Washout Period|Adverse Event|1|||
16287121|NCT00573170|39533326|FG005|Second Washout Period|Adverse Event|0|||
16287122|NCT00573170|39533321|FG000|Second Washout Period|Protocol Violation|2|||
16287123|NCT00573170|39533322|FG001|Second Washout Period|Protocol Violation|1|||
16287124|NCT00573170|39533323|FG002|Second Washout Period|Protocol Violation|1|||
16287125|NCT00573170|39533324|FG003|Second Washout Period|Protocol Violation|0|||
16287126|NCT00573170|39533325|FG004|Second Washout Period|Protocol Violation|0|||
16287127|NCT00573170|39533326|FG005|Second Washout Period|Protocol Violation|0|||
16287128|NCT00573170|39533321|FG000|Second Washout Period|Withdrawal by Subject|1|||
16287129|NCT00573170|39533322|FG001|Second Washout Period|Withdrawal by Subject|1|||
16287130|NCT00573170|39533323|FG002|Second Washout Period|Withdrawal by Subject|2|||
16287131|NCT00573170|39533324|FG003|Second Washout Period|Withdrawal by Subject|0|||
16287132|NCT00573170|39533325|FG004|Second Washout Period|Withdrawal by Subject|1|||
16287133|NCT00573170|39533326|FG005|Second Washout Period|Withdrawal by Subject|0|||
16481388|NCT00150709|40242199|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
16287134|NCT00573170|39533321|FG000|Second Washout Period|Lost to Follow-up|0|||
16287135|NCT00573170|39533322|FG001|Second Washout Period|Lost to Follow-up|0|||
16287136|NCT00573170|39533323|FG002|Second Washout Period|Lost to Follow-up|0|||
16287137|NCT00573170|39533324|FG003|Second Washout Period|Lost to Follow-up|1|||
16287138|NCT00573170|39533325|FG004|Second Washout Period|Lost to Follow-up|0|||
16287139|NCT00573170|39533326|FG005|Second Washout Period|Lost to Follow-up|0|||
16287140|NCT00573170|39533321|FG000|Second Washout Period|Other|1|||
16287141|NCT00573170|39533322|FG001|Second Washout Period|Other|2|||
16287142|NCT00573170|39533323|FG002|Second Washout Period|Other|1|||
16287143|NCT00573170|39533324|FG003|Second Washout Period|Other|4|||
16287144|NCT00573170|39533325|FG004|Second Washout Period|Other|6|||
16287145|NCT00573170|39533326|FG005|Second Washout Period|Other|2|||
16287146|NCT00573170|39533321|FG000|Third Treatment Period|Withdrawal by Subject|1|||
16287147|NCT00573170|39533322|FG001|Third Treatment Period|Withdrawal by Subject|0|||
16287148|NCT00573170|39533323|FG002|Third Treatment Period|Withdrawal by Subject|0|||
16287149|NCT00573170|39533324|FG003|Third Treatment Period|Withdrawal by Subject|0|||
16287150|NCT00573170|39533325|FG004|Third Treatment Period|Withdrawal by Subject|0|||
16287151|NCT00573170|39533326|FG005|Third Treatment Period|Withdrawal by Subject|0|||
16287152|NCT00573170|39533321|FG000|Third Treatment Period|Lost to Follow-up|0|||
16287153|NCT00573170|39533322|FG001|Third Treatment Period|Lost to Follow-up|0|||
16287154|NCT00573170|39533323|FG002|Third Treatment Period|Lost to Follow-up|0|||
16287155|NCT00573170|39533324|FG003|Third Treatment Period|Lost to Follow-up|0|||
16287156|NCT00573170|39533325|FG004|Third Treatment Period|Lost to Follow-up|0|||
16287157|NCT00573170|39533326|FG005|Third Treatment Period|Lost to Follow-up|2|||
16287158|NCT00140413|39533329|FG000|Overall Study|Lost to Follow-up|1|||
16287159|NCT00140413|39533330|FG001|Overall Study|Lost to Follow-up|0|||
16287160|NCT00140413|39533329|FG000|Overall Study|Withdrawal by Subject|2|||
16287161|NCT00140413|39533330|FG001|Overall Study|Withdrawal by Subject|0|||
16287162|NCT01366443|39533331|FG000|Overall Study|Lost to Follow-up|2|||
16287163|NCT01366443|39533331|FG000|Overall Study|Under 18 yo|1|||
16287164|NCT00337428|39533332|FG000|Overall Study|Withdrawal by Subject|1|||
16287165|NCT00337428|39533333|FG001|Overall Study|Withdrawal by Subject|2|||
16481389|NCT00150709|40242200|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
16481390|NCT00150709|40242201|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
16481391|NCT00150709|40242198|FG000|Overall Study|Lack of ease of swallowing|0|||
16481392|NCT00150709|40242199|FG001|Overall Study|Lack of ease of swallowing|1|||
16481393|NCT00150709|40242200|FG002|Overall Study|Lack of ease of swallowing|0|||
16481394|NCT00150709|40242201|FG003|Overall Study|Lack of ease of swallowing|0|||
16481395|NCT00785928|40242205|FG000|Treatment Phase|Adverse Event|1|||
16481396|NCT00785928|40242206|FG001|Treatment Phase|Adverse Event|1|||
16481397|NCT00785928|40242207|FG002|Treatment Phase|Adverse Event|2|||
16481398|NCT00785928|40242208|FG003|Treatment Phase|Adverse Event|0|||
16481399|NCT00785928|40242209|FG004|Treatment Phase|Adverse Event|0|||
16481400|NCT00785928|40242210|FG005|Treatment Phase|Adverse Event|0|||
16481401|NCT00785928|40242211|FG006|Treatment Phase|Adverse Event|2|||
16481402|NCT00785928|40242205|FG000|Treatment Phase|Inadequate Response|0|||
16481403|NCT00785928|40242206|FG001|Treatment Phase|Inadequate Response|1|||
16481404|NCT00785928|40242207|FG002|Treatment Phase|Inadequate Response|0|||
16481405|NCT00785928|40242208|FG003|Treatment Phase|Inadequate Response|0|||
16481406|NCT00785928|40242209|FG004|Treatment Phase|Inadequate Response|0|||
16481407|NCT00785928|40242210|FG005|Treatment Phase|Inadequate Response|0|||
16481408|NCT00785928|40242211|FG006|Treatment Phase|Inadequate Response|0|||
16481409|NCT00785928|40242205|FG000|Treatment Phase|Lack of Efficacy|0|||
16481410|NCT00785928|40242206|FG001|Treatment Phase|Lack of Efficacy|1|||
16481411|NCT00785928|40242207|FG002|Treatment Phase|Lack of Efficacy|1|||
16481412|NCT00785928|40242208|FG003|Treatment Phase|Lack of Efficacy|0|||
16481413|NCT00785928|40242209|FG004|Treatment Phase|Lack of Efficacy|0|||
16481414|NCT00785928|40242210|FG005|Treatment Phase|Lack of Efficacy|0|||
16481415|NCT00785928|40242211|FG006|Treatment Phase|Lack of Efficacy|0|||
16481416|NCT00785928|40242205|FG000|Treatment Phase|Physician Decision|0|||
16481417|NCT00785928|40242206|FG001|Treatment Phase|Physician Decision|0|||
16481418|NCT00785928|40242207|FG002|Treatment Phase|Physician Decision|0|||
16481419|NCT00785928|40242208|FG003|Treatment Phase|Physician Decision|0|||
16481420|NCT00785928|40242209|FG004|Treatment Phase|Physician Decision|1|||
16481421|NCT00785928|40242210|FG005|Treatment Phase|Physician Decision|0|||
16481422|NCT00785928|40242211|FG006|Treatment Phase|Physician Decision|0|||
16481423|NCT00785928|40242205|FG000|Treatment Phase|Sponsor Decision|1|||
16481424|NCT00785928|40242206|FG001|Treatment Phase|Sponsor Decision|0|||
16481425|NCT00785928|40242207|FG002|Treatment Phase|Sponsor Decision|0|||
16481426|NCT00785928|40242208|FG003|Treatment Phase|Sponsor Decision|0|||
16481427|NCT00785928|40242209|FG004|Treatment Phase|Sponsor Decision|0|||
16481428|NCT00785928|40242210|FG005|Treatment Phase|Sponsor Decision|0|||
16481429|NCT00785928|40242211|FG006|Treatment Phase|Sponsor Decision|1|||
16481430|NCT00785928|40242205|FG000|Treatment Phase|Withdrawal by Subject|1|||
16481431|NCT00785928|40242206|FG001|Treatment Phase|Withdrawal by Subject|2|||
16481432|NCT00785928|40242207|FG002|Treatment Phase|Withdrawal by Subject|0|||
16481433|NCT00785928|40242208|FG003|Treatment Phase|Withdrawal by Subject|0|||
16481434|NCT00785928|40242209|FG004|Treatment Phase|Withdrawal by Subject|1|||
16481435|NCT00785928|40242210|FG005|Treatment Phase|Withdrawal by Subject|0|||
16481436|NCT00785928|40242211|FG006|Treatment Phase|Withdrawal by Subject|0|||
16287166|NCT00337428|39533332|FG000|Overall Study|Lack of Time|1|||
16287167|NCT00337428|39533333|FG001|Overall Study|Lack of Time|1|||
16287168|NCT00337428|39533332|FG000|Overall Study|Unwilling to Continue|1|||
16287169|NCT00337428|39533333|FG001|Overall Study|Unwilling to Continue|0|||
16287170|NCT00337428|39533332|FG000|Overall Study|Anorexia|1|||
16481437|NCT00306189|40242212|FG000|Overall Study|Physician Decision|0|||
16481438|NCT00306189|40242213|FG001|Overall Study|Physician Decision|0|||
16481439|NCT00306189|40242214|FG002|Overall Study|Physician Decision|0|||
16481440|NCT00306189|40242215|FG003|Overall Study|Physician Decision|1|||
16481441|NCT00306189|40242212|FG000|Overall Study|Adverse Event|3|||
16481442|NCT00306189|40242213|FG001|Overall Study|Adverse Event|3|||
16481443|NCT00306189|40242214|FG002|Overall Study|Adverse Event|2|||
16481444|NCT00306189|40242215|FG003|Overall Study|Adverse Event|2|||
16481445|NCT00306189|40242212|FG000|Overall Study|Withdrawal by Subject|4|||
16481446|NCT00306189|40242213|FG001|Overall Study|Withdrawal by Subject|2|||
16287171|NCT00337428|39533333|FG001|Overall Study|Anorexia|0|||
16287172|NCT03078582|39533334|FG000|Overall Study|Adverse Event|0|||
16481447|NCT00306189|40242214|FG002|Overall Study|Withdrawal by Subject|8|||
16481448|NCT00306189|40242215|FG003|Overall Study|Withdrawal by Subject|1|||
16481449|NCT00306189|40242212|FG000|Overall Study|Ineligibility determined|1|||
16481450|NCT00306189|40242213|FG001|Overall Study|Ineligibility determined|1|||
16481451|NCT00306189|40242214|FG002|Overall Study|Ineligibility determined|1|||
16481452|NCT00306189|40242215|FG003|Overall Study|Ineligibility determined|1|||
16481453|NCT00306189|40242212|FG000|Overall Study|Other|1|||
16481454|NCT00306189|40242213|FG001|Overall Study|Other|0|||
16481455|NCT00306189|40242214|FG002|Overall Study|Other|0|||
16481456|NCT00306189|40242215|FG003|Overall Study|Other|0|||
16481457|NCT00347360|40242223|FG000|Overall Study|Adverse Event|1|||
16481458|NCT00347360|40242224|FG001|Overall Study|Adverse Event|2|||
16481459|NCT00347360|40242225|FG002|Overall Study|Adverse Event|0|||
16481460|NCT00347360|40242226|FG003|Overall Study|Adverse Event|4|||
16481461|NCT00347360|40242227|FG004|Overall Study|Adverse Event|1|||
16481462|NCT00347360|40242228|FG005|Overall Study|Adverse Event|2|||
16481463|NCT00347360|40242229|FG006|Overall Study|Adverse Event|2|||
16481464|NCT00347360|40242230|FG007|Overall Study|Adverse Event|0|||
16481465|NCT00347360|40242231|FG008|Overall Study|Adverse Event|2|||
16287173|NCT03078582|39533335|FG001|Overall Study|Adverse Event|8|||
16287174|NCT01157897|39533336|FG000|Overall Study|Lost to Follow-up|2|||
16287175|NCT01157897|39533337|FG001|Overall Study|Lost to Follow-up|0|||
16287176|NCT01157897|39533338|FG002|Overall Study|Lost to Follow-up|0|||
16287177|NCT01157897|39533339|FG003|Overall Study|Lost to Follow-up|1|||
16287178|NCT01157897|39533336|FG000|Overall Study|Relocated|0|||
16287179|NCT01157897|39533337|FG001|Overall Study|Relocated|2|||
16287180|NCT01157897|39533338|FG002|Overall Study|Relocated|0|||
16287181|NCT01157897|39533339|FG003|Overall Study|Relocated|0|||
16287182|NCT00059787|39533340|FG000|Overall Study|Adverse Event|13|||
16287183|NCT00059787|39533340|FG000|Overall Study|disease progression|2|||
16287184|NCT00059787|39533340|FG000|Overall Study|ineligible|1|||
16287185|NCT00059787|39533340|FG000|Overall Study|Other|4|||
16287186|NCT04647383|39533341|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
16287187|NCT04647383|39533342|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
16287188|NCT04647383|39533343|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
16287189|NCT04647383|39533344|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
16287190|NCT03197558|39536085|FG000|Overall Study|Tubes not placed|1|||
16287191|NCT04556552|39536086|FG000|Overall Study|Lost to Follow-up|1|||
16287192|NCT04556552|39536087|FG001|Overall Study|Lost to Follow-up|0|||
16287193|NCT04556552|39536086|FG000|Overall Study|Claustrophobia|0|||
16287194|NCT04556552|39536087|FG001|Overall Study|Claustrophobia|1|||
16287195|NCT04556552|39536086|FG000|Overall Study|Inability to continue|0|||
16287196|NCT04556552|39536087|FG001|Overall Study|Inability to continue|1|||
16287197|NCT00958126|39536089|FG000|Overall Study|Serious Adverse Event|0|||
16287198|NCT00958126|39536090|FG001|Overall Study|Serious Adverse Event|2|||
16287199|NCT00958126|39536091|FG002|Overall Study|Serious Adverse Event|0|||
16287200|NCT00958126|39536092|FG003|Overall Study|Serious Adverse Event|0|||
16287201|NCT00958126|39536093|FG004|Overall Study|Serious Adverse Event|0|||
16287202|NCT00958126|39536094|FG005|Overall Study|Serious Adverse Event|0|||
16287203|NCT00958126|39536095|FG006|Overall Study|Serious Adverse Event|1|||
16287204|NCT00958126|39536096|FG007|Overall Study|Serious Adverse Event|0|||
16287205|NCT00958126|39536089|FG000|Overall Study|Withdrawal by Subject|0|||
16287206|NCT00958126|39536090|FG001|Overall Study|Withdrawal by Subject|2|||
16287207|NCT00958126|39536091|FG002|Overall Study|Withdrawal by Subject|0|||
16287208|NCT00958126|39536092|FG003|Overall Study|Withdrawal by Subject|0|||
16481466|NCT00347360|40242232|FG009|Overall Study|Adverse Event|3|||
16481467|NCT00347360|40242233|FG010|Overall Study|Adverse Event|3|||
16481468|NCT00347360|40242234|FG011|Overall Study|Adverse Event|1|||
16287209|NCT00958126|39536093|FG004|Overall Study|Withdrawal by Subject|0|||
16287210|NCT00958126|39536094|FG005|Overall Study|Withdrawal by Subject|0|||
16287211|NCT00958126|39536095|FG006|Overall Study|Withdrawal by Subject|0|||
16287212|NCT00958126|39536096|FG007|Overall Study|Withdrawal by Subject|0|||
16287213|NCT00958126|39536089|FG000|Overall Study|Moved away from study area|0|||
16287214|NCT00958126|39536090|FG001|Overall Study|Moved away from study area|0|||
16481469|NCT00347360|40242235|FG012|Overall Study|Adverse Event|3|||
16481470|NCT00347360|40242236|FG013|Overall Study|Adverse Event|2|||
16481471|NCT00347360|40242237|FG014|Overall Study|Adverse Event|2|||
16481472|NCT00347360|40242223|FG000|Overall Study|Lost to Follow-up|0|||
16287215|NCT00958126|39536091|FG002|Overall Study|Moved away from study area|1|||
16287216|NCT00958126|39536092|FG003|Overall Study|Moved away from study area|1|||
16481473|NCT00347360|40242224|FG001|Overall Study|Lost to Follow-up|0|||
16287217|NCT00958126|39536093|FG004|Overall Study|Moved away from study area|0|||
16287218|NCT00958126|39536094|FG005|Overall Study|Moved away from study area|0|||
16287219|NCT00958126|39536095|FG006|Overall Study|Moved away from study area|0|||
16287220|NCT00958126|39536096|FG007|Overall Study|Moved away from study area|0|||
16287221|NCT00958126|39536089|FG000|Overall Study|Lost to Follow-up|1|||
16287222|NCT00958126|39536090|FG001|Overall Study|Lost to Follow-up|5|||
16287223|NCT00958126|39536091|FG002|Overall Study|Lost to Follow-up|9|||
16287224|NCT00958126|39536092|FG003|Overall Study|Lost to Follow-up|8|||
16287225|NCT00958126|39536093|FG004|Overall Study|Lost to Follow-up|0|||
16287226|NCT00958126|39536094|FG005|Overall Study|Lost to Follow-up|0|||
16287227|NCT00958126|39536095|FG006|Overall Study|Lost to Follow-up|0|||
16287228|NCT00958126|39536096|FG007|Overall Study|Lost to Follow-up|0|||
16287229|NCT00958126|39536089|FG000|Overall Study|Sponsor/Investigator decision|0|||
16287230|NCT00958126|39536090|FG001|Overall Study|Sponsor/Investigator decision|0|||
16287231|NCT00958126|39536091|FG002|Overall Study|Sponsor/Investigator decision|0|||
16287232|NCT00958126|39536092|FG003|Overall Study|Sponsor/Investigator decision|1|||
16287233|NCT00958126|39536093|FG004|Overall Study|Sponsor/Investigator decision|0|||
16287234|NCT00958126|39536094|FG005|Overall Study|Sponsor/Investigator decision|0|||
16287235|NCT00958126|39536095|FG006|Overall Study|Sponsor/Investigator decision|0|||
16287236|NCT00958126|39536096|FG007|Overall Study|Sponsor/Investigator decision|0|||
16287237|NCT00958126|39536089|FG000|Overall Study|Other Reason|0|||
16287238|NCT00958126|39536090|FG001|Overall Study|Other Reason|0|||
16287239|NCT00958126|39536091|FG002|Overall Study|Other Reason|0|||
16287240|NCT00958126|39536092|FG003|Overall Study|Other Reason|1|||
16287241|NCT00958126|39536093|FG004|Overall Study|Other Reason|0|||
16287242|NCT00958126|39536094|FG005|Overall Study|Other Reason|1|||
16287243|NCT00958126|39536095|FG006|Overall Study|Other Reason|0|||
16287244|NCT00958126|39536096|FG007|Overall Study|Other Reason|0|||
16287245|NCT02621034|39536101|FG000|Overall Study|Lost to Follow-up|3|||
16287246|NCT02621034|39536102|FG001|Overall Study|Lost to Follow-up|2|||
16287247|NCT02621034|39536103|FG002|Overall Study|Lost to Follow-up|5|||
16287248|NCT02668822|39536104|FG000|Overall Study|Protocol Violation|2|||
16287249|NCT02668822|39536105|FG001|Overall Study|Protocol Violation|0|||
16287250|NCT02668822|39536104|FG000|Overall Study|Study Terminated by Sponsor|7|||
16287251|NCT02668822|39536105|FG001|Overall Study|Study Terminated by Sponsor|9|||
16287252|NCT00126126|39536107|FG000|Overall Study|Lost to Follow-up|0|||
16287253|NCT00126126|39536108|FG001|Overall Study|Lost to Follow-up|2|||
16287254|NCT00788593|39536109|FG000|Placebo Run-in Phase|Adverse Event|2|||
16287255|NCT00788593|39536110|FG001|Placebo Run-in Phase|Adverse Event|0|||
16287256|NCT00788593|39536111|FG002|Placebo Run-in Phase|Adverse Event|0|||
16287257|NCT00788593|39536109|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
16287258|NCT00788593|39536110|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
16287259|NCT00788593|39536111|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
16287260|NCT00788593|39536109|FG000|Placebo Run-in Phase|Protocol Violation|2|||
16287261|NCT00788593|39536110|FG001|Placebo Run-in Phase|Protocol Violation|0|||
16287262|NCT00788593|39536111|FG002|Placebo Run-in Phase|Protocol Violation|0|||
16287263|NCT00788593|39536109|FG000|First Intervention Period|Adverse Event|0|||
16287264|NCT00788593|39536110|FG001|First Intervention Period|Adverse Event|1|||
16287265|NCT00788593|39536111|FG002|First Intervention Period|Adverse Event|0|||
16287266|NCT00788593|39536109|FG000|Second Intervention Period|Lost to Follow-up|0|||
16287267|NCT00788593|39536110|FG001|Second Intervention Period|Lost to Follow-up|1|||
16287268|NCT00788593|39536111|FG002|Second Intervention Period|Lost to Follow-up|0|||
16287269|NCT00788593|39536109|FG000|Second Intervention Period|Other|0|||
16287270|NCT00788593|39536110|FG001|Second Intervention Period|Other|0|||
16287271|NCT00788593|39536111|FG002|Second Intervention Period|Other|1|||
16287272|NCT02072824|39536113|FG000|Overall Study|Insufficient clinical response|1|||
16287273|NCT02072824|39536114|FG001|Overall Study|Insufficient clinical response|0|||
16287274|NCT02072824|39536115|FG002|Overall Study|Insufficient clinical response|1|||
16287275|NCT02072824|39536113|FG000|Overall Study|No longer willing to participate|1|||
16287276|NCT02072824|39536114|FG001|Overall Study|No longer willing to participate|0|||
16287277|NCT02072824|39536115|FG002|Overall Study|No longer willing to participate|1|||
16287278|NCT02072824|39536113|FG000|Overall Study|Medication error|0|||
16481474|NCT00347360|40242225|FG002|Overall Study|Lost to Follow-up|0|||
16481475|NCT00347360|40242226|FG003|Overall Study|Lost to Follow-up|2|||
16481476|NCT00347360|40242227|FG004|Overall Study|Lost to Follow-up|1|||
16481477|NCT00347360|40242228|FG005|Overall Study|Lost to Follow-up|1|||
16287279|NCT02072824|39536114|FG001|Overall Study|Medication error|1|||
16287280|NCT02072824|39536115|FG002|Overall Study|Medication error|0|||
16287281|NCT02072824|39536113|FG000|Overall Study|Adverse Event|0|||
16287282|NCT02072824|39536114|FG001|Overall Study|Adverse Event|0|||
16287283|NCT02072824|39536115|FG002|Overall Study|Adverse Event|1|||
16287284|NCT01892657|39536117|FG000|Overall Study|Withdrawal by Subject|6|||
16287285|NCT01892657|39536117|FG000|Overall Study|Protocol Violation|12|||
16287286|NCT01301508|39536120|FG000|Overall Study|Withdrawal by Subject|1|||
16287287|NCT01301508|39536121|FG001|Overall Study|Withdrawal by Subject|2|||
16481478|NCT00347360|40242229|FG006|Overall Study|Lost to Follow-up|0|||
16481479|NCT00347360|40242230|FG007|Overall Study|Lost to Follow-up|1|||
16287288|NCT01301508|39536120|FG000|Overall Study|Lost to Follow-up|0|||
16287289|NCT01301508|39536121|FG001|Overall Study|Lost to Follow-up|1|||
16287290|NCT02302859|39536122|FG000|Overall Study|Lost Phone|1|||
16287291|NCT02302859|39536123|FG001|Overall Study|Lost Phone|1|||
16287292|NCT02302859|39536122|FG000|Overall Study|Withdrawal by Subject|0|||
16287293|NCT02302859|39536123|FG001|Overall Study|Withdrawal by Subject|1|||
16287294|NCT04969861|39536124|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
16287295|NCT04969861|39536125|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
16287296|NCT01790113|39536129|FG000|Overall Study|Adverse Event|2|||
16287297|NCT01790113|39536130|FG001|Overall Study|Adverse Event|7|||
16287298|NCT01790113|39536129|FG000|Overall Study|Study ended due to FDA clearance|1|||
16287299|NCT01790113|39536130|FG001|Overall Study|Study ended due to FDA clearance|68|||
16287300|NCT04135196|39536131|FG000|Overall Study|Lost to Follow-up|8|||
16287301|NCT04135196|39536132|FG001|Overall Study|Lost to Follow-up|7|||
16287302|NCT04135196|39536133|FG002|Overall Study|Lost to Follow-up|8|||
16287303|NCT04135196|39536134|FG003|Overall Study|Lost to Follow-up|9|||
16287304|NCT04135196|39536135|FG004|Overall Study|Lost to Follow-up|1|||
16287305|NCT04135196|39536131|FG000|Overall Study|Pregnancy|0|||
16287306|NCT04135196|39536132|FG001|Overall Study|Pregnancy|0|||
16287307|NCT04135196|39536133|FG002|Overall Study|Pregnancy|1|||
16287308|NCT04135196|39536134|FG003|Overall Study|Pregnancy|0|||
16287309|NCT04135196|39536135|FG004|Overall Study|Pregnancy|0|||
16287310|NCT04135196|39536131|FG000|Overall Study|Withdrawal by Subject|0|||
16287311|NCT04135196|39536132|FG001|Overall Study|Withdrawal by Subject|0|||
16287312|NCT04135196|39536133|FG002|Overall Study|Withdrawal by Subject|0|||
16287313|NCT04135196|39536134|FG003|Overall Study|Withdrawal by Subject|0|||
16287314|NCT04135196|39536135|FG004|Overall Study|Withdrawal by Subject|1|||
16287315|NCT02065713|39536143|FG000|Overall Study|Adverse Event|0|||
16287316|NCT02065713|39536144|FG001|Overall Study|Adverse Event|1|||
16287317|NCT02065713|39536143|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16287318|NCT02065713|39536144|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16287319|NCT01000610|39536145|FG000|Overall Study|Adverse Event|1|||
16287320|NCT01000610|39536145|FG000|Overall Study|Lost to Follow-up|4|||
16287321|NCT01000610|39536145|FG000|Overall Study|Treatment failure|1|||
16287322|NCT00136318|39536146|FG000|Overall Study|Adverse Event|5|||
16287323|NCT00136318|39536147|FG001|Overall Study|Adverse Event|5|||
16287324|NCT00136318|39536146|FG000|Overall Study|Withdrawal by Subject|2|||
16287325|NCT00136318|39536147|FG001|Overall Study|Withdrawal by Subject|2|||
16287326|NCT01491035|39536148|FG000|Overall Study|Lost to Follow-up|0|||
16287327|NCT01491035|39536149|FG001|Overall Study|Lost to Follow-up|0|||
16287328|NCT01491035|39536150|FG002|Overall Study|Lost to Follow-up|0|||
16287329|NCT01491035|39536151|FG003|Overall Study|Lost to Follow-up|0|||
16287330|NCT01491035|39536152|FG004|Overall Study|Lost to Follow-up|1|||
16287331|NCT01491035|39536153|FG005|Overall Study|Lost to Follow-up|0|||
16287332|NCT01491035|39536154|FG006|Overall Study|Lost to Follow-up|0|||
16287333|NCT01491035|39536155|FG007|Overall Study|Lost to Follow-up|0|||
16287334|NCT01557842|39536156|FG000|Overall Study|Lost to Follow-up|0|||
16287335|NCT01557842|39536157|FG001|Overall Study|Lost to Follow-up|1|||
16287336|NCT01557842|39536156|FG000|Overall Study|Death|1|||
16287337|NCT01557842|39536157|FG001|Overall Study|Death|0|||
16287338|NCT01557842|39536156|FG000|Overall Study|Lack of Efficacy|0|||
16287339|NCT01557842|39536157|FG001|Overall Study|Lack of Efficacy|1|||
16287340|NCT01557842|39536156|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
16287341|NCT01557842|39536157|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
16287342|NCT01557842|39536156|FG000|Overall Study|Study Terminated by Sponsor|3|||
16287343|NCT01557842|39536157|FG001|Overall Study|Study Terminated by Sponsor|4|||
16287344|NCT01557842|39536156|FG000|Overall Study|Not Ablated|2|||
16287345|NCT01557842|39536157|FG001|Overall Study|Not Ablated|0|||
16287346|NCT00407758|39536164|FG000|Overall Study|ineligible -improper prior treatment|1|||
16287347|NCT02972502|39536165|FG000|Overall Study|Lost to Follow-up|3|||
16287348|NCT02972502|39536166|FG001|Overall Study|Lost to Follow-up|1|||
16287349|NCT02972502|39536165|FG000|Overall Study|Withdrawal by Subject|1|||
16287350|NCT02972502|39536166|FG001|Overall Study|Withdrawal by Subject|1|||
16287351|NCT00704730|39536167|FG000|Overall Study|Adverse Event|35|||
16287352|NCT00704730|39536168|FG001|Overall Study|Adverse Event|9|||
16287353|NCT00704730|39536167|FG000|Overall Study|Death|11|||
16287354|NCT00704730|39536168|FG001|Overall Study|Death|5|||
16287355|NCT00704730|39536167|FG000|Overall Study|Physician Decision|2|||
16287356|NCT00704730|39536168|FG001|Overall Study|Physician Decision|0|||
16287357|NCT00704730|39536167|FG000|Overall Study|Did not receive drug|5|||
16287358|NCT00704730|39536168|FG001|Overall Study|Did not receive drug|2|||
16287359|NCT00704730|39536167|FG000|Overall Study|Disease progression per PI|58|||
16287360|NCT00704730|39536168|FG001|Overall Study|Disease progression per PI|67|||
16287361|NCT00704730|39536167|FG000|Overall Study|data unavailable|1|||
16287362|NCT00704730|39536168|FG001|Overall Study|data unavailable|0|||
16287363|NCT00704730|39536167|FG000|Overall Study|Withdrawal by Subject|9|||
16287364|NCT00704730|39536168|FG001|Overall Study|Withdrawal by Subject|13|||
16287365|NCT03856593|39536169|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
16287366|NCT03856593|39536170|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
16287367|NCT03585959|39536171|FG000|Overall Study|Physician Decision|1|||
16287368|NCT03585959|39536171|FG000|Overall Study|Unsuccessful Procedure|2|||
16287369|NCT00911807|39536173|FG000|Overall Study|Adverse Event|2|||
16287370|NCT00911807|39536174|FG001|Overall Study|Adverse Event|1|||
16287371|NCT00911807|39536175|FG002|Overall Study|Adverse Event|5|||
16287372|NCT00911807|39536173|FG000|Overall Study|Death|0|||
16287373|NCT00911807|39536174|FG001|Overall Study|Death|0|||
16287374|NCT00911807|39536175|FG002|Overall Study|Death|1|||
16287375|NCT00911807|39536173|FG000|Overall Study|Protocol Violation|6|||
16287376|NCT00911807|39536174|FG001|Overall Study|Protocol Violation|4|||
16287377|NCT00911807|39536175|FG002|Overall Study|Protocol Violation|9|||
16287378|NCT00911807|39536173|FG000|Overall Study|Withdrawal by Subject|8|||
16287379|NCT00911807|39536174|FG001|Overall Study|Withdrawal by Subject|10|||
16287380|NCT00911807|39536175|FG002|Overall Study|Withdrawal by Subject|7|||
16287381|NCT00911807|39536173|FG000|Overall Study|Organizational reasons|1|||
16287382|NCT00911807|39536174|FG001|Overall Study|Organizational reasons|3|||
16287383|NCT00911807|39536175|FG002|Overall Study|Organizational reasons|1|||
16287384|NCT00094458|39536177|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
16287385|NCT00094458|39536178|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
16287386|NCT00094458|39536179|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
16287387|NCT00094458|39536180|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
16287388|NCT00094458|39536181|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
16287389|NCT00094458|39536182|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
16287390|NCT00094458|39536177|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
16287391|NCT00094458|39536178|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
16287392|NCT00094458|39536179|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
16287393|NCT00094458|39536180|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
16287394|NCT00094458|39536181|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
16287395|NCT00094458|39536182|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
16287396|NCT00094458|39536177|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
16287397|NCT00094458|39536178|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
16287398|NCT00094458|39536179|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
16287399|NCT00094458|39536180|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
16287400|NCT00094458|39536181|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
16287401|NCT00094458|39536182|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
16287402|NCT00094458|39536177|FG000|Main Study: Through Week 30|Adverse Event|38|||
16287403|NCT00094458|39536178|FG001|Main Study: Through Week 30|Adverse Event|20|||
16287404|NCT00094458|39536179|FG002|Main Study: Through Week 30|Adverse Event|28|||
16287405|NCT00094458|39536180|FG003|Main Study: Through Week 30|Adverse Event|0|||
16287406|NCT00094458|39536181|FG004|Main Study: Through Week 30|Adverse Event|0|||
16287407|NCT00094458|39536182|FG005|Main Study: Through Week 30|Adverse Event|0|||
16287408|NCT00094458|39536177|FG000|Main Study: Through Week 30|Death|1|||
16287409|NCT00094458|39536178|FG001|Main Study: Through Week 30|Death|0|||
16287410|NCT00094458|39536179|FG002|Main Study: Through Week 30|Death|0|||
16287411|NCT00094458|39536180|FG003|Main Study: Through Week 30|Death|0|||
16287412|NCT00094458|39536181|FG004|Main Study: Through Week 30|Death|0|||
16287413|NCT00094458|39536182|FG005|Main Study: Through Week 30|Death|0|||
16287414|NCT00094458|39536177|FG000|Main Study: Through Week 30|Other|19|||
16287415|NCT00094458|39536178|FG001|Main Study: Through Week 30|Other|16|||
16287416|NCT00094458|39536179|FG002|Main Study: Through Week 30|Other|9|||
16287417|NCT00094458|39536180|FG003|Main Study: Through Week 30|Other|0|||
16287418|NCT00094458|39536181|FG004|Main Study: Through Week 30|Other|0|||
16287419|NCT00094458|39536182|FG005|Main Study: Through Week 30|Other|0|||
16287420|NCT00094458|39536177|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
16287421|NCT00094458|39536178|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
16287422|NCT00094458|39536179|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
16287423|NCT00094458|39536180|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
16287424|NCT00094458|39536181|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
16287425|NCT00094458|39536182|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
16287426|NCT00094458|39536177|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
16287427|NCT00094458|39536178|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
16287428|NCT00094458|39536179|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
16287429|NCT00094458|39536180|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
16287430|NCT00094458|39536181|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
16481480|NCT00347360|40242231|FG008|Overall Study|Lost to Follow-up|1|||
16481481|NCT00347360|40242232|FG009|Overall Study|Lost to Follow-up|2|||
16481482|NCT00347360|40242233|FG010|Overall Study|Lost to Follow-up|0|||
16287431|NCT00094458|39536182|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
16287432|NCT00094458|39536177|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
16481483|NCT00347360|40242234|FG011|Overall Study|Lost to Follow-up|0|||
16481484|NCT00347360|40242235|FG012|Overall Study|Lost to Follow-up|1|||
16481485|NCT00347360|40242236|FG013|Overall Study|Lost to Follow-up|0|||
16287433|NCT00094458|39536178|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
16287434|NCT00094458|39536179|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
16287435|NCT00094458|39536180|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
16287436|NCT00094458|39536181|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
16287437|NCT00094458|39536182|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
16287438|NCT00094458|39536177|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
16287439|NCT00094458|39536178|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
16287440|NCT00094458|39536179|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
16287441|NCT00094458|39536180|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
16287442|NCT00094458|39536181|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
16287443|NCT00094458|39536182|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
16287444|NCT00094458|39536177|FG000|OLE: Open-Label Extension|Adverse Event|0|||
16287445|NCT00094458|39536178|FG001|OLE: Open-Label Extension|Adverse Event|0|||
16287446|NCT00094458|39536179|FG002|OLE: Open-Label Extension|Adverse Event|0|||
16287447|NCT00094458|39536180|FG003|OLE: Open-Label Extension|Adverse Event|0|||
16287448|NCT00094458|39536181|FG004|OLE: Open-Label Extension|Adverse Event|3|||
16287449|NCT00094458|39536182|FG005|OLE: Open-Label Extension|Adverse Event|4|||
16287450|NCT00094458|39536177|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
16287451|NCT00094458|39536178|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
16287452|NCT00094458|39536179|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
16287453|NCT00094458|39536180|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
16287454|NCT00094458|39536181|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
16287455|NCT00094458|39536182|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
16287456|NCT00094458|39536177|FG000|OLE: Open-Label Extension|Patient decision|0|||
16287457|NCT00094458|39536178|FG001|OLE: Open-Label Extension|Patient decision|0|||
16287458|NCT00094458|39536179|FG002|OLE: Open-Label Extension|Patient decision|0|||
16287459|NCT00094458|39536180|FG003|OLE: Open-Label Extension|Patient decision|0|||
16287460|NCT00094458|39536181|FG004|OLE: Open-Label Extension|Patient decision|1|||
16287461|NCT00094458|39536182|FG005|OLE: Open-Label Extension|Patient decision|0|||
16287462|NCT02692482|39536185|FG000|Overall Study|Death|2|||
16287463|NCT02692482|39536186|FG001|Overall Study|Death|2|||
16287464|NCT02692482|39536185|FG000|Overall Study|Withdrawal by Subject|1|||
16287465|NCT02692482|39536186|FG001|Overall Study|Withdrawal by Subject|2|||
16287466|NCT03977701|39536187|FG000|Overall Study|COVID-19 pandemic|0|||
16287467|NCT03977701|39536188|FG001|Overall Study|COVID-19 pandemic|0|||
16287468|NCT03977701|39536189|FG002|Overall Study|COVID-19 pandemic|0|||
16287469|NCT03977701|39536190|FG003|Overall Study|COVID-19 pandemic|0|||
16287470|NCT03977701|39536191|FG004|Overall Study|COVID-19 pandemic|0|||
16287471|NCT03977701|39536192|FG005|Overall Study|COVID-19 pandemic|1|||
16287472|NCT03977701|39536193|FG006|Overall Study|COVID-19 pandemic|0|||
16287473|NCT03977701|39536194|FG007|Overall Study|COVID-19 pandemic|1|||
16287474|NCT03977701|39536195|FG008|Overall Study|COVID-19 pandemic|0|||
16287475|NCT03977701|39536196|FG009|Overall Study|COVID-19 pandemic|0|||
16287476|NCT02377921|39536197|FG000|Overall Study|Subject non-compliance|1|||
16287477|NCT02377921|39536198|FG001|Overall Study|Subject non-compliance|1|||
16287478|NCT00606502|39536204|FG000|Randomization|Randomized but not treated|3|||
16287479|NCT00606502|39536205|FG001|Randomization|Randomized but not treated|0|||
16287480|NCT00606502|39536204|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
16287481|NCT00606502|39536205|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
16287482|NCT03188718|39536206|FG000|Overall Study|Participant noncompliance|4|||
16287483|NCT03188718|39536206|FG000|Overall Study|Withdrawal by Subject|1|||
16287484|NCT03188718|39536206|FG000|Overall Study|Device failure|3|||
16287485|NCT01138111|39536209|FG000|Overall Study|Withdrawal by Subject|5|||
16287486|NCT01138111|39536209|FG000|Overall Study|Adverse Event|1|||
16287487|NCT01138111|39536209|FG000|Overall Study|Death|1|||
16287488|NCT01138111|39536209|FG000|Overall Study|Lost to Follow-up|2|||
16287489|NCT01304693|39536211|FG000|Overall Study|Adverse Event|0|||
16287490|NCT01304693|39536212|FG001|Overall Study|Adverse Event|0|||
16287491|NCT01304693|39536213|FG002|Overall Study|Adverse Event|0|||
16287492|NCT01304693|39536214|FG003|Overall Study|Adverse Event|0|||
16287493|NCT01304693|39536215|FG004|Overall Study|Adverse Event|1|||
16287494|NCT01304693|39536211|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
16287495|NCT01304693|39536212|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
16287496|NCT01304693|39536213|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
16287497|NCT01304693|39536214|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
16287498|NCT01304693|39536215|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
16481486|NCT00347360|40242237|FG014|Overall Study|Lost to Follow-up|0|||
16481487|NCT00347360|40242223|FG000|Overall Study|Protocol Violation|2|||
16287499|NCT00468728|39536216|FG000|Treatment|criteria for mITT population|4|||
16481488|NCT00347360|40242224|FG001|Overall Study|Protocol Violation|3|||
16481489|NCT00347360|40242225|FG002|Overall Study|Protocol Violation|1|||
16287500|NCT00468728|39536217|FG001|Treatment|criteria for mITT population|11|||
16287501|NCT00468728|39536216|FG000|Follow-up|mITT failure|34|||
16287502|NCT00468728|39536217|FG001|Follow-up|mITT failure|31|||
16287503|NCT01000493|39536218|FG000|Overall Study|Adverse Event|3|||
16287504|NCT01000493|39536219|FG001|Overall Study|Adverse Event|6|||
16287505|NCT01000493|39536218|FG000|Overall Study|Lack of Efficacy|1|||
16287506|NCT01000493|39536219|FG001|Overall Study|Lack of Efficacy|1|||
16287507|NCT01000493|39536218|FG000|Overall Study|Protocol Violation|1|||
16287508|NCT01000493|39536219|FG001|Overall Study|Protocol Violation|8|||
16287509|NCT01000493|39536218|FG000|Overall Study|Study closed/terminated|25|||
16287510|NCT01000493|39536219|FG001|Overall Study|Study closed/terminated|23|||
16287511|NCT01000493|39536218|FG000|Overall Study|Lost to Follow-up|5|||
16287512|NCT01000493|39536219|FG001|Overall Study|Lost to Follow-up|9|||
16287513|NCT01000493|39536218|FG000|Overall Study|Physician Decision|1|||
16287514|NCT01000493|39536219|FG001|Overall Study|Physician Decision|1|||
16287515|NCT01000493|39536218|FG000|Overall Study|Withdrawal by Subject|3|||
16287516|NCT01000493|39536219|FG001|Overall Study|Withdrawal by Subject|7|||
16287517|NCT04568031|39536220|FG000|Overall Study|Lost to Follow-up|1|||
16287518|NCT04568031|39536221|FG001|Overall Study|Lost to Follow-up|0|||
16287519|NCT04568031|39536222|FG002|Overall Study|Lost to Follow-up|0|||
16287520|NCT04568031|39536223|FG003|Overall Study|Lost to Follow-up|0|||
16287521|NCT04568031|39536220|FG000|Overall Study|Physician Decision|1|||
16287522|NCT04568031|39536221|FG001|Overall Study|Physician Decision|0|||
16287523|NCT04568031|39536222|FG002|Overall Study|Physician Decision|1|||
16287524|NCT04568031|39536223|FG003|Overall Study|Physician Decision|0|||
16287525|NCT04568031|39536220|FG000|Overall Study|Withdrawal by Subject|1|||
16287526|NCT04568031|39536221|FG001|Overall Study|Withdrawal by Subject|0|||
16287527|NCT04568031|39536222|FG002|Overall Study|Withdrawal by Subject|4|||
16287528|NCT04568031|39536223|FG003|Overall Study|Withdrawal by Subject|1|||
16287529|NCT01382251|39536224|FG000|Overall Study|Surgeries cancelled or delayed|16|||
16287530|NCT01382251|39536225|FG001|Overall Study|Surgeries cancelled or delayed|16|||
16287531|NCT01382251|39536224|FG000|Overall Study|Lost to Follow-up|4|||
16287532|NCT01382251|39536225|FG001|Overall Study|Lost to Follow-up|4|||
16287533|NCT01382251|39536224|FG000|Overall Study|Contacted after study closed|1|||
16287534|NCT01382251|39536225|FG001|Overall Study|Contacted after study closed|1|||
16287535|NCT01425723|39536228|FG000|Overall Study|Lack of Efficacy|0|||
16287536|NCT01425723|39536229|FG001|Overall Study|Lack of Efficacy|1|||
16287537|NCT01425723|39536228|FG000|Overall Study|Withdrawal by Subject|1|||
16287538|NCT01425723|39536229|FG001|Overall Study|Withdrawal by Subject|4|||
16287539|NCT01425723|39536228|FG000|Overall Study|Lost to Follow-up|0|||
16287540|NCT01425723|39536229|FG001|Overall Study|Lost to Follow-up|3|||
16287541|NCT01425723|39536228|FG000|Overall Study|Physician Decision|2|||
16287542|NCT01425723|39536229|FG001|Overall Study|Physician Decision|0|||
16287543|NCT01425723|39536228|FG000|Overall Study|Other|1|||
16287544|NCT01425723|39536229|FG001|Overall Study|Other|10|||
16287545|NCT01338987|39536236|FG000|Overall Study|enrolled on new protocol|0|||
16287546|NCT01338987|39536237|FG001|Overall Study|enrolled on new protocol|0|||
16287547|NCT01338987|39536238|FG002|Overall Study|enrolled on new protocol|1|||
16287548|NCT01338987|39536239|FG003|Overall Study|enrolled on new protocol|0|||
16287549|NCT01338987|39536240|FG004|Overall Study|enrolled on new protocol|0|||
16287550|NCT01338987|39536236|FG000|Overall Study|Disease progression on study|2|||
16287551|NCT01338987|39536237|FG001|Overall Study|Disease progression on study|1|||
16287552|NCT01338987|39536238|FG002|Overall Study|Disease progression on study|1|||
16287553|NCT01338987|39536239|FG003|Overall Study|Disease progression on study|0|||
16287554|NCT01338987|39536240|FG004|Overall Study|Disease progression on study|0|||
16287555|NCT01791153|39536241|FG000|Part 1: Blinded Period|Adverse Event|7|||
16287556|NCT01791153|39536242|FG001|Part 1: Blinded Period|Adverse Event|3|||
16287557|NCT01791153|39536243|FG002|Part 1: Blinded Period|Adverse Event|2|||
16287558|NCT01791153|39536244|FG003|Part 1: Blinded Period|Adverse Event|0|||
16287559|NCT01791153|39536245|FG004|Part 1: Blinded Period|Adverse Event|0|||
16287560|NCT01791153|39536246|FG005|Part 1: Blinded Period|Adverse Event|0|||
16287561|NCT01791153|39536247|FG006|Part 1: Blinded Period|Adverse Event|0|||
16287562|NCT01791153|39536248|FG007|Part 1: Blinded Period|Adverse Event|0|||
16287563|NCT01791153|39536241|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
16287564|NCT01791153|39536242|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
16287565|NCT01791153|39536243|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
16287566|NCT01791153|39536244|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
16287567|NCT01791153|39536245|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
16287568|NCT01791153|39536246|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
16287569|NCT01791153|39536247|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
16287570|NCT01791153|39536248|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
16287571|NCT01791153|39536241|FG000|Part 1: Blinded Period|Non-Compliance|1|||
16287572|NCT01791153|39536242|FG001|Part 1: Blinded Period|Non-Compliance|0|||
16287573|NCT01791153|39536243|FG002|Part 1: Blinded Period|Non-Compliance|0|||
16287574|NCT01791153|39536244|FG003|Part 1: Blinded Period|Non-Compliance|0|||
16287575|NCT01791153|39536245|FG004|Part 1: Blinded Period|Non-Compliance|0|||
16287576|NCT01791153|39536246|FG005|Part 1: Blinded Period|Non-Compliance|0|||
16287577|NCT01791153|39536247|FG006|Part 1: Blinded Period|Non-Compliance|0|||
16287578|NCT01791153|39536248|FG007|Part 1: Blinded Period|Non-Compliance|0|||
16287579|NCT01791153|39536241|FG000|Part 1: Blinded Period|Physician Decision|0|||
16287580|NCT01791153|39536242|FG001|Part 1: Blinded Period|Physician Decision|0|||
16287581|NCT01791153|39536243|FG002|Part 1: Blinded Period|Physician Decision|0|||
16287582|NCT01791153|39536244|FG003|Part 1: Blinded Period|Physician Decision|1|||
16287583|NCT01791153|39536245|FG004|Part 1: Blinded Period|Physician Decision|0|||
16287584|NCT01791153|39536246|FG005|Part 1: Blinded Period|Physician Decision|0|||
16287585|NCT01791153|39536247|FG006|Part 1: Blinded Period|Physician Decision|0|||
16287586|NCT01791153|39536248|FG007|Part 1: Blinded Period|Physician Decision|0|||
16287587|NCT01791153|39536241|FG000|Part 1: Blinded Period|Protocol Violation|0|||
16287588|NCT01791153|39536242|FG001|Part 1: Blinded Period|Protocol Violation|0|||
16287589|NCT01791153|39536243|FG002|Part 1: Blinded Period|Protocol Violation|0|||
16287590|NCT01791153|39536244|FG003|Part 1: Blinded Period|Protocol Violation|1|||
16287591|NCT01791153|39536245|FG004|Part 1: Blinded Period|Protocol Violation|0|||
16287592|NCT01791153|39536246|FG005|Part 1: Blinded Period|Protocol Violation|0|||
16287593|NCT01791153|39536247|FG006|Part 1: Blinded Period|Protocol Violation|0|||
16287594|NCT01791153|39536248|FG007|Part 1: Blinded Period|Protocol Violation|0|||
16287595|NCT01791153|39536241|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
16287596|NCT01791153|39536242|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
16287597|NCT01791153|39536243|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
16287598|NCT01791153|39536244|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
16287599|NCT01791153|39536245|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
16481490|NCT00347360|40242226|FG003|Overall Study|Protocol Violation|2|||
16481491|NCT00347360|40242227|FG004|Overall Study|Protocol Violation|1|||
16481492|NCT00347360|40242228|FG005|Overall Study|Protocol Violation|2|||
16481493|NCT00347360|40242229|FG006|Overall Study|Protocol Violation|0|||
16481494|NCT00347360|40242230|FG007|Overall Study|Protocol Violation|0|||
16481495|NCT00347360|40242231|FG008|Overall Study|Protocol Violation|1|||
16481496|NCT00347360|40242232|FG009|Overall Study|Protocol Violation|2|||
16481497|NCT00347360|40242233|FG010|Overall Study|Protocol Violation|0|||
16481498|NCT00347360|40242234|FG011|Overall Study|Protocol Violation|0|||
16481499|NCT00347360|40242235|FG012|Overall Study|Protocol Violation|0|||
16481500|NCT00347360|40242236|FG013|Overall Study|Protocol Violation|1|||
16481501|NCT00347360|40242237|FG014|Overall Study|Protocol Violation|0|||
16481502|NCT00347360|40242223|FG000|Overall Study|Withdrawal by Subject|0|||
16481503|NCT00347360|40242224|FG001|Overall Study|Withdrawal by Subject|1|||
16287600|NCT01791153|39536246|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
16287601|NCT01791153|39536247|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
16287602|NCT01791153|39536248|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
16287603|NCT01791153|39536241|FG000|Part 2: Open-label Period|Adverse Event|0|||
16287604|NCT01791153|39536242|FG001|Part 2: Open-label Period|Adverse Event|0|||
16287605|NCT01791153|39536243|FG002|Part 2: Open-label Period|Adverse Event|0|||
16287606|NCT01791153|39536244|FG003|Part 2: Open-label Period|Adverse Event|0|||
16287607|NCT01791153|39536245|FG004|Part 2: Open-label Period|Adverse Event|0|||
16287608|NCT01791153|39536246|FG005|Part 2: Open-label Period|Adverse Event|1|||
16287609|NCT01791153|39536247|FG006|Part 2: Open-label Period|Adverse Event|1|||
16287610|NCT01791153|39536248|FG007|Part 2: Open-label Period|Adverse Event|2|||
16287611|NCT01791153|39536241|FG000|Part 2: Open-label Period|Death|0|||
16287612|NCT01791153|39536242|FG001|Part 2: Open-label Period|Death|0|||
16287613|NCT01791153|39536243|FG002|Part 2: Open-label Period|Death|0|||
16287614|NCT01791153|39536244|FG003|Part 2: Open-label Period|Death|0|||
16287615|NCT01791153|39536245|FG004|Part 2: Open-label Period|Death|0|||
16287616|NCT01791153|39536246|FG005|Part 2: Open-label Period|Death|1|||
16287617|NCT01791153|39536247|FG006|Part 2: Open-label Period|Death|1|||
16287618|NCT01791153|39536248|FG007|Part 2: Open-label Period|Death|1|||
16287619|NCT01791153|39536241|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
16287620|NCT01791153|39536242|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
16287621|NCT01791153|39536243|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
16287622|NCT01791153|39536244|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
16287623|NCT01791153|39536245|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
16287624|NCT01791153|39536246|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
16481504|NCT00347360|40242225|FG002|Overall Study|Withdrawal by Subject|2|||
16481505|NCT00347360|40242226|FG003|Overall Study|Withdrawal by Subject|4|||
16481506|NCT00347360|40242227|FG004|Overall Study|Withdrawal by Subject|1|||
16287625|NCT01791153|39536247|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
16287626|NCT01791153|39536248|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
16287627|NCT01791153|39536241|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
16287628|NCT01791153|39536242|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
16481507|NCT00347360|40242228|FG005|Overall Study|Withdrawal by Subject|2|||
16481508|NCT00347360|40242229|FG006|Overall Study|Withdrawal by Subject|1|||
16287629|NCT01791153|39536243|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
16287630|NCT01791153|39536244|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
16287631|NCT01791153|39536245|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
16287632|NCT01791153|39536246|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
16287633|NCT01791153|39536247|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
16287634|NCT01791153|39536248|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
16481509|NCT00347360|40242230|FG007|Overall Study|Withdrawal by Subject|1|||
16481510|NCT00347360|40242231|FG008|Overall Study|Withdrawal by Subject|1|||
16481511|NCT00347360|40242232|FG009|Overall Study|Withdrawal by Subject|1|||
16481512|NCT00347360|40242233|FG010|Overall Study|Withdrawal by Subject|0|||
16287635|NCT01791153|39536241|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
16287636|NCT01791153|39536242|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
16287637|NCT01791153|39536243|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
16287638|NCT01791153|39536244|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
16287639|NCT01791153|39536245|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
16287640|NCT01791153|39536246|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
16287641|NCT01791153|39536247|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
16287642|NCT01791153|39536248|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
16287643|NCT01791153|39536241|FG000|Part 2: Open-label Period|Physician Decision|0|||
16287644|NCT01791153|39536242|FG001|Part 2: Open-label Period|Physician Decision|0|||
16287645|NCT01791153|39536243|FG002|Part 2: Open-label Period|Physician Decision|0|||
16287646|NCT01791153|39536244|FG003|Part 2: Open-label Period|Physician Decision|0|||
16287647|NCT01791153|39536245|FG004|Part 2: Open-label Period|Physician Decision|1|||
16287648|NCT01791153|39536246|FG005|Part 2: Open-label Period|Physician Decision|1|||
16287649|NCT01791153|39536247|FG006|Part 2: Open-label Period|Physician Decision|0|||
16287650|NCT01791153|39536248|FG007|Part 2: Open-label Period|Physician Decision|0|||
16287651|NCT03043560|39536249|FG000|Overall Study|Discontinued Intervention|1|||
16287652|NCT03043560|39536250|FG001|Overall Study|Discontinued Intervention|2|||
16287653|NCT03043560|39536249|FG000|Overall Study|Lost to Follow-up|0|||
16287654|NCT03043560|39536250|FG001|Overall Study|Lost to Follow-up|1|||
16287655|NCT02201290|39536251|FG000|Overall Study|Withdrawal by Subject|2|||
16287656|NCT02201290|39536251|FG000|Overall Study|Lack of Efficacy|2|||
16287657|NCT02201290|39536251|FG000|Overall Study|Adverse Event|1|||
16287658|NCT00653991|39536256|FG000|3 Month Follow-up|Participant would not respond|150|||
16287659|NCT00653991|39536257|FG001|3 Month Follow-up|Participant would not respond|157|||
16287660|NCT00653991|39536256|FG000|6 Month Follow-up|Participant would not respond|133|||
16287661|NCT00653991|39536257|FG001|6 Month Follow-up|Participant would not respond|141|||
16287662|NCT01298778|39536258|FG000|Overall Study|Lost to Follow-up|2|||
16287663|NCT01298778|39536259|FG001|Overall Study|Lost to Follow-up|3|||
16287664|NCT01298778|39536258|FG000|Overall Study|Incorrect use of VAS|1|||
16287665|NCT01298778|39536259|FG001|Overall Study|Incorrect use of VAS|0|||
16287666|NCT01298778|39536258|FG000|Overall Study|Withdrawal by Subject|0|||
16287667|NCT01298778|39536259|FG001|Overall Study|Withdrawal by Subject|1|||
16287668|NCT01298778|39536258|FG000|Overall Study|Protocol Violation|0|||
16287669|NCT01298778|39536259|FG001|Overall Study|Protocol Violation|1|||
16287670|NCT01298778|39536258|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
16287671|NCT01298778|39536259|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
16287672|NCT00290251|39536260|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
16287673|NCT00290251|39536261|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
16287674|NCT00290251|39536262|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
16287675|NCT00290251|39536263|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
16287676|NCT00290251|39536264|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
16287677|NCT00290251|39536265|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
16287678|NCT00290251|39536260|FG000|Treatment 1 (Months 2-4)|headache|0|||
16287679|NCT00290251|39536261|FG001|Treatment 1 (Months 2-4)|headache|0|||
16287680|NCT00290251|39536262|FG002|Treatment 1 (Months 2-4)|headache|0|||
16287681|NCT00290251|39536263|FG003|Treatment 1 (Months 2-4)|headache|0|||
16287682|NCT00290251|39536264|FG004|Treatment 1 (Months 2-4)|headache|1|||
16287683|NCT00290251|39536265|FG005|Treatment 1 (Months 2-4)|headache|0|||
16287684|NCT00290251|39536260|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
16287685|NCT00290251|39536261|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
16287686|NCT00290251|39536262|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
16287687|NCT00290251|39536263|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
16287688|NCT00290251|39536264|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
16287689|NCT00290251|39536265|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
16287690|NCT00285584|39536266|FG000|Month 3|Lost to Follow-up|3|||
16287691|NCT00285584|39536267|FG001|Month 3|Lost to Follow-up|3|||
16287692|NCT00285584|39536266|FG000|Month 3|Withdrawal by Subject|1|||
16287693|NCT00285584|39536267|FG001|Month 3|Withdrawal by Subject|0|||
16287694|NCT00285584|39536266|FG000|Month 6|Lost to Follow-up|0|||
16287695|NCT00285584|39536267|FG001|Month 6|Lost to Follow-up|1|||
16481513|NCT00347360|40242234|FG011|Overall Study|Withdrawal by Subject|3|||
16481514|NCT00347360|40242235|FG012|Overall Study|Withdrawal by Subject|4|||
16287696|NCT04142242|39536270|FG000|Stage I|Non-compliance with the protocol|1|||
16287697|NCT04142242|39536271|FG001|Stage I|Non-compliance with the protocol|0|||
16287698|NCT04142242|39536272|FG002|Stage I|Non-compliance with the protocol|0|||
16287699|NCT04142242|39536273|FG003|Stage I|Non-compliance with the protocol|0|||
16287700|NCT04142242|39536274|FG004|Stage I|Non-compliance with the protocol|0|||
16287701|NCT04142242|39536275|FG005|Stage I|Non-compliance with the protocol|1|||
16287702|NCT04142242|39536270|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
16287703|NCT04142242|39536271|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
16287704|NCT04142242|39536272|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
16287705|NCT04142242|39536273|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
16287706|NCT04142242|39536274|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
16287707|NCT04142242|39536275|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
16287708|NCT04142242|39536270|FG000|Stage II|Non-compliance with the protocol|0|||
16287709|NCT04142242|39536271|FG001|Stage II|Non-compliance with the protocol|0|||
16287710|NCT04142242|39536272|FG002|Stage II|Non-compliance with the protocol|0|||
16287711|NCT04142242|39536273|FG003|Stage II|Non-compliance with the protocol|2|||
16287712|NCT04142242|39536274|FG004|Stage II|Non-compliance with the protocol|0|||
16287713|NCT04142242|39536275|FG005|Stage II|Non-compliance with the protocol|0|||
16287714|NCT04142242|39536270|FG000|Stage II|Lost to Follow-up|0|||
16287715|NCT04142242|39536271|FG001|Stage II|Lost to Follow-up|0|||
16287716|NCT04142242|39536272|FG002|Stage II|Lost to Follow-up|1|||
16287717|NCT04142242|39536273|FG003|Stage II|Lost to Follow-up|2|||
16287718|NCT04142242|39536274|FG004|Stage II|Lost to Follow-up|0|||
16287719|NCT04142242|39536275|FG005|Stage II|Lost to Follow-up|0|||
16287720|NCT04142242|39536270|FG000|Stage II|Withdrawal by Subject|0|||
16287721|NCT04142242|39536271|FG001|Stage II|Withdrawal by Subject|0|||
16287722|NCT04142242|39536272|FG002|Stage II|Withdrawal by Subject|5|||
16287723|NCT04142242|39536273|FG003|Stage II|Withdrawal by Subject|9|||
16287724|NCT04142242|39536274|FG004|Stage II|Withdrawal by Subject|0|||
16287725|NCT04142242|39536275|FG005|Stage II|Withdrawal by Subject|0|||
16287726|NCT00546572|39536278|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
16287727|NCT00546572|39536279|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
16287728|NCT00546572|39536278|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
16287729|NCT00546572|39536279|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
16287730|NCT00546572|39536278|FG000|Vax 1 / Year 0|Protocol Violation|3|||
16287731|NCT00546572|39536279|FG001|Vax 1 / Year 0|Protocol Violation|4|||
16287732|NCT00546572|39536278|FG000|Vax 1 / Year 0|Death|2|||
16287733|NCT00546572|39536279|FG001|Vax 1 / Year 0|Death|2|||
16287734|NCT00546572|39536278|FG000|Vax 1 / Year 0|Adverse Event|0|||
16287735|NCT00546572|39536279|FG001|Vax 1 / Year 0|Adverse Event|1|||
16287736|NCT00546572|39536278|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
16287737|NCT00546572|39536279|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
16287738|NCT00546572|39536278|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
16287739|NCT00546572|39536279|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
16287740|NCT00546572|39536278|FG000|Vax 2 / Year 1|Other|1|||
16287741|NCT00546572|39536279|FG001|Vax 2 / Year 1|Other|1|||
16481515|NCT00347360|40242236|FG013|Overall Study|Withdrawal by Subject|2|||
16481516|NCT00347360|40242237|FG014|Overall Study|Withdrawal by Subject|1|||
16481517|NCT00347360|40242223|FG000|Overall Study|Lack of Efficacy|1|||
16481518|NCT00347360|40242224|FG001|Overall Study|Lack of Efficacy|1|||
16481519|NCT00347360|40242225|FG002|Overall Study|Lack of Efficacy|3|||
16481520|NCT00347360|40242226|FG003|Overall Study|Lack of Efficacy|1|||
16481521|NCT00347360|40242227|FG004|Overall Study|Lack of Efficacy|0|||
16481522|NCT00347360|40242228|FG005|Overall Study|Lack of Efficacy|1|||
16481523|NCT00347360|40242229|FG006|Overall Study|Lack of Efficacy|0|||
16481524|NCT00347360|40242230|FG007|Overall Study|Lack of Efficacy|1|||
16481525|NCT00347360|40242231|FG008|Overall Study|Lack of Efficacy|1|||
16481526|NCT00347360|40242232|FG009|Overall Study|Lack of Efficacy|0|||
16481527|NCT00347360|40242233|FG010|Overall Study|Lack of Efficacy|0|||
16481528|NCT00347360|40242234|FG011|Overall Study|Lack of Efficacy|0|||
16481529|NCT00347360|40242235|FG012|Overall Study|Lack of Efficacy|0|||
16481530|NCT00347360|40242236|FG013|Overall Study|Lack of Efficacy|0|||
16481531|NCT00347360|40242237|FG014|Overall Study|Lack of Efficacy|0|||
16481532|NCT00347360|40242223|FG000|Overall Study|Reason not listed/blank|1|||
16481533|NCT00347360|40242224|FG001|Overall Study|Reason not listed/blank|0|||
16481534|NCT00347360|40242225|FG002|Overall Study|Reason not listed/blank|0|||
16481535|NCT00347360|40242226|FG003|Overall Study|Reason not listed/blank|0|||
16481536|NCT00347360|40242227|FG004|Overall Study|Reason not listed/blank|0|||
16481537|NCT00347360|40242228|FG005|Overall Study|Reason not listed/blank|0|||
16481538|NCT00347360|40242229|FG006|Overall Study|Reason not listed/blank|1|||
16287742|NCT00546572|39536278|FG000|Vax 2 / Year 1|Adverse Event|1|||
16481539|NCT00347360|40242230|FG007|Overall Study|Reason not listed/blank|0|||
16481540|NCT00347360|40242231|FG008|Overall Study|Reason not listed/blank|0|||
16481541|NCT00347360|40242232|FG009|Overall Study|Reason not listed/blank|0|||
16481542|NCT00347360|40242233|FG010|Overall Study|Reason not listed/blank|0|||
16481543|NCT00347360|40242234|FG011|Overall Study|Reason not listed/blank|0|||
16481544|NCT00347360|40242235|FG012|Overall Study|Reason not listed/blank|0|||
16481545|NCT00347360|40242236|FG013|Overall Study|Reason not listed/blank|1|||
16481546|NCT00347360|40242237|FG014|Overall Study|Reason not listed/blank|0|||
16481547|NCT00347360|40242223|FG000|Overall Study|Per sponsors instruction|0|||
16481548|NCT00347360|40242224|FG001|Overall Study|Per sponsors instruction|1|||
16287743|NCT00546572|39536279|FG001|Vax 2 / Year 1|Adverse Event|0|||
16287744|NCT00546572|39536278|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
16287745|NCT00546572|39536279|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
16287746|NCT00706381|39536281|FG000|Overall Study|Lost to Follow-up|0|||
16481549|NCT00347360|40242225|FG002|Overall Study|Per sponsors instruction|0|||
16481550|NCT00347360|40242226|FG003|Overall Study|Per sponsors instruction|0|||
16481551|NCT00347360|40242227|FG004|Overall Study|Per sponsors instruction|0|||
16481552|NCT00347360|40242228|FG005|Overall Study|Per sponsors instruction|0|||
16481553|NCT00347360|40242229|FG006|Overall Study|Per sponsors instruction|0|||
16481554|NCT00347360|40242230|FG007|Overall Study|Per sponsors instruction|0|||
16481555|NCT00347360|40242231|FG008|Overall Study|Per sponsors instruction|0|||
16481556|NCT00347360|40242232|FG009|Overall Study|Per sponsors instruction|0|||
16481557|NCT00347360|40242233|FG010|Overall Study|Per sponsors instruction|0|||
16481558|NCT00347360|40242234|FG011|Overall Study|Per sponsors instruction|0|||
16481559|NCT00347360|40242235|FG012|Overall Study|Per sponsors instruction|0|||
16481560|NCT00347360|40242236|FG013|Overall Study|Per sponsors instruction|0|||
16481561|NCT00347360|40242237|FG014|Overall Study|Per sponsors instruction|0|||
16481562|NCT00347360|40242223|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
16481563|NCT00347360|40242224|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
16481564|NCT00347360|40242225|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
16481565|NCT00347360|40242226|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
16481566|NCT00347360|40242227|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
16481567|NCT00347360|40242228|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
16481568|NCT00347360|40242229|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
16481569|NCT00347360|40242230|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
16287747|NCT00706381|39536282|FG001|Overall Study|Lost to Follow-up|1|||
16287748|NCT00706381|39536283|FG002|Overall Study|Lost to Follow-up|1|||
16287749|NCT00706381|39536284|FG003|Overall Study|Lost to Follow-up|0|||
16287750|NCT00321737|39536285|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
16287751|NCT00321737|39536286|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
16287752|NCT00321737|39536287|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
16287753|NCT00321737|39536285|FG000|Overall Study|Adverse Event|11|||
16287754|NCT00321737|39536286|FG001|Overall Study|Adverse Event|3|||
16287755|NCT00321737|39536287|FG002|Overall Study|Adverse Event|6|||
16287756|NCT00321737|39536285|FG000|Overall Study|Lost to Follow-up|5|||
16287757|NCT00321737|39536286|FG001|Overall Study|Lost to Follow-up|5|||
16287758|NCT00321737|39536287|FG002|Overall Study|Lost to Follow-up|6|||
16287759|NCT00321737|39536285|FG000|Overall Study|Withdrawal by Subject|19|||
16287760|NCT00321737|39536286|FG001|Overall Study|Withdrawal by Subject|12|||
16287761|NCT00321737|39536287|FG002|Overall Study|Withdrawal by Subject|17|||
16287762|NCT00321737|39536285|FG000|Overall Study|Protocol Violation|0|||
16287763|NCT00321737|39536286|FG001|Overall Study|Protocol Violation|0|||
16287764|NCT00321737|39536287|FG002|Overall Study|Protocol Violation|1|||
16287765|NCT00321737|39536285|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
16287766|NCT00321737|39536286|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
16287767|NCT00321737|39536287|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
16287768|NCT00321737|39536285|FG000|Overall Study|Possible Barrett's Esophagus|2|||
16287769|NCT00321737|39536286|FG001|Overall Study|Possible Barrett's Esophagus|1|||
16287770|NCT00321737|39536287|FG002|Overall Study|Possible Barrett's Esophagus|1|||
16287771|NCT00321737|39536285|FG000|Overall Study|Therapeutic Failure|6|||
16287772|NCT00321737|39536286|FG001|Overall Study|Therapeutic Failure|0|||
16287773|NCT00321737|39536287|FG002|Overall Study|Therapeutic Failure|2|||
16287774|NCT00321737|39536285|FG000|Overall Study|Pregnancy|0|||
16287775|NCT00321737|39536286|FG001|Overall Study|Pregnancy|2|||
16287776|NCT00321737|39536287|FG002|Overall Study|Pregnancy|0|||
16287777|NCT00321737|39536285|FG000|Overall Study|Noncompliance|2|||
16287778|NCT00321737|39536286|FG001|Overall Study|Noncompliance|0|||
16287779|NCT00321737|39536287|FG002|Overall Study|Noncompliance|0|||
16481570|NCT00347360|40242231|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
16287780|NCT00321737|39536285|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
16287781|NCT00321737|39536286|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
16287782|NCT00321737|39536287|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
16481571|NCT00347360|40242232|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
16481572|NCT00347360|40242233|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
16287783|NCT02865395|39536288|FG000|Overall Study|Physician Decision|6|||
16287784|NCT02865395|39536289|FG001|Overall Study|Physician Decision|10|||
16287785|NCT02865395|39536290|FG002|Overall Study|Physician Decision|7|||
16481573|NCT00347360|40242234|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
16481574|NCT00347360|40242235|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
16481575|NCT00347360|40242236|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
16481576|NCT00347360|40242237|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
16481577|NCT00347360|40242223|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
16481578|NCT00347360|40242224|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
16481579|NCT00347360|40242225|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
16481580|NCT00347360|40242226|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
16481581|NCT00347360|40242227|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
16481582|NCT00347360|40242228|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
16481583|NCT00347360|40242229|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
16481584|NCT00347360|40242230|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
16481585|NCT00347360|40242231|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
16481586|NCT00347360|40242232|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
16481587|NCT00347360|40242233|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
16481588|NCT00347360|40242234|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
16481589|NCT00347360|40242235|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
16481590|NCT00347360|40242236|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
16481591|NCT00347360|40242237|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
16481592|NCT00347360|40242223|FG000|Overall Study|Abnormal lab values|0|||
16481593|NCT00347360|40242224|FG001|Overall Study|Abnormal lab values|0|||
16287786|NCT00257920|39536291|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
16287787|NCT00257920|39536292|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
16481594|NCT00347360|40242225|FG002|Overall Study|Abnormal lab values|0|||
16287788|NCT00257920|39536291|FG000|Period: Second Intervention|Other|2|||
16287789|NCT00257920|39536292|FG001|Period: Second Intervention|Other|1|||
16287790|NCT02792959|39536293|FG000|Overall Study|Protocol Violation|1|||
16287791|NCT01300923|39536294|FG000|Overall Study|Physician Decision|0|||
16287792|NCT01300923|39536295|FG001|Overall Study|Physician Decision|2|||
16287793|NCT02080832|39536298|FG000|Overall Study|Excluded from analysis by MRI|9|||
16287794|NCT02080832|39536299|FG001|Overall Study|Excluded from analysis by MRI|10|||
16287795|NCT02080832|39536300|FG002|Overall Study|Excluded from analysis by MRI|14|||
16287796|NCT02080832|39536298|FG000|Overall Study|Lost to Follow-up|0|||
16287797|NCT02080832|39536299|FG001|Overall Study|Lost to Follow-up|2|||
16287798|NCT02080832|39536300|FG002|Overall Study|Lost to Follow-up|2|||
16287799|NCT00693225|39536301|FG000|Overall Study|Lost to Follow-up|1|||
16287800|NCT00693225|39536302|FG001|Overall Study|Lost to Follow-up|2|||
16287801|NCT00693225|39536301|FG000|Overall Study|Adverse Event|1|||
16287802|NCT00693225|39536302|FG001|Overall Study|Adverse Event|3|||
16287803|NCT01660334|39536308|FG000|Overall Study|Lost to Follow-up|1|||
16287804|NCT00775606|39536309|FG000|Overall Study|Study sponsor terminated funding|3|||
16287805|NCT00775606|39536310|FG001|Overall Study|Study sponsor terminated funding|0|||
16287806|NCT01901848|39536311|FG000|Randomized and Treated|Lost to Follow-up|3|||
16287807|NCT01901848|39536312|FG001|Randomized and Treated|Lost to Follow-up|6|||
16287808|NCT01901848|39536311|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
16287809|NCT01901848|39536312|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
16287810|NCT01005329|39536314|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
16287811|NCT02243293|39536315|FG000|Overall Study|Adverse Event|1|||
16287812|NCT02243293|39536316|FG001|Overall Study|Adverse Event|0|||
16287813|NCT02243293|39536317|FG002|Overall Study|Adverse Event|0|||
16287814|NCT02243293|39536318|FG003|Overall Study|Adverse Event|0|||
16287815|NCT02243293|39536319|FG004|Overall Study|Adverse Event|0|||
16287816|NCT02243293|39536320|FG005|Overall Study|Adverse Event|0|||
16287817|NCT02243293|39536321|FG006|Overall Study|Adverse Event|0|||
16287818|NCT02243293|39536322|FG007|Overall Study|Adverse Event|0|||
16287819|NCT02243293|39536323|FG008|Overall Study|Adverse Event|0|||
16287820|NCT02243293|39536324|FG009|Overall Study|Adverse Event|0|||
16287821|NCT02243293|39536325|FG010|Overall Study|Adverse Event|0|||
16287822|NCT02243293|39536326|FG011|Overall Study|Adverse Event|0|||
16287823|NCT02243293|39536327|FG012|Overall Study|Adverse Event|0|||
16287824|NCT02243293|39536328|FG013|Overall Study|Adverse Event|0|||
16080242|NCT01307267|38786787|FG006|Overall Study|Withdrawal by Subject|0|||
16287825|NCT02243293|39536329|FG014|Overall Study|Adverse Event|0|||
16287826|NCT02243293|39536330|FG015|Overall Study|Adverse Event|1|||
16287827|NCT02243293|39536331|FG016|Overall Study|Adverse Event|0|||
16287828|NCT02243293|39536332|FG017|Overall Study|Adverse Event|0|||
16287829|NCT02243293|39536333|FG018|Overall Study|Adverse Event|0|||
16287830|NCT02243293|39536334|FG019|Overall Study|Adverse Event|0|||
16287831|NCT02243293|39536335|FG020|Overall Study|Adverse Event|1|||
16287832|NCT02243293|39536336|FG021|Overall Study|Adverse Event|0|||
16287833|NCT02243293|39536315|FG000|Overall Study|Withdrawal by Subject|1|||
16287834|NCT02243293|39536316|FG001|Overall Study|Withdrawal by Subject|0|||
16287835|NCT02243293|39536317|FG002|Overall Study|Withdrawal by Subject|0|||
16287836|NCT02243293|39536318|FG003|Overall Study|Withdrawal by Subject|0|||
16287837|NCT02243293|39536319|FG004|Overall Study|Withdrawal by Subject|0|||
16287838|NCT02243293|39536320|FG005|Overall Study|Withdrawal by Subject|0|||
16287839|NCT02243293|39536321|FG006|Overall Study|Withdrawal by Subject|0|||
16287840|NCT02243293|39536322|FG007|Overall Study|Withdrawal by Subject|0|||
16287841|NCT02243293|39536323|FG008|Overall Study|Withdrawal by Subject|0|||
16287842|NCT02243293|39536324|FG009|Overall Study|Withdrawal by Subject|1|||
16287843|NCT02243293|39536325|FG010|Overall Study|Withdrawal by Subject|0|||
16287844|NCT02243293|39536326|FG011|Overall Study|Withdrawal by Subject|1|||
16287845|NCT02243293|39536327|FG012|Overall Study|Withdrawal by Subject|0|||
16287846|NCT02243293|39536328|FG013|Overall Study|Withdrawal by Subject|0|||
16287847|NCT02243293|39536329|FG014|Overall Study|Withdrawal by Subject|0|||
16287848|NCT02243293|39536330|FG015|Overall Study|Withdrawal by Subject|0|||
16287849|NCT02243293|39536331|FG016|Overall Study|Withdrawal by Subject|0|||
16287850|NCT02243293|39536332|FG017|Overall Study|Withdrawal by Subject|0|||
16287851|NCT02243293|39536333|FG018|Overall Study|Withdrawal by Subject|0|||
16287852|NCT02243293|39536334|FG019|Overall Study|Withdrawal by Subject|0|||
16287853|NCT02243293|39536335|FG020|Overall Study|Withdrawal by Subject|0|||
16287854|NCT02243293|39536336|FG021|Overall Study|Withdrawal by Subject|1|||
16287855|NCT02243293|39536315|FG000|Overall Study|Lost to Follow-up|0|||
16287856|NCT02243293|39536316|FG001|Overall Study|Lost to Follow-up|1|||
16287857|NCT02243293|39536317|FG002|Overall Study|Lost to Follow-up|1|||
16287858|NCT02243293|39536318|FG003|Overall Study|Lost to Follow-up|1|||
16287859|NCT02243293|39536319|FG004|Overall Study|Lost to Follow-up|0|||
16287860|NCT02243293|39536320|FG005|Overall Study|Lost to Follow-up|0|||
16287861|NCT02243293|39536321|FG006|Overall Study|Lost to Follow-up|3|||
16287862|NCT02243293|39536322|FG007|Overall Study|Lost to Follow-up|0|||
16287863|NCT02243293|39536323|FG008|Overall Study|Lost to Follow-up|0|||
16287864|NCT02243293|39536324|FG009|Overall Study|Lost to Follow-up|0|||
16287865|NCT02243293|39536325|FG010|Overall Study|Lost to Follow-up|0|||
16287866|NCT02243293|39536326|FG011|Overall Study|Lost to Follow-up|2|||
16287867|NCT02243293|39536327|FG012|Overall Study|Lost to Follow-up|0|||
16287868|NCT02243293|39536328|FG013|Overall Study|Lost to Follow-up|0|||
16287869|NCT02243293|39536329|FG014|Overall Study|Lost to Follow-up|0|||
16287870|NCT02243293|39536330|FG015|Overall Study|Lost to Follow-up|0|||
16287871|NCT02243293|39536331|FG016|Overall Study|Lost to Follow-up|3|||
16287872|NCT02243293|39536332|FG017|Overall Study|Lost to Follow-up|1|||
16287873|NCT02243293|39536333|FG018|Overall Study|Lost to Follow-up|0|||
16287874|NCT02243293|39536334|FG019|Overall Study|Lost to Follow-up|0|||
16287875|NCT02243293|39536335|FG020|Overall Study|Lost to Follow-up|1|||
16287876|NCT02243293|39536336|FG021|Overall Study|Lost to Follow-up|2|||
16287877|NCT02243293|39536315|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
16287878|NCT02243293|39536316|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
16287879|NCT02243293|39536317|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
16287880|NCT02243293|39536318|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
16287881|NCT02243293|39536319|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
16287882|NCT02243293|39536320|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
16287883|NCT02243293|39536321|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
16287884|NCT02243293|39536322|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
16287885|NCT02243293|39536323|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
16287886|NCT02243293|39536324|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
16287887|NCT02243293|39536325|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
16287888|NCT02243293|39536326|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
16287889|NCT02243293|39536327|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
16287890|NCT02243293|39536328|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
16287891|NCT02243293|39536329|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
16287892|NCT02243293|39536330|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
16287893|NCT02243293|39536331|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
16287894|NCT02243293|39536332|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
16287895|NCT02243293|39536333|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
16287896|NCT02243293|39536334|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
16287897|NCT02243293|39536335|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
16287898|NCT02243293|39536336|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
16287899|NCT02243293|39536315|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
16287900|NCT02243293|39536316|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
16287901|NCT02243293|39536317|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
16287902|NCT02243293|39536318|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
16287903|NCT02243293|39536319|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
16287904|NCT02243293|39536320|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
16287905|NCT02243293|39536321|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
16287906|NCT02243293|39536322|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
16287907|NCT02243293|39536323|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
16287908|NCT02243293|39536324|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
16287909|NCT02243293|39536325|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
16287910|NCT02243293|39536326|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
16287911|NCT02243293|39536327|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
16287912|NCT02243293|39536328|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
16287913|NCT02243293|39536329|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
16287914|NCT02243293|39536330|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
16287915|NCT02243293|39536331|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
16287916|NCT02243293|39536332|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
16287917|NCT02243293|39536333|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
16287918|NCT02243293|39536334|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
16287919|NCT02243293|39536335|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
16287920|NCT02243293|39536336|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
16287921|NCT00620659|39536337|FG000|Treatment Period 1|Adverse Event|1|||
16287922|NCT00620659|39536338|FG001|Treatment Period 1|Adverse Event|0|||
16287923|NCT00620659|39536339|FG002|Treatment Period 1|Adverse Event|0|||
16287924|NCT00620659|39536340|FG003|Treatment Period 1|Adverse Event|3|||
16287925|NCT00620659|39536341|FG004|Treatment Period 1|Adverse Event|0|||
16287926|NCT00620659|39536342|FG005|Treatment Period 1|Adverse Event|0|||
16287927|NCT00620659|39536337|FG000|Treatment Period 1|Protocol Violation|1|||
16287928|NCT00620659|39536338|FG001|Treatment Period 1|Protocol Violation|0|||
16287929|NCT00620659|39536339|FG002|Treatment Period 1|Protocol Violation|0|||
16287930|NCT00620659|39536340|FG003|Treatment Period 1|Protocol Violation|0|||
16287931|NCT00620659|39536341|FG004|Treatment Period 1|Protocol Violation|0|||
16287932|NCT00620659|39536342|FG005|Treatment Period 1|Protocol Violation|0|||
16287933|NCT00620659|39536337|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16287934|NCT00620659|39536338|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16287935|NCT00620659|39536339|FG002|Treatment Period 1|Withdrawal by Subject|1|||
16287936|NCT00620659|39536340|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16287937|NCT00620659|39536341|FG004|Treatment Period 1|Withdrawal by Subject|1|||
16287938|NCT00620659|39536342|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16287939|NCT00620659|39536337|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
16287940|NCT00620659|39536338|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
16287941|NCT00620659|39536339|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
16287942|NCT00620659|39536340|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
16287943|NCT00620659|39536341|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
16287944|NCT00620659|39536342|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
16287945|NCT00620659|39536337|FG000|Treatment Period 2|Adverse Event|0|||
16287946|NCT00620659|39536338|FG001|Treatment Period 2|Adverse Event|3|||
16287947|NCT00620659|39536339|FG002|Treatment Period 2|Adverse Event|0|||
16287948|NCT00620659|39536340|FG003|Treatment Period 2|Adverse Event|0|||
16287949|NCT00620659|39536341|FG004|Treatment Period 2|Adverse Event|2|||
16287950|NCT00620659|39536342|FG005|Treatment Period 2|Adverse Event|0|||
16287951|NCT00620659|39536337|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16287952|NCT00620659|39536338|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16287953|NCT00620659|39536339|FG002|Treatment Period 2|Withdrawal by Subject|1|||
16287954|NCT00620659|39536340|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16287955|NCT00620659|39536341|FG004|Treatment Period 2|Withdrawal by Subject|3|||
16287956|NCT00620659|39536342|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16287957|NCT00620659|39536337|FG000|Placebo Washout Period 2|Adverse Event|2|||
16287958|NCT00620659|39536338|FG001|Placebo Washout Period 2|Adverse Event|0|||
16287959|NCT00620659|39536339|FG002|Placebo Washout Period 2|Adverse Event|0|||
16287960|NCT00620659|39536340|FG003|Placebo Washout Period 2|Adverse Event|0|||
16287961|NCT00620659|39536341|FG004|Placebo Washout Period 2|Adverse Event|0|||
16287962|NCT00620659|39536342|FG005|Placebo Washout Period 2|Adverse Event|0|||
16287963|NCT00620659|39536337|FG000|Treatment Period 3|Adverse Event|0|||
16287964|NCT00620659|39536338|FG001|Treatment Period 3|Adverse Event|2|||
16287965|NCT00620659|39536339|FG002|Treatment Period 3|Adverse Event|0|||
16287966|NCT00620659|39536340|FG003|Treatment Period 3|Adverse Event|0|||
16287967|NCT00620659|39536341|FG004|Treatment Period 3|Adverse Event|0|||
16287968|NCT00620659|39536342|FG005|Treatment Period 3|Adverse Event|0|||
16287969|NCT00620659|39536337|FG000|Treatment Period 3|Withdrawal by Subject|0|||
16287970|NCT00620659|39536338|FG001|Treatment Period 3|Withdrawal by Subject|0|||
16287971|NCT00620659|39536339|FG002|Treatment Period 3|Withdrawal by Subject|0|||
16287972|NCT00620659|39536340|FG003|Treatment Period 3|Withdrawal by Subject|1|||
16287973|NCT00620659|39536341|FG004|Treatment Period 3|Withdrawal by Subject|0|||
16287974|NCT00620659|39536342|FG005|Treatment Period 3|Withdrawal by Subject|0|||
16287975|NCT00588640|39536343|FG000|Overall Study|Physician Decision|1|||
16287976|NCT00588640|39536343|FG000|Overall Study|Ineligible Patient|1|||
16287977|NCT02595008|39536350|FG000|Overall Study|Enrolled In Error|1|||
16287978|NCT02595008|39536351|FG001|Overall Study|Enrolled In Error|0|||
16287979|NCT02697773|39536352|FG000|Overall Study|Adverse Event|2|||
16287980|NCT02697773|39536353|FG001|Overall Study|Adverse Event|1|||
16287981|NCT02697773|39536354|FG002|Overall Study|Adverse Event|2|||
16287982|NCT02697773|39536352|FG000|Overall Study|Death|0|||
16287983|NCT02697773|39536353|FG001|Overall Study|Death|0|||
16287984|NCT02697773|39536354|FG002|Overall Study|Death|2|||
16287985|NCT02697773|39536352|FG000|Overall Study|Lack of Efficacy|4|||
16287986|NCT02697773|39536353|FG001|Overall Study|Lack of Efficacy|6|||
16287987|NCT02697773|39536354|FG002|Overall Study|Lack of Efficacy|6|||
16287988|NCT02697773|39536352|FG000|Overall Study|Lost to Follow-up|5|||
16287989|NCT02697773|39536353|FG001|Overall Study|Lost to Follow-up|5|||
16287990|NCT02697773|39536354|FG002|Overall Study|Lost to Follow-up|7|||
16287991|NCT02697773|39536352|FG000|Overall Study|Other|15|||
16287992|NCT02697773|39536353|FG001|Overall Study|Other|11|||
16287993|NCT02697773|39536354|FG002|Overall Study|Other|10|||
16287994|NCT02697773|39536352|FG000|Overall Study|Protocol Violation|1|||
16287995|NCT02697773|39536353|FG001|Overall Study|Protocol Violation|1|||
16287996|NCT02697773|39536354|FG002|Overall Study|Protocol Violation|0|||
16287997|NCT02697773|39536352|FG000|Overall Study|Withdrawal by Subject|10|||
16287998|NCT02697773|39536353|FG001|Overall Study|Withdrawal by Subject|13|||
16287999|NCT02697773|39536354|FG002|Overall Study|Withdrawal by Subject|13|||
16288000|NCT02697773|39536352|FG000|Overall Study|Randomized but not treated|1|||
16288001|NCT02697773|39536353|FG001|Overall Study|Randomized but not treated|1|||
16288002|NCT02697773|39536354|FG002|Overall Study|Randomized but not treated|0|||
16288003|NCT04553913|39536360|FG000|Overall Study|patient's block resolved prior to PACU|1|||
16288004|NCT04553913|39536360|FG000|Overall Study|did not use the device properly|5|||
16288005|NCT05020249|39536364|FG000|Overall Study|Protocol Violation|1|||
16288006|NCT05020249|39536365|FG001|Overall Study|Protocol Violation|0|||
16288007|NCT03739138|39536366|FG000|Overall Study|Death|0|||
16288008|NCT03739138|39536367|FG001|Overall Study|Death|7|||
16288009|NCT03739138|39536368|FG002|Overall Study|Death|4|||
16288010|NCT03739138|39536369|FG003|Overall Study|Death|13|||
16288011|NCT03739138|39536370|FG004|Overall Study|Death|0|||
16288012|NCT03739138|39536366|FG000|Overall Study|Lost to Follow-up|0|||
16288013|NCT03739138|39536367|FG001|Overall Study|Lost to Follow-up|0|||
16288014|NCT03739138|39536368|FG002|Overall Study|Lost to Follow-up|1|||
16288015|NCT03739138|39536369|FG003|Overall Study|Lost to Follow-up|0|||
16288016|NCT03739138|39536370|FG004|Overall Study|Lost to Follow-up|0|||
16288017|NCT03739138|39536366|FG000|Overall Study|Study Terminated By Sponsor|0|||
16288018|NCT03739138|39536367|FG001|Overall Study|Study Terminated By Sponsor|0|||
16288019|NCT03739138|39536368|FG002|Overall Study|Study Terminated By Sponsor|0|||
16288020|NCT03739138|39536369|FG003|Overall Study|Study Terminated By Sponsor|4|||
16288021|NCT03739138|39536370|FG004|Overall Study|Study Terminated By Sponsor|0|||
16288022|NCT03739138|39536366|FG000|Overall Study|Withdrawal by Subject|0|||
16288023|NCT03739138|39536367|FG001|Overall Study|Withdrawal by Subject|0|||
16288024|NCT03739138|39536368|FG002|Overall Study|Withdrawal by Subject|0|||
16288025|NCT03739138|39536369|FG003|Overall Study|Withdrawal by Subject|1|||
16288026|NCT03739138|39536370|FG004|Overall Study|Withdrawal by Subject|0|||
16288027|NCT02478320|39536371|FG000|Overall Study|Adverse Event|2|||
16288028|NCT02478320|39536372|FG001|Overall Study|Adverse Event|0|||
16288029|NCT02478320|39536371|FG000|Overall Study|Death|1|||
16288030|NCT02478320|39536372|FG001|Overall Study|Death|0|||
16288031|NCT02478320|39536371|FG000|Overall Study|Lack of Efficacy|4|||
16288032|NCT02478320|39536372|FG001|Overall Study|Lack of Efficacy|0|||
16288033|NCT02478320|39536371|FG000|Overall Study|Withdrawal by Subject|2|||
16288034|NCT02478320|39536372|FG001|Overall Study|Withdrawal by Subject|0|||
16288035|NCT02478320|39536371|FG000|Overall Study|Screen Failure|3|||
16288036|NCT02478320|39536372|FG001|Overall Study|Screen Failure|0|||
16288037|NCT01386684|39536373|FG000|Overall Study|Lost to Follow-up|51|||
16288038|NCT01386684|39536373|FG000|Overall Study|Other|51|||
16288039|NCT01386684|39536373|FG000|Overall Study|Death|47|||
16288040|NCT01386684|39536373|FG000|Overall Study|Withdrawal of Consent|44|||
16288041|NCT01386684|39536373|FG000|Overall Study|Alternative Therapy Required|37|||
16288042|NCT01386684|39536373|FG000|Overall Study|Disease Progression|28|||
16288043|NCT01386684|39536373|FG000|Overall Study|Adverse Event|20|||
16288044|NCT01386684|39536373|FG000|Overall Study|Noncompliance|8|||
16288045|NCT01386684|39536373|FG000|Overall Study|Protocol Violation|4|||
16288046|NCT01386684|39536373|FG000|Overall Study|Missing|3|||
16481595|NCT00347360|40242226|FG003|Overall Study|Abnormal lab values|0|||
16288047|NCT00857259|39536374|FG000|Overall Study|Protocol Violation|1|||
16288048|NCT00857259|39536375|FG001|Overall Study|Protocol Violation|0|||
16288049|NCT00857259|39536376|FG002|Overall Study|Protocol Violation|1|||
16288050|NCT03001219|39536377|FG000|Proof of Concept|Study Termination by Sponsor|0|||
16288051|NCT03001219|39536378|FG001|Proof of Concept|Study Termination by Sponsor|1|||
16288052|NCT03001219|39536377|FG000|Proof of Concept|Withdrawal by Subject|0|||
16288053|NCT03001219|39536378|FG001|Proof of Concept|Withdrawal by Subject|4|||
16288054|NCT03001219|39536377|FG000|Proof of Concept|Protocol Deviation|0|||
16288055|NCT03001219|39536378|FG001|Proof of Concept|Protocol Deviation|1|||
16288056|NCT03001219|39536377|FG000|Proof of Concept|Adverse Event|1|||
16288057|NCT03001219|39536378|FG001|Proof of Concept|Adverse Event|1|||
16288058|NCT03001219|39536377|FG000|Proof of Concept|Physician Decision|1|||
16288059|NCT03001219|39536378|FG001|Proof of Concept|Physician Decision|0|||
16288060|NCT03001219|39536377|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
16288061|NCT03001219|39536378|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
16288062|NCT03001219|39536377|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
16288063|NCT03001219|39536378|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
16288064|NCT03001219|39536377|FG000|Extension Period Analysis|Physician Decision|0|||
16288065|NCT03001219|39536378|FG001|Extension Period Analysis|Physician Decision|1|||
16288066|NCT03001219|39536377|FG000|Extension Period Analysis|Adverse Event|1|||
16288067|NCT03001219|39536378|FG001|Extension Period Analysis|Adverse Event|1|||
16288068|NCT03001219|39536377|FG000|Extension Period Analysis|Protocol Deviation|0|||
16288069|NCT03001219|39536378|FG001|Extension Period Analysis|Protocol Deviation|1|||
16288070|NCT03001219|39536377|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
16288071|NCT03001219|39536378|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
16288072|NCT02691741|39536379|FG000|Overall Study|Adverse Event|0|||
16288073|NCT02691741|39536380|FG001|Overall Study|Adverse Event|2|||
16288074|NCT02691741|39536379|FG000|Overall Study|Lost to Follow-up|1|||
16288075|NCT02691741|39536380|FG001|Overall Study|Lost to Follow-up|0|||
16288076|NCT02691741|39536379|FG000|Overall Study|Physician Decision|0|||
16288077|NCT02691741|39536380|FG001|Overall Study|Physician Decision|1|||
16288078|NCT02691741|39536379|FG000|Overall Study|Withdrawal by Subject|0|||
16288079|NCT02691741|39536380|FG001|Overall Study|Withdrawal by Subject|4|||
16288080|NCT01917968|39536381|FG000|Overall Study|Death|3|||
16288081|NCT01917968|39536382|FG001|Overall Study|Death|2|||
16288082|NCT01917968|39536381|FG000|Overall Study|Lost to Follow-up|21|||
16288083|NCT01917968|39536382|FG001|Overall Study|Lost to Follow-up|39|||
16288084|NCT01917968|39536381|FG000|Overall Study|Physician Decision|1|||
16288085|NCT01917968|39536382|FG001|Overall Study|Physician Decision|2|||
16288086|NCT01917968|39536381|FG000|Overall Study|Withdrawal by Subject|20|||
16288087|NCT01917968|39536382|FG001|Overall Study|Withdrawal by Subject|35|||
16288088|NCT01917968|39536381|FG000|Overall Study|Subject Relocation|5|||
16288089|NCT01917968|39536382|FG001|Overall Study|Subject Relocation|1|||
16288090|NCT01917968|39536381|FG000|Overall Study|36M Missed Visit|3|||
16288091|NCT01917968|39536382|FG001|Overall Study|36M Missed Visit|2|||
16288092|NCT01917968|39536381|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
16288093|NCT01917968|39536382|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
16288094|NCT01917968|39536381|FG000|Overall Study|Change in Family Circumstances|0|||
16288095|NCT01917968|39536382|FG001|Overall Study|Change in Family Circumstances|1|||
16288096|NCT01917968|39536381|FG000|Overall Study|No Data Available|0|||
16288097|NCT01917968|39536382|FG001|Overall Study|No Data Available|2|||
16288098|NCT01715896|39536383|FG000|Overall Study|Lost to Follow-up|0|||
16288099|NCT01715896|39536384|FG001|Overall Study|Lost to Follow-up|2|||
16288100|NCT01715896|39536383|FG000|Overall Study|Withdrawal by Subject|1|||
16288101|NCT01715896|39536384|FG001|Overall Study|Withdrawal by Subject|4|||
16288102|NCT01715896|39536383|FG000|Overall Study|Other|2|||
16288103|NCT01715896|39536384|FG001|Overall Study|Other|5|||
16288104|NCT04965389|39536385|FG000|Overall Study|Other reasons|1|||
16288105|NCT04965389|39536386|FG001|Overall Study|Other reasons|0|||
16288106|NCT04965389|39536387|FG002|Overall Study|Other reasons|0|||
16288107|NCT04965389|39536388|FG003|Overall Study|Other reasons|0|||
16288108|NCT04965389|39536385|FG000|Overall Study|Participant withdrew consent|0|||
16288109|NCT04965389|39536386|FG001|Overall Study|Participant withdrew consent|1|||
16288110|NCT04965389|39536387|FG002|Overall Study|Participant withdrew consent|0|||
16288111|NCT04965389|39536388|FG003|Overall Study|Participant withdrew consent|0|||
16288112|NCT04965389|39536385|FG000|Overall Study|Poor/Non-compliance|0|||
16288113|NCT04965389|39536386|FG001|Overall Study|Poor/Non-compliance|1|||
16288114|NCT04965389|39536387|FG002|Overall Study|Poor/Non-compliance|0|||
16288115|NCT04965389|39536388|FG003|Overall Study|Poor/Non-compliance|0|||
16288116|NCT03463993|39536389|FG000|Overall Study|Lost to Follow-up|7|||
16288117|NCT03463993|39536390|FG001|Overall Study|Lost to Follow-up|8|||
16288118|NCT03463993|39536389|FG000|Overall Study|Withdrawal by Subject|2|||
16288119|NCT03463993|39536390|FG001|Overall Study|Withdrawal by Subject|0|||
16288120|NCT03463993|39536389|FG000|Overall Study|Protocol Violation|4|||
16288121|NCT03463993|39536390|FG001|Overall Study|Protocol Violation|1|||
16288122|NCT03463993|39536389|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
16288123|NCT03463993|39536390|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
16288124|NCT03463993|39536389|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
16288125|NCT03463993|39536390|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
16288126|NCT04349631|39536391|FG000|Overall Study|Lost to Follow-up|3|||
16288127|NCT04349631|39536391|FG000|Overall Study|Withdrawal by Subject|7|||
16288128|NCT00912093|39536394|FG000|The Controlled Phase|Death|0|||
16288129|NCT00912093|39536395|FG001|The Controlled Phase|Death|1|||
16288130|NCT00912093|39536396|FG002|The Controlled Phase|Death|0|||
16288131|NCT00912093|39536397|FG003|The Controlled Phase|Death|0|||
16288132|NCT00912093|39536398|FG004|The Controlled Phase|Death|0|||
16288133|NCT00912093|39536394|FG000|The Controlled Phase|Medical Condition|0|||
16288134|NCT00912093|39536395|FG001|The Controlled Phase|Medical Condition|1|||
16288135|NCT00912093|39536396|FG002|The Controlled Phase|Medical Condition|0|||
16288136|NCT00912093|39536397|FG003|The Controlled Phase|Medical Condition|0|||
16288137|NCT00912093|39536398|FG004|The Controlled Phase|Medical Condition|0|||
16288138|NCT00912093|39536394|FG000|The Controlled Phase|Lost to Follow-up|0|||
16288139|NCT00912093|39536395|FG001|The Controlled Phase|Lost to Follow-up|0|||
16288140|NCT00912093|39536396|FG002|The Controlled Phase|Lost to Follow-up|0|||
16288141|NCT00912093|39536397|FG003|The Controlled Phase|Lost to Follow-up|0|||
16288142|NCT00912093|39536398|FG004|The Controlled Phase|Lost to Follow-up|1|||
16288143|NCT00251641|39536401|FG000|Overall Study|Adverse Event|80|||
16288144|NCT00251641|39536402|FG001|Overall Study|Adverse Event|8|||
16288145|NCT00251641|39536401|FG000|Overall Study|Lack of Efficacy|2|||
16288146|NCT00251641|39536402|FG001|Overall Study|Lack of Efficacy|1|||
16288147|NCT00251641|39536401|FG000|Overall Study|Progression of Disease|0|||
16288148|NCT00251641|39536402|FG001|Overall Study|Progression of Disease|2|||
16288149|NCT00251641|39536401|FG000|Overall Study|Lost to Follow-up|3|||
16288150|NCT00251641|39536402|FG001|Overall Study|Lost to Follow-up|3|||
16288151|NCT00251641|39536401|FG000|Overall Study|Withdrawal by Subject|6|||
16288152|NCT00251641|39536402|FG001|Overall Study|Withdrawal by Subject|8|||
16288153|NCT00251641|39536401|FG000|Overall Study|Protocol Violation|10|||
16288154|NCT00251641|39536402|FG001|Overall Study|Protocol Violation|2|||
16288155|NCT00251641|39536401|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
16288156|NCT00251641|39536402|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
16288157|NCT00251641|39536401|FG000|Overall Study|Switched Treatment|9|||
16288158|NCT00251641|39536402|FG001|Overall Study|Switched Treatment|63|||
16288159|NCT03341000|39536408|FG000|Overall Study|Adverse Event|1|||
16288160|NCT02916693|39536409|FG000|Overall Study|Lost to Follow-up|7|||
16288161|NCT01930175|39536411|FG000|Core Study|Lost to Follow-up|0|||
16288162|NCT01930175|39536412|FG001|Core Study|Lost to Follow-up|1|||
16288163|NCT01930175|39536413|FG002|Core Study|Lost to Follow-up|0|||
16288164|NCT01930175|39536411|FG000|Core Study|Adverse Event|0|||
16288165|NCT01930175|39536412|FG001|Core Study|Adverse Event|0|||
16288166|NCT01930175|39536413|FG002|Core Study|Adverse Event|1|||
16288167|NCT04039919|39540458|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16288168|NCT04039919|39540459|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16288169|NCT04039919|39540460|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16288170|NCT04039919|39540461|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16288171|NCT04039919|39540462|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16288172|NCT04039919|39540458|FG000|Treatment Period 1|Sponsor's decision|0|||
16288173|NCT04039919|39540459|FG001|Treatment Period 1|Sponsor's decision|0|||
16288174|NCT04039919|39540460|FG002|Treatment Period 1|Sponsor's decision|0|||
16288175|NCT04039919|39540461|FG003|Treatment Period 1|Sponsor's decision|0|||
16288176|NCT04039919|39540462|FG004|Treatment Period 1|Sponsor's decision|16|||
16288177|NCT04039919|39540458|FG000|Treatment Period 5|Withdrawal by Subject|1|||
16288178|NCT04039919|39540459|FG001|Treatment Period 5|Withdrawal by Subject|0|||
16288179|NCT04039919|39540460|FG002|Treatment Period 5|Withdrawal by Subject|0|||
16288180|NCT04039919|39540461|FG003|Treatment Period 5|Withdrawal by Subject|0|||
16288181|NCT04039919|39540462|FG004|Treatment Period 5|Withdrawal by Subject|0|||
16288182|NCT00904748|39540463|FG000|Overall Study|Withdrawal by Subject|1|||
16288183|NCT00904748|39540464|FG001|Overall Study|Withdrawal by Subject|1|||
16288184|NCT00904748|39540465|FG002|Overall Study|Withdrawal by Subject|1|||
16288185|NCT00904748|39540466|FG003|Overall Study|Withdrawal by Subject|2|||
16288186|NCT00904748|39540467|FG004|Overall Study|Withdrawal by Subject|0|||
16288187|NCT00904748|39540468|FG005|Overall Study|Withdrawal by Subject|0|||
16288188|NCT00904748|39540463|FG000|Overall Study|Adverse Event|0|||
16288189|NCT00904748|39540464|FG001|Overall Study|Adverse Event|0|||
16288190|NCT00904748|39540465|FG002|Overall Study|Adverse Event|0|||
16481596|NCT00347360|40242227|FG004|Overall Study|Abnormal lab values|0|||
16481597|NCT00347360|40242228|FG005|Overall Study|Abnormal lab values|0|||
16481598|NCT00347360|40242229|FG006|Overall Study|Abnormal lab values|1|||
16288191|NCT00904748|39540466|FG003|Overall Study|Adverse Event|0|||
16288192|NCT00904748|39540467|FG004|Overall Study|Adverse Event|1|||
16288193|NCT00904748|39540468|FG005|Overall Study|Adverse Event|0|||
16288194|NCT03285308|39540469|FG000|Overall Study|Adverse Event|3|||
16288195|NCT03285308|39540470|FG001|Overall Study|Adverse Event|7|||
16288196|NCT03285308|39540469|FG000|Overall Study|Withdrawal by Subject|8|||
16288197|NCT03285308|39540470|FG001|Overall Study|Withdrawal by Subject|9|||
16288198|NCT03285308|39540469|FG000|Overall Study|Lost to Follow-up|3|||
16288199|NCT03285308|39540470|FG001|Overall Study|Lost to Follow-up|1|||
16288200|NCT03285308|39540469|FG000|Overall Study|Protocol Deviation|6|||
16288201|NCT03285308|39540470|FG001|Overall Study|Protocol Deviation|5|||
16288202|NCT03285308|39540469|FG000|Overall Study|Reason not Specified|0|||
16288203|NCT03285308|39540470|FG001|Overall Study|Reason not Specified|1|||
16288204|NCT03656874|39540471|FG000|Overall Study|Lost to Follow-up|3|||
16288205|NCT03656874|39540472|FG001|Overall Study|Lost to Follow-up|17|||
16288206|NCT00673933|39540473|FG000|Overall Study|Withdrawal by Subject|2|||
16288207|NCT00673933|39540473|FG000|Overall Study|Lost to Follow-up|1|||
16288208|NCT00669071|39540474|FG000|Overall Study|Lost to Follow-up|3|||
16288209|NCT00669071|39540474|FG000|Overall Study|Final visit 40 days out of window|1|||
16288210|NCT05212883|39540475|FG000|Overall Study|Invalid test result|125|||
16288211|NCT03351231|39540476|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
16288212|NCT03351231|39540476|FG000|Combination Therapy Period|Disease progression|2|||
16288213|NCT03351231|39540476|FG000|Combination Therapy Period|Study drug toxicity|1|||
16288214|NCT03351231|39540476|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
16288215|NCT03351231|39540476|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
16288216|NCT03351231|39540476|FG000|Safety Follow-Up Period|Other reason|2|||
16288217|NCT00680186|39540477|FG000|Overall Study|Adverse Event|47|||
16288218|NCT00680186|39540478|FG001|Overall Study|Adverse Event|44|||
16288219|NCT00680186|39540477|FG000|Overall Study|Protocol Violation|31|||
16288220|NCT00680186|39540478|FG001|Overall Study|Protocol Violation|26|||
16288221|NCT00680186|39540477|FG000|Overall Study|Lost to Follow-up|11|||
16288222|NCT00680186|39540478|FG001|Overall Study|Lost to Follow-up|6|||
16288223|NCT00680186|39540477|FG000|Overall Study|Withdrawal by Subject|32|||
16288224|NCT00680186|39540478|FG001|Overall Study|Withdrawal by Subject|39|||
16288225|NCT00680186|39540477|FG000|Overall Study|Other|4|||
16288226|NCT00680186|39540478|FG001|Overall Study|Other|1|||
16288227|NCT01449279|39540479|FG000|Overall Study|Lack of Efficacy|5|||
16288228|NCT01449279|39540479|FG000|Overall Study|Toxicity|2|||
16288229|NCT01725282|39540487|FG000|Overall Study|Adverse Event|1|||
16288230|NCT01725282|39540488|FG001|Overall Study|Adverse Event|3|||
16288231|NCT01725282|39540489|FG002|Overall Study|Adverse Event|6|||
16288232|NCT01725282|39540490|FG003|Overall Study|Adverse Event|4|||
16288233|NCT01725282|39540487|FG000|Overall Study|Exacerbation of Target Disease|1|||
16288234|NCT01725282|39540488|FG001|Overall Study|Exacerbation of Target Disease|0|||
16288235|NCT01725282|39540489|FG002|Overall Study|Exacerbation of Target Disease|0|||
16288236|NCT01725282|39540490|FG003|Overall Study|Exacerbation of Target Disease|1|||
16288237|NCT01725282|39540487|FG000|Overall Study|Met Exclusion Criteria|0|||
16288238|NCT01725282|39540488|FG001|Overall Study|Met Exclusion Criteria|0|||
16288239|NCT01725282|39540489|FG002|Overall Study|Met Exclusion Criteria|1|||
16288240|NCT01725282|39540490|FG003|Overall Study|Met Exclusion Criteria|0|||
16288241|NCT01725282|39540487|FG000|Overall Study|Study Site Withdrawal|0|||
16288242|NCT01725282|39540488|FG001|Overall Study|Study Site Withdrawal|1|||
16288243|NCT01725282|39540489|FG002|Overall Study|Study Site Withdrawal|0|||
16288244|NCT01725282|39540490|FG003|Overall Study|Study Site Withdrawal|0|||
16288245|NCT01725282|39540487|FG000|Overall Study|Withdrawal by Subject|0|||
16288246|NCT01725282|39540488|FG001|Overall Study|Withdrawal by Subject|0|||
16288247|NCT01725282|39540489|FG002|Overall Study|Withdrawal by Subject|1|||
16288248|NCT01725282|39540490|FG003|Overall Study|Withdrawal by Subject|1|||
16288249|NCT01725282|39540487|FG000|Overall Study|Lack of Efficacy|0|||
16288250|NCT01725282|39540488|FG001|Overall Study|Lack of Efficacy|1|||
16288251|NCT01725282|39540489|FG002|Overall Study|Lack of Efficacy|0|||
16288252|NCT01725282|39540490|FG003|Overall Study|Lack of Efficacy|1|||
16288253|NCT00317642|39540492|FG000|Overall Study|Not Received Either Study Drug|1|||
16288254|NCT00317642|39540493|FG001|Overall Study|Not Received Either Study Drug|3|||
16288255|NCT00317642|39540492|FG000|Overall Study|Physician Decision|15|||
16288256|NCT00317642|39540493|FG001|Overall Study|Physician Decision|7|||
16288257|NCT00317642|39540492|FG000|Overall Study|Participant declined treatment|14|||
16288258|NCT00317642|39540493|FG001|Overall Study|Participant declined treatment|3|||
16288259|NCT00317642|39540492|FG000|Overall Study|Adverse Event|17|||
16288260|NCT00317642|39540493|FG001|Overall Study|Adverse Event|5|||
16288261|NCT00317642|39540492|FG000|Overall Study|Treatment Failure|56|||
16288262|NCT00317642|39540493|FG001|Overall Study|Treatment Failure|102|||
16379962|NCT01355627|39874852|FG000|Overall Study|Request By the Patient to Discontinue|5|||
16379963|NCT01355627|39874853|FG001|Overall Study|Request By the Patient to Discontinue|7|||
16379964|NCT01355627|39874852|FG000|Overall Study|Lost to Follow-up|8|||
16379965|NCT01355627|39874853|FG001|Overall Study|Lost to Follow-up|7|||
16379966|NCT01355627|39874852|FG000|Overall Study|Fatal Adverse Event|19|||
16379967|NCT01355627|39874853|FG001|Overall Study|Fatal Adverse Event|23|||
16379968|NCT01355627|39874852|FG000|Overall Study|Other|1|||
16379969|NCT01355627|39874853|FG001|Overall Study|Other|1|||
16379970|NCT00511199|39874854|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
16379971|NCT00511199|39874855|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
16080243|NCT01307267|38786788|FG007|Overall Study|Withdrawal by Subject|1|||
16288263|NCT00317642|39540492|FG000|Overall Study|Disease Recurrence|1|||
16288264|NCT00317642|39540493|FG001|Overall Study|Disease Recurrence|2|||
16288265|NCT00317642|39540492|FG000|Overall Study|Death|14|||
16288266|NCT00317642|39540493|FG001|Overall Study|Death|7|||
16379972|NCT00511199|39874854|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
16288267|NCT00317642|39540492|FG000|Overall Study|Not Continue to Consolidation|2|||
16288268|NCT00317642|39540493|FG001|Overall Study|Not Continue to Consolidation|0|||
16288269|NCT00317642|39540492|FG000|Overall Study|Withdrawal by Subject|0|||
16288270|NCT00317642|39540493|FG001|Overall Study|Withdrawal by Subject|1|||
16288271|NCT00317642|39540492|FG000|Overall Study|Referred For Transplantation|1|||
16080244|NCT01307267|38786789|FG008|Overall Study|Withdrawal by Subject|5|||
16080245|NCT01307267|38786790|FG009|Overall Study|Withdrawal by Subject|1|||
16288272|NCT00317642|39540493|FG001|Overall Study|Referred For Transplantation|0|||
16288273|NCT00317642|39540492|FG000|Overall Study|AML Not Centrally Confirmed|1|||
16288274|NCT00317642|39540493|FG001|Overall Study|AML Not Centrally Confirmed|5|||
16288275|NCT03512262|39540500|FG000|Overall Study|Adverse Event|8|||
16080246|NCT01307267|38786791|FG010|Overall Study|Withdrawal by Subject|1|||
16080247|NCT01307267|38786792|FG011|Overall Study|Withdrawal by Subject|1|||
16080248|NCT01307267|38786793|FG012|Overall Study|Withdrawal by Subject|0|||
16080249|NCT01307267|38786794|FG013|Overall Study|Withdrawal by Subject|0|||
16080250|NCT01307267|38786795|FG014|Overall Study|Withdrawal by Subject|0|||
16379973|NCT00511199|39874855|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
16379974|NCT00511199|39874854|FG000|Overall Study|Withdrawal of Informed Consent|19|||
16379975|NCT00511199|39874855|FG001|Overall Study|Withdrawal of Informed Consent|4|||
16379976|NCT00511199|39874854|FG000|Overall Study|Pregnancy|6|||
16288276|NCT03512262|39540501|FG001|Overall Study|Adverse Event|3|||
16288277|NCT03512262|39540500|FG000|Overall Study|Death (non-treatment emergent)|1|||
16288278|NCT03512262|39540501|FG001|Overall Study|Death (non-treatment emergent)|0|||
16288279|NCT03512262|39540500|FG000|Overall Study|Withdrawal by Subject|17|||
16288280|NCT03512262|39540501|FG001|Overall Study|Withdrawal by Subject|9|||
16288281|NCT03512262|39540500|FG000|Overall Study|Lost to Follow-up|7|||
16288282|NCT03512262|39540501|FG001|Overall Study|Lost to Follow-up|1|||
16288283|NCT03512262|39540500|FG000|Overall Study|Other than Specified|2|||
16288284|NCT03512262|39540501|FG001|Overall Study|Other than Specified|2|||
16288285|NCT00292188|39540502|FG000|Single-Blind|Adverse Event|14|||
16288286|NCT00292188|39540503|FG001|Single-Blind|Adverse Event|0|||
16288287|NCT00292188|39540504|FG002|Single-Blind|Adverse Event|0|||
16288288|NCT00292188|39540502|FG000|Single-Blind|Lack of Efficacy|2|||
16288289|NCT00292188|39540503|FG001|Single-Blind|Lack of Efficacy|0|||
16288290|NCT00292188|39540504|FG002|Single-Blind|Lack of Efficacy|0|||
16288291|NCT00292188|39540502|FG000|Single-Blind|Laboratory Abnormality|5|||
16288292|NCT00292188|39540503|FG001|Single-Blind|Laboratory Abnormality|0|||
16288293|NCT00292188|39540504|FG002|Single-Blind|Laboratory Abnormality|0|||
16288294|NCT00292188|39540502|FG000|Single-Blind|Lost to Follow-up|3|||
16288295|NCT00292188|39540503|FG001|Single-Blind|Lost to Follow-up|0|||
16288296|NCT00292188|39540504|FG002|Single-Blind|Lost to Follow-up|0|||
16288297|NCT00292188|39540502|FG000|Single-Blind|Other|77|||
16288298|NCT00292188|39540503|FG001|Single-Blind|Other|0|||
16288299|NCT00292188|39540504|FG002|Single-Blind|Other|0|||
16288300|NCT00292188|39540502|FG000|Single-Blind|Withdrawal by Subject|12|||
16288301|NCT00292188|39540503|FG001|Single-Blind|Withdrawal by Subject|0|||
16288302|NCT00292188|39540504|FG002|Single-Blind|Withdrawal by Subject|0|||
16288303|NCT00292188|39540502|FG000|Single-Blind|Did not receive treatment|1|||
16288304|NCT00292188|39540503|FG001|Single-Blind|Did not receive treatment|0|||
16288305|NCT00292188|39540504|FG002|Single-Blind|Did not receive treatment|0|||
16288306|NCT00292188|39540502|FG000|Double-Blind|Adverse Event|0|||
16288307|NCT00292188|39540503|FG001|Double-Blind|Adverse Event|25|||
16288308|NCT00292188|39540504|FG002|Double-Blind|Adverse Event|9|||
16288309|NCT00292188|39540502|FG000|Double-Blind|Lack of Efficacy|0|||
16379977|NCT00511199|39874855|FG001|Overall Study|Pregnancy|3|||
16379978|NCT00511199|39874854|FG000|Overall Study|Pregnancy Wish|16|||
16379979|NCT00511199|39874855|FG001|Overall Study|Pregnancy Wish|8|||
16379980|NCT00511199|39874854|FG000|Overall Study|Lost to Follow-up|40|||
16379981|NCT00511199|39874855|FG001|Overall Study|Lost to Follow-up|17|||
16379982|NCT00511199|39874854|FG000|Overall Study|Other Reason|78|||
16080251|NCT01307267|38786796|FG015|Overall Study|Withdrawal by Subject|0|||
16080252|NCT01307267|38786797|FG016|Overall Study|Withdrawal by Subject|0|||
16080253|NCT01307267|38786798|FG017|Overall Study|Withdrawal by Subject|0|||
16080254|NCT01307267|38786799|FG018|Overall Study|Withdrawal by Subject|0|||
16080255|NCT01307267|38786800|FG019|Overall Study|Withdrawal by Subject|3|||
16080256|NCT01307267|38786801|FG020|Overall Study|Withdrawal by Subject|0|||
16080257|NCT01307267|38786802|FG021|Overall Study|Withdrawal by Subject|0|||
16080258|NCT01307267|38786803|FG022|Overall Study|Withdrawal by Subject|0|||
16080259|NCT01307267|38786781|FG000|Overall Study|Other|0|||
16080260|NCT01307267|38786782|FG001|Overall Study|Other|0|||
16080261|NCT01307267|38786783|FG002|Overall Study|Other|0|||
16379983|NCT00511199|39874855|FG001|Overall Study|Other Reason|37|||
16379984|NCT00835354|39874856|FG000|First Intervention|Adverse Event|0|||
16481599|NCT00347360|40242230|FG007|Overall Study|Abnormal lab values|0|||
16080262|NCT01307267|38786784|FG003|Overall Study|Other|0|||
16288310|NCT00292188|39540503|FG001|Double-Blind|Lack of Efficacy|2|||
16288311|NCT00292188|39540504|FG002|Double-Blind|Lack of Efficacy|12|||
16288312|NCT00292188|39540502|FG000|Double-Blind|Lost to Follow-up|0|||
16288313|NCT00292188|39540503|FG001|Double-Blind|Lost to Follow-up|1|||
16288314|NCT00292188|39540504|FG002|Double-Blind|Lost to Follow-up|0|||
16288315|NCT00292188|39540502|FG000|Double-Blind|Other|0|||
16288316|NCT00292188|39540503|FG001|Double-Blind|Other|3|||
16288317|NCT00292188|39540504|FG002|Double-Blind|Other|4|||
16288318|NCT00292188|39540502|FG000|Double-Blind|Withdrawal by Subject|0|||
16080263|NCT01307267|38786785|FG004|Overall Study|Other|0|||
16080264|NCT01307267|38786786|FG005|Overall Study|Other|7|||
16080265|NCT01307267|38786787|FG006|Overall Study|Other|0|||
16080266|NCT01307267|38786788|FG007|Overall Study|Other|1|||
16080267|NCT01307267|38786789|FG008|Overall Study|Other|3|||
16080268|NCT01307267|38786790|FG009|Overall Study|Other|0|||
16080269|NCT01307267|38786791|FG010|Overall Study|Other|1|||
16080270|NCT01307267|38786792|FG011|Overall Study|Other|1|||
16080271|NCT01307267|38786793|FG012|Overall Study|Other|1|||
16080272|NCT01307267|38786794|FG013|Overall Study|Other|0|||
16080273|NCT01307267|38786795|FG014|Overall Study|Other|2|||
16080274|NCT01307267|38786796|FG015|Overall Study|Other|1|||
16080275|NCT01307267|38786797|FG016|Overall Study|Other|0|||
16080276|NCT01307267|38786798|FG017|Overall Study|Other|0|||
16080277|NCT01307267|38786799|FG018|Overall Study|Other|0|||
16080278|NCT01307267|38786800|FG019|Overall Study|Other|19|||
16080279|NCT01307267|38786801|FG020|Overall Study|Other|2|||
16080280|NCT01307267|38786802|FG021|Overall Study|Other|3|||
16481600|NCT00347360|40242231|FG008|Overall Study|Abnormal lab values|0|||
16481601|NCT00347360|40242232|FG009|Overall Study|Abnormal lab values|0|||
16481602|NCT00347360|40242233|FG010|Overall Study|Abnormal lab values|0|||
16481603|NCT00347360|40242234|FG011|Overall Study|Abnormal lab values|0|||
16481604|NCT00347360|40242235|FG012|Overall Study|Abnormal lab values|0|||
16481605|NCT00347360|40242236|FG013|Overall Study|Abnormal lab values|0|||
16481606|NCT00347360|40242237|FG014|Overall Study|Abnormal lab values|0|||
16481607|NCT00347360|40242223|FG000|Overall Study|PI recommended early withdrawal|0|||
16288319|NCT00292188|39540503|FG001|Double-Blind|Withdrawal by Subject|0|||
16288320|NCT00292188|39540504|FG002|Double-Blind|Withdrawal by Subject|3|||
16288321|NCT00292188|39540502|FG000|Double-Blind|Laboratory Abnormality|0|||
16481608|NCT00347360|40242224|FG001|Overall Study|PI recommended early withdrawal|0|||
16481609|NCT00347360|40242225|FG002|Overall Study|PI recommended early withdrawal|0|||
16481610|NCT00347360|40242226|FG003|Overall Study|PI recommended early withdrawal|0|||
16080281|NCT01307267|38786803|FG022|Overall Study|Other|2|||
16080282|NCT03036813|38786804|FG000|Overall Study|Adverse Event|6|||
16080283|NCT03036813|38786805|FG001|Overall Study|Adverse Event|11|||
16080284|NCT03036813|38786806|FG002|Overall Study|Adverse Event|6|||
16080285|NCT03036813|38786804|FG000|Overall Study|Withdrawal by Subject|12|||
16080286|NCT03036813|38786805|FG001|Overall Study|Withdrawal by Subject|6|||
16080287|NCT03036813|38786806|FG002|Overall Study|Withdrawal by Subject|10|||
16080288|NCT03036813|38786804|FG000|Overall Study|Lost to Follow-up|1|||
16080289|NCT03036813|38786805|FG001|Overall Study|Lost to Follow-up|1|||
16080290|NCT03036813|38786806|FG002|Overall Study|Lost to Follow-up|0|||
16080291|NCT03036813|38786804|FG000|Overall Study|Physician Decision|2|||
16080292|NCT03036813|38786805|FG001|Overall Study|Physician Decision|1|||
16288322|NCT00292188|39540503|FG001|Double-Blind|Laboratory Abnormality|0|||
16288323|NCT00292188|39540504|FG002|Double-Blind|Laboratory Abnormality|1|||
16288324|NCT03097588|39540505|FG000|Overall Study|Adverse Event|1|||
16288325|NCT01091103|39540506|FG000|Overall Study|Adverse Event|1|||
16288326|NCT01091103|39540506|FG000|Overall Study|Progressive Disease|3|||
16288327|NCT02516410|39540509|FG000|Overall Study|Adverse Event|0|||
16288328|NCT02516410|39540510|FG001|Overall Study|Adverse Event|1|||
16288329|NCT02516410|39540509|FG000|Overall Study|Withdrawal by Subject|0|||
16288330|NCT02516410|39540510|FG001|Overall Study|Withdrawal by Subject|1|||
16288331|NCT00103038|39540511|FG000|Overall Study|Withdrawal by Subject|8|||
16288332|NCT00103038|39540511|FG000|Overall Study|Screen failure|3|||
16288333|NCT00103038|39540511|FG000|Overall Study|Death|1|||
16288334|NCT00103038|39540511|FG000|Overall Study|Physician Decision|1|||
16288335|NCT01621191|39540514|FG000|Overall Study|Adverse Event|9|||
16288336|NCT01621191|39540514|FG000|Overall Study|Withdrawal by Subject|8|||
16288337|NCT01621191|39540514|FG000|Overall Study|Lack of Efficacy|6|||
16288338|NCT01621191|39540514|FG000|Overall Study|Lost to Follow-up|1|||
16288339|NCT01621191|39540514|FG000|Overall Study|Site Removed From Study|1|||
16288340|NCT02442271|39540517|FG000|Overall Study|Adverse Event|1|||
16288341|NCT02442271|39540517|FG000|Overall Study|Withdrew Consent|1|||
16288342|NCT02442271|39540517|FG000|Overall Study|Lost to Follow-up|1|||
16288343|NCT02442271|39540517|FG000|Overall Study|Other|1|||
16288344|NCT00986570|39540518|FG000|Overall Study|Lost to Follow-up|6|||
16481611|NCT00347360|40242227|FG004|Overall Study|PI recommended early withdrawal|0|||
16481612|NCT00347360|40242228|FG005|Overall Study|PI recommended early withdrawal|0|||
16481613|NCT00347360|40242229|FG006|Overall Study|PI recommended early withdrawal|0|||
16481614|NCT00347360|40242230|FG007|Overall Study|PI recommended early withdrawal|0|||
16080293|NCT03036813|38786806|FG002|Overall Study|Physician Decision|1|||
16080294|NCT03036813|38786804|FG000|Overall Study|Non-Compliance|1|||
16080295|NCT03036813|38786805|FG001|Overall Study|Non-Compliance|5|||
16080296|NCT03036813|38786806|FG002|Overall Study|Non-Compliance|3|||
16080297|NCT03036813|38786804|FG000|Overall Study|Pregnancy|0|||
16288345|NCT00986570|39540518|FG000|Overall Study|Potential bias for objective assessment|1|||
16288346|NCT05132569|39540526|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
16288347|NCT05132569|39540527|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
16288348|NCT05132569|39540526|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
16288349|NCT05132569|39540527|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
16288350|NCT05132569|39540526|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
16288351|NCT05132569|39540527|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
16288352|NCT00507546|39540528|FG000|Overall Study|Withdrawal by Subject|1|||
16288353|NCT00507546|39540529|FG001|Overall Study|Withdrawal by Subject|0|||
16288354|NCT00507546|39540528|FG000|Overall Study|Protocol Violation|1|||
16288355|NCT00507546|39540529|FG001|Overall Study|Protocol Violation|0|||
16288356|NCT00507546|39540528|FG000|Overall Study|Physician Decision|0|||
16288357|NCT00507546|39540529|FG001|Overall Study|Physician Decision|1|||
16288358|NCT00573157|39540535|FG000|Overall Study|Adverse Event|3|||
16288359|NCT00573157|39540536|FG001|Overall Study|Adverse Event|1|||
16288360|NCT00573157|39540535|FG000|Overall Study|Other|1|||
16080298|NCT03036813|38786805|FG001|Overall Study|Pregnancy|0|||
16080299|NCT03036813|38786806|FG002|Overall Study|Pregnancy|1|||
16080300|NCT03036813|38786804|FG000|Overall Study|Other|0|||
16080301|NCT03036813|38786805|FG001|Overall Study|Other|3|||
16080302|NCT03036813|38786806|FG002|Overall Study|Other|5|||
16080303|NCT00807144|38786807|FG000|Overall Study|Lost to Follow-up|0|||
16481615|NCT00347360|40242231|FG008|Overall Study|PI recommended early withdrawal|0|||
16080304|NCT00807144|38786808|FG001|Overall Study|Lost to Follow-up|1|||
16080305|NCT01771731|38786810|FG000|Overall Study|Physician Decision|1|||
16080306|NCT01771731|38786811|FG001|Overall Study|Physician Decision|0|||
16080307|NCT01771731|38786810|FG000|Overall Study|Protocol Violation|0|||
16080308|NCT01771731|38786811|FG001|Overall Study|Protocol Violation|1|||
16080309|NCT01771731|38786810|FG000|Overall Study|Adverse event: Pain Crisis|1|||
16080310|NCT01771731|38786811|FG001|Overall Study|Adverse event: Pain Crisis|1|||
16080311|NCT02318134|38786812|FG000|Overall Study|Withdrawal by Subject|2|||
16080312|NCT02318134|38786813|FG001|Overall Study|Withdrawal by Subject|1|||
16288361|NCT00573157|39540536|FG001|Overall Study|Other|1|||
16288362|NCT01370213|39540537|FG000|Overall Study|Early Death|1|||
16288363|NCT01370213|39540538|FG001|Overall Study|Early Death|0|||
16288364|NCT01370213|39540539|FG002|Overall Study|Early Death|0|||
16288365|NCT01370213|39540537|FG000|Overall Study|Not evaluable|0|||
16080313|NCT02724592|38786816|FG000|Overall Study|Lost to Follow-up|4|||
16080314|NCT02724592|38786817|FG001|Overall Study|Lost to Follow-up|1|||
16080315|NCT04191096|38786821|FG000|Overall Study|Death|102|||
16080316|NCT04191096|38786822|FG001|Overall Study|Death|89|||
16080317|NCT04191096|38786821|FG000|Overall Study|Lost to Follow-up|1|||
16080318|NCT04191096|38786822|FG001|Overall Study|Lost to Follow-up|1|||
16080319|NCT04191096|38786821|FG000|Overall Study|Withdrawal by Subject|5|||
16080320|NCT04191096|38786822|FG001|Overall Study|Withdrawal by Subject|5|||
16080321|NCT04191096|38786821|FG000|Overall Study|Participants Ongoing|518|||
16080322|NCT04191096|38786822|FG001|Overall Study|Participants Ongoing|530|||
16080323|NCT02814838|38786825|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
16080324|NCT02814838|38786826|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
16080325|NCT02814838|38786825|FG000|Overall Study|Consent withdrawal|1|||
16080326|NCT02814838|38786826|FG001|Overall Study|Consent withdrawal|1|||
16080327|NCT04956575|38786828|FG000|Overall Study|Death|1|||
16080328|NCT04956575|38786829|FG001|Overall Study|Death|0|||
16080329|NCT04956575|38786830|FG002|Overall Study|Death|0|||
16080330|NCT04956575|38786831|FG003|Overall Study|Death|0|||
16080331|NCT04956575|38786832|FG004|Overall Study|Death|0|||
16080332|NCT04956575|38786833|FG005|Overall Study|Death|0|||
16080333|NCT04956575|38786834|FG006|Overall Study|Death|0|||
16080334|NCT04956575|38786835|FG007|Overall Study|Death|1|||
16080335|NCT04956575|38786836|FG008|Overall Study|Death|0|||
16080336|NCT04956575|38786837|FG009|Overall Study|Death|1|||
16080337|NCT04956575|38786838|FG010|Overall Study|Death|0|||
16080338|NCT04956575|38786839|FG011|Overall Study|Death|0|||
16080339|NCT04956575|38786828|FG000|Overall Study|Lost to Follow-up|3|||
16080340|NCT04956575|38786829|FG001|Overall Study|Lost to Follow-up|4|||
16080341|NCT04956575|38786830|FG002|Overall Study|Lost to Follow-up|2|||
16080342|NCT04956575|38786831|FG003|Overall Study|Lost to Follow-up|3|||
16080343|NCT04956575|38786832|FG004|Overall Study|Lost to Follow-up|1|||
16080344|NCT04956575|38786833|FG005|Overall Study|Lost to Follow-up|10|||
16080345|NCT04956575|38786834|FG006|Overall Study|Lost to Follow-up|11|||
16080346|NCT04956575|38786835|FG007|Overall Study|Lost to Follow-up|7|||
16080347|NCT04956575|38786836|FG008|Overall Study|Lost to Follow-up|4|||
16080348|NCT04956575|38786837|FG009|Overall Study|Lost to Follow-up|2|||
16288366|NCT01370213|39540538|FG001|Overall Study|Not evaluable|2|||
16288367|NCT01370213|39540539|FG002|Overall Study|Not evaluable|0|||
16288368|NCT01045421|39540540|FG000|Phase 1|Progressive Disease|0|||
16080349|NCT04956575|38786838|FG010|Overall Study|Lost to Follow-up|3|||
16080350|NCT04956575|38786839|FG011|Overall Study|Lost to Follow-up|8|||
16080351|NCT04956575|38786828|FG000|Overall Study|Withdrawal by Subject|1|||
16080352|NCT04956575|38786829|FG001|Overall Study|Withdrawal by Subject|2|||
16080353|NCT04956575|38786830|FG002|Overall Study|Withdrawal by Subject|1|||
16080354|NCT04956575|38786831|FG003|Overall Study|Withdrawal by Subject|4|||
16080355|NCT04956575|38786832|FG004|Overall Study|Withdrawal by Subject|2|||
16288369|NCT01045421|39540541|FG001|Phase 1|Progressive Disease|0|||
16288370|NCT01045421|39540542|FG002|Phase 1|Progressive Disease|0|||
16288371|NCT01045421|39540543|FG003|Phase 1|Progressive Disease|0|||
16288372|NCT01045421|39540544|FG004|Phase 1|Progressive Disease|1|||
16288373|NCT01045421|39540545|FG005|Phase 1|Progressive Disease|0|||
16288374|NCT01045421|39540546|FG006|Phase 1|Progressive Disease|0|||
16288375|NCT01045421|39540547|FG007|Phase 1|Progressive Disease|0|||
16288376|NCT01045421|39540548|FG008|Phase 1|Progressive Disease|0|||
16288377|NCT01045421|39540549|FG009|Phase 1|Progressive Disease|0|||
16288378|NCT01045421|39540550|FG010|Phase 1|Progressive Disease|0|||
16288379|NCT01045421|39540540|FG000|Phase 1|Withdrawal by Subject|0|||
16288380|NCT01045421|39540541|FG001|Phase 1|Withdrawal by Subject|0|||
16288381|NCT01045421|39540542|FG002|Phase 1|Withdrawal by Subject|0|||
16288382|NCT01045421|39540543|FG003|Phase 1|Withdrawal by Subject|1|||
16288383|NCT01045421|39540544|FG004|Phase 1|Withdrawal by Subject|0|||
16288384|NCT01045421|39540545|FG005|Phase 1|Withdrawal by Subject|0|||
16288385|NCT01045421|39540546|FG006|Phase 1|Withdrawal by Subject|0|||
16080356|NCT04956575|38786833|FG005|Overall Study|Withdrawal by Subject|8|||
16080357|NCT04956575|38786834|FG006|Overall Study|Withdrawal by Subject|5|||
16080358|NCT04956575|38786835|FG007|Overall Study|Withdrawal by Subject|1|||
16080359|NCT04956575|38786836|FG008|Overall Study|Withdrawal by Subject|1|||
16080360|NCT04956575|38786837|FG009|Overall Study|Withdrawal by Subject|0|||
16080361|NCT04956575|38786838|FG010|Overall Study|Withdrawal by Subject|3|||
16080362|NCT04956575|38786839|FG011|Overall Study|Withdrawal by Subject|1|||
16080363|NCT01943916|38786840|FG000|Overall Study|Technically invalid images|10|||
16080364|NCT01943916|38786840|FG000|Overall Study|Enrollment Failure|23|||
16080365|NCT01943916|38786840|FG000|Overall Study|Pilot Phase exclusion|100|||
16080366|NCT01943916|38786840|FG000|Overall Study|Quality Assurance Reader Fail|130|||
16288386|NCT01045421|39540547|FG007|Phase 1|Withdrawal by Subject|0|||
16481616|NCT00347360|40242232|FG009|Overall Study|PI recommended early withdrawal|1|||
16481617|NCT00347360|40242233|FG010|Overall Study|PI recommended early withdrawal|0|||
16481618|NCT00347360|40242234|FG011|Overall Study|PI recommended early withdrawal|0|||
16481619|NCT00347360|40242235|FG012|Overall Study|PI recommended early withdrawal|0|||
16481620|NCT00347360|40242236|FG013|Overall Study|PI recommended early withdrawal|0|||
16481621|NCT00347360|40242237|FG014|Overall Study|PI recommended early withdrawal|0|||
16481622|NCT00347360|40242223|FG000|Overall Study|Did not meet criteria before ABPM|0|||
16481623|NCT00347360|40242224|FG001|Overall Study|Did not meet criteria before ABPM|0|||
16481624|NCT00347360|40242225|FG002|Overall Study|Did not meet criteria before ABPM|0|||
16481625|NCT00347360|40242226|FG003|Overall Study|Did not meet criteria before ABPM|0|||
16481626|NCT00347360|40242227|FG004|Overall Study|Did not meet criteria before ABPM|0|||
16481627|NCT00347360|40242228|FG005|Overall Study|Did not meet criteria before ABPM|0|||
16481628|NCT00347360|40242229|FG006|Overall Study|Did not meet criteria before ABPM|0|||
16481629|NCT00347360|40242230|FG007|Overall Study|Did not meet criteria before ABPM|0|||
16481630|NCT00347360|40242231|FG008|Overall Study|Did not meet criteria before ABPM|0|||
16481631|NCT00347360|40242232|FG009|Overall Study|Did not meet criteria before ABPM|0|||
16481632|NCT00347360|40242233|FG010|Overall Study|Did not meet criteria before ABPM|1|||
16481633|NCT00347360|40242234|FG011|Overall Study|Did not meet criteria before ABPM|0|||
16481634|NCT00347360|40242235|FG012|Overall Study|Did not meet criteria before ABPM|0|||
16481635|NCT00347360|40242236|FG013|Overall Study|Did not meet criteria before ABPM|0|||
16481636|NCT00347360|40242237|FG014|Overall Study|Did not meet criteria before ABPM|0|||
16481637|NCT00347360|40242223|FG000|Overall Study|Randomized in error|0|||
16481638|NCT00347360|40242224|FG001|Overall Study|Randomized in error|0|||
16481639|NCT00347360|40242225|FG002|Overall Study|Randomized in error|0|||
16481640|NCT00347360|40242226|FG003|Overall Study|Randomized in error|0|||
16481641|NCT00347360|40242227|FG004|Overall Study|Randomized in error|0|||
16481642|NCT00347360|40242228|FG005|Overall Study|Randomized in error|0|||
16481643|NCT00347360|40242229|FG006|Overall Study|Randomized in error|0|||
16288387|NCT01045421|39540548|FG008|Phase 1|Withdrawal by Subject|0|||
16288388|NCT01045421|39540549|FG009|Phase 1|Withdrawal by Subject|0|||
16288389|NCT01045421|39540550|FG010|Phase 1|Withdrawal by Subject|0|||
16288390|NCT01045421|39540540|FG000|Phase 2|Progressive Disease|0|||
16288391|NCT01045421|39540541|FG001|Phase 2|Progressive Disease|0|||
16288392|NCT01045421|39540542|FG002|Phase 2|Progressive Disease|0|||
16288393|NCT01045421|39540543|FG003|Phase 2|Progressive Disease|0|||
16288394|NCT01045421|39540544|FG004|Phase 2|Progressive Disease|0|||
16288395|NCT01045421|39540545|FG005|Phase 2|Progressive Disease|0|||
16481644|NCT00347360|40242230|FG007|Overall Study|Randomized in error|0|||
16481645|NCT00347360|40242231|FG008|Overall Study|Randomized in error|0|||
16481646|NCT00347360|40242232|FG009|Overall Study|Randomized in error|0|||
16481647|NCT00347360|40242233|FG010|Overall Study|Randomized in error|0|||
16481648|NCT00347360|40242234|FG011|Overall Study|Randomized in error|1|||
16481649|NCT00347360|40242235|FG012|Overall Study|Randomized in error|0|||
16481650|NCT00347360|40242236|FG013|Overall Study|Randomized in error|0|||
16288396|NCT01045421|39540546|FG006|Phase 2|Progressive Disease|0|||
16288397|NCT01045421|39540547|FG007|Phase 2|Progressive Disease|1|||
16288398|NCT01045421|39540548|FG008|Phase 2|Progressive Disease|1|||
16288399|NCT01045421|39540549|FG009|Phase 2|Progressive Disease|1|||
16288400|NCT01045421|39540550|FG010|Phase 2|Progressive Disease|1|||
16481651|NCT00347360|40242237|FG014|Overall Study|Randomized in error|0|||
16288401|NCT01045421|39540540|FG000|Phase 2|Death|0|||
16288402|NCT01045421|39540541|FG001|Phase 2|Death|0|||
16288403|NCT01045421|39540542|FG002|Phase 2|Death|0|||
16288404|NCT01045421|39540543|FG003|Phase 2|Death|0|||
16288405|NCT01045421|39540544|FG004|Phase 2|Death|0|||
16288406|NCT01045421|39540545|FG005|Phase 2|Death|0|||
16288407|NCT01045421|39540546|FG006|Phase 2|Death|0|||
16288408|NCT01045421|39540547|FG007|Phase 2|Death|1|||
16288409|NCT01045421|39540548|FG008|Phase 2|Death|1|||
16288410|NCT01045421|39540549|FG009|Phase 2|Death|2|||
16288411|NCT01045421|39540550|FG010|Phase 2|Death|0|||
16288412|NCT01045421|39540540|FG000|Phase 2|Other|0|||
16288413|NCT01045421|39540541|FG001|Phase 2|Other|0|||
16481652|NCT00347360|40242223|FG000|Overall Study|Failed inclusion criteria #4|0|||
16481653|NCT00347360|40242224|FG001|Overall Study|Failed inclusion criteria #4|0|||
16481654|NCT00347360|40242225|FG002|Overall Study|Failed inclusion criteria #4|0|||
16481655|NCT00347360|40242226|FG003|Overall Study|Failed inclusion criteria #4|0|||
16481656|NCT00347360|40242227|FG004|Overall Study|Failed inclusion criteria #4|0|||
16481657|NCT00347360|40242228|FG005|Overall Study|Failed inclusion criteria #4|0|||
16481658|NCT00347360|40242229|FG006|Overall Study|Failed inclusion criteria #4|0|||
16481659|NCT00347360|40242230|FG007|Overall Study|Failed inclusion criteria #4|0|||
16481660|NCT00347360|40242231|FG008|Overall Study|Failed inclusion criteria #4|0|||
16481661|NCT00347360|40242232|FG009|Overall Study|Failed inclusion criteria #4|0|||
16481662|NCT00347360|40242233|FG010|Overall Study|Failed inclusion criteria #4|0|||
16481663|NCT00347360|40242234|FG011|Overall Study|Failed inclusion criteria #4|1|||
16481664|NCT00347360|40242235|FG012|Overall Study|Failed inclusion criteria #4|0|||
16481665|NCT00347360|40242236|FG013|Overall Study|Failed inclusion criteria #4|0|||
16288414|NCT01045421|39540542|FG002|Phase 2|Other|0|||
16288415|NCT01045421|39540543|FG003|Phase 2|Other|0|||
16288416|NCT01045421|39540544|FG004|Phase 2|Other|0|||
16288417|NCT01045421|39540545|FG005|Phase 2|Other|0|||
16288418|NCT01045421|39540546|FG006|Phase 2|Other|0|||
16288419|NCT01045421|39540547|FG007|Phase 2|Other|3|||
16288420|NCT01045421|39540548|FG008|Phase 2|Other|0|||
16288421|NCT01045421|39540549|FG009|Phase 2|Other|0|||
16288422|NCT01045421|39540550|FG010|Phase 2|Other|1|||
16288423|NCT03118570|39540551|FG000|Overall Study|Adverse Event|2|||
16288424|NCT03118570|39540552|FG001|Overall Study|Adverse Event|0|||
16288425|NCT03118570|39540553|FG002|Overall Study|Adverse Event|0|||
16288426|NCT03118570|39540554|FG003|Overall Study|Adverse Event|0|||
16288427|NCT03118570|39540555|FG004|Overall Study|Adverse Event|3|||
16288428|NCT03118570|39540551|FG000|Overall Study|Withdrawal by Subject|0|||
16288429|NCT03118570|39540552|FG001|Overall Study|Withdrawal by Subject|1|||
16288430|NCT03118570|39540553|FG002|Overall Study|Withdrawal by Subject|4|||
16288431|NCT03118570|39540554|FG003|Overall Study|Withdrawal by Subject|0|||
16288432|NCT03118570|39540555|FG004|Overall Study|Withdrawal by Subject|1|||
16288433|NCT03118570|39540551|FG000|Overall Study|Lost to Follow-up|2|||
16288434|NCT03118570|39540552|FG001|Overall Study|Lost to Follow-up|3|||
16288435|NCT03118570|39540553|FG002|Overall Study|Lost to Follow-up|1|||
16288436|NCT03118570|39540554|FG003|Overall Study|Lost to Follow-up|0|||
16288437|NCT03118570|39540555|FG004|Overall Study|Lost to Follow-up|1|||
16288438|NCT03118570|39540551|FG000|Overall Study|Other, Not Specified|1|||
16288439|NCT03118570|39540552|FG001|Overall Study|Other, Not Specified|3|||
16288440|NCT03118570|39540553|FG002|Overall Study|Other, Not Specified|0|||
16288441|NCT03118570|39540554|FG003|Overall Study|Other, Not Specified|0|||
16288442|NCT03118570|39540555|FG004|Overall Study|Other, Not Specified|0|||
16288443|NCT01277718|39540558|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
16288444|NCT01277718|39540559|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
16288445|NCT01277718|39540558|FG000|Period 2 - Second Intervention|Physician Decision|0|||
16288446|NCT01277718|39540559|FG001|Period 2 - Second Intervention|Physician Decision|2|||
16288447|NCT02370914|39540560|FG000|Overall Study|Protocol Violation|2|||
16288448|NCT04718194|39540561|FG000|Overall Study|Withdrawal by Subject|3|||
16288449|NCT04718194|39540562|FG001|Overall Study|Withdrawal by Subject|0|||
16288450|NCT04718194|39540561|FG000|Overall Study|Lost to Follow-up|3|||
16288451|NCT04718194|39540562|FG001|Overall Study|Lost to Follow-up|0|||
16288452|NCT01859130|39540563|FG000|Overall Study|Death|4|||
16288453|NCT01859130|39540563|FG000|Overall Study|Lost to Follow-up|16|||
16481666|NCT00347360|40242237|FG014|Overall Study|Failed inclusion criteria #4|0|||
16288454|NCT01859130|39540563|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
16288455|NCT01859130|39540563|FG000|Overall Study|Physician Decision|6|||
16288456|NCT01859130|39540563|FG000|Overall Study|Withdrawal by Subject|17|||
16288457|NCT01859130|39540563|FG000|Overall Study|Adverse Event|11|||
16288458|NCT00350402|39540564|FG000|Overall Study|Lost to Follow-up|1|||
16288459|NCT00350402|39540565|FG001|Overall Study|Lost to Follow-up|1|||
16288460|NCT01045993|39540570|FG000|Overall Study|Treated-later found eligibility not met|0|||
16288461|NCT01045993|39540571|FG001|Overall Study|Treated-later found eligibility not met|1|||
16288462|NCT01045993|39540572|FG002|Overall Study|Treated-later found eligibility not met|0|||
16481667|NCT00347360|40242223|FG000|Overall Study|Prolonged duration between visits|0|||
16288463|NCT01045993|39540573|FG003|Overall Study|Treated-later found eligibility not met|0|||
16288464|NCT00499174|39540574|FG000|Overall Study|Physician Decision|78|||
16288465|NCT00499174|39540575|FG001|Overall Study|Physician Decision|9|||
16481668|NCT00347360|40242224|FG001|Overall Study|Prolonged duration between visits|0|||
16481669|NCT00347360|40242225|FG002|Overall Study|Prolonged duration between visits|0|||
16481670|NCT00347360|40242226|FG003|Overall Study|Prolonged duration between visits|0|||
16481671|NCT00347360|40242227|FG004|Overall Study|Prolonged duration between visits|0|||
16481672|NCT00347360|40242228|FG005|Overall Study|Prolonged duration between visits|0|||
16481673|NCT00347360|40242229|FG006|Overall Study|Prolonged duration between visits|0|||
16481674|NCT00347360|40242230|FG007|Overall Study|Prolonged duration between visits|0|||
16481675|NCT00347360|40242231|FG008|Overall Study|Prolonged duration between visits|0|||
16185478|NCT01544595|39159240|FG000|Status at Week 156|Technical problems|3|||
16185479|NCT01544595|39159241|FG001|Status at Week 156|Technical problems|1|||
16185480|NCT01544595|39159242|FG002|Status at Week 156|Technical problems|0|||
16185481|NCT01544595|39159243|FG003|Status at Week 156|Technical problems|1|||
16185482|NCT01544595|39159244|FG004|Status at Week 156|Technical problems|0|||
16185483|NCT01544595|39159245|FG005|Status at Week 156|Technical problems|0|||
16185484|NCT01544595|39159240|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
16185485|NCT01544595|39159241|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
16185486|NCT01544595|39159242|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
16185487|NCT01544595|39159243|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
16185488|NCT01544595|39159244|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
16185489|NCT01544595|39159245|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
16185490|NCT01544595|39159240|FG000|Status at Week 156|Lack of Efficacy|1|||
16185491|NCT01544595|39159241|FG001|Status at Week 156|Lack of Efficacy|0|||
16185492|NCT01544595|39159242|FG002|Status at Week 156|Lack of Efficacy|1|||
16185493|NCT01544595|39159243|FG003|Status at Week 156|Lack of Efficacy|4|||
16185494|NCT01544595|39159244|FG004|Status at Week 156|Lack of Efficacy|10|||
16185495|NCT01544595|39159245|FG005|Status at Week 156|Lack of Efficacy|5|||
16185496|NCT01597193|39159246|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
16185497|NCT01597193|39159247|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
16185498|NCT01597193|39159248|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
16185499|NCT01597193|39159249|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
16185500|NCT01597193|39159250|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
16185501|NCT01597193|39159251|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
16185502|NCT01597193|39159252|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
16185503|NCT01597193|39159246|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
16185504|NCT01597193|39159247|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
16185505|NCT01597193|39159248|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
16185506|NCT01597193|39159249|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
16185507|NCT01597193|39159250|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
16185508|NCT01597193|39159251|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
16185509|NCT01597193|39159252|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
16185510|NCT01597193|39159246|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
16185511|NCT01597193|39159247|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
16185512|NCT01597193|39159248|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
16185513|NCT01597193|39159249|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
16185514|NCT01597193|39159250|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
16185515|NCT01597193|39159251|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
16185516|NCT01597193|39159252|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
16185517|NCT01597193|39159246|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16185518|NCT01597193|39159247|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16185519|NCT01597193|39159248|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16185520|NCT01597193|39159249|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16185521|NCT01597193|39159250|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16185522|NCT01597193|39159251|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
16185523|NCT01597193|39159252|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
16185524|NCT01597193|39159246|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
16185525|NCT01597193|39159247|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
16185526|NCT01597193|39159248|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
16288466|NCT00073021|39540579|FG000|Overall Study|Protocol Violation|2|||
16288467|NCT00073021|39540580|FG001|Overall Study|Protocol Violation|1|||
16288468|NCT00073021|39540579|FG000|Overall Study|Adverse Event|4|||
16288469|NCT00073021|39540580|FG001|Overall Study|Adverse Event|4|||
16481676|NCT00347360|40242232|FG009|Overall Study|Prolonged duration between visits|0|||
16481677|NCT00347360|40242233|FG010|Overall Study|Prolonged duration between visits|0|||
16185527|NCT01597193|39159249|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
16185528|NCT01597193|39159250|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
16185529|NCT01597193|39159251|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
16185530|NCT01597193|39159252|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
16185531|NCT02100657|39159253|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
16185532|NCT02100657|39159254|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
16185533|NCT02100657|39159255|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
16185534|NCT02100657|39159253|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
16185535|NCT02100657|39159254|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
16185536|NCT02100657|39159255|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
16185537|NCT02100657|39159253|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
16185538|NCT02100657|39159254|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
16185539|NCT02100657|39159255|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
16185540|NCT02100657|39159253|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
16185541|NCT02100657|39159254|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
16185542|NCT02100657|39159255|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
16185543|NCT02100657|39159253|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
16185544|NCT02100657|39159254|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
16185545|NCT02100657|39159255|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
16185546|NCT02100657|39159253|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
16185547|NCT02100657|39159254|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
16185548|NCT02100657|39159255|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
16185549|NCT02100657|39159253|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
16185550|NCT02100657|39159254|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
16185551|NCT02100657|39159255|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
16185552|NCT02100657|39159253|FG000|Cohort 3: Dose Level 3|Death|0|||
16185553|NCT02100657|39159254|FG001|Cohort 3: Dose Level 3|Death|0|||
16185554|NCT02100657|39159255|FG002|Cohort 3: Dose Level 3|Death|1|||
16185555|NCT02100657|39159253|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
16185556|NCT02100657|39159254|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
16185557|NCT02100657|39159255|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
16185558|NCT02100657|39159253|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
16185559|NCT02100657|39159254|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
16185560|NCT02100657|39159255|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
16185561|NCT02100657|39159253|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
16185562|NCT02100657|39159254|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
16185563|NCT02100657|39159255|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
16185564|NCT02100657|39159253|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
16185565|NCT02100657|39159254|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
16185566|NCT02100657|39159255|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
16185567|NCT02100657|39159253|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
16185568|NCT02100657|39159254|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
16185569|NCT02100657|39159255|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
16185570|NCT00573131|39159262|FG000|Overall Study|Withdrawal by Subject|10|||
16185571|NCT00573131|39159263|FG001|Overall Study|Withdrawal by Subject|8|||
16185572|NCT03366844|39159273|FG000|Overall Study|Physician Decision|1|||
16185573|NCT03366844|39159273|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
16185574|NCT00101192|39159274|FG000|Overall Study|Ineligible|6|||
16185575|NCT00101192|39159274|FG000|Overall Study|Inevaluable|1|||
16185576|NCT02117050|39159281|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
16185577|NCT03704051|39159282|FG000|Overall Study|Withdrawal by Subject|4|||
16185578|NCT03704051|39159283|FG001|Overall Study|Withdrawal by Subject|0|||
16185579|NCT02691247|39159284|FG000|Overall Study|Withdrawal by Subject|1|||
16185580|NCT02691247|39159285|FG001|Overall Study|Withdrawal by Subject|2|||
16185581|NCT02691247|39159286|FG002|Overall Study|Withdrawal by Subject|2|||
16185582|NCT02691247|39159284|FG000|Overall Study|Lost to Follow-up|2|||
16185583|NCT02691247|39159285|FG001|Overall Study|Lost to Follow-up|0|||
16185584|NCT02691247|39159286|FG002|Overall Study|Lost to Follow-up|1|||
16185585|NCT04705597|39159287|FG000|Overall Study|Death|16|||
16185586|NCT04705597|39159288|FG001|Overall Study|Death|9|||
16288470|NCT00073021|39540579|FG000|Overall Study|Withdrawal by Subject|6|||
16288471|NCT00073021|39540580|FG001|Overall Study|Withdrawal by Subject|5|||
16288472|NCT00073021|39540579|FG000|Overall Study|Physician Decision|3|||
16288473|NCT00073021|39540580|FG001|Overall Study|Physician Decision|1|||
16288474|NCT00073021|39540579|FG000|Overall Study|Lack of Efficacy|11|||
16288475|NCT00073021|39540580|FG001|Overall Study|Lack of Efficacy|5|||
16185587|NCT04705597|39159287|FG000|Overall Study|Lost to Follow-up|1|||
16185588|NCT04705597|39159288|FG001|Overall Study|Lost to Follow-up|0|||
16185589|NCT04705597|39159287|FG000|Overall Study|Withdrawal by Subject|1|||
16185590|NCT04705597|39159288|FG001|Overall Study|Withdrawal by Subject|2|||
16185591|NCT01215734|39159289|FG000|Overall Study|Death|0|||
16185592|NCT01215734|39159290|FG001|Overall Study|Death|1|||
16185593|NCT02416908|39159291|FG000|Dose Escalation Phase|Adverse Event|0|||
16288476|NCT02025751|39540581|FG000|Overall Study|Lost to Follow-up|1|||
16288477|NCT02025751|39540582|FG001|Overall Study|Lost to Follow-up|0|||
16481678|NCT00347360|40242234|FG011|Overall Study|Prolonged duration between visits|0|||
16185594|NCT02416908|39159292|FG001|Dose Escalation Phase|Adverse Event|0|||
16185595|NCT02416908|39159293|FG002|Dose Escalation Phase|Adverse Event|3|||
16185596|NCT02416908|39159294|FG003|Dose Escalation Phase|Adverse Event|0|||
16185597|NCT02416908|39159291|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
16185598|NCT02416908|39159292|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
16185599|NCT02416908|39159293|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
16185600|NCT02416908|39159294|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16185601|NCT00844428|39159296|FG000|Screening Period|Screen Failure|3|||
16481679|NCT00347360|40242235|FG012|Overall Study|Prolonged duration between visits|1|||
16481680|NCT00347360|40242236|FG013|Overall Study|Prolonged duration between visits|0|||
16481681|NCT00347360|40242237|FG014|Overall Study|Prolonged duration between visits|0|||
16481682|NCT00347360|40242223|FG000|Overall Study|Subject left town, ran out of study drug|0|||
16481683|NCT00347360|40242224|FG001|Overall Study|Subject left town, ran out of study drug|0|||
16481684|NCT00347360|40242225|FG002|Overall Study|Subject left town, ran out of study drug|0|||
16481685|NCT00347360|40242226|FG003|Overall Study|Subject left town, ran out of study drug|0|||
16481686|NCT00347360|40242227|FG004|Overall Study|Subject left town, ran out of study drug|0|||
16481687|NCT00347360|40242228|FG005|Overall Study|Subject left town, ran out of study drug|0|||
16481688|NCT00347360|40242229|FG006|Overall Study|Subject left town, ran out of study drug|0|||
16481689|NCT00347360|40242230|FG007|Overall Study|Subject left town, ran out of study drug|0|||
16481690|NCT00347360|40242231|FG008|Overall Study|Subject left town, ran out of study drug|0|||
16481691|NCT00347360|40242232|FG009|Overall Study|Subject left town, ran out of study drug|0|||
16481692|NCT00347360|40242233|FG010|Overall Study|Subject left town, ran out of study drug|0|||
16481693|NCT00347360|40242234|FG011|Overall Study|Subject left town, ran out of study drug|0|||
16185602|NCT00844428|39159296|FG000|Extension Treatment Period|Death|1|||
16185603|NCT00844428|39159296|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
16185604|NCT00634543|39159297|FG000|Overall Study|Other|1|||
16185605|NCT00634543|39159298|FG001|Overall Study|Other|2|||
16185606|NCT00634543|39159297|FG000|Overall Study|Protocol Violation|3|||
16185607|NCT00634543|39159298|FG001|Overall Study|Protocol Violation|3|||
16185608|NCT00634543|39159297|FG000|Overall Study|Adverse Event|11|||
16185609|NCT00634543|39159298|FG001|Overall Study|Adverse Event|11|||
16185610|NCT00634543|39159297|FG000|Overall Study|Withdrawal by Subject|4|||
16185611|NCT00634543|39159298|FG001|Overall Study|Withdrawal by Subject|4|||
16185612|NCT00634543|39159297|FG000|Overall Study|Lost to Follow-up|0|||
16185613|NCT00634543|39159298|FG001|Overall Study|Lost to Follow-up|1|||
16185614|NCT01465178|39159299|FG000|Overall Study|Withdrawal by Subject|1|||
16185615|NCT01465178|39159300|FG001|Overall Study|Withdrawal by Subject|0|||
16185616|NCT01873742|39159301|FG000|Overall Study|Lost to Follow-up|68|||
16185617|NCT01873742|39159302|FG001|Overall Study|Lost to Follow-up|76|||
16185618|NCT00401973|39159303|FG000|Overall Study|Adverse Event|2|||
16185619|NCT00401973|39159304|FG001|Overall Study|Adverse Event|8|||
16185620|NCT00401973|39159305|FG002|Overall Study|Adverse Event|4|||
16185621|NCT00401973|39159303|FG000|Overall Study|Clinical Relapse|0|||
16185622|NCT00401973|39159304|FG001|Overall Study|Clinical Relapse|1|||
16185623|NCT00401973|39159305|FG002|Overall Study|Clinical Relapse|1|||
16185624|NCT00401973|39159303|FG000|Overall Study|Lack of Efficacy|0|||
16185625|NCT00401973|39159304|FG001|Overall Study|Lack of Efficacy|0|||
16185626|NCT00401973|39159305|FG002|Overall Study|Lack of Efficacy|3|||
16185627|NCT00401973|39159303|FG000|Overall Study|Lost to Follow-up|2|||
16185628|NCT00401973|39159304|FG001|Overall Study|Lost to Follow-up|2|||
16185629|NCT00401973|39159305|FG002|Overall Study|Lost to Follow-up|2|||
16185630|NCT00401973|39159303|FG000|Overall Study|Physician Decision|2|||
16185631|NCT00401973|39159304|FG001|Overall Study|Physician Decision|0|||
16185632|NCT00401973|39159305|FG002|Overall Study|Physician Decision|1|||
16185633|NCT00401973|39159303|FG000|Overall Study|Protocol Violation|1|||
16185634|NCT00401973|39159304|FG001|Overall Study|Protocol Violation|2|||
16185635|NCT00401973|39159305|FG002|Overall Study|Protocol Violation|3|||
16185636|NCT00401973|39159303|FG000|Overall Study|Sponsor Decision|0|||
16288478|NCT02025751|39540581|FG000|Overall Study|Adverse Event|0|||
16481694|NCT00347360|40242235|FG012|Overall Study|Subject left town, ran out of study drug|0|||
16481695|NCT00347360|40242236|FG013|Overall Study|Subject left town, ran out of study drug|1|||
16481696|NCT00347360|40242237|FG014|Overall Study|Subject left town, ran out of study drug|0|||
16481697|NCT00347360|40242223|FG000|Overall Study|Subject refuse to sign updated consent|0|||
16481698|NCT00347360|40242224|FG001|Overall Study|Subject refuse to sign updated consent|0|||
16185637|NCT00401973|39159304|FG001|Overall Study|Sponsor Decision|1|||
16185638|NCT00401973|39159305|FG002|Overall Study|Sponsor Decision|0|||
16185639|NCT00401973|39159303|FG000|Overall Study|Withdrawal by Subject|4|||
16185640|NCT00401973|39159304|FG001|Overall Study|Withdrawal by Subject|12|||
16185641|NCT00401973|39159305|FG002|Overall Study|Withdrawal by Subject|9|||
16185642|NCT01519427|39159306|FG000|Overall Study|disease progression|2|||
16288479|NCT02025751|39540582|FG001|Overall Study|Adverse Event|1|||
16185643|NCT00374907|39159307|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
16185644|NCT00374907|39159308|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
16288480|NCT02025751|39540581|FG000|Overall Study|Physician Decision|0|||
16185645|NCT00374907|39159307|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
16185646|NCT00374907|39159308|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
16185647|NCT00374907|39159307|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
16185648|NCT00374907|39159308|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
16185649|NCT00374907|39159307|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
16185650|NCT00374907|39159308|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
16185651|NCT00374907|39159307|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
16185652|NCT00374907|39159308|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
16185653|NCT00886821|39159309|FG000|Stage 2|Adverse Event|0|||
16185654|NCT00886821|39159310|FG001|Stage 2|Adverse Event|0|||
16185655|NCT00886821|39159311|FG002|Stage 2|Adverse Event|0|||
16185656|NCT00886821|39159312|FG003|Stage 2|Adverse Event|0|||
16185657|NCT00886821|39159313|FG004|Stage 2|Adverse Event|0|||
16185658|NCT00886821|39159314|FG005|Stage 2|Adverse Event|0|||
16185659|NCT00886821|39159315|FG006|Stage 2|Adverse Event|0|||
16185660|NCT00886821|39159316|FG007|Stage 2|Adverse Event|0|||
16185661|NCT00886821|39159317|FG008|Stage 2|Adverse Event|0|||
16185662|NCT00886821|39159318|FG009|Stage 2|Adverse Event|0|||
16185663|NCT00886821|39159319|FG010|Stage 2|Adverse Event|0|||
16185664|NCT00886821|39159320|FG011|Stage 2|Adverse Event|1|||
16185665|NCT00886821|39159321|FG012|Stage 2|Adverse Event|3|||
16185666|NCT00886821|39159322|FG013|Stage 2|Adverse Event|0|||
16185667|NCT00886821|39159309|FG000|Stage 2|Lost to Follow-up|0|||
16185668|NCT00886821|39159310|FG001|Stage 2|Lost to Follow-up|0|||
16185669|NCT00886821|39159311|FG002|Stage 2|Lost to Follow-up|0|||
16185670|NCT00886821|39159312|FG003|Stage 2|Lost to Follow-up|0|||
16185671|NCT00886821|39159313|FG004|Stage 2|Lost to Follow-up|0|||
16185672|NCT00886821|39159314|FG005|Stage 2|Lost to Follow-up|0|||
16481699|NCT00347360|40242225|FG002|Overall Study|Subject refuse to sign updated consent|0|||
16481700|NCT00347360|40242226|FG003|Overall Study|Subject refuse to sign updated consent|0|||
16481701|NCT00347360|40242227|FG004|Overall Study|Subject refuse to sign updated consent|0|||
16481702|NCT00347360|40242228|FG005|Overall Study|Subject refuse to sign updated consent|0|||
16481703|NCT00347360|40242229|FG006|Overall Study|Subject refuse to sign updated consent|0|||
16080367|NCT01943916|38786840|FG000|Overall Study|Technical Failure|39|||
16185673|NCT00886821|39159315|FG006|Stage 2|Lost to Follow-up|0|||
16185674|NCT00886821|39159316|FG007|Stage 2|Lost to Follow-up|0|||
16185675|NCT00886821|39159317|FG008|Stage 2|Lost to Follow-up|0|||
16185676|NCT00886821|39159318|FG009|Stage 2|Lost to Follow-up|0|||
16185677|NCT00886821|39159319|FG010|Stage 2|Lost to Follow-up|0|||
16185678|NCT00886821|39159320|FG011|Stage 2|Lost to Follow-up|0|||
16185679|NCT00886821|39159321|FG012|Stage 2|Lost to Follow-up|2|||
16185680|NCT00886821|39159322|FG013|Stage 2|Lost to Follow-up|1|||
16185681|NCT01400971|39159323|FG000|Overall Study|Death|82|||
16185682|NCT01400971|39159323|FG000|Overall Study|Lost to Follow-up|196|||
16185683|NCT01400971|39159323|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
16185684|NCT01400971|39159323|FG000|Overall Study|Physician Decision|57|||
16185685|NCT01400971|39159323|FG000|Overall Study|Withdrawal by Subject|158|||
16185686|NCT01400971|39159323|FG000|Overall Study|Other|422|||
16185687|NCT01721369|39159324|FG000|Overall Study|Not initial etiological diagnosis|12|||
16185688|NCT04283461|39159331|FG000|Overall Study|Enrolled in separate trial|0|||
16185689|NCT04283461|39159332|FG001|Overall Study|Enrolled in separate trial|0|||
16185690|NCT04283461|39159333|FG002|Overall Study|Enrolled in separate trial|8|||
16185691|NCT04283461|39159334|FG003|Overall Study|Enrolled in separate trial|13|||
16185692|NCT04283461|39159335|FG004|Overall Study|Enrolled in separate trial|12|||
16185693|NCT04283461|39159336|FG005|Overall Study|Enrolled in separate trial|0|||
16185694|NCT04283461|39159337|FG006|Overall Study|Enrolled in separate trial|0|||
16185695|NCT04283461|39159338|FG007|Overall Study|Enrolled in separate trial|8|||
16185696|NCT04283461|39159339|FG008|Overall Study|Enrolled in separate trial|0|||
16185697|NCT04283461|39159340|FG009|Overall Study|Enrolled in separate trial|0|||
16288481|NCT02025751|39540582|FG001|Overall Study|Physician Decision|1|||
16288482|NCT02025751|39540581|FG000|Overall Study|Withdrawal by Subject|0|||
16288483|NCT02025751|39540582|FG001|Overall Study|Withdrawal by Subject|1|||
16288484|NCT02225665|39540583|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
16185698|NCT04283461|39159341|FG010|Overall Study|Enrolled in separate trial|0|||
16185699|NCT04283461|39159342|FG011|Overall Study|Enrolled in separate trial|7|||
16185700|NCT04283461|39159343|FG012|Overall Study|Enrolled in separate trial|0|||
16185701|NCT03596177|39159344|FG000|Single Blind Period|Withdrawal by Subject|1|||
16185702|NCT03596177|39159345|FG001|Single Blind Period|Withdrawal by Subject|1|||
16185703|NCT03596177|39159344|FG000|Single Blind Period|Other|1|||
16185704|NCT03596177|39159345|FG001|Single Blind Period|Other|0|||
16185705|NCT03596177|39159344|FG000|Double Blind Period|Withdrawal by Subject|0|||
16288485|NCT02225665|39540584|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
16185706|NCT03596177|39159345|FG001|Double Blind Period|Withdrawal by Subject|1|||
16185707|NCT03596177|39159344|FG000|Double Blind Period|Other|0|||
16185708|NCT03596177|39159345|FG001|Double Blind Period|Other|4|||
16185709|NCT03596177|39159344|FG000|Double Blind Period|Death during safety follow-up|0|||
16185710|NCT03596177|39159345|FG001|Double Blind Period|Death during safety follow-up|1|||
16185711|NCT00893113|39159346|FG000|Overall Study|Lost to Follow-up|4|||
16185712|NCT00893113|39159347|FG001|Overall Study|Lost to Follow-up|8|||
16185713|NCT00893113|39159346|FG000|Overall Study|Early Termination|1|||
16185714|NCT00893113|39159347|FG001|Overall Study|Early Termination|1|||
16185715|NCT00893113|39159346|FG000|Overall Study|Withdrew Consent|8|||
16185716|NCT00893113|39159347|FG001|Overall Study|Withdrew Consent|7|||
16185717|NCT02421120|39159348|FG000|Overall Study|Adverse Event|1|||
16481704|NCT00347360|40242230|FG007|Overall Study|Subject refuse to sign updated consent|0|||
16288486|NCT02225665|39540583|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
16288487|NCT02225665|39540584|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
16288488|NCT01560507|39540585|FG000|Overall Study|Lost to Follow-up|3|||
16288489|NCT01560507|39540586|FG001|Overall Study|Lost to Follow-up|1|||
16288490|NCT01560507|39540587|FG002|Overall Study|Lost to Follow-up|2|||
16288491|NCT01560507|39540585|FG000|Overall Study|Withdrawal by Subject|1|||
16288492|NCT01560507|39540586|FG001|Overall Study|Withdrawal by Subject|1|||
16288493|NCT01560507|39540587|FG002|Overall Study|Withdrawal by Subject|0|||
16288494|NCT02129647|39540588|FG000|Overall Study|Adverse Event|2|||
16288495|NCT02129647|39540588|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
16288496|NCT01144364|39540593|FG000|Induction Phase|Disease progression|14|||
16288497|NCT01144364|39540594|FG001|Induction Phase|Disease progression|0|||
16288498|NCT01144364|39540595|FG002|Induction Phase|Disease progression|0|||
16288499|NCT01144364|39540593|FG000|Induction Phase|Adverse Event|9|||
16288500|NCT01144364|39540594|FG001|Induction Phase|Adverse Event|0|||
16288501|NCT01144364|39540595|FG002|Induction Phase|Adverse Event|0|||
16288502|NCT01144364|39540593|FG000|Induction Phase|Death|1|||
16288503|NCT01144364|39540594|FG001|Induction Phase|Death|0|||
16288504|NCT01144364|39540595|FG002|Induction Phase|Death|0|||
16288505|NCT01144364|39540593|FG000|Induction Phase|Withdrawal by Subject|1|||
16288506|NCT01144364|39540594|FG001|Induction Phase|Withdrawal by Subject|0|||
16288507|NCT01144364|39540595|FG002|Induction Phase|Withdrawal by Subject|0|||
16288508|NCT01144364|39540593|FG000|Induction Phase|Lost to Follow-up|2|||
16288509|NCT01144364|39540594|FG001|Induction Phase|Lost to Follow-up|0|||
16288510|NCT01144364|39540595|FG002|Induction Phase|Lost to Follow-up|0|||
16288511|NCT01144364|39540593|FG000|Induction Phase|Physician Decision|1|||
16288512|NCT01144364|39540594|FG001|Induction Phase|Physician Decision|0|||
16288513|NCT01144364|39540595|FG002|Induction Phase|Physician Decision|0|||
16288514|NCT01144364|39540593|FG000|Induction Phase|Stable disease|2|||
16288515|NCT01144364|39540594|FG001|Induction Phase|Stable disease|0|||
16288516|NCT01144364|39540595|FG002|Induction Phase|Stable disease|0|||
16288517|NCT01144364|39540593|FG000|Induction Phase|Secondary neoplasia|1|||
16288518|NCT01144364|39540594|FG001|Induction Phase|Secondary neoplasia|0|||
16288519|NCT01144364|39540595|FG002|Induction Phase|Secondary neoplasia|0|||
16288520|NCT01144364|39540593|FG000|Induction Phase|Protocol Violation|1|||
16288521|NCT01144364|39540594|FG001|Induction Phase|Protocol Violation|0|||
16481705|NCT00347360|40242231|FG008|Overall Study|Subject refuse to sign updated consent|0|||
16481706|NCT00347360|40242232|FG009|Overall Study|Subject refuse to sign updated consent|0|||
16185718|NCT03430245|39159351|FG000|Overall Study|Withdrawal by Subject|6|||
16185719|NCT03430245|39159351|FG000|Overall Study|Lost to Follow-up|1|||
16185720|NCT01221233|39159353|FG000|Overall Study|Withdrawal by Subject|3|||
16185721|NCT01221233|39159354|FG001|Overall Study|Withdrawal by Subject|1|||
16185722|NCT02090114|39159356|FG000|Overall Study|Withdrawal by Subject|3|||
16185723|NCT02090114|39159357|FG001|Overall Study|Withdrawal by Subject|6|||
16185724|NCT02090114|39159358|FG002|Overall Study|Withdrawal by Subject|2|||
16185725|NCT02090114|39159359|FG003|Overall Study|Withdrawal by Subject|1|||
16185726|NCT02090114|39159356|FG000|Overall Study|Physician Decision|5|||
16185727|NCT02090114|39159357|FG001|Overall Study|Physician Decision|0|||
16185728|NCT02090114|39159358|FG002|Overall Study|Physician Decision|1|||
16185729|NCT02090114|39159359|FG003|Overall Study|Physician Decision|1|||
16185730|NCT02090114|39159356|FG000|Overall Study|Adverse Event|1|||
16185731|NCT02090114|39159357|FG001|Overall Study|Adverse Event|2|||
16185732|NCT02090114|39159358|FG002|Overall Study|Adverse Event|2|||
16185733|NCT02090114|39159359|FG003|Overall Study|Adverse Event|0|||
16185734|NCT02090114|39159356|FG000|Overall Study|Progressive Disease|20|||
16185735|NCT02090114|39159357|FG001|Overall Study|Progressive Disease|21|||
16185736|NCT02090114|39159358|FG002|Overall Study|Progressive Disease|23|||
16288522|NCT01144364|39540595|FG002|Induction Phase|Protocol Violation|0|||
16288523|NCT01144364|39540593|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
16288524|NCT01144364|39540594|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
16288525|NCT01144364|39540595|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
16185737|NCT02090114|39159359|FG003|Overall Study|Progressive Disease|6|||
16185738|NCT02090114|39159356|FG000|Overall Study|Death|1|||
16185739|NCT02090114|39159357|FG001|Overall Study|Death|0|||
16185740|NCT02090114|39159358|FG002|Overall Study|Death|1|||
16185741|NCT02090114|39159359|FG003|Overall Study|Death|0|||
16185742|NCT00426751|39159360|FG000|Overall Study|Adverse Event|8|||
16185743|NCT00426751|39159361|FG001|Overall Study|Adverse Event|1|||
16288526|NCT01144364|39540593|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
16288527|NCT01144364|39540594|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
16288528|NCT01144364|39540595|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
16288529|NCT01144364|39540593|FG000|Follow-Up/Maintenance Phase|Death|0|||
16288530|NCT01144364|39540594|FG001|Follow-Up/Maintenance Phase|Death|2|||
16288531|NCT01144364|39540595|FG002|Follow-Up/Maintenance Phase|Death|0|||
16288532|NCT01144364|39540593|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
16288533|NCT01144364|39540594|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
16288534|NCT01144364|39540595|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
16288535|NCT01144364|39540593|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
16288536|NCT01144364|39540594|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
16288537|NCT01144364|39540595|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
16288538|NCT01144364|39540593|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
16288539|NCT01144364|39540594|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
16288540|NCT01144364|39540595|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
16379985|NCT00835354|39874857|FG001|First Intervention|Adverse Event|1|||
16379986|NCT04856527|39874858|FG000|Overall Study|Unable to complete experimental task|2|||
16379987|NCT04856527|39874859|FG001|Overall Study|Unable to complete experimental task|0|||
16379988|NCT04576455|39874860|FG000|Overall Study|Ongoing in the Study|122|||
16379989|NCT04576455|39874861|FG001|Overall Study|Ongoing in the Study|135|||
16379990|NCT04576455|39874860|FG000|Overall Study|Death|18|||
16379991|NCT04576455|39874861|FG001|Overall Study|Death|12|||
16379992|NCT04576455|39874860|FG000|Overall Study|Lost to Follow-up|1|||
16379993|NCT04576455|39874861|FG001|Overall Study|Lost to Follow-up|0|||
16379994|NCT04576455|39874860|FG000|Overall Study|Withdrawal by Subject|10|||
16379995|NCT04576455|39874861|FG001|Overall Study|Withdrawal by Subject|5|||
16379996|NCT03242434|39874862|FG000|Overall Study|Death|0|||
16379997|NCT03242434|39874863|FG001|Overall Study|Death|2|||
16379998|NCT00851084|39874869|FG000|Overall Study|Randomized but not treated|1|||
16379999|NCT00851084|39874870|FG001|Overall Study|Randomized but not treated|0|||
16380000|NCT00851084|39874869|FG000|Overall Study|Adverse Event|26|||
16288541|NCT01144364|39540593|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
16288542|NCT01144364|39540594|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
16288543|NCT01144364|39540595|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
16288544|NCT04465630|39540596|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
16288545|NCT04465630|39540596|FG000|Overall Study|Screen failure|8|||
16288546|NCT04465630|39540596|FG000|Overall Study|Baseline failure|16|||
16288547|NCT03828448|39540597|FG000|Overall Study|Sponsor's Discretion|34|||
16288548|NCT02377063|39540598|FG000|Overall Study|Non-compliance|5|||
16288549|NCT01855048|39540599|FG000|Overall Study|Withdrawal by Subject|0|||
16288550|NCT01855048|39540600|FG001|Overall Study|Withdrawal by Subject|1|||
16288551|NCT01855048|39540601|FG002|Overall Study|Withdrawal by Subject|0|||
16288552|NCT01855048|39540602|FG003|Overall Study|Withdrawal by Subject|0|||
16288553|NCT01855048|39540603|FG004|Overall Study|Withdrawal by Subject|1|||
16380001|NCT00851084|39874870|FG001|Overall Study|Adverse Event|36|||
16380002|NCT00851084|39874869|FG000|Overall Study|Disease progression|52|||
16380003|NCT00851084|39874870|FG001|Overall Study|Disease progression|47|||
16380004|NCT00851084|39874869|FG000|Overall Study|Poor compliance to protocol|1|||
16380005|NCT00851084|39874870|FG001|Overall Study|Poor compliance to protocol|1|||
16380006|NCT00851084|39874869|FG000|Overall Study|Physician Decision|13|||
16380007|NCT00851084|39874870|FG001|Overall Study|Physician Decision|14|||
16380008|NCT00851084|39874869|FG000|Overall Study|Consent withdrawn|0|||
16380009|NCT00851084|39874870|FG001|Overall Study|Consent withdrawn|2|||
16380010|NCT00851084|39874869|FG000|Overall Study|Withdrawal by Subject|11|||
16380011|NCT00851084|39874870|FG001|Overall Study|Withdrawal by Subject|12|||
16380012|NCT00851084|39874869|FG000|Overall Study|Metastatic surgery|6|||
16380013|NCT00851084|39874870|FG001|Overall Study|Metastatic surgery|6|||
16380014|NCT00851084|39874869|FG000|Overall Study|Other|7|||
16380015|NCT00851084|39874870|FG001|Overall Study|Other|1|||
16380016|NCT04618471|39874871|FG000|Overall Study|Screen Failure|62|||
16380017|NCT04618471|39874871|FG000|Overall Study|Withdrawal by Subject|6|||
16380018|NCT04618471|39874871|FG000|Overall Study|Physician Decision|2|||
16481707|NCT00347360|40242233|FG010|Overall Study|Subject refuse to sign updated consent|0|||
16481708|NCT00347360|40242234|FG011|Overall Study|Subject refuse to sign updated consent|0|||
16481709|NCT00347360|40242235|FG012|Overall Study|Subject refuse to sign updated consent|0|||
16380019|NCT04618471|39874871|FG000|Overall Study|Lost to Follow-up|1|||
16380020|NCT04618471|39874871|FG000|Overall Study|Various other reasons|2|||
16481710|NCT00347360|40242236|FG013|Overall Study|Subject refuse to sign updated consent|0|||
16288554|NCT01855048|39540604|FG005|Overall Study|Withdrawal by Subject|0|||
16288555|NCT01197417|39540609|FG000|Overall Study|Physician Decision|3|||
16288556|NCT01197417|39540610|FG001|Overall Study|Physician Decision|2|||
16288557|NCT01197417|39540609|FG000|Overall Study|Withdrawal by Subject|2|||
16288558|NCT01197417|39540610|FG001|Overall Study|Withdrawal by Subject|4|||
16380021|NCT04618471|39874871|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
16380022|NCT02891226|39874872|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
16380023|NCT02891226|39874873|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
16481711|NCT00347360|40242237|FG014|Overall Study|Subject refuse to sign updated consent|1|||
16481712|NCT00347360|40242223|FG000|Overall Study|Visits conflicted with new job|0|||
16481713|NCT00347360|40242224|FG001|Overall Study|Visits conflicted with new job|0|||
16481714|NCT00347360|40242225|FG002|Overall Study|Visits conflicted with new job|0|||
16481715|NCT00347360|40242226|FG003|Overall Study|Visits conflicted with new job|0|||
16481716|NCT00347360|40242227|FG004|Overall Study|Visits conflicted with new job|0|||
16481717|NCT00347360|40242228|FG005|Overall Study|Visits conflicted with new job|0|||
16481718|NCT00347360|40242229|FG006|Overall Study|Visits conflicted with new job|1|||
16481719|NCT00347360|40242230|FG007|Overall Study|Visits conflicted with new job|0|||
16481720|NCT00347360|40242231|FG008|Overall Study|Visits conflicted with new job|0|||
16288559|NCT01197417|39540609|FG000|Overall Study|Site miscommunication|0|||
16288560|NCT01197417|39540610|FG001|Overall Study|Site miscommunication|1|||
16288561|NCT01197417|39540609|FG000|Overall Study|Subject transferred to intensive care|0|||
16288562|NCT01197417|39540610|FG001|Overall Study|Subject transferred to intensive care|1|||
16288563|NCT01197417|39540609|FG000|Overall Study|Not consented in time to receive drug|0|||
16288564|NCT01197417|39540610|FG001|Overall Study|Not consented in time to receive drug|1|||
16288565|NCT01197417|39540609|FG000|Overall Study|Hypotension|1|||
16288566|NCT01197417|39540610|FG001|Overall Study|Hypotension|2|||
16288567|NCT01197417|39540609|FG000|Overall Study|Found to be ineligible|2|||
16288568|NCT01197417|39540610|FG001|Overall Study|Found to be ineligible|5|||
16288569|NCT01197417|39540609|FG000|Overall Study|No 25-hour magnesium level|0|||
16288570|NCT01197417|39540610|FG001|Overall Study|No 25-hour magnesium level|2|||
16288571|NCT03567382|39540611|FG000|Overall Study|Lost to Follow-up|1|||
16288572|NCT03567382|39540612|FG001|Overall Study|Lost to Follow-up|21|||
16288573|NCT03567382|39540613|FG002|Overall Study|Lost to Follow-up|1|||
16288574|NCT03567382|39540614|FG003|Overall Study|Lost to Follow-up|21|||
16288575|NCT03567382|39540611|FG000|Overall Study|Withdrawal by Subject|2|||
16288576|NCT03567382|39540612|FG001|Overall Study|Withdrawal by Subject|14|||
16288577|NCT03567382|39540613|FG002|Overall Study|Withdrawal by Subject|1|||
16288578|NCT03567382|39540614|FG003|Overall Study|Withdrawal by Subject|12|||
16288579|NCT00614822|39540615|FG000|Overall Study|Adverse Event|3|||
16288580|NCT02618408|39540618|FG000|Overall Study|Withdrawal by Subject|1|||
16288581|NCT02618408|39540619|FG001|Overall Study|Withdrawal by Subject|0|||
16288582|NCT02618408|39540620|FG002|Overall Study|Withdrawal by Subject|4|||
16288583|NCT02618408|39540618|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
16288584|NCT02618408|39540619|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
16288585|NCT02618408|39540620|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
16288586|NCT02618408|39540618|FG000|Overall Study|Lost to Follow-up|4|||
16288587|NCT02618408|39540619|FG001|Overall Study|Lost to Follow-up|2|||
16288588|NCT02618408|39540620|FG002|Overall Study|Lost to Follow-up|6|||
16288589|NCT02618408|39540618|FG000|Overall Study|Adverse Event|4|||
16288590|NCT02618408|39540619|FG001|Overall Study|Adverse Event|0|||
16288591|NCT02618408|39540620|FG002|Overall Study|Adverse Event|10|||
16288592|NCT02618408|39540618|FG000|Overall Study|Physician Decision|1|||
16288593|NCT02618408|39540619|FG001|Overall Study|Physician Decision|1|||
16288594|NCT02618408|39540620|FG002|Overall Study|Physician Decision|2|||
16288595|NCT02618408|39540618|FG000|Overall Study|Protocol Violation|1|||
16288596|NCT02618408|39540619|FG001|Overall Study|Protocol Violation|1|||
16288597|NCT02618408|39540620|FG002|Overall Study|Protocol Violation|2|||
16288598|NCT02618408|39540618|FG000|Overall Study|Other, Multiple Categories|0|||
16288599|NCT02618408|39540619|FG001|Overall Study|Other, Multiple Categories|0|||
16288600|NCT02618408|39540620|FG002|Overall Study|Other, Multiple Categories|4|||
16288601|NCT00914459|39540626|FG000|Overall Study|Protocol Violation|0|||
16288602|NCT00914459|39540627|FG001|Overall Study|Protocol Violation|1|||
16481721|NCT00347360|40242232|FG009|Overall Study|Visits conflicted with new job|0|||
16481722|NCT00347360|40242233|FG010|Overall Study|Visits conflicted with new job|0|||
16481723|NCT00347360|40242234|FG011|Overall Study|Visits conflicted with new job|0|||
16481724|NCT00347360|40242235|FG012|Overall Study|Visits conflicted with new job|0|||
16481725|NCT00347360|40242236|FG013|Overall Study|Visits conflicted with new job|0|||
16481726|NCT00347360|40242237|FG014|Overall Study|Visits conflicted with new job|0|||
16481727|NCT03087643|40242238|FG000|Overall Study|Withdrawal by Subject|2|||
16481728|NCT03087643|40242239|FG001|Overall Study|Withdrawal by Subject|4|||
16481729|NCT03087643|40242238|FG000|Overall Study|Death|2|||
16481730|NCT03087643|40242239|FG001|Overall Study|Death|2|||
16481731|NCT01218113|40242240|FG000|Overall Study|Withdrawal by Subject|1|||
16481732|NCT01218113|40242241|FG001|Overall Study|Withdrawal by Subject|0|||
16481733|NCT01218113|40242242|FG002|Overall Study|Withdrawal by Subject|1|||
16481734|NCT01218113|40242240|FG000|Overall Study|Lost to Follow-up|4|||
16288603|NCT00914459|39540626|FG000|Overall Study|Parent/Legal guardian request|1|||
16288604|NCT00914459|39540627|FG001|Overall Study|Parent/Legal guardian request|0|||
16288605|NCT04322149|39540629|FG000|Overall Study|Adverse Event|1|||
16288606|NCT04322149|39540630|FG001|Overall Study|Adverse Event|1|||
16288607|NCT04322149|39540631|FG002|Overall Study|Adverse Event|0|||
16288608|NCT04322149|39540632|FG003|Overall Study|Adverse Event|0|||
16288609|NCT04322149|39540629|FG000|Overall Study|Withdrawal by Subject|0|||
16288610|NCT04322149|39540630|FG001|Overall Study|Withdrawal by Subject|0|||
16288611|NCT04322149|39540631|FG002|Overall Study|Withdrawal by Subject|0|||
16288612|NCT04322149|39540632|FG003|Overall Study|Withdrawal by Subject|2|||
16288613|NCT04322149|39540629|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
16288614|NCT04322149|39540630|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
16288615|NCT04322149|39540631|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
16288616|NCT04322149|39540632|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
16288617|NCT04109313|39540635|FG000|Overall Study|Pregnancy|1|||
16288618|NCT04109313|39540635|FG000|Overall Study|Adverse Event|11|||
16288619|NCT04109313|39540635|FG000|Overall Study|Lack of Efficacy|11|||
16481735|NCT01218113|40242241|FG001|Overall Study|Lost to Follow-up|1|||
16481736|NCT01218113|40242242|FG002|Overall Study|Lost to Follow-up|4|||
16288620|NCT04109313|39540635|FG000|Overall Study|Lost to Follow-up|1|||
16288621|NCT04109313|39540635|FG000|Overall Study|Physician Decision|2|||
16288622|NCT04109313|39540635|FG000|Overall Study|Subject Decision|13|||
16288623|NCT04109313|39540635|FG000|Overall Study|Covid-19 situation|2|||
16288624|NCT02132754|39540641|FG000|Overall Study|Adverse Event|0|||
16288625|NCT02132754|39540642|FG001|Overall Study|Adverse Event|0|||
16288626|NCT02132754|39540643|FG002|Overall Study|Adverse Event|0|||
16288627|NCT02132754|39540644|FG003|Overall Study|Adverse Event|0|||
16288628|NCT02132754|39540645|FG004|Overall Study|Adverse Event|0|||
16288629|NCT02132754|39540646|FG005|Overall Study|Adverse Event|0|||
16288630|NCT02132754|39540647|FG006|Overall Study|Adverse Event|0|||
16288631|NCT02132754|39540648|FG007|Overall Study|Adverse Event|0|||
16288632|NCT02132754|39540649|FG008|Overall Study|Adverse Event|0|||
16288633|NCT02132754|39540650|FG009|Overall Study|Adverse Event|0|||
16288634|NCT02132754|39540651|FG010|Overall Study|Adverse Event|0|||
16288635|NCT02132754|39540652|FG011|Overall Study|Adverse Event|0|||
16288636|NCT02132754|39540653|FG012|Overall Study|Adverse Event|0|||
16288637|NCT02132754|39540654|FG013|Overall Study|Adverse Event|0|||
16288638|NCT02132754|39540655|FG014|Overall Study|Adverse Event|0|||
16288639|NCT02132754|39540656|FG015|Overall Study|Adverse Event|0|||
16288640|NCT02132754|39540657|FG016|Overall Study|Adverse Event|0|||
16288641|NCT02132754|39540658|FG017|Overall Study|Adverse Event|1|||
16288642|NCT02132754|39540659|FG018|Overall Study|Adverse Event|0|||
16288643|NCT02132754|39540660|FG019|Overall Study|Adverse Event|0|||
16288644|NCT02132754|39540661|FG020|Overall Study|Adverse Event|0|||
16288645|NCT02132754|39540662|FG021|Overall Study|Adverse Event|0|||
16288646|NCT02132754|39540663|FG022|Overall Study|Adverse Event|0|||
16288647|NCT02132754|39540664|FG023|Overall Study|Adverse Event|0|||
16481737|NCT01218113|40242240|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
16481738|NCT01218113|40242241|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
16481739|NCT01218113|40242242|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
16481740|NCT02949700|40242243|FG000|Phase I|Withdrawal by Subject|1|||
16481741|NCT02949700|40242244|FG001|Phase I|Withdrawal by Subject|1|||
16481742|NCT02949700|40242245|FG002|Phase I|Withdrawal by Subject|0|||
16481743|NCT02949700|40242246|FG003|Phase I|Withdrawal by Subject|0|||
16481744|NCT02949700|40242243|FG000|Phase I|Protocol Violation|1|||
16481745|NCT02949700|40242244|FG001|Phase I|Protocol Violation|0|||
16481746|NCT02949700|40242245|FG002|Phase I|Protocol Violation|0|||
16481747|NCT02949700|40242246|FG003|Phase I|Protocol Violation|0|||
16481748|NCT02949700|40242243|FG000|Phase II|Withdrawal by Subject|0|||
16481749|NCT02949700|40242244|FG001|Phase II|Withdrawal by Subject|0|||
16481750|NCT02949700|40242245|FG002|Phase II|Withdrawal by Subject|0|||
16481751|NCT02949700|40242246|FG003|Phase II|Withdrawal by Subject|2|||
16481752|NCT02949700|40242243|FG000|Phase II|Protocol Violation|0|||
16481753|NCT02949700|40242244|FG001|Phase II|Protocol Violation|0|||
16080368|NCT01943916|38786840|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
16288648|NCT02132754|39540665|FG024|Overall Study|Adverse Event|0|||
16288649|NCT02132754|39540666|FG025|Overall Study|Adverse Event|1|||
16481754|NCT02949700|40242245|FG002|Phase II|Protocol Violation|1|||
16481755|NCT02949700|40242246|FG003|Phase II|Protocol Violation|3|||
16481756|NCT00913380|40242248|FG000|Clinical Outcomes|Lost to Follow-up|6|||
16288650|NCT02132754|39540667|FG026|Overall Study|Adverse Event|1|||
16481757|NCT00913380|40242249|FG001|Clinical Outcomes|Lost to Follow-up|6|||
16481758|NCT00622401|40242254|FG000|Overall Study|Disease progression prior to treatment|3|||
16481759|NCT00622401|40242255|FG001|Overall Study|Disease progression prior to treatment|2|||
16481760|NCT00622401|40242256|FG002|Overall Study|Disease progression prior to treatment|0|||
16481761|NCT01180985|40242257|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
16481762|NCT01180985|40242258|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
16288651|NCT02132754|39540668|FG027|Overall Study|Adverse Event|0|||
16288652|NCT02132754|39540669|FG028|Overall Study|Adverse Event|0|||
16288653|NCT02132754|39540670|FG029|Overall Study|Adverse Event|0|||
16288654|NCT02132754|39540671|FG030|Overall Study|Adverse Event|1|||
16481763|NCT00761631|40242259|FG000|Overall Study|Parent/legal guardian request|8|||
16288655|NCT02132754|39540672|FG031|Overall Study|Adverse Event|0|||
16288656|NCT02132754|39540673|FG032|Overall Study|Adverse Event|1|||
16481764|NCT00761631|40242260|FG001|Overall Study|Parent/legal guardian request|3|||
16481765|NCT00761631|40242261|FG002|Overall Study|Parent/legal guardian request|8|||
16481766|NCT00761631|40242262|FG003|Overall Study|Parent/legal guardian request|0|||
16481767|NCT00761631|40242263|FG004|Overall Study|Parent/legal guardian request|5|||
16481768|NCT00761631|40242264|FG005|Overall Study|Parent/legal guardian request|0|||
16481769|NCT00761631|40242259|FG000|Overall Study|Lost to Follow-up|2|||
16481770|NCT00761631|40242260|FG001|Overall Study|Lost to Follow-up|4|||
16481771|NCT00761631|40242261|FG002|Overall Study|Lost to Follow-up|7|||
16481772|NCT00761631|40242262|FG003|Overall Study|Lost to Follow-up|1|||
16481773|NCT00761631|40242263|FG004|Overall Study|Lost to Follow-up|6|||
16481774|NCT00761631|40242264|FG005|Overall Study|Lost to Follow-up|1|||
16481775|NCT00761631|40242259|FG000|Overall Study|Protocol Violation|2|||
16481776|NCT00761631|40242260|FG001|Overall Study|Protocol Violation|0|||
16481777|NCT00761631|40242261|FG002|Overall Study|Protocol Violation|0|||
16288657|NCT02132754|39540674|FG033|Overall Study|Adverse Event|1|||
16288658|NCT02132754|39540641|FG000|Overall Study|Clinical Progression|0|||
16288659|NCT02132754|39540642|FG001|Overall Study|Clinical Progression|0|||
16288660|NCT02132754|39540643|FG002|Overall Study|Clinical Progression|0|||
16288661|NCT02132754|39540644|FG003|Overall Study|Clinical Progression|0|||
16288662|NCT02132754|39540645|FG004|Overall Study|Clinical Progression|0|||
16288663|NCT02132754|39540646|FG005|Overall Study|Clinical Progression|0|||
16380024|NCT02891226|39874874|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
16380025|NCT02891226|39874875|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380026|NCT02891226|39874876|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380027|NCT02891226|39874877|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380028|NCT02891226|39874878|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380029|NCT02891226|39874879|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380030|NCT02891226|39874880|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380031|NCT02891226|39874881|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380032|NCT02891226|39874882|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380033|NCT02891226|39874883|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380034|NCT02891226|39874884|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380035|NCT02891226|39874885|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380036|NCT02891226|39874886|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380037|NCT02891226|39874887|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
16380038|NCT02891226|39874872|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
16380039|NCT02891226|39874873|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
16380040|NCT02891226|39874874|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16380041|NCT02891226|39874875|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16380042|NCT02891226|39874876|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16481778|NCT00761631|40242262|FG003|Overall Study|Protocol Violation|1|||
16380043|NCT02891226|39874877|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16288664|NCT02132754|39540647|FG006|Overall Study|Clinical Progression|0|||
16288665|NCT02132754|39540648|FG007|Overall Study|Clinical Progression|0|||
16481779|NCT00761631|40242263|FG004|Overall Study|Protocol Violation|5|||
16481780|NCT00761631|40242264|FG005|Overall Study|Protocol Violation|1|||
16288666|NCT02132754|39540649|FG008|Overall Study|Clinical Progression|0|||
16288667|NCT02132754|39540650|FG009|Overall Study|Clinical Progression|1|||
16288668|NCT02132754|39540651|FG010|Overall Study|Clinical Progression|0|||
16288669|NCT02132754|39540652|FG011|Overall Study|Clinical Progression|0|||
16288670|NCT02132754|39540653|FG012|Overall Study|Clinical Progression|0|||
16288671|NCT02132754|39540654|FG013|Overall Study|Clinical Progression|0|||
16288672|NCT02132754|39540655|FG014|Overall Study|Clinical Progression|0|||
16288673|NCT02132754|39540656|FG015|Overall Study|Clinical Progression|0|||
16288674|NCT02132754|39540657|FG016|Overall Study|Clinical Progression|1|||
16288675|NCT02132754|39540658|FG017|Overall Study|Clinical Progression|1|||
16288676|NCT02132754|39540659|FG018|Overall Study|Clinical Progression|0|||
16288677|NCT02132754|39540660|FG019|Overall Study|Clinical Progression|1|||
16288678|NCT02132754|39540661|FG020|Overall Study|Clinical Progression|0|||
16288679|NCT02132754|39540662|FG021|Overall Study|Clinical Progression|0|||
16288680|NCT02132754|39540663|FG022|Overall Study|Clinical Progression|1|||
16288681|NCT02132754|39540664|FG023|Overall Study|Clinical Progression|0|||
16288682|NCT02132754|39540665|FG024|Overall Study|Clinical Progression|1|||
16288683|NCT02132754|39540666|FG025|Overall Study|Clinical Progression|1|||
16288684|NCT02132754|39540667|FG026|Overall Study|Clinical Progression|0|||
16288685|NCT02132754|39540668|FG027|Overall Study|Clinical Progression|1|||
16288686|NCT02132754|39540669|FG028|Overall Study|Clinical Progression|1|||
16288687|NCT02132754|39540670|FG029|Overall Study|Clinical Progression|0|||
16288688|NCT02132754|39540671|FG030|Overall Study|Clinical Progression|1|||
16288689|NCT02132754|39540672|FG031|Overall Study|Clinical Progression|0|||
16288690|NCT02132754|39540673|FG032|Overall Study|Clinical Progression|0|||
16288691|NCT02132754|39540674|FG033|Overall Study|Clinical Progression|2|||
16288692|NCT02132754|39540641|FG000|Overall Study|Death|0|||
16288693|NCT02132754|39540642|FG001|Overall Study|Death|0|||
16481781|NCT00761631|40242259|FG000|Overall Study|Randomized, not treated|1|||
16481782|NCT00761631|40242260|FG001|Overall Study|Randomized, not treated|0|||
16481783|NCT00761631|40242261|FG002|Overall Study|Randomized, not treated|0|||
16481784|NCT00761631|40242262|FG003|Overall Study|Randomized, not treated|0|||
16481785|NCT00761631|40242263|FG004|Overall Study|Randomized, not treated|0|||
16481786|NCT00761631|40242264|FG005|Overall Study|Randomized, not treated|0|||
16481787|NCT00761631|40242259|FG000|Overall Study|Failed to return|1|||
16185744|NCT00426751|39159360|FG000|Overall Study|Lost to Follow-up|7|||
16288694|NCT02132754|39540643|FG002|Overall Study|Death|0|||
16288695|NCT02132754|39540644|FG003|Overall Study|Death|0|||
16288696|NCT02132754|39540645|FG004|Overall Study|Death|0|||
16288697|NCT02132754|39540646|FG005|Overall Study|Death|0|||
16288698|NCT02132754|39540647|FG006|Overall Study|Death|0|||
16288699|NCT02132754|39540648|FG007|Overall Study|Death|0|||
16288700|NCT02132754|39540649|FG008|Overall Study|Death|0|||
16288701|NCT02132754|39540650|FG009|Overall Study|Death|0|||
16481788|NCT00761631|40242260|FG001|Overall Study|Failed to return|0|||
16481789|NCT00761631|40242261|FG002|Overall Study|Failed to return|1|||
16288702|NCT02132754|39540651|FG010|Overall Study|Death|0|||
16481790|NCT00761631|40242262|FG003|Overall Study|Failed to return|1|||
16080369|NCT01943916|38786840|FG000|Overall Study|No Truth Panel Review|38|||
16288703|NCT02132754|39540652|FG011|Overall Study|Death|0|||
16288704|NCT02132754|39540653|FG012|Overall Study|Death|0|||
16288705|NCT02132754|39540654|FG013|Overall Study|Death|0|||
16288706|NCT02132754|39540655|FG014|Overall Study|Death|0|||
16288707|NCT02132754|39540656|FG015|Overall Study|Death|1|||
16288708|NCT02132754|39540657|FG016|Overall Study|Death|0|||
16288709|NCT02132754|39540658|FG017|Overall Study|Death|0|||
16288710|NCT02132754|39540659|FG018|Overall Study|Death|0|||
16288711|NCT02132754|39540660|FG019|Overall Study|Death|1|||
16288712|NCT02132754|39540661|FG020|Overall Study|Death|0|||
16288713|NCT02132754|39540662|FG021|Overall Study|Death|1|||
16288714|NCT02132754|39540663|FG022|Overall Study|Death|0|||
16288715|NCT02132754|39540664|FG023|Overall Study|Death|0|||
16288716|NCT02132754|39540665|FG024|Overall Study|Death|0|||
16288717|NCT02132754|39540666|FG025|Overall Study|Death|0|||
16288718|NCT02132754|39540667|FG026|Overall Study|Death|1|||
16288719|NCT02132754|39540668|FG027|Overall Study|Death|0|||
16288720|NCT02132754|39540669|FG028|Overall Study|Death|0|||
16288721|NCT02132754|39540670|FG029|Overall Study|Death|0|||
16288722|NCT02132754|39540671|FG030|Overall Study|Death|0|||
16288723|NCT02132754|39540672|FG031|Overall Study|Death|0|||
16288724|NCT02132754|39540673|FG032|Overall Study|Death|0|||
16288725|NCT02132754|39540674|FG033|Overall Study|Death|2|||
16288726|NCT02132754|39540641|FG000|Overall Study|Excluded Medication|0|||
16288727|NCT02132754|39540642|FG001|Overall Study|Excluded Medication|0|||
16288728|NCT02132754|39540643|FG002|Overall Study|Excluded Medication|0|||
16288729|NCT02132754|39540644|FG003|Overall Study|Excluded Medication|0|||
16288730|NCT02132754|39540645|FG004|Overall Study|Excluded Medication|0|||
16288731|NCT02132754|39540646|FG005|Overall Study|Excluded Medication|0|||
16288732|NCT02132754|39540647|FG006|Overall Study|Excluded Medication|0|||
16288733|NCT02132754|39540648|FG007|Overall Study|Excluded Medication|0|||
16288734|NCT02132754|39540649|FG008|Overall Study|Excluded Medication|0|||
16288735|NCT02132754|39540650|FG009|Overall Study|Excluded Medication|0|||
16288736|NCT02132754|39540651|FG010|Overall Study|Excluded Medication|0|||
16380044|NCT02891226|39874878|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16380045|NCT02891226|39874879|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16380046|NCT02891226|39874880|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16380047|NCT02891226|39874881|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16380048|NCT02891226|39874882|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16380049|NCT02891226|39874883|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16481791|NCT00761631|40242263|FG004|Overall Study|Failed to return|5|||
16481792|NCT00761631|40242264|FG005|Overall Study|Failed to return|2|||
16481793|NCT00761631|40242259|FG000|Overall Study|Physician Decision|1|||
16481794|NCT00761631|40242260|FG001|Overall Study|Physician Decision|0|||
16481795|NCT00761631|40242261|FG002|Overall Study|Physician Decision|0|||
16288737|NCT02132754|39540652|FG011|Overall Study|Excluded Medication|0|||
16288738|NCT02132754|39540653|FG012|Overall Study|Excluded Medication|0|||
16288739|NCT02132754|39540654|FG013|Overall Study|Excluded Medication|0|||
16288740|NCT02132754|39540655|FG014|Overall Study|Excluded Medication|0|||
16380050|NCT02891226|39874884|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16380051|NCT02891226|39874885|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16380052|NCT02891226|39874886|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16380053|NCT02891226|39874887|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16481796|NCT00761631|40242262|FG003|Overall Study|Physician Decision|0|||
16288741|NCT02132754|39540656|FG015|Overall Study|Excluded Medication|0|||
16288742|NCT02132754|39540657|FG016|Overall Study|Excluded Medication|0|||
16288743|NCT02132754|39540658|FG017|Overall Study|Excluded Medication|0|||
16288744|NCT02132754|39540659|FG018|Overall Study|Excluded Medication|0|||
16288745|NCT02132754|39540660|FG019|Overall Study|Excluded Medication|0|||
16288746|NCT02132754|39540661|FG020|Overall Study|Excluded Medication|1|||
16288747|NCT02132754|39540662|FG021|Overall Study|Excluded Medication|0|||
16288748|NCT02132754|39540663|FG022|Overall Study|Excluded Medication|0|||
16288749|NCT02132754|39540664|FG023|Overall Study|Excluded Medication|0|||
16481797|NCT00761631|40242263|FG004|Overall Study|Physician Decision|0|||
16481798|NCT00761631|40242264|FG005|Overall Study|Physician Decision|0|||
16481799|NCT00761631|40242259|FG000|Overall Study|Other|0|||
16288750|NCT02132754|39540665|FG024|Overall Study|Excluded Medication|0|||
16288751|NCT02132754|39540666|FG025|Overall Study|Excluded Medication|0|||
16481800|NCT00761631|40242260|FG001|Overall Study|Other|0|||
16288752|NCT02132754|39540667|FG026|Overall Study|Excluded Medication|0|||
16288753|NCT02132754|39540668|FG027|Overall Study|Excluded Medication|0|||
16288754|NCT02132754|39540669|FG028|Overall Study|Excluded Medication|0|||
16288755|NCT02132754|39540670|FG029|Overall Study|Excluded Medication|0|||
16288756|NCT02132754|39540671|FG030|Overall Study|Excluded Medication|0|||
16288757|NCT02132754|39540672|FG031|Overall Study|Excluded Medication|0|||
16288758|NCT02132754|39540673|FG032|Overall Study|Excluded Medication|0|||
16481801|NCT00761631|40242261|FG002|Overall Study|Other|0|||
16288759|NCT02132754|39540674|FG033|Overall Study|Excluded Medication|1|||
16288760|NCT02132754|39540641|FG000|Overall Study|Physician Decision|0|||
16288761|NCT02132754|39540642|FG001|Overall Study|Physician Decision|0|||
16481802|NCT00761631|40242262|FG003|Overall Study|Other|0|||
16481803|NCT00761631|40242263|FG004|Overall Study|Other|1|||
16481804|NCT00761631|40242264|FG005|Overall Study|Other|1|||
16481805|NCT00843856|40242265|FG000|Overall Study|Lost to Follow-up|1|||
16481806|NCT00843856|40242266|FG001|Overall Study|Lost to Follow-up|2|||
16481807|NCT04057365|40242267|FG000|Overall Study|Withdrawal by Subject|2|||
16481808|NCT04057365|40242268|FG001|Overall Study|Withdrawal by Subject|0|||
16481809|NCT01030536|40242273|FG000|Overall Study|Withdrawal by Subject|0|||
16481810|NCT01030536|40242274|FG001|Overall Study|Withdrawal by Subject|0|||
16481811|NCT01030536|40242275|FG002|Overall Study|Withdrawal by Subject|1|||
16481812|NCT01030536|40242276|FG003|Overall Study|Withdrawal by Subject|0|||
16481813|NCT01030536|40242277|FG004|Overall Study|Withdrawal by Subject|0|||
16481814|NCT01030536|40242273|FG000|Overall Study|undefined|1|||
16481815|NCT01030536|40242274|FG001|Overall Study|undefined|0|||
16481816|NCT01030536|40242275|FG002|Overall Study|undefined|1|||
16481817|NCT01030536|40242276|FG003|Overall Study|undefined|1|||
16481818|NCT01030536|40242277|FG004|Overall Study|undefined|0|||
16481819|NCT01030536|40242273|FG000|Overall Study|Adverse Event|0|||
16481820|NCT01030536|40242274|FG001|Overall Study|Adverse Event|3|||
16481821|NCT01030536|40242275|FG002|Overall Study|Adverse Event|1|||
16481822|NCT01030536|40242276|FG003|Overall Study|Adverse Event|0|||
16481823|NCT01030536|40242277|FG004|Overall Study|Adverse Event|1|||
16481824|NCT01030536|40242273|FG000|Overall Study|Progressive disease|6|||
16481825|NCT01030536|40242274|FG001|Overall Study|Progressive disease|2|||
16481826|NCT01030536|40242275|FG002|Overall Study|Progressive disease|3|||
16481827|NCT01030536|40242276|FG003|Overall Study|Progressive disease|2|||
16481828|NCT01030536|40242277|FG004|Overall Study|Progressive disease|0|||
16481829|NCT01030536|40242273|FG000|Overall Study|Death|0|||
16481830|NCT01030536|40242274|FG001|Overall Study|Death|1|||
16481831|NCT01030536|40242275|FG002|Overall Study|Death|0|||
16481832|NCT01030536|40242276|FG003|Overall Study|Death|0|||
16481833|NCT01030536|40242277|FG004|Overall Study|Death|0|||
16481834|NCT00293215|40242278|FG000|Overall Study|Progressive disease|3|||
16481835|NCT00293215|40242279|FG001|Overall Study|Progressive disease|1|||
16288762|NCT02132754|39540643|FG002|Overall Study|Physician Decision|0|||
16288763|NCT02132754|39540644|FG003|Overall Study|Physician Decision|0|||
16288764|NCT02132754|39540645|FG004|Overall Study|Physician Decision|0|||
16288765|NCT02132754|39540646|FG005|Overall Study|Physician Decision|0|||
16481836|NCT00293215|40242278|FG000|Overall Study|Adverse Event|2|||
16481837|NCT00293215|40242279|FG001|Overall Study|Adverse Event|2|||
16481838|NCT00199875|40242281|FG000|Overall Study|Withdrawal by Subject|0|||
16481839|NCT00199875|40242282|FG001|Overall Study|Withdrawal by Subject|0|||
16481840|NCT00199875|40242283|FG002|Overall Study|Withdrawal by Subject|0|||
16481841|NCT00199875|40242284|FG003|Overall Study|Withdrawal by Subject|0|||
16481842|NCT00199875|40242285|FG004|Overall Study|Withdrawal by Subject|1|||
16481843|NCT02191137|40242286|FG000|Treatment|Death|4|||
16481844|NCT02191137|40242286|FG000|Treatment|Withdrawal by Subject|3|||
16481845|NCT02191137|40242286|FG000|Treatment|Adverse Event|2|||
16481846|NCT02191137|40242286|FG000|Treatment|Other|1|||
16481847|NCT02191137|40242286|FG000|Follow-up|Lost to Follow-up|2|||
16481848|NCT02191137|40242286|FG000|Follow-up|Ongoing/unknown|2|||
16481849|NCT02191137|40242286|FG000|Follow-up|Adverse Event|1|||
16481850|NCT01602120|40242287|FG000|Overall Study|Adverse Event|3|||
16481851|NCT01602120|40242288|FG001|Overall Study|Adverse Event|6|||
16481852|NCT01602120|40242289|FG002|Overall Study|Adverse Event|0|||
16481853|NCT01602120|40242290|FG003|Overall Study|Adverse Event|2|||
16481854|NCT01602120|40242287|FG000|Overall Study|Death|0|||
16481855|NCT01602120|40242288|FG001|Overall Study|Death|4|||
16481856|NCT01602120|40242289|FG002|Overall Study|Death|0|||
16481857|NCT01602120|40242290|FG003|Overall Study|Death|0|||
16481858|NCT01602120|40242287|FG000|Overall Study|Lost to Follow-up|0|||
16481859|NCT01602120|40242288|FG001|Overall Study|Lost to Follow-up|1|||
16481860|NCT01602120|40242289|FG002|Overall Study|Lost to Follow-up|0|||
16481861|NCT01602120|40242290|FG003|Overall Study|Lost to Follow-up|1|||
16481862|NCT01602120|40242287|FG000|Overall Study|Protocol Violation|1|||
16481863|NCT01602120|40242288|FG001|Overall Study|Protocol Violation|1|||
16481864|NCT01602120|40242289|FG002|Overall Study|Protocol Violation|0|||
16481865|NCT01602120|40242290|FG003|Overall Study|Protocol Violation|0|||
16481866|NCT01602120|40242287|FG000|Overall Study|Non-compliance|0|||
16481867|NCT01602120|40242288|FG001|Overall Study|Non-compliance|3|||
16288766|NCT02132754|39540647|FG006|Overall Study|Physician Decision|0|||
16288767|NCT02132754|39540648|FG007|Overall Study|Physician Decision|0|||
16288768|NCT02132754|39540649|FG008|Overall Study|Physician Decision|0|||
16288769|NCT02132754|39540650|FG009|Overall Study|Physician Decision|1|||
16481868|NCT01602120|40242289|FG002|Overall Study|Non-compliance|0|||
16481869|NCT01602120|40242290|FG003|Overall Study|Non-compliance|1|||
16481870|NCT01602120|40242287|FG000|Overall Study|Withdrawal by Subject|8|||
16481871|NCT01602120|40242288|FG001|Overall Study|Withdrawal by Subject|17|||
16481872|NCT01602120|40242289|FG002|Overall Study|Withdrawal by Subject|0|||
16481873|NCT01602120|40242290|FG003|Overall Study|Withdrawal by Subject|3|||
16481874|NCT01602120|40242287|FG000|Overall Study|Study Terminated by Sponsor|12|||
16481875|NCT01602120|40242288|FG001|Overall Study|Study Terminated by Sponsor|24|||
16481876|NCT01602120|40242289|FG002|Overall Study|Study Terminated by Sponsor|17|||
16481877|NCT01602120|40242290|FG003|Overall Study|Study Terminated by Sponsor|44|||
16481878|NCT01602120|40242287|FG000|Overall Study|Physician Decision|2|||
16481879|NCT01602120|40242288|FG001|Overall Study|Physician Decision|3|||
16481880|NCT01602120|40242289|FG002|Overall Study|Physician Decision|0|||
16481881|NCT01602120|40242290|FG003|Overall Study|Physician Decision|0|||
16481882|NCT01602120|40242287|FG000|Overall Study|Unspecified Reason|3|||
16481883|NCT01602120|40242288|FG001|Overall Study|Unspecified Reason|1|||
16481884|NCT01602120|40242289|FG002|Overall Study|Unspecified Reason|0|||
16481885|NCT01602120|40242290|FG003|Overall Study|Unspecified Reason|2|||
16481886|NCT00191269|40242294|FG000|Overall Study|Protocol Violation|0|||
16481887|NCT00191269|40242295|FG001|Overall Study|Protocol Violation|2|||
16481888|NCT00191269|40242294|FG000|Overall Study|Adverse Event|1|||
16481889|NCT00191269|40242295|FG001|Overall Study|Adverse Event|4|||
16481890|NCT00191269|40242294|FG000|Overall Study|Progression of Disease|4|||
16481891|NCT00191269|40242295|FG001|Overall Study|Progression of Disease|42|||
16380054|NCT02891226|39874872|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380055|NCT02891226|39874873|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16481892|NCT00191269|40242294|FG000|Overall Study|Lack of Efficacy|1|||
16481893|NCT00191269|40242295|FG001|Overall Study|Lack of Efficacy|5|||
16481894|NCT00191269|40242294|FG000|Overall Study|Withdrawal by Subject|0|||
16481895|NCT00191269|40242295|FG001|Overall Study|Withdrawal by Subject|1|||
16481896|NCT00191269|40242294|FG000|Overall Study|Pathologic Aggrevation|0|||
16481897|NCT00191269|40242295|FG001|Overall Study|Pathologic Aggrevation|1|||
16481898|NCT00191269|40242294|FG000|Overall Study|Physician Decision|0|||
16481899|NCT00191269|40242295|FG001|Overall Study|Physician Decision|3|||
16380056|NCT02891226|39874874|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380057|NCT02891226|39874875|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
16380058|NCT02891226|39874876|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380059|NCT02891226|39874877|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380060|NCT02891226|39874878|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380061|NCT02891226|39874879|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380062|NCT02891226|39874880|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380063|NCT02891226|39874881|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380064|NCT02891226|39874882|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380065|NCT02891226|39874883|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380066|NCT02891226|39874884|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380067|NCT02891226|39874885|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380068|NCT02891226|39874886|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380069|NCT02891226|39874887|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16380070|NCT02891226|39874872|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380071|NCT02891226|39874873|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380072|NCT02891226|39874874|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
16380073|NCT02891226|39874875|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380074|NCT02891226|39874876|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380075|NCT02891226|39874877|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380076|NCT02891226|39874878|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380077|NCT02891226|39874879|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380078|NCT02891226|39874880|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380079|NCT02891226|39874881|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380080|NCT02891226|39874882|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380081|NCT02891226|39874883|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380082|NCT02891226|39874884|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380083|NCT02891226|39874885|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380084|NCT02891226|39874886|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380085|NCT02891226|39874887|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
16380086|NCT02891226|39874872|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380087|NCT02891226|39874873|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380088|NCT02891226|39874874|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380089|NCT02891226|39874875|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
16380090|NCT02891226|39874876|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380091|NCT02891226|39874877|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380092|NCT02891226|39874878|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380093|NCT02891226|39874879|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380094|NCT02891226|39874880|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380095|NCT02891226|39874881|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380096|NCT02891226|39874882|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380097|NCT02891226|39874883|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380098|NCT02891226|39874884|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16481900|NCT03855228|40242296|FG000|Overall Study|Adverse Event|2|||
16481901|NCT03855228|40242297|FG001|Overall Study|Adverse Event|4|||
16481902|NCT03855228|40242298|FG002|Overall Study|Adverse Event|4|||
16481903|NCT03855228|40242299|FG003|Overall Study|Adverse Event|8|||
16481904|NCT03855228|40242296|FG000|Overall Study|Treatment Failure|1|||
16481905|NCT03855228|40242297|FG001|Overall Study|Treatment Failure|2|||
16481906|NCT03855228|40242298|FG002|Overall Study|Treatment Failure|1|||
16481907|NCT03855228|40242299|FG003|Overall Study|Treatment Failure|8|||
16481908|NCT03855228|40242296|FG000|Overall Study|Lost to Follow-up|0|||
16481909|NCT03855228|40242297|FG001|Overall Study|Lost to Follow-up|0|||
16481910|NCT03855228|40242298|FG002|Overall Study|Lost to Follow-up|0|||
16481911|NCT03855228|40242299|FG003|Overall Study|Lost to Follow-up|1|||
16481912|NCT03855228|40242296|FG000|Overall Study|Protocol Violation|0|||
16481913|NCT03855228|40242297|FG001|Overall Study|Protocol Violation|1|||
16481914|NCT03855228|40242298|FG002|Overall Study|Protocol Violation|2|||
16481915|NCT03855228|40242299|FG003|Overall Study|Protocol Violation|1|||
16481916|NCT03855228|40242296|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
16481917|NCT03855228|40242297|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
16481918|NCT03855228|40242298|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
16481919|NCT03855228|40242299|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
16481920|NCT01447433|40242300|FG000|Overall Study|Lost to Follow-up|0|||
16481921|NCT01447433|40242301|FG001|Overall Study|Lost to Follow-up|2|||
16481922|NCT01447433|40242300|FG000|Overall Study|Withdrawal by Subject|3|||
16481923|NCT01447433|40242301|FG001|Overall Study|Withdrawal by Subject|3|||
16481924|NCT01447433|40242300|FG000|Overall Study|Protocol Violation|1|||
16481925|NCT01447433|40242301|FG001|Overall Study|Protocol Violation|1|||
16481926|NCT01706146|40242302|FG000|Overall Study|Withdrawal by Subject|1|||
16481927|NCT01706146|40242302|FG000|Overall Study|Adverse Event|3|||
16481928|NCT01706146|40242302|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
16481929|NCT01414608|40242310|FG000|Overall Study|Ineligible|5|||
16481930|NCT01414608|40242311|FG001|Overall Study|Ineligible|2|||
16481931|NCT02095223|40242321|FG000|Overall Study|Withdrawal by Subject|1|||
16481932|NCT02095223|40242322|FG001|Overall Study|Withdrawal by Subject|0|||
16481933|NCT03583697|40242329|FG000|Overall Study|Withdrawal by Subject|0|||
16481934|NCT03583697|40242330|FG001|Overall Study|Withdrawal by Subject|0|||
16481935|NCT03583697|40242331|FG002|Overall Study|Withdrawal by Subject|1|||
16481936|NCT03583697|40242329|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
16288770|NCT02132754|39540651|FG010|Overall Study|Physician Decision|0|||
16288771|NCT02132754|39540652|FG011|Overall Study|Physician Decision|1|||
16481937|NCT03583697|40242330|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
16481938|NCT03583697|40242331|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
16481939|NCT01449539|40242332|FG000|Overall Study|Withdrawal by Subject|3|||
16288772|NCT02132754|39540653|FG012|Overall Study|Physician Decision|1|||
16288773|NCT02132754|39540654|FG013|Overall Study|Physician Decision|0|||
16288774|NCT02132754|39540655|FG014|Overall Study|Physician Decision|0|||
16288775|NCT02132754|39540656|FG015|Overall Study|Physician Decision|1|||
16288776|NCT02132754|39540657|FG016|Overall Study|Physician Decision|0|||
16288777|NCT02132754|39540658|FG017|Overall Study|Physician Decision|0|||
16288778|NCT02132754|39540659|FG018|Overall Study|Physician Decision|0|||
16288779|NCT02132754|39540660|FG019|Overall Study|Physician Decision|0|||
16288780|NCT02132754|39540661|FG020|Overall Study|Physician Decision|0|||
16288781|NCT02132754|39540662|FG021|Overall Study|Physician Decision|0|||
16481940|NCT01449539|40242332|FG000|Overall Study|Toxicity not study related|1|||
16481941|NCT03719586|40242333|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
16481942|NCT03719586|40242334|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
16481943|NCT03719586|40242335|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
16481944|NCT03719586|40242336|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
16481945|NCT01788228|40242340|FG000|Overall Study|Migrated/moved from study area|1|||
16481946|NCT01788228|40242341|FG001|Overall Study|Migrated/moved from study area|0|||
16481947|NCT01950169|40242343|FG000|Overall Study|Withdrawal by Subject|2|||
16481948|NCT01950169|40242344|FG001|Overall Study|Withdrawal by Subject|8|||
16481949|NCT01950169|40242345|FG002|Overall Study|Withdrawal by Subject|1|||
16481950|NCT01950169|40242343|FG000|Overall Study|Death|1|||
16481951|NCT01950169|40242344|FG001|Overall Study|Death|0|||
16288782|NCT02132754|39540663|FG022|Overall Study|Physician Decision|0|||
16288783|NCT02132754|39540664|FG023|Overall Study|Physician Decision|0|||
16288784|NCT02132754|39540665|FG024|Overall Study|Physician Decision|1|||
16481952|NCT01950169|40242345|FG002|Overall Study|Death|0|||
16481953|NCT04674644|40242357|FG000|Overall Study|with missing data|37|||
16481954|NCT01797731|40242358|FG000|Overall Study|Didn't have proper radiographs required|3|||
16481955|NCT01797731|40242359|FG001|Overall Study|Didn't have proper radiographs required|3|||
16481956|NCT03945266|40242360|FG000|Overall Study|Withdrawal by Subject|1|||
16288785|NCT02132754|39540666|FG025|Overall Study|Physician Decision|0|||
16288786|NCT02132754|39540667|FG026|Overall Study|Physician Decision|0|||
16481957|NCT03945266|40242361|FG001|Overall Study|Withdrawal by Subject|0|||
16481958|NCT03945266|40242360|FG000|Overall Study|Miscarriage|0|||
16481959|NCT03945266|40242361|FG001|Overall Study|Miscarriage|2|||
16288787|NCT02132754|39540668|FG027|Overall Study|Physician Decision|0|||
16288788|NCT02132754|39540669|FG028|Overall Study|Physician Decision|0|||
16288789|NCT02132754|39540670|FG029|Overall Study|Physician Decision|0|||
16288790|NCT02132754|39540671|FG030|Overall Study|Physician Decision|0|||
16288791|NCT02132754|39540672|FG031|Overall Study|Physician Decision|1|||
16288792|NCT02132754|39540673|FG032|Overall Study|Physician Decision|0|||
16288793|NCT02132754|39540674|FG033|Overall Study|Physician Decision|3|||
16288794|NCT02132754|39540641|FG000|Overall Study|Progressive Disease|1|||
16288795|NCT02132754|39540642|FG001|Overall Study|Progressive Disease|1|||
16288796|NCT02132754|39540643|FG002|Overall Study|Progressive Disease|1|||
16288797|NCT02132754|39540644|FG003|Overall Study|Progressive Disease|1|||
16288798|NCT02132754|39540645|FG004|Overall Study|Progressive Disease|1|||
16288799|NCT02132754|39540646|FG005|Overall Study|Progressive Disease|1|||
16288800|NCT02132754|39540647|FG006|Overall Study|Progressive Disease|1|||
16288801|NCT02132754|39540648|FG007|Overall Study|Progressive Disease|1|||
16080370|NCT01943916|38786840|FG000|Overall Study|Protocol Deviation|1|||
16080371|NCT03903822|38786841|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
16080372|NCT03903822|38786842|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
16080373|NCT03903822|38786843|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
16288802|NCT02132754|39540649|FG008|Overall Study|Progressive Disease|1|||
16288803|NCT02132754|39540650|FG009|Overall Study|Progressive Disease|3|||
16380099|NCT02891226|39874885|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380100|NCT02891226|39874886|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380101|NCT02891226|39874887|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
16380102|NCT02891226|39874872|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380103|NCT02891226|39874873|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380104|NCT02891226|39874874|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380105|NCT02891226|39874875|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
16380106|NCT02891226|39874876|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380107|NCT02891226|39874877|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380108|NCT02891226|39874878|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380109|NCT02891226|39874879|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380110|NCT02891226|39874880|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380111|NCT02891226|39874881|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380112|NCT02891226|39874882|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380113|NCT02891226|39874883|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16288804|NCT02132754|39540651|FG010|Overall Study|Progressive Disease|3|||
16288805|NCT02132754|39540652|FG011|Overall Study|Progressive Disease|2|||
16288806|NCT02132754|39540653|FG012|Overall Study|Progressive Disease|2|||
16288807|NCT02132754|39540654|FG013|Overall Study|Progressive Disease|3|||
16288808|NCT02132754|39540655|FG014|Overall Study|Progressive Disease|2|||
16288809|NCT02132754|39540656|FG015|Overall Study|Progressive Disease|1|||
16288810|NCT02132754|39540657|FG016|Overall Study|Progressive Disease|2|||
16288811|NCT02132754|39540658|FG017|Overall Study|Progressive Disease|1|||
16288812|NCT02132754|39540659|FG018|Overall Study|Progressive Disease|3|||
16288813|NCT02132754|39540660|FG019|Overall Study|Progressive Disease|1|||
16288814|NCT02132754|39540661|FG020|Overall Study|Progressive Disease|1|||
16288815|NCT02132754|39540662|FG021|Overall Study|Progressive Disease|3|||
16288816|NCT02132754|39540663|FG022|Overall Study|Progressive Disease|2|||
16288817|NCT02132754|39540664|FG023|Overall Study|Progressive Disease|3|||
16288818|NCT02132754|39540665|FG024|Overall Study|Progressive Disease|0|||
16288819|NCT02132754|39540666|FG025|Overall Study|Progressive Disease|1|||
16288820|NCT02132754|39540667|FG026|Overall Study|Progressive Disease|2|||
16288821|NCT02132754|39540668|FG027|Overall Study|Progressive Disease|1|||
16288822|NCT02132754|39540669|FG028|Overall Study|Progressive Disease|2|||
16288823|NCT02132754|39540670|FG029|Overall Study|Progressive Disease|3|||
16288824|NCT02132754|39540671|FG030|Overall Study|Progressive Disease|1|||
16288825|NCT02132754|39540672|FG031|Overall Study|Progressive Disease|1|||
16288826|NCT02132754|39540673|FG032|Overall Study|Progressive Disease|3|||
16288827|NCT02132754|39540674|FG033|Overall Study|Progressive Disease|6|||
16288828|NCT02132754|39540641|FG000|Overall Study|Screen Failure|0|||
16288829|NCT02132754|39540642|FG001|Overall Study|Screen Failure|0|||
16288830|NCT02132754|39540643|FG002|Overall Study|Screen Failure|0|||
16288831|NCT02132754|39540644|FG003|Overall Study|Screen Failure|0|||
16288832|NCT02132754|39540645|FG004|Overall Study|Screen Failure|0|||
16288833|NCT02132754|39540646|FG005|Overall Study|Screen Failure|0|||
16288834|NCT02132754|39540647|FG006|Overall Study|Screen Failure|0|||
16288835|NCT02132754|39540648|FG007|Overall Study|Screen Failure|0|||
16288836|NCT02132754|39540649|FG008|Overall Study|Screen Failure|0|||
16288837|NCT02132754|39540650|FG009|Overall Study|Screen Failure|0|||
16288838|NCT02132754|39540651|FG010|Overall Study|Screen Failure|0|||
16288839|NCT02132754|39540652|FG011|Overall Study|Screen Failure|0|||
16380114|NCT02891226|39874884|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380115|NCT02891226|39874885|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16080374|NCT03903822|38786844|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
16185745|NCT00426751|39159361|FG001|Overall Study|Lost to Follow-up|6|||
16380116|NCT02891226|39874886|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16288840|NCT02132754|39540653|FG012|Overall Study|Screen Failure|0|||
16288841|NCT02132754|39540654|FG013|Overall Study|Screen Failure|0|||
16288842|NCT02132754|39540655|FG014|Overall Study|Screen Failure|0|||
16288843|NCT02132754|39540656|FG015|Overall Study|Screen Failure|0|||
16288844|NCT02132754|39540657|FG016|Overall Study|Screen Failure|0|||
16288845|NCT02132754|39540658|FG017|Overall Study|Screen Failure|0|||
16288846|NCT02132754|39540659|FG018|Overall Study|Screen Failure|0|||
16288847|NCT02132754|39540660|FG019|Overall Study|Screen Failure|1|||
16288848|NCT02132754|39540661|FG020|Overall Study|Screen Failure|0|||
16288849|NCT02132754|39540662|FG021|Overall Study|Screen Failure|1|||
16080375|NCT03903822|38786845|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
16288850|NCT02132754|39540663|FG022|Overall Study|Screen Failure|0|||
16288851|NCT02132754|39540664|FG023|Overall Study|Screen Failure|0|||
16288852|NCT02132754|39540665|FG024|Overall Study|Screen Failure|0|||
16288853|NCT02132754|39540666|FG025|Overall Study|Screen Failure|0|||
16288854|NCT02132754|39540667|FG026|Overall Study|Screen Failure|0|||
16288855|NCT02132754|39540668|FG027|Overall Study|Screen Failure|0|||
16288856|NCT02132754|39540669|FG028|Overall Study|Screen Failure|0|||
16288857|NCT02132754|39540670|FG029|Overall Study|Screen Failure|0|||
16288858|NCT02132754|39540671|FG030|Overall Study|Screen Failure|0|||
16288859|NCT02132754|39540672|FG031|Overall Study|Screen Failure|0|||
16288860|NCT02132754|39540673|FG032|Overall Study|Screen Failure|0|||
16288861|NCT02132754|39540674|FG033|Overall Study|Screen Failure|0|||
16288862|NCT02132754|39540641|FG000|Overall Study|Transferred to Extension Study|0|||
16288863|NCT02132754|39540642|FG001|Overall Study|Transferred to Extension Study|0|||
16288864|NCT02132754|39540643|FG002|Overall Study|Transferred to Extension Study|0|||
16288865|NCT02132754|39540644|FG003|Overall Study|Transferred to Extension Study|0|||
16288866|NCT02132754|39540645|FG004|Overall Study|Transferred to Extension Study|0|||
16288867|NCT02132754|39540646|FG005|Overall Study|Transferred to Extension Study|0|||
16288868|NCT02132754|39540647|FG006|Overall Study|Transferred to Extension Study|0|||
16288869|NCT02132754|39540648|FG007|Overall Study|Transferred to Extension Study|0|||
16288870|NCT02132754|39540649|FG008|Overall Study|Transferred to Extension Study|0|||
16380117|NCT02891226|39874887|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
16380118|NCT02891226|39874872|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16380119|NCT02891226|39874873|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16380120|NCT02891226|39874874|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16380121|NCT02891226|39874875|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16380122|NCT02891226|39874876|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16380123|NCT02891226|39874877|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16380124|NCT02891226|39874878|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
16380125|NCT02891226|39874879|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
16380126|NCT02891226|39874880|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
16380127|NCT02891226|39874881|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
16380128|NCT02891226|39874882|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16380129|NCT02891226|39874883|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16380130|NCT02891226|39874884|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16380131|NCT02891226|39874885|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16288871|NCT02132754|39540650|FG009|Overall Study|Transferred to Extension Study|0|||
16288872|NCT02132754|39540651|FG010|Overall Study|Transferred to Extension Study|0|||
16288873|NCT02132754|39540652|FG011|Overall Study|Transferred to Extension Study|0|||
16380132|NCT02891226|39874886|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16380133|NCT02891226|39874887|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
16288874|NCT02132754|39540653|FG012|Overall Study|Transferred to Extension Study|0|||
16288875|NCT02132754|39540654|FG013|Overall Study|Transferred to Extension Study|0|||
16288876|NCT02132754|39540655|FG014|Overall Study|Transferred to Extension Study|0|||
16288877|NCT02132754|39540656|FG015|Overall Study|Transferred to Extension Study|0|||
16288878|NCT02132754|39540657|FG016|Overall Study|Transferred to Extension Study|0|||
16288879|NCT02132754|39540658|FG017|Overall Study|Transferred to Extension Study|0|||
16288880|NCT02132754|39540659|FG018|Overall Study|Transferred to Extension Study|0|||
16288881|NCT02132754|39540660|FG019|Overall Study|Transferred to Extension Study|0|||
16288882|NCT02132754|39540661|FG020|Overall Study|Transferred to Extension Study|0|||
16288883|NCT02132754|39540662|FG021|Overall Study|Transferred to Extension Study|0|||
16288884|NCT02132754|39540663|FG022|Overall Study|Transferred to Extension Study|0|||
16288885|NCT02132754|39540664|FG023|Overall Study|Transferred to Extension Study|0|||
16288886|NCT02132754|39540665|FG024|Overall Study|Transferred to Extension Study|0|||
16288887|NCT02132754|39540666|FG025|Overall Study|Transferred to Extension Study|0|||
16288888|NCT02132754|39540667|FG026|Overall Study|Transferred to Extension Study|0|||
16288889|NCT02132754|39540668|FG027|Overall Study|Transferred to Extension Study|0|||
16288890|NCT02132754|39540669|FG028|Overall Study|Transferred to Extension Study|0|||
16288891|NCT02132754|39540670|FG029|Overall Study|Transferred to Extension Study|0|||
16288892|NCT02132754|39540671|FG030|Overall Study|Transferred to Extension Study|0|||
16288893|NCT02132754|39540672|FG031|Overall Study|Transferred to Extension Study|0|||
16288894|NCT02132754|39540673|FG032|Overall Study|Transferred to Extension Study|0|||
16288895|NCT02132754|39540674|FG033|Overall Study|Transferred to Extension Study|6|||
16288896|NCT02132754|39540641|FG000|Overall Study|Withdrawal by Subject|0|||
16288897|NCT02132754|39540642|FG001|Overall Study|Withdrawal by Subject|0|||
16288898|NCT02132754|39540643|FG002|Overall Study|Withdrawal by Subject|0|||
16288899|NCT02132754|39540644|FG003|Overall Study|Withdrawal by Subject|0|||
16288900|NCT02132754|39540645|FG004|Overall Study|Withdrawal by Subject|0|||
16288901|NCT02132754|39540646|FG005|Overall Study|Withdrawal by Subject|0|||
16288902|NCT02132754|39540647|FG006|Overall Study|Withdrawal by Subject|0|||
16288903|NCT02132754|39540648|FG007|Overall Study|Withdrawal by Subject|0|||
16288904|NCT02132754|39540649|FG008|Overall Study|Withdrawal by Subject|0|||
16288905|NCT02132754|39540650|FG009|Overall Study|Withdrawal by Subject|1|||
16288906|NCT02132754|39540651|FG010|Overall Study|Withdrawal by Subject|0|||
16288907|NCT02132754|39540652|FG011|Overall Study|Withdrawal by Subject|0|||
16288908|NCT02132754|39540653|FG012|Overall Study|Withdrawal by Subject|1|||
16288909|NCT02132754|39540654|FG013|Overall Study|Withdrawal by Subject|0|||
16288910|NCT02132754|39540655|FG014|Overall Study|Withdrawal by Subject|1|||
16288911|NCT02132754|39540656|FG015|Overall Study|Withdrawal by Subject|2|||
16288912|NCT02132754|39540657|FG016|Overall Study|Withdrawal by Subject|1|||
16288913|NCT02132754|39540658|FG017|Overall Study|Withdrawal by Subject|0|||
16288914|NCT02132754|39540659|FG018|Overall Study|Withdrawal by Subject|0|||
16288915|NCT02132754|39540660|FG019|Overall Study|Withdrawal by Subject|0|||
16288916|NCT02132754|39540661|FG020|Overall Study|Withdrawal by Subject|1|||
16288917|NCT02132754|39540662|FG021|Overall Study|Withdrawal by Subject|0|||
16288918|NCT02132754|39540663|FG022|Overall Study|Withdrawal by Subject|0|||
16288919|NCT02132754|39540664|FG023|Overall Study|Withdrawal by Subject|0|||
16288920|NCT02132754|39540665|FG024|Overall Study|Withdrawal by Subject|1|||
16288921|NCT02132754|39540666|FG025|Overall Study|Withdrawal by Subject|0|||
16288922|NCT02132754|39540667|FG026|Overall Study|Withdrawal by Subject|0|||
16288923|NCT02132754|39540668|FG027|Overall Study|Withdrawal by Subject|1|||
16288924|NCT02132754|39540669|FG028|Overall Study|Withdrawal by Subject|0|||
16288925|NCT02132754|39540670|FG029|Overall Study|Withdrawal by Subject|0|||
16288926|NCT02132754|39540671|FG030|Overall Study|Withdrawal by Subject|0|||
16288927|NCT02132754|39540672|FG031|Overall Study|Withdrawal by Subject|1|||
16288928|NCT02132754|39540673|FG032|Overall Study|Withdrawal by Subject|0|||
16288929|NCT02132754|39540674|FG033|Overall Study|Withdrawal by Subject|2|||
16288930|NCT03347422|39540675|FG000|Part A (26 Weeks)|Adverse Event|3|||
16288931|NCT03347422|39540676|FG001|Part A (26 Weeks)|Adverse Event|0|||
16288932|NCT03347422|39540675|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
16288933|NCT03347422|39540676|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
16288934|NCT03347422|39540675|FG000|Part B (149 Weeks)|Adverse Event|0|||
16288935|NCT03347422|39540676|FG001|Part B (149 Weeks)|Adverse Event|1|||
16288936|NCT03347422|39540675|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
16288937|NCT03347422|39540676|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
16288938|NCT03347422|39540675|FG000|Part B (149 Weeks)|Other|1|||
16288939|NCT03347422|39540676|FG001|Part B (149 Weeks)|Other|0|||
16288940|NCT02940730|39540679|FG000|Intervention 2|Physician Decision|7|||
16288941|NCT02940730|39540680|FG001|Intervention 2|Physician Decision|0|||
16288942|NCT02522403|39540682|FG000|Overall Study|Lost to Follow-up|2|||
16288943|NCT02522403|39540683|FG001|Overall Study|Lost to Follow-up|2|||
16380134|NCT02891226|39874872|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16288944|NCT02522403|39540682|FG000|Overall Study|Withdrawal by Subject|2|||
16288945|NCT02522403|39540683|FG001|Overall Study|Withdrawal by Subject|4|||
16288946|NCT02823652|39540684|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
16288947|NCT02823652|39540685|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
16288948|NCT02823652|39540686|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
16288949|NCT02823652|39540684|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
16288950|NCT02823652|39540685|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
16288951|NCT02823652|39540686|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
16288952|NCT02823652|39540684|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
16288953|NCT02823652|39540685|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
16288954|NCT02823652|39540686|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
16288955|NCT02823652|39540684|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
16288956|NCT02823652|39540685|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
16288957|NCT02823652|39540686|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
16288958|NCT03176459|39540704|FG000|Overall Study|Lost to Follow-up|5|||
16288959|NCT03176459|39540705|FG001|Overall Study|Lost to Follow-up|7|||
16288960|NCT00770692|39540708|FG000|Overall Study|Withdrawal by Subject|7|||
16288961|NCT00770692|39540709|FG001|Overall Study|Withdrawal by Subject|9|||
16288962|NCT00770692|39540710|FG002|Overall Study|Withdrawal by Subject|9|||
16288963|NCT00770692|39540711|FG003|Overall Study|Withdrawal by Subject|6|||
16288964|NCT00770692|39540708|FG000|Overall Study|Adverse Event|3|||
16288965|NCT00770692|39540709|FG001|Overall Study|Adverse Event|0|||
16288966|NCT00770692|39540710|FG002|Overall Study|Adverse Event|4|||
16288967|NCT00770692|39540711|FG003|Overall Study|Adverse Event|4|||
16288968|NCT00770692|39540708|FG000|Overall Study|Investigator judgment|2|||
16288969|NCT00770692|39540709|FG001|Overall Study|Investigator judgment|0|||
16288970|NCT00770692|39540710|FG002|Overall Study|Investigator judgment|1|||
16288971|NCT00770692|39540711|FG003|Overall Study|Investigator judgment|1|||
16288972|NCT00107042|39540712|FG000|Overall Study|Lost to Follow-up|9|||
16288973|NCT00107042|39540713|FG001|Overall Study|Lost to Follow-up|7|||
16288974|NCT00107042|39540712|FG000|Overall Study|Withdrawal by Subject|6|||
16288975|NCT00107042|39540713|FG001|Overall Study|Withdrawal by Subject|1|||
16288976|NCT00107042|39540712|FG000|Overall Study|Moved out of area|5|||
16288977|NCT00107042|39540713|FG001|Overall Study|Moved out of area|3|||
16288978|NCT00107042|39540712|FG000|Overall Study|Pregnancy|1|||
16288979|NCT00107042|39540713|FG001|Overall Study|Pregnancy|1|||
16288980|NCT00107042|39540712|FG000|Overall Study|Inadvertent enrollment|0|||
16288981|NCT00107042|39540713|FG001|Overall Study|Inadvertent enrollment|1|||
16288982|NCT00107042|39540712|FG000|Overall Study|vaccinated outside window|1|||
16288983|NCT00107042|39540713|FG001|Overall Study|vaccinated outside window|1|||
16288984|NCT00107042|39540712|FG000|Overall Study|Disallowed medications|0|||
16288985|NCT00107042|39540713|FG001|Overall Study|Disallowed medications|2|||
16288986|NCT01079832|39540716|FG000|Overall Study|Withdrawal by Subject|1|||
16288987|NCT03510182|39540717|FG000|Overall Study|Withdrawal by Subject|2|||
16288988|NCT01753336|39540722|FG000|Overall Study|Patient decision|12|||
16288989|NCT01753336|39540722|FG000|Overall Study|Lost to Follow-up|3|||
16288990|NCT01753336|39540722|FG000|Overall Study|Physician Decision|2|||
16380135|NCT02891226|39874873|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380136|NCT02891226|39874874|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380137|NCT02891226|39874875|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380138|NCT02891226|39874876|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380139|NCT02891226|39874877|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
16380140|NCT02891226|39874878|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380141|NCT02891226|39874879|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380142|NCT02891226|39874880|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380143|NCT02891226|39874881|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
16380144|NCT02891226|39874882|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380145|NCT02891226|39874883|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380146|NCT02891226|39874884|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380147|NCT02891226|39874885|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16481960|NCT03945266|40242360|FG000|Overall Study|Lost to Follow-up|1|||
16481961|NCT03945266|40242361|FG001|Overall Study|Lost to Follow-up|0|||
16288991|NCT01753336|39540722|FG000|Overall Study|Sponsor's decision|2|||
16288992|NCT01753336|39540722|FG000|Overall Study|Withdrawal by Subject|1|||
16288993|NCT03276780|39540723|FG000|Overall Study|Withdrawal by Subject|5|||
16288994|NCT03276780|39540724|FG001|Overall Study|Withdrawal by Subject|3|||
16288995|NCT03276780|39540723|FG000|Overall Study|Lost to Follow-up|3|||
16288996|NCT03276780|39540724|FG001|Overall Study|Lost to Follow-up|5|||
16288997|NCT03276780|39540723|FG000|Overall Study|Moved out of state|1|||
16380148|NCT02891226|39874886|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380149|NCT02891226|39874887|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
16380150|NCT02891226|39874872|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380151|NCT02891226|39874873|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380152|NCT02891226|39874874|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380153|NCT02891226|39874875|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380154|NCT02891226|39874876|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380155|NCT02891226|39874877|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380156|NCT02891226|39874878|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
16380157|NCT02891226|39874879|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
16380158|NCT02891226|39874880|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
16380159|NCT02891226|39874881|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
16380160|NCT02891226|39874882|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380161|NCT02891226|39874883|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380162|NCT02891226|39874884|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380163|NCT02891226|39874885|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380164|NCT02891226|39874886|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16380165|NCT02891226|39874887|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
16288998|NCT03276780|39540724|FG001|Overall Study|Moved out of state|1|||
16288999|NCT03276780|39540723|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
16289000|NCT03276780|39540724|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
16289001|NCT03276780|39540723|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
16380166|NCT02891226|39874872|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380167|NCT02891226|39874873|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380168|NCT02891226|39874874|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16289002|NCT03276780|39540724|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
16289003|NCT03180801|39540726|FG000|Overall Study|Physician Decision|3|||
16289004|NCT03180801|39540727|FG001|Overall Study|Physician Decision|3|||
16289005|NCT03180801|39540728|FG002|Overall Study|Physician Decision|1|||
16289006|NCT03180801|39540726|FG000|Overall Study|Non-compliance|1|||
16380169|NCT02891226|39874875|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380170|NCT02891226|39874876|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
16380171|NCT02891226|39874877|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380172|NCT02891226|39874878|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380173|NCT02891226|39874879|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16289007|NCT03180801|39540727|FG001|Overall Study|Non-compliance|4|||
16289008|NCT03180801|39540728|FG002|Overall Study|Non-compliance|0|||
16289009|NCT03180801|39540726|FG000|Overall Study|Inoculation Target Reached|1|||
16289010|NCT03180801|39540727|FG001|Overall Study|Inoculation Target Reached|1|||
16289011|NCT03180801|39540728|FG002|Overall Study|Inoculation Target Reached|3|||
16289012|NCT03180801|39540726|FG000|Overall Study|Adverse Event|1|||
16289013|NCT03180801|39540727|FG001|Overall Study|Adverse Event|0|||
16289014|NCT03180801|39540728|FG002|Overall Study|Adverse Event|2|||
16289015|NCT03180801|39540726|FG000|Overall Study|Withdrawal by Subject|2|||
16289016|NCT03180801|39540727|FG001|Overall Study|Withdrawal by Subject|2|||
16289017|NCT03180801|39540728|FG002|Overall Study|Withdrawal by Subject|1|||
16289018|NCT03180801|39540726|FG000|Overall Study|Lost to Follow-up|0|||
16289019|NCT03180801|39540727|FG001|Overall Study|Lost to Follow-up|2|||
16289020|NCT03180801|39540728|FG002|Overall Study|Lost to Follow-up|3|||
16289021|NCT02091141|39540729|FG000|Overall Study|Death|280|||
16289022|NCT02091141|39540730|FG001|Overall Study|Death|118|||
16289023|NCT02091141|39540731|FG002|Overall Study|Death|46|||
16289024|NCT02091141|39540732|FG003|Overall Study|Death|13|||
16289025|NCT02091141|39540733|FG004|Overall Study|Death|31|||
16289026|NCT02091141|39540734|FG005|Overall Study|Death|16|||
16289027|NCT02091141|39540735|FG006|Overall Study|Death|12|||
16289028|NCT02091141|39540729|FG000|Overall Study|Withdrawal by Subject|21|||
16289029|NCT02091141|39540730|FG001|Overall Study|Withdrawal by Subject|13|||
16289030|NCT02091141|39540731|FG002|Overall Study|Withdrawal by Subject|3|||
16289031|NCT02091141|39540732|FG003|Overall Study|Withdrawal by Subject|2|||
16289032|NCT02091141|39540733|FG004|Overall Study|Withdrawal by Subject|2|||
16289033|NCT02091141|39540734|FG005|Overall Study|Withdrawal by Subject|3|||
16289034|NCT02091141|39540735|FG006|Overall Study|Withdrawal by Subject|0|||
16289035|NCT02091141|39540729|FG000|Overall Study|Lost to Follow-up|21|||
16289036|NCT02091141|39540730|FG001|Overall Study|Lost to Follow-up|5|||
16289037|NCT02091141|39540731|FG002|Overall Study|Lost to Follow-up|1|||
16289038|NCT02091141|39540732|FG003|Overall Study|Lost to Follow-up|0|||
16380174|NCT02891226|39874880|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380175|NCT02891226|39874881|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380176|NCT02891226|39874882|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380177|NCT02891226|39874883|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380178|NCT02891226|39874884|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380179|NCT02891226|39874885|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380180|NCT02891226|39874886|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380181|NCT02891226|39874887|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
16380182|NCT02891226|39874872|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380183|NCT02891226|39874873|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380184|NCT02891226|39874874|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380185|NCT02891226|39874875|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380186|NCT02891226|39874876|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380187|NCT02891226|39874877|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380188|NCT02891226|39874878|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
16380189|NCT02891226|39874879|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380190|NCT02891226|39874880|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380191|NCT02891226|39874881|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380192|NCT02891226|39874882|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380193|NCT02891226|39874883|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380194|NCT02891226|39874884|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380195|NCT02891226|39874885|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16289039|NCT02091141|39540733|FG004|Overall Study|Lost to Follow-up|1|||
16289040|NCT02091141|39540734|FG005|Overall Study|Lost to Follow-up|2|||
16289041|NCT02091141|39540735|FG006|Overall Study|Lost to Follow-up|0|||
16289042|NCT02091141|39540729|FG000|Overall Study|Reason Not Specified|6|||
16289043|NCT02091141|39540730|FG001|Overall Study|Reason Not Specified|5|||
16289044|NCT02091141|39540731|FG002|Overall Study|Reason Not Specified|2|||
16289045|NCT02091141|39540732|FG003|Overall Study|Reason Not Specified|0|||
16289046|NCT02091141|39540733|FG004|Overall Study|Reason Not Specified|0|||
16289047|NCT02091141|39540734|FG005|Overall Study|Reason Not Specified|0|||
16289048|NCT02091141|39540735|FG006|Overall Study|Reason Not Specified|1|||
16289049|NCT02091141|39540729|FG000|Overall Study|Study Ended by Sponsor|1|||
16481962|NCT05439941|40242362|FG000|Overall Study|Lack of Efficacy|8|||
16481963|NCT05439941|40242363|FG001|Overall Study|Lack of Efficacy|5|||
16481964|NCT05439941|40242364|FG002|Overall Study|Lack of Efficacy|3|||
16481965|NCT05439941|40242362|FG000|Overall Study|Treatment Failure|0|||
16481966|NCT05439941|40242363|FG001|Overall Study|Treatment Failure|1|||
16481967|NCT05439941|40242364|FG002|Overall Study|Treatment Failure|0|||
16481968|NCT05439941|40242362|FG000|Overall Study|Adverse Event|1|||
16481969|NCT05439941|40242363|FG001|Overall Study|Adverse Event|3|||
16481970|NCT05439941|40242364|FG002|Overall Study|Adverse Event|0|||
16481971|NCT05439941|40242362|FG000|Overall Study|Adverse Event - Parent Study|1|||
16481972|NCT05439941|40242363|FG001|Overall Study|Adverse Event - Parent Study|0|||
16481973|NCT05439941|40242364|FG002|Overall Study|Adverse Event - Parent Study|0|||
16481974|NCT05439941|40242362|FG000|Overall Study|Pregnancy|1|||
16481975|NCT05439941|40242363|FG001|Overall Study|Pregnancy|0|||
16481976|NCT05439941|40242364|FG002|Overall Study|Pregnancy|0|||
16481977|NCT05439941|40242362|FG000|Overall Study|Withdrawal by Subject|9|||
16481978|NCT05439941|40242363|FG001|Overall Study|Withdrawal by Subject|6|||
16481979|NCT05439941|40242364|FG002|Overall Study|Withdrawal by Subject|10|||
16481980|NCT05439941|40242362|FG000|Overall Study|Non-Compliance|1|||
16481981|NCT05439941|40242363|FG001|Overall Study|Non-Compliance|1|||
16481982|NCT05439941|40242364|FG002|Overall Study|Non-Compliance|1|||
16481983|NCT05439941|40242362|FG000|Overall Study|Lost to Follow-up|2|||
16481984|NCT05439941|40242363|FG001|Overall Study|Lost to Follow-up|2|||
16481985|NCT05439941|40242364|FG002|Overall Study|Lost to Follow-up|0|||
16481986|NCT05439941|40242362|FG000|Overall Study|Physician Decision|1|||
16481987|NCT05439941|40242363|FG001|Overall Study|Physician Decision|0|||
16481988|NCT05439941|40242364|FG002|Overall Study|Physician Decision|0|||
16481989|NCT05439941|40242362|FG000|Overall Study|Trial Termination by Sponsor|78|||
16481990|NCT05439941|40242363|FG001|Overall Study|Trial Termination by Sponsor|83|||
16481991|NCT05439941|40242364|FG002|Overall Study|Trial Termination by Sponsor|65|||
16481992|NCT05439941|40242362|FG000|Overall Study|Other than Reasons Listed|2|||
16481993|NCT05439941|40242363|FG001|Overall Study|Other than Reasons Listed|1|||
16481994|NCT05439941|40242364|FG002|Overall Study|Other than Reasons Listed|0|||
16481995|NCT00165984|40242365|FG000|Overall Study|Death|15|||
16481996|NCT00437983|40242366|FG000|Overall Study|Adverse Event|6|||
16481997|NCT00437983|40242367|FG001|Overall Study|Adverse Event|6|||
16481998|NCT00437983|40242366|FG000|Overall Study|Protocol Violation|2|||
16481999|NCT00437983|40242367|FG001|Overall Study|Protocol Violation|1|||
16482000|NCT00437983|40242366|FG000|Overall Study|Withdrawal by Subject|5|||
16482001|NCT00437983|40242367|FG001|Overall Study|Withdrawal by Subject|6|||
16482002|NCT00075218|40242371|FG000|Double-Blind Treatment|Adverse Event|23|||
16482003|NCT00075218|40242372|FG001|Double-Blind Treatment|Adverse Event|4|||
16482004|NCT00075218|40242373|FG002|Double-Blind Treatment|Adverse Event|0|||
16080376|NCT03903822|38786846|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
16080377|NCT03903822|38786847|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
16080378|NCT03903822|38786848|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
16080379|NCT03903822|38786841|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
16080380|NCT03903822|38786842|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
16080381|NCT03903822|38786843|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
16080382|NCT03903822|38786844|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
16482005|NCT00075218|40242371|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
16289050|NCT02091141|39540730|FG001|Overall Study|Study Ended by Sponsor|9|||
16289051|NCT02091141|39540731|FG002|Overall Study|Study Ended by Sponsor|0|||
16289052|NCT02091141|39540732|FG003|Overall Study|Study Ended by Sponsor|0|||
16289053|NCT02091141|39540733|FG004|Overall Study|Study Ended by Sponsor|0|||
16289054|NCT02091141|39540734|FG005|Overall Study|Study Ended by Sponsor|0|||
16080383|NCT03903822|38786845|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
16080384|NCT03903822|38786846|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
16289055|NCT02091141|39540735|FG006|Overall Study|Study Ended by Sponsor|0|||
16482006|NCT00075218|40242372|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
16482007|NCT00075218|40242373|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
16482008|NCT00075218|40242371|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
16482009|NCT00075218|40242372|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
16482010|NCT00075218|40242373|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
16482011|NCT00075218|40242371|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
16080385|NCT03903822|38786847|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
16289056|NCT02091141|39540729|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
16482012|NCT00075218|40242372|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
16482013|NCT00075218|40242373|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
16482014|NCT00075218|40242371|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
16482015|NCT00075218|40242372|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
16482016|NCT00075218|40242373|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
16482017|NCT00075218|40242371|FG000|Double-Blind Treatment|No study medication taken|2|||
16482018|NCT00075218|40242372|FG001|Double-Blind Treatment|No study medication taken|0|||
16482019|NCT00075218|40242373|FG002|Double-Blind Treatment|No study medication taken|0|||
16482020|NCT00075218|40242371|FG000|Open-Label Treatment|Lack of Efficacy|0|||
16482021|NCT00075218|40242372|FG001|Open-Label Treatment|Lack of Efficacy|0|||
16482022|NCT00075218|40242373|FG002|Open-Label Treatment|Lack of Efficacy|174|||
16482023|NCT00075218|40242371|FG000|Open-Label Treatment|Adverse Event|0|||
16482024|NCT00075218|40242372|FG001|Open-Label Treatment|Adverse Event|0|||
16482025|NCT00075218|40242373|FG002|Open-Label Treatment|Adverse Event|51|||
16482026|NCT00075218|40242371|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
16482027|NCT00075218|40242372|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
16482028|NCT00075218|40242373|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
16482029|NCT00075218|40242371|FG000|Open-Label Treatment|Decision of Sponsor|0|||
16482030|NCT00075218|40242372|FG001|Open-Label Treatment|Decision of Sponsor|0|||
16482031|NCT00075218|40242373|FG002|Open-Label Treatment|Decision of Sponsor|8|||
16482032|NCT00075218|40242371|FG000|Open-Label Treatment|Protocol Violation|0|||
16482033|NCT00075218|40242372|FG001|Open-Label Treatment|Protocol Violation|0|||
16482034|NCT00075218|40242373|FG002|Open-Label Treatment|Protocol Violation|1|||
16482035|NCT00075218|40242371|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
16482036|NCT00075218|40242372|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
16482037|NCT00075218|40242373|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
16482038|NCT04401423|40242374|FG000|Overall Study|Withdrawal by Subject|3|||
16482039|NCT04401423|40242375|FG001|Overall Study|Withdrawal by Subject|1|||
16482040|NCT04401423|40242374|FG000|Overall Study|Physician Decision|2|||
16482041|NCT04401423|40242375|FG001|Overall Study|Physician Decision|1|||
16482042|NCT01921387|40242376|FG000|Overall Study|Adverse Event|1|||
16482043|NCT02571777|40242377|FG000|Overall Study|Subject/guardian decision|34|||
16482044|NCT02571777|40242378|FG001|Overall Study|Subject/guardian decision|26|||
16482045|NCT02571777|40242379|FG002|Overall Study|Subject/guardian decision|26|||
16482046|NCT02571777|40242380|FG003|Overall Study|Subject/guardian decision|25|||
16482047|NCT02571777|40242381|FG004|Overall Study|Subject/guardian decision|27|||
16185746|NCT00426751|39159360|FG000|Overall Study|Consent Withdrawn|0|||
16482048|NCT02571777|40242377|FG000|Overall Study|Protocol Deviation|2|||
16482049|NCT02571777|40242378|FG001|Overall Study|Protocol Deviation|3|||
16482050|NCT02571777|40242379|FG002|Overall Study|Protocol Deviation|4|||
16482051|NCT02571777|40242380|FG003|Overall Study|Protocol Deviation|8|||
16482052|NCT02571777|40242381|FG004|Overall Study|Protocol Deviation|4|||
16482053|NCT02571777|40242377|FG000|Overall Study|Death|1|||
16482054|NCT02571777|40242378|FG001|Overall Study|Death|1|||
16482055|NCT02571777|40242379|FG002|Overall Study|Death|4|||
16482056|NCT02571777|40242380|FG003|Overall Study|Death|0|||
16482057|NCT02571777|40242381|FG004|Overall Study|Death|0|||
16482058|NCT02571777|40242377|FG000|Overall Study|Lost to Follow-up|1|||
16482059|NCT02571777|40242378|FG001|Overall Study|Lost to Follow-up|1|||
16482060|NCT02571777|40242379|FG002|Overall Study|Lost to Follow-up|2|||
16482061|NCT02571777|40242380|FG003|Overall Study|Lost to Follow-up|0|||
16482062|NCT02571777|40242381|FG004|Overall Study|Lost to Follow-up|1|||
16482063|NCT02571777|40242377|FG000|Overall Study|Physician Decision|1|||
16482064|NCT02571777|40242378|FG001|Overall Study|Physician Decision|7|||
16482065|NCT02571777|40242379|FG002|Overall Study|Physician Decision|5|||
16482066|NCT02571777|40242380|FG003|Overall Study|Physician Decision|2|||
16482067|NCT02571777|40242381|FG004|Overall Study|Physician Decision|4|||
16482068|NCT02571777|40242377|FG000|Overall Study|Pregnancy|0|||
16482069|NCT02571777|40242378|FG001|Overall Study|Pregnancy|0|||
16482070|NCT02571777|40242379|FG002|Overall Study|Pregnancy|0|||
16482071|NCT02571777|40242380|FG003|Overall Study|Pregnancy|2|||
16482072|NCT02571777|40242381|FG004|Overall Study|Pregnancy|0|||
16482073|NCT00915278|40242382|FG000|Overall Study|Death|1|||
16482074|NCT00915278|40242383|FG001|Overall Study|Death|0|||
16482075|NCT00915278|40242384|FG002|Overall Study|Death|0|||
16482076|NCT00915278|40242385|FG003|Overall Study|Death|0|||
16482077|NCT00915278|40242386|FG004|Overall Study|Death|0|||
16482078|NCT00915278|40242387|FG005|Overall Study|Death|0|||
16482079|NCT00915278|40242382|FG000|Overall Study|Lost to Follow-up|0|||
16482080|NCT00915278|40242383|FG001|Overall Study|Lost to Follow-up|1|||
16482081|NCT00915278|40242384|FG002|Overall Study|Lost to Follow-up|0|||
16482082|NCT00915278|40242385|FG003|Overall Study|Lost to Follow-up|0|||
16482083|NCT00915278|40242386|FG004|Overall Study|Lost to Follow-up|0|||
16482084|NCT00915278|40242387|FG005|Overall Study|Lost to Follow-up|0|||
16482085|NCT00915278|40242382|FG000|Overall Study|Withdrawal by Subject|0|||
16482086|NCT00915278|40242383|FG001|Overall Study|Withdrawal by Subject|1|||
16482087|NCT00915278|40242384|FG002|Overall Study|Withdrawal by Subject|0|||
16482088|NCT00915278|40242385|FG003|Overall Study|Withdrawal by Subject|0|||
16482089|NCT00915278|40242386|FG004|Overall Study|Withdrawal by Subject|1|||
16482090|NCT00915278|40242387|FG005|Overall Study|Withdrawal by Subject|4|||
16482091|NCT00915278|40242382|FG000|Overall Study|Adverse Event|4|||
16482092|NCT00915278|40242383|FG001|Overall Study|Adverse Event|1|||
16482093|NCT00915278|40242384|FG002|Overall Study|Adverse Event|0|||
16482094|NCT00915278|40242385|FG003|Overall Study|Adverse Event|0|||
16482095|NCT00915278|40242386|FG004|Overall Study|Adverse Event|0|||
16482096|NCT00915278|40242387|FG005|Overall Study|Adverse Event|0|||
16482097|NCT00915278|40242382|FG000|Overall Study|Progressive disease/clinical progression|0|||
16482098|NCT00915278|40242383|FG001|Overall Study|Progressive disease/clinical progression|0|||
16482099|NCT00915278|40242384|FG002|Overall Study|Progressive disease/clinical progression|0|||
16482100|NCT00915278|40242385|FG003|Overall Study|Progressive disease/clinical progression|3|||
16482101|NCT00915278|40242386|FG004|Overall Study|Progressive disease/clinical progression|1|||
16482102|NCT00915278|40242387|FG005|Overall Study|Progressive disease/clinical progression|2|||
16482103|NCT00915278|40242382|FG000|Overall Study|Infusion related AEs|0|||
16482104|NCT00915278|40242383|FG001|Overall Study|Infusion related AEs|0|||
16482105|NCT00915278|40242384|FG002|Overall Study|Infusion related AEs|0|||
16482106|NCT00915278|40242385|FG003|Overall Study|Infusion related AEs|0|||
16482107|NCT00915278|40242386|FG004|Overall Study|Infusion related AEs|0|||
16482108|NCT00915278|40242387|FG005|Overall Study|Infusion related AEs|2|||
16482109|NCT00915278|40242382|FG000|Overall Study|Admission to hospice|0|||
16482110|NCT00915278|40242383|FG001|Overall Study|Admission to hospice|0|||
16482111|NCT00915278|40242384|FG002|Overall Study|Admission to hospice|1|||
16482112|NCT00915278|40242385|FG003|Overall Study|Admission to hospice|0|||
16482113|NCT00915278|40242386|FG004|Overall Study|Admission to hospice|0|||
16482114|NCT00915278|40242387|FG005|Overall Study|Admission to hospice|0|||
16482115|NCT02339285|40242390|FG000|Overall Study|Withdrawal by Subject|0|||
16482116|NCT02339285|40242391|FG001|Overall Study|Withdrawal by Subject|1|||
16482117|NCT02339285|40242392|FG002|Overall Study|Withdrawal by Subject|1|||
16482118|NCT02339285|40242390|FG000|Overall Study|Lost to Follow-up|1|||
16482119|NCT02339285|40242391|FG001|Overall Study|Lost to Follow-up|1|||
16482120|NCT02339285|40242392|FG002|Overall Study|Lost to Follow-up|1|||
16482121|NCT02339285|40242390|FG000|Overall Study|Protocol Deviation|0|||
16482122|NCT02339285|40242391|FG001|Overall Study|Protocol Deviation|1|||
16482123|NCT02339285|40242392|FG002|Overall Study|Protocol Deviation|0|||
16482124|NCT00799383|40242394|FG000|Overall Study|Protocol Violation|1|||
16482125|NCT00799383|40242395|FG001|Overall Study|Protocol Violation|1|||
16482126|NCT00799383|40242394|FG000|Overall Study|Adverse Event|0|||
16482127|NCT00799383|40242395|FG001|Overall Study|Adverse Event|1|||
16482128|NCT00799383|40242394|FG000|Overall Study|Lost to Follow-up|1|||
16482129|NCT00799383|40242395|FG001|Overall Study|Lost to Follow-up|2|||
16482130|NCT00799383|40242394|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
16482131|NCT00799383|40242395|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
16482132|NCT00799383|40242394|FG000|Overall Study|Withdrawal by Subject|0|||
16482133|NCT00799383|40242395|FG001|Overall Study|Withdrawal by Subject|1|||
16482134|NCT02925923|40242397|FG000|Overall Study|blood samples hemolyzed|0|||
16482135|NCT02925923|40242398|FG001|Overall Study|blood samples hemolyzed|2|||
16080386|NCT03903822|38786848|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
16080387|NCT03903822|38786841|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
16080388|NCT03903822|38786842|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
16080389|NCT03903822|38786843|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
16080390|NCT03903822|38786844|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
16080391|NCT03903822|38786845|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
16482136|NCT00573183|40242399|FG000|Overall Study|Lost to Follow-up|52|||
16482137|NCT00573183|40242400|FG001|Overall Study|Lost to Follow-up|50|||
16482138|NCT00573183|40242399|FG000|Overall Study|Withdrawal by Subject|8|||
16482139|NCT00573183|40242400|FG001|Overall Study|Withdrawal by Subject|2|||
16482140|NCT00573183|40242399|FG000|Overall Study|Death|0|||
16482141|NCT00573183|40242400|FG001|Overall Study|Death|1|||
16482142|NCT00573183|40242399|FG000|Overall Study|Adverse Event|2|||
16482143|NCT00573183|40242400|FG001|Overall Study|Adverse Event|0|||
16289057|NCT02091141|39540730|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
16289058|NCT02091141|39540731|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
16289059|NCT02091141|39540732|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
16289060|NCT02091141|39540733|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
16289061|NCT02091141|39540734|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
16289062|NCT02091141|39540735|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
16289063|NCT04317599|39540736|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
16289064|NCT04317599|39540736|FG000|Overall Study|treatment outside standard of care|4|||
16289065|NCT01481324|39540737|FG000|Overall Study|Missing Data|0|||
16289066|NCT01481324|39540738|FG001|Overall Study|Missing Data|2|||
16289067|NCT01481324|39540739|FG002|Overall Study|Missing Data|2|||
16289068|NCT03575871|39540742|FG000|Overall Study|Adverse Event|5|||
16289069|NCT03575871|39540743|FG001|Overall Study|Adverse Event|5|||
16482144|NCT00573183|40242399|FG000|Overall Study|Incarceration|5|||
16482145|NCT00573183|40242400|FG001|Overall Study|Incarceration|8|||
16482146|NCT00573183|40242399|FG000|Overall Study|Other|5|||
16482147|NCT00573183|40242400|FG001|Overall Study|Other|2|||
16482148|NCT00781274|40242403|FG000|Overall Study|Withdrawal by Subject|2|||
16482149|NCT02021773|40242404|FG000|Overall Study|Adverse Event|1|||
16482150|NCT02021773|40242405|FG001|Overall Study|Adverse Event|4|||
16482151|NCT02021773|40242406|FG002|Overall Study|Adverse Event|3|||
16482152|NCT02021773|40242404|FG000|Overall Study|Lack of Efficacy|2|||
16289070|NCT03575871|39540744|FG002|Overall Study|Adverse Event|8|||
16289071|NCT03575871|39540742|FG000|Overall Study|Death|1|||
16482153|NCT02021773|40242405|FG001|Overall Study|Lack of Efficacy|2|||
16482154|NCT02021773|40242406|FG002|Overall Study|Lack of Efficacy|2|||
16482155|NCT02021773|40242404|FG000|Overall Study|Protocol Violation|2|||
16482156|NCT02021773|40242405|FG001|Overall Study|Protocol Violation|3|||
16482157|NCT02021773|40242406|FG002|Overall Study|Protocol Violation|1|||
16482158|NCT02021773|40242404|FG000|Overall Study|Withdrawal by Subject|3|||
16482159|NCT02021773|40242405|FG001|Overall Study|Withdrawal by Subject|4|||
16482160|NCT02021773|40242406|FG002|Overall Study|Withdrawal by Subject|5|||
16482161|NCT02021773|40242404|FG000|Overall Study|Lost to Follow-up|1|||
16482162|NCT02021773|40242405|FG001|Overall Study|Lost to Follow-up|3|||
16482163|NCT02021773|40242406|FG002|Overall Study|Lost to Follow-up|0|||
16482164|NCT02021773|40242404|FG000|Overall Study|Reason not specified|3|||
16482165|NCT02021773|40242405|FG001|Overall Study|Reason not specified|0|||
16482166|NCT02021773|40242406|FG002|Overall Study|Reason not specified|0|||
16482167|NCT01683383|40242407|FG000|Overall Study|Infant was not transported|1|||
16482168|NCT01683383|40242408|FG001|Overall Study|Infant was not transported|0|||
16482169|NCT00457301|40242411|FG000|Overall Study|Withdrawal by Subject|3|||
16482170|NCT00457301|40242412|FG001|Overall Study|Withdrawal by Subject|3|||
16482171|NCT00457301|40242411|FG000|Overall Study|Censored out of the study|15|||
16482172|NCT00457301|40242412|FG001|Overall Study|Censored out of the study|14|||
16482173|NCT00457301|40242411|FG000|Overall Study|Death|5|||
16482174|NCT00457301|40242412|FG001|Overall Study|Death|7|||
16482175|NCT01453361|40242415|FG000|Overall Study|Disease Progression|6|||
16482176|NCT01453361|40242415|FG000|Overall Study|Screen-Failures|10|||
16482177|NCT03641339|40242417|FG000|Overall Study|Physician Decision|1|||
16482178|NCT03641339|40242418|FG001|Overall Study|Physician Decision|0|||
16482179|NCT03641339|40242419|FG002|Overall Study|Physician Decision|0|||
16482180|NCT03641339|40242420|FG003|Overall Study|Physician Decision|0|||
16482181|NCT03641339|40242421|FG004|Overall Study|Physician Decision|0|||
16482182|NCT03641339|40242422|FG005|Overall Study|Physician Decision|0|||
16482183|NCT03641339|40242417|FG000|Overall Study|Withdrawal by Subject|0|||
16482184|NCT03641339|40242418|FG001|Overall Study|Withdrawal by Subject|2|||
16482185|NCT03641339|40242419|FG002|Overall Study|Withdrawal by Subject|0|||
16482186|NCT03641339|40242420|FG003|Overall Study|Withdrawal by Subject|2|||
16482187|NCT03641339|40242421|FG004|Overall Study|Withdrawal by Subject|0|||
16482188|NCT03641339|40242422|FG005|Overall Study|Withdrawal by Subject|1|||
16289072|NCT03575871|39540743|FG001|Overall Study|Death|0|||
16482189|NCT03113071|40242423|FG000|Overall Study|Withdrawal by Subject|1|||
16482190|NCT03113071|40242424|FG001|Overall Study|Withdrawal by Subject|0|||
16482191|NCT00570765|40242433|FG000|DB Phase|Withdrawal by Subject|1|||
16482192|NCT00570765|40242434|FG001|DB Phase|Withdrawal by Subject|0|||
16482193|NCT00570765|40242435|FG002|DB Phase|Withdrawal by Subject|0|||
16482194|NCT00570765|40242436|FG003|DB Phase|Withdrawal by Subject|0|||
16482195|NCT00570765|40242433|FG000|DB Phase|Protocol Violation|0|||
16080392|NCT03903822|38786846|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
16080393|NCT03903822|38786847|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
16080394|NCT03903822|38786848|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
16080395|NCT03903822|38786841|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
16080396|NCT03903822|38786842|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
16080397|NCT03903822|38786843|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
16289073|NCT03575871|39540744|FG002|Overall Study|Death|0|||
16289074|NCT03575871|39540742|FG000|Overall Study|Lack of Efficacy|5|||
16289075|NCT03575871|39540743|FG001|Overall Study|Lack of Efficacy|4|||
16289076|NCT03575871|39540744|FG002|Overall Study|Lack of Efficacy|7|||
16482196|NCT00570765|40242434|FG001|DB Phase|Protocol Violation|1|||
16482197|NCT00570765|40242435|FG002|DB Phase|Protocol Violation|0|||
16289077|NCT03575871|39540742|FG000|Overall Study|Lost to Follow-up|1|||
16289078|NCT03575871|39540743|FG001|Overall Study|Lost to Follow-up|1|||
16289079|NCT03575871|39540744|FG002|Overall Study|Lost to Follow-up|1|||
16289080|NCT03575871|39540742|FG000|Overall Study|Protocol Deviation|1|||
16289081|NCT03575871|39540743|FG001|Overall Study|Protocol Deviation|1|||
16289082|NCT03575871|39540744|FG002|Overall Study|Protocol Deviation|1|||
16289083|NCT03575871|39540742|FG000|Overall Study|Withdrawal by Subject|6|||
16289084|NCT03575871|39540743|FG001|Overall Study|Withdrawal by Subject|1|||
16289085|NCT03575871|39540744|FG002|Overall Study|Withdrawal by Subject|9|||
16289086|NCT03575871|39540742|FG000|Overall Study|Other than specified|2|||
16289087|NCT03575871|39540743|FG001|Overall Study|Other than specified|2|||
16289088|NCT03575871|39540744|FG002|Overall Study|Other than specified|0|||
16289089|NCT02400671|39540749|FG000|Overall Study|Death|5|||
16289090|NCT02400671|39540750|FG001|Overall Study|Death|3|||
16289091|NCT02400671|39540751|FG002|Overall Study|Death|4|||
16289092|NCT02400671|39540749|FG000|Overall Study|Lost to Follow-up|20|||
16289093|NCT02400671|39540750|FG001|Overall Study|Lost to Follow-up|27|||
16289094|NCT02400671|39540751|FG002|Overall Study|Lost to Follow-up|24|||
16289095|NCT02400671|39540749|FG000|Overall Study|Withdrawal by Subject|2|||
16289096|NCT02400671|39540750|FG001|Overall Study|Withdrawal by Subject|2|||
16289097|NCT02400671|39540751|FG002|Overall Study|Withdrawal by Subject|0|||
16289098|NCT02973321|39540752|FG000|Overall Study|Other than specified|0|||
16289099|NCT02973321|39540753|FG001|Overall Study|Other than specified|5|||
16289100|NCT02973321|39540754|FG002|Overall Study|Other than specified|3|||
16289101|NCT02973321|39540755|FG003|Overall Study|Other than specified|3|||
16289102|NCT02973321|39540756|FG004|Overall Study|Other than specified|1|||
16289103|NCT02973321|39540752|FG000|Overall Study|Lack of Efficacy|0|||
16289104|NCT02973321|39540753|FG001|Overall Study|Lack of Efficacy|0|||
16289105|NCT02973321|39540754|FG002|Overall Study|Lack of Efficacy|0|||
16289106|NCT02973321|39540755|FG003|Overall Study|Lack of Efficacy|0|||
16289107|NCT02973321|39540756|FG004|Overall Study|Lack of Efficacy|1|||
16289108|NCT02973321|39540752|FG000|Overall Study|Adverse Event|1|||
16289109|NCT02973321|39540753|FG001|Overall Study|Adverse Event|10|||
16289110|NCT02973321|39540754|FG002|Overall Study|Adverse Event|11|||
16289111|NCT02973321|39540755|FG003|Overall Study|Adverse Event|13|||
16289112|NCT02973321|39540756|FG004|Overall Study|Adverse Event|3|||
16289113|NCT00003138|39540757|FG000|Step 1|Reasons off treatment not documented|60|||
16289114|NCT00003138|39540758|FG001|Step 1|Reasons off treatment not documented|57|||
16289115|NCT00003138|39540757|FG000|Step 1|Never started treatment|1|||
16289116|NCT00003138|39540758|FG001|Step 1|Never started treatment|0|||
16289117|NCT00003138|39540757|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
16289118|NCT00003138|39540758|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
16289119|NCT00003138|39540757|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
16289120|NCT00003138|39540758|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
16289121|NCT00003138|39540757|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
16289122|NCT00003138|39540758|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
16289123|NCT00003138|39540757|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
16289124|NCT00003138|39540758|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
16289125|NCT00080938|39540759|FG000|Overall Study|Adverse Event|3|||
16289126|NCT00080938|39540759|FG000|Overall Study|Withdrawal by Subject|6|||
16289127|NCT00080938|39540759|FG000|Overall Study|Death|2|||
16289128|NCT00080938|39540759|FG000|Overall Study|Lack of Efficacy|7|||
16289129|NCT00080938|39540759|FG000|Overall Study|other disease|1|||
16289130|NCT00080938|39540759|FG000|Overall Study|Not started protocol therapy|1|||
16289131|NCT00080938|39540759|FG000|Overall Study|Ineligible|4|||
16289132|NCT03493542|39540762|FG000|Overall Study|Ongoing|2|||
16289133|NCT03493542|39540763|FG001|Overall Study|Ongoing|3|||
16289134|NCT03493542|39540762|FG000|Overall Study|Withdrawal by parent or guardian|3|||
16289135|NCT03493542|39540763|FG001|Overall Study|Withdrawal by parent or guardian|0|||
16289136|NCT03493542|39540762|FG000|Overall Study|Withdrawal by Subject|2|||
16289137|NCT03493542|39540763|FG001|Overall Study|Withdrawal by Subject|6|||
16289138|NCT03979820|39540766|FG000|Overall Study|Protocol Violation|1|||
16289139|NCT03979820|39540767|FG001|Overall Study|Protocol Violation|0|||
16482198|NCT00570765|40242436|FG003|DB Phase|Protocol Violation|0|||
16289140|NCT03979820|39540768|FG002|Overall Study|Protocol Violation|0|||
16289141|NCT03979820|39540769|FG003|Overall Study|Protocol Violation|0|||
16289142|NCT03979820|39540766|FG000|Overall Study|Withdrawal by Subject|0|||
16289143|NCT03979820|39540767|FG001|Overall Study|Withdrawal by Subject|0|||
16482199|NCT00570765|40242433|FG000|DB Phase|Adverse Event|3|||
16482200|NCT00570765|40242434|FG001|DB Phase|Adverse Event|6|||
16289144|NCT03979820|39540768|FG002|Overall Study|Withdrawal by Subject|1|||
16289145|NCT03979820|39540769|FG003|Overall Study|Withdrawal by Subject|0|||
16289146|NCT03979820|39540766|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
16289147|NCT03979820|39540767|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
16289148|NCT03979820|39540768|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
16289149|NCT03979820|39540769|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
16289150|NCT01763918|39540772|FG000|Overall Study|Withdrawal by Subject|2|||
16289151|NCT01763918|39540773|FG001|Overall Study|Withdrawal by Subject|1|||
16289152|NCT01763918|39540774|FG002|Overall Study|Withdrawal by Subject|1|||
16289153|NCT01763918|39540775|FG003|Overall Study|Withdrawal by Subject|2|||
16289154|NCT01763918|39540772|FG000|Overall Study|Sponsor Decision|4|||
16289155|NCT01763918|39540773|FG001|Overall Study|Sponsor Decision|0|||
16289156|NCT01763918|39540774|FG002|Overall Study|Sponsor Decision|9|||
16289157|NCT01763918|39540775|FG003|Overall Study|Sponsor Decision|0|||
16289158|NCT03456960|39540778|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
16289159|NCT03456960|39540779|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
16289160|NCT03456960|39540780|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
16289161|NCT03456960|39540781|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
16289162|NCT03456960|39540782|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
16289163|NCT03456960|39540783|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
16289164|NCT03456960|39540778|FG000|Period 2 (1 Day)|Adverse Event|1|||
16289165|NCT03456960|39540779|FG001|Period 2 (1 Day)|Adverse Event|0|||
16289166|NCT03456960|39540780|FG002|Period 2 (1 Day)|Adverse Event|0|||
16289167|NCT03456960|39540781|FG003|Period 2 (1 Day)|Adverse Event|1|||
16289168|NCT03456960|39540782|FG004|Period 2 (1 Day)|Adverse Event|0|||
16289169|NCT03456960|39540783|FG005|Period 2 (1 Day)|Adverse Event|0|||
16289170|NCT03438539|39540784|FG000|Overall Study|Lost to Follow-up|8|||
16289171|NCT03438539|39540785|FG001|Overall Study|Lost to Follow-up|4|||
16289172|NCT03438539|39540786|FG002|Overall Study|Lost to Follow-up|10|||
16289173|NCT03438539|39540787|FG003|Overall Study|Lost to Follow-up|9|||
16289174|NCT03438539|39540788|FG004|Overall Study|Lost to Follow-up|3|||
16289175|NCT03438539|39540789|FG005|Overall Study|Lost to Follow-up|8|||
16289176|NCT01564459|39540790|FG000|Run-In|Adverse Event|7|||
16289177|NCT01564459|39540791|FG001|Run-In|Adverse Event|0|||
16289178|NCT01564459|39540792|FG002|Run-In|Adverse Event|0|||
16289179|NCT01564459|39540790|FG000|Run-In|Lost to Follow-up|1|||
16289180|NCT01564459|39540791|FG001|Run-In|Lost to Follow-up|0|||
16289181|NCT01564459|39540792|FG002|Run-In|Lost to Follow-up|0|||
16289182|NCT01564459|39540790|FG000|Run-In|Non-compliance with study drug|2|||
16289183|NCT01564459|39540791|FG001|Run-In|Non-compliance with study drug|0|||
16289184|NCT01564459|39540792|FG002|Run-In|Non-compliance with study drug|0|||
16289185|NCT01564459|39540790|FG000|Run-In|Protocol Violation|1|||
16289186|NCT01564459|39540791|FG001|Run-In|Protocol Violation|0|||
16289187|NCT01564459|39540792|FG002|Run-In|Protocol Violation|0|||
16289188|NCT01564459|39540790|FG000|Run-In|Withdrawal by Subject|1|||
16289189|NCT01564459|39540791|FG001|Run-In|Withdrawal by Subject|0|||
16289190|NCT01564459|39540792|FG002|Run-In|Withdrawal by Subject|0|||
16289191|NCT01564459|39540790|FG000|Double-blind Treatment|Adverse Event|0|||
16289192|NCT01564459|39540791|FG001|Double-blind Treatment|Adverse Event|0|||
16289193|NCT01564459|39540792|FG002|Double-blind Treatment|Adverse Event|1|||
16289194|NCT02991430|39540793|FG000|Treatment Period 1|Adverse Event|1|||
16289195|NCT02991430|39540794|FG001|Treatment Period 1|Adverse Event|0|||
16289196|NCT02991430|39540795|FG002|Treatment Period 1|Adverse Event|2|||
16289197|NCT02991430|39540793|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16289198|NCT02991430|39540794|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16289199|NCT02991430|39540795|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16289200|NCT02991430|39540793|FG000|Treatment Period 2|Study Termination|6|||
16289201|NCT02991430|39540794|FG001|Treatment Period 2|Study Termination|3|||
16289202|NCT02991430|39540795|FG002|Treatment Period 2|Study Termination|3|||
16289203|NCT02991430|39540793|FG000|Treatment Period 2|Lost to Follow-up|0|||
16289204|NCT02991430|39540794|FG001|Treatment Period 2|Lost to Follow-up|0|||
16289205|NCT02991430|39540795|FG002|Treatment Period 2|Lost to Follow-up|1|||
16289206|NCT02991430|39540793|FG000|Post-treatment Observation Period|Study Termination|3|||
16289207|NCT02991430|39540794|FG001|Post-treatment Observation Period|Study Termination|6|||
16289208|NCT02991430|39540795|FG002|Post-treatment Observation Period|Study Termination|5|||
16289209|NCT03096847|39540797|FG000|Overall Study|Other|2|||
16289210|NCT03096847|39540798|FG001|Overall Study|Other|1|||
16289211|NCT03096847|39540799|FG002|Overall Study|Other|2|||
16289212|NCT03096847|39540797|FG000|Overall Study|Lost to Follow-up|1|||
16482201|NCT00570765|40242435|FG002|DB Phase|Adverse Event|0|||
16482202|NCT00570765|40242436|FG003|DB Phase|Adverse Event|0|||
16185747|NCT00426751|39159361|FG001|Overall Study|Consent Withdrawn|1|||
16185748|NCT00426751|39159360|FG000|Overall Study|Other Reasons|7|||
16185749|NCT00426751|39159361|FG001|Overall Study|Other Reasons|12|||
16185750|NCT01544114|39159362|FG000|Overall Study|Withdrawal by Subject|0|||
16185751|NCT01544114|39159363|FG001|Overall Study|Withdrawal by Subject|0|||
16185752|NCT01544114|39159364|FG002|Overall Study|Withdrawal by Subject|3|||
16185753|NCT01544114|39159362|FG000|Overall Study|Lost to Follow-up|0|||
16185754|NCT01544114|39159363|FG001|Overall Study|Lost to Follow-up|2|||
16185755|NCT01544114|39159364|FG002|Overall Study|Lost to Follow-up|0|||
16185756|NCT01544114|39159362|FG000|Overall Study|Adverse Event|1|||
16185757|NCT01544114|39159363|FG001|Overall Study|Adverse Event|1|||
16185758|NCT01544114|39159364|FG002|Overall Study|Adverse Event|2|||
16185759|NCT01544114|39159362|FG000|Overall Study|Protocol Violation|0|||
16185760|NCT01544114|39159363|FG001|Overall Study|Protocol Violation|1|||
16185761|NCT01544114|39159364|FG002|Overall Study|Protocol Violation|0|||
16185762|NCT01751646|39159365|FG000|Overall Study|Lost to Follow-up|5|||
16289213|NCT03096847|39540798|FG001|Overall Study|Lost to Follow-up|0|||
16289214|NCT03096847|39540799|FG002|Overall Study|Lost to Follow-up|1|||
16289215|NCT03096847|39540797|FG000|Overall Study|Death|6|||
16289216|NCT03096847|39540798|FG001|Overall Study|Death|0|||
16289217|NCT03096847|39540799|FG002|Overall Study|Death|2|||
16289218|NCT03096847|39540797|FG000|Overall Study|Protocol Violation|3|||
16289219|NCT03096847|39540798|FG001|Overall Study|Protocol Violation|0|||
16289220|NCT03096847|39540799|FG002|Overall Study|Protocol Violation|6|||
16289221|NCT03096847|39540797|FG000|Overall Study|Physician Decision|12|||
16289222|NCT03096847|39540798|FG001|Overall Study|Physician Decision|2|||
16289223|NCT03096847|39540799|FG002|Overall Study|Physician Decision|8|||
16289224|NCT03096847|39540797|FG000|Overall Study|Withdrawal by Subject|24|||
16185763|NCT01751646|39159366|FG001|Overall Study|Lost to Follow-up|1|||
16185764|NCT01751646|39159365|FG000|Overall Study|Withdrawal by Subject|0|||
16185765|NCT01751646|39159366|FG001|Overall Study|Withdrawal by Subject|4|||
16185766|NCT01751646|39159365|FG000|Overall Study|Starting hormone therapy|1|||
16185767|NCT01751646|39159366|FG001|Overall Study|Starting hormone therapy|0|||
16185768|NCT01751646|39159365|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
16185769|NCT01751646|39159366|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
16185770|NCT01751646|39159365|FG000|Overall Study|Inadvertent enrollment|1|||
16289225|NCT03096847|39540798|FG001|Overall Study|Withdrawal by Subject|1|||
16289226|NCT03096847|39540799|FG002|Overall Study|Withdrawal by Subject|12|||
16380196|NCT02891226|39874886|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380197|NCT02891226|39874887|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
16380198|NCT02891226|39874872|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380199|NCT02891226|39874873|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380200|NCT02891226|39874874|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380201|NCT02891226|39874875|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380202|NCT02891226|39874876|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380203|NCT02891226|39874877|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380204|NCT02891226|39874878|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380205|NCT02891226|39874879|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
16380206|NCT02891226|39874880|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
16380207|NCT02891226|39874881|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
16380208|NCT02891226|39874882|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380209|NCT02891226|39874883|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380210|NCT02891226|39874884|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380211|NCT02891226|39874885|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380212|NCT02891226|39874886|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380213|NCT02891226|39874887|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
16380214|NCT02891226|39874872|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380215|NCT02891226|39874873|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380216|NCT02891226|39874874|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380217|NCT02891226|39874875|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380218|NCT02891226|39874876|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380219|NCT02891226|39874877|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380220|NCT02891226|39874878|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380221|NCT02891226|39874879|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
16380222|NCT02891226|39874880|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380223|NCT02891226|39874881|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380224|NCT02891226|39874882|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380225|NCT02891226|39874883|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16482203|NCT00570765|40242433|FG000|DB Phase|Did Not Receive Study Drug|0|||
16482204|NCT00570765|40242434|FG001|DB Phase|Did Not Receive Study Drug|0|||
16185771|NCT01751646|39159366|FG001|Overall Study|Inadvertent enrollment|1|||
16185772|NCT01751646|39159365|FG000|Overall Study|Moved out of the area|1|||
16185773|NCT01751646|39159366|FG001|Overall Study|Moved out of the area|5|||
16185774|NCT01751646|39159365|FG000|Overall Study|Inability to attend required visits|0|||
16185775|NCT01751646|39159366|FG001|Overall Study|Inability to attend required visits|1|||
16185776|NCT01751646|39159365|FG000|Overall Study|Off study due to multiple obligations|0|||
16185777|NCT01751646|39159366|FG001|Overall Study|Off study due to multiple obligations|1|||
16185778|NCT01751646|39159365|FG000|Overall Study|Fails to comply with study requirements|0|||
16185779|NCT01751646|39159366|FG001|Overall Study|Fails to comply with study requirements|1|||
16185780|NCT01751646|39159365|FG000|Overall Study|Childcare issues|1|||
16185781|NCT01751646|39159366|FG001|Overall Study|Childcare issues|1|||
16185782|NCT00850460|39159369|FG000|Overall Study|Lost to Follow-up|4|||
16185783|NCT00850460|39159370|FG001|Overall Study|Lost to Follow-up|4|||
16185784|NCT02046564|39159374|FG000|Overall Study|Adverse Event|6|||
16185785|NCT02046564|39159375|FG001|Overall Study|Adverse Event|3|||
16185786|NCT02046564|39159374|FG000|Overall Study|Physician Decision|0|||
16185787|NCT02046564|39159375|FG001|Overall Study|Physician Decision|1|||
16185788|NCT02046564|39159374|FG000|Overall Study|Protocol Violation|3|||
16185789|NCT02046564|39159375|FG001|Overall Study|Protocol Violation|1|||
16185790|NCT02046564|39159374|FG000|Overall Study|Withdrawal by Subject|4|||
16185791|NCT02046564|39159375|FG001|Overall Study|Withdrawal by Subject|10|||
16185792|NCT02046564|39159374|FG000|Overall Study|Subject met withdrawal criteria|2|||
16185793|NCT02046564|39159375|FG001|Overall Study|Subject met withdrawal criteria|5|||
16185794|NCT02778867|39159376|FG000|Phase 1|Withdrawal by Subject|2|||
16185795|NCT02778867|39159377|FG001|Phase 1|Withdrawal by Subject|3|||
16185796|NCT02778867|39159378|FG002|Phase 1|Withdrawal by Subject|0|||
16185797|NCT02778867|39159379|FG003|Phase 1|Withdrawal by Subject|0|||
16185798|NCT02778867|39159376|FG000|Phase 2|Withdrawal by Subject|0|||
16185799|NCT02778867|39159377|FG001|Phase 2|Withdrawal by Subject|0|||
16185800|NCT02778867|39159378|FG002|Phase 2|Withdrawal by Subject|1|||
16185801|NCT02778867|39159379|FG003|Phase 2|Withdrawal by Subject|0|||
16185802|NCT02778867|39159376|FG000|Phase 2|Physician Decision|0|||
16185803|NCT02778867|39159377|FG001|Phase 2|Physician Decision|0|||
16185804|NCT02778867|39159378|FG002|Phase 2|Physician Decision|0|||
16185805|NCT02778867|39159379|FG003|Phase 2|Physician Decision|1|||
16185806|NCT02778867|39159376|FG000|Phase 2|Adverse Event|0|||
16185807|NCT02778867|39159377|FG001|Phase 2|Adverse Event|0|||
16482205|NCT00570765|40242435|FG002|DB Phase|Did Not Receive Study Drug|1|||
16482206|NCT00570765|40242436|FG003|DB Phase|Did Not Receive Study Drug|0|||
16482207|NCT00570765|40242433|FG000|LTSE Phase|Withdrawal by Subject|0|||
16482208|NCT00570765|40242434|FG001|LTSE Phase|Withdrawal by Subject|0|||
16185808|NCT02778867|39159378|FG002|Phase 2|Adverse Event|0|||
16185809|NCT02778867|39159379|FG003|Phase 2|Adverse Event|1|||
16185810|NCT00092547|39159380|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
16185811|NCT00092547|39159381|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
16185812|NCT00092547|39159382|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
16185813|NCT00092547|39159380|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
16185814|NCT00092547|39159381|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
16185815|NCT00092547|39159382|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
16185816|NCT00092547|39159380|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
16185817|NCT00092547|39159381|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
16185818|NCT00092547|39159382|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
16185819|NCT00092547|39159380|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
16185820|NCT00092547|39159381|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
16185821|NCT00092547|39159382|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
16185822|NCT00092547|39159380|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
16185823|NCT00092547|39159381|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
16482209|NCT00570765|40242435|FG002|LTSE Phase|Withdrawal by Subject|0|||
16482210|NCT00570765|40242436|FG003|LTSE Phase|Withdrawal by Subject|1|||
16482211|NCT00570765|40242433|FG000|LTSE Phase|Adverse Event|0|||
16482212|NCT00570765|40242434|FG001|LTSE Phase|Adverse Event|0|||
16482213|NCT00570765|40242435|FG002|LTSE Phase|Adverse Event|0|||
16482214|NCT00570765|40242436|FG003|LTSE Phase|Adverse Event|7|||
16482215|NCT00570765|40242433|FG000|LTSE Phase|Physician Decision|0|||
16482216|NCT00570765|40242434|FG001|LTSE Phase|Physician Decision|0|||
16482217|NCT00570765|40242435|FG002|LTSE Phase|Physician Decision|0|||
16482218|NCT00570765|40242436|FG003|LTSE Phase|Physician Decision|4|||
16482219|NCT00289016|40242440|FG000|Overall Study|Disease Progression|29|||
16185824|NCT00092547|39159382|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
16482220|NCT00289016|40242440|FG000|Overall Study|Death|2|||
16185825|NCT00092547|39159380|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
16185826|NCT00092547|39159381|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
16482221|NCT00289016|40242440|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
16185827|NCT00092547|39159382|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
16185828|NCT00092547|39159380|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
16185829|NCT00092547|39159381|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
16482222|NCT00289016|40242440|FG000|Overall Study|Withdrawal by Subject|2|||
16482223|NCT00289016|40242440|FG000|Overall Study|Adverse Event|1|||
16482224|NCT00289016|40242440|FG000|Overall Study|Other|1|||
16482225|NCT00005044|40242441|FG000|Overall Study|Protocol Violation|37|||
16482226|NCT00005044|40242442|FG001|Overall Study|Protocol Violation|46|||
16482227|NCT00005044|40242441|FG000|Overall Study|Withdrawal by Subject|1|||
16482228|NCT00005044|40242442|FG001|Overall Study|Withdrawal by Subject|5|||
16482229|NCT00005044|40242441|FG000|Overall Study|No protocol treatment|0|||
16185830|NCT00092547|39159382|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
16185831|NCT00092547|39159380|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
16185832|NCT00092547|39159381|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
16380226|NCT02891226|39874884|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380227|NCT02891226|39874885|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16482230|NCT00005044|40242442|FG001|Overall Study|No protocol treatment|1|||
16185833|NCT00092547|39159382|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
16185834|NCT00092547|39159380|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
16482231|NCT02628938|40242443|FG000|Overall Study|Did not attend the follow up recall|2|||
16482232|NCT02628938|40242444|FG001|Overall Study|Did not attend the follow up recall|2|||
16482233|NCT02628938|40242445|FG002|Overall Study|Did not attend the follow up recall|1|||
16482234|NCT02628938|40242443|FG000|Overall Study|Failure to comply with the instructions|3|||
16482235|NCT02628938|40242444|FG001|Overall Study|Failure to comply with the instructions|0|||
16482236|NCT02628938|40242445|FG002|Overall Study|Failure to comply with the instructions|3|||
16482237|NCT04545385|40242446|FG000|Overall Study|Withdrawal by Subject|2|||
16482238|NCT04545385|40242447|FG001|Overall Study|Withdrawal by Subject|0|||
16482239|NCT04545385|40242446|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
16380228|NCT02891226|39874886|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16380229|NCT02891226|39874887|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
16185835|NCT00092547|39159381|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
16185836|NCT00092547|39159382|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
16185837|NCT00092547|39159380|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
16185838|NCT00092547|39159381|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
16185839|NCT00092547|39159382|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
16185840|NCT00092547|39159380|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
16185841|NCT00092547|39159381|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
16185842|NCT00092547|39159382|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
16185843|NCT00092547|39159380|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
16185844|NCT00092547|39159381|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
16185845|NCT00092547|39159382|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
16185846|NCT00092547|39159380|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
16185847|NCT00092547|39159381|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
16185848|NCT00092547|39159382|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
16185849|NCT00092547|39159380|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
16185850|NCT00092547|39159381|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
16185851|NCT00092547|39159382|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
16185852|NCT00092547|39159380|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
16185853|NCT00092547|39159381|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
16185854|NCT00092547|39159382|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
16185855|NCT00092547|39159380|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
16185856|NCT00092547|39159381|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
16185857|NCT00092547|39159382|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
16185858|NCT00092547|39159380|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
16185859|NCT00092547|39159381|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
16185860|NCT00092547|39159382|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
16185861|NCT00092547|39159380|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
16185862|NCT00092547|39159381|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
16185863|NCT00092547|39159382|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
16185864|NCT00092547|39159380|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
16185865|NCT00092547|39159381|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
16185866|NCT00092547|39159382|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
16185867|NCT00092547|39159380|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
16185868|NCT00092547|39159381|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
16185869|NCT00092547|39159382|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
16185870|NCT00092547|39159380|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
16185871|NCT00092547|39159381|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
16380230|NCT02891226|39874872|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380231|NCT02891226|39874873|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380232|NCT02891226|39874874|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380233|NCT02891226|39874875|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380234|NCT02891226|39874876|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380235|NCT02891226|39874877|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380236|NCT02891226|39874878|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380237|NCT02891226|39874879|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380238|NCT02891226|39874880|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
16380239|NCT02891226|39874881|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380240|NCT02891226|39874882|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380241|NCT02891226|39874883|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380242|NCT02891226|39874884|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380243|NCT02891226|39874885|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380244|NCT02891226|39874886|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380245|NCT02891226|39874887|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
16380246|NCT02891226|39874872|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380247|NCT02891226|39874873|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380248|NCT02891226|39874874|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380249|NCT02891226|39874875|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380250|NCT02891226|39874876|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380251|NCT02891226|39874877|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380252|NCT02891226|39874878|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380253|NCT02891226|39874879|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380254|NCT02891226|39874880|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380255|NCT02891226|39874881|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
16380256|NCT02891226|39874882|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380257|NCT02891226|39874883|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380258|NCT02891226|39874884|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380259|NCT02891226|39874885|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380260|NCT02891226|39874886|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380261|NCT02891226|39874887|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
16380262|NCT02891226|39874872|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380263|NCT02891226|39874873|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380264|NCT02891226|39874874|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380265|NCT02891226|39874875|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380266|NCT02891226|39874876|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380267|NCT02891226|39874877|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380268|NCT02891226|39874878|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380269|NCT02891226|39874879|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380270|NCT02891226|39874880|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380271|NCT02891226|39874881|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
16380272|NCT02891226|39874882|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380273|NCT02891226|39874883|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380274|NCT02891226|39874884|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380275|NCT02891226|39874885|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380276|NCT02891226|39874886|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380277|NCT02891226|39874887|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
16380278|NCT02891226|39874872|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380279|NCT02891226|39874873|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380280|NCT02891226|39874874|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380281|NCT02891226|39874875|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380282|NCT02891226|39874876|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380283|NCT02891226|39874877|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380284|NCT02891226|39874878|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380285|NCT02891226|39874879|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380286|NCT02891226|39874880|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380287|NCT02891226|39874881|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380288|NCT02891226|39874882|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
16380289|NCT02891226|39874883|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380290|NCT02891226|39874884|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380291|NCT02891226|39874885|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380292|NCT02891226|39874886|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380293|NCT02891226|39874887|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
16380294|NCT02891226|39874872|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380295|NCT02891226|39874873|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380296|NCT02891226|39874874|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380297|NCT02891226|39874875|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380298|NCT02891226|39874876|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380299|NCT02891226|39874877|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16289227|NCT03096847|39540797|FG000|Overall Study|Adverse Event|72|||
16289228|NCT03096847|39540798|FG001|Overall Study|Adverse Event|6|||
16289229|NCT03096847|39540799|FG002|Overall Study|Adverse Event|28|||
16289230|NCT03096847|39540797|FG000|Overall Study|Progressive disease|97|||
16289231|NCT03096847|39540798|FG001|Overall Study|Progressive disease|10|||
16289232|NCT03096847|39540799|FG002|Overall Study|Progressive disease|78|||
16289233|NCT03096847|39540797|FG000|Overall Study|Non-compliance with study medication|1|||
16289234|NCT03096847|39540798|FG001|Overall Study|Non-compliance with study medication|0|||
16289235|NCT03096847|39540799|FG002|Overall Study|Non-compliance with study medication|0|||
16289236|NCT03096847|39540797|FG000|Overall Study|New therapy for study indication|1|||
16289237|NCT03096847|39540798|FG001|Overall Study|New therapy for study indication|0|||
16289238|NCT03096847|39540799|FG002|Overall Study|New therapy for study indication|1|||
16289239|NCT01691820|39540800|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
16289240|NCT01691820|39540801|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
16289241|NCT01691820|39540800|FG000|Overall Study|Migrated/moved from study area|7|||
16289242|NCT01691820|39540801|FG001|Overall Study|Migrated/moved from study area|4|||
16289243|NCT01691820|39540800|FG000|Overall Study|Lost to Follow-up|6|||
16289244|NCT01691820|39540801|FG001|Overall Study|Lost to Follow-up|17|||
16289245|NCT01691820|39540800|FG000|Overall Study|Other (unspecified)|4|||
16289246|NCT01691820|39540801|FG001|Overall Study|Other (unspecified)|1|||
16289247|NCT01408628|39540802|FG000|Consented|Withdrawal by Subject|12|||
16289248|NCT01408628|39540802|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
16289249|NCT01408628|39540802|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
16289250|NCT01408628|39540802|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
16289251|NCT00983918|39540803|FG000|Overall Study|conversion to open cholecystectomy|0|||
16289252|NCT00983918|39540804|FG001|Overall Study|conversion to open cholecystectomy|2|||
16289253|NCT00983918|39540805|FG002|Overall Study|conversion to open cholecystectomy|2|||
16289254|NCT00983918|39540806|FG003|Overall Study|conversion to open cholecystectomy|2|||
16380300|NCT02891226|39874878|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380301|NCT02891226|39874879|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380302|NCT02891226|39874880|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16482240|NCT04545385|40242447|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
16482241|NCT04545385|40242446|FG000|Overall Study|Study termination|10|||
16482242|NCT04545385|40242447|FG001|Overall Study|Study termination|10|||
16482243|NCT04545385|40242446|FG000|Overall Study|Sponsor decision|2|||
16482244|NCT04545385|40242447|FG001|Overall Study|Sponsor decision|2|||
16482245|NCT04545385|40242446|FG000|Overall Study|Other than specified|1|||
16482246|NCT04545385|40242447|FG001|Overall Study|Other than specified|0|||
16482247|NCT00091442|40242448|FG000|Overall Study|Progressive Disease|220|||
16482248|NCT00091442|40242449|FG001|Overall Study|Progressive Disease|189|||
16482249|NCT00091442|40242448|FG000|Overall Study|Physician Decision|61|||
16482250|NCT00091442|40242449|FG001|Overall Study|Physician Decision|58|||
16482251|NCT00091442|40242448|FG000|Overall Study|Withdrawal by Subject|38|||
16482252|NCT00091442|40242449|FG001|Overall Study|Withdrawal by Subject|46|||
16482253|NCT00091442|40242448|FG000|Overall Study|Adverse Event|29|||
16482254|NCT00091442|40242449|FG001|Overall Study|Adverse Event|48|||
16482255|NCT00091442|40242448|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
16482256|NCT00091442|40242449|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
16482257|NCT00091442|40242448|FG000|Overall Study|Death|9|||
16482258|NCT00091442|40242449|FG001|Overall Study|Death|7|||
16185872|NCT00092547|39159382|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
16185873|NCT01306058|39159385|FG000|Overall Study|Death|1|||
16185874|NCT01306058|39159385|FG000|Overall Study|Enrolled but did not get treatment|1|||
16185875|NCT00406315|39159386|FG000|Overall Study|Death|1|||
16185876|NCT00406315|39159386|FG000|Overall Study|Adverse Event|39|||
16185877|NCT00406315|39159386|FG000|Overall Study|Laboratory Abnormality|4|||
16185878|NCT00406315|39159386|FG000|Overall Study|Lack of Efficacy|13|||
16185879|NCT00406315|39159386|FG000|Overall Study|Other|33|||
16185880|NCT00406315|39159386|FG000|Overall Study|Lost to Follow-up|21|||
16185881|NCT00406315|39159386|FG000|Overall Study|Withdrawal by Subject|30|||
16185882|NCT00069095|39159387|FG000|Primary Treatment Phase|Ongoing|0|||
16185883|NCT00069095|39159388|FG001|Primary Treatment Phase|Ongoing|0|||
16185884|NCT00069095|39159389|FG002|Primary Treatment Phase|Ongoing|5|||
16185885|NCT00069095|39159390|FG003|Primary Treatment Phase|Ongoing|7|||
16185886|NCT00069095|39159391|FG004|Primary Treatment Phase|Ongoing|7|||
16185887|NCT00069095|39159392|FG005|Primary Treatment Phase|Ongoing|4|||
16185888|NCT00069095|39159387|FG000|Primary Treatment Phase|Admin/Other|29|||
16185889|NCT00069095|39159388|FG001|Primary Treatment Phase|Admin/Other|38|||
16185890|NCT00069095|39159389|FG002|Primary Treatment Phase|Admin/Other|31|||
16482259|NCT00091442|40242448|FG000|Overall Study|Lost to Follow-up|1|||
16482260|NCT00091442|40242449|FG001|Overall Study|Lost to Follow-up|3|||
16482261|NCT00091442|40242448|FG000|Overall Study|Other|2|||
16482262|NCT00091442|40242449|FG001|Overall Study|Other|6|||
16185891|NCT00069095|39159390|FG003|Primary Treatment Phase|Admin/Other|45|||
16185892|NCT00069095|39159391|FG004|Primary Treatment Phase|Admin/Other|48|||
16185893|NCT00069095|39159392|FG005|Primary Treatment Phase|Admin/Other|42|||
16185894|NCT00069095|39159387|FG000|Primary Treatment Phase|Adverse Event|99|||
16185895|NCT00069095|39159388|FG001|Primary Treatment Phase|Adverse Event|92|||
16185896|NCT00069095|39159389|FG002|Primary Treatment Phase|Adverse Event|71|||
16185897|NCT00069095|39159390|FG003|Primary Treatment Phase|Adverse Event|72|||
16185898|NCT00069095|39159391|FG004|Primary Treatment Phase|Adverse Event|109|||
16185899|NCT00069095|39159392|FG005|Primary Treatment Phase|Adverse Event|101|||
16185900|NCT00069095|39159387|FG000|Primary Treatment Phase|Death|14|||
16185901|NCT00069095|39159388|FG001|Primary Treatment Phase|Death|8|||
16185902|NCT00069095|39159389|FG002|Primary Treatment Phase|Death|2|||
16185903|NCT00069095|39159390|FG003|Primary Treatment Phase|Death|5|||
16380303|NCT02891226|39874881|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380304|NCT02891226|39874882|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
16380305|NCT02891226|39874883|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380306|NCT02891226|39874884|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380307|NCT02891226|39874885|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380308|NCT02891226|39874886|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380309|NCT02891226|39874887|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
16380310|NCT02891226|39874872|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16185904|NCT00069095|39159391|FG004|Primary Treatment Phase|Death|8|||
16380311|NCT02891226|39874873|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16482263|NCT01854658|40242450|FG000|Overall Study|Protocol Violation|6|||
16482264|NCT01854658|40242451|FG001|Overall Study|Protocol Violation|2|||
16185905|NCT00069095|39159392|FG005|Primary Treatment Phase|Death|8|||
16185906|NCT00069095|39159387|FG000|Primary Treatment Phase|Failure to return|5|||
16185907|NCT00069095|39159388|FG001|Primary Treatment Phase|Failure to return|5|||
16185908|NCT00069095|39159389|FG002|Primary Treatment Phase|Failure to return|0|||
16185909|NCT00069095|39159390|FG003|Primary Treatment Phase|Failure to return|0|||
16185910|NCT00069095|39159391|FG004|Primary Treatment Phase|Failure to return|0|||
16185911|NCT00069095|39159392|FG005|Primary Treatment Phase|Failure to return|2|||
16185912|NCT00069095|39159387|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
16482265|NCT01854658|40242452|FG002|Overall Study|Protocol Violation|2|||
16380312|NCT02891226|39874874|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380313|NCT02891226|39874875|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380314|NCT02891226|39874876|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380315|NCT02891226|39874877|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380316|NCT02891226|39874878|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380317|NCT02891226|39874879|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380318|NCT02891226|39874880|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380319|NCT02891226|39874881|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380320|NCT02891226|39874882|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
16380321|NCT02891226|39874883|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380322|NCT02891226|39874884|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380323|NCT02891226|39874885|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380324|NCT02891226|39874886|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380325|NCT02891226|39874887|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
16380326|NCT02891226|39874872|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380327|NCT02891226|39874873|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380328|NCT02891226|39874874|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380329|NCT02891226|39874875|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380330|NCT02891226|39874876|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380331|NCT02891226|39874877|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380332|NCT02891226|39874878|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380333|NCT02891226|39874879|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380334|NCT02891226|39874880|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380335|NCT02891226|39874881|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380336|NCT02891226|39874882|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
16380337|NCT02891226|39874883|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380338|NCT02891226|39874884|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380339|NCT02891226|39874885|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380340|NCT02891226|39874886|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16380341|NCT02891226|39874887|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
16289255|NCT00891839|39540818|FG000|Overall Study|Adverse Event|2|||
16289256|NCT00891839|39540818|FG000|Overall Study|Withdrawal by Subject|2|||
16289257|NCT00891839|39540818|FG000|Overall Study|Disease progression|3|||
16289258|NCT00109837|39540819|FG000|Overall Study|Adverse Event|2|||
16289259|NCT00109837|39540819|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
16289260|NCT00109837|39540819|FG000|Overall Study|Death|1|||
16289261|NCT00109837|39540819|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
16289262|NCT00109837|39540819|FG000|Overall Study|Not treated|1|||
16289263|NCT00109837|39540819|FG000|Overall Study|Ineligible|1|||
16380342|NCT02891226|39874872|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16289264|NCT01901874|39540820|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
16409900|NCT01143051|39981816|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
16289265|NCT01901874|39540820|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
16289266|NCT01901874|39540820|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
16289267|NCT01901874|39540820|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
16289268|NCT01901874|39540820|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
16289269|NCT01901874|39540820|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
16289270|NCT00354341|39543595|FG000|Overall Study|Adverse Event|1|||
16289271|NCT00354341|39543596|FG001|Overall Study|Adverse Event|0|||
16289272|NCT00354341|39543595|FG000|Overall Study|Death|0|||
16289273|NCT00354341|39543596|FG001|Overall Study|Death|2|||
16289274|NCT00354341|39543595|FG000|Overall Study|Refused treatment|1|||
16289275|NCT00354341|39543596|FG001|Overall Study|Refused treatment|2|||
16289276|NCT00354341|39543595|FG000|Overall Study|Failure to return|0|||
16289277|NCT00354341|39543596|FG001|Overall Study|Failure to return|1|||
16289278|NCT00354341|39543595|FG000|Overall Study|Other|1|||
16289279|NCT00354341|39543596|FG001|Overall Study|Other|2|||
16289280|NCT02667288|39543597|FG000|Overall Study|Protocol Violation|5|||
16289281|NCT02667288|39543597|FG000|Overall Study|Lost to Follow-up|3|||
16289282|NCT02667288|39543597|FG000|Overall Study|Withdrawal by Subject|5|||
16289283|NCT01124695|39543600|FG000|Overall Study|Disease progression|77|||
16289284|NCT01124695|39543600|FG000|Overall Study|Adverse Event|11|||
16289285|NCT01124695|39543600|FG000|Overall Study|Death|1|||
16289286|NCT01124695|39543600|FG000|Overall Study|Withdrawal by Subject|7|||
16289287|NCT01124695|39543600|FG000|Overall Study|Physician Decision|3|||
16289288|NCT01124695|39543600|FG000|Overall Study|Alternative therapy|9|||
16289289|NCT01124695|39543600|FG000|Overall Study|No documentation that patient went off treatment|4|||
16380343|NCT02891226|39874873|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380344|NCT02891226|39874874|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16482266|NCT01854658|40242453|FG003|Overall Study|Protocol Violation|1|||
16482267|NCT01854658|40242450|FG000|Overall Study|Physician Decision|7|||
16482268|NCT01854658|40242451|FG001|Overall Study|Physician Decision|5|||
16080398|NCT03903822|38786844|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
16080399|NCT03903822|38786845|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
16080400|NCT03903822|38786846|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
16482269|NCT01854658|40242452|FG002|Overall Study|Physician Decision|2|||
16482270|NCT01854658|40242453|FG003|Overall Study|Physician Decision|4|||
16482271|NCT01854658|40242450|FG000|Overall Study|Lost to Follow-up|8|||
16482272|NCT01854658|40242451|FG001|Overall Study|Lost to Follow-up|9|||
16080401|NCT03903822|38786847|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
16080402|NCT03903822|38786848|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
16080403|NCT03903822|38786841|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
16080404|NCT03903822|38786842|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
16080405|NCT03903822|38786843|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
16080406|NCT03903822|38786844|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
16080407|NCT03903822|38786845|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
16080408|NCT03903822|38786846|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
16080409|NCT03903822|38786847|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
16080410|NCT03903822|38786848|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
16080411|NCT03903822|38786841|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
16080412|NCT03903822|38786842|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
16080413|NCT03903822|38786843|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
16080414|NCT03903822|38786844|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
16080415|NCT03903822|38786845|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
16080416|NCT03903822|38786846|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
16080417|NCT03903822|38786847|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
16080418|NCT03903822|38786848|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
16080419|NCT03903822|38786841|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
16080420|NCT03903822|38786842|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
16080421|NCT03903822|38786843|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
16080422|NCT03903822|38786844|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
16482273|NCT01854658|40242452|FG002|Overall Study|Lost to Follow-up|8|||
16482274|NCT01854658|40242453|FG003|Overall Study|Lost to Follow-up|4|||
16482275|NCT01854658|40242450|FG000|Overall Study|Withdrawal by Subject|28|||
16080423|NCT03903822|38786845|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
16080424|NCT03903822|38786846|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
16289290|NCT01124695|39543600|FG000|Overall Study|Ineligible|9|||
16289291|NCT01124695|39543600|FG000|Overall Study|Ineligible and never start treatment|2|||
16289292|NCT00720226|39543601|FG000|Overall Study|Withdrawal by Subject|7|||
16080425|NCT03903822|38786847|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
16080426|NCT03903822|38786848|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
16080427|NCT03903822|38786841|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
16080428|NCT03903822|38786842|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
16080429|NCT03903822|38786843|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
16289293|NCT00720226|39543602|FG001|Overall Study|Withdrawal by Subject|4|||
16289294|NCT02932228|39543603|FG000|Overall Study|Death|8|||
16289295|NCT02932228|39543604|FG001|Overall Study|Death|23|||
16289296|NCT02932228|39543603|FG000|Overall Study|not eligible upon chart review|2|||
16289297|NCT02932228|39543604|FG001|Overall Study|not eligible upon chart review|5|||
16289298|NCT01393730|39543608|FG000|Overall Study|Withdrawal by Subject|3|||
16289299|NCT01393730|39543608|FG000|Overall Study|Other|2|||
16289300|NCT01393730|39543608|FG000|Overall Study|Adverse Event|1|||
16289301|NCT01829113|39543609|FG000|Overall Study|Disease Progression|37|||
16289302|NCT01829113|39543610|FG001|Overall Study|Disease Progression|48|||
16289303|NCT01829113|39543609|FG000|Overall Study|Adverse Event|14|||
16289304|NCT01829113|39543610|FG001|Overall Study|Adverse Event|10|||
16289305|NCT01829113|39543609|FG000|Overall Study|Withdrawal by Subject|17|||
16289306|NCT01829113|39543610|FG001|Overall Study|Withdrawal by Subject|10|||
16289307|NCT01829113|39543609|FG000|Overall Study|Death|4|||
16289308|NCT01829113|39543610|FG001|Overall Study|Death|6|||
16289309|NCT01829113|39543609|FG000|Overall Study|Sponsor Decision|1|||
16289310|NCT01829113|39543610|FG001|Overall Study|Sponsor Decision|1|||
16289311|NCT01829113|39543609|FG000|Overall Study|No Study Treatment Received|3|||
16289312|NCT01829113|39543610|FG001|Overall Study|No Study Treatment Received|2|||
16289313|NCT01829113|39543609|FG000|Overall Study|Physician Decision|1|||
16289314|NCT01829113|39543610|FG001|Overall Study|Physician Decision|1|||
16289315|NCT01408563|39543611|FG000|Overall Study|Ineligible after consent/ registration|2|||
16289316|NCT00925301|39543612|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
16289317|NCT00925301|39543613|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
16289318|NCT00925301|39543614|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
16289319|NCT00925301|39543615|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
16289320|NCT00925301|39543612|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
16289321|NCT00925301|39543613|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
16380345|NCT02891226|39874875|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380346|NCT02891226|39874876|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380347|NCT02891226|39874877|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380348|NCT02891226|39874878|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380349|NCT02891226|39874879|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380350|NCT02891226|39874880|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380351|NCT02891226|39874881|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380352|NCT02891226|39874882|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
16380353|NCT02891226|39874883|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380354|NCT02891226|39874884|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380355|NCT02891226|39874885|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380356|NCT02891226|39874886|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16380357|NCT02891226|39874887|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
16289322|NCT00925301|39543614|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
16289323|NCT00925301|39543615|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
16289324|NCT00925301|39543612|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
16289325|NCT00925301|39543613|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
16289326|NCT00925301|39543614|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
16289327|NCT00925301|39543615|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
16289328|NCT00925301|39543612|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
16289329|NCT00925301|39543613|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
16289330|NCT00925301|39543614|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
16289331|NCT00925301|39543615|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
16482276|NCT01854658|40242451|FG001|Overall Study|Withdrawal by Subject|21|||
16482277|NCT01854658|40242452|FG002|Overall Study|Withdrawal by Subject|29|||
16482278|NCT01854658|40242453|FG003|Overall Study|Withdrawal by Subject|15|||
16482279|NCT01854658|40242450|FG000|Overall Study|Protocol-specified criteria|15|||
16482280|NCT01854658|40242451|FG001|Overall Study|Protocol-specified criteria|15|||
16482281|NCT01854658|40242452|FG002|Overall Study|Protocol-specified criteria|10|||
16482282|NCT01854658|40242453|FG003|Overall Study|Protocol-specified criteria|7|||
16482283|NCT01854658|40242450|FG000|Overall Study|Lack of Efficacy|3|||
16482284|NCT01854658|40242451|FG001|Overall Study|Lack of Efficacy|8|||
16482285|NCT01854658|40242452|FG002|Overall Study|Lack of Efficacy|4|||
16482286|NCT01854658|40242453|FG003|Overall Study|Lack of Efficacy|7|||
16482287|NCT01854658|40242450|FG000|Overall Study|Adverse Event|21|||
16482288|NCT01854658|40242451|FG001|Overall Study|Adverse Event|14|||
16482289|NCT01854658|40242452|FG002|Overall Study|Adverse Event|23|||
16482290|NCT01854658|40242453|FG003|Overall Study|Adverse Event|19|||
16482291|NCT01854658|40242450|FG000|Overall Study|Administrative reasons|5|||
16482292|NCT01854658|40242451|FG001|Overall Study|Administrative reasons|1|||
16482293|NCT01854658|40242452|FG002|Overall Study|Administrative reasons|2|||
16482294|NCT01854658|40242453|FG003|Overall Study|Administrative reasons|2|||
16482295|NCT01945281|40242457|FG000|Overall Study|Adverse Event|1|||
16482296|NCT01945281|40242458|FG001|Overall Study|Adverse Event|0|||
16482297|NCT01945281|40242457|FG000|Overall Study|Death|3|||
16482298|NCT01945281|40242458|FG001|Overall Study|Death|3|||
16482299|NCT01945281|40242457|FG000|Overall Study|Physician Decision|1|||
16482300|NCT01945281|40242458|FG001|Overall Study|Physician Decision|1|||
16482301|NCT01945281|40242457|FG000|Overall Study|Technical Problems|1|||
16482302|NCT01945281|40242458|FG001|Overall Study|Technical Problems|0|||
16289332|NCT00925301|39543612|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
16289333|NCT00925301|39543613|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
16482303|NCT01065597|40242459|FG000|Overall Study|Adverse Event|1|||
16482304|NCT00087607|40242460|FG000|Overall Study|Adverse Event|14|||
16482305|NCT00087607|40242461|FG001|Overall Study|Adverse Event|24|||
16482306|NCT00087607|40242460|FG000|Overall Study|Death|0|||
16482307|NCT00087607|40242461|FG001|Overall Study|Death|1|||
16482308|NCT00087607|40242460|FG000|Overall Study|Insufficient Therapeutic Response|53|||
16482309|NCT00087607|40242461|FG001|Overall Study|Insufficient Therapeutic Response|42|||
16482310|NCT00087607|40242460|FG000|Overall Study|Failure to return|21|||
16482311|NCT00087607|40242461|FG001|Overall Study|Failure to return|17|||
16185913|NCT00069095|39159388|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
16185914|NCT00069095|39159389|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
16185915|NCT00069095|39159390|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
16482312|NCT00087607|40242460|FG000|Overall Study|Withdrew Consent|12|||
16482313|NCT00087607|40242461|FG001|Overall Study|Withdrew Consent|16|||
16482314|NCT00087607|40242460|FG000|Overall Study|Administrative|12|||
16482315|NCT00087607|40242461|FG001|Overall Study|Administrative|12|||
16482316|NCT00087607|40242460|FG000|Overall Study|Refused Treatment|5|||
16482317|NCT00087607|40242461|FG001|Overall Study|Refused Treatment|7|||
16482318|NCT00087607|40242460|FG000|Overall Study|Other Protocol Violation|5|||
16482319|NCT00087607|40242461|FG001|Overall Study|Other Protocol Violation|2|||
16482320|NCT00087607|40242460|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
16482321|NCT00087607|40242461|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
16482322|NCT02248701|40242464|FG000|Overall Study|Withdrawal by Subject|2|||
16482323|NCT02248701|40242465|FG001|Overall Study|Withdrawal by Subject|1|||
16482324|NCT02248701|40242464|FG000|Overall Study|Physician Decision|0|||
16482325|NCT02248701|40242465|FG001|Overall Study|Physician Decision|1|||
16482326|NCT02248701|40242464|FG000|Overall Study|Adverse Event|1|||
16482327|NCT02248701|40242465|FG001|Overall Study|Adverse Event|0|||
16482328|NCT02248701|40242464|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
16482329|NCT02248701|40242465|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
16482330|NCT02336373|40242466|FG000|Overall Study|Protocol closed early|4|||
16482331|NCT02336373|40242466|FG000|Overall Study|Physician Decision|14|||
16185916|NCT00069095|39159391|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
16185917|NCT00069095|39159392|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
16185918|NCT00069095|39159387|FG000|Primary Treatment Phase|Refused treatment|15|||
16185919|NCT00069095|39159388|FG001|Primary Treatment Phase|Refused treatment|26|||
16185920|NCT00069095|39159389|FG002|Primary Treatment Phase|Refused treatment|17|||
16185921|NCT00069095|39159390|FG003|Primary Treatment Phase|Refused treatment|31|||
16185922|NCT00069095|39159391|FG004|Primary Treatment Phase|Refused treatment|24|||
16185923|NCT00069095|39159392|FG005|Primary Treatment Phase|Refused treatment|27|||
16185924|NCT00069095|39159387|FG000|Primary Treatment Phase|Withdrew|2|||
16185925|NCT00069095|39159388|FG001|Primary Treatment Phase|Withdrew|3|||
16185926|NCT00069095|39159389|FG002|Primary Treatment Phase|Withdrew|8|||
16185927|NCT00069095|39159390|FG003|Primary Treatment Phase|Withdrew|2|||
16185928|NCT00069095|39159391|FG004|Primary Treatment Phase|Withdrew|4|||
16185929|NCT00069095|39159392|FG005|Primary Treatment Phase|Withdrew|9|||
16185930|NCT00069095|39159387|FG000|Primary Treatment Phase|Other Violation|0|||
16185931|NCT00069095|39159388|FG001|Primary Treatment Phase|Other Violation|1|||
16482332|NCT00530946|40242467|FG000|Overall Study|Adverse Event|1|||
16482333|NCT00530946|40242468|FG001|Overall Study|Adverse Event|2|||
16482334|NCT00530946|40242469|FG002|Overall Study|Adverse Event|1|||
16482335|NCT00530946|40242470|FG003|Overall Study|Adverse Event|1|||
16482336|NCT00530946|40242467|FG000|Overall Study|Protocol Violation|0|||
16482337|NCT00530946|40242468|FG001|Overall Study|Protocol Violation|0|||
16482338|NCT00530946|40242469|FG002|Overall Study|Protocol Violation|0|||
16482339|NCT00530946|40242470|FG003|Overall Study|Protocol Violation|1|||
16185932|NCT00069095|39159389|FG002|Primary Treatment Phase|Other Violation|1|||
16185933|NCT00069095|39159390|FG003|Primary Treatment Phase|Other Violation|1|||
16289334|NCT00925301|39543614|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
16289335|NCT00925301|39543615|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
16289336|NCT00925301|39543612|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
16289337|NCT00925301|39543613|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
16289338|NCT00925301|39543614|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
16289339|NCT00925301|39543615|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
16289340|NCT00925301|39543612|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
16289341|NCT00925301|39543613|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
16289342|NCT00925301|39543614|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
16289343|NCT00925301|39543615|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
16289344|NCT00891371|39543616|FG000|Pre-assignment|Inclusion/exclusion|5|||
16289345|NCT00891371|39543616|FG000|Pre-assignment|Consent withdrawal|1|||
16289346|NCT00891371|39543616|FG000|Treatment|Lack of Efficacy|5|||
16289347|NCT00891371|39543616|FG000|Treatment|Adverse Event|2|||
16289348|NCT00891371|39543616|FG000|Treatment|Death|1|||
16289349|NCT00891371|39543616|FG000|Treatment|Lost to Follow-up|1|||
16289350|NCT02435836|39543617|FG000|Overall Study|Lost to Follow-up|21|||
16289351|NCT02435836|39543617|FG000|Overall Study|Lack of Efficacy|1|||
16289352|NCT02435836|39543617|FG000|Overall Study|Withdrawal by Subject|236|||
16289353|NCT02435836|39543617|FG000|Overall Study|Insufficient Clinical Response|26|||
16289354|NCT02435836|39543617|FG000|Overall Study|Adverse Event|44|||
16289355|NCT02435836|39543617|FG000|Overall Study|Sponsor discontinued trial|167|||
16482340|NCT00530946|40242467|FG000|Overall Study|Noncompliance|1|||
16482341|NCT00530946|40242468|FG001|Overall Study|Noncompliance|0|||
16482342|NCT00530946|40242469|FG002|Overall Study|Noncompliance|0|||
16482343|NCT00530946|40242470|FG003|Overall Study|Noncompliance|0|||
16185934|NCT00069095|39159391|FG004|Primary Treatment Phase|Other Violation|0|||
16289356|NCT02435836|39543617|FG000|Overall Study|Noncompliance|27|||
16289357|NCT02435836|39543617|FG000|Overall Study|Protocol Violation|6|||
16185935|NCT00069095|39159392|FG005|Primary Treatment Phase|Other Violation|1|||
16185936|NCT00069095|39159387|FG000|Primary Treatment Phase|Violation criteria|0|||
16380358|NCT02891226|39874872|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380359|NCT02891226|39874873|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380360|NCT02891226|39874874|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380361|NCT02891226|39874875|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380362|NCT02891226|39874876|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380363|NCT02891226|39874877|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380364|NCT02891226|39874878|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380365|NCT02891226|39874879|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380366|NCT02891226|39874880|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380367|NCT02891226|39874881|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380368|NCT02891226|39874882|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
16380369|NCT02891226|39874883|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380370|NCT02891226|39874884|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380371|NCT02891226|39874885|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380372|NCT02891226|39874886|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380373|NCT02891226|39874887|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
16380374|NCT02891226|39874872|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380375|NCT02891226|39874873|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380376|NCT02891226|39874874|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380377|NCT02891226|39874875|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380378|NCT02891226|39874876|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380379|NCT02891226|39874877|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380380|NCT02891226|39874878|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380381|NCT02891226|39874879|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380382|NCT02891226|39874880|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380383|NCT02891226|39874881|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380384|NCT02891226|39874882|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
16380385|NCT02891226|39874883|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16185937|NCT00069095|39159388|FG001|Primary Treatment Phase|Violation criteria|2|||
16185938|NCT00069095|39159389|FG002|Primary Treatment Phase|Violation criteria|4|||
16185939|NCT00069095|39159390|FG003|Primary Treatment Phase|Violation criteria|3|||
16185940|NCT00069095|39159391|FG004|Primary Treatment Phase|Violation criteria|1|||
16185941|NCT00069095|39159392|FG005|Primary Treatment Phase|Violation criteria|5|||
16185942|NCT00069095|39159387|FG000|Post-study Treatment Phase|Missing reason|1|||
16185943|NCT00069095|39159388|FG001|Post-study Treatment Phase|Missing reason|3|||
16185944|NCT00069095|39159389|FG002|Post-study Treatment Phase|Missing reason|12|||
16185945|NCT00069095|39159390|FG003|Post-study Treatment Phase|Missing reason|8|||
16185946|NCT00069095|39159391|FG004|Post-study Treatment Phase|Missing reason|18|||
16185947|NCT00069095|39159392|FG005|Post-study Treatment Phase|Missing reason|17|||
16185948|NCT00069095|39159387|FG000|Post-study Treatment Phase|Adverse Event|2|||
16185949|NCT00069095|39159388|FG001|Post-study Treatment Phase|Adverse Event|3|||
16185950|NCT00069095|39159389|FG002|Post-study Treatment Phase|Adverse Event|1|||
16185951|NCT00069095|39159390|FG003|Post-study Treatment Phase|Adverse Event|0|||
16185952|NCT00069095|39159391|FG004|Post-study Treatment Phase|Adverse Event|5|||
16185953|NCT00069095|39159392|FG005|Post-study Treatment Phase|Adverse Event|1|||
16185954|NCT00069095|39159387|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
16185955|NCT00069095|39159388|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
16185956|NCT00069095|39159389|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
16185957|NCT00069095|39159390|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
16185958|NCT00069095|39159391|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
16185959|NCT00069095|39159392|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
16185960|NCT00069095|39159387|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
16185961|NCT00069095|39159388|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
16185962|NCT00069095|39159389|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
16185963|NCT00069095|39159390|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
16185964|NCT00069095|39159391|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
16185965|NCT00069095|39159392|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
16185966|NCT00069095|39159387|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
16185967|NCT00069095|39159388|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
16185968|NCT00069095|39159389|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
16185969|NCT00069095|39159390|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
16185970|NCT00069095|39159391|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
16185971|NCT00069095|39159392|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
16185972|NCT00069095|39159387|FG000|Post-study Treatment Phase|Participant had complete response|1|||
16185973|NCT00069095|39159388|FG001|Post-study Treatment Phase|Participant had complete response|1|||
16380386|NCT02891226|39874884|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380387|NCT02891226|39874885|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380388|NCT02891226|39874886|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380389|NCT02891226|39874887|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
16380390|NCT02891226|39874872|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380391|NCT02891226|39874873|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380392|NCT02891226|39874874|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380393|NCT02891226|39874875|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380394|NCT02891226|39874876|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380395|NCT02891226|39874877|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380396|NCT02891226|39874878|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380397|NCT02891226|39874879|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380398|NCT02891226|39874880|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380399|NCT02891226|39874881|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380400|NCT02891226|39874882|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
16380401|NCT02891226|39874883|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380402|NCT02891226|39874884|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380403|NCT02891226|39874885|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380404|NCT02891226|39874886|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380405|NCT02891226|39874887|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
16380406|NCT02891226|39874872|FG000|Follow-up Period|Withdrawal by Subject|0|||
16380407|NCT02891226|39874873|FG001|Follow-up Period|Withdrawal by Subject|0|||
16380408|NCT02891226|39874874|FG002|Follow-up Period|Withdrawal by Subject|0|||
16380409|NCT02891226|39874875|FG003|Follow-up Period|Withdrawal by Subject|0|||
16380410|NCT02891226|39874876|FG004|Follow-up Period|Withdrawal by Subject|0|||
16380411|NCT02891226|39874877|FG005|Follow-up Period|Withdrawal by Subject|0|||
16380412|NCT02891226|39874878|FG006|Follow-up Period|Withdrawal by Subject|0|||
16380413|NCT02891226|39874879|FG007|Follow-up Period|Withdrawal by Subject|0|||
16380414|NCT02891226|39874880|FG008|Follow-up Period|Withdrawal by Subject|0|||
16380415|NCT02891226|39874881|FG009|Follow-up Period|Withdrawal by Subject|0|||
16380416|NCT02891226|39874882|FG010|Follow-up Period|Withdrawal by Subject|0|||
16380417|NCT02891226|39874883|FG011|Follow-up Period|Withdrawal by Subject|1|||
16380418|NCT02891226|39874884|FG012|Follow-up Period|Withdrawal by Subject|0|||
16380419|NCT02891226|39874885|FG013|Follow-up Period|Withdrawal by Subject|0|||
16380420|NCT02891226|39874886|FG014|Follow-up Period|Withdrawal by Subject|1|||
16380421|NCT02891226|39874887|FG015|Follow-up Period|Withdrawal by Subject|1|||
16380422|NCT00830336|39874890|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
16380423|NCT00830336|39874891|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
16380424|NCT00730327|39874892|FG000|Overall Study|Lost to Follow-up|14|||
16380425|NCT00730327|39874893|FG001|Overall Study|Lost to Follow-up|16|||
16380426|NCT00730327|39874892|FG000|Overall Study|Adverse Event|8|||
16380427|NCT00730327|39874893|FG001|Overall Study|Adverse Event|1|||
16380428|NCT00730327|39874892|FG000|Overall Study|Withdrawal by Subject|3|||
16185974|NCT00069095|39159389|FG002|Post-study Treatment Phase|Participant had complete response|0|||
16185975|NCT00069095|39159390|FG003|Post-study Treatment Phase|Participant had complete response|0|||
16185976|NCT00069095|39159391|FG004|Post-study Treatment Phase|Participant had complete response|0|||
16185977|NCT00069095|39159392|FG005|Post-study Treatment Phase|Participant had complete response|0|||
16185978|NCT00069095|39159387|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
16185979|NCT00069095|39159388|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
16185980|NCT00069095|39159389|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
16185981|NCT00069095|39159390|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
16185982|NCT00069095|39159391|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
16185983|NCT00069095|39159392|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
16185984|NCT00069095|39159387|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
16289358|NCT02435836|39543617|FG000|Overall Study|Met Withdrawal Criteria|7|||
16289359|NCT02435836|39543617|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
16289360|NCT00655850|39543619|FG000|Overall Study|Death|2|||
16289361|NCT00655850|39543619|FG000|Overall Study|Withdrawal by Subject|1|||
16185985|NCT00069095|39159388|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
16185986|NCT00069095|39159389|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
16185987|NCT00069095|39159390|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
16289362|NCT01117337|39543620|FG000|Overall Study|Lost to Follow-up|4|||
16289363|NCT01117337|39543621|FG001|Overall Study|Lost to Follow-up|0|||
16289364|NCT02676284|39543626|FG000|Overall Study|Withdrawal by Subject|1|||
16289365|NCT00319982|39543628|FG000|Overall Study|Withdrawal by Subject|1|||
16289366|NCT00319982|39543629|FG001|Overall Study|Withdrawal by Subject|0|||
16289367|NCT03476343|39543630|FG000|Overall Study|Clinical exam moved to another scanner|7|||
16289368|NCT03476343|39543630|FG000|Overall Study|Clinical order cancelled|4|||
16289369|NCT03476343|39543630|FG000|Overall Study|Neonate did not settle down for the scan|1|||
16289370|NCT00846521|39543631|FG000|Overall Study|Withdrawal by Subject|5|||
16289371|NCT00846521|39543631|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
16289372|NCT00846521|39543631|FG000|Overall Study|Protocol Violation|1|||
16380429|NCT00730327|39874893|FG001|Overall Study|Withdrawal by Subject|13|||
16380430|NCT00730327|39874892|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
16380431|NCT00730327|39874893|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
16380432|NCT00734032|39874894|FG000|Overall Study|Adverse Event|0|||
16289373|NCT00423319|39543632|FG000|Overall Study|Death|2|||
16289374|NCT00423319|39543633|FG001|Overall Study|Death|0|||
16289375|NCT00423319|39543632|FG000|Overall Study|Adverse Event|93|||
16289376|NCT00423319|39543633|FG001|Overall Study|Adverse Event|112|||
16289377|NCT00423319|39543632|FG000|Overall Study|Withdrawal by Subject|86|||
16289378|NCT00423319|39543633|FG001|Overall Study|Withdrawal by Subject|99|||
16289379|NCT00423319|39543632|FG000|Overall Study|Lost to Follow-up|4|||
16289380|NCT00423319|39543633|FG001|Overall Study|Lost to Follow-up|3|||
16289381|NCT00423319|39543632|FG000|Overall Study|Poor compliance or noncompliance|1|||
16289382|NCT00423319|39543633|FG001|Overall Study|Poor compliance or noncompliance|1|||
16289383|NCT00423319|39543632|FG000|Overall Study|No longer meets study criteria|15|||
16289384|NCT00423319|39543633|FG001|Overall Study|No longer meets study criteria|15|||
16289385|NCT00423319|39543632|FG000|Overall Study|Other|23|||
16289386|NCT00423319|39543633|FG001|Overall Study|Other|22|||
16289387|NCT02566993|39543634|FG000|Overall Study|Randomized but not treated|5|||
16289388|NCT02566993|39543635|FG001|Overall Study|Randomized but not treated|16|||
16380433|NCT00734032|39874895|FG001|Overall Study|Adverse Event|1|||
16380434|NCT00734032|39874896|FG002|Overall Study|Adverse Event|0|||
16380435|NCT00734032|39874897|FG003|Overall Study|Adverse Event|0|||
16482344|NCT00751933|40242475|FG000|Overall Study|Withdrawal by Subject|0|||
16482345|NCT00751933|40242476|FG001|Overall Study|Withdrawal by Subject|1|||
16482346|NCT00751933|40242477|FG002|Overall Study|Withdrawal by Subject|0|||
16482347|NCT00751933|40242478|FG003|Overall Study|Withdrawal by Subject|0|||
16482348|NCT00751933|40242475|FG000|Overall Study|Physician Decision|0|||
16482349|NCT00751933|40242476|FG001|Overall Study|Physician Decision|0|||
16482350|NCT00751933|40242477|FG002|Overall Study|Physician Decision|1|||
16482351|NCT00751933|40242478|FG003|Overall Study|Physician Decision|1|||
16482352|NCT01409434|40242481|FG000|Overall Study|Protocol Violation|4|||
16482353|NCT00371826|40242482|FG000|Core Phase (12 Months)|Adverse Event|15|||
16482354|NCT00371826|40242483|FG001|Core Phase (12 Months)|Adverse Event|4|||
16482355|NCT00371826|40242484|FG002|Core Phase (12 Months)|Adverse Event|9|||
16482356|NCT00371826|40242482|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
16482357|NCT00371826|40242483|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
16482358|NCT00371826|40242484|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
16289389|NCT02566993|39543634|FG000|Overall Study|Progressive disease|213|||
16289390|NCT02566993|39543635|FG001|Overall Study|Progressive disease|152|||
16289391|NCT02566993|39543634|FG000|Overall Study|Withdrawal by Subject|12|||
16482359|NCT00371826|40242482|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
16380436|NCT03440411|39874899|FG000|Overall Study|Adverse Event|0|||
16482360|NCT00371826|40242483|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
16482361|NCT00371826|40242484|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
16482362|NCT00371826|40242482|FG000|Core Phase (12 Months)|Protocol Violation|1|||
16482363|NCT00371826|40242483|FG001|Core Phase (12 Months)|Protocol Violation|0|||
16482364|NCT00371826|40242484|FG002|Core Phase (12 Months)|Protocol Violation|1|||
16289392|NCT02566993|39543635|FG001|Overall Study|Withdrawal by Subject|28|||
16289393|NCT02566993|39543634|FG000|Overall Study|Death|17|||
16289394|NCT02566993|39543635|FG001|Overall Study|Death|23|||
16289395|NCT02566993|39543634|FG000|Overall Study|Physician Decision|10|||
16289396|NCT02566993|39543635|FG001|Overall Study|Physician Decision|17|||
16289397|NCT02566993|39543634|FG000|Overall Study|Study drug-related adverse event|20|||
16289398|NCT02566993|39543635|FG001|Overall Study|Study drug-related adverse event|41|||
16289399|NCT02566993|39543634|FG000|Overall Study|Non study drug-related adverse event|9|||
16289400|NCT02566993|39543635|FG001|Overall Study|Non study drug-related adverse event|9|||
16289401|NCT02566993|39543634|FG000|Overall Study|Symptomatic deterioration|9|||
16289402|NCT02566993|39543635|FG001|Overall Study|Symptomatic deterioration|16|||
16289403|NCT02566993|39543634|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
16289404|NCT02566993|39543635|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
16289405|NCT02566993|39543634|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
16289406|NCT02566993|39543635|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
16289407|NCT02566993|39543634|FG000|Overall Study|Screening failure|2|||
16289408|NCT02566993|39543635|FG001|Overall Study|Screening failure|0|||
16289409|NCT02566993|39543634|FG000|Overall Study|Lost to Follow-up|0|||
16289410|NCT02566993|39543635|FG001|Overall Study|Lost to Follow-up|1|||
16289411|NCT02566993|39543634|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
16289412|NCT02566993|39543635|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
16289413|NCT03123783|39543638|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
16289414|NCT03123783|39543639|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
16289415|NCT03123783|39543640|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
16289416|NCT03123783|39543641|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
16289417|NCT03123783|39543642|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
16289418|NCT03123783|39543643|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
16289419|NCT03123783|39543644|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
16289420|NCT03123783|39543638|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
16289421|NCT03123783|39543639|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
16289422|NCT03123783|39543640|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
16289423|NCT03123783|39543641|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
16289424|NCT03123783|39543642|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
16289425|NCT03123783|39543643|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
16289426|NCT03123783|39543644|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
16289427|NCT03123783|39543638|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
16289428|NCT03123783|39543639|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
16289429|NCT03123783|39543640|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
16289430|NCT03123783|39543641|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
16289431|NCT03123783|39543642|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
16289432|NCT03123783|39543643|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
16289433|NCT03123783|39543644|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
16289434|NCT03123783|39543638|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
16289435|NCT03123783|39543639|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
16289436|NCT03123783|39543640|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
16289437|NCT03123783|39543641|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
16289438|NCT03123783|39543642|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
16289439|NCT03123783|39543643|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
16289440|NCT03123783|39543644|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
16289441|NCT01360866|39543656|FG000|Overall Study|Lost to Follow-up|11|||
16289442|NCT01360866|39543657|FG001|Overall Study|Lost to Follow-up|28|||
16289443|NCT01360866|39543658|FG002|Overall Study|Lost to Follow-up|41|||
16289444|NCT01360866|39543659|FG003|Overall Study|Lost to Follow-up|0|||
16289445|NCT01360866|39543656|FG000|Overall Study|Adverse Event|56|||
16289446|NCT01360866|39543657|FG001|Overall Study|Adverse Event|61|||
16289447|NCT01360866|39543658|FG002|Overall Study|Adverse Event|134|||
16289448|NCT01360866|39543659|FG003|Overall Study|Adverse Event|6|||
16289449|NCT01360866|39543656|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
16289450|NCT01360866|39543657|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
16482365|NCT00371826|40242482|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
16289451|NCT01360866|39543658|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
16289452|NCT01360866|39543659|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
16289453|NCT01360866|39543656|FG000|Overall Study|Withdrawn by Investigator|9|||
16289454|NCT01360866|39543657|FG001|Overall Study|Withdrawn by Investigator|8|||
16289455|NCT01360866|39543658|FG002|Overall Study|Withdrawn by Investigator|31|||
16289456|NCT01360866|39543659|FG003|Overall Study|Withdrawn by Investigator|2|||
16289457|NCT01360866|39543656|FG000|Overall Study|Withdrawal by participant|79|||
16289458|NCT01360866|39543657|FG001|Overall Study|Withdrawal by participant|89|||
16380437|NCT03440411|39874900|FG001|Overall Study|Adverse Event|0|||
16380438|NCT03440411|39874901|FG002|Overall Study|Adverse Event|1|||
16289459|NCT01360866|39543658|FG002|Overall Study|Withdrawal by participant|168|||
16289460|NCT01360866|39543659|FG003|Overall Study|Withdrawal by participant|8|||
16289461|NCT01360866|39543656|FG000|Overall Study|Protocol Deviation|25|||
16289462|NCT01360866|39543657|FG001|Overall Study|Protocol Deviation|33|||
16289463|NCT01360866|39543658|FG002|Overall Study|Protocol Deviation|61|||
16289464|NCT01360866|39543659|FG003|Overall Study|Protocol Deviation|2|||
16289465|NCT01360866|39543656|FG000|Overall Study|Lack of Efficacy|30|||
16289466|NCT01360866|39543657|FG001|Overall Study|Lack of Efficacy|40|||
16289467|NCT01360866|39543658|FG002|Overall Study|Lack of Efficacy|30|||
16289468|NCT01360866|39543659|FG003|Overall Study|Lack of Efficacy|4|||
16482366|NCT00371826|40242483|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
16482367|NCT00371826|40242484|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
16482368|NCT00371826|40242482|FG000|Core Phase (12 Months)|Administrative problems|1|||
16482369|NCT00371826|40242483|FG001|Core Phase (12 Months)|Administrative problems|0|||
16482370|NCT00371826|40242484|FG002|Core Phase (12 Months)|Administrative problems|8|||
16380439|NCT03440411|39874902|FG003|Overall Study|Adverse Event|0|||
16380440|NCT03440411|39874899|FG000|Overall Study|PD|2|||
16380441|NCT03440411|39874900|FG001|Overall Study|PD|1|||
16380442|NCT03440411|39874901|FG002|Overall Study|PD|1|||
16380443|NCT03440411|39874902|FG003|Overall Study|PD|1|||
16380444|NCT03440411|39874899|FG000|Overall Study|Withdrawal by Subject|1|||
16380445|NCT03440411|39874900|FG001|Overall Study|Withdrawal by Subject|0|||
16380446|NCT03440411|39874901|FG002|Overall Study|Withdrawal by Subject|0|||
16380447|NCT03440411|39874902|FG003|Overall Study|Withdrawal by Subject|0|||
16380448|NCT03440411|39874899|FG000|Overall Study|Closed study by sponsor|0|||
16380449|NCT03440411|39874900|FG001|Overall Study|Closed study by sponsor|0|||
16380450|NCT03440411|39874901|FG002|Overall Study|Closed study by sponsor|0|||
16380451|NCT03440411|39874902|FG003|Overall Study|Closed study by sponsor|1|||
16380452|NCT02263547|39874903|FG000|Overall Study|Adverse Event|1|||
16380453|NCT02263547|39874903|FG000|Overall Study|Lost to Follow-up|2|||
16380454|NCT01538199|39874905|FG000|Overall Study|Lost to Follow-up|1|||
16380455|NCT01538199|39874906|FG001|Overall Study|Lost to Follow-up|2|||
16380456|NCT01538199|39874907|FG002|Overall Study|Lost to Follow-up|1|||
16380457|NCT01538199|39874908|FG003|Overall Study|Lost to Follow-up|0|||
16380458|NCT01538199|39874905|FG000|Overall Study|participant did not have time|1|||
16482371|NCT00371826|40242482|FG000|Core Phase (12 Months)|Graft Loss|0|||
16482372|NCT00371826|40242483|FG001|Core Phase (12 Months)|Graft Loss|1|||
16482373|NCT00371826|40242484|FG002|Core Phase (12 Months)|Graft Loss|0|||
16482374|NCT00371826|40242482|FG000|Extension Phase (24 Months)|Adverse Event|4|||
16482375|NCT00371826|40242483|FG001|Extension Phase (24 Months)|Adverse Event|5|||
16482376|NCT00371826|40242484|FG002|Extension Phase (24 Months)|Adverse Event|0|||
16482377|NCT00371826|40242482|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
16482378|NCT00371826|40242483|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
16482379|NCT00371826|40242484|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
16482380|NCT00371826|40242482|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
16482381|NCT00371826|40242483|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
16289469|NCT00227266|39543662|FG000|Overall Study|Withdrawal by Subject|0|||
16289470|NCT00227266|39543663|FG001|Overall Study|Withdrawal by Subject|0|||
16289471|NCT00227266|39543664|FG002|Overall Study|Withdrawal by Subject|1|||
16289472|NCT00227266|39543662|FG000|Overall Study|Protocol Violation|1|||
16289473|NCT00227266|39543663|FG001|Overall Study|Protocol Violation|0|||
16289474|NCT00227266|39543664|FG002|Overall Study|Protocol Violation|1|||
16289475|NCT00227266|39543662|FG000|Overall Study|Excessive weight gain|0|||
16289476|NCT00227266|39543663|FG001|Overall Study|Excessive weight gain|0|||
16289477|NCT00227266|39543664|FG002|Overall Study|Excessive weight gain|2|||
16289478|NCT01568866|39543667|FG000|Overall Study|Disease Progression|208|||
16289479|NCT01568866|39543668|FG001|Overall Study|Disease Progression|183|||
16289480|NCT01568866|39543667|FG000|Overall Study|Adverse Event|94|||
16380459|NCT01538199|39874906|FG001|Overall Study|participant did not have time|0|||
16289481|NCT01568866|39543668|FG001|Overall Study|Adverse Event|96|||
16289482|NCT01568866|39543667|FG000|Overall Study|Patient Request|55|||
16289483|NCT01568866|39543668|FG001|Overall Study|Patient Request|71|||
16380460|NCT01538199|39874907|FG002|Overall Study|participant did not have time|0|||
16380461|NCT01538199|39874908|FG003|Overall Study|participant did not have time|2|||
16482382|NCT00371826|40242484|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
16482383|NCT00371826|40242482|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
16289484|NCT01568866|39543667|FG000|Overall Study|Physician Decision|40|||
16289485|NCT01568866|39543668|FG001|Overall Study|Physician Decision|32|||
16289486|NCT01568866|39543667|FG000|Overall Study|Withdrawal by Subject|19|||
16289487|NCT01568866|39543668|FG001|Overall Study|Withdrawal by Subject|11|||
16289488|NCT01568866|39543667|FG000|Overall Study|Death|10|||
16289489|NCT01568866|39543668|FG001|Overall Study|Death|18|||
16289490|NCT01568866|39543667|FG000|Overall Study|Protocol Non-compliance|2|||
16289491|NCT01568866|39543668|FG001|Overall Study|Protocol Non-compliance|4|||
16289492|NCT01568866|39543667|FG000|Overall Study|Lost to Follow-up|1|||
16289493|NCT01568866|39543668|FG001|Overall Study|Lost to Follow-up|0|||
16289494|NCT01568866|39543667|FG000|Overall Study|Randomized but Not Dosed|9|||
16289495|NCT01568866|39543668|FG001|Overall Study|Randomized but Not Dosed|1|||
16289496|NCT01359644|39543676|FG000|Treatment Period|Lack of Efficacy|0|||
16289497|NCT01359644|39543677|FG001|Treatment Period|Lack of Efficacy|1|||
16289498|NCT01359644|39543678|FG002|Treatment Period|Lack of Efficacy|0|||
16289499|NCT01359644|39543679|FG003|Treatment Period|Lack of Efficacy|0|||
16289500|NCT01359644|39543680|FG004|Treatment Period|Lack of Efficacy|0|||
16289501|NCT01359644|39543681|FG005|Treatment Period|Lack of Efficacy|0|||
16289502|NCT01359644|39543682|FG006|Treatment Period|Lack of Efficacy|0|||
16289503|NCT01359644|39543683|FG007|Treatment Period|Lack of Efficacy|0|||
16289504|NCT01359644|39543684|FG008|Treatment Period|Lack of Efficacy|0|||
16289505|NCT01359644|39543685|FG009|Treatment Period|Lack of Efficacy|0|||
16289506|NCT01359644|39543676|FG000|Treatment Period|Adverse Event|0|||
16289507|NCT01359644|39543677|FG001|Treatment Period|Adverse Event|0|||
16289508|NCT01359644|39543678|FG002|Treatment Period|Adverse Event|1|||
16289509|NCT01359644|39543679|FG003|Treatment Period|Adverse Event|0|||
16289510|NCT01359644|39543680|FG004|Treatment Period|Adverse Event|0|||
16289511|NCT01359644|39543681|FG005|Treatment Period|Adverse Event|1|||
16289512|NCT01359644|39543682|FG006|Treatment Period|Adverse Event|0|||
16289513|NCT01359644|39543683|FG007|Treatment Period|Adverse Event|0|||
16289514|NCT01359644|39543684|FG008|Treatment Period|Adverse Event|0|||
16289515|NCT01359644|39543685|FG009|Treatment Period|Adverse Event|0|||
16289516|NCT01359644|39543676|FG000|Treatment Period|Lost to Follow-up|0|||
16289517|NCT01359644|39543677|FG001|Treatment Period|Lost to Follow-up|0|||
16289518|NCT01359644|39543678|FG002|Treatment Period|Lost to Follow-up|0|||
16289519|NCT01359644|39543679|FG003|Treatment Period|Lost to Follow-up|0|||
16289520|NCT01359644|39543680|FG004|Treatment Period|Lost to Follow-up|0|||
16289521|NCT01359644|39543681|FG005|Treatment Period|Lost to Follow-up|1|||
16289522|NCT01359644|39543682|FG006|Treatment Period|Lost to Follow-up|0|||
16289523|NCT01359644|39543683|FG007|Treatment Period|Lost to Follow-up|0|||
16289524|NCT01359644|39543684|FG008|Treatment Period|Lost to Follow-up|0|||
16289525|NCT01359644|39543685|FG009|Treatment Period|Lost to Follow-up|0|||
16289526|NCT01359644|39543676|FG000|Follow-up Period|Withdrawal by Subject|0|||
16289527|NCT01359644|39543677|FG001|Follow-up Period|Withdrawal by Subject|0|||
16289528|NCT01359644|39543678|FG002|Follow-up Period|Withdrawal by Subject|0|||
16289529|NCT01359644|39543679|FG003|Follow-up Period|Withdrawal by Subject|0|||
16289530|NCT01359644|39543680|FG004|Follow-up Period|Withdrawal by Subject|0|||
16289531|NCT01359644|39543681|FG005|Follow-up Period|Withdrawal by Subject|1|||
16289532|NCT01359644|39543682|FG006|Follow-up Period|Withdrawal by Subject|0|||
16289533|NCT01359644|39543683|FG007|Follow-up Period|Withdrawal by Subject|0|||
16289534|NCT01359644|39543684|FG008|Follow-up Period|Withdrawal by Subject|0|||
16289535|NCT01359644|39543685|FG009|Follow-up Period|Withdrawal by Subject|0|||
16289536|NCT01359644|39543676|FG000|Follow-up Period|Lost to Follow-up|0|||
16289537|NCT01359644|39543677|FG001|Follow-up Period|Lost to Follow-up|0|||
16289538|NCT01359644|39543678|FG002|Follow-up Period|Lost to Follow-up|0|||
16289539|NCT01359644|39543679|FG003|Follow-up Period|Lost to Follow-up|0|||
16289540|NCT01359644|39543680|FG004|Follow-up Period|Lost to Follow-up|0|||
16380462|NCT01538199|39874905|FG000|Overall Study|Lack of Efficacy|0|||
16482384|NCT00371826|40242483|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
16482385|NCT00371826|40242484|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
16482386|NCT00371826|40242482|FG000|Extension Phase (24 Months)|Administrative problems|0|||
16482387|NCT00371826|40242483|FG001|Extension Phase (24 Months)|Administrative problems|0|||
16482388|NCT00371826|40242484|FG002|Extension Phase (24 Months)|Administrative problems|2|||
16482389|NCT02151110|40242485|FG000|Overall Study|Withdrawal by Subject|0|||
16289541|NCT01359644|39543681|FG005|Follow-up Period|Lost to Follow-up|0|||
16289542|NCT01359644|39543682|FG006|Follow-up Period|Lost to Follow-up|1|||
16289543|NCT01359644|39543683|FG007|Follow-up Period|Lost to Follow-up|2|||
16289544|NCT01359644|39543684|FG008|Follow-up Period|Lost to Follow-up|0|||
16289545|NCT01359644|39543685|FG009|Follow-up Period|Lost to Follow-up|0|||
16289546|NCT04430855|39543686|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
16289547|NCT04430855|39543687|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
16289548|NCT04430855|39543686|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
16289549|NCT04430855|39543687|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
16289550|NCT04430855|39543686|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
16289551|NCT04430855|39543687|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
16289552|NCT04430855|39543686|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
16380463|NCT01538199|39874906|FG001|Overall Study|Lack of Efficacy|1|||
16380464|NCT01538199|39874907|FG002|Overall Study|Lack of Efficacy|0|||
16380465|NCT01538199|39874908|FG003|Overall Study|Lack of Efficacy|0|||
16380466|NCT01448616|39874909|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
16380467|NCT01448616|39874910|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
16380468|NCT01448616|39874911|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
16380469|NCT01448616|39874912|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
16380470|NCT01448616|39874909|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
16380471|NCT01448616|39874910|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
16380472|NCT01448616|39874911|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
16289553|NCT04430855|39543687|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
16289554|NCT04430855|39543686|FG000|Period 1 (Weeks 1-12)|Other|0|||
16289555|NCT04430855|39543687|FG001|Period 1 (Weeks 1-12)|Other|1|||
16289556|NCT04430855|39543686|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
16289557|NCT04430855|39543687|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
16289558|NCT04430855|39543686|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
16289559|NCT04430855|39543687|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
16289560|NCT04430855|39543686|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
16289561|NCT04430855|39543687|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
16289562|NCT00038649|39543689|FG000|Overall Study|Adverse Event|9|||
16289563|NCT01432574|39543690|FG000|Overall Study|Moved|2|||
16289564|NCT01432574|39543690|FG000|Overall Study|Not interested|1|||
16289565|NCT00614926|39543691|FG000|Overall Study|Burden of travel|1|||
16289566|NCT00614926|39543692|FG001|Overall Study|Burden of travel|0|||
16289567|NCT00614926|39543691|FG000|Overall Study|Adverse Event|3|||
16289568|NCT00614926|39543692|FG001|Overall Study|Adverse Event|0|||
16289569|NCT02500641|39543693|FG000|Overall Study|Adverse Event|0|||
16289570|NCT02500641|39543694|FG001|Overall Study|Adverse Event|2|||
16289571|NCT02500641|39543693|FG000|Overall Study|Withdrawal by Subject|4|||
16289572|NCT02500641|39543694|FG001|Overall Study|Withdrawal by Subject|5|||
16289573|NCT02500641|39543693|FG000|Overall Study|Unable to follow study procedures|3|||
16289574|NCT02500641|39543694|FG001|Overall Study|Unable to follow study procedures|2|||
16289575|NCT02500641|39543693|FG000|Overall Study|Protocol Violation|1|||
16289576|NCT02500641|39543694|FG001|Overall Study|Protocol Violation|2|||
16289577|NCT02500641|39543693|FG000|Overall Study|Lost to Follow-up|1|||
16289578|NCT02500641|39543694|FG001|Overall Study|Lost to Follow-up|0|||
16289579|NCT02500641|39543693|FG000|Overall Study|Sponsor decision|1|||
16289580|NCT02500641|39543694|FG001|Overall Study|Sponsor decision|0|||
16289581|NCT02500641|39543693|FG000|Overall Study|Non compliance to study drug|0|||
16289582|NCT02500641|39543694|FG001|Overall Study|Non compliance to study drug|1|||
16289583|NCT02802631|39543697|FG000|Overall Study|Withdrawal by Subject|1|||
16289584|NCT02802631|39543698|FG001|Overall Study|Withdrawal by Subject|0|||
16289585|NCT02802631|39543699|FG002|Overall Study|Withdrawal by Subject|0|||
16289586|NCT02802631|39543700|FG003|Overall Study|Withdrawal by Subject|0|||
16289587|NCT02802631|39543701|FG004|Overall Study|Withdrawal by Subject|0|||
16289588|NCT02802631|39543702|FG005|Overall Study|Withdrawal by Subject|0|||
16289589|NCT02802631|39543703|FG006|Overall Study|Withdrawal by Subject|0|||
16289590|NCT02802631|39543704|FG007|Overall Study|Withdrawal by Subject|0|||
16289591|NCT02802631|39543697|FG000|Overall Study|Physician Decision|1|||
16289592|NCT02802631|39543698|FG001|Overall Study|Physician Decision|0|||
16289593|NCT02802631|39543699|FG002|Overall Study|Physician Decision|0|||
16289594|NCT02802631|39543700|FG003|Overall Study|Physician Decision|0|||
16289595|NCT02802631|39543701|FG004|Overall Study|Physician Decision|0|||
16289596|NCT02802631|39543702|FG005|Overall Study|Physician Decision|0|||
16289597|NCT02802631|39543703|FG006|Overall Study|Physician Decision|1|||
16289598|NCT02802631|39543704|FG007|Overall Study|Physician Decision|0|||
16289599|NCT02802631|39543697|FG000|Overall Study|Adverse Event|0|||
16289600|NCT02802631|39543698|FG001|Overall Study|Adverse Event|2|||
16289601|NCT02802631|39543699|FG002|Overall Study|Adverse Event|0|||
16289602|NCT02802631|39543700|FG003|Overall Study|Adverse Event|1|||
16289603|NCT02802631|39543701|FG004|Overall Study|Adverse Event|6|||
16289604|NCT02802631|39543702|FG005|Overall Study|Adverse Event|1|||
16289605|NCT02802631|39543703|FG006|Overall Study|Adverse Event|4|||
16289606|NCT02802631|39543704|FG007|Overall Study|Adverse Event|0|||
16289607|NCT02802631|39543697|FG000|Overall Study|Sponsor Decision|0|||
16289608|NCT02802631|39543698|FG001|Overall Study|Sponsor Decision|0|||
16380473|NCT01448616|39874912|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
16289609|NCT02802631|39543699|FG002|Overall Study|Sponsor Decision|6|||
16289610|NCT02802631|39543700|FG003|Overall Study|Sponsor Decision|0|||
16289611|NCT02802631|39543701|FG004|Overall Study|Sponsor Decision|2|||
16289612|NCT02802631|39543702|FG005|Overall Study|Sponsor Decision|0|||
16289613|NCT02802631|39543703|FG006|Overall Study|Sponsor Decision|0|||
16289614|NCT02802631|39543704|FG007|Overall Study|Sponsor Decision|4|||
16289615|NCT02722148|39543716|FG000|Overall Study|Lost to Follow-up|2|||
16289616|NCT02722148|39543716|FG000|Overall Study|Non compliant with treatment regimen|3|||
16289617|NCT02980874|39543719|FG000|Overall Study|Adverse Event|2|||
16289618|NCT02980874|39543720|FG001|Overall Study|Adverse Event|7|||
16289619|NCT02980874|39543719|FG000|Overall Study|Withdrawal by Subject|7|||
16289620|NCT02980874|39543720|FG001|Overall Study|Withdrawal by Subject|2|||
16289621|NCT02980874|39543719|FG000|Overall Study|Lost to Follow-up|5|||
16289622|NCT02980874|39543720|FG001|Overall Study|Lost to Follow-up|5|||
16289623|NCT02980874|39543719|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
16289624|NCT02980874|39543720|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
16289625|NCT02980874|39543719|FG000|Overall Study|Unknown study completion status|1|||
16289626|NCT02980874|39543720|FG001|Overall Study|Unknown study completion status|0|||
16289627|NCT04700280|39543721|FG000|Overall Study|Adverse Event|4|||
16289628|NCT04700280|39543722|FG001|Overall Study|Adverse Event|0|||
16289629|NCT04700280|39543721|FG000|Overall Study|Lack of Efficacy|1|||
16289630|NCT04700280|39543722|FG001|Overall Study|Lack of Efficacy|0|||
16289631|NCT04700280|39543721|FG000|Overall Study|Study terminated by sponsor|5|||
16289632|NCT04700280|39543722|FG001|Overall Study|Study terminated by sponsor|3|||
16289633|NCT04700280|39543721|FG000|Overall Study|Other than specified|1|||
16289634|NCT04700280|39543722|FG001|Overall Study|Other than specified|0|||
16289635|NCT03254602|39543724|FG000|Overall Study|Lost to Follow-up|4|||
16289636|NCT02093221|39543725|FG000|Overall Study|Adverse Event|1|||
16289637|NCT02093221|39543726|FG001|Overall Study|Adverse Event|0|||
16289638|NCT02093221|39543727|FG002|Overall Study|Adverse Event|0|||
16289639|NCT02093221|39543728|FG003|Overall Study|Adverse Event|0|||
16289640|NCT02093221|39543729|FG004|Overall Study|Adverse Event|0|||
16289641|NCT02093221|39543725|FG000|Overall Study|Withdrawal by Subject|1|||
16289642|NCT02093221|39543726|FG001|Overall Study|Withdrawal by Subject|1|||
16289643|NCT02093221|39543727|FG002|Overall Study|Withdrawal by Subject|4|||
16289644|NCT02093221|39543728|FG003|Overall Study|Withdrawal by Subject|1|||
16289645|NCT02093221|39543729|FG004|Overall Study|Withdrawal by Subject|1|||
16289646|NCT02093221|39543725|FG000|Overall Study|Lost to Follow-up|2|||
16289647|NCT02093221|39543726|FG001|Overall Study|Lost to Follow-up|0|||
16289648|NCT02093221|39543727|FG002|Overall Study|Lost to Follow-up|1|||
16289649|NCT02093221|39543728|FG003|Overall Study|Lost to Follow-up|1|||
16289650|NCT02093221|39543729|FG004|Overall Study|Lost to Follow-up|0|||
16289651|NCT02093221|39543725|FG000|Overall Study|Death|0|||
16289652|NCT02093221|39543726|FG001|Overall Study|Death|1|||
16289653|NCT02093221|39543727|FG002|Overall Study|Death|0|||
16289654|NCT02093221|39543728|FG003|Overall Study|Death|0|||
16289655|NCT02093221|39543729|FG004|Overall Study|Death|0|||
16289656|NCT02093221|39543725|FG000|Overall Study|Protocol Violation|0|||
16289657|NCT02093221|39543726|FG001|Overall Study|Protocol Violation|1|||
16289658|NCT02093221|39543727|FG002|Overall Study|Protocol Violation|0|||
16289659|NCT02093221|39543728|FG003|Overall Study|Protocol Violation|0|||
16289660|NCT02093221|39543729|FG004|Overall Study|Protocol Violation|0|||
16289661|NCT02093221|39543725|FG000|Overall Study|Study termination|6|||
16289662|NCT02093221|39543726|FG001|Overall Study|Study termination|5|||
16289663|NCT02093221|39543727|FG002|Overall Study|Study termination|4|||
16289664|NCT02093221|39543728|FG003|Overall Study|Study termination|6|||
16289665|NCT02093221|39543729|FG004|Overall Study|Study termination|7|||
16289666|NCT01833533|39543730|FG000|Overall Study|Adverse Event|0|||
16289667|NCT01833533|39543731|FG001|Overall Study|Adverse Event|1|||
16289668|NCT01833533|39543730|FG000|Overall Study|Lost to Follow-up|4|||
16289669|NCT01833533|39543731|FG001|Overall Study|Lost to Follow-up|9|||
16289670|NCT01833533|39543730|FG000|Overall Study|To Enter an Extension Study|0|||
16289671|NCT01833533|39543731|FG001|Overall Study|To Enter an Extension Study|4|||
16289672|NCT01833533|39543730|FG000|Overall Study|Other|2|||
16380474|NCT01448616|39874909|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
16380475|NCT01448616|39874910|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
16380476|NCT01448616|39874911|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
16380477|NCT01448616|39874912|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
16380478|NCT01448616|39874909|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
16380479|NCT01448616|39874910|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
16380480|NCT01448616|39874911|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
16380481|NCT01448616|39874912|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
16380482|NCT01448616|39874909|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
16380483|NCT01448616|39874910|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
16380484|NCT01448616|39874911|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
16380485|NCT01448616|39874912|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
16380486|NCT02697448|39874913|FG000|Overall Study|Protocol Violation|2|||
16380487|NCT02697448|39874914|FG001|Overall Study|Protocol Violation|4|||
16380488|NCT02697448|39874913|FG000|Overall Study|Clinical concerns during ablation|1|||
16380489|NCT02697448|39874914|FG001|Overall Study|Clinical concerns during ablation|1|||
16289673|NCT01833533|39543731|FG001|Overall Study|Other|7|||
16289674|NCT01102374|39543732|FG000|Overall Study|Death|9|||
16289675|NCT01102374|39543733|FG001|Overall Study|Death|13|||
16289676|NCT01102374|39543732|FG000|Overall Study|Lost to Follow-up|7|||
16289677|NCT01102374|39543733|FG001|Overall Study|Lost to Follow-up|6|||
16289678|NCT02939014|39543734|FG000|Overall Study|Lost to Follow-up|1|||
16289679|NCT02939014|39543735|FG001|Overall Study|Lost to Follow-up|0|||
16482390|NCT02151110|40242486|FG001|Overall Study|Withdrawal by Subject|0|||
16482391|NCT02151110|40242487|FG002|Overall Study|Withdrawal by Subject|0|||
16289680|NCT02939014|39543734|FG000|Overall Study|Death|4|||
16289681|NCT02939014|39543735|FG001|Overall Study|Death|3|||
16289682|NCT00793780|39543736|FG000|Overall Study|Withdrawal by Subject|2|||
16289683|NCT00793780|39543737|FG001|Overall Study|Withdrawal by Subject|1|||
16482392|NCT02151110|40242488|FG003|Overall Study|Withdrawal by Subject|0|||
16482393|NCT02151110|40242489|FG004|Overall Study|Withdrawal by Subject|0|||
16482394|NCT02151110|40242490|FG005|Overall Study|Withdrawal by Subject|0|||
16482395|NCT02151110|40242491|FG006|Overall Study|Withdrawal by Subject|0|||
16482396|NCT02151110|40242492|FG007|Overall Study|Withdrawal by Subject|1|||
16482397|NCT02151110|40242485|FG000|Overall Study|Lost to Follow-up|0|||
16482398|NCT02151110|40242486|FG001|Overall Study|Lost to Follow-up|0|||
16482399|NCT02151110|40242487|FG002|Overall Study|Lost to Follow-up|0|||
16482400|NCT02151110|40242488|FG003|Overall Study|Lost to Follow-up|0|||
16482401|NCT02151110|40242489|FG004|Overall Study|Lost to Follow-up|0|||
16482402|NCT02151110|40242490|FG005|Overall Study|Lost to Follow-up|0|||
16482403|NCT02151110|40242491|FG006|Overall Study|Lost to Follow-up|0|||
16482404|NCT02151110|40242492|FG007|Overall Study|Lost to Follow-up|2|||
16482405|NCT01847274|40245433|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
16482406|NCT01847274|40245434|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
16482407|NCT01847274|40245435|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
16482408|NCT01847274|40245436|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
16482409|NCT01847274|40245437|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
16289684|NCT04126213|39543738|FG000|Overall Study|Lost to Follow-up|9|||
16289685|NCT04126213|39543739|FG001|Overall Study|Lost to Follow-up|1|||
16289686|NCT04126213|39543740|FG002|Overall Study|Lost to Follow-up|5|||
16289687|NCT04126213|39543741|FG003|Overall Study|Lost to Follow-up|10|||
16289688|NCT04126213|39543742|FG004|Overall Study|Lost to Follow-up|4|||
16289689|NCT04126213|39543743|FG005|Overall Study|Lost to Follow-up|7|||
16289690|NCT04126213|39543738|FG000|Overall Study|Withdrawal by Subject|3|||
16289691|NCT04126213|39543739|FG001|Overall Study|Withdrawal by Subject|2|||
16289692|NCT04126213|39543740|FG002|Overall Study|Withdrawal by Subject|1|||
16289693|NCT04126213|39543741|FG003|Overall Study|Withdrawal by Subject|1|||
16289694|NCT04126213|39543742|FG004|Overall Study|Withdrawal by Subject|1|||
16289695|NCT04126213|39543743|FG005|Overall Study|Withdrawal by Subject|1|||
16289696|NCT04126213|39543738|FG000|Overall Study|Other|0|||
16289697|NCT04126213|39543739|FG001|Overall Study|Other|0|||
16289698|NCT04126213|39543740|FG002|Overall Study|Other|2|||
16289699|NCT04126213|39543741|FG003|Overall Study|Other|2|||
16289700|NCT04126213|39543742|FG004|Overall Study|Other|0|||
16289701|NCT04126213|39543743|FG005|Overall Study|Other|1|||
16289702|NCT04126213|39543738|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16289703|NCT04126213|39543739|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
16289704|NCT04126213|39543740|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16289705|NCT04126213|39543741|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16289706|NCT04126213|39543742|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16289707|NCT04126213|39543743|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
16289708|NCT03095118|39543755|FG000|Overall Study|Adverse Event|1|||
16289709|NCT03095118|39543755|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
16289710|NCT02041091|39543756|FG000|Treatment|Adverse Event|3|||
16289711|NCT02041091|39543757|FG001|Treatment|Adverse Event|3|||
16289712|NCT02041091|39543756|FG000|Treatment|Withdrawal by Subject|2|||
16289713|NCT02041091|39543757|FG001|Treatment|Withdrawal by Subject|4|||
16289714|NCT02041091|39543756|FG000|Treatment|Physician Decision|1|||
16289715|NCT02041091|39543757|FG001|Treatment|Physician Decision|0|||
16289716|NCT02041091|39543756|FG000|Treatment|Sponsor Decision|15|||
16289717|NCT02041091|39543757|FG001|Treatment|Sponsor Decision|16|||
16289718|NCT02041091|39543756|FG000|Treatment|Lost to Follow-up|1|||
16289719|NCT02041091|39543757|FG001|Treatment|Lost to Follow-up|0|||
16289720|NCT02041091|39543756|FG000|Optional Safety Extension Period|Adverse Event|4|||
16289721|NCT02041091|39543757|FG001|Optional Safety Extension Period|Adverse Event|2|||
16289722|NCT02041091|39543756|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
16289723|NCT02041091|39543757|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
16289724|NCT02041091|39543756|FG000|Optional Safety Extension Period|Protocol Violation|2|||
16289725|NCT02041091|39543757|FG001|Optional Safety Extension Period|Protocol Violation|0|||
16289726|NCT02041091|39543756|FG000|Optional Safety Extension Period|Physician Decision|2|||
16289727|NCT02041091|39543757|FG001|Optional Safety Extension Period|Physician Decision|1|||
16289728|NCT02041091|39543756|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
16289729|NCT02041091|39543757|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
16289730|NCT02041091|39543756|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
16289731|NCT02041091|39543757|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
16289732|NCT01195272|39543761|FG000|Overall Study|Adverse Event|1|||
16289733|NCT01195272|39543761|FG000|Overall Study|Lack of Efficacy|3|||
16482410|NCT01847274|40245438|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
16482411|NCT01847274|40245439|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
16482412|NCT01847274|40245440|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
16482413|NCT01847274|40245441|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
16482414|NCT01847274|40245442|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
16482415|NCT01847274|40245443|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
16482416|NCT01847274|40245433|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
16482417|NCT01847274|40245434|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
16482418|NCT01847274|40245435|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
16482419|NCT01847274|40245436|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
16482420|NCT01847274|40245437|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
16482421|NCT01847274|40245438|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
16289734|NCT04319159|39543762|FG000|Overall Study|Screening failure|13|||
16289735|NCT04319159|39543762|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
16289736|NCT04319159|39543762|FG000|Overall Study|Withdrawal by Subject|1|||
16289737|NCT01698775|39543765|FG000|Phase A|Adverse Event|2|||
16289738|NCT01698775|39543766|FG001|Phase A|Adverse Event|1|||
16289739|NCT01698775|39543765|FG000|Phase A|Death|1|||
16289740|NCT01698775|39543766|FG001|Phase A|Death|1|||
16289741|NCT01698775|39543765|FG000|Phase A|Lack of Efficacy|1|||
16289742|NCT01698775|39543766|FG001|Phase A|Lack of Efficacy|0|||
16289743|NCT01698775|39543765|FG000|Phase A|Lost to Follow-up|1|||
16289744|NCT01698775|39543766|FG001|Phase A|Lost to Follow-up|2|||
16289745|NCT01698775|39543765|FG000|Phase A|Protocol Violation|1|||
16289746|NCT01698775|39543766|FG001|Phase A|Protocol Violation|0|||
16289747|NCT01698775|39543765|FG000|Phase A|Withdrawal by Subject|3|||
16289748|NCT01698775|39543766|FG001|Phase A|Withdrawal by Subject|4|||
16289749|NCT01698775|39543765|FG000|Phase A|Kidney [transplant]|0|||
16482422|NCT01847274|40245439|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
16482423|NCT01847274|40245440|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
16482424|NCT01847274|40245441|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
16482425|NCT01847274|40245442|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
16289750|NCT01698775|39543766|FG001|Phase A|Kidney [transplant]|1|||
16289751|NCT01698775|39543765|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
16289752|NCT01698775|39543766|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
16289753|NCT01698775|39543765|FG000|Phase B|Adverse Event|6|||
16380490|NCT02697448|39874913|FG000|Overall Study|No data collected|2|||
16380491|NCT02697448|39874914|FG001|Overall Study|No data collected|0|||
16380492|NCT00071032|39874917|FG000|Overall Study|Lost to Follow-up|1|||
16380493|NCT00071032|39874918|FG001|Overall Study|Lost to Follow-up|1|||
16380494|NCT00071032|39874917|FG000|Overall Study|Withdrawal by Subject|8|||
16380495|NCT00071032|39874918|FG001|Overall Study|Withdrawal by Subject|6|||
16380496|NCT00071032|39874917|FG000|Overall Study|Missing Primary Outcome|0|||
16380497|NCT00071032|39874918|FG001|Overall Study|Missing Primary Outcome|1|||
16380498|NCT00760552|39874919|FG000|Overall Study|Death|2|||
16380499|NCT00760552|39874920|FG001|Overall Study|Death|0|||
16380500|NCT00760552|39874919|FG000|Overall Study|Lost to Follow-up|11|||
16380501|NCT00760552|39874920|FG001|Overall Study|Lost to Follow-up|10|||
16380502|NCT03110562|39877616|FG000|Initial Treatment Period|Disease Progression|1|||
16380503|NCT03110562|39877617|FG001|Initial Treatment Period|Disease Progression|1|||
16380504|NCT03110562|39877618|FG002|Initial Treatment Period|Disease Progression|0|||
16380505|NCT03110562|39877619|FG003|Initial Treatment Period|Disease Progression|0|||
16380506|NCT03110562|39877616|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
16380507|NCT03110562|39877617|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
16380508|NCT03110562|39877618|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
16380509|NCT03110562|39877619|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
16380510|NCT03110562|39877616|FG000|Initial Treatment Period|Adverse Event|1|||
16380511|NCT03110562|39877617|FG001|Initial Treatment Period|Adverse Event|0|||
16380512|NCT03110562|39877618|FG002|Initial Treatment Period|Adverse Event|0|||
16380513|NCT03110562|39877619|FG003|Initial Treatment Period|Adverse Event|0|||
16380514|NCT03110562|39877616|FG000|Initial Treatment Period|Death|74|||
16380515|NCT03110562|39877617|FG001|Initial Treatment Period|Death|82|||
16380516|NCT03110562|39877618|FG002|Initial Treatment Period|Death|0|||
16380517|NCT03110562|39877619|FG003|Initial Treatment Period|Death|0|||
16380518|NCT03110562|39877616|FG000|Initial Treatment Period|Lost to Follow-up|13|||
16380519|NCT03110562|39877617|FG001|Initial Treatment Period|Lost to Follow-up|8|||
16380520|NCT03110562|39877618|FG002|Initial Treatment Period|Lost to Follow-up|0|||
16380521|NCT03110562|39877619|FG003|Initial Treatment Period|Lost to Follow-up|0|||
16380522|NCT03110562|39877616|FG000|Initial Treatment Period|Protocol Deviation|1|||
16380523|NCT03110562|39877617|FG001|Initial Treatment Period|Protocol Deviation|0|||
16380524|NCT03110562|39877618|FG002|Initial Treatment Period|Protocol Deviation|0|||
16380525|NCT03110562|39877619|FG003|Initial Treatment Period|Protocol Deviation|0|||
16380526|NCT03110562|39877616|FG000|Initial Treatment Period|Physician Decision|2|||
16380527|NCT03110562|39877617|FG001|Initial Treatment Period|Physician Decision|1|||
16380528|NCT03110562|39877618|FG002|Initial Treatment Period|Physician Decision|0|||
16380529|NCT03110562|39877619|FG003|Initial Treatment Period|Physician Decision|0|||
16380530|NCT03110562|39877616|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
16380531|NCT03110562|39877617|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
16380532|NCT03110562|39877618|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
16380533|NCT03110562|39877619|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
16380534|NCT03110562|39877616|FG000|Initial Treatment Period|Other|5|||
16380535|NCT03110562|39877617|FG001|Initial Treatment Period|Other|4|||
16380536|NCT03110562|39877618|FG002|Initial Treatment Period|Other|0|||
16380537|NCT03110562|39877619|FG003|Initial Treatment Period|Other|0|||
16380538|NCT03110562|39877616|FG000|Initial Treatment Period|Randomized but never treated|0|||
16380539|NCT03110562|39877617|FG001|Initial Treatment Period|Randomized but never treated|3|||
16380540|NCT03110562|39877618|FG002|Initial Treatment Period|Randomized but never treated|0|||
16380541|NCT03110562|39877619|FG003|Initial Treatment Period|Randomized but never treated|0|||
16380542|NCT03110562|39877616|FG000|Crossover Period|Disease Progression|0|||
16380543|NCT03110562|39877617|FG001|Crossover Period|Disease Progression|0|||
16380544|NCT03110562|39877618|FG002|Crossover Period|Disease Progression|1|||
16380545|NCT03110562|39877619|FG003|Crossover Period|Disease Progression|0|||
16380546|NCT03110562|39877616|FG000|Crossover Period|Withdrawal by Subject|0|||
16380547|NCT03110562|39877617|FG001|Crossover Period|Withdrawal by Subject|0|||
16380548|NCT03110562|39877618|FG002|Crossover Period|Withdrawal by Subject|8|||
16380549|NCT03110562|39877619|FG003|Crossover Period|Withdrawal by Subject|6|||
16380550|NCT03110562|39877616|FG000|Crossover Period|Death|0|||
16380551|NCT03110562|39877617|FG001|Crossover Period|Death|0|||
16380552|NCT03110562|39877618|FG002|Crossover Period|Death|37|||
16380553|NCT03110562|39877619|FG003|Crossover Period|Death|3|||
16380554|NCT03110562|39877616|FG000|Crossover Period|Lost to Follow-up|0|||
16380555|NCT03110562|39877617|FG001|Crossover Period|Lost to Follow-up|0|||
16380556|NCT03110562|39877618|FG002|Crossover Period|Lost to Follow-up|0|||
16380557|NCT03110562|39877619|FG003|Crossover Period|Lost to Follow-up|1|||
16380558|NCT03110562|39877616|FG000|Crossover Period|Other|0|||
16380559|NCT03110562|39877617|FG001|Crossover Period|Other|0|||
16380560|NCT03110562|39877618|FG002|Crossover Period|Other|1|||
16380561|NCT03110562|39877619|FG003|Crossover Period|Other|1|||
16380562|NCT03110562|39877616|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
16380563|NCT03110562|39877617|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
16482426|NCT01847274|40245443|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
16482427|NCT01847274|40245433|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
16482428|NCT01847274|40245434|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
16482429|NCT01847274|40245435|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
16482430|NCT01847274|40245436|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
16482431|NCT01847274|40245437|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
16482432|NCT01847274|40245438|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
16482433|NCT01847274|40245439|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
16482434|NCT01847274|40245440|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
16482435|NCT01847274|40245441|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
16482436|NCT01847274|40245442|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
16482437|NCT01847274|40245443|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
16482438|NCT01847274|40245433|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16482439|NCT01847274|40245434|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16482440|NCT01847274|40245435|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16482441|NCT01847274|40245436|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
16482442|NCT01847274|40245437|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16482443|NCT01847274|40245438|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16482444|NCT01847274|40245439|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16482445|NCT01847274|40245440|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16482446|NCT01847274|40245441|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16482447|NCT01847274|40245442|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16482448|NCT01847274|40245443|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
16482449|NCT01847274|40245433|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
16482450|NCT01847274|40245434|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
16482451|NCT01847274|40245435|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
16482452|NCT01847274|40245436|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
16482453|NCT01847274|40245437|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
16482454|NCT01847274|40245438|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
16482455|NCT01847274|40245439|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
16482456|NCT01847274|40245440|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
16482457|NCT01847274|40245441|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
16482458|NCT01847274|40245442|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
16482459|NCT01847274|40245443|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
16482460|NCT01847274|40245433|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
16482461|NCT01847274|40245434|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
16482462|NCT01847274|40245435|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
16482463|NCT01847274|40245436|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
16482464|NCT01847274|40245437|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
16482465|NCT01847274|40245438|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
16482466|NCT01847274|40245439|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
16482467|NCT01847274|40245440|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
16482468|NCT01847274|40245441|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
16482469|NCT01847274|40245442|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
16482470|NCT01847274|40245443|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
16482471|NCT01847274|40245433|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
16482472|NCT01847274|40245434|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
16482473|NCT01847274|40245435|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
16482474|NCT01847274|40245436|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
16482475|NCT01847274|40245437|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
16482476|NCT01847274|40245438|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
16482477|NCT01847274|40245439|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
16482478|NCT01847274|40245440|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
16482479|NCT01847274|40245441|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
16482480|NCT01847274|40245442|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
16482481|NCT01847274|40245443|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
16482482|NCT01847274|40245433|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16482483|NCT01847274|40245434|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16482484|NCT01847274|40245435|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16080430|NCT03903822|38786844|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
16080431|NCT03903822|38786845|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
16289754|NCT01698775|39543766|FG001|Phase B|Adverse Event|3|||
16289755|NCT01698775|39543765|FG000|Phase B|Death|0|||
16289756|NCT01698775|39543766|FG001|Phase B|Death|1|||
16289757|NCT01698775|39543765|FG000|Phase B|Lack of Efficacy|0|||
16289758|NCT01698775|39543766|FG001|Phase B|Lack of Efficacy|1|||
16289759|NCT01698775|39543765|FG000|Phase B|Lost to Follow-up|0|||
16289760|NCT01698775|39543766|FG001|Phase B|Lost to Follow-up|1|||
16289761|NCT01698775|39543765|FG000|Phase B|Physician Decision|1|||
16289762|NCT01698775|39543766|FG001|Phase B|Physician Decision|1|||
16289763|NCT01698775|39543765|FG000|Phase B|Protocol Violation|1|||
16289764|NCT01698775|39543766|FG001|Phase B|Protocol Violation|1|||
16289765|NCT01698775|39543765|FG000|Phase B|Withdrawal by Subject|6|||
16289766|NCT01698775|39543766|FG001|Phase B|Withdrawal by Subject|2|||
16289767|NCT00629265|39543767|FG000|Overall Study|Lost to Follow-up|4|||
16289768|NCT00629265|39543768|FG001|Overall Study|Lost to Follow-up|5|||
16289769|NCT00629265|39543767|FG000|Overall Study|Withdrawal by Subject|11|||
16289770|NCT00629265|39543768|FG001|Overall Study|Withdrawal by Subject|8|||
16289771|NCT00629265|39543767|FG000|Overall Study|Death|1|||
16289772|NCT00629265|39543768|FG001|Overall Study|Death|0|||
16289773|NCT00629265|39543767|FG000|Overall Study|Adverse Event|2|||
16289774|NCT00629265|39543768|FG001|Overall Study|Adverse Event|0|||
16289775|NCT00629265|39543767|FG000|Overall Study|HNC Recurrence|4|||
16289776|NCT00629265|39543768|FG001|Overall Study|HNC Recurrence|0|||
16289777|NCT00629265|39543767|FG000|Overall Study|Other CA Requiring Treatment|1|||
16289778|NCT00629265|39543768|FG001|Overall Study|Other CA Requiring Treatment|3|||
16289779|NCT00629265|39543767|FG000|Overall Study|Needed Esophageal Dilation|4|||
16289780|NCT00629265|39543768|FG001|Overall Study|Needed Esophageal Dilation|1|||
16289781|NCT00629265|39543767|FG000|Overall Study|Unrelated Medical Complications|3|||
16289782|NCT00629265|39543768|FG001|Overall Study|Unrelated Medical Complications|1|||
16289783|NCT00629265|39543767|FG000|Overall Study|Unknown Reason|2|||
16289784|NCT00629265|39543768|FG001|Overall Study|Unknown Reason|2|||
16289785|NCT01568320|39543771|FG000|Overall Study|Death|20|||
16289786|NCT01568320|39543771|FG000|Overall Study|Lost to Follow-up|9|||
16289787|NCT01568320|39543771|FG000|Overall Study|Withdrawal by Subject|10|||
16289788|NCT01568320|39543771|FG000|Overall Study|Conversion to open repair|1|||
16289789|NCT01568320|39543771|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
16289790|NCT03955471|39543772|FG000|Overall Study|Death|22|||
16289791|NCT03955471|39543772|FG000|Overall Study|Lost to Follow-up|1|||
16289792|NCT03955471|39543772|FG000|Overall Study|Withdrawal by Subject|6|||
16289793|NCT03955471|39543772|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
16289794|NCT01103466|39543777|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
16289795|NCT01103466|39543778|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
16289796|NCT01103466|39543779|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
16289797|NCT01103466|39543777|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
16289798|NCT01103466|39543778|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
16289799|NCT01103466|39543779|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
16289800|NCT01103466|39543777|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
16289801|NCT01103466|39543778|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
16289802|NCT01103466|39543779|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
16289803|NCT01103466|39543777|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
16289804|NCT01103466|39543778|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
16289805|NCT01103466|39543779|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
16289806|NCT01103466|39543777|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
16289807|NCT01103466|39543778|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
16289808|NCT01103466|39543779|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
16289809|NCT01103466|39543777|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
16289810|NCT01103466|39543778|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
16289811|NCT01103466|39543779|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
16289812|NCT03250299|39543781|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
16289813|NCT03250299|39543782|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
16289814|NCT03250299|39543783|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
16289815|NCT03250299|39543784|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
16289816|NCT03250299|39543785|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
16289817|NCT03250299|39543781|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
16289818|NCT03250299|39543782|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
16289819|NCT03250299|39543783|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
16289820|NCT03250299|39543784|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
16289821|NCT03250299|39543785|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
16289822|NCT03250299|39543781|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
16289823|NCT03250299|39543782|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
16289824|NCT03250299|39543783|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
16289825|NCT03250299|39543784|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
16289826|NCT03250299|39543785|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
16289827|NCT03250299|39543781|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
16289828|NCT03250299|39543782|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
16482485|NCT01847274|40245436|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16482486|NCT01847274|40245437|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16482487|NCT01847274|40245438|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
16482488|NCT01847274|40245439|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16482489|NCT01847274|40245440|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16482490|NCT01847274|40245441|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16482491|NCT01847274|40245442|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16482492|NCT01847274|40245443|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
16482493|NCT01847274|40245433|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16482494|NCT01847274|40245434|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16080432|NCT03903822|38786846|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
16080433|NCT03903822|38786847|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
16080434|NCT03903822|38786848|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
16080435|NCT03903822|38786841|FG000|Treatment Phase (6 Weeks)|Other|2|||
16080436|NCT03903822|38786842|FG001|Treatment Phase (6 Weeks)|Other|1|||
16080437|NCT03903822|38786843|FG002|Treatment Phase (6 Weeks)|Other|0|||
16080438|NCT03903822|38786844|FG003|Treatment Phase (6 Weeks)|Other|0|||
16080439|NCT03903822|38786845|FG004|Treatment Phase (6 Weeks)|Other|1|||
16080440|NCT03903822|38786846|FG005|Treatment Phase (6 Weeks)|Other|1|||
16080441|NCT03903822|38786847|FG006|Treatment Phase (6 Weeks)|Other|0|||
16080442|NCT03903822|38786848|FG007|Treatment Phase (6 Weeks)|Other|0|||
16080443|NCT03903822|38786841|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
16080444|NCT03903822|38786842|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
16080445|NCT03903822|38786843|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
16080446|NCT03903822|38786844|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
16080447|NCT03903822|38786845|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
16080448|NCT03903822|38786846|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
16080449|NCT03903822|38786847|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
16080450|NCT03903822|38786848|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
16289829|NCT03250299|39543783|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
16080451|NCT03903822|38786841|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
16080452|NCT03903822|38786842|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
16080453|NCT03903822|38786843|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
16080454|NCT03903822|38786844|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
16080455|NCT03903822|38786845|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
16080456|NCT03903822|38786846|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
16080457|NCT03903822|38786847|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
16080458|NCT03903822|38786848|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
16080459|NCT03903822|38786841|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
16080460|NCT03903822|38786842|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
16080461|NCT03903822|38786843|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
16080462|NCT03903822|38786844|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
16080463|NCT03903822|38786845|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
16080464|NCT03903822|38786846|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
16080465|NCT03903822|38786847|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
16080466|NCT03903822|38786848|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
16080467|NCT03903822|38786841|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
16080468|NCT03903822|38786842|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
16080469|NCT03903822|38786843|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
16080470|NCT03903822|38786844|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
16080471|NCT03903822|38786845|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
16080472|NCT03903822|38786846|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
16080473|NCT03903822|38786847|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
16080474|NCT03903822|38786848|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
16080475|NCT03903822|38786841|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
16080476|NCT03903822|38786842|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
16080477|NCT03903822|38786843|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
16080478|NCT03903822|38786844|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
16080479|NCT03903822|38786845|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
16080480|NCT03903822|38786846|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
16080481|NCT03903822|38786847|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
16080482|NCT03903822|38786848|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
16080483|NCT03903822|38786841|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
16080484|NCT03903822|38786842|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
16080485|NCT03903822|38786843|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
16080486|NCT03903822|38786844|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
16080487|NCT03903822|38786845|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
16289830|NCT03250299|39543784|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
16080488|NCT03903822|38786846|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
16080489|NCT03903822|38786847|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
16289831|NCT03250299|39543785|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
16080490|NCT03903822|38786848|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
16080491|NCT03903822|38786841|FG000|Follow up Phase (4 Weeks)|Other|1|||
16080492|NCT03903822|38786842|FG001|Follow up Phase (4 Weeks)|Other|1|||
16080493|NCT03903822|38786843|FG002|Follow up Phase (4 Weeks)|Other|0|||
16080494|NCT03903822|38786844|FG003|Follow up Phase (4 Weeks)|Other|0|||
16080495|NCT03903822|38786845|FG004|Follow up Phase (4 Weeks)|Other|0|||
16080496|NCT03903822|38786846|FG005|Follow up Phase (4 Weeks)|Other|0|||
16080497|NCT03903822|38786847|FG006|Follow up Phase (4 Weeks)|Other|0|||
16080498|NCT03903822|38786848|FG007|Follow up Phase (4 Weeks)|Other|0|||
16080499|NCT02224924|38786851|FG000|Overall Study|Withdrawal by Subject|7|||
16080500|NCT02224924|38786852|FG001|Overall Study|Withdrawal by Subject|6|||
16080501|NCT02224924|38786851|FG000|Overall Study|Biopsy cancelled|20|||
16080502|NCT02224924|38786852|FG001|Overall Study|Biopsy cancelled|14|||
16080503|NCT02224924|38786851|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
16080504|NCT02224924|38786852|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
16080505|NCT02224924|38786851|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
16080506|NCT02224924|38786852|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
16080507|NCT01109524|38786853|FG000|Overall Study|Disease Progression|29|||
16080508|NCT01109524|38786853|FG000|Overall Study|Study Drug toxicity|6|||
16080509|NCT01109524|38786853|FG000|Overall Study|Adverse Event|4|||
16080510|NCT01109524|38786853|FG000|Overall Study|Withdrawal by Subject|2|||
16080511|NCT01109524|38786853|FG000|Overall Study|Maximum clinical benefit|3|||
16080512|NCT01109524|38786853|FG000|Overall Study|Death|2|||
16080513|NCT01109524|38786853|FG000|Overall Study|No longer meets criteria|2|||
16080514|NCT01109524|38786853|FG000|Overall Study|Participant requested to end treatment|4|||
16080515|NCT01109524|38786853|FG000|Overall Study|Other|5|||
16080516|NCT02407249|38786858|FG000|Overall Study|Did not complete 12-month follow-up|13|||
16080517|NCT02407249|38786858|FG000|Overall Study|Not treated|13|||
16080518|NCT01414738|38786859|FG000|Overall Study|Death|26|||
16080519|NCT01414738|38786859|FG000|Overall Study|Refused testing|5|||
16080520|NCT01414738|38786859|FG000|Overall Study|Lost to Follow-up|2|||
16080521|NCT01414738|38786859|FG000|Overall Study|Refused, disease progression|8|||
16080522|NCT01414738|38786859|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
16080523|NCT04723394|38786862|FG000|Overall Study|Adverse Event|0|||
16080524|NCT04723394|38786863|FG001|Overall Study|Adverse Event|3|||
16080525|NCT04723394|38786862|FG000|Overall Study|Death|8|||
16080526|NCT04723394|38786863|FG001|Overall Study|Death|8|||
16080527|NCT04723394|38786862|FG000|Overall Study|Lost to Follow-up|20|||
16289832|NCT03514641|39543786|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
16289833|NCT03514641|39543787|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
16289834|NCT03514641|39543788|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
16289835|NCT03514641|39543789|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
16289836|NCT03514641|39543786|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
16289837|NCT03514641|39543787|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
16289838|NCT03514641|39543788|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
16289839|NCT03514641|39543789|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
16289840|NCT03514641|39543786|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
16289841|NCT03514641|39543787|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
16289842|NCT03514641|39543788|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
16289843|NCT03514641|39543789|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
16289844|NCT03514641|39543786|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
16289845|NCT03514641|39543787|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
16289846|NCT03514641|39543788|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
16289847|NCT03514641|39543789|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
16289848|NCT03514641|39543786|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
16289849|NCT03514641|39543787|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
16289850|NCT03514641|39543788|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
16482495|NCT01847274|40245435|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16482496|NCT01847274|40245436|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16080528|NCT04723394|38786863|FG001|Overall Study|Lost to Follow-up|17|||
16080529|NCT04723394|38786862|FG000|Overall Study|Physician Decision|1|||
16080530|NCT04723394|38786863|FG001|Overall Study|Physician Decision|0|||
16080531|NCT04723394|38786862|FG000|Overall Study|Withdrawal by Subject|20|||
16289851|NCT03514641|39543789|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
16289852|NCT03514641|39543786|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
16080532|NCT04723394|38786863|FG001|Overall Study|Withdrawal by Subject|34|||
16080533|NCT04723394|38786862|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
16080534|NCT04723394|38786863|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
16080535|NCT03345901|38786864|FG000|Overall Study|The study was terminated|18|||
16080536|NCT03988842|38786865|FG000|Overall Study|Death|1|||
16080537|NCT03610516|38786866|FG000|Treatment Epoch|Adverse Event|3|||
16080538|NCT03610516|38786867|FG001|Treatment Epoch|Adverse Event|1|||
16289853|NCT03514641|39543787|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
16289854|NCT03514641|39543788|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
16289855|NCT03514641|39543789|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
16289856|NCT03514641|39543786|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
16289857|NCT03514641|39543787|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
16289858|NCT03514641|39543788|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
16289859|NCT03514641|39543789|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
16289860|NCT03514641|39543786|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
16289861|NCT03514641|39543787|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
16289862|NCT03514641|39543788|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
16289863|NCT03514641|39543789|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
16289864|NCT03514641|39543786|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
16289865|NCT03514641|39543787|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
16289866|NCT03514641|39543788|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
16289867|NCT03514641|39543789|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
16289868|NCT03514641|39543786|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
16289869|NCT03514641|39543787|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
16289870|NCT03514641|39543788|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
16289871|NCT03514641|39543789|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
16289872|NCT03514641|39543786|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
16289873|NCT03514641|39543787|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
16289874|NCT03514641|39543788|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
16289875|NCT03514641|39543789|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
16289876|NCT03514641|39543786|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
16289877|NCT03514641|39543787|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
16289878|NCT03514641|39543788|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
16289879|NCT03514641|39543789|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
16289880|NCT01936623|39543791|FG000|Overall Study|Lost to Follow-up|0|||
16289881|NCT01936623|39543792|FG001|Overall Study|Lost to Follow-up|5|||
16289882|NCT00973765|39543793|FG000|Overall Study|Lost to Follow-up|8|||
16289883|NCT00973765|39543794|FG001|Overall Study|Lost to Follow-up|14|||
16289884|NCT01311557|39543797|FG000|Overall Study|Serious adverse event|0|||
16289885|NCT01311557|39543798|FG001|Overall Study|Serious adverse event|1|||
16289886|NCT01311557|39543797|FG000|Overall Study|Protocol Violation|4|||
16289887|NCT01311557|39543798|FG001|Overall Study|Protocol Violation|2|||
16289888|NCT01311557|39543797|FG000|Overall Study|Lost to Follow-up|0|||
16289889|NCT01311557|39543798|FG001|Overall Study|Lost to Follow-up|1|||
16289890|NCT01311557|39543797|FG000|Overall Study|Withdrawal by Subject|1|||
16289891|NCT01311557|39543798|FG001|Overall Study|Withdrawal by Subject|2|||
16289892|NCT02459665|39543799|FG000|Overall Study|Withdrawal by Subject|0|||
16289893|NCT02459665|39543800|FG001|Overall Study|Withdrawal by Subject|1|||
16289894|NCT02459665|39543801|FG002|Overall Study|Withdrawal by Subject|1|||
16289895|NCT02459665|39543802|FG003|Overall Study|Withdrawal by Subject|2|||
16289896|NCT02192164|39543805|FG000|Overall Study|Other|8|||
16289897|NCT02192164|39543805|FG000|Overall Study|Withdrawal by Subject|1|||
16289898|NCT02192164|39543805|FG000|Overall Study|Physician Decision|4|||
16289899|NCT02192164|39543805|FG000|Overall Study|Did not meet the exclusion criteria|1|||
16289900|NCT04440449|39543806|FG000|Overall Study|Lost to Follow-up|2|||
16289901|NCT04440449|39543807|FG001|Overall Study|Lost to Follow-up|0|||
16289902|NCT03578237|39543811|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
16289903|NCT03578237|39543812|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
16289904|NCT03407430|39543824|FG000|Washout|Protocol Violation|1|||
16289905|NCT03407430|39543825|FG001|Washout|Protocol Violation|0|||
16289906|NCT00906373|39543828|FG000|Overall Study|Withdrawal by Subject|0|||
16289907|NCT00906373|39543829|FG001|Overall Study|Withdrawal by Subject|5|||
16289908|NCT00906373|39543828|FG000|Overall Study|Other|0|||
16289909|NCT00906373|39543829|FG001|Overall Study|Other|1|||
16289910|NCT00906373|39543828|FG000|Overall Study|Still on treatment at cutoff date|0|||
16289911|NCT00906373|39543829|FG001|Overall Study|Still on treatment at cutoff date|2|||
16289912|NCT02310646|39543836|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
16289913|NCT02310646|39543837|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
16289914|NCT02310646|39543836|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
16289915|NCT02310646|39543837|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
16289916|NCT01064531|39543846|FG000|Overall Study|Lost to Follow-up|0|||
16289917|NCT01064531|39543847|FG001|Overall Study|Lost to Follow-up|2|||
16289918|NCT01064531|39543846|FG000|Overall Study|Physician Decision|0|||
16289919|NCT01064531|39543847|FG001|Overall Study|Physician Decision|1|||
16289920|NCT01064531|39543846|FG000|Overall Study|Withdrawal by Subject|2|||
16289921|NCT01064531|39543847|FG001|Overall Study|Withdrawal by Subject|2|||
16289922|NCT01064531|39543846|FG000|Overall Study|Revision due to femoral stem loosening|1|||
16289923|NCT01064531|39543847|FG001|Overall Study|Revision due to femoral stem loosening|0|||
16482497|NCT01847274|40245437|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
16482498|NCT01847274|40245438|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16482499|NCT01847274|40245439|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16482500|NCT01847274|40245440|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16482501|NCT01847274|40245441|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16482502|NCT01847274|40245442|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16482503|NCT01847274|40245443|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
16482504|NCT01847274|40245433|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16482505|NCT01847274|40245434|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16482506|NCT01847274|40245435|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16482507|NCT01847274|40245436|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16482508|NCT01847274|40245437|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16482509|NCT01847274|40245438|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16482510|NCT01847274|40245439|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
16482511|NCT01847274|40245440|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16482512|NCT01847274|40245441|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16482513|NCT01847274|40245442|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16482514|NCT01847274|40245443|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
16482515|NCT01847274|40245433|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16482516|NCT01847274|40245434|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16080539|NCT03610516|38786866|FG000|Treatment Epoch|Death|1|||
16080540|NCT03610516|38786867|FG001|Treatment Epoch|Death|0|||
16080541|NCT03610516|38786866|FG000|Treatment Epoch|Lack of Efficacy|0|||
16080542|NCT03610516|38786867|FG001|Treatment Epoch|Lack of Efficacy|1|||
16080543|NCT03610516|38786866|FG000|Treatment Epoch|No longer requires treatment|1|||
16080544|NCT03610516|38786867|FG001|Treatment Epoch|No longer requires treatment|0|||
16080545|NCT03610516|38786866|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
16080546|NCT03610516|38786867|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
16080547|NCT03610516|38786866|FG000|Treatment Epoch|Physician Decision|8|||
16080548|NCT03610516|38786867|FG001|Treatment Epoch|Physician Decision|5|||
16080549|NCT03610516|38786866|FG000|Treatment Epoch|Protocol Deviation|1|||
16080550|NCT03610516|38786867|FG001|Treatment Epoch|Protocol Deviation|0|||
16080551|NCT03610516|38786866|FG000|Treatment Epoch|Withdrawal by Subject|3|||
16080552|NCT03610516|38786867|FG001|Treatment Epoch|Withdrawal by Subject|1|||
16080553|NCT03610516|38786866|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
16080554|NCT03610516|38786867|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
16080555|NCT03610516|38786866|FG000|Post-Treatment Follow-up|Death|1|||
16080556|NCT03610516|38786867|FG001|Post-Treatment Follow-up|Death|0|||
16080557|NCT00332241|38786868|FG000|Overall Study|Lack of Efficacy|6|||
16080558|NCT00332241|38786869|FG001|Overall Study|Lack of Efficacy|1|||
16080559|NCT00332241|38786868|FG000|Overall Study|Adverse Event|3|||
16080560|NCT00332241|38786869|FG001|Overall Study|Adverse Event|5|||
16080561|NCT00332241|38786868|FG000|Overall Study|Withdrawal by Subject|2|||
16080562|NCT00332241|38786869|FG001|Overall Study|Withdrawal by Subject|1|||
16080563|NCT00332241|38786868|FG000|Overall Study|Lost to Follow-up|4|||
16080564|NCT00332241|38786869|FG001|Overall Study|Lost to Follow-up|1|||
16080565|NCT00411151|38786870|FG000|Overall Study|Death|38|||
16080566|NCT00411151|38786870|FG000|Overall Study|Withdrawal by Subject|2|||
16080567|NCT00411151|38786870|FG000|Overall Study|Lost to Follow-up|2|||
16080568|NCT00411151|38786870|FG000|Overall Study|Protocol Violation|1|||
16080569|NCT00411151|38786870|FG000|Overall Study|Trial prematurely closed|4|||
16080570|NCT01989455|38786871|FG000|Overall Study|Adverse Event|0|||
16080571|NCT01989455|38786872|FG001|Overall Study|Adverse Event|1|||
16080572|NCT01989455|38786873|FG002|Overall Study|Adverse Event|0|||
16080573|NCT01989455|38786874|FG003|Overall Study|Adverse Event|0|||
16080574|NCT01989455|38786875|FG004|Overall Study|Adverse Event|0|||
16080575|NCT01989455|38786871|FG000|Overall Study|Withdrawal by Subject|0|||
16080576|NCT01989455|38786872|FG001|Overall Study|Withdrawal by Subject|1|||
16080577|NCT01989455|38786873|FG002|Overall Study|Withdrawal by Subject|0|||
16080578|NCT01989455|38786874|FG003|Overall Study|Withdrawal by Subject|0|||
16080579|NCT01989455|38786875|FG004|Overall Study|Withdrawal by Subject|0|||
16080580|NCT01989455|38786871|FG000|Overall Study|Technical problems with infusion|0|||
16482517|NCT01847274|40245435|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16080581|NCT01989455|38786872|FG001|Overall Study|Technical problems with infusion|0|||
16080582|NCT01989455|38786873|FG002|Overall Study|Technical problems with infusion|1|||
16080583|NCT01989455|38786874|FG003|Overall Study|Technical problems with infusion|0|||
16080584|NCT01989455|38786875|FG004|Overall Study|Technical problems with infusion|1|||
16080585|NCT03485950|38786886|FG000|Overall Study|Adverse Event|1|||
16080586|NCT03485950|38786887|FG001|Overall Study|Adverse Event|0|||
16080587|NCT03485950|38786886|FG000|Overall Study|Death|3|||
16080588|NCT03485950|38786887|FG001|Overall Study|Death|2|||
16080589|NCT03485950|38786886|FG000|Overall Study|Withdrawal by Subject|3|||
16080590|NCT03485950|38786887|FG001|Overall Study|Withdrawal by Subject|0|||
16080591|NCT03714815|38786888|FG000|Overall Study|Physician Decision|2|||
16080592|NCT03714815|38786888|FG000|Overall Study|Withdrawal by Subject|2|||
16080593|NCT03714815|38786888|FG000|Overall Study|Death|11|||
16080594|NCT01149369|38786889|FG000|Overall Study|Adverse Event|6|||
16080595|NCT01149369|38786890|FG001|Overall Study|Adverse Event|3|||
16080596|NCT01198145|38789272|FG000|Overall Study|Withdrawal by Subject|1|||
16080597|NCT01198145|38789273|FG001|Overall Study|Withdrawal by Subject|1|||
16080598|NCT01571596|38789274|FG000|Overall Study|Adverse Event|2|||
16080599|NCT01571596|38789275|FG001|Overall Study|Adverse Event|0|||
16080600|NCT01571596|38789276|FG002|Overall Study|Adverse Event|0|||
16080601|NCT01571596|38789274|FG000|Overall Study|Study Terminated by the Sponsor|0|||
16080602|NCT01571596|38789275|FG001|Overall Study|Study Terminated by the Sponsor|1|||
16080603|NCT01571596|38789276|FG002|Overall Study|Study Terminated by the Sponsor|1|||
16080604|NCT01424397|38789286|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
16080605|NCT01424397|38789287|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
16080606|NCT01424397|38789288|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
16080607|NCT01424397|38789289|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
16080608|NCT01424397|38789290|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
16080609|NCT01424397|38789291|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
16080610|NCT01424397|38789292|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
16080611|NCT01424397|38789293|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
16080612|NCT01424397|38789294|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
16080613|NCT01424397|38789295|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
16482518|NCT01847274|40245436|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16482519|NCT01847274|40245437|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16080614|NCT01424397|38789296|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
16080615|NCT01424397|38789297|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
16080616|NCT00529100|38789298|FG000|Overall Study|Adverse Event|0|||
16080617|NCT00529100|38789299|FG001|Overall Study|Adverse Event|5|||
16080618|NCT00529100|38789298|FG000|Overall Study|Protocol Violation|0|||
16080619|NCT00529100|38789299|FG001|Overall Study|Protocol Violation|1|||
16080620|NCT00529100|38789298|FG000|Overall Study|Progressive Disease|0|||
16080621|NCT00529100|38789299|FG001|Overall Study|Progressive Disease|1|||
16080622|NCT00529100|38789298|FG000|Overall Study|Withdrawal by Subject|0|||
16080623|NCT00529100|38789299|FG001|Overall Study|Withdrawal by Subject|1|||
16080624|NCT00529100|38789298|FG000|Overall Study|Participant Ineligibility|0|||
16080625|NCT00529100|38789299|FG001|Overall Study|Participant Ineligibility|1|||
16080626|NCT00595413|38789300|FG000|Overall Study|Adverse Event|0|||
16080627|NCT00595413|38789301|FG001|Overall Study|Adverse Event|2|||
16080628|NCT00595413|38789302|FG002|Overall Study|Adverse Event|1|||
16080629|NCT00595413|38789303|FG003|Overall Study|Adverse Event|1|||
16080630|NCT00595413|38789300|FG000|Overall Study|Lost to Follow-up|2|||
16080631|NCT00595413|38789301|FG001|Overall Study|Lost to Follow-up|2|||
16080632|NCT00595413|38789302|FG002|Overall Study|Lost to Follow-up|1|||
16080633|NCT00595413|38789303|FG003|Overall Study|Lost to Follow-up|3|||
16080634|NCT00595413|38789300|FG000|Overall Study|Death|0|||
16080635|NCT00595413|38789301|FG001|Overall Study|Death|0|||
16080636|NCT00595413|38789302|FG002|Overall Study|Death|1|||
16080637|NCT00595413|38789303|FG003|Overall Study|Death|0|||
16080638|NCT00595413|38789300|FG000|Overall Study|Other|5|||
16080639|NCT00595413|38789301|FG001|Overall Study|Other|1|||
16080640|NCT00595413|38789302|FG002|Overall Study|Other|5|||
16080641|NCT00595413|38789303|FG003|Overall Study|Other|0|||
16080642|NCT00440011|38789305|FG000|Overall Study|Adverse Event|2|||
16080643|NCT00440011|38789306|FG001|Overall Study|Adverse Event|0|||
16080644|NCT00440011|38789305|FG000|Overall Study|Lost to Follow-up|0|||
16482520|NCT01847274|40245438|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16482521|NCT01847274|40245439|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
16080645|NCT00440011|38789306|FG001|Overall Study|Lost to Follow-up|2|||
16080646|NCT00440011|38789305|FG000|Overall Study|Protocol Violation|1|||
16080647|NCT00440011|38789306|FG001|Overall Study|Protocol Violation|1|||
16080648|NCT00440011|38789305|FG000|Overall Study|Withdrawal by Subject|1|||
16080649|NCT00440011|38789306|FG001|Overall Study|Withdrawal by Subject|0|||
16080650|NCT00593489|38789309|FG000|Allocation|did not attend workshop; allocation not|2|||
16080651|NCT00593489|38789310|FG001|Allocation|did not attend workshop; allocation not|1|||
16080652|NCT00799396|38789313|FG000|Clopidogrel Treatment|Adverse Event|6|||
16080653|NCT00799396|38789313|FG000|Clopidogrel Treatment|Physician Decision|5|||
16080654|NCT00799396|38789313|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
16080655|NCT00799396|38789313|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
16080656|NCT00799396|38789313|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
16080657|NCT02477605|38789316|FG000|Overall Study|Discontinued prior to treatment|1|||
16080658|NCT02477605|38789317|FG001|Overall Study|Discontinued prior to treatment|0|||
16080659|NCT02477605|38789316|FG000|Overall Study|Lost to Follow-up|0|||
16080660|NCT02477605|38789317|FG001|Overall Study|Lost to Follow-up|2|||
16080661|NCT02477605|38789316|FG000|Overall Study|Withdrawal by Subject|0|||
16080662|NCT02477605|38789317|FG001|Overall Study|Withdrawal by Subject|1|||
16080663|NCT02477605|38789316|FG000|Overall Study|Administered gas during surgery|0|||
16080664|NCT02477605|38789317|FG001|Overall Study|Administered gas during surgery|1|||
16080665|NCT04820686|38789318|FG000|Overall Study|Withdrawal by Subject|5|||
16080666|NCT04820686|38789319|FG001|Overall Study|Withdrawal by Subject|2|||
16080667|NCT04820686|38789320|FG002|Overall Study|Withdrawal by Subject|3|||
16080668|NCT04820686|38789318|FG000|Overall Study|Study Termination|25|||
16080669|NCT04820686|38789319|FG001|Overall Study|Study Termination|13|||
16080670|NCT04820686|38789320|FG002|Overall Study|Study Termination|14|||
16289924|NCT01064531|39543846|FG000|Overall Study|Revision due to dislocation|0|||
16289925|NCT01064531|39543847|FG001|Overall Study|Revision due to dislocation|1|||
16289926|NCT01064531|39543846|FG000|Overall Study|Death|0|||
16289927|NCT01064531|39543847|FG001|Overall Study|Death|1|||
16289928|NCT00876018|39543848|FG000|Overall Study|Lost to Follow-up|0|||
16289929|NCT00876018|39543849|FG001|Overall Study|Lost to Follow-up|1|||
16289930|NCT00876018|39543850|FG002|Overall Study|Lost to Follow-up|1|||
16289931|NCT00876018|39543848|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
16289932|NCT00876018|39543849|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
16289933|NCT00876018|39543850|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
16289934|NCT02138136|39543853|FG000|Overall Study|Protocol Violation|4|||
16289935|NCT02138136|39543853|FG000|Overall Study|Physician Decision|7|||
16080671|NCT04820686|38789318|FG000|Overall Study|Adverse Event|0|||
16080672|NCT04820686|38789319|FG001|Overall Study|Adverse Event|1|||
16289936|NCT02138136|39543853|FG000|Overall Study|Lack of Efficacy|35|||
16080673|NCT04820686|38789320|FG002|Overall Study|Adverse Event|0|||
16080674|NCT01205048|38789321|FG000|Overall Study|Withdrawal by Subject|14|||
16080675|NCT01205048|38789321|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
16080676|NCT01205048|38789321|FG000|Overall Study|Lost to Follow-up|4|||
16080677|NCT01205048|38789321|FG000|Overall Study|Other|2|||
16080678|NCT00998881|38789326|FG000|Overall Study|Adverse Event|2|||
16080679|NCT00998881|38789327|FG001|Overall Study|Adverse Event|2|||
16080680|NCT00998881|38789326|FG000|Overall Study|Lack of Efficacy|1|||
16080681|NCT00998881|38789327|FG001|Overall Study|Lack of Efficacy|0|||
16080682|NCT00998881|38789326|FG000|Overall Study|Physician Decision|3|||
16080683|NCT00998881|38789327|FG001|Overall Study|Physician Decision|0|||
16080684|NCT00998881|38789326|FG000|Overall Study|Withdrawal by Subject|1|||
16080685|NCT00998881|38789327|FG001|Overall Study|Withdrawal by Subject|0|||
16080686|NCT00998881|38789326|FG000|Overall Study|Personal matter|1|||
16080687|NCT00998881|38789327|FG001|Overall Study|Personal matter|0|||
16080688|NCT00761189|38789331|FG000|Overall Study|Adverse Event|42|||
16080689|NCT00761189|38789331|FG000|Overall Study|Lack of Efficacy|45|||
16080690|NCT00761189|38789331|FG000|Overall Study|Lost to Follow-up|36|||
16080691|NCT00761189|38789331|FG000|Overall Study|Withdrawal by Subject|49|||
16080692|NCT00761189|38789331|FG000|Overall Study|Other|13|||
16080693|NCT02092116|38789332|FG000|Overall Study|Withdrawal by Subject|0|||
16080694|NCT02092116|38789333|FG001|Overall Study|Withdrawal by Subject|3|||
16080695|NCT02092116|38789332|FG000|Overall Study|Adverse Event|0|||
16080696|NCT02092116|38789333|FG001|Overall Study|Adverse Event|1|||
16080697|NCT00774852|38789339|FG000|Overall Study|Adverse Event|9|||
16080698|NCT00774852|38789340|FG001|Overall Study|Adverse Event|6|||
16080699|NCT00774852|38789339|FG000|Overall Study|Death|2|||
16080700|NCT00774852|38789340|FG001|Overall Study|Death|1|||
16080701|NCT00774852|38789339|FG000|Overall Study|Lack of Efficacy|3|||
16080702|NCT00774852|38789340|FG001|Overall Study|Lack of Efficacy|7|||
16080703|NCT00774852|38789339|FG000|Overall Study|Lost to Follow-up|9|||
16080704|NCT00774852|38789340|FG001|Overall Study|Lost to Follow-up|5|||
16080705|NCT00774852|38789339|FG000|Overall Study|Physician Decision|2|||
16080706|NCT00774852|38789340|FG001|Overall Study|Physician Decision|6|||
16080707|NCT00774852|38789339|FG000|Overall Study|Pregnancy|1|||
16080708|NCT00774852|38789340|FG001|Overall Study|Pregnancy|2|||
16080709|NCT00774852|38789339|FG000|Overall Study|Withdrawal by Subject|2|||
16080710|NCT00774852|38789340|FG001|Overall Study|Withdrawal by Subject|2|||
16080711|NCT00774852|38789339|FG000|Overall Study|Non-responder|15|||
16080712|NCT00774852|38789340|FG001|Overall Study|Non-responder|11|||
16080713|NCT00774852|38789339|FG000|Overall Study|Subject non-compliance|0|||
16080714|NCT00774852|38789340|FG001|Overall Study|Subject non-compliance|1|||
16080715|NCT00774852|38789339|FG000|Overall Study|Protocol Violation|1|||
16289937|NCT02138136|39543853|FG000|Overall Study|Pregnancy|2|||
16289938|NCT02138136|39543853|FG000|Overall Study|Adverse Event|18|||
16080716|NCT00774852|38789340|FG001|Overall Study|Protocol Violation|0|||
16289939|NCT02138136|39543853|FG000|Overall Study|Withdrawal by Subject|36|||
16482522|NCT01847274|40245440|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16482523|NCT01847274|40245441|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16482524|NCT01847274|40245442|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16482525|NCT01847274|40245443|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
16289940|NCT02138136|39543853|FG000|Overall Study|Lost to Follow-up|32|||
16289941|NCT02138136|39543853|FG000|Overall Study|Withdrawn by Sponsor|5|||
16289942|NCT02013375|39543854|FG000|Overall Study|Did not engraft|1|||
16289943|NCT02013375|39543854|FG000|Overall Study|Did not engraft|1|||
16289944|NCT00724373|39543855|FG000|Overall Study|Adverse Event|41|||
16289945|NCT00724373|39543855|FG000|Overall Study|Lack of Efficacy|82|||
16289946|NCT00724373|39543855|FG000|Overall Study|Lost to Follow-up|7|||
16289947|NCT00724373|39543855|FG000|Overall Study|Non-compliance|2|||
16289948|NCT00724373|39543855|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
16289949|NCT00724373|39543855|FG000|Overall Study|Participant moved away|1|||
16289950|NCT00724373|39543855|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
16289951|NCT00724373|39543855|FG000|Overall Study|Only to have 24 week regimen|1|||
16289952|NCT00724373|39543855|FG000|Overall Study|Viral Relapse|1|||
16289953|NCT00724373|39543855|FG000|Overall Study|Acute HCV infection|1|||
16289954|NCT00724373|39543855|FG000|Overall Study|Drug Relapse|1|||
16289955|NCT00724373|39543855|FG000|Overall Study|Tolerability|23|||
16289956|NCT00842530|39543856|FG000|Overall Study|Serious adverse event|0|||
16289957|NCT00842530|39543857|FG001|Overall Study|Serious adverse event|6|||
16289958|NCT00842530|39543856|FG000|Overall Study|Other adverse event|6|||
16289959|NCT00842530|39543857|FG001|Overall Study|Other adverse event|1|||
16289960|NCT00842530|39543856|FG000|Overall Study|Protocol Violation|32|||
16289961|NCT00842530|39543857|FG001|Overall Study|Protocol Violation|14|||
16289962|NCT00842530|39543856|FG000|Overall Study|Lost to Follow-up|6|||
16289963|NCT00842530|39543857|FG001|Overall Study|Lost to Follow-up|8|||
16289964|NCT00842530|39543856|FG000|Overall Study|Withdrawal by Subject|73|||
16289965|NCT00842530|39543857|FG001|Overall Study|Withdrawal by Subject|28|||
16289966|NCT00974974|39543858|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
16289967|NCT00974974|39543859|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
16289968|NCT00974974|39543858|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
16289969|NCT00974974|39543859|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
16289970|NCT00974974|39543858|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
16289971|NCT00974974|39543859|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
16289972|NCT00974974|39543858|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
16289973|NCT00974974|39543859|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
16289974|NCT00974974|39543858|FG000|IR CD-LD Dose Adjustment|Various|0|||
16289975|NCT00974974|39543859|FG001|IR CD-LD Dose Adjustment|Various|9|||
16289976|NCT00974974|39543858|FG000|IPX066 Dose Conversion|Adverse Event|23|||
16289977|NCT00974974|39543859|FG001|IPX066 Dose Conversion|Adverse Event|0|||
16289978|NCT00974974|39543858|FG000|IPX066 Dose Conversion|Death|2|||
16289979|NCT00974974|39543859|FG001|IPX066 Dose Conversion|Death|0|||
16289980|NCT00974974|39543858|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
16289981|NCT00974974|39543859|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
16289982|NCT00974974|39543858|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
16289983|NCT00974974|39543859|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
16289984|NCT00974974|39543858|FG000|IPX066 Dose Conversion|Various|3|||
16289985|NCT00974974|39543859|FG001|IPX066 Dose Conversion|Various|0|||
16289986|NCT00974974|39543858|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
16289987|NCT00974974|39543859|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
16289988|NCT00974974|39543858|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
16289989|NCT00974974|39543859|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
16289990|NCT00974974|39543858|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
16289991|NCT00974974|39543859|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
16289992|NCT00974974|39543858|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
16289993|NCT00974974|39543859|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
16289994|NCT00974974|39543858|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
16289995|NCT00974974|39543859|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
16289996|NCT00974974|39543858|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
16289997|NCT00974974|39543859|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
16289998|NCT00974974|39543858|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
16289999|NCT00974974|39543859|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
16290000|NCT00974974|39543858|FG000|Maintenance - Double Blind Treatment|Various|4|||
16290001|NCT00974974|39543859|FG001|Maintenance - Double Blind Treatment|Various|0|||
16290002|NCT01659736|39543864|FG000|Treatment Period|Adverse Event|1|||
16290003|NCT01659736|39543865|FG001|Treatment Period|Adverse Event|1|||
16290004|NCT01659736|39543864|FG000|Treatment Period|Protocol Violation|3|||
16290005|NCT01659736|39543865|FG001|Treatment Period|Protocol Violation|1|||
16482526|NCT01847274|40245433|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16482527|NCT01847274|40245434|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16290006|NCT01659736|39543864|FG000|Treatment Period|Withdrawal by Subject|1|||
16290007|NCT01659736|39543865|FG001|Treatment Period|Withdrawal by Subject|0|||
16290008|NCT01659736|39543864|FG000|3-month Follow-up|Lost to Follow-up|0|||
16290009|NCT01659736|39543865|FG001|3-month Follow-up|Lost to Follow-up|1|||
16290010|NCT02549573|39543866|FG000|Overall Study|Withdrawal by Subject|0|||
16290011|NCT02549573|39543867|FG001|Overall Study|Withdrawal by Subject|2|||
16290012|NCT02549573|39543866|FG000|Overall Study|Protocol Violation|0|||
16290013|NCT02549573|39543867|FG001|Overall Study|Protocol Violation|1|||
16290014|NCT01117766|39543868|FG000|First Intervention|Adverse Event|0|||
16290015|NCT01117766|39543869|FG001|First Intervention|Adverse Event|1|||
16290016|NCT01117766|39543868|FG000|First Intervention|Protocol Violation|1|||
16290017|NCT01117766|39543869|FG001|First Intervention|Protocol Violation|0|||
16290018|NCT01117766|39543868|FG000|Washout Period|Protocol Violation|0|||
16290019|NCT01117766|39543869|FG001|Washout Period|Protocol Violation|2|||
16290020|NCT01117766|39543868|FG000|Second Intervention|Lost to Follow-up|1|||
16290021|NCT01117766|39543869|FG001|Second Intervention|Lost to Follow-up|0|||
16290022|NCT01117766|39543868|FG000|Second Intervention|Other|1|||
16290023|NCT01117766|39543869|FG001|Second Intervention|Other|2|||
16290024|NCT01117766|39543868|FG000|Second Intervention|Adverse Event|0|||
16290025|NCT01117766|39543869|FG001|Second Intervention|Adverse Event|2|||
16290026|NCT01117766|39543868|FG000|Second Intervention|Withdrawal by Subject|0|||
16290027|NCT01117766|39543869|FG001|Second Intervention|Withdrawal by Subject|1|||
16290028|NCT01649271|39543870|FG000|Overall Study|Progressive disease|4|||
16290029|NCT01649271|39543871|FG001|Overall Study|Progressive disease|5|||
16380564|NCT03110562|39877618|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
16380565|NCT03110562|39877619|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
16380566|NCT01217892|39877620|FG000|Overall Study|Adverse Event|1|||
16380567|NCT01217892|39877621|FG001|Overall Study|Adverse Event|1|||
16380568|NCT01217892|39877622|FG002|Overall Study|Adverse Event|1|||
16380569|NCT01217892|39877623|FG003|Overall Study|Adverse Event|0|||
16380570|NCT01217892|39877620|FG000|Overall Study|Withdrawal by Subject|0|||
16380571|NCT01217892|39877621|FG001|Overall Study|Withdrawal by Subject|2|||
16380572|NCT01217892|39877622|FG002|Overall Study|Withdrawal by Subject|1|||
16380573|NCT01217892|39877623|FG003|Overall Study|Withdrawal by Subject|0|||
16380574|NCT01217892|39877620|FG000|Overall Study|Lab value|1|||
16380575|NCT01217892|39877621|FG001|Overall Study|Lab value|0|||
16380576|NCT01217892|39877622|FG002|Overall Study|Lab value|1|||
16380577|NCT01217892|39877623|FG003|Overall Study|Lab value|0|||
16380578|NCT01217892|39877620|FG000|Overall Study|Subject no longer meets study criteria|5|||
16380579|NCT01217892|39877621|FG001|Overall Study|Subject no longer meets study criteria|2|||
16380580|NCT01217892|39877622|FG002|Overall Study|Subject no longer meets study criteria|4|||
16380581|NCT01217892|39877623|FG003|Overall Study|Subject no longer meets study criteria|8|||
16380582|NCT01217892|39877620|FG000|Overall Study|Incorrect enrollment|0|||
16380583|NCT01217892|39877621|FG001|Overall Study|Incorrect enrollment|1|||
16380584|NCT01217892|39877622|FG002|Overall Study|Incorrect enrollment|1|||
16380585|NCT01217892|39877623|FG003|Overall Study|Incorrect enrollment|0|||
16380586|NCT01217892|39877620|FG000|Overall Study|Poor/Non-Compliance|0|||
16380587|NCT01217892|39877621|FG001|Overall Study|Poor/Non-Compliance|0|||
16380588|NCT01217892|39877622|FG002|Overall Study|Poor/Non-Compliance|1|||
16380589|NCT01217892|39877623|FG003|Overall Study|Poor/Non-Compliance|0|||
16380590|NCT03034044|39877624|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
16380591|NCT02796651|39877625|FG000|Overall Study|Adverse Event|6|||
16380592|NCT02796651|39877625|FG000|Overall Study|Lost to Follow-up|1|||
16380593|NCT02796651|39877625|FG000|Overall Study|Withdrawal by Subject|4|||
16380594|NCT02796651|39877625|FG000|Overall Study|Protocol Violation|4|||
16380595|NCT02796651|39877625|FG000|Overall Study|Lack of Efficacy|1|||
16380596|NCT02796651|39877625|FG000|Overall Study|Other|10|||
16380597|NCT00779909|39877626|FG000|Overall Study|Lost to Follow-up|1|||
16380598|NCT00779909|39877627|FG001|Overall Study|Lost to Follow-up|0|||
16380599|NCT00779909|39877628|FG002|Overall Study|Lost to Follow-up|0|||
16380600|NCT00779909|39877629|FG003|Overall Study|Lost to Follow-up|1|||
16380601|NCT00779909|39877626|FG000|Overall Study|Withdrawal by Subject|0|||
16380602|NCT00779909|39877627|FG001|Overall Study|Withdrawal by Subject|1|||
16380603|NCT00779909|39877628|FG002|Overall Study|Withdrawal by Subject|0|||
16380604|NCT00779909|39877629|FG003|Overall Study|Withdrawal by Subject|0|||
16380605|NCT00856557|39877630|FG000|Overall Study|No patients with contextual flags|12|||
16380606|NCT00856557|39877631|FG001|Overall Study|No patients with contextual flags|16|||
16380607|NCT03498716|39877634|FG000|Overall Study|Withdrawal by Subject|88|||
16380608|NCT03498716|39877635|FG001|Overall Study|Withdrawal by Subject|73|||
16290030|NCT01649271|39543870|FG000|Overall Study|Other Adverse Event|0|||
16290031|NCT01649271|39543871|FG001|Overall Study|Other Adverse Event|2|||
16290032|NCT01649271|39543870|FG000|Overall Study|Withdrawal by Subject|1|||
16290033|NCT01649271|39543871|FG001|Overall Study|Withdrawal by Subject|0|||
16380609|NCT03498716|39877634|FG000|Overall Study|Study Terminated By Sponsor|933|||
16380610|NCT03498716|39877635|FG001|Overall Study|Study Terminated By Sponsor|927|||
16380611|NCT03498716|39877634|FG000|Overall Study|Lost to Follow-up|15|||
16380612|NCT03498716|39877635|FG001|Overall Study|Lost to Follow-up|26|||
16185988|NCT00069095|39159391|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
16185989|NCT00069095|39159392|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
16185990|NCT00069095|39159387|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
16185991|NCT00069095|39159388|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
16185992|NCT00069095|39159389|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
16185993|NCT00069095|39159390|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
16185994|NCT00069095|39159391|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
16185995|NCT00069095|39159392|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
16185996|NCT00069095|39159387|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
16290034|NCT01649271|39543870|FG000|Overall Study|Other than stated above|1|||
16290035|NCT01649271|39543871|FG001|Overall Study|Other than stated above|0|||
16290036|NCT01299805|39543872|FG000|Overall Study|Adverse Event|2|||
16290037|NCT01299805|39543873|FG001|Overall Study|Adverse Event|0|||
16290038|NCT03314662|39543874|FG000|Overall Study|Withdrawal by Subject|1|||
16290039|NCT03314662|39543875|FG001|Overall Study|Withdrawal by Subject|1|||
16290040|NCT03314662|39543876|FG002|Overall Study|Withdrawal by Subject|1|||
16185997|NCT00069095|39159388|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
16185998|NCT00069095|39159389|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
16185999|NCT00069095|39159390|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
16186000|NCT00069095|39159391|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
16186001|NCT00069095|39159392|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
16186002|NCT00069095|39159387|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
16186003|NCT00069095|39159388|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
16186004|NCT00069095|39159389|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
16186005|NCT00069095|39159390|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
16186006|NCT00069095|39159391|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
16186007|NCT00069095|39159392|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
16186008|NCT00069095|39159387|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
16186009|NCT00069095|39159388|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
16186010|NCT00069095|39159389|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
16186011|NCT00069095|39159390|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
16186012|NCT00069095|39159391|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
16186013|NCT00069095|39159392|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
16186014|NCT00069095|39159387|FG000|Post-study Treatment Phase|Surgery|0|||
16186015|NCT00069095|39159388|FG001|Post-study Treatment Phase|Surgery|0|||
16186016|NCT00069095|39159389|FG002|Post-study Treatment Phase|Surgery|0|||
16186017|NCT00069095|39159390|FG003|Post-study Treatment Phase|Surgery|1|||
16186018|NCT00069095|39159391|FG004|Post-study Treatment Phase|Surgery|1|||
16186019|NCT00069095|39159392|FG005|Post-study Treatment Phase|Surgery|0|||
16186020|NCT00069095|39159387|FG000|Post-study Treatment Phase|Death|0|||
16186021|NCT00069095|39159388|FG001|Post-study Treatment Phase|Death|0|||
16186022|NCT00069095|39159389|FG002|Post-study Treatment Phase|Death|0|||
16186023|NCT00069095|39159390|FG003|Post-study Treatment Phase|Death|0|||
16186024|NCT00069095|39159391|FG004|Post-study Treatment Phase|Death|1|||
16186025|NCT00069095|39159392|FG005|Post-study Treatment Phase|Death|0|||
16186026|NCT00069095|39159387|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
16186027|NCT00069095|39159388|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
16186028|NCT00069095|39159389|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
16186029|NCT00069095|39159390|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
16186030|NCT00069095|39159391|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
16186031|NCT00069095|39159392|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
16186032|NCT00069095|39159387|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
16186033|NCT00069095|39159388|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
16186034|NCT00069095|39159389|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
16186035|NCT00069095|39159390|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
16186036|NCT00069095|39159391|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
16290041|NCT03314662|39543874|FG000|Overall Study|Lost to Follow-up|5|||
16290042|NCT03314662|39543875|FG001|Overall Study|Lost to Follow-up|4|||
16290043|NCT03314662|39543876|FG002|Overall Study|Lost to Follow-up|4|||
16290044|NCT03314662|39543874|FG000|Overall Study|Death|2|||
16290045|NCT03314662|39543875|FG001|Overall Study|Death|0|||
16290046|NCT03314662|39543876|FG002|Overall Study|Death|0|||
16290047|NCT04209205|39543877|FG000|Overall Study|Adverse Event|2|||
16290048|NCT04209205|39543878|FG001|Overall Study|Adverse Event|3|||
16290049|NCT04209205|39543877|FG000|Overall Study|Lost to Follow-up|3|||
16186037|NCT00069095|39159392|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
16290050|NCT04209205|39543878|FG001|Overall Study|Lost to Follow-up|1|||
16290051|NCT04209205|39543877|FG000|Overall Study|Physician Decision|1|||
16290052|NCT04209205|39543878|FG001|Overall Study|Physician Decision|1|||
16290053|NCT04209205|39543877|FG000|Overall Study|Subject decision|10|||
16290054|NCT04209205|39543878|FG001|Overall Study|Subject decision|10|||
16290055|NCT04209205|39543877|FG000|Overall Study|Progressive disease|1|||
16290056|NCT04209205|39543878|FG001|Overall Study|Progressive disease|0|||
16290057|NCT04209205|39543877|FG000|Overall Study|Protocol deviation|0|||
16290058|NCT04209205|39543878|FG001|Overall Study|Protocol deviation|1|||
16290059|NCT04209205|39543877|FG000|Overall Study|New therapy for study indication|1|||
16290060|NCT04209205|39543878|FG001|Overall Study|New therapy for study indication|0|||
16290061|NCT04209205|39543877|FG000|Overall Study|Adverse event - placebo not switched|0|||
16290062|NCT04209205|39543878|FG001|Overall Study|Adverse event - placebo not switched|1|||
16290063|NCT04209205|39543877|FG000|Overall Study|Subject decision - placebo not switched|0|||
16290064|NCT04209205|39543878|FG001|Overall Study|Subject decision - placebo not switched|5|||
16290065|NCT04209205|39543877|FG000|Overall Study|Death - placebo not switched|0|||
16290066|NCT04209205|39543878|FG001|Overall Study|Death - placebo not switched|1|||
16290067|NCT01007942|39543881|FG000|Overall Study|Adverse Event|29|||
16290068|NCT01007942|39543882|FG001|Overall Study|Adverse Event|14|||
16290069|NCT01007942|39543881|FG000|Overall Study|Abnormal test procedure|0|||
16290070|NCT01007942|39543882|FG001|Overall Study|Abnormal test procedure|1|||
16290071|NCT01007942|39543881|FG000|Overall Study|Disease progression|217|||
16290072|NCT01007942|39543882|FG001|Overall Study|Disease progression|242|||
16290073|NCT01007942|39543881|FG000|Overall Study|New cancer therapy|5|||
16290074|NCT01007942|39543882|FG001|Overall Study|New cancer therapy|1|||
16290075|NCT01007942|39543881|FG000|Overall Study|Protocol Violation|1|||
16290076|NCT01007942|39543882|FG001|Overall Study|Protocol Violation|1|||
16290077|NCT01007942|39543881|FG000|Overall Study|Withdrawal by Subject|19|||
16290078|NCT01007942|39543882|FG001|Overall Study|Withdrawal by Subject|14|||
16290079|NCT01007942|39543881|FG000|Overall Study|Lost to Follow-up|1|||
16290080|NCT01007942|39543882|FG001|Overall Study|Lost to Follow-up|0|||
16290081|NCT01007942|39543881|FG000|Overall Study|Administrative problems|2|||
16290082|NCT01007942|39543882|FG001|Overall Study|Administrative problems|0|||
16290083|NCT01007942|39543881|FG000|Overall Study|Death|3|||
16290084|NCT01007942|39543882|FG001|Overall Study|Death|2|||
16290085|NCT01007942|39543881|FG000|Overall Study|Patients untreated|4|||
16290086|NCT01007942|39543882|FG001|Overall Study|Patients untreated|3|||
16290087|NCT00505375|39543885|FG000|Overall Study|Death|1|||
16290088|NCT00505375|39543886|FG001|Overall Study|Death|0|||
16290089|NCT00505375|39543885|FG000|Overall Study|Withdrawal by Subject|2|||
16290090|NCT00505375|39543886|FG001|Overall Study|Withdrawal by Subject|2|||
16290091|NCT00505375|39543885|FG000|Overall Study|Lost to Follow-up|0|||
16290092|NCT00505375|39543886|FG001|Overall Study|Lost to Follow-up|2|||
16290093|NCT00505375|39543885|FG000|Overall Study|Pregnancy|1|||
16290094|NCT00505375|39543886|FG001|Overall Study|Pregnancy|0|||
16290095|NCT00505375|39543885|FG000|Overall Study|Travel issues|0|||
16290096|NCT00505375|39543886|FG001|Overall Study|Travel issues|1|||
16290097|NCT04146363|39546688|FG000|Induction Period|Adverse Event|1|||
16290098|NCT04146363|39546689|FG001|Induction Period|Adverse Event|2|||
16290099|NCT04146363|39546690|FG002|Induction Period|Adverse Event|0|||
16290100|NCT04146363|39546691|FG003|Induction Period|Adverse Event|0|||
16290101|NCT04146363|39546692|FG004|Induction Period|Adverse Event|0|||
16290102|NCT04146363|39546693|FG005|Induction Period|Adverse Event|0|||
16290103|NCT04146363|39546694|FG006|Induction Period|Adverse Event|0|||
16290104|NCT04146363|39546695|FG007|Induction Period|Adverse Event|0|||
16290105|NCT04146363|39546696|FG008|Induction Period|Adverse Event|0|||
16290106|NCT04146363|39546697|FG009|Induction Period|Adverse Event|0|||
16290107|NCT04146363|39546698|FG010|Induction Period|Adverse Event|0|||
16290108|NCT04146363|39546688|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
16290109|NCT04146363|39546689|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
16290110|NCT04146363|39546690|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
16290111|NCT04146363|39546691|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
16290112|NCT04146363|39546692|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
16290113|NCT04146363|39546693|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
16290114|NCT04146363|39546694|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
16290115|NCT04146363|39546695|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
16290116|NCT04146363|39546696|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
16290117|NCT04146363|39546697|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
16290118|NCT04146363|39546698|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
16290119|NCT04146363|39546688|FG000|Induction Period|Lack of Efficacy|7|||
16290120|NCT04146363|39546689|FG001|Induction Period|Lack of Efficacy|2|||
16290121|NCT04146363|39546690|FG002|Induction Period|Lack of Efficacy|0|||
16290122|NCT04146363|39546691|FG003|Induction Period|Lack of Efficacy|0|||
16290123|NCT04146363|39546692|FG004|Induction Period|Lack of Efficacy|0|||
16290124|NCT04146363|39546693|FG005|Induction Period|Lack of Efficacy|0|||
16290125|NCT04146363|39546694|FG006|Induction Period|Lack of Efficacy|0|||
16290126|NCT04146363|39546695|FG007|Induction Period|Lack of Efficacy|0|||
16290127|NCT04146363|39546696|FG008|Induction Period|Lack of Efficacy|0|||
16290128|NCT04146363|39546697|FG009|Induction Period|Lack of Efficacy|0|||
16290129|NCT04146363|39546698|FG010|Induction Period|Lack of Efficacy|0|||
16290130|NCT04146363|39546688|FG000|Induction Period|Lost to Follow-up|1|||
16290131|NCT04146363|39546689|FG001|Induction Period|Lost to Follow-up|4|||
16290132|NCT04146363|39546690|FG002|Induction Period|Lost to Follow-up|0|||
16290133|NCT04146363|39546691|FG003|Induction Period|Lost to Follow-up|0|||
16290134|NCT04146363|39546692|FG004|Induction Period|Lost to Follow-up|0|||
16290135|NCT04146363|39546693|FG005|Induction Period|Lost to Follow-up|0|||
16290136|NCT04146363|39546694|FG006|Induction Period|Lost to Follow-up|0|||
16290137|NCT04146363|39546695|FG007|Induction Period|Lost to Follow-up|0|||
16290138|NCT04146363|39546696|FG008|Induction Period|Lost to Follow-up|0|||
16290139|NCT04146363|39546697|FG009|Induction Period|Lost to Follow-up|0|||
16290140|NCT04146363|39546698|FG010|Induction Period|Lost to Follow-up|0|||
16290141|NCT04146363|39546688|FG000|Induction Period|Positive quantiferon test|0|||
16290142|NCT04146363|39546689|FG001|Induction Period|Positive quantiferon test|1|||
16290143|NCT04146363|39546690|FG002|Induction Period|Positive quantiferon test|0|||
16290144|NCT04146363|39546691|FG003|Induction Period|Positive quantiferon test|0|||
16290145|NCT04146363|39546692|FG004|Induction Period|Positive quantiferon test|0|||
16290146|NCT04146363|39546693|FG005|Induction Period|Positive quantiferon test|0|||
16290147|NCT04146363|39546694|FG006|Induction Period|Positive quantiferon test|0|||
16290148|NCT04146363|39546695|FG007|Induction Period|Positive quantiferon test|0|||
16482528|NCT01847274|40245435|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16482529|NCT01847274|40245436|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16482530|NCT01847274|40245437|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16482531|NCT01847274|40245438|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16482532|NCT01847274|40245439|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
16482533|NCT01847274|40245440|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16482534|NCT01847274|40245441|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16482535|NCT01847274|40245442|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16482536|NCT01847274|40245443|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
16482537|NCT01847274|40245433|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
16482538|NCT01847274|40245434|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
16482539|NCT01847274|40245435|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
16482540|NCT01847274|40245436|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
16482541|NCT01847274|40245437|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
16482542|NCT01847274|40245438|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
16482543|NCT01847274|40245439|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
16482544|NCT01847274|40245440|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
16482545|NCT01847274|40245441|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
16482546|NCT01847274|40245442|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
16482547|NCT01847274|40245443|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
16482548|NCT01847274|40245433|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
16482549|NCT01847274|40245434|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
16482550|NCT01847274|40245435|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
16482551|NCT01847274|40245436|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
16482552|NCT01847274|40245437|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
16482553|NCT01847274|40245438|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
16482554|NCT01847274|40245439|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
16546305|NCT02237508|40464779|FG006|Overall Study|Withdrawal by Subject|1|||
16290149|NCT04146363|39546696|FG008|Induction Period|Positive quantiferon test|0|||
16290150|NCT04146363|39546697|FG009|Induction Period|Positive quantiferon test|0|||
16290151|NCT04146363|39546698|FG010|Induction Period|Positive quantiferon test|0|||
16290152|NCT04146363|39546688|FG000|Induction Period|Protocol Deviation|5|||
16290153|NCT04146363|39546689|FG001|Induction Period|Protocol Deviation|6|||
16290154|NCT04146363|39546690|FG002|Induction Period|Protocol Deviation|0|||
16290155|NCT04146363|39546691|FG003|Induction Period|Protocol Deviation|0|||
16290156|NCT04146363|39546692|FG004|Induction Period|Protocol Deviation|0|||
16290157|NCT04146363|39546693|FG005|Induction Period|Protocol Deviation|0|||
16290158|NCT04146363|39546694|FG006|Induction Period|Protocol Deviation|0|||
16290159|NCT04146363|39546695|FG007|Induction Period|Protocol Deviation|0|||
16290160|NCT04146363|39546696|FG008|Induction Period|Protocol Deviation|0|||
16290161|NCT04146363|39546697|FG009|Induction Period|Protocol Deviation|0|||
16290162|NCT04146363|39546698|FG010|Induction Period|Protocol Deviation|0|||
16290163|NCT04146363|39546688|FG000|Induction Period|Withdrawal by Subject|6|||
16290164|NCT04146363|39546689|FG001|Induction Period|Withdrawal by Subject|3|||
16290165|NCT04146363|39546690|FG002|Induction Period|Withdrawal by Subject|0|||
16380613|NCT03498716|39877634|FG000|Overall Study|Disease Relapse|0|||
16290166|NCT04146363|39546691|FG003|Induction Period|Withdrawal by Subject|0|||
16290167|NCT04146363|39546692|FG004|Induction Period|Withdrawal by Subject|0|||
16290168|NCT04146363|39546693|FG005|Induction Period|Withdrawal by Subject|0|||
16290169|NCT04146363|39546694|FG006|Induction Period|Withdrawal by Subject|0|||
16290170|NCT04146363|39546695|FG007|Induction Period|Withdrawal by Subject|0|||
16290171|NCT04146363|39546696|FG008|Induction Period|Withdrawal by Subject|0|||
16290172|NCT04146363|39546697|FG009|Induction Period|Withdrawal by Subject|0|||
16290173|NCT04146363|39546698|FG010|Induction Period|Withdrawal by Subject|0|||
16290174|NCT04146363|39546688|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
16290175|NCT04146363|39546689|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
16290176|NCT04146363|39546690|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
16290177|NCT04146363|39546691|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
16290178|NCT04146363|39546692|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
16290179|NCT04146363|39546693|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
16290180|NCT04146363|39546694|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
16290181|NCT04146363|39546695|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
16290182|NCT04146363|39546696|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
16290183|NCT04146363|39546697|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
16290184|NCT04146363|39546698|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
16290185|NCT04146363|39546688|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16290186|NCT04146363|39546689|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16290187|NCT04146363|39546690|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16290188|NCT04146363|39546691|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16290189|NCT04146363|39546692|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16290190|NCT04146363|39546693|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16290191|NCT04146363|39546694|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16290192|NCT04146363|39546695|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
16290193|NCT04146363|39546696|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16290194|NCT04146363|39546697|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16290195|NCT04146363|39546698|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16290196|NCT04146363|39546688|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16290197|NCT04146363|39546689|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16290198|NCT04146363|39546690|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16290199|NCT04146363|39546691|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16290200|NCT04146363|39546692|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16290201|NCT04146363|39546693|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16290202|NCT04146363|39546694|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
16290203|NCT04146363|39546695|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
16290204|NCT04146363|39546696|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16290205|NCT04146363|39546697|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16290206|NCT04146363|39546698|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16290207|NCT04146363|39546688|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
16290208|NCT04146363|39546689|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
16290209|NCT04146363|39546690|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
16290210|NCT04146363|39546691|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
16290211|NCT04146363|39546692|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
16290212|NCT04146363|39546693|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
16290213|NCT04146363|39546694|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
16290214|NCT04146363|39546695|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
16290215|NCT04146363|39546696|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
16290216|NCT04146363|39546697|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
16290217|NCT04146363|39546698|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
16290218|NCT04146363|39546688|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16290219|NCT04146363|39546689|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16290220|NCT04146363|39546690|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16290221|NCT04146363|39546691|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16290222|NCT04146363|39546692|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
16290223|NCT04146363|39546693|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
16290224|NCT04146363|39546694|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
16290225|NCT04146363|39546695|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
16290226|NCT04146363|39546696|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16290227|NCT04146363|39546697|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16290228|NCT04146363|39546698|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16290229|NCT04146363|39546688|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16290230|NCT04146363|39546689|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16290231|NCT04146363|39546690|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
16380614|NCT03498716|39877635|FG001|Overall Study|Disease Relapse|1|||
16380615|NCT03498716|39877634|FG000|Overall Study|Death|58|||
16380616|NCT03498716|39877635|FG001|Overall Study|Death|72|||
16380617|NCT03498716|39877634|FG000|Overall Study|Physician Decision|4|||
16380618|NCT03498716|39877635|FG001|Overall Study|Physician Decision|2|||
16380619|NCT00863304|39877641|FG000|Overall Study|Adverse Event|10|||
16380620|NCT00863304|39877642|FG001|Overall Study|Adverse Event|4|||
16380621|NCT00863304|39877643|FG002|Overall Study|Adverse Event|14|||
16380622|NCT00863304|39877644|FG003|Overall Study|Adverse Event|16|||
16380623|NCT00863304|39877641|FG000|Overall Study|Lost to Follow-up|1|||
16380624|NCT00863304|39877642|FG001|Overall Study|Lost to Follow-up|5|||
16380625|NCT00863304|39877643|FG002|Overall Study|Lost to Follow-up|4|||
16380626|NCT00863304|39877644|FG003|Overall Study|Lost to Follow-up|2|||
16380627|NCT00863304|39877641|FG000|Overall Study|Lack of Efficacy|57|||
16380628|NCT00863304|39877642|FG001|Overall Study|Lack of Efficacy|26|||
16380629|NCT00863304|39877643|FG002|Overall Study|Lack of Efficacy|30|||
16380630|NCT00863304|39877644|FG003|Overall Study|Lack of Efficacy|28|||
16380631|NCT00863304|39877641|FG000|Overall Study|Withdrawal by Subject|19|||
16290232|NCT04146363|39546691|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16290233|NCT04146363|39546692|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16290234|NCT04146363|39546693|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
16290235|NCT04146363|39546694|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
16290236|NCT04146363|39546695|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
16290237|NCT04146363|39546696|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16290238|NCT04146363|39546697|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16290239|NCT04146363|39546698|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16290240|NCT04146363|39546688|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
16290241|NCT04146363|39546689|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
16290242|NCT04146363|39546690|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
16290243|NCT04146363|39546691|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
16290244|NCT04146363|39546692|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
16290245|NCT04146363|39546693|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
16290246|NCT04146363|39546694|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
16290247|NCT04146363|39546695|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
16290248|NCT04146363|39546696|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
16290249|NCT04146363|39546697|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
16290250|NCT04146363|39546698|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
16290251|NCT04146363|39546688|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16380632|NCT00863304|39877642|FG001|Overall Study|Withdrawal by Subject|14|||
16380633|NCT00863304|39877643|FG002|Overall Study|Withdrawal by Subject|20|||
16380634|NCT00863304|39877644|FG003|Overall Study|Withdrawal by Subject|18|||
16380635|NCT00863304|39877641|FG000|Overall Study|Other|1|||
16380636|NCT00863304|39877642|FG001|Overall Study|Other|0|||
16380637|NCT00863304|39877643|FG002|Overall Study|Other|0|||
16380638|NCT00863304|39877644|FG003|Overall Study|Other|1|||
16380639|NCT00863304|39877641|FG000|Overall Study|Protocol Violation|2|||
16380640|NCT00863304|39877642|FG001|Overall Study|Protocol Violation|6|||
16380641|NCT00863304|39877643|FG002|Overall Study|Protocol Violation|2|||
16380642|NCT00863304|39877644|FG003|Overall Study|Protocol Violation|0|||
16290252|NCT04146363|39546689|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16290253|NCT04146363|39546690|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16290254|NCT04146363|39546691|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16290255|NCT04146363|39546692|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16290256|NCT04146363|39546693|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16290257|NCT04146363|39546694|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16290258|NCT04146363|39546695|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16290259|NCT04146363|39546696|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
16290260|NCT04146363|39546697|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
16290261|NCT04146363|39546698|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
16290262|NCT04146363|39546688|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16290263|NCT04146363|39546689|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16290264|NCT04146363|39546690|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16380643|NCT00863304|39877641|FG000|Overall Study|Randomized, but not Treated|3|||
16380644|NCT00863304|39877642|FG001|Overall Study|Randomized, but not Treated|1|||
16380645|NCT00863304|39877643|FG002|Overall Study|Randomized, but not Treated|4|||
16380646|NCT00863304|39877644|FG003|Overall Study|Randomized, but not Treated|1|||
16380647|NCT00863304|39877641|FG000|Overall Study|Entered extension study|101|||
16380648|NCT00863304|39877642|FG001|Overall Study|Entered extension study|129|||
16290265|NCT04146363|39546691|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16290266|NCT04146363|39546692|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16290267|NCT04146363|39546693|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16290268|NCT04146363|39546694|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16290269|NCT04146363|39546695|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16290270|NCT04146363|39546696|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
16290271|NCT04146363|39546697|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
16290272|NCT04146363|39546698|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16290273|NCT04146363|39546688|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
16290274|NCT04146363|39546689|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
16290275|NCT04146363|39546690|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
16290276|NCT04146363|39546691|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
16290277|NCT04146363|39546692|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
16290278|NCT04146363|39546693|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
16290279|NCT04146363|39546694|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
16290280|NCT04146363|39546695|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
16290281|NCT04146363|39546696|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
16290282|NCT04146363|39546697|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
16290283|NCT04146363|39546698|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
16290284|NCT04146363|39546688|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16290285|NCT04146363|39546689|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16290286|NCT04146363|39546690|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16290287|NCT04146363|39546691|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16290288|NCT04146363|39546692|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16290289|NCT04146363|39546693|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16290290|NCT04146363|39546694|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16290291|NCT04146363|39546695|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16290292|NCT04146363|39546696|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
16290293|NCT04146363|39546697|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
16290294|NCT04146363|39546698|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
16290295|NCT04146363|39546688|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
16290296|NCT04146363|39546689|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
16290297|NCT04146363|39546690|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
16290298|NCT04146363|39546691|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
16290299|NCT04146363|39546692|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
16290300|NCT04146363|39546693|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
16290301|NCT04146363|39546694|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
16290302|NCT04146363|39546695|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
16290303|NCT04146363|39546696|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
16290304|NCT04146363|39546697|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
16290305|NCT04146363|39546698|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
16290306|NCT04146363|39546688|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16290307|NCT04146363|39546689|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16290308|NCT04146363|39546690|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16380649|NCT00863304|39877643|FG002|Overall Study|Entered extension study|113|||
16380650|NCT00863304|39877644|FG003|Overall Study|Entered extension study|125|||
16380651|NCT04614324|39877647|FG000|Overall Study|Lost to Follow-up|3|||
16186038|NCT00069095|39159387|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
16186039|NCT00069095|39159388|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
16186040|NCT00069095|39159389|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
16186041|NCT00069095|39159390|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
16186042|NCT00069095|39159391|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
16186043|NCT00069095|39159392|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
16186044|NCT00069095|39159387|FG000|Post-study Treatment Phase|Investigator decision|0|||
16186045|NCT00069095|39159388|FG001|Post-study Treatment Phase|Investigator decision|0|||
16186046|NCT00069095|39159389|FG002|Post-study Treatment Phase|Investigator decision|0|||
16186047|NCT00069095|39159390|FG003|Post-study Treatment Phase|Investigator decision|0|||
16380652|NCT04614324|39877647|FG000|Overall Study|Physician Decision|1|||
16380653|NCT04614324|39877647|FG000|Overall Study|Withdrawal by Subject|2|||
16380654|NCT04614324|39877647|FG000|Overall Study|Remaining in Follow up|123|||
16080717|NCT00774852|38789339|FG000|Overall Study|Subject received prohibited medication|1|||
16080718|NCT00774852|38789340|FG001|Overall Study|Subject received prohibited medication|0|||
16080719|NCT00670046|38789352|FG000|Overall Study|Lost to Follow-up|1|||
16080720|NCT00670046|38789353|FG001|Overall Study|Lost to Follow-up|1|||
16080721|NCT00670046|38789352|FG000|Overall Study|Withdrawal by Subject|0|||
16080722|NCT00670046|38789353|FG001|Overall Study|Withdrawal by Subject|1|||
16080723|NCT01011946|38789354|FG000|Overall Study|Transferred to another hospital|2|||
16080724|NCT01011946|38789354|FG000|Overall Study|No pathological lab value|1|||
16080725|NCT00542789|38789355|FG000|Overall Study|Adverse Event|18|||
16080726|NCT00542789|38789356|FG001|Overall Study|Adverse Event|17|||
16482555|NCT01847274|40245440|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
16482556|NCT01847274|40245441|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
16482557|NCT01847274|40245442|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
16482558|NCT01847274|40245443|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
16482559|NCT01847274|40245433|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
16482560|NCT01847274|40245434|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
16482561|NCT01847274|40245435|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
16482562|NCT01847274|40245436|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
16482563|NCT01847274|40245437|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
16482564|NCT01847274|40245438|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
16482565|NCT01847274|40245439|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
16080727|NCT00542789|38789355|FG000|Overall Study|Withdrawal by Subject|7|||
16080728|NCT00542789|38789356|FG001|Overall Study|Withdrawal by Subject|3|||
16080729|NCT00542789|38789355|FG000|Overall Study|Protocol Violation|8|||
16080730|NCT00542789|38789356|FG001|Overall Study|Protocol Violation|1|||
16080731|NCT00542789|38789355|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
16080732|NCT00542789|38789356|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
16080733|NCT00431834|38789357|FG000|Overall Study|Withdrawal by Subject|7|||
16482566|NCT01847274|40245440|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
16482567|NCT01847274|40245441|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
16482568|NCT01847274|40245442|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
16482569|NCT01847274|40245443|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
16080734|NCT00431834|38789357|FG000|Overall Study|Death|3|||
16080735|NCT00431834|38789357|FG000|Overall Study|Missed Endpoint Visit|2|||
16080736|NCT00431834|38789357|FG000|Overall Study|Lost to Follow-up|1|||
16080737|NCT03447249|38789362|FG000|Overall Study|Adverse Event|1|||
16080738|NCT03447249|38789363|FG001|Overall Study|Adverse Event|0|||
16080739|NCT03447249|38789362|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
16080740|NCT03447249|38789363|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
16080741|NCT03447249|38789362|FG000|Overall Study|Other|3|||
16080742|NCT03447249|38789363|FG001|Overall Study|Other|0|||
16080743|NCT03454529|38789364|FG000|Overall Study|Did not receive treatment|6|||
16080744|NCT03454529|38789364|FG000|Overall Study|Received < 80% doses|1|||
16080745|NCT00262301|38789365|FG000|Double-blind Phase|Lost to Follow-up|1|||
16080746|NCT00262301|38789366|FG001|Double-blind Phase|Lost to Follow-up|0|||
16080747|NCT00262301|38789367|FG002|Double-blind Phase|Lost to Follow-up|0|||
16080748|NCT00262301|38789365|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
16080749|NCT00262301|38789366|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
16080750|NCT00262301|38789367|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
16080751|NCT02724956|38789376|FG000|Overall Study|Physician Decision|1|||
16080752|NCT02724956|38789377|FG001|Overall Study|Physician Decision|0|||
16080753|NCT02724956|38789376|FG000|Overall Study|Lack of Efficacy|0|||
16290309|NCT04146363|39546691|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16290310|NCT04146363|39546692|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16290311|NCT04146363|39546693|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16290312|NCT04146363|39546694|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16290313|NCT04146363|39546695|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16290314|NCT04146363|39546696|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16290315|NCT04146363|39546697|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
16290316|NCT04146363|39546698|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
16290317|NCT02639052|39546699|FG000|Overall Study|Lost to Follow-up|1|||
16290318|NCT03796039|39546700|FG000|Overall Study|Death|2|||
16290319|NCT03796039|39546701|FG001|Overall Study|Death|1|||
16482570|NCT01847274|40245433|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
16482571|NCT01847274|40245434|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
16482572|NCT01847274|40245435|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
16080754|NCT02724956|38789377|FG001|Overall Study|Lack of Efficacy|1|||
16080755|NCT02724956|38789376|FG000|Overall Study|Withdrawal by Subject|0|||
16080756|NCT02724956|38789377|FG001|Overall Study|Withdrawal by Subject|1|||
16080757|NCT03481816|38789378|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
16080758|NCT03481816|38789379|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
16080759|NCT03481816|38789378|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
16080760|NCT03481816|38789379|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
16080761|NCT03481816|38789378|FG000|Dose Expansion|Withdrawal by Subject|0|||
16080762|NCT03481816|38789379|FG001|Dose Expansion|Withdrawal by Subject|2|||
16080763|NCT03481816|38789378|FG000|Dose Expansion|Physician Decision|0|||
16080764|NCT03481816|38789379|FG001|Dose Expansion|Physician Decision|5|||
16080765|NCT02008916|38789381|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
16080766|NCT02008916|38789382|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
16080767|NCT02008916|38789383|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
16080768|NCT02008916|38789381|FG000|Week 16 - 156|Adverse Event|4|||
16080769|NCT02008916|38789382|FG001|Week 16 - 156|Adverse Event|2|||
16080770|NCT02008916|38789383|FG002|Week 16 - 156|Adverse Event|3|||
16080771|NCT02008916|38789381|FG000|Week 16 - 156|Withdrawal by Subject|7|||
16080772|NCT02008916|38789382|FG001|Week 16 - 156|Withdrawal by Subject|3|||
16080773|NCT02008916|38789383|FG002|Week 16 - 156|Withdrawal by Subject|5|||
16080774|NCT02008916|38789381|FG000|Week 16 - 156|No longer requires treatment|0|||
16080775|NCT02008916|38789382|FG001|Week 16 - 156|No longer requires treatment|1|||
16080776|NCT02008916|38789383|FG002|Week 16 - 156|No longer requires treatment|0|||
16080777|NCT02008916|38789381|FG000|Week 16 - 156|Lost to Follow-up|5|||
16080778|NCT02008916|38789382|FG001|Week 16 - 156|Lost to Follow-up|0|||
16080779|NCT02008916|38789383|FG002|Week 16 - 156|Lost to Follow-up|0|||
16080780|NCT02008916|38789381|FG000|Week 16 - 156|Lack of Efficacy|3|||
16080781|NCT02008916|38789382|FG001|Week 16 - 156|Lack of Efficacy|5|||
16080782|NCT02008916|38789383|FG002|Week 16 - 156|Lack of Efficacy|2|||
16080783|NCT02008916|38789381|FG000|Week 16 - 156|Pregnancy|0|||
16080784|NCT02008916|38789382|FG001|Week 16 - 156|Pregnancy|1|||
16080785|NCT02008916|38789383|FG002|Week 16 - 156|Pregnancy|0|||
16080786|NCT02008916|38789381|FG000|Week 16 - 156|Physician Decision|0|||
16080787|NCT02008916|38789382|FG001|Week 16 - 156|Physician Decision|1|||
16080788|NCT02008916|38789383|FG002|Week 16 - 156|Physician Decision|0|||
16080789|NCT02379819|38789384|FG000|Overall Study|Withdrawal by Subject|10|||
16080790|NCT02379819|38789384|FG000|Overall Study|Death|2|||
16080791|NCT02379819|38789384|FG000|Overall Study|Lack of Efficacy|1|||
16080792|NCT02379819|38789384|FG000|Overall Study|Lost to Follow-up|1|||
16080793|NCT00522951|38789394|FG000|Period 1|body motion|0|||
16080794|NCT00522951|38789395|FG001|Period 1|body motion|1|||
16080795|NCT00522951|38789394|FG000|Washout Period|Adverse Event|0|||
16080796|NCT00522951|38789395|FG001|Washout Period|Adverse Event|1|||
16080797|NCT00522951|38789394|FG000|Washout Period|Death|0|||
16080798|NCT00522951|38789395|FG001|Washout Period|Death|1|||
16080799|NCT00522951|38789394|FG000|Period 2|Withdrawal by Subject|1|||
16080800|NCT00522951|38789395|FG001|Period 2|Withdrawal by Subject|0|||
16080801|NCT00522951|38789394|FG000|Period 2|residual contrast medium|1|||
16080802|NCT00522951|38789395|FG001|Period 2|residual contrast medium|1|||
16080803|NCT03752151|38789401|FG000|Overall Study|Withdrawal by Subject|1|||
16080804|NCT03752151|38789401|FG000|Overall Study|Protocol Violation|1|||
16080805|NCT02423798|38789402|FG000|Overall Study|Withdrawal by Subject|3|||
16080806|NCT01388361|38789403|FG000|Overall Study|Adverse Event|0|||
16080807|NCT01388361|38789404|FG001|Overall Study|Adverse Event|5|||
16080808|NCT01388361|38789405|FG002|Overall Study|Adverse Event|1|||
16080809|NCT01388361|38789403|FG000|Overall Study|Protocol Violation|0|||
16080810|NCT01388361|38789404|FG001|Overall Study|Protocol Violation|0|||
16080811|NCT01388361|38789405|FG002|Overall Study|Protocol Violation|2|||
16080812|NCT01388361|38789403|FG000|Overall Study|Withdrawal criteria|12|||
16080813|NCT01388361|38789404|FG001|Overall Study|Withdrawal criteria|7|||
16080814|NCT01388361|38789405|FG002|Overall Study|Withdrawal criteria|10|||
16080815|NCT01388361|38789403|FG000|Overall Study|Unclassified|0|||
16080816|NCT01388361|38789404|FG001|Overall Study|Unclassified|0|||
16080817|NCT01388361|38789405|FG002|Overall Study|Unclassified|1|||
16080818|NCT01424670|38789410|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
16080819|NCT01424670|38789411|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
16080820|NCT01424670|38789410|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
16080821|NCT01424670|38789411|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
16080822|NCT01424670|38789410|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
16080823|NCT01424670|38789411|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
16290320|NCT03796039|39546700|FG000|Overall Study|Withdrawal by Subject|7|||
16080824|NCT01424670|38789410|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
16080825|NCT01424670|38789411|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
16080826|NCT01424670|38789410|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
16080827|NCT01424670|38789411|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
16080828|NCT01424670|38789410|FG000|Continuation Period|Adverse Event|13|||
16080829|NCT01424670|38789411|FG001|Continuation Period|Adverse Event|5|||
16080830|NCT01424670|38789410|FG000|Continuation Period|Lost to Follow-up|2|||
16080831|NCT01424670|38789411|FG001|Continuation Period|Lost to Follow-up|0|||
16080832|NCT01424670|38789410|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
16080833|NCT01424670|38789411|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
16080834|NCT01424670|38789410|FG000|Continuation Period|Physician Decision|5|||
16080835|NCT01424670|38789411|FG001|Continuation Period|Physician Decision|4|||
16080836|NCT01424670|38789410|FG000|Continuation Period|Withdrawal by Subject|13|||
16080837|NCT01424670|38789411|FG001|Continuation Period|Withdrawal by Subject|4|||
16080838|NCT01494922|38789412|FG000|Overall Study|Adverse Event|1|||
16080839|NCT00546754|38789413|FG000|Overall Study|Serious Adverse Event|1|||
16080840|NCT00546754|38789414|FG001|Overall Study|Serious Adverse Event|1|||
16080841|NCT00546754|38789413|FG000|Overall Study|Adverse Event|11|||
16080842|NCT00546754|38789414|FG001|Overall Study|Adverse Event|16|||
16080843|NCT00546754|38789413|FG000|Overall Study|Lack of Efficacy|1|||
16080844|NCT00546754|38789414|FG001|Overall Study|Lack of Efficacy|1|||
16080845|NCT00546754|38789413|FG000|Overall Study|Lost to Follow-up|9|||
16080846|NCT00546754|38789414|FG001|Overall Study|Lost to Follow-up|15|||
16080847|NCT00546754|38789413|FG000|Overall Study|Protocol Violation|3|||
16080848|NCT00546754|38789414|FG001|Overall Study|Protocol Violation|0|||
16080849|NCT00546754|38789413|FG000|Overall Study|Withdrawal by Subject|6|||
16080850|NCT00546754|38789414|FG001|Overall Study|Withdrawal by Subject|7|||
16080851|NCT00546754|38789413|FG000|Overall Study|Dyspnea|1|||
16080852|NCT00546754|38789414|FG001|Overall Study|Dyspnea|0|||
16080853|NCT00546754|38789413|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
16080854|NCT00546754|38789414|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
16080855|NCT00546754|38789413|FG000|Overall Study|Hip Replacement|1|||
16080856|NCT00546754|38789414|FG001|Overall Study|Hip Replacement|0|||
16080857|NCT00546754|38789413|FG000|Overall Study|Suicide|1|||
16080858|NCT00546754|38789414|FG001|Overall Study|Suicide|0|||
16080859|NCT00546754|38789413|FG000|Overall Study|Missing Cooperation|1|||
16080860|NCT00546754|38789414|FG001|Overall Study|Missing Cooperation|0|||
16080861|NCT00546754|38789413|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
16080862|NCT00546754|38789414|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
16080863|NCT00546754|38789413|FG000|Overall Study|Patient's Decision|0|||
16080864|NCT00546754|38789414|FG001|Overall Study|Patient's Decision|1|||
16080865|NCT00546754|38789413|FG000|Overall Study|Missing|14|||
16080866|NCT00546754|38789414|FG001|Overall Study|Missing|7|||
16080867|NCT00411216|38789415|FG000|Overall Study|Ten participants were entered into the c|0|||
16080868|NCT00411216|38789416|FG001|Overall Study|Ten participants were entered into the c|2|||
16080869|NCT03582722|38789417|FG000|Overall Study|Lost to Follow-up|1|||
16080870|NCT03582722|38789418|FG001|Overall Study|Lost to Follow-up|4|||
16080871|NCT03582722|38789417|FG000|Overall Study|Withdrawal by Subject|3|||
16080872|NCT03582722|38789418|FG001|Overall Study|Withdrawal by Subject|3|||
16080873|NCT03338816|38789419|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
16080874|NCT03338816|38789420|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
16080875|NCT03338816|38789421|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
16080876|NCT03338816|38789422|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
16080877|NCT03338816|38789419|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
16080878|NCT03338816|38789420|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
16080879|NCT03338816|38789421|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
16080880|NCT03338816|38789422|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
16080881|NCT03338816|38789419|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
16080882|NCT03338816|38789420|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
16080883|NCT03338816|38789421|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
16080884|NCT03338816|38789422|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
16080885|NCT03338816|38789419|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
16080886|NCT03338816|38789420|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
16080887|NCT03338816|38789421|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
16080888|NCT03338816|38789422|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
16080889|NCT03338816|38789419|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
16080890|NCT03338816|38789420|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
16080891|NCT03338816|38789421|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
16290321|NCT03796039|39546701|FG001|Overall Study|Withdrawal by Subject|4|||
16290322|NCT01059539|39546705|FG000|Overall Study|Adverse Event|66|||
16482573|NCT01847274|40245436|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
16482574|NCT01847274|40245437|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
16482575|NCT01847274|40245438|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
16482576|NCT01847274|40245439|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
16482577|NCT01847274|40245440|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
16482578|NCT01847274|40245441|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
16482579|NCT01847274|40245442|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
16290323|NCT01059539|39546705|FG000|Overall Study|Insufficient Therapeutic Response|26|||
16080892|NCT03338816|38789422|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
16080893|NCT03338816|38789419|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
16080894|NCT03338816|38789420|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
16080895|NCT03338816|38789421|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
16080896|NCT03338816|38789422|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
16080897|NCT03338816|38789419|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
16080898|NCT03338816|38789420|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
16482580|NCT01847274|40245443|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
16482581|NCT03385564|40245446|FG000|Overall Study|Adverse Event|0|||
16482582|NCT03385564|40245447|FG001|Overall Study|Adverse Event|0|||
16482583|NCT03385564|40245448|FG002|Overall Study|Adverse Event|3|||
16080899|NCT03338816|38789421|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
16080900|NCT03338816|38789422|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
16080901|NCT03578536|38789423|FG000|Overall Study|Lost to Follow-up|1|||
16080902|NCT01248936|38789427|FG000|Overall Study|Sponsor Decision|259|||
16080903|NCT01248936|38789427|FG000|Overall Study|Progression of Disease|50|||
16080904|NCT01248936|38789427|FG000|Overall Study|Death|26|||
16482584|NCT03385564|40245449|FG003|Overall Study|Adverse Event|3|||
16482585|NCT03385564|40245446|FG000|Overall Study|Other than listed|0|||
16482586|NCT03385564|40245447|FG001|Overall Study|Other than listed|0|||
16080905|NCT01248936|38789427|FG000|Overall Study|Withdrawal of Consent|20|||
16080906|NCT01248936|38789427|FG000|Overall Study|Adverse Event|8|||
16080907|NCT01248936|38789427|FG000|Overall Study|Lost to Follow-up|7|||
16080908|NCT01248936|38789427|FG000|Overall Study|Refused Treatment|1|||
16080909|NCT01248936|38789427|FG000|Overall Study|Other reason|3|||
16080910|NCT00274469|38789428|FG000|Overall Study|Death|63|||
16080911|NCT00274469|38789429|FG001|Overall Study|Death|74|||
16080912|NCT00274469|38789428|FG000|Overall Study|Did not consent to OS follow-up|16|||
16080913|NCT00274469|38789429|FG001|Overall Study|Did not consent to OS follow-up|19|||
16080914|NCT03840902|38789430|FG000|Overall Study|Randomized but not treated|1|||
16080915|NCT03840902|38789431|FG001|Overall Study|Randomized but not treated|1|||
16080916|NCT00557492|38789432|FG000|Overall Study|Change in health insurance|1|||
16080917|NCT01636687|38789433|FG000|Induction Period|Withdrawal by Subject|1|||
16080918|NCT01636687|38789434|FG001|Induction Period|Withdrawal by Subject|0|||
16080919|NCT01636687|38789435|FG002|Induction Period|Withdrawal by Subject|0|||
16080920|NCT01636687|38789436|FG003|Induction Period|Withdrawal by Subject|0|||
16080921|NCT01636687|38789437|FG004|Induction Period|Withdrawal by Subject|0|||
16080922|NCT01636687|38789433|FG000|Induction Period|Adverse Event|1|||
16080923|NCT01636687|38789434|FG001|Induction Period|Adverse Event|0|||
16080924|NCT01636687|38789435|FG002|Induction Period|Adverse Event|0|||
16080925|NCT01636687|38789436|FG003|Induction Period|Adverse Event|0|||
16080926|NCT01636687|38789437|FG004|Induction Period|Adverse Event|1|||
16080927|NCT01636687|38789433|FG000|Induction Period|Lack of Efficacy|0|||
16080928|NCT01636687|38789434|FG001|Induction Period|Lack of Efficacy|0|||
16080929|NCT01636687|38789435|FG002|Induction Period|Lack of Efficacy|0|||
16080930|NCT01636687|38789436|FG003|Induction Period|Lack of Efficacy|0|||
16080931|NCT01636687|38789437|FG004|Induction Period|Lack of Efficacy|1|||
16080932|NCT01636687|38789433|FG000|Induction Period|Physician Decision|1|||
16080933|NCT01636687|38789434|FG001|Induction Period|Physician Decision|0|||
16080934|NCT01636687|38789435|FG002|Induction Period|Physician Decision|0|||
16080935|NCT01636687|38789436|FG003|Induction Period|Physician Decision|0|||
16482587|NCT03385564|40245448|FG002|Overall Study|Other than listed|0|||
16482588|NCT03385564|40245449|FG003|Overall Study|Other than listed|5|||
16482589|NCT03385564|40245446|FG000|Overall Study|Withdrawal by Subject|0|||
16482590|NCT03385564|40245447|FG001|Overall Study|Withdrawal by Subject|1|||
16482591|NCT03385564|40245448|FG002|Overall Study|Withdrawal by Subject|1|||
16482592|NCT03385564|40245449|FG003|Overall Study|Withdrawal by Subject|0|||
16482593|NCT03385564|40245446|FG000|Overall Study|Lack of Efficacy|0|||
16482594|NCT03385564|40245447|FG001|Overall Study|Lack of Efficacy|0|||
16482595|NCT03385564|40245448|FG002|Overall Study|Lack of Efficacy|0|||
16482596|NCT03385564|40245449|FG003|Overall Study|Lack of Efficacy|1|||
16482597|NCT03385564|40245446|FG000|Overall Study|Death|0|||
16482598|NCT03385564|40245447|FG001|Overall Study|Death|0|||
16482599|NCT03385564|40245448|FG002|Overall Study|Death|1|||
16482600|NCT03385564|40245449|FG003|Overall Study|Death|0|||
16482601|NCT00003473|40245450|FG000|Overall Study|Three patients were not evaluable.|3|||
16482602|NCT00880009|40245451|FG000|Overall Study|Study terminated by sponsor|14|||
16482603|NCT00880009|40245451|FG000|Overall Study|Withdrawal by Subject|1|||
16482604|NCT00880009|40245451|FG000|Overall Study|Protocol Violation|1|||
16482605|NCT03322631|40245454|FG000|Overall Study|Withdrawal by Subject|0|||
16482606|NCT03322631|40245455|FG001|Overall Study|Withdrawal by Subject|1|||
16080936|NCT01636687|38789437|FG004|Induction Period|Physician Decision|0|||
16080937|NCT01636687|38789433|FG000|Maintenance Period|Withdrawal by Subject|2|||
16080938|NCT01636687|38789434|FG001|Maintenance Period|Withdrawal by Subject|0|||
16080939|NCT01636687|38789435|FG002|Maintenance Period|Withdrawal by Subject|2|||
16080940|NCT01636687|38789436|FG003|Maintenance Period|Withdrawal by Subject|0|||
16482607|NCT03322631|40245456|FG002|Overall Study|Withdrawal by Subject|0|||
16080941|NCT01636687|38789437|FG004|Maintenance Period|Withdrawal by Subject|0|||
16482608|NCT03322631|40245457|FG003|Overall Study|Withdrawal by Subject|0|||
16186048|NCT00069095|39159391|FG004|Post-study Treatment Phase|Investigator decision|0|||
16186049|NCT00069095|39159392|FG005|Post-study Treatment Phase|Investigator decision|1|||
16186050|NCT00069095|39159387|FG000|Follow-up Phase|Death|174|||
16186051|NCT00069095|39159388|FG001|Follow-up Phase|Death|206|||
16186052|NCT00069095|39159389|FG002|Follow-up Phase|Death|120|||
16186053|NCT00069095|39159390|FG003|Follow-up Phase|Death|112|||
16186054|NCT00069095|39159391|FG004|Follow-up Phase|Death|92|||
16186055|NCT00069095|39159392|FG005|Follow-up Phase|Death|101|||
16186056|NCT00504166|39159393|FG000|Overall Study|Adverse Event|1|||
16186057|NCT00504166|39159394|FG001|Overall Study|Adverse Event|4|||
16186058|NCT00504166|39159393|FG000|Overall Study|Withdrawal by Subject|3|||
16186059|NCT00504166|39159394|FG001|Overall Study|Withdrawal by Subject|6|||
16290324|NCT01059539|39546705|FG000|Overall Study|Protocol Violation|55|||
16290325|NCT01059539|39546705|FG000|Overall Study|Withdrawal of Consent|80|||
16290326|NCT01059539|39546705|FG000|Overall Study|Lost to Follow-up|42|||
16290327|NCT01059539|39546705|FG000|Overall Study|Reason Not Specified|2|||
16080942|NCT01636687|38789433|FG000|Maintenance Period|Adverse Event|1|||
16080943|NCT01636687|38789434|FG001|Maintenance Period|Adverse Event|0|||
16080944|NCT01636687|38789435|FG002|Maintenance Period|Adverse Event|0|||
16080945|NCT01636687|38789436|FG003|Maintenance Period|Adverse Event|0|||
16080946|NCT01636687|38789437|FG004|Maintenance Period|Adverse Event|0|||
16080947|NCT01636687|38789433|FG000|Maintenance Period|Lack of Efficacy|4|||
16080948|NCT01636687|38789434|FG001|Maintenance Period|Lack of Efficacy|1|||
16080949|NCT01636687|38789435|FG002|Maintenance Period|Lack of Efficacy|0|||
16080950|NCT01636687|38789436|FG003|Maintenance Period|Lack of Efficacy|0|||
16080951|NCT01636687|38789437|FG004|Maintenance Period|Lack of Efficacy|0|||
16080952|NCT01636687|38789433|FG000|Maintenance Period|Lost to Follow-up|1|||
16080953|NCT01636687|38789434|FG001|Maintenance Period|Lost to Follow-up|1|||
16080954|NCT01636687|38789435|FG002|Maintenance Period|Lost to Follow-up|0|||
16080955|NCT01636687|38789436|FG003|Maintenance Period|Lost to Follow-up|0|||
16080956|NCT01636687|38789437|FG004|Maintenance Period|Lost to Follow-up|1|||
16080957|NCT01636687|38789433|FG000|Maintenance Period|Physician Decision|0|||
16080958|NCT01636687|38789434|FG001|Maintenance Period|Physician Decision|0|||
16080959|NCT01636687|38789435|FG002|Maintenance Period|Physician Decision|0|||
16080960|NCT01636687|38789436|FG003|Maintenance Period|Physician Decision|0|||
16080961|NCT01636687|38789437|FG004|Maintenance Period|Physician Decision|1|||
16080962|NCT01636687|38789433|FG000|Extension Period|technical problems|0|||
16080963|NCT01636687|38789434|FG001|Extension Period|technical problems|1|||
16080964|NCT01636687|38789435|FG002|Extension Period|technical problems|2|||
16080965|NCT01636687|38789436|FG003|Extension Period|technical problems|1|||
16080966|NCT01636687|38789437|FG004|Extension Period|technical problems|0|||
16080967|NCT01636687|38789433|FG000|Extension Period|Adverse Event|4|||
16080968|NCT01636687|38789434|FG001|Extension Period|Adverse Event|3|||
16080969|NCT01636687|38789435|FG002|Extension Period|Adverse Event|2|||
16080970|NCT01636687|38789436|FG003|Extension Period|Adverse Event|1|||
16080971|NCT01636687|38789437|FG004|Extension Period|Adverse Event|0|||
16080972|NCT01636687|38789433|FG000|Extension Period|Lack of Efficacy|7|||
16080973|NCT01636687|38789434|FG001|Extension Period|Lack of Efficacy|0|||
16080974|NCT01636687|38789435|FG002|Extension Period|Lack of Efficacy|2|||
16080975|NCT01636687|38789436|FG003|Extension Period|Lack of Efficacy|1|||
16080976|NCT01636687|38789437|FG004|Extension Period|Lack of Efficacy|0|||
16080977|NCT01636687|38789433|FG000|Extension Period|Lost to Follow-up|1|||
16080978|NCT01636687|38789434|FG001|Extension Period|Lost to Follow-up|0|||
16290328|NCT02603393|39546709|FG000|Overall Study|Patient/guardian decision|32|||
16290329|NCT02603393|39546710|FG001|Overall Study|Patient/guardian decision|18|||
16290330|NCT02603393|39546709|FG000|Overall Study|Adverse Event|17|||
16482609|NCT03322631|40245454|FG000|Overall Study|Adverse Event|0|||
16482610|NCT03322631|40245455|FG001|Overall Study|Adverse Event|0|||
16482611|NCT03322631|40245456|FG002|Overall Study|Adverse Event|1|||
16482612|NCT03322631|40245457|FG003|Overall Study|Adverse Event|0|||
16482613|NCT01790932|40245458|FG000|Overall Study|Disease Progression|41|||
16482614|NCT01790932|40245458|FG000|Overall Study|Adverse Event|7|||
16482615|NCT01790932|40245458|FG000|Overall Study|Physician Decision|1|||
16080979|NCT01636687|38789435|FG002|Extension Period|Lost to Follow-up|1|||
16080980|NCT01636687|38789436|FG003|Extension Period|Lost to Follow-up|0|||
16482616|NCT01790932|40245458|FG000|Overall Study|Withdrawal by Subject|1|||
16080981|NCT01636687|38789437|FG004|Extension Period|Lost to Follow-up|0|||
16080982|NCT01636687|38789433|FG000|Extension Period|Physician Decision|1|||
16080983|NCT01636687|38789434|FG001|Extension Period|Physician Decision|0|||
16080984|NCT01636687|38789435|FG002|Extension Period|Physician Decision|0|||
16080985|NCT01636687|38789436|FG003|Extension Period|Physician Decision|1|||
16186060|NCT00504166|39159393|FG000|Overall Study|Physician Decision|1|||
16186061|NCT00504166|39159394|FG001|Overall Study|Physician Decision|1|||
16186062|NCT00504166|39159393|FG000|Overall Study|Lost to Follow-up|1|||
16186063|NCT00504166|39159394|FG001|Overall Study|Lost to Follow-up|3|||
16186064|NCT03502707|39159395|FG000|Overall Study|Adverse Event|0|||
16186065|NCT03502707|39159396|FG001|Overall Study|Adverse Event|0|||
16186066|NCT03502707|39159397|FG002|Overall Study|Adverse Event|0|||
16290331|NCT02603393|39546710|FG001|Overall Study|Adverse Event|15|||
16290332|NCT02603393|39546709|FG000|Overall Study|Technical problems|4|||
16290333|NCT02603393|39546710|FG001|Overall Study|Technical problems|7|||
16290334|NCT02603393|39546709|FG000|Overall Study|Lack of Efficacy|7|||
16290335|NCT02603393|39546710|FG001|Overall Study|Lack of Efficacy|2|||
16290336|NCT02603393|39546709|FG000|Overall Study|Death|3|||
16290337|NCT02603393|39546710|FG001|Overall Study|Death|4|||
16290338|NCT02603393|39546709|FG000|Overall Study|Physician Decision|3|||
16290339|NCT02603393|39546710|FG001|Overall Study|Physician Decision|3|||
16290340|NCT02603393|39546709|FG000|Overall Study|Protocol deviation|2|||
16290341|NCT02603393|39546710|FG001|Overall Study|Protocol deviation|3|||
16290342|NCT02603393|39546709|FG000|Overall Study|Lost to Follow-up|1|||
16290343|NCT02603393|39546710|FG001|Overall Study|Lost to Follow-up|2|||
16290344|NCT02603393|39546709|FG000|Overall Study|Non-compliance with study treatment|1|||
16482617|NCT03606512|40245459|FG000|Overall Study|Lost to Follow-up|0|||
16482618|NCT03606512|40245460|FG001|Overall Study|Lost to Follow-up|1|||
16482619|NCT03606512|40245459|FG000|Overall Study|'moved from study area|0|||
16482620|NCT03606512|40245460|FG001|Overall Study|'moved from study area|1|||
16482621|NCT00378378|40245465|FG000|Overall Study|Withdrawal by Subject|0|||
16482622|NCT00378378|40245466|FG001|Overall Study|Withdrawal by Subject|1|||
16482623|NCT00378378|40245467|FG002|Overall Study|Withdrawal by Subject|0|||
16482624|NCT00378378|40245465|FG000|Overall Study|Treatment Failure|0|||
16482625|NCT00378378|40245466|FG001|Overall Study|Treatment Failure|0|||
16482626|NCT00378378|40245467|FG002|Overall Study|Treatment Failure|1|||
16482627|NCT00378378|40245465|FG000|Overall Study|Non-compliance with protocol|0|||
16482628|NCT00378378|40245466|FG001|Overall Study|Non-compliance with protocol|0|||
16482629|NCT00378378|40245467|FG002|Overall Study|Non-compliance with protocol|1|||
16482630|NCT02598960|40245468|FG000|Treatment Period|Disease Progression|4|||
16482631|NCT02598960|40245469|FG001|Treatment Period|Disease Progression|4|||
16482632|NCT02598960|40245470|FG002|Treatment Period|Disease Progression|4|||
16482633|NCT02598960|40245471|FG003|Treatment Period|Disease Progression|6|||
16482634|NCT02598960|40245472|FG004|Treatment Period|Disease Progression|8|||
16482635|NCT02598960|40245473|FG005|Treatment Period|Disease Progression|2|||
16482636|NCT02598960|40245474|FG006|Treatment Period|Disease Progression|2|||
16482637|NCT02598960|40245475|FG007|Treatment Period|Disease Progression|3|||
16482638|NCT02598960|40245476|FG008|Treatment Period|Disease Progression|7|||
16080986|NCT01636687|38789437|FG004|Extension Period|Physician Decision|0|||
16186067|NCT03502707|39159398|FG003|Overall Study|Adverse Event|0|||
16290345|NCT02603393|39546710|FG001|Overall Study|Non-compliance with study treatment|0|||
16290346|NCT02603393|39546709|FG000|Overall Study|Sponsor decision|1|||
16290347|NCT02603393|39546710|FG001|Overall Study|Sponsor decision|0|||
16482639|NCT02598960|40245477|FG009|Treatment Period|Disease Progression|9|||
16482640|NCT02598960|40245478|FG010|Treatment Period|Disease Progression|7|||
16482641|NCT02598960|40245479|FG011|Treatment Period|Disease Progression|143|||
16482642|NCT02598960|40245480|FG012|Treatment Period|Disease Progression|23|||
16482643|NCT02598960|40245468|FG000|Treatment Period|Study drug toxicity|0|||
16290348|NCT00252174|39546726|FG000|Overall Study|Withdrawal by Subject|0|||
16290349|NCT00252174|39546727|FG001|Overall Study|Withdrawal by Subject|1|||
16290350|NCT00252174|39546728|FG002|Overall Study|Withdrawal by Subject|0|||
16290351|NCT02558231|39546729|FG000|Overall Study|Death|4|||
16290352|NCT02558231|39546730|FG001|Overall Study|Death|12|||
16290353|NCT02558231|39546729|FG000|Overall Study|Lost to Follow-up|7|||
16290354|NCT02558231|39546730|FG001|Overall Study|Lost to Follow-up|4|||
16290355|NCT02558231|39546729|FG000|Overall Study|Withdrawal by Subject|7|||
16290356|NCT02558231|39546730|FG001|Overall Study|Withdrawal by Subject|4|||
16290357|NCT02558231|39546729|FG000|Overall Study|Physician Decision|7|||
16290358|NCT02558231|39546730|FG001|Overall Study|Physician Decision|5|||
16290359|NCT02558231|39546729|FG000|Overall Study|Sponsor Decision|0|||
16290360|NCT02558231|39546730|FG001|Overall Study|Sponsor Decision|1|||
16290361|NCT01421342|39546733|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
16290362|NCT01421342|39546734|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
16290363|NCT01421342|39546735|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
16290364|NCT01421342|39546733|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
16290365|NCT01421342|39546734|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
16290366|NCT01421342|39546735|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
16290367|NCT01421342|39546733|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
16290368|NCT01421342|39546734|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
16290369|NCT01421342|39546735|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
16080987|NCT01636687|38789433|FG000|Extension Period|study terminated by sponsor|33|||
16290370|NCT01421342|39546733|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
16290371|NCT01421342|39546734|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
16482644|NCT02598960|40245469|FG001|Treatment Period|Study drug toxicity|0|||
16482645|NCT02598960|40245470|FG002|Treatment Period|Study drug toxicity|0|||
16482646|NCT02598960|40245471|FG003|Treatment Period|Study drug toxicity|0|||
16482647|NCT02598960|40245472|FG004|Treatment Period|Study drug toxicity|0|||
16482648|NCT02598960|40245473|FG005|Treatment Period|Study drug toxicity|0|||
16482649|NCT02598960|40245474|FG006|Treatment Period|Study drug toxicity|0|||
16482650|NCT02598960|40245475|FG007|Treatment Period|Study drug toxicity|0|||
16482651|NCT02598960|40245476|FG008|Treatment Period|Study drug toxicity|0|||
16482652|NCT02598960|40245477|FG009|Treatment Period|Study drug toxicity|1|||
16482653|NCT02598960|40245478|FG010|Treatment Period|Study drug toxicity|0|||
16482654|NCT02598960|40245479|FG011|Treatment Period|Study drug toxicity|3|||
16482655|NCT02598960|40245480|FG012|Treatment Period|Study drug toxicity|0|||
16482656|NCT02598960|40245468|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
16482657|NCT02598960|40245469|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
16482658|NCT02598960|40245470|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
16482659|NCT02598960|40245471|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
16482660|NCT02598960|40245472|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
16482661|NCT02598960|40245473|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
16080988|NCT01636687|38789434|FG001|Extension Period|study terminated by sponsor|50|||
16290372|NCT01421342|39546735|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
16290373|NCT01421342|39546733|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
16290374|NCT01421342|39546734|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
16290375|NCT01421342|39546735|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
16290376|NCT01421342|39546733|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
16290377|NCT01421342|39546734|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
16290378|NCT01421342|39546735|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
16380655|NCT02993263|39877654|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
16380656|NCT00381641|39877655|FG000|Overall Study|Withdrawal by Subject|0|||
16380657|NCT00381641|39877656|FG001|Overall Study|Withdrawal by Subject|2|||
16380658|NCT02037529|39877659|FG000|Overall Study|Withdrawal by Subject|1|||
16380659|NCT02037529|39877660|FG001|Overall Study|Withdrawal by Subject|3|||
16380660|NCT02037529|39877659|FG000|Overall Study|Adverse Event|0|||
16380661|NCT02037529|39877660|FG001|Overall Study|Adverse Event|1|||
16380662|NCT01230060|39877666|FG000|Overall Study|Withdrawal by Subject|1|||
16380663|NCT02511106|39877667|FG000|Overall Study|Lost to Follow-up|6|||
16380664|NCT02511106|39877668|FG001|Overall Study|Lost to Follow-up|4|||
16380665|NCT02511106|39877667|FG000|Overall Study|Withdrawal by Subject|24|||
16380666|NCT02511106|39877668|FG001|Overall Study|Withdrawal by Subject|21|||
16380667|NCT02511106|39877667|FG000|Overall Study|Death|42|||
16482662|NCT02598960|40245474|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
16482663|NCT02598960|40245475|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
16482664|NCT02598960|40245476|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
16482665|NCT02598960|40245477|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
16482666|NCT02598960|40245478|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
16482667|NCT02598960|40245479|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
16482668|NCT02598960|40245480|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
16482669|NCT02598960|40245468|FG000|Treatment Period|participant request to discontinue|0|||
16482670|NCT02598960|40245469|FG001|Treatment Period|participant request to discontinue|1|||
16482671|NCT02598960|40245470|FG002|Treatment Period|participant request to discontinue|0|||
16482672|NCT02598960|40245471|FG003|Treatment Period|participant request to discontinue|0|||
16482673|NCT02598960|40245472|FG004|Treatment Period|participant request to discontinue|1|||
16080989|NCT01636687|38789435|FG002|Extension Period|study terminated by sponsor|17|||
16080990|NCT01636687|38789436|FG003|Extension Period|study terminated by sponsor|23|||
16080991|NCT01636687|38789437|FG004|Extension Period|study terminated by sponsor|0|||
16080992|NCT01636687|38789433|FG000|Extension Period|Withdrawal by Subject|1|||
16080993|NCT01636687|38789434|FG001|Extension Period|Withdrawal by Subject|0|||
16080994|NCT01636687|38789435|FG002|Extension Period|Withdrawal by Subject|1|||
16080995|NCT01636687|38789436|FG003|Extension Period|Withdrawal by Subject|1|||
16080996|NCT01636687|38789437|FG004|Extension Period|Withdrawal by Subject|0|||
16080997|NCT01636687|38789433|FG000|Follow-up Period|Withdrawal by Subject|1|||
16080998|NCT01636687|38789434|FG001|Follow-up Period|Withdrawal by Subject|0|||
16080999|NCT01636687|38789435|FG002|Follow-up Period|Withdrawal by Subject|0|||
16081000|NCT01636687|38789436|FG003|Follow-up Period|Withdrawal by Subject|0|||
16081001|NCT01636687|38789437|FG004|Follow-up Period|Withdrawal by Subject|1|||
16081002|NCT01236560|38789438|FG000|Overall Study|Adverse Event|0|||
16081003|NCT01236560|38789439|FG001|Overall Study|Adverse Event|2|||
16081004|NCT01236560|38789440|FG002|Overall Study|Adverse Event|1|||
16081005|NCT01236560|38789441|FG003|Overall Study|Adverse Event|3|||
16081006|NCT01236560|38789442|FG004|Overall Study|Adverse Event|0|||
16081007|NCT01236560|38789443|FG005|Overall Study|Adverse Event|0|||
16081008|NCT01236560|38789438|FG000|Overall Study|Death|0|||
16081009|NCT01236560|38789439|FG001|Overall Study|Death|1|||
16081010|NCT01236560|38789440|FG002|Overall Study|Death|0|||
16081011|NCT01236560|38789441|FG003|Overall Study|Death|1|||
16081012|NCT01236560|38789442|FG004|Overall Study|Death|0|||
16482674|NCT02598960|40245473|FG005|Treatment Period|participant request to discontinue|0|||
16482675|NCT02598960|40245474|FG006|Treatment Period|participant request to discontinue|0|||
16482676|NCT02598960|40245475|FG007|Treatment Period|participant request to discontinue|0|||
16482677|NCT02598960|40245476|FG008|Treatment Period|participant request to discontinue|0|||
16482678|NCT02598960|40245477|FG009|Treatment Period|participant request to discontinue|0|||
16482679|NCT02598960|40245478|FG010|Treatment Period|participant request to discontinue|1|||
16081013|NCT01236560|38789443|FG005|Overall Study|Death|0|||
16081014|NCT01236560|38789438|FG000|Overall Study|Lost to Follow-up|0|||
16081015|NCT01236560|38789439|FG001|Overall Study|Lost to Follow-up|1|||
16081016|NCT01236560|38789440|FG002|Overall Study|Lost to Follow-up|1|||
16081017|NCT01236560|38789441|FG003|Overall Study|Lost to Follow-up|0|||
16081018|NCT01236560|38789442|FG004|Overall Study|Lost to Follow-up|0|||
16081019|NCT01236560|38789443|FG005|Overall Study|Lost to Follow-up|0|||
16081020|NCT01236560|38789438|FG000|Overall Study|Physician Decision|0|||
16081021|NCT01236560|38789439|FG001|Overall Study|Physician Decision|1|||
16081022|NCT01236560|38789440|FG002|Overall Study|Physician Decision|8|||
16081023|NCT01236560|38789441|FG003|Overall Study|Physician Decision|0|||
16081024|NCT01236560|38789442|FG004|Overall Study|Physician Decision|0|||
16081025|NCT01236560|38789443|FG005|Overall Study|Physician Decision|0|||
16081026|NCT01236560|38789438|FG000|Overall Study|Withdrawal by Subject|0|||
16081027|NCT01236560|38789439|FG001|Overall Study|Withdrawal by Subject|0|||
16081028|NCT01236560|38789440|FG002|Overall Study|Withdrawal by Subject|1|||
16081029|NCT01236560|38789441|FG003|Overall Study|Withdrawal by Subject|2|||
16081030|NCT01236560|38789442|FG004|Overall Study|Withdrawal by Subject|0|||
16081031|NCT01236560|38789443|FG005|Overall Study|Withdrawal by Subject|0|||
16081032|NCT01236560|38789438|FG000|Overall Study|Progressive disease|5|||
16081033|NCT01236560|38789439|FG001|Overall Study|Progressive disease|19|||
16081034|NCT01236560|38789440|FG002|Overall Study|Progressive disease|9|||
16081035|NCT01236560|38789441|FG003|Overall Study|Progressive disease|16|||
16290379|NCT01421342|39546733|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
16290380|NCT01421342|39546734|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
16290381|NCT01421342|39546735|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
16290382|NCT01421342|39546733|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
16290383|NCT01421342|39546734|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
16290384|NCT01421342|39546735|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
16290385|NCT01421342|39546733|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
16081036|NCT01236560|38789442|FG004|Overall Study|Progressive disease|0|||
16290386|NCT01421342|39546734|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
16290387|NCT01421342|39546735|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
16290388|NCT01421342|39546733|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
16290389|NCT01421342|39546734|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
16290390|NCT01421342|39546735|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
16482680|NCT02598960|40245479|FG011|Treatment Period|participant request to discontinue|4|||
16482681|NCT02598960|40245480|FG012|Treatment Period|participant request to discontinue|0|||
16482682|NCT02598960|40245468|FG000|Treatment Period|participant withdrew consent|0|||
16482683|NCT02598960|40245469|FG001|Treatment Period|participant withdrew consent|0|||
16482684|NCT02598960|40245470|FG002|Treatment Period|participant withdrew consent|0|||
16482685|NCT02598960|40245471|FG003|Treatment Period|participant withdrew consent|0|||
16482686|NCT02598960|40245472|FG004|Treatment Period|participant withdrew consent|0|||
16482687|NCT02598960|40245473|FG005|Treatment Period|participant withdrew consent|0|||
16482688|NCT02598960|40245474|FG006|Treatment Period|participant withdrew consent|0|||
16482689|NCT02598960|40245475|FG007|Treatment Period|participant withdrew consent|0|||
16482690|NCT02598960|40245476|FG008|Treatment Period|participant withdrew consent|0|||
16482691|NCT02598960|40245477|FG009|Treatment Period|participant withdrew consent|0|||
16482692|NCT02598960|40245478|FG010|Treatment Period|participant withdrew consent|0|||
16482693|NCT02598960|40245479|FG011|Treatment Period|participant withdrew consent|3|||
16482694|NCT02598960|40245480|FG012|Treatment Period|participant withdrew consent|0|||
16482695|NCT02598960|40245468|FG000|Treatment Period|No longer meets study criteria|0|||
16482696|NCT02598960|40245469|FG001|Treatment Period|No longer meets study criteria|0|||
16482697|NCT02598960|40245470|FG002|Treatment Period|No longer meets study criteria|0|||
16482698|NCT02598960|40245471|FG003|Treatment Period|No longer meets study criteria|0|||
16482699|NCT02598960|40245472|FG004|Treatment Period|No longer meets study criteria|0|||
16482700|NCT02598960|40245473|FG005|Treatment Period|No longer meets study criteria|0|||
16482701|NCT02598960|40245474|FG006|Treatment Period|No longer meets study criteria|0|||
16482702|NCT02598960|40245475|FG007|Treatment Period|No longer meets study criteria|0|||
16482703|NCT02598960|40245476|FG008|Treatment Period|No longer meets study criteria|0|||
16482704|NCT02598960|40245477|FG009|Treatment Period|No longer meets study criteria|0|||
16482705|NCT02598960|40245478|FG010|Treatment Period|No longer meets study criteria|0|||
16482706|NCT02598960|40245479|FG011|Treatment Period|No longer meets study criteria|1|||
16482707|NCT02598960|40245480|FG012|Treatment Period|No longer meets study criteria|0|||
16482708|NCT02598960|40245468|FG000|Treatment Period|Other Reasons|0|||
16482709|NCT02598960|40245469|FG001|Treatment Period|Other Reasons|0|||
16482710|NCT02598960|40245470|FG002|Treatment Period|Other Reasons|0|||
16482711|NCT02598960|40245471|FG003|Treatment Period|Other Reasons|0|||
16482712|NCT02598960|40245472|FG004|Treatment Period|Other Reasons|0|||
16482713|NCT02598960|40245473|FG005|Treatment Period|Other Reasons|0|||
16482714|NCT02598960|40245474|FG006|Treatment Period|Other Reasons|0|||
16482715|NCT02598960|40245475|FG007|Treatment Period|Other Reasons|0|||
16482716|NCT02598960|40245476|FG008|Treatment Period|Other Reasons|0|||
16186068|NCT03502707|39159399|FG004|Overall Study|Adverse Event|0|||
16186069|NCT03502707|39159400|FG005|Overall Study|Adverse Event|0|||
16186070|NCT03502707|39159401|FG006|Overall Study|Adverse Event|0|||
16186071|NCT03502707|39159402|FG007|Overall Study|Adverse Event|0|||
16186072|NCT03502707|39159403|FG008|Overall Study|Adverse Event|0|||
16186073|NCT03502707|39159404|FG009|Overall Study|Adverse Event|0|||
16186074|NCT03502707|39159405|FG010|Overall Study|Adverse Event|0|||
16186075|NCT03502707|39159406|FG011|Overall Study|Adverse Event|0|||
16186076|NCT03502707|39159407|FG012|Overall Study|Adverse Event|0|||
16186077|NCT03502707|39159408|FG013|Overall Study|Adverse Event|0|||
16186078|NCT03502707|39159409|FG014|Overall Study|Adverse Event|0|||
16186079|NCT03502707|39159410|FG015|Overall Study|Adverse Event|1|||
16186080|NCT03502707|39159411|FG016|Overall Study|Adverse Event|5|||
16186081|NCT03502707|39159412|FG017|Overall Study|Adverse Event|0|||
16186082|NCT03502707|39159395|FG000|Overall Study|Death|0|||
16186083|NCT03502707|39159396|FG001|Overall Study|Death|0|||
16186084|NCT03502707|39159397|FG002|Overall Study|Death|0|||
16186085|NCT03502707|39159398|FG003|Overall Study|Death|1|||
16186086|NCT03502707|39159399|FG004|Overall Study|Death|0|||
16186087|NCT03502707|39159400|FG005|Overall Study|Death|0|||
16186088|NCT03502707|39159401|FG006|Overall Study|Death|0|||
16186089|NCT03502707|39159402|FG007|Overall Study|Death|0|||
16186090|NCT03502707|39159403|FG008|Overall Study|Death|1|||
16186091|NCT03502707|39159404|FG009|Overall Study|Death|1|||
16186092|NCT03502707|39159405|FG010|Overall Study|Death|0|||
16186093|NCT03502707|39159406|FG011|Overall Study|Death|0|||
16186094|NCT03502707|39159407|FG012|Overall Study|Death|1|||
16186095|NCT03502707|39159408|FG013|Overall Study|Death|0|||
16186096|NCT03502707|39159409|FG014|Overall Study|Death|0|||
16186097|NCT03502707|39159410|FG015|Overall Study|Death|1|||
16186098|NCT03502707|39159411|FG016|Overall Study|Death|0|||
16186099|NCT03502707|39159412|FG017|Overall Study|Death|0|||
16186100|NCT03502707|39159395|FG000|Overall Study|Lost to Follow-up|0|||
16186101|NCT03502707|39159396|FG001|Overall Study|Lost to Follow-up|0|||
16186102|NCT03502707|39159397|FG002|Overall Study|Lost to Follow-up|0|||
16186103|NCT03502707|39159398|FG003|Overall Study|Lost to Follow-up|0|||
16290391|NCT01421342|39546733|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
16290392|NCT01421342|39546734|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
16290393|NCT01421342|39546735|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
16290394|NCT01421342|39546733|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
16290395|NCT01421342|39546734|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
16290396|NCT01421342|39546735|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
16290397|NCT01421342|39546733|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
16290398|NCT01421342|39546734|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
16290399|NCT01421342|39546735|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
16290400|NCT01421342|39546733|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
16290401|NCT01421342|39546734|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
16290402|NCT01421342|39546735|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
16290403|NCT01421342|39546733|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
16290404|NCT01421342|39546734|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
16290405|NCT01421342|39546735|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
16290406|NCT01421342|39546733|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
16290407|NCT01421342|39546734|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
16186104|NCT03502707|39159399|FG004|Overall Study|Lost to Follow-up|0|||
16290408|NCT01421342|39546735|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
16290409|NCT01421342|39546733|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
16290410|NCT01421342|39546734|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
16290411|NCT01421342|39546735|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
16290412|NCT01421342|39546733|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
16290413|NCT01421342|39546734|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
16290414|NCT01421342|39546735|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
16290415|NCT01421342|39546733|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
16290416|NCT01421342|39546734|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
16290417|NCT01421342|39546735|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
16290418|NCT01421342|39546733|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
16290419|NCT01421342|39546734|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
16290420|NCT01421342|39546735|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
16290421|NCT01421342|39546733|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
16290422|NCT01421342|39546734|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
16290423|NCT01421342|39546735|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
16290424|NCT01421342|39546733|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
16290425|NCT01421342|39546734|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
16290426|NCT01421342|39546735|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
16290427|NCT01421342|39546733|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
16290428|NCT01421342|39546734|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
16290429|NCT01421342|39546735|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
16290430|NCT01421342|39546733|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
16290431|NCT01421342|39546734|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
16290432|NCT01421342|39546735|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
16290433|NCT01421342|39546733|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
16290434|NCT01421342|39546734|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
16290435|NCT01421342|39546735|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
16290436|NCT01421342|39546733|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
16482717|NCT02598960|40245477|FG009|Treatment Period|Other Reasons|0|||
16482718|NCT02598960|40245478|FG010|Treatment Period|Other Reasons|0|||
16482719|NCT02598960|40245479|FG011|Treatment Period|Other Reasons|0|||
16482720|NCT02598960|40245480|FG012|Treatment Period|Other Reasons|1|||
16482721|NCT02598960|40245468|FG000|Participants Entering Follow Up Period|Death|1|||
16482722|NCT02598960|40245469|FG001|Participants Entering Follow Up Period|Death|0|||
16482723|NCT02598960|40245470|FG002|Participants Entering Follow Up Period|Death|0|||
16482724|NCT02598960|40245471|FG003|Participants Entering Follow Up Period|Death|0|||
16482725|NCT02598960|40245472|FG004|Participants Entering Follow Up Period|Death|0|||
16482726|NCT02598960|40245473|FG005|Participants Entering Follow Up Period|Death|0|||
16290437|NCT01421342|39546734|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
16290438|NCT01421342|39546735|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
16290439|NCT01421342|39546733|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
16290440|NCT01421342|39546734|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
16290441|NCT01421342|39546735|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
16290442|NCT01421342|39546733|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
16482727|NCT02598960|40245474|FG006|Participants Entering Follow Up Period|Death|0|||
16482728|NCT02598960|40245475|FG007|Participants Entering Follow Up Period|Death|0|||
16482729|NCT02598960|40245476|FG008|Participants Entering Follow Up Period|Death|0|||
16482730|NCT02598960|40245477|FG009|Participants Entering Follow Up Period|Death|1|||
16290443|NCT01421342|39546734|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
16290444|NCT01421342|39546735|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
16290445|NCT01661179|39546736|FG000|Overall Study|Death|1|||
16290446|NCT01661179|39546736|FG000|Overall Study|Withdrawal by Subject|1|||
16290447|NCT01661179|39546736|FG000|Overall Study|Other Eligibility criteria|4|||
16290448|NCT02615171|39546737|FG000|Overall Study|Lost to Follow-up|2|||
16290449|NCT02615171|39546738|FG001|Overall Study|Lost to Follow-up|1|||
16290450|NCT01196078|39546739|FG000|Overall Study|Withdrawal by Subject|3|||
16290451|NCT01196078|39546740|FG001|Overall Study|Withdrawal by Subject|5|||
16290452|NCT01196078|39546739|FG000|Overall Study|Adverse Event|4|||
16290453|NCT01196078|39546740|FG001|Overall Study|Adverse Event|4|||
16290454|NCT01196078|39546739|FG000|Overall Study|Protocol Violation|2|||
16290455|NCT01196078|39546740|FG001|Overall Study|Protocol Violation|1|||
16290456|NCT01196078|39546739|FG000|Overall Study|Lack of Efficacy|17|||
16290457|NCT01196078|39546740|FG001|Overall Study|Lack of Efficacy|23|||
16290458|NCT01196078|39546739|FG000|Overall Study|Lost to Follow-up|1|||
16290459|NCT01196078|39546740|FG001|Overall Study|Lost to Follow-up|0|||
16482731|NCT02598960|40245478|FG010|Participants Entering Follow Up Period|Death|0|||
16081037|NCT01236560|38789443|FG005|Overall Study|Progressive disease|0|||
16186105|NCT03502707|39159400|FG005|Overall Study|Lost to Follow-up|0|||
16186106|NCT03502707|39159401|FG006|Overall Study|Lost to Follow-up|0|||
16186107|NCT03502707|39159402|FG007|Overall Study|Lost to Follow-up|5|||
16186108|NCT03502707|39159403|FG008|Overall Study|Lost to Follow-up|0|||
16186109|NCT03502707|39159404|FG009|Overall Study|Lost to Follow-up|2|||
16186110|NCT03502707|39159405|FG010|Overall Study|Lost to Follow-up|1|||
16186111|NCT03502707|39159406|FG011|Overall Study|Lost to Follow-up|2|||
16186112|NCT03502707|39159407|FG012|Overall Study|Lost to Follow-up|1|||
16186113|NCT03502707|39159408|FG013|Overall Study|Lost to Follow-up|1|||
16186114|NCT03502707|39159409|FG014|Overall Study|Lost to Follow-up|0|||
16186115|NCT03502707|39159410|FG015|Overall Study|Lost to Follow-up|4|||
16186116|NCT03502707|39159411|FG016|Overall Study|Lost to Follow-up|9|||
16186117|NCT03502707|39159412|FG017|Overall Study|Lost to Follow-up|2|||
16186118|NCT03502707|39159395|FG000|Overall Study|Physician Decision|0|||
16186119|NCT03502707|39159396|FG001|Overall Study|Physician Decision|0|||
16186120|NCT03502707|39159397|FG002|Overall Study|Physician Decision|0|||
16186121|NCT03502707|39159398|FG003|Overall Study|Physician Decision|0|||
16186122|NCT03502707|39159399|FG004|Overall Study|Physician Decision|0|||
16186123|NCT03502707|39159400|FG005|Overall Study|Physician Decision|0|||
16186124|NCT03502707|39159401|FG006|Overall Study|Physician Decision|0|||
16186125|NCT03502707|39159402|FG007|Overall Study|Physician Decision|0|||
16186126|NCT03502707|39159403|FG008|Overall Study|Physician Decision|2|||
16186127|NCT03502707|39159404|FG009|Overall Study|Physician Decision|1|||
16186128|NCT03502707|39159405|FG010|Overall Study|Physician Decision|0|||
16186129|NCT03502707|39159406|FG011|Overall Study|Physician Decision|0|||
16186130|NCT03502707|39159407|FG012|Overall Study|Physician Decision|0|||
16186131|NCT03502707|39159408|FG013|Overall Study|Physician Decision|0|||
16186132|NCT03502707|39159409|FG014|Overall Study|Physician Decision|1|||
16186133|NCT03502707|39159410|FG015|Overall Study|Physician Decision|3|||
16186134|NCT03502707|39159411|FG016|Overall Study|Physician Decision|0|||
16186135|NCT03502707|39159412|FG017|Overall Study|Physician Decision|0|||
16186136|NCT03502707|39159395|FG000|Overall Study|Protocol Violation|0|||
16186137|NCT03502707|39159396|FG001|Overall Study|Protocol Violation|0|||
16186138|NCT03502707|39159397|FG002|Overall Study|Protocol Violation|0|||
16186139|NCT03502707|39159398|FG003|Overall Study|Protocol Violation|0|||
16186140|NCT03502707|39159399|FG004|Overall Study|Protocol Violation|0|||
16186141|NCT03502707|39159400|FG005|Overall Study|Protocol Violation|0|||
16186142|NCT03502707|39159401|FG006|Overall Study|Protocol Violation|0|||
16186143|NCT03502707|39159402|FG007|Overall Study|Protocol Violation|0|||
16186144|NCT03502707|39159403|FG008|Overall Study|Protocol Violation|0|||
16186145|NCT03502707|39159404|FG009|Overall Study|Protocol Violation|0|||
16186146|NCT03502707|39159405|FG010|Overall Study|Protocol Violation|0|||
16186147|NCT03502707|39159406|FG011|Overall Study|Protocol Violation|0|||
16186148|NCT03502707|39159407|FG012|Overall Study|Protocol Violation|0|||
16186149|NCT03502707|39159408|FG013|Overall Study|Protocol Violation|0|||
16186150|NCT03502707|39159409|FG014|Overall Study|Protocol Violation|0|||
16186151|NCT03502707|39159410|FG015|Overall Study|Protocol Violation|1|||
16186152|NCT03502707|39159411|FG016|Overall Study|Protocol Violation|0|||
16186153|NCT03502707|39159412|FG017|Overall Study|Protocol Violation|0|||
16186154|NCT03502707|39159395|FG000|Overall Study|Withdrawal by Subject|1|||
16186155|NCT03502707|39159396|FG001|Overall Study|Withdrawal by Subject|1|||
16186156|NCT03502707|39159397|FG002|Overall Study|Withdrawal by Subject|0|||
16186157|NCT03502707|39159398|FG003|Overall Study|Withdrawal by Subject|0|||
16186158|NCT03502707|39159399|FG004|Overall Study|Withdrawal by Subject|0|||
16186159|NCT03502707|39159400|FG005|Overall Study|Withdrawal by Subject|2|||
16186160|NCT03502707|39159401|FG006|Overall Study|Withdrawal by Subject|0|||
16186161|NCT03502707|39159402|FG007|Overall Study|Withdrawal by Subject|3|||
16186162|NCT03502707|39159403|FG008|Overall Study|Withdrawal by Subject|1|||
16186163|NCT03502707|39159404|FG009|Overall Study|Withdrawal by Subject|2|||
16186164|NCT03502707|39159405|FG010|Overall Study|Withdrawal by Subject|12|||
16186165|NCT03502707|39159406|FG011|Overall Study|Withdrawal by Subject|23|||
16186166|NCT03502707|39159407|FG012|Overall Study|Withdrawal by Subject|5|||
16186167|NCT03502707|39159408|FG013|Overall Study|Withdrawal by Subject|3|||
16186168|NCT03502707|39159409|FG014|Overall Study|Withdrawal by Subject|3|||
16186169|NCT03502707|39159410|FG015|Overall Study|Withdrawal by Subject|43|||
16186170|NCT03502707|39159411|FG016|Overall Study|Withdrawal by Subject|44|||
16186171|NCT03502707|39159412|FG017|Overall Study|Withdrawal by Subject|18|||
16380668|NCT02511106|39877668|FG001|Overall Study|Death|82|||
16380669|NCT02511106|39877667|FG000|Overall Study|Ongoing study at data cut-off|3|||
16380670|NCT02511106|39877668|FG001|Overall Study|Ongoing study at data cut-off|2|||
16380671|NCT02511106|39877667|FG000|Overall Study|Without specified reason|3|||
16380672|NCT02511106|39877668|FG001|Overall Study|Without specified reason|0|||
16380673|NCT02006927|39877676|FG000|Overall Study|Adverse Event|2|||
16380674|NCT02006927|39877676|FG000|Overall Study|Withdrawal by Subject|1|||
16380675|NCT01209767|39877677|FG000|Overall Study|Withdrawal by Subject|1|||
16380676|NCT01209767|39877677|FG000|Overall Study|Lost to Follow-up|3|||
16380677|NCT03435380|39877680|FG000|Overall Study|Death|1|||
16380678|NCT03435380|39877681|FG001|Overall Study|Death|2|||
16380679|NCT03435380|39877682|FG002|Overall Study|Death|1|||
16380680|NCT03435380|39877680|FG000|Overall Study|Lost to Follow-up|12|||
16482732|NCT02598960|40245479|FG011|Participants Entering Follow Up Period|Death|11|||
16482733|NCT02598960|40245480|FG012|Participants Entering Follow Up Period|Death|2|||
16482734|NCT02598960|40245468|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
16482735|NCT02598960|40245469|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
16482736|NCT02598960|40245470|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
16482737|NCT02598960|40245471|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
16482738|NCT02598960|40245472|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
16482739|NCT02598960|40245473|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
16482740|NCT02598960|40245474|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
16186172|NCT03502707|39159395|FG000|Overall Study|Sponsor's Decision|1|||
16186173|NCT03502707|39159396|FG001|Overall Study|Sponsor's Decision|0|||
16186174|NCT03502707|39159397|FG002|Overall Study|Sponsor's Decision|0|||
16186175|NCT03502707|39159398|FG003|Overall Study|Sponsor's Decision|0|||
16186176|NCT03502707|39159399|FG004|Overall Study|Sponsor's Decision|0|||
16186177|NCT03502707|39159400|FG005|Overall Study|Sponsor's Decision|0|||
16186178|NCT03502707|39159401|FG006|Overall Study|Sponsor's Decision|0|||
16186179|NCT03502707|39159402|FG007|Overall Study|Sponsor's Decision|0|||
16186180|NCT03502707|39159403|FG008|Overall Study|Sponsor's Decision|0|||
16186181|NCT03502707|39159404|FG009|Overall Study|Sponsor's Decision|1|||
16186182|NCT03502707|39159405|FG010|Overall Study|Sponsor's Decision|0|||
16482741|NCT02598960|40245475|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
16482742|NCT02598960|40245476|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
16482743|NCT02598960|40245477|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
16482744|NCT02598960|40245478|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
16482745|NCT02598960|40245479|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
16482746|NCT02598960|40245480|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
16186183|NCT03502707|39159406|FG011|Overall Study|Sponsor's Decision|0|||
16186184|NCT03502707|39159407|FG012|Overall Study|Sponsor's Decision|0|||
16186185|NCT03502707|39159408|FG013|Overall Study|Sponsor's Decision|0|||
16186186|NCT03502707|39159409|FG014|Overall Study|Sponsor's Decision|0|||
16186187|NCT03502707|39159410|FG015|Overall Study|Sponsor's Decision|2|||
16186188|NCT03502707|39159411|FG016|Overall Study|Sponsor's Decision|1|||
16186189|NCT03502707|39159412|FG017|Overall Study|Sponsor's Decision|0|||
16186190|NCT03502707|39159395|FG000|Overall Study|Initiated Prohibited Medication|0|||
16186191|NCT03502707|39159396|FG001|Overall Study|Initiated Prohibited Medication|0|||
16186192|NCT03502707|39159397|FG002|Overall Study|Initiated Prohibited Medication|0|||
16186193|NCT03502707|39159398|FG003|Overall Study|Initiated Prohibited Medication|0|||
16186194|NCT03502707|39159399|FG004|Overall Study|Initiated Prohibited Medication|0|||
16186195|NCT03502707|39159400|FG005|Overall Study|Initiated Prohibited Medication|0|||
16186196|NCT03502707|39159401|FG006|Overall Study|Initiated Prohibited Medication|0|||
16186197|NCT03502707|39159402|FG007|Overall Study|Initiated Prohibited Medication|0|||
16186198|NCT03502707|39159403|FG008|Overall Study|Initiated Prohibited Medication|0|||
16186199|NCT03502707|39159404|FG009|Overall Study|Initiated Prohibited Medication|0|||
16186200|NCT03502707|39159405|FG010|Overall Study|Initiated Prohibited Medication|0|||
16186201|NCT03502707|39159406|FG011|Overall Study|Initiated Prohibited Medication|0|||
16186202|NCT03502707|39159407|FG012|Overall Study|Initiated Prohibited Medication|0|||
16186203|NCT03502707|39159408|FG013|Overall Study|Initiated Prohibited Medication|0|||
16186204|NCT03502707|39159409|FG014|Overall Study|Initiated Prohibited Medication|0|||
16186205|NCT03502707|39159410|FG015|Overall Study|Initiated Prohibited Medication|0|||
16186206|NCT03502707|39159411|FG016|Overall Study|Initiated Prohibited Medication|1|||
16186207|NCT03502707|39159412|FG017|Overall Study|Initiated Prohibited Medication|0|||
16186208|NCT03502707|39159395|FG000|Overall Study|Other|0|||
16186209|NCT03502707|39159396|FG001|Overall Study|Other|0|||
16380681|NCT03435380|39877681|FG001|Overall Study|Lost to Follow-up|8|||
16380682|NCT03435380|39877682|FG002|Overall Study|Lost to Follow-up|6|||
16186210|NCT03502707|39159397|FG002|Overall Study|Other|0|||
16186211|NCT03502707|39159398|FG003|Overall Study|Other|0|||
16186212|NCT03502707|39159399|FG004|Overall Study|Other|0|||
16186213|NCT03502707|39159400|FG005|Overall Study|Other|0|||
16186214|NCT03502707|39159401|FG006|Overall Study|Other|0|||
16290460|NCT01196078|39546739|FG000|Overall Study|Death|6|||
16290461|NCT01196078|39546740|FG001|Overall Study|Death|4|||
16380683|NCT03435380|39877680|FG000|Overall Study|Physician Decision|1|||
16380684|NCT03435380|39877681|FG001|Overall Study|Physician Decision|0|||
16380685|NCT03435380|39877682|FG002|Overall Study|Physician Decision|0|||
16380686|NCT03435380|39877680|FG000|Overall Study|Withdrawal by Subject|0|||
16380687|NCT03435380|39877681|FG001|Overall Study|Withdrawal by Subject|1|||
16380688|NCT03435380|39877682|FG002|Overall Study|Withdrawal by Subject|1|||
16380689|NCT03435380|39877680|FG000|Overall Study|Ineligible|0|||
16380690|NCT03435380|39877681|FG001|Overall Study|Ineligible|1|||
16380691|NCT03435380|39877682|FG002|Overall Study|Ineligible|1|||
16290462|NCT02856880|39546741|FG000|Overall Study|Withdrawal of consent|1|||
16290463|NCT02699684|39546744|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
16290464|NCT02699684|39546745|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
16290465|NCT02054130|39546746|FG000|Overall Study|Withdrawal by Subject|4|||
16290466|NCT02054130|39546747|FG001|Overall Study|Withdrawal by Subject|4|||
16290467|NCT02054130|39546748|FG002|Overall Study|Withdrawal by Subject|7|||
16290468|NCT02054130|39546749|FG003|Overall Study|Withdrawal by Subject|10|||
16290469|NCT02054130|39546746|FG000|Overall Study|Death|0|||
16290470|NCT02054130|39546747|FG001|Overall Study|Death|1|||
16290471|NCT02054130|39546748|FG002|Overall Study|Death|0|||
16290472|NCT02054130|39546749|FG003|Overall Study|Death|0|||
16380692|NCT02921256|39877685|FG000|Arm 1a v. Arm II|Adverse Event|6|||
16380693|NCT02921256|39877686|FG001|Arm 1a v. Arm II|Adverse Event|15|||
16380694|NCT02921256|39877687|FG002|Arm 1a v. Arm II|Adverse Event|0|||
16380695|NCT02921256|39877685|FG000|Arm 1a v. Arm II|Death|0|||
16380696|NCT02921256|39877686|FG001|Arm 1a v. Arm II|Death|2|||
16380697|NCT02921256|39877687|FG002|Arm 1a v. Arm II|Death|0|||
16380698|NCT02921256|39877685|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
16380699|NCT02921256|39877686|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
16380700|NCT02921256|39877687|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
16380701|NCT02921256|39877685|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
16380702|NCT02921256|39877686|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
16380703|NCT02921256|39877687|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
16380704|NCT02921256|39877685|FG000|Arm 1a v. Arm II|Physician Decision|1|||
16380705|NCT02921256|39877686|FG001|Arm 1a v. Arm II|Physician Decision|1|||
16380706|NCT02921256|39877687|FG002|Arm 1a v. Arm II|Physician Decision|0|||
16380707|NCT02921256|39877685|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
16380708|NCT02921256|39877686|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
16380709|NCT02921256|39877687|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
16380710|NCT02921256|39877685|FG000|Arm Ib v Arm III|Adverse Event|9|||
16380711|NCT02921256|39877686|FG001|Arm Ib v Arm III|Adverse Event|0|||
16380712|NCT02921256|39877687|FG002|Arm Ib v Arm III|Adverse Event|4|||
16380713|NCT02921256|39877685|FG000|Arm Ib v Arm III|Death|1|||
16380714|NCT02921256|39877686|FG001|Arm Ib v Arm III|Death|0|||
16380715|NCT02921256|39877687|FG002|Arm Ib v Arm III|Death|1|||
16186215|NCT03502707|39159402|FG007|Overall Study|Other|0|||
16186216|NCT03502707|39159403|FG008|Overall Study|Other|1|||
16186217|NCT03502707|39159404|FG009|Overall Study|Other|1|||
16186218|NCT03502707|39159405|FG010|Overall Study|Other|2|||
16186219|NCT03502707|39159406|FG011|Overall Study|Other|0|||
16186220|NCT03502707|39159407|FG012|Overall Study|Other|0|||
16186221|NCT03502707|39159408|FG013|Overall Study|Other|0|||
16186222|NCT03502707|39159409|FG014|Overall Study|Other|0|||
16186223|NCT03502707|39159410|FG015|Overall Study|Other|4|||
16186224|NCT03502707|39159411|FG016|Overall Study|Other|1|||
16186225|NCT03502707|39159412|FG017|Overall Study|Other|0|||
16186226|NCT03502707|39159395|FG000|Overall Study|Randomized but not vaccinated|0|||
16186227|NCT03502707|39159396|FG001|Overall Study|Randomized but not vaccinated|0|||
16186228|NCT03502707|39159397|FG002|Overall Study|Randomized but not vaccinated|0|||
16186229|NCT03502707|39159398|FG003|Overall Study|Randomized but not vaccinated|0|||
16186230|NCT03502707|39159399|FG004|Overall Study|Randomized but not vaccinated|0|||
16186231|NCT03502707|39159400|FG005|Overall Study|Randomized but not vaccinated|0|||
16186232|NCT03502707|39159401|FG006|Overall Study|Randomized but not vaccinated|0|||
16186233|NCT03502707|39159402|FG007|Overall Study|Randomized but not vaccinated|0|||
16186234|NCT03502707|39159403|FG008|Overall Study|Randomized but not vaccinated|0|||
16186235|NCT03502707|39159404|FG009|Overall Study|Randomized but not vaccinated|0|||
16186236|NCT03502707|39159405|FG010|Overall Study|Randomized but not vaccinated|0|||
16290473|NCT02054130|39546746|FG000|Overall Study|Lost to Follow-up|0|||
16290474|NCT02054130|39546747|FG001|Overall Study|Lost to Follow-up|0|||
16380716|NCT02921256|39877685|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
16380717|NCT02921256|39877686|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
16380718|NCT02921256|39877687|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
16186237|NCT03502707|39159406|FG011|Overall Study|Randomized but not vaccinated|1|||
16186238|NCT03502707|39159407|FG012|Overall Study|Randomized but not vaccinated|0|||
16186239|NCT03502707|39159408|FG013|Overall Study|Randomized but not vaccinated|0|||
16380719|NCT02921256|39877685|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
16290475|NCT02054130|39546748|FG002|Overall Study|Lost to Follow-up|1|||
16380720|NCT02921256|39877686|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
16380721|NCT02921256|39877687|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
16380722|NCT02921256|39877685|FG000|Arm Ib v Arm III|Physician Decision|4|||
16380723|NCT02921256|39877686|FG001|Arm Ib v Arm III|Physician Decision|0|||
16380724|NCT02921256|39877687|FG002|Arm Ib v Arm III|Physician Decision|1|||
16380725|NCT02921256|39877685|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
16380726|NCT02921256|39877686|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
16380727|NCT02921256|39877687|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
16380728|NCT03639935|39877688|FG000|Overall Study|Death|3|||
16380729|NCT03639935|39877688|FG000|Overall Study|Adverse Event|1|||
16380730|NCT01992757|39877689|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
16380731|NCT00725985|39877692|FG000|ITP- Treatment Disposition|Adverse Event|20|||
16380732|NCT00725985|39877693|FG001|ITP- Treatment Disposition|Adverse Event|10|||
16380733|NCT00725985|39877694|FG002|ITP- Treatment Disposition|Adverse Event|5|||
16380734|NCT00725985|39877695|FG003|ITP- Treatment Disposition|Adverse Event|0|||
16380735|NCT00725985|39877696|FG004|ITP- Treatment Disposition|Adverse Event|0|||
16290476|NCT02054130|39546749|FG003|Overall Study|Lost to Follow-up|2|||
16290477|NCT02054130|39546746|FG000|Overall Study|Missed dose|4|||
16290478|NCT02054130|39546747|FG001|Overall Study|Missed dose|6|||
16290479|NCT02054130|39546748|FG002|Overall Study|Missed dose|7|||
16290480|NCT02054130|39546749|FG003|Overall Study|Missed dose|10|||
16290481|NCT01433549|39546752|FG000|Phase 2: Second Study Product|Adverse Event|0|||
16290482|NCT01433549|39546753|FG001|Phase 2: Second Study Product|Adverse Event|1|||
16290483|NCT00062751|39546757|FG000|Overall Study|Disease progression|24|||
16290484|NCT00062751|39546758|FG001|Overall Study|Disease progression|17|||
16290485|NCT00062751|39546759|FG002|Overall Study|Disease progression|24|||
16290486|NCT00062751|39546760|FG003|Overall Study|Disease progression|2|||
16290487|NCT00062751|39546761|FG004|Overall Study|Disease progression|2|||
16290488|NCT00062751|39546757|FG000|Overall Study|Adverse Event|4|||
16290489|NCT00062751|39546758|FG001|Overall Study|Adverse Event|7|||
16290490|NCT00062751|39546759|FG002|Overall Study|Adverse Event|2|||
16290491|NCT00062751|39546760|FG003|Overall Study|Adverse Event|2|||
16290492|NCT00062751|39546761|FG004|Overall Study|Adverse Event|2|||
16290493|NCT00062751|39546757|FG000|Overall Study|Other|2|||
16290494|NCT00062751|39546758|FG001|Overall Study|Other|3|||
16290495|NCT00062751|39546759|FG002|Overall Study|Other|1|||
16290496|NCT00062751|39546760|FG003|Overall Study|Other|0|||
16290497|NCT00062751|39546761|FG004|Overall Study|Other|1|||
16290498|NCT00062751|39546757|FG000|Overall Study|Withdrawal by Subject|1|||
16290499|NCT00062751|39546758|FG001|Overall Study|Withdrawal by Subject|2|||
16290500|NCT00062751|39546759|FG002|Overall Study|Withdrawal by Subject|2|||
16290501|NCT00062751|39546760|FG003|Overall Study|Withdrawal by Subject|1|||
16290502|NCT00062751|39546761|FG004|Overall Study|Withdrawal by Subject|0|||
16290503|NCT00062751|39546757|FG000|Overall Study|Symptomatic deterioration|1|||
16290504|NCT00062751|39546758|FG001|Overall Study|Symptomatic deterioration|1|||
16290505|NCT00062751|39546759|FG002|Overall Study|Symptomatic deterioration|0|||
16290506|NCT00062751|39546760|FG003|Overall Study|Symptomatic deterioration|0|||
16290507|NCT00062751|39546761|FG004|Overall Study|Symptomatic deterioration|1|||
16290508|NCT00062751|39546757|FG000|Overall Study|Death|1|||
16290509|NCT00062751|39546758|FG001|Overall Study|Death|0|||
16290510|NCT00062751|39546759|FG002|Overall Study|Death|1|||
16290511|NCT00062751|39546760|FG003|Overall Study|Death|0|||
16290512|NCT00062751|39546761|FG004|Overall Study|Death|0|||
16290513|NCT01763684|39546762|FG000|Overall Study|Study terminated early due to low enrollment|126|||
16290514|NCT01763684|39546763|FG001|Overall Study|Study terminated early due to low enrollment|127|||
16290515|NCT01763684|39546762|FG000|Overall Study|Study surgery not performed|7|||
16290516|NCT01763684|39546763|FG001|Overall Study|Study surgery not performed|6|||
16290517|NCT02813421|39546765|FG000|Overall Study|Withdrawal by Subject|1|||
16290518|NCT02813421|39546766|FG001|Overall Study|Withdrawal by Subject|2|||
16290519|NCT02813421|39546765|FG000|Overall Study|Lost to Follow-up|1|||
16290520|NCT02813421|39546766|FG001|Overall Study|Lost to Follow-up|1|||
16290521|NCT02570113|39546771|FG000|Overall Study|Withdrawal by Subject|3|||
16290522|NCT03036839|39546775|FG000|Overall Study|Adverse Event|0|||
16290523|NCT03036839|39546776|FG001|Overall Study|Adverse Event|0|||
16290524|NCT03036839|39546777|FG002|Overall Study|Adverse Event|1|||
16290525|NCT03036839|39546775|FG000|Overall Study|Death|3|||
16290526|NCT03036839|39546776|FG001|Overall Study|Death|0|||
16290527|NCT03036839|39546777|FG002|Overall Study|Death|3|||
16290528|NCT03036839|39546775|FG000|Overall Study|Withdrew Consent|0|||
16290529|NCT03036839|39546776|FG001|Overall Study|Withdrew Consent|0|||
16290530|NCT03036839|39546777|FG002|Overall Study|Withdrew Consent|1|||
16290531|NCT03439852|39546778|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
16290532|NCT03439852|39546779|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
16290533|NCT03439852|39546778|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
16290534|NCT03439852|39546779|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
16380736|NCT00725985|39877697|FG005|ITP- Treatment Disposition|Adverse Event|0|||
16380737|NCT00725985|39877698|FG006|ITP- Treatment Disposition|Adverse Event|0|||
16290535|NCT03439852|39546778|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
16380738|NCT00725985|39877699|FG007|ITP- Treatment Disposition|Adverse Event|0|||
16290536|NCT03439852|39546779|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
16290537|NCT00560937|39546781|FG000|Overall Study|Withdrawal by Subject|0|||
16290538|NCT00560937|39546782|FG001|Overall Study|Withdrawal by Subject|1|||
16290539|NCT00560937|39546781|FG000|Overall Study|Physician Decision|1|||
16290540|NCT00560937|39546782|FG001|Overall Study|Physician Decision|1|||
16290541|NCT00325195|39546783|FG000|Randomized|Not dosed|5|||
16290542|NCT00325195|39546784|FG001|Randomized|Not dosed|5|||
16290543|NCT00325195|39546785|FG002|Randomized|Not dosed|3|||
16290544|NCT00325195|39546783|FG000|Received Intervention: ITT Population|Adverse Event|15|||
16290545|NCT00325195|39546784|FG001|Received Intervention: ITT Population|Adverse Event|17|||
16290546|NCT00325195|39546785|FG002|Received Intervention: ITT Population|Adverse Event|1|||
16290547|NCT00325195|39546783|FG000|Received Intervention: ITT Population|Death|3|||
16290548|NCT00325195|39546784|FG001|Received Intervention: ITT Population|Death|1|||
16290549|NCT00325195|39546785|FG002|Received Intervention: ITT Population|Death|0|||
16290550|NCT00325195|39546783|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
16290551|NCT00325195|39546784|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
16290552|NCT00325195|39546785|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
16290553|NCT00325195|39546783|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
16290554|NCT00325195|39546784|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
16290555|NCT00325195|39546785|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
16290556|NCT00325195|39546783|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
16290557|NCT00325195|39546784|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
16290558|NCT00325195|39546785|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
16290559|NCT02771795|39546786|FG000|Overall Study|Withdrawal by Subject|47|||
16290560|NCT02771795|39546787|FG001|Overall Study|Withdrawal by Subject|37|||
16290561|NCT02771795|39546786|FG000|Overall Study|Termination by premature discontinuation of study|168|||
16290562|NCT02771795|39546787|FG001|Overall Study|Termination by premature discontinuation of study|185|||
16290563|NCT01462318|39546788|FG000|Main Study / TP-DI Study|Other|2|||
16290564|NCT01462318|39546789|FG001|Main Study / TP-DI Study|Other|0|||
16290565|NCT01462318|39546790|FG002|Main Study / TP-DI Study|Other|0|||
16290566|NCT01462318|39546788|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
16290567|NCT01462318|39546789|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
16290568|NCT01462318|39546790|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
16290569|NCT01462318|39546788|FG000|Main Study / TP-DI Study|Adverse Event|4|||
16290570|NCT01462318|39546789|FG001|Main Study / TP-DI Study|Adverse Event|0|||
16290571|NCT01462318|39546790|FG002|Main Study / TP-DI Study|Adverse Event|0|||
16290572|NCT01462318|39546788|FG000|Extension Phase|Lost to Follow-up|0|||
16290573|NCT01462318|39546789|FG001|Extension Phase|Lost to Follow-up|0|||
16290574|NCT01462318|39546790|FG002|Extension Phase|Lost to Follow-up|1|||
16290575|NCT01462318|39546788|FG000|Extension Phase|Other|0|||
16290576|NCT01462318|39546789|FG001|Extension Phase|Other|0|||
16290577|NCT01462318|39546790|FG002|Extension Phase|Other|1|||
16290578|NCT01462318|39546788|FG000|Extension Phase|Disease Progression|0|||
16290579|NCT01462318|39546789|FG001|Extension Phase|Disease Progression|0|||
16290580|NCT01462318|39546790|FG002|Extension Phase|Disease Progression|1|||
16290581|NCT01462318|39546788|FG000|Extension Phase|Withdrawal by Subject|0|||
16290582|NCT01462318|39546789|FG001|Extension Phase|Withdrawal by Subject|0|||
16290583|NCT01462318|39546790|FG002|Extension Phase|Withdrawal by Subject|15|||
16290584|NCT01462318|39546788|FG000|Extension Phase|Investigator Decision|0|||
16290585|NCT01462318|39546789|FG001|Extension Phase|Investigator Decision|0|||
16290586|NCT01462318|39546790|FG002|Extension Phase|Investigator Decision|5|||
16290587|NCT01462318|39546788|FG000|Extension Phase|Adverse Event|0|||
16290588|NCT01462318|39546789|FG001|Extension Phase|Adverse Event|0|||
16290589|NCT01462318|39546790|FG002|Extension Phase|Adverse Event|22|||
16290590|NCT04355663|39546791|FG000|Overall Study|Physician Decision|2|||
16290591|NCT04355663|39546792|FG001|Overall Study|Physician Decision|7|||
16290592|NCT04355663|39546793|FG002|Overall Study|Physician Decision|0|||
16290593|NCT04355663|39546791|FG000|Overall Study|Adverse Event|0|||
16290594|NCT04355663|39546792|FG001|Overall Study|Adverse Event|0|||
16290595|NCT04355663|39546793|FG002|Overall Study|Adverse Event|1|||
16290596|NCT04355663|39546791|FG000|Overall Study|Withdrawal by Subject|0|||
16290597|NCT04355663|39546792|FG001|Overall Study|Withdrawal by Subject|8|||
16290598|NCT04355663|39546793|FG002|Overall Study|Withdrawal by Subject|3|||
16290599|NCT02296684|39546795|FG000|Overall Study|Withdrawal by Subject|0|||
16290600|NCT02296684|39546796|FG001|Overall Study|Withdrawal by Subject|1|||
16290601|NCT02296684|39546797|FG002|Overall Study|Withdrawal by Subject|1|||
16290602|NCT02296684|39546795|FG000|Overall Study|Death|2|||
16290603|NCT02296684|39546796|FG001|Overall Study|Death|0|||
16290604|NCT02296684|39546797|FG002|Overall Study|Death|0|||
16290605|NCT00026312|39546798|FG000|Overall Study|Adverse Event|0|||
16290606|NCT00026312|39546799|FG001|Overall Study|Adverse Event|32|||
16290607|NCT00026312|39546798|FG000|Overall Study|Death|1|||
16290608|NCT00026312|39546799|FG001|Overall Study|Death|7|||
16290609|NCT00026312|39546798|FG000|Overall Study|Lack of Efficacy|19|||
16290610|NCT00026312|39546799|FG001|Overall Study|Lack of Efficacy|114|||
16290611|NCT00026312|39546798|FG000|Overall Study|Lost to Follow-up|0|||
16290612|NCT00026312|39546799|FG001|Overall Study|Lost to Follow-up|5|||
16290613|NCT00026312|39546798|FG000|Overall Study|Physician Decision|1|||
16290614|NCT00026312|39546799|FG001|Overall Study|Physician Decision|37|||
16290615|NCT00026312|39546798|FG000|Overall Study|Protocol Violation|0|||
16290616|NCT00026312|39546799|FG001|Overall Study|Protocol Violation|3|||
16081038|NCT04210180|38789444|FG000|Overall Study|Withdrawal by Subject|2|||
16081039|NCT01976312|38789445|FG000|Overall Study|Pregnancy|0|||
16081040|NCT01976312|38789446|FG001|Overall Study|Pregnancy|1|||
16081041|NCT01976312|38789445|FG000|Overall Study|Lost to Follow-up|2|||
16081042|NCT01976312|38789446|FG001|Overall Study|Lost to Follow-up|0|||
16380739|NCT00725985|39877700|FG008|ITP- Treatment Disposition|Adverse Event|0|||
16380740|NCT00725985|39877701|FG009|ITP- Treatment Disposition|Adverse Event|0|||
16380741|NCT00725985|39877702|FG010|ITP- Treatment Disposition|Adverse Event|0|||
16380742|NCT00725985|39877703|FG011|ITP- Treatment Disposition|Adverse Event|0|||
16380743|NCT00725985|39877692|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
16380744|NCT00725985|39877693|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
16380745|NCT00725985|39877694|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
16380746|NCT00725985|39877695|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
16380747|NCT00725985|39877696|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
16380748|NCT00725985|39877697|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
16380749|NCT00725985|39877698|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
16380750|NCT00725985|39877699|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
16482747|NCT02598960|40245468|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
16482748|NCT02598960|40245469|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
16482749|NCT02598960|40245470|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
16290617|NCT00026312|39546798|FG000|Overall Study|Withdrawal by Subject|1|||
16290618|NCT00026312|39546799|FG001|Overall Study|Withdrawal by Subject|6|||
16290619|NCT00026312|39546798|FG000|Overall Study|Ineligible|4|||
16290620|NCT00026312|39546799|FG001|Overall Study|Ineligible|5|||
16290621|NCT00026312|39546798|FG000|Overall Study|Entry onto another COG study|0|||
16290622|NCT00026312|39546799|FG001|Overall Study|Entry onto another COG study|1|||
16290623|NCT00026312|39546798|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
16290624|NCT00026312|39546799|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
16290625|NCT01744093|39546804|FG000|Overall Study|Withdrawal by Subject|6|||
16290626|NCT01744093|39546805|FG001|Overall Study|Withdrawal by Subject|1|||
16290627|NCT01705236|39546806|FG000|Overall Study|Lost to Follow-up|1|||
16290628|NCT01705236|39546806|FG000|Overall Study|Administrative problems|2|||
16290629|NCT01705236|39546806|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
16290630|NCT01705236|39546806|FG000|Overall Study|Protocol Violation|3|||
16290631|NCT01705236|39546806|FG000|Overall Study|Abnormal test procedure result(s)|4|||
16290632|NCT01705236|39546806|FG000|Overall Study|Abnormal laboratory value(s)|4|||
16290633|NCT01705236|39546806|FG000|Overall Study|Withdrawal by Subject|5|||
16290634|NCT01705236|39546806|FG000|Overall Study|Adverse Event|5|||
16290635|NCT01429051|39546807|FG000|Titration Phase|Death|1|||
16482750|NCT02598960|40245471|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
16081043|NCT01976312|38789445|FG000|Overall Study|Withdrawal by Subject|7|||
16081044|NCT01976312|38789446|FG001|Overall Study|Withdrawal by Subject|2|||
16081045|NCT01976312|38789445|FG000|Overall Study|Adverse Event|6|||
16482751|NCT02598960|40245472|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
16081046|NCT01976312|38789446|FG001|Overall Study|Adverse Event|6|||
16081047|NCT01976312|38789445|FG000|Overall Study|Protocol Violation|2|||
16081048|NCT01976312|38789446|FG001|Overall Study|Protocol Violation|0|||
16111459|NCT00760747|38897275|FG001|Study Period II|Parent/Caregiver Decision|0|||
16290636|NCT01429051|39546807|FG000|Titration Phase|Withdrawal by Subject|7|||
16380751|NCT00725985|39877700|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
16290637|NCT01429051|39546807|FG000|Titration Phase|Physician Decision|1|||
16290638|NCT01429051|39546807|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
16290639|NCT01429051|39546807|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
16380752|NCT00725985|39877701|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
16290640|NCT01429051|39546807|FG000|Efficacy Phase|Adverse Event|1|||
16290641|NCT01429051|39546807|FG000|Efficacy Phase|Death|1|||
16081049|NCT04766034|38789461|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
16482752|NCT02598960|40245473|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
16482753|NCT02598960|40245474|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
16482754|NCT02598960|40245475|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
16482755|NCT02598960|40245476|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
16482756|NCT02598960|40245477|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
16482757|NCT02598960|40245478|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
16081050|NCT04766034|38789462|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
16081051|NCT04766034|38789463|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
16081052|NCT04766034|38789464|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
16081053|NCT04766034|38789465|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
16081054|NCT04766034|38789461|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
16081055|NCT04766034|38789462|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
16081056|NCT04766034|38789463|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
16081057|NCT04766034|38789464|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
16081058|NCT04766034|38789465|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
16081059|NCT04766034|38789461|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
16081060|NCT04766034|38789462|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
16081061|NCT04766034|38789463|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
16081062|NCT04766034|38789464|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
16081063|NCT04766034|38789465|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
16081064|NCT04766034|38789461|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
16081065|NCT04766034|38789462|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
16081066|NCT04766034|38789463|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
16081067|NCT04766034|38789464|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
16081068|NCT04766034|38789465|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
16081069|NCT02121002|38789466|FG000|Overall Study|Physician Decision|2|||
16081070|NCT02121002|38789467|FG001|Overall Study|Physician Decision|0|||
16081071|NCT02121002|38789468|FG002|Overall Study|Physician Decision|0|||
16081072|NCT02121002|38789466|FG000|Overall Study|Withdrawal by Subject|3|||
16081073|NCT02121002|38789467|FG001|Overall Study|Withdrawal by Subject|1|||
16081074|NCT02121002|38789468|FG002|Overall Study|Withdrawal by Subject|4|||
16081075|NCT02121002|38789466|FG000|Overall Study|Protocol Violation|1|||
16081076|NCT02121002|38789467|FG001|Overall Study|Protocol Violation|2|||
16081077|NCT02121002|38789468|FG002|Overall Study|Protocol Violation|4|||
16081078|NCT02121002|38789466|FG000|Overall Study|Concomitant therapy|0|||
16081079|NCT02121002|38789467|FG001|Overall Study|Concomitant therapy|1|||
16081080|NCT02121002|38789468|FG002|Overall Study|Concomitant therapy|1|||
16081081|NCT02121002|38789466|FG000|Overall Study|Others|1|||
16081082|NCT02121002|38789467|FG001|Overall Study|Others|0|||
16081083|NCT02121002|38789468|FG002|Overall Study|Others|1|||
16081084|NCT00818246|38789472|FG000|Overall Study|Impossible to match pictures|5|||
16081085|NCT00249769|38789483|FG000|Overall Study|Withdrawal by Subject|1|||
16081086|NCT00249769|38789484|FG001|Overall Study|Withdrawal by Subject|10|||
16081087|NCT00249769|38789485|FG002|Overall Study|Withdrawal by Subject|6|||
16081088|NCT00249769|38789483|FG000|Overall Study|Migration from Study Area|1|||
16081089|NCT00249769|38789484|FG001|Overall Study|Migration from Study Area|3|||
16081090|NCT00249769|38789485|FG002|Overall Study|Migration from Study Area|14|||
16081091|NCT00249769|38789483|FG000|Overall Study|Miscellaneous|0|||
16081092|NCT00249769|38789484|FG001|Overall Study|Miscellaneous|2|||
16081093|NCT00249769|38789485|FG002|Overall Study|Miscellaneous|2|||
16081094|NCT00249769|38789483|FG000|Overall Study|Adverse Event|0|||
16081095|NCT00249769|38789484|FG001|Overall Study|Adverse Event|0|||
16081096|NCT00249769|38789485|FG002|Overall Study|Adverse Event|1|||
16081097|NCT00249769|38789483|FG000|Overall Study|Physician Decision|0|||
16081098|NCT00249769|38789484|FG001|Overall Study|Physician Decision|0|||
16482758|NCT02598960|40245479|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
16482759|NCT02598960|40245480|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
16482760|NCT02598960|40245468|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482761|NCT02598960|40245469|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482762|NCT02598960|40245470|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482763|NCT02598960|40245471|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482764|NCT02598960|40245472|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16081099|NCT00249769|38789485|FG002|Overall Study|Physician Decision|2|||
16482765|NCT02598960|40245473|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482766|NCT02598960|40245474|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482767|NCT02598960|40245475|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482768|NCT02598960|40245476|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482769|NCT02598960|40245477|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482770|NCT02598960|40245478|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482771|NCT02598960|40245479|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
16482772|NCT02598960|40245480|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
16482773|NCT02598960|40245468|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
16482774|NCT02598960|40245469|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
16482775|NCT02598960|40245470|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
16482776|NCT02598960|40245471|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
16290642|NCT01429051|39546807|FG000|Tolerability Phase|Death|5|||
16290643|NCT01429051|39546807|FG000|Tolerability Phase|Adverse Event|2|||
16290644|NCT01429051|39546807|FG000|Tolerability Phase|Withdrawal by Subject|5|||
16290645|NCT01429051|39546807|FG000|Tolerability Phase|Physician Decision|1|||
16290646|NCT01429051|39546807|FG000|Tolerability Phase|Other|2|||
16290647|NCT00838435|39546809|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
16290648|NCT00838435|39546809|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
16290649|NCT00838435|39546809|FG000|Part 2 (7 Years)|Adverse Event|2|||
16290650|NCT00838435|39546809|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
16290651|NCT00838435|39546809|FG000|Part 2 (7 Years)|Physician Decision|1|||
16290652|NCT00838435|39546809|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
16290653|NCT00838435|39546809|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
16290654|NCT00988065|39546810|FG000|Overall Study|Adverse Event|4|||
16290655|NCT00988065|39546811|FG001|Overall Study|Adverse Event|10|||
16290656|NCT00988065|39546812|FG002|Overall Study|Adverse Event|2|||
16290657|NCT00988065|39546810|FG000|Overall Study|Lost to Follow-up|1|||
16290658|NCT00988065|39546811|FG001|Overall Study|Lost to Follow-up|2|||
16290659|NCT00988065|39546812|FG002|Overall Study|Lost to Follow-up|2|||
16290660|NCT00988065|39546810|FG000|Overall Study|Subject withdrew consent|3|||
16290661|NCT00988065|39546811|FG001|Overall Study|Subject withdrew consent|5|||
16290662|NCT00988065|39546812|FG002|Overall Study|Subject withdrew consent|2|||
16482777|NCT02598960|40245472|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
16482778|NCT02598960|40245473|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
16482779|NCT02598960|40245474|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
16482780|NCT02598960|40245475|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
16081100|NCT00249769|38789483|FG000|Overall Study|Lost to Follow-up|0|||
16081101|NCT00249769|38789484|FG001|Overall Study|Lost to Follow-up|0|||
16081102|NCT00249769|38789485|FG002|Overall Study|Lost to Follow-up|3|||
16081103|NCT02272816|38789486|FG000|Overall Study|Adverse Event|1|||
16081104|NCT02891915|38789490|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
16081105|NCT02891915|38789491|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
16081106|NCT02891915|38789490|FG000|Overall Study|Withdrawal by Subject|3|||
16081107|NCT02891915|38789491|FG001|Overall Study|Withdrawal by Subject|3|||
16081108|NCT02891915|38789490|FG000|Overall Study|Became Ineligible After Enrollment|2|||
16081109|NCT02891915|38789491|FG001|Overall Study|Became Ineligible After Enrollment|1|||
16081110|NCT02891915|38789490|FG000|Overall Study|Lost to Follow-up|1|||
16081111|NCT02891915|38789491|FG001|Overall Study|Lost to Follow-up|4|||
16081112|NCT02891915|38789490|FG000|Overall Study|Physician Decision|1|||
16081113|NCT02891915|38789491|FG001|Overall Study|Physician Decision|0|||
16081114|NCT01063972|38789492|FG000|Overall Study|Death|12|||
16081115|NCT01063972|38789493|FG001|Overall Study|Death|11|||
16081116|NCT01063972|38789492|FG000|Overall Study|Incarcerated|2|||
16081117|NCT01063972|38789493|FG001|Overall Study|Incarcerated|1|||
16081118|NCT01303445|38789494|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
16081119|NCT01303445|38789495|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
16081120|NCT01303445|38789494|FG000|Second Intervention (7 Days)|Adverse Event|0|||
16081121|NCT01303445|38789495|FG001|Second Intervention (7 Days)|Adverse Event|2|||
16290663|NCT00988065|39546810|FG000|Overall Study|Noncompliance with protocol|5|||
16081122|NCT01303445|38789494|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
16081123|NCT01303445|38789495|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
16081124|NCT01303445|38789494|FG000|Washout (14 Days)|Protocol Violation|1|||
16290664|NCT00988065|39546811|FG001|Overall Study|Noncompliance with protocol|6|||
16290665|NCT00988065|39546812|FG002|Overall Study|Noncompliance with protocol|9|||
16290666|NCT05256134|39546813|FG000|Overall Study|Study Terminated by Sponsor|11|||
16081125|NCT01303445|38789495|FG001|Washout (14 Days)|Protocol Violation|0|||
16081126|NCT01303445|38789494|FG000|Washout (14 Days)|Lost to Follow-up|0|||
16290667|NCT05256134|39546814|FG001|Overall Study|Study Terminated by Sponsor|10|||
16290668|NCT05256134|39546813|FG000|Overall Study|Withdrawal by Subject|1|||
16290669|NCT05256134|39546814|FG001|Overall Study|Withdrawal by Subject|3|||
16290670|NCT01968694|39546816|FG000|Washout (1 Month)|Lost to Follow-up|0|||
16290671|NCT01968694|39546817|FG001|Washout (1 Month)|Lost to Follow-up|1|||
16290672|NCT02780167|39546818|FG000|Overall Study|Adverse Event|9|||
16290673|NCT02780167|39546819|FG001|Overall Study|Adverse Event|8|||
16290674|NCT02780167|39546820|FG002|Overall Study|Adverse Event|8|||
16290675|NCT02780167|39546821|FG003|Overall Study|Adverse Event|12|||
16290676|NCT02780167|39546822|FG004|Overall Study|Adverse Event|8|||
16290677|NCT02780167|39546818|FG000|Overall Study|Lack of Efficacy|6|||
16290678|NCT02780167|39546819|FG001|Overall Study|Lack of Efficacy|5|||
16290679|NCT02780167|39546820|FG002|Overall Study|Lack of Efficacy|6|||
16482781|NCT02598960|40245476|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
16081127|NCT01303445|38789495|FG001|Washout (14 Days)|Lost to Follow-up|2|||
16081128|NCT01303445|38789494|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
16081129|NCT01303445|38789495|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
16081130|NCT01303445|38789494|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
16081131|NCT01303445|38789495|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
16081132|NCT02140645|38789497|FG000|Overall Study|Not linked|5489|||
16081133|NCT02140645|38789498|FG001|Overall Study|Not linked|61654|||
16081134|NCT02140645|38789499|FG002|Overall Study|Not linked|4236|||
16081135|NCT02140645|38789500|FG003|Overall Study|Not linked|13833|||
16081136|NCT02140645|38789501|FG004|Overall Study|Not linked|3286|||
16081137|NCT02140645|38789502|FG005|Overall Study|Not linked|70896|||
16482782|NCT02598960|40245477|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
16482783|NCT02598960|40245478|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
16482784|NCT02598960|40245479|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
16482785|NCT02598960|40245480|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
16482786|NCT00518687|40245483|FG000|Overall Study|Adverse Event|201|||
16482787|NCT00518687|40245484|FG001|Overall Study|Adverse Event|177|||
16482788|NCT00518687|40245483|FG000|Overall Study|Lost to Follow-up|144|||
16482789|NCT00518687|40245484|FG001|Overall Study|Lost to Follow-up|155|||
16081138|NCT01121991|38789503|FG000|Overall Study|Lack of Ovarian Response|2|||
16081139|NCT01121991|38789503|FG000|Overall Study|No Oocytes Retrieved|3|||
16081140|NCT01121991|38789503|FG000|Overall Study|No Fertilization|1|||
16081141|NCT01255670|38789504|FG000|Overall Study|Adverse Event|10|||
16081142|NCT01255670|38789505|FG001|Overall Study|Adverse Event|10|||
16081143|NCT01255670|38789504|FG000|Overall Study|Lost to Follow-up|16|||
16081144|NCT01255670|38789505|FG001|Overall Study|Lost to Follow-up|10|||
16081145|NCT01095796|38789506|FG000|Overall Study|Randomized but Not Treated|5|||
16081146|NCT01095796|38789507|FG001|Overall Study|Randomized but Not Treated|2|||
16081147|NCT01095796|38789506|FG000|Overall Study|Adverse Event|9|||
16081148|NCT01095796|38789507|FG001|Overall Study|Adverse Event|19|||
16081149|NCT01095796|38789506|FG000|Overall Study|Death|3|||
16081150|NCT01095796|38789507|FG001|Overall Study|Death|2|||
16081151|NCT01095796|38789506|FG000|Overall Study|Pregnancy|2|||
16081152|NCT01095796|38789507|FG001|Overall Study|Pregnancy|0|||
16081153|NCT01095796|38789506|FG000|Overall Study|Lack of Efficacy|5|||
16081154|NCT01095796|38789507|FG001|Overall Study|Lack of Efficacy|3|||
16081155|NCT01095796|38789506|FG000|Overall Study|Investigator's Discretion|7|||
16081156|NCT01095796|38789507|FG001|Overall Study|Investigator's Discretion|2|||
16081157|NCT01095796|38789506|FG000|Overall Study|Withdrew Consent|16|||
16081158|NCT01095796|38789507|FG001|Overall Study|Withdrew Consent|22|||
16081159|NCT01095796|38789506|FG000|Overall Study|Lost to Follow-up|27|||
16081160|NCT01095796|38789507|FG001|Overall Study|Lost to Follow-up|29|||
16081161|NCT01095796|38789506|FG000|Overall Study|Participant Noncompliance|5|||
16081162|NCT01095796|38789507|FG001|Overall Study|Participant Noncompliance|10|||
16081163|NCT01095796|38789506|FG000|Overall Study|Protocol Violation|1|||
16081164|NCT01095796|38789507|FG001|Overall Study|Protocol Violation|0|||
16081165|NCT01095796|38789506|FG000|Overall Study|Participant Transferred to Another Study|215|||
16081166|NCT01095796|38789507|FG001|Overall Study|Participant Transferred to Another Study|200|||
16081167|NCT03473340|38789508|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
16081168|NCT03473340|38789509|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
16081169|NCT03473340|38789508|FG000|Overall Study|Withdrawal by Subject|1|||
16081170|NCT03473340|38789509|FG001|Overall Study|Withdrawal by Subject|0|||
16290680|NCT02780167|39546821|FG003|Overall Study|Lack of Efficacy|1|||
16482790|NCT00518687|40245483|FG000|Overall Study|Physician Decision|42|||
16482791|NCT00518687|40245484|FG001|Overall Study|Physician Decision|48|||
16482792|NCT00518687|40245483|FG000|Overall Study|Progressive disease|2|||
16081171|NCT03473340|38789508|FG000|Overall Study|Lost to Follow-up|1|||
16081172|NCT03473340|38789509|FG001|Overall Study|Lost to Follow-up|2|||
16081173|NCT03781375|38789513|FG000|Double-blind Phase|Adverse Event|0|||
16081174|NCT03781375|38789514|FG001|Double-blind Phase|Adverse Event|1|||
16081175|NCT03781375|38789513|FG000|Double-blind Phase|Lack of Response|6|||
16081176|NCT03781375|38789514|FG001|Double-blind Phase|Lack of Response|2|||
16081177|NCT03781375|38789513|FG000|Double-blind Phase|Other|1|||
16081178|NCT03781375|38789514|FG001|Double-blind Phase|Other|3|||
16081179|NCT03781375|38789513|FG000|Open-label Phase|Protocol Issues|0|||
16290681|NCT02780167|39546822|FG004|Overall Study|Lack of Efficacy|0|||
16482793|NCT00518687|40245484|FG001|Overall Study|Progressive disease|2|||
16482794|NCT00518687|40245483|FG000|Overall Study|Protocol Violation|8|||
16482795|NCT00518687|40245484|FG001|Overall Study|Protocol Violation|10|||
16482796|NCT00518687|40245483|FG000|Overall Study|Study terminated by sponsor|930|||
16482797|NCT00518687|40245484|FG001|Overall Study|Study terminated by sponsor|918|||
16482798|NCT00518687|40245483|FG000|Overall Study|Withdrawal by Subject|110|||
16482799|NCT00518687|40245484|FG001|Overall Study|Withdrawal by Subject|110|||
16482800|NCT00493025|40245487|FG000|Overall Study|Physician Decision|19|||
16482801|NCT00825682|40245488|FG000|Overall Study|personal reasons/ inconvenience|13|||
16482802|NCT00825682|40245489|FG001|Overall Study|personal reasons/ inconvenience|5|||
16482803|NCT03342963|40245490|FG000|Overall Study|Adverse Event|1|||
16482804|NCT03342963|40245491|FG001|Overall Study|Adverse Event|2|||
16482805|NCT03342963|40245492|FG002|Overall Study|Adverse Event|0|||
16482806|NCT03342963|40245493|FG003|Overall Study|Adverse Event|0|||
16482807|NCT03342963|40245490|FG000|Overall Study|Withdrawal by Subject|1|||
16482808|NCT03342963|40245491|FG001|Overall Study|Withdrawal by Subject|0|||
16482809|NCT03342963|40245492|FG002|Overall Study|Withdrawal by Subject|0|||
16482810|NCT03342963|40245493|FG003|Overall Study|Withdrawal by Subject|0|||
16482811|NCT00094172|40245494|FG000|Overall Study|Adverse Event|0|||
16482812|NCT00094172|40245495|FG001|Overall Study|Adverse Event|1|||
16482813|NCT00094172|40245494|FG000|Overall Study|Lost to Follow-up|2|||
16482814|NCT00094172|40245495|FG001|Overall Study|Lost to Follow-up|0|||
16482815|NCT00094172|40245494|FG000|Overall Study|Protocol Violation|0|||
16482816|NCT00094172|40245495|FG001|Overall Study|Protocol Violation|1|||
16482817|NCT00094172|40245494|FG000|Overall Study|Withdrawal by Subject|10|||
16482818|NCT00094172|40245495|FG001|Overall Study|Withdrawal by Subject|5|||
16482819|NCT00094172|40245494|FG000|Overall Study|Primary endpoint met.|1|||
16482820|NCT00094172|40245495|FG001|Overall Study|Primary endpoint met.|0|||
16482821|NCT00094172|40245494|FG000|Overall Study|Started other MS therapy due to disease|1|||
16482822|NCT00094172|40245495|FG001|Overall Study|Started other MS therapy due to disease|0|||
16482823|NCT02083783|40245497|FG000|Overall Study|Withdrawal by Subject|1|||
16482824|NCT02083783|40245498|FG001|Overall Study|Withdrawal by Subject|0|||
16482825|NCT04528732|40245499|FG000|Overall Study|Death|1|||
16482826|NCT04528732|40245500|FG001|Overall Study|Death|0|||
16482827|NCT04528732|40245501|FG002|Overall Study|Death|1|||
16482828|NCT04528732|40245499|FG000|Overall Study|Lost to Follow-up|0|||
16482829|NCT04528732|40245500|FG001|Overall Study|Lost to Follow-up|1|||
16482830|NCT04528732|40245501|FG002|Overall Study|Lost to Follow-up|2|||
16482831|NCT00508755|40245504|FG000|Overall Study|Withdrawal by Subject|1|||
16186240|NCT03502707|39159409|FG014|Overall Study|Randomized but not vaccinated|0|||
16186241|NCT03502707|39159410|FG015|Overall Study|Randomized but not vaccinated|0|||
16186242|NCT03502707|39159411|FG016|Overall Study|Randomized but not vaccinated|0|||
16186243|NCT03502707|39159412|FG017|Overall Study|Randomized but not vaccinated|1|||
16186244|NCT04359823|39159413|FG000|Overall Study|Lost to Follow-up|0|||
16186245|NCT04359823|39159414|FG001|Overall Study|Lost to Follow-up|1|||
16186246|NCT04359823|39159413|FG000|Overall Study|Withdrawal by Subject|0|||
16186247|NCT04359823|39159414|FG001|Overall Study|Withdrawal by Subject|1|||
16186248|NCT04973228|39159416|FG000|Overall Study|Adverse Event|2|||
16380753|NCT00725985|39877702|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
16380754|NCT00725985|39877703|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
16482832|NCT01387789|40245505|FG000|Overall Study|Adverse Event|5|||
16186249|NCT04973228|39159417|FG001|Overall Study|Adverse Event|3|||
16186250|NCT04973228|39159416|FG000|Overall Study|Lack of Efficacy|1|||
16186251|NCT04973228|39159417|FG001|Overall Study|Lack of Efficacy|3|||
16482833|NCT01387789|40245505|FG000|Overall Study|Lack of Efficacy|2|||
16186252|NCT04973228|39159416|FG000|Overall Study|Lost to Follow-up|12|||
16482834|NCT01387789|40245505|FG000|Overall Study|Lost to Follow-up|1|||
16482835|NCT01496612|40245506|FG000|1st Intervention|Adverse Event|1|||
16482836|NCT01496612|40245507|FG001|1st Intervention|Adverse Event|0|||
16482837|NCT01496612|40245506|FG000|1st Intervention|Withdrawal by Subject|1|||
16290682|NCT02780167|39546818|FG000|Overall Study|Lost to Follow-up|2|||
16290683|NCT02780167|39546819|FG001|Overall Study|Lost to Follow-up|0|||
16290684|NCT02780167|39546820|FG002|Overall Study|Lost to Follow-up|1|||
16290685|NCT02780167|39546821|FG003|Overall Study|Lost to Follow-up|0|||
16290686|NCT02780167|39546822|FG004|Overall Study|Lost to Follow-up|0|||
16290687|NCT02780167|39546818|FG000|Overall Study|Does not meet entrance criteria|0|||
16290688|NCT02780167|39546819|FG001|Overall Study|Does not meet entrance criteria|0|||
16290689|NCT02780167|39546820|FG002|Overall Study|Does not meet entrance criteria|1|||
16290690|NCT02780167|39546821|FG003|Overall Study|Does not meet entrance criteria|0|||
16290691|NCT02780167|39546822|FG004|Overall Study|Does not meet entrance criteria|0|||
16290692|NCT02780167|39546818|FG000|Overall Study|No longer meets eligibility criteria|0|||
16290693|NCT02780167|39546819|FG001|Overall Study|No longer meets eligibility criteria|0|||
16290694|NCT02780167|39546820|FG002|Overall Study|No longer meets eligibility criteria|0|||
16290695|NCT02780167|39546821|FG003|Overall Study|No longer meets eligibility criteria|1|||
16290696|NCT02780167|39546822|FG004|Overall Study|No longer meets eligibility criteria|1|||
16290697|NCT02780167|39546818|FG000|Overall Study|Protocol Violation|5|||
16290698|NCT02780167|39546819|FG001|Overall Study|Protocol Violation|5|||
16290699|NCT02780167|39546820|FG002|Overall Study|Protocol Violation|1|||
16290700|NCT02780167|39546821|FG003|Overall Study|Protocol Violation|1|||
16290701|NCT02780167|39546822|FG004|Overall Study|Protocol Violation|2|||
16290702|NCT02780167|39546818|FG000|Overall Study|Withdrawal by Subject|6|||
16290703|NCT02780167|39546819|FG001|Overall Study|Withdrawal by Subject|4|||
16290704|NCT02780167|39546820|FG002|Overall Study|Withdrawal by Subject|4|||
16290705|NCT02780167|39546821|FG003|Overall Study|Withdrawal by Subject|3|||
16290706|NCT02780167|39546822|FG004|Overall Study|Withdrawal by Subject|4|||
16290707|NCT02780167|39546818|FG000|Overall Study|Other|0|||
16290708|NCT02780167|39546819|FG001|Overall Study|Other|0|||
16290709|NCT02780167|39546820|FG002|Overall Study|Other|3|||
16482838|NCT01496612|40245507|FG001|1st Intervention|Withdrawal by Subject|0|||
16482839|NCT00036270|40245508|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
16482840|NCT00036270|40245509|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
16482841|NCT00036270|40245508|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
16290710|NCT02780167|39546821|FG003|Overall Study|Other|1|||
16290711|NCT02780167|39546822|FG004|Overall Study|Other|2|||
16290712|NCT02551666|39546823|FG000|Overall Study|Withdrawal by Subject|1|||
16290713|NCT02551666|39546824|FG001|Overall Study|Withdrawal by Subject|3|||
16482842|NCT00036270|40245509|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
16482843|NCT00036270|40245508|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
16482844|NCT00036270|40245509|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
16482845|NCT00036270|40245508|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
16482846|NCT00036270|40245509|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
16482847|NCT00036270|40245508|FG000|Study Treatment to 5 Year Report|Other|277|||
16482848|NCT00036270|40245509|FG001|Study Treatment to 5 Year Report|Other|288|||
16482849|NCT00036270|40245508|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
16482850|NCT00036270|40245509|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
16482851|NCT00036270|40245508|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
16482852|NCT00036270|40245509|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
16482853|NCT00036270|40245508|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
16482854|NCT00036270|40245509|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
16290714|NCT03365011|39546829|FG000|Overall Study|Withdrawal by Subject|1|||
16290715|NCT03365011|39546830|FG001|Overall Study|Withdrawal by Subject|2|||
16290716|NCT00605865|39546833|FG000|Overall Study|Protocol Violation|115|||
16290717|NCT01334710|39546835|FG000|Overall Study|Trial was terminated|3|||
16290718|NCT00821873|39546836|FG000|Overall Study|Lost to Follow-up|4|||
16290719|NCT01902628|39546841|FG000|Overall Study|Withdrawal of participant's consent|7|||
16290720|NCT01902628|39546841|FG000|Overall Study|Adverse Event|41|||
16290721|NCT01902628|39546841|FG000|Overall Study|Lost to Follow-up|35|||
16380755|NCT00725985|39877692|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
16380756|NCT00725985|39877693|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
16380757|NCT00725985|39877694|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
16380758|NCT00725985|39877695|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
16380759|NCT00725985|39877696|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
16380760|NCT00725985|39877697|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
16380761|NCT00725985|39877698|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
16380762|NCT00725985|39877699|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
16482855|NCT00036270|40245508|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
16290722|NCT00809965|39546842|FG000|Overall Study|Death|194|||
16290723|NCT00809965|39546843|FG001|Overall Study|Death|147|||
16290724|NCT00809965|39546844|FG002|Overall Study|Death|196|||
16290725|NCT00809965|39546842|FG000|Overall Study|Lost to Follow-up|17|||
16290726|NCT00809965|39546843|FG001|Overall Study|Lost to Follow-up|10|||
16290727|NCT00809965|39546844|FG002|Overall Study|Lost to Follow-up|18|||
16290728|NCT00809965|39546842|FG000|Overall Study|Withdrawal by Subject|405|||
16380763|NCT00725985|39877700|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
16380764|NCT00725985|39877701|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
16380765|NCT00725985|39877702|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
16380766|NCT00725985|39877703|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
16380767|NCT00725985|39877692|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
16380768|NCT00725985|39877693|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
16380769|NCT00725985|39877694|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
16380770|NCT00725985|39877695|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
16380771|NCT00725985|39877696|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
16380772|NCT00725985|39877697|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
16380773|NCT00725985|39877698|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
16380774|NCT00725985|39877699|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
16380775|NCT00725985|39877700|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
16380776|NCT00725985|39877701|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
16380777|NCT00725985|39877702|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
16380778|NCT00725985|39877703|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
16380779|NCT00725985|39877692|FG000|ITP- Treatment Disposition|Other|50|||
16380780|NCT00725985|39877693|FG001|ITP- Treatment Disposition|Other|38|||
16380781|NCT00725985|39877694|FG002|ITP- Treatment Disposition|Other|24|||
16380782|NCT00725985|39877695|FG003|ITP- Treatment Disposition|Other|0|||
16380783|NCT00725985|39877696|FG004|ITP- Treatment Disposition|Other|0|||
16380784|NCT00725985|39877697|FG005|ITP- Treatment Disposition|Other|0|||
16380785|NCT00725985|39877698|FG006|ITP- Treatment Disposition|Other|0|||
16380786|NCT00725985|39877699|FG007|ITP- Treatment Disposition|Other|0|||
16380787|NCT00725985|39877700|FG008|ITP- Treatment Disposition|Other|0|||
16380788|NCT00725985|39877701|FG009|ITP- Treatment Disposition|Other|0|||
16380789|NCT00725985|39877702|FG010|ITP- Treatment Disposition|Other|0|||
16380790|NCT00725985|39877703|FG011|ITP- Treatment Disposition|Other|0|||
16380791|NCT00725985|39877692|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
16380792|NCT00725985|39877693|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
16380793|NCT00725985|39877694|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
16380794|NCT00725985|39877695|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
16380795|NCT00725985|39877696|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
16380796|NCT00725985|39877697|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
16380797|NCT00725985|39877698|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
16380798|NCT00725985|39877699|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
16380799|NCT00725985|39877700|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
16380800|NCT00725985|39877701|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
16380801|NCT00725985|39877702|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
16380802|NCT00725985|39877703|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
16380803|NCT00725985|39877692|FG000|OLMP (Up to 96 Weeks)|Death|0|||
16380804|NCT00725985|39877693|FG001|OLMP (Up to 96 Weeks)|Death|0|||
16380805|NCT00725985|39877694|FG002|OLMP (Up to 96 Weeks)|Death|0|||
16380806|NCT00725985|39877695|FG003|OLMP (Up to 96 Weeks)|Death|0|||
16380807|NCT00725985|39877696|FG004|OLMP (Up to 96 Weeks)|Death|1|||
16380808|NCT00725985|39877697|FG005|OLMP (Up to 96 Weeks)|Death|0|||
16380809|NCT00725985|39877698|FG006|OLMP (Up to 96 Weeks)|Death|0|||
16380810|NCT00725985|39877699|FG007|OLMP (Up to 96 Weeks)|Death|0|||
16380811|NCT00725985|39877700|FG008|OLMP (Up to 96 Weeks)|Death|0|||
16380812|NCT00725985|39877701|FG009|OLMP (Up to 96 Weeks)|Death|0|||
16380813|NCT00725985|39877702|FG010|OLMP (Up to 96 Weeks)|Death|0|||
16380814|NCT00725985|39877703|FG011|OLMP (Up to 96 Weeks)|Death|0|||
16380815|NCT00725985|39877692|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16380816|NCT00725985|39877693|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16380817|NCT00725985|39877694|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16380818|NCT00725985|39877695|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
16380819|NCT00725985|39877696|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16380820|NCT00725985|39877697|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16380821|NCT00725985|39877698|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16482856|NCT00036270|40245509|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
16482857|NCT00036270|40245508|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
16081180|NCT03781375|38789514|FG001|Open-label Phase|Protocol Issues|1|||
16081181|NCT03781375|38789513|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
16081182|NCT03781375|38789514|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
16081183|NCT03781375|38789513|FG000|Open-label Phase|Other|2|||
16081184|NCT03781375|38789514|FG001|Open-label Phase|Other|2|||
16081185|NCT01421667|38789515|FG000|Overall Study|Withdrawal by Subject|0|||
16081186|NCT01421667|38789516|FG001|Overall Study|Withdrawal by Subject|1|||
16380822|NCT00725985|39877699|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16380823|NCT00725985|39877700|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16380824|NCT00725985|39877701|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16380825|NCT00725985|39877702|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16482858|NCT00036270|40245509|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
16482859|NCT00036270|40245508|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
16380826|NCT00725985|39877703|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
16380827|NCT00725985|39877692|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380828|NCT00725985|39877693|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380829|NCT00725985|39877694|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380830|NCT00725985|39877695|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380831|NCT00725985|39877696|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380832|NCT00725985|39877697|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
16380833|NCT00725985|39877698|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380834|NCT00725985|39877699|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380835|NCT00725985|39877700|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380836|NCT00725985|39877701|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380837|NCT00725985|39877702|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380838|NCT00725985|39877703|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
16380839|NCT00725985|39877692|FG000|OLMP (Up to 96 Weeks)|Other|0|||
16380840|NCT00725985|39877693|FG001|OLMP (Up to 96 Weeks)|Other|0|||
16380841|NCT00725985|39877694|FG002|OLMP (Up to 96 Weeks)|Other|0|||
16380842|NCT00725985|39877695|FG003|OLMP (Up to 96 Weeks)|Other|15|||
16380843|NCT00725985|39877696|FG004|OLMP (Up to 96 Weeks)|Other|20|||
16380844|NCT00725985|39877697|FG005|OLMP (Up to 96 Weeks)|Other|44|||
16380845|NCT00725985|39877698|FG006|OLMP (Up to 96 Weeks)|Other|0|||
16290729|NCT00809965|39546843|FG001|Overall Study|Withdrawal by Subject|448|||
16290730|NCT00809965|39546844|FG002|Overall Study|Withdrawal by Subject|441|||
16290731|NCT00809965|39546842|FG000|Overall Study|Other Reason|167|||
16290732|NCT00809965|39546843|FG001|Overall Study|Other Reason|170|||
16290733|NCT00809965|39546844|FG002|Overall Study|Other Reason|189|||
16290734|NCT03340064|39546849|FG000|First Period|Adverse Event, non-fatal|2|||
16290735|NCT03340064|39546850|FG001|First Period|Adverse Event, non-fatal|0|||
16290736|NCT03340064|39546849|FG000|First Period|Lack of Efficacy|3|||
16290737|NCT03340064|39546850|FG001|First Period|Lack of Efficacy|0|||
16290738|NCT03340064|39546849|FG000|Second Period|Adverse Event, non-fatal|1|||
16290739|NCT03340064|39546850|FG001|Second Period|Adverse Event, non-fatal|1|||
16290740|NCT03340064|39546849|FG000|Second Period|Lack of Efficacy|11|||
16290741|NCT03340064|39546850|FG001|Second Period|Lack of Efficacy|0|||
16290742|NCT03340064|39546849|FG000|Second Period|Physician Decision|3|||
16290743|NCT03340064|39546850|FG001|Second Period|Physician Decision|0|||
16290744|NCT03340064|39546849|FG000|Second Period|Withdrawal by Subject|2|||
16290745|NCT03340064|39546850|FG001|Second Period|Withdrawal by Subject|1|||
16290746|NCT03340064|39546849|FG000|Second Period|Approved Drug Available For Indication|1|||
16290747|NCT03340064|39546850|FG001|Second Period|Approved Drug Available For Indication|0|||
16290748|NCT03340064|39546849|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
16290749|NCT03340064|39546850|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
16290750|NCT00754013|39546851|FG000|Overall Study|Lost to Follow-up|1|||
16290751|NCT00754013|39546852|FG001|Overall Study|Lost to Follow-up|1|||
16290752|NCT00754013|39546851|FG000|Overall Study|didn't return after study termed|3|||
16290753|NCT00754013|39546852|FG001|Overall Study|didn't return after study termed|4|||
16290754|NCT03649412|39546856|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
16290755|NCT03649412|39546857|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
16290756|NCT03649412|39546856|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
16290757|NCT03649412|39546857|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
16290758|NCT03649412|39546856|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
16290759|NCT03649412|39546857|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16290760|NCT03649412|39546856|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
16290761|NCT03649412|39546857|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
16290762|NCT03649412|39546856|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
16290763|NCT03649412|39546857|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
16290764|NCT03649412|39546856|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
16290765|NCT03649412|39546857|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
16290766|NCT03346070|39546862|FG000|Overall Study|Death|0|||
16290767|NCT03346070|39546863|FG001|Overall Study|Death|0|||
16290768|NCT03346070|39546864|FG002|Overall Study|Death|0|||
16290769|NCT03346070|39546865|FG003|Overall Study|Death|0|||
16290770|NCT03346070|39546866|FG004|Overall Study|Death|1|||
16290771|NCT03346070|39546862|FG000|Overall Study|Lost to Follow-up|0|||
16290772|NCT03346070|39546863|FG001|Overall Study|Lost to Follow-up|1|||
16290773|NCT03346070|39546864|FG002|Overall Study|Lost to Follow-up|2|||
16290774|NCT03346070|39546865|FG003|Overall Study|Lost to Follow-up|0|||
16290775|NCT03346070|39546866|FG004|Overall Study|Lost to Follow-up|0|||
16290776|NCT03346070|39546862|FG000|Overall Study|Physician Decision|0|||
16290777|NCT03346070|39546863|FG001|Overall Study|Physician Decision|0|||
16380846|NCT00725985|39877699|FG007|OLMP (Up to 96 Weeks)|Other|0|||
16380847|NCT00725985|39877700|FG008|OLMP (Up to 96 Weeks)|Other|0|||
16380848|NCT00725985|39877701|FG009|OLMP (Up to 96 Weeks)|Other|0|||
16290778|NCT03346070|39546864|FG002|Overall Study|Physician Decision|0|||
16290779|NCT03346070|39546865|FG003|Overall Study|Physician Decision|1|||
16290780|NCT03346070|39546866|FG004|Overall Study|Physician Decision|1|||
16290781|NCT03346070|39546862|FG000|Overall Study|Withdrawal by Subject|1|||
16380849|NCT00725985|39877702|FG010|OLMP (Up to 96 Weeks)|Other|0|||
16482860|NCT00036270|40245509|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
16482861|NCT00705289|40245516|FG000|Overall Study|Subject or treating physician's choice|131|||
16482862|NCT00705484|40245523|FG000|Overall Study|Adverse Event|28|||
16482863|NCT00705484|40245524|FG001|Overall Study|Adverse Event|27|||
16482864|NCT00705484|40245523|FG000|Overall Study|Lost to Follow-up|169|||
16482865|NCT00705484|40245524|FG001|Overall Study|Lost to Follow-up|250|||
16482866|NCT00705484|40245523|FG000|Overall Study|Withdrawal by Subject|96|||
16482867|NCT00705484|40245524|FG001|Overall Study|Withdrawal by Subject|72|||
16482868|NCT00705484|40245523|FG000|Overall Study|Administrative|89|||
16482869|NCT00705484|40245524|FG001|Overall Study|Administrative|59|||
16482870|NCT00814164|40245526|FG000|Overall Study|Progression|7|||
16482871|NCT00814164|40245526|FG000|Overall Study|not stated|7|||
16482872|NCT00814164|40245526|FG000|Overall Study|Death|5|||
16482873|NCT01253408|40245527|FG000|Overall Study|Adverse Event|0|||
16482874|NCT01253408|40245528|FG001|Overall Study|Adverse Event|1|||
16482875|NCT01253408|40245529|FG002|Overall Study|Adverse Event|0|||
16482876|NCT02296320|40245530|FG000|Overall Study|Withdrawal by Subject|4|||
16482877|NCT02296320|40245531|FG001|Overall Study|Withdrawal by Subject|0|||
16482878|NCT02296320|40245532|FG002|Overall Study|Withdrawal by Subject|2|||
16482879|NCT02296320|40245530|FG000|Overall Study|Death|24|||
16482880|NCT02296320|40245531|FG001|Overall Study|Death|3|||
16482881|NCT02296320|40245532|FG002|Overall Study|Death|27|||
16482882|NCT02296320|40245530|FG000|Overall Study|Lost to Follow-up|5|||
16482883|NCT02296320|40245531|FG001|Overall Study|Lost to Follow-up|2|||
16482884|NCT02296320|40245532|FG002|Overall Study|Lost to Follow-up|7|||
16482885|NCT02296320|40245530|FG000|Overall Study|Not treated|2|||
16482886|NCT02296320|40245531|FG001|Overall Study|Not treated|0|||
16482887|NCT02296320|40245532|FG002|Overall Study|Not treated|0|||
16482888|NCT02296320|40245530|FG000|Overall Study|Not - specified|0|||
16482889|NCT02296320|40245531|FG001|Overall Study|Not - specified|0|||
16482890|NCT02296320|40245532|FG002|Overall Study|Not - specified|1|||
16482891|NCT03741062|40245533|FG000|Overall Study|Protocol Violation|1|||
16482892|NCT03741062|40245534|FG001|Overall Study|Protocol Violation|0|||
16482893|NCT01217801|40245535|FG000|Period 1|Protocol Violation|1|||
16482894|NCT01217801|40245536|FG001|Period 1|Protocol Violation|1|||
16482895|NCT01217801|40245535|FG000|Period 1|Withdrawal by Subject|0|||
16482896|NCT01217801|40245536|FG001|Period 1|Withdrawal by Subject|1|||
16290782|NCT03346070|39546863|FG001|Overall Study|Withdrawal by Subject|0|||
16290783|NCT03346070|39546864|FG002|Overall Study|Withdrawal by Subject|0|||
16290784|NCT03346070|39546865|FG003|Overall Study|Withdrawal by Subject|1|||
16290785|NCT03346070|39546866|FG004|Overall Study|Withdrawal by Subject|0|||
16290786|NCT03346070|39546862|FG000|Overall Study|Study medication not received as planned|2|||
16290787|NCT03346070|39546863|FG001|Overall Study|Study medication not received as planned|3|||
16290788|NCT03346070|39546864|FG002|Overall Study|Study medication not received as planned|2|||
16290789|NCT03346070|39546865|FG003|Overall Study|Study medication not received as planned|3|||
16290790|NCT03346070|39546866|FG004|Overall Study|Study medication not received as planned|2|||
16290791|NCT03346070|39546862|FG000|Overall Study|Screen Failure|0|||
16290792|NCT03346070|39546863|FG001|Overall Study|Screen Failure|0|||
16290793|NCT03346070|39546864|FG002|Overall Study|Screen Failure|0|||
16290794|NCT03346070|39546865|FG003|Overall Study|Screen Failure|1|||
16290795|NCT03346070|39546866|FG004|Overall Study|Screen Failure|1|||
16290796|NCT03438396|39546869|FG000|Overall Study|Reason Not Specified|9|||
16290797|NCT03438396|39546869|FG000|Overall Study|Withdrawal by Subject|5|||
16290798|NCT03438396|39546869|FG000|Overall Study|Lost to Follow-up|2|||
16290799|NCT03438396|39546869|FG000|Overall Study|Death|85|||
16290800|NCT03438396|39546869|FG000|Overall Study|Not treated|1|||
16290801|NCT04132336|39546870|FG000|Overall Study|Investigator Decision|0|||
16290802|NCT04132336|39546871|FG001|Overall Study|Investigator Decision|1|||
16482897|NCT01768286|40245539|FG000|Overall Study|Randomized But Not Treated|0|||
16290803|NCT04132336|39546872|FG002|Overall Study|Investigator Decision|0|||
16290804|NCT04132336|39546873|FG003|Overall Study|Investigator Decision|0|||
16482898|NCT01768286|40245540|FG001|Overall Study|Randomized But Not Treated|0|||
16290805|NCT04132336|39546874|FG004|Overall Study|Investigator Decision|0|||
16290806|NCT04132336|39546875|FG005|Overall Study|Investigator Decision|0|||
16482899|NCT01768286|40245541|FG002|Overall Study|Randomized But Not Treated|1|||
16482900|NCT01768286|40245542|FG003|Overall Study|Randomized But Not Treated|0|||
16482901|NCT01768286|40245539|FG000|Overall Study|Lack of Efficacy|7|||
16482902|NCT01768286|40245540|FG001|Overall Study|Lack of Efficacy|4|||
16482903|NCT01768286|40245541|FG002|Overall Study|Lack of Efficacy|0|||
16482904|NCT01768286|40245542|FG003|Overall Study|Lack of Efficacy|1|||
16482905|NCT01768286|40245539|FG000|Overall Study|Withdrew Consent|0|||
16482906|NCT01768286|40245540|FG001|Overall Study|Withdrew Consent|0|||
16482907|NCT01768286|40245541|FG002|Overall Study|Withdrew Consent|1|||
16482908|NCT01768286|40245542|FG003|Overall Study|Withdrew Consent|0|||
16482909|NCT01020981|40245543|FG000|Overall Study|Did not return mailed survey|74|||
16482910|NCT01020981|40245544|FG001|Overall Study|Did not return mailed survey|58|||
16482911|NCT01020981|40245543|FG000|Overall Study|Survey returned undeliverable|8|||
16482912|NCT01020981|40245544|FG001|Overall Study|Survey returned undeliverable|32|||
16482913|NCT01020981|40245543|FG000|Overall Study|Participant declined to complete survey|2|||
16482914|NCT01020981|40245544|FG001|Overall Study|Participant declined to complete survey|0|||
16482915|NCT03344796|40245549|FG000|Overall Study|Lost to Follow-up|0|||
16482916|NCT03344796|40245550|FG001|Overall Study|Lost to Follow-up|0|||
16482917|NCT03344796|40245551|FG002|Overall Study|Lost to Follow-up|0|||
16482918|NCT03344796|40245552|FG003|Overall Study|Lost to Follow-up|0|||
16482919|NCT03344796|40245553|FG004|Overall Study|Lost to Follow-up|0|||
16482920|NCT03344796|40245554|FG005|Overall Study|Lost to Follow-up|2|||
16482921|NCT00003487|40245555|FG000|Overall Study|Not evaluable|2|||
16482922|NCT01930123|40245560|FG000|Overall Study|Adverse Event|1|||
16290807|NCT04132336|39546876|FG006|Overall Study|Investigator Decision|0|||
16290808|NCT03835221|39546877|FG000|Methafilcon A|Withdrawal by Subject|1|||
16290809|NCT01875471|39546878|FG000|Overall Study|Adverse Event|0|||
16482923|NCT01930123|40245561|FG001|Overall Study|Adverse Event|0|||
16482924|NCT01930123|40245560|FG000|Overall Study|Physician Decision|21|||
16482925|NCT01930123|40245561|FG001|Overall Study|Physician Decision|8|||
16482926|NCT01930123|40245560|FG000|Overall Study|Withdrawal by Subject|1|||
16482927|NCT01930123|40245561|FG001|Overall Study|Withdrawal by Subject|0|||
16482928|NCT00428792|40245563|FG000|Overall Study|Lack of Efficacy|1|||
16482929|NCT00428792|40245564|FG001|Overall Study|Lack of Efficacy|3|||
16482930|NCT00428792|40245563|FG000|Overall Study|Lost to Follow-up|0|||
16482931|NCT00428792|40245564|FG001|Overall Study|Lost to Follow-up|1|||
16186253|NCT04973228|39159417|FG001|Overall Study|Lost to Follow-up|4|||
16290810|NCT01875471|39546879|FG001|Overall Study|Adverse Event|1|||
16482932|NCT03735121|40245565|FG000|Overall Study|Death|3|||
16482933|NCT03735121|40245566|FG001|Overall Study|Death|6|||
16482934|NCT03735121|40245567|FG002|Overall Study|Death|8|||
16482935|NCT03735121|40245568|FG003|Overall Study|Death|37|||
16482936|NCT03735121|40245569|FG004|Overall Study|Death|86|||
16482937|NCT03735121|40245565|FG000|Overall Study|Withdrawal by Subject|1|||
16482938|NCT03735121|40245566|FG001|Overall Study|Withdrawal by Subject|1|||
16482939|NCT03735121|40245567|FG002|Overall Study|Withdrawal by Subject|3|||
16482940|NCT03735121|40245568|FG003|Overall Study|Withdrawal by Subject|4|||
16482941|NCT03735121|40245569|FG004|Overall Study|Withdrawal by Subject|2|||
16482942|NCT03735121|40245565|FG000|Overall Study|Progressive Disease|0|||
16482943|NCT03735121|40245566|FG001|Overall Study|Progressive Disease|0|||
16482944|NCT03735121|40245567|FG002|Overall Study|Progressive Disease|1|||
16482945|NCT03735121|40245568|FG003|Overall Study|Progressive Disease|0|||
16482946|NCT03735121|40245569|FG004|Overall Study|Progressive Disease|0|||
16482947|NCT03735121|40245565|FG000|Overall Study|Lost to Follow-up|0|||
16482948|NCT03735121|40245566|FG001|Overall Study|Lost to Follow-up|0|||
16482949|NCT03735121|40245567|FG002|Overall Study|Lost to Follow-up|0|||
16482950|NCT03735121|40245568|FG003|Overall Study|Lost to Follow-up|0|||
16482951|NCT03735121|40245569|FG004|Overall Study|Lost to Follow-up|1|||
16482952|NCT03735121|40245565|FG000|Overall Study|Ongoing|3|||
16482953|NCT03735121|40245566|FG001|Overall Study|Ongoing|3|||
16482954|NCT03735121|40245567|FG002|Overall Study|Ongoing|26|||
16482955|NCT03735121|40245568|FG003|Overall Study|Ongoing|83|||
16482956|NCT03735121|40245569|FG004|Overall Study|Ongoing|158|||
16482957|NCT01696695|40245577|FG000|Overall Study|Disease progression|373|||
16482958|NCT01696695|40245577|FG000|Overall Study|Death|29|||
16482959|NCT01696695|40245577|FG000|Overall Study|Adverse Event|74|||
16482960|NCT01696695|40245577|FG000|Overall Study|Withdrawal by Subject|92|||
16482961|NCT01696695|40245577|FG000|Overall Study|Lost to Follow-up|48|||
16482962|NCT01696695|40245577|FG000|Overall Study|Other|74|||
16482963|NCT01696695|40245577|FG000|Overall Study|Major Protocol Violation|192|||
16482964|NCT00945893|40245578|FG000|Overall Study|Lost to Follow-up|2|||
16482965|NCT00945893|40245579|FG001|Overall Study|Lost to Follow-up|8|||
16482966|NCT00945893|40245578|FG000|Overall Study|Withdrawal of consent|1|||
16482967|NCT00945893|40245579|FG001|Overall Study|Withdrawal of consent|2|||
16482968|NCT00259610|40245582|FG000|Overall Study|Withdrawal by Subject|33|||
16482969|NCT00259610|40245583|FG001|Overall Study|Withdrawal by Subject|25|||
16482970|NCT00259610|40245584|FG002|Overall Study|Withdrawal by Subject|29|||
16482971|NCT00259610|40245585|FG003|Overall Study|Withdrawal by Subject|19|||
16482972|NCT00259610|40245582|FG000|Overall Study|Lost to Follow-up|19|||
16482973|NCT00259610|40245583|FG001|Overall Study|Lost to Follow-up|8|||
16482974|NCT00259610|40245584|FG002|Overall Study|Lost to Follow-up|18|||
16482975|NCT00259610|40245585|FG003|Overall Study|Lost to Follow-up|15|||
16482976|NCT00259610|40245582|FG000|Overall Study|Physician Decision|6|||
16482977|NCT00259610|40245583|FG001|Overall Study|Physician Decision|4|||
16482978|NCT00259610|40245584|FG002|Overall Study|Physician Decision|7|||
16482979|NCT00259610|40245585|FG003|Overall Study|Physician Decision|2|||
16482980|NCT00259610|40245582|FG000|Overall Study|Death|1|||
16081187|NCT01421667|38789517|FG002|Overall Study|Withdrawal by Subject|2|||
16081188|NCT01421667|38789518|FG003|Overall Study|Withdrawal by Subject|1|||
16081189|NCT01421667|38789515|FG000|Overall Study|Lost to Follow-up|0|||
16081190|NCT01421667|38789516|FG001|Overall Study|Lost to Follow-up|1|||
16081191|NCT01421667|38789517|FG002|Overall Study|Lost to Follow-up|0|||
16081192|NCT01421667|38789518|FG003|Overall Study|Lost to Follow-up|0|||
16081193|NCT00807937|38789519|FG000|Overall Study|Adverse Event|12|||
16482981|NCT00259610|40245583|FG001|Overall Study|Death|1|||
16482982|NCT00259610|40245584|FG002|Overall Study|Death|2|||
16482983|NCT00259610|40245585|FG003|Overall Study|Death|0|||
16482984|NCT00259610|40245582|FG000|Overall Study|non medical reason|6|||
16482985|NCT00259610|40245583|FG001|Overall Study|non medical reason|2|||
16482986|NCT00259610|40245584|FG002|Overall Study|non medical reason|10|||
16482987|NCT00259610|40245585|FG003|Overall Study|non medical reason|3|||
16482988|NCT00259610|40245582|FG000|Overall Study|Adverse Event|3|||
16482989|NCT00259610|40245583|FG001|Overall Study|Adverse Event|4|||
16482990|NCT00259610|40245584|FG002|Overall Study|Adverse Event|5|||
16482991|NCT00259610|40245585|FG003|Overall Study|Adverse Event|2|||
16482992|NCT00259610|40245582|FG000|Overall Study|Serious Adverse Event|8|||
16482993|NCT00259610|40245583|FG001|Overall Study|Serious Adverse Event|2|||
16482994|NCT00259610|40245584|FG002|Overall Study|Serious Adverse Event|2|||
16482995|NCT00259610|40245585|FG003|Overall Study|Serious Adverse Event|2|||
16482996|NCT02004522|40245586|FG000|Overall Study|Adverse Event|55|||
16482997|NCT02004522|40245587|FG001|Overall Study|Adverse Event|6|||
16482998|NCT02004522|40245586|FG000|Overall Study|Withdrawal by Subject|13|||
16482999|NCT02004522|40245587|FG001|Overall Study|Withdrawal by Subject|7|||
16483000|NCT02004522|40245586|FG000|Overall Study|Death|12|||
16483001|NCT02004522|40245587|FG001|Overall Study|Death|3|||
16483002|NCT02004522|40245586|FG000|Overall Study|Physician Decision|3|||
16483003|NCT02004522|40245587|FG001|Overall Study|Physician Decision|4|||
16483004|NCT02004522|40245586|FG000|Overall Study|Protocol Violation|1|||
16483005|NCT02004522|40245587|FG001|Overall Study|Protocol Violation|0|||
16483006|NCT02004522|40245586|FG000|Overall Study|Other is reason listed by PI|4|||
16483007|NCT02004522|40245587|FG001|Overall Study|Other is reason listed by PI|1|||
16483008|NCT02004522|40245586|FG000|Overall Study|Never Dosed|2|||
16483009|NCT02004522|40245587|FG001|Overall Study|Never Dosed|4|||
16483010|NCT02004522|40245586|FG000|Overall Study|Disease Progression|35|||
16483011|NCT02004522|40245587|FG001|Overall Study|Disease Progression|31|||
16483012|NCT02004522|40245586|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
16483013|NCT02004522|40245587|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
16483014|NCT00850343|40245588|FG000|Overall Study|Withdrawal by Subject|11|||
16483015|NCT00850343|40245589|FG001|Overall Study|Withdrawal by Subject|0|||
16483016|NCT00850343|40245590|FG002|Overall Study|Withdrawal by Subject|3|||
16483017|NCT00850343|40245591|FG003|Overall Study|Withdrawal by Subject|2|||
16483018|NCT00850343|40245588|FG000|Overall Study|Adverse Event|15|||
16483019|NCT00850343|40245589|FG001|Overall Study|Adverse Event|2|||
16483020|NCT00850343|40245590|FG002|Overall Study|Adverse Event|6|||
16483021|NCT00850343|40245591|FG003|Overall Study|Adverse Event|6|||
16483022|NCT00850343|40245588|FG000|Overall Study|Pregnancy|0|||
16483023|NCT00850343|40245589|FG001|Overall Study|Pregnancy|0|||
16483024|NCT00850343|40245590|FG002|Overall Study|Pregnancy|0|||
16483025|NCT00850343|40245591|FG003|Overall Study|Pregnancy|1|||
16483026|NCT00850343|40245588|FG000|Overall Study|Lack of Efficacy|17|||
16483027|NCT00850343|40245589|FG001|Overall Study|Lack of Efficacy|0|||
16483028|NCT00850343|40245590|FG002|Overall Study|Lack of Efficacy|3|||
16483029|NCT00850343|40245591|FG003|Overall Study|Lack of Efficacy|2|||
16483030|NCT00850343|40245588|FG000|Overall Study|Non-compliance with Study Procedures|1|||
16483031|NCT00850343|40245589|FG001|Overall Study|Non-compliance with Study Procedures|0|||
16483032|NCT00850343|40245590|FG002|Overall Study|Non-compliance with Study Procedures|1|||
16081194|NCT00807937|38789520|FG001|Overall Study|Adverse Event|12|||
16081195|NCT00807937|38789521|FG002|Overall Study|Adverse Event|5|||
16483033|NCT00850343|40245591|FG003|Overall Study|Non-compliance with Study Procedures|1|||
16483034|NCT00850343|40245588|FG000|Overall Study|Physician Decision|2|||
16483035|NCT00850343|40245589|FG001|Overall Study|Physician Decision|1|||
16483036|NCT00850343|40245590|FG002|Overall Study|Physician Decision|1|||
16483037|NCT00850343|40245591|FG003|Overall Study|Physician Decision|1|||
16483038|NCT05248867|40245592|FG000|Double-blind Period|Lost to Follow-up|0|||
16483039|NCT05248867|40245593|FG001|Double-blind Period|Lost to Follow-up|3|||
16483040|NCT05248867|40245594|FG002|Double-blind Period|Lost to Follow-up|0|||
16081196|NCT00807937|38789522|FG003|Overall Study|Adverse Event|4|||
16380850|NCT00725985|39877703|FG011|OLMP (Up to 96 Weeks)|Other|0|||
16483041|NCT05248867|40245595|FG003|Double-blind Period|Lost to Follow-up|0|||
16483042|NCT05248867|40245596|FG004|Double-blind Period|Lost to Follow-up|0|||
16483043|NCT05248867|40245597|FG005|Double-blind Period|Lost to Follow-up|0|||
16483044|NCT05248867|40245592|FG000|Double-blind Period|Withdrawal by Subject|5|||
16483045|NCT05248867|40245593|FG001|Double-blind Period|Withdrawal by Subject|14|||
16483046|NCT05248867|40245594|FG002|Double-blind Period|Withdrawal by Subject|0|||
16483047|NCT05248867|40245595|FG003|Double-blind Period|Withdrawal by Subject|0|||
16483048|NCT05248867|40245596|FG004|Double-blind Period|Withdrawal by Subject|0|||
16483049|NCT05248867|40245597|FG005|Double-blind Period|Withdrawal by Subject|0|||
16483050|NCT05248867|40245592|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
16483051|NCT05248867|40245593|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
16483052|NCT05248867|40245594|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
16483053|NCT05248867|40245595|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
16483054|NCT05248867|40245596|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
16483055|NCT05248867|40245597|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
16483056|NCT05248867|40245592|FG000|Double-blind Period|Other, not specified|3|||
16483057|NCT05248867|40245593|FG001|Double-blind Period|Other, not specified|8|||
16483058|NCT05248867|40245594|FG002|Double-blind Period|Other, not specified|0|||
16483059|NCT05248867|40245595|FG003|Double-blind Period|Other, not specified|0|||
16483060|NCT05248867|40245596|FG004|Double-blind Period|Other, not specified|0|||
16483061|NCT05248867|40245597|FG005|Double-blind Period|Other, not specified|0|||
16483062|NCT05248867|40245592|FG000|Open-label Period|Withdrawal by Subject|0|||
16483063|NCT05248867|40245593|FG001|Open-label Period|Withdrawal by Subject|0|||
16483064|NCT05248867|40245594|FG002|Open-label Period|Withdrawal by Subject|3|||
16483065|NCT05248867|40245595|FG003|Open-label Period|Withdrawal by Subject|1|||
16483066|NCT05248867|40245596|FG004|Open-label Period|Withdrawal by Subject|7|||
16483067|NCT05248867|40245597|FG005|Open-label Period|Withdrawal by Subject|9|||
16483068|NCT05248867|40245592|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
16483069|NCT05248867|40245593|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
16483070|NCT05248867|40245594|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
16483071|NCT05248867|40245595|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
16483072|NCT05248867|40245596|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
16081197|NCT00807937|38789519|FG000|Overall Study|Protocol Violation|4|||
16380851|NCT00725985|39877692|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16483073|NCT05248867|40245597|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
16483074|NCT05248867|40245592|FG000|Open-label Period|Lost to Follow-up|0|||
16483075|NCT05248867|40245593|FG001|Open-label Period|Lost to Follow-up|0|||
16483076|NCT05248867|40245594|FG002|Open-label Period|Lost to Follow-up|0|||
16483077|NCT05248867|40245595|FG003|Open-label Period|Lost to Follow-up|0|||
16483078|NCT05248867|40245596|FG004|Open-label Period|Lost to Follow-up|5|||
16483079|NCT05248867|40245597|FG005|Open-label Period|Lost to Follow-up|2|||
16483080|NCT05248867|40245592|FG000|Open-label Period|COVID-19 Infection|0|||
16483081|NCT05248867|40245593|FG001|Open-label Period|COVID-19 Infection|0|||
16483082|NCT05248867|40245594|FG002|Open-label Period|COVID-19 Infection|0|||
16483083|NCT05248867|40245595|FG003|Open-label Period|COVID-19 Infection|0|||
16483084|NCT05248867|40245596|FG004|Open-label Period|COVID-19 Infection|1|||
16483085|NCT05248867|40245597|FG005|Open-label Period|COVID-19 Infection|0|||
16483086|NCT05248867|40245592|FG000|Open-label Period|Other, not specified|0|||
16483087|NCT05248867|40245593|FG001|Open-label Period|Other, not specified|0|||
16483088|NCT05248867|40245594|FG002|Open-label Period|Other, not specified|0|||
16483089|NCT05248867|40245595|FG003|Open-label Period|Other, not specified|0|||
16483090|NCT05248867|40245596|FG004|Open-label Period|Other, not specified|4|||
16483091|NCT05248867|40245597|FG005|Open-label Period|Other, not specified|0|||
16483092|NCT00446251|40245598|FG000|Overall Study|On-study Transplants|2|||
16483093|NCT00446251|40245598|FG000|Overall Study|Rituximab Infusion Reaction|2|||
16483094|NCT00446251|40245598|FG000|Overall Study|Lost to Follow-up|1|||
16483095|NCT02693119|40245600|FG000|Open-Label Period|Withdrawal by Subject|0|||
16483096|NCT02693119|40245601|FG001|Open-Label Period|Withdrawal by Subject|1|||
16483097|NCT01622231|40245602|FG000|Overall Study|Physician Decision|1|||
16483098|NCT01622231|40245602|FG000|Overall Study|Withdrawal by Subject|1|||
16483099|NCT02349061|40245607|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
16483100|NCT02349061|40245608|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
16483101|NCT02349061|40245609|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
16483102|NCT02349061|40245607|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
16483103|NCT02349061|40245608|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
16483104|NCT02349061|40245609|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
16483105|NCT02349061|40245607|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
16483106|NCT02349061|40245608|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
16483107|NCT02349061|40245609|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
16483108|NCT02349061|40245607|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
16483109|NCT02349061|40245608|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
16483110|NCT02349061|40245609|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
16483111|NCT02349061|40245607|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
16483112|NCT02349061|40245608|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
16483113|NCT02349061|40245609|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
16483114|NCT02349061|40245607|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
16483115|NCT02349061|40245608|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
16483116|NCT02349061|40245609|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
16483117|NCT02349061|40245607|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
16483118|NCT02349061|40245608|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
16483119|NCT02349061|40245609|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
16483120|NCT02349061|40245607|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
16483121|NCT02349061|40245608|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
16483122|NCT02349061|40245609|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
16483123|NCT02349061|40245607|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
16483124|NCT02349061|40245608|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
16483125|NCT02349061|40245609|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
16483126|NCT02349061|40245607|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
16483127|NCT02349061|40245608|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
16483128|NCT02349061|40245609|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
16290811|NCT01875471|39546878|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
16483129|NCT02349061|40245607|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
16483130|NCT02349061|40245608|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
16483131|NCT02349061|40245609|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
16483132|NCT02349061|40245607|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
16483133|NCT02349061|40245608|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
16483134|NCT02349061|40245609|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
16483135|NCT02349061|40245607|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
16483136|NCT02349061|40245608|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
16483137|NCT02349061|40245609|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
16483138|NCT03408483|40245611|FG000|Overall Study|Physician Decision|3|||
16483139|NCT03408483|40245612|FG001|Overall Study|Physician Decision|3|||
16483140|NCT03408483|40245611|FG000|Overall Study|Lost to Follow-up|3|||
16483141|NCT03408483|40245612|FG001|Overall Study|Lost to Follow-up|0|||
16483142|NCT03095612|40245613|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
16483143|NCT03095612|40245614|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
16483144|NCT03095612|40245615|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
16483145|NCT03095612|40245616|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
16483146|NCT03095612|40245617|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
16483147|NCT03095612|40245618|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
16483148|NCT03095612|40245619|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
16186254|NCT04973228|39159416|FG000|Overall Study|Withdrawal by Subject|11|||
16186255|NCT04973228|39159417|FG001|Overall Study|Withdrawal by Subject|4|||
16186256|NCT04973228|39159416|FG000|Overall Study|Did not tolerate application|1|||
16186257|NCT04973228|39159417|FG001|Overall Study|Did not tolerate application|0|||
16186258|NCT04973228|39159416|FG000|Overall Study|Wanted to early terminate and use own product|0|||
16186259|NCT04973228|39159417|FG001|Overall Study|Wanted to early terminate and use own product|1|||
16186260|NCT04973228|39159416|FG000|Overall Study|Missed visits due to new work schedule|1|||
16186261|NCT04973228|39159417|FG001|Overall Study|Missed visits due to new work schedule|0|||
16186262|NCT03700892|39159418|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
16186263|NCT03700892|39159419|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
16186264|NCT03700892|39159420|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
16186265|NCT00455858|39161796|FG000|Overall Study|Lost to Follow-up|2|||
16186266|NCT00455858|39161796|FG000|Overall Study|Protocol Violation|1|||
16186267|NCT00455858|39161796|FG000|Overall Study|Lack of Efficacy|1|||
16186268|NCT00455858|39161796|FG000|Overall Study|Well controlled FPG without insulin|1|||
16186269|NCT00455858|39161796|FG000|Overall Study|Withdrawal|1|||
16186270|NCT00950690|39161797|FG000|Overall Study|Death|4|||
16186271|NCT00950690|39161797|FG000|Overall Study|Adverse Event|15|||
16186272|NCT00950690|39161797|FG000|Overall Study|Lack of Efficacy|22|||
16186273|NCT00950690|39161797|FG000|Overall Study|Lost to Follow-up|40|||
16186274|NCT00950690|39161797|FG000|Overall Study|Other|163|||
16186275|NCT04229446|39161800|FG000|Overall Study|Death|12|||
16483149|NCT04092582|40245620|FG000|Overall Study|Death|1|||
16483150|NCT04092582|40245621|FG001|Overall Study|Death|1|||
16186276|NCT04229446|39161801|FG001|Overall Study|Death|10|||
16186277|NCT04229446|39161800|FG000|Overall Study|Lost to Follow-up|5|||
16186278|NCT04229446|39161801|FG001|Overall Study|Lost to Follow-up|8|||
16186279|NCT01323673|39161802|FG000|Overall Study|Adverse Event|0|||
16186280|NCT01323673|39161803|FG001|Overall Study|Adverse Event|1|||
16186281|NCT01323673|39161802|FG000|Overall Study|Lost to Follow-up|0|||
16186282|NCT01323673|39161803|FG001|Overall Study|Lost to Follow-up|1|||
16186283|NCT01323673|39161802|FG000|Overall Study|Protocol Violation|1|||
16186284|NCT01323673|39161803|FG001|Overall Study|Protocol Violation|0|||
16186285|NCT01323673|39161802|FG000|Overall Study|Withdrawal by Subject|2|||
16186286|NCT01323673|39161803|FG001|Overall Study|Withdrawal by Subject|3|||
16186287|NCT01814800|39161804|FG000|Overall Study|Adverse Event|2|||
16290812|NCT01875471|39546879|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
16290813|NCT02547766|39546881|FG000|Overall Study|Withdrawal by Subject|1|||
16290814|NCT00375492|39546884|FG000|Overall Study|Adverse Event|4|||
16290815|NCT00375492|39546885|FG001|Overall Study|Adverse Event|5|||
16290816|NCT00375492|39546884|FG000|Overall Study|Entry Criteria Not Met|0|||
16290817|NCT00375492|39546885|FG001|Overall Study|Entry Criteria Not Met|1|||
16290818|NCT00375492|39546884|FG000|Overall Study|Loss of Glucose Control|0|||
16290819|NCT00375492|39546885|FG001|Overall Study|Loss of Glucose Control|1|||
16290820|NCT00375492|39546884|FG000|Overall Study|Lost to Follow-up|10|||
16483151|NCT04092582|40245620|FG000|Overall Study|Withdrawal by Subject|4|||
16483152|NCT04092582|40245621|FG001|Overall Study|Withdrawal by Subject|1|||
16483153|NCT04092582|40245620|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
16186288|NCT01814800|39161804|FG000|Overall Study|Pregnancy|1|||
16186289|NCT01814800|39161804|FG000|Overall Study|Sponsor decision|1|||
16186290|NCT01814800|39161804|FG000|Overall Study|Subject relocation|1|||
16186291|NCT03011840|39161805|FG000|Overall Study|Not received PIL in post PIL phase|0|||
16186292|NCT03011840|39161806|FG001|Overall Study|Not received PIL in post PIL phase|21|||
16186293|NCT02086565|39161807|FG000|Overall Study|Lost to Follow-up|9|||
16186294|NCT02086565|39161808|FG001|Overall Study|Lost to Follow-up|7|||
16186295|NCT02086565|39161807|FG000|Overall Study|Withdrawal by Subject|2|||
16186296|NCT02086565|39161808|FG001|Overall Study|Withdrawal by Subject|1|||
16483154|NCT04092582|40245621|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
16483155|NCT03689530|40245622|FG000|Overall Study|Withdrawal by Subject|53|||
16483156|NCT03689530|40245623|FG001|Overall Study|Withdrawal by Subject|16|||
16483157|NCT02015754|40245624|FG000|Overall Study|Disease progression|5|||
16483158|NCT02015754|40245624|FG000|Overall Study|Change in treatment modality|5|||
16483159|NCT02015754|40245624|FG000|Overall Study|Lost to Follow-up|1|||
16483160|NCT00675948|40245626|FG000|Overall Study|Adverse Event|23|||
16483161|NCT00675948|40245627|FG001|Overall Study|Adverse Event|1|||
16483162|NCT00675948|40245626|FG000|Overall Study|Lack of Efficacy|3|||
16483163|NCT00675948|40245627|FG001|Overall Study|Lack of Efficacy|0|||
16186297|NCT02086565|39161807|FG000|Overall Study|Death|3|||
16186298|NCT02086565|39161808|FG001|Overall Study|Death|2|||
16186299|NCT02086565|39161807|FG000|Overall Study|withdrawn by research team|2|||
16186300|NCT02086565|39161808|FG001|Overall Study|withdrawn by research team|2|||
16186301|NCT00430521|39161813|FG000|Overall Study|Adverse Event|0|||
16186302|NCT00430521|39161814|FG001|Overall Study|Adverse Event|0|||
16186303|NCT00430521|39161815|FG002|Overall Study|Adverse Event|0|||
16186304|NCT00430521|39161816|FG003|Overall Study|Adverse Event|0|||
16186305|NCT00430521|39161817|FG004|Overall Study|Adverse Event|0|||
16186306|NCT00430521|39161818|FG005|Overall Study|Adverse Event|2|||
16186307|NCT00430521|39161819|FG006|Overall Study|Adverse Event|1|||
16186308|NCT00430521|39161820|FG007|Overall Study|Adverse Event|0|||
16186309|NCT00430521|39161813|FG000|Overall Study|Lost to Follow-up|7|||
16186310|NCT00430521|39161814|FG001|Overall Study|Lost to Follow-up|8|||
16186311|NCT00430521|39161815|FG002|Overall Study|Lost to Follow-up|3|||
16186312|NCT00430521|39161816|FG003|Overall Study|Lost to Follow-up|5|||
16186313|NCT00430521|39161817|FG004|Overall Study|Lost to Follow-up|5|||
16186314|NCT00430521|39161818|FG005|Overall Study|Lost to Follow-up|2|||
16186315|NCT00430521|39161819|FG006|Overall Study|Lost to Follow-up|8|||
16186316|NCT00430521|39161820|FG007|Overall Study|Lost to Follow-up|10|||
16186317|NCT00430521|39161813|FG000|Overall Study|Pregnancy|0|||
16186318|NCT00430521|39161814|FG001|Overall Study|Pregnancy|0|||
16186319|NCT00430521|39161815|FG002|Overall Study|Pregnancy|0|||
16186320|NCT00430521|39161816|FG003|Overall Study|Pregnancy|0|||
16186321|NCT00430521|39161817|FG004|Overall Study|Pregnancy|0|||
16186322|NCT00430521|39161818|FG005|Overall Study|Pregnancy|0|||
16186323|NCT00430521|39161819|FG006|Overall Study|Pregnancy|1|||
16186324|NCT00430521|39161820|FG007|Overall Study|Pregnancy|0|||
16186325|NCT00430521|39161813|FG000|Overall Study|Vaccine Expired|0|||
16186326|NCT00430521|39161814|FG001|Overall Study|Vaccine Expired|0|||
16186327|NCT00430521|39161815|FG002|Overall Study|Vaccine Expired|0|||
16186328|NCT00430521|39161816|FG003|Overall Study|Vaccine Expired|0|||
16186329|NCT00430521|39161817|FG004|Overall Study|Vaccine Expired|0|||
16186330|NCT00430521|39161818|FG005|Overall Study|Vaccine Expired|1|||
16186331|NCT00430521|39161819|FG006|Overall Study|Vaccine Expired|0|||
16186332|NCT00430521|39161820|FG007|Overall Study|Vaccine Expired|0|||
16186333|NCT00430521|39161813|FG000|Overall Study|Protocol Violation|1|||
16186334|NCT00430521|39161814|FG001|Overall Study|Protocol Violation|0|||
16186335|NCT00430521|39161815|FG002|Overall Study|Protocol Violation|0|||
16186336|NCT00430521|39161816|FG003|Overall Study|Protocol Violation|0|||
16186337|NCT00430521|39161817|FG004|Overall Study|Protocol Violation|0|||
16186338|NCT00430521|39161818|FG005|Overall Study|Protocol Violation|0|||
16186339|NCT00430521|39161819|FG006|Overall Study|Protocol Violation|0|||
16186340|NCT00430521|39161820|FG007|Overall Study|Protocol Violation|0|||
16186341|NCT00430521|39161813|FG000|Overall Study|Withdrawal by Subject|3|||
16186342|NCT00430521|39161814|FG001|Overall Study|Withdrawal by Subject|1|||
16186343|NCT00430521|39161815|FG002|Overall Study|Withdrawal by Subject|0|||
16186344|NCT00430521|39161816|FG003|Overall Study|Withdrawal by Subject|3|||
16186345|NCT00430521|39161817|FG004|Overall Study|Withdrawal by Subject|0|||
16186346|NCT00430521|39161818|FG005|Overall Study|Withdrawal by Subject|0|||
16186347|NCT00430521|39161819|FG006|Overall Study|Withdrawal by Subject|0|||
16186348|NCT00430521|39161820|FG007|Overall Study|Withdrawal by Subject|2|||
16186349|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
16186350|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
16186351|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
16186352|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
16186353|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
16186354|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
16186355|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
16186356|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
16483164|NCT00675948|40245626|FG000|Overall Study|Withdrawal by Subject|7|||
16483165|NCT00675948|40245627|FG001|Overall Study|Withdrawal by Subject|0|||
16483166|NCT00675948|40245626|FG000|Overall Study|Lost to Follow-up|2|||
16483167|NCT00675948|40245627|FG001|Overall Study|Lost to Follow-up|0|||
16186357|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
16186358|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
16186359|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
16186360|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
16186361|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
16186362|NCT02232516|39161821|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
16186363|NCT02232516|39161821|FG000|Survival Follow-up|Death|15|||
16186364|NCT02232516|39161821|FG000|Survival Follow-up|Withdrawal by Subject|3|||
16186365|NCT02232516|39161821|FG000|Survival Follow-up|Lost to Follow-up|1|||
16186366|NCT02232516|39161821|FG000|Survival Follow-up|Still in follow-up|5|||
16186367|NCT02037919|39161825|FG000|Overall Study|Lost to Follow-up|30|||
16186368|NCT02037919|39161826|FG001|Overall Study|Lost to Follow-up|45|||
16186369|NCT01721408|39161827|FG000|Overall Study|Adverse Event|6|||
16186370|NCT01721408|39161828|FG001|Overall Study|Adverse Event|1|||
16186371|NCT01721408|39161827|FG000|Overall Study|Death|1|||
16186372|NCT01721408|39161828|FG001|Overall Study|Death|0|||
16186373|NCT01721408|39161827|FG000|Overall Study|Insufficient clinical response|15|||
16186374|NCT01721408|39161828|FG001|Overall Study|Insufficient clinical response|6|||
16186375|NCT01721408|39161827|FG000|Overall Study|No longer willing to participate study|9|||
16186376|NCT01721408|39161828|FG001|Overall Study|No longer willing to participate study|10|||
16186377|NCT01721408|39161827|FG000|Overall Study|Protocol Violation|0|||
16186378|NCT01721408|39161828|FG001|Overall Study|Protocol Violation|2|||
16186379|NCT01721408|39161827|FG000|Overall Study|Other|3|||
16483168|NCT00675948|40245626|FG000|Overall Study|Protocol Violation|1|||
16483169|NCT00675948|40245627|FG001|Overall Study|Protocol Violation|0|||
16483170|NCT00675948|40245626|FG000|Overall Study|Pain under control|1|||
16483171|NCT00675948|40245627|FG001|Overall Study|Pain under control|0|||
16483172|NCT00675948|40245626|FG000|Overall Study|Sponsor decision|0|||
16483173|NCT00675948|40245627|FG001|Overall Study|Sponsor decision|1|||
16483174|NCT00675948|40245626|FG000|Overall Study|Patient died|1|||
16483175|NCT00675948|40245627|FG001|Overall Study|Patient died|0|||
16483176|NCT00675948|40245626|FG000|Overall Study|Patient unable to comply with diaries|1|||
16483177|NCT00675948|40245627|FG001|Overall Study|Patient unable to comply with diaries|0|||
16483178|NCT00675948|40245626|FG000|Overall Study|Patient feels unable to take medication|0|||
16483179|NCT00675948|40245627|FG001|Overall Study|Patient feels unable to take medication|1|||
16483180|NCT02404220|40245628|FG000|Overall Study|Adverse Event|0|||
16483181|NCT02404220|40245629|FG001|Overall Study|Adverse Event|0|||
16483182|NCT02404220|40245630|FG002|Overall Study|Adverse Event|1|||
16483183|NCT02404220|40245631|FG003|Overall Study|Adverse Event|0|||
16186380|NCT01721408|39161828|FG001|Overall Study|Other|3|||
16186381|NCT01721408|39161827|FG000|Overall Study|Lost to Follow-up|1|||
16186382|NCT01721408|39161828|FG001|Overall Study|Lost to Follow-up|2|||
16186383|NCT01721408|39161827|FG000|Overall Study|Does not meet entrance criteria|1|||
16483184|NCT02404220|40245628|FG000|Overall Study|Death|5|||
16483185|NCT02404220|40245629|FG001|Overall Study|Death|5|||
16483186|NCT02404220|40245630|FG002|Overall Study|Death|3|||
16186384|NCT01721408|39161828|FG001|Overall Study|Does not meet entrance criteria|0|||
16290821|NCT00375492|39546885|FG001|Overall Study|Lost to Follow-up|5|||
16081198|NCT00807937|38789520|FG001|Overall Study|Protocol Violation|5|||
16081199|NCT00807937|38789521|FG002|Overall Study|Protocol Violation|3|||
16186385|NCT00540436|39161829|FG000|First 12-Week Treatment Period|Adverse Event|1|||
16186386|NCT00540436|39161829|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
16290822|NCT00375492|39546884|FG000|Overall Study|Physician Decision|0|||
16290823|NCT00375492|39546885|FG001|Overall Study|Physician Decision|4|||
16290824|NCT00375492|39546884|FG000|Overall Study|Protocol Violation|6|||
16290825|NCT00375492|39546885|FG001|Overall Study|Protocol Violation|3|||
16290826|NCT00375492|39546884|FG000|Overall Study|Sponsor Decision|0|||
16290827|NCT00375492|39546885|FG001|Overall Study|Sponsor Decision|1|||
16290828|NCT00375492|39546884|FG000|Overall Study|Withdrawal by Subject|6|||
16290829|NCT00375492|39546885|FG001|Overall Study|Withdrawal by Subject|6|||
16290830|NCT03014180|39546886|FG000|Overall Study|Protocol Violation|2|||
16290831|NCT00448136|39546889|FG000|Overall Study|Death|3|||
16290832|NCT00448136|39546890|FG001|Overall Study|Death|8|||
16290833|NCT00448136|39546889|FG000|Overall Study|Investigator's decision (progression)|1|||
16290834|NCT00448136|39546890|FG001|Overall Study|Investigator's decision (progression)|0|||
16290835|NCT00444457|39546898|FG000|Infant Series|Other|0|||
16290836|NCT00444457|39546899|FG001|Infant Series|Other|1|||
16290837|NCT00444457|39546900|FG002|Infant Series|Other|0|||
16290838|NCT00444457|39546901|FG003|Infant Series|Other|0|||
16290839|NCT00444457|39546898|FG000|Infant Series|Parent or legal guardian request|18|||
16290840|NCT00444457|39546899|FG001|Infant Series|Parent or legal guardian request|29|||
16290841|NCT00444457|39546900|FG002|Infant Series|Parent or legal guardian request|34|||
16290842|NCT00444457|39546901|FG003|Infant Series|Parent or legal guardian request|14|||
16290843|NCT00444457|39546898|FG000|Infant Series|Lost to Follow-up|10|||
16290844|NCT00444457|39546899|FG001|Infant Series|Lost to Follow-up|11|||
16290845|NCT00444457|39546900|FG002|Infant Series|Lost to Follow-up|7|||
16290846|NCT00444457|39546901|FG003|Infant Series|Lost to Follow-up|6|||
16290847|NCT00444457|39546898|FG000|Infant Series|Protocol Violation|16|||
16290848|NCT00444457|39546899|FG001|Infant Series|Protocol Violation|8|||
16290849|NCT00444457|39546900|FG002|Infant Series|Protocol Violation|6|||
16290850|NCT00444457|39546901|FG003|Infant Series|Protocol Violation|3|||
16290851|NCT00444457|39546898|FG000|Infant Series|Failed to return|5|||
16290852|NCT00444457|39546899|FG001|Infant Series|Failed to return|4|||
16290853|NCT00444457|39546900|FG002|Infant Series|Failed to return|4|||
16290854|NCT00444457|39546901|FG003|Infant Series|Failed to return|2|||
16290855|NCT00444457|39546898|FG000|Infant Series|Investigator request|4|||
16290856|NCT00444457|39546899|FG001|Infant Series|Investigator request|3|||
16290857|NCT00444457|39546900|FG002|Infant Series|Investigator request|3|||
16290858|NCT00444457|39546901|FG003|Infant Series|Investigator request|2|||
16290859|NCT00444457|39546898|FG000|Infant Series|Other|0|||
16186387|NCT00540436|39161829|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
16186388|NCT00540436|39161829|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
16186389|NCT00952289|39161830|FG000|All Participants|Death|9|||
16186390|NCT00952289|39161831|FG001|All Participants|Death|9|||
16186391|NCT00952289|39161830|FG000|All Participants|Adverse Event|8|||
16186392|NCT00952289|39161831|FG001|All Participants|Adverse Event|8|||
16186393|NCT00952289|39161830|FG000|All Participants|Disease progression|3|||
16186394|NCT00952289|39161831|FG001|All Participants|Disease progression|12|||
16186395|NCT00952289|39161830|FG000|All Participants|Withdrawal by Subject|1|||
16186396|NCT00952289|39161831|FG001|All Participants|Withdrawal by Subject|10|||
16186397|NCT00952289|39161830|FG000|All Participants|Data lost during site relocation|0|||
16290860|NCT00444457|39546899|FG001|Infant Series|Other|2|||
16290861|NCT00444457|39546900|FG002|Infant Series|Other|4|||
16290862|NCT00444457|39546901|FG003|Infant Series|Other|0|||
16290863|NCT00444457|39546898|FG000|Infant Series|Adverse Event|1|||
16290864|NCT00444457|39546899|FG001|Infant Series|Adverse Event|2|||
16290865|NCT00444457|39546900|FG002|Infant Series|Adverse Event|2|||
16290866|NCT00444457|39546901|FG003|Infant Series|Adverse Event|0|||
16290867|NCT00444457|39546898|FG000|Infant Series|Death|0|||
16290868|NCT00444457|39546899|FG001|Infant Series|Death|1|||
16380852|NCT00725985|39877693|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16380853|NCT00725985|39877694|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16380854|NCT00725985|39877695|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16380855|NCT00725985|39877696|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16380856|NCT00725985|39877697|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16380857|NCT00725985|39877698|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16380858|NCT00725985|39877699|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
16380859|NCT00725985|39877700|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16380860|NCT00725985|39877701|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16380861|NCT00725985|39877702|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16380862|NCT00725985|39877703|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
16380863|NCT00725985|39877692|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16380864|NCT00725985|39877693|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16380865|NCT00725985|39877694|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16483187|NCT02404220|40245631|FG003|Overall Study|Death|8|||
16483188|NCT02404220|40245628|FG000|Overall Study|Progressive Disease|0|||
16483189|NCT02404220|40245629|FG001|Overall Study|Progressive Disease|0|||
16483190|NCT02404220|40245630|FG002|Overall Study|Progressive Disease|1|||
16483191|NCT02404220|40245631|FG003|Overall Study|Progressive Disease|1|||
16483192|NCT02404220|40245628|FG000|Overall Study|Study Terminated by Sponsor|0|||
16483193|NCT02404220|40245629|FG001|Overall Study|Study Terminated by Sponsor|0|||
16483194|NCT02404220|40245630|FG002|Overall Study|Study Terminated by Sponsor|2|||
16483195|NCT02404220|40245631|FG003|Overall Study|Study Terminated by Sponsor|1|||
16483196|NCT02404220|40245628|FG000|Overall Study|Withdrawal by Subject|0|||
16483197|NCT02404220|40245629|FG001|Overall Study|Withdrawal by Subject|1|||
16483198|NCT02404220|40245630|FG002|Overall Study|Withdrawal by Subject|0|||
16483199|NCT02404220|40245631|FG003|Overall Study|Withdrawal by Subject|0|||
16290869|NCT00444457|39546900|FG002|Infant Series|Death|1|||
16290870|NCT00444457|39546901|FG003|Infant Series|Death|1|||
16290871|NCT00444457|39546898|FG000|After Infant Series|Other|0|||
16483200|NCT02404220|40245628|FG000|Overall Study|Enrolled but Never Treated|0|||
16483201|NCT02404220|40245629|FG001|Overall Study|Enrolled but Never Treated|2|||
16483202|NCT02404220|40245630|FG002|Overall Study|Enrolled but Never Treated|0|||
16483203|NCT02404220|40245631|FG003|Overall Study|Enrolled but Never Treated|0|||
16380866|NCT00725985|39877695|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16380867|NCT00725985|39877696|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16380868|NCT00725985|39877697|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16483204|NCT04377620|40245632|FG000|Overall Study|Death|42|||
16483205|NCT04377620|40245633|FG001|Overall Study|Death|48|||
16483206|NCT04377620|40245634|FG002|Overall Study|Death|36|||
16290872|NCT00444457|39546899|FG001|After Infant Series|Other|1|||
16290873|NCT00444457|39546900|FG002|After Infant Series|Other|1|||
16290874|NCT00444457|39546901|FG003|After Infant Series|Other|1|||
16290875|NCT00444457|39546898|FG000|After Infant Series|Parent or legal guardian request|4|||
16290876|NCT00444457|39546899|FG001|After Infant Series|Parent or legal guardian request|11|||
16290877|NCT00444457|39546900|FG002|After Infant Series|Parent or legal guardian request|6|||
16290878|NCT00444457|39546901|FG003|After Infant Series|Parent or legal guardian request|3|||
16290879|NCT00444457|39546898|FG000|After Infant Series|Failed to return|7|||
16290880|NCT00444457|39546899|FG001|After Infant Series|Failed to return|6|||
16290881|NCT00444457|39546900|FG002|After Infant Series|Failed to return|5|||
16290882|NCT00444457|39546901|FG003|After Infant Series|Failed to return|1|||
16290883|NCT00444457|39546898|FG000|After Infant Series|Lost to Follow-up|5|||
16290884|NCT00444457|39546899|FG001|After Infant Series|Lost to Follow-up|5|||
16290885|NCT00444457|39546900|FG002|After Infant Series|Lost to Follow-up|5|||
16380869|NCT00725985|39877698|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16380870|NCT00725985|39877699|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16380871|NCT00725985|39877700|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
16483207|NCT04377620|40245632|FG000|Overall Study|Withdrawal by Subject|0|||
16483208|NCT04377620|40245633|FG001|Overall Study|Withdrawal by Subject|2|||
16483209|NCT04377620|40245634|FG002|Overall Study|Withdrawal by Subject|0|||
16483210|NCT03724032|40245639|FG000|Overall Study|Physician Decision|1|||
16483211|NCT03724032|40245640|FG001|Overall Study|Physician Decision|0|||
16483212|NCT03724032|40245641|FG002|Overall Study|Physician Decision|0|||
16483213|NCT03724032|40245639|FG000|Overall Study|Protocol Violation|2|||
16483214|NCT03724032|40245640|FG001|Overall Study|Protocol Violation|2|||
16483215|NCT03724032|40245641|FG002|Overall Study|Protocol Violation|1|||
16483216|NCT00129272|40245642|FG000|Overall Study|Lost to Follow-up|12|||
16483217|NCT00129272|40245643|FG001|Overall Study|Lost to Follow-up|11|||
16483218|NCT00129272|40245642|FG000|Overall Study|Withdrawal by Subject|5|||
16483219|NCT00129272|40245643|FG001|Overall Study|Withdrawal by Subject|11|||
16483220|NCT03228433|40245646|FG000|Overall Study|Lost to Follow-up|1|||
16483221|NCT03228433|40245647|FG001|Overall Study|Lost to Follow-up|0|||
16290886|NCT00444457|39546901|FG003|After Infant Series|Lost to Follow-up|2|||
16290887|NCT00444457|39546898|FG000|After Infant Series|Protocol Violation|2|||
16290888|NCT00444457|39546899|FG001|After Infant Series|Protocol Violation|4|||
16290889|NCT00444457|39546900|FG002|After Infant Series|Protocol Violation|2|||
16290890|NCT00444457|39546901|FG003|After Infant Series|Protocol Violation|2|||
16290891|NCT00444457|39546898|FG000|After Infant Series|Adverse Event|2|||
16290892|NCT00444457|39546899|FG001|After Infant Series|Adverse Event|2|||
16290893|NCT00444457|39546900|FG002|After Infant Series|Adverse Event|0|||
16290894|NCT00444457|39546901|FG003|After Infant Series|Adverse Event|0|||
16290895|NCT00444457|39546898|FG000|After Infant Series|Investigator request|0|||
16290896|NCT00444457|39546899|FG001|After Infant Series|Investigator request|0|||
16290897|NCT00444457|39546900|FG002|After Infant Series|Investigator request|0|||
16290898|NCT00444457|39546901|FG003|After Infant Series|Investigator request|1|||
16290899|NCT00444457|39546898|FG000|After Infant Series|Other|0|||
16290900|NCT00444457|39546899|FG001|After Infant Series|Other|1|||
16290901|NCT00444457|39546900|FG002|After Infant Series|Other|0|||
16290902|NCT00444457|39546901|FG003|After Infant Series|Other|0|||
16290903|NCT00444457|39546898|FG000|Toddler Dose|Lost to Follow-up|4|||
16290904|NCT00444457|39546899|FG001|Toddler Dose|Lost to Follow-up|1|||
16290905|NCT00444457|39546900|FG002|Toddler Dose|Lost to Follow-up|1|||
16290906|NCT00444457|39546901|FG003|Toddler Dose|Lost to Follow-up|3|||
16290907|NCT00444457|39546898|FG000|Toddler Dose|Failed to return|2|||
16290908|NCT00444457|39546899|FG001|Toddler Dose|Failed to return|2|||
16290909|NCT00444457|39546900|FG002|Toddler Dose|Failed to return|1|||
16290910|NCT00444457|39546901|FG003|Toddler Dose|Failed to return|3|||
16290911|NCT00444457|39546898|FG000|Toddler Dose|Parent or legal guardian request|0|||
16290912|NCT00444457|39546899|FG001|Toddler Dose|Parent or legal guardian request|3|||
16290913|NCT00444457|39546900|FG002|Toddler Dose|Parent or legal guardian request|2|||
16290914|NCT00444457|39546901|FG003|Toddler Dose|Parent or legal guardian request|1|||
16290915|NCT00444457|39546898|FG000|Toddler Dose|Protocol Violation|1|||
16290916|NCT00444457|39546899|FG001|Toddler Dose|Protocol Violation|0|||
16290917|NCT00444457|39546900|FG002|Toddler Dose|Protocol Violation|0|||
16290918|NCT00444457|39546901|FG003|Toddler Dose|Protocol Violation|1|||
16290919|NCT02546362|39546902|FG000|4-week Treatment Period|Lost to Follow-up|1|||
16290920|NCT02546362|39546902|FG000|4-week Treatment Period|Change in medication|2|||
16290921|NCT02546362|39546902|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
16290922|NCT02546362|39546902|FG000|12-week Treatment Period|Lost to Follow-up|2|||
16290923|NCT02546362|39546902|FG000|12-week Treatment Period|Change in medication|1|||
16380872|NCT00725985|39877701|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16380873|NCT00725985|39877702|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16380874|NCT00725985|39877703|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
16380875|NCT00725985|39877692|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
16380876|NCT00725985|39877693|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
16380877|NCT00725985|39877694|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
16380878|NCT00725985|39877695|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
16380879|NCT00725985|39877696|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
16380880|NCT00725985|39877697|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
16380881|NCT00725985|39877698|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
16380882|NCT00725985|39877699|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
16380883|NCT00725985|39877700|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
16380884|NCT00725985|39877701|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
16380885|NCT00725985|39877702|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
16380886|NCT00725985|39877703|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
16380887|NCT00725985|39877692|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
16483222|NCT03228433|40245648|FG002|Overall Study|Lost to Follow-up|0|||
16483223|NCT03228433|40245649|FG003|Overall Study|Lost to Follow-up|0|||
16483224|NCT03228433|40245650|FG004|Overall Study|Lost to Follow-up|0|||
16483225|NCT03228433|40245651|FG005|Overall Study|Lost to Follow-up|0|||
16290924|NCT00667810|39546909|FG000|Overall Study|Adverse Event|13|||
16290925|NCT00667810|39546910|FG001|Overall Study|Adverse Event|14|||
16290926|NCT00667810|39546911|FG002|Overall Study|Adverse Event|19|||
16290927|NCT00667810|39546912|FG003|Overall Study|Adverse Event|1|||
16290928|NCT00667810|39546909|FG000|Overall Study|Death|1|||
16290929|NCT00667810|39546910|FG001|Overall Study|Death|1|||
16290930|NCT00667810|39546911|FG002|Overall Study|Death|3|||
16290931|NCT00667810|39546912|FG003|Overall Study|Death|0|||
16290932|NCT00667810|39546909|FG000|Overall Study|Lack of Efficacy|1|||
16290933|NCT00667810|39546910|FG001|Overall Study|Lack of Efficacy|0|||
16290934|NCT00667810|39546911|FG002|Overall Study|Lack of Efficacy|2|||
16483226|NCT03228433|40245646|FG000|Overall Study|Positive alcohol test|0|||
16290935|NCT00667810|39546912|FG003|Overall Study|Lack of Efficacy|0|||
16290936|NCT00667810|39546909|FG000|Overall Study|Lost to Follow-up|1|||
16290937|NCT00667810|39546910|FG001|Overall Study|Lost to Follow-up|4|||
16290938|NCT00667810|39546911|FG002|Overall Study|Lost to Follow-up|2|||
16290939|NCT00667810|39546912|FG003|Overall Study|Lost to Follow-up|0|||
16290940|NCT00667810|39546909|FG000|Overall Study|Physician Decision|1|||
16290941|NCT00667810|39546910|FG001|Overall Study|Physician Decision|1|||
16290942|NCT00667810|39546911|FG002|Overall Study|Physician Decision|2|||
16290943|NCT00667810|39546912|FG003|Overall Study|Physician Decision|0|||
16290944|NCT00667810|39546909|FG000|Overall Study|Protocol Violation|0|||
16290945|NCT00667810|39546910|FG001|Overall Study|Protocol Violation|2|||
16290946|NCT00667810|39546911|FG002|Overall Study|Protocol Violation|0|||
16290947|NCT00667810|39546912|FG003|Overall Study|Protocol Violation|0|||
16290948|NCT00667810|39546909|FG000|Overall Study|Withdrawal by Subject|14|||
16290949|NCT00667810|39546910|FG001|Overall Study|Withdrawal by Subject|20|||
16290950|NCT00667810|39546911|FG002|Overall Study|Withdrawal by Subject|29|||
16290951|NCT00667810|39546912|FG003|Overall Study|Withdrawal by Subject|1|||
16290952|NCT00667810|39546909|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
16290953|NCT00667810|39546910|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
16290954|NCT00667810|39546911|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
16290955|NCT00667810|39546912|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
16290956|NCT00667810|39546909|FG000|Overall Study|Failed to Return|0|||
16290957|NCT00667810|39546910|FG001|Overall Study|Failed to Return|0|||
16290958|NCT00667810|39546911|FG002|Overall Study|Failed to Return|2|||
16290959|NCT00667810|39546912|FG003|Overall Study|Failed to Return|0|||
16290960|NCT00667810|39546909|FG000|Overall Study|Loss of Caregiver|0|||
16290961|NCT00667810|39546910|FG001|Overall Study|Loss of Caregiver|1|||
16290962|NCT00667810|39546911|FG002|Overall Study|Loss of Caregiver|3|||
16290963|NCT00667810|39546912|FG003|Overall Study|Loss of Caregiver|0|||
16290964|NCT00667810|39546909|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
16290965|NCT00667810|39546910|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
16290966|NCT00667810|39546911|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
16290967|NCT00667810|39546912|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
16290968|NCT00667810|39546909|FG000|Overall Study|Other|6|||
16290969|NCT00667810|39546910|FG001|Overall Study|Other|6|||
16290970|NCT00667810|39546911|FG002|Overall Study|Other|5|||
16290971|NCT00667810|39546912|FG003|Overall Study|Other|0|||
16290972|NCT01249365|39546924|FG000|Overall Study|Lost to Follow-up|1|||
16290973|NCT00121134|39546937|FG000|Overall Study|Progression of Disease|5|||
16290974|NCT00121134|39546938|FG001|Overall Study|Progression of Disease|3|||
16290975|NCT00121134|39546939|FG002|Overall Study|Progression of Disease|4|||
16290976|NCT00121134|39546940|FG003|Overall Study|Progression of Disease|2|||
16290977|NCT00121134|39546937|FG000|Overall Study|Toxicity|4|||
16290978|NCT00121134|39546938|FG001|Overall Study|Toxicity|7|||
16290979|NCT00121134|39546939|FG002|Overall Study|Toxicity|13|||
16290980|NCT00121134|39546940|FG003|Overall Study|Toxicity|5|||
16290981|NCT00121134|39546937|FG000|Overall Study|Physician Decision|6|||
16290982|NCT00121134|39546938|FG001|Overall Study|Physician Decision|4|||
16290983|NCT00121134|39546939|FG002|Overall Study|Physician Decision|4|||
16290984|NCT00121134|39546940|FG003|Overall Study|Physician Decision|1|||
16290985|NCT00121134|39546937|FG000|Overall Study|Treatment Delay|1|||
16290986|NCT00121134|39546938|FG001|Overall Study|Treatment Delay|0|||
16290987|NCT00121134|39546939|FG002|Overall Study|Treatment Delay|0|||
16290988|NCT00121134|39546940|FG003|Overall Study|Treatment Delay|0|||
16290989|NCT00121134|39546937|FG000|Overall Study|Intercurrent Illness|0|||
16290990|NCT00121134|39546938|FG001|Overall Study|Intercurrent Illness|0|||
16290991|NCT00121134|39546939|FG002|Overall Study|Intercurrent Illness|0|||
16290992|NCT00121134|39546940|FG003|Overall Study|Intercurrent Illness|1|||
16290993|NCT00121134|39546937|FG000|Overall Study|Patient Personal Reasons|0|||
16290994|NCT00121134|39546938|FG001|Overall Study|Patient Personal Reasons|1|||
16290995|NCT00121134|39546939|FG002|Overall Study|Patient Personal Reasons|0|||
16290996|NCT00121134|39546940|FG003|Overall Study|Patient Personal Reasons|0|||
16290997|NCT03212521|39546943|FG000|Overall Study|Adverse Event|1|||
16290998|NCT03212521|39546943|FG000|Overall Study|Lost to Follow-up|4|||
16290999|NCT03212521|39546943|FG000|Overall Study|Withdrawal by Subject|1|||
16291000|NCT03212521|39546943|FG000|Overall Study|Other|1|||
16291001|NCT00761865|39546946|FG000|Overall Study|Lost to Follow-up|8|||
16291002|NCT00761865|39546947|FG001|Overall Study|Lost to Follow-up|7|||
16291003|NCT03465436|39546951|FG000|Period 1|Protocol Violation|0|||
16291004|NCT03465436|39546952|FG001|Period 1|Protocol Violation|0|||
16291005|NCT03465436|39546953|FG002|Period 1|Protocol Violation|1|||
16291006|NCT03465436|39546954|FG003|Period 1|Protocol Violation|0|||
16291007|NCT03465436|39546951|FG000|Period 2|Protocol Violation|0|||
16291008|NCT03465436|39546952|FG001|Period 2|Protocol Violation|1|||
16291009|NCT03465436|39546953|FG002|Period 2|Protocol Violation|0|||
16291010|NCT03465436|39546954|FG003|Period 2|Protocol Violation|0|||
16291011|NCT03465436|39546951|FG000|Period 3|Protocol Violation|1|||
16291012|NCT03465436|39546952|FG001|Period 3|Protocol Violation|1|||
16291013|NCT03465436|39546953|FG002|Period 3|Protocol Violation|0|||
16291014|NCT03465436|39546954|FG003|Period 3|Protocol Violation|0|||
16291015|NCT03465436|39546951|FG000|Period 4|Protocol Violation|0|||
16291016|NCT03465436|39546952|FG001|Period 4|Protocol Violation|0|||
16380888|NCT00725985|39877693|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
16380889|NCT00725985|39877694|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
16380890|NCT00725985|39877695|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
16380891|NCT00725985|39877696|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
16380892|NCT00725985|39877697|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
16380893|NCT00725985|39877698|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
16380894|NCT00725985|39877699|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
16380895|NCT00725985|39877700|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
16380896|NCT00725985|39877701|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
16380897|NCT00725985|39877702|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
16380898|NCT00725985|39877703|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
16380899|NCT01554904|39877704|FG000|Overall Study|Withdrawal by Subject|3|||
16380900|NCT01554904|39877704|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
16380901|NCT02448381|39877705|FG000|Overall Study|Adverse Event|2|||
16380902|NCT02448381|39877706|FG001|Overall Study|Adverse Event|0|||
16380903|NCT02448381|39877705|FG000|Overall Study|Lost to Follow-up|16|||
16291017|NCT03465436|39546953|FG002|Period 4|Protocol Violation|1|||
16291018|NCT03465436|39546954|FG003|Period 4|Protocol Violation|0|||
16291019|NCT03582826|39546955|FG000|Overall Study|Lost to Follow-up|39|||
16291020|NCT03582826|39546956|FG001|Overall Study|Lost to Follow-up|0|||
16291021|NCT03582826|39546955|FG000|Overall Study|Withdrawal by Subject|2|||
16291022|NCT03582826|39546956|FG001|Overall Study|Withdrawal by Subject|0|||
16291023|NCT00609466|39546958|FG000|Overall Study|Withdrawal by Subject|0|||
16291024|NCT00609466|39546959|FG001|Overall Study|Withdrawal by Subject|1|||
16291025|NCT00609466|39546960|FG002|Overall Study|Withdrawal by Subject|1|||
16291026|NCT00609466|39546958|FG000|Overall Study|Adverse Event|2|||
16291027|NCT00609466|39546959|FG001|Overall Study|Adverse Event|3|||
16291028|NCT00609466|39546960|FG002|Overall Study|Adverse Event|1|||
16291029|NCT00609466|39546958|FG000|Overall Study|Lack of Efficacy|0|||
16291030|NCT00609466|39546959|FG001|Overall Study|Lack of Efficacy|2|||
16291031|NCT00609466|39546960|FG002|Overall Study|Lack of Efficacy|2|||
16291032|NCT00809159|39550475|FG000|Part 1|Adverse Event|1|||
16291033|NCT00809159|39550476|FG001|Part 1|Adverse Event|1|||
16291034|NCT00809159|39550477|FG002|Part 1|Adverse Event|0|||
16291035|NCT00809159|39550478|FG003|Part 1|Adverse Event|0|||
16291036|NCT00809159|39550479|FG004|Part 1|Adverse Event|0|||
16291037|NCT00809159|39550480|FG005|Part 1|Adverse Event|0|||
16291038|NCT00809159|39550475|FG000|Part 1|Lost to Follow-up|1|||
16291039|NCT00809159|39550476|FG001|Part 1|Lost to Follow-up|0|||
16291040|NCT00809159|39550477|FG002|Part 1|Lost to Follow-up|0|||
16291041|NCT00809159|39550478|FG003|Part 1|Lost to Follow-up|0|||
16291042|NCT00809159|39550479|FG004|Part 1|Lost to Follow-up|0|||
16291043|NCT00809159|39550480|FG005|Part 1|Lost to Follow-up|0|||
16291044|NCT00809159|39550475|FG000|Part 1|Withdrawal by Subject|3|||
16291045|NCT00809159|39550476|FG001|Part 1|Withdrawal by Subject|1|||
16291046|NCT00809159|39550477|FG002|Part 1|Withdrawal by Subject|0|||
16291047|NCT00809159|39550478|FG003|Part 1|Withdrawal by Subject|0|||
16291048|NCT00809159|39550479|FG004|Part 1|Withdrawal by Subject|0|||
16291049|NCT00809159|39550480|FG005|Part 1|Withdrawal by Subject|0|||
16291050|NCT00809159|39550475|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
16291051|NCT00809159|39550476|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
16291052|NCT00809159|39550477|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
16291053|NCT00809159|39550478|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
16291054|NCT00809159|39550479|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
16291055|NCT00809159|39550480|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
16291056|NCT00809159|39550475|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
16291057|NCT00809159|39550476|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
16291058|NCT00809159|39550477|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
16291059|NCT00809159|39550478|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
16291060|NCT00809159|39550479|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
16380904|NCT02448381|39877706|FG001|Overall Study|Lost to Follow-up|9|||
16380905|NCT02448381|39877705|FG000|Overall Study|Physician Decision|1|||
16380906|NCT02448381|39877706|FG001|Overall Study|Physician Decision|1|||
16291061|NCT00809159|39550480|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
16291062|NCT00809159|39550475|FG000|Part 1 and 2|Administrative problems|0|||
16291063|NCT00809159|39550476|FG001|Part 1 and 2|Administrative problems|0|||
16380907|NCT02448381|39877705|FG000|Overall Study|Pregnancy|1|||
16380908|NCT02448381|39877706|FG001|Overall Study|Pregnancy|0|||
16291064|NCT00809159|39550477|FG002|Part 1 and 2|Administrative problems|0|||
16291065|NCT00809159|39550478|FG003|Part 1 and 2|Administrative problems|1|||
16291066|NCT00809159|39550479|FG004|Part 1 and 2|Administrative problems|0|||
16291067|NCT00809159|39550480|FG005|Part 1 and 2|Administrative problems|0|||
16291068|NCT00809159|39550475|FG000|Part 1 and 2|Adverse Event|0|||
16291069|NCT00809159|39550476|FG001|Part 1 and 2|Adverse Event|0|||
16291070|NCT00809159|39550477|FG002|Part 1 and 2|Adverse Event|1|||
16291071|NCT00809159|39550478|FG003|Part 1 and 2|Adverse Event|0|||
16291072|NCT00809159|39550479|FG004|Part 1 and 2|Adverse Event|1|||
16291073|NCT00809159|39550480|FG005|Part 1 and 2|Adverse Event|1|||
16291074|NCT00809159|39550475|FG000|Part 1 and 2|Lost to Follow-up|0|||
16291075|NCT00809159|39550476|FG001|Part 1 and 2|Lost to Follow-up|0|||
16291076|NCT00809159|39550477|FG002|Part 1 and 2|Lost to Follow-up|1|||
16291077|NCT00809159|39550478|FG003|Part 1 and 2|Lost to Follow-up|1|||
16291078|NCT00809159|39550479|FG004|Part 1 and 2|Lost to Follow-up|0|||
16291079|NCT00809159|39550480|FG005|Part 1 and 2|Lost to Follow-up|0|||
16291080|NCT00809159|39550475|FG000|Part 1 and 2|Withdrawal by Subject|0|||
16291081|NCT00809159|39550476|FG001|Part 1 and 2|Withdrawal by Subject|0|||
16291082|NCT00809159|39550477|FG002|Part 1 and 2|Withdrawal by Subject|4|||
16291083|NCT00809159|39550478|FG003|Part 1 and 2|Withdrawal by Subject|0|||
16291084|NCT00809159|39550479|FG004|Part 1 and 2|Withdrawal by Subject|0|||
16291085|NCT00809159|39550480|FG005|Part 1 and 2|Withdrawal by Subject|1|||
16291086|NCT02674061|39550483|FG000|Overall Study|Death|229|||
16291087|NCT02674061|39550484|FG001|Overall Study|Death|77|||
16291088|NCT02674061|39550483|FG000|Overall Study|Lost to Follow-up|3|||
16291089|NCT02674061|39550484|FG001|Overall Study|Lost to Follow-up|3|||
16291090|NCT02674061|39550483|FG000|Overall Study|Withdrawal by Subject|9|||
16291091|NCT02674061|39550484|FG001|Overall Study|Withdrawal by Subject|1|||
16291092|NCT02674061|39550483|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
16291093|NCT02674061|39550484|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
16291094|NCT03258853|39550485|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
16291095|NCT03258853|39550486|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
16291096|NCT05065983|39550487|FG000|Overall Study|Lost to Follow-up|2|||
16291097|NCT04442490|39550488|FG000|Overall Study|Withdrawal by Subject|18|||
16291098|NCT04442490|39550489|FG001|Overall Study|Withdrawal by Subject|10|||
16291099|NCT04442490|39550488|FG000|Overall Study|Lost to Follow-up|7|||
16291100|NCT04442490|39550489|FG001|Overall Study|Lost to Follow-up|7|||
16291101|NCT04442490|39550488|FG000|Overall Study|Adverse Event|2|||
16291102|NCT04442490|39550489|FG001|Overall Study|Adverse Event|6|||
16291103|NCT04442490|39550488|FG000|Overall Study|Noncompliance|3|||
16291104|NCT04442490|39550489|FG001|Overall Study|Noncompliance|1|||
16291105|NCT04442490|39550488|FG000|Overall Study|Physician Decision|2|||
16291106|NCT04442490|39550489|FG001|Overall Study|Physician Decision|1|||
16291107|NCT04442490|39550488|FG000|Overall Study|Reason not Specified|2|||
16291108|NCT04442490|39550489|FG001|Overall Study|Reason not Specified|1|||
16291109|NCT04442490|39550488|FG000|Overall Study|Randomized but not Treated|3|||
16291110|NCT04442490|39550489|FG001|Overall Study|Randomized but not Treated|3|||
16291111|NCT02177136|39550490|FG000|DB Phase|Withdrawal by Subject|2|||
16291112|NCT02177136|39550491|FG001|DB Phase|Withdrawal by Subject|0|||
16291113|NCT02177136|39550492|FG002|DB Phase|Withdrawal by Subject|0|||
16291114|NCT02177136|39550493|FG003|DB Phase|Withdrawal by Subject|0|||
16291115|NCT02177136|39550490|FG000|DB Phase|Discontinued Due to Pruritus|1|||
16291116|NCT02177136|39550491|FG001|DB Phase|Discontinued Due to Pruritus|3|||
16483227|NCT03228433|40245647|FG001|Overall Study|Positive alcohol test|0|||
16483228|NCT03228433|40245648|FG002|Overall Study|Positive alcohol test|0|||
16483229|NCT03228433|40245649|FG003|Overall Study|Positive alcohol test|1|||
16483230|NCT03228433|40245650|FG004|Overall Study|Positive alcohol test|0|||
16483231|NCT03228433|40245651|FG005|Overall Study|Positive alcohol test|0|||
16483232|NCT01909674|40245652|FG000|Overall Study|Withdrawal by Subject|5|||
16483233|NCT01909674|40245653|FG001|Overall Study|Withdrawal by Subject|2|||
16483234|NCT02465515|40245656|FG000|Overall Study|Investigator site closed|4|||
16483235|NCT02465515|40245657|FG001|Overall Study|Investigator site closed|5|||
16483236|NCT02465515|40245656|FG000|Overall Study|Withdrawal by Subject|74|||
16483237|NCT02465515|40245657|FG001|Overall Study|Withdrawal by Subject|43|||
16483238|NCT02465515|40245656|FG000|Overall Study|Physician Decision|8|||
16291117|NCT02177136|39550492|FG002|DB Phase|Discontinued Due to Pruritus|0|||
16291118|NCT02177136|39550493|FG003|DB Phase|Discontinued Due to Pruritus|0|||
16291119|NCT02177136|39550490|FG000|DB Phase|Adverse Event|3|||
16483239|NCT02465515|40245657|FG001|Overall Study|Physician Decision|12|||
16483240|NCT02465515|40245656|FG000|Overall Study|Lost to Follow-up|68|||
16291120|NCT02177136|39550491|FG001|DB Phase|Adverse Event|2|||
16291121|NCT02177136|39550492|FG002|DB Phase|Adverse Event|3|||
16291122|NCT02177136|39550493|FG003|DB Phase|Adverse Event|0|||
16483241|NCT02465515|40245657|FG001|Overall Study|Lost to Follow-up|51|||
16483242|NCT03602482|40245659|FG000|Overall Study|Withdrawal by Subject|6|||
16291123|NCT02177136|39550490|FG000|DB Phase|Protocol Violation|0|||
16291124|NCT02177136|39550491|FG001|DB Phase|Protocol Violation|0|||
16291125|NCT02177136|39550492|FG002|DB Phase|Protocol Violation|1|||
16291126|NCT02177136|39550493|FG003|DB Phase|Protocol Violation|0|||
16291127|NCT02177136|39550490|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
16291128|NCT02177136|39550491|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
16291129|NCT02177136|39550492|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
16291130|NCT02177136|39550493|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
16380909|NCT02448381|39877705|FG000|Overall Study|Withdrawal by Subject|13|||
16291131|NCT02177136|39550490|FG000|LTSE Phase|Withdrawal by Subject|0|||
16291132|NCT02177136|39550491|FG001|LTSE Phase|Withdrawal by Subject|0|||
16380910|NCT02448381|39877706|FG001|Overall Study|Withdrawal by Subject|9|||
16483243|NCT03602482|40245660|FG001|Overall Study|Withdrawal by Subject|7|||
16483244|NCT03602482|40245661|FG002|Overall Study|Withdrawal by Subject|0|||
16483245|NCT03602482|40245662|FG003|Overall Study|Withdrawal by Subject|0|||
16483246|NCT00190671|40245663|FG000|Overall Study|Satisfactory Response|4|||
16483247|NCT00190671|40245664|FG001|Overall Study|Satisfactory Response|7|||
16483248|NCT00190671|40245663|FG000|Overall Study|Lack of Efficacy|19|||
16483249|NCT00190671|40245664|FG001|Overall Study|Lack of Efficacy|24|||
16483250|NCT00190671|40245663|FG000|Overall Study|Death from Study Disease|1|||
16483251|NCT00190671|40245664|FG001|Overall Study|Death from Study Disease|1|||
16483252|NCT00190671|40245663|FG000|Overall Study|Adverse Event|3|||
16483253|NCT00190671|40245664|FG001|Overall Study|Adverse Event|2|||
16483254|NCT00190671|40245663|FG000|Overall Study|Clinical Relapse|0|||
16483255|NCT00190671|40245664|FG001|Overall Study|Clinical Relapse|1|||
16483256|NCT00190671|40245663|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
16483257|NCT00190671|40245664|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
16483258|NCT00190671|40245663|FG000|Overall Study|Death from Other Causes|0|||
16483259|NCT00190671|40245664|FG001|Overall Study|Death from Other Causes|2|||
16483260|NCT00190671|40245663|FG000|Overall Study|Protocol Violation|0|||
16483261|NCT00190671|40245664|FG001|Overall Study|Protocol Violation|1|||
16483262|NCT00190671|40245663|FG000|Overall Study|Withdrawal by Subject|0|||
16483263|NCT00190671|40245664|FG001|Overall Study|Withdrawal by Subject|2|||
16483264|NCT00313300|40245665|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
16483265|NCT00313300|40245666|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
16483266|NCT00313300|40245667|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
16483267|NCT00313300|40245668|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
16483268|NCT00313300|40245669|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
16483269|NCT00313300|40245665|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
16483270|NCT00313300|40245666|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
16483271|NCT00313300|40245667|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
16483272|NCT00313300|40245668|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
16483273|NCT00313300|40245669|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
16483274|NCT00313300|40245665|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
16483275|NCT00313300|40245666|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
16483276|NCT00313300|40245667|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
16483277|NCT00313300|40245668|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
16483278|NCT00313300|40245669|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
16483279|NCT00313300|40245665|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
16483280|NCT00313300|40245666|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
16483281|NCT00313300|40245667|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
16483282|NCT00313300|40245668|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
16483283|NCT00313300|40245669|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
16483284|NCT00313300|40245665|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
16483285|NCT00313300|40245666|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
16483286|NCT00313300|40245667|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
16483287|NCT00313300|40245668|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
16483288|NCT00313300|40245669|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
16483289|NCT00313300|40245665|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
16483290|NCT00313300|40245666|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
16483291|NCT00313300|40245667|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
16483292|NCT00313300|40245668|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
16483293|NCT00313300|40245669|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
16483294|NCT00313300|40245665|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
16483295|NCT00313300|40245666|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
16483296|NCT00313300|40245667|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
16483297|NCT00313300|40245668|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
16483298|NCT00313300|40245669|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
16291133|NCT02177136|39550492|FG002|LTSE Phase|Withdrawal by Subject|0|||
16291134|NCT02177136|39550493|FG003|LTSE Phase|Withdrawal by Subject|6|||
16380911|NCT02448381|39877705|FG000|Overall Study|Noncompliance with Study Procedures|2|||
16291135|NCT02177136|39550490|FG000|LTSE Phase|Adverse Event|0|||
16483299|NCT00313300|40245665|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
16483300|NCT00313300|40245666|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
16483301|NCT00313300|40245667|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
16483302|NCT00313300|40245668|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
16483303|NCT00313300|40245669|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
16483304|NCT00313300|40245665|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
16483305|NCT00313300|40245666|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
16483306|NCT00313300|40245667|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
16483307|NCT00313300|40245668|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
16483308|NCT00313300|40245669|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
16483309|NCT00313300|40245665|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
16483310|NCT00313300|40245666|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
16483311|NCT00313300|40245667|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
16483312|NCT00313300|40245668|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
16483313|NCT00313300|40245669|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
16483314|NCT00313300|40245665|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
16483315|NCT00313300|40245666|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
16483316|NCT00313300|40245667|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
16483317|NCT00313300|40245668|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
16483318|NCT00313300|40245669|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
16483319|NCT00313300|40245665|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
16483320|NCT00313300|40245666|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
16483321|NCT00313300|40245667|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
16483322|NCT00313300|40245668|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
16483323|NCT00313300|40245669|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
16483324|NCT00313300|40245665|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
16483325|NCT00313300|40245666|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
16483326|NCT00313300|40245667|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
16483327|NCT00313300|40245668|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
16483328|NCT00313300|40245669|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
16483329|NCT00313300|40245665|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
16483330|NCT00313300|40245666|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
16483331|NCT00313300|40245667|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
16483332|NCT00313300|40245668|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
16483333|NCT00313300|40245669|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
16483334|NCT00313300|40245665|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
16483335|NCT00313300|40245666|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
16483336|NCT00313300|40245667|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
16483337|NCT00313300|40245668|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
16483338|NCT00313300|40245669|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
16483339|NCT00313300|40245665|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
16483340|NCT00313300|40245666|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
16483341|NCT00313300|40245667|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
16483342|NCT00313300|40245668|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
16483343|NCT00313300|40245669|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
16483344|NCT00313300|40245665|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
16483345|NCT00313300|40245666|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
16483346|NCT00313300|40245667|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
16483347|NCT00313300|40245668|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
16483348|NCT00313300|40245669|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
16483349|NCT00313300|40245665|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
16483350|NCT00313300|40245666|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
16483351|NCT00313300|40245667|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
16483352|NCT00313300|40245668|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
16483353|NCT00313300|40245669|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
16483354|NCT00313300|40245665|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
16483355|NCT00313300|40245666|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
16483356|NCT00313300|40245667|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
16483357|NCT00313300|40245668|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
16483358|NCT00313300|40245669|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
16483359|NCT00313300|40245665|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
16483360|NCT00313300|40245666|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
16483361|NCT00313300|40245667|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
16483362|NCT00313300|40245668|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
16483363|NCT00313300|40245669|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
16483364|NCT00313300|40245665|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
16483365|NCT00313300|40245666|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
16483366|NCT00313300|40245667|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
16483367|NCT00313300|40245668|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
16483368|NCT00313300|40245669|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
16483369|NCT01233258|40245670|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
16483370|NCT01233258|40245671|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
16483371|NCT01233258|40245672|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
16483372|NCT01233258|40245673|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
16483373|NCT01233258|40245674|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
16483374|NCT01233258|40245675|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
16483375|NCT01233258|40245670|FG000|First Intervention (6 Months)|Protocol Violation|0|||
16483376|NCT01233258|40245671|FG001|First Intervention (6 Months)|Protocol Violation|0|||
16483377|NCT01233258|40245672|FG002|First Intervention (6 Months)|Protocol Violation|1|||
16483378|NCT01233258|40245673|FG003|First Intervention (6 Months)|Protocol Violation|0|||
16483379|NCT01233258|40245674|FG004|First Intervention (6 Months)|Protocol Violation|0|||
16483380|NCT01233258|40245675|FG005|First Intervention (6 Months)|Protocol Violation|0|||
16483381|NCT01233258|40245670|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
16483382|NCT01233258|40245671|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
16483383|NCT01233258|40245672|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
16483384|NCT01233258|40245673|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
16483385|NCT01233258|40245674|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
16483386|NCT01233258|40245675|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
16483387|NCT01702961|40245676|FG000|Overall Study|Additional treatment|3|||
16483388|NCT01702961|40245676|FG000|Overall Study|Progressive disease|5|||
16483389|NCT01702961|40245676|FG000|Overall Study|Relapse|20|||
16483390|NCT01702961|40245676|FG000|Overall Study|Death|6|||
16483391|NCT01702961|40245676|FG000|Overall Study|Lost to Follow-up|2|||
16483392|NCT01702961|40245676|FG000|Overall Study|Ongoing|11|||
16483393|NCT01824875|40245684|FG000|Overall Study|Disease progression|22|||
16483394|NCT01824875|40245685|FG001|Overall Study|Disease progression|15|||
16483395|NCT01824875|40245684|FG000|Overall Study|Withdrawal by Subject|5|||
16483396|NCT01824875|40245685|FG001|Overall Study|Withdrawal by Subject|4|||
16483397|NCT01824875|40245684|FG000|Overall Study|Adverse Event|4|||
16483398|NCT01824875|40245685|FG001|Overall Study|Adverse Event|10|||
16483399|NCT01824875|40245684|FG000|Overall Study|Alternative therapy|3|||
16483400|NCT01824875|40245685|FG001|Overall Study|Alternative therapy|0|||
16483401|NCT01824875|40245684|FG000|Overall Study|Complicating disease|1|||
16483402|NCT01824875|40245685|FG001|Overall Study|Complicating disease|0|||
16483403|NCT01824875|40245684|FG000|Overall Study|Physician Decision|0|||
16483404|NCT01824875|40245685|FG001|Overall Study|Physician Decision|1|||
16483405|NCT01824875|40245684|FG000|Overall Study|Non-compliance|1|||
16483406|NCT01824875|40245685|FG001|Overall Study|Non-compliance|1|||
16483407|NCT01824875|40245684|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
16483408|NCT01824875|40245685|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
16483409|NCT01824875|40245684|FG000|Overall Study|Administrative issues|0|||
16483410|NCT01824875|40245685|FG001|Overall Study|Administrative issues|2|||
16483411|NCT01824875|40245684|FG000|Overall Study|Ineligible or never started treatment|9|||
16483412|NCT01824875|40245685|FG001|Overall Study|Ineligible or never started treatment|5|||
16483413|NCT01824875|40245684|FG000|Overall Study|Other|0|||
16483414|NCT01824875|40245685|FG001|Overall Study|Other|2|||
16483415|NCT00799422|40245688|FG000|First Week of Wear|Lost to Follow-up|0|||
16483416|NCT00799422|40245689|FG001|First Week of Wear|Lost to Follow-up|0|||
16483417|NCT00799422|40245690|FG002|First Week of Wear|Lost to Follow-up|1|||
16483418|NCT00799422|40245691|FG003|First Week of Wear|Lost to Follow-up|0|||
16483419|NCT00799422|40245692|FG004|First Week of Wear|Lost to Follow-up|0|||
16483420|NCT00799422|40245693|FG005|First Week of Wear|Lost to Follow-up|0|||
16483421|NCT00799422|40245688|FG000|First Week of Wear|Adverse Event|0|||
16483422|NCT00799422|40245689|FG001|First Week of Wear|Adverse Event|0|||
16483423|NCT00799422|40245690|FG002|First Week of Wear|Adverse Event|0|||
16483424|NCT00799422|40245691|FG003|First Week of Wear|Adverse Event|1|||
16483425|NCT00799422|40245692|FG004|First Week of Wear|Adverse Event|0|||
16483426|NCT00799422|40245693|FG005|First Week of Wear|Adverse Event|0|||
16483427|NCT00191139|40245694|FG000|Overall Study|Adverse Event|2|||
16483428|NCT00191139|40245695|FG001|Overall Study|Adverse Event|6|||
16483429|NCT00191139|40245694|FG000|Overall Study|Death|2|||
16483430|NCT00191139|40245695|FG001|Overall Study|Death|0|||
16483431|NCT00191139|40245694|FG000|Overall Study|Withdrawal by Subject|0|||
16483432|NCT00191139|40245695|FG001|Overall Study|Withdrawal by Subject|3|||
16483433|NCT00191139|40245694|FG000|Overall Study|Disease Progression|0|||
16483434|NCT00191139|40245695|FG001|Overall Study|Disease Progression|1|||
16483435|NCT00191139|40245694|FG000|Overall Study|Other|1|||
16483436|NCT00191139|40245695|FG001|Overall Study|Other|2|||
16483437|NCT03068455|40245696|FG000|Pre-treatment Period|Disease progression|0|||
16483438|NCT03068455|40245697|FG001|Pre-treatment Period|Disease progression|1|||
16483439|NCT03068455|40245696|FG000|Pre-treatment Period|Participant withdrew consent|1|||
16483440|NCT03068455|40245697|FG001|Pre-treatment Period|Participant withdrew consent|1|||
16483441|NCT03068455|40245696|FG000|Pre-treatment Period|Poor/non-compliance|0|||
16483442|NCT03068455|40245697|FG001|Pre-treatment Period|Poor/non-compliance|1|||
16483443|NCT03068455|40245696|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
16483444|NCT03068455|40245697|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
16483445|NCT03068455|40245696|FG000|Pre-treatment Period|Not reported|2|||
16483446|NCT03068455|40245697|FG001|Pre-treatment Period|Not reported|1|||
16483447|NCT03068455|40245696|FG000|Treatment Period|Disease progression|166|||
16483448|NCT03068455|40245697|FG001|Treatment Period|Disease progression|208|||
16483449|NCT03068455|40245696|FG000|Treatment Period|Study drug toxicity|317|||
16483450|NCT03068455|40245697|FG001|Treatment Period|Study drug toxicity|104|||
16483451|NCT03068455|40245696|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
16483452|NCT03068455|40245697|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
16483453|NCT03068455|40245696|FG000|Treatment Period|Participant request to stop therapy|33|||
16483454|NCT03068455|40245697|FG001|Treatment Period|Participant request to stop therapy|20|||
16483455|NCT03068455|40245696|FG000|Treatment Period|Participant withdrew consent|5|||
16483456|NCT03068455|40245697|FG001|Treatment Period|Participant withdrew consent|10|||
16483457|NCT03068455|40245696|FG000|Treatment Period|Poor/non-compliance|3|||
16483458|NCT03068455|40245697|FG001|Treatment Period|Poor/non-compliance|0|||
16483459|NCT03068455|40245696|FG000|Treatment Period|Participant no longer meets study criteria|1|||
16483460|NCT03068455|40245697|FG001|Treatment Period|Participant no longer meets study criteria|3|||
16483461|NCT03068455|40245696|FG000|Treatment Period|Other reasons|12|||
16483462|NCT03068455|40245697|FG001|Treatment Period|Other reasons|4|||
16483463|NCT01365052|40245698|FG000|Overall Study|Adverse Event|4|||
16483464|NCT01365052|40245699|FG001|Overall Study|Adverse Event|4|||
16483465|NCT01128842|40245700|FG000|Overall Study|Adverse Event|1|||
16483466|NCT01128842|40245700|FG000|Overall Study|Disease Progression|6|||
16483467|NCT01637272|40245702|FG000|Overall Study|Adverse Event|6|||
16483468|NCT01637272|40245702|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16483469|NCT01637272|40245702|FG000|Overall Study|Withdrawal by Subject|3|||
16483470|NCT01637272|40245702|FG000|Overall Study|Lost to Follow-up|2|||
16483471|NCT01637272|40245702|FG000|Overall Study|completed core, did not enter ext. phase|4|||
16483472|NCT01637272|40245702|FG000|Overall Study|Administrative problems|1|||
16483473|NCT01637272|40245702|FG000|Overall Study|Protocol Violation|2|||
16483474|NCT00365508|40245703|FG000|Overall Study|Lost to Follow-up|139|||
16483475|NCT00365508|40245704|FG001|Overall Study|Lost to Follow-up|154|||
16483476|NCT00658814|40245705|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
16483477|NCT00658814|40245706|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
16483478|NCT00658814|40245705|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
16483479|NCT00658814|40245706|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
16483480|NCT00658814|40245705|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
16483481|NCT00658814|40245706|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
16483482|NCT00658814|40245705|FG000|Remission Induction Chemotherapy|Death|1|||
16483483|NCT00658814|40245706|FG001|Remission Induction Chemotherapy|Death|4|||
16291136|NCT02177136|39550491|FG001|LTSE Phase|Adverse Event|0|||
16291137|NCT02177136|39550492|FG002|LTSE Phase|Adverse Event|0|||
16291138|NCT02177136|39550493|FG003|LTSE Phase|Adverse Event|10|||
16291139|NCT02177136|39550490|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
16291140|NCT02177136|39550491|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
16291141|NCT02177136|39550492|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
16291142|NCT02177136|39550493|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
16291143|NCT02177136|39550490|FG000|LTSE Phase|Physician Decision|0|||
16291144|NCT02177136|39550491|FG001|LTSE Phase|Physician Decision|0|||
16291145|NCT02177136|39550492|FG002|LTSE Phase|Physician Decision|0|||
16291146|NCT02177136|39550493|FG003|LTSE Phase|Physician Decision|2|||
16291147|NCT02177136|39550490|FG000|LTSE Phase|Lost to Follow-up|0|||
16291148|NCT02177136|39550491|FG001|LTSE Phase|Lost to Follow-up|0|||
16291149|NCT02177136|39550492|FG002|LTSE Phase|Lost to Follow-up|0|||
16291150|NCT02177136|39550493|FG003|LTSE Phase|Lost to Follow-up|1|||
16291151|NCT02177136|39550490|FG000|LTSE Phase|Participant Moved|0|||
16291152|NCT02177136|39550491|FG001|LTSE Phase|Participant Moved|0|||
16291153|NCT02177136|39550492|FG002|LTSE Phase|Participant Moved|0|||
16291154|NCT02177136|39550493|FG003|LTSE Phase|Participant Moved|1|||
16291155|NCT02034058|39550497|FG000|Overall Study|Death|3|||
16291156|NCT00622466|39550498|FG000|Overall Study|Death|1|||
16291157|NCT00622466|39550498|FG000|Overall Study|Adverse Event|1|||
16380912|NCT02448381|39877706|FG001|Overall Study|Noncompliance with Study Procedures|0|||
16483484|NCT00658814|40245705|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
16483485|NCT00658814|40245706|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
16291158|NCT00622466|39550498|FG000|Overall Study|Withdrawal by Subject|2|||
16291159|NCT03334721|39550501|FG000|Overall Study|Withdrawal by Subject|1|||
16291160|NCT03334721|39550502|FG001|Overall Study|Withdrawal by Subject|0|||
16483486|NCT00658814|40245705|FG000|Remission Induction Chemotherapy|Not eligible|1|||
16483487|NCT00658814|40245706|FG001|Remission Induction Chemotherapy|Not eligible|2|||
16483488|NCT00658814|40245705|FG000|Consolidation Therapy|Not protocol specified|0|||
16483489|NCT00658814|40245706|FG001|Consolidation Therapy|Not protocol specified|1|||
16483490|NCT00658814|40245705|FG000|Consolidation Therapy|Not eligible|2|||
16483491|NCT00658814|40245706|FG001|Consolidation Therapy|Not eligible|2|||
16483492|NCT00658814|40245705|FG000|Maintenance Therapy|Adverse Event|1|||
16483493|NCT00658814|40245706|FG001|Maintenance Therapy|Adverse Event|1|||
16483494|NCT00658814|40245705|FG000|Maintenance Therapy|Not protocol specified|1|||
16483495|NCT00658814|40245706|FG001|Maintenance Therapy|Not protocol specified|0|||
16483496|NCT00658814|40245705|FG000|Maintenance Therapy|Not eligible|1|||
16483497|NCT00658814|40245706|FG001|Maintenance Therapy|Not eligible|0|||
16483498|NCT01999114|40245708|FG000|Overall Study|Adverse Event|8|||
16483499|NCT01999114|40245709|FG001|Overall Study|Adverse Event|7|||
16483500|NCT01999114|40245710|FG002|Overall Study|Adverse Event|2|||
16483501|NCT01999114|40245711|FG003|Overall Study|Adverse Event|2|||
16483502|NCT01999114|40245712|FG004|Overall Study|Adverse Event|1|||
16483503|NCT01999114|40245708|FG000|Overall Study|Withdrawal by Subject|0|||
16483504|NCT01999114|40245709|FG001|Overall Study|Withdrawal by Subject|0|||
16483505|NCT01999114|40245710|FG002|Overall Study|Withdrawal by Subject|1|||
16483506|NCT01999114|40245711|FG003|Overall Study|Withdrawal by Subject|0|||
16483507|NCT01999114|40245712|FG004|Overall Study|Withdrawal by Subject|1|||
16483508|NCT01999114|40245708|FG000|Overall Study|Lost to Follow-up|0|||
16483509|NCT01999114|40245709|FG001|Overall Study|Lost to Follow-up|0|||
16186398|NCT00952289|39161831|FG001|All Participants|Data lost during site relocation|1|||
16186399|NCT00952289|39161830|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
16186400|NCT00952289|39161831|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
16186401|NCT00952289|39161830|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
16186402|NCT00952289|39161831|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
16186403|NCT00952289|39161830|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
16186404|NCT00952289|39161831|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
16186405|NCT00952289|39161830|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
16186406|NCT00952289|39161831|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
16186407|NCT00952289|39161830|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
16186408|NCT00952289|39161831|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
16186409|NCT03977727|39161832|FG000|Second Treatment|Lost to Follow-up|0|||
16186410|NCT03977727|39161833|FG001|Second Treatment|Lost to Follow-up|3|||
16186411|NCT02635737|39161834|FG000|Overall Study|Protocol Violation|1|||
16186412|NCT00907478|39161835|FG000|Overall Study|Ineligibility determined|0|||
16186413|NCT00907478|39161836|FG001|Overall Study|Ineligibility determined|0|||
16186414|NCT00907478|39161837|FG002|Overall Study|Ineligibility determined|1|||
16186415|NCT00907478|39161835|FG000|Overall Study|Noncompliance|0|||
16186416|NCT00907478|39161836|FG001|Overall Study|Noncompliance|0|||
16186417|NCT00907478|39161837|FG002|Overall Study|Noncompliance|1|||
16186418|NCT00907478|39161835|FG000|Overall Study|Adverse Event|3|||
16186419|NCT00907478|39161836|FG001|Overall Study|Adverse Event|1|||
16186420|NCT00907478|39161837|FG002|Overall Study|Adverse Event|2|||
16186421|NCT00907478|39161835|FG000|Overall Study|Withdrawal by Subject|8|||
16186422|NCT00907478|39161836|FG001|Overall Study|Withdrawal by Subject|9|||
16186423|NCT00907478|39161837|FG002|Overall Study|Withdrawal by Subject|6|||
16186424|NCT00907478|39161835|FG000|Overall Study|Requirement for alternative therapy|1|||
16186425|NCT00907478|39161836|FG001|Overall Study|Requirement for alternative therapy|2|||
16186426|NCT00907478|39161837|FG002|Overall Study|Requirement for alternative therapy|3|||
16186427|NCT00907478|39161835|FG000|Overall Study|Physician Decision|2|||
16186428|NCT00907478|39161836|FG001|Overall Study|Physician Decision|0|||
16186429|NCT00907478|39161837|FG002|Overall Study|Physician Decision|3|||
16186430|NCT00907478|39161835|FG000|Overall Study|Death|4|||
16186431|NCT00907478|39161836|FG001|Overall Study|Death|2|||
16186432|NCT00907478|39161837|FG002|Overall Study|Death|1|||
16186433|NCT00907478|39161835|FG000|Overall Study|Protocol-specified criteria|5|||
16186434|NCT00907478|39161836|FG001|Overall Study|Protocol-specified criteria|2|||
16186435|NCT00907478|39161837|FG002|Overall Study|Protocol-specified criteria|3|||
16186436|NCT00907478|39161835|FG000|Overall Study|Pregnancy|0|||
16186437|NCT00907478|39161836|FG001|Overall Study|Pregnancy|1|||
16186438|NCT00907478|39161837|FG002|Overall Study|Pregnancy|1|||
16186439|NCT00907478|39161835|FG000|Overall Study|Lost to Follow-up|1|||
16186440|NCT00907478|39161836|FG001|Overall Study|Lost to Follow-up|0|||
16186441|NCT00907478|39161837|FG002|Overall Study|Lost to Follow-up|0|||
16186442|NCT00907478|39161835|FG000|Overall Study|Other|3|||
16186443|NCT00907478|39161836|FG001|Overall Study|Other|0|||
16186444|NCT00907478|39161837|FG002|Overall Study|Other|1|||
16186445|NCT00589472|39161840|FG000|Overall Study|Adverse Event|1|||
16483510|NCT01999114|40245710|FG002|Overall Study|Lost to Follow-up|1|||
16186446|NCT00894413|39161841|FG000|Overall Study|Physician Decision|0|||
16186447|NCT00894413|39161842|FG001|Overall Study|Physician Decision|2|||
16483511|NCT01999114|40245711|FG003|Overall Study|Lost to Follow-up|0|||
16186448|NCT00894413|39161841|FG000|Overall Study|Adverse Event|0|||
16186449|NCT00894413|39161842|FG001|Overall Study|Adverse Event|2|||
16186450|NCT00894413|39161841|FG000|Overall Study|Withdrawal by Subject|0|||
16186451|NCT00894413|39161842|FG001|Overall Study|Withdrawal by Subject|4|||
16186452|NCT00243230|39161843|FG000|Double-Blind Period|Adverse Event|0|||
16186453|NCT00243230|39161844|FG001|Double-Blind Period|Adverse Event|2|||
16186454|NCT00243230|39161845|FG002|Double-Blind Period|Adverse Event|2|||
16186455|NCT00243230|39161846|FG003|Double-Blind Period|Adverse Event|0|||
16186456|NCT00243230|39161843|FG000|Double-Blind Period|Withdrawal by Subject|1|||
16186457|NCT00243230|39161844|FG001|Double-Blind Period|Withdrawal by Subject|0|||
16186458|NCT00243230|39161845|FG002|Double-Blind Period|Withdrawal by Subject|0|||
16186459|NCT00243230|39161846|FG003|Double-Blind Period|Withdrawal by Subject|0|||
16186460|NCT00243230|39161843|FG000|Double-Blind Period|Protocol Violation|0|||
16186461|NCT00243230|39161844|FG001|Double-Blind Period|Protocol Violation|0|||
16186462|NCT00243230|39161845|FG002|Double-Blind Period|Protocol Violation|1|||
16186463|NCT00243230|39161846|FG003|Double-Blind Period|Protocol Violation|0|||
16186464|NCT00243230|39161843|FG000|Double-Blind Period|Randomized but Not Treated|0|||
16186465|NCT00243230|39161844|FG001|Double-Blind Period|Randomized but Not Treated|0|||
16186466|NCT00243230|39161845|FG002|Double-Blind Period|Randomized but Not Treated|2|||
16186467|NCT00243230|39161846|FG003|Double-Blind Period|Randomized but Not Treated|0|||
16186468|NCT00243230|39161843|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
16186469|NCT00243230|39161844|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
16186470|NCT00243230|39161845|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
16186471|NCT00243230|39161846|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
16186472|NCT00243230|39161843|FG000|Open Label Period|Adverse Event|0|||
16186473|NCT00243230|39161844|FG001|Open Label Period|Adverse Event|0|||
16186474|NCT00243230|39161845|FG002|Open Label Period|Adverse Event|0|||
16186475|NCT00243230|39161846|FG003|Open Label Period|Adverse Event|2|||
16186476|NCT00243230|39161843|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
16186477|NCT00243230|39161844|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
16186478|NCT00243230|39161845|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
16186479|NCT00243230|39161846|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
16186480|NCT00243230|39161843|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
16186481|NCT00243230|39161844|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
16186482|NCT00243230|39161845|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
16186483|NCT00243230|39161846|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
16186484|NCT00243230|39161843|FG000|Open Label Period|Lost to Follow-up|0|||
16186485|NCT00243230|39161844|FG001|Open Label Period|Lost to Follow-up|0|||
16186486|NCT00243230|39161845|FG002|Open Label Period|Lost to Follow-up|0|||
16186487|NCT00243230|39161846|FG003|Open Label Period|Lost to Follow-up|2|||
16186488|NCT00243230|39161843|FG000|Open Label Period|Withdrawal by Subject|0|||
16186489|NCT00243230|39161844|FG001|Open Label Period|Withdrawal by Subject|0|||
16186490|NCT00243230|39161845|FG002|Open Label Period|Withdrawal by Subject|0|||
16186491|NCT00243230|39161846|FG003|Open Label Period|Withdrawal by Subject|2|||
16186492|NCT00243230|39161843|FG000|Open Label Period|Protocol Violation|0|||
16186493|NCT00243230|39161844|FG001|Open Label Period|Protocol Violation|0|||
16186494|NCT00243230|39161845|FG002|Open Label Period|Protocol Violation|0|||
16186495|NCT00243230|39161846|FG003|Open Label Period|Protocol Violation|2|||
16186496|NCT00243230|39161843|FG000|Open Label Period|Administrative Reason|0|||
16186497|NCT00243230|39161844|FG001|Open Label Period|Administrative Reason|0|||
16186498|NCT00243230|39161845|FG002|Open Label Period|Administrative Reason|0|||
16186499|NCT00243230|39161846|FG003|Open Label Period|Administrative Reason|63|||
16186500|NCT01106534|39161852|FG000|Overall Study|Withdrawal by Subject|18|||
16186501|NCT01106534|39161852|FG000|Overall Study|Lost to Follow-up|2|||
16186502|NCT01106534|39161852|FG000|Overall Study|Death|16|||
16186503|NCT01106534|39161852|FG000|Overall Study|Physician Decision|1|||
16186504|NCT00421343|39161858|FG000|Overall Study|Death|1|||
16186505|NCT00421343|39161858|FG000|Overall Study|Withdrawal by Subject|2|||
16186506|NCT00421343|39161858|FG000|Overall Study|Lost to Follow-up|3|||
16186507|NCT01259492|39161859|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
16186508|NCT01259492|39161860|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
16186509|NCT01259492|39161861|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
16186510|NCT01259492|39161862|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
16186511|NCT01259492|39161859|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
16186512|NCT01259492|39161860|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
16186513|NCT01259492|39161861|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
16186514|NCT01259492|39161862|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
16186515|NCT01259492|39161859|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
16186516|NCT01259492|39161860|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
16186517|NCT01259492|39161861|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
16186518|NCT01259492|39161862|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
16186519|NCT01259492|39161859|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
16186520|NCT01259492|39161860|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
16186521|NCT01259492|39161861|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
16186522|NCT01259492|39161862|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
16186523|NCT01259492|39161859|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
16186524|NCT01259492|39161860|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
16186525|NCT01259492|39161861|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
16186526|NCT01259492|39161862|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
16186527|NCT01259492|39161859|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
16186528|NCT01259492|39161860|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
16186529|NCT01259492|39161861|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
16186530|NCT01259492|39161862|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
16186531|NCT01259492|39161859|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
16186532|NCT01259492|39161860|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
16186533|NCT01259492|39161861|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
16186534|NCT01259492|39161862|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
16186535|NCT01259492|39161859|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
16186536|NCT01259492|39161860|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
16186537|NCT01259492|39161861|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
16186538|NCT01259492|39161862|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
16186539|NCT01259492|39161859|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
16186540|NCT01259492|39161860|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
16186541|NCT01259492|39161861|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
16186542|NCT01259492|39161862|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
16186543|NCT01259492|39161859|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
16186544|NCT01259492|39161860|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
16186545|NCT01259492|39161861|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
16186546|NCT01259492|39161862|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
16186547|NCT01259492|39161859|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
16186548|NCT01259492|39161860|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
16186549|NCT01259492|39161861|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
16186550|NCT01259492|39161862|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
16186551|NCT01259492|39161859|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
16186552|NCT01259492|39161860|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
16186553|NCT01259492|39161861|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
16186554|NCT01259492|39161862|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
16186555|NCT01259492|39161859|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
16186556|NCT01259492|39161860|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
16186557|NCT01259492|39161861|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
16186558|NCT01259492|39161862|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
16186559|NCT01259492|39161859|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
16186560|NCT01259492|39161860|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
16186561|NCT01259492|39161861|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
16483512|NCT01999114|40245712|FG004|Overall Study|Lost to Follow-up|0|||
16483513|NCT01999114|40245708|FG000|Overall Study|Administrative|0|||
16483514|NCT01999114|40245709|FG001|Overall Study|Administrative|0|||
16483515|NCT01999114|40245710|FG002|Overall Study|Administrative|1|||
16483516|NCT01999114|40245711|FG003|Overall Study|Administrative|1|||
16483517|NCT01999114|40245712|FG004|Overall Study|Administrative|2|||
16483518|NCT00398411|40245730|FG000|Overall Study|Death|0|||
16483519|NCT00398411|40245731|FG001|Overall Study|Death|1|||
16483520|NCT01534962|40245732|FG000|Overall Study|Randomized but did not start treatment|2|||
16483521|NCT01534962|40245733|FG001|Overall Study|Randomized but did not start treatment|0|||
16483522|NCT01534962|40245734|FG002|Overall Study|Randomized but did not start treatment|0|||
16483523|NCT01534962|40245735|FG003|Overall Study|Randomized but did not start treatment|1|||
16483524|NCT01534962|40245732|FG000|Overall Study|Discontinued at AF recurrence|35|||
16483525|NCT01534962|40245733|FG001|Overall Study|Discontinued at AF recurrence|26|||
16483526|NCT01534962|40245734|FG002|Overall Study|Discontinued at AF recurrence|24|||
16483527|NCT01534962|40245735|FG003|Overall Study|Discontinued at AF recurrence|31|||
16483528|NCT05209360|40245736|FG000|Overall Study|Withdrawal by Subject|0|||
16483529|NCT05209360|40245737|FG001|Overall Study|Withdrawal by Subject|0|||
16186562|NCT01259492|39161862|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
16186563|NCT01259492|39161859|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
16186564|NCT01259492|39161860|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
16483530|NCT05209360|40245738|FG002|Overall Study|Withdrawal by Subject|1|||
16483531|NCT05209360|40245739|FG003|Overall Study|Withdrawal by Subject|0|||
16380913|NCT01817777|39877722|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
16380914|NCT01817777|39877723|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
16380915|NCT01817777|39877724|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
16380916|NCT01817777|39877722|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
16380917|NCT01817777|39877723|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
16380918|NCT01817777|39877724|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
16380919|NCT01817777|39877722|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
16380920|NCT01817777|39877723|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
16380921|NCT01817777|39877724|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
16380922|NCT01817777|39877722|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
16380923|NCT01817777|39877723|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
16380924|NCT01817777|39877724|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
16380925|NCT01817777|39877722|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
16380926|NCT01817777|39877723|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
16380927|NCT01817777|39877724|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
16380928|NCT04138056|39877725|FG000|Primary Study|Lost to Follow-up|3|||
16380929|NCT04138056|39877726|FG001|Primary Study|Lost to Follow-up|4|||
16380930|NCT04138056|39877727|FG002|Primary Study|Lost to Follow-up|1|||
16380931|NCT04138056|39877728|FG003|Primary Study|Lost to Follow-up|1|||
16380932|NCT04138056|39877729|FG004|Primary Study|Lost to Follow-up|4|||
16380933|NCT04138056|39877725|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
16380934|NCT04138056|39877726|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
16380935|NCT04138056|39877727|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
16380936|NCT04138056|39877728|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
16380937|NCT04138056|39877729|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
16483532|NCT05209360|40245740|FG004|Overall Study|Withdrawal by Subject|0|||
16483533|NCT05209360|40245741|FG005|Overall Study|Withdrawal by Subject|0|||
16483534|NCT03386448|40245744|FG000|Overall Study|Adverse Event|0|||
16483535|NCT03386448|40245745|FG001|Overall Study|Adverse Event|2|||
16483536|NCT00178633|40245746|FG000|Overall Study|Lost to Follow-up|6|||
16483537|NCT01090492|40245747|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
16483538|NCT01090492|40245748|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
16483539|NCT01090492|40245749|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
16483540|NCT01090492|40245750|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
16483541|NCT01090492|40245751|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
16186565|NCT01259492|39161861|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
16186566|NCT01259492|39161862|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
16186567|NCT01259492|39161859|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
16186568|NCT01259492|39161860|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
16380938|NCT04138056|39877725|FG000|Extension Study|Lost to Follow-up|1|||
16380939|NCT04138056|39877726|FG001|Extension Study|Lost to Follow-up|2|||
16380940|NCT04138056|39877727|FG002|Extension Study|Lost to Follow-up|1|||
16380941|NCT04138056|39877728|FG003|Extension Study|Lost to Follow-up|0|||
16380942|NCT04138056|39877729|FG004|Extension Study|Lost to Follow-up|1|||
16380943|NCT01889251|39877730|FG000|Overall Study|Adverse Event|1|||
16380944|NCT01889251|39877731|FG001|Overall Study|Adverse Event|0|||
16380945|NCT02457065|39877732|FG000|Overall Study|Lost to Follow-up|9|||
16380946|NCT02457065|39877733|FG001|Overall Study|Lost to Follow-up|11|||
16380947|NCT02284191|39877734|FG000|Overall Study|Withdrawal by Subject|1|||
16380948|NCT02284191|39877735|FG001|Overall Study|Withdrawal by Subject|3|||
16483542|NCT01090492|40245752|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
16483543|NCT01090492|40245753|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
16186569|NCT01259492|39161861|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
16186570|NCT01259492|39161862|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
16186571|NCT01259492|39161859|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
16186572|NCT01259492|39161860|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
16186573|NCT01259492|39161861|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
16186574|NCT01259492|39161862|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
16186575|NCT01259492|39161859|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
16186576|NCT01259492|39161860|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
16186577|NCT01259492|39161861|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
16186578|NCT01259492|39161862|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
16186579|NCT01259492|39161859|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
16186580|NCT01259492|39161860|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
16186581|NCT01259492|39161861|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
16186582|NCT01259492|39161862|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
16186583|NCT01259492|39161859|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
16483544|NCT01090492|40245754|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
16291161|NCT03334721|39550501|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
16291162|NCT03334721|39550502|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
16291163|NCT02227147|39550503|FG000|Controlled Treatment Period|Adverse Event|4|||
16291164|NCT02227147|39550504|FG001|Controlled Treatment Period|Adverse Event|3|||
16291165|NCT02227147|39550503|FG000|Controlled Treatment Period|Other|2|||
16291166|NCT02227147|39550504|FG001|Controlled Treatment Period|Other|0|||
16291167|NCT02227147|39550503|FG000|Follow-up Period|Other|3|||
16291168|NCT02227147|39550504|FG001|Follow-up Period|Other|5|||
16291169|NCT00289874|39550505|FG000|Overall Study|Adverse Event|1|||
16291170|NCT00289874|39550506|FG001|Overall Study|Adverse Event|5|||
16291171|NCT00289874|39550505|FG000|Overall Study|Lost to Follow-up|1|||
16291172|NCT00289874|39550506|FG001|Overall Study|Lost to Follow-up|1|||
16291173|NCT00289874|39550505|FG000|Overall Study|Protocol Violation|3|||
16291174|NCT00289874|39550506|FG001|Overall Study|Protocol Violation|2|||
16291175|NCT00289874|39550505|FG000|Overall Study|Did not meet eligibility|1|||
16291176|NCT00289874|39550506|FG001|Overall Study|Did not meet eligibility|0|||
16291177|NCT02351960|39550515|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
16291178|NCT02351960|39550516|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
16291179|NCT02351960|39550515|FG000|Overall Study|Voluntary Withdrawal|5|||
16291180|NCT02351960|39550516|FG001|Overall Study|Voluntary Withdrawal|4|||
16291181|NCT02351960|39550515|FG000|Overall Study|Significant Protocol Deviation|0|||
16291182|NCT02351960|39550516|FG001|Overall Study|Significant Protocol Deviation|5|||
16291183|NCT00430495|39550517|FG000|Overall Study|Adverse Event|2|||
16291184|NCT00430495|39550518|FG001|Overall Study|Adverse Event|3|||
16291185|NCT00430495|39550519|FG002|Overall Study|Adverse Event|2|||
16291186|NCT00430495|39550520|FG003|Overall Study|Adverse Event|0|||
16291187|NCT00430495|39550517|FG000|Overall Study|Death|0|||
16291188|NCT00430495|39550518|FG001|Overall Study|Death|0|||
16291189|NCT00430495|39550519|FG002|Overall Study|Death|1|||
16291190|NCT00430495|39550520|FG003|Overall Study|Death|0|||
16291191|NCT00430495|39550517|FG000|Overall Study|Lost to Follow-up|0|||
16291192|NCT00430495|39550518|FG001|Overall Study|Lost to Follow-up|1|||
16291193|NCT00430495|39550519|FG002|Overall Study|Lost to Follow-up|4|||
16291194|NCT00430495|39550520|FG003|Overall Study|Lost to Follow-up|0|||
16291195|NCT00430495|39550517|FG000|Overall Study|Protocol Violation|1|||
16291196|NCT00430495|39550518|FG001|Overall Study|Protocol Violation|0|||
16291197|NCT00430495|39550519|FG002|Overall Study|Protocol Violation|1|||
16291198|NCT00430495|39550520|FG003|Overall Study|Protocol Violation|0|||
16291199|NCT00430495|39550517|FG000|Overall Study|Disease Progression|1|||
16291200|NCT00430495|39550518|FG001|Overall Study|Disease Progression|1|||
16291201|NCT00430495|39550519|FG002|Overall Study|Disease Progression|0|||
16291202|NCT00430495|39550520|FG003|Overall Study|Disease Progression|0|||
16291203|NCT00430495|39550517|FG000|Overall Study|Other|8|||
16291204|NCT00430495|39550518|FG001|Overall Study|Other|2|||
16291205|NCT00430495|39550519|FG002|Overall Study|Other|5|||
16483545|NCT01090492|40245747|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16483546|NCT01090492|40245748|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
16291206|NCT00430495|39550520|FG003|Overall Study|Other|4|||
16291207|NCT00430495|39550517|FG000|Overall Study|Randomized but not Treated|2|||
16291208|NCT00430495|39550518|FG001|Overall Study|Randomized but not Treated|0|||
16291209|NCT00430495|39550519|FG002|Overall Study|Randomized but not Treated|0|||
16291210|NCT00430495|39550520|FG003|Overall Study|Randomized but not Treated|0|||
16291211|NCT00678041|39550521|FG000|Overall Study|Physician Decision|5|||
16291212|NCT00678041|39550522|FG001|Overall Study|Physician Decision|5|||
16291213|NCT00968799|39550527|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
16291214|NCT02358343|39550528|FG000|Screening Intervention|Death|0|||
16291215|NCT02358343|39550529|FG001|Screening Intervention|Death|2|||
16291216|NCT02358343|39550530|FG002|Screening Intervention|Death|0|||
16291217|NCT02358343|39550531|FG003|Screening Intervention|Death|0|||
16291218|NCT02358343|39550532|FG004|Screening Intervention|Death|0|||
16291219|NCT02358343|39550528|FG000|Screening Intervention|Withdrawal by Subject|1|||
16291220|NCT02358343|39550529|FG001|Screening Intervention|Withdrawal by Subject|0|||
16291221|NCT02358343|39550530|FG002|Screening Intervention|Withdrawal by Subject|0|||
16291222|NCT02358343|39550531|FG003|Screening Intervention|Withdrawal by Subject|0|||
16291223|NCT02358343|39550532|FG004|Screening Intervention|Withdrawal by Subject|0|||
16291224|NCT02358343|39550528|FG000|Screening Intervention|Determined Ineligible|5|||
16291225|NCT02358343|39550529|FG001|Screening Intervention|Determined Ineligible|6|||
16291226|NCT02358343|39550530|FG002|Screening Intervention|Determined Ineligible|0|||
16291227|NCT02358343|39550531|FG003|Screening Intervention|Determined Ineligible|0|||
16291228|NCT02358343|39550532|FG004|Screening Intervention|Determined Ineligible|0|||
16291229|NCT02358343|39550528|FG000|Comparative Efficacy Trial / Observation|Death|0|||
16291230|NCT02358343|39550529|FG001|Comparative Efficacy Trial / Observation|Death|0|||
16291231|NCT02358343|39550530|FG002|Comparative Efficacy Trial / Observation|Death|2|||
16291232|NCT02358343|39550531|FG003|Comparative Efficacy Trial / Observation|Death|0|||
16291233|NCT02358343|39550532|FG004|Comparative Efficacy Trial / Observation|Death|0|||
16291234|NCT02358343|39550528|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
16291235|NCT02358343|39550529|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
16291236|NCT02358343|39550530|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
16291237|NCT02358343|39550531|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
16291238|NCT02358343|39550532|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
16291239|NCT02358343|39550528|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
16291240|NCT02358343|39550529|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
16291241|NCT02358343|39550530|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
16291242|NCT02358343|39550531|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
16291243|NCT02358343|39550532|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
16291244|NCT02622113|39550533|FG000|Overall Study|Adverse Event|4|||
16291245|NCT02622113|39550534|FG001|Overall Study|Adverse Event|4|||
16291246|NCT02622113|39550533|FG000|Overall Study|Physician Decision|0|||
16291247|NCT02622113|39550534|FG001|Overall Study|Physician Decision|1|||
16291248|NCT02622113|39550533|FG000|Overall Study|Withdrawal by Subject|0|||
16291249|NCT02622113|39550534|FG001|Overall Study|Withdrawal by Subject|2|||
16291250|NCT02622113|39550533|FG000|Overall Study|Stopping Criteria|1|||
16291251|NCT02622113|39550534|FG001|Overall Study|Stopping Criteria|3|||
16291252|NCT02149121|39550535|FG000|Main Study Period|Lack of Efficacy|2|||
16291253|NCT02149121|39550536|FG001|Main Study Period|Lack of Efficacy|2|||
16291254|NCT02149121|39550537|FG002|Main Study Period|Lack of Efficacy|1|||
16291255|NCT02149121|39550538|FG003|Main Study Period|Lack of Efficacy|0|||
16291256|NCT02149121|39550539|FG004|Main Study Period|Lack of Efficacy|0|||
16291257|NCT02149121|39550540|FG005|Main Study Period|Lack of Efficacy|0|||
16291258|NCT02149121|39550541|FG006|Main Study Period|Lack of Efficacy|0|||
16291259|NCT02149121|39550535|FG000|Main Study Period|Withdrawal by Subject|9|||
16291260|NCT02149121|39550536|FG001|Main Study Period|Withdrawal by Subject|5|||
16291261|NCT02149121|39550537|FG002|Main Study Period|Withdrawal by Subject|1|||
16291262|NCT02149121|39550538|FG003|Main Study Period|Withdrawal by Subject|0|||
16291263|NCT02149121|39550539|FG004|Main Study Period|Withdrawal by Subject|0|||
16291264|NCT02149121|39550540|FG005|Main Study Period|Withdrawal by Subject|0|||
16483547|NCT01090492|40245749|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16483548|NCT01090492|40245750|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16483549|NCT01090492|40245751|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16483550|NCT01090492|40245752|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16483551|NCT01090492|40245753|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
16483552|NCT01090492|40245754|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
16483553|NCT01090492|40245747|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483554|NCT01090492|40245748|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483555|NCT01090492|40245749|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
16483556|NCT01090492|40245750|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483557|NCT01090492|40245751|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483558|NCT01090492|40245752|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483559|NCT01090492|40245753|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483560|NCT01090492|40245754|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483561|NCT01090492|40245747|FG000|First Intervention Period (4 Weeks)|Other|0|||
16483562|NCT01090492|40245748|FG001|First Intervention Period (4 Weeks)|Other|0|||
16483563|NCT01090492|40245749|FG002|First Intervention Period (4 Weeks)|Other|1|||
16483564|NCT01090492|40245750|FG003|First Intervention Period (4 Weeks)|Other|1|||
16483565|NCT01090492|40245751|FG004|First Intervention Period (4 Weeks)|Other|2|||
16483566|NCT01090492|40245752|FG005|First Intervention Period (4 Weeks)|Other|0|||
16483567|NCT01090492|40245753|FG006|First Intervention Period (4 Weeks)|Other|0|||
16483568|NCT01090492|40245754|FG007|First Intervention Period (4 Weeks)|Other|0|||
16291265|NCT02149121|39550541|FG006|Main Study Period|Withdrawal by Subject|0|||
16291266|NCT02149121|39550535|FG000|Main Study Period|Adverse Event|2|||
16291267|NCT02149121|39550536|FG001|Main Study Period|Adverse Event|5|||
16291268|NCT02149121|39550537|FG002|Main Study Period|Adverse Event|1|||
16291269|NCT02149121|39550538|FG003|Main Study Period|Adverse Event|0|||
16291270|NCT02149121|39550539|FG004|Main Study Period|Adverse Event|0|||
16483569|NCT01090492|40245747|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
16483570|NCT01090492|40245748|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
16483571|NCT01090492|40245749|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
16483572|NCT01090492|40245750|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
16291271|NCT02149121|39550540|FG005|Main Study Period|Adverse Event|0|||
16291272|NCT02149121|39550541|FG006|Main Study Period|Adverse Event|0|||
16291273|NCT02149121|39550535|FG000|Main Study Period|Protocol Violation|2|||
16483573|NCT01090492|40245751|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
16483574|NCT01090492|40245752|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
16483575|NCT01090492|40245753|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
16483576|NCT01090492|40245754|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
16483577|NCT01090492|40245747|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
16483578|NCT01090492|40245748|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
16483579|NCT01090492|40245749|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
16483580|NCT01090492|40245750|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
16483581|NCT01090492|40245751|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
16483582|NCT01090492|40245752|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
16483583|NCT01090492|40245753|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
16483584|NCT01090492|40245754|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
16483585|NCT01090492|40245747|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
16483586|NCT01090492|40245748|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
16483587|NCT01090492|40245749|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
16483588|NCT01090492|40245750|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
16483589|NCT01090492|40245751|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
16483590|NCT01090492|40245752|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
16483591|NCT01090492|40245753|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
16483592|NCT01090492|40245754|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
16483593|NCT01090492|40245747|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16483594|NCT01090492|40245748|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
16483595|NCT01090492|40245749|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16483596|NCT01090492|40245750|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16483597|NCT01090492|40245751|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16483598|NCT01090492|40245752|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16483599|NCT01090492|40245753|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16483600|NCT01090492|40245754|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
16483601|NCT01090492|40245747|FG000|Second Intervention Period (4 Weeks)|Other|0|||
16483602|NCT01090492|40245748|FG001|Second Intervention Period (4 Weeks)|Other|1|||
16483603|NCT01090492|40245749|FG002|Second Intervention Period (4 Weeks)|Other|1|||
16483604|NCT01090492|40245750|FG003|Second Intervention Period (4 Weeks)|Other|0|||
16483605|NCT01090492|40245751|FG004|Second Intervention Period (4 Weeks)|Other|0|||
16483606|NCT01090492|40245752|FG005|Second Intervention Period (4 Weeks)|Other|0|||
16483607|NCT01090492|40245753|FG006|Second Intervention Period (4 Weeks)|Other|0|||
16483608|NCT01090492|40245754|FG007|Second Intervention Period (4 Weeks)|Other|0|||
16483609|NCT01090492|40245747|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
16483610|NCT01090492|40245748|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
16483611|NCT01090492|40245749|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
16483612|NCT01090492|40245750|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
16483613|NCT01090492|40245751|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
16483614|NCT01090492|40245752|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
16483615|NCT01090492|40245753|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
16483616|NCT01090492|40245754|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
16483617|NCT01090492|40245747|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483618|NCT01090492|40245748|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483619|NCT01090492|40245749|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483620|NCT01090492|40245750|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483621|NCT01090492|40245751|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483622|NCT01090492|40245752|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483623|NCT01090492|40245753|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
16483624|NCT01090492|40245754|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
16483625|NCT02229383|40245755|FG000|Overall Study|Adverse Event|7|||
16483626|NCT02229383|40245756|FG001|Overall Study|Adverse Event|4|||
16483627|NCT02229383|40245755|FG000|Overall Study|Death|0|||
16483628|NCT02229383|40245756|FG001|Overall Study|Death|1|||
16483629|NCT02229383|40245755|FG000|Overall Study|Lost to Follow-up|5|||
16483630|NCT02229383|40245756|FG001|Overall Study|Lost to Follow-up|3|||
16483631|NCT02229383|40245755|FG000|Overall Study|Withdrawal by Subject|4|||
16483632|NCT02229383|40245756|FG001|Overall Study|Withdrawal by Subject|6|||
16483633|NCT02229383|40245755|FG000|Overall Study|Did not receive treatment|1|||
16483634|NCT02229383|40245756|FG001|Overall Study|Did not receive treatment|0|||
16483635|NCT02229383|40245755|FG000|Overall Study|Other|3|||
16483636|NCT02229383|40245756|FG001|Overall Study|Other|8|||
16483637|NCT03840174|40245757|FG000|Overall Study|Withdrawal by Subject|1|||
16483638|NCT03840174|40245758|FG001|Overall Study|Withdrawal by Subject|0|||
16483639|NCT03840174|40245759|FG002|Overall Study|Withdrawal by Subject|0|||
16483640|NCT03840174|40245760|FG003|Overall Study|Withdrawal by Subject|0|||
16483641|NCT01970397|40245761|FG000|Overall Study|Adverse Event|0|||
16483642|NCT01970397|40245762|FG001|Overall Study|Adverse Event|1|||
16483643|NCT01970397|40245761|FG000|Overall Study|Lost to Follow-up|0|||
16483644|NCT01970397|40245762|FG001|Overall Study|Lost to Follow-up|1|||
16483645|NCT01970397|40245761|FG000|Overall Study|Personal Reasons|1|||
16483646|NCT01970397|40245762|FG001|Overall Study|Personal Reasons|2|||
16483647|NCT01970397|40245761|FG000|Overall Study|Protocol Violation|1|||
16483648|NCT01970397|40245762|FG001|Overall Study|Protocol Violation|1|||
16483649|NCT02130297|40245763|FG000|Overall Study|Lost to Follow-up|4|||
16483650|NCT01964430|40245764|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
16483651|NCT01964430|40245765|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
16483652|NCT01964430|40245764|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
16483653|NCT01964430|40245765|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
16483654|NCT01964430|40245764|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
16483655|NCT01964430|40245765|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
16483656|NCT01964430|40245764|FG000|Treatment Period|Adverse Event|71|||
16483657|NCT01964430|40245765|FG001|Treatment Period|Adverse Event|37|||
16483658|NCT01964430|40245764|FG000|Treatment Period|Withdrawal by Subject|36|||
16483659|NCT01964430|40245765|FG001|Treatment Period|Withdrawal by Subject|27|||
16483660|NCT01964430|40245764|FG000|Treatment Period|Death|1|||
16483661|NCT01964430|40245765|FG001|Treatment Period|Death|3|||
16483662|NCT01964430|40245764|FG000|Treatment Period|Protocol Deviation|0|||
16483663|NCT01964430|40245765|FG001|Treatment Period|Protocol Deviation|1|||
16483664|NCT01964430|40245764|FG000|Treatment Period|Physician Decision|5|||
16483665|NCT01964430|40245765|FG001|Treatment Period|Physician Decision|4|||
16483666|NCT01964430|40245764|FG000|Treatment Period|Disease Relapse|28|||
16483667|NCT01964430|40245765|FG001|Treatment Period|Disease Relapse|38|||
16483668|NCT01964430|40245764|FG000|Treatment Period|Other reasons|1|||
16483669|NCT01964430|40245765|FG001|Treatment Period|Other reasons|3|||
16483670|NCT02899299|40245766|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
16483671|NCT02899299|40245767|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
16483672|NCT02899299|40245766|FG000|Pre-treatment|Participant withdrew consent|1|||
16483673|NCT02899299|40245767|FG001|Pre-treatment|Participant withdrew consent|11|||
16483674|NCT02899299|40245766|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
16483675|NCT02899299|40245767|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
16483676|NCT02899299|40245766|FG000|Pre-treatment|Not reported|0|||
16483677|NCT02899299|40245767|FG001|Pre-treatment|Not reported|1|||
16483678|NCT02899299|40245766|FG000|Treatment|Disease Progression|182|||
16483679|NCT02899299|40245767|FG001|Treatment|Disease Progression|43|||
16483680|NCT02899299|40245766|FG000|Treatment|Study Drug Toxicity|60|||
16483681|NCT02899299|40245767|FG001|Treatment|Study Drug Toxicity|24|||
16483682|NCT02899299|40245766|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
16483683|NCT02899299|40245767|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
16483684|NCT02899299|40245766|FG000|Treatment|Participant request to discontinue Study treatment|4|||
16483685|NCT02899299|40245767|FG001|Treatment|Participant request to discontinue Study treatment|10|||
16483686|NCT02899299|40245766|FG000|Treatment|Participant withdrew consent|6|||
16483687|NCT02899299|40245767|FG001|Treatment|Participant withdrew consent|3|||
16483688|NCT02899299|40245766|FG000|Treatment|Lost to Follow-up|0|||
16483689|NCT02899299|40245767|FG001|Treatment|Lost to Follow-up|2|||
16483690|NCT02899299|40245766|FG000|Treatment|Maximum Clinical Benefit|11|||
16483691|NCT02899299|40245767|FG001|Treatment|Maximum Clinical Benefit|2|||
16483692|NCT02899299|40245766|FG000|Treatment|Poor/Non-compliance|1|||
16081200|NCT00807937|38789522|FG003|Overall Study|Protocol Violation|3|||
16081201|NCT00807937|38789519|FG000|Overall Study|Withdrawal by Subject|5|||
16081202|NCT00807937|38789520|FG001|Overall Study|Withdrawal by Subject|4|||
16081203|NCT00807937|38789521|FG002|Overall Study|Withdrawal by Subject|1|||
16081204|NCT00807937|38789522|FG003|Overall Study|Withdrawal by Subject|4|||
16081205|NCT00807937|38789519|FG000|Overall Study|Lost to Follow-up|4|||
16081206|NCT00807937|38789520|FG001|Overall Study|Lost to Follow-up|0|||
16081207|NCT00807937|38789521|FG002|Overall Study|Lost to Follow-up|2|||
16081208|NCT00807937|38789522|FG003|Overall Study|Lost to Follow-up|1|||
16081209|NCT00807937|38789519|FG000|Overall Study|Lack of Efficacy|0|||
16081210|NCT00807937|38789520|FG001|Overall Study|Lack of Efficacy|0|||
16081211|NCT00807937|38789521|FG002|Overall Study|Lack of Efficacy|1|||
16081212|NCT00807937|38789522|FG003|Overall Study|Lack of Efficacy|2|||
16081213|NCT00807937|38789519|FG000|Overall Study|Intake of prohibited medicine|0|||
16483693|NCT02899299|40245767|FG001|Treatment|Poor/Non-compliance|0|||
16483694|NCT02899299|40245766|FG000|Treatment|Participant no longer meets Study criteria|4|||
16483695|NCT02899299|40245767|FG001|Treatment|Participant no longer meets Study criteria|0|||
16483696|NCT02899299|40245766|FG000|Treatment|Administrative reason by Sponsor|2|||
16483697|NCT02899299|40245767|FG001|Treatment|Administrative reason by Sponsor|0|||
16483698|NCT02899299|40245766|FG000|Treatment|Other reasons|12|||
16483699|NCT02899299|40245767|FG001|Treatment|Other reasons|2|||
16483700|NCT02899299|40245766|FG000|Treatment|Not reported|7|||
16483701|NCT02899299|40245767|FG001|Treatment|Not reported|0|||
16081214|NCT00807937|38789520|FG001|Overall Study|Intake of prohibited medicine|0|||
16081215|NCT00807937|38789521|FG002|Overall Study|Intake of prohibited medicine|2|||
16081216|NCT00807937|38789522|FG003|Overall Study|Intake of prohibited medicine|0|||
16081217|NCT00807937|38789519|FG000|Overall Study|All other reasons (not provided)|2|||
16081218|NCT00807937|38789520|FG001|Overall Study|All other reasons (not provided)|4|||
16483702|NCT02527161|40248634|FG000|Overall Study|Failed MRI|52|||
16483703|NCT02527161|40248634|FG000|Overall Study|Withdrawal by Subject|19|||
16483704|NCT02527161|40248634|FG000|Overall Study|Delay in or unfit for surgery|16|||
16081219|NCT00807937|38789521|FG002|Overall Study|All other reasons (not provided)|0|||
16081220|NCT00807937|38789522|FG003|Overall Study|All other reasons (not provided)|1|||
16081221|NCT04056624|38789527|FG000|Overall Study|Withdrawal by Subject|0|||
16081222|NCT04056624|38789528|FG001|Overall Study|Withdrawal by Subject|0|||
16483705|NCT02527161|40248634|FG000|Overall Study|MRI contraindication|6|||
16483706|NCT02527161|40248634|FG000|Overall Study|Consent violation|4|||
16483707|NCT02527161|40248634|FG000|Overall Study|Only Recruited to Part A|27|||
16483708|NCT02527161|40248634|FG000|Overall Study|Physician Decision|1|||
16483709|NCT02527161|40248634|FG000|Overall Study|Adverse Event|1|||
16483710|NCT02527161|40248634|FG000|Overall Study|Lost to Follow-up|6|||
16483711|NCT02582983|40248635|FG000|Overall Study|Death|3|||
16483712|NCT02582983|40248635|FG000|Overall Study|Withdrawal by Subject|2|||
16483713|NCT02582983|40248635|FG000|Overall Study|Adverse Event|1|||
16483714|NCT04930965|40248636|FG000|Overall Study|Lost to Follow-up|7|||
16483715|NCT04930965|40248637|FG001|Overall Study|Lost to Follow-up|5|||
16483716|NCT02564796|40248638|FG000|Overall Study|Physician Decision|2|||
16483717|NCT02564796|40248639|FG001|Overall Study|Physician Decision|2|||
16483718|NCT01281865|40248641|FG000|Overall Study|Adverse Event|1|||
16483719|NCT01281865|40248642|FG001|Overall Study|Adverse Event|1|||
16483720|NCT01281865|40248641|FG000|Overall Study|Withdrawal by Subject|1|||
16483721|NCT01281865|40248642|FG001|Overall Study|Withdrawal by Subject|0|||
16291274|NCT02149121|39550536|FG001|Main Study Period|Protocol Violation|0|||
16291275|NCT02149121|39550537|FG002|Main Study Period|Protocol Violation|0|||
16291276|NCT02149121|39550538|FG003|Main Study Period|Protocol Violation|0|||
16483722|NCT01281865|40248641|FG000|Overall Study|Lack of Efficacy|1|||
16483723|NCT01281865|40248642|FG001|Overall Study|Lack of Efficacy|0|||
16483724|NCT02993757|40248643|FG000|Overall Study|Non compliance with the protocol|155|||
16081223|NCT04056624|38789529|FG002|Overall Study|Withdrawal by Subject|1|||
16081224|NCT04056624|38789527|FG000|Overall Study|Protocol Violation|1|||
16081225|NCT04056624|38789528|FG001|Overall Study|Protocol Violation|2|||
16081226|NCT04056624|38789529|FG002|Overall Study|Protocol Violation|0|||
16081227|NCT02269475|38789532|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
16291277|NCT02149121|39550539|FG004|Main Study Period|Protocol Violation|0|||
16291278|NCT02149121|39550540|FG005|Main Study Period|Protocol Violation|0|||
16291279|NCT02149121|39550541|FG006|Main Study Period|Protocol Violation|0|||
16291280|NCT02149121|39550535|FG000|Main Study Period|Lost to Follow-up|2|||
16483725|NCT02993757|40248644|FG001|Overall Study|Non compliance with the protocol|170|||
16483726|NCT02993757|40248643|FG000|Overall Study|Lost to Follow-up|1|||
16081228|NCT02269475|38789533|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
16291281|NCT02149121|39550536|FG001|Main Study Period|Lost to Follow-up|1|||
16291282|NCT02149121|39550537|FG002|Main Study Period|Lost to Follow-up|0|||
16291283|NCT02149121|39550538|FG003|Main Study Period|Lost to Follow-up|0|||
16291284|NCT02149121|39550539|FG004|Main Study Period|Lost to Follow-up|0|||
16291285|NCT02149121|39550540|FG005|Main Study Period|Lost to Follow-up|0|||
16291286|NCT02149121|39550541|FG006|Main Study Period|Lost to Follow-up|0|||
16291287|NCT02149121|39550535|FG000|Main Study Period|Death|1|||
16291288|NCT02149121|39550536|FG001|Main Study Period|Death|0|||
16291289|NCT02149121|39550537|FG002|Main Study Period|Death|0|||
16291290|NCT02149121|39550538|FG003|Main Study Period|Death|0|||
16291291|NCT02149121|39550539|FG004|Main Study Period|Death|0|||
16291292|NCT02149121|39550540|FG005|Main Study Period|Death|0|||
16291293|NCT02149121|39550541|FG006|Main Study Period|Death|0|||
16291294|NCT02149121|39550535|FG000|Main Study Period|Physician Decision|1|||
16291295|NCT02149121|39550536|FG001|Main Study Period|Physician Decision|0|||
16291296|NCT02149121|39550537|FG002|Main Study Period|Physician Decision|0|||
16291297|NCT02149121|39550538|FG003|Main Study Period|Physician Decision|0|||
16291298|NCT02149121|39550539|FG004|Main Study Period|Physician Decision|0|||
16291299|NCT02149121|39550540|FG005|Main Study Period|Physician Decision|0|||
16291300|NCT02149121|39550541|FG006|Main Study Period|Physician Decision|0|||
16291301|NCT02149121|39550535|FG000|Main Study Period|Developed any malignancy|0|||
16380949|NCT02284191|39877734|FG000|Overall Study|Lost to Follow-up|1|||
16380950|NCT02284191|39877735|FG001|Overall Study|Lost to Follow-up|0|||
16380951|NCT00590967|39877736|FG000|Overall Study|Withdrawal by Subject|1|||
16380952|NCT00590967|39877737|FG001|Overall Study|Withdrawal by Subject|1|||
16483727|NCT02993757|40248644|FG001|Overall Study|Lost to Follow-up|0|||
16483728|NCT02993757|40248643|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
16291302|NCT02149121|39550536|FG001|Main Study Period|Developed any malignancy|1|||
16291303|NCT02149121|39550537|FG002|Main Study Period|Developed any malignancy|1|||
16291304|NCT02149121|39550538|FG003|Main Study Period|Developed any malignancy|0|||
16291305|NCT02149121|39550539|FG004|Main Study Period|Developed any malignancy|0|||
16380953|NCT00590967|39877736|FG000|Overall Study|Ineligible|1|||
16081229|NCT02269475|38789532|FG000|Overall Study|Withdrawal by Subject|0|||
16081230|NCT02269475|38789533|FG001|Overall Study|Withdrawal by Subject|1|||
16483729|NCT02993757|40248644|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
16483730|NCT01817530|40248645|FG000|Overall Study|Exclusionary Medication Received|0|||
16483731|NCT01817530|40248646|FG001|Overall Study|Exclusionary Medication Received|0|||
16483732|NCT01817530|40248647|FG002|Overall Study|Exclusionary Medication Received|0|||
16483733|NCT01817530|40248648|FG003|Overall Study|Exclusionary Medication Received|0|||
16483734|NCT01817530|40248649|FG004|Overall Study|Exclusionary Medication Received|1|||
16483735|NCT01817530|40248650|FG005|Overall Study|Exclusionary Medication Received|0|||
16483736|NCT01817530|40248651|FG006|Overall Study|Exclusionary Medication Received|0|||
16483737|NCT01817530|40248652|FG007|Overall Study|Exclusionary Medication Received|0|||
16483738|NCT01817530|40248645|FG000|Overall Study|Adverse Event|6|||
16483739|NCT01817530|40248646|FG001|Overall Study|Adverse Event|3|||
16483740|NCT01817530|40248647|FG002|Overall Study|Adverse Event|2|||
16483741|NCT01817530|40248648|FG003|Overall Study|Adverse Event|5|||
16081231|NCT00857649|38789535|FG000|Overall Study|Adverse Event|15|||
16081232|NCT00857649|38789536|FG001|Overall Study|Adverse Event|10|||
16081233|NCT00857649|38789535|FG000|Overall Study|Non-compliance|1|||
16081234|NCT00857649|38789536|FG001|Overall Study|Non-compliance|1|||
16483742|NCT01817530|40248649|FG004|Overall Study|Adverse Event|0|||
16483743|NCT01817530|40248650|FG005|Overall Study|Adverse Event|10|||
16483744|NCT01817530|40248651|FG006|Overall Study|Adverse Event|5|||
16483745|NCT01817530|40248652|FG007|Overall Study|Adverse Event|8|||
16483746|NCT01817530|40248645|FG000|Overall Study|Subject Noncompliant|3|||
16081235|NCT00857649|38789535|FG000|Overall Study|Protocol Violation|2|||
16081236|NCT00857649|38789536|FG001|Overall Study|Protocol Violation|2|||
16081237|NCT00857649|38789535|FG000|Overall Study|Withdrawal of Consent|10|||
16081238|NCT00857649|38789536|FG001|Overall Study|Withdrawal of Consent|7|||
16291306|NCT02149121|39550540|FG005|Main Study Period|Developed any malignancy|0|||
16291307|NCT02149121|39550541|FG006|Main Study Period|Developed any malignancy|0|||
16291308|NCT02149121|39550535|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
16291309|NCT02149121|39550536|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
16483747|NCT01817530|40248646|FG001|Overall Study|Subject Noncompliant|1|||
16483748|NCT01817530|40248647|FG002|Overall Study|Subject Noncompliant|0|||
16483749|NCT01817530|40248648|FG003|Overall Study|Subject Noncompliant|4|||
16483750|NCT01817530|40248649|FG004|Overall Study|Subject Noncompliant|0|||
16483751|NCT01817530|40248650|FG005|Overall Study|Subject Noncompliant|1|||
16483752|NCT01817530|40248651|FG006|Overall Study|Subject Noncompliant|1|||
16483753|NCT01817530|40248652|FG007|Overall Study|Subject Noncompliant|1|||
16483754|NCT01817530|40248645|FG000|Overall Study|Lack of Efficacy|1|||
16483755|NCT01817530|40248646|FG001|Overall Study|Lack of Efficacy|0|||
16483756|NCT01817530|40248647|FG002|Overall Study|Lack of Efficacy|0|||
16483757|NCT01817530|40248648|FG003|Overall Study|Lack of Efficacy|0|||
16483758|NCT01817530|40248649|FG004|Overall Study|Lack of Efficacy|0|||
16483759|NCT01817530|40248650|FG005|Overall Study|Lack of Efficacy|1|||
16483760|NCT01817530|40248651|FG006|Overall Study|Lack of Efficacy|0|||
16483761|NCT01817530|40248652|FG007|Overall Study|Lack of Efficacy|1|||
16483762|NCT01817530|40248645|FG000|Overall Study|Pregnancy|0|||
16483763|NCT01817530|40248646|FG001|Overall Study|Pregnancy|0|||
16483764|NCT01817530|40248647|FG002|Overall Study|Pregnancy|0|||
16483765|NCT01817530|40248648|FG003|Overall Study|Pregnancy|0|||
16483766|NCT01817530|40248649|FG004|Overall Study|Pregnancy|0|||
16483767|NCT01817530|40248650|FG005|Overall Study|Pregnancy|1|||
16483768|NCT01817530|40248651|FG006|Overall Study|Pregnancy|0|||
16483769|NCT01817530|40248652|FG007|Overall Study|Pregnancy|0|||
16483770|NCT01817530|40248645|FG000|Overall Study|Other|0|||
16483771|NCT01817530|40248646|FG001|Overall Study|Other|1|||
16483772|NCT01817530|40248647|FG002|Overall Study|Other|0|||
16483773|NCT01817530|40248648|FG003|Overall Study|Other|0|||
16483774|NCT01817530|40248649|FG004|Overall Study|Other|1|||
16483775|NCT01817530|40248650|FG005|Overall Study|Other|0|||
16483776|NCT01817530|40248651|FG006|Overall Study|Other|5|||
16483777|NCT01817530|40248652|FG007|Overall Study|Other|0|||
16483778|NCT01817530|40248645|FG000|Overall Study|Surgery or Invasive Intervention|1|||
16483779|NCT01817530|40248646|FG001|Overall Study|Surgery or Invasive Intervention|0|||
16483780|NCT01817530|40248647|FG002|Overall Study|Surgery or Invasive Intervention|0|||
16483781|NCT01817530|40248648|FG003|Overall Study|Surgery or Invasive Intervention|0|||
16483782|NCT01817530|40248649|FG004|Overall Study|Surgery or Invasive Intervention|1|||
16081239|NCT00857649|38789535|FG000|Overall Study|Nursing Home Placement|2|||
16081240|NCT00857649|38789536|FG001|Overall Study|Nursing Home Placement|9|||
16483783|NCT01817530|40248650|FG005|Overall Study|Surgery or Invasive Intervention|1|||
16483784|NCT01817530|40248651|FG006|Overall Study|Surgery or Invasive Intervention|1|||
16483785|NCT01817530|40248652|FG007|Overall Study|Surgery or Invasive Intervention|0|||
16483786|NCT01817530|40248645|FG000|Overall Study|Consent Withdrawn by Subject|3|||
16483787|NCT01817530|40248646|FG001|Overall Study|Consent Withdrawn by Subject|4|||
16483788|NCT01817530|40248647|FG002|Overall Study|Consent Withdrawn by Subject|7|||
16081241|NCT00857649|38789535|FG000|Overall Study|Other Reasons|1|||
16483789|NCT01817530|40248648|FG003|Overall Study|Consent Withdrawn by Subject|3|||
16483790|NCT01817530|40248649|FG004|Overall Study|Consent Withdrawn by Subject|5|||
16483791|NCT01817530|40248650|FG005|Overall Study|Consent Withdrawn by Subject|3|||
16483792|NCT01817530|40248651|FG006|Overall Study|Consent Withdrawn by Subject|3|||
16483793|NCT01817530|40248652|FG007|Overall Study|Consent Withdrawn by Subject|10|||
16483794|NCT01817530|40248645|FG000|Overall Study|Lost to Follow-up|1|||
16483795|NCT01817530|40248646|FG001|Overall Study|Lost to Follow-up|4|||
16483796|NCT01817530|40248647|FG002|Overall Study|Lost to Follow-up|2|||
16483797|NCT01817530|40248648|FG003|Overall Study|Lost to Follow-up|1|||
16483798|NCT01817530|40248649|FG004|Overall Study|Lost to Follow-up|3|||
16483799|NCT01817530|40248650|FG005|Overall Study|Lost to Follow-up|2|||
16483800|NCT01817530|40248651|FG006|Overall Study|Lost to Follow-up|8|||
16483801|NCT01817530|40248652|FG007|Overall Study|Lost to Follow-up|4|||
16483802|NCT03943147|40248653|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
16483803|NCT03943147|40248654|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
16483804|NCT03943147|40248653|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
16483805|NCT03943147|40248654|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
16483806|NCT03943147|40248653|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
16081242|NCT00857649|38789536|FG001|Overall Study|Other Reasons|3|||
16081243|NCT01250769|38789537|FG000|Overall Study|Withdrawal by Subject|0|||
16081244|NCT01250769|38789538|FG001|Overall Study|Withdrawal by Subject|1|||
16081245|NCT01250769|38789539|FG002|Overall Study|Withdrawal by Subject|1|||
16081246|NCT01250769|38789540|FG003|Overall Study|Withdrawal by Subject|0|||
16081247|NCT01250769|38789537|FG000|Overall Study|Adverse Event|0|||
16186584|NCT01259492|39161860|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
16186585|NCT01259492|39161861|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
16186586|NCT01259492|39161862|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
16186587|NCT00798967|39161863|FG000|Overall Study|Adverse Event|2|||
16186588|NCT00798967|39161864|FG001|Overall Study|Adverse Event|3|||
16186589|NCT00798967|39161863|FG000|Overall Study|Withdrawal by Subject|0|||
16186590|NCT00798967|39161864|FG001|Overall Study|Withdrawal by Subject|1|||
16186591|NCT00798967|39161863|FG000|Overall Study|Physician Decision|1|||
16186592|NCT00798967|39161864|FG001|Overall Study|Physician Decision|0|||
16186593|NCT00798967|39161863|FG000|Overall Study|Randomized in error by site|1|||
16186594|NCT00798967|39161864|FG001|Overall Study|Randomized in error by site|0|||
16186595|NCT01208662|39161866|FG000|Induction and Consolidation|Disease Progression|23|||
16186596|NCT01208662|39161867|FG001|Induction and Consolidation|Disease Progression|13|||
16186597|NCT01208662|39161868|FG002|Induction and Consolidation|Disease Progression|0|||
16186598|NCT01208662|39161866|FG000|Induction and Consolidation|Adverse Event|16|||
16186599|NCT01208662|39161867|FG001|Induction and Consolidation|Adverse Event|18|||
16186600|NCT01208662|39161868|FG002|Induction and Consolidation|Adverse Event|2|||
16186601|NCT01208662|39161866|FG000|Induction and Consolidation|MD or Participant Decision|16|||
16186602|NCT01208662|39161867|FG001|Induction and Consolidation|MD or Participant Decision|34|||
16186603|NCT01208662|39161868|FG002|Induction and Consolidation|MD or Participant Decision|4|||
16186604|NCT01208662|39161866|FG000|Induction and Consolidation|Death|1|||
16186605|NCT01208662|39161867|FG001|Induction and Consolidation|Death|3|||
16186606|NCT01208662|39161868|FG002|Induction and Consolidation|Death|1|||
16186607|NCT01208662|39161866|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
16291310|NCT02149121|39550537|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
16291311|NCT02149121|39550538|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
16291312|NCT02149121|39550539|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
16291313|NCT02149121|39550540|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
16291314|NCT02149121|39550541|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
16291315|NCT02149121|39550535|FG000|Main Study Period|Disease progression|0|||
16291316|NCT02149121|39550536|FG001|Main Study Period|Disease progression|1|||
16483807|NCT03943147|40248654|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
16483808|NCT03943147|40248653|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
16186608|NCT01208662|39161867|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
16186609|NCT01208662|39161868|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
16186610|NCT01208662|39161866|FG000|Maintenance|Disease Progression|156|||
16186611|NCT01208662|39161867|FG001|Maintenance|Disease Progression|102|||
16186612|NCT01208662|39161868|FG002|Maintenance|Disease Progression|0|||
16186613|NCT01208662|39161866|FG000|Maintenance|Adverse Event|12|||
16186614|NCT01208662|39161867|FG001|Maintenance|Adverse Event|28|||
16186615|NCT01208662|39161868|FG002|Maintenance|Adverse Event|0|||
16186616|NCT01208662|39161866|FG000|Maintenance|MD or Participant Decision|24|||
16186617|NCT01208662|39161867|FG001|Maintenance|MD or Participant Decision|36|||
16186618|NCT01208662|39161868|FG002|Maintenance|MD or Participant Decision|0|||
16291317|NCT02149121|39550537|FG002|Main Study Period|Disease progression|0|||
16291318|NCT02149121|39550538|FG003|Main Study Period|Disease progression|0|||
16291319|NCT02149121|39550539|FG004|Main Study Period|Disease progression|0|||
16483809|NCT03943147|40248654|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
16081248|NCT01250769|38789538|FG001|Overall Study|Adverse Event|0|||
16186619|NCT01208662|39161866|FG000|Maintenance|Death|0|||
16186620|NCT01208662|39161867|FG001|Maintenance|Death|3|||
16186621|NCT01208662|39161868|FG002|Maintenance|Death|0|||
16186622|NCT01208662|39161866|FG000|Maintenance|Discontinued for other reasons|21|||
16186623|NCT01208662|39161867|FG001|Maintenance|Discontinued for other reasons|31|||
16186624|NCT01208662|39161868|FG002|Maintenance|Discontinued for other reasons|0|||
16186625|NCT01208662|39161866|FG000|Maintenance|Still on Treatment|78|||
16186626|NCT01208662|39161867|FG001|Maintenance|Still on Treatment|89|||
16186627|NCT01208662|39161868|FG002|Maintenance|Still on Treatment|0|||
16186628|NCT02296840|39161871|FG000|Overall Study|Adverse Event|1|||
16186629|NCT02296840|39161872|FG001|Overall Study|Adverse Event|1|||
16186630|NCT02296840|39161871|FG000|Overall Study|Protocol Violation|2|||
16186631|NCT02296840|39161872|FG001|Overall Study|Protocol Violation|1|||
16186632|NCT02296840|39161871|FG000|Overall Study|Lost to Follow-up|6|||
16186633|NCT02296840|39161872|FG001|Overall Study|Lost to Follow-up|17|||
16186634|NCT01879618|39161882|FG000|Overall Study|Does not meet entrance criteria|1|||
16186635|NCT01879618|39161882|FG000|Overall Study|Withdrawal by Subject|1|||
16186636|NCT01879618|39161882|FG000|Overall Study|Surgery;changed schedule; not available|8|||
16186637|NCT01879618|39161882|FG000|Overall Study|Protocol Violation|6|||
16186638|NCT01879618|39161882|FG000|Overall Study|Adverse Event|5|||
16186639|NCT01455428|39161892|FG000|Overall Study|Protocol Violation|2|||
16186640|NCT01455428|39161893|FG001|Overall Study|Protocol Violation|1|||
16186641|NCT01455428|39161892|FG000|Overall Study|Adverse Event|6|||
16186642|NCT01455428|39161893|FG001|Overall Study|Adverse Event|2|||
16186643|NCT01455428|39161892|FG000|Overall Study|Lost to Follow-up|1|||
16186644|NCT01455428|39161893|FG001|Overall Study|Lost to Follow-up|1|||
16186645|NCT01455428|39161892|FG000|Overall Study|Withdrawal by Subject|2|||
16186646|NCT01455428|39161893|FG001|Overall Study|Withdrawal by Subject|5|||
16186647|NCT01455428|39161892|FG000|Overall Study|Did not meet entrance criteria|0|||
16186648|NCT01455428|39161893|FG001|Overall Study|Did not meet entrance criteria|2|||
16186649|NCT01455428|39161892|FG000|Overall Study|Insufficient clinical response|0|||
16186650|NCT01455428|39161893|FG001|Overall Study|Insufficient clinical response|2|||
16186651|NCT01455428|39161892|FG000|Overall Study|Did not receive treatment|1|||
16186652|NCT01455428|39161893|FG001|Overall Study|Did not receive treatment|1|||
16186653|NCT01455428|39161892|FG000|Overall Study|Other|2|||
16186654|NCT01455428|39161893|FG001|Overall Study|Other|4|||
16186655|NCT01000064|39161894|FG000|Overall Study|Withdrawal by Subject|1|||
16186656|NCT01000064|39161895|FG001|Overall Study|Withdrawal by Subject|1|||
16186657|NCT02606045|39161896|FG000|Overall Study|Study closed before treament could begin|1|||
16186658|NCT02606045|39161897|FG001|Overall Study|Study closed before treament could begin|2|||
16186659|NCT02612077|39161899|FG000|Overall Study|Adverse Event|3|||
16186660|NCT02612077|39161899|FG000|Overall Study|Withdrawal by Subject|9|||
16186661|NCT02612077|39161899|FG000|Overall Study|Protocol Violation|28|||
16186662|NCT02612077|39161899|FG000|Overall Study|Lost to Follow-up|20|||
16186663|NCT02612077|39161899|FG000|Overall Study|Death|377|||
16186664|NCT02612077|39161899|FG000|Overall Study|Moved or Changed Medical Team|23|||
16186665|NCT02612077|39161899|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
16186666|NCT02612077|39161899|FG000|Overall Study|Disease Progression|3|||
16186667|NCT02612077|39161899|FG000|Overall Study|Unknown reason|2|||
16186668|NCT01372878|39161903|FG000|Overall Study|Withdrawal by Subject|63|||
16186669|NCT01372878|39161903|FG000|Overall Study|Protocol Violation|17|||
16186670|NCT01372878|39161903|FG000|Overall Study|incomplete study procedure|104|||
16186671|NCT01555463|39161904|FG000|Treatment|Adverse Event|6|||
16186672|NCT01555463|39161905|FG001|Treatment|Adverse Event|12|||
16186673|NCT01555463|39161904|FG000|Treatment|Withdrawal by Subject|24|||
16186674|NCT01555463|39161905|FG001|Treatment|Withdrawal by Subject|36|||
16186675|NCT01555463|39161904|FG000|Treatment|Lost to Follow-up|28|||
16186676|NCT01555463|39161905|FG001|Treatment|Lost to Follow-up|23|||
16186677|NCT01555463|39161904|FG000|Treatment|Protocol Violation|4|||
16186678|NCT01555463|39161905|FG001|Treatment|Protocol Violation|5|||
16186679|NCT01555463|39161904|FG000|Treatment|Other reason|2|||
16186680|NCT01555463|39161905|FG001|Treatment|Other reason|3|||
16186681|NCT01555463|39161904|FG000|Follow up|Adverse Event|2|||
16186682|NCT01555463|39161905|FG001|Follow up|Adverse Event|5|||
16186683|NCT01555463|39161904|FG000|Follow up|Death|0|||
16186684|NCT01555463|39161905|FG001|Follow up|Death|1|||
16186685|NCT01555463|39161904|FG000|Follow up|Withdrawal by Subject|22|||
16186686|NCT01555463|39161905|FG001|Follow up|Withdrawal by Subject|22|||
16186687|NCT01555463|39161904|FG000|Follow up|Lost to Follow-up|9|||
16186688|NCT01555463|39161905|FG001|Follow up|Lost to Follow-up|10|||
16186689|NCT01555463|39161904|FG000|Follow up|Protocol Violation|2|||
16186690|NCT01555463|39161905|FG001|Follow up|Protocol Violation|4|||
16186691|NCT01555463|39161904|FG000|Follow up|Other reason|3|||
16186692|NCT01555463|39161905|FG001|Follow up|Other reason|3|||
16186693|NCT04160468|39161908|FG000|Overall Study|Lost to Follow-up|19|||
16186694|NCT04160468|39161909|FG001|Overall Study|Lost to Follow-up|4|||
16186695|NCT04160468|39161908|FG000|Overall Study|Randomized but not dosed|6|||
16186696|NCT04160468|39161909|FG001|Overall Study|Randomized but not dosed|0|||
16186697|NCT04160468|39161908|FG000|Overall Study|Withdrawal by Subject|4|||
16186698|NCT04160468|39161909|FG001|Overall Study|Withdrawal by Subject|1|||
16186699|NCT04160468|39161908|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
16186700|NCT04160468|39161909|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
16186701|NCT04160468|39161908|FG000|Overall Study|Participant incarcerated|1|||
16186702|NCT04160468|39161909|FG001|Overall Study|Participant incarcerated|0|||
16186703|NCT01254604|39161912|FG000|Overall Study|Lost to Follow-up|1|||
16186704|NCT01254604|39161913|FG001|Overall Study|Lost to Follow-up|1|||
16186705|NCT01254604|39161912|FG000|Overall Study|Protocol Violation|2|||
16186706|NCT01254604|39161913|FG001|Overall Study|Protocol Violation|2|||
16186707|NCT01254604|39161912|FG000|Overall Study|Withdrawal by Subject|2|||
16186708|NCT01254604|39161913|FG001|Overall Study|Withdrawal by Subject|4|||
16186709|NCT01254604|39161912|FG000|Overall Study|Adverse Event|3|||
16186710|NCT01254604|39161913|FG001|Overall Study|Adverse Event|2|||
16186711|NCT00496873|39161917|FG000|Overall Study|Ineligible|2|||
16186712|NCT00496873|39161917|FG000|Overall Study|Death|2|||
16186713|NCT00496873|39161917|FG000|Overall Study|Withdrawal by Subject|3|||
16186714|NCT00875017|39161920|FG000|First Intervention|Withdrawal by Subject|1|||
16186715|NCT00875017|39161921|FG001|First Intervention|Withdrawal by Subject|0|||
16186716|NCT00875017|39161922|FG002|First Intervention|Withdrawal by Subject|1|||
16186717|NCT00875017|39161923|FG003|First Intervention|Withdrawal by Subject|0|||
16186718|NCT00875017|39161924|FG004|First Intervention|Withdrawal by Subject|0|||
16186719|NCT00875017|39161925|FG005|First Intervention|Withdrawal by Subject|0|||
16186720|NCT00875017|39161920|FG000|First Intervention|Adverse Event|0|||
16186721|NCT00875017|39161921|FG001|First Intervention|Adverse Event|0|||
16186722|NCT00875017|39161922|FG002|First Intervention|Adverse Event|0|||
16380954|NCT00590967|39877737|FG001|Overall Study|Ineligible|0|||
16380955|NCT00590967|39877736|FG000|Overall Study|Poor performance status|0|||
16380956|NCT00590967|39877737|FG001|Overall Study|Poor performance status|1|||
16380957|NCT00590967|39877736|FG000|Overall Study|Non-compliant|0|||
16380958|NCT00590967|39877737|FG001|Overall Study|Non-compliant|2|||
16380959|NCT00590967|39877736|FG000|Overall Study|Did not sign consent form|0|||
16380960|NCT00590967|39877737|FG001|Overall Study|Did not sign consent form|1|||
16380961|NCT00590967|39877736|FG000|Overall Study|Did not receive chemo per protocol|1|||
16380962|NCT00590967|39877737|FG001|Overall Study|Did not receive chemo per protocol|0|||
16380963|NCT00829998|39877738|FG000|Washout|Adverse Event|0|||
16380964|NCT00829998|39877739|FG001|Washout|Adverse Event|1|||
16380965|NCT03787615|39877740|FG000|Overall Study|Withdrawal by Subject|2|||
16380966|NCT03787615|39877740|FG000|Overall Study|Lost to Follow-up|2|||
16380967|NCT03402841|39877741|FG000|Overall Study|Withdrawal by Subject|3|||
16380968|NCT03402841|39877741|FG000|Overall Study|Lost to Follow-up|2|||
16380969|NCT03402841|39877741|FG000|Overall Study|Death|146|||
16380970|NCT02684461|39877746|FG000|Overall Study|Adverse Event|1|||
16380971|NCT02684461|39877747|FG001|Overall Study|Adverse Event|0|||
16380972|NCT02684461|39877748|FG002|Overall Study|Adverse Event|0|||
16380973|NCT02684461|39877746|FG000|Overall Study|Lack of Efficacy|1|||
16186723|NCT00875017|39161923|FG003|First Intervention|Adverse Event|1|||
16186724|NCT00875017|39161924|FG004|First Intervention|Adverse Event|0|||
16186725|NCT00875017|39161925|FG005|First Intervention|Adverse Event|0|||
16186726|NCT00875017|39161920|FG000|First Intervention|Problems collecting rectal effluent|1|||
16186727|NCT00875017|39161921|FG001|First Intervention|Problems collecting rectal effluent|0|||
16186728|NCT00875017|39161922|FG002|First Intervention|Problems collecting rectal effluent|0|||
16186729|NCT00875017|39161923|FG003|First Intervention|Problems collecting rectal effluent|0|||
16186730|NCT00875017|39161924|FG004|First Intervention|Problems collecting rectal effluent|0|||
16186731|NCT00875017|39161925|FG005|First Intervention|Problems collecting rectal effluent|0|||
16186732|NCT00875017|39161920|FG000|First Intervention|Intolerance to nasogastric tube|0|||
16186733|NCT00875017|39161921|FG001|First Intervention|Intolerance to nasogastric tube|0|||
16186734|NCT00875017|39161922|FG002|First Intervention|Intolerance to nasogastric tube|0|||
16186735|NCT00875017|39161923|FG003|First Intervention|Intolerance to nasogastric tube|0|||
16186736|NCT00875017|39161924|FG004|First Intervention|Intolerance to nasogastric tube|1|||
16186737|NCT00875017|39161925|FG005|First Intervention|Intolerance to nasogastric tube|0|||
16186738|NCT00875017|39161920|FG000|Washout|Problem collecting rectal effluent|0|||
16186739|NCT00875017|39161921|FG001|Washout|Problem collecting rectal effluent|0|||
16186740|NCT00875017|39161922|FG002|Washout|Problem collecting rectal effluent|1|||
16186741|NCT00875017|39161923|FG003|Washout|Problem collecting rectal effluent|0|||
16186742|NCT00875017|39161924|FG004|Washout|Problem collecting rectal effluent|0|||
16186743|NCT00875017|39161925|FG005|Washout|Problem collecting rectal effluent|0|||
16186744|NCT00875017|39161920|FG000|Second Intervention|Adverse Event|0|||
16186745|NCT00875017|39161921|FG001|Second Intervention|Adverse Event|0|||
16186746|NCT00875017|39161922|FG002|Second Intervention|Adverse Event|0|||
16186747|NCT00875017|39161923|FG003|Second Intervention|Adverse Event|1|||
16186748|NCT00875017|39161924|FG004|Second Intervention|Adverse Event|0|||
16186749|NCT00875017|39161925|FG005|Second Intervention|Adverse Event|0|||
16380974|NCT02684461|39877747|FG001|Overall Study|Lack of Efficacy|2|||
16380975|NCT02684461|39877748|FG002|Overall Study|Lack of Efficacy|0|||
16380976|NCT01166646|39877752|FG000|Overall Study|Protocol Violation|0|||
16186750|NCT00875017|39161920|FG000|Washout|Problems collecting rectal effluent|0|||
16186751|NCT00875017|39161921|FG001|Washout|Problems collecting rectal effluent|1|||
16186752|NCT00875017|39161922|FG002|Washout|Problems collecting rectal effluent|0|||
16186753|NCT00875017|39161923|FG003|Washout|Problems collecting rectal effluent|0|||
16186754|NCT00875017|39161924|FG004|Washout|Problems collecting rectal effluent|0|||
16186755|NCT00875017|39161925|FG005|Washout|Problems collecting rectal effluent|0|||
16186756|NCT00875017|39161920|FG000|Third Intervention|Adverse Event|0|||
16186757|NCT00875017|39161921|FG001|Third Intervention|Adverse Event|1|||
16186758|NCT00875017|39161922|FG002|Third Intervention|Adverse Event|1|||
16186759|NCT00875017|39161923|FG003|Third Intervention|Adverse Event|0|||
16186760|NCT00875017|39161924|FG004|Third Intervention|Adverse Event|0|||
16186761|NCT00875017|39161925|FG005|Third Intervention|Adverse Event|0|||
16186762|NCT00875017|39161920|FG000|Washout|Withdrawal by Subject|0|||
16186763|NCT00875017|39161921|FG001|Washout|Withdrawal by Subject|0|||
16186764|NCT00875017|39161922|FG002|Washout|Withdrawal by Subject|0|||
16186765|NCT00875017|39161923|FG003|Washout|Withdrawal by Subject|0|||
16186766|NCT00875017|39161924|FG004|Washout|Withdrawal by Subject|1|||
16291320|NCT02149121|39550540|FG005|Main Study Period|Disease progression|0|||
16186767|NCT00875017|39161925|FG005|Washout|Withdrawal by Subject|0|||
16186768|NCT00875017|39161920|FG000|Fourth Intervention|Inability to comply with fasting|0|||
16291321|NCT02149121|39550541|FG006|Main Study Period|Disease progression|0|||
16291322|NCT02149121|39550535|FG000|Extension Study Period|Withdrawal by Subject|0|||
16291323|NCT02149121|39550536|FG001|Extension Study Period|Withdrawal by Subject|0|||
16291324|NCT02149121|39550537|FG002|Extension Study Period|Withdrawal by Subject|0|||
16291325|NCT02149121|39550538|FG003|Extension Study Period|Withdrawal by Subject|1|||
16291326|NCT02149121|39550539|FG004|Extension Study Period|Withdrawal by Subject|0|||
16291327|NCT02149121|39550540|FG005|Extension Study Period|Withdrawal by Subject|2|||
16291328|NCT02149121|39550541|FG006|Extension Study Period|Withdrawal by Subject|0|||
16291329|NCT02914236|39550543|FG000|Overall Study|Lost to Follow-up|1|||
16291330|NCT02493777|39550552|FG000|Overall Study|Lost to Follow-up|0|||
16291331|NCT02493777|39550553|FG001|Overall Study|Lost to Follow-up|1|||
16291332|NCT01780987|39550554|FG000|Overall Study|Adverse Event|0|||
16291333|NCT01780987|39550555|FG001|Overall Study|Adverse Event|4|||
16291334|NCT01780987|39550554|FG000|Overall Study|Withdrawal by Subject|2|||
16291335|NCT01780987|39550555|FG001|Overall Study|Withdrawal by Subject|0|||
16291336|NCT01780987|39550554|FG000|Overall Study|Request of Changing Hospital|0|||
16291337|NCT01780987|39550555|FG001|Overall Study|Request of Changing Hospital|1|||
16291338|NCT01780987|39550554|FG000|Overall Study|Changing Residence|1|||
16291339|NCT01780987|39550555|FG001|Overall Study|Changing Residence|0|||
16291340|NCT01780987|39550554|FG000|Overall Study|Not Receiving any Study Medication|0|||
16291341|NCT01780987|39550555|FG001|Overall Study|Not Receiving any Study Medication|1|||
16186769|NCT00875017|39161921|FG001|Fourth Intervention|Inability to comply with fasting|0|||
16186770|NCT00875017|39161922|FG002|Fourth Intervention|Inability to comply with fasting|0|||
16186771|NCT00875017|39161923|FG003|Fourth Intervention|Inability to comply with fasting|0|||
16186772|NCT00875017|39161924|FG004|Fourth Intervention|Inability to comply with fasting|0|||
16186773|NCT00875017|39161925|FG005|Fourth Intervention|Inability to comply with fasting|1|||
16186774|NCT01103349|39161930|FG000|Overall Study|Adverse Event|8|||
16186775|NCT01103349|39161931|FG001|Overall Study|Adverse Event|5|||
16186776|NCT01103349|39161932|FG002|Overall Study|Adverse Event|3|||
16186777|NCT01103349|39161930|FG000|Overall Study|Consent withdrawn|1|||
16186778|NCT01103349|39161931|FG001|Overall Study|Consent withdrawn|0|||
16291342|NCT01550744|39550559|FG000|Open-Label|Lost to Follow-up|7|||
16291343|NCT01550744|39550560|FG001|Open-Label|Lost to Follow-up|0|||
16291344|NCT01550744|39550561|FG002|Open-Label|Lost to Follow-up|0|||
16291345|NCT01550744|39550559|FG000|Open-Label|Withdrawal by Subject|13|||
16291346|NCT01550744|39550560|FG001|Open-Label|Withdrawal by Subject|0|||
16291347|NCT01550744|39550561|FG002|Open-Label|Withdrawal by Subject|0|||
16291348|NCT01550744|39550559|FG000|Open-Label|Adverse Event|11|||
16291349|NCT01550744|39550560|FG001|Open-Label|Adverse Event|0|||
16291350|NCT01550744|39550561|FG002|Open-Label|Adverse Event|0|||
16291351|NCT01550744|39550559|FG000|Open-Label|Lack of Efficacy|4|||
16291352|NCT01550744|39550560|FG001|Open-Label|Lack of Efficacy|0|||
16291353|NCT01550744|39550561|FG002|Open-Label|Lack of Efficacy|0|||
16291354|NCT01550744|39550559|FG000|Open-Label|Protocol Violation|4|||
16291355|NCT01550744|39550560|FG001|Open-Label|Protocol Violation|0|||
16291356|NCT01550744|39550561|FG002|Open-Label|Protocol Violation|0|||
16291357|NCT01550744|39550559|FG000|Open-Label|Not all 3 study drug injections received|2|||
16291358|NCT01550744|39550560|FG001|Open-Label|Not all 3 study drug injections received|0|||
16291359|NCT01550744|39550561|FG002|Open-Label|Not all 3 study drug injections received|0|||
16291360|NCT01550744|39550559|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
16291361|NCT01550744|39550560|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
16291362|NCT01550744|39550561|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
16483810|NCT03943147|40248653|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
16186779|NCT01103349|39161932|FG002|Overall Study|Consent withdrawn|0|||
16186780|NCT01103349|39161930|FG000|Overall Study|Incorrectly included in the trial|1|||
16291363|NCT01550744|39550559|FG000|Open-Label|Other|1|||
16291364|NCT01550744|39550560|FG001|Open-Label|Other|0|||
16291365|NCT01550744|39550561|FG002|Open-Label|Other|0|||
16291366|NCT01550744|39550559|FG000|Double-Blind|Lost to Follow-up|0|||
16291367|NCT01550744|39550560|FG001|Double-Blind|Lost to Follow-up|6|||
16291368|NCT01550744|39550561|FG002|Double-Blind|Lost to Follow-up|12|||
16291369|NCT01550744|39550559|FG000|Double-Blind|Withdrawal by Subject|0|||
16291370|NCT01550744|39550560|FG001|Double-Blind|Withdrawal by Subject|2|||
16291371|NCT01550744|39550561|FG002|Double-Blind|Withdrawal by Subject|15|||
16291372|NCT01550744|39550559|FG000|Double-Blind|Adverse Event|0|||
16291373|NCT01550744|39550560|FG001|Double-Blind|Adverse Event|4|||
16081249|NCT01250769|38789539|FG002|Overall Study|Adverse Event|1|||
16081250|NCT01250769|38789540|FG003|Overall Study|Adverse Event|0|||
16081251|NCT02275611|38789541|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
16081252|NCT02275611|38789542|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
16081253|NCT02275611|38789543|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
16081254|NCT02275611|38789544|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
16081255|NCT01113931|38789545|FG000|Overall Study|Adverse Event|2|||
16081256|NCT01113931|38789546|FG001|Overall Study|Adverse Event|2|||
16291374|NCT01550744|39550561|FG002|Double-Blind|Adverse Event|15|||
16291375|NCT01550744|39550559|FG000|Double-Blind|Death|0|||
16380977|NCT01166646|39877753|FG001|Overall Study|Protocol Violation|1|||
16186781|NCT01103349|39161931|FG001|Overall Study|Incorrectly included in the trial|0|||
16186782|NCT01103349|39161932|FG002|Overall Study|Incorrectly included in the trial|0|||
16186783|NCT01103349|39161930|FG000|Overall Study|Withdrawal by Subject|1|||
16186784|NCT01103349|39161931|FG001|Overall Study|Withdrawal by Subject|1|||
16186785|NCT01103349|39161932|FG002|Overall Study|Withdrawal by Subject|0|||
16186786|NCT01103349|39161930|FG000|Overall Study|did not want to take trial medication|0|||
16186787|NCT01103349|39161931|FG001|Overall Study|did not want to take trial medication|1|||
16186788|NCT01103349|39161932|FG002|Overall Study|did not want to take trial medication|0|||
16186789|NCT01103349|39161930|FG000|Overall Study|forgot to take medication|0|||
16186790|NCT01103349|39161931|FG001|Overall Study|forgot to take medication|0|||
16186791|NCT01103349|39161932|FG002|Overall Study|forgot to take medication|1|||
16186792|NCT04370028|39161933|FG000|Overall Study|Withdrawal by Subject|695|||
16186793|NCT04370028|39161933|FG000|Overall Study|Protocol Violation|9|||
16186794|NCT04370028|39161933|FG000|Overall Study|Adverse Event|3|||
16186795|NCT01166659|39161935|FG000|Overall Study|Subject Decision|8|||
16186796|NCT01166659|39161935|FG000|Overall Study|Investigator Decision|2|||
16186797|NCT01166659|39161935|FG000|Overall Study|Death|1|||
16186798|NCT01166659|39161935|FG000|Overall Study|Lost to Follow-up|1|||
16186799|NCT01166659|39161935|FG000|Overall Study|Study Closed at Site|1|||
16186800|NCT01614769|39161937|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
16186801|NCT01614769|39161938|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
16186802|NCT01614769|39161939|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
16186803|NCT01614769|39161940|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
16186804|NCT01614769|39161941|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
16186805|NCT01614769|39161942|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
16186806|NCT01614769|39161937|FG000|Period 1|Protocol Violation|0|||
16186807|NCT01614769|39161938|FG001|Period 1|Protocol Violation|0|||
16186808|NCT01614769|39161939|FG002|Period 1|Protocol Violation|0|||
16186809|NCT01614769|39161940|FG003|Period 1|Protocol Violation|1|||
16186810|NCT01614769|39161941|FG004|Period 1|Protocol Violation|0|||
16186811|NCT01614769|39161942|FG005|Period 1|Protocol Violation|0|||
16186812|NCT01614769|39161937|FG000|Period 1|Withdrawal by Subject|1|||
16186813|NCT01614769|39161938|FG001|Period 1|Withdrawal by Subject|0|||
16186814|NCT01614769|39161939|FG002|Period 1|Withdrawal by Subject|0|||
16186815|NCT01614769|39161940|FG003|Period 1|Withdrawal by Subject|0|||
16186816|NCT01614769|39161941|FG004|Period 1|Withdrawal by Subject|0|||
16186817|NCT01614769|39161942|FG005|Period 1|Withdrawal by Subject|0|||
16186818|NCT01614769|39161937|FG000|Period 3|Withdrawal by Subject|0|||
16186819|NCT01614769|39161938|FG001|Period 3|Withdrawal by Subject|0|||
16186820|NCT01614769|39161939|FG002|Period 3|Withdrawal by Subject|1|||
16186821|NCT01614769|39161940|FG003|Period 3|Withdrawal by Subject|0|||
16186822|NCT01614769|39161941|FG004|Period 3|Withdrawal by Subject|0|||
16186823|NCT01614769|39161942|FG005|Period 3|Withdrawal by Subject|0|||
16186824|NCT01518699|39161943|FG000|Period 2|Protocol Violation|1|||
16186825|NCT01518699|39161944|FG001|Period 2|Protocol Violation|1|||
16186826|NCT01518699|39161945|FG002|Period 2|Protocol Violation|0|||
16186827|NCT01518699|39161946|FG003|Period 2|Protocol Violation|0|||
16186828|NCT01518699|39161947|FG004|Period 2|Protocol Violation|0|||
16081257|NCT01113931|38789545|FG000|Overall Study|Physician Decision|0|||
16081258|NCT01113931|38789546|FG001|Overall Study|Physician Decision|2|||
16186829|NCT01518699|39161948|FG005|Period 2|Protocol Violation|0|||
16186830|NCT01518699|39161943|FG000|Period 2|Lost to Follow-up|0|||
16186831|NCT01518699|39161944|FG001|Period 2|Lost to Follow-up|1|||
16186832|NCT01518699|39161945|FG002|Period 2|Lost to Follow-up|0|||
16186833|NCT01518699|39161946|FG003|Period 2|Lost to Follow-up|0|||
16291376|NCT01550744|39550560|FG001|Double-Blind|Death|1|||
16081259|NCT01113931|38789545|FG000|Overall Study|Lost to Follow-up|12|||
16081260|NCT01113931|38789546|FG001|Overall Study|Lost to Follow-up|9|||
16081261|NCT01113931|38789545|FG000|Overall Study|Various|2|||
16081262|NCT01113931|38789546|FG001|Overall Study|Various|4|||
16081263|NCT01113931|38789545|FG000|Overall Study|Withdrawal by Subject|3|||
16081264|NCT01113931|38789546|FG001|Overall Study|Withdrawal by Subject|0|||
16081265|NCT02556138|38789548|FG000|Overall Study|Withdrawal by Subject|1|||
16081266|NCT01036724|38789549|FG000|Overall Study|Adverse Event|1|||
16081267|NCT01036724|38789550|FG001|Overall Study|Adverse Event|2|||
16186834|NCT01518699|39161947|FG004|Period 2|Lost to Follow-up|0|||
16186835|NCT01518699|39161948|FG005|Period 2|Lost to Follow-up|0|||
16186836|NCT01518699|39161943|FG000|Period 2|Adverse Event|1|||
16186837|NCT01518699|39161944|FG001|Period 2|Adverse Event|0|||
16186838|NCT01518699|39161945|FG002|Period 2|Adverse Event|0|||
16186839|NCT01518699|39161946|FG003|Period 2|Adverse Event|0|||
16186840|NCT01518699|39161947|FG004|Period 2|Adverse Event|0|||
16186841|NCT01518699|39161948|FG005|Period 2|Adverse Event|0|||
16186842|NCT04594239|39161949|FG000|Overall Study|Withdrawal by Subject|3|||
16186843|NCT04594239|39161950|FG001|Overall Study|Withdrawal by Subject|4|||
16186844|NCT04594239|39161951|FG002|Overall Study|Withdrawal by Subject|2|||
16186845|NCT04594239|39161952|FG003|Overall Study|Withdrawal by Subject|4|||
16186846|NCT04594239|39161949|FG000|Overall Study|Lost to Follow-up|8|||
16186847|NCT04594239|39161950|FG001|Overall Study|Lost to Follow-up|5|||
16186848|NCT04594239|39161951|FG002|Overall Study|Lost to Follow-up|4|||
16186849|NCT04594239|39161952|FG003|Overall Study|Lost to Follow-up|6|||
16291377|NCT01550744|39550561|FG002|Double-Blind|Death|0|||
16291378|NCT01550744|39550559|FG000|Double-Blind|Lack of Efficacy|0|||
16291379|NCT01550744|39550560|FG001|Double-Blind|Lack of Efficacy|2|||
16291380|NCT01550744|39550561|FG002|Double-Blind|Lack of Efficacy|8|||
16291381|NCT01550744|39550559|FG000|Double-Blind|Protocol Violation|0|||
16291382|NCT01550744|39550560|FG001|Double-Blind|Protocol Violation|0|||
16291383|NCT01550744|39550561|FG002|Double-Blind|Protocol Violation|4|||
16291384|NCT01550744|39550559|FG000|Double-Blind|Pregnancy|0|||
16291385|NCT01550744|39550560|FG001|Double-Blind|Pregnancy|0|||
16291386|NCT01550744|39550561|FG002|Double-Blind|Pregnancy|3|||
16291387|NCT01550744|39550559|FG000|Double-Blind|Other|0|||
16291388|NCT01550744|39550560|FG001|Double-Blind|Other|2|||
16291389|NCT01550744|39550561|FG002|Double-Blind|Other|10|||
16291390|NCT01951885|39550564|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
16291391|NCT01951885|39550565|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
16291392|NCT01951885|39550564|FG000|Overall Study|Adverse Event|1|||
16291393|NCT01951885|39550565|FG001|Overall Study|Adverse Event|0|||
16291394|NCT01951885|39550564|FG000|Overall Study|Withdrawal by Subject|0|||
16291395|NCT01951885|39550565|FG001|Overall Study|Withdrawal by Subject|1|||
16291396|NCT01951885|39550564|FG000|Overall Study|ineligible due to a change in donor|0|||
16291397|NCT01951885|39550565|FG001|Overall Study|ineligible due to a change in donor|1|||
16291398|NCT01951885|39550564|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
16291399|NCT01951885|39550565|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
16291400|NCT02331368|39550573|FG000|Overall Study|Withdrawal by Subject|3|||
16291401|NCT00415194|39550574|FG000|Overall Study|Adverse Event|37|||
16291402|NCT00415194|39550575|FG001|Overall Study|Adverse Event|32|||
16291403|NCT00415194|39550574|FG000|Overall Study|Entry Criteria Not Met|4|||
16291404|NCT00415194|39550575|FG001|Overall Study|Entry Criteria Not Met|8|||
16291405|NCT00415194|39550574|FG000|Overall Study|Lost to Follow-up|1|||
16291406|NCT00415194|39550575|FG001|Overall Study|Lost to Follow-up|0|||
16291407|NCT00415194|39550574|FG000|Overall Study|Physician Decision|10|||
16291408|NCT00415194|39550575|FG001|Overall Study|Physician Decision|16|||
16291409|NCT00415194|39550574|FG000|Overall Study|Progressive Disease|180|||
16291410|NCT00415194|39550575|FG001|Overall Study|Progressive Disease|217|||
16291411|NCT00415194|39550574|FG000|Overall Study|Protocol Violation|4|||
16291412|NCT00415194|39550575|FG001|Overall Study|Protocol Violation|2|||
16291413|NCT00415194|39550574|FG000|Overall Study|Withdrawal by Subject|28|||
16291414|NCT00415194|39550575|FG001|Overall Study|Withdrawal by Subject|21|||
16291415|NCT00415194|39550574|FG000|Overall Study|Death Due to Study Disease|26|||
16291416|NCT00415194|39550575|FG001|Overall Study|Death Due to Study Disease|29|||
16291417|NCT00415194|39550574|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
16291418|NCT00415194|39550575|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
16291419|NCT00415194|39550574|FG000|Overall Study|Death Due to Procedural Related AE|0|||
16291420|NCT00415194|39550575|FG001|Overall Study|Death Due to Procedural Related AE|1|||
16291421|NCT00415194|39550574|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
16291422|NCT00415194|39550575|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
16081268|NCT01036724|38789549|FG000|Overall Study|Lack of Efficacy|1|||
16081269|NCT01036724|38789550|FG001|Overall Study|Lack of Efficacy|1|||
16081270|NCT01036724|38789549|FG000|Overall Study|Protocol Violation|4|||
16081271|NCT01036724|38789550|FG001|Overall Study|Protocol Violation|5|||
16186850|NCT04594239|39161949|FG000|Overall Study|Subject relocated|0|||
16186851|NCT04594239|39161950|FG001|Overall Study|Subject relocated|0|||
16186852|NCT04594239|39161951|FG002|Overall Study|Subject relocated|0|||
16291423|NCT02128217|39550578|FG000|Overall Study|Lost to Follow-up|0|||
16380978|NCT01166646|39877752|FG000|Overall Study|Adverse Event|1|||
16380979|NCT01166646|39877753|FG001|Overall Study|Adverse Event|0|||
16380980|NCT03058952|39877754|FG000|Overall Study|Adverse Event|1|||
16380981|NCT03058952|39877755|FG001|Overall Study|Adverse Event|0|||
16380982|NCT03058952|39877754|FG000|Overall Study|Lost to Follow-up|15|||
16380983|NCT03058952|39877755|FG001|Overall Study|Lost to Follow-up|15|||
16380984|NCT03058952|39877754|FG000|Overall Study|Withdrawal by Subject|7|||
16380985|NCT03058952|39877755|FG001|Overall Study|Withdrawal by Subject|11|||
16380986|NCT02919618|39877756|FG000|Overall Study|Death|1|||
16380987|NCT00209131|39877757|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
16380988|NCT00209131|39877758|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
16380989|NCT00654732|39877759|FG000|Overall Study|Adverse Event|4|||
16380990|NCT00654732|39877760|FG001|Overall Study|Adverse Event|6|||
16380991|NCT01972659|39877761|FG000|Overall Study|Protocol Violation|2|||
16380992|NCT01972659|39877762|FG001|Overall Study|Protocol Violation|2|||
16380993|NCT01972659|39877761|FG000|Overall Study|problems realted to acceleromyograph|2|||
16380994|NCT01972659|39877762|FG001|Overall Study|problems realted to acceleromyograph|1|||
16380995|NCT00480532|39877763|FG000|Overall Study|Withdrawal by Subject|2|||
16380996|NCT00480532|39877764|FG001|Overall Study|Withdrawal by Subject|4|||
16380997|NCT00480532|39877765|FG002|Overall Study|Withdrawal by Subject|3|||
16380998|NCT00480532|39877766|FG003|Overall Study|Withdrawal by Subject|1|||
16380999|NCT00480532|39877763|FG000|Overall Study|Protocol Violation|0|||
16381000|NCT00480532|39877764|FG001|Overall Study|Protocol Violation|0|||
16381001|NCT00480532|39877765|FG002|Overall Study|Protocol Violation|1|||
16381002|NCT00480532|39877766|FG003|Overall Study|Protocol Violation|0|||
16381003|NCT00543985|39877771|FG000|Overall Study|Withdrawal by Subject|4|||
16381004|NCT00027560|39877777|FG000|Overall Study|Withdrawal by Subject|1|||
16381005|NCT02526290|39877781|FG000|Overall Study|Adverse Event|3|||
16381006|NCT02526290|39877781|FG000|Overall Study|Withdrawal by Subject|4|||
16381007|NCT02526290|39877781|FG000|Overall Study|Physician Decision|1|||
16381008|NCT00829868|39877782|FG000|Washout|Physician Decision|1|||
16381009|NCT00829868|39877783|FG001|Washout|Physician Decision|0|||
16381010|NCT02367456|39877784|FG000|Overall Study|Death|8|||
16381011|NCT02367456|39877785|FG001|Overall Study|Death|24|||
16381012|NCT02367456|39877786|FG002|Overall Study|Death|17|||
16291424|NCT02128217|39550579|FG001|Overall Study|Lost to Follow-up|1|||
16291425|NCT01280617|39550584|FG000|Overall Study|Adverse Event|0|||
16291426|NCT01280617|39550585|FG001|Overall Study|Adverse Event|1|||
16291427|NCT03970837|39550586|FG000|Overall Study|Adverse Event|23|||
16291428|NCT03970837|39550587|FG001|Overall Study|Adverse Event|20|||
16291429|NCT03970837|39550588|FG002|Overall Study|Adverse Event|16|||
16291430|NCT03970837|39550589|FG003|Overall Study|Adverse Event|6|||
16291431|NCT03970837|39550590|FG004|Overall Study|Adverse Event|4|||
16291432|NCT03970837|39550591|FG005|Overall Study|Adverse Event|5|||
16291433|NCT03970837|39550592|FG006|Overall Study|Adverse Event|1|||
16291434|NCT03970837|39550593|FG007|Overall Study|Adverse Event|5|||
16291435|NCT03970837|39550594|FG008|Overall Study|Adverse Event|0|||
16291436|NCT03970837|39550595|FG009|Overall Study|Adverse Event|0|||
16291437|NCT03970837|39550596|FG010|Overall Study|Adverse Event|1|||
16291438|NCT03970837|39550597|FG011|Overall Study|Adverse Event|1|||
16291439|NCT03970837|39550586|FG000|Overall Study|Lack of Efficacy|14|||
16291440|NCT03970837|39550587|FG001|Overall Study|Lack of Efficacy|12|||
16291441|NCT03970837|39550588|FG002|Overall Study|Lack of Efficacy|1|||
16381013|NCT02367456|39877784|FG000|Overall Study|Lost to Follow-up|1|||
16381014|NCT02367456|39877785|FG001|Overall Study|Lost to Follow-up|3|||
16381015|NCT02367456|39877786|FG002|Overall Study|Lost to Follow-up|1|||
16381016|NCT02367456|39877784|FG000|Overall Study|Other reason|3|||
16381017|NCT02367456|39877785|FG001|Overall Study|Other reason|3|||
16381018|NCT02367456|39877786|FG002|Overall Study|Other reason|9|||
16381019|NCT02367456|39877784|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
16381020|NCT02367456|39877785|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
16381021|NCT02367456|39877786|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
16381022|NCT02259114|39877787|FG000|Overall Study|Progressive Disease|14|||
16381023|NCT02259114|39877788|FG001|Overall Study|Progressive Disease|2|||
16381024|NCT02259114|39877789|FG002|Overall Study|Progressive Disease|10|||
16381025|NCT02259114|39877790|FG003|Overall Study|Progressive Disease|2|||
16381026|NCT02259114|39877791|FG004|Overall Study|Progressive Disease|5|||
16081272|NCT00077675|38789552|FG000|Overall Study|Adverse Event|1|||
16291442|NCT03970837|39550589|FG003|Overall Study|Lack of Efficacy|2|||
16291443|NCT03970837|39550590|FG004|Overall Study|Lack of Efficacy|3|||
16291444|NCT03970837|39550591|FG005|Overall Study|Lack of Efficacy|4|||
16291445|NCT03970837|39550592|FG006|Overall Study|Lack of Efficacy|6|||
16381027|NCT02259114|39877787|FG000|Overall Study|Adverse Event|2|||
16381028|NCT02259114|39877788|FG001|Overall Study|Adverse Event|1|||
16381029|NCT02259114|39877789|FG002|Overall Study|Adverse Event|0|||
16291446|NCT03970837|39550593|FG007|Overall Study|Lack of Efficacy|1|||
16291447|NCT03970837|39550594|FG008|Overall Study|Lack of Efficacy|1|||
16291448|NCT03970837|39550595|FG009|Overall Study|Lack of Efficacy|0|||
16291449|NCT03970837|39550596|FG010|Overall Study|Lack of Efficacy|0|||
16291450|NCT03970837|39550597|FG011|Overall Study|Lack of Efficacy|0|||
16291451|NCT03970837|39550586|FG000|Overall Study|Lost to Follow-up|6|||
16291452|NCT03970837|39550587|FG001|Overall Study|Lost to Follow-up|5|||
16291453|NCT03970837|39550588|FG002|Overall Study|Lost to Follow-up|5|||
16291454|NCT03970837|39550589|FG003|Overall Study|Lost to Follow-up|1|||
16291455|NCT03970837|39550590|FG004|Overall Study|Lost to Follow-up|0|||
16291456|NCT03970837|39550591|FG005|Overall Study|Lost to Follow-up|2|||
16291457|NCT03970837|39550592|FG006|Overall Study|Lost to Follow-up|0|||
16291458|NCT03970837|39550593|FG007|Overall Study|Lost to Follow-up|0|||
16291459|NCT03970837|39550594|FG008|Overall Study|Lost to Follow-up|0|||
16291460|NCT03970837|39550595|FG009|Overall Study|Lost to Follow-up|0|||
16291461|NCT03970837|39550596|FG010|Overall Study|Lost to Follow-up|0|||
16291462|NCT03970837|39550597|FG011|Overall Study|Lost to Follow-up|0|||
16291463|NCT03970837|39550586|FG000|Overall Study|Protocol Violation|1|||
16291464|NCT03970837|39550587|FG001|Overall Study|Protocol Violation|0|||
16291465|NCT03970837|39550588|FG002|Overall Study|Protocol Violation|0|||
16483811|NCT03943147|40248654|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
16483812|NCT03943147|40248653|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
16081273|NCT00077675|38789553|FG001|Overall Study|Adverse Event|2|||
16081274|NCT00077675|38789552|FG000|Overall Study|Lost to Follow-up|6|||
16483813|NCT03943147|40248654|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
16483814|NCT02763462|40248655|FG000|Overall Study|Protocol Violation|6|||
16483815|NCT03727230|40248656|FG000|Overall Study|Lost to Follow-up|12|||
16483816|NCT00231842|40248658|FG000|Overall Study|Withdrawal by Subject|3|||
16483817|NCT00231842|40248658|FG000|Overall Study|Did not complete the last 3 cycle|8|||
16483818|NCT00316719|40248663|FG000|Overall Study|Adverse Event|0|||
16483819|NCT00316719|40248664|FG001|Overall Study|Adverse Event|6|||
16483820|NCT00316719|40248663|FG000|Overall Study|Consent withdrawn|2|||
16483821|NCT00316719|40248664|FG001|Overall Study|Consent withdrawn|0|||
16081275|NCT00077675|38789553|FG001|Overall Study|Lost to Follow-up|3|||
16081276|NCT00077675|38789552|FG000|Overall Study|Withdrawal by Subject|1|||
16081277|NCT00077675|38789553|FG001|Overall Study|Withdrawal by Subject|0|||
16081278|NCT00077675|38789552|FG000|Overall Study|Other|0|||
16081279|NCT00077675|38789553|FG001|Overall Study|Other|1|||
16081280|NCT00077675|38789552|FG000|Overall Study|Never received study treatment|3|||
16081281|NCT00077675|38789553|FG001|Overall Study|Never received study treatment|3|||
16081282|NCT01808339|38789554|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16483822|NCT01604408|40248666|FG000|Treatment Period 1|Protocol Violation|0|||
16483823|NCT01604408|40248667|FG001|Treatment Period 1|Protocol Violation|1|||
16483824|NCT01604408|40248666|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16483825|NCT01604408|40248667|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16081283|NCT01808339|38789555|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16081284|NCT01808339|38789556|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16081285|NCT01808339|38789557|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
16081286|NCT01808339|38789558|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
16081287|NCT01808339|38789559|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
16081288|NCT01808339|38789554|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16081289|NCT01808339|38789555|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16081290|NCT01808339|38789556|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16081291|NCT01808339|38789557|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16081292|NCT01808339|38789558|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16483826|NCT01604408|40248666|FG000|Treatment Period 2|Protocol Violation|1|||
16081293|NCT01808339|38789559|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16186853|NCT04594239|39161952|FG003|Overall Study|Subject relocated|1|||
16291466|NCT03970837|39550589|FG003|Overall Study|Protocol Violation|0|||
16291467|NCT03970837|39550590|FG004|Overall Study|Protocol Violation|0|||
16291468|NCT03970837|39550591|FG005|Overall Study|Protocol Violation|0|||
16291469|NCT03970837|39550592|FG006|Overall Study|Protocol Violation|0|||
16291470|NCT03970837|39550593|FG007|Overall Study|Protocol Violation|0|||
16291471|NCT03970837|39550594|FG008|Overall Study|Protocol Violation|0|||
16291472|NCT03970837|39550595|FG009|Overall Study|Protocol Violation|0|||
16291473|NCT03970837|39550596|FG010|Overall Study|Protocol Violation|0|||
16291474|NCT03970837|39550597|FG011|Overall Study|Protocol Violation|0|||
16291475|NCT03970837|39550586|FG000|Overall Study|Physician Decision|5|||
16291476|NCT03970837|39550587|FG001|Overall Study|Physician Decision|8|||
16291477|NCT03970837|39550588|FG002|Overall Study|Physician Decision|4|||
16483827|NCT01604408|40248667|FG001|Treatment Period 2|Protocol Violation|0|||
16483828|NCT01604408|40248666|FG000|Treatment Period 2|Adverse Event|0|||
16483829|NCT01604408|40248667|FG001|Treatment Period 2|Adverse Event|1|||
16483830|NCT01604408|40248666|FG000|Treatment Period 3|Protocol Violation|1|||
16483831|NCT01604408|40248667|FG001|Treatment Period 3|Protocol Violation|1|||
16483832|NCT01604408|40248666|FG000|Treatment Period 3|Adverse Event|0|||
16483833|NCT01604408|40248667|FG001|Treatment Period 3|Adverse Event|3|||
16483834|NCT01604408|40248666|FG000|Treatment Period 3|Withdrawal by Subject|3|||
16483835|NCT01604408|40248667|FG001|Treatment Period 3|Withdrawal by Subject|1|||
16483836|NCT01604408|40248666|FG000|Treatment Period 3|Sponsor Decision|1|||
16483837|NCT01604408|40248667|FG001|Treatment Period 3|Sponsor Decision|0|||
16483838|NCT01604408|40248666|FG000|Treatment Period 4|Death|1|||
16483839|NCT01604408|40248667|FG001|Treatment Period 4|Death|0|||
16483840|NCT01604408|40248666|FG000|Treatment Period 4|Withdrawal by Subject|2|||
16483841|NCT01604408|40248667|FG001|Treatment Period 4|Withdrawal by Subject|1|||
16483842|NCT01604408|40248666|FG000|Treatment Period 4|Adverse Event|0|||
16483843|NCT01604408|40248667|FG001|Treatment Period 4|Adverse Event|1|||
16483844|NCT01604408|40248666|FG000|Treatment Period 5|Adverse Event|4|||
16483845|NCT01604408|40248667|FG001|Treatment Period 5|Adverse Event|0|||
16483846|NCT01604408|40248666|FG000|Treatment Period 6|Lost to Follow-up|0|||
16483847|NCT01604408|40248667|FG001|Treatment Period 6|Lost to Follow-up|1|||
16483848|NCT01604408|40248666|FG000|Treatment Period 6|Adverse Event|2|||
16483849|NCT01604408|40248667|FG001|Treatment Period 6|Adverse Event|0|||
16483850|NCT01604408|40248666|FG000|Treatment Period 6|Sponsor decision|0|||
16483851|NCT01604408|40248667|FG001|Treatment Period 6|Sponsor decision|1|||
16483852|NCT01604408|40248666|FG000|Observation Period|Adverse Event|1|||
16483853|NCT01604408|40248667|FG001|Observation Period|Adverse Event|1|||
16483854|NCT01604408|40248666|FG000|Observation Period|Withdrawal by Subject|0|||
16483855|NCT01604408|40248667|FG001|Observation Period|Withdrawal by Subject|2|||
16483856|NCT01787331|40248672|FG000|Overall Study|Physician Decision|1|||
16483857|NCT01787331|40248672|FG000|Overall Study|Withdrawal by Subject|1|||
16483858|NCT01146665|40248678|FG000|Overall Study|Withdrawal by Subject|10|||
16483859|NCT01146665|40248679|FG001|Overall Study|Withdrawal by Subject|16|||
16483860|NCT02570074|40248682|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
16483861|NCT02570074|40248683|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
16483862|NCT04752475|40248684|FG000|Overall Study|Withdrawal by Subject|1|||
16483863|NCT04752475|40248685|FG001|Overall Study|Withdrawal by Subject|1|||
16483864|NCT00996307|40248688|FG000|Overall Study|Adverse Event|0|||
16483865|NCT00996307|40248689|FG001|Overall Study|Adverse Event|1|||
16483866|NCT00996307|40248690|FG002|Overall Study|Adverse Event|0|||
16483867|NCT00996307|40248691|FG003|Overall Study|Adverse Event|0|||
16483868|NCT00996307|40248688|FG000|Overall Study|Withdrawal by Subject|3|||
16483869|NCT00996307|40248689|FG001|Overall Study|Withdrawal by Subject|2|||
16483870|NCT00996307|40248690|FG002|Overall Study|Withdrawal by Subject|5|||
16483871|NCT00996307|40248691|FG003|Overall Study|Withdrawal by Subject|5|||
16483872|NCT00996307|40248688|FG000|Overall Study|Lost to Follow-up|13|||
16483873|NCT00996307|40248689|FG001|Overall Study|Lost to Follow-up|13|||
16483874|NCT00996307|40248690|FG002|Overall Study|Lost to Follow-up|7|||
16483875|NCT00996307|40248691|FG003|Overall Study|Lost to Follow-up|15|||
16483876|NCT00996307|40248688|FG000|Overall Study|Administrative reason|0|||
16483877|NCT00996307|40248689|FG001|Overall Study|Administrative reason|1|||
16483878|NCT00996307|40248690|FG002|Overall Study|Administrative reason|0|||
16483879|NCT00996307|40248691|FG003|Overall Study|Administrative reason|0|||
16483880|NCT00996307|40248688|FG000|Overall Study|Unable to classify|4|||
16483881|NCT00996307|40248689|FG001|Overall Study|Unable to classify|0|||
16483882|NCT00996307|40248690|FG002|Overall Study|Unable to classify|2|||
16483883|NCT00996307|40248691|FG003|Overall Study|Unable to classify|1|||
16291478|NCT03970837|39550589|FG003|Overall Study|Physician Decision|1|||
16291479|NCT03970837|39550590|FG004|Overall Study|Physician Decision|5|||
16483884|NCT00450255|40248698|FG000|Overall Study|Prior RFA ablation of liver|1|||
16483885|NCT02369016|40248699|FG000|Overall Study|AE associated with clinical disease progression|2|||
16483886|NCT02369016|40248700|FG001|Overall Study|AE associated with clinical disease progression|1|||
16483887|NCT02369016|40248699|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
16483888|NCT02369016|40248700|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
16483889|NCT02369016|40248699|FG000|Overall Study|Progressive disease - clinical progression|1|||
16483890|NCT02369016|40248700|FG001|Overall Study|Progressive disease - clinical progression|4|||
16291480|NCT03970837|39550591|FG005|Overall Study|Physician Decision|2|||
16291481|NCT03970837|39550592|FG006|Overall Study|Physician Decision|4|||
16483891|NCT02369016|40248699|FG000|Overall Study|withdrawal by patient|4|||
16291482|NCT03970837|39550593|FG007|Overall Study|Physician Decision|5|||
16291483|NCT03970837|39550594|FG008|Overall Study|Physician Decision|0|||
16291484|NCT03970837|39550595|FG009|Overall Study|Physician Decision|1|||
16291485|NCT03970837|39550596|FG010|Overall Study|Physician Decision|0|||
16291486|NCT03970837|39550597|FG011|Overall Study|Physician Decision|0|||
16291487|NCT03970837|39550586|FG000|Overall Study|Withdrawal by Subject|32|||
16291488|NCT03970837|39550587|FG001|Overall Study|Withdrawal by Subject|35|||
16291489|NCT03970837|39550588|FG002|Overall Study|Withdrawal by Subject|12|||
16291490|NCT03970837|39550589|FG003|Overall Study|Withdrawal by Subject|8|||
16186854|NCT01666444|39161953|FG000|Overall Study|Did not initiate treatment|2|||
16186855|NCT01666444|39161954|FG001|Overall Study|Did not initiate treatment|1|||
16186856|NCT00705224|39161955|FG000|Overall Study|Adverse Event|1|||
16186857|NCT00705224|39161955|FG000|Overall Study|Lack of Efficacy|2|||
16186858|NCT00705224|39161955|FG000|Overall Study|Withdrawal by Subject|3|||
16186859|NCT00705224|39161955|FG000|Overall Study|Lost to Follow-up|5|||
16186860|NCT01987986|39161957|FG000|Overall Study|Lost to Follow-up|1|||
16186861|NCT01987986|39161958|FG001|Overall Study|Lost to Follow-up|0|||
16186862|NCT01987986|39161959|FG002|Overall Study|Lost to Follow-up|0|||
16186863|NCT01987986|39161960|FG003|Overall Study|Lost to Follow-up|0|||
16186864|NCT01987986|39161957|FG000|Overall Study|Adverse Event|1|||
16186865|NCT01987986|39161958|FG001|Overall Study|Adverse Event|0|||
16186866|NCT01987986|39161959|FG002|Overall Study|Adverse Event|2|||
16186867|NCT01987986|39161960|FG003|Overall Study|Adverse Event|0|||
16186868|NCT02660580|39161961|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
16186869|NCT02660580|39161962|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
16186870|NCT02660580|39161963|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
16483892|NCT02369016|40248700|FG001|Overall Study|withdrawal by patient|0|||
16483893|NCT02369016|40248699|FG000|Overall Study|Progressive disease - radiological progression|6|||
16483894|NCT02369016|40248700|FG001|Overall Study|Progressive disease - radiological progression|2|||
16483895|NCT01300650|40248701|FG000|Overall Study|Adverse Event|1|||
16483896|NCT04138810|40248705|FG000|Overall Study|Withdrawal by Subject|0|||
16483897|NCT04138810|40248706|FG001|Overall Study|Withdrawal by Subject|1|||
16483898|NCT04138810|40248705|FG000|Overall Study|Subject cancelled surgery|1|||
16483899|NCT04138810|40248706|FG001|Overall Study|Subject cancelled surgery|0|||
16483900|NCT03338010|40248707|FG000|Overall Study|Withdrawal by Subject|14|||
16483901|NCT03338010|40248708|FG001|Overall Study|Withdrawal by Subject|8|||
16483902|NCT03338010|40248707|FG000|Overall Study|Lost to Follow-up|4|||
16483903|NCT03338010|40248708|FG001|Overall Study|Lost to Follow-up|2|||
16483904|NCT03338010|40248707|FG000|Overall Study|Adverse Event|3|||
16483905|NCT03338010|40248708|FG001|Overall Study|Adverse Event|2|||
16483906|NCT03338010|40248707|FG000|Overall Study|Physician Decision|2|||
16483907|NCT03338010|40248708|FG001|Overall Study|Physician Decision|2|||
16483908|NCT03338010|40248707|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16186871|NCT02660580|39161964|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
16291491|NCT03970837|39550590|FG004|Overall Study|Withdrawal by Subject|6|||
16483909|NCT03338010|40248708|FG001|Overall Study|Non-Compliance with Study Drug|3|||
16483910|NCT03338010|40248707|FG000|Overall Study|Protocol Violation|0|||
16483911|NCT03338010|40248708|FG001|Overall Study|Protocol Violation|1|||
16186872|NCT02660580|39161965|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
16291492|NCT03970837|39550591|FG005|Overall Study|Withdrawal by Subject|8|||
16291493|NCT03970837|39550592|FG006|Overall Study|Withdrawal by Subject|2|||
16483912|NCT00709761|40248709|FG000|Overall Study|Withdrawal by Subject|8|||
16381030|NCT02259114|39877790|FG003|Overall Study|Adverse Event|0|||
16381031|NCT02259114|39877791|FG004|Overall Study|Adverse Event|1|||
16381032|NCT02259114|39877787|FG000|Overall Study|Death|3|||
16381033|NCT02259114|39877788|FG001|Overall Study|Death|0|||
16483913|NCT00709761|40248709|FG000|Overall Study|study closed/terminated|17|||
16483914|NCT00709761|40248709|FG000|Overall Study|Lost to Follow-up|2|||
16483915|NCT01686828|40248710|FG000|Overall Study|Physician Decision|1|||
16483916|NCT01686828|40248711|FG001|Overall Study|Physician Decision|0|||
16483917|NCT01686828|40248712|FG002|Overall Study|Physician Decision|0|||
16483918|NCT01686828|40248713|FG003|Overall Study|Physician Decision|0|||
16483919|NCT01686828|40248710|FG000|Overall Study|New Job|0|||
16483920|NCT01686828|40248711|FG001|Overall Study|New Job|1|||
16483921|NCT01686828|40248712|FG002|Overall Study|New Job|0|||
16483922|NCT01686828|40248713|FG003|Overall Study|New Job|0|||
16483923|NCT01686828|40248710|FG000|Overall Study|Weight Loss|0|||
16483924|NCT01686828|40248711|FG001|Overall Study|Weight Loss|0|||
16483925|NCT01686828|40248712|FG002|Overall Study|Weight Loss|1|||
16483926|NCT01686828|40248713|FG003|Overall Study|Weight Loss|0|||
16483927|NCT04523220|40248715|FG000|Main Treatment Period|Physician Decision|1|||
16483928|NCT04523220|40248716|FG001|Main Treatment Period|Physician Decision|1|||
16483929|NCT04523220|40248717|FG002|Main Treatment Period|Physician Decision|0|||
16483930|NCT04523220|40248715|FG000|Main Treatment Period|Other|5|||
16381034|NCT02259114|39877789|FG002|Overall Study|Death|1|||
16381035|NCT02259114|39877790|FG003|Overall Study|Death|0|||
16381036|NCT02259114|39877791|FG004|Overall Study|Death|0|||
16381037|NCT02259114|39877787|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
16381038|NCT02259114|39877788|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
16381039|NCT02259114|39877789|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
16381040|NCT02259114|39877790|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
16381041|NCT02259114|39877791|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
16381042|NCT02259114|39877787|FG000|Overall Study|Withdrawal by Subject|0|||
16381043|NCT02259114|39877788|FG001|Overall Study|Withdrawal by Subject|0|||
16381044|NCT02259114|39877789|FG002|Overall Study|Withdrawal by Subject|1|||
16381045|NCT02259114|39877790|FG003|Overall Study|Withdrawal by Subject|1|||
16381046|NCT02259114|39877791|FG004|Overall Study|Withdrawal by Subject|0|||
16483931|NCT04523220|40248716|FG001|Main Treatment Period|Other|2|||
16483932|NCT04523220|40248717|FG002|Main Treatment Period|Other|4|||
16483933|NCT04523220|40248715|FG000|Main Treatment Period|Subject Decision|5|||
16483934|NCT04523220|40248716|FG001|Main Treatment Period|Subject Decision|7|||
16483935|NCT04523220|40248717|FG002|Main Treatment Period|Subject Decision|3|||
16186873|NCT02660580|39161961|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
16483936|NCT04523220|40248715|FG000|Main Treatment Period|Death|5|||
16483937|NCT04523220|40248716|FG001|Main Treatment Period|Death|11|||
16483938|NCT04523220|40248717|FG002|Main Treatment Period|Death|4|||
16186874|NCT02660580|39161962|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
16186875|NCT02660580|39161963|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
16186876|NCT02660580|39161964|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
16186877|NCT02660580|39161965|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
16186878|NCT02660580|39161961|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
16186879|NCT02660580|39161962|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
16186880|NCT02660580|39161963|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
16186881|NCT02660580|39161964|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
16186882|NCT02660580|39161965|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
16186883|NCT02660580|39161961|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
16186884|NCT02660580|39161962|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
16186885|NCT02660580|39161963|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
16186886|NCT02660580|39161964|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
16186887|NCT02660580|39161965|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
16186888|NCT02660580|39161961|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
16186889|NCT02660580|39161962|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
16186890|NCT02660580|39161963|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
16381047|NCT02259114|39877787|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
16381048|NCT02259114|39877788|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
16381049|NCT02259114|39877789|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
16381050|NCT02259114|39877790|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
16381051|NCT02259114|39877791|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
16483939|NCT04523220|40248715|FG000|Main Treatment Period|Adverse Event|11|||
16483940|NCT04523220|40248716|FG001|Main Treatment Period|Adverse Event|9|||
16483941|NCT04523220|40248717|FG002|Main Treatment Period|Adverse Event|9|||
16483942|NCT04523220|40248715|FG000|Main Treatment Period|Withdrawal by Subject|3|||
16483943|NCT04523220|40248716|FG001|Main Treatment Period|Withdrawal by Subject|3|||
16483944|NCT04523220|40248717|FG002|Main Treatment Period|Withdrawal by Subject|4|||
16483945|NCT04523220|40248715|FG000|Main Treatment Period|Study drug never adminstered|10|||
16483946|NCT04523220|40248716|FG001|Main Treatment Period|Study drug never adminstered|3|||
16483947|NCT04523220|40248717|FG002|Main Treatment Period|Study drug never adminstered|5|||
16483948|NCT04523220|40248715|FG000|Extension Treatment Period|Physician Decision|1|||
16483949|NCT04523220|40248716|FG001|Extension Treatment Period|Physician Decision|0|||
16483950|NCT04523220|40248717|FG002|Extension Treatment Period|Physician Decision|3|||
16483951|NCT04523220|40248715|FG000|Extension Treatment Period|Other|2|||
16483952|NCT04523220|40248716|FG001|Extension Treatment Period|Other|6|||
16483953|NCT04523220|40248717|FG002|Extension Treatment Period|Other|6|||
16483954|NCT04523220|40248715|FG000|Extension Treatment Period|Subject Decision|5|||
16483955|NCT04523220|40248716|FG001|Extension Treatment Period|Subject Decision|2|||
16483956|NCT04523220|40248717|FG002|Extension Treatment Period|Subject Decision|4|||
16483957|NCT04523220|40248715|FG000|Extension Treatment Period|Death|6|||
16483958|NCT04523220|40248716|FG001|Extension Treatment Period|Death|4|||
16483959|NCT04523220|40248717|FG002|Extension Treatment Period|Death|7|||
16483960|NCT04523220|40248715|FG000|Extension Treatment Period|Adverse Event|6|||
16483961|NCT04523220|40248716|FG001|Extension Treatment Period|Adverse Event|7|||
16483962|NCT04523220|40248717|FG002|Extension Treatment Period|Adverse Event|9|||
16483963|NCT04523220|40248715|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
16483964|NCT04523220|40248716|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
16483965|NCT04523220|40248717|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
16483966|NCT04523220|40248715|FG000|Extension Treatment Period|Study drug never administered|0|||
16483967|NCT04523220|40248716|FG001|Extension Treatment Period|Study drug never administered|1|||
16483968|NCT04523220|40248717|FG002|Extension Treatment Period|Study drug never administered|0|||
16483969|NCT00660699|40248723|FG000|Overall Study|Withdrawal by Subject|2|||
16483970|NCT00911547|40248724|FG000|Overall Study|Adverse Event|8|||
16483971|NCT00911547|40248725|FG001|Overall Study|Adverse Event|27|||
16483972|NCT00911547|40248726|FG002|Overall Study|Adverse Event|11|||
16483973|NCT00911547|40248727|FG003|Overall Study|Adverse Event|6|||
16483974|NCT00911547|40248724|FG000|Overall Study|Lost to Follow-up|0|||
16483975|NCT00911547|40248725|FG001|Overall Study|Lost to Follow-up|0|||
16483976|NCT00911547|40248726|FG002|Overall Study|Lost to Follow-up|2|||
16483977|NCT00911547|40248727|FG003|Overall Study|Lost to Follow-up|1|||
16483978|NCT00911547|40248724|FG000|Overall Study|Protocol Violation|0|||
16483979|NCT00911547|40248725|FG001|Overall Study|Protocol Violation|5|||
16483980|NCT00911547|40248726|FG002|Overall Study|Protocol Violation|5|||
16291494|NCT03970837|39550593|FG007|Overall Study|Withdrawal by Subject|3|||
16291495|NCT03970837|39550594|FG008|Overall Study|Withdrawal by Subject|0|||
16291496|NCT03970837|39550595|FG009|Overall Study|Withdrawal by Subject|0|||
16291497|NCT03970837|39550596|FG010|Overall Study|Withdrawal by Subject|0|||
16291498|NCT03970837|39550597|FG011|Overall Study|Withdrawal by Subject|1|||
16291499|NCT03970837|39550586|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
16291500|NCT03970837|39550587|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
16291501|NCT03970837|39550588|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
16291502|NCT03970837|39550589|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
16291503|NCT03970837|39550590|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
16291504|NCT03970837|39550591|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
16291505|NCT03970837|39550592|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
16291506|NCT03970837|39550593|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
16291507|NCT03970837|39550594|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
16291508|NCT03970837|39550595|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
16291509|NCT03970837|39550596|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
16291510|NCT03970837|39550597|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
16291511|NCT03970837|39550586|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
16291512|NCT03970837|39550587|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
16291513|NCT03970837|39550588|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
16291514|NCT03970837|39550589|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
16291515|NCT03970837|39550590|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
16291516|NCT03970837|39550591|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
16291517|NCT03970837|39550592|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
16291518|NCT03970837|39550593|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
16291519|NCT03970837|39550594|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
16291520|NCT03970837|39550595|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
16291521|NCT03970837|39550596|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
16483981|NCT00911547|40248727|FG003|Overall Study|Protocol Violation|1|||
16483982|NCT00911547|40248724|FG000|Overall Study|Withdrawal by Subject|3|||
16483983|NCT00911547|40248725|FG001|Overall Study|Withdrawal by Subject|10|||
16483984|NCT00911547|40248726|FG002|Overall Study|Withdrawal by Subject|4|||
16483985|NCT00911547|40248727|FG003|Overall Study|Withdrawal by Subject|8|||
16291522|NCT03970837|39550597|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
16483986|NCT00481078|40248728|FG000|Overall Study|Progression of disease|11|||
16483987|NCT00481078|40248729|FG001|Overall Study|Progression of disease|11|||
16483988|NCT00481078|40248728|FG000|Overall Study|Adverse Event|15|||
16483989|NCT00481078|40248729|FG001|Overall Study|Adverse Event|3|||
16483990|NCT00481078|40248728|FG000|Overall Study|Death|5|||
16291523|NCT00103311|39550602|FG000|Overall Study|Lost to Follow-up|1|||
16483991|NCT00481078|40248729|FG001|Overall Study|Death|3|||
16483992|NCT00481078|40248728|FG000|Overall Study|Intercurrent illness|1|||
16483993|NCT00481078|40248729|FG001|Overall Study|Intercurrent illness|0|||
16483994|NCT00481078|40248728|FG000|Overall Study|Withdrawal by Subject|7|||
16483995|NCT00481078|40248729|FG001|Overall Study|Withdrawal by Subject|1|||
16483996|NCT00481078|40248728|FG000|Overall Study|Information not available|1|||
16483997|NCT00481078|40248729|FG001|Overall Study|Information not available|0|||
16483998|NCT00481078|40248728|FG000|Overall Study|Received other treatment|2|||
16483999|NCT00481078|40248729|FG001|Overall Study|Received other treatment|1|||
16484000|NCT00481078|40248728|FG000|Overall Study|Brain metastasis|0|||
16484001|NCT00481078|40248729|FG001|Overall Study|Brain metastasis|1|||
16484002|NCT00289133|40248732|FG000|Overall Study|Non-study device implanted|12|||
16186891|NCT02660580|39161964|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
16186892|NCT02660580|39161965|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
16186893|NCT02660580|39161961|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
16186894|NCT02660580|39161962|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
16186895|NCT02660580|39161963|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
16186896|NCT02660580|39161964|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
16186897|NCT02660580|39161965|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
16186898|NCT02660580|39161961|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
16186899|NCT02660580|39161962|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
16186900|NCT02660580|39161963|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
16186901|NCT02660580|39161964|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
16186902|NCT02660580|39161965|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
16186903|NCT02660580|39161961|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
16186904|NCT02660580|39161962|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
16186905|NCT02660580|39161963|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
16186906|NCT02660580|39161964|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
16186907|NCT02660580|39161965|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
16186908|NCT02660580|39161961|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
16186909|NCT02660580|39161962|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
16186910|NCT02660580|39161963|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
16186911|NCT02660580|39161964|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
16186912|NCT02660580|39161965|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
16186913|NCT02660580|39161961|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
16186914|NCT02660580|39161962|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
16186915|NCT02660580|39161963|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
16186916|NCT02660580|39161964|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
16186917|NCT02660580|39161965|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
16291524|NCT00103311|39550603|FG001|Overall Study|Lost to Follow-up|0|||
16484003|NCT00289133|40248733|FG001|Overall Study|Non-study device implanted|0|||
16484004|NCT00289133|40248732|FG000|Overall Study|Protocol Violation|32|||
16484005|NCT00289133|40248733|FG001|Overall Study|Protocol Violation|38|||
16484006|NCT00289133|40248732|FG000|Overall Study|Withdrawal by Subject|9|||
16484007|NCT00289133|40248733|FG001|Overall Study|Withdrawal by Subject|10|||
16484008|NCT00289133|40248732|FG000|Overall Study|Death|5|||
16484009|NCT00289133|40248733|FG001|Overall Study|Death|10|||
16484010|NCT00289133|40248732|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
16484011|NCT00289133|40248733|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
16291525|NCT00103311|39550602|FG000|Overall Study|Withdrawal by Subject|2|||
16291526|NCT00103311|39550603|FG001|Overall Study|Withdrawal by Subject|1|||
16291527|NCT00103311|39550602|FG000|Overall Study|Adverse Event|1|||
16291528|NCT00103311|39550603|FG001|Overall Study|Adverse Event|0|||
16484012|NCT00289133|40248732|FG000|Overall Study|Physician Decision|41|||
16484013|NCT00289133|40248733|FG001|Overall Study|Physician Decision|45|||
16291529|NCT00986180|39550604|FG000|Overall Study|Adverse Event|21|||
16291530|NCT00986180|39550605|FG001|Overall Study|Adverse Event|23|||
16291531|NCT00986180|39550604|FG000|Overall Study|Lack of Efficacy|4|||
16291532|NCT00986180|39550605|FG001|Overall Study|Lack of Efficacy|3|||
16291533|NCT00986180|39550604|FG000|Overall Study|Lost to Follow-up|5|||
16484014|NCT00289133|40248732|FG000|Overall Study|Revision|8|||
16484015|NCT00289133|40248733|FG001|Overall Study|Revision|6|||
16484016|NCT00289133|40248732|FG000|Overall Study|Lost to Follow-up|92|||
16484017|NCT00289133|40248733|FG001|Overall Study|Lost to Follow-up|115|||
16484018|NCT01606007|40248740|FG000|Overall Study|Reason 'Other' in the protocol|0|||
16484019|NCT01606007|40248741|FG001|Overall Study|Reason 'Other' in the protocol|1|||
16484020|NCT01606007|40248742|FG002|Overall Study|Reason 'Other' in the protocol|1|||
16484021|NCT01606007|40248740|FG000|Overall Study|Pregnancy|0|||
16484022|NCT01606007|40248741|FG001|Overall Study|Pregnancy|1|||
16484023|NCT01606007|40248742|FG002|Overall Study|Pregnancy|1|||
16484024|NCT01606007|40248740|FG000|Overall Study|Withdrawal by Subject|8|||
16484025|NCT01606007|40248741|FG001|Overall Study|Withdrawal by Subject|6|||
16484026|NCT01606007|40248742|FG002|Overall Study|Withdrawal by Subject|1|||
16484027|NCT01606007|40248740|FG000|Overall Study|Adverse Event|0|||
16484028|NCT01606007|40248741|FG001|Overall Study|Adverse Event|1|||
16484029|NCT01606007|40248742|FG002|Overall Study|Adverse Event|1|||
16484030|NCT01606007|40248740|FG000|Overall Study|discontinue study treatment|0|||
16484031|NCT01606007|40248741|FG001|Overall Study|discontinue study treatment|2|||
16484032|NCT01606007|40248742|FG002|Overall Study|discontinue study treatment|1|||
16484033|NCT01606007|40248740|FG000|Overall Study|Lost to Follow-up|6|||
16484034|NCT01606007|40248741|FG001|Overall Study|Lost to Follow-up|8|||
16484035|NCT01606007|40248742|FG002|Overall Study|Lost to Follow-up|5|||
16484036|NCT01606007|40248740|FG000|Overall Study|Poor/Non-compliance|1|||
16484037|NCT01606007|40248741|FG001|Overall Study|Poor/Non-compliance|0|||
16484038|NCT01606007|40248742|FG002|Overall Study|Poor/Non-compliance|0|||
16484039|NCT00001880|40248748|FG000|Overall Study|Death|14|||
16484040|NCT01926015|40248752|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16484041|NCT01926015|40248753|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16484042|NCT01926015|40248752|FG000|Overall Study|Randomized not treated|2|||
16484043|NCT01926015|40248753|FG001|Overall Study|Randomized not treated|0|||
16484044|NCT01708161|40248757|FG000|Overall Study|Adverse Event|1|||
16484045|NCT01708161|40248758|FG001|Overall Study|Adverse Event|3|||
16484046|NCT01708161|40248759|FG002|Overall Study|Adverse Event|4|||
16484047|NCT01708161|40248760|FG003|Overall Study|Adverse Event|2|||
16484048|NCT01708161|40248761|FG004|Overall Study|Adverse Event|3|||
16484049|NCT01708161|40248762|FG005|Overall Study|Adverse Event|0|||
16484050|NCT01708161|40248757|FG000|Overall Study|Death|0|||
16484051|NCT01708161|40248758|FG001|Overall Study|Death|0|||
16484052|NCT01708161|40248759|FG002|Overall Study|Death|0|||
16484053|NCT01708161|40248760|FG003|Overall Study|Death|1|||
16484054|NCT01708161|40248761|FG004|Overall Study|Death|0|||
16484055|NCT01708161|40248762|FG005|Overall Study|Death|1|||
16484056|NCT01708161|40248757|FG000|Overall Study|Withdrawal by Subject|0|||
16484057|NCT01708161|40248758|FG001|Overall Study|Withdrawal by Subject|1|||
16484058|NCT01708161|40248759|FG002|Overall Study|Withdrawal by Subject|1|||
16484059|NCT01708161|40248760|FG003|Overall Study|Withdrawal by Subject|0|||
16484060|NCT01708161|40248761|FG004|Overall Study|Withdrawal by Subject|0|||
16484061|NCT01708161|40248762|FG005|Overall Study|Withdrawal by Subject|0|||
16484062|NCT01708161|40248757|FG000|Overall Study|Administrative problems|0|||
16484063|NCT01708161|40248758|FG001|Overall Study|Administrative problems|1|||
16484064|NCT01708161|40248759|FG002|Overall Study|Administrative problems|0|||
16484065|NCT01708161|40248760|FG003|Overall Study|Administrative problems|0|||
16484066|NCT01708161|40248761|FG004|Overall Study|Administrative problems|0|||
16484067|NCT01708161|40248762|FG005|Overall Study|Administrative problems|0|||
16484068|NCT01708161|40248757|FG000|Overall Study|Disease progression|3|||
16484069|NCT01708161|40248758|FG001|Overall Study|Disease progression|5|||
16484070|NCT01708161|40248759|FG002|Overall Study|Disease progression|5|||
16484071|NCT01708161|40248760|FG003|Overall Study|Disease progression|13|||
16484072|NCT01708161|40248761|FG004|Overall Study|Disease progression|3|||
16484073|NCT01708161|40248762|FG005|Overall Study|Disease progression|0|||
16291534|NCT00986180|39550605|FG001|Overall Study|Lost to Follow-up|7|||
16484074|NCT03345914|40248763|FG000|Overall Study|Transition to another study at week 16|80|||
16291535|NCT00986180|39550604|FG000|Overall Study|Physician Decision|1|||
16291536|NCT00986180|39550605|FG001|Overall Study|Physician Decision|3|||
16291537|NCT00986180|39550604|FG000|Overall Study|Protocol Violation|2|||
16291538|NCT00986180|39550605|FG001|Overall Study|Protocol Violation|0|||
16291539|NCT00986180|39550604|FG000|Overall Study|Withdrawal by Subject|1|||
16291540|NCT00986180|39550605|FG001|Overall Study|Withdrawal by Subject|9|||
16291541|NCT00986180|39550604|FG000|Overall Study|Miscellanies|10|||
16291542|NCT00986180|39550605|FG001|Overall Study|Miscellanies|11|||
16291543|NCT01175811|39550607|FG000|Overall Study|Adverse Event|1|||
16291544|NCT01175811|39550608|FG001|Overall Study|Adverse Event|1|||
16291545|NCT01175811|39550607|FG000|Overall Study|Entry criteria not met|3|||
16291546|NCT01175811|39550608|FG001|Overall Study|Entry criteria not met|1|||
16291547|NCT01175811|39550607|FG000|Overall Study|Lack of Efficacy|1|||
16291548|NCT01175811|39550608|FG001|Overall Study|Lack of Efficacy|0|||
16291549|NCT01175811|39550607|FG000|Overall Study|Lost to Follow-up|3|||
16291550|NCT01175811|39550608|FG001|Overall Study|Lost to Follow-up|2|||
16291551|NCT01175811|39550607|FG000|Overall Study|Physician Decision|1|||
16291552|NCT01175811|39550608|FG001|Overall Study|Physician Decision|1|||
16484075|NCT03345914|40248764|FG001|Overall Study|Transition to another study at week 16|86|||
16484076|NCT03345914|40248765|FG002|Overall Study|Transition to another study at week 16|78|||
16484077|NCT03345914|40248763|FG000|Overall Study|Transition to OLE during follow-up|37|||
16484078|NCT03345914|40248764|FG001|Overall Study|Transition to OLE during follow-up|33|||
16484079|NCT03345914|40248765|FG002|Overall Study|Transition to OLE during follow-up|39|||
16484080|NCT03345914|40248763|FG000|Overall Study|Physician Decision|0|||
16484081|NCT03345914|40248764|FG001|Overall Study|Physician Decision|1|||
16484082|NCT03345914|40248765|FG002|Overall Study|Physician Decision|1|||
16484083|NCT03345914|40248763|FG000|Overall Study|Withdrawal by Subject|5|||
16484084|NCT03345914|40248764|FG001|Overall Study|Withdrawal by Subject|1|||
16484085|NCT03345914|40248765|FG002|Overall Study|Withdrawal by Subject|2|||
16484086|NCT03345914|40248763|FG000|Overall Study|Other|1|||
16484087|NCT03345914|40248764|FG001|Overall Study|Other|1|||
16484088|NCT03345914|40248765|FG002|Overall Study|Other|1|||
16291553|NCT01175811|39550607|FG000|Overall Study|Protocol Violation|1|||
16291554|NCT01175811|39550608|FG001|Overall Study|Protocol Violation|2|||
16291555|NCT01175811|39550607|FG000|Overall Study|Withdrawal by Subject|6|||
16291556|NCT01175811|39550608|FG001|Overall Study|Withdrawal by Subject|7|||
16291557|NCT00759902|39550609|FG000|Overall Study|Adverse Event|0|||
16291558|NCT00759902|39550610|FG001|Overall Study|Adverse Event|1|||
16291559|NCT00719849|39550613|FG000|Overall Study|Death|0|||
16291560|NCT00719849|39550614|FG001|Overall Study|Death|1|||
16291561|NCT01150890|39550615|FG000|Overall Study|Other|0|||
16291562|NCT01150890|39550616|FG001|Overall Study|Other|1|||
16291563|NCT01150890|39550617|FG002|Overall Study|Other|0|||
16291564|NCT01150890|39550618|FG003|Overall Study|Other|2|||
16081294|NCT01808339|38789554|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16081295|NCT01808339|38789555|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16081296|NCT01808339|38789556|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
16081297|NCT01808339|38789557|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16081298|NCT01808339|38789558|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16291565|NCT01150890|39550615|FG000|Overall Study|Pregnancy|0|||
16291566|NCT01150890|39550616|FG001|Overall Study|Pregnancy|0|||
16291567|NCT01150890|39550617|FG002|Overall Study|Pregnancy|0|||
16291568|NCT01150890|39550618|FG003|Overall Study|Pregnancy|1|||
16291569|NCT01150890|39550615|FG000|Overall Study|Administrative Decision|4|||
16291570|NCT01150890|39550616|FG001|Overall Study|Administrative Decision|4|||
16291571|NCT01150890|39550617|FG002|Overall Study|Administrative Decision|5|||
16291572|NCT01150890|39550618|FG003|Overall Study|Administrative Decision|6|||
16291573|NCT01150890|39550615|FG000|Overall Study|Ineligibility determined|0|||
16291574|NCT01150890|39550616|FG001|Overall Study|Ineligibility determined|1|||
16291575|NCT01150890|39550617|FG002|Overall Study|Ineligibility determined|0|||
16291576|NCT01150890|39550618|FG003|Overall Study|Ineligibility determined|0|||
16291577|NCT01150890|39550615|FG000|Overall Study|Adverse Event|0|||
16291578|NCT01150890|39550616|FG001|Overall Study|Adverse Event|0|||
16291579|NCT01150890|39550617|FG002|Overall Study|Adverse Event|2|||
16291580|NCT01150890|39550618|FG003|Overall Study|Adverse Event|0|||
16291581|NCT01150890|39550615|FG000|Overall Study|Withdrawal by Subject|0|||
16291582|NCT01150890|39550616|FG001|Overall Study|Withdrawal by Subject|0|||
16291583|NCT01150890|39550617|FG002|Overall Study|Withdrawal by Subject|2|||
16291584|NCT01150890|39550618|FG003|Overall Study|Withdrawal by Subject|1|||
16291585|NCT01150890|39550615|FG000|Overall Study|Disease progression|0|||
16291586|NCT01150890|39550616|FG001|Overall Study|Disease progression|7|||
16291587|NCT01150890|39550617|FG002|Overall Study|Disease progression|3|||
16291588|NCT01150890|39550618|FG003|Overall Study|Disease progression|7|||
16291589|NCT02751359|39550622|FG000|Overall Study|Lost to Follow-up|1|||
16291590|NCT00515541|39550623|FG000|Overall Study|Physician Decision|0|||
16291591|NCT00515541|39550624|FG001|Overall Study|Physician Decision|2|||
16291592|NCT00515541|39550625|FG002|Overall Study|Physician Decision|0|||
16291593|NCT00515541|39550626|FG003|Overall Study|Physician Decision|1|||
16291594|NCT00515541|39550623|FG000|Overall Study|No show for appointments|0|||
16291595|NCT00515541|39550624|FG001|Overall Study|No show for appointments|1|||
16291596|NCT00515541|39550625|FG002|Overall Study|No show for appointments|0|||
16291597|NCT00515541|39550626|FG003|Overall Study|No show for appointments|2|||
16291598|NCT00515541|39550623|FG000|Overall Study|Withdrawal by Subject|0|||
16291599|NCT00515541|39550624|FG001|Overall Study|Withdrawal by Subject|2|||
16291600|NCT00515541|39550625|FG002|Overall Study|Withdrawal by Subject|0|||
16291601|NCT00515541|39550626|FG003|Overall Study|Withdrawal by Subject|2|||
16291602|NCT02196701|39550627|FG000|Overall Study|Adverse Event|1|||
16291603|NCT02196701|39550627|FG000|Overall Study|Lost to Follow-up|1|||
16291604|NCT02196701|39550627|FG000|Overall Study|Non-adherence to Protocol|1|||
16291605|NCT02206620|39550628|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
16291606|NCT02206620|39550629|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
16291607|NCT02206620|39550628|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
16291608|NCT02206620|39550629|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
16291609|NCT00871741|39550630|FG000|Overall Study|Premature study termination|9|||
16291610|NCT00871741|39550631|FG001|Overall Study|Premature study termination|7|||
16291611|NCT02989168|39550632|FG000|Overall Study|Withdrawal by Subject|2|||
16291612|NCT02989168|39550633|FG001|Overall Study|Withdrawal by Subject|0|||
16291613|NCT02989168|39550632|FG000|Overall Study|Physician Decision|0|||
16291614|NCT02989168|39550633|FG001|Overall Study|Physician Decision|1|||
16291615|NCT02989168|39550632|FG000|Overall Study|Adverse Event|1|||
16291616|NCT02989168|39550633|FG001|Overall Study|Adverse Event|2|||
16291617|NCT02989168|39550632|FG000|Overall Study|Sponsor stopped study.|1|||
16291618|NCT02989168|39550633|FG001|Overall Study|Sponsor stopped study.|0|||
16291619|NCT04032158|39550634|FG000|Overall Study|Study Termination|2|||
16291620|NCT04032158|39550635|FG001|Overall Study|Study Termination|1|||
16291621|NCT04049617|39550636|FG000|Overall Study|Adverse Event|0|||
16291622|NCT04049617|39550637|FG001|Overall Study|Adverse Event|0|||
16291623|NCT04049617|39550638|FG002|Overall Study|Adverse Event|0|||
16291624|NCT04049617|39550639|FG003|Overall Study|Adverse Event|1|||
16291625|NCT04049617|39550640|FG004|Overall Study|Adverse Event|0|||
16291626|NCT04049617|39550641|FG005|Overall Study|Adverse Event|0|||
16291627|NCT04049617|39550636|FG000|Overall Study|Death|0|||
16291628|NCT04049617|39550637|FG001|Overall Study|Death|0|||
16291629|NCT04049617|39550638|FG002|Overall Study|Death|0|||
16291630|NCT04049617|39550639|FG003|Overall Study|Death|0|||
16291631|NCT04049617|39550640|FG004|Overall Study|Death|0|||
16291632|NCT04049617|39550641|FG005|Overall Study|Death|1|||
16291633|NCT04049617|39550636|FG000|Overall Study|Lost to Follow-up|0|||
16291634|NCT04049617|39550637|FG001|Overall Study|Lost to Follow-up|0|||
16291635|NCT04049617|39550638|FG002|Overall Study|Lost to Follow-up|0|||
16291636|NCT04049617|39550639|FG003|Overall Study|Lost to Follow-up|1|||
16291637|NCT04049617|39550640|FG004|Overall Study|Lost to Follow-up|0|||
16291638|NCT04049617|39550641|FG005|Overall Study|Lost to Follow-up|0|||
16291639|NCT04049617|39550636|FG000|Overall Study|Withdrew consent|0|||
16291640|NCT04049617|39550637|FG001|Overall Study|Withdrew consent|0|||
16291641|NCT04049617|39550638|FG002|Overall Study|Withdrew consent|1|||
16291642|NCT04049617|39550639|FG003|Overall Study|Withdrew consent|0|||
16291643|NCT04049617|39550640|FG004|Overall Study|Withdrew consent|0|||
16291644|NCT04049617|39550641|FG005|Overall Study|Withdrew consent|0|||
16291645|NCT00390221|39550643|FG000|Overall Study|Lost to Follow-up|0|||
16291646|NCT00390221|39550644|FG001|Overall Study|Lost to Follow-up|3|||
16291647|NCT00390221|39550645|FG002|Overall Study|Lost to Follow-up|0|||
16291648|NCT00390221|39550643|FG000|Overall Study|Adverse Event|1|||
16291649|NCT00390221|39550644|FG001|Overall Study|Adverse Event|4|||
16291650|NCT00390221|39550645|FG002|Overall Study|Adverse Event|3|||
16291651|NCT00390221|39550643|FG000|Overall Study|Investigator Decision|0|||
16291652|NCT00390221|39550644|FG001|Overall Study|Investigator Decision|0|||
16291653|NCT00390221|39550645|FG002|Overall Study|Investigator Decision|1|||
16291654|NCT00390221|39550643|FG000|Overall Study|Withdrawal by Subject|13|||
16291655|NCT00390221|39550644|FG001|Overall Study|Withdrawal by Subject|9|||
16291656|NCT00390221|39550645|FG002|Overall Study|Withdrawal by Subject|7|||
16291657|NCT00390221|39550643|FG000|Overall Study|Subject Non-compliance|1|||
16291658|NCT00390221|39550644|FG001|Overall Study|Subject Non-compliance|0|||
16291659|NCT00390221|39550645|FG002|Overall Study|Subject Non-compliance|2|||
16291660|NCT00390221|39550643|FG000|Overall Study|Other|3|||
16291661|NCT00390221|39550644|FG001|Overall Study|Other|4|||
16291662|NCT00390221|39550645|FG002|Overall Study|Other|2|||
16291663|NCT02444793|39550646|FG000|Overall Study|Lost to Follow-up|2|||
16291664|NCT02444793|39550647|FG001|Overall Study|Lost to Follow-up|2|||
16291665|NCT02444793|39550648|FG002|Overall Study|Lost to Follow-up|0|||
16291666|NCT02444793|39550649|FG003|Overall Study|Lost to Follow-up|0|||
16291667|NCT02444793|39550646|FG000|Overall Study|Death|0|||
16291668|NCT02444793|39550647|FG001|Overall Study|Death|3|||
16291669|NCT02444793|39550648|FG002|Overall Study|Death|0|||
16291670|NCT02444793|39550649|FG003|Overall Study|Death|0|||
16291671|NCT02444793|39550646|FG000|Overall Study|Other|0|||
16291672|NCT02444793|39550647|FG001|Overall Study|Other|0|||
16291673|NCT02444793|39550648|FG002|Overall Study|Other|2|||
16291674|NCT02444793|39550649|FG003|Overall Study|Other|0|||
16291675|NCT02444793|39550646|FG000|Overall Study|Objective progression or relapse|9|||
16291676|NCT02444793|39550647|FG001|Overall Study|Objective progression or relapse|1|||
16291677|NCT02444793|39550648|FG002|Overall Study|Objective progression or relapse|2|||
16291678|NCT02444793|39550649|FG003|Overall Study|Objective progression or relapse|3|||
16291679|NCT01167257|39550650|FG000|Overall Study|Lost to Follow-up|2|||
16291680|NCT01167257|39550651|FG001|Overall Study|Lost to Follow-up|2|||
16291681|NCT01167257|39550650|FG000|Overall Study|Withdrew consent|1|||
16291682|NCT01167257|39550651|FG001|Overall Study|Withdrew consent|1|||
16291683|NCT00931268|39550652|FG000|Overall Study|Lost to Follow-up|6|||
16291684|NCT01447420|39550655|FG000|Overall Study|Adverse Event|2|||
16291685|NCT01447420|39550656|FG001|Overall Study|Adverse Event|4|||
16291686|NCT01447420|39550657|FG002|Overall Study|Adverse Event|2|||
16291687|NCT01447420|39550655|FG000|Overall Study|Protocol Violation|3|||
16291688|NCT01447420|39550656|FG001|Overall Study|Protocol Violation|3|||
16291689|NCT01447420|39550657|FG002|Overall Study|Protocol Violation|0|||
16291690|NCT01447420|39550655|FG000|Overall Study|Withdrawal by Subject|4|||
16291691|NCT01447420|39550656|FG001|Overall Study|Withdrawal by Subject|1|||
16291692|NCT01447420|39550657|FG002|Overall Study|Withdrawal by Subject|0|||
16291693|NCT01447420|39550655|FG000|Overall Study|Lack of Efficacy|1|||
16291694|NCT01447420|39550656|FG001|Overall Study|Lack of Efficacy|19|||
16291695|NCT01447420|39550657|FG002|Overall Study|Lack of Efficacy|8|||
16291696|NCT00160641|39550660|FG000|Overall Study|Adverse Event|102|||
16291697|NCT00160641|39550660|FG000|Overall Study|Withdrawal by Subject|87|||
16291698|NCT00160641|39550660|FG000|Overall Study|Lost to Follow-up|8|||
16291699|NCT00160641|39550660|FG000|Overall Study|Lack of Efficacy|12|||
16291700|NCT00160641|39550660|FG000|Overall Study|Protocol Violation|3|||
16291701|NCT00160641|39550660|FG000|Overall Study|Other|9|||
16291702|NCT01111019|39550663|FG000|Overall Study|Withdrew Prematurely|2|||
16291703|NCT01111019|39550663|FG000|Overall Study|Other|1|||
16291704|NCT01641133|39550664|FG000|Overall Study|Protocol Violation|0|||
16291705|NCT01641133|39550665|FG001|Overall Study|Protocol Violation|1|||
16291706|NCT01641133|39550666|FG002|Overall Study|Protocol Violation|1|||
16291707|NCT01641133|39550664|FG000|Overall Study|Migrated/moved from study area|5|||
16081299|NCT01808339|38789559|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
16291708|NCT01641133|39550665|FG001|Overall Study|Migrated/moved from study area|3|||
16291709|NCT01641133|39550666|FG002|Overall Study|Migrated/moved from study area|1|||
16291710|NCT01641133|39550664|FG000|Overall Study|Adverse Event|0|||
16291711|NCT01641133|39550665|FG001|Overall Study|Adverse Event|0|||
16291712|NCT01641133|39550666|FG002|Overall Study|Adverse Event|1|||
16291713|NCT01641133|39550664|FG000|Overall Study|Withdrawal by Subject|5|||
16291714|NCT01641133|39550665|FG001|Overall Study|Withdrawal by Subject|3|||
16291715|NCT01641133|39550666|FG002|Overall Study|Withdrawal by Subject|3|||
16291716|NCT01641133|39550664|FG000|Overall Study|Lost to Follow-up|0|||
16291717|NCT01641133|39550665|FG001|Overall Study|Lost to Follow-up|2|||
16291718|NCT01641133|39550666|FG002|Overall Study|Lost to Follow-up|2|||
16291719|NCT02707861|39550668|FG000|Overall Study|Went onto commercial drug|30|||
16291720|NCT02707861|39550669|FG001|Overall Study|Went onto commercial drug|23|||
16291721|NCT02707861|39550668|FG000|Overall Study|Adverse Event|2|||
16081300|NCT02015520|38789560|FG000|Overall Study|Lack of Efficacy|1|||
16081301|NCT02015520|38789561|FG001|Overall Study|Lack of Efficacy|0|||
16081302|NCT02015520|38789562|FG002|Overall Study|Lack of Efficacy|3|||
16081303|NCT02015520|38789563|FG003|Overall Study|Lack of Efficacy|2|||
16081304|NCT02015520|38789560|FG000|Overall Study|Adverse Event|0|||
16081305|NCT02015520|38789561|FG001|Overall Study|Adverse Event|0|||
16081306|NCT02015520|38789562|FG002|Overall Study|Adverse Event|0|||
16186918|NCT02660580|39161961|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
16186919|NCT02660580|39161962|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
16186920|NCT02660580|39161963|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
16186921|NCT02660580|39161964|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
16186922|NCT02660580|39161965|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
16186923|NCT02660580|39161961|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
16186924|NCT02660580|39161962|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
16186925|NCT02660580|39161963|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
16186926|NCT02660580|39161964|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
16186927|NCT02660580|39161965|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
16186928|NCT02660580|39161961|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
16186929|NCT02660580|39161962|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
16186930|NCT02660580|39161963|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
16186931|NCT02660580|39161964|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
16186932|NCT02660580|39161965|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
16291722|NCT02707861|39550669|FG001|Overall Study|Adverse Event|3|||
16291723|NCT02707861|39550668|FG000|Overall Study|Death|5|||
16291724|NCT02707861|39550669|FG001|Overall Study|Death|2|||
16291725|NCT02707861|39550668|FG000|Overall Study|Lack of Efficacy|0|||
16291726|NCT02707861|39550669|FG001|Overall Study|Lack of Efficacy|2|||
16291727|NCT02707861|39550668|FG000|Overall Study|Physician Decision|1|||
16291728|NCT02707861|39550669|FG001|Overall Study|Physician Decision|4|||
16291729|NCT02707861|39550668|FG000|Overall Study|Withdrawal by Subject|2|||
16291730|NCT02707861|39550669|FG001|Overall Study|Withdrawal by Subject|1|||
16291731|NCT02707861|39550668|FG000|Overall Study|Lost to Follow-up|1|||
16291732|NCT02707861|39550669|FG001|Overall Study|Lost to Follow-up|3|||
16291733|NCT04234984|39550672|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
16291734|NCT04234984|39550672|FG000|Follow-up at the Second Time Point|Death|1|||
16291735|NCT04234984|39550672|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
16291736|NCT01181271|39550680|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
16291737|NCT01181271|39550680|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
16291738|NCT01181271|39550680|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
16291739|NCT01181271|39550680|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
16291740|NCT02581163|39550683|FG000|Overall Study|Failure to return|15|||
16291741|NCT02581163|39550683|FG000|Overall Study|Insufficient virological response|3|||
16291742|NCT02581163|39550683|FG000|Overall Study|Withdrew consent|1|||
16291743|NCT02581163|39550683|FG000|Overall Study|Death|1|||
16291744|NCT02581163|39550683|FG000|Overall Study|Other, not specified|9|||
16291745|NCT03914950|39550686|FG000|Overall Study|Physician Decision|54|||
16291746|NCT00855803|39550687|FG000|Overall Study|Death|2|||
16291747|NCT00855803|39550687|FG000|Overall Study|Lost to Follow-up|2|||
16291748|NCT00855803|39550687|FG000|Overall Study|Technical inability to undergo procedure|2|||
16291749|NCT00855803|39550687|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
16291750|NCT00855803|39550687|FG000|Overall Study|Withdrawal by Subject|3|||
16291751|NCT00855803|39550687|FG000|Overall Study|Physician Decision|3|||
16291752|NCT01995266|39550688|FG000|Overall Study|Death|1|||
16081307|NCT02015520|38789563|FG003|Overall Study|Adverse Event|1|||
16081308|NCT02015520|38789560|FG000|Overall Study|Withdrawal by Subject|2|||
16081309|NCT02015520|38789561|FG001|Overall Study|Withdrawal by Subject|2|||
16291753|NCT01995266|39550688|FG000|Overall Study|Lack of Efficacy|6|||
16291754|NCT01995266|39550688|FG000|Overall Study|Adverse Event|2|||
16484089|NCT03345914|40248763|FG000|Overall Study|Ongoing|0|||
16484090|NCT03345914|40248764|FG001|Overall Study|Ongoing|0|||
16291755|NCT00851643|39550689|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
16291756|NCT00851643|39550690|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
16291757|NCT00851643|39550691|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
16291758|NCT00851643|39550692|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
16291759|NCT00851643|39550693|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
16291760|NCT00851643|39550694|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
16291761|NCT00851643|39550689|FG000|Base Study (Up to 12 Months)|Other|0|||
16291762|NCT00851643|39550690|FG001|Base Study (Up to 12 Months)|Other|0|||
16291763|NCT00851643|39550691|FG002|Base Study (Up to 12 Months)|Other|0|||
16291764|NCT00851643|39550692|FG003|Base Study (Up to 12 Months)|Other|0|||
16291765|NCT00851643|39550693|FG004|Base Study (Up to 12 Months)|Other|0|||
16291766|NCT00851643|39550694|FG005|Base Study (Up to 12 Months)|Other|1|||
16291767|NCT00851643|39550689|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
16291768|NCT00851643|39550690|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
16291769|NCT00851643|39550691|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
16291770|NCT00851643|39550692|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
16291771|NCT00851643|39550693|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
16291772|NCT00851643|39550694|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
16291773|NCT00851643|39550689|FG000|Extension Study (Up to 36 Months)|Moved|0|||
16291774|NCT00851643|39550690|FG001|Extension Study (Up to 36 Months)|Moved|2|||
16291775|NCT00851643|39550691|FG002|Extension Study (Up to 36 Months)|Moved|1|||
16291776|NCT00851643|39550692|FG003|Extension Study (Up to 36 Months)|Moved|1|||
16291777|NCT00851643|39550693|FG004|Extension Study (Up to 36 Months)|Moved|0|||
16291778|NCT00851643|39550694|FG005|Extension Study (Up to 36 Months)|Moved|1|||
16291779|NCT00324649|39550695|FG000|Overall Study|Adverse Event|1|||
16291780|NCT00324649|39550696|FG001|Overall Study|Adverse Event|4|||
16291781|NCT00324649|39550695|FG000|Overall Study|Withdrawal by Subject|0|||
16291782|NCT00324649|39550696|FG001|Overall Study|Withdrawal by Subject|1|||
16291783|NCT00324649|39550695|FG000|Overall Study|Noncompliance|1|||
16291784|NCT00324649|39550696|FG001|Overall Study|Noncompliance|0|||
16291785|NCT02669758|39550697|FG000|Overall Study|Withdrawal by Subject|43|||
16291786|NCT02669758|39550697|FG000|Overall Study|Lost to Follow-up|19|||
16291787|NCT02669758|39550697|FG000|Overall Study|Adverse Event|16|||
16291788|NCT02669758|39550697|FG000|Overall Study|Non-Compliance with Study Drug|8|||
16291789|NCT02669758|39550697|FG000|Overall Study|Lack of Efficacy|5|||
16291790|NCT02669758|39550697|FG000|Overall Study|Pregnancy|1|||
16291791|NCT02669758|39550697|FG000|Overall Study|Study noncompliance|1|||
16291792|NCT02669758|39550697|FG000|Overall Study|Protocol Violation|1|||
16291793|NCT00750308|39550706|FG000|First Treatment|Adverse Event|0|||
16291794|NCT00750308|39550707|FG001|First Treatment|Adverse Event|1|||
16291795|NCT00750308|39550708|FG002|First Treatment|Adverse Event|0|||
16291796|NCT00750308|39550709|FG003|First Treatment|Adverse Event|0|||
16291797|NCT00750308|39550710|FG004|First Treatment|Adverse Event|0|||
16291798|NCT00750308|39550711|FG005|First Treatment|Adverse Event|0|||
16291799|NCT00750308|39550712|FG006|First Treatment|Adverse Event|0|||
16291800|NCT00750308|39550713|FG007|First Treatment|Adverse Event|0|||
16291801|NCT00750308|39550714|FG008|First Treatment|Adverse Event|0|||
16291802|NCT00750308|39550715|FG009|First Treatment|Adverse Event|0|||
16291803|NCT00750308|39550716|FG010|First Treatment|Adverse Event|1|||
16291804|NCT00750308|39550717|FG011|First Treatment|Adverse Event|1|||
16291805|NCT00750308|39550706|FG000|First Treatment|Withdrawal by Subject|0|||
16291806|NCT00750308|39550707|FG001|First Treatment|Withdrawal by Subject|0|||
16291807|NCT00750308|39550708|FG002|First Treatment|Withdrawal by Subject|0|||
16291808|NCT00750308|39550709|FG003|First Treatment|Withdrawal by Subject|1|||
16291809|NCT00750308|39550710|FG004|First Treatment|Withdrawal by Subject|0|||
16291810|NCT00750308|39550711|FG005|First Treatment|Withdrawal by Subject|0|||
16291811|NCT00750308|39550712|FG006|First Treatment|Withdrawal by Subject|0|||
16484091|NCT03345914|40248765|FG002|Overall Study|Ongoing|1|||
16484092|NCT01332331|40248766|FG000|Overall Study|Lost to Follow-up|0|||
16291812|NCT00750308|39550713|FG007|First Treatment|Withdrawal by Subject|1|||
16081310|NCT02015520|38789562|FG002|Overall Study|Withdrawal by Subject|1|||
16291813|NCT00750308|39550714|FG008|First Treatment|Withdrawal by Subject|0|||
16291814|NCT00750308|39550715|FG009|First Treatment|Withdrawal by Subject|0|||
16291815|NCT00750308|39550716|FG010|First Treatment|Withdrawal by Subject|0|||
16291816|NCT00750308|39550717|FG011|First Treatment|Withdrawal by Subject|0|||
16291817|NCT00750308|39550706|FG000|Second Treatment|Adverse Event|0|||
16291818|NCT00750308|39550707|FG001|Second Treatment|Adverse Event|0|||
16291819|NCT00750308|39550708|FG002|Second Treatment|Adverse Event|0|||
16291820|NCT00750308|39550709|FG003|Second Treatment|Adverse Event|0|||
16291821|NCT00750308|39550710|FG004|Second Treatment|Adverse Event|0|||
16484093|NCT01332331|40248767|FG001|Overall Study|Lost to Follow-up|1|||
16484094|NCT01332331|40248766|FG000|Overall Study|Adverse Event|1|||
16484095|NCT01332331|40248767|FG001|Overall Study|Adverse Event|1|||
16484096|NCT01332331|40248766|FG000|Overall Study|Physician Decision|1|||
16081311|NCT02015520|38789563|FG003|Overall Study|Withdrawal by Subject|0|||
16081312|NCT02015520|38789560|FG000|Overall Study|Death|1|||
16081313|NCT02015520|38789561|FG001|Overall Study|Death|0|||
16081314|NCT02015520|38789562|FG002|Overall Study|Death|0|||
16081315|NCT02015520|38789563|FG003|Overall Study|Death|0|||
16081316|NCT02015520|38789560|FG000|Overall Study|Lost to Follow-up|0|||
16081317|NCT02015520|38789561|FG001|Overall Study|Lost to Follow-up|0|||
16081318|NCT02015520|38789562|FG002|Overall Study|Lost to Follow-up|1|||
16081319|NCT02015520|38789563|FG003|Overall Study|Lost to Follow-up|0|||
16081320|NCT02015520|38789560|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
16081321|NCT02015520|38789561|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
16081322|NCT02015520|38789562|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
16081323|NCT02015520|38789563|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
16081324|NCT02015520|38789560|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
16081325|NCT02015520|38789561|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
16081326|NCT02015520|38789562|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
16081327|NCT02015520|38789563|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
16081328|NCT03912831|38789566|FG000|Overall Study|Death|1|||
16484097|NCT01332331|40248767|FG001|Overall Study|Physician Decision|0|||
16484098|NCT01133522|40248777|FG000|Overall Study|Withdrawal by Subject|0|||
16484099|NCT01133522|40248778|FG001|Overall Study|Withdrawal by Subject|1|||
16484100|NCT01133522|40248779|FG002|Overall Study|Withdrawal by Subject|0|||
16484101|NCT01133522|40248780|FG003|Overall Study|Withdrawal by Subject|1|||
16291822|NCT00750308|39550711|FG005|Second Treatment|Adverse Event|1|||
16291823|NCT00750308|39550712|FG006|Second Treatment|Adverse Event|0|||
16291824|NCT00750308|39550713|FG007|Second Treatment|Adverse Event|0|||
16291825|NCT00750308|39550714|FG008|Second Treatment|Adverse Event|1|||
16291826|NCT00750308|39550715|FG009|Second Treatment|Adverse Event|0|||
16291827|NCT00750308|39550716|FG010|Second Treatment|Adverse Event|0|||
16291828|NCT00750308|39550717|FG011|Second Treatment|Adverse Event|0|||
16291829|NCT00750308|39550706|FG000|Second Treatment|Withdrawal by Subject|0|||
16291830|NCT00750308|39550707|FG001|Second Treatment|Withdrawal by Subject|0|||
16291831|NCT00750308|39550708|FG002|Second Treatment|Withdrawal by Subject|0|||
16291832|NCT00750308|39550709|FG003|Second Treatment|Withdrawal by Subject|0|||
16291833|NCT00750308|39550710|FG004|Second Treatment|Withdrawal by Subject|1|||
16291834|NCT00750308|39550711|FG005|Second Treatment|Withdrawal by Subject|0|||
16291835|NCT00750308|39550712|FG006|Second Treatment|Withdrawal by Subject|0|||
16081329|NCT03912831|38789567|FG001|Overall Study|Death|1|||
16081330|NCT03912831|38789568|FG002|Overall Study|Death|1|||
16081331|NCT03912831|38789569|FG003|Overall Study|Death|1|||
16081332|NCT03912831|38789570|FG004|Overall Study|Death|1|||
16081333|NCT03912831|38789571|FG005|Overall Study|Death|1|||
16081334|NCT03912831|38789566|FG000|Overall Study|Reason not Specified|0|||
16291836|NCT00750308|39550713|FG007|Second Treatment|Withdrawal by Subject|0|||
16291837|NCT00750308|39550714|FG008|Second Treatment|Withdrawal by Subject|0|||
16291838|NCT00750308|39550715|FG009|Second Treatment|Withdrawal by Subject|0|||
16291839|NCT00750308|39550716|FG010|Second Treatment|Withdrawal by Subject|0|||
16291840|NCT00750308|39550717|FG011|Second Treatment|Withdrawal by Subject|0|||
16291841|NCT00750308|39550706|FG000|Third Treatment|Withdrawal by Subject|0|||
16291842|NCT00750308|39550707|FG001|Third Treatment|Withdrawal by Subject|1|||
16291843|NCT00750308|39550708|FG002|Third Treatment|Withdrawal by Subject|0|||
16291844|NCT00750308|39550709|FG003|Third Treatment|Withdrawal by Subject|0|||
16291845|NCT00750308|39550710|FG004|Third Treatment|Withdrawal by Subject|0|||
16291846|NCT00750308|39550711|FG005|Third Treatment|Withdrawal by Subject|0|||
16291847|NCT00750308|39550712|FG006|Third Treatment|Withdrawal by Subject|0|||
16291848|NCT00750308|39550713|FG007|Third Treatment|Withdrawal by Subject|0|||
16291849|NCT00750308|39550714|FG008|Third Treatment|Withdrawal by Subject|0|||
16291850|NCT00750308|39550715|FG009|Third Treatment|Withdrawal by Subject|0|||
16291851|NCT00750308|39550716|FG010|Third Treatment|Withdrawal by Subject|0|||
16291852|NCT00750308|39550717|FG011|Third Treatment|Withdrawal by Subject|0|||
16291853|NCT02939950|39550724|FG000|Overall Study|Lost to Follow-up|13|||
16291854|NCT02939950|39550725|FG001|Overall Study|Lost to Follow-up|16|||
16291855|NCT02939950|39550724|FG000|Overall Study|Positive slit lamp findings|0|||
16291856|NCT02939950|39550725|FG001|Overall Study|Positive slit lamp findings|1|||
16291857|NCT02939950|39550724|FG000|Overall Study|Chalazion upper lid|0|||
16291858|NCT02939950|39550725|FG001|Overall Study|Chalazion upper lid|1|||
16484102|NCT01133522|40248781|FG004|Overall Study|Withdrawal by Subject|0|||
16484103|NCT01133522|40248782|FG005|Overall Study|Withdrawal by Subject|0|||
16484104|NCT01133522|40248783|FG006|Overall Study|Withdrawal by Subject|0|||
16291859|NCT02939950|39550724|FG000|Overall Study|Lack of motivation|0|||
16291860|NCT02939950|39550725|FG001|Overall Study|Lack of motivation|2|||
16484105|NCT01133522|40248784|FG007|Overall Study|Withdrawal by Subject|0|||
16484106|NCT01133522|40248785|FG008|Overall Study|Withdrawal by Subject|0|||
16081335|NCT03912831|38789567|FG001|Overall Study|Reason not Specified|0|||
16081336|NCT03912831|38789568|FG002|Overall Study|Reason not Specified|0|||
16081337|NCT03912831|38789569|FG003|Overall Study|Reason not Specified|0|||
16081338|NCT03912831|38789570|FG004|Overall Study|Reason not Specified|1|||
16081339|NCT03912831|38789571|FG005|Overall Study|Reason not Specified|0|||
16081340|NCT03912831|38789566|FG000|Overall Study|Withdrawal by Participant|0|||
16081341|NCT03912831|38789567|FG001|Overall Study|Withdrawal by Participant|0|||
16081342|NCT03912831|38789568|FG002|Overall Study|Withdrawal by Participant|0|||
16081343|NCT03912831|38789569|FG003|Overall Study|Withdrawal by Participant|0|||
16081344|NCT03912831|38789570|FG004|Overall Study|Withdrawal by Participant|1|||
16081345|NCT03912831|38789571|FG005|Overall Study|Withdrawal by Participant|0|||
16081346|NCT00901901|38789572|FG000|Treatment Period|Adverse Event|120|||
16081347|NCT00901901|38789573|FG001|Treatment Period|Adverse Event|128|||
16081348|NCT00901901|38789572|FG000|Treatment Period|Withdrawal by Subject|26|||
16081349|NCT00901901|38789573|FG001|Treatment Period|Withdrawal by Subject|24|||
16081350|NCT00901901|38789572|FG000|Treatment Period|Physician Decision|2|||
16081351|NCT00901901|38789573|FG001|Treatment Period|Physician Decision|2|||
16081352|NCT00901901|38789572|FG000|Treatment Period|Lost to Follow-up|3|||
16081353|NCT00901901|38789573|FG001|Treatment Period|Lost to Follow-up|5|||
16081354|NCT00901901|38789572|FG000|Treatment Period|Noncompliance with study medication|4|||
16081355|NCT00901901|38789573|FG001|Treatment Period|Noncompliance with study medication|1|||
16081356|NCT00901901|38789572|FG000|Treatment Period|Missing|1|||
16081357|NCT00901901|38789573|FG001|Treatment Period|Missing|0|||
16081358|NCT00901901|38789572|FG000|Treatment Period|Never treated|0|||
16081359|NCT00901901|38789573|FG001|Treatment Period|Never treated|3|||
16081360|NCT00901901|38789572|FG000|Treatment Period|Protocol driven decision point|0|||
16081361|NCT00901901|38789573|FG001|Treatment Period|Protocol driven decision point|2|||
16081362|NCT00901901|38789572|FG000|Treatment Period|Study terminated by sponsor|2|||
16081363|NCT00901901|38789573|FG001|Treatment Period|Study terminated by sponsor|0|||
16081364|NCT00901901|38789572|FG000|Treatment Period|Protocol Violation|5|||
16081365|NCT00901901|38789573|FG001|Treatment Period|Protocol Violation|9|||
16081366|NCT00901901|38789572|FG000|Treatment Period|Switch to commercial drug|1|||
16081367|NCT00901901|38789573|FG001|Treatment Period|Switch to commercial drug|1|||
16081368|NCT00901901|38789572|FG000|Treatment Period|Transfer to treatment continuation study|5|||
16081369|NCT00901901|38789573|FG001|Treatment Period|Transfer to treatment continuation study|2|||
16081370|NCT00901901|38789572|FG000|Follow-up Period|Death|181|||
16081371|NCT00901901|38789573|FG001|Follow-up Period|Death|208|||
16186933|NCT03242928|39161966|FG000|Overall Study|Adverse Event|2|||
16186934|NCT03242928|39161967|FG001|Overall Study|Adverse Event|1|||
16186935|NCT03242928|39161966|FG000|Overall Study|Lost to Follow-up|2|||
16186936|NCT03242928|39161967|FG001|Overall Study|Lost to Follow-up|0|||
16186937|NCT03242928|39161966|FG000|Overall Study|Physician Decision|0|||
16186938|NCT03242928|39161967|FG001|Overall Study|Physician Decision|1|||
16186939|NCT03242928|39161966|FG000|Overall Study|Withdrawal by Subject|5|||
16186940|NCT03242928|39161967|FG001|Overall Study|Withdrawal by Subject|3|||
16381052|NCT02259114|39877787|FG000|Overall Study|Not Treated|1|||
16081372|NCT00901901|38789572|FG000|Follow-up Period|Protocol driven decision point|47|||
16081373|NCT00901901|38789573|FG001|Follow-up Period|Protocol driven decision point|36|||
16081374|NCT00901901|38789572|FG000|Follow-up Period|Withdrawal by Subject|6|||
16081375|NCT00901901|38789573|FG001|Follow-up Period|Withdrawal by Subject|9|||
16081376|NCT00901901|38789572|FG000|Follow-up Period|Lost to Follow-up|12|||
16081377|NCT00901901|38789573|FG001|Follow-up Period|Lost to Follow-up|8|||
16081378|NCT00901901|38789572|FG000|Follow-up Period|Missing|94|||
16081379|NCT00901901|38789573|FG001|Follow-up Period|Missing|80|||
16081380|NCT02616900|38789574|FG000|Overall Study|Lack of Efficacy|7|||
16081381|NCT02616900|38789574|FG000|Overall Study|Lost to Follow-up|2|||
16081382|NCT02616900|38789574|FG000|Overall Study|Protocol Violation|5|||
16081383|NCT02616900|38789574|FG000|Overall Study|Withdrawal by Subject|3|||
16081384|NCT02616900|38789574|FG000|Overall Study|Incomplete data|6|||
16081385|NCT02797184|38789575|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
16186941|NCT00450372|39161968|FG000|Overall Study|Physician Decision|1|||
16186942|NCT00830037|39161969|FG000|Overall Study|Withdrawal by Subject|2|||
16081386|NCT02797184|38789576|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
16081387|NCT03527160|38789577|FG000|Overall Study|No urine collected|13|||
16186943|NCT00830037|39161970|FG001|Overall Study|Withdrawal by Subject|3|||
16186944|NCT00830037|39161969|FG000|Overall Study|Lost to Follow-up|1|||
16186945|NCT00830037|39161970|FG001|Overall Study|Lost to Follow-up|2|||
16186946|NCT00830037|39161969|FG000|Overall Study|Active when terminated by DSMB|15|||
16186947|NCT00830037|39161970|FG001|Overall Study|Active when terminated by DSMB|14|||
16186948|NCT04760314|39161976|FG000|Induction Period|Withdrawal by Subject|0|||
16186949|NCT04760314|39161977|FG001|Induction Period|Withdrawal by Subject|1|||
16186950|NCT04760314|39161978|FG002|Induction Period|Withdrawal by Subject|1|||
16186951|NCT04760314|39161979|FG003|Induction Period|Withdrawal by Subject|0|||
16186952|NCT04760314|39161980|FG004|Induction Period|Withdrawal by Subject|0|||
16186953|NCT04760314|39161981|FG005|Induction Period|Withdrawal by Subject|0|||
16186954|NCT04760314|39161982|FG006|Induction Period|Withdrawal by Subject|0|||
16186955|NCT04760314|39161983|FG007|Induction Period|Withdrawal by Subject|0|||
16186956|NCT04760314|39161984|FG008|Induction Period|Withdrawal by Subject|0|||
16186957|NCT04760314|39161985|FG009|Induction Period|Withdrawal by Subject|0|||
16186958|NCT04760314|39161986|FG010|Induction Period|Withdrawal by Subject|0|||
16186959|NCT04760314|39161976|FG000|Induction Period|Adverse Event|0|||
16186960|NCT04760314|39161977|FG001|Induction Period|Adverse Event|0|||
16186961|NCT04760314|39161978|FG002|Induction Period|Adverse Event|2|||
16186962|NCT04760314|39161979|FG003|Induction Period|Adverse Event|0|||
16186963|NCT04760314|39161980|FG004|Induction Period|Adverse Event|0|||
16186964|NCT04760314|39161981|FG005|Induction Period|Adverse Event|0|||
16186965|NCT04760314|39161982|FG006|Induction Period|Adverse Event|0|||
16186966|NCT04760314|39161983|FG007|Induction Period|Adverse Event|0|||
16186967|NCT04760314|39161984|FG008|Induction Period|Adverse Event|0|||
16186968|NCT04760314|39161985|FG009|Induction Period|Adverse Event|0|||
16186969|NCT04760314|39161986|FG010|Induction Period|Adverse Event|0|||
16186970|NCT04760314|39161976|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
16186971|NCT04760314|39161977|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
16186972|NCT04760314|39161978|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
16186973|NCT04760314|39161979|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
16186974|NCT04760314|39161980|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
16186975|NCT04760314|39161981|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
16186976|NCT04760314|39161982|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
16186977|NCT04760314|39161983|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
16186978|NCT04760314|39161984|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
16186979|NCT04760314|39161985|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
16186980|NCT04760314|39161986|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
16186981|NCT04760314|39161976|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
16186982|NCT04760314|39161977|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
16186983|NCT04760314|39161978|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
16186984|NCT04760314|39161979|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
16186985|NCT04760314|39161980|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
16186986|NCT04760314|39161981|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
16186987|NCT04760314|39161982|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
16186988|NCT04760314|39161983|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
16186989|NCT04760314|39161984|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
16186990|NCT04760314|39161985|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
16186991|NCT04760314|39161986|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
16186992|NCT04760314|39161976|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
16186993|NCT04760314|39161977|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
16186994|NCT04760314|39161978|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
16186995|NCT04760314|39161979|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
16186996|NCT04760314|39161980|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
16186997|NCT04760314|39161981|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
16186998|NCT04760314|39161982|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
16186999|NCT04760314|39161983|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
16187000|NCT04760314|39161984|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
16291861|NCT02939950|39550724|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
16291862|NCT02939950|39550725|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
16187001|NCT04760314|39161985|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
16187002|NCT04760314|39161986|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
16187003|NCT04760314|39161976|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
16187004|NCT04760314|39161977|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
16187005|NCT04760314|39161978|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
16187006|NCT04760314|39161979|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
16187007|NCT04760314|39161980|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
16187008|NCT04760314|39161981|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
16187009|NCT04760314|39161982|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
16187010|NCT04760314|39161983|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
16187011|NCT04760314|39161984|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
16187012|NCT04760314|39161985|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
16187013|NCT04760314|39161986|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
16187014|NCT04760314|39161976|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16187015|NCT04760314|39161977|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16187016|NCT04760314|39161978|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16187017|NCT04760314|39161979|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16187018|NCT04760314|39161980|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16187019|NCT04760314|39161981|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16187020|NCT04760314|39161982|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16187021|NCT04760314|39161983|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
16187022|NCT04760314|39161984|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16187023|NCT04760314|39161985|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
16187024|NCT04760314|39161986|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
16187025|NCT04760314|39161976|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16187026|NCT04760314|39161977|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16187027|NCT04760314|39161978|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16187028|NCT04760314|39161979|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16187029|NCT04760314|39161980|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16187030|NCT04760314|39161981|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16187031|NCT04760314|39161982|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16187032|NCT04760314|39161983|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
16187033|NCT04760314|39161984|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
16187034|NCT04760314|39161985|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
16187035|NCT04760314|39161986|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16187036|NCT04760314|39161976|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16187037|NCT04760314|39161977|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16187038|NCT04760314|39161978|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16291863|NCT02939950|39550724|FG000|Overall Study|Military orders|1|||
16291864|NCT02939950|39550725|FG001|Overall Study|Military orders|0|||
16291865|NCT02939950|39550724|FG000|Overall Study|Participant Relocated|5|||
16291866|NCT02939950|39550725|FG001|Overall Study|Participant Relocated|3|||
16381053|NCT02259114|39877788|FG001|Overall Study|Not Treated|0|||
16381054|NCT02259114|39877789|FG002|Overall Study|Not Treated|0|||
16381055|NCT02259114|39877790|FG003|Overall Study|Not Treated|0|||
16381056|NCT02259114|39877791|FG004|Overall Study|Not Treated|0|||
16381057|NCT03791060|39877794|FG000|Overall Study|Withdrawal by Subject|1|||
16381058|NCT02090764|39877795|FG000|Overall Study|Adverse Event|1|||
16381059|NCT02090764|39877796|FG001|Overall Study|Adverse Event|3|||
16381060|NCT02090764|39877795|FG000|Overall Study|Lack of Efficacy|0|||
16291867|NCT02939950|39550724|FG000|Overall Study|Study related symptoms|8|||
16291868|NCT02939950|39550725|FG001|Overall Study|Study related symptoms|8|||
16291869|NCT02939950|39550724|FG000|Overall Study|Unacceptable lens movement|2|||
16291870|NCT02939950|39550725|FG001|Overall Study|Unacceptable lens movement|0|||
16291871|NCT02939950|39550724|FG000|Overall Study|Protocol Violation|6|||
16381061|NCT02090764|39877796|FG001|Overall Study|Lack of Efficacy|13|||
16187039|NCT04760314|39161979|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16187040|NCT04760314|39161980|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16187041|NCT04760314|39161981|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16187042|NCT04760314|39161982|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16187043|NCT04760314|39161983|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
16187044|NCT04760314|39161984|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16187045|NCT04760314|39161985|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16187046|NCT04760314|39161986|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16187047|NCT04760314|39161976|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
16187048|NCT04760314|39161977|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
16187049|NCT04760314|39161978|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
16381062|NCT02090764|39877795|FG000|Overall Study|Withdrawal by Subject|2|||
16381063|NCT02090764|39877796|FG001|Overall Study|Withdrawal by Subject|1|||
16187050|NCT04760314|39161979|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
16187051|NCT04760314|39161980|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
16187052|NCT04760314|39161981|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
16187053|NCT04760314|39161982|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
16187054|NCT04760314|39161983|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
16187055|NCT04760314|39161984|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
16291872|NCT02939950|39550725|FG001|Overall Study|Protocol Violation|3|||
16291873|NCT02939950|39550724|FG000|Overall Study|Physician Decision|2|||
16381064|NCT02090764|39877795|FG000|Overall Study|Intercurrent illness and other|1|||
16291874|NCT02939950|39550725|FG001|Overall Study|Physician Decision|0|||
16381065|NCT02090764|39877796|FG001|Overall Study|Intercurrent illness and other|1|||
16381066|NCT02090764|39877795|FG000|Overall Study|Lost to Follow-up|2|||
16381067|NCT02090764|39877796|FG001|Overall Study|Lost to Follow-up|2|||
16381068|NCT00492557|39877803|FG000|Overall Study|Subject request|12|||
16381069|NCT00492557|39877804|FG001|Overall Study|Subject request|11|||
16381070|NCT00492557|39877803|FG000|Overall Study|Protocol Violation|7|||
16381071|NCT00492557|39877804|FG001|Overall Study|Protocol Violation|8|||
16381072|NCT00492557|39877803|FG000|Overall Study|Other|2|||
16381073|NCT00492557|39877804|FG001|Overall Study|Other|2|||
16381074|NCT00492557|39877803|FG000|Overall Study|Death|1|||
16381075|NCT00492557|39877804|FG001|Overall Study|Death|1|||
16381076|NCT00492557|39877803|FG000|Overall Study|Adverse Event|1|||
16381077|NCT00492557|39877804|FG001|Overall Study|Adverse Event|0|||
16381078|NCT00492557|39877803|FG000|Overall Study|Failed to return|1|||
16381079|NCT00492557|39877804|FG001|Overall Study|Failed to return|0|||
16381080|NCT00492557|39877803|FG000|Overall Study|Lost to Follow-up|0|||
16381081|NCT00492557|39877804|FG001|Overall Study|Lost to Follow-up|1|||
16381082|NCT03069716|39877805|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
16381083|NCT03069716|39877806|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
16291875|NCT02939950|39550724|FG000|Overall Study|Pregnancy|6|||
16291876|NCT02939950|39550725|FG001|Overall Study|Pregnancy|7|||
16291877|NCT02939950|39550724|FG000|Overall Study|Withdrawal by Subject|12|||
16291878|NCT02939950|39550725|FG001|Overall Study|Withdrawal by Subject|28|||
16291879|NCT02939950|39550724|FG000|Overall Study|Adverse Event|7|||
16291880|NCT02939950|39550725|FG001|Overall Study|Adverse Event|3|||
16291881|NCT02939950|39550724|FG000|Overall Study|Randomized, not dispensed|1|||
16291882|NCT02939950|39550725|FG001|Overall Study|Randomized, not dispensed|0|||
16291883|NCT02939950|39550724|FG000|Overall Study|Ineligible at Baseline|2|||
16291884|NCT02939950|39550725|FG001|Overall Study|Ineligible at Baseline|8|||
16291885|NCT00741936|39550730|FG000|Overall Study|Lost to Follow-up|1|||
16291886|NCT00741936|39550731|FG001|Overall Study|Lost to Follow-up|1|||
16291887|NCT00741936|39550730|FG000|Overall Study|Adverse Event|3|||
16291888|NCT00741936|39550731|FG001|Overall Study|Adverse Event|4|||
16291889|NCT00741936|39550730|FG000|Overall Study|Pregnancy|0|||
16291890|NCT00741936|39550731|FG001|Overall Study|Pregnancy|1|||
16291891|NCT00741936|39550730|FG000|Overall Study|Protocol Violation|2|||
16291892|NCT00741936|39550731|FG001|Overall Study|Protocol Violation|0|||
16291893|NCT00741936|39550730|FG000|Overall Study|Lack of Efficacy|0|||
16291894|NCT00741936|39550731|FG001|Overall Study|Lack of Efficacy|2|||
16291895|NCT00741936|39550730|FG000|Overall Study|Low compliance|3|||
16291896|NCT00741936|39550731|FG001|Overall Study|Low compliance|0|||
16291897|NCT00440466|39550732|FG000|Overall Study|Death|3|||
16291898|NCT00440466|39550733|FG001|Overall Study|Death|2|||
16291899|NCT00440466|39550734|FG002|Overall Study|Death|9|||
16291900|NCT00440466|39550732|FG000|Overall Study|Adverse Event|3|||
16291901|NCT00440466|39550733|FG001|Overall Study|Adverse Event|4|||
16291902|NCT00440466|39550734|FG002|Overall Study|Adverse Event|11|||
16291903|NCT00440466|39550732|FG000|Overall Study|Lost to Follow-up|1|||
16291904|NCT00440466|39550733|FG001|Overall Study|Lost to Follow-up|0|||
16291905|NCT00440466|39550734|FG002|Overall Study|Lost to Follow-up|2|||
16291906|NCT00440466|39550732|FG000|Overall Study|Physician Decision|2|||
16291907|NCT00440466|39550733|FG001|Overall Study|Physician Decision|0|||
16291908|NCT00440466|39550734|FG002|Overall Study|Physician Decision|1|||
16291909|NCT00440466|39550732|FG000|Overall Study|Protocol Violation|2|||
16291910|NCT00440466|39550733|FG001|Overall Study|Protocol Violation|0|||
16291911|NCT00440466|39550734|FG002|Overall Study|Protocol Violation|4|||
16291912|NCT00440466|39550732|FG000|Overall Study|Withdrawal by Subject|2|||
16291913|NCT00440466|39550733|FG001|Overall Study|Withdrawal by Subject|5|||
16291914|NCT00440466|39550734|FG002|Overall Study|Withdrawal by Subject|9|||
16291915|NCT00440466|39550732|FG000|Overall Study|Began Dialysis|0|||
16291916|NCT00440466|39550733|FG001|Overall Study|Began Dialysis|0|||
16291917|NCT00440466|39550734|FG002|Overall Study|Began Dialysis|1|||
16381084|NCT03069716|39877807|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
16381085|NCT03069716|39877805|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
16291918|NCT00440466|39550732|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
16291919|NCT00440466|39550733|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
16291920|NCT00440466|39550734|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
16291921|NCT05304611|39550737|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
16291922|NCT05304611|39550738|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
16291923|NCT05304611|39550739|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
16291924|NCT05304611|39550740|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
16291925|NCT05304611|39550741|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
16291926|NCT05304611|39550742|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
16291927|NCT05304611|39550743|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
16291928|NCT05304611|39550744|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
16381086|NCT03069716|39877806|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
16381087|NCT03069716|39877807|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
16381088|NCT03069716|39877805|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
16291929|NCT05304611|39550745|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
16291930|NCT05304611|39550737|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
16291931|NCT05304611|39550738|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
16291932|NCT05304611|39550739|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
16291933|NCT05304611|39550740|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
16291934|NCT05304611|39550741|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
16291935|NCT05304611|39550742|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
16291936|NCT05304611|39550743|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
16291937|NCT05304611|39550744|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
16291938|NCT05304611|39550745|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
16291939|NCT02145026|39550746|FG000|Overall Study|Adverse Event|2|||
16291940|NCT02145026|39550746|FG000|Overall Study|Death|4|||
16291941|NCT02145026|39550746|FG000|Overall Study|Withdrawal by Subject|2|||
16291942|NCT02145026|39550746|FG000|Overall Study|Physician Decision|4|||
16291943|NCT02640053|39550747|FG000|Overall Study|Withdrawal by Subject|2|||
16291944|NCT02640053|39550748|FG001|Overall Study|Withdrawal by Subject|1|||
16291945|NCT02640053|39550747|FG000|Overall Study|Adverse Event|1|||
16291946|NCT02640053|39550748|FG001|Overall Study|Adverse Event|1|||
16291947|NCT02640053|39550747|FG000|Overall Study|Alternative Therapy|1|||
16291948|NCT02640053|39550748|FG001|Overall Study|Alternative Therapy|1|||
16291949|NCT02640053|39550747|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
16291950|NCT02640053|39550748|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
16291951|NCT01458106|39550749|FG000|Overall Study|Withdrawal by Subject|2|||
16291952|NCT01458106|39550750|FG001|Overall Study|Withdrawal by Subject|0|||
16291953|NCT01458106|39550749|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
16291954|NCT01458106|39550750|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
16291955|NCT01458106|39550749|FG000|Overall Study|Withdrawn Per Protocol|0|||
16291956|NCT01458106|39550750|FG001|Overall Study|Withdrawn Per Protocol|1|||
16291957|NCT02698865|39550751|FG000|Overall Study|Other|11|||
16291958|NCT02698865|39550752|FG001|Overall Study|Other|11|||
16291959|NCT02698865|39550751|FG000|Overall Study|Withdrawal by Subject|20|||
16291960|NCT02698865|39550752|FG001|Overall Study|Withdrawal by Subject|16|||
16291961|NCT02698865|39550751|FG000|Overall Study|Physician Decision|0|||
16291962|NCT02698865|39550752|FG001|Overall Study|Physician Decision|4|||
16291963|NCT02698865|39550751|FG000|Overall Study|Lost to Follow-up|4|||
16291964|NCT02698865|39550752|FG001|Overall Study|Lost to Follow-up|2|||
16291965|NCT01321008|39550754|FG000|Overall Study|Early Study Termination|1|||
16291966|NCT01297465|39550756|FG000|Overall Study|Lack of Ovarian Response|1|||
16291967|NCT01297465|39550757|FG001|Overall Study|Lack of Ovarian Response|1|||
16291968|NCT01297465|39550756|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
16291969|NCT01297465|39550757|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
16291970|NCT01297465|39550756|FG000|Overall Study|No Oocytes Retrieved|1|||
16291971|NCT01297465|39550757|FG001|Overall Study|No Oocytes Retrieved|1|||
16291972|NCT01297465|39550756|FG000|Overall Study|Poor oocyte quality|0|||
16291973|NCT01297465|39550757|FG001|Overall Study|Poor oocyte quality|1|||
16291974|NCT01297465|39550756|FG000|Overall Study|No Fertilization|6|||
16291975|NCT01297465|39550757|FG001|Overall Study|No Fertilization|4|||
16291976|NCT01297465|39550756|FG000|Overall Study|All Embryos Discarded|0|||
16291977|NCT01297465|39550757|FG001|Overall Study|All Embryos Discarded|1|||
16291978|NCT01297465|39550756|FG000|Overall Study|Intention to Freeze all Embryos|0|||
16291979|NCT01297465|39550757|FG001|Overall Study|Intention to Freeze all Embryos|1|||
16291980|NCT01597479|39554562|FG000|Overall Study|Protocol Violation|1|||
16291981|NCT01597479|39554563|FG001|Overall Study|Protocol Violation|0|||
16291982|NCT01597479|39554562|FG000|Overall Study|Lost to Follow-up|1|||
16291983|NCT01597479|39554563|FG001|Overall Study|Lost to Follow-up|0|||
16291984|NCT00548093|39554564|FG000|Overall Study|Death|33|||
16291985|NCT00548093|39554565|FG001|Overall Study|Death|13|||
16291986|NCT00548093|39554564|FG000|Overall Study|Lost to Follow-up|3|||
16291987|NCT00548093|39554565|FG001|Overall Study|Lost to Follow-up|1|||
16291988|NCT00548093|39554564|FG000|Overall Study|Objective progression or relapse|1|||
16291989|NCT00548093|39554565|FG001|Overall Study|Objective progression or relapse|1|||
16291990|NCT00548093|39554564|FG000|Overall Study|Other|11|||
16291991|NCT00548093|39554565|FG001|Overall Study|Other|1|||
16291992|NCT00548093|39554564|FG000|Overall Study|Withdrawal by Subject|1|||
16291993|NCT00548093|39554565|FG001|Overall Study|Withdrawal by Subject|0|||
16291994|NCT00548093|39554564|FG000|Overall Study|Completed post-treatment follow-up|1|||
16291995|NCT00548093|39554565|FG001|Overall Study|Completed post-treatment follow-up|0|||
16291996|NCT02791893|39554570|FG000|Blinded Phase|Lost to Follow-up|2|||
16291997|NCT02791893|39554571|FG001|Blinded Phase|Lost to Follow-up|2|||
16291998|NCT02791893|39554570|FG000|Blinded Phase|Withdrawal by Subject|1|||
16291999|NCT02791893|39554571|FG001|Blinded Phase|Withdrawal by Subject|2|||
16292000|NCT02791893|39554570|FG000|Open Label Phase|Lost to Follow-up|3|||
16292001|NCT02791893|39554571|FG001|Open Label Phase|Lost to Follow-up|0|||
16292002|NCT02791893|39554570|FG000|Open Label Phase|Withdrawal by Subject|0|||
16292003|NCT02791893|39554571|FG001|Open Label Phase|Withdrawal by Subject|2|||
16292004|NCT04156620|39554572|FG000|Overall Study|Adverse event - TP 1|5|||
16292005|NCT04156620|39554573|FG001|Overall Study|Adverse event - TP 1|2|||
16292006|NCT04156620|39554572|FG000|Overall Study|Lost to follow-up TP 1|1|||
16292007|NCT04156620|39554573|FG001|Overall Study|Lost to follow-up TP 1|1|||
16292008|NCT04156620|39554572|FG000|Overall Study|Progressive disease - TP 1|0|||
16292009|NCT04156620|39554573|FG001|Overall Study|Progressive disease - TP 1|1|||
16292010|NCT04156620|39554572|FG000|Overall Study|Subject decision - TP 1|3|||
16292011|NCT04156620|39554573|FG001|Overall Study|Subject decision - TP 1|5|||
16292012|NCT04156620|39554572|FG000|Overall Study|Adverse event - TP 2|5|||
16292013|NCT04156620|39554573|FG001|Overall Study|Adverse event - TP 2|6|||
16292014|NCT04156620|39554572|FG000|Overall Study|Death - TP 2|1|||
16292015|NCT04156620|39554573|FG001|Overall Study|Death - TP 2|0|||
16292016|NCT04156620|39554572|FG000|Overall Study|Lost to follow-up - TP 2|5|||
16292017|NCT04156620|39554573|FG001|Overall Study|Lost to follow-up - TP 2|2|||
16292018|NCT04156620|39554572|FG000|Overall Study|Physician decision - TP 2|4|||
16292019|NCT04156620|39554573|FG001|Overall Study|Physician decision - TP 2|2|||
16292020|NCT04156620|39554572|FG000|Overall Study|Pregnancy - TP 2|1|||
16292021|NCT04156620|39554573|FG001|Overall Study|Pregnancy - TP 2|1|||
16292022|NCT04156620|39554572|FG000|Overall Study|Subject decision - TP 2|11|||
16292023|NCT04156620|39554573|FG001|Overall Study|Subject decision - TP 2|9|||
16292024|NCT04156620|39554572|FG000|Overall Study|New therapy for study indication - TP 2|1|||
16292025|NCT04156620|39554573|FG001|Overall Study|New therapy for study indication - TP 2|0|||
16292026|NCT01765582|39554574|FG000|Overall Study|Other|3|||
16292027|NCT01765582|39554575|FG001|Overall Study|Other|6|||
16292028|NCT01765582|39554576|FG002|Overall Study|Other|9|||
16292029|NCT01765582|39554574|FG000|Overall Study|Lost to Follow-up|2|||
16292030|NCT01765582|39554575|FG001|Overall Study|Lost to Follow-up|2|||
16292031|NCT01765582|39554576|FG002|Overall Study|Lost to Follow-up|1|||
16292032|NCT01765582|39554574|FG000|Overall Study|Death|31|||
16292033|NCT01765582|39554575|FG001|Overall Study|Death|36|||
16292034|NCT01765582|39554576|FG002|Overall Study|Death|33|||
16292035|NCT01765582|39554574|FG000|Overall Study|Sponsor Decision|46|||
16292036|NCT01765582|39554575|FG001|Overall Study|Sponsor Decision|42|||
16292037|NCT01765582|39554576|FG002|Overall Study|Sponsor Decision|42|||
16292038|NCT01765582|39554574|FG000|Overall Study|Withdrawal of Consent|11|||
16292039|NCT01765582|39554575|FG001|Overall Study|Withdrawal of Consent|6|||
16292040|NCT01765582|39554576|FG002|Overall Study|Withdrawal of Consent|10|||
16292041|NCT00616941|39554577|FG000|Overall Study|Progressive Disease|1|||
16292042|NCT00616941|39554578|FG001|Overall Study|Progressive Disease|2|||
16292043|NCT00616941|39554579|FG002|Overall Study|Progressive Disease|1|||
16292044|NCT00616941|39554577|FG000|Overall Study|Adverse Event|0|||
16292045|NCT00616941|39554578|FG001|Overall Study|Adverse Event|1|||
16292046|NCT00616941|39554579|FG002|Overall Study|Adverse Event|1|||
16292047|NCT00616941|39554577|FG000|Overall Study|Subject Non-compliance|0|||
16292048|NCT00616941|39554578|FG001|Overall Study|Subject Non-compliance|0|||
16292049|NCT00616941|39554579|FG002|Overall Study|Subject Non-compliance|1|||
16292050|NCT00616941|39554577|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
16292051|NCT00616941|39554578|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
16292052|NCT00616941|39554579|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
16292053|NCT00616941|39554577|FG000|Overall Study|Vaccination Suspended|0|||
16292054|NCT00616941|39554578|FG001|Overall Study|Vaccination Suspended|0|||
16292055|NCT00616941|39554579|FG002|Overall Study|Vaccination Suspended|3|||
16292056|NCT04663295|39554580|FG000|Run-in Period|Withdrawal by Subject|3|||
16292057|NCT04663295|39554580|FG000|Overall Study Period|Pregnancy|1|||
16292058|NCT04663295|39554580|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
16292059|NCT03812991|39554581|FG000|Overall Study|Lost to Follow-up|3|||
16292060|NCT03812991|39554582|FG001|Overall Study|Lost to Follow-up|1|||
16292061|NCT02071849|39554586|FG000|6-month Primary Endpoint|Did not receive device|4|||
16292062|NCT02071849|39554586|FG000|6-month Primary Endpoint|Adverse Event|1|||
16292063|NCT02071849|39554586|FG000|2-year Extended Follow-up|Adverse Event|1|||
16292064|NCT02923674|39554587|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
16292065|NCT02923674|39554588|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
16292066|NCT02923674|39554589|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
16292067|NCT02923674|39554587|FG000|Overall Study|Lost to Follow-up|7|||
16292068|NCT02923674|39554588|FG001|Overall Study|Lost to Follow-up|12|||
16292069|NCT02923674|39554589|FG002|Overall Study|Lost to Follow-up|7|||
16292070|NCT02923674|39554587|FG000|Overall Study|Problem with intervention|2|||
16292071|NCT02923674|39554588|FG001|Overall Study|Problem with intervention|2|||
16292072|NCT02923674|39554589|FG002|Overall Study|Problem with intervention|1|||
16292073|NCT02923674|39554587|FG000|Overall Study|Adverse Event|3|||
16292074|NCT02923674|39554588|FG001|Overall Study|Adverse Event|1|||
16292075|NCT02923674|39554589|FG002|Overall Study|Adverse Event|1|||
16292076|NCT02923674|39554587|FG000|Overall Study|Withdrawal by Subject|2|||
16292077|NCT02923674|39554588|FG001|Overall Study|Withdrawal by Subject|2|||
16292078|NCT02923674|39554589|FG002|Overall Study|Withdrawal by Subject|2|||
16381089|NCT03069716|39877806|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
16381090|NCT03069716|39877807|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
16381091|NCT03069716|39877805|FG000|Randomized Treatment|Withdrawal by Subject|0|||
16381092|NCT03069716|39877806|FG001|Randomized Treatment|Withdrawal by Subject|2|||
16381093|NCT03069716|39877807|FG002|Randomized Treatment|Withdrawal by Subject|0|||
16292079|NCT01868893|39554590|FG000|Overall Study|Adverse Event|2|||
16292080|NCT01868893|39554590|FG000|Overall Study|Commercial availability of study drug|17|||
16292081|NCT01868893|39554590|FG000|Overall Study|Neutropenia|1|||
16292082|NCT01970865|39554592|FG000|Overall Study|Death|3|||
16292083|NCT01970865|39554593|FG001|Overall Study|Death|2|||
16292084|NCT01970865|39554594|FG002|Overall Study|Death|3|||
16292085|NCT01970865|39554595|FG003|Overall Study|Death|6|||
16381094|NCT02734004|39877808|FG000|Overall Study|Death|36|||
16381095|NCT02734004|39877809|FG001|Overall Study|Death|24|||
16381096|NCT02734004|39877810|FG002|Overall Study|Death|26|||
16381097|NCT02734004|39877811|FG003|Overall Study|Death|35|||
16381098|NCT02734004|39877812|FG004|Overall Study|Death|13|||
16381099|NCT02734004|39877813|FG005|Overall Study|Death|17|||
16381100|NCT02734004|39877814|FG006|Overall Study|Death|20|||
16381101|NCT02734004|39877808|FG000|Overall Study|Lost to Follow-up|1|||
16381102|NCT02734004|39877809|FG001|Overall Study|Lost to Follow-up|1|||
16381103|NCT02734004|39877810|FG002|Overall Study|Lost to Follow-up|0|||
16381104|NCT02734004|39877811|FG003|Overall Study|Lost to Follow-up|0|||
16381105|NCT02734004|39877812|FG004|Overall Study|Lost to Follow-up|1|||
16381106|NCT02734004|39877813|FG005|Overall Study|Lost to Follow-up|0|||
16381107|NCT02734004|39877814|FG006|Overall Study|Lost to Follow-up|0|||
16381108|NCT02734004|39877808|FG000|Overall Study|Withdrawal by Subject|3|||
16381109|NCT02734004|39877809|FG001|Overall Study|Withdrawal by Subject|1|||
16381110|NCT02734004|39877810|FG002|Overall Study|Withdrawal by Subject|1|||
16381111|NCT02734004|39877811|FG003|Overall Study|Withdrawal by Subject|1|||
16381112|NCT02734004|39877812|FG004|Overall Study|Withdrawal by Subject|3|||
16381113|NCT02734004|39877813|FG005|Overall Study|Withdrawal by Subject|0|||
16381114|NCT02734004|39877814|FG006|Overall Study|Withdrawal by Subject|2|||
16381115|NCT02734004|39877808|FG000|Overall Study|Other|0|||
16381116|NCT02734004|39877809|FG001|Overall Study|Other|8|||
16381117|NCT02734004|39877810|FG002|Overall Study|Other|7|||
16381118|NCT02734004|39877811|FG003|Overall Study|Other|4|||
16381119|NCT02734004|39877812|FG004|Overall Study|Other|34|||
16381120|NCT02734004|39877813|FG005|Overall Study|Other|14|||
16381121|NCT02734004|39877814|FG006|Overall Study|Other|10|||
16381122|NCT01188967|39877815|FG000|Overall Study|Withdrawal by Subject|1|||
16381123|NCT01188967|39877816|FG001|Overall Study|Withdrawal by Subject|1|||
16381124|NCT01188967|39877815|FG000|Overall Study|Physician Decision|1|||
16381125|NCT01188967|39877816|FG001|Overall Study|Physician Decision|1|||
16381126|NCT01188967|39877815|FG000|Overall Study|Lost to Follow-up|3|||
16381127|NCT01188967|39877816|FG001|Overall Study|Lost to Follow-up|2|||
16381128|NCT01969409|39877821|FG000|Overall Study|Death|2|||
16381129|NCT01969409|39877822|FG001|Overall Study|Death|2|||
16381130|NCT01969409|39877821|FG000|Overall Study|Transplant|1|||
16381131|NCT01969409|39877822|FG001|Overall Study|Transplant|1|||
16381132|NCT01969409|39877821|FG000|Overall Study|Withdrawal by Subject|0|||
16381133|NCT01969409|39877822|FG001|Overall Study|Withdrawal by Subject|1|||
16381134|NCT04617860|39877826|FG000|Overall Study|Adverse Event|0|||
16381135|NCT04617860|39877827|FG001|Overall Study|Adverse Event|2|||
16381136|NCT04617860|39877828|FG002|Overall Study|Adverse Event|2|||
16381137|NCT04617860|39877826|FG000|Overall Study|Withdrawal by Subject|0|||
16381138|NCT04617860|39877827|FG001|Overall Study|Withdrawal by Subject|0|||
16381139|NCT04617860|39877828|FG002|Overall Study|Withdrawal by Subject|2|||
16381140|NCT04617860|39877826|FG000|Overall Study|Physician Decision|0|||
16381141|NCT04617860|39877827|FG001|Overall Study|Physician Decision|1|||
16381142|NCT04617860|39877828|FG002|Overall Study|Physician Decision|0|||
16381143|NCT04617860|39877826|FG000|Overall Study|Sponsor Decision|0|||
16381144|NCT04617860|39877827|FG001|Overall Study|Sponsor Decision|3|||
16292086|NCT01970865|39554596|FG004|Overall Study|Death|9|||
16292087|NCT01970865|39554597|FG005|Overall Study|Death|3|||
16292088|NCT01970865|39554598|FG006|Overall Study|Death|2|||
16292089|NCT01970865|39554599|FG007|Overall Study|Death|3|||
16292090|NCT01970865|39554600|FG008|Overall Study|Death|2|||
16381145|NCT04617860|39877828|FG002|Overall Study|Sponsor Decision|1|||
16381146|NCT04617860|39877826|FG000|Overall Study|Termination of Study by Sponsor|8|||
16381147|NCT04617860|39877827|FG001|Overall Study|Termination of Study by Sponsor|4|||
16381148|NCT04617860|39877828|FG002|Overall Study|Termination of Study by Sponsor|13|||
16381149|NCT00478257|39877829|FG000|Overall Study|Withdrawal by Subject|8|||
16381150|NCT00478257|39877830|FG001|Overall Study|Withdrawal by Subject|3|||
16381151|NCT04339062|39877835|FG000|Overall Study|Death|0|||
16381152|NCT04339062|39877836|FG001|Overall Study|Death|1|||
16381153|NCT01728246|39877839|FG000|Overall Study|Participant needed rescue medication|1|||
16381154|NCT01728246|39877840|FG001|Overall Study|Participant needed rescue medication|5|||
16381155|NCT01728246|39877839|FG000|Overall Study|Protocol Violation|1|||
16292091|NCT01970865|39554601|FG009|Overall Study|Death|2|||
16381156|NCT01728246|39877840|FG001|Overall Study|Protocol Violation|0|||
16381157|NCT01728246|39877839|FG000|Overall Study|Withdrawal by Subject|2|||
16381158|NCT01728246|39877840|FG001|Overall Study|Withdrawal by Subject|3|||
16381159|NCT01728246|39877839|FG000|Overall Study|Lost to Follow-up|23|||
16381160|NCT01728246|39877840|FG001|Overall Study|Lost to Follow-up|22|||
16381161|NCT01728246|39877839|FG000|Overall Study|Lack of Efficacy|1|||
16381162|NCT01728246|39877840|FG001|Overall Study|Lack of Efficacy|1|||
16381163|NCT01728246|39877839|FG000|Overall Study|Adverse Event|8|||
16381164|NCT01728246|39877840|FG001|Overall Study|Adverse Event|5|||
16381165|NCT02314923|39877841|FG000|Overall Study|Death|0|||
16381166|NCT02314923|39877842|FG001|Overall Study|Death|0|||
16381167|NCT02314923|39877843|FG002|Overall Study|Death|0|||
16381168|NCT02314923|39877844|FG003|Overall Study|Death|1|||
16381169|NCT02314923|39877845|FG004|Overall Study|Death|0|||
16381170|NCT02314923|39877846|FG005|Overall Study|Death|0|||
16381171|NCT02314923|39877847|FG006|Overall Study|Death|0|||
16381172|NCT02314923|39877848|FG007|Overall Study|Death|0|||
16381173|NCT02314923|39877849|FG008|Overall Study|Death|0|||
16381174|NCT02314923|39877850|FG009|Overall Study|Death|0|||
16381175|NCT02314923|39877841|FG000|Overall Study|Lost to Follow-up|2|||
16381176|NCT02314923|39877842|FG001|Overall Study|Lost to Follow-up|3|||
16381177|NCT02314923|39877843|FG002|Overall Study|Lost to Follow-up|1|||
16381178|NCT02314923|39877844|FG003|Overall Study|Lost to Follow-up|0|||
16381179|NCT02314923|39877845|FG004|Overall Study|Lost to Follow-up|0|||
16381180|NCT02314923|39877846|FG005|Overall Study|Lost to Follow-up|0|||
16381181|NCT02314923|39877847|FG006|Overall Study|Lost to Follow-up|3|||
16381182|NCT02314923|39877848|FG007|Overall Study|Lost to Follow-up|4|||
16381183|NCT02314923|39877849|FG008|Overall Study|Lost to Follow-up|2|||
16381184|NCT02314923|39877850|FG009|Overall Study|Lost to Follow-up|0|||
16381185|NCT02314923|39877841|FG000|Overall Study|Withdrawal by Subject|0|||
16381186|NCT02314923|39877842|FG001|Overall Study|Withdrawal by Subject|0|||
16292092|NCT01970865|39554602|FG010|Overall Study|Death|8|||
16292093|NCT01970865|39554603|FG011|Overall Study|Death|13|||
16381187|NCT02314923|39877843|FG002|Overall Study|Withdrawal by Subject|1|||
16292094|NCT01970865|39554604|FG012|Overall Study|Death|25|||
16292095|NCT01970865|39554605|FG013|Overall Study|Death|46|||
16292096|NCT01970865|39554606|FG014|Overall Study|Death|37|||
16292097|NCT01970865|39554607|FG015|Overall Study|Death|22|||
16292098|NCT01970865|39554608|FG016|Overall Study|Death|1|||
16292099|NCT01970865|39554609|FG017|Overall Study|Death|17|||
16292100|NCT01970865|39554592|FG000|Overall Study|Lost to Follow-up|0|||
16292101|NCT01970865|39554593|FG001|Overall Study|Lost to Follow-up|0|||
16292102|NCT01970865|39554594|FG002|Overall Study|Lost to Follow-up|0|||
16292103|NCT01970865|39554595|FG003|Overall Study|Lost to Follow-up|1|||
16292104|NCT01970865|39554596|FG004|Overall Study|Lost to Follow-up|1|||
16292105|NCT01970865|39554597|FG005|Overall Study|Lost to Follow-up|0|||
16292106|NCT01970865|39554598|FG006|Overall Study|Lost to Follow-up|0|||
16292107|NCT01970865|39554599|FG007|Overall Study|Lost to Follow-up|0|||
16292108|NCT01970865|39554600|FG008|Overall Study|Lost to Follow-up|0|||
16292109|NCT01970865|39554601|FG009|Overall Study|Lost to Follow-up|0|||
16292110|NCT01970865|39554602|FG010|Overall Study|Lost to Follow-up|1|||
16292111|NCT01970865|39554603|FG011|Overall Study|Lost to Follow-up|0|||
16292112|NCT01970865|39554604|FG012|Overall Study|Lost to Follow-up|2|||
16292113|NCT01970865|39554605|FG013|Overall Study|Lost to Follow-up|0|||
16292114|NCT01970865|39554606|FG014|Overall Study|Lost to Follow-up|1|||
16292115|NCT01970865|39554607|FG015|Overall Study|Lost to Follow-up|4|||
16292116|NCT01970865|39554608|FG016|Overall Study|Lost to Follow-up|0|||
16292117|NCT01970865|39554609|FG017|Overall Study|Lost to Follow-up|1|||
16292118|NCT01970865|39554592|FG000|Overall Study|Other|0|||
16292119|NCT01970865|39554593|FG001|Overall Study|Other|1|||
16292120|NCT01970865|39554594|FG002|Overall Study|Other|0|||
16292121|NCT01970865|39554595|FG003|Overall Study|Other|1|||
16381188|NCT02314923|39877844|FG003|Overall Study|Withdrawal by Subject|0|||
16381189|NCT02314923|39877845|FG004|Overall Study|Withdrawal by Subject|1|||
16381190|NCT02314923|39877846|FG005|Overall Study|Withdrawal by Subject|0|||
16381191|NCT02314923|39877847|FG006|Overall Study|Withdrawal by Subject|1|||
16381192|NCT02314923|39877848|FG007|Overall Study|Withdrawal by Subject|0|||
16292122|NCT01970865|39554596|FG004|Overall Study|Other|1|||
16292123|NCT01970865|39554597|FG005|Overall Study|Other|0|||
16292124|NCT01970865|39554598|FG006|Overall Study|Other|1|||
16292125|NCT01970865|39554599|FG007|Overall Study|Other|0|||
16292126|NCT01970865|39554600|FG008|Overall Study|Other|0|||
16381193|NCT02314923|39877849|FG008|Overall Study|Withdrawal by Subject|0|||
16381194|NCT02314923|39877850|FG009|Overall Study|Withdrawal by Subject|0|||
16292127|NCT01970865|39554601|FG009|Overall Study|Other|0|||
16292128|NCT01970865|39554602|FG010|Overall Study|Other|2|||
16292129|NCT01970865|39554603|FG011|Overall Study|Other|3|||
16292130|NCT01970865|39554604|FG012|Overall Study|Other|8|||
16292131|NCT01970865|39554605|FG013|Overall Study|Other|3|||
16381195|NCT02314923|39877841|FG000|Overall Study|Physician Decision|0|||
16381196|NCT02314923|39877842|FG001|Overall Study|Physician Decision|1|||
16292132|NCT01970865|39554606|FG014|Overall Study|Other|2|||
16292133|NCT01970865|39554607|FG015|Overall Study|Other|3|||
16292134|NCT01970865|39554608|FG016|Overall Study|Other|0|||
16292135|NCT01970865|39554609|FG017|Overall Study|Other|2|||
16292136|NCT01970865|39554592|FG000|Overall Study|Participant refused further follow-up|0|||
16292137|NCT01970865|39554593|FG001|Overall Study|Participant refused further follow-up|0|||
16292138|NCT01970865|39554594|FG002|Overall Study|Participant refused further follow-up|0|||
16292139|NCT01970865|39554595|FG003|Overall Study|Participant refused further follow-up|2|||
16292140|NCT01970865|39554596|FG004|Overall Study|Participant refused further follow-up|3|||
16292141|NCT01970865|39554597|FG005|Overall Study|Participant refused further follow-up|0|||
16292142|NCT01970865|39554598|FG006|Overall Study|Participant refused further follow-up|0|||
16292143|NCT01970865|39554599|FG007|Overall Study|Participant refused further follow-up|0|||
16292144|NCT01970865|39554600|FG008|Overall Study|Participant refused further follow-up|0|||
16292145|NCT01970865|39554601|FG009|Overall Study|Participant refused further follow-up|0|||
16292146|NCT01970865|39554602|FG010|Overall Study|Participant refused further follow-up|1|||
16292147|NCT01970865|39554603|FG011|Overall Study|Participant refused further follow-up|4|||
16292148|NCT01970865|39554604|FG012|Overall Study|Participant refused further follow-up|7|||
16292149|NCT01970865|39554605|FG013|Overall Study|Participant refused further follow-up|8|||
16292150|NCT01970865|39554606|FG014|Overall Study|Participant refused further follow-up|3|||
16292151|NCT01970865|39554607|FG015|Overall Study|Participant refused further follow-up|11|||
16292152|NCT01970865|39554608|FG016|Overall Study|Participant refused further follow-up|0|||
16292153|NCT01970865|39554609|FG017|Overall Study|Participant refused further follow-up|6|||
16292154|NCT02372071|39554610|FG000|Overall Study|Protocol Violation|18|||
16292155|NCT01561430|39554611|FG000|Overall Study|Adverse Event|0|||
16292156|NCT01561430|39554612|FG001|Overall Study|Adverse Event|0|||
16292157|NCT01561430|39554613|FG002|Overall Study|Adverse Event|3|||
16292158|NCT01561430|39554614|FG003|Overall Study|Adverse Event|1|||
16292159|NCT01561430|39554611|FG000|Overall Study|Withdrawal by Subject|0|||
16292160|NCT01561430|39554612|FG001|Overall Study|Withdrawal by Subject|0|||
16292161|NCT01561430|39554613|FG002|Overall Study|Withdrawal by Subject|1|||
16292162|NCT01561430|39554614|FG003|Overall Study|Withdrawal by Subject|0|||
16292163|NCT01561430|39554611|FG000|Overall Study|Physician Decision|0|||
16292164|NCT01561430|39554612|FG001|Overall Study|Physician Decision|1|||
16292165|NCT01561430|39554613|FG002|Overall Study|Physician Decision|0|||
16292166|NCT01561430|39554614|FG003|Overall Study|Physician Decision|0|||
16292167|NCT01561430|39554611|FG000|Overall Study|Sponsor Decision|1|||
16292168|NCT01561430|39554612|FG001|Overall Study|Sponsor Decision|14|||
16292169|NCT01561430|39554613|FG002|Overall Study|Sponsor Decision|13|||
16381197|NCT02314923|39877843|FG002|Overall Study|Physician Decision|0|||
16381198|NCT02314923|39877844|FG003|Overall Study|Physician Decision|0|||
16381199|NCT02314923|39877845|FG004|Overall Study|Physician Decision|0|||
16381200|NCT02314923|39877846|FG005|Overall Study|Physician Decision|0|||
16381201|NCT02314923|39877847|FG006|Overall Study|Physician Decision|0|||
16381202|NCT02314923|39877848|FG007|Overall Study|Physician Decision|0|||
16381203|NCT02314923|39877849|FG008|Overall Study|Physician Decision|0|||
16292170|NCT01561430|39554614|FG003|Overall Study|Sponsor Decision|12|||
16381204|NCT02314923|39877850|FG009|Overall Study|Physician Decision|0|||
16381205|NCT02314923|39877841|FG000|Overall Study|Participant unavailable|0|||
16381206|NCT02314923|39877842|FG001|Overall Study|Participant unavailable|0|||
16381207|NCT02314923|39877843|FG002|Overall Study|Participant unavailable|0|||
16381208|NCT02314923|39877844|FG003|Overall Study|Participant unavailable|0|||
16381209|NCT02314923|39877845|FG004|Overall Study|Participant unavailable|0|||
16381210|NCT02314923|39877846|FG005|Overall Study|Participant unavailable|1|||
16381211|NCT02314923|39877847|FG006|Overall Study|Participant unavailable|0|||
16381212|NCT02314923|39877848|FG007|Overall Study|Participant unavailable|0|||
16381213|NCT02314923|39877849|FG008|Overall Study|Participant unavailable|0|||
16381214|NCT02314923|39877850|FG009|Overall Study|Participant unavailable|0|||
16381215|NCT02314923|39877841|FG000|Overall Study|Screen failure|0|||
16381216|NCT02314923|39877842|FG001|Overall Study|Screen failure|0|||
16381217|NCT02314923|39877843|FG002|Overall Study|Screen failure|0|||
16381218|NCT02314923|39877844|FG003|Overall Study|Screen failure|0|||
16381219|NCT02314923|39877845|FG004|Overall Study|Screen failure|0|||
16381220|NCT02314923|39877846|FG005|Overall Study|Screen failure|0|||
16381221|NCT02314923|39877847|FG006|Overall Study|Screen failure|1|||
16381222|NCT02314923|39877848|FG007|Overall Study|Screen failure|0|||
16381223|NCT02314923|39877849|FG008|Overall Study|Screen failure|0|||
16292171|NCT02229539|39554615|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
16292172|NCT02229539|39554616|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
16292173|NCT02229539|39554617|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
16292174|NCT02229539|39554615|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
16292175|NCT02229539|39554616|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
16292176|NCT02229539|39554617|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
16381224|NCT02314923|39877850|FG009|Overall Study|Screen failure|0|||
16381225|NCT02314923|39877841|FG000|Overall Study|Participant relocation|1|||
16381226|NCT02314923|39877842|FG001|Overall Study|Participant relocation|0|||
16292177|NCT02229539|39554615|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
16292178|NCT02229539|39554616|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
16292179|NCT02229539|39554617|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
16292180|NCT02229539|39554615|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
16292181|NCT02229539|39554616|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
16292182|NCT02229539|39554617|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
16292183|NCT02229539|39554615|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
16292184|NCT02229539|39554616|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
16292185|NCT02229539|39554617|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
16292186|NCT02229539|39554615|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
16292187|NCT02229539|39554616|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
16292188|NCT02229539|39554617|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
16292189|NCT02229539|39554615|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
16292190|NCT02229539|39554616|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
16292191|NCT02229539|39554617|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
16292192|NCT02229539|39554615|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
16292193|NCT02229539|39554616|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
16292194|NCT02229539|39554617|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
16292195|NCT02229539|39554615|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
16292196|NCT02229539|39554616|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
16292197|NCT02229539|39554617|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
16292198|NCT01403064|39554618|FG000|Overall Study|Death|0|||
16292199|NCT01403064|39554619|FG001|Overall Study|Death|0|||
16292200|NCT01403064|39554620|FG002|Overall Study|Death|1|||
16292201|NCT01403064|39554621|FG003|Overall Study|Death|1|||
16292202|NCT01403064|39554618|FG000|Overall Study|Withdrawal by Subject|0|||
16292203|NCT01403064|39554619|FG001|Overall Study|Withdrawal by Subject|0|||
16292204|NCT01403064|39554620|FG002|Overall Study|Withdrawal by Subject|1|||
16292205|NCT01403064|39554621|FG003|Overall Study|Withdrawal by Subject|1|||
16292206|NCT01403064|39554618|FG000|Overall Study|Other|1|||
16292207|NCT01403064|39554619|FG001|Overall Study|Other|0|||
16292208|NCT01403064|39554620|FG002|Overall Study|Other|2|||
16292209|NCT01403064|39554621|FG003|Overall Study|Other|1|||
16292210|NCT02655666|39554622|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
16292211|NCT01855074|39554623|FG000|Overall Study|Adverse Event|1|||
16292212|NCT01855074|39554623|FG000|Overall Study|Lost to Follow-up|4|||
16292213|NCT01855074|39554623|FG000|Overall Study|Withdrawal by Subject|8|||
16292214|NCT01855074|39554623|FG000|Overall Study|Started but not treated|1|||
16292215|NCT00112866|39554624|FG000|Overall Study|Protocol Violation|1|||
16292216|NCT00112866|39554625|FG001|Overall Study|Protocol Violation|0|||
16292217|NCT00112866|39554624|FG000|Overall Study|did not start treatment post-op|1|||
16292218|NCT00112866|39554625|FG001|Overall Study|did not start treatment post-op|2|||
16292219|NCT03321630|39554626|FG000|Overall Study|Adverse Event|1|||
16292220|NCT03321630|39554626|FG000|Overall Study|Investigator Discretion|2|||
16292221|NCT03321630|39554626|FG000|Overall Study|Withdrawal by Subject|1|||
16292222|NCT00114166|39554628|FG000|Overall Study|Wrong primary|0|||
16292223|NCT00114166|39554629|FG001|Overall Study|Wrong primary|1|||
16292224|NCT04397445|39554630|FG000|Overall Study|Withdrawal by Subject|1|||
16292225|NCT04397445|39554631|FG001|Overall Study|Withdrawal by Subject|0|||
16292226|NCT04397445|39554632|FG002|Overall Study|Withdrawal by Subject|0|||
16292227|NCT04397445|39554633|FG003|Overall Study|Withdrawal by Subject|0|||
16292228|NCT03052322|39554636|FG000|Overall Study|Other un-specified|1|||
16292229|NCT03052322|39554637|FG001|Overall Study|Other un-specified|2|||
16292230|NCT03052322|39554636|FG000|Overall Study|Withdrawal by Subject|10|||
16292231|NCT03052322|39554637|FG001|Overall Study|Withdrawal by Subject|9|||
16292232|NCT03052322|39554636|FG000|Overall Study|Death|0|||
16292233|NCT03052322|39554637|FG001|Overall Study|Death|2|||
16292234|NCT03052322|39554636|FG000|Overall Study|Lack of Efficacy|1|||
16292235|NCT03052322|39554637|FG001|Overall Study|Lack of Efficacy|2|||
16292236|NCT03052322|39554636|FG000|Overall Study|Protocol Violation|1|||
16292237|NCT03052322|39554637|FG001|Overall Study|Protocol Violation|0|||
16292238|NCT03052322|39554636|FG000|Overall Study|Lost to Follow-up|2|||
16292239|NCT03052322|39554637|FG001|Overall Study|Lost to Follow-up|4|||
16292240|NCT03052322|39554636|FG000|Overall Study|Adverse Event|6|||
16292241|NCT03052322|39554637|FG001|Overall Study|Adverse Event|13|||
16292242|NCT02384941|39554645|FG000|Overall Study|Adverse Event|11|||
16292243|NCT02384941|39554646|FG001|Overall Study|Adverse Event|13|||
16292244|NCT02384941|39554647|FG002|Overall Study|Adverse Event|17|||
16292245|NCT02384941|39554645|FG000|Overall Study|Lost to Follow-up|3|||
16292246|NCT02384941|39554646|FG001|Overall Study|Lost to Follow-up|2|||
16292247|NCT02384941|39554647|FG002|Overall Study|Lost to Follow-up|1|||
16292248|NCT02384941|39554645|FG000|Overall Study|Non-Compliance With Study Drug|2|||
16292249|NCT02384941|39554646|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16292250|NCT02384941|39554647|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16292251|NCT02384941|39554645|FG000|Overall Study|Physician Decision|1|||
16292252|NCT02384941|39554646|FG001|Overall Study|Physician Decision|1|||
16292253|NCT02384941|39554647|FG002|Overall Study|Physician Decision|0|||
16292254|NCT02384941|39554645|FG000|Overall Study|Protocol Violation|3|||
16292255|NCT02384941|39554646|FG001|Overall Study|Protocol Violation|0|||
16292256|NCT02384941|39554647|FG002|Overall Study|Protocol Violation|0|||
16292257|NCT02384941|39554645|FG000|Overall Study|Withdrawal by Subject|26|||
16292258|NCT02384941|39554646|FG001|Overall Study|Withdrawal by Subject|19|||
16292259|NCT02384941|39554647|FG002|Overall Study|Withdrawal by Subject|20|||
16292260|NCT02384941|39554645|FG000|Overall Study|Pregnancy|0|||
16292261|NCT02384941|39554646|FG001|Overall Study|Pregnancy|0|||
16292262|NCT02384941|39554647|FG002|Overall Study|Pregnancy|1|||
16292263|NCT02384941|39554645|FG000|Overall Study|Other than specified above|4|||
16292264|NCT02384941|39554646|FG001|Overall Study|Other than specified above|0|||
16292265|NCT02384941|39554647|FG002|Overall Study|Other than specified above|1|||
16292266|NCT01490866|39554650|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
16292267|NCT01490866|39554650|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
16292268|NCT01490866|39554650|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
16292269|NCT01490866|39554650|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
16292270|NCT01490866|39554650|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
16292271|NCT01490866|39554650|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
16292272|NCT01490866|39554650|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
16292273|NCT01490866|39554650|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
16292274|NCT01490866|39554650|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
16292275|NCT01490866|39554650|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
16292276|NCT01490866|39554650|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
16292277|NCT00311311|39554651|FG000|Overall Study|Adverse Event|3|||
16292278|NCT00311311|39554652|FG001|Overall Study|Adverse Event|2|||
16292279|NCT00311311|39554651|FG000|Overall Study|Withdrawal by Subject|1|||
16292280|NCT00311311|39554652|FG001|Overall Study|Withdrawal by Subject|1|||
16292281|NCT00311311|39554651|FG000|Overall Study|Noncompliance|0|||
16292282|NCT00311311|39554652|FG001|Overall Study|Noncompliance|1|||
16292283|NCT00311311|39554651|FG000|Overall Study|Study Termination by Sponsor|3|||
16292284|NCT00311311|39554652|FG001|Overall Study|Study Termination by Sponsor|4|||
16292285|NCT00311311|39554651|FG000|Overall Study|Death|1|||
16292286|NCT00311311|39554652|FG001|Overall Study|Death|0|||
16292287|NCT00311311|39554651|FG000|Overall Study|Lack of ancillary assistance|0|||
16292288|NCT00311311|39554652|FG001|Overall Study|Lack of ancillary assistance|1|||
16292289|NCT03188666|39554657|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
16292290|NCT03188666|39554658|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
16292291|NCT03188666|39554659|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
16292292|NCT03188666|39554660|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
16292293|NCT03188666|39554657|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
16292294|NCT03188666|39554658|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
16292295|NCT03188666|39554659|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
16292296|NCT03188666|39554660|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
16292297|NCT03188666|39554657|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
16292298|NCT03188666|39554658|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
16292299|NCT03188666|39554659|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
16292300|NCT03188666|39554660|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
16292301|NCT03188666|39554657|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
16292302|NCT03188666|39554658|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
16292303|NCT03188666|39554659|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
16292304|NCT03188666|39554660|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
16292305|NCT02746471|39554661|FG000|Overall Study|Death|43|||
16292306|NCT02746471|39554661|FG000|Overall Study|Exited before 36 months|1119|||
16292307|NCT00450619|39554664|FG000|Overall Study|refused treatment after randomization|2|||
16292308|NCT00450619|39554665|FG001|Overall Study|refused treatment after randomization|0|||
16292309|NCT00450619|39554664|FG000|Overall Study|did not progress; refused further trmt|1|||
16292310|NCT00450619|39554665|FG001|Overall Study|did not progress; refused further trmt|1|||
16292311|NCT00450619|39554664|FG000|Overall Study|Adverse Event|1|||
16292312|NCT00450619|39554665|FG001|Overall Study|Adverse Event|0|||
16292313|NCT00922987|39554666|FG000|Overall Study|Insufficient clinical response|1|||
16292314|NCT00922987|39554666|FG000|Overall Study|Protocol Violation|2|||
16292315|NCT00922987|39554666|FG000|Overall Study|Adverse Event|1|||
16292316|NCT00988442|39554667|FG000|Overall Study|Death|1|||
16292317|NCT00988442|39554668|FG001|Overall Study|Death|2|||
16292318|NCT00988442|39554667|FG000|Overall Study|Lost to Follow-up|0|||
16081388|NCT03527160|38789577|FG000|Overall Study|No clinical serum creatinine collected|6|||
16292319|NCT00988442|39554668|FG001|Overall Study|Lost to Follow-up|1|||
16292320|NCT00988442|39554667|FG000|Overall Study|Early Study Closure|29|||
16292321|NCT00988442|39554668|FG001|Overall Study|Early Study Closure|25|||
16292322|NCT01806506|39554669|FG000|Overall Study|Lost to Follow-up|2|||
16292323|NCT01806506|39554670|FG001|Overall Study|Lost to Follow-up|1|||
16292324|NCT03923530|39554671|FG000|Overall Study|Withdrawal by Subject|1|||
16292325|NCT03923530|39554671|FG000|Overall Study|screen failure|3|||
16292326|NCT00076804|39554672|FG000|Overall Study|Death|9|||
16292327|NCT00076804|39554673|FG001|Overall Study|Death|20|||
16292328|NCT00076804|39554672|FG000|Overall Study|Lost to Follow-up|9|||
16292329|NCT00076804|39554673|FG001|Overall Study|Lost to Follow-up|9|||
16292330|NCT00076804|39554672|FG000|Overall Study|Withdrawal by Subject|10|||
16292331|NCT00076804|39554673|FG001|Overall Study|Withdrawal by Subject|8|||
16292332|NCT00076804|39554672|FG000|Overall Study|Early study Closure|32|||
16292333|NCT00076804|39554673|FG001|Overall Study|Early study Closure|32|||
16292334|NCT00848107|39554675|FG000|Overall Study|Lost to Follow-up|2|||
16292335|NCT00848107|39554675|FG000|Overall Study|Withdrawal by Subject|8|||
16292336|NCT00848107|39554675|FG000|Overall Study|Adverse Event|9|||
16292337|NCT00848107|39554675|FG000|Overall Study|Death|1|||
16292338|NCT00848107|39554675|FG000|Overall Study|Pregnancy|1|||
16292339|NCT00102687|39554676|FG000|Initial Period|Withdrawal by Subject|6|||
16292340|NCT00102687|39554677|FG001|Initial Period|Withdrawal by Subject|3|||
16292341|NCT00102687|39554678|FG002|Initial Period|Withdrawal by Subject|5|||
16292342|NCT00102687|39554679|FG003|Initial Period|Withdrawal by Subject|0|||
16292343|NCT00102687|39554680|FG004|Initial Period|Withdrawal by Subject|0|||
16292344|NCT00102687|39554676|FG000|Initial Period|Adverse Event|4|||
16292345|NCT00102687|39554677|FG001|Initial Period|Adverse Event|7|||
16292346|NCT00102687|39554678|FG002|Initial Period|Adverse Event|9|||
16292347|NCT00102687|39554679|FG003|Initial Period|Adverse Event|0|||
16292348|NCT00102687|39554680|FG004|Initial Period|Adverse Event|0|||
16292349|NCT00102687|39554676|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
16292350|NCT00102687|39554677|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
16292351|NCT00102687|39554678|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
16292352|NCT00102687|39554679|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
16292353|NCT00102687|39554680|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
16292354|NCT00102687|39554676|FG000|Initial Period|Protocol Violation|0|||
16292355|NCT00102687|39554677|FG001|Initial Period|Protocol Violation|0|||
16292356|NCT00102687|39554678|FG002|Initial Period|Protocol Violation|2|||
16292357|NCT00102687|39554679|FG003|Initial Period|Protocol Violation|0|||
16292358|NCT00102687|39554680|FG004|Initial Period|Protocol Violation|0|||
16292359|NCT00102687|39554676|FG000|Initial Period|Physician Decision|2|||
16292360|NCT00102687|39554677|FG001|Initial Period|Physician Decision|9|||
16292361|NCT00102687|39554678|FG002|Initial Period|Physician Decision|6|||
16292362|NCT00102687|39554679|FG003|Initial Period|Physician Decision|0|||
16292363|NCT00102687|39554680|FG004|Initial Period|Physician Decision|0|||
16292364|NCT00102687|39554676|FG000|Initial Period|Sponsor's decision|0|||
16292365|NCT00102687|39554677|FG001|Initial Period|Sponsor's decision|1|||
16292366|NCT00102687|39554678|FG002|Initial Period|Sponsor's decision|1|||
16292367|NCT00102687|39554679|FG003|Initial Period|Sponsor's decision|0|||
16292368|NCT00102687|39554680|FG004|Initial Period|Sponsor's decision|0|||
16292369|NCT00102687|39554676|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
16292370|NCT00102687|39554677|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
16292371|NCT00102687|39554678|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
16292372|NCT00102687|39554679|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
16292373|NCT00102687|39554680|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
16292374|NCT00102687|39554676|FG000|Initial Period|Death|1|||
16292375|NCT00102687|39554677|FG001|Initial Period|Death|1|||
16292376|NCT00102687|39554678|FG002|Initial Period|Death|1|||
16292377|NCT00102687|39554679|FG003|Initial Period|Death|0|||
16292378|NCT00102687|39554680|FG004|Initial Period|Death|0|||
16292379|NCT00102687|39554676|FG000|Maintenance Period|Withdrawal by Subject|4|||
16292380|NCT00102687|39554677|FG001|Maintenance Period|Withdrawal by Subject|0|||
16292381|NCT00102687|39554678|FG002|Maintenance Period|Withdrawal by Subject|2|||
16292382|NCT00102687|39554679|FG003|Maintenance Period|Withdrawal by Subject|3|||
16292383|NCT00102687|39554680|FG004|Maintenance Period|Withdrawal by Subject|1|||
16292384|NCT00102687|39554676|FG000|Maintenance Period|Adverse Event|1|||
16292385|NCT00102687|39554677|FG001|Maintenance Period|Adverse Event|0|||
16292386|NCT00102687|39554678|FG002|Maintenance Period|Adverse Event|0|||
16292387|NCT00102687|39554679|FG003|Maintenance Period|Adverse Event|1|||
16292388|NCT00102687|39554680|FG004|Maintenance Period|Adverse Event|3|||
16292389|NCT00102687|39554676|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
16292390|NCT00102687|39554677|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
16292391|NCT00102687|39554678|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
16292392|NCT00102687|39554679|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
16292393|NCT00102687|39554680|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
16292394|NCT00102687|39554676|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
16292395|NCT00102687|39554677|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
16292396|NCT00102687|39554678|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
16292397|NCT00102687|39554679|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
16292398|NCT00102687|39554680|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
16187056|NCT04760314|39161985|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
16187057|NCT04760314|39161986|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
16187058|NCT04429503|39161990|FG000|Overall Study|Non-compliance with protocol by the subject|2|||
16187059|NCT04429503|39161991|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
16187060|NCT04429503|39161992|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
16187061|NCT04429503|39161990|FG000|Overall Study|Adverse Event|1|||
16187062|NCT04429503|39161991|FG001|Overall Study|Adverse Event|9|||
16187063|NCT04429503|39161992|FG002|Overall Study|Adverse Event|2|||
16187064|NCT04429503|39161990|FG000|Overall Study|Decision by the investigator/sponsor|2|||
16187065|NCT04429503|39161991|FG001|Overall Study|Decision by the investigator/sponsor|9|||
16187066|NCT04429503|39161992|FG002|Overall Study|Decision by the investigator/sponsor|3|||
16187067|NCT04429503|39161990|FG000|Overall Study|Withdrawal by Subject|9|||
16187068|NCT04429503|39161991|FG001|Overall Study|Withdrawal by Subject|17|||
16187069|NCT04429503|39161992|FG002|Overall Study|Withdrawal by Subject|8|||
16187070|NCT04429503|39161990|FG000|Overall Study|Lost to Follow-up|5|||
16187071|NCT04429503|39161991|FG001|Overall Study|Lost to Follow-up|19|||
16187072|NCT04429503|39161992|FG002|Overall Study|Lost to Follow-up|7|||
16187073|NCT04429503|39161990|FG000|Overall Study|Death|9|||
16187074|NCT04429503|39161991|FG001|Overall Study|Death|18|||
16187075|NCT04429503|39161992|FG002|Overall Study|Death|5|||
16187076|NCT00392171|39161993|FG000|Overall Study|Did not meet inclusion criteria|4|||
16187077|NCT00392171|39161993|FG000|Overall Study|Disease progression|101|||
16187078|NCT00942877|39161994|FG000|Overall Study|Refused further treatment|1|||
16187079|NCT00942877|39161995|FG001|Overall Study|Refused further treatment|1|||
16187080|NCT00942877|39161994|FG000|Overall Study|Patient was not treated|1|||
16187081|NCT00942877|39161995|FG001|Overall Study|Patient was not treated|0|||
16187082|NCT00942877|39161994|FG000|Overall Study|Adverse Event|1|||
16187083|NCT00942877|39161995|FG001|Overall Study|Adverse Event|0|||
16187084|NCT00942877|39161994|FG000|Overall Study|Progressive disease|42|||
16187085|NCT00942877|39161995|FG001|Overall Study|Progressive disease|3|||
16187086|NCT01184989|39161996|FG000|Overall Study|Adverse Event|11|||
16187087|NCT01184989|39161996|FG000|Overall Study|Withdrawal by Subject|1|||
16187088|NCT01984346|39161997|FG000|Overall Study|Physician Decision|4|||
16187089|NCT01984346|39161998|FG001|Overall Study|Physician Decision|2|||
16187090|NCT01984346|39161997|FG000|Overall Study|Withdrawal by Subject|2|||
16187091|NCT01984346|39161998|FG001|Overall Study|Withdrawal by Subject|2|||
16187092|NCT01984346|39161997|FG000|Overall Study|Enrollment Closed|8|||
16187093|NCT01984346|39161998|FG001|Overall Study|Enrollment Closed|1|||
16187094|NCT01984346|39161997|FG000|Overall Study|Insurance Coverage|1|||
16187095|NCT01984346|39161998|FG001|Overall Study|Insurance Coverage|0|||
16187096|NCT01984346|39161997|FG000|Overall Study|Intra-operative Exclusion|2|||
16187097|NCT01984346|39161998|FG001|Overall Study|Intra-operative Exclusion|0|||
16187098|NCT02747043|39162000|FG000|Overall Study|Other|1|||
16187099|NCT02747043|39162001|FG001|Overall Study|Other|1|||
16187100|NCT02747043|39162000|FG000|Overall Study|Adverse Event|3|||
16187101|NCT02747043|39162001|FG001|Overall Study|Adverse Event|1|||
16187102|NCT02747043|39162000|FG000|Overall Study|Withdrawal by Subject|1|||
16187103|NCT02747043|39162001|FG001|Overall Study|Withdrawal by Subject|1|||
16187104|NCT02747043|39162000|FG000|Overall Study|Physician Decision|1|||
16187105|NCT02747043|39162001|FG001|Overall Study|Physician Decision|1|||
16187106|NCT02747043|39162000|FG000|Overall Study|Protocol Violation|0|||
16187107|NCT02747043|39162001|FG001|Overall Study|Protocol Violation|1|||
16187108|NCT02747043|39162000|FG000|Overall Study|Disease progression|4|||
16187109|NCT02747043|39162001|FG001|Overall Study|Disease progression|0|||
16187110|NCT01097616|39162005|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
16187111|NCT01097616|39162006|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
16187112|NCT01097616|39162007|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
16187113|NCT01097616|39162008|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16187114|NCT01097616|39162009|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16187115|NCT01097616|39162010|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16187116|NCT01097616|39162011|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16187117|NCT01097616|39162012|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16187118|NCT01097616|39162005|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
16187119|NCT01097616|39162006|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
16187120|NCT01097616|39162007|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
16187121|NCT01097616|39162008|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16187122|NCT01097616|39162009|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16187123|NCT01097616|39162010|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16381227|NCT02314923|39877843|FG002|Overall Study|Participant relocation|0|||
16187124|NCT01097616|39162011|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16187125|NCT01097616|39162012|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16187126|NCT01097616|39162005|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
16187127|NCT01097616|39162006|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
16381228|NCT02314923|39877844|FG003|Overall Study|Participant relocation|0|||
16381229|NCT02314923|39877845|FG004|Overall Study|Participant relocation|0|||
16381230|NCT02314923|39877846|FG005|Overall Study|Participant relocation|0|||
16381231|NCT02314923|39877847|FG006|Overall Study|Participant relocation|0|||
16381232|NCT02314923|39877848|FG007|Overall Study|Participant relocation|1|||
16381233|NCT02314923|39877849|FG008|Overall Study|Participant relocation|0|||
16381234|NCT02314923|39877850|FG009|Overall Study|Participant relocation|0|||
16381235|NCT01734902|39877858|FG000|Overall Study|Other than listed|0|||
16381236|NCT01734902|39877859|FG001|Overall Study|Other than listed|2|||
16381237|NCT02943473|39877860|FG000|Overall Study|enrolled but not dosed|1|||
16381238|NCT02943473|39877860|FG000|Overall Study|screen failure|1|||
16381239|NCT02943473|39877860|FG000|Overall Study|Physician Decision|4|||
16381240|NCT00656370|39877861|FG000|Overall Study|Screen Failures|7|||
16381241|NCT00656370|39877861|FG000|Overall Study|Alternates|3|||
16381242|NCT04992273|39877862|FG000|Overall Study|Lost to Follow-up|0|||
16381243|NCT04992273|39877863|FG001|Overall Study|Lost to Follow-up|1|||
16381244|NCT02420314|39877864|FG000|Overall Study|Withdrawal by Subject|1|||
16381245|NCT02420314|39877864|FG000|Overall Study|Protocol Violation|1|||
16381246|NCT04466891|39877865|FG000|Overall Study|Death|52|||
16381247|NCT04466891|39877866|FG001|Overall Study|Death|5|||
16381248|NCT04466891|39877865|FG000|Overall Study|Withdrawal by Subject|8|||
16381249|NCT04466891|39877866|FG001|Overall Study|Withdrawal by Subject|1|||
16381250|NCT00643279|39877868|FG000|Overall Study|Death|13|||
16381251|NCT00643279|39877869|FG001|Overall Study|Death|11|||
16381252|NCT00643279|39877868|FG000|Overall Study|Withdrawal by Subject|3|||
16381253|NCT00643279|39877869|FG001|Overall Study|Withdrawal by Subject|0|||
16381254|NCT00643279|39877868|FG000|Overall Study|Lost to Follow-up|0|||
16381255|NCT00643279|39877869|FG001|Overall Study|Lost to Follow-up|1|||
16381256|NCT00643279|39877868|FG000|Overall Study|Physician Decision|0|||
16381257|NCT00643279|39877869|FG001|Overall Study|Physician Decision|1|||
16381258|NCT01055028|39877871|FG000|Screening|Screen Failure|1|||
16381259|NCT01055028|39877872|FG001|Screening|Screen Failure|1|||
16381260|NCT01055028|39877871|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
16381261|NCT01055028|39877872|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
16381262|NCT01055028|39877871|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
16381263|NCT01055028|39877872|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
16381264|NCT01055028|39877871|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
16381265|NCT01055028|39877872|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
16381266|NCT00835172|39877873|FG000|Washout|Protocol Violation|0|||
16381267|NCT00835172|39877874|FG001|Washout|Protocol Violation|1|||
16381268|NCT01362790|39877877|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
16381269|NCT01362790|39877878|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16381270|NCT01362790|39877879|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16292399|NCT00102687|39554676|FG000|Maintenance Period|Death|0|||
16292400|NCT00102687|39554677|FG001|Maintenance Period|Death|0|||
16292401|NCT00102687|39554678|FG002|Maintenance Period|Death|0|||
16292402|NCT00102687|39554679|FG003|Maintenance Period|Death|1|||
16292403|NCT00102687|39554680|FG004|Maintenance Period|Death|1|||
16292404|NCT00102687|39554676|FG000|Maintenance Period|Physician Decision|1|||
16292405|NCT00102687|39554677|FG001|Maintenance Period|Physician Decision|2|||
16292406|NCT00102687|39554678|FG002|Maintenance Period|Physician Decision|3|||
16292407|NCT00102687|39554679|FG003|Maintenance Period|Physician Decision|0|||
16292408|NCT00102687|39554680|FG004|Maintenance Period|Physician Decision|4|||
16292409|NCT02987959|39554686|FG000|Overall Study|Grantor stopped supply of drugs|6|||
16292410|NCT02912650|39554691|FG000|Overall Study|Withdrawal by Subject|1|||
16292411|NCT02912650|39554692|FG001|Overall Study|Withdrawal by Subject|0|||
16292412|NCT02912650|39554693|FG002|Overall Study|Withdrawal by Subject|1|||
16292413|NCT02912650|39554694|FG003|Overall Study|Withdrawal by Subject|5|||
16292414|NCT02912650|39554691|FG000|Overall Study|Adverse Event|0|||
16292415|NCT02912650|39554692|FG001|Overall Study|Adverse Event|0|||
16292416|NCT02912650|39554693|FG002|Overall Study|Adverse Event|1|||
16292417|NCT02912650|39554694|FG003|Overall Study|Adverse Event|0|||
16292418|NCT01946191|39554696|FG000|Allocation|Did not complete orientation|1|||
16292419|NCT01946191|39554697|FG001|Allocation|Did not complete orientation|1|||
16292420|NCT01946191|39554696|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
16292421|NCT01946191|39554697|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
16292422|NCT01946191|39554696|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
16292423|NCT01946191|39554697|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
16292424|NCT01946191|39554696|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
16292425|NCT01946191|39554697|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
16292426|NCT01366092|39554698|FG000|Overall Study|Progressive cGVHD|2|||
16381271|NCT01362790|39877880|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16381272|NCT01362790|39877881|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16381273|NCT01362790|39877882|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16292427|NCT01366092|39554698|FG000|Overall Study|Physician Decision|1|||
16292428|NCT01366092|39554698|FG000|Overall Study|Withdrawal by Subject|1|||
16484107|NCT01133522|40248786|FG009|Overall Study|Withdrawal by Subject|0|||
16484108|NCT01133522|40248777|FG000|Overall Study|Physician Decision|0|||
16484109|NCT01133522|40248778|FG001|Overall Study|Physician Decision|0|||
16081389|NCT03527160|38789577|FG000|Overall Study|Did not meet inclusion|2|||
16081390|NCT04149002|38789578|FG000|Overall Study|Lost to Follow-up|1|||
16081391|NCT04149002|38789579|FG001|Overall Study|Lost to Follow-up|0|||
16081392|NCT04149002|38789578|FG000|Overall Study|Withdrawal by Subject|1|||
16081393|NCT04149002|38789579|FG001|Overall Study|Withdrawal by Subject|0|||
16081394|NCT00274261|38792606|FG000|Overall Study|Adverse Event|19|||
16081395|NCT00274261|38792607|FG001|Overall Study|Adverse Event|11|||
16292429|NCT01183221|39554699|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
16292430|NCT01183221|39554700|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
16081396|NCT00274261|38792606|FG000|Overall Study|Pregnancy|114|||
16081397|NCT00274261|38792607|FG001|Overall Study|Pregnancy|83|||
16081398|NCT00274261|38792606|FG000|Overall Study|Withdrawal by Subject|179|||
16081399|NCT00274261|38792607|FG001|Overall Study|Withdrawal by Subject|126|||
16081400|NCT00274261|38792606|FG000|Overall Study|Protocol Violation|71|||
16081401|NCT00274261|38792607|FG001|Overall Study|Protocol Violation|42|||
16081402|NCT00274261|38792606|FG000|Overall Study|Lost to Follow-up|106|||
16081403|NCT00274261|38792607|FG001|Overall Study|Lost to Follow-up|75|||
16081404|NCT00840177|38792611|FG000|Overall Study|Adverse Event|5|||
16081405|NCT00840177|38792612|FG001|Overall Study|Adverse Event|1|||
16081406|NCT00840177|38792613|FG002|Overall Study|Adverse Event|1|||
16081407|NCT00840177|38792611|FG000|Overall Study|Refusal unrelated to adverse events|1|||
16081408|NCT00840177|38792612|FG001|Overall Study|Refusal unrelated to adverse events|0|||
16081409|NCT00840177|38792613|FG002|Overall Study|Refusal unrelated to adverse events|1|||
16081410|NCT00840177|38792611|FG000|Overall Study|Progression/relapse|2|||
16187128|NCT01097616|39162007|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
16187129|NCT01097616|39162008|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16187130|NCT01097616|39162009|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16187131|NCT01097616|39162010|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16187132|NCT01097616|39162011|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16187133|NCT01097616|39162012|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16187134|NCT01097616|39162005|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
16187135|NCT01097616|39162006|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
16187136|NCT01097616|39162007|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16187137|NCT01097616|39162008|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16187138|NCT01097616|39162009|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16187139|NCT01097616|39162010|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16187140|NCT01097616|39162011|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16187141|NCT01097616|39162012|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16187142|NCT01097616|39162005|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
16292431|NCT01367665|39554701|FG000|Overall Study|Death|102|||
16292432|NCT01367665|39554702|FG001|Overall Study|Death|19|||
16292433|NCT01367665|39554701|FG000|Overall Study|Lost to Follow-up|222|||
16292434|NCT01367665|39554702|FG001|Overall Study|Lost to Follow-up|22|||
16292435|NCT01367665|39554701|FG000|Overall Study|Not Done|118|||
16292436|NCT01367665|39554702|FG001|Overall Study|Not Done|14|||
16292437|NCT02005887|39554704|FG000|Overall Study|Protocol Violation|0|||
16292438|NCT02005887|39554705|FG001|Overall Study|Protocol Violation|2|||
16292439|NCT02685202|39554706|FG000|Overall Study|Lost to Follow-up|9|||
16292440|NCT00777036|39554707|FG000|On Treatment|Reason Not Specified|4|||
16292441|NCT00777036|39554708|FG001|On Treatment|Reason Not Specified|7|||
16292442|NCT00777036|39554709|FG002|On Treatment|Reason Not Specified|12|||
16292443|NCT00777036|39554707|FG000|On Treatment|Failure to Meet Study Criteria|0|||
16292444|NCT00777036|39554708|FG001|On Treatment|Failure to Meet Study Criteria|1|||
16292445|NCT00777036|39554709|FG002|On Treatment|Failure to Meet Study Criteria|0|||
16292446|NCT00777036|39554707|FG000|On Treatment|Non-compliance with Study Drug|1|||
16292447|NCT00777036|39554708|FG001|On Treatment|Non-compliance with Study Drug|0|||
16292448|NCT00777036|39554709|FG002|On Treatment|Non-compliance with Study Drug|0|||
16381274|NCT01362790|39877883|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
16484110|NCT01133522|40248779|FG002|Overall Study|Physician Decision|0|||
16484111|NCT01133522|40248780|FG003|Overall Study|Physician Decision|0|||
16081411|NCT00840177|38792612|FG001|Overall Study|Progression/relapse|0|||
16081412|NCT00840177|38792613|FG002|Overall Study|Progression/relapse|0|||
16081413|NCT00840177|38792611|FG000|Overall Study|Death|4|||
16081414|NCT00840177|38792612|FG001|Overall Study|Death|5|||
16081415|NCT00840177|38792613|FG002|Overall Study|Death|5|||
16081416|NCT00840177|38792611|FG000|Overall Study|not protocol specified|6|||
16081417|NCT00840177|38792612|FG001|Overall Study|not protocol specified|3|||
16081418|NCT00840177|38792613|FG002|Overall Study|not protocol specified|0|||
16081419|NCT00840177|38792611|FG000|Overall Study|Ineligible|0|||
16081420|NCT00840177|38792612|FG001|Overall Study|Ineligible|0|||
16081421|NCT00840177|38792613|FG002|Overall Study|Ineligible|3|||
16081422|NCT00840177|38792611|FG000|Overall Study|Did not start treatment|0|||
16187143|NCT01097616|39162006|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
16187144|NCT01097616|39162007|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
16187145|NCT01097616|39162008|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16292449|NCT00777036|39554707|FG000|On Treatment|Maximum Clinical Benefit|2|||
16292450|NCT00777036|39554708|FG001|On Treatment|Maximum Clinical Benefit|0|||
16292451|NCT00777036|39554709|FG002|On Treatment|Maximum Clinical Benefit|1|||
16292452|NCT00777036|39554707|FG000|On Treatment|Withdrawal by Subject|3|||
16292453|NCT00777036|39554708|FG001|On Treatment|Withdrawal by Subject|2|||
16187146|NCT01097616|39162009|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16187147|NCT01097616|39162010|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16187148|NCT01097616|39162011|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16187149|NCT01097616|39162012|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16187150|NCT01097616|39162005|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
16187151|NCT01097616|39162006|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
16187152|NCT01097616|39162007|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16187153|NCT01097616|39162008|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16187154|NCT01097616|39162009|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16187155|NCT01097616|39162010|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16187156|NCT01097616|39162011|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16292454|NCT00777036|39554709|FG002|On Treatment|Withdrawal by Subject|3|||
16292455|NCT00777036|39554707|FG000|On Treatment|Death|0|||
16292456|NCT00777036|39554708|FG001|On Treatment|Death|2|||
16292457|NCT00777036|39554709|FG002|On Treatment|Death|0|||
16292458|NCT00777036|39554707|FG000|On Treatment|Study Drug Toxicity|0|||
16292459|NCT00777036|39554708|FG001|On Treatment|Study Drug Toxicity|0|||
16292460|NCT00777036|39554709|FG002|On Treatment|Study Drug Toxicity|1|||
16292461|NCT00777036|39554707|FG000|On Treatment|Progressive Disease|5|||
16292462|NCT00777036|39554708|FG001|On Treatment|Progressive Disease|4|||
16381275|NCT01362790|39877877|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
16381276|NCT01362790|39877878|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
16381277|NCT01362790|39877879|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
16381278|NCT01362790|39877880|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
16381279|NCT01362790|39877881|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
16381280|NCT01362790|39877882|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
16381281|NCT01362790|39877883|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
16381282|NCT01362790|39877877|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
16381283|NCT01362790|39877878|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
16292463|NCT00777036|39554709|FG002|On Treatment|Progressive Disease|6|||
16484112|NCT01133522|40248781|FG004|Overall Study|Physician Decision|1|||
16292464|NCT00777036|39554707|FG000|Follow-Up|Lost to Follow-up|1|||
16292465|NCT00777036|39554708|FG001|Follow-Up|Lost to Follow-up|0|||
16292466|NCT00777036|39554709|FG002|Follow-Up|Lost to Follow-up|0|||
16292467|NCT00777036|39554707|FG000|Follow-Up|Reason Not Specified|2|||
16381284|NCT01362790|39877879|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
16381285|NCT01362790|39877880|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
16381286|NCT01362790|39877881|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
16381287|NCT01362790|39877882|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
16381288|NCT01362790|39877883|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
16381289|NCT01362790|39877877|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
16381290|NCT01362790|39877878|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
16381291|NCT01362790|39877879|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
16381292|NCT01362790|39877880|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
16381293|NCT01362790|39877881|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
16381294|NCT01362790|39877882|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
16381295|NCT01362790|39877883|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
16381296|NCT01362790|39877877|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
16381297|NCT01362790|39877878|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
16381298|NCT01362790|39877879|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
16381299|NCT01362790|39877880|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
16381300|NCT01362790|39877881|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
16381301|NCT01362790|39877882|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
16381302|NCT01362790|39877883|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
16381303|NCT01362790|39877877|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
16484113|NCT01133522|40248782|FG005|Overall Study|Physician Decision|0|||
16484114|NCT01133522|40248783|FG006|Overall Study|Physician Decision|0|||
16484115|NCT01133522|40248784|FG007|Overall Study|Physician Decision|0|||
16484116|NCT01133522|40248785|FG008|Overall Study|Physician Decision|0|||
16187157|NCT01097616|39162012|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
16292468|NCT00777036|39554708|FG001|Follow-Up|Reason Not Specified|0|||
16292469|NCT00777036|39554709|FG002|Follow-Up|Reason Not Specified|0|||
16292470|NCT00777036|39554707|FG000|Follow-Up|Withdrawal by Subject|1|||
16292471|NCT00777036|39554708|FG001|Follow-Up|Withdrawal by Subject|0|||
16381304|NCT01362790|39877878|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
16484117|NCT01133522|40248786|FG009|Overall Study|Physician Decision|0|||
16187158|NCT01097616|39162005|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
16187159|NCT01097616|39162006|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
16187160|NCT01097616|39162007|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16187161|NCT01097616|39162008|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16187162|NCT01097616|39162009|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16187163|NCT01097616|39162010|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16187164|NCT01097616|39162011|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16187165|NCT01097616|39162012|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16187166|NCT01097616|39162005|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16187167|NCT01097616|39162006|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16187168|NCT01097616|39162007|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
16187169|NCT01097616|39162008|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16187170|NCT01097616|39162009|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16187171|NCT01097616|39162010|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16187172|NCT01097616|39162011|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16187173|NCT01097616|39162012|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16187174|NCT01097616|39162005|FG000|Optional DB EXT Phase|Adverse Event|0|||
16187175|NCT01097616|39162006|FG001|Optional DB EXT Phase|Adverse Event|7|||
16187176|NCT01097616|39162007|FG002|Optional DB EXT Phase|Adverse Event|2|||
16187177|NCT01097616|39162008|FG003|Optional DB EXT Phase|Adverse Event|0|||
16187178|NCT01097616|39162009|FG004|Optional DB EXT Phase|Adverse Event|0|||
16187179|NCT01097616|39162010|FG005|Optional DB EXT Phase|Adverse Event|0|||
16187180|NCT01097616|39162011|FG006|Optional DB EXT Phase|Adverse Event|0|||
16187181|NCT01097616|39162012|FG007|Optional DB EXT Phase|Adverse Event|0|||
16187182|NCT01097616|39162005|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
16187183|NCT01097616|39162006|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
16292472|NCT00777036|39554709|FG002|Follow-Up|Withdrawal by Subject|4|||
16292473|NCT00777036|39554707|FG000|Follow-Up|Death|1|||
16292474|NCT00777036|39554708|FG001|Follow-Up|Death|8|||
16292475|NCT00777036|39554709|FG002|Follow-Up|Death|0|||
16292476|NCT04688931|39554715|FG000|Overall Study|Adverse Event|4|||
16292477|NCT04688931|39554716|FG001|Overall Study|Adverse Event|1|||
16292478|NCT04688931|39554715|FG000|Overall Study|Withdrawal by Subject|5|||
16292479|NCT04688931|39554716|FG001|Overall Study|Withdrawal by Subject|16|||
16292480|NCT04688931|39554715|FG000|Overall Study|Physician Decision|3|||
16292481|NCT04688931|39554716|FG001|Overall Study|Physician Decision|5|||
16292482|NCT04688931|39554715|FG000|Overall Study|Noncompliance|0|||
16292483|NCT04688931|39554716|FG001|Overall Study|Noncompliance|1|||
16292484|NCT04688931|39554715|FG000|Overall Study|Lost to Follow-up|1|||
16292485|NCT04688931|39554716|FG001|Overall Study|Lost to Follow-up|3|||
16292486|NCT04688931|39554715|FG000|Overall Study|Randomization Error|3|||
16292487|NCT04688931|39554716|FG001|Overall Study|Randomization Error|0|||
16292488|NCT04688931|39554715|FG000|Overall Study|Not Eligible|1|||
16292489|NCT04688931|39554716|FG001|Overall Study|Not Eligible|3|||
16292490|NCT04688931|39554715|FG000|Overall Study|Disease Progression|0|||
16292491|NCT04688931|39554716|FG001|Overall Study|Disease Progression|2|||
16292492|NCT04688931|39554715|FG000|Overall Study|Sponsor Requirement|1|||
16292493|NCT04688931|39554716|FG001|Overall Study|Sponsor Requirement|1|||
16292494|NCT04688931|39554715|FG000|Overall Study|Other Reason|1|||
16292495|NCT04688931|39554716|FG001|Overall Study|Other Reason|2|||
16292496|NCT01929031|39554717|FG000|Overall Study|Adverse Event|3|||
16292497|NCT01929031|39554718|FG001|Overall Study|Adverse Event|1|||
16292498|NCT01929031|39554719|FG002|Overall Study|Adverse Event|1|||
16292499|NCT01929031|39554720|FG003|Overall Study|Adverse Event|0|||
16292500|NCT01929031|39554721|FG004|Overall Study|Adverse Event|0|||
16292501|NCT01929031|39554722|FG005|Overall Study|Adverse Event|0|||
16292502|NCT01929031|39554717|FG000|Overall Study|Protocol Violation|1|||
16292503|NCT01929031|39554718|FG001|Overall Study|Protocol Violation|0|||
16292504|NCT01929031|39554719|FG002|Overall Study|Protocol Violation|0|||
16292505|NCT01929031|39554720|FG003|Overall Study|Protocol Violation|0|||
16292506|NCT01929031|39554721|FG004|Overall Study|Protocol Violation|0|||
16292507|NCT01929031|39554722|FG005|Overall Study|Protocol Violation|1|||
16292508|NCT01929031|39554717|FG000|Overall Study|Reason other than specified above|0|||
16292509|NCT01929031|39554718|FG001|Overall Study|Reason other than specified above|1|||
16292510|NCT01929031|39554719|FG002|Overall Study|Reason other than specified above|0|||
16292511|NCT01929031|39554720|FG003|Overall Study|Reason other than specified above|0|||
16292512|NCT01929031|39554721|FG004|Overall Study|Reason other than specified above|1|||
16292513|NCT01929031|39554722|FG005|Overall Study|Reason other than specified above|0|||
16484118|NCT01558739|40248789|FG000|Overall Study|Adverse Event|7|||
16292514|NCT00197496|39554723|FG000|Baseline to Discharge|not interested|1|||
16292515|NCT00197496|39554724|FG001|Baseline to Discharge|not interested|0|||
16292516|NCT00197496|39554723|FG000|Baseline to Discharge|MRSA|1|||
16292517|NCT00197496|39554724|FG001|Baseline to Discharge|MRSA|0|||
16292518|NCT00197496|39554723|FG000|Baseline to Discharge|Physician Decision|0|||
16292519|NCT00197496|39554724|FG001|Baseline to Discharge|Physician Decision|1|||
16292520|NCT00197496|39554723|FG000|Baseline to Discharge|Protocol Violation|0|||
16292521|NCT00197496|39554724|FG001|Baseline to Discharge|Protocol Violation|1|||
16292522|NCT00197496|39554723|FG000|Follow-up|Lost to Follow-up|2|||
16292523|NCT00197496|39554724|FG001|Follow-up|Lost to Follow-up|1|||
16292524|NCT04730349|39554725|FG000|Overall Study|Participant withdrew consent|1|||
16292525|NCT04730349|39554726|FG001|Overall Study|Participant withdrew consent|0|||
16292526|NCT04730349|39554725|FG000|Overall Study|Disease progression|6|||
16292527|NCT04730349|39554726|FG001|Overall Study|Disease progression|4|||
16292528|NCT04730349|39554725|FG000|Overall Study|Study drug toxicity|0|||
16292529|NCT04730349|39554726|FG001|Overall Study|Study drug toxicity|1|||
16292530|NCT02304458|39554728|FG000|Overall Study|Adverse Event|0|||
16292531|NCT02304458|39554729|FG001|Overall Study|Adverse Event|0|||
16292532|NCT02304458|39554730|FG002|Overall Study|Adverse Event|7|||
16292533|NCT02304458|39554731|FG003|Overall Study|Adverse Event|0|||
16292534|NCT02304458|39554732|FG004|Overall Study|Adverse Event|0|||
16292535|NCT02304458|39554733|FG005|Overall Study|Adverse Event|0|||
16292536|NCT02304458|39554734|FG006|Overall Study|Adverse Event|3|||
16292537|NCT02304458|39554735|FG007|Overall Study|Adverse Event|4|||
16292538|NCT02304458|39554728|FG000|Overall Study|Death|0|||
16292539|NCT02304458|39554729|FG001|Overall Study|Death|0|||
16292540|NCT02304458|39554730|FG002|Overall Study|Death|2|||
16292541|NCT02304458|39554731|FG003|Overall Study|Death|0|||
16292542|NCT02304458|39554732|FG004|Overall Study|Death|0|||
16292543|NCT02304458|39554733|FG005|Overall Study|Death|0|||
16292544|NCT02304458|39554734|FG006|Overall Study|Death|1|||
16292545|NCT02304458|39554735|FG007|Overall Study|Death|0|||
16292546|NCT02304458|39554728|FG000|Overall Study|Lack of Efficacy|4|||
16292547|NCT02304458|39554729|FG001|Overall Study|Lack of Efficacy|6|||
16292548|NCT02304458|39554730|FG002|Overall Study|Lack of Efficacy|38|||
16292549|NCT02304458|39554731|FG003|Overall Study|Lack of Efficacy|5|||
16292550|NCT02304458|39554732|FG004|Overall Study|Lack of Efficacy|6|||
16292551|NCT02304458|39554733|FG005|Overall Study|Lack of Efficacy|6|||
16292552|NCT02304458|39554734|FG006|Overall Study|Lack of Efficacy|21|||
16292553|NCT02304458|39554735|FG007|Overall Study|Lack of Efficacy|4|||
16292554|NCT02304458|39554728|FG000|Overall Study|Physician Decision|2|||
16292555|NCT02304458|39554729|FG001|Overall Study|Physician Decision|0|||
16292556|NCT02304458|39554730|FG002|Overall Study|Physician Decision|16|||
16292557|NCT02304458|39554731|FG003|Overall Study|Physician Decision|1|||
16292558|NCT02304458|39554732|FG004|Overall Study|Physician Decision|0|||
16292559|NCT02304458|39554733|FG005|Overall Study|Physician Decision|0|||
16292560|NCT02304458|39554734|FG006|Overall Study|Physician Decision|3|||
16292561|NCT02304458|39554735|FG007|Overall Study|Physician Decision|0|||
16292562|NCT02304458|39554728|FG000|Overall Study|Protocol Violation|0|||
16292563|NCT02304458|39554729|FG001|Overall Study|Protocol Violation|0|||
16292564|NCT02304458|39554730|FG002|Overall Study|Protocol Violation|1|||
16292565|NCT02304458|39554731|FG003|Overall Study|Protocol Violation|0|||
16292566|NCT02304458|39554732|FG004|Overall Study|Protocol Violation|0|||
16292567|NCT02304458|39554733|FG005|Overall Study|Protocol Violation|0|||
16292568|NCT02304458|39554734|FG006|Overall Study|Protocol Violation|0|||
16292569|NCT02304458|39554735|FG007|Overall Study|Protocol Violation|0|||
16292570|NCT02304458|39554728|FG000|Overall Study|Withdrawal by Subject|1|||
16292571|NCT02304458|39554729|FG001|Overall Study|Withdrawal by Subject|0|||
16292572|NCT02304458|39554730|FG002|Overall Study|Withdrawal by Subject|7|||
16292573|NCT02304458|39554731|FG003|Overall Study|Withdrawal by Subject|0|||
16292574|NCT02304458|39554732|FG004|Overall Study|Withdrawal by Subject|0|||
16292575|NCT02304458|39554733|FG005|Overall Study|Withdrawal by Subject|0|||
16292576|NCT02304458|39554734|FG006|Overall Study|Withdrawal by Subject|1|||
16292577|NCT02304458|39554735|FG007|Overall Study|Withdrawal by Subject|0|||
16292578|NCT00540293|39554738|FG000|Overall Study|Adverse event related to study drug|10|||
16292579|NCT00540293|39554738|FG000|Overall Study|Adverse event not related to study drug|7|||
16292580|NCT00540293|39554738|FG000|Overall Study|Withdrawal by Subject|6|||
16292581|NCT00540293|39554738|FG000|Overall Study|Protocol violation, & subject schedule|12|||
16292582|NCT00270257|39554739|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
16292583|NCT00270257|39554740|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
16381305|NCT01362790|39877879|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
16381306|NCT01362790|39877880|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
16292584|NCT03469336|39554747|FG000|Overall Study|Adverse Event|1|||
16292585|NCT02749292|39554748|FG000|Overall Study|Physician Decision|1|||
16292586|NCT02749292|39554749|FG001|Overall Study|Physician Decision|0|||
16292587|NCT02749292|39554748|FG000|Overall Study|Withdrawal by Subject|5|||
16292588|NCT02749292|39554749|FG001|Overall Study|Withdrawal by Subject|7|||
16292589|NCT02749292|39554748|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
16292590|NCT02749292|39554749|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
16292591|NCT02749292|39554748|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
16292592|NCT02749292|39554749|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
16292593|NCT02749292|39554748|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
16292594|NCT02749292|39554749|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
16292595|NCT02749292|39554748|FG000|Overall Study|Adverse Event|4|||
16381307|NCT01362790|39877881|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
16381308|NCT01362790|39877882|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
16381309|NCT01362790|39877883|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
16381310|NCT01362790|39877877|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
16381311|NCT01362790|39877878|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16292596|NCT02749292|39554749|FG001|Overall Study|Adverse Event|1|||
16292597|NCT02749292|39554748|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
16292598|NCT02749292|39554749|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
16292599|NCT02749292|39554748|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
16292600|NCT02749292|39554749|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
16292601|NCT02749292|39554748|FG000|Overall Study|Requiring glucocorticoids|0|||
16292602|NCT02749292|39554749|FG001|Overall Study|Requiring glucocorticoids|3|||
16292603|NCT02749292|39554748|FG000|Overall Study|Cancer|1|||
16292604|NCT02749292|39554749|FG001|Overall Study|Cancer|0|||
16292605|NCT04639713|39554750|FG000|Overall Study|Protocol Noncompliance|2|||
16292606|NCT04639713|39554750|FG000|Overall Study|Withdrawal by Subject|1|||
16292607|NCT02533375|39554752|FG000|Overall Study|Lack of Efficacy|3|||
16292608|NCT02533375|39554752|FG000|Overall Study|Adverse Event|2|||
16292609|NCT04874636|39554754|FG000|Overall Study|Adverse Event|17|||
16292610|NCT04874636|39554755|FG001|Overall Study|Adverse Event|7|||
16292611|NCT04874636|39554754|FG000|Overall Study|Lost to Follow-up|1|||
16292612|NCT04874636|39554755|FG001|Overall Study|Lost to Follow-up|0|||
16292613|NCT04874636|39554754|FG000|Overall Study|Non-Compliance with Study Drug|2|||
16292614|NCT04874636|39554755|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16292615|NCT04874636|39554754|FG000|Overall Study|Physician Decision|1|||
16292616|NCT04874636|39554755|FG001|Overall Study|Physician Decision|0|||
16292617|NCT04874636|39554754|FG000|Overall Study|Withdrawal by Subject|6|||
16292618|NCT04874636|39554755|FG001|Overall Study|Withdrawal by Subject|5|||
16292619|NCT02981303|39554756|FG000|Overall Study|Progressive Disease|17|||
16292620|NCT02981303|39554757|FG001|Overall Study|Progressive Disease|37|||
16292621|NCT02981303|39554756|FG000|Overall Study|Adverse Event|1|||
16292622|NCT02981303|39554757|FG001|Overall Study|Adverse Event|4|||
16292623|NCT02981303|39554756|FG000|Overall Study|Withdrawal by Subject|0|||
16292624|NCT02981303|39554757|FG001|Overall Study|Withdrawal by Subject|1|||
16292625|NCT03393806|39554760|FG000|Overall Study|Physician Decision|1|||
16292626|NCT03393806|39554761|FG001|Overall Study|Physician Decision|0|||
16292627|NCT00289536|39554762|FG000|Period 3|Lost to Follow-up|0|||
16292628|NCT00289536|39554763|FG001|Period 3|Lost to Follow-up|0|||
16292629|NCT00289536|39554764|FG002|Period 3|Lost to Follow-up|1|||
16292630|NCT04498403|39554765|FG000|Overall Study|Adverse Event|1|||
16292631|NCT04498403|39554766|FG001|Overall Study|Adverse Event|0|||
16292632|NCT04498403|39554765|FG000|Overall Study|Study Terminated By Sponsor|29|||
16292633|NCT04498403|39554766|FG001|Overall Study|Study Terminated By Sponsor|10|||
16292634|NCT02139124|39554767|FG000|Overall Study|Adverse Event|2|||
16292635|NCT02139124|39554768|FG001|Overall Study|Adverse Event|0|||
16292636|NCT02139124|39554769|FG002|Overall Study|Adverse Event|1|||
16292637|NCT02139124|39554770|FG003|Overall Study|Adverse Event|2|||
16292638|NCT02139124|39554771|FG004|Overall Study|Adverse Event|5|||
16292639|NCT02139124|39554767|FG000|Overall Study|Withdrawal by Subject|2|||
16292640|NCT02139124|39554768|FG001|Overall Study|Withdrawal by Subject|2|||
16292641|NCT02139124|39554769|FG002|Overall Study|Withdrawal by Subject|2|||
16292642|NCT02139124|39554770|FG003|Overall Study|Withdrawal by Subject|2|||
16292643|NCT02139124|39554771|FG004|Overall Study|Withdrawal by Subject|3|||
16292644|NCT02139124|39554767|FG000|Overall Study|Protocol Violation|0|||
16292645|NCT02139124|39554768|FG001|Overall Study|Protocol Violation|0|||
16292646|NCT02139124|39554769|FG002|Overall Study|Protocol Violation|0|||
16292647|NCT02139124|39554770|FG003|Overall Study|Protocol Violation|1|||
16292648|NCT02139124|39554771|FG004|Overall Study|Protocol Violation|1|||
16292649|NCT02139124|39554767|FG000|Overall Study|non-compliant|1|||
16292650|NCT02139124|39554768|FG001|Overall Study|non-compliant|0|||
16292651|NCT02139124|39554769|FG002|Overall Study|non-compliant|0|||
16292652|NCT02139124|39554770|FG003|Overall Study|non-compliant|2|||
16292653|NCT02139124|39554771|FG004|Overall Study|non-compliant|0|||
16292654|NCT02139124|39554767|FG000|Overall Study|incarceration|0|||
16292655|NCT02139124|39554768|FG001|Overall Study|incarceration|0|||
16292656|NCT02139124|39554769|FG002|Overall Study|incarceration|1|||
16292657|NCT02139124|39554770|FG003|Overall Study|incarceration|0|||
16292658|NCT02139124|39554771|FG004|Overall Study|incarceration|0|||
16292659|NCT02139124|39554767|FG000|Overall Study|subject moved|1|||
16292660|NCT02139124|39554768|FG001|Overall Study|subject moved|0|||
16381312|NCT01362790|39877879|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16381313|NCT01362790|39877880|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16292661|NCT02139124|39554769|FG002|Overall Study|subject moved|0|||
16292662|NCT02139124|39554770|FG003|Overall Study|subject moved|0|||
16292663|NCT02139124|39554771|FG004|Overall Study|subject moved|0|||
16292664|NCT02139124|39554767|FG000|Overall Study|Lost to Follow-up|3|||
16292665|NCT02139124|39554768|FG001|Overall Study|Lost to Follow-up|2|||
16381314|NCT01362790|39877881|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16381315|NCT01362790|39877882|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16381316|NCT01362790|39877883|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
16381317|NCT01362790|39877877|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16381318|NCT01362790|39877878|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
16292666|NCT02139124|39554769|FG002|Overall Study|Lost to Follow-up|0|||
16292667|NCT02139124|39554770|FG003|Overall Study|Lost to Follow-up|5|||
16292668|NCT02139124|39554771|FG004|Overall Study|Lost to Follow-up|4|||
16292669|NCT00477295|39554773|FG000|Overall Study|Adverse Event|31|||
16292670|NCT00477295|39554774|FG001|Overall Study|Adverse Event|35|||
16292671|NCT00477295|39554773|FG000|Overall Study|Withdrawal by Subject|35|||
16292672|NCT00477295|39554774|FG001|Overall Study|Withdrawal by Subject|24|||
16292673|NCT00477295|39554773|FG000|Overall Study|Lack of Efficacy|23|||
16292674|NCT00477295|39554774|FG001|Overall Study|Lack of Efficacy|23|||
16292675|NCT00477295|39554773|FG000|Overall Study|Protocol Violation|3|||
16381319|NCT01362790|39877879|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16381320|NCT01362790|39877880|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16381321|NCT01362790|39877881|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16381322|NCT01362790|39877882|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16381323|NCT01362790|39877883|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
16381324|NCT01362790|39877877|FG000|Pilot Phase & Phase 2|Death on study|0|||
16381325|NCT01362790|39877878|FG001|Pilot Phase & Phase 2|Death on study|0|||
16381326|NCT01362790|39877879|FG002|Pilot Phase & Phase 2|Death on study|0|||
16381327|NCT01362790|39877880|FG003|Pilot Phase & Phase 2|Death on study|1|||
16381328|NCT01362790|39877881|FG004|Pilot Phase & Phase 2|Death on study|0|||
16381329|NCT01362790|39877882|FG005|Pilot Phase & Phase 2|Death on study|0|||
16381330|NCT01362790|39877883|FG006|Pilot Phase & Phase 2|Death on study|0|||
16381331|NCT01362790|39877877|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
16381332|NCT01362790|39877878|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
16381333|NCT01362790|39877879|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
16381334|NCT01362790|39877880|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
16381335|NCT01362790|39877881|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
16381336|NCT01362790|39877882|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
16381337|NCT01362790|39877883|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
16381338|NCT01362790|39877877|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16381339|NCT01362790|39877878|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16381340|NCT01362790|39877879|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16381341|NCT01362790|39877880|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16381342|NCT01362790|39877881|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
16381343|NCT01362790|39877882|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16381344|NCT01362790|39877883|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
16381345|NCT01362790|39877877|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
16381346|NCT01362790|39877878|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
16381347|NCT01362790|39877879|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
16381348|NCT01362790|39877880|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
16292676|NCT00477295|39554774|FG001|Overall Study|Protocol Violation|8|||
16292677|NCT00477295|39554773|FG000|Overall Study|Physician Decision|4|||
16292678|NCT00477295|39554774|FG001|Overall Study|Physician Decision|5|||
16292679|NCT00477295|39554773|FG000|Overall Study|Lost to Follow-up|21|||
16292680|NCT00477295|39554774|FG001|Overall Study|Lost to Follow-up|11|||
16292681|NCT00477295|39554773|FG000|Overall Study|Other|4|||
16292682|NCT00477295|39554774|FG001|Overall Study|Other|3|||
16292683|NCT04551911|39554775|FG000|Overall Study|Lost to Follow-up|2|||
16292684|NCT04551911|39554776|FG001|Overall Study|Lost to Follow-up|1|||
16292685|NCT04551911|39554775|FG000|Overall Study|Withdrawal by Subject|10|||
16292686|NCT04551911|39554776|FG001|Overall Study|Withdrawal by Subject|10|||
16292687|NCT04551911|39554775|FG000|Overall Study|Did not receive the study drug|3|||
16292688|NCT04551911|39554776|FG001|Overall Study|Did not receive the study drug|4|||
16292689|NCT03484117|39554777|FG000|Overall Study|Lost to Follow-up|1|||
16292690|NCT03484117|39554778|FG001|Overall Study|Lost to Follow-up|3|||
16292691|NCT03484117|39554777|FG000|Overall Study|Declined participation in exit assess|1|||
16292692|NCT03484117|39554778|FG001|Overall Study|Declined participation in exit assess|1|||
16292693|NCT03918109|39554779|FG000|Overall Study|Withdrawal by Subject|0|||
16292694|NCT03918109|39554780|FG001|Overall Study|Withdrawal by Subject|0|||
16292695|NCT03918109|39554781|FG002|Overall Study|Withdrawal by Subject|2|||
16292696|NCT03918109|39554782|FG003|Overall Study|Withdrawal by Subject|1|||
16381349|NCT01362790|39877881|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
16381350|NCT01362790|39877882|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
16292697|NCT03918109|39554779|FG000|Overall Study|Lost to Follow-up|0|||
16292698|NCT03918109|39554780|FG001|Overall Study|Lost to Follow-up|0|||
16292699|NCT03918109|39554781|FG002|Overall Study|Lost to Follow-up|0|||
16292700|NCT03918109|39554782|FG003|Overall Study|Lost to Follow-up|1|||
16381351|NCT01362790|39877883|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
16292701|NCT01524913|39554785|FG000|Overall Study|Lost to Follow-up|4|||
16292702|NCT01524913|39554786|FG001|Overall Study|Lost to Follow-up|0|||
16292703|NCT01524913|39554787|FG002|Overall Study|Lost to Follow-up|0|||
16292704|NCT02348723|39554788|FG000|Overall Study|No ablation|21|||
16292705|NCT02348723|39554789|FG001|Overall Study|No ablation|20|||
16292706|NCT02348723|39554788|FG000|Overall Study|Non-compliant with Protocol|1|||
16381352|NCT02489279|39877886|FG000|Overall Study|Lost to Follow-up|12|||
16381353|NCT02489279|39877887|FG001|Overall Study|Lost to Follow-up|10|||
16381354|NCT01702298|39877895|FG000|Overall Study|Withdrawal by Subject|1|||
16381355|NCT01928433|39877896|FG000|Overall Study|Adverse Event|5|||
16381356|NCT01928433|39877897|FG001|Overall Study|Adverse Event|2|||
16381357|NCT01928433|39877898|FG002|Overall Study|Adverse Event|5|||
16381358|NCT01928433|39877896|FG000|Overall Study|Protocol Violation|0|||
16381359|NCT01928433|39877897|FG001|Overall Study|Protocol Violation|0|||
16381360|NCT01928433|39877898|FG002|Overall Study|Protocol Violation|2|||
16381361|NCT01928433|39877896|FG000|Overall Study|Lack of Efficacy|5|||
16381362|NCT01928433|39877897|FG001|Overall Study|Lack of Efficacy|4|||
16381363|NCT01928433|39877898|FG002|Overall Study|Lack of Efficacy|4|||
16381364|NCT01928433|39877896|FG000|Overall Study|Withdrawal by Subject|0|||
16381365|NCT01928433|39877897|FG001|Overall Study|Withdrawal by Subject|4|||
16381366|NCT01928433|39877898|FG002|Overall Study|Withdrawal by Subject|0|||
16381367|NCT01928433|39877896|FG000|Overall Study|Negative screening urine culture|7|||
16381368|NCT01928433|39877897|FG001|Overall Study|Negative screening urine culture|6|||
16381369|NCT01928433|39877898|FG002|Overall Study|Negative screening urine culture|10|||
16381370|NCT01928433|39877896|FG000|Overall Study|Lost to Follow-up|0|||
16381371|NCT01928433|39877897|FG001|Overall Study|Lost to Follow-up|2|||
16381372|NCT01928433|39877898|FG002|Overall Study|Lost to Follow-up|3|||
16381373|NCT01928433|39877896|FG000|Overall Study|Other reasons|3|||
16381374|NCT01928433|39877897|FG001|Overall Study|Other reasons|3|||
16381375|NCT01928433|39877898|FG002|Overall Study|Other reasons|4|||
16381376|NCT04282148|39877899|FG000|Overall Study|Death|1|||
16381377|NCT04282148|39877899|FG000|Overall Study|Withdrawal by Subject|1|||
16381378|NCT04282148|39877899|FG000|Overall Study|Physician Decision|1|||
16381379|NCT02276040|39877900|FG000|Overall Study|Physician Decision|15|||
16381380|NCT04110145|39877902|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
16381381|NCT04110145|39877903|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
16381382|NCT04110145|39877904|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
16381383|NCT04110145|39877905|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
16381384|NCT04110145|39877906|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
16381385|NCT04237584|39877907|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
16381386|NCT04237584|39877908|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
16292707|NCT02348723|39554789|FG001|Overall Study|Non-compliant with Protocol|0|||
16381387|NCT04237584|39877909|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
16381388|NCT04237584|39877910|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
16381389|NCT04237584|39877907|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
16381390|NCT04237584|39877908|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
16381391|NCT04237584|39877909|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
16381392|NCT04237584|39877910|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
16381393|NCT04237584|39877907|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
16381394|NCT04237584|39877908|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
16381395|NCT04237584|39877909|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
16381396|NCT04237584|39877910|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
16292708|NCT02348723|39554788|FG000|Overall Study|Lost to Follow-up|1|||
16292709|NCT02348723|39554789|FG001|Overall Study|Lost to Follow-up|1|||
16292710|NCT02348723|39554788|FG000|Overall Study|Consent withdrawn|1|||
16292711|NCT02348723|39554789|FG001|Overall Study|Consent withdrawn|3|||
16292712|NCT02348723|39554788|FG000|Overall Study|Reason other than specified|1|||
16292713|NCT02348723|39554789|FG001|Overall Study|Reason other than specified|1|||
16292714|NCT02348723|39554788|FG000|Overall Study|Adverse Event|3|||
16381397|NCT04237584|39877907|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
16381398|NCT04237584|39877908|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
16292715|NCT02348723|39554789|FG001|Overall Study|Adverse Event|1|||
16292716|NCT01700049|39554790|FG000|Overall Study|Withdrawal by Subject|1|||
16292717|NCT00706511|39554791|FG000|Overall Study|Withdrawal by Subject|1|||
16381399|NCT04237584|39877909|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
16381400|NCT04237584|39877910|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
16381401|NCT04237584|39877907|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
16381402|NCT04237584|39877908|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
16381403|NCT04237584|39877909|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
16381404|NCT04237584|39877910|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
16381405|NCT00688740|39877911|FG000|Overall Study|Adverse Event|45|||
16381406|NCT00688740|39877912|FG001|Overall Study|Adverse Event|8|||
16381407|NCT00688740|39877911|FG000|Overall Study|Death|2|||
16381408|NCT00688740|39877912|FG001|Overall Study|Death|2|||
16381409|NCT00688740|39877911|FG000|Overall Study|Lost to Follow-up|0|||
16381410|NCT00688740|39877912|FG001|Overall Study|Lost to Follow-up|1|||
16381411|NCT00688740|39877911|FG000|Overall Study|Consent Withdrawn|17|||
16381412|NCT00688740|39877912|FG001|Overall Study|Consent Withdrawn|17|||
16381413|NCT00688740|39877911|FG000|Overall Study|Breast Cancer Relapse|1|||
16381414|NCT00688740|39877912|FG001|Overall Study|Breast Cancer Relapse|4|||
16381415|NCT00688740|39877911|FG000|Overall Study|Violation of Inclusion Criteria|1|||
16381416|NCT00688740|39877912|FG001|Overall Study|Violation of Inclusion Criteria|3|||
16381417|NCT01052779|39877913|FG000|Overall Study|Adverse Event|1|||
16381418|NCT01052779|39877914|FG001|Overall Study|Adverse Event|4|||
16381419|NCT01052779|39877913|FG000|Overall Study|Withdrawal by Subject|1|||
16381420|NCT01052779|39877914|FG001|Overall Study|Withdrawal by Subject|2|||
16381421|NCT01052779|39877913|FG000|Overall Study|Other-Protocol Violation|1|||
16381422|NCT01052779|39877914|FG001|Overall Study|Other-Protocol Violation|1|||
16381423|NCT01052779|39877913|FG000|Overall Study|Other-Surgery|0|||
16381424|NCT01052779|39877914|FG001|Overall Study|Other-Surgery|2|||
16381425|NCT01052779|39877913|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
16381426|NCT01052779|39877914|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
16381427|NCT02112656|39881453|FG000|Overall Study|Death|78|||
16381428|NCT02112656|39881454|FG001|Overall Study|Death|82|||
16381429|NCT02112656|39881453|FG000|Overall Study|Withdrawal by Subject|9|||
16381430|NCT02112656|39881454|FG001|Overall Study|Withdrawal by Subject|11|||
16381431|NCT02112656|39881453|FG000|Overall Study|Lost to Follow-up|2|||
16381432|NCT02112656|39881454|FG001|Overall Study|Lost to Follow-up|4|||
16381433|NCT02112656|39881453|FG000|Overall Study|Noncompliance|1|||
16381434|NCT02112656|39881454|FG001|Overall Study|Noncompliance|2|||
16381435|NCT03122184|39881455|FG000|Overall Study|Lost to Follow-up|4|||
16381436|NCT03122184|39881456|FG001|Overall Study|Lost to Follow-up|6|||
16381437|NCT03122184|39881455|FG000|Overall Study|Withdrawal by Subject|3|||
16381438|NCT03122184|39881456|FG001|Overall Study|Withdrawal by Subject|0|||
16381439|NCT03122184|39881455|FG000|Overall Study|Terminated due to cognitive problem|1|||
16381440|NCT03122184|39881456|FG001|Overall Study|Terminated due to cognitive problem|0|||
16381441|NCT00404248|39881457|FG000|Overall Study|pts declining status|0|||
16381442|NCT00404248|39881458|FG001|Overall Study|pts declining status|1|||
16187184|NCT01097616|39162007|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
16187185|NCT01097616|39162008|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
16381443|NCT00404248|39881459|FG002|Overall Study|pts declining status|0|||
16381444|NCT00404248|39881460|FG003|Overall Study|pts declining status|0|||
16381445|NCT00404248|39881461|FG004|Overall Study|pts declining status|0|||
16381446|NCT00404248|39881462|FG005|Overall Study|pts declining status|0|||
16381447|NCT00404248|39881463|FG006|Overall Study|pts declining status|0|||
16381448|NCT00404248|39881464|FG007|Overall Study|pts declining status|0|||
16381449|NCT00404248|39881465|FG008|Overall Study|pts declining status|0|||
16381450|NCT01432444|39881466|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
16381451|NCT01432444|39881467|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
16381452|NCT01432444|39881468|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
16381453|NCT01432444|39881466|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
16381454|NCT01432444|39881467|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
16381455|NCT01432444|39881468|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
16381456|NCT01432444|39881466|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
16381457|NCT01432444|39881467|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
16381458|NCT01432444|39881468|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
16381459|NCT01432444|39881466|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
16381460|NCT01432444|39881467|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
16381461|NCT01432444|39881468|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
16187186|NCT01097616|39162009|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
16381462|NCT01432444|39881466|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
16381463|NCT01432444|39881467|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
16381464|NCT01432444|39881468|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
16292718|NCT00706511|39554792|FG001|Overall Study|Withdrawal by Subject|0|||
16292719|NCT00706511|39554793|FG002|Overall Study|Withdrawal by Subject|0|||
16292720|NCT00706511|39554794|FG003|Overall Study|Withdrawal by Subject|0|||
16292721|NCT01675661|39554795|FG000|Overall Study|Lost to Follow-up|22|||
16292722|NCT01675661|39554796|FG001|Overall Study|Lost to Follow-up|23|||
16292723|NCT01675661|39554795|FG000|Overall Study|Practical problems|9|||
16292724|NCT01675661|39554796|FG001|Overall Study|Practical problems|5|||
16292725|NCT01675661|39554795|FG000|Overall Study|Moved away|5|||
16292726|NCT01675661|39554796|FG001|Overall Study|Moved away|6|||
16292727|NCT01675661|39554795|FG000|Overall Study|Withdrawal by Subject|3|||
16292728|NCT01675661|39554796|FG001|Overall Study|Withdrawal by Subject|7|||
16292729|NCT01675661|39554795|FG000|Overall Study|Physician Decision|0|||
16381465|NCT01432444|39881466|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
16292730|NCT01675661|39554796|FG001|Overall Study|Physician Decision|2|||
16292731|NCT01675661|39554795|FG000|Overall Study|Death|0|||
16292732|NCT01675661|39554796|FG001|Overall Study|Death|1|||
16292733|NCT01675661|39554795|FG000|Overall Study|Other reason|1|||
16292734|NCT01675661|39554796|FG001|Overall Study|Other reason|2|||
16292735|NCT02312063|39554798|FG000|Overall Study|Withdrawal by Subject|0|||
16292736|NCT02312063|39554799|FG001|Overall Study|Withdrawal by Subject|1|||
16292737|NCT04168190|39554800|FG000|Overall Study|Lost to Follow-up|0|||
16292738|NCT04168190|39554801|FG001|Overall Study|Lost to Follow-up|1|||
16292739|NCT04168190|39554802|FG002|Overall Study|Lost to Follow-up|0|||
16292740|NCT04168190|39554803|FG003|Overall Study|Lost to Follow-up|7|||
16292741|NCT04168190|39554804|FG004|Overall Study|Lost to Follow-up|5|||
16292742|NCT04168190|39554800|FG000|Overall Study|Withdrawal by Subject|1|||
16292743|NCT04168190|39554801|FG001|Overall Study|Withdrawal by Subject|0|||
16292744|NCT04168190|39554802|FG002|Overall Study|Withdrawal by Subject|0|||
16292745|NCT04168190|39554803|FG003|Overall Study|Withdrawal by Subject|2|||
16292746|NCT04168190|39554804|FG004|Overall Study|Withdrawal by Subject|4|||
16292747|NCT04168190|39554800|FG000|Overall Study|Death|0|||
16292748|NCT04168190|39554801|FG001|Overall Study|Death|0|||
16292749|NCT04168190|39554802|FG002|Overall Study|Death|0|||
16292750|NCT04168190|39554803|FG003|Overall Study|Death|1|||
16292751|NCT04168190|39554804|FG004|Overall Study|Death|0|||
16292752|NCT00468650|39554805|FG000|Overall Study|Lost to Follow-up|4|||
16292753|NCT00468650|39554805|FG000|Overall Study|Withdrawal by Subject|2|||
16292754|NCT00468650|39554805|FG000|Overall Study|Protocol Violation|1|||
16292755|NCT02628743|39554806|FG000|Overall Study|Other|3|||
16292756|NCT02628743|39554806|FG000|Overall Study|Withdrawal by Subject|50|||
16292757|NCT02628743|39554806|FG000|Overall Study|Study Terminated by Sponsor|76|||
16292758|NCT02628743|39554806|FG000|Overall Study|Physician Decision|2|||
16292759|NCT00541970|39554807|FG000|Month 7|Protocol Violation|9|||
16292760|NCT00541970|39554808|FG001|Month 7|Protocol Violation|13|||
16292761|NCT00541970|39554809|FG002|Month 7|Protocol Violation|11|||
16292762|NCT00541970|39554810|FG003|Month 7|Protocol Violation|5|||
16292763|NCT00541970|39554807|FG000|Month 12|Adverse Event|0|||
16292764|NCT00541970|39554808|FG001|Month 12|Adverse Event|1|||
16292765|NCT00541970|39554809|FG002|Month 12|Adverse Event|1|||
16292766|NCT00541970|39554810|FG003|Month 12|Adverse Event|1|||
16292767|NCT00541970|39554807|FG000|Month 12|Protocol Violation|12|||
16292768|NCT00541970|39554808|FG001|Month 12|Protocol Violation|21|||
16292769|NCT00541970|39554809|FG002|Month 12|Protocol Violation|20|||
16292770|NCT00541970|39554810|FG003|Month 12|Protocol Violation|15|||
16292771|NCT00541970|39554807|FG000|Month 18|Adverse Event|0|||
16292772|NCT00541970|39554808|FG001|Month 18|Adverse Event|1|||
16292773|NCT00541970|39554809|FG002|Month 18|Adverse Event|1|||
16292774|NCT00541970|39554810|FG003|Month 18|Adverse Event|1|||
16292775|NCT00541970|39554807|FG000|Month 18|Protocol Violation|14|||
16292776|NCT00541970|39554808|FG001|Month 18|Protocol Violation|23|||
16292777|NCT00541970|39554809|FG002|Month 18|Protocol Violation|24|||
16292778|NCT00541970|39554810|FG003|Month 18|Protocol Violation|16|||
16381466|NCT01432444|39881467|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
16292779|NCT00541970|39554807|FG000|Month 24|Adverse Event|0|||
16292780|NCT00541970|39554808|FG001|Month 24|Adverse Event|1|||
16292781|NCT00541970|39554809|FG002|Month 24|Adverse Event|1|||
16292782|NCT00541970|39554810|FG003|Month 24|Adverse Event|1|||
16292783|NCT00541970|39554807|FG000|Month 24|Protocol Violation|29|||
16381467|NCT01432444|39881468|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
16292784|NCT00541970|39554808|FG001|Month 24|Protocol Violation|31|||
16292785|NCT00541970|39554809|FG002|Month 24|Protocol Violation|31|||
16292786|NCT00541970|39554810|FG003|Month 24|Protocol Violation|21|||
16292787|NCT00541970|39554807|FG000|Month 36|Protocol Violation|61|||
16292788|NCT00541970|39554808|FG001|Month 36|Protocol Violation|66|||
16292789|NCT00541970|39554809|FG002|Month 36|Protocol Violation|66|||
16292790|NCT00541970|39554810|FG003|Month 36|Protocol Violation|60|||
16292791|NCT00541970|39554807|FG000|Month 48|Withdrawal by Subject|2|||
16292792|NCT00541970|39554808|FG001|Month 48|Withdrawal by Subject|4|||
16292793|NCT00541970|39554809|FG002|Month 48|Withdrawal by Subject|4|||
16292794|NCT00541970|39554810|FG003|Month 48|Withdrawal by Subject|2|||
16292795|NCT00541970|39554807|FG000|Month 48|Other|3|||
16381468|NCT01432444|39881466|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
16381469|NCT01432444|39881467|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
16381470|NCT01432444|39881468|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
16381471|NCT01432444|39881466|FG000|Treatment Phase|Lost to Follow-up|0|||
16292796|NCT00541970|39554808|FG001|Month 48|Other|1|||
16292797|NCT00541970|39554809|FG002|Month 48|Other|1|||
16292798|NCT00541970|39554810|FG003|Month 48|Other|0|||
16292799|NCT00541970|39554807|FG000|Month 48|Lost to Follow-up|66|||
16292800|NCT00541970|39554808|FG001|Month 48|Lost to Follow-up|68|||
16292801|NCT00541970|39554809|FG002|Month 48|Lost to Follow-up|68|||
16292802|NCT00541970|39554810|FG003|Month 48|Lost to Follow-up|73|||
16292803|NCT00541970|39554807|FG000|Month 60|Protocol Violation|78|||
16292804|NCT00541970|39554808|FG001|Month 60|Protocol Violation|77|||
16292805|NCT00541970|39554809|FG002|Month 60|Protocol Violation|82|||
16292806|NCT00541970|39554810|FG003|Month 60|Protocol Violation|72|||
16292807|NCT03247517|39554811|FG000|Overall Study|Adverse Event|0|||
16292808|NCT03247517|39554812|FG001|Overall Study|Adverse Event|4|||
16292809|NCT03247517|39554813|FG002|Overall Study|Adverse Event|2|||
16292810|NCT03247517|39554811|FG000|Overall Study|Lost to Follow-up|2|||
16292811|NCT03247517|39554812|FG001|Overall Study|Lost to Follow-up|6|||
16292812|NCT03247517|39554813|FG002|Overall Study|Lost to Follow-up|4|||
16292813|NCT03247517|39554811|FG000|Overall Study|Consent withdrawn by caregiver|1|||
16292814|NCT03247517|39554812|FG001|Overall Study|Consent withdrawn by caregiver|4|||
16292815|NCT03247517|39554813|FG002|Overall Study|Consent withdrawn by caregiver|7|||
16292816|NCT03247517|39554811|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
16292817|NCT03247517|39554812|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
16292818|NCT03247517|39554813|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
16292819|NCT03247517|39554811|FG000|Overall Study|Protocol Violation|0|||
16292820|NCT03247517|39554812|FG001|Overall Study|Protocol Violation|2|||
16292821|NCT03247517|39554813|FG002|Overall Study|Protocol Violation|0|||
16292822|NCT03247517|39554811|FG000|Overall Study|Multiple reasons|3|||
16292823|NCT03247517|39554812|FG001|Overall Study|Multiple reasons|1|||
16292824|NCT03247517|39554813|FG002|Overall Study|Multiple reasons|0|||
16292825|NCT01570283|39554814|FG000|Cohort 1: Dose Level 1|Death|0|||
16292826|NCT01570283|39554815|FG001|Cohort 1: Dose Level 1|Death|1|||
16292827|NCT01570283|39554816|FG002|Cohort 1: Dose Level 1|Death|0|||
16292828|NCT01570283|39554817|FG003|Cohort 1: Dose Level 1|Death|0|||
16292829|NCT01570283|39554818|FG004|Cohort 1: Dose Level 1|Death|0|||
16292830|NCT01570283|39554819|FG005|Cohort 1: Dose Level 1|Death|0|||
16292831|NCT01570283|39554814|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
16292832|NCT01570283|39554815|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
16292833|NCT01570283|39554816|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
16292834|NCT01570283|39554817|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
16292835|NCT01570283|39554818|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
16292836|NCT01570283|39554819|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
16292837|NCT01570283|39554814|FG000|Cohort 2: Dose Level 2|Death|0|||
16292838|NCT01570283|39554815|FG001|Cohort 2: Dose Level 2|Death|0|||
16292839|NCT01570283|39554816|FG002|Cohort 2: Dose Level 2|Death|1|||
16292840|NCT01570283|39554817|FG003|Cohort 2: Dose Level 2|Death|0|||
16292841|NCT01570283|39554818|FG004|Cohort 2: Dose Level 2|Death|0|||
16292842|NCT01570283|39554819|FG005|Cohort 2: Dose Level 2|Death|0|||
16292843|NCT01570283|39554814|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
16292844|NCT01570283|39554815|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
16292845|NCT01570283|39554816|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
16292846|NCT01570283|39554817|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
16292847|NCT01570283|39554818|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
16292848|NCT01570283|39554819|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
16292849|NCT01570283|39554814|FG000|Cohort 3: Dose Level 3|Death|0|||
16292850|NCT01570283|39554815|FG001|Cohort 3: Dose Level 3|Death|0|||
16292851|NCT01570283|39554816|FG002|Cohort 3: Dose Level 3|Death|0|||
16292852|NCT01570283|39554817|FG003|Cohort 3: Dose Level 3|Death|0|||
16381472|NCT01432444|39881467|FG001|Treatment Phase|Lost to Follow-up|33|||
16381473|NCT01432444|39881468|FG002|Treatment Phase|Lost to Follow-up|0|||
16381474|NCT01432444|39881466|FG000|Treatment Phase|Adverse Event|0|||
16292853|NCT01570283|39554818|FG004|Cohort 3: Dose Level 3|Death|0|||
16292854|NCT01570283|39554819|FG005|Cohort 3: Dose Level 3|Death|1|||
16292855|NCT01570283|39554814|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
16292856|NCT01570283|39554815|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
16292857|NCT01570283|39554816|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
16292858|NCT01570283|39554817|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
16292859|NCT01570283|39554818|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
16292860|NCT01570283|39554819|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
16292861|NCT04614246|39554820|FG000|Overall Study|Adverse Event|0|||
16292862|NCT04614246|39554821|FG001|Overall Study|Adverse Event|1|||
16292863|NCT04614246|39554822|FG002|Overall Study|Adverse Event|1|||
16292864|NCT04614246|39554823|FG003|Overall Study|Adverse Event|2|||
16381475|NCT01432444|39881467|FG001|Treatment Phase|Adverse Event|37|||
16381476|NCT01432444|39881468|FG002|Treatment Phase|Adverse Event|0|||
16381477|NCT01432444|39881466|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
16381478|NCT01432444|39881467|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
16381479|NCT01432444|39881468|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
16381480|NCT01432444|39881466|FG000|Treatment Phase|Physician Decision|0|||
16381481|NCT01432444|39881467|FG001|Treatment Phase|Physician Decision|5|||
16381482|NCT01432444|39881468|FG002|Treatment Phase|Physician Decision|0|||
16381483|NCT01432444|39881466|FG000|Treatment Phase|Withdrawal by Subject|0|||
16381484|NCT01432444|39881467|FG001|Treatment Phase|Withdrawal by Subject|41|||
16381485|NCT01432444|39881468|FG002|Treatment Phase|Withdrawal by Subject|0|||
16381486|NCT01432444|39881466|FG000|Treatment Phase|Protocol Deviation|0|||
16381487|NCT01432444|39881467|FG001|Treatment Phase|Protocol Deviation|3|||
16381488|NCT01432444|39881468|FG002|Treatment Phase|Protocol Deviation|0|||
16381489|NCT01432444|39881466|FG000|Treatment Phase|Lack of Efficacy|0|||
16381490|NCT01432444|39881467|FG001|Treatment Phase|Lack of Efficacy|10|||
16381491|NCT01432444|39881468|FG002|Treatment Phase|Lack of Efficacy|0|||
16381492|NCT01432444|39881466|FG000|Extension Phase|Lost to Follow-up|0|||
16381493|NCT01432444|39881467|FG001|Extension Phase|Lost to Follow-up|0|||
16381494|NCT01432444|39881468|FG002|Extension Phase|Lost to Follow-up|17|||
16381495|NCT01432444|39881466|FG000|Extension Phase|Adverse Event|0|||
16381496|NCT01432444|39881467|FG001|Extension Phase|Adverse Event|0|||
16381497|NCT01432444|39881468|FG002|Extension Phase|Adverse Event|10|||
16381498|NCT01432444|39881466|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
16381499|NCT01432444|39881467|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
16381500|NCT01432444|39881468|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
16381501|NCT01432444|39881466|FG000|Extension Phase|Met Withdrawal Criteria|0|||
16381502|NCT01432444|39881467|FG001|Extension Phase|Met Withdrawal Criteria|0|||
16381503|NCT01432444|39881468|FG002|Extension Phase|Met Withdrawal Criteria|144|||
16381504|NCT01432444|39881466|FG000|Extension Phase|Physician Decision|0|||
16381505|NCT01432444|39881467|FG001|Extension Phase|Physician Decision|0|||
16381506|NCT01432444|39881468|FG002|Extension Phase|Physician Decision|1|||
16381507|NCT01432444|39881466|FG000|Extension Phase|Withdrawal by Subject|0|||
16081423|NCT00840177|38792612|FG001|Overall Study|Did not start treatment|0|||
16081424|NCT00840177|38792613|FG002|Overall Study|Did not start treatment|1|||
16081425|NCT00792636|38792616|FG000|Overall Study|Protocol Violation|17|||
16081426|NCT00792636|38792617|FG001|Overall Study|Protocol Violation|23|||
16081427|NCT00792636|38792618|FG002|Overall Study|Protocol Violation|20|||
16081428|NCT00792636|38792616|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
16081429|NCT00792636|38792617|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
16081430|NCT00792636|38792618|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
16081431|NCT00792636|38792616|FG000|Overall Study|Lost to Follow-up|13|||
16081432|NCT00792636|38792617|FG001|Overall Study|Lost to Follow-up|19|||
16081433|NCT00792636|38792618|FG002|Overall Study|Lost to Follow-up|14|||
16081434|NCT00792636|38792616|FG000|Overall Study|Withdrew Consent|10|||
16081435|NCT00792636|38792617|FG001|Overall Study|Withdrew Consent|13|||
16081436|NCT00792636|38792618|FG002|Overall Study|Withdrew Consent|9|||
16081437|NCT00792636|38792616|FG000|Overall Study|Lack of Efficacy|3|||
16081438|NCT00792636|38792617|FG001|Overall Study|Lack of Efficacy|4|||
16081439|NCT00792636|38792618|FG002|Overall Study|Lack of Efficacy|13|||
16081440|NCT00792636|38792616|FG000|Overall Study|Adverse Event|4|||
16081441|NCT00792636|38792617|FG001|Overall Study|Adverse Event|2|||
16081442|NCT00792636|38792618|FG002|Overall Study|Adverse Event|3|||
16081443|NCT00792636|38792616|FG000|Overall Study|Investigator Discretion|2|||
16081444|NCT00792636|38792617|FG001|Overall Study|Investigator Discretion|0|||
16292865|NCT04614246|39554824|FG004|Overall Study|Adverse Event|1|||
16292866|NCT04614246|39554820|FG000|Overall Study|Lost to Follow-up|0|||
16292867|NCT04614246|39554821|FG001|Overall Study|Lost to Follow-up|1|||
16292868|NCT04614246|39554822|FG002|Overall Study|Lost to Follow-up|0|||
16292869|NCT04614246|39554823|FG003|Overall Study|Lost to Follow-up|1|||
16292870|NCT04614246|39554824|FG004|Overall Study|Lost to Follow-up|3|||
16292871|NCT04614246|39554820|FG000|Overall Study|Other reason|0|||
16292872|NCT04614246|39554821|FG001|Overall Study|Other reason|1|||
16292873|NCT04614246|39554822|FG002|Overall Study|Other reason|2|||
16292874|NCT04614246|39554823|FG003|Overall Study|Other reason|0|||
16292875|NCT04614246|39554824|FG004|Overall Study|Other reason|0|||
16292876|NCT04614246|39554820|FG000|Overall Study|Withdrawal by Subject|4|||
16292877|NCT04614246|39554821|FG001|Overall Study|Withdrawal by Subject|2|||
16381508|NCT01432444|39881467|FG001|Extension Phase|Withdrawal by Subject|0|||
16081445|NCT00792636|38792618|FG002|Overall Study|Investigator Discretion|2|||
16081446|NCT04638816|38792621|FG000|Overall Study|Withdrawal by Subject|0|||
16081447|NCT04638816|38792622|FG001|Overall Study|Withdrawal by Subject|1|||
16081448|NCT04638816|38792621|FG000|Overall Study|Lost to Follow-up|0|||
16081449|NCT04638816|38792622|FG001|Overall Study|Lost to Follow-up|1|||
16081450|NCT02006758|38792623|FG000|Overall Study|Protocol Violation|1|||
16292878|NCT04614246|39554822|FG002|Overall Study|Withdrawal by Subject|4|||
16292879|NCT04614246|39554823|FG003|Overall Study|Withdrawal by Subject|3|||
16081451|NCT02006758|38792623|FG000|Overall Study|Death|1|||
16081452|NCT02006758|38792623|FG000|Overall Study|Lost to Follow-up|4|||
16484119|NCT01558739|40248789|FG000|Overall Study|Withdrawal by Subject|2|||
16484120|NCT01558739|40248789|FG000|Overall Study|Death|3|||
16484121|NCT01558739|40248789|FG000|Overall Study|Disease Progression|4|||
16484122|NCT01558739|40248789|FG000|Overall Study|Protocol Violation|1|||
16484123|NCT00261807|40248790|FG000|Overall Study|Lost to Follow-up|2|||
16484124|NCT00261807|40248790|FG000|Overall Study|Adverse Event|2|||
16484125|NCT00261807|40248790|FG000|Overall Study|Death|1|||
16484126|NCT00261807|40248790|FG000|Overall Study|Protocol Violation|2|||
16484127|NCT03307967|40248791|FG000|Overall Study|Lost to Follow-up|4|||
16484128|NCT02256631|40248794|FG000|Overall Study|Lost to Follow-up|1|||
16484129|NCT02256631|40248795|FG001|Overall Study|Lost to Follow-up|1|||
16484130|NCT02256631|40248796|FG002|Overall Study|Lost to Follow-up|0|||
16484131|NCT02256631|40248797|FG003|Overall Study|Lost to Follow-up|2|||
16484132|NCT02256631|40248798|FG004|Overall Study|Lost to Follow-up|0|||
16484133|NCT02256631|40248799|FG005|Overall Study|Lost to Follow-up|4|||
16484134|NCT02256631|40248800|FG006|Overall Study|Lost to Follow-up|1|||
16484135|NCT02256631|40248794|FG000|Overall Study|Withdrawal by Subject|0|||
16484136|NCT02256631|40248795|FG001|Overall Study|Withdrawal by Subject|0|||
16484137|NCT02256631|40248796|FG002|Overall Study|Withdrawal by Subject|0|||
16484138|NCT02256631|40248797|FG003|Overall Study|Withdrawal by Subject|1|||
16484139|NCT02256631|40248798|FG004|Overall Study|Withdrawal by Subject|1|||
16484140|NCT02256631|40248799|FG005|Overall Study|Withdrawal by Subject|0|||
16484141|NCT02256631|40248800|FG006|Overall Study|Withdrawal by Subject|1|||
16484142|NCT02256631|40248794|FG000|Overall Study|Unable to get to clinic|0|||
16484143|NCT02256631|40248795|FG001|Overall Study|Unable to get to clinic|2|||
16484144|NCT02256631|40248796|FG002|Overall Study|Unable to get to clinic|0|||
16484145|NCT02256631|40248797|FG003|Overall Study|Unable to get to clinic|1|||
16484146|NCT02256631|40248798|FG004|Overall Study|Unable to get to clinic|0|||
16081453|NCT02006758|38792623|FG000|Overall Study|Withdrawal by Subject|4|||
16081454|NCT02006758|38792623|FG000|Overall Study|Procedurally excluded|1|||
16081455|NCT02006758|38792623|FG000|Overall Study|Other|2|||
16484147|NCT02256631|40248799|FG005|Overall Study|Unable to get to clinic|1|||
16484148|NCT02256631|40248800|FG006|Overall Study|Unable to get to clinic|2|||
16081456|NCT01179334|38792624|FG000|Treatment Period|Adverse Event|1|||
16081457|NCT01179334|38792625|FG001|Treatment Period|Adverse Event|0|||
16081458|NCT01179334|38792624|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
16081459|NCT01179334|38792625|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
16081460|NCT01179334|38792624|FG000|Long-term Extension (LTE) Period|Death|3|||
16081461|NCT01179334|38792625|FG001|Long-term Extension (LTE) Period|Death|0|||
16081462|NCT01179334|38792624|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
16081463|NCT01179334|38792625|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
16081464|NCT02499159|38792628|FG000|Randomization|Protocol Violation|1|||
16081465|NCT02499159|38792629|FG001|Randomization|Protocol Violation|1|||
16081466|NCT02499159|38792628|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
16081467|NCT02499159|38792629|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
16081468|NCT02499159|38792628|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
16081469|NCT02499159|38792629|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
16081470|NCT02499159|38792628|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
16081471|NCT02499159|38792629|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
16081472|NCT02499159|38792628|FG000|30-Day Follow-Up Phone Call|Other|1|||
16081473|NCT02499159|38792629|FG001|30-Day Follow-Up Phone Call|Other|0|||
16081474|NCT01951170|38792630|FG000|Overall Study|Investigator decision|1|||
16081475|NCT00945321|38792631|FG000|Period 1|Adverse Event|0|||
16081476|NCT00945321|38792632|FG001|Period 1|Adverse Event|0|||
16081477|NCT00945321|38792633|FG002|Period 1|Adverse Event|0|||
16081478|NCT00945321|38792634|FG003|Period 1|Adverse Event|0|||
16081479|NCT00945321|38792635|FG004|Period 1|Adverse Event|1|||
16081480|NCT00945321|38792636|FG005|Period 1|Adverse Event|0|||
16081481|NCT00945321|38792631|FG000|Period 4|Lost to Follow-up|0|||
16081482|NCT00945321|38792632|FG001|Period 4|Lost to Follow-up|0|||
16081483|NCT00945321|38792633|FG002|Period 4|Lost to Follow-up|0|||
16081484|NCT00945321|38792634|FG003|Period 4|Lost to Follow-up|0|||
16484149|NCT02605824|40248801|FG000|Overall Study|Physician Decision|1|||
16081485|NCT00945321|38792635|FG004|Period 4|Lost to Follow-up|0|||
16484150|NCT02605824|40248802|FG001|Overall Study|Physician Decision|0|||
16081486|NCT00945321|38792636|FG005|Period 4|Lost to Follow-up|1|||
16081487|NCT02251652|38792637|FG000|Overall Study|Withdrawal by Subject|1|||
16081488|NCT01616459|38792641|FG000|Overall Study|Adverse Event|1|||
16081489|NCT01616459|38792642|FG001|Overall Study|Adverse Event|1|||
16484151|NCT03846804|40248803|FG000|Overall Study|Refused blood draw|1|||
16484152|NCT03846804|40248803|FG000|Overall Study|Protocol Violation|1|||
16484153|NCT01392443|40248806|FG000|Overall Study|Disease progression|30|||
16484154|NCT01392443|40248806|FG000|Overall Study|Adverse Event|24|||
16484155|NCT01392443|40248806|FG000|Overall Study|Death|7|||
16081490|NCT01616459|38792643|FG002|Overall Study|Adverse Event|2|||
16484156|NCT01392443|40248806|FG000|Overall Study|Withdrawal by Subject|5|||
16081491|NCT01616459|38792644|FG003|Overall Study|Adverse Event|0|||
16081492|NCT01616459|38792641|FG000|Overall Study|Lost to Follow-up|1|||
16081493|NCT01616459|38792642|FG001|Overall Study|Lost to Follow-up|11|||
16081494|NCT01616459|38792643|FG002|Overall Study|Lost to Follow-up|3|||
16081495|NCT01616459|38792644|FG003|Overall Study|Lost to Follow-up|2|||
16081496|NCT01616459|38792641|FG000|Overall Study|Protocol Violation|0|||
16081497|NCT01616459|38792642|FG001|Overall Study|Protocol Violation|0|||
16081498|NCT01616459|38792643|FG002|Overall Study|Protocol Violation|0|||
16081499|NCT01616459|38792644|FG003|Overall Study|Protocol Violation|2|||
16081500|NCT01616459|38792641|FG000|Overall Study|Withdrawal by Subject|2|||
16081501|NCT01616459|38792642|FG001|Overall Study|Withdrawal by Subject|4|||
16081502|NCT01616459|38792643|FG002|Overall Study|Withdrawal by Subject|4|||
16081503|NCT01616459|38792644|FG003|Overall Study|Withdrawal by Subject|4|||
16081504|NCT01616459|38792641|FG000|Overall Study|Other reason|0|||
16081505|NCT01616459|38792642|FG001|Overall Study|Other reason|1|||
16081506|NCT01616459|38792643|FG002|Overall Study|Other reason|1|||
16081507|NCT01616459|38792644|FG003|Overall Study|Other reason|0|||
16081508|NCT00858117|38792654|FG000|Treatment on Study|Adverse Event|2|||
16081509|NCT00858117|38792654|FG000|Follow up for 5 Years|Death|4|||
16081510|NCT00858117|38792654|FG000|Follow up for 5 Years|No further data collected for study|9|||
16081511|NCT00931710|38792669|FG000|Overall Study|Adverse Event|16|||
16081512|NCT00931710|38792670|FG001|Overall Study|Adverse Event|10|||
16081513|NCT00931710|38792669|FG000|Overall Study|Abnormal test procedure results|2|||
16081514|NCT00931710|38792670|FG001|Overall Study|Abnormal test procedure results|0|||
16081515|NCT00931710|38792669|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
16081516|NCT00931710|38792670|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
16081517|NCT00931710|38792669|FG000|Overall Study|Patient withdrew consent|4|||
16081518|NCT00931710|38792670|FG001|Overall Study|Patient withdrew consent|9|||
16081519|NCT00931710|38792669|FG000|Overall Study|Lost to Follow-up|6|||
16081520|NCT00931710|38792670|FG001|Overall Study|Lost to Follow-up|5|||
16081521|NCT00931710|38792669|FG000|Overall Study|Protocol deviation|1|||
16081522|NCT00931710|38792670|FG001|Overall Study|Protocol deviation|2|||
16081523|NCT02754596|38792675|FG000|Overall Study|Withdrawal by Subject|3|||
16081524|NCT02754596|38792676|FG001|Overall Study|Withdrawal by Subject|4|||
16081525|NCT02754596|38792677|FG002|Overall Study|Withdrawal by Subject|0|||
16081526|NCT02754596|38792675|FG000|Overall Study|Physician Decision|1|||
16081527|NCT02754596|38792676|FG001|Overall Study|Physician Decision|1|||
16081528|NCT02754596|38792677|FG002|Overall Study|Physician Decision|1|||
16081529|NCT02754596|38792675|FG000|Overall Study|Lost to Follow-up|1|||
16081530|NCT02754596|38792676|FG001|Overall Study|Lost to Follow-up|1|||
16081531|NCT02754596|38792677|FG002|Overall Study|Lost to Follow-up|2|||
16081532|NCT02754596|38792675|FG000|Overall Study|Death|0|||
16081533|NCT02754596|38792676|FG001|Overall Study|Death|2|||
16081534|NCT02754596|38792677|FG002|Overall Study|Death|0|||
16081535|NCT02754596|38792675|FG000|Overall Study|Adverse Event|1|||
16081536|NCT02754596|38792676|FG001|Overall Study|Adverse Event|0|||
16081537|NCT02754596|38792677|FG002|Overall Study|Adverse Event|1|||
16081538|NCT02754596|38792675|FG000|Overall Study|Other|1|||
16081539|NCT02754596|38792676|FG001|Overall Study|Other|0|||
16081540|NCT02754596|38792677|FG002|Overall Study|Other|0|||
16081541|NCT00093496|38792678|FG000|Overall Study|Protocol Violation|1|||
16081542|NCT00093496|38792679|FG001|Overall Study|Protocol Violation|3|||
16081543|NCT02392234|38792680|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
16081544|NCT02392234|38792681|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
16081545|NCT02392234|38792682|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
16081546|NCT02392234|38792683|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
16187187|NCT01097616|39162010|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
16187188|NCT01097616|39162011|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
16187189|NCT01097616|39162012|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
16187190|NCT01097616|39162005|FG000|Optional DB EXT Phase|Protocol Violation|0|||
16187191|NCT01097616|39162006|FG001|Optional DB EXT Phase|Protocol Violation|2|||
16292880|NCT04614246|39554824|FG004|Overall Study|Withdrawal by Subject|4|||
16292881|NCT04614246|39554820|FG000|Overall Study|Physician Decision|0|||
16081547|NCT02392234|38792684|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
16081548|NCT02392234|38792685|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
16081549|NCT02392234|38792680|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
16081550|NCT02392234|38792681|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
16081551|NCT02392234|38792682|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
16081552|NCT02392234|38792683|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
16081553|NCT02392234|38792684|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
16081554|NCT02392234|38792685|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
16081555|NCT02392234|38792680|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
16081556|NCT02392234|38792681|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
16081557|NCT02392234|38792682|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
16081558|NCT02392234|38792683|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
16187192|NCT01097616|39162007|FG002|Optional DB EXT Phase|Protocol Violation|3|||
16187193|NCT01097616|39162008|FG003|Optional DB EXT Phase|Protocol Violation|0|||
16187194|NCT01097616|39162009|FG004|Optional DB EXT Phase|Protocol Violation|0|||
16187195|NCT01097616|39162010|FG005|Optional DB EXT Phase|Protocol Violation|0|||
16187196|NCT01097616|39162011|FG006|Optional DB EXT Phase|Protocol Violation|0|||
16187197|NCT01097616|39162012|FG007|Optional DB EXT Phase|Protocol Violation|0|||
16187198|NCT01097616|39162005|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
16187199|NCT01097616|39162006|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
16187200|NCT01097616|39162007|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
16187201|NCT01097616|39162008|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
16187202|NCT01097616|39162009|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
16187203|NCT01097616|39162010|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
16187204|NCT01097616|39162011|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
16187205|NCT01097616|39162012|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
16187206|NCT01097616|39162005|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
16187207|NCT01097616|39162006|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
16187208|NCT01097616|39162007|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
16187209|NCT01097616|39162008|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
16187210|NCT01097616|39162009|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
16187211|NCT01097616|39162010|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
16187212|NCT01097616|39162011|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
16187213|NCT01097616|39162012|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
16187214|NCT01097616|39162005|FG000|Optional DB EXT Phase|Physician Decision|1|||
16187215|NCT01097616|39162006|FG001|Optional DB EXT Phase|Physician Decision|0|||
16187216|NCT01097616|39162007|FG002|Optional DB EXT Phase|Physician Decision|0|||
16187217|NCT01097616|39162008|FG003|Optional DB EXT Phase|Physician Decision|0|||
16187218|NCT01097616|39162009|FG004|Optional DB EXT Phase|Physician Decision|0|||
16187219|NCT01097616|39162010|FG005|Optional DB EXT Phase|Physician Decision|0|||
16187220|NCT01097616|39162011|FG006|Optional DB EXT Phase|Physician Decision|0|||
16187221|NCT01097616|39162012|FG007|Optional DB EXT Phase|Physician Decision|0|||
16187222|NCT01097616|39162005|FG000|DB RO Phase|Adverse Event|0|||
16187223|NCT01097616|39162006|FG001|DB RO Phase|Adverse Event|0|||
16187224|NCT01097616|39162007|FG002|DB RO Phase|Adverse Event|0|||
16187225|NCT01097616|39162008|FG003|DB RO Phase|Adverse Event|0|||
16187226|NCT01097616|39162009|FG004|DB RO Phase|Adverse Event|0|||
16187227|NCT01097616|39162010|FG005|DB RO Phase|Adverse Event|0|||
16187228|NCT01097616|39162011|FG006|DB RO Phase|Adverse Event|1|||
16187229|NCT01097616|39162012|FG007|DB RO Phase|Adverse Event|0|||
16187230|NCT01097616|39162005|FG000|DB RO Phase|Withdrawal by Subject|0|||
16187231|NCT01097616|39162006|FG001|DB RO Phase|Withdrawal by Subject|0|||
16187232|NCT01097616|39162007|FG002|DB RO Phase|Withdrawal by Subject|0|||
16187233|NCT01097616|39162008|FG003|DB RO Phase|Withdrawal by Subject|0|||
16187234|NCT01097616|39162009|FG004|DB RO Phase|Withdrawal by Subject|0|||
16187235|NCT01097616|39162010|FG005|DB RO Phase|Withdrawal by Subject|1|||
16187236|NCT01097616|39162011|FG006|DB RO Phase|Withdrawal by Subject|0|||
16187237|NCT01097616|39162012|FG007|DB RO Phase|Withdrawal by Subject|0|||
16187238|NCT01097616|39162005|FG000|DB RO Phase|Lost to Follow-up|0|||
16187239|NCT01097616|39162006|FG001|DB RO Phase|Lost to Follow-up|0|||
16187240|NCT01097616|39162007|FG002|DB RO Phase|Lost to Follow-up|0|||
16187241|NCT01097616|39162008|FG003|DB RO Phase|Lost to Follow-up|1|||
16187242|NCT01097616|39162009|FG004|DB RO Phase|Lost to Follow-up|1|||
16187243|NCT01097616|39162010|FG005|DB RO Phase|Lost to Follow-up|0|||
16187244|NCT01097616|39162011|FG006|DB RO Phase|Lost to Follow-up|0|||
16187245|NCT01097616|39162012|FG007|DB RO Phase|Lost to Follow-up|1|||
16187246|NCT01097616|39162005|FG000|DB RO Phase|Not Treated in RO|0|||
16187247|NCT01097616|39162006|FG001|DB RO Phase|Not Treated in RO|0|||
16187248|NCT01097616|39162007|FG002|DB RO Phase|Not Treated in RO|0|||
16187249|NCT01097616|39162008|FG003|DB RO Phase|Not Treated in RO|0|||
16187250|NCT01097616|39162009|FG004|DB RO Phase|Not Treated in RO|0|||
16187251|NCT01097616|39162010|FG005|DB RO Phase|Not Treated in RO|1|||
16187252|NCT01097616|39162011|FG006|DB RO Phase|Not Treated in RO|0|||
16187253|NCT01097616|39162012|FG007|DB RO Phase|Not Treated in RO|0|||
16187254|NCT02775864|39162015|FG000|Overall Study|Data ended end of 2010|1764|||
16187255|NCT02775864|39162016|FG001|Overall Study|Data ended end of 2010|2880|||
16187256|NCT02775864|39162017|FG002|Overall Study|Data ended end of 2010|1140|||
16187257|NCT02775864|39162018|FG003|Overall Study|Data ended end of 2010|1194|||
16187258|NCT02775864|39162015|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
16381509|NCT01432444|39881468|FG002|Extension Phase|Withdrawal by Subject|13|||
16381510|NCT03801525|39881471|FG000|Overall Study|Adverse Event|17|||
16187259|NCT02775864|39162016|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
16187260|NCT02775864|39162017|FG002|Overall Study|Medicaid eligibility discontinued|720|||
16187261|NCT02775864|39162018|FG003|Overall Study|Medicaid eligibility discontinued|890|||
16187262|NCT03807739|39162019|FG000|Overall Study|Adverse Event|1|||
16381511|NCT03801525|39881472|FG001|Overall Study|Adverse Event|1|||
16187263|NCT03807739|39162020|FG001|Overall Study|Adverse Event|0|||
16187264|NCT03807739|39162021|FG002|Overall Study|Adverse Event|0|||
16187265|NCT03807739|39162022|FG003|Overall Study|Adverse Event|0|||
16187266|NCT03807739|39162019|FG000|Overall Study|Withdrawal by Subject|1|||
16187267|NCT03807739|39162020|FG001|Overall Study|Withdrawal by Subject|0|||
16187268|NCT03807739|39162021|FG002|Overall Study|Withdrawal by Subject|0|||
16187269|NCT03807739|39162022|FG003|Overall Study|Withdrawal by Subject|0|||
16187270|NCT01996319|39162023|FG000|Overall Study|Protocol Violation|1|||
16187271|NCT01996319|39162024|FG001|Overall Study|Protocol Violation|0|||
16187272|NCT01996319|39162023|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
16187273|NCT01996319|39162024|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
16187274|NCT01996319|39162023|FG000|Overall Study|Adverse Event|2|||
16187275|NCT01996319|39162024|FG001|Overall Study|Adverse Event|2|||
16187276|NCT01118143|39162031|FG000|Overall Study|Withdrawal by Subject|2|||
16187277|NCT01118143|39162032|FG001|Overall Study|Withdrawal by Subject|5|||
16187278|NCT00224107|39162033|FG000|Overall Study|Adverse Event|20|||
16187279|NCT00224107|39162034|FG001|Overall Study|Adverse Event|6|||
16187280|NCT00224107|39162033|FG000|Overall Study|Protocol Violation|2|||
16187281|NCT00224107|39162034|FG001|Overall Study|Protocol Violation|3|||
16187282|NCT00224107|39162033|FG000|Overall Study|Withdrawal by Subject|1|||
16187283|NCT00224107|39162034|FG001|Overall Study|Withdrawal by Subject|4|||
16187284|NCT00224107|39162033|FG000|Overall Study|Lack of Efficacy|2|||
16187285|NCT00224107|39162034|FG001|Overall Study|Lack of Efficacy|0|||
16187286|NCT00224107|39162033|FG000|Overall Study|Lost to Follow-up|4|||
16187287|NCT00224107|39162034|FG001|Overall Study|Lost to Follow-up|0|||
16187288|NCT00224107|39162033|FG000|Overall Study|Physician Decision|1|||
16187289|NCT00224107|39162034|FG001|Overall Study|Physician Decision|0|||
16187290|NCT00224107|39162033|FG000|Overall Study|Other|1|||
16187291|NCT00224107|39162034|FG001|Overall Study|Other|1|||
16187292|NCT00935220|39162035|FG000|Overall Study|Adverse Event|1|||
16187293|NCT00935220|39162035|FG000|Overall Study|Other reason (not specified)|1|||
16187294|NCT01971476|39162036|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
16187295|NCT01971476|39162037|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
16187296|NCT01971476|39162038|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
16187297|NCT01971476|39162036|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
16187298|NCT01971476|39162037|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
16187299|NCT01971476|39162038|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
16187300|NCT01971476|39162036|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
16187301|NCT01971476|39162037|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
16187302|NCT01971476|39162038|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
16187303|NCT01713036|39162040|FG000|Overall Study|Death|1|||
16187304|NCT02345434|39162042|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
16187305|NCT02345434|39162043|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
16187306|NCT01617681|39162044|FG000|Period 1 Double Blind|Adverse Event|2|||
16187307|NCT01617681|39162045|FG001|Period 1 Double Blind|Adverse Event|0|||
16187308|NCT01617681|39162046|FG002|Period 1 Double Blind|Adverse Event|0|||
16187309|NCT01617681|39162047|FG003|Period 1 Double Blind|Adverse Event|2|||
16187310|NCT01617681|39162048|FG004|Period 1 Double Blind|Adverse Event|0|||
16187311|NCT01617681|39162044|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
16187312|NCT01617681|39162045|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
16187313|NCT01617681|39162046|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
16187314|NCT01617681|39162047|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
16187315|NCT01617681|39162048|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
16187316|NCT01617681|39162044|FG000|Period 2 Open Label|Adverse Event|0|||
16187317|NCT01617681|39162045|FG001|Period 2 Open Label|Adverse Event|0|||
16187318|NCT01617681|39162046|FG002|Period 2 Open Label|Adverse Event|0|||
16187319|NCT01617681|39162047|FG003|Period 2 Open Label|Adverse Event|0|||
16187320|NCT01617681|39162048|FG004|Period 2 Open Label|Adverse Event|3|||
16187321|NCT01617681|39162044|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
16187322|NCT01617681|39162045|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
16187323|NCT01617681|39162046|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
16187324|NCT01617681|39162047|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
16187325|NCT01617681|39162048|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
16187326|NCT00592358|39162049|FG000|Overall Study|Withdrawal by Subject|2|||
16381512|NCT03801525|39881473|FG002|Overall Study|Adverse Event|0|||
16187327|NCT00592358|39162049|FG000|Overall Study|Adverse Event|1|||
16187328|NCT00592358|39162049|FG000|Overall Study|Lack of Efficacy|2|||
16187329|NCT00592358|39162049|FG000|Overall Study|Inability to swallow pills|1|||
16187330|NCT02538666|39162052|FG000|Pre-Treatment|Disease progression|1|||
16187331|NCT02538666|39162053|FG001|Pre-Treatment|Disease progression|0|||
16187332|NCT02538666|39162054|FG002|Pre-Treatment|Disease progression|0|||
16187333|NCT02538666|39162052|FG000|Pre-Treatment|no longer meets study criteria|1|||
16187334|NCT02538666|39162053|FG001|Pre-Treatment|no longer meets study criteria|0|||
16187335|NCT02538666|39162054|FG002|Pre-Treatment|no longer meets study criteria|0|||
16187336|NCT02538666|39162052|FG000|Pre-Treatment|Withdrew Consent|0|||
16187337|NCT02538666|39162053|FG001|Pre-Treatment|Withdrew Consent|1|||
16187338|NCT02538666|39162054|FG002|Pre-Treatment|Withdrew Consent|1|||
16187339|NCT02538666|39162052|FG000|Treatment|Disease progression|270|||
16187340|NCT02538666|39162053|FG001|Treatment|Disease progression|227|||
16187341|NCT02538666|39162054|FG002|Treatment|Disease progression|165|||
16381513|NCT03801525|39881471|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
16187342|NCT02538666|39162052|FG000|Treatment|Study drug toxicity|1|||
16187343|NCT02538666|39162053|FG001|Treatment|Study drug toxicity|29|||
16187344|NCT02538666|39162054|FG002|Treatment|Study drug toxicity|92|||
16187345|NCT02538666|39162052|FG000|Treatment|Death|0|||
16187346|NCT02538666|39162053|FG001|Treatment|Death|2|||
16187347|NCT02538666|39162054|FG002|Treatment|Death|3|||
16187348|NCT02538666|39162052|FG000|Treatment|Adverse event unrelated to study drug|8|||
16292882|NCT04614246|39554821|FG001|Overall Study|Physician Decision|2|||
16292883|NCT04614246|39554822|FG002|Overall Study|Physician Decision|1|||
16292884|NCT04614246|39554823|FG003|Overall Study|Physician Decision|0|||
16292885|NCT04614246|39554824|FG004|Overall Study|Physician Decision|0|||
16292886|NCT04614246|39554820|FG000|Overall Study|Study terminated by sponsor|10|||
16292887|NCT04614246|39554821|FG001|Overall Study|Study terminated by sponsor|15|||
16292888|NCT04614246|39554822|FG002|Overall Study|Study terminated by sponsor|12|||
16292889|NCT04614246|39554823|FG003|Overall Study|Study terminated by sponsor|13|||
16292890|NCT04614246|39554824|FG004|Overall Study|Study terminated by sponsor|9|||
16292891|NCT04614246|39554820|FG000|Overall Study|Pregnancy|2|||
16292892|NCT04614246|39554821|FG001|Overall Study|Pregnancy|0|||
16292893|NCT04614246|39554822|FG002|Overall Study|Pregnancy|1|||
16381514|NCT03801525|39881472|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
16381515|NCT03801525|39881473|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
16381516|NCT03801525|39881471|FG000|Overall Study|Death|29|||
16381517|NCT03801525|39881472|FG001|Overall Study|Death|1|||
16381518|NCT03801525|39881473|FG002|Overall Study|Death|4|||
16381519|NCT03801525|39881471|FG000|Overall Study|Disease Progression|6|||
16292894|NCT04614246|39554823|FG003|Overall Study|Pregnancy|0|||
16292895|NCT04614246|39554824|FG004|Overall Study|Pregnancy|0|||
16292896|NCT02238626|39554825|FG000|Overall Study|Adverse Event|3|||
16381520|NCT03801525|39881472|FG001|Overall Study|Disease Progression|0|||
16381521|NCT03801525|39881473|FG002|Overall Study|Disease Progression|1|||
16381522|NCT03801525|39881471|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
16381523|NCT03801525|39881472|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
16381524|NCT03801525|39881473|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
16381525|NCT03801525|39881471|FG000|Overall Study|Investigator Decision|18|||
16381526|NCT03801525|39881472|FG001|Overall Study|Investigator Decision|1|||
16381527|NCT03801525|39881473|FG002|Overall Study|Investigator Decision|0|||
16381528|NCT03801525|39881471|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
16381529|NCT03801525|39881472|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
16381530|NCT03801525|39881473|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
16381531|NCT03801525|39881471|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
16381532|NCT03801525|39881472|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
16381533|NCT03801525|39881473|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
16381534|NCT03801525|39881471|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
16381535|NCT03801525|39881472|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
16381536|NCT03801525|39881473|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
16381537|NCT03801525|39881471|FG000|Overall Study|Withdrawal of Subject Consent|38|||
16381538|NCT03801525|39881472|FG001|Overall Study|Withdrawal of Subject Consent|2|||
16381539|NCT03801525|39881473|FG002|Overall Study|Withdrawal of Subject Consent|1|||
16381540|NCT03801525|39881471|FG000|Overall Study|Reason not Specified|4|||
16381541|NCT03801525|39881472|FG001|Overall Study|Reason not Specified|0|||
16381542|NCT03801525|39881473|FG002|Overall Study|Reason not Specified|4|||
16381543|NCT01537432|39881476|FG000|Overall Study|Lost to Follow-up|3|||
16381544|NCT01537432|39881477|FG001|Overall Study|Lost to Follow-up|1|||
16381545|NCT01537432|39881476|FG000|Overall Study|Withdrawal by Subject|0|||
16381546|NCT01537432|39881477|FG001|Overall Study|Withdrawal by Subject|1|||
16381547|NCT01537432|39881476|FG000|Overall Study|Administrative problems|1|||
16381548|NCT01537432|39881477|FG001|Overall Study|Administrative problems|0|||
16381549|NCT01537432|39881476|FG000|Overall Study|Adverse Event|1|||
16381550|NCT01537432|39881477|FG001|Overall Study|Adverse Event|0|||
16381551|NCT01537432|39881476|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16381552|NCT01537432|39881477|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16381553|NCT00347269|39881486|FG000|Overall Study|Lost to Follow-up|74|||
16187349|NCT02538666|39162053|FG001|Treatment|Adverse event unrelated to study drug|10|||
16292897|NCT02238626|39554826|FG001|Overall Study|Adverse Event|5|||
16292898|NCT02238626|39554827|FG002|Overall Study|Adverse Event|0|||
16292899|NCT02238626|39554828|FG003|Overall Study|Adverse Event|3|||
16292900|NCT02238626|39554825|FG000|Overall Study|Lost to Follow-up|2|||
16292901|NCT02238626|39554826|FG001|Overall Study|Lost to Follow-up|4|||
16292902|NCT02238626|39554827|FG002|Overall Study|Lost to Follow-up|2|||
16187350|NCT02538666|39162054|FG002|Treatment|Adverse event unrelated to study drug|15|||
16187351|NCT02538666|39162052|FG000|Treatment|Participant request to discontinue study treatment|3|||
16292903|NCT02238626|39554828|FG003|Overall Study|Lost to Follow-up|2|||
16292904|NCT02238626|39554825|FG000|Overall Study|Withdrawal by Subject|0|||
16292905|NCT02238626|39554826|FG001|Overall Study|Withdrawal by Subject|3|||
16381554|NCT00347269|39881487|FG001|Overall Study|Lost to Follow-up|65|||
16381555|NCT00347269|39881486|FG000|Overall Study|Withdrawal by Subject|18|||
16381556|NCT00347269|39881487|FG001|Overall Study|Withdrawal by Subject|38|||
16381557|NCT00347269|39881486|FG000|Overall Study|Death|2|||
16381558|NCT00347269|39881487|FG001|Overall Study|Death|3|||
16381559|NCT04507204|39881488|FG000|Overall Study|Adverse Event|8|||
16381560|NCT04507204|39881489|FG001|Overall Study|Adverse Event|13|||
16381561|NCT04507204|39881488|FG000|Overall Study|Death|0|||
16381562|NCT04507204|39881489|FG001|Overall Study|Death|1|||
16381563|NCT04507204|39881488|FG000|Overall Study|Lost to Follow-up|15|||
16381564|NCT04507204|39881489|FG001|Overall Study|Lost to Follow-up|14|||
16381565|NCT04507204|39881488|FG000|Overall Study|Poor Compliance with Protocol|2|||
16381566|NCT04507204|39881489|FG001|Overall Study|Poor Compliance with Protocol|4|||
16381567|NCT04507204|39881488|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
16381568|NCT04507204|39881489|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
16381569|NCT04507204|39881488|FG000|Overall Study|Withdrawal of Patient Consent|21|||
16381570|NCT04507204|39881489|FG001|Overall Study|Withdrawal of Patient Consent|13|||
16381571|NCT00457626|39881496|FG000|Overall Study|Adverse Event|3|||
16381572|NCT00457626|39881496|FG000|Overall Study|Administrative Problems|2|||
16381573|NCT00457626|39881496|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
16381574|NCT01085214|39881497|FG000|Overall Study|Alternate treatment required|1|||
16381575|NCT01038323|39881498|FG000|Overall Study|Withdrawal by Subject|3|||
16381576|NCT01038323|39881499|FG001|Overall Study|Withdrawal by Subject|2|||
16381577|NCT01038323|39881500|FG002|Overall Study|Withdrawal by Subject|4|||
16381578|NCT03309202|39881503|FG000|Overall Study|Lost to Follow-up|1|||
16381579|NCT03309202|39881504|FG001|Overall Study|Lost to Follow-up|0|||
16381580|NCT03309202|39881505|FG002|Overall Study|Lost to Follow-up|0|||
16381581|NCT03309202|39881506|FG003|Overall Study|Lost to Follow-up|0|||
16381582|NCT03391882|39881512|FG000|Study Overall|Adverse Event|3|||
16381583|NCT03391882|39881513|FG001|Study Overall|Adverse Event|6|||
16381584|NCT03391882|39881514|FG002|Study Overall|Adverse Event|1|||
16381585|NCT03391882|39881515|FG003|Study Overall|Adverse Event|1|||
16381586|NCT03391882|39881516|FG004|Study Overall|Adverse Event|3|||
16381587|NCT03391882|39881517|FG005|Study Overall|Adverse Event|1|||
16381588|NCT03391882|39881512|FG000|Study Overall|Lack of Efficacy|13|||
16381589|NCT03391882|39881513|FG001|Study Overall|Lack of Efficacy|9|||
16381590|NCT03391882|39881514|FG002|Study Overall|Lack of Efficacy|0|||
16381591|NCT03391882|39881515|FG003|Study Overall|Lack of Efficacy|0|||
16381592|NCT03391882|39881516|FG004|Study Overall|Lack of Efficacy|0|||
16381593|NCT03391882|39881517|FG005|Study Overall|Lack of Efficacy|0|||
16381594|NCT03391882|39881512|FG000|Study Overall|Withdrawal by Subject|3|||
16381595|NCT03391882|39881513|FG001|Study Overall|Withdrawal by Subject|3|||
16381596|NCT03391882|39881514|FG002|Study Overall|Withdrawal by Subject|2|||
16381597|NCT03391882|39881515|FG003|Study Overall|Withdrawal by Subject|2|||
16381598|NCT03391882|39881516|FG004|Study Overall|Withdrawal by Subject|1|||
16381599|NCT03391882|39881517|FG005|Study Overall|Withdrawal by Subject|3|||
16381600|NCT03391882|39881512|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
16381601|NCT03391882|39881513|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
16381602|NCT03391882|39881514|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
16381603|NCT03391882|39881515|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
16381604|NCT03391882|39881516|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
16381605|NCT03391882|39881517|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
16381606|NCT03391882|39881512|FG000|Study Overall|Protocol Violation|1|||
16381607|NCT03391882|39881513|FG001|Study Overall|Protocol Violation|0|||
16381608|NCT03391882|39881514|FG002|Study Overall|Protocol Violation|0|||
16381609|NCT03391882|39881515|FG003|Study Overall|Protocol Violation|0|||
16381610|NCT03391882|39881516|FG004|Study Overall|Protocol Violation|0|||
16381611|NCT03391882|39881517|FG005|Study Overall|Protocol Violation|0|||
16381612|NCT03391882|39881512|FG000|Part A - Titration Phase|Adverse Event|3|||
16381613|NCT03391882|39881513|FG001|Part A - Titration Phase|Adverse Event|6|||
16381614|NCT03391882|39881514|FG002|Part A - Titration Phase|Adverse Event|0|||
16381615|NCT03391882|39881515|FG003|Part A - Titration Phase|Adverse Event|0|||
16381616|NCT03391882|39881516|FG004|Part A - Titration Phase|Adverse Event|0|||
16381617|NCT03391882|39881517|FG005|Part A - Titration Phase|Adverse Event|0|||
16381618|NCT03391882|39881512|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
16381619|NCT03391882|39881513|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
16381620|NCT03391882|39881514|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
16381621|NCT03391882|39881515|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
16381622|NCT03391882|39881516|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
16381623|NCT03391882|39881517|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
16381624|NCT03391882|39881512|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
16381625|NCT03391882|39881513|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
16381626|NCT03391882|39881514|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
16381627|NCT03391882|39881515|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
16381628|NCT03391882|39881516|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
16381629|NCT03391882|39881517|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
16381630|NCT03391882|39881512|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
16381631|NCT03391882|39881513|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
16381632|NCT03391882|39881514|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
16381633|NCT03391882|39881515|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
16381634|NCT03391882|39881516|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
16381635|NCT03391882|39881517|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
16381636|NCT03391882|39881512|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
16381637|NCT03391882|39881513|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
16381638|NCT03391882|39881514|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
16381639|NCT03391882|39881515|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
16381640|NCT03391882|39881516|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
16381641|NCT03391882|39881517|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
16381642|NCT03391882|39881512|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
16381643|NCT03391882|39881513|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
16381644|NCT03391882|39881514|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
16381645|NCT03391882|39881515|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
16381646|NCT03391882|39881516|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
16381647|NCT03391882|39881517|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
16381648|NCT03391882|39881512|FG000|Part B - Treatment Phase|Adverse Event|0|||
16381649|NCT03391882|39881513|FG001|Part B - Treatment Phase|Adverse Event|0|||
16381650|NCT03391882|39881514|FG002|Part B - Treatment Phase|Adverse Event|1|||
16381651|NCT03391882|39881515|FG003|Part B - Treatment Phase|Adverse Event|1|||
16381652|NCT03391882|39881516|FG004|Part B - Treatment Phase|Adverse Event|3|||
16381653|NCT03391882|39881517|FG005|Part B - Treatment Phase|Adverse Event|1|||
16381654|NCT03391882|39881512|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
16381655|NCT03391882|39881513|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
16381656|NCT03391882|39881514|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
16381657|NCT03391882|39881515|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
16381658|NCT03391882|39881516|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
16484157|NCT01392443|40248806|FG000|Overall Study|Lost to Follow-up|1|||
16484158|NCT01392443|40248806|FG000|Overall Study|Protocol Violation|1|||
16484159|NCT00644228|40248809|FG000|Randomization & Eligibility|Ineligible|31|||
16484160|NCT00644228|40248810|FG001|Randomization & Eligibility|Ineligible|21|||
16484161|NCT00644228|40248809|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
16484162|NCT00644228|40248810|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
16484163|NCT00644228|40248809|FG000|Randomization & Eligibility|Invalid Consent|0|||
16484164|NCT00644228|40248810|FG001|Randomization & Eligibility|Invalid Consent|1|||
16484165|NCT00644228|40248809|FG000|Induction Therapy|Adverse Event|22|||
16484166|NCT00644228|40248810|FG001|Induction Therapy|Adverse Event|55|||
16484167|NCT00644228|40248809|FG000|Induction Therapy|Withdrawal by Subject|10|||
16484168|NCT00644228|40248810|FG001|Induction Therapy|Withdrawal by Subject|3|||
16484169|NCT00644228|40248809|FG000|Induction Therapy|Progression/Relapse|24|||
16484170|NCT00644228|40248810|FG001|Induction Therapy|Progression/Relapse|12|||
16484171|NCT00644228|40248809|FG000|Induction Therapy|Death|3|||
16484172|NCT00644228|40248810|FG001|Induction Therapy|Death|7|||
16484173|NCT00644228|40248809|FG000|Induction Therapy|Not Protocol-Specified|24|||
16484174|NCT00644228|40248810|FG001|Induction Therapy|Not Protocol-Specified|28|||
16484175|NCT00644228|40248809|FG000|Maintenance|Adverse Event|27|||
16484176|NCT00644228|40248810|FG001|Maintenance|Adverse Event|31|||
16484177|NCT00644228|40248809|FG000|Maintenance|Withdrawal by Subject|6|||
16484178|NCT00644228|40248810|FG001|Maintenance|Withdrawal by Subject|4|||
16484179|NCT00644228|40248809|FG000|Maintenance|Progression/Relapse|67|||
16484180|NCT00644228|40248810|FG001|Maintenance|Progression/Relapse|42|||
16484181|NCT00644228|40248809|FG000|Maintenance|Death|3|||
16484182|NCT00644228|40248810|FG001|Maintenance|Death|3|||
16484183|NCT00644228|40248809|FG000|Maintenance|Not Protocol-Specified|14|||
16484184|NCT00644228|40248810|FG001|Maintenance|Not Protocol-Specified|15|||
16484185|NCT00644228|40248809|FG000|Maintenance|On Treatment|26|||
16484186|NCT00644228|40248810|FG001|Maintenance|On Treatment|40|||
16484187|NCT00926328|40248811|FG000|Overall Study|Lost to Follow-up|12|||
16484188|NCT00926328|40248812|FG001|Overall Study|Lost to Follow-up|14|||
16484189|NCT03600818|40248817|FG000|Overall Study|Adverse Event|4|||
16484190|NCT03600818|40248818|FG001|Overall Study|Adverse Event|7|||
16484191|NCT03600818|40248817|FG000|Overall Study|Lack of Efficacy|9|||
16484192|NCT03600818|40248818|FG001|Overall Study|Lack of Efficacy|4|||
16484193|NCT03600818|40248817|FG000|Overall Study|Withdrawal by Subject|4|||
16484194|NCT03600818|40248818|FG001|Overall Study|Withdrawal by Subject|3|||
16484195|NCT03600818|40248817|FG000|Overall Study|Other-unspecified|5|||
16484196|NCT03600818|40248818|FG001|Overall Study|Other-unspecified|3|||
16484197|NCT03600818|40248817|FG000|Overall Study|Randomized and not treated|0|||
16484198|NCT03600818|40248818|FG001|Overall Study|Randomized and not treated|1|||
16292906|NCT02238626|39554827|FG002|Overall Study|Withdrawal by Subject|0|||
16292907|NCT02238626|39554828|FG003|Overall Study|Withdrawal by Subject|1|||
16292908|NCT02238626|39554825|FG000|Overall Study|Death|0|||
16292909|NCT02238626|39554826|FG001|Overall Study|Death|0|||
16292910|NCT02238626|39554827|FG002|Overall Study|Death|1|||
16292911|NCT02238626|39554828|FG003|Overall Study|Death|1|||
16292912|NCT02238626|39554825|FG000|Overall Study|Other|0|||
16484199|NCT03469934|40248820|FG000|Overall Study|Withdrawal by Subject|0|||
16484200|NCT03469934|40248821|FG001|Overall Study|Withdrawal by Subject|1|||
16484201|NCT03715530|40248822|FG000|Overall Study|Lost to Follow-up|3|||
16484202|NCT03715530|40248823|FG001|Overall Study|Lost to Follow-up|1|||
16381659|NCT03391882|39881517|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
16381660|NCT00836706|39881518|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
16381661|NCT00836706|39881519|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
16381662|NCT04064905|39881520|FG000|Overall Study|Lost to Follow-up|0|||
16381663|NCT04064905|39881521|FG001|Overall Study|Lost to Follow-up|3|||
16381664|NCT04064905|39881522|FG002|Overall Study|Lost to Follow-up|1|||
16381665|NCT04064905|39881523|FG003|Overall Study|Lost to Follow-up|4|||
16381666|NCT04064905|39881524|FG004|Overall Study|Lost to Follow-up|2|||
16381667|NCT00415636|39881527|FG000|Overall Study|Symptomatic deterioration|1|||
16381668|NCT00415636|39881528|FG001|Overall Study|Symptomatic deterioration|0|||
16381669|NCT00415636|39881529|FG002|Overall Study|Symptomatic deterioration|1|||
16381670|NCT00415636|39881530|FG003|Overall Study|Symptomatic deterioration|2|||
16381671|NCT00415636|39881531|FG004|Overall Study|Symptomatic deterioration|0|||
16381672|NCT00415636|39881532|FG005|Overall Study|Symptomatic deterioration|1|||
16381673|NCT00415636|39881527|FG000|Overall Study|Adverse Event|0|||
16484203|NCT03715530|40248824|FG002|Overall Study|Lost to Follow-up|2|||
16484204|NCT02091960|40248825|FG000|Overall Study|Death|7|||
16484205|NCT02091960|40248825|FG000|Overall Study|Withdrawal by Subject|1|||
16484206|NCT02091960|40248825|FG000|Overall Study|Miscellaneous Reasons|31|||
16484207|NCT02091960|40248825|FG000|Overall Study|On Study at Data Cut-off|12|||
16484208|NCT01370356|40248826|FG000|Overall Study|Death|1|||
16484209|NCT01370356|40248827|FG001|Overall Study|Death|0|||
16187352|NCT02538666|39162053|FG001|Treatment|Participant request to discontinue study treatment|6|||
16484210|NCT01370356|40248826|FG000|Overall Study|Lack of Efficacy|6|||
16484211|NCT01370356|40248827|FG001|Overall Study|Lack of Efficacy|28|||
16187353|NCT02538666|39162054|FG002|Treatment|Participant request to discontinue study treatment|11|||
16187354|NCT02538666|39162052|FG000|Treatment|Participant withdrew consent|2|||
16484212|NCT01370356|40248826|FG000|Overall Study|Lost to Follow-up|76|||
16484213|NCT01370356|40248827|FG001|Overall Study|Lost to Follow-up|81|||
16484214|NCT01370356|40248826|FG000|Overall Study|Withdrawal by Subject|54|||
16484215|NCT01370356|40248827|FG001|Overall Study|Withdrawal by Subject|59|||
16484216|NCT01370356|40248826|FG000|Overall Study|Reason not specified|39|||
16187355|NCT02538666|39162053|FG001|Treatment|Participant withdrew consent|5|||
16187356|NCT02538666|39162054|FG002|Treatment|Participant withdrew consent|3|||
16187357|NCT02538666|39162052|FG000|Treatment|Lost to Follow-up|0|||
16187358|NCT02538666|39162053|FG001|Treatment|Lost to Follow-up|1|||
16187359|NCT02538666|39162054|FG002|Treatment|Lost to Follow-up|1|||
16187360|NCT02538666|39162052|FG000|Treatment|Maximum clinical benefit|4|||
16187361|NCT02538666|39162053|FG001|Treatment|Maximum clinical benefit|3|||
16187362|NCT02538666|39162054|FG002|Treatment|Maximum clinical benefit|4|||
16187363|NCT02538666|39162052|FG000|Treatment|Poor/non-compliance|0|||
16187364|NCT02538666|39162053|FG001|Treatment|Poor/non-compliance|1|||
16187365|NCT02538666|39162054|FG002|Treatment|Poor/non-compliance|0|||
16187366|NCT02538666|39162052|FG000|Treatment|Participant no longer meets study criteria|0|||
16484217|NCT01370356|40248827|FG001|Overall Study|Reason not specified|43|||
16484218|NCT01370356|40248826|FG000|Overall Study|Protocol Violation|3|||
16484219|NCT01370356|40248827|FG001|Overall Study|Protocol Violation|3|||
16187367|NCT02538666|39162053|FG001|Treatment|Participant no longer meets study criteria|2|||
16187368|NCT02538666|39162054|FG002|Treatment|Participant no longer meets study criteria|0|||
16187369|NCT02538666|39162052|FG000|Treatment|Administrative reason by sponsor|0|||
16187370|NCT02538666|39162053|FG001|Treatment|Administrative reason by sponsor|0|||
16187371|NCT02538666|39162054|FG002|Treatment|Administrative reason by sponsor|1|||
16187372|NCT02538666|39162052|FG000|Treatment|Other reasons|8|||
16484220|NCT01370356|40248826|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
16187373|NCT02538666|39162053|FG001|Treatment|Other reasons|15|||
16484221|NCT01370356|40248827|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
16484222|NCT01370356|40248826|FG000|Overall Study|AE Not Related to Study Drug|1|||
16292913|NCT02238626|39554826|FG001|Overall Study|Other|2|||
16292914|NCT02238626|39554827|FG002|Overall Study|Other|0|||
16292915|NCT02238626|39554828|FG003|Overall Study|Other|0|||
16381674|NCT00415636|39881528|FG001|Overall Study|Adverse Event|0|||
16292916|NCT01244061|39554829|FG000|Overall Study|Death|1|||
16292917|NCT01244061|39554830|FG001|Overall Study|Death|0|||
16292918|NCT01244061|39554829|FG000|Overall Study|Did not meet entrance criteria|1|||
16292919|NCT01244061|39554830|FG001|Overall Study|Did not meet entrance criteria|0|||
16292920|NCT01244061|39554829|FG000|Overall Study|Lack of Efficacy|1|||
16292921|NCT01244061|39554830|FG001|Overall Study|Lack of Efficacy|3|||
16292922|NCT01244061|39554829|FG000|Overall Study|Lost to Follow-up|34|||
16292923|NCT01244061|39554830|FG001|Overall Study|Lost to Follow-up|30|||
16292924|NCT01244061|39554829|FG000|Overall Study|Withdrawal by Subject|29|||
16292925|NCT01244061|39554830|FG001|Overall Study|Withdrawal by Subject|46|||
16292926|NCT01244061|39554829|FG000|Overall Study|Other|8|||
16292927|NCT01244061|39554830|FG001|Overall Study|Other|19|||
16292928|NCT01244061|39554829|FG000|Overall Study|Protocol Violation|1|||
16292929|NCT01244061|39554830|FG001|Overall Study|Protocol Violation|1|||
16292930|NCT01244061|39554829|FG000|Overall Study|Adverse Event|5|||
16292931|NCT01244061|39554830|FG001|Overall Study|Adverse Event|2|||
16292932|NCT01244061|39554829|FG000|Overall Study|Randomized but not treated|2|||
16292933|NCT01244061|39554830|FG001|Overall Study|Randomized but not treated|2|||
16292934|NCT02534844|39554832|FG000|Part B|Withdrawal by Subject|0|||
16292935|NCT02534844|39554833|FG001|Part B|Withdrawal by Subject|0|||
16292936|NCT02534844|39554834|FG002|Part B|Withdrawal by Subject|0|||
16292937|NCT02534844|39554835|FG003|Part B|Withdrawal by Subject|0|||
16292938|NCT02534844|39554836|FG004|Part B|Withdrawal by Subject|2|||
16292939|NCT02534844|39554837|FG005|Part B|Withdrawal by Subject|1|||
16292940|NCT01769339|39554838|FG000|Overall Study|Lost to Follow-up|42|||
16292941|NCT01769339|39554838|FG000|Overall Study|Adverse Event|1|||
16292942|NCT04853992|39554839|FG000|Treatment Period A|Adverse Event|0|||
16292943|NCT04853992|39554840|FG001|Treatment Period A|Adverse Event|1|||
16292944|NCT04853992|39554839|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
16292945|NCT04853992|39554840|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
16292946|NCT01558297|39554841|FG000|Overall Study|Withdrawal by Subject|2|||
16292947|NCT01558297|39554842|FG001|Overall Study|Withdrawal by Subject|2|||
16292948|NCT01558297|39554843|FG002|Overall Study|Withdrawal by Subject|1|||
16292949|NCT01229735|39554846|FG000|Overall Study|Lack of Efficacy|8|||
16292950|NCT01229735|39554847|FG001|Overall Study|Lack of Efficacy|8|||
16292951|NCT01229735|39554846|FG000|Overall Study|Protocol Violation|13|||
16292952|NCT01229735|39554847|FG001|Overall Study|Protocol Violation|8|||
16292953|NCT01229735|39554846|FG000|Overall Study|Lost to Follow-up|0|||
16292954|NCT01229735|39554847|FG001|Overall Study|Lost to Follow-up|2|||
16292955|NCT01229735|39554846|FG000|Overall Study|Withdrawal by Subject|18|||
16292956|NCT01229735|39554847|FG001|Overall Study|Withdrawal by Subject|17|||
16292957|NCT01229735|39554846|FG000|Overall Study|Other Reason|13|||
16292958|NCT01229735|39554847|FG001|Overall Study|Other Reason|10|||
16292959|NCT01229735|39554846|FG000|Overall Study|SAE, non-fatal|0|||
16292960|NCT01229735|39554847|FG001|Overall Study|SAE, non-fatal|4|||
16292961|NCT01229735|39554846|FG000|Overall Study|AE, non-serious non-fatal|13|||
16292962|NCT01229735|39554847|FG001|Overall Study|AE, non-serious non-fatal|17|||
16292963|NCT01229735|39554846|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16292964|NCT01229735|39554847|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
16292965|NCT02072148|39554849|FG000|Overall Study|withdrew prior to surgery|23|||
16292966|NCT02072148|39554850|FG001|Overall Study|withdrew prior to surgery|0|||
16292967|NCT02072148|39554851|FG002|Overall Study|withdrew prior to surgery|0|||
16292968|NCT02072148|39554849|FG000|Overall Study|Death|0|||
16292969|NCT02072148|39554850|FG001|Overall Study|Death|0|||
16292970|NCT02072148|39554851|FG002|Overall Study|Death|1|||
16292971|NCT02072148|39554849|FG000|Overall Study|Withdrawal by Subject|0|||
16292972|NCT02072148|39554850|FG001|Overall Study|Withdrawal by Subject|13|||
16292973|NCT02072148|39554851|FG002|Overall Study|Withdrawal by Subject|12|||
16292974|NCT00557076|39554852|FG000|Overall Study|Unblinding|0|||
16292975|NCT00557076|39554853|FG001|Overall Study|Unblinding|1|||
16292976|NCT00599521|39554854|FG000|Overall Study|Lack of Efficacy|4|||
16292977|NCT00599521|39554855|FG001|Overall Study|Lack of Efficacy|8|||
16292978|NCT00599521|39554854|FG000|Overall Study|Adverse Event|4|||
16292979|NCT00599521|39554855|FG001|Overall Study|Adverse Event|1|||
16292980|NCT00599521|39554854|FG000|Overall Study|Withdrawal by Subject|28|||
16292981|NCT00599521|39554855|FG001|Overall Study|Withdrawal by Subject|34|||
16292982|NCT00599521|39554854|FG000|Overall Study|Protocol Violation|1|||
16292983|NCT00599521|39554855|FG001|Overall Study|Protocol Violation|1|||
16292984|NCT00599521|39554854|FG000|Overall Study|Lost to Follow-up|23|||
16292985|NCT00599521|39554855|FG001|Overall Study|Lost to Follow-up|23|||
16292986|NCT00599521|39554854|FG000|Overall Study|Pregnancy|0|||
16292987|NCT00599521|39554855|FG001|Overall Study|Pregnancy|2|||
16292988|NCT00688376|39554856|FG000|Double-Blind Phase|Adverse Event|4|||
16292989|NCT00688376|39554857|FG001|Double-Blind Phase|Adverse Event|4|||
16292990|NCT00688376|39554856|FG000|Double-Blind Phase|Protocol Violation|1|||
16292991|NCT00688376|39554857|FG001|Double-Blind Phase|Protocol Violation|2|||
16292992|NCT00688376|39554856|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
16292993|NCT00688376|39554857|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
16292994|NCT00688376|39554856|FG000|Double-Blind Phase|Not treated|0|||
16292995|NCT00688376|39554857|FG001|Double-Blind Phase|Not treated|1|||
16292996|NCT00688376|39554856|FG000|Blinded Extension Phase|Adverse Event|3|||
16292997|NCT00688376|39554857|FG001|Blinded Extension Phase|Adverse Event|4|||
16292998|NCT00688376|39554856|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
16292999|NCT00688376|39554857|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
16293000|NCT00688376|39554856|FG000|Blinded Extension Phase|Physician Decision|1|||
16293001|NCT00688376|39554857|FG001|Blinded Extension Phase|Physician Decision|0|||
16081559|NCT02392234|38792684|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
16081560|NCT02392234|38792685|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
16081561|NCT02392234|38792680|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
16081562|NCT02392234|38792681|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
16081563|NCT02392234|38792682|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
16081564|NCT02392234|38792683|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
16293002|NCT00688376|39554856|FG000|Blinded Extension Phase|Other|1|||
16293003|NCT00688376|39554857|FG001|Blinded Extension Phase|Other|0|||
16293004|NCT02582866|39554858|FG000|Overall Study|Death|1|||
16293005|NCT02582866|39554858|FG000|Overall Study|Lack of Efficacy|2|||
16293006|NCT02582866|39554858|FG000|Overall Study|Lost to Follow-up|2|||
16293007|NCT02582866|39554858|FG000|Overall Study|Withdrawal by Subject|7|||
16293008|NCT02582866|39554858|FG000|Overall Study|Investigator decision|5|||
16293009|NCT02582866|39554858|FG000|Overall Study|Participant wants to get pregnant|1|||
16293010|NCT02582866|39554858|FG000|Overall Study|Pregnancy|2|||
16293011|NCT02582866|39554858|FG000|Overall Study|Sponsor decision|1|||
16293012|NCT02582866|39554858|FG000|Overall Study|Withdrawal due to personal reasons|1|||
16293013|NCT02440568|39554859|FG000|Overall Study|Death|1|||
16293014|NCT02440568|39554860|FG001|Overall Study|Death|3|||
16293015|NCT02440568|39554861|FG002|Overall Study|Death|4|||
16293016|NCT02440568|39554862|FG003|Overall Study|Death|2|||
16293017|NCT02440568|39554859|FG000|Overall Study|Lack of Efficacy|2|||
16293018|NCT02440568|39554860|FG001|Overall Study|Lack of Efficacy|0|||
16293019|NCT02440568|39554861|FG002|Overall Study|Lack of Efficacy|1|||
16293020|NCT02440568|39554862|FG003|Overall Study|Lack of Efficacy|0|||
16293021|NCT02440568|39554859|FG000|Overall Study|Lost to Follow-up|1|||
16293022|NCT02440568|39554860|FG001|Overall Study|Lost to Follow-up|0|||
16293023|NCT02440568|39554861|FG002|Overall Study|Lost to Follow-up|0|||
16293024|NCT02440568|39554862|FG003|Overall Study|Lost to Follow-up|0|||
16293025|NCT01777620|39554867|FG000|Overall Study|Subject Withdrawal|1|||
16293026|NCT01777620|39554868|FG001|Overall Study|Subject Withdrawal|0|||
16293027|NCT01345175|39554869|FG000|Overall Study|Physician Decision|0|||
16293028|NCT01345175|39554870|FG001|Overall Study|Physician Decision|1|||
16293029|NCT01345175|39554869|FG000|Overall Study|Withdrawal by Subject|1|||
16293030|NCT01345175|39554870|FG001|Overall Study|Withdrawal by Subject|1|||
16293031|NCT01345175|39554869|FG000|Overall Study|Failed to complete BFI|3|||
16293032|NCT01345175|39554870|FG001|Overall Study|Failed to complete BFI|2|||
16293033|NCT01345175|39554869|FG000|Overall Study|Stopped taking medication|2|||
16293034|NCT01345175|39554870|FG001|Overall Study|Stopped taking medication|2|||
16293035|NCT01831765|39554871|FG000|Overall Study|Lack of Efficacy|1|||
16293036|NCT01831765|39554872|FG001|Overall Study|Lack of Efficacy|0|||
16293037|NCT01831765|39554873|FG002|Overall Study|Lack of Efficacy|0|||
16293038|NCT01831765|39554871|FG000|Overall Study|Other, sponsor withdrew subject|0|||
16293039|NCT01831765|39554872|FG001|Overall Study|Other, sponsor withdrew subject|1|||
16293040|NCT01831765|39554873|FG002|Overall Study|Other, sponsor withdrew subject|0|||
16293041|NCT01831765|39554871|FG000|Overall Study|Pregnancy|1|||
16293042|NCT01831765|39554872|FG001|Overall Study|Pregnancy|1|||
16293043|NCT01831765|39554873|FG002|Overall Study|Pregnancy|2|||
16293044|NCT01831765|39554871|FG000|Overall Study|Death|0|||
16293045|NCT01831765|39554872|FG001|Overall Study|Death|1|||
16293046|NCT01831765|39554873|FG002|Overall Study|Death|1|||
16293047|NCT01831765|39554871|FG000|Overall Study|Other, site closed|1|||
16293048|NCT01831765|39554872|FG001|Overall Study|Other, site closed|1|||
16293049|NCT01831765|39554873|FG002|Overall Study|Other, site closed|0|||
16293050|NCT01831765|39554871|FG000|Overall Study|Adverse Event|5|||
16293051|NCT01831765|39554872|FG001|Overall Study|Adverse Event|3|||
16293052|NCT01831765|39554873|FG002|Overall Study|Adverse Event|3|||
16293053|NCT01831765|39554871|FG000|Overall Study|Withdrawal by Subject|22|||
16293054|NCT01831765|39554872|FG001|Overall Study|Withdrawal by Subject|7|||
16293055|NCT01831765|39554873|FG002|Overall Study|Withdrawal by Subject|17|||
16293056|NCT01831765|39554871|FG000|Overall Study|Withdrawal criteria|12|||
16293057|NCT01831765|39554872|FG001|Overall Study|Withdrawal criteria|10|||
16293058|NCT01831765|39554873|FG002|Overall Study|Withdrawal criteria|16|||
16293059|NCT01831765|39554871|FG000|Overall Study|Lost to Follow-up|2|||
16293060|NCT01831765|39554872|FG001|Overall Study|Lost to Follow-up|3|||
16293061|NCT01831765|39554873|FG002|Overall Study|Lost to Follow-up|3|||
16293062|NCT00673387|39554874|FG000|Overall Study|Withdrawal by Subject|15|||
16293063|NCT00673387|39554875|FG001|Overall Study|Withdrawal by Subject|16|||
16293064|NCT00673387|39554876|FG002|Overall Study|Withdrawal by Subject|20|||
16293065|NCT00673387|39554877|FG003|Overall Study|Withdrawal by Subject|16|||
16293066|NCT00673387|39554878|FG004|Overall Study|Withdrawal by Subject|18|||
16293067|NCT00673387|39554879|FG005|Overall Study|Withdrawal by Subject|21|||
16293068|NCT00673387|39554880|FG006|Overall Study|Withdrawal by Subject|15|||
16293069|NCT00673387|39554881|FG007|Overall Study|Withdrawal by Subject|21|||
16293070|NCT00673387|39554874|FG000|Overall Study|Adverse Event|3|||
16293071|NCT00673387|39554875|FG001|Overall Study|Adverse Event|1|||
16293072|NCT00673387|39554876|FG002|Overall Study|Adverse Event|5|||
16293073|NCT00673387|39554877|FG003|Overall Study|Adverse Event|2|||
16293074|NCT00673387|39554878|FG004|Overall Study|Adverse Event|6|||
16293075|NCT00673387|39554879|FG005|Overall Study|Adverse Event|2|||
16293076|NCT00673387|39554880|FG006|Overall Study|Adverse Event|5|||
16293077|NCT00673387|39554881|FG007|Overall Study|Adverse Event|5|||
16293078|NCT00673387|39554874|FG000|Overall Study|Physician Decision|0|||
16293079|NCT00673387|39554875|FG001|Overall Study|Physician Decision|0|||
16293080|NCT00673387|39554876|FG002|Overall Study|Physician Decision|0|||
16293081|NCT00673387|39554877|FG003|Overall Study|Physician Decision|0|||
16293082|NCT00673387|39554878|FG004|Overall Study|Physician Decision|0|||
16293083|NCT00673387|39554879|FG005|Overall Study|Physician Decision|5|||
16293084|NCT00673387|39554880|FG006|Overall Study|Physician Decision|1|||
16293085|NCT00673387|39554881|FG007|Overall Study|Physician Decision|1|||
16293086|NCT00673387|39554874|FG000|Overall Study|Protocol Violation|3|||
16293087|NCT00673387|39554875|FG001|Overall Study|Protocol Violation|0|||
16293088|NCT00673387|39554876|FG002|Overall Study|Protocol Violation|1|||
16293089|NCT00673387|39554877|FG003|Overall Study|Protocol Violation|2|||
16293090|NCT00673387|39554878|FG004|Overall Study|Protocol Violation|0|||
16293091|NCT00673387|39554879|FG005|Overall Study|Protocol Violation|1|||
16293092|NCT00673387|39554880|FG006|Overall Study|Protocol Violation|1|||
16293093|NCT00673387|39554881|FG007|Overall Study|Protocol Violation|3|||
16293094|NCT00673387|39554874|FG000|Overall Study|Lost to Follow-up|8|||
16293095|NCT00673387|39554875|FG001|Overall Study|Lost to Follow-up|6|||
16293096|NCT00673387|39554876|FG002|Overall Study|Lost to Follow-up|5|||
16293097|NCT00673387|39554877|FG003|Overall Study|Lost to Follow-up|6|||
16484223|NCT01370356|40248827|FG001|Overall Study|AE Not Related to Study Drug|4|||
16484224|NCT02099708|40248830|FG000|Overall Study|Data Not Available|30|||
16484225|NCT02099708|40248830|FG000|Overall Study|Lost to Follow-up|141|||
16484226|NCT02099708|40248830|FG000|Overall Study|Other|29|||
16484227|NCT02059395|40248831|FG000|Overall Study|Lost to Follow-up|2|||
16484228|NCT02059395|40248832|FG001|Overall Study|Lost to Follow-up|4|||
16484229|NCT02378961|40248836|FG000|Overall Study|Lack of Efficacy|4|||
16484230|NCT02378961|40248837|FG001|Overall Study|Lack of Efficacy|2|||
16484231|NCT02378961|40248838|FG002|Overall Study|Lack of Efficacy|0|||
16293098|NCT00673387|39554878|FG004|Overall Study|Lost to Follow-up|6|||
16293099|NCT00673387|39554879|FG005|Overall Study|Lost to Follow-up|5|||
16293100|NCT00673387|39554880|FG006|Overall Study|Lost to Follow-up|8|||
16293101|NCT00673387|39554881|FG007|Overall Study|Lost to Follow-up|5|||
16484232|NCT02378961|40248839|FG003|Overall Study|Lack of Efficacy|1|||
16484233|NCT02378961|40248836|FG000|Overall Study|Death|0|||
16484234|NCT02378961|40248837|FG001|Overall Study|Death|0|||
16484235|NCT02378961|40248838|FG002|Overall Study|Death|1|||
16484236|NCT02378961|40248839|FG003|Overall Study|Death|0|||
16484237|NCT01330030|40248840|FG000|Overall Study|Lost to Follow-up|16|||
16484238|NCT01330030|40248841|FG001|Overall Study|Lost to Follow-up|17|||
16484239|NCT01441180|40248843|FG000|Overall Study|Lost to Follow-up|1|||
16484240|NCT01441180|40248844|FG001|Overall Study|Lost to Follow-up|1|||
16484241|NCT01441180|40248845|FG002|Overall Study|Lost to Follow-up|1|||
16484242|NCT01441180|40248843|FG000|Overall Study|Discontinued|0|||
16484243|NCT01441180|40248844|FG001|Overall Study|Discontinued|0|||
16484244|NCT01441180|40248845|FG002|Overall Study|Discontinued|2|||
16484245|NCT03137537|40248846|FG000|Overall Study|Adverse Event|0|||
16484246|NCT03137537|40248847|FG001|Overall Study|Adverse Event|1|||
16484247|NCT00478231|40248852|FG000|Overall Study|Death|7|||
16484248|NCT00478231|40248852|FG000|Overall Study|Lack of Efficacy|47|||
16293102|NCT01292226|39559415|FG000|Overall Study|Adverse Event|5|||
16293103|NCT01292226|39559415|FG000|Overall Study|Death|1|||
16293104|NCT01292226|39559415|FG000|Overall Study|Graft loss|1|||
16293105|NCT01292226|39559415|FG000|Overall Study|Protocol Violation|3|||
16293106|NCT01292226|39559415|FG000|Overall Study|Withdrawal by Subject|1|||
16293107|NCT01292226|39559415|FG000|Overall Study|Other|2|||
16484249|NCT00478231|40248852|FG000|Overall Study|Lost to Follow-up|7|||
16484250|NCT00478231|40248852|FG000|Overall Study|Withdrawal by Subject|6|||
16484251|NCT00478231|40248852|FG000|Overall Study|Other|9|||
16484252|NCT00478231|40248852|FG000|Overall Study|Adverse Event|5|||
16187374|NCT02538666|39162054|FG002|Treatment|Other reasons|5|||
16293108|NCT03579966|39559416|FG000|Overall Study|Adverse Event|6|||
16293109|NCT03579966|39559416|FG000|Overall Study|Lost to Follow-up|4|||
16293110|NCT03579966|39559416|FG000|Overall Study|Physician Decision|10|||
16293111|NCT03579966|39559416|FG000|Overall Study|Pregnancy|1|||
16484253|NCT00478231|40248852|FG000|Overall Study|Randomized, not treated|3|||
16293112|NCT03579966|39559416|FG000|Overall Study|Withdrawal by Subject|16|||
16293113|NCT03579966|39559416|FG000|Overall Study|Study terminated by Sponsor|22|||
16293114|NCT03579966|39559416|FG000|Overall Study|Protocol Violation|1|||
16293115|NCT02575911|39559417|FG000|Overall Study|Lost to Follow-up|1|||
16293116|NCT03573505|39559420|FG000|Overall Study|Adverse Event|1|||
16293117|NCT03573505|39559421|FG001|Overall Study|Adverse Event|1|||
16293118|NCT03573505|39559420|FG000|Overall Study|Consent withdrawn|0|||
16293119|NCT03573505|39559421|FG001|Overall Study|Consent withdrawn|1|||
16293120|NCT03573505|39559420|FG000|Overall Study|Disease progression|0|||
16293121|NCT03573505|39559421|FG001|Overall Study|Disease progression|1|||
16293122|NCT03573505|39559420|FG000|Overall Study|Site Terminated by Sponsor|1|||
16293123|NCT03573505|39559421|FG001|Overall Study|Site Terminated by Sponsor|1|||
16293124|NCT03573505|39559420|FG000|Overall Study|Study terminated by sponsor|50|||
16293125|NCT03573505|39559421|FG001|Overall Study|Study terminated by sponsor|45|||
16293126|NCT03573505|39559420|FG000|Overall Study|Reason not specified|0|||
16293127|NCT03573505|39559421|FG001|Overall Study|Reason not specified|1|||
16293128|NCT03573505|39559420|FG000|Overall Study|Death|0|||
16293129|NCT03573505|39559421|FG001|Overall Study|Death|4|||
16293130|NCT01523457|39559422|FG000|Overall Study|Withdrawal by Subject|7|||
16293131|NCT01523457|39559423|FG001|Overall Study|Withdrawal by Subject|2|||
16293132|NCT03283319|39559424|FG000|Overall Study|Lost to Follow-up|5|||
16293133|NCT03283319|39559425|FG001|Overall Study|Lost to Follow-up|4|||
16293134|NCT03283319|39559426|FG002|Overall Study|Lost to Follow-up|5|||
16293135|NCT03283319|39559427|FG003|Overall Study|Lost to Follow-up|5|||
16293136|NCT03283319|39559428|FG004|Overall Study|Lost to Follow-up|4|||
16293137|NCT03283319|39559429|FG005|Overall Study|Lost to Follow-up|3|||
16293138|NCT03283319|39559424|FG000|Overall Study|Withdrawal by Subject|2|||
16293139|NCT03283319|39559425|FG001|Overall Study|Withdrawal by Subject|2|||
16293140|NCT03283319|39559426|FG002|Overall Study|Withdrawal by Subject|2|||
16293141|NCT03283319|39559427|FG003|Overall Study|Withdrawal by Subject|1|||
16293142|NCT03283319|39559428|FG004|Overall Study|Withdrawal by Subject|0|||
16293143|NCT03283319|39559429|FG005|Overall Study|Withdrawal by Subject|1|||
16293144|NCT03283319|39559424|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
16293145|NCT03283319|39559425|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
16293146|NCT03283319|39559426|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
16293147|NCT03283319|39559427|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
16293148|NCT03283319|39559428|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
16293149|NCT03283319|39559429|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
16293150|NCT04078126|39559433|FG000|Washout|Study put on hold due to COVID-19|0|||
16293151|NCT04078126|39559434|FG001|Washout|Study put on hold due to COVID-19|2|||
16293152|NCT04078126|39559433|FG000|Period 2|Study put on hold due to COVID-19|1|||
16293153|NCT04078126|39559434|FG001|Period 2|Study put on hold due to COVID-19|1|||
16293154|NCT02293863|39559435|FG000|Overall Study|Death|4|||
16293155|NCT02293863|39559436|FG001|Overall Study|Death|6|||
16293156|NCT02293863|39559437|FG002|Overall Study|Death|4|||
16293157|NCT02293863|39559435|FG000|Overall Study|Lost to Follow-up|2|||
16293158|NCT02293863|39559436|FG001|Overall Study|Lost to Follow-up|2|||
16293159|NCT02293863|39559437|FG002|Overall Study|Lost to Follow-up|2|||
16293160|NCT02293863|39559435|FG000|Overall Study|Withdrawal by Subject|3|||
16293161|NCT02293863|39559436|FG001|Overall Study|Withdrawal by Subject|3|||
16293162|NCT02293863|39559437|FG002|Overall Study|Withdrawal by Subject|1|||
16293163|NCT02293863|39559435|FG000|Overall Study|Reason Not Specified|0|||
16293164|NCT02293863|39559436|FG001|Overall Study|Reason Not Specified|2|||
16293165|NCT02293863|39559437|FG002|Overall Study|Reason Not Specified|2|||
16293166|NCT01884311|39559443|FG000|Overall Study|Withdrawal by Subject|3|||
16293167|NCT01884311|39559443|FG000|Overall Study|withdrew consent due to AEs|1|||
16293168|NCT01884311|39559443|FG000|Overall Study|Precautionary measure|1|||
16293169|NCT00127036|39559446|FG000|Overall Study|Insufficient Data for Analysis|6|||
16293170|NCT00127036|39559447|FG001|Overall Study|Insufficient Data for Analysis|11|||
16293171|NCT00127036|39559446|FG000|Overall Study|Screen Failure|2|||
16293172|NCT00127036|39559447|FG001|Overall Study|Screen Failure|0|||
16293173|NCT01941940|39559448|FG000|Overall Study|Adverse Event|11|||
16293174|NCT01941940|39559448|FG000|Overall Study|Lost to Follow-up|2|||
16293175|NCT01941940|39559448|FG000|Overall Study|Physician Decision|2|||
16293176|NCT01941940|39559448|FG000|Overall Study|Withdrawal by Subject|15|||
16381675|NCT00415636|39881529|FG002|Overall Study|Adverse Event|0|||
16381676|NCT00415636|39881530|FG003|Overall Study|Adverse Event|1|||
16187375|NCT02538666|39162052|FG000|Treatment|Not reported|2|||
16293177|NCT01941940|39559448|FG000|Overall Study|Death|1|||
16293178|NCT01941940|39559448|FG000|Overall Study|Other|1|||
16293179|NCT01941940|39559448|FG000|Overall Study|Other|1|||
16381677|NCT00415636|39881531|FG004|Overall Study|Adverse Event|1|||
16293180|NCT00826449|39559449|FG000|Overall Study|Disease Progression|4|||
16293181|NCT00826449|39559449|FG000|Overall Study|Withdrawal by Subject|1|||
16381678|NCT00415636|39881532|FG005|Overall Study|Adverse Event|0|||
16381679|NCT00415636|39881527|FG000|Overall Study|Withdrawal by Subject|0|||
16381680|NCT00415636|39881528|FG001|Overall Study|Withdrawal by Subject|0|||
16381681|NCT00415636|39881529|FG002|Overall Study|Withdrawal by Subject|0|||
16381682|NCT00415636|39881530|FG003|Overall Study|Withdrawal by Subject|0|||
16381683|NCT00415636|39881531|FG004|Overall Study|Withdrawal by Subject|1|||
16381684|NCT00415636|39881532|FG005|Overall Study|Withdrawal by Subject|0|||
16381685|NCT00415636|39881527|FG000|Overall Study|Disease progression|0|||
16381686|NCT00415636|39881528|FG001|Overall Study|Disease progression|0|||
16381687|NCT00415636|39881529|FG002|Overall Study|Disease progression|0|||
16293182|NCT02317614|39559463|FG000|Overall Study|Lost to Follow-up|1|||
16381688|NCT00415636|39881530|FG003|Overall Study|Disease progression|3|||
16081565|NCT02392234|38792684|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
16293183|NCT02317614|39559464|FG001|Overall Study|Lost to Follow-up|1|||
16293184|NCT02317614|39559463|FG000|Overall Study|Withdrawal by Subject|1|||
16293185|NCT02317614|39559464|FG001|Overall Study|Withdrawal by Subject|0|||
16293186|NCT02317614|39559463|FG000|Overall Study|Death|1|||
16293187|NCT02317614|39559464|FG001|Overall Study|Death|1|||
16293188|NCT00895947|39559465|FG000|Overall Study|Adverse Event|3|||
16293189|NCT00895947|39559466|FG001|Overall Study|Adverse Event|4|||
16293190|NCT00895947|39559465|FG000|Overall Study|Lost to Follow-up|3|||
16293191|NCT00895947|39559466|FG001|Overall Study|Lost to Follow-up|4|||
16293192|NCT00895947|39559465|FG000|Overall Study|Protocol Violation|4|||
16293193|NCT00895947|39559466|FG001|Overall Study|Protocol Violation|2|||
16293194|NCT00895947|39559465|FG000|Overall Study|Withdrawal by Subject|2|||
16293195|NCT00895947|39559466|FG001|Overall Study|Withdrawal by Subject|0|||
16293196|NCT02119819|39559467|FG000|Overall Study|Adverse Event|3|||
16293197|NCT02119819|39559468|FG001|Overall Study|Adverse Event|1|||
16293198|NCT02119819|39559469|FG002|Overall Study|Adverse Event|2|||
16293199|NCT02119819|39559470|FG003|Overall Study|Adverse Event|3|||
16293200|NCT02119819|39559471|FG004|Overall Study|Adverse Event|0|||
16293201|NCT02119819|39559472|FG005|Overall Study|Adverse Event|1|||
16293202|NCT02119819|39559467|FG000|Overall Study|Lack of Efficacy|0|||
16293203|NCT02119819|39559468|FG001|Overall Study|Lack of Efficacy|0|||
16293204|NCT02119819|39559469|FG002|Overall Study|Lack of Efficacy|0|||
16293205|NCT02119819|39559470|FG003|Overall Study|Lack of Efficacy|0|||
16293206|NCT02119819|39559471|FG004|Overall Study|Lack of Efficacy|0|||
16293207|NCT02119819|39559472|FG005|Overall Study|Lack of Efficacy|1|||
16293208|NCT02119819|39559467|FG000|Overall Study|Lost to Follow-up|0|||
16293209|NCT02119819|39559468|FG001|Overall Study|Lost to Follow-up|0|||
16293210|NCT02119819|39559469|FG002|Overall Study|Lost to Follow-up|1|||
16293211|NCT02119819|39559470|FG003|Overall Study|Lost to Follow-up|2|||
16293212|NCT02119819|39559471|FG004|Overall Study|Lost to Follow-up|1|||
16293213|NCT02119819|39559472|FG005|Overall Study|Lost to Follow-up|2|||
16293214|NCT02119819|39559467|FG000|Overall Study|Physician Decision|1|||
16293215|NCT02119819|39559468|FG001|Overall Study|Physician Decision|1|||
16293216|NCT02119819|39559469|FG002|Overall Study|Physician Decision|0|||
16293217|NCT02119819|39559470|FG003|Overall Study|Physician Decision|0|||
16293218|NCT02119819|39559471|FG004|Overall Study|Physician Decision|0|||
16293219|NCT02119819|39559472|FG005|Overall Study|Physician Decision|1|||
16293220|NCT02119819|39559467|FG000|Overall Study|Withdrawal by Subject|5|||
16293221|NCT02119819|39559468|FG001|Overall Study|Withdrawal by Subject|3|||
16293222|NCT02119819|39559469|FG002|Overall Study|Withdrawal by Subject|0|||
16293223|NCT02119819|39559470|FG003|Overall Study|Withdrawal by Subject|0|||
16293224|NCT02119819|39559471|FG004|Overall Study|Withdrawal by Subject|6|||
16293225|NCT02119819|39559472|FG005|Overall Study|Withdrawal by Subject|10|||
16293226|NCT02119819|39559467|FG000|Overall Study|Jury Duty|0|||
16293227|NCT02119819|39559468|FG001|Overall Study|Jury Duty|0|||
16293228|NCT02119819|39559469|FG002|Overall Study|Jury Duty|1|||
16293229|NCT02119819|39559470|FG003|Overall Study|Jury Duty|0|||
16293230|NCT02119819|39559471|FG004|Overall Study|Jury Duty|0|||
16293231|NCT02119819|39559472|FG005|Overall Study|Jury Duty|0|||
16293232|NCT02119819|39559467|FG000|Overall Study|Protocol Violation|0|||
16293233|NCT02119819|39559468|FG001|Overall Study|Protocol Violation|0|||
16293234|NCT02119819|39559469|FG002|Overall Study|Protocol Violation|0|||
16293235|NCT02119819|39559470|FG003|Overall Study|Protocol Violation|1|||
16293236|NCT02119819|39559471|FG004|Overall Study|Protocol Violation|0|||
16293237|NCT02119819|39559472|FG005|Overall Study|Protocol Violation|0|||
16293238|NCT02119819|39559467|FG000|Overall Study|Left the city to get a job|0|||
16293239|NCT02119819|39559468|FG001|Overall Study|Left the city to get a job|0|||
16293240|NCT02119819|39559469|FG002|Overall Study|Left the city to get a job|0|||
16293241|NCT02119819|39559470|FG003|Overall Study|Left the city to get a job|1|||
16381689|NCT00415636|39881531|FG004|Overall Study|Disease progression|0|||
16293242|NCT02119819|39559471|FG004|Overall Study|Left the city to get a job|0|||
16293243|NCT02119819|39559472|FG005|Overall Study|Left the city to get a job|0|||
16293244|NCT00228423|39559473|FG000|Overall Study|Adverse Event|2|||
16293245|NCT00228423|39559474|FG001|Overall Study|Adverse Event|5|||
16293246|NCT00228423|39559473|FG000|Overall Study|Withdrawal by Subject|7|||
16293247|NCT00228423|39559474|FG001|Overall Study|Withdrawal by Subject|3|||
16293248|NCT00228423|39559473|FG000|Overall Study|Protocol Violation|1|||
16293249|NCT00228423|39559474|FG001|Overall Study|Protocol Violation|3|||
16293250|NCT00228423|39559473|FG000|Overall Study|Physician Decision|0|||
16293251|NCT00228423|39559474|FG001|Overall Study|Physician Decision|1|||
16293252|NCT02588950|39559475|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
16293253|NCT02588950|39559476|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
16293254|NCT02588950|39559477|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
16293255|NCT02588950|39559478|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
16293256|NCT02588950|39559475|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
16484254|NCT05399641|40248853|FG000|Overall Study|Adverse Event|0|||
16484255|NCT05399641|40248854|FG001|Overall Study|Adverse Event|1|||
16484256|NCT05399641|40248855|FG002|Overall Study|Adverse Event|1|||
16484257|NCT05399641|40248853|FG000|Overall Study|Lost to Follow-up|1|||
16484258|NCT05399641|40248854|FG001|Overall Study|Lost to Follow-up|2|||
16484259|NCT05399641|40248855|FG002|Overall Study|Lost to Follow-up|2|||
16484260|NCT05399641|40248853|FG000|Overall Study|Physician Decision|1|||
16484261|NCT05399641|40248854|FG001|Overall Study|Physician Decision|3|||
16484262|NCT05399641|40248855|FG002|Overall Study|Physician Decision|3|||
16484263|NCT05399641|40248853|FG000|Overall Study|Withdrawal by Subject|4|||
16484264|NCT05399641|40248854|FG001|Overall Study|Withdrawal by Subject|11|||
16484265|NCT05399641|40248855|FG002|Overall Study|Withdrawal by Subject|7|||
16293257|NCT02588950|39559476|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
16293258|NCT02588950|39559477|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
16293259|NCT02588950|39559478|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
16293260|NCT03375203|39559479|FG000|Overall Study|Protocol Violation|0|||
16293261|NCT03375203|39559480|FG001|Overall Study|Protocol Violation|0|||
16293262|NCT03375203|39559481|FG002|Overall Study|Protocol Violation|1|||
16293263|NCT03375203|39559482|FG003|Overall Study|Protocol Violation|0|||
16293264|NCT03375203|39559483|FG004|Overall Study|Protocol Violation|0|||
16293265|NCT03375203|39559479|FG000|Overall Study|Adverse Event|2|||
16293266|NCT03375203|39559480|FG001|Overall Study|Adverse Event|3|||
16293267|NCT03375203|39559481|FG002|Overall Study|Adverse Event|0|||
16484266|NCT05399641|40248853|FG000|Overall Study|Reason not defined|3|||
16484267|NCT05399641|40248854|FG001|Overall Study|Reason not defined|5|||
16484268|NCT05399641|40248855|FG002|Overall Study|Reason not defined|6|||
16484269|NCT01781975|40248856|FG000|Overall Study|Death|1|||
16484270|NCT01781975|40248857|FG001|Overall Study|Death|0|||
16484271|NCT01781975|40248856|FG000|Overall Study|Withdrawal by Subject|1|||
16484272|NCT01781975|40248857|FG001|Overall Study|Withdrawal by Subject|1|||
16484273|NCT02192359|40248858|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
16484274|NCT02192359|40248859|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
16484275|NCT02192359|40248860|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
16484276|NCT02192359|40248861|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
16484277|NCT02192359|40248858|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
16484278|NCT02192359|40248859|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
16484279|NCT02192359|40248860|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
16484280|NCT02192359|40248861|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
16484281|NCT02192359|40248858|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
16484282|NCT02192359|40248859|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
16484283|NCT02192359|40248860|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
16484284|NCT02192359|40248861|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
16484285|NCT00762229|40248865|FG000|Overall Study|Lost to Follow-up|1|||
16484286|NCT00762229|40248866|FG001|Overall Study|Lost to Follow-up|1|||
16484287|NCT00762229|40248865|FG000|Overall Study|did not recveive intervention|0|||
16484288|NCT00762229|40248866|FG001|Overall Study|did not recveive intervention|1|||
16484289|NCT01719783|40248867|FG000|Dose 2|Physician Decision|1|||
16484290|NCT01719783|40248868|FG001|Dose 2|Physician Decision|0|||
16484291|NCT00816595|40248872|FG000|Overall Study|Withdrawal by Subject|2|||
16484292|NCT00816595|40248873|FG001|Overall Study|Withdrawal by Subject|0|||
16484293|NCT02747875|40248874|FG000|Overall Study|Physician Decision|1|||
16484294|NCT02747875|40248875|FG001|Overall Study|Physician Decision|0|||
16484295|NCT02747875|40248874|FG000|Overall Study|Adverse Event|0|||
16484296|NCT02747875|40248875|FG001|Overall Study|Adverse Event|1|||
16484297|NCT02639065|40248876|FG000|Study Treatment|Disease Progression|13|||
16484298|NCT02639065|40248876|FG000|Study Treatment|Adverse Event|9|||
16293268|NCT03375203|39559482|FG003|Overall Study|Adverse Event|2|||
16293269|NCT03375203|39559483|FG004|Overall Study|Adverse Event|2|||
16293270|NCT03375203|39559479|FG000|Overall Study|Withdrawal by Subject|3|||
16484299|NCT02639065|40248876|FG000|Study Treatment|Withdrawal by Subject|1|||
16484300|NCT02639065|40248876|FG000|Follow up|Subject refused to follow up|1|||
16293271|NCT03375203|39559480|FG001|Overall Study|Withdrawal by Subject|0|||
16293272|NCT03375203|39559481|FG002|Overall Study|Withdrawal by Subject|1|||
16484301|NCT02639065|40248876|FG000|Follow up|Symptomatic Deterioration|2|||
16484302|NCT02639065|40248876|FG000|Follow up|Death|2|||
16484303|NCT02639065|40248876|FG000|Follow up|Study Terminated|1|||
16484304|NCT02639065|40248876|FG000|Follow up|Disease Progression|3|||
16484305|NCT00142298|40248879|FG000|Overall Study|Adverse Event|10|||
16484306|NCT00142298|40248880|FG001|Overall Study|Adverse Event|10|||
16484307|NCT00142298|40248881|FG002|Overall Study|Adverse Event|1|||
16484308|NCT00142298|40248882|FG003|Overall Study|Adverse Event|5|||
16484309|NCT00142298|40248883|FG004|Overall Study|Adverse Event|2|||
16484310|NCT00142298|40248884|FG005|Overall Study|Adverse Event|2|||
16484311|NCT00142298|40248885|FG006|Overall Study|Adverse Event|0|||
16484312|NCT00142298|40248886|FG007|Overall Study|Adverse Event|0|||
16484313|NCT00142298|40248887|FG008|Overall Study|Adverse Event|0|||
16484314|NCT00142298|40248888|FG009|Overall Study|Adverse Event|0|||
16484315|NCT00142298|40248879|FG000|Overall Study|Clinical disease progression|1|||
16484316|NCT00142298|40248880|FG001|Overall Study|Clinical disease progression|0|||
16293273|NCT03375203|39559482|FG003|Overall Study|Withdrawal by Subject|0|||
16293274|NCT03375203|39559483|FG004|Overall Study|Withdrawal by Subject|2|||
16484317|NCT00142298|40248881|FG002|Overall Study|Clinical disease progression|0|||
16484318|NCT00142298|40248882|FG003|Overall Study|Clinical disease progression|0|||
16484319|NCT00142298|40248883|FG004|Overall Study|Clinical disease progression|0|||
16484320|NCT00142298|40248884|FG005|Overall Study|Clinical disease progression|0|||
16484321|NCT00142298|40248885|FG006|Overall Study|Clinical disease progression|0|||
16484322|NCT00142298|40248886|FG007|Overall Study|Clinical disease progression|0|||
16293275|NCT03375203|39559479|FG000|Overall Study|Non-compliance with study drug|1|||
16484323|NCT00142298|40248887|FG008|Overall Study|Clinical disease progression|0|||
16484324|NCT00142298|40248888|FG009|Overall Study|Clinical disease progression|0|||
16484325|NCT00142298|40248879|FG000|Overall Study|Death|1|||
16484326|NCT00142298|40248880|FG001|Overall Study|Death|1|||
16484327|NCT00142298|40248881|FG002|Overall Study|Death|1|||
16484328|NCT00142298|40248882|FG003|Overall Study|Death|0|||
16484329|NCT00142298|40248883|FG004|Overall Study|Death|0|||
16293276|NCT03375203|39559480|FG001|Overall Study|Non-compliance with study drug|0|||
16293277|NCT03375203|39559481|FG002|Overall Study|Non-compliance with study drug|0|||
16293278|NCT03375203|39559482|FG003|Overall Study|Non-compliance with study drug|0|||
16293279|NCT03375203|39559483|FG004|Overall Study|Non-compliance with study drug|0|||
16293280|NCT03375203|39559479|FG000|Overall Study|Randomized, not treated.|0|||
16293281|NCT03375203|39559480|FG001|Overall Study|Randomized, not treated.|1|||
16293282|NCT03375203|39559481|FG002|Overall Study|Randomized, not treated.|0|||
16293283|NCT03375203|39559482|FG003|Overall Study|Randomized, not treated.|0|||
16293284|NCT03375203|39559483|FG004|Overall Study|Randomized, not treated.|0|||
16293285|NCT00315731|39559488|FG000|Overall Study|Lost to Follow-up|1|||
16293286|NCT00315731|39559488|FG000|Overall Study|Death|5|||
16293287|NCT03551496|39559490|FG000|Overall Study|Death|11|||
16293288|NCT03551496|39559491|FG001|Overall Study|Death|7|||
16293289|NCT03551496|39559490|FG000|Overall Study|Withdrawal by Subject|4|||
16293290|NCT03551496|39559491|FG001|Overall Study|Withdrawal by Subject|3|||
16293291|NCT03551496|39559490|FG000|Overall Study|Other Reasons|1|||
16293292|NCT03551496|39559491|FG001|Overall Study|Other Reasons|0|||
16293293|NCT04091659|39559494|FG000|Overall Study|Protocol Violation|3|||
16293294|NCT04091659|39559495|FG001|Overall Study|Protocol Violation|0|||
16293295|NCT04091659|39559494|FG000|Overall Study|Lost to Follow-up|0|||
16293296|NCT04091659|39559495|FG001|Overall Study|Lost to Follow-up|1|||
16293297|NCT00773734|39559497|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
16293298|NCT00773734|39559498|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
16293299|NCT00773734|39559499|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
16293300|NCT00773734|39559500|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
16293301|NCT00773734|39559501|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
16293302|NCT00773734|39559502|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
16293303|NCT00773734|39559497|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
16293304|NCT00773734|39559498|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
16293305|NCT00773734|39559499|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
16293306|NCT00773734|39559500|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
16293307|NCT00773734|39559501|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
16293308|NCT00773734|39559502|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
16381690|NCT00415636|39881532|FG005|Overall Study|Disease progression|1|||
16381691|NCT04724837|39881533|FG000|Overall Study|Other|4|||
16484330|NCT00142298|40248884|FG005|Overall Study|Death|6|||
16484331|NCT00142298|40248885|FG006|Overall Study|Death|0|||
16484332|NCT00142298|40248886|FG007|Overall Study|Death|0|||
16484333|NCT00142298|40248887|FG008|Overall Study|Death|0|||
16484334|NCT00142298|40248888|FG009|Overall Study|Death|0|||
16484335|NCT00142298|40248879|FG000|Overall Study|Lack of Efficacy|44|||
16484336|NCT00142298|40248880|FG001|Overall Study|Lack of Efficacy|62|||
16484337|NCT00142298|40248881|FG002|Overall Study|Lack of Efficacy|9|||
16484338|NCT00142298|40248882|FG003|Overall Study|Lack of Efficacy|12|||
16381692|NCT04724837|39881534|FG001|Overall Study|Other|16|||
16381693|NCT04724837|39881535|FG002|Overall Study|Other|0|||
16381694|NCT04724837|39881533|FG000|Overall Study|Withdrawal by Subject|2|||
16381695|NCT04724837|39881534|FG001|Overall Study|Withdrawal by Subject|9|||
16381696|NCT04724837|39881535|FG002|Overall Study|Withdrawal by Subject|9|||
16381697|NCT04724837|39881533|FG000|Overall Study|Adverse Event|2|||
16381698|NCT04724837|39881534|FG001|Overall Study|Adverse Event|7|||
16381699|NCT04724837|39881535|FG002|Overall Study|Adverse Event|4|||
16381700|NCT04724837|39881533|FG000|Overall Study|Lost to Follow-up|0|||
16381701|NCT04724837|39881534|FG001|Overall Study|Lost to Follow-up|1|||
16381702|NCT04724837|39881535|FG002|Overall Study|Lost to Follow-up|3|||
16381703|NCT04724837|39881533|FG000|Overall Study|Physician Decision|1|||
16381704|NCT04724837|39881534|FG001|Overall Study|Physician Decision|2|||
16381705|NCT04724837|39881535|FG002|Overall Study|Physician Decision|0|||
16381706|NCT04724837|39881533|FG000|Overall Study|Death|0|||
16381707|NCT04724837|39881534|FG001|Overall Study|Death|0|||
16381708|NCT04724837|39881535|FG002|Overall Study|Death|1|||
16381709|NCT04724837|39881533|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
16381710|NCT04724837|39881534|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
16381711|NCT04724837|39881535|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
16381712|NCT04724837|39881533|FG000|Overall Study|Study Terminated by Sponsor|0|||
16381713|NCT04724837|39881534|FG001|Overall Study|Study Terminated by Sponsor|1|||
16381714|NCT04724837|39881535|FG002|Overall Study|Study Terminated by Sponsor|0|||
16381715|NCT00654355|39881536|FG000|Overall Study|Lost to Follow-up|2|||
16381716|NCT00654355|39881537|FG001|Overall Study|Lost to Follow-up|2|||
16381717|NCT00444106|39881540|FG000|Overall Study|Lost to Follow-up|2|||
16381718|NCT00444106|39881541|FG001|Overall Study|Lost to Follow-up|1|||
16293309|NCT00773734|39559497|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
16293310|NCT00773734|39559498|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
16293311|NCT00773734|39559499|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
16293312|NCT00773734|39559500|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
16293313|NCT00773734|39559501|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
16293314|NCT00773734|39559502|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
16293315|NCT00773734|39559497|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
16293316|NCT00773734|39559498|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
16293317|NCT00773734|39559499|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
16293318|NCT00773734|39559500|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
16293319|NCT00773734|39559501|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
16293320|NCT00773734|39559502|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
16293321|NCT00773734|39559497|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
16293322|NCT00773734|39559498|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
16293323|NCT00773734|39559499|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
16293324|NCT00773734|39559500|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
16293325|NCT00773734|39559501|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
16293326|NCT00773734|39559502|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
16293327|NCT00773734|39559497|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
16293328|NCT00773734|39559498|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
16293329|NCT00773734|39559499|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
16293330|NCT00773734|39559500|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
16293331|NCT00773734|39559501|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
16293332|NCT00773734|39559502|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
16293333|NCT00773734|39559497|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
16293334|NCT00773734|39559498|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
16293335|NCT00773734|39559499|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
16293336|NCT00773734|39559500|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
16381719|NCT00444106|39881542|FG002|Overall Study|Lost to Follow-up|0|||
16381720|NCT00444106|39881540|FG000|Overall Study|Abnormal Test Procedure Results|0|||
16381721|NCT00444106|39881541|FG001|Overall Study|Abnormal Test Procedure Results|0|||
16381722|NCT00444106|39881542|FG002|Overall Study|Abnormal Test Procedure Results|1|||
16381723|NCT03707821|39881546|FG000|Overall Study|Protocol Violation|0|||
16381724|NCT03707821|39881547|FG001|Overall Study|Protocol Violation|1|||
16381725|NCT03707821|39881546|FG000|Overall Study|Unsatisfactory Visual Response|1|||
16381726|NCT03707821|39881547|FG001|Overall Study|Unsatisfactory Visual Response|0|||
16381727|NCT03707821|39881546|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
16381728|NCT03707821|39881547|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
16381729|NCT03386773|39881550|FG000|Overall Study|Lost to Follow-up|24|||
16381730|NCT03386773|39881551|FG001|Overall Study|Lost to Follow-up|33|||
16381731|NCT03386773|39881550|FG000|Overall Study|Withdrawal by Subject|3|||
16381732|NCT03386773|39881551|FG001|Overall Study|Withdrawal by Subject|2|||
16381733|NCT00876447|39881552|FG000|Overall Study|Other miscellaneous reasons|3|||
16381734|NCT00876447|39881553|FG001|Overall Study|Other miscellaneous reasons|8|||
16381735|NCT00876447|39881552|FG000|Overall Study|Site closure|19|||
16381736|NCT00876447|39881553|FG001|Overall Study|Site closure|14|||
16381737|NCT00876447|39881552|FG000|Overall Study|Protocol Violation|9|||
16381738|NCT00876447|39881553|FG001|Overall Study|Protocol Violation|3|||
16381739|NCT00876447|39881552|FG000|Overall Study|Personal reasons|30|||
16381740|NCT00876447|39881553|FG001|Overall Study|Personal reasons|28|||
16381741|NCT00876447|39881552|FG000|Overall Study|Lost to Follow-up|6|||
16381742|NCT00876447|39881553|FG001|Overall Study|Lost to Follow-up|15|||
16381743|NCT00876447|39881552|FG000|Overall Study|Pregnancy|4|||
16381744|NCT00876447|39881553|FG001|Overall Study|Pregnancy|2|||
16381745|NCT00876447|39881552|FG000|Overall Study|Lack of Efficacy|5|||
16381746|NCT00876447|39881553|FG001|Overall Study|Lack of Efficacy|3|||
16381747|NCT00876447|39881552|FG000|Overall Study|Adverse Event|4|||
16381748|NCT00876447|39881553|FG001|Overall Study|Adverse Event|8|||
16381749|NCT03802916|39881554|FG000|Overall Study|Adverse Event|0|||
16381750|NCT03802916|39881555|FG001|Overall Study|Adverse Event|1|||
16381751|NCT03802916|39881554|FG000|Overall Study|Withdrawal by Subject|0|||
16381752|NCT03802916|39881555|FG001|Overall Study|Withdrawal by Subject|1|||
16381753|NCT04436744|39881558|FG000|Overall Study|Adverse Event|1|||
16381754|NCT04436744|39881559|FG001|Overall Study|Adverse Event|1|||
16381755|NCT04436744|39881558|FG000|Overall Study|Death|1|||
16381756|NCT04436744|39881559|FG001|Overall Study|Death|0|||
16381757|NCT04436744|39881558|FG000|Overall Study|Lost to Follow-up|0|||
16381758|NCT04436744|39881559|FG001|Overall Study|Lost to Follow-up|2|||
16381759|NCT04436744|39881558|FG000|Overall Study|Physician Decision|0|||
16381760|NCT04436744|39881559|FG001|Overall Study|Physician Decision|1|||
16381761|NCT04436744|39881558|FG000|Overall Study|Progressive Disease|0|||
16381762|NCT04436744|39881559|FG001|Overall Study|Progressive Disease|4|||
16381763|NCT04436744|39881558|FG000|Overall Study|Protocol Deviation|1|||
16381764|NCT04436744|39881559|FG001|Overall Study|Protocol Deviation|1|||
16381765|NCT04436744|39881558|FG000|Overall Study|Withdrawal by Subject|1|||
16381766|NCT04436744|39881559|FG001|Overall Study|Withdrawal by Subject|2|||
16381767|NCT00485173|39881560|FG000|Overall Study|Death|4|||
16381768|NCT00485173|39881561|FG001|Overall Study|Death|3|||
16381769|NCT00485173|39881560|FG000|Overall Study|Lost to Follow-up|32|||
16381770|NCT00485173|39881561|FG001|Overall Study|Lost to Follow-up|61|||
16381771|NCT00789555|39881564|FG000|Overall Study|Protocol Amendment|78|||
16381772|NCT00789555|39881565|FG001|Overall Study|Protocol Amendment|76|||
16381773|NCT00789555|39881566|FG002|Overall Study|Protocol Amendment|80|||
16381774|NCT00789555|39881564|FG000|Overall Study|Adverse Event|17|||
16381775|NCT00789555|39881565|FG001|Overall Study|Adverse Event|7|||
16381776|NCT00789555|39881566|FG002|Overall Study|Adverse Event|10|||
16381777|NCT00789555|39881564|FG000|Overall Study|Lost to Follow-up|9|||
16381778|NCT00789555|39881565|FG001|Overall Study|Lost to Follow-up|10|||
16381779|NCT00789555|39881566|FG002|Overall Study|Lost to Follow-up|18|||
16381780|NCT00789555|39881564|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
16381781|NCT00789555|39881565|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
16381782|NCT00789555|39881566|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
16381783|NCT00789555|39881564|FG000|Overall Study|Treatment failure|11|||
16381784|NCT00789555|39881565|FG001|Overall Study|Treatment failure|8|||
16381785|NCT00789555|39881566|FG002|Overall Study|Treatment failure|12|||
16381786|NCT00789555|39881564|FG000|Overall Study|Protocol Violation|6|||
16381787|NCT00789555|39881565|FG001|Overall Study|Protocol Violation|9|||
16381788|NCT00789555|39881566|FG002|Overall Study|Protocol Violation|13|||
16381789|NCT01156844|39881567|FG000|Overall Study|Adverse Event|0|||
16381790|NCT01156844|39881568|FG001|Overall Study|Adverse Event|0|||
16381791|NCT01156844|39881569|FG002|Overall Study|Adverse Event|1|||
16381792|NCT01156844|39881570|FG003|Overall Study|Adverse Event|1|||
16381793|NCT01156844|39881567|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16381794|NCT01156844|39881568|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16381795|NCT01156844|39881569|FG002|Overall Study|Abnormal test procedure result(s)|2|||
16381796|NCT01156844|39881570|FG003|Overall Study|Abnormal test procedure result(s)|2|||
16381797|NCT01156844|39881567|FG000|Overall Study|Withdrawal by Subject|0|||
16381798|NCT01156844|39881568|FG001|Overall Study|Withdrawal by Subject|0|||
16381799|NCT01156844|39881569|FG002|Overall Study|Withdrawal by Subject|2|||
16381800|NCT01156844|39881570|FG003|Overall Study|Withdrawal by Subject|2|||
16381801|NCT01156844|39881567|FG000|Overall Study|Lost to Follow-up|0|||
16484339|NCT00142298|40248883|FG004|Overall Study|Lack of Efficacy|1|||
16484340|NCT00142298|40248884|FG005|Overall Study|Lack of Efficacy|0|||
16484341|NCT00142298|40248885|FG006|Overall Study|Lack of Efficacy|0|||
16381802|NCT01156844|39881568|FG001|Overall Study|Lost to Follow-up|0|||
16381803|NCT01156844|39881569|FG002|Overall Study|Lost to Follow-up|1|||
16381804|NCT01156844|39881570|FG003|Overall Study|Lost to Follow-up|0|||
16381805|NCT01156844|39881567|FG000|Overall Study|Administrative problems|0|||
16381806|NCT01156844|39881568|FG001|Overall Study|Administrative problems|1|||
16381807|NCT01156844|39881569|FG002|Overall Study|Administrative problems|0|||
16381808|NCT01156844|39881570|FG003|Overall Study|Administrative problems|1|||
16381809|NCT01156844|39881567|FG000|Overall Study|Protocol deviation|2|||
16381810|NCT01156844|39881568|FG001|Overall Study|Protocol deviation|0|||
16484342|NCT00142298|40248886|FG007|Overall Study|Lack of Efficacy|1|||
16293337|NCT00773734|39559501|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
16293338|NCT00773734|39559502|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
16293339|NCT00773734|39559497|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
16293340|NCT00773734|39559498|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
16293341|NCT00773734|39559499|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
16293342|NCT00773734|39559500|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
16293343|NCT00773734|39559501|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
16293344|NCT00773734|39559502|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
16293345|NCT00773734|39559497|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
16293346|NCT00773734|39559498|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
16293347|NCT00773734|39559499|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
16293348|NCT00773734|39559500|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
16293349|NCT00773734|39559501|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
16293350|NCT00773734|39559502|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
16293351|NCT00773734|39559497|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
16293352|NCT00773734|39559498|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
16293353|NCT00773734|39559499|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
16293354|NCT00773734|39559500|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
16293355|NCT00773734|39559501|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
16293356|NCT00773734|39559502|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
16293357|NCT00773734|39559497|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
16293358|NCT00773734|39559498|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
16293359|NCT00773734|39559499|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
16293360|NCT00773734|39559500|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
16293361|NCT00773734|39559501|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
16293362|NCT00773734|39559502|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
16293363|NCT00773734|39559497|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
16293364|NCT00773734|39559498|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
16293365|NCT00773734|39559499|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
16293366|NCT00773734|39559500|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
16293367|NCT00773734|39559501|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
16293368|NCT00773734|39559502|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
16293369|NCT00773734|39559497|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
16293370|NCT00773734|39559498|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
16293371|NCT00773734|39559499|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
16293372|NCT00773734|39559500|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
16293373|NCT00773734|39559501|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
16293374|NCT00773734|39559502|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
16293375|NCT00773734|39559497|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
16293376|NCT00773734|39559498|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
16293377|NCT00773734|39559499|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
16293378|NCT00773734|39559500|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
16293379|NCT00773734|39559501|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
16293380|NCT00773734|39559502|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
16293381|NCT00773734|39559497|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
16293382|NCT00773734|39559498|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
16293383|NCT00773734|39559499|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
16293384|NCT00773734|39559500|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
16293385|NCT00773734|39559501|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
16293386|NCT00773734|39559502|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
16293387|NCT00773734|39559497|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
16293388|NCT00773734|39559498|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
16293389|NCT00773734|39559499|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
16293390|NCT00773734|39559500|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
16293391|NCT00773734|39559501|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
16293392|NCT00773734|39559502|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
16293393|NCT00773734|39559497|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
16293394|NCT00773734|39559498|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
16293395|NCT00773734|39559499|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
16293396|NCT00773734|39559500|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
16293397|NCT00773734|39559501|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
16293398|NCT00773734|39559502|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
16293399|NCT00773734|39559497|FG000|Extension: Active Treatment Week 24-52|Other|0|||
16293400|NCT00773734|39559498|FG001|Extension: Active Treatment Week 24-52|Other|0|||
16187376|NCT02538666|39162053|FG001|Treatment|Not reported|2|||
16381811|NCT01156844|39881569|FG002|Overall Study|Protocol deviation|0|||
16381812|NCT01156844|39881570|FG003|Overall Study|Protocol deviation|0|||
16381813|NCT00329420|39881571|FG000|Re-induction Phase|Lack of Efficacy|0|||
16381814|NCT00329420|39881572|FG001|Re-induction Phase|Lack of Efficacy|1|||
16381815|NCT00329420|39881573|FG002|Re-induction Phase|Lack of Efficacy|0|||
16381816|NCT00329420|39881571|FG000|Re-induction Phase|Withdrawal of Consent|0|||
16381817|NCT00329420|39881572|FG001|Re-induction Phase|Withdrawal of Consent|0|||
16381818|NCT00329420|39881573|FG002|Re-induction Phase|Withdrawal of Consent|1|||
16381819|NCT00329420|39881571|FG000|Re-induction Phase|Did not respond to re-induction|6|||
16381820|NCT00329420|39881572|FG001|Re-induction Phase|Did not respond to re-induction|5|||
16381821|NCT00329420|39881573|FG002|Re-induction Phase|Did not respond to re-induction|7|||
16381822|NCT00329420|39881571|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
16381823|NCT00329420|39881572|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
16381824|NCT00329420|39881573|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
16381825|NCT00329420|39881571|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
16381826|NCT00329420|39881572|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
16381827|NCT00329420|39881573|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
16381828|NCT00329420|39881571|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
16381829|NCT00329420|39881572|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
16381830|NCT00329420|39881573|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
16381831|NCT02415556|39881574|FG000|Overall Study|Adverse Event|3|||
16381832|NCT02415556|39881575|FG001|Overall Study|Adverse Event|4|||
16381833|NCT02415556|39881576|FG002|Overall Study|Adverse Event|2|||
16381834|NCT02415556|39881577|FG003|Overall Study|Adverse Event|4|||
16381835|NCT02415556|39881574|FG000|Overall Study|Lost to Follow-up|4|||
16381836|NCT02415556|39881575|FG001|Overall Study|Lost to Follow-up|5|||
16381837|NCT02415556|39881576|FG002|Overall Study|Lost to Follow-up|4|||
16381838|NCT02415556|39881577|FG003|Overall Study|Lost to Follow-up|1|||
16381839|NCT02415556|39881574|FG000|Overall Study|Withdrawal by Subject|13|||
16381840|NCT02415556|39881575|FG001|Overall Study|Withdrawal by Subject|4|||
16381841|NCT02415556|39881576|FG002|Overall Study|Withdrawal by Subject|14|||
16381842|NCT02415556|39881577|FG003|Overall Study|Withdrawal by Subject|12|||
16381843|NCT02415556|39881574|FG000|Overall Study|Physician Decision|1|||
16381844|NCT02415556|39881575|FG001|Overall Study|Physician Decision|3|||
16381845|NCT02415556|39881576|FG002|Overall Study|Physician Decision|1|||
16381846|NCT02415556|39881577|FG003|Overall Study|Physician Decision|2|||
16381847|NCT02415556|39881574|FG000|Overall Study|Censored - study completion|4|||
16381848|NCT02415556|39881575|FG001|Overall Study|Censored - study completion|5|||
16381849|NCT02415556|39881576|FG002|Overall Study|Censored - study completion|1|||
16381850|NCT02415556|39881577|FG003|Overall Study|Censored - study completion|0|||
16381851|NCT02415556|39881574|FG000|Overall Study|Family-related issues|0|||
16381852|NCT02415556|39881575|FG001|Overall Study|Family-related issues|0|||
16381853|NCT02415556|39881576|FG002|Overall Study|Family-related issues|0|||
16381854|NCT02415556|39881577|FG003|Overall Study|Family-related issues|1|||
16381855|NCT00140140|39881580|FG000|Overall Study|Unacceptable toxicity|1|||
16381856|NCT00140140|39881581|FG001|Overall Study|Unacceptable toxicity|1|||
16484343|NCT00142298|40248887|FG008|Overall Study|Lack of Efficacy|0|||
16484344|NCT00142298|40248888|FG009|Overall Study|Lack of Efficacy|0|||
16484345|NCT00142298|40248879|FG000|Overall Study|Non-compliance|15|||
16484346|NCT00142298|40248880|FG001|Overall Study|Non-compliance|13|||
16484347|NCT00142298|40248881|FG002|Overall Study|Non-compliance|0|||
16484348|NCT00142298|40248882|FG003|Overall Study|Non-compliance|6|||
16484349|NCT00142298|40248883|FG004|Overall Study|Non-compliance|1|||
16484350|NCT00142298|40248884|FG005|Overall Study|Non-compliance|0|||
16484351|NCT00142298|40248885|FG006|Overall Study|Non-compliance|0|||
16484352|NCT00142298|40248886|FG007|Overall Study|Non-compliance|3|||
16484353|NCT00142298|40248887|FG008|Overall Study|Non-compliance|3|||
16484354|NCT00142298|40248888|FG009|Overall Study|Non-compliance|0|||
16484355|NCT00142298|40248879|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
16484356|NCT00142298|40248880|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
16381857|NCT00140140|39881582|FG002|Overall Study|Unacceptable toxicity|2|||
16381858|NCT00140140|39881580|FG000|Overall Study|Physician Decision|1|||
16484357|NCT00142298|40248881|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
16484358|NCT00142298|40248882|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
16484359|NCT00142298|40248883|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
16484360|NCT00142298|40248884|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
16381859|NCT00140140|39881581|FG001|Overall Study|Physician Decision|1|||
16381860|NCT00140140|39881582|FG002|Overall Study|Physician Decision|0|||
16381861|NCT01051661|39881583|FG000|Overall Study|Adverse Event|1|||
16484361|NCT00142298|40248885|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
16484362|NCT00142298|40248886|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
16484363|NCT00142298|40248887|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
16484364|NCT00142298|40248888|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
16484365|NCT00142298|40248879|FG000|Overall Study|Pregnancy|4|||
16484366|NCT00142298|40248880|FG001|Overall Study|Pregnancy|4|||
16484367|NCT00142298|40248881|FG002|Overall Study|Pregnancy|2|||
16484368|NCT00142298|40248882|FG003|Overall Study|Pregnancy|3|||
16484369|NCT00142298|40248883|FG004|Overall Study|Pregnancy|0|||
16484370|NCT00142298|40248884|FG005|Overall Study|Pregnancy|0|||
16484371|NCT00142298|40248885|FG006|Overall Study|Pregnancy|0|||
16484372|NCT00142298|40248886|FG007|Overall Study|Pregnancy|0|||
16484373|NCT00142298|40248887|FG008|Overall Study|Pregnancy|1|||
16484374|NCT00142298|40248888|FG009|Overall Study|Pregnancy|0|||
16484375|NCT00142298|40248879|FG000|Overall Study|Virologic breakthrough|19|||
16293401|NCT00773734|39559499|FG002|Extension: Active Treatment Week 24-52|Other|1|||
16293402|NCT00773734|39559500|FG003|Extension: Active Treatment Week 24-52|Other|2|||
16293403|NCT00773734|39559501|FG004|Extension: Active Treatment Week 24-52|Other|0|||
16293404|NCT00773734|39559502|FG005|Extension: Active Treatment Week 24-52|Other|1|||
16293405|NCT00773734|39559497|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
16293406|NCT00773734|39559498|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
16293407|NCT00773734|39559499|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
16293408|NCT00773734|39559500|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
16293409|NCT00773734|39559501|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
16293410|NCT00773734|39559502|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
16293411|NCT00773734|39559497|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
16293412|NCT00773734|39559498|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
16293413|NCT00773734|39559499|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
16293414|NCT00773734|39559500|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
16293415|NCT00773734|39559501|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
16293416|NCT00773734|39559502|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
16293417|NCT00773734|39559497|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
16293418|NCT00773734|39559498|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
16293419|NCT00773734|39559499|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
16293420|NCT00773734|39559500|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
16293421|NCT00773734|39559501|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
16293422|NCT00773734|39559502|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
16293423|NCT00773734|39559497|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
16293424|NCT00773734|39559498|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
16293425|NCT00773734|39559499|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
16293426|NCT00773734|39559500|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
16293427|NCT00773734|39559501|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
16293428|NCT00773734|39559502|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
16293429|NCT01732484|39559503|FG000|Overall Study|Death|7|||
16293430|NCT01732484|39559503|FG000|Overall Study|Lost to Follow-up|14|||
16293431|NCT01732484|39559503|FG000|Overall Study|chronical illness|5|||
16293432|NCT00643565|39559504|FG000|Overall Study|Death|12|||
16293433|NCT00643565|39559505|FG001|Overall Study|Death|11|||
16293434|NCT00643565|39559504|FG000|Overall Study|Withdrawal by Subject|4|||
16293435|NCT00643565|39559505|FG001|Overall Study|Withdrawal by Subject|1|||
16293436|NCT00643565|39559504|FG000|Overall Study|Lost to Follow-up|0|||
16293437|NCT00643565|39559505|FG001|Overall Study|Lost to Follow-up|6|||
16293438|NCT00643565|39559504|FG000|Overall Study|Other|7|||
16293439|NCT00643565|39559505|FG001|Overall Study|Other|8|||
16293440|NCT00643565|39559504|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
16293441|NCT00643565|39559505|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
16293442|NCT00643565|39559504|FG000|Overall Study|Recurrence of Disease|2|||
16293443|NCT00643565|39559505|FG001|Overall Study|Recurrence of Disease|1|||
16293444|NCT00643565|39559504|FG000|Overall Study|Progression of Disease|18|||
16293445|NCT00643565|39559505|FG001|Overall Study|Progression of Disease|14|||
16293446|NCT00643565|39559504|FG000|Overall Study|Protocol Violation|3|||
16293447|NCT00643565|39559505|FG001|Overall Study|Protocol Violation|0|||
16293448|NCT00643565|39559504|FG000|Overall Study|Did Not Cooperate|0|||
16293449|NCT00643565|39559505|FG001|Overall Study|Did Not Cooperate|1|||
16381862|NCT01051661|39881584|FG001|Overall Study|Adverse Event|1|||
16293450|NCT00643565|39559504|FG000|Overall Study|Administrative|22|||
16293451|NCT00643565|39559505|FG001|Overall Study|Administrative|16|||
16293452|NCT00643565|39559504|FG000|Overall Study|Adverse Event|5|||
16293453|NCT00643565|39559505|FG001|Overall Study|Adverse Event|8|||
16484376|NCT00142298|40248880|FG001|Overall Study|Virologic breakthrough|23|||
16381863|NCT01051661|39881585|FG002|Overall Study|Adverse Event|1|||
16484377|NCT00142298|40248881|FG002|Overall Study|Virologic breakthrough|9|||
16484378|NCT00142298|40248882|FG003|Overall Study|Virologic breakthrough|7|||
16484379|NCT00142298|40248883|FG004|Overall Study|Virologic breakthrough|2|||
16484380|NCT00142298|40248884|FG005|Overall Study|Virologic breakthrough|3|||
16381864|NCT01051661|39881586|FG003|Overall Study|Adverse Event|1|||
16381865|NCT01051661|39881587|FG004|Overall Study|Adverse Event|0|||
16381866|NCT01051661|39881588|FG005|Overall Study|Adverse Event|0|||
16293454|NCT03246646|39559512|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
16293455|NCT03246646|39559513|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
16293456|NCT03246646|39559512|FG000|Overall Study|Withdrawal by Subject|3|||
16293457|NCT03246646|39559513|FG001|Overall Study|Withdrawal by Subject|0|||
16293458|NCT03246646|39559512|FG000|Overall Study|Lost to Follow-up|7|||
16381867|NCT01051661|39881583|FG000|Overall Study|Lost to Follow-up|13|||
16381868|NCT01051661|39881584|FG001|Overall Study|Lost to Follow-up|22|||
16381869|NCT01051661|39881585|FG002|Overall Study|Lost to Follow-up|15|||
16381870|NCT01051661|39881586|FG003|Overall Study|Lost to Follow-up|17|||
16381871|NCT01051661|39881587|FG004|Overall Study|Lost to Follow-up|10|||
16381872|NCT01051661|39881588|FG005|Overall Study|Lost to Follow-up|24|||
16381873|NCT01051661|39881583|FG000|Overall Study|Migrated/moved from study area|1|||
16381874|NCT01051661|39881584|FG001|Overall Study|Migrated/moved from study area|6|||
16381875|NCT01051661|39881585|FG002|Overall Study|Migrated/moved from study area|6|||
16484381|NCT00142298|40248885|FG006|Overall Study|Virologic breakthrough|3|||
16381876|NCT01051661|39881586|FG003|Overall Study|Migrated/moved from study area|8|||
16381877|NCT01051661|39881587|FG004|Overall Study|Migrated/moved from study area|7|||
16381878|NCT01051661|39881588|FG005|Overall Study|Migrated/moved from study area|3|||
16381879|NCT01051661|39881583|FG000|Overall Study|Refused blood sampling|0|||
16381880|NCT01051661|39881584|FG001|Overall Study|Refused blood sampling|0|||
16381881|NCT01051661|39881585|FG002|Overall Study|Refused blood sampling|0|||
16381882|NCT01051661|39881586|FG003|Overall Study|Refused blood sampling|0|||
16293459|NCT03246646|39559513|FG001|Overall Study|Lost to Follow-up|0|||
16381883|NCT01051661|39881587|FG004|Overall Study|Refused blood sampling|0|||
16381884|NCT01051661|39881588|FG005|Overall Study|Refused blood sampling|1|||
16381885|NCT01051661|39881583|FG000|Overall Study|Data not reliable|1|||
16381886|NCT01051661|39881584|FG001|Overall Study|Data not reliable|0|||
16381887|NCT01051661|39881585|FG002|Overall Study|Data not reliable|0|||
16381888|NCT01051661|39881586|FG003|Overall Study|Data not reliable|0|||
16381889|NCT01051661|39881587|FG004|Overall Study|Data not reliable|0|||
16381890|NCT01051661|39881588|FG005|Overall Study|Data not reliable|1|||
16381891|NCT01051661|39881583|FG000|Overall Study|Unable to attend visit(s)|2|||
16381892|NCT01051661|39881584|FG001|Overall Study|Unable to attend visit(s)|4|||
16381893|NCT01051661|39881585|FG002|Overall Study|Unable to attend visit(s)|2|||
16381894|NCT01051661|39881586|FG003|Overall Study|Unable to attend visit(s)|1|||
16381895|NCT01051661|39881587|FG004|Overall Study|Unable to attend visit(s)|3|||
16381896|NCT01051661|39881588|FG005|Overall Study|Unable to attend visit(s)|2|||
16293460|NCT02963441|39559517|FG000|Overall Study|Protocol violation or withdrawn|8|||
16293461|NCT02963441|39559517|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
16293462|NCT02963441|39559517|FG000|Overall Study|IDx-DR insufficient quality|33|||
16293463|NCT02528123|39559520|FG000|Overall Study|Lost to Follow-up|1|||
16293464|NCT01070771|39559525|FG000|Overall Study|Adverse Event|2|||
16293465|NCT01070771|39559525|FG000|Overall Study|Protocol Violation|1|||
16293466|NCT00321828|39559526|FG000|Overall Study|Ineligible|3|||
16293467|NCT00321828|39559526|FG000|Overall Study|No follow up data|1|||
16293468|NCT00311402|39559527|FG000|Overall Study|Adverse Event|118|||
16293469|NCT00311402|39559528|FG001|Overall Study|Adverse Event|105|||
16293470|NCT00311402|39559527|FG000|Overall Study|Lost to Follow-up|0|||
16293471|NCT00311402|39559528|FG001|Overall Study|Lost to Follow-up|3|||
16293472|NCT00311402|39559527|FG000|Overall Study|Withdrawal by Subject|17|||
16293473|NCT00311402|39559528|FG001|Overall Study|Withdrawal by Subject|18|||
16293474|NCT00311402|39559527|FG000|Overall Study|Lack of Efficacy|58|||
16293475|NCT00311402|39559528|FG001|Overall Study|Lack of Efficacy|42|||
16293476|NCT00311402|39559527|FG000|Overall Study|Protocol Violation|7|||
16293477|NCT00311402|39559528|FG001|Overall Study|Protocol Violation|6|||
16293478|NCT00311402|39559527|FG000|Overall Study|IRB's rejection etc.|10|||
16293479|NCT00311402|39559528|FG001|Overall Study|IRB's rejection etc.|3|||
16293480|NCT01346774|39559529|FG000|Overall Study|Did not take a single dose|6|||
16293481|NCT01346774|39559530|FG001|Overall Study|Did not take a single dose|4|||
16293482|NCT01346774|39559529|FG000|Overall Study|Lost to Follow-up|3|||
16293483|NCT01346774|39559530|FG001|Overall Study|Lost to Follow-up|4|||
16293484|NCT01346774|39559529|FG000|Overall Study|Withdrawal by Subject|1|||
16293485|NCT01346774|39559530|FG001|Overall Study|Withdrawal by Subject|4|||
16293486|NCT01346774|39559529|FG000|Overall Study|Protocol Violation|2|||
16381897|NCT01051661|39881583|FG000|Overall Study|Consent not received from both parents|0|||
16381898|NCT01051661|39881584|FG001|Overall Study|Consent not received from both parents|0|||
16293487|NCT01346774|39559530|FG001|Overall Study|Protocol Violation|3|||
16293488|NCT01346774|39559529|FG000|Overall Study|Adverse Event|1|||
16381899|NCT01051661|39881585|FG002|Overall Study|Consent not received from both parents|0|||
16381900|NCT01051661|39881586|FG003|Overall Study|Consent not received from both parents|0|||
16484382|NCT00142298|40248886|FG007|Overall Study|Virologic breakthrough|0|||
16293489|NCT01346774|39559530|FG001|Overall Study|Adverse Event|2|||
16293490|NCT01259115|39559531|FG000|Period 1|Adverse Event|1|||
16484383|NCT00142298|40248887|FG008|Overall Study|Virologic breakthrough|0|||
16484384|NCT00142298|40248888|FG009|Overall Study|Virologic breakthrough|0|||
16484385|NCT00142298|40248879|FG000|Overall Study|Other- not specified|0|||
16484386|NCT00142298|40248880|FG001|Overall Study|Other- not specified|3|||
16484387|NCT00142298|40248881|FG002|Overall Study|Other- not specified|0|||
16484388|NCT00142298|40248882|FG003|Overall Study|Other- not specified|1|||
16484389|NCT00142298|40248883|FG004|Overall Study|Other- not specified|0|||
16484390|NCT00142298|40248884|FG005|Overall Study|Other- not specified|0|||
16484391|NCT00142298|40248885|FG006|Overall Study|Other- not specified|0|||
16381901|NCT01051661|39881587|FG004|Overall Study|Consent not received from both parents|0|||
16081566|NCT02392234|38792685|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
16081567|NCT02392234|38792680|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
16081568|NCT02392234|38792681|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
16293491|NCT01259115|39559532|FG001|Period 1|Adverse Event|0|||
16293492|NCT01259115|39559531|FG000|Period 1|Protocol Violation|2|||
16293493|NCT01259115|39559532|FG001|Period 1|Protocol Violation|0|||
16293494|NCT01259115|39559531|FG000|Period 1|Lost to Follow-up|0|||
16187377|NCT02538666|39162054|FG002|Treatment|Not reported|2|||
16187378|NCT01356602|39162055|FG000|Overall Study|Protocol Deviation|0|||
16187379|NCT01356602|39162056|FG001|Overall Study|Protocol Deviation|1|||
16187380|NCT01356602|39162057|FG002|Overall Study|Protocol Deviation|1|||
16187381|NCT01356602|39162055|FG000|Overall Study|Administrative Problems|1|||
16187382|NCT01356602|39162056|FG001|Overall Study|Administrative Problems|4|||
16187383|NCT01356602|39162057|FG002|Overall Study|Administrative Problems|5|||
16187384|NCT01356602|39162055|FG000|Overall Study|Lost to Follow-up|4|||
16187385|NCT01356602|39162056|FG001|Overall Study|Lost to Follow-up|5|||
16187386|NCT01356602|39162057|FG002|Overall Study|Lost to Follow-up|6|||
16187387|NCT01356602|39162055|FG000|Overall Study|Withdrawal by Subject|4|||
16187388|NCT01356602|39162056|FG001|Overall Study|Withdrawal by Subject|3|||
16187389|NCT01356602|39162057|FG002|Overall Study|Withdrawal by Subject|7|||
16187390|NCT01356602|39162055|FG000|Overall Study|Lack of Efficacy|0|||
16187391|NCT01356602|39162056|FG001|Overall Study|Lack of Efficacy|1|||
16187392|NCT01356602|39162057|FG002|Overall Study|Lack of Efficacy|4|||
16187393|NCT01356602|39162055|FG000|Overall Study|Adverse Event|0|||
16187394|NCT01356602|39162056|FG001|Overall Study|Adverse Event|1|||
16187395|NCT01356602|39162057|FG002|Overall Study|Adverse Event|1|||
16187396|NCT02092389|39162058|FG000|Overall Study|Adverse Event|1|||
16187397|NCT02092389|39162058|FG000|Overall Study|Other|5|||
16187398|NCT01797783|39164888|FG000|Overall Study|Adverse Event|1|||
16187399|NCT01797783|39164889|FG001|Overall Study|Adverse Event|1|||
16187400|NCT01797783|39164888|FG000|Overall Study|Withdrawal by Subject|1|||
16187401|NCT01797783|39164889|FG001|Overall Study|Withdrawal by Subject|0|||
16187402|NCT01703819|39164890|FG000|Overall Study|Adverse Event|0|||
16187403|NCT01703819|39164891|FG001|Overall Study|Adverse Event|1|||
16187404|NCT01703819|39164890|FG000|Overall Study|Withdrawal by Subject|0|||
16187405|NCT01703819|39164891|FG001|Overall Study|Withdrawal by Subject|1|||
16187406|NCT00807846|39164892|FG000|Overall Study|Adverse Event|5|||
16187407|NCT00807846|39164893|FG001|Overall Study|Adverse Event|0|||
16293495|NCT01259115|39559532|FG001|Period 1|Lost to Follow-up|1|||
16293496|NCT01259115|39559531|FG000|Period 2|Adverse Event|1|||
16293497|NCT01259115|39559532|FG001|Period 2|Adverse Event|0|||
16293498|NCT00251719|39559533|FG000|Overall Study|Adverse Event|14|||
16293499|NCT00251719|39559534|FG001|Overall Study|Adverse Event|8|||
16293500|NCT00251719|39559535|FG002|Overall Study|Adverse Event|7|||
16293501|NCT00251719|39559533|FG000|Overall Study|Protocol Violation|1|||
16293502|NCT00251719|39559534|FG001|Overall Study|Protocol Violation|1|||
16293503|NCT00251719|39559535|FG002|Overall Study|Protocol Violation|1|||
16293504|NCT00251719|39559533|FG000|Overall Study|Lost to Follow-up|5|||
16187408|NCT00807846|39164892|FG000|Overall Study|Lack of Efficacy|2|||
16187409|NCT00807846|39164893|FG001|Overall Study|Lack of Efficacy|0|||
16187410|NCT00807846|39164892|FG000|Overall Study|Protocol Violation|2|||
16187411|NCT00807846|39164893|FG001|Overall Study|Protocol Violation|1|||
16187412|NCT00807846|39164892|FG000|Overall Study|Withdrawal by Subject|2|||
16187413|NCT00807846|39164893|FG001|Overall Study|Withdrawal by Subject|1|||
16187414|NCT00807846|39164892|FG000|Overall Study|Other|1|||
16293505|NCT00251719|39559534|FG001|Overall Study|Lost to Follow-up|11|||
16187415|NCT00807846|39164893|FG001|Overall Study|Other|2|||
16484392|NCT00142298|40248886|FG007|Overall Study|Other- not specified|0|||
16187416|NCT01993329|39164896|FG000|Period 2|Adverse Event|0|||
16187417|NCT01993329|39164897|FG001|Period 2|Adverse Event|0|||
16293506|NCT00251719|39559535|FG002|Overall Study|Lost to Follow-up|8|||
16293507|NCT00251719|39559533|FG000|Overall Study|Withdrawal by Subject|14|||
16187418|NCT01993329|39164898|FG002|Period 2|Adverse Event|0|||
16187419|NCT01993329|39164899|FG003|Period 2|Adverse Event|0|||
16187420|NCT01993329|39164900|FG004|Period 2|Adverse Event|0|||
16187421|NCT01993329|39164901|FG005|Period 2|Adverse Event|1|||
16187422|NCT01993329|39164896|FG000|Wash-out|Personal reasons|0|||
16187423|NCT01993329|39164897|FG001|Wash-out|Personal reasons|1|||
16187424|NCT01993329|39164898|FG002|Wash-out|Personal reasons|0|||
16187425|NCT01993329|39164899|FG003|Wash-out|Personal reasons|0|||
16187426|NCT01993329|39164900|FG004|Wash-out|Personal reasons|0|||
16187427|NCT01993329|39164901|FG005|Wash-out|Personal reasons|0|||
16187428|NCT01371838|39164906|FG000|Overall Study|Withdrawal by Subject|27|||
16187429|NCT01371838|39164907|FG001|Overall Study|Withdrawal by Subject|33|||
16187430|NCT01371838|39164906|FG000|Overall Study|Lost to Follow-up|10|||
16187431|NCT01371838|39164907|FG001|Overall Study|Lost to Follow-up|20|||
16293508|NCT00251719|39559534|FG001|Overall Study|Withdrawal by Subject|12|||
16293509|NCT00251719|39559535|FG002|Overall Study|Withdrawal by Subject|11|||
16293510|NCT00251719|39559533|FG000|Overall Study|Lack of Efficacy|2|||
16293511|NCT00251719|39559534|FG001|Overall Study|Lack of Efficacy|1|||
16293512|NCT00251719|39559535|FG002|Overall Study|Lack of Efficacy|0|||
16293513|NCT00251719|39559533|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
16484393|NCT00142298|40248887|FG008|Overall Study|Other- not specified|0|||
16484394|NCT00142298|40248888|FG009|Overall Study|Other- not specified|0|||
16187432|NCT01371838|39164906|FG000|Overall Study|Death|3|||
16187433|NCT01371838|39164907|FG001|Overall Study|Death|4|||
16293514|NCT00251719|39559534|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
16293515|NCT00251719|39559535|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
16293516|NCT00251719|39559533|FG000|Overall Study|Investigator decision|1|||
16293517|NCT00251719|39559534|FG001|Overall Study|Investigator decision|1|||
16293518|NCT00251719|39559535|FG002|Overall Study|Investigator decision|0|||
16293519|NCT00251719|39559533|FG000|Overall Study|Noncompliance|2|||
16293520|NCT00251719|39559534|FG001|Overall Study|Noncompliance|3|||
16293521|NCT00251719|39559535|FG002|Overall Study|Noncompliance|1|||
16293522|NCT00251719|39559533|FG000|Overall Study|Barrett's esophagus|2|||
16293523|NCT00251719|39559534|FG001|Overall Study|Barrett's esophagus|2|||
16293524|NCT00251719|39559535|FG002|Overall Study|Barrett's esophagus|0|||
16293525|NCT04053465|39559536|FG000|Overall Study|Withdrawal by Subject|4|||
16293526|NCT04053465|39559537|FG001|Overall Study|Withdrawal by Subject|4|||
16293527|NCT00186043|39559538|FG000|Overall Study|Lack of Efficacy|1|||
16293528|NCT00186043|39559539|FG001|Overall Study|Lack of Efficacy|3|||
16293529|NCT00186043|39559538|FG000|Overall Study|Lost to Follow-up|4|||
16293530|NCT00186043|39559539|FG001|Overall Study|Lost to Follow-up|6|||
16293531|NCT00186043|39559538|FG000|Overall Study|Withdrawal by Subject|1|||
16293532|NCT00186043|39559539|FG001|Overall Study|Withdrawal by Subject|0|||
16293533|NCT00186043|39559538|FG000|Overall Study|Adverse Event|7|||
16293534|NCT00186043|39559539|FG001|Overall Study|Adverse Event|3|||
16293535|NCT00186043|39559538|FG000|Overall Study|Protocol Violation|2|||
16293536|NCT00186043|39559539|FG001|Overall Study|Protocol Violation|1|||
16293537|NCT03071094|39559549|FG000|Overall Study|Death|1|||
16293538|NCT03071094|39559550|FG001|Overall Study|Death|1|||
16293539|NCT03071094|39559549|FG000|Overall Study|Adverse Event|1|||
16293540|NCT03071094|39559550|FG001|Overall Study|Adverse Event|0|||
16293541|NCT01565850|39559553|FG000|Overall Study|Adverse Event|0|||
16293542|NCT01565850|39559554|FG001|Overall Study|Adverse Event|1|||
16293543|NCT01565850|39559553|FG000|Overall Study|Lost to Follow-up|12|||
16293544|NCT01565850|39559554|FG001|Overall Study|Lost to Follow-up|4|||
16293545|NCT01565850|39559553|FG000|Overall Study|Investigator's Discretion|2|||
16293546|NCT01565850|39559554|FG001|Overall Study|Investigator's Discretion|1|||
16293547|NCT01565850|39559553|FG000|Overall Study|Participant noncompliance|2|||
16293548|NCT01565850|39559554|FG001|Overall Study|Participant noncompliance|0|||
16293549|NCT01565850|39559553|FG000|Overall Study|Withdrew Consent|4|||
16293550|NCT01565850|39559554|FG001|Overall Study|Withdrew Consent|2|||
16293551|NCT01680497|39559555|FG000|Overall Study|Lost to Follow-up|2|||
16293552|NCT01121666|39559556|FG000|Overall Study|Protocol Violation|29|||
16293553|NCT01121666|39559557|FG001|Overall Study|Protocol Violation|10|||
16293554|NCT05012163|39559560|FG000|Overall Study|Protocol Violation|0|||
16293555|NCT05012163|39559561|FG001|Overall Study|Protocol Violation|0|||
16293556|NCT05012163|39559562|FG002|Overall Study|Protocol Violation|1|||
16293557|NCT05012163|39559563|FG003|Overall Study|Protocol Violation|1|||
16293558|NCT01971970|39559564|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
16293559|NCT01971970|39559565|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
16293560|NCT01971970|39559564|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
16293561|NCT01971970|39559565|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
16293562|NCT01971970|39559564|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
16293563|NCT01971970|39559565|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
16293564|NCT01971970|39559564|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
16293565|NCT01971970|39559565|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
16293566|NCT01971970|39559564|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
16293567|NCT01971970|39559565|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
16293568|NCT01971970|39559564|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
16293569|NCT01971970|39559565|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
16293570|NCT01971970|39559564|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
16187434|NCT01371838|39164906|FG000|Overall Study|Protocol Violation|3|||
16381902|NCT01051661|39881588|FG005|Overall Study|Consent not received from both parents|1|||
16293571|NCT01971970|39559565|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
16293572|NCT04319718|39559566|FG000|Overall Study|Adverse Event|0|||
16293573|NCT04319718|39559567|FG001|Overall Study|Adverse Event|2|||
16293574|NCT04319718|39559566|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
16293575|NCT04319718|39559567|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
16293576|NCT00960115|39559568|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
16293577|NCT00960115|39559569|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
16293578|NCT02056392|39559570|FG000|Overall Study|Lost to Follow-up|0|||
16293579|NCT02056392|39559571|FG001|Overall Study|Lost to Follow-up|1|||
16293580|NCT02056392|39559572|FG002|Overall Study|Lost to Follow-up|2|||
16293581|NCT02056392|39559573|FG003|Overall Study|Lost to Follow-up|0|||
16381903|NCT01051661|39881583|FG000|Overall Study|Failure to comply with protocol|0|||
16381904|NCT01051661|39881584|FG001|Overall Study|Failure to comply with protocol|0|||
16381905|NCT01051661|39881585|FG002|Overall Study|Failure to comply with protocol|2|||
16381906|NCT01051661|39881586|FG003|Overall Study|Failure to comply with protocol|0|||
16381907|NCT01051661|39881587|FG004|Overall Study|Failure to comply with protocol|0|||
16381908|NCT01051661|39881588|FG005|Overall Study|Failure to comply with protocol|0|||
16381909|NCT01051661|39881583|FG000|Overall Study|Subject lost legal representation|0|||
16381910|NCT01051661|39881584|FG001|Overall Study|Subject lost legal representation|0|||
16381911|NCT01051661|39881585|FG002|Overall Study|Subject lost legal representation|0|||
16381912|NCT01051661|39881586|FG003|Overall Study|Subject lost legal representation|0|||
16381913|NCT01051661|39881587|FG004|Overall Study|Subject lost legal representation|1|||
16381914|NCT01051661|39881588|FG005|Overall Study|Subject lost legal representation|0|||
16381915|NCT01051661|39881583|FG000|Overall Study|Protocol Violation|0|||
16381916|NCT01051661|39881584|FG001|Overall Study|Protocol Violation|0|||
16381917|NCT01051661|39881585|FG002|Overall Study|Protocol Violation|0|||
16381918|NCT01051661|39881586|FG003|Overall Study|Protocol Violation|1|||
16381919|NCT01051661|39881587|FG004|Overall Study|Protocol Violation|2|||
16381920|NCT01051661|39881588|FG005|Overall Study|Protocol Violation|1|||
16381921|NCT01051661|39881583|FG000|Overall Study|Withdrawal by Subject|16|||
16381922|NCT01051661|39881584|FG001|Overall Study|Withdrawal by Subject|30|||
16381923|NCT01051661|39881585|FG002|Overall Study|Withdrawal by Subject|13|||
16381924|NCT01051661|39881586|FG003|Overall Study|Withdrawal by Subject|28|||
16381925|NCT01051661|39881587|FG004|Overall Study|Withdrawal by Subject|12|||
16381926|NCT01051661|39881588|FG005|Overall Study|Withdrawal by Subject|34|||
16381927|NCT01214837|39881589|FG000|Overall Study|Death|0|||
16381928|NCT01214837|39881590|FG001|Overall Study|Death|0|||
16381929|NCT01214837|39881591|FG002|Overall Study|Death|1|||
16381930|NCT01214837|39881589|FG000|Overall Study|Adverse Event|1|||
16381931|NCT01214837|39881590|FG001|Overall Study|Adverse Event|2|||
16381932|NCT01214837|39881591|FG002|Overall Study|Adverse Event|1|||
16381933|NCT01214837|39881589|FG000|Overall Study|Withdrawal by Subject|27|||
16293582|NCT02056392|39559574|FG004|Overall Study|Lost to Follow-up|0|||
16293583|NCT02056392|39559575|FG005|Overall Study|Lost to Follow-up|0|||
16293584|NCT02056392|39559570|FG000|Overall Study|Protocol Violation|1|||
16293585|NCT02056392|39559571|FG001|Overall Study|Protocol Violation|0|||
16293586|NCT02056392|39559572|FG002|Overall Study|Protocol Violation|1|||
16293587|NCT02056392|39559573|FG003|Overall Study|Protocol Violation|0|||
16293588|NCT02056392|39559574|FG004|Overall Study|Protocol Violation|0|||
16293589|NCT02056392|39559575|FG005|Overall Study|Protocol Violation|0|||
16293590|NCT02056392|39559570|FG000|Overall Study|Withdrawal by Subject|1|||
16293591|NCT02056392|39559571|FG001|Overall Study|Withdrawal by Subject|0|||
16293592|NCT02056392|39559572|FG002|Overall Study|Withdrawal by Subject|0|||
16293593|NCT02056392|39559573|FG003|Overall Study|Withdrawal by Subject|0|||
16293594|NCT02056392|39559574|FG004|Overall Study|Withdrawal by Subject|1|||
16293595|NCT02056392|39559575|FG005|Overall Study|Withdrawal by Subject|0|||
16381934|NCT01214837|39881590|FG001|Overall Study|Withdrawal by Subject|36|||
16381935|NCT01214837|39881591|FG002|Overall Study|Withdrawal by Subject|28|||
16381936|NCT01214837|39881589|FG000|Overall Study|Lost to Follow-up|20|||
16381937|NCT01214837|39881590|FG001|Overall Study|Lost to Follow-up|15|||
16381938|NCT01214837|39881591|FG002|Overall Study|Lost to Follow-up|21|||
16293596|NCT00123474|39559578|FG000|Randomized to Treatment|Randomized, never treated|1|||
16293597|NCT00123474|39559579|FG001|Randomized to Treatment|Randomized, never treated|4|||
16381939|NCT01214837|39881589|FG000|Overall Study|Inappropriate Enrolment|0|||
16381940|NCT01214837|39881590|FG001|Overall Study|Inappropriate Enrolment|1|||
16381941|NCT01214837|39881591|FG002|Overall Study|Inappropriate Enrolment|2|||
16381942|NCT01214837|39881589|FG000|Overall Study|Administrative Reason|2|||
16381943|NCT01214837|39881590|FG001|Overall Study|Administrative Reason|6|||
16381944|NCT01214837|39881591|FG002|Overall Study|Administrative Reason|4|||
16381945|NCT01214837|39881589|FG000|Overall Study|Protocol Violation|3|||
16484395|NCT00142298|40248879|FG000|Overall Study|Lost to Follow-up|0|||
16484396|NCT00142298|40248880|FG001|Overall Study|Lost to Follow-up|0|||
16484397|NCT00142298|40248881|FG002|Overall Study|Lost to Follow-up|0|||
16484398|NCT00142298|40248882|FG003|Overall Study|Lost to Follow-up|0|||
16484399|NCT00142298|40248883|FG004|Overall Study|Lost to Follow-up|0|||
16484400|NCT00142298|40248884|FG005|Overall Study|Lost to Follow-up|0|||
16484401|NCT00142298|40248885|FG006|Overall Study|Lost to Follow-up|2|||
16484402|NCT00142298|40248886|FG007|Overall Study|Lost to Follow-up|0|||
16484403|NCT00142298|40248887|FG008|Overall Study|Lost to Follow-up|0|||
16484404|NCT00142298|40248888|FG009|Overall Study|Lost to Follow-up|0|||
16484405|NCT00142298|40248879|FG000|Overall Study|Treatment Failure|0|||
16484406|NCT00142298|40248880|FG001|Overall Study|Treatment Failure|0|||
16484407|NCT00142298|40248881|FG002|Overall Study|Treatment Failure|0|||
16484408|NCT00142298|40248882|FG003|Overall Study|Treatment Failure|0|||
16381946|NCT01214837|39881590|FG001|Overall Study|Protocol Violation|1|||
16293598|NCT00123474|39559580|FG002|Randomized to Treatment|Randomized, never treated|2|||
16293599|NCT00123474|39559581|FG003|Randomized to Treatment|Randomized, never treated|1|||
16381947|NCT01214837|39881591|FG002|Overall Study|Protocol Violation|5|||
16381948|NCT01214837|39881589|FG000|Overall Study|Unable to Classify|1|||
16381949|NCT01214837|39881590|FG001|Overall Study|Unable to Classify|3|||
16381950|NCT01214837|39881591|FG002|Overall Study|Unable to Classify|0|||
16381951|NCT05201807|39881594|FG000|Overall Study|Adverse Event|1|||
16484409|NCT00142298|40248883|FG004|Overall Study|Treatment Failure|0|||
16484410|NCT00142298|40248884|FG005|Overall Study|Treatment Failure|2|||
16484411|NCT00142298|40248885|FG006|Overall Study|Treatment Failure|2|||
16484412|NCT00142298|40248886|FG007|Overall Study|Treatment Failure|0|||
16484413|NCT00142298|40248887|FG008|Overall Study|Treatment Failure|0|||
16484414|NCT00142298|40248888|FG009|Overall Study|Treatment Failure|0|||
16484415|NCT01929343|40248892|FG000|Overall Study|Physician Decision|0|||
16484416|NCT01929343|40248893|FG001|Overall Study|Physician Decision|2|||
16484417|NCT01929343|40248894|FG002|Overall Study|Physician Decision|0|||
16484418|NCT01929343|40248892|FG000|Overall Study|Withdrawal by Subject|1|||
16484419|NCT01929343|40248893|FG001|Overall Study|Withdrawal by Subject|0|||
16484420|NCT01929343|40248894|FG002|Overall Study|Withdrawal by Subject|0|||
16484421|NCT01681472|40248898|FG000|Overall Study|Adverse Event|0|||
16484422|NCT01681472|40248899|FG001|Overall Study|Adverse Event|1|||
16484423|NCT01681472|40248900|FG002|Overall Study|Adverse Event|0|||
16484424|NCT01681472|40248901|FG003|Overall Study|Adverse Event|0|||
16484425|NCT01488370|40248906|FG000|Overall Study|Protocol Violation|0|||
16484426|NCT01488370|40248907|FG001|Overall Study|Protocol Violation|1|||
16484427|NCT01488370|40248908|FG002|Overall Study|Protocol Violation|1|||
16484428|NCT01393301|40248909|FG000|Overall Study|Lost to Follow-up|5|||
16293600|NCT00123474|39559578|FG000|As Treated at Study Closure|not reported when site closed|1|||
16293601|NCT00123474|39559579|FG001|As Treated at Study Closure|not reported when site closed|0|||
16484429|NCT01393301|40248910|FG001|Overall Study|Lost to Follow-up|3|||
16484430|NCT01393301|40248909|FG000|Overall Study|Withdrawal by Subject|2|||
16293602|NCT00123474|39559580|FG002|As Treated at Study Closure|not reported when site closed|1|||
16293603|NCT00123474|39559581|FG003|As Treated at Study Closure|not reported when site closed|0|||
16293604|NCT00123474|39559578|FG000|As Treated at Study Closure|Adverse Event|10|||
16293605|NCT00123474|39559579|FG001|As Treated at Study Closure|Adverse Event|4|||
16293606|NCT00123474|39559580|FG002|As Treated at Study Closure|Adverse Event|10|||
16293607|NCT00123474|39559581|FG003|As Treated at Study Closure|Adverse Event|8|||
16293608|NCT00123474|39559578|FG000|As Treated at Study Closure|Disease Progression|35|||
16293609|NCT00123474|39559579|FG001|As Treated at Study Closure|Disease Progression|42|||
16293610|NCT00123474|39559580|FG002|As Treated at Study Closure|Disease Progression|29|||
16293611|NCT00123474|39559581|FG003|As Treated at Study Closure|Disease Progression|27|||
16293612|NCT00123474|39559578|FG000|As Treated at Study Closure|Investigator Request|12|||
16293613|NCT00123474|39559579|FG001|As Treated at Study Closure|Investigator Request|6|||
16293614|NCT00123474|39559580|FG002|As Treated at Study Closure|Investigator Request|7|||
16293615|NCT00123474|39559581|FG003|As Treated at Study Closure|Investigator Request|5|||
16484431|NCT01393301|40248910|FG001|Overall Study|Withdrawal by Subject|0|||
16484432|NCT01393301|40248909|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
16484433|NCT01393301|40248910|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
16484434|NCT01084083|40248911|FG000|Overall Study|Adverse Event|5|||
16484435|NCT01084083|40248911|FG000|Overall Study|Death|1|||
16484436|NCT01084083|40248911|FG000|Overall Study|Withdrawal by Subject|2|||
16484437|NCT01084083|40248911|FG000|Overall Study|Complicating disease|1|||
16484438|NCT01084083|40248911|FG000|Overall Study|Other|2|||
16484439|NCT01084083|40248911|FG000|Overall Study|Never started assigned therapy|1|||
16484440|NCT01999868|40248912|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
16293616|NCT00123474|39559578|FG000|As Treated at Study Closure|non-specified|54|||
16293617|NCT00123474|39559579|FG001|As Treated at Study Closure|non-specified|47|||
16381952|NCT05201807|39881594|FG000|Overall Study|COVID-19 Related|1|||
16293618|NCT00123474|39559580|FG002|As Treated at Study Closure|non-specified|57|||
16293619|NCT00123474|39559581|FG003|As Treated at Study Closure|non-specified|60|||
16293620|NCT00123474|39559578|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
16293621|NCT00123474|39559579|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
16293622|NCT00123474|39559580|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
16293623|NCT00123474|39559581|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
16293624|NCT00123474|39559578|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
16293625|NCT00123474|39559579|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
16293626|NCT00123474|39559580|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
16293627|NCT00123474|39559581|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
16293628|NCT03276221|39559582|FG000|Overall Study|Lost to Follow-up|6|||
16293629|NCT03276221|39559583|FG001|Overall Study|Lost to Follow-up|2|||
16293630|NCT03276221|39559584|FG002|Overall Study|Lost to Follow-up|0|||
16293631|NCT03276221|39559582|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
16293632|NCT03276221|39559583|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
16293633|NCT03276221|39559584|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
16293634|NCT02669940|39559586|FG000|Overall Study|Failure to return|0|||
16293635|NCT02669940|39559587|FG001|Overall Study|Failure to return|3|||
16293636|NCT02669940|39559586|FG000|Overall Study|Insufficient follow-up data|1|||
16293637|NCT02669940|39559587|FG001|Overall Study|Insufficient follow-up data|0|||
16293638|NCT00725205|39559588|FG000|Overall Study|Adverse Event|22|||
16293639|NCT00725205|39559588|FG000|Overall Study|Investigator Discontinued|1|||
16293640|NCT00725205|39559588|FG000|Overall Study|Non-compliance With Protocol|14|||
16293641|NCT00725205|39559588|FG000|Overall Study|Other|8|||
16293642|NCT00725205|39559588|FG000|Overall Study|Protocol Defined Clinical Event|1|||
16293643|NCT00725205|39559588|FG000|Overall Study|Treatment Failure|41|||
16293644|NCT02963311|39559589|FG000|Overall Study|Withdrawal by Subject|1|||
16293645|NCT02963311|39559589|FG000|Overall Study|Screen Failure|4|||
16293646|NCT03301623|39559590|FG000|Overall Study|Death|3|||
16293647|NCT03301623|39559591|FG001|Overall Study|Death|1|||
16293648|NCT03301623|39559590|FG000|Overall Study|Withdrawal by Subject|11|||
16293649|NCT03301623|39559591|FG001|Overall Study|Withdrawal by Subject|13|||
16293650|NCT03301623|39559590|FG000|Overall Study|Lost to Follow-up|3|||
16293651|NCT03301623|39559591|FG001|Overall Study|Lost to Follow-up|1|||
16293652|NCT01193127|39559594|FG000|Randomized|Surgery Cancelled|0|||
16293653|NCT01193127|39559595|FG001|Randomized|Surgery Cancelled|0|||
16293654|NCT01193127|39559596|FG002|Randomized|Surgery Cancelled|0|||
16293655|NCT01193127|39559597|FG003|Randomized|Surgery Cancelled|1|||
16293656|NCT01193127|39559594|FG000|Treated|Withdrawal by Subject|0|||
16293657|NCT01193127|39559595|FG001|Treated|Withdrawal by Subject|0|||
16293658|NCT01193127|39559596|FG002|Treated|Withdrawal by Subject|0|||
16293659|NCT01193127|39559597|FG003|Treated|Withdrawal by Subject|1|||
16293660|NCT00278889|39559598|FG000|Overall Study|Withdrawal by Subject|0|||
16293661|NCT00278889|39559599|FG001|Overall Study|Withdrawal by Subject|5|||
16293662|NCT00278889|39559600|FG002|Overall Study|Withdrawal by Subject|3|||
16293663|NCT00278889|39559598|FG000|Overall Study|Lost to Follow-up|1|||
16293664|NCT00278889|39559599|FG001|Overall Study|Lost to Follow-up|1|||
16293665|NCT00278889|39559600|FG002|Overall Study|Lost to Follow-up|0|||
16293666|NCT00278889|39559598|FG000|Overall Study|Death|24|||
16293667|NCT00278889|39559599|FG001|Overall Study|Death|21|||
16293668|NCT00278889|39559600|FG002|Overall Study|Death|17|||
16293669|NCT05142566|39559601|FG000|Overall Study|Protocol Violation|1|||
16293670|NCT02828241|39559602|FG000|Overall Study|Adverse Event|7|||
16484441|NCT01999868|40248913|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
16484442|NCT01999868|40248914|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
16484443|NCT01999868|40248912|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
16484444|NCT01999868|40248913|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
16484445|NCT01999868|40248914|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
16484446|NCT01999868|40248912|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
16484447|NCT01999868|40248913|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
16484448|NCT01999868|40248914|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
16293671|NCT02828241|39559603|FG001|Overall Study|Adverse Event|2|||
16293672|NCT02828241|39559602|FG000|Overall Study|Protocol Violation|1|||
16293673|NCT02828241|39559603|FG001|Overall Study|Protocol Violation|0|||
16293674|NCT03760250|39559604|FG000|Overall Study|Withdrawal by Subject|1|||
16293675|NCT03760250|39559604|FG000|Overall Study|Physician Decision|1|||
16293676|NCT00686075|39559605|FG000|Overall Study|Withdrawal by Subject|4|||
16293677|NCT00686075|39559606|FG001|Overall Study|Withdrawal by Subject|3|||
16293678|NCT00686075|39559607|FG002|Overall Study|Withdrawal by Subject|3|||
16293679|NCT00686075|39559608|FG003|Overall Study|Withdrawal by Subject|7|||
16293680|NCT00686075|39559609|FG004|Overall Study|Withdrawal by Subject|1|||
16484449|NCT01999868|40248912|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
16293681|NCT00686075|39559610|FG005|Overall Study|Withdrawal by Subject|0|||
16293682|NCT00686075|39559611|FG006|Overall Study|Withdrawal by Subject|0|||
16484450|NCT01999868|40248913|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
16187435|NCT01371838|39164907|FG001|Overall Study|Protocol Violation|0|||
16187436|NCT01371838|39164906|FG000|Overall Study|Investigator Decision|3|||
16187437|NCT01371838|39164907|FG001|Overall Study|Investigator Decision|8|||
16187438|NCT01371838|39164906|FG000|Overall Study|Last follow-up visit not conducted|2|||
16187439|NCT01371838|39164907|FG001|Overall Study|Last follow-up visit not conducted|0|||
16187440|NCT01371838|39164906|FG000|Overall Study|Lack of therapeutic response|0|||
16187441|NCT01371838|39164907|FG001|Overall Study|Lack of therapeutic response|1|||
16187442|NCT01371838|39164906|FG000|Overall Study|Surgery|1|||
16187443|NCT01371838|39164907|FG001|Overall Study|Surgery|0|||
16187444|NCT01035606|39164908|FG000|Overall Study|change in health, job demands,family|3|||
16187445|NCT01035606|39164909|FG001|Overall Study|change in health, job demands,family|3|||
16187446|NCT01035606|39164910|FG002|Overall Study|change in health, job demands,family|4|||
16187447|NCT02050048|39164917|FG000|Overall Study|Lost to Follow-up|0|||
16187448|NCT02050048|39164918|FG001|Overall Study|Lost to Follow-up|1|||
16187449|NCT02050048|39164917|FG000|Overall Study|Death|1|||
16187450|NCT02050048|39164918|FG001|Overall Study|Death|0|||
16187451|NCT02050048|39164917|FG000|Overall Study|Ineligible after ERCP|4|||
16187452|NCT02050048|39164918|FG001|Overall Study|Ineligible after ERCP|1|||
16187453|NCT01765764|39164919|FG000|Treatment Period|Adverse Event|1|||
16187454|NCT01765764|39164920|FG001|Treatment Period|Adverse Event|2|||
16187455|NCT01765764|39164921|FG002|Treatment Period|Adverse Event|1|||
16187456|NCT01765764|39164919|FG000|Treatment Period|Lost to Follow-up|0|||
16187457|NCT01765764|39164920|FG001|Treatment Period|Lost to Follow-up|3|||
16187458|NCT01765764|39164921|FG002|Treatment Period|Lost to Follow-up|2|||
16187459|NCT01765764|39164919|FG000|Treatment Period|Personal Reasons|1|||
16187460|NCT01765764|39164920|FG001|Treatment Period|Personal Reasons|2|||
16187461|NCT01765764|39164921|FG002|Treatment Period|Personal Reasons|1|||
16187462|NCT01765764|39164919|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
16187463|NCT01765764|39164920|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
16187464|NCT01765764|39164921|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
16187465|NCT01958671|39164922|FG000|Overall Study|Adverse Event|1|||
16187466|NCT01958671|39164923|FG001|Overall Study|Adverse Event|1|||
16187467|NCT01958671|39164924|FG002|Overall Study|Adverse Event|5|||
16187468|NCT01958671|39164922|FG000|Overall Study|Death|1|||
16187469|NCT01958671|39164923|FG001|Overall Study|Death|0|||
16187470|NCT01958671|39164924|FG002|Overall Study|Death|0|||
16187471|NCT01958671|39164922|FG000|Overall Study|Excluded medication|0|||
16187472|NCT01958671|39164923|FG001|Overall Study|Excluded medication|0|||
16187473|NCT01958671|39164924|FG002|Overall Study|Excluded medication|1|||
16187474|NCT01958671|39164922|FG000|Overall Study|Hyperglycemia|0|||
16187475|NCT01958671|39164923|FG001|Overall Study|Hyperglycemia|0|||
16187476|NCT01958671|39164924|FG002|Overall Study|Hyperglycemia|2|||
16187477|NCT01958671|39164922|FG000|Overall Study|Lost to Follow-up|7|||
16187478|NCT01958671|39164923|FG001|Overall Study|Lost to Follow-up|11|||
16187479|NCT01958671|39164924|FG002|Overall Study|Lost to Follow-up|7|||
16187480|NCT01958671|39164922|FG000|Overall Study|Non-compliance with study drug|1|||
16187481|NCT01958671|39164923|FG001|Overall Study|Non-compliance with study drug|1|||
16187482|NCT01958671|39164924|FG002|Overall Study|Non-compliance with study drug|1|||
16187483|NCT01958671|39164922|FG000|Overall Study|Pregnancy|0|||
16187484|NCT01958671|39164923|FG001|Overall Study|Pregnancy|0|||
16187485|NCT01958671|39164924|FG002|Overall Study|Pregnancy|1|||
16187486|NCT01958671|39164922|FG000|Overall Study|Protocol Violation|0|||
16187487|NCT01958671|39164923|FG001|Overall Study|Protocol Violation|1|||
16187488|NCT01958671|39164924|FG002|Overall Study|Protocol Violation|0|||
16187489|NCT01958671|39164922|FG000|Overall Study|Study site terminated by sponsor|1|||
16187490|NCT01958671|39164923|FG001|Overall Study|Study site terminated by sponsor|0|||
16187491|NCT01958671|39164924|FG002|Overall Study|Study site terminated by sponsor|1|||
16187492|NCT01958671|39164922|FG000|Overall Study|Participant moved|0|||
16187493|NCT01958671|39164923|FG001|Overall Study|Participant moved|0|||
16187494|NCT01958671|39164924|FG002|Overall Study|Participant moved|1|||
16187495|NCT01958671|39164922|FG000|Overall Study|Withdrawal by Subject|8|||
16187496|NCT01958671|39164923|FG001|Overall Study|Withdrawal by Subject|10|||
16187497|NCT01958671|39164924|FG002|Overall Study|Withdrawal by Subject|13|||
16187498|NCT03488472|39164927|FG000|Overall Study|disease progression additional mets|1|||
16187499|NCT02761993|39164928|FG000|Overall Study|Adverse Event|0|||
16187500|NCT02761993|39164929|FG001|Overall Study|Adverse Event|2|||
16187501|NCT02761993|39164930|FG002|Overall Study|Adverse Event|0|||
16187502|NCT02761993|39164928|FG000|Overall Study|Lost to Follow-up|1|||
16187503|NCT02761993|39164929|FG001|Overall Study|Lost to Follow-up|3|||
16187504|NCT02761993|39164930|FG002|Overall Study|Lost to Follow-up|2|||
16187505|NCT02761993|39164928|FG000|Overall Study|Withdrawal by Subject|1|||
16187506|NCT02761993|39164929|FG001|Overall Study|Withdrawal by Subject|1|||
16187507|NCT02761993|39164930|FG002|Overall Study|Withdrawal by Subject|2|||
16187508|NCT01097330|39164931|FG000|Overall Study|Study terminated early|7|||
16187509|NCT01097330|39164932|FG001|Overall Study|Study terminated early|5|||
16187510|NCT03074162|39164933|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
16381953|NCT00522379|39881598|FG000|Overall Study|Adverse Event|12|||
16293683|NCT00686075|39559612|FG007|Overall Study|Withdrawal by Subject|2|||
16293684|NCT00686075|39559613|FG008|Overall Study|Withdrawal by Subject|4|||
16293685|NCT00686075|39559614|FG009|Overall Study|Withdrawal by Subject|6|||
16484451|NCT01999868|40248914|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
16484452|NCT01999868|40248912|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
16484453|NCT01999868|40248913|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
16484454|NCT01999868|40248914|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
16484455|NCT01999868|40248912|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
16484456|NCT01999868|40248913|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
16293686|NCT00686075|39559605|FG000|Overall Study|Lost to Follow-up|3|||
16293687|NCT00686075|39559606|FG001|Overall Study|Lost to Follow-up|6|||
16293688|NCT00686075|39559607|FG002|Overall Study|Lost to Follow-up|3|||
16293689|NCT00686075|39559608|FG003|Overall Study|Lost to Follow-up|2|||
16293690|NCT00686075|39559609|FG004|Overall Study|Lost to Follow-up|3|||
16293691|NCT00686075|39559610|FG005|Overall Study|Lost to Follow-up|3|||
16293692|NCT00686075|39559611|FG006|Overall Study|Lost to Follow-up|0|||
16293693|NCT00686075|39559612|FG007|Overall Study|Lost to Follow-up|0|||
16293694|NCT00686075|39559613|FG008|Overall Study|Lost to Follow-up|2|||
16293695|NCT00686075|39559614|FG009|Overall Study|Lost to Follow-up|3|||
16293696|NCT00686075|39559605|FG000|Overall Study|Other|1|||
16293697|NCT00686075|39559606|FG001|Overall Study|Other|1|||
16293698|NCT00686075|39559607|FG002|Overall Study|Other|0|||
16293699|NCT00686075|39559608|FG003|Overall Study|Other|0|||
16293700|NCT00686075|39559609|FG004|Overall Study|Other|0|||
16293701|NCT00686075|39559610|FG005|Overall Study|Other|0|||
16293702|NCT00686075|39559611|FG006|Overall Study|Other|0|||
16293703|NCT00686075|39559612|FG007|Overall Study|Other|0|||
16293704|NCT00686075|39559613|FG008|Overall Study|Other|0|||
16293705|NCT00686075|39559614|FG009|Overall Study|Other|1|||
16293706|NCT01173471|39559615|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16293707|NCT01173471|39559616|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16293708|NCT01173471|39559617|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
16293709|NCT01173471|39559618|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
16293710|NCT01173471|39559615|FG000|Overall Study|Condition under investigation worsened|2|||
16293711|NCT01173471|39559616|FG001|Overall Study|Condition under investigation worsened|0|||
16293712|NCT01173471|39559617|FG002|Overall Study|Condition under investigation worsened|0|||
16381954|NCT00522379|39881599|FG001|Overall Study|Adverse Event|15|||
16381955|NCT00522379|39881600|FG002|Overall Study|Adverse Event|12|||
16381956|NCT00522379|39881601|FG003|Overall Study|Adverse Event|5|||
16381957|NCT00522379|39881602|FG004|Overall Study|Adverse Event|17|||
16381958|NCT00522379|39881598|FG000|Overall Study|Lack of Efficacy|3|||
16381959|NCT00522379|39881599|FG001|Overall Study|Lack of Efficacy|0|||
16381960|NCT00522379|39881600|FG002|Overall Study|Lack of Efficacy|2|||
16293713|NCT01173471|39559618|FG003|Overall Study|Condition under investigation worsened|0|||
16293714|NCT01173471|39559615|FG000|Overall Study|Lost to Follow-up|0|||
16293715|NCT01173471|39559616|FG001|Overall Study|Lost to Follow-up|0|||
16293716|NCT01173471|39559617|FG002|Overall Study|Lost to Follow-up|1|||
16381961|NCT00522379|39881601|FG003|Overall Study|Lack of Efficacy|2|||
16381962|NCT00522379|39881602|FG004|Overall Study|Lack of Efficacy|7|||
16293717|NCT01173471|39559618|FG003|Overall Study|Lost to Follow-up|0|||
16381963|NCT00522379|39881598|FG000|Overall Study|Withdrawal by Subject|2|||
16484457|NCT01999868|40248914|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
16484458|NCT01999868|40248912|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
16484459|NCT01999868|40248913|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
16484460|NCT01999868|40248914|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
16484461|NCT01999868|40248912|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
16484462|NCT01999868|40248913|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
16484463|NCT01999868|40248914|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
16484464|NCT01999868|40248912|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
16484465|NCT01999868|40248913|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
16484466|NCT01999868|40248914|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
16293718|NCT01173471|39559615|FG000|Overall Study|Reason given as Other|0|||
16293719|NCT01173471|39559616|FG001|Overall Study|Reason given as Other|0|||
16293720|NCT01173471|39559617|FG002|Overall Study|Reason given as Other|1|||
16293721|NCT01173471|39559618|FG003|Overall Study|Reason given as Other|0|||
16381964|NCT00522379|39881599|FG001|Overall Study|Withdrawal by Subject|3|||
16081569|NCT02392234|38792682|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
16081570|NCT02392234|38792683|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
16081571|NCT02392234|38792684|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
16081572|NCT02392234|38792685|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
16081573|NCT02392234|38792680|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
16081574|NCT02392234|38792681|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
16081575|NCT02392234|38792682|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
16081576|NCT02392234|38792683|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
16081577|NCT02392234|38792684|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
16081578|NCT02392234|38792685|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
16081579|NCT02392234|38792680|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
16081580|NCT02392234|38792681|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
16081581|NCT02392234|38792682|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
16081582|NCT02392234|38792683|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
16081583|NCT02392234|38792684|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
16081584|NCT02392234|38792685|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
16081585|NCT02392234|38792680|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
16081586|NCT02392234|38792681|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
16081587|NCT02392234|38792682|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
16081588|NCT02392234|38792683|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
16081589|NCT02392234|38792684|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
16081590|NCT02392234|38792685|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
16081591|NCT00609336|38792686|FG000|Overall Study|Protocol Violation|3|||
16081592|NCT00609336|38792686|FG000|Overall Study|Death|1|||
16081593|NCT00609336|38792686|FG000|Overall Study|LA or Met at Surgery|9|||
16081594|NCT03664960|38792687|FG000|Overall Study|Adverse Event|0|||
16381965|NCT00522379|39881600|FG002|Overall Study|Withdrawal by Subject|1|||
16381966|NCT00522379|39881601|FG003|Overall Study|Withdrawal by Subject|2|||
16381967|NCT00522379|39881602|FG004|Overall Study|Withdrawal by Subject|0|||
16381968|NCT00522379|39881598|FG000|Overall Study|Protocol Violation|1|||
16381969|NCT00522379|39881599|FG001|Overall Study|Protocol Violation|1|||
16381970|NCT00522379|39881600|FG002|Overall Study|Protocol Violation|2|||
16381971|NCT00522379|39881601|FG003|Overall Study|Protocol Violation|0|||
16381972|NCT00522379|39881602|FG004|Overall Study|Protocol Violation|0|||
16381973|NCT00522379|39881598|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
16381974|NCT00522379|39881599|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
16381975|NCT00522379|39881600|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
16381976|NCT00522379|39881601|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
16381977|NCT00522379|39881602|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
16381978|NCT00522379|39881598|FG000|Overall Study|Lost to Follow-up|1|||
16381979|NCT00522379|39881599|FG001|Overall Study|Lost to Follow-up|0|||
16381980|NCT00522379|39881600|FG002|Overall Study|Lost to Follow-up|4|||
16381981|NCT00522379|39881601|FG003|Overall Study|Lost to Follow-up|2|||
16381982|NCT00522379|39881602|FG004|Overall Study|Lost to Follow-up|2|||
16381983|NCT00522379|39881598|FG000|Overall Study|Randomization error|0|||
16381984|NCT00522379|39881599|FG001|Overall Study|Randomization error|0|||
16381985|NCT00522379|39881600|FG002|Overall Study|Randomization error|0|||
16381986|NCT00522379|39881601|FG003|Overall Study|Randomization error|0|||
16381987|NCT00522379|39881602|FG004|Overall Study|Randomization error|1|||
16381988|NCT00522379|39881598|FG000|Overall Study|Dispensing error|1|||
16381989|NCT00522379|39881599|FG001|Overall Study|Dispensing error|0|||
16381990|NCT00522379|39881600|FG002|Overall Study|Dispensing error|0|||
16381991|NCT00522379|39881601|FG003|Overall Study|Dispensing error|1|||
16381992|NCT00522379|39881602|FG004|Overall Study|Dispensing error|0|||
16381993|NCT00522379|39881598|FG000|Overall Study|Subject Moved|1|||
16381994|NCT00522379|39881599|FG001|Overall Study|Subject Moved|1|||
16381995|NCT00522379|39881600|FG002|Overall Study|Subject Moved|0|||
16381996|NCT00522379|39881601|FG003|Overall Study|Subject Moved|0|||
16381997|NCT00522379|39881602|FG004|Overall Study|Subject Moved|0|||
16381998|NCT00522379|39881598|FG000|Overall Study|Sponsor Request|0|||
16381999|NCT00522379|39881599|FG001|Overall Study|Sponsor Request|1|||
16382000|NCT00522379|39881600|FG002|Overall Study|Sponsor Request|0|||
16382001|NCT00522379|39881601|FG003|Overall Study|Sponsor Request|0|||
16382002|NCT00522379|39881602|FG004|Overall Study|Sponsor Request|0|||
16382003|NCT00522379|39881598|FG000|Overall Study|Family Problem|0|||
16081595|NCT03664960|38792688|FG001|Overall Study|Adverse Event|3|||
16187511|NCT03074162|39164934|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
16382004|NCT00522379|39881599|FG001|Overall Study|Family Problem|0|||
16382005|NCT00522379|39881600|FG002|Overall Study|Family Problem|1|||
16382006|NCT00522379|39881601|FG003|Overall Study|Family Problem|0|||
16382007|NCT00522379|39881602|FG004|Overall Study|Family Problem|0|||
16382008|NCT00522379|39881598|FG000|Overall Study|Site Closed|0|||
16382009|NCT00522379|39881599|FG001|Overall Study|Site Closed|0|||
16382010|NCT00522379|39881600|FG002|Overall Study|Site Closed|0|||
16382011|NCT00522379|39881601|FG003|Overall Study|Site Closed|1|||
16382012|NCT00522379|39881602|FG004|Overall Study|Site Closed|0|||
16382013|NCT00522379|39881598|FG000|Overall Study|Subject Withdrawal|0|||
16382014|NCT00522379|39881599|FG001|Overall Study|Subject Withdrawal|0|||
16382015|NCT00522379|39881600|FG002|Overall Study|Subject Withdrawal|0|||
16382016|NCT00522379|39881601|FG003|Overall Study|Subject Withdrawal|1|||
16382017|NCT00522379|39881602|FG004|Overall Study|Subject Withdrawal|0|||
16382018|NCT02561962|39881603|FG000|Overall Study|Withdrawal by Subject|1|||
16382019|NCT02561962|39881604|FG001|Overall Study|Withdrawal by Subject|0|||
16382020|NCT02561962|39881605|FG002|Overall Study|Withdrawal by Subject|0|||
16382021|NCT02561962|39881606|FG003|Overall Study|Withdrawal by Subject|0|||
16382022|NCT02561962|39881607|FG004|Overall Study|Withdrawal by Subject|1|||
16382023|NCT02561962|39881608|FG005|Overall Study|Withdrawal by Subject|1|||
16382024|NCT02561962|39881609|FG006|Overall Study|Withdrawal by Subject|2|||
16382025|NCT02561962|39881610|FG007|Overall Study|Withdrawal by Subject|1|||
16382026|NCT02561962|39881611|FG008|Overall Study|Withdrawal by Subject|0|||
16382027|NCT02561962|39881603|FG000|Overall Study|Decision by sponsor|0|||
16382028|NCT02561962|39881604|FG001|Overall Study|Decision by sponsor|0|||
16382029|NCT02561962|39881605|FG002|Overall Study|Decision by sponsor|0|||
16382030|NCT02561962|39881606|FG003|Overall Study|Decision by sponsor|0|||
16382031|NCT02561962|39881607|FG004|Overall Study|Decision by sponsor|1|||
16382032|NCT02561962|39881608|FG005|Overall Study|Decision by sponsor|1|||
16382033|NCT02561962|39881609|FG006|Overall Study|Decision by sponsor|0|||
16382034|NCT02561962|39881610|FG007|Overall Study|Decision by sponsor|3|||
16382035|NCT02561962|39881611|FG008|Overall Study|Decision by sponsor|0|||
16382036|NCT02561962|39881603|FG000|Overall Study|Lost to Follow-up|0|||
16382037|NCT02561962|39881604|FG001|Overall Study|Lost to Follow-up|0|||
16382038|NCT02561962|39881605|FG002|Overall Study|Lost to Follow-up|0|||
16382039|NCT02561962|39881606|FG003|Overall Study|Lost to Follow-up|0|||
16382040|NCT02561962|39881607|FG004|Overall Study|Lost to Follow-up|0|||
16382041|NCT02561962|39881608|FG005|Overall Study|Lost to Follow-up|1|||
16382042|NCT02561962|39881609|FG006|Overall Study|Lost to Follow-up|0|||
16382043|NCT02561962|39881610|FG007|Overall Study|Lost to Follow-up|0|||
16382044|NCT02561962|39881611|FG008|Overall Study|Lost to Follow-up|0|||
16382045|NCT00565747|39881612|FG000|Overall Study|No embryo transfer|67|||
16382046|NCT00565747|39881613|FG001|Overall Study|No embryo transfer|73|||
16382047|NCT03132467|39881614|FG000|Overall Study|Adverse Event|2|||
16382048|NCT03132467|39881614|FG000|Overall Study|Withdrawal by Subject|2|||
16382049|NCT00163189|39881616|FG000|Overall Study|Other|6|||
16382050|NCT00163189|39881616|FG000|Overall Study|Lost to Follow-up|1|||
16382051|NCT00163189|39881616|FG000|Overall Study|Protocol Violation|2|||
16382052|NCT00163189|39881616|FG000|Overall Study|Death|3|||
16187512|NCT03074162|39164935|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
16187513|NCT03074162|39164936|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
16187514|NCT03074162|39164937|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
16187515|NCT03074162|39164938|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
16187516|NCT03074162|39164933|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
16187517|NCT03074162|39164934|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
16187518|NCT03074162|39164935|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
16187519|NCT03074162|39164936|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
16187520|NCT03074162|39164937|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
16187521|NCT03074162|39164938|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
16187522|NCT03074162|39164933|FG000|Period 3|Withdrawal by Subject|1|||
16187523|NCT03074162|39164934|FG001|Period 3|Withdrawal by Subject|0|||
16187524|NCT03074162|39164935|FG002|Period 3|Withdrawal by Subject|0|||
16187525|NCT03074162|39164936|FG003|Period 3|Withdrawal by Subject|0|||
16187526|NCT03074162|39164937|FG004|Period 3|Withdrawal by Subject|1|||
16187527|NCT03074162|39164938|FG005|Period 3|Withdrawal by Subject|0|||
16187528|NCT01505491|39164939|FG000|Overall Study|Other reason not listed|1|||
16187529|NCT01505491|39164940|FG001|Overall Study|Other reason not listed|0|||
16187530|NCT01505491|39164941|FG002|Overall Study|Other reason not listed|0|||
16187531|NCT01505491|39164939|FG000|Overall Study|Withdrawal by Subject|1|||
16187532|NCT01505491|39164940|FG001|Overall Study|Withdrawal by Subject|1|||
16187533|NCT01505491|39164941|FG002|Overall Study|Withdrawal by Subject|4|||
16187534|NCT01505491|39164939|FG000|Overall Study|Lost to Follow-up|0|||
16187535|NCT01505491|39164940|FG001|Overall Study|Lost to Follow-up|0|||
16187536|NCT01505491|39164941|FG002|Overall Study|Lost to Follow-up|1|||
16187537|NCT02720016|39164942|FG000|Overall Study|Separation of couple|6|||
16382053|NCT00163189|39881616|FG000|Overall Study|Adverse Event|6|||
16382054|NCT00163189|39881616|FG000|Overall Study|Lack of Efficacy|7|||
16382055|NCT00163189|39881616|FG000|Overall Study|Study terminated by sponsor|11|||
16382056|NCT00163189|39881616|FG000|Overall Study|Withdrawal by Subject|11|||
16382057|NCT00163189|39881616|FG000|Overall Study|Did not meet continuation criterion|16|||
16382058|NCT05166902|39881619|FG000|First Intervention|Lost to Follow-up|0|||
16382059|NCT05166902|39881620|FG001|First Intervention|Lost to Follow-up|1|||
16382060|NCT01959932|39881621|FG000|Overall Study|Withdrawal by Subject|1|||
16382061|NCT01959932|39881622|FG001|Overall Study|Withdrawal by Subject|0|||
16382062|NCT01959932|39881623|FG002|Overall Study|Withdrawal by Subject|0|||
16382063|NCT00754572|39881625|FG000|Overall Study|Adverse Event|19|||
16187538|NCT02720016|39164943|FG001|Overall Study|Separation of couple|8|||
16187539|NCT02720016|39164944|FG002|Overall Study|Separation of couple|2|||
16187540|NCT02720016|39164942|FG000|Overall Study|Withdrawal by Subject|6|||
16187541|NCT02720016|39164943|FG001|Overall Study|Withdrawal by Subject|6|||
16187542|NCT02720016|39164944|FG002|Overall Study|Withdrawal by Subject|4|||
16187543|NCT02720016|39164942|FG000|Overall Study|Scheduling issues|2|||
16187544|NCT02720016|39164943|FG001|Overall Study|Scheduling issues|4|||
16187545|NCT02720016|39164944|FG002|Overall Study|Scheduling issues|7|||
16187546|NCT02720016|39164942|FG000|Overall Study|Childcare|2|||
16187547|NCT02720016|39164943|FG001|Overall Study|Childcare|0|||
16187548|NCT02720016|39164944|FG002|Overall Study|Childcare|2|||
16187549|NCT02720016|39164942|FG000|Overall Study|Withdrawal by PI|2|||
16187550|NCT02720016|39164943|FG001|Overall Study|Withdrawal by PI|2|||
16187551|NCT02720016|39164944|FG002|Overall Study|Withdrawal by PI|0|||
16187552|NCT02720016|39164942|FG000|Overall Study|Moved away|2|||
16187553|NCT02720016|39164943|FG001|Overall Study|Moved away|0|||
16187554|NCT02720016|39164944|FG002|Overall Study|Moved away|0|||
16187555|NCT02720016|39164942|FG000|Overall Study|Not Primary Health Concern|0|||
16187556|NCT02720016|39164943|FG001|Overall Study|Not Primary Health Concern|0|||
16187557|NCT02720016|39164944|FG002|Overall Study|Not Primary Health Concern|2|||
16187558|NCT02720016|39164942|FG000|Overall Study|Transportation issues|0|||
16187559|NCT02720016|39164943|FG001|Overall Study|Transportation issues|0|||
16187560|NCT02720016|39164944|FG002|Overall Study|Transportation issues|1|||
16187561|NCT02720016|39164942|FG000|Overall Study|Other|0|||
16187562|NCT02720016|39164943|FG001|Overall Study|Other|0|||
16187563|NCT02720016|39164944|FG002|Overall Study|Other|2|||
16187564|NCT01259297|39164945|FG000|Double Blind Randomized Period|Death|1|||
16187565|NCT01259297|39164946|FG001|Double Blind Randomized Period|Death|1|||
16187566|NCT01259297|39164947|FG002|Double Blind Randomized Period|Death|1|||
16187567|NCT01259297|39164948|FG003|Double Blind Randomized Period|Death|2|||
16187568|NCT01259297|39164949|FG004|Double Blind Randomized Period|Death|1|||
16187569|NCT01259297|39164950|FG005|Double Blind Randomized Period|Death|5|||
16187570|NCT01259297|39164951|FG006|Double Blind Randomized Period|Death|2|||
16187571|NCT01259297|39164952|FG007|Double Blind Randomized Period|Death|1|||
16187572|NCT01259297|39164945|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
16293722|NCT03733210|39559619|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
16293723|NCT03733210|39559620|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
16293724|NCT00418821|39559621|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
16293725|NCT02303041|39559622|FG000|Overall Study|Adverse Event|1|||
16293726|NCT02303041|39559623|FG001|Overall Study|Adverse Event|2|||
16293727|NCT00158600|39559624|FG000|Overall Study|unable to commit time to study|0|||
16293728|NCT00158600|39559625|FG001|Overall Study|unable to commit time to study|1|||
16293729|NCT00158600|39559624|FG000|Overall Study|Adverse Event|2|||
16293730|NCT00158600|39559625|FG001|Overall Study|Adverse Event|1|||
16293731|NCT00158600|39559624|FG000|Overall Study|Death|1|||
16293732|NCT00158600|39559625|FG001|Overall Study|Death|0|||
16293733|NCT00158600|39559624|FG000|Overall Study|Withdrawal by Subject|2|||
16293734|NCT00158600|39559625|FG001|Overall Study|Withdrawal by Subject|2|||
16293735|NCT01300052|39559626|FG000|Overall Study|Adverse Event|3|||
16293736|NCT01300052|39559627|FG001|Overall Study|Adverse Event|0|||
16293737|NCT01300052|39559626|FG000|Overall Study|Withdrawal by Subject|2|||
16293738|NCT01300052|39559627|FG001|Overall Study|Withdrawal by Subject|2|||
16293739|NCT01300052|39559626|FG000|Overall Study|Protocol Violation|1|||
16293740|NCT01300052|39559627|FG001|Overall Study|Protocol Violation|1|||
16293741|NCT01172821|39559628|FG000|Overall Study|Adverse Event|5|||
16293742|NCT01172821|39559629|FG001|Overall Study|Adverse Event|2|||
16187573|NCT01259297|39164946|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
16187574|NCT01259297|39164947|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
16187575|NCT01259297|39164948|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
16187576|NCT01259297|39164949|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
16187577|NCT01259297|39164950|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
16187578|NCT01259297|39164951|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
16187579|NCT01259297|39164952|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
16187580|NCT01259297|39164945|FG000|Double Blind Randomized Period|Other reasons|0|||
16187581|NCT01259297|39164946|FG001|Double Blind Randomized Period|Other reasons|1|||
16187582|NCT01259297|39164947|FG002|Double Blind Randomized Period|Other reasons|0|||
16293743|NCT01172821|39559630|FG002|Overall Study|Adverse Event|2|||
16293744|NCT01172821|39559631|FG003|Overall Study|Adverse Event|7|||
16293745|NCT01172821|39559628|FG000|Overall Study|Protocol Violation|0|||
16293746|NCT01172821|39559629|FG001|Overall Study|Protocol Violation|2|||
16293747|NCT01172821|39559630|FG002|Overall Study|Protocol Violation|1|||
16293748|NCT01172821|39559631|FG003|Overall Study|Protocol Violation|2|||
16293749|NCT01172821|39559628|FG000|Overall Study|Lost to Follow-up|4|||
16293750|NCT01172821|39559629|FG001|Overall Study|Lost to Follow-up|1|||
16293751|NCT01172821|39559630|FG002|Overall Study|Lost to Follow-up|2|||
16293752|NCT01172821|39559631|FG003|Overall Study|Lost to Follow-up|2|||
16293753|NCT01172821|39559628|FG000|Overall Study|Withdrawal by Subject|2|||
16293754|NCT01172821|39559629|FG001|Overall Study|Withdrawal by Subject|3|||
16293755|NCT01172821|39559630|FG002|Overall Study|Withdrawal by Subject|3|||
16293756|NCT01172821|39559631|FG003|Overall Study|Withdrawal by Subject|3|||
16293757|NCT01172821|39559628|FG000|Overall Study|Other|3|||
16293758|NCT01172821|39559629|FG001|Overall Study|Other|4|||
16293759|NCT01172821|39559630|FG002|Overall Study|Other|5|||
16187583|NCT01259297|39164948|FG003|Double Blind Randomized Period|Other reasons|0|||
16187584|NCT01259297|39164949|FG004|Double Blind Randomized Period|Other reasons|1|||
16187585|NCT01259297|39164950|FG005|Double Blind Randomized Period|Other reasons|2|||
16187586|NCT01259297|39164951|FG006|Double Blind Randomized Period|Other reasons|3|||
16187587|NCT01259297|39164952|FG007|Double Blind Randomized Period|Other reasons|1|||
16187588|NCT03510663|39164953|FG000|Overall Study|Withdrawal by Subject|0|||
16187589|NCT03510663|39164954|FG001|Overall Study|Withdrawal by Subject|1|||
16187590|NCT03510663|39164955|FG002|Overall Study|Withdrawal by Subject|0|||
16187591|NCT03510663|39164956|FG003|Overall Study|Withdrawal by Subject|0|||
16187592|NCT03510663|39164957|FG004|Overall Study|Withdrawal by Subject|0|||
16187593|NCT03510663|39164958|FG005|Overall Study|Withdrawal by Subject|0|||
16484467|NCT01999868|40248912|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
16484468|NCT01999868|40248913|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
16484469|NCT01999868|40248914|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
16484470|NCT01999868|40248912|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
16484471|NCT01999868|40248913|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
16484472|NCT01999868|40248914|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
16484473|NCT01999868|40248912|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
16484474|NCT01999868|40248913|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
16484475|NCT01999868|40248914|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
16484476|NCT01999868|40248912|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
16484477|NCT01999868|40248913|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
16484478|NCT01999868|40248914|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
16484479|NCT01999868|40248912|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
16484480|NCT01999868|40248913|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
16484481|NCT01999868|40248914|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
16484482|NCT01999868|40248912|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
16484483|NCT01999868|40248913|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
16187594|NCT03510663|39164959|FG006|Overall Study|Withdrawal by Subject|0|||
16187595|NCT03510663|39164960|FG007|Overall Study|Withdrawal by Subject|0|||
16187596|NCT02508701|39164966|FG000|Overall Study|Lost to Follow-up|9|||
16187597|NCT02508701|39164967|FG001|Overall Study|Lost to Follow-up|5|||
16187598|NCT02508701|39164968|FG002|Overall Study|Lost to Follow-up|5|||
16293760|NCT01172821|39559631|FG003|Overall Study|Other|3|||
16293761|NCT00361335|39559632|FG000|IV Period: Baseline to E0|Adverse Event|9|||
16293762|NCT00361335|39559633|FG001|IV Period: Baseline to E0|Adverse Event|4|||
16187599|NCT02508701|39164969|FG003|Overall Study|Lost to Follow-up|3|||
16187600|NCT01629667|39164971|FG000|Overall Study|Lost to Follow-up|0|||
16293763|NCT00361335|39559634|FG002|IV Period: Baseline to E0|Adverse Event|5|||
16293764|NCT00361335|39559635|FG003|IV Period: Baseline to E0|Adverse Event|9|||
16293765|NCT00361335|39559636|FG004|IV Period: Baseline to E0|Adverse Event|8|||
16484484|NCT01999868|40248914|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
16484485|NCT01313858|40248915|FG000|Overall Study|Premature Treatment Termination|251|||
16484486|NCT01313858|40248916|FG001|Overall Study|Premature Treatment Termination|219|||
16484487|NCT01313858|40248917|FG002|Overall Study|Premature Treatment Termination|191|||
16484488|NCT01313858|40248915|FG000|Overall Study|Lost to Follow-up|35|||
16484489|NCT01313858|40248916|FG001|Overall Study|Lost to Follow-up|51|||
16484490|NCT01313858|40248917|FG002|Overall Study|Lost to Follow-up|47|||
16484491|NCT00717093|40248918|FG000|Overall Study|Adverse Event|19|||
16484492|NCT00717093|40248919|FG001|Overall Study|Adverse Event|9|||
16484493|NCT00717093|40248918|FG000|Overall Study|Lack of Efficacy|3|||
16187601|NCT01629667|39164972|FG001|Overall Study|Lost to Follow-up|1|||
16187602|NCT01629667|39164973|FG002|Overall Study|Lost to Follow-up|1|||
16187603|NCT01629667|39164971|FG000|Overall Study|Withdrawal by Subject|31|||
16293766|NCT00361335|39559637|FG005|IV Period: Baseline to E0|Adverse Event|0|||
16293767|NCT00361335|39559638|FG006|IV Period: Baseline to E0|Adverse Event|0|||
16293768|NCT00361335|39559632|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
16293769|NCT00361335|39559633|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
16187604|NCT01629667|39164972|FG001|Overall Study|Withdrawal by Subject|20|||
16187605|NCT01629667|39164973|FG002|Overall Study|Withdrawal by Subject|28|||
16187606|NCT01629667|39164971|FG000|Overall Study|Death|1|||
16187607|NCT01629667|39164972|FG001|Overall Study|Death|5|||
16187608|NCT01629667|39164973|FG002|Overall Study|Death|3|||
16187609|NCT01629667|39164971|FG000|Overall Study|Randomized, not treated|2|||
16187610|NCT01629667|39164972|FG001|Overall Study|Randomized, not treated|1|||
16187611|NCT01629667|39164973|FG002|Overall Study|Randomized, not treated|0|||
16187612|NCT01629667|39164971|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
16187613|NCT01629667|39164972|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
16187614|NCT01629667|39164973|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
16187615|NCT01629667|39164971|FG000|Overall Study|Requiring lung transplant|2|||
16187616|NCT01629667|39164972|FG001|Overall Study|Requiring lung transplant|1|||
16187617|NCT01629667|39164973|FG002|Overall Study|Requiring lung transplant|3|||
16187618|NCT01629667|39164971|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
16484494|NCT00717093|40248919|FG001|Overall Study|Lack of Efficacy|13|||
16484495|NCT00717093|40248918|FG000|Overall Study|Lost to Follow-up|9|||
16484496|NCT00717093|40248919|FG001|Overall Study|Lost to Follow-up|6|||
16484497|NCT00717093|40248918|FG000|Overall Study|Withdrawal by Subject|12|||
16484498|NCT00717093|40248919|FG001|Overall Study|Withdrawal by Subject|19|||
16484499|NCT00717093|40248918|FG000|Overall Study|Other|0|||
16484500|NCT00717093|40248919|FG001|Overall Study|Other|1|||
16484501|NCT00717093|40248918|FG000|Overall Study|Randomized but not treated|1|||
16484502|NCT00717093|40248919|FG001|Overall Study|Randomized but not treated|0|||
16484503|NCT00986830|40248920|FG000|Overall Study|Death|1|||
16484504|NCT00986830|40248920|FG000|Overall Study|Lost to Follow-up|1|||
16484505|NCT00986830|40248920|FG000|Overall Study|Lack of Efficacy|1|||
16484506|NCT00986830|40248920|FG000|Overall Study|Unable to access sinus with device|5|||
16484507|NCT02850965|40248923|FG000|Overall Study|Other than listed|3|||
16484508|NCT02850965|40248924|FG001|Overall Study|Other than listed|4|||
16484509|NCT02850965|40248923|FG000|Overall Study|Protocol Violation|0|||
16484510|NCT02850965|40248924|FG001|Overall Study|Protocol Violation|2|||
16484511|NCT02850965|40248923|FG000|Overall Study|Lost to Follow-up|5|||
16484512|NCT02850965|40248924|FG001|Overall Study|Lost to Follow-up|3|||
16484513|NCT02850965|40248923|FG000|Overall Study|Lack of Efficacy|4|||
16484514|NCT02850965|40248924|FG001|Overall Study|Lack of Efficacy|8|||
16484515|NCT02850965|40248923|FG000|Overall Study|Adverse Event|3|||
16484516|NCT02850965|40248924|FG001|Overall Study|Adverse Event|2|||
16484517|NCT02850965|40248923|FG000|Overall Study|Withdrawal by Subject|3|||
16484518|NCT02850965|40248924|FG001|Overall Study|Withdrawal by Subject|4|||
16484519|NCT02850965|40248923|FG000|Overall Study|Physician Decision|0|||
16484520|NCT02850965|40248924|FG001|Overall Study|Physician Decision|1|||
16484521|NCT02850965|40248923|FG000|Overall Study|Randomized but not treated|0|||
16484522|NCT02850965|40248924|FG001|Overall Study|Randomized but not treated|1|||
16484523|NCT00496470|40248928|FG000|Overall Study|Adverse Event|8|||
16484524|NCT00496470|40248929|FG001|Overall Study|Adverse Event|10|||
16484525|NCT00496470|40248928|FG000|Overall Study|Withdrawal by Subject|5|||
16484526|NCT00496470|40248929|FG001|Overall Study|Withdrawal by Subject|12|||
16484527|NCT00496470|40248928|FG000|Overall Study|Incorrectly enrolled|13|||
16484528|NCT00496470|40248929|FG001|Overall Study|Incorrectly enrolled|5|||
16484529|NCT00496470|40248928|FG000|Overall Study|Other reason|0|||
16484530|NCT00496470|40248929|FG001|Overall Study|Other reason|2|||
16484531|NCT01999179|40252504|FG000|Overall Study|Adverse Event|1|||
16484532|NCT01999179|40252504|FG000|Overall Study|Lost to Follow-up|1|||
16484533|NCT01999179|40252504|FG000|Overall Study|Change in Therapy|3|||
16484534|NCT01999179|40252504|FG000|Overall Study|New catheter|2|||
16484535|NCT01197560|40252507|FG000|Overall Study|Adverse Event|6|||
16484536|NCT01197560|40252508|FG001|Overall Study|Adverse Event|8|||
16484537|NCT01197560|40252507|FG000|Overall Study|Death|3|||
16484538|NCT01197560|40252508|FG001|Overall Study|Death|5|||
16484539|NCT01197560|40252507|FG000|Overall Study|Withdrawal by Subject|1|||
16484540|NCT01197560|40252508|FG001|Overall Study|Withdrawal by Subject|1|||
16484541|NCT01197560|40252507|FG000|Overall Study|Disease progression|40|||
16484542|NCT01197560|40252508|FG001|Overall Study|Disease progression|35|||
16484543|NCT01197560|40252507|FG000|Overall Study|Miscellaneous|4|||
16484544|NCT01197560|40252508|FG001|Overall Study|Miscellaneous|3|||
16187619|NCT01629667|39164972|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
16484545|NCT01197560|40252507|FG000|Overall Study|Missing|0|||
16484546|NCT01197560|40252508|FG001|Overall Study|Missing|1|||
16484547|NCT02422303|40252509|FG000|Overall Study|Lost to Follow-up|1|||
16484548|NCT02422303|40252510|FG001|Overall Study|Lost to Follow-up|1|||
16382064|NCT00754572|39881625|FG000|Overall Study|Other|39|||
16484549|NCT02021331|40252513|FG000|Overall Study|Adverse Event|0|||
16484550|NCT02021331|40252514|FG001|Overall Study|Adverse Event|2|||
16484551|NCT01587001|40252515|FG000|Overall Study|Lost to Follow-up|2|||
16484552|NCT01587001|40252516|FG001|Overall Study|Lost to Follow-up|0|||
16484553|NCT01587001|40252515|FG000|Overall Study|Insufficient samples to complete testing|4|||
16484554|NCT01587001|40252516|FG001|Overall Study|Insufficient samples to complete testing|1|||
16484555|NCT02094677|40252517|FG000|Overall Study|Screening|3|||
16484556|NCT02094677|40252518|FG001|Overall Study|Screening|1|||
16484557|NCT00777608|40252519|FG000|Overall Study|Lost to Follow-up|1|||
16484558|NCT00777608|40252520|FG001|Overall Study|Lost to Follow-up|1|||
16484559|NCT00777608|40252519|FG000|Overall Study|Withdrawal by Subject|1|||
16484560|NCT00777608|40252520|FG001|Overall Study|Withdrawal by Subject|3|||
16484561|NCT00777608|40252519|FG000|Overall Study|Protocol Violation|1|||
16484562|NCT00777608|40252520|FG001|Overall Study|Protocol Violation|0|||
16484563|NCT00777608|40252519|FG000|Overall Study|Investigator Decision|1|||
16484564|NCT00777608|40252520|FG001|Overall Study|Investigator Decision|2|||
16484565|NCT03845985|40252522|FG000|Overall Study|Lost to Follow-up|2|||
16484566|NCT03845985|40252523|FG001|Overall Study|Lost to Follow-up|1|||
16484567|NCT03845985|40252522|FG000|Overall Study|Physician Decision|1|||
16484568|NCT03845985|40252523|FG001|Overall Study|Physician Decision|0|||
16484569|NCT03845985|40252522|FG000|Overall Study|Withdrawal by Subject|4|||
16484570|NCT03845985|40252523|FG001|Overall Study|Withdrawal by Subject|1|||
16484571|NCT02496611|40252526|FG000|Overall Study|Lost to Follow-up|2|||
16484572|NCT02496611|40252527|FG001|Overall Study|Lost to Follow-up|1|||
16484573|NCT02496611|40252526|FG000|Overall Study|Withdrawal by Subject|5|||
16484574|NCT02496611|40252527|FG001|Overall Study|Withdrawal by Subject|2|||
16484575|NCT04749615|40252528|FG000|Overall Study|Lost to Follow-up|6|||
16484576|NCT04749615|40252529|FG001|Overall Study|Lost to Follow-up|10|||
16484577|NCT02321800|40252532|FG000|Overall Study|Withdrawal by Subject|3|||
16484578|NCT02321800|40252533|FG001|Overall Study|Withdrawal by Subject|3|||
16484579|NCT02321800|40252532|FG000|Overall Study|Death|1|||
16484580|NCT02321800|40252533|FG001|Overall Study|Death|0|||
16484581|NCT02321800|40252532|FG000|Overall Study|Protocol Violation|1|||
16484582|NCT02321800|40252533|FG001|Overall Study|Protocol Violation|0|||
16484583|NCT02321800|40252532|FG000|Overall Study|Lost to Follow-up|10|||
16484584|NCT02321800|40252533|FG001|Overall Study|Lost to Follow-up|4|||
16484585|NCT02321800|40252532|FG000|Overall Study|Adverse Event|2|||
16484586|NCT02321800|40252533|FG001|Overall Study|Adverse Event|3|||
16484587|NCT02321800|40252532|FG000|Overall Study|Other, Miscellaneous|3|||
16484588|NCT02321800|40252533|FG001|Overall Study|Other, Miscellaneous|1|||
16484589|NCT02195583|40252534|FG000|Overall Study|Lost to Follow-up|1|||
16484590|NCT02195583|40252534|FG000|Overall Study|Withdrawal by Subject|4|||
16484591|NCT02195583|40252534|FG000|Overall Study|Adverse Event|2|||
16484592|NCT02195583|40252534|FG000|Overall Study|Other Reason|2|||
16484593|NCT00533897|40252537|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
16484594|NCT00533897|40252538|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
16484595|NCT00533897|40252539|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
16484596|NCT00533897|40252540|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
16484597|NCT00533897|40252541|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
16484598|NCT00533897|40252542|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
16484599|NCT00533897|40252543|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
16484600|NCT00533897|40252544|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
16484601|NCT00533897|40252537|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
16484602|NCT00533897|40252538|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
16484603|NCT00533897|40252539|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
16484604|NCT00533897|40252540|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
16484605|NCT00533897|40252541|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
16484606|NCT00533897|40252542|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
16484607|NCT00533897|40252543|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
16484608|NCT00533897|40252544|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
16484609|NCT00533897|40252537|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
16484610|NCT00533897|40252538|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
16484611|NCT00533897|40252539|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
16484612|NCT00533897|40252540|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
16484613|NCT00533897|40252541|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
16484614|NCT00533897|40252542|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
16293770|NCT00361335|39559634|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
16484615|NCT00533897|40252543|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
16484616|NCT00533897|40252544|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
16484617|NCT00533897|40252537|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
16484618|NCT00533897|40252538|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
16484619|NCT00533897|40252539|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
16484620|NCT00533897|40252540|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
16484621|NCT00533897|40252541|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
16484622|NCT00533897|40252542|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
16484623|NCT00533897|40252543|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
16484624|NCT00533897|40252544|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
16484625|NCT00533897|40252537|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
16484626|NCT00533897|40252538|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
16484627|NCT00533897|40252539|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
16484628|NCT00533897|40252540|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
16484629|NCT00533897|40252541|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
16484630|NCT00533897|40252542|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
16484631|NCT00533897|40252543|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
16484632|NCT00533897|40252544|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
16187620|NCT01629667|39164973|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
16187621|NCT01629667|39164971|FG000|Overall Study|Started other medicine|1|||
16187622|NCT01629667|39164972|FG001|Overall Study|Started other medicine|0|||
16187623|NCT01629667|39164973|FG002|Overall Study|Started other medicine|1|||
16484633|NCT00533897|40252537|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
16484634|NCT00533897|40252538|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
16187624|NCT01629667|39164971|FG000|Overall Study|Site error in safety follow-up|0|||
16187625|NCT01629667|39164972|FG001|Overall Study|Site error in safety follow-up|0|||
16187626|NCT01629667|39164973|FG002|Overall Study|Site error in safety follow-up|1|||
16187627|NCT01629667|39164971|FG000|Overall Study|Enrolled in another clinical study|0|||
16484635|NCT00533897|40252539|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
16484636|NCT00533897|40252540|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
16484637|NCT00533897|40252541|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
16484638|NCT00533897|40252542|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
16484639|NCT00533897|40252543|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
16484640|NCT00533897|40252544|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
16484641|NCT00533897|40252537|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
16187628|NCT01629667|39164972|FG001|Overall Study|Enrolled in another clinical study|1|||
16187629|NCT01629667|39164973|FG002|Overall Study|Enrolled in another clinical study|0|||
16187630|NCT01629667|39164971|FG000|Overall Study|Code break|1|||
16187631|NCT01629667|39164972|FG001|Overall Study|Code break|0|||
16293771|NCT00361335|39559635|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
16293772|NCT00361335|39559636|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
16293773|NCT00361335|39559637|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
16293774|NCT00361335|39559638|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
16293775|NCT00361335|39559632|FG000|IV Period: Baseline to E0|Death|1|||
16293776|NCT00361335|39559633|FG001|IV Period: Baseline to E0|Death|1|||
16293777|NCT00361335|39559634|FG002|IV Period: Baseline to E0|Death|1|||
16293778|NCT00361335|39559635|FG003|IV Period: Baseline to E0|Death|1|||
16293779|NCT00361335|39559636|FG004|IV Period: Baseline to E0|Death|0|||
16293780|NCT00361335|39559637|FG005|IV Period: Baseline to E0|Death|0|||
16293781|NCT00361335|39559638|FG006|IV Period: Baseline to E0|Death|0|||
16293782|NCT00361335|39559632|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
16293783|NCT00361335|39559633|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
16293784|NCT00361335|39559634|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
16293785|NCT00361335|39559635|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
16293786|NCT00361335|39559636|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
16293787|NCT00361335|39559637|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
16293788|NCT00361335|39559638|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
16293789|NCT00361335|39559632|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
16293790|NCT00361335|39559633|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
16293791|NCT00361335|39559634|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
16293792|NCT00361335|39559635|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
16293793|NCT00361335|39559636|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
16293794|NCT00361335|39559637|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
16293795|NCT00361335|39559638|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
16293796|NCT00361335|39559632|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
16293797|NCT00361335|39559633|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
16293798|NCT00361335|39559634|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
16293799|NCT00361335|39559635|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
16293800|NCT00361335|39559636|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
16293801|NCT00361335|39559637|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
16293802|NCT00361335|39559638|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
16484642|NCT00533897|40252538|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
16187632|NCT01629667|39164973|FG002|Overall Study|Code break|0|||
16187633|NCT02190435|39164978|FG000|Overall Study|First 12 patients were lead-ins|12|||
16484643|NCT00533897|40252539|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
16484644|NCT00533897|40252540|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
16484645|NCT00533897|40252541|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
16484646|NCT00533897|40252542|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
16484647|NCT00533897|40252543|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
16484648|NCT00533897|40252544|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
16293803|NCT00361335|39559632|FG000|IV Period: Baseline to E0|Other|2|||
16293804|NCT00361335|39559633|FG001|IV Period: Baseline to E0|Other|9|||
16293805|NCT00361335|39559634|FG002|IV Period: Baseline to E0|Other|9|||
16293806|NCT00361335|39559635|FG003|IV Period: Baseline to E0|Other|3|||
16293807|NCT00361335|39559636|FG004|IV Period: Baseline to E0|Other|2|||
16293808|NCT00361335|39559637|FG005|IV Period: Baseline to E0|Other|0|||
16293809|NCT00361335|39559638|FG006|IV Period: Baseline to E0|Other|0|||
16293810|NCT00361335|39559632|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
16293811|NCT00361335|39559633|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
16293812|NCT00361335|39559634|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
16293813|NCT00361335|39559635|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
16293814|NCT00361335|39559636|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
16293815|NCT00361335|39559637|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
16293816|NCT00361335|39559638|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
16293817|NCT00361335|39559632|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
16293818|NCT00361335|39559633|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
16293819|NCT00361335|39559634|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
16293820|NCT00361335|39559635|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
16293821|NCT00361335|39559636|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
16293822|NCT00361335|39559637|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
16293823|NCT00361335|39559638|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
16293824|NCT00361335|39559632|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
16293825|NCT00361335|39559633|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
16293826|NCT00361335|39559634|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
16293827|NCT00361335|39559635|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
16293828|NCT00361335|39559636|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
16293829|NCT00361335|39559637|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
16293830|NCT00361335|39559638|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
16293831|NCT00361335|39559632|FG000|SC Period: Week E0 to Week E24|Death|0|||
16293832|NCT00361335|39559633|FG001|SC Period: Week E0 to Week E24|Death|0|||
16293833|NCT00361335|39559634|FG002|SC Period: Week E0 to Week E24|Death|0|||
16293834|NCT00361335|39559635|FG003|SC Period: Week E0 to Week E24|Death|0|||
16293835|NCT00361335|39559636|FG004|SC Period: Week E0 to Week E24|Death|0|||
16293836|NCT00361335|39559637|FG005|SC Period: Week E0 to Week E24|Death|0|||
16293837|NCT00361335|39559638|FG006|SC Period: Week E0 to Week E24|Death|1|||
16293838|NCT00361335|39559632|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
16293839|NCT00361335|39559633|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
16293840|NCT00361335|39559634|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
16293841|NCT00361335|39559635|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
16293842|NCT00361335|39559636|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
16293843|NCT00361335|39559637|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
16293844|NCT00361335|39559638|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
16293845|NCT00361335|39559632|FG000|SC Period: Week E0 to Week E24|Other|1|||
16293846|NCT00361335|39559633|FG001|SC Period: Week E0 to Week E24|Other|0|||
16484649|NCT00533897|40252537|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
16484650|NCT00533897|40252538|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
16484651|NCT00533897|40252539|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
16484652|NCT00533897|40252540|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
16484653|NCT00533897|40252541|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
16484654|NCT00533897|40252542|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
16484655|NCT00533897|40252543|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
16484656|NCT00533897|40252544|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
16484657|NCT00533897|40252537|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
16484658|NCT00533897|40252538|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
16484659|NCT00533897|40252539|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
16484660|NCT00533897|40252540|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
16484661|NCT00533897|40252541|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
16293847|NCT00361335|39559634|FG002|SC Period: Week E0 to Week E24|Other|0|||
16293848|NCT00361335|39559635|FG003|SC Period: Week E0 to Week E24|Other|1|||
16293849|NCT00361335|39559636|FG004|SC Period: Week E0 to Week E24|Other|0|||
16293850|NCT00361335|39559637|FG005|SC Period: Week E0 to Week E24|Other|1|||
16293851|NCT00361335|39559638|FG006|SC Period: Week E0 to Week E24|Other|2|||
16293852|NCT00361335|39559632|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
16484662|NCT00533897|40252542|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
16293853|NCT00361335|39559633|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
16293854|NCT00361335|39559634|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
16293855|NCT00361335|39559635|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
16293856|NCT00361335|39559636|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
16293857|NCT00361335|39559637|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
16293858|NCT00361335|39559638|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
16293859|NCT00816361|39559641|FG000|Overall Study|Withdrawal by Subject|0|||
16293860|NCT00816361|39559642|FG001|Overall Study|Withdrawal by Subject|0|||
16293861|NCT00816361|39559643|FG002|Overall Study|Withdrawal by Subject|0|||
16382065|NCT00754572|39881625|FG000|Overall Study|Protocol Violation|3|||
16382066|NCT00754572|39881625|FG000|Overall Study|Withdrawal by Subject|3|||
16382067|NCT00754572|39881625|FG000|Overall Study|Lack of Efficacy|2|||
16382068|NCT00754572|39881625|FG000|Overall Study|Death|1|||
16382069|NCT00754572|39881625|FG000|Overall Study|Administrative Reason|3|||
16382070|NCT00754572|39881625|FG000|Overall Study|Lost to Follow-up|1|||
16382071|NCT04540367|39881626|FG000|Overall Study|Withdrawal by Subject|0|||
16382072|NCT04540367|39881627|FG001|Overall Study|Withdrawal by Subject|0|||
16382073|NCT04540367|39881628|FG002|Overall Study|Withdrawal by Subject|0|||
16382074|NCT04540367|39881629|FG003|Overall Study|Withdrawal by Subject|2|||
16382075|NCT04540367|39881626|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
16382076|NCT04540367|39881627|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
16382077|NCT04540367|39881628|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
16382078|NCT04540367|39881629|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
16382079|NCT04540367|39881626|FG000|Overall Study|Adverse Event|0|||
16382080|NCT04540367|39881627|FG001|Overall Study|Adverse Event|0|||
16382081|NCT04540367|39881628|FG002|Overall Study|Adverse Event|1|||
16382082|NCT04540367|39881629|FG003|Overall Study|Adverse Event|1|||
16382083|NCT00437073|39881630|FG000|Overall Study|Sponsor Terminated Study|1|||
16382084|NCT00437073|39881631|FG001|Overall Study|Sponsor Terminated Study|0|||
16382085|NCT00437073|39881630|FG000|Overall Study|Physician Decision|0|||
16382086|NCT00437073|39881631|FG001|Overall Study|Physician Decision|1|||
16382087|NCT02853136|39881648|FG000|Wash-out|Adverse Event|0|||
16382088|NCT02853136|39881649|FG001|Wash-out|Adverse Event|0|||
16382089|NCT02853136|39881650|FG002|Wash-out|Adverse Event|0|||
16382090|NCT02853136|39881651|FG003|Wash-out|Adverse Event|1|||
16382091|NCT05538728|39881652|FG000|Overall Study|Withdrawal by Subject|1|||
16382092|NCT05538728|39881653|FG001|Overall Study|Withdrawal by Subject|1|||
16382093|NCT00183248|39881655|FG000|Overall Study|Lost to Follow-up|0|||
16382094|NCT00183248|39881656|FG001|Overall Study|Lost to Follow-up|1|||
16382095|NCT00183248|39881655|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
16382096|NCT00183248|39881656|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
16382097|NCT02271880|39881662|FG000|Overall Study|Premature discontinuation of study|3|||
16382098|NCT02271880|39881663|FG001|Overall Study|Premature discontinuation of study|4|||
16382099|NCT00666263|39881664|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
16382100|NCT00666263|39881665|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
16382101|NCT00666263|39881664|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
16382102|NCT00666263|39881665|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
16382103|NCT00666263|39881664|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
16293862|NCT00816361|39559644|FG003|Overall Study|Withdrawal by Subject|0|||
16293863|NCT00816361|39559645|FG004|Overall Study|Withdrawal by Subject|1|||
16293864|NCT00816361|39559646|FG005|Overall Study|Withdrawal by Subject|2|||
16293865|NCT00816361|39559647|FG006|Overall Study|Withdrawal by Subject|0|||
16293866|NCT00816361|39559648|FG007|Overall Study|Withdrawal by Subject|2|||
16382104|NCT00666263|39881665|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
16382105|NCT02706392|39881666|FG000|Overall Study|Death|1|||
16382106|NCT02706392|39881667|FG001|Overall Study|Death|0|||
16382107|NCT02706392|39881668|FG002|Overall Study|Death|2|||
16382108|NCT02706392|39881669|FG003|Overall Study|Death|2|||
16382109|NCT02706392|39881670|FG004|Overall Study|Death|5|||
16382110|NCT02706392|39881671|FG005|Overall Study|Death|2|||
16382111|NCT01148771|39881683|FG000|Washout Period|Withdrawal by Subject|0|||
16382112|NCT01148771|39881684|FG001|Washout Period|Withdrawal by Subject|1|||
16382113|NCT02390076|39881685|FG000|Overall Study|Lost to Follow-up|2|||
16382114|NCT02390076|39881686|FG001|Overall Study|Lost to Follow-up|1|||
16382115|NCT02390076|39881687|FG002|Overall Study|Lost to Follow-up|4|||
16382116|NCT03663582|39881691|FG000|Overall Study|Physician Decision|1|||
16293867|NCT00816361|39559649|FG008|Overall Study|Withdrawal by Subject|1|||
16293868|NCT00816361|39559641|FG000|Overall Study|Death|4|||
16293869|NCT00816361|39559642|FG001|Overall Study|Death|3|||
16293870|NCT00816361|39559643|FG002|Overall Study|Death|3|||
16293871|NCT00816361|39559644|FG003|Overall Study|Death|3|||
16293872|NCT00816361|39559645|FG004|Overall Study|Death|1|||
16293873|NCT00816361|39559646|FG005|Overall Study|Death|1|||
16293874|NCT00816361|39559647|FG006|Overall Study|Death|3|||
16293875|NCT00816361|39559648|FG007|Overall Study|Death|7|||
16293876|NCT00816361|39559649|FG008|Overall Study|Death|8|||
16293877|NCT00816361|39559641|FG000|Overall Study|Other|0|||
16293878|NCT00816361|39559642|FG001|Overall Study|Other|0|||
16293879|NCT00816361|39559643|FG002|Overall Study|Other|0|||
16293880|NCT00816361|39559644|FG003|Overall Study|Other|0|||
16293881|NCT00816361|39559645|FG004|Overall Study|Other|0|||
16293882|NCT00816361|39559646|FG005|Overall Study|Other|0|||
16293883|NCT00816361|39559647|FG006|Overall Study|Other|0|||
16293884|NCT00816361|39559648|FG007|Overall Study|Other|0|||
16382139|NCT04023487|39881694|FG000|Overall Study|Lost to Follow-up|5|||
16382140|NCT04023487|39881695|FG001|Overall Study|Lost to Follow-up|4|||
16382141|NCT04023487|39881694|FG000|Overall Study|Pregnancy|1|||
16382142|NCT04023487|39881695|FG001|Overall Study|Pregnancy|2|||
16382143|NCT04023487|39881694|FG000|Overall Study|Withdrawal by Subject|4|||
16382144|NCT04023487|39881695|FG001|Overall Study|Withdrawal by Subject|5|||
16382145|NCT04023487|39881694|FG000|Overall Study|Partially completed testing|8|||
16382146|NCT04023487|39881695|FG001|Overall Study|Partially completed testing|4|||
16382147|NCT03038087|39881696|FG000|Overall Study|lost data|1|||
16382148|NCT02038036|39881697|FG000|Core Study|Adverse Event|7|||
16382149|NCT02038036|39881698|FG001|Core Study|Adverse Event|7|||
16293885|NCT00816361|39559649|FG008|Overall Study|Other|1|||
16382150|NCT02038036|39881697|FG000|Core Study|Death|1|||
16382151|NCT02038036|39881698|FG001|Core Study|Death|1|||
16382152|NCT02038036|39881697|FG000|Core Study|Disease progression|2|||
16382153|NCT02038036|39881698|FG001|Core Study|Disease progression|2|||
16382154|NCT02038036|39881697|FG000|Core Study|Lost to Follow-up|0|||
16382155|NCT02038036|39881698|FG001|Core Study|Lost to Follow-up|1|||
16382156|NCT02038036|39881697|FG000|Core Study|Physician Decision|2|||
16382157|NCT02038036|39881698|FG001|Core Study|Physician Decision|1|||
16382158|NCT02038036|39881697|FG000|Core Study|Subject/guardian decision|0|||
16382159|NCT02038036|39881698|FG001|Core Study|Subject/guardian decision|1|||
16382160|NCT02038036|39881697|FG000|Core Study|Withdrawal by Subject|3|||
16382161|NCT02038036|39881698|FG001|Core Study|Withdrawal by Subject|1|||
16382162|NCT02038036|39881697|FG000|Crossover Period|Withdrawal by Subject|0|||
16382163|NCT02038036|39881698|FG001|Crossover Period|Withdrawal by Subject|3|||
16382164|NCT02038036|39881697|FG000|Crossover Period|Adverse Event|0|||
16382165|NCT02038036|39881698|FG001|Crossover Period|Adverse Event|9|||
16382166|NCT02038036|39881697|FG000|Crossover Period|Death|0|||
16382167|NCT02038036|39881698|FG001|Crossover Period|Death|2|||
16382168|NCT02038036|39881697|FG000|Crossover Period|Disease progression|0|||
16382169|NCT02038036|39881698|FG001|Crossover Period|Disease progression|3|||
16382170|NCT02038036|39881697|FG000|Crossover Period|Lost to Follow-up|0|||
16382171|NCT02038036|39881698|FG001|Crossover Period|Lost to Follow-up|1|||
16293886|NCT00857584|39559650|FG000|Overall Study|Lack of Efficacy|1|||
16293887|NCT00857584|39559651|FG001|Overall Study|Lack of Efficacy|2|||
16382172|NCT02038036|39881697|FG000|Crossover Period|Physician Decision|0|||
16293888|NCT00857584|39559650|FG000|Overall Study|Adverse Event|2|||
16293889|NCT00857584|39559651|FG001|Overall Study|Adverse Event|2|||
16382173|NCT02038036|39881698|FG001|Crossover Period|Physician Decision|2|||
16293890|NCT00857584|39559650|FG000|Overall Study|Physician Decision|1|||
16293891|NCT00857584|39559651|FG001|Overall Study|Physician Decision|1|||
16293892|NCT02944383|39559652|FG000|Overall Study|Lost to Follow-up|0|||
16382174|NCT03341936|39881700|FG000|Overall Study|Ineligible|1|||
16382175|NCT03341936|39881700|FG000|Overall Study|Disease Progression|2|||
16382176|NCT03341936|39881700|FG000|Overall Study|Withdrew Consent|4|||
16382177|NCT03341936|39881700|FG000|Overall Study|Non-Compliance|1|||
16484663|NCT00533897|40252543|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
16484664|NCT00533897|40252544|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
16484665|NCT00533897|40252537|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
16484666|NCT00533897|40252538|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
16484667|NCT00533897|40252539|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
16484668|NCT00533897|40252540|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
16484669|NCT00533897|40252541|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
16484670|NCT00533897|40252542|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
16484671|NCT00533897|40252543|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
16484672|NCT00533897|40252544|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
16484673|NCT00533897|40252537|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
16484674|NCT00533897|40252538|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
16382178|NCT03341936|39881700|FG000|Overall Study|Physician Decision|1|||
16382179|NCT03341936|39881700|FG000|Overall Study|Withdrawal by Subject|1|||
16382180|NCT03341936|39881700|FG000|Overall Study|Other|1|||
16382181|NCT02704208|39881708|FG000|Overall Study|Lost to Follow-up|42|||
16382182|NCT02704208|39881709|FG001|Overall Study|Lost to Follow-up|37|||
16382183|NCT01998477|39881711|FG000|Overall Study|Lost to Follow-up|4|||
16382184|NCT01998477|39881712|FG001|Overall Study|Lost to Follow-up|5|||
16382185|NCT01998477|39881711|FG000|Overall Study|Withdrawal by Subject|6|||
16382186|NCT01998477|39881712|FG001|Overall Study|Withdrawal by Subject|0|||
16382187|NCT01987557|39881715|FG000|Overall Study|Protocol Violation|1|||
16382188|NCT01987557|39881716|FG001|Overall Study|Protocol Violation|0|||
16382189|NCT01987557|39881717|FG002|Overall Study|Protocol Violation|1|||
16382190|NCT01987557|39881715|FG000|Overall Study|Withdrawal by Subject|2|||
16382191|NCT01987557|39881716|FG001|Overall Study|Withdrawal by Subject|1|||
16382192|NCT01987557|39881717|FG002|Overall Study|Withdrawal by Subject|2|||
16382193|NCT01987557|39881715|FG000|Overall Study|Adverse Event|0|||
16382194|NCT01987557|39881716|FG001|Overall Study|Adverse Event|2|||
16382195|NCT01987557|39881717|FG002|Overall Study|Adverse Event|0|||
16382196|NCT03289039|39881718|FG000|Overall Study|Withdrawal by Subject|0|||
16382197|NCT03289039|39881719|FG001|Overall Study|Withdrawal by Subject|1|||
16382198|NCT03289039|39881718|FG000|Overall Study|Became ineligible prior to treatment start|0|||
16382199|NCT03289039|39881719|FG001|Overall Study|Became ineligible prior to treatment start|1|||
16382200|NCT03289039|39881718|FG000|Overall Study|progressed before treatment start|1|||
16382201|NCT03289039|39881719|FG001|Overall Study|progressed before treatment start|0|||
16382202|NCT00954447|39881724|FG000|Overall Study|Adverse Event|33|||
16382203|NCT00954447|39881725|FG001|Overall Study|Adverse Event|25|||
16382204|NCT00954447|39881724|FG000|Overall Study|Lack of Efficacy|17|||
16382205|NCT00954447|39881725|FG001|Overall Study|Lack of Efficacy|3|||
16382206|NCT00954447|39881724|FG000|Overall Study|Protocol Violation|5|||
16382207|NCT00954447|39881725|FG001|Overall Study|Protocol Violation|7|||
16382208|NCT00954447|39881724|FG000|Overall Study|Lost to Follow-up|8|||
16382209|NCT00954447|39881725|FG001|Overall Study|Lost to Follow-up|14|||
16382210|NCT00954447|39881724|FG000|Overall Study|Withdrawal by Subject|26|||
16382211|NCT00954447|39881725|FG001|Overall Study|Withdrawal by Subject|21|||
16382212|NCT00954447|39881724|FG000|Overall Study|Other|21|||
16382213|NCT00954447|39881725|FG001|Overall Study|Other|18|||
16382214|NCT00841815|39881727|FG000|Washout|Withdrawal by Subject|0|||
16382215|NCT00841815|39881728|FG001|Washout|Withdrawal by Subject|1|||
16382216|NCT01693367|39881731|FG000|Overall Study|Withdrawal by Subject|1|||
16382217|NCT01693367|39881732|FG001|Overall Study|Withdrawal by Subject|1|||
16382218|NCT01693367|39881731|FG000|Overall Study|Physician Decision|0|||
16382219|NCT01693367|39881732|FG001|Overall Study|Physician Decision|1|||
16382220|NCT01634152|39881733|FG000|Overall Study|Adverse Event|2|||
16382221|NCT01634152|39881734|FG001|Overall Study|Adverse Event|0|||
16382222|NCT01634152|39881735|FG002|Overall Study|Adverse Event|2|||
16382223|NCT01634152|39881733|FG000|Overall Study|Consent withdrawn not due to AE|1|||
16382224|NCT01634152|39881734|FG001|Overall Study|Consent withdrawn not due to AE|0|||
16382225|NCT01634152|39881735|FG002|Overall Study|Consent withdrawn not due to AE|1|||
16382226|NCT01634152|39881733|FG000|Overall Study|Not treated|0|||
16382227|NCT01634152|39881734|FG001|Overall Study|Not treated|1|||
16382228|NCT01634152|39881735|FG002|Overall Study|Not treated|0|||
16382229|NCT01634152|39881733|FG000|Overall Study|Other reason not defined above|1|||
16382230|NCT01634152|39881734|FG001|Overall Study|Other reason not defined above|0|||
16382231|NCT01634152|39881735|FG002|Overall Study|Other reason not defined above|1|||
16382232|NCT05014919|39881736|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
16382233|NCT05014919|39881737|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
16382234|NCT05014919|39881738|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
16382235|NCT05014919|39881736|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
16382236|NCT05014919|39881737|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
16382237|NCT05014919|39881738|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
16382238|NCT05014919|39881736|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
16382239|NCT05014919|39881737|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
16382240|NCT05014919|39881738|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
16382241|NCT05014919|39881736|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
16382242|NCT05014919|39881737|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
16382243|NCT05014919|39881738|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
16382244|NCT05014919|39881736|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
16382245|NCT05014919|39881737|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
16382246|NCT05014919|39881738|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
16382247|NCT05014919|39881736|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
16382248|NCT05014919|39881737|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
16382249|NCT05014919|39881738|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
16382250|NCT05014919|39881736|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
16382251|NCT05014919|39881737|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
16382252|NCT05014919|39881738|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
16382253|NCT05014919|39881736|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
16382254|NCT05014919|39881737|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
16382255|NCT05014919|39881738|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
16382256|NCT03514134|39881739|FG000|Overall Study|Lost to Follow-up|0|||
16382257|NCT03514134|39881740|FG001|Overall Study|Lost to Follow-up|1|||
16382258|NCT00397540|39881742|FG000|Overall Study|short follow-up duration < 12 months|1|||
16382259|NCT00397540|39881743|FG001|Overall Study|short follow-up duration < 12 months|0|||
16382260|NCT01405196|39881746|FG000|Overall Study|Study Terminated by Sponsor|0|||
16484675|NCT00533897|40252539|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
16484676|NCT00533897|40252540|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
16484677|NCT00533897|40252541|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
16293893|NCT02944383|39559653|FG001|Overall Study|Lost to Follow-up|0|||
16293894|NCT02944383|39559654|FG002|Overall Study|Lost to Follow-up|1|||
16293895|NCT02944383|39559652|FG000|Overall Study|Withdrawal by Subject|1|||
16293896|NCT02944383|39559653|FG001|Overall Study|Withdrawal by Subject|0|||
16293897|NCT02944383|39559654|FG002|Overall Study|Withdrawal by Subject|0|||
16293898|NCT01940497|39559655|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
16293899|NCT01940497|39559656|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
16293900|NCT01940497|39559655|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
16293901|NCT01940497|39559656|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
16293902|NCT01940497|39559655|FG000|Overall Study|Violation of Entry Criteria|1|||
16293903|NCT01940497|39559656|FG001|Overall Study|Violation of Entry Criteria|1|||
16293904|NCT01940497|39559655|FG000|Overall Study|Refused Treatment|1|||
16293905|NCT01940497|39559656|FG001|Overall Study|Refused Treatment|3|||
16484678|NCT00533897|40252542|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
16484679|NCT00533897|40252543|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
16484680|NCT00533897|40252544|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
16484681|NCT00533897|40252537|FG000|Long Term Extension (LTE)|Death|0|||
16484682|NCT00533897|40252538|FG001|Long Term Extension (LTE)|Death|0|||
16484683|NCT00533897|40252539|FG002|Long Term Extension (LTE)|Death|0|||
16484684|NCT00533897|40252540|FG003|Long Term Extension (LTE)|Death|0|||
16484685|NCT00533897|40252541|FG004|Long Term Extension (LTE)|Death|0|||
16484686|NCT00533897|40252542|FG005|Long Term Extension (LTE)|Death|0|||
16484687|NCT00533897|40252543|FG006|Long Term Extension (LTE)|Death|1|||
16484688|NCT00533897|40252544|FG007|Long Term Extension (LTE)|Death|3|||
16484689|NCT00533897|40252537|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
16484690|NCT00533897|40252538|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
16484691|NCT00533897|40252539|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
16484692|NCT00533897|40252540|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
16484693|NCT00533897|40252541|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
16484694|NCT00533897|40252542|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
16484695|NCT00533897|40252543|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
16484696|NCT00533897|40252544|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
16484697|NCT00533897|40252537|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
16484698|NCT00533897|40252538|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
16484699|NCT00533897|40252539|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
16484700|NCT00533897|40252540|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
16484701|NCT00533897|40252541|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
16484702|NCT00533897|40252542|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
16293906|NCT01940497|39559655|FG000|Overall Study|Withdrew Consent|6|||
16382261|NCT01405196|39881747|FG001|Overall Study|Study Terminated by Sponsor|0|||
16382262|NCT01405196|39881748|FG002|Overall Study|Study Terminated by Sponsor|9|||
16382263|NCT01405196|39881749|FG003|Overall Study|Study Terminated by Sponsor|0|||
16484703|NCT00533897|40252543|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
16484704|NCT00533897|40252544|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
16293907|NCT01940497|39559656|FG001|Overall Study|Withdrew Consent|2|||
16293908|NCT01940497|39559655|FG000|Overall Study|Administrative/Other|1|||
16293909|NCT01940497|39559656|FG001|Overall Study|Administrative/Other|1|||
16293910|NCT00380692|39559658|FG000|Study Period II - Double Blind|Adverse Event|1|||
16293911|NCT00380692|39559659|FG001|Study Period II - Double Blind|Adverse Event|0|||
16293912|NCT00380692|39559658|FG000|Study Period II - Double Blind|Protocol Violation|2|||
16382264|NCT01405196|39881746|FG000|Overall Study|Other|2|||
16382265|NCT01405196|39881747|FG001|Overall Study|Other|2|||
16382266|NCT01405196|39881748|FG002|Overall Study|Other|5|||
16382267|NCT01405196|39881749|FG003|Overall Study|Other|0|||
16382268|NCT01405196|39881746|FG000|Overall Study|Withdrawal by Subject|4|||
16382269|NCT01405196|39881747|FG001|Overall Study|Withdrawal by Subject|6|||
16484705|NCT00533897|40252537|FG000|Long Term Extension (LTE)|Adverse Event|0|||
16484706|NCT00533897|40252538|FG001|Long Term Extension (LTE)|Adverse Event|0|||
16484707|NCT00533897|40252539|FG002|Long Term Extension (LTE)|Adverse Event|0|||
16484708|NCT00533897|40252540|FG003|Long Term Extension (LTE)|Adverse Event|0|||
16484709|NCT00533897|40252541|FG004|Long Term Extension (LTE)|Adverse Event|0|||
16484710|NCT00533897|40252542|FG005|Long Term Extension (LTE)|Adverse Event|0|||
16484711|NCT00533897|40252543|FG006|Long Term Extension (LTE)|Adverse Event|2|||
16293913|NCT00380692|39559659|FG001|Study Period II - Double Blind|Protocol Violation|2|||
16293914|NCT00380692|39559658|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
16293915|NCT00380692|39559659|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
16293916|NCT00380692|39559658|FG000|Study Period II - Double Blind|Physician Decision|0|||
16293917|NCT00380692|39559659|FG001|Study Period II - Double Blind|Physician Decision|1|||
16382270|NCT01405196|39881748|FG002|Overall Study|Withdrawal by Subject|3|||
16382271|NCT01405196|39881749|FG003|Overall Study|Withdrawal by Subject|6|||
16382272|NCT01405196|39881746|FG000|Overall Study|Adverse Event|2|||
16382273|NCT01405196|39881747|FG001|Overall Study|Adverse Event|2|||
16382274|NCT01405196|39881748|FG002|Overall Study|Adverse Event|0|||
16382275|NCT01405196|39881749|FG003|Overall Study|Adverse Event|2|||
16382276|NCT01405196|39881746|FG000|Overall Study|Death|1|||
16382277|NCT01405196|39881747|FG001|Overall Study|Death|0|||
16382278|NCT01405196|39881748|FG002|Overall Study|Death|3|||
16382279|NCT01405196|39881749|FG003|Overall Study|Death|0|||
16382280|NCT01405196|39881746|FG000|Overall Study|Lost to Follow-up|2|||
16382281|NCT01405196|39881747|FG001|Overall Study|Lost to Follow-up|2|||
16382282|NCT01405196|39881748|FG002|Overall Study|Lost to Follow-up|3|||
16382283|NCT01405196|39881749|FG003|Overall Study|Lost to Follow-up|1|||
16382284|NCT01155050|39881750|FG000|Overall Study|Lost to Follow-up|15|||
16382285|NCT01155050|39881751|FG001|Overall Study|Lost to Follow-up|20|||
16382286|NCT01155050|39881752|FG002|Overall Study|Lost to Follow-up|19|||
16382287|NCT01155050|39881753|FG003|Overall Study|Lost to Follow-up|22|||
16382288|NCT00949533|39881754|FG000|Overall Study|Lost to Follow-up|0|||
16382289|NCT00949533|39881755|FG001|Overall Study|Lost to Follow-up|1|||
16382290|NCT01646827|39881756|FG000|Overall Study|Lost to Follow-up|0|||
16382291|NCT01646827|39881757|FG001|Overall Study|Lost to Follow-up|3|||
16382292|NCT01646827|39881756|FG000|Overall Study|Physician Decision|1|||
16382293|NCT01646827|39881757|FG001|Overall Study|Physician Decision|2|||
16382294|NCT01646827|39881756|FG000|Overall Study|Withdrawal by Subject|1|||
16484712|NCT00533897|40252544|FG007|Long Term Extension (LTE)|Adverse Event|5|||
16293918|NCT00380692|39559658|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
16382295|NCT01646827|39881757|FG001|Overall Study|Withdrawal by Subject|0|||
16382296|NCT00399529|39881760|FG000|Overall Study|Off Study Prior to Treatment|2|||
16382297|NCT02835690|39881761|FG000|Overall Study|Death|12|||
16382298|NCT02835690|39881762|FG001|Overall Study|Death|11|||
16382299|NCT02835690|39881763|FG002|Overall Study|Death|13|||
16382300|NCT02835690|39881761|FG000|Overall Study|Transferred to Extension Study|2|||
16382301|NCT02835690|39881762|FG001|Overall Study|Transferred to Extension Study|2|||
16382302|NCT02835690|39881763|FG002|Overall Study|Transferred to Extension Study|1|||
16484713|NCT00533897|40252537|FG000|Long Term Extension (LTE)|Pregnancy|0|||
16293919|NCT00380692|39559659|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
16293920|NCT00380692|39559658|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
16293921|NCT00380692|39559659|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
16293922|NCT00380692|39559658|FG000|Study Period III - Open Label|Adverse Event|5|||
16293923|NCT00380692|39559659|FG001|Study Period III - Open Label|Adverse Event|3|||
16293924|NCT00380692|39559658|FG000|Study Period III - Open Label|Protocol Violation|0|||
16293925|NCT00380692|39559659|FG001|Study Period III - Open Label|Protocol Violation|0|||
16293926|NCT00380692|39559658|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
16293927|NCT00380692|39559659|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
16293928|NCT00380692|39559658|FG000|Study Period III - Open Label|Physician Decision|0|||
16293929|NCT00380692|39559659|FG001|Study Period III - Open Label|Physician Decision|3|||
16293930|NCT00380692|39559658|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
16293931|NCT00380692|39559659|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
16293932|NCT00380692|39559658|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
16293933|NCT00380692|39559659|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
16382303|NCT02835690|39881761|FG000|Overall Study|Did Not Continue on Extension Study|0|||
16382304|NCT02835690|39881762|FG001|Overall Study|Did Not Continue on Extension Study|0|||
16382305|NCT02835690|39881763|FG002|Overall Study|Did Not Continue on Extension Study|1|||
16382306|NCT02835690|39881761|FG000|Overall Study|Not Treated|0|||
16382307|NCT02835690|39881762|FG001|Overall Study|Not Treated|2|||
16382308|NCT02835690|39881763|FG002|Overall Study|Not Treated|0|||
16382309|NCT00454116|39881764|FG000|Overall Study|Adverse Event|5|||
16382310|NCT00454116|39881765|FG001|Overall Study|Adverse Event|11|||
16382311|NCT00454116|39881766|FG002|Overall Study|Adverse Event|9|||
16382312|NCT00454116|39881764|FG000|Overall Study|Condition under investigation worsened|17|||
16382313|NCT00454116|39881765|FG001|Overall Study|Condition under investigation worsened|13|||
16382314|NCT00454116|39881766|FG002|Overall Study|Condition under investigation worsened|18|||
16382315|NCT00454116|39881764|FG000|Overall Study|Withdrawal by Subject|3|||
16382316|NCT00454116|39881765|FG001|Overall Study|Withdrawal by Subject|3|||
16382317|NCT00454116|39881766|FG002|Overall Study|Withdrawal by Subject|1|||
16382318|NCT00454116|39881764|FG000|Overall Study|Other|2|||
16382319|NCT00454116|39881765|FG001|Overall Study|Other|2|||
16382320|NCT00454116|39881766|FG002|Overall Study|Other|0|||
16382321|NCT01168596|39881767|FG000|Overall Study|Withdrawal by Subject|3|||
16382322|NCT01168596|39881768|FG001|Overall Study|Withdrawal by Subject|1|||
16382323|NCT01323192|39881770|FG000|Overall Study|Adverse Event|6|||
16382324|NCT01323192|39881771|FG001|Overall Study|Adverse Event|1|||
16382325|NCT01323192|39881770|FG000|Overall Study|Withdrawal by Subject|3|||
16382326|NCT01323192|39881771|FG001|Overall Study|Withdrawal by Subject|1|||
16293934|NCT01315132|39559660|FG000|Overall Study|not treated due to disease progression|1|||
16382327|NCT01323192|39881770|FG000|Overall Study|Noncompliance with study medication|0|||
16382328|NCT01323192|39881771|FG001|Overall Study|Noncompliance with study medication|3|||
16382329|NCT01323192|39881770|FG000|Overall Study|Nonmedical reasons|0|||
16484714|NCT00533897|40252538|FG001|Long Term Extension (LTE)|Pregnancy|0|||
16484715|NCT00533897|40252539|FG002|Long Term Extension (LTE)|Pregnancy|0|||
16484716|NCT00533897|40252540|FG003|Long Term Extension (LTE)|Pregnancy|0|||
16484717|NCT00533897|40252541|FG004|Long Term Extension (LTE)|Pregnancy|0|||
16484718|NCT00533897|40252542|FG005|Long Term Extension (LTE)|Pregnancy|0|||
16484719|NCT00533897|40252543|FG006|Long Term Extension (LTE)|Pregnancy|0|||
16484720|NCT00533897|40252544|FG007|Long Term Extension (LTE)|Pregnancy|2|||
16484721|NCT00533897|40252537|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
16484722|NCT00533897|40252538|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
16484723|NCT00533897|40252539|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
16484724|NCT00533897|40252540|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
16382330|NCT01323192|39881771|FG001|Overall Study|Nonmedical reasons|1|||
16382331|NCT00815633|39884446|FG000|Overall Study|study terminated|1|||
16382332|NCT00545779|39884447|FG000|Overall Study|Violation of selection criteria at entry|8|||
16484725|NCT00533897|40252541|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
16484726|NCT00533897|40252542|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
16382333|NCT00545779|39884447|FG000|Overall Study|Other protocol violation|1|||
16382334|NCT00545779|39884447|FG000|Overall Study|Did not cooperate|7|||
16382335|NCT00545779|39884447|FG000|Overall Study|Withdrawal by Subject|20|||
16484727|NCT00533897|40252543|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
16484728|NCT00533897|40252544|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
16484729|NCT00533897|40252537|FG000|Long Term Extension (LTE)|Other|0|||
16484730|NCT00533897|40252538|FG001|Long Term Extension (LTE)|Other|0|||
16484731|NCT00533897|40252539|FG002|Long Term Extension (LTE)|Other|0|||
16484732|NCT00533897|40252540|FG003|Long Term Extension (LTE)|Other|0|||
16484733|NCT00533897|40252541|FG004|Long Term Extension (LTE)|Other|0|||
16484734|NCT00533897|40252542|FG005|Long Term Extension (LTE)|Other|0|||
16484735|NCT00533897|40252543|FG006|Long Term Extension (LTE)|Other|1|||
16484736|NCT00533897|40252544|FG007|Long Term Extension (LTE)|Other|6|||
16484737|NCT03797014|40252545|FG000|Overall Study|Withdrawal by Subject|1|||
16484738|NCT03797014|40252545|FG000|Overall Study|Lost to Follow-up|1|||
16484739|NCT03797014|40252545|FG000|Overall Study|Protocol Violation|1|||
16484740|NCT00923156|40252546|FG000|Overall Study|Adverse Event|0|||
16484741|NCT00923156|40252547|FG001|Overall Study|Adverse Event|2|||
16484742|NCT00923156|40252548|FG002|Overall Study|Adverse Event|1|||
16081596|NCT03664960|38792687|FG000|Overall Study|Lost to Follow-up|3|||
16081597|NCT03664960|38792688|FG001|Overall Study|Lost to Follow-up|2|||
16081598|NCT03664960|38792687|FG000|Overall Study|Physician Decision|1|||
16081599|NCT03664960|38792688|FG001|Overall Study|Physician Decision|0|||
16081600|NCT03664960|38792687|FG000|Overall Study|Withdrawal by Subject|3|||
16081601|NCT03664960|38792688|FG001|Overall Study|Withdrawal by Subject|14|||
16081602|NCT03664960|38792687|FG000|Overall Study|Sponsor Decision|1|||
16081603|NCT03664960|38792688|FG001|Overall Study|Sponsor Decision|1|||
16484743|NCT00923156|40252546|FG000|Overall Study|Abnormal laboratory values|0|||
16081604|NCT03664960|38792687|FG000|Overall Study|Other|1|||
16081605|NCT03664960|38792688|FG001|Overall Study|Other|2|||
16081606|NCT02567656|38792689|FG000|Overall Study|Premature discontinuation due to PD|1|||
16081607|NCT02567656|38792690|FG001|Overall Study|Premature discontinuation due to PD|1|||
16081608|NCT02567656|38792691|FG002|Overall Study|Premature discontinuation due to PD|2|||
16081609|NCT02567656|38792692|FG003|Overall Study|Premature discontinuation due to PD|0|||
16081610|NCT02567656|38792693|FG004|Overall Study|Premature discontinuation due to PD|0|||
16081611|NCT02567656|38792694|FG005|Overall Study|Premature discontinuation due to PD|0|||
16081612|NCT01094184|38792695|FG000|Overall Study|Death|35|||
16484744|NCT00923156|40252547|FG001|Overall Study|Abnormal laboratory values|0|||
16484745|NCT00923156|40252548|FG002|Overall Study|Abnormal laboratory values|1|||
16484746|NCT00923156|40252546|FG000|Overall Study|Withdrawal by Subject|0|||
16484747|NCT00923156|40252547|FG001|Overall Study|Withdrawal by Subject|1|||
16484748|NCT00923156|40252548|FG002|Overall Study|Withdrawal by Subject|0|||
16484749|NCT00923156|40252546|FG000|Overall Study|Death|0|||
16484750|NCT00923156|40252547|FG001|Overall Study|Death|1|||
16484751|NCT00923156|40252548|FG002|Overall Study|Death|0|||
16484752|NCT00923156|40252546|FG000|Overall Study|Lack of Efficacy|0|||
16484753|NCT00923156|40252547|FG001|Overall Study|Lack of Efficacy|0|||
16484754|NCT00923156|40252548|FG002|Overall Study|Lack of Efficacy|1|||
16484755|NCT03758066|40252549|FG000|Overall Study|Lost to Follow-up|14|||
16484756|NCT00724932|40252550|FG000|Overall Study|Lost to Follow-up|1|||
16484757|NCT00724932|40252551|FG001|Overall Study|Lost to Follow-up|0|||
16484758|NCT00724932|40252550|FG000|Overall Study|Not treated|4|||
16484759|NCT00724932|40252551|FG001|Overall Study|Not treated|3|||
16484760|NCT01402011|40252557|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
16484761|NCT01402011|40252558|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
16484762|NCT01402011|40252559|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
16484763|NCT01402011|40252557|FG000|Active Treatment Period|Withdrawal by Subject|1|||
16081613|NCT01094184|38792696|FG001|Overall Study|Death|11|||
16081614|NCT03733119|38792697|FG000|Overall Study|Physician Decision|2|||
16081615|NCT03733119|38792698|FG001|Overall Study|Physician Decision|1|||
16081616|NCT03733119|38792697|FG000|Overall Study|ineligible to treat per protocol|0|||
16081617|NCT03733119|38792698|FG001|Overall Study|ineligible to treat per protocol|1|||
16081618|NCT04512482|38792699|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
16081619|NCT04512482|38792700|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
16081620|NCT01185561|38792701|FG000|Overall Study|Lost to Follow-up|0|||
16293935|NCT01268501|39559663|FG000|Overall Study|Lost to Follow-up|1|||
16293936|NCT01268501|39559663|FG000|Overall Study|Withdrawal by Subject|3|||
16293937|NCT01268501|39559663|FG000|Overall Study|Unacceptable Subjective Vision|3|||
16293938|NCT01268501|39559663|FG000|Overall Study|Handling Difficulties|2|||
16293939|NCT01347866|39559666|FG000|Overall Study|Death|0|||
16293940|NCT01347866|39559667|FG001|Overall Study|Death|0|||
16081621|NCT01185561|38792702|FG001|Overall Study|Lost to Follow-up|4|||
16081622|NCT01185561|38792701|FG000|Overall Study|Withdrawal by Subject|2|||
16484764|NCT01402011|40252558|FG001|Active Treatment Period|Withdrawal by Subject|3|||
16484765|NCT01402011|40252559|FG002|Active Treatment Period|Withdrawal by Subject|0|||
16484766|NCT01402011|40252557|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
16484767|NCT01402011|40252558|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
16484768|NCT01402011|40252559|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
16484769|NCT03155178|40252560|FG000|Overall Study|Did not meet treatment day baseline|7|||
16484770|NCT03155178|40252561|FG001|Overall Study|Did not meet treatment day baseline|7|||
16293941|NCT01347866|39559668|FG002|Overall Study|Death|0|||
16293942|NCT01347866|39559669|FG003|Overall Study|Death|1|||
16293943|NCT01347866|39559670|FG004|Overall Study|Death|2|||
16293944|NCT01347866|39559671|FG005|Overall Study|Death|2|||
16293945|NCT01347866|39559672|FG006|Overall Study|Death|1|||
16293946|NCT01347866|39559673|FG007|Overall Study|Death|0|||
16293947|NCT01347866|39559674|FG008|Overall Study|Death|4|||
16293948|NCT01347866|39559675|FG009|Overall Study|Death|1|||
16293949|NCT01347866|39559676|FG010|Overall Study|Death|3|||
16293950|NCT01347866|39559677|FG011|Overall Study|Death|1|||
16293951|NCT01347866|39559678|FG012|Overall Study|Death|2|||
16293952|NCT01347866|39559679|FG013|Overall Study|Death|0|||
16293953|NCT01347866|39559680|FG014|Overall Study|Death|0|||
16293954|NCT01347866|39559681|FG015|Overall Study|Death|1|||
16293955|NCT01347866|39559682|FG016|Overall Study|Death|0|||
16293956|NCT01347866|39559666|FG000|Overall Study|Lost to Follow-up|0|||
16293957|NCT01347866|39559667|FG001|Overall Study|Lost to Follow-up|0|||
16293958|NCT01347866|39559668|FG002|Overall Study|Lost to Follow-up|0|||
16293959|NCT01347866|39559669|FG003|Overall Study|Lost to Follow-up|0|||
16081623|NCT01185561|38792702|FG001|Overall Study|Withdrawal by Subject|8|||
16081624|NCT00308997|38792705|FG000|Overall Study|Subject feigned clinical data|0|||
16081625|NCT00308997|38792706|FG001|Overall Study|Subject feigned clinical data|1|||
16081626|NCT00308997|38792705|FG000|Overall Study|Unable to tolerate intervention|1|||
16081627|NCT00308997|38792706|FG001|Overall Study|Unable to tolerate intervention|0|||
16081628|NCT02590432|38792708|FG000|Open-label Treatment Period|Adverse Event|97|||
16081629|NCT02590432|38792709|FG001|Open-label Treatment Period|Adverse Event|79|||
16081630|NCT02590432|38792710|FG002|Open-label Treatment Period|Adverse Event|0|||
16081631|NCT02590432|38792711|FG003|Open-label Treatment Period|Adverse Event|0|||
16081632|NCT02590432|38792712|FG004|Open-label Treatment Period|Adverse Event|0|||
16081633|NCT02590432|38792713|FG005|Open-label Treatment Period|Adverse Event|0|||
16081634|NCT02590432|38792714|FG006|Open-label Treatment Period|Adverse Event|0|||
16081635|NCT02590432|38792715|FG007|Open-label Treatment Period|Adverse Event|0|||
16081636|NCT02590432|38792716|FG008|Open-label Treatment Period|Adverse Event|0|||
16081637|NCT02590432|38792708|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
16081638|NCT02590432|38792709|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
16081639|NCT02590432|38792710|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
16081640|NCT02590432|38792711|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
16081641|NCT02590432|38792712|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
16081642|NCT02590432|38792713|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
16081643|NCT02590432|38792714|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
16081644|NCT02590432|38792715|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
16081645|NCT02590432|38792716|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
16081646|NCT02590432|38792708|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
16081647|NCT02590432|38792709|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
16081648|NCT02590432|38792710|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
16081649|NCT02590432|38792711|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
16081650|NCT02590432|38792712|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
16081651|NCT02590432|38792713|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
16081652|NCT02590432|38792714|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
16081653|NCT02590432|38792715|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
16081654|NCT02590432|38792716|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
16081655|NCT02590432|38792708|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
16081656|NCT02590432|38792709|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
16081657|NCT02590432|38792710|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
16081658|NCT02590432|38792711|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
16081659|NCT02590432|38792712|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
16081660|NCT02590432|38792713|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
16081661|NCT02590432|38792714|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
16081662|NCT02590432|38792715|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
16081663|NCT02590432|38792716|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
16081664|NCT02590432|38792708|FG000|Open-label Treatment Period|Protocol Violation|10|||
16081665|NCT02590432|38792709|FG001|Open-label Treatment Period|Protocol Violation|4|||
16081666|NCT02590432|38792710|FG002|Open-label Treatment Period|Protocol Violation|0|||
16081667|NCT02590432|38792711|FG003|Open-label Treatment Period|Protocol Violation|0|||
16081668|NCT02590432|38792712|FG004|Open-label Treatment Period|Protocol Violation|0|||
16187634|NCT02190435|39164979|FG001|Overall Study|First 12 patients were lead-ins|0|||
16293960|NCT01347866|39559670|FG004|Overall Study|Lost to Follow-up|0|||
16293961|NCT01347866|39559671|FG005|Overall Study|Lost to Follow-up|0|||
16081669|NCT02590432|38792713|FG005|Open-label Treatment Period|Protocol Violation|0|||
16081670|NCT02590432|38792714|FG006|Open-label Treatment Period|Protocol Violation|0|||
16081671|NCT02590432|38792715|FG007|Open-label Treatment Period|Protocol Violation|0|||
16081672|NCT02590432|38792716|FG008|Open-label Treatment Period|Protocol Violation|0|||
16293962|NCT01347866|39559672|FG006|Overall Study|Lost to Follow-up|0|||
16293963|NCT01347866|39559673|FG007|Overall Study|Lost to Follow-up|1|||
16293964|NCT01347866|39559674|FG008|Overall Study|Lost to Follow-up|1|||
16187635|NCT02190435|39164978|FG000|Overall Study|3 consented screen fails|3|||
16187636|NCT02190435|39164979|FG001|Overall Study|3 consented screen fails|0|||
16187637|NCT04328623|39164980|FG000|Overall Study|Protocol Violation|0|||
16187638|NCT04328623|39164981|FG001|Overall Study|Protocol Violation|1|||
16187639|NCT03987620|39164982|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
16187640|NCT03987620|39164983|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
16187641|NCT03987620|39164982|FG000|Overall Study|Adverse Event|3|||
16187642|NCT03987620|39164983|FG001|Overall Study|Adverse Event|0|||
16187643|NCT03987620|39164982|FG000|Overall Study|Lost to Follow-up|1|||
16187644|NCT03987620|39164983|FG001|Overall Study|Lost to Follow-up|2|||
16187645|NCT03987620|39164982|FG000|Overall Study|Physician Decision|0|||
16187646|NCT03987620|39164983|FG001|Overall Study|Physician Decision|1|||
16187647|NCT03987620|39164982|FG000|Overall Study|Pregnancy|1|||
16293965|NCT01347866|39559675|FG009|Overall Study|Lost to Follow-up|0|||
16293966|NCT01347866|39559676|FG010|Overall Study|Lost to Follow-up|0|||
16293967|NCT01347866|39559677|FG011|Overall Study|Lost to Follow-up|0|||
16293968|NCT01347866|39559678|FG012|Overall Study|Lost to Follow-up|0|||
16293969|NCT01347866|39559679|FG013|Overall Study|Lost to Follow-up|0|||
16293970|NCT01347866|39559680|FG014|Overall Study|Lost to Follow-up|0|||
16293971|NCT01347866|39559681|FG015|Overall Study|Lost to Follow-up|0|||
16293972|NCT01347866|39559682|FG016|Overall Study|Lost to Follow-up|0|||
16293973|NCT01347866|39559666|FG000|Overall Study|Other|3|||
16293974|NCT01347866|39559667|FG001|Overall Study|Other|1|||
16293975|NCT01347866|39559668|FG002|Overall Study|Other|1|||
16293976|NCT01347866|39559669|FG003|Overall Study|Other|4|||
16293977|NCT01347866|39559670|FG004|Overall Study|Other|5|||
16293978|NCT01347866|39559671|FG005|Overall Study|Other|0|||
16293979|NCT01347866|39559672|FG006|Overall Study|Other|5|||
16293980|NCT01347866|39559673|FG007|Overall Study|Other|3|||
16293981|NCT01347866|39559674|FG008|Overall Study|Other|22|||
16293982|NCT01347866|39559675|FG009|Overall Study|Other|5|||
16293983|NCT01347866|39559676|FG010|Overall Study|Other|0|||
16293984|NCT01347866|39559677|FG011|Overall Study|Other|3|||
16293985|NCT01347866|39559678|FG012|Overall Study|Other|4|||
16293986|NCT01347866|39559679|FG013|Overall Study|Other|4|||
16293987|NCT01347866|39559680|FG014|Overall Study|Other|2|||
16293988|NCT01347866|39559681|FG015|Overall Study|Other|3|||
16293989|NCT01347866|39559682|FG016|Overall Study|Other|0|||
16293990|NCT01347866|39559666|FG000|Overall Study|Subject refused further follow-up|2|||
16293991|NCT01347866|39559667|FG001|Overall Study|Subject refused further follow-up|0|||
16293992|NCT01347866|39559668|FG002|Overall Study|Subject refused further follow-up|0|||
16293993|NCT01347866|39559669|FG003|Overall Study|Subject refused further follow-up|2|||
16293994|NCT01347866|39559670|FG004|Overall Study|Subject refused further follow-up|0|||
16293995|NCT01347866|39559671|FG005|Overall Study|Subject refused further follow-up|1|||
16293996|NCT01347866|39559672|FG006|Overall Study|Subject refused further follow-up|0|||
16293997|NCT01347866|39559673|FG007|Overall Study|Subject refused further follow-up|0|||
16293998|NCT01347866|39559674|FG008|Overall Study|Subject refused further follow-up|4|||
16293999|NCT01347866|39559675|FG009|Overall Study|Subject refused further follow-up|1|||
16294000|NCT01347866|39559676|FG010|Overall Study|Subject refused further follow-up|0|||
16294001|NCT01347866|39559677|FG011|Overall Study|Subject refused further follow-up|0|||
16294002|NCT01347866|39559678|FG012|Overall Study|Subject refused further follow-up|1|||
16294003|NCT01347866|39559679|FG013|Overall Study|Subject refused further follow-up|3|||
16294004|NCT01347866|39559680|FG014|Overall Study|Subject refused further follow-up|1|||
16294005|NCT01347866|39559681|FG015|Overall Study|Subject refused further follow-up|0|||
16294006|NCT01347866|39559682|FG016|Overall Study|Subject refused further follow-up|2|||
16294007|NCT01939496|39559683|FG000|Overall Study|Adverse Event|2|||
16294008|NCT01939496|39559684|FG001|Overall Study|Adverse Event|0|||
16294009|NCT01939496|39559685|FG002|Overall Study|Adverse Event|0|||
16294010|NCT01939496|39559683|FG000|Overall Study|Lost to Follow-up|1|||
16294011|NCT01939496|39559684|FG001|Overall Study|Lost to Follow-up|1|||
16294012|NCT01939496|39559685|FG002|Overall Study|Lost to Follow-up|0|||
16294013|NCT01939496|39559683|FG000|Overall Study|Physician Decision|1|||
16294014|NCT01939496|39559684|FG001|Overall Study|Physician Decision|0|||
16294015|NCT01939496|39559685|FG002|Overall Study|Physician Decision|0|||
16294016|NCT01939496|39559683|FG000|Overall Study|Protocol Violation|3|||
16294017|NCT01939496|39559684|FG001|Overall Study|Protocol Violation|0|||
16294018|NCT01939496|39559685|FG002|Overall Study|Protocol Violation|0|||
16484771|NCT03155178|40252562|FG002|Overall Study|Did not meet treatment day baseline|7|||
16294019|NCT01939496|39559683|FG000|Overall Study|Withdrawal by Subject|0|||
16294020|NCT01939496|39559684|FG001|Overall Study|Withdrawal by Subject|1|||
16294021|NCT01939496|39559685|FG002|Overall Study|Withdrawal by Subject|1|||
16294022|NCT01939496|39559683|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
16294023|NCT01939496|39559684|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
16294024|NCT01939496|39559685|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
16187648|NCT03987620|39164983|FG001|Overall Study|Pregnancy|0|||
16187649|NCT03987620|39164982|FG000|Overall Study|Withdrawal by Subject|7|||
16187650|NCT03987620|39164983|FG001|Overall Study|Withdrawal by Subject|1|||
16294025|NCT01939496|39559683|FG000|Overall Study|Other|2|||
16187651|NCT03987620|39164982|FG000|Overall Study|Other|2|||
16187652|NCT03987620|39164983|FG001|Overall Study|Other|5|||
16187653|NCT03648996|39164986|FG000|Overall Study|Withdrawal by Subject|0|||
16187654|NCT03648996|39164987|FG001|Overall Study|Withdrawal by Subject|2|||
16187655|NCT03648996|39164988|FG002|Overall Study|Withdrawal by Subject|2|||
16187656|NCT03648996|39164986|FG000|Overall Study|Physician Decision|2|||
16187657|NCT03648996|39164987|FG001|Overall Study|Physician Decision|0|||
16187658|NCT03648996|39164988|FG002|Overall Study|Physician Decision|0|||
16187659|NCT01954121|39164989|FG000|Overall Study|Lack of Efficacy|94|||
16187660|NCT01954121|39164990|FG001|Overall Study|Lack of Efficacy|41|||
16187661|NCT01954121|39164989|FG000|Overall Study|Protocol Violation|0|||
16187662|NCT01954121|39164990|FG001|Overall Study|Protocol Violation|2|||
16187663|NCT01954121|39164989|FG000|Overall Study|Lost to Follow-up|5|||
16187664|NCT01954121|39164990|FG001|Overall Study|Lost to Follow-up|6|||
16187665|NCT01954121|39164989|FG000|Overall Study|Withdrawal by Subject|18|||
16187666|NCT01954121|39164990|FG001|Overall Study|Withdrawal by Subject|12|||
16187667|NCT01954121|39164989|FG000|Overall Study|Pregnancy|1|||
16187668|NCT01954121|39164990|FG001|Overall Study|Pregnancy|1|||
16187669|NCT01954121|39164989|FG000|Overall Study|AE, serious fatal|1|||
16187670|NCT01954121|39164990|FG001|Overall Study|AE, serious fatal|0|||
16187671|NCT01954121|39164989|FG000|Overall Study|AE, non-serious non-fatal|5|||
16187672|NCT01954121|39164990|FG001|Overall Study|AE, non-serious non-fatal|22|||
16187673|NCT01954121|39164989|FG000|Overall Study|SAE, non-fatal|1|||
16187674|NCT01954121|39164990|FG001|Overall Study|SAE, non-fatal|4|||
16187675|NCT01954121|39164989|FG000|Overall Study|Non-compliant with study procedures|1|||
16187676|NCT01954121|39164990|FG001|Overall Study|Non-compliant with study procedures|0|||
16187677|NCT01954121|39164989|FG000|Overall Study|Non-compliant patient|1|||
16187678|NCT01954121|39164990|FG001|Overall Study|Non-compliant patient|1|||
16187679|NCT01954121|39164989|FG000|Overall Study|Subject did not follow instructions|0|||
16187680|NCT01954121|39164990|FG001|Overall Study|Subject did not follow instructions|2|||
16187681|NCT00651118|39165004|FG000|Overall Study|Adverse Event|4|||
16187682|NCT00651118|39165005|FG001|Overall Study|Adverse Event|0|||
16187683|NCT00651118|39165006|FG002|Overall Study|Adverse Event|1|||
16187684|NCT00651118|39165007|FG003|Overall Study|Adverse Event|1|||
16187685|NCT00651118|39165004|FG000|Overall Study|Protocol Violation|2|||
16187686|NCT00651118|39165005|FG001|Overall Study|Protocol Violation|2|||
16187687|NCT00651118|39165006|FG002|Overall Study|Protocol Violation|6|||
16187688|NCT00651118|39165007|FG003|Overall Study|Protocol Violation|2|||
16187689|NCT00651118|39165004|FG000|Overall Study|Lost to Follow-up|2|||
16187690|NCT00651118|39165005|FG001|Overall Study|Lost to Follow-up|0|||
16187691|NCT00651118|39165006|FG002|Overall Study|Lost to Follow-up|1|||
16187692|NCT00651118|39165007|FG003|Overall Study|Lost to Follow-up|2|||
16187693|NCT00651118|39165004|FG000|Overall Study|administrative|1|||
16187694|NCT00651118|39165005|FG001|Overall Study|administrative|4|||
16187695|NCT00651118|39165006|FG002|Overall Study|administrative|2|||
16187696|NCT00651118|39165007|FG003|Overall Study|administrative|1|||
16187697|NCT00651118|39165004|FG000|Overall Study|Withdrawal by Subject|0|||
16187698|NCT00651118|39165005|FG001|Overall Study|Withdrawal by Subject|1|||
16187699|NCT00651118|39165006|FG002|Overall Study|Withdrawal by Subject|1|||
16187700|NCT00651118|39165007|FG003|Overall Study|Withdrawal by Subject|1|||
16187701|NCT01312428|39165008|FG000|Overall Study|Study Termination|3|||
16187702|NCT01312428|39165009|FG001|Overall Study|Study Termination|4|||
16187703|NCT01850563|39165010|FG000|Overall Study|Not eligible|3|||
16187704|NCT01850563|39165011|FG001|Overall Study|Not eligible|0|||
16187705|NCT02371759|39165012|FG000|Overall Study|Protocol Violation|3|||
16187706|NCT02371759|39165013|FG001|Overall Study|Protocol Violation|1|||
16187707|NCT02371759|39165014|FG002|Overall Study|Protocol Violation|1|||
16187708|NCT02371759|39165015|FG003|Overall Study|Protocol Violation|0|||
16187709|NCT02371759|39165016|FG004|Overall Study|Protocol Violation|3|||
16187710|NCT02371759|39165017|FG005|Overall Study|Protocol Violation|1|||
16187711|NCT02371759|39165018|FG006|Overall Study|Protocol Violation|0|||
16187712|NCT02371759|39165019|FG007|Overall Study|Protocol Violation|3|||
16187713|NCT02371759|39165012|FG000|Overall Study|Withdrawal by Subject|0|||
16187714|NCT02371759|39165013|FG001|Overall Study|Withdrawal by Subject|0|||
16187715|NCT02371759|39165014|FG002|Overall Study|Withdrawal by Subject|0|||
16187716|NCT02371759|39165015|FG003|Overall Study|Withdrawal by Subject|0|||
16187717|NCT02371759|39165016|FG004|Overall Study|Withdrawal by Subject|0|||
16187718|NCT02371759|39165017|FG005|Overall Study|Withdrawal by Subject|0|||
16187719|NCT02371759|39165018|FG006|Overall Study|Withdrawal by Subject|0|||
16187720|NCT02371759|39165019|FG007|Overall Study|Withdrawal by Subject|1|||
16187721|NCT03072719|39165021|FG000|Overall Study|Adverse Event|1|||
16187722|NCT03072719|39165022|FG001|Overall Study|Adverse Event|1|||
16187723|NCT00084682|39165023|FG000|Overall Study|Withdrawal by Subject|1|||
16187724|NCT02680847|39165024|FG000|Overall Study|Other|2|||
16187725|NCT02680847|39165025|FG001|Overall Study|Other|0|||
16187726|NCT02680847|39165026|FG002|Overall Study|Other|0|||
16187727|NCT02680847|39165024|FG000|Overall Study|No longer met eligibility criteria|2|||
16187728|NCT02680847|39165025|FG001|Overall Study|No longer met eligibility criteria|2|||
16187729|NCT02680847|39165026|FG002|Overall Study|No longer met eligibility criteria|0|||
16294026|NCT01939496|39559684|FG001|Overall Study|Other|0|||
16294027|NCT01939496|39559685|FG002|Overall Study|Other|1|||
16294028|NCT02269163|39559686|FG000|Overall Study|Lost to Follow-up|1|||
16294029|NCT02269163|39559687|FG001|Overall Study|Lost to Follow-up|0|||
16294030|NCT02269163|39559686|FG000|Overall Study|Major protocol violation|0|||
16294031|NCT02269163|39559687|FG001|Overall Study|Major protocol violation|1|||
16294032|NCT02269163|39559686|FG000|Overall Study|Other|2|||
16294033|NCT02269163|39559687|FG001|Overall Study|Other|2|||
16294034|NCT02269163|39559686|FG000|Overall Study|Withdrawal by Subject|0|||
16294035|NCT02269163|39559687|FG001|Overall Study|Withdrawal by Subject|3|||
16294036|NCT02269163|39559686|FG000|Overall Study|Physician Decision|0|||
16294037|NCT02269163|39559687|FG001|Overall Study|Physician Decision|1|||
16294038|NCT00910091|39559691|FG000|Pre-assignment|Withdrawal by Subject|0|||
16294039|NCT00910091|39559692|FG001|Pre-assignment|Withdrawal by Subject|2|||
16294040|NCT00910091|39559691|FG000|Treatment and Survival|Withdrawal by Subject|3|||
16294041|NCT00910091|39559692|FG001|Treatment and Survival|Withdrawal by Subject|4|||
16294042|NCT00910091|39559691|FG000|Treatment and Survival|Adverse Event|1|||
16294043|NCT00910091|39559692|FG001|Treatment and Survival|Adverse Event|0|||
16294044|NCT01996332|39559697|FG000|Overall Study|Adverse Event|117|||
16294045|NCT01996332|39559697|FG000|Overall Study|Lack of Efficacy|1245|||
16294046|NCT01996332|39559697|FG000|Overall Study|Death|264|||
16294047|NCT01996332|39559697|FG000|Overall Study|Protocol Violation|9|||
16294048|NCT01996332|39559697|FG000|Overall Study|Withdrawal by Subject|71|||
16294049|NCT01996332|39559697|FG000|Overall Study|Other|20|||
16294050|NCT01996332|39559697|FG000|Overall Study|Clinical Deterioration|28|||
16294051|NCT01996332|39559697|FG000|Overall Study|Physician Decision|17|||
16294052|NCT01996332|39559697|FG000|Overall Study|Lost to Follow-up|34|||
16294053|NCT00424775|39559700|FG000|Overall Study|Adverse Event|2|||
16294054|NCT00424775|39559701|FG001|Overall Study|Adverse Event|0|||
16294055|NCT00424775|39559700|FG000|Overall Study|Lack of Efficacy|1|||
16294056|NCT00424775|39559701|FG001|Overall Study|Lack of Efficacy|0|||
16294057|NCT03255655|39562744|FG000|Overall Study|Lost to Follow-up|7|||
16294058|NCT03255655|39562745|FG001|Overall Study|Lost to Follow-up|4|||
16294059|NCT00259272|39562746|FG000|Overall Study|Adverse Event|2|||
16294060|NCT00259272|39562747|FG001|Overall Study|Adverse Event|1|||
16294061|NCT00259272|39562748|FG002|Overall Study|Adverse Event|0|||
16294062|NCT00259272|39562749|FG003|Overall Study|Adverse Event|3|||
16294063|NCT00259272|39562746|FG000|Overall Study|Lack of Efficacy|5|||
16294064|NCT00259272|39562747|FG001|Overall Study|Lack of Efficacy|1|||
16294065|NCT00259272|39562748|FG002|Overall Study|Lack of Efficacy|2|||
16294066|NCT00259272|39562749|FG003|Overall Study|Lack of Efficacy|6|||
16294067|NCT00259272|39562746|FG000|Overall Study|Physician Decision|1|||
16294068|NCT00259272|39562747|FG001|Overall Study|Physician Decision|2|||
16294069|NCT00259272|39562748|FG002|Overall Study|Physician Decision|1|||
16294070|NCT00259272|39562749|FG003|Overall Study|Physician Decision|3|||
16294071|NCT00259272|39562746|FG000|Overall Study|Protocol Violation|2|||
16294072|NCT00259272|39562747|FG001|Overall Study|Protocol Violation|0|||
16294073|NCT00259272|39562748|FG002|Overall Study|Protocol Violation|0|||
16294074|NCT00259272|39562749|FG003|Overall Study|Protocol Violation|1|||
16294075|NCT00259272|39562746|FG000|Overall Study|Sponsor Decision|0|||
16294076|NCT00259272|39562747|FG001|Overall Study|Sponsor Decision|1|||
16294077|NCT00259272|39562748|FG002|Overall Study|Sponsor Decision|0|||
16294078|NCT00259272|39562749|FG003|Overall Study|Sponsor Decision|0|||
16294079|NCT00259272|39562746|FG000|Overall Study|Withdrawal by Subject|4|||
16294080|NCT00259272|39562747|FG001|Overall Study|Withdrawal by Subject|2|||
16294081|NCT00259272|39562748|FG002|Overall Study|Withdrawal by Subject|2|||
16294082|NCT00259272|39562749|FG003|Overall Study|Withdrawal by Subject|7|||
16294083|NCT00259272|39562746|FG000|Overall Study|Lost to Follow-up|1|||
16294084|NCT00259272|39562747|FG001|Overall Study|Lost to Follow-up|0|||
16294085|NCT00259272|39562748|FG002|Overall Study|Lost to Follow-up|0|||
16294086|NCT00259272|39562749|FG003|Overall Study|Lost to Follow-up|1|||
16294087|NCT01284621|39562750|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
16294088|NCT01284621|39562751|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
16294089|NCT01284621|39562752|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
16294090|NCT01284621|39562753|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
16081673|NCT02590432|38792708|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
16294091|NCT01284621|39562754|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
16294092|NCT01284621|39562755|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
16294093|NCT01032018|39562756|FG000|Overall Study|Lost to Follow-up|6|||
16294094|NCT01032018|39562757|FG001|Overall Study|Lost to Follow-up|5|||
16294095|NCT01032018|39562756|FG000|Overall Study|Death|0|||
16294096|NCT01032018|39562757|FG001|Overall Study|Death|1|||
16294097|NCT00856973|39562758|FG000|Overall Study|Adverse Event|5|||
16294098|NCT00856973|39562759|FG001|Overall Study|Adverse Event|5|||
16294099|NCT00856973|39562760|FG002|Overall Study|Adverse Event|3|||
16294100|NCT00856973|39562758|FG000|Overall Study|Lost to Follow-up|6|||
16294101|NCT00856973|39562759|FG001|Overall Study|Lost to Follow-up|3|||
16294102|NCT00856973|39562760|FG002|Overall Study|Lost to Follow-up|5|||
16187730|NCT02680847|39165024|FG000|Overall Study|Unwilling to participate in study|1|||
16187731|NCT02680847|39165025|FG001|Overall Study|Unwilling to participate in study|1|||
16187732|NCT02680847|39165026|FG002|Overall Study|Unwilling to participate in study|0|||
16187733|NCT02680847|39165024|FG000|Overall Study|Lack of Efficacy|0|||
16187734|NCT02680847|39165025|FG001|Overall Study|Lack of Efficacy|0|||
16187735|NCT02680847|39165026|FG002|Overall Study|Lack of Efficacy|2|||
16187736|NCT02680847|39165024|FG000|Overall Study|Adverse Event|0|||
16187737|NCT02680847|39165025|FG001|Overall Study|Adverse Event|0|||
16187738|NCT02680847|39165026|FG002|Overall Study|Adverse Event|1|||
16187739|NCT02379923|39165030|FG000|Overall Study|Death|5|||
16187740|NCT01701583|39165031|FG000|Overall Study|Withdrawal by Subject|2|||
16187741|NCT01701583|39165032|FG001|Overall Study|Withdrawal by Subject|0|||
16187742|NCT02399813|39165033|FG000|Overall Study|Progressive Disease-Radiographic|2|||
16187743|NCT02399813|39165033|FG000|Overall Study|Death|20|||
16187744|NCT02399813|39165033|FG000|Overall Study|Withdrawal by Subject|3|||
16187745|NCT02399813|39165033|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
16187746|NCT02399813|39165033|FG000|Overall Study|Lost to Follow-up|2|||
16187747|NCT02399813|39165033|FG000|Overall Study|Other than specified|5|||
16187748|NCT03303339|39165034|FG000|Overall Study|Death|2|||
16187749|NCT03303339|39165035|FG001|Overall Study|Death|2|||
16187750|NCT03303339|39165036|FG002|Overall Study|Death|2|||
16187751|NCT03303339|39165037|FG003|Overall Study|Death|1|||
16187752|NCT03303339|39165038|FG004|Overall Study|Death|4|||
16187753|NCT03303339|39165039|FG005|Overall Study|Death|2|||
16187754|NCT03303339|39165040|FG006|Overall Study|Death|2|||
16187755|NCT03303339|39165041|FG007|Overall Study|Death|2|||
16187756|NCT03303339|39165042|FG008|Overall Study|Death|3|||
16187757|NCT03303339|39165043|FG009|Overall Study|Death|3|||
16187758|NCT03303339|39165044|FG010|Overall Study|Death|4|||
16187759|NCT03303339|39165045|FG011|Overall Study|Death|24|||
16187760|NCT03303339|39165034|FG000|Overall Study|Study Terminated by Sponsor|0|||
16187761|NCT03303339|39165035|FG001|Overall Study|Study Terminated by Sponsor|0|||
16187762|NCT03303339|39165036|FG002|Overall Study|Study Terminated by Sponsor|0|||
16187763|NCT03303339|39165037|FG003|Overall Study|Study Terminated by Sponsor|0|||
16187764|NCT03303339|39165038|FG004|Overall Study|Study Terminated by Sponsor|0|||
16187765|NCT03303339|39165039|FG005|Overall Study|Study Terminated by Sponsor|0|||
16187766|NCT03303339|39165040|FG006|Overall Study|Study Terminated by Sponsor|0|||
16187767|NCT03303339|39165041|FG007|Overall Study|Study Terminated by Sponsor|0|||
16187768|NCT03303339|39165042|FG008|Overall Study|Study Terminated by Sponsor|1|||
16187769|NCT03303339|39165043|FG009|Overall Study|Study Terminated by Sponsor|0|||
16187770|NCT03303339|39165044|FG010|Overall Study|Study Terminated by Sponsor|1|||
16187771|NCT03303339|39165045|FG011|Overall Study|Study Terminated by Sponsor|1|||
16187772|NCT03303339|39165034|FG000|Overall Study|Withdrawal by Subject|1|||
16187773|NCT03303339|39165035|FG001|Overall Study|Withdrawal by Subject|0|||
16187774|NCT03303339|39165036|FG002|Overall Study|Withdrawal by Subject|0|||
16187775|NCT03303339|39165037|FG003|Overall Study|Withdrawal by Subject|0|||
16187776|NCT03303339|39165038|FG004|Overall Study|Withdrawal by Subject|0|||
16484772|NCT03155178|40252563|FG003|Overall Study|Did not meet treatment day baseline|7|||
16484773|NCT04112784|40252564|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
16484774|NCT04112784|40252564|FG000|Overall Study|Screen Failures|4|||
16484775|NCT03173313|40252565|FG000|Overall Study|Lost to Follow-up|2|||
16484776|NCT03173313|40252566|FG001|Overall Study|Lost to Follow-up|3|||
16484777|NCT03173313|40252565|FG000|Overall Study|Withdrawal by Subject|0|||
16484778|NCT03173313|40252566|FG001|Overall Study|Withdrawal by Subject|1|||
16484779|NCT03173313|40252565|FG000|Overall Study|Death|5|||
16484780|NCT03173313|40252566|FG001|Overall Study|Death|0|||
16484781|NCT03173313|40252565|FG000|Overall Study|Physician Decision|1|||
16484782|NCT03173313|40252566|FG001|Overall Study|Physician Decision|0|||
16484783|NCT03173313|40252565|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
16484784|NCT03173313|40252566|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
16484785|NCT03173313|40252565|FG000|Overall Study|Bone Fracture|1|||
16484786|NCT03173313|40252566|FG001|Overall Study|Bone Fracture|0|||
16484787|NCT02610725|40252568|FG000|Overall Study|Lost to Follow-up|197|||
16484788|NCT02610725|40252568|FG000|Overall Study|self-reported contraindication|9|||
16484789|NCT00824720|40252569|FG000|Overall Study|failed plug insertion|3|||
16484790|NCT00824720|40252570|FG001|Overall Study|failed plug insertion|1|||
16484791|NCT00824720|40252571|FG002|Overall Study|failed plug insertion|0|||
16484792|NCT00824720|40252569|FG000|Overall Study|Protocol Violation|0|||
16484793|NCT00824720|40252570|FG001|Overall Study|Protocol Violation|0|||
16484794|NCT00824720|40252571|FG002|Overall Study|Protocol Violation|1|||
16484795|NCT02657369|40252574|FG000|Overall Study|Death|27|||
16484796|NCT02657369|40252574|FG000|Overall Study|Study terminated by sponsor|7|||
16484797|NCT03733470|40252576|FG000|Overall Study|PI Decision|1|||
16484798|NCT03733470|40252577|FG001|Overall Study|PI Decision|1|||
16484799|NCT03230097|40252584|FG000|Overall Study|Adverse Event|2|||
16484800|NCT03230097|40252585|FG001|Overall Study|Adverse Event|1|||
16484801|NCT03230097|40252584|FG000|Overall Study|non-compliance|0|||
16484802|NCT03230097|40252585|FG001|Overall Study|non-compliance|1|||
16484803|NCT03230097|40252584|FG000|Overall Study|Lost to Follow-up|2|||
16484804|NCT03230097|40252585|FG001|Overall Study|Lost to Follow-up|4|||
16484805|NCT03230097|40252584|FG000|Overall Study|Withdrawal by Subject|7|||
16484806|NCT03230097|40252585|FG001|Overall Study|Withdrawal by Subject|3|||
16484807|NCT03230097|40252584|FG000|Overall Study|Trial termination|4|||
16484808|NCT03230097|40252585|FG001|Overall Study|Trial termination|5|||
16484809|NCT03230097|40252584|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
16484810|NCT03230097|40252585|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
16484811|NCT03230097|40252584|FG000|Overall Study|outcome event|0|||
16484812|NCT03230097|40252585|FG001|Overall Study|outcome event|1|||
16484813|NCT01350492|40252587|FG000|Intervention|Lost to Follow-up|2|||
16484814|NCT01350492|40252588|FG001|Intervention|Lost to Follow-up|5|||
16484815|NCT01350492|40252587|FG000|Intervention|Withdrawal by Subject|3|||
16484816|NCT01350492|40252588|FG001|Intervention|Withdrawal by Subject|1|||
16484817|NCT01350492|40252587|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
16187777|NCT03303339|39165039|FG005|Overall Study|Withdrawal by Subject|1|||
16187778|NCT03303339|39165040|FG006|Overall Study|Withdrawal by Subject|1|||
16484818|NCT01350492|40252588|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
16484819|NCT01350492|40252587|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
16187779|NCT03303339|39165041|FG007|Overall Study|Withdrawal by Subject|0|||
16187780|NCT03303339|39165042|FG008|Overall Study|Withdrawal by Subject|0|||
16187781|NCT03303339|39165043|FG009|Overall Study|Withdrawal by Subject|0|||
16187782|NCT03303339|39165044|FG010|Overall Study|Withdrawal by Subject|0|||
16187783|NCT03303339|39165045|FG011|Overall Study|Withdrawal by Subject|2|||
16187784|NCT03303339|39165034|FG000|Overall Study|Physician Decision|0|||
16187785|NCT03303339|39165035|FG001|Overall Study|Physician Decision|0|||
16187786|NCT03303339|39165036|FG002|Overall Study|Physician Decision|0|||
16187787|NCT03303339|39165037|FG003|Overall Study|Physician Decision|0|||
16187788|NCT03303339|39165038|FG004|Overall Study|Physician Decision|1|||
16187789|NCT03303339|39165039|FG005|Overall Study|Physician Decision|0|||
16187790|NCT03303339|39165040|FG006|Overall Study|Physician Decision|0|||
16187791|NCT03303339|39165041|FG007|Overall Study|Physician Decision|0|||
16187792|NCT03303339|39165042|FG008|Overall Study|Physician Decision|0|||
16187793|NCT03303339|39165043|FG009|Overall Study|Physician Decision|0|||
16187794|NCT03303339|39165044|FG010|Overall Study|Physician Decision|0|||
16187795|NCT03303339|39165045|FG011|Overall Study|Physician Decision|0|||
16187796|NCT03303339|39165034|FG000|Overall Study|Safety/Non-compliance|0|||
16187797|NCT03303339|39165035|FG001|Overall Study|Safety/Non-compliance|0|||
16187798|NCT03303339|39165036|FG002|Overall Study|Safety/Non-compliance|0|||
16294103|NCT00856973|39562758|FG000|Overall Study|Physician Decision|0|||
16294104|NCT00856973|39562759|FG001|Overall Study|Physician Decision|3|||
16294105|NCT00856973|39562760|FG002|Overall Study|Physician Decision|1|||
16294106|NCT00856973|39562758|FG000|Overall Study|Protocol Violation|1|||
16294107|NCT00856973|39562759|FG001|Overall Study|Protocol Violation|2|||
16294108|NCT00856973|39562760|FG002|Overall Study|Protocol Violation|1|||
16294109|NCT00856973|39562758|FG000|Overall Study|Withdrawal by Subject|13|||
16294110|NCT00856973|39562759|FG001|Overall Study|Withdrawal by Subject|16|||
16187799|NCT03303339|39165037|FG003|Overall Study|Safety/Non-compliance|0|||
16187800|NCT03303339|39165038|FG004|Overall Study|Safety/Non-compliance|0|||
16187801|NCT03303339|39165039|FG005|Overall Study|Safety/Non-compliance|0|||
16187802|NCT03303339|39165040|FG006|Overall Study|Safety/Non-compliance|0|||
16187803|NCT03303339|39165041|FG007|Overall Study|Safety/Non-compliance|0|||
16187804|NCT03303339|39165042|FG008|Overall Study|Safety/Non-compliance|0|||
16187805|NCT03303339|39165043|FG009|Overall Study|Safety/Non-compliance|0|||
16294111|NCT00856973|39562760|FG002|Overall Study|Withdrawal by Subject|15|||
16294112|NCT00856973|39562758|FG000|Overall Study|Other|11|||
16294113|NCT00856973|39562759|FG001|Overall Study|Other|12|||
16294114|NCT00856973|39562760|FG002|Overall Study|Other|13|||
16294115|NCT01055132|39562763|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
16294116|NCT01055132|39562764|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
16294117|NCT01055132|39562763|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
16294118|NCT01055132|39562764|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
16294119|NCT02677714|39562765|FG000|Overall Study|Withdrawal by Subject|2|||
16294120|NCT02677714|39562766|FG001|Overall Study|Withdrawal by Subject|0|||
16294121|NCT03201250|39562767|FG000|Overall Study|screen failures|3|||
16294122|NCT03201250|39562768|FG001|Overall Study|screen failures|0|||
16294123|NCT03201250|39562769|FG002|Overall Study|screen failures|0|||
16294124|NCT00593736|39562770|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
16294125|NCT00593736|39562771|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
16294126|NCT00593736|39562772|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
16294127|NCT00593736|39562773|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
16294128|NCT00593736|39562770|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
16294129|NCT00593736|39562771|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
16294130|NCT00593736|39562772|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
16294131|NCT00593736|39562773|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
16294132|NCT00593736|39562770|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
16294133|NCT00593736|39562771|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
16294134|NCT00593736|39562772|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
16294135|NCT00593736|39562773|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
16294136|NCT00593736|39562770|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
16294137|NCT00593736|39562771|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
16294138|NCT00593736|39562772|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
16294139|NCT00593736|39562773|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
16294140|NCT00593736|39562770|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
16294141|NCT00593736|39562771|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
16294142|NCT00593736|39562772|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
16294143|NCT00593736|39562773|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
16294144|NCT00593736|39562770|FG000|Screening Period and Placebo Run-in|Various|0|||
16294145|NCT00593736|39562771|FG001|Screening Period and Placebo Run-in|Various|0|||
16187806|NCT03303339|39165044|FG010|Overall Study|Safety/Non-compliance|0|||
16187807|NCT03303339|39165045|FG011|Overall Study|Safety/Non-compliance|1|||
16187808|NCT01199263|39165046|FG000|Overall Study|Ineligible|0|||
16187809|NCT01199263|39165047|FG001|Overall Study|Ineligible|2|||
16294146|NCT00593736|39562772|FG002|Screening Period and Placebo Run-in|Various|0|||
16294147|NCT00593736|39562773|FG003|Screening Period and Placebo Run-in|Various|25|||
16294148|NCT00593736|39562770|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
16294149|NCT00593736|39562771|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
16294150|NCT00593736|39562772|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
16294151|NCT00593736|39562773|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
16294152|NCT00593736|39562770|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
16382336|NCT00545779|39884447|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
16382337|NCT00545779|39884447|FG000|Overall Study|Failure to return|3|||
16382338|NCT00431964|39884448|FG000|Overall Study|Adverse Event|1|||
16382339|NCT00431964|39884449|FG001|Overall Study|Adverse Event|0|||
16382340|NCT00431964|39884448|FG000|Overall Study|Lost to Follow-up|1|||
16382341|NCT00431964|39884449|FG001|Overall Study|Lost to Follow-up|2|||
16382342|NCT00431964|39884448|FG000|Overall Study|Physician Decision|2|||
16382343|NCT00431964|39884449|FG001|Overall Study|Physician Decision|2|||
16382344|NCT00431964|39884448|FG000|Overall Study|Withdrawal by Subject|2|||
16382345|NCT00431964|39884449|FG001|Overall Study|Withdrawal by Subject|1|||
16382346|NCT00431964|39884448|FG000|Overall Study|Parental Consent Withdrawn|0|||
16382347|NCT00431964|39884449|FG001|Overall Study|Parental Consent Withdrawn|2|||
16382348|NCT00431964|39884448|FG000|Overall Study|Due to Unstable Health|0|||
16382349|NCT00431964|39884449|FG001|Overall Study|Due to Unstable Health|1|||
16382350|NCT04573972|39884450|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
16382351|NCT04573972|39884451|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
16382352|NCT00443456|39884452|FG000|Overall Study|Adverse Event|16|||
16382353|NCT00443456|39884452|FG000|Overall Study|Move|1|||
16382354|NCT00443456|39884452|FG000|Overall Study|Withdrawal by Subject|1|||
16382355|NCT01342094|39884453|FG000|Overall Study|Adverse Event|5|||
16382356|NCT01342094|39884454|FG001|Overall Study|Adverse Event|0|||
16382357|NCT01342094|39884453|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
16382358|NCT01342094|39884454|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
16382359|NCT01342094|39884453|FG000|Overall Study|Withdrawal by Subject|0|||
16382360|NCT01342094|39884454|FG001|Overall Study|Withdrawal by Subject|2|||
16382361|NCT03139448|39884460|FG000|Overall Study|Lack of Efficacy|6|||
16382362|NCT03139448|39884461|FG001|Overall Study|Lack of Efficacy|7|||
16382363|NCT03139448|39884460|FG000|Overall Study|Location of procedure changed|2|||
16382364|NCT03139448|39884461|FG001|Overall Study|Location of procedure changed|8|||
16382365|NCT03139448|39884460|FG000|Overall Study|Withdrawal by Subject|3|||
16382366|NCT03139448|39884461|FG001|Overall Study|Withdrawal by Subject|6|||
16382367|NCT03139448|39884460|FG000|Overall Study|Screen fail|1|||
16382368|NCT03139448|39884461|FG001|Overall Study|Screen fail|3|||
16382369|NCT03139448|39884460|FG000|Overall Study|Physician Decision|0|||
16382370|NCT03139448|39884461|FG001|Overall Study|Physician Decision|2|||
16382371|NCT04047446|39884462|FG000|Overall Study|Physician Decision|1|||
16081674|NCT02590432|38792709|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
16294153|NCT00593736|39562771|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
16382372|NCT04047446|39884463|FG001|Overall Study|Physician Decision|0|||
16294154|NCT00593736|39562772|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
16294155|NCT00593736|39562773|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
16294156|NCT00593736|39562770|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
16382373|NCT02437318|39884468|FG000|Overall Study|Progressive disease|173|||
16382374|NCT02437318|39884469|FG001|Overall Study|Progressive disease|208|||
16382375|NCT02437318|39884468|FG000|Overall Study|Subject/guardian decision|22|||
16382376|NCT02437318|39884469|FG001|Overall Study|Subject/guardian decision|10|||
16382377|NCT02437318|39884468|FG000|Overall Study|Physician Decision|11|||
16484820|NCT01350492|40252588|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
16484821|NCT00401531|40252589|FG000|Overall Study|Adverse Event|2|||
16294157|NCT00593736|39562771|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
16484822|NCT00401531|40252590|FG001|Overall Study|Adverse Event|0|||
16081675|NCT02590432|38792710|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
16294158|NCT00593736|39562772|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
16294159|NCT00593736|39562773|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
16294160|NCT00593736|39562770|FG000|Treatment Period and Placebo Run-out|Various|1|||
16294161|NCT00593736|39562771|FG001|Treatment Period and Placebo Run-out|Various|1|||
16294162|NCT00593736|39562772|FG002|Treatment Period and Placebo Run-out|Various|1|||
16294163|NCT00593736|39562773|FG003|Treatment Period and Placebo Run-out|Various|0|||
16294164|NCT02516553|39562774|FG000|Overall Study|Progressive disease|2|||
16294165|NCT02516553|39562775|FG001|Overall Study|Progressive disease|2|||
16382378|NCT02437318|39884469|FG001|Overall Study|Physician Decision|10|||
16382379|NCT02437318|39884468|FG000|Overall Study|Adverse Event|14|||
16382380|NCT02437318|39884469|FG001|Overall Study|Adverse Event|3|||
16382381|NCT02437318|39884468|FG000|Overall Study|Death|4|||
16382382|NCT02437318|39884469|FG001|Overall Study|Death|4|||
16382383|NCT02437318|39884468|FG000|Overall Study|Protocol Violation|5|||
16382384|NCT02437318|39884469|FG001|Overall Study|Protocol Violation|6|||
16382385|NCT02437318|39884468|FG000|Overall Study|Untreated|0|||
16294166|NCT02516553|39562776|FG002|Overall Study|Progressive disease|3|||
16294167|NCT02516553|39562777|FG003|Overall Study|Progressive disease|5|||
16294168|NCT02516553|39562778|FG004|Overall Study|Progressive disease|3|||
16294169|NCT02516553|39562779|FG005|Overall Study|Progressive disease|0|||
16294170|NCT02516553|39562780|FG006|Overall Study|Progressive disease|5|||
16294171|NCT02516553|39562781|FG007|Overall Study|Progressive disease|5|||
16294172|NCT02516553|39562782|FG008|Overall Study|Progressive disease|11|||
16294173|NCT02516553|39562783|FG009|Overall Study|Progressive disease|3|||
16294174|NCT02516553|39562784|FG010|Overall Study|Progressive disease|10|||
16294175|NCT02516553|39562785|FG011|Overall Study|Progressive disease|8|||
16294176|NCT02516553|39562786|FG012|Overall Study|Progressive disease|8|||
16294177|NCT02516553|39562787|FG013|Overall Study|Progressive disease|2|||
16294178|NCT02516553|39562788|FG014|Overall Study|Progressive disease|2|||
16294179|NCT02516553|39562789|FG015|Overall Study|Progressive disease|2|||
16294180|NCT02516553|39562790|FG016|Overall Study|Progressive disease|1|||
16294181|NCT02516553|39562791|FG017|Overall Study|Progressive disease|9|||
16294182|NCT02516553|39562792|FG018|Overall Study|Progressive disease|12|||
16294183|NCT02516553|39562793|FG019|Overall Study|Progressive disease|7|||
16081676|NCT02590432|38792711|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
16081677|NCT02590432|38792712|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
16081678|NCT02590432|38792713|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
16081679|NCT02590432|38792714|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
16081680|NCT02590432|38792715|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
16081681|NCT02590432|38792716|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
16081682|NCT02590432|38792708|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
16294184|NCT02516553|39562794|FG020|Overall Study|Progressive disease|16|||
16294185|NCT02516553|39562795|FG021|Overall Study|Progressive disease|18|||
16294186|NCT02516553|39562774|FG000|Overall Study|Dose limiting toxicity|0|||
16081683|NCT02590432|38792709|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
16081684|NCT02590432|38792710|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
16294187|NCT02516553|39562775|FG001|Overall Study|Dose limiting toxicity|0|||
16294188|NCT02516553|39562776|FG002|Overall Study|Dose limiting toxicity|0|||
16294189|NCT02516553|39562777|FG003|Overall Study|Dose limiting toxicity|0|||
16294190|NCT02516553|39562778|FG004|Overall Study|Dose limiting toxicity|3|||
16294191|NCT02516553|39562779|FG005|Overall Study|Dose limiting toxicity|1|||
16294192|NCT02516553|39562780|FG006|Overall Study|Dose limiting toxicity|1|||
16294193|NCT02516553|39562781|FG007|Overall Study|Dose limiting toxicity|0|||
16294194|NCT02516553|39562782|FG008|Overall Study|Dose limiting toxicity|1|||
16294195|NCT02516553|39562783|FG009|Overall Study|Dose limiting toxicity|0|||
16294196|NCT02516553|39562784|FG010|Overall Study|Dose limiting toxicity|0|||
16294197|NCT02516553|39562785|FG011|Overall Study|Dose limiting toxicity|1|||
16294198|NCT02516553|39562786|FG012|Overall Study|Dose limiting toxicity|0|||
16294199|NCT02516553|39562787|FG013|Overall Study|Dose limiting toxicity|1|||
16382386|NCT02437318|39884469|FG001|Overall Study|Untreated|1|||
16484823|NCT00401531|40252589|FG000|Overall Study|Protocol Violation|3|||
16294200|NCT02516553|39562788|FG014|Overall Study|Dose limiting toxicity|0|||
16294201|NCT02516553|39562789|FG015|Overall Study|Dose limiting toxicity|0|||
16294202|NCT02516553|39562790|FG016|Overall Study|Dose limiting toxicity|1|||
16294203|NCT02516553|39562791|FG017|Overall Study|Dose limiting toxicity|1|||
16294204|NCT02516553|39562792|FG018|Overall Study|Dose limiting toxicity|0|||
16294205|NCT02516553|39562793|FG019|Overall Study|Dose limiting toxicity|2|||
16294206|NCT02516553|39562794|FG020|Overall Study|Dose limiting toxicity|0|||
16294207|NCT02516553|39562795|FG021|Overall Study|Dose limiting toxicity|0|||
16294208|NCT02516553|39562774|FG000|Overall Study|Other Adverse Events|0|||
16294209|NCT02516553|39562775|FG001|Overall Study|Other Adverse Events|0|||
16294210|NCT02516553|39562776|FG002|Overall Study|Other Adverse Events|0|||
16294211|NCT02516553|39562777|FG003|Overall Study|Other Adverse Events|1|||
16294212|NCT02516553|39562778|FG004|Overall Study|Other Adverse Events|0|||
16294213|NCT02516553|39562779|FG005|Overall Study|Other Adverse Events|1|||
16294214|NCT02516553|39562780|FG006|Overall Study|Other Adverse Events|0|||
16294215|NCT02516553|39562781|FG007|Overall Study|Other Adverse Events|0|||
16294216|NCT02516553|39562782|FG008|Overall Study|Other Adverse Events|0|||
16294217|NCT02516553|39562783|FG009|Overall Study|Other Adverse Events|1|||
16294218|NCT02516553|39562784|FG010|Overall Study|Other Adverse Events|3|||
16294219|NCT02516553|39562785|FG011|Overall Study|Other Adverse Events|2|||
16294220|NCT02516553|39562786|FG012|Overall Study|Other Adverse Events|0|||
16294221|NCT02516553|39562787|FG013|Overall Study|Other Adverse Events|1|||
16294222|NCT02516553|39562788|FG014|Overall Study|Other Adverse Events|0|||
16294223|NCT02516553|39562789|FG015|Overall Study|Other Adverse Events|0|||
16294224|NCT02516553|39562790|FG016|Overall Study|Other Adverse Events|0|||
16294225|NCT02516553|39562791|FG017|Overall Study|Other Adverse Events|2|||
16294226|NCT02516553|39562792|FG018|Overall Study|Other Adverse Events|1|||
16294227|NCT02516553|39562793|FG019|Overall Study|Other Adverse Events|2|||
16294228|NCT02516553|39562794|FG020|Overall Study|Other Adverse Events|2|||
16294229|NCT02516553|39562795|FG021|Overall Study|Other Adverse Events|1|||
16294230|NCT02516553|39562774|FG000|Overall Study|Refused to continue trial medication|0|||
16294231|NCT02516553|39562775|FG001|Overall Study|Refused to continue trial medication|0|||
16294232|NCT02516553|39562776|FG002|Overall Study|Refused to continue trial medication|0|||
16294233|NCT02516553|39562777|FG003|Overall Study|Refused to continue trial medication|0|||
16294234|NCT02516553|39562778|FG004|Overall Study|Refused to continue trial medication|0|||
16294235|NCT02516553|39562779|FG005|Overall Study|Refused to continue trial medication|0|||
16294236|NCT02516553|39562780|FG006|Overall Study|Refused to continue trial medication|0|||
16294237|NCT02516553|39562781|FG007|Overall Study|Refused to continue trial medication|0|||
16294238|NCT02516553|39562782|FG008|Overall Study|Refused to continue trial medication|0|||
16294239|NCT02516553|39562783|FG009|Overall Study|Refused to continue trial medication|0|||
16294240|NCT02516553|39562784|FG010|Overall Study|Refused to continue trial medication|1|||
16294241|NCT02516553|39562785|FG011|Overall Study|Refused to continue trial medication|0|||
16294242|NCT02516553|39562786|FG012|Overall Study|Refused to continue trial medication|0|||
16294243|NCT02516553|39562787|FG013|Overall Study|Refused to continue trial medication|0|||
16294244|NCT02516553|39562788|FG014|Overall Study|Refused to continue trial medication|0|||
16294245|NCT02516553|39562789|FG015|Overall Study|Refused to continue trial medication|0|||
16294246|NCT02516553|39562790|FG016|Overall Study|Refused to continue trial medication|0|||
16294247|NCT02516553|39562791|FG017|Overall Study|Refused to continue trial medication|0|||
16294248|NCT02516553|39562792|FG018|Overall Study|Refused to continue trial medication|1|||
16294249|NCT02516553|39562793|FG019|Overall Study|Refused to continue trial medication|0|||
16294250|NCT02516553|39562794|FG020|Overall Study|Refused to continue trial medication|0|||
16294251|NCT02516553|39562795|FG021|Overall Study|Refused to continue trial medication|1|||
16294252|NCT02516553|39562774|FG000|Overall Study|other reasons than listed|0|||
16294253|NCT02516553|39562775|FG001|Overall Study|other reasons than listed|0|||
16294254|NCT02516553|39562776|FG002|Overall Study|other reasons than listed|0|||
16294255|NCT02516553|39562777|FG003|Overall Study|other reasons than listed|0|||
16294256|NCT02516553|39562778|FG004|Overall Study|other reasons than listed|0|||
16294257|NCT02516553|39562779|FG005|Overall Study|other reasons than listed|0|||
16294258|NCT02516553|39562780|FG006|Overall Study|other reasons than listed|0|||
16294259|NCT02516553|39562781|FG007|Overall Study|other reasons than listed|1|||
16294260|NCT02516553|39562782|FG008|Overall Study|other reasons than listed|1|||
16294261|NCT02516553|39562783|FG009|Overall Study|other reasons than listed|0|||
16294262|NCT02516553|39562784|FG010|Overall Study|other reasons than listed|1|||
16294263|NCT02516553|39562785|FG011|Overall Study|other reasons than listed|1|||
16294264|NCT02516553|39562786|FG012|Overall Study|other reasons than listed|0|||
16294265|NCT02516553|39562787|FG013|Overall Study|other reasons than listed|0|||
16294266|NCT02516553|39562788|FG014|Overall Study|other reasons than listed|0|||
16294267|NCT02516553|39562789|FG015|Overall Study|other reasons than listed|0|||
16294268|NCT02516553|39562790|FG016|Overall Study|other reasons than listed|0|||
16294269|NCT02516553|39562791|FG017|Overall Study|other reasons than listed|0|||
16294270|NCT02516553|39562792|FG018|Overall Study|other reasons than listed|0|||
16294271|NCT02516553|39562793|FG019|Overall Study|other reasons than listed|0|||
16294272|NCT02516553|39562794|FG020|Overall Study|other reasons than listed|2|||
16294273|NCT02516553|39562795|FG021|Overall Study|other reasons than listed|2|||
16294274|NCT02307266|39562797|FG000|Overall Study|Adverse Event|3|||
16294275|NCT02307266|39562798|FG001|Overall Study|Adverse Event|1|||
16294276|NCT02307266|39562799|FG002|Overall Study|Adverse Event|5|||
16382387|NCT00967499|39884474|FG000|Overall Study|Adverse Event|0|||
16382388|NCT00967499|39884475|FG001|Overall Study|Adverse Event|1|||
16382389|NCT00967499|39884474|FG000|Overall Study|Protocol Violation|1|||
16382390|NCT00967499|39884475|FG001|Overall Study|Protocol Violation|0|||
16382391|NCT00967499|39884474|FG000|Overall Study|Sponsor Decision|1|||
16382392|NCT00967499|39884475|FG001|Overall Study|Sponsor Decision|0|||
16382393|NCT00967499|39884474|FG000|Overall Study|Randomized but not treated|63|||
16382394|NCT00967499|39884475|FG001|Overall Study|Randomized but not treated|59|||
16382395|NCT01876381|39884476|FG000|Overall Study|Lack of Efficacy|5|||
16382396|NCT01876381|39884476|FG000|Overall Study|Physician Decision|1|||
16382397|NCT01876381|39884476|FG000|Overall Study|Withdrawal by Subject|1|||
16382398|NCT00366457|39884484|FG000|Overall Study|never began study therapy|2|||
16382399|NCT04704193|39884487|FG000|Overall Study|Withdrawal by Subject|1|||
16382400|NCT01359956|39884488|FG000|Overall Study|Death|58|||
16382401|NCT01359956|39884489|FG001|Overall Study|Death|60|||
16382402|NCT01359956|39884490|FG002|Overall Study|Death|66|||
16382403|NCT01359956|39884491|FG003|Overall Study|Death|57|||
16382404|NCT01359956|39884488|FG000|Overall Study|Lost to Follow-up|3|||
16382405|NCT01359956|39884489|FG001|Overall Study|Lost to Follow-up|4|||
16382406|NCT01359956|39884490|FG002|Overall Study|Lost to Follow-up|1|||
16382407|NCT01359956|39884491|FG003|Overall Study|Lost to Follow-up|1|||
16382408|NCT01645176|39884494|FG000|Overall Study|Lack of Efficacy|4|||
16382409|NCT01645176|39884494|FG000|Overall Study|did not complete final MRI|1|||
16382410|NCT01437189|39884496|FG000|Overall Study|Adverse Event|3|||
16382411|NCT01437189|39884496|FG000|Overall Study|Lack of Efficacy|4|||
16382412|NCT01437189|39884496|FG000|Overall Study|Withdrawal by Subject|8|||
16294277|NCT02307266|39562797|FG000|Overall Study|Withdrawal by Subject|2|||
16294278|NCT02307266|39562798|FG001|Overall Study|Withdrawal by Subject|0|||
16294279|NCT02307266|39562799|FG002|Overall Study|Withdrawal by Subject|1|||
16294280|NCT02307266|39562797|FG000|Overall Study|Lost to Follow-up|3|||
16294281|NCT02307266|39562798|FG001|Overall Study|Lost to Follow-up|0|||
16294282|NCT02307266|39562799|FG002|Overall Study|Lost to Follow-up|0|||
16294283|NCT00077857|39562801|FG000|Overall Study|Adverse Event|30|||
16294284|NCT00077857|39562802|FG001|Overall Study|Adverse Event|32|||
16294285|NCT00077857|39562801|FG000|Overall Study|Death|7|||
16294286|NCT00077857|39562802|FG001|Overall Study|Death|3|||
16294287|NCT00077857|39562801|FG000|Overall Study|Insufficient therapeutic response|112|||
16294288|NCT00077857|39562802|FG001|Overall Study|Insufficient therapeutic response|128|||
16294289|NCT00077857|39562801|FG000|Overall Study|Violation of selection criteria at entry|3|||
16294290|NCT00077857|39562802|FG001|Overall Study|Violation of selection criteria at entry|1|||
16294291|NCT00077857|39562801|FG000|Overall Study|Other protocol violation|0|||
16294292|NCT00077857|39562802|FG001|Overall Study|Other protocol violation|1|||
16294293|NCT00077857|39562801|FG000|Overall Study|Refused treatment|29|||
16294294|NCT00077857|39562802|FG001|Overall Study|Refused treatment|21|||
16294295|NCT00077857|39562801|FG000|Overall Study|Failure to return|5|||
16294296|NCT00077857|39562802|FG001|Overall Study|Failure to return|5|||
16294297|NCT00077857|39562801|FG000|Overall Study|Other|15|||
16294298|NCT00077857|39562802|FG001|Overall Study|Other|13|||
16294299|NCT03623386|39562803|FG000|Overall Study|Protocol Violation|3|||
16294300|NCT03623386|39562804|FG001|Overall Study|Protocol Violation|2|||
16294301|NCT03623386|39562805|FG002|Overall Study|Protocol Violation|0|||
16294302|NCT03623386|39562803|FG000|Overall Study|Physician Decision|1|||
16294303|NCT03623386|39562804|FG001|Overall Study|Physician Decision|1|||
16294304|NCT03623386|39562805|FG002|Overall Study|Physician Decision|0|||
16294305|NCT03623386|39562803|FG000|Overall Study|Lost to Follow-up|0|||
16294306|NCT03623386|39562804|FG001|Overall Study|Lost to Follow-up|2|||
16294307|NCT03623386|39562805|FG002|Overall Study|Lost to Follow-up|0|||
16294308|NCT03623386|39562803|FG000|Overall Study|COVID-19|0|||
16294309|NCT03623386|39562804|FG001|Overall Study|COVID-19|1|||
16294310|NCT03623386|39562805|FG002|Overall Study|COVID-19|0|||
16294311|NCT00210249|39562806|FG000|Overall Study|Lost to Follow-up|5|||
16294312|NCT00210249|39562806|FG000|Overall Study|Protocol Violation|11|||
16294313|NCT01197755|39562807|FG000|Overall Study|Adverse Event|8|||
16294314|NCT01197755|39562808|FG001|Overall Study|Adverse Event|10|||
16294315|NCT01197755|39562809|FG002|Overall Study|Adverse Event|10|||
16294316|NCT01197755|39562807|FG000|Overall Study|Study-specific discontinuation criteria|2|||
16484824|NCT00401531|40252590|FG001|Overall Study|Protocol Violation|7|||
16294317|NCT01197755|39562808|FG001|Overall Study|Study-specific discontinuation criteria|1|||
16294318|NCT01197755|39562809|FG002|Overall Study|Study-specific discontinuation criteria|0|||
16294319|NCT01197755|39562807|FG000|Overall Study|Entered the long-term extension study|18|||
16294320|NCT01197755|39562808|FG001|Overall Study|Entered the long-term extension study|21|||
16294321|NCT01197755|39562809|FG002|Overall Study|Entered the long-term extension study|35|||
16294322|NCT01197755|39562807|FG000|Overall Study|Lack of therapeutic response|0|||
16294323|NCT01197755|39562808|FG001|Overall Study|Lack of therapeutic response|7|||
16382413|NCT01994876|39884497|FG000|Test Period 1|Withdrawal by Subject|0|||
16382414|NCT01994876|39884498|FG001|Test Period 1|Withdrawal by Subject|1|||
16382415|NCT01994876|39884497|FG000|Test Period 1|Adverse Event|0|||
16382416|NCT01994876|39884498|FG001|Test Period 1|Adverse Event|1|||
16294324|NCT01197755|39562809|FG002|Overall Study|Lack of therapeutic response|4|||
16294325|NCT01197755|39562807|FG000|Overall Study|Severe non-compliance to the protocol|2|||
16294326|NCT01197755|39562808|FG001|Overall Study|Severe non-compliance to the protocol|1|||
16294327|NCT01197755|39562809|FG002|Overall Study|Severe non-compliance to the protocol|2|||
16294328|NCT01197755|39562807|FG000|Overall Study|Withdrawal by Subject|1|||
16294329|NCT01197755|39562808|FG001|Overall Study|Withdrawal by Subject|0|||
16294330|NCT01197755|39562809|FG002|Overall Study|Withdrawal by Subject|0|||
16484825|NCT00401531|40252589|FG000|Overall Study|Lost to Follow-up|1|||
16484826|NCT00401531|40252590|FG001|Overall Study|Lost to Follow-up|1|||
16484827|NCT00401531|40252589|FG000|Overall Study|Withdrawal by Subject|3|||
16484828|NCT00401531|40252590|FG001|Overall Study|Withdrawal by Subject|2|||
16484829|NCT00134082|40252591|FG000|Overall Study|Adverse Event|2|||
16484830|NCT00134082|40252591|FG000|Overall Study|Death|1|||
16484831|NCT01032837|40252592|FG000|Overall Study|Adverse event/internal illness|0|||
16484832|NCT01032837|40252593|FG001|Overall Study|Adverse event/internal illness|1|||
16081685|NCT02590432|38792711|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
16081686|NCT02590432|38792712|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
16081687|NCT02590432|38792713|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
16081688|NCT02590432|38792714|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
16081689|NCT02590432|38792715|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
16187810|NCT01199263|39165046|FG000|Overall Study|Never Treated|6|||
16187811|NCT01199263|39165047|FG001|Overall Study|Never Treated|0|||
16187812|NCT03161678|39165060|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
16294331|NCT01197755|39562807|FG000|Overall Study|Lost to Follow-up|0|||
16294332|NCT01197755|39562808|FG001|Overall Study|Lost to Follow-up|0|||
16294333|NCT01197755|39562809|FG002|Overall Study|Lost to Follow-up|1|||
16294334|NCT01197755|39562807|FG000|Overall Study|eg, change in circumstances|7|||
16294335|NCT01197755|39562808|FG001|Overall Study|eg, change in circumstances|3|||
16294336|NCT01197755|39562809|FG002|Overall Study|eg, change in circumstances|2|||
16294337|NCT04619992|39562812|FG000|Overall Study|Withdrawal by Subject|1|||
16294338|NCT04619992|39562813|FG001|Overall Study|Withdrawal by Subject|0|||
16294339|NCT02149108|39562814|FG000|Overall Study|Not treated|1|||
16294340|NCT02149108|39562815|FG001|Overall Study|Not treated|2|||
16294341|NCT02149108|39562814|FG000|Overall Study|Progressive Disease (PD)|324|||
16294342|NCT02149108|39562815|FG001|Overall Study|Progressive Disease (PD)|318|||
16294343|NCT02149108|39562814|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
16294344|NCT02149108|39562815|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
16294345|NCT02149108|39562814|FG000|Overall Study|Other Adverse Event (AE)|8|||
16294346|NCT02149108|39562815|FG001|Overall Study|Other Adverse Event (AE)|18|||
16294347|NCT02149108|39562814|FG000|Overall Study|Other not defined above|0|||
16294348|NCT02149108|39562815|FG001|Overall Study|Other not defined above|2|||
16294349|NCT02149108|39562814|FG000|Overall Study|Refusal to continue trial medication|15|||
16294350|NCT02149108|39562815|FG001|Overall Study|Refusal to continue trial medication|11|||
16294351|NCT02149108|39562814|FG000|Overall Study|Lost to Follow-up|1|||
16294352|NCT02149108|39562815|FG001|Overall Study|Lost to Follow-up|0|||
16294353|NCT04505293|39562816|FG000|Overall Study|Lost to Follow-up|2|||
16294354|NCT04505293|39562816|FG000|Overall Study|Withdrawal by Subject|6|||
16294355|NCT04505293|39562816|FG000|Overall Study|CT scan unreadable|277|||
16294356|NCT01770392|39562820|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
16294357|NCT02352779|39562821|FG000|Overall Study|Personal Issues|1|||
16294358|NCT02352779|39562822|FG001|Overall Study|Personal Issues|1|||
16294359|NCT02352779|39562823|FG002|Overall Study|Personal Issues|0|||
16294360|NCT02352779|39562821|FG000|Overall Study|Too Many Forms|2|||
16187813|NCT03161678|39165061|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
16187814|NCT03161678|39165062|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
16187815|NCT03161678|39165063|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
16187816|NCT03161678|39165064|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
16187817|NCT03161678|39165065|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
16187818|NCT03161678|39165060|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
16187819|NCT03161678|39165061|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
16187820|NCT03161678|39165062|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
16187821|NCT03161678|39165063|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
16187822|NCT03161678|39165064|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
16187823|NCT03161678|39165065|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
16187824|NCT03161678|39165060|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
16187825|NCT03161678|39165061|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
16187826|NCT03161678|39165062|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
16187827|NCT03161678|39165063|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
16382417|NCT01994876|39884497|FG000|Test Period 2|Adverse Event|1|||
16484833|NCT01032837|40252594|FG002|Overall Study|Adverse event/internal illness|0|||
16187828|NCT03161678|39165064|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
16187829|NCT03161678|39165065|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
16294361|NCT02352779|39562822|FG001|Overall Study|Too Many Forms|0|||
16294362|NCT02352779|39562823|FG002|Overall Study|Too Many Forms|0|||
16081690|NCT02590432|38792716|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
16081691|NCT02590432|38792708|FG000|Double-blind Treatment Period|Adverse Event|0|||
16081692|NCT02590432|38792709|FG001|Double-blind Treatment Period|Adverse Event|0|||
16081693|NCT02590432|38792710|FG002|Double-blind Treatment Period|Adverse Event|14|||
16081694|NCT02590432|38792711|FG003|Double-blind Treatment Period|Adverse Event|12|||
16081695|NCT02590432|38792712|FG004|Double-blind Treatment Period|Adverse Event|6|||
16081696|NCT02590432|38792713|FG005|Double-blind Treatment Period|Adverse Event|22|||
16081697|NCT02590432|38792714|FG006|Double-blind Treatment Period|Adverse Event|20|||
16081698|NCT02590432|38792715|FG007|Double-blind Treatment Period|Adverse Event|0|||
16081699|NCT02590432|38792716|FG008|Double-blind Treatment Period|Adverse Event|0|||
16081700|NCT02590432|38792708|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
16081701|NCT02590432|38792709|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
16081702|NCT02590432|38792710|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
16081703|NCT02590432|38792711|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
16081704|NCT02590432|38792712|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
16081705|NCT02590432|38792713|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
16081706|NCT02590432|38792714|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
16081707|NCT02590432|38792715|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
16081708|NCT02590432|38792716|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
16081709|NCT02590432|38792708|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
16081710|NCT02590432|38792709|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
16081711|NCT02590432|38792710|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
16187830|NCT03161678|39165060|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
16187831|NCT03161678|39165061|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
16187832|NCT03161678|39165062|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
16382418|NCT01994876|39884498|FG001|Test Period 2|Adverse Event|0|||
16081712|NCT02590432|38792711|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
16081713|NCT02590432|38792712|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
16187833|NCT03161678|39165063|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
16187834|NCT03161678|39165064|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
16187835|NCT03161678|39165065|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
16187836|NCT01441440|39165066|FG000|Overall Study|Death|1|||
16187837|NCT01441440|39165067|FG001|Overall Study|Death|0|||
16187838|NCT01441440|39165068|FG002|Overall Study|Death|1|||
16187839|NCT01441440|39165066|FG000|Overall Study|Adverse Event|2|||
16187840|NCT01441440|39165067|FG001|Overall Study|Adverse Event|9|||
16187841|NCT01441440|39165068|FG002|Overall Study|Adverse Event|9|||
16187842|NCT01441440|39165066|FG000|Overall Study|Lost to Follow-up|0|||
16187843|NCT01441440|39165067|FG001|Overall Study|Lost to Follow-up|2|||
16187844|NCT01441440|39165068|FG002|Overall Study|Lost to Follow-up|1|||
16187845|NCT01441440|39165066|FG000|Overall Study|Withdrawal by Subject|11|||
16187846|NCT01441440|39165067|FG001|Overall Study|Withdrawal by Subject|9|||
16187847|NCT01441440|39165068|FG002|Overall Study|Withdrawal by Subject|9|||
16187848|NCT01441440|39165066|FG000|Overall Study|Pregnancy|1|||
16187849|NCT01441440|39165067|FG001|Overall Study|Pregnancy|0|||
16187850|NCT01441440|39165068|FG002|Overall Study|Pregnancy|0|||
16187851|NCT01441440|39165066|FG000|Overall Study|Lack of Efficacy|1|||
16187852|NCT01441440|39165067|FG001|Overall Study|Lack of Efficacy|0|||
16187853|NCT01441440|39165068|FG002|Overall Study|Lack of Efficacy|1|||
16187854|NCT01441440|39165066|FG000|Overall Study|Moving|0|||
16187855|NCT01441440|39165067|FG001|Overall Study|Moving|1|||
16187856|NCT01441440|39165068|FG002|Overall Study|Moving|1|||
16187857|NCT01441440|39165066|FG000|Overall Study|Work-related matter|0|||
16187858|NCT01441440|39165067|FG001|Overall Study|Work-related matter|1|||
16187859|NCT01441440|39165068|FG002|Overall Study|Work-related matter|0|||
16187860|NCT01441440|39165066|FG000|Overall Study|Difficllty in keeping the schedule|1|||
16187861|NCT01441440|39165067|FG001|Overall Study|Difficllty in keeping the schedule|1|||
16187862|NCT01441440|39165068|FG002|Overall Study|Difficllty in keeping the schedule|0|||
16187863|NCT00303108|39165071|FG000|Overall Study|Adverse Event|5|||
16187864|NCT00303108|39165072|FG001|Overall Study|Adverse Event|6|||
16187865|NCT00303108|39165073|FG002|Overall Study|Adverse Event|7|||
16187866|NCT00303108|39165071|FG000|Overall Study|Patient Request|4|||
16187867|NCT00303108|39165072|FG001|Overall Study|Patient Request|2|||
16187868|NCT00303108|39165073|FG002|Overall Study|Patient Request|8|||
16187869|NCT00303108|39165071|FG000|Overall Study|Failed Entry|1|||
16187870|NCT00303108|39165072|FG001|Overall Study|Failed Entry|0|||
16187871|NCT00303108|39165073|FG002|Overall Study|Failed Entry|1|||
16187872|NCT00303108|39165071|FG000|Overall Study|ineligible|2|||
16187873|NCT00303108|39165072|FG001|Overall Study|ineligible|1|||
16187874|NCT00303108|39165073|FG002|Overall Study|ineligible|0|||
16187875|NCT01790438|39165078|FG000|Overall Study|Adverse Event|3|||
16187876|NCT01790438|39165079|FG001|Overall Study|Adverse Event|2|||
16187877|NCT01790438|39165078|FG000|Overall Study|Death|4|||
16187878|NCT01790438|39165079|FG001|Overall Study|Death|0|||
16187879|NCT01790438|39165078|FG000|Overall Study|Lost to Follow-up|5|||
16187880|NCT01790438|39165079|FG001|Overall Study|Lost to Follow-up|2|||
16187881|NCT01790438|39165078|FG000|Overall Study|Withdrawal by Subject|13|||
16187882|NCT01790438|39165079|FG001|Overall Study|Withdrawal by Subject|2|||
16187883|NCT01790438|39165078|FG000|Overall Study|Physician Decision|3|||
16187884|NCT01790438|39165079|FG001|Overall Study|Physician Decision|1|||
16187885|NCT01790438|39165078|FG000|Overall Study|Sponsor Decision|0|||
16187886|NCT01790438|39165079|FG001|Overall Study|Sponsor Decision|3|||
16187887|NCT01790438|39165078|FG000|Overall Study|Protocol Required Discontinuation|7|||
16484834|NCT01032837|40252595|FG003|Overall Study|Adverse event/internal illness|1|||
16484835|NCT01032837|40252592|FG000|Overall Study|Withdrew consent|0|||
16484836|NCT01032837|40252593|FG001|Overall Study|Withdrew consent|2|||
16484837|NCT01032837|40252594|FG002|Overall Study|Withdrew consent|0|||
16484838|NCT01032837|40252595|FG003|Overall Study|Withdrew consent|1|||
16484839|NCT01032837|40252592|FG000|Overall Study|Failed to return|0|||
16484840|NCT01032837|40252593|FG001|Overall Study|Failed to return|0|||
16484841|NCT01032837|40252594|FG002|Overall Study|Failed to return|1|||
16484842|NCT01032837|40252595|FG003|Overall Study|Failed to return|0|||
16187888|NCT01790438|39165079|FG001|Overall Study|Protocol Required Discontinuation|1|||
16187889|NCT01283581|39165080|FG000|Overall Study|Lost to Follow-up|8|||
16187890|NCT01283581|39165081|FG001|Overall Study|Lost to Follow-up|6|||
16187891|NCT01283581|39165082|FG002|Overall Study|Lost to Follow-up|8|||
16187892|NCT01283581|39165080|FG000|Overall Study|Withdrawal by Subject|2|||
16187893|NCT01283581|39165081|FG001|Overall Study|Withdrawal by Subject|5|||
16187894|NCT01283581|39165082|FG002|Overall Study|Withdrawal by Subject|2|||
16187895|NCT01283581|39165080|FG000|Overall Study|Adverse Event|1|||
16187896|NCT01283581|39165081|FG001|Overall Study|Adverse Event|1|||
16187897|NCT01283581|39165082|FG002|Overall Study|Adverse Event|4|||
16187898|NCT01283581|39165080|FG000|Overall Study|Physician Decision|0|||
16187899|NCT01283581|39165081|FG001|Overall Study|Physician Decision|1|||
16484843|NCT01032837|40252592|FG000|Overall Study|Refused treatment|0|||
16187900|NCT01283581|39165082|FG002|Overall Study|Physician Decision|2|||
16187901|NCT01283581|39165080|FG000|Overall Study|Protocol Violation|0|||
16187902|NCT01283581|39165081|FG001|Overall Study|Protocol Violation|1|||
16484844|NCT01032837|40252593|FG001|Overall Study|Refused treatment|0|||
16484845|NCT01032837|40252594|FG002|Overall Study|Refused treatment|0|||
16484846|NCT01032837|40252595|FG003|Overall Study|Refused treatment|1|||
16484847|NCT01397890|40252598|FG000|Overall Study|Withdrawal by Subject|7|||
16484848|NCT01397890|40252599|FG001|Overall Study|Withdrawal by Subject|11|||
16484849|NCT01397890|40252598|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
16484850|NCT01397890|40252599|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
16484851|NCT01397890|40252598|FG000|Overall Study|Death|2|||
16484852|NCT01397890|40252599|FG001|Overall Study|Death|3|||
16484853|NCT01397890|40252598|FG000|Overall Study|Lost to Follow-up|1|||
16484854|NCT01397890|40252599|FG001|Overall Study|Lost to Follow-up|4|||
16484855|NCT01397890|40252598|FG000|Overall Study|Condition under Investigation Worsened|1|||
16484856|NCT01397890|40252599|FG001|Overall Study|Condition under Investigation Worsened|3|||
16484857|NCT01397890|40252598|FG000|Overall Study|Adverse Event|1|||
16484858|NCT01397890|40252599|FG001|Overall Study|Adverse Event|2|||
16484859|NCT01397890|40252598|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
16484860|NCT01397890|40252599|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
16484861|NCT01397890|40252598|FG000|Overall Study|Others|2|||
16484862|NCT01397890|40252599|FG001|Overall Study|Others|1|||
16484863|NCT00361569|40252600|FG000|Overall Study|Protocol Violation|3|||
16484864|NCT00361569|40252601|FG001|Overall Study|Protocol Violation|2|||
16484865|NCT00361569|40252602|FG002|Overall Study|Protocol Violation|4|||
16484866|NCT00361569|40252603|FG003|Overall Study|Protocol Violation|2|||
16484867|NCT00361569|40252600|FG000|Overall Study|Withdrawal by Subject|2|||
16484868|NCT00361569|40252601|FG001|Overall Study|Withdrawal by Subject|1|||
16484869|NCT00361569|40252602|FG002|Overall Study|Withdrawal by Subject|9|||
16484870|NCT00361569|40252603|FG003|Overall Study|Withdrawal by Subject|14|||
16484871|NCT00361569|40252600|FG000|Overall Study|Adverse Event|3|||
16187903|NCT01283581|39165082|FG002|Overall Study|Protocol Violation|2|||
16484872|NCT00361569|40252601|FG001|Overall Study|Adverse Event|5|||
16484873|NCT00361569|40252602|FG002|Overall Study|Adverse Event|2|||
16484874|NCT00361569|40252603|FG003|Overall Study|Adverse Event|2|||
16484875|NCT00361569|40252600|FG000|Overall Study|Lost to Follow-up|2|||
16484876|NCT00361569|40252601|FG001|Overall Study|Lost to Follow-up|3|||
16484877|NCT00361569|40252602|FG002|Overall Study|Lost to Follow-up|3|||
16187904|NCT01283581|39165080|FG000|Overall Study|Noncompliance|1|||
16187905|NCT01283581|39165081|FG001|Overall Study|Noncompliance|0|||
16187906|NCT01283581|39165082|FG002|Overall Study|Noncompliance|0|||
16187907|NCT01283581|39165080|FG000|Overall Study|Investigator unblinded|0|||
16187908|NCT01283581|39165081|FG001|Overall Study|Investigator unblinded|0|||
16294363|NCT02352779|39562821|FG000|Overall Study|Feeling Overwhelmed|1|||
16187909|NCT01283581|39165082|FG002|Overall Study|Investigator unblinded|1|||
16187910|NCT01283581|39165080|FG000|Overall Study|"Early termination"|0|||
16187911|NCT01283581|39165081|FG001|Overall Study|"Early termination"|0|||
16294364|NCT02352779|39562822|FG001|Overall Study|Feeling Overwhelmed|0|||
16187912|NCT01283581|39165082|FG002|Overall Study|"Early termination"|1|||
16187913|NCT02689219|39165083|FG000|Overall Study|Death|1|||
16187914|NCT02689219|39165084|FG001|Overall Study|Death|1|||
16187915|NCT02689219|39165083|FG000|Overall Study|Disease Progression|10|||
16187916|NCT02689219|39165084|FG001|Overall Study|Disease Progression|6|||
16187917|NCT00469014|39165085|FG000|Initial Phase Randomization|Disease Progression|0|||
16187918|NCT00469014|39165086|FG001|Initial Phase Randomization|Disease Progression|1|||
16187919|NCT00469014|39165087|FG002|Initial Phase Randomization|Disease Progression|1|||
16294365|NCT02352779|39562823|FG002|Overall Study|Feeling Overwhelmed|0|||
16294366|NCT02352779|39562821|FG000|Overall Study|Disliked Intervention|1|||
16294367|NCT02352779|39562822|FG001|Overall Study|Disliked Intervention|0|||
16294368|NCT02352779|39562823|FG002|Overall Study|Disliked Intervention|0|||
16294369|NCT02352779|39562821|FG000|Overall Study|Changed Mind|1|||
16294370|NCT02352779|39562822|FG001|Overall Study|Changed Mind|0|||
16294371|NCT02352779|39562823|FG002|Overall Study|Changed Mind|0|||
16294372|NCT02352779|39562821|FG000|Overall Study|Study Related Symptoms|1|||
16484878|NCT00361569|40252603|FG003|Overall Study|Lost to Follow-up|2|||
16484879|NCT00361569|40252600|FG000|Overall Study|Not specified by investigator|2|||
16484880|NCT00361569|40252601|FG001|Overall Study|Not specified by investigator|0|||
16484881|NCT00361569|40252602|FG002|Overall Study|Not specified by investigator|0|||
16187920|NCT00469014|39165088|FG003|Initial Phase Randomization|Disease Progression|0|||
16294373|NCT02352779|39562822|FG001|Overall Study|Study Related Symptoms|0|||
16294374|NCT02352779|39562823|FG002|Overall Study|Study Related Symptoms|0|||
16484882|NCT00361569|40252603|FG003|Overall Study|Not specified by investigator|1|||
16294375|NCT02352779|39562821|FG000|Overall Study|Absence of Symptoms|1|||
16382419|NCT01994876|39884497|FG000|Test Period 2|Protocol Violation|0|||
16382420|NCT01994876|39884498|FG001|Test Period 2|Protocol Violation|1|||
16382421|NCT02327169|39884505|FG000|Overall Study|Progressive Disease|1|||
16382422|NCT02327169|39884506|FG001|Overall Study|Progressive Disease|3|||
16382423|NCT02327169|39884507|FG002|Overall Study|Progressive Disease|4|||
16382424|NCT02327169|39884508|FG003|Overall Study|Progressive Disease|3|||
16382425|NCT02327169|39884509|FG004|Overall Study|Progressive Disease|4|||
16382426|NCT02327169|39884510|FG005|Overall Study|Progressive Disease|3|||
16382427|NCT02327169|39884511|FG006|Overall Study|Progressive Disease|3|||
16382428|NCT02327169|39884512|FG007|Overall Study|Progressive Disease|3|||
16382429|NCT02327169|39884513|FG008|Overall Study|Progressive Disease|4|||
16382430|NCT02327169|39884514|FG009|Overall Study|Progressive Disease|4|||
16382431|NCT02327169|39884515|FG010|Overall Study|Progressive Disease|4|||
16382432|NCT02327169|39884516|FG011|Overall Study|Progressive Disease|3|||
16382433|NCT02327169|39884517|FG012|Overall Study|Progressive Disease|1|||
16382434|NCT02327169|39884518|FG013|Overall Study|Progressive Disease|3|||
16382435|NCT02327169|39884519|FG014|Overall Study|Progressive Disease|3|||
16382436|NCT02327169|39884505|FG000|Overall Study|Adverse Event|2|||
16382437|NCT02327169|39884506|FG001|Overall Study|Adverse Event|0|||
16382438|NCT02327169|39884507|FG002|Overall Study|Adverse Event|1|||
16294376|NCT02352779|39562822|FG001|Overall Study|Absence of Symptoms|0|||
16294377|NCT02352779|39562823|FG002|Overall Study|Absence of Symptoms|0|||
16294378|NCT02352779|39562821|FG000|Overall Study|Other Medical Reason|0|||
16294379|NCT02352779|39562822|FG001|Overall Study|Other Medical Reason|0|||
16294380|NCT02352779|39562823|FG002|Overall Study|Other Medical Reason|1|||
16294381|NCT02352779|39562821|FG000|Overall Study|No Reason|0|||
16294382|NCT02352779|39562822|FG001|Overall Study|No Reason|0|||
16294383|NCT02352779|39562823|FG002|Overall Study|No Reason|1|||
16294384|NCT01602965|39562825|FG000|Overall Study|Lost to Follow-up|4|||
16294385|NCT01602965|39562826|FG001|Overall Study|Lost to Follow-up|2|||
16294386|NCT02447744|39562827|FG000|Overall Study|Withdrawal by Subject|3|||
16294387|NCT02447744|39562828|FG001|Overall Study|Withdrawal by Subject|1|||
16294388|NCT02447744|39562827|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
16294389|NCT02447744|39562828|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
16294390|NCT01910389|39562831|FG000|Overall Study|Withdrawal by Subject|2|||
16294391|NCT01910389|39562832|FG001|Overall Study|Withdrawal by Subject|0|||
16294392|NCT01910389|39562831|FG000|Overall Study|Study Closed|13|||
16294393|NCT01910389|39562832|FG001|Overall Study|Study Closed|8|||
16294394|NCT01672970|39562833|FG000|Overall Study|Lack of Efficacy|12|||
16294395|NCT01672970|39562833|FG000|Overall Study|Adverse Event|18|||
16294396|NCT01672970|39562833|FG000|Overall Study|Withdrawal by Subject|2|||
16294397|NCT01672970|39562833|FG000|Overall Study|Lost to Follow-up|5|||
16294398|NCT01672970|39562833|FG000|Overall Study|Other|9|||
16294399|NCT01672970|39562833|FG000|Overall Study|Enrolled but not treated|1|||
16294400|NCT02065700|39562834|FG000|Overall Study|Adverse Event|165|||
16294401|NCT02065700|39562835|FG001|Overall Study|Adverse Event|101|||
16294402|NCT02065700|39562834|FG000|Overall Study|Withdrawal by Subject|90|||
16294403|NCT02065700|39562835|FG001|Overall Study|Withdrawal by Subject|29|||
16294404|NCT02065700|39562834|FG000|Overall Study|Lost to Follow-up|12|||
16294405|NCT02065700|39562835|FG001|Overall Study|Lost to Follow-up|9|||
16294406|NCT02065700|39562834|FG000|Overall Study|Physician Decision|2|||
16294407|NCT02065700|39562835|FG001|Overall Study|Physician Decision|0|||
16294408|NCT02065700|39562834|FG000|Overall Study|Sponsor Request|38|||
16294409|NCT02065700|39562835|FG001|Overall Study|Sponsor Request|15|||
16294410|NCT02065700|39562834|FG000|Overall Study|Treatment Failure|3|||
16294411|NCT02065700|39562835|FG001|Overall Study|Treatment Failure|2|||
16294412|NCT02065700|39562834|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
16294413|NCT02065700|39562835|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
16294414|NCT02065700|39562834|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
16294415|NCT02065700|39562835|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
16294416|NCT02065700|39562834|FG000|Overall Study|Non-compliance with Study Procedures|2|||
16294417|NCT02065700|39562835|FG001|Overall Study|Non-compliance with Study Procedures|0|||
16294418|NCT02065700|39562834|FG000|Overall Study|Not Defined|21|||
16294419|NCT02065700|39562835|FG001|Overall Study|Not Defined|3|||
16294420|NCT04647721|39562844|FG000|Overall Study|Withdrawal by Subject|0|||
16294421|NCT04647721|39562845|FG001|Overall Study|Withdrawal by Subject|2|||
16294422|NCT04647721|39562844|FG000|Overall Study|Lost to Follow-up|2|||
16294423|NCT04647721|39562845|FG001|Overall Study|Lost to Follow-up|0|||
16294424|NCT01629966|39562846|FG000|Overall Study|Pregnancy|0|||
16294425|NCT01629966|39562847|FG001|Overall Study|Pregnancy|1|||
16294426|NCT01629966|39562848|FG002|Overall Study|Pregnancy|0|||
16294427|NCT01629966|39562846|FG000|Overall Study|Lost to Follow-up|10|||
16294428|NCT01629966|39562847|FG001|Overall Study|Lost to Follow-up|13|||
16294429|NCT01629966|39562848|FG002|Overall Study|Lost to Follow-up|9|||
16294430|NCT01629966|39562846|FG000|Overall Study|Withdrawal by Subject|8|||
16294431|NCT01629966|39562847|FG001|Overall Study|Withdrawal by Subject|9|||
16294432|NCT01629966|39562848|FG002|Overall Study|Withdrawal by Subject|16|||
16382439|NCT02327169|39884508|FG003|Overall Study|Adverse Event|0|||
16382440|NCT02327169|39884509|FG004|Overall Study|Adverse Event|1|||
16382441|NCT02327169|39884510|FG005|Overall Study|Adverse Event|0|||
16382442|NCT02327169|39884511|FG006|Overall Study|Adverse Event|0|||
16382443|NCT02327169|39884512|FG007|Overall Study|Adverse Event|0|||
16382444|NCT02327169|39884513|FG008|Overall Study|Adverse Event|0|||
16382445|NCT02327169|39884514|FG009|Overall Study|Adverse Event|2|||
16382446|NCT02327169|39884515|FG010|Overall Study|Adverse Event|0|||
16382447|NCT02327169|39884516|FG011|Overall Study|Adverse Event|3|||
16382448|NCT02327169|39884517|FG012|Overall Study|Adverse Event|0|||
16382449|NCT02327169|39884518|FG013|Overall Study|Adverse Event|2|||
16382450|NCT02327169|39884519|FG014|Overall Study|Adverse Event|1|||
16382451|NCT02327169|39884505|FG000|Overall Study|Symptomatic Deterioration|0|||
16382452|NCT02327169|39884506|FG001|Overall Study|Symptomatic Deterioration|0|||
16382453|NCT02327169|39884507|FG002|Overall Study|Symptomatic Deterioration|1|||
16382454|NCT02327169|39884508|FG003|Overall Study|Symptomatic Deterioration|0|||
16382455|NCT02327169|39884509|FG004|Overall Study|Symptomatic Deterioration|1|||
16382456|NCT02327169|39884510|FG005|Overall Study|Symptomatic Deterioration|1|||
16382457|NCT02327169|39884511|FG006|Overall Study|Symptomatic Deterioration|0|||
16382458|NCT02327169|39884512|FG007|Overall Study|Symptomatic Deterioration|0|||
16382459|NCT02327169|39884513|FG008|Overall Study|Symptomatic Deterioration|2|||
16382460|NCT02327169|39884514|FG009|Overall Study|Symptomatic Deterioration|1|||
16382461|NCT02327169|39884515|FG010|Overall Study|Symptomatic Deterioration|0|||
16382462|NCT02327169|39884516|FG011|Overall Study|Symptomatic Deterioration|0|||
16382463|NCT02327169|39884517|FG012|Overall Study|Symptomatic Deterioration|0|||
16382464|NCT02327169|39884518|FG013|Overall Study|Symptomatic Deterioration|2|||
16382465|NCT02327169|39884519|FG014|Overall Study|Symptomatic Deterioration|1|||
16382466|NCT02327169|39884505|FG000|Overall Study|Reason Not Specified|0|||
16382467|NCT02327169|39884506|FG001|Overall Study|Reason Not Specified|0|||
16382468|NCT02327169|39884507|FG002|Overall Study|Reason Not Specified|1|||
16382469|NCT02327169|39884508|FG003|Overall Study|Reason Not Specified|0|||
16382470|NCT02327169|39884509|FG004|Overall Study|Reason Not Specified|0|||
16382471|NCT02327169|39884510|FG005|Overall Study|Reason Not Specified|0|||
16382472|NCT02327169|39884511|FG006|Overall Study|Reason Not Specified|0|||
16382473|NCT02327169|39884512|FG007|Overall Study|Reason Not Specified|0|||
16294433|NCT01629966|39562846|FG000|Overall Study|Protocol Violation|7|||
16294434|NCT01629966|39562847|FG001|Overall Study|Protocol Violation|9|||
16294435|NCT01629966|39562848|FG002|Overall Study|Protocol Violation|7|||
16294436|NCT01629966|39562846|FG000|Overall Study|Lack of Efficacy|5|||
16294437|NCT01629966|39562847|FG001|Overall Study|Lack of Efficacy|2|||
16294438|NCT01629966|39562848|FG002|Overall Study|Lack of Efficacy|4|||
16294439|NCT01629966|39562846|FG000|Overall Study|Adverse Event|11|||
16294440|NCT01629966|39562847|FG001|Overall Study|Adverse Event|18|||
16294441|NCT01629966|39562848|FG002|Overall Study|Adverse Event|30|||
16294442|NCT00658658|39562851|FG000|Overall Study|Withdrawal by Subject|0|||
16294443|NCT00658658|39562852|FG001|Overall Study|Withdrawal by Subject|1|||
16294444|NCT00658658|39562853|FG002|Overall Study|Withdrawal by Subject|0|||
16294445|NCT00658658|39562854|FG003|Overall Study|Withdrawal by Subject|0|||
16294446|NCT00658658|39562855|FG004|Overall Study|Withdrawal by Subject|0|||
16294447|NCT00658658|39562851|FG000|Overall Study|Death|4|||
16294448|NCT00658658|39562852|FG001|Overall Study|Death|0|||
16294449|NCT00658658|39562853|FG002|Overall Study|Death|0|||
16294450|NCT00658658|39562854|FG003|Overall Study|Death|1|||
16294451|NCT00658658|39562855|FG004|Overall Study|Death|1|||
16294452|NCT00658658|39562851|FG000|Overall Study|Disease Progression|0|||
16294453|NCT00658658|39562852|FG001|Overall Study|Disease Progression|1|||
16294454|NCT00658658|39562853|FG002|Overall Study|Disease Progression|0|||
16382474|NCT02327169|39884513|FG008|Overall Study|Reason Not Specified|0|||
16294455|NCT00658658|39562854|FG003|Overall Study|Disease Progression|1|||
16294456|NCT00658658|39562855|FG004|Overall Study|Disease Progression|3|||
16294457|NCT00658658|39562851|FG000|Overall Study|Protocol-specified Criteria|1|||
16294458|NCT00658658|39562852|FG001|Overall Study|Protocol-specified Criteria|0|||
16294459|NCT00658658|39562853|FG002|Overall Study|Protocol-specified Criteria|0|||
16294460|NCT00658658|39562854|FG003|Overall Study|Protocol-specified Criteria|0|||
16294461|NCT00658658|39562855|FG004|Overall Study|Protocol-specified Criteria|0|||
16294462|NCT00658658|39562851|FG000|Overall Study|Other|0|||
16382475|NCT02327169|39884514|FG009|Overall Study|Reason Not Specified|1|||
16382476|NCT02327169|39884515|FG010|Overall Study|Reason Not Specified|2|||
16294463|NCT00658658|39562852|FG001|Overall Study|Other|0|||
16294464|NCT00658658|39562853|FG002|Overall Study|Other|0|||
16294465|NCT00658658|39562854|FG003|Overall Study|Other|0|||
16382477|NCT02327169|39884516|FG011|Overall Study|Reason Not Specified|1|||
16382478|NCT02327169|39884517|FG012|Overall Study|Reason Not Specified|0|||
16294466|NCT00658658|39562855|FG004|Overall Study|Other|1|||
16294467|NCT03734666|39562856|FG000|Overall Study|Other|7|||
16294468|NCT03734666|39562857|FG001|Overall Study|Other|4|||
16294469|NCT03734666|39562856|FG000|Overall Study|Lost to Follow-up|12|||
16382479|NCT02327169|39884518|FG013|Overall Study|Reason Not Specified|0|||
16382480|NCT02327169|39884519|FG014|Overall Study|Reason Not Specified|2|||
16294470|NCT03734666|39562857|FG001|Overall Study|Lost to Follow-up|12|||
16294471|NCT01083810|39562858|FG000|Overall Study|Lost to Follow-up|23|||
16294472|NCT01083810|39562859|FG001|Overall Study|Lost to Follow-up|11|||
16294473|NCT01083810|39562860|FG002|Overall Study|Lost to Follow-up|4|||
16294474|NCT01083810|39562858|FG000|Overall Study|Adverse Event|15|||
16294475|NCT01083810|39562859|FG001|Overall Study|Adverse Event|11|||
16294476|NCT01083810|39562860|FG002|Overall Study|Adverse Event|4|||
16294477|NCT01083810|39562858|FG000|Overall Study|Withdrawal by Subject|7|||
16294478|NCT01083810|39562859|FG001|Overall Study|Withdrawal by Subject|2|||
16294479|NCT01083810|39562860|FG002|Overall Study|Withdrawal by Subject|4|||
16294480|NCT01083810|39562858|FG000|Overall Study|Reason not reported|6|||
16294481|NCT01083810|39562859|FG001|Overall Study|Reason not reported|1|||
16294482|NCT01083810|39562860|FG002|Overall Study|Reason not reported|1|||
16294483|NCT01083810|39562858|FG000|Overall Study|Non-compliance|4|||
16294484|NCT01083810|39562859|FG001|Overall Study|Non-compliance|7|||
16294485|NCT01083810|39562860|FG002|Overall Study|Non-compliance|2|||
16294486|NCT01083810|39562858|FG000|Overall Study|Simplification|4|||
16294487|NCT01083810|39562859|FG001|Overall Study|Simplification|1|||
16484883|NCT01397162|40252604|FG000|Overall Study|Adverse Event|4|||
16484884|NCT01397162|40252605|FG001|Overall Study|Adverse Event|0|||
16484885|NCT01397162|40252606|FG002|Overall Study|Adverse Event|0|||
16484886|NCT01397162|40252607|FG003|Overall Study|Adverse Event|0|||
16484887|NCT01397162|40252608|FG004|Overall Study|Adverse Event|0|||
16484888|NCT01397162|40252604|FG000|Overall Study|Not yet defined|3|||
16484889|NCT01397162|40252605|FG001|Overall Study|Not yet defined|4|||
16484890|NCT01397162|40252606|FG002|Overall Study|Not yet defined|3|||
16484891|NCT01397162|40252607|FG003|Overall Study|Not yet defined|5|||
16484892|NCT01397162|40252608|FG004|Overall Study|Not yet defined|3|||
16484893|NCT03334539|40252611|FG000|Overall Study|Adverse Event|3|||
16484894|NCT03334539|40252612|FG001|Overall Study|Adverse Event|5|||
16484895|NCT03334539|40252613|FG002|Overall Study|Adverse Event|0|||
16484896|NCT03334539|40252611|FG000|Overall Study|Withdrawal by Subject|0|||
16484897|NCT03334539|40252612|FG001|Overall Study|Withdrawal by Subject|1|||
16484898|NCT03334539|40252613|FG002|Overall Study|Withdrawal by Subject|1|||
16484899|NCT03334539|40252611|FG000|Overall Study|Administrative Reasons|1|||
16484900|NCT03334539|40252612|FG001|Overall Study|Administrative Reasons|0|||
16484901|NCT03334539|40252613|FG002|Overall Study|Administrative Reasons|0|||
16484902|NCT03334539|40252611|FG000|Overall Study|Hypertension Not Controlled|0|||
16484903|NCT03334539|40252612|FG001|Overall Study|Hypertension Not Controlled|1|||
16484904|NCT03334539|40252613|FG002|Overall Study|Hypertension Not Controlled|0|||
16484905|NCT01091974|40252614|FG000|Overall Study|Did not start intervention|3|||
16484906|NCT01091974|40252615|FG001|Overall Study|Did not start intervention|1|||
16484907|NCT01091974|40252616|FG002|Overall Study|Did not start intervention|3|||
16484908|NCT01091974|40252617|FG003|Overall Study|Did not start intervention|1|||
16484909|NCT01091974|40252614|FG000|Overall Study|resumed sleep medication|0|||
16484910|NCT01091974|40252615|FG001|Overall Study|resumed sleep medication|0|||
16484911|NCT01091974|40252616|FG002|Overall Study|resumed sleep medication|1|||
16484912|NCT01091974|40252617|FG003|Overall Study|resumed sleep medication|2|||
16484913|NCT01091974|40252614|FG000|Overall Study|Withdrawal by Subject|1|||
16081714|NCT02590432|38792713|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
16081715|NCT02590432|38792714|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
16081716|NCT02590432|38792715|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
16081717|NCT02590432|38792716|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
16081718|NCT02590432|38792708|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16081719|NCT02590432|38792709|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
16081720|NCT02590432|38792710|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
16081721|NCT02590432|38792711|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
16081722|NCT02590432|38792712|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
16081723|NCT02590432|38792713|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
16081724|NCT02590432|38792714|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
16081725|NCT02590432|38792715|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
16081726|NCT02590432|38792716|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
16081727|NCT02590432|38792708|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
16081728|NCT02590432|38792709|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
16081729|NCT02590432|38792710|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
16187921|NCT00469014|39165085|FG000|Initial Phase Randomization|No Response|1|||
16294488|NCT01083810|39562860|FG002|Overall Study|Simplification|0|||
16294489|NCT01083810|39562858|FG000|Overall Study|Death|2|||
16382481|NCT02327169|39884505|FG000|Overall Study|Withdrawal by Subject|1|||
16081730|NCT02590432|38792711|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
16294490|NCT01083810|39562859|FG001|Overall Study|Death|2|||
16294491|NCT01083810|39562860|FG002|Overall Study|Death|3|||
16484914|NCT01091974|40252615|FG001|Overall Study|Withdrawal by Subject|3|||
16484915|NCT01091974|40252616|FG002|Overall Study|Withdrawal by Subject|2|||
16484916|NCT01091974|40252617|FG003|Overall Study|Withdrawal by Subject|2|||
16294492|NCT01083810|39562858|FG000|Overall Study|Co-morbidities|1|||
16081731|NCT02590432|38792712|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
16081732|NCT02590432|38792713|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
16081733|NCT02590432|38792714|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
16081734|NCT02590432|38792715|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
16081735|NCT02590432|38792716|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
16081736|NCT02590432|38792708|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
16081737|NCT02590432|38792709|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
16081738|NCT02590432|38792710|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
16081739|NCT02590432|38792711|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
16081740|NCT02590432|38792712|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
16081741|NCT02590432|38792713|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
16081742|NCT02590432|38792714|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
16081743|NCT02590432|38792715|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
16081744|NCT02590432|38792716|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
16081745|NCT02590432|38792708|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
16081746|NCT02590432|38792709|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
16081747|NCT02590432|38792710|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
16081748|NCT02590432|38792711|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
16081749|NCT02590432|38792712|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
16081750|NCT02590432|38792713|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
16081751|NCT02590432|38792714|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
16081752|NCT02590432|38792715|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
16081753|NCT02590432|38792716|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
16081754|NCT02590432|38792708|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
16081755|NCT02590432|38792709|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
16484917|NCT01091974|40252614|FG000|Overall Study|side-effects|1|||
16484918|NCT01091974|40252615|FG001|Overall Study|side-effects|1|||
16484919|NCT01091974|40252616|FG002|Overall Study|side-effects|0|||
16484920|NCT01091974|40252617|FG003|Overall Study|side-effects|2|||
16484921|NCT02538029|40252625|FG000|Overall Study|unable to complete cognitive assessments|1|||
16081756|NCT02590432|38792710|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
16081757|NCT02590432|38792711|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
16081758|NCT02590432|38792712|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
16081759|NCT02590432|38792713|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
16081760|NCT02590432|38792714|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
16081761|NCT02590432|38792715|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
16081762|NCT02590432|38792716|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
16081763|NCT02590432|38792708|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
16081764|NCT02590432|38792709|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
16081765|NCT02590432|38792710|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
16081766|NCT02590432|38792711|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
16081767|NCT02590432|38792712|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
16081768|NCT02590432|38792713|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
16081769|NCT02590432|38792714|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
16081770|NCT02590432|38792715|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
16081771|NCT02590432|38792716|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
16081772|NCT02590432|38792708|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
16081773|NCT02590432|38792709|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
16081774|NCT02590432|38792710|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
16081775|NCT02590432|38792711|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
16081776|NCT02590432|38792712|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
16081777|NCT02590432|38792713|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
16081778|NCT02590432|38792714|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
16081779|NCT02590432|38792715|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
16081780|NCT02590432|38792716|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
16081781|NCT02590432|38792708|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
16081782|NCT02590432|38792709|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
16081783|NCT02590432|38792710|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
16081784|NCT02590432|38792711|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
16081785|NCT02590432|38792712|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
16081786|NCT02590432|38792713|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
16294493|NCT01083810|39562859|FG001|Overall Study|Co-morbidities|0|||
16294494|NCT01083810|39562860|FG002|Overall Study|Co-morbidities|0|||
16484922|NCT02538029|40252626|FG001|Overall Study|unable to complete cognitive assessments|0|||
16081787|NCT02590432|38792714|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
16081788|NCT02590432|38792715|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
16081789|NCT02590432|38792716|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
16081790|NCT02590432|38792708|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
16294495|NCT01083810|39562858|FG000|Overall Study|Participation in study|1|||
16382482|NCT02327169|39884506|FG001|Overall Study|Withdrawal by Subject|0|||
16382483|NCT02327169|39884507|FG002|Overall Study|Withdrawal by Subject|0|||
16382484|NCT02327169|39884508|FG003|Overall Study|Withdrawal by Subject|0|||
16382485|NCT02327169|39884509|FG004|Overall Study|Withdrawal by Subject|1|||
16382486|NCT02327169|39884510|FG005|Overall Study|Withdrawal by Subject|0|||
16382487|NCT02327169|39884511|FG006|Overall Study|Withdrawal by Subject|0|||
16382488|NCT02327169|39884512|FG007|Overall Study|Withdrawal by Subject|1|||
16382489|NCT02327169|39884513|FG008|Overall Study|Withdrawal by Subject|0|||
16382490|NCT02327169|39884514|FG009|Overall Study|Withdrawal by Subject|0|||
16382491|NCT02327169|39884515|FG010|Overall Study|Withdrawal by Subject|0|||
16382492|NCT02327169|39884516|FG011|Overall Study|Withdrawal by Subject|0|||
16382493|NCT02327169|39884517|FG012|Overall Study|Withdrawal by Subject|0|||
16382494|NCT02327169|39884518|FG013|Overall Study|Withdrawal by Subject|0|||
16382495|NCT02327169|39884519|FG014|Overall Study|Withdrawal by Subject|3|||
16382496|NCT02327169|39884505|FG000|Overall Study|Lost to Follow-up|0|||
16382497|NCT02327169|39884506|FG001|Overall Study|Lost to Follow-up|0|||
16382498|NCT02327169|39884507|FG002|Overall Study|Lost to Follow-up|0|||
16382499|NCT02327169|39884508|FG003|Overall Study|Lost to Follow-up|0|||
16382500|NCT02327169|39884509|FG004|Overall Study|Lost to Follow-up|1|||
16382501|NCT02327169|39884510|FG005|Overall Study|Lost to Follow-up|0|||
16382502|NCT02327169|39884511|FG006|Overall Study|Lost to Follow-up|0|||
16484923|NCT02538029|40252627|FG002|Overall Study|unable to complete cognitive assessments|1|||
16484924|NCT02572401|40252628|FG000|Overall Study|Lost to Follow-up|5|||
16294496|NCT01083810|39562859|FG001|Overall Study|Participation in study|0|||
16294497|NCT01083810|39562860|FG002|Overall Study|Participation in study|0|||
16294498|NCT01083810|39562858|FG000|Overall Study|Therapy break|1|||
16294499|NCT01083810|39562859|FG001|Overall Study|Therapy break|2|||
16294500|NCT01083810|39562860|FG002|Overall Study|Therapy break|2|||
16294501|NCT01083810|39562858|FG000|Overall Study|Virologic failure|1|||
16294502|NCT01083810|39562859|FG001|Overall Study|Virologic failure|8|||
16294503|NCT01083810|39562860|FG002|Overall Study|Virologic failure|0|||
16294504|NCT03768726|39562861|FG000|Treatment Phase|Adverse Event|2|||
16382503|NCT02327169|39884512|FG007|Overall Study|Lost to Follow-up|0|||
16382504|NCT02327169|39884513|FG008|Overall Study|Lost to Follow-up|0|||
16382505|NCT02327169|39884514|FG009|Overall Study|Lost to Follow-up|0|||
16382506|NCT02327169|39884515|FG010|Overall Study|Lost to Follow-up|0|||
16382507|NCT02327169|39884516|FG011|Overall Study|Lost to Follow-up|0|||
16382508|NCT02327169|39884517|FG012|Overall Study|Lost to Follow-up|0|||
16382509|NCT02327169|39884518|FG013|Overall Study|Lost to Follow-up|0|||
16382510|NCT02327169|39884519|FG014|Overall Study|Lost to Follow-up|0|||
16382511|NCT02439957|39884520|FG000|Overall Study|Study Terminated|3|||
16382512|NCT02439957|39884521|FG001|Overall Study|Study Terminated|3|||
16382513|NCT01605097|39884522|FG000|Overall Study|Protocol Violation|1|||
16382514|NCT03612570|39884537|FG000|Overall Study|Lost to Follow-up|1|||
16382515|NCT02862574|39884538|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16382516|NCT02862574|39884539|FG001|Double-Blind Treatment Period|Adverse Event|1|||
16382517|NCT02862574|39884540|FG002|Double-Blind Treatment Period|Adverse Event|0|||
16294505|NCT03768726|39562862|FG001|Treatment Phase|Adverse Event|2|||
16294506|NCT03768726|39562861|FG000|Treatment Phase|Lost to Follow-up|1|||
16294507|NCT03768726|39562862|FG001|Treatment Phase|Lost to Follow-up|0|||
16294508|NCT03768726|39562861|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
16294509|NCT03768726|39562862|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
16294510|NCT03768726|39562861|FG000|Treatment Phase|Withdrawal by Subject|3|||
16382518|NCT02862574|39884538|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
16382519|NCT02862574|39884539|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
16382520|NCT02862574|39884540|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
16382521|NCT02862574|39884538|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
16382522|NCT02862574|39884539|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
16382523|NCT02862574|39884540|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
16382524|NCT03958331|39884541|FG000|Overall Study|Withdrawal by Subject|3|||
16382525|NCT03958331|39884542|FG001|Overall Study|Withdrawal by Subject|1|||
16382526|NCT03958331|39884543|FG002|Overall Study|Withdrawal by Subject|5|||
16382527|NCT03958331|39884541|FG000|Overall Study|Weaned from medicine|2|||
16382528|NCT03958331|39884542|FG001|Overall Study|Weaned from medicine|0|||
16294511|NCT03768726|39562862|FG001|Treatment Phase|Withdrawal by Subject|1|||
16382529|NCT03958331|39884543|FG002|Overall Study|Weaned from medicine|0|||
16382530|NCT03958331|39884541|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
16484925|NCT02572401|40252629|FG001|Overall Study|Lost to Follow-up|8|||
16294512|NCT03768726|39562861|FG000|Follow-Up|Adverse Event|2|||
16294513|NCT03768726|39562862|FG001|Follow-Up|Adverse Event|2|||
16294514|NCT03768726|39562861|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
16294515|NCT03768726|39562862|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
16294516|NCT03768726|39562861|FG000|Follow-Up|Withdrawal by Subject|2|||
16294517|NCT03768726|39562862|FG001|Follow-Up|Withdrawal by Subject|0|||
16294518|NCT03768726|39562861|FG000|Follow-Up|Other|1|||
16294519|NCT03768726|39562862|FG001|Follow-Up|Other|0|||
16294520|NCT00936897|39562863|FG000|Overall Study|Withdrawal by Subject|9|||
16294521|NCT00936897|39562864|FG001|Overall Study|Withdrawal by Subject|19|||
16294522|NCT00936897|39562863|FG000|Overall Study|Adverse Event|4|||
16294523|NCT00936897|39562864|FG001|Overall Study|Adverse Event|13|||
16294524|NCT00936897|39562863|FG000|Overall Study|Other|3|||
16294525|NCT00936897|39562864|FG001|Overall Study|Other|9|||
16294526|NCT00936897|39562863|FG000|Overall Study|Lost to Follow-up|1|||
16294527|NCT00936897|39562864|FG001|Overall Study|Lost to Follow-up|10|||
16294528|NCT00936897|39562863|FG000|Overall Study|Administrative Decision|1|||
16294529|NCT00936897|39562864|FG001|Overall Study|Administrative Decision|2|||
16294530|NCT00936897|39562863|FG000|Overall Study|Protocol Violation|1|||
16294531|NCT00936897|39562864|FG001|Overall Study|Protocol Violation|1|||
16294532|NCT00936897|39562863|FG000|Overall Study|Ineligibility Determined|0|||
16294533|NCT00936897|39562864|FG001|Overall Study|Ineligibility Determined|3|||
16294534|NCT00936897|39562863|FG000|Overall Study|Noncompliance|0|||
16294535|NCT00936897|39562864|FG001|Overall Study|Noncompliance|2|||
16294536|NCT00936897|39562863|FG000|Overall Study|Death|0|||
16294537|NCT00936897|39562864|FG001|Overall Study|Death|1|||
16294538|NCT02105974|39562865|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
16294539|NCT02105974|39562866|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
16294540|NCT02105974|39562867|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
16294541|NCT02105974|39562865|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
16294542|NCT02105974|39562866|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
16294543|NCT02105974|39562867|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
16294544|NCT02105974|39562865|FG000|2 Week Run-in Period|Adverse Event|6|||
16294545|NCT02105974|39562866|FG001|2 Week Run-in Period|Adverse Event|0|||
16294546|NCT02105974|39562867|FG002|2 Week Run-in Period|Adverse Event|0|||
16294547|NCT02105974|39562865|FG000|2 Week Run-in Period|Study closed/terminated|1|||
16294548|NCT02105974|39562866|FG001|2 Week Run-in Period|Study closed/terminated|0|||
16294549|NCT02105974|39562867|FG002|2 Week Run-in Period|Study closed/terminated|0|||
16294550|NCT02105974|39562865|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
16294551|NCT02105974|39562866|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
16294552|NCT02105974|39562867|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
16294553|NCT02105974|39562865|FG000|2 Week Run-in Period|Withdrew consent|23|||
16294554|NCT02105974|39562866|FG001|2 Week Run-in Period|Withdrew consent|0|||
16294555|NCT02105974|39562867|FG002|2 Week Run-in Period|Withdrew consent|0|||
16294556|NCT02105974|39562865|FG000|2 Week Run-in Period|Investigator discretion|8|||
16294557|NCT02105974|39562866|FG001|2 Week Run-in Period|Investigator discretion|0|||
16294558|NCT02105974|39562867|FG002|2 Week Run-in Period|Investigator discretion|0|||
16294559|NCT02105974|39562865|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
16294560|NCT02105974|39562866|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
16294561|NCT02105974|39562867|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
16294562|NCT02105974|39562865|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
16294563|NCT02105974|39562866|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
16294564|NCT02105974|39562867|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
16294565|NCT02105974|39562865|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
16294566|NCT02105974|39562866|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
16294567|NCT02105974|39562867|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
16294568|NCT02105974|39562865|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
16294569|NCT02105974|39562866|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
16294570|NCT02105974|39562867|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
16294571|NCT02105974|39562865|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
16294572|NCT02105974|39562866|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
16294573|NCT02105974|39562867|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
16294574|NCT02105974|39562865|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
16294575|NCT02105974|39562866|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
16294576|NCT02105974|39562867|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
16294577|NCT02105974|39562865|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
16294578|NCT02105974|39562866|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
16294579|NCT02105974|39562867|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
16294580|NCT00302081|39562870|FG000|Overall Study|Adverse Event|6|||
16294581|NCT00302081|39562871|FG001|Overall Study|Adverse Event|5|||
16294582|NCT00302081|39562872|FG002|Overall Study|Adverse Event|4|||
16294583|NCT00302081|39562870|FG000|Overall Study|Lost to Follow-up|21|||
16294584|NCT00302081|39562871|FG001|Overall Study|Lost to Follow-up|18|||
16294585|NCT00302081|39562872|FG002|Overall Study|Lost to Follow-up|28|||
16484926|NCT02572401|40252630|FG002|Overall Study|Lost to Follow-up|9|||
16484927|NCT02572401|40252631|FG003|Overall Study|Lost to Follow-up|9|||
16484928|NCT02572401|40252628|FG000|Overall Study|Death|0|||
16484929|NCT02572401|40252629|FG001|Overall Study|Death|0|||
16484930|NCT02572401|40252630|FG002|Overall Study|Death|0|||
16294586|NCT00302081|39562870|FG000|Overall Study|Withdrawal by Subject|8|||
16484931|NCT02572401|40252631|FG003|Overall Study|Death|1|||
16081791|NCT02590432|38792709|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
16081792|NCT02590432|38792710|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
16081793|NCT02590432|38792711|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
16081794|NCT02590432|38792712|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
16081795|NCT02590432|38792713|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
16081796|NCT02590432|38792714|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
16081797|NCT02590432|38792715|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
16484932|NCT04390191|40252632|FG000|Overall Study|Withdrawal by Subject|1|||
16484933|NCT04390191|40252633|FG001|Overall Study|Withdrawal by Subject|0|||
16081798|NCT02590432|38792716|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
16081799|NCT04337931|38792717|FG000|Overall Study|Death|4|||
16081800|NCT04337931|38792718|FG001|Overall Study|Death|1|||
16081801|NCT04337931|38792719|FG002|Overall Study|Death|7|||
16081802|NCT04337931|38792717|FG000|Overall Study|Withdrawal by Subject|0|||
16081803|NCT04337931|38792718|FG001|Overall Study|Withdrawal by Subject|1|||
16081804|NCT04337931|38792719|FG002|Overall Study|Withdrawal by Subject|0|||
16081805|NCT04337931|38792717|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
16081806|NCT04337931|38792718|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
16081807|NCT04337931|38792719|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
16081808|NCT04337931|38792717|FG000|Overall Study|Study terminated by sponsor|3|||
16081809|NCT04337931|38792718|FG001|Overall Study|Study terminated by sponsor|6|||
16081810|NCT04337931|38792719|FG002|Overall Study|Study terminated by sponsor|2|||
16081811|NCT04337931|38792717|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
16081812|NCT04337931|38792718|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
16081813|NCT04337931|38792719|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
16081814|NCT04337931|38792717|FG000|Overall Study|Colorectal cancer treatment|1|||
16081815|NCT04337931|38792718|FG001|Overall Study|Colorectal cancer treatment|0|||
16081816|NCT04337931|38792719|FG002|Overall Study|Colorectal cancer treatment|0|||
16081817|NCT04337931|38792717|FG000|Overall Study|Participant decision|0|||
16081818|NCT04337931|38792718|FG001|Overall Study|Participant decision|1|||
16081819|NCT04337931|38792719|FG002|Overall Study|Participant decision|0|||
16081820|NCT02267824|38792720|FG000|Overall Study|Pregnancy|1|||
16081821|NCT02267824|38792721|FG001|Overall Study|Pregnancy|1|||
16081822|NCT02267824|38792720|FG000|Overall Study|Lost to Follow-up|4|||
16081823|NCT02267824|38792721|FG001|Overall Study|Lost to Follow-up|0|||
16081824|NCT02267824|38792720|FG000|Overall Study|Protocol Violation|3|||
16081825|NCT02267824|38792721|FG001|Overall Study|Protocol Violation|0|||
16081826|NCT02267824|38792720|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
16081827|NCT02267824|38792721|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
16081828|NCT00703820|38792728|FG000|Overall Study|Adverse Event|12|||
16081829|NCT00703820|38792729|FG001|Overall Study|Adverse Event|17|||
16081830|NCT00703820|38792728|FG000|Overall Study|Death|5|||
16081831|NCT00703820|38792729|FG001|Overall Study|Death|0|||
16081832|NCT00703820|38792728|FG000|Overall Study|Lack of Efficacy|11|||
16294587|NCT00302081|39562871|FG001|Overall Study|Withdrawal by Subject|12|||
16294588|NCT00302081|39562872|FG002|Overall Study|Withdrawal by Subject|8|||
16294589|NCT00302081|39562870|FG000|Overall Study|Protocol Violation|5|||
16294590|NCT00302081|39562871|FG001|Overall Study|Protocol Violation|1|||
16294591|NCT00302081|39562872|FG002|Overall Study|Protocol Violation|2|||
16294592|NCT00302081|39562870|FG000|Overall Study|Lack of Efficacy|1|||
16294593|NCT00302081|39562871|FG001|Overall Study|Lack of Efficacy|0|||
16294594|NCT00302081|39562872|FG002|Overall Study|Lack of Efficacy|5|||
16294595|NCT00302081|39562870|FG000|Overall Study|Death|2|||
16294596|NCT00302081|39562871|FG001|Overall Study|Death|1|||
16294597|NCT00302081|39562872|FG002|Overall Study|Death|0|||
16294598|NCT00302081|39562870|FG000|Overall Study|Other|13|||
16294599|NCT00302081|39562871|FG001|Overall Study|Other|6|||
16294600|NCT00302081|39562872|FG002|Overall Study|Other|5|||
16484934|NCT00847379|40252636|FG000|Overall Study|Study terminated by Sponsor|59|||
16081833|NCT00703820|38792729|FG001|Overall Study|Lack of Efficacy|11|||
16081834|NCT00703820|38792728|FG000|Overall Study|Received non-protocol therapy|1|||
16294601|NCT00757848|39562875|FG000|Overall Study|Voluntary discontinuation|1|||
16294602|NCT00757848|39562876|FG001|Overall Study|Voluntary discontinuation|0|||
16294603|NCT00757848|39562875|FG000|Overall Study|Adverse Event|1|||
16294604|NCT00757848|39562876|FG001|Overall Study|Adverse Event|2|||
16294605|NCT00757848|39562875|FG000|Overall Study|Incorrect enrolment|1|||
16484935|NCT00847379|40252637|FG001|Overall Study|Study terminated by Sponsor|57|||
16484936|NCT00847379|40252638|FG002|Overall Study|Study terminated by Sponsor|57|||
16294606|NCT00757848|39562876|FG001|Overall Study|Incorrect enrolment|0|||
16294607|NCT04421586|39562877|FG000|Overall Study|Death|0|||
16484937|NCT02784431|40252640|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
16484938|NCT02784431|40252640|FG000|Overall Study|Early Study Termination|19|||
16484939|NCT02742441|40252641|FG000|Overall Study|Lost to Follow-up|4|||
16484940|NCT02742441|40252642|FG001|Overall Study|Lost to Follow-up|4|||
16484941|NCT02742441|40252641|FG000|Overall Study|Withdrawal by Subject|2|||
16484942|NCT02742441|40252642|FG001|Overall Study|Withdrawal by Subject|2|||
16484943|NCT02742441|40252641|FG000|Overall Study|Adverse Event|0|||
16484944|NCT02742441|40252642|FG001|Overall Study|Adverse Event|2|||
16484945|NCT04066023|40252643|FG000|Overall Study|Adverse Event|0|||
16484946|NCT04066023|40252644|FG001|Overall Study|Adverse Event|0|||
16484947|NCT04066023|40252645|FG002|Overall Study|Adverse Event|1|||
16484948|NCT04066023|40252643|FG000|Overall Study|Sponsor decision|3|||
16484949|NCT04066023|40252644|FG001|Overall Study|Sponsor decision|6|||
16484950|NCT04066023|40252645|FG002|Overall Study|Sponsor decision|2|||
16484951|NCT04066023|40252643|FG000|Overall Study|Physician Decision|0|||
16484952|NCT04066023|40252644|FG001|Overall Study|Physician Decision|0|||
16484953|NCT04066023|40252645|FG002|Overall Study|Physician Decision|1|||
16484954|NCT04066023|40252643|FG000|Overall Study|Lost to Follow-up|0|||
16484955|NCT04066023|40252644|FG001|Overall Study|Lost to Follow-up|1|||
16484956|NCT04066023|40252645|FG002|Overall Study|Lost to Follow-up|1|||
16484957|NCT04066023|40252643|FG000|Overall Study|Noncompliance|0|||
16484958|NCT04066023|40252644|FG001|Overall Study|Noncompliance|1|||
16484959|NCT04066023|40252645|FG002|Overall Study|Noncompliance|1|||
16484960|NCT00696800|40252646|FG000|Overall Study|Adverse Event|16|||
16484961|NCT00696800|40252647|FG001|Overall Study|Adverse Event|3|||
16484962|NCT00696800|40252646|FG000|Overall Study|Insufficient compliance with medication|2|||
16484963|NCT00696800|40252647|FG001|Overall Study|Insufficient compliance with medication|1|||
16484964|NCT00696800|40252646|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
16484965|NCT00696800|40252647|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
16484966|NCT00696800|40252646|FG000|Overall Study|Insufficient ovarian response|4|||
16484967|NCT00696800|40252647|FG001|Overall Study|Insufficient ovarian response|1|||
16484968|NCT00696800|40252646|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
16484969|NCT00696800|40252647|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
16484970|NCT00696800|40252646|FG000|Overall Study|Too high ovarian response|6|||
16484971|NCT00696800|40252647|FG001|Overall Study|Too high ovarian response|1|||
16484972|NCT00696800|40252646|FG000|Overall Study|No/too few/bad quality oocytes|4|||
16484973|NCT00696800|40252647|FG001|Overall Study|No/too few/bad quality oocytes|3|||
16484974|NCT00696800|40252646|FG000|Overall Study|No/abnormal fertilization|11|||
16484975|NCT00696800|40252647|FG001|Overall Study|No/abnormal fertilization|13|||
16484976|NCT00696800|40252646|FG000|Overall Study|No/too few/bad quality embryos|24|||
16484977|NCT00696800|40252647|FG001|Overall Study|No/too few/bad quality embryos|18|||
16294608|NCT04421586|39562878|FG001|Overall Study|Death|1|||
16484978|NCT00696800|40252646|FG000|Overall Study|Other Reasons|5|||
16484979|NCT00696800|40252647|FG001|Overall Study|Other Reasons|3|||
16484980|NCT00696800|40252646|FG000|Overall Study|Not treated|1|||
16484981|NCT00696800|40252647|FG001|Overall Study|Not treated|2|||
16484982|NCT00404235|40252648|FG000|Overall Study|Withdrawal by Subject|1|||
16484983|NCT00404235|40252649|FG001|Overall Study|Withdrawal by Subject|2|||
16484984|NCT01382212|40252652|FG000|Overall Study|Kidney transplant|1|||
16484985|NCT01382212|40252652|FG000|Overall Study|Withdrew consent|1|||
16484986|NCT00282412|40252655|FG000|Overall Study|Death|2|||
16484987|NCT00126191|40252656|FG000|Overall Study|Physician Decision|0|||
16294609|NCT04421586|39562877|FG000|Overall Study|Lost to Follow-up|2|||
16294610|NCT04421586|39562878|FG001|Overall Study|Lost to Follow-up|2|||
16294611|NCT04421586|39562877|FG000|Overall Study|Withdrawn by PI|1|||
16294612|NCT04421586|39562878|FG001|Overall Study|Withdrawn by PI|0|||
16294613|NCT04421586|39562877|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
16294614|NCT04421586|39562878|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
16294615|NCT01246011|39562879|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
16294616|NCT01246011|39562880|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
16294617|NCT01246011|39562881|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
16294618|NCT01246011|39562879|FG000|Overall Study|Withdrawal by Subject|0|||
16294619|NCT01246011|39562880|FG001|Overall Study|Withdrawal by Subject|0|||
16294620|NCT01246011|39562881|FG002|Overall Study|Withdrawal by Subject|1|||
16294621|NCT00171301|39562885|FG000|Overall Study|Death|1|||
16294622|NCT00171301|39562886|FG001|Overall Study|Death|2|||
16294623|NCT00171301|39562885|FG000|Overall Study|Adverse Event|1|||
16294624|NCT00171301|39562886|FG001|Overall Study|Adverse Event|2|||
16294625|NCT00171301|39562885|FG000|Overall Study|Lost to Follow-up|6|||
16294626|NCT00171301|39562886|FG001|Overall Study|Lost to Follow-up|2|||
16294627|NCT00171301|39562885|FG000|Overall Study|Protocol Violation|0|||
16294628|NCT00171301|39562886|FG001|Overall Study|Protocol Violation|2|||
16294629|NCT00171301|39562885|FG000|Overall Study|Withdrawal by Subject|0|||
16294630|NCT00171301|39562886|FG001|Overall Study|Withdrawal by Subject|1|||
16294631|NCT01288053|39562887|FG000|Overall Study|Death|1|||
16294632|NCT00758680|39562888|FG000|Overall Study|Adverse Event|0|||
16294633|NCT00758680|39562889|FG001|Overall Study|Adverse Event|0|||
16294634|NCT00758680|39562890|FG002|Overall Study|Adverse Event|0|||
16294635|NCT00758680|39562891|FG003|Overall Study|Adverse Event|0|||
16294636|NCT00758680|39562892|FG004|Overall Study|Adverse Event|0|||
16294637|NCT00758680|39562893|FG005|Overall Study|Adverse Event|0|||
16294638|NCT00758680|39562894|FG006|Overall Study|Adverse Event|0|||
16294639|NCT00758680|39562895|FG007|Overall Study|Adverse Event|1|||
16294640|NCT00758680|39562896|FG008|Overall Study|Adverse Event|0|||
16294641|NCT00758680|39562897|FG009|Overall Study|Adverse Event|1|||
16294642|NCT00758680|39562888|FG000|Overall Study|Laboratory Adverse Event|0|||
16294643|NCT00758680|39562889|FG001|Overall Study|Laboratory Adverse Event|0|||
16294644|NCT00758680|39562890|FG002|Overall Study|Laboratory Adverse Event|0|||
16294645|NCT00758680|39562891|FG003|Overall Study|Laboratory Adverse Event|0|||
16294646|NCT00758680|39562892|FG004|Overall Study|Laboratory Adverse Event|0|||
16294647|NCT00758680|39562893|FG005|Overall Study|Laboratory Adverse Event|0|||
16294648|NCT00758680|39562894|FG006|Overall Study|Laboratory Adverse Event|0|||
16294649|NCT00758680|39562895|FG007|Overall Study|Laboratory Adverse Event|0|||
16294650|NCT00758680|39562896|FG008|Overall Study|Laboratory Adverse Event|1|||
16294651|NCT00758680|39562897|FG009|Overall Study|Laboratory Adverse Event|0|||
16294652|NCT00758680|39562888|FG000|Overall Study|Withdrawal by Subject|0|||
16187922|NCT00469014|39165086|FG001|Initial Phase Randomization|No Response|0|||
16187923|NCT00469014|39165087|FG002|Initial Phase Randomization|No Response|0|||
16187924|NCT00469014|39165088|FG003|Initial Phase Randomization|No Response|1|||
16187925|NCT00469014|39165085|FG000|Adaptive Randomization|Not Evaluable|1|||
16187926|NCT00469014|39165086|FG001|Adaptive Randomization|Not Evaluable|0|||
16187927|NCT00469014|39165087|FG002|Adaptive Randomization|Not Evaluable|0|||
16187928|NCT00469014|39165088|FG003|Adaptive Randomization|Not Evaluable|1|||
16294653|NCT00758680|39562889|FG001|Overall Study|Withdrawal by Subject|0|||
16294654|NCT00758680|39562890|FG002|Overall Study|Withdrawal by Subject|0|||
16294655|NCT00758680|39562891|FG003|Overall Study|Withdrawal by Subject|0|||
16294656|NCT00758680|39562892|FG004|Overall Study|Withdrawal by Subject|0|||
16294657|NCT00758680|39562893|FG005|Overall Study|Withdrawal by Subject|0|||
16294658|NCT00758680|39562894|FG006|Overall Study|Withdrawal by Subject|1|||
16484988|NCT00126191|40252657|FG001|Overall Study|Physician Decision|1|||
16484989|NCT00126191|40252656|FG000|Overall Study|Death|0|||
16484990|NCT00126191|40252657|FG001|Overall Study|Death|1|||
16484991|NCT01876420|40252658|FG000|Overall Study|Missed 30 day visit|1|||
16484992|NCT02289417|40252661|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
16484993|NCT02289417|40252662|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16187929|NCT00469014|39165085|FG000|Adaptive Randomization|No Response|0|||
16294659|NCT00758680|39562895|FG007|Overall Study|Withdrawal by Subject|0|||
16294660|NCT00758680|39562896|FG008|Overall Study|Withdrawal by Subject|1|||
16294661|NCT00758680|39562897|FG009|Overall Study|Withdrawal by Subject|0|||
16294662|NCT00478426|39562898|FG000|Overall Study|Withdrawal by Subject|1|||
16294663|NCT01671332|39562899|FG000|Overall Study|Withdrawal by Subject|1|||
16294664|NCT01671332|39562900|FG001|Overall Study|Withdrawal by Subject|1|||
16294665|NCT00003875|39562908|FG000|Overall Study|Screen Failed|1|||
16294666|NCT02040779|39562909|FG000|Overall Study|Adverse Event|1|||
16294667|NCT02040779|39562910|FG001|Overall Study|Adverse Event|0|||
16294668|NCT02040779|39562911|FG002|Overall Study|Adverse Event|0|||
16294669|NCT02040779|39562909|FG000|Overall Study|Withdrawal by Subject|4|||
16484994|NCT02289417|40252663|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
16484995|NCT02289417|40252664|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16484996|NCT02289417|40252665|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16484997|NCT02289417|40252666|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16484998|NCT02289417|40252667|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16484999|NCT02289417|40252668|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16485000|NCT02289417|40252669|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
16485001|NCT02289417|40252661|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
16485002|NCT02289417|40252662|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
16485003|NCT02289417|40252663|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
16485004|NCT02289417|40252664|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16485005|NCT02289417|40252665|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16485006|NCT02289417|40252666|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16485007|NCT02289417|40252667|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16485008|NCT02289417|40252668|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16485009|NCT02289417|40252669|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
16485010|NCT02289417|40252661|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16485011|NCT02289417|40252662|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
16081835|NCT00703820|38792729|FG001|Overall Study|Received non-protocol therapy|0|||
16081836|NCT00703820|38792728|FG000|Overall Study|Physician Decision|4|||
16485012|NCT02289417|40252663|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16485013|NCT02289417|40252664|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16485014|NCT02289417|40252665|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16485015|NCT02289417|40252666|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16485016|NCT02289417|40252667|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16485017|NCT02289417|40252668|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16485018|NCT02289417|40252669|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
16081837|NCT00703820|38792729|FG001|Overall Study|Physician Decision|5|||
16485019|NCT02289417|40252661|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
16485020|NCT02289417|40252662|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16485021|NCT02289417|40252663|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16485022|NCT02289417|40252664|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16485023|NCT02289417|40252665|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16485024|NCT02289417|40252666|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16485025|NCT02289417|40252667|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16485026|NCT02289417|40252668|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16485027|NCT02289417|40252669|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
16081838|NCT00703820|38792728|FG000|Overall Study|Withdrawal by Subject|2|||
16081839|NCT00703820|38792729|FG001|Overall Study|Withdrawal by Subject|1|||
16081840|NCT03580369|38792730|FG000|Overall Study|No treatment due to mis-randomization|1|||
16081841|NCT03580369|38792731|FG001|Overall Study|No treatment due to mis-randomization|0|||
16081842|NCT03580369|38792732|FG002|Overall Study|No treatment due to mis-randomization|0|||
16081843|NCT03580369|38792733|FG003|Overall Study|No treatment due to mis-randomization|0|||
16081844|NCT03580369|38792734|FG004|Overall Study|No treatment due to mis-randomization|3|||
16081845|NCT03580369|38792735|FG005|Overall Study|No treatment due to mis-randomization|0|||
16081846|NCT03580369|38792736|FG006|Overall Study|No treatment due to mis-randomization|0|||
16081847|NCT03580369|38792737|FG007|Overall Study|No treatment due to mis-randomization|0|||
16081848|NCT03580369|38792730|FG000|Overall Study|Reason unknown|0|||
16081849|NCT03580369|38792731|FG001|Overall Study|Reason unknown|0|||
16081850|NCT03580369|38792732|FG002|Overall Study|Reason unknown|1|||
16081851|NCT03580369|38792733|FG003|Overall Study|Reason unknown|0|||
16081852|NCT03580369|38792734|FG004|Overall Study|Reason unknown|0|||
16187930|NCT00469014|39165086|FG001|Adaptive Randomization|No Response|1|||
16187931|NCT00469014|39165087|FG002|Adaptive Randomization|No Response|0|||
16187932|NCT00469014|39165088|FG003|Adaptive Randomization|No Response|0|||
16187933|NCT00469014|39165085|FG000|Adaptive Randomization|Death|0|||
16187934|NCT00469014|39165086|FG001|Adaptive Randomization|Death|0|||
16187935|NCT00469014|39165087|FG002|Adaptive Randomization|Death|1|||
16187936|NCT00469014|39165088|FG003|Adaptive Randomization|Death|0|||
16187937|NCT00128206|39165089|FG000|Overall Study|Lost to Follow-up|137|||
16187938|NCT00128206|39165090|FG001|Overall Study|Lost to Follow-up|118|||
16187939|NCT00128206|39165089|FG000|Overall Study|Adverse Event|0|||
16187940|NCT00128206|39165090|FG001|Overall Study|Adverse Event|2|||
16187941|NCT03569293|39165095|FG000|Overall Study|Adverse Event|4|||
16187942|NCT03569293|39165096|FG001|Overall Study|Adverse Event|1|||
16187943|NCT03569293|39165097|FG002|Overall Study|Adverse Event|5|||
16187944|NCT03569293|39165098|FG003|Overall Study|Adverse Event|1|||
16187945|NCT03569293|39165099|FG004|Overall Study|Adverse Event|0|||
16187946|NCT03569293|39165100|FG005|Overall Study|Adverse Event|0|||
16187947|NCT03569293|39165095|FG000|Overall Study|Withdrawal by Subject|16|||
16187948|NCT03569293|39165096|FG001|Overall Study|Withdrawal by Subject|2|||
16187949|NCT03569293|39165097|FG002|Overall Study|Withdrawal by Subject|4|||
16187950|NCT03569293|39165098|FG003|Overall Study|Withdrawal by Subject|1|||
16187951|NCT03569293|39165099|FG004|Overall Study|Withdrawal by Subject|0|||
16187952|NCT03569293|39165100|FG005|Overall Study|Withdrawal by Subject|0|||
16187953|NCT03569293|39165095|FG000|Overall Study|Lost to Follow-up|1|||
16187954|NCT03569293|39165096|FG001|Overall Study|Lost to Follow-up|3|||
16187955|NCT03569293|39165097|FG002|Overall Study|Lost to Follow-up|1|||
16187956|NCT03569293|39165098|FG003|Overall Study|Lost to Follow-up|1|||
16187957|NCT03569293|39165099|FG004|Overall Study|Lost to Follow-up|0|||
16187958|NCT03569293|39165100|FG005|Overall Study|Lost to Follow-up|0|||
16187959|NCT03569293|39165095|FG000|Overall Study|Other|8|||
16187960|NCT03569293|39165096|FG001|Overall Study|Other|2|||
16187961|NCT03569293|39165097|FG002|Overall Study|Other|1|||
16187962|NCT03569293|39165098|FG003|Overall Study|Other|1|||
16187963|NCT03569293|39165099|FG004|Overall Study|Other|0|||
16187964|NCT03569293|39165100|FG005|Overall Study|Other|0|||
16187965|NCT03569293|39165095|FG000|Overall Study|Ongoing at Time of Analysis|8|||
16187966|NCT03569293|39165096|FG001|Overall Study|Ongoing at Time of Analysis|1|||
16187967|NCT03569293|39165097|FG002|Overall Study|Ongoing at Time of Analysis|3|||
16294670|NCT02040779|39562910|FG001|Overall Study|Withdrawal by Subject|1|||
16294671|NCT02040779|39562911|FG002|Overall Study|Withdrawal by Subject|3|||
16294672|NCT02040779|39562909|FG000|Overall Study|Non-compliance|0|||
16294673|NCT02040779|39562910|FG001|Overall Study|Non-compliance|1|||
16294674|NCT02040779|39562911|FG002|Overall Study|Non-compliance|0|||
16187968|NCT03569293|39165098|FG003|Overall Study|Ongoing at Time of Analysis|0|||
16294675|NCT02040779|39562909|FG000|Overall Study|Protocol Violation|2|||
16294676|NCT02040779|39562910|FG001|Overall Study|Protocol Violation|1|||
16294677|NCT02040779|39562911|FG002|Overall Study|Protocol Violation|0|||
16294678|NCT02040779|39562909|FG000|Overall Study|Lost to Follow-up|1|||
16294679|NCT02040779|39562910|FG001|Overall Study|Lost to Follow-up|2|||
16187969|NCT03569293|39165099|FG004|Overall Study|Ongoing at Time of Analysis|0|||
16294680|NCT02040779|39562911|FG002|Overall Study|Lost to Follow-up|1|||
16294681|NCT02040779|39562909|FG000|Overall Study|Lack of Efficacy|4|||
16294682|NCT02040779|39562910|FG001|Overall Study|Lack of Efficacy|2|||
16294683|NCT02040779|39562911|FG002|Overall Study|Lack of Efficacy|0|||
16294684|NCT03786718|39562914|FG000|Overall Study|Lost to Follow-up|3|||
16294685|NCT03786718|39562914|FG000|Overall Study|Withdrawal by Subject|1|||
16294686|NCT03786718|39562914|FG000|Overall Study|Did not use the intervention|2|||
16294687|NCT03786718|39562914|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
16081853|NCT03580369|38792735|FG005|Overall Study|Reason unknown|0|||
16081854|NCT03580369|38792736|FG006|Overall Study|Reason unknown|0|||
16081855|NCT03580369|38792737|FG007|Overall Study|Reason unknown|0|||
16081856|NCT03580369|38792730|FG000|Overall Study|Technical problems|0|||
16187970|NCT03569293|39165100|FG005|Overall Study|Ongoing at Time of Analysis|0|||
16187971|NCT02084134|39165101|FG000|Overall Study|Protocol Violation|4|||
16187972|NCT02084134|39165102|FG001|Overall Study|Protocol Violation|2|||
16187973|NCT02084134|39165101|FG000|Overall Study|Death|0|||
16187974|NCT02084134|39165102|FG001|Overall Study|Death|1|||
16187975|NCT00406640|39165103|FG000|Acute Phase|Adverse Event|18|||
16187976|NCT00406640|39165104|FG001|Acute Phase|Adverse Event|13|||
16294688|NCT03151408|39562917|FG000|Overall Study|Adverse Event|24|||
16187977|NCT00406640|39165103|FG000|Acute Phase|Failed to Return|5|||
16187978|NCT00406640|39165104|FG001|Acute Phase|Failed to Return|1|||
16187979|NCT00406640|39165103|FG000|Acute Phase|Physician Decision|0|||
16187980|NCT00406640|39165104|FG001|Acute Phase|Physician Decision|1|||
16294689|NCT03151408|39562918|FG001|Overall Study|Adverse Event|23|||
16294690|NCT03151408|39562917|FG000|Overall Study|Death|46|||
16294691|NCT03151408|39562918|FG001|Overall Study|Death|26|||
16294692|NCT03151408|39562917|FG000|Overall Study|Physician Decision|13|||
16294693|NCT03151408|39562918|FG001|Overall Study|Physician Decision|19|||
16294694|NCT03151408|39562917|FG000|Overall Study|Withdrawal by Subject|16|||
16187981|NCT00406640|39165103|FG000|Acute Phase|Lost to Follow-up|7|||
16187982|NCT00406640|39165104|FG001|Acute Phase|Lost to Follow-up|4|||
16187983|NCT00406640|39165103|FG000|Acute Phase|Protocol deviation|4|||
16187984|NCT00406640|39165104|FG001|Acute Phase|Protocol deviation|10|||
16187985|NCT00406640|39165103|FG000|Acute Phase|Protocol Violation|3|||
16187986|NCT00406640|39165104|FG001|Acute Phase|Protocol Violation|2|||
16187987|NCT00406640|39165103|FG000|Acute Phase|Withdrawal by Subject|11|||
16187988|NCT00406640|39165104|FG001|Acute Phase|Withdrawal by Subject|9|||
16187989|NCT00406640|39165103|FG000|Acute Phase|Lack of Efficacy|3|||
16187990|NCT00406640|39165104|FG001|Acute Phase|Lack of Efficacy|3|||
16187991|NCT00406640|39165103|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
16187992|NCT00406640|39165104|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
16187993|NCT00406640|39165103|FG000|DB Continuation Phase for Responders|Death|1|||
16187994|NCT00406640|39165104|FG001|DB Continuation Phase for Responders|Death|0|||
16187995|NCT00406640|39165103|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
16187996|NCT00406640|39165104|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
16187997|NCT00406640|39165103|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
16187998|NCT00406640|39165104|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
16187999|NCT00406640|39165103|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
16188000|NCT00406640|39165104|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
16188001|NCT00406640|39165103|FG000|DB Continuation Phase for Responders|non-compliance|7|||
16188002|NCT00406640|39165104|FG001|DB Continuation Phase for Responders|non-compliance|5|||
16188003|NCT00406640|39165103|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
16188004|NCT00406640|39165104|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
16188005|NCT00406640|39165103|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
16188006|NCT00406640|39165104|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
16188007|NCT00406640|39165103|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
16188008|NCT00406640|39165104|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
16188009|NCT00406640|39165103|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
16188010|NCT00406640|39165104|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
16188011|NCT00406640|39165103|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
16188012|NCT00406640|39165104|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
16188013|NCT00406640|39165103|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
16188014|NCT00406640|39165104|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
16188015|NCT00406640|39165103|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
16188016|NCT00406640|39165104|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
16188017|NCT00406640|39165103|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
16188018|NCT00406640|39165104|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
16188019|NCT00406640|39165103|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
16188020|NCT00406640|39165104|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
16188021|NCT00406640|39165103|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
16188022|NCT00406640|39165104|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
16188023|NCT00536978|39165105|FG000|Overall Study|Not eligible for Adback Infusion|22|||
16188024|NCT01214434|39165106|FG000|Overall Study|Withdrawal by Subject|1|||
16188025|NCT01214434|39165107|FG001|Overall Study|Withdrawal by Subject|0|||
16188026|NCT01214434|39165106|FG000|Overall Study|Lost to Follow-up|2|||
16294695|NCT03151408|39562918|FG001|Overall Study|Withdrawal by Subject|20|||
16188027|NCT01214434|39165107|FG001|Overall Study|Lost to Follow-up|2|||
16294696|NCT03151408|39562917|FG000|Overall Study|Progressive disease|45|||
16294697|NCT03151408|39562918|FG001|Overall Study|Progressive disease|61|||
16294698|NCT03151408|39562917|FG000|Overall Study|non-compliance by patient|1|||
16294699|NCT03151408|39562918|FG001|Overall Study|non-compliance by patient|0|||
16294700|NCT03151408|39562917|FG000|Overall Study|other reasons|56|||
16294701|NCT03151408|39562918|FG001|Overall Study|other reasons|52|||
16294702|NCT03151408|39562917|FG000|Overall Study|randomized and not treated|2|||
16294703|NCT03151408|39562918|FG001|Overall Study|randomized and not treated|2|||
16294704|NCT01248013|39562925|FG000|Overall Study|Withdrawal by Subject|14|||
16294705|NCT03837743|39562926|FG000|Overall Study|Adverse Event|1|||
16294706|NCT03837743|39562926|FG000|Overall Study|Withdrawal by Subject|2|||
16294707|NCT02130882|39562927|FG000|Overall Study|Withdrawal by Subject|0|||
16294708|NCT02130882|39562928|FG001|Overall Study|Withdrawal by Subject|1|||
16294709|NCT02518919|39562929|FG000|Overall Study|Protocol Violation|1|||
16294710|NCT02518919|39562930|FG001|Overall Study|Protocol Violation|1|||
16188028|NCT01214434|39165106|FG000|Overall Study|Site error|1|||
16188029|NCT01214434|39165107|FG001|Overall Study|Site error|0|||
16188030|NCT00641043|39165108|FG000|Overall Study|Adverse Event|6|||
16188031|NCT00641043|39165109|FG001|Overall Study|Adverse Event|4|||
16188032|NCT00641043|39165108|FG000|Overall Study|Protocol Violation|2|||
16188033|NCT00641043|39165109|FG001|Overall Study|Protocol Violation|3|||
16188034|NCT00641043|39165108|FG000|Overall Study|Lost to Follow-up|3|||
16188035|NCT00641043|39165109|FG001|Overall Study|Lost to Follow-up|2|||
16188036|NCT00641043|39165108|FG000|Overall Study|Withdrawal by Subject|4|||
16188037|NCT00641043|39165109|FG001|Overall Study|Withdrawal by Subject|4|||
16188038|NCT00641043|39165108|FG000|Overall Study|Other incl. lack of efficacy|4|||
16188039|NCT00641043|39165109|FG001|Overall Study|Other incl. lack of efficacy|2|||
16188040|NCT01554956|39165113|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
16188041|NCT01554956|39165114|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
16188042|NCT01554956|39165115|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
16188043|NCT01554956|39165113|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
16188044|NCT01554956|39165114|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
16188045|NCT01554956|39165115|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
16188046|NCT01554956|39165113|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
16188047|NCT01554956|39165114|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
16188048|NCT01554956|39165115|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
16188049|NCT02493426|39165116|FG000|Overall Study|Withdrawal by Subject|0|||
16188050|NCT02493426|39165117|FG001|Overall Study|Withdrawal by Subject|1|||
16188051|NCT03345836|39165118|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
16188052|NCT03345836|39165119|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
16188053|NCT03345836|39165120|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
16188054|NCT03345836|39165121|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
16188055|NCT03345836|39165122|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
16188056|NCT03345836|39165123|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
16188057|NCT03345836|39165118|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
16188058|NCT03345836|39165119|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
16188059|NCT03345836|39165120|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
16188060|NCT03345836|39165121|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
16188061|NCT03345836|39165122|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
16188062|NCT03345836|39165123|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
16188063|NCT03345836|39165118|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
16188064|NCT03345836|39165119|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
16294711|NCT02518919|39562931|FG002|Overall Study|Protocol Violation|2|||
16294712|NCT00852969|39562938|FG000|Overall Study|Adverse Event|0|||
16294713|NCT00852969|39562939|FG001|Overall Study|Adverse Event|1|||
16294714|NCT00852969|39562938|FG000|Overall Study|Lost to Follow-up|0|||
16294715|NCT00852969|39562939|FG001|Overall Study|Lost to Follow-up|1|||
16294716|NCT00780910|39562940|FG000|Overall Study|Adverse Event|2|||
16294717|NCT01154816|39562942|FG000|Overall Study|Withdrawal by Subject|1|||
16294718|NCT01154816|39562943|FG001|Overall Study|Withdrawal by Subject|0|||
16294719|NCT01154816|39562944|FG002|Overall Study|Withdrawal by Subject|0|||
16294720|NCT01154816|39562945|FG003|Overall Study|Withdrawal by Subject|1|||
16294721|NCT01154816|39562946|FG004|Overall Study|Withdrawal by Subject|0|||
16294722|NCT01154816|39562947|FG005|Overall Study|Withdrawal by Subject|0|||
16485028|NCT02289417|40252661|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
16485029|NCT02289417|40252662|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
16485030|NCT02289417|40252663|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
16485031|NCT02289417|40252664|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
16485032|NCT02289417|40252665|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
16188065|NCT03345836|39165120|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
16188066|NCT03345836|39165121|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
16294723|NCT01154816|39562948|FG006|Overall Study|Withdrawal by Subject|0|||
16294724|NCT01154816|39562949|FG007|Overall Study|Withdrawal by Subject|0|||
16294725|NCT01154816|39562950|FG008|Overall Study|Withdrawal by Subject|1|||
16294726|NCT01154816|39562951|FG009|Overall Study|Withdrawal by Subject|3|||
16294727|NCT01154816|39562952|FG010|Overall Study|Withdrawal by Subject|0|||
16294728|NCT01154816|39562953|FG011|Overall Study|Withdrawal by Subject|0|||
16485033|NCT02289417|40252666|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
16294729|NCT01154816|39562942|FG000|Overall Study|Progressive Disease|13|||
16294730|NCT01154816|39562943|FG001|Overall Study|Progressive Disease|8|||
16294731|NCT01154816|39562944|FG002|Overall Study|Progressive Disease|9|||
16294732|NCT01154816|39562945|FG003|Overall Study|Progressive Disease|9|||
16294733|NCT01154816|39562946|FG004|Overall Study|Progressive Disease|8|||
16294734|NCT01154816|39562947|FG005|Overall Study|Progressive Disease|8|||
16294735|NCT01154816|39562948|FG006|Overall Study|Progressive Disease|5|||
16294736|NCT01154816|39562949|FG007|Overall Study|Progressive Disease|6|||
16294737|NCT01154816|39562950|FG008|Overall Study|Progressive Disease|8|||
16294738|NCT01154816|39562951|FG009|Overall Study|Progressive Disease|6|||
16294739|NCT01154816|39562952|FG010|Overall Study|Progressive Disease|10|||
16294740|NCT01154816|39562953|FG011|Overall Study|Progressive Disease|3|||
16294741|NCT01154816|39562942|FG000|Overall Study|Physician Decision|1|||
16294742|NCT01154816|39562943|FG001|Overall Study|Physician Decision|0|||
16294743|NCT01154816|39562944|FG002|Overall Study|Physician Decision|1|||
16294744|NCT01154816|39562945|FG003|Overall Study|Physician Decision|0|||
16294745|NCT01154816|39562946|FG004|Overall Study|Physician Decision|2|||
16294746|NCT01154816|39562947|FG005|Overall Study|Physician Decision|0|||
16382531|NCT03958331|39884542|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
16382532|NCT03958331|39884543|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
16382533|NCT00806585|39884545|FG000|Overall Study|Study terminated by Sponsor|0|||
16382534|NCT00806585|39884546|FG001|Overall Study|Study terminated by Sponsor|0|||
16382535|NCT00806585|39884547|FG002|Overall Study|Study terminated by Sponsor|1|||
16382536|NCT00806585|39884548|FG003|Overall Study|Study terminated by Sponsor|2|||
16382537|NCT00806585|39884549|FG004|Overall Study|Study terminated by Sponsor|0|||
16382538|NCT00806585|39884545|FG000|Overall Study|Protocol Violation|3|||
16382539|NCT00806585|39884546|FG001|Overall Study|Protocol Violation|1|||
16382540|NCT00806585|39884547|FG002|Overall Study|Protocol Violation|2|||
16485034|NCT02289417|40252667|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
16485035|NCT02289417|40252668|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
16485036|NCT02289417|40252669|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
16485037|NCT02289417|40252661|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16485038|NCT02289417|40252662|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16485039|NCT02289417|40252663|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
16485040|NCT02289417|40252664|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16485041|NCT02289417|40252665|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16485042|NCT02289417|40252666|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16294747|NCT01154816|39562948|FG006|Overall Study|Physician Decision|0|||
16294748|NCT01154816|39562949|FG007|Overall Study|Physician Decision|0|||
16294749|NCT01154816|39562950|FG008|Overall Study|Physician Decision|0|||
16294750|NCT01154816|39562951|FG009|Overall Study|Physician Decision|1|||
16294751|NCT01154816|39562952|FG010|Overall Study|Physician Decision|1|||
16294752|NCT01154816|39562953|FG011|Overall Study|Physician Decision|1|||
16294753|NCT01154816|39562942|FG000|Overall Study|Adverse Event|5|||
16294754|NCT01154816|39562943|FG001|Overall Study|Adverse Event|2|||
16294755|NCT01154816|39562944|FG002|Overall Study|Adverse Event|0|||
16485043|NCT02289417|40252667|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16485044|NCT02289417|40252668|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16485045|NCT02289417|40252669|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
16485046|NCT02289417|40252661|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
16485047|NCT02289417|40252662|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
16485048|NCT02289417|40252663|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
16485049|NCT02289417|40252664|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
16485050|NCT02289417|40252665|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
16485051|NCT02289417|40252666|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
16485052|NCT02289417|40252667|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
16485053|NCT02289417|40252668|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
16485054|NCT02289417|40252669|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
16485055|NCT02289417|40252661|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16485056|NCT02289417|40252662|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16485057|NCT02289417|40252663|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
16294756|NCT01154816|39562945|FG003|Overall Study|Adverse Event|0|||
16294757|NCT01154816|39562946|FG004|Overall Study|Adverse Event|0|||
16294758|NCT01154816|39562947|FG005|Overall Study|Adverse Event|0|||
16294759|NCT01154816|39562948|FG006|Overall Study|Adverse Event|1|||
16294760|NCT01154816|39562949|FG007|Overall Study|Adverse Event|1|||
16294761|NCT01154816|39562950|FG008|Overall Study|Adverse Event|0|||
16382541|NCT00806585|39884548|FG003|Overall Study|Protocol Violation|0|||
16382542|NCT00806585|39884549|FG004|Overall Study|Protocol Violation|0|||
16382543|NCT00806585|39884545|FG000|Overall Study|Physician Decision|0|||
16485058|NCT02289417|40252664|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16485059|NCT02289417|40252665|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
16294762|NCT01154816|39562951|FG009|Overall Study|Adverse Event|0|||
16294763|NCT01154816|39562952|FG010|Overall Study|Adverse Event|0|||
16485060|NCT02289417|40252666|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
16485061|NCT02289417|40252667|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16485062|NCT02289417|40252668|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16485063|NCT02289417|40252669|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
16485064|NCT02289417|40252661|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16485065|NCT02289417|40252662|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16485066|NCT02289417|40252663|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16485067|NCT02289417|40252664|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16485068|NCT02289417|40252665|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16485069|NCT02289417|40252666|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16485070|NCT02289417|40252667|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
16485071|NCT02289417|40252668|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16294764|NCT01154816|39562953|FG011|Overall Study|Adverse Event|0|||
16294765|NCT03402750|39562954|FG000|Overall Study|Lost to Follow-up|2|||
16294766|NCT03402750|39562955|FG001|Overall Study|Lost to Follow-up|1|||
16294767|NCT00062010|39562957|FG000|Overall Study|Ineligible|3|||
16294768|NCT01957176|39562958|FG000|Overall Study|Adverse Event|2|||
16294769|NCT01957176|39562959|FG001|Overall Study|Adverse Event|0|||
16294770|NCT01957176|39562958|FG000|Overall Study|Physician Decision|2|||
16294771|NCT01957176|39562959|FG001|Overall Study|Physician Decision|1|||
16294772|NCT01957176|39562958|FG000|Overall Study|Withdrawal by Subject|1|||
16294773|NCT01957176|39562959|FG001|Overall Study|Withdrawal by Subject|0|||
16294774|NCT00918138|39562960|FG000|Overall Study|Subject withdrew consent|1|||
16294775|NCT00918138|39562961|FG001|Overall Study|Subject withdrew consent|1|||
16294776|NCT00918138|39562960|FG000|Overall Study|Death|1|||
16294777|NCT00918138|39562961|FG001|Overall Study|Death|0|||
16294778|NCT03251963|39562962|FG000|Overall Study|inappropriate Xa level timing|6|||
16294779|NCT03251963|39562963|FG001|Overall Study|inappropriate Xa level timing|3|||
16294780|NCT03251963|39562962|FG000|Overall Study|no peak Xa level drawn|2|||
16294781|NCT03251963|39562963|FG001|Overall Study|no peak Xa level drawn|0|||
16294782|NCT03251963|39562962|FG000|Overall Study|bled prior to Xa level|1|||
16294783|NCT03251963|39562963|FG001|Overall Study|bled prior to Xa level|2|||
16294784|NCT01732874|39562964|FG000|Overall Study|Withdrawal by Subject|5|||
16294785|NCT01732874|39562965|FG001|Overall Study|Withdrawal by Subject|1|||
16294786|NCT01732874|39562964|FG000|Overall Study|Death of Infant|3|||
16294787|NCT01732874|39562965|FG001|Overall Study|Death of Infant|2|||
16294788|NCT01685073|39562967|FG000|Overall Study|Lost to Follow-up|6|||
16294789|NCT01685073|39562968|FG001|Overall Study|Lost to Follow-up|8|||
16294790|NCT01685073|39562967|FG000|Overall Study|Withdrawal by Subject|24|||
16294791|NCT01685073|39562968|FG001|Overall Study|Withdrawal by Subject|24|||
16294792|NCT02288182|39562971|FG000|Overall Study|Adverse Event|0|||
16294793|NCT02288182|39562972|FG001|Overall Study|Adverse Event|1|||
16294794|NCT02288182|39562971|FG000|Overall Study|Lost to Follow-up|0|||
16294795|NCT02288182|39562972|FG001|Overall Study|Lost to Follow-up|1|||
16294796|NCT01517373|39562975|FG000|Run-in Period|Death|1|||
16294797|NCT01517373|39562976|FG001|Run-in Period|Death|0|||
16294798|NCT01517373|39562977|FG002|Run-in Period|Death|0|||
16294799|NCT01517373|39562978|FG003|Run-in Period|Death|0|||
16294800|NCT01517373|39562979|FG004|Run-in Period|Death|0|||
16294801|NCT01517373|39562980|FG005|Run-in Period|Death|0|||
16294802|NCT01517373|39562975|FG000|Run-in Period|Adverse Event|5|||
16294803|NCT01517373|39562976|FG001|Run-in Period|Adverse Event|0|||
16294804|NCT01517373|39562977|FG002|Run-in Period|Adverse Event|0|||
16294805|NCT01517373|39562978|FG003|Run-in Period|Adverse Event|0|||
16294806|NCT01517373|39562979|FG004|Run-in Period|Adverse Event|0|||
16294807|NCT01517373|39562980|FG005|Run-in Period|Adverse Event|0|||
16294808|NCT01517373|39562975|FG000|Run-in Period|Did not meet eligibility criteria|34|||
16294809|NCT01517373|39562976|FG001|Run-in Period|Did not meet eligibility criteria|0|||
16294810|NCT01517373|39562977|FG002|Run-in Period|Did not meet eligibility criteria|0|||
16485072|NCT02289417|40252669|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
16294811|NCT01517373|39562978|FG003|Run-in Period|Did not meet eligibility criteria|0|||
16294812|NCT01517373|39562979|FG004|Run-in Period|Did not meet eligibility criteria|0|||
16294813|NCT01517373|39562980|FG005|Run-in Period|Did not meet eligibility criteria|0|||
16294814|NCT01517373|39562975|FG000|Run-in Period|Lost to Follow-up|1|||
16294815|NCT01517373|39562976|FG001|Run-in Period|Lost to Follow-up|0|||
16294816|NCT01517373|39562977|FG002|Run-in Period|Lost to Follow-up|0|||
16294817|NCT01517373|39562978|FG003|Run-in Period|Lost to Follow-up|0|||
16294818|NCT01517373|39562979|FG004|Run-in Period|Lost to Follow-up|0|||
16294819|NCT01517373|39562980|FG005|Run-in Period|Lost to Follow-up|0|||
16294820|NCT01517373|39562975|FG000|Run-in Period|Withdrawal by Subject|12|||
16294821|NCT01517373|39562976|FG001|Run-in Period|Withdrawal by Subject|0|||
16294822|NCT01517373|39562977|FG002|Run-in Period|Withdrawal by Subject|0|||
16294823|NCT01517373|39562978|FG003|Run-in Period|Withdrawal by Subject|0|||
16294824|NCT01517373|39562979|FG004|Run-in Period|Withdrawal by Subject|0|||
16294825|NCT01517373|39562980|FG005|Run-in Period|Withdrawal by Subject|0|||
16294826|NCT01517373|39562975|FG000|Run-in Period|Sponsor Decision|3|||
16294827|NCT01517373|39562976|FG001|Run-in Period|Sponsor Decision|0|||
16294828|NCT01517373|39562977|FG002|Run-in Period|Sponsor Decision|0|||
16294829|NCT01517373|39562978|FG003|Run-in Period|Sponsor Decision|0|||
16294830|NCT01517373|39562979|FG004|Run-in Period|Sponsor Decision|0|||
16294831|NCT01517373|39562980|FG005|Run-in Period|Sponsor Decision|0|||
16294832|NCT01517373|39562975|FG000|Run-in Period|Other|1|||
16294833|NCT01517373|39562976|FG001|Run-in Period|Other|0|||
16294834|NCT01517373|39562977|FG002|Run-in Period|Other|0|||
16294835|NCT01517373|39562978|FG003|Run-in Period|Other|0|||
16294836|NCT01517373|39562979|FG004|Run-in Period|Other|0|||
16294837|NCT01517373|39562980|FG005|Run-in Period|Other|0|||
16294838|NCT01517373|39562975|FG000|Treatment Period|Adverse Event|0|||
16294839|NCT01517373|39562976|FG001|Treatment Period|Adverse Event|0|||
16294840|NCT01517373|39562977|FG002|Treatment Period|Adverse Event|0|||
16294841|NCT01517373|39562978|FG003|Treatment Period|Adverse Event|0|||
16294842|NCT01517373|39562979|FG004|Treatment Period|Adverse Event|0|||
16294843|NCT01517373|39562980|FG005|Treatment Period|Adverse Event|2|||
16294844|NCT01517373|39562975|FG000|Treatment Period|Lost to Follow-up|0|||
16294845|NCT01517373|39562976|FG001|Treatment Period|Lost to Follow-up|0|||
16294846|NCT01517373|39562977|FG002|Treatment Period|Lost to Follow-up|1|||
16294847|NCT01517373|39562978|FG003|Treatment Period|Lost to Follow-up|1|||
16294848|NCT01517373|39562979|FG004|Treatment Period|Lost to Follow-up|0|||
16294849|NCT01517373|39562980|FG005|Treatment Period|Lost to Follow-up|0|||
16294850|NCT01517373|39562975|FG000|Treatment Period|Withdrawal by Subject|0|||
16294851|NCT01517373|39562976|FG001|Treatment Period|Withdrawal by Subject|3|||
16294852|NCT01517373|39562977|FG002|Treatment Period|Withdrawal by Subject|2|||
16294853|NCT01517373|39562978|FG003|Treatment Period|Withdrawal by Subject|2|||
16294854|NCT01517373|39562979|FG004|Treatment Period|Withdrawal by Subject|2|||
16294855|NCT01517373|39562980|FG005|Treatment Period|Withdrawal by Subject|3|||
16294856|NCT01517373|39562975|FG000|Treatment Period|Other|0|||
16294857|NCT01517373|39562976|FG001|Treatment Period|Other|0|||
16294858|NCT01517373|39562977|FG002|Treatment Period|Other|0|||
16294859|NCT01517373|39562978|FG003|Treatment Period|Other|0|||
16294860|NCT01517373|39562979|FG004|Treatment Period|Other|1|||
16294861|NCT01517373|39562980|FG005|Treatment Period|Other|0|||
16294862|NCT01517373|39562975|FG000|Treatment Period|Protocol Violation|0|||
16294863|NCT01517373|39562976|FG001|Treatment Period|Protocol Violation|0|||
16294864|NCT01517373|39562977|FG002|Treatment Period|Protocol Violation|0|||
16294865|NCT01517373|39562978|FG003|Treatment Period|Protocol Violation|0|||
16294866|NCT01517373|39562979|FG004|Treatment Period|Protocol Violation|1|||
16294867|NCT01517373|39562980|FG005|Treatment Period|Protocol Violation|0|||
16294868|NCT01517373|39562975|FG000|Treatment Period|Lack of Efficacy|0|||
16294869|NCT01517373|39562976|FG001|Treatment Period|Lack of Efficacy|1|||
16294870|NCT01517373|39562977|FG002|Treatment Period|Lack of Efficacy|1|||
16294871|NCT01517373|39562978|FG003|Treatment Period|Lack of Efficacy|3|||
16294872|NCT01517373|39562979|FG004|Treatment Period|Lack of Efficacy|2|||
16294873|NCT01517373|39562980|FG005|Treatment Period|Lack of Efficacy|0|||
16294874|NCT01517373|39562975|FG000|Treatment Period|Medication error without AEs|0|||
16294875|NCT01517373|39562976|FG001|Treatment Period|Medication error without AEs|0|||
16294876|NCT01517373|39562977|FG002|Treatment Period|Medication error without AEs|2|||
16294877|NCT01517373|39562978|FG003|Treatment Period|Medication error without AEs|1|||
16294878|NCT01517373|39562979|FG004|Treatment Period|Medication error without AEs|0|||
16294879|NCT01517373|39562980|FG005|Treatment Period|Medication error without AEs|2|||
16294880|NCT03489109|39562981|FG000|Overall Study|Lost to Follow-up|1|||
16294881|NCT03489109|39562982|FG001|Overall Study|Lost to Follow-up|2|||
16294882|NCT01584843|39562983|FG000|First Treatment Period|Adverse Event|0|||
16294883|NCT01584843|39562984|FG001|First Treatment Period|Adverse Event|0|||
16294884|NCT01584843|39562985|FG002|First Treatment Period|Adverse Event|1|||
16081857|NCT03580369|38792731|FG001|Overall Study|Technical problems|0|||
16294885|NCT01584843|39562986|FG003|First Treatment Period|Adverse Event|0|||
16294886|NCT01584843|39562987|FG004|First Treatment Period|Adverse Event|0|||
16294887|NCT01584843|39562988|FG005|First Treatment Period|Adverse Event|0|||
16294888|NCT01584843|39562983|FG000|First Treatment Period|Protocol Violation|0|||
16294889|NCT01584843|39562984|FG001|First Treatment Period|Protocol Violation|0|||
16294890|NCT01584843|39562985|FG002|First Treatment Period|Protocol Violation|0|||
16294891|NCT01584843|39562986|FG003|First Treatment Period|Protocol Violation|0|||
16294892|NCT01584843|39562987|FG004|First Treatment Period|Protocol Violation|0|||
16294893|NCT01584843|39562988|FG005|First Treatment Period|Protocol Violation|1|||
16294894|NCT01584843|39562983|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
16294895|NCT01584843|39562984|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
16294896|NCT01584843|39562985|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
16294897|NCT01584843|39562986|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
16294898|NCT01584843|39562987|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
16485073|NCT02289417|40252661|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16485074|NCT02289417|40252662|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16485075|NCT02289417|40252663|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16485076|NCT02289417|40252664|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
16294899|NCT01584843|39562988|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
16294900|NCT01584843|39562983|FG000|Second Treatment Period|Withdrawal by Subject|0|||
16294901|NCT01584843|39562984|FG001|Second Treatment Period|Withdrawal by Subject|0|||
16294902|NCT01584843|39562985|FG002|Second Treatment Period|Withdrawal by Subject|0|||
16485077|NCT02289417|40252665|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16485078|NCT02289417|40252666|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16485079|NCT02289417|40252667|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
16485080|NCT02289417|40252668|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16485081|NCT02289417|40252669|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
16485082|NCT02289417|40252661|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
16485083|NCT02289417|40252662|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
16485084|NCT02289417|40252663|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
16485085|NCT02289417|40252664|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
16485086|NCT02289417|40252665|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
16485087|NCT02289417|40252666|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
16485088|NCT02289417|40252667|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
16485089|NCT02289417|40252668|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
16485090|NCT02289417|40252669|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
16485091|NCT02289417|40252661|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16485092|NCT02289417|40252662|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16485093|NCT02289417|40252663|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16485094|NCT02289417|40252664|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16485095|NCT02289417|40252665|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16485096|NCT02289417|40252666|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16485097|NCT02289417|40252667|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
16485098|NCT02289417|40252668|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
16485099|NCT02289417|40252669|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
16485100|NCT02289417|40252661|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16485101|NCT02289417|40252662|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16485102|NCT02289417|40252663|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16485103|NCT02289417|40252664|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16485104|NCT02289417|40252665|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16485105|NCT02289417|40252666|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16485106|NCT02289417|40252667|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
16485107|NCT02289417|40252668|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
16294903|NCT01584843|39562986|FG003|Second Treatment Period|Withdrawal by Subject|0|||
16294904|NCT01584843|39562987|FG004|Second Treatment Period|Withdrawal by Subject|0|||
16294905|NCT01584843|39562988|FG005|Second Treatment Period|Withdrawal by Subject|1|||
16294906|NCT04771403|39562991|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
16294907|NCT04771403|39562992|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
16294908|NCT04771403|39562991|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
16294909|NCT04771403|39562992|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
16294910|NCT04771403|39562991|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
16294911|NCT04771403|39562992|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
16294912|NCT04771403|39562991|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
16294913|NCT04771403|39562992|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
16294914|NCT04771403|39562991|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
16294915|NCT04771403|39562992|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
16294916|NCT04771403|39562991|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
16294917|NCT04771403|39562992|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
16294918|NCT04771403|39562991|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
16485108|NCT02289417|40252669|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
16485109|NCT02289417|40252661|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
16485110|NCT02289417|40252662|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
16485111|NCT02289417|40252663|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
16485112|NCT02289417|40252664|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
16485113|NCT02289417|40252665|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
16485114|NCT02289417|40252666|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
16485115|NCT02289417|40252667|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
16485116|NCT02289417|40252668|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
16485117|NCT02289417|40252669|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
16485118|NCT00228384|40252672|FG000|Overall Study|Death|9|||
16485119|NCT00228384|40252673|FG001|Overall Study|Death|3|||
16485120|NCT00228384|40252672|FG000|Overall Study|Lost to Follow-up|6|||
16485121|NCT00228384|40252673|FG001|Overall Study|Lost to Follow-up|10|||
16294919|NCT04771403|39562992|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
16294920|NCT04771403|39562991|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
16294921|NCT04771403|39562992|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
16294922|NCT00384176|39562993|FG000|Overall Study|Death|239|||
16294923|NCT00384176|39562994|FG001|Overall Study|Death|247|||
16294924|NCT00384176|39562995|FG002|Overall Study|Death|105|||
16294925|NCT00384176|39562993|FG000|Overall Study|Withdrawal by Subject|52|||
16294926|NCT00384176|39562994|FG001|Overall Study|Withdrawal by Subject|48|||
16294927|NCT00384176|39562995|FG002|Overall Study|Withdrawal by Subject|22|||
16294928|NCT00384176|39562993|FG000|Overall Study|Lost to Follow-up|16|||
16294929|NCT00384176|39562994|FG001|Overall Study|Lost to Follow-up|18|||
16294930|NCT00384176|39562995|FG002|Overall Study|Lost to Follow-up|4|||
16485122|NCT00228384|40252672|FG000|Overall Study|Surgical Intervention (bypass)|5|||
16485123|NCT00228384|40252673|FG001|Overall Study|Surgical Intervention (bypass)|5|||
16294931|NCT00384176|39562993|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
16294932|NCT00384176|39562994|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
16485124|NCT00228384|40252672|FG000|Overall Study|Withdrawal by Subject|9|||
16485125|NCT00228384|40252673|FG001|Overall Study|Withdrawal by Subject|10|||
16485126|NCT00228384|40252672|FG000|Overall Study|Physician Decision|0|||
16485127|NCT00228384|40252673|FG001|Overall Study|Physician Decision|1|||
16485128|NCT03725852|40252676|FG000|Overall Study|Death|1|||
16485129|NCT03725852|40252677|FG001|Overall Study|Death|0|||
16485130|NCT03725852|40252676|FG000|Overall Study|Withdrawal by Subject|1|||
16485131|NCT03725852|40252677|FG001|Overall Study|Withdrawal by Subject|0|||
16485132|NCT03725852|40252676|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
16485133|NCT03725852|40252677|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
16485134|NCT05048784|40252684|FG000|Period 1|Adverse Event|3|||
16485135|NCT05048784|40252685|FG001|Period 1|Adverse Event|1|||
16485136|NCT05048784|40252686|FG002|Period 1|Adverse Event|0|||
16485137|NCT05048784|40252687|FG003|Period 1|Adverse Event|0|||
16485138|NCT05048784|40252684|FG000|Period 2|Lost to Follow-up|0|||
16485139|NCT05048784|40252685|FG001|Period 2|Lost to Follow-up|1|||
16485140|NCT05048784|40252686|FG002|Period 2|Lost to Follow-up|0|||
16485141|NCT05048784|40252687|FG003|Period 2|Lost to Follow-up|0|||
16485142|NCT02400333|40252688|FG000|Overall Study|Withdrawal by Subject|0|||
16485143|NCT02400333|40252689|FG001|Overall Study|Withdrawal by Subject|1|||
16485144|NCT02400333|40252690|FG002|Overall Study|Withdrawal by Subject|0|||
16485145|NCT02400333|40252691|FG003|Overall Study|Withdrawal by Subject|1|||
16485146|NCT02400333|40252688|FG000|Overall Study|Protocol Violation|1|||
16485147|NCT02400333|40252689|FG001|Overall Study|Protocol Violation|0|||
16485148|NCT02400333|40252690|FG002|Overall Study|Protocol Violation|2|||
16485149|NCT02400333|40252691|FG003|Overall Study|Protocol Violation|1|||
16485150|NCT03128411|40252692|FG000|Treatment Phase|Adverse Event|21|||
16485151|NCT03128411|40252692|FG000|Treatment Phase|Physician Decision|1|||
16485152|NCT03128411|40252692|FG000|Treatment Phase|Other|2|||
16485153|NCT03128411|40252692|FG000|Long Term Follow-up Phase|Death|2|||
16485154|NCT02100514|40252694|FG000|Treatment Period|Adverse Event|0|||
16485155|NCT02100514|40252695|FG001|Treatment Period|Adverse Event|5|||
16485156|NCT02100514|40252696|FG002|Treatment Period|Adverse Event|0|||
16485157|NCT02100514|40252697|FG003|Treatment Period|Adverse Event|0|||
16485158|NCT02100514|40252698|FG004|Treatment Period|Adverse Event|0|||
16485159|NCT02100514|40252694|FG000|Treatment Period|Death|2|||
16485160|NCT02100514|40252695|FG001|Treatment Period|Death|2|||
16294933|NCT00384176|39562995|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
16485161|NCT02100514|40252696|FG002|Treatment Period|Death|0|||
16485162|NCT02100514|40252697|FG003|Treatment Period|Death|0|||
16485163|NCT02100514|40252698|FG004|Treatment Period|Death|0|||
16485164|NCT02100514|40252694|FG000|Treatment Period|Lost to Follow-up|5|||
16485165|NCT02100514|40252695|FG001|Treatment Period|Lost to Follow-up|17|||
16485166|NCT02100514|40252696|FG002|Treatment Period|Lost to Follow-up|0|||
16485167|NCT02100514|40252697|FG003|Treatment Period|Lost to Follow-up|0|||
16485168|NCT02100514|40252698|FG004|Treatment Period|Lost to Follow-up|0|||
16485169|NCT02100514|40252694|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
16485170|NCT02100514|40252695|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
16485171|NCT02100514|40252696|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
16485172|NCT02100514|40252697|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
16485173|NCT02100514|40252698|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
16485174|NCT02100514|40252694|FG000|Treatment Period|Protocol Violation|1|||
16485175|NCT02100514|40252695|FG001|Treatment Period|Protocol Violation|1|||
16485176|NCT02100514|40252696|FG002|Treatment Period|Protocol Violation|0|||
16485177|NCT02100514|40252697|FG003|Treatment Period|Protocol Violation|0|||
16485178|NCT02100514|40252698|FG004|Treatment Period|Protocol Violation|0|||
16485179|NCT02100514|40252694|FG000|Treatment Period|Withdrawal by Subject|12|||
16485180|NCT02100514|40252695|FG001|Treatment Period|Withdrawal by Subject|37|||
16485181|NCT02100514|40252696|FG002|Treatment Period|Withdrawal by Subject|0|||
16485182|NCT02100514|40252697|FG003|Treatment Period|Withdrawal by Subject|0|||
16485183|NCT02100514|40252698|FG004|Treatment Period|Withdrawal by Subject|0|||
16485184|NCT02100514|40252694|FG000|Treatment Period|Other|9|||
16485185|NCT02100514|40252695|FG001|Treatment Period|Other|11|||
16485186|NCT02100514|40252696|FG002|Treatment Period|Other|0|||
16485187|NCT02100514|40252697|FG003|Treatment Period|Other|0|||
16485188|NCT02100514|40252698|FG004|Treatment Period|Other|0|||
16485189|NCT02100514|40252694|FG000|Extension Period|Withdrew consent|0|||
16485190|NCT02100514|40252695|FG001|Extension Period|Withdrew consent|0|||
16485191|NCT02100514|40252696|FG002|Extension Period|Withdrew consent|2|||
16485192|NCT02100514|40252697|FG003|Extension Period|Withdrew consent|0|||
16485193|NCT02100514|40252698|FG004|Extension Period|Withdrew consent|0|||
16485194|NCT00259649|40252699|FG000|Overall Study|Lost to Follow-up|7|||
16485195|NCT00259649|40252699|FG000|Overall Study|irregular menses|3|||
16485196|NCT04545060|40252705|FG000|Overall Study|Adverse Event|0|||
16485197|NCT04545060|40252706|FG001|Overall Study|Adverse Event|1|||
16485198|NCT04545060|40252705|FG000|Overall Study|Death|0|||
16485199|NCT04545060|40252706|FG001|Overall Study|Death|5|||
16485200|NCT04545060|40252705|FG000|Overall Study|Lost to Follow-up|10|||
16485201|NCT04545060|40252706|FG001|Overall Study|Lost to Follow-up|13|||
16485202|NCT04545060|40252705|FG000|Overall Study|Physician Decision|3|||
16485203|NCT04545060|40252706|FG001|Overall Study|Physician Decision|0|||
16485204|NCT04545060|40252705|FG000|Overall Study|Withdrawal by Subject|17|||
16485205|NCT04545060|40252706|FG001|Overall Study|Withdrawal by Subject|22|||
16485206|NCT00205881|40252711|FG000|Overall Study|Withdrawal by Subject|16|||
16485207|NCT00560105|40252712|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
16485208|NCT00560105|40252713|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
16485209|NCT00242216|40252717|FG000|Overall Study|Lost to Follow-up|12|||
16485210|NCT00242216|40252718|FG001|Overall Study|Lost to Follow-up|17|||
16485211|NCT00242216|40252717|FG000|Overall Study|Death|4|||
16485212|NCT00242216|40252718|FG001|Overall Study|Death|2|||
16485213|NCT00242216|40252717|FG000|Overall Study|Lack of Efficacy|1|||
16485214|NCT00242216|40252718|FG001|Overall Study|Lack of Efficacy|2|||
16485215|NCT00242216|40252717|FG000|Overall Study|no medicaiton dispensed|1|||
16485216|NCT00242216|40252718|FG001|Overall Study|no medicaiton dispensed|1|||
16485217|NCT01189604|40252719|FG000|Overall Study|Impossible to visit|0|||
16485218|NCT01189604|40252720|FG001|Overall Study|Impossible to visit|0|||
16485219|NCT01189604|40252721|FG002|Overall Study|Impossible to visit|0|||
16485220|NCT01189604|40252722|FG003|Overall Study|Impossible to visit|0|||
16485221|NCT01189604|40252723|FG004|Overall Study|Impossible to visit|0|||
16485222|NCT01189604|40252724|FG005|Overall Study|Impossible to visit|1|||
16485223|NCT01189604|40252725|FG006|Overall Study|Impossible to visit|0|||
16485224|NCT01189604|40252719|FG000|Overall Study|Adverse Event|0|||
16485225|NCT01189604|40252720|FG001|Overall Study|Adverse Event|1|||
16485226|NCT01189604|40252721|FG002|Overall Study|Adverse Event|0|||
16485227|NCT01189604|40252722|FG003|Overall Study|Adverse Event|0|||
16485228|NCT01189604|40252723|FG004|Overall Study|Adverse Event|2|||
16485229|NCT01189604|40252724|FG005|Overall Study|Adverse Event|0|||
16485230|NCT01189604|40252725|FG006|Overall Study|Adverse Event|1|||
16485231|NCT01189604|40252719|FG000|Overall Study|Withdrawal by Subject|1|||
16485232|NCT01189604|40252720|FG001|Overall Study|Withdrawal by Subject|0|||
16485233|NCT01189604|40252721|FG002|Overall Study|Withdrawal by Subject|0|||
16485234|NCT01189604|40252722|FG003|Overall Study|Withdrawal by Subject|0|||
16188067|NCT03345836|39165122|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
16485235|NCT01189604|40252723|FG004|Overall Study|Withdrawal by Subject|0|||
16485236|NCT01189604|40252724|FG005|Overall Study|Withdrawal by Subject|0|||
16485237|NCT01189604|40252725|FG006|Overall Study|Withdrawal by Subject|0|||
16485238|NCT01546883|40252731|FG000|Overall Study|Withdrawal by Subject|3|||
16485239|NCT01546883|40252731|FG000|Overall Study|Adverse Event|4|||
16485240|NCT01546883|40252731|FG000|Overall Study|Lost to Follow-up|2|||
16485241|NCT01546883|40252731|FG000|Overall Study|early closure of study|2|||
16485242|NCT01546883|40252731|FG000|Overall Study|other unrelated illness|1|||
16485243|NCT01552694|40252732|FG000|Overall Study|Lost to Follow-up|0|||
16485244|NCT01552694|40252733|FG001|Overall Study|Lost to Follow-up|1|||
16485245|NCT01552694|40252732|FG000|Overall Study|Protocol Violation|0|||
16081858|NCT03580369|38792732|FG002|Overall Study|Technical problems|0|||
16294934|NCT00384176|39562993|FG000|Overall Study|Longer QTC as Visit 1|1|||
16294935|NCT00384176|39562994|FG001|Overall Study|Longer QTC as Visit 1|0|||
16294936|NCT00384176|39562995|FG002|Overall Study|Longer QTC as Visit 1|0|||
16294937|NCT00384176|39562993|FG000|Overall Study|Toxicity of treatment|1|||
16294938|NCT00384176|39562994|FG001|Overall Study|Toxicity of treatment|0|||
16294939|NCT00384176|39562995|FG002|Overall Study|Toxicity of treatment|0|||
16294940|NCT00384176|39562993|FG000|Overall Study|Did not receive study treatment|0|||
16294941|NCT00384176|39562994|FG001|Overall Study|Did not receive study treatment|1|||
16294942|NCT00384176|39562995|FG002|Overall Study|Did not receive study treatment|1|||
16294943|NCT00384176|39562993|FG000|Overall Study|Physician Decision|0|||
16294944|NCT00384176|39562994|FG001|Overall Study|Physician Decision|2|||
16294945|NCT00384176|39562995|FG002|Overall Study|Physician Decision|0|||
16294946|NCT00384176|39562993|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
16294947|NCT00384176|39562994|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
16294948|NCT00384176|39562995|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
16294949|NCT01797835|39562996|FG000|Overall Study|Lost to Follow-up|31|||
16294950|NCT01797835|39562997|FG001|Overall Study|Lost to Follow-up|27|||
16294951|NCT01214915|39563000|FG000|Overall Study|Adverse Event|8|||
16294952|NCT01214915|39563000|FG000|Overall Study|Lack of Efficacy|3|||
16294953|NCT01593696|39563004|FG000|Dose Escalation|Progressive Disease|2|||
16294954|NCT01593696|39563005|FG001|Dose Escalation|Progressive Disease|0|||
16294955|NCT01593696|39563006|FG002|Dose Escalation|Progressive Disease|0|||
16294956|NCT01593696|39563007|FG003|Dose Escalation|Progressive Disease|0|||
16294957|NCT01593696|39563004|FG000|Dose Expansion|Fungal infection|0|||
16294958|NCT01593696|39563005|FG001|Dose Expansion|Fungal infection|0|||
16294959|NCT01593696|39563006|FG002|Dose Expansion|Fungal infection|1|||
16294960|NCT01593696|39563007|FG003|Dose Expansion|Fungal infection|0|||
16294961|NCT01470612|39563008|FG000|Overall Study|Adverse Event|20|||
16294962|NCT01470612|39563009|FG001|Overall Study|Adverse Event|80|||
16294963|NCT01470612|39563008|FG000|Overall Study|Death|0|||
16294964|NCT01470612|39563009|FG001|Overall Study|Death|1|||
16294965|NCT01470612|39563008|FG000|Overall Study|Lack of Efficacy|20|||
16294966|NCT01470612|39563009|FG001|Overall Study|Lack of Efficacy|326|||
16294967|NCT01470612|39563008|FG000|Overall Study|Lost to Follow-up|2|||
16294968|NCT01470612|39563009|FG001|Overall Study|Lost to Follow-up|5|||
16294969|NCT01470612|39563008|FG000|Overall Study|Did not meet entrance criteria|0|||
16294970|NCT01470612|39563009|FG001|Overall Study|Did not meet entrance criteria|1|||
16294971|NCT01470612|39563008|FG000|Overall Study|Pregnancy|2|||
16294972|NCT01470612|39563009|FG001|Overall Study|Pregnancy|10|||
16294973|NCT01470612|39563008|FG000|Overall Study|Protocol Violation|2|||
16294974|NCT01470612|39563009|FG001|Overall Study|Protocol Violation|7|||
16294975|NCT01470612|39563008|FG000|Overall Study|Withdrawal by Subject|24|||
16294976|NCT01470612|39563009|FG001|Overall Study|Withdrawal by Subject|79|||
16294977|NCT01470612|39563008|FG000|Overall Study|Other|14|||
16294978|NCT01470612|39563009|FG001|Overall Study|Other|156|||
16294979|NCT00123955|39563012|FG000|Overall Study|Adverse Event|1|||
16294980|NCT00123955|39563013|FG001|Overall Study|Adverse Event|0|||
16294981|NCT00123955|39563012|FG000|Overall Study|Withdrawal by Subject|4|||
16294982|NCT00123955|39563013|FG001|Overall Study|Withdrawal by Subject|3|||
16294983|NCT00123955|39563012|FG000|Overall Study|Death|0|||
16294984|NCT00123955|39563013|FG001|Overall Study|Death|1|||
16294985|NCT02906930|39563015|FG000|Overall Study|Withdrawal by Subject|0|||
16294986|NCT02906930|39563016|FG001|Overall Study|Withdrawal by Subject|5|||
16294987|NCT02906930|39563017|FG002|Overall Study|Withdrawal by Subject|5|||
16294988|NCT02906930|39563018|FG003|Overall Study|Withdrawal by Subject|4|||
16294989|NCT02906930|39563015|FG000|Overall Study|Lost to Follow-up|5|||
16294990|NCT02906930|39563016|FG001|Overall Study|Lost to Follow-up|7|||
16294991|NCT02906930|39563017|FG002|Overall Study|Lost to Follow-up|5|||
16294992|NCT02906930|39563018|FG003|Overall Study|Lost to Follow-up|2|||
16294993|NCT02906930|39563015|FG000|Overall Study|Death|0|||
16294994|NCT02906930|39563016|FG001|Overall Study|Death|0|||
16294995|NCT02906930|39563017|FG002|Overall Study|Death|1|||
16294996|NCT02906930|39563018|FG003|Overall Study|Death|0|||
16294997|NCT02906930|39563015|FG000|Overall Study|Other|1|||
16294998|NCT02906930|39563016|FG001|Overall Study|Other|2|||
16294999|NCT02906930|39563017|FG002|Overall Study|Other|1|||
16295000|NCT02906930|39563018|FG003|Overall Study|Other|2|||
16295001|NCT00712985|39563019|FG000|Overall Study|1 withdrew prior to start of drug|1|||
16295002|NCT00712985|39563019|FG000|Overall Study|1 patient moved out of state|1|||
16295003|NCT00712985|39563019|FG000|Overall Study|Lack of Efficacy|3|||
16295004|NCT00714493|39563020|FG000|Overall Study|Adverse Event|11|||
16295005|NCT00714493|39563020|FG000|Overall Study|Death|3|||
16295006|NCT00714493|39563020|FG000|Overall Study|Lack of Efficacy|10|||
16295007|NCT00714493|39563020|FG000|Overall Study|Lost to Follow-up|3|||
16295008|NCT00714493|39563020|FG000|Overall Study|Protocol Violation|12|||
16295009|NCT00714493|39563020|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
16295010|NCT00714493|39563020|FG000|Overall Study|OTHER|2|||
16295011|NCT04268316|39563025|FG000|Overall Study|Withdrawal by Subject|2|||
16485246|NCT01552694|40252733|FG001|Overall Study|Protocol Violation|1|||
16485247|NCT00256750|40252736|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
16485248|NCT00256750|40252737|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
16485249|NCT00256750|40252738|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
16485250|NCT00256750|40252736|FG000|Transplanted Pre-Treatment|Other|2|||
16485251|NCT00256750|40252737|FG001|Transplanted Pre-Treatment|Other|0|||
16485252|NCT00256750|40252738|FG002|Transplanted Pre-Treatment|Other|0|||
16485253|NCT00256750|40252736|FG000|Transplanted Pre-Treatment|Death|1|||
16485254|NCT00256750|40252737|FG001|Transplanted Pre-Treatment|Death|0|||
16485255|NCT00256750|40252738|FG002|Transplanted Pre-Treatment|Death|0|||
16485256|NCT00256750|40252736|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
16485257|NCT00256750|40252737|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
16081859|NCT03580369|38792733|FG003|Overall Study|Technical problems|0|||
16081860|NCT03580369|38792734|FG004|Overall Study|Technical problems|1|||
16081861|NCT03580369|38792735|FG005|Overall Study|Technical problems|0|||
16081862|NCT03580369|38792736|FG006|Overall Study|Technical problems|2|||
16081863|NCT03580369|38792737|FG007|Overall Study|Technical problems|0|||
16081864|NCT03580369|38792730|FG000|Overall Study|Pregnancy|2|||
16081865|NCT03580369|38792731|FG001|Overall Study|Pregnancy|0|||
16081866|NCT03580369|38792732|FG002|Overall Study|Pregnancy|3|||
16081867|NCT03580369|38792733|FG003|Overall Study|Pregnancy|0|||
16081868|NCT03580369|38792734|FG004|Overall Study|Pregnancy|2|||
16081869|NCT03580369|38792735|FG005|Overall Study|Pregnancy|0|||
16081870|NCT03580369|38792736|FG006|Overall Study|Pregnancy|0|||
16081871|NCT03580369|38792737|FG007|Overall Study|Pregnancy|0|||
16081872|NCT03580369|38792730|FG000|Overall Study|Lost to Follow-up|2|||
16081873|NCT03580369|38792731|FG001|Overall Study|Lost to Follow-up|0|||
16081874|NCT03580369|38792732|FG002|Overall Study|Lost to Follow-up|2|||
16081875|NCT03580369|38792733|FG003|Overall Study|Lost to Follow-up|0|||
16081876|NCT03580369|38792734|FG004|Overall Study|Lost to Follow-up|3|||
16081877|NCT03580369|38792735|FG005|Overall Study|Lost to Follow-up|0|||
16081878|NCT03580369|38792736|FG006|Overall Study|Lost to Follow-up|1|||
16081879|NCT03580369|38792737|FG007|Overall Study|Lost to Follow-up|0|||
16081880|NCT03580369|38792730|FG000|Overall Study|Physician Decision|4|||
16081881|NCT03580369|38792731|FG001|Overall Study|Physician Decision|0|||
16081882|NCT03580369|38792732|FG002|Overall Study|Physician Decision|4|||
16081883|NCT03580369|38792733|FG003|Overall Study|Physician Decision|1|||
16081884|NCT03580369|38792734|FG004|Overall Study|Physician Decision|1|||
16081885|NCT03580369|38792735|FG005|Overall Study|Physician Decision|0|||
16081886|NCT03580369|38792736|FG006|Overall Study|Physician Decision|0|||
16081887|NCT03580369|38792737|FG007|Overall Study|Physician Decision|0|||
16081888|NCT03580369|38792730|FG000|Overall Study|Lack of Efficacy|3|||
16081889|NCT03580369|38792731|FG001|Overall Study|Lack of Efficacy|0|||
16081890|NCT03580369|38792732|FG002|Overall Study|Lack of Efficacy|7|||
16081891|NCT03580369|38792733|FG003|Overall Study|Lack of Efficacy|0|||
16081892|NCT03580369|38792734|FG004|Overall Study|Lack of Efficacy|2|||
16081893|NCT03580369|38792735|FG005|Overall Study|Lack of Efficacy|0|||
16081894|NCT03580369|38792736|FG006|Overall Study|Lack of Efficacy|3|||
16081895|NCT03580369|38792737|FG007|Overall Study|Lack of Efficacy|0|||
16081896|NCT03580369|38792730|FG000|Overall Study|Protocol Violation|6|||
16081897|NCT03580369|38792731|FG001|Overall Study|Protocol Violation|0|||
16081898|NCT03580369|38792732|FG002|Overall Study|Protocol Violation|6|||
16081899|NCT03580369|38792733|FG003|Overall Study|Protocol Violation|1|||
16081900|NCT03580369|38792734|FG004|Overall Study|Protocol Violation|8|||
16081901|NCT03580369|38792735|FG005|Overall Study|Protocol Violation|2|||
16081902|NCT03580369|38792736|FG006|Overall Study|Protocol Violation|1|||
16081903|NCT03580369|38792737|FG007|Overall Study|Protocol Violation|0|||
16081904|NCT03580369|38792730|FG000|Overall Study|Adverse Event|7|||
16081905|NCT03580369|38792731|FG001|Overall Study|Adverse Event|0|||
16081906|NCT03580369|38792732|FG002|Overall Study|Adverse Event|14|||
16081907|NCT03580369|38792733|FG003|Overall Study|Adverse Event|1|||
16295012|NCT04268316|39563026|FG001|Overall Study|Withdrawal by Subject|1|||
16485258|NCT00256750|40252738|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
16081908|NCT03580369|38792734|FG004|Overall Study|Adverse Event|6|||
16081909|NCT03580369|38792735|FG005|Overall Study|Adverse Event|0|||
16081910|NCT03580369|38792736|FG006|Overall Study|Adverse Event|1|||
16081911|NCT03580369|38792737|FG007|Overall Study|Adverse Event|0|||
16081912|NCT03580369|38792730|FG000|Overall Study|Withdrawal by Subject|19|||
16081913|NCT03580369|38792731|FG001|Overall Study|Withdrawal by Subject|0|||
16081914|NCT03580369|38792732|FG002|Overall Study|Withdrawal by Subject|17|||
16081915|NCT03580369|38792733|FG003|Overall Study|Withdrawal by Subject|0|||
16081916|NCT03580369|38792734|FG004|Overall Study|Withdrawal by Subject|16|||
16081917|NCT03580369|38792735|FG005|Overall Study|Withdrawal by Subject|1|||
16081918|NCT03580369|38792736|FG006|Overall Study|Withdrawal by Subject|7|||
16081919|NCT03580369|38792737|FG007|Overall Study|Withdrawal by Subject|0|||
16081920|NCT02962284|38792738|FG000|Overall Study|Death|2|||
16295013|NCT04268316|39563027|FG002|Overall Study|Withdrawal by Subject|0|||
16081921|NCT02962284|38792739|FG001|Overall Study|Death|0|||
16081922|NCT02962284|38792738|FG000|Overall Study|Progressive disease|2|||
16081923|NCT02962284|38792739|FG001|Overall Study|Progressive disease|3|||
16081924|NCT02962284|38792738|FG000|Overall Study|Withdrawal by Subject|1|||
16081925|NCT02962284|38792739|FG001|Overall Study|Withdrawal by Subject|0|||
16081926|NCT02147093|38792741|FG000|Period 1|Lost to Follow-up|0|||
16081927|NCT02147093|38792742|FG001|Period 1|Lost to Follow-up|1|||
16081928|NCT02147093|38792741|FG000|Period 2|Protocol Violation|2|||
16081929|NCT02147093|38792742|FG001|Period 2|Protocol Violation|0|||
16081930|NCT02409667|38792743|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
16081931|NCT02409667|38792744|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
16081932|NCT02409667|38792745|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
16081933|NCT02409667|38792746|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
16081934|NCT02409667|38792747|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
16081935|NCT02409667|38792743|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
16081936|NCT02409667|38792744|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
16081937|NCT02409667|38792745|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
16081938|NCT02409667|38792746|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
16081939|NCT02409667|38792747|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
16081940|NCT02409667|38792743|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
16081941|NCT02409667|38792744|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
16081942|NCT02409667|38792745|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
16081943|NCT02409667|38792746|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
16081944|NCT02409667|38792747|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
16081945|NCT02409667|38792743|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
16081946|NCT02409667|38792744|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
16081947|NCT02409667|38792745|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
16081948|NCT02409667|38792746|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
16081949|NCT02409667|38792747|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
16081950|NCT02409667|38792743|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
16081951|NCT02409667|38792744|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
16081952|NCT02409667|38792745|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
16081953|NCT02409667|38792746|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
16081954|NCT02409667|38792747|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
16081955|NCT02409667|38792743|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
16081956|NCT02409667|38792744|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
16081957|NCT02409667|38792745|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
16081958|NCT02409667|38792746|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
16081959|NCT02409667|38792747|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
16081960|NCT02409667|38792743|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
16081961|NCT02409667|38792744|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
16081962|NCT02409667|38792745|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
16081963|NCT02409667|38792746|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
16081964|NCT02409667|38792747|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
16081965|NCT02409667|38792743|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
16081966|NCT02409667|38792744|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
16081967|NCT02409667|38792745|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
16081968|NCT02409667|38792746|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
16081969|NCT02409667|38792747|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
16081970|NCT02409667|38792743|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
16081971|NCT02409667|38792744|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
16081972|NCT02409667|38792745|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
16081973|NCT02409667|38792746|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
16081974|NCT02409667|38792747|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
16081975|NCT02409667|38792743|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
16081976|NCT02409667|38792744|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
16081977|NCT02409667|38792745|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
16081978|NCT02409667|38792746|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
16081979|NCT02409667|38792747|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
16081980|NCT02409667|38792743|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
16081981|NCT02409667|38792744|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
16081982|NCT02409667|38792745|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
16081983|NCT02409667|38792746|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
16188068|NCT03345836|39165123|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
16081984|NCT02409667|38792747|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
16081985|NCT02409667|38792743|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
16188069|NCT03345836|39165118|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
16081986|NCT02409667|38792744|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
16081987|NCT02409667|38792745|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
16081988|NCT02409667|38792746|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
16081989|NCT02409667|38792747|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
16081990|NCT02409667|38792743|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
16081991|NCT02409667|38792744|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
16081992|NCT02409667|38792745|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
16081993|NCT02409667|38792746|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
16081994|NCT02409667|38792747|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
16081995|NCT02409667|38792743|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
16081996|NCT02409667|38792744|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
16081997|NCT02409667|38792745|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
16081998|NCT02409667|38792746|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
16081999|NCT02409667|38792747|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
16295014|NCT01372774|39563028|FG000|Overall Study|Withdrawal prior to treatment|4|||
16295015|NCT01372774|39563029|FG001|Overall Study|Withdrawal prior to treatment|5|||
16295016|NCT03146962|39563030|FG000|Overall Study|Lost to Follow-up|1|||
16295017|NCT03146962|39563031|FG001|Overall Study|Lost to Follow-up|1|||
16295018|NCT03146962|39563032|FG002|Overall Study|Lost to Follow-up|0|||
16295019|NCT03146962|39563033|FG003|Overall Study|Lost to Follow-up|0|||
16295020|NCT03146962|39563034|FG004|Overall Study|Lost to Follow-up|0|||
16295021|NCT03146962|39563035|FG005|Overall Study|Lost to Follow-up|0|||
16295022|NCT03146962|39563036|FG006|Overall Study|Lost to Follow-up|0|||
16295023|NCT03146962|39563037|FG007|Overall Study|Lost to Follow-up|0|||
16295024|NCT03146962|39563038|FG008|Overall Study|Lost to Follow-up|0|||
16295025|NCT03146962|39563039|FG009|Overall Study|Lost to Follow-up|0|||
16295026|NCT03146962|39563030|FG000|Overall Study|Adverse Event|0|||
16295027|NCT03146962|39563031|FG001|Overall Study|Adverse Event|3|||
16295028|NCT03146962|39563032|FG002|Overall Study|Adverse Event|0|||
16295029|NCT03146962|39563033|FG003|Overall Study|Adverse Event|0|||
16295030|NCT03146962|39563034|FG004|Overall Study|Adverse Event|0|||
16295031|NCT03146962|39563035|FG005|Overall Study|Adverse Event|0|||
16295032|NCT03146962|39563036|FG006|Overall Study|Adverse Event|0|||
16295033|NCT03146962|39563037|FG007|Overall Study|Adverse Event|1|||
16295034|NCT03146962|39563038|FG008|Overall Study|Adverse Event|0|||
16295035|NCT03146962|39563039|FG009|Overall Study|Adverse Event|0|||
16295036|NCT03146962|39563030|FG000|Overall Study|Withdrawal by Subject|0|||
16295037|NCT03146962|39563031|FG001|Overall Study|Withdrawal by Subject|0|||
16295038|NCT03146962|39563032|FG002|Overall Study|Withdrawal by Subject|0|||
16295039|NCT03146962|39563033|FG003|Overall Study|Withdrawal by Subject|0|||
16295040|NCT03146962|39563034|FG004|Overall Study|Withdrawal by Subject|1|||
16295041|NCT03146962|39563035|FG005|Overall Study|Withdrawal by Subject|0|||
16295042|NCT03146962|39563036|FG006|Overall Study|Withdrawal by Subject|0|||
16295043|NCT03146962|39563037|FG007|Overall Study|Withdrawal by Subject|0|||
16295044|NCT03146962|39563038|FG008|Overall Study|Withdrawal by Subject|0|||
16295045|NCT03146962|39563039|FG009|Overall Study|Withdrawal by Subject|0|||
16295046|NCT03146962|39563030|FG000|Overall Study|Death|0|||
16295047|NCT03146962|39563031|FG001|Overall Study|Death|1|||
16295048|NCT03146962|39563032|FG002|Overall Study|Death|0|||
16295049|NCT03146962|39563033|FG003|Overall Study|Death|0|||
16295050|NCT03146962|39563034|FG004|Overall Study|Death|0|||
16295051|NCT03146962|39563035|FG005|Overall Study|Death|0|||
16295052|NCT03146962|39563036|FG006|Overall Study|Death|0|||
16295053|NCT03146962|39563037|FG007|Overall Study|Death|0|||
16295054|NCT03146962|39563038|FG008|Overall Study|Death|0|||
16295055|NCT03146962|39563039|FG009|Overall Study|Death|0|||
16295056|NCT03146962|39563030|FG000|Overall Study|COVID Precautions|1|||
16295057|NCT03146962|39563031|FG001|Overall Study|COVID Precautions|0|||
16295058|NCT03146962|39563032|FG002|Overall Study|COVID Precautions|0|||
16295059|NCT03146962|39563033|FG003|Overall Study|COVID Precautions|0|||
16295060|NCT03146962|39563034|FG004|Overall Study|COVID Precautions|0|||
16295061|NCT03146962|39563035|FG005|Overall Study|COVID Precautions|0|||
16295062|NCT03146962|39563036|FG006|Overall Study|COVID Precautions|0|||
16295063|NCT03146962|39563037|FG007|Overall Study|COVID Precautions|0|||
16295064|NCT03146962|39563038|FG008|Overall Study|COVID Precautions|0|||
16295065|NCT03146962|39563039|FG009|Overall Study|COVID Precautions|0|||
16295066|NCT03146962|39563030|FG000|Overall Study|Physician Decision|0|||
16295067|NCT03146962|39563031|FG001|Overall Study|Physician Decision|0|||
16295068|NCT03146962|39563032|FG002|Overall Study|Physician Decision|0|||
16295069|NCT03146962|39563033|FG003|Overall Study|Physician Decision|0|||
16295070|NCT03146962|39563034|FG004|Overall Study|Physician Decision|0|||
16295071|NCT03146962|39563035|FG005|Overall Study|Physician Decision|0|||
16295072|NCT03146962|39563036|FG006|Overall Study|Physician Decision|0|||
16295073|NCT03146962|39563037|FG007|Overall Study|Physician Decision|0|||
16295074|NCT03146962|39563038|FG008|Overall Study|Physician Decision|0|||
16295075|NCT03146962|39563039|FG009|Overall Study|Physician Decision|1|||
16082000|NCT02409667|38792743|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
16082001|NCT02409667|38792744|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
16082002|NCT02409667|38792745|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
16082003|NCT02409667|38792746|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
16082004|NCT02409667|38792747|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
16082005|NCT02409667|38792743|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
16082006|NCT02409667|38792744|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
16082007|NCT02409667|38792745|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
16082008|NCT02409667|38792746|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
16082009|NCT02409667|38792747|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
16082010|NCT02376790|38792748|FG000|Overall Study|Withdrawal by Subject|43|||
16082011|NCT02376790|38792749|FG001|Overall Study|Withdrawal by Subject|36|||
16082012|NCT02376790|38792750|FG002|Overall Study|Withdrawal by Subject|37|||
16082013|NCT02376790|38792748|FG000|Overall Study|Decision by Sponsor|2|||
16082014|NCT02376790|38792749|FG001|Overall Study|Decision by Sponsor|1|||
16082015|NCT02376790|38792750|FG002|Overall Study|Decision by Sponsor|4|||
16082016|NCT02376790|38792748|FG000|Overall Study|Lost to Follow-up|15|||
16082017|NCT02376790|38792749|FG001|Overall Study|Lost to Follow-up|10|||
16082018|NCT02376790|38792750|FG002|Overall Study|Lost to Follow-up|12|||
16082019|NCT01367236|38792753|FG000|Overall Study|Withdrawal by Subject|3|||
16082020|NCT01367236|38792754|FG001|Overall Study|Withdrawal by Subject|1|||
16082021|NCT00229658|38792777|FG000|Overall Study|Administrative|2|||
16082022|NCT00229658|38792778|FG001|Overall Study|Administrative|1|||
16082023|NCT00229658|38792777|FG000|Overall Study|Investigator decision|13|||
16082024|NCT00229658|38792778|FG001|Overall Study|Investigator decision|10|||
16082025|NCT00229658|38792777|FG000|Overall Study|Other|80|||
16082026|NCT00229658|38792778|FG001|Overall Study|Other|60|||
16082027|NCT00229658|38792777|FG000|Overall Study|Lost to Follow-up|82|||
16082028|NCT00229658|38792778|FG001|Overall Study|Lost to Follow-up|55|||
16082029|NCT00229658|38792777|FG000|Overall Study|Serious Adverse Event|2|||
16082030|NCT00229658|38792778|FG001|Overall Study|Serious Adverse Event|2|||
16082031|NCT00229658|38792777|FG000|Overall Study|Withdrawal of consent|46|||
16082032|NCT00229658|38792778|FG001|Overall Study|Withdrawal of consent|39|||
16082033|NCT00879710|38792784|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
16082034|NCT00879710|38792785|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
16082035|NCT00879710|38792786|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
16082036|NCT00879710|38792787|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
16082037|NCT00879710|38792784|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
16082038|NCT00879710|38792785|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
16082039|NCT00879710|38792786|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
16082040|NCT00879710|38792787|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
16082041|NCT02189252|38792788|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
16082042|NCT02189252|38792789|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
16082043|NCT02189252|38792790|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
16082044|NCT02189252|38792791|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
16082045|NCT02189252|38792788|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
16082046|NCT02189252|38792789|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
16082047|NCT02189252|38792790|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
16082048|NCT02189252|38792791|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
16082049|NCT03756571|38792799|FG000|Overall Study|Lost to Follow-up|1|||
16082050|NCT03756571|38792800|FG001|Overall Study|Lost to Follow-up|1|||
16082051|NCT03292913|38792801|FG000|Overall Study|Death|9|||
16082052|NCT03292913|38792802|FG001|Overall Study|Death|3|||
16082053|NCT03292913|38792801|FG000|Overall Study|Lost to Follow-up|49|||
16082054|NCT03292913|38792802|FG001|Overall Study|Lost to Follow-up|49|||
16082055|NCT03292913|38792801|FG000|Overall Study|Withdrawal by Subject|2|||
16082056|NCT03292913|38792802|FG001|Overall Study|Withdrawal by Subject|0|||
16082057|NCT03292913|38792801|FG000|Overall Study|Clinic closed due to COVID|22|||
16082058|NCT03292913|38792802|FG001|Overall Study|Clinic closed due to COVID|36|||
16082059|NCT02426138|38792803|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
16082060|NCT02426138|38792804|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
16082061|NCT03475316|38792805|FG000|6 Month Intervention|Adverse Event|2|||
16082062|NCT03475316|38792806|FG001|6 Month Intervention|Adverse Event|1|||
16082063|NCT03475316|38792805|FG000|6 Month Intervention|Withdrawal by Subject|2|||
16082064|NCT03475316|38792806|FG001|6 Month Intervention|Withdrawal by Subject|0|||
16082065|NCT03475316|38792805|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
16082066|NCT03475316|38792806|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
16082067|NCT03475316|38792805|FG000|9 Months|Study stopped due to COVID pandemic|3|||
16082068|NCT03475316|38792806|FG001|9 Months|Study stopped due to COVID pandemic|4|||
16082069|NCT02157116|38792810|FG000|Overall Study|Withdrawal by Subject|4|||
16082070|NCT02157116|38792810|FG000|Overall Study|Physician Decision|3|||
16082071|NCT02157116|38792810|FG000|Overall Study|Failed Screening|2|||
16082072|NCT00145470|38792811|FG000|Overall Study|Adverse Event|19|||
16082073|NCT00145470|38792812|FG001|Overall Study|Adverse Event|25|||
16082074|NCT00145470|38792811|FG000|Overall Study|Lack of Efficacy|27|||
16082075|NCT00145470|38792812|FG001|Overall Study|Lack of Efficacy|13|||
16082076|NCT00145470|38792811|FG000|Overall Study|Withdrawal by Subject|36|||
16082077|NCT00145470|38792812|FG001|Overall Study|Withdrawal by Subject|34|||
16082078|NCT00145470|38792811|FG000|Overall Study|Lost to Follow-up|21|||
16082079|NCT00145470|38792812|FG001|Overall Study|Lost to Follow-up|17|||
16082080|NCT00145470|38792811|FG000|Overall Study|Reason Not Reported|9|||
16082081|NCT00145470|38792812|FG001|Overall Study|Reason Not Reported|9|||
16082082|NCT01510717|38792813|FG000|Overall Study|Adverse Event|1|||
16082083|NCT01510717|38792814|FG001|Overall Study|Adverse Event|2|||
16082084|NCT01510717|38792813|FG000|Overall Study|Death|1|||
16082085|NCT01510717|38792814|FG001|Overall Study|Death|0|||
16082086|NCT01510717|38792813|FG000|Overall Study|Lost to Follow-up|0|||
16082087|NCT01510717|38792814|FG001|Overall Study|Lost to Follow-up|1|||
16082088|NCT01510717|38792813|FG000|Overall Study|Withdrawal by Subject|0|||
16082089|NCT01510717|38792814|FG001|Overall Study|Withdrawal by Subject|2|||
16082090|NCT01288443|38792815|FG000|Overall Study|Adverse Event|0|||
16082091|NCT01288443|38792816|FG001|Overall Study|Adverse Event|0|||
16082092|NCT01288443|38792817|FG002|Overall Study|Adverse Event|1|||
16082093|NCT01288443|38792818|FG003|Overall Study|Adverse Event|1|||
16082094|NCT01288443|38792819|FG004|Overall Study|Adverse Event|3|||
16082095|NCT01288443|38792820|FG005|Overall Study|Adverse Event|1|||
16082096|NCT01288443|38792815|FG000|Overall Study|Poor compliance to protocol|0|||
16082097|NCT01288443|38792816|FG001|Overall Study|Poor compliance to protocol|0|||
16082098|NCT01288443|38792817|FG002|Overall Study|Poor compliance to protocol|0|||
16082099|NCT01288443|38792818|FG003|Overall Study|Poor compliance to protocol|0|||
16082100|NCT01288443|38792819|FG004|Overall Study|Poor compliance to protocol|0|||
16082101|NCT01288443|38792820|FG005|Overall Study|Poor compliance to protocol|1|||
16082102|NCT01288443|38792815|FG000|Overall Study|Participant Moved|0|||
16082103|NCT01288443|38792816|FG001|Overall Study|Participant Moved|0|||
16082104|NCT01288443|38792817|FG002|Overall Study|Participant Moved|0|||
16082105|NCT01288443|38792818|FG003|Overall Study|Participant Moved|1|||
16082106|NCT01288443|38792819|FG004|Overall Study|Participant Moved|2|||
16082107|NCT01288443|38792820|FG005|Overall Study|Participant Moved|1|||
16082108|NCT01288443|38792815|FG000|Overall Study|Consent withdrawn by Participant|0|||
16082109|NCT01288443|38792816|FG001|Overall Study|Consent withdrawn by Participant|0|||
16082110|NCT01288443|38792817|FG002|Overall Study|Consent withdrawn by Participant|0|||
16082111|NCT01288443|38792818|FG003|Overall Study|Consent withdrawn by Participant|0|||
16082112|NCT01288443|38792819|FG004|Overall Study|Consent withdrawn by Participant|0|||
16082113|NCT01288443|38792820|FG005|Overall Study|Consent withdrawn by Participant|1|||
16082114|NCT01288443|38792815|FG000|Overall Study|Lost to Follow-up|0|||
16082115|NCT01288443|38792816|FG001|Overall Study|Lost to Follow-up|1|||
16082116|NCT01288443|38792817|FG002|Overall Study|Lost to Follow-up|0|||
16082117|NCT01288443|38792818|FG003|Overall Study|Lost to Follow-up|0|||
16082118|NCT01288443|38792819|FG004|Overall Study|Lost to Follow-up|0|||
16082119|NCT01288443|38792820|FG005|Overall Study|Lost to Follow-up|0|||
16082120|NCT01288443|38792815|FG000|Overall Study|Study drug auto-injector administration|0|||
16082121|NCT01288443|38792816|FG001|Overall Study|Study drug auto-injector administration|0|||
16082122|NCT01288443|38792817|FG002|Overall Study|Study drug auto-injector administration|0|||
16082123|NCT01288443|38792818|FG003|Overall Study|Study drug auto-injector administration|0|||
16082124|NCT01288443|38792819|FG004|Overall Study|Study drug auto-injector administration|1|||
16082125|NCT01288443|38792820|FG005|Overall Study|Study drug auto-injector administration|1|||
16082126|NCT01288443|38792815|FG000|Overall Study|Other than above|0|||
16082127|NCT01288443|38792816|FG001|Overall Study|Other than above|0|||
16082128|NCT01288443|38792817|FG002|Overall Study|Other than above|0|||
16082129|NCT01288443|38792818|FG003|Overall Study|Other than above|2|||
16082130|NCT01288443|38792819|FG004|Overall Study|Other than above|1|||
16082131|NCT01288443|38792820|FG005|Overall Study|Other than above|0|||
16082132|NCT00003222|38792821|FG000|Overall Study|Physician Decision|0|||
16082133|NCT00003222|38792822|FG001|Overall Study|Physician Decision|1|||
16082134|NCT02574455|38792823|FG000|Overall Study|Death|197|||
16082135|NCT02574455|38792824|FG001|Overall Study|Death|210|||
16082136|NCT02574455|38792823|FG000|Overall Study|Withdrawal of Consent|11|||
16082137|NCT02574455|38792824|FG001|Overall Study|Withdrawal of Consent|28|||
16082138|NCT02574455|38792823|FG000|Overall Study|Lost to Follow-up|4|||
16082139|NCT02574455|38792824|FG001|Overall Study|Lost to Follow-up|4|||
16082140|NCT02574455|38792823|FG000|Overall Study|Sponsor's Decision|55|||
16082141|NCT02574455|38792824|FG001|Overall Study|Sponsor's Decision|20|||
16082142|NCT00687219|38792827|FG000|Overall Study|Adverse Event|8|||
16082143|NCT00687219|38792827|FG000|Overall Study|Discontinuance criteria met|7|||
16082144|NCT00687219|38792827|FG000|Overall Study|HCV-RNA positive conversion|34|||
16082145|NCT00687219|38792827|FG000|Overall Study|Withdrawal by Subject|1|||
16082146|NCT00687219|38792827|FG000|Overall Study|Lack of Efficacy|1|||
16082147|NCT00434304|38792828|FG000|Overall Study|Adverse Event|14|||
16082148|NCT00434304|38792828|FG000|Overall Study|Lack of Efficacy|2|||
16082149|NCT00434304|38792828|FG000|Overall Study|Withdrawal by Subject|4|||
16082150|NCT00709098|38792829|FG000|Double-blind Period|Withdrawal of consent|3|||
16082151|NCT00709098|38792830|FG001|Double-blind Period|Withdrawal of consent|3|||
16082152|NCT00709098|38792831|FG002|Double-blind Period|Withdrawal of consent|0|||
16082153|NCT00709098|38792829|FG000|Double-blind Period|Administrative reason|1|||
16082154|NCT00709098|38792830|FG001|Double-blind Period|Administrative reason|3|||
16082155|NCT00709098|38792831|FG002|Double-blind Period|Administrative reason|0|||
16082156|NCT00709098|38792829|FG000|Double-blind Period|Death|1|||
16082157|NCT00709098|38792830|FG001|Double-blind Period|Death|1|||
16082158|NCT00709098|38792831|FG002|Double-blind Period|Death|0|||
16082159|NCT00709098|38792829|FG000|Double-blind Period|Lost to Follow-up|1|||
16082160|NCT00709098|38792830|FG001|Double-blind Period|Lost to Follow-up|1|||
16082161|NCT00709098|38792831|FG002|Double-blind Period|Lost to Follow-up|0|||
16082162|NCT00709098|38792829|FG000|Open-label Period|Withdrawal of consent|0|||
16082163|NCT00709098|38792830|FG001|Open-label Period|Withdrawal of consent|0|||
16082164|NCT00709098|38792831|FG002|Open-label Period|Withdrawal of consent|7|||
16082165|NCT00709098|38792829|FG000|Open-label Period|Administrative reason|0|||
16082166|NCT00709098|38792830|FG001|Open-label Period|Administrative reason|0|||
16082167|NCT00709098|38792831|FG002|Open-label Period|Administrative reason|5|||
16082168|NCT00709098|38792829|FG000|Open-label Period|Death|0|||
16082169|NCT00709098|38792830|FG001|Open-label Period|Death|0|||
16082170|NCT00709098|38792831|FG002|Open-label Period|Death|1|||
16082171|NCT00709098|38792829|FG000|Open-label Period|Lost to Follow-up|0|||
16082172|NCT00709098|38792830|FG001|Open-label Period|Lost to Follow-up|0|||
16082173|NCT00709098|38792831|FG002|Open-label Period|Lost to Follow-up|1|||
16082174|NCT00632749|38792832|FG000|Overall Study|Progressive disease|3|||
16082175|NCT00632749|38792833|FG001|Overall Study|Progressive disease|2|||
16082176|NCT00632749|38792834|FG002|Overall Study|Progressive disease|2|||
16082177|NCT00632749|38792835|FG003|Overall Study|Progressive disease|2|||
16082178|NCT00632749|38792836|FG004|Overall Study|Progressive disease|4|||
16082179|NCT00632749|38792837|FG005|Overall Study|Progressive disease|4|||
16082180|NCT00632749|38792838|FG006|Overall Study|Progressive disease|3|||
16082181|NCT00632749|38792839|FG007|Overall Study|Progressive disease|2|||
16082182|NCT00632749|38792840|FG008|Overall Study|Progressive disease|3|||
16082183|NCT00632749|38792841|FG009|Overall Study|Progressive disease|2|||
16082184|NCT00632749|38792842|FG010|Overall Study|Progressive disease|4|||
16082185|NCT00632749|38792843|FG011|Overall Study|Progressive disease|3|||
16082186|NCT00632749|38792844|FG012|Overall Study|Progressive disease|2|||
16082187|NCT00632749|38792845|FG013|Overall Study|Progressive disease|4|||
16082188|NCT00632749|38792832|FG000|Overall Study|Other Adverse event|1|||
16082189|NCT00632749|38792833|FG001|Overall Study|Other Adverse event|1|||
16082190|NCT00632749|38792834|FG002|Overall Study|Other Adverse event|1|||
16082191|NCT00632749|38792835|FG003|Overall Study|Other Adverse event|1|||
16082192|NCT00632749|38792836|FG004|Overall Study|Other Adverse event|2|||
16082193|NCT00632749|38792837|FG005|Overall Study|Other Adverse event|4|||
16082194|NCT00632749|38792838|FG006|Overall Study|Other Adverse event|1|||
16082195|NCT00632749|38792839|FG007|Overall Study|Other Adverse event|2|||
16082196|NCT00632749|38792840|FG008|Overall Study|Other Adverse event|2|||
16082197|NCT00632749|38792841|FG009|Overall Study|Other Adverse event|0|||
16082198|NCT00632749|38792842|FG010|Overall Study|Other Adverse event|1|||
16082199|NCT00632749|38792843|FG011|Overall Study|Other Adverse event|0|||
16295076|NCT03146962|39563030|FG000|Overall Study|Started New Treatment|0|||
16295077|NCT03146962|39563031|FG001|Overall Study|Started New Treatment|1|||
16295078|NCT03146962|39563032|FG002|Overall Study|Started New Treatment|0|||
16295079|NCT03146962|39563033|FG003|Overall Study|Started New Treatment|0|||
16295080|NCT03146962|39563034|FG004|Overall Study|Started New Treatment|0|||
16295081|NCT03146962|39563035|FG005|Overall Study|Started New Treatment|0|||
16295082|NCT03146962|39563036|FG006|Overall Study|Started New Treatment|0|||
16295083|NCT03146962|39563037|FG007|Overall Study|Started New Treatment|0|||
16082200|NCT00632749|38792844|FG012|Overall Study|Other Adverse event|1|||
16082201|NCT00632749|38792845|FG013|Overall Study|Other Adverse event|0|||
16485259|NCT00256750|40252736|FG000|Post-Transplant Treated (12 Months)|Death|3|||
16082202|NCT00632749|38792832|FG000|Overall Study|Refuse to continue medication|0|||
16082203|NCT00632749|38792833|FG001|Overall Study|Refuse to continue medication|0|||
16082204|NCT00632749|38792834|FG002|Overall Study|Refuse to continue medication|0|||
16082205|NCT00632749|38792835|FG003|Overall Study|Refuse to continue medication|1|||
16082206|NCT00632749|38792836|FG004|Overall Study|Refuse to continue medication|0|||
16082207|NCT00632749|38792837|FG005|Overall Study|Refuse to continue medication|0|||
16295084|NCT03146962|39563038|FG008|Overall Study|Started New Treatment|0|||
16295085|NCT03146962|39563039|FG009|Overall Study|Started New Treatment|0|||
16295086|NCT00927394|39563040|FG000|Overall Study|Adverse Event|14|||
16295087|NCT00927394|39563041|FG001|Overall Study|Adverse Event|9|||
16295088|NCT00927394|39563040|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
16082208|NCT00632749|38792838|FG006|Overall Study|Refuse to continue medication|0|||
16082209|NCT00632749|38792839|FG007|Overall Study|Refuse to continue medication|0|||
16082210|NCT00632749|38792840|FG008|Overall Study|Refuse to continue medication|0|||
16082211|NCT00632749|38792841|FG009|Overall Study|Refuse to continue medication|1|||
16295089|NCT00927394|39563041|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
16082212|NCT00632749|38792842|FG010|Overall Study|Refuse to continue medication|0|||
16295090|NCT00927394|39563040|FG000|Overall Study|Withdrawal by Subject|20|||
16295091|NCT00927394|39563041|FG001|Overall Study|Withdrawal by Subject|24|||
16295092|NCT00927394|39563040|FG000|Overall Study|Lost to Follow-up|8|||
16295093|NCT00927394|39563041|FG001|Overall Study|Lost to Follow-up|14|||
16295094|NCT00927394|39563040|FG000|Overall Study|Administrative Problem|1|||
16295095|NCT00927394|39563041|FG001|Overall Study|Administrative Problem|0|||
16295096|NCT00927394|39563040|FG000|Overall Study|Death|1|||
16295097|NCT00927394|39563041|FG001|Overall Study|Death|1|||
16295098|NCT00927394|39563040|FG000|Overall Study|Protocol deviation|16|||
16295099|NCT00927394|39563041|FG001|Overall Study|Protocol deviation|13|||
16295100|NCT00927394|39563040|FG000|Overall Study|Randomized in error|0|||
16295101|NCT00927394|39563041|FG001|Overall Study|Randomized in error|1|||
16295102|NCT01437943|39563044|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
16295103|NCT01437943|39563045|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
16295104|NCT01437943|39563044|FG000|Overall Study|Subject expressed pregnancy plans|1|||
16295105|NCT01437943|39563045|FG001|Overall Study|Subject expressed pregnancy plans|0|||
16295106|NCT01437943|39563044|FG000|Overall Study|Adverse Event|2|||
16295107|NCT01437943|39563045|FG001|Overall Study|Adverse Event|0|||
16295108|NCT04625725|39563051|FG000|Overall Study|Adverse Event|2|||
16188070|NCT03345836|39165119|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
16188071|NCT03345836|39165120|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
16188072|NCT03345836|39165121|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
16188073|NCT03345836|39165122|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
16188074|NCT03345836|39165123|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
16188075|NCT03345836|39165118|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
16188076|NCT03345836|39165119|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
16188077|NCT03345836|39165120|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
16188078|NCT03345836|39165121|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
16188079|NCT03345836|39165122|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
16188080|NCT03345836|39165123|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
16295109|NCT04625725|39563052|FG001|Overall Study|Adverse Event|1|||
16295110|NCT04625725|39563051|FG000|Overall Study|Death|22|||
16295111|NCT04625725|39563052|FG001|Overall Study|Death|10|||
16295112|NCT04625725|39563051|FG000|Overall Study|Lost to Follow-up|357|||
16188081|NCT03345836|39165118|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
16188082|NCT03345836|39165119|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
16188083|NCT03345836|39165120|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
16188084|NCT03345836|39165121|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
16188085|NCT03345836|39165122|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
16188086|NCT03345836|39165123|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
16188087|NCT03345836|39165118|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
16485260|NCT00256750|40252737|FG001|Post-Transplant Treated (12 Months)|Death|2|||
16485261|NCT00256750|40252738|FG002|Post-Transplant Treated (12 Months)|Death|4|||
16485262|NCT00256750|40252736|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
16485263|NCT00256750|40252737|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
16485264|NCT00256750|40252738|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
16485265|NCT00256750|40252736|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
16485266|NCT00256750|40252737|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
16485267|NCT00256750|40252738|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
16485268|NCT00256750|40252736|FG000|Post-Transplant Treated (12 Months)|Other|5|||
16485269|NCT00256750|40252737|FG001|Post-Transplant Treated (12 Months)|Other|4|||
16485270|NCT00256750|40252738|FG002|Post-Transplant Treated (12 Months)|Other|2|||
16485271|NCT00256750|40252736|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
16485272|NCT00256750|40252737|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
16485273|NCT00256750|40252738|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
16485274|NCT00256750|40252736|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
16485275|NCT00256750|40252737|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
16485276|NCT00256750|40252738|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
16188088|NCT03345836|39165119|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
16188089|NCT03345836|39165120|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
16188090|NCT03345836|39165121|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
16188091|NCT03345836|39165122|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
16188092|NCT03345836|39165123|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
16188093|NCT03345836|39165118|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
16188094|NCT03345836|39165119|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
16188095|NCT03345836|39165120|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
16188096|NCT03345836|39165121|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
16188097|NCT03345836|39165122|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
16188098|NCT03345836|39165123|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
16188099|NCT03345836|39165118|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
16188100|NCT03345836|39165119|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
16188101|NCT03345836|39165120|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
16188102|NCT03345836|39165121|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
16188103|NCT03345836|39165122|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
16295113|NCT04625725|39563052|FG001|Overall Study|Lost to Follow-up|200|||
16295114|NCT04625725|39563051|FG000|Overall Study|Dosed in sub-study|310|||
16295115|NCT04625725|39563052|FG001|Overall Study|Dosed in sub-study|193|||
16295116|NCT04625725|39563051|FG000|Overall Study|Physician Decision|5|||
16188104|NCT03345836|39165123|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
16188105|NCT03345836|39165118|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
16188106|NCT03345836|39165119|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
16188107|NCT03345836|39165120|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
16188108|NCT03345836|39165121|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
16188109|NCT03345836|39165122|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
16188110|NCT03345836|39165123|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
16188111|NCT03345836|39165118|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
16188112|NCT03345836|39165119|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
16188113|NCT03345836|39165120|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
16188114|NCT03345836|39165121|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
16188115|NCT03345836|39165122|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
16188116|NCT03345836|39165123|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
16188117|NCT01539837|39165124|FG000|Overall Study|reduce neutrophil level|0|||
16188118|NCT01539837|39165125|FG001|Overall Study|reduce neutrophil level|1|||
16188119|NCT01539837|39165126|FG002|Overall Study|reduce neutrophil level|1|||
16188120|NCT01539837|39165124|FG000|Overall Study|bad compliance|0|||
16188121|NCT01539837|39165125|FG001|Overall Study|bad compliance|0|||
16188122|NCT01539837|39165126|FG002|Overall Study|bad compliance|1|||
16295117|NCT04625725|39563052|FG001|Overall Study|Physician Decision|0|||
16188123|NCT00337467|39165127|FG000|Overall Study|Adverse Event|3|||
16188124|NCT00337467|39165127|FG000|Overall Study|Subject Withdrew Consent|2|||
16188125|NCT00337467|39165127|FG000|Overall Study|Pregnancy|1|||
16188126|NCT00337467|39165127|FG000|Overall Study|Lost to Follow-up|2|||
16188127|NCT00337467|39165127|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
16188128|NCT03375112|39165130|FG000|Overall Study|Withdrawal by Subject|3|||
16188129|NCT03375112|39165131|FG001|Overall Study|Withdrawal by Subject|0|||
16188130|NCT02588248|39165132|FG000|Overall Study|Physician Decision|4|||
16188131|NCT02588248|39165133|FG001|Overall Study|Physician Decision|3|||
16188132|NCT03282123|39165135|FG000|Overall Study|Withdrawal by Subject|5|||
16188133|NCT03865407|39165136|FG000|Overall Study|Adverse Event|1|||
16188134|NCT03865407|39165137|FG001|Overall Study|Adverse Event|0|||
16188135|NCT03865407|39165136|FG000|Overall Study|Withdrawal by Subject|1|||
16188136|NCT03865407|39165137|FG001|Overall Study|Withdrawal by Subject|0|||
16188137|NCT03865407|39165136|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
16188138|NCT03865407|39165137|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
16188139|NCT01929044|39165138|FG000|Overall Study|Adverse Event|1|||
16188140|NCT01929044|39165139|FG001|Overall Study|Adverse Event|0|||
16188141|NCT01929044|39165138|FG000|Overall Study|Protocol Violation|9|||
16188142|NCT01929044|39165139|FG001|Overall Study|Protocol Violation|14|||
16188143|NCT01929044|39165138|FG000|Overall Study|Not Treated|1|||
16188144|NCT01929044|39165139|FG001|Overall Study|Not Treated|3|||
16188145|NCT00001262|39165140|FG000|Overall Study|Death|10|||
16188146|NCT00001262|39165141|FG001|Overall Study|Death|11|||
16188147|NCT00001262|39165142|FG002|Overall Study|Death|0|||
16188148|NCT00001262|39165140|FG000|Overall Study|Withdrawal by Subject|0|||
16188149|NCT00001262|39165141|FG001|Overall Study|Withdrawal by Subject|3|||
16188150|NCT00001262|39165142|FG002|Overall Study|Withdrawal by Subject|0|||
16188151|NCT01605071|39165150|FG000|Overall Study|Withdrawal by Subject|3|||
16188152|NCT01605071|39165151|FG001|Overall Study|Withdrawal by Subject|2|||
16188153|NCT01355068|39165152|FG000|First Intervention Period|Adverse Event|0|||
16188154|NCT01355068|39165153|FG001|First Intervention Period|Adverse Event|1|||
16188155|NCT01355068|39165152|FG000|First Intervention Period|Withdrawal by Subject|0|||
16188156|NCT01355068|39165153|FG001|First Intervention Period|Withdrawal by Subject|1|||
16188157|NCT00258154|39165154|FG000|Overall Study|Adverse Event|1|||
16188158|NCT00258154|39165155|FG001|Overall Study|Adverse Event|0|||
16188159|NCT00258154|39165154|FG000|Overall Study|Lost to Follow-up|0|||
16188160|NCT00258154|39165155|FG001|Overall Study|Lost to Follow-up|1|||
16188161|NCT00258154|39165154|FG000|Overall Study|Protocol Violation|2|||
16188162|NCT00258154|39165155|FG001|Overall Study|Protocol Violation|1|||
16188163|NCT00258154|39165154|FG000|Overall Study|Withdrawal by Subject|3|||
16188164|NCT00258154|39165155|FG001|Overall Study|Withdrawal by Subject|4|||
16188165|NCT00258154|39165154|FG000|Overall Study|Patient Moved|3|||
16188166|NCT00258154|39165155|FG001|Overall Study|Patient Moved|1|||
16188167|NCT01302041|39165160|FG000|Overall Study|Death|5|||
16188168|NCT01302041|39165160|FG000|Overall Study|Withdrawal by Subject|4|||
16188169|NCT01302041|39165160|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
16188170|NCT01302041|39165160|FG000|Overall Study|Other-Miscellaneous Reason|2|||
16188171|NCT01844700|39165161|FG000|Overall Study|Lack of Efficacy|1|||
16188172|NCT01844700|39165162|FG001|Overall Study|Lack of Efficacy|0|||
16188173|NCT01844700|39165161|FG000|Overall Study|refused medication switch|1|||
16188174|NCT01844700|39165162|FG001|Overall Study|refused medication switch|0|||
16188175|NCT01844700|39165161|FG000|Overall Study|Withdrawal by Subject|1|||
16188176|NCT01844700|39165162|FG001|Overall Study|Withdrawal by Subject|0|||
16188177|NCT01844700|39165161|FG000|Overall Study|stopped taking meds|0|||
16188178|NCT01844700|39165162|FG001|Overall Study|stopped taking meds|1|||
16188179|NCT02207530|39165163|FG000|Overall Study|Worsening condition under investigation|78|||
16188180|NCT02207530|39165163|FG000|Overall Study|Patient decision to stop study treatment|5|||
16188181|NCT02207530|39165163|FG000|Overall Study|Adverse Event|8|||
16188182|NCT01419665|39165166|FG000|Combination Treatment|Adverse Event|7|||
16188183|NCT01419665|39165167|FG001|Combination Treatment|Adverse Event|10|||
16188184|NCT01419665|39165166|FG000|Combination Treatment|Physician Decision|5|||
16188185|NCT01419665|39165167|FG001|Combination Treatment|Physician Decision|8|||
16188186|NCT01419665|39165166|FG000|Combination Treatment|Protocol Violation|6|||
16188187|NCT01419665|39165167|FG001|Combination Treatment|Protocol Violation|2|||
16188188|NCT01419665|39165166|FG000|Combination Treatment|disease progression|10|||
16188189|NCT01419665|39165167|FG001|Combination Treatment|disease progression|9|||
16188190|NCT01419665|39165166|FG000|Combination Treatment|Death|5|||
16188191|NCT01419665|39165167|FG001|Combination Treatment|Death|7|||
16188192|NCT01419665|39165166|FG000|Combination Treatment|administrative problems|0|||
16188193|NCT01419665|39165167|FG001|Combination Treatment|administrative problems|1|||
16188194|NCT01419665|39165166|FG000|Combination Treatment|Withdrawal by Subject|5|||
16188195|NCT01419665|39165167|FG001|Combination Treatment|Withdrawal by Subject|4|||
16188196|NCT01419665|39165166|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
16188197|NCT01419665|39165167|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
16295118|NCT04625725|39563051|FG000|Overall Study|Protocol Violation|1|||
16188198|NCT01419665|39165166|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
16188199|NCT01419665|39165167|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
16188200|NCT01419665|39165166|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
16188201|NCT01419665|39165167|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
16188202|NCT01419665|39165166|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
16188203|NCT01419665|39165167|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
16188204|NCT01419665|39165166|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
16188205|NCT01419665|39165167|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
16188206|NCT01419665|39165166|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
16485277|NCT00256750|40252736|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
16188207|NCT01419665|39165167|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
16188208|NCT01419665|39165166|FG000|Maintenance Treatment and/or Follow up|Death|1|||
16188209|NCT01419665|39165167|FG001|Maintenance Treatment and/or Follow up|Death|2|||
16188210|NCT01419665|39165166|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
16188211|NCT01419665|39165167|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
16188212|NCT01419665|39165166|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
16188213|NCT01419665|39165167|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
16188214|NCT01419665|39165166|FG000|Open Label Phase|Death|1|||
16188215|NCT01419665|39165167|FG001|Open Label Phase|Death|0|||
16188216|NCT01419665|39165166|FG000|Open Label Phase|disease progression|0|||
16188217|NCT01419665|39165167|FG001|Open Label Phase|disease progression|1|||
16188218|NCT00540449|39165168|FG000|Overall Study|Adverse Event|12|||
16188219|NCT00540449|39165169|FG001|Overall Study|Adverse Event|32|||
16188220|NCT00540449|39165168|FG000|Overall Study|Sponsor's Decision|1|||
16188221|NCT00540449|39165169|FG001|Overall Study|Sponsor's Decision|1|||
16188222|NCT00540449|39165168|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
16188223|NCT00540449|39165169|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
16188224|NCT00540449|39165168|FG000|Overall Study|Lost to Follow-up|19|||
16188225|NCT00540449|39165169|FG001|Overall Study|Lost to Follow-up|17|||
16188226|NCT00540449|39165168|FG000|Overall Study|Subject Non-Compliant|7|||
16188227|NCT00540449|39165169|FG001|Overall Study|Subject Non-Compliant|5|||
16188228|NCT00540449|39165168|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
16188229|NCT00540449|39165169|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
16485278|NCT00256750|40252737|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
16485279|NCT00256750|40252738|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
16485280|NCT00256750|40252736|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
16485281|NCT00256750|40252737|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
16485282|NCT00256750|40252738|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
16485283|NCT00256750|40252736|FG000|Post-Transplant Treated (24 Months)|Death|3|||
16485284|NCT00256750|40252737|FG001|Post-Transplant Treated (24 Months)|Death|0|||
16485285|NCT00256750|40252738|FG002|Post-Transplant Treated (24 Months)|Death|0|||
16485286|NCT00256750|40252736|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
16485287|NCT00256750|40252737|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
16485288|NCT00256750|40252738|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
16485289|NCT00256750|40252736|FG000|Post-Transplant Treated (24 Months)|Other|2|||
16485290|NCT00256750|40252737|FG001|Post-Transplant Treated (24 Months)|Other|0|||
16485291|NCT00256750|40252738|FG002|Post-Transplant Treated (24 Months)|Other|1|||
16485292|NCT00256750|40252736|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
16485293|NCT00256750|40252737|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
16485294|NCT00256750|40252738|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
16485295|NCT00256750|40252736|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
16485296|NCT00256750|40252737|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
16485297|NCT00256750|40252738|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
16485298|NCT00256750|40252736|FG000|Post-Transplant Treated (36 Months)|Death|0|||
16485299|NCT00256750|40252737|FG001|Post-Transplant Treated (36 Months)|Death|2|||
16485300|NCT00256750|40252738|FG002|Post-Transplant Treated (36 Months)|Death|1|||
16485301|NCT00256750|40252736|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
16485302|NCT00256750|40252737|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
16485303|NCT00256750|40252738|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
16485304|NCT00256750|40252736|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
16485305|NCT00256750|40252737|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
16485306|NCT00256750|40252738|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
16485307|NCT00256750|40252736|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
16188230|NCT00540449|39165168|FG000|Overall Study|Withdrawal by Subject|10|||
16295119|NCT04625725|39563052|FG001|Overall Study|Protocol Violation|0|||
16188231|NCT00540449|39165169|FG001|Overall Study|Withdrawal by Subject|10|||
16188232|NCT00540449|39165168|FG000|Overall Study|Other|1|||
16188233|NCT00540449|39165169|FG001|Overall Study|Other|4|||
16188234|NCT00301067|39165170|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
16485308|NCT00256750|40252737|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
16485309|NCT00256750|40252738|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
16485310|NCT00256750|40252736|FG000|Post-Transplant Treated (36 Months)|Other|0|||
16485311|NCT00256750|40252737|FG001|Post-Transplant Treated (36 Months)|Other|1|||
16485312|NCT00256750|40252738|FG002|Post-Transplant Treated (36 Months)|Other|1|||
16485313|NCT00256750|40252736|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
16485314|NCT00256750|40252737|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
16485315|NCT00256750|40252738|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
16485316|NCT00256750|40252736|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
16485317|NCT00256750|40252737|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
16485318|NCT00256750|40252738|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
16485319|NCT00256750|40252736|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
16485320|NCT00256750|40252737|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
16485321|NCT00256750|40252738|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
16485322|NCT00256750|40252736|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
16485323|NCT00256750|40252737|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
16485324|NCT00256750|40252738|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
16485325|NCT00256750|40252736|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
16485326|NCT00256750|40252737|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
16485327|NCT00256750|40252738|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
16485328|NCT00256750|40252736|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
16485329|NCT00256750|40252737|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
16485330|NCT00256750|40252738|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
16485331|NCT00256750|40252736|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
16485332|NCT00256750|40252737|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
16485333|NCT00256750|40252738|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
16485334|NCT00256750|40252736|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
16485335|NCT00256750|40252737|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
16485336|NCT00256750|40252738|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
16485337|NCT00256750|40252736|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
16485338|NCT00256750|40252737|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
16485339|NCT00256750|40252738|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
16485340|NCT00289783|40252739|FG000|Primary Phase|Adverse Event|10|||
16485341|NCT00289783|40252740|FG001|Primary Phase|Adverse Event|1|||
16485342|NCT00289783|40252739|FG000|Primary Phase|Protocol Violation|27|||
16485343|NCT00289783|40252740|FG001|Primary Phase|Protocol Violation|6|||
16485344|NCT00289783|40252739|FG000|Primary Phase|Withdrawal by Subject|93|||
16485345|NCT00289783|40252740|FG001|Primary Phase|Withdrawal by Subject|40|||
16485346|NCT00289783|40252739|FG000|Primary Phase|Lost to Follow-up|60|||
16485347|NCT00289783|40252740|FG001|Primary Phase|Lost to Follow-up|14|||
16485348|NCT00289783|40252739|FG000|Primary Phase|Migration from the study area|26|||
16485349|NCT00289783|40252740|FG001|Primary Phase|Migration from the study area|10|||
16485350|NCT00289783|40252739|FG000|Primary Phase|Other|32|||
16295120|NCT04625725|39563051|FG000|Overall Study|Withdrawal by Subject|242|||
16295121|NCT04625725|39563052|FG001|Overall Study|Withdrawal by Subject|144|||
16295122|NCT04625725|39563051|FG000|Overall Study|Not specified otherwise|31|||
16295123|NCT04625725|39563052|FG001|Overall Study|Not specified otherwise|9|||
16295124|NCT04625725|39563051|FG000|Overall Study|Missing|0|||
16295125|NCT04625725|39563052|FG001|Overall Study|Missing|1|||
16295126|NCT02338193|39563053|FG000|Overall Study|Withdrawal by Subject|0|||
16295127|NCT02338193|39563054|FG001|Overall Study|Withdrawal by Subject|0|||
16485351|NCT00289783|40252740|FG001|Primary Phase|Other|12|||
16485352|NCT00289783|40252739|FG000|Fourth Dose Phase|Adverse Event|1|||
16485353|NCT00289783|40252740|FG001|Fourth Dose Phase|Adverse Event|0|||
16485354|NCT00289783|40252739|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
16295128|NCT02338193|39563055|FG002|Overall Study|Withdrawal by Subject|2|||
16295129|NCT02338193|39563053|FG000|Overall Study|Pregnancy|0|||
16485355|NCT00289783|40252740|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
16485356|NCT00289783|40252739|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
16485357|NCT00289783|40252740|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
16485358|NCT00289783|40252739|FG000|Fourth Dose Phase|Migration from the study area|1|||
16485359|NCT00289783|40252740|FG001|Fourth Dose Phase|Migration from the study area|1|||
16485360|NCT00289783|40252739|FG000|Fourth Dose Phase|Other|22|||
16485361|NCT00289783|40252740|FG001|Fourth Dose Phase|Other|10|||
16485362|NCT02756013|40252743|FG000|Overall Study|Adverse Event|1|||
16485363|NCT02756013|40252743|FG000|Overall Study|Hypersensitivity|1|||
16485364|NCT01269463|40252745|FG000|First Intervention|Withdrawal by Subject|1|||
16485365|NCT01269463|40252746|FG001|First Intervention|Withdrawal by Subject|0|||
16485366|NCT01269463|40252745|FG000|First Intervention|Adverse Event|1|||
16485367|NCT01269463|40252746|FG001|First Intervention|Adverse Event|0|||
16485368|NCT01269463|40252745|FG000|First Intervention|Lack of Efficacy|0|||
16485369|NCT01269463|40252746|FG001|First Intervention|Lack of Efficacy|1|||
16485370|NCT01269463|40252745|FG000|First Intervention|Physician Decision|0|||
16485371|NCT01269463|40252746|FG001|First Intervention|Physician Decision|1|||
16485372|NCT01578187|40252747|FG000|Usability Phase|Withdrawal by Subject|1|||
16485373|NCT00968201|40252748|FG000|Base Study - (Period II)|Adverse Event|8|||
16485374|NCT00968201|40252749|FG001|Base Study - (Period II)|Adverse Event|0|||
16485375|NCT00968201|40252750|FG002|Base Study - (Period II)|Adverse Event|16|||
16485376|NCT00968201|40252748|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
16485377|NCT00968201|40252749|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
16485378|NCT00968201|40252750|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
16485379|NCT00968201|40252748|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
16485380|NCT00968201|40252749|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
16485381|NCT00968201|40252750|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
16485382|NCT00968201|40252748|FG000|Base Study - (Period II)|Protocol Violation|12|||
16485383|NCT00968201|40252749|FG001|Base Study - (Period II)|Protocol Violation|0|||
16485384|NCT00968201|40252750|FG002|Base Study - (Period II)|Protocol Violation|12|||
16485385|NCT00968201|40252748|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
16485386|NCT00968201|40252749|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
16485387|NCT00968201|40252750|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
16485388|NCT00968201|40252748|FG000|Base Study - (Period II)|Site Error|0|||
16485389|NCT00968201|40252749|FG001|Base Study - (Period II)|Site Error|0|||
16485390|NCT00968201|40252750|FG002|Base Study - (Period II)|Site Error|1|||
16485391|NCT00968201|40252748|FG000|Extension Study - (Period III)|Adverse Event|0|||
16485392|NCT00968201|40252749|FG001|Extension Study - (Period III)|Adverse Event|5|||
16485393|NCT00968201|40252750|FG002|Extension Study - (Period III)|Adverse Event|22|||
16485394|NCT00968201|40252748|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
16485395|NCT00968201|40252749|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
16485396|NCT00968201|40252750|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
16485397|NCT00968201|40252748|FG000|Extension Study - (Period III)|Protocol Violation|0|||
16485398|NCT00968201|40252749|FG001|Extension Study - (Period III)|Protocol Violation|17|||
16485399|NCT00968201|40252750|FG002|Extension Study - (Period III)|Protocol Violation|14|||
16485400|NCT00968201|40252748|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
16485401|NCT00968201|40252749|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
16485402|NCT00968201|40252750|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
16485403|NCT00968201|40252748|FG000|Extension Study - (Period III)|Patient Relocated|0|||
16485404|NCT00968201|40252749|FG001|Extension Study - (Period III)|Patient Relocated|1|||
16485405|NCT00968201|40252750|FG002|Extension Study - (Period III)|Patient Relocated|1|||
16485406|NCT00968201|40252748|FG000|Extension Study - (Period III)|Noncompliance|0|||
16485407|NCT00968201|40252749|FG001|Extension Study - (Period III)|Noncompliance|0|||
16485408|NCT00968201|40252750|FG002|Extension Study - (Period III)|Noncompliance|3|||
16485409|NCT00968201|40252748|FG000|Extension Study - (Period III)|Other|0|||
16485410|NCT00968201|40252749|FG001|Extension Study - (Period III)|Other|0|||
16188235|NCT00301067|39165171|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
16188236|NCT00301067|39165172|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
16188237|NCT00301067|39165173|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
16188238|NCT00301067|39165170|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
16188239|NCT00301067|39165171|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
16485411|NCT00968201|40252750|FG002|Extension Study - (Period III)|Other|2|||
16485412|NCT00968201|40252748|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
16485413|NCT00968201|40252749|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
16485414|NCT00968201|40252750|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
16485415|NCT00105469|40252751|FG000|Overall Study|Adverse Event|9|||
16485416|NCT00105469|40252752|FG001|Overall Study|Adverse Event|8|||
16485417|NCT00105469|40252751|FG000|Overall Study|Protocol Violation|4|||
16485418|NCT00105469|40252752|FG001|Overall Study|Protocol Violation|0|||
16485419|NCT00105469|40252751|FG000|Overall Study|Withdrawal by Subject|2|||
16485420|NCT00105469|40252752|FG001|Overall Study|Withdrawal by Subject|3|||
16295130|NCT02338193|39563054|FG001|Overall Study|Pregnancy|1|||
16485421|NCT00105469|40252751|FG000|Overall Study|Lost to Follow-up|1|||
16485422|NCT00105469|40252752|FG001|Overall Study|Lost to Follow-up|0|||
16485423|NCT00105469|40252751|FG000|Overall Study|Lack of Efficacy|2|||
16485424|NCT00105469|40252752|FG001|Overall Study|Lack of Efficacy|0|||
16485425|NCT00105469|40252751|FG000|Overall Study|Other Reason|4|||
16485426|NCT00105469|40252752|FG001|Overall Study|Other Reason|0|||
16485427|NCT00293033|40252765|FG000|Open-label Titration Period|Adverse Event|10|||
16485428|NCT00293033|40252765|FG000|Open-label Titration Period|Death|3|||
16485429|NCT00293033|40252765|FG000|Open-label Titration Period|Lack of Efficacy|5|||
16485430|NCT00293033|40252765|FG000|Open-label Titration Period|Protocol Violation|2|||
16485431|NCT00293033|40252765|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
16485432|NCT00293033|40252765|FG000|Open-label Titration Period|Noncompliance and other|27|||
16485433|NCT00293033|40252765|FG000|Double-blind Treatment Period|Adverse Event|3|||
16485434|NCT00293033|40252765|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
16485435|NCT00293033|40252765|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
16485436|NCT00293033|40252765|FG000|Double-blind Treatment Period|Noncompliance|4|||
16485437|NCT01064310|40252766|FG000|Period 1|Adverse Event|7|||
16485438|NCT01064310|40252767|FG001|Period 1|Adverse Event|10|||
16485439|NCT01064310|40252768|FG002|Period 1|Adverse Event|0|||
16485440|NCT01064310|40252766|FG000|Period 1|Physician Decision|1|||
16485441|NCT01064310|40252767|FG001|Period 1|Physician Decision|0|||
16295131|NCT02338193|39563055|FG002|Overall Study|Pregnancy|1|||
16295132|NCT02338193|39563053|FG000|Overall Study|Noncompliant with visits|2|||
16295133|NCT02338193|39563054|FG001|Overall Study|Noncompliant with visits|2|||
16295134|NCT02338193|39563055|FG002|Overall Study|Noncompliant with visits|7|||
16295135|NCT02338193|39563053|FG000|Overall Study|moved out of state|0|||
16295136|NCT02338193|39563054|FG001|Overall Study|moved out of state|1|||
16295137|NCT02338193|39563055|FG002|Overall Study|moved out of state|0|||
16295138|NCT02338193|39563053|FG000|Overall Study|intolerant of side effects|1|||
16295139|NCT02338193|39563054|FG001|Overall Study|intolerant of side effects|0|||
16295140|NCT02338193|39563055|FG002|Overall Study|intolerant of side effects|0|||
16295141|NCT00085423|39563058|FG000|Overall Study|Withdrawal by Subject|1|||
16295142|NCT00085423|39563058|FG000|Overall Study|screen failure|1|||
16295143|NCT00856830|39563060|FG000|Irinotecan & Bendamustine|Death|0|||
16295144|NCT00856830|39563061|FG001|Irinotecan & Bendamustine|Death|0|||
16295145|NCT00856830|39563062|FG002|Irinotecan & Bendamustine|Death|0|||
16295146|NCT00856830|39563063|FG003|Irinotecan & Bendamustine|Death|2|||
16485442|NCT01064310|40252768|FG002|Period 1|Physician Decision|0|||
16485443|NCT01064310|40252766|FG000|Period 1|Withdrawal by Subject|2|||
16485444|NCT01064310|40252767|FG001|Period 1|Withdrawal by Subject|2|||
16485445|NCT01064310|40252768|FG002|Period 1|Withdrawal by Subject|0|||
16485446|NCT01064310|40252766|FG000|Period 1|Lack of Efficacy|3|||
16485447|NCT01064310|40252767|FG001|Period 1|Lack of Efficacy|5|||
16485448|NCT01064310|40252768|FG002|Period 1|Lack of Efficacy|0|||
16485449|NCT01064310|40252766|FG000|Period 1|Entered Open-label Period|1|||
16485450|NCT01064310|40252767|FG001|Period 1|Entered Open-label Period|1|||
16485451|NCT01064310|40252768|FG002|Period 1|Entered Open-label Period|0|||
16485452|NCT01064310|40252766|FG000|Period 2|Adverse Event|2|||
16485453|NCT01064310|40252767|FG001|Period 2|Adverse Event|1|||
16485454|NCT01064310|40252768|FG002|Period 2|Adverse Event|0|||
16485455|NCT01064310|40252766|FG000|Period 2|Physician Decision|0|||
16485456|NCT01064310|40252767|FG001|Period 2|Physician Decision|1|||
16485457|NCT01064310|40252768|FG002|Period 2|Physician Decision|0|||
16485458|NCT01064310|40252766|FG000|Period 2|Entered Open-label Period|1|||
16485459|NCT01064310|40252767|FG001|Period 2|Entered Open-label Period|0|||
16188240|NCT00301067|39165172|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
16188241|NCT00301067|39165173|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
16188242|NCT00301067|39165170|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
16188243|NCT00301067|39165171|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
16188244|NCT00301067|39165172|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
16188245|NCT00301067|39165173|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
16188246|NCT00301067|39165170|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
16188247|NCT00301067|39165171|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
16295147|NCT00856830|39563060|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
16295148|NCT00856830|39563061|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
16485460|NCT01064310|40252768|FG002|Period 2|Entered Open-label Period|0|||
16485461|NCT01064310|40252766|FG000|Period 2|Lack of Efficacy|1|||
16485462|NCT01064310|40252767|FG001|Period 2|Lack of Efficacy|4|||
16485463|NCT01064310|40252768|FG002|Period 2|Lack of Efficacy|0|||
16485464|NCT01064310|40252766|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
16485465|NCT01064310|40252767|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
16485466|NCT01064310|40252768|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
16295149|NCT00856830|39563062|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
16295150|NCT00856830|39563063|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
16485467|NCT01064310|40252766|FG000|Open Label Pazopinib|Adverse Event|0|||
16485468|NCT01064310|40252767|FG001|Open Label Pazopinib|Adverse Event|0|||
16485469|NCT01064310|40252768|FG002|Open Label Pazopinib|Adverse Event|12|||
16188248|NCT00301067|39165172|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
16295151|NCT02563106|39563064|FG000|Overall Study|Withdrawal by Subject|7|||
16295152|NCT02563106|39563065|FG001|Overall Study|Withdrawal by Subject|8|||
16295153|NCT02563106|39563064|FG000|Overall Study|Adverse Event|17|||
16295154|NCT02563106|39563065|FG001|Overall Study|Adverse Event|15|||
16295155|NCT02563106|39563064|FG000|Overall Study|Protocol Violation|1|||
16295156|NCT02563106|39563065|FG001|Overall Study|Protocol Violation|0|||
16295157|NCT02563106|39563064|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
16295158|NCT02563106|39563065|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
16295159|NCT02563106|39563064|FG000|Overall Study|Lost to Follow-up|3|||
16295160|NCT02563106|39563065|FG001|Overall Study|Lost to Follow-up|2|||
16295161|NCT02563106|39563064|FG000|Overall Study|Physician Decision|3|||
16295162|NCT02563106|39563065|FG001|Overall Study|Physician Decision|1|||
16295163|NCT02563106|39563064|FG000|Overall Study|Other reason - not specified|2|||
16295164|NCT02563106|39563065|FG001|Overall Study|Other reason - not specified|1|||
16295165|NCT01335997|39563067|FG000|Period I and II|Adverse Event|63|||
16295166|NCT01335997|39563068|FG001|Period I and II|Adverse Event|43|||
16295167|NCT01335997|39563067|FG000|Period I and II|Noncompliance with Study Drug|1|||
16295168|NCT01335997|39563068|FG001|Period I and II|Noncompliance with Study Drug|1|||
16295169|NCT01335997|39563067|FG000|Period I and II|Lost to Follow-up|3|||
16485470|NCT01064310|40252766|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
16485471|NCT01064310|40252767|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
16485472|NCT01064310|40252768|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
16485473|NCT01064310|40252766|FG000|Open Label Pazopinib|Physician Decision|0|||
16485474|NCT01064310|40252767|FG001|Open Label Pazopinib|Physician Decision|0|||
16485475|NCT01064310|40252768|FG002|Open Label Pazopinib|Physician Decision|20|||
16485476|NCT01896050|40252771|FG000|Overall Study|Adverse Event|37|||
16485477|NCT01896050|40252772|FG001|Overall Study|Adverse Event|2|||
16485478|NCT01896050|40252771|FG000|Overall Study|Death|1|||
16485479|NCT01896050|40252772|FG001|Overall Study|Death|0|||
16485480|NCT02339584|40252775|FG000|Overall Study|Adverse Event|11|||
16188249|NCT00301067|39165173|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
16188250|NCT00301067|39165170|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
16188251|NCT00301067|39165171|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
16188252|NCT00301067|39165172|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
16188253|NCT00301067|39165173|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
16188254|NCT00301067|39165170|FG000|Follow up Until Death|Alive at last data cut point|1|||
16188255|NCT00301067|39165171|FG001|Follow up Until Death|Alive at last data cut point|0|||
16188256|NCT00301067|39165172|FG002|Follow up Until Death|Alive at last data cut point|0|||
16188257|NCT00301067|39165173|FG003|Follow up Until Death|Alive at last data cut point|1|||
16188258|NCT02495077|39165175|FG000|Overall Study|Adverse Event|0|||
16188259|NCT02495077|39165176|FG001|Overall Study|Adverse Event|1|||
16188260|NCT02495077|39165177|FG002|Overall Study|Adverse Event|1|||
16188261|NCT02495077|39165178|FG003|Overall Study|Adverse Event|0|||
16188262|NCT02495077|39165175|FG000|Overall Study|Death|3|||
16188263|NCT02495077|39165176|FG001|Overall Study|Death|5|||
16188264|NCT02495077|39165177|FG002|Overall Study|Death|0|||
16188265|NCT02495077|39165178|FG003|Overall Study|Death|0|||
16188266|NCT02495077|39165175|FG000|Overall Study|Lost to Follow-up|6|||
16188267|NCT02495077|39165176|FG001|Overall Study|Lost to Follow-up|4|||
16188268|NCT02495077|39165177|FG002|Overall Study|Lost to Follow-up|0|||
16188269|NCT02495077|39165178|FG003|Overall Study|Lost to Follow-up|0|||
16188270|NCT02495077|39165175|FG000|Overall Study|Physician Decision|2|||
16188271|NCT02495077|39165176|FG001|Overall Study|Physician Decision|1|||
16188272|NCT02495077|39165177|FG002|Overall Study|Physician Decision|4|||
16188273|NCT02495077|39165178|FG003|Overall Study|Physician Decision|0|||
16188274|NCT02495077|39165175|FG000|Overall Study|Protocol Violation|0|||
16188275|NCT02495077|39165176|FG001|Overall Study|Protocol Violation|1|||
16188276|NCT02495077|39165177|FG002|Overall Study|Protocol Violation|0|||
16188277|NCT02495077|39165178|FG003|Overall Study|Protocol Violation|0|||
16188278|NCT02495077|39165175|FG000|Overall Study|Screen Failure|0|||
16188279|NCT02495077|39165176|FG001|Overall Study|Screen Failure|0|||
16188280|NCT02495077|39165177|FG002|Overall Study|Screen Failure|0|||
16188281|NCT02495077|39165178|FG003|Overall Study|Screen Failure|48|||
16188282|NCT02495077|39165175|FG000|Overall Study|Withdrawal by Subject|7|||
16295170|NCT01335997|39563068|FG001|Period I and II|Lost to Follow-up|5|||
16295171|NCT01335997|39563067|FG000|Period I and II|Withdrawal by Subject|9|||
16485481|NCT02339584|40252776|FG001|Overall Study|Adverse Event|7|||
16188283|NCT02495077|39165176|FG001|Overall Study|Withdrawal by Subject|7|||
16188284|NCT02495077|39165177|FG002|Overall Study|Withdrawal by Subject|7|||
16188285|NCT02495077|39165178|FG003|Overall Study|Withdrawal by Subject|0|||
16188286|NCT02495077|39165175|FG000|Overall Study|Covid-19 research restrictions|1|||
16188287|NCT02495077|39165176|FG001|Overall Study|Covid-19 research restrictions|0|||
16485482|NCT02339584|40252775|FG000|Overall Study|Lack of Efficacy|0|||
16188288|NCT02495077|39165177|FG002|Overall Study|Covid-19 research restrictions|0|||
16188289|NCT02495077|39165178|FG003|Overall Study|Covid-19 research restrictions|0|||
16295172|NCT01335997|39563068|FG001|Period I and II|Withdrawal by Subject|4|||
16485483|NCT02339584|40252776|FG001|Overall Study|Lack of Efficacy|1|||
16485484|NCT02339584|40252775|FG000|Overall Study|Physician Decision|1|||
16485485|NCT02339584|40252776|FG001|Overall Study|Physician Decision|2|||
16485486|NCT02339584|40252775|FG000|Overall Study|Protocol Violation|1|||
16485487|NCT02339584|40252776|FG001|Overall Study|Protocol Violation|1|||
16485488|NCT02339584|40252775|FG000|Overall Study|Withdrawal by Subject|2|||
16485489|NCT02339584|40252776|FG001|Overall Study|Withdrawal by Subject|4|||
16485490|NCT00639678|40252779|FG000|Overall Study|Withdrawal by Subject|3|||
16485491|NCT00639678|40252780|FG001|Overall Study|Withdrawal by Subject|0|||
16485492|NCT00639678|40252781|FG002|Overall Study|Withdrawal by Subject|4|||
16485493|NCT00639678|40252782|FG003|Overall Study|Withdrawal by Subject|0|||
16485494|NCT00639678|40252779|FG000|Overall Study|Lost to Follow-up|1|||
16485495|NCT00639678|40252780|FG001|Overall Study|Lost to Follow-up|0|||
16485496|NCT00639678|40252781|FG002|Overall Study|Lost to Follow-up|6|||
16485497|NCT00639678|40252782|FG003|Overall Study|Lost to Follow-up|0|||
16485498|NCT00639678|40252779|FG000|Overall Study|Adverse Event|0|||
16485499|NCT00639678|40252780|FG001|Overall Study|Adverse Event|1|||
16485500|NCT00639678|40252781|FG002|Overall Study|Adverse Event|0|||
16485501|NCT00639678|40252782|FG003|Overall Study|Adverse Event|0|||
16485502|NCT00639678|40252779|FG000|Overall Study|Lack of Compliance|0|||
16485503|NCT00639678|40252780|FG001|Overall Study|Lack of Compliance|0|||
16485504|NCT00639678|40252781|FG002|Overall Study|Lack of Compliance|1|||
16485505|NCT00639678|40252782|FG003|Overall Study|Lack of Compliance|0|||
16485506|NCT03298867|40255995|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
16485507|NCT03298867|40255996|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
16485508|NCT03298867|40255995|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
16485509|NCT03298867|40255996|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
16485510|NCT03298867|40255995|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
16485511|NCT03298867|40255996|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
16485512|NCT03298867|40255995|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
16485513|NCT03298867|40255996|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
16485514|NCT03298867|40255995|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
16485515|NCT03298867|40255996|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
16485516|NCT03298867|40255995|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
16485517|NCT03298867|40255996|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
16485518|NCT03298867|40255995|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
16485519|NCT03298867|40255996|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
16485520|NCT03298867|40255995|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
16485521|NCT03298867|40255996|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
16485522|NCT03298867|40255995|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
16485523|NCT03298867|40255996|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
16485524|NCT00743483|40255997|FG000|Baseline Period|Physician Decision|1|||
16485525|NCT00743483|40255997|FG000|Treatment Period|Adverse Event|1|||
16485526|NCT01513343|40256000|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
16485527|NCT01513343|40256001|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
16485528|NCT01513343|40256000|FG000|Post Data Collection|Dropped/withdrew from study|7|||
16485529|NCT01513343|40256001|FG001|Post Data Collection|Dropped/withdrew from study|1|||
16485530|NCT01513343|40256000|FG000|Post Data Collection|Lost to Follow-up|10|||
16485531|NCT01513343|40256001|FG001|Post Data Collection|Lost to Follow-up|23|||
16485532|NCT01513343|40256000|FG000|6-month Follow-up|Lost to Follow-up|28|||
16485533|NCT01513343|40256001|FG001|6-month Follow-up|Lost to Follow-up|17|||
16485534|NCT01513343|40256000|FG000|12-month Follow-up|Lost to Follow-up|10|||
16485535|NCT01513343|40256001|FG001|12-month Follow-up|Lost to Follow-up|3|||
16485536|NCT01484197|40256004|FG000|Treatment Period 1|Adverse Event|1|||
16485537|NCT01484197|40256005|FG001|Treatment Period 1|Adverse Event|0|||
16485538|NCT01484197|40256006|FG002|Treatment Period 1|Adverse Event|0|||
16485539|NCT01484197|40256007|FG003|Treatment Period 1|Adverse Event|0|||
16485540|NCT01484197|40256004|FG000|Treatment Period 2|Subject withdrew consent|0|||
16485541|NCT01484197|40256005|FG001|Treatment Period 2|Subject withdrew consent|0|||
16485542|NCT01484197|40256006|FG002|Treatment Period 2|Subject withdrew consent|0|||
16485543|NCT01484197|40256007|FG003|Treatment Period 2|Subject withdrew consent|1|||
16485544|NCT02619175|40256010|FG000|Overall Study|Withdrawal by Subject|1|||
16485545|NCT02619175|40256011|FG001|Overall Study|Withdrawal by Subject|0|||
16188290|NCT02495077|39165175|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
16188291|NCT02495077|39165176|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
16485546|NCT02619175|40256010|FG000|Overall Study|foot pain|1|||
16485547|NCT02619175|40256011|FG001|Overall Study|foot pain|0|||
16485548|NCT02200211|40256012|FG000|Overall Study|Lost to Follow-up|7|||
16485549|NCT02200211|40256013|FG001|Overall Study|Lost to Follow-up|7|||
16485550|NCT02200211|40256014|FG002|Overall Study|Lost to Follow-up|1|||
16485551|NCT02200211|40256015|FG003|Overall Study|Lost to Follow-up|2|||
16485552|NCT02200211|40256012|FG000|Overall Study|Withdrawal by Subject|1|||
16485553|NCT02200211|40256013|FG001|Overall Study|Withdrawal by Subject|0|||
16485554|NCT02200211|40256014|FG002|Overall Study|Withdrawal by Subject|0|||
16485555|NCT02200211|40256015|FG003|Overall Study|Withdrawal by Subject|0|||
16485556|NCT00851747|40256016|FG000|Overall Study|Physician Decision|6|||
16485557|NCT00851747|40256017|FG001|Overall Study|Physician Decision|6|||
16485558|NCT00851747|40256018|FG002|Overall Study|Physician Decision|6|||
16485559|NCT00667875|40256020|FG000|Overall Study|Adverse Event|0|||
16485560|NCT00667875|40256021|FG001|Overall Study|Adverse Event|2|||
16485561|NCT00667875|40256022|FG002|Overall Study|Adverse Event|6|||
16485562|NCT00667875|40256020|FG000|Overall Study|Withdrawal by Subject|10|||
16485563|NCT00667875|40256021|FG001|Overall Study|Withdrawal by Subject|9|||
16485564|NCT00667875|40256022|FG002|Overall Study|Withdrawal by Subject|7|||
16485565|NCT03521934|40256024|FG000|Overall Study|Death|65|||
16485566|NCT03521934|40256025|FG001|Overall Study|Death|73|||
16485567|NCT03521934|40256024|FG000|Overall Study|Withdrawal by Subject|18|||
16485568|NCT03521934|40256025|FG001|Overall Study|Withdrawal by Subject|23|||
16485569|NCT03521934|40256024|FG000|Overall Study|Site Terminated by Sponsor|39|||
16485570|NCT03521934|40256025|FG001|Overall Study|Site Terminated by Sponsor|35|||
16485571|NCT03521934|40256024|FG000|Overall Study|Study Terminated by Sponsor|483|||
16485572|NCT03521934|40256025|FG001|Overall Study|Study Terminated by Sponsor|477|||
16485573|NCT03521934|40256024|FG000|Overall Study|Reason not Specified|3|||
16485574|NCT03521934|40256025|FG001|Overall Study|Reason not Specified|6|||
16485575|NCT02591290|40256026|FG000|Overall Study|Withdrawal by Subject|2|||
16485576|NCT00114530|40256027|FG000|Overall Study|Death|3|||
16485577|NCT00114530|40256028|FG001|Overall Study|Death|11|||
16485578|NCT00114530|40256027|FG000|Overall Study|Lost to Follow-up|1|||
16485579|NCT00114530|40256028|FG001|Overall Study|Lost to Follow-up|1|||
16485580|NCT00114530|40256027|FG000|Overall Study|Physician Decision|1|||
16485581|NCT00114530|40256028|FG001|Overall Study|Physician Decision|1|||
16485582|NCT00114530|40256027|FG000|Overall Study|Withdrawal by Subject|2|||
16485583|NCT00114530|40256028|FG001|Overall Study|Withdrawal by Subject|6|||
16485584|NCT00114530|40256027|FG000|Overall Study|Breast Cancer|1|||
16485585|NCT00114530|40256028|FG001|Overall Study|Breast Cancer|0|||
16485586|NCT00114530|40256027|FG000|Overall Study|Subject decision after endpoint failure|0|||
16485587|NCT00114530|40256028|FG001|Overall Study|Subject decision after endpoint failure|1|||
16485588|NCT00114530|40256027|FG000|Overall Study|Ineligible|1|||
16485589|NCT00114530|40256028|FG001|Overall Study|Ineligible|0|||
16485590|NCT00074152|40256029|FG000|Overall Study|Death|21|||
16485591|NCT00074152|40256030|FG001|Overall Study|Death|9|||
16485592|NCT00074152|40256029|FG000|Overall Study|Lack of Efficacy|34|||
16485593|NCT00074152|40256030|FG001|Overall Study|Lack of Efficacy|24|||
16485594|NCT03681405|40256031|FG000|Overall Study|Found to be ineligible after randomized|1|||
16485595|NCT03681405|40256032|FG001|Overall Study|Found to be ineligible after randomized|0|||
16485596|NCT00594659|40256033|FG000|Overall Study|Lost to Follow-up|13|||
16485597|NCT00594659|40256034|FG001|Overall Study|Lost to Follow-up|9|||
16485598|NCT00594659|40256035|FG002|Overall Study|Lost to Follow-up|7|||
16485599|NCT00282984|40256042|FG000|Overall Study|Death|2|||
16485600|NCT00282984|40256043|FG001|Overall Study|Death|5|||
16485601|NCT00282984|40256042|FG000|Overall Study|Adverse Event|8|||
16485602|NCT00282984|40256043|FG001|Overall Study|Adverse Event|5|||
16485603|NCT00282984|40256042|FG000|Overall Study|Lack of Efficacy|0|||
16485604|NCT00282984|40256043|FG001|Overall Study|Lack of Efficacy|2|||
16485605|NCT00282984|40256042|FG000|Overall Study|Lost to Follow-up|14|||
16485606|NCT00282984|40256043|FG001|Overall Study|Lost to Follow-up|10|||
16485607|NCT00282984|40256042|FG000|Overall Study|Withdrawal by Participant|22|||
16485608|NCT00282984|40256043|FG001|Overall Study|Withdrawal by Participant|34|||
16485609|NCT00282984|40256042|FG000|Overall Study|Participant stopped study medication|2|||
16485610|NCT00282984|40256043|FG001|Overall Study|Participant stopped study medication|2|||
16485611|NCT00282984|40256042|FG000|Overall Study|Participant only allowed phone follow-up|0|||
16485612|NCT00282984|40256043|FG001|Overall Study|Participant only allowed phone follow-up|1|||
16485613|NCT00282984|40256042|FG000|Overall Study|Participant used antipsychosis meds|0|||
16485614|NCT00282984|40256043|FG001|Overall Study|Participant used antipsychosis meds|1|||
16485615|NCT00282984|40256042|FG000|Overall Study|lack of motivation|1|||
16485616|NCT00282984|40256043|FG001|Overall Study|lack of motivation|0|||
16485617|NCT00282984|40256042|FG000|Overall Study|in prison|0|||
16485618|NCT00282984|40256043|FG001|Overall Study|in prison|1|||
16485619|NCT00282984|40256042|FG000|Overall Study|Protocol Violation|2|||
16485620|NCT00282984|40256043|FG001|Overall Study|Protocol Violation|0|||
16485621|NCT02969369|40256044|FG000|Study|Adverse Event|1|||
16485622|NCT02969369|40256045|FG001|Study|Adverse Event|6|||
16485623|NCT02969369|40256044|FG000|Study|Lack of Efficacy|0|||
16485624|NCT02969369|40256045|FG001|Study|Lack of Efficacy|1|||
16485625|NCT02969369|40256044|FG000|Study|Lost to Follow-up|0|||
16485626|NCT02969369|40256045|FG001|Study|Lost to Follow-up|1|||
16485627|NCT02969369|40256044|FG000|Study|Withdrawal by Subject|3|||
16485628|NCT02969369|40256045|FG001|Study|Withdrawal by Subject|5|||
16485629|NCT02969369|40256044|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
16485630|NCT02969369|40256045|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
16485631|NCT02969369|40256044|FG000|Double-blind Period|Adverse Event|1|||
16485632|NCT02969369|40256045|FG001|Double-blind Period|Adverse Event|5|||
16485633|NCT02969369|40256044|FG000|Double-blind Period|Lost to Follow-up|0|||
16485634|NCT02969369|40256045|FG001|Double-blind Period|Lost to Follow-up|1|||
16485635|NCT02969369|40256044|FG000|Double-blind Period|Withdrawal by Subject|2|||
16485636|NCT02969369|40256045|FG001|Double-blind Period|Withdrawal by Subject|3|||
16485637|NCT02969369|40256044|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
16485638|NCT02969369|40256045|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
16485639|NCT02969369|40256044|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
16485640|NCT02969369|40256045|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
16485641|NCT02969369|40256044|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
16485642|NCT02969369|40256045|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
16485643|NCT02969369|40256044|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
16485644|NCT02969369|40256045|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
16485645|NCT00762385|40256048|FG000|First Intervention|Lens Issue|1|||
16485646|NCT00762385|40256049|FG001|First Intervention|Lens Issue|1|||
16485647|NCT00762385|40256048|FG000|First Intervention|Lost to Follow-up|0|||
16485648|NCT00762385|40256049|FG001|First Intervention|Lost to Follow-up|2|||
16485649|NCT00762385|40256048|FG000|First Intervention|Ineligible|1|||
16485650|NCT00762385|40256049|FG001|First Intervention|Ineligible|0|||
16485651|NCT00762385|40256048|FG000|First Intervention|Protocol Violation|0|||
16485652|NCT00762385|40256049|FG001|First Intervention|Protocol Violation|1|||
16485653|NCT00762385|40256048|FG000|Second Intervention|Protocol Violation|3|||
16485654|NCT00762385|40256049|FG001|Second Intervention|Protocol Violation|3|||
16485655|NCT03706456|40256051|FG000|Overall Study|Adverse Event|1|||
16485656|NCT03706456|40256051|FG000|Overall Study|Lack of Efficacy|2|||
16485657|NCT03060629|40256053|FG000|Overall Study|Death|4|||
16485658|NCT03060629|40256054|FG001|Overall Study|Death|5|||
16485659|NCT03060629|40256053|FG000|Overall Study|Withdrawal by Subject|50|||
16485660|NCT03060629|40256054|FG001|Overall Study|Withdrawal by Subject|35|||
16485661|NCT03060629|40256053|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
16485662|NCT03060629|40256054|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
16485663|NCT03060629|40256053|FG000|Overall Study|Participant Relocate|15|||
16485664|NCT03060629|40256054|FG001|Overall Study|Participant Relocate|15|||
16485665|NCT03060629|40256053|FG000|Overall Study|Unable to Contact Participant|34|||
16485666|NCT03060629|40256054|FG001|Overall Study|Unable to Contact Participant|23|||
16485667|NCT03060629|40256053|FG000|Overall Study|Investigator Decision|7|||
16485668|NCT03060629|40256054|FG001|Overall Study|Investigator Decision|7|||
16485669|NCT03060629|40256053|FG000|Overall Study|Study Terminated by Sponsor|1100|||
16485670|NCT03060629|40256054|FG001|Overall Study|Study Terminated by Sponsor|1123|||
16485671|NCT03060629|40256053|FG000|Overall Study|Other|4|||
16485672|NCT03060629|40256054|FG001|Overall Study|Other|4|||
16485673|NCT01169493|40256055|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
16485674|NCT01169493|40256056|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
16485675|NCT01169493|40256057|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
16485676|NCT01169493|40256058|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
16485677|NCT01169493|40256059|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
16485678|NCT01169493|40256060|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
16295173|NCT01335997|39563067|FG000|Period I and II|Study Terminated by Sponsor|406|||
16295174|NCT01335997|39563068|FG001|Period I and II|Study Terminated by Sponsor|415|||
16295175|NCT01335997|39563067|FG000|Period I and II|Protocol Violation|9|||
16295176|NCT01335997|39563068|FG001|Period I and II|Protocol Violation|10|||
16295177|NCT01335997|39563067|FG000|Period I and II|Physician Decision|2|||
16295178|NCT01335997|39563068|FG001|Period I and II|Physician Decision|1|||
16295179|NCT01335997|39563067|FG000|Period III|Adverse Event|0|||
16295180|NCT01335997|39563068|FG001|Period III|Adverse Event|2|||
16295181|NCT01335997|39563067|FG000|Period III|Study Terminated by Sponsor|77|||
16295182|NCT01335997|39563068|FG001|Period III|Study Terminated by Sponsor|76|||
16295183|NCT01335997|39563067|FG000|Period III|Protocol Violation|0|||
16485679|NCT01169493|40256055|FG000|Period 3 (6 Months)|Adverse Event|0|||
16485680|NCT01169493|40256056|FG001|Period 3 (6 Months)|Adverse Event|1|||
16485681|NCT01169493|40256057|FG002|Period 3 (6 Months)|Adverse Event|0|||
16485682|NCT01169493|40256058|FG003|Period 3 (6 Months)|Adverse Event|0|||
16485683|NCT01169493|40256059|FG004|Period 3 (6 Months)|Adverse Event|0|||
16485684|NCT01169493|40256060|FG005|Period 3 (6 Months)|Adverse Event|0|||
16485685|NCT01169493|40256055|FG000|Period 3 (6 Months)|Physician Decision|0|||
16485686|NCT01169493|40256056|FG001|Period 3 (6 Months)|Physician Decision|1|||
16485687|NCT01169493|40256057|FG002|Period 3 (6 Months)|Physician Decision|1|||
16485688|NCT01169493|40256058|FG003|Period 3 (6 Months)|Physician Decision|0|||
16485689|NCT01169493|40256059|FG004|Period 3 (6 Months)|Physician Decision|0|||
16485690|NCT01169493|40256060|FG005|Period 3 (6 Months)|Physician Decision|0|||
16295184|NCT01335997|39563068|FG001|Period III|Protocol Violation|1|||
16295185|NCT01335997|39563067|FG000|Period III|Lost to Follow-up|1|||
16295186|NCT01335997|39563068|FG001|Period III|Lost to Follow-up|0|||
16295187|NCT01177059|39563069|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
16295188|NCT01177059|39563069|FG000|Overall Study|Withdrew consent|2|||
16295189|NCT01177059|39563069|FG000|Overall Study|Lost to Follow-up|18|||
16295190|NCT02325518|39563070|FG000|Overall Study|Adverse Event|4|||
16295191|NCT02325518|39563071|FG001|Overall Study|Adverse Event|1|||
16295192|NCT02325518|39563070|FG000|Overall Study|Physician Decision|0|||
16295193|NCT02325518|39563071|FG001|Overall Study|Physician Decision|1|||
16295194|NCT02325518|39563070|FG000|Overall Study|Withdrawal by Subject|0|||
16295195|NCT02325518|39563071|FG001|Overall Study|Withdrawal by Subject|1|||
16295196|NCT01553279|39563073|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
16295197|NCT01553279|39563074|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
16295198|NCT01553279|39563073|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
16295199|NCT01553279|39563074|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
16295200|NCT01553279|39563073|FG000|Interim Period|Withdrawal by Subject|2|||
16295201|NCT01553279|39563074|FG001|Interim Period|Withdrawal by Subject|2|||
16295202|NCT01553279|39563073|FG000|Interim Period|Lost to Follow-up|1|||
16295203|NCT01553279|39563074|FG001|Interim Period|Lost to Follow-up|0|||
16295204|NCT01553279|39563073|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
16295205|NCT01553279|39563074|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
16295206|NCT01553279|39563073|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
16295207|NCT01553279|39563074|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
16295208|NCT00620555|39563075|FG000|Overall Study|Adverse Event|4|||
16295209|NCT00620555|39563075|FG000|Overall Study|Protocol Violation|2|||
16295210|NCT00620555|39563075|FG000|Overall Study|Lack of Efficacy|12|||
16295211|NCT00620555|39563075|FG000|Overall Study|Withdrawal by Subject|1|||
16295212|NCT00620555|39563075|FG000|Overall Study|Choice of other treatment|1|||
16295213|NCT00620555|39563075|FG000|Overall Study|Visit failure against planned|1|||
16295214|NCT00681590|39563076|FG000|Overall Study|Withdrawal by Subject|2|||
16485691|NCT01427972|40256064|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485692|NCT01427972|40256065|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485693|NCT01427972|40256066|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485694|NCT01427972|40256067|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485695|NCT01427972|40256068|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485696|NCT01427972|40256069|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485697|NCT01427972|40256070|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485698|NCT01427972|40256071|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
16485699|NCT01427972|40256072|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485700|NCT01427972|40256073|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485701|NCT01427972|40256074|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485702|NCT01427972|40256075|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
16485703|NCT01427972|40256064|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485704|NCT01427972|40256065|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485705|NCT01427972|40256066|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485706|NCT01427972|40256067|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485707|NCT01427972|40256068|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485708|NCT01427972|40256069|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
16485709|NCT01427972|40256070|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485710|NCT01427972|40256071|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485711|NCT01427972|40256072|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485712|NCT01427972|40256073|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485713|NCT01427972|40256074|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485714|NCT01427972|40256075|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
16485715|NCT01427972|40256064|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485716|NCT01427972|40256065|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
16485717|NCT01427972|40256066|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485718|NCT01427972|40256067|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485719|NCT01427972|40256068|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485720|NCT01427972|40256069|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485721|NCT01427972|40256070|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485722|NCT01427972|40256071|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485723|NCT01427972|40256072|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485724|NCT01427972|40256073|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485725|NCT01427972|40256074|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485726|NCT01427972|40256075|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
16485727|NCT04661839|40256076|FG000|Overall Study|Not Treated|0|||
16485728|NCT04661839|40256077|FG001|Overall Study|Not Treated|0|||
16485729|NCT04661839|40256078|FG002|Overall Study|Not Treated|1|||
16485730|NCT04661839|40256079|FG003|Overall Study|Not Treated|0|||
16485731|NCT04661839|40256076|FG000|Overall Study|Lost to Follow-up|1|||
16295215|NCT00681590|39563077|FG001|Overall Study|Withdrawal by Subject|12|||
16295216|NCT00506129|39563079|FG000|Overall Study|Disease Progression/Relapse|15|||
16485732|NCT04661839|40256077|FG001|Overall Study|Lost to Follow-up|0|||
16485733|NCT04661839|40256078|FG002|Overall Study|Lost to Follow-up|0|||
16485734|NCT04661839|40256079|FG003|Overall Study|Lost to Follow-up|1|||
16485735|NCT02571075|40256081|FG000|Overall Study|Lost to Follow-up|20|||
16485736|NCT02571075|40256082|FG001|Overall Study|Lost to Follow-up|24|||
16485737|NCT00640601|40256083|FG000|Overall Study|Adverse Event|43|||
16485738|NCT00640601|40256083|FG000|Overall Study|Withdrawal by Subject|20|||
16485739|NCT00640601|40256083|FG000|Overall Study|Protocol Violation|6|||
16485740|NCT00640601|40256083|FG000|Overall Study|Lack of Efficacy|16|||
16485741|NCT00640601|40256083|FG000|Overall Study|Lost to Follow-up|9|||
16485742|NCT00640601|40256083|FG000|Overall Study|Physician Decision|8|||
16485743|NCT00640601|40256083|FG000|Overall Study|treatment naive, combination therapy|10|||
16485744|NCT01201850|40256084|FG000|Overall Study|Tumor progression|4|||
16485745|NCT00453063|40256085|FG000|Overall Study|Adverse Event|1|||
16485746|NCT00453063|40256086|FG001|Overall Study|Adverse Event|2|||
16485747|NCT00453063|40256085|FG000|Overall Study|Withdrawal by Subject|1|||
16485748|NCT00453063|40256086|FG001|Overall Study|Withdrawal by Subject|1|||
16485749|NCT00453063|40256085|FG000|Overall Study|Protocol Violation|1|||
16485750|NCT00453063|40256086|FG001|Overall Study|Protocol Violation|0|||
16485751|NCT02854631|40256090|FG000|Overall Study|Adverse Event|1|||
16485752|NCT02854631|40256091|FG001|Overall Study|Adverse Event|2|||
16485753|NCT02854631|40256090|FG000|Overall Study|Withdrew Consent|3|||
16485754|NCT02854631|40256091|FG001|Overall Study|Withdrew Consent|2|||
16485755|NCT02854631|40256090|FG000|Overall Study|Investigator's Discretion|2|||
16485756|NCT02854631|40256091|FG001|Overall Study|Investigator's Discretion|0|||
16485757|NCT02854631|40256090|FG000|Overall Study|Death|12|||
16485758|NCT02854631|40256091|FG001|Overall Study|Death|8|||
16485759|NCT02854631|40256090|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
16485760|NCT02854631|40256091|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
16485761|NCT02854631|40256090|FG000|Overall Study|Protocol Violation|0|||
16485762|NCT02854631|40256091|FG001|Overall Study|Protocol Violation|1|||
16485763|NCT02854631|40256090|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
16485764|NCT02854631|40256091|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
16485765|NCT02854631|40256090|FG000|Overall Study|Lost to Follow-up|4|||
16485766|NCT02854631|40256091|FG001|Overall Study|Lost to Follow-up|2|||
16485767|NCT01962896|40256092|FG000|Overall Study|Lack of Efficacy|4|||
16485768|NCT00868608|40256093|FG000|Overall Study|Withdrawal by Subject|3|||
16485769|NCT00868608|40256094|FG001|Overall Study|Withdrawal by Subject|1|||
16485770|NCT00868608|40256095|FG002|Overall Study|Withdrawal by Subject|0|||
16485771|NCT00868608|40256093|FG000|Overall Study|Lost to Follow-up|3|||
16485772|NCT00868608|40256094|FG001|Overall Study|Lost to Follow-up|0|||
16485773|NCT00868608|40256095|FG002|Overall Study|Lost to Follow-up|1|||
16485774|NCT00868608|40256093|FG000|Overall Study|Death|16|||
16382544|NCT00806585|39884546|FG001|Overall Study|Physician Decision|2|||
16382545|NCT00806585|39884547|FG002|Overall Study|Physician Decision|3|||
16382546|NCT00806585|39884548|FG003|Overall Study|Physician Decision|0|||
16382547|NCT00806585|39884549|FG004|Overall Study|Physician Decision|1|||
16382548|NCT00806585|39884545|FG000|Overall Study|Lost to Follow-up|2|||
16485775|NCT00868608|40256094|FG001|Overall Study|Death|2|||
16485776|NCT00868608|40256095|FG002|Overall Study|Death|4|||
16485777|NCT00868608|40256093|FG000|Overall Study|Other - Unspecified|1|||
16485778|NCT00868608|40256094|FG001|Overall Study|Other - Unspecified|0|||
16485779|NCT00868608|40256095|FG002|Overall Study|Other - Unspecified|0|||
16485780|NCT00221403|40256096|FG000|Overall Study|Protocol Violation|1|||
16485781|NCT00221403|40256097|FG001|Overall Study|Protocol Violation|0|||
16485782|NCT00221403|40256098|FG002|Overall Study|Protocol Violation|0|||
16382549|NCT00806585|39884546|FG001|Overall Study|Lost to Follow-up|1|||
16382550|NCT00806585|39884547|FG002|Overall Study|Lost to Follow-up|2|||
16382551|NCT00806585|39884548|FG003|Overall Study|Lost to Follow-up|2|||
16485783|NCT00221403|40256096|FG000|Overall Study|Physician Decision|1|||
16485784|NCT00221403|40256097|FG001|Overall Study|Physician Decision|0|||
16485785|NCT00221403|40256098|FG002|Overall Study|Physician Decision|0|||
16485786|NCT00221403|40256096|FG000|Overall Study|Withdrawal by Subject|0|||
16485787|NCT00221403|40256097|FG001|Overall Study|Withdrawal by Subject|3|||
16485788|NCT00221403|40256098|FG002|Overall Study|Withdrawal by Subject|0|||
16485789|NCT00221403|40256096|FG000|Overall Study|Lack of Efficacy|0|||
16082213|NCT00632749|38792843|FG011|Overall Study|Refuse to continue medication|0|||
16082214|NCT00632749|38792844|FG012|Overall Study|Refuse to continue medication|0|||
16082215|NCT00632749|38792845|FG013|Overall Study|Refuse to continue medication|0|||
16082216|NCT00632749|38792832|FG000|Overall Study|Reason other than those specified above|0|||
16382552|NCT00806585|39884549|FG004|Overall Study|Lost to Follow-up|5|||
16382553|NCT00806585|39884545|FG000|Overall Study|Lack of Efficacy|1|||
16382554|NCT00806585|39884546|FG001|Overall Study|Lack of Efficacy|0|||
16382555|NCT00806585|39884547|FG002|Overall Study|Lack of Efficacy|0|||
16485790|NCT00221403|40256097|FG001|Overall Study|Lack of Efficacy|1|||
16485791|NCT00221403|40256098|FG002|Overall Study|Lack of Efficacy|0|||
16485792|NCT00221403|40256096|FG000|Overall Study|Adverse Event|0|||
16485793|NCT00221403|40256097|FG001|Overall Study|Adverse Event|1|||
16485794|NCT00221403|40256098|FG002|Overall Study|Adverse Event|0|||
16188292|NCT02495077|39165177|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
16188293|NCT02495077|39165178|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
16188294|NCT02495077|39165175|FG000|Overall Study|Incarcerated|0|||
16188295|NCT02495077|39165176|FG001|Overall Study|Incarcerated|1|||
16188296|NCT02495077|39165177|FG002|Overall Study|Incarcerated|0|||
16188297|NCT02495077|39165178|FG003|Overall Study|Incarcerated|0|||
16188298|NCT02495077|39165175|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
16188299|NCT02495077|39165176|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
16188300|NCT02495077|39165177|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
16188301|NCT02495077|39165178|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
16188302|NCT02495077|39165175|FG000|Overall Study|Timing of transplant and randomization|0|||
16188303|NCT02495077|39165176|FG001|Overall Study|Timing of transplant and randomization|0|||
16188304|NCT02495077|39165177|FG002|Overall Study|Timing of transplant and randomization|5|||
16188305|NCT02495077|39165178|FG003|Overall Study|Timing of transplant and randomization|0|||
16188306|NCT02834403|39165179|FG000|Overall Study|Physician Decision|2|||
16188307|NCT02834403|39165180|FG001|Overall Study|Physician Decision|1|||
16188308|NCT02834403|39165181|FG002|Overall Study|Physician Decision|2|||
16188309|NCT02834403|39165182|FG003|Overall Study|Physician Decision|1|||
16188310|NCT02834403|39165183|FG004|Overall Study|Physician Decision|1|||
16188311|NCT02834403|39165184|FG005|Overall Study|Physician Decision|2|||
16188312|NCT02834403|39165185|FG006|Overall Study|Physician Decision|12|||
16188313|NCT02834403|39165179|FG000|Overall Study|Adverse Event|0|||
16485795|NCT02197520|40256099|FG000|Period 1|Withdrawal by Subject|1|||
16485796|NCT02197520|40256100|FG001|Period 1|Withdrawal by Subject|0|||
16485797|NCT02197520|40256099|FG000|Period 2|Adverse Event|0|||
16485798|NCT02197520|40256100|FG001|Period 2|Adverse Event|2|||
16485799|NCT02197520|40256099|FG000|Period 2|Withdrawal by Subject|1|||
16485800|NCT02197520|40256100|FG001|Period 2|Withdrawal by Subject|0|||
16485801|NCT02439138|40256101|FG000|Overall Study|Adverse Event|1|||
16485802|NCT02439138|40256101|FG000|Overall Study|PI decision to terminate the study|2|||
16485803|NCT04786990|40256102|FG000|Overall Study|Withdrawal by Subject|1|||
16485804|NCT04786990|40256102|FG000|Overall Study|Adverse Event|1|||
16485805|NCT04786990|40256102|FG000|Overall Study|Lost to Follow-up|1|||
16485806|NCT04786990|40256102|FG000|Overall Study|Noncompliance|1|||
16485807|NCT04786990|40256102|FG000|Overall Study|Unable to complete site visits|1|||
16485808|NCT04786990|40256102|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
16485809|NCT04974697|40256103|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
16485810|NCT04974697|40256103|FG000|Overall Study|Lens discomfort|1|||
16485811|NCT01774968|40256105|FG000|Overall Study|Adverse Event|4|||
16485812|NCT01774968|40256106|FG001|Overall Study|Adverse Event|4|||
16485813|NCT01774968|40256105|FG000|Overall Study|Death|0|||
16485814|NCT01774968|40256106|FG001|Overall Study|Death|1|||
16485815|NCT01774968|40256105|FG000|Overall Study|Lost to Follow-up|1|||
16188314|NCT02834403|39165180|FG001|Overall Study|Adverse Event|0|||
16188315|NCT02834403|39165181|FG002|Overall Study|Adverse Event|0|||
16188316|NCT02834403|39165182|FG003|Overall Study|Adverse Event|0|||
16188317|NCT02834403|39165183|FG004|Overall Study|Adverse Event|1|||
16295217|NCT00506129|39563079|FG000|Overall Study|Death|7|||
16485816|NCT01774968|40256106|FG001|Overall Study|Lost to Follow-up|3|||
16485817|NCT01774968|40256105|FG000|Overall Study|Physician Decision|5|||
16485818|NCT01774968|40256106|FG001|Overall Study|Physician Decision|1|||
16485819|NCT01774968|40256105|FG000|Overall Study|Protocol Violation|14|||
16485820|NCT01774968|40256106|FG001|Overall Study|Protocol Violation|13|||
16188318|NCT02834403|39165184|FG005|Overall Study|Adverse Event|1|||
16188319|NCT02834403|39165185|FG006|Overall Study|Adverse Event|3|||
16188320|NCT02834403|39165179|FG000|Overall Study|Withdrawal by Subject|0|||
16188321|NCT02834403|39165180|FG001|Overall Study|Withdrawal by Subject|1|||
16188322|NCT02834403|39165181|FG002|Overall Study|Withdrawal by Subject|0|||
16188323|NCT02834403|39165182|FG003|Overall Study|Withdrawal by Subject|0|||
16188324|NCT02834403|39165183|FG004|Overall Study|Withdrawal by Subject|1|||
16188325|NCT02834403|39165184|FG005|Overall Study|Withdrawal by Subject|0|||
16188326|NCT02834403|39165185|FG006|Overall Study|Withdrawal by Subject|0|||
16188327|NCT02834403|39165179|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
16188328|NCT02834403|39165180|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
16188329|NCT02834403|39165181|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
16188330|NCT02834403|39165182|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
16188331|NCT02834403|39165183|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
16188332|NCT02834403|39165184|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
16188333|NCT02834403|39165185|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
16188334|NCT04598165|39165188|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
16188335|NCT04598165|39165189|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
16188336|NCT04598165|39165188|FG000|Completed 6-week Follow-up|Death|2|||
16188337|NCT04598165|39165189|FG001|Completed 6-week Follow-up|Death|1|||
16188338|NCT04598165|39165188|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
16188339|NCT04598165|39165189|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
16188340|NCT04598165|39165188|FG000|Completed 6-week Follow-up|Ineligible|4|||
16188341|NCT04598165|39165189|FG001|Completed 6-week Follow-up|Ineligible|3|||
16485821|NCT01774968|40256105|FG000|Overall Study|Sponsor Decision|0|||
16485822|NCT01774968|40256106|FG001|Overall Study|Sponsor Decision|2|||
16485823|NCT01774968|40256105|FG000|Overall Study|Withdrawal by Subject|6|||
16485824|NCT01774968|40256106|FG001|Overall Study|Withdrawal by Subject|11|||
16485825|NCT05229406|40256107|FG000|Overall Study|Withdrawal by Subject|1|||
16485826|NCT05229406|40256108|FG001|Overall Study|Withdrawal by Subject|2|||
16485827|NCT03868124|40256109|FG000|Overall Study|Withdrawal by Subject|4|||
16485828|NCT03868124|40256110|FG001|Overall Study|Withdrawal by Subject|0|||
16485829|NCT03868124|40256111|FG002|Overall Study|Withdrawal by Subject|1|||
16485830|NCT03868124|40256109|FG000|Overall Study|Physician Decision|1|||
16485831|NCT03868124|40256110|FG001|Overall Study|Physician Decision|0|||
16485832|NCT03868124|40256111|FG002|Overall Study|Physician Decision|1|||
16485833|NCT03868124|40256109|FG000|Overall Study|Lost to Follow-up|1|||
16485834|NCT03868124|40256110|FG001|Overall Study|Lost to Follow-up|1|||
16485835|NCT03868124|40256111|FG002|Overall Study|Lost to Follow-up|2|||
16485836|NCT03868124|40256109|FG000|Overall Study|Death|1|||
16485837|NCT03868124|40256110|FG001|Overall Study|Death|1|||
16485838|NCT03868124|40256111|FG002|Overall Study|Death|2|||
16485839|NCT03868124|40256109|FG000|Overall Study|Adverse Event|0|||
16485840|NCT03868124|40256110|FG001|Overall Study|Adverse Event|0|||
16485841|NCT03868124|40256111|FG002|Overall Study|Adverse Event|3|||
16485842|NCT03868124|40256109|FG000|Overall Study|Explanted|2|||
16485843|NCT03868124|40256110|FG001|Overall Study|Explanted|1|||
16485844|NCT03868124|40256111|FG002|Overall Study|Explanted|0|||
16485845|NCT03868124|40256109|FG000|Overall Study|Ongoing in study|176|||
16485846|NCT03868124|40256110|FG001|Overall Study|Ongoing in study|180|||
16485847|NCT03868124|40256111|FG002|Overall Study|Ongoing in study|183|||
16485848|NCT02795832|40256113|FG000|Overall Study|Adverse Event|0|||
16485849|NCT02795832|40256114|FG001|Overall Study|Adverse Event|0|||
16188342|NCT04598165|39165188|FG000|Completed 6-week Follow-up|Partner refusal|0|||
16188343|NCT04598165|39165189|FG001|Completed 6-week Follow-up|Partner refusal|1|||
16188344|NCT04598165|39165188|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
16188345|NCT04598165|39165189|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
16188346|NCT01915849|39165190|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
16188347|NCT01915849|39165191|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
16188348|NCT01915849|39165192|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
16188349|NCT01915849|39165193|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
16188350|NCT01915849|39165190|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
16485850|NCT02795832|40256115|FG002|Overall Study|Adverse Event|0|||
16485851|NCT02795832|40256116|FG003|Overall Study|Adverse Event|0|||
16485852|NCT02795832|40256117|FG004|Overall Study|Adverse Event|0|||
16485853|NCT02795832|40256118|FG005|Overall Study|Adverse Event|3|||
16485854|NCT00672646|40256119|FG000|Overall Study|Lost to Follow-up|0|||
16485855|NCT00672646|40256120|FG001|Overall Study|Lost to Follow-up|1|||
16485856|NCT00672646|40256121|FG002|Overall Study|Lost to Follow-up|2|||
16485857|NCT00672646|40256119|FG000|Overall Study|Withdrawal by Subject|0|||
16485858|NCT00672646|40256120|FG001|Overall Study|Withdrawal by Subject|0|||
16485859|NCT00672646|40256121|FG002|Overall Study|Withdrawal by Subject|1|||
16485860|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
16485861|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
16485862|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
16485863|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
16485864|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
16485865|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
16485866|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
16485867|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
16485868|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
16188351|NCT01915849|39165191|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16188352|NCT01915849|39165192|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16188353|NCT01915849|39165193|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16188354|NCT00546819|39165197|FG000|Overall Study|Adverse Event|2|||
16188355|NCT00546819|39165198|FG001|Overall Study|Adverse Event|3|||
16188356|NCT00546819|39165197|FG000|Overall Study|Lost to Follow-up|2|||
16188357|NCT00546819|39165198|FG001|Overall Study|Lost to Follow-up|1|||
16188358|NCT00546819|39165197|FG000|Overall Study|Withdrawal by Subject|4|||
16188359|NCT00546819|39165198|FG001|Overall Study|Withdrawal by Subject|2|||
16188360|NCT00051558|39165206|FG000|Overall Study|Adverse Event|30|||
16188361|NCT00051558|39165207|FG001|Overall Study|Adverse Event|18|||
16188362|NCT00051558|39165206|FG000|Overall Study|Withdrawal by Subject|29|||
16188363|NCT00051558|39165207|FG001|Overall Study|Withdrawal by Subject|42|||
16188364|NCT00051558|39165206|FG000|Overall Study|Death|9|||
16188365|NCT00051558|39165207|FG001|Overall Study|Death|15|||
16188366|NCT00051558|39165206|FG000|Overall Study|Lost to Follow-up|4|||
16188367|NCT00051558|39165207|FG001|Overall Study|Lost to Follow-up|13|||
16188368|NCT00051558|39165206|FG000|Overall Study|Protocol Violation|3|||
16188369|NCT00051558|39165207|FG001|Overall Study|Protocol Violation|4|||
16382556|NCT00806585|39884548|FG003|Overall Study|Lack of Efficacy|0|||
16382557|NCT00806585|39884549|FG004|Overall Study|Lack of Efficacy|0|||
16382558|NCT00806585|39884545|FG000|Overall Study|Adverse Event|1|||
16382559|NCT00806585|39884546|FG001|Overall Study|Adverse Event|5|||
16382560|NCT00806585|39884547|FG002|Overall Study|Adverse Event|3|||
16382561|NCT00806585|39884548|FG003|Overall Study|Adverse Event|4|||
16382562|NCT00806585|39884549|FG004|Overall Study|Adverse Event|2|||
16382563|NCT00806585|39884545|FG000|Overall Study|Withdrawal by Subject|10|||
16382564|NCT00806585|39884546|FG001|Overall Study|Withdrawal by Subject|8|||
16382565|NCT00806585|39884547|FG002|Overall Study|Withdrawal by Subject|9|||
16382566|NCT00806585|39884548|FG003|Overall Study|Withdrawal by Subject|3|||
16382567|NCT00806585|39884549|FG004|Overall Study|Withdrawal by Subject|11|||
16382568|NCT00806585|39884545|FG000|Overall Study|Completion status unknown|15|||
16382569|NCT00806585|39884546|FG001|Overall Study|Completion status unknown|14|||
16382570|NCT00806585|39884547|FG002|Overall Study|Completion status unknown|12|||
16382571|NCT00806585|39884548|FG003|Overall Study|Completion status unknown|4|||
16382572|NCT00806585|39884549|FG004|Overall Study|Completion status unknown|12|||
16382573|NCT03937479|39884550|FG000|Overall Study|Adverse Event|2|||
16382574|NCT03937479|39884551|FG001|Overall Study|Adverse Event|3|||
16382575|NCT03937479|39884552|FG002|Overall Study|Adverse Event|0|||
16382576|NCT03937479|39884553|FG003|Overall Study|Adverse Event|0|||
16382577|NCT03937479|39884554|FG004|Overall Study|Adverse Event|1|||
16382578|NCT03937479|39884550|FG000|Overall Study|Withdrawal by Subject|3|||
16382579|NCT03937479|39884551|FG001|Overall Study|Withdrawal by Subject|5|||
16382580|NCT03937479|39884552|FG002|Overall Study|Withdrawal by Subject|2|||
16382581|NCT03937479|39884553|FG003|Overall Study|Withdrawal by Subject|2|||
16382582|NCT03937479|39884554|FG004|Overall Study|Withdrawal by Subject|1|||
16382583|NCT03937479|39884550|FG000|Overall Study|Protocol Violation|5|||
16485869|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
16188370|NCT00051558|39165206|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
16188371|NCT00051558|39165207|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
16188372|NCT00051558|39165206|FG000|Overall Study|Sponsor Decision|6|||
16188373|NCT00051558|39165207|FG001|Overall Study|Sponsor Decision|1|||
16382584|NCT03937479|39884551|FG001|Overall Study|Protocol Violation|6|||
16382585|NCT03937479|39884552|FG002|Overall Study|Protocol Violation|4|||
16382586|NCT03937479|39884553|FG003|Overall Study|Protocol Violation|3|||
16382587|NCT03937479|39884554|FG004|Overall Study|Protocol Violation|2|||
16382588|NCT03937479|39884550|FG000|Overall Study|Lost to Follow-up|0|||
16382589|NCT03937479|39884551|FG001|Overall Study|Lost to Follow-up|1|||
16485870|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
16188374|NCT00051558|39165206|FG000|Overall Study|Other|2|||
16188375|NCT00051558|39165207|FG001|Overall Study|Other|1|||
16188376|NCT00051558|39165206|FG000|Overall Study|Significant Lab Value|2|||
16188377|NCT00051558|39165207|FG001|Overall Study|Significant Lab Value|0|||
16188378|NCT00051558|39165206|FG000|Overall Study|Physician Decision|5|||
16188379|NCT00051558|39165207|FG001|Overall Study|Physician Decision|0|||
16188380|NCT01931462|39169342|FG000|Overall Study|Withdrawal by Subject|1|||
16188381|NCT00940342|39169343|FG000|Overall Study|Adverse Event|0|||
16188382|NCT00940342|39169344|FG001|Overall Study|Adverse Event|2|||
16188383|NCT00940342|39169345|FG002|Overall Study|Adverse Event|1|||
16188384|NCT01930799|39169347|FG000|Overall Study|Withdrawal by Subject|3|||
16188385|NCT01930799|39169347|FG000|Overall Study|Lost to Follow-up|5|||
16188386|NCT02402218|39169348|FG000|Overall Study|Did not pickup study medication|12|||
16188387|NCT02402218|39169349|FG001|Overall Study|Did not pickup study medication|9|||
16188388|NCT02402218|39169350|FG002|Overall Study|Did not pickup study medication|13|||
16295218|NCT00724048|39566154|FG000|Overall Study|Adverse Event|1|||
16295219|NCT00724048|39566155|FG001|Overall Study|Adverse Event|1|||
16295220|NCT00724048|39566156|FG002|Overall Study|Adverse Event|1|||
16295221|NCT00724048|39566157|FG003|Overall Study|Adverse Event|0|||
16295222|NCT00724048|39566154|FG000|Overall Study|Lost to Follow-up|0|||
16295223|NCT00724048|39566155|FG001|Overall Study|Lost to Follow-up|1|||
16295224|NCT00724048|39566156|FG002|Overall Study|Lost to Follow-up|0|||
16295225|NCT00724048|39566157|FG003|Overall Study|Lost to Follow-up|0|||
16295226|NCT00724048|39566154|FG000|Overall Study|Withdrawal by Subject|1|||
16295227|NCT00724048|39566155|FG001|Overall Study|Withdrawal by Subject|2|||
16295228|NCT00724048|39566156|FG002|Overall Study|Withdrawal by Subject|1|||
16295229|NCT00724048|39566157|FG003|Overall Study|Withdrawal by Subject|2|||
16295230|NCT00724048|39566154|FG000|Overall Study|Investigator decision|0|||
16295231|NCT00724048|39566155|FG001|Overall Study|Investigator decision|0|||
16295232|NCT00724048|39566156|FG002|Overall Study|Investigator decision|1|||
16295233|NCT00724048|39566157|FG003|Overall Study|Investigator decision|0|||
16295234|NCT00724048|39566154|FG000|Overall Study|Did not tolerate study drug|0|||
16295235|NCT00724048|39566155|FG001|Overall Study|Did not tolerate study drug|0|||
16295236|NCT00724048|39566156|FG002|Overall Study|Did not tolerate study drug|0|||
16295237|NCT00724048|39566157|FG003|Overall Study|Did not tolerate study drug|1|||
16295238|NCT00724048|39566154|FG000|Overall Study|Other than specified|1|||
16295239|NCT00724048|39566155|FG001|Overall Study|Other than specified|1|||
16295240|NCT00724048|39566156|FG002|Overall Study|Other than specified|0|||
16295241|NCT00724048|39566157|FG003|Overall Study|Other than specified|0|||
16295242|NCT02585934|39566158|FG000|Overall Study|Lost to Follow-up|2|||
16295243|NCT02585934|39566159|FG001|Overall Study|Lost to Follow-up|2|||
16295244|NCT02585934|39566158|FG000|Overall Study|Protocol Violation|14|||
16485871|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
16485872|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
16485873|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
16295245|NCT02585934|39566159|FG001|Overall Study|Protocol Violation|11|||
16295246|NCT02585934|39566158|FG000|Overall Study|Adverse Event|21|||
16295247|NCT02585934|39566159|FG001|Overall Study|Adverse Event|22|||
16295248|NCT02585934|39566158|FG000|Overall Study|Physician Decision|3|||
16295249|NCT02585934|39566159|FG001|Overall Study|Physician Decision|2|||
16295250|NCT02585934|39566158|FG000|Overall Study|Withdrawal by Subject|7|||
16295251|NCT02585934|39566159|FG001|Overall Study|Withdrawal by Subject|21|||
16295252|NCT02585934|39566158|FG000|Overall Study|Lack of Efficacy|2|||
16295253|NCT02585934|39566159|FG001|Overall Study|Lack of Efficacy|1|||
16295254|NCT02585934|39566158|FG000|Overall Study|Death|2|||
16295255|NCT02585934|39566159|FG001|Overall Study|Death|0|||
16295256|NCT02585934|39566158|FG000|Overall Study|Caregiver Withdrew Consent|7|||
16295257|NCT02585934|39566159|FG001|Overall Study|Caregiver Withdrew Consent|7|||
16295258|NCT02585934|39566158|FG000|Overall Study|Sponsor Termination|1|||
16295259|NCT02585934|39566159|FG001|Overall Study|Sponsor Termination|2|||
16295260|NCT02585934|39566158|FG000|Overall Study|Another Reason|10|||
16295261|NCT02585934|39566159|FG001|Overall Study|Another Reason|5|||
16295262|NCT00049530|39566165|FG000|Overall Study|Lack of Efficacy|25|||
16295263|NCT00049530|39566165|FG000|Overall Study|Adverse Event|2|||
16295264|NCT00049530|39566165|FG000|Overall Study|Death|1|||
16295265|NCT00049530|39566165|FG000|Overall Study|symptomatic deterioration|1|||
16295266|NCT00049530|39566165|FG000|Overall Study|ineligible|3|||
16295267|NCT01959035|39566171|FG000|Overall Study|Adverse Event|5|||
16295268|NCT01959035|39566171|FG000|Overall Study|Withdrawal by Subject|4|||
16188389|NCT02402218|39169348|FG000|Overall Study|Lack of Efficacy|0|||
16188390|NCT02402218|39169349|FG001|Overall Study|Lack of Efficacy|1|||
16295269|NCT01959035|39566171|FG000|Overall Study|Lost to Follow-up|1|||
16295270|NCT01959035|39566171|FG000|Overall Study|Other (no primary reason given)|1|||
16295271|NCT01030341|39566172|FG000|Overall Study|Withdrawal by Subject|1|||
16295272|NCT01030341|39566172|FG000|Overall Study|Lost to Follow-up|2|||
16295273|NCT01783548|39566173|FG000|Overall Study|Adverse Event|8|||
16188391|NCT02402218|39169350|FG002|Overall Study|Lack of Efficacy|1|||
16295274|NCT01783548|39566174|FG001|Overall Study|Adverse Event|4|||
16485874|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
16485875|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
16485876|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
16485877|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
16485878|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
16485879|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
16485880|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
16485881|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
16485882|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
16485883|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
16188392|NCT02402218|39169348|FG000|Overall Study|Death|1|||
16485884|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
16485885|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
16485886|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
16485887|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
16485888|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
16485889|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
16485890|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
16485891|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
16485892|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
16485893|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
16485894|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
16485895|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
16485896|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
16485897|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
16485898|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
16485899|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
16485900|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
16485901|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
16485902|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
16485903|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
16485904|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
16485905|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
16485906|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
16485907|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
16485908|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
16485909|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
16485910|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
16485911|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
16485912|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
16485913|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
16188393|NCT02402218|39169349|FG001|Overall Study|Death|0|||
16188394|NCT02402218|39169350|FG002|Overall Study|Death|0|||
16188395|NCT02402218|39169348|FG000|Overall Study|Reinfection|0|||
16188396|NCT02402218|39169349|FG001|Overall Study|Reinfection|0|||
16188397|NCT02402218|39169350|FG002|Overall Study|Reinfection|1|||
16188398|NCT02402218|39169348|FG000|Overall Study|Adverse Event|0|||
16188399|NCT02402218|39169349|FG001|Overall Study|Adverse Event|2|||
16188400|NCT02402218|39169350|FG002|Overall Study|Adverse Event|1|||
16188401|NCT02402218|39169348|FG000|Overall Study|Withdrawal by Subject|1|||
16188402|NCT02402218|39169349|FG001|Overall Study|Withdrawal by Subject|1|||
16188403|NCT02402218|39169350|FG002|Overall Study|Withdrawal by Subject|1|||
16188404|NCT01457118|39169351|FG000|Overall Study|Adverse Event|1|||
16188405|NCT01457118|39169352|FG001|Overall Study|Adverse Event|0|||
16188406|NCT01457118|39169353|FG002|Overall Study|Adverse Event|0|||
16188407|NCT01457118|39169354|FG003|Overall Study|Adverse Event|1|||
16188408|NCT01457118|39169351|FG000|Overall Study|Clinical Progression|0|||
16188409|NCT01457118|39169352|FG001|Overall Study|Clinical Progression|1|||
16188410|NCT01457118|39169353|FG002|Overall Study|Clinical Progression|0|||
16188411|NCT01457118|39169354|FG003|Overall Study|Clinical Progression|1|||
16188412|NCT01457118|39169351|FG000|Overall Study|Physician Decision|2|||
16188413|NCT01457118|39169352|FG001|Overall Study|Physician Decision|0|||
16188414|NCT01457118|39169353|FG002|Overall Study|Physician Decision|0|||
16188415|NCT01457118|39169354|FG003|Overall Study|Physician Decision|0|||
16188416|NCT01457118|39169351|FG000|Overall Study|Progressive Disease by RECIST|12|||
16188417|NCT01457118|39169352|FG001|Overall Study|Progressive Disease by RECIST|3|||
16188418|NCT01457118|39169353|FG002|Overall Study|Progressive Disease by RECIST|1|||
16188419|NCT01457118|39169354|FG003|Overall Study|Progressive Disease by RECIST|0|||
16188420|NCT01457118|39169351|FG000|Overall Study|Withdrawal by Subject|5|||
16485914|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
16485915|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
16485916|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
16485917|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
16485918|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
16485919|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
16485920|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
16485921|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
16485922|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
16485923|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
16485924|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
16485925|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
16485926|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
16485927|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
16485928|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
16485929|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
16382590|NCT03937479|39884552|FG002|Overall Study|Lost to Follow-up|0|||
16382591|NCT03937479|39884553|FG003|Overall Study|Lost to Follow-up|1|||
16382592|NCT03937479|39884554|FG004|Overall Study|Lost to Follow-up|0|||
16382593|NCT03937479|39884550|FG000|Overall Study|Physician Decision|0|||
16382594|NCT03937479|39884551|FG001|Overall Study|Physician Decision|0|||
16382595|NCT03937479|39884552|FG002|Overall Study|Physician Decision|1|||
16382596|NCT03937479|39884553|FG003|Overall Study|Physician Decision|0|||
16382597|NCT03937479|39884554|FG004|Overall Study|Physician Decision|1|||
16382598|NCT03983421|39884555|FG000|Overall Study|Lost to Follow-up|1|||
16382599|NCT01722669|39884556|FG000|Overall Study|Withdrawal by Subject|0|||
16382600|NCT01722669|39884557|FG001|Overall Study|Withdrawal by Subject|0|||
16382601|NCT01722669|39884558|FG002|Overall Study|Withdrawal by Subject|0|||
16382602|NCT01722669|39884559|FG003|Overall Study|Withdrawal by Subject|0|||
16382603|NCT01722669|39884560|FG004|Overall Study|Withdrawal by Subject|0|||
16382604|NCT01722669|39884561|FG005|Overall Study|Withdrawal by Subject|2|||
16382605|NCT00582907|39884562|FG000|1st Course|Withdrawal by Subject|1|||
16382606|NCT00582907|39884563|FG001|1st Course|Withdrawal by Subject|0|||
16382607|NCT00582907|39884564|FG002|1st Course|Withdrawal by Subject|0|||
16382608|NCT00582907|39884565|FG003|1st Course|Withdrawal by Subject|0|||
16382609|NCT00582907|39884562|FG000|1st Course|Lost to Follow-up|0|||
16382610|NCT00582907|39884563|FG001|1st Course|Lost to Follow-up|0|||
16382611|NCT00582907|39884564|FG002|1st Course|Lost to Follow-up|0|||
16382612|NCT00582907|39884565|FG003|1st Course|Lost to Follow-up|1|||
16382613|NCT00582907|39884562|FG000|2nd Course|Lack of Efficacy|1|||
16485930|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Change of location|0|||
16382614|NCT00582907|39884563|FG001|2nd Course|Lack of Efficacy|0|||
16382615|NCT00582907|39884564|FG002|2nd Course|Lack of Efficacy|0|||
16382616|NCT00582907|39884565|FG003|2nd Course|Lack of Efficacy|0|||
16382617|NCT01936831|39884566|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
16382618|NCT01936831|39884567|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
16382619|NCT01936831|39884568|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
16382620|NCT01936831|39884569|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
16382621|NCT01936831|39884570|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
16382622|NCT01936831|39884571|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
16382623|NCT01936831|39884572|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
16382624|NCT01936831|39884573|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
16382625|NCT01936831|39884574|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
16382626|NCT02136914|39884578|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
16382627|NCT02136914|39884579|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
16382628|NCT02136914|39884578|FG000|Overall Study|Withdrawal by Subject|3|||
16382629|NCT02136914|39884579|FG001|Overall Study|Withdrawal by Subject|10|||
16382630|NCT02136914|39884578|FG000|Overall Study|Subject Unwilling to Proceed|7|||
16382631|NCT02136914|39884579|FG001|Overall Study|Subject Unwilling to Proceed|2|||
16382632|NCT02136914|39884578|FG000|Overall Study|Lost to Follow-up|1|||
16382633|NCT02136914|39884579|FG001|Overall Study|Lost to Follow-up|1|||
16382634|NCT02136914|39884578|FG000|Overall Study|Did Not Receive Study Drug|2|||
16382635|NCT02136914|39884579|FG001|Overall Study|Did Not Receive Study Drug|0|||
16382636|NCT02136914|39884578|FG000|Overall Study|Lack of Efficacy|1|||
16382637|NCT02136914|39884579|FG001|Overall Study|Lack of Efficacy|0|||
16382638|NCT02136914|39884578|FG000|Overall Study|Death|0|||
16382639|NCT02136914|39884579|FG001|Overall Study|Death|1|||
16382640|NCT00770679|39884580|FG000|Overall Study|Lost to Follow-up|3|||
16382641|NCT00770679|39884580|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
16485931|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Change of location|0|||
16485932|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Change of location|0|||
16485933|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Change of location|1|||
16485934|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Change of location|0|||
16485935|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
16485936|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
16485937|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
16485938|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
16485939|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
16485940|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
16485941|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
16485942|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
16485943|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
16485944|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
16485945|NCT00730405|40256122|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
16485946|NCT00730405|40256123|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
16485947|NCT00730405|40256124|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
16485948|NCT00730405|40256125|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
16485949|NCT00730405|40256126|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
16485950|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
16485951|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
16485952|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
16485953|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
16485954|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
16485955|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
16485956|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
16485957|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
16485958|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
16485959|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
16382642|NCT04570384|39884581|FG000|Overall Study|Adverse Event|2|||
16382643|NCT04570384|39884582|FG001|Overall Study|Adverse Event|1|||
16485960|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
16485961|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
16485962|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
16485963|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
16485964|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
16485965|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Death|0|||
16485966|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Death|1|||
16485967|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Death|0|||
16382644|NCT04570384|39884581|FG000|Overall Study|Death|2|||
16382645|NCT04570384|39884582|FG001|Overall Study|Death|5|||
16382646|NCT04570384|39884581|FG000|Overall Study|Lost to Follow-up|1|||
16382647|NCT04570384|39884582|FG001|Overall Study|Lost to Follow-up|0|||
16382648|NCT04570384|39884581|FG000|Overall Study|Other|1|||
16382649|NCT04570384|39884582|FG001|Overall Study|Other|0|||
16382650|NCT04570384|39884581|FG000|Overall Study|Protocol Violation|0|||
16485968|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Death|1|||
16485969|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Death|0|||
16485970|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Change of location|1|||
16485971|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Change of location|1|||
16485972|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Change of location|0|||
16295275|NCT01783548|39566173|FG000|Overall Study|Withdrawal by Subject|11|||
16295276|NCT01783548|39566174|FG001|Overall Study|Withdrawal by Subject|8|||
16295277|NCT01783548|39566173|FG000|Overall Study|Non-compliance|4|||
16295278|NCT01783548|39566174|FG001|Overall Study|Non-compliance|0|||
16295279|NCT01783548|39566173|FG000|Overall Study|Protocol Violation|2|||
16295280|NCT01783548|39566174|FG001|Overall Study|Protocol Violation|2|||
16295281|NCT01783548|39566173|FG000|Overall Study|Lost to Follow-up|8|||
16295282|NCT01783548|39566174|FG001|Overall Study|Lost to Follow-up|3|||
16295283|NCT01783548|39566173|FG000|Overall Study|Lack of Efficacy|1|||
16295284|NCT01783548|39566174|FG001|Overall Study|Lack of Efficacy|1|||
16295285|NCT02246439|39566180|FG000|Overall Study|Adverse Event|3|||
16295286|NCT02246439|39566181|FG001|Overall Study|Adverse Event|0|||
16295287|NCT02246439|39566180|FG000|Overall Study|Lost to Follow-up|7|||
16295288|NCT02246439|39566181|FG001|Overall Study|Lost to Follow-up|5|||
16295289|NCT02246439|39566180|FG000|Overall Study|Protocol Violation|0|||
16295290|NCT02246439|39566181|FG001|Overall Study|Protocol Violation|2|||
16382651|NCT04570384|39884582|FG001|Overall Study|Protocol Violation|1|||
16382652|NCT04570384|39884581|FG000|Overall Study|Sponsor Decision|1|||
16382653|NCT04570384|39884582|FG001|Overall Study|Sponsor Decision|0|||
16382654|NCT04570384|39884581|FG000|Overall Study|Withdrawal by Subject|4|||
16382655|NCT04570384|39884582|FG001|Overall Study|Withdrawal by Subject|2|||
16382656|NCT00261833|39884585|FG000|Overall Study|Death|1|||
16295291|NCT02246439|39566180|FG000|Overall Study|Physician Decision|0|||
16295292|NCT02246439|39566181|FG001|Overall Study|Physician Decision|1|||
16295293|NCT02246439|39566180|FG000|Overall Study|Unkonwn|1|||
16295294|NCT02246439|39566181|FG001|Overall Study|Unkonwn|3|||
16295295|NCT02246439|39566180|FG000|Overall Study|Withdrawal by Subject|1|||
16295296|NCT02246439|39566181|FG001|Overall Study|Withdrawal by Subject|0|||
16295297|NCT02968849|39566184|FG000|Overall Study|Death|8|||
16382657|NCT00261833|39884586|FG001|Overall Study|Death|3|||
16295298|NCT02968849|39566185|FG001|Overall Study|Death|10|||
16295299|NCT02968849|39566184|FG000|Overall Study|Lost to Follow-up|31|||
16382658|NCT00261833|39884585|FG000|Overall Study|Adverse Event|1|||
16382659|NCT00261833|39884586|FG001|Overall Study|Adverse Event|4|||
16382660|NCT00261833|39884585|FG000|Overall Study|Withdrawal by Subject|5|||
16382661|NCT00261833|39884586|FG001|Overall Study|Withdrawal by Subject|7|||
16382662|NCT00261833|39884585|FG000|Overall Study|Protocol Violation|0|||
16382663|NCT00261833|39884586|FG001|Overall Study|Protocol Violation|1|||
16382664|NCT00261833|39884585|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
16382665|NCT00261833|39884586|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
16382666|NCT00261833|39884585|FG000|Overall Study|Lung transplantation|1|||
16382667|NCT00261833|39884586|FG001|Overall Study|Lung transplantation|1|||
16382668|NCT00261833|39884585|FG000|Overall Study|Missing reason|1|||
16382669|NCT00261833|39884586|FG001|Overall Study|Missing reason|0|||
16382670|NCT00261833|39884585|FG000|Overall Study|Not interested in being participant|0|||
16382671|NCT00261833|39884586|FG001|Overall Study|Not interested in being participant|1|||
16382672|NCT03674281|39884589|FG000|Overall Study|screen failure|2|||
16382673|NCT03674281|39884590|FG001|Overall Study|screen failure|0|||
16382674|NCT03674281|39884591|FG002|Overall Study|screen failure|0|||
16382675|NCT03674281|39884589|FG000|Overall Study|Withdrawal by Subject|1|||
16382676|NCT03674281|39884590|FG001|Overall Study|Withdrawal by Subject|3|||
16382677|NCT03674281|39884591|FG002|Overall Study|Withdrawal by Subject|3|||
16382678|NCT02629861|39884592|FG000|Overall Study|Adverse Event|7|||
16382679|NCT02629861|39884593|FG001|Overall Study|Adverse Event|5|||
16382680|NCT02629861|39884594|FG002|Overall Study|Adverse Event|4|||
16382681|NCT02629861|39884592|FG000|Overall Study|Withdrawal by Subject|5|||
16382682|NCT02629861|39884593|FG001|Overall Study|Withdrawal by Subject|8|||
16382683|NCT02629861|39884594|FG002|Overall Study|Withdrawal by Subject|13|||
16382684|NCT02629861|39884592|FG000|Overall Study|Protocol Violation|2|||
16382685|NCT02629861|39884593|FG001|Overall Study|Protocol Violation|3|||
16382686|NCT02629861|39884594|FG002|Overall Study|Protocol Violation|7|||
16382687|NCT02629861|39884592|FG000|Overall Study|Lost to Follow-up|12|||
16382688|NCT02629861|39884593|FG001|Overall Study|Lost to Follow-up|9|||
16382689|NCT02629861|39884594|FG002|Overall Study|Lost to Follow-up|4|||
16382690|NCT02629861|39884592|FG000|Overall Study|Other|1|||
16485973|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Change of location|1|||
16485974|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Change of location|0|||
16485975|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
16295300|NCT02968849|39566185|FG001|Overall Study|Lost to Follow-up|29|||
16295301|NCT02968849|39566184|FG000|Overall Study|Withdrawal by Subject|73|||
16382691|NCT02629861|39884593|FG001|Overall Study|Other|1|||
16382692|NCT02629861|39884594|FG002|Overall Study|Other|0|||
16382693|NCT02629861|39884592|FG000|Overall Study|Pregnancy|2|||
16295302|NCT02968849|39566185|FG001|Overall Study|Withdrawal by Subject|64|||
16485976|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
16485977|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
16485978|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
16485979|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
16485980|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
16485981|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
16485982|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
16485983|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
16485984|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
16485985|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
16485986|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
16485987|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
16485988|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
16485989|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
16485990|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
16485991|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
16485992|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
16485993|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
16485994|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
16485995|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
16485996|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
16485997|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
16485998|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
16485999|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
16486000|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
16486001|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
16486002|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
16486003|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
16486004|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
16295303|NCT02968849|39566184|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
16295304|NCT02968849|39566185|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
16188421|NCT01457118|39169352|FG001|Overall Study|Withdrawal by Subject|0|||
16295305|NCT02968849|39566184|FG000|Overall Study|Physician Decision|6|||
16295306|NCT02968849|39566185|FG001|Overall Study|Physician Decision|9|||
16295307|NCT02968849|39566184|FG000|Overall Study|Other|16|||
16295308|NCT02968849|39566185|FG001|Overall Study|Other|10|||
16295309|NCT04188301|39566196|FG000|Month 3|Lost to Follow-up|0|||
16295310|NCT04188301|39566197|FG001|Month 3|Lost to Follow-up|0|||
16295311|NCT04188301|39566198|FG002|Month 3|Lost to Follow-up|1|||
16295312|NCT04188301|39566196|FG000|Month 12|Lost to Follow-up|0|||
16295313|NCT04188301|39566197|FG001|Month 12|Lost to Follow-up|0|||
16295314|NCT04188301|39566198|FG002|Month 12|Lost to Follow-up|2|||
16295315|NCT04188301|39566196|FG000|Month 12|Death|1|||
16295316|NCT04188301|39566197|FG001|Month 12|Death|1|||
16295317|NCT04188301|39566198|FG002|Month 12|Death|0|||
16295318|NCT04188301|39566196|FG000|Month 18|Lost to Follow-up|6|||
16295319|NCT04188301|39566197|FG001|Month 18|Lost to Follow-up|0|||
16295320|NCT04188301|39566198|FG002|Month 18|Lost to Follow-up|0|||
16295321|NCT02272634|39566199|FG000|Overall Study|Adverse Event|1|||
16295322|NCT02272634|39566200|FG001|Overall Study|Adverse Event|0|||
16295323|NCT02272634|39566201|FG002|Overall Study|Adverse Event|0|||
16295324|NCT02272634|39566199|FG000|Overall Study|Protocol Violation|0|||
16295325|NCT02272634|39566200|FG001|Overall Study|Protocol Violation|0|||
16295326|NCT02272634|39566201|FG002|Overall Study|Protocol Violation|1|||
16295327|NCT02272634|39566199|FG000|Overall Study|Withdrawal by Subject|0|||
16295328|NCT02272634|39566200|FG001|Overall Study|Withdrawal by Subject|1|||
16295329|NCT02272634|39566201|FG002|Overall Study|Withdrawal by Subject|0|||
16295330|NCT01212588|39566207|FG000|Overall Study|Physician Decision|0|||
16295331|NCT01212588|39566208|FG001|Overall Study|Physician Decision|1|||
16295332|NCT01212588|39566207|FG000|Overall Study|Protocol Violation|1|||
16295333|NCT01212588|39566208|FG001|Overall Study|Protocol Violation|1|||
16295334|NCT00584844|39566215|FG000|Overall Study|Withdrawal by Subject|59|||
16295335|NCT00584844|39566215|FG000|Overall Study|Screen Failure|20|||
16295336|NCT00638027|39566216|FG000|Overall Study|Adverse Event|0|||
16295337|NCT00638027|39566217|FG001|Overall Study|Adverse Event|2|||
16295338|NCT02448706|39566218|FG000|Overall Study|Withdrawal by Subject|4|||
16295339|NCT02448706|39566219|FG001|Overall Study|Withdrawal by Subject|3|||
16295340|NCT02448706|39566218|FG000|Overall Study|Protocol Violation|1|||
16295341|NCT02448706|39566219|FG001|Overall Study|Protocol Violation|1|||
16295342|NCT02910063|39566220|FG000|Phase 2|Withdrawal by Subject|3|||
16295343|NCT02910063|39566221|FG001|Phase 2|Withdrawal by Subject|0|||
16486005|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
16486006|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
16486007|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
16486008|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
16486009|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
16486010|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
16486011|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
16486012|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
16486013|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
16486014|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
16486015|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
16486016|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
16486017|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
16486018|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
16486019|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
16486020|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
16486021|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
16486022|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
16486023|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
16486024|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
16486025|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Missing|0|||
16486026|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Missing|0|||
16486027|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Missing|2|||
16486028|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Missing|0|||
16486029|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Missing|0|||
16486030|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
16486031|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
16486032|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
16486033|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
16486034|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
16082217|NCT00632749|38792833|FG001|Overall Study|Reason other than those specified above|2|||
16082218|NCT00632749|38792834|FG002|Overall Study|Reason other than those specified above|0|||
16082219|NCT00632749|38792835|FG003|Overall Study|Reason other than those specified above|0|||
16082220|NCT00632749|38792836|FG004|Overall Study|Reason other than those specified above|1|||
16082221|NCT00632749|38792837|FG005|Overall Study|Reason other than those specified above|0|||
16082222|NCT00632749|38792838|FG006|Overall Study|Reason other than those specified above|1|||
16295344|NCT02910063|39566222|FG002|Phase 2|Withdrawal by Subject|0|||
16295345|NCT02910063|39566220|FG000|Phase 2|Lost to Follow-up|1|||
16486035|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
16082223|NCT00632749|38792839|FG007|Overall Study|Reason other than those specified above|0|||
16082224|NCT00632749|38792840|FG008|Overall Study|Reason other than those specified above|0|||
16082225|NCT00632749|38792841|FG009|Overall Study|Reason other than those specified above|0|||
16082226|NCT00632749|38792842|FG010|Overall Study|Reason other than those specified above|2|||
16082227|NCT00632749|38792843|FG011|Overall Study|Reason other than those specified above|1|||
16082228|NCT00632749|38792844|FG012|Overall Study|Reason other than those specified above|0|||
16082229|NCT00632749|38792845|FG013|Overall Study|Reason other than those specified above|2|||
16295346|NCT02910063|39566221|FG001|Phase 2|Lost to Follow-up|0|||
16295347|NCT02910063|39566222|FG002|Phase 2|Lost to Follow-up|0|||
16486036|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
16486037|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
16486038|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
16486039|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
16486040|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
16486041|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
16486042|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
16486043|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
16486044|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
16486045|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
16486046|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
16486047|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
16486048|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
16486049|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
16486050|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
16082230|NCT02555215|38792863|FG000|Overall Study|Other|1|||
16295348|NCT02910063|39566220|FG000|Phase 2|Death|24|||
16295349|NCT02910063|39566221|FG001|Phase 2|Death|0|||
16082231|NCT02555215|38792863|FG000|Overall Study|Investigator Decision|2|||
16082232|NCT00331136|38792864|FG000|Overall Study|Adverse Event|3|||
16082233|NCT00331136|38792865|FG001|Overall Study|Adverse Event|5|||
16082234|NCT00331136|38792866|FG002|Overall Study|Adverse Event|0|||
16082235|NCT00331136|38792867|FG003|Overall Study|Adverse Event|1|||
16082236|NCT00331136|38792864|FG000|Overall Study|Withdrawal by Subject|0|||
16082237|NCT00331136|38792865|FG001|Overall Study|Withdrawal by Subject|1|||
16082238|NCT00331136|38792866|FG002|Overall Study|Withdrawal by Subject|0|||
16082239|NCT00331136|38792867|FG003|Overall Study|Withdrawal by Subject|0|||
16082240|NCT00331136|38792864|FG000|Overall Study|Lost to Follow-up|0|||
16082241|NCT00331136|38792865|FG001|Overall Study|Lost to Follow-up|1|||
16082242|NCT00331136|38792866|FG002|Overall Study|Lost to Follow-up|0|||
16082243|NCT00331136|38792867|FG003|Overall Study|Lost to Follow-up|0|||
16082244|NCT00331136|38792864|FG000|Overall Study|Protocol Violation|1|||
16082245|NCT00331136|38792865|FG001|Overall Study|Protocol Violation|0|||
16082246|NCT00331136|38792866|FG002|Overall Study|Protocol Violation|0|||
16082247|NCT00331136|38792867|FG003|Overall Study|Protocol Violation|0|||
16082248|NCT00331136|38792864|FG000|Overall Study|Not treated|1|||
16382694|NCT02629861|39884593|FG001|Overall Study|Pregnancy|1|||
16082249|NCT00331136|38792865|FG001|Overall Study|Not treated|0|||
16082250|NCT00331136|38792866|FG002|Overall Study|Not treated|0|||
16082251|NCT00331136|38792867|FG003|Overall Study|Not treated|0|||
16082252|NCT02866942|38792868|FG000|Overall Study|Invalid consent|1|||
16382695|NCT02629861|39884594|FG002|Overall Study|Pregnancy|0|||
16082253|NCT00529789|38792869|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
16082254|NCT00529789|38792869|FG000|Study Period II/III|Adverse Event|3|||
16082255|NCT00529789|38792869|FG000|Study Period II/III|Lack of Efficacy|2|||
16082256|NCT00529789|38792869|FG000|Study Period II/III|Withdrawal by Subject|1|||
16082257|NCT00529789|38792869|FG000|Study Period II/III|Protocol Violation|3|||
16082258|NCT00529789|38792869|FG000|Study Period II/III|Physician Decision|3|||
16082259|NCT00529789|38792869|FG000|Study Period II/III|Lost to Follow-up|3|||
16082260|NCT00529789|38792869|FG000|Study Period IV|Parent/Caregiver Decision|1|||
16082261|NCT00529789|38792869|FG000|Study Period IV|Adverse Event|1|||
16082262|NCT00529789|38792869|FG000|Study Period IV|Lack of Efficacy|1|||
16082263|NCT00529789|38792869|FG000|Study Period IV|Lost to Follow-up|3|||
16082264|NCT02438137|38792870|FG000|Overall Study|Lost to Follow-up|3|||
16082265|NCT02438137|38792871|FG001|Overall Study|Lost to Follow-up|2|||
16082266|NCT02438137|38792870|FG000|Overall Study|Adverse Event|1|||
16082267|NCT02438137|38792871|FG001|Overall Study|Adverse Event|0|||
16082268|NCT02438137|38792870|FG000|Overall Study|Withdrawal by Subject|4|||
16082269|NCT02438137|38792871|FG001|Overall Study|Withdrawal by Subject|3|||
16082270|NCT02438137|38792870|FG000|Overall Study|Physician Decision|0|||
16082271|NCT02438137|38792871|FG001|Overall Study|Physician Decision|1|||
16295350|NCT02910063|39566222|FG002|Phase 2|Death|0|||
16295351|NCT00565617|39566223|FG000|Overall Study|Withdrawal by Subject|1|||
16295352|NCT00699374|39566224|FG000|Overall Study|Death|93|||
16295353|NCT00699374|39566225|FG001|Overall Study|Death|83|||
16295354|NCT00699374|39566224|FG000|Overall Study|Adverse Event|70|||
16295355|NCT00699374|39566225|FG001|Overall Study|Adverse Event|67|||
16295356|NCT00699374|39566224|FG000|Overall Study|Global deterioration of health status|7|||
16295357|NCT00699374|39566225|FG001|Overall Study|Global deterioration of health status|8|||
16295358|NCT00699374|39566224|FG000|Overall Study|Lost to Follow-up|3|||
16295359|NCT00699374|39566225|FG001|Overall Study|Lost to Follow-up|5|||
16295360|NCT00699374|39566224|FG000|Overall Study|Withdrawal by Subject|34|||
16382696|NCT02371889|39884607|FG000|Overall Study|Adverse medication effect|11|||
16082272|NCT02242487|38792872|FG000|Overall Study|Adverse Event|13|||
16082273|NCT02242487|38792873|FG001|Overall Study|Adverse Event|15|||
16082274|NCT02242487|38792872|FG000|Overall Study|Lack of Efficacy|4|||
16082275|NCT02242487|38792873|FG001|Overall Study|Lack of Efficacy|6|||
16382697|NCT02371889|39884608|FG001|Overall Study|Adverse medication effect|2|||
16295361|NCT00699374|39566225|FG001|Overall Study|Withdrawal by Subject|44|||
16295362|NCT00699374|39566224|FG000|Overall Study|Objective progression or relapse|281|||
16082276|NCT02242487|38792872|FG000|Overall Study|Protocol Violation|2|||
16082277|NCT02242487|38792873|FG001|Overall Study|Protocol Violation|0|||
16082278|NCT02242487|38792872|FG000|Overall Study|Lost to Follow-up|2|||
16082279|NCT02242487|38792873|FG001|Overall Study|Lost to Follow-up|1|||
16082280|NCT02242487|38792872|FG000|Overall Study|Other - Miscellaneous|4|||
16082281|NCT02242487|38792873|FG001|Overall Study|Other - Miscellaneous|6|||
16082282|NCT02242487|38792872|FG000|Overall Study|Withdrawal by Subject|37|||
16082283|NCT02242487|38792873|FG001|Overall Study|Withdrawal by Subject|19|||
16082284|NCT02647905|38792874|FG000|Overall Study|Lost to Follow-up|1|||
16082285|NCT02647905|38792874|FG000|Overall Study|Withdrawal by Subject|2|||
16082286|NCT03892564|38792887|FG000|Overall Study|Withdrawal by Subject|2|||
16486051|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
16486052|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
16486053|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
16486054|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
16486055|NCT00730405|40256122|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
16486056|NCT00730405|40256123|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
16082287|NCT02079844|38792888|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
16082288|NCT02079844|38792889|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
16082289|NCT02079844|38792890|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
16082290|NCT02079844|38792888|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
16082291|NCT02079844|38792889|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
16382698|NCT02371889|39884607|FG000|Overall Study|Lost to Follow-up|6|||
16382699|NCT02371889|39884608|FG001|Overall Study|Lost to Follow-up|5|||
16382700|NCT02371889|39884607|FG000|Overall Study|Personal time constraints|2|||
16382701|NCT02371889|39884608|FG001|Overall Study|Personal time constraints|4|||
16382702|NCT02371889|39884607|FG000|Overall Study|Lack of Efficacy|0|||
16382703|NCT02371889|39884608|FG001|Overall Study|Lack of Efficacy|2|||
16382704|NCT02371889|39884607|FG000|Overall Study|Relapse|0|||
16382705|NCT02371889|39884608|FG001|Overall Study|Relapse|1|||
16382706|NCT01373281|39884609|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
16382707|NCT01373281|39884610|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
16382708|NCT01373281|39884609|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
16382709|NCT01373281|39884610|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
16382710|NCT01373281|39884609|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
16382711|NCT01373281|39884610|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
16382712|NCT01373281|39884609|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
16382713|NCT01373281|39884610|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
16382714|NCT01373281|39884609|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
16382715|NCT01373281|39884610|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
16382716|NCT01373281|39884609|FG000|Surveillance Expansion Period|Protocol Violation|9|||
16382717|NCT01373281|39884610|FG001|Surveillance Expansion Period|Protocol Violation|1|||
16382718|NCT01373281|39884609|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
16382719|NCT01373281|39884610|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
16382720|NCT01373281|39884609|FG000|Surveillance Expansion Period|Serious adverse event|3|||
16382721|NCT01373281|39884610|FG001|Surveillance Expansion Period|Serious adverse event|4|||
16382722|NCT05223673|39884611|FG000|Overall Study|Protocol Violation|1|||
16382723|NCT05223673|39884611|FG000|Overall Study|Study termination|6|||
16382724|NCT01133847|39884612|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
16382725|NCT01133847|39884613|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
16382726|NCT01133847|39884614|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
16382727|NCT01133847|39884612|FG000|Follow-Up Phase|Lost to Follow-up|1|||
16382728|NCT01133847|39884613|FG001|Follow-Up Phase|Lost to Follow-up|3|||
16382729|NCT01133847|39884614|FG002|Follow-Up Phase|Lost to Follow-up|7|||
16382730|NCT01225952|39884618|FG000|Overall Study|Lost to Follow-up|1|||
16382731|NCT01225952|39884619|FG001|Overall Study|Lost to Follow-up|0|||
16382732|NCT01225952|39884620|FG002|Overall Study|Lost to Follow-up|0|||
16382733|NCT01225952|39884618|FG000|Overall Study|Study Eye Explanted|0|||
16382734|NCT01225952|39884619|FG001|Overall Study|Study Eye Explanted|0|||
16382735|NCT01225952|39884620|FG002|Overall Study|Study Eye Explanted|1|||
16382736|NCT01225952|39884618|FG000|Overall Study|Withdrawal by Subject|4|||
16382737|NCT01225952|39884619|FG001|Overall Study|Withdrawal by Subject|4|||
16382738|NCT01225952|39884620|FG002|Overall Study|Withdrawal by Subject|5|||
16382739|NCT01225952|39884618|FG000|Overall Study|Surgical complications|1|||
16082292|NCT02079844|38792890|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
16082293|NCT03593876|38792891|FG000|Overall Study|Withdrawal by Subject|1|||
16082294|NCT03593876|38792891|FG000|Overall Study|Discharged home before intervention completion|2|||
16082295|NCT01420549|38792893|FG000|Overall Study|Adverse Event|1|||
16382740|NCT01225952|39884619|FG001|Overall Study|Surgical complications|0|||
16382741|NCT01225952|39884620|FG002|Overall Study|Surgical complications|0|||
16382742|NCT00557440|39884621|FG000|Treatment Period 1|Adverse Event|0|||
16382743|NCT00557440|39884622|FG001|Treatment Period 1|Adverse Event|0|||
16382744|NCT00557440|39884623|FG002|Treatment Period 1|Adverse Event|1|||
16188422|NCT01457118|39169353|FG002|Overall Study|Withdrawal by Subject|0|||
16188423|NCT01457118|39169354|FG003|Overall Study|Withdrawal by Subject|0|||
16188424|NCT01552928|39169355|FG000|Period 3|Adverse Event|0|||
16188425|NCT01552928|39169356|FG001|Period 3|Adverse Event|0|||
16188426|NCT01552928|39169357|FG002|Period 3|Adverse Event|1|||
16188427|NCT01552928|39169358|FG003|Period 3|Adverse Event|0|||
16188428|NCT01617434|39169359|FG000|Overall Study|Adverse Event|12|||
16188429|NCT01617434|39169360|FG001|Overall Study|Adverse Event|3|||
16188430|NCT01617434|39169359|FG000|Overall Study|Protocol Violation|8|||
16188431|NCT01617434|39169360|FG001|Overall Study|Protocol Violation|7|||
16188432|NCT01617434|39169359|FG000|Overall Study|Withdrawal Criteria|12|||
16188433|NCT01617434|39169360|FG001|Overall Study|Withdrawal Criteria|37|||
16188434|NCT01617434|39169359|FG000|Overall Study|Unclassified|3|||
16188435|NCT01617434|39169360|FG001|Overall Study|Unclassified|4|||
16188436|NCT00748540|39169368|FG000|Overall Study|Physician Decision|1|||
16188437|NCT00114972|39169371|FG000|Overall Study|Withdrawal by Subject|40|||
16188438|NCT00114972|39169372|FG001|Overall Study|Withdrawal by Subject|7|||
16188439|NCT00114972|39169371|FG000|Overall Study|Lost to Follow-up|8|||
16188440|NCT00114972|39169372|FG001|Overall Study|Lost to Follow-up|5|||
16188441|NCT01766336|39169373|FG000|Overall Study|Adverse Event|11|||
16188442|NCT01766336|39169374|FG001|Overall Study|Adverse Event|8|||
16188443|NCT01766336|39169373|FG000|Overall Study|Death|4|||
16188444|NCT01766336|39169374|FG001|Overall Study|Death|3|||
16188445|NCT01766336|39169373|FG000|Overall Study|Lost to Follow-up|1|||
16188446|NCT01766336|39169374|FG001|Overall Study|Lost to Follow-up|3|||
16188447|NCT01766336|39169373|FG000|Overall Study|Physician Decision|4|||
16188448|NCT01766336|39169374|FG001|Overall Study|Physician Decision|2|||
16188449|NCT01766336|39169373|FG000|Overall Study|Protocol Violation|0|||
16188450|NCT01766336|39169374|FG001|Overall Study|Protocol Violation|1|||
16188451|NCT01766336|39169373|FG000|Overall Study|Sponsor Decision|52|||
16188452|NCT01766336|39169374|FG001|Overall Study|Sponsor Decision|43|||
16188453|NCT01766336|39169373|FG000|Overall Study|Withdrawal by Subject|18|||
16188454|NCT01766336|39169374|FG001|Overall Study|Withdrawal by Subject|15|||
16188455|NCT01253421|39169375|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
16188456|NCT01253421|39169376|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
16082296|NCT01420549|38792894|FG001|Overall Study|Adverse Event|1|||
16082297|NCT01420549|38792893|FG000|Overall Study|Lost to Follow-up|2|||
16082298|NCT01420549|38792894|FG001|Overall Study|Lost to Follow-up|2|||
16082299|NCT01420549|38792893|FG000|Overall Study|Protocol Violation|0|||
16082300|NCT01420549|38792894|FG001|Overall Study|Protocol Violation|1|||
16082301|NCT01420549|38792893|FG000|Overall Study|Non-adherence to medication|4|||
16082302|NCT01420549|38792894|FG001|Overall Study|Non-adherence to medication|1|||
16082303|NCT01953224|38792899|FG000|Overall Study|Lost to Follow-up|1|||
16082304|NCT01953224|38792900|FG001|Overall Study|Lost to Follow-up|1|||
16188457|NCT01253421|39169377|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
16188458|NCT01253421|39169378|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
16188459|NCT01253421|39169379|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
16188460|NCT01253421|39169375|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
16188461|NCT01253421|39169376|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
16188462|NCT01253421|39169377|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
16188463|NCT01253421|39169378|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
16188464|NCT01253421|39169379|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
16188465|NCT01253421|39169375|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
16188466|NCT01253421|39169376|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
16188467|NCT01253421|39169377|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
16188468|NCT01253421|39169378|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
16188469|NCT01253421|39169379|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
16188470|NCT01253421|39169375|FG000|Assessment and Scheduling|Physician Decision|1|||
16188471|NCT01253421|39169376|FG001|Assessment and Scheduling|Physician Decision|0|||
16188472|NCT01253421|39169377|FG002|Assessment and Scheduling|Physician Decision|0|||
16188473|NCT01253421|39169378|FG003|Assessment and Scheduling|Physician Decision|0|||
16188474|NCT01253421|39169379|FG004|Assessment and Scheduling|Physician Decision|0|||
16188475|NCT01253421|39169375|FG000|Drug+Scanning Visit|Physician Decision|0|||
16188476|NCT01253421|39169376|FG001|Drug+Scanning Visit|Physician Decision|0|||
16188477|NCT01253421|39169377|FG002|Drug+Scanning Visit|Physician Decision|0|||
16188478|NCT01253421|39169378|FG003|Drug+Scanning Visit|Physician Decision|0|||
16188479|NCT01253421|39169379|FG004|Drug+Scanning Visit|Physician Decision|1|||
16188480|NCT03792750|39169380|FG000|Overall Study|Death|3|||
16188481|NCT03126539|39169383|FG000|Overall Study|Lost to Follow-up|1|||
16188482|NCT03126539|39169384|FG001|Overall Study|Lost to Follow-up|1|||
16188483|NCT03126539|39169385|FG002|Overall Study|Lost to Follow-up|1|||
16188484|NCT03126539|39169386|FG003|Overall Study|Lost to Follow-up|0|||
16188485|NCT03126539|39169387|FG004|Overall Study|Lost to Follow-up|0|||
16188486|NCT00859898|39169389|FG000|Overall Study|Lack of Efficacy|0|||
16188487|NCT00859898|39169390|FG001|Overall Study|Lack of Efficacy|1|||
16188488|NCT00859898|39169391|FG002|Overall Study|Lack of Efficacy|1|||
16188489|NCT00859898|39169389|FG000|Overall Study|Adverse Event|4|||
16188490|NCT00859898|39169390|FG001|Overall Study|Adverse Event|9|||
16188491|NCT00859898|39169391|FG002|Overall Study|Adverse Event|8|||
16188492|NCT00859898|39169389|FG000|Overall Study|Withdrawal by Subject|11|||
16188493|NCT00859898|39169390|FG001|Overall Study|Withdrawal by Subject|8|||
16295363|NCT00699374|39566225|FG001|Overall Study|Objective progression or relapse|277|||
16295364|NCT00699374|39566224|FG000|Overall Study|Other|18|||
16295365|NCT00699374|39566225|FG001|Overall Study|Other|15|||
16295366|NCT00699374|39566224|FG000|Overall Study|Protocol Violation|2|||
16295367|NCT00699374|39566225|FG001|Overall Study|Protocol Violation|6|||
16295368|NCT00699374|39566224|FG000|Overall Study|Study terminated by sponsor|13|||
16295369|NCT00699374|39566225|FG001|Overall Study|Study terminated by sponsor|28|||
16295370|NCT00699374|39566224|FG000|Overall Study|Randomized but not treated|4|||
16295371|NCT00699374|39566225|FG001|Overall Study|Randomized but not treated|2|||
16295372|NCT00699374|39566224|FG000|Overall Study|Died 28 days after last dose|5|||
16295373|NCT00699374|39566225|FG001|Overall Study|Died 28 days after last dose|9|||
16295374|NCT02119286|39566226|FG000|Overall Study|Adverse Event|9|||
16295375|NCT02119286|39566227|FG001|Overall Study|Adverse Event|7|||
16295376|NCT02119286|39566228|FG002|Overall Study|Adverse Event|2|||
16295377|NCT02119286|39566226|FG000|Overall Study|Lack of Efficacy|11|||
16295378|NCT02119286|39566227|FG001|Overall Study|Lack of Efficacy|3|||
16295379|NCT02119286|39566228|FG002|Overall Study|Lack of Efficacy|4|||
16295380|NCT02119286|39566226|FG000|Overall Study|Lost to Follow-up|2|||
16295381|NCT02119286|39566227|FG001|Overall Study|Lost to Follow-up|0|||
16295382|NCT02119286|39566228|FG002|Overall Study|Lost to Follow-up|1|||
16295383|NCT02119286|39566226|FG000|Overall Study|Withdrawal by Subject|4|||
16295384|NCT02119286|39566227|FG001|Overall Study|Withdrawal by Subject|1|||
16188494|NCT00859898|39169391|FG002|Overall Study|Withdrawal by Subject|11|||
16188495|NCT00859898|39169389|FG000|Overall Study|Death|0|||
16188496|NCT00859898|39169390|FG001|Overall Study|Death|0|||
16188497|NCT00859898|39169391|FG002|Overall Study|Death|1|||
16188498|NCT00859898|39169389|FG000|Overall Study|Lost to Follow-up|10|||
16295385|NCT02119286|39566228|FG002|Overall Study|Withdrawal by Subject|0|||
16295386|NCT03421730|39566229|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295387|NCT03421730|39566230|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
16486057|NCT00730405|40256124|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
16486058|NCT00730405|40256125|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
16486059|NCT00730405|40256126|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
16486060|NCT02871297|40256133|FG000|Overall Study|Adverse Event|34|||
16486061|NCT02871297|40256133|FG000|Overall Study|Lack of Efficacy|10|||
16486062|NCT02871297|40256133|FG000|Overall Study|Non-compliance with study drug|15|||
16486063|NCT02871297|40256133|FG000|Overall Study|Protocol Violation|3|||
16486064|NCT02871297|40256133|FG000|Overall Study|Withdrawal by Subject|20|||
16486065|NCT02871297|40256133|FG000|Overall Study|Lost to Follow-up|13|||
16486066|NCT02871297|40256133|FG000|Overall Study|Rolled over to 13546A|2|||
16486067|NCT02871297|40256133|FG000|Overall Study|Other than specified|39|||
16188499|NCT00859898|39169390|FG001|Overall Study|Lost to Follow-up|11|||
16188500|NCT00859898|39169391|FG002|Overall Study|Lost to Follow-up|5|||
16295388|NCT03421730|39566231|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295389|NCT03421730|39566232|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295390|NCT03421730|39566233|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295391|NCT03421730|39566234|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295392|NCT03421730|39566235|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295393|NCT03421730|39566236|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295394|NCT03421730|39566237|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295395|NCT03421730|39566238|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295396|NCT03421730|39566239|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295397|NCT03421730|39566240|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
16295398|NCT03421730|39566229|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16295399|NCT03421730|39566230|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16486068|NCT02499783|40256134|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
16295400|NCT03421730|39566231|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16295401|NCT03421730|39566232|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16295402|NCT03421730|39566233|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
16295403|NCT03421730|39566234|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16295404|NCT03421730|39566235|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16486069|NCT02499783|40256135|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
16486070|NCT02499783|40256136|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
16486071|NCT02499783|40256134|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
16486072|NCT02499783|40256135|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
16486073|NCT02499783|40256136|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
16486074|NCT02499783|40256134|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
16486075|NCT02499783|40256135|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
16486076|NCT02499783|40256136|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
16486077|NCT02499783|40256134|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
16486078|NCT02499783|40256135|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
16486079|NCT02499783|40256136|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
16486080|NCT02499783|40256134|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
16486081|NCT02499783|40256135|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
16486082|NCT02499783|40256136|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
16486083|NCT02499783|40256134|FG000|DB Period: Weeks 0-8|Other|1|||
16486084|NCT02499783|40256135|FG001|DB Period: Weeks 0-8|Other|1|||
16188501|NCT00859898|39169389|FG000|Overall Study|poor/non-compliance|2|||
16188502|NCT00859898|39169390|FG001|Overall Study|poor/non-compliance|0|||
16188503|NCT00859898|39169391|FG002|Overall Study|poor/non-compliance|0|||
16188504|NCT00859898|39169389|FG000|Overall Study|No longer meets criteria|0|||
16188505|NCT00859898|39169390|FG001|Overall Study|No longer meets criteria|1|||
16188506|NCT00859898|39169391|FG002|Overall Study|No longer meets criteria|0|||
16188507|NCT00859898|39169389|FG000|Overall Study|non-specified|1|||
16188508|NCT00859898|39169390|FG001|Overall Study|non-specified|1|||
16188509|NCT00859898|39169391|FG002|Overall Study|non-specified|1|||
16295405|NCT03421730|39566236|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16295406|NCT03421730|39566237|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16295407|NCT03421730|39566238|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16295408|NCT03421730|39566239|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16486085|NCT02499783|40256136|FG002|DB Period: Weeks 0-8|Other|0|||
16188510|NCT00553059|39169394|FG000|Overall Study|Deemed ineligible|1|||
16188511|NCT00553059|39169395|FG001|Overall Study|Deemed ineligible|1|||
16295409|NCT03421730|39566240|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
16295410|NCT04492020|39566241|FG000|Overall Study|Adverse Event|1|||
16295411|NCT04492020|39566242|FG001|Overall Study|Adverse Event|3|||
16295412|NCT04492020|39566241|FG000|Overall Study|Withdrawal by Subject|4|||
16295413|NCT04492020|39566242|FG001|Overall Study|Withdrawal by Subject|3|||
16295414|NCT04492020|39566241|FG000|Overall Study|Lost to Follow-up|4|||
16295415|NCT04492020|39566242|FG001|Overall Study|Lost to Follow-up|3|||
16295416|NCT04492020|39566241|FG000|Overall Study|Protocol Violation|5|||
16295417|NCT04492020|39566242|FG001|Overall Study|Protocol Violation|2|||
16295418|NCT04492020|39566241|FG000|Overall Study|Lack of Qualifying Event|25|||
16295419|NCT04492020|39566242|FG001|Overall Study|Lack of Qualifying Event|27|||
16295420|NCT04492020|39566241|FG000|Overall Study|Non-compliance with Study Drug|2|||
16295421|NCT04492020|39566242|FG001|Overall Study|Non-compliance with Study Drug|1|||
16295422|NCT02186834|39566251|FG000|Dose Escalation|Death|0|||
16295423|NCT02186834|39566252|FG001|Dose Escalation|Death|0|||
16295424|NCT02186834|39566253|FG002|Dose Escalation|Death|0|||
16295425|NCT02186834|39566254|FG003|Dose Escalation|Death|1|||
16295426|NCT02186834|39566255|FG004|Dose Escalation|Death|0|||
16295427|NCT02186834|39566256|FG005|Dose Escalation|Death|0|||
16295428|NCT02186834|39566251|FG000|Treatment at RP2D|Died prior to treatment|0|||
16295429|NCT02186834|39566252|FG001|Treatment at RP2D|Died prior to treatment|0|||
16295430|NCT02186834|39566253|FG002|Treatment at RP2D|Died prior to treatment|0|||
16295431|NCT02186834|39566254|FG003|Treatment at RP2D|Died prior to treatment|0|||
16295432|NCT02186834|39566255|FG004|Treatment at RP2D|Died prior to treatment|0|||
16295433|NCT02186834|39566256|FG005|Treatment at RP2D|Died prior to treatment|1|||
16295434|NCT00509795|39566257|FG000|Overall Study|Adverse Event|4|||
16295435|NCT00509795|39566258|FG001|Overall Study|Adverse Event|3|||
16295436|NCT00509795|39566259|FG002|Overall Study|Adverse Event|5|||
16295437|NCT00509795|39566260|FG003|Overall Study|Adverse Event|4|||
16295438|NCT00509795|39566257|FG000|Overall Study|Death|3|||
16295439|NCT00509795|39566258|FG001|Overall Study|Death|1|||
16295440|NCT00509795|39566259|FG002|Overall Study|Death|2|||
16295441|NCT00509795|39566260|FG003|Overall Study|Death|7|||
16295442|NCT00509795|39566257|FG000|Overall Study|Lack of Efficacy|0|||
16295443|NCT00509795|39566258|FG001|Overall Study|Lack of Efficacy|0|||
16295444|NCT00509795|39566259|FG002|Overall Study|Lack of Efficacy|2|||
16295445|NCT00509795|39566260|FG003|Overall Study|Lack of Efficacy|2|||
16295446|NCT00509795|39566257|FG000|Overall Study|Lost to Follow-up|1|||
16382745|NCT00523978|39884624|FG000|Overall Study|Withdrawal by Subject|3|||
16382746|NCT00523978|39884625|FG001|Overall Study|Withdrawal by Subject|7|||
16382747|NCT00523978|39884624|FG000|Overall Study|Screen Failures|5|||
16382748|NCT00523978|39884625|FG001|Overall Study|Screen Failures|1|||
16382749|NCT00523978|39884624|FG000|Overall Study|Death|1|||
16382750|NCT00523978|39884625|FG001|Overall Study|Death|0|||
16382751|NCT01853280|39884626|FG000|Overall Study|Lack of Efficacy|2|||
16382752|NCT01853280|39884627|FG001|Overall Study|Lack of Efficacy|2|||
16382753|NCT01853280|39884626|FG000|Overall Study|Lost to Follow-up|0|||
16382754|NCT01853280|39884627|FG001|Overall Study|Lost to Follow-up|1|||
16382755|NCT01853280|39884626|FG000|Overall Study|Physician Decision|0|||
16382756|NCT01853280|39884627|FG001|Overall Study|Physician Decision|1|||
16382757|NCT01853280|39884626|FG000|Overall Study|Withdrawal by Subject|0|||
16382758|NCT01853280|39884627|FG001|Overall Study|Withdrawal by Subject|1|||
16382759|NCT01853280|39884626|FG000|Overall Study|Ineligible|0|||
16382760|NCT01853280|39884627|FG001|Overall Study|Ineligible|1|||
16382761|NCT02805790|39884630|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
16382762|NCT02805790|39884631|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
16382763|NCT03950856|39884632|FG000|Overall Study|Death|1|||
16382764|NCT03950856|39884633|FG001|Overall Study|Death|2|||
16382765|NCT03950856|39884634|FG002|Overall Study|Death|0|||
16382766|NCT03950856|39884635|FG003|Overall Study|Death|0|||
16382767|NCT03950856|39884632|FG000|Overall Study|Lost to Follow-up|5|||
16382768|NCT03950856|39884633|FG001|Overall Study|Lost to Follow-up|6|||
16382769|NCT03950856|39884634|FG002|Overall Study|Lost to Follow-up|8|||
16382770|NCT03950856|39884635|FG003|Overall Study|Lost to Follow-up|2|||
16382771|NCT03950856|39884632|FG000|Overall Study|Protocol Violation|2|||
16382772|NCT03950856|39884633|FG001|Overall Study|Protocol Violation|0|||
16382773|NCT03950856|39884634|FG002|Overall Study|Protocol Violation|0|||
16382774|NCT03950856|39884635|FG003|Overall Study|Protocol Violation|1|||
16382775|NCT03950856|39884632|FG000|Overall Study|Withdrawal by Subject|4|||
16382776|NCT03950856|39884633|FG001|Overall Study|Withdrawal by Subject|1|||
16382777|NCT03950856|39884634|FG002|Overall Study|Withdrawal by Subject|3|||
16382778|NCT03950856|39884635|FG003|Overall Study|Withdrawal by Subject|1|||
16382779|NCT03950856|39884632|FG000|Overall Study|Unable to phone|7|||
16382780|NCT03950856|39884633|FG001|Overall Study|Unable to phone|6|||
16382781|NCT03950856|39884634|FG002|Overall Study|Unable to phone|7|||
16382782|NCT03950856|39884635|FG003|Overall Study|Unable to phone|2|||
16382783|NCT01882465|39884636|FG000|Period 1|Lens Discomfort|0|||
16382784|NCT01882465|39884637|FG001|Period 1|Lens Discomfort|0|||
16382785|NCT01882465|39884638|FG002|Period 1|Lens Discomfort|0|||
16382786|NCT01882465|39884639|FG003|Period 1|Lens Discomfort|1|||
16382787|NCT01882465|39884640|FG004|Period 1|Lens Discomfort|0|||
16382788|NCT01882465|39884641|FG005|Period 1|Lens Discomfort|0|||
16382789|NCT01882465|39884642|FG006|Period 1|Lens Discomfort|0|||
16382790|NCT01882465|39884636|FG000|Period 1|Withdrawal by Subject|0|||
16382791|NCT01882465|39884637|FG001|Period 1|Withdrawal by Subject|0|||
16382792|NCT01882465|39884638|FG002|Period 1|Withdrawal by Subject|0|||
16382793|NCT01882465|39884639|FG003|Period 1|Withdrawal by Subject|0|||
16382794|NCT01882465|39884640|FG004|Period 1|Withdrawal by Subject|0|||
16486086|NCT02499783|40256134|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
16295447|NCT00509795|39566258|FG001|Overall Study|Lost to Follow-up|2|||
16295448|NCT00509795|39566259|FG002|Overall Study|Lost to Follow-up|4|||
16295449|NCT00509795|39566260|FG003|Overall Study|Lost to Follow-up|4|||
16295450|NCT00509795|39566257|FG000|Overall Study|OTHER|1|||
16295451|NCT00509795|39566258|FG001|Overall Study|OTHER|0|||
16295452|NCT00509795|39566259|FG002|Overall Study|OTHER|4|||
16295453|NCT00509795|39566260|FG003|Overall Study|OTHER|1|||
16295454|NCT00509795|39566257|FG000|Overall Study|Protocol Violation|3|||
16295455|NCT00509795|39566258|FG001|Overall Study|Protocol Violation|0|||
16295456|NCT00509795|39566259|FG002|Overall Study|Protocol Violation|3|||
16295457|NCT00509795|39566260|FG003|Overall Study|Protocol Violation|1|||
16295458|NCT00509795|39566257|FG000|Overall Study|Withdrawal by Subject|10|||
16295459|NCT00509795|39566258|FG001|Overall Study|Withdrawal by Subject|5|||
16295460|NCT00509795|39566259|FG002|Overall Study|Withdrawal by Subject|7|||
16295461|NCT00509795|39566260|FG003|Overall Study|Withdrawal by Subject|8|||
16382795|NCT01882465|39884641|FG005|Period 1|Withdrawal by Subject|0|||
16382796|NCT01882465|39884642|FG006|Period 1|Withdrawal by Subject|1|||
16382797|NCT01882465|39884636|FG000|Period 2|Protocol Violation|0|||
16382798|NCT01882465|39884637|FG001|Period 2|Protocol Violation|0|||
16382799|NCT01882465|39884638|FG002|Period 2|Protocol Violation|0|||
16382800|NCT01882465|39884639|FG003|Period 2|Protocol Violation|0|||
16382801|NCT01882465|39884640|FG004|Period 2|Protocol Violation|1|||
16382802|NCT01882465|39884641|FG005|Period 2|Protocol Violation|0|||
16382803|NCT01882465|39884642|FG006|Period 2|Protocol Violation|0|||
16295462|NCT00140426|39566261|FG000|Overall Study|Withdrawal by Subject|0|||
16295463|NCT00140426|39566262|FG001|Overall Study|Withdrawal by Subject|3|||
16295464|NCT04516759|39566266|FG000|Overall Study|Withdrawal by Subject|1|||
16295465|NCT04516759|39566267|FG001|Overall Study|Withdrawal by Subject|1|||
16382804|NCT00129974|39884643|FG000|Overall Study|Other|1|||
16382805|NCT03524157|39884646|FG000|Overall Study|cytology not readable|0|||
16295466|NCT04516759|39566266|FG000|Overall Study|Other|0|||
16295467|NCT04516759|39566267|FG001|Overall Study|Other|1|||
16295468|NCT00132028|39566268|FG000|Overall Study|Adverse Event|7|||
16295469|NCT00132028|39566268|FG000|Overall Study|Death|2|||
16295470|NCT00132028|39566268|FG000|Overall Study|Lack of Efficacy|11|||
16295471|NCT00132028|39566268|FG000|Overall Study|Withdrawal by Subject|2|||
16295472|NCT00132028|39566268|FG000|Overall Study|not eligible|2|||
16295473|NCT00132028|39566268|FG000|Overall Study|Physician Decision|3|||
16295474|NCT01287039|39566269|FG000|Overall Study|Noncompliance with study procedures|0|||
16295475|NCT01287039|39566270|FG001|Overall Study|Noncompliance with study procedures|1|||
16295476|NCT01287039|39566269|FG000|Overall Study|Change of location/residence|0|||
16295477|NCT01287039|39566270|FG001|Overall Study|Change of location/residence|3|||
16295478|NCT01287039|39566269|FG000|Overall Study|Elective surgery|0|||
16295479|NCT01287039|39566270|FG001|Overall Study|Elective surgery|1|||
16295480|NCT01287039|39566269|FG000|Overall Study|Protocol Violation|2|||
16295481|NCT01287039|39566270|FG001|Overall Study|Protocol Violation|3|||
16295482|NCT01287039|39566269|FG000|Overall Study|Excluded medication taken|1|||
16295483|NCT01287039|39566270|FG001|Overall Study|Excluded medication taken|0|||
16295484|NCT01287039|39566269|FG000|Overall Study|Noncompliance with study medication|0|||
16295485|NCT01287039|39566270|FG001|Overall Study|Noncompliance with study medication|1|||
16295486|NCT01287039|39566269|FG000|Overall Study|Problem with travel|0|||
16295487|NCT01287039|39566270|FG001|Overall Study|Problem with travel|1|||
16295488|NCT01287039|39566269|FG000|Overall Study|Death|1|||
16295489|NCT01287039|39566270|FG001|Overall Study|Death|0|||
16295490|NCT01287039|39566269|FG000|Overall Study|Change of residence|1|||
16295491|NCT01287039|39566270|FG001|Overall Study|Change of residence|0|||
16295492|NCT01287039|39566269|FG000|Overall Study|Adverse Event|7|||
16295493|NCT01287039|39566270|FG001|Overall Study|Adverse Event|4|||
16295494|NCT01287039|39566269|FG000|Overall Study|Withdrawal by Subject|14|||
16295495|NCT01287039|39566270|FG001|Overall Study|Withdrawal by Subject|11|||
16295496|NCT01287039|39566269|FG000|Overall Study|Lost to Follow-up|3|||
16295497|NCT01287039|39566270|FG001|Overall Study|Lost to Follow-up|2|||
16295498|NCT02266134|39566271|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
16295499|NCT02266134|39566272|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
16295500|NCT02266134|39566273|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
16295501|NCT02266134|39566274|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
16295502|NCT02266134|39566271|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
16295503|NCT02266134|39566272|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
16295504|NCT02266134|39566273|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
16295505|NCT02266134|39566274|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
16295506|NCT02266134|39566271|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
16295507|NCT02266134|39566272|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
16295508|NCT02266134|39566273|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
16295509|NCT02266134|39566274|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
16295510|NCT02266134|39566271|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
16295511|NCT02266134|39566272|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
16295512|NCT02266134|39566273|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
16295513|NCT02266134|39566274|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
16295514|NCT02266134|39566271|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
16295515|NCT02266134|39566272|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
16295516|NCT02266134|39566273|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
16295517|NCT02266134|39566274|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
16295518|NCT02266134|39566271|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
16295519|NCT02266134|39566272|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
16295520|NCT02266134|39566273|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
16295521|NCT02266134|39566274|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
16295522|NCT03028740|39566275|FG000|Overall Study|Did not Receive Study Drug|4|||
16295523|NCT03028740|39566276|FG001|Overall Study|Did not Receive Study Drug|5|||
16295524|NCT03028740|39566275|FG000|Overall Study|Adverse Event|8|||
16295525|NCT03028740|39566276|FG001|Overall Study|Adverse Event|26|||
16295526|NCT03028740|39566275|FG000|Overall Study|Lack of Efficacy|0|||
16295527|NCT03028740|39566276|FG001|Overall Study|Lack of Efficacy|1|||
16295528|NCT03028740|39566275|FG000|Overall Study|Withdrawal by Subject|48|||
16295529|NCT03028740|39566276|FG001|Overall Study|Withdrawal by Subject|101|||
16295530|NCT03028740|39566275|FG000|Overall Study|Lost to Follow-up|30|||
16295531|NCT03028740|39566276|FG001|Overall Study|Lost to Follow-up|54|||
16295532|NCT03028740|39566275|FG000|Overall Study|Physician Decision|4|||
16295533|NCT03028740|39566276|FG001|Overall Study|Physician Decision|11|||
16295534|NCT03028740|39566275|FG000|Overall Study|Protocol Violation|4|||
16295535|NCT03028740|39566276|FG001|Overall Study|Protocol Violation|8|||
16295536|NCT03028740|39566275|FG000|Overall Study|Non-compliance with Study Drug|0|||
16295537|NCT03028740|39566276|FG001|Overall Study|Non-compliance with Study Drug|2|||
16295538|NCT03028740|39566275|FG000|Overall Study|Study Terminated by Sponsor|467|||
16295539|NCT03028740|39566276|FG001|Overall Study|Study Terminated by Sponsor|917|||
16295540|NCT03028740|39566275|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
16295541|NCT03028740|39566276|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
16295542|NCT03028740|39566275|FG000|Overall Study|Reason not Specified|1|||
16295543|NCT03028740|39566276|FG001|Overall Study|Reason not Specified|5|||
16295544|NCT03981419|39566277|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
16295545|NCT03981419|39566278|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
16295546|NCT02924727|39566279|FG000|Overall Study|Withdrawal by Subject|2|||
16295547|NCT02924727|39566280|FG001|Overall Study|Withdrawal by Subject|4|||
16295548|NCT02924727|39566279|FG000|Overall Study|Lost to Follow-up|2|||
16295549|NCT02924727|39566280|FG001|Overall Study|Lost to Follow-up|5|||
16295550|NCT02924727|39566279|FG000|Overall Study|Death|221|||
16295551|NCT02924727|39566280|FG001|Overall Study|Death|247|||
16295552|NCT02924727|39566279|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
16486087|NCT02499783|40256135|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
16295553|NCT02924727|39566280|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
16295554|NCT04620135|39566281|FG000|Study Completion|Adverse Event|2|||
16295555|NCT04620135|39566282|FG001|Study Completion|Adverse Event|3|||
16295556|NCT04620135|39566281|FG000|Study Completion|Withdrawal by Subject|2|||
16295557|NCT04620135|39566282|FG001|Study Completion|Withdrawal by Subject|0|||
16295558|NCT02730351|39566284|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
16295559|NCT02730351|39566285|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
16295560|NCT02730351|39566284|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
16295561|NCT02730351|39566285|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
16295562|NCT02730351|39566284|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
16295563|NCT02730351|39566285|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
16295564|NCT02730351|39566284|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
16295565|NCT02730351|39566285|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
16295566|NCT02730351|39566284|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
16295567|NCT02730351|39566285|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
16295568|NCT03596151|39566296|FG000|Overall Study|Withdrawal by Subject|1|||
16295569|NCT00509366|39566299|FG000|Overall Study|Not Treated (Screen Failure)|1|||
16295570|NCT00509366|39566300|FG001|Overall Study|Not Treated (Screen Failure)|1|||
16295571|NCT00509366|39566301|FG002|Overall Study|Not Treated (Screen Failure)|1|||
16295572|NCT00509366|39566302|FG003|Overall Study|Not Treated (Screen Failure)|0|||
16295573|NCT00509366|39566303|FG004|Overall Study|Not Treated (Screen Failure)|0|||
16295574|NCT04159935|39566304|FG000|Overall Study|Study terminated due to COVID-19|1|||
16295575|NCT04159935|39566305|FG001|Overall Study|Study terminated due to COVID-19|3|||
16295576|NCT01275430|39566306|FG000|Overall Study|Adverse Event|1|||
16295577|NCT01275430|39566306|FG000|Overall Study|No Contrast Injection|6|||
16295578|NCT01275430|39566306|FG000|Overall Study|Device Malfunction|1|||
16295579|NCT01275430|39566306|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
16295580|NCT00128830|39566307|FG000|Overall Study|Adverse Event|10|||
16295581|NCT00128830|39566307|FG000|Overall Study|Withdrawal by Subject|14|||
16295582|NCT00128830|39566307|FG000|Overall Study|Lost to Follow-up|4|||
16295583|NCT00128830|39566307|FG000|Overall Study|Reached a virologic endpoint|29|||
16295584|NCT00128830|39566307|FG000|Overall Study|Non-compliant|4|||
16295585|NCT00128830|39566307|FG000|Overall Study|Discontinued or ineligible for study|2|||
16295586|NCT00128830|39566307|FG000|Overall Study|Other|9|||
16295587|NCT00922272|39566308|FG000|Open-label Phase|Adverse Event|5|||
16295588|NCT00922272|39566309|FG001|Open-label Phase|Adverse Event|0|||
16295589|NCT00922272|39566308|FG000|Open-label Phase|Protocol Violation|1|||
16295590|NCT00922272|39566309|FG001|Open-label Phase|Protocol Violation|0|||
16295591|NCT00922272|39566308|FG000|Open-label Phase|Withdrawal by Subject|11|||
16295592|NCT00922272|39566309|FG001|Open-label Phase|Withdrawal by Subject|0|||
16295593|NCT00922272|39566308|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
16295594|NCT00922272|39566309|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
16295595|NCT00922272|39566308|FG000|Open-label Phase|Withdrawal criteria met|5|||
16295596|NCT00922272|39566309|FG001|Open-label Phase|Withdrawal criteria met|0|||
16295597|NCT00922272|39566308|FG000|Double-blind Phase|Adverse Event|1|||
16295598|NCT00922272|39566309|FG001|Double-blind Phase|Adverse Event|1|||
16295599|NCT00922272|39566308|FG000|Double-blind Phase|Withdrawal by Subject|1|||
16295600|NCT00922272|39566309|FG001|Double-blind Phase|Withdrawal by Subject|1|||
16295601|NCT00922272|39566308|FG000|Double-blind Phase|Lost to Follow-up|2|||
16295602|NCT00922272|39566309|FG001|Double-blind Phase|Lost to Follow-up|1|||
16295603|NCT00922272|39566308|FG000|Double-blind Phase|Withdrawal criteria met|1|||
16295604|NCT00922272|39566309|FG001|Double-blind Phase|Withdrawal criteria met|1|||
16295605|NCT00922272|39566308|FG000|Double-blind Phase|Noncompliance|1|||
16295606|NCT00922272|39566309|FG001|Double-blind Phase|Noncompliance|1|||
16295607|NCT00922272|39566308|FG000|Double-blind Phase|Positive urine drug screen|1|||
16295608|NCT00922272|39566309|FG001|Double-blind Phase|Positive urine drug screen|1|||
16295609|NCT02549027|39566310|FG000|Washout After Period 4|Withdrawal by Subject|0|||
16295610|NCT02549027|39566311|FG001|Washout After Period 4|Withdrawal by Subject|1|||
16382806|NCT03524157|39884647|FG001|Overall Study|cytology not readable|0|||
16295611|NCT02549027|39566312|FG002|Washout After Period 4|Withdrawal by Subject|1|||
16295612|NCT02549027|39566313|FG003|Washout After Period 4|Withdrawal by Subject|1|||
16295613|NCT02549027|39566314|FG004|Washout After Period 4|Withdrawal by Subject|0|||
16295614|NCT02549027|39566315|FG005|Washout After Period 4|Withdrawal by Subject|0|||
16295615|NCT02549027|39566310|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
16295616|NCT02549027|39566311|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
16295617|NCT02549027|39566312|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
16295618|NCT02549027|39566313|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
16295619|NCT02549027|39566314|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
16295620|NCT02549027|39566315|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
16295621|NCT00394524|39566320|FG000|Overall Study|Protocol Violation|2|||
16295622|NCT00394524|39566321|FG001|Overall Study|Protocol Violation|3|||
16295623|NCT00394524|39566320|FG000|Overall Study|Death|1|||
16295624|NCT00394524|39566321|FG001|Overall Study|Death|0|||
16295625|NCT00394524|39566320|FG000|Overall Study|Withdrawal by Subject|0|||
16295626|NCT00394524|39566321|FG001|Overall Study|Withdrawal by Subject|1|||
16295627|NCT02517463|39566323|FG000|Overall Study|Lost to Follow-up|5|||
16295628|NCT02517463|39566324|FG001|Overall Study|Lost to Follow-up|2|||
16295629|NCT01195103|39566325|FG000|Overall Study|Withdrawal by Subject|1|||
16295630|NCT01195103|39566326|FG001|Overall Study|Withdrawal by Subject|0|||
16295631|NCT01195103|39566327|FG002|Overall Study|Withdrawal by Subject|0|||
16295632|NCT01642914|39566331|FG000|Overall Study|Adverse Event|11|||
16295633|NCT01642914|39566332|FG001|Overall Study|Adverse Event|7|||
16295634|NCT01642914|39566333|FG002|Overall Study|Adverse Event|15|||
16295635|NCT01642914|39566331|FG000|Overall Study|Lack of Efficacy|9|||
16295636|NCT01642914|39566332|FG001|Overall Study|Lack of Efficacy|4|||
16295637|NCT01642914|39566333|FG002|Overall Study|Lack of Efficacy|2|||
16295638|NCT01642914|39566331|FG000|Overall Study|Protocol Violation|15|||
16295639|NCT01642914|39566332|FG001|Overall Study|Protocol Violation|13|||
16295640|NCT01642914|39566333|FG002|Overall Study|Protocol Violation|6|||
16295641|NCT01642914|39566331|FG000|Overall Study|Withdrawal by Subject|5|||
16295642|NCT01642914|39566332|FG001|Overall Study|Withdrawal by Subject|5|||
16295643|NCT01642914|39566333|FG002|Overall Study|Withdrawal by Subject|10|||
16295644|NCT01642914|39566331|FG000|Overall Study|Lost to Follow-up|5|||
16295645|NCT01642914|39566332|FG001|Overall Study|Lost to Follow-up|3|||
16295646|NCT01642914|39566333|FG002|Overall Study|Lost to Follow-up|7|||
16295647|NCT01642914|39566331|FG000|Overall Study|Other Reason|1|||
16295648|NCT01642914|39566332|FG001|Overall Study|Other Reason|0|||
16295649|NCT01642914|39566333|FG002|Overall Study|Other Reason|0|||
16295650|NCT01156142|39566336|FG000|Overall Study|Withdrawal by Subject|8|||
16295651|NCT01156142|39566337|FG001|Overall Study|Withdrawal by Subject|6|||
16295652|NCT01156142|39566336|FG000|Overall Study|Ineligible|0|||
16382807|NCT03524157|39884648|FG002|Overall Study|cytology not readable|1|||
16382808|NCT01344226|39884649|FG000|Overall Study|Protocol Violation|2|||
16382809|NCT01344226|39884649|FG000|Overall Study|Withdrawal by Subject|3|||
16382810|NCT01344226|39884649|FG000|Overall Study|Lack of Efficacy|3|||
16382811|NCT00104884|39884650|FG000|Overall Study|Disease progression|4|||
16382812|NCT00800735|39884651|FG000|Overall Study|Administrative/Other|2|||
16382813|NCT00800735|39884651|FG000|Overall Study|Insufficient Therapeutic Response|2|||
16382814|NCT00800735|39884651|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
16382815|NCT00800735|39884651|FG000|Overall Study|Withdrew Consent|3|||
16382816|NCT02154061|39884653|FG000|Overall Study|Pregnancy|1|||
16382817|NCT02154061|39884654|FG001|Overall Study|Pregnancy|0|||
16382818|NCT02154061|39884653|FG000|Overall Study|enrolled but not vaccinated|1|||
16382819|NCT02154061|39884654|FG001|Overall Study|enrolled but not vaccinated|0|||
16382820|NCT02746809|39884655|FG000|Enrollment|Inclusion Exclusion not met|9|||
16382821|NCT02746809|39884655|FG000|Enrollment|Withdrawal by Subject|1|||
16295653|NCT01156142|39566337|FG001|Overall Study|Ineligible|1|||
16295654|NCT01189487|39566338|FG000|Overall Study|Lack of Efficacy|2|||
16295655|NCT01189487|39566338|FG000|Overall Study|Adverse Event|1|||
16295656|NCT00369317|39566341|FG000|Overall Study|Adverse Event|3|||
16295657|NCT00369317|39566341|FG000|Overall Study|Death|1|||
16295658|NCT00369317|39566341|FG000|Overall Study|Lack of Efficacy|5|||
16295659|NCT00369317|39566341|FG000|Overall Study|Physician Decision|2|||
16382822|NCT02746809|39884655|FG000|Enrollment|Expected Enrollment Met|2|||
16382823|NCT02746809|39884655|FG000|Procedure|Death|1|||
16382824|NCT02746809|39884655|FG000|1-Month|Death|5|||
16382825|NCT02746809|39884655|FG000|6-Month|Death|2|||
16295660|NCT00369317|39566341|FG000|Overall Study|Withdrawal by Subject|8|||
16295661|NCT00369317|39566341|FG000|Overall Study|Ineligible|1|||
16295662|NCT00227370|39566342|FG000|Overall Study|Withdrawal by Subject|1|||
16295663|NCT00227370|39566343|FG001|Overall Study|Withdrawal by Subject|2|||
16295664|NCT00227370|39566342|FG000|Overall Study|Death|3|||
16295665|NCT00227370|39566343|FG001|Overall Study|Death|4|||
16295666|NCT00227370|39566342|FG000|Overall Study|Adverse Event|6|||
16295667|NCT00227370|39566343|FG001|Overall Study|Adverse Event|11|||
16382826|NCT02746809|39884655|FG000|6-Month|Withdrawal by Subject|1|||
16486088|NCT02499783|40256136|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
16486089|NCT02499783|40256134|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
16486090|NCT02499783|40256135|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
16486091|NCT02499783|40256136|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
16188512|NCT00553059|39169394|FG000|Overall Study|Drug supply not available|0|||
16295668|NCT00227370|39566342|FG000|Overall Study|Physician Decision|9|||
16295669|NCT00227370|39566343|FG001|Overall Study|Physician Decision|6|||
16295670|NCT00227370|39566342|FG000|Overall Study|Other reasons|2|||
16295671|NCT00227370|39566343|FG001|Overall Study|Other reasons|1|||
16295672|NCT00536263|39566344|FG000|Overall Study|Adverse Event|5|||
16295673|NCT00536263|39566345|FG001|Overall Study|Adverse Event|5|||
16295674|NCT00536263|39566346|FG002|Overall Study|Adverse Event|7|||
16295675|NCT00536263|39566344|FG000|Overall Study|Lost to Follow-up|3|||
16295676|NCT00536263|39566345|FG001|Overall Study|Lost to Follow-up|4|||
16295677|NCT00536263|39566346|FG002|Overall Study|Lost to Follow-up|4|||
16295678|NCT00536263|39566344|FG000|Overall Study|Subject withdrew - not treatment related|2|||
16295679|NCT00536263|39566345|FG001|Overall Study|Subject withdrew - not treatment related|0|||
16295680|NCT00536263|39566346|FG002|Overall Study|Subject withdrew - not treatment related|5|||
16295681|NCT00536263|39566344|FG000|Overall Study|Subject withdrew - treatment related|0|||
16295682|NCT00536263|39566345|FG001|Overall Study|Subject withdrew - treatment related|3|||
16295683|NCT00536263|39566346|FG002|Overall Study|Subject withdrew - treatment related|2|||
16295684|NCT00536263|39566344|FG000|Overall Study|Noncompliance with protocol|0|||
16295685|NCT00536263|39566345|FG001|Overall Study|Noncompliance with protocol|0|||
16295686|NCT00536263|39566346|FG002|Overall Study|Noncompliance with protocol|1|||
16188513|NCT00553059|39169395|FG001|Overall Study|Drug supply not available|1|||
16188514|NCT00960440|39169396|FG000|Overall Study|Death|0|||
16188515|NCT00960440|39169397|FG001|Overall Study|Death|0|||
16188516|NCT00960440|39169398|FG002|Overall Study|Death|0|||
16188517|NCT00960440|39169399|FG003|Overall Study|Death|1|||
16188518|NCT00960440|39169396|FG000|Overall Study|Adverse Event|12|||
16188519|NCT00960440|39169397|FG001|Overall Study|Adverse Event|12|||
16188520|NCT00960440|39169398|FG002|Overall Study|Adverse Event|4|||
16188521|NCT00960440|39169399|FG003|Overall Study|Adverse Event|4|||
16188522|NCT00960440|39169396|FG000|Overall Study|Lack of Efficacy|2|||
16188523|NCT00960440|39169397|FG001|Overall Study|Lack of Efficacy|5|||
16188524|NCT00960440|39169398|FG002|Overall Study|Lack of Efficacy|3|||
16188525|NCT00960440|39169399|FG003|Overall Study|Lack of Efficacy|8|||
16188526|NCT00960440|39169396|FG000|Overall Study|Protocol Violation|2|||
16188527|NCT00960440|39169397|FG001|Overall Study|Protocol Violation|8|||
16188528|NCT00960440|39169398|FG002|Overall Study|Protocol Violation|3|||
16188529|NCT00960440|39169399|FG003|Overall Study|Protocol Violation|4|||
16295687|NCT00536263|39566344|FG000|Overall Study|Did not meet protocol eligibility|1|||
16295688|NCT00536263|39566345|FG001|Overall Study|Did not meet protocol eligibility|2|||
16295689|NCT00536263|39566346|FG002|Overall Study|Did not meet protocol eligibility|2|||
16295690|NCT02408068|39566347|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
16295691|NCT02408068|39566348|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
16295692|NCT02408068|39566349|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
16295693|NCT02408068|39566350|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
16295694|NCT02408068|39566351|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
16295695|NCT02408068|39566352|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
16295696|NCT04590040|39566356|FG000|Treatment Period|Lost to Follow-up|2|||
16295697|NCT04590040|39566357|FG001|Treatment Period|Lost to Follow-up|5|||
16295698|NCT04590040|39566358|FG002|Treatment Period|Lost to Follow-up|0|||
16295699|NCT04590040|39566356|FG000|Treatment Period|Physician Decision|0|||
16295700|NCT04590040|39566357|FG001|Treatment Period|Physician Decision|0|||
16295701|NCT04590040|39566358|FG002|Treatment Period|Physician Decision|2|||
16295702|NCT02377427|39566359|FG000|Part A (Up to Week 20)|Physician Decision|1|||
16295703|NCT02377427|39566360|FG001|Part A (Up to Week 20)|Physician Decision|0|||
16295704|NCT02377427|39566361|FG002|Part A (Up to Week 20)|Physician Decision|0|||
16295705|NCT02377427|39566362|FG003|Part A (Up to Week 20)|Physician Decision|0|||
16295706|NCT02377427|39566363|FG004|Part A (Up to Week 20)|Physician Decision|0|||
16188530|NCT00960440|39169396|FG000|Overall Study|Withdrawal by Subject|9|||
16295707|NCT02377427|39566359|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
16188531|NCT00960440|39169397|FG001|Overall Study|Withdrawal by Subject|5|||
16188532|NCT00960440|39169398|FG002|Overall Study|Withdrawal by Subject|2|||
16188533|NCT00960440|39169399|FG003|Overall Study|Withdrawal by Subject|1|||
16295708|NCT02377427|39566360|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
16188534|NCT00960440|39169396|FG000|Overall Study|Other|1|||
16295709|NCT02377427|39566361|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
16295710|NCT02377427|39566362|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
16295711|NCT02377427|39566363|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
16295712|NCT02377427|39566359|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
16295713|NCT02377427|39566360|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
16295714|NCT02377427|39566361|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
16188535|NCT00960440|39169397|FG001|Overall Study|Other|1|||
16295715|NCT02377427|39566362|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
16295716|NCT02377427|39566363|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
16295717|NCT02377427|39566359|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
16295718|NCT02377427|39566360|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
16295719|NCT02377427|39566361|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
16295720|NCT02377427|39566362|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
16295721|NCT02377427|39566363|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
16295722|NCT00655876|39566364|FG000|Overall Study|Protocol Violation|9|||
16295723|NCT00655876|39566365|FG001|Overall Study|Protocol Violation|7|||
16295724|NCT04431726|39566368|FG000|Overall Study|Ongoing in the Study|55|||
16295725|NCT03123861|39566370|FG000|Overall Study|Protocol Violation|1|||
16295726|NCT03123861|39566371|FG001|Overall Study|Protocol Violation|1|||
16082305|NCT01953224|38792899|FG000|Overall Study|Withdrawal by Subject|1|||
16082306|NCT01953224|38792900|FG001|Overall Study|Withdrawal by Subject|2|||
16082307|NCT03621735|38792901|FG000|Overall Study|Withdrawal by Subject|13|||
16082308|NCT03621735|38792902|FG001|Overall Study|Withdrawal by Subject|13|||
16082309|NCT02107261|38792903|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
16082310|NCT02107261|38792904|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
16082311|NCT02107261|38792903|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
16082312|NCT02107261|38792904|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
16082313|NCT02978716|38795879|FG000|Overall Study|Death|25|||
16082314|NCT02978716|38795880|FG001|Overall Study|Death|13|||
16082315|NCT02978716|38795881|FG002|Overall Study|Death|20|||
16082316|NCT02978716|38795879|FG000|Overall Study|Lost to Follow-up|0|||
16082317|NCT02978716|38795880|FG001|Overall Study|Lost to Follow-up|0|||
16082318|NCT02978716|38795881|FG002|Overall Study|Lost to Follow-up|1|||
16082319|NCT02978716|38795879|FG000|Overall Study|Withdrawal by Subject|6|||
16295727|NCT03123861|39566370|FG000|Overall Study|Withdrawal by Subject|2|||
16382827|NCT02746809|39884655|FG000|12-Month|Death|3|||
16382828|NCT02746809|39884655|FG000|12-Month|Withdrawal by Subject|2|||
16382829|NCT02746809|39884655|FG000|24-Month|Death|1|||
16382830|NCT02746809|39884655|FG000|24-Month|Withdrawal by Subject|1|||
16382831|NCT02746809|39884655|FG000|36-Month|Death|8|||
16382832|NCT02746809|39884655|FG000|36-Month|Withdrawal by Subject|1|||
16382833|NCT02746809|39884655|FG000|48-Month|Death|7|||
16382834|NCT02746809|39884655|FG000|48-Month|Withdrawal by Subject|1|||
16382835|NCT02746809|39884655|FG000|60-Month|Death|1|||
16382836|NCT02746809|39884655|FG000|60-Month|Lost to Follow-up|2|||
16382837|NCT01935947|39884658|FG000|Overall Study|Adverse Event|0|||
16382838|NCT01935947|39884659|FG001|Overall Study|Adverse Event|2|||
16382839|NCT01935947|39884660|FG002|Overall Study|Adverse Event|0|||
16382840|NCT01935947|39884658|FG000|Overall Study|Diease Progression|2|||
16382841|NCT01935947|39884659|FG001|Overall Study|Diease Progression|2|||
16382842|NCT01935947|39884660|FG002|Overall Study|Diease Progression|2|||
16382843|NCT01935947|39884658|FG000|Overall Study|Death|1|||
16382844|NCT01935947|39884659|FG001|Overall Study|Death|0|||
16382845|NCT01935947|39884660|FG002|Overall Study|Death|0|||
16382846|NCT01358734|39884661|FG000|Overall Study|Adverse Event|4|||
16382847|NCT01358734|39884662|FG001|Overall Study|Adverse Event|7|||
16382848|NCT01358734|39884663|FG002|Overall Study|Adverse Event|3|||
16382849|NCT01358734|39884661|FG000|Overall Study|Lack of Efficacy|0|||
16382850|NCT01358734|39884662|FG001|Overall Study|Lack of Efficacy|1|||
16382851|NCT01358734|39884663|FG002|Overall Study|Lack of Efficacy|3|||
16382852|NCT01358734|39884661|FG000|Overall Study|Withdrawal by Subject|1|||
16382853|NCT01358734|39884662|FG001|Overall Study|Withdrawal by Subject|6|||
16382854|NCT01358734|39884663|FG002|Overall Study|Withdrawal by Subject|3|||
16382855|NCT01358734|39884661|FG000|Overall Study|Death|3|||
16382856|NCT01358734|39884662|FG001|Overall Study|Death|7|||
16382857|NCT01358734|39884663|FG002|Overall Study|Death|2|||
16382858|NCT01358734|39884661|FG000|Overall Study|Progressive Disease|5|||
16382859|NCT01358734|39884662|FG001|Overall Study|Progressive Disease|13|||
16082320|NCT02978716|38795880|FG001|Overall Study|Withdrawal by Subject|4|||
16082321|NCT02978716|38795881|FG002|Overall Study|Withdrawal by Subject|5|||
16082322|NCT02978716|38795879|FG000|Overall Study|Sponsor terminated|2|||
16295728|NCT03123861|39566371|FG001|Overall Study|Withdrawal by Subject|2|||
16295729|NCT00742924|39566374|FG000|Overall Study|Adverse Event|0|||
16382860|NCT01358734|39884663|FG002|Overall Study|Progressive Disease|16|||
16382861|NCT01358734|39884661|FG000|Overall Study|Non-compliance with study drug|0|||
16382862|NCT01358734|39884662|FG001|Overall Study|Non-compliance with study drug|0|||
16382863|NCT01358734|39884663|FG002|Overall Study|Non-compliance with study drug|1|||
16382864|NCT01358734|39884661|FG000|Overall Study|Other|2|||
16382865|NCT01358734|39884662|FG001|Overall Study|Other|5|||
16295730|NCT00742924|39566375|FG001|Overall Study|Adverse Event|0|||
16295731|NCT00742924|39566376|FG002|Overall Study|Adverse Event|1|||
16382866|NCT01358734|39884663|FG002|Overall Study|Other|4|||
16382867|NCT01358734|39884661|FG000|Overall Study|Protocol Violation|0|||
16382868|NCT01358734|39884662|FG001|Overall Study|Protocol Violation|0|||
16382869|NCT01358734|39884663|FG002|Overall Study|Protocol Violation|2|||
16082323|NCT02978716|38795880|FG001|Overall Study|Sponsor terminated|13|||
16082324|NCT02978716|38795881|FG002|Overall Study|Sponsor terminated|9|||
16082325|NCT02978716|38795879|FG000|Overall Study|Other|1|||
16082326|NCT02978716|38795880|FG001|Overall Study|Other|3|||
16082327|NCT02978716|38795881|FG002|Overall Study|Other|0|||
16082328|NCT02852824|38795889|FG000|Overall Study|Withdrawal by Subject|1|||
16082329|NCT02852824|38795890|FG001|Overall Study|Withdrawal by Subject|0|||
16082330|NCT02852824|38795891|FG002|Overall Study|Withdrawal by Subject|0|||
16082331|NCT02852824|38795892|FG003|Overall Study|Withdrawal by Subject|0|||
16082332|NCT02852824|38795893|FG004|Overall Study|Withdrawal by Subject|0|||
16082333|NCT02852824|38795894|FG005|Overall Study|Withdrawal by Subject|0|||
16082334|NCT02852824|38795895|FG006|Overall Study|Withdrawal by Subject|0|||
16082335|NCT02852824|38795889|FG000|Overall Study|Adverse Event|0|||
16082336|NCT02852824|38795890|FG001|Overall Study|Adverse Event|0|||
16082337|NCT02852824|38795891|FG002|Overall Study|Adverse Event|0|||
16082338|NCT02852824|38795892|FG003|Overall Study|Adverse Event|0|||
16486092|NCT02499783|40256134|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
16486093|NCT02499783|40256135|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
16486094|NCT02499783|40256136|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
16486095|NCT02499783|40256134|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
16486096|NCT02499783|40256135|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
16486097|NCT02499783|40256136|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
16486098|NCT01317160|40256137|FG000|Overall Study|Incorrect inclusion|1|||
16486099|NCT01317160|40256138|FG001|Overall Study|Incorrect inclusion|1|||
16486100|NCT01317160|40256137|FG000|Overall Study|Lost to Follow-up|3|||
16486101|NCT01317160|40256138|FG001|Overall Study|Lost to Follow-up|3|||
16486102|NCT01317160|40256137|FG000|Overall Study|Withdrawal by Subject|0|||
16486103|NCT01317160|40256138|FG001|Overall Study|Withdrawal by Subject|2|||
16486104|NCT01896102|40256139|FG000|Overall Study|Death|1|||
16486105|NCT01896102|40256139|FG000|Overall Study|Participant to receive allogenic transplant|2|||
16486106|NCT00345839|40256140|FG000|Overall Study|Withdrawal by Subject|91|||
16486107|NCT00345839|40256141|FG001|Overall Study|Withdrawal by Subject|98|||
16486108|NCT00345839|40256140|FG000|Overall Study|Lost to Follow-up|58|||
16486109|NCT00345839|40256141|FG001|Overall Study|Lost to Follow-up|61|||
16486110|NCT01727297|40256142|FG000|Overall Study|Death|13|||
16486111|NCT01727297|40256143|FG001|Overall Study|Death|0|||
16082339|NCT02852824|38795893|FG004|Overall Study|Adverse Event|2|||
16082340|NCT02852824|38795894|FG005|Overall Study|Adverse Event|0|||
16082341|NCT02852824|38795895|FG006|Overall Study|Adverse Event|0|||
16082342|NCT00503906|38795898|FG000|Overall Study|Withdrawal by Subject|1|||
16082343|NCT02730871|38795899|FG000|Overall Study|Adverse Event|6|||
16486112|NCT01727297|40256142|FG000|Overall Study|Protocol Violation|1|||
16082344|NCT02730871|38795900|FG001|Overall Study|Adverse Event|0|||
16082345|NCT03102034|38795904|FG000|Overall Study|Withdrawal by Subject|1|||
16082346|NCT03102034|38795905|FG001|Overall Study|Withdrawal by Subject|0|||
16082347|NCT00087139|38795906|FG000|Overall Study|Adverse Event|18|||
16082348|NCT00087139|38795907|FG001|Overall Study|Adverse Event|17|||
16082349|NCT00087139|38795908|FG002|Overall Study|Adverse Event|13|||
16082350|NCT00087139|38795906|FG000|Overall Study|Death|2|||
16082351|NCT00087139|38795907|FG001|Overall Study|Death|1|||
16082352|NCT00087139|38795908|FG002|Overall Study|Death|0|||
16082353|NCT00087139|38795906|FG000|Overall Study|Withdrawal by Subject|3|||
16082354|NCT00087139|38795907|FG001|Overall Study|Withdrawal by Subject|2|||
16082355|NCT00087139|38795908|FG002|Overall Study|Withdrawal by Subject|2|||
16082356|NCT00087139|38795906|FG000|Overall Study|Physician Decision|1|||
16082357|NCT00087139|38795907|FG001|Overall Study|Physician Decision|1|||
16082358|NCT00087139|38795908|FG002|Overall Study|Physician Decision|1|||
16082359|NCT00087139|38795906|FG000|Overall Study|Disease progression|9|||
16082360|NCT00087139|38795907|FG001|Overall Study|Disease progression|19|||
16082361|NCT00087139|38795908|FG002|Overall Study|Disease progression|12|||
16082362|NCT00087139|38795906|FG000|Overall Study|Ineligible|4|||
16082363|NCT00087139|38795907|FG001|Overall Study|Ineligible|7|||
16082364|NCT00087139|38795908|FG002|Overall Study|Ineligible|4|||
16082365|NCT00087139|38795906|FG000|Overall Study|Symptomatic deterioration|1|||
16082366|NCT00087139|38795907|FG001|Overall Study|Symptomatic deterioration|1|||
16082367|NCT00087139|38795908|FG002|Overall Study|Symptomatic deterioration|3|||
16082368|NCT00087139|38795906|FG000|Overall Study|Use of coumadin|1|||
16082369|NCT00087139|38795907|FG001|Overall Study|Use of coumadin|0|||
16082370|NCT00087139|38795908|FG002|Overall Study|Use of coumadin|0|||
16082371|NCT00087139|38795906|FG000|Overall Study|Response achieved|0|||
16082372|NCT00087139|38795907|FG001|Overall Study|Response achieved|1|||
16082373|NCT00087139|38795908|FG002|Overall Study|Response achieved|0|||
16082374|NCT00087139|38795906|FG000|Overall Study|Extradural disease|0|||
16082375|NCT00087139|38795907|FG001|Overall Study|Extradural disease|0|||
16082376|NCT00087139|38795908|FG002|Overall Study|Extradural disease|1|||
16082377|NCT03246724|38795910|FG000|Overall Study|Withdrawal by Subject|5|||
16082378|NCT03246724|38795911|FG001|Overall Study|Withdrawal by Subject|2|||
16082379|NCT03246724|38795912|FG002|Overall Study|Withdrawal by Subject|4|||
16082380|NCT03246724|38795913|FG003|Overall Study|Withdrawal by Subject|2|||
16082381|NCT03246724|38795910|FG000|Overall Study|Ineligible on day of surgery|7|||
16082382|NCT03246724|38795911|FG001|Overall Study|Ineligible on day of surgery|2|||
16082383|NCT03246724|38795912|FG002|Overall Study|Ineligible on day of surgery|0|||
16082384|NCT03246724|38795913|FG003|Overall Study|Ineligible on day of surgery|3|||
16082385|NCT03246724|38795910|FG000|Overall Study|Study completed before surgical date|2|||
16082386|NCT03246724|38795911|FG001|Overall Study|Study completed before surgical date|1|||
16082387|NCT03246724|38795912|FG002|Overall Study|Study completed before surgical date|8|||
16082388|NCT03246724|38795913|FG003|Overall Study|Study completed before surgical date|1|||
16082389|NCT03246724|38795910|FG000|Overall Study|Transferred to other arm|0|||
16082390|NCT03246724|38795911|FG001|Overall Study|Transferred to other arm|0|||
16082391|NCT03246724|38795912|FG002|Overall Study|Transferred to other arm|1|||
16082392|NCT03246724|38795913|FG003|Overall Study|Transferred to other arm|0|||
16082393|NCT03246724|38795910|FG000|Overall Study|Unable to obtain medication timely|0|||
16082394|NCT03246724|38795911|FG001|Overall Study|Unable to obtain medication timely|2|||
16082395|NCT03246724|38795912|FG002|Overall Study|Unable to obtain medication timely|2|||
16082396|NCT03246724|38795913|FG003|Overall Study|Unable to obtain medication timely|1|||
16082397|NCT03246724|38795910|FG000|Overall Study|Re-consented to participate|0|||
16082398|NCT03246724|38795911|FG001|Overall Study|Re-consented to participate|0|||
16082399|NCT03246724|38795912|FG002|Overall Study|Re-consented to participate|0|||
16082400|NCT03246724|38795913|FG003|Overall Study|Re-consented to participate|1|||
16082401|NCT01400958|38795914|FG000|Overall Study|Physician Decision|0|||
16486113|NCT01727297|40256143|FG001|Overall Study|Protocol Violation|10|||
16082402|NCT01400958|38795915|FG001|Overall Study|Physician Decision|1|||
16082403|NCT01400958|38795914|FG000|Overall Study|Withdrawal by Subject|0|||
16082404|NCT01400958|38795915|FG001|Overall Study|Withdrawal by Subject|1|||
16082405|NCT01400958|38795914|FG000|Overall Study|Adverse Event|1|||
16082406|NCT01400958|38795915|FG001|Overall Study|Adverse Event|0|||
16082407|NCT00468052|38795916|FG000|Overall Study|Protocol Violation|7|||
16082408|NCT00468052|38795917|FG001|Overall Study|Protocol Violation|8|||
16082409|NCT02285270|38795919|FG000|Overall Study|Lost to Follow-up|1|||
16082410|NCT02285270|38795919|FG000|Overall Study|Physician Decision|3|||
16082411|NCT02285270|38795919|FG000|Overall Study|Determined to be ineligible|1|||
16082412|NCT01211184|38795921|FG000|Overall Study|Withdrawal by Subject|0|||
16082413|NCT01211184|38795922|FG001|Overall Study|Withdrawal by Subject|2|||
16082414|NCT01211184|38795923|FG002|Overall Study|Withdrawal by Subject|1|||
16082415|NCT03014453|38795924|FG000|Overall Study|Lost to Follow-up|12|||
16082416|NCT03014453|38795924|FG000|Overall Study|Discontinued GER|3|||
16082417|NCT03014453|38795924|FG000|Overall Study|Excluded|19|||
16082418|NCT03014453|38795924|FG000|Overall Study|Refused to take part in|37|||
16082419|NCT01939899|38795925|FG000|Lead-in Dose Finding Phase|Death|0|||
16082420|NCT01939899|38795926|FG001|Lead-in Dose Finding Phase|Death|3|||
16082421|NCT01939899|38795927|FG002|Lead-in Dose Finding Phase|Death|1|||
16082422|NCT01939899|38795928|FG003|Lead-in Dose Finding Phase|Death|0|||
16082423|NCT01939899|38795929|FG004|Lead-in Dose Finding Phase|Death|0|||
16082424|NCT01939899|38795925|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
16082425|NCT01939899|38795926|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
16082426|NCT01939899|38795927|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
16082427|NCT01939899|38795928|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
16082428|NCT01939899|38795929|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
16082429|NCT01939899|38795925|FG000|Lead-in Dose Finding Phase|Other|0|||
16082430|NCT01939899|38795926|FG001|Lead-in Dose Finding Phase|Other|0|||
16082431|NCT01939899|38795927|FG002|Lead-in Dose Finding Phase|Other|1|||
16082432|NCT01939899|38795928|FG003|Lead-in Dose Finding Phase|Other|0|||
16082433|NCT01939899|38795929|FG004|Lead-in Dose Finding Phase|Other|0|||
16082434|NCT01939899|38795925|FG000|Phase 2|Withdrawal by Subject|0|||
16082435|NCT01939899|38795926|FG001|Phase 2|Withdrawal by Subject|0|||
16486114|NCT01727297|40256142|FG000|Overall Study|Adverse Event|3|||
16486115|NCT01727297|40256143|FG001|Overall Study|Adverse Event|1|||
16082436|NCT01939899|38795927|FG002|Phase 2|Withdrawal by Subject|0|||
16082437|NCT01939899|38795928|FG003|Phase 2|Withdrawal by Subject|2|||
16082438|NCT01939899|38795929|FG004|Phase 2|Withdrawal by Subject|0|||
16082439|NCT01939899|38795925|FG000|Phase 2|Disease Progression|0|||
16082440|NCT01939899|38795926|FG001|Phase 2|Disease Progression|0|||
16082441|NCT01939899|38795927|FG002|Phase 2|Disease Progression|0|||
16082442|NCT01939899|38795928|FG003|Phase 2|Disease Progression|9|||
16082443|NCT01939899|38795929|FG004|Phase 2|Disease Progression|1|||
16082444|NCT00960141|38795930|FG000|Overall Study|Adverse Event|4|||
16082445|NCT00960141|38795931|FG001|Overall Study|Adverse Event|8|||
16082446|NCT00960141|38795932|FG002|Overall Study|Adverse Event|2|||
16082447|NCT00960141|38795930|FG000|Overall Study|Lack of Efficacy|3|||
16082448|NCT00960141|38795931|FG001|Overall Study|Lack of Efficacy|4|||
16082449|NCT00960141|38795932|FG002|Overall Study|Lack of Efficacy|2|||
16082450|NCT00960141|38795930|FG000|Overall Study|Lost to Follow-up|1|||
16082451|NCT00960141|38795931|FG001|Overall Study|Lost to Follow-up|0|||
16082452|NCT00960141|38795932|FG002|Overall Study|Lost to Follow-up|0|||
16082453|NCT00960141|38795930|FG000|Overall Study|Protocol Violation|1|||
16082454|NCT00960141|38795931|FG001|Overall Study|Protocol Violation|3|||
16082455|NCT00960141|38795932|FG002|Overall Study|Protocol Violation|2|||
16082456|NCT00960141|38795930|FG000|Overall Study|Withdrawal by Subject|1|||
16486116|NCT01727297|40256142|FG000|Overall Study|Lost to Follow-up|11|||
16486117|NCT01727297|40256143|FG001|Overall Study|Lost to Follow-up|0|||
16486118|NCT01727297|40256142|FG000|Overall Study|Withdrawal by Subject|26|||
16486119|NCT01727297|40256143|FG001|Overall Study|Withdrawal by Subject|27|||
16486120|NCT01727297|40256142|FG000|Overall Study|Physician Decision|19|||
16486121|NCT01727297|40256143|FG001|Overall Study|Physician Decision|5|||
16486122|NCT01727297|40256142|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
16486123|NCT01727297|40256143|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
16486124|NCT04094883|40256147|FG000|Overall Study|Withdrawal by Subject|1|||
16486125|NCT02915016|40256148|FG000|Overall Study|Lost to Follow-up|4|||
16486126|NCT02915016|40256149|FG001|Overall Study|Lost to Follow-up|2|||
16486127|NCT02915016|40256150|FG002|Overall Study|Lost to Follow-up|5|||
16486128|NCT02915016|40256151|FG003|Overall Study|Lost to Follow-up|3|||
16486129|NCT02915016|40256152|FG004|Overall Study|Lost to Follow-up|5|||
16486130|NCT02915016|40256153|FG005|Overall Study|Lost to Follow-up|2|||
16486131|NCT02915016|40256154|FG006|Overall Study|Lost to Follow-up|8|||
16486132|NCT02915016|40256155|FG007|Overall Study|Lost to Follow-up|2|||
16486133|NCT02915016|40256148|FG000|Overall Study|Physician Decision|0|||
16486134|NCT02915016|40256149|FG001|Overall Study|Physician Decision|0|||
16486135|NCT02915016|40256150|FG002|Overall Study|Physician Decision|1|||
16486136|NCT02915016|40256151|FG003|Overall Study|Physician Decision|0|||
16486137|NCT02915016|40256152|FG004|Overall Study|Physician Decision|0|||
16486138|NCT02915016|40256153|FG005|Overall Study|Physician Decision|1|||
16486139|NCT02915016|40256154|FG006|Overall Study|Physician Decision|2|||
16486140|NCT02915016|40256155|FG007|Overall Study|Physician Decision|0|||
16486141|NCT02915016|40256148|FG000|Overall Study|Withdrawal by Subject|2|||
16486142|NCT02915016|40256149|FG001|Overall Study|Withdrawal by Subject|0|||
16082457|NCT00960141|38795931|FG001|Overall Study|Withdrawal by Subject|2|||
16486143|NCT02915016|40256150|FG002|Overall Study|Withdrawal by Subject|1|||
16486144|NCT02915016|40256151|FG003|Overall Study|Withdrawal by Subject|0|||
16486145|NCT02915016|40256152|FG004|Overall Study|Withdrawal by Subject|1|||
16082458|NCT00960141|38795932|FG002|Overall Study|Withdrawal by Subject|1|||
16082459|NCT03101371|38795935|FG000|Overall Study|Physician Decision|0|||
16082460|NCT03101371|38795936|FG001|Overall Study|Physician Decision|1|||
16082461|NCT03101371|38795935|FG000|Overall Study|Lost to Follow-up|1|||
16082462|NCT03101371|38795936|FG001|Overall Study|Lost to Follow-up|4|||
16486146|NCT02915016|40256153|FG005|Overall Study|Withdrawal by Subject|3|||
16486147|NCT02915016|40256154|FG006|Overall Study|Withdrawal by Subject|1|||
16486148|NCT02915016|40256155|FG007|Overall Study|Withdrawal by Subject|1|||
16486149|NCT02915016|40256148|FG000|Overall Study|Elected not to continue|0|||
16295732|NCT00742924|39566377|FG003|Overall Study|Adverse Event|1|||
16295733|NCT00742924|39566374|FG000|Overall Study|Lack of Efficacy|5|||
16295734|NCT00742924|39566375|FG001|Overall Study|Lack of Efficacy|1|||
16295735|NCT00742924|39566376|FG002|Overall Study|Lack of Efficacy|2|||
16295736|NCT00742924|39566377|FG003|Overall Study|Lack of Efficacy|4|||
16295737|NCT00742924|39566374|FG000|Overall Study|Physician Decision|0|||
16295738|NCT00742924|39566375|FG001|Overall Study|Physician Decision|0|||
16295739|NCT00742924|39566376|FG002|Overall Study|Physician Decision|0|||
16295740|NCT00742924|39566377|FG003|Overall Study|Physician Decision|1|||
16295741|NCT00742924|39566374|FG000|Overall Study|Withdrawal by Subject|0|||
16295742|NCT00742924|39566375|FG001|Overall Study|Withdrawal by Subject|1|||
16295743|NCT00742924|39566376|FG002|Overall Study|Withdrawal by Subject|1|||
16295744|NCT00742924|39566377|FG003|Overall Study|Withdrawal by Subject|0|||
16295745|NCT01394952|39566383|FG000|Overall Study|Lost to Follow-up|0|||
16295746|NCT01394952|39566384|FG001|Overall Study|Lost to Follow-up|5|||
16295747|NCT01394952|39566383|FG000|Overall Study|Withdrawal by Subject|10|||
16295748|NCT01394952|39566384|FG001|Overall Study|Withdrawal by Subject|5|||
16295749|NCT01394952|39566383|FG000|Overall Study|Physician Decision|2|||
16295750|NCT01394952|39566384|FG001|Overall Study|Physician Decision|0|||
16295751|NCT01394952|39566383|FG000|Overall Study|Sponsor Decision|5|||
16295752|NCT01394952|39566384|FG001|Overall Study|Sponsor Decision|7|||
16295753|NCT00893737|39566385|FG000|Overall Study|Adverse Event|4|||
16295754|NCT00893737|39566385|FG000|Overall Study|Withdrawal by Subject|2|||
16295755|NCT00893737|39566385|FG000|Overall Study|Lost to Follow-up|6|||
16295756|NCT01388166|39566386|FG000|Overall Study|Adverse Event|16|||
16295757|NCT01388166|39566386|FG000|Overall Study|Lost to Follow-up|30|||
16382870|NCT01677988|39884664|FG000|Overall Study|Lack of Efficacy|2|||
16382871|NCT04577781|39884665|FG000|Overall Study|Adverse Event|2|||
16382872|NCT04577781|39884666|FG001|Overall Study|Adverse Event|2|||
16382873|NCT04577781|39884665|FG000|Overall Study|Physician Decision|1|||
16382874|NCT04577781|39884666|FG001|Overall Study|Physician Decision|0|||
16382875|NCT01263119|39884667|FG000|Period 1|Protocol Violation|2|||
16382876|NCT01263119|39884667|FG000|Period 2|Adverse Event|2|||
16486150|NCT02915016|40256149|FG001|Overall Study|Elected not to continue|0|||
16486151|NCT02915016|40256150|FG002|Overall Study|Elected not to continue|0|||
16486152|NCT02915016|40256151|FG003|Overall Study|Elected not to continue|1|||
16486153|NCT02915016|40256152|FG004|Overall Study|Elected not to continue|0|||
16486154|NCT02915016|40256153|FG005|Overall Study|Elected not to continue|0|||
16486155|NCT02915016|40256154|FG006|Overall Study|Elected not to continue|1|||
16486156|NCT02915016|40256155|FG007|Overall Study|Elected not to continue|0|||
16486157|NCT02915016|40256148|FG000|Overall Study|HIV infection|1|||
16382877|NCT02216526|39884668|FG000|Overall Study|Adverse Event|1|||
16382878|NCT02216526|39884669|FG001|Overall Study|Adverse Event|1|||
16382879|NCT02216526|39884670|FG002|Overall Study|Adverse Event|0|||
16382880|NCT02216526|39884668|FG000|Overall Study|Death|0|||
16382881|NCT02216526|39884669|FG001|Overall Study|Death|1|||
16382882|NCT02216526|39884670|FG002|Overall Study|Death|3|||
16382883|NCT02216526|39884668|FG000|Overall Study|Protocol Violation|2|||
16382884|NCT02216526|39884669|FG001|Overall Study|Protocol Violation|0|||
16382885|NCT02216526|39884670|FG002|Overall Study|Protocol Violation|2|||
16382886|NCT02216526|39884668|FG000|Overall Study|Hospitalization|2|||
16382887|NCT02216526|39884669|FG001|Overall Study|Hospitalization|1|||
16382888|NCT02216526|39884670|FG002|Overall Study|Hospitalization|3|||
16382889|NCT01121757|39884671|FG000|First Drug|Death|1|||
16382890|NCT01121757|39884672|FG001|First Drug|Death|0|||
16382891|NCT01121757|39884671|FG000|First Drug|Disease Progression|0|||
16382892|NCT01121757|39884672|FG001|First Drug|Disease Progression|2|||
16382893|NCT01121757|39884671|FG000|Combination|Physician Decision|0|||
16382894|NCT01121757|39884672|FG001|Combination|Physician Decision|1|||
16382895|NCT01121757|39884671|FG000|Combination|Disease Progression|2|||
16382896|NCT01121757|39884672|FG001|Combination|Disease Progression|0|||
16382897|NCT02393859|39884674|FG000|Overall Study|Decision by Sponsor|2|||
16382898|NCT02393859|39884675|FG001|Overall Study|Decision by Sponsor|4|||
16382899|NCT02393859|39884674|FG000|Overall Study|Withdrawal by Subject|11|||
16382900|NCT02393859|39884675|FG001|Overall Study|Withdrawal by Subject|6|||
16382901|NCT02393859|39884674|FG000|Overall Study|Death|27|||
16382902|NCT02393859|39884675|FG001|Overall Study|Death|10|||
16295758|NCT01388166|39566386|FG000|Overall Study|Others than specified above|13|||
16295759|NCT03246126|39566394|FG000|Overall Study|Withdrawal by Subject|0|||
16295760|NCT03246126|39566395|FG001|Overall Study|Withdrawal by Subject|1|||
16295761|NCT03222583|39566396|FG000|Overall Study|Withdrawal by Subject|3|||
16295762|NCT03222583|39566397|FG001|Overall Study|Withdrawal by Subject|3|||
16295763|NCT03222583|39566396|FG000|Overall Study|Lost to Follow-up|1|||
16295764|NCT03222583|39566397|FG001|Overall Study|Lost to Follow-up|0|||
16295765|NCT03222583|39566396|FG000|Overall Study|Other|1|||
16382903|NCT02393859|39884674|FG000|Overall Study|Lost to Follow-up|1|||
16382904|NCT02393859|39884675|FG001|Overall Study|Lost to Follow-up|1|||
16382905|NCT03673176|39884676|FG000|Overall Study|Death prior to intervention|1|||
16382906|NCT03673176|39884676|FG000|Overall Study|Death following intervention|3|||
16486158|NCT02915016|40256149|FG001|Overall Study|HIV infection|1|||
16486159|NCT02915016|40256150|FG002|Overall Study|HIV infection|1|||
16486160|NCT02915016|40256151|FG003|Overall Study|HIV infection|0|||
16486161|NCT02915016|40256152|FG004|Overall Study|HIV infection|1|||
16486162|NCT02915016|40256153|FG005|Overall Study|HIV infection|0|||
16486163|NCT02915016|40256154|FG006|Overall Study|HIV infection|0|||
16486164|NCT02915016|40256155|FG007|Overall Study|HIV infection|0|||
16486165|NCT02915016|40256148|FG000|Overall Study|Participant unable to adhere|0|||
16486166|NCT02915016|40256149|FG001|Overall Study|Participant unable to adhere|0|||
16486167|NCT02915016|40256150|FG002|Overall Study|Participant unable to adhere|0|||
16486168|NCT02915016|40256151|FG003|Overall Study|Participant unable to adhere|0|||
16486169|NCT02915016|40256152|FG004|Overall Study|Participant unable to adhere|0|||
16486170|NCT02915016|40256153|FG005|Overall Study|Participant unable to adhere|0|||
16486171|NCT02915016|40256154|FG006|Overall Study|Participant unable to adhere|0|||
16486172|NCT02915016|40256155|FG007|Overall Study|Participant unable to adhere|1|||
16486173|NCT00873912|40256156|FG000|Overall Study|Withdrawal by Subject|1|||
16486174|NCT00873912|40256157|FG001|Overall Study|Withdrawal by Subject|0|||
16486175|NCT00873912|40256156|FG000|Overall Study|Lost to Follow-up|2|||
16486176|NCT00873912|40256157|FG001|Overall Study|Lost to Follow-up|0|||
16486177|NCT02879305|40256158|FG000|Overall Study|Investigator Site Closed|55|||
16486178|NCT02879305|40256159|FG001|Overall Study|Investigator Site Closed|57|||
16486179|NCT02879305|40256158|FG000|Overall Study|Withdrawal by Subject|44|||
16486180|NCT02879305|40256159|FG001|Overall Study|Withdrawal by Subject|42|||
16486181|NCT02879305|40256158|FG000|Overall Study|Lost to Follow-up|17|||
16486182|NCT02879305|40256159|FG001|Overall Study|Lost to Follow-up|12|||
16486183|NCT02879305|40256158|FG000|Overall Study|Other|1|||
16486184|NCT02879305|40256159|FG001|Overall Study|Other|0|||
16486185|NCT02412618|40256160|FG000|Overall Study|Withdrawal by Subject|1|||
16486186|NCT02412618|40256161|FG001|Overall Study|Withdrawal by Subject|1|||
16486187|NCT02412618|40256160|FG000|Overall Study|Expulsion|1|||
16486188|NCT02412618|40256161|FG001|Overall Study|Expulsion|1|||
16486189|NCT00040365|40256162|FG000|Overall Study|Death|1|||
16486190|NCT00040365|40256162|FG000|Overall Study|Progressive disease|7|||
16486191|NCT00040365|40256162|FG000|Overall Study|Lost to Follow-up|3|||
16486192|NCT00582166|40256163|FG000|Overall Study|Death|1|||
16486193|NCT00582166|40256163|FG000|Overall Study|Ineligible pathology|1|||
16486194|NCT03167411|40256164|FG000|Overall Study|Adverse Event|0|||
16486195|NCT03167411|40256165|FG001|Overall Study|Adverse Event|1|||
16486196|NCT01744197|40256166|FG000|Overall Study|Received 1 patch|2|||
16486197|NCT01744197|40256167|FG001|Overall Study|Received 1 patch|1|||
16486198|NCT01744197|40256166|FG000|Overall Study|No patch received|2|||
16486199|NCT01744197|40256167|FG001|Overall Study|No patch received|2|||
16486200|NCT00629707|40256168|FG000|Overall Study|Withdrawal by Subject|0|||
16486201|NCT00629707|40256169|FG001|Overall Study|Withdrawal by Subject|1|||
16486202|NCT00629707|40256168|FG000|Overall Study|Physician Decision|0|||
16486203|NCT00629707|40256169|FG001|Overall Study|Physician Decision|1|||
16486204|NCT02030041|40256178|FG000|Overall Study|Withdrawal by Subject|2|||
16486205|NCT02030041|40256179|FG001|Overall Study|Withdrawal by Subject|2|||
16486206|NCT02030041|40256180|FG002|Overall Study|Withdrawal by Subject|1|||
16486207|NCT00660309|40256182|FG000|Overall Study|Adverse Event|2|||
16486208|NCT00660309|40256183|FG001|Overall Study|Adverse Event|0|||
16486209|NCT00660309|40256182|FG000|Overall Study|Withdrawal by Subject|0|||
16486210|NCT00660309|40256183|FG001|Overall Study|Withdrawal by Subject|3|||
16486211|NCT00726986|40256190|FG000|Induction Phase|Adverse Event|4|||
16486212|NCT00726986|40256190|FG000|Induction Phase|Withdrawal by Subject|2|||
16486213|NCT00726986|40256190|FG000|Induction Phase|Death|2|||
16486214|NCT00726986|40256190|FG000|Induction Phase|Lack of Efficacy|5|||
16486215|NCT00726986|40256190|FG000|Induction Phase|Secondary Disease|2|||
16486216|NCT00726986|40256190|FG000|Maintenance Phase|Adverse Event|1|||
16486217|NCT00726986|40256190|FG000|Maintenance Phase|Lack of Efficacy|2|||
16486218|NCT00300274|40256196|FG000|Overall Study|Withdrawal by Subject|12|||
16295766|NCT03222583|39566397|FG001|Overall Study|Other|3|||
16295767|NCT04280705|39566398|FG000|Overall Study|Enrolled but not treated|4|||
16486219|NCT00300274|40256197|FG001|Overall Study|Withdrawal by Subject|3|||
16486220|NCT00300274|40256198|FG002|Overall Study|Withdrawal by Subject|14|||
16486221|NCT00300274|40256196|FG000|Overall Study|Lost to Follow-up|3|||
16486222|NCT00300274|40256197|FG001|Overall Study|Lost to Follow-up|4|||
16486223|NCT00300274|40256198|FG002|Overall Study|Lost to Follow-up|5|||
16486224|NCT00300274|40256196|FG000|Overall Study|Death|31|||
16486225|NCT00300274|40256197|FG001|Overall Study|Death|20|||
16486226|NCT00300274|40256198|FG002|Overall Study|Death|25|||
16486227|NCT00300274|40256196|FG000|Overall Study|Re-transplant|0|||
16486228|NCT00300274|40256197|FG001|Overall Study|Re-transplant|0|||
16486229|NCT00300274|40256198|FG002|Overall Study|Re-transplant|1|||
16486230|NCT02166905|40256199|FG000|Overall Study|Withdrawal by Subject|1|||
16486231|NCT02166905|40256200|FG001|Overall Study|Withdrawal by Subject|0|||
16486232|NCT02166905|40256201|FG002|Overall Study|Withdrawal by Subject|0|||
16486233|NCT02166905|40256202|FG003|Overall Study|Withdrawal by Subject|0|||
16486234|NCT03736447|40256207|FG000|Overall Study|Adverse Event|5|||
16188536|NCT00960440|39169398|FG002|Overall Study|Other|1|||
16188537|NCT00960440|39169399|FG003|Overall Study|Other|0|||
16188538|NCT03382899|39169400|FG000|Overall Study|Ineligibility Determined|0|||
16188539|NCT03382899|39169401|FG001|Overall Study|Ineligibility Determined|1|||
16188540|NCT03382899|39169400|FG000|Overall Study|Lost to Follow-up|0|||
16188541|NCT03382899|39169401|FG001|Overall Study|Lost to Follow-up|1|||
16188542|NCT03382899|39169400|FG000|Overall Study|Sponsor's decision|31|||
16188543|NCT03382899|39169401|FG001|Overall Study|Sponsor's decision|28|||
16188544|NCT03382899|39169400|FG000|Overall Study|Withdrawal by Subject|0|||
16188545|NCT03382899|39169401|FG001|Overall Study|Withdrawal by Subject|5|||
16188546|NCT05038163|39169402|FG000|Stage 1|Did not complete survey|374|||
16188547|NCT05038163|39169403|FG001|Stage 1|Did not complete survey|0|||
16188548|NCT05038163|39169404|FG002|Stage 1|Did not complete survey|0|||
16188549|NCT05038163|39169405|FG003|Stage 1|Did not complete survey|0|||
16188550|NCT05038163|39169406|FG004|Stage 1|Did not complete survey|0|||
16188551|NCT05038163|39169407|FG005|Stage 1|Did not complete survey|0|||
16188552|NCT05038163|39169402|FG000|Stage 2|Did not complete Stage 2 survey|0|||
16188553|NCT05038163|39169403|FG001|Stage 2|Did not complete Stage 2 survey|29|||
16188554|NCT05038163|39169404|FG002|Stage 2|Did not complete Stage 2 survey|30|||
16188555|NCT05038163|39169405|FG003|Stage 2|Did not complete Stage 2 survey|24|||
16188556|NCT05038163|39169406|FG004|Stage 2|Did not complete Stage 2 survey|21|||
16188557|NCT05038163|39169407|FG005|Stage 2|Did not complete Stage 2 survey|100|||
16188558|NCT03255291|39169408|FG000|Overall Study|Determined to be ineligible|10|||
16188559|NCT03255291|39169409|FG001|Overall Study|Determined to be ineligible|12|||
16188560|NCT03255291|39169410|FG002|Overall Study|Determined to be ineligible|6|||
16188561|NCT03255291|39169411|FG003|Overall Study|Determined to be ineligible|6|||
16188562|NCT03255291|39169412|FG004|Overall Study|Determined to be ineligible|5|||
16188563|NCT03255291|39169413|FG005|Overall Study|Determined to be ineligible|10|||
16188564|NCT03255291|39169408|FG000|Overall Study|Baseline data collection issues|3|||
16188565|NCT03255291|39169409|FG001|Overall Study|Baseline data collection issues|0|||
16188566|NCT03255291|39169410|FG002|Overall Study|Baseline data collection issues|0|||
16188567|NCT03255291|39169411|FG003|Overall Study|Baseline data collection issues|0|||
16188568|NCT03255291|39169412|FG004|Overall Study|Baseline data collection issues|2|||
16188569|NCT03255291|39169413|FG005|Overall Study|Baseline data collection issues|0|||
16188570|NCT02584634|39169414|FG000|Overall Study|Adverse Event|3|||
16188571|NCT02584634|39169415|FG001|Overall Study|Adverse Event|5|||
16188572|NCT02584634|39169414|FG000|Overall Study|Death|0|||
16188573|NCT02584634|39169415|FG001|Overall Study|Death|1|||
16486235|NCT03736447|40256208|FG001|Overall Study|Adverse Event|1|||
16486236|NCT03736447|40256207|FG000|Overall Study|Withdrawal by Subject|5|||
16486237|NCT03736447|40256208|FG001|Overall Study|Withdrawal by Subject|1|||
16188574|NCT02584634|39169414|FG000|Overall Study|Lost to Follow-up|0|||
16188575|NCT02584634|39169415|FG001|Overall Study|Lost to Follow-up|1|||
16188576|NCT02584634|39169414|FG000|Overall Study|Physician Decision|1|||
16188577|NCT02584634|39169415|FG001|Overall Study|Physician Decision|2|||
16188578|NCT02584634|39169414|FG000|Overall Study|Progressive disease|7|||
16188579|NCT02584634|39169415|FG001|Overall Study|Progressive disease|15|||
16188580|NCT02584634|39169414|FG000|Overall Study|Withdrawal by Subject|1|||
16188581|NCT02584634|39169415|FG001|Overall Study|Withdrawal by Subject|1|||
16188582|NCT02584634|39169414|FG000|Overall Study|Other|0|||
16188583|NCT02584634|39169415|FG001|Overall Study|Other|6|||
16188584|NCT05896761|39169416|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
16188585|NCT05896761|39169417|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
16188586|NCT05896761|39169416|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
16188587|NCT05896761|39169417|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
16188588|NCT00988559|39169418|FG000|Overall Study|Withdrawal by Subject|1|||
16188589|NCT00988559|39169419|FG001|Overall Study|Withdrawal by Subject|1|||
16188590|NCT00988559|39169420|FG002|Overall Study|Withdrawal by Subject|0|||
16188591|NCT00988559|39169421|FG003|Overall Study|Withdrawal by Subject|1|||
16188592|NCT00988559|39169418|FG000|Overall Study|Pregnancy|0|||
16486238|NCT03736447|40256207|FG000|Overall Study|Lost to Follow-up|1|||
16486239|NCT03736447|40256208|FG001|Overall Study|Lost to Follow-up|0|||
16082463|NCT03101371|38795935|FG000|Overall Study|Did not meet eligibility criteria|2|||
16188593|NCT00988559|39169419|FG001|Overall Study|Pregnancy|1|||
16188594|NCT00988559|39169420|FG002|Overall Study|Pregnancy|1|||
16188595|NCT00988559|39169421|FG003|Overall Study|Pregnancy|0|||
16188596|NCT00988559|39169418|FG000|Overall Study|Lost to Follow-up|0|||
16188597|NCT00988559|39169419|FG001|Overall Study|Lost to Follow-up|0|||
16188598|NCT00988559|39169420|FG002|Overall Study|Lost to Follow-up|1|||
16188599|NCT00988559|39169421|FG003|Overall Study|Lost to Follow-up|0|||
16188600|NCT01428063|39169422|FG000|Overall Study|Lack of Efficacy|8|||
16188601|NCT01428063|39169423|FG001|Overall Study|Lack of Efficacy|4|||
16188602|NCT01428063|39169424|FG002|Overall Study|Lack of Efficacy|1|||
16188603|NCT01428063|39169422|FG000|Overall Study|Adverse Event|2|||
16188604|NCT01428063|39169423|FG001|Overall Study|Adverse Event|3|||
16188605|NCT01428063|39169424|FG002|Overall Study|Adverse Event|0|||
16188606|NCT01428063|39169422|FG000|Overall Study|Lost to Follow-up|0|||
16486240|NCT03736447|40256207|FG000|Overall Study|Physician Decision|1|||
16188607|NCT01428063|39169423|FG001|Overall Study|Lost to Follow-up|2|||
16486241|NCT03736447|40256208|FG001|Overall Study|Physician Decision|0|||
16486242|NCT03736447|40256207|FG000|Overall Study|Continued commitment to study treatment|3|||
16486243|NCT03736447|40256208|FG001|Overall Study|Continued commitment to study treatment|0|||
16295768|NCT04280705|39566399|FG001|Overall Study|Enrolled but not treated|10|||
16295769|NCT04280705|39566398|FG000|Overall Study|Physician Decision|1|||
16295770|NCT04280705|39566399|FG001|Overall Study|Physician Decision|0|||
16295771|NCT04280705|39566398|FG000|Overall Study|Withdrawal by Subject|7|||
16188608|NCT01428063|39169424|FG002|Overall Study|Lost to Follow-up|0|||
16188609|NCT01428063|39169422|FG000|Overall Study|No longer meets study criteria|0|||
16188610|NCT01428063|39169423|FG001|Overall Study|No longer meets study criteria|1|||
16486244|NCT03736447|40256207|FG000|Overall Study|Taste aversion to study product|0|||
16486245|NCT03736447|40256208|FG001|Overall Study|Taste aversion to study product|1|||
16486246|NCT01192516|40256215|FG000|Overall Study|Lost to Follow-up|7|||
16188611|NCT01428063|39169424|FG002|Overall Study|No longer meets study criteria|0|||
16188612|NCT00915005|39169425|FG000|Overall Study|Withdrawal by Subject|4|||
16295772|NCT04280705|39566399|FG001|Overall Study|Withdrawal by Subject|9|||
16295773|NCT04280705|39566398|FG000|Overall Study|Adverse Event|0|||
16295774|NCT04280705|39566399|FG001|Overall Study|Adverse Event|4|||
16295775|NCT04280705|39566398|FG000|Overall Study|Transferred to another hospital|1|||
16295776|NCT04280705|39566399|FG001|Overall Study|Transferred to another hospital|1|||
16295777|NCT03511326|39566400|FG000|Overall Study|Withdrawal by Subject|1|||
16295778|NCT00706095|39566403|FG000|Overall Study|Progressive Disease|4|||
16295779|NCT00706095|39566404|FG001|Overall Study|Progressive Disease|5|||
16295780|NCT00706095|39566405|FG002|Overall Study|Progressive Disease|3|||
16295781|NCT00706095|39566403|FG000|Overall Study|Clinical Progression|1|||
16295782|NCT00706095|39566404|FG001|Overall Study|Clinical Progression|2|||
16295783|NCT00706095|39566405|FG002|Overall Study|Clinical Progression|2|||
16295784|NCT00706095|39566403|FG000|Overall Study|Withdrawal by Subject|1|||
16295785|NCT00706095|39566404|FG001|Overall Study|Withdrawal by Subject|0|||
16295786|NCT00706095|39566405|FG002|Overall Study|Withdrawal by Subject|0|||
16295787|NCT00090363|39566406|FG000|Overall Study|Lost to Follow-up|1|||
16295788|NCT00090363|39566407|FG001|Overall Study|Lost to Follow-up|2|||
16295789|NCT00090363|39566408|FG002|Overall Study|Lost to Follow-up|1|||
16295790|NCT00090363|39566406|FG000|Overall Study|Withdrawal by Subject|7|||
16295791|NCT00090363|39566407|FG001|Overall Study|Withdrawal by Subject|7|||
16295792|NCT00090363|39566408|FG002|Overall Study|Withdrawal by Subject|6|||
16295793|NCT00090363|39566406|FG000|Overall Study|Study-specific discontinuation criteria|75|||
16295794|NCT00090363|39566407|FG001|Overall Study|Study-specific discontinuation criteria|74|||
16295795|NCT00090363|39566408|FG002|Overall Study|Study-specific discontinuation criteria|62|||
16295796|NCT00090363|39566406|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16295797|NCT00090363|39566407|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16295798|NCT00090363|39566408|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
16295799|NCT00090363|39566406|FG000|Overall Study|Consent expired|7|||
16295800|NCT00090363|39566407|FG001|Overall Study|Consent expired|10|||
16295801|NCT00090363|39566408|FG002|Overall Study|Consent expired|9|||
16295802|NCT00090363|39566406|FG000|Overall Study|Reasons not specified|2|||
16486247|NCT01192516|40256216|FG001|Overall Study|Lost to Follow-up|10|||
16486248|NCT01192516|40256217|FG002|Overall Study|Lost to Follow-up|7|||
16486249|NCT01192516|40256215|FG000|Overall Study|Withdrawal by Subject|4|||
16486250|NCT01192516|40256216|FG001|Overall Study|Withdrawal by Subject|4|||
16486251|NCT01192516|40256217|FG002|Overall Study|Withdrawal by Subject|1|||
16486252|NCT01192516|40256215|FG000|Overall Study|started new treatment|5|||
16486253|NCT01192516|40256216|FG001|Overall Study|started new treatment|1|||
16486254|NCT01192516|40256217|FG002|Overall Study|started new treatment|0|||
16486255|NCT01192516|40256215|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
16486256|NCT01192516|40256216|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
16486257|NCT01192516|40256217|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
16486258|NCT01862874|40256218|FG000|Overall Study|Randomized not treated|1|||
16486259|NCT01862874|40256219|FG001|Overall Study|Randomized not treated|0|||
16486260|NCT01862874|40256218|FG000|Overall Study|Adverse Event|0|||
16486261|NCT01862874|40256219|FG001|Overall Study|Adverse Event|3|||
16188613|NCT00915005|39169426|FG001|Overall Study|Withdrawal by Subject|4|||
16188614|NCT00915005|39169425|FG000|Overall Study|Patient preferred protons therapy|6|||
16295803|NCT00090363|39566407|FG001|Overall Study|Reasons not specified|1|||
16295804|NCT00090363|39566408|FG002|Overall Study|Reasons not specified|1|||
16295805|NCT00090363|39566406|FG000|Overall Study|Continuing on study off treatment|14|||
16295806|NCT00090363|39566407|FG001|Overall Study|Continuing on study off treatment|13|||
16295807|NCT00090363|39566408|FG002|Overall Study|Continuing on study off treatment|16|||
16295808|NCT04713553|39566409|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
16295809|NCT04713553|39566410|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
16295810|NCT04713553|39566411|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
16486262|NCT01862874|40256218|FG000|Overall Study|Lost to Follow-up|26|||
16486263|NCT01862874|40256219|FG001|Overall Study|Lost to Follow-up|29|||
16295811|NCT04713553|39566412|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
16295812|NCT04713553|39566413|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
16295813|NCT04713553|39566414|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
16295814|NCT04713553|39566415|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
16295815|NCT04713553|39566409|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16295816|NCT04713553|39566410|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16295817|NCT04713553|39566411|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16295818|NCT04713553|39566412|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
16295819|NCT04713553|39566413|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16295820|NCT04713553|39566414|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16295821|NCT04713553|39566415|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
16382907|NCT03673176|39884676|FG000|Overall Study|Withdrawal by Subject|1|||
16382908|NCT00746811|39884677|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
16382909|NCT00746811|39884678|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
16382910|NCT02997202|39884680|FG000|Overall Study|Miscellaneous|2|||
16382911|NCT02997202|39884681|FG001|Overall Study|Miscellaneous|2|||
16382912|NCT02997202|39884680|FG000|Overall Study|Withdrawal by Subject|8|||
16382913|NCT02997202|39884681|FG001|Overall Study|Withdrawal by Subject|12|||
16382914|NCT02997202|39884680|FG000|Overall Study|Lost to Follow-up|5|||
16382915|NCT02997202|39884681|FG001|Overall Study|Lost to Follow-up|3|||
16382916|NCT02997202|39884680|FG000|Overall Study|Death|41|||
16382917|NCT02997202|39884681|FG001|Overall Study|Death|45|||
16382918|NCT04490278|39884682|FG000|Overall Study|Lost to Follow-up|6|||
16382919|NCT02297516|39884696|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
16382920|NCT02297516|39884697|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
16382921|NCT02297516|39884696|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
16382922|NCT02297516|39884697|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
16382923|NCT02297516|39884696|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
16382924|NCT02297516|39884697|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
16382925|NCT01570387|39884705|FG000|Overall Study|Adverse Event|1|||
16486264|NCT01862874|40256218|FG000|Overall Study|Physician Decision|5|||
16486265|NCT01862874|40256219|FG001|Overall Study|Physician Decision|3|||
16486266|NCT01862874|40256218|FG000|Overall Study|Withdrawn by parent/guardian|1|||
16486267|NCT01862874|40256219|FG001|Overall Study|Withdrawn by parent/guardian|1|||
16486268|NCT01862874|40256218|FG000|Overall Study|Withdrawal by Subject|46|||
16486269|NCT01862874|40256219|FG001|Overall Study|Withdrawal by Subject|40|||
16486270|NCT01862874|40256218|FG000|Overall Study|Death|0|||
16486271|NCT01862874|40256219|FG001|Overall Study|Death|1|||
16486272|NCT00393029|40256220|FG000|Overall Study|Not treated|0|||
16486273|NCT00393029|40256221|FG001|Overall Study|Not treated|1|||
16486274|NCT01049308|40256223|FG000|Pill Counts|Withdrawal by Subject|83|||
16486275|NCT02849678|40256224|FG000|Overall Study|Protocol Violation|3|||
16486276|NCT02849678|40256225|FG001|Overall Study|Protocol Violation|6|||
16486277|NCT01318993|40256226|FG000|Overall Study|Adverse Event|53|||
16486278|NCT01318993|40256226|FG000|Overall Study|Lack of Efficacy|121|||
16486279|NCT01318993|40256226|FG000|Overall Study|Protocol Violation|3|||
16486280|NCT01318993|40256226|FG000|Overall Study|Protocol based stopping criteria|6|||
16486281|NCT01318993|40256226|FG000|Overall Study|Study closed or terminated|174|||
16486282|NCT01318993|40256226|FG000|Overall Study|Lost to Follow-up|4|||
16486283|NCT01318993|40256226|FG000|Overall Study|Physician Decision|13|||
16486284|NCT01318993|40256226|FG000|Overall Study|Withdrawal by Subject|24|||
16486285|NCT00939770|40256231|FG000|Overall Study|Adverse Event|1|||
16486286|NCT00939770|40256232|FG001|Overall Study|Adverse Event|1|||
16486287|NCT00939770|40256233|FG002|Overall Study|Adverse Event|0|||
16486288|NCT00939770|40256234|FG003|Overall Study|Adverse Event|0|||
16486289|NCT00939770|40256235|FG004|Overall Study|Adverse Event|6|||
16486290|NCT00939770|40256236|FG005|Overall Study|Adverse Event|2|||
16486291|NCT00939770|40256237|FG006|Overall Study|Adverse Event|1|||
16486292|NCT00939770|40256238|FG007|Overall Study|Adverse Event|1|||
16486293|NCT00939770|40256231|FG000|Overall Study|Lack of Efficacy|4|||
16486294|NCT00939770|40256232|FG001|Overall Study|Lack of Efficacy|6|||
16486295|NCT00939770|40256233|FG002|Overall Study|Lack of Efficacy|13|||
16486296|NCT00939770|40256234|FG003|Overall Study|Lack of Efficacy|9|||
16486297|NCT00939770|40256235|FG004|Overall Study|Lack of Efficacy|16|||
16486298|NCT00939770|40256236|FG005|Overall Study|Lack of Efficacy|8|||
16486299|NCT00939770|40256237|FG006|Overall Study|Lack of Efficacy|11|||
16486300|NCT00939770|40256238|FG007|Overall Study|Lack of Efficacy|1|||
16486301|NCT00939770|40256231|FG000|Overall Study|Lost to Follow-up|0|||
16486302|NCT00939770|40256232|FG001|Overall Study|Lost to Follow-up|0|||
16486303|NCT00939770|40256233|FG002|Overall Study|Lost to Follow-up|0|||
16486304|NCT00939770|40256234|FG003|Overall Study|Lost to Follow-up|0|||
16295822|NCT04713553|39566409|FG000|Primary Study (2 Months)|Other|1|||
16382926|NCT01570387|39884706|FG001|Overall Study|Adverse Event|0|||
16382927|NCT01570387|39884707|FG002|Overall Study|Adverse Event|0|||
16486305|NCT00939770|40256235|FG004|Overall Study|Lost to Follow-up|1|||
16382928|NCT01570387|39884708|FG003|Overall Study|Adverse Event|0|||
16382929|NCT01570387|39884705|FG000|Overall Study|Death|0|||
16382930|NCT01570387|39884706|FG001|Overall Study|Death|0|||
16382931|NCT01570387|39884707|FG002|Overall Study|Death|0|||
16382932|NCT01570387|39884708|FG003|Overall Study|Death|1|||
16382933|NCT01570387|39884705|FG000|Overall Study|Withdrawal by Subject|0|||
16382934|NCT01570387|39884706|FG001|Overall Study|Withdrawal by Subject|0|||
16382935|NCT01570387|39884707|FG002|Overall Study|Withdrawal by Subject|0|||
16382936|NCT01570387|39884708|FG003|Overall Study|Withdrawal by Subject|1|||
16382937|NCT03728933|39884715|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
16382938|NCT03728933|39884716|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16382939|NCT03728933|39884717|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16382940|NCT03728933|39884715|FG000|Overall Study|Withdrawal by Subject|0|||
16382941|NCT03728933|39884716|FG001|Overall Study|Withdrawal by Subject|0|||
16382942|NCT03728933|39884717|FG002|Overall Study|Withdrawal by Subject|1|||
16382943|NCT03728933|39884715|FG000|Overall Study|Lost to Follow-up|0|||
16382944|NCT03728933|39884716|FG001|Overall Study|Lost to Follow-up|1|||
16382945|NCT03728933|39884717|FG002|Overall Study|Lost to Follow-up|0|||
16382946|NCT03728933|39884715|FG000|Overall Study|Adverse Event|1|||
16382947|NCT03728933|39884716|FG001|Overall Study|Adverse Event|0|||
16382948|NCT03728933|39884717|FG002|Overall Study|Adverse Event|0|||
16382949|NCT00791648|39884719|FG000|Overall Study|Physician Decision|0|||
16382950|NCT00791648|39884720|FG001|Overall Study|Physician Decision|1|||
16382951|NCT00791648|39884719|FG000|Overall Study|Withdrawal by Subject|0|||
16382952|NCT00791648|39884720|FG001|Overall Study|Withdrawal by Subject|1|||
16382953|NCT01198587|39884721|FG000|Overall Study|Lost to Follow-up|8|||
16295823|NCT04713553|39566410|FG001|Primary Study (2 Months)|Other|2|||
16295824|NCT04713553|39566411|FG002|Primary Study (2 Months)|Other|0|||
16295825|NCT04713553|39566412|FG003|Primary Study (2 Months)|Other|0|||
16295826|NCT04713553|39566413|FG004|Primary Study (2 Months)|Other|1|||
16295827|NCT04713553|39566414|FG005|Primary Study (2 Months)|Other|0|||
16295828|NCT04713553|39566415|FG006|Primary Study (2 Months)|Other|0|||
16295829|NCT04713553|39566409|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
16295830|NCT04713553|39566410|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
16295831|NCT04713553|39566411|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
16295832|NCT04713553|39566412|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
16295833|NCT04713553|39566413|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
16295834|NCT04713553|39566414|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
16295835|NCT04713553|39566415|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
16295836|NCT04713553|39566409|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
16382954|NCT01198587|39884722|FG001|Overall Study|Lost to Follow-up|0|||
16382955|NCT01198587|39884723|FG002|Overall Study|Lost to Follow-up|9|||
16382956|NCT01198587|39884724|FG003|Overall Study|Lost to Follow-up|0|||
16382957|NCT00271544|39884725|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
16382958|NCT00271544|39884725|FG000|Overall Study|Model 4196 lead not attempted|9|||
16382959|NCT00271544|39884725|FG000|Overall Study|Implant not attempted|4|||
16382960|NCT01285102|39884736|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
16382961|NCT02519842|39884739|FG000|Base Study: Cycle 1|Screening Failure|1|||
16382962|NCT02519842|39884740|FG001|Base Study: Cycle 1|Screening Failure|1|||
16382963|NCT02519842|39884741|FG002|Base Study: Cycle 1|Screening Failure|0|||
16382964|NCT02519842|39884739|FG000|Base Study: Cycle 1|Adverse Event|1|||
16382965|NCT02519842|39884740|FG001|Base Study: Cycle 1|Adverse Event|0|||
16295837|NCT04713553|39566410|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
16382966|NCT02519842|39884741|FG002|Base Study: Cycle 1|Adverse Event|0|||
16382967|NCT02519842|39884739|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
16382968|NCT02519842|39884740|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
16382969|NCT02519842|39884741|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
16382970|NCT02519842|39884739|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
16486306|NCT00939770|40256236|FG005|Overall Study|Lost to Follow-up|0|||
16295838|NCT04713553|39566411|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
16382971|NCT02519842|39884740|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
16382972|NCT02519842|39884741|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
16486307|NCT00939770|40256237|FG006|Overall Study|Lost to Follow-up|0|||
16295839|NCT04713553|39566412|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
16295840|NCT04713553|39566413|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
16295841|NCT04713553|39566414|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
16295842|NCT04713553|39566415|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
16295843|NCT03493386|39566419|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16295844|NCT03493386|39566420|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
16295845|NCT03493386|39566421|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16295846|NCT03493386|39566422|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16295847|NCT00699283|39566423|FG000|Overall Study|Lack of Efficacy|15|||
16295848|NCT00699283|39566424|FG001|Overall Study|Lack of Efficacy|5|||
16295849|NCT00699283|39566423|FG000|Overall Study|Lost to Follow-up|2|||
16295850|NCT00699283|39566424|FG001|Overall Study|Lost to Follow-up|0|||
16295851|NCT00699283|39566423|FG000|Overall Study|Withdrawal by Subject|1|||
16295852|NCT00699283|39566424|FG001|Overall Study|Withdrawal by Subject|0|||
16295853|NCT00699283|39566423|FG000|Overall Study|Other Reason|5|||
16295854|NCT00699283|39566424|FG001|Overall Study|Other Reason|1|||
16295855|NCT00699283|39566423|FG000|Overall Study|SAE, non-fatal|1|||
16295856|NCT00699283|39566424|FG001|Overall Study|SAE, non-fatal|1|||
16295857|NCT00699283|39566423|FG000|Overall Study|AE, non-serious non-fatal|8|||
16295858|NCT00699283|39566424|FG001|Overall Study|AE, non-serious non-fatal|1|||
16295859|NCT00699283|39566423|FG000|Overall Study|AE of unknown type|1|||
16295860|NCT00699283|39566424|FG001|Overall Study|AE of unknown type|0|||
16295861|NCT02858492|39566425|FG000|Overall Study|Withdrawal by Subject|0|||
16295862|NCT02858492|39566426|FG001|Overall Study|Withdrawal by Subject|1|||
16295863|NCT02858492|39566427|FG002|Overall Study|Withdrawal by Subject|0|||
16295864|NCT02858492|39566428|FG003|Overall Study|Withdrawal by Subject|1|||
16295865|NCT02858492|39566425|FG000|Overall Study|Adverse Event|0|||
16295866|NCT02858492|39566426|FG001|Overall Study|Adverse Event|0|||
16295867|NCT02858492|39566427|FG002|Overall Study|Adverse Event|0|||
16295868|NCT02858492|39566428|FG003|Overall Study|Adverse Event|3|||
16295869|NCT02858492|39566425|FG000|Overall Study|Lack of Efficacy|0|||
16295870|NCT02858492|39566426|FG001|Overall Study|Lack of Efficacy|0|||
16295871|NCT02858492|39566427|FG002|Overall Study|Lack of Efficacy|0|||
16295872|NCT02858492|39566428|FG003|Overall Study|Lack of Efficacy|1|||
16295873|NCT02858492|39566425|FG000|Overall Study|Protocol defined stopping criteria|0|||
16295874|NCT02858492|39566426|FG001|Overall Study|Protocol defined stopping criteria|0|||
16295875|NCT02858492|39566427|FG002|Overall Study|Protocol defined stopping criteria|0|||
16295876|NCT02858492|39566428|FG003|Overall Study|Protocol defined stopping criteria|1|||
16295877|NCT00158756|39566429|FG000|Overall Study|Withdrawal by Subject|5|||
16295878|NCT00158756|39566430|FG001|Overall Study|Withdrawal by Subject|0|||
16295879|NCT00158756|39566431|FG002|Overall Study|Withdrawal by Subject|6|||
16295880|NCT00158756|39566432|FG003|Overall Study|Withdrawal by Subject|1|||
16295881|NCT00158756|39566433|FG004|Overall Study|Withdrawal by Subject|3|||
16295882|NCT00158756|39566429|FG000|Overall Study|Adverse Event|0|||
16295883|NCT00158756|39566430|FG001|Overall Study|Adverse Event|0|||
16295884|NCT00158756|39566431|FG002|Overall Study|Adverse Event|1|||
16295885|NCT00158756|39566432|FG003|Overall Study|Adverse Event|0|||
16295886|NCT00158756|39566433|FG004|Overall Study|Adverse Event|0|||
16295887|NCT00158756|39566429|FG000|Overall Study|Serious adverse event|0|||
16295888|NCT00158756|39566430|FG001|Overall Study|Serious adverse event|0|||
16295889|NCT00158756|39566431|FG002|Overall Study|Serious adverse event|1|||
16295890|NCT00158756|39566432|FG003|Overall Study|Serious adverse event|0|||
16295891|NCT00158756|39566433|FG004|Overall Study|Serious adverse event|0|||
16295892|NCT02365558|39566434|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
16295893|NCT02365558|39566435|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
16486308|NCT00939770|40256238|FG007|Overall Study|Lost to Follow-up|0|||
16486309|NCT00939770|40256231|FG000|Overall Study|Physician Decision|0|||
16486310|NCT00939770|40256232|FG001|Overall Study|Physician Decision|0|||
16486311|NCT00939770|40256233|FG002|Overall Study|Physician Decision|2|||
16486312|NCT00939770|40256234|FG003|Overall Study|Physician Decision|0|||
16486313|NCT00939770|40256235|FG004|Overall Study|Physician Decision|7|||
16486314|NCT00939770|40256236|FG005|Overall Study|Physician Decision|1|||
16486315|NCT00939770|40256237|FG006|Overall Study|Physician Decision|0|||
16082464|NCT03101371|38795936|FG001|Overall Study|Did not meet eligibility criteria|1|||
16486316|NCT00939770|40256238|FG007|Overall Study|Physician Decision|6|||
16486317|NCT00939770|40256231|FG000|Overall Study|Protocol Violation|0|||
16188615|NCT00915005|39169426|FG001|Overall Study|Patient preferred protons therapy|0|||
16295894|NCT02365558|39566434|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
16295895|NCT02365558|39566435|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
16295896|NCT01155024|39566439|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
16295897|NCT01155024|39566440|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
16295898|NCT01155024|39566439|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
16295899|NCT01155024|39566440|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
16295900|NCT01155024|39566439|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
16295901|NCT01155024|39566440|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
16295902|NCT02593773|39566441|FG000|Overall Study|Voluntary Withdrawal|3|||
16295903|NCT02593773|39566441|FG000|Overall Study|Study Terminated by Sponsor|31|||
16295904|NCT02593773|39566441|FG000|Overall Study|Death|1|||
16295905|NCT01635218|39566442|FG000|Overall Study|Lost to Follow-up|3|||
16295906|NCT01635218|39566443|FG001|Overall Study|Lost to Follow-up|7|||
16295907|NCT01635218|39566444|FG002|Overall Study|Lost to Follow-up|6|||
16295908|NCT00975286|39566451|FG000|Overall Study|Adverse Event|9|||
16295909|NCT00975286|39566452|FG001|Overall Study|Adverse Event|19|||
16295910|NCT00975286|39566451|FG000|Overall Study|Protocol Violation|1|||
16295911|NCT00975286|39566452|FG001|Overall Study|Protocol Violation|2|||
16295912|NCT00975286|39566451|FG000|Overall Study|Withdrawal by Subject|0|||
16295913|NCT00975286|39566452|FG001|Overall Study|Withdrawal by Subject|2|||
16295914|NCT00975286|39566451|FG000|Overall Study|Familial and Personal Reasons|2|||
16295915|NCT00975286|39566452|FG001|Overall Study|Familial and Personal Reasons|2|||
16295916|NCT00975286|39566451|FG000|Overall Study|Poor Compliance to Protocol|0|||
16295917|NCT00975286|39566452|FG001|Overall Study|Poor Compliance to Protocol|2|||
16295918|NCT00975286|39566451|FG000|Overall Study|Sponsor Decision|0|||
16295919|NCT00975286|39566452|FG001|Overall Study|Sponsor Decision|2|||
16295920|NCT02455050|39566454|FG000|Treatment Period 1|Lost to Follow-up|1|||
16295921|NCT02455050|39566455|FG001|Treatment Period 1|Lost to Follow-up|1|||
16295922|NCT02455050|39566456|FG002|Treatment Period 1|Lost to Follow-up|1|||
16295923|NCT02455050|39566457|FG003|Treatment Period 1|Lost to Follow-up|2|||
16295924|NCT02455050|39566454|FG000|Treatment Period 2|Lost to Follow-up|1|||
16295925|NCT02455050|39566455|FG001|Treatment Period 2|Lost to Follow-up|0|||
16295926|NCT02455050|39566456|FG002|Treatment Period 2|Lost to Follow-up|2|||
16295927|NCT02455050|39566457|FG003|Treatment Period 2|Lost to Follow-up|1|||
16346226|NCT03782298|39753264|FG000|Overall Study|Protocol Deviation|4|||
16346227|NCT01615029|39753265|FG000|Overall Study|Adverse Event|0|||
16082465|NCT02513667|38795937|FG000|Overall Study|Withdrawal by Subject|0|||
16346228|NCT01615029|39753266|FG001|Overall Study|Adverse Event|0|||
16346229|NCT01615029|39753267|FG002|Overall Study|Adverse Event|0|||
16346230|NCT01615029|39753268|FG003|Overall Study|Adverse Event|0|||
16346231|NCT01615029|39753269|FG004|Overall Study|Adverse Event|1|||
16346232|NCT01615029|39753265|FG000|Overall Study|Death|0|||
16346233|NCT01615029|39753266|FG001|Overall Study|Death|0|||
16346234|NCT01615029|39753267|FG002|Overall Study|Death|0|||
16082466|NCT02513667|38795938|FG001|Overall Study|Withdrawal by Subject|1|||
16346235|NCT01615029|39753268|FG003|Overall Study|Death|0|||
16346236|NCT01615029|39753269|FG004|Overall Study|Death|1|||
16346237|NCT01615029|39753265|FG000|Overall Study|Lost to Follow-up|0|||
16346238|NCT01615029|39753266|FG001|Overall Study|Lost to Follow-up|0|||
16486318|NCT00939770|40256232|FG001|Overall Study|Protocol Violation|0|||
16486319|NCT00939770|40256233|FG002|Overall Study|Protocol Violation|0|||
16486320|NCT00939770|40256234|FG003|Overall Study|Protocol Violation|0|||
16486321|NCT00939770|40256235|FG004|Overall Study|Protocol Violation|1|||
16486322|NCT00939770|40256236|FG005|Overall Study|Protocol Violation|0|||
16486323|NCT00939770|40256237|FG006|Overall Study|Protocol Violation|0|||
16486324|NCT00939770|40256238|FG007|Overall Study|Protocol Violation|0|||
16486325|NCT00939770|40256231|FG000|Overall Study|Withdrawal by Subject|0|||
16486326|NCT00939770|40256232|FG001|Overall Study|Withdrawal by Subject|1|||
16486327|NCT00939770|40256233|FG002|Overall Study|Withdrawal by Subject|5|||
16486328|NCT00939770|40256234|FG003|Overall Study|Withdrawal by Subject|2|||
16295928|NCT00616629|39570671|FG000|Overall Study|Protocol Violation|1|||
16295929|NCT00616629|39570672|FG001|Overall Study|Protocol Violation|2|||
16295930|NCT00616629|39570673|FG002|Overall Study|Protocol Violation|1|||
16295931|NCT00616629|39570674|FG003|Overall Study|Protocol Violation|0|||
16295932|NCT00616629|39570675|FG004|Overall Study|Protocol Violation|0|||
16295933|NCT00616629|39570671|FG000|Overall Study|AV-block|1|||
16295934|NCT00616629|39570672|FG001|Overall Study|AV-block|0|||
16295935|NCT00616629|39570673|FG002|Overall Study|AV-block|0|||
16295936|NCT00616629|39570674|FG003|Overall Study|AV-block|0|||
16295937|NCT00616629|39570675|FG004|Overall Study|AV-block|0|||
16295938|NCT02038907|39570679|FG000|Overall Study|Protocol Violation|0|||
16295939|NCT02038907|39570680|FG001|Overall Study|Protocol Violation|0|||
16295940|NCT02038907|39570681|FG002|Overall Study|Protocol Violation|0|||
16295941|NCT02038907|39570682|FG003|Overall Study|Protocol Violation|0|||
16295942|NCT02038907|39570683|FG004|Overall Study|Protocol Violation|0|||
16486329|NCT00939770|40256235|FG004|Overall Study|Withdrawal by Subject|6|||
16486330|NCT00939770|40256236|FG005|Overall Study|Withdrawal by Subject|0|||
16295943|NCT02038907|39570684|FG005|Overall Study|Protocol Violation|0|||
16295944|NCT02038907|39570685|FG006|Overall Study|Protocol Violation|0|||
16295945|NCT02038907|39570686|FG007|Overall Study|Protocol Violation|0|||
16382973|NCT02519842|39884739|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
16382974|NCT02519842|39884740|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
16382975|NCT02519842|39884741|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
16382976|NCT02519842|39884739|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
16382977|NCT02519842|39884740|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
16382978|NCT02519842|39884741|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
16382979|NCT02519842|39884739|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16382980|NCT02519842|39884740|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16382981|NCT02519842|39884741|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
16382982|NCT02519842|39884739|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
16382983|NCT02519842|39884740|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
16382984|NCT02519842|39884741|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
16382985|NCT02519842|39884739|FG000|Optional Extension: Cycles 2-6|Death|0|||
16382986|NCT02519842|39884740|FG001|Optional Extension: Cycles 2-6|Death|0|||
16382987|NCT02519842|39884741|FG002|Optional Extension: Cycles 2-6|Death|1|||
16382988|NCT02519842|39884739|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
16382989|NCT02519842|39884740|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
16382990|NCT02519842|39884741|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
16382991|NCT02519842|39884739|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
16382992|NCT02519842|39884740|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
16382993|NCT02519842|39884741|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
16382994|NCT02519842|39884739|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
16382995|NCT02519842|39884740|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
16382996|NCT02519842|39884741|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
16382997|NCT02519842|39884739|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
16382998|NCT02519842|39884740|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
16382999|NCT02519842|39884741|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
16383000|NCT00518180|39884745|FG000|Overall Study|Withdrawal by Subject|29|||
16383001|NCT00518180|39884746|FG001|Overall Study|Withdrawal by Subject|30|||
16383002|NCT00518180|39884747|FG002|Overall Study|Withdrawal by Subject|42|||
16383003|NCT00518180|39884745|FG000|Overall Study|Lost to Follow-up|30|||
16383004|NCT00518180|39884746|FG001|Overall Study|Lost to Follow-up|28|||
16383005|NCT00518180|39884747|FG002|Overall Study|Lost to Follow-up|34|||
16383006|NCT00518180|39884745|FG000|Overall Study|Administrative reason|0|||
16383007|NCT00518180|39884746|FG001|Overall Study|Administrative reason|2|||
16383008|NCT00518180|39884747|FG002|Overall Study|Administrative reason|2|||
16383009|NCT00518180|39884745|FG000|Overall Study|Protocol Violation|5|||
16383010|NCT00518180|39884746|FG001|Overall Study|Protocol Violation|7|||
16383011|NCT00518180|39884747|FG002|Overall Study|Protocol Violation|4|||
16383012|NCT00518180|39884745|FG000|Overall Study|Unable to classify|0|||
16383013|NCT00518180|39884746|FG001|Overall Study|Unable to classify|2|||
16383014|NCT00518180|39884747|FG002|Overall Study|Unable to classify|0|||
16383015|NCT00518180|39884745|FG000|Overall Study|Adverse Event|1|||
16383016|NCT00518180|39884746|FG001|Overall Study|Adverse Event|0|||
16383017|NCT00518180|39884747|FG002|Overall Study|Adverse Event|0|||
16383018|NCT01164007|39888392|FG000|Overall Study|Adverse Event|5|||
16383019|NCT01164007|39888392|FG000|Overall Study|Progression of Disease|30|||
16383020|NCT01164007|39888392|FG000|Overall Study|Protocol Violation|1|||
16383021|NCT01164007|39888392|FG000|Overall Study|Withdrawal by Subject|1|||
16383022|NCT01164007|39888392|FG000|Overall Study|Medical Decision|3|||
16383023|NCT02604511|39888393|FG000|Overall Study|Adverse Event|3|||
16383024|NCT02604511|39888393|FG000|Overall Study|Disease Progression|4|||
16383025|NCT02604511|39888393|FG000|Overall Study|Withdrawal by Subject|3|||
16188616|NCT00915005|39169425|FG000|Overall Study|Insurance denial|3|||
16383026|NCT02604511|39888393|FG000|Overall Study|Participant ineligible|1|||
16383027|NCT02604511|39888393|FG000|Overall Study|Intercurrent illness|1|||
16383028|NCT00619866|39888394|FG000|Weeks 1 - 12|Adverse Event|0|||
16383029|NCT00619866|39888395|FG001|Weeks 1 - 12|Adverse Event|1|||
16383030|NCT00619866|39888396|FG002|Weeks 1 - 12|Adverse Event|2|||
16383031|NCT00619866|39888397|FG003|Weeks 1 - 12|Adverse Event|0|||
16383032|NCT00619866|39888398|FG004|Weeks 1 - 12|Adverse Event|0|||
16383033|NCT00619866|39888394|FG000|Weeks 1 - 12|Non-compliance|0|||
16383034|NCT00619866|39888395|FG001|Weeks 1 - 12|Non-compliance|0|||
16383035|NCT00619866|39888396|FG002|Weeks 1 - 12|Non-compliance|1|||
16383036|NCT00619866|39888397|FG003|Weeks 1 - 12|Non-compliance|0|||
16383037|NCT00619866|39888398|FG004|Weeks 1 - 12|Non-compliance|0|||
16383038|NCT00619866|39888394|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
16383039|NCT00619866|39888395|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
16383040|NCT00619866|39888396|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
16383041|NCT00619866|39888397|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
16383042|NCT00619866|39888398|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
16383043|NCT00619866|39888394|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
16383044|NCT00619866|39888395|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
16383045|NCT00619866|39888396|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
16383046|NCT00619866|39888397|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
16295946|NCT02038907|39570687|FG008|Overall Study|Protocol Violation|0|||
16295947|NCT02038907|39570688|FG009|Overall Study|Protocol Violation|0|||
16295948|NCT02038907|39570689|FG010|Overall Study|Protocol Violation|1|||
16295949|NCT02038907|39570690|FG011|Overall Study|Protocol Violation|0|||
16295950|NCT02038907|39570691|FG012|Overall Study|Protocol Violation|0|||
16383047|NCT00619866|39888398|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
16383048|NCT00619866|39888394|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
16383049|NCT00619866|39888395|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
16383050|NCT00619866|39888396|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
16383051|NCT00619866|39888397|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
16383052|NCT00619866|39888398|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
16383053|NCT00619866|39888394|FG000|Weeks 1 - 12|Sponsor Decision|0|||
16383054|NCT00619866|39888395|FG001|Weeks 1 - 12|Sponsor Decision|1|||
16383055|NCT00619866|39888396|FG002|Weeks 1 - 12|Sponsor Decision|0|||
16383056|NCT00619866|39888397|FG003|Weeks 1 - 12|Sponsor Decision|0|||
16383057|NCT00619866|39888398|FG004|Weeks 1 - 12|Sponsor Decision|0|||
16383058|NCT00619866|39888394|FG000|Weeks 13 - 24|Adverse Event|0|||
16295951|NCT02038907|39570692|FG013|Overall Study|Protocol Violation|0|||
16295952|NCT02038907|39570679|FG000|Overall Study|Withdrawal by Subject|0|||
16295953|NCT02038907|39570680|FG001|Overall Study|Withdrawal by Subject|0|||
16295954|NCT02038907|39570681|FG002|Overall Study|Withdrawal by Subject|0|||
16295955|NCT02038907|39570682|FG003|Overall Study|Withdrawal by Subject|0|||
16295956|NCT02038907|39570683|FG004|Overall Study|Withdrawal by Subject|0|||
16295957|NCT02038907|39570684|FG005|Overall Study|Withdrawal by Subject|0|||
16295958|NCT02038907|39570685|FG006|Overall Study|Withdrawal by Subject|0|||
16295959|NCT02038907|39570686|FG007|Overall Study|Withdrawal by Subject|0|||
16295960|NCT02038907|39570687|FG008|Overall Study|Withdrawal by Subject|0|||
16295961|NCT02038907|39570688|FG009|Overall Study|Withdrawal by Subject|0|||
16295962|NCT02038907|39570689|FG010|Overall Study|Withdrawal by Subject|1|||
16295963|NCT02038907|39570690|FG011|Overall Study|Withdrawal by Subject|0|||
16295964|NCT02038907|39570691|FG012|Overall Study|Withdrawal by Subject|0|||
16295965|NCT02038907|39570692|FG013|Overall Study|Withdrawal by Subject|0|||
16295966|NCT02387983|39570699|FG000|Overall Study|Adverse Event|4|||
16295967|NCT02387983|39570699|FG000|Overall Study|Protocol Violation|1|||
16295968|NCT02387983|39570699|FG000|Overall Study|Withdrawal by Subject|2|||
16295969|NCT02116608|39570700|FG000|Overall Study|Lost to Follow-up|0|||
16295970|NCT02116608|39570701|FG001|Overall Study|Lost to Follow-up|0|||
16295971|NCT02116608|39570702|FG002|Overall Study|Lost to Follow-up|1|||
16295972|NCT02116608|39570700|FG000|Overall Study|Physician Decision|0|||
16295973|NCT02116608|39570701|FG001|Overall Study|Physician Decision|1|||
16295974|NCT02116608|39570702|FG002|Overall Study|Physician Decision|0|||
16295975|NCT02116608|39570700|FG000|Overall Study|Death|0|||
16295976|NCT02116608|39570701|FG001|Overall Study|Death|1|||
16295977|NCT02116608|39570702|FG002|Overall Study|Death|0|||
16295978|NCT03233230|39570704|FG000|Overall Study|Adverse Event|6|||
16295979|NCT03233230|39570705|FG001|Overall Study|Adverse Event|3|||
16295980|NCT03233230|39570706|FG002|Overall Study|Adverse Event|6|||
16295981|NCT03233230|39570707|FG003|Overall Study|Adverse Event|3|||
16295982|NCT03233230|39570704|FG000|Overall Study|Protocol Violation|1|||
16295983|NCT03233230|39570705|FG001|Overall Study|Protocol Violation|2|||
16295984|NCT03233230|39570706|FG002|Overall Study|Protocol Violation|1|||
16295985|NCT03233230|39570707|FG003|Overall Study|Protocol Violation|1|||
16295986|NCT03233230|39570704|FG000|Overall Study|Lack of Efficacy|1|||
16295987|NCT03233230|39570705|FG001|Overall Study|Lack of Efficacy|0|||
16295988|NCT03233230|39570706|FG002|Overall Study|Lack of Efficacy|0|||
16295989|NCT03233230|39570707|FG003|Overall Study|Lack of Efficacy|0|||
16295990|NCT03233230|39570704|FG000|Overall Study|Other|5|||
16295991|NCT03233230|39570705|FG001|Overall Study|Other|5|||
16383059|NCT00619866|39888395|FG001|Weeks 13 - 24|Adverse Event|0|||
16383060|NCT00619866|39888396|FG002|Weeks 13 - 24|Adverse Event|2|||
16383061|NCT00619866|39888397|FG003|Weeks 13 - 24|Adverse Event|1|||
16383062|NCT00619866|39888398|FG004|Weeks 13 - 24|Adverse Event|0|||
16383063|NCT00619866|39888394|FG000|Weeks 13 - 24|Protocol Deviation|0|||
16383064|NCT00619866|39888395|FG001|Weeks 13 - 24|Protocol Deviation|0|||
16383065|NCT00619866|39888396|FG002|Weeks 13 - 24|Protocol Deviation|0|||
16383066|NCT00619866|39888397|FG003|Weeks 13 - 24|Protocol Deviation|1|||
16383067|NCT00619866|39888398|FG004|Weeks 13 - 24|Protocol Deviation|0|||
16295992|NCT03233230|39570706|FG002|Overall Study|Other|5|||
16383068|NCT00619866|39888394|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
16383069|NCT00619866|39888395|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
16082467|NCT02554786|38795941|FG000|Overall Study|Subject/guardian decision|29|||
16082468|NCT02554786|38795942|FG001|Overall Study|Subject/guardian decision|17|||
16082469|NCT02554786|38795943|FG002|Overall Study|Subject/guardian decision|18|||
16082470|NCT02554786|38795944|FG003|Overall Study|Subject/guardian decision|30|||
16082471|NCT02554786|38795945|FG004|Overall Study|Subject/guardian decision|20|||
16082472|NCT02554786|38795941|FG000|Overall Study|Lost to Follow-up|4|||
16295993|NCT03233230|39570707|FG003|Overall Study|Other|3|||
16383070|NCT00619866|39888396|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
16383071|NCT00619866|39888397|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
16383072|NCT00619866|39888398|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
16383073|NCT00619866|39888394|FG000|Weeks 13 - 24|Non-compliance|0|||
16383074|NCT00619866|39888395|FG001|Weeks 13 - 24|Non-compliance|1|||
16383075|NCT00619866|39888396|FG002|Weeks 13 - 24|Non-compliance|1|||
16383076|NCT00619866|39888397|FG003|Weeks 13 - 24|Non-compliance|0|||
16383077|NCT00619866|39888398|FG004|Weeks 13 - 24|Non-compliance|0|||
16383078|NCT00619866|39888394|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
16383079|NCT00619866|39888395|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
16383080|NCT00619866|39888396|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
16383081|NCT00619866|39888397|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
16383082|NCT00619866|39888398|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
16383083|NCT04507763|39888400|FG000|Overall Study|Participants did not meet entrance criteria|201|||
16383084|NCT01397253|39888403|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
16383085|NCT01397253|39888404|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
16383086|NCT01280968|39888405|FG000|Overall Study|Lost to Follow-up|8|||
16383087|NCT01280968|39888406|FG001|Overall Study|Lost to Follow-up|2|||
16383088|NCT01280968|39888405|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
16383089|NCT01280968|39888406|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
16383090|NCT01280968|39888405|FG000|Overall Study|Commuting Problems|2|||
16383091|NCT01280968|39888406|FG001|Overall Study|Commuting Problems|0|||
16383092|NCT01280968|39888405|FG000|Overall Study|Anxiety|2|||
16383093|NCT01280968|39888406|FG001|Overall Study|Anxiety|0|||
16383094|NCT01280968|39888405|FG000|Overall Study|Adverse Event|1|||
16295994|NCT03233230|39570704|FG000|Overall Study|Withdrawal by Subject|2|||
16295995|NCT03233230|39570705|FG001|Overall Study|Withdrawal by Subject|2|||
16295996|NCT03233230|39570706|FG002|Overall Study|Withdrawal by Subject|0|||
16295997|NCT03233230|39570707|FG003|Overall Study|Withdrawal by Subject|1|||
16295998|NCT03233230|39570704|FG000|Overall Study|Lost to Follow-up|0|||
16295999|NCT03233230|39570705|FG001|Overall Study|Lost to Follow-up|3|||
16296000|NCT03233230|39570706|FG002|Overall Study|Lost to Follow-up|0|||
16296001|NCT03233230|39570707|FG003|Overall Study|Lost to Follow-up|0|||
16296002|NCT02908672|39570714|FG000|Overall Study|Death|112|||
16296003|NCT02908672|39570715|FG001|Overall Study|Death|93|||
16296004|NCT02908672|39570714|FG000|Overall Study|Lost to Follow-up|3|||
16296005|NCT02908672|39570715|FG001|Overall Study|Lost to Follow-up|3|||
16296006|NCT02908672|39570714|FG000|Overall Study|Other|2|||
16296007|NCT02908672|39570715|FG001|Overall Study|Other|0|||
16296008|NCT02908672|39570714|FG000|Overall Study|Protocol Violation|1|||
16296009|NCT02908672|39570715|FG001|Overall Study|Protocol Violation|1|||
16296010|NCT02908672|39570714|FG000|Overall Study|Withdrawal by Subject|13|||
16296011|NCT02908672|39570715|FG001|Overall Study|Withdrawal by Subject|18|||
16296012|NCT02908672|39570714|FG000|Overall Study|Study is ongoing|124|||
16296013|NCT02908672|39570715|FG001|Overall Study|Study is ongoing|141|||
16383095|NCT01280968|39888406|FG001|Overall Study|Adverse Event|0|||
16383096|NCT01280968|39888405|FG000|Overall Study|Scheduling Conflicts|1|||
16383097|NCT01280968|39888406|FG001|Overall Study|Scheduling Conflicts|1|||
16383098|NCT01280968|39888405|FG000|Overall Study|Pre-existing Neurological Condition|1|||
16082473|NCT02554786|38795942|FG001|Overall Study|Lost to Follow-up|3|||
16082474|NCT02554786|38795943|FG002|Overall Study|Lost to Follow-up|4|||
16296014|NCT02908672|39570714|FG000|Overall Study|Discontinued the study during run-in|3|||
16296015|NCT02908672|39570715|FG001|Overall Study|Discontinued the study during run-in|0|||
16296016|NCT01955083|39570716|FG000|Overall Study|Lost to Follow-up|1|||
16296017|NCT01955083|39570717|FG001|Overall Study|Lost to Follow-up|1|||
16383099|NCT01280968|39888406|FG001|Overall Study|Pre-existing Neurological Condition|0|||
16383100|NCT01280968|39888405|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
16383101|NCT01280968|39888406|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
16383102|NCT02434081|39888407|FG000|Overall Study|Death (never started treatment)|2|||
16383103|NCT02434081|39888407|FG000|Overall Study|Death|2|||
16383104|NCT02434081|39888407|FG000|Overall Study|Progression|20|||
16383105|NCT02434081|39888407|FG000|Overall Study|Adverse Event|20|||
16383106|NCT02434081|39888407|FG000|Overall Study|Physician Decision|2|||
16383107|NCT02434081|39888407|FG000|Overall Study|Withdrawal by Subject|1|||
16383108|NCT02434081|39888407|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
16383109|NCT00633126|39888408|FG000|Overall Study|Did not receive full dose|1|||
16383110|NCT00145626|39888409|FG000|Overall Study|Did not have NK infusions|2|||
16383111|NCT00145626|39888409|FG000|Overall Study|Turned 2 years old before treatment|1|||
16383112|NCT00145626|39888409|FG000|Overall Study|Death|1|||
16383113|NCT00145626|39888409|FG000|Overall Study|Withdrawal by Subject|1|||
16383114|NCT00688597|39888410|FG000|Overall Study|Adverse Event|2|||
16383115|NCT00688597|39888411|FG001|Overall Study|Adverse Event|0|||
16383116|NCT00688597|39888412|FG002|Overall Study|Adverse Event|0|||
16383117|NCT00688597|39888410|FG000|Overall Study|Physician Decision|1|||
16383118|NCT00688597|39888411|FG001|Overall Study|Physician Decision|0|||
16383119|NCT00688597|39888412|FG002|Overall Study|Physician Decision|0|||
16383120|NCT02670473|39888414|FG000|Overall Study|Withdrawal by Subject|1|||
16383121|NCT01880957|39888416|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
16383122|NCT01880957|39888417|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
16383123|NCT01880957|39888416|FG000|Overall Study|Lost to Follow-up|11|||
16383124|NCT01880957|39888417|FG001|Overall Study|Lost to Follow-up|0|||
16383125|NCT01880957|39888416|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
16383126|NCT01880957|39888417|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
16383127|NCT03586973|39888418|FG000|Overall Study|Death|15|||
16296018|NCT02283294|39570718|FG000|Overall Study|Lost to Follow-up|1|||
16296019|NCT02283294|39570719|FG001|Overall Study|Lost to Follow-up|1|||
16296020|NCT02283294|39570718|FG000|Overall Study|Withdrawal by Subject|1|||
16296021|NCT02283294|39570719|FG001|Overall Study|Withdrawal by Subject|6|||
16296022|NCT02283294|39570718|FG000|Overall Study|Protocol Violation|1|||
16296023|NCT02283294|39570719|FG001|Overall Study|Protocol Violation|0|||
16296024|NCT02283294|39570718|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
16296025|NCT02283294|39570719|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
16296026|NCT00205803|39570720|FG000|Infant Series|Lost to Follow-up|10|||
16383128|NCT03586973|39888419|FG001|Overall Study|Death|8|||
16383129|NCT03586973|39888418|FG000|Overall Study|Site Terminated by Sponsor|3|||
16383130|NCT03586973|39888419|FG001|Overall Study|Site Terminated by Sponsor|6|||
16383131|NCT03586973|39888418|FG000|Overall Study|Withdrawal by Subject|1|||
16383132|NCT03586973|39888419|FG001|Overall Study|Withdrawal by Subject|0|||
16383133|NCT03586973|39888418|FG000|Overall Study|Lost to Follow-up|1|||
16383134|NCT03586973|39888419|FG001|Overall Study|Lost to Follow-up|0|||
16383135|NCT01784029|39888420|FG000|Overall Study|Lost to Follow-up|19|||
16383136|NCT01784029|39888421|FG001|Overall Study|Lost to Follow-up|20|||
16383137|NCT01784029|39888422|FG002|Overall Study|Lost to Follow-up|22|||
16383138|NCT02724839|39888424|FG000|Overall Study|Withdrawal by Subject|1|||
16383139|NCT02724839|39888425|FG001|Overall Study|Withdrawal by Subject|1|||
16486331|NCT00939770|40256237|FG006|Overall Study|Withdrawal by Subject|2|||
16486332|NCT00939770|40256238|FG007|Overall Study|Withdrawal by Subject|2|||
16296027|NCT00205803|39570721|FG001|Infant Series|Lost to Follow-up|4|||
16296028|NCT00205803|39570720|FG000|Infant Series|Withdrawal by Subject|2|||
16296029|NCT00205803|39570721|FG001|Infant Series|Withdrawal by Subject|5|||
16486333|NCT01256008|40256239|FG000|Overall Study|Lost to Follow-up|6|||
16486334|NCT01256008|40256240|FG001|Overall Study|Lost to Follow-up|4|||
16486335|NCT01256008|40256241|FG002|Overall Study|Lost to Follow-up|11|||
16486336|NCT01256008|40256239|FG000|Overall Study|Withdrawal by Subject|2|||
16486337|NCT01256008|40256240|FG001|Overall Study|Withdrawal by Subject|3|||
16486338|NCT01256008|40256241|FG002|Overall Study|Withdrawal by Subject|10|||
16486339|NCT00873015|40256242|FG000|Overall Study|Withdrawal by Subject|0|||
16486340|NCT00873015|40256243|FG001|Overall Study|Withdrawal by Subject|1|||
16486341|NCT00873015|40256244|FG002|Overall Study|Withdrawal by Subject|0|||
16082475|NCT02554786|38795944|FG003|Overall Study|Lost to Follow-up|2|||
16296030|NCT00205803|39570720|FG000|Infant Series|Physician Decision|3|||
16383140|NCT02724839|39888426|FG002|Overall Study|Withdrawal by Subject|0|||
16383141|NCT02724839|39888424|FG000|Overall Study|Lost to Follow-up|0|||
16383142|NCT02724839|39888425|FG001|Overall Study|Lost to Follow-up|3|||
16383143|NCT02724839|39888426|FG002|Overall Study|Lost to Follow-up|2|||
16383144|NCT02724839|39888424|FG000|Overall Study|Physician Decision|0|||
16383145|NCT02724839|39888425|FG001|Overall Study|Physician Decision|0|||
16383146|NCT02724839|39888426|FG002|Overall Study|Physician Decision|3|||
16383147|NCT01378117|39888428|FG000|Overall Study|withdrawal|2|||
16383148|NCT01378117|39888429|FG001|Overall Study|withdrawal|1|||
16486342|NCT00873015|40256245|FG003|Overall Study|Withdrawal by Subject|0|||
16486343|NCT03607487|40256248|FG000|Overall Study|Withdrawal by Subject|2|||
16486344|NCT03607487|40256249|FG001|Overall Study|Withdrawal by Subject|0|||
16486345|NCT03607487|40256250|FG002|Overall Study|Withdrawal by Subject|0|||
16486346|NCT03607487|40256251|FG003|Overall Study|Withdrawal by Subject|1|||
16486347|NCT00843024|40256254|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
16486348|NCT00843024|40256255|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
16486349|NCT00843024|40256256|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
16486350|NCT00843024|40256257|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
16486351|NCT00843024|40256258|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
16486352|NCT00843024|40256259|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
16486353|NCT00843024|40256254|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
16486354|NCT00843024|40256255|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
16486355|NCT00843024|40256256|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
16486356|NCT00843024|40256257|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
16486357|NCT00843024|40256258|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
16188617|NCT00915005|39169426|FG001|Overall Study|Insurance denial|15|||
16188618|NCT01187901|39169427|FG000|Overall Study|Protocol Violation|1|||
16188619|NCT01187901|39169428|FG001|Overall Study|Protocol Violation|0|||
16188620|NCT01187901|39169427|FG000|Overall Study|Lost to Follow-up|1|||
16188621|NCT01187901|39169428|FG001|Overall Study|Lost to Follow-up|2|||
16188622|NCT01187901|39169427|FG000|Overall Study|Unrelated Health Reasons|1|||
16188623|NCT01187901|39169428|FG001|Overall Study|Unrelated Health Reasons|2|||
16296031|NCT00205803|39570721|FG001|Infant Series|Physician Decision|1|||
16296032|NCT00205803|39570720|FG000|Infant Series|Protocol Violation|1|||
16296033|NCT00205803|39570721|FG001|Infant Series|Protocol Violation|0|||
16296034|NCT00205803|39570720|FG000|Infant Series|Lost Kaiser coverage|0|||
16296035|NCT00205803|39570721|FG001|Infant Series|Lost Kaiser coverage|1|||
16296036|NCT00205803|39570720|FG000|Infant Series|Non-compliant|1|||
16296037|NCT00205803|39570721|FG001|Infant Series|Non-compliant|0|||
16296038|NCT00205803|39570720|FG000|Infant Series|Sponsor request|1|||
16296039|NCT00205803|39570721|FG001|Infant Series|Sponsor request|0|||
16296040|NCT00205803|39570720|FG000|After Infant Series|Adverse Event|1|||
16296041|NCT00205803|39570721|FG001|After Infant Series|Adverse Event|1|||
16296042|NCT00205803|39570720|FG000|After Infant Series|Protocol Violation|1|||
16296043|NCT00205803|39570721|FG001|After Infant Series|Protocol Violation|1|||
16296044|NCT00205803|39570720|FG000|After Infant Series|Lost to Follow-up|2|||
16296045|NCT00205803|39570721|FG001|After Infant Series|Lost to Follow-up|1|||
16296046|NCT00205803|39570720|FG000|After Infant Series|Physician Decision|3|||
16296047|NCT00205803|39570721|FG001|After Infant Series|Physician Decision|2|||
16296048|NCT00205803|39570720|FG000|After Infant Series|Withdrawal by Subject|1|||
16296049|NCT00205803|39570721|FG001|After Infant Series|Withdrawal by Subject|4|||
16296050|NCT00205803|39570720|FG000|After Infant Series|Other|10|||
16383149|NCT01378117|39888430|FG002|Overall Study|withdrawal|2|||
16383150|NCT01378117|39888428|FG000|Overall Study|discharged before med given|2|||
16383151|NCT01378117|39888429|FG001|Overall Study|discharged before med given|0|||
16383152|NCT01378117|39888430|FG002|Overall Study|discharged before med given|1|||
16383153|NCT01047540|39888432|FG000|Overall Study|Protocol Violation|1|||
16383154|NCT01047540|39888433|FG001|Overall Study|Protocol Violation|0|||
16296051|NCT00205803|39570721|FG001|After Infant Series|Other|4|||
16296052|NCT00205803|39570720|FG000|Toddler Dose|Lost to Follow-up|2|||
16296053|NCT00205803|39570721|FG001|Toddler Dose|Lost to Follow-up|3|||
16296054|NCT04283500|39570724|FG000|Overall Study|Lost to Follow-up|8|||
16296055|NCT04283500|39570724|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
16296056|NCT00861198|39570725|FG000|Overall Study|SpyGlass Failed|5|||
16296057|NCT01616953|39570729|FG000|Overall Study|Lost to Follow-up|1|||
16296058|NCT01616953|39570730|FG001|Overall Study|Lost to Follow-up|0|||
16383155|NCT01047540|39888434|FG002|Overall Study|Protocol Violation|0|||
16383156|NCT01047540|39888435|FG003|Overall Study|Protocol Violation|0|||
16383157|NCT01047540|39888436|FG004|Overall Study|Protocol Violation|0|||
16383158|NCT01047540|39888432|FG000|Overall Study|Lost to Follow-up|1|||
16383159|NCT01047540|39888433|FG001|Overall Study|Lost to Follow-up|0|||
16486358|NCT00843024|40256259|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
16188624|NCT01187901|39169427|FG000|Overall Study|Suspected Allergic Reaction|1|||
16296059|NCT01616953|39570729|FG000|Overall Study|lack of bone and soft tissue|1|||
16296060|NCT01616953|39570730|FG001|Overall Study|lack of bone and soft tissue|0|||
16296061|NCT03560986|39570736|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
16296062|NCT03560986|39570737|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
16296063|NCT03560986|39570736|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
16296064|NCT03560986|39570737|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
16383160|NCT01047540|39888434|FG002|Overall Study|Lost to Follow-up|0|||
16383161|NCT01047540|39888435|FG003|Overall Study|Lost to Follow-up|0|||
16383162|NCT01047540|39888436|FG004|Overall Study|Lost to Follow-up|0|||
16188625|NCT01187901|39169428|FG001|Overall Study|Suspected Allergic Reaction|1|||
16188626|NCT01187901|39169427|FG000|Overall Study|Adverse Event|3|||
16486359|NCT00843024|40256254|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
16486360|NCT00843024|40256255|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
16486361|NCT00843024|40256256|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
16486362|NCT00843024|40256257|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
16486363|NCT00843024|40256258|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
16486364|NCT00843024|40256259|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
16486365|NCT00843024|40256254|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
16486366|NCT00843024|40256255|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
16486367|NCT00843024|40256256|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
16486368|NCT00843024|40256257|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
16486369|NCT00843024|40256258|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
16486370|NCT00843024|40256259|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
16486371|NCT00843024|40256254|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
16486372|NCT00843024|40256255|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
16082476|NCT02554786|38795945|FG004|Overall Study|Lost to Follow-up|2|||
16082477|NCT02554786|38795941|FG000|Overall Study|Protocol deviation|1|||
16082478|NCT02554786|38795942|FG001|Overall Study|Protocol deviation|3|||
16082479|NCT02554786|38795943|FG002|Overall Study|Protocol deviation|3|||
16486373|NCT00843024|40256256|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
16486374|NCT00843024|40256257|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
16486375|NCT00843024|40256258|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
16486376|NCT00843024|40256259|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
16486377|NCT00843024|40256254|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
16486378|NCT00843024|40256255|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
16486379|NCT00843024|40256256|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
16486380|NCT00843024|40256257|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
16486381|NCT00843024|40256258|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
16486382|NCT00843024|40256259|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
16486383|NCT00843024|40256254|FG000|Single-blind Placebo Run-In Phase|Other|0|||
16486384|NCT00843024|40256255|FG001|Single-blind Placebo Run-In Phase|Other|1|||
16486385|NCT00843024|40256256|FG002|Single-blind Placebo Run-In Phase|Other|0|||
16486386|NCT00843024|40256257|FG003|Single-blind Placebo Run-In Phase|Other|0|||
16486387|NCT00843024|40256258|FG004|Single-blind Placebo Run-In Phase|Other|0|||
16486388|NCT00843024|40256259|FG005|Single-blind Placebo Run-In Phase|Other|0|||
16486389|NCT00843024|40256254|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
16486390|NCT00843024|40256255|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
16486391|NCT00843024|40256256|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
16486392|NCT00843024|40256257|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
16486393|NCT00843024|40256258|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
16486394|NCT00843024|40256259|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
16486395|NCT00843024|40256254|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
16486396|NCT00843024|40256255|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
16486397|NCT00843024|40256256|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
16486398|NCT00843024|40256257|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
16486399|NCT00843024|40256258|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
16486400|NCT00843024|40256259|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
16486401|NCT00843024|40256254|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16486402|NCT00843024|40256255|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16486403|NCT00843024|40256256|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16082480|NCT02554786|38795944|FG003|Overall Study|Protocol deviation|4|||
16082481|NCT02554786|38795945|FG004|Overall Study|Protocol deviation|2|||
16082482|NCT02554786|38795941|FG000|Overall Study|Technical problems|1|||
16082483|NCT02554786|38795942|FG001|Overall Study|Technical problems|1|||
16082484|NCT02554786|38795943|FG002|Overall Study|Technical problems|0|||
16082485|NCT02554786|38795944|FG003|Overall Study|Technical problems|2|||
16082486|NCT02554786|38795945|FG004|Overall Study|Technical problems|1|||
16082487|NCT02554786|38795941|FG000|Overall Study|Adverse Event|0|||
16082488|NCT02554786|38795942|FG001|Overall Study|Adverse Event|0|||
16082489|NCT02554786|38795943|FG002|Overall Study|Adverse Event|0|||
16082490|NCT02554786|38795944|FG003|Overall Study|Adverse Event|0|||
16082491|NCT02554786|38795945|FG004|Overall Study|Adverse Event|2|||
16082492|NCT02554786|38795941|FG000|Overall Study|Death|0|||
16082493|NCT02554786|38795942|FG001|Overall Study|Death|0|||
16188627|NCT01187901|39169428|FG001|Overall Study|Adverse Event|0|||
16188628|NCT01187901|39169427|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
16082494|NCT02554786|38795943|FG002|Overall Study|Death|0|||
16082495|NCT02554786|38795944|FG003|Overall Study|Death|1|||
16082496|NCT02554786|38795945|FG004|Overall Study|Death|0|||
16082497|NCT02554786|38795941|FG000|Overall Study|Non-compliance with study treatment|0|||
16082498|NCT02554786|38795942|FG001|Overall Study|Non-compliance with study treatment|1|||
16082499|NCT02554786|38795943|FG002|Overall Study|Non-compliance with study treatment|1|||
16082500|NCT02554786|38795944|FG003|Overall Study|Non-compliance with study treatment|0|||
16082501|NCT02554786|38795945|FG004|Overall Study|Non-compliance with study treatment|1|||
16082502|NCT02554786|38795941|FG000|Overall Study|Physician Decision|0|||
16082503|NCT02554786|38795942|FG001|Overall Study|Physician Decision|1|||
16082504|NCT02554786|38795943|FG002|Overall Study|Physician Decision|4|||
16082505|NCT02554786|38795944|FG003|Overall Study|Physician Decision|1|||
16082506|NCT02554786|38795945|FG004|Overall Study|Physician Decision|1|||
16082507|NCT02554786|38795941|FG000|Overall Study|Pregnancy|0|||
16082508|NCT02554786|38795942|FG001|Overall Study|Pregnancy|0|||
16082509|NCT02554786|38795943|FG002|Overall Study|Pregnancy|0|||
16082510|NCT02554786|38795944|FG003|Overall Study|Pregnancy|1|||
16082511|NCT02554786|38795945|FG004|Overall Study|Pregnancy|1|||
16082512|NCT03287622|38795947|FG000|Overall Study|Withdrawal by Subject|1|||
16082513|NCT03287622|38795948|FG001|Overall Study|Withdrawal by Subject|0|||
16082514|NCT03287622|38795947|FG000|Overall Study|Lost to Follow-up|27|||
16082515|NCT03287622|38795948|FG001|Overall Study|Lost to Follow-up|15|||
16082516|NCT03287622|38795947|FG000|Overall Study|No prescripion after surgery|28|||
16082517|NCT03287622|38795948|FG001|Overall Study|No prescripion after surgery|31|||
16082518|NCT03287622|38795947|FG000|Overall Study|prolonged Length of stay|2|||
16082519|NCT03287622|38795948|FG001|Overall Study|prolonged Length of stay|0|||
16082520|NCT03287622|38795947|FG000|Overall Study|surgery related|0|||
16082521|NCT03287622|38795948|FG001|Overall Study|surgery related|2|||
16082522|NCT03951805|38795949|FG000|Overall Study|Adverse Event|1|||
16082523|NCT03951805|38795950|FG001|Overall Study|Adverse Event|0|||
16082524|NCT03951805|38795951|FG002|Overall Study|Adverse Event|0|||
16082525|NCT03951805|38795952|FG003|Overall Study|Adverse Event|0|||
16082526|NCT00925587|38795953|FG000|Overall Study|Protocol Specified Criteria|6|||
16082527|NCT00925587|38795954|FG001|Overall Study|Protocol Specified Criteria|6|||
16082528|NCT00925587|38795953|FG000|Overall Study|Physician Decision|4|||
16082529|NCT00925587|38795954|FG001|Overall Study|Physician Decision|1|||
16082530|NCT00925587|38795953|FG000|Overall Study|Protocol Violation|6|||
16082531|NCT00925587|38795954|FG001|Overall Study|Protocol Violation|4|||
16082532|NCT00925587|38795953|FG000|Overall Study|Withdrawal by Subject|9|||
16082533|NCT00925587|38795954|FG001|Overall Study|Withdrawal by Subject|6|||
16082534|NCT00925587|38795953|FG000|Overall Study|Death|5|||
16082535|NCT00925587|38795954|FG001|Overall Study|Death|5|||
16082536|NCT00925587|38795953|FG000|Overall Study|Adverse Event|6|||
16082537|NCT00925587|38795954|FG001|Overall Study|Adverse Event|2|||
16082538|NCT00925587|38795953|FG000|Overall Study|Lost to Follow-up|0|||
16082539|NCT00925587|38795954|FG001|Overall Study|Lost to Follow-up|1|||
16082540|NCT04110054|38795955|FG000|Overall Study|COVID-19 reason other than AE|0|||
16082541|NCT04110054|38795956|FG001|Overall Study|COVID-19 reason other than AE|0|||
16082542|NCT04110054|38795957|FG002|Overall Study|COVID-19 reason other than AE|2|||
16082543|NCT04110054|38795958|FG003|Overall Study|COVID-19 reason other than AE|0|||
16082544|NCT04110054|38795955|FG000|Overall Study|Withdrawal by Subject|0|||
16082545|NCT04110054|38795956|FG001|Overall Study|Withdrawal by Subject|3|||
16082546|NCT04110054|38795957|FG002|Overall Study|Withdrawal by Subject|2|||
16082547|NCT04110054|38795958|FG003|Overall Study|Withdrawal by Subject|0|||
16082548|NCT04110054|38795955|FG000|Overall Study|Adverse Event|1|||
16082549|NCT04110054|38795956|FG001|Overall Study|Adverse Event|1|||
16082550|NCT04110054|38795957|FG002|Overall Study|Adverse Event|4|||
16082551|NCT04110054|38795958|FG003|Overall Study|Adverse Event|3|||
16082552|NCT00585052|38795960|FG000|Overall Study|Withdrawal by Subject|1|||
16082553|NCT00795184|38795961|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
16082554|NCT00795184|38795962|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
16082555|NCT01323790|38795963|FG000|Overall Study|Other|3|||
16082556|NCT01323790|38795964|FG001|Overall Study|Other|2|||
16082557|NCT01323790|38795965|FG002|Overall Study|Other|1|||
16082558|NCT01323790|38795963|FG000|Overall Study|Lost to Follow-up|11|||
16486404|NCT00843024|40256257|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
16486405|NCT00843024|40256258|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16486406|NCT00843024|40256259|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
16486407|NCT00843024|40256254|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
16486408|NCT00843024|40256255|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
16486409|NCT00843024|40256256|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
16486410|NCT00843024|40256257|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
16486411|NCT00843024|40256258|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
16082559|NCT01323790|38795964|FG001|Overall Study|Lost to Follow-up|9|||
16082560|NCT01323790|38795965|FG002|Overall Study|Lost to Follow-up|9|||
16082561|NCT01323790|38795963|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
16082562|NCT01323790|38795964|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
16082563|NCT01323790|38795965|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
16082564|NCT01323790|38795963|FG000|Overall Study|Lack of Efficacy|3|||
16082565|NCT01323790|38795964|FG001|Overall Study|Lack of Efficacy|0|||
16082566|NCT01323790|38795965|FG002|Overall Study|Lack of Efficacy|3|||
16486412|NCT00843024|40256259|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
16486413|NCT00843024|40256254|FG000|Double-blind Treatment Phase|Physician Decision|0|||
16486414|NCT00843024|40256255|FG001|Double-blind Treatment Phase|Physician Decision|0|||
16486415|NCT00843024|40256256|FG002|Double-blind Treatment Phase|Physician Decision|0|||
16486416|NCT00843024|40256257|FG003|Double-blind Treatment Phase|Physician Decision|3|||
16486417|NCT00843024|40256258|FG004|Double-blind Treatment Phase|Physician Decision|1|||
16486418|NCT00843024|40256259|FG005|Double-blind Treatment Phase|Physician Decision|1|||
16486419|NCT00843024|40256254|FG000|Double-blind Treatment Phase|Adverse Event|0|||
16486420|NCT00843024|40256255|FG001|Double-blind Treatment Phase|Adverse Event|0|||
16486421|NCT00843024|40256256|FG002|Double-blind Treatment Phase|Adverse Event|0|||
16486422|NCT00843024|40256257|FG003|Double-blind Treatment Phase|Adverse Event|0|||
16486423|NCT00843024|40256258|FG004|Double-blind Treatment Phase|Adverse Event|1|||
16486424|NCT00843024|40256259|FG005|Double-blind Treatment Phase|Adverse Event|1|||
16486425|NCT00843024|40256254|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
16486426|NCT00843024|40256255|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
16486427|NCT00843024|40256256|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
16486428|NCT00843024|40256257|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
16486429|NCT00843024|40256258|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
16486430|NCT00843024|40256259|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
16486431|NCT01540838|40256262|FG000|Overall Study|Open nasogastric tube|9|||
16486432|NCT01540838|40256263|FG001|Overall Study|Open nasogastric tube|7|||
16486433|NCT01540838|40256262|FG000|Overall Study|Treatment doses missing|8|||
16486434|NCT01540838|40256263|FG001|Overall Study|Treatment doses missing|12|||
16082567|NCT01323790|38795963|FG000|Overall Study|Adverse Event|11|||
16082568|NCT01323790|38795964|FG001|Overall Study|Adverse Event|24|||
16082569|NCT01323790|38795965|FG002|Overall Study|Adverse Event|12|||
16082570|NCT01323790|38795963|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16082571|NCT01323790|38795964|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16486435|NCT01540838|40256262|FG000|Overall Study|Additional antibiotic treatment|1|||
16486436|NCT01540838|40256263|FG001|Overall Study|Additional antibiotic treatment|2|||
16486437|NCT01540838|40256262|FG000|Overall Study|Died before treatment initiation|1|||
16082572|NCT01323790|38795965|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
16188629|NCT01187901|39169428|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
16296065|NCT03560986|39570736|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
16296066|NCT03560986|39570737|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
16296067|NCT03560986|39570736|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
16486438|NCT01540838|40256263|FG001|Overall Study|Died before treatment initiation|1|||
16296068|NCT03560986|39570737|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
16296069|NCT03560986|39570736|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
16296070|NCT03560986|39570737|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
16296071|NCT03560986|39570736|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
16188630|NCT01187901|39169427|FG000|Overall Study|Pregnancy|0|||
16188631|NCT01187901|39169428|FG001|Overall Study|Pregnancy|2|||
16188632|NCT04956692|39169429|FG000|Overall Study|Death|115|||
16188633|NCT04956692|39169430|FG001|Overall Study|Death|47|||
16188634|NCT04956692|39169429|FG000|Overall Study|Lost to Follow-up|0|||
16188635|NCT04956692|39169430|FG001|Overall Study|Lost to Follow-up|1|||
16188636|NCT04956692|39169429|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
16188637|NCT04956692|39169430|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16188638|NCT04956692|39169429|FG000|Overall Study|Withdrawal by Subject|5|||
16188639|NCT04956692|39169430|FG001|Overall Study|Withdrawal by Subject|2|||
16188640|NCT04956692|39169429|FG000|Overall Study|Ongoing in Study|236|||
16188641|NCT04956692|39169430|FG001|Overall Study|Ongoing in Study|123|||
16188642|NCT04346628|39169432|FG000|Overall Study|Lost to Follow-up|4|||
16188643|NCT04346628|39169433|FG001|Overall Study|Lost to Follow-up|4|||
16188644|NCT04346628|39169432|FG000|Overall Study|Withdrew (had personal reasons)|2|||
16188645|NCT04346628|39169433|FG001|Overall Study|Withdrew (had personal reasons)|5|||
16188646|NCT04346628|39169432|FG000|Overall Study|Withdrew (medication intolerant)|0|||
16188647|NCT04346628|39169433|FG001|Overall Study|Withdrew (medication intolerant)|3|||
16296072|NCT03560986|39570737|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
16296073|NCT03560986|39570736|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
16296074|NCT03560986|39570737|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
16296075|NCT04594707|39570738|FG000|Overall Study|Adverse Event|0|||
16296076|NCT04594707|39570739|FG001|Overall Study|Adverse Event|0|||
16296077|NCT04594707|39570740|FG002|Overall Study|Adverse Event|1|||
16296078|NCT04594707|39570738|FG000|Overall Study|Death|0|||
16296079|NCT04594707|39570739|FG001|Overall Study|Death|2|||
16296080|NCT04594707|39570740|FG002|Overall Study|Death|2|||
16486439|NCT01540838|40256262|FG000|Overall Study|Not BM. Other treatment|3|||
16486440|NCT01540838|40256263|FG001|Overall Study|Not BM. Other treatment|1|||
16486441|NCT01866293|40256268|FG000|Overall Study|Adverse Event|2|||
16486442|NCT00566995|40256277|FG000|Overall Study|Toxicity|4|||
16486443|NCT00566995|40256277|FG000|Overall Study|Withdrew consent|3|||
16082573|NCT01323790|38795963|FG000|Overall Study|Withdrawal by Subject|23|||
16082574|NCT01323790|38795964|FG001|Overall Study|Withdrawal by Subject|20|||
16082575|NCT01323790|38795965|FG002|Overall Study|Withdrawal by Subject|13|||
16082576|NCT01323790|38795963|FG000|Overall Study|Did Not Receive Treatment|2|||
16082577|NCT01323790|38795964|FG001|Overall Study|Did Not Receive Treatment|0|||
16082578|NCT01323790|38795965|FG002|Overall Study|Did Not Receive Treatment|1|||
16082579|NCT01323790|38795963|FG000|Overall Study|Severe non-compliance with protocol|2|||
16082580|NCT01323790|38795964|FG001|Overall Study|Severe non-compliance with protocol|2|||
16082581|NCT01323790|38795965|FG002|Overall Study|Severe non-compliance with protocol|2|||
16082582|NCT00632203|38795966|FG000|Overall Study|Did not start study treatment|1|||
16082583|NCT00632203|38795967|FG001|Overall Study|Did not start study treatment|0|||
16082584|NCT04876417|38795968|FG000|Overall Study|Lost to Follow-up|5|||
16082585|NCT04876417|38795969|FG001|Overall Study|Lost to Follow-up|8|||
16082586|NCT04876417|38795970|FG002|Overall Study|Lost to Follow-up|0|||
16082587|NCT04876417|38795971|FG003|Overall Study|Lost to Follow-up|0|||
16082588|NCT03655262|38795972|FG000|Overall Study|Withdrawal by Subject|0|||
16082589|NCT03655262|38795973|FG001|Overall Study|Withdrawal by Subject|0|||
16082590|NCT03655262|38795974|FG002|Overall Study|Withdrawal by Subject|1|||
16082591|NCT02538341|38795975|FG000|Overall Study|Lost to Follow-up|51|||
16082592|NCT02538341|38795976|FG001|Overall Study|Lost to Follow-up|46|||
16082593|NCT02538341|38795975|FG000|Overall Study|Withdrawal by Subject|3|||
16082594|NCT02538341|38795976|FG001|Overall Study|Withdrawal by Subject|1|||
16082595|NCT02538341|38795975|FG000|Overall Study|Death|2|||
16082596|NCT02538341|38795976|FG001|Overall Study|Death|0|||
16082597|NCT01532388|38795977|FG000|3-month Follow-up|Lost to Follow-up|68|||
16082598|NCT01532388|38795978|FG001|3-month Follow-up|Lost to Follow-up|68|||
16082599|NCT01532388|38795977|FG000|6-month Follow-up|Lost to Follow-up|74|||
16082600|NCT01532388|38795978|FG001|6-month Follow-up|Lost to Follow-up|66|||
16082601|NCT01532388|38795977|FG000|12-month Follow-up|Lost to Follow-up|69|||
16082602|NCT01532388|38795978|FG001|12-month Follow-up|Lost to Follow-up|67|||
16082603|NCT00975585|38795980|FG000|Overall Study|Adverse Event|0|||
16082604|NCT00975585|38795981|FG001|Overall Study|Adverse Event|4|||
16082605|NCT00975585|38795980|FG000|Overall Study|Lost to Follow-up|3|||
16082606|NCT00975585|38795981|FG001|Overall Study|Lost to Follow-up|5|||
16082607|NCT00975585|38795980|FG000|Overall Study|Withdrawal by Subject|2|||
16082608|NCT00975585|38795981|FG001|Overall Study|Withdrawal by Subject|1|||
16082609|NCT00975585|38795980|FG000|Overall Study|Lens issue|2|||
16082610|NCT00975585|38795981|FG001|Overall Study|Lens issue|2|||
16082611|NCT01574716|38795982|FG000|Part 1|Death|3|||
16082612|NCT01574716|38795983|FG001|Part 1|Death|1|||
16082613|NCT01574716|38795984|FG002|Part 1|Death|8|||
16082614|NCT01574716|38795985|FG003|Part 1|Death|0|||
16082615|NCT01574716|38795986|FG004|Part 1|Death|0|||
16082616|NCT01574716|38795982|FG000|Part 1|Discontinuation of study by sponsor|0|||
16082617|NCT01574716|38795983|FG001|Part 1|Discontinuation of study by sponsor|0|||
16082618|NCT01574716|38795984|FG002|Part 1|Discontinuation of study by sponsor|1|||
16082619|NCT01574716|38795985|FG003|Part 1|Discontinuation of study by sponsor|0|||
16082620|NCT01574716|38795986|FG004|Part 1|Discontinuation of study by sponsor|0|||
16082621|NCT01574716|38795982|FG000|Part 1|Withdrawal by Subject|0|||
16082622|NCT01574716|38795983|FG001|Part 1|Withdrawal by Subject|2|||
16082623|NCT01574716|38795984|FG002|Part 1|Withdrawal by Subject|0|||
16082624|NCT01574716|38795985|FG003|Part 1|Withdrawal by Subject|0|||
16082625|NCT01574716|38795986|FG004|Part 1|Withdrawal by Subject|0|||
16082626|NCT01574716|38795982|FG000|Part 1|Lost to Follow-up|0|||
16188648|NCT04346628|39169432|FG000|Overall Study|Withdrew (declined intervention)|0|||
16296081|NCT04594707|39570738|FG000|Overall Study|Lung Transplant|0|||
16082627|NCT01574716|38795983|FG001|Part 1|Lost to Follow-up|1|||
16082628|NCT01574716|38795984|FG002|Part 1|Lost to Follow-up|0|||
16082629|NCT01574716|38795985|FG003|Part 1|Lost to Follow-up|0|||
16082630|NCT01574716|38795986|FG004|Part 1|Lost to Follow-up|0|||
16082631|NCT01574716|38795982|FG000|Part 2|Progressive disease|0|||
16082632|NCT01574716|38795983|FG001|Part 2|Progressive disease|0|||
16082633|NCT01574716|38795984|FG002|Part 2|Progressive disease|0|||
16296082|NCT04594707|39570739|FG001|Overall Study|Lung Transplant|0|||
16082634|NCT01574716|38795985|FG003|Part 2|Progressive disease|1|||
16082635|NCT01574716|38795986|FG004|Part 2|Progressive disease|0|||
16082636|NCT01574716|38795982|FG000|Part 2|Death|0|||
16082637|NCT01574716|38795983|FG001|Part 2|Death|0|||
16082638|NCT01574716|38795984|FG002|Part 2|Death|0|||
16082639|NCT01574716|38795985|FG003|Part 2|Death|76|||
16082640|NCT01574716|38795986|FG004|Part 2|Death|35|||
16082641|NCT01574716|38795982|FG000|Part 2|Discontinuation of study by sponsor|0|||
16082642|NCT01574716|38795983|FG001|Part 2|Discontinuation of study by sponsor|0|||
16082643|NCT01574716|38795984|FG002|Part 2|Discontinuation of study by sponsor|0|||
16082644|NCT01574716|38795985|FG003|Part 2|Discontinuation of study by sponsor|51|||
16082645|NCT01574716|38795986|FG004|Part 2|Discontinuation of study by sponsor|31|||
16082646|NCT01574716|38795982|FG000|Part 2|Withdrawal by Subject|0|||
16082647|NCT01574716|38795983|FG001|Part 2|Withdrawal by Subject|0|||
16082648|NCT01574716|38795984|FG002|Part 2|Withdrawal by Subject|0|||
16082649|NCT01574716|38795985|FG003|Part 2|Withdrawal by Subject|5|||
16082650|NCT01574716|38795986|FG004|Part 2|Withdrawal by Subject|4|||
16082651|NCT01574716|38795982|FG000|Part 2|Brain metastases|0|||
16082652|NCT01574716|38795983|FG001|Part 2|Brain metastases|0|||
16082653|NCT01574716|38795984|FG002|Part 2|Brain metastases|0|||
16082654|NCT01574716|38795985|FG003|Part 2|Brain metastases|1|||
16082655|NCT01574716|38795986|FG004|Part 2|Brain metastases|0|||
16082656|NCT01574716|38795982|FG000|Part 2|Lost to Follow-up|0|||
16082657|NCT01574716|38795983|FG001|Part 2|Lost to Follow-up|0|||
16082658|NCT01574716|38795984|FG002|Part 2|Lost to Follow-up|0|||
16082659|NCT01574716|38795985|FG003|Part 2|Lost to Follow-up|3|||
16082660|NCT01574716|38795986|FG004|Part 2|Lost to Follow-up|0|||
16082661|NCT01078116|38795987|FG000|Overall Study|Lost to Follow-up|17|||
16082662|NCT01078116|38795987|FG000|Overall Study|Adverse Event|5|||
16082663|NCT01078116|38795987|FG000|Overall Study|Withdrawal by Subject|8|||
16082664|NCT01078116|38795987|FG000|Overall Study|Lack of effectiveness|15|||
16082665|NCT01078116|38795987|FG000|Overall Study|Case report form not completed|3|||
16082666|NCT00894543|38795988|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
16082667|NCT00894543|38795989|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
16486444|NCT01273597|40256280|FG000|Overall Study|Adverse Event|5|||
16486445|NCT01273597|40256280|FG000|Overall Study|Underwent Kidney Transplantation|2|||
16486446|NCT01273597|40256280|FG000|Overall Study|Reason Not Reported|1|||
16486447|NCT01487200|40256285|FG000|Overall Study|Withdrawal by Subject|0|||
16082668|NCT00894543|38795988|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
16082669|NCT00894543|38795989|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
16082670|NCT01227265|38795990|FG000|Overall Study|Did Not Receive Treatment|1|||
16082671|NCT01227265|38795991|FG001|Overall Study|Did Not Receive Treatment|2|||
16082672|NCT01227265|38795992|FG002|Overall Study|Did Not Receive Treatment|0|||
16082673|NCT01227265|38795990|FG000|Overall Study|Administrative|1|||
16082674|NCT01227265|38795991|FG001|Overall Study|Administrative|0|||
16082675|NCT01227265|38795992|FG002|Overall Study|Administrative|2|||
16082676|NCT01227265|38795990|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
16082677|NCT01227265|38795991|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
16082678|NCT01227265|38795992|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
16082679|NCT01227265|38795990|FG000|Overall Study|Protocol Violation|2|||
16082680|NCT01227265|38795991|FG001|Overall Study|Protocol Violation|1|||
16082681|NCT01227265|38795992|FG002|Overall Study|Protocol Violation|0|||
16082682|NCT01227265|38795990|FG000|Overall Study|Withdrawal by Subject|7|||
16082683|NCT01227265|38795991|FG001|Overall Study|Withdrawal by Subject|7|||
16082684|NCT01227265|38795992|FG002|Overall Study|Withdrawal by Subject|3|||
16082685|NCT01227265|38795990|FG000|Overall Study|Lost to Follow-up|2|||
16082686|NCT01227265|38795991|FG001|Overall Study|Lost to Follow-up|0|||
16188649|NCT04346628|39169433|FG001|Overall Study|Withdrew (declined intervention)|1|||
16188650|NCT01126619|39169434|FG000|Overall Study|Not eligible for the study|2|||
16188651|NCT01126619|39169434|FG000|Overall Study|Investigator decision|4|||
16188652|NCT01126619|39169434|FG000|Overall Study|Serious adverse event|1|||
16296083|NCT04594707|39570740|FG002|Overall Study|Lung Transplant|1|||
16486448|NCT01487200|40256286|FG001|Overall Study|Withdrawal by Subject|1|||
16486449|NCT01487200|40256287|FG002|Overall Study|Withdrawal by Subject|0|||
16486450|NCT01487200|40256288|FG003|Overall Study|Withdrawal by Subject|0|||
16486451|NCT03478657|40256292|FG000|Overall Study|Withdrawal by Subject|0|||
16486452|NCT03478657|40256293|FG001|Overall Study|Withdrawal by Subject|1|||
16546306|NCT02237508|40464780|FG007|Overall Study|Withdrawal by Subject|0|||
16082687|NCT01227265|38795992|FG002|Overall Study|Lost to Follow-up|3|||
16082688|NCT01227265|38795990|FG000|Overall Study|Adverse Event|6|||
16082689|NCT01227265|38795991|FG001|Overall Study|Adverse Event|10|||
16082690|NCT01227265|38795992|FG002|Overall Study|Adverse Event|5|||
16082691|NCT01391832|38796009|FG000|Overall Study|Withdrawal by Subject|21|||
16082692|NCT01391832|38796010|FG001|Overall Study|Withdrawal by Subject|22|||
16082693|NCT01391832|38796009|FG000|Overall Study|Lost to Follow-up|0|||
16082694|NCT01391832|38796010|FG001|Overall Study|Lost to Follow-up|1|||
16082695|NCT04075396|38796011|FG000|Overall Study|Death|11|||
16082696|NCT04075396|38796012|FG001|Overall Study|Death|9|||
16346239|NCT01615029|39753267|FG002|Overall Study|Lost to Follow-up|0|||
16188653|NCT01126619|39169434|FG000|Overall Study|Withdrawal by Subject|9|||
16188654|NCT01126619|39169434|FG000|Overall Study|Non-compliance|1|||
16188655|NCT05523362|39169437|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
16188656|NCT05523362|39169437|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
16188657|NCT05523362|39169437|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
16188658|NCT05523362|39169437|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
16188659|NCT00365716|39169438|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
16188660|NCT00365716|39169439|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
16188661|NCT00365716|39169440|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
16188662|NCT00365716|39169441|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
16188663|NCT00365716|39169442|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
16188664|NCT00365716|39169443|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
16188665|NCT00365716|39169444|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
16188666|NCT00365716|39169438|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
16188667|NCT00365716|39169439|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
16188668|NCT00365716|39169440|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
16188669|NCT00365716|39169441|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
16296084|NCT04594707|39570738|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
16296085|NCT04594707|39570739|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
16296086|NCT04594707|39570740|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
16296087|NCT04594707|39570738|FG000|Overall Study|Study Terminated By Sponsor|19|||
16296088|NCT04594707|39570739|FG001|Overall Study|Study Terminated By Sponsor|47|||
16296089|NCT04594707|39570740|FG002|Overall Study|Study Terminated By Sponsor|41|||
16296090|NCT04594707|39570738|FG000|Overall Study|Withdrawal by Subject|1|||
16296091|NCT04594707|39570739|FG001|Overall Study|Withdrawal by Subject|0|||
16296092|NCT04594707|39570740|FG002|Overall Study|Withdrawal by Subject|2|||
16296093|NCT00537303|39570741|FG000|Overall Study|Adverse Event|1|||
16296094|NCT00537303|39570742|FG001|Overall Study|Adverse Event|4|||
16296095|NCT00537303|39570741|FG000|Overall Study|Lack of Efficacy|6|||
16296096|NCT00537303|39570742|FG001|Overall Study|Lack of Efficacy|7|||
16296097|NCT00537303|39570741|FG000|Overall Study|Protocol Violation|8|||
16296098|NCT00537303|39570742|FG001|Overall Study|Protocol Violation|4|||
16296099|NCT00537303|39570741|FG000|Overall Study|Withdrawal criteria|3|||
16296100|NCT00537303|39570742|FG001|Overall Study|Withdrawal criteria|3|||
16296101|NCT00537303|39570741|FG000|Overall Study|Unclassified|8|||
16296102|NCT00537303|39570742|FG001|Overall Study|Unclassified|7|||
16296103|NCT02524730|39570743|FG000|Overall Study|Lost to Follow-up|5|||
16296104|NCT02524730|39570743|FG000|Overall Study|Withdrawal by Subject|18|||
16296105|NCT02524730|39570743|FG000|Overall Study|Death|10|||
16383163|NCT01047540|39888432|FG000|Overall Study|Withdrawal by Subject|1|||
16383164|NCT01047540|39888433|FG001|Overall Study|Withdrawal by Subject|0|||
16383165|NCT01047540|39888434|FG002|Overall Study|Withdrawal by Subject|3|||
16383166|NCT01047540|39888435|FG003|Overall Study|Withdrawal by Subject|0|||
16383167|NCT01047540|39888436|FG004|Overall Study|Withdrawal by Subject|1|||
16383168|NCT01047540|39888432|FG000|Overall Study|Pregnancy|1|||
16188670|NCT00365716|39169442|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
16296106|NCT02524730|39570743|FG000|Overall Study|Adverse Event|8|||
16296107|NCT02524730|39570743|FG000|Overall Study|Protocol Violation|1|||
16296108|NCT02524730|39570743|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
16296109|NCT02885181|39570746|FG000|Overall Study|Investigator's Discretion|0|||
16296110|NCT02885181|39570747|FG001|Overall Study|Investigator's Discretion|1|||
16296111|NCT02885181|39570748|FG002|Overall Study|Investigator's Discretion|0|||
16296112|NCT02885181|39570749|FG003|Overall Study|Investigator's Discretion|1|||
16296113|NCT02885181|39570746|FG000|Overall Study|Adverse Event|0|||
16296114|NCT02885181|39570747|FG001|Overall Study|Adverse Event|0|||
16296115|NCT02885181|39570748|FG002|Overall Study|Adverse Event|0|||
16296116|NCT02885181|39570749|FG003|Overall Study|Adverse Event|1|||
16296117|NCT02885181|39570746|FG000|Overall Study|Withdrawal by Subject|0|||
16296118|NCT02885181|39570747|FG001|Overall Study|Withdrawal by Subject|0|||
16296119|NCT02885181|39570748|FG002|Overall Study|Withdrawal by Subject|0|||
16296120|NCT02885181|39570749|FG003|Overall Study|Withdrawal by Subject|1|||
16296121|NCT02994940|39570750|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
16296122|NCT02994940|39570751|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
16296123|NCT02994940|39570750|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
16383169|NCT01047540|39888433|FG001|Overall Study|Pregnancy|0|||
16188671|NCT00365716|39169443|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
16296124|NCT02994940|39570751|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
16296125|NCT02994940|39570750|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
16296126|NCT02994940|39570751|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
16383170|NCT01047540|39888434|FG002|Overall Study|Pregnancy|0|||
16383171|NCT01047540|39888435|FG003|Overall Study|Pregnancy|0|||
16383172|NCT01047540|39888436|FG004|Overall Study|Pregnancy|0|||
16296127|NCT03825341|39570752|FG000|Overall Study|Withdrawal by Subject|0|||
16296128|NCT03825341|39570753|FG001|Overall Study|Withdrawal by Subject|1|||
16296129|NCT00191113|39570754|FG000|Core Study|Withdrawal by Subject|25|||
16296130|NCT00191113|39570755|FG001|Core Study|Withdrawal by Subject|9|||
16296131|NCT00191113|39570754|FG000|Core Study|Protocol Violation|6|||
16296132|NCT00191113|39570755|FG001|Core Study|Protocol Violation|2|||
16296133|NCT00191113|39570754|FG000|Core Study|Lost to Follow-up|3|||
16296134|NCT00191113|39570755|FG001|Core Study|Lost to Follow-up|0|||
16296135|NCT00191113|39570754|FG000|Core Study|Adverse Event|0|||
16296136|NCT00191113|39570755|FG001|Core Study|Adverse Event|2|||
16296137|NCT00191113|39570754|FG000|Core Study|Lack of Efficacy|0|||
16296138|NCT00191113|39570755|FG001|Core Study|Lack of Efficacy|2|||
16296139|NCT00191113|39570754|FG000|Core Study|Death|1|||
16296140|NCT00191113|39570755|FG001|Core Study|Death|0|||
16296141|NCT04645966|39570761|FG000|Vaccination Phase|Adverse Event|1|||
16296142|NCT04645966|39570762|FG001|Vaccination Phase|Adverse Event|0|||
16296143|NCT04645966|39570763|FG002|Vaccination Phase|Adverse Event|0|||
16296144|NCT04645966|39570764|FG003|Vaccination Phase|Adverse Event|0|||
16296145|NCT04645966|39570765|FG004|Vaccination Phase|Adverse Event|0|||
16296146|NCT04645966|39570766|FG005|Vaccination Phase|Adverse Event|0|||
16296147|NCT04645966|39570767|FG006|Vaccination Phase|Adverse Event|1|||
16296148|NCT04645966|39570768|FG007|Vaccination Phase|Adverse Event|0|||
16296149|NCT04645966|39570769|FG008|Vaccination Phase|Adverse Event|0|||
16296150|NCT04645966|39570761|FG000|Vaccination Phase|Death|0|||
16296151|NCT04645966|39570762|FG001|Vaccination Phase|Death|0|||
16296152|NCT04645966|39570763|FG002|Vaccination Phase|Death|0|||
16296153|NCT04645966|39570764|FG003|Vaccination Phase|Death|0|||
16296154|NCT04645966|39570765|FG004|Vaccination Phase|Death|0|||
16296155|NCT04645966|39570766|FG005|Vaccination Phase|Death|1|||
16296156|NCT04645966|39570767|FG006|Vaccination Phase|Death|0|||
16296157|NCT04645966|39570768|FG007|Vaccination Phase|Death|0|||
16296158|NCT04645966|39570769|FG008|Vaccination Phase|Death|0|||
16296159|NCT04645966|39570761|FG000|Vaccination Phase|Protocol Violation|0|||
16296160|NCT04645966|39570762|FG001|Vaccination Phase|Protocol Violation|0|||
16296161|NCT04645966|39570763|FG002|Vaccination Phase|Protocol Violation|0|||
16296162|NCT04645966|39570764|FG003|Vaccination Phase|Protocol Violation|0|||
16296163|NCT04645966|39570765|FG004|Vaccination Phase|Protocol Violation|1|||
16296164|NCT04645966|39570766|FG005|Vaccination Phase|Protocol Violation|0|||
16296165|NCT04645966|39570767|FG006|Vaccination Phase|Protocol Violation|0|||
16296166|NCT04645966|39570768|FG007|Vaccination Phase|Protocol Violation|0|||
16296167|NCT04645966|39570769|FG008|Vaccination Phase|Protocol Violation|0|||
16296168|NCT04645966|39570761|FG000|Vaccination Phase|Study terminated by sponsor|0|||
16296169|NCT04645966|39570762|FG001|Vaccination Phase|Study terminated by sponsor|0|||
16296170|NCT04645966|39570763|FG002|Vaccination Phase|Study terminated by sponsor|14|||
16296171|NCT04645966|39570764|FG003|Vaccination Phase|Study terminated by sponsor|15|||
16296172|NCT04645966|39570765|FG004|Vaccination Phase|Study terminated by sponsor|47|||
16296173|NCT04645966|39570766|FG005|Vaccination Phase|Study terminated by sponsor|43|||
16296174|NCT04645966|39570767|FG006|Vaccination Phase|Study terminated by sponsor|29|||
16296175|NCT04645966|39570768|FG007|Vaccination Phase|Study terminated by sponsor|29|||
16296176|NCT04645966|39570769|FG008|Vaccination Phase|Study terminated by sponsor|12|||
16296177|NCT04645966|39570761|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
16486453|NCT03486223|40256306|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
16486454|NCT03486223|40256307|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
16486455|NCT01558271|40256308|FG000|Overall Study|Adverse Event|6|||
16486456|NCT01558271|40256309|FG001|Overall Study|Adverse Event|3|||
16486457|NCT01558271|40256310|FG002|Overall Study|Adverse Event|4|||
16486458|NCT01558271|40256308|FG000|Overall Study|Lost to Follow-up|1|||
16486459|NCT01558271|40256309|FG001|Overall Study|Lost to Follow-up|0|||
16486460|NCT01558271|40256310|FG002|Overall Study|Lost to Follow-up|0|||
16486461|NCT01558271|40256308|FG000|Overall Study|Protocol Violation|1|||
16486462|NCT01558271|40256309|FG001|Overall Study|Protocol Violation|0|||
16486463|NCT01558271|40256310|FG002|Overall Study|Protocol Violation|0|||
16486464|NCT01558271|40256308|FG000|Overall Study|Withdrawal by Subject|10|||
16486465|NCT01558271|40256309|FG001|Overall Study|Withdrawal by Subject|6|||
16486466|NCT01558271|40256310|FG002|Overall Study|Withdrawal by Subject|12|||
16486467|NCT01558271|40256308|FG000|Overall Study|Physician Decision|0|||
16296178|NCT04645966|39570762|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
16296179|NCT04645966|39570763|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
16296180|NCT04645966|39570764|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
16296181|NCT04645966|39570765|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
16296182|NCT04645966|39570766|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
16296183|NCT04645966|39570767|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
16296184|NCT04645966|39570768|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
16296185|NCT04645966|39570769|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
16296186|NCT04645966|39570761|FG000|Vaccination Phase|Other|0|||
16296187|NCT04645966|39570762|FG001|Vaccination Phase|Other|0|||
16296188|NCT04645966|39570763|FG002|Vaccination Phase|Other|0|||
16486468|NCT01558271|40256309|FG001|Overall Study|Physician Decision|2|||
16486469|NCT01558271|40256310|FG002|Overall Study|Physician Decision|1|||
16486470|NCT00353262|40256315|FG000|Overall Study|Adverse Event|8|||
16486471|NCT00353262|40256315|FG000|Overall Study|Withdrawal by Subject|2|||
16486472|NCT00353262|40256315|FG000|Overall Study|Insufficient Therapeutic Response|13|||
16486473|NCT00353262|40256315|FG000|Overall Study|Progression|1|||
16486474|NCT00353262|40256315|FG000|Overall Study|Surgery|4|||
16486475|NCT00353262|40256315|FG000|Overall Study|Break from Chemotherapy|1|||
16486476|NCT00211510|40256318|FG000|Overall Study|Physician Decision|3|||
16486477|NCT00211510|40256319|FG001|Overall Study|Physician Decision|1|||
16486478|NCT00211510|40256318|FG000|Overall Study|Withdrawal by Subject|3|||
16486479|NCT00211510|40256319|FG001|Overall Study|Withdrawal by Subject|1|||
16486480|NCT01081678|40256320|FG000|Overall Study|Ineligibility Determined|0|||
16486481|NCT01081678|40256321|FG001|Overall Study|Ineligibility Determined|0|||
16486482|NCT01081678|40256322|FG002|Overall Study|Ineligibility Determined|1|||
16486483|NCT01081678|40256323|FG003|Overall Study|Ineligibility Determined|1|||
16486484|NCT01081678|40256320|FG000|Overall Study|Noncompliance|3|||
16486485|NCT01081678|40256321|FG001|Overall Study|Noncompliance|4|||
16486486|NCT01081678|40256322|FG002|Overall Study|Noncompliance|5|||
16486487|NCT01081678|40256323|FG003|Overall Study|Noncompliance|2|||
16486488|NCT01081678|40256320|FG000|Overall Study|Adverse Event|2|||
16486489|NCT01081678|40256321|FG001|Overall Study|Adverse Event|1|||
16486490|NCT01081678|40256322|FG002|Overall Study|Adverse Event|2|||
16486491|NCT01081678|40256323|FG003|Overall Study|Adverse Event|2|||
16296189|NCT04645966|39570764|FG003|Vaccination Phase|Other|0|||
16296190|NCT04645966|39570765|FG004|Vaccination Phase|Other|0|||
16296191|NCT04645966|39570766|FG005|Vaccination Phase|Other|2|||
16296192|NCT04645966|39570767|FG006|Vaccination Phase|Other|0|||
16296193|NCT04645966|39570768|FG007|Vaccination Phase|Other|0|||
16296194|NCT04645966|39570769|FG008|Vaccination Phase|Other|0|||
16296195|NCT04645966|39570761|FG000|Vaccination Phase|Lost to Follow-up|0|||
16296196|NCT04645966|39570762|FG001|Vaccination Phase|Lost to Follow-up|0|||
16296197|NCT04645966|39570763|FG002|Vaccination Phase|Lost to Follow-up|0|||
16296198|NCT04645966|39570764|FG003|Vaccination Phase|Lost to Follow-up|0|||
16296199|NCT04645966|39570765|FG004|Vaccination Phase|Lost to Follow-up|0|||
16296200|NCT04645966|39570766|FG005|Vaccination Phase|Lost to Follow-up|0|||
16296201|NCT04645966|39570767|FG006|Vaccination Phase|Lost to Follow-up|0|||
16296202|NCT04645966|39570768|FG007|Vaccination Phase|Lost to Follow-up|1|||
16296203|NCT04645966|39570769|FG008|Vaccination Phase|Lost to Follow-up|0|||
16296204|NCT04645966|39570761|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
16296205|NCT04645966|39570762|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
16296206|NCT04645966|39570763|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
16296207|NCT04645966|39570764|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
16296208|NCT04645966|39570765|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
16296209|NCT04645966|39570766|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
16296210|NCT04645966|39570767|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
16296211|NCT04645966|39570768|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
16296212|NCT04645966|39570769|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
16296213|NCT04645966|39570761|FG000|Follow-up Phase|Lost to Follow-up|0|||
16296214|NCT04645966|39570762|FG001|Follow-up Phase|Lost to Follow-up|0|||
16296215|NCT04645966|39570763|FG002|Follow-up Phase|Lost to Follow-up|0|||
16296216|NCT04645966|39570764|FG003|Follow-up Phase|Lost to Follow-up|0|||
16296217|NCT04645966|39570765|FG004|Follow-up Phase|Lost to Follow-up|0|||
16296218|NCT04645966|39570766|FG005|Follow-up Phase|Lost to Follow-up|0|||
16296219|NCT04645966|39570767|FG006|Follow-up Phase|Lost to Follow-up|0|||
16296220|NCT04645966|39570768|FG007|Follow-up Phase|Lost to Follow-up|1|||
16486492|NCT01081678|40256320|FG000|Overall Study|Withdrawal by Subject|15|||
16486493|NCT01081678|40256321|FG001|Overall Study|Withdrawal by Subject|7|||
16486494|NCT01081678|40256322|FG002|Overall Study|Withdrawal by Subject|17|||
16486495|NCT01081678|40256323|FG003|Overall Study|Withdrawal by Subject|14|||
16486496|NCT01081678|40256320|FG000|Overall Study|Administrative Decision|1|||
16486497|NCT01081678|40256321|FG001|Overall Study|Administrative Decision|0|||
16486498|NCT01081678|40256322|FG002|Overall Study|Administrative Decision|0|||
16296221|NCT04645966|39570769|FG008|Follow-up Phase|Lost to Follow-up|0|||
16296222|NCT00867503|39570772|FG000|Overall Study|Withdrawal by Subject|1|||
16296223|NCT02704403|39570773|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
16296224|NCT02704403|39570774|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
16296225|NCT02704403|39570773|FG000|Overall Study|Administrative reasons by sponsor|1251|||
16296226|NCT02704403|39570774|FG001|Overall Study|Administrative reasons by sponsor|616|||
16296227|NCT02704403|39570773|FG000|Overall Study|Death|4|||
16296228|NCT02704403|39570774|FG001|Overall Study|Death|3|||
16296229|NCT02704403|39570773|FG000|Overall Study|Endpoint event|52|||
16296230|NCT02704403|39570774|FG001|Overall Study|Endpoint event|24|||
16296231|NCT02704403|39570773|FG000|Overall Study|Lost to Follow-up|22|||
16486499|NCT01081678|40256323|FG003|Overall Study|Administrative Decision|1|||
16296232|NCT02704403|39570774|FG001|Overall Study|Lost to Follow-up|11|||
16296233|NCT02704403|39570773|FG000|Overall Study|Protocol Violation|15|||
16296234|NCT02704403|39570774|FG001|Overall Study|Protocol Violation|15|||
16296235|NCT02704403|39570773|FG000|Overall Study|Adverse Event|2|||
16296236|NCT02704403|39570774|FG001|Overall Study|Adverse Event|0|||
16296237|NCT02704403|39570773|FG000|Overall Study|Withdrawal by Subject|85|||
16296238|NCT02704403|39570774|FG001|Overall Study|Withdrawal by Subject|45|||
16296239|NCT02704403|39570773|FG000|Overall Study|Investigator decision|1|||
16296240|NCT02704403|39570774|FG001|Overall Study|Investigator decision|1|||
16296241|NCT02704403|39570773|FG000|Overall Study|Follow-up not possible|1|||
16296242|NCT02704403|39570774|FG001|Overall Study|Follow-up not possible|2|||
16296243|NCT01359969|39570775|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
16383173|NCT01047540|39888432|FG000|Overall Study|Adverse Event|1|||
16188672|NCT00365716|39169444|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
16188673|NCT00365716|39169438|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
16188674|NCT00365716|39169439|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
16188675|NCT00365716|39169440|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
16188676|NCT00365716|39169441|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
16188677|NCT00365716|39169442|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
16188678|NCT00365716|39169443|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
16188679|NCT00365716|39169444|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
16188680|NCT00365716|39169438|FG000|Base Study (Day 1 to Month 7)|Other|0|||
16188681|NCT00365716|39169439|FG001|Base Study (Day 1 to Month 7)|Other|1|||
16188682|NCT00365716|39169440|FG002|Base Study (Day 1 to Month 7)|Other|0|||
16188683|NCT00365716|39169441|FG003|Base Study (Day 1 to Month 7)|Other|0|||
16188684|NCT00365716|39169442|FG004|Base Study (Day 1 to Month 7)|Other|0|||
16188685|NCT00365716|39169443|FG005|Base Study (Day 1 to Month 7)|Other|0|||
16188686|NCT00365716|39169444|FG006|Base Study (Day 1 to Month 7)|Other|0|||
16188687|NCT00365716|39169438|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
16486500|NCT01081678|40256320|FG000|Overall Study|Lost to Follow-up|4|||
16486501|NCT01081678|40256321|FG001|Overall Study|Lost to Follow-up|1|||
16486502|NCT01081678|40256322|FG002|Overall Study|Lost to Follow-up|4|||
16486503|NCT01081678|40256323|FG003|Overall Study|Lost to Follow-up|3|||
16486504|NCT01081678|40256320|FG000|Overall Study|Death|2|||
16486505|NCT01081678|40256321|FG001|Overall Study|Death|2|||
16486506|NCT01081678|40256322|FG002|Overall Study|Death|2|||
16486507|NCT01081678|40256323|FG003|Overall Study|Death|6|||
16486508|NCT01081678|40256320|FG000|Overall Study|Other|0|||
16486509|NCT01081678|40256321|FG001|Overall Study|Other|1|||
16486510|NCT01081678|40256322|FG002|Overall Study|Other|0|||
16486511|NCT01081678|40256323|FG003|Overall Study|Other|0|||
16486512|NCT01500694|40259506|FG000|Overall Study|Adverse Event|4|||
16486513|NCT01500694|40259507|FG001|Overall Study|Adverse Event|3|||
16486514|NCT01500694|40259506|FG000|Overall Study|Protocol Violation|0|||
16486515|NCT01500694|40259507|FG001|Overall Study|Protocol Violation|1|||
16486516|NCT01500694|40259506|FG000|Overall Study|Withdrawal by Subject|23|||
16486517|NCT01500694|40259507|FG001|Overall Study|Withdrawal by Subject|14|||
16486518|NCT01500694|40259506|FG000|Overall Study|Lost to Follow-up|2|||
16486519|NCT01500694|40259507|FG001|Overall Study|Lost to Follow-up|3|||
16486520|NCT01500694|40259506|FG000|Overall Study|Lack of Efficacy|14|||
16486521|NCT01500694|40259507|FG001|Overall Study|Lack of Efficacy|5|||
16486522|NCT01500694|40259506|FG000|Overall Study|Other|9|||
16486523|NCT01500694|40259507|FG001|Overall Study|Other|3|||
16486524|NCT00521014|40259509|FG000|Overall Study|Inevaluable, not treated|1|||
16486525|NCT03798483|40259510|FG000|Overall Study|Lost to Follow-up|2|||
16486526|NCT01364649|40259515|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
16486527|NCT01364649|40259516|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
16486528|NCT01364649|40259515|FG000|Overall Study|Lack of Efficacy|6|||
16486529|NCT01364649|40259516|FG001|Overall Study|Lack of Efficacy|0|||
16486530|NCT01364649|40259515|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
16486531|NCT01364649|40259516|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
16486532|NCT01364649|40259515|FG000|Overall Study|Protocol Deviations|4|||
16188688|NCT00365716|39169439|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
16188689|NCT00365716|39169440|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
16188690|NCT00365716|39169441|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
16188691|NCT00365716|39169442|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
16296244|NCT00510289|39570786|FG000|Overall Study|Withdrawal by Subject|7|||
16486533|NCT01364649|40259516|FG001|Overall Study|Protocol Deviations|8|||
16486534|NCT01364649|40259515|FG000|Overall Study|Withdrawal of Consent|9|||
16486535|NCT01364649|40259516|FG001|Overall Study|Withdrawal of Consent|7|||
16486536|NCT01364649|40259515|FG000|Overall Study|Lost to Follow-up|12|||
16486537|NCT01364649|40259516|FG001|Overall Study|Lost to Follow-up|13|||
16486538|NCT01364649|40259515|FG000|Overall Study|Other|4|||
16486539|NCT01364649|40259516|FG001|Overall Study|Other|1|||
16296245|NCT00510289|39570786|FG000|Overall Study|Refused bone marrow biopsy|2|||
16486540|NCT02010775|40259518|FG000|Overall Study|Adverse Event|0|||
16486541|NCT02010775|40259519|FG001|Overall Study|Adverse Event|0|||
16486542|NCT02010775|40259520|FG002|Overall Study|Adverse Event|0|||
16486543|NCT02010775|40259521|FG003|Overall Study|Adverse Event|0|||
16486544|NCT02010775|40259522|FG004|Overall Study|Adverse Event|1|||
16486545|NCT02010775|40259518|FG000|Overall Study|Pregnancy|0|||
16486546|NCT02010775|40259519|FG001|Overall Study|Pregnancy|0|||
16486547|NCT02010775|40259520|FG002|Overall Study|Pregnancy|2|||
16486548|NCT02010775|40259521|FG003|Overall Study|Pregnancy|0|||
16486549|NCT02010775|40259522|FG004|Overall Study|Pregnancy|0|||
16486550|NCT02010775|40259518|FG000|Overall Study|Lost to Follow-up|2|||
16486551|NCT02010775|40259519|FG001|Overall Study|Lost to Follow-up|0|||
16486552|NCT02010775|40259520|FG002|Overall Study|Lost to Follow-up|0|||
16486553|NCT02010775|40259521|FG003|Overall Study|Lost to Follow-up|1|||
16486554|NCT02010775|40259522|FG004|Overall Study|Lost to Follow-up|1|||
16486555|NCT02010775|40259518|FG000|Overall Study|Personal Reasons|3|||
16486556|NCT02010775|40259519|FG001|Overall Study|Personal Reasons|3|||
16486557|NCT02010775|40259520|FG002|Overall Study|Personal Reasons|1|||
16486558|NCT02010775|40259521|FG003|Overall Study|Personal Reasons|2|||
16486559|NCT02010775|40259522|FG004|Overall Study|Personal Reasons|4|||
16486560|NCT01785069|40259528|FG000|Overall Study|Implanted with nonstudy device|1|||
16486561|NCT01785069|40259529|FG001|Overall Study|Implanted with nonstudy device|2|||
16486562|NCT01785069|40259530|FG002|Overall Study|Implanted with nonstudy device|1|||
16486563|NCT01785069|40259531|FG003|Overall Study|Implanted with nonstudy device|0|||
16486564|NCT01785069|40259528|FG000|Overall Study|Death|0|||
16486565|NCT01785069|40259529|FG001|Overall Study|Death|0|||
16486566|NCT01785069|40259530|FG002|Overall Study|Death|2|||
16486567|NCT01785069|40259531|FG003|Overall Study|Death|0|||
16486568|NCT01785069|40259528|FG000|Overall Study|Subject choice|2|||
16486569|NCT01785069|40259529|FG001|Overall Study|Subject choice|2|||
16486570|NCT01785069|40259530|FG002|Overall Study|Subject choice|0|||
16486571|NCT01785069|40259531|FG003|Overall Study|Subject choice|1|||
16486572|NCT01785069|40259528|FG000|Overall Study|Lost to Follow-up|1|||
16486573|NCT01785069|40259529|FG001|Overall Study|Lost to Follow-up|2|||
16486574|NCT01785069|40259530|FG002|Overall Study|Lost to Follow-up|4|||
16486575|NCT01785069|40259531|FG003|Overall Study|Lost to Follow-up|1|||
16486576|NCT01785069|40259528|FG000|Overall Study|Reason not Specified|1|||
16486577|NCT01785069|40259529|FG001|Overall Study|Reason not Specified|2|||
16486578|NCT01785069|40259530|FG002|Overall Study|Reason not Specified|1|||
16486579|NCT01785069|40259531|FG003|Overall Study|Reason not Specified|4|||
16486580|NCT01785069|40259528|FG000|Overall Study|Not evaluable|7|||
16486581|NCT01785069|40259529|FG001|Overall Study|Not evaluable|4|||
16486582|NCT01785069|40259530|FG002|Overall Study|Not evaluable|5|||
16486583|NCT01785069|40259531|FG003|Overall Study|Not evaluable|8|||
16486584|NCT03926169|40259532|FG000|Period A|Adverse Event|2|||
16486585|NCT03926169|40259533|FG001|Period A|Adverse Event|2|||
16486586|NCT03926169|40259534|FG002|Period A|Adverse Event|1|||
16486587|NCT03926169|40259532|FG000|Period A|Withdrawal by Subject|2|||
16383174|NCT01047540|39888433|FG001|Overall Study|Adverse Event|0|||
16383175|NCT01047540|39888434|FG002|Overall Study|Adverse Event|0|||
16383176|NCT01047540|39888435|FG003|Overall Study|Adverse Event|0|||
16383177|NCT01047540|39888436|FG004|Overall Study|Adverse Event|0|||
16383178|NCT02757430|39888437|FG000|Overall Study|Physician Decision|6|||
16383179|NCT02757430|39888437|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
16383180|NCT02757430|39888437|FG000|Overall Study|No informed consent|1|||
16383181|NCT02757430|39888437|FG000|Overall Study|No procedure performed|2|||
16383182|NCT01985022|39888438|FG000|Overall Study|Lost to Follow-up|0|||
16383183|NCT01985022|39888439|FG001|Overall Study|Lost to Follow-up|1|||
16383184|NCT01985022|39888438|FG000|Overall Study|Protocol Violation|0|||
16383185|NCT01985022|39888439|FG001|Overall Study|Protocol Violation|1|||
16383186|NCT01985022|39888438|FG000|Overall Study|Withdrawal by Subject|4|||
16383187|NCT01985022|39888439|FG001|Overall Study|Withdrawal by Subject|1|||
16486588|NCT03926169|40259533|FG001|Period A|Withdrawal by Subject|2|||
16486589|NCT03926169|40259534|FG002|Period A|Withdrawal by Subject|2|||
16486590|NCT03926169|40259532|FG000|Period A|Lost to Follow-up|3|||
16486591|NCT03926169|40259533|FG001|Period A|Lost to Follow-up|1|||
16486592|NCT03926169|40259534|FG002|Period A|Lost to Follow-up|0|||
16486593|NCT03926169|40259532|FG000|Period A|Lack of Efficacy|0|||
16188692|NCT00365716|39169443|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
16383188|NCT03837509|39888440|FG000|Phase 1|Death|5|||
16383189|NCT03837509|39888441|FG001|Phase 1|Death|2|||
16383190|NCT03837509|39888442|FG002|Phase 1|Death|0|||
16383191|NCT03837509|39888443|FG003|Phase 1|Death|0|||
16486594|NCT03926169|40259533|FG001|Period A|Lack of Efficacy|2|||
16486595|NCT03926169|40259534|FG002|Period A|Lack of Efficacy|2|||
16486596|NCT03926169|40259532|FG000|Period A|COVID-19 Infection|0|||
16486597|NCT03926169|40259533|FG001|Period A|COVID-19 Infection|1|||
16486598|NCT03926169|40259534|FG002|Period A|COVID-19 Infection|0|||
16486599|NCT03926169|40259532|FG000|Period A|COVID-19 Logistical Restrictions|0|||
16486600|NCT03926169|40259533|FG001|Period A|COVID-19 Logistical Restrictions|2|||
16486601|NCT03926169|40259534|FG002|Period A|COVID-19 Logistical Restrictions|1|||
16486602|NCT03926169|40259532|FG000|Period A|Other, Not Specified|1|||
16383192|NCT03837509|39888444|FG004|Phase 1|Death|0|||
16383193|NCT03837509|39888440|FG000|Phase 2|Death|0|||
16486603|NCT03926169|40259533|FG001|Period A|Other, Not Specified|0|||
16486604|NCT03926169|40259534|FG002|Period A|Other, Not Specified|0|||
16486605|NCT03926169|40259532|FG000|Period B|Adverse Event|3|||
16486606|NCT03926169|40259533|FG001|Period B|Adverse Event|1|||
16486607|NCT03926169|40259534|FG002|Period B|Adverse Event|1|||
16486608|NCT03926169|40259532|FG000|Period B|Withdrawal by Subject|1|||
16486609|NCT03926169|40259533|FG001|Period B|Withdrawal by Subject|3|||
16486610|NCT03926169|40259534|FG002|Period B|Withdrawal by Subject|0|||
16486611|NCT03926169|40259532|FG000|Period B|Lack of Efficacy|3|||
16486612|NCT03926169|40259533|FG001|Period B|Lack of Efficacy|1|||
16486613|NCT03926169|40259534|FG002|Period B|Lack of Efficacy|1|||
16486614|NCT03926169|40259532|FG000|Period B|Lost to Follow-up|1|||
16486615|NCT03926169|40259533|FG001|Period B|Lost to Follow-up|1|||
16486616|NCT03926169|40259534|FG002|Period B|Lost to Follow-up|4|||
16486617|NCT03926169|40259532|FG000|Period B|Other, Not Specified|62|||
16486618|NCT03926169|40259533|FG001|Period B|Other, Not Specified|57|||
16486619|NCT03926169|40259534|FG002|Period B|Other, Not Specified|65|||
16486620|NCT00963937|40259540|FG000|Overall Study|Protocol Violation|1|||
16486621|NCT00963937|40259541|FG001|Overall Study|Protocol Violation|1|||
16486622|NCT00963937|40259542|FG002|Overall Study|Protocol Violation|0|||
16486623|NCT00963937|40259540|FG000|Overall Study|Physician Decision|18|||
16486624|NCT00963937|40259541|FG001|Overall Study|Physician Decision|10|||
16486625|NCT00963937|40259542|FG002|Overall Study|Physician Decision|4|||
16486626|NCT01471171|40259543|FG000|Treatment Period 1|Adverse Event|4|||
16486627|NCT01471171|40259544|FG001|Treatment Period 1|Adverse Event|1|||
16486628|NCT01471171|40259543|FG000|Treatment Period 2|Adverse Event|1|||
16486629|NCT01471171|40259544|FG001|Treatment Period 2|Adverse Event|0|||
16486630|NCT01416272|40259545|FG000|Overall Study|Unacceptable distance visual acuity|2|||
16486631|NCT01416272|40259545|FG000|Overall Study|Lost to Follow-up|1|||
16486632|NCT01416272|40259545|FG000|Overall Study|Study related complaints|1|||
16486633|NCT02794883|40259550|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
16486634|NCT02794883|40259551|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
16486635|NCT02794883|40259552|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
16486636|NCT02794883|40259550|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
16486637|NCT02794883|40259551|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
16486638|NCT02794883|40259552|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
16486639|NCT02794883|40259550|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
16486640|NCT02794883|40259551|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
16296246|NCT00510289|39570786|FG000|Overall Study|Lost to Follow-up|1|||
16296247|NCT00510289|39570786|FG000|Overall Study|Progressed prior to starting drug|2|||
16296248|NCT00896480|39570789|FG000|Overall Study|Disease progression/recurrence|21|||
16486641|NCT02794883|40259552|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
16486642|NCT02794883|40259550|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
16486643|NCT02794883|40259551|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
16486644|NCT02794883|40259552|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
16486645|NCT02794883|40259550|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
16486646|NCT02794883|40259551|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
16486647|NCT02794883|40259552|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
16486648|NCT02794883|40259550|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
16486649|NCT02794883|40259551|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
16486650|NCT02794883|40259552|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
16486651|NCT02794883|40259550|FG000|Follow-up Period (up to 2 Years)|Death|12|||
16486652|NCT02794883|40259551|FG001|Follow-up Period (up to 2 Years)|Death|10|||
16486653|NCT02794883|40259552|FG002|Follow-up Period (up to 2 Years)|Death|10|||
16486654|NCT03302234|40259553|FG000|Overall Study|Death|191|||
16486655|NCT03302234|40259554|FG001|Overall Study|Death|192|||
16486656|NCT03302234|40259553|FG000|Overall Study|Withdrawal by Subject|2|||
16486657|NCT03302234|40259554|FG001|Overall Study|Withdrawal by Subject|2|||
16486658|NCT03302234|40259553|FG000|Overall Study|Sponsor Decision|90|||
16486659|NCT03302234|40259554|FG001|Overall Study|Sponsor Decision|89|||
16486660|NCT03302234|40259553|FG000|Overall Study|Laryngeal carcinoma|0|||
16486661|NCT03302234|40259554|FG001|Overall Study|Laryngeal carcinoma|1|||
16486662|NCT03302234|40259553|FG000|Overall Study|Not Reported|1|||
16486663|NCT03302234|40259554|FG001|Overall Study|Not Reported|0|||
16486664|NCT00587054|40259555|FG000|Overall Study|Patient not treated|9|||
16486665|NCT02280304|40259556|FG000|Overall Study|Lost to Follow-up|7|||
16486666|NCT02280304|40259557|FG001|Overall Study|Lost to Follow-up|8|||
16486667|NCT01666782|40259558|FG000|Overall Study|Received 2 doses of vaccine|0|||
16486668|NCT01666782|40259559|FG001|Overall Study|Received 2 doses of vaccine|1|||
16486669|NCT01666782|40259558|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
16486670|NCT01666782|40259559|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
16486671|NCT02228460|40259570|FG000|Overall Study|Adverse Event|1|||
16486672|NCT02228460|40259570|FG000|Overall Study|Lost to Follow-up|1|||
16486673|NCT03478930|40259571|FG000|Overall Study|Adverse Event|0|||
16296249|NCT02011386|39570790|FG000|Overall Study|Non-compliance|2|||
16486674|NCT03478930|40259572|FG001|Overall Study|Adverse Event|1|||
16486675|NCT03478930|40259571|FG000|Overall Study|Lack of Efficacy|3|||
16486676|NCT03478930|40259572|FG001|Overall Study|Lack of Efficacy|3|||
16486677|NCT03478930|40259571|FG000|Overall Study|Withdrawal by Subject|6|||
16486678|NCT03478930|40259572|FG001|Overall Study|Withdrawal by Subject|5|||
16486679|NCT00538291|40259573|FG000|Overall Study|Adverse Event|2|||
16486680|NCT00538291|40259573|FG000|Overall Study|Withdrawal by Subject|1|||
16486681|NCT01709513|40259576|FG000|Overall Study|Randomized but not treated|0|||
16486682|NCT01709513|40259577|FG001|Overall Study|Randomized but not treated|1|||
16486683|NCT01709513|40259578|FG002|Overall Study|Randomized but not treated|0|||
16486684|NCT01709513|40259576|FG000|Overall Study|Adverse Event|16|||
16486685|NCT01709513|40259577|FG001|Overall Study|Adverse Event|31|||
16486686|NCT01709513|40259578|FG002|Overall Study|Adverse Event|23|||
16486687|NCT01709513|40259576|FG000|Overall Study|Poor compliance to protocol|2|||
16486688|NCT01709513|40259577|FG001|Overall Study|Poor compliance to protocol|0|||
16486689|NCT01709513|40259578|FG002|Overall Study|Poor compliance to protocol|0|||
16486690|NCT01709513|40259576|FG000|Overall Study|Other|3|||
16486691|NCT01709513|40259577|FG001|Overall Study|Other|11|||
16486692|NCT01709513|40259578|FG002|Overall Study|Other|7|||
16486693|NCT02725710|40259579|FG000|Overall Study|Lost to Follow-up|1|||
16486694|NCT02725710|40259580|FG001|Overall Study|Lost to Follow-up|0|||
16486695|NCT01786668|40259581|FG000|Overall Study|Adverse Event|0|||
16486696|NCT01786668|40259582|FG001|Overall Study|Adverse Event|1|||
16486697|NCT01786668|40259583|FG002|Overall Study|Adverse Event|1|||
16486698|NCT01786668|40259584|FG003|Overall Study|Adverse Event|2|||
16296250|NCT02011386|39570790|FG000|Overall Study|Lack of Efficacy|3|||
16296251|NCT00372411|39570791|FG000|Overall Study|Withdrawal by Subject|3|||
16296252|NCT00372411|39570792|FG001|Overall Study|Withdrawal by Subject|4|||
16296253|NCT00372411|39570793|FG002|Overall Study|Withdrawal by Subject|1|||
16296254|NCT00372411|39570791|FG000|Overall Study|Death|0|||
16296255|NCT00372411|39570792|FG001|Overall Study|Death|2|||
16296256|NCT00372411|39570793|FG002|Overall Study|Death|1|||
16296257|NCT00372411|39570791|FG000|Overall Study|Lost to Follow-up|1|||
16296258|NCT00372411|39570792|FG001|Overall Study|Lost to Follow-up|1|||
16296259|NCT00372411|39570793|FG002|Overall Study|Lost to Follow-up|1|||
16296260|NCT00372411|39570791|FG000|Overall Study|Adverse Event|1|||
16296261|NCT00372411|39570792|FG001|Overall Study|Adverse Event|1|||
16296262|NCT00372411|39570793|FG002|Overall Study|Adverse Event|0|||
16296263|NCT03323437|39570794|FG000|Overall Study|Withdrawal by Subject|0|||
16296264|NCT03323437|39570795|FG001|Overall Study|Withdrawal by Subject|4|||
16296265|NCT02143583|39570801|FG000|Overall Study|Withdrawal by Subject|1|||
16296266|NCT02143583|39570802|FG001|Overall Study|Withdrawal by Subject|0|||
16296267|NCT02143583|39570803|FG002|Overall Study|Withdrawal by Subject|1|||
16296268|NCT02143583|39570801|FG000|Overall Study|husband illness|0|||
16296269|NCT02143583|39570802|FG001|Overall Study|husband illness|0|||
16296270|NCT02143583|39570803|FG002|Overall Study|husband illness|1|||
16296271|NCT00857792|39570804|FG000|Overall Study|inadequate image quality for analysis|12|||
16296272|NCT00950963|39570816|FG000|Overall Study|Lost to Follow-up|29|||
16296273|NCT00950963|39570817|FG001|Overall Study|Lost to Follow-up|24|||
16296274|NCT04295135|39570819|FG000|Overall Study|Withdrawal by Subject|2|||
16296275|NCT04295135|39570820|FG001|Overall Study|Withdrawal by Subject|1|||
16296276|NCT04295135|39570819|FG000|Overall Study|Subject left organization|8|||
16296277|NCT04295135|39570820|FG001|Overall Study|Subject left organization|4|||
16296278|NCT00976911|39570821|FG000|Overall Study|Withdrawal by Subject|4|||
16296279|NCT00976911|39570822|FG001|Overall Study|Withdrawal by Subject|6|||
16296280|NCT00976911|39570821|FG000|Overall Study|Death|138|||
16296281|NCT00976911|39570822|FG001|Overall Study|Death|126|||
16296282|NCT00976911|39570821|FG000|Overall Study|Adverse Event|0|||
16486699|NCT01786668|40259581|FG000|Overall Study|Withdrawal by Subject|0|||
16486700|NCT01786668|40259582|FG001|Overall Study|Withdrawal by Subject|0|||
16486701|NCT01786668|40259583|FG002|Overall Study|Withdrawal by Subject|3|||
16486702|NCT01786668|40259584|FG003|Overall Study|Withdrawal by Subject|1|||
16486703|NCT01786668|40259581|FG000|Overall Study|Pregnancy|0|||
16486704|NCT01786668|40259582|FG001|Overall Study|Pregnancy|0|||
16486705|NCT01786668|40259583|FG002|Overall Study|Pregnancy|0|||
16486706|NCT01786668|40259584|FG003|Overall Study|Pregnancy|1|||
16486707|NCT01786668|40259581|FG000|Overall Study|Lost to Follow-up|1|||
16486708|NCT01786668|40259582|FG001|Overall Study|Lost to Follow-up|0|||
16486709|NCT01786668|40259583|FG002|Overall Study|Lost to Follow-up|1|||
16486710|NCT01786668|40259584|FG003|Overall Study|Lost to Follow-up|0|||
16082697|NCT04075396|38796011|FG000|Overall Study|Withdrawal by Subject|1|||
16082698|NCT04075396|38796012|FG001|Overall Study|Withdrawal by Subject|2|||
16296283|NCT00976911|39570822|FG001|Overall Study|Adverse Event|1|||
16296284|NCT00976911|39570821|FG000|Overall Study|Protocol Violation|2|||
16296285|NCT00976911|39570822|FG001|Overall Study|Protocol Violation|0|||
16296286|NCT00976911|39570821|FG000|Overall Study|Other|8|||
16296287|NCT00976911|39570822|FG001|Overall Study|Other|9|||
16296288|NCT00976911|39570821|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
16296289|NCT00976911|39570822|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
16296290|NCT01724489|39570823|FG000|Overall Study|Adverse Event|8|||
16486711|NCT00299104|40259585|FG000|Treatment Period|Adverse Event|14|||
16486712|NCT00299104|40259586|FG001|Treatment Period|Adverse Event|9|||
16486713|NCT00299104|40259587|FG002|Treatment Period|Adverse Event|7|||
16486714|NCT00299104|40259585|FG000|Treatment Period|Death|1|||
16486715|NCT00299104|40259586|FG001|Treatment Period|Death|1|||
16486716|NCT00299104|40259587|FG002|Treatment Period|Death|1|||
16486717|NCT00299104|40259585|FG000|Treatment Period|Insufficient therapeutic response|34|||
16486718|NCT00299104|40259586|FG001|Treatment Period|Insufficient therapeutic response|13|||
16486719|NCT00299104|40259587|FG002|Treatment Period|Insufficient therapeutic response|8|||
16486720|NCT00299104|40259585|FG000|Treatment Period|Failure to return|9|||
16486721|NCT00299104|40259586|FG001|Treatment Period|Failure to return|8|||
16383194|NCT03837509|39888441|FG001|Phase 2|Death|0|||
16383195|NCT03837509|39888442|FG002|Phase 2|Death|0|||
16383196|NCT03837509|39888443|FG003|Phase 2|Death|1|||
16383197|NCT03837509|39888444|FG004|Phase 2|Death|1|||
16296291|NCT01724489|39570824|FG001|Overall Study|Adverse Event|3|||
16296292|NCT01724489|39570823|FG000|Overall Study|Surgery, medication|1|||
16296293|NCT01724489|39570824|FG001|Overall Study|Surgery, medication|1|||
16296294|NCT01724489|39570823|FG000|Overall Study|Lost to Follow-up|1|||
16296295|NCT01724489|39570824|FG001|Overall Study|Lost to Follow-up|2|||
16296296|NCT01724489|39570823|FG000|Overall Study|Withdrawal by Subject|6|||
16296297|NCT01724489|39570824|FG001|Overall Study|Withdrawal by Subject|6|||
16296298|NCT02085135|39570831|FG000|Overall Study|Adverse Event|4|||
16296299|NCT02085135|39570832|FG001|Overall Study|Adverse Event|7|||
16296300|NCT02085135|39570831|FG000|Overall Study|Lost to Follow-up|2|||
16296301|NCT02085135|39570832|FG001|Overall Study|Lost to Follow-up|2|||
16296302|NCT02085135|39570831|FG000|Overall Study|Withdrawal by Subject|3|||
16296303|NCT02085135|39570832|FG001|Overall Study|Withdrawal by Subject|0|||
16296304|NCT02085135|39570831|FG000|Overall Study|Lack of Efficacy|2|||
16296305|NCT02085135|39570832|FG001|Overall Study|Lack of Efficacy|0|||
16296306|NCT00940316|39570834|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
16296307|NCT00940316|39570835|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
16383198|NCT02471144|39888447|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
16486722|NCT00299104|40259587|FG002|Treatment Period|Failure to return|8|||
16296308|NCT00940316|39570836|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
16296309|NCT00940316|39570834|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
16296310|NCT00940316|39570835|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
16296311|NCT00940316|39570836|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
16296312|NCT00940316|39570834|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
16383199|NCT02471144|39888448|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
16383200|NCT02471144|39888449|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
16383201|NCT02471144|39888450|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
16383202|NCT02471144|39888451|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
16383203|NCT02471144|39888452|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
16383204|NCT02471144|39888453|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
16383205|NCT02471144|39888454|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
16383206|NCT02471144|39888455|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
16383207|NCT02471144|39888456|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
16383208|NCT02471144|39888457|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
16383209|NCT02471144|39888447|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
16383210|NCT02471144|39888448|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
16383211|NCT02471144|39888449|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
16383212|NCT02471144|39888450|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
16383213|NCT02471144|39888451|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
16383214|NCT02471144|39888452|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
16383215|NCT02471144|39888453|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
16383216|NCT02471144|39888454|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
16383217|NCT02471144|39888455|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
16383218|NCT02471144|39888456|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
16383219|NCT02471144|39888457|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
16383220|NCT02471144|39888447|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
16383221|NCT02471144|39888448|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
16383222|NCT02471144|39888449|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
16383223|NCT02471144|39888450|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
16383224|NCT02471144|39888451|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
16383225|NCT02471144|39888452|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
16383226|NCT02471144|39888453|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
16383227|NCT02471144|39888454|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
16383228|NCT02471144|39888455|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
16383229|NCT02471144|39888456|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
16383230|NCT02471144|39888457|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
16383231|NCT02471144|39888447|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
16383232|NCT02471144|39888448|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
16383233|NCT02471144|39888449|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
16383234|NCT02471144|39888450|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
16383235|NCT02471144|39888451|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
16383236|NCT02471144|39888452|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
16383237|NCT02471144|39888453|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
16383238|NCT02471144|39888454|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
16383239|NCT02471144|39888455|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
16383240|NCT02471144|39888456|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
16383241|NCT02471144|39888457|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
16383242|NCT02471144|39888447|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
16383243|NCT02471144|39888448|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
16383244|NCT02471144|39888449|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
16486723|NCT00299104|40259585|FG000|Treatment Period|Violation of selection criteria|1|||
16486724|NCT00299104|40259586|FG001|Treatment Period|Violation of selection criteria|2|||
16486725|NCT00299104|40259587|FG002|Treatment Period|Violation of selection criteria|0|||
16486726|NCT00299104|40259585|FG000|Treatment Period|Protocol Violation|1|||
16486727|NCT00299104|40259586|FG001|Treatment Period|Protocol Violation|1|||
16486728|NCT00299104|40259587|FG002|Treatment Period|Protocol Violation|0|||
16486729|NCT00299104|40259585|FG000|Treatment Period|Refused treatment|9|||
16486730|NCT00299104|40259586|FG001|Treatment Period|Refused treatment|2|||
16486731|NCT00299104|40259587|FG002|Treatment Period|Refused treatment|2|||
16486732|NCT00299104|40259585|FG000|Treatment Period|Withdrew consent|14|||
16486733|NCT00299104|40259586|FG001|Treatment Period|Withdrew consent|19|||
16486734|NCT00299104|40259587|FG002|Treatment Period|Withdrew consent|9|||
16486735|NCT00299104|40259585|FG000|Treatment Period|Administrative reasons|106|||
16486736|NCT00299104|40259586|FG001|Treatment Period|Administrative reasons|120|||
16486737|NCT00299104|40259587|FG002|Treatment Period|Administrative reasons|137|||
16486738|NCT00299104|40259585|FG000|Safety Follow-Up (SFU) Period|Death|3|||
16486739|NCT00299104|40259586|FG001|Safety Follow-Up (SFU) Period|Death|2|||
16486740|NCT00299104|40259587|FG002|Safety Follow-Up (SFU) Period|Death|1|||
16486741|NCT00299104|40259585|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
16111460|NCT00760747|38897274|FG000|Study Period II|Protocol Violation|6|||
16383245|NCT02471144|39888450|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
16383246|NCT02471144|39888451|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
16383247|NCT02471144|39888452|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
16383248|NCT02471144|39888453|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
16383249|NCT02471144|39888454|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
16383250|NCT02471144|39888455|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
16383251|NCT02471144|39888456|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
16383252|NCT02471144|39888457|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
16383253|NCT02471144|39888447|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
16383254|NCT02471144|39888448|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
16383255|NCT02471144|39888449|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
16383256|NCT02471144|39888450|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
16383257|NCT02471144|39888451|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
16383258|NCT02471144|39888452|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
16383259|NCT02471144|39888453|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
16383260|NCT02471144|39888454|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
16383261|NCT02471144|39888455|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
16383262|NCT02471144|39888456|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
16383263|NCT02471144|39888457|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
16383264|NCT02471144|39888447|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
16383265|NCT02471144|39888448|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
16383266|NCT02471144|39888449|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
16383267|NCT02471144|39888450|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
16383268|NCT02471144|39888451|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
16383269|NCT02471144|39888452|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
16486742|NCT00299104|40259586|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
16486743|NCT00299104|40259587|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
16486744|NCT00299104|40259585|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
16486745|NCT00299104|40259586|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
16486746|NCT00299104|40259587|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
16486747|NCT00299104|40259585|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
16486748|NCT00299104|40259586|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
16486749|NCT00299104|40259587|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
16486750|NCT00299104|40259585|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
16486751|NCT00299104|40259586|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
16486752|NCT00299104|40259587|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
16486753|NCT00299104|40259585|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
16486754|NCT00299104|40259586|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
16486755|NCT00299104|40259587|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
16486756|NCT00299104|40259585|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
16486757|NCT00299104|40259586|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
16486758|NCT00299104|40259587|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
16486759|NCT00299104|40259585|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
16296313|NCT00940316|39570835|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
16296314|NCT00940316|39570836|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
16296315|NCT00940316|39570834|FG000|Treated After Cycle 5|Adverse Event|0|||
16296316|NCT00940316|39570835|FG001|Treated After Cycle 5|Adverse Event|0|||
16296317|NCT00940316|39570836|FG002|Treated After Cycle 5|Adverse Event|1|||
16296318|NCT00940316|39570834|FG000|Treated After Cycle 5|Progressive disease|0|||
16296319|NCT00940316|39570835|FG001|Treated After Cycle 5|Progressive disease|1|||
16296320|NCT00940316|39570836|FG002|Treated After Cycle 5|Progressive disease|0|||
16296321|NCT00859586|39570837|FG000|Overall Study|Donors|4|||
16296322|NCT00895414|39570842|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
16296323|NCT00895414|39570843|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
16486760|NCT00299104|40259586|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
16486761|NCT00299104|40259587|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
16486762|NCT02516163|40259590|FG000|Overall Study|Withdrawal by Subject|1|||
16486763|NCT02516163|40259590|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
16486764|NCT02516163|40259590|FG000|Overall Study|Unfit/delay in surgery|3|||
16296324|NCT00895414|39570842|FG000|First Intervention (14 Days)|Physician Decision|0|||
16383270|NCT02471144|39888453|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
16383271|NCT02471144|39888454|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
16383272|NCT02471144|39888455|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
16383273|NCT02471144|39888456|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
16383274|NCT02471144|39888457|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
16383275|NCT02471144|39888447|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
16383276|NCT02471144|39888448|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
16383277|NCT02471144|39888449|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
16383278|NCT02471144|39888450|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
16383279|NCT02471144|39888451|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
16383280|NCT02471144|39888452|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
16383281|NCT02471144|39888453|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
16383282|NCT02471144|39888454|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
16383283|NCT02471144|39888455|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
16383284|NCT02471144|39888456|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
16383285|NCT02471144|39888457|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
16383286|NCT02471144|39888447|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
16383287|NCT02471144|39888448|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
16383288|NCT02471144|39888449|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
16383289|NCT02471144|39888450|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
16383290|NCT02471144|39888451|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
16383291|NCT02471144|39888452|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
16383292|NCT02471144|39888453|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
16383293|NCT02471144|39888454|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
16383294|NCT02471144|39888455|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
16383295|NCT02471144|39888456|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
16383296|NCT02471144|39888457|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
16383297|NCT02471144|39888447|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
16383298|NCT02471144|39888448|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
16383299|NCT02471144|39888449|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
16383300|NCT02471144|39888450|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
16486765|NCT02516163|40259590|FG000|Overall Study|Use of incorrect measurement technique|5|||
16486766|NCT02516163|40259590|FG000|Overall Study|Data not recorded|2|||
16486767|NCT02516163|40259590|FG000|Overall Study|MRI contraindication exclusion|6|||
16486768|NCT00407797|40259591|FG000|Overall Study|Lost to Follow-up|2|||
16486769|NCT00407797|40259591|FG000|Overall Study|Adverse Event|6|||
16486770|NCT00407797|40259591|FG000|Overall Study|Other|7|||
16383301|NCT02471144|39888451|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
16383302|NCT02471144|39888452|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
16486771|NCT00407797|40259591|FG000|Overall Study|Withdrawal by Subject|3|||
16486772|NCT01606800|40259592|FG000|Overall Study|Adverse Event|3|||
16486773|NCT01606800|40259593|FG001|Overall Study|Adverse Event|1|||
16486774|NCT01606800|40259592|FG000|Overall Study|Participant withdrew consent|0|||
16486775|NCT01606800|40259593|FG001|Overall Study|Participant withdrew consent|1|||
16486776|NCT01606800|40259592|FG000|Overall Study|Missing completion status|2|||
16486777|NCT01606800|40259593|FG001|Overall Study|Missing completion status|0|||
16486778|NCT04051008|40259597|FG000|Overall Study|Withdrawal by Subject|2|||
16486779|NCT04051008|40259598|FG001|Overall Study|Withdrawal by Subject|0|||
16486780|NCT04051008|40259599|FG002|Overall Study|Withdrawal by Subject|1|||
16486781|NCT02853604|40259600|FG000|Overall Study|Withdrawal by Subject|12|||
16486782|NCT02853604|40259601|FG001|Overall Study|Withdrawal by Subject|35|||
16486783|NCT02853604|40259600|FG000|Overall Study|Lost to Follow-up|4|||
16486784|NCT02853604|40259601|FG001|Overall Study|Lost to Follow-up|8|||
16486785|NCT02853604|40259600|FG000|Overall Study|Death|1|||
16486786|NCT02853604|40259601|FG001|Overall Study|Death|5|||
16486787|NCT02853604|40259600|FG000|Overall Study|Miscellaneous|11|||
16486788|NCT02853604|40259601|FG001|Overall Study|Miscellaneous|2|||
16486789|NCT02853604|40259600|FG000|Overall Study|Progressive Disease|0|||
16486790|NCT02853604|40259601|FG001|Overall Study|Progressive Disease|2|||
16486791|NCT01051323|40259606|FG000|Overall Study|Discontinuation of treatment|103|||
16486792|NCT01051323|40259606|FG000|Overall Study|Transplantation|28|||
16486793|NCT01051323|40259606|FG000|Overall Study|Dialysis dependency|22|||
16486794|NCT01051323|40259606|FG000|Overall Study|Withdrawal by Subject|13|||
16486795|NCT01051323|40259606|FG000|Overall Study|Lost to Follow-up|31|||
16486796|NCT01051323|40259606|FG000|Overall Study|Death|129|||
16486797|NCT01051323|40259606|FG000|Overall Study|Hospitalization|28|||
16486798|NCT01051323|40259606|FG000|Overall Study|Other|148|||
16486799|NCT01051323|40259606|FG000|Overall Study|Missing|37|||
16486800|NCT00679432|40259607|FG000|Overall Study|Adverse Event|5|||
16486801|NCT00679432|40259608|FG001|Overall Study|Adverse Event|6|||
16486802|NCT00679432|40259609|FG002|Overall Study|Adverse Event|10|||
16486803|NCT00679432|40259610|FG003|Overall Study|Adverse Event|7|||
16486804|NCT00679432|40259607|FG000|Overall Study|Protocol Violation|1|||
16486805|NCT00679432|40259608|FG001|Overall Study|Protocol Violation|1|||
16486806|NCT00679432|40259609|FG002|Overall Study|Protocol Violation|2|||
16486807|NCT00679432|40259610|FG003|Overall Study|Protocol Violation|1|||
16486808|NCT00679432|40259607|FG000|Overall Study|Withdrawal by Subject|8|||
16486809|NCT00679432|40259608|FG001|Overall Study|Withdrawal by Subject|11|||
16486810|NCT00679432|40259609|FG002|Overall Study|Withdrawal by Subject|10|||
16486811|NCT00679432|40259610|FG003|Overall Study|Withdrawal by Subject|9|||
16486812|NCT00679432|40259607|FG000|Overall Study|Lost to Follow-up|1|||
16486813|NCT00679432|40259608|FG001|Overall Study|Lost to Follow-up|5|||
16486814|NCT00679432|40259609|FG002|Overall Study|Lost to Follow-up|4|||
16486815|NCT00679432|40259610|FG003|Overall Study|Lost to Follow-up|2|||
16486816|NCT00679432|40259607|FG000|Overall Study|Physician Decision|3|||
16486817|NCT00679432|40259608|FG001|Overall Study|Physician Decision|2|||
16486818|NCT00679432|40259609|FG002|Overall Study|Physician Decision|2|||
16486819|NCT00679432|40259610|FG003|Overall Study|Physician Decision|2|||
16486820|NCT00679432|40259607|FG000|Overall Study|Sponsor decision|1|||
16486821|NCT00679432|40259608|FG001|Overall Study|Sponsor decision|0|||
16082699|NCT04075396|38796011|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
16082700|NCT04075396|38796012|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
16082701|NCT04075396|38796011|FG000|Overall Study|Enrolled but not-treated|0|||
16082702|NCT04075396|38796012|FG001|Overall Study|Enrolled but not-treated|1|||
16383303|NCT02471144|39888453|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
16383304|NCT02471144|39888454|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
16383305|NCT02471144|39888455|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
16383306|NCT02471144|39888456|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
16082703|NCT01426412|38796013|FG000|Overall Study|Withdrawal by Subject|1|||
16296325|NCT00895414|39570843|FG001|First Intervention (14 Days)|Physician Decision|1|||
16296326|NCT00574912|39570844|FG000|Overall Study|Could not place IV lines.|3|||
16296327|NCT00574912|39570844|FG000|Overall Study|scheduling conflicts|3|||
16296328|NCT00574912|39570844|FG000|Overall Study|Physician Decision|2|||
16296329|NCT00470067|39570845|FG000|Overall Study|Death|1|||
16296330|NCT00470067|39570845|FG000|Overall Study|Disease Progression|6|||
16296331|NCT01140503|39570850|FG000|Overall Study|Withdrawal by Subject|1|||
16296332|NCT02488330|39570851|FG000|Overall Study|Adverse Event|1|||
16296333|NCT02488330|39570851|FG000|Overall Study|Physician Decision|2|||
16296334|NCT02488330|39570851|FG000|Overall Study|Death|2|||
16296335|NCT02488330|39570851|FG000|Overall Study|Disease Progression|3|||
16296336|NCT02488330|39570851|FG000|Overall Study|Study Termination by Sponsor|4|||
16296337|NCT00824616|39570852|FG000|Overall Study|Adverse Event|2|||
16296338|NCT00824616|39570853|FG001|Overall Study|Adverse Event|1|||
16296339|NCT00824616|39570852|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
16296340|NCT00824616|39570853|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
16296341|NCT00824616|39570852|FG000|Overall Study|Hyperglycemia|1|||
16296342|NCT00824616|39570853|FG001|Overall Study|Hyperglycemia|1|||
16296343|NCT00824616|39570852|FG000|Overall Study|Lack of Efficacy|2|||
16296344|NCT00824616|39570853|FG001|Overall Study|Lack of Efficacy|1|||
16296345|NCT00824616|39570852|FG000|Overall Study|Lost to Follow-up|0|||
16296346|NCT00824616|39570853|FG001|Overall Study|Lost to Follow-up|1|||
16296347|NCT00824616|39570852|FG000|Overall Study|Withdrawal by Subject|1|||
16296348|NCT00824616|39570853|FG001|Overall Study|Withdrawal by Subject|1|||
16296349|NCT00807248|39570860|FG000|Overall Study|Adverse Event|1|||
16296350|NCT00807248|39570861|FG001|Overall Study|Adverse Event|2|||
16296351|NCT00807248|39570862|FG002|Overall Study|Adverse Event|2|||
16296352|NCT00807248|39570863|FG003|Overall Study|Adverse Event|6|||
16296353|NCT00807248|39570860|FG000|Overall Study|Lack of Efficacy|14|||
16296354|NCT00807248|39570861|FG001|Overall Study|Lack of Efficacy|4|||
16296355|NCT00807248|39570862|FG002|Overall Study|Lack of Efficacy|8|||
16486822|NCT00679432|40259609|FG002|Overall Study|Sponsor decision|0|||
16486823|NCT00679432|40259610|FG003|Overall Study|Sponsor decision|0|||
16486824|NCT00679432|40259607|FG000|Overall Study|Lack of Efficacy|13|||
16486825|NCT00679432|40259608|FG001|Overall Study|Lack of Efficacy|9|||
16188693|NCT00365716|39169444|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
16296356|NCT00807248|39570863|FG003|Overall Study|Lack of Efficacy|3|||
16296357|NCT00807248|39570860|FG000|Overall Study|Protocol Violation|0|||
16296358|NCT00807248|39570861|FG001|Overall Study|Protocol Violation|1|||
16296359|NCT00807248|39570862|FG002|Overall Study|Protocol Violation|1|||
16296360|NCT00807248|39570863|FG003|Overall Study|Protocol Violation|0|||
16296361|NCT00807248|39570860|FG000|Overall Study|Withdrawal of Consent|5|||
16296362|NCT00807248|39570861|FG001|Overall Study|Withdrawal of Consent|5|||
16296363|NCT00807248|39570862|FG002|Overall Study|Withdrawal of Consent|5|||
16486826|NCT00679432|40259609|FG002|Overall Study|Lack of Efficacy|14|||
16486827|NCT00679432|40259610|FG003|Overall Study|Lack of Efficacy|8|||
16486828|NCT00679432|40259607|FG000|Overall Study|Infectious colitis, normal histology|5|||
16486829|NCT00679432|40259608|FG001|Overall Study|Infectious colitis, normal histology|4|||
16486830|NCT00679432|40259609|FG002|Overall Study|Infectious colitis, normal histology|8|||
16486831|NCT00679432|40259610|FG003|Overall Study|Infectious colitis, normal histology|3|||
16486832|NCT00679432|40259607|FG000|Overall Study|Randomization error, return to prior Rx|0|||
16486833|NCT00679432|40259608|FG001|Overall Study|Randomization error, return to prior Rx|0|||
16486834|NCT00679432|40259609|FG002|Overall Study|Randomization error, return to prior Rx|3|||
16486835|NCT00679432|40259610|FG003|Overall Study|Randomization error, return to prior Rx|0|||
16486836|NCT03693300|40259611|FG000|Overall Study|Withdrawal by Subject|6|||
16486837|NCT03693300|40259612|FG001|Overall Study|Withdrawal by Subject|0|||
16486838|NCT03693300|40259611|FG000|Overall Study|Death|50|||
16486839|NCT03693300|40259612|FG001|Overall Study|Death|2|||
16486840|NCT03693300|40259611|FG000|Overall Study|Lost to Follow-up|2|||
16486841|NCT03693300|40259612|FG001|Overall Study|Lost to Follow-up|0|||
16486842|NCT00443261|40259613|FG000|Overall Study|Death|1|||
16486843|NCT01466153|40259614|FG000|Overall Study|Disease Progression|2|||
16486844|NCT01466153|40259615|FG001|Overall Study|Disease Progression|2|||
16486845|NCT01466153|40259616|FG002|Overall Study|Disease Progression|0|||
16486846|NCT01466153|40259614|FG000|Overall Study|Adverse Event|14|||
16486847|NCT01466153|40259615|FG001|Overall Study|Adverse Event|13|||
16486848|NCT01466153|40259616|FG002|Overall Study|Adverse Event|17|||
16486849|NCT01466153|40259614|FG000|Overall Study|Withdrawal of Consent|2|||
16486850|NCT01466153|40259615|FG001|Overall Study|Withdrawal of Consent|0|||
16486851|NCT01466153|40259616|FG002|Overall Study|Withdrawal of Consent|0|||
16486852|NCT01466153|40259614|FG000|Overall Study|Investigator Discretion|3|||
16486853|NCT01466153|40259615|FG001|Overall Study|Investigator Discretion|2|||
16486854|NCT01466153|40259616|FG002|Overall Study|Investigator Discretion|2|||
16486855|NCT01466153|40259614|FG000|Overall Study|Randomized-Not Treated|2|||
16486856|NCT01466153|40259615|FG001|Overall Study|Randomized-Not Treated|3|||
16486857|NCT01466153|40259616|FG002|Overall Study|Randomized-Not Treated|4|||
16486858|NCT01466153|40259614|FG000|Overall Study|Other-Unspecified|6|||
16486859|NCT01466153|40259615|FG001|Overall Study|Other-Unspecified|4|||
16486860|NCT01466153|40259616|FG002|Overall Study|Other-Unspecified|2|||
16486861|NCT01866930|40259617|FG000|Treatment Period|Other|1|||
16486862|NCT01866930|40259618|FG001|Treatment Period|Other|0|||
16486863|NCT01866930|40259617|FG000|Treatment Period|Death|0|||
16486864|NCT01866930|40259618|FG001|Treatment Period|Death|2|||
16486865|NCT01866930|40259617|FG000|Treatment Period|Poor/non compliance|0|||
16486866|NCT01866930|40259618|FG001|Treatment Period|Poor/non compliance|2|||
16486867|NCT01866930|40259617|FG000|Treatment Period|No longer meets study criteria|0|||
16486868|NCT01866930|40259618|FG001|Treatment Period|No longer meets study criteria|1|||
16486869|NCT01866930|40259617|FG000|Treatment Period|Withdrawal by Subject|2|||
16486870|NCT01866930|40259618|FG001|Treatment Period|Withdrawal by Subject|8|||
16486871|NCT01866930|40259617|FG000|Treatment Period|Lack of Efficacy|1|||
16486872|NCT01866930|40259618|FG001|Treatment Period|Lack of Efficacy|9|||
16486873|NCT01866930|40259617|FG000|Treatment Period|Adverse Event|4|||
16486874|NCT01866930|40259618|FG001|Treatment Period|Adverse Event|12|||
16486875|NCT01866930|40259617|FG000|Treatment Period|Lost to Follow-up|1|||
16486876|NCT01866930|40259618|FG001|Treatment Period|Lost to Follow-up|1|||
16486877|NCT01866930|40259617|FG000|Follow-up Period|Lost to Follow-up|1|||
16082704|NCT01426412|38796014|FG001|Overall Study|Withdrawal by Subject|0|||
16188694|NCT00365716|39169438|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
16188695|NCT00365716|39169439|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
16188696|NCT00365716|39169440|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
16188697|NCT00365716|39169441|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
16188698|NCT00365716|39169442|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
16188699|NCT00365716|39169443|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
16188700|NCT00365716|39169444|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
16486878|NCT01866930|40259618|FG001|Follow-up Period|Lost to Follow-up|1|||
16486879|NCT01866930|40259617|FG000|Follow-up Period|Other|1|||
16486880|NCT01866930|40259618|FG001|Follow-up Period|Other|5|||
16486881|NCT01866930|40259617|FG000|Follow-up Period|No longer required per protocol|1|||
16346240|NCT01615029|39753268|FG003|Overall Study|Lost to Follow-up|0|||
16486882|NCT01866930|40259618|FG001|Follow-up Period|No longer required per protocol|0|||
16486883|NCT01866930|40259617|FG000|Follow-up Period|Withdrawal by Subject|3|||
16082705|NCT01426412|38796015|FG002|Overall Study|Withdrawal by Subject|0|||
16082706|NCT01426412|38796016|FG003|Overall Study|Withdrawal by Subject|0|||
16082707|NCT01426412|38796017|FG004|Overall Study|Withdrawal by Subject|1|||
16082708|NCT01426412|38796018|FG005|Overall Study|Withdrawal by Subject|0|||
16082709|NCT01426412|38796019|FG006|Overall Study|Withdrawal by Subject|0|||
16082710|NCT01426412|38796020|FG007|Overall Study|Withdrawal by Subject|3|||
16082711|NCT01426412|38796021|FG008|Overall Study|Withdrawal by Subject|1|||
16486884|NCT01866930|40259618|FG001|Follow-up Period|Withdrawal by Subject|3|||
16486885|NCT00845858|40259621|FG000|Overall Study|Withdrawal by Subject|5|||
16486886|NCT00845858|40259622|FG001|Overall Study|Withdrawal by Subject|1|||
16486887|NCT00845858|40259623|FG002|Overall Study|Withdrawal by Subject|1|||
16486888|NCT00845858|40259621|FG000|Overall Study|Adverse Event|3|||
16486889|NCT00845858|40259622|FG001|Overall Study|Adverse Event|8|||
16486890|NCT00845858|40259623|FG002|Overall Study|Adverse Event|4|||
16486891|NCT00845858|40259621|FG000|Overall Study|Protocol Violation|0|||
16486892|NCT00845858|40259622|FG001|Overall Study|Protocol Violation|0|||
16486893|NCT00845858|40259623|FG002|Overall Study|Protocol Violation|1|||
16486894|NCT00845858|40259621|FG000|Overall Study|not eligible|0|||
16486895|NCT00845858|40259622|FG001|Overall Study|not eligible|3|||
16486896|NCT00845858|40259623|FG002|Overall Study|not eligible|2|||
16486897|NCT00279305|40259624|FG000|Overall Study|Pregnancy|1|||
16486898|NCT00279305|40259625|FG001|Overall Study|Pregnancy|0|||
16486899|NCT00279305|40259624|FG000|Overall Study|Withdrawal by Subject|2|||
16082712|NCT02374463|38796032|FG000|Overall Study|Withdrawal by Subject|3|||
16082713|NCT02374463|38796033|FG001|Overall Study|Withdrawal by Subject|3|||
16082714|NCT01808534|38796034|FG000|Overall Study|Disease progression|3|||
16082715|NCT01808534|38796034|FG000|Overall Study|Physician Decision|1|||
16082716|NCT00220740|38796035|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
16082717|NCT00220740|38796036|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
16082718|NCT00220740|38796035|FG000|Efficacy Period|Adverse Event|1|||
16082719|NCT00220740|38796036|FG001|Efficacy Period|Adverse Event|1|||
16082720|NCT00220740|38796035|FG000|Efficacy Period|Withdrawal by Subject|1|||
16082721|NCT00220740|38796036|FG001|Efficacy Period|Withdrawal by Subject|0|||
16082722|NCT00220740|38796035|FG000|Efficacy Period|Protocol Violation|1|||
16082723|NCT00220740|38796036|FG001|Efficacy Period|Protocol Violation|0|||
16082724|NCT00220740|38796035|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
16082725|NCT00220740|38796036|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
16082726|NCT02034916|38796039|FG000|Overall Study|Death|39|||
16082727|NCT02034916|38796040|FG001|Overall Study|Death|28|||
16082728|NCT02034916|38796039|FG000|Overall Study|Withdrawal by Subject|2|||
16082729|NCT02034916|38796040|FG001|Overall Study|Withdrawal by Subject|1|||
16082730|NCT02034916|38796039|FG000|Overall Study|Lost to Follow-up|4|||
16082731|NCT02034916|38796040|FG001|Overall Study|Lost to Follow-up|1|||
16082732|NCT02034916|38796039|FG000|Overall Study|Study terminated by sponsor|4|||
16486900|NCT00279305|40259625|FG001|Overall Study|Withdrawal by Subject|0|||
16296364|NCT00807248|39570863|FG003|Overall Study|Withdrawal of Consent|5|||
16486901|NCT00279305|40259624|FG000|Overall Study|Dificulting establishing IV|1|||
16486902|NCT00279305|40259625|FG001|Overall Study|Dificulting establishing IV|0|||
16486903|NCT00279305|40259624|FG000|Overall Study|FDA Safety Alert|4|||
16486904|NCT00279305|40259625|FG001|Overall Study|FDA Safety Alert|1|||
16486905|NCT00006237|40259628|FG000|Overall Study|Adverse Event|39|||
16486906|NCT00006237|40259629|FG001|Overall Study|Adverse Event|29|||
16486907|NCT00006237|40259628|FG000|Overall Study|Death|1|||
16486908|NCT00006237|40259629|FG001|Overall Study|Death|0|||
16486909|NCT00006237|40259628|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
16486910|NCT00006237|40259629|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
16486911|NCT00006237|40259628|FG000|Overall Study|Progression/relapse|54|||
16486912|NCT00006237|40259629|FG001|Overall Study|Progression/relapse|2|||
16486913|NCT00006237|40259628|FG000|Overall Study|Not eligible|9|||
16486914|NCT00006237|40259629|FG001|Overall Study|Not eligible|20|||
16486915|NCT00006237|40259628|FG000|Overall Study|Withdrawal by Subject|0|||
16486916|NCT00006237|40259629|FG001|Overall Study|Withdrawal by Subject|1|||
16486917|NCT00006237|40259628|FG000|Overall Study|Not protocol specified|14|||
16486918|NCT00006237|40259629|FG001|Overall Study|Not protocol specified|5|||
16486919|NCT01405742|40259631|FG000|Overall Study|Lost to Follow-up|1|||
16486920|NCT01405742|40259632|FG001|Overall Study|Lost to Follow-up|0|||
16486921|NCT01678911|40259637|FG000|Second Intervention|Lost to Follow-up|2|||
16486922|NCT01678911|40259638|FG001|Second Intervention|Lost to Follow-up|0|||
16486923|NCT01367002|40259639|FG000|Overall Study|Withdrawal by Subject|1|||
16486924|NCT01367002|40259640|FG001|Overall Study|Withdrawal by Subject|0|||
16486925|NCT01367002|40259639|FG000|Overall Study|Physician Decision|0|||
16486926|NCT01367002|40259640|FG001|Overall Study|Physician Decision|2|||
16486927|NCT00844896|40259641|FG000|Overall Study|Lost to Follow-up|12|||
16486928|NCT00844896|40259642|FG001|Overall Study|Lost to Follow-up|16|||
16486929|NCT00844896|40259641|FG000|Overall Study|Parents did not have time to complete|0|||
16486930|NCT00844896|40259642|FG001|Overall Study|Parents did not have time to complete|1|||
16486931|NCT02590003|40259643|FG000|Overall Study|Death|1|||
16486932|NCT02590003|40259644|FG001|Overall Study|Death|2|||
16486933|NCT00558558|40259649|FG000|Overall Study|Unable to swallow|1|||
16486934|NCT00558558|40259649|FG000|Overall Study|Withdrawal by Subject|1|||
16486935|NCT00558558|40259649|FG000|Overall Study|Lack of Efficacy|4|||
16486936|NCT01594762|40259650|FG000|Overall Study|Withdrawal by Subject|1|||
16082733|NCT02034916|38796040|FG001|Overall Study|Study terminated by sponsor|5|||
16082734|NCT01637402|38796041|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
16082735|NCT01637402|38796042|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
16082736|NCT01637402|38796041|FG000|Standard Dose Regimen|Adverse Event|1|||
16082737|NCT01637402|38796042|FG001|Standard Dose Regimen|Adverse Event|0|||
16082738|NCT01637402|38796041|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
16082739|NCT01637402|38796042|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
16082740|NCT01637402|38796041|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
16082741|NCT01637402|38796042|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
16082742|NCT01637402|38796041|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
16082743|NCT01637402|38796042|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
16082744|NCT01637402|38796041|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
16082745|NCT01637402|38796042|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
16082746|NCT01622868|38796043|FG000|Overall Study|Protocol Violation|7|||
16082747|NCT01622868|38796044|FG001|Overall Study|Protocol Violation|0|||
16082748|NCT01007396|38796045|FG000|Overall Study|Lost to Follow-up|47|||
16082749|NCT02022657|38796046|FG000|Overall Study|Withdrawal by Subject|2|||
16082750|NCT02022657|38796047|FG001|Overall Study|Withdrawal by Subject|0|||
16082751|NCT02022657|38796048|FG002|Overall Study|Withdrawal by Subject|1|||
16082752|NCT02022657|38796049|FG003|Overall Study|Withdrawal by Subject|0|||
16082753|NCT02022657|38796050|FG004|Overall Study|Withdrawal by Subject|0|||
16082754|NCT02022657|38796051|FG005|Overall Study|Withdrawal by Subject|0|||
16082755|NCT02022657|38796046|FG000|Overall Study|Physician Decision|0|||
16082756|NCT02022657|38796047|FG001|Overall Study|Physician Decision|0|||
16082757|NCT02022657|38796048|FG002|Overall Study|Physician Decision|0|||
16082758|NCT02022657|38796049|FG003|Overall Study|Physician Decision|0|||
16082759|NCT02022657|38796050|FG004|Overall Study|Physician Decision|0|||
16082760|NCT02022657|38796051|FG005|Overall Study|Physician Decision|1|||
16082761|NCT00446459|38796052|FG000|8 Months|Protocol Violation|12|||
16082762|NCT00446459|38796052|FG000|12 Months|Protocol Violation|4|||
16082763|NCT00446459|38796052|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
16082764|NCT00976495|38796055|FG000|Overall Study|Withdrawal by Subject|0|||
16082765|NCT00976495|38796056|FG001|Overall Study|Withdrawal by Subject|1|||
16082766|NCT00976495|38796057|FG002|Overall Study|Withdrawal by Subject|0|||
16383307|NCT02471144|39888457|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
16486937|NCT01594762|40259651|FG001|Overall Study|Withdrawal by Subject|0|||
16486938|NCT01594762|40259650|FG000|Overall Study|Lost to Follow-up|10|||
16486939|NCT01594762|40259651|FG001|Overall Study|Lost to Follow-up|10|||
16486940|NCT00571948|40259652|FG000|Overall Study|Lost to Follow-up|2|||
16486941|NCT00571948|40259653|FG001|Overall Study|Lost to Follow-up|0|||
16486942|NCT00571948|40259652|FG000|Overall Study|Withdrawal by Subject|1|||
16486943|NCT00571948|40259653|FG001|Overall Study|Withdrawal by Subject|2|||
16486944|NCT00571948|40259652|FG000|Overall Study|Protocol Violation|3|||
16486945|NCT00571948|40259653|FG001|Overall Study|Protocol Violation|3|||
16082767|NCT02291913|38796063|FG000|Overall Study|Progressive Disease|32|||
16082768|NCT02291913|38796063|FG000|Overall Study|Adverse Event|11|||
16082769|NCT02291913|38796063|FG000|Overall Study|Death|2|||
16082770|NCT02291913|38796063|FG000|Overall Study|Physician Decision|1|||
16082771|NCT02291913|38796063|FG000|Overall Study|Withdrawal by Subject|1|||
16082772|NCT02291913|38796063|FG000|Overall Study|Protocol Violation|1|||
16082773|NCT01972724|38796067|FG000|Double-Blind|Rescue Criteria Met|1|||
16082774|NCT01972724|38796068|FG001|Double-Blind|Rescue Criteria Met|0|||
16486946|NCT00571948|40259652|FG000|Overall Study|infant refused study meal|3|||
16486947|NCT00571948|40259653|FG001|Overall Study|infant refused study meal|4|||
16486948|NCT00571948|40259652|FG000|Overall Study|Parent were afraid of blood colection|2|||
16486949|NCT00571948|40259653|FG001|Overall Study|Parent were afraid of blood colection|5|||
16486950|NCT01782222|40259654|FG000|Overall Study|Adverse Event|4|||
16486951|NCT01782222|40259655|FG001|Overall Study|Adverse Event|5|||
16486952|NCT01782222|40259656|FG002|Overall Study|Adverse Event|3|||
16486953|NCT01782222|40259654|FG000|Overall Study|Lack of Efficacy|2|||
16486954|NCT01782222|40259655|FG001|Overall Study|Lack of Efficacy|1|||
16486955|NCT01782222|40259656|FG002|Overall Study|Lack of Efficacy|0|||
16486956|NCT01782222|40259654|FG000|Overall Study|Protocol Violation|1|||
16486957|NCT01782222|40259655|FG001|Overall Study|Protocol Violation|0|||
16486958|NCT01782222|40259656|FG002|Overall Study|Protocol Violation|0|||
16486959|NCT01782222|40259654|FG000|Overall Study|Withdrawal by Subject|1|||
16486960|NCT01782222|40259655|FG001|Overall Study|Withdrawal by Subject|4|||
16486961|NCT01782222|40259656|FG002|Overall Study|Withdrawal by Subject|1|||
16486962|NCT01782222|40259654|FG000|Overall Study|Moved to other state|0|||
16486963|NCT01782222|40259655|FG001|Overall Study|Moved to other state|1|||
16486964|NCT01782222|40259656|FG002|Overall Study|Moved to other state|0|||
16486965|NCT01950741|40259657|FG000|Overall Study|Lost to Follow-up|1|||
16486966|NCT01950741|40259657|FG000|Overall Study|Death|1|||
16486967|NCT01950741|40259657|FG000|Overall Study|Withdrawal by Subject|1|||
16486968|NCT00745823|40259658|FG000|Overall Study|Adverse Event|5|||
16486969|NCT00745823|40259659|FG001|Overall Study|Adverse Event|3|||
16486970|NCT00745823|40259658|FG000|Overall Study|Lack of Efficacy|20|||
16486971|NCT00745823|40259659|FG001|Overall Study|Lack of Efficacy|6|||
16486972|NCT00745823|40259658|FG000|Overall Study|Lost to Follow-up|10|||
16486973|NCT00745823|40259659|FG001|Overall Study|Lost to Follow-up|11|||
16383308|NCT02471144|39888447|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
16486974|NCT00745823|40259658|FG000|Overall Study|Physician Decision|10|||
16296365|NCT00807248|39570860|FG000|Overall Study|Lost to Follow-up|1|||
16296366|NCT00807248|39570861|FG001|Overall Study|Lost to Follow-up|0|||
16296367|NCT00807248|39570862|FG002|Overall Study|Lost to Follow-up|0|||
16296368|NCT00807248|39570863|FG003|Overall Study|Lost to Follow-up|0|||
16296369|NCT00807248|39570860|FG000|Overall Study|Other Reason|0|||
16296370|NCT00807248|39570861|FG001|Overall Study|Other Reason|0|||
16486975|NCT00745823|40259659|FG001|Overall Study|Physician Decision|5|||
16486976|NCT00745823|40259658|FG000|Overall Study|Pregnancy|0|||
16486977|NCT00745823|40259659|FG001|Overall Study|Pregnancy|4|||
16486978|NCT00745823|40259658|FG000|Overall Study|Withdrawal by Subject|14|||
16486979|NCT00745823|40259659|FG001|Overall Study|Withdrawal by Subject|8|||
16486980|NCT00745823|40259658|FG000|Overall Study|Study Terminated by Sponsor|326|||
16486981|NCT00745823|40259659|FG001|Overall Study|Study Terminated by Sponsor|349|||
16486982|NCT02521870|40259660|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486983|NCT02521870|40259661|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
16486984|NCT02521870|40259662|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486985|NCT02521870|40259663|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486986|NCT02521870|40259664|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486987|NCT02521870|40259665|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486988|NCT02521870|40259666|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486989|NCT02521870|40259667|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486990|NCT02521870|40259668|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486991|NCT02521870|40259669|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486992|NCT02521870|40259670|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486993|NCT02521870|40259671|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
16486994|NCT02521870|40259660|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
16486995|NCT02521870|40259661|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
16486996|NCT02521870|40259662|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
16486997|NCT02521870|40259663|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
16486998|NCT02521870|40259664|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
16486999|NCT02521870|40259665|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
16487000|NCT02521870|40259666|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
16487001|NCT02521870|40259667|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
16383309|NCT02471144|39888448|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
16383310|NCT02471144|39888449|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
16383311|NCT02471144|39888450|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
16383312|NCT02471144|39888451|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
16296371|NCT00807248|39570862|FG002|Overall Study|Other Reason|2|||
16487002|NCT02521870|40259668|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
16487003|NCT02521870|40259669|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
16188701|NCT00365716|39169438|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
16188702|NCT00365716|39169439|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
16188703|NCT00365716|39169440|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
16188704|NCT00365716|39169441|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
16188705|NCT00365716|39169442|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
16188706|NCT00365716|39169443|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
16188707|NCT00365716|39169444|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
16188708|NCT00365716|39169438|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
16188709|NCT00365716|39169439|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
16188710|NCT00365716|39169440|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
16188711|NCT00365716|39169441|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
16188712|NCT00365716|39169442|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
16188713|NCT00365716|39169443|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
16188714|NCT00365716|39169444|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
16383313|NCT02471144|39888452|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
16383314|NCT02471144|39888453|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
16383315|NCT02471144|39888454|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
16383316|NCT02471144|39888455|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
16383317|NCT02471144|39888456|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
16383318|NCT02471144|39888457|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
16383319|NCT02471144|39888447|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
16383320|NCT02471144|39888448|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
16383321|NCT02471144|39888449|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
16383322|NCT02471144|39888450|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
16383323|NCT02471144|39888451|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
16383324|NCT02471144|39888452|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
16383325|NCT02471144|39888453|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
16383326|NCT02471144|39888454|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
16383327|NCT02471144|39888455|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
16383328|NCT02471144|39888456|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
16383329|NCT02471144|39888457|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
16383330|NCT02471144|39888447|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
16383331|NCT02471144|39888448|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
16383332|NCT02471144|39888449|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
16383333|NCT02471144|39888450|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
16383334|NCT02471144|39888451|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
16383335|NCT02471144|39888452|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
16383336|NCT02471144|39888453|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
16383337|NCT02471144|39888454|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
16383338|NCT02471144|39888455|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
16383339|NCT02471144|39888456|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
16383340|NCT02471144|39888457|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
16383341|NCT02471144|39888447|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
16383342|NCT02471144|39888448|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
16383343|NCT02471144|39888449|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
16383344|NCT02471144|39888450|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
16383345|NCT02471144|39888451|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
16383346|NCT02471144|39888452|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
16383347|NCT02471144|39888453|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
16383348|NCT02471144|39888454|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
16383349|NCT02471144|39888455|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
16383350|NCT02471144|39888456|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
16383351|NCT02471144|39888457|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
16383352|NCT01143402|39888461|FG000|Overall Study|Rapid clinical decline|1|||
16383353|NCT01143402|39888462|FG001|Overall Study|Rapid clinical decline|1|||
16383354|NCT01143402|39888463|FG002|Overall Study|Rapid clinical decline|0|||
16383355|NCT01143402|39888461|FG000|Overall Study|Not Treated|0|||
16383356|NCT01143402|39888462|FG001|Overall Study|Not Treated|0|||
16383357|NCT01143402|39888463|FG002|Overall Study|Not Treated|1|||
16383358|NCT02157610|39888464|FG000|Overall Study|Death|4|||
16383359|NCT02157610|39888465|FG001|Overall Study|Death|4|||
16383360|NCT00370292|39888466|FG000|Overall Study|Disease Progression|4|||
16296372|NCT00807248|39570863|FG003|Overall Study|Other Reason|0|||
16383361|NCT00370292|39888466|FG000|Overall Study|Adverse Event|7|||
16383362|NCT00370292|39888466|FG000|Overall Study|Physician Decision|2|||
16383363|NCT02573948|39888469|FG000|Longitudinal Cohort|Death|9|||
16383364|NCT02573948|39888469|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
16383365|NCT02573948|39888469|FG000|Longitudinal Cohort|Incarcerated|25|||
16383366|NCT03610048|39888476|FG000|Overall Study|Study terminated by sponsor|84|||
16383367|NCT03610048|39888476|FG000|Overall Study|Adverse Event|32|||
16383368|NCT03610048|39888476|FG000|Overall Study|Withdrawal by Subject|31|||
16383369|NCT03610048|39888476|FG000|Overall Study|Lost to Follow-up|8|||
16383370|NCT03610048|39888476|FG000|Overall Study|Other|4|||
16383371|NCT03610048|39888476|FG000|Overall Study|Physician Decision|1|||
16383372|NCT03610048|39888476|FG000|Overall Study|Pregnancy|1|||
16383373|NCT01983111|39888477|FG000|Overall Study|Withdrawal by Subject|8|||
16383374|NCT01983111|39888478|FG001|Overall Study|Withdrawal by Subject|6|||
16383375|NCT01983111|39888477|FG000|Overall Study|Adverse Event|4|||
16383376|NCT01983111|39888478|FG001|Overall Study|Adverse Event|0|||
16383377|NCT01983111|39888477|FG000|Overall Study|Protocol Violation|0|||
16383378|NCT01983111|39888478|FG001|Overall Study|Protocol Violation|1|||
16383379|NCT00474903|39888481|FG000|Overall Study|Protocol Violation|1|||
16383380|NCT00474903|39888482|FG001|Overall Study|Protocol Violation|5|||
16383381|NCT00474903|39888483|FG002|Overall Study|Protocol Violation|2|||
16383382|NCT02803203|39888484|FG000|Overall Study|Adverse Event|4|||
16383383|NCT02803203|39888484|FG000|Overall Study|Death|4|||
16383384|NCT02803203|39888484|FG000|Overall Study|Progressive disease|29|||
16296373|NCT03127644|39570864|FG000|Overall Study|Study-specific withdrawal criteria|0|||
16296374|NCT03127644|39570865|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16296375|NCT03127644|39570866|FG002|Overall Study|Study-specific withdrawal criteria|2|||
16296376|NCT02011113|39570877|FG000|Overall Study|Adverse Event|4|||
16296377|NCT02011113|39570877|FG000|Overall Study|Disease Progression (DP)|16|||
16296378|NCT02011113|39570877|FG000|Overall Study|Death|1|||
16296379|NCT02011113|39570877|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
16296380|NCT02011113|39570877|FG000|Overall Study|Investigator's judgement- DP|3|||
16296381|NCT02011113|39570877|FG000|Overall Study|Study terminated by sponsor|11|||
16296382|NCT02113189|39570878|FG000|Overall Study|Lost to follow up|2|||
16296383|NCT02113189|39570879|FG001|Overall Study|Lost to follow up|1|||
16296384|NCT02113189|39570880|FG002|Overall Study|Lost to follow up|3|||
16296385|NCT03753763|39570881|FG000|Overall Study|Adverse Event|2|||
16296386|NCT03753763|39570882|FG001|Overall Study|Adverse Event|0|||
16296387|NCT03753763|39570881|FG000|Overall Study|Withdrawal by Subject|3|||
16188715|NCT00365716|39169438|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
16383385|NCT02803203|39888484|FG000|Overall Study|Withdrawal by Subject|8|||
16383386|NCT02803203|39888484|FG000|Overall Study|Complete resection of target disease|2|||
16383387|NCT02803203|39888484|FG000|Overall Study|Switched to commercial Osi|1|||
16383388|NCT02803203|39888484|FG000|Overall Study|Participant moved away|1|||
16383389|NCT01215851|39888503|FG000|Treatment Period|Adverse Event|1|||
16383390|NCT01215851|39888504|FG001|Treatment Period|Adverse Event|1|||
16383391|NCT01215851|39888505|FG002|Treatment Period|Adverse Event|1|||
16383392|NCT01215851|39888506|FG003|Treatment Period|Adverse Event|3|||
16188716|NCT00365716|39169439|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
16188717|NCT00365716|39169440|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
16188718|NCT00365716|39169441|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
16188719|NCT00365716|39169442|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
16188720|NCT00365716|39169443|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
16188721|NCT00365716|39169444|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
16188722|NCT00365716|39169438|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
16188723|NCT00365716|39169439|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
16188724|NCT00365716|39169440|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
16188725|NCT00365716|39169441|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
16188726|NCT00365716|39169442|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
16188727|NCT00365716|39169443|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
16188728|NCT00365716|39169444|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
16188729|NCT00365716|39169438|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
16188730|NCT00365716|39169439|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
16188731|NCT00365716|39169440|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
16188732|NCT00365716|39169441|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
16188733|NCT00365716|39169442|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
16188734|NCT00365716|39169443|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
16188735|NCT00365716|39169444|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
16188736|NCT00365716|39169438|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
16188737|NCT00365716|39169439|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
16296388|NCT03753763|39570882|FG001|Overall Study|Withdrawal by Subject|1|||
16383393|NCT01215851|39888507|FG004|Treatment Period|Adverse Event|0|||
16383394|NCT01215851|39888508|FG005|Treatment Period|Adverse Event|1|||
16296389|NCT03753763|39570881|FG000|Overall Study|clinical deterioration|1|||
16383395|NCT01215851|39888503|FG000|Follow up Period|Lost to Follow-up|0|||
16296390|NCT03753763|39570882|FG001|Overall Study|clinical deterioration|0|||
16296391|NCT01934335|39570883|FG000|Overall Study|Withdrawal by Subject|1|||
16296392|NCT01934335|39570884|FG001|Overall Study|Withdrawal by Subject|1|||
16296393|NCT00912912|39570886|FG000|Overall Study|Withdrawal by Subject|1|||
16296394|NCT00912912|39570886|FG000|Overall Study|Disease Progression|3|||
16296395|NCT03050060|39570887|FG000|Overall Study|Adverse Event|7|||
16296396|NCT03050060|39570887|FG000|Overall Study|Withdrawal by Subject|1|||
16296397|NCT03050060|39570887|FG000|Overall Study|Progression|7|||
16296398|NCT00985712|39570888|FG000|Overall Study|Adverse Event|0|||
16296399|NCT00985712|39570889|FG001|Overall Study|Adverse Event|1|||
16296400|NCT00985712|39570888|FG000|Overall Study|Lost to Follow-up|2|||
16296401|NCT00985712|39570889|FG001|Overall Study|Lost to Follow-up|2|||
16296402|NCT00985712|39570888|FG000|Overall Study|Protocol Violation|0|||
16296403|NCT00985712|39570889|FG001|Overall Study|Protocol Violation|1|||
16296404|NCT00985712|39570888|FG000|Overall Study|Withdrawal by Subject|4|||
16296405|NCT00985712|39570889|FG001|Overall Study|Withdrawal by Subject|1|||
16296406|NCT00985712|39570888|FG000|Overall Study|Sponsor decision|0|||
16296407|NCT00985712|39570889|FG001|Overall Study|Sponsor decision|2|||
16296408|NCT02087189|39570890|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
16296409|NCT02932306|39570891|FG000|Overall Study|Withdrawal by Subject|16|||
16296410|NCT02932306|39570892|FG001|Overall Study|Withdrawal by Subject|25|||
16296411|NCT02932306|39570891|FG000|Overall Study|Adverse Event|3|||
16296412|NCT02932306|39570892|FG001|Overall Study|Adverse Event|0|||
16296413|NCT02932306|39570891|FG000|Overall Study|Pregnancy|2|||
16296414|NCT02932306|39570892|FG001|Overall Study|Pregnancy|0|||
16296415|NCT02932306|39570891|FG000|Overall Study|Protocol Violation|1|||
16296416|NCT02932306|39570892|FG001|Overall Study|Protocol Violation|1|||
16296417|NCT02932306|39570891|FG000|Overall Study|Noncompliance with Study Drug|1|||
16296418|NCT02932306|39570892|FG001|Overall Study|Noncompliance with Study Drug|1|||
16296419|NCT02932306|39570891|FG000|Overall Study|Lost to Follow-up|36|||
16296420|NCT02932306|39570892|FG001|Overall Study|Lost to Follow-up|40|||
16296421|NCT02932306|39570891|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
16296422|NCT02932306|39570892|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
16296423|NCT02932306|39570891|FG000|Overall Study|Lack of Efficacy|0|||
16296424|NCT02932306|39570892|FG001|Overall Study|Lack of Efficacy|2|||
16296425|NCT02932306|39570891|FG000|Overall Study|Worsening condition|2|||
16296426|NCT02932306|39570892|FG001|Overall Study|Worsening condition|0|||
16296427|NCT02932306|39570891|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
16296428|NCT02932306|39570892|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
16296429|NCT00658021|39570893|FG000|28-Week Treatment Period|Adverse Event|3|||
16296430|NCT00658021|39570894|FG001|28-Week Treatment Period|Adverse Event|1|||
16296431|NCT00658021|39570895|FG002|28-Week Treatment Period|Adverse Event|0|||
16296432|NCT00658021|39570893|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
16296433|NCT00658021|39570894|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
16296434|NCT00658021|39570895|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
16296435|NCT00658021|39570893|FG000|28-Week Treatment Period|Protocol Violation|0|||
16296436|NCT00658021|39570894|FG001|28-Week Treatment Period|Protocol Violation|2|||
16296437|NCT00658021|39570895|FG002|28-Week Treatment Period|Protocol Violation|1|||
16296438|NCT00658021|39570893|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
16296439|NCT00658021|39570894|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
16296440|NCT00658021|39570895|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
16296441|NCT00658021|39570893|FG000|28-Week Treatment Period|Physician Decision|1|||
16296442|NCT00658021|39570894|FG001|28-Week Treatment Period|Physician Decision|2|||
16296443|NCT00658021|39570895|FG002|28-Week Treatment Period|Physician Decision|1|||
16296444|NCT00658021|39570893|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
16296445|NCT00658021|39570894|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
16296446|NCT00658021|39570895|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
16296447|NCT00658021|39570893|FG000|28-Week Treatment Period|Loss of glucose control|1|||
16296448|NCT00658021|39570894|FG001|28-Week Treatment Period|Loss of glucose control|1|||
16296449|NCT00658021|39570895|FG002|28-Week Treatment Period|Loss of glucose control|10|||
16296450|NCT00658021|39570893|FG000|28-Week Treatment Period|Other|2|||
16296451|NCT00658021|39570894|FG001|28-Week Treatment Period|Other|3|||
16296452|NCT00658021|39570895|FG002|28-Week Treatment Period|Other|1|||
16296453|NCT00658021|39570893|FG000|28-Week Treatment Period|Did not receive treatment|2|||
16296454|NCT00658021|39570894|FG001|28-Week Treatment Period|Did not receive treatment|0|||
16296455|NCT00658021|39570895|FG002|28-Week Treatment Period|Did not receive treatment|0|||
16296456|NCT00658021|39570893|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
16296457|NCT00658021|39570894|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
16296458|NCT00658021|39570895|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
16296459|NCT00658021|39570893|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
16296460|NCT00658021|39570894|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
16296461|NCT00658021|39570895|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
16296462|NCT03400943|39570896|FG000|Treatment Period 1|Adverse Event|0|||
16296463|NCT03400943|39570897|FG001|Treatment Period 1|Adverse Event|0|||
16383396|NCT01215851|39888504|FG001|Follow up Period|Lost to Follow-up|0|||
16383397|NCT01215851|39888505|FG002|Follow up Period|Lost to Follow-up|0|||
16383398|NCT01215851|39888506|FG003|Follow up Period|Lost to Follow-up|0|||
16383399|NCT01215851|39888507|FG004|Follow up Period|Lost to Follow-up|0|||
16383400|NCT01215851|39888508|FG005|Follow up Period|Lost to Follow-up|1|||
16383401|NCT01049373|39888509|FG000|Overall Study|Protocol Violation|9|||
16383402|NCT01049373|39888510|FG001|Overall Study|Protocol Violation|9|||
16383403|NCT01049373|39888509|FG000|Overall Study|Withdrawal by Subject|8|||
16383404|NCT01049373|39888510|FG001|Overall Study|Withdrawal by Subject|5|||
16383405|NCT01049373|39888509|FG000|Overall Study|Adverse Event|3|||
16383406|NCT01049373|39888510|FG001|Overall Study|Adverse Event|3|||
16296464|NCT03400943|39570898|FG002|Treatment Period 1|Adverse Event|0|||
16296465|NCT03400943|39570899|FG003|Treatment Period 1|Adverse Event|1|||
16296466|NCT03400943|39570896|FG000|Treatment Period 1|Lost to Follow-up|1|||
16296467|NCT03400943|39570897|FG001|Treatment Period 1|Lost to Follow-up|0|||
16296468|NCT03400943|39570898|FG002|Treatment Period 1|Lost to Follow-up|0|||
16296469|NCT03400943|39570899|FG003|Treatment Period 1|Lost to Follow-up|0|||
16296470|NCT03400943|39570896|FG000|Treatment Period 1|Protocol Violation|0|||
16296471|NCT03400943|39570897|FG001|Treatment Period 1|Protocol Violation|1|||
16296472|NCT03400943|39570898|FG002|Treatment Period 1|Protocol Violation|1|||
16296473|NCT03400943|39570899|FG003|Treatment Period 1|Protocol Violation|0|||
16296474|NCT03400943|39570896|FG000|Treatment Period 1|Study terminated by sponsor|2|||
16296475|NCT03400943|39570897|FG001|Treatment Period 1|Study terminated by sponsor|0|||
16296476|NCT03400943|39570898|FG002|Treatment Period 1|Study terminated by sponsor|0|||
16296477|NCT03400943|39570899|FG003|Treatment Period 1|Study terminated by sponsor|1|||
16296478|NCT03400943|39570896|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16383407|NCT01049373|39888509|FG000|Overall Study|Lost to Follow-up|9|||
16383408|NCT01049373|39888510|FG001|Overall Study|Lost to Follow-up|4|||
16383409|NCT01049373|39888509|FG000|Overall Study|no evaluable study values|9|||
16383410|NCT01049373|39888510|FG001|Overall Study|no evaluable study values|21|||
16383411|NCT01049373|39888509|FG000|Overall Study|Other|1|||
16383412|NCT01049373|39888510|FG001|Overall Study|Other|1|||
16383413|NCT01049373|39888509|FG000|Overall Study|Non-cooperation|0|||
16383414|NCT01049373|39888510|FG001|Overall Study|Non-cooperation|1|||
16383415|NCT01246960|39888511|FG000|Overall Study|Lost to Follow-up|3|||
16383416|NCT01246960|39888512|FG001|Overall Study|Lost to Follow-up|1|||
16383417|NCT01246960|39888511|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
16383418|NCT01246960|39888512|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
16383419|NCT00256126|39888513|FG000|Overall Study|Adverse Event|1|||
16383420|NCT00256126|39888514|FG001|Overall Study|Adverse Event|0|||
16383421|NCT00256126|39888513|FG000|Overall Study|Other|1|||
16383422|NCT00256126|39888514|FG001|Overall Study|Other|2|||
16383423|NCT00907621|39888517|FG000|Overall Study|Lost to Follow-up|6|||
16383424|NCT00907621|39888518|FG001|Overall Study|Lost to Follow-up|3|||
16383425|NCT00907621|39888517|FG000|Overall Study|intercurrent febrile illness|1|||
16383426|NCT00907621|39888518|FG001|Overall Study|intercurrent febrile illness|1|||
16383427|NCT03485157|39888519|FG000|Double Blind Phase|Lost to Follow-up|4|||
16383428|NCT03485157|39888520|FG001|Double Blind Phase|Lost to Follow-up|4|||
16383429|NCT03485157|39888519|FG000|Double Blind Phase|Adverse Event|2|||
16383430|NCT03485157|39888520|FG001|Double Blind Phase|Adverse Event|1|||
16383431|NCT03485157|39888519|FG000|Double Blind Phase|Withdrawal by Subject|6|||
16383432|NCT03485157|39888520|FG001|Double Blind Phase|Withdrawal by Subject|9|||
16383433|NCT03485157|39888519|FG000|Double Blind Phase|Removal by PI|3|||
16383434|NCT03485157|39888520|FG001|Double Blind Phase|Removal by PI|7|||
16383435|NCT03485157|39888519|FG000|Open Label Phase|Lost to Follow-up|1|||
16383436|NCT03485157|39888520|FG001|Open Label Phase|Lost to Follow-up|2|||
16383437|NCT03485157|39888519|FG000|Open Label Phase|Adverse Event|0|||
16383438|NCT03485157|39888520|FG001|Open Label Phase|Adverse Event|1|||
16383439|NCT03485157|39888519|FG000|Open Label Phase|Withdrawal by Subject|1|||
16383440|NCT03485157|39888520|FG001|Open Label Phase|Withdrawal by Subject|2|||
16383441|NCT03485157|39888519|FG000|Open Label Phase|Removal by PI|2|||
16383442|NCT03485157|39888520|FG001|Open Label Phase|Removal by PI|0|||
16296479|NCT03400943|39570897|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16296480|NCT03400943|39570898|FG002|Treatment Period 1|Withdrawal by Subject|3|||
16296481|NCT03400943|39570899|FG003|Treatment Period 1|Withdrawal by Subject|1|||
16296482|NCT03400943|39570896|FG000|Treatment Period 1|Other|2|||
16296483|NCT03400943|39570897|FG001|Treatment Period 1|Other|1|||
16383443|NCT00940602|39888525|FG000|Overall Study|Administrative problems|1|||
16383444|NCT00940602|39888526|FG001|Overall Study|Administrative problems|1|||
16383445|NCT00940602|39888525|FG000|Overall Study|Patient/guardian decision|13|||
16383446|NCT00940602|39888526|FG001|Overall Study|Patient/guardian decision|28|||
16383447|NCT00940602|39888525|FG000|Overall Study|Physician Decision|8|||
16383448|NCT00940602|39888526|FG001|Overall Study|Physician Decision|5|||
16383449|NCT00940602|39888525|FG000|Overall Study|Pregnancy|1|||
16383450|NCT00940602|39888526|FG001|Overall Study|Pregnancy|0|||
16383451|NCT00940602|39888525|FG000|Overall Study|Protocol Deviation (untreated)|1|||
16296484|NCT03400943|39570898|FG002|Treatment Period 1|Other|2|||
16383452|NCT00940602|39888526|FG001|Overall Study|Protocol Deviation (untreated)|0|||
16383453|NCT00940602|39888525|FG000|Overall Study|Disease progression|8|||
16383454|NCT00940602|39888526|FG001|Overall Study|Disease progression|2|||
16383455|NCT00940602|39888525|FG000|Overall Study|Death|38|||
16383456|NCT00940602|39888526|FG001|Overall Study|Death|19|||
16383457|NCT00940602|39888525|FG000|Overall Study|Lost to Follow-up|3|||
16383458|NCT00940602|39888526|FG001|Overall Study|Lost to Follow-up|1|||
16383459|NCT00940602|39888525|FG000|Overall Study|Patient withdrew consent|26|||
16383460|NCT00940602|39888526|FG001|Overall Study|Patient withdrew consent|13|||
16383461|NCT00940602|39888525|FG000|Overall Study|Adverse Event|7|||
16383462|NCT00940602|39888526|FG001|Overall Study|Adverse Event|2|||
16383463|NCT00940602|39888525|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
16383464|NCT00940602|39888526|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
16383465|NCT03213509|39888527|FG000|Overall Study|Did not consent for verbal autopsy|4|||
16383466|NCT03213509|39888528|FG001|Overall Study|Did not consent for verbal autopsy|5|||
16383467|NCT04099277|39888529|FG000|Overall Study|Physician Decision|1|||
16383468|NCT04099277|39888529|FG000|Overall Study|Withdrawal by Subject|1|||
16383469|NCT03692403|39888530|FG000|Overall Study|Withdrawal by Subject|1|||
16383470|NCT03692403|39888531|FG001|Overall Study|Withdrawal by Subject|0|||
16383471|NCT03692403|39888532|FG002|Overall Study|Withdrawal by Subject|1|||
16383472|NCT03692403|39888533|FG003|Overall Study|Withdrawal by Subject|0|||
16383473|NCT03692403|39888530|FG000|Overall Study|Adverse Event|0|||
16383474|NCT03692403|39888531|FG001|Overall Study|Adverse Event|0|||
16383475|NCT03692403|39888532|FG002|Overall Study|Adverse Event|0|||
16383476|NCT03692403|39888533|FG003|Overall Study|Adverse Event|1|||
16383477|NCT03692403|39888530|FG000|Overall Study|Pregnancy|0|||
16383478|NCT03692403|39888531|FG001|Overall Study|Pregnancy|1|||
16383479|NCT03692403|39888532|FG002|Overall Study|Pregnancy|0|||
16383480|NCT03692403|39888533|FG003|Overall Study|Pregnancy|0|||
16383481|NCT03692403|39888530|FG000|Overall Study|Other|0|||
16383482|NCT03692403|39888531|FG001|Overall Study|Other|0|||
16383483|NCT03692403|39888532|FG002|Overall Study|Other|1|||
16383484|NCT03692403|39888533|FG003|Overall Study|Other|0|||
16383485|NCT00077974|39888534|FG000|Overall Study|Adverse Event|22|||
16383486|NCT00077974|39888534|FG000|Overall Study|Protocol Violation|1|||
16383487|NCT00077974|39888534|FG000|Overall Study|Withdrawal by Subject|3|||
16383488|NCT00077974|39888534|FG000|Overall Study|Lack of Efficacy|76|||
16383489|NCT00077974|39888534|FG000|Overall Study|Decision of Sponsor|2|||
16383490|NCT00127855|39888538|FG000|Primary Vaccination Course|Adverse Event|0|||
16383491|NCT00127855|39888539|FG001|Primary Vaccination Course|Adverse Event|0|||
16383492|NCT00127855|39888540|FG002|Primary Vaccination Course|Adverse Event|1|||
16383493|NCT00127855|39888541|FG003|Primary Vaccination Course|Adverse Event|0|||
16383494|NCT00127855|39888542|FG004|Primary Vaccination Course|Adverse Event|0|||
16383495|NCT00127855|39888538|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
16383496|NCT00127855|39888539|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
16383497|NCT00127855|39888540|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
16383498|NCT00127855|39888541|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
16383499|NCT00127855|39888542|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
16383500|NCT00127855|39888538|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
16383501|NCT00127855|39888539|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
16383502|NCT00127855|39888540|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
16383503|NCT00127855|39888541|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
16383504|NCT00127855|39888542|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
16383505|NCT00127855|39888538|FG000|Primary Vaccination Course|Other|0|||
16383506|NCT00127855|39888539|FG001|Primary Vaccination Course|Other|0|||
16383507|NCT00127855|39888540|FG002|Primary Vaccination Course|Other|0|||
16383508|NCT00127855|39888541|FG003|Primary Vaccination Course|Other|0|||
16383509|NCT00127855|39888542|FG004|Primary Vaccination Course|Other|1|||
16383510|NCT02133573|39888543|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
16383511|NCT02133573|39888544|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
16383512|NCT02133573|39888543|FG000|Overall Study|Child Deaths|3|||
16383513|NCT02133573|39888544|FG001|Overall Study|Child Deaths|5|||
16383514|NCT02133573|39888543|FG000|Overall Study|Child Declined Follow Ups|2|||
16383515|NCT02133573|39888544|FG001|Overall Study|Child Declined Follow Ups|1|||
16383516|NCT02133573|39888543|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
16383517|NCT02133573|39888544|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
16383518|NCT01870869|39888545|FG000|Overall Study|Implanted with nonstudy device|1|||
16383519|NCT01870869|39888546|FG001|Overall Study|Implanted with nonstudy device|3|||
16383520|NCT01870869|39888547|FG002|Overall Study|Implanted with nonstudy device|14|||
16383521|NCT01870869|39888548|FG003|Overall Study|Implanted with nonstudy device|4|||
16383522|NCT01870869|39888545|FG000|Overall Study|Death|0|||
16383523|NCT01870869|39888546|FG001|Overall Study|Death|0|||
16383524|NCT01870869|39888547|FG002|Overall Study|Death|7|||
16383525|NCT01870869|39888548|FG003|Overall Study|Death|1|||
16383526|NCT01870869|39888545|FG000|Overall Study|Subject choice|6|||
16082775|NCT01972724|38796069|FG002|Double-Blind|Rescue Criteria Met|0|||
16082776|NCT01972724|38796067|FG000|Double-Blind|Adverse Event|1|||
16082777|NCT01972724|38796068|FG001|Double-Blind|Adverse Event|0|||
16082778|NCT01972724|38796069|FG002|Double-Blind|Adverse Event|0|||
16082779|NCT01972724|38796067|FG000|Double-Blind|Withdrawal of Consent|2|||
16082780|NCT01972724|38796068|FG001|Double-Blind|Withdrawal of Consent|1|||
16082781|NCT01972724|38796069|FG002|Double-Blind|Withdrawal of Consent|0|||
16082782|NCT01972724|38796067|FG000|Double-Blind|Significant Protocol Deviation|5|||
16487004|NCT02521870|40259670|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
16487005|NCT02521870|40259671|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
16487006|NCT02521870|40259660|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
16487007|NCT02521870|40259661|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
16487008|NCT02521870|40259662|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
16487009|NCT02521870|40259663|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
16487010|NCT02521870|40259664|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
16487011|NCT02521870|40259665|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
16487012|NCT02521870|40259666|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
16487013|NCT02521870|40259667|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
16487014|NCT02521870|40259668|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
16487015|NCT02521870|40259669|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
16487016|NCT02521870|40259670|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
16487017|NCT02521870|40259671|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
16487018|NCT02521870|40259660|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
16487019|NCT02521870|40259661|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
16487020|NCT02521870|40259662|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
16487021|NCT02521870|40259663|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
16487022|NCT02521870|40259664|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
16487023|NCT02521870|40259665|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
16487024|NCT02521870|40259666|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
16487025|NCT02521870|40259667|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
16487026|NCT02521870|40259668|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
16487027|NCT02521870|40259669|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
16487028|NCT02521870|40259670|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
16487029|NCT02521870|40259671|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
16487030|NCT02521870|40259660|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
16487031|NCT02521870|40259661|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
16487032|NCT02521870|40259662|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
16487033|NCT02521870|40259663|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
16487034|NCT02521870|40259664|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
16487035|NCT02521870|40259665|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
16487036|NCT02521870|40259666|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
16082783|NCT01972724|38796068|FG001|Double-Blind|Significant Protocol Deviation|8|||
16082784|NCT01972724|38796069|FG002|Double-Blind|Significant Protocol Deviation|0|||
16082785|NCT01972724|38796067|FG000|Open-Label|Withdrew Consent|0|||
16082786|NCT01972724|38796068|FG001|Open-Label|Withdrew Consent|0|||
16082787|NCT01972724|38796069|FG002|Open-Label|Withdrew Consent|3|||
16082788|NCT01972724|38796067|FG000|Open-Label|Significant Protocol Deviation|0|||
16082789|NCT01972724|38796068|FG001|Open-Label|Significant Protocol Deviation|0|||
16082790|NCT01972724|38796069|FG002|Open-Label|Significant Protocol Deviation|2|||
16082791|NCT02411084|38796070|FG000|Overall Study|Lack of Efficacy|6|||
16082792|NCT02411084|38796071|FG001|Overall Study|Lack of Efficacy|3|||
16082793|NCT02411084|38796070|FG000|Overall Study|Death|5|||
16082794|NCT02411084|38796071|FG001|Overall Study|Death|4|||
16082795|NCT02411084|38796070|FG000|Overall Study|Adverse Event|2|||
16082796|NCT02411084|38796071|FG001|Overall Study|Adverse Event|1|||
16082797|NCT02411084|38796070|FG000|Overall Study|Other reasons|0|||
16082798|NCT02411084|38796071|FG001|Overall Study|Other reasons|5|||
16082799|NCT02500758|38796080|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
16082800|NCT02500758|38796081|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
16082801|NCT02500758|38796080|FG000|Washout (1 Week)|Lost to Follow-up|2|||
16082802|NCT02500758|38796081|FG001|Washout (1 Week)|Lost to Follow-up|2|||
16082803|NCT02500758|38796080|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
16082804|NCT02500758|38796081|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
16082805|NCT02500758|38796080|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
16487037|NCT02521870|40259667|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
16487038|NCT02521870|40259668|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
16487039|NCT02521870|40259669|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
16487040|NCT02521870|40259670|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
16082806|NCT02500758|38796081|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
16082807|NCT02500758|38796080|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
16082808|NCT02500758|38796081|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
16082809|NCT00508924|38796082|FG000|Overall Study|Protocol Violation|0|||
16082810|NCT00508924|38796083|FG001|Overall Study|Protocol Violation|0|||
16082811|NCT00508924|38796084|FG002|Overall Study|Protocol Violation|1|||
16188738|NCT00365716|39169440|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
16188739|NCT00365716|39169441|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
16188740|NCT00365716|39169442|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
16188741|NCT00365716|39169443|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
16188742|NCT00365716|39169444|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
16188743|NCT00365716|39169438|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
16188744|NCT00365716|39169439|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
16188745|NCT00365716|39169440|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
16188746|NCT00365716|39169441|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
16188747|NCT00365716|39169442|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
16188748|NCT00365716|39169443|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
16188749|NCT00365716|39169444|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
16188750|NCT00365716|39169438|FG000|Extension 1|Lost to Follow-up|0|||
16188751|NCT00365716|39169439|FG001|Extension 1|Lost to Follow-up|0|||
16188752|NCT00365716|39169440|FG002|Extension 1|Lost to Follow-up|0|||
16188753|NCT00365716|39169441|FG003|Extension 1|Lost to Follow-up|0|||
16188754|NCT00365716|39169442|FG004|Extension 1|Lost to Follow-up|0|||
16188755|NCT00365716|39169443|FG005|Extension 1|Lost to Follow-up|1|||
16188756|NCT00365716|39169444|FG006|Extension 1|Lost to Follow-up|0|||
16188757|NCT00365716|39169438|FG000|Extension 1|Other|0|||
16188758|NCT00365716|39169439|FG001|Extension 1|Other|0|||
16188759|NCT00365716|39169440|FG002|Extension 1|Other|0|||
16188760|NCT00365716|39169441|FG003|Extension 1|Other|0|||
16188761|NCT00365716|39169442|FG004|Extension 1|Other|0|||
16188762|NCT00365716|39169443|FG005|Extension 1|Other|9|||
16188763|NCT00365716|39169444|FG006|Extension 1|Other|0|||
16188764|NCT00365716|39169438|FG000|Extension 1|Moved|0|||
16188765|NCT00365716|39169439|FG001|Extension 1|Moved|0|||
16188766|NCT00365716|39169440|FG002|Extension 1|Moved|0|||
16188767|NCT00365716|39169441|FG003|Extension 1|Moved|0|||
16188768|NCT00365716|39169442|FG004|Extension 1|Moved|0|||
16188769|NCT00365716|39169443|FG005|Extension 1|Moved|4|||
16188770|NCT00365716|39169444|FG006|Extension 1|Moved|0|||
16188771|NCT00365716|39169438|FG000|Extension 1|Withdrawal by Subject|0|||
16188772|NCT00365716|39169439|FG001|Extension 1|Withdrawal by Subject|0|||
16188773|NCT00365716|39169440|FG002|Extension 1|Withdrawal by Subject|0|||
16188774|NCT00365716|39169441|FG003|Extension 1|Withdrawal by Subject|0|||
16188775|NCT00365716|39169442|FG004|Extension 1|Withdrawal by Subject|0|||
16188776|NCT00365716|39169443|FG005|Extension 1|Withdrawal by Subject|3|||
16188777|NCT00365716|39169444|FG006|Extension 1|Withdrawal by Subject|0|||
16188778|NCT00365716|39169438|FG000|Extension 1|Pregnancy|0|||
16188779|NCT00365716|39169439|FG001|Extension 1|Pregnancy|0|||
16188780|NCT00365716|39169440|FG002|Extension 1|Pregnancy|0|||
16188781|NCT00365716|39169441|FG003|Extension 1|Pregnancy|0|||
16188782|NCT00365716|39169442|FG004|Extension 1|Pregnancy|0|||
16188783|NCT00365716|39169443|FG005|Extension 1|Pregnancy|4|||
16188784|NCT00365716|39169444|FG006|Extension 1|Pregnancy|0|||
16188785|NCT00365716|39169438|FG000|Extension 1|Protocol Violation|0|||
16188786|NCT00365716|39169439|FG001|Extension 1|Protocol Violation|0|||
16188787|NCT00365716|39169440|FG002|Extension 1|Protocol Violation|0|||
16188788|NCT00365716|39169441|FG003|Extension 1|Protocol Violation|0|||
16188789|NCT00365716|39169442|FG004|Extension 1|Protocol Violation|0|||
16188790|NCT00365716|39169443|FG005|Extension 1|Protocol Violation|1|||
16188791|NCT00365716|39169444|FG006|Extension 1|Protocol Violation|0|||
16188792|NCT00365716|39169438|FG000|Extension 2|Lost to Follow-up|0|||
16188793|NCT00365716|39169439|FG001|Extension 2|Lost to Follow-up|0|||
16188794|NCT00365716|39169440|FG002|Extension 2|Lost to Follow-up|0|||
16188795|NCT00365716|39169441|FG003|Extension 2|Lost to Follow-up|0|||
16188796|NCT00365716|39169442|FG004|Extension 2|Lost to Follow-up|0|||
16188797|NCT00365716|39169443|FG005|Extension 2|Lost to Follow-up|0|||
16188798|NCT00365716|39169444|FG006|Extension 2|Lost to Follow-up|2|||
16188799|NCT00365716|39169438|FG000|Extension 2|Other|0|||
16188800|NCT00365716|39169439|FG001|Extension 2|Other|0|||
16188801|NCT00365716|39169440|FG002|Extension 2|Other|0|||
16296485|NCT03400943|39570899|FG003|Treatment Period 1|Other|2|||
16082812|NCT00508924|38796085|FG003|Overall Study|Protocol Violation|1|||
16188802|NCT00365716|39169441|FG003|Extension 2|Other|0|||
16188803|NCT00365716|39169442|FG004|Extension 2|Other|0|||
16188804|NCT00365716|39169443|FG005|Extension 2|Other|0|||
16188805|NCT00365716|39169444|FG006|Extension 2|Other|3|||
16188806|NCT00365716|39169438|FG000|Extension 2|Withdrawal by Subject|0|||
16188807|NCT00365716|39169439|FG001|Extension 2|Withdrawal by Subject|0|||
16188808|NCT00365716|39169440|FG002|Extension 2|Withdrawal by Subject|0|||
16188809|NCT00365716|39169441|FG003|Extension 2|Withdrawal by Subject|0|||
16188810|NCT00365716|39169442|FG004|Extension 2|Withdrawal by Subject|0|||
16188811|NCT00365716|39169443|FG005|Extension 2|Withdrawal by Subject|0|||
16188812|NCT00365716|39169444|FG006|Extension 2|Withdrawal by Subject|5|||
16188813|NCT04230486|39169445|FG000|Overall Study|Screen Failure|1|||
16188814|NCT01728584|39169446|FG000|Overall Study|Adverse Event|1|||
16188815|NCT01728584|39169447|FG001|Overall Study|Adverse Event|0|||
16188816|NCT01728584|39169448|FG002|Overall Study|Adverse Event|0|||
16188817|NCT01728584|39169449|FG003|Overall Study|Adverse Event|0|||
16188818|NCT01728584|39169446|FG000|Overall Study|Physician Decision|4|||
16188819|NCT01728584|39169447|FG001|Overall Study|Physician Decision|0|||
16188820|NCT01728584|39169448|FG002|Overall Study|Physician Decision|1|||
16188821|NCT01728584|39169449|FG003|Overall Study|Physician Decision|0|||
16188822|NCT01728584|39169446|FG000|Overall Study|Withdrawal by Subject|1|||
16188823|NCT01728584|39169447|FG001|Overall Study|Withdrawal by Subject|0|||
16188824|NCT01728584|39169448|FG002|Overall Study|Withdrawal by Subject|0|||
16296486|NCT03400943|39570896|FG000|Post-treatment Period 1|Adverse Event|2|||
16296487|NCT03400943|39570897|FG001|Post-treatment Period 1|Adverse Event|0|||
16296488|NCT03400943|39570898|FG002|Post-treatment Period 1|Adverse Event|0|||
16296489|NCT03400943|39570899|FG003|Post-treatment Period 1|Adverse Event|0|||
16296490|NCT03400943|39570896|FG000|Post-treatment Period 1|Protocol Violation|1|||
16296491|NCT03400943|39570897|FG001|Post-treatment Period 1|Protocol Violation|0|||
16296492|NCT03400943|39570898|FG002|Post-treatment Period 1|Protocol Violation|0|||
16296493|NCT03400943|39570899|FG003|Post-treatment Period 1|Protocol Violation|0|||
16296494|NCT03400943|39570896|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
16296495|NCT03400943|39570897|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
16296496|NCT03400943|39570898|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
16296497|NCT03400943|39570899|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
16296498|NCT03400943|39570896|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
16296499|NCT03400943|39570897|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
16296500|NCT03400943|39570898|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
16296501|NCT03400943|39570899|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
16296502|NCT03400943|39570896|FG000|Post-treatment Period 1|Other|2|||
16296503|NCT03400943|39570897|FG001|Post-treatment Period 1|Other|0|||
16296504|NCT03400943|39570898|FG002|Post-treatment Period 1|Other|4|||
16296505|NCT03400943|39570899|FG003|Post-treatment Period 1|Other|5|||
16296506|NCT03400943|39570896|FG000|Treatment Period 2|Study terminated by sponsor|0|||
16188825|NCT01728584|39169449|FG003|Overall Study|Withdrawal by Subject|0|||
16188826|NCT01728584|39169446|FG000|Overall Study|Screen failure|1|||
16188827|NCT01728584|39169447|FG001|Overall Study|Screen failure|0|||
16188828|NCT01728584|39169448|FG002|Overall Study|Screen failure|0|||
16188829|NCT01728584|39169449|FG003|Overall Study|Screen failure|0|||
16188830|NCT01728584|39169446|FG000|Overall Study|Other reason (not specified)|1|||
16188831|NCT01728584|39169447|FG001|Overall Study|Other reason (not specified)|0|||
16188832|NCT01728584|39169448|FG002|Overall Study|Other reason (not specified)|0|||
16188833|NCT01728584|39169449|FG003|Overall Study|Other reason (not specified)|1|||
16188834|NCT02742649|39169450|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
16188835|NCT02742649|39169451|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
16188836|NCT02742649|39169452|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
16188837|NCT02742649|39169453|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
16188838|NCT02742649|39169454|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
16188839|NCT02742649|39169450|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16188840|NCT02742649|39169451|FG001|Double-Blind Treatment Period|Adverse Event|1|||
16188841|NCT02742649|39169452|FG002|Double-Blind Treatment Period|Adverse Event|0|||
16188842|NCT02742649|39169453|FG003|Double-Blind Treatment Period|Adverse Event|0|||
16188843|NCT02742649|39169454|FG004|Double-Blind Treatment Period|Adverse Event|0|||
16188844|NCT02742649|39169450|FG000|Open-Label Period|Lost to Follow-up|0|||
16188845|NCT02742649|39169451|FG001|Open-Label Period|Lost to Follow-up|0|||
16188846|NCT02742649|39169452|FG002|Open-Label Period|Lost to Follow-up|0|||
16188847|NCT02742649|39169453|FG003|Open-Label Period|Lost to Follow-up|0|||
16188848|NCT02742649|39169454|FG004|Open-Label Period|Lost to Follow-up|1|||
16188849|NCT00234104|39169455|FG000|Overall Study|Adverse Event|4|||
16188850|NCT00234104|39169456|FG001|Overall Study|Adverse Event|0|||
16188851|NCT00234104|39169457|FG002|Overall Study|Adverse Event|3|||
16188852|NCT00234104|39169458|FG003|Overall Study|Adverse Event|5|||
16188853|NCT00234104|39169455|FG000|Overall Study|Protocol Violation|0|||
16188854|NCT00234104|39169456|FG001|Overall Study|Protocol Violation|0|||
16188855|NCT00234104|39169457|FG002|Overall Study|Protocol Violation|0|||
16188856|NCT00234104|39169458|FG003|Overall Study|Protocol Violation|1|||
16188857|NCT00234104|39169455|FG000|Overall Study|Physician Decision|0|||
16188858|NCT00234104|39169456|FG001|Overall Study|Physician Decision|1|||
16188859|NCT00234104|39169457|FG002|Overall Study|Physician Decision|2|||
16188860|NCT00234104|39169458|FG003|Overall Study|Physician Decision|2|||
16296507|NCT03400943|39570897|FG001|Treatment Period 2|Study terminated by sponsor|1|||
16296508|NCT03400943|39570898|FG002|Treatment Period 2|Study terminated by sponsor|0|||
16296509|NCT03400943|39570899|FG003|Treatment Period 2|Study terminated by sponsor|0|||
16188861|NCT00256867|39169459|FG000|Overall Study|Adverse Event|0|||
16188862|NCT00256867|39169460|FG001|Overall Study|Adverse Event|1|||
16188863|NCT00256867|39169461|FG002|Overall Study|Adverse Event|1|||
16188864|NCT00256867|39169462|FG003|Overall Study|Adverse Event|1|||
16188865|NCT00256867|39169463|FG004|Overall Study|Adverse Event|2|||
16188866|NCT00256867|39169464|FG005|Overall Study|Adverse Event|2|||
16188867|NCT00256867|39169465|FG006|Overall Study|Adverse Event|1|||
16188868|NCT00256867|39169466|FG007|Overall Study|Adverse Event|4|||
16188869|NCT00256867|39169459|FG000|Overall Study|Lost to Follow-up|2|||
16188870|NCT00256867|39169460|FG001|Overall Study|Lost to Follow-up|2|||
16188871|NCT00256867|39169461|FG002|Overall Study|Lost to Follow-up|2|||
16188872|NCT00256867|39169462|FG003|Overall Study|Lost to Follow-up|3|||
16188873|NCT00256867|39169463|FG004|Overall Study|Lost to Follow-up|2|||
16188874|NCT00256867|39169464|FG005|Overall Study|Lost to Follow-up|0|||
16188875|NCT00256867|39169465|FG006|Overall Study|Lost to Follow-up|1|||
16188876|NCT00256867|39169466|FG007|Overall Study|Lost to Follow-up|2|||
16188877|NCT00256867|39169459|FG000|Overall Study|Protocol Violation|0|||
16188878|NCT00256867|39169460|FG001|Overall Study|Protocol Violation|0|||
16188879|NCT00256867|39169461|FG002|Overall Study|Protocol Violation|0|||
16188880|NCT00256867|39169462|FG003|Overall Study|Protocol Violation|1|||
16188881|NCT00256867|39169463|FG004|Overall Study|Protocol Violation|0|||
16188882|NCT00256867|39169464|FG005|Overall Study|Protocol Violation|1|||
16188883|NCT00256867|39169465|FG006|Overall Study|Protocol Violation|0|||
16188884|NCT00256867|39169466|FG007|Overall Study|Protocol Violation|1|||
16188885|NCT00256867|39169459|FG000|Overall Study|Withdrawal by Subject|0|||
16188886|NCT00256867|39169460|FG001|Overall Study|Withdrawal by Subject|0|||
16188887|NCT00256867|39169461|FG002|Overall Study|Withdrawal by Subject|1|||
16188888|NCT00256867|39169462|FG003|Overall Study|Withdrawal by Subject|1|||
16188889|NCT00256867|39169463|FG004|Overall Study|Withdrawal by Subject|2|||
16188890|NCT00256867|39169464|FG005|Overall Study|Withdrawal by Subject|2|||
16188891|NCT00256867|39169465|FG006|Overall Study|Withdrawal by Subject|3|||
16188892|NCT00256867|39169466|FG007|Overall Study|Withdrawal by Subject|2|||
16188893|NCT00256867|39169459|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
16188894|NCT00256867|39169460|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
16188895|NCT00256867|39169461|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
16188896|NCT00256867|39169462|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
16188897|NCT00256867|39169463|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
16188898|NCT00256867|39169464|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
16188899|NCT00256867|39169465|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
16188900|NCT00256867|39169466|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
16188901|NCT00256867|39169459|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
16188902|NCT00256867|39169460|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
16188903|NCT00256867|39169461|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
16188904|NCT00256867|39169462|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
16188905|NCT00256867|39169463|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
16188906|NCT00256867|39169464|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
16188907|NCT00256867|39169465|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
16188908|NCT00256867|39169466|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
16188909|NCT00256867|39169459|FG000|Overall Study|Investigator's Decision|0|||
16188910|NCT00256867|39169460|FG001|Overall Study|Investigator's Decision|0|||
16188911|NCT00256867|39169461|FG002|Overall Study|Investigator's Decision|0|||
16188912|NCT00256867|39169462|FG003|Overall Study|Investigator's Decision|0|||
16188913|NCT00256867|39169463|FG004|Overall Study|Investigator's Decision|1|||
16188914|NCT00256867|39169464|FG005|Overall Study|Investigator's Decision|0|||
16188915|NCT00256867|39169465|FG006|Overall Study|Investigator's Decision|0|||
16188916|NCT00256867|39169466|FG007|Overall Study|Investigator's Decision|0|||
16188917|NCT00256867|39169459|FG000|Overall Study|Non-compliance with study medication|0|||
16188918|NCT00256867|39169460|FG001|Overall Study|Non-compliance with study medication|0|||
16188919|NCT00256867|39169461|FG002|Overall Study|Non-compliance with study medication|0|||
16188920|NCT00256867|39169462|FG003|Overall Study|Non-compliance with study medication|0|||
16188921|NCT00256867|39169463|FG004|Overall Study|Non-compliance with study medication|0|||
16188922|NCT00256867|39169464|FG005|Overall Study|Non-compliance with study medication|0|||
16188923|NCT00256867|39169465|FG006|Overall Study|Non-compliance with study medication|0|||
16188924|NCT00256867|39169466|FG007|Overall Study|Non-compliance with study medication|1|||
16188925|NCT00256867|39169459|FG000|Overall Study|Participant travelled Overseas|0|||
16188926|NCT00256867|39169460|FG001|Overall Study|Participant travelled Overseas|1|||
16188927|NCT00256867|39169461|FG002|Overall Study|Participant travelled Overseas|0|||
16188928|NCT00256867|39169462|FG003|Overall Study|Participant travelled Overseas|0|||
16188929|NCT00256867|39169463|FG004|Overall Study|Participant travelled Overseas|0|||
16188930|NCT00256867|39169464|FG005|Overall Study|Participant travelled Overseas|0|||
16188931|NCT00256867|39169465|FG006|Overall Study|Participant travelled Overseas|0|||
16188932|NCT00256867|39169466|FG007|Overall Study|Participant travelled Overseas|0|||
16188933|NCT00256867|39169459|FG000|Overall Study|Participant out of assessment window|0|||
16188934|NCT00256867|39169460|FG001|Overall Study|Participant out of assessment window|0|||
16188935|NCT00256867|39169461|FG002|Overall Study|Participant out of assessment window|1|||
16188936|NCT00256867|39169462|FG003|Overall Study|Participant out of assessment window|0|||
16346241|NCT01615029|39753269|FG004|Overall Study|Lost to Follow-up|1|||
16188937|NCT00256867|39169463|FG004|Overall Study|Participant out of assessment window|0|||
16188938|NCT00256867|39169464|FG005|Overall Study|Participant out of assessment window|0|||
16188939|NCT00256867|39169465|FG006|Overall Study|Participant out of assessment window|0|||
16188940|NCT00256867|39169466|FG007|Overall Study|Participant out of assessment window|0|||
16188941|NCT00256867|39169459|FG000|Overall Study|Withdrawal by participant|0|||
16188942|NCT00256867|39169460|FG001|Overall Study|Withdrawal by participant|0|||
16188943|NCT00256867|39169461|FG002|Overall Study|Withdrawal by participant|0|||
16188944|NCT00256867|39169462|FG003|Overall Study|Withdrawal by participant|0|||
16188945|NCT00256867|39169463|FG004|Overall Study|Withdrawal by participant|0|||
16188946|NCT00256867|39169464|FG005|Overall Study|Withdrawal by participant|1|||
16188947|NCT00256867|39169465|FG006|Overall Study|Withdrawal by participant|0|||
16188948|NCT00256867|39169466|FG007|Overall Study|Withdrawal by participant|0|||
16188949|NCT01193348|39169467|FG000|Screening Period|Screen Failure|5|||
16188950|NCT01193348|39169467|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
16188951|NCT01193348|39169467|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
16188952|NCT01193348|39169467|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
16188953|NCT01193348|39169467|FG000|Extension Treatment Period|Physician Decision|1|||
16188954|NCT01193348|39169467|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
16188955|NCT04095286|39169477|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
16188956|NCT04095286|39169478|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
16188957|NCT04095286|39169479|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
16188958|NCT04095286|39169480|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
16188959|NCT04095286|39169481|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
16188960|NCT04095286|39169482|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
16188961|NCT04095286|39169477|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
16188962|NCT04095286|39169478|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
16188963|NCT04095286|39169479|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
16188964|NCT04095286|39169480|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
16188965|NCT04095286|39169481|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
16188966|NCT04095286|39169482|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
16188967|NCT04095286|39169477|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
16188968|NCT04095286|39169478|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
16188969|NCT04095286|39169479|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
16188970|NCT04095286|39169480|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
16188971|NCT04095286|39169481|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
16188972|NCT04095286|39169482|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
16188973|NCT04095286|39169477|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
16188974|NCT04095286|39169478|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
16188975|NCT04095286|39169479|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
16188976|NCT04095286|39169480|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
16188977|NCT04095286|39169481|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
16188978|NCT04095286|39169482|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
16188979|NCT04095286|39169477|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
16188980|NCT04095286|39169478|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
16188981|NCT04095286|39169479|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
16188982|NCT04095286|39169480|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
16188983|NCT04095286|39169481|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
16188984|NCT04095286|39169482|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
16188985|NCT03643432|39169485|FG000|Overall Study|Lost to Follow-up|1|||
16188986|NCT03643432|39169486|FG001|Overall Study|Lost to Follow-up|0|||
16188987|NCT00833248|39169487|FG000|Overall Study|Adverse Event|3|||
16188988|NCT00833248|39169488|FG001|Overall Study|Adverse Event|0|||
16188989|NCT00833248|39169487|FG000|Overall Study|Protocol Violation|1|||
16188990|NCT00833248|39169488|FG001|Overall Study|Protocol Violation|2|||
16188991|NCT00833248|39169487|FG000|Overall Study|Withdrawal by Subject|0|||
16188992|NCT00833248|39169488|FG001|Overall Study|Withdrawal by Subject|1|||
16188993|NCT00634244|39169490|FG000|Overall Study|Never started treatment|0|||
16188994|NCT00634244|39169491|FG001|Overall Study|Never started treatment|1|||
16188995|NCT00634244|39169492|FG002|Overall Study|Never started treatment|0|||
16188996|NCT00634244|39169490|FG000|Overall Study|Death|1|||
16188997|NCT00634244|39169491|FG001|Overall Study|Death|6|||
16188998|NCT00634244|39169492|FG002|Overall Study|Death|0|||
16188999|NCT00634244|39169490|FG000|Overall Study|Adverse Event|0|||
16189000|NCT00634244|39169491|FG001|Overall Study|Adverse Event|2|||
16189001|NCT00634244|39169492|FG002|Overall Study|Adverse Event|0|||
16189002|NCT00634244|39169490|FG000|Overall Study|Withdrawal by Subject|0|||
16189003|NCT00634244|39169491|FG001|Overall Study|Withdrawal by Subject|1|||
16189004|NCT00634244|39169492|FG002|Overall Study|Withdrawal by Subject|0|||
16189005|NCT00634244|39169490|FG000|Overall Study|Physician Decision|0|||
16189006|NCT00634244|39169491|FG001|Overall Study|Physician Decision|1|||
16189007|NCT00634244|39169492|FG002|Overall Study|Physician Decision|0|||
16189008|NCT00634244|39169490|FG000|Overall Study|Disease progression/relapse|0|||
16189009|NCT00634244|39169491|FG001|Overall Study|Disease progression/relapse|1|||
16189010|NCT00634244|39169492|FG002|Overall Study|Disease progression/relapse|0|||
16189011|NCT00634244|39169490|FG000|Overall Study|Other complicating disease|0|||
16189012|NCT00634244|39169491|FG001|Overall Study|Other complicating disease|1|||
16189013|NCT00634244|39169492|FG002|Overall Study|Other complicating disease|0|||
16189014|NCT00365976|39169493|FG000|Overall Study|Withdrawal by Subject|1|||
16189015|NCT00365976|39169494|FG001|Overall Study|Withdrawal by Subject|5|||
16189016|NCT03294681|39169497|FG000|Overall Study|Withdrawal by Subject|1|||
16189017|NCT04964063|39169501|FG000|Overall Study|Adverse Event|4|||
16189018|NCT04964063|39169501|FG000|Overall Study|Lost to Follow-up|47|||
16189019|NCT04964063|39169501|FG000|Overall Study|Withdrawal by Subject|5|||
16189020|NCT04964063|39169501|FG000|Overall Study|Baseline Tasks Expired|41|||
16189021|NCT04964063|39169501|FG000|Overall Study|Participant withdrawn in error|1|||
16189022|NCT01423617|39169502|FG000|Overall Study|Lost to Follow-up|0|||
16189023|NCT01423617|39169503|FG001|Overall Study|Lost to Follow-up|1|||
16189024|NCT00532883|39169504|FG000|Overall Study|Adverse Event|1|||
16189025|NCT00532883|39169505|FG001|Overall Study|Adverse Event|0|||
16189026|NCT00532883|39169506|FG002|Overall Study|Adverse Event|0|||
16189027|NCT00532883|39169507|FG003|Overall Study|Adverse Event|1|||
16189028|NCT00532883|39169504|FG000|Overall Study|Lost to Follow-up|1|||
16189029|NCT00532883|39169505|FG001|Overall Study|Lost to Follow-up|1|||
16189030|NCT00532883|39169506|FG002|Overall Study|Lost to Follow-up|1|||
16189031|NCT00532883|39169507|FG003|Overall Study|Lost to Follow-up|0|||
16189032|NCT00532883|39169504|FG000|Overall Study|Withdrawal by Subject|0|||
16189033|NCT00532883|39169505|FG001|Overall Study|Withdrawal by Subject|1|||
16189034|NCT00532883|39169506|FG002|Overall Study|Withdrawal by Subject|1|||
16189035|NCT00532883|39169507|FG003|Overall Study|Withdrawal by Subject|0|||
16189036|NCT00532883|39169504|FG000|Overall Study|Subject was Nonadherent|0|||
16189037|NCT00532883|39169505|FG001|Overall Study|Subject was Nonadherent|1|||
16189038|NCT00532883|39169506|FG002|Overall Study|Subject was Nonadherent|1|||
16189039|NCT00532883|39169507|FG003|Overall Study|Subject was Nonadherent|0|||
16189040|NCT00532883|39169504|FG000|Overall Study|Early Study Termination|4|||
16296510|NCT03400943|39570896|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16296511|NCT03400943|39570897|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16296512|NCT03400943|39570898|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16296513|NCT03400943|39570899|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16296514|NCT03400943|39570896|FG000|Treatment Period 2|Other|1|||
16296515|NCT03400943|39570897|FG001|Treatment Period 2|Other|6|||
16296516|NCT03400943|39570898|FG002|Treatment Period 2|Other|0|||
16296517|NCT03400943|39570899|FG003|Treatment Period 2|Other|0|||
16296518|NCT03400943|39570896|FG000|Follow-up Period|Withdrawal by Subject|1|||
16296519|NCT03400943|39570897|FG001|Follow-up Period|Withdrawal by Subject|0|||
16296520|NCT03400943|39570898|FG002|Follow-up Period|Withdrawal by Subject|0|||
16296521|NCT03400943|39570899|FG003|Follow-up Period|Withdrawal by Subject|0|||
16296522|NCT00587990|39570900|FG000|Overall Study|Death|0|||
16296523|NCT00587990|39570901|FG001|Overall Study|Death|0|||
16296524|NCT00587990|39570902|FG002|Overall Study|Death|1|||
16296525|NCT02437903|39570903|FG000|Overall Study|Adverse Event|1|||
16296526|NCT02437903|39570903|FG000|Overall Study|Withdrawal by Subject|1|||
16296527|NCT02437903|39570903|FG000|Overall Study|Lost to Follow-up|3|||
16296528|NCT00106964|39570904|FG000|Overall Study|Lost to Follow-up|8|||
16296529|NCT00106964|39570905|FG001|Overall Study|Lost to Follow-up|6|||
16296530|NCT00106964|39570906|FG002|Overall Study|Lost to Follow-up|2|||
16296531|NCT00106964|39570904|FG000|Overall Study|Pregnancy|2|||
16296532|NCT00106964|39570905|FG001|Overall Study|Pregnancy|3|||
16296533|NCT00106964|39570906|FG002|Overall Study|Pregnancy|2|||
16296534|NCT00106964|39570904|FG000|Overall Study|Death|1|||
16296535|NCT00106964|39570905|FG001|Overall Study|Death|1|||
16296536|NCT00106964|39570906|FG002|Overall Study|Death|0|||
16296537|NCT00106964|39570904|FG000|Overall Study|Incarceration|0|||
16296538|NCT00106964|39570905|FG001|Overall Study|Incarceration|1|||
16296539|NCT00106964|39570906|FG002|Overall Study|Incarceration|0|||
16296540|NCT00106964|39570904|FG000|Overall Study|Site Funding Terminated|0|||
16189041|NCT00532883|39169505|FG001|Overall Study|Early Study Termination|4|||
16189042|NCT00532883|39169506|FG002|Overall Study|Early Study Termination|1|||
16189043|NCT00532883|39169507|FG003|Overall Study|Early Study Termination|4|||
16189044|NCT01029002|39169508|FG000|Overall Study|Lost to Follow-up|2|||
16189045|NCT01029002|39169509|FG001|Overall Study|Lost to Follow-up|4|||
16189046|NCT01989546|39169522|FG000|Overall Study|Clinical Progression|1|||
16189047|NCT01989546|39169522|FG000|Overall Study|Disease progression on study|8|||
16296541|NCT00106964|39570905|FG001|Overall Study|Site Funding Terminated|1|||
16296542|NCT00106964|39570906|FG002|Overall Study|Site Funding Terminated|1|||
16296543|NCT00106964|39570904|FG000|Overall Study|Failure to adhere|2|||
16296544|NCT00106964|39570905|FG001|Overall Study|Failure to adhere|0|||
16296545|NCT00106964|39570906|FG002|Overall Study|Failure to adhere|0|||
16296546|NCT00106964|39570904|FG000|Overall Study|Did not meet eligibility criteria|0|||
16296547|NCT00106964|39570905|FG001|Overall Study|Did not meet eligibility criteria|2|||
16296548|NCT00106964|39570906|FG002|Overall Study|Did not meet eligibility criteria|2|||
16296549|NCT00106964|39570904|FG000|Overall Study|Required disallowed medication|0|||
16296550|NCT00106964|39570905|FG001|Overall Study|Required disallowed medication|1|||
16296551|NCT00106964|39570906|FG002|Overall Study|Required disallowed medication|0|||
16296552|NCT01775189|39570907|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16296553|NCT01775189|39570908|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
16296554|NCT01775189|39570909|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16296555|NCT01775189|39570910|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16296556|NCT01775189|39570911|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16296557|NCT01775189|39570912|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16296558|NCT01775189|39570913|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16296559|NCT01775189|39570907|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16296560|NCT01775189|39570908|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
16296561|NCT01775189|39570909|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16296562|NCT01775189|39570910|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16296563|NCT01775189|39570911|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16296564|NCT01775189|39570912|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16296565|NCT01775189|39570913|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16296566|NCT01775189|39570907|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
16296567|NCT01775189|39570908|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
16296568|NCT01775189|39570909|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
16296569|NCT01775189|39570910|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
16296570|NCT01775189|39570911|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
16296571|NCT01775189|39570912|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
16296572|NCT01775189|39570913|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
16296573|NCT01775189|39570907|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16296574|NCT01775189|39570908|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16296575|NCT01775189|39570909|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16296576|NCT01775189|39570910|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16296577|NCT01775189|39570911|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16296578|NCT01775189|39570912|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
16296579|NCT01775189|39570913|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
16296580|NCT01775189|39570907|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16296581|NCT01775189|39570908|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16296582|NCT01775189|39570909|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16296583|NCT01775189|39570910|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
16296584|NCT01775189|39570911|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16296585|NCT01775189|39570912|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16296586|NCT01775189|39570913|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
16296587|NCT01775189|39570907|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
16296588|NCT01775189|39570908|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
16296589|NCT01775189|39570909|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
16296590|NCT01775189|39570910|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
16296591|NCT01775189|39570911|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
16487041|NCT02521870|40259671|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
16487042|NCT02521870|40259660|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
16487043|NCT02521870|40259661|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
16487044|NCT02521870|40259662|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
16487045|NCT02521870|40259663|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
16487046|NCT02521870|40259664|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
16487047|NCT02521870|40259665|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
16487048|NCT02521870|40259666|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
16487049|NCT02521870|40259667|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
16487050|NCT02521870|40259668|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
16487051|NCT02521870|40259669|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
16487052|NCT02521870|40259670|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
16487053|NCT02521870|40259671|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
16296592|NCT01775189|39570912|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
16296593|NCT01775189|39570913|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
16296594|NCT03327792|39570914|FG000|Overall Study|Adverse Event|4|||
16296595|NCT03327792|39570915|FG001|Overall Study|Adverse Event|0|||
16383527|NCT01870869|39888546|FG001|Overall Study|Subject choice|2|||
16383528|NCT01870869|39888547|FG002|Overall Study|Subject choice|22|||
16487054|NCT02521870|40259660|FG000|Phase 2: Dose Expansion|Death|0|||
16487055|NCT02521870|40259661|FG001|Phase 2: Dose Expansion|Death|0|||
16383529|NCT01870869|39888548|FG003|Overall Study|Subject choice|8|||
16383530|NCT01870869|39888545|FG000|Overall Study|Lost to Follow-up|10|||
16383531|NCT01870869|39888546|FG001|Overall Study|Lost to Follow-up|2|||
16383532|NCT01870869|39888547|FG002|Overall Study|Lost to Follow-up|25|||
16383533|NCT01870869|39888548|FG003|Overall Study|Lost to Follow-up|3|||
16383534|NCT01870869|39888545|FG000|Overall Study|Reason not Specified|1|||
16383535|NCT01870869|39888546|FG001|Overall Study|Reason not Specified|2|||
16383536|NCT01870869|39888547|FG002|Overall Study|Reason not Specified|20|||
16383537|NCT01870869|39888548|FG003|Overall Study|Reason not Specified|4|||
16383538|NCT01870869|39888545|FG000|Overall Study|Not evaluable|10|||
16296596|NCT03327792|39570914|FG000|Overall Study|Family/Personal issues|3|||
16296597|NCT03327792|39570915|FG001|Overall Study|Family/Personal issues|2|||
16296598|NCT03327792|39570914|FG000|Overall Study|Lost to Follow-up|0|||
16296599|NCT03327792|39570915|FG001|Overall Study|Lost to Follow-up|1|||
16296600|NCT00987389|39570916|FG000|Overall Study|Ineligible|0|||
16296601|NCT00987389|39570917|FG001|Overall Study|Ineligible|3|||
16296602|NCT00987389|39570918|FG002|Overall Study|Ineligible|0|||
16296603|NCT00987389|39570919|FG003|Overall Study|Ineligible|0|||
16296604|NCT00987389|39570916|FG000|Overall Study|Lost to Follow-up|4|||
16296605|NCT00987389|39570917|FG001|Overall Study|Lost to Follow-up|1|||
16296606|NCT00987389|39570918|FG002|Overall Study|Lost to Follow-up|3|||
16296607|NCT00987389|39570919|FG003|Overall Study|Lost to Follow-up|1|||
16296608|NCT00987389|39570916|FG000|Overall Study|Withdrawal by Subject|4|||
16296609|NCT00987389|39570917|FG001|Overall Study|Withdrawal by Subject|3|||
16296610|NCT00987389|39570918|FG002|Overall Study|Withdrawal by Subject|2|||
16296611|NCT00987389|39570919|FG003|Overall Study|Withdrawal by Subject|1|||
16296612|NCT00987389|39570916|FG000|Overall Study|Withdrawn from Treatment|0|||
16296613|NCT00987389|39570917|FG001|Overall Study|Withdrawn from Treatment|1|||
16296614|NCT00987389|39570918|FG002|Overall Study|Withdrawn from Treatment|0|||
16296615|NCT00987389|39570919|FG003|Overall Study|Withdrawn from Treatment|0|||
16383539|NCT01870869|39888546|FG001|Overall Study|Not evaluable|5|||
16383540|NCT01870869|39888547|FG002|Overall Study|Not evaluable|42|||
16383541|NCT01870869|39888548|FG003|Overall Study|Not evaluable|10|||
16383542|NCT00325143|39888549|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
16383543|NCT00325143|39888549|FG000|Overall Study|Migrated/moved from study area|1|||
16383544|NCT00325143|39888549|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
16383545|NCT00325143|39888549|FG000|Overall Study|Withdrawal by Subject|8|||
16383546|NCT00639457|39888550|FG000|Overall Study|Withdrawal by Subject|2|||
16383547|NCT00639457|39888551|FG001|Overall Study|Withdrawal by Subject|3|||
16383548|NCT02660229|39888552|FG000|Overall Study|Adverse Event|2|||
16383549|NCT02660229|39888553|FG001|Overall Study|Adverse Event|0|||
16383550|NCT02660229|39888552|FG000|Overall Study|Withdrawal by Subject|0|||
16383551|NCT02660229|39888553|FG001|Overall Study|Withdrawal by Subject|1|||
16383552|NCT01802788|39888554|FG000|Overall Study|Withdrawal by Subject|102|||
16383553|NCT01802788|39888555|FG001|Overall Study|Withdrawal by Subject|5|||
16383554|NCT01802788|39888554|FG000|Overall Study|Death|382|||
16383555|NCT01802788|39888555|FG001|Overall Study|Death|18|||
16383556|NCT01802788|39888554|FG000|Overall Study|Lost to Follow-up|31|||
16383557|NCT01802788|39888555|FG001|Overall Study|Lost to Follow-up|2|||
16383558|NCT01802788|39888554|FG000|Overall Study|Physician Decision|3|||
16383559|NCT01802788|39888555|FG001|Overall Study|Physician Decision|0|||
16383560|NCT01802788|39888554|FG000|Overall Study|Patient Non-Compliance|1|||
16383561|NCT01802788|39888555|FG001|Overall Study|Patient Non-Compliance|0|||
16383562|NCT01802788|39888554|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
16383563|NCT01802788|39888555|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
16383564|NCT01802788|39888554|FG000|Overall Study|Other Reasons|19|||
16189048|NCT01655823|39169523|FG000|Overall Study|Lost to Follow-up|0|||
16189049|NCT01655823|39169524|FG001|Overall Study|Lost to Follow-up|1|||
16189050|NCT01655823|39169525|FG002|Overall Study|Lost to Follow-up|0|||
16189051|NCT01655823|39169526|FG003|Overall Study|Lost to Follow-up|0|||
16189052|NCT01655823|39169527|FG004|Overall Study|Lost to Follow-up|1|||
16189053|NCT01655823|39169523|FG000|Overall Study|Withdrawal by Subject|0|||
16189054|NCT01655823|39169524|FG001|Overall Study|Withdrawal by Subject|1|||
16189055|NCT01655823|39169525|FG002|Overall Study|Withdrawal by Subject|0|||
16189056|NCT01655823|39169526|FG003|Overall Study|Withdrawal by Subject|1|||
16189057|NCT01655823|39169527|FG004|Overall Study|Withdrawal by Subject|0|||
16189058|NCT01402284|39169536|FG000|Overall Study|Withdrawal consent|2|||
16296616|NCT00987389|39570916|FG000|Overall Study|Multiple different reasons|1|||
16296617|NCT00987389|39570917|FG001|Overall Study|Multiple different reasons|0|||
16296618|NCT00987389|39570918|FG002|Overall Study|Multiple different reasons|3|||
16383565|NCT01802788|39888555|FG001|Overall Study|Other Reasons|0|||
16383566|NCT00889005|39888556|FG000|Overall Study|Lost to Follow-up|4|||
16383567|NCT00889005|39888557|FG001|Overall Study|Lost to Follow-up|2|||
16383568|NCT00889005|39888556|FG000|Overall Study|Withdrawal by Subject|4|||
16383569|NCT00889005|39888557|FG001|Overall Study|Withdrawal by Subject|0|||
16383570|NCT03032484|39888558|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
16383571|NCT03032484|39888559|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
16383572|NCT03032484|39888558|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
16383573|NCT03032484|39888559|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
16383574|NCT01729039|39888560|FG000|Overall Study|disqualified|2|||
16383575|NCT01729039|39888561|FG001|Overall Study|disqualified|5|||
16383576|NCT01729039|39888560|FG000|Overall Study|Withdrawal by Subject|8|||
16383577|NCT01729039|39888561|FG001|Overall Study|Withdrawal by Subject|7|||
16383578|NCT00419744|39888562|FG000|Overall Study|Adverse Event|39|||
16383579|NCT00419744|39888563|FG001|Overall Study|Adverse Event|40|||
16383580|NCT00419744|39888564|FG002|Overall Study|Adverse Event|50|||
16383581|NCT00419744|39888562|FG000|Overall Study|Withdrawal by Subject|45|||
16383582|NCT00419744|39888563|FG001|Overall Study|Withdrawal by Subject|49|||
16383583|NCT00419744|39888564|FG002|Overall Study|Withdrawal by Subject|52|||
16383584|NCT00419744|39888562|FG000|Overall Study|Lost to Follow-up|8|||
16383585|NCT00419744|39888563|FG001|Overall Study|Lost to Follow-up|10|||
16383586|NCT00419744|39888564|FG002|Overall Study|Lost to Follow-up|6|||
16383587|NCT00419744|39888562|FG000|Overall Study|Protocol Violation|4|||
16383588|NCT00419744|39888563|FG001|Overall Study|Protocol Violation|7|||
16383589|NCT00419744|39888564|FG002|Overall Study|Protocol Violation|8|||
16383590|NCT00419744|39888562|FG000|Overall Study|Randomized in error|9|||
16383591|NCT00419744|39888563|FG001|Overall Study|Randomized in error|6|||
16383592|NCT00419744|39888564|FG002|Overall Study|Randomized in error|7|||
16383593|NCT00419744|39888562|FG000|Overall Study|Moving out of state|2|||
16383594|NCT00419744|39888563|FG001|Overall Study|Moving out of state|0|||
16383595|NCT00419744|39888564|FG002|Overall Study|Moving out of state|1|||
16383596|NCT00419744|39888562|FG000|Overall Study|Physician Decision|10|||
16383597|NCT00419744|39888563|FG001|Overall Study|Physician Decision|5|||
16383598|NCT00419744|39888564|FG002|Overall Study|Physician Decision|6|||
16383599|NCT00419744|39888562|FG000|Overall Study|Spirometry mouthpiece issues|0|||
16383600|NCT00419744|39888563|FG001|Overall Study|Spirometry mouthpiece issues|1|||
16296619|NCT00987389|39570919|FG003|Overall Study|Multiple different reasons|1|||
16296620|NCT01377987|39570926|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
16296621|NCT01377987|39570927|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
16296622|NCT02140411|39570928|FG000|Overall Study|Adverse Event|1|||
16296623|NCT02099682|39570934|FG000|Overall Study|Data Not Available|51|||
16296624|NCT02099682|39570934|FG000|Overall Study|Lost to Follow-up|31|||
16296625|NCT02099682|39570934|FG000|Overall Study|Other|29|||
16296626|NCT04241315|39570937|FG000|Overall Study|Withdrawal by Subject|0|||
16296627|NCT04241315|39570938|FG001|Overall Study|Withdrawal by Subject|1|||
16296628|NCT01986010|39570939|FG000|Overall Study|Adverse Event|0|||
16296629|NCT01986010|39570940|FG001|Overall Study|Adverse Event|1|||
16296630|NCT01986010|39570941|FG002|Overall Study|Adverse Event|0|||
16296631|NCT01986010|39570942|FG003|Overall Study|Adverse Event|0|||
16296632|NCT01986010|39570943|FG004|Overall Study|Adverse Event|0|||
16296633|NCT01986010|39570944|FG005|Overall Study|Adverse Event|0|||
16296634|NCT01986010|39570945|FG006|Overall Study|Adverse Event|0|||
16296635|NCT01986010|39570946|FG007|Overall Study|Adverse Event|0|||
16296636|NCT01986010|39570947|FG008|Overall Study|Adverse Event|0|||
16296637|NCT01986010|39570948|FG009|Overall Study|Adverse Event|0|||
16296638|NCT01986010|39570949|FG010|Overall Study|Adverse Event|0|||
16082813|NCT03939312|38796092|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
16082814|NCT03939312|38796092|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
16082815|NCT03939312|38796092|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
16082816|NCT03939312|38796092|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
16082817|NCT03939312|38796092|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
16082818|NCT03939312|38796092|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
16082819|NCT03939312|38796092|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
16082820|NCT03939312|38796092|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
16082821|NCT03939312|38796092|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
16082822|NCT03939312|38796092|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
16082823|NCT03939312|38796092|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
16082824|NCT03939312|38796092|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
16082825|NCT02119650|38796093|FG000|Overall Study|Adverse Event|3|||
16082826|NCT02119650|38796094|FG001|Overall Study|Adverse Event|4|||
16082827|NCT02119650|38796093|FG000|Overall Study|Subject decision|2|||
16082828|NCT02119650|38796094|FG001|Overall Study|Subject decision|3|||
16082829|NCT02119650|38796093|FG000|Overall Study|Disease progression|11|||
16189059|NCT01402284|39169536|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
16296639|NCT01986010|39570950|FG011|Overall Study|Adverse Event|0|||
16296640|NCT01986010|39570951|FG012|Overall Study|Adverse Event|0|||
16383601|NCT00419744|39888564|FG002|Overall Study|Spirometry mouthpiece issues|2|||
16383602|NCT00419744|39888562|FG000|Overall Study|Incorrect medication kit dispensed|0|||
16296641|NCT01986010|39570952|FG013|Overall Study|Adverse Event|0|||
16383603|NCT00419744|39888563|FG001|Overall Study|Incorrect medication kit dispensed|0|||
16082830|NCT02119650|38796094|FG001|Overall Study|Disease progression|14|||
16082831|NCT02119650|38796093|FG000|Overall Study|Death|5|||
16082832|NCT02119650|38796094|FG001|Overall Study|Death|1|||
16296642|NCT01986010|39570953|FG014|Overall Study|Adverse Event|0|||
16082833|NCT02119650|38796093|FG000|Overall Study|Noncompliance with study treatment|1|||
16082834|NCT02119650|38796094|FG001|Overall Study|Noncompliance with study treatment|1|||
16082835|NCT02119650|38796093|FG000|Overall Study|Study terminated by the sponsor|1|||
16082836|NCT02119650|38796094|FG001|Overall Study|Study terminated by the sponsor|0|||
16082837|NCT02119650|38796093|FG000|Overall Study|Physician Decision|0|||
16082838|NCT02119650|38796094|FG001|Overall Study|Physician Decision|2|||
16082839|NCT02119650|38796093|FG000|Overall Study|Multiple reasons for termination|2|||
16082840|NCT02119650|38796094|FG001|Overall Study|Multiple reasons for termination|1|||
16082841|NCT00409838|38796095|FG000|Short-term Period|Adverse Event|0|||
16082842|NCT00409838|38796096|FG001|Short-term Period|Adverse Event|1|||
16082843|NCT00409838|38796095|FG000|Short-term Period|Lost to Follow-up|0|||
16082844|NCT00409838|38796096|FG001|Short-term Period|Lost to Follow-up|1|||
16082845|NCT00409838|38796095|FG000|Short-term Period|Withdrawal by Subject|2|||
16082846|NCT00409838|38796096|FG001|Short-term Period|Withdrawal by Subject|3|||
16082847|NCT00409838|38796095|FG000|Short-term Period|Never Treated|1|||
16082848|NCT00409838|38796096|FG001|Short-term Period|Never Treated|0|||
16082849|NCT00409838|38796095|FG000|Long-term Extension Period|Adverse Event|10|||
16082850|NCT00409838|38796096|FG001|Long-term Extension Period|Adverse Event|0|||
16082851|NCT00409838|38796095|FG000|Long-term Extension Period|Death|1|||
16082852|NCT00409838|38796096|FG001|Long-term Extension Period|Death|0|||
16082853|NCT00409838|38796095|FG000|Long-term Extension Period|Lack of Efficacy|2|||
16082854|NCT00409838|38796096|FG001|Long-term Extension Period|Lack of Efficacy|0|||
16082855|NCT00409838|38796095|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
16082856|NCT00409838|38796096|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
16082857|NCT00409838|38796095|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
16487056|NCT02521870|40259662|FG002|Phase 2: Dose Expansion|Death|0|||
16487057|NCT02521870|40259663|FG003|Phase 2: Dose Expansion|Death|0|||
16487058|NCT02521870|40259664|FG004|Phase 2: Dose Expansion|Death|1|||
16487059|NCT02521870|40259665|FG005|Phase 2: Dose Expansion|Death|1|||
16487060|NCT02521870|40259666|FG006|Phase 2: Dose Expansion|Death|3|||
16487061|NCT02521870|40259667|FG007|Phase 2: Dose Expansion|Death|1|||
16487062|NCT02521870|40259668|FG008|Phase 2: Dose Expansion|Death|1|||
16487063|NCT02521870|40259669|FG009|Phase 2: Dose Expansion|Death|5|||
16082858|NCT00409838|38796096|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
16082859|NCT00409838|38796095|FG000|Long-term Extension Period|Pregnancy|1|||
16082860|NCT00409838|38796096|FG001|Long-term Extension Period|Pregnancy|0|||
16082861|NCT02029235|38796097|FG000|Overall Study|Non-compliance with study meds or diary|4|||
16082862|NCT02029235|38796098|FG001|Overall Study|Non-compliance with study meds or diary|1|||
16082863|NCT02204982|38796103|FG000|Overall Study|Patient ineligible-medical monitor|1|||
16082864|NCT02204982|38796104|FG001|Overall Study|Patient ineligible-medical monitor|0|||
16082865|NCT02204982|38796103|FG000|Overall Study|Withdrawal by Subject|1|||
16082866|NCT02204982|38796104|FG001|Overall Study|Withdrawal by Subject|0|||
16082867|NCT02204982|38796103|FG000|Overall Study|Adverse Event|1|||
16082868|NCT02204982|38796104|FG001|Overall Study|Adverse Event|0|||
16082869|NCT02204982|38796103|FG000|Overall Study|Adverse Event and Investigator decision|1|||
16082870|NCT02204982|38796104|FG001|Overall Study|Adverse Event and Investigator decision|0|||
16082871|NCT02204982|38796103|FG000|Overall Study|Physician Decision|0|||
16082872|NCT02204982|38796104|FG001|Overall Study|Physician Decision|2|||
16082873|NCT02204982|38796103|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
16082874|NCT02204982|38796104|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
16082875|NCT02204982|38796103|FG000|Overall Study|Termination of Study bySponsor|0|||
16082876|NCT02204982|38796104|FG001|Overall Study|Termination of Study bySponsor|1|||
16082877|NCT00203411|38796105|FG000|Follow-up|Progressive Disease|4|||
16082878|NCT02698475|38796106|FG000|Main Study Period|Lack of Efficacy|1|||
16082879|NCT02698475|38796106|FG000|Main Study Period|Protocol Violation|2|||
16082880|NCT02698475|38796106|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
16082881|NCT02698475|38796106|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
16082882|NCT02698475|38796106|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
16082883|NCT02698475|38796106|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
16082884|NCT02698475|38796106|FG000|Long-Term Extension Period|Other|1|||
16082885|NCT01083316|38796108|FG000|Overall Study|Adverse Event|2|||
16383604|NCT00419744|39888564|FG002|Overall Study|Incorrect medication kit dispensed|1|||
16383605|NCT04476784|39888565|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
16487064|NCT02521870|40259670|FG010|Phase 2: Dose Expansion|Death|2|||
16487065|NCT02521870|40259671|FG011|Phase 2: Dose Expansion|Death|2|||
16082886|NCT01083316|38796108|FG000|Overall Study|Withdrawal by Subject|1|||
16082887|NCT03785405|38796109|FG000|Overall Study|Adverse Event|16|||
16082888|NCT03785405|38796110|FG001|Overall Study|Adverse Event|1|||
16082889|NCT03785405|38796109|FG000|Overall Study|Death|6|||
16082890|NCT03785405|38796110|FG001|Overall Study|Death|4|||
16082891|NCT03785405|38796109|FG000|Overall Study|Guardian decision|4|||
16082892|NCT03785405|38796110|FG001|Overall Study|Guardian decision|1|||
16082893|NCT03785405|38796109|FG000|Overall Study|Lost to Follow-up|1|||
16487066|NCT02521870|40259660|FG000|Phase 2: Dose Expansion|Other|0|||
16487067|NCT02521870|40259661|FG001|Phase 2: Dose Expansion|Other|0|||
16082894|NCT03785405|38796110|FG001|Overall Study|Lost to Follow-up|0|||
16082895|NCT03785405|38796109|FG000|Overall Study|Physician Decision|8|||
16082896|NCT03785405|38796110|FG001|Overall Study|Physician Decision|5|||
16082897|NCT03785405|38796109|FG000|Overall Study|Participant decision|2|||
16082898|NCT03785405|38796110|FG001|Overall Study|Participant decision|0|||
16082899|NCT03785405|38796109|FG000|Overall Study|Other|1|||
16082900|NCT03785405|38796110|FG001|Overall Study|Other|0|||
16082901|NCT03785405|38796109|FG000|Overall Study|No treatment was received|0|||
16082902|NCT03785405|38796110|FG001|Overall Study|No treatment was received|1|||
16082903|NCT02932579|38796111|FG000|Overall Study|Withdrawal by Subject|4|||
16082904|NCT02932579|38796112|FG001|Overall Study|Withdrawal by Subject|1|||
16082905|NCT00371787|38796113|FG000|Overall Study|Withdrawal by Subject|3|||
16082906|NCT00371787|38796114|FG001|Overall Study|Withdrawal by Subject|1|||
16082907|NCT00999167|38796115|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
16082908|NCT00999167|38796116|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
16082909|NCT00999167|38796117|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
16082910|NCT00999167|38796115|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
16082911|NCT00999167|38796116|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
16082912|NCT00999167|38796117|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
16082913|NCT00999167|38796115|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
16082914|NCT00999167|38796116|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
16082915|NCT00999167|38796117|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
16082916|NCT00999167|38796115|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
16082917|NCT00999167|38796116|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
16082918|NCT00999167|38796117|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
16082919|NCT00999167|38796115|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
16082920|NCT00999167|38796116|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
16082921|NCT00999167|38796117|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
16082922|NCT00999167|38796115|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
16082923|NCT00999167|38796116|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
16082924|NCT00999167|38796117|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
16082925|NCT00999167|38796115|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
16082926|NCT00999167|38796116|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
16082927|NCT00999167|38796117|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
16082928|NCT00999167|38796115|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
16082929|NCT00999167|38796116|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
16082930|NCT00999167|38796117|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
16082931|NCT04788641|38796119|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
16082932|NCT04788641|38796120|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
16082933|NCT04788641|38796121|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
16082934|NCT04788641|38796122|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
16082935|NCT04788641|38796119|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
16082936|NCT04788641|38796120|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
16082937|NCT04788641|38796121|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
16082938|NCT04788641|38796122|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
16082939|NCT04788641|38796119|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
16082940|NCT04788641|38796120|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
16082941|NCT04788641|38796121|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
16082942|NCT04788641|38796122|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
16082943|NCT00826280|38796130|FG000|Overall Study|Randomized but drug not received|1|||
16082944|NCT00826280|38796131|FG001|Overall Study|Randomized but drug not received|0|||
16296643|NCT01986010|39570954|FG015|Overall Study|Adverse Event|1|||
16296644|NCT01986010|39570955|FG016|Overall Study|Adverse Event|0|||
16296645|NCT01986010|39570939|FG000|Overall Study|Lost to Follow-up|2|||
16487068|NCT02521870|40259662|FG002|Phase 2: Dose Expansion|Other|0|||
16487069|NCT02521870|40259663|FG003|Phase 2: Dose Expansion|Other|0|||
16487070|NCT02521870|40259664|FG004|Phase 2: Dose Expansion|Other|10|||
16487071|NCT02521870|40259665|FG005|Phase 2: Dose Expansion|Other|3|||
16487072|NCT02521870|40259666|FG006|Phase 2: Dose Expansion|Other|2|||
16487073|NCT02521870|40259667|FG007|Phase 2: Dose Expansion|Other|0|||
16487074|NCT02521870|40259668|FG008|Phase 2: Dose Expansion|Other|10|||
16487075|NCT02521870|40259669|FG009|Phase 2: Dose Expansion|Other|5|||
16487076|NCT02521870|40259670|FG010|Phase 2: Dose Expansion|Other|1|||
16487077|NCT02521870|40259671|FG011|Phase 2: Dose Expansion|Other|7|||
16082945|NCT00826280|38796132|FG002|Overall Study|Randomized but drug not received|1|||
16082946|NCT00826280|38796130|FG000|Overall Study|Adverse Event|1|||
16296646|NCT01986010|39570940|FG001|Overall Study|Lost to Follow-up|1|||
16487078|NCT02521870|40259660|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487079|NCT02521870|40259661|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487080|NCT02521870|40259662|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487081|NCT02521870|40259663|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487082|NCT02521870|40259664|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
16487083|NCT02521870|40259665|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487084|NCT02521870|40259666|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487085|NCT02521870|40259667|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487086|NCT02521870|40259668|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487087|NCT02521870|40259669|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487088|NCT02521870|40259670|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487089|NCT02521870|40259671|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
16487090|NCT02521870|40259660|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487091|NCT02521870|40259661|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487092|NCT02521870|40259662|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487093|NCT02521870|40259663|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487094|NCT02521870|40259664|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
16487095|NCT02521870|40259665|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487096|NCT02521870|40259666|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487097|NCT02521870|40259667|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487098|NCT02521870|40259668|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487099|NCT02521870|40259669|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487100|NCT02521870|40259670|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487101|NCT02521870|40259671|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
16487102|NCT03706079|40259673|FG000|Predecessor Study|Death|0|||
16487103|NCT03706079|40259674|FG001|Predecessor Study|Death|2|||
16487104|NCT03706079|40259675|FG002|Predecessor Study|Death|0|||
16487105|NCT03706079|40259676|FG003|Predecessor Study|Death|1|||
16487106|NCT03706079|40259677|FG004|Predecessor Study|Death|0|||
16487107|NCT03706079|40259678|FG005|Predecessor Study|Death|0|||
16487108|NCT03706079|40259673|FG000|Predecessor Study|Lost to Follow-up|5|||
16487109|NCT03706079|40259674|FG001|Predecessor Study|Lost to Follow-up|2|||
16487110|NCT03706079|40259675|FG002|Predecessor Study|Lost to Follow-up|0|||
16487111|NCT03706079|40259676|FG003|Predecessor Study|Lost to Follow-up|0|||
16487112|NCT03706079|40259677|FG004|Predecessor Study|Lost to Follow-up|1|||
16487113|NCT03706079|40259678|FG005|Predecessor Study|Lost to Follow-up|0|||
16487114|NCT03706079|40259673|FG000|Predecessor Study|Withdrawal by Subject|8|||
16487115|NCT03706079|40259674|FG001|Predecessor Study|Withdrawal by Subject|15|||
16487116|NCT03706079|40259675|FG002|Predecessor Study|Withdrawal by Subject|0|||
16487117|NCT03706079|40259676|FG003|Predecessor Study|Withdrawal by Subject|5|||
16487118|NCT03706079|40259677|FG004|Predecessor Study|Withdrawal by Subject|2|||
16487119|NCT03706079|40259678|FG005|Predecessor Study|Withdrawal by Subject|0|||
16487120|NCT03706079|40259673|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
16487121|NCT03706079|40259674|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
16487122|NCT03706079|40259675|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
16487123|NCT03706079|40259676|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
16487124|NCT03706079|40259677|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
16487125|NCT03706079|40259678|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
16487126|NCT03706079|40259673|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
16487127|NCT03706079|40259674|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
16487128|NCT03706079|40259675|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
16487129|NCT03706079|40259676|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
16487130|NCT03706079|40259677|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
16487131|NCT03706079|40259678|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
16487132|NCT03706079|40259673|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
16487133|NCT03706079|40259674|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
16487134|NCT03706079|40259675|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
16487135|NCT03706079|40259676|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
16487136|NCT03706079|40259677|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
16487137|NCT03706079|40259678|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
16487138|NCT03706079|40259673|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
16487139|NCT03706079|40259674|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
16487140|NCT03706079|40259675|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
16487141|NCT03706079|40259676|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
16487142|NCT03706079|40259677|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
16487143|NCT03706079|40259678|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
16487144|NCT03706079|40259673|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
16487145|NCT03706079|40259674|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
16487146|NCT03706079|40259675|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
16487147|NCT03706079|40259676|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
16487148|NCT03706079|40259677|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
16487149|NCT03706079|40259678|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
16487150|NCT03706079|40259673|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
16487151|NCT03706079|40259674|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
16487152|NCT03706079|40259675|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
16487153|NCT03706079|40259676|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
16487154|NCT03706079|40259677|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
16487155|NCT03706079|40259678|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
16487156|NCT03706079|40259673|FG000|Long Term Extension (DESTINATION)|Death|8|||
16189060|NCT01402284|39169536|FG000|Overall Study|Physician Decision|1|||
16189061|NCT01402284|39169536|FG000|Overall Study|Disease progression on study|10|||
16189062|NCT00369668|39169537|FG000|Overall Study|Lack of Efficacy|4|||
16189063|NCT00369668|39169538|FG001|Overall Study|Lack of Efficacy|5|||
16189064|NCT00369668|39169539|FG002|Overall Study|Lack of Efficacy|7|||
16189065|NCT02426658|39169540|FG000|Overall Study|Withdrawal by Subject|1|||
16189066|NCT02426658|39169540|FG000|Overall Study|Patient expired before treatment|2|||
16189067|NCT05118386|39169546|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
16189068|NCT05118386|39169547|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
16189069|NCT05118386|39169548|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
16189070|NCT05118386|39169549|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
16189071|NCT05118386|39169550|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
16189072|NCT05118386|39169551|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
16189073|NCT05118386|39169546|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
16189074|NCT05118386|39169547|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
16189075|NCT05118386|39169548|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
16189076|NCT05118386|39169549|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
16189077|NCT05118386|39169550|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
16189078|NCT05118386|39169551|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
16189079|NCT00849693|39169552|FG000|Acute Treatment Phase|Adverse Event|12|||
16189080|NCT00849693|39169553|FG001|Acute Treatment Phase|Adverse Event|7|||
16189081|NCT00849693|39169554|FG002|Acute Treatment Phase|Adverse Event|6|||
16189082|NCT00849693|39169555|FG003|Acute Treatment Phase|Adverse Event|4|||
16189083|NCT00849693|39169552|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
16189084|NCT00849693|39169553|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
16189085|NCT00849693|39169554|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
16189086|NCT00849693|39169555|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
16189087|NCT00849693|39169552|FG000|Acute Treatment Phase|Protocol Violation|1|||
16189088|NCT00849693|39169553|FG001|Acute Treatment Phase|Protocol Violation|5|||
16189089|NCT00849693|39169554|FG002|Acute Treatment Phase|Protocol Violation|2|||
16189090|NCT00849693|39169555|FG003|Acute Treatment Phase|Protocol Violation|6|||
16189091|NCT00849693|39169552|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
16189092|NCT00849693|39169553|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
16189093|NCT00849693|39169554|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
16189094|NCT00849693|39169555|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
16189095|NCT00849693|39169552|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
16189096|NCT00849693|39169553|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
16189097|NCT00849693|39169554|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
16189098|NCT00849693|39169555|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
16189099|NCT00849693|39169552|FG000|Acute Treatment Phase|Physician Decision|2|||
16189100|NCT00849693|39169553|FG001|Acute Treatment Phase|Physician Decision|1|||
16189101|NCT00849693|39169554|FG002|Acute Treatment Phase|Physician Decision|2|||
16189102|NCT00849693|39169555|FG003|Acute Treatment Phase|Physician Decision|1|||
16189103|NCT00849693|39169552|FG000|Acute Treatment Phase|Sponsor decision|0|||
16189104|NCT00849693|39169553|FG001|Acute Treatment Phase|Sponsor decision|0|||
16189105|NCT00849693|39169554|FG002|Acute Treatment Phase|Sponsor decision|1|||
16189106|NCT00849693|39169555|FG003|Acute Treatment Phase|Sponsor decision|0|||
16189107|NCT00849693|39169552|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
16189108|NCT00849693|39169553|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
16189109|NCT00849693|39169554|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
16487157|NCT03706079|40259674|FG001|Long Term Extension (DESTINATION)|Death|2|||
16487158|NCT03706079|40259675|FG002|Long Term Extension (DESTINATION)|Death|2|||
16082947|NCT00826280|38796131|FG001|Overall Study|Adverse Event|3|||
16189110|NCT00849693|39169555|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
16189111|NCT00849693|39169552|FG000|Extension Phase|Adverse Event|4|||
16189112|NCT00849693|39169553|FG001|Extension Phase|Adverse Event|6|||
16189113|NCT00849693|39169554|FG002|Extension Phase|Adverse Event|3|||
16082948|NCT00826280|38796132|FG002|Overall Study|Adverse Event|0|||
16487159|NCT03706079|40259676|FG003|Long Term Extension (DESTINATION)|Death|1|||
16487160|NCT03706079|40259677|FG004|Long Term Extension (DESTINATION)|Death|0|||
16487161|NCT03706079|40259678|FG005|Long Term Extension (DESTINATION)|Death|0|||
16487162|NCT01713686|40259689|FG000|Overall Study|Lost to Follow-up|9|||
16487163|NCT01713686|40259689|FG000|Overall Study|Withdrawal by Subject|6|||
16487164|NCT01235351|40259695|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
16487165|NCT01235351|40259696|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
16487166|NCT01217814|40259697|FG000|Overall Study|Adverse Event|1|||
16487167|NCT01217814|40259698|FG001|Overall Study|Adverse Event|1|||
16487168|NCT01217814|40259699|FG002|Overall Study|Adverse Event|0|||
16487169|NCT01217814|40259697|FG000|Overall Study|Lack of Efficacy|0|||
16487170|NCT01217814|40259698|FG001|Overall Study|Lack of Efficacy|0|||
16487171|NCT01217814|40259699|FG002|Overall Study|Lack of Efficacy|1|||
16487172|NCT03727347|40259703|FG000|Overall Study|Withdrawal by Subject|2|||
16189114|NCT00849693|39169555|FG003|Extension Phase|Adverse Event|7|||
16189115|NCT00849693|39169552|FG000|Extension Phase|Lost to Follow-up|7|||
16189116|NCT00849693|39169553|FG001|Extension Phase|Lost to Follow-up|5|||
16189117|NCT00849693|39169554|FG002|Extension Phase|Lost to Follow-up|6|||
16189118|NCT00849693|39169555|FG003|Extension Phase|Lost to Follow-up|6|||
16189119|NCT00849693|39169552|FG000|Extension Phase|Protocol Violation|0|||
16189120|NCT00849693|39169553|FG001|Extension Phase|Protocol Violation|3|||
16189121|NCT00849693|39169554|FG002|Extension Phase|Protocol Violation|2|||
16189122|NCT00849693|39169555|FG003|Extension Phase|Protocol Violation|3|||
16189123|NCT00849693|39169552|FG000|Extension Phase|Withdrawal by Subject|6|||
16189124|NCT00849693|39169553|FG001|Extension Phase|Withdrawal by Subject|9|||
16189125|NCT00849693|39169554|FG002|Extension Phase|Withdrawal by Subject|10|||
16189126|NCT00849693|39169555|FG003|Extension Phase|Withdrawal by Subject|15|||
16189127|NCT00849693|39169552|FG000|Extension Phase|Parent or caregiver decision|9|||
16189128|NCT00849693|39169553|FG001|Extension Phase|Parent or caregiver decision|4|||
16189129|NCT00849693|39169554|FG002|Extension Phase|Parent or caregiver decision|10|||
16189130|NCT00849693|39169555|FG003|Extension Phase|Parent or caregiver decision|5|||
16189131|NCT00849693|39169552|FG000|Extension Phase|Physician Decision|1|||
16189132|NCT00849693|39169553|FG001|Extension Phase|Physician Decision|1|||
16189133|NCT00849693|39169554|FG002|Extension Phase|Physician Decision|2|||
16189134|NCT00849693|39169555|FG003|Extension Phase|Physician Decision|0|||
16189135|NCT00849693|39169552|FG000|Extension Phase|Sponsor decision|1|||
16189136|NCT00849693|39169553|FG001|Extension Phase|Sponsor decision|0|||
16189137|NCT00849693|39169554|FG002|Extension Phase|Sponsor decision|0|||
16189138|NCT00849693|39169555|FG003|Extension Phase|Sponsor decision|1|||
16189139|NCT00849693|39169552|FG000|Extension Phase|Lack of Efficacy|2|||
16189140|NCT00849693|39169553|FG001|Extension Phase|Lack of Efficacy|2|||
16189141|NCT00849693|39169554|FG002|Extension Phase|Lack of Efficacy|2|||
16189142|NCT00849693|39169555|FG003|Extension Phase|Lack of Efficacy|1|||
16189143|NCT03471767|39169564|FG000|Overall Study|Withdrawal by Subject|3|||
16189144|NCT03471767|39169565|FG001|Overall Study|Withdrawal by Subject|1|||
16189145|NCT03471767|39169564|FG000|Overall Study|Adverse Event|1|||
16189146|NCT03471767|39169565|FG001|Overall Study|Adverse Event|0|||
16189147|NCT03471767|39169564|FG000|Overall Study|Lost to Follow-up|1|||
16189148|NCT03471767|39169565|FG001|Overall Study|Lost to Follow-up|0|||
16189149|NCT03471767|39169564|FG000|Overall Study|PI Withdrawal|1|||
16189150|NCT03471767|39169565|FG001|Overall Study|PI Withdrawal|3|||
16189151|NCT01576016|39169566|FG000|Lead Safety|Death|132|||
16189152|NCT01576016|39169567|FG001|Lead Safety|Death|0|||
16189153|NCT01576016|39169566|FG000|Lead Safety|Withdrawal by Subject|81|||
16189154|NCT01576016|39169567|FG001|Lead Safety|Withdrawal by Subject|0|||
16189155|NCT01576016|39169566|FG000|Lead Safety|System Explanted without Replacement|24|||
16189156|NCT01576016|39169567|FG001|Lead Safety|System Explanted without Replacement|0|||
16189157|NCT01576016|39169566|FG000|Lead Safety|Physician Decision|14|||
16487173|NCT03727347|40259703|FG000|Overall Study|Lost to Follow-up|1|||
16487174|NCT00458211|40259707|FG000|Overall Study|Lack of Efficacy|12|||
16487175|NCT00458211|40259707|FG000|Overall Study|Withdrawal by Subject|2|||
16487176|NCT00458211|40259707|FG000|Overall Study|Protocol Violation|2|||
16487177|NCT02695329|40259708|FG000|Overall Study|Adverse Event|1|||
16487178|NCT02695329|40259709|FG001|Overall Study|Adverse Event|0|||
16487179|NCT02695329|40259708|FG000|Overall Study|Poor X-ray quality for measurement|4|||
16189158|NCT01576016|39169567|FG001|Lead Safety|Physician Decision|0|||
16189159|NCT01576016|39169566|FG000|Lead Safety|Lost to Follow-up|13|||
16189160|NCT01576016|39169567|FG001|Lead Safety|Lost to Follow-up|0|||
16189161|NCT01576016|39169566|FG000|Lead Safety|Unsuccessful implant|2|||
16487180|NCT02695329|40259709|FG001|Overall Study|Poor X-ray quality for measurement|5|||
16487181|NCT01749137|40259710|FG000|Overall Study|Adverse Event|4|||
16487182|NCT01749137|40259711|FG001|Overall Study|Adverse Event|4|||
16189162|NCT01576016|39169567|FG001|Lead Safety|Unsuccessful implant|0|||
16189163|NCT01576016|39169566|FG000|Lead Safety|Sponsor request|1|||
16189164|NCT01576016|39169567|FG001|Lead Safety|Sponsor request|0|||
16189165|NCT01576016|39169566|FG000|Lead Safety|Device replaced with CRT-D|1|||
16189166|NCT01576016|39169567|FG001|Lead Safety|Device replaced with CRT-D|0|||
16189167|NCT01576016|39169566|FG000|Lead Safety|Patient on Palliative Care|1|||
16487183|NCT01749137|40259710|FG000|Overall Study|Lost to Follow-up|2|||
16487184|NCT01749137|40259711|FG001|Overall Study|Lost to Follow-up|3|||
16487185|NCT01749137|40259710|FG000|Overall Study|Physician Decision|1|||
16487186|NCT01749137|40259711|FG001|Overall Study|Physician Decision|0|||
16487187|NCT01749137|40259710|FG000|Overall Study|Withdrawal by Subject|8|||
16487188|NCT01749137|40259711|FG001|Overall Study|Withdrawal by Subject|4|||
16189168|NCT01576016|39169567|FG001|Lead Safety|Patient on Palliative Care|0|||
16189169|NCT01576016|39169566|FG000|Lead Safety|Patient noncompliance|1|||
16189170|NCT01576016|39169567|FG001|Lead Safety|Patient noncompliance|0|||
16189171|NCT01576016|39169566|FG000|Lead Safety|Too far from study site|1|||
16487189|NCT00885846|40259712|FG000|Overall Study|Withdrawal by Subject|2|||
16487190|NCT00885846|40259713|FG001|Overall Study|Withdrawal by Subject|5|||
16487191|NCT00885846|40259714|FG002|Overall Study|Withdrawal by Subject|2|||
16487192|NCT02244606|40259715|FG000|Overall Study|Adverse Event|0|||
16487193|NCT02244606|40259716|FG001|Overall Study|Adverse Event|1|||
16487194|NCT02244606|40259717|FG002|Overall Study|Adverse Event|1|||
16487195|NCT02244606|40259718|FG003|Overall Study|Adverse Event|0|||
16487196|NCT02244606|40259715|FG000|Overall Study|Lost to Follow-up|2|||
16487197|NCT02244606|40259716|FG001|Overall Study|Lost to Follow-up|2|||
16487198|NCT02244606|40259717|FG002|Overall Study|Lost to Follow-up|1|||
16487199|NCT02244606|40259718|FG003|Overall Study|Lost to Follow-up|0|||
16487200|NCT02244606|40259715|FG000|Overall Study|Protocol Violation|0|||
16189172|NCT01576016|39169567|FG001|Lead Safety|Too far from study site|0|||
16189173|NCT01576016|39169566|FG000|Lead Safety|System deactivated|1|||
16189174|NCT01576016|39169567|FG001|Lead Safety|System deactivated|0|||
16189175|NCT01576016|39169566|FG000|Lead Safety|Patient no longer followed by study PI|1|||
16189176|NCT01576016|39169567|FG001|Lead Safety|Patient no longer followed by study PI|0|||
16189177|NCT01576016|39169566|FG000|MRI Safety|Withdrawal by Subject|0|||
16189178|NCT01576016|39169567|FG001|MRI Safety|Withdrawal by Subject|10|||
16189179|NCT01576016|39169566|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
16189180|NCT01576016|39169567|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
16189181|NCT01576016|39169566|FG000|MRI Safety|Has not yet completed MRI scan|0|||
16189182|NCT01576016|39169567|FG001|MRI Safety|Has not yet completed MRI scan|56|||
16189183|NCT01576016|39169566|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
16189184|NCT01576016|39169567|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
16189185|NCT00601523|39169568|FG000|Overall Study|Adverse Event|42|||
16189186|NCT00601523|39169569|FG001|Overall Study|Adverse Event|14|||
16189187|NCT00601523|39169568|FG000|Overall Study|Lack of Efficacy|3|||
16189188|NCT00601523|39169569|FG001|Overall Study|Lack of Efficacy|0|||
16189189|NCT00601523|39169568|FG000|Overall Study|Protocol Violation|5|||
16189190|NCT00601523|39169569|FG001|Overall Study|Protocol Violation|1|||
16189191|NCT00601523|39169568|FG000|Overall Study|Lost to Follow-up|0|||
16189192|NCT00601523|39169569|FG001|Overall Study|Lost to Follow-up|1|||
16189193|NCT00601523|39169568|FG000|Overall Study|Withdrawal by Subject|18|||
16189194|NCT00601523|39169569|FG001|Overall Study|Withdrawal by Subject|9|||
16189195|NCT00601523|39169568|FG000|Overall Study|Other|9|||
16189196|NCT00601523|39169569|FG001|Overall Study|Other|1|||
16189197|NCT02993224|39169578|FG000|Core Phase - Period 1|Adverse Event|4|||
16189198|NCT02993224|39169578|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
16189199|NCT02993224|39169578|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
16189200|NCT02993224|39169578|FG000|Core Phase- Period 2|Adverse Event|1|||
16189201|NCT02993224|39169578|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
16189202|NCT02993224|39169578|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
16189203|NCT02993224|39169578|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
16189204|NCT02993224|39169578|FG000|Extension Phase|Adverse Event|3|||
16487201|NCT02244606|40259716|FG001|Overall Study|Protocol Violation|0|||
16487202|NCT02244606|40259717|FG002|Overall Study|Protocol Violation|0|||
16487203|NCT02244606|40259718|FG003|Overall Study|Protocol Violation|1|||
16487204|NCT02244606|40259715|FG000|Overall Study|Withdrawal by Subject|1|||
16487205|NCT02244606|40259716|FG001|Overall Study|Withdrawal by Subject|1|||
16487206|NCT02244606|40259717|FG002|Overall Study|Withdrawal by Subject|0|||
16487207|NCT02244606|40259718|FG003|Overall Study|Withdrawal by Subject|0|||
16487208|NCT02244606|40259715|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
16487209|NCT02244606|40259716|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
16487210|NCT02244606|40259717|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
16487211|NCT02244606|40259718|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
16487212|NCT00329238|40259719|FG000|Overall Study|Adverse Event|147|||
16487213|NCT00329238|40259720|FG001|Overall Study|Adverse Event|129|||
16189205|NCT02993224|39169578|FG000|Extension Phase|Withdrawal by Subject|3|||
16189206|NCT02993224|39169578|FG000|Extension Phase|Lost to Follow-up|2|||
16189207|NCT02993224|39169578|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
16189208|NCT04799405|39169592|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
16189209|NCT02577406|39169593|FG000|Randomized Period|Death|1|||
16189210|NCT02577406|39169594|FG001|Randomized Period|Death|0|||
16487214|NCT00329238|40259719|FG000|Overall Study|Protocol Violation|23|||
16487215|NCT00329238|40259720|FG001|Overall Study|Protocol Violation|34|||
16487216|NCT00329238|40259719|FG000|Overall Study|Lost to Follow-up|2|||
16487217|NCT00329238|40259720|FG001|Overall Study|Lost to Follow-up|6|||
16487218|NCT00329238|40259719|FG000|Overall Study|Withdrawal by Subject|64|||
16383606|NCT04476784|39888566|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
16383607|NCT00002766|39888567|FG000|Overall Study|Withdrawal by Subject|0|||
16487219|NCT00329238|40259720|FG001|Overall Study|Withdrawal by Subject|58|||
16487220|NCT00329238|40259719|FG000|Overall Study|Other reason (not specified)|40|||
16487221|NCT00329238|40259720|FG001|Overall Study|Other reason (not specified)|54|||
16487222|NCT03572062|40259721|FG000|Overall Study|Adverse Event|0|||
16487223|NCT03572062|40259722|FG001|Overall Study|Adverse Event|0|||
16487224|NCT03572062|40259723|FG002|Overall Study|Adverse Event|0|||
16487225|NCT03572062|40259724|FG003|Overall Study|Adverse Event|0|||
16487226|NCT03572062|40259725|FG004|Overall Study|Adverse Event|0|||
16487227|NCT03572062|40259726|FG005|Overall Study|Adverse Event|0|||
16383608|NCT00002766|39888568|FG001|Overall Study|Withdrawal by Subject|1|||
16383609|NCT00002766|39888567|FG000|Overall Study|Patient Not Treated|1|||
16383610|NCT00002766|39888568|FG001|Overall Study|Patient Not Treated|2|||
16383611|NCT00002766|39888567|FG000|Overall Study|Adverse Event|1|||
16383612|NCT00002766|39888568|FG001|Overall Study|Adverse Event|1|||
16383613|NCT00002766|39888567|FG000|Overall Study|Protocol Violation|1|||
16383614|NCT00002766|39888568|FG001|Overall Study|Protocol Violation|0|||
16383615|NCT01832727|39888569|FG000|Overall Study|Adverse Event|4|||
16383616|NCT01832727|39888570|FG001|Overall Study|Adverse Event|6|||
16383617|NCT01832727|39888571|FG002|Overall Study|Adverse Event|1|||
16383618|NCT01832727|39888572|FG003|Overall Study|Adverse Event|0|||
16383619|NCT01832727|39888573|FG004|Overall Study|Adverse Event|1|||
16383620|NCT01832727|39888574|FG005|Overall Study|Adverse Event|1|||
16383621|NCT01832727|39888575|FG006|Overall Study|Adverse Event|2|||
16383622|NCT01832727|39888576|FG007|Overall Study|Adverse Event|1|||
16383623|NCT01832727|39888577|FG008|Overall Study|Adverse Event|9|||
16383624|NCT01832727|39888569|FG000|Overall Study|Disease progression|3|||
16383625|NCT01832727|39888570|FG001|Overall Study|Disease progression|0|||
16383626|NCT01832727|39888571|FG002|Overall Study|Disease progression|2|||
16383627|NCT01832727|39888572|FG003|Overall Study|Disease progression|1|||
16383628|NCT01832727|39888573|FG004|Overall Study|Disease progression|3|||
16383629|NCT01832727|39888574|FG005|Overall Study|Disease progression|3|||
16383630|NCT01832727|39888575|FG006|Overall Study|Disease progression|6|||
16383631|NCT01832727|39888576|FG007|Overall Study|Disease progression|2|||
16383632|NCT01832727|39888577|FG008|Overall Study|Disease progression|7|||
16383633|NCT01832727|39888569|FG000|Overall Study|Lost to Follow-up|0|||
16383634|NCT01832727|39888570|FG001|Overall Study|Lost to Follow-up|0|||
16383635|NCT01832727|39888571|FG002|Overall Study|Lost to Follow-up|0|||
16383636|NCT01832727|39888572|FG003|Overall Study|Lost to Follow-up|1|||
16383637|NCT01832727|39888573|FG004|Overall Study|Lost to Follow-up|0|||
16383638|NCT01832727|39888574|FG005|Overall Study|Lost to Follow-up|0|||
16383639|NCT01832727|39888575|FG006|Overall Study|Lost to Follow-up|0|||
16383640|NCT01832727|39888576|FG007|Overall Study|Lost to Follow-up|0|||
16383641|NCT01832727|39888577|FG008|Overall Study|Lost to Follow-up|0|||
16383642|NCT01832727|39888569|FG000|Overall Study|Physician Decision|1|||
16383643|NCT01832727|39888570|FG001|Overall Study|Physician Decision|0|||
16383644|NCT01832727|39888571|FG002|Overall Study|Physician Decision|0|||
16383645|NCT01832727|39888572|FG003|Overall Study|Physician Decision|1|||
16383646|NCT01832727|39888573|FG004|Overall Study|Physician Decision|0|||
16383647|NCT01832727|39888574|FG005|Overall Study|Physician Decision|1|||
16383648|NCT01832727|39888575|FG006|Overall Study|Physician Decision|0|||
16383649|NCT01832727|39888576|FG007|Overall Study|Physician Decision|0|||
16383650|NCT01832727|39888577|FG008|Overall Study|Physician Decision|0|||
16383651|NCT01832727|39888569|FG000|Overall Study|Withdrawal by Subject|1|||
16383652|NCT01832727|39888570|FG001|Overall Study|Withdrawal by Subject|1|||
16383653|NCT01832727|39888571|FG002|Overall Study|Withdrawal by Subject|0|||
16383654|NCT01832727|39888572|FG003|Overall Study|Withdrawal by Subject|1|||
16383655|NCT01832727|39888573|FG004|Overall Study|Withdrawal by Subject|0|||
16383656|NCT01832727|39888574|FG005|Overall Study|Withdrawal by Subject|1|||
16383657|NCT01832727|39888575|FG006|Overall Study|Withdrawal by Subject|0|||
16383658|NCT01832727|39888576|FG007|Overall Study|Withdrawal by Subject|2|||
16487228|NCT03572062|40259727|FG006|Overall Study|Adverse Event|0|||
16487229|NCT03572062|40259728|FG007|Overall Study|Adverse Event|0|||
16082949|NCT00826280|38796130|FG000|Overall Study|Lost to Follow-up|0|||
16082950|NCT00826280|38796131|FG001|Overall Study|Lost to Follow-up|1|||
16082951|NCT00826280|38796132|FG002|Overall Study|Lost to Follow-up|0|||
16487230|NCT03572062|40259729|FG008|Overall Study|Adverse Event|1|||
16487231|NCT03572062|40259730|FG009|Overall Study|Adverse Event|3|||
16383659|NCT01832727|39888577|FG008|Overall Study|Withdrawal by Subject|1|||
16383660|NCT01832727|39888569|FG000|Overall Study|Study terminated by sponsor|0|||
16383661|NCT01832727|39888570|FG001|Overall Study|Study terminated by sponsor|0|||
16383662|NCT01832727|39888571|FG002|Overall Study|Study terminated by sponsor|0|||
16383663|NCT01832727|39888572|FG003|Overall Study|Study terminated by sponsor|0|||
16383664|NCT01832727|39888573|FG004|Overall Study|Study terminated by sponsor|0|||
16383665|NCT01832727|39888574|FG005|Overall Study|Study terminated by sponsor|0|||
16383666|NCT01832727|39888575|FG006|Overall Study|Study terminated by sponsor|0|||
16383667|NCT01832727|39888576|FG007|Overall Study|Study terminated by sponsor|1|||
16383668|NCT01832727|39888577|FG008|Overall Study|Study terminated by sponsor|1|||
16383669|NCT04388826|39888581|FG000|Overall Study|Lost to Follow-up|3|||
16487232|NCT03572062|40259721|FG000|Overall Study|Death|0|||
16296647|NCT01986010|39570941|FG002|Overall Study|Lost to Follow-up|2|||
16296648|NCT01986010|39570942|FG003|Overall Study|Lost to Follow-up|2|||
16296649|NCT01986010|39570943|FG004|Overall Study|Lost to Follow-up|2|||
16296650|NCT01986010|39570944|FG005|Overall Study|Lost to Follow-up|2|||
16296651|NCT01986010|39570945|FG006|Overall Study|Lost to Follow-up|0|||
16296652|NCT01986010|39570946|FG007|Overall Study|Lost to Follow-up|0|||
16296653|NCT01986010|39570947|FG008|Overall Study|Lost to Follow-up|4|||
16296654|NCT01986010|39570948|FG009|Overall Study|Lost to Follow-up|2|||
16296655|NCT01986010|39570949|FG010|Overall Study|Lost to Follow-up|0|||
16296656|NCT01986010|39570950|FG011|Overall Study|Lost to Follow-up|1|||
16296657|NCT01986010|39570951|FG012|Overall Study|Lost to Follow-up|1|||
16296658|NCT01986010|39570952|FG013|Overall Study|Lost to Follow-up|1|||
16296659|NCT01986010|39570953|FG014|Overall Study|Lost to Follow-up|2|||
16296660|NCT01986010|39570954|FG015|Overall Study|Lost to Follow-up|0|||
16296661|NCT01986010|39570955|FG016|Overall Study|Lost to Follow-up|0|||
16296662|NCT01986010|39570939|FG000|Overall Study|Physician Decision|0|||
16296663|NCT01986010|39570940|FG001|Overall Study|Physician Decision|0|||
16296664|NCT01986010|39570941|FG002|Overall Study|Physician Decision|0|||
16296665|NCT01986010|39570942|FG003|Overall Study|Physician Decision|0|||
16296666|NCT01986010|39570943|FG004|Overall Study|Physician Decision|0|||
16296667|NCT01986010|39570944|FG005|Overall Study|Physician Decision|0|||
16296668|NCT01986010|39570945|FG006|Overall Study|Physician Decision|0|||
16296669|NCT01986010|39570946|FG007|Overall Study|Physician Decision|0|||
16296670|NCT01986010|39570947|FG008|Overall Study|Physician Decision|0|||
16296671|NCT01986010|39570948|FG009|Overall Study|Physician Decision|0|||
16296672|NCT01986010|39570949|FG010|Overall Study|Physician Decision|0|||
16296673|NCT01986010|39570950|FG011|Overall Study|Physician Decision|0|||
16296674|NCT01986010|39570951|FG012|Overall Study|Physician Decision|0|||
16383670|NCT04388826|39888582|FG001|Overall Study|Lost to Follow-up|2|||
16487233|NCT03572062|40259722|FG001|Overall Study|Death|0|||
16487234|NCT03572062|40259723|FG002|Overall Study|Death|0|||
16487235|NCT03572062|40259724|FG003|Overall Study|Death|0|||
16487236|NCT03572062|40259725|FG004|Overall Study|Death|0|||
16487237|NCT03572062|40259726|FG005|Overall Study|Death|1|||
16487238|NCT03572062|40259727|FG006|Overall Study|Death|0|||
16487239|NCT03572062|40259728|FG007|Overall Study|Death|0|||
16487240|NCT03572062|40259729|FG008|Overall Study|Death|0|||
16487241|NCT03572062|40259730|FG009|Overall Study|Death|0|||
16487242|NCT03572062|40259721|FG000|Overall Study|Lost to Follow-up|0|||
16487243|NCT03572062|40259722|FG001|Overall Study|Lost to Follow-up|0|||
16487244|NCT03572062|40259723|FG002|Overall Study|Lost to Follow-up|0|||
16487245|NCT03572062|40259724|FG003|Overall Study|Lost to Follow-up|0|||
16487246|NCT03572062|40259725|FG004|Overall Study|Lost to Follow-up|0|||
16487247|NCT03572062|40259726|FG005|Overall Study|Lost to Follow-up|1|||
16487248|NCT03572062|40259727|FG006|Overall Study|Lost to Follow-up|1|||
16487249|NCT03572062|40259728|FG007|Overall Study|Lost to Follow-up|0|||
16487250|NCT03572062|40259729|FG008|Overall Study|Lost to Follow-up|0|||
16487251|NCT03572062|40259730|FG009|Overall Study|Lost to Follow-up|0|||
16487252|NCT03572062|40259721|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16487253|NCT03572062|40259722|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16487254|NCT03572062|40259723|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
16487255|NCT03572062|40259724|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
16487256|NCT03572062|40259725|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
16487257|NCT03572062|40259726|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
16487258|NCT03572062|40259727|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
16487259|NCT03572062|40259728|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
16296675|NCT01986010|39570952|FG013|Overall Study|Physician Decision|0|||
16487260|NCT03572062|40259729|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
16383671|NCT04388826|39888581|FG000|Overall Study|Adverse Event|1|||
16383672|NCT04388826|39888582|FG001|Overall Study|Adverse Event|0|||
16383673|NCT00657267|39888586|FG000|Overall Study|Progressive disease|45|||
16296676|NCT01986010|39570953|FG014|Overall Study|Physician Decision|1|||
16296677|NCT01986010|39570954|FG015|Overall Study|Physician Decision|0|||
16296678|NCT01986010|39570955|FG016|Overall Study|Physician Decision|0|||
16296679|NCT01986010|39570939|FG000|Overall Study|Withdrawal by Subject|2|||
16296680|NCT01986010|39570940|FG001|Overall Study|Withdrawal by Subject|2|||
16296681|NCT01986010|39570941|FG002|Overall Study|Withdrawal by Subject|3|||
16296682|NCT01986010|39570942|FG003|Overall Study|Withdrawal by Subject|0|||
16296683|NCT01986010|39570943|FG004|Overall Study|Withdrawal by Subject|2|||
16296684|NCT01986010|39570944|FG005|Overall Study|Withdrawal by Subject|4|||
16296685|NCT01986010|39570945|FG006|Overall Study|Withdrawal by Subject|0|||
16296686|NCT01986010|39570946|FG007|Overall Study|Withdrawal by Subject|0|||
16296687|NCT01986010|39570947|FG008|Overall Study|Withdrawal by Subject|0|||
16296688|NCT01986010|39570948|FG009|Overall Study|Withdrawal by Subject|0|||
16296689|NCT01986010|39570949|FG010|Overall Study|Withdrawal by Subject|0|||
16296690|NCT01986010|39570950|FG011|Overall Study|Withdrawal by Subject|2|||
16296691|NCT01986010|39570951|FG012|Overall Study|Withdrawal by Subject|0|||
16296692|NCT01986010|39570952|FG013|Overall Study|Withdrawal by Subject|1|||
16296693|NCT01986010|39570953|FG014|Overall Study|Withdrawal by Subject|2|||
16296694|NCT01986010|39570954|FG015|Overall Study|Withdrawal by Subject|0|||
16296695|NCT01986010|39570955|FG016|Overall Study|Withdrawal by Subject|0|||
16383674|NCT00657267|39888586|FG000|Overall Study|Adverse Event|9|||
16383675|NCT03283241|39888587|FG000|Overall Study|Adverse Event|4|||
16383676|NCT03283241|39888588|FG001|Overall Study|Adverse Event|1|||
16383677|NCT03283241|39888587|FG000|Overall Study|Withdrawal by Subject|0|||
16383678|NCT03283241|39888588|FG001|Overall Study|Withdrawal by Subject|1|||
16383679|NCT03283241|39888587|FG000|Overall Study|Subject relocated to Finland|0|||
16383680|NCT03283241|39888588|FG001|Overall Study|Subject relocated to Finland|1|||
16383681|NCT00730886|39888589|FG000|Overall Study|Lost to Follow-up|1|||
16383682|NCT00730886|39888590|FG001|Overall Study|Lost to Follow-up|0|||
16383683|NCT00730886|39888589|FG000|Overall Study|Physician Decision|1|||
16383684|NCT00730886|39888590|FG001|Overall Study|Physician Decision|0|||
16383685|NCT04976777|39888591|FG000|Overall Study|COVID-19 Infection|1|||
16383686|NCT04976777|39888592|FG001|Overall Study|COVID-19 Infection|0|||
16383687|NCT01696643|39888594|FG000|Overall Study|Adverse Event|15|||
16383688|NCT01696643|39888595|FG001|Overall Study|Adverse Event|7|||
16383689|NCT01696643|39888594|FG000|Overall Study|Death|1|||
16383690|NCT01696643|39888595|FG001|Overall Study|Death|2|||
16383691|NCT01696643|39888594|FG000|Overall Study|Lack of Efficacy|3|||
16383692|NCT01696643|39888595|FG001|Overall Study|Lack of Efficacy|0|||
16383693|NCT01696643|39888594|FG000|Overall Study|Lost to Follow-up|67|||
16383694|NCT01696643|39888595|FG001|Overall Study|Lost to Follow-up|67|||
16383695|NCT01696643|39888594|FG000|Overall Study|Physician Decision|3|||
16383696|NCT01696643|39888595|FG001|Overall Study|Physician Decision|2|||
16383697|NCT01696643|39888594|FG000|Overall Study|Pregnancy|0|||
16383698|NCT01696643|39888595|FG001|Overall Study|Pregnancy|1|||
16487261|NCT03572062|40259730|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
16487262|NCT03572062|40259721|FG000|Overall Study|Study Terminated By Sponsor|0|||
16487263|NCT03572062|40259722|FG001|Overall Study|Study Terminated By Sponsor|0|||
16487264|NCT03572062|40259723|FG002|Overall Study|Study Terminated By Sponsor|0|||
16487265|NCT03572062|40259724|FG003|Overall Study|Study Terminated By Sponsor|0|||
16487266|NCT03572062|40259725|FG004|Overall Study|Study Terminated By Sponsor|0|||
16487267|NCT03572062|40259726|FG005|Overall Study|Study Terminated By Sponsor|0|||
16487268|NCT03572062|40259727|FG006|Overall Study|Study Terminated By Sponsor|0|||
16487269|NCT03572062|40259728|FG007|Overall Study|Study Terminated By Sponsor|0|||
16487270|NCT03572062|40259729|FG008|Overall Study|Study Terminated By Sponsor|29|||
16487271|NCT03572062|40259730|FG009|Overall Study|Study Terminated By Sponsor|27|||
16487272|NCT03572062|40259721|FG000|Overall Study|Physician Decision|0|||
16487273|NCT03572062|40259722|FG001|Overall Study|Physician Decision|0|||
16487274|NCT03572062|40259723|FG002|Overall Study|Physician Decision|0|||
16487275|NCT03572062|40259724|FG003|Overall Study|Physician Decision|0|||
16487276|NCT03572062|40259725|FG004|Overall Study|Physician Decision|0|||
16487277|NCT03572062|40259726|FG005|Overall Study|Physician Decision|0|||
16487278|NCT03572062|40259727|FG006|Overall Study|Physician Decision|0|||
16487279|NCT03572062|40259728|FG007|Overall Study|Physician Decision|0|||
16383699|NCT01696643|39888594|FG000|Overall Study|Protocol Violation|7|||
16383700|NCT01696643|39888595|FG001|Overall Study|Protocol Violation|7|||
16383701|NCT01696643|39888594|FG000|Overall Study|Study Terminated by Sponsor|286|||
16383702|NCT01696643|39888595|FG001|Overall Study|Study Terminated by Sponsor|294|||
16383703|NCT01696643|39888594|FG000|Overall Study|Withdrawal by Subject|142|||
16383704|NCT01696643|39888595|FG001|Overall Study|Withdrawal by Subject|149|||
16383705|NCT01696643|39888594|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
16383706|NCT01696643|39888595|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
16383707|NCT01696643|39888594|FG000|Overall Study|Site Error|2|||
16487280|NCT03572062|40259729|FG008|Overall Study|Physician Decision|1|||
16487281|NCT03572062|40259730|FG009|Overall Study|Physician Decision|0|||
16383708|NCT01696643|39888595|FG001|Overall Study|Site Error|1|||
16383709|NCT01696643|39888594|FG000|Overall Study|Participant Incarcerated|0|||
16383710|NCT01696643|39888595|FG001|Overall Study|Participant Incarcerated|1|||
16383711|NCT01696643|39888594|FG000|Overall Study|Medical Monitor Decision|0|||
16383712|NCT01696643|39888595|FG001|Overall Study|Medical Monitor Decision|2|||
16296696|NCT01986010|39570939|FG000|Overall Study|Status Not Recorded|2|||
16296697|NCT01986010|39570940|FG001|Overall Study|Status Not Recorded|4|||
16296698|NCT01986010|39570941|FG002|Overall Study|Status Not Recorded|2|||
16296699|NCT01986010|39570942|FG003|Overall Study|Status Not Recorded|0|||
16296700|NCT01986010|39570943|FG004|Overall Study|Status Not Recorded|1|||
16296701|NCT01986010|39570944|FG005|Overall Study|Status Not Recorded|2|||
16296702|NCT01986010|39570945|FG006|Overall Study|Status Not Recorded|0|||
16296703|NCT01986010|39570946|FG007|Overall Study|Status Not Recorded|0|||
16296704|NCT01986010|39570947|FG008|Overall Study|Status Not Recorded|2|||
16296705|NCT01986010|39570948|FG009|Overall Study|Status Not Recorded|1|||
16296706|NCT01986010|39570949|FG010|Overall Study|Status Not Recorded|7|||
16296707|NCT01986010|39570950|FG011|Overall Study|Status Not Recorded|7|||
16296708|NCT01986010|39570951|FG012|Overall Study|Status Not Recorded|9|||
16296709|NCT01986010|39570952|FG013|Overall Study|Status Not Recorded|9|||
16296710|NCT01986010|39570953|FG014|Overall Study|Status Not Recorded|5|||
16296711|NCT01986010|39570954|FG015|Overall Study|Status Not Recorded|10|||
16296712|NCT01986010|39570955|FG016|Overall Study|Status Not Recorded|4|||
16296713|NCT04271735|39570963|FG000|Overall Study|Physician Decision|2|||
16296714|NCT04271735|39570964|FG001|Overall Study|Physician Decision|0|||
16296715|NCT00849186|39570970|FG000|Overall Study|Adverse Event|2|||
16296716|NCT00849186|39570970|FG000|Overall Study|Withdrawal by Subject|1|||
16296717|NCT00849186|39570970|FG000|Overall Study|not treated|6|||
16296718|NCT00849186|39570970|FG000|Overall Study|Other|1|||
16296719|NCT00144781|39570971|FG000|Overall Study|Adverse Event|0|||
16296720|NCT00144781|39570972|FG001|Overall Study|Adverse Event|1|||
16296721|NCT00144781|39570973|FG002|Overall Study|Adverse Event|0|||
16296722|NCT00144781|39570974|FG003|Overall Study|Adverse Event|0|||
16296723|NCT00144781|39570971|FG000|Overall Study|Non-compliant|0|||
16296724|NCT00144781|39570972|FG001|Overall Study|Non-compliant|1|||
16296725|NCT00144781|39570973|FG002|Overall Study|Non-compliant|0|||
16296726|NCT00144781|39570974|FG003|Overall Study|Non-compliant|0|||
16296727|NCT02605993|39570982|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
16296728|NCT02605993|39570983|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
16296729|NCT02605993|39570984|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
16296730|NCT02605993|39570985|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
16296731|NCT03084367|39570988|FG000|Overall Study|Lost to Follow-up|32|||
16296732|NCT03084367|39570988|FG000|Overall Study|Withdrawal by Subject|4|||
16296733|NCT03084367|39570988|FG000|Overall Study|Other|1|||
16296734|NCT02006628|39570989|FG000|Overall Study|Adverse Event|1|||
16296735|NCT02006628|39570990|FG001|Overall Study|Adverse Event|1|||
16296736|NCT02006628|39570989|FG000|Overall Study|Withdrawal by Subject|2|||
16296737|NCT02006628|39570990|FG001|Overall Study|Withdrawal by Subject|1|||
16296738|NCT04740814|39570991|FG000|Overall Study|Adverse Event|3|||
16296739|NCT04740814|39570991|FG000|Overall Study|Protocol Violation|2|||
16296740|NCT04740814|39570991|FG000|Overall Study|Lost to Follow-up|2|||
16296741|NCT04740814|39570991|FG000|Overall Study|Withdrawal by Subject|3|||
16296742|NCT01753297|39570995|FG000|Overall Study|Lost to Follow-up|7|||
16296743|NCT01753297|39570996|FG001|Overall Study|Lost to Follow-up|2|||
16296744|NCT01753297|39570995|FG000|Overall Study|Withdrawal by Subject|26|||
16296745|NCT01753297|39570996|FG001|Overall Study|Withdrawal by Subject|23|||
16296746|NCT01753297|39570995|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
16296747|NCT01753297|39570996|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
16296748|NCT01753297|39570995|FG000|Overall Study|Death|0|||
16296749|NCT01753297|39570996|FG001|Overall Study|Death|2|||
16296750|NCT01753297|39570995|FG000|Overall Study|Did not attend end of study visit|7|||
16296751|NCT01753297|39570996|FG001|Overall Study|Did not attend end of study visit|8|||
16296752|NCT01502410|39571000|FG000|Overall Study|Adverse Event|1|||
16296753|NCT01502410|39571001|FG001|Overall Study|Adverse Event|2|||
16383713|NCT01696643|39888594|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
16383714|NCT01696643|39888595|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
16383715|NCT02287610|39888596|FG000|Overall Study|Lost to Follow-up|3|||
16383716|NCT02287610|39888596|FG000|Overall Study|Withdrawal by Subject|8|||
16383717|NCT02287610|39888596|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
16296754|NCT01502410|39571002|FG002|Overall Study|Adverse Event|0|||
16296755|NCT01502410|39571003|FG003|Overall Study|Adverse Event|0|||
16296756|NCT01502410|39571000|FG000|Overall Study|Lack of Efficacy|7|||
16296757|NCT01502410|39571001|FG001|Overall Study|Lack of Efficacy|7|||
16296758|NCT01502410|39571002|FG002|Overall Study|Lack of Efficacy|0|||
16296759|NCT01502410|39571003|FG003|Overall Study|Lack of Efficacy|0|||
16296760|NCT01502410|39571000|FG000|Overall Study|Physician Decision|0|||
16383718|NCT01445847|39888599|FG000|Overall Study|Protocol Violation|13|||
16296761|NCT01502410|39571001|FG001|Overall Study|Physician Decision|1|||
16296762|NCT01502410|39571002|FG002|Overall Study|Physician Decision|0|||
16296763|NCT01502410|39571003|FG003|Overall Study|Physician Decision|0|||
16296764|NCT01502410|39571000|FG000|Overall Study|Withdrawal by Subject|2|||
16296765|NCT01502410|39571001|FG001|Overall Study|Withdrawal by Subject|0|||
16296766|NCT01502410|39571002|FG002|Overall Study|Withdrawal by Subject|0|||
16487282|NCT03572062|40259721|FG000|Overall Study|Withdrawal by Subject|0|||
16487283|NCT03572062|40259722|FG001|Overall Study|Withdrawal by Subject|0|||
16487284|NCT03572062|40259723|FG002|Overall Study|Withdrawal by Subject|0|||
16487285|NCT03572062|40259724|FG003|Overall Study|Withdrawal by Subject|0|||
16487286|NCT03572062|40259725|FG004|Overall Study|Withdrawal by Subject|0|||
16487287|NCT03572062|40259726|FG005|Overall Study|Withdrawal by Subject|0|||
16487288|NCT03572062|40259727|FG006|Overall Study|Withdrawal by Subject|0|||
16487289|NCT03572062|40259728|FG007|Overall Study|Withdrawal by Subject|0|||
16487290|NCT03572062|40259729|FG008|Overall Study|Withdrawal by Subject|0|||
16487291|NCT03572062|40259730|FG009|Overall Study|Withdrawal by Subject|1|||
16487292|NCT03572062|40259721|FG000|Overall Study|Randomized But Not Treated|0|||
16487293|NCT03572062|40259722|FG001|Overall Study|Randomized But Not Treated|0|||
16487294|NCT03572062|40259723|FG002|Overall Study|Randomized But Not Treated|0|||
16487295|NCT03572062|40259724|FG003|Overall Study|Randomized But Not Treated|0|||
16487296|NCT03572062|40259725|FG004|Overall Study|Randomized But Not Treated|1|||
16487297|NCT03572062|40259726|FG005|Overall Study|Randomized But Not Treated|2|||
16487298|NCT03572062|40259727|FG006|Overall Study|Randomized But Not Treated|0|||
16487299|NCT03572062|40259728|FG007|Overall Study|Randomized But Not Treated|1|||
16487300|NCT03572062|40259729|FG008|Overall Study|Randomized But Not Treated|0|||
16487301|NCT03572062|40259730|FG009|Overall Study|Randomized But Not Treated|0|||
16487302|NCT04213079|40259731|FG000|Overall Study|Lost to Follow-up|0|||
16487303|NCT04213079|40259732|FG001|Overall Study|Lost to Follow-up|2|||
16487304|NCT01644565|40259734|FG000|Overall Study|Undisclosed Medical History|1|||
16487305|NCT01644565|40259735|FG001|Overall Study|Undisclosed Medical History|0|||
16487306|NCT01644565|40259736|FG002|Overall Study|Undisclosed Medical History|0|||
16487307|NCT01644565|40259737|FG003|Overall Study|Undisclosed Medical History|0|||
16487308|NCT01644565|40259738|FG004|Overall Study|Undisclosed Medical History|0|||
16487309|NCT01644565|40259739|FG005|Overall Study|Undisclosed Medical History|0|||
16487310|NCT01644565|40259740|FG006|Overall Study|Undisclosed Medical History|0|||
16487311|NCT01644565|40259741|FG007|Overall Study|Undisclosed Medical History|0|||
16296767|NCT01502410|39571003|FG003|Overall Study|Withdrawal by Subject|0|||
16296768|NCT02394730|39571006|FG000|Overall Study|Lost to Follow-up|1|||
16296769|NCT02394730|39571007|FG001|Overall Study|Lost to Follow-up|0|||
16296770|NCT02394730|39571006|FG000|Overall Study|Withdrawal by Subject|0|||
16296771|NCT02394730|39571007|FG001|Overall Study|Withdrawal by Subject|1|||
16296772|NCT00619112|39571009|FG000|Overall Study|Adverse Event|1|||
16296773|NCT00619112|39571010|FG001|Overall Study|Adverse Event|2|||
16296774|NCT04669691|39571011|FG000|Overall Study|Death|0|||
16487312|NCT01644565|40259742|FG008|Overall Study|Undisclosed Medical History|0|||
16487313|NCT01644565|40259734|FG000|Overall Study|Lost to Follow-up|0|||
16487314|NCT01644565|40259735|FG001|Overall Study|Lost to Follow-up|0|||
16487315|NCT01644565|40259736|FG002|Overall Study|Lost to Follow-up|0|||
16487316|NCT01644565|40259737|FG003|Overall Study|Lost to Follow-up|1|||
16487317|NCT01644565|40259738|FG004|Overall Study|Lost to Follow-up|0|||
16487318|NCT01644565|40259739|FG005|Overall Study|Lost to Follow-up|0|||
16487319|NCT01644565|40259740|FG006|Overall Study|Lost to Follow-up|0|||
16487320|NCT01644565|40259741|FG007|Overall Study|Lost to Follow-up|2|||
16487321|NCT01644565|40259742|FG008|Overall Study|Lost to Follow-up|0|||
16487322|NCT01644565|40259734|FG000|Overall Study|Family emergency|0|||
16487323|NCT01644565|40259735|FG001|Overall Study|Family emergency|0|||
16487324|NCT01644565|40259736|FG002|Overall Study|Family emergency|0|||
16487325|NCT01644565|40259737|FG003|Overall Study|Family emergency|0|||
16487326|NCT01644565|40259738|FG004|Overall Study|Family emergency|1|||
16487327|NCT01644565|40259739|FG005|Overall Study|Family emergency|0|||
16487328|NCT01644565|40259740|FG006|Overall Study|Family emergency|0|||
16487329|NCT01644565|40259741|FG007|Overall Study|Family emergency|0|||
16487330|NCT01644565|40259742|FG008|Overall Study|Family emergency|0|||
16487331|NCT01644565|40259734|FG000|Overall Study|Relocation|0|||
16082952|NCT00826280|38796130|FG000|Overall Study|Sponsor discontinued subject or study|1|||
16082953|NCT00826280|38796131|FG001|Overall Study|Sponsor discontinued subject or study|0|||
16487332|NCT01644565|40259735|FG001|Overall Study|Relocation|0|||
16487333|NCT01644565|40259736|FG002|Overall Study|Relocation|0|||
16487334|NCT01644565|40259737|FG003|Overall Study|Relocation|0|||
16487335|NCT01644565|40259738|FG004|Overall Study|Relocation|0|||
16487336|NCT01644565|40259739|FG005|Overall Study|Relocation|0|||
16487337|NCT01644565|40259740|FG006|Overall Study|Relocation|0|||
16487338|NCT01644565|40259741|FG007|Overall Study|Relocation|0|||
16296775|NCT04669691|39571012|FG001|Overall Study|Death|1|||
16296776|NCT04669691|39571013|FG002|Overall Study|Death|0|||
16296777|NCT04669691|39571014|FG003|Overall Study|Death|0|||
16296778|NCT04669691|39571015|FG004|Overall Study|Death|0|||
16296779|NCT04669691|39571016|FG005|Overall Study|Death|0|||
16296780|NCT00837473|39571017|FG000|Overall Study|Lost to Follow-up|1|||
16487339|NCT01644565|40259742|FG008|Overall Study|Relocation|1|||
16487340|NCT02985957|40259747|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16487341|NCT02985957|40259748|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16487342|NCT02985957|40259749|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16487343|NCT02985957|40259750|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16487344|NCT02985957|40259751|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16487345|NCT02985957|40259752|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16487346|NCT02985957|40259753|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16296781|NCT00837473|39571017|FG000|Overall Study|Withdrawal by Subject|2|||
16296782|NCT04581369|39571018|FG000|Overall Study|Death|7|||
16296783|NCT04581369|39571019|FG001|Overall Study|Death|6|||
16296784|NCT04581369|39571020|FG002|Overall Study|Death|0|||
16296785|NCT04581369|39571018|FG000|Overall Study|Lost to Follow-up|7|||
16296786|NCT04581369|39571019|FG001|Overall Study|Lost to Follow-up|3|||
16296787|NCT04581369|39571020|FG002|Overall Study|Lost to Follow-up|0|||
16296788|NCT04581369|39571018|FG000|Overall Study|liver transplant|2|||
16296789|NCT04581369|39571019|FG001|Overall Study|liver transplant|2|||
16296790|NCT04581369|39571020|FG002|Overall Study|liver transplant|0|||
16296791|NCT04581369|39571018|FG000|Overall Study|transitioned to hospice care|0|||
16296792|NCT04581369|39571019|FG001|Overall Study|transitioned to hospice care|5|||
16296793|NCT04581369|39571020|FG002|Overall Study|transitioned to hospice care|0|||
16296794|NCT02397408|39571026|FG000|Overall Study|Physician Decision|4|||
16296795|NCT02397408|39571026|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
16296796|NCT01468818|39573890|FG000|Overall Study|Death during treatment|2|||
16296797|NCT00265395|39573896|FG000|Overall Study|Adverse Event|3|||
16296798|NCT00265395|39573897|FG001|Overall Study|Adverse Event|6|||
16296799|NCT00265395|39573896|FG000|Overall Study|Lost to Follow-up|2|||
16296800|NCT00265395|39573897|FG001|Overall Study|Lost to Follow-up|1|||
16296801|NCT00265395|39573896|FG000|Overall Study|Withdrawal by Subject|1|||
16296802|NCT00265395|39573897|FG001|Overall Study|Withdrawal by Subject|6|||
16296803|NCT00265395|39573896|FG000|Overall Study|Protocol Violation|2|||
16296804|NCT00265395|39573897|FG001|Overall Study|Protocol Violation|2|||
16383719|NCT01445847|39888600|FG001|Overall Study|Protocol Violation|14|||
16383720|NCT01445847|39888599|FG000|Overall Study|Missed Data|1|||
16383721|NCT01445847|39888600|FG001|Overall Study|Missed Data|0|||
16383722|NCT01822925|39888605|FG000|Overall Study|Adverse Event|1|||
16487347|NCT02985957|40259747|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
16487348|NCT02985957|40259748|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
16487349|NCT02985957|40259749|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
16487350|NCT02985957|40259750|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
16487351|NCT02985957|40259751|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
16487352|NCT02985957|40259752|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
16487353|NCT02985957|40259753|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
16487354|NCT02985957|40259747|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
16487355|NCT02985957|40259748|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
16487356|NCT02985957|40259749|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
16487357|NCT02985957|40259750|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
16487358|NCT02985957|40259751|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
16487359|NCT02985957|40259752|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
16487360|NCT02985957|40259753|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
16487361|NCT02985957|40259747|FG000|Treatment Period|Death|0|||
16487362|NCT02985957|40259748|FG001|Treatment Period|Death|0|||
16487363|NCT02985957|40259749|FG002|Treatment Period|Death|0|||
16487364|NCT02985957|40259750|FG003|Treatment Period|Death|0|||
16487365|NCT02985957|40259751|FG004|Treatment Period|Death|1|||
16487366|NCT02985957|40259752|FG005|Treatment Period|Death|0|||
16487367|NCT02985957|40259753|FG006|Treatment Period|Death|0|||
16487368|NCT02985957|40259747|FG000|Treatment Period|Participant withdrew consent|0|||
16487369|NCT02985957|40259748|FG001|Treatment Period|Participant withdrew consent|0|||
16296805|NCT00265395|39573896|FG000|Overall Study|Lack of Efficacy|0|||
16383723|NCT01822925|39888606|FG001|Overall Study|Adverse Event|1|||
16383724|NCT01822925|39888607|FG002|Overall Study|Adverse Event|1|||
16383725|NCT01822925|39888608|FG003|Overall Study|Adverse Event|1|||
16487370|NCT02985957|40259749|FG002|Treatment Period|Participant withdrew consent|0|||
16487371|NCT02985957|40259750|FG003|Treatment Period|Participant withdrew consent|1|||
16296806|NCT00265395|39573897|FG001|Overall Study|Lack of Efficacy|1|||
16296807|NCT00265395|39573896|FG000|Overall Study|Administrative|0|||
16296808|NCT00265395|39573897|FG001|Overall Study|Administrative|1|||
16296809|NCT04112173|39573900|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
16296810|NCT03371459|39573901|FG000|Washout|Lost to Follow-up|0|||
16296811|NCT03371459|39573902|FG001|Washout|Lost to Follow-up|1|||
16383726|NCT01822925|39888605|FG000|Overall Study|Lost to Follow-up|0|||
16487372|NCT02985957|40259751|FG004|Treatment Period|Participant withdrew consent|3|||
16487373|NCT02985957|40259752|FG005|Treatment Period|Participant withdrew consent|0|||
16487374|NCT02985957|40259753|FG006|Treatment Period|Participant withdrew consent|1|||
16487375|NCT02985957|40259747|FG000|Treatment Period|Lost to Follow-up|0|||
16487376|NCT02985957|40259748|FG001|Treatment Period|Lost to Follow-up|0|||
16487377|NCT02985957|40259749|FG002|Treatment Period|Lost to Follow-up|0|||
16487378|NCT02985957|40259750|FG003|Treatment Period|Lost to Follow-up|0|||
16487379|NCT02985957|40259751|FG004|Treatment Period|Lost to Follow-up|1|||
16487380|NCT02985957|40259752|FG005|Treatment Period|Lost to Follow-up|0|||
16296812|NCT01383135|39573904|FG000|Overall Study|Not Scanned / Imaged|1|||
16296813|NCT01383135|39573905|FG001|Overall Study|Not Scanned / Imaged|0|||
16296814|NCT01383135|39573906|FG002|Overall Study|Not Scanned / Imaged|1|||
16296815|NCT01383135|39573907|FG003|Overall Study|Not Scanned / Imaged|0|||
16296816|NCT01119508|39573908|FG000|Overall Study|Adverse Event|56|||
16296817|NCT01119508|39573908|FG000|Overall Study|Withdrawal by Subject|2|||
16296818|NCT01119508|39573908|FG000|Overall Study|Died before tumor response evaluation|1|||
16296819|NCT01908816|39573910|FG000|Overall Study|Subject's no longer requires study drug|0|||
16487381|NCT02985957|40259753|FG006|Treatment Period|Lost to Follow-up|0|||
16487382|NCT02985957|40259747|FG000|Treatment Period|Other reasons|0|||
16487383|NCT02985957|40259748|FG001|Treatment Period|Other reasons|0|||
16189211|NCT02577406|39169593|FG000|Randomized Period|Other reasons|0|||
16296820|NCT01908816|39573911|FG001|Overall Study|Subject's no longer requires study drug|0|||
16346242|NCT01615029|39753265|FG000|Overall Study|Progressive disease|2|||
16346243|NCT01615029|39753266|FG001|Overall Study|Progressive disease|1|||
16346244|NCT01615029|39753267|FG002|Overall Study|Progressive disease|1|||
16346245|NCT01615029|39753268|FG003|Overall Study|Progressive disease|1|||
16346246|NCT01615029|39753269|FG004|Overall Study|Progressive disease|5|||
16346247|NCT01615029|39753265|FG000|Overall Study|Physician Decision|0|||
16346248|NCT01615029|39753266|FG001|Overall Study|Physician Decision|0|||
16346249|NCT01615029|39753267|FG002|Overall Study|Physician Decision|0|||
16346250|NCT01615029|39753268|FG003|Overall Study|Physician Decision|0|||
16346251|NCT01615029|39753269|FG004|Overall Study|Physician Decision|1|||
16346252|NCT01615029|39753265|FG000|Overall Study|Ongoing|1|||
16346253|NCT01615029|39753266|FG001|Overall Study|Ongoing|2|||
16346254|NCT01615029|39753267|FG002|Overall Study|Ongoing|3|||
16346255|NCT01615029|39753268|FG003|Overall Study|Ongoing|2|||
16346256|NCT01615029|39753269|FG004|Overall Study|Ongoing|23|||
16296821|NCT01908816|39573912|FG002|Overall Study|Subject's no longer requires study drug|0|||
16296822|NCT01908816|39573913|FG003|Overall Study|Subject's no longer requires study drug|1|||
16296823|NCT01908816|39573910|FG000|Overall Study|Protocol deviation|1|||
16296824|NCT01908816|39573911|FG001|Overall Study|Protocol deviation|2|||
16296825|NCT01908816|39573912|FG002|Overall Study|Protocol deviation|1|||
16296826|NCT01908816|39573913|FG003|Overall Study|Protocol deviation|1|||
16296827|NCT01908816|39573910|FG000|Overall Study|Withdrawal by Subject|0|||
16296828|NCT01908816|39573911|FG001|Overall Study|Withdrawal by Subject|4|||
16296829|NCT01908816|39573912|FG002|Overall Study|Withdrawal by Subject|2|||
16296830|NCT01908816|39573913|FG003|Overall Study|Withdrawal by Subject|2|||
16296831|NCT01908816|39573910|FG000|Overall Study|Lost to Follow-up|3|||
16383727|NCT01822925|39888606|FG001|Overall Study|Lost to Follow-up|1|||
16487384|NCT02985957|40259749|FG002|Treatment Period|Other reasons|1|||
16487385|NCT02985957|40259750|FG003|Treatment Period|Other reasons|3|||
16487386|NCT02985957|40259751|FG004|Treatment Period|Other reasons|6|||
16487387|NCT02985957|40259752|FG005|Treatment Period|Other reasons|0|||
16487388|NCT02985957|40259753|FG006|Treatment Period|Other reasons|1|||
16487389|NCT02985957|40259747|FG000|Treatment Period|Not reported|0|||
16487390|NCT02985957|40259748|FG001|Treatment Period|Not reported|1|||
16296832|NCT01908816|39573911|FG001|Overall Study|Lost to Follow-up|5|||
16296833|NCT01908816|39573912|FG002|Overall Study|Lost to Follow-up|4|||
16296834|NCT01908816|39573913|FG003|Overall Study|Lost to Follow-up|2|||
16296835|NCT01908816|39573910|FG000|Overall Study|Death|1|||
16296836|NCT01908816|39573911|FG001|Overall Study|Death|0|||
16296837|NCT01908816|39573912|FG002|Overall Study|Death|7|||
16296838|NCT01908816|39573913|FG003|Overall Study|Death|1|||
16296839|NCT01908816|39573910|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16296840|NCT01908816|39573911|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
16296841|NCT01908816|39573912|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
16296842|NCT01908816|39573913|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
16296843|NCT01908816|39573910|FG000|Overall Study|Early termination|87|||
16296844|NCT01908816|39573911|FG001|Overall Study|Early termination|60|||
16296845|NCT01908816|39573912|FG002|Overall Study|Early termination|43|||
16296846|NCT01908816|39573913|FG003|Overall Study|Early termination|28|||
16296847|NCT03822832|39573919|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
16296848|NCT03822832|39573920|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
16487391|NCT02985957|40259749|FG002|Treatment Period|Not reported|2|||
16296849|NCT03822832|39573919|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
16296850|NCT03822832|39573920|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
16296851|NCT03822832|39573919|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
16296852|NCT03822832|39573920|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
16487392|NCT02985957|40259750|FG003|Treatment Period|Not reported|5|||
16487393|NCT02985957|40259751|FG004|Treatment Period|Not reported|0|||
16487394|NCT02985957|40259752|FG005|Treatment Period|Not reported|0|||
16487395|NCT02985957|40259753|FG006|Treatment Period|Not reported|0|||
16487396|NCT02985957|40259747|FG000|Treatment Period|Maximum clinical benefit|0|||
16487397|NCT02985957|40259748|FG001|Treatment Period|Maximum clinical benefit|0|||
16487398|NCT02985957|40259749|FG002|Treatment Period|Maximum clinical benefit|1|||
16487399|NCT02985957|40259750|FG003|Treatment Period|Maximum clinical benefit|1|||
16487400|NCT02985957|40259751|FG004|Treatment Period|Maximum clinical benefit|0|||
16487401|NCT02985957|40259752|FG005|Treatment Period|Maximum clinical benefit|0|||
16487402|NCT02985957|40259753|FG006|Treatment Period|Maximum clinical benefit|2|||
16487403|NCT02985957|40259747|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
16487404|NCT02985957|40259748|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
16487405|NCT02985957|40259749|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
16296853|NCT03822832|39573919|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
16296854|NCT03822832|39573920|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
16296855|NCT03822832|39573919|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
16296856|NCT03822832|39573920|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
16296857|NCT03822832|39573919|FG000|Re-allocation|Not re-allocated to open label period|2|||
16296858|NCT03822832|39573920|FG001|Re-allocation|Not re-allocated to open label period|6|||
16296859|NCT03822832|39573919|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
16296860|NCT03822832|39573920|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
16296861|NCT03822832|39573919|FG000|Period 2 - Open Label Period|Adverse Event|0|||
16296862|NCT03822832|39573920|FG001|Period 2 - Open Label Period|Adverse Event|3|||
16296863|NCT00928707|39573921|FG000|Overall Study|Protocol Violation|1|||
16296864|NCT00928707|39573922|FG001|Overall Study|Protocol Violation|0|||
16296865|NCT01094886|39573923|FG000|Overall Study|Adverse Event|2|||
16296866|NCT01094886|39573923|FG000|Overall Study|Withdrawal by Subject|5|||
16296867|NCT01844856|39573926|FG000|Overall Study|Lost to Follow-up|15|||
16296868|NCT01844856|39573927|FG001|Overall Study|Lost to Follow-up|3|||
16296869|NCT01844856|39573926|FG000|Overall Study|Adverse Event|3|||
16296870|NCT01844856|39573927|FG001|Overall Study|Adverse Event|6|||
16296871|NCT01844856|39573926|FG000|Overall Study|Withdrawal by Subject|3|||
16383728|NCT01822925|39888607|FG002|Overall Study|Lost to Follow-up|0|||
16487406|NCT02985957|40259750|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
16487407|NCT02985957|40259751|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
16296872|NCT01844856|39573927|FG001|Overall Study|Withdrawal by Subject|2|||
16296873|NCT01844856|39573926|FG000|Overall Study|Noncompliance|2|||
16296874|NCT01844856|39573927|FG001|Overall Study|Noncompliance|3|||
16296875|NCT01844856|39573926|FG000|Overall Study|Enterococcus Resistant|0|||
16296876|NCT01844856|39573927|FG001|Overall Study|Enterococcus Resistant|1|||
16296877|NCT01844856|39573926|FG000|Overall Study|Inadvertently Not Scheduled|1|||
16487408|NCT02985957|40259752|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
16487409|NCT02985957|40259753|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
16487410|NCT02985957|40259747|FG000|Treatment Period|Study drug toxicity|1|||
16487411|NCT02985957|40259748|FG001|Treatment Period|Study drug toxicity|23|||
16082954|NCT00826280|38796132|FG002|Overall Study|Sponsor discontinued subject or study|0|||
16082955|NCT00826280|38796130|FG000|Overall Study|Reversible ischemic defect not present|43|||
16082956|NCT00826280|38796131|FG001|Overall Study|Reversible ischemic defect not present|40|||
16082957|NCT00826280|38796132|FG002|Overall Study|Reversible ischemic defect not present|44|||
16082958|NCT00826280|38796130|FG000|Overall Study|Interpretation Failure|1|||
16082959|NCT00826280|38796131|FG001|Overall Study|Interpretation Failure|0|||
16487412|NCT02985957|40259749|FG002|Treatment Period|Study drug toxicity|20|||
16487413|NCT02985957|40259750|FG003|Treatment Period|Study drug toxicity|11|||
16487414|NCT02985957|40259751|FG004|Treatment Period|Study drug toxicity|19|||
16487415|NCT02985957|40259752|FG005|Treatment Period|Study drug toxicity|3|||
16487416|NCT02985957|40259753|FG006|Treatment Period|Study drug toxicity|5|||
16487417|NCT02985957|40259747|FG000|Treatment Period|Disease progression|0|||
16487418|NCT02985957|40259748|FG001|Treatment Period|Disease progression|16|||
16487419|NCT02985957|40259749|FG002|Treatment Period|Disease progression|20|||
16487420|NCT02985957|40259750|FG003|Treatment Period|Disease progression|39|||
16487421|NCT02985957|40259751|FG004|Treatment Period|Disease progression|29|||
16487422|NCT02985957|40259752|FG005|Treatment Period|Disease progression|11|||
16487423|NCT02985957|40259753|FG006|Treatment Period|Disease progression|28|||
16487424|NCT02985957|40259747|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
16487425|NCT02985957|40259748|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
16487426|NCT02985957|40259749|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
16487427|NCT02985957|40259750|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
16487428|NCT02985957|40259751|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
16487429|NCT02985957|40259752|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
16487430|NCT02985957|40259753|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
16487431|NCT02985957|40259747|FG000|Treatment Period|Poor/Non-Compliance|0|||
16487432|NCT02985957|40259748|FG001|Treatment Period|Poor/Non-Compliance|0|||
16487433|NCT02985957|40259749|FG002|Treatment Period|Poor/Non-Compliance|0|||
16487434|NCT02985957|40259750|FG003|Treatment Period|Poor/Non-Compliance|0|||
16487435|NCT02985957|40259751|FG004|Treatment Period|Poor/Non-Compliance|1|||
16487436|NCT02985957|40259752|FG005|Treatment Period|Poor/Non-Compliance|1|||
16487437|NCT02985957|40259753|FG006|Treatment Period|Poor/Non-Compliance|0|||
16487438|NCT02985957|40259747|FG000|Treatment Period|Continuing in Treatment Period|0|||
16487439|NCT02985957|40259748|FG001|Treatment Period|Continuing in Treatment Period|1|||
16487440|NCT02985957|40259749|FG002|Treatment Period|Continuing in Treatment Period|0|||
16487441|NCT02985957|40259750|FG003|Treatment Period|Continuing in Treatment Period|4|||
16487442|NCT02985957|40259751|FG004|Treatment Period|Continuing in Treatment Period|4|||
16487443|NCT02985957|40259752|FG005|Treatment Period|Continuing in Treatment Period|0|||
16487444|NCT02985957|40259753|FG006|Treatment Period|Continuing in Treatment Period|0|||
16487445|NCT01203098|40259754|FG000|Overall Study|Adverse Event|3|||
16487446|NCT01203098|40259755|FG001|Overall Study|Adverse Event|1|||
16487447|NCT01203098|40259756|FG002|Overall Study|Adverse Event|7|||
16487448|NCT01203098|40259754|FG000|Overall Study|Lost to Follow-up|0|||
16487449|NCT01203098|40259755|FG001|Overall Study|Lost to Follow-up|0|||
16487450|NCT01203098|40259756|FG002|Overall Study|Lost to Follow-up|1|||
16487451|NCT01203098|40259754|FG000|Overall Study|Physician Decision|2|||
16487452|NCT01203098|40259755|FG001|Overall Study|Physician Decision|2|||
16487453|NCT01203098|40259756|FG002|Overall Study|Physician Decision|0|||
16487454|NCT01203098|40259754|FG000|Overall Study|Withdrawal by Subject|1|||
16296878|NCT01844856|39573927|FG001|Overall Study|Inadvertently Not Scheduled|0|||
16487455|NCT01203098|40259755|FG001|Overall Study|Withdrawal by Subject|1|||
16487456|NCT01203098|40259756|FG002|Overall Study|Withdrawal by Subject|3|||
16487457|NCT01756898|40259757|FG000|Overall Study|Adverse Event|7|||
16487458|NCT01756898|40259758|FG001|Overall Study|Adverse Event|1|||
16487459|NCT01756898|40259759|FG002|Overall Study|Adverse Event|0|||
16487460|NCT01756898|40259760|FG003|Overall Study|Adverse Event|0|||
16487461|NCT01756898|40259757|FG000|Overall Study|Lack of Efficacy|4|||
16487462|NCT01756898|40259758|FG001|Overall Study|Lack of Efficacy|7|||
16487463|NCT01756898|40259759|FG002|Overall Study|Lack of Efficacy|6|||
16487464|NCT01756898|40259760|FG003|Overall Study|Lack of Efficacy|6|||
16296879|NCT01844856|39573926|FG000|Overall Study|Randomized but was a Screen Failure|0|||
16487465|NCT01756898|40259757|FG000|Overall Study|Lost to Follow-up|2|||
16487466|NCT01756898|40259758|FG001|Overall Study|Lost to Follow-up|4|||
16487467|NCT01756898|40259759|FG002|Overall Study|Lost to Follow-up|2|||
16487468|NCT01756898|40259760|FG003|Overall Study|Lost to Follow-up|3|||
16487469|NCT01756898|40259757|FG000|Overall Study|Protocol Violation|1|||
16487470|NCT01756898|40259758|FG001|Overall Study|Protocol Violation|2|||
16487471|NCT01756898|40259759|FG002|Overall Study|Protocol Violation|2|||
16487472|NCT01756898|40259760|FG003|Overall Study|Protocol Violation|1|||
16189212|NCT02577406|39169594|FG001|Randomized Period|Other reasons|20|||
16189213|NCT02577406|39169593|FG000|Treatment Period|Transition to commercially available treatment|1|||
16189214|NCT02577406|39169594|FG001|Treatment Period|Transition to commercially available treatment|0|||
16189215|NCT02577406|39169593|FG000|Treatment Period|Progressive disease|47|||
16189216|NCT02577406|39169594|FG001|Treatment Period|Progressive disease|36|||
16189217|NCT02577406|39169593|FG000|Treatment Period|Death|36|||
16189218|NCT02577406|39169594|FG001|Treatment Period|Death|23|||
16189219|NCT02577406|39169593|FG000|Treatment Period|Other reasons|3|||
16189220|NCT02577406|39169594|FG001|Treatment Period|Other reasons|37|||
16189221|NCT02577406|39169593|FG000|Treatment Period|Withdrawal by Subject|10|||
16189222|NCT02577406|39169594|FG001|Treatment Period|Withdrawal by Subject|24|||
16189223|NCT02577406|39169593|FG000|Treatment Period|Adverse Event|17|||
16189224|NCT02577406|39169594|FG001|Treatment Period|Adverse Event|12|||
16296880|NCT01844856|39573927|FG001|Overall Study|Randomized but was a Screen Failure|1|||
16487473|NCT01756898|40259757|FG000|Overall Study|Withdrew Consent|5|||
16487474|NCT01756898|40259758|FG001|Overall Study|Withdrew Consent|3|||
16189225|NCT02577406|39169593|FG000|Treatment Period|Disease relapse|27|||
16189226|NCT02577406|39169594|FG001|Treatment Period|Disease relapse|1|||
16487475|NCT01756898|40259759|FG002|Overall Study|Withdrew Consent|5|||
16487476|NCT01756898|40259760|FG003|Overall Study|Withdrew Consent|6|||
16487477|NCT01756898|40259757|FG000|Overall Study|Other|0|||
16487478|NCT01756898|40259758|FG001|Overall Study|Other|2|||
16487479|NCT01756898|40259759|FG002|Overall Study|Other|2|||
16487480|NCT01756898|40259760|FG003|Overall Study|Other|0|||
16189227|NCT02577406|39169593|FG000|Treatment Period|HSCT|6|||
16189228|NCT02577406|39169594|FG001|Treatment Period|HSCT|2|||
16189229|NCT02577406|39169593|FG000|Treatment Period|Lost to Follow-up|0|||
16189230|NCT02577406|39169594|FG001|Treatment Period|Lost to Follow-up|1|||
16189231|NCT02577406|39169593|FG000|Treatment Period|Protocol Violation|0|||
16189232|NCT02577406|39169594|FG001|Treatment Period|Protocol Violation|1|||
16189233|NCT00488033|39169595|FG000|Overall Study|Withdrawal by Subject|1|||
16189234|NCT00488033|39169596|FG001|Overall Study|Withdrawal by Subject|0|||
16189235|NCT03097328|39169597|FG000|Overall Study|Still on Therapy|2|||
16189236|NCT03097328|39169597|FG000|Overall Study|Progressive Disease|29|||
16189237|NCT03097328|39169597|FG000|Overall Study|Adverse Event|4|||
16189238|NCT03097328|39169597|FG000|Overall Study|Withdrawal by Subject|1|||
16189239|NCT03097328|39169597|FG000|Overall Study|Physician Decision|1|||
16189240|NCT03097328|39169597|FG000|Overall Study|Patient Decision|1|||
16189241|NCT03097328|39169597|FG000|Overall Study|Ineligible for Study Drug|1|||
16189242|NCT02739594|39169598|FG000|Overall Study|Undesired Event|3|||
16189243|NCT02739594|39169599|FG001|Overall Study|Undesired Event|4|||
16189244|NCT02739594|39169598|FG000|Overall Study|Violation of Eligibility Criteria|1|||
16189245|NCT02739594|39169599|FG001|Overall Study|Violation of Eligibility Criteria|2|||
16189246|NCT02739594|39169598|FG000|Overall Study|Protocol Violation|5|||
16189247|NCT02739594|39169599|FG001|Overall Study|Protocol Violation|6|||
16189248|NCT02739594|39169598|FG000|Overall Study|Death|4|||
16189249|NCT02739594|39169599|FG001|Overall Study|Death|2|||
16189250|NCT02739594|39169598|FG000|Overall Study|Renal Insufficiency|4|||
16189251|NCT02739594|39169599|FG001|Overall Study|Renal Insufficiency|6|||
16189252|NCT02739594|39169598|FG000|Overall Study|Administrative Reasons|1|||
16189253|NCT02739594|39169599|FG001|Overall Study|Administrative Reasons|3|||
16189254|NCT02739594|39169598|FG000|Overall Study|Withdrawal by Subject|1|||
16189255|NCT02739594|39169599|FG001|Overall Study|Withdrawal by Subject|1|||
16487481|NCT04502693|40259763|FG000|Overall Study|Adverse Event|7|||
16487482|NCT04502693|40259764|FG001|Overall Study|Adverse Event|6|||
16487483|NCT04502693|40259765|FG002|Overall Study|Adverse Event|11|||
16487484|NCT04502693|40259766|FG003|Overall Study|Adverse Event|1|||
16487485|NCT04502693|40259763|FG000|Overall Study|Lost to Follow-up|32|||
16487486|NCT04502693|40259764|FG001|Overall Study|Lost to Follow-up|36|||
16487487|NCT04502693|40259765|FG002|Overall Study|Lost to Follow-up|69|||
16487488|NCT04502693|40259766|FG003|Overall Study|Lost to Follow-up|4|||
16487489|NCT04502693|40259763|FG000|Overall Study|Protocol Violation|8|||
16487490|NCT04502693|40259764|FG001|Overall Study|Protocol Violation|8|||
16487491|NCT04502693|40259765|FG002|Overall Study|Protocol Violation|16|||
16487492|NCT04502693|40259766|FG003|Overall Study|Protocol Violation|1|||
16487493|NCT04502693|40259763|FG000|Overall Study|Withdrawal by Subject|46|||
16487494|NCT04502693|40259764|FG001|Overall Study|Withdrawal by Subject|38|||
16487495|NCT04502693|40259765|FG002|Overall Study|Withdrawal by Subject|54|||
16487496|NCT04502693|40259766|FG003|Overall Study|Withdrawal by Subject|7|||
16487497|NCT04502693|40259763|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
16487498|NCT04502693|40259764|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
16487499|NCT04502693|40259765|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
16487500|NCT04502693|40259766|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16487501|NCT04502693|40259763|FG000|Overall Study|Other|1|||
16487502|NCT04502693|40259764|FG001|Overall Study|Other|0|||
16487503|NCT04502693|40259765|FG002|Overall Study|Other|1|||
16487504|NCT04502693|40259766|FG003|Overall Study|Other|1|||
16487505|NCT00039130|40259767|FG000|Overall Study|Adverse Event|11|||
16487506|NCT00039130|40259767|FG000|Overall Study|Death|9|||
16487507|NCT00039130|40259767|FG000|Overall Study|Withdrawal by Subject|3|||
16487508|NCT00039130|40259767|FG000|Overall Study|Progression|2|||
16487509|NCT00039130|40259767|FG000|Overall Study|Subsequent treatment|2|||
16487510|NCT00039130|40259767|FG000|Overall Study|Physician Decision|3|||
16487511|NCT04189081|40259768|FG000|Overall Study|Lost to Follow-up|1|||
16487512|NCT04189081|40259769|FG001|Overall Study|Lost to Follow-up|0|||
16487513|NCT04189081|40259770|FG002|Overall Study|Lost to Follow-up|0|||
16487514|NCT04189081|40259768|FG000|Overall Study|Withdrawal by Subject|0|||
16189256|NCT02739594|39169598|FG000|Overall Study|Lost to Follow-up|0|||
16189257|NCT02739594|39169599|FG001|Overall Study|Lost to Follow-up|1|||
16189258|NCT02739594|39169598|FG000|Overall Study|Elevated Serum Creatinine|0|||
16189259|NCT02739594|39169599|FG001|Overall Study|Elevated Serum Creatinine|1|||
16189260|NCT02739594|39169598|FG000|Overall Study|Other|6|||
16487515|NCT04189081|40259769|FG001|Overall Study|Withdrawal by Subject|0|||
16487516|NCT04189081|40259770|FG002|Overall Study|Withdrawal by Subject|1|||
16487517|NCT00518284|40259773|FG000|Overall Study|Adverse Event|0|||
16487518|NCT00518284|40259774|FG001|Overall Study|Adverse Event|1|||
16189261|NCT02739594|39169599|FG001|Overall Study|Other|2|||
16487519|NCT00518284|40259775|FG002|Overall Study|Adverse Event|0|||
16487520|NCT00518284|40259776|FG003|Overall Study|Adverse Event|0|||
16487521|NCT00518284|40259773|FG000|Overall Study|Study Termination|0|||
16487522|NCT00518284|40259774|FG001|Overall Study|Study Termination|2|||
16487523|NCT00518284|40259775|FG002|Overall Study|Study Termination|1|||
16487524|NCT00518284|40259776|FG003|Overall Study|Study Termination|2|||
16487525|NCT02578316|40259777|FG000|Extension Phase|Progression of disease|6|||
16487526|NCT01691781|40259778|FG000|Overall Study|Withdrawal by Subject|4|||
16487527|NCT01691781|40259779|FG001|Overall Study|Withdrawal by Subject|3|||
16487528|NCT01691781|40259778|FG000|Overall Study|Physician Decision|1|||
16487529|NCT01691781|40259779|FG001|Overall Study|Physician Decision|1|||
16487530|NCT01691781|40259778|FG000|Overall Study|Protocol Violation|2|||
16487531|NCT01691781|40259779|FG001|Overall Study|Protocol Violation|2|||
16487532|NCT01691781|40259778|FG000|Overall Study|Adverse Event|0|||
16487533|NCT01691781|40259779|FG001|Overall Study|Adverse Event|1|||
16487534|NCT01348165|40259780|FG000|Overall Study|Adverse Event|0|||
16487535|NCT01348165|40259781|FG001|Overall Study|Adverse Event|0|||
16487536|NCT01348165|40259782|FG002|Overall Study|Adverse Event|0|||
16487537|NCT01348165|40259783|FG003|Overall Study|Adverse Event|0|||
16487538|NCT01348165|40259784|FG004|Overall Study|Adverse Event|0|||
16487539|NCT01348165|40259785|FG005|Overall Study|Adverse Event|0|||
16487540|NCT01348165|40259786|FG006|Overall Study|Adverse Event|1|||
16487541|NCT01389817|40259793|FG000|Overall Study|Physician Decision|1|||
16487542|NCT01389817|40259794|FG001|Overall Study|Physician Decision|0|||
16487543|NCT01389817|40259793|FG000|Overall Study|Lost to Follow-up|1|||
16487544|NCT01389817|40259794|FG001|Overall Study|Lost to Follow-up|0|||
16487545|NCT01389817|40259793|FG000|Overall Study|Withdrawal by Subject|2|||
16487546|NCT01389817|40259794|FG001|Overall Study|Withdrawal by Subject|0|||
16189262|NCT00524745|39169602|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
16189263|NCT00524745|39169603|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
16189264|NCT00524745|39169604|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
16189265|NCT00524745|39169605|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
16189266|NCT01519245|39169607|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
16189267|NCT01519245|39169608|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
16189268|NCT03041116|39169610|FG000|Double-blind|Death|0|||
16189269|NCT03041116|39169611|FG001|Double-blind|Death|2|||
16189270|NCT03041116|39169610|FG000|Double-blind|Withdrawal by Subject|0|||
16189271|NCT03041116|39169611|FG001|Double-blind|Withdrawal by Subject|4|||
16189272|NCT03041116|39169610|FG000|Open-label|Death|1|||
16189273|NCT03041116|39169611|FG001|Open-label|Death|0|||
16189274|NCT03041116|39169610|FG000|Open-label|Termination of the study by Sponsor|39|||
16189275|NCT03041116|39169611|FG001|Open-label|Termination of the study by Sponsor|37|||
16189276|NCT03041116|39169610|FG000|Open-label|Withdrawal by Subject|1|||
16189277|NCT03041116|39169611|FG001|Open-label|Withdrawal by Subject|0|||
16189278|NCT05094154|39169612|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
16189279|NCT05094154|39169613|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
16189280|NCT05094154|39169612|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
16189281|NCT05094154|39169613|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
16189282|NCT02435277|39169614|FG000|Overall Study|Adverse Event|1|||
16189283|NCT02435277|39169615|FG001|Overall Study|Adverse Event|1|||
16189284|NCT02435277|39169616|FG002|Overall Study|Adverse Event|0|||
16296881|NCT02752087|39573928|FG000|Washout|Physician Decision|1|||
16296882|NCT02752087|39573929|FG001|Washout|Physician Decision|0|||
16296883|NCT03559400|39573930|FG000|Overall Study|Lost to Follow-up|9|||
16487547|NCT01845831|40259796|FG000|Inpatient Phase|Withdrawal by Subject|1|||
16487548|NCT01845831|40259797|FG001|Inpatient Phase|Withdrawal by Subject|1|||
16082960|NCT00826280|38796132|FG002|Overall Study|Interpretation Failure|0|||
16189285|NCT02435277|39169617|FG003|Overall Study|Adverse Event|0|||
16189286|NCT02435277|39169614|FG000|Overall Study|Withdrawal by Subject|1|||
16189287|NCT02435277|39169615|FG001|Overall Study|Withdrawal by Subject|0|||
16189288|NCT02435277|39169616|FG002|Overall Study|Withdrawal by Subject|0|||
16296884|NCT03559400|39573931|FG001|Overall Study|Lost to Follow-up|7|||
16296885|NCT03559400|39573930|FG000|Overall Study|Death|0|||
16487549|NCT01845831|40259798|FG002|Inpatient Phase|Withdrawal by Subject|0|||
16189289|NCT02435277|39169617|FG003|Overall Study|Withdrawal by Subject|0|||
16189290|NCT00149825|39169618|FG000|Overall Study|Intolerance to medication side effects|1|||
16189291|NCT00149825|39169619|FG001|Overall Study|Intolerance to medication side effects|2|||
16189292|NCT00149825|39169618|FG000|Overall Study|Time commitments|2|||
16189293|NCT00149825|39169619|FG001|Overall Study|Time commitments|1|||
16189294|NCT00149825|39169618|FG000|Overall Study|Not liking insomnia therapy|1|||
16189295|NCT00149825|39169619|FG001|Overall Study|Not liking insomnia therapy|0|||
16189296|NCT00149825|39169618|FG000|Overall Study|Other|1|||
16189297|NCT00149825|39169619|FG001|Overall Study|Other|0|||
16189298|NCT03484923|39169620|FG000|Overall Study|Adverse Event|3|||
16189299|NCT03484923|39169621|FG001|Overall Study|Adverse Event|3|||
16189300|NCT03484923|39169622|FG002|Overall Study|Adverse Event|5|||
16189301|NCT03484923|39169623|FG003|Overall Study|Adverse Event|11|||
16189302|NCT03484923|39169624|FG004|Overall Study|Adverse Event|1|||
16189303|NCT03484923|39169620|FG000|Overall Study|Death|2|||
16189304|NCT03484923|39169621|FG001|Overall Study|Death|2|||
16189305|NCT03484923|39169622|FG002|Overall Study|Death|3|||
16189306|NCT03484923|39169623|FG003|Overall Study|Death|0|||
16189307|NCT03484923|39169624|FG004|Overall Study|Death|1|||
16189308|NCT03484923|39169620|FG000|Overall Study|Physician Decision|6|||
16189309|NCT03484923|39169621|FG001|Overall Study|Physician Decision|7|||
16189310|NCT03484923|39169622|FG002|Overall Study|Physician Decision|6|||
16189311|NCT03484923|39169623|FG003|Overall Study|Physician Decision|3|||
16189312|NCT03484923|39169624|FG004|Overall Study|Physician Decision|2|||
16189313|NCT03484923|39169620|FG000|Overall Study|Progressive disease|33|||
16189314|NCT03484923|39169621|FG001|Overall Study|Progressive disease|28|||
16189315|NCT03484923|39169622|FG002|Overall Study|Progressive disease|26|||
16189316|NCT03484923|39169623|FG003|Overall Study|Progressive disease|30|||
16189317|NCT03484923|39169624|FG004|Overall Study|Progressive disease|16|||
16189318|NCT03484923|39169620|FG000|Overall Study|Subject Decision|1|||
16189319|NCT03484923|39169621|FG001|Overall Study|Subject Decision|3|||
16189320|NCT03484923|39169622|FG002|Overall Study|Subject Decision|3|||
16189321|NCT03484923|39169623|FG003|Overall Study|Subject Decision|0|||
16189322|NCT03484923|39169624|FG004|Overall Study|Subject Decision|1|||
16189323|NCT01842620|39169625|FG000|Period 1|Withdrawal by Subject|1|||
16189324|NCT01842620|39169626|FG001|Period 1|Withdrawal by Subject|0|||
16189325|NCT00700752|39169631|FG000|First Intervention|Withdrawal by Subject|0|||
16189326|NCT00700752|39169632|FG001|First Intervention|Withdrawal by Subject|2|||
16189327|NCT01752842|39169633|FG000|Overall Study|Adverse Event|3|||
16189328|NCT01752842|39169634|FG001|Overall Study|Adverse Event|0|||
16189329|NCT01752842|39169633|FG000|Overall Study|Withdrawal by Subject|0|||
16189330|NCT01752842|39169634|FG001|Overall Study|Withdrawal by Subject|2|||
16189331|NCT03552549|39169635|FG000|Overall Study|Disease progression|25|||
16189332|NCT03552549|39169636|FG001|Overall Study|Disease progression|17|||
16189333|NCT03552549|39169635|FG000|Overall Study|Adverse event in first 12 months|12|||
16189334|NCT03552549|39169636|FG001|Overall Study|Adverse event in first 12 months|8|||
16189335|NCT03552549|39169635|FG000|Overall Study|Withdrawal by Subject|7|||
16189336|NCT03552549|39169636|FG001|Overall Study|Withdrawal by Subject|7|||
16189337|NCT03552549|39169635|FG000|Overall Study|Unknown (no reason provided)|4|||
16189338|NCT03552549|39169636|FG001|Overall Study|Unknown (no reason provided)|2|||
16189339|NCT03552549|39169635|FG000|Overall Study|Not in participant's best interest|2|||
16189340|NCT03552549|39169636|FG001|Overall Study|Not in participant's best interest|1|||
16189341|NCT03552549|39169635|FG000|Overall Study|Did not complete study treatment|2|||
16189342|NCT03552549|39169636|FG001|Overall Study|Did not complete study treatment|3|||
16189343|NCT03552549|39169635|FG000|Overall Study|Did not meet eligibility criteria|1|||
16189344|NCT03552549|39169636|FG001|Overall Study|Did not meet eligibility criteria|0|||
16189345|NCT03552549|39169635|FG000|Overall Study|Administrative|0|||
16189346|NCT03552549|39169636|FG001|Overall Study|Administrative|14|||
16189347|NCT03567291|39169644|FG000|Period I|Adverse Event|14|||
16189348|NCT03567291|39169645|FG001|Period I|Adverse Event|0|||
16189349|NCT03567291|39169646|FG002|Period I|Adverse Event|0|||
16189350|NCT03567291|39169647|FG003|Period I|Adverse Event|0|||
16189351|NCT03567291|39169644|FG000|Period I|Protocol Violation|1|||
16189352|NCT03567291|39169645|FG001|Period I|Protocol Violation|0|||
16189353|NCT03567291|39169646|FG002|Period I|Protocol Violation|0|||
16189354|NCT03567291|39169647|FG003|Period I|Protocol Violation|0|||
16189355|NCT03567291|39169644|FG000|Period I|Withdrawal by Subject|23|||
16189356|NCT03567291|39169645|FG001|Period I|Withdrawal by Subject|0|||
16189357|NCT03567291|39169646|FG002|Period I|Withdrawal by Subject|0|||
16189358|NCT03567291|39169647|FG003|Period I|Withdrawal by Subject|0|||
16189359|NCT03567291|39169644|FG000|Period I|Lost to Follow-up|2|||
16189360|NCT03567291|39169645|FG001|Period I|Lost to Follow-up|0|||
16487550|NCT01845831|40259799|FG003|Inpatient Phase|Withdrawal by Subject|0|||
16189361|NCT03567291|39169646|FG002|Period I|Lost to Follow-up|0|||
16189362|NCT03567291|39169647|FG003|Period I|Lost to Follow-up|0|||
16189363|NCT03567291|39169644|FG000|Period I|Terminated by sponsor|44|||
16189364|NCT03567291|39169645|FG001|Period I|Terminated by sponsor|0|||
16189365|NCT03567291|39169646|FG002|Period I|Terminated by sponsor|0|||
16189366|NCT03567291|39169647|FG003|Period I|Terminated by sponsor|0|||
16189367|NCT03567291|39169644|FG000|Period I|Missing or unknown|7|||
16189368|NCT03567291|39169645|FG001|Period I|Missing or unknown|0|||
16189369|NCT03567291|39169646|FG002|Period I|Missing or unknown|0|||
16189370|NCT03567291|39169647|FG003|Period I|Missing or unknown|0|||
16189371|NCT03567291|39169644|FG000|Period II|Adverse Event|0|||
16189372|NCT03567291|39169645|FG001|Period II|Adverse Event|1|||
16189373|NCT03567291|39169646|FG002|Period II|Adverse Event|0|||
16296886|NCT03559400|39573931|FG001|Overall Study|Death|2|||
16296887|NCT00368979|39573933|FG000|Overall Study|Adverse Event|9|||
16383729|NCT01822925|39888608|FG003|Overall Study|Lost to Follow-up|0|||
16383730|NCT01822925|39888605|FG000|Overall Study|Protocol Violation|1|||
16296888|NCT00368979|39573934|FG001|Overall Study|Adverse Event|16|||
16296889|NCT00368979|39573933|FG000|Overall Study|Lack of Efficacy|5|||
16296890|NCT00368979|39573934|FG001|Overall Study|Lack of Efficacy|3|||
16296891|NCT00368979|39573933|FG000|Overall Study|Other|3|||
16296892|NCT00368979|39573934|FG001|Overall Study|Other|1|||
16296893|NCT00368979|39573933|FG000|Overall Study|Lost to Follow-up|1|||
16296894|NCT00368979|39573934|FG001|Overall Study|Lost to Follow-up|0|||
16296895|NCT00368979|39573933|FG000|Overall Study|Protocol Violation|2|||
16296896|NCT00368979|39573934|FG001|Overall Study|Protocol Violation|1|||
16296897|NCT00368979|39573933|FG000|Overall Study|Withdrawal by Subject|5|||
16296898|NCT00368979|39573934|FG001|Overall Study|Withdrawal by Subject|9|||
16296899|NCT01814553|39573935|FG000|Overall Study|PD per clinical progression|6|||
16296900|NCT01814553|39573936|FG001|Overall Study|PD per clinical progression|8|||
16296901|NCT01814553|39573935|FG000|Overall Study|Other Adverse Event|4|||
16296902|NCT01814553|39573936|FG001|Overall Study|Other Adverse Event|5|||
16296903|NCT01814553|39573935|FG000|Overall Study|Withdrawal by Subject|1|||
16296904|NCT01814553|39573936|FG001|Overall Study|Withdrawal by Subject|1|||
16296905|NCT01814553|39573935|FG000|Overall Study|Other than stated|7|||
16296906|NCT01814553|39573936|FG001|Overall Study|Other than stated|8|||
16296907|NCT00307437|39573937|FG000|Controlled Period|Adverse Event|7|||
16296908|NCT00307437|39573938|FG001|Controlled Period|Adverse Event|2|||
16296909|NCT00307437|39573939|FG002|Controlled Period|Adverse Event|5|||
16296910|NCT00307437|39573940|FG003|Controlled Period|Adverse Event|0|||
16383731|NCT01822925|39888606|FG001|Overall Study|Protocol Violation|0|||
16383732|NCT01822925|39888607|FG002|Overall Study|Protocol Violation|0|||
16383733|NCT01822925|39888608|FG003|Overall Study|Protocol Violation|1|||
16383734|NCT01822925|39888605|FG000|Overall Study|Withdrawal by Subject|2|||
16383735|NCT01822925|39888606|FG001|Overall Study|Withdrawal by Subject|0|||
16383736|NCT01822925|39888607|FG002|Overall Study|Withdrawal by Subject|2|||
16383737|NCT01822925|39888608|FG003|Overall Study|Withdrawal by Subject|2|||
16383738|NCT01822925|39888605|FG000|Overall Study|Taking prohibited medication|2|||
16383739|NCT01822925|39888606|FG001|Overall Study|Taking prohibited medication|0|||
16383740|NCT01822925|39888607|FG002|Overall Study|Taking prohibited medication|0|||
16383741|NCT01822925|39888608|FG003|Overall Study|Taking prohibited medication|1|||
16383742|NCT00320606|39888610|FG000|Overall Study|Adverse Event|1|||
16296911|NCT00307437|39573941|FG004|Controlled Period|Adverse Event|0|||
16296912|NCT00307437|39573942|FG005|Controlled Period|Adverse Event|0|||
16296913|NCT00307437|39573943|FG006|Controlled Period|Adverse Event|0|||
16383743|NCT00320606|39888610|FG000|Overall Study|Protocol Violation|1|||
16383744|NCT00320606|39888610|FG000|Overall Study|Withdrawal by Subject|1|||
16383745|NCT01170663|39888611|FG000|Overall Study|Lost to Follow-up|3|||
16383746|NCT01170663|39888612|FG001|Overall Study|Lost to Follow-up|9|||
16383747|NCT01170663|39888611|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
16383748|NCT01170663|39888612|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
16383749|NCT03342560|39888619|FG000|Overall Study|Lost to Follow-up|2|||
16383750|NCT00542178|39888620|FG000|Overall Study|did not complete year 4 follow-up|75|||
16383751|NCT00542178|39888621|FG001|Overall Study|did not complete year 4 follow-up|80|||
16383752|NCT00542178|39888622|FG002|Overall Study|did not complete year 4 follow-up|74|||
16383753|NCT00542178|39888623|FG003|Overall Study|did not complete year 4 follow-up|62|||
16383754|NCT00542178|39888624|FG004|Overall Study|did not complete year 4 follow-up|64|||
16383755|NCT00542178|39888625|FG005|Overall Study|did not complete year 4 follow-up|89|||
16383756|NCT00542178|39888626|FG006|Overall Study|did not complete year 4 follow-up|87|||
16189374|NCT03567291|39169647|FG003|Period II|Adverse Event|0|||
16189375|NCT03567291|39169644|FG000|Period II|Missing or unknown|0|||
16296914|NCT00307437|39573937|FG000|Controlled Period|Death|0|||
16383757|NCT00542178|39888627|FG007|Overall Study|did not complete year 4 follow-up|85|||
16383758|NCT00659425|39888628|FG000|Overall Study|Disease progression|1|||
16383759|NCT00659425|39888629|FG001|Overall Study|Disease progression|0|||
16383760|NCT00659425|39888630|FG002|Overall Study|Disease progression|0|||
16383761|NCT00659425|39888631|FG003|Overall Study|Disease progression|1|||
16189376|NCT03567291|39169645|FG001|Period II|Missing or unknown|2|||
16296915|NCT00307437|39573938|FG001|Controlled Period|Death|0|||
16296916|NCT00307437|39573939|FG002|Controlled Period|Death|1|||
16296917|NCT00307437|39573940|FG003|Controlled Period|Death|0|||
16296918|NCT00307437|39573941|FG004|Controlled Period|Death|0|||
16296919|NCT00307437|39573942|FG005|Controlled Period|Death|0|||
16296920|NCT00307437|39573943|FG006|Controlled Period|Death|0|||
16296921|NCT00307437|39573937|FG000|Controlled Period|Lack of Efficacy|2|||
16383762|NCT00659425|39888632|FG004|Overall Study|Disease progression|0|||
16383763|NCT00659425|39888633|FG005|Overall Study|Disease progression|2|||
16383764|NCT00659425|39888634|FG006|Overall Study|Disease progression|4|||
16383765|NCT00659425|39888635|FG007|Overall Study|Disease progression|3|||
16383766|NCT00659425|39888636|FG008|Overall Study|Disease progression|5|||
16383767|NCT00659425|39888637|FG009|Overall Study|Disease progression|3|||
16383768|NCT00659425|39888628|FG000|Overall Study|Death|0|||
16383769|NCT00659425|39888629|FG001|Overall Study|Death|0|||
16383770|NCT00659425|39888630|FG002|Overall Study|Death|0|||
16383771|NCT00659425|39888631|FG003|Overall Study|Death|1|||
16383772|NCT00659425|39888632|FG004|Overall Study|Death|0|||
16383773|NCT00659425|39888633|FG005|Overall Study|Death|0|||
16383774|NCT00659425|39888634|FG006|Overall Study|Death|1|||
16383775|NCT00659425|39888635|FG007|Overall Study|Death|0|||
16383776|NCT00659425|39888636|FG008|Overall Study|Death|0|||
16383777|NCT00659425|39888637|FG009|Overall Study|Death|0|||
16383778|NCT00659425|39888628|FG000|Overall Study|Adverse Event|0|||
16383779|NCT00659425|39888629|FG001|Overall Study|Adverse Event|0|||
16383780|NCT00659425|39888630|FG002|Overall Study|Adverse Event|0|||
16383781|NCT00659425|39888631|FG003|Overall Study|Adverse Event|0|||
16383782|NCT00659425|39888632|FG004|Overall Study|Adverse Event|0|||
16383783|NCT00659425|39888633|FG005|Overall Study|Adverse Event|1|||
16383784|NCT00659425|39888634|FG006|Overall Study|Adverse Event|0|||
16383785|NCT00659425|39888635|FG007|Overall Study|Adverse Event|3|||
16383786|NCT00659425|39888636|FG008|Overall Study|Adverse Event|1|||
16383787|NCT00659425|39888637|FG009|Overall Study|Adverse Event|4|||
16383788|NCT00659425|39888628|FG000|Overall Study|Investigator Discretion|0|||
16383789|NCT00659425|39888629|FG001|Overall Study|Investigator Discretion|0|||
16383790|NCT00659425|39888630|FG002|Overall Study|Investigator Discretion|0|||
16383791|NCT00659425|39888631|FG003|Overall Study|Investigator Discretion|0|||
16383792|NCT00659425|39888632|FG004|Overall Study|Investigator Discretion|0|||
16383793|NCT00659425|39888633|FG005|Overall Study|Investigator Discretion|1|||
16383794|NCT00659425|39888634|FG006|Overall Study|Investigator Discretion|0|||
16383795|NCT00659425|39888635|FG007|Overall Study|Investigator Discretion|3|||
16383796|NCT00659425|39888636|FG008|Overall Study|Investigator Discretion|0|||
16383797|NCT00659425|39888637|FG009|Overall Study|Investigator Discretion|0|||
16383798|NCT00659425|39888628|FG000|Overall Study|Other|0|||
16383799|NCT00659425|39888629|FG001|Overall Study|Other|1|||
16383800|NCT00659425|39888630|FG002|Overall Study|Other|1|||
16383801|NCT00659425|39888631|FG003|Overall Study|Other|2|||
16383802|NCT00659425|39888632|FG004|Overall Study|Other|4|||
16383803|NCT00659425|39888633|FG005|Overall Study|Other|0|||
16383804|NCT00659425|39888634|FG006|Overall Study|Other|3|||
16383805|NCT00659425|39888635|FG007|Overall Study|Other|2|||
16383806|NCT00659425|39888636|FG008|Overall Study|Other|0|||
16383807|NCT00659425|39888637|FG009|Overall Study|Other|6|||
16383808|NCT01475721|39888638|FG000|Overall Study|Death|3|||
16383809|NCT01475721|39888639|FG001|Overall Study|Death|6|||
16383810|NCT01475721|39888638|FG000|Overall Study|Withdrawal by Subject|8|||
16383811|NCT01475721|39888639|FG001|Overall Study|Withdrawal by Subject|8|||
16383812|NCT01152437|39888642|FG000|Overall Study|Other Adverse Event|8|||
16383813|NCT01152437|39888643|FG001|Overall Study|Other Adverse Event|1|||
16383814|NCT01152437|39888644|FG002|Overall Study|Other Adverse Event|7|||
16383815|NCT01152437|39888642|FG000|Overall Study|Not treated|0|||
16383816|NCT01152437|39888643|FG001|Overall Study|Not treated|1|||
16383817|NCT01152437|39888644|FG002|Overall Study|Not treated|2|||
16383818|NCT01152437|39888642|FG000|Overall Study|Progressive disease|27|||
16383819|NCT01152437|39888643|FG001|Overall Study|Progressive disease|13|||
16383820|NCT01152437|39888644|FG002|Overall Study|Progressive disease|32|||
16383821|NCT01152437|39888642|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
16383822|NCT01152437|39888643|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
16383823|NCT01152437|39888644|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
16383824|NCT01542788|39888645|FG000|Overall Study|Randomized but Not Treated|2|||
16383825|NCT01542788|39888646|FG001|Overall Study|Randomized but Not Treated|0|||
16383826|NCT01542788|39888645|FG000|Overall Study|Lack of Efficacy|41|||
16383827|NCT01542788|39888646|FG001|Overall Study|Lack of Efficacy|71|||
16383828|NCT01542788|39888645|FG000|Overall Study|Lost to Follow-up|5|||
16383829|NCT01542788|39888646|FG001|Overall Study|Lost to Follow-up|0|||
16383830|NCT01542788|39888645|FG000|Overall Study|Death|3|||
16383831|NCT01542788|39888646|FG001|Overall Study|Death|0|||
16383832|NCT01542788|39888645|FG000|Overall Study|Protocol Violation|2|||
16383833|NCT01542788|39888646|FG001|Overall Study|Protocol Violation|0|||
16383834|NCT01542788|39888645|FG000|Overall Study|Physician Decision|1|||
16383835|NCT01542788|39888646|FG001|Overall Study|Physician Decision|0|||
16383836|NCT01542788|39888645|FG000|Overall Study|Withdrawal by Subject|1|||
16383837|NCT01542788|39888646|FG001|Overall Study|Withdrawal by Subject|0|||
16383838|NCT01114737|39888649|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
16383839|NCT01114737|39888650|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
16383840|NCT01114737|39888649|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
16383841|NCT01114737|39888650|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
16383842|NCT01114737|39888649|FG000|Randomized Treatment Period|Pregnancy|1|||
16383843|NCT01114737|39888650|FG001|Randomized Treatment Period|Pregnancy|0|||
16383844|NCT01114737|39888649|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
16383845|NCT01114737|39888650|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
16383846|NCT01114737|39888649|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
16383847|NCT01114737|39888650|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
16383848|NCT01114737|39888649|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
16383849|NCT01114737|39888650|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
16383850|NCT04567524|39888651|FG000|Overall Study|Adverse Event|1|||
16383851|NCT04567524|39888652|FG001|Overall Study|Adverse Event|1|||
16383852|NCT04567524|39888653|FG002|Overall Study|Adverse Event|0|||
16383853|NCT04567524|39888654|FG003|Overall Study|Adverse Event|0|||
16383854|NCT04567524|39888651|FG000|Overall Study|Withdrawal by Subject|2|||
16383855|NCT04567524|39888652|FG001|Overall Study|Withdrawal by Subject|0|||
16383856|NCT04567524|39888653|FG002|Overall Study|Withdrawal by Subject|0|||
16383857|NCT04567524|39888654|FG003|Overall Study|Withdrawal by Subject|1|||
16383858|NCT02735200|39888656|FG000|Overall Study|Lost to Follow-up|0|||
16383859|NCT02735200|39888657|FG001|Overall Study|Lost to Follow-up|5|||
16383860|NCT02735200|39888656|FG000|Overall Study|Withdrawal by Subject|8|||
16383861|NCT02735200|39888657|FG001|Overall Study|Withdrawal by Subject|0|||
16383862|NCT00332696|39888658|FG000|Overall Study|Death|24|||
16383863|NCT00332696|39888659|FG001|Overall Study|Death|14|||
16383864|NCT00332696|39888658|FG000|Overall Study|Insufficient therapeutic effect|4|||
16383865|NCT00332696|39888659|FG001|Overall Study|Insufficient therapeutic effect|11|||
16383866|NCT00332696|39888658|FG000|Overall Study|Adverse Event|1|||
16383867|NCT00332696|39888659|FG001|Overall Study|Adverse Event|2|||
16383868|NCT00332696|39888658|FG000|Overall Study|Condition does not justify treatment|0|||
16383869|NCT00332696|39888659|FG001|Overall Study|Condition does not justify treatment|2|||
16383870|NCT00332696|39888658|FG000|Overall Study|Lost to Follow-up|0|||
16383871|NCT00332696|39888659|FG001|Overall Study|Lost to Follow-up|1|||
16383872|NCT00332696|39888658|FG000|Overall Study|Withdrawal by Subject|1|||
16383873|NCT00332696|39888659|FG001|Overall Study|Withdrawal by Subject|0|||
16383874|NCT03235050|39888660|FG000|Overall Study|Adverse Event|0|||
16383875|NCT03235050|39888661|FG001|Overall Study|Adverse Event|0|||
16383876|NCT03235050|39888662|FG002|Overall Study|Adverse Event|1|||
16383877|NCT03235050|39888663|FG003|Overall Study|Adverse Event|4|||
16383878|NCT03235050|39888664|FG004|Overall Study|Adverse Event|1|||
16082961|NCT00826280|38796130|FG000|Overall Study|Machine Failure|1|||
16082962|NCT00826280|38796131|FG001|Overall Study|Machine Failure|1|||
16082963|NCT00826280|38796132|FG002|Overall Study|Machine Failure|0|||
16082964|NCT00826280|38796130|FG000|Overall Study|One or more non-interpretable scan|0|||
16296922|NCT00307437|39573938|FG001|Controlled Period|Lack of Efficacy|0|||
16296923|NCT00307437|39573939|FG002|Controlled Period|Lack of Efficacy|0|||
16296924|NCT00307437|39573940|FG003|Controlled Period|Lack of Efficacy|0|||
16296925|NCT00307437|39573941|FG004|Controlled Period|Lack of Efficacy|0|||
16296926|NCT00307437|39573942|FG005|Controlled Period|Lack of Efficacy|0|||
16296927|NCT00307437|39573943|FG006|Controlled Period|Lack of Efficacy|0|||
16296928|NCT00307437|39573937|FG000|Controlled Period|Lost to Follow-up|2|||
16296929|NCT00307437|39573938|FG001|Controlled Period|Lost to Follow-up|3|||
16296930|NCT00307437|39573939|FG002|Controlled Period|Lost to Follow-up|0|||
16296931|NCT00307437|39573940|FG003|Controlled Period|Lost to Follow-up|0|||
16296932|NCT00307437|39573941|FG004|Controlled Period|Lost to Follow-up|0|||
16296933|NCT00307437|39573942|FG005|Controlled Period|Lost to Follow-up|0|||
16296934|NCT00307437|39573943|FG006|Controlled Period|Lost to Follow-up|0|||
16296935|NCT00307437|39573937|FG000|Controlled Period|Other|5|||
16296936|NCT00307437|39573938|FG001|Controlled Period|Other|1|||
16296937|NCT00307437|39573939|FG002|Controlled Period|Other|3|||
16296938|NCT00307437|39573940|FG003|Controlled Period|Other|0|||
16296939|NCT00307437|39573941|FG004|Controlled Period|Other|0|||
16296940|NCT00307437|39573942|FG005|Controlled Period|Other|0|||
16296941|NCT00307437|39573943|FG006|Controlled Period|Other|0|||
16296942|NCT00307437|39573937|FG000|After Controlled Period|Adverse Event|0|||
16296943|NCT00307437|39573938|FG001|After Controlled Period|Adverse Event|0|||
16296944|NCT00307437|39573939|FG002|After Controlled Period|Adverse Event|0|||
16296945|NCT00307437|39573940|FG003|After Controlled Period|Adverse Event|18|||
16296946|NCT00307437|39573941|FG004|After Controlled Period|Adverse Event|16|||
16296947|NCT00307437|39573942|FG005|After Controlled Period|Adverse Event|31|||
16296948|NCT00307437|39573943|FG006|After Controlled Period|Adverse Event|40|||
16296949|NCT00307437|39573937|FG000|After Controlled Period|Death|0|||
16296950|NCT00307437|39573938|FG001|After Controlled Period|Death|0|||
16296951|NCT00307437|39573939|FG002|After Controlled Period|Death|0|||
16296952|NCT00307437|39573940|FG003|After Controlled Period|Death|3|||
16296953|NCT00307437|39573941|FG004|After Controlled Period|Death|1|||
16383879|NCT03235050|39888660|FG000|Overall Study|Death|0|||
16296954|NCT00307437|39573942|FG005|After Controlled Period|Death|1|||
16296955|NCT00307437|39573943|FG006|After Controlled Period|Death|3|||
16296956|NCT00307437|39573937|FG000|After Controlled Period|Lack of Efficacy|0|||
16383880|NCT03235050|39888661|FG001|Overall Study|Death|0|||
16383881|NCT03235050|39888662|FG002|Overall Study|Death|0|||
16082965|NCT00826280|38796131|FG001|Overall Study|One or more non-interpretable scan|1|||
16296957|NCT00307437|39573938|FG001|After Controlled Period|Lack of Efficacy|0|||
16296958|NCT00307437|39573939|FG002|After Controlled Period|Lack of Efficacy|0|||
16296959|NCT00307437|39573940|FG003|After Controlled Period|Lack of Efficacy|15|||
16296960|NCT00307437|39573941|FG004|After Controlled Period|Lack of Efficacy|17|||
16296961|NCT00307437|39573942|FG005|After Controlled Period|Lack of Efficacy|37|||
16296962|NCT00307437|39573943|FG006|After Controlled Period|Lack of Efficacy|24|||
16487551|NCT01845831|40259800|FG004|Inpatient Phase|Withdrawal by Subject|0|||
16082966|NCT00826280|38796132|FG002|Overall Study|One or more non-interpretable scan|1|||
16296963|NCT00307437|39573937|FG000|After Controlled Period|Lost to Follow-up|0|||
16296964|NCT00307437|39573938|FG001|After Controlled Period|Lost to Follow-up|0|||
16296965|NCT00307437|39573939|FG002|After Controlled Period|Lost to Follow-up|0|||
16296966|NCT00307437|39573940|FG003|After Controlled Period|Lost to Follow-up|7|||
16296967|NCT00307437|39573941|FG004|After Controlled Period|Lost to Follow-up|12|||
16296968|NCT00307437|39573942|FG005|After Controlled Period|Lost to Follow-up|13|||
16296969|NCT00307437|39573943|FG006|After Controlled Period|Lost to Follow-up|18|||
16296970|NCT00307437|39573937|FG000|After Controlled Period|Other|0|||
16296971|NCT00307437|39573938|FG001|After Controlled Period|Other|0|||
16296972|NCT00307437|39573939|FG002|After Controlled Period|Other|0|||
16296973|NCT00307437|39573940|FG003|After Controlled Period|Other|15|||
16296974|NCT00307437|39573941|FG004|After Controlled Period|Other|9|||
16296975|NCT00307437|39573942|FG005|After Controlled Period|Other|40|||
16296976|NCT00307437|39573943|FG006|After Controlled Period|Other|28|||
16296977|NCT01330459|39573944|FG000|Overall Study|Physician Decision|0|||
16383882|NCT03235050|39888663|FG003|Overall Study|Death|2|||
16296978|NCT01330459|39573945|FG001|Overall Study|Physician Decision|2|||
16296979|NCT02714426|39573946|FG000|Overall Study|Withdrawal by Subject|2|||
16296980|NCT02714426|39573947|FG001|Overall Study|Withdrawal by Subject|2|||
16383883|NCT03235050|39888664|FG004|Overall Study|Death|1|||
16383884|NCT03235050|39888660|FG000|Overall Study|Lost to Follow-up|1|||
16383885|NCT03235050|39888661|FG001|Overall Study|Lost to Follow-up|2|||
16383886|NCT03235050|39888662|FG002|Overall Study|Lost to Follow-up|1|||
16383887|NCT03235050|39888663|FG003|Overall Study|Lost to Follow-up|2|||
16383888|NCT03235050|39888664|FG004|Overall Study|Lost to Follow-up|0|||
16383889|NCT03235050|39888660|FG000|Overall Study|Withdrawal by Subject|3|||
16383890|NCT03235050|39888661|FG001|Overall Study|Withdrawal by Subject|2|||
16383891|NCT03235050|39888662|FG002|Overall Study|Withdrawal by Subject|2|||
16383892|NCT03235050|39888663|FG003|Overall Study|Withdrawal by Subject|5|||
16383893|NCT03235050|39888664|FG004|Overall Study|Withdrawal by Subject|7|||
16383894|NCT03235050|39888660|FG000|Overall Study|Other reasons|0|||
16383895|NCT03235050|39888661|FG001|Overall Study|Other reasons|1|||
16383896|NCT03235050|39888662|FG002|Overall Study|Other reasons|0|||
16383897|NCT03235050|39888663|FG003|Overall Study|Other reasons|1|||
16383898|NCT03235050|39888664|FG004|Overall Study|Other reasons|2|||
16383899|NCT02712788|39888665|FG000|Overall Study|Physician Decision|1|||
16487552|NCT02042183|40259803|FG000|Overall Study|Physician Decision|7|||
16487553|NCT02042183|40259804|FG001|Overall Study|Physician Decision|2|||
16487554|NCT02042183|40259803|FG000|Overall Study|Lack of Efficacy|4|||
16487555|NCT02042183|40259804|FG001|Overall Study|Lack of Efficacy|3|||
16487556|NCT02042183|40259803|FG000|Overall Study|Non-compliance with Study Drug|2|||
16487557|NCT02042183|40259804|FG001|Overall Study|Non-compliance with Study Drug|3|||
16487558|NCT02042183|40259803|FG000|Overall Study|Adverse Event|17|||
16487559|NCT02042183|40259804|FG001|Overall Study|Adverse Event|6|||
16487560|NCT02042183|40259803|FG000|Overall Study|Other|3|||
16487561|NCT02042183|40259804|FG001|Overall Study|Other|3|||
16487562|NCT02042183|40259803|FG000|Overall Study|Withdrawal by Subject|21|||
16487563|NCT02042183|40259804|FG001|Overall Study|Withdrawal by Subject|16|||
16487564|NCT02042183|40259803|FG000|Overall Study|Site Terminated by Sponsor|2|||
16487565|NCT02042183|40259804|FG001|Overall Study|Site Terminated by Sponsor|1|||
16487566|NCT02042183|40259803|FG000|Overall Study|Lost to Follow-up|9|||
16487567|NCT02042183|40259804|FG001|Overall Study|Lost to Follow-up|2|||
16487568|NCT00042289|40259805|FG000|Overall Study|Lost to Follow-up|3|||
16487569|NCT00042289|40259806|FG001|Overall Study|Lost to Follow-up|0|||
16487570|NCT00042289|40259807|FG002|Overall Study|Lost to Follow-up|0|||
16487571|NCT00042289|40259808|FG003|Overall Study|Lost to Follow-up|1|||
16082967|NCT00073749|38796140|FG000|Overall Study|Disease Progression|2|||
16082968|NCT00073749|38796141|FG001|Overall Study|Disease Progression|0|||
16383900|NCT02712788|39888666|FG001|Overall Study|Physician Decision|0|||
16383901|NCT02712788|39888665|FG000|Overall Study|Protocol Violation|1|||
16383902|NCT02712788|39888666|FG001|Overall Study|Protocol Violation|0|||
16383903|NCT01073293|39888667|FG000|Overall Study|Lost to Follow-up|0|||
16487572|NCT00042289|40259809|FG004|Overall Study|Lost to Follow-up|3|||
16487573|NCT00042289|40259810|FG005|Overall Study|Lost to Follow-up|3|||
16487574|NCT00042289|40259811|FG006|Overall Study|Lost to Follow-up|6|||
16487575|NCT00042289|40259812|FG007|Overall Study|Lost to Follow-up|1|||
16487576|NCT00042289|40259813|FG008|Overall Study|Lost to Follow-up|1|||
16487577|NCT00042289|40259814|FG009|Overall Study|Lost to Follow-up|0|||
16296981|NCT00554606|39573948|FG000|Overall Study|Adverse Event|3|||
16487578|NCT00042289|40259815|FG010|Overall Study|Lost to Follow-up|0|||
16383904|NCT01073293|39888668|FG001|Overall Study|Lost to Follow-up|1|||
16296982|NCT00554606|39573948|FG000|Overall Study|Abnormal laboratory values|1|||
16383905|NCT01073293|39888667|FG000|Overall Study|Withdrawal by Subject|5|||
16383906|NCT01073293|39888668|FG001|Overall Study|Withdrawal by Subject|10|||
16383907|NCT04068922|39888669|FG000|Overall Study|Lost to Follow-up|5|||
16383908|NCT04068922|39888669|FG000|Overall Study|Withdrawal by Subject|7|||
16383909|NCT04068922|39888669|FG000|Overall Study|Adverse Event|1|||
16383910|NCT00652834|39888672|FG000|Overall Study|Withdrawal by Subject|3|||
16383911|NCT00652834|39888672|FG000|Overall Study|Lost to Follow-up|2|||
16383912|NCT04881760|39888675|FG000|Overall Study|Adverse Event|0|||
16383913|NCT04881760|39888676|FG001|Overall Study|Adverse Event|1|||
16383914|NCT04881760|39888677|FG002|Overall Study|Adverse Event|1|||
16383915|NCT04881760|39888678|FG003|Overall Study|Adverse Event|0|||
16383916|NCT04881760|39888679|FG004|Overall Study|Adverse Event|1|||
16383917|NCT04881760|39888680|FG005|Overall Study|Adverse Event|1|||
16383918|NCT04881760|39888681|FG006|Overall Study|Adverse Event|2|||
16383919|NCT04881760|39888675|FG000|Overall Study|Death|0|||
16383920|NCT04881760|39888676|FG001|Overall Study|Death|0|||
16296983|NCT00554606|39573948|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
16296984|NCT00554606|39573948|FG000|Overall Study|Subject withdrew consent|2|||
16296985|NCT00554606|39573948|FG000|Overall Study|Lost to Follow-up|2|||
16296986|NCT00554606|39573948|FG000|Overall Study|Administrative problems|60|||
16296987|NCT00554606|39573948|FG000|Overall Study|Death|1|||
16296988|NCT00554606|39573948|FG000|Overall Study|Protocol deviation|2|||
16296989|NCT03186781|39573949|FG000|Overall Study|Lost to Follow-up|0|||
16296990|NCT03186781|39573950|FG001|Overall Study|Lost to Follow-up|0|||
16296991|NCT03186781|39573951|FG002|Overall Study|Lost to Follow-up|1|||
16296992|NCT03186781|39573952|FG003|Overall Study|Lost to Follow-up|0|||
16296993|NCT03186781|39573953|FG004|Overall Study|Lost to Follow-up|1|||
16296994|NCT03186781|39573954|FG005|Overall Study|Lost to Follow-up|0|||
16296995|NCT03186781|39573949|FG000|Overall Study|Moved from Area|0|||
16296996|NCT03186781|39573950|FG001|Overall Study|Moved from Area|0|||
16296997|NCT03186781|39573951|FG002|Overall Study|Moved from Area|0|||
16383921|NCT04881760|39888677|FG002|Overall Study|Death|0|||
16383922|NCT04881760|39888678|FG003|Overall Study|Death|1|||
16383923|NCT04881760|39888679|FG004|Overall Study|Death|0|||
16383924|NCT04881760|39888680|FG005|Overall Study|Death|0|||
16383925|NCT04881760|39888681|FG006|Overall Study|Death|0|||
16383926|NCT04881760|39888675|FG000|Overall Study|Lost to Follow-up|5|||
16383927|NCT04881760|39888676|FG001|Overall Study|Lost to Follow-up|7|||
16383928|NCT04881760|39888677|FG002|Overall Study|Lost to Follow-up|5|||
16383929|NCT04881760|39888678|FG003|Overall Study|Lost to Follow-up|1|||
16383930|NCT04881760|39888679|FG004|Overall Study|Lost to Follow-up|2|||
16383931|NCT04881760|39888680|FG005|Overall Study|Lost to Follow-up|4|||
16383932|NCT04881760|39888681|FG006|Overall Study|Lost to Follow-up|4|||
16383933|NCT04881760|39888675|FG000|Overall Study|Withdrawal by Subject|13|||
16383934|NCT04881760|39888676|FG001|Overall Study|Withdrawal by Subject|1|||
16383935|NCT04881760|39888677|FG002|Overall Study|Withdrawal by Subject|1|||
16383936|NCT04881760|39888678|FG003|Overall Study|Withdrawal by Subject|4|||
16383937|NCT04881760|39888679|FG004|Overall Study|Withdrawal by Subject|2|||
16383938|NCT04881760|39888680|FG005|Overall Study|Withdrawal by Subject|1|||
16383939|NCT04881760|39888681|FG006|Overall Study|Withdrawal by Subject|2|||
16383940|NCT04881760|39888675|FG000|Overall Study|Randomized but Never Treated|0|||
16383941|NCT04881760|39888676|FG001|Overall Study|Randomized but Never Treated|0|||
16383942|NCT04881760|39888677|FG002|Overall Study|Randomized but Never Treated|0|||
16383943|NCT04881760|39888678|FG003|Overall Study|Randomized but Never Treated|1|||
16383944|NCT04881760|39888679|FG004|Overall Study|Randomized but Never Treated|0|||
16383945|NCT04881760|39888680|FG005|Overall Study|Randomized but Never Treated|0|||
16383946|NCT04881760|39888681|FG006|Overall Study|Randomized but Never Treated|0|||
16383947|NCT04881760|39888675|FG000|Overall Study|Inadvertent Enrollment|2|||
16082969|NCT00073749|38796142|FG002|Overall Study|Disease Progression|3|||
16296998|NCT03186781|39573952|FG003|Overall Study|Moved from Area|0|||
16383948|NCT04881760|39888676|FG001|Overall Study|Inadvertent Enrollment|0|||
16383949|NCT04881760|39888677|FG002|Overall Study|Inadvertent Enrollment|0|||
16383950|NCT04881760|39888678|FG003|Overall Study|Inadvertent Enrollment|0|||
16383951|NCT04881760|39888679|FG004|Overall Study|Inadvertent Enrollment|0|||
16383952|NCT04881760|39888680|FG005|Overall Study|Inadvertent Enrollment|0|||
16383953|NCT04881760|39888681|FG006|Overall Study|Inadvertent Enrollment|0|||
16383954|NCT04881760|39888675|FG000|Overall Study|Site Closure|0|||
16296999|NCT03186781|39573953|FG004|Overall Study|Moved from Area|1|||
16297000|NCT03186781|39573954|FG005|Overall Study|Moved from Area|0|||
16297001|NCT03186781|39573949|FG000|Overall Study|Withdrawal by Subject|0|||
16383955|NCT04881760|39888676|FG001|Overall Study|Site Closure|0|||
16383956|NCT04881760|39888677|FG002|Overall Study|Site Closure|0|||
16383957|NCT04881760|39888678|FG003|Overall Study|Site Closure|1|||
16383958|NCT04881760|39888679|FG004|Overall Study|Site Closure|0|||
16383959|NCT04881760|39888680|FG005|Overall Study|Site Closure|0|||
16383960|NCT04881760|39888681|FG006|Overall Study|Site Closure|0|||
16383961|NCT01441960|39888693|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
16383962|NCT01441960|39888694|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
16383963|NCT01441960|39888693|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
16383964|NCT01441960|39888694|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
16383965|NCT01441960|39888693|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
16383966|NCT01441960|39888694|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
16383967|NCT00573768|39888695|FG000|Overall Study|Adverse Event|1|||
16383968|NCT00573768|39888696|FG001|Overall Study|Adverse Event|1|||
16383969|NCT00573768|39888697|FG002|Overall Study|Adverse Event|2|||
16383970|NCT00573768|39888695|FG000|Overall Study|Protocol Violation|1|||
16383971|NCT00573768|39888696|FG001|Overall Study|Protocol Violation|0|||
16383972|NCT00573768|39888697|FG002|Overall Study|Protocol Violation|1|||
16383973|NCT00573768|39888695|FG000|Overall Study|Withdrawal by Subject|0|||
16383974|NCT00573768|39888696|FG001|Overall Study|Withdrawal by Subject|1|||
16383975|NCT00573768|39888697|FG002|Overall Study|Withdrawal by Subject|0|||
16383976|NCT00573768|39888695|FG000|Overall Study|Lost to Follow-up|0|||
16383977|NCT00573768|39888696|FG001|Overall Study|Lost to Follow-up|0|||
16383978|NCT00573768|39888697|FG002|Overall Study|Lost to Follow-up|1|||
16383979|NCT00557193|39888698|FG000|Induction|Adverse Event|2|||
16383980|NCT00557193|39888699|FG001|Induction|Adverse Event|0|||
16383981|NCT00557193|39888700|FG002|Induction|Adverse Event|0|||
16383982|NCT00557193|39888701|FG003|Induction|Adverse Event|0|||
16383983|NCT00557193|39888702|FG004|Induction|Adverse Event|0|||
16383984|NCT00557193|39888703|FG005|Induction|Adverse Event|0|||
16383985|NCT00557193|39888698|FG000|Induction|Death|6|||
16383986|NCT00557193|39888699|FG001|Induction|Death|0|||
16383987|NCT00557193|39888700|FG002|Induction|Death|0|||
16383988|NCT00557193|39888701|FG003|Induction|Death|0|||
16383989|NCT00557193|39888702|FG004|Induction|Death|0|||
16383990|NCT00557193|39888703|FG005|Induction|Death|0|||
16383991|NCT00557193|39888698|FG000|Induction|Physician Decision|3|||
16383992|NCT00557193|39888699|FG001|Induction|Physician Decision|0|||
16383993|NCT00557193|39888700|FG002|Induction|Physician Decision|0|||
16383994|NCT00557193|39888701|FG003|Induction|Physician Decision|0|||
16383995|NCT00557193|39888702|FG004|Induction|Physician Decision|0|||
16383996|NCT00557193|39888703|FG005|Induction|Physician Decision|0|||
16383997|NCT00557193|39888698|FG000|Induction|Withdrawal by Subject|1|||
16297002|NCT03186781|39573950|FG001|Overall Study|Withdrawal by Subject|0|||
16297003|NCT03186781|39573951|FG002|Overall Study|Withdrawal by Subject|0|||
16297004|NCT03186781|39573952|FG003|Overall Study|Withdrawal by Subject|0|||
16297005|NCT03186781|39573953|FG004|Overall Study|Withdrawal by Subject|1|||
16297006|NCT03186781|39573954|FG005|Overall Study|Withdrawal by Subject|0|||
16297007|NCT01320150|39573957|FG000|Overall Study|Protocol Violation|15|||
16297008|NCT01320150|39573957|FG000|Overall Study|Withdrawal by Subject|5|||
16297009|NCT01320150|39573957|FG000|Overall Study|Death|2|||
16297010|NCT01320150|39573957|FG000|Overall Study|Lost to Follow-up|44|||
16297011|NCT01716715|39573958|FG000|Overall Study|Never Treated|2|||
16383998|NCT00557193|39888699|FG001|Induction|Withdrawal by Subject|0|||
16383999|NCT00557193|39888700|FG002|Induction|Withdrawal by Subject|0|||
16384000|NCT00557193|39888701|FG003|Induction|Withdrawal by Subject|0|||
16487579|NCT00042289|40259816|FG011|Overall Study|Lost to Follow-up|0|||
16487580|NCT00042289|40259817|FG012|Overall Study|Lost to Follow-up|0|||
16487581|NCT00042289|40259818|FG013|Overall Study|Lost to Follow-up|0|||
16082970|NCT00073749|38796143|FG003|Overall Study|Disease Progression|2|||
16082971|NCT00073749|38796144|FG004|Overall Study|Disease Progression|3|||
16082972|NCT00073749|38796145|FG005|Overall Study|Disease Progression|1|||
16082973|NCT00073749|38796146|FG006|Overall Study|Disease Progression|3|||
16082974|NCT00073749|38796140|FG000|Overall Study|Death|0|||
16082975|NCT00073749|38796141|FG001|Overall Study|Death|1|||
16082976|NCT00073749|38796142|FG002|Overall Study|Death|1|||
16297012|NCT01716715|39573959|FG001|Overall Study|Never Treated|4|||
16384001|NCT00557193|39888702|FG004|Induction|Withdrawal by Subject|0|||
16384002|NCT00557193|39888703|FG005|Induction|Withdrawal by Subject|0|||
16384003|NCT00557193|39888698|FG000|Induction|Refusal of Further Protocol Therapy|2|||
16384004|NCT00557193|39888699|FG001|Induction|Refusal of Further Protocol Therapy|0|||
16384005|NCT00557193|39888700|FG002|Induction|Refusal of Further Protocol Therapy|0|||
16487582|NCT00042289|40259819|FG014|Overall Study|Lost to Follow-up|0|||
16082977|NCT00073749|38796143|FG003|Overall Study|Death|0|||
16297013|NCT03709823|39573963|FG000|Overall Study|Adverse Event|0|||
16384006|NCT00557193|39888701|FG003|Induction|Refusal of Further Protocol Therapy|0|||
16384007|NCT00557193|39888702|FG004|Induction|Refusal of Further Protocol Therapy|0|||
16384008|NCT00557193|39888703|FG005|Induction|Refusal of Further Protocol Therapy|0|||
16384009|NCT00557193|39888698|FG000|Induction|Ineligible|8|||
16487583|NCT00042289|40259820|FG015|Overall Study|Lost to Follow-up|1|||
16297014|NCT03709823|39573964|FG001|Overall Study|Adverse Event|0|||
16297015|NCT03709823|39573965|FG002|Overall Study|Adverse Event|1|||
16297016|NCT03709823|39573966|FG003|Overall Study|Adverse Event|0|||
16297017|NCT03709823|39573967|FG004|Overall Study|Adverse Event|0|||
16297018|NCT03709823|39573968|FG005|Overall Study|Adverse Event|0|||
16297019|NCT03709823|39573963|FG000|Overall Study|Lost to Follow-up|2|||
16297020|NCT03709823|39573964|FG001|Overall Study|Lost to Follow-up|2|||
16297021|NCT03709823|39573965|FG002|Overall Study|Lost to Follow-up|2|||
16297022|NCT03709823|39573966|FG003|Overall Study|Lost to Follow-up|1|||
16297023|NCT03709823|39573967|FG004|Overall Study|Lost to Follow-up|1|||
16297024|NCT03709823|39573968|FG005|Overall Study|Lost to Follow-up|0|||
16297025|NCT03709823|39573963|FG000|Overall Study|Withdrawal by Subject|1|||
16297026|NCT03709823|39573964|FG001|Overall Study|Withdrawal by Subject|3|||
16297027|NCT03709823|39573965|FG002|Overall Study|Withdrawal by Subject|0|||
16297028|NCT03709823|39573966|FG003|Overall Study|Withdrawal by Subject|0|||
16297029|NCT03709823|39573967|FG004|Overall Study|Withdrawal by Subject|0|||
16297030|NCT03709823|39573968|FG005|Overall Study|Withdrawal by Subject|0|||
16297031|NCT03709823|39573963|FG000|Overall Study|Other, Not Specified|0|||
16297032|NCT03709823|39573964|FG001|Overall Study|Other, Not Specified|0|||
16297033|NCT03709823|39573965|FG002|Overall Study|Other, Not Specified|0|||
16297034|NCT03709823|39573966|FG003|Overall Study|Other, Not Specified|1|||
16297035|NCT03709823|39573967|FG004|Overall Study|Other, Not Specified|0|||
16297036|NCT03709823|39573968|FG005|Overall Study|Other, Not Specified|0|||
16297037|NCT02393248|39573969|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297038|NCT02393248|39573970|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
16297039|NCT02393248|39573971|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297040|NCT02393248|39573972|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297041|NCT02393248|39573973|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297042|NCT02393248|39573974|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
16297043|NCT02393248|39573975|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
16297044|NCT02393248|39573976|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297045|NCT02393248|39573977|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297046|NCT02393248|39573978|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297047|NCT02393248|39573979|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297048|NCT02393248|39573980|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297049|NCT02393248|39573981|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297050|NCT02393248|39573982|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297051|NCT02393248|39573983|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297052|NCT02393248|39573984|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297053|NCT02393248|39573985|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297054|NCT02393248|39573986|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297055|NCT02393248|39573987|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297056|NCT02393248|39573988|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297057|NCT02393248|39573989|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297058|NCT02393248|39573990|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297059|NCT02393248|39573991|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297060|NCT02393248|39573992|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297061|NCT02393248|39573993|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
16297062|NCT02393248|39573969|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297063|NCT02393248|39573970|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
16297064|NCT02393248|39573971|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297065|NCT02393248|39573972|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297066|NCT02393248|39573973|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297067|NCT02393248|39573974|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297068|NCT02393248|39573975|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297069|NCT02393248|39573976|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297070|NCT02393248|39573977|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297071|NCT02393248|39573978|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297072|NCT02393248|39573979|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297073|NCT02393248|39573980|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297074|NCT02393248|39573981|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297075|NCT02393248|39573982|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297076|NCT02393248|39573983|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16082978|NCT00073749|38796144|FG004|Overall Study|Death|0|||
16297077|NCT02393248|39573984|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297078|NCT02393248|39573985|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297079|NCT02393248|39573986|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297080|NCT02393248|39573987|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297081|NCT02393248|39573988|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16487584|NCT00042289|40259821|FG016|Overall Study|Lost to Follow-up|1|||
16487585|NCT00042289|40259822|FG017|Overall Study|Lost to Follow-up|0|||
16297082|NCT02393248|39573989|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297083|NCT02393248|39573990|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297084|NCT02393248|39573991|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297085|NCT02393248|39573992|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297086|NCT02393248|39573993|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
16297087|NCT02393248|39573969|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
16297088|NCT02393248|39573970|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
16297089|NCT02393248|39573971|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
16297090|NCT02393248|39573972|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
16297091|NCT02393248|39573973|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
16297092|NCT02393248|39573974|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
16297093|NCT02393248|39573975|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
16297094|NCT02393248|39573976|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
16297095|NCT02393248|39573977|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
16297096|NCT02393248|39573978|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
16297097|NCT02393248|39573979|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
16297098|NCT02393248|39573980|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
16297099|NCT02393248|39573981|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
16297100|NCT02393248|39573982|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
16297101|NCT02393248|39573983|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
16297102|NCT02393248|39573984|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
16297103|NCT02393248|39573985|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
16297104|NCT02393248|39573986|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
16297105|NCT02393248|39573987|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
16297106|NCT02393248|39573988|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
16297107|NCT02393248|39573989|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
16297108|NCT02393248|39573990|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
16297109|NCT02393248|39573991|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
16297110|NCT02393248|39573992|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
16297111|NCT02393248|39573993|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
16297112|NCT02393248|39573969|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
16297113|NCT02393248|39573970|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297114|NCT02393248|39573971|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297115|NCT02393248|39573972|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297116|NCT02393248|39573973|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297117|NCT02393248|39573974|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297118|NCT02393248|39573975|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297119|NCT02393248|39573976|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297120|NCT02393248|39573977|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297121|NCT02393248|39573978|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297122|NCT02393248|39573979|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297123|NCT02393248|39573980|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297124|NCT02393248|39573981|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297125|NCT02393248|39573982|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297126|NCT02393248|39573983|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297127|NCT02393248|39573984|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297128|NCT02393248|39573985|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297129|NCT02393248|39573986|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297130|NCT02393248|39573987|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297131|NCT02393248|39573988|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297132|NCT02393248|39573989|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297133|NCT02393248|39573990|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297134|NCT02393248|39573991|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297135|NCT02393248|39573992|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297136|NCT02393248|39573993|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
16297137|NCT02393248|39573969|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297138|NCT02393248|39573970|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16487586|NCT00042289|40259823|FG018|Overall Study|Lost to Follow-up|3|||
16487587|NCT00042289|40259824|FG019|Overall Study|Lost to Follow-up|2|||
16082979|NCT00073749|38796145|FG005|Overall Study|Death|0|||
16082980|NCT00073749|38796146|FG006|Overall Study|Death|29|||
16082981|NCT00073749|38796140|FG000|Overall Study|Adverse Event|0|||
16082982|NCT00073749|38796141|FG001|Overall Study|Adverse Event|3|||
16082983|NCT00073749|38796142|FG002|Overall Study|Adverse Event|6|||
16082984|NCT00073749|38796143|FG003|Overall Study|Adverse Event|4|||
16082985|NCT00073749|38796144|FG004|Overall Study|Adverse Event|2|||
16082986|NCT00073749|38796145|FG005|Overall Study|Adverse Event|1|||
16082987|NCT00073749|38796146|FG006|Overall Study|Adverse Event|0|||
16082988|NCT00073749|38796140|FG000|Overall Study|Physician Decision|0|||
16082989|NCT00073749|38796141|FG001|Overall Study|Physician Decision|0|||
16082990|NCT00073749|38796142|FG002|Overall Study|Physician Decision|1|||
16082991|NCT00073749|38796143|FG003|Overall Study|Physician Decision|0|||
16082992|NCT00073749|38796144|FG004|Overall Study|Physician Decision|0|||
16082993|NCT00073749|38796145|FG005|Overall Study|Physician Decision|2|||
16082994|NCT00073749|38796146|FG006|Overall Study|Physician Decision|0|||
16082995|NCT00073749|38796140|FG000|Overall Study|Withdrawal by Subject|0|||
16082996|NCT00073749|38796141|FG001|Overall Study|Withdrawal by Subject|1|||
16082997|NCT00073749|38796142|FG002|Overall Study|Withdrawal by Subject|0|||
16082998|NCT00073749|38796143|FG003|Overall Study|Withdrawal by Subject|0|||
16487588|NCT00042289|40259825|FG020|Overall Study|Lost to Follow-up|0|||
16487589|NCT00042289|40259826|FG021|Overall Study|Lost to Follow-up|0|||
16189377|NCT03567291|39169646|FG002|Period II|Missing or unknown|1|||
16189378|NCT03567291|39169647|FG003|Period II|Missing or unknown|0|||
16189379|NCT03567291|39169644|FG000|Period III|Adverse Event|0|||
16189380|NCT03567291|39169645|FG001|Period III|Adverse Event|0|||
16189381|NCT03567291|39169646|FG002|Period III|Adverse Event|0|||
16189382|NCT03567291|39169647|FG003|Period III|Adverse Event|4|||
16189383|NCT03567291|39169644|FG000|Period III|Withdrawal by Subject|0|||
16189384|NCT03567291|39169645|FG001|Period III|Withdrawal by Subject|0|||
16189385|NCT03567291|39169646|FG002|Period III|Withdrawal by Subject|0|||
16189386|NCT03567291|39169647|FG003|Period III|Withdrawal by Subject|4|||
16189387|NCT03567291|39169644|FG000|Period III|Lost to Follow-up|0|||
16189388|NCT03567291|39169645|FG001|Period III|Lost to Follow-up|0|||
16487590|NCT00042289|40259827|FG022|Overall Study|Lost to Follow-up|0|||
16487591|NCT00042289|40259828|FG023|Overall Study|Lost to Follow-up|0|||
16487592|NCT00042289|40259829|FG024|Overall Study|Lost to Follow-up|0|||
16487593|NCT00042289|40259830|FG025|Overall Study|Lost to Follow-up|0|||
16487594|NCT00042289|40259831|FG026|Overall Study|Lost to Follow-up|2|||
16487595|NCT00042289|40259832|FG027|Overall Study|Lost to Follow-up|2|||
16487596|NCT00042289|40259833|FG028|Overall Study|Lost to Follow-up|2|||
16487597|NCT00042289|40259834|FG029|Overall Study|Lost to Follow-up|0|||
16487598|NCT00042289|40259835|FG030|Overall Study|Lost to Follow-up|0|||
16487599|NCT00042289|40259836|FG031|Overall Study|Lost to Follow-up|2|||
16487600|NCT00042289|40259837|FG032|Overall Study|Lost to Follow-up|1|||
16487601|NCT00042289|40259838|FG033|Overall Study|Lost to Follow-up|1|||
16487602|NCT00042289|40259839|FG034|Overall Study|Lost to Follow-up|1|||
16487603|NCT00042289|40259840|FG035|Overall Study|Lost to Follow-up|2|||
16487604|NCT00042289|40259841|FG036|Overall Study|Lost to Follow-up|1|||
16487605|NCT00042289|40259842|FG037|Overall Study|Lost to Follow-up|1|||
16487606|NCT00042289|40259843|FG038|Overall Study|Lost to Follow-up|0|||
16487607|NCT00042289|40259844|FG039|Overall Study|Lost to Follow-up|5|||
16082999|NCT00073749|38796144|FG004|Overall Study|Withdrawal by Subject|1|||
16083000|NCT00073749|38796145|FG005|Overall Study|Withdrawal by Subject|0|||
16083001|NCT00073749|38796146|FG006|Overall Study|Withdrawal by Subject|2|||
16083002|NCT00073749|38796140|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
16083003|NCT00073749|38796141|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
16083004|NCT00073749|38796142|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
16083005|NCT00073749|38796143|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
16083006|NCT00073749|38796144|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
16083007|NCT00073749|38796145|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
16083008|NCT00073749|38796146|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
16083009|NCT00073749|38796140|FG000|Overall Study|Lost to Follow-up|0|||
16083010|NCT00073749|38796141|FG001|Overall Study|Lost to Follow-up|0|||
16083011|NCT00073749|38796142|FG002|Overall Study|Lost to Follow-up|0|||
16083012|NCT00073749|38796143|FG003|Overall Study|Lost to Follow-up|0|||
16083013|NCT00073749|38796144|FG004|Overall Study|Lost to Follow-up|0|||
16189389|NCT03567291|39169646|FG002|Period III|Lost to Follow-up|0|||
16083014|NCT00073749|38796145|FG005|Overall Study|Lost to Follow-up|0|||
16083015|NCT00073749|38796146|FG006|Overall Study|Lost to Follow-up|2|||
16189390|NCT03567291|39169647|FG003|Period III|Lost to Follow-up|1|||
16487608|NCT00042289|40259845|FG040|Overall Study|Lost to Follow-up|0|||
16487609|NCT00042289|40259846|FG041|Overall Study|Lost to Follow-up|2|||
16189391|NCT03567291|39169644|FG000|Period III|Terminated by sponsor|0|||
16083016|NCT00073749|38796140|FG000|Overall Study|Other|0|||
16487610|NCT00042289|40259847|FG042|Overall Study|Lost to Follow-up|2|||
16487611|NCT00042289|40259848|FG043|Overall Study|Lost to Follow-up|0|||
16083017|NCT00073749|38796141|FG001|Overall Study|Other|0|||
16083018|NCT00073749|38796142|FG002|Overall Study|Other|0|||
16083019|NCT00073749|38796143|FG003|Overall Study|Other|0|||
16083020|NCT00073749|38796144|FG004|Overall Study|Other|0|||
16083021|NCT00073749|38796145|FG005|Overall Study|Other|2|||
16083022|NCT00073749|38796146|FG006|Overall Study|Other|0|||
16083023|NCT04425863|38796149|FG000|Overall Study|Death|0|||
16083024|NCT04425863|38796150|FG001|Overall Study|Death|0|||
16083025|NCT04425863|38796151|FG002|Overall Study|Death|1|||
16083026|NCT02601820|38796152|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
16083027|NCT02601820|38796152|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
16083028|NCT02601820|38796152|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
16083029|NCT02601820|38796152|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
16083030|NCT00739908|38796153|FG000|Overall Study|Adverse Event|5|||
16083031|NCT00739908|38796154|FG001|Overall Study|Adverse Event|6|||
16083032|NCT00739908|38796153|FG000|Overall Study|Withdrawal by Subject|4|||
16083033|NCT00739908|38796154|FG001|Overall Study|Withdrawal by Subject|2|||
16083034|NCT00739908|38796153|FG000|Overall Study|Lost to Follow-up|14|||
16083035|NCT00739908|38796154|FG001|Overall Study|Lost to Follow-up|9|||
16083036|NCT00739908|38796153|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
16083037|NCT00739908|38796154|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
16083038|NCT00739908|38796153|FG000|Overall Study|Non-Compliance With Study Medication|0|||
16083039|NCT00739908|38796154|FG001|Overall Study|Non-Compliance With Study Medication|3|||
16083040|NCT00739908|38796153|FG000|Overall Study|Lack of Efficacy|0|||
16083041|NCT00739908|38796154|FG001|Overall Study|Lack of Efficacy|1|||
16083042|NCT00739908|38796153|FG000|Overall Study|Relocation|0|||
16083043|NCT00739908|38796154|FG001|Overall Study|Relocation|1|||
16083044|NCT00424645|38796155|FG000|Overall Study|Death|1|||
16083045|NCT00424645|38796156|FG001|Overall Study|Death|0|||
16083046|NCT00988858|38796158|FG000|Overall Study|Adverse Event|7|||
16083047|NCT00988858|38796158|FG000|Overall Study|Death|1|||
16083048|NCT00988858|38796158|FG000|Overall Study|Physician Decision|1|||
16083049|NCT00988858|38796158|FG000|Overall Study|Sponsor Decision|1|||
16083050|NCT00439270|38796165|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
16083051|NCT00439270|38796166|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
16083052|NCT00439270|38796167|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
16083053|NCT00439270|38796168|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
16083054|NCT00439270|38796169|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
16083055|NCT00439270|38796165|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
16083056|NCT00439270|38796166|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
16083057|NCT00439270|38796167|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
16083058|NCT00439270|38796168|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
16083059|NCT00439270|38796169|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
16083060|NCT00439270|38796165|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
16083061|NCT00439270|38796166|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
16083062|NCT00439270|38796167|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
16083063|NCT00439270|38796168|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
16083064|NCT00439270|38796169|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
16083065|NCT00439270|38796165|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
16487612|NCT00042289|40259849|FG044|Overall Study|Lost to Follow-up|0|||
16487613|NCT00042289|40259850|FG045|Overall Study|Lost to Follow-up|1|||
16487614|NCT00042289|40259851|FG046|Overall Study|Lost to Follow-up|0|||
16487615|NCT00042289|40259805|FG000|Overall Study|Other reason|0|||
16487616|NCT00042289|40259806|FG001|Overall Study|Other reason|0|||
16487617|NCT00042289|40259807|FG002|Overall Study|Other reason|0|||
16487618|NCT00042289|40259808|FG003|Overall Study|Other reason|2|||
16487619|NCT00042289|40259809|FG004|Overall Study|Other reason|0|||
16487620|NCT00042289|40259810|FG005|Overall Study|Other reason|0|||
16487621|NCT00042289|40259811|FG006|Overall Study|Other reason|0|||
16487622|NCT00042289|40259812|FG007|Overall Study|Other reason|0|||
16487623|NCT00042289|40259813|FG008|Overall Study|Other reason|0|||
16083066|NCT00439270|38796166|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
16083067|NCT00439270|38796167|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
16083068|NCT00439270|38796168|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
16083069|NCT00439270|38796169|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
16487624|NCT00042289|40259814|FG009|Overall Study|Other reason|0|||
16487625|NCT00042289|40259815|FG010|Overall Study|Other reason|0|||
16487626|NCT00042289|40259816|FG011|Overall Study|Other reason|0|||
16487627|NCT00042289|40259817|FG012|Overall Study|Other reason|0|||
16487628|NCT00042289|40259818|FG013|Overall Study|Other reason|0|||
16083070|NCT00439270|38796165|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
16083071|NCT00439270|38796166|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
16083072|NCT00439270|38796167|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
16083073|NCT00439270|38796168|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
16083074|NCT00439270|38796169|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
16487629|NCT00042289|40259819|FG014|Overall Study|Other reason|0|||
16487630|NCT00042289|40259820|FG015|Overall Study|Other reason|0|||
16487631|NCT00042289|40259821|FG016|Overall Study|Other reason|0|||
16487632|NCT00042289|40259822|FG017|Overall Study|Other reason|0|||
16487633|NCT00042289|40259823|FG018|Overall Study|Other reason|1|||
16487634|NCT00042289|40259824|FG019|Overall Study|Other reason|0|||
16487635|NCT00042289|40259825|FG020|Overall Study|Other reason|0|||
16487636|NCT00042289|40259826|FG021|Overall Study|Other reason|0|||
16487637|NCT00042289|40259827|FG022|Overall Study|Other reason|0|||
16487638|NCT00042289|40259828|FG023|Overall Study|Other reason|1|||
16487639|NCT00042289|40259829|FG024|Overall Study|Other reason|0|||
16487640|NCT00042289|40259830|FG025|Overall Study|Other reason|0|||
16083075|NCT00439270|38796165|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
16083076|NCT00439270|38796166|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
16083077|NCT00439270|38796167|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
16083078|NCT00439270|38796168|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
16083079|NCT00439270|38796169|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
16083080|NCT00439270|38796165|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
16487641|NCT00042289|40259831|FG026|Overall Study|Other reason|1|||
16487642|NCT00042289|40259832|FG027|Overall Study|Other reason|0|||
16083081|NCT00439270|38796166|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
16083082|NCT00439270|38796167|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
16189392|NCT03567291|39169645|FG001|Period III|Terminated by sponsor|0|||
16189393|NCT03567291|39169646|FG002|Period III|Terminated by sponsor|0|||
16189394|NCT03567291|39169647|FG003|Period III|Terminated by sponsor|68|||
16487643|NCT00042289|40259833|FG028|Overall Study|Other reason|3|||
16487644|NCT00042289|40259834|FG029|Overall Study|Other reason|0|||
16487645|NCT00042289|40259835|FG030|Overall Study|Other reason|0|||
16487646|NCT00042289|40259836|FG031|Overall Study|Other reason|1|||
16487647|NCT00042289|40259837|FG032|Overall Study|Other reason|0|||
16487648|NCT00042289|40259838|FG033|Overall Study|Other reason|1|||
16487649|NCT00042289|40259839|FG034|Overall Study|Other reason|0|||
16487650|NCT00042289|40259840|FG035|Overall Study|Other reason|2|||
16189395|NCT03567291|39169644|FG000|Period III|Missing or unknown|0|||
16189396|NCT03567291|39169645|FG001|Period III|Missing or unknown|0|||
16189397|NCT03567291|39169646|FG002|Period III|Missing or unknown|0|||
16189398|NCT03567291|39169647|FG003|Period III|Missing or unknown|8|||
16189399|NCT01798706|39169649|FG000|Overall Study|Adverse Event|15|||
16189400|NCT01798706|39169650|FG001|Overall Study|Adverse Event|10|||
16189401|NCT01798706|39169649|FG000|Overall Study|Lack of Efficacy|0|||
16189402|NCT01798706|39169650|FG001|Overall Study|Lack of Efficacy|2|||
16189403|NCT01798706|39169649|FG000|Overall Study|Poor compliance to protocol|1|||
16189404|NCT01798706|39169650|FG001|Overall Study|Poor compliance to protocol|0|||
16189405|NCT01798706|39169649|FG000|Overall Study|Other than specified above|5|||
16189406|NCT01798706|39169650|FG001|Overall Study|Other than specified above|9|||
16189407|NCT03010423|39169651|FG000|Overall Study|Study termination|8|||
16189408|NCT00620321|39169652|FG000|Overall Study|Adverse Event|1|||
16189409|NCT00620321|39169653|FG001|Overall Study|Adverse Event|1|||
16189410|NCT00620321|39169652|FG000|Overall Study|Death|1|||
16189411|NCT00620321|39169653|FG001|Overall Study|Death|1|||
16189412|NCT00620321|39169652|FG000|Overall Study|Physician Decision|0|||
16189413|NCT00620321|39169653|FG001|Overall Study|Physician Decision|7|||
16189414|NCT00620321|39169652|FG000|Overall Study|Progressive Disease|5|||
16189415|NCT00620321|39169653|FG001|Overall Study|Progressive Disease|5|||
16189416|NCT00620321|39169652|FG000|Overall Study|Sponsor Decision|0|||
16189417|NCT00620321|39169653|FG001|Overall Study|Sponsor Decision|1|||
16189418|NCT00620321|39169652|FG000|Overall Study|Withdrawal by Subject|1|||
16189419|NCT00620321|39169653|FG001|Overall Study|Withdrawal by Subject|1|||
16487651|NCT00042289|40259841|FG036|Overall Study|Other reason|0|||
16487652|NCT00042289|40259842|FG037|Overall Study|Other reason|0|||
16487653|NCT00042289|40259843|FG038|Overall Study|Other reason|0|||
16487654|NCT00042289|40259844|FG039|Overall Study|Other reason|0|||
16487655|NCT00042289|40259845|FG040|Overall Study|Other reason|0|||
16487656|NCT00042289|40259846|FG041|Overall Study|Other reason|0|||
16487657|NCT00042289|40259847|FG042|Overall Study|Other reason|0|||
16487658|NCT00042289|40259848|FG043|Overall Study|Other reason|1|||
16487659|NCT00042289|40259849|FG044|Overall Study|Other reason|0|||
16189420|NCT02750800|39169655|FG000|Overall Study|Adverse Event|18|||
16189421|NCT02750800|39169655|FG000|Overall Study|Lost to Follow-up|12|||
16189422|NCT02750800|39169655|FG000|Overall Study|Investigator decision|53|||
16189423|NCT02750800|39169655|FG000|Overall Study|Patient request|12|||
16189424|NCT02750800|39169655|FG000|Overall Study|Other, not specified|3|||
16487660|NCT00042289|40259850|FG045|Overall Study|Other reason|0|||
16487661|NCT00042289|40259851|FG046|Overall Study|Other reason|0|||
16487662|NCT00042289|40259805|FG000|Overall Study|Severe debilitation, unable to continue|0|||
16487663|NCT00042289|40259806|FG001|Overall Study|Severe debilitation, unable to continue|0|||
16487664|NCT00042289|40259807|FG002|Overall Study|Severe debilitation, unable to continue|0|||
16487665|NCT00042289|40259808|FG003|Overall Study|Severe debilitation, unable to continue|0|||
16487666|NCT00042289|40259809|FG004|Overall Study|Severe debilitation, unable to continue|0|||
16487667|NCT00042289|40259810|FG005|Overall Study|Severe debilitation, unable to continue|0|||
16189425|NCT02632110|39169658|FG000|Overall Study|Withdrawal by Subject|1|||
16189426|NCT02632110|39169659|FG001|Overall Study|Withdrawal by Subject|1|||
16189427|NCT02632110|39169660|FG002|Overall Study|Withdrawal by Subject|0|||
16189428|NCT02632110|39169661|FG003|Overall Study|Withdrawal by Subject|0|||
16189429|NCT02632110|39169662|FG004|Overall Study|Withdrawal by Subject|1|||
16189430|NCT02632110|39169663|FG005|Overall Study|Withdrawal by Subject|1|||
16189431|NCT02632110|39169664|FG006|Overall Study|Withdrawal by Subject|3|||
16189432|NCT02632110|39169665|FG007|Overall Study|Withdrawal by Subject|3|||
16189433|NCT02632110|39169666|FG008|Overall Study|Withdrawal by Subject|1|||
16189434|NCT02632110|39169667|FG009|Overall Study|Withdrawal by Subject|1|||
16189435|NCT03117049|39169668|FG000|Overall Study|Continued the follow-up period|109|||
16189436|NCT03117049|39169669|FG001|Overall Study|Continued the follow-up period|129|||
16189437|NCT03117049|39169668|FG000|Overall Study|Died|82|||
16189438|NCT03117049|39169669|FG001|Overall Study|Died|93|||
16189439|NCT03117049|39169668|FG000|Overall Study|Consent withdrawal|7|||
16189440|NCT03117049|39169669|FG001|Overall Study|Consent withdrawal|6|||
16189441|NCT03117049|39169668|FG000|Overall Study|Missing contact|3|||
16189442|NCT03117049|39169669|FG001|Overall Study|Missing contact|3|||
16189443|NCT01108809|39169670|FG000|Overall Study|Adverse Event|3|||
16189444|NCT01108809|39169670|FG000|Overall Study|Lost to Follow-up|1|||
16189445|NCT02626819|39169672|FG000|Overall Study|Lost to Follow-up|3|||
16189446|NCT02626819|39169673|FG001|Overall Study|Lost to Follow-up|2|||
16189447|NCT02626819|39169672|FG000|Overall Study|Withdrawal by Subject|1|||
16189448|NCT02626819|39169673|FG001|Overall Study|Withdrawal by Subject|0|||
16189449|NCT02626819|39169672|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
16189450|NCT02626819|39169673|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
16189451|NCT03633227|39169674|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
16189452|NCT03633227|39169675|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
16189453|NCT03633227|39169674|FG000|Double Blind (DB), up to Week 48|Death|2|||
16189454|NCT03633227|39169675|FG001|Double Blind (DB), up to Week 48|Death|1|||
16189455|NCT03633227|39169674|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
16189456|NCT03633227|39169675|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
16189457|NCT03633227|39169674|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
16189458|NCT03633227|39169675|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
16189459|NCT03633227|39169674|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
16189460|NCT03633227|39169675|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
16189461|NCT03633227|39169674|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
16189462|NCT03633227|39169675|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
16189463|NCT03633227|39169674|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
16189464|NCT03633227|39169675|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
16189465|NCT03633227|39169674|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
16189466|NCT03633227|39169675|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
16189467|NCT03633227|39169674|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
16189468|NCT03633227|39169675|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
16189469|NCT03633227|39169674|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
16189470|NCT03633227|39169675|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
16189471|NCT03633227|39169674|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
16189472|NCT03633227|39169675|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
16189473|NCT03633227|39169674|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
16189474|NCT03633227|39169675|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
16189475|NCT02926573|39169678|FG000|Overall Study|Nausea|1|||
16189476|NCT02926573|39169679|FG001|Overall Study|Nausea|0|||
16189477|NCT02926573|39169678|FG000|Overall Study|Remain intubated|2|||
16189478|NCT02926573|39169679|FG001|Overall Study|Remain intubated|2|||
16189479|NCT02926573|39169678|FG000|Overall Study|Change in surgery plan|3|||
16189480|NCT02926573|39169679|FG001|Overall Study|Change in surgery plan|1|||
16189481|NCT02926573|39169678|FG000|Overall Study|Change to outpatient status|5|||
16189482|NCT02926573|39169679|FG001|Overall Study|Change to outpatient status|1|||
16189483|NCT02926573|39169678|FG000|Overall Study|Withdrawal by Subject|0|||
16384010|NCT00557193|39888699|FG001|Induction|Ineligible|0|||
16384011|NCT00557193|39888700|FG002|Induction|Ineligible|0|||
16384012|NCT00557193|39888701|FG003|Induction|Ineligible|0|||
16384013|NCT00557193|39888702|FG004|Induction|Ineligible|0|||
16384014|NCT00557193|39888703|FG005|Induction|Ineligible|0|||
16384015|NCT00557193|39888698|FG000|Induction|Inevaluable for post Induction|2|||
16384016|NCT00557193|39888699|FG001|Induction|Inevaluable for post Induction|0|||
16384017|NCT00557193|39888700|FG002|Induction|Inevaluable for post Induction|0|||
16189484|NCT02926573|39169679|FG001|Overall Study|Withdrawal by Subject|2|||
16189485|NCT02926573|39169678|FG000|Overall Study|Return to operating room|0|||
16189486|NCT02926573|39169679|FG001|Overall Study|Return to operating room|2|||
16189487|NCT02926573|39169678|FG000|Overall Study|Delirium|0|||
16384018|NCT00557193|39888701|FG003|Induction|Inevaluable for post Induction|0|||
16384019|NCT00557193|39888702|FG004|Induction|Inevaluable for post Induction|0|||
16384020|NCT00557193|39888703|FG005|Induction|Inevaluable for post Induction|0|||
16384021|NCT00557193|39888698|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
16384022|NCT00557193|39888699|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
16384023|NCT00557193|39888700|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
16384024|NCT00557193|39888701|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
16384025|NCT00557193|39888702|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
16384026|NCT00557193|39888703|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
16384027|NCT00557193|39888698|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
16384028|NCT00557193|39888699|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
16384029|NCT00557193|39888700|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
16384030|NCT00557193|39888701|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
16384031|NCT00557193|39888702|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
16384032|NCT00557193|39888703|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
16384033|NCT00557193|39888698|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
16384034|NCT00557193|39888699|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
16384035|NCT00557193|39888700|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
16384036|NCT00557193|39888701|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
16384037|NCT00557193|39888702|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
16384038|NCT00557193|39888703|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
16487668|NCT00042289|40259811|FG006|Overall Study|Severe debilitation, unable to continue|0|||
16487669|NCT00042289|40259812|FG007|Overall Study|Severe debilitation, unable to continue|0|||
16487670|NCT00042289|40259813|FG008|Overall Study|Severe debilitation, unable to continue|0|||
16487671|NCT00042289|40259814|FG009|Overall Study|Severe debilitation, unable to continue|0|||
16487672|NCT00042289|40259815|FG010|Overall Study|Severe debilitation, unable to continue|0|||
16487673|NCT00042289|40259816|FG011|Overall Study|Severe debilitation, unable to continue|0|||
16487674|NCT00042289|40259817|FG012|Overall Study|Severe debilitation, unable to continue|0|||
16487675|NCT00042289|40259818|FG013|Overall Study|Severe debilitation, unable to continue|0|||
16487676|NCT00042289|40259819|FG014|Overall Study|Severe debilitation, unable to continue|0|||
16487677|NCT00042289|40259820|FG015|Overall Study|Severe debilitation, unable to continue|0|||
16487678|NCT00042289|40259821|FG016|Overall Study|Severe debilitation, unable to continue|0|||
16487679|NCT00042289|40259822|FG017|Overall Study|Severe debilitation, unable to continue|0|||
16487680|NCT00042289|40259823|FG018|Overall Study|Severe debilitation, unable to continue|0|||
16487681|NCT00042289|40259824|FG019|Overall Study|Severe debilitation, unable to continue|0|||
16487682|NCT00042289|40259825|FG020|Overall Study|Severe debilitation, unable to continue|0|||
16487683|NCT00042289|40259826|FG021|Overall Study|Severe debilitation, unable to continue|1|||
16487684|NCT00042289|40259827|FG022|Overall Study|Severe debilitation, unable to continue|0|||
16487685|NCT00042289|40259828|FG023|Overall Study|Severe debilitation, unable to continue|1|||
16487686|NCT00042289|40259829|FG024|Overall Study|Severe debilitation, unable to continue|0|||
16487687|NCT00042289|40259830|FG025|Overall Study|Severe debilitation, unable to continue|0|||
16487688|NCT00042289|40259831|FG026|Overall Study|Severe debilitation, unable to continue|0|||
16487689|NCT00042289|40259832|FG027|Overall Study|Severe debilitation, unable to continue|1|||
16487690|NCT00042289|40259833|FG028|Overall Study|Severe debilitation, unable to continue|0|||
16487691|NCT00042289|40259834|FG029|Overall Study|Severe debilitation, unable to continue|0|||
16487692|NCT00042289|40259835|FG030|Overall Study|Severe debilitation, unable to continue|0|||
16487693|NCT00042289|40259836|FG031|Overall Study|Severe debilitation, unable to continue|1|||
16487694|NCT00042289|40259837|FG032|Overall Study|Severe debilitation, unable to continue|1|||
16487695|NCT00042289|40259838|FG033|Overall Study|Severe debilitation, unable to continue|0|||
16487696|NCT00042289|40259839|FG034|Overall Study|Severe debilitation, unable to continue|0|||
16487697|NCT00042289|40259840|FG035|Overall Study|Severe debilitation, unable to continue|0|||
16487698|NCT00042289|40259841|FG036|Overall Study|Severe debilitation, unable to continue|0|||
16384039|NCT00557193|39888698|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
16384040|NCT00557193|39888699|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
16384041|NCT00557193|39888700|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
16384042|NCT00557193|39888701|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
16384043|NCT00557193|39888702|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
16083083|NCT00439270|38796168|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
16083084|NCT00439270|38796169|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
16083085|NCT00439270|38796165|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
16384044|NCT00557193|39888703|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
16384045|NCT00557193|39888698|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
16384046|NCT00557193|39888699|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
16384047|NCT00557193|39888700|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
16384048|NCT00557193|39888701|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
16384049|NCT00557193|39888702|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
16189488|NCT02926573|39169679|FG001|Overall Study|Delirium|1|||
16487699|NCT00042289|40259842|FG037|Overall Study|Severe debilitation, unable to continue|0|||
16487700|NCT00042289|40259843|FG038|Overall Study|Severe debilitation, unable to continue|0|||
16487701|NCT00042289|40259844|FG039|Overall Study|Severe debilitation, unable to continue|0|||
16487702|NCT00042289|40259845|FG040|Overall Study|Severe debilitation, unable to continue|0|||
16487703|NCT00042289|40259846|FG041|Overall Study|Severe debilitation, unable to continue|0|||
16487704|NCT00042289|40259847|FG042|Overall Study|Severe debilitation, unable to continue|0|||
16487705|NCT00042289|40259848|FG043|Overall Study|Severe debilitation, unable to continue|0|||
16487706|NCT00042289|40259849|FG044|Overall Study|Severe debilitation, unable to continue|0|||
16487707|NCT00042289|40259850|FG045|Overall Study|Severe debilitation, unable to continue|0|||
16487708|NCT00042289|40259851|FG046|Overall Study|Severe debilitation, unable to continue|0|||
16487709|NCT00042289|40259805|FG000|Overall Study|Site closed|0|||
16487710|NCT00042289|40259806|FG001|Overall Study|Site closed|0|||
16487711|NCT00042289|40259807|FG002|Overall Study|Site closed|0|||
16487712|NCT00042289|40259808|FG003|Overall Study|Site closed|0|||
16487713|NCT00042289|40259809|FG004|Overall Study|Site closed|0|||
16487714|NCT00042289|40259810|FG005|Overall Study|Site closed|0|||
16487715|NCT00042289|40259811|FG006|Overall Study|Site closed|0|||
16487716|NCT00042289|40259812|FG007|Overall Study|Site closed|0|||
16487717|NCT00042289|40259813|FG008|Overall Study|Site closed|0|||
16487718|NCT00042289|40259814|FG009|Overall Study|Site closed|0|||
16487719|NCT00042289|40259815|FG010|Overall Study|Site closed|0|||
16487720|NCT00042289|40259816|FG011|Overall Study|Site closed|0|||
16487721|NCT00042289|40259817|FG012|Overall Study|Site closed|0|||
16189489|NCT00320385|39169680|FG000|Overall Study|Lost to Follow-up|7|||
16487722|NCT00042289|40259818|FG013|Overall Study|Site closed|0|||
16487723|NCT00042289|40259819|FG014|Overall Study|Site closed|0|||
16487724|NCT00042289|40259820|FG015|Overall Study|Site closed|0|||
16487725|NCT00042289|40259821|FG016|Overall Study|Site closed|0|||
16487726|NCT00042289|40259822|FG017|Overall Study|Site closed|0|||
16487727|NCT00042289|40259823|FG018|Overall Study|Site closed|0|||
16487728|NCT00042289|40259824|FG019|Overall Study|Site closed|0|||
16487729|NCT00042289|40259825|FG020|Overall Study|Site closed|0|||
16487730|NCT00042289|40259826|FG021|Overall Study|Site closed|0|||
16487731|NCT00042289|40259827|FG022|Overall Study|Site closed|0|||
16487732|NCT00042289|40259828|FG023|Overall Study|Site closed|0|||
16487733|NCT00042289|40259829|FG024|Overall Study|Site closed|0|||
16487734|NCT00042289|40259830|FG025|Overall Study|Site closed|0|||
16487735|NCT00042289|40259831|FG026|Overall Study|Site closed|0|||
16487736|NCT00042289|40259832|FG027|Overall Study|Site closed|0|||
16487737|NCT00042289|40259833|FG028|Overall Study|Site closed|0|||
16487738|NCT00042289|40259834|FG029|Overall Study|Site closed|0|||
16189490|NCT00320385|39169681|FG001|Overall Study|Lost to Follow-up|10|||
16189491|NCT00320385|39169680|FG000|Overall Study|Withdrawal by Subject|6|||
16297139|NCT02393248|39573971|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297140|NCT02393248|39573972|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297141|NCT02393248|39573973|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297142|NCT02393248|39573974|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
16297143|NCT02393248|39573975|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
16297144|NCT02393248|39573976|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297145|NCT02393248|39573977|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297146|NCT02393248|39573978|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
16297147|NCT02393248|39573979|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297148|NCT02393248|39573980|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297149|NCT02393248|39573981|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297150|NCT02393248|39573982|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297151|NCT02393248|39573983|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297152|NCT02393248|39573984|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297153|NCT02393248|39573985|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297154|NCT02393248|39573986|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297155|NCT02393248|39573987|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297156|NCT02393248|39573988|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16384050|NCT00557193|39888703|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
16487739|NCT00042289|40259835|FG030|Overall Study|Site closed|0|||
16487740|NCT00042289|40259836|FG031|Overall Study|Site closed|3|||
16487741|NCT00042289|40259837|FG032|Overall Study|Site closed|0|||
16487742|NCT00042289|40259838|FG033|Overall Study|Site closed|0|||
16487743|NCT00042289|40259839|FG034|Overall Study|Site closed|0|||
16487744|NCT00042289|40259840|FG035|Overall Study|Site closed|0|||
16487745|NCT00042289|40259841|FG036|Overall Study|Site closed|1|||
16487746|NCT00042289|40259842|FG037|Overall Study|Site closed|0|||
16487747|NCT00042289|40259843|FG038|Overall Study|Site closed|0|||
16487748|NCT00042289|40259844|FG039|Overall Study|Site closed|0|||
16189492|NCT00320385|39169681|FG001|Overall Study|Withdrawal by Subject|7|||
16487749|NCT00042289|40259845|FG040|Overall Study|Site closed|0|||
16487750|NCT00042289|40259846|FG041|Overall Study|Site closed|0|||
16487751|NCT00042289|40259847|FG042|Overall Study|Site closed|1|||
16083086|NCT00439270|38796166|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
16083087|NCT00439270|38796167|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
16083088|NCT00439270|38796168|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
16189493|NCT00320385|39169680|FG000|Overall Study|Sponsor Terminated Study|2|||
16297157|NCT02393248|39573989|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297158|NCT02393248|39573990|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297159|NCT02393248|39573991|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297160|NCT02393248|39573992|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16487752|NCT00042289|40259848|FG043|Overall Study|Site closed|0|||
16487753|NCT00042289|40259849|FG044|Overall Study|Site closed|0|||
16487754|NCT00042289|40259850|FG045|Overall Study|Site closed|0|||
16487755|NCT00042289|40259851|FG046|Overall Study|Site closed|0|||
16487756|NCT00042289|40259805|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
16487757|NCT00042289|40259806|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
16487758|NCT00042289|40259807|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
16487759|NCT00042289|40259808|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
16487760|NCT00042289|40259809|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
16487761|NCT00042289|40259810|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
16487762|NCT00042289|40259811|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
16487763|NCT00042289|40259812|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
16487764|NCT00042289|40259813|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
16487765|NCT00042289|40259814|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
16487766|NCT00042289|40259815|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
16487767|NCT00042289|40259816|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
16487768|NCT00042289|40259817|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
16487769|NCT00042289|40259818|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
16487770|NCT00042289|40259819|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
16487771|NCT00042289|40259820|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
16487772|NCT00042289|40259821|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
16487773|NCT00042289|40259822|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
16487774|NCT00042289|40259823|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
16487775|NCT00042289|40259824|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
16487776|NCT00042289|40259825|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
16487777|NCT00042289|40259826|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
16487778|NCT00042289|40259827|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
16487779|NCT00042289|40259828|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
16487780|NCT00042289|40259829|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
16487781|NCT00042289|40259830|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
16487782|NCT00042289|40259831|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
16487783|NCT00042289|40259832|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
16487784|NCT00042289|40259833|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
16487785|NCT00042289|40259834|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
16487786|NCT00042289|40259835|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
16487787|NCT00042289|40259836|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
16487788|NCT00042289|40259837|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
16487789|NCT00042289|40259838|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
16487790|NCT00042289|40259839|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
16487791|NCT00042289|40259840|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
16487792|NCT00042289|40259841|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
16487793|NCT00042289|40259842|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
16487794|NCT00042289|40259843|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
16487795|NCT00042289|40259844|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
16487796|NCT00042289|40259845|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
16487797|NCT00042289|40259846|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
16487798|NCT00042289|40259847|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
16297161|NCT02393248|39573993|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
16297162|NCT02393248|39573969|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297163|NCT02393248|39573970|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297164|NCT02393248|39573971|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297165|NCT02393248|39573972|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297166|NCT02393248|39573973|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16083089|NCT00439270|38796169|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
16297167|NCT02393248|39573974|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297168|NCT02393248|39573975|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
16297169|NCT02393248|39573976|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297170|NCT02393248|39573977|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297171|NCT02393248|39573978|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297172|NCT02393248|39573979|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297173|NCT02393248|39573980|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297174|NCT02393248|39573981|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297175|NCT02393248|39573982|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297176|NCT02393248|39573983|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297177|NCT02393248|39573984|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297178|NCT02393248|39573985|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297179|NCT02393248|39573986|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297180|NCT02393248|39573987|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297181|NCT02393248|39573988|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297182|NCT02393248|39573989|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297183|NCT02393248|39573990|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297184|NCT02393248|39573991|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297185|NCT02393248|39573992|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297186|NCT02393248|39573993|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
16297187|NCT02393248|39573969|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297188|NCT02393248|39573970|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297189|NCT02393248|39573971|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297190|NCT02393248|39573972|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297191|NCT02393248|39573973|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297192|NCT02393248|39573974|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297193|NCT02393248|39573975|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297194|NCT02393248|39573976|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297195|NCT02393248|39573977|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297196|NCT02393248|39573978|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16487799|NCT00042289|40259848|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
16487800|NCT00042289|40259849|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
16487801|NCT00042289|40259850|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
16487802|NCT00042289|40259851|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
16487803|NCT00042289|40259805|FG000|Overall Study|Protocol Violation|0|||
16487804|NCT00042289|40259806|FG001|Overall Study|Protocol Violation|0|||
16487805|NCT00042289|40259807|FG002|Overall Study|Protocol Violation|0|||
16487806|NCT00042289|40259808|FG003|Overall Study|Protocol Violation|0|||
16487807|NCT00042289|40259809|FG004|Overall Study|Protocol Violation|0|||
16487808|NCT00042289|40259810|FG005|Overall Study|Protocol Violation|1|||
16487809|NCT00042289|40259811|FG006|Overall Study|Protocol Violation|0|||
16487810|NCT00042289|40259812|FG007|Overall Study|Protocol Violation|1|||
16487811|NCT00042289|40259813|FG008|Overall Study|Protocol Violation|0|||
16487812|NCT00042289|40259814|FG009|Overall Study|Protocol Violation|0|||
16487813|NCT00042289|40259815|FG010|Overall Study|Protocol Violation|0|||
16487814|NCT00042289|40259816|FG011|Overall Study|Protocol Violation|0|||
16487815|NCT00042289|40259817|FG012|Overall Study|Protocol Violation|0|||
16487816|NCT00042289|40259818|FG013|Overall Study|Protocol Violation|0|||
16487817|NCT00042289|40259819|FG014|Overall Study|Protocol Violation|0|||
16487818|NCT00042289|40259820|FG015|Overall Study|Protocol Violation|0|||
16487819|NCT00042289|40259821|FG016|Overall Study|Protocol Violation|0|||
16487820|NCT00042289|40259822|FG017|Overall Study|Protocol Violation|0|||
16487821|NCT00042289|40259823|FG018|Overall Study|Protocol Violation|0|||
16487822|NCT00042289|40259824|FG019|Overall Study|Protocol Violation|0|||
16487823|NCT00042289|40259825|FG020|Overall Study|Protocol Violation|0|||
16487824|NCT00042289|40259826|FG021|Overall Study|Protocol Violation|0|||
16487825|NCT00042289|40259827|FG022|Overall Study|Protocol Violation|0|||
16487826|NCT00042289|40259828|FG023|Overall Study|Protocol Violation|1|||
16487827|NCT00042289|40259829|FG024|Overall Study|Protocol Violation|1|||
16487828|NCT00042289|40259830|FG025|Overall Study|Protocol Violation|0|||
16487829|NCT00042289|40259831|FG026|Overall Study|Protocol Violation|2|||
16487830|NCT00042289|40259832|FG027|Overall Study|Protocol Violation|0|||
16487831|NCT00042289|40259833|FG028|Overall Study|Protocol Violation|0|||
16487832|NCT00042289|40259834|FG029|Overall Study|Protocol Violation|0|||
16487833|NCT00042289|40259835|FG030|Overall Study|Protocol Violation|1|||
16487834|NCT00042289|40259836|FG031|Overall Study|Protocol Violation|0|||
16487835|NCT00042289|40259837|FG032|Overall Study|Protocol Violation|0|||
16297197|NCT02393248|39573979|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297198|NCT02393248|39573980|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
16297199|NCT02393248|39573981|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
16297200|NCT02393248|39573982|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
16297201|NCT02393248|39573983|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
16297202|NCT02393248|39573984|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297203|NCT02393248|39573985|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297204|NCT02393248|39573986|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297205|NCT02393248|39573987|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297206|NCT02393248|39573988|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297207|NCT02393248|39573989|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297208|NCT02393248|39573990|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297209|NCT02393248|39573991|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297210|NCT02393248|39573992|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297211|NCT02393248|39573993|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
16297212|NCT02393248|39573969|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297213|NCT02393248|39573970|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297214|NCT02393248|39573971|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297215|NCT02393248|39573972|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297216|NCT02393248|39573973|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297217|NCT02393248|39573974|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297218|NCT02393248|39573975|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297219|NCT02393248|39573976|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297220|NCT02393248|39573977|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297221|NCT02393248|39573978|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297222|NCT02393248|39573979|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
16297223|NCT02393248|39573980|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
16384051|NCT00557193|39888698|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
16384052|NCT00557193|39888699|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
16384053|NCT00557193|39888700|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
16384054|NCT00557193|39888701|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
16384055|NCT00557193|39888702|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
16384056|NCT00557193|39888703|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
16384057|NCT00557193|39888698|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
16384058|NCT00557193|39888699|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
16384059|NCT00557193|39888700|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
16487836|NCT00042289|40259838|FG033|Overall Study|Protocol Violation|0|||
16487837|NCT00042289|40259839|FG034|Overall Study|Protocol Violation|0|||
16487838|NCT00042289|40259840|FG035|Overall Study|Protocol Violation|0|||
16487839|NCT00042289|40259841|FG036|Overall Study|Protocol Violation|0|||
16487840|NCT00042289|40259842|FG037|Overall Study|Protocol Violation|0|||
16487841|NCT00042289|40259843|FG038|Overall Study|Protocol Violation|0|||
16487842|NCT00042289|40259844|FG039|Overall Study|Protocol Violation|0|||
16487843|NCT00042289|40259845|FG040|Overall Study|Protocol Violation|0|||
16487844|NCT00042289|40259846|FG041|Overall Study|Protocol Violation|1|||
16487845|NCT00042289|40259847|FG042|Overall Study|Protocol Violation|1|||
16189494|NCT00320385|39169681|FG001|Overall Study|Sponsor Terminated Study|1|||
16487846|NCT00042289|40259848|FG043|Overall Study|Protocol Violation|1|||
16487847|NCT00042289|40259849|FG044|Overall Study|Protocol Violation|0|||
16487848|NCT00042289|40259850|FG045|Overall Study|Protocol Violation|0|||
16487849|NCT00042289|40259851|FG046|Overall Study|Protocol Violation|0|||
16487850|NCT00042289|40259805|FG000|Overall Study|Withdrawal by Subject|4|||
16487851|NCT00042289|40259806|FG001|Overall Study|Withdrawal by Subject|1|||
16487852|NCT00042289|40259807|FG002|Overall Study|Withdrawal by Subject|0|||
16487853|NCT00042289|40259808|FG003|Overall Study|Withdrawal by Subject|2|||
16487854|NCT00042289|40259809|FG004|Overall Study|Withdrawal by Subject|0|||
16487855|NCT00042289|40259810|FG005|Overall Study|Withdrawal by Subject|2|||
16487856|NCT00042289|40259811|FG006|Overall Study|Withdrawal by Subject|0|||
16487857|NCT00042289|40259812|FG007|Overall Study|Withdrawal by Subject|0|||
16487858|NCT00042289|40259813|FG008|Overall Study|Withdrawal by Subject|0|||
16487859|NCT00042289|40259814|FG009|Overall Study|Withdrawal by Subject|1|||
16487860|NCT00042289|40259815|FG010|Overall Study|Withdrawal by Subject|0|||
16487861|NCT00042289|40259816|FG011|Overall Study|Withdrawal by Subject|0|||
16487862|NCT00042289|40259817|FG012|Overall Study|Withdrawal by Subject|2|||
16487863|NCT00042289|40259818|FG013|Overall Study|Withdrawal by Subject|0|||
16487864|NCT00042289|40259819|FG014|Overall Study|Withdrawal by Subject|0|||
16487865|NCT00042289|40259820|FG015|Overall Study|Withdrawal by Subject|0|||
16487866|NCT00042289|40259821|FG016|Overall Study|Withdrawal by Subject|0|||
16487867|NCT00042289|40259822|FG017|Overall Study|Withdrawal by Subject|0|||
16487868|NCT00042289|40259823|FG018|Overall Study|Withdrawal by Subject|0|||
16487869|NCT00042289|40259824|FG019|Overall Study|Withdrawal by Subject|0|||
16487870|NCT00042289|40259825|FG020|Overall Study|Withdrawal by Subject|0|||
16487871|NCT00042289|40259826|FG021|Overall Study|Withdrawal by Subject|1|||
16487872|NCT00042289|40259827|FG022|Overall Study|Withdrawal by Subject|1|||
16384060|NCT00557193|39888701|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
16384061|NCT00557193|39888702|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
16487873|NCT00042289|40259828|FG023|Overall Study|Withdrawal by Subject|1|||
16487874|NCT00042289|40259829|FG024|Overall Study|Withdrawal by Subject|0|||
16487875|NCT00042289|40259830|FG025|Overall Study|Withdrawal by Subject|0|||
16487876|NCT00042289|40259831|FG026|Overall Study|Withdrawal by Subject|1|||
16487877|NCT00042289|40259832|FG027|Overall Study|Withdrawal by Subject|0|||
16487878|NCT00042289|40259833|FG028|Overall Study|Withdrawal by Subject|2|||
16083090|NCT00439270|38796165|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
16083091|NCT00439270|38796166|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
16083092|NCT00439270|38796167|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
16083093|NCT00439270|38796168|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
16083094|NCT00439270|38796169|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
16083095|NCT00439270|38796165|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
16083096|NCT00439270|38796166|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
16083097|NCT00439270|38796167|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
16083098|NCT00439270|38796168|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
16083099|NCT00439270|38796169|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
16083100|NCT02622568|38796170|FG000|Overall Study|Lost to Follow-up|5|||
16083101|NCT02622568|38796171|FG001|Overall Study|Lost to Follow-up|5|||
16083102|NCT02404441|38796172|FG000|Phase 1 Part|Adverse Event|1|||
16083103|NCT02404441|38796173|FG001|Phase 1 Part|Adverse Event|0|||
16083104|NCT02404441|38796174|FG002|Phase 1 Part|Adverse Event|0|||
16083105|NCT02404441|38796175|FG003|Phase 1 Part|Adverse Event|0|||
16083106|NCT02404441|38796176|FG004|Phase 1 Part|Adverse Event|0|||
16083107|NCT02404441|38796177|FG005|Phase 1 Part|Adverse Event|0|||
16083108|NCT02404441|38796178|FG006|Phase 1 Part|Adverse Event|0|||
16083109|NCT02404441|38796179|FG007|Phase 1 Part|Adverse Event|0|||
16083110|NCT02404441|38796180|FG008|Phase 1 Part|Adverse Event|0|||
16083111|NCT02404441|38796181|FG009|Phase 1 Part|Adverse Event|0|||
16083112|NCT02404441|38796172|FG000|Phase 1 Part|Physician Decision|0|||
16083113|NCT02404441|38796173|FG001|Phase 1 Part|Physician Decision|1|||
16083114|NCT02404441|38796174|FG002|Phase 1 Part|Physician Decision|0|||
16083115|NCT02404441|38796175|FG003|Phase 1 Part|Physician Decision|0|||
16083116|NCT02404441|38796176|FG004|Phase 1 Part|Physician Decision|0|||
16083117|NCT02404441|38796177|FG005|Phase 1 Part|Physician Decision|0|||
16083118|NCT02404441|38796178|FG006|Phase 1 Part|Physician Decision|0|||
16083119|NCT02404441|38796179|FG007|Phase 1 Part|Physician Decision|0|||
16083120|NCT02404441|38796180|FG008|Phase 1 Part|Physician Decision|0|||
16083121|NCT02404441|38796181|FG009|Phase 1 Part|Physician Decision|0|||
16083122|NCT02404441|38796172|FG000|Phase 1 Part|Progressive Disease|14|||
16083123|NCT02404441|38796173|FG001|Phase 1 Part|Progressive Disease|11|||
16083124|NCT02404441|38796174|FG002|Phase 1 Part|Progressive Disease|7|||
16083125|NCT02404441|38796175|FG003|Phase 1 Part|Progressive Disease|6|||
16083126|NCT02404441|38796176|FG004|Phase 1 Part|Progressive Disease|9|||
16083127|NCT02404441|38796177|FG005|Phase 1 Part|Progressive Disease|0|||
16083128|NCT02404441|38796178|FG006|Phase 1 Part|Progressive Disease|0|||
16083129|NCT02404441|38796179|FG007|Phase 1 Part|Progressive Disease|0|||
16487879|NCT00042289|40259834|FG029|Overall Study|Withdrawal by Subject|0|||
16083130|NCT02404441|38796180|FG008|Phase 1 Part|Progressive Disease|0|||
16487880|NCT00042289|40259835|FG030|Overall Study|Withdrawal by Subject|0|||
16487881|NCT00042289|40259836|FG031|Overall Study|Withdrawal by Subject|1|||
16487882|NCT00042289|40259837|FG032|Overall Study|Withdrawal by Subject|2|||
16487883|NCT00042289|40259838|FG033|Overall Study|Withdrawal by Subject|1|||
16083131|NCT02404441|38796181|FG009|Phase 1 Part|Progressive Disease|0|||
16083132|NCT02404441|38796172|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
16083133|NCT02404441|38796173|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
16083134|NCT02404441|38796174|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
16384062|NCT00557193|39888703|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
16384063|NCT00557193|39888698|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
16487884|NCT00042289|40259839|FG034|Overall Study|Withdrawal by Subject|0|||
16487885|NCT00042289|40259840|FG035|Overall Study|Withdrawal by Subject|0|||
16487886|NCT00042289|40259841|FG036|Overall Study|Withdrawal by Subject|0|||
16487887|NCT00042289|40259842|FG037|Overall Study|Withdrawal by Subject|1|||
16384064|NCT00557193|39888699|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
16384065|NCT00557193|39888700|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
16384066|NCT00557193|39888701|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
16384067|NCT00557193|39888702|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
16384068|NCT00557193|39888703|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
16384069|NCT00557193|39888698|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
16384070|NCT00557193|39888699|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
16384071|NCT00557193|39888700|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
16384072|NCT00557193|39888701|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
16487888|NCT00042289|40259843|FG038|Overall Study|Withdrawal by Subject|0|||
16487889|NCT00042289|40259844|FG039|Overall Study|Withdrawal by Subject|0|||
16487890|NCT00042289|40259845|FG040|Overall Study|Withdrawal by Subject|0|||
16487891|NCT00042289|40259846|FG041|Overall Study|Withdrawal by Subject|0|||
16487892|NCT00042289|40259847|FG042|Overall Study|Withdrawal by Subject|1|||
16487893|NCT00042289|40259848|FG043|Overall Study|Withdrawal by Subject|0|||
16487894|NCT00042289|40259849|FG044|Overall Study|Withdrawal by Subject|0|||
16487895|NCT00042289|40259850|FG045|Overall Study|Withdrawal by Subject|0|||
16487896|NCT00042289|40259851|FG046|Overall Study|Withdrawal by Subject|0|||
16487897|NCT02505867|40259852|FG000|Overall Study|Lack of Efficacy|6|||
16487898|NCT02505867|40259853|FG001|Overall Study|Lack of Efficacy|6|||
16487899|NCT04659161|40259854|FG000|Overall Study|Adverse Event|10|||
16487900|NCT04659161|40259855|FG001|Overall Study|Adverse Event|6|||
16487901|NCT04659161|40259854|FG000|Overall Study|Withdrawal by Subject|13|||
16487902|NCT04659161|40259855|FG001|Overall Study|Withdrawal by Subject|12|||
16487903|NCT04659161|40259854|FG000|Overall Study|Other|9|||
16083135|NCT02404441|38796175|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
16487904|NCT04659161|40259855|FG001|Overall Study|Other|8|||
16487905|NCT05570500|40259856|FG000|Overall Study|Lost to Follow-up|7|||
16487906|NCT05570500|40259857|FG001|Overall Study|Lost to Follow-up|5|||
16487907|NCT00119106|40259858|FG000|Overall Study|HIV infected at baseline|179|||
16487908|NCT00119106|40259859|FG001|Overall Study|HIV infected at baseline|178|||
16487909|NCT02397278|40259871|FG000|Overall Study|Withdrawal by Subject|0|||
16487910|NCT02397278|40259872|FG001|Overall Study|Withdrawal by Subject|2|||
16487911|NCT02397278|40259871|FG000|Overall Study|Deemed ineligible following surgery|1|||
16487912|NCT02397278|40259872|FG001|Overall Study|Deemed ineligible following surgery|1|||
16487913|NCT03978832|40259874|FG000|Overall Study|Adverse Event|1|||
16487914|NCT03978832|40259874|FG000|Overall Study|Lost to Follow-up|1|||
16487915|NCT03978832|40259874|FG000|Overall Study|Withdrawal by Subject|6|||
16487916|NCT03978832|40259874|FG000|Overall Study|Physician Decision|2|||
16487917|NCT03978832|40259874|FG000|Overall Study|did not pass screening criteria|44|||
16487918|NCT03305575|40259875|FG000|Overall Study|Physician Decision|1|||
16487919|NCT03305575|40259876|FG001|Overall Study|Physician Decision|0|||
16487920|NCT02197130|40259877|FG000|Overall Study|Adverse Event|13|||
16487921|NCT02197130|40259878|FG001|Overall Study|Adverse Event|4|||
16487922|NCT02197130|40259879|FG002|Overall Study|Adverse Event|23|||
16487923|NCT02197130|40259877|FG000|Overall Study|Death|0|||
16487924|NCT02197130|40259878|FG001|Overall Study|Death|1|||
16487925|NCT02197130|40259879|FG002|Overall Study|Death|0|||
16487926|NCT02197130|40259877|FG000|Overall Study|Lost to Follow-up|2|||
16487927|NCT02197130|40259878|FG001|Overall Study|Lost to Follow-up|0|||
16189495|NCT00320385|39169680|FG000|Overall Study|Investigator Decision|0|||
16189496|NCT00320385|39169681|FG001|Overall Study|Investigator Decision|1|||
16189497|NCT00320385|39169680|FG000|Overall Study|Death|1|||
16189498|NCT00320385|39169681|FG001|Overall Study|Death|2|||
16189499|NCT00320385|39169680|FG000|Overall Study|Serious Adverse Event|1|||
16189500|NCT00320385|39169681|FG001|Overall Study|Serious Adverse Event|0|||
16189501|NCT00320385|39169680|FG000|Overall Study|Withdrew Consent|1|||
16189502|NCT00320385|39169681|FG001|Overall Study|Withdrew Consent|0|||
16189503|NCT00320385|39169680|FG000|Overall Study|Adverse Event|0|||
16189504|NCT00320385|39169681|FG001|Overall Study|Adverse Event|1|||
16189505|NCT03032068|39169682|FG000|Overall Study|Adverse Event|1|||
16189506|NCT03260205|39169683|FG000|Overall Study|Adverse Event|2|||
16189507|NCT03260205|39169684|FG001|Overall Study|Adverse Event|0|||
16189508|NCT03260205|39169685|FG002|Overall Study|Adverse Event|2|||
16189509|NCT03260205|39169686|FG003|Overall Study|Adverse Event|2|||
16189510|NCT03260205|39169687|FG004|Overall Study|Adverse Event|4|||
16189511|NCT03260205|39169683|FG000|Overall Study|Lost to Follow-up|2|||
16189512|NCT03260205|39169684|FG001|Overall Study|Lost to Follow-up|2|||
16189513|NCT03260205|39169685|FG002|Overall Study|Lost to Follow-up|1|||
16189514|NCT03260205|39169686|FG003|Overall Study|Lost to Follow-up|1|||
16189515|NCT03260205|39169687|FG004|Overall Study|Lost to Follow-up|5|||
16189516|NCT03260205|39169683|FG000|Overall Study|Protocol Violation|0|||
16487928|NCT02197130|40259879|FG002|Overall Study|Lost to Follow-up|1|||
16189517|NCT03260205|39169684|FG001|Overall Study|Protocol Violation|0|||
16189518|NCT03260205|39169685|FG002|Overall Study|Protocol Violation|2|||
16189519|NCT03260205|39169686|FG003|Overall Study|Protocol Violation|0|||
16189520|NCT03260205|39169687|FG004|Overall Study|Protocol Violation|1|||
16189521|NCT03260205|39169683|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
16297224|NCT02393248|39573981|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16487929|NCT02197130|40259877|FG000|Overall Study|Does not meet entrance criteria|0|||
16487930|NCT02197130|40259878|FG001|Overall Study|Does not meet entrance criteria|0|||
16189522|NCT03260205|39169684|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
16189523|NCT03260205|39169685|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
16487931|NCT02197130|40259879|FG002|Overall Study|Does not meet entrance criteria|1|||
16487932|NCT02197130|40259877|FG000|Overall Study|Withdrawal by Subject|0|||
16384073|NCT00557193|39888702|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
16189524|NCT03260205|39169686|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
16189525|NCT03260205|39169687|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
16189526|NCT03260205|39169683|FG000|Overall Study|Other: Unspecified|0|||
16189527|NCT03260205|39169684|FG001|Overall Study|Other: Unspecified|0|||
16189528|NCT03260205|39169685|FG002|Overall Study|Other: Unspecified|3|||
16189529|NCT03260205|39169686|FG003|Overall Study|Other: Unspecified|1|||
16189530|NCT03260205|39169687|FG004|Overall Study|Other: Unspecified|1|||
16189531|NCT03260205|39169683|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
16189532|NCT03260205|39169684|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
16189533|NCT03260205|39169685|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
16189534|NCT03260205|39169686|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
16189535|NCT03260205|39169687|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
16189536|NCT00786838|39169690|FG000|Overall Study|Physician Decision|4|||
16189537|NCT00786838|39169690|FG000|Overall Study|Death|4|||
16189538|NCT00786838|39169690|FG000|Overall Study|Adverse Event|6|||
16189539|NCT00786838|39169690|FG000|Overall Study|Progressive disease|31|||
16189540|NCT00786838|39169690|FG000|Overall Study|Withdrawal by Subject|4|||
16189541|NCT03827473|39169693|FG000|Overall Study|Withdrawal by Subject|1|||
16189542|NCT03827473|39169694|FG001|Overall Study|Withdrawal by Subject|0|||
16189543|NCT02650284|39169695|FG000|Overall Study|Lost to Follow-up|3|||
16189544|NCT02650284|39169696|FG001|Overall Study|Lost to Follow-up|3|||
16189545|NCT02650284|39169695|FG000|Overall Study|Consent incorrectly taken|0|||
16189546|NCT02650284|39169696|FG001|Overall Study|Consent incorrectly taken|1|||
16189547|NCT01240811|39172633|FG000|Overall Study|Physician Decision|0|||
16189548|NCT01240811|39172634|FG001|Overall Study|Physician Decision|1|||
16189549|NCT01240811|39172635|FG002|Overall Study|Physician Decision|0|||
16189550|NCT01240811|39172633|FG000|Overall Study|Withdrawal by Subject|0|||
16189551|NCT01240811|39172634|FG001|Overall Study|Withdrawal by Subject|0|||
16189552|NCT01240811|39172635|FG002|Overall Study|Withdrawal by Subject|1|||
16189553|NCT01477892|39172640|FG000|Overall Study|Withdrawal by Subject|0|||
16189554|NCT01477892|39172641|FG001|Overall Study|Withdrawal by Subject|2|||
16189555|NCT02564120|39172644|FG000|Overall Study|Did not return release forms|160|||
16189556|NCT02564120|39172644|FG000|Overall Study|Death|58|||
16189557|NCT02564120|39172644|FG000|Overall Study|Withdrawal by Subject|204|||
16189558|NCT02564120|39172644|FG000|Overall Study|Other medical condition|24|||
16189559|NCT05058664|39172645|FG000|Overall Study|No follow-up data provided|4|||
16384074|NCT00557193|39888703|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
16384075|NCT01517984|39888704|FG000|Overall Study|Lost to Follow-up|0|||
16384076|NCT01517984|39888705|FG001|Overall Study|Lost to Follow-up|1|||
16384077|NCT01517984|39888706|FG002|Overall Study|Lost to Follow-up|0|||
16189560|NCT05058664|39172646|FG001|Overall Study|No follow-up data provided|0|||
16384078|NCT01517984|39888707|FG003|Overall Study|Lost to Follow-up|0|||
16384079|NCT01517984|39888704|FG000|Overall Study|Withdrawal by Subject|1|||
16384080|NCT01517984|39888705|FG001|Overall Study|Withdrawal by Subject|8|||
16384081|NCT01517984|39888706|FG002|Overall Study|Withdrawal by Subject|4|||
16384082|NCT01517984|39888707|FG003|Overall Study|Withdrawal by Subject|1|||
16384083|NCT01517984|39888704|FG000|Overall Study|Screen Failure|4|||
16384084|NCT01517984|39888705|FG001|Overall Study|Screen Failure|0|||
16384085|NCT01517984|39888706|FG002|Overall Study|Screen Failure|0|||
16384086|NCT01517984|39888707|FG003|Overall Study|Screen Failure|0|||
16384087|NCT01517984|39888704|FG000|Overall Study|Ineligible for randomization|0|||
16384088|NCT01517984|39888705|FG001|Overall Study|Ineligible for randomization|14|||
16384089|NCT01517984|39888706|FG002|Overall Study|Ineligible for randomization|0|||
16384090|NCT01517984|39888707|FG003|Overall Study|Ineligible for randomization|0|||
16384091|NCT00718315|39888711|FG000|Overall Study|Adverse Event|1|||
16384092|NCT00718315|39888712|FG001|Overall Study|Adverse Event|2|||
16384093|NCT00718315|39888713|FG002|Overall Study|Adverse Event|3|||
16384094|NCT00718315|39888711|FG000|Overall Study|Death|6|||
16384095|NCT00718315|39888712|FG001|Overall Study|Death|6|||
16384096|NCT00718315|39888713|FG002|Overall Study|Death|5|||
16384097|NCT00718315|39888711|FG000|Overall Study|Lost to Follow-up|2|||
16384098|NCT00718315|39888712|FG001|Overall Study|Lost to Follow-up|3|||
16384099|NCT00718315|39888713|FG002|Overall Study|Lost to Follow-up|4|||
16384100|NCT00718315|39888711|FG000|Overall Study|Protocol Violation|5|||
16384101|NCT00718315|39888712|FG001|Overall Study|Protocol Violation|5|||
16384102|NCT00718315|39888713|FG002|Overall Study|Protocol Violation|3|||
16384103|NCT00718315|39888711|FG000|Overall Study|Erlotinib dose decreased|4|||
16384104|NCT00718315|39888712|FG001|Overall Study|Erlotinib dose decreased|3|||
16189561|NCT05058664|39172647|FG002|Overall Study|No follow-up data provided|2|||
16189562|NCT05058664|39172645|FG000|Overall Study|Withdrawal by Subject|0|||
16384105|NCT00718315|39888713|FG002|Overall Study|Erlotinib dose decreased|1|||
16384106|NCT00718315|39888711|FG000|Overall Study|Use of Minocyclin|1|||
16384107|NCT00718315|39888712|FG001|Overall Study|Use of Minocyclin|1|||
16189563|NCT05058664|39172646|FG001|Overall Study|Withdrawal by Subject|0|||
16189564|NCT05058664|39172647|FG002|Overall Study|Withdrawal by Subject|1|||
16189565|NCT02531035|39172648|FG000|Overall Study|Death|0|||
16189566|NCT02531035|39172649|FG001|Overall Study|Death|1|||
16189567|NCT02531035|39172648|FG000|Overall Study|Protocol Violation|1|||
16189568|NCT02531035|39172649|FG001|Overall Study|Protocol Violation|1|||
16189569|NCT02531035|39172648|FG000|Overall Study|Noncompliance with study drug|8|||
16487933|NCT02197130|40259878|FG001|Overall Study|Withdrawal by Subject|3|||
16487934|NCT02197130|40259879|FG002|Overall Study|Withdrawal by Subject|4|||
16487935|NCT02197130|40259877|FG000|Overall Study|Other|1|||
16487936|NCT02197130|40259878|FG001|Overall Study|Other|0|||
16487937|NCT02197130|40259879|FG002|Overall Study|Other|3|||
16487938|NCT01306942|40259884|FG000|Phase I|Adverse Event|2|||
16487939|NCT01306942|40259885|FG001|Phase I|Adverse Event|2|||
16487940|NCT01306942|40259886|FG002|Phase I|Adverse Event|0|||
16487941|NCT01306942|40259887|FG003|Phase I|Adverse Event|0|||
16487942|NCT01306942|40259884|FG000|Phase I|Physician Decision|3|||
16487943|NCT01306942|40259885|FG001|Phase I|Physician Decision|1|||
16487944|NCT01306942|40259886|FG002|Phase I|Physician Decision|0|||
16189570|NCT02531035|39172649|FG001|Overall Study|Noncompliance with study drug|3|||
16487945|NCT01306942|40259887|FG003|Phase I|Physician Decision|0|||
16189571|NCT02531035|39172648|FG000|Overall Study|Physician Decision|1|||
16189572|NCT02531035|39172649|FG001|Overall Study|Physician Decision|0|||
16189573|NCT02531035|39172648|FG000|Overall Study|Adverse Event|16|||
16189574|NCT02531035|39172649|FG001|Overall Study|Adverse Event|45|||
16189575|NCT02531035|39172648|FG000|Overall Study|Other|3|||
16487946|NCT01306942|40259884|FG000|Phase II|Adverse Event|0|||
16487947|NCT01306942|40259885|FG001|Phase II|Adverse Event|0|||
16487948|NCT01306942|40259886|FG002|Phase II|Adverse Event|0|||
16487949|NCT01306942|40259887|FG003|Phase II|Adverse Event|6|||
16487950|NCT01306942|40259884|FG000|Phase II|Physician Decision|2|||
16487951|NCT01306942|40259885|FG001|Phase II|Physician Decision|0|||
16487952|NCT01306942|40259886|FG002|Phase II|Physician Decision|0|||
16487953|NCT01306942|40259887|FG003|Phase II|Physician Decision|5|||
16487954|NCT01306942|40259884|FG000|Phase II|Withdrawal by Subject|0|||
16487955|NCT01306942|40259885|FG001|Phase II|Withdrawal by Subject|0|||
16487956|NCT01306942|40259886|FG002|Phase II|Withdrawal by Subject|0|||
16487957|NCT01306942|40259887|FG003|Phase II|Withdrawal by Subject|2|||
16189576|NCT02531035|39172649|FG001|Overall Study|Other|2|||
16189577|NCT02531035|39172648|FG000|Overall Study|Withdrawal by Subject|42|||
16189578|NCT02531035|39172649|FG001|Overall Study|Withdrawal by Subject|32|||
16189579|NCT02531035|39172648|FG000|Overall Study|Lost to Follow-up|8|||
16189580|NCT02531035|39172649|FG001|Overall Study|Lost to Follow-up|10|||
16189581|NCT02531035|39172648|FG000|Overall Study|Randomized, not treated|2|||
16189582|NCT02531035|39172649|FG001|Overall Study|Randomized, not treated|1|||
16189583|NCT02951988|39172650|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
16189584|NCT02951988|39172651|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
16189585|NCT02951988|39172652|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
16189586|NCT02951988|39172653|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
16189587|NCT02951988|39172650|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
16189588|NCT02951988|39172651|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
16189589|NCT02951988|39172652|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
16189590|NCT02951988|39172653|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
16189591|NCT02951988|39172650|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
16189592|NCT02951988|39172651|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
16189593|NCT02951988|39172652|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
16189594|NCT02951988|39172653|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
16189595|NCT02951988|39172650|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
16189596|NCT02951988|39172651|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
16189597|NCT02951988|39172652|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
16189598|NCT02951988|39172653|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
16487958|NCT01306942|40259884|FG000|Phase II|Death|0|||
16487959|NCT01306942|40259885|FG001|Phase II|Death|0|||
16189599|NCT02951988|39172650|FG000|Open-Label Treatment Period|Protocol Violation|22|||
16189600|NCT02951988|39172651|FG001|Open-Label Treatment Period|Protocol Violation|0|||
16487960|NCT01306942|40259886|FG002|Phase II|Death|0|||
16487961|NCT01306942|40259887|FG003|Phase II|Death|1|||
16487962|NCT01306942|40259884|FG000|Phase II|Not finished treatment|0|||
16487963|NCT01306942|40259885|FG001|Phase II|Not finished treatment|0|||
16487964|NCT01306942|40259886|FG002|Phase II|Not finished treatment|0|||
16487965|NCT01306942|40259887|FG003|Phase II|Not finished treatment|1|||
16487966|NCT01306942|40259884|FG000|Phase II|Protocol Violation|0|||
16487967|NCT01306942|40259885|FG001|Phase II|Protocol Violation|0|||
16487968|NCT01306942|40259886|FG002|Phase II|Protocol Violation|0|||
16487969|NCT01306942|40259887|FG003|Phase II|Protocol Violation|1|||
16487970|NCT05201703|40259888|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
16487971|NCT05201703|40259889|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
16487972|NCT05201703|40259888|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
16487973|NCT05201703|40259889|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
16487974|NCT01898806|40263156|FG000|Overall Study|Withdrawal by Subject|2|||
16487975|NCT01898806|40263156|FG000|Overall Study|Physician Decision|1|||
16487976|NCT02478632|40263157|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
16189601|NCT02951988|39172652|FG002|Open-Label Treatment Period|Protocol Violation|0|||
16189602|NCT02951988|39172653|FG003|Open-Label Treatment Period|Protocol Violation|0|||
16189603|NCT02951988|39172650|FG000|Open-Label Treatment Period|Pregnancy|2|||
16189604|NCT02951988|39172651|FG001|Open-Label Treatment Period|Pregnancy|0|||
16189605|NCT02951988|39172652|FG002|Open-Label Treatment Period|Pregnancy|0|||
16189606|NCT02951988|39172653|FG003|Open-Label Treatment Period|Pregnancy|0|||
16189607|NCT02951988|39172650|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
16189608|NCT02951988|39172651|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
16189609|NCT02951988|39172652|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
16189610|NCT02951988|39172653|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
16189611|NCT02951988|39172650|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
16189612|NCT02951988|39172651|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
16189613|NCT02951988|39172652|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
16189614|NCT02951988|39172653|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
16189615|NCT02951988|39172650|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
16189616|NCT02951988|39172651|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
16189617|NCT02951988|39172652|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
16189618|NCT02951988|39172653|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
16384108|NCT00718315|39888713|FG002|Overall Study|Use of Minocyclin|1|||
16384109|NCT00718315|39888711|FG000|Overall Study|Disease progression|0|||
16384110|NCT00718315|39888712|FG001|Overall Study|Disease progression|1|||
16384111|NCT00718315|39888713|FG002|Overall Study|Disease progression|1|||
16384112|NCT00718315|39888711|FG000|Overall Study|Other|0|||
16189619|NCT02951988|39172650|FG000|Open-Label Treatment Period|Adverse Event|45|||
16189620|NCT02951988|39172651|FG001|Open-Label Treatment Period|Adverse Event|0|||
16083136|NCT02404441|38796176|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
16083137|NCT02404441|38796177|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
16083138|NCT02404441|38796178|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
16083139|NCT02404441|38796179|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
16083140|NCT02404441|38796180|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
16083141|NCT02404441|38796181|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
16083142|NCT02404441|38796172|FG000|Phase 1 Part|Death|1|||
16083143|NCT02404441|38796173|FG001|Phase 1 Part|Death|1|||
16083144|NCT02404441|38796174|FG002|Phase 1 Part|Death|1|||
16297225|NCT02393248|39573982|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297226|NCT02393248|39573983|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297227|NCT02393248|39573984|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297228|NCT02393248|39573985|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297229|NCT02393248|39573986|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297230|NCT02393248|39573987|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297231|NCT02393248|39573988|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16384113|NCT00718315|39888712|FG001|Overall Study|Other|0|||
16384114|NCT00718315|39888713|FG002|Overall Study|Other|1|||
16384115|NCT00718315|39888711|FG000|Overall Study|Use of ATB and Corticoids|0|||
16384116|NCT00718315|39888712|FG001|Overall Study|Use of ATB and Corticoids|1|||
16384117|NCT00718315|39888713|FG002|Overall Study|Use of ATB and Corticoids|2|||
16384118|NCT03323164|39888714|FG000|Overall Study|Poor quality imaging/scans|2|||
16487977|NCT02478632|40263158|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
16487978|NCT02478632|40263157|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
16384119|NCT03323164|39888715|FG001|Overall Study|Poor quality imaging/scans|2|||
16384120|NCT03781414|39888716|FG000|Overall Study|Study terminated by sponsor|39|||
16384121|NCT03781414|39888717|FG001|Overall Study|Study terminated by sponsor|34|||
16384122|NCT03781414|39888718|FG002|Overall Study|Study terminated by sponsor|25|||
16384123|NCT03781414|39888716|FG000|Overall Study|Adverse Event|3|||
16384124|NCT03781414|39888717|FG001|Overall Study|Adverse Event|6|||
16384125|NCT03781414|39888718|FG002|Overall Study|Adverse Event|3|||
16384126|NCT03781414|39888716|FG000|Overall Study|Physician Decision|2|||
16384127|NCT03781414|39888717|FG001|Overall Study|Physician Decision|0|||
16384128|NCT03781414|39888718|FG002|Overall Study|Physician Decision|1|||
16384129|NCT03781414|39888716|FG000|Overall Study|Withdrawal by Subject|2|||
16384130|NCT03781414|39888717|FG001|Overall Study|Withdrawal by Subject|3|||
16384131|NCT03781414|39888718|FG002|Overall Study|Withdrawal by Subject|3|||
16384132|NCT03781414|39888716|FG000|Overall Study|Death|1|||
16384133|NCT03781414|39888717|FG001|Overall Study|Death|4|||
16384134|NCT03781414|39888718|FG002|Overall Study|Death|0|||
16384135|NCT03781414|39888716|FG000|Overall Study|Lost to Follow-up|1|||
16384136|NCT03781414|39888717|FG001|Overall Study|Lost to Follow-up|1|||
16384137|NCT03781414|39888718|FG002|Overall Study|Lost to Follow-up|0|||
16384138|NCT01071954|39888719|FG000|Overall Study|Noncompliance|4|||
16384139|NCT01071954|39888719|FG000|Overall Study|Adverse Event|1|||
16384140|NCT01071954|39888719|FG000|Overall Study|Withdrawal by Subject|11|||
16384141|NCT01071954|39888719|FG000|Overall Study|Requirement for Alternative Therapy|5|||
16384142|NCT01071954|39888719|FG000|Overall Study|Administrative Decision|5|||
16384143|NCT01071954|39888719|FG000|Overall Study|Protocol Specified Criteria|1|||
16384144|NCT00508482|39888720|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
16384145|NCT00508482|39888721|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
16384146|NCT00508482|39888722|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
16487979|NCT02478632|40263158|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
16487980|NCT02478632|40263157|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
16487981|NCT02478632|40263158|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
16487982|NCT03372096|40263160|FG000|Overall Study|Study Closed|8|||
16487983|NCT01806298|40263161|FG000|Overall Study|Adverse Event|3|||
16487984|NCT01806298|40263161|FG000|Overall Study|Protocol Non-compliance|1|||
16487985|NCT01806298|40263161|FG000|Overall Study|Withdrawal by Subject|1|||
16487986|NCT01806298|40263161|FG000|Overall Study|Other|5|||
16487987|NCT02468674|40263162|FG000|Overall Study|Adverse Event|0|||
16487988|NCT02468674|40263163|FG001|Overall Study|Adverse Event|0|||
16487989|NCT02468674|40263164|FG002|Overall Study|Adverse Event|0|||
16487990|NCT02468674|40263165|FG003|Overall Study|Adverse Event|1|||
16487991|NCT02468674|40263166|FG004|Overall Study|Adverse Event|0|||
16487992|NCT02468674|40263167|FG005|Overall Study|Adverse Event|1|||
16487993|NCT02468674|40263168|FG006|Overall Study|Adverse Event|0|||
16487994|NCT02468674|40263169|FG007|Overall Study|Adverse Event|0|||
16487995|NCT02468674|40263170|FG008|Overall Study|Adverse Event|0|||
16487996|NCT02468674|40263162|FG000|Overall Study|Lost to Follow-up|1|||
16487997|NCT02468674|40263163|FG001|Overall Study|Lost to Follow-up|0|||
16083145|NCT02404441|38796175|FG003|Phase 1 Part|Death|0|||
16083146|NCT02404441|38796176|FG004|Phase 1 Part|Death|1|||
16384147|NCT00508482|39888720|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
16384148|NCT00508482|39888721|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
16083147|NCT02404441|38796177|FG005|Phase 1 Part|Death|0|||
16083148|NCT02404441|38796178|FG006|Phase 1 Part|Death|0|||
16083149|NCT02404441|38796179|FG007|Phase 1 Part|Death|0|||
16083150|NCT02404441|38796180|FG008|Phase 1 Part|Death|0|||
16083151|NCT02404441|38796181|FG009|Phase 1 Part|Death|0|||
16083152|NCT02404441|38796172|FG000|Phase 2 Part|Adverse Event|0|||
16083153|NCT02404441|38796173|FG001|Phase 2 Part|Adverse Event|0|||
16083154|NCT02404441|38796174|FG002|Phase 2 Part|Adverse Event|0|||
16083155|NCT02404441|38796175|FG003|Phase 2 Part|Adverse Event|0|||
16083156|NCT02404441|38796176|FG004|Phase 2 Part|Adverse Event|0|||
16083157|NCT02404441|38796177|FG005|Phase 2 Part|Adverse Event|2|||
16083158|NCT02404441|38796178|FG006|Phase 2 Part|Adverse Event|3|||
16083159|NCT02404441|38796179|FG007|Phase 2 Part|Adverse Event|3|||
16083160|NCT02404441|38796180|FG008|Phase 2 Part|Adverse Event|6|||
16083161|NCT02404441|38796181|FG009|Phase 2 Part|Adverse Event|1|||
16083162|NCT02404441|38796172|FG000|Phase 2 Part|Physician Decision|0|||
16083163|NCT02404441|38796173|FG001|Phase 2 Part|Physician Decision|0|||
16083164|NCT02404441|38796174|FG002|Phase 2 Part|Physician Decision|0|||
16083165|NCT02404441|38796175|FG003|Phase 2 Part|Physician Decision|0|||
16083166|NCT02404441|38796176|FG004|Phase 2 Part|Physician Decision|0|||
16083167|NCT02404441|38796177|FG005|Phase 2 Part|Physician Decision|7|||
16083168|NCT02404441|38796178|FG006|Phase 2 Part|Physician Decision|9|||
16083169|NCT02404441|38796179|FG007|Phase 2 Part|Physician Decision|2|||
16083170|NCT02404441|38796180|FG008|Phase 2 Part|Physician Decision|1|||
16083171|NCT02404441|38796181|FG009|Phase 2 Part|Physician Decision|3|||
16083172|NCT02404441|38796172|FG000|Phase 2 Part|Progressive disease|0|||
16083173|NCT02404441|38796173|FG001|Phase 2 Part|Progressive disease|0|||
16083174|NCT02404441|38796174|FG002|Phase 2 Part|Progressive disease|0|||
16083175|NCT02404441|38796175|FG003|Phase 2 Part|Progressive disease|0|||
16297232|NCT02393248|39573989|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297233|NCT02393248|39573990|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297234|NCT02393248|39573991|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297235|NCT02393248|39573992|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297236|NCT02393248|39573993|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
16297237|NCT02393248|39573969|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
16384149|NCT00508482|39888722|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
16384150|NCT00508482|39888720|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
16384151|NCT00508482|39888721|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
16384152|NCT00508482|39888722|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
16384153|NCT00016354|39888723|FG000|Overall Study|Lack of Efficacy|0|||
16384154|NCT00016354|39888724|FG001|Overall Study|Lack of Efficacy|0|||
16384155|NCT00016354|39888725|FG002|Overall Study|Lack of Efficacy|0|||
16384156|NCT00016354|39888726|FG003|Overall Study|Lack of Efficacy|0|||
16384157|NCT00016354|39888727|FG004|Overall Study|Lack of Efficacy|0|||
16384158|NCT00016354|39888728|FG005|Overall Study|Lack of Efficacy|0|||
16384159|NCT00016354|39888729|FG006|Overall Study|Lack of Efficacy|0|||
16384160|NCT00016354|39888730|FG007|Overall Study|Lack of Efficacy|1|||
16384161|NCT00461708|39888731|FG000|Overall Study|Adverse Event|17|||
16384162|NCT00461708|39888732|FG001|Overall Study|Adverse Event|7|||
16384163|NCT00461708|39888731|FG000|Overall Study|Lack of Efficacy|68|||
16384164|NCT00461708|39888732|FG001|Overall Study|Lack of Efficacy|20|||
16384165|NCT00461708|39888731|FG000|Overall Study|Physician Decision|10|||
16384166|NCT00461708|39888732|FG001|Overall Study|Physician Decision|4|||
16384167|NCT00461708|39888731|FG000|Overall Study|Withdrawal by Subject|8|||
16384168|NCT00461708|39888732|FG001|Overall Study|Withdrawal by Subject|2|||
16384169|NCT00461708|39888731|FG000|Overall Study|Other|4|||
16384170|NCT00461708|39888732|FG001|Overall Study|Other|4|||
16384171|NCT00461708|39888731|FG000|Overall Study|Death|8|||
16384172|NCT00461708|39888732|FG001|Overall Study|Death|1|||
16384173|NCT00776230|39888735|FG000|Overall Study|Lost to Follow-up|2|||
16384174|NCT00776230|39888736|FG001|Overall Study|Lost to Follow-up|1|||
16384175|NCT00776230|39888737|FG002|Overall Study|Lost to Follow-up|5|||
16083176|NCT02404441|38796176|FG004|Phase 2 Part|Progressive disease|0|||
16297238|NCT02393248|39573970|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
16297239|NCT02393248|39573971|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
16297240|NCT02393248|39573972|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
16297241|NCT02393248|39573973|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
16297242|NCT02393248|39573974|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
16297243|NCT02393248|39573975|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
16083177|NCT02404441|38796177|FG005|Phase 2 Part|Progressive disease|43|||
16083178|NCT02404441|38796178|FG006|Phase 2 Part|Progressive disease|32|||
16083179|NCT02404441|38796179|FG007|Phase 2 Part|Progressive disease|31|||
16083180|NCT02404441|38796180|FG008|Phase 2 Part|Progressive disease|39|||
16297244|NCT02393248|39573976|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
16384176|NCT00776230|39888735|FG000|Overall Study|Not vaccinated at Day 0|1|||
16384177|NCT00776230|39888736|FG001|Overall Study|Not vaccinated at Day 0|0|||
16083181|NCT02404441|38796181|FG009|Phase 2 Part|Progressive disease|27|||
16083182|NCT02404441|38796172|FG000|Phase 2 Part|Subject/guardian decision|0|||
16083183|NCT02404441|38796173|FG001|Phase 2 Part|Subject/guardian decision|0|||
16384178|NCT00776230|39888737|FG002|Overall Study|Not vaccinated at Day 0|0|||
16384179|NCT00776230|39888735|FG000|Overall Study|Withdrawal by Subject|0|||
16384180|NCT00776230|39888736|FG001|Overall Study|Withdrawal by Subject|1|||
16384181|NCT00776230|39888737|FG002|Overall Study|Withdrawal by Subject|0|||
16384182|NCT00776230|39888735|FG000|Overall Study|Subject missed Visit 4|0|||
16384183|NCT00776230|39888736|FG001|Overall Study|Subject missed Visit 4|1|||
16384184|NCT00776230|39888737|FG002|Overall Study|Subject missed Visit 4|0|||
16384185|NCT03243084|39888739|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
16384186|NCT03243084|39888740|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
16384187|NCT00503984|39892515|FG000|Overall Study|Protocol Violation|0|||
16384188|NCT00503984|39892516|FG001|Overall Study|Protocol Violation|1|||
16384189|NCT00503984|39892517|FG002|Overall Study|Protocol Violation|0|||
16384190|NCT00503984|39892518|FG003|Overall Study|Protocol Violation|0|||
16384191|NCT00503984|39892519|FG004|Overall Study|Protocol Violation|0|||
16384192|NCT00503984|39892520|FG005|Overall Study|Protocol Violation|0|||
16384193|NCT00503984|39892515|FG000|Overall Study|Adverse Event|0|||
16384194|NCT00503984|39892516|FG001|Overall Study|Adverse Event|1|||
16384195|NCT00503984|39892517|FG002|Overall Study|Adverse Event|0|||
16384196|NCT00503984|39892518|FG003|Overall Study|Adverse Event|0|||
16384197|NCT00503984|39892519|FG004|Overall Study|Adverse Event|0|||
16384198|NCT00503984|39892520|FG005|Overall Study|Adverse Event|0|||
16384199|NCT00503984|39892515|FG000|Overall Study|Death|0|||
16384200|NCT00503984|39892516|FG001|Overall Study|Death|0|||
16384201|NCT00503984|39892517|FG002|Overall Study|Death|0|||
16384202|NCT00503984|39892518|FG003|Overall Study|Death|0|||
16384203|NCT00503984|39892519|FG004|Overall Study|Death|1|||
16384204|NCT00503984|39892520|FG005|Overall Study|Death|0|||
16384205|NCT04194450|39892521|FG000|Overall Study|not eligible|1|||
16384206|NCT04194450|39892522|FG001|Overall Study|not eligible|0|||
16384207|NCT02296476|39892523|FG000|Overall Study|Disease Progression|6|||
16384208|NCT02296476|39892524|FG001|Overall Study|Disease Progression|4|||
16384209|NCT02296476|39892525|FG002|Overall Study|Disease Progression|2|||
16384210|NCT01463033|39892526|FG000|Overall Study|Lost to Follow-up|4|||
16384211|NCT01463033|39892527|FG001|Overall Study|Lost to Follow-up|4|||
16384212|NCT01463033|39892526|FG000|Overall Study|Death|3|||
16384213|NCT01463033|39892527|FG001|Overall Study|Death|2|||
16384214|NCT00399035|39892528|FG000|Overall Study|Death|289|||
16384215|NCT00399035|39892529|FG001|Overall Study|Death|141|||
16384216|NCT00399035|39892530|FG002|Overall Study|Death|234|||
16384217|NCT00399035|39892528|FG000|Overall Study|Lost to Follow-up|2|||
16384218|NCT00399035|39892529|FG001|Overall Study|Lost to Follow-up|1|||
16384219|NCT00399035|39892530|FG002|Overall Study|Lost to Follow-up|5|||
16384220|NCT00399035|39892528|FG000|Overall Study|Withdrawal by Subject|19|||
16384221|NCT00399035|39892529|FG001|Overall Study|Withdrawal by Subject|15|||
16384222|NCT00399035|39892530|FG002|Overall Study|Withdrawal by Subject|12|||
16384223|NCT00399035|39892528|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
16384224|NCT00399035|39892529|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
16384225|NCT00399035|39892530|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
16384226|NCT00399035|39892528|FG000|Overall Study|Severe non-compliance with protocol|2|||
16384227|NCT00399035|39892529|FG001|Overall Study|Severe non-compliance with protocol|1|||
16384228|NCT00399035|39892530|FG002|Overall Study|Severe non-compliance with protocol|0|||
16384229|NCT02300233|39892535|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
16384230|NCT02300233|39892536|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
16384231|NCT02300233|39892537|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
16384232|NCT02300233|39892535|FG000|Overall Study|Withdrawal by Subject|1|||
16384233|NCT02300233|39892536|FG001|Overall Study|Withdrawal by Subject|0|||
16384234|NCT02300233|39892537|FG002|Overall Study|Withdrawal by Subject|3|||
16384235|NCT02300233|39892535|FG000|Overall Study|Investigator Judgement|0|||
16384236|NCT02300233|39892536|FG001|Overall Study|Investigator Judgement|0|||
16384237|NCT02300233|39892537|FG002|Overall Study|Investigator Judgement|1|||
16384238|NCT02300233|39892535|FG000|Overall Study|Reason Not Specified|0|||
16384239|NCT02300233|39892536|FG001|Overall Study|Reason Not Specified|0|||
16384240|NCT02300233|39892537|FG002|Overall Study|Reason Not Specified|5|||
16384241|NCT02332928|39892540|FG000|Overall Study|Withdrawal by Subject|0|||
16384242|NCT02332928|39892541|FG001|Overall Study|Withdrawal by Subject|2|||
16384243|NCT02332928|39892540|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
16384244|NCT02332928|39892541|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
16384245|NCT02234362|39892547|FG000|Overall Study|Not eligible after first screening visit|17|||
16384246|NCT02234362|39892547|FG000|Overall Study|Lost to Follow-up|6|||
16384247|NCT02234362|39892547|FG000|Overall Study|Withdrawal by Subject|3|||
16384248|NCT00337168|39892548|FG000|Overall Study|Death|5|||
16384249|NCT00337168|39892548|FG000|Overall Study|Not protocol specified|2|||
16384250|NCT00337168|39892548|FG000|Overall Study|Did not start therapy|1|||
16384251|NCT02378480|39892551|FG000|Overall Study|Physician Decision|1|||
16384252|NCT02378480|39892552|FG001|Overall Study|Physician Decision|1|||
16384253|NCT02378480|39892551|FG000|Overall Study|Death|1|||
16384254|NCT02378480|39892552|FG001|Overall Study|Death|2|||
16384255|NCT02378480|39892551|FG000|Overall Study|Randomized, but Not Treated|6|||
16384256|NCT02378480|39892552|FG001|Overall Study|Randomized, but Not Treated|4|||
16384257|NCT02378480|39892551|FG000|Overall Study|Adverse Event|0|||
16384258|NCT02378480|39892552|FG001|Overall Study|Adverse Event|1|||
16384259|NCT02378480|39892551|FG000|Overall Study|Missed EOT/PTE Visit|1|||
16384260|NCT02378480|39892552|FG001|Overall Study|Missed EOT/PTE Visit|2|||
16384261|NCT02378480|39892551|FG000|Overall Study|Withdrawal by Subject|9|||
16384262|NCT02378480|39892552|FG001|Overall Study|Withdrawal by Subject|4|||
16384263|NCT02378480|39892551|FG000|Overall Study|Lost to Follow-up|10|||
16384264|NCT02378480|39892552|FG001|Overall Study|Lost to Follow-up|18|||
16384265|NCT01887717|39892553|FG000|Overall Study|Withdrawal by Subject|1|||
16384266|NCT01887717|39892554|FG001|Overall Study|Withdrawal by Subject|7|||
16384267|NCT01887717|39892553|FG000|Overall Study|Physician Decision|0|||
16384268|NCT01887717|39892554|FG001|Overall Study|Physician Decision|2|||
16384269|NCT01887717|39892553|FG000|Overall Study|Administrative reasons|5|||
16384270|NCT01887717|39892554|FG001|Overall Study|Administrative reasons|2|||
16384271|NCT01368614|39892556|FG000|Screening Period|Screen Failure|58|||
16384272|NCT01368614|39892557|FG001|Screening Period|Screen Failure|0|||
16384273|NCT01368614|39892558|FG002|Screening Period|Screen Failure|0|||
16384274|NCT01368614|39892559|FG003|Screening Period|Screen Failure|0|||
16384275|NCT01368614|39892556|FG000|Study Period|Withdrawal by Subject|0|||
16384276|NCT01368614|39892557|FG001|Study Period|Withdrawal by Subject|1|||
16384277|NCT01368614|39892558|FG002|Study Period|Withdrawal by Subject|1|||
16384278|NCT01368614|39892559|FG003|Study Period|Withdrawal by Subject|3|||
16384279|NCT01368614|39892556|FG000|Study Period|Lost to Follow-up|0|||
16384280|NCT01368614|39892557|FG001|Study Period|Lost to Follow-up|0|||
16384281|NCT01368614|39892558|FG002|Study Period|Lost to Follow-up|1|||
16384282|NCT01368614|39892559|FG003|Study Period|Lost to Follow-up|0|||
16384283|NCT00710593|39892560|FG000|Overall Study|Incarceration|1|||
16384284|NCT00710593|39892561|FG001|Overall Study|Incarceration|0|||
16384285|NCT00710593|39892560|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
16487998|NCT02468674|40263164|FG002|Overall Study|Lost to Follow-up|0|||
16487999|NCT02468674|40263165|FG003|Overall Study|Lost to Follow-up|0|||
16297245|NCT02393248|39573977|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
16297246|NCT02393248|39573978|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
16297247|NCT02393248|39573979|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
16297248|NCT02393248|39573980|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
16297249|NCT02393248|39573981|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
16297250|NCT02393248|39573982|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
16297251|NCT02393248|39573983|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
16297252|NCT02393248|39573984|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
16297253|NCT02393248|39573985|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
16297254|NCT02393248|39573986|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
16297255|NCT02393248|39573987|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
16297256|NCT02393248|39573988|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
16297257|NCT02393248|39573989|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
16297258|NCT02393248|39573990|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
16297259|NCT02393248|39573991|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
16297260|NCT02393248|39573992|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
16297261|NCT02393248|39573993|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
16297262|NCT02393248|39573969|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297263|NCT02393248|39573970|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297264|NCT02393248|39573971|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297265|NCT02393248|39573972|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297266|NCT02393248|39573973|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297267|NCT02393248|39573974|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297268|NCT02393248|39573975|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297269|NCT02393248|39573976|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297270|NCT02393248|39573977|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297271|NCT02393248|39573978|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297272|NCT02393248|39573979|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16384286|NCT00710593|39892561|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
16384287|NCT00710593|39892560|FG000|Overall Study|Lost to Follow-up|3|||
16384288|NCT00710593|39892561|FG001|Overall Study|Lost to Follow-up|1|||
16384289|NCT00710593|39892560|FG000|Overall Study|Moved out of area|1|||
16384290|NCT00710593|39892561|FG001|Overall Study|Moved out of area|0|||
16384291|NCT00710593|39892560|FG000|Overall Study|Failure to adhere or complete study eval|1|||
16384292|NCT00710593|39892561|FG001|Overall Study|Failure to adhere or complete study eval|1|||
16297273|NCT02393248|39573980|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
16297274|NCT02393248|39573981|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297275|NCT02393248|39573982|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
16297276|NCT02393248|39573983|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297277|NCT02393248|39573984|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297278|NCT02393248|39573985|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297279|NCT02393248|39573986|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297280|NCT02393248|39573987|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297281|NCT02393248|39573988|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297282|NCT02393248|39573989|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297283|NCT02393248|39573990|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297284|NCT02393248|39573991|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297285|NCT02393248|39573992|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297286|NCT02393248|39573993|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
16297287|NCT02393248|39573969|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297288|NCT02393248|39573970|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297289|NCT02393248|39573971|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297290|NCT02393248|39573972|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297291|NCT02393248|39573973|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297292|NCT02393248|39573974|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297293|NCT02393248|39573975|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297294|NCT02393248|39573976|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297295|NCT02393248|39573977|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297296|NCT02393248|39573978|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297297|NCT02393248|39573979|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297298|NCT02393248|39573980|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297299|NCT02393248|39573981|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297300|NCT02393248|39573982|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297301|NCT02393248|39573983|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297302|NCT02393248|39573984|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297303|NCT02393248|39573985|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297304|NCT02393248|39573986|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297305|NCT02393248|39573987|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
16297306|NCT02393248|39573988|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297307|NCT02393248|39573989|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
16297308|NCT02393248|39573990|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
16297309|NCT02393248|39573991|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297310|NCT02393248|39573992|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
16297311|NCT02393248|39573993|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
16297312|NCT02393248|39573969|FG000|Part 3: Combination Therapy|Death|0|||
16297313|NCT02393248|39573970|FG001|Part 3: Combination Therapy|Death|0|||
16297314|NCT02393248|39573971|FG002|Part 3: Combination Therapy|Death|0|||
16297315|NCT02393248|39573972|FG003|Part 3: Combination Therapy|Death|0|||
16297316|NCT02393248|39573973|FG004|Part 3: Combination Therapy|Death|0|||
16297317|NCT02393248|39573974|FG005|Part 3: Combination Therapy|Death|0|||
16297318|NCT02393248|39573975|FG006|Part 3: Combination Therapy|Death|0|||
16297319|NCT02393248|39573976|FG007|Part 3: Combination Therapy|Death|0|||
16297320|NCT02393248|39573977|FG008|Part 3: Combination Therapy|Death|0|||
16297321|NCT02393248|39573978|FG009|Part 3: Combination Therapy|Death|0|||
16297322|NCT02393248|39573979|FG010|Part 3: Combination Therapy|Death|0|||
16297323|NCT02393248|39573980|FG011|Part 3: Combination Therapy|Death|0|||
16297324|NCT02393248|39573981|FG012|Part 3: Combination Therapy|Death|0|||
16297325|NCT02393248|39573982|FG013|Part 3: Combination Therapy|Death|0|||
16297326|NCT02393248|39573983|FG014|Part 3: Combination Therapy|Death|0|||
16297327|NCT02393248|39573984|FG015|Part 3: Combination Therapy|Death|1|||
16297328|NCT02393248|39573985|FG016|Part 3: Combination Therapy|Death|7|||
16297329|NCT02393248|39573986|FG017|Part 3: Combination Therapy|Death|5|||
16297330|NCT02393248|39573987|FG018|Part 3: Combination Therapy|Death|5|||
16297331|NCT02393248|39573988|FG019|Part 3: Combination Therapy|Death|3|||
16488000|NCT02468674|40263166|FG004|Overall Study|Lost to Follow-up|0|||
16488001|NCT02468674|40263167|FG005|Overall Study|Lost to Follow-up|0|||
16488002|NCT02468674|40263168|FG006|Overall Study|Lost to Follow-up|0|||
16488003|NCT02468674|40263169|FG007|Overall Study|Lost to Follow-up|1|||
16297332|NCT02393248|39573989|FG020|Part 3: Combination Therapy|Death|7|||
16297333|NCT02393248|39573990|FG021|Part 3: Combination Therapy|Death|5|||
16297334|NCT02393248|39573991|FG022|Part 3: Combination Therapy|Death|6|||
16297335|NCT02393248|39573992|FG023|Part 3: Combination Therapy|Death|3|||
16297336|NCT02393248|39573993|FG024|Part 3: Combination Therapy|Death|0|||
16297337|NCT02393248|39573969|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297338|NCT02393248|39573970|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16384293|NCT00710593|39892560|FG000|Overall Study|Protocol Violation|1|||
16297339|NCT02393248|39573971|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297340|NCT02393248|39573972|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297341|NCT02393248|39573973|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297342|NCT02393248|39573974|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297343|NCT02393248|39573975|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297344|NCT02393248|39573976|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297345|NCT02393248|39573977|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297346|NCT02393248|39573978|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297347|NCT02393248|39573979|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297348|NCT02393248|39573980|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297349|NCT02393248|39573981|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297350|NCT02393248|39573982|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297351|NCT02393248|39573983|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297352|NCT02393248|39573984|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297353|NCT02393248|39573985|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297354|NCT02393248|39573986|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
16297355|NCT02393248|39573987|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
16297356|NCT02393248|39573988|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
16297357|NCT02393248|39573989|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
16297358|NCT02393248|39573990|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
16297359|NCT02393248|39573991|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
16297360|NCT02393248|39573992|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
16297361|NCT02393248|39573993|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
16297362|NCT02393248|39573969|FG000|Part 3: Combination Therapy|Disease Progression|0|||
16297363|NCT02393248|39573970|FG001|Part 3: Combination Therapy|Disease Progression|0|||
16297364|NCT02393248|39573971|FG002|Part 3: Combination Therapy|Disease Progression|0|||
16297365|NCT02393248|39573972|FG003|Part 3: Combination Therapy|Disease Progression|0|||
16297366|NCT02393248|39573973|FG004|Part 3: Combination Therapy|Disease Progression|0|||
16297367|NCT02393248|39573974|FG005|Part 3: Combination Therapy|Disease Progression|0|||
16297368|NCT02393248|39573975|FG006|Part 3: Combination Therapy|Disease Progression|0|||
16297369|NCT02393248|39573976|FG007|Part 3: Combination Therapy|Disease Progression|0|||
16297370|NCT02393248|39573977|FG008|Part 3: Combination Therapy|Disease Progression|0|||
16297371|NCT02393248|39573978|FG009|Part 3: Combination Therapy|Disease Progression|0|||
16297372|NCT02393248|39573979|FG010|Part 3: Combination Therapy|Disease Progression|0|||
16297373|NCT02393248|39573980|FG011|Part 3: Combination Therapy|Disease Progression|0|||
16297374|NCT02393248|39573981|FG012|Part 3: Combination Therapy|Disease Progression|0|||
16297375|NCT02393248|39573982|FG013|Part 3: Combination Therapy|Disease Progression|0|||
16297376|NCT02393248|39573983|FG014|Part 3: Combination Therapy|Disease Progression|0|||
16384294|NCT00710593|39892561|FG001|Overall Study|Protocol Violation|1|||
16384295|NCT00710593|39892560|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
16384296|NCT00710593|39892561|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
16384297|NCT01346176|39892562|FG000|Recruited|Protocol Violation|1|||
16384298|NCT01346176|39892563|FG001|Recruited|Protocol Violation|0|||
16384299|NCT01346176|39892564|FG002|Recruited|Protocol Violation|0|||
16384300|NCT01346176|39892562|FG000|Completed Advance Directive|Death|3|||
16384301|NCT01346176|39892563|FG001|Completed Advance Directive|Death|2|||
16384302|NCT01346176|39892564|FG002|Completed Advance Directive|Death|2|||
16384303|NCT01346176|39892562|FG000|Completed Advance Directive|Became Ineligible|3|||
16488004|NCT02468674|40263170|FG008|Overall Study|Lost to Follow-up|1|||
16488005|NCT02468674|40263162|FG000|Overall Study|Physician Decision|0|||
16488006|NCT02468674|40263163|FG001|Overall Study|Physician Decision|0|||
16488007|NCT02468674|40263164|FG002|Overall Study|Physician Decision|0|||
16488008|NCT02468674|40263165|FG003|Overall Study|Physician Decision|0|||
16488009|NCT02468674|40263166|FG004|Overall Study|Physician Decision|0|||
16488010|NCT02468674|40263167|FG005|Overall Study|Physician Decision|0|||
16488011|NCT02468674|40263168|FG006|Overall Study|Physician Decision|1|||
16488012|NCT02468674|40263169|FG007|Overall Study|Physician Decision|0|||
16488013|NCT02468674|40263170|FG008|Overall Study|Physician Decision|0|||
16488014|NCT02468674|40263162|FG000|Overall Study|Patient/Guardian Decision|0|||
16488015|NCT02468674|40263163|FG001|Overall Study|Patient/Guardian Decision|0|||
16488016|NCT02468674|40263164|FG002|Overall Study|Patient/Guardian Decision|0|||
16488017|NCT02468674|40263165|FG003|Overall Study|Patient/Guardian Decision|0|||
16488018|NCT02468674|40263166|FG004|Overall Study|Patient/Guardian Decision|1|||
16488019|NCT02468674|40263167|FG005|Overall Study|Patient/Guardian Decision|0|||
16297377|NCT02393248|39573984|FG015|Part 3: Combination Therapy|Disease Progression|0|||
16297378|NCT02393248|39573985|FG016|Part 3: Combination Therapy|Disease Progression|0|||
16384304|NCT01346176|39892563|FG001|Completed Advance Directive|Became Ineligible|0|||
16488020|NCT02468674|40263168|FG006|Overall Study|Patient/Guardian Decision|0|||
16297379|NCT02393248|39573986|FG017|Part 3: Combination Therapy|Disease Progression|0|||
16384305|NCT01346176|39892564|FG002|Completed Advance Directive|Became Ineligible|1|||
16488021|NCT02468674|40263169|FG007|Overall Study|Patient/Guardian Decision|2|||
16384306|NCT01346176|39892562|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
16384307|NCT01346176|39892563|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
16384308|NCT01346176|39892564|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
16384309|NCT01346176|39892562|FG000|Completed Satisfaction Survey|Death|3|||
16384310|NCT01346176|39892563|FG001|Completed Satisfaction Survey|Death|0|||
16488022|NCT02468674|40263170|FG008|Overall Study|Patient/Guardian Decision|1|||
16488023|NCT02468674|40263162|FG000|Overall Study|Protocol Deviation|0|||
16488024|NCT02468674|40263163|FG001|Overall Study|Protocol Deviation|0|||
16488025|NCT02468674|40263164|FG002|Overall Study|Protocol Deviation|0|||
16488026|NCT02468674|40263165|FG003|Overall Study|Protocol Deviation|0|||
16488027|NCT02468674|40263166|FG004|Overall Study|Protocol Deviation|0|||
16488028|NCT02468674|40263167|FG005|Overall Study|Protocol Deviation|0|||
16488029|NCT02468674|40263168|FG006|Overall Study|Protocol Deviation|0|||
16488030|NCT02468674|40263169|FG007|Overall Study|Protocol Deviation|1|||
16488031|NCT02468674|40263170|FG008|Overall Study|Protocol Deviation|1|||
16488032|NCT02310568|40263177|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
16488033|NCT02310568|40263178|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
16488034|NCT02310568|40263179|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
16488035|NCT02310568|40263180|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
16488036|NCT02310568|40263181|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
16488037|NCT02310568|40263177|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
16488038|NCT02310568|40263178|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
16488039|NCT02310568|40263179|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
16488040|NCT02310568|40263180|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
16488041|NCT02310568|40263181|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
16488042|NCT02310568|40263177|FG000|Stage 1 ( 4 Weeks)|Other|1|||
16488043|NCT02310568|40263178|FG001|Stage 1 ( 4 Weeks)|Other|1|||
16488044|NCT02310568|40263179|FG002|Stage 1 ( 4 Weeks)|Other|0|||
16488045|NCT02310568|40263180|FG003|Stage 1 ( 4 Weeks)|Other|0|||
16488046|NCT02310568|40263181|FG004|Stage 1 ( 4 Weeks)|Other|0|||
16488047|NCT02310568|40263177|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
16488048|NCT02310568|40263178|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
16488049|NCT02310568|40263179|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
16488050|NCT02310568|40263180|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
16488051|NCT02310568|40263181|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
16488052|NCT02310568|40263177|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
16488053|NCT02310568|40263178|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
16488054|NCT02310568|40263179|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
16488055|NCT02310568|40263180|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
16488056|NCT02310568|40263181|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
16488057|NCT02310568|40263177|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
16488058|NCT02310568|40263178|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
16488059|NCT02310568|40263179|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
16488060|NCT02310568|40263180|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
16488061|NCT02310568|40263181|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
16488062|NCT02310568|40263177|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
16488063|NCT02310568|40263178|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
16488064|NCT02310568|40263179|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
16488065|NCT02310568|40263180|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
16488066|NCT02310568|40263181|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
16488067|NCT02310568|40263177|FG000|Stage 2 (4 Weeks)|Other|0|||
16488068|NCT02310568|40263178|FG001|Stage 2 (4 Weeks)|Other|1|||
16488069|NCT02310568|40263179|FG002|Stage 2 (4 Weeks)|Other|1|||
16488070|NCT02310568|40263180|FG003|Stage 2 (4 Weeks)|Other|0|||
16488071|NCT02310568|40263181|FG004|Stage 2 (4 Weeks)|Other|0|||
16488072|NCT02310568|40263177|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
16488073|NCT02310568|40263178|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
16488074|NCT02310568|40263179|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
16488075|NCT02310568|40263180|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
16488076|NCT02310568|40263181|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
16488077|NCT02310568|40263177|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
16488078|NCT02310568|40263178|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
16488079|NCT02310568|40263179|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
16488080|NCT02310568|40263180|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
16488081|NCT02310568|40263181|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
16488082|NCT02310568|40263177|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
16488083|NCT02310568|40263178|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
16384311|NCT01346176|39892564|FG002|Completed Satisfaction Survey|Death|2|||
16488084|NCT02310568|40263179|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
16488085|NCT02310568|40263180|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
16488086|NCT02310568|40263181|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
16488087|NCT01129960|40263182|FG000|Overall Study|Withdrawal by Subject|3|||
16488088|NCT01129960|40263183|FG001|Overall Study|Withdrawal by Subject|0|||
16488089|NCT01129960|40263184|FG002|Overall Study|Withdrawal by Subject|3|||
16488090|NCT01129960|40263185|FG003|Overall Study|Withdrawal by Subject|2|||
16488091|NCT01129960|40263182|FG000|Overall Study|Lack of Efficacy|1|||
16488092|NCT01129960|40263183|FG001|Overall Study|Lack of Efficacy|1|||
16488093|NCT01129960|40263184|FG002|Overall Study|Lack of Efficacy|1|||
16488094|NCT01129960|40263185|FG003|Overall Study|Lack of Efficacy|1|||
16488095|NCT01129960|40263182|FG000|Overall Study|Adverse Event|23|||
16488096|NCT01129960|40263183|FG001|Overall Study|Adverse Event|16|||
16488097|NCT01129960|40263184|FG002|Overall Study|Adverse Event|16|||
16488098|NCT01129960|40263185|FG003|Overall Study|Adverse Event|7|||
16488099|NCT01129960|40263182|FG000|Overall Study|Protocol Violation|1|||
16488100|NCT01129960|40263183|FG001|Overall Study|Protocol Violation|2|||
16488101|NCT01129960|40263184|FG002|Overall Study|Protocol Violation|3|||
16488102|NCT01129960|40263185|FG003|Overall Study|Protocol Violation|0|||
16488103|NCT01129960|40263182|FG000|Overall Study|Lost to Follow-up|0|||
16488104|NCT01129960|40263183|FG001|Overall Study|Lost to Follow-up|2|||
16488105|NCT01129960|40263184|FG002|Overall Study|Lost to Follow-up|3|||
16488106|NCT01129960|40263185|FG003|Overall Study|Lost to Follow-up|3|||
16488107|NCT01129960|40263182|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
16488108|NCT01129960|40263183|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
16488109|NCT01129960|40263184|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
16488110|NCT01129960|40263185|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
16488111|NCT01129960|40263182|FG000|Overall Study|Physician Decision|1|||
16488112|NCT01129960|40263183|FG001|Overall Study|Physician Decision|0|||
16488113|NCT01129960|40263184|FG002|Overall Study|Physician Decision|0|||
16488114|NCT01129960|40263185|FG003|Overall Study|Physician Decision|0|||
16488115|NCT01129960|40263182|FG000|Overall Study|Pregnancy|1|||
16488116|NCT01129960|40263183|FG001|Overall Study|Pregnancy|0|||
16488117|NCT01129960|40263184|FG002|Overall Study|Pregnancy|0|||
16488118|NCT01129960|40263185|FG003|Overall Study|Pregnancy|0|||
16488119|NCT00299975|40263204|FG000|Overall Study|Adverse Event|1|||
16488120|NCT00299975|40263205|FG001|Overall Study|Adverse Event|0|||
16488121|NCT00299975|40263206|FG002|Overall Study|Adverse Event|2|||
16488122|NCT00299975|40263204|FG000|Overall Study|Pregnancy|0|||
16488123|NCT00299975|40263205|FG001|Overall Study|Pregnancy|0|||
16488124|NCT00299975|40263206|FG002|Overall Study|Pregnancy|1|||
16488125|NCT00299975|40263204|FG000|Overall Study|Lack of Efficacy|1|||
16488126|NCT00299975|40263205|FG001|Overall Study|Lack of Efficacy|0|||
16488127|NCT00299975|40263206|FG002|Overall Study|Lack of Efficacy|1|||
16488128|NCT00299975|40263204|FG000|Overall Study|Lost to Follow-up|1|||
16488129|NCT00299975|40263205|FG001|Overall Study|Lost to Follow-up|0|||
16488130|NCT00299975|40263206|FG002|Overall Study|Lost to Follow-up|0|||
16488131|NCT00299975|40263204|FG000|Overall Study|Withdrawal by Subject|0|||
16488132|NCT00299975|40263205|FG001|Overall Study|Withdrawal by Subject|1|||
16488133|NCT00299975|40263206|FG002|Overall Study|Withdrawal by Subject|3|||
16488134|NCT00299975|40263204|FG000|Overall Study|Physician Decision|0|||
16488135|NCT00299975|40263205|FG001|Overall Study|Physician Decision|0|||
16488136|NCT00299975|40263206|FG002|Overall Study|Physician Decision|1|||
16488137|NCT02532972|40263208|FG000|Overall Study|Withdrawal by Subject|1|||
16488138|NCT02549937|40263211|FG000|Overall Study|Death|0|||
16488139|NCT02549937|40263212|FG001|Overall Study|Death|1|||
16488140|NCT02549937|40263213|FG002|Overall Study|Death|0|||
16488141|NCT02549937|40263214|FG003|Overall Study|Death|1|||
16488142|NCT02549937|40263215|FG004|Overall Study|Death|0|||
16488143|NCT02549937|40263216|FG005|Overall Study|Death|8|||
16488144|NCT02549937|40263217|FG006|Overall Study|Death|0|||
16488145|NCT02549937|40263218|FG007|Overall Study|Death|0|||
16488146|NCT02549937|40263219|FG008|Overall Study|Death|19|||
16488147|NCT02549937|40263211|FG000|Overall Study|No follow up required|3|||
16488148|NCT02549937|40263212|FG001|Overall Study|No follow up required|6|||
16488149|NCT02549937|40263213|FG002|Overall Study|No follow up required|3|||
16488150|NCT02549937|40263214|FG003|Overall Study|No follow up required|8|||
16488151|NCT02549937|40263215|FG004|Overall Study|No follow up required|12|||
16488152|NCT02549937|40263216|FG005|Overall Study|No follow up required|21|||
16488153|NCT02549937|40263217|FG006|Overall Study|No follow up required|9|||
16488154|NCT02549937|40263218|FG007|Overall Study|No follow up required|11|||
16083184|NCT02404441|38796174|FG002|Phase 2 Part|Subject/guardian decision|0|||
16488155|NCT02549937|40263219|FG008|Overall Study|No follow up required|0|||
16488156|NCT02549937|40263211|FG000|Overall Study|Other|0|||
16488157|NCT02549937|40263212|FG001|Overall Study|Other|0|||
16488158|NCT02549937|40263213|FG002|Overall Study|Other|0|||
16488159|NCT02549937|40263214|FG003|Overall Study|Other|0|||
16488160|NCT02549937|40263215|FG004|Overall Study|Other|1|||
16488161|NCT02549937|40263216|FG005|Overall Study|Other|0|||
16488162|NCT02549937|40263217|FG006|Overall Study|Other|3|||
16083185|NCT02404441|38796175|FG003|Phase 2 Part|Subject/guardian decision|0|||
16488163|NCT02549937|40263218|FG007|Overall Study|Other|2|||
16488164|NCT02549937|40263219|FG008|Overall Study|Other|3|||
16488165|NCT02549937|40263211|FG000|Overall Study|Lost to Follow-up|0|||
16488166|NCT02549937|40263212|FG001|Overall Study|Lost to Follow-up|0|||
16488167|NCT02549937|40263213|FG002|Overall Study|Lost to Follow-up|0|||
16488168|NCT02549937|40263214|FG003|Overall Study|Lost to Follow-up|0|||
16488169|NCT02549937|40263215|FG004|Overall Study|Lost to Follow-up|0|||
16488170|NCT02549937|40263216|FG005|Overall Study|Lost to Follow-up|0|||
16488171|NCT02549937|40263217|FG006|Overall Study|Lost to Follow-up|0|||
16488172|NCT02549937|40263218|FG007|Overall Study|Lost to Follow-up|0|||
16488173|NCT02549937|40263219|FG008|Overall Study|Lost to Follow-up|3|||
16488174|NCT02549937|40263211|FG000|Overall Study|Withdrawal by Subject|0|||
16488175|NCT02549937|40263212|FG001|Overall Study|Withdrawal by Subject|0|||
16488176|NCT02549937|40263213|FG002|Overall Study|Withdrawal by Subject|0|||
16488177|NCT02549937|40263214|FG003|Overall Study|Withdrawal by Subject|0|||
16488178|NCT02549937|40263215|FG004|Overall Study|Withdrawal by Subject|0|||
16488179|NCT02549937|40263216|FG005|Overall Study|Withdrawal by Subject|1|||
16488180|NCT02549937|40263217|FG006|Overall Study|Withdrawal by Subject|4|||
16488181|NCT02549937|40263218|FG007|Overall Study|Withdrawal by Subject|3|||
16488182|NCT02549937|40263219|FG008|Overall Study|Withdrawal by Subject|2|||
16488183|NCT02549937|40263211|FG000|Overall Study|Sponsor Decision|0|||
16488184|NCT02549937|40263212|FG001|Overall Study|Sponsor Decision|0|||
16488185|NCT02549937|40263213|FG002|Overall Study|Sponsor Decision|0|||
16488186|NCT02549937|40263214|FG003|Overall Study|Sponsor Decision|0|||
16488187|NCT02549937|40263215|FG004|Overall Study|Sponsor Decision|0|||
16297380|NCT02393248|39573987|FG018|Part 3: Combination Therapy|Disease Progression|0|||
16297381|NCT02393248|39573988|FG019|Part 3: Combination Therapy|Disease Progression|0|||
16297382|NCT02393248|39573989|FG020|Part 3: Combination Therapy|Disease Progression|2|||
16297383|NCT02393248|39573990|FG021|Part 3: Combination Therapy|Disease Progression|1|||
16297384|NCT02393248|39573991|FG022|Part 3: Combination Therapy|Disease Progression|0|||
16297385|NCT02393248|39573992|FG023|Part 3: Combination Therapy|Disease Progression|0|||
16297386|NCT02393248|39573993|FG024|Part 3: Combination Therapy|Disease Progression|0|||
16297387|NCT02393248|39573969|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297388|NCT02393248|39573970|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297389|NCT02393248|39573971|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297390|NCT02393248|39573972|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297391|NCT02393248|39573973|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297392|NCT02393248|39573974|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297393|NCT02393248|39573975|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297394|NCT02393248|39573976|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297395|NCT02393248|39573977|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297396|NCT02393248|39573978|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297397|NCT02393248|39573979|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297398|NCT02393248|39573980|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297399|NCT02393248|39573981|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297400|NCT02393248|39573982|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297401|NCT02393248|39573983|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297402|NCT02393248|39573984|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297403|NCT02393248|39573985|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297404|NCT02393248|39573986|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297405|NCT02393248|39573987|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297406|NCT02393248|39573988|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297407|NCT02393248|39573989|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
16297408|NCT02393248|39573990|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
16297409|NCT02393248|39573991|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297410|NCT02393248|39573992|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297411|NCT02393248|39573993|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
16297412|NCT02393248|39573969|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297413|NCT02393248|39573970|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297414|NCT02393248|39573971|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297415|NCT02393248|39573972|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297416|NCT02393248|39573973|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297417|NCT02393248|39573974|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297418|NCT02393248|39573975|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297419|NCT02393248|39573976|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297420|NCT02393248|39573977|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297421|NCT02393248|39573978|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297422|NCT02393248|39573979|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297423|NCT02393248|39573980|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297424|NCT02393248|39573981|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297425|NCT02393248|39573982|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297426|NCT02393248|39573983|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16488188|NCT02549937|40263216|FG005|Overall Study|Sponsor Decision|0|||
16488189|NCT02549937|40263217|FG006|Overall Study|Sponsor Decision|0|||
16488190|NCT02549937|40263218|FG007|Overall Study|Sponsor Decision|0|||
16488191|NCT02549937|40263219|FG008|Overall Study|Sponsor Decision|6|||
16488192|NCT00288054|40263226|FG000|Overall Study|Protocol Violation|2|||
16488193|NCT00288054|40263226|FG000|Overall Study|Lack of Efficacy|16|||
16488194|NCT00288054|40263226|FG000|Overall Study|Adverse Event|3|||
16488195|NCT00288054|40263226|FG000|Overall Study|Withdrawal by Subject|1|||
16488196|NCT00288054|40263226|FG000|Overall Study|Not protocol specified|2|||
16488197|NCT02862171|40263227|FG000|Overall Study|Death|1|||
16488198|NCT02862171|40263227|FG000|Overall Study|Lost to Follow-up|13|||
16488199|NCT02862171|40263227|FG000|Overall Study|Withdrawal by Subject|57|||
16488200|NCT02862171|40263227|FG000|Overall Study|Non-compliance|4|||
16488201|NCT02862171|40263227|FG000|Overall Study|HIV-1 seroconversion|18|||
16488202|NCT00826943|40263235|FG000|Overall Study|Withdrawal by Subject|0|||
16488203|NCT00826943|40263236|FG001|Overall Study|Withdrawal by Subject|0|||
16488204|NCT00826943|40263237|FG002|Overall Study|Withdrawal by Subject|0|||
16488205|NCT00826943|40263238|FG003|Overall Study|Withdrawal by Subject|0|||
16488206|NCT00826943|40263239|FG004|Overall Study|Withdrawal by Subject|1|||
16488207|NCT00826943|40263240|FG005|Overall Study|Withdrawal by Subject|0|||
16488208|NCT01751178|40263242|FG000|Overall Study|Adverse Event|2|||
16488209|NCT01751178|40263243|FG001|Overall Study|Adverse Event|0|||
16488210|NCT01751178|40263244|FG002|Overall Study|Adverse Event|0|||
16488211|NCT01751178|40263242|FG000|Overall Study|Other Reason (unknown)|1|||
16488212|NCT01751178|40263243|FG001|Overall Study|Other Reason (unknown)|0|||
16488213|NCT01751178|40263244|FG002|Overall Study|Other Reason (unknown)|2|||
16488214|NCT01088997|40263245|FG000|Overall Study|Physician Decision|1|||
16488215|NCT01088997|40263246|FG001|Overall Study|Physician Decision|1|||
16488216|NCT01088997|40263245|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
16488217|NCT01088997|40263246|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
16488218|NCT01088997|40263245|FG000|Overall Study|Excluded prior to receiving drug|1|||
16488219|NCT01088997|40263246|FG001|Overall Study|Excluded prior to receiving drug|1|||
16488220|NCT00382252|40263247|FG000|Overall Study|Death|4|||
16488221|NCT00382252|40263247|FG000|Overall Study|Protocol Violation|8|||
16488222|NCT00382252|40263247|FG000|Overall Study|Not treated by RFA|1|||
16488223|NCT04649060|40263248|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
16488224|NCT04649060|40263249|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
16488225|NCT04649060|40263248|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
16488226|NCT04649060|40263249|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
16488227|NCT04649060|40263248|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
16488228|NCT04649060|40263249|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
16488229|NCT04649060|40263248|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
16488230|NCT04649060|40263249|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
16488231|NCT04649060|40263248|FG000|Arm A/Arm B Treatment|Patient Request|1|||
16488232|NCT04649060|40263249|FG001|Arm A/Arm B Treatment|Patient Request|0|||
16488233|NCT04649060|40263248|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
16488234|NCT04649060|40263249|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
16488235|NCT04649060|40263248|FG000|Arm A/Arm B Treatment|Other|1|||
16488236|NCT04649060|40263249|FG001|Arm A/Arm B Treatment|Other|0|||
16488237|NCT04649060|40263248|FG000|Crossover (Arm B)|Adverse Event|0|||
16488238|NCT04649060|40263249|FG001|Crossover (Arm B)|Adverse Event|1|||
16488239|NCT04649060|40263248|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
16488240|NCT04649060|40263249|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
16488241|NCT01737697|40263251|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488242|NCT01737697|40263252|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
16488243|NCT01737697|40263253|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488244|NCT01737697|40263254|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
16488245|NCT01737697|40263255|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
16488246|NCT01737697|40263256|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488247|NCT01737697|40263257|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488248|NCT01737697|40263258|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488249|NCT01737697|40263259|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488250|NCT01737697|40263260|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488251|NCT01737697|40263261|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488252|NCT01737697|40263262|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16083186|NCT02404441|38796176|FG004|Phase 2 Part|Subject/guardian decision|0|||
16488253|NCT01737697|40263263|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488254|NCT01737697|40263264|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488255|NCT01737697|40263265|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
16488256|NCT01737697|40263251|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
16488257|NCT01737697|40263252|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
16488258|NCT01737697|40263253|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
16488259|NCT01737697|40263254|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488260|NCT01737697|40263255|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488261|NCT01737697|40263256|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488262|NCT01737697|40263257|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488263|NCT01737697|40263258|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488264|NCT01737697|40263259|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488265|NCT01737697|40263260|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488266|NCT01737697|40263261|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488267|NCT01737697|40263262|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488268|NCT01737697|40263263|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488269|NCT01737697|40263264|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488270|NCT01737697|40263265|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
16488271|NCT01737697|40263251|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488272|NCT01737697|40263252|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488273|NCT01737697|40263253|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488274|NCT01737697|40263254|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
16488275|NCT01737697|40263255|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488276|NCT01737697|40263256|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488277|NCT01737697|40263257|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488278|NCT01737697|40263258|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488279|NCT01737697|40263259|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488280|NCT01737697|40263260|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
16083187|NCT02404441|38796177|FG005|Phase 2 Part|Subject/guardian decision|3|||
16083188|NCT02404441|38796178|FG006|Phase 2 Part|Subject/guardian decision|9|||
16083189|NCT02404441|38796179|FG007|Phase 2 Part|Subject/guardian decision|0|||
16083190|NCT02404441|38796180|FG008|Phase 2 Part|Subject/guardian decision|3|||
16083191|NCT02404441|38796181|FG009|Phase 2 Part|Subject/guardian decision|2|||
16083192|NCT02404441|38796172|FG000|Phase 2 Part|Death|0|||
16083193|NCT02404441|38796173|FG001|Phase 2 Part|Death|0|||
16083194|NCT02404441|38796174|FG002|Phase 2 Part|Death|0|||
16083195|NCT02404441|38796175|FG003|Phase 2 Part|Death|0|||
16083196|NCT02404441|38796176|FG004|Phase 2 Part|Death|0|||
16083197|NCT02404441|38796177|FG005|Phase 2 Part|Death|4|||
16083198|NCT02404441|38796178|FG006|Phase 2 Part|Death|8|||
16083199|NCT02404441|38796179|FG007|Phase 2 Part|Death|4|||
16083200|NCT02404441|38796180|FG008|Phase 2 Part|Death|10|||
16083201|NCT02404441|38796181|FG009|Phase 2 Part|Death|9|||
16083202|NCT00943917|38799023|FG000|Stage I|Adverse Event|1|||
16083203|NCT00943917|38799024|FG001|Stage I|Adverse Event|2|||
16083204|NCT00943917|38799025|FG002|Stage I|Adverse Event|2|||
16083205|NCT00943917|38799026|FG003|Stage I|Adverse Event|0|||
16083206|NCT00943917|38799027|FG004|Stage I|Adverse Event|0|||
16083207|NCT00943917|38799028|FG005|Stage I|Adverse Event|0|||
16083208|NCT00943917|38799029|FG006|Stage I|Adverse Event|0|||
16083209|NCT00943917|38799030|FG007|Stage I|Adverse Event|0|||
16083210|NCT00943917|38799031|FG008|Stage I|Adverse Event|0|||
16083211|NCT00943917|38799032|FG009|Stage I|Adverse Event|0|||
16083212|NCT00943917|38799033|FG010|Stage I|Adverse Event|0|||
16083213|NCT00943917|38799034|FG011|Stage I|Adverse Event|0|||
16189621|NCT02951988|39172652|FG002|Open-Label Treatment Period|Adverse Event|0|||
16189622|NCT02951988|39172653|FG003|Open-Label Treatment Period|Adverse Event|0|||
16189623|NCT02951988|39172650|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
16488281|NCT01737697|40263261|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488282|NCT01737697|40263262|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488283|NCT01737697|40263263|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488284|NCT01737697|40263264|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
16488285|NCT01737697|40263265|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
16189624|NCT02951988|39172651|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
16488286|NCT01737697|40263251|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16083214|NCT00943917|38799035|FG012|Stage I|Adverse Event|0|||
16083215|NCT00943917|38799036|FG013|Stage I|Adverse Event|0|||
16083216|NCT00943917|38799037|FG014|Stage I|Adverse Event|0|||
16083217|NCT00943917|38799023|FG000|Stage I|Lost to Follow-up|0|||
16083218|NCT00943917|38799024|FG001|Stage I|Lost to Follow-up|0|||
16083219|NCT00943917|38799025|FG002|Stage I|Lost to Follow-up|1|||
16083220|NCT00943917|38799026|FG003|Stage I|Lost to Follow-up|0|||
16083221|NCT00943917|38799027|FG004|Stage I|Lost to Follow-up|0|||
16083222|NCT00943917|38799028|FG005|Stage I|Lost to Follow-up|0|||
16083223|NCT00943917|38799029|FG006|Stage I|Lost to Follow-up|0|||
16083224|NCT00943917|38799030|FG007|Stage I|Lost to Follow-up|0|||
16083225|NCT00943917|38799031|FG008|Stage I|Lost to Follow-up|0|||
16083226|NCT00943917|38799032|FG009|Stage I|Lost to Follow-up|0|||
16083227|NCT00943917|38799033|FG010|Stage I|Lost to Follow-up|0|||
16083228|NCT00943917|38799034|FG011|Stage I|Lost to Follow-up|0|||
16083229|NCT00943917|38799035|FG012|Stage I|Lost to Follow-up|0|||
16083230|NCT00943917|38799036|FG013|Stage I|Lost to Follow-up|0|||
16083231|NCT00943917|38799037|FG014|Stage I|Lost to Follow-up|0|||
16083232|NCT00943917|38799023|FG000|Stage I|hyperglycemia|0|||
16083233|NCT00943917|38799024|FG001|Stage I|hyperglycemia|0|||
16083234|NCT00943917|38799025|FG002|Stage I|hyperglycemia|1|||
16083235|NCT00943917|38799026|FG003|Stage I|hyperglycemia|0|||
16083236|NCT00943917|38799027|FG004|Stage I|hyperglycemia|0|||
16083237|NCT00943917|38799028|FG005|Stage I|hyperglycemia|0|||
16083238|NCT00943917|38799029|FG006|Stage I|hyperglycemia|0|||
16083239|NCT00943917|38799030|FG007|Stage I|hyperglycemia|0|||
16083240|NCT00943917|38799031|FG008|Stage I|hyperglycemia|0|||
16083241|NCT00943917|38799032|FG009|Stage I|hyperglycemia|0|||
16083242|NCT00943917|38799033|FG010|Stage I|hyperglycemia|0|||
16083243|NCT00943917|38799034|FG011|Stage I|hyperglycemia|0|||
16083244|NCT00943917|38799035|FG012|Stage I|hyperglycemia|0|||
16083245|NCT00943917|38799036|FG013|Stage I|hyperglycemia|0|||
16083246|NCT00943917|38799037|FG014|Stage I|hyperglycemia|0|||
16083247|NCT00943917|38799023|FG000|Stage I|A1C elevation|1|||
16083248|NCT00943917|38799024|FG001|Stage I|A1C elevation|0|||
16083249|NCT00943917|38799025|FG002|Stage I|A1C elevation|0|||
16083250|NCT00943917|38799026|FG003|Stage I|A1C elevation|0|||
16083251|NCT00943917|38799027|FG004|Stage I|A1C elevation|0|||
16083252|NCT00943917|38799028|FG005|Stage I|A1C elevation|0|||
16083253|NCT00943917|38799029|FG006|Stage I|A1C elevation|0|||
16083254|NCT00943917|38799030|FG007|Stage I|A1C elevation|0|||
16083255|NCT00943917|38799031|FG008|Stage I|A1C elevation|0|||
16083256|NCT00943917|38799032|FG009|Stage I|A1C elevation|0|||
16083257|NCT00943917|38799033|FG010|Stage I|A1C elevation|0|||
16083258|NCT00943917|38799034|FG011|Stage I|A1C elevation|0|||
16083259|NCT00943917|38799035|FG012|Stage I|A1C elevation|0|||
16083260|NCT00943917|38799036|FG013|Stage I|A1C elevation|0|||
16083261|NCT00943917|38799037|FG014|Stage I|A1C elevation|0|||
16083262|NCT00943917|38799023|FG000|Stage I|Withdrawal by Subject|2|||
16083263|NCT00943917|38799024|FG001|Stage I|Withdrawal by Subject|1|||
16083264|NCT00943917|38799025|FG002|Stage I|Withdrawal by Subject|2|||
16083265|NCT00943917|38799026|FG003|Stage I|Withdrawal by Subject|0|||
16083266|NCT00943917|38799027|FG004|Stage I|Withdrawal by Subject|0|||
16083267|NCT00943917|38799028|FG005|Stage I|Withdrawal by Subject|0|||
16083268|NCT00943917|38799029|FG006|Stage I|Withdrawal by Subject|0|||
16083269|NCT00943917|38799030|FG007|Stage I|Withdrawal by Subject|0|||
16083270|NCT00943917|38799031|FG008|Stage I|Withdrawal by Subject|0|||
16083271|NCT00943917|38799032|FG009|Stage I|Withdrawal by Subject|0|||
16083272|NCT00943917|38799033|FG010|Stage I|Withdrawal by Subject|0|||
16083273|NCT00943917|38799034|FG011|Stage I|Withdrawal by Subject|0|||
16083274|NCT00943917|38799035|FG012|Stage I|Withdrawal by Subject|0|||
16083275|NCT00943917|38799036|FG013|Stage I|Withdrawal by Subject|0|||
16083276|NCT00943917|38799037|FG014|Stage I|Withdrawal by Subject|0|||
16083277|NCT00943917|38799023|FG000|Stage II|Adverse Event|0|||
16083278|NCT00943917|38799024|FG001|Stage II|Adverse Event|0|||
16083279|NCT00943917|38799025|FG002|Stage II|Adverse Event|0|||
16083280|NCT00943917|38799026|FG003|Stage II|Adverse Event|0|||
16083281|NCT00943917|38799027|FG004|Stage II|Adverse Event|0|||
16083282|NCT00943917|38799028|FG005|Stage II|Adverse Event|1|||
16083283|NCT00943917|38799029|FG006|Stage II|Adverse Event|3|||
16083284|NCT00943917|38799030|FG007|Stage II|Adverse Event|0|||
16083285|NCT00943917|38799031|FG008|Stage II|Adverse Event|1|||
16083286|NCT00943917|38799032|FG009|Stage II|Adverse Event|0|||
16083287|NCT00943917|38799033|FG010|Stage II|Adverse Event|0|||
16083288|NCT00943917|38799034|FG011|Stage II|Adverse Event|0|||
16083289|NCT00943917|38799035|FG012|Stage II|Adverse Event|0|||
16083290|NCT00943917|38799036|FG013|Stage II|Adverse Event|0|||
16083291|NCT00943917|38799037|FG014|Stage II|Adverse Event|0|||
16083292|NCT00943917|38799023|FG000|Stage II|Withdrawal by Subject|0|||
16083293|NCT00943917|38799024|FG001|Stage II|Withdrawal by Subject|0|||
16083294|NCT00943917|38799025|FG002|Stage II|Withdrawal by Subject|0|||
16083295|NCT00943917|38799026|FG003|Stage II|Withdrawal by Subject|0|||
16083296|NCT00943917|38799027|FG004|Stage II|Withdrawal by Subject|0|||
16083297|NCT00943917|38799028|FG005|Stage II|Withdrawal by Subject|1|||
16083298|NCT00943917|38799029|FG006|Stage II|Withdrawal by Subject|0|||
16083299|NCT00943917|38799030|FG007|Stage II|Withdrawal by Subject|0|||
16083300|NCT00943917|38799031|FG008|Stage II|Withdrawal by Subject|0|||
16083301|NCT00943917|38799032|FG009|Stage II|Withdrawal by Subject|0|||
16083302|NCT00943917|38799033|FG010|Stage II|Withdrawal by Subject|0|||
16083303|NCT00943917|38799034|FG011|Stage II|Withdrawal by Subject|0|||
16083304|NCT00943917|38799035|FG012|Stage II|Withdrawal by Subject|0|||
16083305|NCT00943917|38799036|FG013|Stage II|Withdrawal by Subject|0|||
16083306|NCT00943917|38799037|FG014|Stage II|Withdrawal by Subject|0|||
16083307|NCT00943917|38799023|FG000|Stage II|Pregnancy|0|||
16083308|NCT00943917|38799024|FG001|Stage II|Pregnancy|0|||
16083309|NCT00943917|38799025|FG002|Stage II|Pregnancy|0|||
16083310|NCT00943917|38799026|FG003|Stage II|Pregnancy|0|||
16083311|NCT00943917|38799027|FG004|Stage II|Pregnancy|0|||
16083312|NCT00943917|38799028|FG005|Stage II|Pregnancy|1|||
16083313|NCT00943917|38799029|FG006|Stage II|Pregnancy|0|||
16083314|NCT00943917|38799030|FG007|Stage II|Pregnancy|0|||
16488287|NCT01737697|40263252|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
16488288|NCT01737697|40263253|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488289|NCT01737697|40263254|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488290|NCT01737697|40263255|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488291|NCT01737697|40263256|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488292|NCT01737697|40263257|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488293|NCT01737697|40263258|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488294|NCT01737697|40263259|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488295|NCT01737697|40263260|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488296|NCT01737697|40263261|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488297|NCT01737697|40263262|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488298|NCT01737697|40263263|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488299|NCT01737697|40263264|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488300|NCT01737697|40263265|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
16488301|NCT01737697|40263251|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488302|NCT01737697|40263252|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488303|NCT01737697|40263253|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488304|NCT01737697|40263254|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488305|NCT01737697|40263255|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
16488306|NCT01737697|40263256|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488307|NCT01737697|40263257|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488308|NCT01737697|40263258|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488309|NCT01737697|40263259|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488310|NCT01737697|40263260|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488311|NCT01737697|40263261|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488312|NCT01737697|40263262|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488313|NCT01737697|40263263|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488314|NCT01737697|40263264|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488315|NCT01737697|40263265|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
16488316|NCT01737697|40263251|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488317|NCT01737697|40263252|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
16488318|NCT01737697|40263253|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
16488319|NCT01737697|40263254|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
16488320|NCT01737697|40263255|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
16488321|NCT01737697|40263256|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488322|NCT01737697|40263257|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488323|NCT01737697|40263258|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488324|NCT01737697|40263259|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488325|NCT01737697|40263260|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488326|NCT01737697|40263261|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488327|NCT01737697|40263262|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488328|NCT01737697|40263263|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488329|NCT01737697|40263264|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488330|NCT01737697|40263265|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
16488331|NCT01737697|40263251|FG000|Subacute Phase|Adverse Event|0|||
16488332|NCT01737697|40263252|FG001|Subacute Phase|Adverse Event|0|||
16488333|NCT01737697|40263253|FG002|Subacute Phase|Adverse Event|0|||
16488334|NCT01737697|40263254|FG003|Subacute Phase|Adverse Event|0|||
16488335|NCT01737697|40263255|FG004|Subacute Phase|Adverse Event|0|||
16488336|NCT01737697|40263256|FG005|Subacute Phase|Adverse Event|1|||
16488337|NCT01737697|40263257|FG006|Subacute Phase|Adverse Event|1|||
16488338|NCT01737697|40263258|FG007|Subacute Phase|Adverse Event|1|||
16083315|NCT00943917|38799031|FG008|Stage II|Pregnancy|0|||
16083316|NCT00943917|38799032|FG009|Stage II|Pregnancy|0|||
16083317|NCT00943917|38799033|FG010|Stage II|Pregnancy|0|||
16083318|NCT00943917|38799034|FG011|Stage II|Pregnancy|0|||
16488339|NCT01737697|40263259|FG008|Subacute Phase|Adverse Event|1|||
16488340|NCT01737697|40263260|FG009|Subacute Phase|Adverse Event|1|||
16488341|NCT01737697|40263261|FG010|Subacute Phase|Adverse Event|4|||
16488342|NCT01737697|40263262|FG011|Subacute Phase|Adverse Event|1|||
16488343|NCT01737697|40263263|FG012|Subacute Phase|Adverse Event|1|||
16488344|NCT01737697|40263264|FG013|Subacute Phase|Adverse Event|0|||
16488345|NCT01737697|40263265|FG014|Subacute Phase|Adverse Event|0|||
16488346|NCT01737697|40263251|FG000|Subacute Phase|Withdrawal by Subject|0|||
16488347|NCT01737697|40263252|FG001|Subacute Phase|Withdrawal by Subject|0|||
16488348|NCT01737697|40263253|FG002|Subacute Phase|Withdrawal by Subject|0|||
16488349|NCT01737697|40263254|FG003|Subacute Phase|Withdrawal by Subject|0|||
16488350|NCT01737697|40263255|FG004|Subacute Phase|Withdrawal by Subject|0|||
16488351|NCT01737697|40263256|FG005|Subacute Phase|Withdrawal by Subject|1|||
16488352|NCT01737697|40263257|FG006|Subacute Phase|Withdrawal by Subject|0|||
16488353|NCT01737697|40263258|FG007|Subacute Phase|Withdrawal by Subject|2|||
16488354|NCT01737697|40263259|FG008|Subacute Phase|Withdrawal by Subject|0|||
16488355|NCT01737697|40263260|FG009|Subacute Phase|Withdrawal by Subject|1|||
16488356|NCT01737697|40263261|FG010|Subacute Phase|Withdrawal by Subject|0|||
16488357|NCT01737697|40263262|FG011|Subacute Phase|Withdrawal by Subject|1|||
16488358|NCT01737697|40263263|FG012|Subacute Phase|Withdrawal by Subject|1|||
16488359|NCT01737697|40263264|FG013|Subacute Phase|Withdrawal by Subject|1|||
16488360|NCT01737697|40263265|FG014|Subacute Phase|Withdrawal by Subject|0|||
16488361|NCT01737697|40263251|FG000|Subacute Phase|Lost to Follow-up|0|||
16488362|NCT01737697|40263252|FG001|Subacute Phase|Lost to Follow-up|0|||
16488363|NCT01737697|40263253|FG002|Subacute Phase|Lost to Follow-up|0|||
16488364|NCT01737697|40263254|FG003|Subacute Phase|Lost to Follow-up|0|||
16488365|NCT01737697|40263255|FG004|Subacute Phase|Lost to Follow-up|0|||
16488366|NCT01737697|40263256|FG005|Subacute Phase|Lost to Follow-up|0|||
16488367|NCT01737697|40263257|FG006|Subacute Phase|Lost to Follow-up|0|||
16488368|NCT01737697|40263258|FG007|Subacute Phase|Lost to Follow-up|0|||
16384312|NCT01346176|39892562|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
16488369|NCT01737697|40263259|FG008|Subacute Phase|Lost to Follow-up|0|||
16488370|NCT01737697|40263260|FG009|Subacute Phase|Lost to Follow-up|0|||
16488371|NCT01737697|40263261|FG010|Subacute Phase|Lost to Follow-up|0|||
16488372|NCT01737697|40263262|FG011|Subacute Phase|Lost to Follow-up|0|||
16488373|NCT01737697|40263263|FG012|Subacute Phase|Lost to Follow-up|0|||
16488374|NCT01737697|40263264|FG013|Subacute Phase|Lost to Follow-up|0|||
16083319|NCT00943917|38799035|FG012|Stage II|Pregnancy|0|||
16083320|NCT00943917|38799036|FG013|Stage II|Pregnancy|0|||
16083321|NCT00943917|38799037|FG014|Stage II|Pregnancy|0|||
16083322|NCT00943917|38799023|FG000|Stage II Continuation|Adverse Event|0|||
16083323|NCT00943917|38799024|FG001|Stage II Continuation|Adverse Event|0|||
16083324|NCT00943917|38799025|FG002|Stage II Continuation|Adverse Event|0|||
16083325|NCT00943917|38799026|FG003|Stage II Continuation|Adverse Event|0|||
16083326|NCT00943917|38799027|FG004|Stage II Continuation|Adverse Event|0|||
16083327|NCT00943917|38799028|FG005|Stage II Continuation|Adverse Event|0|||
16083328|NCT00943917|38799029|FG006|Stage II Continuation|Adverse Event|0|||
16083329|NCT00943917|38799030|FG007|Stage II Continuation|Adverse Event|0|||
16083330|NCT00943917|38799031|FG008|Stage II Continuation|Adverse Event|0|||
16083331|NCT00943917|38799032|FG009|Stage II Continuation|Adverse Event|0|||
16083332|NCT00943917|38799033|FG010|Stage II Continuation|Adverse Event|0|||
16083333|NCT00943917|38799034|FG011|Stage II Continuation|Adverse Event|1|||
16083334|NCT00943917|38799035|FG012|Stage II Continuation|Adverse Event|2|||
16083335|NCT00943917|38799036|FG013|Stage II Continuation|Adverse Event|1|||
16083336|NCT00943917|38799037|FG014|Stage II Continuation|Adverse Event|1|||
16083337|NCT00943917|38799023|FG000|Stage II Continuation|Withdrawal by Subject|0|||
16083338|NCT00943917|38799024|FG001|Stage II Continuation|Withdrawal by Subject|0|||
16083339|NCT00943917|38799025|FG002|Stage II Continuation|Withdrawal by Subject|0|||
16083340|NCT00943917|38799026|FG003|Stage II Continuation|Withdrawal by Subject|0|||
16083341|NCT00943917|38799027|FG004|Stage II Continuation|Withdrawal by Subject|0|||
16083342|NCT00943917|38799028|FG005|Stage II Continuation|Withdrawal by Subject|0|||
16083343|NCT00943917|38799029|FG006|Stage II Continuation|Withdrawal by Subject|0|||
16083344|NCT00943917|38799030|FG007|Stage II Continuation|Withdrawal by Subject|0|||
16083345|NCT00943917|38799031|FG008|Stage II Continuation|Withdrawal by Subject|0|||
16083346|NCT00943917|38799032|FG009|Stage II Continuation|Withdrawal by Subject|0|||
16083347|NCT00943917|38799033|FG010|Stage II Continuation|Withdrawal by Subject|0|||
16083348|NCT00943917|38799034|FG011|Stage II Continuation|Withdrawal by Subject|0|||
16083349|NCT00943917|38799035|FG012|Stage II Continuation|Withdrawal by Subject|0|||
16083350|NCT00943917|38799036|FG013|Stage II Continuation|Withdrawal by Subject|1|||
16083351|NCT00943917|38799037|FG014|Stage II Continuation|Withdrawal by Subject|3|||
16083352|NCT00943917|38799023|FG000|Stage II Continuation|Protocol Violation|0|||
16083353|NCT00943917|38799024|FG001|Stage II Continuation|Protocol Violation|0|||
16083354|NCT00943917|38799025|FG002|Stage II Continuation|Protocol Violation|0|||
16083355|NCT00943917|38799026|FG003|Stage II Continuation|Protocol Violation|0|||
16083356|NCT00943917|38799027|FG004|Stage II Continuation|Protocol Violation|0|||
16083357|NCT00943917|38799028|FG005|Stage II Continuation|Protocol Violation|0|||
16083358|NCT00943917|38799029|FG006|Stage II Continuation|Protocol Violation|0|||
16083359|NCT00943917|38799030|FG007|Stage II Continuation|Protocol Violation|0|||
16083360|NCT00943917|38799031|FG008|Stage II Continuation|Protocol Violation|0|||
16083361|NCT00943917|38799032|FG009|Stage II Continuation|Protocol Violation|1|||
16083362|NCT00943917|38799033|FG010|Stage II Continuation|Protocol Violation|0|||
16083363|NCT00943917|38799034|FG011|Stage II Continuation|Protocol Violation|1|||
16083364|NCT00943917|38799035|FG012|Stage II Continuation|Protocol Violation|0|||
16083365|NCT00943917|38799036|FG013|Stage II Continuation|Protocol Violation|0|||
16083366|NCT00943917|38799037|FG014|Stage II Continuation|Protocol Violation|0|||
16083367|NCT00943917|38799023|FG000|Stage II Continuation|hypoglycemia|0|||
16083368|NCT00943917|38799024|FG001|Stage II Continuation|hypoglycemia|0|||
16083369|NCT00943917|38799025|FG002|Stage II Continuation|hypoglycemia|0|||
16083370|NCT00943917|38799026|FG003|Stage II Continuation|hypoglycemia|0|||
16083371|NCT00943917|38799027|FG004|Stage II Continuation|hypoglycemia|0|||
16083372|NCT00943917|38799028|FG005|Stage II Continuation|hypoglycemia|0|||
16083373|NCT00943917|38799029|FG006|Stage II Continuation|hypoglycemia|0|||
16083374|NCT00943917|38799030|FG007|Stage II Continuation|hypoglycemia|0|||
16083375|NCT00943917|38799031|FG008|Stage II Continuation|hypoglycemia|0|||
16083376|NCT00943917|38799032|FG009|Stage II Continuation|hypoglycemia|0|||
16083377|NCT00943917|38799033|FG010|Stage II Continuation|hypoglycemia|0|||
16083378|NCT00943917|38799034|FG011|Stage II Continuation|hypoglycemia|0|||
16083379|NCT00943917|38799035|FG012|Stage II Continuation|hypoglycemia|1|||
16083380|NCT00943917|38799036|FG013|Stage II Continuation|hypoglycemia|0|||
16083381|NCT00943917|38799037|FG014|Stage II Continuation|hypoglycemia|0|||
16083382|NCT00943917|38799023|FG000|Stage II Continuation|A1C elevation|0|||
16083383|NCT00943917|38799024|FG001|Stage II Continuation|A1C elevation|0|||
16083384|NCT00943917|38799025|FG002|Stage II Continuation|A1C elevation|0|||
16083385|NCT00943917|38799026|FG003|Stage II Continuation|A1C elevation|0|||
16083386|NCT00943917|38799027|FG004|Stage II Continuation|A1C elevation|0|||
16083387|NCT00943917|38799028|FG005|Stage II Continuation|A1C elevation|0|||
16083388|NCT00943917|38799029|FG006|Stage II Continuation|A1C elevation|0|||
16083389|NCT00943917|38799030|FG007|Stage II Continuation|A1C elevation|0|||
16083390|NCT00943917|38799031|FG008|Stage II Continuation|A1C elevation|0|||
16083391|NCT00943917|38799032|FG009|Stage II Continuation|A1C elevation|0|||
16083392|NCT00943917|38799033|FG010|Stage II Continuation|A1C elevation|0|||
16488375|NCT01737697|40263265|FG014|Subacute Phase|Lost to Follow-up|1|||
16083393|NCT00943917|38799034|FG011|Stage II Continuation|A1C elevation|0|||
16488376|NCT01737697|40263251|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
16488377|NCT01737697|40263252|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
16488378|NCT01737697|40263253|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
16488379|NCT01737697|40263254|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
16488380|NCT01737697|40263255|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
16488381|NCT01737697|40263256|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
16189625|NCT02951988|39172652|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
16189626|NCT02951988|39172653|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
16189627|NCT02951988|39172650|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
16189628|NCT02951988|39172651|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
16189629|NCT02951988|39172652|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
16189630|NCT02951988|39172653|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
16189631|NCT02951988|39172650|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
16189632|NCT02951988|39172651|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
16189633|NCT02951988|39172652|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
16189634|NCT02951988|39172653|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
16189635|NCT02951988|39172650|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
16189636|NCT02951988|39172651|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
16189637|NCT02951988|39172652|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
16189638|NCT02951988|39172653|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
16189639|NCT02951988|39172650|FG000|Double-Blind Treatment Period|Pregnancy|0|||
16189640|NCT02951988|39172651|FG001|Double-Blind Treatment Period|Pregnancy|1|||
16189641|NCT02951988|39172652|FG002|Double-Blind Treatment Period|Pregnancy|1|||
16189642|NCT02951988|39172653|FG003|Double-Blind Treatment Period|Pregnancy|0|||
16189643|NCT02951988|39172650|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16189644|NCT02951988|39172651|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
16189645|NCT02951988|39172652|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
16189646|NCT02951988|39172653|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
16189647|NCT02951988|39172650|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16189648|NCT02951988|39172651|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
16189649|NCT02951988|39172652|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
16189650|NCT02951988|39172653|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
16189651|NCT02951988|39172650|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16189652|NCT02951988|39172651|FG001|Double-Blind Treatment Period|Adverse Event|8|||
16189653|NCT02951988|39172652|FG002|Double-Blind Treatment Period|Adverse Event|3|||
16189654|NCT02951988|39172653|FG003|Double-Blind Treatment Period|Adverse Event|6|||
16189655|NCT02951988|39172650|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
16189656|NCT02951988|39172651|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
16189657|NCT02951988|39172652|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
16189658|NCT02951988|39172653|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
16189659|NCT05373706|39172654|FG000|Overall Study|Lost to Follow-up|2|||
16189660|NCT05373706|39172655|FG001|Overall Study|Lost to Follow-up|2|||
16189661|NCT03201198|39172663|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
16189662|NCT03201198|39172664|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
16189663|NCT03201198|39172663|FG000|Overall Study|Withdrawal by Subject|2|||
16189664|NCT03201198|39172664|FG001|Overall Study|Withdrawal by Subject|3|||
16189665|NCT02137772|39172667|FG000|Overall Study|Adverse Event|6|||
16189666|NCT02137772|39172668|FG001|Overall Study|Adverse Event|3|||
16189667|NCT02137772|39172667|FG000|Overall Study|Death|71|||
16189668|NCT02137772|39172668|FG001|Overall Study|Death|44|||
16189669|NCT02137772|39172667|FG000|Overall Study|Lost to Follow-up|8|||
16189670|NCT02137772|39172668|FG001|Overall Study|Lost to Follow-up|4|||
16189671|NCT02137772|39172667|FG000|Overall Study|Physician Decision|15|||
16189672|NCT02137772|39172668|FG001|Overall Study|Physician Decision|5|||
16189673|NCT02137772|39172667|FG000|Overall Study|Withdrawal by Subject|28|||
16189674|NCT02137772|39172668|FG001|Overall Study|Withdrawal by Subject|17|||
16189675|NCT02137772|39172667|FG000|Overall Study|Non-compliance with study drug|1|||
16189676|NCT02137772|39172668|FG001|Overall Study|Non-compliance with study drug|0|||
16488382|NCT01737697|40263257|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
16488383|NCT01737697|40263258|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
16488384|NCT01737697|40263259|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
16488385|NCT01737697|40263260|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
16189677|NCT02137772|39172667|FG000|Overall Study|Not treated|3|||
16189678|NCT02137772|39172668|FG001|Overall Study|Not treated|2|||
16189679|NCT00527111|39172669|FG000|Overall Study|Adverse Event|14|||
16189680|NCT00527111|39172670|FG001|Overall Study|Adverse Event|13|||
16189681|NCT00527111|39172669|FG000|Overall Study|Death|0|||
16189682|NCT00527111|39172670|FG001|Overall Study|Death|1|||
16083394|NCT00943917|38799035|FG012|Stage II Continuation|A1C elevation|0|||
16189683|NCT00527111|39172669|FG000|Overall Study|Investigator Request|2|||
16189684|NCT00527111|39172670|FG001|Overall Study|Investigator Request|1|||
16189685|NCT00527111|39172669|FG000|Overall Study|Patient Request|2|||
16189686|NCT00527111|39172670|FG001|Overall Study|Patient Request|5|||
16189687|NCT00527111|39172669|FG000|Overall Study|Other|2|||
16488386|NCT01737697|40263261|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
16488387|NCT01737697|40263262|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
16488388|NCT01737697|40263263|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
16488389|NCT01737697|40263264|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
16488390|NCT01737697|40263265|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
16488391|NCT01737697|40263251|FG000|Subacute Phase|Protocol Violation|0|||
16488392|NCT01737697|40263252|FG001|Subacute Phase|Protocol Violation|0|||
16189688|NCT00527111|39172670|FG001|Overall Study|Other|2|||
16189689|NCT00872170|39172671|FG000|Overall Study|Adverse Event|1|||
16189690|NCT00872170|39172672|FG001|Overall Study|Adverse Event|0|||
16189691|NCT02948777|39172673|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
16189692|NCT03670641|39172674|FG000|Overall Study|Lost to Follow-up|3|||
16189693|NCT03350750|39172678|FG000|Overall Study|Death|1|||
16189694|NCT03350750|39172679|FG001|Overall Study|Death|1|||
16189695|NCT04072146|39172682|FG000|Overall Study|Adverse Event|0|||
16189696|NCT04072146|39172683|FG001|Overall Study|Adverse Event|1|||
16189697|NCT02075255|39172687|FG000|Overall Study|Study specific withdrawal criteria|0|||
16189698|NCT02075255|39172688|FG001|Overall Study|Study specific withdrawal criteria|1|||
16189699|NCT02075255|39172689|FG002|Overall Study|Study specific withdrawal criteria|1|||
16189700|NCT02075255|39172687|FG000|Overall Study|Withdrawal by Subject|4|||
16189701|NCT02075255|39172688|FG001|Overall Study|Withdrawal by Subject|1|||
16189702|NCT02075255|39172689|FG002|Overall Study|Withdrawal by Subject|0|||
16189703|NCT02075255|39172687|FG000|Overall Study|Lost to Follow-up|0|||
16189704|NCT02075255|39172688|FG001|Overall Study|Lost to Follow-up|0|||
16189705|NCT02075255|39172689|FG002|Overall Study|Lost to Follow-up|1|||
16189706|NCT02075255|39172687|FG000|Overall Study|Adverse Event|0|||
16189707|NCT02075255|39172688|FG001|Overall Study|Adverse Event|0|||
16189708|NCT02075255|39172689|FG002|Overall Study|Adverse Event|1|||
16189709|NCT02075255|39172687|FG000|Overall Study|Death|0|||
16189710|NCT02075255|39172688|FG001|Overall Study|Death|2|||
16189711|NCT02075255|39172689|FG002|Overall Study|Death|0|||
16189712|NCT02928406|39172690|FG000|Overall Study|Death|780|||
16189713|NCT02928406|39172690|FG000|Overall Study|Progressive disease|3|||
16189714|NCT02928406|39172690|FG000|Overall Study|Lost to Follow-up|49|||
16189715|NCT02928406|39172690|FG000|Overall Study|Non-compliance|2|||
16189716|NCT02928406|39172690|FG000|Overall Study|Withdrawal by Subject|40|||
16189717|NCT02928406|39172690|FG000|Overall Study|Study terminated by sponsor|57|||
16189718|NCT02928406|39172690|FG000|Overall Study|Physician Decision|1|||
16488393|NCT01737697|40263253|FG002|Subacute Phase|Protocol Violation|0|||
16488394|NCT01737697|40263254|FG003|Subacute Phase|Protocol Violation|0|||
16488395|NCT01737697|40263255|FG004|Subacute Phase|Protocol Violation|0|||
16488396|NCT01737697|40263256|FG005|Subacute Phase|Protocol Violation|1|||
16488397|NCT01737697|40263257|FG006|Subacute Phase|Protocol Violation|0|||
16488398|NCT01737697|40263258|FG007|Subacute Phase|Protocol Violation|0|||
16488399|NCT01737697|40263259|FG008|Subacute Phase|Protocol Violation|0|||
16488400|NCT01737697|40263260|FG009|Subacute Phase|Protocol Violation|0|||
16189719|NCT02928406|39172690|FG000|Overall Study|Various reasons|72|||
16189720|NCT02196038|39172691|FG000|Overall Study|Death|16|||
16189721|NCT02196038|39172692|FG001|Overall Study|Death|21|||
16189722|NCT02196038|39172691|FG000|Overall Study|Withdrawal by Subject|0|||
16189723|NCT02196038|39172692|FG001|Overall Study|Withdrawal by Subject|1|||
16189724|NCT02196038|39172691|FG000|Overall Study|Lost to Follow-up|1|||
16189725|NCT02196038|39172692|FG001|Overall Study|Lost to Follow-up|0|||
16189726|NCT04191577|39172695|FG000|Overall Study|Withdrawal by Subject|2|||
16488401|NCT01737697|40263261|FG010|Subacute Phase|Protocol Violation|1|||
16488402|NCT01737697|40263262|FG011|Subacute Phase|Protocol Violation|0|||
16488403|NCT01737697|40263263|FG012|Subacute Phase|Protocol Violation|0|||
16488404|NCT01737697|40263264|FG013|Subacute Phase|Protocol Violation|0|||
16189727|NCT04191577|39172696|FG001|Overall Study|Withdrawal by Subject|2|||
16189728|NCT04191577|39172697|FG002|Overall Study|Withdrawal by Subject|1|||
16189729|NCT04191577|39172695|FG000|Overall Study|Physician Decision|1|||
16189730|NCT04191577|39172696|FG001|Overall Study|Physician Decision|1|||
16189731|NCT04191577|39172697|FG002|Overall Study|Physician Decision|0|||
16189732|NCT04191577|39172695|FG000|Overall Study|Adverse Event|0|||
16189733|NCT04191577|39172696|FG001|Overall Study|Adverse Event|0|||
16488405|NCT01737697|40263265|FG014|Subacute Phase|Protocol Violation|0|||
16488406|NCT01737697|40263251|FG000|Subacute Phase|Physician Decision|0|||
16488407|NCT01737697|40263252|FG001|Subacute Phase|Physician Decision|0|||
16488408|NCT01737697|40263253|FG002|Subacute Phase|Physician Decision|0|||
16189734|NCT04191577|39172697|FG002|Overall Study|Adverse Event|1|||
16189735|NCT04191577|39172695|FG000|Overall Study|Death|0|||
16189736|NCT04191577|39172696|FG001|Overall Study|Death|0|||
16189737|NCT04191577|39172697|FG002|Overall Study|Death|1|||
16189738|NCT00907881|39172702|FG000|Overall Study|Lost to Follow-up|59|||
16189739|NCT00907881|39172702|FG000|Overall Study|Noncompliance|5|||
16189740|NCT00907881|39172702|FG000|Overall Study|Withdrawal by Subject|5|||
16384313|NCT01346176|39892563|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
16384314|NCT01346176|39892564|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
16189741|NCT00907881|39172702|FG000|Overall Study|Protocol Violation|1|||
16189742|NCT00907881|39172702|FG000|Overall Study|Missing discontinuation information|15|||
16189743|NCT00099359|39172703|FG000|Overall Study|Death|11|||
16189744|NCT00099359|39172704|FG001|Overall Study|Death|15|||
16189745|NCT00099359|39172705|FG002|Overall Study|Death|17|||
16189746|NCT00099359|39172703|FG000|Overall Study|Withdrawal by Subject|19|||
16189747|NCT00099359|39172704|FG001|Overall Study|Withdrawal by Subject|19|||
16189748|NCT00099359|39172705|FG002|Overall Study|Withdrawal by Subject|23|||
16189749|NCT00099359|39172703|FG000|Overall Study|Lost to Follow-up|15|||
16189750|NCT00099359|39172704|FG001|Overall Study|Lost to Follow-up|24|||
16189751|NCT00099359|39172705|FG002|Overall Study|Lost to Follow-up|24|||
16189752|NCT00099359|39172703|FG000|Overall Study|moved out of area|9|||
16189753|NCT00099359|39172704|FG001|Overall Study|moved out of area|7|||
16189754|NCT00099359|39172705|FG002|Overall Study|moved out of area|4|||
16189755|NCT02052960|39172706|FG000|Overall Study|Adverse Event|19|||
16189756|NCT02052960|39172707|FG001|Overall Study|Adverse Event|17|||
16189757|NCT02052960|39172706|FG000|Overall Study|Protocol Violation|4|||
16189758|NCT02052960|39172707|FG001|Overall Study|Protocol Violation|3|||
16189759|NCT02052960|39172706|FG000|Overall Study|Withdrawal by Subject|6|||
16189760|NCT02052960|39172707|FG001|Overall Study|Withdrawal by Subject|11|||
16189761|NCT02052960|39172706|FG000|Overall Study|Other|25|||
16189762|NCT02052960|39172707|FG001|Overall Study|Other|15|||
16189763|NCT01703286|39172711|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
16189764|NCT01703286|39172712|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
16189765|NCT01703286|39172713|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
16189766|NCT01703286|39172714|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
16189767|NCT01703286|39172715|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
16189768|NCT01703286|39172716|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
16189769|NCT01703286|39172711|FG000|Period 2 Including Washout|Adverse Event|0|||
16189770|NCT01703286|39172712|FG001|Period 2 Including Washout|Adverse Event|0|||
16189771|NCT01703286|39172713|FG002|Period 2 Including Washout|Adverse Event|0|||
16189772|NCT01703286|39172714|FG003|Period 2 Including Washout|Adverse Event|1|||
16189773|NCT01703286|39172715|FG004|Period 2 Including Washout|Adverse Event|0|||
16189774|NCT01703286|39172716|FG005|Period 2 Including Washout|Adverse Event|0|||
16189775|NCT00109733|39172717|FG000|Overall Study|Protocol Violation|0|||
16189776|NCT00109733|39172718|FG001|Overall Study|Protocol Violation|1|||
16189777|NCT00109733|39172717|FG000|Overall Study|Stopped taking study drug|1|||
16189778|NCT00109733|39172718|FG001|Overall Study|Stopped taking study drug|1|||
16189779|NCT00109733|39172717|FG000|Overall Study|Non-compliant|0|||
16189780|NCT00109733|39172718|FG001|Overall Study|Non-compliant|1|||
16189781|NCT00109733|39172717|FG000|Overall Study|Could not commit time for study|1|||
16189782|NCT00109733|39172718|FG001|Overall Study|Could not commit time for study|1|||
16189783|NCT03799718|39172721|FG000|Overall Study|Adverse Event|2|||
16189784|NCT03442829|39172722|FG000|Overall Study|Scheduling clash|3|||
16189785|NCT03442829|39172723|FG001|Overall Study|Scheduling clash|1|||
16189786|NCT03442829|39172722|FG000|Overall Study|Illness unrelated to study|1|||
16189787|NCT03442829|39172723|FG001|Overall Study|Illness unrelated to study|1|||
16189788|NCT01921270|39172724|FG000|Overall Study|Withdrawal by Subject|1|||
16189789|NCT01856595|39172727|FG000|Overall Study|Withdrawal by Subject|0|||
16189790|NCT01856595|39172728|FG001|Overall Study|Withdrawal by Subject|1|||
16189791|NCT01856595|39172729|FG002|Overall Study|Withdrawal by Subject|0|||
16189792|NCT01856595|39172730|FG003|Overall Study|Withdrawal by Subject|0|||
16189793|NCT01856595|39172731|FG004|Overall Study|Withdrawal by Subject|0|||
16189794|NCT01856595|39172732|FG005|Overall Study|Withdrawal by Subject|0|||
16384315|NCT00833690|39892565|FG000|Overall Study|Withdrawal by Subject|1|||
16384316|NCT00833690|39892566|FG001|Overall Study|Withdrawal by Subject|0|||
16384317|NCT00833690|39892567|FG002|Overall Study|Withdrawal by Subject|0|||
16384318|NCT00833690|39892565|FG000|Overall Study|Discontinued study drug|3|||
16384319|NCT00833690|39892566|FG001|Overall Study|Discontinued study drug|2|||
16384320|NCT00833690|39892567|FG002|Overall Study|Discontinued study drug|0|||
16384321|NCT02359903|39892568|FG000|Overall Study|Adverse Event|0|||
16384322|NCT02359903|39892569|FG001|Overall Study|Adverse Event|2|||
16384323|NCT00462826|39892570|FG000|Overall Study|Ineligible - second primary|1|||
16384324|NCT00462826|39892570|FG000|Overall Study|Ineligible - wrong cell type|1|||
16384325|NCT00462826|39892570|FG000|Overall Study|Ineligible - wrong primary|2|||
16384326|NCT00462826|39892570|FG000|Overall Study|Never treated|1|||
16384327|NCT00673920|39892573|FG000|Baseline up to Week 48|Withdrew consent|1|||
16384328|NCT00673920|39892574|FG001|Baseline up to Week 48|Withdrew consent|0|||
16189795|NCT01856595|39172733|FG006|Overall Study|Withdrawal by Subject|1|||
16189796|NCT01856595|39172734|FG007|Overall Study|Withdrawal by Subject|0|||
16189797|NCT01856595|39172735|FG008|Overall Study|Withdrawal by Subject|0|||
16189798|NCT00975195|39172736|FG000|Overall Study|Adverse Event|108|||
16189799|NCT00975195|39172737|FG001|Overall Study|Adverse Event|101|||
16189800|NCT00975195|39172736|FG000|Overall Study|Lack of Efficacy|6|||
16384329|NCT00673920|39892575|FG002|Baseline up to Week 48|Withdrew consent|2|||
16189801|NCT00975195|39172737|FG001|Overall Study|Lack of Efficacy|6|||
16189802|NCT00975195|39172736|FG000|Overall Study|Protocol Violation|27|||
16189803|NCT00975195|39172737|FG001|Overall Study|Protocol Violation|23|||
16189804|NCT00975195|39172736|FG000|Overall Study|Lost to Follow-up|9|||
16189805|NCT00975195|39172737|FG001|Overall Study|Lost to Follow-up|7|||
16189806|NCT00975195|39172736|FG000|Overall Study|Withdrawal by Subject|48|||
16189807|NCT00975195|39172737|FG001|Overall Study|Withdrawal by Subject|61|||
16189808|NCT00975195|39172736|FG000|Overall Study|Other reason not defined above|29|||
16189809|NCT00975195|39172737|FG001|Overall Study|Other reason not defined above|33|||
16189810|NCT00975195|39172736|FG000|Overall Study|Not treated|1|||
16189811|NCT00975195|39172737|FG001|Overall Study|Not treated|2|||
16189812|NCT02869867|39172740|FG000|Overall Study|Protocol Violation|1|||
16189813|NCT02869867|39172741|FG001|Overall Study|Protocol Violation|0|||
16189814|NCT02869867|39172740|FG000|Overall Study|Lost to Follow-up|5|||
16189815|NCT02869867|39172741|FG001|Overall Study|Lost to Follow-up|5|||
16488409|NCT01737697|40263254|FG003|Subacute Phase|Physician Decision|0|||
16488410|NCT01737697|40263255|FG004|Subacute Phase|Physician Decision|0|||
16488411|NCT01737697|40263256|FG005|Subacute Phase|Physician Decision|0|||
16189816|NCT01912768|39172742|FG000|Overall Study|Adverse Event|2|||
16189817|NCT01912768|39172743|FG001|Overall Study|Adverse Event|0|||
16189818|NCT01912768|39172742|FG000|Overall Study|Lost to Follow-up|2|||
16189819|NCT01912768|39172743|FG001|Overall Study|Lost to Follow-up|1|||
16189820|NCT01912768|39172742|FG000|Overall Study|Withdrawal by Subject|5|||
16189821|NCT01912768|39172743|FG001|Overall Study|Withdrawal by Subject|3|||
16189822|NCT01912768|39172742|FG000|Overall Study|Randomized in error|1|||
16189823|NCT01912768|39172743|FG001|Overall Study|Randomized in error|0|||
16189824|NCT00992446|39172749|FG000|Overall Study|Disease Progression|1|||
16189825|NCT00992446|39172749|FG000|Overall Study|Withdrawal by Subject|2|||
16189826|NCT00992446|39172749|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
16189827|NCT03007953|39172752|FG000|Overall Study|Withdrawal by Subject|5|||
16189828|NCT03007953|39172753|FG001|Overall Study|Withdrawal by Subject|2|||
16189829|NCT03007953|39172752|FG000|Overall Study|Death|5|||
16189830|NCT03007953|39172753|FG001|Overall Study|Death|7|||
16189831|NCT03007953|39172752|FG000|Overall Study|Lost to Follow-up|3|||
16189832|NCT03007953|39172753|FG001|Overall Study|Lost to Follow-up|2|||
16189833|NCT03007953|39172752|FG000|Overall Study|Enrolled in Hospice|3|||
16189834|NCT03007953|39172753|FG001|Overall Study|Enrolled in Hospice|2|||
16189835|NCT00417976|39172754|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
16189836|NCT00417976|39172754|FG000|Overall Study|Treatment -related toxicity|2|||
16189837|NCT03229759|39172761|FG000|Overall Study|Screen Failure|30|||
16189838|NCT00520676|39172762|FG000|Overall Study|Death|84|||
16189839|NCT00520676|39172763|FG001|Overall Study|Death|81|||
16189840|NCT00520676|39172762|FG000|Overall Study|Lost to Follow-up|6|||
16189841|NCT00520676|39172763|FG001|Overall Study|Lost to Follow-up|10|||
16189842|NCT00520676|39172762|FG000|Overall Study|Physician Decision|4|||
16189843|NCT00520676|39172763|FG001|Overall Study|Physician Decision|1|||
16189844|NCT00520676|39172762|FG000|Overall Study|Withdrawal by Subject|7|||
16189845|NCT00520676|39172763|FG001|Overall Study|Withdrawal by Subject|11|||
16189846|NCT01638000|39172768|FG000|Overall Study|Randomized but Never Received Drug|7|||
16189847|NCT01638000|39172769|FG001|Overall Study|Randomized but Never Received Drug|10|||
16189848|NCT01638000|39172768|FG000|Overall Study|Adverse Event|14|||
16189849|NCT01638000|39172769|FG001|Overall Study|Adverse Event|16|||
16189850|NCT01638000|39172768|FG000|Overall Study|Lack of Efficacy|5|||
16189851|NCT01638000|39172769|FG001|Overall Study|Lack of Efficacy|6|||
16189852|NCT01638000|39172768|FG000|Overall Study|Protocol Violation|11|||
16189853|NCT01638000|39172769|FG001|Overall Study|Protocol Violation|13|||
16189854|NCT01638000|39172768|FG000|Overall Study|Withdrawal by Subject|21|||
16189855|NCT01638000|39172769|FG001|Overall Study|Withdrawal by Subject|24|||
16189856|NCT01638000|39172768|FG000|Overall Study|Miscellaneous|2|||
16189857|NCT01638000|39172769|FG001|Overall Study|Miscellaneous|2|||
16189858|NCT03744676|39172770|FG000|Pre-Treatment Phase|Death|7|||
16189859|NCT03744676|39172770|FG000|Pre-Treatment Phase|Disease related complications|2|||
16189860|NCT03744676|39172770|FG000|Pre-Treatment Phase|No longer meets eligibility criteria for other reasons|4|||
16189861|NCT03744676|39172770|FG000|Pre-Treatment Phase|Other reasons|8|||
16189862|NCT03744676|39172770|FG000|Treatment Phase|Ongoing in study|18|||
16189863|NCT03744676|39172770|FG000|Treatment Phase|Death|31|||
16189864|NCT03744676|39172770|FG000|Treatment Phase|Withdrawal of consent|8|||
16189865|NCT03744676|39172770|FG000|Treatment Phase|Other reasons|6|||
16189866|NCT02340819|39172771|FG000|Overall Study|Adverse Event|1|||
16189867|NCT02340819|39172771|FG000|Overall Study|Withdrawal by Subject|2|||
16488412|NCT01737697|40263257|FG006|Subacute Phase|Physician Decision|0|||
16189868|NCT02340819|39172771|FG000|Overall Study|Discontinued with other reason|1|||
16189869|NCT03141086|39172772|FG000|Overall Study|Study Terminated By Sponsor|1|||
16488413|NCT01737697|40263258|FG007|Subacute Phase|Physician Decision|0|||
16189870|NCT03141086|39172773|FG001|Overall Study|Study Terminated By Sponsor|1|||
16189871|NCT03141086|39172772|FG000|Overall Study|Withdrawal by Subject|0|||
16189872|NCT03141086|39172773|FG001|Overall Study|Withdrawal by Subject|1|||
16189873|NCT03141086|39172772|FG000|Overall Study|Protocol Violation|0|||
16488414|NCT01737697|40263259|FG008|Subacute Phase|Physician Decision|1|||
16189874|NCT03141086|39172773|FG001|Overall Study|Protocol Violation|1|||
16189875|NCT03141086|39172772|FG000|Overall Study|Adverse Event|0|||
16189876|NCT03141086|39172773|FG001|Overall Study|Adverse Event|2|||
16189877|NCT02596711|39172777|FG000|Overall Study|Lost to Follow-up|1|||
16189878|NCT02596711|39172778|FG001|Overall Study|Lost to Follow-up|2|||
16189879|NCT02596711|39172779|FG002|Overall Study|Lost to Follow-up|3|||
16189880|NCT02554253|39172789|FG000|Overall Study|ineligible after enrollment|1|||
16189881|NCT02554253|39172790|FG001|Overall Study|ineligible after enrollment|0|||
16189882|NCT02554253|39172789|FG000|Overall Study|converted to transcatheter procedure|0|||
16189883|NCT02554253|39172790|FG001|Overall Study|converted to transcatheter procedure|1|||
16189884|NCT02554253|39172789|FG000|Overall Study|received both drugs|0|||
16488415|NCT01737697|40263260|FG009|Subacute Phase|Physician Decision|0|||
16488416|NCT01737697|40263261|FG010|Subacute Phase|Physician Decision|0|||
16189885|NCT02554253|39172790|FG001|Overall Study|received both drugs|1|||
16189886|NCT01228071|39172791|FG000|Overall Study|Protocol Violation|1|||
16189887|NCT01228071|39172791|FG000|Overall Study|Withdrawal by Subject|1|||
16189888|NCT02064439|39172792|FG000|Overall Study|Adverse Event|51|||
16189889|NCT02064439|39172793|FG001|Overall Study|Adverse Event|47|||
16189890|NCT02064439|39172794|FG002|Overall Study|Adverse Event|46|||
16189891|NCT02064439|39172792|FG000|Overall Study|Death|0|||
16189892|NCT02064439|39172793|FG001|Overall Study|Death|2|||
16189893|NCT02064439|39172794|FG002|Overall Study|Death|3|||
16189894|NCT02064439|39172792|FG000|Overall Study|Withdrawal by Subject|29|||
16189895|NCT02064439|39172793|FG001|Overall Study|Withdrawal by Subject|18|||
16189896|NCT02064439|39172794|FG002|Overall Study|Withdrawal by Subject|26|||
16189897|NCT02064439|39172792|FG000|Overall Study|Protocol Violation|3|||
16297427|NCT02393248|39573984|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297428|NCT02393248|39573985|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297429|NCT02393248|39573986|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297430|NCT02393248|39573987|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297431|NCT02393248|39573988|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297432|NCT02393248|39573989|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
16297433|NCT02393248|39573990|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297434|NCT02393248|39573991|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16488417|NCT01737697|40263262|FG011|Subacute Phase|Physician Decision|0|||
16488418|NCT01737697|40263263|FG012|Subacute Phase|Physician Decision|0|||
16488419|NCT01737697|40263264|FG013|Subacute Phase|Physician Decision|0|||
16488420|NCT01737697|40263265|FG014|Subacute Phase|Physician Decision|0|||
16488421|NCT01737697|40263251|FG000|Subacute Phase|Death|0|||
16488422|NCT01737697|40263252|FG001|Subacute Phase|Death|0|||
16488423|NCT01737697|40263253|FG002|Subacute Phase|Death|0|||
16488424|NCT01737697|40263254|FG003|Subacute Phase|Death|0|||
16488425|NCT01737697|40263255|FG004|Subacute Phase|Death|0|||
16488426|NCT01737697|40263256|FG005|Subacute Phase|Death|0|||
16488427|NCT01737697|40263257|FG006|Subacute Phase|Death|0|||
16488428|NCT01737697|40263258|FG007|Subacute Phase|Death|0|||
16488429|NCT01737697|40263259|FG008|Subacute Phase|Death|0|||
16488430|NCT01737697|40263260|FG009|Subacute Phase|Death|0|||
16488431|NCT01737697|40263261|FG010|Subacute Phase|Death|1|||
16488432|NCT01737697|40263262|FG011|Subacute Phase|Death|0|||
16488433|NCT01737697|40263263|FG012|Subacute Phase|Death|0|||
16488434|NCT01737697|40263264|FG013|Subacute Phase|Death|0|||
16189898|NCT02064439|39172793|FG001|Overall Study|Protocol Violation|5|||
16189899|NCT02064439|39172794|FG002|Overall Study|Protocol Violation|3|||
16488435|NCT01737697|40263265|FG014|Subacute Phase|Death|0|||
16488436|NCT03616600|40263269|FG000|Overall Study|Withdrawal by Subject|1|||
16488437|NCT03616600|40263270|FG001|Overall Study|Withdrawal by Subject|0|||
16488438|NCT00680017|40263283|FG000|Overall Study|Adverse Event|13|||
16488439|NCT00680017|40263284|FG001|Overall Study|Adverse Event|7|||
16488440|NCT00680017|40263283|FG000|Overall Study|Withdrawal by Subject|2|||
16488441|NCT00680017|40263284|FG001|Overall Study|Withdrawal by Subject|5|||
16488442|NCT00680017|40263283|FG000|Overall Study|Lost to Follow-up|2|||
16488443|NCT00680017|40263284|FG001|Overall Study|Lost to Follow-up|0|||
16488444|NCT03288129|40263287|FG000|Overall Study|Adverse Event|10|||
16488445|NCT03288129|40263287|FG000|Overall Study|Lost to Follow-up|3|||
16488446|NCT03288129|40263287|FG000|Overall Study|Withdrawal by Subject|3|||
16488447|NCT03288129|40263287|FG000|Overall Study|Withdrawal of consent/assent|1|||
16488448|NCT03288129|40263287|FG000|Overall Study|Other|5|||
16488449|NCT00319553|40263288|FG000|Overall Study|Protocol Violation|1|||
16488450|NCT00319553|40263289|FG001|Overall Study|Protocol Violation|2|||
16488451|NCT00319553|40263288|FG000|Overall Study|Lost to Follow-up|2|||
16488452|NCT00319553|40263289|FG001|Overall Study|Lost to Follow-up|1|||
16488453|NCT00319553|40263288|FG000|Overall Study|Withdrawal by Subject|1|||
16488454|NCT00319553|40263289|FG001|Overall Study|Withdrawal by Subject|1|||
16488455|NCT02034110|40263291|FG000|Overall Study|Physician Decision|0|||
16488456|NCT02034110|40263292|FG001|Overall Study|Physician Decision|0|||
16488457|NCT02034110|40263293|FG002|Overall Study|Physician Decision|0|||
16488458|NCT02034110|40263294|FG003|Overall Study|Physician Decision|0|||
16488459|NCT02034110|40263295|FG004|Overall Study|Physician Decision|2|||
16488460|NCT02034110|40263296|FG005|Overall Study|Physician Decision|0|||
16488461|NCT02034110|40263297|FG006|Overall Study|Physician Decision|1|||
16488462|NCT02034110|40263298|FG007|Overall Study|Physician Decision|0|||
16488463|NCT02034110|40263291|FG000|Overall Study|Lost to Follow-up|1|||
16488464|NCT02034110|40263292|FG001|Overall Study|Lost to Follow-up|0|||
16488465|NCT02034110|40263293|FG002|Overall Study|Lost to Follow-up|0|||
16488466|NCT02034110|40263294|FG003|Overall Study|Lost to Follow-up|0|||
16488467|NCT02034110|40263295|FG004|Overall Study|Lost to Follow-up|1|||
16488468|NCT02034110|40263296|FG005|Overall Study|Lost to Follow-up|0|||
16488469|NCT02034110|40263297|FG006|Overall Study|Lost to Follow-up|1|||
16488470|NCT02034110|40263298|FG007|Overall Study|Lost to Follow-up|0|||
16488471|NCT02034110|40263291|FG000|Overall Study|Withdrawal by Subject|5|||
16488472|NCT02034110|40263292|FG001|Overall Study|Withdrawal by Subject|7|||
16488473|NCT02034110|40263293|FG002|Overall Study|Withdrawal by Subject|0|||
16488474|NCT02034110|40263294|FG003|Overall Study|Withdrawal by Subject|3|||
16488475|NCT02034110|40263295|FG004|Overall Study|Withdrawal by Subject|7|||
16488476|NCT02034110|40263296|FG005|Overall Study|Withdrawal by Subject|0|||
16488477|NCT02034110|40263297|FG006|Overall Study|Withdrawal by Subject|3|||
16488478|NCT02034110|40263298|FG007|Overall Study|Withdrawal by Subject|1|||
16488479|NCT02034110|40263291|FG000|Overall Study|Study closed by sponsor|6|||
16488480|NCT02034110|40263292|FG001|Overall Study|Study closed by sponsor|2|||
16488481|NCT02034110|40263293|FG002|Overall Study|Study closed by sponsor|0|||
16488482|NCT02034110|40263294|FG003|Overall Study|Study closed by sponsor|6|||
16488483|NCT02034110|40263295|FG004|Overall Study|Study closed by sponsor|7|||
16488484|NCT02034110|40263296|FG005|Overall Study|Study closed by sponsor|0|||
16488485|NCT02034110|40263297|FG006|Overall Study|Study closed by sponsor|42|||
16488486|NCT02034110|40263298|FG007|Overall Study|Study closed by sponsor|0|||
16488487|NCT02340975|40263300|FG000|Overall Study|Death|6|||
16488488|NCT02340975|40263301|FG001|Overall Study|Death|23|||
16488489|NCT02340975|40263302|FG002|Overall Study|Death|21|||
16488490|NCT02340975|40263303|FG003|Overall Study|Death|7|||
16488491|NCT02340975|40263304|FG004|Overall Study|Death|21|||
16488492|NCT02340975|40263305|FG005|Overall Study|Death|13|||
16488493|NCT02340975|40263300|FG000|Overall Study|Lost to Follow-up|0|||
16488494|NCT02340975|40263301|FG001|Overall Study|Lost to Follow-up|0|||
16488495|NCT02340975|40263302|FG002|Overall Study|Lost to Follow-up|0|||
16488496|NCT02340975|40263303|FG003|Overall Study|Lost to Follow-up|0|||
16488497|NCT02340975|40263304|FG004|Overall Study|Lost to Follow-up|2|||
16488498|NCT02340975|40263305|FG005|Overall Study|Lost to Follow-up|0|||
16488499|NCT02340975|40263300|FG000|Overall Study|Withdrawal by Subject|0|||
16488500|NCT02340975|40263301|FG001|Overall Study|Withdrawal by Subject|0|||
16488501|NCT02340975|40263302|FG002|Overall Study|Withdrawal by Subject|3|||
16488502|NCT02340975|40263303|FG003|Overall Study|Withdrawal by Subject|3|||
16488503|NCT02340975|40263304|FG004|Overall Study|Withdrawal by Subject|2|||
16488504|NCT02340975|40263305|FG005|Overall Study|Withdrawal by Subject|0|||
16488505|NCT02340975|40263300|FG000|Overall Study|Other|0|||
16488506|NCT02340975|40263301|FG001|Overall Study|Other|4|||
16488507|NCT02340975|40263302|FG002|Overall Study|Other|0|||
16488508|NCT02340975|40263303|FG003|Overall Study|Other|2|||
16488509|NCT02340975|40263304|FG004|Overall Study|Other|0|||
16488510|NCT02340975|40263305|FG005|Overall Study|Other|6|||
16488511|NCT02651922|40263306|FG000|Overall Study|due to exclusion criteria|2|||
16488512|NCT03648983|40263307|FG000|Overall Study|Study was terminated due to PI departure|95|||
16488513|NCT01626456|40263308|FG000|Overall Study|Withdrawal by Subject|21|||
16488514|NCT01626456|40263309|FG001|Overall Study|Withdrawal by Subject|46|||
16488515|NCT01626456|40263308|FG000|Overall Study|Adverse Event|2|||
16488516|NCT01626456|40263309|FG001|Overall Study|Adverse Event|27|||
16488517|NCT01626456|40263308|FG000|Overall Study|Lost to Follow-up|2|||
16488518|NCT01626456|40263309|FG001|Overall Study|Lost to Follow-up|27|||
16488519|NCT01626456|40263308|FG000|Overall Study|Lack of Efficacy|6|||
16488520|NCT01626456|40263309|FG001|Overall Study|Lack of Efficacy|7|||
16488521|NCT01626456|40263308|FG000|Overall Study|Physician Decision|1|||
16488522|NCT01626456|40263309|FG001|Overall Study|Physician Decision|4|||
16488523|NCT01626456|40263308|FG000|Overall Study|Protocol Violation|1|||
16488524|NCT01626456|40263309|FG001|Overall Study|Protocol Violation|1|||
16488525|NCT01626456|40263308|FG000|Overall Study|Site Closure|2|||
16488526|NCT01626456|40263309|FG001|Overall Study|Site Closure|3|||
16488527|NCT01626456|40263308|FG000|Overall Study|Incarceration|0|||
16488528|NCT01626456|40263309|FG001|Overall Study|Incarceration|2|||
16488529|NCT02555683|40263314|FG000|Overall Study|Physician Decision|1|||
16488530|NCT02555683|40263315|FG001|Overall Study|Physician Decision|0|||
16488531|NCT02555683|40263316|FG002|Overall Study|Physician Decision|2|||
16488532|NCT02555683|40263314|FG000|Overall Study|Lost to Follow-up|2|||
16488533|NCT02555683|40263315|FG001|Overall Study|Lost to Follow-up|1|||
16488534|NCT02555683|40263316|FG002|Overall Study|Lost to Follow-up|2|||
16488535|NCT02555683|40263314|FG000|Overall Study|Technical Problems|1|||
16488536|NCT02555683|40263315|FG001|Overall Study|Technical Problems|1|||
16384330|NCT00673920|39892576|FG003|Baseline up to Week 48|Withdrew consent|0|||
16384331|NCT00673920|39892577|FG004|Baseline up to Week 48|Withdrew consent|0|||
16384332|NCT00673920|39892578|FG005|Baseline up to Week 48|Withdrew consent|0|||
16488537|NCT02555683|40263316|FG002|Overall Study|Technical Problems|0|||
16488538|NCT02555683|40263314|FG000|Overall Study|Protocol deviation|0|||
16488539|NCT02555683|40263315|FG001|Overall Study|Protocol deviation|1|||
16488540|NCT02555683|40263316|FG002|Overall Study|Protocol deviation|0|||
16488541|NCT02555683|40263314|FG000|Overall Study|Lack of Efficacy|2|||
16488542|NCT02555683|40263315|FG001|Overall Study|Lack of Efficacy|0|||
16488543|NCT02555683|40263316|FG002|Overall Study|Lack of Efficacy|0|||
16488544|NCT02555683|40263314|FG000|Overall Study|Death|0|||
16488545|NCT02555683|40263315|FG001|Overall Study|Death|1|||
16384333|NCT00673920|39892579|FG006|Baseline up to Week 48|Withdrew consent|0|||
16384334|NCT00673920|39892580|FG007|Baseline up to Week 48|Withdrew consent|0|||
16384335|NCT00673920|39892573|FG000|Baseline up to Week 48|Refused treatment|1|||
16384336|NCT00673920|39892574|FG001|Baseline up to Week 48|Refused treatment|0|||
16384337|NCT00673920|39892575|FG002|Baseline up to Week 48|Refused treatment|0|||
16384338|NCT00673920|39892576|FG003|Baseline up to Week 48|Refused treatment|0|||
16384339|NCT00673920|39892577|FG004|Baseline up to Week 48|Refused treatment|0|||
16384340|NCT00673920|39892578|FG005|Baseline up to Week 48|Refused treatment|0|||
16384341|NCT00673920|39892579|FG006|Baseline up to Week 48|Refused treatment|0|||
16384342|NCT00673920|39892580|FG007|Baseline up to Week 48|Refused treatment|0|||
16384343|NCT00673920|39892573|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
16384344|NCT00673920|39892574|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
16384345|NCT00673920|39892575|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
16384346|NCT00673920|39892576|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
16384347|NCT00673920|39892577|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
16384348|NCT00673920|39892578|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
16384349|NCT00673920|39892579|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
16384350|NCT00673920|39892580|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
16384351|NCT00673920|39892573|FG000|Baseline up to Week 48|Protocol Violation|0|||
16384352|NCT00673920|39892574|FG001|Baseline up to Week 48|Protocol Violation|0|||
16384353|NCT00673920|39892575|FG002|Baseline up to Week 48|Protocol Violation|1|||
16384354|NCT00673920|39892576|FG003|Baseline up to Week 48|Protocol Violation|0|||
16384355|NCT00673920|39892577|FG004|Baseline up to Week 48|Protocol Violation|0|||
16384356|NCT00673920|39892578|FG005|Baseline up to Week 48|Protocol Violation|0|||
16384357|NCT00673920|39892579|FG006|Baseline up to Week 48|Protocol Violation|0|||
16384358|NCT00673920|39892580|FG007|Baseline up to Week 48|Protocol Violation|0|||
16384359|NCT00673920|39892573|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
16384360|NCT00673920|39892574|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
16384361|NCT00673920|39892575|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
16488546|NCT02555683|40263316|FG002|Overall Study|Death|2|||
16488547|NCT02555683|40263314|FG000|Overall Study|Adverse Event|1|||
16488548|NCT02555683|40263315|FG001|Overall Study|Adverse Event|0|||
16384362|NCT00673920|39892576|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
16384363|NCT00673920|39892577|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
16488549|NCT02555683|40263316|FG002|Overall Study|Adverse Event|1|||
16488550|NCT02555683|40263314|FG000|Overall Study|Subject/guardian decision|12|||
16488551|NCT02555683|40263315|FG001|Overall Study|Subject/guardian decision|12|||
16488552|NCT02555683|40263316|FG002|Overall Study|Subject/guardian decision|22|||
16488553|NCT02555683|40263314|FG000|Overall Study|Death post Treatment/safety period|0|||
16488554|NCT02555683|40263315|FG001|Overall Study|Death post Treatment/safety period|1|||
16488555|NCT02555683|40263316|FG002|Overall Study|Death post Treatment/safety period|0|||
16488556|NCT01336764|40263317|FG000|Overall Study|Withdrawal by Subject|5|||
16488557|NCT01336764|40263318|FG001|Overall Study|Withdrawal by Subject|5|||
16488558|NCT02615145|40263319|FG000|Overall Study|Did Not Start Treatment|0|||
16488559|NCT02615145|40263320|FG001|Overall Study|Did Not Start Treatment|0|||
16488560|NCT02615145|40263321|FG002|Overall Study|Did Not Start Treatment|1|||
16488561|NCT02615145|40263322|FG003|Overall Study|Did Not Start Treatment|1|||
16384364|NCT00673920|39892578|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
16384365|NCT00673920|39892579|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
16384366|NCT00673920|39892580|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
16384367|NCT00673920|39892573|FG000|Baseline up to Week 48|Administrative/Other|0|||
16189900|NCT02064439|39172792|FG000|Overall Study|Lost to Follow-up|1|||
16189901|NCT02064439|39172793|FG001|Overall Study|Lost to Follow-up|3|||
16384368|NCT00673920|39892574|FG001|Baseline up to Week 48|Administrative/Other|1|||
16189902|NCT02064439|39172794|FG002|Overall Study|Lost to Follow-up|4|||
16189903|NCT02064439|39172792|FG000|Overall Study|Non-compliance with study medication|21|||
16189904|NCT02064439|39172793|FG001|Overall Study|Non-compliance with study medication|19|||
16189905|NCT02064439|39172794|FG002|Overall Study|Non-compliance with study medication|23|||
16189906|NCT02064439|39172792|FG000|Overall Study|Physician Decision|0|||
16189907|NCT02064439|39172793|FG001|Overall Study|Physician Decision|1|||
16189908|NCT02064439|39172794|FG002|Overall Study|Physician Decision|1|||
16189909|NCT02064439|39172792|FG000|Overall Study|Logistical difficulties|6|||
16384369|NCT00673920|39892575|FG002|Baseline up to Week 48|Administrative/Other|2|||
16384370|NCT00673920|39892576|FG003|Baseline up to Week 48|Administrative/Other|0|||
16189910|NCT02064439|39172793|FG001|Overall Study|Logistical difficulties|5|||
16189911|NCT02064439|39172794|FG002|Overall Study|Logistical difficulties|2|||
16189912|NCT02064439|39172792|FG000|Overall Study|Efficacy outcome reached|18|||
16189913|NCT02064439|39172793|FG001|Overall Study|Efficacy outcome reached|16|||
16189914|NCT02064439|39172794|FG002|Overall Study|Efficacy outcome reached|57|||
16189915|NCT02064439|39172792|FG000|Overall Study|Safety outcome reached|12|||
16189916|NCT02064439|39172793|FG001|Overall Study|Safety outcome reached|20|||
16384371|NCT00673920|39892577|FG004|Baseline up to Week 48|Administrative/Other|0|||
16384372|NCT00673920|39892578|FG005|Baseline up to Week 48|Administrative/Other|0|||
16384373|NCT00673920|39892579|FG006|Baseline up to Week 48|Administrative/Other|0|||
16189917|NCT02064439|39172794|FG002|Overall Study|Safety outcome reached|10|||
16189918|NCT02064439|39172792|FG000|Overall Study|Other|2|||
16488562|NCT02615145|40263319|FG000|Overall Study|Failure to Return|20|||
16488563|NCT02615145|40263320|FG001|Overall Study|Failure to Return|10|||
16488564|NCT02615145|40263321|FG002|Overall Study|Failure to Return|7|||
16488565|NCT02615145|40263322|FG003|Overall Study|Failure to Return|0|||
16488566|NCT02615145|40263319|FG000|Overall Study|Death|2|||
16488567|NCT02615145|40263320|FG001|Overall Study|Death|3|||
16488568|NCT02615145|40263321|FG002|Overall Study|Death|0|||
16488569|NCT02615145|40263322|FG003|Overall Study|Death|0|||
16488570|NCT02615145|40263319|FG000|Overall Study|Other, Not Specified|5|||
16488571|NCT02615145|40263320|FG001|Overall Study|Other, Not Specified|2|||
16488572|NCT02615145|40263321|FG002|Overall Study|Other, Not Specified|0|||
16488573|NCT02615145|40263322|FG003|Overall Study|Other, Not Specified|0|||
16488574|NCT02197247|40263323|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
16488575|NCT02197247|40263323|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
16488576|NCT02197247|40263323|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
16488577|NCT02197247|40263323|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
16488578|NCT02197247|40263323|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
16488579|NCT02197247|40263323|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
16488580|NCT02197247|40263323|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
16488581|NCT02197247|40263323|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
16488582|NCT03200860|40263324|FG000|Overall Study|Withdrawal by Subject|1|||
16488583|NCT03200860|40263325|FG001|Overall Study|Withdrawal by Subject|0|||
16488584|NCT01858389|40263331|FG000|Overall Study|Death|1|||
16488585|NCT01858389|40263332|FG001|Overall Study|Death|3|||
16488586|NCT01858389|40263331|FG000|Overall Study|Study terminated by sponsor|0|||
16488587|NCT01858389|40263332|FG001|Overall Study|Study terminated by sponsor|2|||
16488588|NCT01858389|40263331|FG000|Overall Study|Withdrawal by Subject|0|||
16488589|NCT01858389|40263332|FG001|Overall Study|Withdrawal by Subject|1|||
16488590|NCT01858389|40263331|FG000|Overall Study|Progressive disease|10|||
16488591|NCT01858389|40263332|FG001|Overall Study|Progressive disease|11|||
16488592|NCT01858389|40263331|FG000|Overall Study|Other|2|||
16488593|NCT01858389|40263332|FG001|Overall Study|Other|4|||
16488594|NCT01858389|40263331|FG000|Overall Study|Adverse Event|3|||
16488595|NCT01858389|40263332|FG001|Overall Study|Adverse Event|1|||
16488596|NCT01858389|40263331|FG000|Overall Study|Did not receive treatment|0|||
16488597|NCT01858389|40263332|FG001|Overall Study|Did not receive treatment|3|||
16488598|NCT02006719|40263334|FG000|Overall Study|Withdrawal by Subject|10|||
16488599|NCT02006719|40263335|FG001|Overall Study|Withdrawal by Subject|2|||
16488600|NCT02006719|40263334|FG000|Overall Study|Lost to Follow-up|5|||
16488601|NCT02006719|40263335|FG001|Overall Study|Lost to Follow-up|1|||
16488602|NCT02006719|40263334|FG000|Overall Study|Protocol Violation|2|||
16488603|NCT02006719|40263335|FG001|Overall Study|Protocol Violation|0|||
16488604|NCT02006719|40263334|FG000|Overall Study|Adverse Event|1|||
16488605|NCT02006719|40263335|FG001|Overall Study|Adverse Event|1|||
16488606|NCT02006719|40263334|FG000|Overall Study|Other/Unknown|0|||
16488607|NCT02006719|40263335|FG001|Overall Study|Other/Unknown|1|||
16488608|NCT00717197|40263340|FG000|Overall Study|Unable to purchase study drug|5|||
16488609|NCT00717197|40263340|FG000|Overall Study|Tumor Progression|1|||
16488610|NCT00717197|40263340|FG000|Overall Study|Physician Decision|1|||
16488611|NCT02469298|40263341|FG000|Overall Study|Protocol Violation|0|||
16488612|NCT02469298|40263342|FG001|Overall Study|Protocol Violation|1|||
16488613|NCT02469298|40263343|FG002|Overall Study|Protocol Violation|1|||
16488614|NCT02469298|40263344|FG003|Overall Study|Protocol Violation|0|||
16488615|NCT02469298|40263341|FG000|Overall Study|Lost to Follow-up|1|||
16488616|NCT02469298|40263342|FG001|Overall Study|Lost to Follow-up|0|||
16488617|NCT02469298|40263343|FG002|Overall Study|Lost to Follow-up|1|||
16488618|NCT02469298|40263344|FG003|Overall Study|Lost to Follow-up|0|||
16488619|NCT02469298|40263341|FG000|Overall Study|Physician Decision|0|||
16488620|NCT02469298|40263342|FG001|Overall Study|Physician Decision|0|||
16488621|NCT02469298|40263343|FG002|Overall Study|Physician Decision|0|||
16488622|NCT02469298|40263344|FG003|Overall Study|Physician Decision|1|||
16488623|NCT02469298|40263341|FG000|Overall Study|Withdrawal by Subject|0|||
16488624|NCT02469298|40263342|FG001|Overall Study|Withdrawal by Subject|0|||
16488625|NCT02469298|40263343|FG002|Overall Study|Withdrawal by Subject|0|||
16488626|NCT02469298|40263344|FG003|Overall Study|Withdrawal by Subject|1|||
16488627|NCT01243892|40263346|FG000|Overall Study|Did not meet eligibility criteria|2|||
16488628|NCT01243892|40263347|FG001|Overall Study|Did not meet eligibility criteria|0|||
16488629|NCT01819831|40263352|FG000|Overall Study|Withdrawal by Subject|1|||
16488630|NCT04678661|40263355|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
16488631|NCT04678661|40263356|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
16488632|NCT04678661|40263355|FG000|Overall Study|Protocol Violation|2|||
16488633|NCT04678661|40263356|FG001|Overall Study|Protocol Violation|0|||
16488634|NCT04678661|40263355|FG000|Overall Study|Withdrawal by Subject|1|||
16488635|NCT04678661|40263356|FG001|Overall Study|Withdrawal by Subject|0|||
16488636|NCT04678661|40263355|FG000|Overall Study|Lost to Follow-up|2|||
16488637|NCT04678661|40263356|FG001|Overall Study|Lost to Follow-up|0|||
16189919|NCT02064439|39172793|FG001|Overall Study|Other|2|||
16189920|NCT02064439|39172794|FG002|Overall Study|Other|7|||
16189921|NCT02116660|39172795|FG000|Overall Study|Deteriorating renal function|0|||
16189922|NCT02116660|39172796|FG001|Overall Study|Deteriorating renal function|1|||
16189923|NCT02116660|39172795|FG000|Overall Study|Adverse Event|1|||
16189924|NCT02116660|39172796|FG001|Overall Study|Adverse Event|1|||
16189925|NCT02116660|39172795|FG000|Overall Study|Withdrawal by Subject|0|||
16189926|NCT02116660|39172796|FG001|Overall Study|Withdrawal by Subject|2|||
16297435|NCT02393248|39573992|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297436|NCT02393248|39573993|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
16297437|NCT02393248|39573969|FG000|Part 3: Combination Therapy|Adverse Event|0|||
16297438|NCT02393248|39573970|FG001|Part 3: Combination Therapy|Adverse Event|0|||
16297439|NCT02393248|39573971|FG002|Part 3: Combination Therapy|Adverse Event|0|||
16297440|NCT02393248|39573972|FG003|Part 3: Combination Therapy|Adverse Event|0|||
16297441|NCT02393248|39573973|FG004|Part 3: Combination Therapy|Adverse Event|0|||
16297442|NCT02393248|39573974|FG005|Part 3: Combination Therapy|Adverse Event|0|||
16297443|NCT02393248|39573975|FG006|Part 3: Combination Therapy|Adverse Event|0|||
16297444|NCT02393248|39573976|FG007|Part 3: Combination Therapy|Adverse Event|0|||
16297445|NCT02393248|39573977|FG008|Part 3: Combination Therapy|Adverse Event|0|||
16297446|NCT02393248|39573978|FG009|Part 3: Combination Therapy|Adverse Event|0|||
16297447|NCT02393248|39573979|FG010|Part 3: Combination Therapy|Adverse Event|0|||
16297448|NCT02393248|39573980|FG011|Part 3: Combination Therapy|Adverse Event|0|||
16297449|NCT02393248|39573981|FG012|Part 3: Combination Therapy|Adverse Event|0|||
16297450|NCT02393248|39573982|FG013|Part 3: Combination Therapy|Adverse Event|0|||
16488638|NCT04678661|40263355|FG000|Overall Study|Death|2|||
16488639|NCT04678661|40263356|FG001|Overall Study|Death|0|||
16189927|NCT02116660|39172795|FG000|Overall Study|Organization reason|1|||
16297451|NCT02393248|39573983|FG014|Part 3: Combination Therapy|Adverse Event|0|||
16488640|NCT00713323|40263357|FG000|Overall Study|Adverse Event|75|||
16488641|NCT00713323|40263357|FG000|Overall Study|Withdrawal by Subject|15|||
16189928|NCT02116660|39172796|FG001|Overall Study|Organization reason|0|||
16189929|NCT02115815|39172800|FG000|Overall Study|Withdrawal by Subject|2|||
16189930|NCT02115815|39172801|FG001|Overall Study|Withdrawal by Subject|0|||
16189931|NCT02115815|39172802|FG002|Overall Study|Withdrawal by Subject|0|||
16189932|NCT02115815|39172803|FG003|Overall Study|Withdrawal by Subject|0|||
16189933|NCT02115815|39172804|FG004|Overall Study|Withdrawal by Subject|0|||
16189934|NCT02115815|39172805|FG005|Overall Study|Withdrawal by Subject|0|||
16189935|NCT02115815|39172806|FG006|Overall Study|Withdrawal by Subject|0|||
16189936|NCT02115815|39172800|FG000|Overall Study|Not enough drug to dose participant|0|||
16189937|NCT02115815|39172801|FG001|Overall Study|Not enough drug to dose participant|0|||
16189938|NCT02115815|39172802|FG002|Overall Study|Not enough drug to dose participant|0|||
16189939|NCT02115815|39172803|FG003|Overall Study|Not enough drug to dose participant|0|||
16189940|NCT02115815|39172804|FG004|Overall Study|Not enough drug to dose participant|0|||
16189941|NCT02115815|39172805|FG005|Overall Study|Not enough drug to dose participant|1|||
16189942|NCT02115815|39172806|FG006|Overall Study|Not enough drug to dose participant|0|||
16189943|NCT02115815|39172800|FG000|Overall Study|Missed appointment, randomized in error|0|||
16189944|NCT02115815|39172801|FG001|Overall Study|Missed appointment, randomized in error|0|||
16189945|NCT02115815|39172802|FG002|Overall Study|Missed appointment, randomized in error|0|||
16189946|NCT02115815|39172803|FG003|Overall Study|Missed appointment, randomized in error|0|||
16189947|NCT02115815|39172804|FG004|Overall Study|Missed appointment, randomized in error|0|||
16189948|NCT02115815|39172805|FG005|Overall Study|Missed appointment, randomized in error|1|||
16189949|NCT02115815|39172806|FG006|Overall Study|Missed appointment, randomized in error|0|||
16189950|NCT01189435|39172807|FG000|Overall Study|Withdrawal by Subject|1|||
16189951|NCT01189435|39172807|FG000|Overall Study|Physician Decision|1|||
16189952|NCT01745393|39172814|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
16189953|NCT01745393|39172815|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
16189954|NCT01745393|39172814|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
16189955|NCT01745393|39172815|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
16189956|NCT01745393|39172814|FG000|12-month Follow-up|Lost to Follow-up|6|||
16189957|NCT01745393|39172815|FG001|12-month Follow-up|Lost to Follow-up|5|||
16189958|NCT01005732|39172816|FG000|Overall Study|Lost to Follow-up|10|||
16189959|NCT01005732|39172816|FG000|Overall Study|Death|1|||
16189960|NCT00321984|39172819|FG000|Overall Study|Adverse Event|9|||
16189961|NCT00321984|39172820|FG001|Overall Study|Adverse Event|6|||
16189962|NCT00321984|39172821|FG002|Overall Study|Adverse Event|8|||
16189963|NCT00321984|39172819|FG000|Overall Study|Protocol Violation|0|||
16189964|NCT00321984|39172820|FG001|Overall Study|Protocol Violation|1|||
16189965|NCT00321984|39172821|FG002|Overall Study|Protocol Violation|1|||
16189966|NCT00321984|39172819|FG000|Overall Study|Lost to Follow-up|2|||
16189967|NCT00321984|39172820|FG001|Overall Study|Lost to Follow-up|4|||
16189968|NCT00321984|39172821|FG002|Overall Study|Lost to Follow-up|2|||
16189969|NCT00321984|39172819|FG000|Overall Study|Withdrawal by Subject|8|||
16189970|NCT00321984|39172820|FG001|Overall Study|Withdrawal by Subject|6|||
16189971|NCT00321984|39172821|FG002|Overall Study|Withdrawal by Subject|5|||
16189972|NCT00321984|39172819|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
16189973|NCT00321984|39172820|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
16189974|NCT00321984|39172821|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
16189975|NCT00321984|39172819|FG000|Overall Study|Lack of Efficacy|3|||
16189976|NCT00321984|39172820|FG001|Overall Study|Lack of Efficacy|1|||
16189977|NCT00321984|39172821|FG002|Overall Study|Lack of Efficacy|3|||
16189978|NCT00321984|39172819|FG000|Overall Study|Noncompliant|0|||
16384374|NCT00673920|39892580|FG007|Baseline up to Week 48|Administrative/Other|0|||
16189979|NCT00321984|39172820|FG001|Overall Study|Noncompliant|0|||
16189980|NCT00321984|39172821|FG002|Overall Study|Noncompliant|2|||
16488642|NCT00713323|40263357|FG000|Overall Study|Lost to Follow-up|11|||
16488643|NCT00713323|40263357|FG000|Overall Study|Lack of Efficacy|36|||
16488644|NCT00713323|40263357|FG000|Overall Study|Low creatine clearance at screening|1|||
16488645|NCT00713323|40263357|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
16488646|NCT00713323|40263357|FG000|Overall Study|Surgery cured allodynic pain|1|||
16488647|NCT00713323|40263357|FG000|Overall Study|Pain free|1|||
16488648|NCT00713323|40263357|FG000|Overall Study|Non-compliance|1|||
16488649|NCT00713323|40263357|FG000|Overall Study|Pain resolved|1|||
16488650|NCT00713323|40263357|FG000|Overall Study|Subject travelling to USA|1|||
16488651|NCT00713323|40263357|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
16488652|NCT00713323|40263357|FG000|Overall Study|Treatment that may interact with Sativex|1|||
16488653|NCT01434667|40263358|FG000|Overall Study|Lost to Follow-up|5|||
16488654|NCT01434667|40263359|FG001|Overall Study|Lost to Follow-up|10|||
16189981|NCT00321984|39172819|FG000|Overall Study|Pregnancy|0|||
16189982|NCT00321984|39172820|FG001|Overall Study|Pregnancy|1|||
16384375|NCT00673920|39892573|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
16488655|NCT02801396|40263360|FG000|Period 1|Withdrawal by Subject|0|||
16488656|NCT02801396|40263361|FG001|Period 1|Withdrawal by Subject|0|||
16488657|NCT02801396|40263362|FG002|Period 1|Withdrawal by Subject|0|||
16189983|NCT00321984|39172821|FG002|Overall Study|Pregnancy|0|||
16189984|NCT00321984|39172819|FG000|Overall Study|Per Subject Request|1|||
16189985|NCT00321984|39172820|FG001|Overall Study|Per Subject Request|0|||
16189986|NCT00321984|39172821|FG002|Overall Study|Per Subject Request|0|||
16189987|NCT00321984|39172819|FG000|Overall Study|Per Investigator Request|1|||
16189988|NCT00321984|39172820|FG001|Overall Study|Per Investigator Request|0|||
16189989|NCT00321984|39172821|FG002|Overall Study|Per Investigator Request|0|||
16189990|NCT00321984|39172819|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
16189991|NCT00321984|39172820|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
16189992|NCT00321984|39172821|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
16189993|NCT00611455|39172822|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
16189994|NCT00611455|39172823|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
16189995|NCT00611455|39172824|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
16488658|NCT02801396|40263363|FG003|Period 1|Withdrawal by Subject|0|||
16488659|NCT02801396|40263364|FG004|Period 1|Withdrawal by Subject|1|||
16189996|NCT00611455|39172822|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
16189997|NCT00611455|39172823|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
16189998|NCT00611455|39172824|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
16189999|NCT00611455|39172822|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
16190000|NCT00611455|39172823|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
16190001|NCT00611455|39172824|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
16190002|NCT00611455|39172822|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
16190003|NCT00611455|39172823|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
16190004|NCT00611455|39172824|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16190005|NCT00611455|39172822|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
16190006|NCT00611455|39172823|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
16190007|NCT00611455|39172824|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
16190008|NCT00611455|39172822|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
16190009|NCT00611455|39172823|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
16190010|NCT00611455|39172824|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
16190011|NCT00611455|39172822|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
16190012|NCT00611455|39172823|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
16190013|NCT00611455|39172824|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
16190014|NCT00611455|39172822|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
16190015|NCT00611455|39172823|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
16190016|NCT00611455|39172824|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
16190017|NCT00611455|39172822|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
16190018|NCT00611455|39172823|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
16190019|NCT00611455|39172824|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
16190020|NCT00611455|39172822|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
16190021|NCT00611455|39172823|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
16190022|NCT00611455|39172824|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
16190023|NCT00611455|39172822|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
16190024|NCT00611455|39172823|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
16190025|NCT00611455|39172824|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
16297452|NCT02393248|39573984|FG015|Part 3: Combination Therapy|Adverse Event|0|||
16297453|NCT02393248|39573985|FG016|Part 3: Combination Therapy|Adverse Event|0|||
16297454|NCT02393248|39573986|FG017|Part 3: Combination Therapy|Adverse Event|0|||
16297455|NCT02393248|39573987|FG018|Part 3: Combination Therapy|Adverse Event|0|||
16297456|NCT02393248|39573988|FG019|Part 3: Combination Therapy|Adverse Event|0|||
16297457|NCT02393248|39573989|FG020|Part 3: Combination Therapy|Adverse Event|0|||
16297458|NCT02393248|39573990|FG021|Part 3: Combination Therapy|Adverse Event|0|||
16297459|NCT02393248|39573991|FG022|Part 3: Combination Therapy|Adverse Event|0|||
16297460|NCT02393248|39573992|FG023|Part 3: Combination Therapy|Adverse Event|1|||
16297461|NCT02393248|39573993|FG024|Part 3: Combination Therapy|Adverse Event|0|||
16297462|NCT02393248|39573969|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297463|NCT02393248|39573970|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16488660|NCT02801396|40263365|FG005|Period 1|Withdrawal by Subject|0|||
16488661|NCT02007109|40263370|FG000|Overall Study|Diary not returned or excluded|102|||
16488662|NCT02007109|40263370|FG000|Overall Study|Excluded - Age<7yo|9|||
16488663|NCT00982137|40263371|FG000|Overall Study|Lost to Follow-up|0|||
16488664|NCT00982137|40263372|FG001|Overall Study|Lost to Follow-up|0|||
16488665|NCT00982137|40263373|FG002|Overall Study|Lost to Follow-up|0|||
16488666|NCT00982137|40263374|FG003|Overall Study|Lost to Follow-up|1|||
16083395|NCT00943917|38799036|FG013|Stage II Continuation|A1C elevation|1|||
16190026|NCT00611455|39172822|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
16190027|NCT00611455|39172823|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
16190028|NCT00611455|39172824|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
16297464|NCT02393248|39573971|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16488667|NCT00982137|40263371|FG000|Overall Study|Withdrawal by Subject|0|||
16297465|NCT02393248|39573972|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297466|NCT02393248|39573973|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297467|NCT02393248|39573974|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297468|NCT02393248|39573975|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297469|NCT02393248|39573976|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297470|NCT02393248|39573977|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297471|NCT02393248|39573978|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297472|NCT02393248|39573979|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16488668|NCT00982137|40263372|FG001|Overall Study|Withdrawal by Subject|1|||
16488669|NCT00982137|40263373|FG002|Overall Study|Withdrawal by Subject|0|||
16488670|NCT00982137|40263374|FG003|Overall Study|Withdrawal by Subject|0|||
16488671|NCT03066804|40263378|FG000|Overall Study|Physician Decision|0|||
16488672|NCT03066804|40263379|FG001|Overall Study|Physician Decision|4|||
16488673|NCT03066804|40263378|FG000|Overall Study|Death|23|||
16488674|NCT03066804|40263379|FG001|Overall Study|Death|17|||
16488675|NCT03066804|40263378|FG000|Overall Study|Withdrawal by Subject|19|||
16488676|NCT03066804|40263379|FG001|Overall Study|Withdrawal by Subject|25|||
16488677|NCT03066804|40263378|FG000|Overall Study|Lost to Follow-up|2|||
16488678|NCT03066804|40263379|FG001|Overall Study|Lost to Follow-up|0|||
16488679|NCT03066804|40263378|FG000|Overall Study|Adverse Event|2|||
16488680|NCT03066804|40263379|FG001|Overall Study|Adverse Event|3|||
16488681|NCT03066804|40263378|FG000|Overall Study|Technical problems|5|||
16488682|NCT03066804|40263379|FG001|Overall Study|Technical problems|1|||
16488683|NCT03310021|40263380|FG000|Overall Study|Withdrawal by Subject|0|||
16488684|NCT03310021|40263381|FG001|Overall Study|Withdrawal by Subject|0|||
16488685|NCT03310021|40263382|FG002|Overall Study|Withdrawal by Subject|0|||
16488686|NCT03310021|40263383|FG003|Overall Study|Withdrawal by Subject|0|||
16488687|NCT03310021|40263384|FG004|Overall Study|Withdrawal by Subject|0|||
16488688|NCT03310021|40263385|FG005|Overall Study|Withdrawal by Subject|0|||
16488689|NCT03310021|40263386|FG006|Overall Study|Withdrawal by Subject|1|||
16488690|NCT03310021|40263387|FG007|Overall Study|Withdrawal by Subject|0|||
16488691|NCT03310021|40263388|FG008|Overall Study|Withdrawal by Subject|0|||
16488692|NCT03310021|40263389|FG009|Overall Study|Withdrawal by Subject|0|||
16488693|NCT03310021|40263390|FG010|Overall Study|Withdrawal by Subject|0|||
16488694|NCT03310021|40263391|FG011|Overall Study|Withdrawal by Subject|0|||
16488695|NCT03310021|40263392|FG012|Overall Study|Withdrawal by Subject|0|||
16488696|NCT03310021|40263393|FG013|Overall Study|Withdrawal by Subject|0|||
16488697|NCT03310021|40263394|FG014|Overall Study|Withdrawal by Subject|0|||
16488698|NCT03310021|40263395|FG015|Overall Study|Withdrawal by Subject|0|||
16488699|NCT03310021|40263396|FG016|Overall Study|Withdrawal by Subject|0|||
16488700|NCT03310021|40263397|FG017|Overall Study|Withdrawal by Subject|0|||
16488701|NCT03310021|40263398|FG018|Overall Study|Withdrawal by Subject|0|||
16488702|NCT03310021|40263399|FG019|Overall Study|Withdrawal by Subject|0|||
16488703|NCT03310021|40263380|FG000|Overall Study|Lost to Follow-up|0|||
16488704|NCT03310021|40263381|FG001|Overall Study|Lost to Follow-up|0|||
16488705|NCT03310021|40263382|FG002|Overall Study|Lost to Follow-up|0|||
16297473|NCT02393248|39573980|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297474|NCT02393248|39573981|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297475|NCT02393248|39573982|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16488706|NCT03310021|40263383|FG003|Overall Study|Lost to Follow-up|0|||
16488707|NCT03310021|40263384|FG004|Overall Study|Lost to Follow-up|0|||
16488708|NCT03310021|40263385|FG005|Overall Study|Lost to Follow-up|0|||
16488709|NCT03310021|40263386|FG006|Overall Study|Lost to Follow-up|0|||
16488710|NCT03310021|40263387|FG007|Overall Study|Lost to Follow-up|0|||
16488711|NCT03310021|40263388|FG008|Overall Study|Lost to Follow-up|0|||
16297476|NCT02393248|39573983|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297477|NCT02393248|39573984|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297478|NCT02393248|39573985|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297479|NCT02393248|39573986|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297480|NCT02393248|39573987|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297481|NCT02393248|39573988|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297482|NCT02393248|39573989|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297483|NCT02393248|39573990|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297484|NCT02393248|39573991|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297485|NCT02393248|39573992|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
16297486|NCT02393248|39573993|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
16297487|NCT01221363|39573997|FG000|Overall Study|Pregnancy|1|||
16297488|NCT01221363|39573998|FG001|Overall Study|Pregnancy|0|||
16297489|NCT01221363|39573997|FG000|Overall Study|Withdrawal by Subject|11|||
16297490|NCT01221363|39573998|FG001|Overall Study|Withdrawal by Subject|5|||
16297491|NCT01104792|39573999|FG000|Overall Study|Adverse Event|77|||
16297492|NCT01104792|39573999|FG000|Overall Study|Insufficient Therapeutic Response|22|||
16297493|NCT01104792|39573999|FG000|Overall Study|Protocol Violation|45|||
16297494|NCT01104792|39573999|FG000|Overall Study|Withdrawal of Consent|179|||
16297495|NCT01104792|39573999|FG000|Overall Study|Lost to Follow-up|43|||
16297496|NCT01104792|39573999|FG000|Overall Study|Reasons Not Specified|27|||
16297497|NCT01104792|39573999|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
16297498|NCT03456453|39574000|FG000|Overall Study|Withdrawal by Subject|2|||
16297499|NCT03456453|39574001|FG001|Overall Study|Withdrawal by Subject|0|||
16297500|NCT03456453|39574000|FG000|Overall Study|Not released to community|1|||
16297501|NCT03456453|39574001|FG001|Overall Study|Not released to community|5|||
16297502|NCT03456453|39574000|FG000|Overall Study|Lost to Follow-up|0|||
16297503|NCT03456453|39574001|FG001|Overall Study|Lost to Follow-up|2|||
16297504|NCT02564211|39574003|FG000|Overall Study|Adverse Event|4|||
16297505|NCT01199471|39574004|FG000|Overall Study|Protocol Violation|4|||
16297506|NCT01199471|39574004|FG000|Overall Study|Withdrawal by Subject|1|||
16297507|NCT01199471|39574004|FG000|Overall Study|Physician Decision|1|||
16297508|NCT01439009|39574005|FG000|Overall Study|Physician Decision|5|||
16297509|NCT01439009|39574006|FG001|Overall Study|Physician Decision|3|||
16297510|NCT01439009|39574005|FG000|Overall Study|Protocol Violation|2|||
16297511|NCT01439009|39574006|FG001|Overall Study|Protocol Violation|0|||
16297512|NCT01439009|39574005|FG000|Overall Study|Deviation of exclusion criteria|1|||
16297513|NCT01439009|39574006|FG001|Overall Study|Deviation of exclusion criteria|0|||
16297514|NCT02458287|39574007|FG000|Overall Study|Adverse Event|0|||
16297515|NCT02458287|39574008|FG001|Overall Study|Adverse Event|0|||
16297516|NCT02458287|39574009|FG002|Overall Study|Adverse Event|0|||
16297517|NCT02458287|39574010|FG003|Overall Study|Adverse Event|1|||
16384376|NCT00673920|39892574|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
16384377|NCT00673920|39892575|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
16384378|NCT00673920|39892576|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
16384379|NCT00673920|39892577|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
16384380|NCT00673920|39892578|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
16384381|NCT00673920|39892579|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
16384382|NCT00673920|39892580|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
16384383|NCT00673920|39892573|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
16384384|NCT00673920|39892574|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
16384385|NCT00673920|39892575|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
16384386|NCT00673920|39892576|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
16384387|NCT00673920|39892577|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
16384388|NCT00673920|39892578|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
16384389|NCT00673920|39892579|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
16488712|NCT03310021|40263389|FG009|Overall Study|Lost to Follow-up|0|||
16297518|NCT02458287|39574007|FG000|Overall Study|Lost to Follow-up|0|||
16297519|NCT02458287|39574008|FG001|Overall Study|Lost to Follow-up|1|||
16297520|NCT02458287|39574009|FG002|Overall Study|Lost to Follow-up|1|||
16297521|NCT02458287|39574010|FG003|Overall Study|Lost to Follow-up|0|||
16297522|NCT02458287|39574007|FG000|Overall Study|Protocol Violation|0|||
16297523|NCT02458287|39574008|FG001|Overall Study|Protocol Violation|1|||
16384390|NCT00673920|39892580|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
16384391|NCT00673920|39892573|FG000|Week 24 to Week 48|Failure to return|0|||
16384392|NCT00673920|39892574|FG001|Week 24 to Week 48|Failure to return|0|||
16384393|NCT00673920|39892575|FG002|Week 24 to Week 48|Failure to return|0|||
16384394|NCT00673920|39892576|FG003|Week 24 to Week 48|Failure to return|0|||
16384395|NCT00673920|39892577|FG004|Week 24 to Week 48|Failure to return|0|||
16384396|NCT00673920|39892578|FG005|Week 24 to Week 48|Failure to return|1|||
16384397|NCT00673920|39892579|FG006|Week 24 to Week 48|Failure to return|0|||
16384398|NCT00673920|39892580|FG007|Week 24 to Week 48|Failure to return|0|||
16384399|NCT00673920|39892573|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
16384400|NCT00673920|39892574|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
16384401|NCT00673920|39892575|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
16384402|NCT00673920|39892576|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
16384403|NCT00673920|39892577|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
16384404|NCT00673920|39892578|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
16384405|NCT00673920|39892579|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
16384406|NCT00673920|39892580|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
16384407|NCT00673920|39892573|FG000|Week 24 to Week 48|Death|0|||
16384408|NCT00673920|39892574|FG001|Week 24 to Week 48|Death|0|||
16384409|NCT00673920|39892575|FG002|Week 24 to Week 48|Death|0|||
16384410|NCT00673920|39892576|FG003|Week 24 to Week 48|Death|0|||
16384411|NCT00673920|39892577|FG004|Week 24 to Week 48|Death|0|||
16384412|NCT00673920|39892578|FG005|Week 24 to Week 48|Death|1|||
16384413|NCT00673920|39892579|FG006|Week 24 to Week 48|Death|0|||
16384414|NCT00673920|39892580|FG007|Week 24 to Week 48|Death|0|||
16384415|NCT00673920|39892573|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
16384416|NCT00673920|39892574|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
16384417|NCT00673920|39892575|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
16384418|NCT00673920|39892576|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
16384419|NCT00673920|39892577|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
16384420|NCT00673920|39892578|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
16384421|NCT00673920|39892579|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
16488713|NCT03310021|40263390|FG010|Overall Study|Lost to Follow-up|1|||
16488714|NCT03310021|40263391|FG011|Overall Study|Lost to Follow-up|0|||
16488715|NCT03310021|40263392|FG012|Overall Study|Lost to Follow-up|0|||
16488716|NCT03310021|40263393|FG013|Overall Study|Lost to Follow-up|0|||
16488717|NCT03310021|40263394|FG014|Overall Study|Lost to Follow-up|0|||
16488718|NCT03310021|40263395|FG015|Overall Study|Lost to Follow-up|0|||
16488719|NCT03310021|40263396|FG016|Overall Study|Lost to Follow-up|0|||
16384422|NCT00673920|39892580|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
16384423|NCT02031302|39892581|FG000|Overall Study|Death|115|||
16384424|NCT02031302|39892582|FG001|Overall Study|Death|0|||
16488720|NCT03310021|40263397|FG017|Overall Study|Lost to Follow-up|0|||
16488721|NCT03310021|40263398|FG018|Overall Study|Lost to Follow-up|0|||
16297524|NCT02458287|39574009|FG002|Overall Study|Protocol Violation|0|||
16488722|NCT03310021|40263399|FG019|Overall Study|Lost to Follow-up|0|||
16488723|NCT01405456|40263415|FG000|Overall Study|Lost to Follow-up|2|||
16488724|NCT01405456|40263416|FG001|Overall Study|Lost to Follow-up|1|||
16488725|NCT01405456|40263415|FG000|Overall Study|Physician Decision|1|||
16488726|NCT01405456|40263416|FG001|Overall Study|Physician Decision|0|||
16488727|NCT01546207|40263426|FG000|Overall Study|Death|1|||
16488728|NCT04203238|40263427|FG000|Overall Study|Withdrawal by Subject|1|||
16488729|NCT04203238|40263428|FG001|Overall Study|Withdrawal by Subject|1|||
16488730|NCT04203238|40263427|FG000|Overall Study|Covid-19|3|||
16488731|NCT04203238|40263428|FG001|Overall Study|Covid-19|0|||
16488732|NCT02302807|40263429|FG000|Overall Study|Withdrawal by Subject|28|||
16488733|NCT02302807|40263430|FG001|Overall Study|Withdrawal by Subject|11|||
16488734|NCT02302807|40263429|FG000|Overall Study|Lost to Follow-up|4|||
16488735|NCT02302807|40263430|FG001|Overall Study|Lost to Follow-up|6|||
16488736|NCT02302807|40263429|FG000|Overall Study|Death|397|||
16488737|NCT02302807|40263430|FG001|Overall Study|Death|385|||
16488738|NCT02302807|40263429|FG000|Overall Study|Study Terminated By Sponsor|35|||
16384425|NCT02031302|39892581|FG000|Overall Study|Not treated with study valve system|18|||
16384426|NCT02031302|39892582|FG001|Overall Study|Not treated with study valve system|0|||
16384427|NCT02031302|39892581|FG000|Overall Study|Missed Follow Up|27|||
16384428|NCT02031302|39892582|FG001|Overall Study|Missed Follow Up|0|||
16384429|NCT02031302|39892581|FG000|Overall Study|Lost to Follow-up|4|||
16384430|NCT02031302|39892582|FG001|Overall Study|Lost to Follow-up|0|||
16384431|NCT03376516|39892583|FG000|Overall Study|Not treated|1|||
16384432|NCT03376516|39892583|FG000|Overall Study|Consent withdrawn|1|||
16384433|NCT01736917|39892584|FG000|Overall Study|Adverse Event|1|||
16384434|NCT01736917|39892584|FG000|Overall Study|Protocol Violation|10|||
16384435|NCT02317627|39892587|FG000|Overall Study|Withdrawal by Subject|0|||
16384436|NCT02317627|39892588|FG001|Overall Study|Withdrawal by Subject|1|||
16384437|NCT02317627|39892589|FG002|Overall Study|Withdrawal by Subject|1|||
16384438|NCT02317627|39892587|FG000|Overall Study|Lost to Follow-up|2|||
16384439|NCT02317627|39892588|FG001|Overall Study|Lost to Follow-up|0|||
16384440|NCT02317627|39892589|FG002|Overall Study|Lost to Follow-up|0|||
16384441|NCT02317627|39892587|FG000|Overall Study|Stopped by Investigator|0|||
16384442|NCT02317627|39892588|FG001|Overall Study|Stopped by Investigator|1|||
16384443|NCT02317627|39892589|FG002|Overall Study|Stopped by Investigator|0|||
16384444|NCT02317627|39892587|FG000|Overall Study|Adverse Event|0|||
16384445|NCT02317627|39892588|FG001|Overall Study|Adverse Event|2|||
16384446|NCT02317627|39892589|FG002|Overall Study|Adverse Event|3|||
16384447|NCT02317627|39892587|FG000|Overall Study|Non-compliance with study drug|0|||
16384448|NCT02317627|39892588|FG001|Overall Study|Non-compliance with study drug|1|||
16384449|NCT02317627|39892589|FG002|Overall Study|Non-compliance with study drug|0|||
16384450|NCT01732536|39892591|FG000|Overall Study|Withdrawal by Subject|1|||
16384451|NCT01732536|39892592|FG001|Overall Study|Withdrawal by Subject|1|||
16384452|NCT00805389|39892593|FG000|Overall Study|Adverse Event|0|||
16384453|NCT00805389|39892594|FG001|Overall Study|Adverse Event|0|||
16384454|NCT00805389|39892595|FG002|Overall Study|Adverse Event|1|||
16384455|NCT00805389|39892596|FG003|Overall Study|Adverse Event|2|||
16384456|NCT00805389|39892597|FG004|Overall Study|Adverse Event|0|||
16384457|NCT00805389|39892593|FG000|Overall Study|Lost to Follow-up|4|||
16384458|NCT00805389|39892594|FG001|Overall Study|Lost to Follow-up|3|||
16384459|NCT00805389|39892595|FG002|Overall Study|Lost to Follow-up|6|||
16384460|NCT00805389|39892596|FG003|Overall Study|Lost to Follow-up|10|||
16384461|NCT00805389|39892597|FG004|Overall Study|Lost to Follow-up|9|||
16384462|NCT00805389|39892593|FG000|Overall Study|Protocol Violation|0|||
16384463|NCT00805389|39892594|FG001|Overall Study|Protocol Violation|0|||
16384464|NCT00805389|39892595|FG002|Overall Study|Protocol Violation|1|||
16384465|NCT00805389|39892596|FG003|Overall Study|Protocol Violation|0|||
16384466|NCT00805389|39892597|FG004|Overall Study|Protocol Violation|0|||
16384467|NCT00805389|39892593|FG000|Overall Study|Withdrawal by Subject|3|||
16384468|NCT00805389|39892594|FG001|Overall Study|Withdrawal by Subject|2|||
16384469|NCT00805389|39892595|FG002|Overall Study|Withdrawal by Subject|4|||
16384470|NCT00805389|39892596|FG003|Overall Study|Withdrawal by Subject|5|||
16384471|NCT00805389|39892597|FG004|Overall Study|Withdrawal by Subject|4|||
16384472|NCT02536664|39892598|FG000|Overall Study|Inadequate completion of documentation|2|||
16384473|NCT02536664|39892599|FG001|Overall Study|Inadequate completion of documentation|4|||
16384474|NCT02536664|39892598|FG000|Overall Study|Progression|13|||
16384475|NCT02536664|39892599|FG001|Overall Study|Progression|18|||
16384476|NCT02536664|39892598|FG000|Overall Study|Death due to lymphoma|2|||
16384477|NCT02536664|39892599|FG001|Overall Study|Death due to lymphoma|1|||
16488739|NCT02302807|40263430|FG001|Overall Study|Study Terminated By Sponsor|64|||
16488740|NCT02302807|40263429|FG000|Overall Study|Physician Decision|0|||
16488741|NCT02302807|40263430|FG001|Overall Study|Physician Decision|1|||
16297525|NCT02458287|39574010|FG003|Overall Study|Protocol Violation|0|||
16297526|NCT02458287|39574007|FG000|Overall Study|Withdrawal by Subject|0|||
16297527|NCT02458287|39574008|FG001|Overall Study|Withdrawal by Subject|2|||
16297528|NCT02458287|39574009|FG002|Overall Study|Withdrawal by Subject|2|||
16190029|NCT00611455|39172822|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
16190030|NCT00611455|39172823|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
16190031|NCT00611455|39172824|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
16190032|NCT00611455|39172822|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
16190033|NCT00611455|39172823|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
16190034|NCT00611455|39172824|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
16190035|NCT00611455|39172822|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
16190036|NCT00611455|39172823|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
16190037|NCT00611455|39172824|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
16297529|NCT02458287|39574010|FG003|Overall Study|Withdrawal by Subject|1|||
16297530|NCT02458287|39574007|FG000|Overall Study|Relocated Out of State|0|||
16297531|NCT02458287|39574008|FG001|Overall Study|Relocated Out of State|0|||
16297532|NCT02458287|39574009|FG002|Overall Study|Relocated Out of State|0|||
16297533|NCT02458287|39574010|FG003|Overall Study|Relocated Out of State|1|||
16297534|NCT01161407|39574011|FG000|Overall Study|Protocol Violation|3|||
16297535|NCT01161407|39574012|FG001|Overall Study|Protocol Violation|1|||
16297536|NCT02752906|39574020|FG000|Overall Study|Protocol Violation|2|||
16190038|NCT00611455|39172822|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
16297537|NCT02752906|39574021|FG001|Overall Study|Protocol Violation|1|||
16297538|NCT02752906|39574020|FG000|Overall Study|Withdrawal by Subject|2|||
16297539|NCT02752906|39574021|FG001|Overall Study|Withdrawal by Subject|2|||
16297540|NCT02752906|39574020|FG000|Overall Study|Lost to Follow-up|3|||
16297541|NCT02752906|39574021|FG001|Overall Study|Lost to Follow-up|2|||
16297542|NCT02036775|39574022|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
16297543|NCT02036775|39574023|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
16297544|NCT02036775|39574024|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
16297545|NCT02036775|39574025|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
16297546|NCT02036775|39574026|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
16297547|NCT02036775|39574027|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
16297548|NCT00856375|39574028|FG000|Overall Study|Other|0|||
16297549|NCT00856375|39574029|FG001|Overall Study|Other|1|||
16297550|NCT00856375|39574028|FG000|Overall Study|Death|32|||
16190039|NCT00611455|39172823|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
16190040|NCT00611455|39172824|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
16190041|NCT00611455|39172822|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
16297551|NCT00856375|39574029|FG001|Overall Study|Death|30|||
16297552|NCT00856375|39574028|FG000|Overall Study|Sponsor Terminated Study|7|||
16297553|NCT00856375|39574029|FG001|Overall Study|Sponsor Terminated Study|7|||
16297554|NCT00856375|39574028|FG000|Overall Study|Withdrawal by Subject|2|||
16297555|NCT00856375|39574029|FG001|Overall Study|Withdrawal by Subject|1|||
16297556|NCT00856375|39574028|FG000|Overall Study|Lost to Follow-up|1|||
16297557|NCT00856375|39574029|FG001|Overall Study|Lost to Follow-up|2|||
16297558|NCT00642278|39574048|FG000|Overall Study|Adverse Event|2|||
16297559|NCT00642278|39574049|FG001|Overall Study|Adverse Event|1|||
16297560|NCT00642278|39574050|FG002|Overall Study|Adverse Event|3|||
16297561|NCT00642278|39574051|FG003|Overall Study|Adverse Event|1|||
16297562|NCT00642278|39574052|FG004|Overall Study|Adverse Event|2|||
16297563|NCT00642278|39574053|FG005|Overall Study|Adverse Event|2|||
16297564|NCT00642278|39574054|FG006|Overall Study|Adverse Event|0|||
16297565|NCT00642278|39574048|FG000|Overall Study|Lack of Efficacy|0|||
16297566|NCT00642278|39574049|FG001|Overall Study|Lack of Efficacy|1|||
16297567|NCT00642278|39574050|FG002|Overall Study|Lack of Efficacy|0|||
16297568|NCT00642278|39574051|FG003|Overall Study|Lack of Efficacy|0|||
16297569|NCT00642278|39574052|FG004|Overall Study|Lack of Efficacy|0|||
16384478|NCT02536664|39892598|FG000|Overall Study|Death due to other reason|3|||
16297570|NCT00642278|39574053|FG005|Overall Study|Lack of Efficacy|0|||
16297571|NCT00642278|39574054|FG006|Overall Study|Lack of Efficacy|0|||
16297572|NCT00642278|39574048|FG000|Overall Study|Lost to Follow-up|5|||
16297573|NCT00642278|39574049|FG001|Overall Study|Lost to Follow-up|1|||
16190042|NCT00611455|39172823|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
16190043|NCT00611455|39172824|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
16190044|NCT00611455|39172822|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
16190045|NCT00611455|39172823|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
16190046|NCT00611455|39172824|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
16488742|NCT01061177|40263436|FG000|Overall Study|Adverse Event|117|||
16488743|NCT01061177|40263436|FG000|Overall Study|Withdrawal by Subject|27|||
16488744|NCT01061177|40263436|FG000|Overall Study|Disease progression|17|||
16488745|NCT01061177|40263436|FG000|Overall Study|Protocol Violation|11|||
16488746|NCT01061177|40263436|FG000|Overall Study|Lost to Follow-up|9|||
16488747|NCT01061177|40263436|FG000|Overall Study|New cancer therapy|9|||
16488748|NCT01061177|40263436|FG000|Overall Study|Abnormal laboratory values|6|||
16488749|NCT01061177|40263436|FG000|Overall Study|Abnormal test procedure results|4|||
16488750|NCT01061177|40263436|FG000|Overall Study|Administratie problems|4|||
16488751|NCT01061177|40263436|FG000|Overall Study|Death|4|||
16488752|NCT00555971|40263439|FG000|Overall Study|Adverse Event|1|||
16488753|NCT00555971|40263440|FG001|Overall Study|Adverse Event|1|||
16488754|NCT01516437|40263441|FG000|Overall Study|Reason not specified|0|||
16488755|NCT01516437|40263442|FG001|Overall Study|Reason not specified|0|||
16488756|NCT01516437|40263443|FG002|Overall Study|Reason not specified|1|||
16488757|NCT01516437|40263444|FG003|Overall Study|Reason not specified|1|||
16488758|NCT03003390|40263445|FG000|Overall Study|Physician Decision|2|||
16488759|NCT03003390|40263446|FG001|Overall Study|Physician Decision|0|||
16488760|NCT03003390|40263445|FG000|Overall Study|Parent refused intervention|2|||
16488761|NCT03003390|40263446|FG001|Overall Study|Parent refused intervention|0|||
16083396|NCT00943917|38799037|FG014|Stage II Continuation|A1C elevation|0|||
16083397|NCT00692913|38799038|FG000|Overall Study|Adverse Event|8|||
16083398|NCT00692913|38799039|FG001|Overall Study|Adverse Event|4|||
16083399|NCT00692913|38799038|FG000|Overall Study|Lost to Follow-up|3|||
16083400|NCT00692913|38799039|FG001|Overall Study|Lost to Follow-up|5|||
16083401|NCT00692913|38799038|FG000|Overall Study|Physician Decision|2|||
16083402|NCT00692913|38799039|FG001|Overall Study|Physician Decision|0|||
16083403|NCT00692913|38799038|FG000|Overall Study|Protocol Violation|1|||
16083404|NCT00692913|38799039|FG001|Overall Study|Protocol Violation|1|||
16083405|NCT00692913|38799038|FG000|Overall Study|Withdrawal by Subject|15|||
16488762|NCT04212650|40263447|FG000|Overall Study|Withdrawal by Subject|1|||
16190047|NCT00611455|39172822|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
16190048|NCT00611455|39172823|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
16190049|NCT00611455|39172824|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
16190050|NCT00611455|39172822|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
16190051|NCT00611455|39172823|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
16190052|NCT00611455|39172824|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
16190053|NCT00611455|39172822|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
16190054|NCT00611455|39172823|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
16190055|NCT00611455|39172824|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
16190056|NCT01165021|39172826|FG000|Overall Study|Death|1|||
16190057|NCT00524316|39172827|FG000|Overall Study|Withdrawal by Subject|2|||
16190058|NCT00524316|39172827|FG000|Overall Study|Adverse Event|7|||
16190059|NCT00524316|39172827|FG000|Overall Study|Disease Progression|7|||
16190060|NCT01426425|39172828|FG000|Overall Study|Exited prior to EP study|22|||
16190061|NCT01426425|39172828|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
16190062|NCT01426425|39172828|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
16190063|NCT01425190|39172836|FG000|Overall Study|Full dose not consumed.|1|||
16190064|NCT01425190|39172837|FG001|Overall Study|Full dose not consumed.|0|||
16190065|NCT01425190|39172838|FG002|Overall Study|Full dose not consumed.|0|||
16190066|NCT00536731|39172839|FG000|Overall Study|Adverse Event|3|||
16190067|NCT00536731|39172840|FG001|Overall Study|Adverse Event|2|||
16190068|NCT00536731|39172841|FG002|Overall Study|Adverse Event|3|||
16190069|NCT00536731|39172839|FG000|Overall Study|Withdrawal by Subject|0|||
16190070|NCT00536731|39172840|FG001|Overall Study|Withdrawal by Subject|2|||
16190071|NCT00536731|39172841|FG002|Overall Study|Withdrawal by Subject|0|||
16190072|NCT00536731|39172839|FG000|Overall Study|Intake of prohibited conc. medication|0|||
16190073|NCT00536731|39172840|FG001|Overall Study|Intake of prohibited conc. medication|0|||
16190074|NCT00536731|39172841|FG002|Overall Study|Intake of prohibited conc. medication|1|||
16488763|NCT04212650|40263448|FG001|Overall Study|Withdrawal by Subject|0|||
16488764|NCT00730132|40263449|FG000|Overall Study|Protocol Violation|154|||
16083406|NCT00692913|38799039|FG001|Overall Study|Withdrawal by Subject|20|||
16190075|NCT00536731|39172839|FG000|Overall Study|Safety reasons|0|||
16190076|NCT00536731|39172840|FG001|Overall Study|Safety reasons|0|||
16190077|NCT00536731|39172841|FG002|Overall Study|Safety reasons|1|||
16083407|NCT00293397|38799040|FG000|Overall Study|Death|2|||
16488765|NCT00730132|40263449|FG000|Overall Study|Death|1|||
16488766|NCT00913497|40263450|FG000|Overall Study|Adverse Event|1|||
16190078|NCT00536731|39172839|FG000|Overall Study|Other|1|||
16190079|NCT00536731|39172840|FG001|Overall Study|Other|1|||
16190080|NCT00536731|39172841|FG002|Overall Study|Other|0|||
16190081|NCT01120093|39172844|FG000|Treatment Period 1|Adverse Event|0|||
16190082|NCT01120093|39172845|FG001|Treatment Period 1|Adverse Event|0|||
16190083|NCT01120093|39172846|FG002|Treatment Period 1|Adverse Event|1|||
16190084|NCT01120093|39172847|FG003|Treatment Period 1|Adverse Event|0|||
16190085|NCT01120093|39172848|FG004|Treatment Period 1|Adverse Event|1|||
16190086|NCT01120093|39172844|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16190087|NCT01120093|39172845|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16190088|NCT01120093|39172846|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16190089|NCT01120093|39172847|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16297574|NCT00642278|39574050|FG002|Overall Study|Lost to Follow-up|0|||
16297575|NCT00642278|39574051|FG003|Overall Study|Lost to Follow-up|1|||
16297576|NCT00642278|39574052|FG004|Overall Study|Lost to Follow-up|0|||
16297577|NCT00642278|39574053|FG005|Overall Study|Lost to Follow-up|1|||
16297578|NCT00642278|39574054|FG006|Overall Study|Lost to Follow-up|1|||
16297579|NCT00642278|39574048|FG000|Overall Study|Physician Decision|0|||
16297580|NCT00642278|39574049|FG001|Overall Study|Physician Decision|0|||
16488767|NCT00913497|40263450|FG000|Overall Study|Withdrawal by Subject|2|||
16190090|NCT01120093|39172848|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16190091|NCT01120093|39172844|FG000|Treatment Period 2|Adverse Event|0|||
16190092|NCT01120093|39172845|FG001|Treatment Period 2|Adverse Event|0|||
16190093|NCT01120093|39172846|FG002|Treatment Period 2|Adverse Event|0|||
16190094|NCT01120093|39172847|FG003|Treatment Period 2|Adverse Event|1|||
16190095|NCT01120093|39172848|FG004|Treatment Period 2|Adverse Event|0|||
16190096|NCT01120093|39172844|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16190097|NCT01120093|39172845|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16190098|NCT01120093|39172846|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16190099|NCT01120093|39172847|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16190100|NCT01120093|39172848|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16190101|NCT01120093|39172844|FG000|Treatment Period 3|Lack of Efficacy|0|||
16190102|NCT01120093|39172845|FG001|Treatment Period 3|Lack of Efficacy|0|||
16190103|NCT01120093|39172846|FG002|Treatment Period 3|Lack of Efficacy|0|||
16190104|NCT01120093|39172847|FG003|Treatment Period 3|Lack of Efficacy|1|||
16190105|NCT01120093|39172848|FG004|Treatment Period 3|Lack of Efficacy|0|||
16190106|NCT01120093|39172844|FG000|Treatment Period 3|Adverse Event|0|||
16190107|NCT01120093|39172845|FG001|Treatment Period 3|Adverse Event|0|||
16190108|NCT01120093|39172846|FG002|Treatment Period 3|Adverse Event|0|||
16190109|NCT01120093|39172847|FG003|Treatment Period 3|Adverse Event|0|||
16190110|NCT01120093|39172848|FG004|Treatment Period 3|Adverse Event|1|||
16190111|NCT01120093|39172844|FG000|Treatment Period 3|Withdrawal by Subject|0|||
16190112|NCT01120093|39172845|FG001|Treatment Period 3|Withdrawal by Subject|0|||
16190113|NCT01120093|39172846|FG002|Treatment Period 3|Withdrawal by Subject|1|||
16190114|NCT01120093|39172847|FG003|Treatment Period 3|Withdrawal by Subject|0|||
16190115|NCT01120093|39172848|FG004|Treatment Period 3|Withdrawal by Subject|0|||
16190116|NCT01120093|39172844|FG000|Treatment Period 4|Adverse Event|1|||
16190117|NCT01120093|39172845|FG001|Treatment Period 4|Adverse Event|0|||
16190118|NCT01120093|39172846|FG002|Treatment Period 4|Adverse Event|0|||
16190119|NCT01120093|39172847|FG003|Treatment Period 4|Adverse Event|0|||
16190120|NCT01120093|39172848|FG004|Treatment Period 4|Adverse Event|0|||
16190121|NCT01120093|39172844|FG000|Treatment Period 5|Adverse Event|0|||
16190122|NCT01120093|39172845|FG001|Treatment Period 5|Adverse Event|1|||
16190123|NCT01120093|39172846|FG002|Treatment Period 5|Adverse Event|0|||
16190124|NCT01120093|39172847|FG003|Treatment Period 5|Adverse Event|1|||
16190125|NCT01120093|39172848|FG004|Treatment Period 5|Adverse Event|0|||
16190126|NCT02184143|39172849|FG000|Overall Study|Withdrawal by Subject|4|||
16190127|NCT02184143|39172850|FG001|Overall Study|Withdrawal by Subject|4|||
16190128|NCT02184143|39172849|FG000|Overall Study|Lost to Follow-up|5|||
16190129|NCT02184143|39172850|FG001|Overall Study|Lost to Follow-up|3|||
16190130|NCT02184143|39172849|FG000|Overall Study|Death|1|||
16190131|NCT02184143|39172850|FG001|Overall Study|Death|0|||
16190132|NCT03276936|39172851|FG000|Overall Study|Adverse Event|4|||
16190133|NCT03276936|39172852|FG001|Overall Study|Adverse Event|2|||
16190134|NCT03276936|39172851|FG000|Overall Study|Lost to Follow-up|16|||
16190135|NCT03276936|39172852|FG001|Overall Study|Lost to Follow-up|13|||
16190136|NCT03276936|39172851|FG000|Overall Study|Withdrawal by Subject|30|||
16190137|NCT03276936|39172852|FG001|Overall Study|Withdrawal by Subject|20|||
16297581|NCT00642278|39574050|FG002|Overall Study|Physician Decision|0|||
16190138|NCT03276936|39172851|FG000|Overall Study|Not mentioned|6|||
16190139|NCT03276936|39172852|FG001|Overall Study|Not mentioned|3|||
16190140|NCT01798134|39172854|FG000|Overall Study|Lost to Follow-up|1|||
16190141|NCT01798134|39172854|FG000|Overall Study|Withdrawal by Subject|3|||
16190142|NCT01798134|39172854|FG000|Overall Study|Death|2|||
16190143|NCT01798134|39172854|FG000|Overall Study|Adverse Event|3|||
16190144|NCT01798134|39172854|FG000|Overall Study|Physician Decision|3|||
16190145|NCT01798134|39172854|FG000|Overall Study|Liver transplant/surgery|4|||
16297582|NCT00642278|39574051|FG003|Overall Study|Physician Decision|1|||
16297583|NCT00642278|39574052|FG004|Overall Study|Physician Decision|0|||
16190146|NCT02750813|39172862|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
16190147|NCT02750813|39172863|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
16190148|NCT02750813|39172862|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
16190149|NCT02750813|39172863|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
16190150|NCT01474746|39172864|FG000|Overall Study|Lost to Follow-up|1|||
16190151|NCT01474746|39172865|FG001|Overall Study|Lost to Follow-up|1|||
16190152|NCT01474746|39172864|FG000|Overall Study|Withdrawal by Subject|2|||
16190153|NCT01474746|39172865|FG001|Overall Study|Withdrawal by Subject|1|||
16190154|NCT03213626|39172872|FG000|Overall Study|Adverse Event|1|||
16190155|NCT03213626|39172872|FG000|Overall Study|Progressive Disease|6|||
16190156|NCT02179515|39172874|FG000|Overall Study|switched to alternative treatment|0|||
16190157|NCT02179515|39172875|FG001|Overall Study|switched to alternative treatment|1|||
16190158|NCT02179515|39172876|FG002|Overall Study|switched to alternative treatment|1|||
16190159|NCT02179515|39172874|FG000|Overall Study|Death|0|||
16190160|NCT02179515|39172875|FG001|Overall Study|Death|1|||
16190161|NCT02179515|39172876|FG002|Overall Study|Death|1|||
16190162|NCT02179515|39172874|FG000|Overall Study|refused further treatment|0|||
16190163|NCT02179515|39172875|FG001|Overall Study|refused further treatment|3|||
16190164|NCT02179515|39172876|FG002|Overall Study|refused further treatment|4|||
16190165|NCT02179515|39172874|FG000|Overall Study|Disease progression on study|2|||
16190166|NCT02179515|39172875|FG001|Overall Study|Disease progression on study|11|||
16190167|NCT02179515|39172876|FG002|Overall Study|Disease progression on study|8|||
16190168|NCT01543490|39172877|FG000|Overall Study|Adverse Event|4|||
16190169|NCT01543490|39172878|FG001|Overall Study|Adverse Event|0|||
16190170|NCT01543490|39172877|FG000|Overall Study|Physician Decision|1|||
16190171|NCT01543490|39172878|FG001|Overall Study|Physician Decision|0|||
16190172|NCT01543490|39172877|FG000|Overall Study|Lack of Efficacy|3|||
16190173|NCT01543490|39172878|FG001|Overall Study|Lack of Efficacy|3|||
16190174|NCT01543490|39172877|FG000|Overall Study|Lost to Follow-up|5|||
16190175|NCT01543490|39172878|FG001|Overall Study|Lost to Follow-up|0|||
16190176|NCT01543490|39172877|FG000|Overall Study|Withdrawal by Subject|2|||
16190177|NCT01543490|39172878|FG001|Overall Study|Withdrawal by Subject|0|||
16190178|NCT01543490|39172877|FG000|Overall Study|Other-Various Administrative Reasons|1|||
16190179|NCT01543490|39172878|FG001|Overall Study|Other-Various Administrative Reasons|2|||
16190180|NCT02773238|39172879|FG000|Overall Study|Lack of Efficacy|4|||
16190181|NCT00938327|39172883|FG000|Overall Study|Adverse Event|2|||
16190182|NCT00938327|39172883|FG000|Overall Study|Protocol Violation|1|||
16190183|NCT00938327|39172883|FG000|Overall Study|Withdrawal by Subject|4|||
16190184|NCT00938327|39172883|FG000|Overall Study|Lost to Follow-up|37|||
16190185|NCT00938327|39172883|FG000|Overall Study|2nd dose received outside of the study|7|||
16190186|NCT00938327|39172883|FG000|Overall Study|Vaccine not received as out of stock|9|||
16190187|NCT01921257|39172890|FG000|Overall Study|Adverse Event|1|||
16190188|NCT01921257|39172890|FG000|Overall Study|Protocol Violation|1|||
16190189|NCT01921257|39172890|FG000|Overall Study|Withdrawal by Subject|1|||
16190190|NCT02042404|39172894|FG000|Overall Study|Death|1|||
16190191|NCT02042404|39172895|FG001|Overall Study|Death|0|||
16190192|NCT02042404|39172894|FG000|Overall Study|Unrelated Adverse Event|3|||
16190193|NCT02042404|39172895|FG001|Overall Study|Unrelated Adverse Event|0|||
16190194|NCT02042404|39172894|FG000|Overall Study|Inability to meet time requirements|1|||
16190195|NCT02042404|39172895|FG001|Overall Study|Inability to meet time requirements|0|||
16190196|NCT04385277|39172896|FG000|Overall Study|Physician Decision|2|||
16190197|NCT04385277|39172896|FG000|Overall Study|Ineligible|1|||
16190198|NCT04385277|39172896|FG000|Overall Study|Patient/Parent Refusal|2|||
16190199|NCT01295905|39172899|FG000|Overall Study|Did not meet inclusion criteria|1|||
16190200|NCT01295905|39172900|FG001|Overall Study|Did not meet inclusion criteria|0|||
16190201|NCT01295905|39172899|FG000|Overall Study|Met exclusion criteria|1|||
16190202|NCT01295905|39172900|FG001|Overall Study|Met exclusion criteria|0|||
16190203|NCT01597622|39172901|FG000|Overall Study|Adverse Event|7|||
16190204|NCT01597622|39172901|FG000|Overall Study|Lack of Efficacy|3|||
16190205|NCT01597622|39172901|FG000|Overall Study|Protocol Violation|1|||
16190206|NCT01597622|39172901|FG000|Overall Study|Lost to Follow-up|1|||
16190207|NCT01597622|39172901|FG000|Overall Study|Investigator Discretion|5|||
16190208|NCT01597622|39172901|FG000|Overall Study|Withdrawal by Subject|20|||
16190209|NCT01597622|39172901|FG000|Overall Study|Death|1|||
16190210|NCT04009096|39172902|FG000|Overall Study|Withdrawal by Subject|0|||
16488768|NCT02975336|40263453|FG000|DBPC (52 Weeks)|Adverse Event|16|||
16190211|NCT04009096|39172903|FG001|Overall Study|Withdrawal by Subject|7|||
16190212|NCT04009096|39172904|FG002|Overall Study|Withdrawal by Subject|0|||
16190213|NCT04009096|39172902|FG000|Overall Study|Physician Decision|0|||
16190214|NCT04009096|39172903|FG001|Overall Study|Physician Decision|1|||
16190215|NCT04009096|39172904|FG002|Overall Study|Physician Decision|0|||
16190216|NCT01081873|39172905|FG000|Overall Study|Death|86|||
16190217|NCT01081873|39172905|FG000|Overall Study|Withdrawal by Subject|10|||
16190218|NCT01081873|39172905|FG000|Overall Study|Lost to Follow-up|142|||
16190219|NCT01081873|39172905|FG000|Overall Study|Progression of prostate cancer|13|||
16190220|NCT01081873|39172905|FG000|Overall Study|Other|47|||
16190221|NCT00130208|39172906|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
16190222|NCT00130208|39172907|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
16190223|NCT00130208|39172906|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
16190224|NCT00130208|39172907|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
16190225|NCT00130208|39172906|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
16190226|NCT00130208|39172907|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
16190227|NCT00130208|39172906|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
16190228|NCT00130208|39172907|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
16190229|NCT00130208|39172906|FG000|Maintenance Period (26 Weeks)|Other|1|||
16190230|NCT00130208|39172907|FG001|Maintenance Period (26 Weeks)|Other|1|||
16190231|NCT00130208|39172906|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
16190232|NCT00130208|39172907|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
16190233|NCT00130208|39172906|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
16190234|NCT00130208|39172907|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
16190235|NCT00130208|39172906|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
16190236|NCT00130208|39172907|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
16190237|NCT00130208|39172906|FG000|Washout Period (8 Weeks)|Other|1|||
16190238|NCT00130208|39172907|FG001|Washout Period (8 Weeks)|Other|1|||
16190239|NCT01863849|39172908|FG000|Overall Study|Lost to Follow-up|1|||
16190240|NCT01863849|39172909|FG001|Overall Study|Lost to Follow-up|0|||
16190241|NCT00632463|39172912|FG000|Overall Study|Adverse Event|0|||
16190242|NCT00632463|39172913|FG001|Overall Study|Adverse Event|1|||
16190243|NCT00632463|39172914|FG002|Overall Study|Adverse Event|0|||
16190244|NCT00804193|39172915|FG000|Overall Study|Lack of baseline fungus|32|||
16190245|NCT00804193|39172916|FG001|Overall Study|Lack of baseline fungus|31|||
16190246|NCT00804193|39172917|FG002|Overall Study|Lack of baseline fungus|19|||
16190247|NCT00804193|39172915|FG000|Overall Study|Adverse Event|0|||
16190248|NCT00804193|39172916|FG001|Overall Study|Adverse Event|0|||
16190249|NCT00804193|39172917|FG002|Overall Study|Adverse Event|2|||
16190250|NCT00804193|39172915|FG000|Overall Study|Lack of Efficacy|1|||
16190251|NCT00804193|39172916|FG001|Overall Study|Lack of Efficacy|1|||
16190252|NCT00804193|39172917|FG002|Overall Study|Lack of Efficacy|3|||
16190253|NCT00804193|39172915|FG000|Overall Study|Protocol Violation|0|||
16190254|NCT00804193|39172916|FG001|Overall Study|Protocol Violation|8|||
16190255|NCT00804193|39172917|FG002|Overall Study|Protocol Violation|2|||
16190256|NCT00804193|39172915|FG000|Overall Study|Lost to Follow-up|3|||
16190257|NCT00804193|39172916|FG001|Overall Study|Lost to Follow-up|3|||
16190258|NCT00804193|39172917|FG002|Overall Study|Lost to Follow-up|4|||
16190259|NCT00804193|39172915|FG000|Overall Study|Withdrawal by Subject|3|||
16190260|NCT00804193|39172916|FG001|Overall Study|Withdrawal by Subject|1|||
16190261|NCT00804193|39172917|FG002|Overall Study|Withdrawal by Subject|2|||
16190262|NCT01793051|39175936|FG000|Overall Study|Withdrawal by Subject|6|||
16190263|NCT01793051|39175937|FG001|Overall Study|Withdrawal by Subject|4|||
16190264|NCT01793051|39175936|FG000|Overall Study|Adverse Event|0|||
16190265|NCT01793051|39175937|FG001|Overall Study|Adverse Event|2|||
16190266|NCT01793051|39175936|FG000|Overall Study|Too ill to continue|1|||
16190267|NCT01793051|39175937|FG001|Overall Study|Too ill to continue|0|||
16190268|NCT01793051|39175936|FG000|Overall Study|Switched chemo|1|||
16190269|NCT01793051|39175937|FG001|Overall Study|Switched chemo|1|||
16190270|NCT01793051|39175936|FG000|Overall Study|Lack of compliance|1|||
16190271|NCT01793051|39175937|FG001|Overall Study|Lack of compliance|0|||
16190272|NCT01793051|39175936|FG000|Overall Study|Requested to be removed from the study|1|||
16190273|NCT01793051|39175937|FG001|Overall Study|Requested to be removed from the study|1|||
16190274|NCT01808118|39175938|FG000|Period 1|Adverse Event|15|||
16190275|NCT01808118|39175939|FG001|Period 1|Adverse Event|0|||
16190276|NCT01808118|39175940|FG002|Period 1|Adverse Event|0|||
16190277|NCT01808118|39175938|FG000|Period 1|Withdrew consent|24|||
16190278|NCT01808118|39175939|FG001|Period 1|Withdrew consent|0|||
16190279|NCT01808118|39175940|FG002|Period 1|Withdrew consent|0|||
16190280|NCT01808118|39175938|FG000|Period 1|Lost to Follow-up|9|||
16190281|NCT01808118|39175939|FG001|Period 1|Lost to Follow-up|0|||
16190282|NCT01808118|39175940|FG002|Period 1|Lost to Follow-up|0|||
16190283|NCT01808118|39175938|FG000|Period 1|Did not meet criteria for remission|303|||
16190284|NCT01808118|39175939|FG001|Period 1|Did not meet criteria for remission|0|||
16190285|NCT01808118|39175940|FG002|Period 1|Did not meet criteria for remission|0|||
16190286|NCT01808118|39175938|FG000|Period 1|Enrolled in error|7|||
16190287|NCT01808118|39175939|FG001|Period 1|Enrolled in error|0|||
16190288|NCT01808118|39175940|FG002|Period 1|Enrolled in error|0|||
16190289|NCT01808118|39175938|FG000|Period 1|Did not meet inclusion criteria|3|||
16190290|NCT01808118|39175939|FG001|Period 1|Did not meet inclusion criteria|0|||
16190291|NCT01808118|39175940|FG002|Period 1|Did not meet inclusion criteria|0|||
16190292|NCT01808118|39175938|FG000|Period 1|Non-conformance with inclusion criteria|3|||
16190293|NCT01808118|39175939|FG001|Period 1|Non-conformance with inclusion criteria|0|||
16190294|NCT01808118|39175940|FG002|Period 1|Non-conformance with inclusion criteria|0|||
16190295|NCT01808118|39175938|FG000|Period 1|Investigator decision: site closure|2|||
16190296|NCT01808118|39175939|FG001|Period 1|Investigator decision: site closure|0|||
16488769|NCT02975336|40263454|FG001|DBPC (52 Weeks)|Adverse Event|17|||
16190297|NCT01808118|39175940|FG002|Period 1|Investigator decision: site closure|0|||
16190298|NCT01808118|39175938|FG000|Period 1|Non-compliance per sponsor|1|||
16190299|NCT01808118|39175939|FG001|Period 1|Non-compliance per sponsor|0|||
16190300|NCT01808118|39175940|FG002|Period 1|Non-compliance per sponsor|0|||
16190301|NCT01808118|39175938|FG000|Period 1|Lack of Efficacy|1|||
16190302|NCT01808118|39175939|FG001|Period 1|Lack of Efficacy|0|||
16190303|NCT01808118|39175940|FG002|Period 1|Lack of Efficacy|0|||
16190304|NCT01808118|39175938|FG000|Period 2|Adverse Event|0|||
16190305|NCT01808118|39175939|FG001|Period 2|Adverse Event|4|||
16190306|NCT01808118|39175940|FG002|Period 2|Adverse Event|0|||
16190307|NCT01808118|39175938|FG000|Period 2|Withdrew consent|0|||
16190308|NCT01808118|39175939|FG001|Period 2|Withdrew consent|7|||
16190309|NCT01808118|39175940|FG002|Period 2|Withdrew consent|6|||
16190310|NCT01808118|39175938|FG000|Period 2|Lost to Follow-up|0|||
16190311|NCT01808118|39175939|FG001|Period 2|Lost to Follow-up|0|||
16190312|NCT01808118|39175940|FG002|Period 2|Lost to Follow-up|2|||
16190313|NCT01808118|39175938|FG000|Period 2|Investigator no longer conducting trials|0|||
16190314|NCT01808118|39175939|FG001|Period 2|Investigator no longer conducting trials|1|||
16190315|NCT01808118|39175940|FG002|Period 2|Investigator no longer conducting trials|0|||
16190316|NCT01808118|39175938|FG000|Period 2|Switched to other therapy|0|||
16190317|NCT01808118|39175939|FG001|Period 2|Switched to other therapy|1|||
16190318|NCT01808118|39175940|FG002|Period 2|Switched to other therapy|0|||
16190319|NCT02488551|39175941|FG000|Overall Study|Lost to Follow-up|4|||
16190320|NCT02488551|39175942|FG001|Overall Study|Lost to Follow-up|7|||
16190321|NCT02488551|39175943|FG002|Overall Study|Lost to Follow-up|0|||
16190322|NCT02488551|39175944|FG003|Overall Study|Lost to Follow-up|0|||
16190323|NCT02488551|39175941|FG000|Overall Study|Military Deployment|1|||
16190324|NCT02488551|39175942|FG001|Overall Study|Military Deployment|1|||
16190325|NCT02488551|39175943|FG002|Overall Study|Military Deployment|0|||
16190326|NCT02488551|39175944|FG003|Overall Study|Military Deployment|0|||
16190327|NCT00506077|39175945|FG000|Treatment Period 1|Adverse Event|2|||
16190328|NCT00506077|39175946|FG001|Treatment Period 1|Adverse Event|1|||
16190329|NCT00506077|39175945|FG000|Treatment Period 1|Lost to Follow-up|0|||
16190330|NCT00506077|39175946|FG001|Treatment Period 1|Lost to Follow-up|2|||
16190331|NCT00506077|39175945|FG000|Treatment Period 1|Withdrawal by Subject|2|||
16190332|NCT00506077|39175946|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16190333|NCT00506077|39175945|FG000|Treatment Period 2|Adverse Event|0|||
16190334|NCT00506077|39175946|FG001|Treatment Period 2|Adverse Event|1|||
16190335|NCT00506077|39175945|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16190336|NCT00506077|39175946|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16190337|NCT01058369|39175950|FG000|Overall Study|Adverse Event|1|||
16190338|NCT01058369|39175950|FG000|Overall Study|Early termination study|1|||
16190339|NCT03314519|39175956|FG000|Overall Study|Protocol Violation|3|||
16190340|NCT03314519|39175957|FG001|Overall Study|Protocol Violation|2|||
16190341|NCT03176277|39175960|FG000|Part A Dose Escalation Study|Adverse Event|1|||
16190342|NCT03176277|39175961|FG001|Part A Dose Escalation Study|Adverse Event|0|||
16190343|NCT03176277|39175962|FG002|Part A Dose Escalation Study|Adverse Event|1|||
16190344|NCT03176277|39175963|FG003|Part A Dose Escalation Study|Adverse Event|0|||
16190345|NCT03176277|39175960|FG000|Part A Dose Escalation Study|Physician Decision|1|||
16190346|NCT03176277|39175961|FG001|Part A Dose Escalation Study|Physician Decision|1|||
16190347|NCT03176277|39175962|FG002|Part A Dose Escalation Study|Physician Decision|2|||
16190348|NCT03176277|39175963|FG003|Part A Dose Escalation Study|Physician Decision|0|||
16190349|NCT03176277|39175960|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
16190350|NCT03176277|39175961|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
16190351|NCT03176277|39175962|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
16190352|NCT03176277|39175963|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
16190353|NCT03176277|39175960|FG000|Part A Dose Escalation Study|Progressive disease|3|||
16190354|NCT03176277|39175961|FG001|Part A Dose Escalation Study|Progressive disease|1|||
16190355|NCT03176277|39175962|FG002|Part A Dose Escalation Study|Progressive disease|3|||
16190356|NCT03176277|39175963|FG003|Part A Dose Escalation Study|Progressive disease|0|||
16190357|NCT01153763|39175964|FG000|Overall Study|Study Closed|16|||
16190358|NCT01153763|39175964|FG000|Overall Study|Lost to Follow-up|1|||
16190359|NCT01153763|39175964|FG000|Overall Study|Physician Decision|2|||
16190360|NCT01153763|39175964|FG000|Overall Study|Withdrawal by Subject|2|||
16190361|NCT00242580|39175966|FG000|Overall Study|Adverse Event|3|||
16190362|NCT00242580|39175967|FG001|Overall Study|Adverse Event|0|||
16190363|NCT00242580|39175968|FG002|Overall Study|Adverse Event|2|||
16190364|NCT00242580|39175966|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16190365|NCT00242580|39175967|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
16190366|NCT00242580|39175968|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
16190367|NCT00242580|39175966|FG000|Overall Study|Protocol Violation|0|||
16190368|NCT00242580|39175967|FG001|Overall Study|Protocol Violation|0|||
16190369|NCT00242580|39175968|FG002|Overall Study|Protocol Violation|1|||
16190370|NCT00242580|39175966|FG000|Overall Study|Subject withdrew consent|2|||
16190371|NCT00242580|39175967|FG001|Overall Study|Subject withdrew consent|2|||
16190372|NCT00242580|39175968|FG002|Overall Study|Subject withdrew consent|5|||
16190373|NCT00242580|39175966|FG000|Overall Study|Lost to Follow-up|0|||
16190374|NCT00242580|39175967|FG001|Overall Study|Lost to Follow-up|3|||
16190375|NCT00242580|39175968|FG002|Overall Study|Lost to Follow-up|0|||
16190376|NCT00242580|39175966|FG000|Overall Study|Death|1|||
16190377|NCT00242580|39175967|FG001|Overall Study|Death|2|||
16190378|NCT00242580|39175968|FG002|Overall Study|Death|1|||
16190379|NCT00237796|39175970|FG000|Overall Study|Baseline and one other ILSS required|10|||
16190380|NCT00237796|39175971|FG001|Overall Study|Baseline and one other ILSS required|5|||
16190381|NCT03691610|39175972|FG000|Overall Study|Adverse Event|0|||
16190382|NCT03691610|39175973|FG001|Overall Study|Adverse Event|1|||
16190383|NCT03691610|39175974|FG002|Overall Study|Adverse Event|0|||
16190384|NCT03691610|39175975|FG003|Overall Study|Adverse Event|0|||
16190385|NCT03691610|39175972|FG000|Overall Study|Protocol Deviation|15|||
16190386|NCT03691610|39175973|FG001|Overall Study|Protocol Deviation|8|||
16190387|NCT03691610|39175974|FG002|Overall Study|Protocol Deviation|1|||
16190388|NCT03691610|39175975|FG003|Overall Study|Protocol Deviation|2|||
16190389|NCT03691610|39175972|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
16190390|NCT03691610|39175973|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
16190391|NCT03691610|39175974|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
16190392|NCT03691610|39175975|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
16190393|NCT03691610|39175972|FG000|Overall Study|Lost to Follow-up|20|||
16190394|NCT03691610|39175973|FG001|Overall Study|Lost to Follow-up|11|||
16190395|NCT03691610|39175974|FG002|Overall Study|Lost to Follow-up|5|||
16190396|NCT03691610|39175975|FG003|Overall Study|Lost to Follow-up|2|||
16190397|NCT02427477|39175976|FG000|Period 1|Adverse Event|1|||
16190398|NCT02427477|39175977|FG001|Period 1|Adverse Event|0|||
16190399|NCT02324842|39175978|FG000|Overall Study|Lost to Follow-up|1|||
16190400|NCT02324842|39175979|FG001|Overall Study|Lost to Follow-up|1|||
16190401|NCT02324842|39175980|FG002|Overall Study|Lost to Follow-up|2|||
16190402|NCT04285346|39175981|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
16190403|NCT04285346|39175982|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
16190404|NCT04285346|39175981|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
16190405|NCT04285346|39175982|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
16190406|NCT04285346|39175981|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
16190407|NCT04285346|39175982|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
16190408|NCT00858702|39175983|FG000|Overall Study|Lack of Efficacy|1|||
16190409|NCT00858702|39175984|FG001|Overall Study|Lack of Efficacy|0|||
16190410|NCT00858702|39175983|FG000|Overall Study|Protocol Violation|1|||
16190411|NCT00858702|39175984|FG001|Overall Study|Protocol Violation|1|||
16190412|NCT00858702|39175983|FG000|Overall Study|Other|2|||
16190413|NCT00858702|39175984|FG001|Overall Study|Other|1|||
16190414|NCT00858702|39175983|FG000|Overall Study|Withdrawal by Subject|1|||
16190415|NCT00858702|39175984|FG001|Overall Study|Withdrawal by Subject|0|||
16190416|NCT01585961|39175985|FG000|Overall Study|Death|6|||
16190417|NCT01585961|39175985|FG000|Overall Study|Physician Decision|1|||
16190418|NCT01585961|39175985|FG000|Overall Study|Decision to use non-study catheter|1|||
16190419|NCT01585961|39175985|FG000|Overall Study|Withdrawal by Subject|1|||
16190420|NCT01585961|39175985|FG000|Overall Study|Lost to Follow-up|23|||
16190421|NCT01585961|39175985|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
16190422|NCT01876732|39175986|FG000|Overall Study|MMA was not over 800mg/dL|75|||
16190423|NCT03491553|39175987|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
16190424|NCT03491553|39175988|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
16190425|NCT03491553|39175989|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
16190426|NCT03491553|39175990|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
16190427|NCT03491553|39175991|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
16190428|NCT03491553|39175992|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
16190429|NCT03491553|39175987|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
16190430|NCT03491553|39175988|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
16190431|NCT03491553|39175989|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
16190432|NCT03491553|39175990|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
16190433|NCT03491553|39175991|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
16190434|NCT03491553|39175992|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
16190435|NCT01234402|39175997|FG000|Overall Study|Lost to Follow-up|0|||
16190436|NCT01234402|39175998|FG001|Overall Study|Lost to Follow-up|1|||
16190437|NCT01234402|39175999|FG002|Overall Study|Lost to Follow-up|3|||
16190438|NCT01234402|39175997|FG000|Overall Study|Withdrawal by Subject|1|||
16190439|NCT01234402|39175998|FG001|Overall Study|Withdrawal by Subject|3|||
16190440|NCT01234402|39175999|FG002|Overall Study|Withdrawal by Subject|4|||
16190441|NCT01234402|39175997|FG000|Overall Study|Never treated: Death|0|||
16190442|NCT01234402|39175998|FG001|Overall Study|Never treated: Death|0|||
16190443|NCT01234402|39175999|FG002|Overall Study|Never treated: Death|1|||
16190444|NCT01234402|39175997|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
16190445|NCT01234402|39175998|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
16190446|NCT01234402|39175999|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
16488770|NCT02975336|40263455|FG002|DBPC (52 Weeks)|Adverse Event|13|||
16297584|NCT00642278|39574053|FG005|Overall Study|Physician Decision|0|||
16488771|NCT02975336|40263456|FG003|DBPC (52 Weeks)|Adverse Event|18|||
16488772|NCT02975336|40263457|FG004|DBPC (52 Weeks)|Adverse Event|0|||
16488773|NCT02975336|40263458|FG005|DBPC (52 Weeks)|Adverse Event|0|||
16488774|NCT02975336|40263459|FG006|DBPC (52 Weeks)|Adverse Event|0|||
16488775|NCT02975336|40263460|FG007|DBPC (52 Weeks)|Adverse Event|0|||
16488776|NCT02975336|40263453|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
16488777|NCT02975336|40263454|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
16488778|NCT02975336|40263455|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
16488779|NCT02975336|40263456|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
16488780|NCT02975336|40263457|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
16384479|NCT02536664|39892599|FG001|Overall Study|Death due to other reason|2|||
16384480|NCT02536664|39892598|FG000|Overall Study|Intolerability|8|||
16384481|NCT02536664|39892599|FG001|Overall Study|Intolerability|6|||
16384482|NCT02536664|39892598|FG000|Overall Study|Withdrawal by Subject|8|||
16384483|NCT02536664|39892599|FG001|Overall Study|Withdrawal by Subject|5|||
16384484|NCT02536664|39892598|FG000|Overall Study|Other|18|||
16384485|NCT02536664|39892599|FG001|Overall Study|Other|24|||
16384486|NCT02536664|39892598|FG000|Overall Study|Missing|53|||
16384487|NCT02536664|39892599|FG001|Overall Study|Missing|20|||
16384488|NCT00716274|39892600|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
16384489|NCT00716274|39892601|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
16488781|NCT02975336|40263458|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
16488782|NCT02975336|40263459|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
16488783|NCT02975336|40263460|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
16488784|NCT02975336|40263453|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
16488785|NCT02975336|40263454|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
16488786|NCT02975336|40263455|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
16488787|NCT02975336|40263456|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
16297585|NCT00642278|39574054|FG006|Overall Study|Physician Decision|0|||
16297586|NCT00642278|39574048|FG000|Overall Study|Protocol Violation|0|||
16297587|NCT00642278|39574049|FG001|Overall Study|Protocol Violation|0|||
16297588|NCT00642278|39574050|FG002|Overall Study|Protocol Violation|1|||
16297589|NCT00642278|39574051|FG003|Overall Study|Protocol Violation|1|||
16297590|NCT00642278|39574052|FG004|Overall Study|Protocol Violation|0|||
16297591|NCT00642278|39574053|FG005|Overall Study|Protocol Violation|1|||
16297592|NCT00642278|39574054|FG006|Overall Study|Protocol Violation|2|||
16297593|NCT00642278|39574048|FG000|Overall Study|Withdrawal by Subject|1|||
16297594|NCT00642278|39574049|FG001|Overall Study|Withdrawal by Subject|1|||
16297595|NCT00642278|39574050|FG002|Overall Study|Withdrawal by Subject|1|||
16297596|NCT00642278|39574051|FG003|Overall Study|Withdrawal by Subject|3|||
16297597|NCT00642278|39574052|FG004|Overall Study|Withdrawal by Subject|6|||
16297598|NCT00642278|39574053|FG005|Overall Study|Withdrawal by Subject|2|||
16297599|NCT00642278|39574054|FG006|Overall Study|Withdrawal by Subject|2|||
16297600|NCT00642278|39574048|FG000|Overall Study|Noncompliance with study drug regimen|0|||
16297601|NCT00642278|39574049|FG001|Overall Study|Noncompliance with study drug regimen|0|||
16297602|NCT00642278|39574050|FG002|Overall Study|Noncompliance with study drug regimen|0|||
16297603|NCT00642278|39574051|FG003|Overall Study|Noncompliance with study drug regimen|1|||
16297604|NCT00642278|39574052|FG004|Overall Study|Noncompliance with study drug regimen|0|||
16297605|NCT00642278|39574053|FG005|Overall Study|Noncompliance with study drug regimen|0|||
16297606|NCT00642278|39574054|FG006|Overall Study|Noncompliance with study drug regimen|0|||
16297607|NCT00642278|39574048|FG000|Overall Study|Other|2|||
16297608|NCT00642278|39574049|FG001|Overall Study|Other|1|||
16297609|NCT00642278|39574050|FG002|Overall Study|Other|0|||
16297610|NCT00642278|39574051|FG003|Overall Study|Other|1|||
16297611|NCT00642278|39574052|FG004|Overall Study|Other|0|||
16297612|NCT00642278|39574053|FG005|Overall Study|Other|1|||
16297613|NCT00642278|39574054|FG006|Overall Study|Other|0|||
16297614|NCT00252239|39574055|FG000|Overall Study|Withdrawal by Subject|1|||
16297615|NCT00252239|39574056|FG001|Overall Study|Withdrawal by Subject|0|||
16297616|NCT00252239|39574057|FG002|Overall Study|Withdrawal by Subject|0|||
16297617|NCT00252239|39574058|FG003|Overall Study|Withdrawal by Subject|1|||
16297618|NCT00252239|39574055|FG000|Overall Study|Lost to Follow-up|0|||
16297619|NCT00252239|39574056|FG001|Overall Study|Lost to Follow-up|0|||
16297620|NCT00252239|39574057|FG002|Overall Study|Lost to Follow-up|2|||
16297621|NCT00252239|39574058|FG003|Overall Study|Lost to Follow-up|0|||
16384490|NCT00716274|39892602|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
16488788|NCT02975336|40263457|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
16488789|NCT02975336|40263458|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
16488790|NCT02975336|40263459|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
16488791|NCT02975336|40263460|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
16488792|NCT02975336|40263453|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
16297622|NCT00977379|39574061|FG000|Overall Study|Withdrawal by Subject|1|||
16297623|NCT00977379|39574062|FG001|Overall Study|Withdrawal by Subject|1|||
16297624|NCT00977379|39574061|FG000|Overall Study|Death|7|||
16297625|NCT00977379|39574062|FG001|Overall Study|Death|9|||
16297626|NCT00977379|39574061|FG000|Overall Study|Premature Study Termination|4|||
16384491|NCT00716274|39892603|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
16297627|NCT00977379|39574062|FG001|Overall Study|Premature Study Termination|0|||
16297628|NCT00977379|39574061|FG000|Overall Study|Participant Moving House|0|||
16297629|NCT00977379|39574062|FG001|Overall Study|Participant Moving House|1|||
16297630|NCT00977379|39574061|FG000|Overall Study|Randomization Error|0|||
16297631|NCT00977379|39574062|FG001|Overall Study|Randomization Error|1|||
16297632|NCT02933255|39574067|FG000|Overall Study|Discontinued due to study closure.|1|||
16297633|NCT02933255|39574068|FG001|Overall Study|Discontinued due to study closure.|0|||
16297634|NCT04392583|39574070|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
16297635|NCT02492880|39574072|FG000|Overall Study|Lost to Follow-up|1|||
16297636|NCT02492880|39574072|FG000|Overall Study|Protocol Violation|1|||
16297637|NCT00326963|39574073|FG000|Overall Study|Adverse Event|2|||
16297638|NCT00326963|39574073|FG000|Overall Study|Injection site reaction|1|||
16297639|NCT00326963|39574073|FG000|Overall Study|Death|1|||
16297640|NCT00326963|39574073|FG000|Overall Study|Failure to return|10|||
16297641|NCT00326963|39574073|FG000|Overall Study|Withdrawal by Subject|10|||
16297642|NCT00326963|39574073|FG000|Overall Study|Refused treatment / did not cooperate|5|||
16297643|NCT00326963|39574073|FG000|Overall Study|Violation of selection criteria at entry|2|||
16297644|NCT00326963|39574073|FG000|Overall Study|Other protocol violation|1|||
16297645|NCT00326963|39574073|FG000|Overall Study|Administrative / other|1|||
16297646|NCT00469144|39574074|FG000|Overall Study|Death|0|||
16297647|NCT00469144|39574075|FG001|Overall Study|Death|1|||
16297648|NCT00469144|39574074|FG000|Overall Study|No Response|5|||
16297649|NCT00469144|39574075|FG001|Overall Study|No Response|5|||
16297650|NCT00469144|39574074|FG000|Overall Study|Progressive Disease|1|||
16297651|NCT00469144|39574075|FG001|Overall Study|Progressive Disease|0|||
16297652|NCT04729309|39574076|FG000|Period 1|Subject unable to return for Period 2|3|||
16297653|NCT04729309|39574077|FG001|Period 1|Subject unable to return for Period 2|0|||
16297654|NCT04729309|39574076|FG000|Period 1|Lost to Follow-up|1|||
16297655|NCT04729309|39574077|FG001|Period 1|Lost to Follow-up|0|||
16297656|NCT01340768|39574080|FG000|Overall Study|Lost to Follow-up|10|||
16297657|NCT01340768|39574081|FG001|Overall Study|Lost to Follow-up|4|||
16297658|NCT01340768|39574080|FG000|Overall Study|Withdrawal by Subject|5|||
16297659|NCT01340768|39574081|FG001|Overall Study|Withdrawal by Subject|1|||
16297660|NCT01340768|39574080|FG000|Overall Study|Other|2|||
16297661|NCT01340768|39574081|FG001|Overall Study|Other|0|||
16297662|NCT02006693|39574082|FG000|Overall Study|No Reason Specified|6|||
16297663|NCT02006693|39574083|FG001|Overall Study|No Reason Specified|8|||
16297664|NCT02006693|39574082|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
16297665|NCT02006693|39574083|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
16297666|NCT02006693|39574082|FG000|Overall Study|XEN Implant Explantation|0|||
16297667|NCT02006693|39574083|FG001|Overall Study|XEN Implant Explantation|1|||
16297668|NCT02006693|39574082|FG000|Overall Study|Death|2|||
16297669|NCT02006693|39574083|FG001|Overall Study|Death|2|||
16297670|NCT02006693|39574082|FG000|Overall Study|Lost to Follow-up|4|||
16297671|NCT02006693|39574083|FG001|Overall Study|Lost to Follow-up|1|||
16297672|NCT02006693|39574082|FG000|Overall Study|Patient Decision|4|||
16297673|NCT02006693|39574083|FG001|Overall Study|Patient Decision|0|||
16297674|NCT01946529|39574084|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
16297675|NCT01946529|39574085|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
16297676|NCT01946529|39574086|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
16297677|NCT01946529|39574084|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
16297678|NCT01946529|39574085|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
16297679|NCT01946529|39574086|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
16297680|NCT02132637|39574089|FG000|Study Period 1|Withdrawal by Subject|0|||
16297681|NCT02132637|39574090|FG001|Study Period 1|Withdrawal by Subject|4|||
16297682|NCT02132637|39574089|FG000|Study Period 1|Physician Decision|1|||
16297683|NCT02132637|39574090|FG001|Study Period 1|Physician Decision|0|||
16297684|NCT02132637|39574089|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
16297685|NCT02132637|39574090|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
16297686|NCT02132637|39574089|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
16297687|NCT02132637|39574090|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
16384492|NCT00716274|39892604|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
16384493|NCT00716274|39892605|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
16297688|NCT01524679|39574091|FG000|Overall Study|Lost to Follow-up|1|||
16297689|NCT01524679|39574092|FG001|Overall Study|Lost to Follow-up|4|||
16297690|NCT01524679|39574091|FG000|Overall Study|Withdrawal by Subject|4|||
16297691|NCT01524679|39574092|FG001|Overall Study|Withdrawal by Subject|4|||
16297692|NCT01524679|39574091|FG000|Overall Study|Adverse Event|9|||
16297693|NCT01524679|39574092|FG001|Overall Study|Adverse Event|0|||
16297694|NCT01524679|39574091|FG000|Overall Study|Protocol Violation|1|||
16297695|NCT01524679|39574092|FG001|Overall Study|Protocol Violation|0|||
16297696|NCT01524679|39574091|FG000|Overall Study|Lack of Efficacy|2|||
16297697|NCT01524679|39574092|FG001|Overall Study|Lack of Efficacy|0|||
16297698|NCT01524679|39574091|FG000|Overall Study|e.g.wish for children, relocation|6|||
16297699|NCT01524679|39574092|FG001|Overall Study|e.g.wish for children, relocation|1|||
16297700|NCT01755767|39574096|FG000|Overall Study|Progressive Disease|8|||
16297701|NCT01755767|39574097|FG001|Overall Study|Progressive Disease|7|||
16297702|NCT01755767|39574098|FG002|Overall Study|Progressive Disease|91|||
16297703|NCT01755767|39574099|FG003|Overall Study|Progressive Disease|43|||
16297704|NCT01755767|39574096|FG000|Overall Study|Clinical Disease Progression|4|||
16297705|NCT01755767|39574097|FG001|Overall Study|Clinical Disease Progression|2|||
16297706|NCT01755767|39574098|FG002|Overall Study|Clinical Disease Progression|29|||
16297707|NCT01755767|39574099|FG003|Overall Study|Clinical Disease Progression|20|||
16297708|NCT01755767|39574096|FG000|Overall Study|Radiographic Disease Progression|9|||
16297709|NCT01755767|39574097|FG001|Overall Study|Radiographic Disease Progression|4|||
16297710|NCT01755767|39574098|FG002|Overall Study|Radiographic Disease Progression|44|||
16297711|NCT01755767|39574099|FG003|Overall Study|Radiographic Disease Progression|27|||
16297712|NCT01755767|39574096|FG000|Overall Study|Adverse Event|6|||
16297713|NCT01755767|39574097|FG001|Overall Study|Adverse Event|0|||
16297714|NCT01755767|39574098|FG002|Overall Study|Adverse Event|28|||
16297715|NCT01755767|39574099|FG003|Overall Study|Adverse Event|11|||
16488793|NCT02975336|40263454|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
16488794|NCT02975336|40263455|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
16488795|NCT02975336|40263456|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
16488796|NCT02975336|40263457|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
16297716|NCT01755767|39574096|FG000|Overall Study|Death|1|||
16297717|NCT01755767|39574097|FG001|Overall Study|Death|2|||
16297718|NCT01755767|39574098|FG002|Overall Study|Death|15|||
16297719|NCT01755767|39574099|FG003|Overall Study|Death|4|||
16297720|NCT01755767|39574096|FG000|Overall Study|Subject Decision|0|||
16297721|NCT01755767|39574097|FG001|Overall Study|Subject Decision|0|||
16297722|NCT01755767|39574098|FG002|Overall Study|Subject Decision|10|||
16297723|NCT01755767|39574099|FG003|Overall Study|Subject Decision|3|||
16297724|NCT01755767|39574096|FG000|Overall Study|Withdrawal by Subject|0|||
16297725|NCT01755767|39574097|FG001|Overall Study|Withdrawal by Subject|0|||
16297726|NCT01755767|39574098|FG002|Overall Study|Withdrawal by Subject|2|||
16297727|NCT01755767|39574099|FG003|Overall Study|Withdrawal by Subject|1|||
16297728|NCT01755767|39574096|FG000|Overall Study|Other|0|||
16297729|NCT01755767|39574097|FG001|Overall Study|Other|0|||
16297730|NCT01755767|39574098|FG002|Overall Study|Other|2|||
16297731|NCT01755767|39574099|FG003|Overall Study|Other|3|||
16297732|NCT01755767|39574096|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
16297733|NCT01755767|39574097|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
16488797|NCT02975336|40263458|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
16488798|NCT02975336|40263459|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
16488799|NCT02975336|40263460|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
16488800|NCT02975336|40263453|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
16488801|NCT02975336|40263454|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
16488802|NCT02975336|40263455|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
16488803|NCT02975336|40263456|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
16488804|NCT02975336|40263457|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
16488805|NCT02975336|40263458|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
16488806|NCT02975336|40263459|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
16488807|NCT02975336|40263460|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
16488808|NCT02975336|40263453|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
16297734|NCT01755767|39574098|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
16297735|NCT01755767|39574099|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
16297736|NCT00369655|39574100|FG000|Overall Study|Refusal of further treatment|2|||
16297737|NCT00282919|39574103|FG000|Overall Study|Lack of Efficacy|4|||
16297738|NCT00282919|39574103|FG000|Overall Study|Withdrawal by Subject|1|||
16297739|NCT00282919|39574103|FG000|Overall Study|Asymptomatic Parasitemia|2|||
16297740|NCT04844762|39574106|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297741|NCT04844762|39574107|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297742|NCT04844762|39574108|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
16297743|NCT04844762|39574109|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297744|NCT04844762|39574110|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297745|NCT04844762|39574111|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297746|NCT04844762|39574106|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
16297747|NCT04844762|39574107|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
16297748|NCT04844762|39574108|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
16297749|NCT04844762|39574109|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
16297750|NCT04844762|39574110|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
16297751|NCT04844762|39574111|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
16384494|NCT00716274|39892600|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
16488809|NCT02975336|40263454|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
16488810|NCT02975336|40263455|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
16297752|NCT04844762|39574106|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16384495|NCT00716274|39892601|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
16384496|NCT00716274|39892602|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
16384497|NCT00716274|39892603|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
16384498|NCT00716274|39892604|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
16384499|NCT00716274|39892605|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
16384500|NCT00716274|39892600|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
16384501|NCT00716274|39892601|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
16384502|NCT00716274|39892602|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
16384503|NCT00716274|39892603|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
16384504|NCT00716274|39892604|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
16384505|NCT00716274|39892605|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
16384506|NCT00716274|39892600|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
16384507|NCT00716274|39892601|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
16384508|NCT00716274|39892602|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
16384509|NCT00716274|39892603|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
16384510|NCT00716274|39892604|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
16384511|NCT00716274|39892605|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
16384512|NCT00716274|39892600|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
16384513|NCT00716274|39892601|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
16384514|NCT00716274|39892602|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
16384515|NCT00716274|39892603|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
16384516|NCT00716274|39892604|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
16384517|NCT00716274|39892605|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
16384518|NCT00716274|39892600|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
16384519|NCT00716274|39892601|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
16384520|NCT00716274|39892602|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
16384521|NCT00716274|39892603|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
16384522|NCT00716274|39892604|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
16384523|NCT00716274|39892605|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
16384524|NCT00716274|39892600|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
16384525|NCT00716274|39892601|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
16384526|NCT00716274|39892602|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
16384527|NCT00716274|39892603|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
16384528|NCT00716274|39892604|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
16384529|NCT00716274|39892605|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
16384530|NCT00716274|39892600|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
16384531|NCT00716274|39892601|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
16384532|NCT00716274|39892602|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
16384533|NCT00716274|39892603|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
16384534|NCT00716274|39892604|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
16384535|NCT00716274|39892605|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
16384536|NCT00716274|39892600|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
16384537|NCT00716274|39892601|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
16384538|NCT00716274|39892602|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
16384539|NCT00716274|39892603|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
16384540|NCT00716274|39892604|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
16384541|NCT00716274|39892605|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
16384542|NCT00716274|39892600|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
16384543|NCT00716274|39892601|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
16384544|NCT00716274|39892602|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
16384545|NCT00716274|39892603|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
16384546|NCT00716274|39892604|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
16384547|NCT00716274|39892605|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
16384548|NCT03038620|39892606|FG000|Overall Study|Lost to Follow-up|18|||
16384549|NCT03038620|39892607|FG001|Overall Study|Lost to Follow-up|23|||
16384550|NCT03038620|39892606|FG000|Overall Study|Withdrawal by Subject|0|||
16384551|NCT03038620|39892607|FG001|Overall Study|Withdrawal by Subject|15|||
16384552|NCT03038620|39892606|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
16384553|NCT03038620|39892607|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
16384554|NCT01276704|39892608|FG000|Overall Study|Lost to Follow-up|2|||
16384555|NCT01276704|39892609|FG001|Overall Study|Lost to Follow-up|3|||
16384556|NCT01276704|39892608|FG000|Overall Study|Non-compliant|2|||
16297753|NCT04844762|39574107|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16297754|NCT04844762|39574108|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
16297755|NCT04844762|39574109|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
16297756|NCT04844762|39574110|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16297757|NCT04844762|39574111|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
16297758|NCT04844762|39574106|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297759|NCT04844762|39574107|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297760|NCT04844762|39574108|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
16297761|NCT04844762|39574109|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
16297762|NCT04844762|39574110|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
16297763|NCT04844762|39574111|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297764|NCT04844762|39574106|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
16297765|NCT04844762|39574107|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
16297766|NCT04844762|39574108|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
16297767|NCT04844762|39574109|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
16297768|NCT04844762|39574110|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
16297769|NCT04844762|39574111|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
16297770|NCT04844762|39574106|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
16297771|NCT04844762|39574107|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16297772|NCT04844762|39574108|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16297773|NCT04844762|39574109|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16297774|NCT04844762|39574110|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16297775|NCT04844762|39574111|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16297776|NCT04844762|39574106|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297777|NCT04844762|39574107|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297778|NCT04844762|39574108|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297779|NCT04844762|39574109|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297780|NCT04844762|39574110|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
16297781|NCT04844762|39574111|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
16297782|NCT04844762|39574106|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
16297783|NCT04844762|39574107|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
16297784|NCT04844762|39574108|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
16297785|NCT04844762|39574109|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
16297786|NCT04844762|39574110|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
16488811|NCT02975336|40263456|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
16488812|NCT02975336|40263457|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
16488813|NCT02975336|40263458|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
16488814|NCT02975336|40263459|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
16488815|NCT02975336|40263460|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
16488816|NCT02975336|40263453|FG000|LTE (104 Weeks)|Adverse Event|0|||
16488817|NCT02975336|40263454|FG001|LTE (104 Weeks)|Adverse Event|0|||
16488818|NCT02975336|40263455|FG002|LTE (104 Weeks)|Adverse Event|0|||
16488819|NCT02975336|40263456|FG003|LTE (104 Weeks)|Adverse Event|0|||
16488820|NCT02975336|40263457|FG004|LTE (104 Weeks)|Adverse Event|7|||
16488821|NCT02975336|40263458|FG005|LTE (104 Weeks)|Adverse Event|4|||
16488822|NCT02975336|40263459|FG006|LTE (104 Weeks)|Adverse Event|2|||
16384557|NCT01276704|39892609|FG001|Overall Study|Non-compliant|2|||
16384558|NCT01276704|39892608|FG000|Overall Study|Withdrawal by Subject|7|||
16384559|NCT01276704|39892609|FG001|Overall Study|Withdrawal by Subject|1|||
16384560|NCT01276704|39892608|FG000|Overall Study|Physician Decision|3|||
16384561|NCT01276704|39892609|FG001|Overall Study|Physician Decision|5|||
16384562|NCT00506142|39892612|FG000|Overall Study|Adverse Event|8|||
16488823|NCT02975336|40263460|FG007|LTE (104 Weeks)|Adverse Event|0|||
16488824|NCT02975336|40263453|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
16488825|NCT02975336|40263454|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
16297787|NCT04844762|39574111|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
16297788|NCT04844762|39574106|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
16297789|NCT04844762|39574107|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16297790|NCT04844762|39574108|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16297791|NCT04844762|39574109|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16297792|NCT04844762|39574110|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
16384563|NCT00506142|39892613|FG001|Overall Study|Adverse Event|7|||
16384564|NCT00506142|39892612|FG000|Overall Study|Lack of Efficacy|21|||
16488826|NCT02975336|40263455|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
16488827|NCT02975336|40263456|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
16488828|NCT02975336|40263457|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
16297793|NCT04844762|39574111|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
16297794|NCT04844762|39574106|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
16297795|NCT04844762|39574107|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
16297796|NCT04844762|39574108|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
16297797|NCT04844762|39574109|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
16297798|NCT04844762|39574110|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
16297799|NCT04844762|39574111|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
16297800|NCT04844762|39574106|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
16297801|NCT04844762|39574107|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
16297802|NCT04844762|39574108|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
16297803|NCT04844762|39574109|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
16297804|NCT04844762|39574110|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
16297805|NCT04844762|39574111|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
16297806|NCT01682863|39574115|FG000|Overall Study|Subject/guardian decision|19|||
16488829|NCT02975336|40263458|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
16488830|NCT02975336|40263459|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
16488831|NCT02975336|40263460|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
16488832|NCT02975336|40263453|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
16297807|NCT01682863|39574116|FG001|Overall Study|Subject/guardian decision|12|||
16297808|NCT01682863|39574117|FG002|Overall Study|Subject/guardian decision|10|||
16297809|NCT01682863|39574115|FG000|Overall Study|Lost to Follow-up|5|||
16297810|NCT01682863|39574116|FG001|Overall Study|Lost to Follow-up|1|||
16297811|NCT01682863|39574117|FG002|Overall Study|Lost to Follow-up|6|||
16488833|NCT02975336|40263454|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
16488834|NCT02975336|40263455|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
16488835|NCT02975336|40263456|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
16488836|NCT02975336|40263457|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
16488837|NCT02975336|40263458|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
16488838|NCT02975336|40263459|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
16488839|NCT02975336|40263460|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
16488840|NCT02975336|40263453|FG000|LTE (104 Weeks)|Other|0|||
16488841|NCT02975336|40263454|FG001|LTE (104 Weeks)|Other|0|||
16488842|NCT02975336|40263455|FG002|LTE (104 Weeks)|Other|0|||
16488843|NCT02975336|40263456|FG003|LTE (104 Weeks)|Other|0|||
16488844|NCT02975336|40263457|FG004|LTE (104 Weeks)|Other|55|||
16488845|NCT02975336|40263458|FG005|LTE (104 Weeks)|Other|63|||
16488846|NCT02975336|40263459|FG006|LTE (104 Weeks)|Other|76|||
16488847|NCT02975336|40263460|FG007|LTE (104 Weeks)|Other|72|||
16297812|NCT01682863|39574115|FG000|Overall Study|Death|1|||
16488848|NCT02859454|40263461|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
16488849|NCT01402492|40263464|FG000|Overall Study|Withdrawal by Subject|17|||
16488850|NCT01402492|40263465|FG001|Overall Study|Withdrawal by Subject|11|||
16488851|NCT01402492|40263466|FG002|Overall Study|Withdrawal by Subject|11|||
16488852|NCT01402492|40263464|FG000|Overall Study|Adverse Event|2|||
16488853|NCT01402492|40263465|FG001|Overall Study|Adverse Event|3|||
16488854|NCT01402492|40263466|FG002|Overall Study|Adverse Event|4|||
16488855|NCT01402492|40263464|FG000|Overall Study|Physician Decision|0|||
16488856|NCT01402492|40263465|FG001|Overall Study|Physician Decision|3|||
16488857|NCT01402492|40263466|FG002|Overall Study|Physician Decision|0|||
16488858|NCT01402492|40263464|FG000|Overall Study|Incarcerated (N=3)|2|||
16488859|NCT01402492|40263465|FG001|Overall Study|Incarcerated (N=3)|0|||
16488860|NCT01402492|40263466|FG002|Overall Study|Incarcerated (N=3)|1|||
16488861|NCT00612040|40263467|FG000|Overall Study|Adverse Event|0|||
16488862|NCT00612040|40263468|FG001|Overall Study|Adverse Event|2|||
16488863|NCT00612040|40263469|FG002|Overall Study|Adverse Event|1|||
16488864|NCT00612040|40263467|FG000|Overall Study|Protocol Violation|1|||
16488865|NCT00612040|40263468|FG001|Overall Study|Protocol Violation|2|||
16488866|NCT00612040|40263469|FG002|Overall Study|Protocol Violation|1|||
16488867|NCT00612040|40263467|FG000|Overall Study|Lack of Efficacy|2|||
16488868|NCT00612040|40263468|FG001|Overall Study|Lack of Efficacy|1|||
16488869|NCT00612040|40263469|FG002|Overall Study|Lack of Efficacy|0|||
16488870|NCT00612040|40263467|FG000|Overall Study|Unclassified|2|||
16488871|NCT00612040|40263468|FG001|Overall Study|Unclassified|2|||
16488872|NCT00612040|40263469|FG002|Overall Study|Unclassified|5|||
16488873|NCT01325584|40263470|FG000|Overall Study|Death|1|||
16488874|NCT02587234|40263471|FG000|Overall Study|Withdrawal by Subject|1|||
16488875|NCT02587234|40263472|FG001|Overall Study|Withdrawal by Subject|1|||
16488876|NCT02587234|40263471|FG000|Overall Study|Lost to Follow-up|0|||
16488877|NCT02587234|40263472|FG001|Overall Study|Lost to Follow-up|2|||
16488878|NCT01619423|40263473|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
16488879|NCT01619423|40263474|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
16488880|NCT01619423|40263475|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
16488881|NCT01619423|40263476|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
16488882|NCT00506662|40263477|FG000|Overall Study|Adverse Event|0|||
16297813|NCT01682863|39574116|FG001|Overall Study|Death|3|||
16488883|NCT00506662|40263478|FG001|Overall Study|Adverse Event|2|||
16488884|NCT00506662|40263477|FG000|Overall Study|Lack of Efficacy|1|||
16488885|NCT00506662|40263478|FG001|Overall Study|Lack of Efficacy|0|||
16488886|NCT00506662|40263477|FG000|Overall Study|Protocol Violation|2|||
16488887|NCT00506662|40263478|FG001|Overall Study|Protocol Violation|4|||
16488888|NCT00506662|40263477|FG000|Overall Study|Trial terminated|10|||
16488889|NCT00506662|40263478|FG001|Overall Study|Trial terminated|16|||
16488890|NCT00506662|40263477|FG000|Overall Study|Not recorded|4|||
16488891|NCT00506662|40263478|FG001|Overall Study|Not recorded|6|||
16488892|NCT00471328|40263479|FG000|Core Phase|Adverse Event|18|||
16488893|NCT00471328|40263480|FG001|Core Phase|Adverse Event|6|||
16488894|NCT00471328|40263479|FG000|Core Phase|Death|8|||
16488895|NCT00471328|40263480|FG001|Core Phase|Death|4|||
16488896|NCT00471328|40263479|FG000|Core Phase|Withdrawal by Subject|2|||
16488897|NCT00471328|40263480|FG001|Core Phase|Withdrawal by Subject|2|||
16488898|NCT00471328|40263479|FG000|Core Phase|Abnormal laboratory value|1|||
16488899|NCT00471328|40263480|FG001|Core Phase|Abnormal laboratory value|0|||
16297814|NCT01682863|39574117|FG002|Overall Study|Death|4|||
16297815|NCT01682863|39574115|FG000|Overall Study|Protocol deviation|1|||
16297816|NCT01682863|39574116|FG001|Overall Study|Protocol deviation|0|||
16297817|NCT01682863|39574117|FG002|Overall Study|Protocol deviation|1|||
16297818|NCT01682863|39574115|FG000|Overall Study|Technical problems|1|||
16297819|NCT01682863|39574116|FG001|Overall Study|Technical problems|0|||
16297820|NCT01682863|39574117|FG002|Overall Study|Technical problems|0|||
16297821|NCT01682863|39574115|FG000|Overall Study|Adverse Event|0|||
16297822|NCT01682863|39574116|FG001|Overall Study|Adverse Event|1|||
16488900|NCT00471328|40263479|FG000|Core Phase|Disease Progression|78|||
16488901|NCT00471328|40263480|FG001|Core Phase|Disease Progression|53|||
16488902|NCT00471328|40263479|FG000|Core Phase|Administrative Problem|0|||
16488903|NCT00471328|40263480|FG001|Core Phase|Administrative Problem|1|||
16488904|NCT00471328|40263479|FG000|Core Phase|Protocol Deviation|0|||
16488905|NCT00471328|40263480|FG001|Core Phase|Protocol Deviation|1|||
16488906|NCT00471328|40263479|FG000|Extension Phase|Adverse Event|3|||
16488907|NCT00471328|40263480|FG001|Extension Phase|Adverse Event|12|||
16488908|NCT00471328|40263479|FG000|Extension Phase|Withdrawal by Subject|0|||
16488909|NCT00471328|40263480|FG001|Extension Phase|Withdrawal by Subject|2|||
16488910|NCT00471328|40263479|FG000|Extension Phase|Death|1|||
16297823|NCT01682863|39574117|FG002|Overall Study|Adverse Event|2|||
16488911|NCT00471328|40263480|FG001|Extension Phase|Death|7|||
16488912|NCT00471328|40263479|FG000|Extension Phase|Protocol Deviation|3|||
16488913|NCT00471328|40263480|FG001|Extension Phase|Protocol Deviation|1|||
16488914|NCT00471328|40263479|FG000|Extension Phase|Treatment duration as per protocol|0|||
16297824|NCT01682863|39574115|FG000|Overall Study|Physician Decision|0|||
16297825|NCT01682863|39574116|FG001|Overall Study|Physician Decision|0|||
16297826|NCT01682863|39574117|FG002|Overall Study|Physician Decision|1|||
16297827|NCT00678886|39574118|FG000|Overall Study|Withdrawal by Subject|0|||
16297828|NCT00678886|39574119|FG001|Overall Study|Withdrawal by Subject|0|||
16297829|NCT00678886|39574120|FG002|Overall Study|Withdrawal by Subject|4|||
16297830|NCT00678886|39574121|FG003|Overall Study|Withdrawal by Subject|6|||
16297831|NCT00678886|39574118|FG000|Overall Study|Physician Decision|0|||
16297832|NCT00678886|39574119|FG001|Overall Study|Physician Decision|0|||
16297833|NCT00678886|39574120|FG002|Overall Study|Physician Decision|1|||
16297834|NCT00678886|39574121|FG003|Overall Study|Physician Decision|1|||
16297835|NCT00678886|39574118|FG000|Overall Study|Lost to Follow-up|0|||
16297836|NCT00678886|39574119|FG001|Overall Study|Lost to Follow-up|0|||
16297837|NCT00678886|39574120|FG002|Overall Study|Lost to Follow-up|3|||
16297838|NCT00678886|39574121|FG003|Overall Study|Lost to Follow-up|2|||
16297839|NCT00678886|39574118|FG000|Overall Study|Other|0|||
16297840|NCT00678886|39574119|FG001|Overall Study|Other|0|||
16297841|NCT00678886|39574120|FG002|Overall Study|Other|1|||
16297842|NCT00678886|39574121|FG003|Overall Study|Other|0|||
16297843|NCT02836496|39574122|FG000|Overall Study|Adverse Event|2|||
16297844|NCT02836496|39574123|FG001|Overall Study|Adverse Event|1|||
16297845|NCT02836496|39574122|FG000|Overall Study|Withdrawal by Subject|0|||
16297846|NCT02836496|39574123|FG001|Overall Study|Withdrawal by Subject|1|||
16297847|NCT01136967|39574124|FG000|Overall Study|Adverse Event|9|||
16297848|NCT01136967|39574125|FG001|Overall Study|Adverse Event|12|||
16297849|NCT01136967|39574124|FG000|Overall Study|Participant Choice|8|||
16488915|NCT00471328|40263480|FG001|Extension Phase|Treatment duration as per protocol|1|||
16488916|NCT00471328|40263479|FG000|Extension Phase|Disease Progression|32|||
16297850|NCT01136967|39574125|FG001|Overall Study|Participant Choice|3|||
16297851|NCT01136967|39574124|FG000|Overall Study|Lost to Follow-up|0|||
16297852|NCT01136967|39574125|FG001|Overall Study|Lost to Follow-up|1|||
16488917|NCT00471328|40263480|FG001|Extension Phase|Disease Progression|44|||
16488918|NCT00471328|40263479|FG000|Extension Phase|New cancer Therapy|1|||
16297853|NCT01136967|39574124|FG000|Overall Study|Withdrawal by Subject|1|||
16297854|NCT01136967|39574125|FG001|Overall Study|Withdrawal by Subject|2|||
16297855|NCT01136967|39574124|FG000|Overall Study|Clinical Progression|3|||
16297856|NCT01136967|39574125|FG001|Overall Study|Clinical Progression|5|||
16297857|NCT01136967|39574124|FG000|Overall Study|Radiation|1|||
16297858|NCT01136967|39574125|FG001|Overall Study|Radiation|0|||
16297859|NCT01136967|39574124|FG000|Overall Study|Non-compliance|1|||
16297860|NCT01136967|39574125|FG001|Overall Study|Non-compliance|0|||
16297861|NCT01136967|39574124|FG000|Overall Study|Investigator's Choice|1|||
16297862|NCT01136967|39574125|FG001|Overall Study|Investigator's Choice|1|||
16297863|NCT01136967|39574124|FG000|Overall Study|Increase in Lesion Size|0|||
16297864|NCT01136967|39574125|FG001|Overall Study|Increase in Lesion Size|2|||
16297865|NCT01136967|39574124|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
16297866|NCT01136967|39574125|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
16297867|NCT01735955|39574135|FG000|Overall Study|Administrative problems|1|||
16297868|NCT01735955|39574135|FG000|Overall Study|Patient/guardian decision|1|||
16297869|NCT01735955|39574135|FG000|Overall Study|Patient withdrew consent|2|||
16297870|NCT01735955|39574135|FG000|Overall Study|Physician Decision|4|||
16297871|NCT01735955|39574135|FG000|Overall Study|Disease progression|24|||
16297872|NCT01735955|39574135|FG000|Overall Study|Adverse Event|5|||
16297873|NCT02952898|39574136|FG000|Overall Study|Withdrawal by Subject|10|||
16297874|NCT02952898|39574137|FG001|Overall Study|Withdrawal by Subject|8|||
16297875|NCT02952898|39574138|FG002|Overall Study|Withdrawal by Subject|8|||
16297876|NCT02952898|39574136|FG000|Overall Study|Adverse Event|8|||
16297877|NCT02952898|39574137|FG001|Overall Study|Adverse Event|8|||
16297878|NCT02952898|39574138|FG002|Overall Study|Adverse Event|3|||
16297879|NCT02952898|39574136|FG000|Overall Study|Lost to Follow-up|3|||
16297880|NCT02952898|39574137|FG001|Overall Study|Lost to Follow-up|2|||
16297881|NCT02952898|39574138|FG002|Overall Study|Lost to Follow-up|2|||
16297882|NCT02952898|39574136|FG000|Overall Study|Non-compliance with study drug|1|||
16297883|NCT02952898|39574137|FG001|Overall Study|Non-compliance with study drug|1|||
16297884|NCT02952898|39574138|FG002|Overall Study|Non-compliance with study drug|2|||
16488919|NCT00471328|40263480|FG001|Extension Phase|New cancer Therapy|0|||
16488920|NCT00471328|40263479|FG000|Extension Phase|Administrative Problem|1|||
16488921|NCT00471328|40263480|FG001|Extension Phase|Administrative Problem|0|||
16488922|NCT00165776|40266795|FG000|Overall Study|Lack of Efficacy|0|||
16488923|NCT00165776|40266796|FG001|Overall Study|Lack of Efficacy|0|||
16488924|NCT00165776|40266797|FG002|Overall Study|Lack of Efficacy|0|||
16083408|NCT03394885|38799041|FG000|Overall Study|Adverse Event|4|||
16083409|NCT03394885|38799041|FG000|Overall Study|Lack of Efficacy|1|||
16083410|NCT03394885|38799041|FG000|Overall Study|Physician Decision|1|||
16083411|NCT03394885|38799041|FG000|Overall Study|Withdrawal by Subject|8|||
16083412|NCT03394885|38799041|FG000|Overall Study|Alternative Therapy|1|||
16297885|NCT03052959|39574139|FG000|Overall Study|Lost to Follow-up|4|||
16297886|NCT03052959|39574140|FG001|Overall Study|Lost to Follow-up|5|||
16297887|NCT03052127|39574146|FG000|Overall Study|Withdrawal by Subject|0|||
16488925|NCT00165776|40266798|FG003|Overall Study|Lack of Efficacy|1|||
16488926|NCT00165776|40266795|FG000|Overall Study|Withdrawal by Subject|4|||
16488927|NCT00165776|40266796|FG001|Overall Study|Withdrawal by Subject|1|||
16488928|NCT00165776|40266797|FG002|Overall Study|Withdrawal by Subject|2|||
16488929|NCT00165776|40266798|FG003|Overall Study|Withdrawal by Subject|0|||
16488930|NCT00165776|40266795|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
16488931|NCT00165776|40266796|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
16488932|NCT00165776|40266797|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
16488933|NCT00165776|40266798|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
16488934|NCT01605877|40266799|FG000|Overall Study|Withdrawal by Subject|1|||
16488935|NCT01010061|40266800|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
16488936|NCT01010061|40266801|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
16488937|NCT01010061|40266800|FG000|Overall Study|Disease Progression|2|||
16488938|NCT01010061|40266801|FG001|Overall Study|Disease Progression|8|||
16488939|NCT01010061|40266800|FG000|Overall Study|Withdrew Consent|5|||
16488940|NCT01010061|40266801|FG001|Overall Study|Withdrew Consent|1|||
16488941|NCT01010061|40266800|FG000|Overall Study|Death|3|||
16488942|NCT01010061|40266801|FG001|Overall Study|Death|6|||
16488943|NCT01010061|40266800|FG000|Overall Study|Administrative/Other|0|||
16488944|NCT01010061|40266801|FG001|Overall Study|Administrative/Other|1|||
16488945|NCT01010061|40266800|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
16488946|NCT01010061|40266801|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
16083413|NCT02111096|38799042|FG000|Overall Study|Adverse Event|4|||
16297888|NCT03052127|39574147|FG001|Overall Study|Withdrawal by Subject|0|||
16297889|NCT03052127|39574148|FG002|Overall Study|Withdrawal by Subject|0|||
16297890|NCT03052127|39574149|FG003|Overall Study|Withdrawal by Subject|0|||
16297891|NCT03052127|39574150|FG004|Overall Study|Withdrawal by Subject|0|||
16488947|NCT01010061|40266800|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16488948|NCT01010061|40266801|FG001|Overall Study|Insufficient Therapeutic Response|5|||
16488949|NCT01010061|40266800|FG000|Overall Study|Violation of Selection Criteria|0|||
16488950|NCT01010061|40266801|FG001|Overall Study|Violation of Selection Criteria|1|||
16488951|NCT01010061|40266800|FG000|Overall Study|Did Not Receive Treatment|2|||
16488952|NCT01010061|40266801|FG001|Overall Study|Did Not Receive Treatment|2|||
16488953|NCT03334903|40266805|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
16488954|NCT03334903|40266806|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
16488955|NCT03334903|40266805|FG000|Overall Study|Protocol Violation|1|||
16488956|NCT03334903|40266806|FG001|Overall Study|Protocol Violation|3|||
16083414|NCT02111096|38799043|FG001|Overall Study|Adverse Event|1|||
16083415|NCT02111096|38799044|FG002|Overall Study|Adverse Event|2|||
16488957|NCT03334903|40266805|FG000|Overall Study|Surgery postponed|1|||
16488958|NCT03334903|40266806|FG001|Overall Study|Surgery postponed|0|||
16488959|NCT03334903|40266805|FG000|Overall Study|Adverse Event|1|||
16488960|NCT03334903|40266806|FG001|Overall Study|Adverse Event|1|||
16488961|NCT03334903|40266805|FG000|Overall Study|Withdrawal by Subject|0|||
16488962|NCT03334903|40266806|FG001|Overall Study|Withdrawal by Subject|1|||
16488963|NCT02216591|40266807|FG000|Overall Study|Lost to Follow-up|0|||
16488964|NCT02216591|40266808|FG001|Overall Study|Lost to Follow-up|1|||
16488965|NCT02864498|40266809|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
16488966|NCT02864498|40266810|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
16488967|NCT02864498|40266811|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
16488968|NCT02864498|40266809|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
16384565|NCT00506142|39892613|FG001|Overall Study|Lack of Efficacy|7|||
16384566|NCT00506142|39892612|FG000|Overall Study|Withdrawal by Subject|4|||
16384567|NCT00506142|39892613|FG001|Overall Study|Withdrawal by Subject|5|||
16384568|NCT00506142|39892612|FG000|Overall Study|Physician Decision|1|||
16384569|NCT00506142|39892613|FG001|Overall Study|Physician Decision|0|||
16384570|NCT00506142|39892612|FG000|Overall Study|New health condition|1|||
16384571|NCT00506142|39892613|FG001|Overall Study|New health condition|0|||
16384572|NCT01593917|39892615|FG000|Overall Study|Death|67|||
16384573|NCT01593917|39892615|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
16384574|NCT01593917|39892615|FG000|Overall Study|Withdrawal by Subject|23|||
16384575|NCT01593917|39892615|FG000|Overall Study|Lost to Follow-up|12|||
16384576|NCT01593917|39892615|FG000|Overall Study|Protocol Violation|5|||
16384577|NCT01593917|39892615|FG000|Overall Study|Physician Decision|3|||
16384578|NCT00402987|39892616|FG000|Overall Study|Lack of Efficacy|0|||
16384579|NCT00402987|39892617|FG001|Overall Study|Lack of Efficacy|0|||
16384580|NCT00402987|39892618|FG002|Overall Study|Lack of Efficacy|1|||
16384581|NCT00402987|39892619|FG003|Overall Study|Lack of Efficacy|0|||
16384582|NCT01061385|39892623|FG000|Overall Study|Lost to Follow-up|1|||
16384583|NCT01061385|39892624|FG001|Overall Study|Lost to Follow-up|0|||
16488969|NCT02864498|40266810|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
16488970|NCT02864498|40266811|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
16488971|NCT02864498|40266809|FG000|Overall Study|Investigator Discretion|0|||
16488972|NCT02864498|40266810|FG001|Overall Study|Investigator Discretion|2|||
16488973|NCT02864498|40266811|FG002|Overall Study|Investigator Discretion|1|||
16488974|NCT02864498|40266809|FG000|Overall Study|Lost to Follow-up|8|||
16488975|NCT02864498|40266810|FG001|Overall Study|Lost to Follow-up|6|||
16488976|NCT02864498|40266811|FG002|Overall Study|Lost to Follow-up|3|||
16488977|NCT02864498|40266809|FG000|Overall Study|Lack of Efficacy|5|||
16083416|NCT02111096|38799042|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16083417|NCT02111096|38799043|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16083418|NCT02111096|38799044|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16083419|NCT02111096|38799042|FG000|Overall Study|Lost to Follow Up|1|||
16083420|NCT02111096|38799043|FG001|Overall Study|Lost to Follow Up|1|||
16083421|NCT02111096|38799044|FG002|Overall Study|Lost to Follow Up|1|||
16083422|NCT02111096|38799042|FG000|Overall Study|Physician Decision|0|||
16083423|NCT02111096|38799043|FG001|Overall Study|Physician Decision|1|||
16083424|NCT02111096|38799044|FG002|Overall Study|Physician Decision|0|||
16083425|NCT02111096|38799042|FG000|Overall Study|Protocol Violation|1|||
16083426|NCT02111096|38799043|FG001|Overall Study|Protocol Violation|0|||
16083427|NCT02111096|38799044|FG002|Overall Study|Protocol Violation|1|||
16083428|NCT02111096|38799042|FG000|Overall Study|Terminated by Sponsor|53|||
16083429|NCT02111096|38799043|FG001|Overall Study|Terminated by Sponsor|35|||
16083430|NCT02111096|38799044|FG002|Overall Study|Terminated by Sponsor|54|||
16083431|NCT02111096|38799042|FG000|Overall Study|Withdrawal by Subject|4|||
16083432|NCT02111096|38799043|FG001|Overall Study|Withdrawal by Subject|2|||
16083433|NCT02111096|38799044|FG002|Overall Study|Withdrawal by Subject|8|||
16384584|NCT01061385|39892623|FG000|Overall Study|subject decision not related to AE|0|||
16384585|NCT01061385|39892624|FG001|Overall Study|subject decision not related to AE|1|||
16083434|NCT04048681|38799047|FG000|Overall Study|family emergency|0|||
16083435|NCT04048681|38799048|FG001|Overall Study|family emergency|0|||
16083436|NCT04048681|38799049|FG002|Overall Study|family emergency|0|||
16083437|NCT04048681|38799050|FG003|Overall Study|family emergency|1|||
16384586|NCT01823289|39892625|FG000|Overall Study|Lost to Follow-up|5|||
16384587|NCT01823289|39892625|FG000|Overall Study|Adverse Event|5|||
16384588|NCT01823289|39892625|FG000|Overall Study|Lack of Efficacy|1|||
16488978|NCT02864498|40266810|FG001|Overall Study|Lack of Efficacy|3|||
16488979|NCT02864498|40266811|FG002|Overall Study|Lack of Efficacy|3|||
16488980|NCT02864498|40266809|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
16488981|NCT02864498|40266810|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
16488982|NCT02864498|40266811|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
16488983|NCT02864498|40266809|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
16488984|NCT02864498|40266810|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
16488985|NCT02864498|40266811|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
16488986|NCT02864498|40266809|FG000|Overall Study|Subject moved out of the country.|0|||
16488987|NCT02864498|40266810|FG001|Overall Study|Subject moved out of the country.|0|||
16488988|NCT02864498|40266811|FG002|Overall Study|Subject moved out of the country.|1|||
16488989|NCT05228132|40266812|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
16488990|NCT05228132|40266812|FG000|Overall Study|Adverse Event|3|||
16488991|NCT05228132|40266812|FG000|Overall Study|Lost to Follow-up|1|||
16488992|NCT05228132|40266812|FG000|Overall Study|Arteriovenous-fistula mature|1|||
16488993|NCT01063868|40266817|FG000|Overall Study|Adverse Event|9|||
16488994|NCT01063868|40266818|FG001|Overall Study|Adverse Event|7|||
16488995|NCT01063868|40266817|FG000|Overall Study|Withdrawal by Subject|3|||
16488996|NCT01063868|40266818|FG001|Overall Study|Withdrawal by Subject|1|||
16488997|NCT01063868|40266817|FG000|Overall Study|Study Terminated By Sponsor|23|||
16488998|NCT01063868|40266818|FG001|Overall Study|Study Terminated By Sponsor|4|||
16488999|NCT02837783|40266819|FG000|Overall Study|Adverse Event|1|||
16489000|NCT02837783|40266820|FG001|Overall Study|Adverse Event|0|||
16489001|NCT02837783|40266819|FG000|Overall Study|Other, Not Specified|1|||
16489002|NCT02837783|40266820|FG001|Overall Study|Other, Not Specified|2|||
16489003|NCT00381485|40266823|FG000|Open-Label Run-In Period|Adverse Event|9|||
16489004|NCT00381485|40266824|FG001|Open-Label Run-In Period|Adverse Event|0|||
16489005|NCT00381485|40266825|FG002|Open-Label Run-In Period|Adverse Event|0|||
16489006|NCT00381485|40266826|FG003|Open-Label Run-In Period|Adverse Event|0|||
16489007|NCT00381485|40266823|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
16384589|NCT01823289|39892625|FG000|Overall Study|Physician Decision|9|||
16384590|NCT01823289|39892625|FG000|Overall Study|Administered contraindicated medicine|1|||
16384591|NCT01823289|39892625|FG000|Overall Study|Transaminase increased more than 3 times|1|||
16384592|NCT01823289|39892625|FG000|Overall Study|Drug affected efficacy and safety|1|||
16083438|NCT04048681|38799051|FG004|Overall Study|family emergency|0|||
16083439|NCT00090519|38799052|FG000|Overall Study|Adverse Event|5|||
16489008|NCT00381485|40266824|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
16489009|NCT00381485|40266825|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
16489010|NCT00381485|40266826|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
16489011|NCT00381485|40266823|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
16489012|NCT00381485|40266824|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
16489013|NCT00381485|40266825|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
16489014|NCT00381485|40266826|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
16489015|NCT00381485|40266823|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
16489016|NCT00381485|40266824|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
16489017|NCT00381485|40266825|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
16489018|NCT00381485|40266826|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
16489019|NCT00381485|40266823|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
16489020|NCT00381485|40266824|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
16489021|NCT00381485|40266825|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
16489022|NCT00381485|40266826|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
16489023|NCT00381485|40266823|FG000|Open-Label Run-In Period|Treatment failure|1|||
16489024|NCT00381485|40266824|FG001|Open-Label Run-In Period|Treatment failure|0|||
16489025|NCT00381485|40266825|FG002|Open-Label Run-In Period|Treatment failure|0|||
16489026|NCT00381485|40266826|FG003|Open-Label Run-In Period|Treatment failure|0|||
16489027|NCT00381485|40266823|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16489028|NCT00381485|40266824|FG001|Double-Blind Treatment Period|Adverse Event|2|||
16489029|NCT00381485|40266825|FG002|Double-Blind Treatment Period|Adverse Event|2|||
16489030|NCT00381485|40266826|FG003|Double-Blind Treatment Period|Adverse Event|5|||
16489031|NCT00381485|40266823|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
16083440|NCT00090519|38799053|FG001|Overall Study|Adverse Event|4|||
16083441|NCT00090519|38799052|FG000|Overall Study|Death|9|||
16083442|NCT00090519|38799053|FG001|Overall Study|Death|9|||
16083443|NCT00090519|38799052|FG000|Overall Study|Lost to Follow-up|26|||
16083444|NCT00090519|38799053|FG001|Overall Study|Lost to Follow-up|29|||
16083445|NCT00090519|38799052|FG000|Overall Study|Withdrawal by Subject|28|||
16489032|NCT00381485|40266824|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
16489033|NCT00381485|40266825|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
16489034|NCT00381485|40266826|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
16489035|NCT00381485|40266823|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16489036|NCT00381485|40266824|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
16489037|NCT00381485|40266825|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
16489038|NCT00381485|40266826|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
16489039|NCT00381485|40266823|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
16489040|NCT00381485|40266824|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
16489041|NCT00381485|40266825|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
16489042|NCT00381485|40266826|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
16489043|NCT00381485|40266823|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
16489044|NCT00381485|40266824|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
16489045|NCT00381485|40266825|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
16489046|NCT00381485|40266826|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
16083446|NCT00090519|38799053|FG001|Overall Study|Withdrawal by Subject|29|||
16083447|NCT00090519|38799052|FG000|Overall Study|Physician Decision|2|||
16083448|NCT00090519|38799053|FG001|Overall Study|Physician Decision|3|||
16083449|NCT00090519|38799052|FG000|Overall Study|Sponsor Decision|3|||
16083450|NCT00090519|38799053|FG001|Overall Study|Sponsor Decision|1|||
16083451|NCT04334317|38799057|FG000|Overall Study|Adverse Event|1|||
16083452|NCT04334317|38799058|FG001|Overall Study|Adverse Event|2|||
16083453|NCT04334317|38799059|FG002|Overall Study|Adverse Event|0|||
16083454|NCT04334317|38799060|FG003|Overall Study|Adverse Event|0|||
16083455|NCT04334317|38799057|FG000|Overall Study|Protocol Deviation|0|||
16083456|NCT04334317|38799058|FG001|Overall Study|Protocol Deviation|1|||
16083457|NCT04334317|38799059|FG002|Overall Study|Protocol Deviation|0|||
16083458|NCT04334317|38799060|FG003|Overall Study|Protocol Deviation|0|||
16083459|NCT04334317|38799057|FG000|Overall Study|Withdrawal by Subject|2|||
16083460|NCT04334317|38799058|FG001|Overall Study|Withdrawal by Subject|2|||
16083461|NCT04334317|38799059|FG002|Overall Study|Withdrawal by Subject|0|||
16083462|NCT04334317|38799060|FG003|Overall Study|Withdrawal by Subject|0|||
16083463|NCT03274076|38799067|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
16083464|NCT03274076|38799068|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
16083465|NCT03274076|38799069|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
16083466|NCT03274076|38799070|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
16083467|NCT03274076|38799067|FG000|24 Weeks Open Label|Adverse Event|0|||
16083468|NCT03274076|38799068|FG001|24 Weeks Open Label|Adverse Event|0|||
16083469|NCT03274076|38799069|FG002|24 Weeks Open Label|Adverse Event|2|||
16489047|NCT00381485|40266823|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
16489048|NCT00381485|40266824|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
16489049|NCT00381485|40266825|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
16489050|NCT00381485|40266826|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
16489051|NCT00381485|40266823|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
16489052|NCT00381485|40266824|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
16489053|NCT00381485|40266825|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
16083470|NCT03274076|38799070|FG003|24 Weeks Open Label|Adverse Event|0|||
16083471|NCT03274076|38799067|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
16083472|NCT03274076|38799068|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
16083473|NCT03274076|38799069|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
16083474|NCT03274076|38799070|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
16083475|NCT04712019|38799071|FG000|Overall Study|Withdrawal by Subject|2|||
16083476|NCT04712019|38799072|FG001|Overall Study|Withdrawal by Subject|2|||
16083477|NCT04712019|38799071|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
16083478|NCT04712019|38799072|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
16083479|NCT01040689|38799073|FG000|Overall Study|Adverse Event|0|||
16083480|NCT01040689|38799074|FG001|Overall Study|Adverse Event|0|||
16083481|NCT01040689|38799075|FG002|Overall Study|Adverse Event|2|||
16083482|NCT01040689|38799076|FG003|Overall Study|Adverse Event|4|||
16083483|NCT01040689|38799073|FG000|Overall Study|Lack of Efficacy|0|||
16083484|NCT01040689|38799074|FG001|Overall Study|Lack of Efficacy|0|||
16083485|NCT01040689|38799075|FG002|Overall Study|Lack of Efficacy|1|||
16083486|NCT01040689|38799076|FG003|Overall Study|Lack of Efficacy|0|||
16083487|NCT01040689|38799073|FG000|Overall Study|Lost to Follow-up|1|||
16083488|NCT01040689|38799074|FG001|Overall Study|Lost to Follow-up|0|||
16083489|NCT01040689|38799075|FG002|Overall Study|Lost to Follow-up|0|||
16190447|NCT01234402|39175997|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
16190448|NCT01234402|39175998|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
16190449|NCT01234402|39175999|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
16190450|NCT00913978|39176000|FG000|Overall Study|Surgeon choice|1|||
16190451|NCT00913978|39176001|FG001|Overall Study|Surgeon choice|3|||
16489054|NCT00381485|40266826|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
16489055|NCT00381485|40266823|FG000|Double-Blind Treatment Period|Administrative|0|||
16489056|NCT00381485|40266824|FG001|Double-Blind Treatment Period|Administrative|1|||
16489057|NCT00381485|40266825|FG002|Double-Blind Treatment Period|Administrative|0|||
16489058|NCT00381485|40266826|FG003|Double-Blind Treatment Period|Administrative|1|||
16489059|NCT04439110|40266827|FG000|Overall Study|Ineligible|2|||
16489060|NCT04439110|40266827|FG000|Overall Study|Adverse Event|4|||
16489061|NCT04439110|40266827|FG000|Overall Study|Death|2|||
16489062|NCT04439110|40266827|FG000|Overall Study|Disease proression|25|||
16489063|NCT04439110|40266827|FG000|Overall Study|Withdrawal by Subject|1|||
16489064|NCT04439110|40266827|FG000|Overall Study|Alternative therapy|1|||
16190452|NCT04544709|39176002|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
16190453|NCT01998581|39176007|FG000|Overall Study|Refused repeat treatment|20|||
16190454|NCT01998581|39176008|FG001|Overall Study|Refused repeat treatment|4|||
16190455|NCT01998581|39176007|FG000|Overall Study|Protocol Violation|1|||
16190456|NCT01998581|39176008|FG001|Overall Study|Protocol Violation|0|||
16297892|NCT03052127|39574151|FG005|Overall Study|Withdrawal by Subject|0|||
16297893|NCT03052127|39574152|FG006|Overall Study|Withdrawal by Subject|0|||
16297894|NCT03052127|39574153|FG007|Overall Study|Withdrawal by Subject|1|||
16297895|NCT03052127|39574154|FG008|Overall Study|Withdrawal by Subject|1|||
16297896|NCT03052127|39574155|FG009|Overall Study|Withdrawal by Subject|1|||
16297897|NCT03052127|39574156|FG010|Overall Study|Withdrawal by Subject|0|||
16297898|NCT03052127|39574157|FG011|Overall Study|Withdrawal by Subject|0|||
16489065|NCT04439110|40266827|FG000|Overall Study|Other complicating disease|1|||
16297899|NCT03052127|39574146|FG000|Overall Study|Discontinuation by Sponsor|0|||
16489066|NCT04439110|40266827|FG000|Overall Study|Personal reasons|1|||
16489067|NCT04439110|40266827|FG000|Overall Study|Still on treatment|1|||
16489068|NCT01433991|40266828|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
16489069|NCT01433991|40266829|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
16297900|NCT03052127|39574147|FG001|Overall Study|Discontinuation by Sponsor|0|||
16297901|NCT03052127|39574148|FG002|Overall Study|Discontinuation by Sponsor|0|||
16297902|NCT03052127|39574149|FG003|Overall Study|Discontinuation by Sponsor|0|||
16297903|NCT03052127|39574150|FG004|Overall Study|Discontinuation by Sponsor|0|||
16297904|NCT03052127|39574151|FG005|Overall Study|Discontinuation by Sponsor|0|||
16384593|NCT01823289|39892625|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
16083490|NCT01040689|38799076|FG003|Overall Study|Lost to Follow-up|0|||
16083491|NCT01040689|38799073|FG000|Overall Study|Withdrawal by Subject|2|||
16083492|NCT01040689|38799074|FG001|Overall Study|Withdrawal by Subject|1|||
16083493|NCT01040689|38799075|FG002|Overall Study|Withdrawal by Subject|1|||
16083494|NCT01040689|38799076|FG003|Overall Study|Withdrawal by Subject|0|||
16384594|NCT00382174|39892628|FG000|Overall Study|Lost to Follow-up|1|||
16384595|NCT00382174|39892629|FG001|Overall Study|Lost to Follow-up|4|||
16384596|NCT00382174|39892630|FG002|Overall Study|Lost to Follow-up|5|||
16384597|NCT00382174|39892628|FG000|Overall Study|Adverse Event|1|||
16489070|NCT01433991|40266830|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
16489071|NCT01433991|40266831|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
16489072|NCT01433991|40266828|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
16489073|NCT01433991|40266829|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
16489074|NCT01433991|40266830|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
16489075|NCT01433991|40266831|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
16489076|NCT01433991|40266828|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
16489077|NCT01433991|40266829|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
16489078|NCT01433991|40266830|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
16489079|NCT01433991|40266831|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
16489080|NCT01433991|40266828|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
16489081|NCT01433991|40266829|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
16489082|NCT01433991|40266830|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
16489083|NCT01433991|40266831|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
16489084|NCT01433991|40266828|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
16489085|NCT01433991|40266829|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
16489086|NCT01433991|40266830|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
16489087|NCT01433991|40266831|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
16489088|NCT01433991|40266828|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
16489089|NCT01433991|40266829|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
16190457|NCT01998581|39176007|FG000|Overall Study|Withdrawal by Subject|8|||
16190458|NCT01998581|39176008|FG001|Overall Study|Withdrawal by Subject|1|||
16190459|NCT01998581|39176007|FG000|Overall Study|Lost to Follow-up|12|||
16190460|NCT01998581|39176008|FG001|Overall Study|Lost to Follow-up|4|||
16190461|NCT01998581|39176007|FG000|Overall Study|Adverse Event|1|||
16190462|NCT01998581|39176008|FG001|Overall Study|Adverse Event|1|||
16190463|NCT01998581|39176007|FG000|Overall Study|Other reasons|3|||
16190464|NCT01998581|39176008|FG001|Overall Study|Other reasons|2|||
16190465|NCT01998581|39176007|FG000|Overall Study|Randomized but withdrew before treatment|1|||
16190466|NCT01998581|39176008|FG001|Overall Study|Randomized but withdrew before treatment|0|||
16190467|NCT01936649|39176009|FG000|Overall Study|Withdrawal by Subject|4|||
16190468|NCT01936649|39176009|FG000|Overall Study|Physician Decision|2|||
16190469|NCT01936649|39176009|FG000|Overall Study|Protocol Violation|2|||
16190470|NCT01936649|39176009|FG000|Overall Study|Other than specified above|5|||
16190471|NCT02411201|39176012|FG000|Overall Study|Adverse Event|2|||
16190472|NCT02411201|39176012|FG000|Overall Study|Withdrawal by Subject|2|||
16190473|NCT02411201|39176012|FG000|Overall Study|Age group completed|2|||
16190474|NCT05515601|39176013|FG000|Overall Study|Withdrawal by Subject|1|||
16190475|NCT05515601|39176014|FG001|Overall Study|Withdrawal by Subject|3|||
16190476|NCT05515601|39176015|FG002|Overall Study|Withdrawal by Subject|2|||
16190477|NCT05515601|39176016|FG003|Overall Study|Withdrawal by Subject|1|||
16190478|NCT05515601|39176017|FG004|Overall Study|Withdrawal by Subject|1|||
16190479|NCT05515601|39176018|FG005|Overall Study|Withdrawal by Subject|1|||
16190480|NCT05515601|39176013|FG000|Overall Study|Lost to Follow-up|0|||
16190481|NCT05515601|39176014|FG001|Overall Study|Lost to Follow-up|0|||
16190482|NCT05515601|39176015|FG002|Overall Study|Lost to Follow-up|0|||
16190483|NCT05515601|39176016|FG003|Overall Study|Lost to Follow-up|0|||
16190484|NCT05515601|39176017|FG004|Overall Study|Lost to Follow-up|1|||
16190485|NCT05515601|39176018|FG005|Overall Study|Lost to Follow-up|0|||
16190486|NCT03123354|39176019|FG000|Overall Study|Physician Decision|6|||
16190487|NCT03628508|39176020|FG000|Overall Study|Lost to Follow-up|1|||
16190488|NCT00414310|39176021|FG000|Overall Study|Not treated|1|||
16190489|NCT00414310|39176022|FG001|Overall Study|Not treated|0|||
16190490|NCT03011034|39176025|FG000|Overall Study|Adverse Event|1|||
16190491|NCT03011034|39176026|FG001|Overall Study|Adverse Event|0|||
16190492|NCT01599754|39176029|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
16190493|NCT01599754|39176030|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
16190494|NCT01599754|39176029|FG000|Overall Study|Participant noncompliance|4|||
16190495|NCT01599754|39176030|FG001|Overall Study|Participant noncompliance|4|||
16190496|NCT01599754|39176029|FG000|Overall Study|Lost to Follow-up|13|||
16190497|NCT01599754|39176030|FG001|Overall Study|Lost to Follow-up|6|||
16190498|NCT01599754|39176029|FG000|Overall Study|Death|31|||
16190499|NCT01599754|39176030|FG001|Overall Study|Death|33|||
16190500|NCT01599754|39176029|FG000|Overall Study|Adverse Event|3|||
16190501|NCT01599754|39176030|FG001|Overall Study|Adverse Event|2|||
16190502|NCT01599754|39176029|FG000|Overall Study|Investigator decision|1|||
16489090|NCT01433991|40266830|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
16489091|NCT01433991|40266831|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
16190503|NCT01599754|39176030|FG001|Overall Study|Investigator decision|3|||
16190504|NCT01599754|39176029|FG000|Overall Study|Withdrawal by Subject|24|||
16489092|NCT01433991|40266828|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
16489093|NCT01433991|40266829|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
16489094|NCT01433991|40266830|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
16489095|NCT01433991|40266831|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
16489096|NCT00619177|40266834|FG000|Overall Study|Adverse Event|18|||
16489097|NCT00619177|40266834|FG000|Overall Study|Lost to Follow-up|2|||
16489098|NCT00619177|40266834|FG000|Overall Study|Lack of Efficacy|1|||
16489099|NCT00619177|40266834|FG000|Overall Study|Missing termination information|481|||
16489100|NCT00619177|40266834|FG000|Overall Study|Not specified reasons|6|||
16489101|NCT00963547|40266836|FG000|Overall Study|Adverse Event|0|||
16489102|NCT00963547|40266837|FG001|Overall Study|Adverse Event|1|||
16489103|NCT00963547|40266838|FG002|Overall Study|Adverse Event|0|||
16489104|NCT00963547|40266839|FG003|Overall Study|Adverse Event|1|||
16489105|NCT00963547|40266840|FG004|Overall Study|Adverse Event|0|||
16489106|NCT00963547|40266841|FG005|Overall Study|Adverse Event|0|||
16297905|NCT03052127|39574152|FG006|Overall Study|Discontinuation by Sponsor|0|||
16297906|NCT03052127|39574153|FG007|Overall Study|Discontinuation by Sponsor|0|||
16297907|NCT03052127|39574154|FG008|Overall Study|Discontinuation by Sponsor|4|||
16297908|NCT03052127|39574155|FG009|Overall Study|Discontinuation by Sponsor|2|||
16297909|NCT03052127|39574156|FG010|Overall Study|Discontinuation by Sponsor|5|||
16489107|NCT00963547|40266842|FG006|Overall Study|Adverse Event|0|||
16489108|NCT00963547|40266836|FG000|Overall Study|Physician Decision|1|||
16489109|NCT00963547|40266837|FG001|Overall Study|Physician Decision|1|||
16489110|NCT00963547|40266838|FG002|Overall Study|Physician Decision|0|||
16489111|NCT00963547|40266839|FG003|Overall Study|Physician Decision|0|||
16489112|NCT00963547|40266840|FG004|Overall Study|Physician Decision|0|||
16489113|NCT00963547|40266841|FG005|Overall Study|Physician Decision|0|||
16489114|NCT00963547|40266842|FG006|Overall Study|Physician Decision|0|||
16489115|NCT00963547|40266836|FG000|Overall Study|Progressive Disease|3|||
16489116|NCT00963547|40266837|FG001|Overall Study|Progressive Disease|8|||
16489117|NCT00963547|40266838|FG002|Overall Study|Progressive Disease|9|||
16489118|NCT00963547|40266839|FG003|Overall Study|Progressive Disease|5|||
16489119|NCT00963547|40266840|FG004|Overall Study|Progressive Disease|0|||
16489120|NCT00963547|40266841|FG005|Overall Study|Progressive Disease|0|||
16489121|NCT00963547|40266842|FG006|Overall Study|Progressive Disease|0|||
16489122|NCT00963547|40266836|FG000|Overall Study|Withdrawal by Subject|0|||
16489123|NCT00963547|40266837|FG001|Overall Study|Withdrawal by Subject|0|||
16384598|NCT00382174|39892629|FG001|Overall Study|Adverse Event|4|||
16297910|NCT03052127|39574157|FG011|Overall Study|Discontinuation by Sponsor|13|||
16297911|NCT03052127|39574146|FG000|Overall Study|Inability to comply with trial requirements|0|||
16297912|NCT03052127|39574147|FG001|Overall Study|Inability to comply with trial requirements|0|||
16297913|NCT03052127|39574148|FG002|Overall Study|Inability to comply with trial requirements|1|||
16297914|NCT03052127|39574149|FG003|Overall Study|Inability to comply with trial requirements|0|||
16297915|NCT03052127|39574150|FG004|Overall Study|Inability to comply with trial requirements|0|||
16297916|NCT03052127|39574151|FG005|Overall Study|Inability to comply with trial requirements|0|||
16297917|NCT03052127|39574152|FG006|Overall Study|Inability to comply with trial requirements|0|||
16297918|NCT03052127|39574153|FG007|Overall Study|Inability to comply with trial requirements|0|||
16297919|NCT03052127|39574154|FG008|Overall Study|Inability to comply with trial requirements|0|||
16297920|NCT03052127|39574155|FG009|Overall Study|Inability to comply with trial requirements|0|||
16297921|NCT03052127|39574156|FG010|Overall Study|Inability to comply with trial requirements|0|||
16297922|NCT03052127|39574157|FG011|Overall Study|Inability to comply with trial requirements|0|||
16297923|NCT03052127|39574146|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
16297924|NCT03052127|39574147|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
16297925|NCT03052127|39574148|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
16297926|NCT03052127|39574149|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
16297927|NCT03052127|39574150|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
16297928|NCT03052127|39574151|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
16297929|NCT03052127|39574152|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
16297930|NCT03052127|39574153|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
16297931|NCT03052127|39574154|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
16297932|NCT03052127|39574155|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
16297933|NCT03052127|39574156|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
16384599|NCT00382174|39892630|FG002|Overall Study|Adverse Event|5|||
16384600|NCT00382174|39892628|FG000|Overall Study|Withdrawal by Subject|1|||
16489124|NCT00963547|40266838|FG002|Overall Study|Withdrawal by Subject|3|||
16489125|NCT00963547|40266839|FG003|Overall Study|Withdrawal by Subject|0|||
16489126|NCT00963547|40266840|FG004|Overall Study|Withdrawal by Subject|0|||
16489127|NCT00963547|40266841|FG005|Overall Study|Withdrawal by Subject|0|||
16489128|NCT00963547|40266842|FG006|Overall Study|Withdrawal by Subject|0|||
16489129|NCT00963547|40266836|FG000|Overall Study|Reason Unknown|0|||
16489130|NCT00963547|40266837|FG001|Overall Study|Reason Unknown|1|||
16489131|NCT00963547|40266838|FG002|Overall Study|Reason Unknown|0|||
16489132|NCT00963547|40266839|FG003|Overall Study|Reason Unknown|0|||
16489133|NCT00963547|40266840|FG004|Overall Study|Reason Unknown|0|||
16489134|NCT00963547|40266841|FG005|Overall Study|Reason Unknown|0|||
16489135|NCT00963547|40266842|FG006|Overall Study|Reason Unknown|0|||
16489136|NCT01606436|40266843|FG000|Overall Study|Withdrawal by Subject|0|||
16489137|NCT01606436|40266844|FG001|Overall Study|Withdrawal by Subject|0|||
16489138|NCT01606436|40266845|FG002|Overall Study|Withdrawal by Subject|1|||
16489139|NCT01606436|40266846|FG003|Overall Study|Withdrawal by Subject|1|||
16489140|NCT01606436|40266847|FG004|Overall Study|Withdrawal by Subject|1|||
16489141|NCT01606436|40266848|FG005|Overall Study|Withdrawal by Subject|0|||
16489142|NCT01606436|40266843|FG000|Overall Study|Adverse Event|0|||
16489143|NCT01606436|40266844|FG001|Overall Study|Adverse Event|0|||
16489144|NCT01606436|40266845|FG002|Overall Study|Adverse Event|1|||
16489145|NCT01606436|40266846|FG003|Overall Study|Adverse Event|0|||
16489146|NCT01606436|40266847|FG004|Overall Study|Adverse Event|0|||
16489147|NCT01606436|40266848|FG005|Overall Study|Adverse Event|0|||
16190505|NCT01599754|39176030|FG001|Overall Study|Withdrawal by Subject|25|||
16190506|NCT01599754|39176029|FG000|Overall Study|Study terminated by sponsor|282|||
16190507|NCT01599754|39176030|FG001|Overall Study|Study terminated by sponsor|285|||
16190508|NCT04369430|39176031|FG000|Overall Study|Adverse Event|2|||
16489148|NCT01606436|40266843|FG000|Overall Study|Sponsor Decision|0|||
16489149|NCT01606436|40266844|FG001|Overall Study|Sponsor Decision|0|||
16384601|NCT00382174|39892629|FG001|Overall Study|Withdrawal by Subject|4|||
16190509|NCT04369430|39176032|FG001|Overall Study|Adverse Event|3|||
16190510|NCT04369430|39176031|FG000|Overall Study|Death|1|||
16190511|NCT04369430|39176032|FG001|Overall Study|Death|0|||
16297934|NCT03052127|39574157|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
16297935|NCT04502212|39574158|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
16297936|NCT04502212|39574158|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
16297937|NCT00827632|39574159|FG000|Overall Study|Lost to Follow-up|8|||
16297938|NCT00827632|39574160|FG001|Overall Study|Lost to Follow-up|12|||
16297939|NCT00827632|39574159|FG000|Overall Study|Early withdrawal|14|||
16297940|NCT00827632|39574160|FG001|Overall Study|Early withdrawal|11|||
16297941|NCT04933968|39574168|FG000|Overall Study|Adverse Event|0|||
16297942|NCT04933968|39574169|FG001|Overall Study|Adverse Event|0|||
16297943|NCT04933968|39574170|FG002|Overall Study|Adverse Event|1|||
16297944|NCT04933968|39574171|FG003|Overall Study|Adverse Event|1|||
16297945|NCT04933968|39574172|FG004|Overall Study|Adverse Event|0|||
16297946|NCT04933968|39574173|FG005|Overall Study|Adverse Event|0|||
16297947|NCT04933968|39574168|FG000|Overall Study|Lost to Follow-up|1|||
16297948|NCT04933968|39574169|FG001|Overall Study|Lost to Follow-up|0|||
16297949|NCT04933968|39574170|FG002|Overall Study|Lost to Follow-up|1|||
16297950|NCT04933968|39574171|FG003|Overall Study|Lost to Follow-up|0|||
16297951|NCT04933968|39574172|FG004|Overall Study|Lost to Follow-up|0|||
16297952|NCT04933968|39574173|FG005|Overall Study|Lost to Follow-up|0|||
16297953|NCT04933968|39574168|FG000|Overall Study|Randomized not treated|1|||
16297954|NCT04933968|39574169|FG001|Overall Study|Randomized not treated|0|||
16297955|NCT04933968|39574170|FG002|Overall Study|Randomized not treated|0|||
16297956|NCT04933968|39574171|FG003|Overall Study|Randomized not treated|0|||
16190512|NCT04369430|39176031|FG000|Overall Study|Withdrawal by Subject|4|||
16190513|NCT04369430|39176032|FG001|Overall Study|Withdrawal by Subject|3|||
16190514|NCT04369430|39176031|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
16190515|NCT04369430|39176032|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
16190516|NCT04369430|39176031|FG000|Overall Study|Lost to Follow-up|0|||
16190517|NCT04369430|39176032|FG001|Overall Study|Lost to Follow-up|1|||
16190518|NCT04045613|39176035|FG000|Overall Study|Adverse Event|2|||
16190519|NCT04045613|39176036|FG001|Overall Study|Adverse Event|2|||
16190520|NCT04045613|39176037|FG002|Overall Study|Adverse Event|1|||
16190521|NCT04045613|39176038|FG003|Overall Study|Adverse Event|1|||
16190522|NCT04045613|39176039|FG004|Overall Study|Adverse Event|0|||
16190523|NCT04045613|39176040|FG005|Overall Study|Adverse Event|0|||
16190524|NCT04045613|39176041|FG006|Overall Study|Adverse Event|1|||
16190525|NCT04045613|39176035|FG000|Overall Study|Withdrawal by Subject|0|||
16190526|NCT04045613|39176036|FG001|Overall Study|Withdrawal by Subject|5|||
16190527|NCT04045613|39176037|FG002|Overall Study|Withdrawal by Subject|0|||
16190528|NCT04045613|39176038|FG003|Overall Study|Withdrawal by Subject|0|||
16190529|NCT04045613|39176039|FG004|Overall Study|Withdrawal by Subject|0|||
16190530|NCT04045613|39176040|FG005|Overall Study|Withdrawal by Subject|1|||
16190531|NCT04045613|39176041|FG006|Overall Study|Withdrawal by Subject|0|||
16190532|NCT04045613|39176035|FG000|Overall Study|Physician Decision|2|||
16190533|NCT04045613|39176036|FG001|Overall Study|Physician Decision|0|||
16297957|NCT04933968|39574172|FG004|Overall Study|Randomized not treated|0|||
16297958|NCT04933968|39574173|FG005|Overall Study|Randomized not treated|0|||
16489150|NCT01606436|40266845|FG002|Overall Study|Sponsor Decision|0|||
16489151|NCT01606436|40266846|FG003|Overall Study|Sponsor Decision|1|||
16489152|NCT01606436|40266847|FG004|Overall Study|Sponsor Decision|0|||
16489153|NCT01606436|40266848|FG005|Overall Study|Sponsor Decision|0|||
16297959|NCT04933968|39574168|FG000|Overall Study|Sponsor terminated study|0|||
16297960|NCT04933968|39574169|FG001|Overall Study|Sponsor terminated study|0|||
16384602|NCT00382174|39892630|FG002|Overall Study|Withdrawal by Subject|5|||
16384603|NCT00382174|39892628|FG000|Overall Study|Non compliance|1|||
16384604|NCT00382174|39892629|FG001|Overall Study|Non compliance|0|||
16384605|NCT00382174|39892630|FG002|Overall Study|Non compliance|1|||
16384606|NCT00382174|39892628|FG000|Overall Study|Physician Decision|0|||
16384607|NCT00382174|39892629|FG001|Overall Study|Physician Decision|2|||
16384608|NCT00382174|39892630|FG002|Overall Study|Physician Decision|2|||
16384609|NCT00382174|39892628|FG000|Overall Study|Failed to meet criteria|0|||
16384610|NCT00382174|39892629|FG001|Overall Study|Failed to meet criteria|1|||
16384611|NCT00382174|39892630|FG002|Overall Study|Failed to meet criteria|1|||
16384612|NCT00382174|39892628|FG000|Overall Study|Wounds merged|0|||
16384613|NCT00382174|39892629|FG001|Overall Study|Wounds merged|2|||
16384614|NCT00382174|39892630|FG002|Overall Study|Wounds merged|2|||
16384615|NCT02655887|39892636|FG000|Overall Study|Lost to Follow-up|3|||
16384616|NCT02655887|39892636|FG000|Overall Study|Death|4|||
16297961|NCT04933968|39574170|FG002|Overall Study|Sponsor terminated study|0|||
16297962|NCT04933968|39574171|FG003|Overall Study|Sponsor terminated study|1|||
16297963|NCT04933968|39574172|FG004|Overall Study|Sponsor terminated study|2|||
16297964|NCT04933968|39574173|FG005|Overall Study|Sponsor terminated study|0|||
16297965|NCT04933968|39574168|FG000|Overall Study|Other|0|||
16297966|NCT04933968|39574169|FG001|Overall Study|Other|0|||
16297967|NCT04933968|39574170|FG002|Overall Study|Other|0|||
16297968|NCT04933968|39574171|FG003|Overall Study|Other|1|||
16297969|NCT04933968|39574172|FG004|Overall Study|Other|0|||
16384617|NCT02655887|39892636|FG000|Overall Study|Withdrawal by Subject|3|||
16384618|NCT02655887|39892636|FG000|Overall Study|Missed 12-month follow-up visit|4|||
16384619|NCT02301897|39892648|FG000|Treatment Course 1|Non-Compliance|0|||
16384620|NCT02301897|39892649|FG001|Treatment Course 1|Non-Compliance|0|||
16384621|NCT02301897|39892650|FG002|Treatment Course 1|Non-Compliance|1|||
16297970|NCT04933968|39574173|FG005|Overall Study|Other|0|||
16297971|NCT04933968|39574168|FG000|Overall Study|Missing|1|||
16297972|NCT04933968|39574169|FG001|Overall Study|Missing|3|||
16297973|NCT04933968|39574170|FG002|Overall Study|Missing|2|||
16297974|NCT04933968|39574171|FG003|Overall Study|Missing|1|||
16297975|NCT04933968|39574172|FG004|Overall Study|Missing|1|||
16297976|NCT04933968|39574173|FG005|Overall Study|Missing|0|||
16297977|NCT01004003|39574178|FG000|Overall Study|Progressive disease|2|||
16297978|NCT01004003|39574179|FG001|Overall Study|Progressive disease|1|||
16297979|NCT01004003|39574180|FG002|Overall Study|Progressive disease|1|||
16297980|NCT01004003|39574181|FG003|Overall Study|Progressive disease|0|||
16297981|NCT01004003|39574182|FG004|Overall Study|Progressive disease|2|||
16384622|NCT02301897|39892648|FG000|Treatment Course 1|Adverse Event|1|||
16297982|NCT01004003|39574183|FG005|Overall Study|Progressive disease|1|||
16297983|NCT01004003|39574184|FG006|Overall Study|Progressive disease|1|||
16384623|NCT02301897|39892649|FG001|Treatment Course 1|Adverse Event|1|||
16297984|NCT01004003|39574185|FG007|Overall Study|Progressive disease|39|||
16297985|NCT01004003|39574186|FG008|Overall Study|Progressive disease|22|||
16297986|NCT01004003|39574178|FG000|Overall Study|Adverse Event|4|||
16297987|NCT01004003|39574179|FG001|Overall Study|Adverse Event|2|||
16297988|NCT01004003|39574180|FG002|Overall Study|Adverse Event|3|||
16297989|NCT01004003|39574181|FG003|Overall Study|Adverse Event|3|||
16297990|NCT01004003|39574182|FG004|Overall Study|Adverse Event|2|||
16297991|NCT01004003|39574183|FG005|Overall Study|Adverse Event|2|||
16297992|NCT01004003|39574184|FG006|Overall Study|Adverse Event|7|||
16297993|NCT01004003|39574185|FG007|Overall Study|Adverse Event|21|||
16297994|NCT01004003|39574186|FG008|Overall Study|Adverse Event|6|||
16297995|NCT01004003|39574178|FG000|Overall Study|Refused to continue taking trial med.|0|||
16297996|NCT01004003|39574179|FG001|Overall Study|Refused to continue taking trial med.|0|||
16297997|NCT01004003|39574180|FG002|Overall Study|Refused to continue taking trial med.|0|||
16297998|NCT01004003|39574181|FG003|Overall Study|Refused to continue taking trial med.|0|||
16297999|NCT01004003|39574182|FG004|Overall Study|Refused to continue taking trial med.|0|||
16298000|NCT01004003|39574183|FG005|Overall Study|Refused to continue taking trial med.|0|||
16298001|NCT01004003|39574184|FG006|Overall Study|Refused to continue taking trial med.|0|||
16298002|NCT01004003|39574185|FG007|Overall Study|Refused to continue taking trial med.|0|||
16298003|NCT01004003|39574186|FG008|Overall Study|Refused to continue taking trial med.|2|||
16298004|NCT01004003|39574178|FG000|Overall Study|Other|0|||
16298005|NCT01004003|39574179|FG001|Overall Study|Other|0|||
16298006|NCT01004003|39574180|FG002|Overall Study|Other|0|||
16298007|NCT01004003|39574181|FG003|Overall Study|Other|0|||
16190534|NCT04045613|39176037|FG002|Overall Study|Physician Decision|0|||
16190535|NCT04045613|39176038|FG003|Overall Study|Physician Decision|0|||
16190536|NCT04045613|39176039|FG004|Overall Study|Physician Decision|1|||
16190537|NCT04045613|39176040|FG005|Overall Study|Physician Decision|0|||
16190538|NCT04045613|39176041|FG006|Overall Study|Physician Decision|0|||
16190539|NCT04045613|39176035|FG000|Overall Study|Death|3|||
16190540|NCT04045613|39176036|FG001|Overall Study|Death|0|||
16190541|NCT04045613|39176037|FG002|Overall Study|Death|0|||
16190542|NCT04045613|39176038|FG003|Overall Study|Death|0|||
16190543|NCT04045613|39176039|FG004|Overall Study|Death|0|||
16190544|NCT04045613|39176040|FG005|Overall Study|Death|0|||
16190545|NCT04045613|39176041|FG006|Overall Study|Death|1|||
16190546|NCT04045613|39176035|FG000|Overall Study|Other reasons|0|||
16190547|NCT04045613|39176036|FG001|Overall Study|Other reasons|1|||
16190548|NCT04045613|39176037|FG002|Overall Study|Other reasons|0|||
16190549|NCT04045613|39176038|FG003|Overall Study|Other reasons|0|||
16190550|NCT04045613|39176039|FG004|Overall Study|Other reasons|0|||
16190551|NCT04045613|39176040|FG005|Overall Study|Other reasons|0|||
16190552|NCT04045613|39176041|FG006|Overall Study|Other reasons|1|||
16190553|NCT04045613|39176035|FG000|Overall Study|Progressive disease: Clinical progression|1|||
16190554|NCT04045613|39176036|FG001|Overall Study|Progressive disease: Clinical progression|0|||
16190555|NCT04045613|39176037|FG002|Overall Study|Progressive disease: Clinical progression|3|||
16190556|NCT04045613|39176038|FG003|Overall Study|Progressive disease: Clinical progression|1|||
16190557|NCT04045613|39176039|FG004|Overall Study|Progressive disease: Clinical progression|1|||
16190558|NCT04045613|39176040|FG005|Overall Study|Progressive disease: Clinical progression|3|||
16190559|NCT04045613|39176041|FG006|Overall Study|Progressive disease: Clinical progression|3|||
16190560|NCT04045613|39176035|FG000|Overall Study|Progressive disease: Radiological progression|24|||
16190561|NCT04045613|39176036|FG001|Overall Study|Progressive disease: Radiological progression|6|||
16190562|NCT04045613|39176037|FG002|Overall Study|Progressive disease: Radiological progression|8|||
16190563|NCT04045613|39176038|FG003|Overall Study|Progressive disease: Radiological progression|0|||
16190564|NCT04045613|39176039|FG004|Overall Study|Progressive disease: Radiological progression|6|||
16190565|NCT04045613|39176040|FG005|Overall Study|Progressive disease: Radiological progression|6|||
16190566|NCT04045613|39176041|FG006|Overall Study|Progressive disease: Radiological progression|11|||
16190567|NCT03738566|39176044|FG000|Initial Study Phase|Withdrawal by Subject|1|||
16190568|NCT03738566|39176045|FG001|Initial Study Phase|Withdrawal by Subject|1|||
16190569|NCT03738566|39176046|FG002|Initial Study Phase|Withdrawal by Subject|2|||
16190570|NCT03738566|39176047|FG003|Initial Study Phase|Withdrawal by Subject|0|||
16190571|NCT03738566|39176044|FG000|Initial Study Phase|Death|0|||
16190572|NCT03738566|39176045|FG001|Initial Study Phase|Death|1|||
16190573|NCT03738566|39176046|FG002|Initial Study Phase|Death|0|||
16190574|NCT03738566|39176047|FG003|Initial Study Phase|Death|0|||
16190575|NCT03738566|39176044|FG000|Initial Study Phase|Treatment failure|5|||
16190576|NCT03738566|39176045|FG001|Initial Study Phase|Treatment failure|0|||
16190577|NCT03738566|39176046|FG002|Initial Study Phase|Treatment failure|0|||
16190578|NCT03738566|39176047|FG003|Initial Study Phase|Treatment failure|0|||
16190579|NCT03738566|39176044|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
16190580|NCT03738566|39176045|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
16190581|NCT03738566|39176046|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
16298008|NCT01004003|39574182|FG004|Overall Study|Other|0|||
16298009|NCT01004003|39574183|FG005|Overall Study|Other|1|||
16298010|NCT01004003|39574184|FG006|Overall Study|Other|0|||
16384624|NCT02301897|39892650|FG002|Treatment Course 1|Adverse Event|0|||
16384625|NCT02301897|39892648|FG000|Treatment Course 1|Lost to Follow-up|1|||
16384626|NCT02301897|39892649|FG001|Treatment Course 1|Lost to Follow-up|2|||
16384627|NCT02301897|39892650|FG002|Treatment Course 1|Lost to Follow-up|1|||
16384628|NCT02301897|39892648|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
16384629|NCT02301897|39892649|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
16298011|NCT01004003|39574185|FG007|Overall Study|Other|0|||
16298012|NCT01004003|39574186|FG008|Overall Study|Other|0|||
16298013|NCT03480386|39574187|FG000|Overall Study|Did not complete measures at 3-months|17|||
16298014|NCT03480386|39574188|FG001|Overall Study|Did not complete measures at 3-months|14|||
16298015|NCT03480386|39574187|FG000|Overall Study|No baseline measures|11|||
16298016|NCT03480386|39574188|FG001|Overall Study|No baseline measures|14|||
16298017|NCT03480386|39574187|FG000|Overall Study|Death|0|||
16298018|NCT03480386|39574188|FG001|Overall Study|Death|5|||
16298019|NCT03480386|39574187|FG000|Overall Study|Withdrawal by Subject|12|||
16298020|NCT03480386|39574188|FG001|Overall Study|Withdrawal by Subject|8|||
16298021|NCT03480386|39574187|FG000|Overall Study|Lost to Follow-up|2|||
16298022|NCT03480386|39574188|FG001|Overall Study|Lost to Follow-up|1|||
16298023|NCT03480386|39574187|FG000|Overall Study|Complicating disease|0|||
16298024|NCT03480386|39574188|FG001|Overall Study|Complicating disease|1|||
16298025|NCT03480386|39574187|FG000|Overall Study|Disease progression|3|||
16298026|NCT03480386|39574188|FG001|Overall Study|Disease progression|0|||
16298027|NCT03480386|39574187|FG000|Overall Study|Became ineligible|0|||
16298028|NCT03480386|39574188|FG001|Overall Study|Became ineligible|2|||
16298029|NCT00721630|39574189|FG000|Overall Study|Participant found to be ineligible|1|||
16298030|NCT03397771|39574190|FG000|Overall Study|2 erroneously randomized, never treated|3|||
16298031|NCT03397771|39574191|FG001|Overall Study|2 erroneously randomized, never treated|1|||
16298032|NCT03397771|39574190|FG000|Overall Study|Withdrawal by Subject|1|||
16298033|NCT03397771|39574191|FG001|Overall Study|Withdrawal by Subject|3|||
16298034|NCT03397771|39574190|FG000|Overall Study|Protocol Violation|2|||
16384630|NCT02301897|39892650|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
16298035|NCT03397771|39574191|FG001|Overall Study|Protocol Violation|2|||
16298036|NCT03397771|39574190|FG000|Overall Study|Adverse Event|2|||
16298037|NCT03397771|39574191|FG001|Overall Study|Adverse Event|1|||
16298038|NCT03665441|39574194|FG000|Overall Study|survival follow up ongoing|23|||
16298039|NCT03665441|39574195|FG001|Overall Study|survival follow up ongoing|0|||
16298040|NCT03665441|39574194|FG000|Overall Study|Patients ongoing on treatment|9|||
16298041|NCT03665441|39574195|FG001|Overall Study|Patients ongoing on treatment|6|||
16298042|NCT03665441|39574194|FG000|Overall Study|Randomized but not treated|7|||
16298043|NCT03665441|39574195|FG001|Overall Study|Randomized but not treated|11|||
16298044|NCT02648932|39574196|FG000|Overall Study|No transplant|3|||
16298045|NCT02648932|39574197|FG001|Overall Study|No transplant|1|||
16298046|NCT04555720|39574198|FG000|Overall Study|Lost to Follow-up|2|||
16298047|NCT04555720|39574199|FG001|Overall Study|Lost to Follow-up|0|||
16298048|NCT04555720|39574200|FG002|Overall Study|Lost to Follow-up|0|||
16298049|NCT04555720|39574201|FG003|Overall Study|Lost to Follow-up|0|||
16384631|NCT02301897|39892648|FG000|Treatment Course 1|Withdrawal by Subject|0|||
16384632|NCT02301897|39892649|FG001|Treatment Course 1|Withdrawal by Subject|0|||
16384633|NCT02301897|39892650|FG002|Treatment Course 1|Withdrawal by Subject|2|||
16384634|NCT02301897|39892648|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
16489154|NCT02144012|40266849|FG000|Overall Study|Adverse Event|1|||
16298050|NCT04555720|39574198|FG000|Overall Study|Withdrawal by Subject|4|||
16298051|NCT04555720|39574199|FG001|Overall Study|Withdrawal by Subject|6|||
16298052|NCT04555720|39574200|FG002|Overall Study|Withdrawal by Subject|0|||
16298053|NCT04555720|39574201|FG003|Overall Study|Withdrawal by Subject|0|||
16298054|NCT01329549|39574205|FG000|Overall Study|Withdrawal by Subject|1|||
16298055|NCT01329549|39574205|FG000|Overall Study|Adverse Event|1|||
16298056|NCT02731326|39574211|FG000|Overall Study|Withdrawal by Subject|4|||
16298057|NCT02731326|39574212|FG001|Overall Study|Withdrawal by Subject|1|||
16298058|NCT02731326|39574211|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
16298059|NCT02731326|39574212|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
16298060|NCT02731326|39574211|FG000|Overall Study|Discharged without AliveCor|10|||
16298061|NCT02731326|39574212|FG001|Overall Study|Discharged without AliveCor|0|||
16298062|NCT02731326|39574211|FG000|Overall Study|Duplicate Participant|1|||
16298063|NCT02731326|39574212|FG001|Overall Study|Duplicate Participant|1|||
16298064|NCT00213135|39574213|FG000|Overall Study|Adverse Event|9|||
16298065|NCT00213135|39574214|FG001|Overall Study|Adverse Event|5|||
16298066|NCT00213135|39574215|FG002|Overall Study|Adverse Event|5|||
16298067|NCT00213135|39574213|FG000|Overall Study|Lost to Follow-up|11|||
16298068|NCT00213135|39574214|FG001|Overall Study|Lost to Follow-up|8|||
16298069|NCT00213135|39574215|FG002|Overall Study|Lost to Follow-up|4|||
16298070|NCT00213135|39574213|FG000|Overall Study|Protocol Violation|4|||
16298071|NCT00213135|39574214|FG001|Overall Study|Protocol Violation|4|||
16298072|NCT00213135|39574215|FG002|Overall Study|Protocol Violation|10|||
16298073|NCT00213135|39574213|FG000|Overall Study|Death|1|||
16298074|NCT00213135|39574214|FG001|Overall Study|Death|1|||
16298075|NCT00213135|39574215|FG002|Overall Study|Death|2|||
16298076|NCT00213135|39574213|FG000|Overall Study|Disease progression|4|||
16298077|NCT00213135|39574214|FG001|Overall Study|Disease progression|5|||
16298078|NCT00213135|39574215|FG002|Overall Study|Disease progression|21|||
16298079|NCT00213135|39574213|FG000|Overall Study|Other|21|||
16298080|NCT00213135|39574214|FG001|Overall Study|Other|12|||
16298081|NCT00213135|39574215|FG002|Overall Study|Other|15|||
16298082|NCT01085201|39574216|FG000|Overall Study|Scheduling conflict|1|||
16298083|NCT01085201|39574217|FG001|Overall Study|Scheduling conflict|0|||
16298084|NCT01085201|39574218|FG002|Overall Study|Scheduling conflict|1|||
16298085|NCT01085201|39574219|FG003|Overall Study|Scheduling conflict|0|||
16298086|NCT01085201|39574220|FG004|Overall Study|Scheduling conflict|0|||
16298087|NCT01085201|39574216|FG000|Overall Study|Unknown- no study drug|2|||
16298088|NCT01085201|39574217|FG001|Overall Study|Unknown- no study drug|0|||
16298089|NCT01085201|39574218|FG002|Overall Study|Unknown- no study drug|0|||
16298090|NCT01085201|39574219|FG003|Overall Study|Unknown- no study drug|0|||
16298091|NCT01085201|39574220|FG004|Overall Study|Unknown- no study drug|0|||
16298092|NCT01085201|39574216|FG000|Overall Study|Fond ineligible after consent|0|||
16298093|NCT01085201|39574217|FG001|Overall Study|Fond ineligible after consent|1|||
16298094|NCT01085201|39574218|FG002|Overall Study|Fond ineligible after consent|1|||
16298095|NCT01085201|39574219|FG003|Overall Study|Fond ineligible after consent|0|||
16384635|NCT02301897|39892649|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
16384636|NCT02301897|39892650|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
16384637|NCT02301897|39892648|FG000|Treatment Course 2|Lost to Follow-up|0|||
16384638|NCT02301897|39892649|FG001|Treatment Course 2|Lost to Follow-up|2|||
16384639|NCT02301897|39892650|FG002|Treatment Course 2|Lost to Follow-up|0|||
16384640|NCT02301897|39892648|FG000|Treatment Course 2|Pregnancy|0|||
16384641|NCT02301897|39892649|FG001|Treatment Course 2|Pregnancy|1|||
16384642|NCT02301897|39892650|FG002|Treatment Course 2|Pregnancy|1|||
16384643|NCT02301897|39892648|FG000|Treatment Course 2|Withdrawal by Subject|0|||
16384644|NCT02301897|39892649|FG001|Treatment Course 2|Withdrawal by Subject|2|||
16384645|NCT02301897|39892650|FG002|Treatment Course 2|Withdrawal by Subject|0|||
16384646|NCT02301897|39892648|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
16384647|NCT02301897|39892649|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
16384648|NCT02301897|39892650|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
16384649|NCT00529633|39892651|FG000|Overall Study|Withdrawal by Subject|1|||
16384650|NCT00529633|39892652|FG001|Overall Study|Withdrawal by Subject|1|||
16384651|NCT00189423|39892653|FG000|Overall Study|Death|746|||
16384652|NCT00189423|39892654|FG001|Overall Study|Death|747|||
16384653|NCT00189423|39892653|FG000|Overall Study|Withdrawal by Subject|9|||
16384654|NCT00189423|39892654|FG001|Overall Study|Withdrawal by Subject|9|||
16384655|NCT00189423|39892653|FG000|Overall Study|Lost to Follow-up|10|||
16298096|NCT01085201|39574220|FG004|Overall Study|Fond ineligible after consent|0|||
16298097|NCT00969540|39574222|FG000|Overall Study|Lost to Follow-up|1|||
16298098|NCT00969540|39574223|FG001|Overall Study|Lost to Follow-up|1|||
16298099|NCT04709835|39574225|FG000|Overall Study|Withdrawal by Subject|0|||
16298100|NCT04709835|39574226|FG001|Overall Study|Withdrawal by Subject|1|||
16384656|NCT00189423|39892654|FG001|Overall Study|Lost to Follow-up|10|||
16384657|NCT00698841|39892656|FG000|Overall Study|Withdrawal by Subject|2|||
16384658|NCT00698841|39892656|FG000|Overall Study|Adverse Event|3|||
16384659|NCT00698841|39892656|FG000|Overall Study|Disease progression|7|||
16384660|NCT00698841|39892656|FG000|Overall Study|Failure to meet eligibility criteria|2|||
16298101|NCT04709835|39574227|FG002|Overall Study|Withdrawal by Subject|0|||
16298102|NCT03283761|39574228|FG000|Study Treatment|Patient Non-Compliance|1|||
16298103|NCT03283761|39574228|FG000|Study Treatment|Alternative Cancer Therapy|7|||
16298104|NCT03283761|39574228|FG000|Study Treatment|Disease progression|21|||
16298105|NCT03283761|39574228|FG000|Study Treatment|Adverse Event|3|||
16298106|NCT03283761|39574228|FG000|Study Treatment|Withdrawal by Subject|4|||
16298107|NCT03283761|39574228|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
16298108|NCT03283761|39574228|FG000|Study Treatment|Symptomatic Deterioration|1|||
16298109|NCT03283761|39574228|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
16298110|NCT03283761|39574228|FG000|Follow up|Lost to Follow-up|1|||
16298111|NCT03283761|39574228|FG000|Follow up|Symptomatic Deterioration|1|||
16298112|NCT03283761|39574228|FG000|Follow up|Death|29|||
16298113|NCT03283761|39574228|FG000|Follow up|study terminated|4|||
16298114|NCT03283761|39574228|FG000|Follow up|Primary Investigator Withdrawal|1|||
16298115|NCT03283761|39574228|FG000|Follow up|Switched to alternative therapy|1|||
16298116|NCT03283761|39574228|FG000|Follow up|Subject is now in Hospice|1|||
16298117|NCT02032706|39574229|FG000|Overall Study|Did not qualify|5|||
16298118|NCT02032706|39574229|FG000|Overall Study|Protocol Violation|1|||
16298119|NCT01293539|39574230|FG000|Overall Study|Physician Decision|1|||
16298120|NCT03200912|39574231|FG000|Overall Study|Adverse Event|3|||
16298121|NCT03200912|39574232|FG001|Overall Study|Adverse Event|0|||
16298122|NCT03200912|39574233|FG002|Overall Study|Adverse Event|0|||
16298123|NCT03200912|39574231|FG000|Overall Study|Withdrawal by Subject|1|||
16298124|NCT03200912|39574232|FG001|Overall Study|Withdrawal by Subject|2|||
16298125|NCT03200912|39574233|FG002|Overall Study|Withdrawal by Subject|4|||
16298126|NCT03200912|39574231|FG000|Overall Study|Non-compliance with study drug|0|||
16298127|NCT03200912|39574232|FG001|Overall Study|Non-compliance with study drug|1|||
16298128|NCT03200912|39574233|FG002|Overall Study|Non-compliance with study drug|0|||
16298129|NCT00609518|39574240|FG000|Overall Study|Death from Study Disease|32|||
16298130|NCT00609518|39574241|FG001|Overall Study|Death from Study Disease|32|||
16298131|NCT00609518|39574240|FG000|Overall Study|Withdrawal by Subject|5|||
16298132|NCT00609518|39574241|FG001|Overall Study|Withdrawal by Subject|3|||
16298133|NCT00609518|39574240|FG000|Overall Study|Lost to Follow-up|3|||
16298134|NCT00609518|39574241|FG001|Overall Study|Lost to Follow-up|0|||
16298135|NCT00609518|39574240|FG000|Overall Study|Physician Decision|1|||
16298136|NCT00609518|39574241|FG001|Overall Study|Physician Decision|3|||
16298137|NCT00609518|39574240|FG000|Overall Study|Death from Adverse Event|2|||
16298138|NCT00609518|39574241|FG001|Overall Study|Death from Adverse Event|2|||
16298139|NCT01664130|39574242|FG000|Overall Study|competing secondary disease|2|||
16298140|NCT02049450|39577667|FG000|Overall Study|Adverse Event|2|||
16298141|NCT02049450|39577667|FG000|Overall Study|Withdrawal by Subject|1|||
16298142|NCT02049450|39577667|FG000|Overall Study|Patients/guardian decision|1|||
16298143|NCT02853370|39577668|FG000|Overall Study|Physician Decision|1|||
16298144|NCT02853370|39577668|FG000|Overall Study|Lack of Efficacy|2|||
16298145|NCT02853370|39577668|FG000|Overall Study|Death|1|||
16298146|NCT02853370|39577668|FG000|Overall Study|Adverse Event|4|||
16298147|NCT02853370|39577668|FG000|Overall Study|Withdrawal by Subject|3|||
16298148|NCT00351533|39577671|FG000|Overall Study|Extubated before first BAL|1|||
16298149|NCT00351533|39577672|FG001|Overall Study|Extubated before first BAL|0|||
16298150|NCT00351533|39577671|FG000|Overall Study|Lost to Follow-up|1|||
16298151|NCT00351533|39577672|FG001|Overall Study|Lost to Follow-up|3|||
16298152|NCT00351533|39577671|FG000|Overall Study|Physician Decision|0|||
16298153|NCT00351533|39577672|FG001|Overall Study|Physician Decision|1|||
16298154|NCT00351533|39577671|FG000|Overall Study|Withdrawal by Subject|0|||
16298155|NCT00351533|39577672|FG001|Overall Study|Withdrawal by Subject|1|||
16298156|NCT00090610|39577673|FG000|Overall Study|Withdrawal by Subject|1|||
16298157|NCT00090610|39577674|FG001|Overall Study|Withdrawal by Subject|1|||
16298158|NCT03853148|39577675|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
16298159|NCT03853148|39577676|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
16298160|NCT03853148|39577677|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
16190582|NCT03738566|39176047|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
16190583|NCT00142519|39176048|FG000|Overall Study|Not Treated|7|||
16298161|NCT03853148|39577678|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
16298162|NCT01147107|39577685|FG000|Overall Study|Lack of Efficacy|5|||
16298163|NCT01147107|39577686|FG001|Overall Study|Lack of Efficacy|0|||
16298164|NCT01147107|39577685|FG000|Overall Study|Withdrawal by Subject|1|||
16298165|NCT01147107|39577686|FG001|Overall Study|Withdrawal by Subject|1|||
16298166|NCT02679235|39577687|FG000|Overall Study|Withdrawal by Subject|3|||
16298167|NCT02679235|39577687|FG000|Overall Study|Adverse Event|1|||
16298168|NCT00206323|39577689|FG000|Overall Study|Lack of Efficacy|4|||
16298169|NCT00206323|39577690|FG001|Overall Study|Lack of Efficacy|1|||
16298170|NCT00206323|39577689|FG000|Overall Study|Adverse Event|1|||
16298171|NCT00206323|39577690|FG001|Overall Study|Adverse Event|1|||
16298172|NCT00206323|39577689|FG000|Overall Study|Lost to Follow-up|1|||
16298173|NCT00206323|39577690|FG001|Overall Study|Lost to Follow-up|1|||
16298174|NCT03861481|39577691|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
16298175|NCT03861481|39577692|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
16298176|NCT03861481|39577691|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
16298177|NCT03861481|39577692|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
16298178|NCT03861481|39577691|FG000|Overall Study|Relapse|1|||
16298179|NCT03861481|39577692|FG001|Overall Study|Relapse|0|||
16298180|NCT03861481|39577691|FG000|Overall Study|Withdrawal by Subject|0|||
16298181|NCT03861481|39577692|FG001|Overall Study|Withdrawal by Subject|1|||
16298182|NCT03861481|39577691|FG000|Overall Study|Lack of Efficacy|4|||
16298183|NCT03861481|39577692|FG001|Overall Study|Lack of Efficacy|5|||
16298184|NCT00923273|39577693|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
16298185|NCT00923273|39577694|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
16298186|NCT00923273|39577695|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
16298187|NCT00923273|39577696|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
16298188|NCT00923273|39577697|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
16298189|NCT00923273|39577693|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
16298190|NCT00923273|39577694|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
16298191|NCT00923273|39577695|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
16298192|NCT00923273|39577696|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
16298193|NCT00923273|39577697|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
16298194|NCT00806286|39577700|FG000|Overall Study|Adverse Event|5|||
16298195|NCT00806286|39577701|FG001|Overall Study|Adverse Event|2|||
16298196|NCT00806286|39577702|FG002|Overall Study|Adverse Event|0|||
16298197|NCT00806286|39577700|FG000|Overall Study|Disease progression|31|||
16298198|NCT00806286|39577701|FG001|Overall Study|Disease progression|38|||
16298199|NCT00806286|39577702|FG002|Overall Study|Disease progression|1|||
16298200|NCT00806286|39577700|FG000|Overall Study|Death|1|||
16298201|NCT00806286|39577701|FG001|Overall Study|Death|6|||
16298202|NCT00806286|39577702|FG002|Overall Study|Death|0|||
16298203|NCT00806286|39577700|FG000|Overall Study|Lost to Follow-up|0|||
16298204|NCT00806286|39577701|FG001|Overall Study|Lost to Follow-up|1|||
16298205|NCT00806286|39577702|FG002|Overall Study|Lost to Follow-up|0|||
16298206|NCT00806286|39577700|FG000|Overall Study|Withdrawal by Subject|8|||
16298207|NCT00806286|39577701|FG001|Overall Study|Withdrawal by Subject|3|||
16298208|NCT00806286|39577702|FG002|Overall Study|Withdrawal by Subject|1|||
16298209|NCT00806286|39577700|FG000|Overall Study|Physician Decision|2|||
16298210|NCT00806286|39577701|FG001|Overall Study|Physician Decision|2|||
16298211|NCT00806286|39577702|FG002|Overall Study|Physician Decision|0|||
16298212|NCT00806286|39577700|FG000|Overall Study|Due to a variety of reasons|7|||
16298213|NCT00806286|39577701|FG001|Overall Study|Due to a variety of reasons|2|||
16298214|NCT00806286|39577702|FG002|Overall Study|Due to a variety of reasons|1|||
16298215|NCT00951496|39577703|FG000|Overall Study|Did not initiate study treatment|10|||
16298216|NCT00951496|39577704|FG001|Overall Study|Did not initiate study treatment|8|||
16298217|NCT00951496|39577705|FG002|Overall Study|Did not initiate study treatment|13|||
16298218|NCT00741286|39577707|FG000|Overall Study|Lost to Follow-up|15|||
16298219|NCT00741286|39577708|FG001|Overall Study|Lost to Follow-up|10|||
16298220|NCT00741286|39577707|FG000|Overall Study|Adverse Event|1|||
16298221|NCT00741286|39577708|FG001|Overall Study|Adverse Event|6|||
16298222|NCT00741286|39577707|FG000|Overall Study|Protocol Violation|3|||
16298223|NCT00741286|39577708|FG001|Overall Study|Protocol Violation|2|||
16298224|NCT00741286|39577707|FG000|Overall Study|Primary Outcome|1|||
16298225|NCT00741286|39577708|FG001|Overall Study|Primary Outcome|1|||
16298226|NCT02538965|39577709|FG000|Treatment Period|Other = Death due to disease progression|1|||
16298227|NCT02538965|39577709|FG000|Treatment Period|Adverse Event|2|||
16298228|NCT02538965|39577709|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
16298229|NCT02538965|39577709|FG000|Treatment Period|Treatment Failure|9|||
16298230|NCT02538965|39577709|FG000|Treatment Period|Disease Progression|1|||
16298231|NCT02538965|39577709|FG000|Treatment Period|Physician Decision|2|||
16190584|NCT00142519|39176049|FG001|Overall Study|Not Treated|9|||
16298232|NCT02538965|39577709|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
16298233|NCT02538965|39577709|FG000|Follow-Up Period|Withdrawal by Parent|4|||
16298234|NCT01104779|39577710|FG000|Overall Study|Protocol Violation|1|||
16298235|NCT01104779|39577711|FG001|Overall Study|Protocol Violation|2|||
16298236|NCT01104779|39577712|FG002|Overall Study|Protocol Violation|2|||
16298237|NCT01104779|39577710|FG000|Overall Study|Lack of Efficacy|26|||
16298238|NCT01104779|39577711|FG001|Overall Study|Lack of Efficacy|12|||
16298239|NCT01104779|39577712|FG002|Overall Study|Lack of Efficacy|13|||
16298240|NCT01104779|39577710|FG000|Overall Study|Adverse Event|13|||
16298241|NCT01104779|39577711|FG001|Overall Study|Adverse Event|14|||
16298242|NCT01104779|39577712|FG002|Overall Study|Adverse Event|13|||
16298243|NCT01104779|39577710|FG000|Overall Study|Did not meet inc/exc criteria|1|||
16298244|NCT01104779|39577711|FG001|Overall Study|Did not meet inc/exc criteria|1|||
16298245|NCT01104779|39577712|FG002|Overall Study|Did not meet inc/exc criteria|1|||
16298246|NCT01104779|39577710|FG000|Overall Study|Other reasons|0|||
16298247|NCT01104779|39577711|FG001|Overall Study|Other reasons|1|||
16298248|NCT01104779|39577712|FG002|Overall Study|Other reasons|0|||
16298249|NCT01104779|39577710|FG000|Overall Study|Lost to Follow-up|2|||
16298250|NCT01104779|39577711|FG001|Overall Study|Lost to Follow-up|0|||
16298251|NCT01104779|39577712|FG002|Overall Study|Lost to Follow-up|1|||
16298252|NCT01104779|39577710|FG000|Overall Study|Withdrawal by Subject|16|||
16298253|NCT01104779|39577711|FG001|Overall Study|Withdrawal by Subject|25|||
16298254|NCT01104779|39577712|FG002|Overall Study|Withdrawal by Subject|32|||
16298255|NCT02967692|39577715|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
16298256|NCT02967692|39577716|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
16298257|NCT02967692|39577717|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
16298258|NCT02967692|39577718|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
16298259|NCT02967692|39577715|FG000|Overall Study|Progressive disease|3|||
16298260|NCT02967692|39577716|FG001|Overall Study|Progressive disease|15|||
16298261|NCT02967692|39577717|FG002|Overall Study|Progressive disease|99|||
16298262|NCT02967692|39577718|FG003|Overall Study|Progressive disease|128|||
16298263|NCT02967692|39577715|FG000|Overall Study|Subject/guardian decision|1|||
16298264|NCT02967692|39577716|FG001|Overall Study|Subject/guardian decision|1|||
16298265|NCT02967692|39577717|FG002|Overall Study|Subject/guardian decision|6|||
16298266|NCT02967692|39577718|FG003|Overall Study|Subject/guardian decision|13|||
16298267|NCT02967692|39577715|FG000|Overall Study|Death|0|||
16298268|NCT02967692|39577716|FG001|Overall Study|Death|1|||
16298269|NCT02967692|39577717|FG002|Overall Study|Death|10|||
16298270|NCT02967692|39577718|FG003|Overall Study|Death|9|||
16298271|NCT02967692|39577715|FG000|Overall Study|Protocol deviation|1|||
16298272|NCT02967692|39577716|FG001|Overall Study|Protocol deviation|0|||
16298273|NCT02967692|39577717|FG002|Overall Study|Protocol deviation|1|||
16298274|NCT02967692|39577718|FG003|Overall Study|Protocol deviation|1|||
16298275|NCT02967692|39577715|FG000|Overall Study|Lost to Follow-up|0|||
16298276|NCT02967692|39577716|FG001|Overall Study|Lost to Follow-up|0|||
16298277|NCT02967692|39577717|FG002|Overall Study|Lost to Follow-up|1|||
16298278|NCT02967692|39577718|FG003|Overall Study|Lost to Follow-up|0|||
16298279|NCT02967692|39577715|FG000|Overall Study|Physician Decision|0|||
16298280|NCT02967692|39577716|FG001|Overall Study|Physician Decision|0|||
16298281|NCT02967692|39577717|FG002|Overall Study|Physician Decision|13|||
16298282|NCT02967692|39577718|FG003|Overall Study|Physician Decision|9|||
16298283|NCT02967692|39577715|FG000|Overall Study|Adverse Event|1|||
16298284|NCT02967692|39577716|FG001|Overall Study|Adverse Event|9|||
16298285|NCT02967692|39577717|FG002|Overall Study|Adverse Event|51|||
16298286|NCT02967692|39577718|FG003|Overall Study|Adverse Event|23|||
16298287|NCT00174954|39577722|FG000|Overall Study|Adverse Event|2|||
16298288|NCT00174954|39577722|FG000|Overall Study|No tophi found in MRI|1|||
16298289|NCT00174954|39577722|FG000|Overall Study|Physician Decision|1|||
16298290|NCT01857271|39577725|FG000|Overall Study|Lost to Follow-up|1|||
16298291|NCT02806024|39577726|FG000|Overall Study|Night Delivery|1|||
16298292|NCT02806024|39577727|FG001|Overall Study|Night Delivery|1|||
16298293|NCT02806024|39577726|FG000|Overall Study|DVT during antepartum admission|0|||
16298294|NCT02806024|39577727|FG001|Overall Study|DVT during antepartum admission|1|||
16298295|NCT01283035|39577730|FG000|Overall Study|Subject later found ineligible|1|||
16298296|NCT01220297|39577731|FG000|Overall Study|Death|2|||
16298297|NCT01220297|39577731|FG000|Overall Study|Lost to Follow-up|1|||
16298298|NCT01822275|39577733|FG000|Overall Study|Withdrawal by Subject|3|||
16298299|NCT01822275|39577733|FG000|Overall Study|Adverse Event|3|||
16298300|NCT01822275|39577733|FG000|Overall Study|Progression|14|||
16298301|NCT01822275|39577733|FG000|Overall Study|Physician Decision|2|||
16298302|NCT01001988|39577734|FG000|Overall Study|Protocol Violation|84|||
16298303|NCT01001988|39577734|FG000|Overall Study|Withdrawal by Subject|18|||
16298304|NCT01001988|39577734|FG000|Overall Study|Lost to Follow-up|15|||
16298305|NCT02728843|39577736|FG000|Overall Study|Adverse Event|0|||
16298306|NCT02728843|39577737|FG001|Overall Study|Adverse Event|2|||
16298307|NCT02728843|39577738|FG002|Overall Study|Adverse Event|3|||
16298308|NCT02728843|39577739|FG003|Overall Study|Adverse Event|1|||
16298309|NCT02728843|39577740|FG004|Overall Study|Adverse Event|2|||
16298310|NCT02728843|39577736|FG000|Overall Study|Lack of Efficacy|0|||
16298311|NCT02728843|39577737|FG001|Overall Study|Lack of Efficacy|1|||
16298312|NCT02728843|39577738|FG002|Overall Study|Lack of Efficacy|1|||
16298313|NCT02728843|39577739|FG003|Overall Study|Lack of Efficacy|0|||
16298314|NCT02728843|39577740|FG004|Overall Study|Lack of Efficacy|0|||
16298315|NCT02728843|39577736|FG000|Overall Study|Protocol Violation|2|||
16298316|NCT02728843|39577737|FG001|Overall Study|Protocol Violation|0|||
16298317|NCT02728843|39577738|FG002|Overall Study|Protocol Violation|4|||
16298318|NCT02728843|39577739|FG003|Overall Study|Protocol Violation|2|||
16298319|NCT02728843|39577740|FG004|Overall Study|Protocol Violation|2|||
16298320|NCT02728843|39577736|FG000|Overall Study|Withdrawal by Subject|1|||
16298321|NCT02728843|39577737|FG001|Overall Study|Withdrawal by Subject|0|||
16298322|NCT02728843|39577738|FG002|Overall Study|Withdrawal by Subject|0|||
16298323|NCT02728843|39577739|FG003|Overall Study|Withdrawal by Subject|1|||
16298324|NCT02728843|39577740|FG004|Overall Study|Withdrawal by Subject|0|||
16298325|NCT02728843|39577736|FG000|Overall Study|Use of rescue medication|0|||
16298326|NCT02728843|39577737|FG001|Overall Study|Use of rescue medication|2|||
16298327|NCT02728843|39577738|FG002|Overall Study|Use of rescue medication|0|||
16298328|NCT02728843|39577739|FG003|Overall Study|Use of rescue medication|2|||
16298329|NCT02728843|39577740|FG004|Overall Study|Use of rescue medication|1|||
16298330|NCT02712333|39577743|FG000|First Period|Withdrawal by Subject|3|||
16298331|NCT02712333|39577744|FG001|First Period|Withdrawal by Subject|2|||
16298332|NCT03249792|39577745|FG000|Arms 1, 2, and 4|Death|1|||
16298333|NCT03249792|39577746|FG001|Arms 1, 2, and 4|Death|1|||
16298334|NCT03249792|39577747|FG002|Arms 1, 2, and 4|Death|0|||
16298335|NCT03249792|39577748|FG003|Arms 1, 2, and 4|Death|2|||
16298336|NCT03249792|39577749|FG004|Arms 1, 2, and 4|Death|3|||
16298337|NCT03249792|39577750|FG005|Arms 1, 2, and 4|Death|2|||
16298338|NCT03249792|39577751|FG006|Arms 1, 2, and 4|Death|2|||
16298339|NCT03249792|39577752|FG007|Arms 1, 2, and 4|Death|4|||
16298340|NCT03249792|39577753|FG008|Arms 1, 2, and 4|Death|2|||
16298341|NCT03249792|39577754|FG009|Arms 1, 2, and 4|Death|1|||
16298342|NCT03249792|39577755|FG010|Arms 1, 2, and 4|Death|7|||
16298343|NCT03249792|39577756|FG011|Arms 1, 2, and 4|Death|7|||
16298344|NCT03249792|39577757|FG012|Arms 1, 2, and 4|Death|12|||
16298345|NCT03249792|39577758|FG013|Arms 1, 2, and 4|Death|7|||
16298346|NCT03249792|39577759|FG014|Arms 1, 2, and 4|Death|0|||
16298347|NCT03249792|39577760|FG015|Arms 1, 2, and 4|Death|4|||
16298348|NCT03249792|39577761|FG016|Arms 1, 2, and 4|Death|4|||
16298349|NCT03249792|39577762|FG017|Arms 1, 2, and 4|Death|12|||
16298350|NCT03249792|39577763|FG018|Arms 1, 2, and 4|Death|6|||
16298351|NCT03249792|39577764|FG019|Arms 1, 2, and 4|Death|4|||
16298352|NCT03249792|39577765|FG020|Arms 1, 2, and 4|Death|2|||
16298353|NCT03249792|39577766|FG021|Arms 1, 2, and 4|Death|3|||
16298354|NCT03249792|39577767|FG022|Arms 1, 2, and 4|Death|1|||
16298355|NCT03249792|39577768|FG023|Arms 1, 2, and 4|Death|1|||
16298356|NCT03249792|39577769|FG024|Arms 1, 2, and 4|Death|4|||
16298357|NCT03249792|39577770|FG025|Arms 1, 2, and 4|Death|0|||
16298358|NCT03249792|39577771|FG026|Arms 1, 2, and 4|Death|0|||
16298359|NCT03249792|39577772|FG027|Arms 1, 2, and 4|Death|0|||
16298360|NCT03249792|39577773|FG028|Arms 1, 2, and 4|Death|0|||
16298361|NCT03249792|39577774|FG029|Arms 1, 2, and 4|Death|0|||
16298362|NCT03249792|39577775|FG030|Arms 1, 2, and 4|Death|0|||
16298363|NCT03249792|39577776|FG031|Arms 1, 2, and 4|Death|0|||
16298364|NCT03249792|39577777|FG032|Arms 1, 2, and 4|Death|0|||
16298365|NCT03249792|39577745|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298366|NCT03249792|39577746|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298367|NCT03249792|39577747|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
16298368|NCT03249792|39577748|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298369|NCT03249792|39577749|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298370|NCT03249792|39577750|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
16298371|NCT03249792|39577751|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
16298372|NCT03249792|39577752|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298373|NCT03249792|39577753|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
16298374|NCT03249792|39577754|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
16298375|NCT03249792|39577755|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
16298376|NCT03249792|39577756|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
16298377|NCT03249792|39577757|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
16298378|NCT03249792|39577758|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
16298379|NCT03249792|39577759|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298380|NCT03249792|39577760|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298381|NCT03249792|39577761|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
16298382|NCT03249792|39577762|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298383|NCT03249792|39577763|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
16298384|NCT03249792|39577764|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298385|NCT03249792|39577765|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298386|NCT03249792|39577766|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298387|NCT03249792|39577767|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
16298388|NCT03249792|39577768|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
16298389|NCT03249792|39577769|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298390|NCT03249792|39577770|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298391|NCT03249792|39577771|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298392|NCT03249792|39577772|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298393|NCT03249792|39577773|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298394|NCT03249792|39577774|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298395|NCT03249792|39577775|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298396|NCT03249792|39577776|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298397|NCT03249792|39577777|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
16298398|NCT03249792|39577745|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
16298399|NCT03249792|39577746|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
16298400|NCT03249792|39577747|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
16298401|NCT03249792|39577748|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
16298402|NCT03249792|39577749|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
16298403|NCT03249792|39577750|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
16298404|NCT03249792|39577751|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
16298405|NCT03249792|39577752|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
16298406|NCT03249792|39577753|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
16298407|NCT03249792|39577754|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
16298408|NCT03249792|39577755|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
16298409|NCT03249792|39577756|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
16298410|NCT03249792|39577757|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
16298411|NCT03249792|39577758|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
16298412|NCT03249792|39577759|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
16298413|NCT03249792|39577760|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
16298414|NCT03249792|39577761|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
16298415|NCT03249792|39577762|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
16298416|NCT03249792|39577763|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
16298417|NCT03249792|39577764|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
16298418|NCT03249792|39577765|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
16298419|NCT03249792|39577766|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
16298420|NCT03249792|39577767|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
16298421|NCT03249792|39577768|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
16298422|NCT03249792|39577769|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
16298423|NCT03249792|39577770|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
16298424|NCT03249792|39577771|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
16298425|NCT03249792|39577772|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
16298426|NCT03249792|39577773|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
16298427|NCT03249792|39577774|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
16298428|NCT03249792|39577775|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
16298429|NCT03249792|39577776|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
16298430|NCT03249792|39577777|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
16298431|NCT03249792|39577745|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298432|NCT03249792|39577746|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298433|NCT03249792|39577747|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298434|NCT03249792|39577748|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298435|NCT03249792|39577749|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298436|NCT03249792|39577750|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298437|NCT03249792|39577751|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298438|NCT03249792|39577752|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298439|NCT03249792|39577753|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
16298440|NCT03249792|39577754|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298441|NCT03249792|39577755|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298442|NCT03249792|39577756|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298443|NCT03249792|39577757|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298444|NCT03249792|39577758|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298445|NCT03249792|39577759|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298446|NCT03249792|39577760|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298447|NCT03249792|39577761|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
16298448|NCT03249792|39577762|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
16298449|NCT03249792|39577763|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298450|NCT03249792|39577764|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
16298451|NCT03249792|39577765|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298452|NCT03249792|39577766|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298453|NCT03249792|39577767|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298454|NCT03249792|39577768|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298455|NCT03249792|39577769|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298456|NCT03249792|39577770|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298457|NCT03249792|39577771|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298458|NCT03249792|39577772|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298459|NCT03249792|39577773|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298460|NCT03249792|39577774|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298461|NCT03249792|39577775|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298462|NCT03249792|39577776|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298463|NCT03249792|39577777|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
16298464|NCT03249792|39577745|FG000|Switch Over Period|Withdrawal by Subject|0|||
16298465|NCT03249792|39577746|FG001|Switch Over Period|Withdrawal by Subject|0|||
16298466|NCT03249792|39577747|FG002|Switch Over Period|Withdrawal by Subject|0|||
16298467|NCT03249792|39577748|FG003|Switch Over Period|Withdrawal by Subject|0|||
16298468|NCT03249792|39577749|FG004|Switch Over Period|Withdrawal by Subject|0|||
16298469|NCT03249792|39577750|FG005|Switch Over Period|Withdrawal by Subject|0|||
16298470|NCT03249792|39577751|FG006|Switch Over Period|Withdrawal by Subject|0|||
16298471|NCT03249792|39577752|FG007|Switch Over Period|Withdrawal by Subject|0|||
16298472|NCT03249792|39577753|FG008|Switch Over Period|Withdrawal by Subject|0|||
16298473|NCT03249792|39577754|FG009|Switch Over Period|Withdrawal by Subject|0|||
16384661|NCT00698841|39892656|FG000|Overall Study|Study drug toxicity|2|||
16298474|NCT03249792|39577755|FG010|Switch Over Period|Withdrawal by Subject|0|||
16384662|NCT00698841|39892656|FG000|Overall Study|Other|2|||
16384663|NCT02538614|39892660|FG000|Overall Study|Progressive Disease|2|||
16384664|NCT03205761|39892661|FG000|Overall Study|Withdrawal by Subject|1|||
16384665|NCT03205761|39892661|FG000|Overall Study|Progressive Disease|10|||
16384666|NCT01668004|39892662|FG000|Overall Study|Adverse Event|7|||
16384667|NCT01668004|39892662|FG000|Overall Study|Withdrawal by Subject|2|||
16384668|NCT01668004|39892662|FG000|Overall Study|Lost to Follow-up|5|||
16384669|NCT01668004|39892662|FG000|Overall Study|Lack of Efficacy|9|||
16384670|NCT01668004|39892662|FG000|Overall Study|Non-compliance with treatment|2|||
16384671|NCT04749914|39892663|FG000|Period 1|Adverse Event|1|||
16384672|NCT04749914|39892664|FG001|Period 1|Adverse Event|0|||
16384673|NCT04749914|39892665|FG002|Period 1|Adverse Event|0|||
16384674|NCT04749914|39892666|FG003|Period 1|Adverse Event|0|||
16384675|NCT04749914|39892663|FG000|Period 1|Withdrawal by Subject|1|||
16384676|NCT04749914|39892664|FG001|Period 1|Withdrawal by Subject|0|||
16384677|NCT04749914|39892665|FG002|Period 1|Withdrawal by Subject|1|||
16384678|NCT04749914|39892666|FG003|Period 1|Withdrawal by Subject|0|||
16384679|NCT01816048|39892667|FG000|Overall Study|Adverse Event|1|||
16384680|NCT01816048|39892667|FG000|Overall Study|Death|1|||
16384681|NCT01816048|39892667|FG000|Overall Study|Withdrawal by Subject|1|||
16384682|NCT01816048|39892667|FG000|Overall Study|Disease Progression|3|||
16384683|NCT00560417|39892668|FG000|Overall Study|Adverse Event|3|||
16384684|NCT00560417|39892669|FG001|Overall Study|Adverse Event|2|||
16384685|NCT00560417|39892668|FG000|Overall Study|Entry Criteria Not Met|1|||
16384686|NCT00560417|39892669|FG001|Overall Study|Entry Criteria Not Met|0|||
16384687|NCT00560417|39892668|FG000|Overall Study|Lost to Follow-up|0|||
16384688|NCT00560417|39892669|FG001|Overall Study|Lost to Follow-up|1|||
16384689|NCT00560417|39892668|FG000|Overall Study|Physician Decision|2|||
16384690|NCT00560417|39892669|FG001|Overall Study|Physician Decision|6|||
16384691|NCT00560417|39892668|FG000|Overall Study|Protocol Violation|6|||
16384692|NCT00560417|39892669|FG001|Overall Study|Protocol Violation|5|||
16384693|NCT00560417|39892668|FG000|Overall Study|Sponsor Decision|2|||
16384694|NCT00560417|39892669|FG001|Overall Study|Sponsor Decision|0|||
16384695|NCT00560417|39892668|FG000|Overall Study|Withdrawal by Subject|3|||
16384696|NCT00560417|39892669|FG001|Overall Study|Withdrawal by Subject|3|||
16384697|NCT01561976|39892672|FG000|Period 1|Adverse Event|0|||
16384698|NCT01561976|39892673|FG001|Period 1|Adverse Event|0|||
16384699|NCT01561976|39892674|FG002|Period 1|Adverse Event|1|||
16384700|NCT01561976|39892675|FG003|Period 1|Adverse Event|0|||
16384701|NCT01561976|39892676|FG004|Period 1|Adverse Event|0|||
16384702|NCT01561976|39892677|FG005|Period 1|Adverse Event|0|||
16384703|NCT01561976|39892672|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
16384704|NCT01561976|39892673|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
16384705|NCT01561976|39892674|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
16384706|NCT01561976|39892675|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
16384707|NCT01561976|39892676|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
16384708|NCT01561976|39892677|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
16384709|NCT01561976|39892672|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16384710|NCT01561976|39892673|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16384711|NCT01561976|39892674|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16384712|NCT01561976|39892675|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16384713|NCT01561976|39892676|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16384714|NCT01561976|39892677|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16384715|NCT01561976|39892672|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
16384716|NCT01561976|39892673|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
16384717|NCT01561976|39892674|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
16384718|NCT01561976|39892675|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
16384719|NCT01561976|39892676|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
16384720|NCT01561976|39892677|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
16384721|NCT01425814|39892678|FG000|Period 1|Stability criteria not fulfilled|0|||
16384722|NCT01425814|39892679|FG001|Period 1|Stability criteria not fulfilled|1|||
16384723|NCT01425814|39892680|FG002|Period 1|Stability criteria not fulfilled|0|||
16384724|NCT01425814|39892681|FG003|Period 1|Stability criteria not fulfilled|0|||
16384725|NCT01425814|39892682|FG004|Period 1|Stability criteria not fulfilled|0|||
16384726|NCT01425814|39892683|FG005|Period 1|Stability criteria not fulfilled|0|||
16384727|NCT01425814|39892678|FG000|Period 2|Stability criteria not fulfilled|0|||
16384728|NCT01425814|39892679|FG001|Period 2|Stability criteria not fulfilled|1|||
16384729|NCT01425814|39892680|FG002|Period 2|Stability criteria not fulfilled|0|||
16384730|NCT01425814|39892681|FG003|Period 2|Stability criteria not fulfilled|0|||
16384731|NCT01425814|39892682|FG004|Period 2|Stability criteria not fulfilled|0|||
16384732|NCT01425814|39892683|FG005|Period 2|Stability criteria not fulfilled|0|||
16384733|NCT01425814|39892678|FG000|Period 3|Adverse Event|0|||
16384734|NCT01425814|39892679|FG001|Period 3|Adverse Event|0|||
16384735|NCT01425814|39892680|FG002|Period 3|Adverse Event|0|||
16384736|NCT01425814|39892681|FG003|Period 3|Adverse Event|0|||
16384737|NCT01425814|39892682|FG004|Period 3|Adverse Event|0|||
16384738|NCT01425814|39892683|FG005|Period 3|Adverse Event|1|||
16384739|NCT01425814|39892678|FG000|Period 4|Adverse Event|1|||
16384740|NCT01425814|39892679|FG001|Period 4|Adverse Event|0|||
16384741|NCT01425814|39892680|FG002|Period 4|Adverse Event|1|||
16298475|NCT03249792|39577756|FG011|Switch Over Period|Withdrawal by Subject|0|||
16298476|NCT03249792|39577757|FG012|Switch Over Period|Withdrawal by Subject|0|||
16298477|NCT03249792|39577758|FG013|Switch Over Period|Withdrawal by Subject|0|||
16298478|NCT03249792|39577759|FG014|Switch Over Period|Withdrawal by Subject|0|||
16298479|NCT03249792|39577760|FG015|Switch Over Period|Withdrawal by Subject|0|||
16298480|NCT03249792|39577761|FG016|Switch Over Period|Withdrawal by Subject|0|||
16298481|NCT03249792|39577762|FG017|Switch Over Period|Withdrawal by Subject|0|||
16298482|NCT03249792|39577763|FG018|Switch Over Period|Withdrawal by Subject|0|||
16298483|NCT03249792|39577764|FG019|Switch Over Period|Withdrawal by Subject|0|||
16298484|NCT03249792|39577765|FG020|Switch Over Period|Withdrawal by Subject|0|||
16298485|NCT03249792|39577766|FG021|Switch Over Period|Withdrawal by Subject|0|||
16298486|NCT03249792|39577767|FG022|Switch Over Period|Withdrawal by Subject|0|||
16298487|NCT03249792|39577768|FG023|Switch Over Period|Withdrawal by Subject|0|||
16298488|NCT03249792|39577769|FG024|Switch Over Period|Withdrawal by Subject|0|||
16298489|NCT03249792|39577770|FG025|Switch Over Period|Withdrawal by Subject|0|||
16298490|NCT03249792|39577771|FG026|Switch Over Period|Withdrawal by Subject|0|||
16298491|NCT03249792|39577772|FG027|Switch Over Period|Withdrawal by Subject|0|||
16298492|NCT03249792|39577773|FG028|Switch Over Period|Withdrawal by Subject|0|||
16298493|NCT03249792|39577774|FG029|Switch Over Period|Withdrawal by Subject|0|||
16298494|NCT03249792|39577775|FG030|Switch Over Period|Withdrawal by Subject|0|||
16298495|NCT03249792|39577776|FG031|Switch Over Period|Withdrawal by Subject|1|||
16298496|NCT03249792|39577777|FG032|Switch Over Period|Withdrawal by Subject|0|||
16298497|NCT03249792|39577745|FG000|Switch Over Period|Progressive Disease|0|||
16298498|NCT03249792|39577746|FG001|Switch Over Period|Progressive Disease|0|||
16298499|NCT03249792|39577747|FG002|Switch Over Period|Progressive Disease|0|||
16298500|NCT03249792|39577748|FG003|Switch Over Period|Progressive Disease|0|||
16298501|NCT03249792|39577749|FG004|Switch Over Period|Progressive Disease|0|||
16298502|NCT03249792|39577750|FG005|Switch Over Period|Progressive Disease|0|||
16298503|NCT03249792|39577751|FG006|Switch Over Period|Progressive Disease|0|||
16298504|NCT03249792|39577752|FG007|Switch Over Period|Progressive Disease|0|||
16298505|NCT03249792|39577753|FG008|Switch Over Period|Progressive Disease|0|||
16298506|NCT03249792|39577754|FG009|Switch Over Period|Progressive Disease|0|||
16298507|NCT03249792|39577755|FG010|Switch Over Period|Progressive Disease|0|||
16298508|NCT03249792|39577756|FG011|Switch Over Period|Progressive Disease|0|||
16298509|NCT03249792|39577757|FG012|Switch Over Period|Progressive Disease|0|||
16298510|NCT03249792|39577758|FG013|Switch Over Period|Progressive Disease|0|||
16298511|NCT03249792|39577759|FG014|Switch Over Period|Progressive Disease|0|||
16298512|NCT03249792|39577760|FG015|Switch Over Period|Progressive Disease|0|||
16298513|NCT03249792|39577761|FG016|Switch Over Period|Progressive Disease|0|||
16298514|NCT03249792|39577762|FG017|Switch Over Period|Progressive Disease|0|||
16298515|NCT03249792|39577763|FG018|Switch Over Period|Progressive Disease|0|||
16298516|NCT03249792|39577764|FG019|Switch Over Period|Progressive Disease|0|||
16489155|NCT02144012|40266850|FG001|Overall Study|Adverse Event|0|||
16489156|NCT02144012|40266849|FG000|Overall Study|Death|1|||
16489157|NCT02144012|40266850|FG001|Overall Study|Death|0|||
16489158|NCT02144012|40266849|FG000|Overall Study|Withdrawal by Subject|11|||
16489159|NCT02144012|40266850|FG001|Overall Study|Withdrawal by Subject|3|||
16489160|NCT02144012|40266849|FG000|Overall Study|Study Terminated by Sponsor|18|||
16489161|NCT02144012|40266850|FG001|Overall Study|Study Terminated by Sponsor|12|||
16489162|NCT02144012|40266849|FG000|Overall Study|Other|3|||
16489163|NCT02144012|40266850|FG001|Overall Study|Other|0|||
16298517|NCT03249792|39577765|FG020|Switch Over Period|Progressive Disease|0|||
16298518|NCT03249792|39577766|FG021|Switch Over Period|Progressive Disease|0|||
16298519|NCT03249792|39577767|FG022|Switch Over Period|Progressive Disease|0|||
16298520|NCT03249792|39577768|FG023|Switch Over Period|Progressive Disease|0|||
16298521|NCT03249792|39577769|FG024|Switch Over Period|Progressive Disease|0|||
16298522|NCT03249792|39577770|FG025|Switch Over Period|Progressive Disease|0|||
16298523|NCT03249792|39577771|FG026|Switch Over Period|Progressive Disease|1|||
16298524|NCT03249792|39577772|FG027|Switch Over Period|Progressive Disease|0|||
16298525|NCT03249792|39577773|FG028|Switch Over Period|Progressive Disease|1|||
16298526|NCT03249792|39577774|FG029|Switch Over Period|Progressive Disease|2|||
16298527|NCT03249792|39577775|FG030|Switch Over Period|Progressive Disease|1|||
16298528|NCT03249792|39577776|FG031|Switch Over Period|Progressive Disease|0|||
16298529|NCT03249792|39577777|FG032|Switch Over Period|Progressive Disease|1|||
16298530|NCT03249792|39577745|FG000|Switch Over Period|Adverse Event|0|||
16298531|NCT03249792|39577746|FG001|Switch Over Period|Adverse Event|0|||
16298532|NCT03249792|39577747|FG002|Switch Over Period|Adverse Event|0|||
16298533|NCT03249792|39577748|FG003|Switch Over Period|Adverse Event|0|||
16298534|NCT03249792|39577749|FG004|Switch Over Period|Adverse Event|0|||
16298535|NCT03249792|39577750|FG005|Switch Over Period|Adverse Event|0|||
16384742|NCT01425814|39892681|FG003|Period 4|Adverse Event|0|||
16298536|NCT03249792|39577751|FG006|Switch Over Period|Adverse Event|0|||
16298537|NCT03249792|39577752|FG007|Switch Over Period|Adverse Event|0|||
16298538|NCT03249792|39577753|FG008|Switch Over Period|Adverse Event|0|||
16489164|NCT03808545|40266851|FG000|Overall Study|Withdrawal by Subject|1|||
16489165|NCT03808545|40266852|FG001|Overall Study|Withdrawal by Subject|1|||
16489166|NCT00496054|40266853|FG000|Overall Study|Adverse Event|1|||
16298539|NCT03249792|39577754|FG009|Switch Over Period|Adverse Event|0|||
16298540|NCT03249792|39577755|FG010|Switch Over Period|Adverse Event|0|||
16298541|NCT03249792|39577756|FG011|Switch Over Period|Adverse Event|0|||
16298542|NCT03249792|39577757|FG012|Switch Over Period|Adverse Event|0|||
16298543|NCT03249792|39577758|FG013|Switch Over Period|Adverse Event|0|||
16298544|NCT03249792|39577759|FG014|Switch Over Period|Adverse Event|0|||
16298545|NCT03249792|39577760|FG015|Switch Over Period|Adverse Event|0|||
16298546|NCT03249792|39577761|FG016|Switch Over Period|Adverse Event|0|||
16298547|NCT03249792|39577762|FG017|Switch Over Period|Adverse Event|0|||
16298548|NCT03249792|39577763|FG018|Switch Over Period|Adverse Event|0|||
16298549|NCT03249792|39577764|FG019|Switch Over Period|Adverse Event|0|||
16298550|NCT03249792|39577765|FG020|Switch Over Period|Adverse Event|0|||
16298551|NCT03249792|39577766|FG021|Switch Over Period|Adverse Event|0|||
16298552|NCT03249792|39577767|FG022|Switch Over Period|Adverse Event|0|||
16298553|NCT03249792|39577768|FG023|Switch Over Period|Adverse Event|0|||
16298554|NCT03249792|39577769|FG024|Switch Over Period|Adverse Event|0|||
16298555|NCT03249792|39577770|FG025|Switch Over Period|Adverse Event|1|||
16298556|NCT03249792|39577771|FG026|Switch Over Period|Adverse Event|0|||
16298557|NCT03249792|39577772|FG027|Switch Over Period|Adverse Event|1|||
16298558|NCT03249792|39577773|FG028|Switch Over Period|Adverse Event|0|||
16298559|NCT03249792|39577774|FG029|Switch Over Period|Adverse Event|0|||
16298560|NCT03249792|39577775|FG030|Switch Over Period|Adverse Event|0|||
16298561|NCT03249792|39577776|FG031|Switch Over Period|Adverse Event|0|||
16298562|NCT03249792|39577777|FG032|Switch Over Period|Adverse Event|0|||
16298563|NCT01860677|39577778|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
16298564|NCT01860677|39577779|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
16298565|NCT01464931|39577780|FG000|Overall Study|Withdrawal by Subject|1|||
16298566|NCT01464931|39577781|FG001|Overall Study|Withdrawal by Subject|0|||
16298567|NCT01398514|39577782|FG000|Overall Study|Adverse Event|1|||
16298568|NCT01398514|39577783|FG001|Overall Study|Adverse Event|0|||
16298569|NCT01398514|39577782|FG000|Overall Study|Non-compliance with study procedures|2|||
16298570|NCT01398514|39577783|FG001|Overall Study|Non-compliance with study procedures|0|||
16298571|NCT01398514|39577782|FG000|Overall Study|Physiologic non-responsiveness|1|||
16298572|NCT01398514|39577783|FG001|Overall Study|Physiologic non-responsiveness|3|||
16489167|NCT00496054|40266853|FG000|Overall Study|Lost to Follow-up|7|||
16489168|NCT00601458|40266854|FG000|Overall Study|Dosing Error|1|||
16190585|NCT00142519|39176048|FG000|Overall Study|Protocol Violation|1|||
16298573|NCT01398514|39577782|FG000|Overall Study|Failure to show a conditioned response|4|||
16298574|NCT01398514|39577783|FG001|Overall Study|Failure to show a conditioned response|3|||
16298575|NCT04893018|39577787|FG000|Overall Study|Lost to Follow-up|1|||
16298576|NCT04893018|39577788|FG001|Overall Study|Lost to Follow-up|0|||
16298577|NCT04893018|39577787|FG000|Overall Study|Withdrawal by Subject|2|||
16298578|NCT04893018|39577788|FG001|Overall Study|Withdrawal by Subject|0|||
16298579|NCT04893018|39577787|FG000|Overall Study|Study Terminated|1|||
16298580|NCT04893018|39577788|FG001|Overall Study|Study Terminated|2|||
16298581|NCT04495283|39577796|FG000|Overall Study|Physician Decision|0|||
16298582|NCT04495283|39577797|FG001|Overall Study|Physician Decision|0|||
16298583|NCT04495283|39577798|FG002|Overall Study|Physician Decision|1|||
16298584|NCT04495283|39577796|FG000|Overall Study|Withdrawal by Subject|0|||
16298585|NCT04495283|39577797|FG001|Overall Study|Withdrawal by Subject|1|||
16298586|NCT04495283|39577798|FG002|Overall Study|Withdrawal by Subject|1|||
16298587|NCT04495283|39577796|FG000|Overall Study|Other|1|||
16298588|NCT04495283|39577797|FG001|Overall Study|Other|0|||
16298589|NCT04495283|39577798|FG002|Overall Study|Other|1|||
16298590|NCT02992418|39577802|FG000|Overall Study|Withdrawal by Subject|11|||
16298591|NCT02992418|39577803|FG001|Overall Study|Withdrawal by Subject|12|||
16298592|NCT02992418|39577802|FG000|Overall Study|Non-compliance with the protocol|308|||
16298593|NCT02992418|39577803|FG001|Overall Study|Non-compliance with the protocol|308|||
16298594|NCT02992418|39577802|FG000|Overall Study|Lost to Follow-up|27|||
16384743|NCT01425814|39892682|FG004|Period 4|Adverse Event|0|||
16298595|NCT02992418|39577803|FG001|Overall Study|Lost to Follow-up|22|||
16298596|NCT03866902|39577804|FG000|Overall Study|Lost to Follow-up|98|||
16298597|NCT03866902|39577805|FG001|Overall Study|Lost to Follow-up|82|||
16298598|NCT03866902|39577804|FG000|Overall Study|Pregnancy|18|||
16298599|NCT03866902|39577805|FG001|Overall Study|Pregnancy|24|||
16298600|NCT01739348|39577806|FG000|Part I (Base Study)|Adverse Event|41|||
16298601|NCT01739348|39577807|FG001|Part I (Base Study)|Adverse Event|52|||
16298602|NCT01739348|39577808|FG002|Part I (Base Study)|Adverse Event|8|||
16298603|NCT01739348|39577809|FG003|Part I (Base Study)|Adverse Event|33|||
16298604|NCT01739348|39577806|FG000|Part I (Base Study)|Death|10|||
16298605|NCT01739348|39577807|FG001|Part I (Base Study)|Death|7|||
16298606|NCT01739348|39577808|FG002|Part I (Base Study)|Death|2|||
16298607|NCT01739348|39577809|FG003|Part I (Base Study)|Death|8|||
16298608|NCT01739348|39577806|FG000|Part I (Base Study)|Lack of Efficacy|3|||
16298609|NCT01739348|39577807|FG001|Part I (Base Study)|Lack of Efficacy|8|||
16298610|NCT01739348|39577808|FG002|Part I (Base Study)|Lack of Efficacy|0|||
16298611|NCT01739348|39577809|FG003|Part I (Base Study)|Lack of Efficacy|7|||
16298612|NCT01739348|39577806|FG000|Part I (Base Study)|Lost to Follow-up|4|||
16489169|NCT00601458|40266855|FG001|Overall Study|Dosing Error|0|||
16298613|NCT01739348|39577807|FG001|Part I (Base Study)|Lost to Follow-up|2|||
16298614|NCT01739348|39577808|FG002|Part I (Base Study)|Lost to Follow-up|4|||
16298615|NCT01739348|39577809|FG003|Part I (Base Study)|Lost to Follow-up|4|||
16298616|NCT01739348|39577806|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
16298617|NCT01739348|39577807|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
16298618|NCT01739348|39577808|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
16298619|NCT01739348|39577809|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
16298620|NCT01739348|39577806|FG000|Part I (Base Study)|Physician Decision|10|||
16298621|NCT01739348|39577807|FG001|Part I (Base Study)|Physician Decision|7|||
16298622|NCT01739348|39577808|FG002|Part I (Base Study)|Physician Decision|1|||
16298623|NCT01739348|39577809|FG003|Part I (Base Study)|Physician Decision|4|||
16298624|NCT01739348|39577806|FG000|Part I (Base Study)|Protocol Violation|2|||
16298625|NCT01739348|39577807|FG001|Part I (Base Study)|Protocol Violation|0|||
16298626|NCT01739348|39577808|FG002|Part I (Base Study)|Protocol Violation|1|||
16298627|NCT01739348|39577809|FG003|Part I (Base Study)|Protocol Violation|2|||
16298628|NCT01739348|39577806|FG000|Part I (Base Study)|Screen Failure|2|||
16384744|NCT01425814|39892683|FG005|Period 4|Adverse Event|0|||
16384745|NCT01425814|39892678|FG000|Period 5|Stability criteria not fulfilled|0|||
16384746|NCT01425814|39892679|FG001|Period 5|Stability criteria not fulfilled|0|||
16384747|NCT01425814|39892680|FG002|Period 5|Stability criteria not fulfilled|1|||
16384748|NCT01425814|39892681|FG003|Period 5|Stability criteria not fulfilled|0|||
16384749|NCT01425814|39892682|FG004|Period 5|Stability criteria not fulfilled|0|||
16384750|NCT01425814|39892683|FG005|Period 5|Stability criteria not fulfilled|1|||
16384751|NCT03639610|39892689|FG000|Overall Study|Adverse Event|7|||
16384752|NCT03639610|39892690|FG001|Overall Study|Adverse Event|1|||
16384753|NCT03639610|39892691|FG002|Overall Study|Adverse Event|0|||
16384754|NCT03639610|39892689|FG000|Overall Study|Physician Decision|3|||
16384755|NCT03639610|39892690|FG001|Overall Study|Physician Decision|1|||
16384756|NCT03639610|39892691|FG002|Overall Study|Physician Decision|0|||
16384757|NCT03639610|39892689|FG000|Overall Study|Disease progression|8|||
16384758|NCT03639610|39892690|FG001|Overall Study|Disease progression|5|||
16384759|NCT03639610|39892691|FG002|Overall Study|Disease progression|3|||
16384760|NCT03639610|39892689|FG000|Overall Study|Study terminated by sponsor|2|||
16384761|NCT03639610|39892690|FG001|Overall Study|Study terminated by sponsor|1|||
16384762|NCT03639610|39892691|FG002|Overall Study|Study terminated by sponsor|1|||
16384763|NCT03639610|39892689|FG000|Overall Study|Patient request to stop treatment|1|||
16384764|NCT03639610|39892690|FG001|Overall Study|Patient request to stop treatment|2|||
16384765|NCT03639610|39892691|FG002|Overall Study|Patient request to stop treatment|0|||
16384766|NCT03247829|39892692|FG000|Overall Study|Death|3|||
16384767|NCT03247829|39892693|FG001|Overall Study|Death|4|||
16384768|NCT03247829|39892692|FG000|Overall Study|Enter Hospice Care|1|||
16384769|NCT03247829|39892693|FG001|Overall Study|Enter Hospice Care|0|||
16384770|NCT03247829|39892692|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
16384771|NCT03247829|39892693|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
16384772|NCT03247829|39892692|FG000|Overall Study|LVAD Explant|1|||
16384773|NCT03247829|39892693|FG001|Overall Study|LVAD Explant|1|||
16384774|NCT03247829|39892692|FG000|Overall Study|Transplant|1|||
16384775|NCT03247829|39892693|FG001|Overall Study|Transplant|1|||
16384776|NCT02431325|39892696|FG000|Overall Study|Adverse Event|3|||
16384777|NCT02431325|39892697|FG001|Overall Study|Adverse Event|0|||
16384778|NCT02431325|39892696|FG000|Overall Study|Lost to Follow-up|0|||
16384779|NCT02431325|39892697|FG001|Overall Study|Lost to Follow-up|1|||
16384780|NCT02431325|39892696|FG000|Overall Study|Withdrawal by Subject|1|||
16384781|NCT02431325|39892697|FG001|Overall Study|Withdrawal by Subject|2|||
16384782|NCT02431325|39892696|FG000|Overall Study|Declined to take study medication|1|||
16384783|NCT02431325|39892697|FG001|Overall Study|Declined to take study medication|0|||
16384784|NCT02431325|39892696|FG000|Overall Study|Withdrew before starting study medication|1|||
16384785|NCT02431325|39892697|FG001|Overall Study|Withdrew before starting study medication|0|||
16384786|NCT02431325|39892696|FG000|Overall Study|Placebo shortage|2|||
16384787|NCT02431325|39892697|FG001|Overall Study|Placebo shortage|0|||
16384788|NCT00812955|39892700|FG000|Overall Study|Adverse Event|7|||
16384789|NCT00812955|39892701|FG001|Overall Study|Adverse Event|6|||
16384790|NCT00812955|39892702|FG002|Overall Study|Adverse Event|3|||
16384791|NCT00812955|39892703|FG003|Overall Study|Adverse Event|4|||
16384792|NCT00812955|39892700|FG000|Overall Study|Lost to Follow-up|2|||
16384793|NCT00812955|39892701|FG001|Overall Study|Lost to Follow-up|1|||
16384794|NCT00812955|39892702|FG002|Overall Study|Lost to Follow-up|1|||
16298629|NCT01739348|39577807|FG001|Part I (Base Study)|Screen Failure|0|||
16298630|NCT01739348|39577808|FG002|Part I (Base Study)|Screen Failure|0|||
16298631|NCT01739348|39577809|FG003|Part I (Base Study)|Screen Failure|0|||
16384795|NCT00812955|39892703|FG003|Overall Study|Lost to Follow-up|2|||
16384796|NCT00812955|39892700|FG000|Overall Study|Withdrawal by Subject|1|||
16384797|NCT00812955|39892701|FG001|Overall Study|Withdrawal by Subject|0|||
16384798|NCT00812955|39892702|FG002|Overall Study|Withdrawal by Subject|1|||
16384799|NCT00812955|39892703|FG003|Overall Study|Withdrawal by Subject|2|||
16298632|NCT01739348|39577806|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
16384800|NCT00812955|39892700|FG000|Overall Study|randomized in error|0|||
16384801|NCT00812955|39892701|FG001|Overall Study|randomized in error|0|||
16384802|NCT00812955|39892702|FG002|Overall Study|randomized in error|1|||
16384803|NCT00812955|39892703|FG003|Overall Study|randomized in error|0|||
16384804|NCT01900665|39892704|FG000|Placebo Controlled Period|Death|9|||
16384805|NCT01900665|39892705|FG001|Placebo Controlled Period|Death|16|||
16384806|NCT01900665|39892704|FG000|Placebo Controlled Period|Adverse Event|48|||
16384807|NCT01900665|39892705|FG001|Placebo Controlled Period|Adverse Event|39|||
16384808|NCT01900665|39892704|FG000|Placebo Controlled Period|Protocol Violation|1|||
16384809|NCT01900665|39892705|FG001|Placebo Controlled Period|Protocol Violation|7|||
16384810|NCT01900665|39892704|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
16384811|NCT01900665|39892705|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
16384812|NCT01900665|39892704|FG000|Placebo Controlled Period|Physician Decision|11|||
16384813|NCT01900665|39892705|FG001|Placebo Controlled Period|Physician Decision|7|||
16384814|NCT01900665|39892704|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
16384815|NCT01900665|39892705|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
16384816|NCT01900665|39892704|FG000|Placebo Controlled Period|Caregiver Decision|33|||
16384817|NCT01900665|39892705|FG001|Placebo Controlled Period|Caregiver Decision|41|||
16384818|NCT01900665|39892704|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
16384819|NCT01900665|39892705|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
16384820|NCT01900665|39892704|FG000|Open Label Period|Adverse Event|16|||
16384821|NCT01900665|39892705|FG001|Open Label Period|Adverse Event|20|||
16384822|NCT01900665|39892704|FG000|Open Label Period|Death|5|||
16384823|NCT01900665|39892705|FG001|Open Label Period|Death|6|||
16384824|NCT01900665|39892704|FG000|Open Label Period|Lost to Follow-up|1|||
16384825|NCT01900665|39892705|FG001|Open Label Period|Lost to Follow-up|1|||
16384826|NCT01900665|39892704|FG000|Open Label Period|Parent/Caregiver Decision|33|||
16384827|NCT01900665|39892705|FG001|Open Label Period|Parent/Caregiver Decision|34|||
16384828|NCT01900665|39892704|FG000|Open Label Period|Physician Decision|4|||
16384829|NCT01900665|39892705|FG001|Open Label Period|Physician Decision|4|||
16384830|NCT01900665|39892704|FG000|Open Label Period|Protocol Violation|0|||
16384831|NCT01900665|39892705|FG001|Open Label Period|Protocol Violation|1|||
16384832|NCT01900665|39892704|FG000|Open Label Period|Sponsor Decision|802|||
16384833|NCT01900665|39892705|FG001|Open Label Period|Sponsor Decision|765|||
16384834|NCT01900665|39892704|FG000|Open Label Period|Withdrawal by Subject|20|||
16384835|NCT01900665|39892705|FG001|Open Label Period|Withdrawal by Subject|28|||
16384836|NCT01968980|39892712|FG000|Overall Study|Death|0|||
16384837|NCT01968980|39892713|FG001|Overall Study|Death|1|||
16384838|NCT01968980|39892712|FG000|Overall Study|Adverse Event|1|||
16384839|NCT01968980|39892713|FG001|Overall Study|Adverse Event|3|||
16384840|NCT01968980|39892712|FG000|Overall Study|Does not meet entry criteria|1|||
16384841|NCT01968980|39892713|FG001|Overall Study|Does not meet entry criteria|3|||
16384842|NCT01968980|39892712|FG000|Overall Study|Withdrawal by Subject|13|||
16384843|NCT01968980|39892713|FG001|Overall Study|Withdrawal by Subject|5|||
16384844|NCT01968980|39892712|FG000|Overall Study|Other unspecified|1|||
16384845|NCT01968980|39892713|FG001|Overall Study|Other unspecified|2|||
16384846|NCT02701764|39892714|FG000|Overall Study|Lost to Follow-up|0|||
16384847|NCT02701764|39892715|FG001|Overall Study|Lost to Follow-up|1|||
16384848|NCT00160563|39892716|FG000|Overall Study|Adverse Event|1|||
16384849|NCT00160563|39892717|FG001|Overall Study|Adverse Event|1|||
16384850|NCT00160563|39892718|FG002|Overall Study|Adverse Event|1|||
16384851|NCT00160563|39892716|FG000|Overall Study|Lost to Follow-up|1|||
16384852|NCT00160563|39892717|FG001|Overall Study|Lost to Follow-up|1|||
16489170|NCT00601458|40266856|FG002|Overall Study|Dosing Error|0|||
16489171|NCT00601458|40266854|FG000|Overall Study|Incomplete Data|0|||
16489172|NCT00601458|40266855|FG001|Overall Study|Incomplete Data|2|||
16489173|NCT00601458|40266856|FG002|Overall Study|Incomplete Data|0|||
16489174|NCT00601458|40266854|FG000|Overall Study|Protocol Violation|3|||
16489175|NCT00601458|40266855|FG001|Overall Study|Protocol Violation|2|||
16489176|NCT00601458|40266856|FG002|Overall Study|Protocol Violation|1|||
16489177|NCT00601458|40266854|FG000|Overall Study|Early Termination|0|||
16489178|NCT00601458|40266855|FG001|Overall Study|Early Termination|1|||
16489179|NCT00601458|40266856|FG002|Overall Study|Early Termination|1|||
16489180|NCT00289991|40266862|FG000|Overall Study|Death|35|||
16384853|NCT00160563|39892718|FG002|Overall Study|Lost to Follow-up|2|||
16384854|NCT00160563|39892716|FG000|Overall Study|Protocol Violation|0|||
16384855|NCT00160563|39892717|FG001|Overall Study|Protocol Violation|0|||
16384856|NCT00160563|39892718|FG002|Overall Study|Protocol Violation|3|||
16384857|NCT00160563|39892716|FG000|Overall Study|Withdrawal by Subject|1|||
16384858|NCT00160563|39892717|FG001|Overall Study|Withdrawal by Subject|2|||
16489181|NCT00289991|40266863|FG001|Overall Study|Death|38|||
16384859|NCT00160563|39892718|FG002|Overall Study|Withdrawal by Subject|3|||
16384860|NCT00160563|39892716|FG000|Overall Study|Other (listed in the study report)|48|||
16489182|NCT00289991|40266862|FG000|Overall Study|Adverse Event|15|||
16489183|NCT00289991|40266863|FG001|Overall Study|Adverse Event|13|||
16489184|NCT00289991|40266862|FG000|Overall Study|Failure of prophylaxis|1|||
16489185|NCT00289991|40266863|FG001|Overall Study|Failure of prophylaxis|1|||
16489186|NCT00289991|40266862|FG000|Overall Study|Fungal breakthrough infection|0|||
16298633|NCT01739348|39577807|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
16298634|NCT01739348|39577808|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
16489187|NCT00289991|40266863|FG001|Overall Study|Fungal breakthrough infection|1|||
16489188|NCT00289991|40266862|FG000|Overall Study|Lost to Follow-up|0|||
16489189|NCT00289991|40266863|FG001|Overall Study|Lost to Follow-up|1|||
16489190|NCT00289991|40266862|FG000|Overall Study|Withdrawal by Subject|2|||
16489191|NCT00289991|40266863|FG001|Overall Study|Withdrawal by Subject|12|||
16489192|NCT00289991|40266862|FG000|Overall Study|Other|5|||
16489193|NCT00289991|40266863|FG001|Overall Study|Other|14|||
16489194|NCT02036294|40266864|FG000|Overall Study|Death|7|||
16489195|NCT02036294|40266865|FG001|Overall Study|Death|8|||
16489196|NCT02036294|40266864|FG000|Overall Study|Withdrawal by Subject|2|||
16489197|NCT02036294|40266865|FG001|Overall Study|Withdrawal by Subject|3|||
16489198|NCT00541931|40266866|FG000|Overall Study|Adverse Event|1|||
16489199|NCT00541931|40266867|FG001|Overall Study|Adverse Event|0|||
16489200|NCT00541931|40266866|FG000|Overall Study|Lost to Follow-up|3|||
16489201|NCT00541931|40266867|FG001|Overall Study|Lost to Follow-up|3|||
16489202|NCT00541931|40266866|FG000|Overall Study|Withdrawal by Subject|1|||
16489203|NCT00541931|40266867|FG001|Overall Study|Withdrawal by Subject|0|||
16489204|NCT00541931|40266866|FG000|Overall Study|Transportation Issue|0|||
16489205|NCT00541931|40266867|FG001|Overall Study|Transportation Issue|1|||
16489206|NCT02966028|40266873|FG000|Overall Study|Adverse Event|7|||
16489207|NCT02966028|40266874|FG001|Overall Study|Adverse Event|13|||
16489208|NCT02966028|40266875|FG002|Overall Study|Adverse Event|10|||
16489209|NCT02966028|40266873|FG000|Overall Study|Physician Decision|1|||
16489210|NCT02966028|40266874|FG001|Overall Study|Physician Decision|0|||
16489211|NCT02966028|40266875|FG002|Overall Study|Physician Decision|2|||
16489212|NCT02966028|40266873|FG000|Overall Study|Withdrawal by Subject|7|||
16489213|NCT02966028|40266874|FG001|Overall Study|Withdrawal by Subject|5|||
16489214|NCT02966028|40266875|FG002|Overall Study|Withdrawal by Subject|5|||
16489215|NCT02966028|40266873|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
16489216|NCT02966028|40266874|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
16489217|NCT02966028|40266875|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
16489218|NCT00787891|40266876|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
16489219|NCT00787891|40266877|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
16489220|NCT00787891|40266876|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
16489221|NCT00787891|40266877|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
16489222|NCT00787891|40266876|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
16489223|NCT00787891|40266877|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
16489224|NCT00787891|40266876|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
16489225|NCT00787891|40266877|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
16489226|NCT00787891|40266876|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
16489227|NCT00787891|40266877|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
16489228|NCT00787891|40266876|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
16489229|NCT00787891|40266877|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
16489230|NCT00787891|40266876|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
16489231|NCT00787891|40266877|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
16489232|NCT00787891|40266876|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
16489233|NCT00787891|40266877|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
16489234|NCT00787891|40266876|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
16489235|NCT00787891|40266877|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
16489236|NCT00787891|40266876|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
16489237|NCT00787891|40266877|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
16489238|NCT02944968|40266878|FG000|Overall Study|Subject excluded before study procedure|1|||
16489239|NCT02944968|40266878|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
16489240|NCT04444895|40266879|FG000|Overall Study|Adverse Event|2|||
16489241|NCT04444895|40266879|FG000|Overall Study|Lost to Follow-up|2|||
16489242|NCT04444895|40266879|FG000|Overall Study|Withdrawal by Subject|5|||
16489243|NCT02717611|40266881|FG000|Overall Study|Death|13|||
16489244|NCT02717611|40266881|FG000|Overall Study|Withdrawal by Subject|6|||
16489245|NCT02717611|40266881|FG000|Overall Study|Active, not recruiting|40|||
16489246|NCT02717611|40266881|FG000|Overall Study|Complicating disease|1|||
16489247|NCT00444912|40266885|FG000|Overall Study|Death|1|||
16489248|NCT00444912|40266886|FG001|Overall Study|Death|2|||
16489249|NCT00444912|40266885|FG000|Overall Study|Lost to Follow-up|1|||
16489250|NCT00444912|40266886|FG001|Overall Study|Lost to Follow-up|0|||
16489251|NCT00444912|40266885|FG000|Overall Study|Participant Failed Mobilization|1|||
16489252|NCT00444912|40266886|FG001|Overall Study|Participant Failed Mobilization|0|||
16489253|NCT02860169|40266887|FG000|Part A|Withdrawal by Subject|1|||
16489254|NCT02860169|40266887|FG000|Part A|Other (Screening failure)|6|||
16489255|NCT02860169|40266887|FG000|Part A|Other (Survey not completed)|3|||
16489256|NCT02860169|40266887|FG000|Part A|Other (did not completed consent)|1|||
16489257|NCT02860169|40266887|FG000|Part B|Other (Screening failure)|10|||
16489258|NCT02860169|40266887|FG000|Part B|Withdrawal by Subject|1|||
16489259|NCT02860169|40266887|FG000|Part C|Other (Screening failure)|1|||
16489260|NCT02612727|40266890|FG000|Overall Study|Parent request|4|||
16489261|NCT02612727|40266891|FG001|Overall Study|Parent request|1|||
16489262|NCT02612727|40266890|FG000|Overall Study|Needed treatment incompatible with PT|1|||
16489263|NCT02612727|40266891|FG001|Overall Study|Needed treatment incompatible with PT|1|||
16489264|NCT02612727|40266890|FG000|Overall Study|Direct hyperbilirubinemia|0|||
16489265|NCT02612727|40266891|FG001|Overall Study|Direct hyperbilirubinemia|2|||
16489266|NCT02468232|40266893|FG000|Core Part of Study|Adverse Event|0|||
16489267|NCT02468232|40266894|FG001|Core Part of Study|Adverse Event|1|||
16489268|NCT02468232|40266895|FG002|Core Part of Study|Adverse Event|0|||
16489269|NCT02468232|40266896|FG003|Core Part of Study|Adverse Event|0|||
16489270|NCT02468232|40266893|FG000|Core Part of Study|Death|20|||
16489271|NCT02468232|40266894|FG001|Core Part of Study|Death|17|||
16489272|NCT02468232|40266895|FG002|Core Part of Study|Death|0|||
16298635|NCT01739348|39577809|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
16298636|NCT01739348|39577806|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
16190586|NCT00142519|39176049|FG001|Overall Study|Protocol Violation|0|||
16190587|NCT00142519|39176048|FG000|Overall Study|Withdrawal by Subject|10|||
16190588|NCT00142519|39176049|FG001|Overall Study|Withdrawal by Subject|7|||
16190589|NCT02819310|39176051|FG000|Overall Study|Withdrawal by Subject|37|||
16190590|NCT02819310|39176051|FG000|Overall Study|Lost to Follow-up|16|||
16190591|NCT02819310|39176051|FG000|Overall Study|Adverse Event|13|||
16190592|NCT02819310|39176051|FG000|Overall Study|Lack of Efficacy|5|||
16190593|NCT02819310|39176051|FG000|Overall Study|Physician Decision|8|||
16190594|NCT02819310|39176051|FG000|Overall Study|Protocol Violation|30|||
16190595|NCT02998554|39176052|FG000|Overall Study|Adverse Event|8|||
16190596|NCT02998554|39176053|FG001|Overall Study|Adverse Event|3|||
16190597|NCT02998554|39176052|FG000|Overall Study|Protocol deviation|1|||
16190598|NCT02998554|39176053|FG001|Overall Study|Protocol deviation|0|||
16190599|NCT02998554|39176052|FG000|Overall Study|Withdrawal by Subject|2|||
16190600|NCT02998554|39176053|FG001|Overall Study|Withdrawal by Subject|6|||
16190601|NCT02998554|39176052|FG000|Overall Study|Lost to Follow-up|0|||
16190602|NCT02998554|39176053|FG001|Overall Study|Lost to Follow-up|1|||
16190603|NCT02998554|39176052|FG000|Overall Study|Lack of Efficacy|0|||
16190604|NCT02998554|39176053|FG001|Overall Study|Lack of Efficacy|1|||
16190605|NCT01839188|39176054|FG000|Overall Study|Withdrawal by Subject|1|||
16190606|NCT01683071|39176056|FG000|Part 1|Lack of Efficacy|1|||
16190607|NCT01683071|39176057|FG001|Part 1|Lack of Efficacy|0|||
16190608|NCT01683071|39176058|FG002|Part 1|Lack of Efficacy|0|||
16190609|NCT01683071|39176059|FG003|Part 1|Lack of Efficacy|3|||
16190610|NCT01683071|39176060|FG004|Part 1|Lack of Efficacy|0|||
16190611|NCT01683071|39176061|FG005|Part 1|Lack of Efficacy|0|||
16190612|NCT01683071|39176056|FG000|Part 1|Withdrawal by Subject|1|||
16190613|NCT01683071|39176057|FG001|Part 1|Withdrawal by Subject|2|||
16190614|NCT01683071|39176058|FG002|Part 1|Withdrawal by Subject|2|||
16190615|NCT01683071|39176059|FG003|Part 1|Withdrawal by Subject|1|||
16190616|NCT01683071|39176060|FG004|Part 1|Withdrawal by Subject|0|||
16190617|NCT01683071|39176061|FG005|Part 1|Withdrawal by Subject|0|||
16190618|NCT01683071|39176056|FG000|Part 1|Surgery Cancelled|1|||
16190619|NCT01683071|39176057|FG001|Part 1|Surgery Cancelled|0|||
16190620|NCT01683071|39176058|FG002|Part 1|Surgery Cancelled|0|||
16190621|NCT01683071|39176059|FG003|Part 1|Surgery Cancelled|0|||
16190622|NCT01683071|39176060|FG004|Part 1|Surgery Cancelled|0|||
16190623|NCT01683071|39176061|FG005|Part 1|Surgery Cancelled|0|||
16489273|NCT02468232|40266896|FG003|Core Part of Study|Death|0|||
16489274|NCT02468232|40266893|FG000|Core Part of Study|Technical Problems|1|||
16489275|NCT02468232|40266894|FG001|Core Part of Study|Technical Problems|1|||
16489276|NCT02468232|40266895|FG002|Core Part of Study|Technical Problems|0|||
16190624|NCT01683071|39176056|FG000|Part 1|Did not receive study drug|1|||
16489277|NCT02468232|40266896|FG003|Core Part of Study|Technical Problems|0|||
16190625|NCT01683071|39176057|FG001|Part 1|Did not receive study drug|0|||
16190626|NCT01683071|39176058|FG002|Part 1|Did not receive study drug|0|||
16489278|NCT02468232|40266893|FG000|OLE Part of Study|Adverse Event|0|||
16489279|NCT02468232|40266894|FG001|OLE Part of Study|Adverse Event|0|||
16489280|NCT02468232|40266895|FG002|OLE Part of Study|Adverse Event|4|||
16489281|NCT02468232|40266896|FG003|OLE Part of Study|Adverse Event|5|||
16489282|NCT02468232|40266893|FG000|OLE Part of Study|Death|0|||
16190627|NCT01683071|39176059|FG003|Part 1|Did not receive study drug|1|||
16190628|NCT01683071|39176060|FG004|Part 1|Did not receive study drug|0|||
16190629|NCT01683071|39176061|FG005|Part 1|Did not receive study drug|0|||
16190630|NCT01683071|39176056|FG000|Part 1|Early termination; met exclusion criteria|0|||
16190631|NCT01683071|39176057|FG001|Part 1|Early termination; met exclusion criteria|2|||
16190632|NCT01683071|39176058|FG002|Part 1|Early termination; met exclusion criteria|1|||
16190633|NCT01683071|39176059|FG003|Part 1|Early termination; met exclusion criteria|0|||
16190634|NCT01683071|39176060|FG004|Part 1|Early termination; met exclusion criteria|0|||
16190635|NCT01683071|39176061|FG005|Part 1|Early termination; met exclusion criteria|0|||
16190636|NCT01683071|39176056|FG000|Part 2|Lack of Efficacy|0|||
16190637|NCT01683071|39176057|FG001|Part 2|Lack of Efficacy|0|||
16298637|NCT01739348|39577807|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
16298638|NCT01739348|39577808|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
16298639|NCT01739348|39577809|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
16298640|NCT01739348|39577806|FG000|Part I (Base Study)|Participant Moved|4|||
16298641|NCT01739348|39577807|FG001|Part I (Base Study)|Participant Moved|3|||
16298642|NCT01739348|39577808|FG002|Part I (Base Study)|Participant Moved|1|||
16298643|NCT01739348|39577809|FG003|Part I (Base Study)|Participant Moved|7|||
16298644|NCT01739348|39577806|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
16298645|NCT01739348|39577807|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
16298646|NCT01739348|39577808|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
16298647|NCT01739348|39577809|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
16298648|NCT01739348|39577806|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
16298649|NCT01739348|39577807|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
16298650|NCT01739348|39577808|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
16298651|NCT01739348|39577809|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
16298652|NCT01739348|39577806|FG000|Part II (Extension Study)|Adverse Event|10|||
16298653|NCT01739348|39577807|FG001|Part II (Extension Study)|Adverse Event|11|||
16298654|NCT01739348|39577808|FG002|Part II (Extension Study)|Adverse Event|7|||
16298655|NCT01739348|39577809|FG003|Part II (Extension Study)|Adverse Event|26|||
16298656|NCT01739348|39577806|FG000|Part II (Extension Study)|Death|3|||
16298657|NCT01739348|39577807|FG001|Part II (Extension Study)|Death|3|||
16298658|NCT01739348|39577808|FG002|Part II (Extension Study)|Death|2|||
16298659|NCT01739348|39577809|FG003|Part II (Extension Study)|Death|6|||
16298660|NCT01739348|39577806|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
16298661|NCT01739348|39577807|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
16298662|NCT01739348|39577808|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
16298663|NCT01739348|39577809|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
16298664|NCT01739348|39577806|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
16298665|NCT01739348|39577807|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
16298666|NCT01739348|39577808|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
16298667|NCT01739348|39577809|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
16298668|NCT01739348|39577806|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
16298669|NCT01739348|39577807|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
16298670|NCT01739348|39577808|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
16298671|NCT01739348|39577809|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
16298672|NCT01739348|39577806|FG000|Part II (Extension Study)|Physician Decision|7|||
16298673|NCT01739348|39577807|FG001|Part II (Extension Study)|Physician Decision|11|||
16298674|NCT01739348|39577808|FG002|Part II (Extension Study)|Physician Decision|6|||
16384861|NCT00160563|39892717|FG001|Overall Study|Other (listed in the study report)|40|||
16384862|NCT00160563|39892718|FG002|Overall Study|Other (listed in the study report)|81|||
16384863|NCT00160563|39892716|FG000|Overall Study|Missing reason|0|||
16384864|NCT00160563|39892717|FG001|Overall Study|Missing reason|1|||
16384865|NCT00160563|39892718|FG002|Overall Study|Missing reason|0|||
16384866|NCT00943761|39892719|FG000|Overall Study|Lost to Follow-up|2|||
16384867|NCT00943761|39892720|FG001|Overall Study|Lost to Follow-up|0|||
16384868|NCT00943761|39892719|FG000|Overall Study|Withdrawal by Subject|2|||
16384869|NCT00943761|39892720|FG001|Overall Study|Withdrawal by Subject|1|||
16384870|NCT01822665|39892721|FG000|Overall Study|Adverse Event|3|||
16298675|NCT01739348|39577809|FG003|Part II (Extension Study)|Physician Decision|12|||
16384871|NCT01822665|39892721|FG000|Overall Study|Other Reason|5|||
16384872|NCT03984825|39892722|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
16489283|NCT02468232|40266894|FG001|OLE Part of Study|Death|0|||
16489284|NCT02468232|40266895|FG002|OLE Part of Study|Death|4|||
16489285|NCT02468232|40266896|FG003|OLE Part of Study|Death|2|||
16190638|NCT01683071|39176058|FG002|Part 2|Lack of Efficacy|0|||
16190639|NCT01683071|39176059|FG003|Part 2|Lack of Efficacy|0|||
16190640|NCT01683071|39176060|FG004|Part 2|Lack of Efficacy|3|||
16298676|NCT01739348|39577806|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
16298677|NCT01739348|39577807|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
16298678|NCT01739348|39577808|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
16298679|NCT01739348|39577809|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
16298680|NCT01739348|39577806|FG000|Part II (Extension Study)|Participant Moved|3|||
16298681|NCT01739348|39577807|FG001|Part II (Extension Study)|Participant Moved|3|||
16298682|NCT01739348|39577808|FG002|Part II (Extension Study)|Participant Moved|0|||
16298683|NCT01739348|39577809|FG003|Part II (Extension Study)|Participant Moved|3|||
16298684|NCT01739348|39577806|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
16298685|NCT01739348|39577807|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
16298686|NCT01739348|39577808|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
16298687|NCT01739348|39577809|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
16298688|NCT01739348|39577806|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
16298689|NCT01739348|39577807|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
16298690|NCT01739348|39577808|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
16298691|NCT01739348|39577809|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
16298692|NCT03783039|39577810|FG000|Overall Study|Death|2|||
16298693|NCT03783039|39577811|FG001|Overall Study|Death|1|||
16298694|NCT01683838|39577812|FG000|Overall Study|Adverse Event|12|||
16298695|NCT01683838|39577813|FG001|Overall Study|Adverse Event|2|||
16298696|NCT01683838|39577812|FG000|Overall Study|Protocol Violation|3|||
16298697|NCT01683838|39577813|FG001|Overall Study|Protocol Violation|1|||
16298698|NCT01683838|39577812|FG000|Overall Study|Withdrawal by Subject|6|||
16298699|NCT01683838|39577813|FG001|Overall Study|Withdrawal by Subject|5|||
16298700|NCT01683838|39577812|FG000|Overall Study|Lost to Follow-up|1|||
16298701|NCT01683838|39577813|FG001|Overall Study|Lost to Follow-up|1|||
16298702|NCT01683838|39577812|FG000|Overall Study|Other|4|||
16298703|NCT01683838|39577813|FG001|Overall Study|Other|3|||
16298704|NCT01169532|39577814|FG000|Overall Study|Withdrawal by Subject|1|||
16298705|NCT03310411|39577819|FG000|Period 1|Adverse Event|0|||
16298706|NCT03310411|39577820|FG001|Period 1|Adverse Event|0|||
16298707|NCT03310411|39577821|FG002|Period 1|Adverse Event|0|||
16298708|NCT03310411|39577822|FG003|Period 1|Adverse Event|1|||
16298709|NCT01687478|39577824|FG000|Overall Study|Adverse Event|3|||
16298710|NCT01687478|39577825|FG001|Overall Study|Adverse Event|10|||
16298711|NCT01687478|39577824|FG000|Overall Study|Lost to Follow-up|1|||
16384873|NCT03984825|39892722|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
16384874|NCT03984825|39892722|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
16489286|NCT02468232|40266893|FG000|OLE Part of Study|Physician Decision|0|||
16489287|NCT02468232|40266894|FG001|OLE Part of Study|Physician Decision|0|||
16489288|NCT02468232|40266895|FG002|OLE Part of Study|Physician Decision|4|||
16384875|NCT00069641|39892723|FG000|Overall Study|Death|1|||
16384876|NCT00069641|39892724|FG001|Overall Study|Death|0|||
16384877|NCT00069641|39892725|FG002|Overall Study|Death|1|||
16298712|NCT01687478|39577825|FG001|Overall Study|Lost to Follow-up|3|||
16298713|NCT01687478|39577824|FG000|Overall Study|Protocol Violation|0|||
16298714|NCT01687478|39577825|FG001|Overall Study|Protocol Violation|2|||
16384878|NCT02750514|39892726|FG000|Track 1|Disease progression|20|||
16384879|NCT02750514|39892727|FG001|Track 1|Disease progression|1|||
16384880|NCT02750514|39892728|FG002|Track 1|Disease progression|0|||
16384881|NCT02750514|39892729|FG003|Track 1|Disease progression|1|||
16384882|NCT02750514|39892730|FG004|Track 1|Disease progression|0|||
16384883|NCT02750514|39892726|FG000|Track 1|Adverse event unrelated to study drug|1|||
16384884|NCT02750514|39892727|FG001|Track 1|Adverse event unrelated to study drug|0|||
16384885|NCT02750514|39892728|FG002|Track 1|Adverse event unrelated to study drug|0|||
16384886|NCT02750514|39892729|FG003|Track 1|Adverse event unrelated to study drug|0|||
16384887|NCT02750514|39892730|FG004|Track 1|Adverse event unrelated to study drug|0|||
16384888|NCT02750514|39892726|FG000|Track 1|Study drug toxicity|4|||
16384889|NCT02750514|39892727|FG001|Track 1|Study drug toxicity|1|||
16384890|NCT02750514|39892728|FG002|Track 1|Study drug toxicity|0|||
16384891|NCT02750514|39892729|FG003|Track 1|Study drug toxicity|1|||
16384892|NCT02750514|39892730|FG004|Track 1|Study drug toxicity|0|||
16384893|NCT02750514|39892726|FG000|Track 1|Participant request to discontinue|1|||
16384894|NCT02750514|39892727|FG001|Track 1|Participant request to discontinue|0|||
16489289|NCT02468232|40266896|FG003|OLE Part of Study|Physician Decision|0|||
16489290|NCT02468232|40266893|FG000|OLE Part of Study|Subject/Guardian decision|0|||
16489291|NCT02468232|40266894|FG001|OLE Part of Study|Subject/Guardian decision|0|||
16489292|NCT02468232|40266895|FG002|OLE Part of Study|Subject/Guardian decision|2|||
16489293|NCT02468232|40266896|FG003|OLE Part of Study|Subject/Guardian decision|5|||
16298715|NCT01687478|39577824|FG000|Overall Study|Withdrawal by Subject|21|||
16298716|NCT01687478|39577825|FG001|Overall Study|Withdrawal by Subject|19|||
16384895|NCT02750514|39892728|FG002|Track 1|Participant request to discontinue|0|||
16384896|NCT02750514|39892729|FG003|Track 1|Participant request to discontinue|0|||
16298717|NCT01687478|39577824|FG000|Overall Study|Physician Decision|1|||
16384897|NCT02750514|39892730|FG004|Track 1|Participant request to discontinue|0|||
16298718|NCT01687478|39577825|FG001|Overall Study|Physician Decision|3|||
16298719|NCT01687478|39577824|FG000|Overall Study|Entry Criteria Not Met|6|||
16384898|NCT02750514|39892726|FG000|Track 1|Other reasons|1|||
16384899|NCT02750514|39892727|FG001|Track 1|Other reasons|0|||
16384900|NCT02750514|39892728|FG002|Track 1|Other reasons|0|||
16384901|NCT02750514|39892729|FG003|Track 1|Other reasons|0|||
16384902|NCT02750514|39892730|FG004|Track 1|Other reasons|0|||
16384903|NCT02750514|39892726|FG000|Track 2|Disease progression|4|||
16384904|NCT02750514|39892727|FG001|Track 2|Disease progression|5|||
16384905|NCT02750514|39892728|FG002|Track 2|Disease progression|2|||
16384906|NCT02750514|39892729|FG003|Track 2|Disease progression|5|||
16384907|NCT02750514|39892730|FG004|Track 2|Disease progression|0|||
16384908|NCT02750514|39892726|FG000|Track 2|Adverse event unrelated to study drug|1|||
16384909|NCT02750514|39892727|FG001|Track 2|Adverse event unrelated to study drug|0|||
16384910|NCT02750514|39892728|FG002|Track 2|Adverse event unrelated to study drug|0|||
16384911|NCT02750514|39892729|FG003|Track 2|Adverse event unrelated to study drug|0|||
16384912|NCT02750514|39892730|FG004|Track 2|Adverse event unrelated to study drug|0|||
16384913|NCT02750514|39892726|FG000|Track 2|Study drug toxicity|1|||
16384914|NCT02750514|39892727|FG001|Track 2|Study drug toxicity|2|||
16384915|NCT02750514|39892728|FG002|Track 2|Study drug toxicity|0|||
16384916|NCT02750514|39892729|FG003|Track 2|Study drug toxicity|2|||
16384917|NCT02750514|39892730|FG004|Track 2|Study drug toxicity|0|||
16384918|NCT02750514|39892726|FG000|Track 2|Participant withdrew consent|0|||
16384919|NCT02750514|39892727|FG001|Track 2|Participant withdrew consent|1|||
16384920|NCT02750514|39892728|FG002|Track 2|Participant withdrew consent|0|||
16384921|NCT02750514|39892729|FG003|Track 2|Participant withdrew consent|0|||
16384922|NCT02750514|39892730|FG004|Track 2|Participant withdrew consent|0|||
16384923|NCT02750514|39892726|FG000|Track 3|Disease progression|0|||
16384924|NCT02750514|39892727|FG001|Track 3|Disease progression|24|||
16384925|NCT02750514|39892728|FG002|Track 3|Disease progression|13|||
16384926|NCT02750514|39892729|FG003|Track 3|Disease progression|14|||
16384927|NCT02750514|39892730|FG004|Track 3|Disease progression|0|||
16384928|NCT02750514|39892726|FG000|Track 3|Adverse event unrelated to study drug|0|||
16384929|NCT02750514|39892727|FG001|Track 3|Adverse event unrelated to study drug|1|||
16384930|NCT02750514|39892728|FG002|Track 3|Adverse event unrelated to study drug|1|||
16384931|NCT02750514|39892729|FG003|Track 3|Adverse event unrelated to study drug|1|||
16384932|NCT02750514|39892730|FG004|Track 3|Adverse event unrelated to study drug|0|||
16384933|NCT02750514|39892726|FG000|Track 3|Study drug toxicity|0|||
16384934|NCT02750514|39892727|FG001|Track 3|Study drug toxicity|3|||
16384935|NCT02750514|39892728|FG002|Track 3|Study drug toxicity|0|||
16384936|NCT02750514|39892729|FG003|Track 3|Study drug toxicity|1|||
16384937|NCT02750514|39892730|FG004|Track 3|Study drug toxicity|0|||
16384938|NCT02750514|39892726|FG000|Track 3|Participant request to discontinue|0|||
16384939|NCT02750514|39892727|FG001|Track 3|Participant request to discontinue|2|||
16384940|NCT02750514|39892728|FG002|Track 3|Participant request to discontinue|0|||
16384941|NCT02750514|39892729|FG003|Track 3|Participant request to discontinue|0|||
16384942|NCT02750514|39892730|FG004|Track 3|Participant request to discontinue|0|||
16384943|NCT02750514|39892726|FG000|Track 3|Participant withdrew consent|0|||
16384944|NCT02750514|39892727|FG001|Track 3|Participant withdrew consent|3|||
16384945|NCT02750514|39892728|FG002|Track 3|Participant withdrew consent|1|||
16384946|NCT02750514|39892729|FG003|Track 3|Participant withdrew consent|0|||
16384947|NCT02750514|39892730|FG004|Track 3|Participant withdrew consent|0|||
16384948|NCT02750514|39892726|FG000|Track 3|Other reasons|0|||
16384949|NCT02750514|39892727|FG001|Track 3|Other reasons|3|||
16384950|NCT02750514|39892728|FG002|Track 3|Other reasons|0|||
16298720|NCT01687478|39577825|FG001|Overall Study|Entry Criteria Not Met|2|||
16298721|NCT03151811|39577827|FG000|Overall Study|Randomized But Not Treated|18|||
16298722|NCT03151811|39577828|FG001|Overall Study|Randomized But Not Treated|3|||
16298723|NCT03151811|39577827|FG000|Overall Study|Progressive Disease|130|||
16298724|NCT03151811|39577828|FG001|Overall Study|Progressive Disease|170|||
16298725|NCT03151811|39577827|FG000|Overall Study|Adverse Event|49|||
16298726|NCT03151811|39577828|FG001|Overall Study|Adverse Event|40|||
16298727|NCT03151811|39577827|FG000|Overall Study|Lack of Efficacy|6|||
16298728|NCT03151811|39577828|FG001|Overall Study|Lack of Efficacy|8|||
16298729|NCT03151811|39577827|FG000|Overall Study|Physician Decision|21|||
16298730|NCT03151811|39577828|FG001|Overall Study|Physician Decision|9|||
16298731|NCT03151811|39577827|FG000|Overall Study|Withdrawal by Subject|17|||
16298732|NCT03151811|39577828|FG001|Overall Study|Withdrawal by Subject|7|||
16298733|NCT03151811|39577827|FG000|Overall Study|Lost to Follow-up|0|||
16298734|NCT03151811|39577828|FG001|Overall Study|Lost to Follow-up|1|||
16298735|NCT03151811|39577827|FG000|Overall Study|Study Terminated by Sponsor|5|||
16298736|NCT03151811|39577828|FG001|Overall Study|Study Terminated by Sponsor|11|||
16384951|NCT02750514|39892729|FG003|Track 3|Other reasons|0|||
16384952|NCT02750514|39892730|FG004|Track 3|Other reasons|0|||
16384953|NCT02750514|39892726|FG000|Track 4|Study drug toxicity|0|||
16384954|NCT02750514|39892727|FG001|Track 4|Study drug toxicity|6|||
16384955|NCT02750514|39892728|FG002|Track 4|Study drug toxicity|0|||
16384956|NCT02750514|39892729|FG003|Track 4|Study drug toxicity|5|||
16384957|NCT02750514|39892730|FG004|Track 4|Study drug toxicity|0|||
16298737|NCT01267994|39577831|FG000|Overall Study|Adverse Event|2|||
16298738|NCT01982812|39577833|FG000|Overall Study|Death|1|||
16298739|NCT01982812|39577834|FG001|Overall Study|Death|5|||
16298740|NCT01982812|39577833|FG000|Overall Study|Adverse Event|0|||
16384958|NCT02750514|39892726|FG000|Track 4|Participant request to discontinue|0|||
16384959|NCT02750514|39892727|FG001|Track 4|Participant request to discontinue|1|||
16384960|NCT02750514|39892728|FG002|Track 4|Participant request to discontinue|0|||
16384961|NCT02750514|39892729|FG003|Track 4|Participant request to discontinue|1|||
16384962|NCT02750514|39892730|FG004|Track 4|Participant request to discontinue|0|||
16384963|NCT02750514|39892726|FG000|Track 4|Participant withdrew consent|0|||
16384964|NCT02750514|39892727|FG001|Track 4|Participant withdrew consent|1|||
16384965|NCT02750514|39892728|FG002|Track 4|Participant withdrew consent|0|||
16384966|NCT02750514|39892729|FG003|Track 4|Participant withdrew consent|0|||
16384967|NCT02750514|39892730|FG004|Track 4|Participant withdrew consent|0|||
16384968|NCT02750514|39892726|FG000|Track 4|Other reasons|0|||
16384969|NCT02750514|39892727|FG001|Track 4|Other reasons|5|||
16384970|NCT02750514|39892728|FG002|Track 4|Other reasons|0|||
16384971|NCT02750514|39892729|FG003|Track 4|Other reasons|3|||
16384972|NCT02750514|39892730|FG004|Track 4|Other reasons|0|||
16384973|NCT02750514|39892726|FG000|Track 4|Disease progression|0|||
16384974|NCT02750514|39892727|FG001|Track 4|Disease progression|33|||
16384975|NCT02750514|39892728|FG002|Track 4|Disease progression|0|||
16298741|NCT01982812|39577834|FG001|Overall Study|Adverse Event|5|||
16298742|NCT03190330|39577839|FG000|Overall Study|Adverse Event|2|||
16298743|NCT03190330|39577839|FG000|Overall Study|Death|10|||
16298744|NCT03190330|39577839|FG000|Overall Study|Lost to Follow-up|1|||
16298745|NCT03190330|39577839|FG000|Overall Study|Withdrawal by Subject|6|||
16298746|NCT03190330|39577839|FG000|Overall Study|Progressive Disease|1|||
16298747|NCT00805961|39577840|FG000|Modality Therapy|Withdrawal by Subject|1|||
16298748|NCT00805961|39577840|FG000|Modality Therapy|Adverse Event|1|||
16298749|NCT00805961|39577840|FG000|Modality Therapy|Disease Progression|2|||
16298750|NCT00805961|39577840|FG000|Treatment-Free Interval|Adverse Event|3|||
16298751|NCT00805961|39577840|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
16298752|NCT00805961|39577840|FG000|Treatment-Free Interval|Physician Decision|1|||
16298753|NCT00805961|39577840|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
16298754|NCT00805961|39577840|FG000|Maintenance Treatment|Lack of Efficacy|13|||
16298755|NCT00805961|39577840|FG000|Maintenance Treatment|Intercurrent Illness|7|||
16298756|NCT00805961|39577840|FG000|Maintenance Treatment|Adverse Event|6|||
16298757|NCT00805961|39577840|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
16298758|NCT00805961|39577840|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
16298759|NCT00805961|39577840|FG000|Maintenance Treatment|Withdrawn Consent|1|||
16298760|NCT02521376|39577841|FG000|Overall Study|Enrolled, But Not Treated|1|||
16298761|NCT02521376|39577842|FG001|Overall Study|Enrolled, But Not Treated|0|||
16298762|NCT02521376|39577843|FG002|Overall Study|Enrolled, But Not Treated|0|||
16298763|NCT02521376|39577844|FG003|Overall Study|Enrolled, But Not Treated|0|||
16298764|NCT03548337|39577845|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
16298765|NCT03548337|39577846|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
16298766|NCT03548337|39577845|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
16384976|NCT02750514|39892729|FG003|Track 4|Disease progression|32|||
16384977|NCT02750514|39892730|FG004|Track 4|Disease progression|0|||
16384978|NCT02750514|39892726|FG000|Track 4|Adverse event unrelated to study drug|0|||
16384979|NCT02750514|39892727|FG001|Track 4|Adverse event unrelated to study drug|5|||
16384980|NCT02750514|39892728|FG002|Track 4|Adverse event unrelated to study drug|0|||
16384981|NCT02750514|39892729|FG003|Track 4|Adverse event unrelated to study drug|0|||
16384982|NCT02750514|39892730|FG004|Track 4|Adverse event unrelated to study drug|0|||
16384983|NCT02750514|39892726|FG000|Track 4|Death|0|||
16384984|NCT02750514|39892727|FG001|Track 4|Death|0|||
16384985|NCT02750514|39892728|FG002|Track 4|Death|0|||
16384986|NCT02750514|39892729|FG003|Track 4|Death|1|||
16384987|NCT02750514|39892730|FG004|Track 4|Death|0|||
16384988|NCT02750514|39892726|FG000|Track 5|Disease progression|0|||
16384989|NCT02750514|39892727|FG001|Track 5|Disease progression|0|||
16384990|NCT02750514|39892728|FG002|Track 5|Disease progression|0|||
16384991|NCT02750514|39892729|FG003|Track 5|Disease progression|0|||
16384992|NCT02750514|39892730|FG004|Track 5|Disease progression|34|||
16384993|NCT02750514|39892726|FG000|Track 5|Adverse event unrelated to study drug|0|||
16384994|NCT02750514|39892727|FG001|Track 5|Adverse event unrelated to study drug|0|||
16384995|NCT02750514|39892728|FG002|Track 5|Adverse event unrelated to study drug|0|||
16384996|NCT02750514|39892729|FG003|Track 5|Adverse event unrelated to study drug|0|||
16384997|NCT02750514|39892730|FG004|Track 5|Adverse event unrelated to study drug|2|||
16384998|NCT02750514|39892726|FG000|Track 5|Study drug toxicity|0|||
16384999|NCT02750514|39892727|FG001|Track 5|Study drug toxicity|0|||
16385000|NCT02750514|39892728|FG002|Track 5|Study drug toxicity|0|||
16385001|NCT02750514|39892729|FG003|Track 5|Study drug toxicity|0|||
16385002|NCT02750514|39892730|FG004|Track 5|Study drug toxicity|2|||
16385003|NCT02750514|39892726|FG000|Track 5|Participant request to discontinue|0|||
16385004|NCT02750514|39892727|FG001|Track 5|Participant request to discontinue|0|||
16385005|NCT02750514|39892728|FG002|Track 5|Participant request to discontinue|0|||
16385006|NCT02750514|39892729|FG003|Track 5|Participant request to discontinue|0|||
16385007|NCT02750514|39892730|FG004|Track 5|Participant request to discontinue|3|||
16385008|NCT02750514|39892726|FG000|Track 5|Other reasons|0|||
16385009|NCT02750514|39892727|FG001|Track 5|Other reasons|0|||
16385010|NCT02750514|39892728|FG002|Track 5|Other reasons|0|||
16385011|NCT02750514|39892729|FG003|Track 5|Other reasons|0|||
16385012|NCT02750514|39892730|FG004|Track 5|Other reasons|2|||
16385013|NCT01365455|39892732|FG000|Induction Period|Adverse Event|5|||
16385014|NCT01365455|39892733|FG001|Induction Period|Adverse Event|3|||
16385015|NCT01365455|39892734|FG002|Induction Period|Adverse Event|4|||
16385016|NCT01365455|39892735|FG003|Induction Period|Adverse Event|0|||
16385017|NCT01365455|39892736|FG004|Induction Period|Adverse Event|0|||
16385018|NCT01365455|39892732|FG000|Induction Period|Lack of Efficacy|1|||
16385019|NCT01365455|39892733|FG001|Induction Period|Lack of Efficacy|1|||
16385020|NCT01365455|39892734|FG002|Induction Period|Lack of Efficacy|0|||
16385021|NCT01365455|39892735|FG003|Induction Period|Lack of Efficacy|0|||
16385022|NCT01365455|39892736|FG004|Induction Period|Lack of Efficacy|0|||
16385023|NCT01365455|39892732|FG000|Induction Period|Pregnancy|0|||
16385024|NCT01365455|39892733|FG001|Induction Period|Pregnancy|1|||
16385025|NCT01365455|39892734|FG002|Induction Period|Pregnancy|0|||
16385026|NCT01365455|39892735|FG003|Induction Period|Pregnancy|0|||
16385027|NCT01365455|39892736|FG004|Induction Period|Pregnancy|0|||
16385028|NCT01365455|39892732|FG000|Induction Period|Protocol deviation|0|||
16385029|NCT01365455|39892733|FG001|Induction Period|Protocol deviation|1|||
16385030|NCT01365455|39892734|FG002|Induction Period|Protocol deviation|1|||
16385031|NCT01365455|39892735|FG003|Induction Period|Protocol deviation|0|||
16385032|NCT01365455|39892736|FG004|Induction Period|Protocol deviation|0|||
16385033|NCT01365455|39892732|FG000|Induction Period|Subject/guardian decision|9|||
16385034|NCT01365455|39892733|FG001|Induction Period|Subject/guardian decision|1|||
16385035|NCT01365455|39892734|FG002|Induction Period|Subject/guardian decision|8|||
16385036|NCT01365455|39892735|FG003|Induction Period|Subject/guardian decision|0|||
16385037|NCT01365455|39892736|FG004|Induction Period|Subject/guardian decision|0|||
16385038|NCT01365455|39892732|FG000|Induction Period|Lost to Follow-up|0|||
16385039|NCT01365455|39892733|FG001|Induction Period|Lost to Follow-up|0|||
16385040|NCT01365455|39892734|FG002|Induction Period|Lost to Follow-up|3|||
16385041|NCT01365455|39892735|FG003|Induction Period|Lost to Follow-up|0|||
16385042|NCT01365455|39892736|FG004|Induction Period|Lost to Follow-up|0|||
16385043|NCT01365455|39892732|FG000|Maintenance Period|Adverse Event|12|||
16385044|NCT01365455|39892733|FG001|Maintenance Period|Adverse Event|5|||
16385045|NCT01365455|39892734|FG002|Maintenance Period|Adverse Event|1|||
16385046|NCT01365455|39892735|FG003|Maintenance Period|Adverse Event|2|||
16385047|NCT01365455|39892736|FG004|Maintenance Period|Adverse Event|4|||
16385048|NCT01365455|39892732|FG000|Maintenance Period|Lack of Efficacy|10|||
16385049|NCT01365455|39892733|FG001|Maintenance Period|Lack of Efficacy|2|||
16385050|NCT01365455|39892734|FG002|Maintenance Period|Lack of Efficacy|0|||
16385051|NCT01365455|39892735|FG003|Maintenance Period|Lack of Efficacy|2|||
16385052|NCT01365455|39892736|FG004|Maintenance Period|Lack of Efficacy|2|||
16385053|NCT01365455|39892732|FG000|Maintenance Period|Lost to Follow-up|2|||
16385054|NCT01365455|39892733|FG001|Maintenance Period|Lost to Follow-up|4|||
16385055|NCT01365455|39892734|FG002|Maintenance Period|Lost to Follow-up|0|||
16385056|NCT01365455|39892735|FG003|Maintenance Period|Lost to Follow-up|0|||
16385057|NCT01365455|39892736|FG004|Maintenance Period|Lost to Follow-up|3|||
16385058|NCT01365455|39892732|FG000|Maintenance Period|Non-compliance with study treatment|0|||
16385059|NCT01365455|39892733|FG001|Maintenance Period|Non-compliance with study treatment|0|||
16385060|NCT01365455|39892734|FG002|Maintenance Period|Non-compliance with study treatment|0|||
16385061|NCT01365455|39892735|FG003|Maintenance Period|Non-compliance with study treatment|1|||
16385062|NCT01365455|39892736|FG004|Maintenance Period|Non-compliance with study treatment|0|||
16385063|NCT01365455|39892732|FG000|Maintenance Period|Physician Decision|0|||
16385064|NCT01365455|39892733|FG001|Maintenance Period|Physician Decision|1|||
16385065|NCT01365455|39892734|FG002|Maintenance Period|Physician Decision|0|||
16385066|NCT01365455|39892735|FG003|Maintenance Period|Physician Decision|0|||
16385067|NCT01365455|39892736|FG004|Maintenance Period|Physician Decision|1|||
16385068|NCT01365455|39892732|FG000|Maintenance Period|Pregnancy|0|||
16385069|NCT01365455|39892733|FG001|Maintenance Period|Pregnancy|4|||
16385070|NCT01365455|39892734|FG002|Maintenance Period|Pregnancy|0|||
16385071|NCT01365455|39892735|FG003|Maintenance Period|Pregnancy|0|||
16385072|NCT01365455|39892736|FG004|Maintenance Period|Pregnancy|2|||
16385073|NCT01365455|39892732|FG000|Maintenance Period|Protocol deviation|1|||
16385074|NCT01365455|39892733|FG001|Maintenance Period|Protocol deviation|1|||
16385075|NCT01365455|39892734|FG002|Maintenance Period|Protocol deviation|0|||
16385076|NCT01365455|39892735|FG003|Maintenance Period|Protocol deviation|0|||
16385077|NCT01365455|39892736|FG004|Maintenance Period|Protocol deviation|0|||
16385078|NCT01365455|39892732|FG000|Maintenance Period|Subject/guardian decision|4|||
16385079|NCT01365455|39892733|FG001|Maintenance Period|Subject/guardian decision|6|||
16385080|NCT01365455|39892734|FG002|Maintenance Period|Subject/guardian decision|2|||
16385081|NCT01365455|39892735|FG003|Maintenance Period|Subject/guardian decision|4|||
16385082|NCT01365455|39892736|FG004|Maintenance Period|Subject/guardian decision|1|||
16385083|NCT02394561|39892737|FG000|CORE Phase|Adverse Event|7|||
16385084|NCT02394561|39892738|FG001|CORE Phase|Adverse Event|9|||
16385085|NCT02394561|39892737|FG000|CORE Phase|Death|0|||
16385086|NCT02394561|39892738|FG001|CORE Phase|Death|1|||
16385087|NCT02394561|39892737|FG000|CORE Phase|Pregnancy|1|||
16385088|NCT02394561|39892738|FG001|CORE Phase|Pregnancy|0|||
16385089|NCT02394561|39892737|FG000|CORE Phase|Lost to Follow-up|1|||
16385090|NCT02394561|39892738|FG001|CORE Phase|Lost to Follow-up|0|||
16385091|NCT02394561|39892737|FG000|CORE Phase|Physician Decision|1|||
16385092|NCT02394561|39892738|FG001|CORE Phase|Physician Decision|1|||
16385093|NCT02394561|39892737|FG000|CORE Phase|Withdrawal by Subject|2|||
16298767|NCT03548337|39577846|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
16298768|NCT03548337|39577845|FG000|Infant Series|Lost to Follow-up|2|||
16298769|NCT03548337|39577846|FG001|Infant Series|Lost to Follow-up|1|||
16298770|NCT03548337|39577845|FG000|Infant Series|Adverse Event|0|||
16298771|NCT03548337|39577846|FG001|Infant Series|Adverse Event|2|||
16298772|NCT03548337|39577845|FG000|Infant Series|Randomized but Not Vaccinated|1|||
16385094|NCT02394561|39892738|FG001|CORE Phase|Withdrawal by Subject|2|||
16298773|NCT03548337|39577846|FG001|Infant Series|Randomized but Not Vaccinated|0|||
16298774|NCT03548337|39577845|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
16298775|NCT03548337|39577846|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
16298776|NCT00492024|39577850|FG000|Treatment|Adverse Event|3|||
16298777|NCT00492024|39577851|FG001|Treatment|Adverse Event|1|||
16385095|NCT02394561|39892737|FG000|CORE Phase|Lack of Efficacy|1|||
16489294|NCT01846416|40266897|FG000|Treatment Phase|Death|2|||
16489295|NCT01846416|40266898|FG001|Treatment Phase|Death|9|||
16489296|NCT01846416|40266899|FG002|Treatment Phase|Death|1|||
16489297|NCT01846416|40266897|FG000|Treatment Phase|Withdrawal by Subject|2|||
16489298|NCT01846416|40266898|FG001|Treatment Phase|Withdrawal by Subject|4|||
16489299|NCT01846416|40266899|FG002|Treatment Phase|Withdrawal by Subject|2|||
16489300|NCT01846416|40266897|FG000|Treatment Phase|Other|1|||
16489301|NCT01846416|40266898|FG001|Treatment Phase|Other|5|||
16489302|NCT01846416|40266899|FG002|Treatment Phase|Other|1|||
16489303|NCT01846416|40266897|FG000|Treatment Phase|Physician Decision|1|||
16489304|NCT01846416|40266898|FG001|Treatment Phase|Physician Decision|2|||
16489305|NCT01846416|40266899|FG002|Treatment Phase|Physician Decision|0|||
16489306|NCT01846416|40266897|FG000|Treatment Phase|Adverse Event|3|||
16489307|NCT01846416|40266898|FG001|Treatment Phase|Adverse Event|4|||
16489308|NCT01846416|40266899|FG002|Treatment Phase|Adverse Event|0|||
16489309|NCT01846416|40266897|FG000|Treatment Phase|Non-compliance|0|||
16298778|NCT00492024|39577850|FG000|Treatment|Lack of Efficacy|21|||
16298779|NCT00492024|39577851|FG001|Treatment|Lack of Efficacy|20|||
16298780|NCT00492024|39577850|FG000|Treatment|Lost to Follow-up|3|||
16385096|NCT02394561|39892738|FG001|CORE Phase|Lack of Efficacy|6|||
16385097|NCT02394561|39892737|FG000|Extension Phase|Adverse Event|6|||
16385098|NCT02394561|39892738|FG001|Extension Phase|Adverse Event|1|||
16385099|NCT02394561|39892737|FG000|Extension Phase|Death|0|||
16385100|NCT02394561|39892738|FG001|Extension Phase|Death|1|||
16385101|NCT02394561|39892737|FG000|Extension Phase|Protocol Violation|1|||
16385102|NCT02394561|39892738|FG001|Extension Phase|Protocol Violation|0|||
16298781|NCT00492024|39577851|FG001|Treatment|Lost to Follow-up|1|||
16489310|NCT01846416|40266898|FG001|Treatment Phase|Non-compliance|2|||
16489311|NCT01846416|40266899|FG002|Treatment Phase|Non-compliance|0|||
16385103|NCT02394561|39892737|FG000|Extension Phase|Lost to Follow-up|1|||
16083495|NCT01040689|38799073|FG000|Overall Study|Other reasons not listed above|0|||
16083496|NCT01040689|38799074|FG001|Overall Study|Other reasons not listed above|1|||
16083497|NCT01040689|38799075|FG002|Overall Study|Other reasons not listed above|0|||
16083498|NCT01040689|38799076|FG003|Overall Study|Other reasons not listed above|0|||
16083499|NCT01932970|38799083|FG000|Overall Study|Withdrawal by Subject|5|||
16083500|NCT01932970|38799083|FG000|Overall Study|Death|1|||
16083501|NCT01932970|38799083|FG000|Overall Study|Lost to Follow-up|2|||
16083502|NCT01932970|38799083|FG000|Overall Study|Protocol Specified Criteria|10|||
16083503|NCT00566735|38799084|FG000|Overall Study|Withdrawal by Subject|0|||
16083504|NCT00566735|38799085|FG001|Overall Study|Withdrawal by Subject|1|||
16489312|NCT01846416|40266897|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
16489313|NCT01846416|40266898|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
16489314|NCT01846416|40266899|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
16489315|NCT01846416|40266897|FG000|Treatment Phase|Progressive Disease|21|||
16489316|NCT01846416|40266898|FG001|Treatment Phase|Progressive Disease|63|||
16489317|NCT01846416|40266899|FG002|Treatment Phase|Progressive Disease|9|||
16489318|NCT01846416|40266897|FG000|Survival Follow-up|Death|21|||
16489319|NCT01846416|40266898|FG001|Survival Follow-up|Death|62|||
16489320|NCT01846416|40266899|FG002|Survival Follow-up|Death|9|||
16489321|NCT01846416|40266897|FG000|Survival Follow-up|Lost to Follow-up|0|||
16489322|NCT01846416|40266898|FG001|Survival Follow-up|Lost to Follow-up|2|||
16489323|NCT01846416|40266899|FG002|Survival Follow-up|Lost to Follow-up|2|||
16489324|NCT01846416|40266897|FG000|Survival Follow-up|Withdrawal by Subject|2|||
16489325|NCT01846416|40266898|FG001|Survival Follow-up|Withdrawal by Subject|7|||
16190641|NCT01683071|39176061|FG005|Part 2|Lack of Efficacy|4|||
16190642|NCT01683071|39176056|FG000|Part 2|Lost to Follow-up|0|||
16190643|NCT01683071|39176057|FG001|Part 2|Lost to Follow-up|0|||
16083505|NCT00566735|38799084|FG000|Overall Study|Refused neuropsychological testing|2|||
16083506|NCT00566735|38799085|FG001|Overall Study|Refused neuropsychological testing|5|||
16083507|NCT00566735|38799084|FG000|Overall Study|Switched into a manic episode|0|||
16083508|NCT00566735|38799085|FG001|Overall Study|Switched into a manic episode|1|||
16083509|NCT02910713|38799089|FG000|Overall Study|Protocol Violation|2|||
16083510|NCT02910713|38799089|FG000|Overall Study|Subject Choice|4|||
16190644|NCT01683071|39176058|FG002|Part 2|Lost to Follow-up|0|||
16190645|NCT01683071|39176059|FG003|Part 2|Lost to Follow-up|0|||
16190646|NCT01683071|39176060|FG004|Part 2|Lost to Follow-up|2|||
16190647|NCT01683071|39176061|FG005|Part 2|Lost to Follow-up|0|||
16190648|NCT01683071|39176056|FG000|Part 2|Withdrawal by Subject|0|||
16489326|NCT01846416|40266899|FG002|Survival Follow-up|Withdrawal by Subject|0|||
16489327|NCT01846416|40266897|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
16489328|NCT01846416|40266898|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
16489329|NCT01846416|40266899|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
16489330|NCT01846416|40266897|FG000|Survival Follow-up|Other|3|||
16489331|NCT01846416|40266898|FG001|Survival Follow-up|Other|1|||
16489332|NCT01846416|40266899|FG002|Survival Follow-up|Other|1|||
16489333|NCT00737282|40266902|FG000|Overall Study|Study prematurely terminated|175|||
16489334|NCT01340898|40266903|FG000|Primary Phase|Serious Adverse Events|0|||
16489335|NCT01340898|40266904|FG001|Primary Phase|Serious Adverse Events|0|||
16489336|NCT01340898|40266905|FG002|Primary Phase|Serious Adverse Events|1|||
16489337|NCT01340898|40266903|FG000|Primary Phase|Withdrawal by Subject|8|||
16489338|NCT01340898|40266904|FG001|Primary Phase|Withdrawal by Subject|7|||
16489339|NCT01340898|40266905|FG002|Primary Phase|Withdrawal by Subject|5|||
16489340|NCT01340898|40266903|FG000|Primary Phase|Migrated/moved from study area|4|||
16489341|NCT01340898|40266904|FG001|Primary Phase|Migrated/moved from study area|1|||
16489342|NCT01340898|40266905|FG002|Primary Phase|Migrated/moved from study area|0|||
16489343|NCT01340898|40266903|FG000|Primary Phase|Lost to Follow-up|4|||
16489344|NCT01340898|40266904|FG001|Primary Phase|Lost to Follow-up|1|||
16489345|NCT01340898|40266905|FG002|Primary Phase|Lost to Follow-up|0|||
16489346|NCT01340898|40266903|FG000|Booster Phase|Withdrawal by Subject|3|||
16489347|NCT01340898|40266904|FG001|Booster Phase|Withdrawal by Subject|0|||
16489348|NCT01340898|40266905|FG002|Booster Phase|Withdrawal by Subject|4|||
16489349|NCT01340898|40266903|FG000|Booster Phase|Migrated/moved from study area|3|||
16489350|NCT01340898|40266904|FG001|Booster Phase|Migrated/moved from study area|0|||
16489351|NCT01340898|40266905|FG002|Booster Phase|Migrated/moved from study area|0|||
16190649|NCT01683071|39176057|FG001|Part 2|Withdrawal by Subject|0|||
16298782|NCT00492024|39577850|FG000|Treatment|Withdrawal by Subject|2|||
16489352|NCT01340898|40266903|FG000|Booster Phase|Lost to Follow-up|4|||
16489353|NCT01340898|40266904|FG001|Booster Phase|Lost to Follow-up|2|||
16489354|NCT01340898|40266905|FG002|Booster Phase|Lost to Follow-up|3|||
16489355|NCT00621153|40266906|FG000|Overall Study|Safety Reason|8|||
16083511|NCT02910713|38799089|FG000|Overall Study|Received One Application|10|||
16083512|NCT02910713|38799089|FG000|Overall Study|Received Neither Application|18|||
16083513|NCT02910713|38799089|FG000|Overall Study|Enrollment cap|7|||
16083514|NCT02910713|38799089|FG000|Overall Study|Investigator Discretion|1|||
16083515|NCT00623194|38799090|FG000|Overall Study|Lack of Efficacy|1|||
16190650|NCT01683071|39176058|FG002|Part 2|Withdrawal by Subject|0|||
16489356|NCT00621153|40266907|FG001|Overall Study|Safety Reason|7|||
16489357|NCT00621153|40266906|FG000|Overall Study|Adverse Event|3|||
16489358|NCT00621153|40266907|FG001|Overall Study|Adverse Event|2|||
16489359|NCT00621153|40266906|FG000|Overall Study|Lost to Follow-up|5|||
16489360|NCT00621153|40266907|FG001|Overall Study|Lost to Follow-up|1|||
16489361|NCT00621153|40266906|FG000|Overall Study|Withdrawal by Subject|4|||
16190651|NCT01683071|39176059|FG003|Part 2|Withdrawal by Subject|0|||
16190652|NCT01683071|39176060|FG004|Part 2|Withdrawal by Subject|3|||
16190653|NCT01683071|39176061|FG005|Part 2|Withdrawal by Subject|3|||
16489362|NCT00621153|40266907|FG001|Overall Study|Withdrawal by Subject|5|||
16489363|NCT01086033|40266908|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
16489364|NCT01086033|40266908|FG000|Overall Study|Lost to Follow-up|86|||
16489365|NCT01086033|40266908|FG000|Overall Study|Adverse Event|42|||
16489366|NCT01086033|40266908|FG000|Overall Study|Withdrawal by Subject|41|||
16489367|NCT01086033|40266908|FG000|Overall Study|Other|14|||
16489368|NCT01086033|40266908|FG000|Overall Study|Other|13|||
16489369|NCT01086033|40266908|FG000|Overall Study|AE and Withdrew Consent|5|||
16489370|NCT01086033|40266908|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
16489371|NCT01086033|40266908|FG000|Overall Study|Withdrew consent and Other Reason|4|||
16489372|NCT01086033|40266908|FG000|Overall Study|AE and Lack of Efficacy|4|||
16489373|NCT01086033|40266908|FG000|Overall Study|Death|1|||
16489374|NCT01086033|40266908|FG000|Overall Study|AE and Lost to Follow-up|1|||
16489375|NCT01086033|40266908|FG000|Overall Study|AE and Other Reason|1|||
16489376|NCT01086033|40266908|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
16489377|NCT01575769|40266909|FG000|Overall Study|Adverse Event|1|||
16489378|NCT01575769|40266909|FG000|Overall Study|Study terminated by sponsor|40|||
16489379|NCT04669600|40266915|FG000|Overall Study|Withdrawal by Subject|1|||
16489380|NCT04669600|40266915|FG000|Overall Study|Other|6|||
16489381|NCT01664533|40266916|FG000|Overall Study|Death|42|||
16489382|NCT01664533|40266916|FG000|Overall Study|Lost to Follow-up|3|||
16489383|NCT01664533|40266916|FG000|Overall Study|Study termination|9|||
16489384|NCT01664533|40266916|FG000|Overall Study|Protocol Violation|3|||
16489385|NCT01530997|40266917|FG000|Overall Study|Physician Decision|1|||
16489386|NCT01530997|40266917|FG000|Overall Study|Withdrawal by Subject|1|||
16298783|NCT00492024|39577851|FG001|Treatment|Withdrawal by Subject|0|||
16298784|NCT00492024|39577850|FG000|Follow up|Lack of Efficacy|0|||
16298785|NCT00492024|39577851|FG001|Follow up|Lack of Efficacy|1|||
16298786|NCT00492024|39577850|FG000|Follow up|Lost to Follow-up|1|||
16298787|NCT00492024|39577851|FG001|Follow up|Lost to Follow-up|1|||
16489387|NCT03033394|40266921|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
16489388|NCT03033394|40266921|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
16489389|NCT03033394|40266921|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
16190654|NCT01683071|39176056|FG000|Part 2|Surgery cancelled|0|||
16190655|NCT01683071|39176057|FG001|Part 2|Surgery cancelled|0|||
16190656|NCT01683071|39176058|FG002|Part 2|Surgery cancelled|0|||
16190657|NCT01683071|39176059|FG003|Part 2|Surgery cancelled|0|||
16190658|NCT01683071|39176060|FG004|Part 2|Surgery cancelled|4|||
16190659|NCT01683071|39176061|FG005|Part 2|Surgery cancelled|2|||
16190660|NCT01683071|39176056|FG000|Part 2|Did not receive study drug|0|||
16190661|NCT01683071|39176057|FG001|Part 2|Did not receive study drug|0|||
16190662|NCT01683071|39176058|FG002|Part 2|Did not receive study drug|0|||
16190663|NCT01683071|39176059|FG003|Part 2|Did not receive study drug|0|||
16190664|NCT01683071|39176060|FG004|Part 2|Did not receive study drug|2|||
16190665|NCT01683071|39176061|FG005|Part 2|Did not receive study drug|1|||
16190666|NCT01683071|39176056|FG000|Part 2|Met exclusion criterion|0|||
16385104|NCT02394561|39892738|FG001|Extension Phase|Lost to Follow-up|0|||
16489390|NCT03033394|40266921|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
16489391|NCT03033394|40266921|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
16489392|NCT00980057|40266922|FG000|Overall Study|Death|13|||
16489393|NCT00980057|40266923|FG001|Overall Study|Death|3|||
16489394|NCT00980057|40266922|FG000|Overall Study|Adverse Event|0|||
16489395|NCT00980057|40266923|FG001|Overall Study|Adverse Event|1|||
16489396|NCT00980057|40266922|FG000|Overall Study|Physician Decision|4|||
16489397|NCT00980057|40266923|FG001|Overall Study|Physician Decision|0|||
16190667|NCT01683071|39176057|FG001|Part 2|Met exclusion criterion|0|||
16190668|NCT01683071|39176058|FG002|Part 2|Met exclusion criterion|0|||
16489398|NCT00980057|40266922|FG000|Overall Study|Lost to Follow-up|1|||
16489399|NCT00980057|40266923|FG001|Overall Study|Lost to Follow-up|0|||
16489400|NCT00980057|40266922|FG000|Overall Study|Withdrawal by Subject|1|||
16190669|NCT01683071|39176059|FG003|Part 2|Met exclusion criterion|0|||
16190670|NCT01683071|39176060|FG004|Part 2|Met exclusion criterion|1|||
16190671|NCT01683071|39176061|FG005|Part 2|Met exclusion criterion|1|||
16489401|NCT00980057|40266923|FG001|Overall Study|Withdrawal by Subject|1|||
16489402|NCT00599924|40266924|FG000|Overall Study|Lack of Efficacy|3|||
16190672|NCT01683071|39176056|FG000|Part 2|Protocol deviation|0|||
16298788|NCT03496610|39577852|FG000|Overall Study|Lost to Follow-up|3|||
16298789|NCT03496610|39577853|FG001|Overall Study|Lost to Follow-up|2|||
16298790|NCT03496610|39577852|FG000|Overall Study|Physician Decision|1|||
16298791|NCT03496610|39577853|FG001|Overall Study|Physician Decision|0|||
16298792|NCT03496610|39577852|FG000|Overall Study|Withdrawal by Subject|1|||
16298793|NCT03496610|39577853|FG001|Overall Study|Withdrawal by Subject|0|||
16298794|NCT04546724|39577854|FG000|Overall Study|Withdrawal by Subject|145|||
16298795|NCT04546724|39577855|FG001|Overall Study|Withdrawal by Subject|41|||
16298796|NCT04546724|39577854|FG000|Overall Study|Adverse Event|1|||
16298797|NCT04546724|39577855|FG001|Overall Study|Adverse Event|1|||
16298798|NCT04546724|39577854|FG000|Overall Study|Lost to Follow-up|186|||
16298799|NCT04546724|39577855|FG001|Overall Study|Lost to Follow-up|63|||
16298800|NCT04546724|39577854|FG000|Overall Study|Physician Decision|8|||
16298801|NCT04546724|39577855|FG001|Overall Study|Physician Decision|2|||
16298802|NCT04546724|39577854|FG000|Overall Study|Death|2|||
16298803|NCT04546724|39577855|FG001|Overall Study|Death|1|||
16298804|NCT04546724|39577854|FG000|Overall Study|subject has been out of town|1|||
16298805|NCT04546724|39577855|FG001|Overall Study|subject has been out of town|0|||
16298806|NCT04546724|39577854|FG000|Overall Study|subject is incarcerated|2|||
16298807|NCT04546724|39577855|FG001|Overall Study|subject is incarcerated|0|||
16298808|NCT04546724|39577854|FG000|Overall Study|subject is relocating|12|||
16298809|NCT04546724|39577855|FG001|Overall Study|subject is relocating|4|||
16298810|NCT04546724|39577854|FG000|Overall Study|Subject in another study|1|||
16298811|NCT04546724|39577855|FG001|Overall Study|Subject in another study|1|||
16298812|NCT02901548|39577856|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
16298813|NCT00729248|39577867|FG000|Overall Study|Physician Decision|2|||
16298814|NCT03858634|39577870|FG000|Overall Study|Withdrawal by Subject|1|||
16298815|NCT03858634|39577871|FG001|Overall Study|Withdrawal by Subject|0|||
16298816|NCT03858634|39577870|FG000|Overall Study|Adverse Event|1|||
16298817|NCT03858634|39577871|FG001|Overall Study|Adverse Event|0|||
16298818|NCT03858634|39577870|FG000|Overall Study|Lost to Follow-up|0|||
16298819|NCT03858634|39577871|FG001|Overall Study|Lost to Follow-up|1|||
16298820|NCT03858634|39577870|FG000|Overall Study|Other, Not Specified|1|||
16298821|NCT03858634|39577871|FG001|Overall Study|Other, Not Specified|1|||
16298822|NCT03058289|39577872|FG000|Overall Study|Radiographic Deterioration|0|||
16298823|NCT03058289|39577873|FG001|Overall Study|Radiographic Deterioration|3|||
16298824|NCT03058289|39577874|FG002|Overall Study|Radiographic Deterioration|1|||
16489403|NCT00599924|40266925|FG001|Overall Study|Lack of Efficacy|5|||
16489404|NCT00599924|40266926|FG002|Overall Study|Lack of Efficacy|1|||
16489405|NCT00599924|40266927|FG003|Overall Study|Lack of Efficacy|2|||
16489406|NCT00599924|40266928|FG004|Overall Study|Lack of Efficacy|3|||
16489407|NCT00599924|40266929|FG005|Overall Study|Lack of Efficacy|2|||
16489408|NCT00599924|40266930|FG006|Overall Study|Lack of Efficacy|0|||
16489409|NCT00599924|40266924|FG000|Overall Study|Adverse Event|0|||
16190673|NCT01683071|39176057|FG001|Part 2|Protocol deviation|0|||
16190674|NCT01683071|39176058|FG002|Part 2|Protocol deviation|0|||
16190675|NCT01683071|39176059|FG003|Part 2|Protocol deviation|0|||
16190676|NCT01683071|39176060|FG004|Part 2|Protocol deviation|1|||
16190677|NCT01683071|39176061|FG005|Part 2|Protocol deviation|2|||
16190678|NCT01683071|39176056|FG000|Part 2|Withdrawal by investigator decision|0|||
16190679|NCT01683071|39176057|FG001|Part 2|Withdrawal by investigator decision|0|||
16190680|NCT01683071|39176058|FG002|Part 2|Withdrawal by investigator decision|0|||
16190681|NCT01683071|39176059|FG003|Part 2|Withdrawal by investigator decision|0|||
16190682|NCT01683071|39176060|FG004|Part 2|Withdrawal by investigator decision|1|||
16190683|NCT01683071|39176061|FG005|Part 2|Withdrawal by investigator decision|2|||
16190684|NCT00883558|39176070|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
16190685|NCT00883558|39176071|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
16190686|NCT00883558|39176072|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
16190687|NCT00883558|39176070|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
16190688|NCT00883558|39176071|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
16190689|NCT00883558|39176072|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
16298825|NCT03058289|39577875|FG003|Overall Study|Radiographic Deterioration|2|||
16298826|NCT03058289|39577876|FG004|Overall Study|Radiographic Deterioration|6|||
16298827|NCT03058289|39577877|FG005|Overall Study|Radiographic Deterioration|3|||
16298828|NCT03058289|39577878|FG006|Overall Study|Radiographic Deterioration|0|||
16298829|NCT03058289|39577879|FG007|Overall Study|Radiographic Deterioration|4|||
16298830|NCT03058289|39577880|FG008|Overall Study|Radiographic Deterioration|2|||
16298831|NCT03058289|39577872|FG000|Overall Study|Adverse Event|2|||
16298832|NCT03058289|39577873|FG001|Overall Study|Adverse Event|0|||
16298833|NCT03058289|39577874|FG002|Overall Study|Adverse Event|1|||
16489410|NCT00599924|40266925|FG001|Overall Study|Adverse Event|0|||
16489411|NCT00599924|40266926|FG002|Overall Study|Adverse Event|0|||
16489412|NCT00599924|40266927|FG003|Overall Study|Adverse Event|2|||
16083516|NCT00623194|38799090|FG000|Overall Study|Protocol Violation|3|||
16489413|NCT00599924|40266928|FG004|Overall Study|Adverse Event|0|||
16190690|NCT00883558|39176070|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
16190691|NCT00883558|39176071|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
16190692|NCT00883558|39176072|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
16190693|NCT00883558|39176070|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
16489414|NCT00599924|40266929|FG005|Overall Study|Adverse Event|0|||
16489415|NCT00599924|40266930|FG006|Overall Study|Adverse Event|2|||
16190694|NCT00883558|39176071|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
16190695|NCT00883558|39176072|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
16190696|NCT00883558|39176070|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
16190697|NCT00883558|39176071|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
16190698|NCT00883558|39176072|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
16190699|NCT01096446|39176077|FG000|Overall Study|Death|1|||
16190700|NCT01096446|39176078|FG001|Overall Study|Death|0|||
16190701|NCT01096446|39176077|FG000|Overall Study|Protocol Violation|2|||
16190702|NCT01096446|39176078|FG001|Overall Study|Protocol Violation|0|||
16190703|NCT05131451|39176082|FG000|Overall Study|Protocol Violation|1|||
16190704|NCT05131451|39176083|FG001|Overall Study|Protocol Violation|0|||
16190705|NCT01994226|39176087|FG000|Overall Study|Protocol Violation|13|||
16190706|NCT01994226|39176088|FG001|Overall Study|Protocol Violation|10|||
16190707|NCT01994226|39176087|FG000|Overall Study|Early Cessation of treatment|6|||
16190708|NCT01994226|39176088|FG001|Overall Study|Early Cessation of treatment|11|||
16190709|NCT02361762|39176092|FG000|Overall Study|Withdrawal by Subject|0|||
16190710|NCT02361762|39176093|FG001|Overall Study|Withdrawal by Subject|1|||
16190711|NCT02361762|39176092|FG000|Overall Study|Lost to Follow-up|0|||
16190712|NCT02361762|39176093|FG001|Overall Study|Lost to Follow-up|1|||
16190713|NCT01746732|39176094|FG000|Lead-In Period|Withdrawal by Subject|1|||
16190714|NCT01746732|39176095|FG001|Lead-In Period|Withdrawal by Subject|0|||
16190715|NCT01746732|39176096|FG002|Lead-In Period|Withdrawal by Subject|0|||
16190716|NCT01746732|39176094|FG000|Period 1|Physician Decision|0|||
16190717|NCT01746732|39176095|FG001|Period 1|Physician Decision|1|||
16190718|NCT01746732|39176096|FG002|Period 1|Physician Decision|0|||
16190719|NCT01746732|39176094|FG000|Period 2|Withdrawal by Subject|0|||
16190720|NCT01746732|39176095|FG001|Period 2|Withdrawal by Subject|0|||
16190721|NCT01746732|39176096|FG002|Period 2|Withdrawal by Subject|2|||
16190722|NCT01746732|39176094|FG000|Period 2|Adverse Event|0|||
16190723|NCT01746732|39176095|FG001|Period 2|Adverse Event|0|||
16190724|NCT01746732|39176096|FG002|Period 2|Adverse Event|1|||
16190725|NCT01746732|39176094|FG000|Period 2|Lost to Follow-up|0|||
16190726|NCT01746732|39176095|FG001|Period 2|Lost to Follow-up|0|||
16190727|NCT01746732|39176096|FG002|Period 2|Lost to Follow-up|1|||
16190728|NCT00089843|39176100|FG000|Overall Study|Withdrawal by Subject|1|||
16190729|NCT00089843|39176101|FG001|Overall Study|Withdrawal by Subject|4|||
16190730|NCT00089843|39176102|FG002|Overall Study|Withdrawal by Subject|5|||
16190731|NCT00089843|39176103|FG003|Overall Study|Withdrawal by Subject|6|||
16190732|NCT00089843|39176100|FG000|Overall Study|Physician Decision|1|||
16190733|NCT00089843|39176101|FG001|Overall Study|Physician Decision|0|||
16190734|NCT00089843|39176102|FG002|Overall Study|Physician Decision|0|||
16190735|NCT00089843|39176103|FG003|Overall Study|Physician Decision|1|||
16190736|NCT01401010|39176109|FG000|Overall Study|Could not interpret assay results|1|||
16190737|NCT01401010|39176110|FG001|Overall Study|Could not interpret assay results|0|||
16190738|NCT03259334|39176111|FG000|Overall Study|Adverse Event|3|||
16190739|NCT03259334|39176112|FG001|Overall Study|Adverse Event|8|||
16298834|NCT03058289|39577875|FG003|Overall Study|Adverse Event|3|||
16298835|NCT03058289|39577876|FG004|Overall Study|Adverse Event|1|||
16298836|NCT03058289|39577877|FG005|Overall Study|Adverse Event|0|||
16298837|NCT03058289|39577878|FG006|Overall Study|Adverse Event|1|||
16489416|NCT00599924|40266924|FG000|Overall Study|Death|0|||
16489417|NCT00599924|40266925|FG001|Overall Study|Death|0|||
16489418|NCT00599924|40266926|FG002|Overall Study|Death|0|||
16190740|NCT03259334|39176113|FG002|Overall Study|Adverse Event|5|||
16190741|NCT03259334|39176111|FG000|Overall Study|Withdrawal by Subject|4|||
16190742|NCT03259334|39176112|FG001|Overall Study|Withdrawal by Subject|2|||
16190743|NCT03259334|39176113|FG002|Overall Study|Withdrawal by Subject|4|||
16190744|NCT03259334|39176111|FG000|Overall Study|Physician Decision|1|||
16190745|NCT03259334|39176112|FG001|Overall Study|Physician Decision|0|||
16190746|NCT03259334|39176113|FG002|Overall Study|Physician Decision|0|||
16190747|NCT03259334|39176111|FG000|Overall Study|Lost to Follow-up|0|||
16190748|NCT03259334|39176112|FG001|Overall Study|Lost to Follow-up|2|||
16190749|NCT03259334|39176113|FG002|Overall Study|Lost to Follow-up|1|||
16298838|NCT03058289|39577879|FG007|Overall Study|Adverse Event|3|||
16190750|NCT03259334|39176111|FG000|Overall Study|Protocol Deviation|0|||
16190751|NCT03259334|39176112|FG001|Overall Study|Protocol Deviation|3|||
16190752|NCT03259334|39176113|FG002|Overall Study|Protocol Deviation|2|||
16190753|NCT03259334|39176111|FG000|Overall Study|Lack of Efficacy|2|||
16190754|NCT03259334|39176112|FG001|Overall Study|Lack of Efficacy|0|||
16298839|NCT03058289|39577880|FG008|Overall Study|Adverse Event|0|||
16489419|NCT00599924|40266927|FG003|Overall Study|Death|2|||
16298840|NCT03058289|39577872|FG000|Overall Study|Withdrawal by Subject|0|||
16298841|NCT03058289|39577873|FG001|Overall Study|Withdrawal by Subject|0|||
16298842|NCT03058289|39577874|FG002|Overall Study|Withdrawal by Subject|0|||
16298843|NCT03058289|39577875|FG003|Overall Study|Withdrawal by Subject|2|||
16489420|NCT00599924|40266928|FG004|Overall Study|Death|0|||
16489421|NCT00599924|40266929|FG005|Overall Study|Death|2|||
16489422|NCT00599924|40266930|FG006|Overall Study|Death|1|||
16489423|NCT00599924|40266924|FG000|Overall Study|Protocol Violation|0|||
16489424|NCT00599924|40266925|FG001|Overall Study|Protocol Violation|0|||
16489425|NCT00599924|40266926|FG002|Overall Study|Protocol Violation|0|||
16298844|NCT03058289|39577876|FG004|Overall Study|Withdrawal by Subject|0|||
16298845|NCT03058289|39577877|FG005|Overall Study|Withdrawal by Subject|2|||
16298846|NCT03058289|39577878|FG006|Overall Study|Withdrawal by Subject|0|||
16298847|NCT03058289|39577879|FG007|Overall Study|Withdrawal by Subject|4|||
16489426|NCT00599924|40266927|FG003|Overall Study|Protocol Violation|1|||
16489427|NCT00599924|40266928|FG004|Overall Study|Protocol Violation|0|||
16489428|NCT00599924|40266929|FG005|Overall Study|Protocol Violation|0|||
16489429|NCT00599924|40266930|FG006|Overall Study|Protocol Violation|0|||
16489430|NCT00599924|40266924|FG000|Overall Study|Withdrawal by Subject|0|||
16489431|NCT00599924|40266925|FG001|Overall Study|Withdrawal by Subject|0|||
16489432|NCT00599924|40266926|FG002|Overall Study|Withdrawal by Subject|1|||
16489433|NCT00599924|40266927|FG003|Overall Study|Withdrawal by Subject|0|||
16489434|NCT00599924|40266928|FG004|Overall Study|Withdrawal by Subject|1|||
16489435|NCT00599924|40266929|FG005|Overall Study|Withdrawal by Subject|0|||
16489436|NCT00599924|40266930|FG006|Overall Study|Withdrawal by Subject|0|||
16489437|NCT00599924|40266924|FG000|Overall Study|Other|0|||
16489438|NCT00599924|40266925|FG001|Overall Study|Other|0|||
16489439|NCT00599924|40266926|FG002|Overall Study|Other|0|||
16489440|NCT00599924|40266927|FG003|Overall Study|Other|1|||
16489441|NCT00599924|40266928|FG004|Overall Study|Other|2|||
16489442|NCT00599924|40266929|FG005|Overall Study|Other|0|||
16489443|NCT00599924|40266930|FG006|Overall Study|Other|2|||
16489444|NCT01446289|40266935|FG000|Overall Study|Withdrawal by Subject|1|||
16489445|NCT01446289|40266936|FG001|Overall Study|Withdrawal by Subject|0|||
16489446|NCT01446289|40266937|FG002|Overall Study|Withdrawal by Subject|1|||
16489447|NCT01446289|40266938|FG003|Overall Study|Withdrawal by Subject|0|||
16489448|NCT02165215|40266939|FG000|Induction Phase|Adverse Event|1|||
16489449|NCT02165215|40266940|FG001|Induction Phase|Adverse Event|0|||
16489450|NCT02165215|40266941|FG002|Induction Phase|Adverse Event|0|||
16489451|NCT02165215|40266939|FG000|Induction Phase|Withdrawal by Subject|10|||
16489452|NCT02165215|40266940|FG001|Induction Phase|Withdrawal by Subject|0|||
16489453|NCT02165215|40266941|FG002|Induction Phase|Withdrawal by Subject|0|||
16489454|NCT02165215|40266939|FG000|Induction Phase|Protocol Violation|1|||
16489455|NCT02165215|40266940|FG001|Induction Phase|Protocol Violation|0|||
16489456|NCT02165215|40266941|FG002|Induction Phase|Protocol Violation|0|||
16489457|NCT02165215|40266939|FG000|Induction Phase|Physician Decision|1|||
16489458|NCT02165215|40266940|FG001|Induction Phase|Physician Decision|0|||
16489459|NCT02165215|40266941|FG002|Induction Phase|Physician Decision|0|||
16489460|NCT02165215|40266939|FG000|Induction Phase|Lack of Efficacy|2|||
16489461|NCT02165215|40266940|FG001|Induction Phase|Lack of Efficacy|0|||
16489462|NCT02165215|40266941|FG002|Induction Phase|Lack of Efficacy|0|||
16489463|NCT02165215|40266939|FG000|Induction Phase|Non-Compliance|2|||
16489464|NCT02165215|40266940|FG001|Induction Phase|Non-Compliance|0|||
16489465|NCT02165215|40266941|FG002|Induction Phase|Non-Compliance|0|||
16489466|NCT02165215|40266939|FG000|Induction Phase|Lost to Follow-up|6|||
16489467|NCT02165215|40266940|FG001|Induction Phase|Lost to Follow-up|0|||
16489468|NCT02165215|40266941|FG002|Induction Phase|Lost to Follow-up|0|||
16190755|NCT03259334|39176113|FG002|Overall Study|Lack of Efficacy|1|||
16190756|NCT03259334|39176111|FG000|Overall Study|Randomized but never treated|0|||
16190757|NCT03259334|39176112|FG001|Overall Study|Randomized but never treated|2|||
16190758|NCT03259334|39176113|FG002|Overall Study|Randomized but never treated|0|||
16190759|NCT02357849|39176114|FG000|Overall Study|Withdrawal by Subject|2|||
16190760|NCT02357849|39176115|FG001|Overall Study|Withdrawal by Subject|3|||
16190761|NCT00777491|39176118|FG000|Overall Study|Protocol Violation|0|||
16190762|NCT00777491|39176119|FG001|Overall Study|Protocol Violation|2|||
16190763|NCT00777491|39176118|FG000|Overall Study|Did not receive any protocol treatment|2|||
16190764|NCT00777491|39176119|FG001|Overall Study|Did not receive any protocol treatment|0|||
16190765|NCT02164513|39176122|FG000|Overall Study|Adverse Event|162|||
16190766|NCT02164513|39176123|FG001|Overall Study|Adverse Event|180|||
16190767|NCT02164513|39176124|FG002|Overall Study|Adverse Event|111|||
16385105|NCT02394561|39892737|FG000|Extension Phase|Physician Decision|0|||
16489469|NCT02165215|40266939|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16489470|NCT02165215|40266940|FG001|Maintenance Phase|Withdrawal by Subject|7|||
16489471|NCT02165215|40266941|FG002|Maintenance Phase|Withdrawal by Subject|3|||
16489472|NCT02165215|40266939|FG000|Maintenance Phase|Multiple reasons|0|||
16190768|NCT02164513|39176122|FG000|Overall Study|Other: Study Closed or terminated|5|||
16298848|NCT03058289|39577880|FG008|Overall Study|Withdrawal by Subject|1|||
16298849|NCT03058289|39577872|FG000|Overall Study|Physician Decision|1|||
16298850|NCT03058289|39577873|FG001|Overall Study|Physician Decision|0|||
16298851|NCT03058289|39577874|FG002|Overall Study|Physician Decision|0|||
16298852|NCT03058289|39577875|FG003|Overall Study|Physician Decision|2|||
16298853|NCT03058289|39577876|FG004|Overall Study|Physician Decision|1|||
16489473|NCT02165215|40266940|FG001|Maintenance Phase|Multiple reasons|2|||
16489474|NCT02165215|40266941|FG002|Maintenance Phase|Multiple reasons|1|||
16190769|NCT02164513|39176123|FG001|Overall Study|Other: Study Closed or terminated|2|||
16190770|NCT02164513|39176124|FG002|Overall Study|Other: Study Closed or terminated|4|||
16190771|NCT02164513|39176122|FG000|Overall Study|Lost to Follow-up|30|||
16190772|NCT02164513|39176123|FG001|Overall Study|Lost to Follow-up|36|||
16190773|NCT02164513|39176124|FG002|Overall Study|Lost to Follow-up|22|||
16190774|NCT02164513|39176122|FG000|Overall Study|Physician Decision|47|||
16190775|NCT02164513|39176123|FG001|Overall Study|Physician Decision|57|||
16190776|NCT02164513|39176124|FG002|Overall Study|Physician Decision|28|||
16190777|NCT02164513|39176122|FG000|Overall Study|Withdrawal by Subject|192|||
16190778|NCT02164513|39176123|FG001|Overall Study|Withdrawal by Subject|261|||
16190779|NCT02164513|39176124|FG002|Overall Study|Withdrawal by Subject|130|||
16190780|NCT02164513|39176122|FG000|Overall Study|Other: Reason not provided by site|1|||
16190781|NCT02164513|39176123|FG001|Overall Study|Other: Reason not provided by site|0|||
16190782|NCT02164513|39176124|FG002|Overall Study|Other: Reason not provided by site|0|||
16190783|NCT00603980|39176127|FG000|Study Qualification|Protocol Violation|3|||
16190784|NCT00603980|39176127|FG000|Study Qualification|Inconsistent data reporting|13|||
16190785|NCT00603980|39176127|FG000|Main Study|14th subject completed trial|1|||
16190786|NCT00698516|39176136|FG000|Overall Study|Study Termination|2|||
16190787|NCT00698516|39176136|FG000|Overall Study|Withdrawal by Subject|3|||
16190788|NCT00488618|39176137|FG000|Overall Study|Adverse Event|13|||
16190789|NCT00488618|39176138|FG001|Overall Study|Adverse Event|17|||
16190790|NCT00488618|39176137|FG000|Overall Study|Insufficient Therapeutic Response|18|||
16190791|NCT00488618|39176138|FG001|Overall Study|Insufficient Therapeutic Response|11|||
16190792|NCT00488618|39176137|FG000|Overall Study|Protocol Violation|0|||
16190793|NCT00488618|39176138|FG001|Overall Study|Protocol Violation|2|||
16190794|NCT00488618|39176137|FG000|Overall Study|Withdrawal of Consent|15|||
16190795|NCT00488618|39176138|FG001|Overall Study|Withdrawal of Consent|13|||
16190796|NCT00488618|39176137|FG000|Overall Study|Lost to Follow-up|1|||
16190797|NCT00488618|39176138|FG001|Overall Study|Lost to Follow-up|0|||
16190798|NCT01551758|39176139|FG000|Overall Study|Adverse Event|29|||
16190799|NCT01551758|39176140|FG001|Overall Study|Adverse Event|43|||
16190800|NCT01551758|39176139|FG000|Overall Study|Lack of Efficacy|0|||
16190801|NCT01551758|39176140|FG001|Overall Study|Lack of Efficacy|1|||
16489475|NCT02165215|40266939|FG000|Maintenance Phase|Lost to Follow-up|0|||
16190802|NCT01551758|39176139|FG000|Overall Study|Protocol Violation|5|||
16190803|NCT01551758|39176140|FG001|Overall Study|Protocol Violation|6|||
16190804|NCT01551758|39176139|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
16190805|NCT01551758|39176140|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
16190806|NCT01551758|39176139|FG000|Overall Study|Lost to Follow-up|29|||
16190807|NCT01551758|39176140|FG001|Overall Study|Lost to Follow-up|25|||
16190808|NCT01551758|39176139|FG000|Overall Study|Physician Decision|9|||
16190809|NCT01551758|39176140|FG001|Overall Study|Physician Decision|3|||
16190810|NCT01551758|39176139|FG000|Overall Study|Withdrawal by Subject|14|||
16190811|NCT01551758|39176140|FG001|Overall Study|Withdrawal by Subject|17|||
16190812|NCT03439748|39176141|FG000|Overall Study|Withdrawal by Subject|11|||
16190813|NCT03439748|39176142|FG001|Overall Study|Withdrawal by Subject|17|||
16190814|NCT02433288|39176143|FG000|Overall Study|Severe non-compliance to protocol|13|||
16190815|NCT02433288|39176144|FG001|Overall Study|Severe non-compliance to protocol|7|||
16190816|NCT02433288|39176143|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
16190817|NCT02433288|39176144|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
16190818|NCT02433288|39176143|FG000|Overall Study|Withdrawal by Subject|101|||
16190819|NCT02433288|39176144|FG001|Overall Study|Withdrawal by Subject|99|||
16190820|NCT02433288|39176143|FG000|Overall Study|Lost to Follow-up|2|||
16190821|NCT02433288|39176144|FG001|Overall Study|Lost to Follow-up|14|||
16190822|NCT02433288|39176143|FG000|Overall Study|Death|0|||
16190823|NCT02433288|39176144|FG001|Overall Study|Death|3|||
16190824|NCT01260467|39176145|FG000|Overall Study|Withdrawal by Subject|2|||
16190825|NCT03504774|39176146|FG000|Overall Study|Adverse Event|2|||
16190826|NCT03504774|39176147|FG001|Overall Study|Adverse Event|0|||
16190827|NCT03504774|39176146|FG000|Overall Study|Lost to Follow-up|0|||
16190828|NCT03504774|39176147|FG001|Overall Study|Lost to Follow-up|1|||
16190829|NCT03504774|39176146|FG000|Overall Study|Protocol Violation|11|||
16190830|NCT03504774|39176147|FG001|Overall Study|Protocol Violation|3|||
16190831|NCT03504774|39176146|FG000|Overall Study|failed wk 52 DBPCFC|1|||
16190832|NCT03504774|39176147|FG001|Overall Study|failed wk 52 DBPCFC|0|||
16190833|NCT02280291|39176167|FG000|Overall Study|Lost to Follow-up|2|||
16190834|NCT02280291|39176168|FG001|Overall Study|Lost to Follow-up|1|||
16190835|NCT02280291|39176169|FG002|Overall Study|Lost to Follow-up|3|||
16190836|NCT02280291|39176170|FG003|Overall Study|Lost to Follow-up|8|||
16190837|NCT02280291|39176167|FG000|Overall Study|Protocol Violation|1|||
16298854|NCT03058289|39577877|FG005|Overall Study|Physician Decision|0|||
16190838|NCT02280291|39176168|FG001|Overall Study|Protocol Violation|0|||
16190839|NCT02280291|39176169|FG002|Overall Study|Protocol Violation|0|||
16190840|NCT02280291|39176170|FG003|Overall Study|Protocol Violation|0|||
16190841|NCT02280291|39176167|FG000|Overall Study|Other|1|||
16190842|NCT02280291|39176168|FG001|Overall Study|Other|1|||
16190843|NCT02280291|39176169|FG002|Overall Study|Other|0|||
16190844|NCT02280291|39176170|FG003|Overall Study|Other|0|||
16190845|NCT00850759|39176171|FG000|Overall Study|Lost to Follow-up|7|||
16190846|NCT00850759|39176172|FG001|Overall Study|Lost to Follow-up|5|||
16190847|NCT00850759|39176173|FG002|Overall Study|Lost to Follow-up|5|||
16190848|NCT00850759|39176174|FG003|Overall Study|Lost to Follow-up|3|||
16190849|NCT01028651|39176175|FG000|Overall Study|Death|2|||
16190850|NCT01028651|39176175|FG000|Overall Study|Adverse Event|1|||
16190851|NCT03132805|39176177|FG000|Overall Study|Lost to Follow-up|142|||
16190852|NCT03132805|39176178|FG001|Overall Study|Lost to Follow-up|141|||
16190853|NCT03132805|39176179|FG002|Overall Study|Lost to Follow-up|113|||
16190854|NCT01577160|39176180|FG000|Overall Study|Adverse Event|9|||
16298855|NCT03058289|39577878|FG006|Overall Study|Physician Decision|2|||
16298856|NCT03058289|39577879|FG007|Overall Study|Physician Decision|3|||
16298857|NCT03058289|39577880|FG008|Overall Study|Physician Decision|0|||
16298858|NCT03058289|39577872|FG000|Overall Study|Clinical Deterioration|2|||
16298859|NCT03058289|39577873|FG001|Overall Study|Clinical Deterioration|0|||
16298860|NCT03058289|39577874|FG002|Overall Study|Clinical Deterioration|0|||
16298861|NCT03058289|39577875|FG003|Overall Study|Clinical Deterioration|2|||
16298862|NCT03058289|39577876|FG004|Overall Study|Clinical Deterioration|1|||
16489476|NCT02165215|40266940|FG001|Maintenance Phase|Lost to Follow-up|2|||
16489477|NCT02165215|40266941|FG002|Maintenance Phase|Lost to Follow-up|0|||
16489478|NCT02165215|40266939|FG000|Maintenance Phase|Adverse Event|0|||
16489479|NCT02165215|40266940|FG001|Maintenance Phase|Adverse Event|1|||
16489480|NCT02165215|40266941|FG002|Maintenance Phase|Adverse Event|1|||
16489481|NCT01496807|40266944|FG000|Overall Study|Progressive Disease|21|||
16489482|NCT01496807|40266944|FG000|Overall Study|Participant preference/toxicity|8|||
16489483|NCT01496807|40266944|FG000|Overall Study|Change in diagnosis|1|||
16489484|NCT03930797|40266945|FG000|Overall Study|Lost to Follow-up|3|||
16489485|NCT03930797|40266946|FG001|Overall Study|Lost to Follow-up|10|||
16489486|NCT02161731|40266962|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
16489487|NCT02161731|40266963|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
16489488|NCT02161731|40266962|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
16489489|NCT02161731|40266963|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
16489490|NCT03039283|40266964|FG000|Overall Study|Protocol Violation|2|||
16489491|NCT00519831|40266965|FG000|Overall Study|Adverse Event|3|||
16489492|NCT04115839|40266966|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
16489493|NCT04115839|40266967|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
16489494|NCT04115839|40266968|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
16489495|NCT04115839|40266969|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
16489496|NCT04115839|40266970|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
16489497|NCT04115839|40266971|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
16489498|NCT04115839|40266972|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
16489499|NCT04115839|40266966|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
16489500|NCT04115839|40266967|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
16489501|NCT04115839|40266968|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
16489502|NCT04115839|40266969|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
16489503|NCT04115839|40266970|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
16489504|NCT04115839|40266971|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
16489505|NCT04115839|40266972|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
16489506|NCT04115839|40266966|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
16489507|NCT04115839|40266967|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
16489508|NCT04115839|40266968|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
16489509|NCT04115839|40266969|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
16489510|NCT04115839|40266970|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
16489511|NCT04115839|40266971|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
16489512|NCT04115839|40266972|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
16489513|NCT04115839|40266966|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
16489514|NCT04115839|40266967|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
16489515|NCT04115839|40266968|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
16489516|NCT04115839|40266969|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
16489517|NCT04115839|40266970|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
16190855|NCT01577160|39176180|FG000|Overall Study|Lack of Efficacy|15|||
16190856|NCT01577160|39176180|FG000|Overall Study|Lost to Follow-up|40|||
16298863|NCT03058289|39577877|FG005|Overall Study|Clinical Deterioration|1|||
16298864|NCT03058289|39577878|FG006|Overall Study|Clinical Deterioration|0|||
16298865|NCT03058289|39577879|FG007|Overall Study|Clinical Deterioration|3|||
16489518|NCT04115839|40266971|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
16489519|NCT04115839|40266972|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
16489520|NCT04115839|40266966|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
16489521|NCT04115839|40266967|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
16385106|NCT02394561|39892738|FG001|Extension Phase|Physician Decision|2|||
16385107|NCT02394561|39892737|FG000|Extension Phase|Withdrawal by Subject|0|||
16385108|NCT02394561|39892738|FG001|Extension Phase|Withdrawal by Subject|5|||
16385109|NCT02394561|39892737|FG000|Extension Phase|Lack of Efficacy|3|||
16385110|NCT02394561|39892738|FG001|Extension Phase|Lack of Efficacy|3|||
16489522|NCT04115839|40266968|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
16489523|NCT04115839|40266969|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
16489524|NCT04115839|40266970|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
16489525|NCT04115839|40266971|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
16489526|NCT04115839|40266972|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
16489527|NCT04115839|40266966|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
16489528|NCT04115839|40266967|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
16489529|NCT04115839|40266968|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
16489530|NCT04115839|40266969|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
16489531|NCT04115839|40266970|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
16489532|NCT04115839|40266971|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
16489533|NCT04115839|40266972|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
16489534|NCT00673465|40266973|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
16489535|NCT00673465|40266974|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
16489536|NCT00673465|40266975|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
16489537|NCT00673465|40266976|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
16489538|NCT00673465|40266977|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
16489539|NCT00673465|40266978|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
16489540|NCT00673465|40266979|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
16489541|NCT00673465|40266980|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
16489542|NCT00673465|40266981|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
16489543|NCT00673465|40266982|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
16489544|NCT00673465|40266983|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
16489545|NCT00673465|40266984|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
16489546|NCT00673465|40266973|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489547|NCT00673465|40266974|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489548|NCT00673465|40266975|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489549|NCT00673465|40266976|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489550|NCT00673465|40266977|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
16489551|NCT00673465|40266978|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489552|NCT00673465|40266979|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489553|NCT00673465|40266980|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489554|NCT00673465|40266981|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489555|NCT00673465|40266982|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489556|NCT00673465|40266983|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489557|NCT00673465|40266984|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
16489558|NCT01397084|40266985|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
16489559|NCT01397084|40266985|FG000|Overall Study|Protocol Violation|2|||
16489560|NCT01397084|40266985|FG000|Overall Study|Adverse Event|2|||
16489561|NCT01397084|40266985|FG000|Overall Study|Withdrawal by Subject|1|||
16489562|NCT01397084|40266985|FG000|Overall Study|Lost to Follow-up|1|||
16489563|NCT01397084|40266985|FG000|Overall Study|Used other proton pump inhibitor|1|||
16489564|NCT01812174|40266986|FG000|Overall Study|Death|1|||
16489565|NCT01812174|40266987|FG001|Overall Study|Death|0|||
16489566|NCT01812174|40266986|FG000|Overall Study|Protocol Violation|2|||
16489567|NCT01812174|40266987|FG001|Overall Study|Protocol Violation|0|||
16385111|NCT00928668|39892742|FG000|Overall Study|Adverse Event|1|||
16385112|NCT00928668|39892743|FG001|Overall Study|Adverse Event|0|||
16489568|NCT00307294|40266991|FG000|Overall Study|Withdrawal by Subject|1|||
16489569|NCT00967668|40266992|FG000|Overall Study|Withdrawal by Subject|13|||
16489570|NCT00967668|40266993|FG001|Overall Study|Withdrawal by Subject|8|||
16489571|NCT00967668|40266994|FG002|Overall Study|Withdrawal by Subject|8|||
16489572|NCT00967668|40266992|FG000|Overall Study|Death|0|||
16083517|NCT00623194|38799090|FG000|Overall Study|Unclassified|1|||
16489573|NCT00967668|40266993|FG001|Overall Study|Death|2|||
16489574|NCT00967668|40266994|FG002|Overall Study|Death|4|||
16489575|NCT00967668|40266992|FG000|Overall Study|Removed due to behavior|1|||
16489576|NCT00967668|40266993|FG001|Overall Study|Removed due to behavior|1|||
16489577|NCT00967668|40266994|FG002|Overall Study|Removed due to behavior|2|||
16489578|NCT00967668|40266992|FG000|Overall Study|Refused Year 2|11|||
16489579|NCT00967668|40266993|FG001|Overall Study|Refused Year 2|6|||
16489580|NCT00967668|40266994|FG002|Overall Study|Refused Year 2|4|||
16385113|NCT00928668|39892744|FG002|Overall Study|Adverse Event|0|||
16385114|NCT00928668|39892745|FG003|Overall Study|Adverse Event|0|||
16489581|NCT00967668|40266992|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
16489582|NCT00967668|40266993|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
16489583|NCT00967668|40266994|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
16489584|NCT00967668|40266992|FG000|Overall Study|Lost to Follow-up|15|||
16489585|NCT00967668|40266993|FG001|Overall Study|Lost to Follow-up|9|||
16489586|NCT00967668|40266994|FG002|Overall Study|Lost to Follow-up|16|||
16489587|NCT00967668|40266992|FG000|Overall Study|Refused 12-mo assessment|3|||
16489588|NCT00967668|40266993|FG001|Overall Study|Refused 12-mo assessment|1|||
16489589|NCT00967668|40266994|FG002|Overall Study|Refused 12-mo assessment|9|||
16489590|NCT00967668|40266992|FG000|Overall Study|Pregnancy|1|||
16489591|NCT00967668|40266993|FG001|Overall Study|Pregnancy|0|||
16489592|NCT00967668|40266994|FG002|Overall Study|Pregnancy|0|||
16489593|NCT01648101|40266995|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
16489594|NCT01648101|40266996|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
16489595|NCT01648101|40266997|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
16489596|NCT01648101|40266995|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
16385115|NCT00928668|39892746|FG004|Overall Study|Adverse Event|0|||
16385116|NCT00928668|39892742|FG000|Overall Study|Protocol Violation|0|||
16385117|NCT00928668|39892743|FG001|Overall Study|Protocol Violation|0|||
16385118|NCT00928668|39892744|FG002|Overall Study|Protocol Violation|0|||
16385119|NCT00928668|39892745|FG003|Overall Study|Protocol Violation|0|||
16385120|NCT00928668|39892746|FG004|Overall Study|Protocol Violation|1|||
16385121|NCT00928668|39892742|FG000|Overall Study|Withdrawal by Subject|0|||
16385122|NCT00928668|39892743|FG001|Overall Study|Withdrawal by Subject|1|||
16385123|NCT00928668|39892744|FG002|Overall Study|Withdrawal by Subject|1|||
16385124|NCT00928668|39892745|FG003|Overall Study|Withdrawal by Subject|0|||
16385125|NCT00928668|39892746|FG004|Overall Study|Withdrawal by Subject|0|||
16385126|NCT00928668|39892742|FG000|Overall Study|Other reasons not listed above|0|||
16385127|NCT00928668|39892743|FG001|Overall Study|Other reasons not listed above|0|||
16385128|NCT00928668|39892744|FG002|Overall Study|Other reasons not listed above|0|||
16385129|NCT00928668|39892745|FG003|Overall Study|Other reasons not listed above|1|||
16385130|NCT00928668|39892746|FG004|Overall Study|Other reasons not listed above|0|||
16385131|NCT00744861|39892747|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
16385132|NCT00744861|39892748|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
16385133|NCT00744861|39892749|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
16385134|NCT00744861|39892750|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
16385135|NCT00744861|39892747|FG000|Feasibility Stage 1|Pregnancy|0|||
16385136|NCT00744861|39892748|FG001|Feasibility Stage 1|Pregnancy|1|||
16385137|NCT00744861|39892749|FG002|Feasibility Stage 1|Pregnancy|0|||
16385138|NCT00744861|39892750|FG003|Feasibility Stage 1|Pregnancy|0|||
16385139|NCT00744861|39892747|FG000|Pivotal Stage 2|Adverse Event|0|||
16385140|NCT00744861|39892748|FG001|Pivotal Stage 2|Adverse Event|0|||
16385141|NCT00744861|39892749|FG002|Pivotal Stage 2|Adverse Event|6|||
16385142|NCT00744861|39892750|FG003|Pivotal Stage 2|Adverse Event|11|||
16385143|NCT00744861|39892747|FG000|Pivotal Stage 2|Death|0|||
16385144|NCT00744861|39892748|FG001|Pivotal Stage 2|Death|0|||
16489597|NCT01648101|40266996|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
16489598|NCT01648101|40266997|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
16489599|NCT01648101|40266995|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
16489600|NCT01648101|40266996|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
16489601|NCT01648101|40266997|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
16298866|NCT03058289|39577880|FG008|Overall Study|Clinical Deterioration|2|||
16298867|NCT03058289|39577872|FG000|Overall Study|Lost to Follow-up|0|||
16298868|NCT03058289|39577873|FG001|Overall Study|Lost to Follow-up|0|||
16298869|NCT03058289|39577874|FG002|Overall Study|Lost to Follow-up|0|||
16298870|NCT03058289|39577875|FG003|Overall Study|Lost to Follow-up|0|||
16298871|NCT03058289|39577876|FG004|Overall Study|Lost to Follow-up|1|||
16298872|NCT03058289|39577877|FG005|Overall Study|Lost to Follow-up|0|||
16298873|NCT03058289|39577878|FG006|Overall Study|Lost to Follow-up|0|||
16298874|NCT03058289|39577879|FG007|Overall Study|Lost to Follow-up|0|||
16298875|NCT03058289|39577880|FG008|Overall Study|Lost to Follow-up|0|||
16298876|NCT03058289|39577872|FG000|Overall Study|Refused Further Treatment|0|||
16298877|NCT03058289|39577873|FG001|Overall Study|Refused Further Treatment|0|||
16385145|NCT00744861|39892749|FG002|Pivotal Stage 2|Death|0|||
16385146|NCT00744861|39892750|FG003|Pivotal Stage 2|Death|1|||
16385147|NCT00744861|39892747|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
16385148|NCT00744861|39892748|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
16385149|NCT00744861|39892749|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
16385150|NCT00744861|39892750|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
16385151|NCT00744861|39892747|FG000|Pivotal Stage 2|Physician Decision|0|||
16489602|NCT01648101|40266995|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
16489603|NCT01648101|40266996|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
16489604|NCT01648101|40266997|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
16298878|NCT03058289|39577874|FG002|Overall Study|Refused Further Treatment|1|||
16298879|NCT03058289|39577875|FG003|Overall Study|Refused Further Treatment|0|||
16385152|NCT00744861|39892748|FG001|Pivotal Stage 2|Physician Decision|0|||
16385153|NCT00744861|39892749|FG002|Pivotal Stage 2|Physician Decision|3|||
16489605|NCT01648101|40266995|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
16489606|NCT01648101|40266996|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
16489607|NCT01648101|40266997|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
16489608|NCT01648101|40266995|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
16489609|NCT01648101|40266996|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
16489610|NCT01648101|40266997|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
16489611|NCT01648101|40266995|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
16489612|NCT01648101|40266996|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
16489613|NCT01648101|40266997|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
16489614|NCT01648101|40266995|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
16298880|NCT03058289|39577876|FG004|Overall Study|Refused Further Treatment|1|||
16298881|NCT03058289|39577877|FG005|Overall Study|Refused Further Treatment|0|||
16298882|NCT03058289|39577878|FG006|Overall Study|Refused Further Treatment|0|||
16298883|NCT03058289|39577879|FG007|Overall Study|Refused Further Treatment|0|||
16298884|NCT03058289|39577880|FG008|Overall Study|Refused Further Treatment|0|||
16298885|NCT03058289|39577872|FG000|Overall Study|Rapid Progression of Disease|0|||
16298886|NCT03058289|39577873|FG001|Overall Study|Rapid Progression of Disease|0|||
16298887|NCT03058289|39577874|FG002|Overall Study|Rapid Progression of Disease|0|||
16298888|NCT03058289|39577875|FG003|Overall Study|Rapid Progression of Disease|1|||
16385154|NCT00744861|39892750|FG003|Pivotal Stage 2|Physician Decision|1|||
16489615|NCT01648101|40266996|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
16489616|NCT01648101|40266997|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
16489617|NCT01648101|40266995|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
16489618|NCT01648101|40266996|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
16489619|NCT01648101|40266997|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
16489620|NCT01648101|40266995|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
16489621|NCT01648101|40266996|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
16489622|NCT01648101|40266997|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
16489623|NCT01648101|40266995|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
16489624|NCT01648101|40266996|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
16489625|NCT01648101|40266997|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
16489626|NCT04404361|40266998|FG000|Overall Study|Death|12|||
16489627|NCT04404361|40266999|FG001|Overall Study|Death|12|||
16489628|NCT04404361|40266998|FG000|Overall Study|Withdrawal by Subject|13|||
16489629|NCT04404361|40266999|FG001|Overall Study|Withdrawal by Subject|5|||
16489630|NCT04404361|40266998|FG000|Overall Study|Lost to Follow-up|6|||
16489631|NCT04404361|40266999|FG001|Overall Study|Lost to Follow-up|3|||
16489632|NCT04404361|40266998|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
16385155|NCT00744861|39892747|FG000|Pivotal Stage 2|Protocol Violation|0|||
16385156|NCT00744861|39892748|FG001|Pivotal Stage 2|Protocol Violation|0|||
16385157|NCT00744861|39892749|FG002|Pivotal Stage 2|Protocol Violation|0|||
16385158|NCT00744861|39892750|FG003|Pivotal Stage 2|Protocol Violation|1|||
16385159|NCT00744861|39892747|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
16385160|NCT00744861|39892748|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
16385161|NCT00744861|39892749|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
16385162|NCT00744861|39892750|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
16385163|NCT00744861|39892747|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
16385164|NCT00744861|39892748|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
16385165|NCT00744861|39892749|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
16385166|NCT00744861|39892750|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
16385167|NCT02191618|39892757|FG000|Overall Study|Withdrawal by Subject|3|||
16385168|NCT02191618|39892757|FG000|Overall Study|Missed Visit|4|||
16489633|NCT04404361|40266999|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
16489634|NCT01826604|40267000|FG000|Overall Study|Lost to Follow-up|8|||
16489635|NCT01826604|40267001|FG001|Overall Study|Lost to Follow-up|9|||
16489636|NCT00753415|40267002|FG000|Part A|Disease progression|1|||
16489637|NCT00753415|40267003|FG001|Part A|Disease progression|0|||
16489638|NCT00753415|40267004|FG002|Part A|Disease progression|1|||
16489639|NCT00753415|40267005|FG003|Part A|Disease progression|2|||
16489640|NCT00753415|40267006|FG004|Part A|Disease progression|0|||
16489641|NCT00753415|40267007|FG005|Part A|Disease progression|0|||
16489642|NCT00753415|40267008|FG006|Part A|Disease progression|0|||
16489643|NCT00753415|40267009|FG007|Part A|Disease progression|0|||
16489644|NCT00753415|40267010|FG008|Part A|Disease progression|0|||
16489645|NCT00753415|40267011|FG009|Part A|Disease progression|0|||
16385169|NCT00457392|39892761|FG000|Overall Study|Objective Progression or Relapse|229|||
16385170|NCT00457392|39892762|FG001|Overall Study|Objective Progression or Relapse|296|||
16489646|NCT00753415|40267002|FG000|Part A|Withdrawal by Subject|0|||
16489647|NCT00753415|40267003|FG001|Part A|Withdrawal by Subject|0|||
16489648|NCT00753415|40267004|FG002|Part A|Withdrawal by Subject|1|||
16489649|NCT00753415|40267005|FG003|Part A|Withdrawal by Subject|0|||
16489650|NCT00753415|40267006|FG004|Part A|Withdrawal by Subject|0|||
16190857|NCT01577160|39176180|FG000|Overall Study|Withdrawal by Subject|18|||
16298889|NCT03058289|39577876|FG004|Overall Study|Rapid Progression of Disease|0|||
16489651|NCT00753415|40267007|FG005|Part A|Withdrawal by Subject|0|||
16489652|NCT00753415|40267008|FG006|Part A|Withdrawal by Subject|0|||
16489653|NCT00753415|40267009|FG007|Part A|Withdrawal by Subject|0|||
16489654|NCT00753415|40267010|FG008|Part A|Withdrawal by Subject|0|||
16489655|NCT00753415|40267011|FG009|Part A|Withdrawal by Subject|0|||
16489656|NCT00753415|40267002|FG000|Part B|Lost to Follow-up|0|||
16489657|NCT00753415|40267003|FG001|Part B|Lost to Follow-up|0|||
16489658|NCT00753415|40267004|FG002|Part B|Lost to Follow-up|0|||
16489659|NCT00753415|40267005|FG003|Part B|Lost to Follow-up|0|||
16489660|NCT00753415|40267006|FG004|Part B|Lost to Follow-up|0|||
16489661|NCT00753415|40267007|FG005|Part B|Lost to Follow-up|0|||
16489662|NCT00753415|40267008|FG006|Part B|Lost to Follow-up|0|||
16083518|NCT02568215|38799097|FG000|Overall Study|Death|1|||
16083519|NCT02568215|38799098|FG001|Overall Study|Death|2|||
16083520|NCT02568215|38799099|FG002|Overall Study|Death|0|||
16083521|NCT02568215|38799097|FG000|Overall Study|Physician Decision|2|||
16083522|NCT02568215|38799098|FG001|Overall Study|Physician Decision|2|||
16083523|NCT02568215|38799099|FG002|Overall Study|Physician Decision|2|||
16083524|NCT02568215|38799097|FG000|Overall Study|Lost to Follow-up|29|||
16083525|NCT02568215|38799098|FG001|Overall Study|Lost to Follow-up|32|||
16083526|NCT02568215|38799099|FG002|Overall Study|Lost to Follow-up|41|||
16083527|NCT02568215|38799097|FG000|Overall Study|Withdrawal by Subject|21|||
16083528|NCT02568215|38799098|FG001|Overall Study|Withdrawal by Subject|19|||
16083529|NCT02568215|38799099|FG002|Overall Study|Withdrawal by Subject|22|||
16083530|NCT02568215|38799097|FG000|Overall Study|Protocol Violation|1|||
16083531|NCT02568215|38799098|FG001|Overall Study|Protocol Violation|1|||
16083532|NCT02568215|38799099|FG002|Overall Study|Protocol Violation|0|||
16083533|NCT02568215|38799097|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
16083534|NCT02568215|38799098|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
16489663|NCT00753415|40267009|FG007|Part B|Lost to Follow-up|1|||
16489664|NCT00753415|40267010|FG008|Part B|Lost to Follow-up|1|||
16489665|NCT00753415|40267011|FG009|Part B|Lost to Follow-up|0|||
16489666|NCT00753415|40267002|FG000|Part B|Disease progression|0|||
16489667|NCT00753415|40267003|FG001|Part B|Disease progression|0|||
16489668|NCT00753415|40267004|FG002|Part B|Disease progression|0|||
16489669|NCT00753415|40267005|FG003|Part B|Disease progression|0|||
16489670|NCT00753415|40267006|FG004|Part B|Disease progression|0|||
16489671|NCT00753415|40267007|FG005|Part B|Disease progression|0|||
16489672|NCT00753415|40267008|FG006|Part B|Disease progression|0|||
16083535|NCT02568215|38799099|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
16083536|NCT02568215|38799097|FG000|Overall Study|Other|0|||
16083537|NCT02568215|38799098|FG001|Overall Study|Other|1|||
16083538|NCT02568215|38799099|FG002|Overall Study|Other|4|||
16083539|NCT03644849|38799101|FG000|Overall Study|Lost to Follow-up|1|||
16083540|NCT03644849|38799102|FG001|Overall Study|Lost to Follow-up|3|||
16083541|NCT00823472|38799107|FG000|Overall Study|Physician Decision|24|||
16083542|NCT00823472|38799108|FG001|Overall Study|Physician Decision|28|||
16083543|NCT00982644|38799109|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
16083544|NCT00982644|38799110|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
16083545|NCT00982644|38799109|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
16083546|NCT00982644|38799110|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
16083547|NCT00982644|38799109|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
16083548|NCT00982644|38799110|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
16083549|NCT00982644|38799109|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
16083550|NCT00982644|38799110|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
16083551|NCT00982644|38799109|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
16083552|NCT00982644|38799110|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
16083553|NCT00982644|38799109|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
16083554|NCT00982644|38799110|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
16083555|NCT00982644|38799109|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
16083556|NCT00982644|38799110|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
16489673|NCT00753415|40267009|FG007|Part B|Disease progression|0|||
16489674|NCT00753415|40267010|FG008|Part B|Disease progression|2|||
16489675|NCT00753415|40267011|FG009|Part B|Disease progression|1|||
16489676|NCT00840450|40267012|FG000|Overall Study|Adverse Event|1|||
16083557|NCT00982644|38799109|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
16083558|NCT00982644|38799110|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
16083559|NCT00982644|38799109|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
16083560|NCT00982644|38799110|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
16190858|NCT01577160|39176180|FG000|Overall Study|Subject Uncooperative|7|||
16489677|NCT00840450|40267012|FG000|Overall Study|Lack of Efficacy|2|||
16489678|NCT00573534|40267013|FG000|Overall Study|oppositional behavior|3|||
16489679|NCT03672747|40267014|FG000|Overall Study|Lost to Follow-up|1|||
16489680|NCT03672747|40267015|FG001|Overall Study|Lost to Follow-up|1|||
16489681|NCT03672747|40267016|FG002|Overall Study|Lost to Follow-up|2|||
16489682|NCT03672747|40267017|FG003|Overall Study|Lost to Follow-up|2|||
16489683|NCT03672747|40267018|FG004|Overall Study|Lost to Follow-up|2|||
16083561|NCT00982644|38799109|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
16083562|NCT00982644|38799110|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
16083563|NCT02964741|38799111|FG000|Overall Study|Protocol Violation|1|||
16489684|NCT03672747|40267019|FG005|Overall Study|Lost to Follow-up|1|||
16489685|NCT01687998|40267023|FG000|Overall Study|Withdrawal by Subject|49|||
16489686|NCT01687998|40267024|FG001|Overall Study|Withdrawal by Subject|51|||
16489687|NCT01687998|40267023|FG000|Overall Study|Known to be Alive at Study End|54|||
16489688|NCT01687998|40267024|FG001|Overall Study|Known to be Alive at Study End|62|||
16489689|NCT01687998|40267023|FG000|Overall Study|Lost to Follow-up|9|||
16489690|NCT01687998|40267024|FG001|Overall Study|Lost to Follow-up|7|||
16489691|NCT00691015|40267025|FG000|Overall Study|Refused further treatment|1|||
16489692|NCT03851705|40267028|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
16489693|NCT03851705|40267029|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
16489694|NCT03851705|40267030|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
16489695|NCT03851705|40267031|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
16489696|NCT03851705|40267028|FG000|Part 1: Double-Blind Period|Other reason|1|||
16489697|NCT03851705|40267029|FG001|Part 1: Double-Blind Period|Other reason|0|||
16489698|NCT03851705|40267030|FG002|Part 1: Double-Blind Period|Other reason|0|||
16489699|NCT03851705|40267031|FG003|Part 1: Double-Blind Period|Other reason|0|||
16489700|NCT03851705|40267028|FG000|Part 2: Open-Label Period|Other reason|0|||
16083564|NCT02964741|38799112|FG001|Overall Study|Protocol Violation|0|||
16083565|NCT02964741|38799113|FG002|Overall Study|Protocol Violation|0|||
16083566|NCT02964741|38799111|FG000|Overall Study|Withdrawal by Subject|0|||
16083567|NCT02964741|38799112|FG001|Overall Study|Withdrawal by Subject|1|||
16083568|NCT02964741|38799113|FG002|Overall Study|Withdrawal by Subject|0|||
16083569|NCT02964741|38799111|FG000|Overall Study|claustrophobia|1|||
16083570|NCT02964741|38799112|FG001|Overall Study|claustrophobia|0|||
16083571|NCT02964741|38799113|FG002|Overall Study|claustrophobia|0|||
16083572|NCT02132949|38799114|FG000|Overall Study|Death|7|||
16083573|NCT02132949|38799115|FG001|Overall Study|Death|13|||
16489701|NCT03851705|40267029|FG001|Part 2: Open-Label Period|Other reason|0|||
16489702|NCT03851705|40267030|FG002|Part 2: Open-Label Period|Other reason|0|||
16489703|NCT03851705|40267031|FG003|Part 2: Open-Label Period|Other reason|1|||
16489704|NCT03851705|40267028|FG000|Part 2: Open-Label Period|Death|0|||
16489705|NCT03851705|40267029|FG001|Part 2: Open-Label Period|Death|0|||
16489706|NCT03851705|40267030|FG002|Part 2: Open-Label Period|Death|3|||
16489707|NCT03851705|40267031|FG003|Part 2: Open-Label Period|Death|0|||
16489708|NCT03851705|40267028|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
16489709|NCT03851705|40267029|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
16489710|NCT03851705|40267030|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
16489711|NCT03851705|40267031|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
16489712|NCT00662012|40267032|FG000|Overall Study|Lost to Follow-up|85|||
16489713|NCT00662012|40267032|FG000|Overall Study|Death|1|||
16489714|NCT00662012|40267032|FG000|Overall Study|Withdrawal by Subject|1|||
16489715|NCT00291577|40267035|FG000|Overall Study|Adverse Event|1|||
16489716|NCT00291577|40267035|FG000|Overall Study|Other|4|||
16489717|NCT00291577|40267035|FG000|Overall Study|Withdrawal by Subject|2|||
16489718|NCT00291577|40267035|FG000|Overall Study|Lack of Efficacy|14|||
16489719|NCT02627144|40267036|FG000|Overall Study|Serious adverse event|32|||
16489720|NCT02627144|40267036|FG000|Overall Study|Cancer progression|171|||
16489721|NCT02627144|40267036|FG000|Overall Study|Death from cancer|20|||
16489722|NCT02627144|40267036|FG000|Overall Study|Death from other cause|8|||
16489723|NCT02627144|40267036|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
16489724|NCT02627144|40267036|FG000|Overall Study|Administrative reasons|65|||
16489725|NCT02627144|40267036|FG000|Overall Study|Lost to Follow-up|8|||
16489726|NCT02627144|40267036|FG000|Overall Study|Enrolled, not treated|6|||
16489727|NCT02627144|40267036|FG000|Overall Study|Other|17|||
16083574|NCT02132949|38799114|FG000|Overall Study|Lost to Follow-up|14|||
16083575|NCT02132949|38799115|FG001|Overall Study|Lost to Follow-up|4|||
16083576|NCT02132949|38799114|FG000|Overall Study|Withdrawal by Subject|6|||
16083577|NCT02132949|38799115|FG001|Overall Study|Withdrawal by Subject|5|||
16083578|NCT02132949|38799114|FG000|Overall Study|Noncompliance|5|||
16083579|NCT02132949|38799115|FG001|Overall Study|Noncompliance|1|||
16083580|NCT02132949|38799114|FG000|Overall Study|Physician Decision|3|||
16083581|NCT02132949|38799115|FG001|Overall Study|Physician Decision|1|||
16489728|NCT00003499|40267037|FG000|Overall Study|Not evaluable|8|||
16489729|NCT01408485|40267038|FG000|Overall Study|Withdrawal by Subject|21|||
16489730|NCT02170298|40267039|FG000|Overall Study|Withdrawal by Subject|0|||
16489731|NCT02170298|40267040|FG001|Overall Study|Withdrawal by Subject|1|||
16489732|NCT02170298|40267039|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
16489733|NCT02170298|40267040|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
16489734|NCT01897454|40267041|FG000|Overall Study|Withdrawal by Subject|1|||
16083582|NCT02132949|38799114|FG000|Overall Study|Disease Progression|3|||
16083583|NCT02132949|38799115|FG001|Overall Study|Disease Progression|0|||
16083584|NCT02132949|38799114|FG000|Overall Study|Adverse Event|2|||
16083585|NCT02132949|38799115|FG001|Overall Study|Adverse Event|1|||
16083586|NCT02132949|38799114|FG000|Overall Study|Withdrew Prior to Treatment|1|||
16489735|NCT04805541|40267042|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
16489736|NCT00833794|40267043|FG000|Open-label Phase|Adverse Event|225|||
16489737|NCT00833794|40267044|FG001|Open-label Phase|Adverse Event|0|||
16489738|NCT00833794|40267043|FG000|Open-label Phase|Lack of Efficacy|28|||
16489739|NCT00833794|40267044|FG001|Open-label Phase|Lack of Efficacy|0|||
16489740|NCT00833794|40267043|FG000|Open-label Phase|Withdrawal by Subject|48|||
16489741|NCT00833794|40267044|FG001|Open-label Phase|Withdrawal by Subject|0|||
16489742|NCT00833794|40267043|FG000|Open-label Phase|Physician Decision|20|||
16489743|NCT00833794|40267044|FG001|Open-label Phase|Physician Decision|0|||
16489744|NCT00833794|40267043|FG000|Open-label Phase|Administrative reason|1|||
16489745|NCT00833794|40267044|FG001|Open-label Phase|Administrative reason|0|||
16489746|NCT00833794|40267043|FG000|Open-label Phase|Protocol Violation|47|||
16489747|NCT00833794|40267044|FG001|Open-label Phase|Protocol Violation|0|||
16489748|NCT00833794|40267043|FG000|Open-label Phase|Did not complete wash-out period|12|||
16298890|NCT03058289|39577877|FG005|Overall Study|Rapid Progression of Disease|0|||
16298891|NCT03058289|39577878|FG006|Overall Study|Rapid Progression of Disease|0|||
16298892|NCT03058289|39577879|FG007|Overall Study|Rapid Progression of Disease|0|||
16298893|NCT03058289|39577880|FG008|Overall Study|Rapid Progression of Disease|0|||
16298894|NCT01884337|39577881|FG000|Treatment|Adverse Event|2|||
16298895|NCT01884337|39577882|FG001|Treatment|Adverse Event|2|||
16385171|NCT00457392|39892761|FG000|Overall Study|Death|106|||
16385172|NCT00457392|39892762|FG001|Overall Study|Death|106|||
16385173|NCT00457392|39892761|FG000|Overall Study|Adverse Event|84|||
16385174|NCT00457392|39892762|FG001|Overall Study|Adverse Event|41|||
16083587|NCT02132949|38799115|FG001|Overall Study|Withdrew Prior to Treatment|2|||
16083588|NCT02132949|38799114|FG000|Overall Study|Reason Unspecified|0|||
16083589|NCT02132949|38799115|FG001|Overall Study|Reason Unspecified|1|||
16083590|NCT00116649|38799125|FG000|Overall Study|Adverse Event|20|||
16083591|NCT00116649|38799125|FG000|Overall Study|Lack of Efficacy|1|||
16083592|NCT00116649|38799125|FG000|Overall Study|Lost to Follow-up|32|||
16489749|NCT00833794|40267044|FG001|Open-label Phase|Did not complete wash-out period|0|||
16489750|NCT00833794|40267043|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
16489751|NCT00833794|40267044|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
16489752|NCT00833794|40267043|FG000|Double-blind Phase|Adverse Event|44|||
16489753|NCT00833794|40267044|FG001|Double-blind Phase|Adverse Event|11|||
16489754|NCT00833794|40267043|FG000|Double-blind Phase|Lack of Efficacy|34|||
16489755|NCT00833794|40267044|FG001|Double-blind Phase|Lack of Efficacy|22|||
16489756|NCT00833794|40267043|FG000|Double-blind Phase|Withdrawal by Subject|23|||
16489757|NCT00833794|40267044|FG001|Double-blind Phase|Withdrawal by Subject|6|||
16083593|NCT00116649|38799125|FG000|Overall Study|Withdrawal by Subject|68|||
16083594|NCT00116649|38799125|FG000|Overall Study|Local Skin Reaction|9|||
16083595|NCT00116649|38799125|FG000|Overall Study|Various Reasons|18|||
16083596|NCT00116649|38799125|FG000|Overall Study|Protocol Specified|7|||
16083597|NCT00774397|38799126|FG000|Overall Study|Adverse Event|1|||
16083598|NCT00774397|38799127|FG001|Overall Study|Adverse Event|3|||
16083599|NCT00774397|38799128|FG002|Overall Study|Adverse Event|16|||
16083600|NCT00774397|38799129|FG003|Overall Study|Adverse Event|8|||
16083601|NCT00774397|38799130|FG004|Overall Study|Adverse Event|8|||
16083602|NCT00774397|38799131|FG005|Overall Study|Adverse Event|3|||
16385175|NCT00457392|39892761|FG000|Overall Study|Global Deterioration of Health Status|22|||
16385176|NCT00457392|39892762|FG001|Overall Study|Global Deterioration of Health Status|8|||
16385177|NCT00457392|39892761|FG000|Overall Study|Withdrawal by Subject|14|||
16385178|NCT00457392|39892762|FG001|Overall Study|Withdrawal by Subject|8|||
16385179|NCT00457392|39892761|FG000|Overall Study|Lost to Follow-up|6|||
16385180|NCT00457392|39892762|FG001|Overall Study|Lost to Follow-up|7|||
16385181|NCT00457392|39892761|FG000|Overall Study|Protocol Violation|4|||
16385182|NCT00457392|39892762|FG001|Overall Study|Protocol Violation|3|||
16385183|NCT00457392|39892761|FG000|Overall Study|Other|7|||
16385184|NCT00457392|39892762|FG001|Overall Study|Other|4|||
16385185|NCT00457392|39892761|FG000|Overall Study|Study Terminated by Sponsor|1|||
16385186|NCT00457392|39892762|FG001|Overall Study|Study Terminated by Sponsor|4|||
16385187|NCT00457392|39892761|FG000|Overall Study|Randomized, Not Treated|7|||
16083603|NCT00774397|38799132|FG006|Overall Study|Adverse Event|16|||
16083604|NCT00774397|38799126|FG000|Overall Study|Lack of Efficacy|11|||
16298896|NCT01884337|39577881|FG000|Treatment|Subj. request to discont. treatment|2|||
16298897|NCT01884337|39577882|FG001|Treatment|Subj. request to discont. treatment|0|||
16298898|NCT01884337|39577881|FG000|Follow-up Period|Lost to Follow-up|1|||
16385188|NCT00457392|39892762|FG001|Overall Study|Randomized, Not Treated|3|||
16385189|NCT02095106|39892765|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
16385190|NCT02095106|39892766|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
16385191|NCT01404234|39892767|FG000|Overall Study|Withdrawal by Subject|2|||
16083605|NCT00774397|38799127|FG001|Overall Study|Lack of Efficacy|4|||
16083606|NCT00774397|38799128|FG002|Overall Study|Lack of Efficacy|5|||
16298899|NCT01884337|39577882|FG001|Follow-up Period|Lost to Follow-up|1|||
16489758|NCT00833794|40267043|FG000|Double-blind Phase|Physician Decision|4|||
16489759|NCT00833794|40267044|FG001|Double-blind Phase|Physician Decision|7|||
16489760|NCT00833794|40267043|FG000|Double-blind Phase|Administrative reason|1|||
16489761|NCT00833794|40267044|FG001|Double-blind Phase|Administrative reason|3|||
16489762|NCT03782792|40267045|FG000|Overall Study|Patient left the country|0|||
16489763|NCT03782792|40267046|FG001|Overall Study|Patient left the country|1|||
16489764|NCT03782792|40267045|FG000|Overall Study|Withdrawal by Subject|1|||
16489765|NCT03782792|40267046|FG001|Overall Study|Withdrawal by Subject|2|||
16489766|NCT01702805|40267049|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
16489767|NCT01702805|40267050|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
16489768|NCT01702805|40267049|FG000|Overall Study|Incomplete Follow-up|18|||
16489769|NCT01702805|40267050|FG001|Overall Study|Incomplete Follow-up|15|||
16489770|NCT01702805|40267049|FG000|Overall Study|Vital Status Assessment Only|40|||
16489771|NCT01702805|40267050|FG001|Overall Study|Vital Status Assessment Only|39|||
16489772|NCT01702805|40267049|FG000|Overall Study|Lost to Follow-up|5|||
16489773|NCT01702805|40267050|FG001|Overall Study|Lost to Follow-up|5|||
16489774|NCT03098550|40267051|FG000|Overall Study|Disease Progression|30|||
16489775|NCT03098550|40267052|FG001|Overall Study|Disease Progression|19|||
16489776|NCT03098550|40267053|FG002|Overall Study|Disease Progression|41|||
16489777|NCT03098550|40267051|FG000|Overall Study|Study Drug Toxicity|2|||
16489778|NCT03098550|40267052|FG001|Overall Study|Study Drug Toxicity|1|||
16489779|NCT03098550|40267053|FG002|Overall Study|Study Drug Toxicity|0|||
16489780|NCT03098550|40267051|FG000|Overall Study|Death|1|||
16083607|NCT00774397|38799129|FG003|Overall Study|Lack of Efficacy|3|||
16083608|NCT00774397|38799130|FG004|Overall Study|Lack of Efficacy|27|||
16083609|NCT00774397|38799131|FG005|Overall Study|Lack of Efficacy|15|||
16083610|NCT00774397|38799132|FG006|Overall Study|Lack of Efficacy|9|||
16083611|NCT00774397|38799126|FG000|Overall Study|Protocol Violation|0|||
16083612|NCT00774397|38799127|FG001|Overall Study|Protocol Violation|1|||
16083613|NCT00774397|38799128|FG002|Overall Study|Protocol Violation|3|||
16083614|NCT00774397|38799129|FG003|Overall Study|Protocol Violation|1|||
16083615|NCT00774397|38799130|FG004|Overall Study|Protocol Violation|2|||
16083616|NCT00774397|38799131|FG005|Overall Study|Protocol Violation|1|||
16083617|NCT00774397|38799132|FG006|Overall Study|Protocol Violation|0|||
16083618|NCT00774397|38799126|FG000|Overall Study|Lost to Follow-up|0|||
16083619|NCT00774397|38799127|FG001|Overall Study|Lost to Follow-up|1|||
16083620|NCT00774397|38799128|FG002|Overall Study|Lost to Follow-up|1|||
16083621|NCT00774397|38799129|FG003|Overall Study|Lost to Follow-up|1|||
16083622|NCT00774397|38799130|FG004|Overall Study|Lost to Follow-up|0|||
16083623|NCT00774397|38799131|FG005|Overall Study|Lost to Follow-up|1|||
16083624|NCT00774397|38799132|FG006|Overall Study|Lost to Follow-up|0|||
16083625|NCT00774397|38799126|FG000|Overall Study|Refused to continue trial medication|1|||
16083626|NCT00774397|38799127|FG001|Overall Study|Refused to continue trial medication|3|||
16298900|NCT02451943|39577884|FG000|Overall Study|On Treatment|4|||
16298901|NCT02451943|39577885|FG001|Overall Study|On Treatment|4|||
16298902|NCT02451943|39577884|FG000|Overall Study|Withdrawal by Subject|13|||
16190859|NCT01577160|39176180|FG000|Overall Study|Other|9|||
16190860|NCT02214186|39176181|FG000|Overall Study|Lost to Follow-up|1|||
16190861|NCT02214186|39176182|FG001|Overall Study|Lost to Follow-up|1|||
16190862|NCT02214186|39176181|FG000|Overall Study|Protocol Violation|1|||
16190863|NCT02214186|39176182|FG001|Overall Study|Protocol Violation|1|||
16190864|NCT01204658|39176183|FG000|Primary Phase|Adverse Event|0|||
16190865|NCT01204658|39176184|FG001|Primary Phase|Adverse Event|0|||
16190866|NCT01204658|39176185|FG002|Primary Phase|Adverse Event|1|||
16190867|NCT01204658|39176186|FG003|Primary Phase|Adverse Event|0|||
16190868|NCT00789477|39176189|FG000|Overall Study|Withdrawal by Subject|2|||
16190869|NCT00789477|39176190|FG001|Overall Study|Withdrawal by Subject|1|||
16190870|NCT00789477|39176191|FG002|Overall Study|Withdrawal by Subject|3|||
16190871|NCT00789477|39176192|FG003|Overall Study|Withdrawal by Subject|2|||
16190872|NCT00789477|39176193|FG004|Overall Study|Withdrawal by Subject|3|||
16190873|NCT00789477|39176189|FG000|Overall Study|Protocol Violation|1|||
16190874|NCT00789477|39176190|FG001|Overall Study|Protocol Violation|0|||
16190875|NCT00789477|39176191|FG002|Overall Study|Protocol Violation|0|||
16190876|NCT00789477|39176192|FG003|Overall Study|Protocol Violation|1|||
16190877|NCT00789477|39176193|FG004|Overall Study|Protocol Violation|0|||
16190878|NCT00789477|39176189|FG000|Overall Study|Adverse Event|3|||
16190879|NCT00789477|39176190|FG001|Overall Study|Adverse Event|3|||
16190880|NCT00789477|39176191|FG002|Overall Study|Adverse Event|1|||
16190881|NCT00789477|39176192|FG003|Overall Study|Adverse Event|0|||
16190882|NCT00789477|39176193|FG004|Overall Study|Adverse Event|0|||
16190883|NCT00789477|39176189|FG000|Overall Study|Death|1|||
16190884|NCT00789477|39176190|FG001|Overall Study|Death|1|||
16190885|NCT00789477|39176191|FG002|Overall Study|Death|2|||
16190886|NCT00789477|39176192|FG003|Overall Study|Death|2|||
16190887|NCT00789477|39176193|FG004|Overall Study|Death|0|||
16190888|NCT00789477|39176189|FG000|Overall Study|Lost to Follow-up|0|||
16190889|NCT00789477|39176190|FG001|Overall Study|Lost to Follow-up|1|||
16190890|NCT00789477|39176191|FG002|Overall Study|Lost to Follow-up|4|||
16190891|NCT00789477|39176192|FG003|Overall Study|Lost to Follow-up|2|||
16190892|NCT00789477|39176193|FG004|Overall Study|Lost to Follow-up|4|||
16190893|NCT00789477|39176189|FG000|Overall Study|Lack of Efficacy|2|||
16190894|NCT00789477|39176190|FG001|Overall Study|Lack of Efficacy|0|||
16190895|NCT00789477|39176191|FG002|Overall Study|Lack of Efficacy|0|||
16190896|NCT00789477|39176192|FG003|Overall Study|Lack of Efficacy|0|||
16190897|NCT00789477|39176193|FG004|Overall Study|Lack of Efficacy|0|||
16190898|NCT00789477|39176189|FG000|Overall Study|Other|2|||
16190899|NCT00789477|39176190|FG001|Overall Study|Other|0|||
16190900|NCT00789477|39176191|FG002|Overall Study|Other|1|||
16190901|NCT00789477|39176192|FG003|Overall Study|Other|3|||
16083627|NCT00774397|38799128|FG002|Overall Study|Refused to continue trial medication|2|||
16190902|NCT00789477|39176193|FG004|Overall Study|Other|0|||
16190903|NCT02566525|39176194|FG000|Overall Study|Protocol Violation|3|||
16190904|NCT02566525|39176195|FG001|Overall Study|Protocol Violation|5|||
16190905|NCT01514188|39176196|FG000|Overall Study|Adverse Event|3|||
16190906|NCT01514188|39176197|FG001|Overall Study|Adverse Event|5|||
16190907|NCT01514188|39176196|FG000|Overall Study|Withdrawal by Subject|2|||
16190908|NCT01514188|39176197|FG001|Overall Study|Withdrawal by Subject|4|||
16083628|NCT00774397|38799129|FG003|Overall Study|Refused to continue trial medication|2|||
16083629|NCT00774397|38799130|FG004|Overall Study|Refused to continue trial medication|6|||
16190909|NCT01514188|39176196|FG000|Overall Study|Protocol Violation|2|||
16190910|NCT01514188|39176197|FG001|Overall Study|Protocol Violation|4|||
16190911|NCT01514188|39176196|FG000|Overall Study|Physician Decision|0|||
16190912|NCT01514188|39176197|FG001|Overall Study|Physician Decision|2|||
16190913|NCT01514188|39176196|FG000|Overall Study|Disease Progression|13|||
16190914|NCT01514188|39176197|FG001|Overall Study|Disease Progression|14|||
16190915|NCT01514188|39176196|FG000|Overall Study|Death|1|||
16190916|NCT01514188|39176197|FG001|Overall Study|Death|3|||
16190917|NCT01514188|39176196|FG000|Overall Study|Other|2|||
16190918|NCT01514188|39176197|FG001|Overall Study|Other|1|||
16190919|NCT01912729|39176201|FG000|Overall Study|Withdrawal by Subject|0|||
16190920|NCT01912729|39176202|FG001|Overall Study|Withdrawal by Subject|1|||
16190921|NCT04633473|39176204|FG000|Overall Study|Withdrawal by Subject|6|||
16190922|NCT00195260|39176205|FG000|Part 1: Dose Escalation|Adverse Event|0|||
16190923|NCT00195260|39176206|FG001|Part 1: Dose Escalation|Adverse Event|1|||
16190924|NCT00195260|39176207|FG002|Part 1: Dose Escalation|Adverse Event|0|||
16190925|NCT00195260|39176208|FG003|Part 1: Dose Escalation|Adverse Event|1|||
16190926|NCT00195260|39176209|FG004|Part 1: Dose Escalation|Adverse Event|1|||
16190927|NCT00195260|39176210|FG005|Part 1: Dose Escalation|Adverse Event|0|||
16190928|NCT00195260|39176211|FG006|Part 1: Dose Escalation|Adverse Event|3|||
16190929|NCT00195260|39176212|FG007|Part 1: Dose Escalation|Adverse Event|0|||
16190930|NCT00195260|39176213|FG008|Part 1: Dose Escalation|Adverse Event|0|||
16190931|NCT00195260|39176214|FG009|Part 1: Dose Escalation|Adverse Event|0|||
16190932|NCT00195260|39176215|FG010|Part 1: Dose Escalation|Adverse Event|0|||
16190933|NCT00195260|39176205|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16190934|NCT00195260|39176206|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16489781|NCT03098550|40267052|FG001|Overall Study|Death|0|||
16190935|NCT00195260|39176207|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16190936|NCT00195260|39176208|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16190937|NCT00195260|39176209|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
16190938|NCT00195260|39176210|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16190939|NCT00195260|39176211|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16190940|NCT00195260|39176212|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
16190941|NCT00195260|39176213|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16190942|NCT00195260|39176214|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16190943|NCT00195260|39176215|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16190944|NCT00195260|39176205|FG000|Part 1: Dose Escalation|Death|0|||
16190945|NCT00195260|39176206|FG001|Part 1: Dose Escalation|Death|0|||
16190946|NCT00195260|39176207|FG002|Part 1: Dose Escalation|Death|0|||
16190947|NCT00195260|39176208|FG003|Part 1: Dose Escalation|Death|0|||
16190948|NCT00195260|39176209|FG004|Part 1: Dose Escalation|Death|0|||
16190949|NCT00195260|39176210|FG005|Part 1: Dose Escalation|Death|0|||
16190950|NCT00195260|39176211|FG006|Part 1: Dose Escalation|Death|0|||
16190951|NCT00195260|39176212|FG007|Part 1: Dose Escalation|Death|1|||
16190952|NCT00195260|39176213|FG008|Part 1: Dose Escalation|Death|0|||
16190953|NCT00195260|39176214|FG009|Part 1: Dose Escalation|Death|0|||
16190954|NCT00195260|39176215|FG010|Part 1: Dose Escalation|Death|0|||
16190955|NCT00195260|39176205|FG000|Part 1: Dose Escalation|Disease Progression|3|||
16190956|NCT00195260|39176206|FG001|Part 1: Dose Escalation|Disease Progression|2|||
16190957|NCT00195260|39176207|FG002|Part 1: Dose Escalation|Disease Progression|5|||
16190958|NCT00195260|39176208|FG003|Part 1: Dose Escalation|Disease Progression|6|||
16190959|NCT00195260|39176209|FG004|Part 1: Dose Escalation|Disease Progression|4|||
16190960|NCT00195260|39176210|FG005|Part 1: Dose Escalation|Disease Progression|6|||
16190961|NCT00195260|39176211|FG006|Part 1: Dose Escalation|Disease Progression|7|||
16190962|NCT00195260|39176212|FG007|Part 1: Dose Escalation|Disease Progression|4|||
16190963|NCT00195260|39176213|FG008|Part 1: Dose Escalation|Disease Progression|0|||
16190964|NCT00195260|39176214|FG009|Part 1: Dose Escalation|Disease Progression|0|||
16190965|NCT00195260|39176215|FG010|Part 1: Dose Escalation|Disease Progression|0|||
16190966|NCT00195260|39176205|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
16190967|NCT00195260|39176206|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
16190968|NCT00195260|39176207|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
16190969|NCT00195260|39176208|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
16190970|NCT00195260|39176209|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
16190971|NCT00195260|39176210|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
16190972|NCT00195260|39176211|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
16190973|NCT00195260|39176212|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
16190974|NCT00195260|39176213|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
16190975|NCT00195260|39176214|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
16190976|NCT00195260|39176215|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
16190977|NCT00195260|39176205|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
16190978|NCT00195260|39176206|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
16298903|NCT02451943|39577885|FG001|Overall Study|Withdrawal by Subject|16|||
16190979|NCT00195260|39176207|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
16298904|NCT02451943|39577884|FG000|Overall Study|Lost to Follow-up|3|||
16298905|NCT02451943|39577885|FG001|Overall Study|Lost to Follow-up|4|||
16190980|NCT00195260|39176208|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
16298906|NCT01400919|39577906|FG000|Overall Study|Withdrawal by Subject|4|||
16190981|NCT00195260|39176209|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
16190982|NCT00195260|39176210|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
16190983|NCT00195260|39176211|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
16190984|NCT00195260|39176212|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
16190985|NCT00195260|39176213|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
16190986|NCT00195260|39176214|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
16190987|NCT00195260|39176215|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
16385192|NCT03047135|39892768|FG000|Overall Study|Still being treated|3|||
16190988|NCT00195260|39176205|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
16190989|NCT00195260|39176206|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
16190990|NCT00195260|39176207|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
16190991|NCT00195260|39176208|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
16190992|NCT00195260|39176209|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
16190993|NCT00195260|39176210|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
16190994|NCT00195260|39176211|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
16190995|NCT00195260|39176212|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
16190996|NCT00195260|39176213|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
16190997|NCT00195260|39176214|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
16190998|NCT00195260|39176215|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
16190999|NCT00195260|39176205|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
16191000|NCT00195260|39176206|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
16191001|NCT00195260|39176207|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
16191002|NCT00195260|39176208|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
16191003|NCT00195260|39176209|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
16191004|NCT00195260|39176210|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
16191005|NCT00195260|39176211|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
16191006|NCT00195260|39176212|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
16385193|NCT00387088|39892769|FG000|Overall Study|Adverse Event|143|||
16191007|NCT00195260|39176213|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
16191008|NCT00195260|39176214|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
16191009|NCT00195260|39176215|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
16385194|NCT00387088|39892770|FG001|Overall Study|Adverse Event|156|||
16385195|NCT00387088|39892769|FG000|Overall Study|Protocol Violation|47|||
16385196|NCT00387088|39892770|FG001|Overall Study|Protocol Violation|35|||
16385197|NCT00387088|39892769|FG000|Overall Study|Withdrawal by Subject|20|||
16385198|NCT00387088|39892770|FG001|Overall Study|Withdrawal by Subject|35|||
16385199|NCT00387088|39892769|FG000|Overall Study|Lack of Efficacy|28|||
16385200|NCT00387088|39892770|FG001|Overall Study|Lack of Efficacy|67|||
16385201|NCT00387088|39892769|FG000|Overall Study|Lost to Follow-up|22|||
16385202|NCT00387088|39892770|FG001|Overall Study|Lost to Follow-up|28|||
16385203|NCT00387088|39892769|FG000|Overall Study|Other|58|||
16385204|NCT00387088|39892770|FG001|Overall Study|Other|52|||
16385205|NCT00279214|39892771|FG000|Overall Study|Physician Decision|3|||
16385206|NCT00279214|39892772|FG001|Overall Study|Physician Decision|2|||
16385207|NCT00622726|39892774|FG000|March, 2008 to August, 2010|Death|5|||
16385208|NCT00622726|39892775|FG001|March, 2008 to August, 2010|Death|2|||
16385209|NCT00622726|39892774|FG000|August, 2010 to April, 2013|Death|1|||
16385210|NCT00622726|39892775|FG001|August, 2010 to April, 2013|Death|5|||
16385211|NCT03366337|39892776|FG000|Overall Study|Lost to Follow-up|1|||
16385212|NCT03366337|39892777|FG001|Overall Study|Lost to Follow-up|0|||
16385213|NCT03366337|39892778|FG002|Overall Study|Lost to Follow-up|1|||
16385214|NCT03366337|39892779|FG003|Overall Study|Lost to Follow-up|0|||
16385215|NCT03366337|39892776|FG000|Overall Study|Withdrawal by Subject|2|||
16385216|NCT03366337|39892777|FG001|Overall Study|Withdrawal by Subject|0|||
16385217|NCT03366337|39892778|FG002|Overall Study|Withdrawal by Subject|1|||
16385218|NCT03366337|39892779|FG003|Overall Study|Withdrawal by Subject|1|||
16385219|NCT01493089|39892782|FG000|Overall Study|Protocol Violation|2|||
16385220|NCT01493089|39892783|FG001|Overall Study|Protocol Violation|2|||
16385221|NCT01493089|39892782|FG000|Overall Study|Withdrawal by Subject|1|||
16385222|NCT01493089|39892783|FG001|Overall Study|Withdrawal by Subject|0|||
16385223|NCT01493089|39892782|FG000|Overall Study|Physician Decision|0|||
16385224|NCT01493089|39892783|FG001|Overall Study|Physician Decision|1|||
16489782|NCT03098550|40267053|FG002|Overall Study|Death|0|||
16385225|NCT00590317|39892784|FG000|Overall Study|Lack of Efficacy|1|||
16385226|NCT00590317|39892785|FG001|Overall Study|Lack of Efficacy|5|||
16385227|NCT02122380|39892788|FG000|First Intervention (30 Days)|Adverse Event|1|||
16385228|NCT02122380|39892789|FG001|First Intervention (30 Days)|Adverse Event|0|||
16385229|NCT02122380|39892788|FG000|First Intervention (30 Days)|Physician Decision|0|||
16385230|NCT02122380|39892789|FG001|First Intervention (30 Days)|Physician Decision|1|||
16385231|NCT02122380|39892788|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
16385232|NCT02122380|39892789|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
16489783|NCT03098550|40267051|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
16385233|NCT02122380|39892788|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
16385234|NCT02122380|39892789|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
16385235|NCT02122380|39892788|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
16385236|NCT02122380|39892789|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
16385237|NCT00448448|39892793|FG000|Overall Study|Withdrawal by Subject|13|||
16385238|NCT00448448|39892794|FG001|Overall Study|Withdrawal by Subject|2|||
16191010|NCT00195260|39176205|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
16191011|NCT00195260|39176206|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
16191012|NCT00195260|39176207|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
16191013|NCT00195260|39176208|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
16191014|NCT00195260|39176209|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
16191015|NCT00195260|39176210|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
16191016|NCT00195260|39176211|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
16191017|NCT00195260|39176212|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
16191018|NCT00195260|39176213|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
16191019|NCT00195260|39176214|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
16191020|NCT00195260|39176215|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
16191021|NCT00972244|39176216|FG000|Overall Study|Incorrect Enrolment|1|||
16191022|NCT00972244|39176217|FG001|Overall Study|Incorrect Enrolment|0|||
16191023|NCT00972244|39176218|FG002|Overall Study|Incorrect Enrolment|0|||
16191024|NCT00972244|39176219|FG003|Overall Study|Incorrect Enrolment|0|||
16191025|NCT00972244|39176220|FG004|Overall Study|Incorrect Enrolment|0|||
16191026|NCT00972244|39176216|FG000|Overall Study|Adverse Event|0|||
16191027|NCT00972244|39176217|FG001|Overall Study|Adverse Event|1|||
16191028|NCT00972244|39176218|FG002|Overall Study|Adverse Event|1|||
16191029|NCT00972244|39176219|FG003|Overall Study|Adverse Event|0|||
16191030|NCT00972244|39176220|FG004|Overall Study|Adverse Event|0|||
16191031|NCT00972244|39176216|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
16191032|NCT00972244|39176217|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
16191033|NCT00972244|39176218|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
16191034|NCT00972244|39176219|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
16191035|NCT00972244|39176220|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
16191036|NCT00972244|39176216|FG000|Overall Study|Withdrawal by Subject|1|||
16191037|NCT00972244|39176217|FG001|Overall Study|Withdrawal by Subject|2|||
16191038|NCT00972244|39176218|FG002|Overall Study|Withdrawal by Subject|1|||
16191039|NCT00972244|39176219|FG003|Overall Study|Withdrawal by Subject|0|||
16191040|NCT00972244|39176220|FG004|Overall Study|Withdrawal by Subject|1|||
16191041|NCT00972244|39176216|FG000|Overall Study|Safety|0|||
16191042|NCT00972244|39176217|FG001|Overall Study|Safety|0|||
16191043|NCT00972244|39176218|FG002|Overall Study|Safety|0|||
16191044|NCT00972244|39176219|FG003|Overall Study|Safety|0|||
16191045|NCT00972244|39176220|FG004|Overall Study|Safety|1|||
16191046|NCT00972244|39176216|FG000|Overall Study|Death|1|||
16191047|NCT00972244|39176217|FG001|Overall Study|Death|0|||
16191048|NCT00972244|39176218|FG002|Overall Study|Death|0|||
16191049|NCT00972244|39176219|FG003|Overall Study|Death|0|||
16191050|NCT00972244|39176220|FG004|Overall Study|Death|0|||
16191051|NCT00972244|39176216|FG000|Overall Study|Various|0|||
16191052|NCT00972244|39176217|FG001|Overall Study|Various|0|||
16191053|NCT00972244|39176218|FG002|Overall Study|Various|0|||
16191054|NCT00972244|39176219|FG003|Overall Study|Various|0|||
16191055|NCT00972244|39176220|FG004|Overall Study|Various|2|||
16191056|NCT01689207|39176221|FG000|Overall Study|Adverse Event|0|||
16191057|NCT01689207|39176222|FG001|Overall Study|Adverse Event|1|||
16191058|NCT01689207|39176223|FG002|Overall Study|Adverse Event|0|||
16191059|NCT01689207|39176224|FG003|Overall Study|Adverse Event|0|||
16191060|NCT01689207|39176225|FG004|Overall Study|Adverse Event|2|||
16191061|NCT01689207|39176226|FG005|Overall Study|Adverse Event|1|||
16191062|NCT01689207|39176227|FG006|Overall Study|Adverse Event|0|||
16191063|NCT01689207|39176228|FG007|Overall Study|Adverse Event|0|||
16191064|NCT01689207|39176229|FG008|Overall Study|Adverse Event|1|||
16191065|NCT01689207|39176230|FG009|Overall Study|Adverse Event|0|||
16191066|NCT01689207|39176231|FG010|Overall Study|Adverse Event|0|||
16191067|NCT03342469|39176232|FG000|Overall Study|Withdrawal by Subject|0|||
16191068|NCT03342469|39176233|FG001|Overall Study|Withdrawal by Subject|1|||
16191069|NCT03342469|39176234|FG002|Overall Study|Withdrawal by Subject|0|||
16385239|NCT00448448|39892793|FG000|Overall Study|On protocol when study ended|83|||
16191070|NCT03342469|39176235|FG003|Overall Study|Withdrawal by Subject|0|||
16191071|NCT00118482|39176240|FG000|Overall Study|Lost to Follow-up|7|||
16191072|NCT00118482|39176241|FG001|Overall Study|Lost to Follow-up|7|||
16191073|NCT00118482|39176240|FG000|Overall Study|Withdrawal by Subject|23|||
16191074|NCT00118482|39176241|FG001|Overall Study|Withdrawal by Subject|22|||
16191075|NCT01345123|39176242|FG000|Overall Study|participants no longer with health plan|79|||
16385240|NCT00448448|39892794|FG001|Overall Study|On protocol when study ended|36|||
16191076|NCT01345123|39176243|FG001|Overall Study|participants no longer with health plan|85|||
16191077|NCT01345123|39176244|FG002|Overall Study|participants no longer with health plan|88|||
16191078|NCT03599141|39176245|FG000|Overall Study|Lost to Follow-up|3|||
16191079|NCT03599141|39176246|FG001|Overall Study|Lost to Follow-up|1|||
16191080|NCT00408421|39176247|FG000|Treatment Initial Randomization|Adverse Event|5|||
16191081|NCT00408421|39176248|FG001|Treatment Initial Randomization|Adverse Event|9|||
16191082|NCT00408421|39176249|FG002|Treatment Initial Randomization|Adverse Event|0|||
16191083|NCT00408421|39176247|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
16191084|NCT00408421|39176248|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
16191085|NCT00408421|39176249|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
16191086|NCT00408421|39176247|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
16191087|NCT00408421|39176248|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
16191088|NCT00408421|39176249|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
16191089|NCT00408421|39176247|FG000|Treatment Initial Randomization|Physician Decision|1|||
16191090|NCT00408421|39176248|FG001|Treatment Initial Randomization|Physician Decision|0|||
16191091|NCT00408421|39176249|FG002|Treatment Initial Randomization|Physician Decision|0|||
16191092|NCT00408421|39176247|FG000|Treatment Initial Randomization|Protocol Violation|0|||
16191093|NCT00408421|39176248|FG001|Treatment Initial Randomization|Protocol Violation|1|||
16191094|NCT00408421|39176249|FG002|Treatment Initial Randomization|Protocol Violation|0|||
16191095|NCT00408421|39176247|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
16191096|NCT00408421|39176248|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
16191097|NCT00408421|39176249|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
16191098|NCT00408421|39176247|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
16191099|NCT00408421|39176248|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
16191100|NCT00408421|39176249|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
16191101|NCT00408421|39176247|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
16191102|NCT00408421|39176248|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
16191103|NCT00408421|39176249|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
16191104|NCT00408421|39176247|FG000|Treatment Re-Randomization|Adverse Event|2|||
16489784|NCT03098550|40267052|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
16489785|NCT03098550|40267053|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
16191105|NCT00408421|39176248|FG001|Treatment Re-Randomization|Adverse Event|2|||
16191106|NCT00408421|39176249|FG002|Treatment Re-Randomization|Adverse Event|4|||
16489786|NCT03098550|40267051|FG000|Overall Study|Administrative reason by sponsor|0|||
16489787|NCT03098550|40267052|FG001|Overall Study|Administrative reason by sponsor|0|||
16489788|NCT03098550|40267053|FG002|Overall Study|Administrative reason by sponsor|1|||
16489789|NCT03098550|40267051|FG000|Overall Study|Other reasons|2|||
16489790|NCT03098550|40267052|FG001|Overall Study|Other reasons|0|||
16489791|NCT03098550|40267053|FG002|Overall Study|Other reasons|0|||
16489792|NCT03338998|40267054|FG000|Treatment Period|Withdrawal by Subject|1|||
16489793|NCT03338998|40267055|FG001|Treatment Period|Withdrawal by Subject|1|||
16489794|NCT03338998|40267054|FG000|Treatment Period|Adverse Event|0|||
16489795|NCT03338998|40267055|FG001|Treatment Period|Adverse Event|2|||
16489796|NCT03338998|40267054|FG000|Treatment Period|Protocol deviation|1|||
16489797|NCT03338998|40267055|FG001|Treatment Period|Protocol deviation|0|||
16489798|NCT03338998|40267054|FG000|Treatment Period|Physician Decision|2|||
16489799|NCT03338998|40267055|FG001|Treatment Period|Physician Decision|0|||
16489800|NCT03338998|40267054|FG000|Treatment Period|Subject failed swallow test|4|||
16489801|NCT03338998|40267055|FG001|Treatment Period|Subject failed swallow test|0|||
16489802|NCT03338998|40267054|FG000|Safety Follow-Up Period|Adverse Event|0|||
16489803|NCT03338998|40267055|FG001|Safety Follow-Up Period|Adverse Event|1|||
16489804|NCT03338998|40267054|FG000|Safety Follow-Up Period|Protocol deviation|1|||
16489805|NCT03338998|40267055|FG001|Safety Follow-Up Period|Protocol deviation|0|||
16489806|NCT03338998|40267054|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
16489807|NCT03338998|40267055|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
16489808|NCT03965962|40267059|FG000|Overall Study|Adverse Event|1|||
16489809|NCT03965962|40267060|FG001|Overall Study|Adverse Event|0|||
16489810|NCT03965962|40267061|FG002|Overall Study|Adverse Event|0|||
16489811|NCT03965962|40267062|FG003|Overall Study|Adverse Event|0|||
16489812|NCT03965962|40267059|FG000|Overall Study|Protocol Violation|21|||
16489813|NCT03965962|40267060|FG001|Overall Study|Protocol Violation|4|||
16489814|NCT03965962|40267061|FG002|Overall Study|Protocol Violation|10|||
16489815|NCT03965962|40267062|FG003|Overall Study|Protocol Violation|5|||
16489816|NCT03965962|40267059|FG000|Overall Study|Lost to Follow-up|0|||
16489817|NCT03965962|40267060|FG001|Overall Study|Lost to Follow-up|1|||
16489818|NCT03965962|40267061|FG002|Overall Study|Lost to Follow-up|0|||
16489819|NCT03965962|40267062|FG003|Overall Study|Lost to Follow-up|0|||
16489820|NCT03965962|40267059|FG000|Overall Study|Withdrawal by Subject|3|||
16489821|NCT03965962|40267060|FG001|Overall Study|Withdrawal by Subject|0|||
16489822|NCT03965962|40267061|FG002|Overall Study|Withdrawal by Subject|0|||
16489823|NCT03965962|40267062|FG003|Overall Study|Withdrawal by Subject|1|||
16489824|NCT02955602|40267081|FG000|Overall Study|Adverse Event|0|||
16191107|NCT00408421|39176247|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
16191108|NCT00408421|39176248|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
16489825|NCT02955602|40267082|FG001|Overall Study|Adverse Event|3|||
16191109|NCT00408421|39176249|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
16191110|NCT00408421|39176247|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
16191111|NCT00408421|39176248|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
16191112|NCT00408421|39176249|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
16191113|NCT00408421|39176247|FG000|Treatment Re-Randomization|Physician Decision|1|||
16191114|NCT00408421|39176248|FG001|Treatment Re-Randomization|Physician Decision|3|||
16191115|NCT00408421|39176249|FG002|Treatment Re-Randomization|Physician Decision|0|||
16298907|NCT01400919|39577906|FG000|Overall Study|Lost to Follow-up|2|||
16298908|NCT01400919|39577906|FG000|Overall Study|Missed visit|2|||
16298909|NCT04715932|39577911|FG000|Overall Study|Lost to Follow-up|1|||
16191116|NCT00408421|39176247|FG000|Treatment Re-Randomization|Protocol Violation|1|||
16298910|NCT04715932|39577912|FG001|Overall Study|Lost to Follow-up|0|||
16298911|NCT00794339|39577917|FG000|Overall Study|Withdrawal by Subject|3|||
16298912|NCT00794339|39577917|FG000|Overall Study|Ineligible|4|||
16298913|NCT00794339|39577917|FG000|Overall Study|Tx prior to ATSM|3|||
16298914|NCT00794339|39577917|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
16298915|NCT00794339|39577917|FG000|Overall Study|Tx not per protocol|1|||
16298916|NCT04497948|39577921|FG000|Overall Study|Death|2|||
16298917|NCT01520870|39577922|FG000|Overall Study|Withdrawal by Subject|2|||
16298918|NCT03107026|39577923|FG000|Overall Study|Adverse Event|2|||
16298919|NCT03107026|39577924|FG001|Overall Study|Adverse Event|14|||
16298920|NCT03107026|39577925|FG002|Overall Study|Adverse Event|23|||
16298921|NCT03107026|39577923|FG000|Overall Study|Lost to Follow-up|12|||
16298922|NCT03107026|39577924|FG001|Overall Study|Lost to Follow-up|12|||
16298923|NCT03107026|39577925|FG002|Overall Study|Lost to Follow-up|13|||
16298924|NCT03107026|39577923|FG000|Overall Study|Protocol Violation|1|||
16298925|NCT03107026|39577924|FG001|Overall Study|Protocol Violation|2|||
16298926|NCT03107026|39577925|FG002|Overall Study|Protocol Violation|0|||
16298927|NCT03107026|39577923|FG000|Overall Study|Pregnancy|1|||
16298928|NCT03107026|39577924|FG001|Overall Study|Pregnancy|0|||
16298929|NCT03107026|39577925|FG002|Overall Study|Pregnancy|0|||
16298930|NCT03107026|39577923|FG000|Overall Study|Withdrawal by Subject|13|||
16298931|NCT03107026|39577924|FG001|Overall Study|Withdrawal by Subject|5|||
16298932|NCT03107026|39577925|FG002|Overall Study|Withdrawal by Subject|17|||
16298933|NCT03107026|39577923|FG000|Overall Study|non compliance with study visits|1|||
16298934|NCT03107026|39577924|FG001|Overall Study|non compliance with study visits|2|||
16298935|NCT03107026|39577925|FG002|Overall Study|non compliance with study visits|0|||
16298936|NCT03107026|39577923|FG000|Overall Study|non-compliance with study drug|2|||
16298937|NCT03107026|39577924|FG001|Overall Study|non-compliance with study drug|2|||
16298938|NCT03107026|39577925|FG002|Overall Study|non-compliance with study drug|3|||
16298939|NCT03107026|39577923|FG000|Overall Study|Physician Decision|0|||
16298940|NCT03107026|39577924|FG001|Overall Study|Physician Decision|1|||
16298941|NCT03107026|39577925|FG002|Overall Study|Physician Decision|0|||
16298942|NCT03138564|39577926|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
16298943|NCT03138564|39577927|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
16298944|NCT03138564|39577926|FG000|Overall Study|Lost to Follow-up|16|||
16298945|NCT03138564|39577927|FG001|Overall Study|Lost to Follow-up|2|||
16298946|NCT03138564|39577926|FG000|Overall Study|Withdrawal by Subject|48|||
16298947|NCT03138564|39577927|FG001|Overall Study|Withdrawal by Subject|4|||
16298948|NCT03138564|39577926|FG000|Overall Study|No longer met eligibility criteria|2|||
16298949|NCT03138564|39577927|FG001|Overall Study|No longer met eligibility criteria|0|||
16298950|NCT03138564|39577926|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
16298951|NCT03138564|39577927|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
16298952|NCT03138564|39577926|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
16298953|NCT03138564|39577927|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
16298954|NCT03138564|39577926|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
16191117|NCT00408421|39176248|FG001|Treatment Re-Randomization|Protocol Violation|1|||
16298955|NCT03138564|39577927|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
16298956|NCT03138564|39577926|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
16298957|NCT03138564|39577927|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
16298958|NCT01635283|39577928|FG000|Overall Study|Tumor Progression|3|||
16298959|NCT01635283|39577928|FG000|Overall Study|Lost to Follow-up|1|||
16298960|NCT02185053|39577929|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
16298961|NCT02185053|39577930|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
16298962|NCT02185053|39577931|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
16298963|NCT02185053|39577929|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
16298964|NCT02185053|39577930|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
16298965|NCT02185053|39577931|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
16298966|NCT02185053|39577929|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
16298967|NCT02185053|39577930|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
16298968|NCT02185053|39577931|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
16298969|NCT02185053|39577929|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
16298970|NCT02185053|39577930|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
16298971|NCT02185053|39577931|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
16298972|NCT02185053|39577929|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
16298973|NCT02185053|39577930|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
16298974|NCT02185053|39577931|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
16298975|NCT02185053|39577929|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
16298976|NCT02185053|39577930|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
16298977|NCT02185053|39577931|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
16298978|NCT02185053|39577929|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
16385241|NCT00448448|39892793|FG000|Overall Study|Lost to Follow-up|2|||
16385242|NCT00448448|39892794|FG001|Overall Study|Lost to Follow-up|1|||
16385243|NCT00448448|39892793|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
16385244|NCT00448448|39892794|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
16385245|NCT00448448|39892793|FG000|Overall Study|Signed consent lost|0|||
16385246|NCT00448448|39892794|FG001|Overall Study|Signed consent lost|1|||
16298979|NCT02185053|39577930|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
16298980|NCT02185053|39577931|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
16298981|NCT02185053|39577929|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
16298982|NCT02185053|39577930|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
16298983|NCT02185053|39577931|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
16298984|NCT02927366|39577935|FG000|Overall Study|Adverse Event|1|||
16298985|NCT02927366|39577936|FG001|Overall Study|Adverse Event|0|||
16298986|NCT02927366|39577935|FG000|Overall Study|Patient schedule|1|||
16298987|NCT02927366|39577936|FG001|Overall Study|Patient schedule|0|||
16298988|NCT01206101|39577937|FG000|Overall Study|Adverse Event|1|||
16298989|NCT01206101|39577938|FG001|Overall Study|Adverse Event|0|||
16298990|NCT01206101|39577937|FG000|Overall Study|Physician Decision|0|||
16298991|NCT01206101|39577938|FG001|Overall Study|Physician Decision|1|||
16298992|NCT01206101|39577937|FG000|Overall Study|Unclassified|1|||
16298993|NCT01206101|39577938|FG001|Overall Study|Unclassified|0|||
16298994|NCT01898650|39577943|FG000|Overall Study|the subject would not lie still for imaging|1|||
16298995|NCT02593110|39577957|FG000|Overall Study|Withdrawal by Subject|0|||
16298996|NCT02593110|39577958|FG001|Overall Study|Withdrawal by Subject|3|||
16298997|NCT02593110|39577959|FG002|Overall Study|Withdrawal by Subject|3|||
16298998|NCT02593110|39577960|FG003|Overall Study|Withdrawal by Subject|2|||
16298999|NCT02593110|39577957|FG000|Overall Study|Death|0|||
16299000|NCT02593110|39577958|FG001|Overall Study|Death|0|||
16299001|NCT02593110|39577959|FG002|Overall Study|Death|1|||
16385247|NCT00586157|39892803|FG000|First Intervention|Worsening behavior|1|||
16083630|NCT00774397|38799131|FG005|Overall Study|Refused to continue trial medication|2|||
16083631|NCT00774397|38799132|FG006|Overall Study|Refused to continue trial medication|3|||
16299002|NCT02593110|39577960|FG003|Overall Study|Death|0|||
16299003|NCT00103610|39577961|FG000|Overall Study|Entered Rescue Procedure|10|||
16299004|NCT00103610|39577962|FG001|Overall Study|Entered Rescue Procedure|52|||
16299005|NCT00103610|39577961|FG000|Overall Study|Death|16|||
16299006|NCT00103610|39577962|FG001|Overall Study|Death|12|||
16299007|NCT00103610|39577961|FG000|Overall Study|Elective Withdrawal|4|||
16299008|NCT00103610|39577962|FG001|Overall Study|Elective Withdrawal|0|||
16299009|NCT00103610|39577961|FG000|Overall Study|Lost to Follow-up|3|||
16299010|NCT00103610|39577962|FG001|Overall Study|Lost to Follow-up|1|||
16299011|NCT00103610|39577961|FG000|Overall Study|Adverse Event|2|||
16299012|NCT00103610|39577962|FG001|Overall Study|Adverse Event|2|||
16299013|NCT00103610|39577961|FG000|Overall Study|Other|2|||
16299014|NCT00103610|39577962|FG001|Overall Study|Other|7|||
16299015|NCT00103610|39577961|FG000|Overall Study|Failed mobilization|1|||
16299016|NCT00103610|39577962|FG001|Overall Study|Failed mobilization|5|||
16299017|NCT00103610|39577961|FG000|Overall Study|Noncompliance|0|||
16299018|NCT00103610|39577962|FG001|Overall Study|Noncompliance|1|||
16299019|NCT01243775|39577966|FG000|Overall Study|Withdrawal by Subject|2|||
16299020|NCT02903030|39577967|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
16299021|NCT02903030|39577968|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
16299022|NCT02092467|39577969|FG000|Overall Study|Death|49|||
16299023|NCT02092467|39577970|FG001|Overall Study|Death|66|||
16299024|NCT02092467|39577971|FG002|Overall Study|Death|38|||
16299025|NCT02092467|39577969|FG000|Overall Study|Lost to Follow-up|38|||
16299026|NCT02092467|39577970|FG001|Overall Study|Lost to Follow-up|35|||
16299027|NCT02092467|39577971|FG002|Overall Study|Lost to Follow-up|40|||
16299028|NCT02092467|39577969|FG000|Overall Study|Global Deterioration of Health Status|1|||
16299029|NCT02092467|39577970|FG001|Overall Study|Global Deterioration of Health Status|0|||
16299030|NCT02092467|39577971|FG002|Overall Study|Global Deterioration of Health Status|0|||
16299031|NCT02092467|39577969|FG000|Overall Study|Other|32|||
16299032|NCT02092467|39577970|FG001|Overall Study|Other|30|||
16299033|NCT02092467|39577971|FG002|Overall Study|Other|24|||
16299034|NCT02092467|39577969|FG000|Overall Study|Withdrawal by Subject|282|||
16299035|NCT02092467|39577970|FG001|Overall Study|Withdrawal by Subject|327|||
16299036|NCT02092467|39577971|FG002|Overall Study|Withdrawal by Subject|289|||
16299037|NCT02092467|39577969|FG000|Overall Study|Randomized but not treated|2|||
16299038|NCT02092467|39577970|FG001|Overall Study|Randomized but not treated|1|||
16299039|NCT02092467|39577971|FG002|Overall Study|Randomized but not treated|7|||
16299040|NCT01982448|39577972|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
16299041|NCT01982448|39577973|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
16299042|NCT01982448|39577972|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
16299043|NCT01982448|39577973|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
16299044|NCT01982448|39577972|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
16299045|NCT01982448|39577973|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
16299046|NCT01982448|39577972|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
16299047|NCT01982448|39577973|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
16299048|NCT02504671|39577974|FG000|Overall Study|Withdrawal by Subject|1|||
16299049|NCT02504671|39577975|FG001|Overall Study|Withdrawal by Subject|5|||
16299050|NCT02504671|39577976|FG002|Overall Study|Withdrawal by Subject|4|||
16299051|NCT02504671|39577977|FG003|Overall Study|Withdrawal by Subject|4|||
16299052|NCT02504671|39577978|FG004|Overall Study|Withdrawal by Subject|5|||
16299053|NCT02504671|39577979|FG005|Overall Study|Withdrawal by Subject|3|||
16299054|NCT02504671|39577974|FG000|Overall Study|Lack of Efficacy|1|||
16299055|NCT02504671|39577975|FG001|Overall Study|Lack of Efficacy|3|||
16299056|NCT02504671|39577976|FG002|Overall Study|Lack of Efficacy|1|||
16299057|NCT02504671|39577977|FG003|Overall Study|Lack of Efficacy|0|||
16299058|NCT02504671|39577978|FG004|Overall Study|Lack of Efficacy|4|||
16299059|NCT02504671|39577979|FG005|Overall Study|Lack of Efficacy|4|||
16299060|NCT02504671|39577974|FG000|Overall Study|Adverse Event|1|||
16299061|NCT02504671|39577975|FG001|Overall Study|Adverse Event|1|||
16299062|NCT02504671|39577976|FG002|Overall Study|Adverse Event|0|||
16299063|NCT02504671|39577977|FG003|Overall Study|Adverse Event|1|||
16299064|NCT02504671|39577978|FG004|Overall Study|Adverse Event|0|||
16299065|NCT02504671|39577979|FG005|Overall Study|Adverse Event|2|||
16299066|NCT02504671|39577974|FG000|Overall Study|Protocol Violation|2|||
16299067|NCT02504671|39577975|FG001|Overall Study|Protocol Violation|1|||
16299068|NCT02504671|39577976|FG002|Overall Study|Protocol Violation|0|||
16083632|NCT00774397|38799126|FG000|Overall Study|Not treated|0|||
16299069|NCT02504671|39577977|FG003|Overall Study|Protocol Violation|0|||
16299070|NCT02504671|39577978|FG004|Overall Study|Protocol Violation|0|||
16299071|NCT02504671|39577979|FG005|Overall Study|Protocol Violation|1|||
16299072|NCT02504671|39577974|FG000|Overall Study|Lost to Follow-up|0|||
16299073|NCT02504671|39577975|FG001|Overall Study|Lost to Follow-up|0|||
16299074|NCT02504671|39577976|FG002|Overall Study|Lost to Follow-up|2|||
16299075|NCT02504671|39577977|FG003|Overall Study|Lost to Follow-up|0|||
16299076|NCT02504671|39577978|FG004|Overall Study|Lost to Follow-up|0|||
16299077|NCT02504671|39577979|FG005|Overall Study|Lost to Follow-up|1|||
16385248|NCT00586157|39892804|FG001|First Intervention|Worsening behavior|0|||
16385249|NCT00586157|39892803|FG000|Second Intervention|Withdrawal by Subject|1|||
16385250|NCT00586157|39892804|FG001|Second Intervention|Withdrawal by Subject|0|||
16385251|NCT00586157|39892803|FG000|Second Intervention|Worsening behavior|1|||
16385252|NCT00586157|39892804|FG001|Second Intervention|Worsening behavior|0|||
16385253|NCT00586157|39892803|FG000|Second Intervention|Adverse Event|0|||
16385254|NCT00586157|39892804|FG001|Second Intervention|Adverse Event|1|||
16385255|NCT01567722|39892807|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
16385256|NCT01567722|39892808|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
16385257|NCT01567722|39892809|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
16385258|NCT01567722|39892807|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
16385259|NCT01567722|39892808|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
16385260|NCT01567722|39892809|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
16385261|NCT01567722|39892807|FG000|Overall Study|Protocol closure by the OCG|2|||
16385262|NCT01567722|39892808|FG001|Overall Study|Protocol closure by the OCG|0|||
16385263|NCT01567722|39892809|FG002|Overall Study|Protocol closure by the OCG|0|||
16385264|NCT01567722|39892807|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
16385265|NCT01567722|39892808|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
16385266|NCT01567722|39892809|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
16385267|NCT02015039|39892812|FG000|Overall Study|Not eligible|0|||
16385268|NCT02015039|39892813|FG001|Overall Study|Not eligible|1|||
16385269|NCT04484857|39892814|FG000|Overall Study|Adverse Event|2|||
16385270|NCT04484857|39892814|FG000|Overall Study|Death|10|||
16385271|NCT04484857|39892814|FG000|Overall Study|Withdrawal by Subject|3|||
16385272|NCT04484857|39892814|FG000|Overall Study|Transferred/Relocation|5|||
16385273|NCT04484857|39892814|FG000|Overall Study|Kidney Transplant|7|||
16385274|NCT04484857|39892814|FG000|Overall Study|Other than specified|4|||
16385275|NCT04484857|39892814|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
16385276|NCT01602484|39892815|FG000|Overall Study|Airway issues unrelated to study|0|||
16385277|NCT01602484|39892816|FG001|Overall Study|Airway issues unrelated to study|1|||
16385278|NCT03358030|39892818|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
16385279|NCT03358030|39892819|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
16385280|NCT03358030|39892820|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
16385281|NCT03358030|39892821|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
16385282|NCT03358030|39892818|FG000|Overall Study|Ineligibility|0|||
16385283|NCT03358030|39892819|FG001|Overall Study|Ineligibility|0|||
16385284|NCT03358030|39892820|FG002|Overall Study|Ineligibility|0|||
16385285|NCT03358030|39892821|FG003|Overall Study|Ineligibility|2|||
16385286|NCT03358030|39892818|FG000|Overall Study|Voluntary Withdrawal|1|||
16385287|NCT03358030|39892819|FG001|Overall Study|Voluntary Withdrawal|1|||
16385288|NCT03358030|39892820|FG002|Overall Study|Voluntary Withdrawal|3|||
16385289|NCT03358030|39892821|FG003|Overall Study|Voluntary Withdrawal|1|||
16385290|NCT03358030|39892818|FG000|Overall Study|Other|0|||
16385291|NCT03358030|39892819|FG001|Overall Study|Other|0|||
16385292|NCT03358030|39892820|FG002|Overall Study|Other|1|||
16385293|NCT03358030|39892821|FG003|Overall Study|Other|0|||
16385294|NCT01459666|39892822|FG000|Overall Study|PI left institution|5|||
16385295|NCT01459666|39892823|FG001|Overall Study|PI left institution|4|||
16385296|NCT02343302|39892824|FG000|Overall Study|Physician Decision|1|||
16385297|NCT02343302|39892825|FG001|Overall Study|Physician Decision|1|||
16385298|NCT01128569|39892829|FG000|Washout Period 1|Adverse Event|0|||
16385299|NCT01128569|39892830|FG001|Washout Period 1|Adverse Event|0|||
16385300|NCT01128569|39892831|FG002|Washout Period 1|Adverse Event|1|||
16385301|NCT01128569|39892832|FG003|Washout Period 1|Adverse Event|0|||
16385302|NCT01128569|39892833|FG004|Washout Period 1|Adverse Event|0|||
16385303|NCT01128569|39892834|FG005|Washout Period 1|Adverse Event|0|||
16385304|NCT01128569|39892829|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16385305|NCT01128569|39892830|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16385306|NCT01128569|39892831|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16385307|NCT01128569|39892832|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16385308|NCT01128569|39892833|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16385309|NCT01128569|39892834|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16385310|NCT00575666|39892835|FG000|Overall Study|Withdrawal by Subject|3|||
16385311|NCT00575666|39892836|FG001|Overall Study|Withdrawal by Subject|2|||
16385312|NCT00575666|39892835|FG000|Overall Study|Physician Decision|1|||
16385313|NCT00575666|39892836|FG001|Overall Study|Physician Decision|1|||
16385314|NCT00904371|39892837|FG000|Overall Study|Adverse Event|2|||
16385315|NCT00904371|39892837|FG000|Overall Study|Lost to Follow-up|4|||
16385316|NCT00904371|39892837|FG000|Overall Study|Discontinued at target blood pressure|2|||
16083633|NCT00774397|38799127|FG001|Overall Study|Not treated|0|||
16083634|NCT00774397|38799128|FG002|Overall Study|Not treated|0|||
16083635|NCT00774397|38799129|FG003|Overall Study|Not treated|0|||
16083636|NCT00774397|38799130|FG004|Overall Study|Not treated|1|||
16083637|NCT00774397|38799131|FG005|Overall Study|Not treated|0|||
16083638|NCT00774397|38799132|FG006|Overall Study|Not treated|1|||
16083639|NCT00774397|38799126|FG000|Overall Study|Other than those stated above|1|||
16083640|NCT00774397|38799127|FG001|Overall Study|Other than those stated above|1|||
16083641|NCT00774397|38799128|FG002|Overall Study|Other than those stated above|3|||
16083642|NCT00774397|38799129|FG003|Overall Study|Other than those stated above|2|||
16083643|NCT00774397|38799130|FG004|Overall Study|Other than those stated above|2|||
16083644|NCT00774397|38799131|FG005|Overall Study|Other than those stated above|0|||
16083645|NCT00774397|38799132|FG006|Overall Study|Other than those stated above|1|||
16083646|NCT00589875|38799134|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
16083647|NCT00589875|38799134|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
16083648|NCT00879333|38799135|FG000|Overall Study|Adverse Event|94|||
16083649|NCT00879333|38799136|FG001|Overall Study|Adverse Event|34|||
16299078|NCT02504671|39577974|FG000|Overall Study|Protocol defined stopping criteria|7|||
16299079|NCT02504671|39577975|FG001|Overall Study|Protocol defined stopping criteria|4|||
16385317|NCT00904371|39892837|FG000|Overall Study|Continued with Tritace|1|||
16385318|NCT02569853|39892838|FG000|Overall Study|Adverse Event|2|||
16385319|NCT02569853|39892839|FG001|Overall Study|Adverse Event|0|||
16385320|NCT02569853|39892838|FG000|Overall Study|Withdrawal by Subject|3|||
16385321|NCT02569853|39892839|FG001|Overall Study|Withdrawal by Subject|2|||
16385322|NCT02569853|39892838|FG000|Overall Study|Lost to Follow-up|3|||
16385323|NCT02569853|39892839|FG001|Overall Study|Lost to Follow-up|3|||
16385324|NCT02569853|39892838|FG000|Overall Study|Protocol Violation|1|||
16299080|NCT02504671|39577976|FG002|Overall Study|Protocol defined stopping criteria|3|||
16299081|NCT02504671|39577977|FG003|Overall Study|Protocol defined stopping criteria|5|||
16299082|NCT02504671|39577978|FG004|Overall Study|Protocol defined stopping criteria|3|||
16299083|NCT02504671|39577979|FG005|Overall Study|Protocol defined stopping criteria|3|||
16299084|NCT00879411|39577980|FG000|Overall Study|lost to follow-up (non-AE)|162|||
16299085|NCT01085734|39577981|FG000|Overall Study|Adverse Event|0|||
16299086|NCT01085734|39577982|FG001|Overall Study|Adverse Event|2|||
16299087|NCT01085734|39577981|FG000|Overall Study|Death|1|||
16083650|NCT00879333|38799135|FG000|Overall Study|Abnormal Laboratory Value|1|||
16083651|NCT00879333|38799136|FG001|Overall Study|Abnormal Laboratory Value|0|||
16083652|NCT00879333|38799135|FG000|Overall Study|Withdrawal by Subject|20|||
16083653|NCT00879333|38799136|FG001|Overall Study|Withdrawal by Subject|7|||
16083654|NCT00879333|38799135|FG000|Overall Study|Lost to Follow-up|2|||
16083655|NCT00879333|38799136|FG001|Overall Study|Lost to Follow-up|1|||
16191118|NCT00408421|39176249|FG002|Treatment Re-Randomization|Protocol Violation|0|||
16191119|NCT00408421|39176247|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
16191120|NCT00408421|39176248|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
16191121|NCT00408421|39176249|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
16191122|NCT02940626|39176250|FG000|Overall Study|Death|40|||
16191123|NCT02940626|39176251|FG001|Overall Study|Death|32|||
16191124|NCT02940626|39176250|FG000|Overall Study|Lost to Follow-up|5|||
16191125|NCT02940626|39176251|FG001|Overall Study|Lost to Follow-up|2|||
16191126|NCT02940626|39176250|FG000|Overall Study|Withdrawal by Subject|1|||
16191127|NCT02940626|39176251|FG001|Overall Study|Withdrawal by Subject|0|||
16191128|NCT02940626|39176250|FG000|Overall Study|Transfer to Hospice Care|1|||
16191129|NCT02940626|39176251|FG001|Overall Study|Transfer to Hospice Care|0|||
16191130|NCT02940626|39176250|FG000|Overall Study|Prohibited Concomitant Medication|0|||
16191131|NCT02940626|39176251|FG001|Overall Study|Prohibited Concomitant Medication|1|||
16191132|NCT00372190|39179185|FG000|Overall Study|Lost to Follow-up|3|||
16191133|NCT00372190|39179186|FG001|Overall Study|Lost to Follow-up|1|||
16191134|NCT03235544|39179187|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
16191135|NCT03235544|39179188|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
16191136|NCT03235544|39179189|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
16191137|NCT03235544|39179190|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
16191138|NCT03235544|39179187|FG000|Overall Study|Death|11|||
16191139|NCT03235544|39179188|FG001|Overall Study|Death|23|||
16191140|NCT03235544|39179189|FG002|Overall Study|Death|11|||
16191141|NCT03235544|39179190|FG003|Overall Study|Death|20|||
16191142|NCT03235544|39179187|FG000|Overall Study|Lost to Follow-up|0|||
16191143|NCT03235544|39179188|FG001|Overall Study|Lost to Follow-up|1|||
16191144|NCT03235544|39179189|FG002|Overall Study|Lost to Follow-up|0|||
16299088|NCT01085734|39577982|FG001|Overall Study|Death|0|||
16299089|NCT01085734|39577981|FG000|Overall Study|Lost to Follow-up|0|||
16083656|NCT00879333|38799135|FG000|Overall Study|Administrative Problems|2|||
16083657|NCT00879333|38799136|FG001|Overall Study|Administrative Problems|0|||
16083658|NCT00879333|38799135|FG000|Overall Study|Death|16|||
16191145|NCT03235544|39179190|FG003|Overall Study|Lost to Follow-up|1|||
16191146|NCT03235544|39179187|FG000|Overall Study|Withdrawal by Participant|0|||
16385325|NCT02569853|39892839|FG001|Overall Study|Protocol Violation|1|||
16489826|NCT02955602|40267083|FG002|Overall Study|Adverse Event|0|||
16191147|NCT03235544|39179188|FG001|Overall Study|Withdrawal by Participant|0|||
16191148|NCT03235544|39179189|FG002|Overall Study|Withdrawal by Participant|1|||
16191149|NCT03235544|39179190|FG003|Overall Study|Withdrawal by Participant|0|||
16191150|NCT03235544|39179187|FG000|Overall Study|Reason not Specified|0|||
16191151|NCT03235544|39179188|FG001|Overall Study|Reason not Specified|4|||
16191152|NCT03235544|39179189|FG002|Overall Study|Reason not Specified|0|||
16191153|NCT03235544|39179190|FG003|Overall Study|Reason not Specified|1|||
16191154|NCT01496430|39179191|FG000|Overall Study|Adverse Event|0|||
16191155|NCT01496430|39179192|FG001|Overall Study|Adverse Event|0|||
16191156|NCT01496430|39179193|FG002|Overall Study|Adverse Event|1|||
16191157|NCT01496430|39179191|FG000|Overall Study|Major Protocol Deviation|0|||
16191158|NCT01496430|39179192|FG001|Overall Study|Major Protocol Deviation|0|||
16191159|NCT01496430|39179193|FG002|Overall Study|Major Protocol Deviation|1|||
16191160|NCT01496430|39179191|FG000|Overall Study|Lost to Follow-up|2|||
16191161|NCT01496430|39179192|FG001|Overall Study|Lost to Follow-up|3|||
16191162|NCT01496430|39179193|FG002|Overall Study|Lost to Follow-up|1|||
16191163|NCT01496430|39179191|FG000|Overall Study|Voluntary Withdrawal|2|||
16191164|NCT01496430|39179192|FG001|Overall Study|Voluntary Withdrawal|1|||
16191165|NCT01496430|39179193|FG002|Overall Study|Voluntary Withdrawal|6|||
16191166|NCT01496430|39179191|FG000|Overall Study|Principal Investigator Discretion|0|||
16191167|NCT01496430|39179192|FG001|Overall Study|Principal Investigator Discretion|1|||
16191168|NCT01496430|39179193|FG002|Overall Study|Principal Investigator Discretion|1|||
16191169|NCT01496430|39179191|FG000|Overall Study|Other|2|||
16191170|NCT01496430|39179192|FG001|Overall Study|Other|0|||
16191171|NCT01496430|39179193|FG002|Overall Study|Other|0|||
16191172|NCT03100942|39179194|FG000|Randomized Treatment Period|Withdrew Consent|4|||
16191173|NCT03100942|39179195|FG001|Randomized Treatment Period|Withdrew Consent|5|||
16191174|NCT03100942|39179196|FG002|Randomized Treatment Period|Withdrew Consent|3|||
16489827|NCT02955602|40267081|FG000|Overall Study|Withdrawal of informed consent|1|||
16191175|NCT03100942|39179197|FG003|Randomized Treatment Period|Withdrew Consent|3|||
16191176|NCT03100942|39179198|FG004|Randomized Treatment Period|Withdrew Consent|0|||
16191177|NCT03100942|39179199|FG005|Randomized Treatment Period|Withdrew Consent|0|||
16191178|NCT03100942|39179200|FG006|Randomized Treatment Period|Withdrew Consent|0|||
16191179|NCT03100942|39179194|FG000|Randomized Treatment Period|Adverse Event|5|||
16191180|NCT03100942|39179195|FG001|Randomized Treatment Period|Adverse Event|2|||
16191181|NCT03100942|39179196|FG002|Randomized Treatment Period|Adverse Event|1|||
16191182|NCT03100942|39179197|FG003|Randomized Treatment Period|Adverse Event|0|||
16191183|NCT03100942|39179198|FG004|Randomized Treatment Period|Adverse Event|0|||
16191184|NCT03100942|39179199|FG005|Randomized Treatment Period|Adverse Event|0|||
16191185|NCT03100942|39179200|FG006|Randomized Treatment Period|Adverse Event|0|||
16191186|NCT03100942|39179194|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
16191187|NCT03100942|39179195|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
16191188|NCT03100942|39179196|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
16191189|NCT03100942|39179197|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
16191190|NCT03100942|39179198|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
16191191|NCT03100942|39179199|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
16191192|NCT03100942|39179200|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
16191193|NCT03100942|39179194|FG000|Randomized Treatment Period|Protocol Violation|0|||
16191194|NCT03100942|39179195|FG001|Randomized Treatment Period|Protocol Violation|1|||
16191195|NCT03100942|39179196|FG002|Randomized Treatment Period|Protocol Violation|1|||
16191196|NCT03100942|39179197|FG003|Randomized Treatment Period|Protocol Violation|1|||
16191197|NCT03100942|39179198|FG004|Randomized Treatment Period|Protocol Violation|0|||
16191198|NCT03100942|39179199|FG005|Randomized Treatment Period|Protocol Violation|0|||
16191199|NCT03100942|39179200|FG006|Randomized Treatment Period|Protocol Violation|0|||
16191200|NCT03100942|39179194|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
16191201|NCT03100942|39179195|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
16299090|NCT01085734|39577982|FG001|Overall Study|Lost to Follow-up|1|||
16299091|NCT01085734|39577981|FG000|Overall Study|Withdrawal by Subject|0|||
16299092|NCT01085734|39577982|FG001|Overall Study|Withdrawal by Subject|1|||
16299093|NCT03207243|39577983|FG000|Overall Study|Adverse Event|2|||
16299094|NCT03207243|39577984|FG001|Overall Study|Adverse Event|2|||
16299095|NCT03207243|39577983|FG000|Overall Study|Loss of Asthma Control|47|||
16299096|NCT03207243|39577984|FG001|Overall Study|Loss of Asthma Control|31|||
16299097|NCT03207243|39577983|FG000|Overall Study|Withdrawal by Subject|2|||
16299098|NCT03207243|39577984|FG001|Overall Study|Withdrawal by Subject|4|||
16299099|NCT03207243|39577983|FG000|Overall Study|Physician Decision|1|||
16299100|NCT03207243|39577984|FG001|Overall Study|Physician Decision|1|||
16299101|NCT03207243|39577983|FG000|Overall Study|Lost to Follow-up|0|||
16299102|NCT03207243|39577984|FG001|Overall Study|Lost to Follow-up|1|||
16299103|NCT03207243|39577983|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
16299104|NCT03207243|39577984|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
16299105|NCT03207243|39577983|FG000|Overall Study|Protocol Violation|0|||
16299106|NCT03207243|39577984|FG001|Overall Study|Protocol Violation|3|||
16191202|NCT03100942|39179196|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
16191203|NCT03100942|39179197|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
16191204|NCT03100942|39179198|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
16191205|NCT03100942|39179199|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
16191206|NCT03100942|39179200|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
16191207|NCT03100942|39179194|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
16191208|NCT03100942|39179195|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
16191209|NCT03100942|39179196|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
16191210|NCT03100942|39179197|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
16191211|NCT03100942|39179198|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
16191212|NCT03100942|39179199|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
16191213|NCT03100942|39179200|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
16191214|NCT03100942|39179194|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
16191215|NCT03100942|39179195|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
16191216|NCT03100942|39179196|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
16191217|NCT03100942|39179197|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
16191218|NCT03100942|39179198|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
16191219|NCT03100942|39179199|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
16191220|NCT03100942|39179200|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
16191221|NCT00702052|39179201|FG000|Overall Study|Adverse Event|23|||
16191222|NCT00702052|39179201|FG000|Overall Study|Disease Progression|30|||
16191223|NCT00702052|39179201|FG000|Overall Study|Withdrawal by Subject|5|||
16191224|NCT02653976|39179202|FG000|Overall Study|Withdrawal by Subject|5|||
16191225|NCT02653976|39179202|FG000|Overall Study|Death|4|||
16191226|NCT01242020|39179216|FG000|Overall Study|Withdrawal by Subject|2|||
16191227|NCT01242020|39179217|FG001|Overall Study|Withdrawal by Subject|0|||
16191228|NCT01242020|39179216|FG000|Overall Study|Failed screening|1|||
16191229|NCT01242020|39179217|FG001|Overall Study|Failed screening|0|||
16191230|NCT05127421|39179218|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
16191231|NCT05127421|39179219|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
16191232|NCT05127421|39179220|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
16191233|NCT05127421|39179221|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
16191234|NCT05127421|39179218|FG000|4-Week Double-Blind Period|Physician Decision|1|||
16191235|NCT05127421|39179219|FG001|4-Week Double-Blind Period|Physician Decision|0|||
16299107|NCT02121392|39577985|FG000|Prior to Intervention|Protocol Violation|40|||
16299108|NCT02121392|39577986|FG001|Prior to Intervention|Protocol Violation|35|||
16299109|NCT02121392|39577985|FG000|Prior to Intervention|Withdrawal by Subject|8|||
16299110|NCT02121392|39577986|FG001|Prior to Intervention|Withdrawal by Subject|6|||
16299111|NCT02121392|39577985|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
16191236|NCT05127421|39179220|FG002|4-Week Double-Blind Period|Physician Decision|0|||
16083659|NCT00879333|38799136|FG001|Overall Study|Death|5|||
16191237|NCT05127421|39179221|FG003|4-Week Double-Blind Period|Physician Decision|0|||
16191238|NCT05127421|39179218|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
16191239|NCT05127421|39179219|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
16191240|NCT05127421|39179220|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
16191241|NCT05127421|39179221|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
16191242|NCT05127421|39179218|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
16191243|NCT05127421|39179219|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
16191244|NCT05127421|39179220|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
16191245|NCT05127421|39179221|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
16191246|NCT05127421|39179218|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
16191247|NCT05127421|39179219|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
16191248|NCT05127421|39179220|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
16191249|NCT05127421|39179221|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
16191250|NCT05127421|39179218|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
16191251|NCT05127421|39179219|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
16191252|NCT05127421|39179220|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
16191253|NCT05127421|39179221|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
16191254|NCT05127421|39179218|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
16191255|NCT05127421|39179219|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
16191256|NCT05127421|39179220|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
16299112|NCT02121392|39577986|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
16299113|NCT02121392|39577985|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
16299114|NCT02121392|39577986|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
16299115|NCT00229723|39577988|FG000|Concomitant Phase|Adverse Event|4|||
16299116|NCT00229723|39577989|FG001|Concomitant Phase|Adverse Event|2|||
16299117|NCT00229723|39577990|FG002|Concomitant Phase|Adverse Event|5|||
16299118|NCT00229723|39577991|FG003|Concomitant Phase|Adverse Event|2|||
16299119|NCT00229723|39577992|FG004|Concomitant Phase|Adverse Event|0|||
16299120|NCT00229723|39577993|FG005|Concomitant Phase|Adverse Event|1|||
16299121|NCT00229723|39577994|FG006|Concomitant Phase|Adverse Event|2|||
16191257|NCT05127421|39179221|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
16191258|NCT05127421|39179218|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
16191259|NCT05127421|39179219|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
16191260|NCT05127421|39179220|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
16191261|NCT05127421|39179221|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
16191262|NCT02938585|39179229|FG000|Overall Study|Withdrawal by parent or guardian|0|||
16191263|NCT02938585|39179230|FG001|Overall Study|Withdrawal by parent or guardian|1|||
16191264|NCT02938585|39179231|FG002|Overall Study|Withdrawal by parent or guardian|0|||
16191265|NCT02938585|39179232|FG003|Overall Study|Withdrawal by parent or guardian|0|||
16191266|NCT02938585|39179229|FG000|Overall Study|Withdrawal by Subject|0|||
16191267|NCT02938585|39179230|FG001|Overall Study|Withdrawal by Subject|0|||
16191268|NCT02938585|39179231|FG002|Overall Study|Withdrawal by Subject|0|||
16191269|NCT02938585|39179232|FG003|Overall Study|Withdrawal by Subject|5|||
16191270|NCT01810042|39179233|FG000|Overall Study|Lost to Follow-up|10|||
16191271|NCT02108600|39179236|FG000|Overall Study|Withdrawal by Subject|2|||
16191272|NCT02108600|39179237|FG001|Overall Study|Withdrawal by Subject|0|||
16191273|NCT02108600|39179236|FG000|Overall Study|Lost to Follow-up|1|||
16191274|NCT02108600|39179237|FG001|Overall Study|Lost to Follow-up|1|||
16191275|NCT01586156|39179238|FG000|Overall Study|Pregnancy|0|||
16191276|NCT01586156|39179239|FG001|Overall Study|Pregnancy|1|||
16191277|NCT01586156|39179240|FG002|Overall Study|Pregnancy|0|||
16191278|NCT00002663|39179241|FG000|Overall Study|Death|4|||
16191279|NCT00002663|39179242|FG001|Overall Study|Death|1|||
16191280|NCT00002663|39179243|FG002|Overall Study|Death|1|||
16191281|NCT00002663|39179244|FG003|Overall Study|Death|0|||
16191282|NCT00002663|39179245|FG004|Overall Study|Death|0|||
16191283|NCT00002663|39179246|FG005|Overall Study|Death|13|||
16191284|NCT00002663|39179247|FG006|Overall Study|Death|0|||
16191285|NCT00002663|39179248|FG007|Overall Study|Death|1|||
16191286|NCT00002663|39179249|FG008|Overall Study|Death|1|||
16191287|NCT00002663|39179250|FG009|Overall Study|Death|1|||
16191288|NCT00002663|39179241|FG000|Overall Study|Lost to Follow-up|3|||
16191289|NCT00002663|39179242|FG001|Overall Study|Lost to Follow-up|0|||
16191290|NCT00002663|39179243|FG002|Overall Study|Lost to Follow-up|0|||
16191291|NCT00002663|39179244|FG003|Overall Study|Lost to Follow-up|1|||
16191292|NCT00002663|39179245|FG004|Overall Study|Lost to Follow-up|0|||
16191293|NCT00002663|39179246|FG005|Overall Study|Lost to Follow-up|1|||
16191294|NCT00002663|39179247|FG006|Overall Study|Lost to Follow-up|0|||
16191295|NCT00002663|39179248|FG007|Overall Study|Lost to Follow-up|0|||
16191296|NCT00002663|39179249|FG008|Overall Study|Lost to Follow-up|0|||
16191297|NCT00002663|39179250|FG009|Overall Study|Lost to Follow-up|0|||
16191298|NCT00002663|39179241|FG000|Overall Study|Other|0|||
16191299|NCT00002663|39179242|FG001|Overall Study|Other|1|||
16191300|NCT00002663|39179243|FG002|Overall Study|Other|0|||
16191301|NCT00002663|39179244|FG003|Overall Study|Other|0|||
16191302|NCT00002663|39179245|FG004|Overall Study|Other|0|||
16191303|NCT00002663|39179246|FG005|Overall Study|Other|1|||
16191304|NCT00002663|39179247|FG006|Overall Study|Other|1|||
16191305|NCT00002663|39179248|FG007|Overall Study|Other|0|||
16191306|NCT00002663|39179249|FG008|Overall Study|Other|0|||
16191307|NCT00002663|39179250|FG009|Overall Study|Other|0|||
16191308|NCT00002663|39179241|FG000|Overall Study|Physician Decision|0|||
16191309|NCT00002663|39179242|FG001|Overall Study|Physician Decision|0|||
16191310|NCT00002663|39179243|FG002|Overall Study|Physician Decision|0|||
16191311|NCT00002663|39179244|FG003|Overall Study|Physician Decision|0|||
16191312|NCT00002663|39179245|FG004|Overall Study|Physician Decision|1|||
16191313|NCT00002663|39179246|FG005|Overall Study|Physician Decision|0|||
16191314|NCT00002663|39179247|FG006|Overall Study|Physician Decision|0|||
16191315|NCT00002663|39179248|FG007|Overall Study|Physician Decision|0|||
16191316|NCT00002663|39179249|FG008|Overall Study|Physician Decision|1|||
16191317|NCT00002663|39179250|FG009|Overall Study|Physician Decision|1|||
16191318|NCT00002663|39179241|FG000|Overall Study|Adverse Event|0|||
16385326|NCT02569853|39892838|FG000|Overall Study|Did not experience migraine attack|10|||
16385327|NCT02569853|39892839|FG001|Overall Study|Did not experience migraine attack|7|||
16385328|NCT02569853|39892838|FG000|Overall Study|Physician Decision|1|||
16385329|NCT02569853|39892839|FG001|Overall Study|Physician Decision|1|||
16191319|NCT00002663|39179242|FG001|Overall Study|Adverse Event|0|||
16191320|NCT00002663|39179243|FG002|Overall Study|Adverse Event|0|||
16191321|NCT00002663|39179244|FG003|Overall Study|Adverse Event|1|||
16191322|NCT00002663|39179245|FG004|Overall Study|Adverse Event|0|||
16191323|NCT00002663|39179246|FG005|Overall Study|Adverse Event|0|||
16191324|NCT00002663|39179247|FG006|Overall Study|Adverse Event|0|||
16191325|NCT00002663|39179248|FG007|Overall Study|Adverse Event|1|||
16191326|NCT00002663|39179249|FG008|Overall Study|Adverse Event|0|||
16191327|NCT00002663|39179250|FG009|Overall Study|Adverse Event|0|||
16191328|NCT02145156|39179253|FG000|Overall Study|No match to vaccination records|60|||
16191329|NCT02145156|39179254|FG001|Overall Study|No match to vaccination records|52|||
16191330|NCT02145156|39179255|FG002|Overall Study|No match to vaccination records|41|||
16191331|NCT01395368|39179256|FG000|Overall Study|Physician Decision|14|||
16191332|NCT01395368|39179256|FG000|Overall Study|Withdrawal by Subject|2|||
16385330|NCT00902330|39892846|FG000|Overall Study|Too overwhelmed by treatment|2|||
16385331|NCT00902330|39892847|FG001|Overall Study|Too overwhelmed by treatment|5|||
16385332|NCT00902330|39892846|FG000|Overall Study|Adverse Event|1|||
16385333|NCT00902330|39892847|FG001|Overall Study|Adverse Event|0|||
16385334|NCT00902330|39892846|FG000|Overall Study|No post baseline data|1|||
16191333|NCT01251276|39179257|FG000|Overall Study|Protocol Violation|1|||
16191334|NCT01251276|39179258|FG001|Overall Study|Protocol Violation|0|||
16191335|NCT01251276|39179257|FG000|Overall Study|Lost to Follow-up|0|||
16191336|NCT01251276|39179258|FG001|Overall Study|Lost to Follow-up|1|||
16191337|NCT00525148|39179261|FG000|Overall Study|Other Adverse Event|3|||
16191338|NCT00525148|39179262|FG001|Overall Study|Other Adverse Event|5|||
16191339|NCT00525148|39179263|FG002|Overall Study|Other Adverse Event|1|||
16191340|NCT00525148|39179264|FG003|Overall Study|Other Adverse Event|8|||
16191341|NCT00525148|39179261|FG000|Overall Study|Progressive disease|18|||
16191342|NCT00525148|39179262|FG001|Overall Study|Progressive disease|30|||
16191343|NCT00525148|39179263|FG002|Overall Study|Progressive disease|6|||
16191344|NCT00525148|39179264|FG003|Overall Study|Progressive disease|49|||
16191345|NCT00525148|39179261|FG000|Overall Study|Refused continuation of study medication|0|||
16191346|NCT00525148|39179262|FG001|Overall Study|Refused continuation of study medication|2|||
16191347|NCT00525148|39179263|FG002|Overall Study|Refused continuation of study medication|0|||
16191348|NCT00525148|39179264|FG003|Overall Study|Refused continuation of study medication|1|||
16385335|NCT00902330|39892847|FG001|Overall Study|No post baseline data|0|||
16385336|NCT04211363|39892849|FG000|Overall Study|Adverse Event|5|||
16385337|NCT04211363|39892850|FG001|Overall Study|Adverse Event|2|||
16385338|NCT04211363|39892849|FG000|Overall Study|Physician Decision|0|||
16385339|NCT04211363|39892850|FG001|Overall Study|Physician Decision|1|||
16385340|NCT04211363|39892849|FG000|Overall Study|Protocol Violation|1|||
16385341|NCT04211363|39892850|FG001|Overall Study|Protocol Violation|0|||
16385342|NCT04211363|39892849|FG000|Overall Study|Pregnancy|1|||
16385343|NCT04211363|39892850|FG001|Overall Study|Pregnancy|0|||
16385344|NCT04211363|39892849|FG000|Overall Study|Lost to Follow-up|12|||
16489828|NCT02955602|40267082|FG001|Overall Study|Withdrawal of informed consent|3|||
16489829|NCT02955602|40267083|FG002|Overall Study|Withdrawal of informed consent|2|||
16489830|NCT02955602|40267081|FG000|Overall Study|Lost to Follow-up|0|||
16489831|NCT02955602|40267082|FG001|Overall Study|Lost to Follow-up|0|||
16191349|NCT00525148|39179261|FG000|Overall Study|Other than stated|2|||
16191350|NCT00525148|39179262|FG001|Overall Study|Other than stated|1|||
16191351|NCT00525148|39179263|FG002|Overall Study|Other than stated|0|||
16489832|NCT02955602|40267083|FG002|Overall Study|Lost to Follow-up|1|||
16489833|NCT02955602|40267081|FG000|Overall Study|Other|0|||
16489834|NCT02955602|40267082|FG001|Overall Study|Other|1|||
16489835|NCT02955602|40267083|FG002|Overall Study|Other|3|||
16489836|NCT03547583|40267085|FG000|Overall Study|Adverse Event|16|||
16489837|NCT03547583|40267086|FG001|Overall Study|Adverse Event|11|||
16489838|NCT03547583|40267087|FG002|Overall Study|Adverse Event|10|||
16489839|NCT03547583|40267085|FG000|Overall Study|Death|11|||
16191352|NCT00525148|39179264|FG003|Overall Study|Other than stated|3|||
16191353|NCT01934192|39179265|FG000|Overall Study|Protocol Violation|0|||
16191354|NCT01934192|39179266|FG001|Overall Study|Protocol Violation|0|||
16191355|NCT01934192|39179267|FG002|Overall Study|Protocol Violation|0|||
16191356|NCT01934192|39179268|FG003|Overall Study|Protocol Violation|1|||
16191357|NCT01934192|39179265|FG000|Overall Study|Other: reached stopping criteria|6|||
16191358|NCT01934192|39179266|FG001|Overall Study|Other: reached stopping criteria|5|||
16299122|NCT00229723|39577988|FG000|Concomitant Phase|Objective disease progression|0|||
16489840|NCT03547583|40267086|FG001|Overall Study|Death|7|||
16489841|NCT03547583|40267087|FG002|Overall Study|Death|4|||
16489842|NCT03547583|40267085|FG000|Overall Study|Lost to Follow-up|1|||
16191359|NCT01934192|39179267|FG002|Overall Study|Other: reached stopping criteria|1|||
16191360|NCT01934192|39179268|FG003|Overall Study|Other: reached stopping criteria|0|||
16191361|NCT01934192|39179265|FG000|Overall Study|Physician Decision|3|||
16191362|NCT01934192|39179266|FG001|Overall Study|Physician Decision|2|||
16191363|NCT01934192|39179267|FG002|Overall Study|Physician Decision|0|||
16191364|NCT01934192|39179268|FG003|Overall Study|Physician Decision|0|||
16191365|NCT00943319|39179269|FG000|Overall Study|Death|1|||
16299123|NCT00229723|39577989|FG001|Concomitant Phase|Objective disease progression|0|||
16299124|NCT00229723|39577990|FG002|Concomitant Phase|Objective disease progression|0|||
16299125|NCT00229723|39577991|FG003|Concomitant Phase|Objective disease progression|0|||
16299126|NCT00229723|39577992|FG004|Concomitant Phase|Objective disease progression|0|||
16299127|NCT00229723|39577993|FG005|Concomitant Phase|Objective disease progression|0|||
16299128|NCT00229723|39577994|FG006|Concomitant Phase|Objective disease progression|0|||
16299129|NCT00229723|39577988|FG000|Concomitant Phase|Clinical progression|0|||
16299130|NCT00229723|39577989|FG001|Concomitant Phase|Clinical progression|0|||
16299131|NCT00229723|39577990|FG002|Concomitant Phase|Clinical progression|0|||
16299132|NCT00229723|39577991|FG003|Concomitant Phase|Clinical progression|0|||
16299133|NCT00229723|39577992|FG004|Concomitant Phase|Clinical progression|0|||
16299134|NCT00229723|39577993|FG005|Concomitant Phase|Clinical progression|0|||
16299135|NCT00229723|39577994|FG006|Concomitant Phase|Clinical progression|1|||
16385345|NCT04211363|39892850|FG001|Overall Study|Lost to Follow-up|4|||
16385346|NCT04211363|39892849|FG000|Overall Study|Withdrawal by Subject|11|||
16385347|NCT04211363|39892850|FG001|Overall Study|Withdrawal by Subject|11|||
16385348|NCT04211363|39892849|FG000|Overall Study|Other|1|||
16385349|NCT04211363|39892850|FG001|Overall Study|Other|2|||
16385350|NCT02164864|39896095|FG000|Overall Study|Trial disease worsening|7|||
16385351|NCT02164864|39896096|FG001|Overall Study|Trial disease worsening|5|||
16385352|NCT02164864|39896097|FG002|Overall Study|Trial disease worsening|1|||
16385353|NCT02164864|39896095|FG000|Overall Study|Other pre-existing disease worsening|6|||
16385354|NCT02164864|39896096|FG001|Overall Study|Other pre-existing disease worsening|4|||
16385355|NCT02164864|39896097|FG002|Overall Study|Other pre-existing disease worsening|9|||
16385356|NCT02164864|39896095|FG000|Overall Study|Other Adverse Event (AE)|52|||
16385357|NCT02164864|39896096|FG001|Overall Study|Other Adverse Event (AE)|32|||
16385358|NCT02164864|39896097|FG002|Overall Study|Other Adverse Event (AE)|49|||
16385359|NCT02164864|39896095|FG000|Overall Study|Protocol Violation|2|||
16385360|NCT02164864|39896096|FG001|Overall Study|Protocol Violation|4|||
16385361|NCT02164864|39896097|FG002|Overall Study|Protocol Violation|1|||
16385362|NCT02164864|39896095|FG000|Overall Study|Lost to Follow-up|4|||
16385363|NCT02164864|39896096|FG001|Overall Study|Lost to Follow-up|3|||
16385364|NCT02164864|39896097|FG002|Overall Study|Lost to Follow-up|2|||
16385365|NCT02164864|39896095|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
16385366|NCT02164864|39896096|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
16385367|NCT02164864|39896097|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
16191366|NCT02436577|39179270|FG000|Overall Study|Protocol Deviation|0|||
16191367|NCT02436577|39179271|FG001|Overall Study|Protocol Deviation|1|||
16191368|NCT02436577|39179272|FG002|Overall Study|Protocol Deviation|0|||
16191369|NCT02436577|39179273|FG003|Overall Study|Protocol Deviation|0|||
16191370|NCT02436577|39179274|FG004|Overall Study|Protocol Deviation|0|||
16191371|NCT02436577|39179275|FG005|Overall Study|Protocol Deviation|0|||
16191372|NCT02365584|39179276|FG000|Overall Study|Adverse Event|2|||
16191373|NCT02365584|39179277|FG001|Overall Study|Adverse Event|2|||
16191374|NCT02365584|39179276|FG000|Overall Study|Withdrawal by Subject|1|||
16191375|NCT02365584|39179277|FG001|Overall Study|Withdrawal by Subject|0|||
16191376|NCT02365584|39179276|FG000|Overall Study|Disease Progression|9|||
16191377|NCT02365584|39179277|FG001|Overall Study|Disease Progression|12|||
16191378|NCT02410772|39179278|FG000|Overall Study|Death|3|||
16191379|NCT02410772|39179279|FG001|Overall Study|Death|4|||
16191380|NCT02410772|39179280|FG002|Overall Study|Death|8|||
16191381|NCT02410772|39179278|FG000|Overall Study|Lost to Follow-up|31|||
16191382|NCT02410772|39179279|FG001|Overall Study|Lost to Follow-up|23|||
16191383|NCT02410772|39179280|FG002|Overall Study|Lost to Follow-up|22|||
16191384|NCT02410772|39179278|FG000|Overall Study|Pregnancy|8|||
16191385|NCT02410772|39179279|FG001|Overall Study|Pregnancy|4|||
16191386|NCT02410772|39179280|FG002|Overall Study|Pregnancy|5|||
16191387|NCT02410772|39179278|FG000|Overall Study|Protocol Violation|8|||
16191388|NCT02410772|39179279|FG001|Overall Study|Protocol Violation|8|||
16191389|NCT02410772|39179280|FG002|Overall Study|Protocol Violation|4|||
16191390|NCT02410772|39179278|FG000|Overall Study|Baseline Drug Resistance|49|||
16191391|NCT02410772|39179279|FG001|Overall Study|Baseline Drug Resistance|40|||
16191392|NCT02410772|39179280|FG002|Overall Study|Baseline Drug Resistance|51|||
16191393|NCT02410772|39179278|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
16191394|NCT02410772|39179279|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
16191395|NCT02410772|39179280|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
16191396|NCT02410772|39179278|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
16191397|NCT02410772|39179279|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
16191398|NCT02410772|39179280|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
16191399|NCT00431847|39179286|FG000|Overall Study|completion of less than two study visits|6|||
16191400|NCT00431847|39179287|FG001|Overall Study|completion of less than two study visits|3|||
16191401|NCT00431847|39179288|FG002|Overall Study|completion of less than two study visits|4|||
16191402|NCT00431847|39179289|FG003|Overall Study|completion of less than two study visits|14|||
16191403|NCT00431847|39179290|FG004|Overall Study|completion of less than two study visits|0|||
16191404|NCT00431847|39179286|FG000|Overall Study|Protocol Violation|0|||
16083660|NCT00879333|38799135|FG000|Overall Study|Disease Progression|292|||
16083661|NCT00879333|38799136|FG001|Overall Study|Disease Progression|169|||
16385368|NCT02164864|39896095|FG000|Overall Study|Other than stated|3|||
16385369|NCT02164864|39896096|FG001|Overall Study|Other than stated|4|||
16385370|NCT02164864|39896097|FG002|Overall Study|Other than stated|14|||
16385371|NCT01905540|39896106|FG000|Period 3|Other|1|||
16385372|NCT01905540|39896107|FG001|Period 3|Other|0|||
16385373|NCT01905540|39896108|FG002|Period 3|Other|1|||
16191405|NCT00431847|39179287|FG001|Overall Study|Protocol Violation|0|||
16191406|NCT00431847|39179288|FG002|Overall Study|Protocol Violation|0|||
16191407|NCT00431847|39179289|FG003|Overall Study|Protocol Violation|0|||
16191408|NCT00431847|39179290|FG004|Overall Study|Protocol Violation|1|||
16191409|NCT03136185|39179291|FG000|Overall Study|Adverse Event|0|||
16191410|NCT03136185|39179292|FG001|Overall Study|Adverse Event|1|||
16191411|NCT03136185|39179293|FG002|Overall Study|Adverse Event|3|||
16489843|NCT03547583|40267086|FG001|Overall Study|Lost to Follow-up|0|||
16489844|NCT03547583|40267087|FG002|Overall Study|Lost to Follow-up|0|||
16083662|NCT00879333|38799135|FG000|Overall Study|Protocol Violation|1|||
16083663|NCT00879333|38799136|FG001|Overall Study|Protocol Violation|1|||
16083664|NCT03283371|38799138|FG000|Placebo-controlled|Adverse Event|1|||
16083665|NCT03283371|38799139|FG001|Placebo-controlled|Adverse Event|1|||
16083666|NCT03283371|38799140|FG002|Placebo-controlled|Adverse Event|0|||
16083667|NCT03283371|38799141|FG003|Placebo-controlled|Adverse Event|0|||
16083668|NCT03283371|38799138|FG000|Placebo-controlled|Lack of Efficacy|1|||
16083669|NCT03283371|38799139|FG001|Placebo-controlled|Lack of Efficacy|0|||
16083670|NCT03283371|38799140|FG002|Placebo-controlled|Lack of Efficacy|0|||
16083671|NCT03283371|38799141|FG003|Placebo-controlled|Lack of Efficacy|0|||
16083672|NCT03283371|38799138|FG000|Placebo-controlled|Withdrawal by Subject|1|||
16083673|NCT03283371|38799139|FG001|Placebo-controlled|Withdrawal by Subject|1|||
16083674|NCT03283371|38799140|FG002|Placebo-controlled|Withdrawal by Subject|0|||
16083675|NCT03283371|38799141|FG003|Placebo-controlled|Withdrawal by Subject|0|||
16083676|NCT03283371|38799138|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
16083677|NCT03283371|38799139|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
16083678|NCT03283371|38799140|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
16083679|NCT03283371|38799141|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
16083680|NCT03283371|38799138|FG000|Open-label Phase|Adverse Event|0|||
16083681|NCT03283371|38799139|FG001|Open-label Phase|Adverse Event|0|||
16083682|NCT03283371|38799140|FG002|Open-label Phase|Adverse Event|2|||
16083683|NCT03283371|38799141|FG003|Open-label Phase|Adverse Event|0|||
16083684|NCT03283371|38799138|FG000|Open-label Phase|Withdrawal by Subject|0|||
16083685|NCT03283371|38799139|FG001|Open-label Phase|Withdrawal by Subject|0|||
16083686|NCT03283371|38799140|FG002|Open-label Phase|Withdrawal by Subject|1|||
16083687|NCT03283371|38799141|FG003|Open-label Phase|Withdrawal by Subject|0|||
16083688|NCT03283371|38799138|FG000|Open-label Phase|Other|0|||
16083689|NCT03283371|38799139|FG001|Open-label Phase|Other|0|||
16083690|NCT03283371|38799140|FG002|Open-label Phase|Other|1|||
16083691|NCT03283371|38799141|FG003|Open-label Phase|Other|1|||
16083692|NCT04860505|38799144|FG000|Overall Study|Lost to Follow-up|2|||
16083693|NCT00914589|38799147|FG000|Overall Study|Adverse Event|1|||
16083694|NCT00914589|38799148|FG001|Overall Study|Adverse Event|0|||
16083695|NCT00914589|38799149|FG002|Overall Study|Adverse Event|1|||
16083696|NCT00914589|38799147|FG000|Overall Study|Protocol Violation|8|||
16083697|NCT00914589|38799148|FG001|Overall Study|Protocol Violation|6|||
16083698|NCT00914589|38799149|FG002|Overall Study|Protocol Violation|3|||
16083699|NCT00914589|38799147|FG000|Overall Study|unclassified|16|||
16083700|NCT00914589|38799148|FG001|Overall Study|unclassified|9|||
16083701|NCT00914589|38799149|FG002|Overall Study|unclassified|7|||
16083702|NCT00914589|38799147|FG000|Overall Study|Death|0|||
16083703|NCT00914589|38799148|FG001|Overall Study|Death|1|||
16083704|NCT00914589|38799149|FG002|Overall Study|Death|1|||
16083705|NCT01037985|38799157|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
16083706|NCT01037985|38799158|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
16489845|NCT03547583|40267085|FG000|Overall Study|Non-compliance with study drug|0|||
16489846|NCT03547583|40267086|FG001|Overall Study|Non-compliance with study drug|0|||
16489847|NCT03547583|40267087|FG002|Overall Study|Non-compliance with study drug|1|||
16489848|NCT03547583|40267085|FG000|Overall Study|Physician Decision|1|||
16489849|NCT03547583|40267086|FG001|Overall Study|Physician Decision|0|||
16489850|NCT03547583|40267087|FG002|Overall Study|Physician Decision|3|||
16489851|NCT03547583|40267085|FG000|Overall Study|Protocol Violation|2|||
16489852|NCT03547583|40267086|FG001|Overall Study|Protocol Violation|1|||
16489853|NCT03547583|40267087|FG002|Overall Study|Protocol Violation|1|||
16489854|NCT03547583|40267085|FG000|Overall Study|Withdrawal by Subject|12|||
16489855|NCT03547583|40267086|FG001|Overall Study|Withdrawal by Subject|19|||
16489856|NCT03547583|40267087|FG002|Overall Study|Withdrawal by Subject|10|||
16489857|NCT03547583|40267085|FG000|Overall Study|Other|2|||
16489858|NCT03547583|40267086|FG001|Overall Study|Other|2|||
16489859|NCT03547583|40267087|FG002|Overall Study|Other|3|||
16489860|NCT02601469|40267088|FG000|Overall Study|Enrolled in Error|1|||
16489861|NCT02601469|40267089|FG001|Overall Study|Enrolled in Error|0|||
16489862|NCT04285879|40267100|FG000|Overall Study|Lost to Follow-up|1|||
16083707|NCT01037985|38799157|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
16083708|NCT01037985|38799158|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
16083709|NCT01037985|38799157|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
16083710|NCT01037985|38799158|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
16083711|NCT01037985|38799157|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
16083712|NCT01037985|38799158|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
16489863|NCT04285879|40267101|FG001|Overall Study|Lost to Follow-up|8|||
16489864|NCT04285879|40267100|FG000|Overall Study|medical/surgical exclusion|16|||
16489865|NCT04285879|40267101|FG001|Overall Study|medical/surgical exclusion|0|||
16489866|NCT02207244|40267102|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
16083713|NCT02128113|38799160|FG000|Overall Study|Withdrawal by Subject|3|||
16191412|NCT03136185|39179294|FG003|Overall Study|Adverse Event|1|||
16191413|NCT03136185|39179295|FG004|Overall Study|Adverse Event|2|||
16191414|NCT03136185|39179296|FG005|Overall Study|Adverse Event|2|||
16191415|NCT03136185|39179297|FG006|Overall Study|Adverse Event|5|||
16191416|NCT03136185|39179298|FG007|Overall Study|Adverse Event|1|||
16191417|NCT03136185|39179299|FG008|Overall Study|Adverse Event|1|||
16191418|NCT03136185|39179291|FG000|Overall Study|Death|0|||
16191419|NCT03136185|39179292|FG001|Overall Study|Death|0|||
16191420|NCT03136185|39179293|FG002|Overall Study|Death|0|||
16191421|NCT03136185|39179294|FG003|Overall Study|Death|1|||
16191422|NCT03136185|39179295|FG004|Overall Study|Death|1|||
16191423|NCT03136185|39179296|FG005|Overall Study|Death|0|||
16191424|NCT03136185|39179297|FG006|Overall Study|Death|1|||
16191425|NCT03136185|39179298|FG007|Overall Study|Death|0|||
16191426|NCT03136185|39179299|FG008|Overall Study|Death|0|||
16191427|NCT03136185|39179291|FG000|Overall Study|Physician Decision|3|||
16191428|NCT03136185|39179292|FG001|Overall Study|Physician Decision|1|||
16191429|NCT03136185|39179293|FG002|Overall Study|Physician Decision|1|||
16191430|NCT03136185|39179294|FG003|Overall Study|Physician Decision|2|||
16191431|NCT03136185|39179295|FG004|Overall Study|Physician Decision|1|||
16191432|NCT03136185|39179296|FG005|Overall Study|Physician Decision|2|||
16191433|NCT03136185|39179297|FG006|Overall Study|Physician Decision|1|||
16191434|NCT03136185|39179298|FG007|Overall Study|Physician Decision|0|||
16191435|NCT03136185|39179299|FG008|Overall Study|Physician Decision|1|||
16191436|NCT03136185|39179291|FG000|Overall Study|Protocol Defined Disease Progression|0|||
16191437|NCT03136185|39179292|FG001|Overall Study|Protocol Defined Disease Progression|0|||
16191438|NCT03136185|39179293|FG002|Overall Study|Protocol Defined Disease Progression|1|||
16191439|NCT03136185|39179294|FG003|Overall Study|Protocol Defined Disease Progression|0|||
16191440|NCT03136185|39179295|FG004|Overall Study|Protocol Defined Disease Progression|0|||
16191441|NCT03136185|39179296|FG005|Overall Study|Protocol Defined Disease Progression|1|||
16191442|NCT03136185|39179297|FG006|Overall Study|Protocol Defined Disease Progression|0|||
16191443|NCT03136185|39179298|FG007|Overall Study|Protocol Defined Disease Progression|1|||
16191444|NCT03136185|39179299|FG008|Overall Study|Protocol Defined Disease Progression|1|||
16191445|NCT03136185|39179291|FG000|Overall Study|Withdrawal by Subject|1|||
16191446|NCT03136185|39179292|FG001|Overall Study|Withdrawal by Subject|0|||
16191447|NCT03136185|39179293|FG002|Overall Study|Withdrawal by Subject|1|||
16191448|NCT03136185|39179294|FG003|Overall Study|Withdrawal by Subject|1|||
16191449|NCT03136185|39179295|FG004|Overall Study|Withdrawal by Subject|1|||
16191450|NCT03136185|39179296|FG005|Overall Study|Withdrawal by Subject|1|||
16191451|NCT03136185|39179297|FG006|Overall Study|Withdrawal by Subject|2|||
16191452|NCT03136185|39179298|FG007|Overall Study|Withdrawal by Subject|3|||
16191453|NCT03136185|39179299|FG008|Overall Study|Withdrawal by Subject|3|||
16191454|NCT03136185|39179291|FG000|Overall Study|Not Reported|4|||
16191455|NCT03136185|39179292|FG001|Overall Study|Not Reported|1|||
16191456|NCT03136185|39179293|FG002|Overall Study|Not Reported|0|||
16191457|NCT03136185|39179294|FG003|Overall Study|Not Reported|1|||
16191458|NCT03136185|39179295|FG004|Overall Study|Not Reported|0|||
16191459|NCT03136185|39179296|FG005|Overall Study|Not Reported|2|||
16191460|NCT03136185|39179297|FG006|Overall Study|Not Reported|1|||
16191461|NCT03136185|39179298|FG007|Overall Study|Not Reported|1|||
16191462|NCT03136185|39179299|FG008|Overall Study|Not Reported|0|||
16191463|NCT02006667|39179300|FG000|Overall Study|Adverse Event|3|||
16191464|NCT02006667|39179300|FG000|Overall Study|Death|2|||
16191465|NCT02006667|39179300|FG000|Overall Study|Withdrawal by Subject|1|||
16191466|NCT04360187|39179303|FG000|Double-Blind Treatment|Adverse Event|9|||
16191467|NCT04360187|39179304|FG001|Double-Blind Treatment|Adverse Event|11|||
16191468|NCT04360187|39179303|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
16191469|NCT04360187|39179304|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
16191470|NCT04360187|39179303|FG000|Double-Blind Treatment|Physician Decision|1|||
16191471|NCT04360187|39179304|FG001|Double-Blind Treatment|Physician Decision|0|||
16489867|NCT02207244|40267103|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
16191472|NCT04360187|39179303|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
16191473|NCT04360187|39179304|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
16191474|NCT04360187|39179303|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
16191475|NCT04360187|39179304|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
16191476|NCT04360187|39179303|FG000|Follow-Up|Lost to Follow-up|1|||
16191477|NCT04360187|39179304|FG001|Follow-Up|Lost to Follow-up|0|||
16191478|NCT01361009|39179305|FG000|Overall Study|Protocol Violation|116|||
16191479|NCT01276457|39179306|FG000|Core Study|Adverse Event|6|||
16191480|NCT01276457|39179307|FG001|Core Study|Adverse Event|3|||
16191481|NCT01276457|39179306|FG000|Core Study|Lost to Follow-up|1|||
16191482|NCT01276457|39179307|FG001|Core Study|Lost to Follow-up|2|||
16191483|NCT01276457|39179306|FG000|Core Study|Administrative problems|1|||
16191484|NCT01276457|39179307|FG001|Core Study|Administrative problems|1|||
16191485|NCT01276457|39179306|FG000|Core Study|Death|2|||
16191486|NCT01276457|39179307|FG001|Core Study|Death|2|||
16191487|NCT01276457|39179306|FG000|Core Study|Lack of Efficacy|3|||
16191488|NCT01276457|39179307|FG001|Core Study|Lack of Efficacy|12|||
16191489|NCT01276457|39179306|FG000|Extension Study|Lost to Follow-up|3|||
16191490|NCT01276457|39179307|FG001|Extension Study|Lost to Follow-up|0|||
16191491|NCT01276457|39179306|FG000|Extension Study|Death|0|||
16191492|NCT01276457|39179307|FG001|Extension Study|Death|1|||
16191493|NCT01276457|39179306|FG000|Extension Study|Lack of Efficacy|3|||
16191494|NCT01276457|39179307|FG001|Extension Study|Lack of Efficacy|1|||
16191495|NCT01087528|39179308|FG000|Overall Study|Withdrawal by Subject|1|||
16191496|NCT01087528|39179308|FG000|Overall Study|Incomplete CE procedure|6|||
16191497|NCT02149836|39179310|FG000|Overall Study|Withdrawal by Subject|1|||
16191498|NCT00986258|39179311|FG000|Observation Period|Not eligible to be dosed|11|||
16191499|NCT00986258|39179311|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
16191500|NCT00986258|39179311|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
16191501|NCT00986258|39179311|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
16191502|NCT00986258|39179311|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
16191503|NCT00986258|39179311|FG000|Titration and Optimal Dose Period|Other|1|||
16191504|NCT00986258|39179311|FG000|Maintenance Period|Adverse Event|5|||
16191505|NCT00986258|39179311|FG000|Maintenance Period|Lack of Efficacy|2|||
16191506|NCT00986258|39179311|FG000|Maintenance Period|Withdrawal by Subject|2|||
16191507|NCT00403559|39179312|FG000|Overall Study|Adverse Event|0|||
16191508|NCT00403559|39179313|FG001|Overall Study|Adverse Event|1|||
16191509|NCT00403559|39179312|FG000|Overall Study|Lost to Follow-up|3|||
16191510|NCT00403559|39179313|FG001|Overall Study|Lost to Follow-up|3|||
16191511|NCT00403559|39179312|FG000|Overall Study|Withdrawal by Subject|1|||
16191512|NCT00403559|39179313|FG001|Overall Study|Withdrawal by Subject|0|||
16191513|NCT02460822|39179314|FG000|Overall Study|Withdrawal by Subject|1|||
16191514|NCT02202031|39179315|FG000|Overall Study|Lost to Follow-up|1|||
16191515|NCT02202031|39179316|FG001|Overall Study|Lost to Follow-up|0|||
16191516|NCT02202031|39179315|FG000|Overall Study|Too Busy|1|||
16191517|NCT02202031|39179316|FG001|Overall Study|Too Busy|3|||
16191518|NCT02202031|39179315|FG000|Overall Study|Illness/Medical Reason|0|||
16191519|NCT02202031|39179316|FG001|Overall Study|Illness/Medical Reason|2|||
16191520|NCT02202031|39179315|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
16191521|NCT02202031|39179316|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
16191522|NCT01763905|39179317|FG000|Overall Study|Withdrawal by Subject|1|||
16191523|NCT01763905|39179318|FG001|Overall Study|Withdrawal by Subject|1|||
16191524|NCT01763905|39179319|FG002|Overall Study|Withdrawal by Subject|0|||
16299136|NCT00229723|39577988|FG000|Concomitant Phase|Lost to Follow-up|0|||
16299137|NCT00229723|39577989|FG001|Concomitant Phase|Lost to Follow-up|0|||
16299138|NCT00229723|39577990|FG002|Concomitant Phase|Lost to Follow-up|0|||
16299139|NCT00229723|39577991|FG003|Concomitant Phase|Lost to Follow-up|0|||
16299140|NCT00229723|39577992|FG004|Concomitant Phase|Lost to Follow-up|1|||
16299141|NCT00229723|39577993|FG005|Concomitant Phase|Lost to Follow-up|0|||
16299142|NCT00229723|39577994|FG006|Concomitant Phase|Lost to Follow-up|0|||
16299143|NCT00229723|39577988|FG000|Concomitant Phase|Informed consent withdrawn|3|||
16299144|NCT00229723|39577989|FG001|Concomitant Phase|Informed consent withdrawn|2|||
16299145|NCT00229723|39577990|FG002|Concomitant Phase|Informed consent withdrawn|0|||
16299146|NCT00229723|39577991|FG003|Concomitant Phase|Informed consent withdrawn|2|||
16299147|NCT00229723|39577992|FG004|Concomitant Phase|Informed consent withdrawn|0|||
16299148|NCT00229723|39577993|FG005|Concomitant Phase|Informed consent withdrawn|0|||
16299149|NCT00229723|39577994|FG006|Concomitant Phase|Informed consent withdrawn|0|||
16299150|NCT00229723|39577988|FG000|Concomitant Phase|Severe non-compliance|0|||
16299151|NCT00229723|39577989|FG001|Concomitant Phase|Severe non-compliance|1|||
16299152|NCT00229723|39577990|FG002|Concomitant Phase|Severe non-compliance|0|||
16299153|NCT00229723|39577991|FG003|Concomitant Phase|Severe non-compliance|0|||
16299154|NCT00229723|39577992|FG004|Concomitant Phase|Severe non-compliance|1|||
16299155|NCT00229723|39577993|FG005|Concomitant Phase|Severe non-compliance|0|||
16299156|NCT00229723|39577994|FG006|Concomitant Phase|Severe non-compliance|0|||
16299157|NCT00229723|39577988|FG000|Concomitant Phase|Other|3|||
16299158|NCT00229723|39577989|FG001|Concomitant Phase|Other|0|||
16299159|NCT00229723|39577990|FG002|Concomitant Phase|Other|1|||
16299160|NCT00229723|39577991|FG003|Concomitant Phase|Other|1|||
16299161|NCT00229723|39577992|FG004|Concomitant Phase|Other|0|||
16299162|NCT00229723|39577993|FG005|Concomitant Phase|Other|2|||
16299163|NCT00229723|39577994|FG006|Concomitant Phase|Other|0|||
16299164|NCT00229723|39577988|FG000|Maintenance Phase|Adverse Event|7|||
16299165|NCT00229723|39577989|FG001|Maintenance Phase|Adverse Event|2|||
16299166|NCT00229723|39577990|FG002|Maintenance Phase|Adverse Event|1|||
16299167|NCT00229723|39577991|FG003|Maintenance Phase|Adverse Event|4|||
16299168|NCT00229723|39577992|FG004|Maintenance Phase|Adverse Event|7|||
16299169|NCT00229723|39577993|FG005|Maintenance Phase|Adverse Event|5|||
16191525|NCT01763905|39179320|FG003|Overall Study|Withdrawal by Subject|1|||
16191526|NCT01763905|39179317|FG000|Overall Study|Decision by sponsor|5|||
16191527|NCT01763905|39179318|FG001|Overall Study|Decision by sponsor|0|||
16191528|NCT01763905|39179319|FG002|Overall Study|Decision by sponsor|8|||
16191529|NCT01763905|39179320|FG003|Overall Study|Decision by sponsor|0|||
16191530|NCT01763905|39179317|FG000|Overall Study|Lost to Follow-up|0|||
16191531|NCT01763905|39179318|FG001|Overall Study|Lost to Follow-up|0|||
16385374|NCT01905540|39896109|FG003|Period 3|Other|1|||
16385375|NCT00328172|39896114|FG000|Overall Study|Adverse Event|3|||
16385376|NCT00328172|39896115|FG001|Overall Study|Adverse Event|2|||
16385377|NCT00328172|39896116|FG002|Overall Study|Adverse Event|1|||
16385378|NCT00328172|39896117|FG003|Overall Study|Adverse Event|2|||
16385379|NCT00328172|39896118|FG004|Overall Study|Adverse Event|1|||
16385380|NCT00328172|39896114|FG000|Overall Study|Protocol Violation|0|||
16385381|NCT00328172|39896115|FG001|Overall Study|Protocol Violation|1|||
16385382|NCT00328172|39896116|FG002|Overall Study|Protocol Violation|1|||
16385383|NCT00328172|39896117|FG003|Overall Study|Protocol Violation|0|||
16385384|NCT00328172|39896118|FG004|Overall Study|Protocol Violation|0|||
16385385|NCT00328172|39896114|FG000|Overall Study|Lost to Follow-up|1|||
16385386|NCT00328172|39896115|FG001|Overall Study|Lost to Follow-up|1|||
16385387|NCT00328172|39896116|FG002|Overall Study|Lost to Follow-up|2|||
16385388|NCT00328172|39896117|FG003|Overall Study|Lost to Follow-up|1|||
16385389|NCT00328172|39896118|FG004|Overall Study|Lost to Follow-up|1|||
16385390|NCT00328172|39896114|FG000|Overall Study|Withdrawal by Subject|1|||
16385391|NCT00328172|39896115|FG001|Overall Study|Withdrawal by Subject|1|||
16385392|NCT00328172|39896116|FG002|Overall Study|Withdrawal by Subject|1|||
16385393|NCT00328172|39896117|FG003|Overall Study|Withdrawal by Subject|6|||
16385394|NCT00328172|39896118|FG004|Overall Study|Withdrawal by Subject|0|||
16385395|NCT00328172|39896114|FG000|Overall Study|Lack of Efficacy|14|||
16299170|NCT00229723|39577994|FG006|Maintenance Phase|Adverse Event|2|||
16299171|NCT00229723|39577988|FG000|Maintenance Phase|Objective disease progression|5|||
16299172|NCT00229723|39577989|FG001|Maintenance Phase|Objective disease progression|5|||
16299173|NCT00229723|39577990|FG002|Maintenance Phase|Objective disease progression|3|||
16299174|NCT00229723|39577991|FG003|Maintenance Phase|Objective disease progression|6|||
16299175|NCT00229723|39577992|FG004|Maintenance Phase|Objective disease progression|2|||
16299176|NCT00229723|39577993|FG005|Maintenance Phase|Objective disease progression|9|||
16299177|NCT00229723|39577994|FG006|Maintenance Phase|Objective disease progression|5|||
16299178|NCT00229723|39577988|FG000|Maintenance Phase|Clinical progression|4|||
16299179|NCT00229723|39577989|FG001|Maintenance Phase|Clinical progression|1|||
16299180|NCT00229723|39577990|FG002|Maintenance Phase|Clinical progression|2|||
16299181|NCT00229723|39577991|FG003|Maintenance Phase|Clinical progression|2|||
16299182|NCT00229723|39577992|FG004|Maintenance Phase|Clinical progression|1|||
16299183|NCT00229723|39577993|FG005|Maintenance Phase|Clinical progression|1|||
16299184|NCT00229723|39577994|FG006|Maintenance Phase|Clinical progression|1|||
16299185|NCT00229723|39577988|FG000|Maintenance Phase|Lost to Follow-up|0|||
16299186|NCT00229723|39577989|FG001|Maintenance Phase|Lost to Follow-up|1|||
16299187|NCT00229723|39577990|FG002|Maintenance Phase|Lost to Follow-up|2|||
16299188|NCT00229723|39577991|FG003|Maintenance Phase|Lost to Follow-up|2|||
16299189|NCT00229723|39577992|FG004|Maintenance Phase|Lost to Follow-up|0|||
16299190|NCT00229723|39577993|FG005|Maintenance Phase|Lost to Follow-up|0|||
16299191|NCT00229723|39577994|FG006|Maintenance Phase|Lost to Follow-up|1|||
16385396|NCT00328172|39896115|FG001|Overall Study|Lack of Efficacy|9|||
16385397|NCT00328172|39896116|FG002|Overall Study|Lack of Efficacy|4|||
16385398|NCT00328172|39896117|FG003|Overall Study|Lack of Efficacy|4|||
16385399|NCT00328172|39896118|FG004|Overall Study|Lack of Efficacy|3|||
16385400|NCT00328172|39896114|FG000|Overall Study|Other reason (not specified)|3|||
16385401|NCT00328172|39896115|FG001|Overall Study|Other reason (not specified)|0|||
16385402|NCT00328172|39896116|FG002|Overall Study|Other reason (not specified)|1|||
16385403|NCT00328172|39896117|FG003|Overall Study|Other reason (not specified)|0|||
16385404|NCT00328172|39896118|FG004|Overall Study|Other reason (not specified)|0|||
16385405|NCT05489328|39896119|FG000|Overall Study|Lost to Follow-up|0|||
16385406|NCT05489328|39896120|FG001|Overall Study|Lost to Follow-up|0|||
16299192|NCT00229723|39577988|FG000|Maintenance Phase|Informed consent withdrawn|1|||
16299193|NCT00229723|39577989|FG001|Maintenance Phase|Informed consent withdrawn|0|||
16299194|NCT00229723|39577990|FG002|Maintenance Phase|Informed consent withdrawn|0|||
16385407|NCT05489328|39896121|FG002|Overall Study|Lost to Follow-up|1|||
16385408|NCT05489328|39896122|FG003|Overall Study|Lost to Follow-up|0|||
16385409|NCT05489328|39896123|FG004|Overall Study|Lost to Follow-up|2|||
16385410|NCT05489328|39896124|FG005|Overall Study|Lost to Follow-up|0|||
16385411|NCT05489328|39896125|FG006|Overall Study|Lost to Follow-up|0|||
16385412|NCT05489328|39896126|FG007|Overall Study|Lost to Follow-up|1|||
16385413|NCT05489328|39896127|FG008|Overall Study|Lost to Follow-up|0|||
16385414|NCT05489328|39896119|FG000|Overall Study|Withdrawal by Subject|0|||
16385415|NCT05489328|39896120|FG001|Overall Study|Withdrawal by Subject|0|||
16385416|NCT05489328|39896121|FG002|Overall Study|Withdrawal by Subject|0|||
16385417|NCT05489328|39896122|FG003|Overall Study|Withdrawal by Subject|0|||
16385418|NCT05489328|39896123|FG004|Overall Study|Withdrawal by Subject|0|||
16385419|NCT05489328|39896124|FG005|Overall Study|Withdrawal by Subject|0|||
16385420|NCT05489328|39896125|FG006|Overall Study|Withdrawal by Subject|1|||
16385421|NCT05489328|39896126|FG007|Overall Study|Withdrawal by Subject|1|||
16385422|NCT05489328|39896127|FG008|Overall Study|Withdrawal by Subject|0|||
16385423|NCT05489328|39896119|FG000|Overall Study|Other|0|||
16385424|NCT05489328|39896120|FG001|Overall Study|Other|0|||
16385425|NCT05489328|39896121|FG002|Overall Study|Other|0|||
16385426|NCT05489328|39896122|FG003|Overall Study|Other|0|||
16385427|NCT05489328|39896123|FG004|Overall Study|Other|0|||
16385428|NCT05489328|39896124|FG005|Overall Study|Other|0|||
16385429|NCT05489328|39896125|FG006|Overall Study|Other|0|||
16385430|NCT05489328|39896126|FG007|Overall Study|Other|1|||
16385431|NCT05489328|39896127|FG008|Overall Study|Other|1|||
16385432|NCT01152788|39896133|FG000|Overall Study|Withdrawal by Subject|0|||
16385433|NCT01152788|39896134|FG001|Overall Study|Withdrawal by Subject|3|||
16385434|NCT01152788|39896133|FG000|Overall Study|No treatment|0|||
16385435|NCT01152788|39896134|FG001|Overall Study|No treatment|1|||
16385436|NCT03383666|39896138|FG000|Overall Study|Withdrawal by Subject|2|||
16385437|NCT03383666|39896138|FG000|Overall Study|Lost to Follow-up|2|||
16385438|NCT00533429|39896139|FG000|Overall Study|Adverse Event|3|||
16385439|NCT00533429|39896140|FG001|Overall Study|Adverse Event|1|||
16385440|NCT00533429|39896139|FG000|Overall Study|Death|1|||
16385441|NCT00533429|39896140|FG001|Overall Study|Death|0|||
16385442|NCT00533429|39896139|FG000|Overall Study|Withdrawal by Subject|2|||
16385443|NCT00533429|39896140|FG001|Overall Study|Withdrawal by Subject|0|||
16385444|NCT00533429|39896139|FG000|Overall Study|Progressive Disease|12|||
16385445|NCT00533429|39896140|FG001|Overall Study|Progressive Disease|13|||
16385446|NCT00533429|39896139|FG000|Overall Study|Symptomatic deterioration|1|||
16385447|NCT00533429|39896140|FG001|Overall Study|Symptomatic deterioration|2|||
16385448|NCT04108273|39896141|FG000|Overall Study|COVID Pandemic|1|||
16385449|NCT04108273|39896142|FG001|Overall Study|COVID Pandemic|0|||
16385450|NCT03508050|39896143|FG000|Overall Study|Pleural adhesions|1|||
16385451|NCT03508050|39896144|FG001|Overall Study|Pleural adhesions|0|||
16385452|NCT03508050|39896143|FG000|Overall Study|Mucus plug|1|||
16385453|NCT03508050|39896144|FG001|Overall Study|Mucus plug|0|||
16385454|NCT03508050|39896143|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
16385455|NCT03508050|39896144|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
16191532|NCT01763905|39179319|FG002|Overall Study|Lost to Follow-up|1|||
16299195|NCT00229723|39577991|FG003|Maintenance Phase|Informed consent withdrawn|1|||
16299196|NCT00229723|39577992|FG004|Maintenance Phase|Informed consent withdrawn|1|||
16299197|NCT00229723|39577993|FG005|Maintenance Phase|Informed consent withdrawn|1|||
16299198|NCT00229723|39577994|FG006|Maintenance Phase|Informed consent withdrawn|0|||
16299199|NCT00229723|39577988|FG000|Maintenance Phase|Severe non-compliance|3|||
16299200|NCT00229723|39577989|FG001|Maintenance Phase|Severe non-compliance|1|||
16299201|NCT00229723|39577990|FG002|Maintenance Phase|Severe non-compliance|0|||
16299202|NCT00229723|39577991|FG003|Maintenance Phase|Severe non-compliance|0|||
16299203|NCT00229723|39577992|FG004|Maintenance Phase|Severe non-compliance|1|||
16299204|NCT00229723|39577993|FG005|Maintenance Phase|Severe non-compliance|0|||
16299205|NCT00229723|39577994|FG006|Maintenance Phase|Severe non-compliance|0|||
16299206|NCT00229723|39577988|FG000|Maintenance Phase|Other|5|||
16299207|NCT00229723|39577989|FG001|Maintenance Phase|Other|4|||
16299208|NCT00229723|39577990|FG002|Maintenance Phase|Other|1|||
16299209|NCT00229723|39577991|FG003|Maintenance Phase|Other|2|||
16299210|NCT00229723|39577992|FG004|Maintenance Phase|Other|3|||
16299211|NCT00229723|39577993|FG005|Maintenance Phase|Other|3|||
16299212|NCT00229723|39577994|FG006|Maintenance Phase|Other|1|||
16299213|NCT00447993|39577997|FG000|Overall Study|Lost to Follow-up|0|||
16299214|NCT00447993|39577998|FG001|Overall Study|Lost to Follow-up|0|||
16299215|NCT00447993|39577999|FG002|Overall Study|Lost to Follow-up|2|||
16299216|NCT00447993|39578000|FG003|Overall Study|Lost to Follow-up|2|||
16299217|NCT00447993|39577997|FG000|Overall Study|Withdrawal by Subject|0|||
16299218|NCT00447993|39577998|FG001|Overall Study|Withdrawal by Subject|0|||
16299219|NCT00447993|39577999|FG002|Overall Study|Withdrawal by Subject|2|||
16385456|NCT03508050|39896143|FG000|Overall Study|Sustained desaturation|0|||
16385457|NCT03508050|39896144|FG001|Overall Study|Sustained desaturation|1|||
16385458|NCT01492088|39896159|FG000|Overall Study|Withdrawal by Patient|0|||
16385459|NCT01492088|39896160|FG001|Overall Study|Withdrawal by Patient|2|||
16191533|NCT01763905|39179320|FG003|Overall Study|Lost to Follow-up|0|||
16299220|NCT00447993|39578000|FG003|Overall Study|Withdrawal by Subject|2|||
16385460|NCT01492088|39896161|FG002|Overall Study|Withdrawal by Patient|0|||
16489868|NCT02207244|40267104|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
16191534|NCT00316303|39179321|FG000|Overall Study|Lost to Follow-up|11|||
16385461|NCT01492088|39896159|FG000|Overall Study|Death|1|||
16385462|NCT01492088|39896160|FG001|Overall Study|Death|6|||
16385463|NCT01492088|39896161|FG002|Overall Study|Death|2|||
16299221|NCT05005312|39581838|FG000|Overall Study|Enrolled, but not treated|0|||
16299222|NCT05005312|39581839|FG001|Overall Study|Enrolled, but not treated|1|||
16299223|NCT02906358|39581840|FG000|Overall Study|Withdrawal by Subject|10|||
16299224|NCT02906358|39581841|FG001|Overall Study|Withdrawal by Subject|7|||
16299225|NCT02906358|39581840|FG000|Overall Study|Lost to Follow-up|12|||
16299226|NCT02906358|39581841|FG001|Overall Study|Lost to Follow-up|15|||
16299227|NCT03589326|39581842|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
16299228|NCT03589326|39581843|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
16299229|NCT03589326|39581842|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
16299230|NCT03589326|39581843|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
16299231|NCT03589326|39581842|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
16299232|NCT03589326|39581843|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
16299233|NCT03589326|39581842|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
16299234|NCT03589326|39581843|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
16299235|NCT03589326|39581842|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
16299236|NCT03589326|39581843|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
16299237|NCT00528411|39581845|FG000|Overall Study|Adverse Event|4|||
16299238|NCT00528411|39581846|FG001|Overall Study|Adverse Event|0|||
16299239|NCT00528411|39581847|FG002|Overall Study|Adverse Event|1|||
16299240|NCT00528411|39581845|FG000|Overall Study|Incorrect Enrolment|1|||
16299241|NCT00528411|39581846|FG001|Overall Study|Incorrect Enrolment|1|||
16299242|NCT00528411|39581847|FG002|Overall Study|Incorrect Enrolment|0|||
16299243|NCT00528411|39581845|FG000|Overall Study|Severe non-compliance to protocol|0|||
16299244|NCT00528411|39581846|FG001|Overall Study|Severe non-compliance to protocol|1|||
16299245|NCT00528411|39581847|FG002|Overall Study|Severe non-compliance to protocol|0|||
16299246|NCT00528411|39581845|FG000|Overall Study|Prior commitment medication|0|||
16299247|NCT00528411|39581846|FG001|Overall Study|Prior commitment medication|1|||
16299248|NCT00528411|39581847|FG002|Overall Study|Prior commitment medication|0|||
16299249|NCT02013674|39581848|FG000|Overall Study|Death|0|||
16299250|NCT02013674|39581849|FG001|Overall Study|Death|1|||
16299251|NCT02013674|39581848|FG000|Overall Study|Lost to Follow-up|1|||
16385464|NCT01492088|39896159|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
16299252|NCT02013674|39581849|FG001|Overall Study|Lost to Follow-up|0|||
16299253|NCT03138655|39581850|FG000|Overall Study|Adverse Event|2|||
16299254|NCT03138655|39581851|FG001|Overall Study|Adverse Event|1|||
16299255|NCT03138655|39581852|FG002|Overall Study|Adverse Event|2|||
16299256|NCT03138655|39581853|FG003|Overall Study|Adverse Event|1|||
16385465|NCT01492088|39896160|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
16385466|NCT01492088|39896161|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
16385467|NCT01492088|39896159|FG000|Overall Study|Alive at Last Follow-up|0|||
16385468|NCT01492088|39896160|FG001|Overall Study|Alive at Last Follow-up|6|||
16385469|NCT01492088|39896161|FG002|Overall Study|Alive at Last Follow-up|11|||
16385470|NCT02239926|39896162|FG000|Overall Study|Withdrawal by Subject|0|||
16385471|NCT02239926|39896163|FG001|Overall Study|Withdrawal by Subject|1|||
16385472|NCT00854360|39896165|FG000|Overall Study|Adverse Event|0|||
16385473|NCT00854360|39896166|FG001|Overall Study|Adverse Event|1|||
16385474|NCT00854360|39896167|FG002|Overall Study|Adverse Event|2|||
16385475|NCT00854360|39896168|FG003|Overall Study|Adverse Event|6|||
16385476|NCT00854360|39896165|FG000|Overall Study|Withdrawal by Subject|0|||
16385477|NCT00854360|39896166|FG001|Overall Study|Withdrawal by Subject|0|||
16385478|NCT00854360|39896167|FG002|Overall Study|Withdrawal by Subject|0|||
16489869|NCT02207244|40267105|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16489870|NCT02207244|40267106|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16489871|NCT02207244|40267107|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16489872|NCT02207244|40267108|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16489873|NCT02207244|40267109|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16489874|NCT02207244|40267110|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16489875|NCT02207244|40267111|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16489876|NCT02207244|40267112|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
16489877|NCT02207244|40267102|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
16489878|NCT02207244|40267103|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16489879|NCT02207244|40267104|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
16489880|NCT02207244|40267105|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16489881|NCT02207244|40267106|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16489882|NCT02207244|40267107|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16489883|NCT02207244|40267108|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16489884|NCT02207244|40267109|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16489885|NCT02207244|40267110|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16489886|NCT02207244|40267111|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16299257|NCT03138655|39581854|FG004|Overall Study|Adverse Event|1|||
16385479|NCT00854360|39896168|FG003|Overall Study|Withdrawal by Subject|1|||
16385480|NCT00854360|39896165|FG000|Overall Study|Pregnancy|0|||
16385481|NCT00854360|39896166|FG001|Overall Study|Pregnancy|1|||
16385482|NCT00854360|39896167|FG002|Overall Study|Pregnancy|0|||
16385483|NCT00854360|39896168|FG003|Overall Study|Pregnancy|0|||
16385484|NCT00854360|39896165|FG000|Overall Study|Lack of Efficacy|2|||
16385485|NCT00854360|39896166|FG001|Overall Study|Lack of Efficacy|1|||
16385486|NCT00854360|39896167|FG002|Overall Study|Lack of Efficacy|0|||
16385487|NCT00854360|39896168|FG003|Overall Study|Lack of Efficacy|0|||
16385488|NCT00854360|39896165|FG000|Overall Study|Other|0|||
16385489|NCT00854360|39896166|FG001|Overall Study|Other|0|||
16385490|NCT00854360|39896167|FG002|Overall Study|Other|0|||
16385491|NCT00854360|39896168|FG003|Overall Study|Other|3|||
16385492|NCT04290624|39896169|FG000|Overall Study|Adverse Event|1|||
16385493|NCT04290624|39896170|FG001|Overall Study|Adverse Event|0|||
16385494|NCT01757665|39896171|FG000|Overall Study|Still on Study - Visit Completed|240|||
16385495|NCT01757665|39896172|FG001|Overall Study|Still on Study - Visit Completed|30|||
16385496|NCT01757665|39896171|FG000|Overall Study|Still on Study - Visit Pending|398|||
16385497|NCT01757665|39896172|FG001|Overall Study|Still on Study - Visit Pending|40|||
16385498|NCT01757665|39896171|FG000|Overall Study|Still on Study - Missed Visit|14|||
16385499|NCT01757665|39896172|FG001|Overall Study|Still on Study - Missed Visit|1|||
16385500|NCT01757665|39896171|FG000|Overall Study|Death|25|||
16385501|NCT01757665|39896172|FG001|Overall Study|Death|8|||
16385502|NCT01757665|39896171|FG000|Overall Study|Explant|1|||
16385503|NCT01757665|39896172|FG001|Overall Study|Explant|2|||
16385504|NCT01757665|39896171|FG000|Overall Study|Withdrawal by Subject|10|||
16385505|NCT01757665|39896172|FG001|Overall Study|Withdrawal by Subject|0|||
16385506|NCT01757665|39896171|FG000|Overall Study|Lost to Follow-up|1|||
16385507|NCT01757665|39896172|FG001|Overall Study|Lost to Follow-up|1|||
16385508|NCT01757665|39896171|FG000|Overall Study|Not Implanted with Device|5|||
16385509|NCT01757665|39896172|FG001|Overall Study|Not Implanted with Device|1|||
16385510|NCT02412670|39896175|FG000|Overall Study|Adverse Event|4|||
16385511|NCT02412670|39896176|FG001|Overall Study|Adverse Event|1|||
16385512|NCT02412670|39896175|FG000|Overall Study|Physician Decision|1|||
16385513|NCT02412670|39896176|FG001|Overall Study|Physician Decision|0|||
16385514|NCT02412670|39896175|FG000|Overall Study|Withdrawal by Subject|1|||
16385515|NCT02412670|39896176|FG001|Overall Study|Withdrawal by Subject|0|||
16385516|NCT02412670|39896175|FG000|Overall Study|Ineligible|1|||
16385517|NCT02412670|39896176|FG001|Overall Study|Ineligible|0|||
16385518|NCT01378195|39896177|FG000|Overall Study|Lost to Follow-up|29|||
16385519|NCT01378195|39896178|FG001|Overall Study|Lost to Follow-up|18|||
16385520|NCT00546481|39896179|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
16385521|NCT00546481|39896180|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
16385522|NCT00546481|39896181|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
16385523|NCT00546481|39896179|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
16385524|NCT00546481|39896180|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
16385525|NCT00546481|39896181|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
16385526|NCT00546481|39896179|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
16385527|NCT00546481|39896180|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
16385528|NCT00546481|39896181|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
16385529|NCT00546481|39896179|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
16385530|NCT00546481|39896180|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
16385531|NCT00546481|39896181|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
16385532|NCT00546481|39896179|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
16385533|NCT00546481|39896180|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
16385534|NCT00546481|39896181|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
16385535|NCT00546481|39896179|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
16385536|NCT00546481|39896180|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
16385537|NCT00546481|39896181|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
16385538|NCT00546481|39896179|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
16385539|NCT00546481|39896180|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
16385540|NCT00546481|39896181|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
16385541|NCT00546481|39896179|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
16385542|NCT00546481|39896180|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
16385543|NCT00546481|39896181|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
16385544|NCT00546481|39896179|FG000|Maintenance Phase (CERA)|Other Reason|0|||
16385545|NCT00546481|39896180|FG001|Maintenance Phase (CERA)|Other Reason|0|||
16385546|NCT00546481|39896181|FG002|Maintenance Phase (CERA)|Other Reason|1|||
16385547|NCT02197572|39896182|FG000|Overall Study|Progressive Disease|28|||
16385548|NCT02197572|39896182|FG000|Overall Study|Withdrawal by Subject|9|||
16385549|NCT02197572|39896182|FG000|Overall Study|Adverse Event|3|||
16385550|NCT02197572|39896182|FG000|Overall Study|Reason Not Specified|4|||
16385551|NCT02553629|39896183|FG000|Overall Study|Logistic reasons|3|||
16385552|NCT02553629|39896184|FG001|Overall Study|Logistic reasons|6|||
16385553|NCT04622592|39896185|FG000|Overall Study|Death|0|||
16385554|NCT04622592|39896186|FG001|Overall Study|Death|0|||
16385555|NCT04622592|39896187|FG002|Overall Study|Death|1|||
16385556|NCT04622592|39896188|FG003|Overall Study|Death|0|||
16385557|NCT04622592|39896189|FG004|Overall Study|Death|0|||
16385558|NCT04622592|39896190|FG005|Overall Study|Death|0|||
16385559|NCT04622592|39896191|FG006|Overall Study|Death|0|||
16385560|NCT04622592|39896192|FG007|Overall Study|Death|1|||
16385561|NCT04622592|39896185|FG000|Overall Study|Lost to Follow-up|0|||
16385562|NCT04622592|39896186|FG001|Overall Study|Lost to Follow-up|0|||
16385563|NCT04622592|39896187|FG002|Overall Study|Lost to Follow-up|0|||
16385564|NCT04622592|39896188|FG003|Overall Study|Lost to Follow-up|3|||
16385565|NCT04622592|39896189|FG004|Overall Study|Lost to Follow-up|1|||
16385566|NCT04622592|39896190|FG005|Overall Study|Lost to Follow-up|0|||
16385567|NCT04622592|39896191|FG006|Overall Study|Lost to Follow-up|2|||
16385568|NCT04622592|39896192|FG007|Overall Study|Lost to Follow-up|2|||
16385569|NCT04622592|39896185|FG000|Overall Study|Physician Decision|0|||
16385570|NCT04622592|39896186|FG001|Overall Study|Physician Decision|0|||
16385571|NCT04622592|39896187|FG002|Overall Study|Physician Decision|0|||
16385572|NCT04622592|39896188|FG003|Overall Study|Physician Decision|0|||
16385573|NCT04622592|39896189|FG004|Overall Study|Physician Decision|1|||
16385574|NCT04622592|39896190|FG005|Overall Study|Physician Decision|0|||
16385575|NCT04622592|39896191|FG006|Overall Study|Physician Decision|0|||
16385576|NCT04622592|39896192|FG007|Overall Study|Physician Decision|0|||
16385577|NCT04622592|39896185|FG000|Overall Study|Withdrawal by Subject|1|||
16385578|NCT04622592|39896186|FG001|Overall Study|Withdrawal by Subject|0|||
16385579|NCT04622592|39896187|FG002|Overall Study|Withdrawal by Subject|2|||
16385580|NCT04622592|39896188|FG003|Overall Study|Withdrawal by Subject|0|||
16385581|NCT04622592|39896189|FG004|Overall Study|Withdrawal by Subject|0|||
16385582|NCT04622592|39896190|FG005|Overall Study|Withdrawal by Subject|0|||
16385583|NCT04622592|39896191|FG006|Overall Study|Withdrawal by Subject|1|||
16385584|NCT04622592|39896192|FG007|Overall Study|Withdrawal by Subject|4|||
16385585|NCT04622592|39896185|FG000|Overall Study|Other than specified above|0|||
16385586|NCT04622592|39896186|FG001|Overall Study|Other than specified above|0|||
16385587|NCT04622592|39896187|FG002|Overall Study|Other than specified above|1|||
16385588|NCT04622592|39896188|FG003|Overall Study|Other than specified above|0|||
16385589|NCT04622592|39896189|FG004|Overall Study|Other than specified above|0|||
16385590|NCT04622592|39896190|FG005|Overall Study|Other than specified above|0|||
16385591|NCT04622592|39896191|FG006|Overall Study|Other than specified above|0|||
16385592|NCT04622592|39896192|FG007|Overall Study|Other than specified above|0|||
16385593|NCT00276419|39896193|FG000|First Intervention|Adverse Event|1|||
16385594|NCT00276419|39896194|FG001|First Intervention|Adverse Event|0|||
16385595|NCT00276419|39896193|FG000|First Intervention|Withdrawal by Subject|0|||
16385596|NCT00276419|39896194|FG001|First Intervention|Withdrawal by Subject|2|||
16385597|NCT01392573|39896197|FG000|Overall Study|Adverse Event|1|||
16385598|NCT01392573|39896198|FG001|Overall Study|Adverse Event|3|||
16385599|NCT01392573|39896197|FG000|Overall Study|Lack of Efficacy|1|||
16385600|NCT01392573|39896198|FG001|Overall Study|Lack of Efficacy|2|||
16385601|NCT01392573|39896197|FG000|Overall Study|Protocol Violation|0|||
16299258|NCT03138655|39581855|FG005|Overall Study|Adverse Event|4|||
16299259|NCT03138655|39581856|FG006|Overall Study|Adverse Event|2|||
16299260|NCT03138655|39581857|FG007|Overall Study|Adverse Event|2|||
16299261|NCT03138655|39581850|FG000|Overall Study|Withdrawal by Subject|0|||
16299262|NCT03138655|39581851|FG001|Overall Study|Withdrawal by Subject|1|||
16299263|NCT03138655|39581852|FG002|Overall Study|Withdrawal by Subject|0|||
16299264|NCT03138655|39581853|FG003|Overall Study|Withdrawal by Subject|0|||
16299265|NCT03138655|39581854|FG004|Overall Study|Withdrawal by Subject|0|||
16299266|NCT03138655|39581855|FG005|Overall Study|Withdrawal by Subject|0|||
16299267|NCT03138655|39581856|FG006|Overall Study|Withdrawal by Subject|1|||
16299268|NCT03138655|39581857|FG007|Overall Study|Withdrawal by Subject|0|||
16299269|NCT03138655|39581850|FG000|Overall Study|Reason not Specified|1|||
16299270|NCT03138655|39581851|FG001|Overall Study|Reason not Specified|0|||
16299271|NCT03138655|39581852|FG002|Overall Study|Reason not Specified|0|||
16299272|NCT03138655|39581853|FG003|Overall Study|Reason not Specified|2|||
16299273|NCT03138655|39581854|FG004|Overall Study|Reason not Specified|1|||
16299274|NCT03138655|39581855|FG005|Overall Study|Reason not Specified|1|||
16299275|NCT03138655|39581856|FG006|Overall Study|Reason not Specified|0|||
16299276|NCT03138655|39581857|FG007|Overall Study|Reason not Specified|0|||
16299277|NCT01059344|39581858|FG000|Overall Study|Adverse Event|12|||
16385602|NCT01392573|39896198|FG001|Overall Study|Protocol Violation|2|||
16385603|NCT01392573|39896197|FG000|Overall Study|Withdrawal Criteria|13|||
16385604|NCT01392573|39896198|FG001|Overall Study|Withdrawal Criteria|15|||
16385605|NCT01392573|39896197|FG000|Overall Study|Site closure|8|||
16385606|NCT01392573|39896198|FG001|Overall Study|Site closure|7|||
16385607|NCT01392573|39896197|FG000|Overall Study|Unclassified|9|||
16385608|NCT01392573|39896198|FG001|Overall Study|Unclassified|6|||
16385609|NCT00501644|39896199|FG000|Overall Study|Adverse Event|4|||
16385610|NCT00501644|39896199|FG000|Overall Study|Withdrawal by Subject|1|||
16385611|NCT03931330|39896210|FG000|Overall Study|Physician Decision|1|||
16385612|NCT00278161|39896213|FG000|Overall Study|Death|11|||
16385613|NCT01881789|39896214|FG000|Overall Study|Withdrawal by Subject|0|||
16385614|NCT01881789|39896215|FG001|Overall Study|Withdrawal by Subject|2|||
16299278|NCT01059344|39581859|FG001|Overall Study|Adverse Event|30|||
16299279|NCT01059344|39581858|FG000|Overall Study|Withdrawal by Subject|6|||
16299280|NCT01059344|39581859|FG001|Overall Study|Withdrawal by Subject|9|||
16299281|NCT01059344|39581858|FG000|Overall Study|Lost to Follow-up|1|||
16299282|NCT01059344|39581859|FG001|Overall Study|Lost to Follow-up|1|||
16299283|NCT01059344|39581858|FG000|Overall Study|Other|3|||
16299284|NCT01059344|39581859|FG001|Overall Study|Other|6|||
16299285|NCT02335983|39581860|FG000|Overall Study|Sponsor Decision|0|||
16299286|NCT02335983|39581861|FG001|Overall Study|Sponsor Decision|0|||
16299287|NCT02335983|39581862|FG002|Overall Study|Sponsor Decision|1|||
16299288|NCT02335983|39581863|FG003|Overall Study|Sponsor Decision|1|||
16299289|NCT02335983|39581864|FG004|Overall Study|Sponsor Decision|0|||
16299290|NCT02335983|39581865|FG005|Overall Study|Sponsor Decision|1|||
16299291|NCT02335983|39581860|FG000|Overall Study|Withdrawal by Subject|3|||
16299292|NCT02335983|39581861|FG001|Overall Study|Withdrawal by Subject|2|||
16299293|NCT02335983|39581862|FG002|Overall Study|Withdrawal by Subject|2|||
16299294|NCT02335983|39581863|FG003|Overall Study|Withdrawal by Subject|1|||
16299295|NCT02335983|39581864|FG004|Overall Study|Withdrawal by Subject|3|||
16299296|NCT02335983|39581865|FG005|Overall Study|Withdrawal by Subject|9|||
16299297|NCT02335983|39581860|FG000|Overall Study|Death|0|||
16299298|NCT02335983|39581861|FG001|Overall Study|Death|0|||
16299299|NCT02335983|39581862|FG002|Overall Study|Death|2|||
16299300|NCT02335983|39581863|FG003|Overall Study|Death|0|||
16299301|NCT02335983|39581864|FG004|Overall Study|Death|0|||
16299302|NCT02335983|39581865|FG005|Overall Study|Death|0|||
16299303|NCT02335983|39581860|FG000|Overall Study|Lost to Follow-up|0|||
16299304|NCT02335983|39581861|FG001|Overall Study|Lost to Follow-up|0|||
16299305|NCT02335983|39581862|FG002|Overall Study|Lost to Follow-up|0|||
16299306|NCT02335983|39581863|FG003|Overall Study|Lost to Follow-up|0|||
16299307|NCT02335983|39581864|FG004|Overall Study|Lost to Follow-up|0|||
16299308|NCT02335983|39581865|FG005|Overall Study|Lost to Follow-up|1|||
16299309|NCT02335983|39581860|FG000|Overall Study|Protocol Specified Criteria|5|||
16299310|NCT02335983|39581861|FG001|Overall Study|Protocol Specified Criteria|7|||
16299311|NCT02335983|39581862|FG002|Overall Study|Protocol Specified Criteria|27|||
16299312|NCT02335983|39581863|FG003|Overall Study|Protocol Specified Criteria|7|||
16299313|NCT02335983|39581864|FG004|Overall Study|Protocol Specified Criteria|5|||
16299314|NCT02335983|39581865|FG005|Overall Study|Protocol Specified Criteria|21|||
16299315|NCT02954991|39581866|FG000|Overall Study|Death|92|||
16299316|NCT02954991|39581867|FG001|Overall Study|Death|11|||
16299317|NCT02954991|39581868|FG002|Overall Study|Death|2|||
16299318|NCT02954991|39581866|FG000|Overall Study|Lost to Follow-up|3|||
16299319|NCT02954991|39581867|FG001|Overall Study|Lost to Follow-up|2|||
16299320|NCT02954991|39581868|FG002|Overall Study|Lost to Follow-up|0|||
16299321|NCT02954991|39581866|FG000|Overall Study|Withdrawal by Subject|9|||
16299322|NCT02954991|39581867|FG001|Overall Study|Withdrawal by Subject|8|||
16299323|NCT02954991|39581868|FG002|Overall Study|Withdrawal by Subject|1|||
16299324|NCT02954991|39581866|FG000|Overall Study|Study Terminated by Sponsor|18|||
16299325|NCT02954991|39581867|FG001|Overall Study|Study Terminated by Sponsor|10|||
16299326|NCT02954991|39581868|FG002|Overall Study|Study Terminated by Sponsor|1|||
16299327|NCT02954991|39581866|FG000|Overall Study|Miscellaneous|2|||
16083714|NCT02128113|38799161|FG001|Overall Study|Withdrawal by Subject|1|||
16191535|NCT00316303|39179322|FG001|Overall Study|Lost to Follow-up|16|||
16299328|NCT02954991|39581867|FG001|Overall Study|Miscellaneous|1|||
16299329|NCT02954991|39581868|FG002|Overall Study|Miscellaneous|1|||
16299330|NCT00380744|39581869|FG000|Overall Study|Death|0|||
16299331|NCT00380744|39581870|FG001|Overall Study|Death|0|||
16299332|NCT00380744|39581871|FG002|Overall Study|Death|0|||
16299333|NCT00380744|39581872|FG003|Overall Study|Death|0|||
16299334|NCT00380744|39581873|FG004|Overall Study|Death|0|||
16299335|NCT00380744|39581874|FG005|Overall Study|Death|0|||
16299336|NCT00380744|39581875|FG006|Overall Study|Death|1|||
16299337|NCT00380744|39581869|FG000|Overall Study|Withdrawal by Subject|1|||
16489887|NCT02207244|40267112|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
16191536|NCT03554005|39179323|FG000|Overall Study|Not in participant's best interest|0|||
16489888|NCT02207244|40267102|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
16489889|NCT02207244|40267103|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
16489890|NCT02207244|40267104|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
16489891|NCT02207244|40267105|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16489892|NCT02207244|40267106|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16489893|NCT02207244|40267107|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16489894|NCT02207244|40267108|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16489895|NCT02207244|40267109|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16489896|NCT02207244|40267110|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16489897|NCT02207244|40267111|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16489898|NCT02207244|40267112|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
16489899|NCT02207244|40267102|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
16489900|NCT02207244|40267103|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
16489901|NCT02207244|40267104|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16489902|NCT02207244|40267105|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16489903|NCT02207244|40267106|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16489904|NCT02207244|40267107|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16489905|NCT02207244|40267108|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16489906|NCT02207244|40267109|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16489907|NCT02207244|40267110|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16489908|NCT02207244|40267111|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16489909|NCT02207244|40267112|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
16489910|NCT02207244|40267102|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
16489911|NCT02207244|40267103|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
16489912|NCT02207244|40267104|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
16489913|NCT02207244|40267105|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16489914|NCT02207244|40267106|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16299338|NCT00380744|39581870|FG001|Overall Study|Withdrawal by Subject|0|||
16299339|NCT00380744|39581871|FG002|Overall Study|Withdrawal by Subject|0|||
16299340|NCT00380744|39581872|FG003|Overall Study|Withdrawal by Subject|0|||
16299341|NCT00380744|39581873|FG004|Overall Study|Withdrawal by Subject|0|||
16299342|NCT00380744|39581874|FG005|Overall Study|Withdrawal by Subject|0|||
16299343|NCT00380744|39581875|FG006|Overall Study|Withdrawal by Subject|0|||
16299344|NCT00577395|39581876|FG000|Overall Study|Study was terminated early by Sponsor|7|||
16299345|NCT00577395|39581877|FG001|Overall Study|Study was terminated early by Sponsor|6|||
16299346|NCT01352416|39581878|FG000|Overall Study|Physician Decision|1|||
16299347|NCT01352416|39581879|FG001|Overall Study|Physician Decision|2|||
16299348|NCT01352416|39581880|FG002|Overall Study|Physician Decision|2|||
16299349|NCT01352416|39581881|FG003|Overall Study|Physician Decision|1|||
16299350|NCT03262038|39581885|FG000|Overall Study|Withdrawal by Subject|0|||
16299351|NCT03262038|39581886|FG001|Overall Study|Withdrawal by Subject|1|||
16299352|NCT01307111|39581887|FG000|IUD Insertion|Lost to Follow-up|2|||
16299353|NCT01307111|39581888|FG001|IUD Insertion|Lost to Follow-up|0|||
16299354|NCT01307111|39581887|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
16299355|NCT01307111|39581888|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
16299356|NCT02643355|39581889|FG000|Overall Study|Withdrawal by Subject|1|||
16299357|NCT02643355|39581890|FG001|Overall Study|Withdrawal by Subject|3|||
16299358|NCT02643355|39581889|FG000|Overall Study|Protocol Violation|0|||
16083715|NCT02128113|38799162|FG002|Overall Study|Withdrawal by Subject|0|||
16299359|NCT02643355|39581890|FG001|Overall Study|Protocol Violation|2|||
16299360|NCT02276807|39581891|FG000|Overall Study|Withdrawal by Subject|8|||
16299361|NCT02276807|39581892|FG001|Overall Study|Withdrawal by Subject|7|||
16299362|NCT02276807|39581891|FG000|Overall Study|Lost to Follow-up|10|||
16299363|NCT02276807|39581892|FG001|Overall Study|Lost to Follow-up|10|||
16299364|NCT00886288|39581893|FG000|Overall Study|no respect of the 12 weeks period|657|||
16299365|NCT00886288|39581894|FG001|Overall Study|no respect of the 12 weeks period|227|||
16299366|NCT00886288|39581893|FG000|Overall Study|Lost to Follow-up|86|||
16299367|NCT00886288|39581894|FG001|Overall Study|Lost to Follow-up|0|||
16299368|NCT03477903|39581895|FG000|Overall Study|Study Terminated by Sponsor|1|||
16299369|NCT04480710|39581896|FG000|Overall Study|Adverse Event|0|||
16299370|NCT04480710|39581897|FG001|Overall Study|Adverse Event|2|||
16299371|NCT04480710|39581898|FG002|Overall Study|Adverse Event|0|||
16299372|NCT04480710|39581899|FG003|Overall Study|Adverse Event|0|||
16299373|NCT04480710|39581896|FG000|Overall Study|Withdrawal by Subject|0|||
16299374|NCT04480710|39581897|FG001|Overall Study|Withdrawal by Subject|1|||
16299375|NCT04480710|39581898|FG002|Overall Study|Withdrawal by Subject|0|||
16299376|NCT04480710|39581899|FG003|Overall Study|Withdrawal by Subject|0|||
16299377|NCT04480710|39581896|FG000|Overall Study|Physician Decision|0|||
16299378|NCT04480710|39581897|FG001|Overall Study|Physician Decision|0|||
16299379|NCT04480710|39581898|FG002|Overall Study|Physician Decision|1|||
16299380|NCT04480710|39581899|FG003|Overall Study|Physician Decision|0|||
16299381|NCT01685840|39581900|FG000|Overall Study|Death|77|||
16299382|NCT01685840|39581901|FG001|Overall Study|Death|66|||
16299383|NCT01685840|39581900|FG000|Overall Study|Lost to Follow-up|27|||
16299384|NCT01685840|39581901|FG001|Overall Study|Lost to Follow-up|25|||
16299385|NCT01685840|39581900|FG000|Overall Study|Physician Decision|3|||
16299386|NCT01685840|39581901|FG001|Overall Study|Physician Decision|7|||
16299387|NCT01685840|39581900|FG000|Overall Study|Withdrawal by Subject|14|||
16299388|NCT01685840|39581901|FG001|Overall Study|Withdrawal by Subject|17|||
16299389|NCT01685840|39581900|FG000|Overall Study|Futility|197|||
16299390|NCT01685840|39581901|FG001|Overall Study|Futility|200|||
16299391|NCT01685840|39581900|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
16299392|NCT01685840|39581901|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
16299393|NCT00253448|39581902|FG000|Overall Study|Withdrawal by Subject|1|||
16299394|NCT04839692|39581903|FG000|Overall Study|Withdrawal by Subject|0|||
16299395|NCT04839692|39581904|FG001|Overall Study|Withdrawal by Subject|3|||
16299396|NCT04839692|39581903|FG000|Overall Study|Physician Decision|1|||
16299397|NCT04839692|39581904|FG001|Overall Study|Physician Decision|0|||
16299398|NCT00000378|39581905|FG000|Overall Study|Lack of Efficacy|16|||
16299399|NCT00000378|39581906|FG001|Overall Study|Lack of Efficacy|14|||
16299400|NCT00168818|39581907|FG000|Overall Study|Adverse Event|23|||
16299401|NCT00168818|39581908|FG001|Overall Study|Adverse Event|29|||
16299402|NCT00168818|39581909|FG002|Overall Study|Adverse Event|31|||
16299403|NCT00168818|39581907|FG000|Overall Study|Protocol Violation|16|||
16299404|NCT00168818|39581908|FG001|Overall Study|Protocol Violation|11|||
16299405|NCT00168818|39581909|FG002|Overall Study|Protocol Violation|11|||
16299406|NCT00168818|39581907|FG000|Overall Study|Lost to Follow-up|13|||
16299407|NCT00168818|39581908|FG001|Overall Study|Lost to Follow-up|4|||
16299408|NCT00168818|39581909|FG002|Overall Study|Lost to Follow-up|15|||
16299409|NCT00168818|39581907|FG000|Overall Study|Withdrawal by Subject|43|||
16299410|NCT00168818|39581908|FG001|Overall Study|Withdrawal by Subject|41|||
16299411|NCT00168818|39581909|FG002|Overall Study|Withdrawal by Subject|37|||
16299412|NCT00168818|39581907|FG000|Overall Study|Other|22|||
16299413|NCT00168818|39581908|FG001|Overall Study|Other|24|||
16299414|NCT00168818|39581909|FG002|Overall Study|Other|30|||
16299415|NCT00168818|39581907|FG000|Treatment|Adverse Event|77|||
16299416|NCT00168818|39581908|FG001|Treatment|Adverse Event|89|||
16299417|NCT00168818|39581909|FG002|Treatment|Adverse Event|68|||
16299418|NCT00168818|39581907|FG000|Treatment|Protocol Violation|8|||
16299419|NCT00168818|39581908|FG001|Treatment|Protocol Violation|11|||
16299420|NCT00168818|39581909|FG002|Treatment|Protocol Violation|11|||
16299421|NCT00168818|39581907|FG000|Treatment|Lost to Follow-up|0|||
16299422|NCT00168818|39581908|FG001|Treatment|Lost to Follow-up|2|||
16299423|NCT00168818|39581909|FG002|Treatment|Lost to Follow-up|1|||
16299424|NCT00168818|39581907|FG000|Treatment|Withdrawal by Subject|25|||
16299425|NCT00168818|39581908|FG001|Treatment|Withdrawal by Subject|20|||
16489915|NCT02207244|40267107|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16489916|NCT02207244|40267108|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16299426|NCT00168818|39581909|FG002|Treatment|Withdrawal by Subject|22|||
16299427|NCT00168818|39581907|FG000|Treatment|Other|23|||
16299428|NCT00168818|39581908|FG001|Treatment|Other|29|||
16299429|NCT00168818|39581909|FG002|Treatment|Other|31|||
16299430|NCT02552212|39581910|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
16299431|NCT02552212|39581911|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
16299432|NCT02552212|39581912|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
16385615|NCT01881789|39896216|FG002|Overall Study|Withdrawal by Subject|1|||
16385616|NCT01881789|39896217|FG003|Overall Study|Withdrawal by Subject|0|||
16385617|NCT01881789|39896218|FG004|Overall Study|Withdrawal by Subject|1|||
16385618|NCT01881789|39896219|FG005|Overall Study|Withdrawal by Subject|1|||
16385619|NCT01881789|39896214|FG000|Overall Study|Study Terminated by Sponsor|0|||
16385620|NCT01881789|39896215|FG001|Overall Study|Study Terminated by Sponsor|0|||
16385621|NCT01881789|39896216|FG002|Overall Study|Study Terminated by Sponsor|0|||
16385622|NCT01881789|39896217|FG003|Overall Study|Study Terminated by Sponsor|0|||
16385623|NCT01881789|39896218|FG004|Overall Study|Study Terminated by Sponsor|0|||
16385624|NCT01881789|39896219|FG005|Overall Study|Study Terminated by Sponsor|1|||
16385625|NCT01881789|39896214|FG000|Overall Study|Other|3|||
16385626|NCT01881789|39896215|FG001|Overall Study|Other|5|||
16385627|NCT01881789|39896216|FG002|Overall Study|Other|2|||
16385628|NCT01881789|39896217|FG003|Overall Study|Other|3|||
16385629|NCT01881789|39896218|FG004|Overall Study|Other|1|||
16385630|NCT01881789|39896219|FG005|Overall Study|Other|1|||
16385631|NCT02935192|39896221|FG000|Overall Study|Withdrawal by Subject|8|||
16385632|NCT02935192|39896222|FG001|Overall Study|Withdrawal by Subject|4|||
16385633|NCT01628913|39896223|FG000|Overall Study|Adverse Event|12|||
16385634|NCT01628913|39896224|FG001|Overall Study|Adverse Event|5|||
16385635|NCT01628913|39896223|FG000|Overall Study|Disease Progression|11|||
16489917|NCT02207244|40267109|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16489918|NCT02207244|40267110|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16489919|NCT02207244|40267111|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16489920|NCT02207244|40267112|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
16489921|NCT02207244|40267102|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16489922|NCT02207244|40267103|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
16489923|NCT02207244|40267104|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
16489924|NCT02207244|40267105|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16489925|NCT02207244|40267106|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16385636|NCT01628913|39896224|FG001|Overall Study|Disease Progression|14|||
16385637|NCT01628913|39896223|FG000|Overall Study|Protocol Violation|1|||
16299433|NCT02552212|39581910|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
16299434|NCT02552212|39581911|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
16299435|NCT02552212|39581912|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
16299436|NCT02552212|39581910|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
16299437|NCT02552212|39581911|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
16299438|NCT02552212|39581912|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
16299439|NCT02552212|39581910|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
16299440|NCT02552212|39581911|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
16299441|NCT02552212|39581912|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
16299442|NCT02552212|39581910|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
16299443|NCT02552212|39581911|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
16299444|NCT02552212|39581912|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
16299445|NCT02552212|39581910|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
16299446|NCT02552212|39581911|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
16299447|NCT02552212|39581912|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
16299448|NCT02552212|39581910|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
16299449|NCT02552212|39581911|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
16299450|NCT02552212|39581912|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
16299451|NCT02552212|39581910|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
16299452|NCT02552212|39581911|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
16299453|NCT02552212|39581912|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
16299454|NCT02552212|39581910|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
16299455|NCT02552212|39581911|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
16299456|NCT02552212|39581912|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
16299457|NCT02552212|39581910|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
16299458|NCT02552212|39581911|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
16299459|NCT02552212|39581912|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
16299460|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
16299461|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
16299462|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
16299463|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
16299464|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
16299465|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
16299466|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
16385638|NCT01628913|39896224|FG001|Overall Study|Protocol Violation|0|||
16299467|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
16299468|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
16299469|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
16489926|NCT02207244|40267107|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16489927|NCT02207244|40267108|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16489928|NCT02207244|40267109|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16489929|NCT02207244|40267110|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16489930|NCT02207244|40267111|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16489931|NCT02207244|40267112|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
16489932|NCT02207244|40267102|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
16489933|NCT02207244|40267103|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
16489934|NCT02207244|40267104|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
16489935|NCT02207244|40267105|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
16489936|NCT02207244|40267106|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
16489937|NCT02207244|40267107|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
16489938|NCT02207244|40267108|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
16299470|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
16299471|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
16299472|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
16299473|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
16299474|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
16299475|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
16299476|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
16299477|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
16299478|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
16299479|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
16299480|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
16299481|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
16299482|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
16299483|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
16299484|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
16299485|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
16299486|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
16299487|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
16385639|NCT01628913|39896223|FG000|Overall Study|Death|1|||
16385640|NCT01628913|39896224|FG001|Overall Study|Death|0|||
16489939|NCT02207244|40267109|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
16489940|NCT02207244|40267110|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
16489941|NCT02207244|40267111|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
16489942|NCT02207244|40267112|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
16489943|NCT02207244|40267102|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16489944|NCT02207244|40267103|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16489945|NCT02207244|40267104|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16489946|NCT02207244|40267105|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16489947|NCT02207244|40267106|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
16489948|NCT02207244|40267107|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
16489949|NCT02207244|40267108|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16489950|NCT02207244|40267109|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16489951|NCT02207244|40267110|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16489952|NCT02207244|40267111|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16489953|NCT02207244|40267112|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
16489954|NCT02207244|40267102|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16489955|NCT02207244|40267103|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16489956|NCT02207244|40267104|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16489957|NCT02207244|40267105|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16489958|NCT02207244|40267106|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16489959|NCT02207244|40267107|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
16489960|NCT02207244|40267108|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16489961|NCT02207244|40267109|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16489962|NCT02207244|40267110|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16489963|NCT02207244|40267111|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16489964|NCT02207244|40267112|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
16489965|NCT02207244|40267102|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16489966|NCT02207244|40267103|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16489967|NCT02207244|40267104|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16489968|NCT02207244|40267105|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
16299488|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
16299489|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
16299490|NCT02552212|39581910|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
16299491|NCT02552212|39581911|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
16299492|NCT02552212|39581912|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
16299493|NCT04628793|39581913|FG000|Overall Study|Study terminated by sponsor|0|||
16299494|NCT04628793|39581914|FG001|Overall Study|Study terminated by sponsor|0|||
16299495|NCT04628793|39581915|FG002|Overall Study|Study terminated by sponsor|8|||
16299496|NCT04628793|39581913|FG000|Overall Study|Withdrawal by Subject|2|||
16299497|NCT04628793|39581914|FG001|Overall Study|Withdrawal by Subject|3|||
16299498|NCT04628793|39581915|FG002|Overall Study|Withdrawal by Subject|0|||
16299499|NCT04628793|39581913|FG000|Overall Study|Lost to Follow-up|0|||
16299500|NCT04628793|39581914|FG001|Overall Study|Lost to Follow-up|1|||
16299501|NCT04628793|39581915|FG002|Overall Study|Lost to Follow-up|0|||
16299502|NCT01130597|39581916|FG000|Overall Study|Protocol-specified (High K+)|1|||
16299503|NCT01130597|39581916|FG000|Overall Study|Adverse Event|4|||
16299504|NCT01130597|39581916|FG000|Overall Study|Death|1|||
16299505|NCT01130597|39581916|FG000|Overall Study|Protocol Violation|1|||
16299506|NCT04623086|39581917|FG000|Overall Study|Withdrawal by Subject|0|||
16299507|NCT04623086|39581918|FG001|Overall Study|Withdrawal by Subject|0|||
16299508|NCT04623086|39581919|FG002|Overall Study|Withdrawal by Subject|10|||
16299509|NCT00507130|39581920|FG000|Overall Study|Lost to Follow-up|0|||
16299510|NCT00507130|39581921|FG001|Overall Study|Lost to Follow-up|0|||
16299511|NCT00507130|39581922|FG002|Overall Study|Lost to Follow-up|1|||
16299512|NCT00507130|39581923|FG003|Overall Study|Lost to Follow-up|1|||
16299513|NCT00507130|39581920|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
16299514|NCT00507130|39581921|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
16299515|NCT00507130|39581922|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
16299516|NCT00507130|39581923|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
16299517|NCT00839254|39581924|FG000|Overall Study|Protocol Violation|0|||
16299518|NCT00839254|39581925|FG001|Overall Study|Protocol Violation|1|||
16299519|NCT00839254|39581926|FG002|Overall Study|Protocol Violation|1|||
16299520|NCT00839254|39581927|FG003|Overall Study|Protocol Violation|1|||
16299521|NCT00839254|39581928|FG004|Overall Study|Protocol Violation|0|||
16299522|NCT00839254|39581929|FG005|Overall Study|Protocol Violation|0|||
16299523|NCT00839254|39581930|FG006|Overall Study|Protocol Violation|1|||
16299524|NCT00839254|39581931|FG007|Overall Study|Protocol Violation|2|||
16083716|NCT02128113|38799160|FG000|Overall Study|Protocol Violation|0|||
16299525|NCT00839254|39581924|FG000|Overall Study|Physician Decision|0|||
16299526|NCT00839254|39581925|FG001|Overall Study|Physician Decision|1|||
16299527|NCT00839254|39581926|FG002|Overall Study|Physician Decision|0|||
16299528|NCT00839254|39581927|FG003|Overall Study|Physician Decision|0|||
16299529|NCT00839254|39581928|FG004|Overall Study|Physician Decision|0|||
16299530|NCT00839254|39581929|FG005|Overall Study|Physician Decision|0|||
16299531|NCT00839254|39581930|FG006|Overall Study|Physician Decision|0|||
16299532|NCT00839254|39581931|FG007|Overall Study|Physician Decision|1|||
16299533|NCT00839254|39581924|FG000|Overall Study|Wrong treatment number allocation|0|||
16299534|NCT00839254|39581925|FG001|Overall Study|Wrong treatment number allocation|1|||
16299535|NCT00839254|39581926|FG002|Overall Study|Wrong treatment number allocation|0|||
16299536|NCT00839254|39581927|FG003|Overall Study|Wrong treatment number allocation|0|||
16299537|NCT00839254|39581928|FG004|Overall Study|Wrong treatment number allocation|0|||
16299538|NCT00839254|39581929|FG005|Overall Study|Wrong treatment number allocation|1|||
16299539|NCT00839254|39581930|FG006|Overall Study|Wrong treatment number allocation|0|||
16299540|NCT00839254|39581931|FG007|Overall Study|Wrong treatment number allocation|0|||
16299541|NCT00839254|39581924|FG000|Overall Study|Adverse Event|12|||
16299542|NCT00839254|39581925|FG001|Overall Study|Adverse Event|6|||
16299543|NCT00839254|39581926|FG002|Overall Study|Adverse Event|3|||
16299544|NCT00839254|39581927|FG003|Overall Study|Adverse Event|5|||
16299545|NCT00839254|39581928|FG004|Overall Study|Adverse Event|2|||
16299546|NCT00839254|39581929|FG005|Overall Study|Adverse Event|1|||
16299547|NCT00839254|39581930|FG006|Overall Study|Adverse Event|0|||
16299548|NCT00839254|39581931|FG007|Overall Study|Adverse Event|1|||
16299549|NCT00839254|39581924|FG000|Overall Study|Withdrawal by Subject|87|||
16299550|NCT00839254|39581925|FG001|Overall Study|Withdrawal by Subject|53|||
16299551|NCT00839254|39581926|FG002|Overall Study|Withdrawal by Subject|54|||
16299552|NCT00839254|39581927|FG003|Overall Study|Withdrawal by Subject|32|||
16299553|NCT00839254|39581928|FG004|Overall Study|Withdrawal by Subject|27|||
16299554|NCT00839254|39581929|FG005|Overall Study|Withdrawal by Subject|15|||
16299555|NCT00839254|39581930|FG006|Overall Study|Withdrawal by Subject|22|||
16299556|NCT00839254|39581931|FG007|Overall Study|Withdrawal by Subject|9|||
16299557|NCT00839254|39581924|FG000|Overall Study|Wrong group allocation|0|||
16299558|NCT00839254|39581925|FG001|Overall Study|Wrong group allocation|0|||
16299559|NCT00839254|39581926|FG002|Overall Study|Wrong group allocation|0|||
16299560|NCT00839254|39581927|FG003|Overall Study|Wrong group allocation|0|||
16299561|NCT00839254|39581928|FG004|Overall Study|Wrong group allocation|0|||
16299562|NCT00839254|39581929|FG005|Overall Study|Wrong group allocation|0|||
16299563|NCT00839254|39581930|FG006|Overall Study|Wrong group allocation|1|||
16299564|NCT00839254|39581931|FG007|Overall Study|Wrong group allocation|0|||
16299565|NCT00839254|39581924|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
16299566|NCT00839254|39581925|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
16299567|NCT00839254|39581926|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
16299568|NCT00839254|39581927|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
16299569|NCT00839254|39581928|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
16299570|NCT00839254|39581929|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
16299571|NCT00839254|39581930|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
16083717|NCT02128113|38799161|FG001|Overall Study|Protocol Violation|1|||
16083718|NCT02128113|38799162|FG002|Overall Study|Protocol Violation|0|||
16083719|NCT02128113|38799160|FG000|Overall Study|Surgery cancelled|0|||
16299572|NCT00839254|39581931|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
16299573|NCT00839254|39581924|FG000|Overall Study|Withdrawn due to non-compliance|2|||
16299574|NCT00839254|39581925|FG001|Overall Study|Withdrawn due to non-compliance|0|||
16083720|NCT02128113|38799161|FG001|Overall Study|Surgery cancelled|1|||
16083721|NCT02128113|38799162|FG002|Overall Study|Surgery cancelled|0|||
16299575|NCT00839254|39581926|FG002|Overall Study|Withdrawn due to non-compliance|0|||
16299576|NCT00839254|39581927|FG003|Overall Study|Withdrawn due to non-compliance|0|||
16299577|NCT00839254|39581928|FG004|Overall Study|Withdrawn due to non-compliance|0|||
16299578|NCT00839254|39581929|FG005|Overall Study|Withdrawn due to non-compliance|0|||
16299579|NCT00839254|39581930|FG006|Overall Study|Withdrawn due to non-compliance|0|||
16299580|NCT00839254|39581931|FG007|Overall Study|Withdrawn due to non-compliance|0|||
16299581|NCT00839254|39581924|FG000|Overall Study|Lost to Follow-up|51|||
16299582|NCT00839254|39581925|FG001|Overall Study|Lost to Follow-up|30|||
16299583|NCT00839254|39581926|FG002|Overall Study|Lost to Follow-up|32|||
16299584|NCT00839254|39581927|FG003|Overall Study|Lost to Follow-up|24|||
16299585|NCT00839254|39581928|FG004|Overall Study|Lost to Follow-up|8|||
16299586|NCT00839254|39581929|FG005|Overall Study|Lost to Follow-up|8|||
16299587|NCT00839254|39581930|FG006|Overall Study|Lost to Follow-up|4|||
16299588|NCT00839254|39581931|FG007|Overall Study|Lost to Follow-up|2|||
16299589|NCT00851318|39581932|FG000|Overall Study|Withdrawal by Subject|7|||
16299590|NCT00851318|39581933|FG001|Overall Study|Withdrawal by Subject|1|||
16299591|NCT00851318|39581934|FG002|Overall Study|Withdrawal by Subject|5|||
16299592|NCT00851318|39581935|FG003|Overall Study|Withdrawal by Subject|3|||
16299593|NCT00851318|39581932|FG000|Overall Study|Adverse Event|13|||
16299594|NCT00851318|39581933|FG001|Overall Study|Adverse Event|2|||
16299595|NCT00851318|39581934|FG002|Overall Study|Adverse Event|9|||
16299596|NCT00851318|39581935|FG003|Overall Study|Adverse Event|12|||
16299597|NCT00851318|39581932|FG000|Overall Study|Pregnancy|0|||
16299598|NCT00851318|39581933|FG001|Overall Study|Pregnancy|0|||
16299599|NCT00851318|39581934|FG002|Overall Study|Pregnancy|1|||
16299600|NCT00851318|39581935|FG003|Overall Study|Pregnancy|1|||
16299601|NCT00851318|39581932|FG000|Overall Study|Lack of Efficacy|8|||
16299602|NCT00851318|39581933|FG001|Overall Study|Lack of Efficacy|2|||
16299603|NCT00851318|39581934|FG002|Overall Study|Lack of Efficacy|4|||
16299604|NCT00851318|39581935|FG003|Overall Study|Lack of Efficacy|2|||
16299605|NCT00851318|39581932|FG000|Overall Study|Non-compliance with Study Procedures|2|||
16299606|NCT00851318|39581933|FG001|Overall Study|Non-compliance with Study Procedures|0|||
16299607|NCT00851318|39581934|FG002|Overall Study|Non-compliance with Study Procedures|1|||
16299608|NCT00851318|39581935|FG003|Overall Study|Non-compliance with Study Procedures|0|||
16299609|NCT00851318|39581932|FG000|Overall Study|Physician Decision|0|||
16299610|NCT00851318|39581933|FG001|Overall Study|Physician Decision|0|||
16299611|NCT00851318|39581934|FG002|Overall Study|Physician Decision|1|||
16299612|NCT00851318|39581935|FG003|Overall Study|Physician Decision|1|||
16299613|NCT03086551|39581940|FG000|First Intervention|Failure to meet inclusion criterion|1|||
16299614|NCT03086551|39581941|FG001|First Intervention|Failure to meet inclusion criterion|0|||
16299615|NCT03086551|39581940|FG000|First Intervention|Lost to Follow-up|0|||
16299616|NCT03086551|39581941|FG001|First Intervention|Lost to Follow-up|1|||
16083722|NCT02128113|38799160|FG000|Overall Study|Adverse Event|0|||
16299617|NCT03086551|39581940|FG000|Washout|Lost to Follow-up|1|||
16299618|NCT03086551|39581941|FG001|Washout|Lost to Follow-up|2|||
16299619|NCT03086551|39581940|FG000|Washout|Withdrawal by Subject|2|||
16299620|NCT03086551|39581941|FG001|Washout|Withdrawal by Subject|1|||
16083723|NCT02128113|38799161|FG001|Overall Study|Adverse Event|0|||
16083724|NCT02128113|38799162|FG002|Overall Study|Adverse Event|1|||
16191537|NCT03554005|39179324|FG001|Overall Study|Not in participant's best interest|0|||
16191538|NCT03554005|39179325|FG002|Overall Study|Not in participant's best interest|0|||
16191539|NCT03554005|39179326|FG003|Overall Study|Not in participant's best interest|0|||
16191540|NCT03554005|39179327|FG004|Overall Study|Not in participant's best interest|0|||
16191541|NCT03554005|39179328|FG005|Overall Study|Not in participant's best interest|1|||
16191542|NCT03554005|39179323|FG000|Overall Study|Disease Progression|1|||
16191543|NCT03554005|39179324|FG001|Overall Study|Disease Progression|1|||
16191544|NCT03554005|39179325|FG002|Overall Study|Disease Progression|1|||
16191545|NCT03554005|39179326|FG003|Overall Study|Disease Progression|1|||
16191546|NCT03554005|39179327|FG004|Overall Study|Disease Progression|5|||
16191547|NCT03554005|39179328|FG005|Overall Study|Disease Progression|6|||
16191548|NCT03554005|39179323|FG000|Overall Study|Adverse Event|0|||
16299621|NCT01421511|39581942|FG000|Overall Study|Lost to Follow-up|11|||
16299622|NCT01421511|39581943|FG001|Overall Study|Lost to Follow-up|14|||
16299623|NCT01421511|39581942|FG000|Overall Study|Randomized but didn't receive study drug|1|||
16299624|NCT01421511|39581943|FG001|Overall Study|Randomized but didn't receive study drug|7|||
16299625|NCT01421511|39581942|FG000|Overall Study|Physician Decision|0|||
16299626|NCT01421511|39581943|FG001|Overall Study|Physician Decision|1|||
16299627|NCT01421511|39581942|FG000|Overall Study|Withdrawal by Subject|6|||
16299628|NCT01421511|39581943|FG001|Overall Study|Withdrawal by Subject|5|||
16299629|NCT01421511|39581942|FG000|Overall Study|Death|1|||
16299630|NCT01421511|39581943|FG001|Overall Study|Death|1|||
16299631|NCT01866098|39581944|FG000|Overall Study|Lost to Follow-up|11|||
16299632|NCT01866098|39581945|FG001|Overall Study|Lost to Follow-up|18|||
16299633|NCT01866098|39581946|FG002|Overall Study|Lost to Follow-up|13|||
16299634|NCT01866098|39581944|FG000|Overall Study|Physician Decision|0|||
16299635|NCT01866098|39581945|FG001|Overall Study|Physician Decision|1|||
16299636|NCT01866098|39581946|FG002|Overall Study|Physician Decision|2|||
16299637|NCT01866098|39581944|FG000|Overall Study|Adverse Event|1|||
16299638|NCT01866098|39581945|FG001|Overall Study|Adverse Event|5|||
16299639|NCT01866098|39581946|FG002|Overall Study|Adverse Event|4|||
16299640|NCT01866098|39581944|FG000|Overall Study|Protocol Violation|1|||
16299641|NCT01866098|39581945|FG001|Overall Study|Protocol Violation|0|||
16299642|NCT01866098|39581946|FG002|Overall Study|Protocol Violation|0|||
16299643|NCT01866098|39581944|FG000|Overall Study|Withdrawal by Subject|1|||
16299644|NCT01866098|39581945|FG001|Overall Study|Withdrawal by Subject|2|||
16299645|NCT01866098|39581946|FG002|Overall Study|Withdrawal by Subject|0|||
16299646|NCT01866098|39581944|FG000|Overall Study|Unrelated Hospitalization|2|||
16299647|NCT01866098|39581945|FG001|Overall Study|Unrelated Hospitalization|0|||
16299648|NCT01866098|39581946|FG002|Overall Study|Unrelated Hospitalization|1|||
16299649|NCT01866098|39581944|FG000|Overall Study|Non-compliance|1|||
16299650|NCT01866098|39581945|FG001|Overall Study|Non-compliance|0|||
16299651|NCT01866098|39581946|FG002|Overall Study|Non-compliance|1|||
16299652|NCT01866098|39581944|FG000|Overall Study|Pregnancy|2|||
16299653|NCT01866098|39581945|FG001|Overall Study|Pregnancy|0|||
16299654|NCT01866098|39581946|FG002|Overall Study|Pregnancy|0|||
16299655|NCT01866098|39581944|FG000|Overall Study|Death|0|||
16299656|NCT01866098|39581945|FG001|Overall Study|Death|1|||
16299657|NCT01866098|39581946|FG002|Overall Study|Death|0|||
16299658|NCT02129608|39581947|FG000|Overall Study|Lost to Follow-up|0|||
16299659|NCT02129608|39581948|FG001|Overall Study|Lost to Follow-up|1|||
16299660|NCT02129608|39581949|FG002|Overall Study|Lost to Follow-up|1|||
16299661|NCT02129608|39581947|FG000|Overall Study|Withdrawal by Subject|0|||
16385641|NCT01628913|39896223|FG000|Overall Study|study terminated by Sponsor|4|||
16385642|NCT01628913|39896224|FG001|Overall Study|study terminated by Sponsor|9|||
16083725|NCT02919449|38799163|FG000|Overall Study|Withdrawal by Subject|1|||
16083726|NCT02919449|38799163|FG000|Overall Study|Investigator decision|1|||
16083727|NCT02462759|38799178|FG000|Part 1: Double Blind|Death|1|||
16083728|NCT02462759|38799179|FG001|Part 1: Double Blind|Death|0|||
16191549|NCT03554005|39179324|FG001|Overall Study|Adverse Event|0|||
16299662|NCT02129608|39581948|FG001|Overall Study|Withdrawal by Subject|0|||
16385643|NCT01628913|39896223|FG000|Overall Study|Withdrawal by Subject|1|||
16489969|NCT02207244|40267106|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
16299663|NCT02129608|39581949|FG002|Overall Study|Withdrawal by Subject|2|||
16299664|NCT02552303|39581954|FG000|Allocation|Withdrawal by Subject|2|||
16083729|NCT02462759|38799180|FG002|Part 1: Double Blind|Death|0|||
16191550|NCT03554005|39179325|FG002|Overall Study|Adverse Event|0|||
16083730|NCT00640159|38799187|FG000|Overall Study|Lost to Follow-up|2|||
16191551|NCT03554005|39179326|FG003|Overall Study|Adverse Event|0|||
16299665|NCT02552303|39581955|FG001|Allocation|Withdrawal by Subject|1|||
16299666|NCT02552303|39581956|FG002|Allocation|Withdrawal by Subject|1|||
16299667|NCT02552303|39581957|FG003|Allocation|Withdrawal by Subject|1|||
16299668|NCT02552303|39581954|FG000|Allocation|ineligible|1|||
16385644|NCT01628913|39896224|FG001|Overall Study|Withdrawal by Subject|0|||
16385645|NCT01628913|39896223|FG000|Overall Study|Physician Decision|1|||
16385646|NCT01628913|39896224|FG001|Overall Study|Physician Decision|3|||
16385647|NCT01783444|39896225|FG000|Treatment Phase|Adverse Event|9|||
16385648|NCT01783444|39896226|FG001|Treatment Phase|Adverse Event|20|||
16385649|NCT01783444|39896227|FG002|Treatment Phase|Adverse Event|19|||
16385650|NCT01783444|39896225|FG000|Treatment Phase|Disease Progression|76|||
16385651|NCT01783444|39896226|FG001|Treatment Phase|Disease Progression|66|||
16385652|NCT01783444|39896227|FG002|Treatment Phase|Disease Progression|64|||
16385653|NCT01783444|39896225|FG000|Treatment Phase|Death|2|||
16385654|NCT01783444|39896226|FG001|Treatment Phase|Death|2|||
16385655|NCT01783444|39896227|FG002|Treatment Phase|Death|2|||
16385656|NCT01783444|39896225|FG000|Treatment Phase|Protocol Violation|1|||
16385657|NCT01783444|39896226|FG001|Treatment Phase|Protocol Violation|1|||
16385658|NCT01783444|39896227|FG002|Treatment Phase|Protocol Violation|2|||
16385659|NCT01783444|39896225|FG000|Treatment Phase|Withdrawal by Subject|6|||
16385660|NCT01783444|39896226|FG001|Treatment Phase|Withdrawal by Subject|8|||
16385661|NCT01783444|39896227|FG002|Treatment Phase|Withdrawal by Subject|9|||
16385662|NCT01783444|39896225|FG000|Treatment Phase|Administrative problems|2|||
16385663|NCT01783444|39896226|FG001|Treatment Phase|Administrative problems|0|||
16385664|NCT01783444|39896227|FG002|Treatment Phase|Administrative problems|1|||
16385665|NCT01783444|39896225|FG000|Treatment Phase|Physician Decision|8|||
16385666|NCT01783444|39896226|FG001|Treatment Phase|Physician Decision|6|||
16385667|NCT01783444|39896227|FG002|Treatment Phase|Physician Decision|5|||
16385668|NCT01783444|39896225|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
16385669|NCT01783444|39896226|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
16385670|NCT01783444|39896227|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
16385671|NCT01783444|39896225|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
16385672|NCT01783444|39896226|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
16385673|NCT01783444|39896227|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
16385674|NCT01783444|39896225|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
16385675|NCT01783444|39896226|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
16385676|NCT01783444|39896227|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
16385677|NCT01783444|39896225|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
16385678|NCT01783444|39896226|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
16385679|NCT01783444|39896227|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
16385680|NCT01783444|39896225|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
16385681|NCT01783444|39896226|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
16385682|NCT01783444|39896227|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
16385683|NCT01783444|39896225|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
16385684|NCT01783444|39896226|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
16385685|NCT01783444|39896227|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
16385686|NCT01464879|39896228|FG000|Overall Study|Physician Decision|1|||
16385687|NCT01464879|39896228|FG000|Overall Study|Non-compliance|1|||
16385688|NCT02286895|39896229|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
16489970|NCT02207244|40267107|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
16083731|NCT00419341|38799194|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
16083732|NCT00419341|38799194|FG000|Wash in/Wash Out Period|Adverse Event|2|||
16083733|NCT00419341|38799194|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
16083734|NCT00419341|38799194|FG000|Efficacy Period|Withdrawal by Subject|6|||
16083735|NCT00419341|38799194|FG000|Efficacy Period|Protocol Violation|1|||
16083736|NCT00419341|38799194|FG000|Efficacy Period|Lost to Follow-up|1|||
16083737|NCT00419341|38799194|FG000|Efficacy Period|Non-compliance|1|||
16083738|NCT00419341|38799194|FG000|Efficacy Period|Termination of study site|1|||
16083739|NCT02058108|38799200|FG000|Overall Study|Abnormal Laboratory Values|0|||
16083740|NCT02058108|38799201|FG001|Overall Study|Abnormal Laboratory Values|1|||
16083741|NCT02058108|38799200|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
16083742|NCT02058108|38799201|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
16083743|NCT02058108|38799200|FG000|Overall Study|No longer requires study drug|0|||
16083744|NCT02058108|38799201|FG001|Overall Study|No longer requires study drug|1|||
16083745|NCT02058108|38799200|FG000|Overall Study|Withdrawal by Subject|1|||
16083746|NCT02058108|38799201|FG001|Overall Study|Withdrawal by Subject|0|||
16083747|NCT02058108|38799200|FG000|Overall Study|Administrative problems|3|||
16083748|NCT02058108|38799201|FG001|Overall Study|Administrative problems|3|||
16083749|NCT02058108|38799200|FG000|Overall Study|Protocol Violation|0|||
16191552|NCT03554005|39179327|FG004|Overall Study|Adverse Event|0|||
16385689|NCT02286895|39896230|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
16385690|NCT02286895|39896229|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
16489971|NCT02207244|40267108|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16083750|NCT02058108|38799201|FG001|Overall Study|Protocol Violation|1|||
16083751|NCT01074294|38799202|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
16385691|NCT02286895|39896230|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
16385692|NCT02286895|39896229|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
16385693|NCT02286895|39896230|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
16385694|NCT01500317|39896233|FG000|Overall Study|Withdrawal by Subject|3|||
16385695|NCT01500317|39896234|FG001|Overall Study|Withdrawal by Subject|2|||
16385696|NCT01500317|39896235|FG002|Overall Study|Withdrawal by Subject|0|||
16385697|NCT00867334|39896237|FG000|Overall Study|Withdrawal by Subject|0|||
16385698|NCT00867334|39896238|FG001|Overall Study|Withdrawal by Subject|1|||
16385699|NCT00867334|39896237|FG000|Overall Study|Withdrawal by Subject|1|||
16385700|NCT00867334|39896238|FG001|Overall Study|Withdrawal by Subject|0|||
16385701|NCT00867334|39896237|FG000|Overall Study|Withdrawal by Subject|1|||
16299669|NCT02552303|39581955|FG001|Allocation|ineligible|1|||
16299670|NCT02552303|39581956|FG002|Allocation|ineligible|0|||
16299671|NCT02552303|39581957|FG003|Allocation|ineligible|0|||
16299672|NCT02552303|39581954|FG000|Follow-Up|Lost to Follow-up|0|||
16299673|NCT02552303|39581955|FG001|Follow-Up|Lost to Follow-up|0|||
16299674|NCT02552303|39581956|FG002|Follow-Up|Lost to Follow-up|1|||
16299675|NCT02552303|39581957|FG003|Follow-Up|Lost to Follow-up|0|||
16299676|NCT02552303|39581954|FG000|Follow-Up|ineligible|0|||
16299677|NCT02552303|39581955|FG001|Follow-Up|ineligible|2|||
16299678|NCT02552303|39581956|FG002|Follow-Up|ineligible|0|||
16299679|NCT02552303|39581957|FG003|Follow-Up|ineligible|0|||
16385702|NCT00867334|39896238|FG001|Overall Study|Withdrawal by Subject|0|||
16385703|NCT01816984|39896239|FG000|Overall Study|declining health status|1|||
16385704|NCT01673126|39896241|FG000|Overall Study|change of diagnosis|4|||
16385705|NCT01673126|39896242|FG001|Overall Study|change of diagnosis|3|||
16385706|NCT00329030|39896243|FG000|Overall Study|Withdrawal by Subject|1|||
16385707|NCT00329030|39896244|FG001|Overall Study|Withdrawal by Subject|3|||
16385708|NCT00329030|39896243|FG000|Overall Study|Progressive Disease|6|||
16385709|NCT00329030|39896244|FG001|Overall Study|Progressive Disease|2|||
16385710|NCT00329030|39896243|FG000|Overall Study|Ineligible Pathology|1|||
16385711|NCT00329030|39896244|FG001|Overall Study|Ineligible Pathology|1|||
16385712|NCT00403130|39896245|FG000|2 Years From Start of Treatment|Not Eligible|3|||
16385713|NCT00403130|39896245|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
16385714|NCT00403130|39896245|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
16385715|NCT00403130|39896245|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
16385716|NCT01656161|39896248|FG000|Overall Study|Death|3|||
16385717|NCT01656161|39896248|FG000|Overall Study|Adverse Event|2|||
16385718|NCT01656161|39896248|FG000|Overall Study|Protocol Violation|1|||
16385719|NCT01656161|39896248|FG000|Overall Study|Withdrawal by Subject|1|||
16385720|NCT00980044|39896249|FG000|Overall Study|Withdrawal by Subject|5|||
16385721|NCT00980044|39896250|FG001|Overall Study|Withdrawal by Subject|7|||
16385722|NCT00980044|39896251|FG002|Overall Study|Withdrawal by Subject|3|||
16385723|NCT00980044|39896249|FG000|Overall Study|Protocol Violation|0|||
16385724|NCT00980044|39896250|FG001|Overall Study|Protocol Violation|0|||
16385725|NCT00980044|39896251|FG002|Overall Study|Protocol Violation|2|||
16385726|NCT03322566|39896252|FG000|Overall Study|Death|34|||
16385727|NCT03322566|39896253|FG001|Overall Study|Death|35|||
16385728|NCT03322566|39896254|FG002|Overall Study|Death|23|||
16385729|NCT03322566|39896252|FG000|Overall Study|Physician Decision|6|||
16385730|NCT03322566|39896253|FG001|Overall Study|Physician Decision|7|||
16385731|NCT03322566|39896254|FG002|Overall Study|Physician Decision|2|||
16385732|NCT03322566|39896252|FG000|Overall Study|Withdrawal by Subject|4|||
16385733|NCT03322566|39896253|FG001|Overall Study|Withdrawal by Subject|3|||
16385734|NCT03322566|39896254|FG002|Overall Study|Withdrawal by Subject|6|||
16385735|NCT03322566|39896252|FG000|Overall Study|Lost to Follow-up|0|||
16385736|NCT03322566|39896253|FG001|Overall Study|Lost to Follow-up|0|||
16385737|NCT03322566|39896254|FG002|Overall Study|Lost to Follow-up|1|||
16385738|NCT03322566|39896252|FG000|Overall Study|Study terminated by sponsor|1|||
16385739|NCT03322566|39896253|FG001|Overall Study|Study terminated by sponsor|0|||
16385740|NCT03322566|39896254|FG002|Overall Study|Study terminated by sponsor|1|||
16385741|NCT02289469|39896255|FG000|Overall Study|Unable to match a control|6|||
16385742|NCT02289469|39896256|FG001|Overall Study|Unable to match a control|0|||
16299680|NCT01438996|39581966|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
16299681|NCT01438996|39581967|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
16385743|NCT02379052|39896257|FG000|Overall Study|Protocol Violation|0|||
16385744|NCT02379052|39896258|FG001|Overall Study|Protocol Violation|1|||
16385745|NCT02379052|39896257|FG000|Overall Study|Adverse Event|0|||
16385746|NCT02379052|39896258|FG001|Overall Study|Adverse Event|1|||
16385747|NCT02379052|39896257|FG000|Overall Study|Physician Decision|1|||
16385748|NCT02379052|39896258|FG001|Overall Study|Physician Decision|1|||
16385749|NCT02379052|39896257|FG000|Overall Study|Withdrawal by Subject|2|||
16385750|NCT02379052|39896258|FG001|Overall Study|Withdrawal by Subject|0|||
16385751|NCT02379052|39896257|FG000|Overall Study|Lost to Follow-up|2|||
16299682|NCT01438996|39581968|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
16299683|NCT02212379|39581969|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
16385752|NCT02379052|39896258|FG001|Overall Study|Lost to Follow-up|1|||
16385753|NCT02379052|39896257|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
16385754|NCT02379052|39896258|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
16385755|NCT02379052|39896257|FG000|Overall Study|Subject was Incarcerated|0|||
16385756|NCT02379052|39896258|FG001|Overall Study|Subject was Incarcerated|1|||
16385757|NCT03510273|39896259|FG000|Overall Study|Withdrawal by Subject|2|||
16385758|NCT03510273|39896259|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
16385759|NCT03510273|39896259|FG000|Overall Study|Moved away from study area|4|||
16385760|NCT03443687|39896260|FG000|Overall Study|Lost to Follow-up|3|||
16299684|NCT02212379|39581969|FG000|From Baseline to Week 48|Adverse Event|7|||
16299685|NCT02212379|39581969|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
16299686|NCT02212379|39581969|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
16299687|NCT02212379|39581969|FG000|From Week 48 to Week 96|Adverse Event|1|||
16299688|NCT02212379|39581969|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
16385761|NCT03443687|39896261|FG001|Overall Study|Lost to Follow-up|5|||
16385762|NCT03443687|39896260|FG000|Overall Study|Withdrawal by Subject|1|||
16385763|NCT03443687|39896261|FG001|Overall Study|Withdrawal by Subject|0|||
16385764|NCT03443687|39896260|FG000|Overall Study|Discontinued intervention|1|||
16385765|NCT03443687|39896261|FG001|Overall Study|Discontinued intervention|1|||
16385766|NCT02612311|39896262|FG000|Overall Study|Adverse Event|16|||
16385767|NCT02612311|39896263|FG001|Overall Study|Adverse Event|12|||
16385768|NCT02612311|39896264|FG002|Overall Study|Adverse Event|7|||
16385769|NCT02612311|39896265|FG003|Overall Study|Adverse Event|13|||
16385770|NCT02612311|39896262|FG000|Overall Study|Death|29|||
16385771|NCT02612311|39896263|FG001|Overall Study|Death|10|||
16385772|NCT02612311|39896264|FG002|Overall Study|Death|11|||
16385773|NCT02612311|39896265|FG003|Overall Study|Death|11|||
16385774|NCT02612311|39896262|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
16385775|NCT02612311|39896263|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
16385776|NCT02612311|39896264|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
16385777|NCT02612311|39896265|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
16385778|NCT02612311|39896262|FG000|Overall Study|Investigator's Decision|11|||
16385779|NCT02612311|39896263|FG001|Overall Study|Investigator's Decision|15|||
16299689|NCT01422187|39581972|FG000|Overall Study|Personal reason|1|||
16299690|NCT01422187|39581973|FG001|Overall Study|Personal reason|0|||
16299691|NCT01422187|39581974|FG002|Overall Study|Personal reason|0|||
16299692|NCT01422187|39581972|FG000|Overall Study|Lost to Follow-up|0|||
16299693|NCT01422187|39581973|FG001|Overall Study|Lost to Follow-up|1|||
16299694|NCT01422187|39581974|FG002|Overall Study|Lost to Follow-up|0|||
16299695|NCT02031458|39581978|FG000|May 8, 2015 to January 11, 2019|Death|89|||
16299696|NCT02031458|39581979|FG001|May 8, 2015 to January 11, 2019|Death|193|||
16299697|NCT02031458|39581980|FG002|May 8, 2015 to January 11, 2019|Death|198|||
16299698|NCT02031458|39581978|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
16299699|NCT02031458|39581979|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
16299700|NCT02031458|39581980|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
16299701|NCT02031458|39581978|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
16299702|NCT02031458|39581979|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
16299703|NCT02031458|39581980|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
16299704|NCT02031458|39581978|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
16299705|NCT02031458|39581979|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
16385780|NCT02612311|39896264|FG002|Overall Study|Investigator's Decision|6|||
16385781|NCT02612311|39896265|FG003|Overall Study|Investigator's Decision|6|||
16385782|NCT02612311|39896262|FG000|Overall Study|Lack of Efficacy|0|||
16385783|NCT02612311|39896263|FG001|Overall Study|Lack of Efficacy|0|||
16489972|NCT02207244|40267109|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16385784|NCT02612311|39896264|FG002|Overall Study|Lack of Efficacy|1|||
16385785|NCT02612311|39896265|FG003|Overall Study|Lack of Efficacy|1|||
16385786|NCT02612311|39896262|FG000|Overall Study|Lost to Follow-up|2|||
16385787|NCT02612311|39896263|FG001|Overall Study|Lost to Follow-up|2|||
16385788|NCT02612311|39896264|FG002|Overall Study|Lost to Follow-up|1|||
16385789|NCT02612311|39896265|FG003|Overall Study|Lost to Follow-up|2|||
16385790|NCT02612311|39896262|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
16385791|NCT02612311|39896263|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
16385792|NCT02612311|39896264|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
16385793|NCT02612311|39896265|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
16385794|NCT02612311|39896262|FG000|Overall Study|Site Terminated by Sponsor|29|||
16385795|NCT02612311|39896263|FG001|Overall Study|Site Terminated by Sponsor|12|||
16385796|NCT02612311|39896264|FG002|Overall Study|Site Terminated by Sponsor|13|||
16385797|NCT02612311|39896265|FG003|Overall Study|Site Terminated by Sponsor|5|||
16385798|NCT02612311|39896262|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
16385799|NCT02612311|39896263|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
16385800|NCT02612311|39896264|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
16385801|NCT02612311|39896265|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
16385802|NCT02612311|39896262|FG000|Overall Study|Reason Not Specified|3|||
16385803|NCT02612311|39896263|FG001|Overall Study|Reason Not Specified|7|||
16385804|NCT02612311|39896264|FG002|Overall Study|Reason Not Specified|4|||
16385805|NCT02612311|39896265|FG003|Overall Study|Reason Not Specified|5|||
16385806|NCT02612311|39896262|FG000|Overall Study|Unknown/Missing|10|||
16385807|NCT02612311|39896263|FG001|Overall Study|Unknown/Missing|13|||
16385808|NCT02612311|39896264|FG002|Overall Study|Unknown/Missing|4|||
16385809|NCT02612311|39896265|FG003|Overall Study|Unknown/Missing|0|||
16385810|NCT02612311|39896262|FG000|Overall Study|Non-Compliance with Study|1|||
16385811|NCT02612311|39896263|FG001|Overall Study|Non-Compliance with Study|0|||
16385812|NCT02612311|39896264|FG002|Overall Study|Non-Compliance with Study|0|||
16385813|NCT02612311|39896265|FG003|Overall Study|Non-Compliance with Study|0|||
16385814|NCT01307449|39896266|FG000|Overall Study|Adverse Event|1|||
16385815|NCT01307449|39896267|FG001|Overall Study|Adverse Event|0|||
16385816|NCT01307449|39896268|FG002|Overall Study|Adverse Event|0|||
16385817|NCT01307449|39896269|FG003|Overall Study|Adverse Event|0|||
16385818|NCT01334554|39896270|FG000|Overall Study|Adverse Event|4|||
16385819|NCT01334554|39896271|FG001|Overall Study|Adverse Event|2|||
16385820|NCT00613106|39896272|FG000|Overall Study|Adverse Event|3|||
16385821|NCT00613106|39896273|FG001|Overall Study|Adverse Event|1|||
16385822|NCT00613106|39896272|FG000|Overall Study|Withdrawal by Subject|6|||
16385823|NCT00613106|39896273|FG001|Overall Study|Withdrawal by Subject|3|||
16385824|NCT00613106|39896272|FG000|Overall Study|Lost to Follow-up|7|||
16385825|NCT00613106|39896273|FG001|Overall Study|Lost to Follow-up|2|||
16385826|NCT00613106|39896272|FG000|Overall Study|misc|4|||
16385827|NCT00613106|39896273|FG001|Overall Study|misc|3|||
16385828|NCT00831389|39896274|FG000|Overall Study|Withdrawal by Subject|0|||
16385829|NCT00831389|39896275|FG001|Overall Study|Withdrawal by Subject|1|||
16385830|NCT01374425|39896276|FG000|Overall Study|Radiographic Disease Progression|86|||
16385831|NCT01374425|39896277|FG001|Overall Study|Radiographic Disease Progression|81|||
16385832|NCT01374425|39896276|FG000|Overall Study|Clinical Disease Progression|9|||
16385833|NCT01374425|39896277|FG001|Overall Study|Clinical Disease Progression|6|||
16385834|NCT01374425|39896276|FG000|Overall Study|Adverse Event|29|||
16385835|NCT01374425|39896277|FG001|Overall Study|Adverse Event|18|||
16385836|NCT01374425|39896276|FG000|Overall Study|Death (Progression of Disease)|1|||
16385837|NCT01374425|39896277|FG001|Overall Study|Death (Progression of Disease)|0|||
16385838|NCT01374425|39896276|FG000|Overall Study|Death (Adverse Event)|2|||
16385839|NCT01374425|39896277|FG001|Overall Study|Death (Adverse Event)|4|||
16385840|NCT01374425|39896276|FG000|Overall Study|Withdrawal by Subject|6|||
16385841|NCT01374425|39896277|FG001|Overall Study|Withdrawal by Subject|7|||
16385842|NCT01374425|39896276|FG000|Overall Study|Refused Treatment|10|||
16385843|NCT01374425|39896277|FG001|Overall Study|Refused Treatment|24|||
16385844|NCT01374425|39896276|FG000|Overall Study|Protocol Violation|2|||
16385845|NCT01374425|39896277|FG001|Overall Study|Protocol Violation|3|||
16385846|NCT01374425|39896276|FG000|Overall Study|Sponsor Decision|0|||
16385847|NCT01374425|39896277|FG001|Overall Study|Sponsor Decision|1|||
16385848|NCT01374425|39896276|FG000|Overall Study|Lost to Follow-up|2|||
16385849|NCT01374425|39896277|FG001|Overall Study|Lost to Follow-up|1|||
16385850|NCT01374425|39896276|FG000|Overall Study|Other|41|||
16385851|NCT01374425|39896277|FG001|Overall Study|Other|43|||
16385852|NCT01990742|39896278|FG000|Overall Study|Withdrawal by facility|407|||
16385853|NCT01990742|39896279|FG001|Overall Study|Withdrawal by facility|1083|||
16489973|NCT02207244|40267110|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16385854|NCT01990742|39896278|FG000|Overall Study|Facility closed|0|||
16385855|NCT01990742|39896279|FG001|Overall Study|Facility closed|270|||
16385856|NCT02170064|39896280|FG000|Overall Study|Withdrawal by Subject|5|||
16385857|NCT02170064|39896281|FG001|Overall Study|Withdrawal by Subject|1|||
16385858|NCT02170064|39896282|FG002|Overall Study|Withdrawal by Subject|1|||
16385859|NCT02170064|39896280|FG000|Overall Study|Physician Decision|1|||
16385860|NCT02170064|39896281|FG001|Overall Study|Physician Decision|1|||
16385861|NCT02170064|39896282|FG002|Overall Study|Physician Decision|0|||
16385862|NCT02138825|39896283|FG000|Main Study Treatment|Adverse Event|11|||
16385863|NCT02138825|39896284|FG001|Main Study Treatment|Adverse Event|3|||
16385864|NCT02138825|39896283|FG000|Main Study Treatment|Death|1|||
16385865|NCT02138825|39896284|FG001|Main Study Treatment|Death|2|||
16385866|NCT02138825|39896283|FG000|Main Study Treatment|Protocol Violation|2|||
16385867|NCT02138825|39896284|FG001|Main Study Treatment|Protocol Violation|2|||
16385868|NCT02138825|39896283|FG000|Main Study Treatment|Sponsor decision|12|||
16385869|NCT02138825|39896284|FG001|Main Study Treatment|Sponsor decision|18|||
16385870|NCT02138825|39896283|FG000|Main Study Treatment|Study terminated by sponsor|10|||
16385871|NCT02138825|39896284|FG001|Main Study Treatment|Study terminated by sponsor|9|||
16385872|NCT02138825|39896283|FG000|Main Study Treatment|Withdrawal by Subject|3|||
16385873|NCT02138825|39896284|FG001|Main Study Treatment|Withdrawal by Subject|1|||
16385874|NCT02138825|39896283|FG000|Main Study Treatment|Medical decision|1|||
16385875|NCT02138825|39896284|FG001|Main Study Treatment|Medical decision|0|||
16385876|NCT02138825|39896283|FG000|Long-term Extension|Study termination by sponsor|32|||
16385877|NCT02138825|39896284|FG001|Long-term Extension|Study termination by sponsor|38|||
16385878|NCT02138825|39896283|FG000|Safety Follow-up|Adverse Event|4|||
16385879|NCT02138825|39896284|FG001|Safety Follow-up|Adverse Event|3|||
16385880|NCT02138825|39896283|FG000|Safety Follow-up|Death|11|||
16385881|NCT02138825|39896284|FG001|Safety Follow-up|Death|5|||
16299706|NCT02031458|39581980|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
16299707|NCT02031458|39581978|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
16299708|NCT02031458|39581979|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
16299709|NCT02031458|39581980|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
16299710|NCT02031458|39581978|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
16299711|NCT02031458|39581979|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
16299712|NCT02031458|39581980|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
16299713|NCT02031458|39581978|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
16299714|NCT02031458|39581979|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
16299715|NCT02031458|39581980|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
16299716|NCT02031458|39581978|FG000|Baseline to May 8, 2015|Death|36|||
16299717|NCT02031458|39581979|FG001|Baseline to May 8, 2015|Death|87|||
16299718|NCT02031458|39581980|FG002|Baseline to May 8, 2015|Death|100|||
16299719|NCT02031458|39581978|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
16299720|NCT02031458|39581979|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
16299721|NCT02031458|39581980|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
16299722|NCT02031458|39581978|FG000|Baseline to May 8, 2015|Physician Decision|0|||
16299723|NCT02031458|39581979|FG001|Baseline to May 8, 2015|Physician Decision|1|||
16385882|NCT02138825|39896283|FG000|Safety Follow-up|Withdrawal by Subject|5|||
16385883|NCT02138825|39896284|FG001|Safety Follow-up|Withdrawal by Subject|3|||
16385884|NCT02138825|39896283|FG000|Safety Follow-up|clinic worsening|1|||
16385885|NCT02138825|39896284|FG001|Safety Follow-up|clinic worsening|0|||
16385886|NCT02138825|39896283|FG000|Safety Follow-up|withdrawal by PI|1|||
16385887|NCT02138825|39896284|FG001|Safety Follow-up|withdrawal by PI|0|||
16385888|NCT02138825|39896283|FG000|Safety Follow-up|logistical difficulties|0|||
16385889|NCT02138825|39896284|FG001|Safety Follow-up|logistical difficulties|1|||
16385890|NCT02138825|39896283|FG000|Safety Follow-up|progressive disease|0|||
16385891|NCT02138825|39896284|FG001|Safety Follow-up|progressive disease|2|||
16385892|NCT02138825|39896283|FG000|Safety Follow-up|too unwell to attend the visit|0|||
16385893|NCT02138825|39896284|FG001|Safety Follow-up|too unwell to attend the visit|1|||
16385894|NCT02138825|39896283|FG000|Safety Follow-up|treatment unblinded|0|||
16385895|NCT02138825|39896284|FG001|Safety Follow-up|treatment unblinded|1|||
16385896|NCT02138825|39896283|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
16385897|NCT02138825|39896284|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
16385898|NCT02115321|39896285|FG000|Overall Study|Death|1|||
16385899|NCT02115321|39896286|FG001|Overall Study|Death|0|||
16385900|NCT01664624|39896289|FG000|Overall Study|Adverse Event|0|||
16385901|NCT01664624|39896290|FG001|Overall Study|Adverse Event|1|||
16385902|NCT01664624|39896291|FG002|Overall Study|Adverse Event|0|||
16385903|NCT01664624|39896292|FG003|Overall Study|Adverse Event|0|||
16385904|NCT01932788|39896293|FG000|Overall Study|Protocol Violation|18|||
16385905|NCT01932788|39896294|FG001|Overall Study|Protocol Violation|0|||
16385906|NCT01932788|39896293|FG000|Overall Study|Lost to Follow-up|18|||
16385907|NCT01932788|39896294|FG001|Overall Study|Lost to Follow-up|46|||
16385908|NCT01932788|39896293|FG000|Overall Study|Lack of Efficacy|2|||
16385909|NCT01932788|39896294|FG001|Overall Study|Lack of Efficacy|0|||
16385910|NCT01932788|39896293|FG000|Overall Study|Withdrawal by Subject|0|||
16385911|NCT01932788|39896294|FG001|Overall Study|Withdrawal by Subject|5|||
16385912|NCT04046939|39896295|FG000|Primary Assessment Period|Adverse Event|1|||
16385913|NCT04046939|39896296|FG001|Primary Assessment Period|Adverse Event|0|||
16299724|NCT02031458|39581980|FG002|Baseline to May 8, 2015|Physician Decision|0|||
16299725|NCT02031458|39581978|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
16299726|NCT02031458|39581979|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
16299727|NCT02031458|39581980|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
16299728|NCT02031458|39581978|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
16299729|NCT02031458|39581979|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
16299730|NCT02031458|39581980|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
16299731|NCT02031458|39581978|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
16299732|NCT02031458|39581979|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
16299733|NCT02031458|39581980|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
16299734|NCT02031458|39581978|FG000|Baseline to May 8, 2015|On Treatment|43|||
16299735|NCT02031458|39581979|FG001|Baseline to May 8, 2015|On Treatment|81|||
16299736|NCT02031458|39581980|FG002|Baseline to May 8, 2015|On Treatment|73|||
16299737|NCT02031458|39581978|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
16299738|NCT02031458|39581979|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
16299739|NCT02031458|39581980|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
16299740|NCT01646138|39581981|FG000|Overall Study|Lost to Follow-up|0|||
16299741|NCT01646138|39581982|FG001|Overall Study|Lost to Follow-up|0|||
16299742|NCT01646138|39581983|FG002|Overall Study|Lost to Follow-up|0|||
16299743|NCT01646138|39581984|FG003|Overall Study|Lost to Follow-up|0|||
16299744|NCT01646138|39581985|FG004|Overall Study|Lost to Follow-up|2|||
16299745|NCT00605540|39581986|FG000|Overall Study|Death|15|||
16299746|NCT00605540|39581986|FG000|Overall Study|Lost to Follow-up|23|||
16299747|NCT01823835|39581995|FG000|Overall Study|Adverse Event|0|||
16299748|NCT01823835|39581996|FG001|Overall Study|Adverse Event|0|||
16299749|NCT01823835|39581997|FG002|Overall Study|Adverse Event|0|||
16299750|NCT01823835|39581998|FG003|Overall Study|Adverse Event|0|||
16299751|NCT01823835|39581999|FG004|Overall Study|Adverse Event|1|||
16299752|NCT01823835|39582000|FG005|Overall Study|Adverse Event|0|||
16299753|NCT01823835|39582001|FG006|Overall Study|Adverse Event|1|||
16299754|NCT01823835|39582002|FG007|Overall Study|Adverse Event|0|||
16299755|NCT01823835|39582003|FG008|Overall Study|Adverse Event|0|||
16299756|NCT01823835|39582004|FG009|Overall Study|Adverse Event|0|||
16299757|NCT01823835|39582005|FG010|Overall Study|Adverse Event|1|||
16299758|NCT01823835|39582006|FG011|Overall Study|Adverse Event|2|||
16299759|NCT01823835|39582007|FG012|Overall Study|Adverse Event|0|||
16299760|NCT01823835|39582008|FG013|Overall Study|Adverse Event|0|||
16299761|NCT01823835|39582009|FG014|Overall Study|Adverse Event|0|||
16299762|NCT01823835|39581995|FG000|Overall Study|Physician Decision|0|||
16299763|NCT01823835|39581996|FG001|Overall Study|Physician Decision|0|||
16299764|NCT01823835|39581997|FG002|Overall Study|Physician Decision|0|||
16299765|NCT01823835|39581998|FG003|Overall Study|Physician Decision|0|||
16299766|NCT01823835|39581999|FG004|Overall Study|Physician Decision|0|||
16299767|NCT01823835|39582000|FG005|Overall Study|Physician Decision|0|||
16299768|NCT01823835|39582001|FG006|Overall Study|Physician Decision|0|||
16299769|NCT01823835|39582002|FG007|Overall Study|Physician Decision|0|||
16299770|NCT01823835|39582003|FG008|Overall Study|Physician Decision|0|||
16299771|NCT01823835|39582004|FG009|Overall Study|Physician Decision|0|||
16299772|NCT01823835|39582005|FG010|Overall Study|Physician Decision|0|||
16299773|NCT01823835|39582006|FG011|Overall Study|Physician Decision|2|||
16299774|NCT01823835|39582007|FG012|Overall Study|Physician Decision|0|||
16299775|NCT01823835|39582008|FG013|Overall Study|Physician Decision|0|||
16299776|NCT01823835|39582009|FG014|Overall Study|Physician Decision|0|||
16299777|NCT01823835|39581995|FG000|Overall Study|Progressive Disease|3|||
16299778|NCT01823835|39581996|FG001|Overall Study|Progressive Disease|4|||
16299779|NCT01823835|39581997|FG002|Overall Study|Progressive Disease|3|||
16299780|NCT01823835|39581998|FG003|Overall Study|Progressive Disease|6|||
16299781|NCT01823835|39581999|FG004|Overall Study|Progressive Disease|4|||
16299782|NCT01823835|39582000|FG005|Overall Study|Progressive Disease|6|||
16299783|NCT01823835|39582001|FG006|Overall Study|Progressive Disease|5|||
16299784|NCT01823835|39582002|FG007|Overall Study|Progressive Disease|3|||
16299785|NCT01823835|39582003|FG008|Overall Study|Progressive Disease|3|||
16299786|NCT01823835|39582004|FG009|Overall Study|Progressive Disease|18|||
16299787|NCT01823835|39582005|FG010|Overall Study|Progressive Disease|8|||
16299788|NCT01823835|39582006|FG011|Overall Study|Progressive Disease|46|||
16299789|NCT01823835|39582007|FG012|Overall Study|Progressive Disease|18|||
16299790|NCT01823835|39582008|FG013|Overall Study|Progressive Disease|4|||
16299791|NCT01823835|39582009|FG014|Overall Study|Progressive Disease|6|||
16299792|NCT01823835|39581995|FG000|Overall Study|Study Termination|0|||
16299793|NCT01823835|39581996|FG001|Overall Study|Study Termination|0|||
16299794|NCT01823835|39581997|FG002|Overall Study|Study Termination|0|||
16299795|NCT01823835|39581998|FG003|Overall Study|Study Termination|0|||
16299796|NCT01823835|39581999|FG004|Overall Study|Study Termination|1|||
16299797|NCT01823835|39582000|FG005|Overall Study|Study Termination|0|||
16299798|NCT01823835|39582001|FG006|Overall Study|Study Termination|0|||
16489974|NCT02207244|40267111|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16299799|NCT01823835|39582002|FG007|Overall Study|Study Termination|0|||
16299800|NCT01823835|39582003|FG008|Overall Study|Study Termination|0|||
16299801|NCT01823835|39582004|FG009|Overall Study|Study Termination|0|||
16489975|NCT02207244|40267112|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
16489976|NCT02207244|40267102|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16083752|NCT01074294|38799203|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
16299802|NCT01823835|39582005|FG010|Overall Study|Study Termination|0|||
16299803|NCT01823835|39582006|FG011|Overall Study|Study Termination|1|||
16299804|NCT01823835|39582007|FG012|Overall Study|Study Termination|0|||
16299805|NCT01823835|39582008|FG013|Overall Study|Study Termination|0|||
16299806|NCT01823835|39582009|FG014|Overall Study|Study Termination|0|||
16299807|NCT01823835|39581995|FG000|Overall Study|Withdrawal by Subject|0|||
16299808|NCT01823835|39581996|FG001|Overall Study|Withdrawal by Subject|0|||
16299809|NCT01823835|39581997|FG002|Overall Study|Withdrawal by Subject|1|||
16299810|NCT01823835|39581998|FG003|Overall Study|Withdrawal by Subject|0|||
16299811|NCT01823835|39581999|FG004|Overall Study|Withdrawal by Subject|0|||
16299812|NCT01823835|39582000|FG005|Overall Study|Withdrawal by Subject|0|||
16299813|NCT01823835|39582001|FG006|Overall Study|Withdrawal by Subject|0|||
16299814|NCT01823835|39582002|FG007|Overall Study|Withdrawal by Subject|0|||
16299815|NCT01823835|39582003|FG008|Overall Study|Withdrawal by Subject|0|||
16299816|NCT01823835|39582004|FG009|Overall Study|Withdrawal by Subject|1|||
16299817|NCT01823835|39582005|FG010|Overall Study|Withdrawal by Subject|1|||
16299818|NCT01823835|39582006|FG011|Overall Study|Withdrawal by Subject|2|||
16299819|NCT01823835|39582007|FG012|Overall Study|Withdrawal by Subject|1|||
16299820|NCT01823835|39582008|FG013|Overall Study|Withdrawal by Subject|0|||
16299821|NCT01823835|39582009|FG014|Overall Study|Withdrawal by Subject|0|||
16299822|NCT03678285|39582011|FG000|Overall Study|Adverse Event|2|||
16299823|NCT03678285|39582011|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
16385914|NCT04046939|39896297|FG002|Primary Assessment Period|Adverse Event|0|||
16385915|NCT04046939|39896298|FG003|Primary Assessment Period|Adverse Event|0|||
16385916|NCT04046939|39896295|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
16385917|NCT04046939|39896296|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
16385918|NCT04046939|39896297|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
16385919|NCT04046939|39896298|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
16385920|NCT04046939|39896295|FG000|Primary Assessment Period|Physician Decision|0|||
16385921|NCT04046939|39896296|FG001|Primary Assessment Period|Physician Decision|0|||
16385922|NCT04046939|39896297|FG002|Primary Assessment Period|Physician Decision|1|||
16385923|NCT04046939|39896298|FG003|Primary Assessment Period|Physician Decision|0|||
16385924|NCT04046939|39896295|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
16385925|NCT04046939|39896296|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
16385926|NCT04046939|39896297|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
16385927|NCT04046939|39896298|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
16385928|NCT02493764|39896300|FG000|Overall Study|Adverse Event|2|||
16385929|NCT02493764|39896301|FG001|Overall Study|Adverse Event|2|||
16385930|NCT02493764|39896300|FG000|Overall Study|Death|44|||
16385931|NCT02493764|39896301|FG001|Overall Study|Death|58|||
16385932|NCT02493764|39896300|FG000|Overall Study|Lost to Follow-up|2|||
16385933|NCT02493764|39896301|FG001|Overall Study|Lost to Follow-up|1|||
16385934|NCT02493764|39896300|FG000|Overall Study|Protocol Violation|6|||
16385935|NCT02493764|39896301|FG001|Overall Study|Protocol Violation|7|||
16385936|NCT02493764|39896300|FG000|Overall Study|Physician Decision|1|||
16083753|NCT01074294|38799204|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
16083754|NCT01074294|38799205|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
16083755|NCT01074294|38799202|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
16083756|NCT01074294|38799203|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
16083757|NCT01074294|38799204|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
16083758|NCT01074294|38799205|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
16191553|NCT03554005|39179328|FG005|Overall Study|Adverse Event|3|||
16191554|NCT03554005|39179323|FG000|Overall Study|Physician Decision|0|||
16385937|NCT02493764|39896301|FG001|Overall Study|Physician Decision|1|||
16385938|NCT02493764|39896300|FG000|Overall Study|Participant moved|17|||
16385939|NCT02493764|39896301|FG001|Overall Study|Participant moved|5|||
16385940|NCT02493764|39896300|FG000|Overall Study|Withdrawal parent/guardian|0|||
16385941|NCT02493764|39896301|FG001|Overall Study|Withdrawal parent/guardian|1|||
16385942|NCT02493764|39896300|FG000|Overall Study|Withdrawal by Subject|11|||
16299824|NCT03678285|39582011|FG000|Overall Study|Dehydrated prior to start of workout|1|||
16299825|NCT01210612|39582015|FG000|Overall Study|Withdrawal by Subject|0|||
16299826|NCT01210612|39582016|FG001|Overall Study|Withdrawal by Subject|2|||
16299827|NCT01081834|39582017|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
16385943|NCT02493764|39896301|FG001|Overall Study|Withdrawal by Subject|7|||
16385944|NCT02303262|39896305|FG000|Overall Study|Withdrawal by Subject|2|||
16385945|NCT00335829|39896307|FG000|Overall Study|Withdrawal by Subject|1|||
16385946|NCT00335829|39896307|FG000|Overall Study|Lost to Follow-up|1|||
16385947|NCT00335829|39896307|FG000|Overall Study|Adverse Event|1|||
16385948|NCT04079738|39896310|FG000|Study Treatment|Death|1|||
16385949|NCT04079738|39896311|FG001|Study Treatment|Death|0|||
16385950|NCT04079738|39896312|FG002|Study Treatment|Death|0|||
16385951|NCT04079738|39896313|FG003|Study Treatment|Death|0|||
16385952|NCT04079738|39896310|FG000|Study Treatment|Adverse Event|2|||
16385953|NCT04079738|39896311|FG001|Study Treatment|Adverse Event|0|||
16385954|NCT04079738|39896312|FG002|Study Treatment|Adverse Event|0|||
16385955|NCT04079738|39896313|FG003|Study Treatment|Adverse Event|0|||
16385956|NCT04079738|39896310|FG000|Study Treatment|withdrawal before treatment|1|||
16299828|NCT01081834|39582018|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
16299829|NCT01081834|39582019|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
16299830|NCT01081834|39582020|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
16299831|NCT01081834|39582021|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
16299832|NCT01081834|39582017|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
16299833|NCT01081834|39582018|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
16299834|NCT01081834|39582019|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
16299835|NCT01081834|39582020|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
16299836|NCT01081834|39582021|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
16299837|NCT01081834|39582017|FG000|Core Period: Baseline to Week 26|Death|1|||
16299838|NCT01081834|39582018|FG001|Core Period: Baseline to Week 26|Death|0|||
16299839|NCT01081834|39582019|FG002|Core Period: Baseline to Week 26|Death|0|||
16299840|NCT01081834|39582020|FG003|Core Period: Baseline to Week 26|Death|0|||
16299841|NCT01081834|39582021|FG004|Core Period: Baseline to Week 26|Death|0|||
16385957|NCT04079738|39896311|FG001|Study Treatment|withdrawal before treatment|0|||
16385958|NCT04079738|39896312|FG002|Study Treatment|withdrawal before treatment|0|||
16385959|NCT04079738|39896313|FG003|Study Treatment|withdrawal before treatment|0|||
16385960|NCT04079738|39896310|FG000|Study Treatment|symptomatic deterioration|2|||
16385961|NCT04079738|39896311|FG001|Study Treatment|symptomatic deterioration|0|||
16385962|NCT04079738|39896312|FG002|Study Treatment|symptomatic deterioration|0|||
16385963|NCT04079738|39896313|FG003|Study Treatment|symptomatic deterioration|0|||
16385964|NCT04079738|39896310|FG000|Study Treatment|Disease Progression|1|||
16385965|NCT04079738|39896311|FG001|Study Treatment|Disease Progression|0|||
16385966|NCT04079738|39896312|FG002|Study Treatment|Disease Progression|0|||
16299842|NCT01081834|39582017|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
16385967|NCT04079738|39896313|FG003|Study Treatment|Disease Progression|0|||
16385968|NCT04079738|39896310|FG000|Study Treatment|withdrawal after treatment|1|||
16385969|NCT04079738|39896311|FG001|Study Treatment|withdrawal after treatment|0|||
16385970|NCT04079738|39896312|FG002|Study Treatment|withdrawal after treatment|0|||
16385971|NCT04079738|39896313|FG003|Study Treatment|withdrawal after treatment|0|||
16385972|NCT04079738|39896310|FG000|Follow up|Withdrawal by Subject|3|||
16385973|NCT04079738|39896311|FG001|Follow up|Withdrawal by Subject|0|||
16385974|NCT04079738|39896312|FG002|Follow up|Withdrawal by Subject|0|||
16385975|NCT04079738|39896313|FG003|Follow up|Withdrawal by Subject|0|||
16489977|NCT02207244|40267103|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16489978|NCT02207244|40267104|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16489979|NCT02207244|40267105|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
16489980|NCT02207244|40267106|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
16489981|NCT02207244|40267107|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
16489982|NCT02207244|40267108|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16489983|NCT02207244|40267109|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16385976|NCT04079738|39896310|FG000|Follow up|Death|5|||
16385977|NCT04079738|39896311|FG001|Follow up|Death|0|||
16385978|NCT04079738|39896312|FG002|Follow up|Death|0|||
16385979|NCT04079738|39896313|FG003|Follow up|Death|0|||
16489984|NCT02207244|40267110|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16489985|NCT02207244|40267111|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16489986|NCT02207244|40267112|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
16489987|NCT02207244|40267102|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16489988|NCT02207244|40267103|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16489989|NCT02207244|40267104|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16489990|NCT02207244|40267105|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
16489991|NCT02207244|40267106|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16489992|NCT02207244|40267107|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
16489993|NCT02207244|40267108|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16489994|NCT02207244|40267109|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16489995|NCT02207244|40267110|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16489996|NCT02207244|40267111|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16489997|NCT02207244|40267112|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
16083759|NCT01074294|38799202|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
16083760|NCT01074294|38799203|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
16083761|NCT01074294|38799204|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
16083762|NCT01074294|38799205|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
16083763|NCT01074294|38799202|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
16083764|NCT01074294|38799203|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
16083765|NCT01074294|38799204|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
16191555|NCT03554005|39179324|FG001|Overall Study|Physician Decision|0|||
16191556|NCT03554005|39179325|FG002|Overall Study|Physician Decision|0|||
16191557|NCT03554005|39179326|FG003|Overall Study|Physician Decision|0|||
16191558|NCT03554005|39179327|FG004|Overall Study|Physician Decision|1|||
16191559|NCT03554005|39179328|FG005|Overall Study|Physician Decision|0|||
16191560|NCT03554005|39179323|FG000|Overall Study|Other|0|||
16191561|NCT03554005|39179324|FG001|Overall Study|Other|0|||
16191562|NCT03554005|39179325|FG002|Overall Study|Other|0|||
16191563|NCT03554005|39179326|FG003|Overall Study|Other|0|||
16191564|NCT03554005|39179327|FG004|Overall Study|Other|0|||
16191565|NCT03554005|39179328|FG005|Overall Study|Other|1|||
16191566|NCT05142332|39179330|FG000|Overall Study|Withdrawal by Subject|0|||
16191567|NCT05142332|39179331|FG001|Overall Study|Withdrawal by Subject|1|||
16489998|NCT02207244|40267102|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
16489999|NCT02207244|40267103|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
16490000|NCT02207244|40267104|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
16490001|NCT02207244|40267105|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
16490002|NCT02207244|40267106|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
16490003|NCT02207244|40267107|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
16490004|NCT02207244|40267108|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
16191568|NCT05142332|39179332|FG002|Overall Study|Withdrawal by Subject|2|||
16191569|NCT05142332|39179333|FG003|Overall Study|Withdrawal by Subject|0|||
16191570|NCT05142332|39179334|FG004|Overall Study|Withdrawal by Subject|0|||
16191571|NCT05142332|39179335|FG005|Overall Study|Withdrawal by Subject|2|||
16191572|NCT05142332|39179336|FG006|Overall Study|Withdrawal by Subject|6|||
16191573|NCT05142332|39179330|FG000|Overall Study|Left ED|3|||
16191574|NCT05142332|39179331|FG001|Overall Study|Left ED|0|||
16191575|NCT05142332|39179332|FG002|Overall Study|Left ED|4|||
16191576|NCT05142332|39179333|FG003|Overall Study|Left ED|6|||
16191577|NCT05142332|39179334|FG004|Overall Study|Left ED|1|||
16191578|NCT05142332|39179335|FG005|Overall Study|Left ED|2|||
16191579|NCT05142332|39179336|FG006|Overall Study|Left ED|6|||
16191580|NCT05142332|39179330|FG000|Overall Study|Physician Decision|0|||
16385980|NCT03012334|39896319|FG000|Period 1|Withdrawal by Subject|0|||
16385981|NCT03012334|39896320|FG001|Period 1|Withdrawal by Subject|0|||
16385982|NCT03012334|39896321|FG002|Period 1|Withdrawal by Subject|0|||
16385983|NCT03012334|39896322|FG003|Period 1|Withdrawal by Subject|0|||
16191581|NCT05142332|39179331|FG001|Overall Study|Physician Decision|0|||
16191582|NCT05142332|39179332|FG002|Overall Study|Physician Decision|2|||
16191583|NCT05142332|39179333|FG003|Overall Study|Physician Decision|1|||
16191584|NCT05142332|39179334|FG004|Overall Study|Physician Decision|0|||
16191585|NCT05142332|39179335|FG005|Overall Study|Physician Decision|0|||
16191586|NCT05142332|39179336|FG006|Overall Study|Physician Decision|3|||
16191587|NCT05142332|39179330|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
16191588|NCT05142332|39179331|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
16191589|NCT05142332|39179332|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
16191590|NCT05142332|39179333|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
16191591|NCT05142332|39179334|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
16191592|NCT05142332|39179335|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
16191593|NCT05142332|39179336|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
16385984|NCT03012334|39896323|FG004|Period 1|Withdrawal by Subject|0|||
16385985|NCT03012334|39896324|FG005|Period 1|Withdrawal by Subject|0|||
16385986|NCT03012334|39896325|FG006|Period 1|Withdrawal by Subject|0|||
16385987|NCT03012334|39896326|FG007|Period 1|Withdrawal by Subject|0|||
16385988|NCT03012334|39896327|FG008|Period 1|Withdrawal by Subject|0|||
16490005|NCT02207244|40267109|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
16490006|NCT02207244|40267110|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
16191594|NCT05460871|39179337|FG000|Overall Study|Withdrawal by Subject|1|||
16191595|NCT05460871|39179338|FG001|Overall Study|Withdrawal by Subject|2|||
16191596|NCT00937560|39179342|FG000|Initial Treatment|Death|6|||
16191597|NCT00937560|39179342|FG000|Initial Treatment|Withdraw consent|3|||
16191598|NCT00937560|39179342|FG000|Initial Treatment|Adverse Event|1|||
16191599|NCT00937560|39179342|FG000|Initial Treatment|Lost to Follow-up|1|||
16191600|NCT00937560|39179342|FG000|Initial Treatment|No end of study page|10|||
16191601|NCT00937560|39179342|FG000|Maintenance Treatment|Death|12|||
16385989|NCT03012334|39896328|FG009|Period 1|Withdrawal by Subject|1|||
16385990|NCT03012334|39896319|FG000|Period 2|Withdrawal by Subject|0|||
16385991|NCT03012334|39896320|FG001|Period 2|Withdrawal by Subject|1|||
16385992|NCT03012334|39896321|FG002|Period 2|Withdrawal by Subject|0|||
16385993|NCT03012334|39896322|FG003|Period 2|Withdrawal by Subject|0|||
16385994|NCT03012334|39896323|FG004|Period 2|Withdrawal by Subject|0|||
16385995|NCT03012334|39896324|FG005|Period 2|Withdrawal by Subject|0|||
16385996|NCT03012334|39896325|FG006|Period 2|Withdrawal by Subject|0|||
16385997|NCT03012334|39896326|FG007|Period 2|Withdrawal by Subject|0|||
16385998|NCT03012334|39896327|FG008|Period 2|Withdrawal by Subject|0|||
16385999|NCT03012334|39896328|FG009|Period 2|Withdrawal by Subject|0|||
16386000|NCT03012334|39896319|FG000|Period 2|Protocol Violation|0|||
16386001|NCT03012334|39896320|FG001|Period 2|Protocol Violation|0|||
16191602|NCT00937560|39179342|FG000|Maintenance Treatment|Withdraw consent|5|||
16191603|NCT00937560|39179342|FG000|Maintenance Treatment|According to protocol|1|||
16191604|NCT03215264|39179345|FG000|Dose Level 2|Adverse Event|0|||
16191605|NCT03215264|39179346|FG001|Dose Level 2|Adverse Event|1|||
16191606|NCT03215264|39179347|FG002|Dose Level 2|Adverse Event|0|||
16191607|NCT03215264|39179345|FG000|Dose Level 3|Withdrawal by Subject|0|||
16191608|NCT03215264|39179346|FG001|Dose Level 3|Withdrawal by Subject|0|||
16191609|NCT03215264|39179347|FG002|Dose Level 3|Withdrawal by Subject|1|||
16191610|NCT00905021|39179348|FG000|Overall Study|Adverse Event|2|||
16191611|NCT01104584|39179349|FG000|Overall Study|Study drug never administered|21|||
16191612|NCT01104584|39179349|FG000|Overall Study|Study prematurely discontinued|2|||
16191613|NCT03050359|39179352|FG000|Overall Study|Randomized But Not Treated|2|||
16191614|NCT03050359|39179353|FG001|Overall Study|Randomized But Not Treated|0|||
16191615|NCT03050359|39179352|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
16191616|NCT03050359|39179353|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
16191617|NCT03050359|39179352|FG000|Overall Study|Significant Protocol Deviation|2|||
16386002|NCT03012334|39896321|FG002|Period 2|Protocol Violation|1|||
16386003|NCT03012334|39896322|FG003|Period 2|Protocol Violation|0|||
16386004|NCT03012334|39896323|FG004|Period 2|Protocol Violation|0|||
16386005|NCT03012334|39896324|FG005|Period 2|Protocol Violation|0|||
16386006|NCT03012334|39896325|FG006|Period 2|Protocol Violation|0|||
16386007|NCT03012334|39896326|FG007|Period 2|Protocol Violation|1|||
16191618|NCT03050359|39179353|FG001|Overall Study|Significant Protocol Deviation|3|||
16191619|NCT03050359|39179352|FG000|Overall Study|Lost to Follow-up|2|||
16386008|NCT03012334|39896327|FG008|Period 2|Protocol Violation|0|||
16386009|NCT03012334|39896328|FG009|Period 2|Protocol Violation|0|||
16386010|NCT03012334|39896319|FG000|Period 4|Non-Compliance|0|||
16386011|NCT03012334|39896320|FG001|Period 4|Non-Compliance|0|||
16386012|NCT03012334|39896321|FG002|Period 4|Non-Compliance|0|||
16386013|NCT03012334|39896322|FG003|Period 4|Non-Compliance|0|||
16386014|NCT03012334|39896323|FG004|Period 4|Non-Compliance|0|||
16386015|NCT03012334|39896324|FG005|Period 4|Non-Compliance|0|||
16386016|NCT03012334|39896325|FG006|Period 4|Non-Compliance|1|||
16386017|NCT03012334|39896326|FG007|Period 4|Non-Compliance|0|||
16191620|NCT03050359|39179353|FG001|Overall Study|Lost to Follow-up|1|||
16191621|NCT03050359|39179352|FG000|Overall Study|Voluntary Withdrawal|4|||
16191622|NCT03050359|39179353|FG001|Overall Study|Voluntary Withdrawal|6|||
16191623|NCT03050359|39179352|FG000|Overall Study|Pregnancy|1|||
16191624|NCT03050359|39179353|FG001|Overall Study|Pregnancy|0|||
16191625|NCT03050359|39179352|FG000|Overall Study|Reason Not Specified|1|||
16191626|NCT03050359|39179353|FG001|Overall Study|Reason Not Specified|0|||
16191627|NCT01740440|39179354|FG000|Overall Study|Lost to Follow-up|3|||
16191628|NCT01675011|39179355|FG000|Overall Study|Trial terminated by Sponsor|3|||
16191629|NCT01675011|39179356|FG001|Overall Study|Trial terminated by Sponsor|1|||
16191630|NCT03116399|39179357|FG000|Overall Study|Death|8|||
16191631|NCT03116399|39179358|FG001|Overall Study|Death|3|||
16191632|NCT03116399|39179357|FG000|Overall Study|Lost to Follow-up|7|||
16191633|NCT03116399|39179358|FG001|Overall Study|Lost to Follow-up|11|||
16191634|NCT03116399|39179357|FG000|Overall Study|Investigator Decision|1|||
16191635|NCT03116399|39179358|FG001|Overall Study|Investigator Decision|1|||
16386018|NCT03012334|39896327|FG008|Period 4|Non-Compliance|0|||
16386019|NCT03012334|39896328|FG009|Period 4|Non-Compliance|0|||
16386020|NCT03012334|39896319|FG000|Period 4|Adverse Event|0|||
16386021|NCT03012334|39896320|FG001|Period 4|Adverse Event|0|||
16386022|NCT03012334|39896321|FG002|Period 4|Adverse Event|0|||
16191636|NCT03116399|39179357|FG000|Overall Study|Withdrawal by Subject|24|||
16191637|NCT03116399|39179358|FG001|Overall Study|Withdrawal by Subject|9|||
16191638|NCT03521687|39179361|FG000|Overall Study|Adverse Event|4|||
16191639|NCT03521687|39179361|FG000|Overall Study|Physician Decision|1|||
16191640|NCT01468909|39179362|FG000|Overall Study|Never Treated|2|||
16191641|NCT01468909|39179363|FG001|Overall Study|Never Treated|2|||
16191642|NCT01258348|39179364|FG000|Overall Study|Adverse Event|1|||
16386023|NCT03012334|39896322|FG003|Period 4|Adverse Event|0|||
16386024|NCT03012334|39896323|FG004|Period 4|Adverse Event|0|||
16386025|NCT03012334|39896324|FG005|Period 4|Adverse Event|0|||
16386026|NCT03012334|39896325|FG006|Period 4|Adverse Event|0|||
16191643|NCT01258348|39179365|FG001|Overall Study|Adverse Event|1|||
16191644|NCT01258348|39179366|FG002|Overall Study|Adverse Event|3|||
16191645|NCT01258348|39179367|FG003|Overall Study|Adverse Event|2|||
16191646|NCT01258348|39179368|FG004|Overall Study|Adverse Event|4|||
16191647|NCT01258348|39179364|FG000|Overall Study|Progressive Disease|0|||
16191648|NCT01258348|39179365|FG001|Overall Study|Progressive Disease|3|||
16191649|NCT01258348|39179366|FG002|Overall Study|Progressive Disease|0|||
16191650|NCT01258348|39179367|FG003|Overall Study|Progressive Disease|2|||
16191651|NCT01258348|39179368|FG004|Overall Study|Progressive Disease|2|||
16191652|NCT01258348|39179364|FG000|Overall Study|Physician Decision|0|||
16191653|NCT01258348|39179365|FG001|Overall Study|Physician Decision|0|||
16191654|NCT01258348|39179366|FG002|Overall Study|Physician Decision|0|||
16191655|NCT01258348|39179367|FG003|Overall Study|Physician Decision|2|||
16191656|NCT01258348|39179368|FG004|Overall Study|Physician Decision|0|||
16191657|NCT01258348|39179364|FG000|Overall Study|Withdrawal by Subject|0|||
16191658|NCT01258348|39179365|FG001|Overall Study|Withdrawal by Subject|1|||
16191659|NCT01258348|39179366|FG002|Overall Study|Withdrawal by Subject|0|||
16191660|NCT01258348|39179367|FG003|Overall Study|Withdrawal by Subject|0|||
16191661|NCT01258348|39179368|FG004|Overall Study|Withdrawal by Subject|0|||
16191662|NCT02849990|39179369|FG000|Overall Study|Adverse Event|1|||
16191663|NCT02849990|39179369|FG000|Overall Study|Withdrawal by Subject|1|||
16191664|NCT01035255|39179370|FG000|Overall Study|Death|724|||
16191665|NCT01035255|39179371|FG001|Overall Study|Death|844|||
16191666|NCT01035255|39179370|FG000|Overall Study|Lost to Follow-up|2|||
16191667|NCT01035255|39179371|FG001|Overall Study|Lost to Follow-up|5|||
16191668|NCT01035255|39179370|FG000|Overall Study|patient's request|15|||
16191669|NCT01035255|39179371|FG001|Overall Study|patient's request|13|||
16191670|NCT00339183|39179372|FG000|Overall Study|Adverse Event|5|||
16191671|NCT00339183|39179373|FG001|Overall Study|Adverse Event|3|||
16191672|NCT00339183|39179372|FG000|Overall Study|Withdrawal by Subject|16|||
16191673|NCT00339183|39179373|FG001|Overall Study|Withdrawal by Subject|19|||
16191674|NCT00339183|39179372|FG000|Overall Study|Physician Decision|2|||
16191675|NCT00339183|39179373|FG001|Overall Study|Physician Decision|4|||
16191676|NCT00339183|39179372|FG000|Overall Study|Lost to Follow-up|17|||
16191677|NCT00339183|39179373|FG001|Overall Study|Lost to Follow-up|17|||
16191678|NCT00339183|39179372|FG000|Overall Study|Protocol-specified criteria|12|||
16191679|NCT00339183|39179373|FG001|Overall Study|Protocol-specified criteria|8|||
16191680|NCT00339183|39179372|FG000|Overall Study|Missing reason|3|||
16191681|NCT00339183|39179373|FG001|Overall Study|Missing reason|1|||
16191682|NCT00339183|39179372|FG000|Overall Study|Other|46|||
16191683|NCT00339183|39179373|FG001|Overall Study|Other|40|||
16191684|NCT00339183|39179372|FG000|Overall Study|Ongoing|20|||
16191685|NCT00339183|39179373|FG001|Overall Study|Ongoing|13|||
16191686|NCT00586924|39179374|FG000|Overall Study|Adverse event/serious adverse event|0|||
16191687|NCT00586924|39179375|FG001|Overall Study|Adverse event/serious adverse event|0|||
16191688|NCT00586924|39179376|FG002|Overall Study|Adverse event/serious adverse event|0|||
16191689|NCT00586924|39179377|FG003|Overall Study|Adverse event/serious adverse event|1|||
16191690|NCT00586924|39179378|FG004|Overall Study|Adverse event/serious adverse event|0|||
16191691|NCT00586924|39179379|FG005|Overall Study|Adverse event/serious adverse event|2|||
16191692|NCT00586924|39179374|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
16191693|NCT00586924|39179375|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
16191694|NCT00586924|39179376|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
16299843|NCT01081834|39582018|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
16299844|NCT01081834|39582019|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
16299845|NCT01081834|39582020|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
16299846|NCT01081834|39582021|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
16299847|NCT01081834|39582017|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
16299848|NCT01081834|39582018|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
16299849|NCT01081834|39582019|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
16191695|NCT00586924|39179377|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
16191696|NCT00586924|39179378|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
16191697|NCT00586924|39179379|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
16191698|NCT00586924|39179374|FG000|Overall Study|Disease progression|0|||
16191699|NCT00586924|39179375|FG001|Overall Study|Disease progression|0|||
16299850|NCT01081834|39582020|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
16191700|NCT00586924|39179376|FG002|Overall Study|Disease progression|0|||
16191701|NCT00586924|39179377|FG003|Overall Study|Disease progression|1|||
16191702|NCT00586924|39179378|FG004|Overall Study|Disease progression|1|||
16191703|NCT00586924|39179379|FG005|Overall Study|Disease progression|0|||
16191704|NCT00586924|39179374|FG000|Overall Study|Development of neutralizing antibodies|2|||
16191705|NCT00586924|39179375|FG001|Overall Study|Development of neutralizing antibodies|2|||
16191706|NCT00586924|39179376|FG002|Overall Study|Development of neutralizing antibodies|2|||
16191707|NCT00586924|39179377|FG003|Overall Study|Development of neutralizing antibodies|0|||
16191708|NCT00586924|39179378|FG004|Overall Study|Development of neutralizing antibodies|0|||
16191709|NCT00586924|39179379|FG005|Overall Study|Development of neutralizing antibodies|22|||
16191710|NCT00586924|39179374|FG000|Overall Study|Complete response|0|||
16191711|NCT00586924|39179375|FG001|Overall Study|Complete response|1|||
16191712|NCT00586924|39179376|FG002|Overall Study|Complete response|0|||
16191713|NCT00586924|39179377|FG003|Overall Study|Complete response|0|||
16191714|NCT00586924|39179378|FG004|Overall Study|Complete response|2|||
16191715|NCT00586924|39179379|FG005|Overall Study|Complete response|2|||
16191716|NCT00586924|39179374|FG000|Overall Study|Other|1|||
16191717|NCT00586924|39179375|FG001|Overall Study|Other|0|||
16191718|NCT00586924|39179376|FG002|Overall Study|Other|1|||
16191719|NCT00586924|39179377|FG003|Overall Study|Other|1|||
16191720|NCT00586924|39179378|FG004|Overall Study|Other|1|||
16191721|NCT00586924|39179379|FG005|Overall Study|Other|6|||
16191722|NCT03218826|39179380|FG000|Overall Study|Non-compliance with protocol|1|||
16191723|NCT03218826|39179381|FG001|Overall Study|Non-compliance with protocol|0|||
16191724|NCT03218826|39179382|FG002|Overall Study|Non-compliance with protocol|2|||
16191725|NCT03218826|39179383|FG003|Overall Study|Non-compliance with protocol|1|||
16191726|NCT03218826|39179384|FG004|Overall Study|Non-compliance with protocol|1|||
16191727|NCT01675531|39179387|FG000|Overall Study|Adverse Event|9|||
16191728|NCT01675531|39179387|FG000|Overall Study|Withdrawal by Subject|7|||
16191729|NCT01675531|39179387|FG000|Overall Study|Lack of Efficacy|1|||
16191730|NCT01675531|39179387|FG000|Overall Study|Protocol Violation|8|||
16191731|NCT00615290|39179388|FG000|Overall Study|Adverse Event|2|||
16191732|NCT00615290|39179388|FG000|Overall Study|Lost to Follow-up|3|||
16191733|NCT00615290|39179388|FG000|Overall Study|Withdrawal by Subject|1|||
16191734|NCT00615290|39179388|FG000|Overall Study|Other|2|||
16191735|NCT01687413|39179389|FG000|Overall Study|Withdrawal by Subject|0|||
16191736|NCT01687413|39179390|FG001|Overall Study|Withdrawal by Subject|2|||
16191737|NCT01687413|39179389|FG000|Overall Study|Not eligible|0|||
16191738|NCT01687413|39179390|FG001|Overall Study|Not eligible|2|||
16191739|NCT01687413|39179389|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
16191740|NCT01687413|39179390|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
16191741|NCT00953043|39179391|FG000|Overall Study|Withdrawal by Subject|4|||
16191742|NCT00953043|39179392|FG001|Overall Study|Withdrawal by Subject|0|||
16191743|NCT00953043|39179391|FG000|Overall Study|Physician Decision|0|||
16191744|NCT00953043|39179392|FG001|Overall Study|Physician Decision|2|||
16191745|NCT00718419|39179393|FG000|Overall Study|Adverse Event|2|||
16191746|NCT00718419|39179394|FG001|Overall Study|Adverse Event|1|||
16191747|NCT00718419|39179393|FG000|Overall Study|Physician Decision|1|||
16191748|NCT00718419|39179394|FG001|Overall Study|Physician Decision|6|||
16191749|NCT00718419|39179393|FG000|Overall Study|Sponsor decision|0|||
16191750|NCT00718419|39179394|FG001|Overall Study|Sponsor decision|1|||
16191751|NCT00718419|39179393|FG000|Overall Study|Withdrawal by Subject|0|||
16191752|NCT00718419|39179394|FG001|Overall Study|Withdrawal by Subject|5|||
16191753|NCT00718419|39179393|FG000|Overall Study|Progressive Disease|7|||
16191754|NCT00718419|39179394|FG001|Overall Study|Progressive Disease|25|||
16191755|NCT00718419|39179393|FG000|Overall Study|Death Due to Progressive Disease|2|||
16191756|NCT00718419|39179394|FG001|Overall Study|Death Due to Progressive Disease|0|||
16191757|NCT00718419|39179393|FG000|Overall Study|Death Due to Study Drug Related|0|||
16191758|NCT00718419|39179394|FG001|Overall Study|Death Due to Study Drug Related|1|||
16191759|NCT00718419|39179393|FG000|Overall Study|Death Due to Adverse Events|1|||
16191760|NCT00718419|39179394|FG001|Overall Study|Death Due to Adverse Events|0|||
16386027|NCT03012334|39896326|FG007|Period 4|Adverse Event|0|||
16191761|NCT02768194|39179397|FG000|Period 1|Adverse Event|0|||
16191762|NCT02768194|39179398|FG001|Period 1|Adverse Event|0|||
16191763|NCT02768194|39179399|FG002|Period 1|Adverse Event|0|||
16191764|NCT02768194|39179400|FG003|Period 1|Adverse Event|1|||
16191765|NCT02768194|39179401|FG004|Period 1|Adverse Event|0|||
16191766|NCT02768194|39179402|FG005|Period 1|Adverse Event|0|||
16386028|NCT03012334|39896327|FG008|Period 4|Adverse Event|1|||
16386029|NCT03012334|39896328|FG009|Period 4|Adverse Event|0|||
16386030|NCT01917318|39896330|FG000|First Treatment|Withdrawal by Subject|0|||
16386031|NCT01917318|39896331|FG001|First Treatment|Withdrawal by Subject|1|||
16386032|NCT00920556|39896332|FG000|Overall Study|Adverse Event|16|||
16191767|NCT02768194|39179397|FG000|Period 2|Other (Reason not specified)|1|||
16191768|NCT02768194|39179398|FG001|Period 2|Other (Reason not specified)|0|||
16191769|NCT02768194|39179399|FG002|Period 2|Other (Reason not specified)|0|||
16191770|NCT02768194|39179400|FG003|Period 2|Other (Reason not specified)|0|||
16386033|NCT00920556|39896332|FG000|Overall Study|Physician Decision|7|||
16299851|NCT01081834|39582021|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
16299852|NCT01081834|39582017|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
16299853|NCT01081834|39582018|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
16299854|NCT01081834|39582019|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
16299855|NCT01081834|39582020|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
16299856|NCT01081834|39582021|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
16299857|NCT01081834|39582017|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
16299858|NCT01081834|39582018|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
16299859|NCT01081834|39582019|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
16299860|NCT01081834|39582020|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
16299861|NCT01081834|39582021|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16299862|NCT01081834|39582017|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
16299863|NCT01081834|39582018|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16299864|NCT01081834|39582019|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16299865|NCT01081834|39582020|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16299866|NCT01081834|39582021|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16299867|NCT01081834|39582017|FG000|Core Period: Baseline to Week 26|Other|4|||
16299868|NCT01081834|39582018|FG001|Core Period: Baseline to Week 26|Other|4|||
16299869|NCT01081834|39582019|FG002|Core Period: Baseline to Week 26|Other|3|||
16299870|NCT01081834|39582020|FG003|Core Period: Baseline to Week 26|Other|1|||
16299871|NCT01081834|39582021|FG004|Core Period: Baseline to Week 26|Other|0|||
16299872|NCT01081834|39582017|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
16386034|NCT00920556|39896332|FG000|Overall Study|Withdrawal by Subject|1|||
16386035|NCT02951780|39896339|FG000|Period 1|Adverse Event|0|||
16386036|NCT02951780|39896340|FG001|Period 1|Adverse Event|0|||
16386037|NCT02951780|39896341|FG002|Period 1|Adverse Event|0|||
16386038|NCT02951780|39896342|FG003|Period 1|Adverse Event|1|||
16386039|NCT02951780|39896343|FG004|Period 1|Adverse Event|0|||
16386040|NCT02951780|39896344|FG005|Period 1|Adverse Event|0|||
16386041|NCT02951780|39896345|FG006|Period 1|Adverse Event|0|||
16386042|NCT02951780|39896346|FG007|Period 1|Adverse Event|0|||
16386043|NCT02951780|39896347|FG008|Period 1|Adverse Event|0|||
16386044|NCT02951780|39896339|FG000|Period 1|Scheduling Conflicts|0|||
16386045|NCT02951780|39896340|FG001|Period 1|Scheduling Conflicts|0|||
16386046|NCT02951780|39896341|FG002|Period 1|Scheduling Conflicts|0|||
16386047|NCT02951780|39896342|FG003|Period 1|Scheduling Conflicts|0|||
16386048|NCT02951780|39896343|FG004|Period 1|Scheduling Conflicts|0|||
16386049|NCT02951780|39896344|FG005|Period 1|Scheduling Conflicts|0|||
16386050|NCT02951780|39896345|FG006|Period 1|Scheduling Conflicts|0|||
16386051|NCT02951780|39896346|FG007|Period 1|Scheduling Conflicts|1|||
16386052|NCT02951780|39896347|FG008|Period 1|Scheduling Conflicts|0|||
16386053|NCT02951780|39896339|FG000|Period 2|Scheduling Conflicts|0|||
16386054|NCT02951780|39896340|FG001|Period 2|Scheduling Conflicts|0|||
16386055|NCT02951780|39896341|FG002|Period 2|Scheduling Conflicts|0|||
16386056|NCT02951780|39896342|FG003|Period 2|Scheduling Conflicts|0|||
16386057|NCT02951780|39896343|FG004|Period 2|Scheduling Conflicts|0|||
16386058|NCT02951780|39896344|FG005|Period 2|Scheduling Conflicts|0|||
16386059|NCT02951780|39896345|FG006|Period 2|Scheduling Conflicts|0|||
16386060|NCT02951780|39896346|FG007|Period 2|Scheduling Conflicts|1|||
16386061|NCT02951780|39896347|FG008|Period 2|Scheduling Conflicts|0|||
16386062|NCT02806414|39896351|FG000|Overall Study|Lost to Follow-up|2|||
16386063|NCT03434834|39896352|FG000|Overall Study|unable to swallow OCT probe|16|||
16386064|NCT01854528|39896353|FG000|Overall Study|Adverse Event|0|||
16386065|NCT01854528|39896354|FG001|Overall Study|Adverse Event|4|||
16386066|NCT01854528|39896353|FG000|Overall Study|Withdrawal by Subject|0|||
16386067|NCT01854528|39896354|FG001|Overall Study|Withdrawal by Subject|2|||
16386068|NCT01854528|39896353|FG000|Overall Study|Virologic Failure|0|||
16386069|NCT01854528|39896354|FG001|Overall Study|Virologic Failure|9|||
16386070|NCT02441218|39896355|FG000|Overall Study|Death|503|||
16386071|NCT02441218|39896356|FG001|Overall Study|Death|553|||
16386072|NCT02441218|39896355|FG000|Overall Study|Withdrawal by Subject|73|||
16386073|NCT02441218|39896356|FG001|Overall Study|Withdrawal by Subject|58|||
16386074|NCT02441218|39896355|FG000|Overall Study|Lost to Follow-up|2|||
16386075|NCT02441218|39896356|FG001|Overall Study|Lost to Follow-up|1|||
16386076|NCT03412929|39896357|FG000|Overall Study|Protocol Violation|3|||
16386077|NCT01434654|39896361|FG000|Overall Study|Withdrawal by Subject|1|||
16386078|NCT01434654|39896362|FG001|Overall Study|Withdrawal by Subject|0|||
16386079|NCT01434654|39896361|FG000|Overall Study|Lost to Follow-up|1|||
16386080|NCT01434654|39896362|FG001|Overall Study|Lost to Follow-up|0|||
16386081|NCT03507127|39896363|FG000|Overall Study|Withdrawal by Subject|1|||
16386082|NCT03507127|39896364|FG001|Overall Study|Withdrawal by Subject|0|||
16386083|NCT03507127|39896363|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
16386084|NCT03507127|39896364|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
16299873|NCT01081834|39582018|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
16299874|NCT01081834|39582019|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
16299875|NCT01081834|39582020|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
16299876|NCT01081834|39582021|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
16299877|NCT01081834|39582017|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
16299878|NCT01081834|39582018|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
16299879|NCT01081834|39582019|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
16299880|NCT01081834|39582020|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
16299881|NCT01081834|39582021|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
16299882|NCT01081834|39582017|FG000|Extension Period: Week 26 to Week 52|Death|1|||
16299883|NCT01081834|39582018|FG001|Extension Period: Week 26 to Week 52|Death|0|||
16299884|NCT01081834|39582019|FG002|Extension Period: Week 26 to Week 52|Death|0|||
16299885|NCT01081834|39582020|FG003|Extension Period: Week 26 to Week 52|Death|0|||
16299886|NCT01081834|39582021|FG004|Extension Period: Week 26 to Week 52|Death|0|||
16299887|NCT01081834|39582017|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
16299888|NCT01081834|39582018|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
16299889|NCT01081834|39582019|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16299890|NCT01081834|39582020|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16299891|NCT01081834|39582021|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16299892|NCT01081834|39582017|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16299893|NCT01081834|39582018|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
16299894|NCT01081834|39582019|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16299895|NCT01081834|39582020|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16299896|NCT01081834|39582021|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16299897|NCT01081834|39582017|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16299898|NCT01081834|39582018|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
16299899|NCT01081834|39582019|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16299900|NCT01081834|39582020|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16299901|NCT01081834|39582021|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16299902|NCT01081834|39582017|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
16299903|NCT01081834|39582018|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16299904|NCT01081834|39582019|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
16299905|NCT01081834|39582020|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16299906|NCT01081834|39582021|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16299907|NCT01081834|39582017|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
16299908|NCT01081834|39582018|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
16299909|NCT01081834|39582019|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
16299910|NCT01081834|39582020|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
16299911|NCT01081834|39582021|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
16299912|NCT01081834|39582017|FG000|Extension Period: Week 26 to Week 52|Other|4|||
16299913|NCT01081834|39582018|FG001|Extension Period: Week 26 to Week 52|Other|5|||
16299914|NCT01081834|39582019|FG002|Extension Period: Week 26 to Week 52|Other|4|||
16299915|NCT01081834|39582020|FG003|Extension Period: Week 26 to Week 52|Other|0|||
16299916|NCT01081834|39582021|FG004|Extension Period: Week 26 to Week 52|Other|0|||
16299917|NCT01081834|39582017|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
16299918|NCT01081834|39582018|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
16299919|NCT01081834|39582019|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
16299920|NCT01081834|39582020|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
16299921|NCT01081834|39582021|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
16299922|NCT01081834|39582017|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16299923|NCT01081834|39582018|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
16299924|NCT01081834|39582019|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16299925|NCT01081834|39582020|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16299926|NCT01081834|39582021|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16299927|NCT03597529|39582022|FG000|Overall Study|Lost to Follow-up|10|||
16299928|NCT03597529|39582023|FG001|Overall Study|Lost to Follow-up|12|||
16299929|NCT03597529|39582022|FG000|Overall Study|Physician Decision|3|||
16299930|NCT03597529|39582023|FG001|Overall Study|Physician Decision|1|||
16386085|NCT01979614|39896367|FG000|Overall Study|Adverse Event|1|||
16386086|NCT01979614|39896368|FG001|Overall Study|Adverse Event|1|||
16386087|NCT01074931|39896369|FG000|Overall Study|Economic reasons|1|||
16386088|NCT01074931|39896369|FG000|Overall Study|Death|5|||
16386089|NCT00558636|39899263|FG000|Treatment|Adverse Event|9|||
16386090|NCT00558636|39899264|FG001|Treatment|Adverse Event|2|||
16386091|NCT00558636|39899263|FG000|Treatment|Withdrawal by Subject|2|||
16490007|NCT02207244|40267111|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
16490008|NCT02207244|40267112|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
16490009|NCT02207244|40267102|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16490010|NCT02207244|40267103|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16490011|NCT02207244|40267104|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16299931|NCT03597529|39582022|FG000|Overall Study|Withdrawal by Subject|6|||
16083766|NCT01074294|38799205|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
16083767|NCT01074294|38799202|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
16083768|NCT01074294|38799203|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
16083769|NCT01074294|38799204|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
16083770|NCT01074294|38799205|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
16083771|NCT01074294|38799202|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
16083772|NCT01074294|38799203|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
16083773|NCT01074294|38799204|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
16083774|NCT01074294|38799205|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
16083775|NCT01074294|38799202|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
16083776|NCT01074294|38799203|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
16299932|NCT03597529|39582023|FG001|Overall Study|Withdrawal by Subject|3|||
16299933|NCT03597529|39582022|FG000|Overall Study|Non-compliant with study activities|1|||
16299934|NCT03597529|39582023|FG001|Overall Study|Non-compliant with study activities|2|||
16299935|NCT01473524|39582024|FG000|DB Phase|Adverse Event|4|||
16299936|NCT01473524|39582025|FG001|DB Phase|Adverse Event|8|||
16299937|NCT01473524|39582026|FG002|DB Phase|Adverse Event|2|||
16299938|NCT01473524|39582027|FG003|DB Phase|Adverse Event|0|||
16299939|NCT01473524|39582028|FG004|DB Phase|Adverse Event|0|||
16299940|NCT01473524|39582029|FG005|DB Phase|Adverse Event|0|||
16299941|NCT01473524|39582024|FG000|DB Phase|Death|1|||
16299942|NCT01473524|39582025|FG001|DB Phase|Death|0|||
16299943|NCT01473524|39582026|FG002|DB Phase|Death|0|||
16299944|NCT01473524|39582027|FG003|DB Phase|Death|0|||
16299945|NCT01473524|39582028|FG004|DB Phase|Death|0|||
16299946|NCT01473524|39582029|FG005|DB Phase|Death|0|||
16299947|NCT01473524|39582024|FG000|DB Phase|Withdrawal by Subject|2|||
16299948|NCT01473524|39582025|FG001|DB Phase|Withdrawal by Subject|1|||
16299949|NCT01473524|39582026|FG002|DB Phase|Withdrawal by Subject|1|||
16299950|NCT01473524|39582027|FG003|DB Phase|Withdrawal by Subject|0|||
16299951|NCT01473524|39582028|FG004|DB Phase|Withdrawal by Subject|0|||
16299952|NCT01473524|39582029|FG005|DB Phase|Withdrawal by Subject|0|||
16299953|NCT01473524|39582024|FG000|LTSE Phase|Withdrawal by Subject|0|||
16299954|NCT01473524|39582025|FG001|LTSE Phase|Withdrawal by Subject|0|||
16299955|NCT01473524|39582026|FG002|LTSE Phase|Withdrawal by Subject|0|||
16299956|NCT01473524|39582027|FG003|LTSE Phase|Withdrawal by Subject|3|||
16299957|NCT01473524|39582028|FG004|LTSE Phase|Withdrawal by Subject|3|||
16299958|NCT01473524|39582029|FG005|LTSE Phase|Withdrawal by Subject|6|||
16299959|NCT01473524|39582024|FG000|LTSE Phase|Death|0|||
16299960|NCT01473524|39582025|FG001|LTSE Phase|Death|0|||
16299961|NCT01473524|39582026|FG002|LTSE Phase|Death|0|||
16299962|NCT01473524|39582027|FG003|LTSE Phase|Death|0|||
16299963|NCT01473524|39582028|FG004|LTSE Phase|Death|1|||
16299964|NCT01473524|39582029|FG005|LTSE Phase|Death|0|||
16299965|NCT01473524|39582024|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
16299966|NCT01473524|39582025|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
16299967|NCT01473524|39582026|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
16299968|NCT01473524|39582027|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
16299969|NCT01473524|39582028|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
16299970|NCT01473524|39582029|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
16299971|NCT01473524|39582024|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
16490012|NCT02207244|40267105|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16299972|NCT01473524|39582025|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
16386092|NCT00558636|39899264|FG001|Treatment|Withdrawal by Subject|0|||
16299973|NCT01473524|39582026|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
16299974|NCT01473524|39582027|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
16299975|NCT01473524|39582028|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
16299976|NCT01473524|39582029|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
16299977|NCT01473524|39582024|FG000|LTSE Phase|Lost to Follow-up|0|||
16299978|NCT01473524|39582025|FG001|LTSE Phase|Lost to Follow-up|0|||
16299979|NCT01473524|39582026|FG002|LTSE Phase|Lost to Follow-up|0|||
16299980|NCT01473524|39582027|FG003|LTSE Phase|Lost to Follow-up|1|||
16299981|NCT01473524|39582028|FG004|LTSE Phase|Lost to Follow-up|3|||
16299982|NCT01473524|39582029|FG005|LTSE Phase|Lost to Follow-up|2|||
16083777|NCT01074294|38799204|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
16083778|NCT01074294|38799205|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
16299983|NCT01473524|39582024|FG000|LTSE Phase|Principal Investigator Decision|0|||
16299984|NCT01473524|39582025|FG001|LTSE Phase|Principal Investigator Decision|0|||
16299985|NCT01473524|39582026|FG002|LTSE Phase|Principal Investigator Decision|0|||
16299986|NCT01473524|39582027|FG003|LTSE Phase|Principal Investigator Decision|1|||
16299987|NCT01473524|39582028|FG004|LTSE Phase|Principal Investigator Decision|1|||
16299988|NCT01473524|39582029|FG005|LTSE Phase|Principal Investigator Decision|3|||
16299989|NCT01473524|39582024|FG000|LTSE Phase|Liver Transplantation|0|||
16299990|NCT01473524|39582025|FG001|LTSE Phase|Liver Transplantation|0|||
16299991|NCT01473524|39582026|FG002|LTSE Phase|Liver Transplantation|0|||
16299992|NCT01473524|39582027|FG003|LTSE Phase|Liver Transplantation|0|||
16299993|NCT01473524|39582028|FG004|LTSE Phase|Liver Transplantation|0|||
16299994|NCT01473524|39582029|FG005|LTSE Phase|Liver Transplantation|1|||
16299995|NCT01473524|39582024|FG000|LTSE Phase|Pregnancy|0|||
16299996|NCT01473524|39582025|FG001|LTSE Phase|Pregnancy|0|||
16299997|NCT01473524|39582026|FG002|LTSE Phase|Pregnancy|0|||
16299998|NCT01473524|39582027|FG003|LTSE Phase|Pregnancy|1|||
16299999|NCT01473524|39582028|FG004|LTSE Phase|Pregnancy|0|||
16300000|NCT01473524|39582029|FG005|LTSE Phase|Pregnancy|0|||
16300001|NCT01473524|39582024|FG000|LTSE Phase|Protocol Violation|0|||
16300002|NCT01473524|39582025|FG001|LTSE Phase|Protocol Violation|0|||
16300003|NCT01473524|39582026|FG002|LTSE Phase|Protocol Violation|0|||
16300004|NCT01473524|39582027|FG003|LTSE Phase|Protocol Violation|0|||
16083779|NCT01074294|38799202|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
16083780|NCT01074294|38799203|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
16083781|NCT01074294|38799204|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
16083782|NCT01074294|38799205|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
16083783|NCT01074294|38799202|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
16083784|NCT01074294|38799203|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
16083785|NCT01074294|38799204|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
16083786|NCT01074294|38799205|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
16083787|NCT01074294|38799202|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
16083788|NCT01074294|38799203|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
16083789|NCT01074294|38799204|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
16083790|NCT01074294|38799205|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
16083791|NCT01074294|38799202|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
16083792|NCT01074294|38799203|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
16083793|NCT01074294|38799204|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
16083794|NCT01074294|38799205|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
16083795|NCT01074294|38799202|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
16083796|NCT01074294|38799203|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
16083797|NCT01074294|38799204|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
16300005|NCT01473524|39582028|FG004|LTSE Phase|Protocol Violation|0|||
16300006|NCT01473524|39582029|FG005|LTSE Phase|Protocol Violation|1|||
16300007|NCT00626392|39582034|FG000|Run-in Period|Adverse Event|0|||
16300008|NCT00626392|39582035|FG001|Run-in Period|Adverse Event|0|||
16300009|NCT00626392|39582036|FG002|Run-in Period|Adverse Event|1|||
16300010|NCT00626392|39582037|FG003|Run-in Period|Adverse Event|0|||
16300011|NCT00626392|39582038|FG004|Run-in Period|Adverse Event|1|||
16300012|NCT00626392|39582039|FG005|Run-in Period|Adverse Event|0|||
16300013|NCT00626392|39582034|FG000|Run-in Period|Withdrawal by Subject|0|||
16300014|NCT00626392|39582035|FG001|Run-in Period|Withdrawal by Subject|1|||
16300015|NCT00626392|39582036|FG002|Run-in Period|Withdrawal by Subject|1|||
16300016|NCT00626392|39582037|FG003|Run-in Period|Withdrawal by Subject|1|||
16300017|NCT00626392|39582038|FG004|Run-in Period|Withdrawal by Subject|3|||
16300018|NCT00626392|39582039|FG005|Run-in Period|Withdrawal by Subject|1|||
16300019|NCT00626392|39582034|FG000|Run-in Period|Noncompliance|1|||
16300020|NCT00626392|39582035|FG001|Run-in Period|Noncompliance|0|||
16300021|NCT00626392|39582036|FG002|Run-in Period|Noncompliance|1|||
16300022|NCT00626392|39582037|FG003|Run-in Period|Noncompliance|0|||
16300023|NCT00626392|39582038|FG004|Run-in Period|Noncompliance|0|||
16300024|NCT00626392|39582039|FG005|Run-in Period|Noncompliance|0|||
16300025|NCT00626392|39582034|FG000|Coadministration Period|Adverse Event|3|||
16300026|NCT00626392|39582035|FG001|Coadministration Period|Adverse Event|1|||
16300027|NCT00626392|39582036|FG002|Coadministration Period|Adverse Event|7|||
16300028|NCT00626392|39582037|FG003|Coadministration Period|Adverse Event|4|||
16300029|NCT00626392|39582038|FG004|Coadministration Period|Adverse Event|3|||
16300030|NCT00626392|39582039|FG005|Coadministration Period|Adverse Event|4|||
16300031|NCT00626392|39582034|FG000|Coadministration Period|Withdrawal by Subject|1|||
16300032|NCT00626392|39582035|FG001|Coadministration Period|Withdrawal by Subject|1|||
16300033|NCT00626392|39582036|FG002|Coadministration Period|Withdrawal by Subject|0|||
16300034|NCT00626392|39582037|FG003|Coadministration Period|Withdrawal by Subject|1|||
16300035|NCT00626392|39582038|FG004|Coadministration Period|Withdrawal by Subject|0|||
16300036|NCT00626392|39582039|FG005|Coadministration Period|Withdrawal by Subject|1|||
16300037|NCT00626392|39582034|FG000|Coadministration Period|Protocol Violation|0|||
16300038|NCT00626392|39582035|FG001|Coadministration Period|Protocol Violation|1|||
16300039|NCT00626392|39582036|FG002|Coadministration Period|Protocol Violation|0|||
16300040|NCT00626392|39582037|FG003|Coadministration Period|Protocol Violation|1|||
16300041|NCT00626392|39582038|FG004|Coadministration Period|Protocol Violation|1|||
16300042|NCT00626392|39582039|FG005|Coadministration Period|Protocol Violation|0|||
16300043|NCT00626392|39582034|FG000|Coadministration Period|Other|0|||
16300044|NCT00626392|39582035|FG001|Coadministration Period|Other|2|||
16300045|NCT00626392|39582036|FG002|Coadministration Period|Other|3|||
16300046|NCT00626392|39582037|FG003|Coadministration Period|Other|1|||
16300047|NCT00626392|39582038|FG004|Coadministration Period|Other|1|||
16300048|NCT00626392|39582039|FG005|Coadministration Period|Other|1|||
16300049|NCT00919854|39582040|FG000|Overall Study|Adverse Event|1|||
16300050|NCT03021486|39582041|FG000|Overall Study|Withdrawal by Subject|1|||
16300051|NCT03021486|39582042|FG001|Overall Study|Withdrawal by Subject|1|||
16300052|NCT03021486|39582043|FG002|Overall Study|Withdrawal by Subject|3|||
16300053|NCT03021486|39582041|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
16300054|NCT03021486|39582042|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
16300055|NCT03021486|39582043|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
16300056|NCT00086281|39582045|FG000|Phase 1|Adverse Event|0|||
16300057|NCT00086281|39582046|FG001|Phase 1|Adverse Event|0|||
16300058|NCT00086281|39582047|FG002|Phase 1|Adverse Event|0|||
16300059|NCT00086281|39582048|FG003|Phase 1|Adverse Event|0|||
16300060|NCT00086281|39582049|FG004|Phase 1|Adverse Event|0|||
16300061|NCT00086281|39582050|FG005|Phase 1|Adverse Event|0|||
16300062|NCT00086281|39582051|FG006|Phase 1|Adverse Event|0|||
16300063|NCT00086281|39582052|FG007|Phase 1|Adverse Event|0|||
16300064|NCT00086281|39582053|FG008|Phase 1|Adverse Event|0|||
16300065|NCT00086281|39582054|FG009|Phase 1|Adverse Event|1|||
16300066|NCT00086281|39582055|FG010|Phase 1|Adverse Event|2|||
16300067|NCT00086281|39582056|FG011|Phase 1|Adverse Event|1|||
16300068|NCT00086281|39582057|FG012|Phase 1|Adverse Event|1|||
16300069|NCT00086281|39582058|FG013|Phase 1|Adverse Event|1|||
16300070|NCT00086281|39582059|FG014|Phase 1|Adverse Event|2|||
16300071|NCT00086281|39582045|FG000|Phase 1|Protocol Violation|0|||
16300072|NCT00086281|39582046|FG001|Phase 1|Protocol Violation|0|||
16300073|NCT00086281|39582047|FG002|Phase 1|Protocol Violation|0|||
16300074|NCT00086281|39582048|FG003|Phase 1|Protocol Violation|0|||
16490013|NCT02207244|40267106|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16490014|NCT02207244|40267107|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16300075|NCT00086281|39582049|FG004|Phase 1|Protocol Violation|0|||
16300076|NCT00086281|39582050|FG005|Phase 1|Protocol Violation|0|||
16300077|NCT00086281|39582051|FG006|Phase 1|Protocol Violation|0|||
16300078|NCT00086281|39582052|FG007|Phase 1|Protocol Violation|0|||
16300079|NCT00086281|39582053|FG008|Phase 1|Protocol Violation|0|||
16300080|NCT00086281|39582054|FG009|Phase 1|Protocol Violation|0|||
16300081|NCT00086281|39582055|FG010|Phase 1|Protocol Violation|1|||
16300082|NCT00086281|39582056|FG011|Phase 1|Protocol Violation|0|||
16300083|NCT00086281|39582057|FG012|Phase 1|Protocol Violation|0|||
16300084|NCT00086281|39582058|FG013|Phase 1|Protocol Violation|0|||
16300085|NCT00086281|39582059|FG014|Phase 1|Protocol Violation|0|||
16300086|NCT00086281|39582045|FG000|Phase 1|Serious Adverse Event|0|||
16300087|NCT00086281|39582046|FG001|Phase 1|Serious Adverse Event|0|||
16300088|NCT00086281|39582047|FG002|Phase 1|Serious Adverse Event|0|||
16386093|NCT00558636|39899263|FG000|Treatment|Premature termination of the study|35|||
16386094|NCT00558636|39899264|FG001|Treatment|Premature termination of the study|37|||
16386095|NCT00558636|39899263|FG000|Treatment|Disease progression|1|||
16386096|NCT00558636|39899264|FG001|Treatment|Disease progression|5|||
16386097|NCT00558636|39899263|FG000|Follow-up|Premature termination of the study|12|||
16386098|NCT00558636|39899264|FG001|Follow-up|Premature termination of the study|7|||
16386099|NCT00305448|39899266|FG000|Overall Study|Protocol Violation|0|||
16386100|NCT00305448|39899267|FG001|Overall Study|Protocol Violation|1|||
16386101|NCT00305448|39899268|FG002|Overall Study|Protocol Violation|0|||
16386102|NCT00305448|39899266|FG000|Overall Study|Withdrawal by Subject|2|||
16386103|NCT00305448|39899267|FG001|Overall Study|Withdrawal by Subject|0|||
16386104|NCT00305448|39899268|FG002|Overall Study|Withdrawal by Subject|1|||
16386105|NCT00305448|39899266|FG000|Overall Study|Adverse Event|1|||
16386106|NCT00305448|39899267|FG001|Overall Study|Adverse Event|0|||
16386107|NCT00305448|39899268|FG002|Overall Study|Adverse Event|1|||
16386108|NCT00305448|39899266|FG000|Overall Study|Disease Progression|27|||
16386109|NCT00305448|39899267|FG001|Overall Study|Disease Progression|31|||
16386110|NCT00305448|39899268|FG002|Overall Study|Disease Progression|28|||
16386111|NCT00305448|39899266|FG000|Overall Study|Subjective Disease Progression|1|||
16386112|NCT00305448|39899267|FG001|Overall Study|Subjective Disease Progression|2|||
16386113|NCT00305448|39899268|FG002|Overall Study|Subjective Disease Progression|2|||
16386114|NCT00305448|39899266|FG000|Overall Study|Tumor Marker Elevation|0|||
16386115|NCT00305448|39899267|FG001|Overall Study|Tumor Marker Elevation|0|||
16386116|NCT00305448|39899268|FG002|Overall Study|Tumor Marker Elevation|1|||
16386117|NCT01282866|39899269|FG000|Overall Study|Adverse Event|1|||
16386118|NCT04409834|39899270|FG000|Overall Study|Death|55|||
16386119|NCT04409834|39899271|FG001|Overall Study|Death|62|||
16386120|NCT01621178|39899272|FG000|Overall Study|Adverse Event|5|||
16386121|NCT01621178|39899273|FG001|Overall Study|Adverse Event|2|||
16386122|NCT01621178|39899274|FG002|Overall Study|Adverse Event|8|||
16386123|NCT01621178|39899272|FG000|Overall Study|Death|6|||
16386124|NCT01621178|39899273|FG001|Overall Study|Death|7|||
16386125|NCT01621178|39899274|FG002|Overall Study|Death|2|||
16386126|NCT01621178|39899272|FG000|Overall Study|Lost to Follow-up|1|||
16386127|NCT01621178|39899273|FG001|Overall Study|Lost to Follow-up|2|||
16386128|NCT01621178|39899274|FG002|Overall Study|Lost to Follow-up|1|||
16386129|NCT01621178|39899272|FG000|Overall Study|Withdrawal by Subject|14|||
16386130|NCT01621178|39899273|FG001|Overall Study|Withdrawal by Subject|17|||
16386131|NCT01621178|39899274|FG002|Overall Study|Withdrawal by Subject|18|||
16386132|NCT01621178|39899272|FG000|Overall Study|Physician Decision|5|||
16386133|NCT01621178|39899273|FG001|Overall Study|Physician Decision|2|||
16386134|NCT01621178|39899274|FG002|Overall Study|Physician Decision|7|||
16386135|NCT02986074|39899275|FG000|First Trial Period|Adverse Event|1|||
16386136|NCT02986074|39899276|FG001|First Trial Period|Adverse Event|0|||
16386137|NCT02986074|39899277|FG002|First Trial Period|Adverse Event|0|||
16386138|NCT02986074|39899278|FG003|First Trial Period|Adverse Event|0|||
16386139|NCT02986074|39899275|FG000|Follow up Period|system explant|0|||
16386140|NCT02986074|39899276|FG001|Follow up Period|system explant|0|||
16386141|NCT02986074|39899277|FG002|Follow up Period|system explant|1|||
16386142|NCT02986074|39899278|FG003|Follow up Period|system explant|2|||
16386143|NCT02986074|39899275|FG000|Follow up Period|Physician Decision|0|||
16386144|NCT02986074|39899276|FG001|Follow up Period|Physician Decision|0|||
16386145|NCT02986074|39899277|FG002|Follow up Period|Physician Decision|0|||
16386146|NCT02986074|39899278|FG003|Follow up Period|Physician Decision|1|||
16386147|NCT01657305|39899279|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
16386148|NCT01657305|39899279|FG000|Overall Study|Withdrawal by Subject|4|||
16300089|NCT00086281|39582048|FG003|Phase 1|Serious Adverse Event|0|||
16300090|NCT00086281|39582049|FG004|Phase 1|Serious Adverse Event|0|||
16300091|NCT00086281|39582050|FG005|Phase 1|Serious Adverse Event|0|||
16300092|NCT00086281|39582051|FG006|Phase 1|Serious Adverse Event|0|||
16300093|NCT00086281|39582052|FG007|Phase 1|Serious Adverse Event|0|||
16300094|NCT00086281|39582053|FG008|Phase 1|Serious Adverse Event|0|||
16300095|NCT00086281|39582054|FG009|Phase 1|Serious Adverse Event|0|||
16300096|NCT00086281|39582055|FG010|Phase 1|Serious Adverse Event|0|||
16386149|NCT01657305|39899279|FG000|Overall Study|Adverse Event|1|||
16386150|NCT01657305|39899279|FG000|Overall Study|Lost to Follow-up|1|||
16386151|NCT01657305|39899279|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
16300097|NCT00086281|39582056|FG011|Phase 1|Serious Adverse Event|0|||
16386152|NCT01865487|39899280|FG000|Overall Study|Lost to Follow-up|0|||
16386153|NCT01865487|39899281|FG001|Overall Study|Lost to Follow-up|0|||
16386154|NCT01865487|39899282|FG002|Overall Study|Lost to Follow-up|0|||
16386155|NCT01865487|39899283|FG003|Overall Study|Lost to Follow-up|1|||
16386156|NCT01865487|39899284|FG004|Overall Study|Lost to Follow-up|0|||
16386157|NCT01865487|39899285|FG005|Overall Study|Lost to Follow-up|0|||
16386158|NCT01865487|39899286|FG006|Overall Study|Lost to Follow-up|1|||
16386159|NCT01865487|39899287|FG007|Overall Study|Lost to Follow-up|0|||
16386160|NCT01865487|39899288|FG008|Overall Study|Lost to Follow-up|0|||
16386161|NCT01865487|39899289|FG009|Overall Study|Lost to Follow-up|0|||
16386162|NCT01865487|39899280|FG000|Overall Study|Withdrawal by Subject|0|||
16386163|NCT01865487|39899281|FG001|Overall Study|Withdrawal by Subject|0|||
16386164|NCT01865487|39899282|FG002|Overall Study|Withdrawal by Subject|0|||
16386165|NCT01865487|39899283|FG003|Overall Study|Withdrawal by Subject|0|||
16386166|NCT01865487|39899284|FG004|Overall Study|Withdrawal by Subject|1|||
16386167|NCT01865487|39899285|FG005|Overall Study|Withdrawal by Subject|0|||
16386168|NCT01865487|39899286|FG006|Overall Study|Withdrawal by Subject|0|||
16386169|NCT01865487|39899287|FG007|Overall Study|Withdrawal by Subject|0|||
16386170|NCT01865487|39899288|FG008|Overall Study|Withdrawal by Subject|0|||
16386171|NCT01865487|39899289|FG009|Overall Study|Withdrawal by Subject|0|||
16386172|NCT00105534|39899290|FG000|Overall Study|Adverse Event|2|||
16386173|NCT00105534|39899291|FG001|Overall Study|Adverse Event|5|||
16386174|NCT00105534|39899290|FG000|Overall Study|Protocol Violation|1|||
16386175|NCT00105534|39899291|FG001|Overall Study|Protocol Violation|4|||
16386176|NCT00105534|39899290|FG000|Overall Study|Withdrawal by Subject|6|||
16386177|NCT00105534|39899291|FG001|Overall Study|Withdrawal by Subject|6|||
16386178|NCT00105534|39899290|FG000|Overall Study|Lost to Follow-up|5|||
16386179|NCT00105534|39899291|FG001|Overall Study|Lost to Follow-up|1|||
16386180|NCT00105534|39899290|FG000|Overall Study|Lack of Efficacy|7|||
16386181|NCT00105534|39899291|FG001|Overall Study|Lack of Efficacy|15|||
16386182|NCT00105534|39899290|FG000|Overall Study|Treatment unmasked|1|||
16386183|NCT00105534|39899291|FG001|Overall Study|Treatment unmasked|0|||
16386184|NCT00105534|39899290|FG000|Overall Study|Other Reason|0|||
16386185|NCT00105534|39899291|FG001|Overall Study|Other Reason|2|||
16386186|NCT02114177|39899292|FG000|Overall Study|Lost to Follow-up|1|||
16386187|NCT02114177|39899293|FG001|Overall Study|Lost to Follow-up|2|||
16386188|NCT02114177|39899292|FG000|Overall Study|Withdrawal by Subject|6|||
16386189|NCT02114177|39899293|FG001|Overall Study|Withdrawal by Subject|1|||
16386190|NCT02114177|39899292|FG000|Overall Study|Other|2|||
16386191|NCT02114177|39899293|FG001|Overall Study|Other|1|||
16386192|NCT02829996|39899294|FG000|Overall Study|Withdrawal by Subject|1|||
16386193|NCT02829996|39899295|FG001|Overall Study|Withdrawal by Subject|0|||
16386194|NCT02829996|39899296|FG002|Overall Study|Withdrawal by Subject|0|||
16386195|NCT02829996|39899297|FG003|Overall Study|Withdrawal by Subject|0|||
16386196|NCT02829996|39899298|FG004|Overall Study|Withdrawal by Subject|0|||
16386197|NCT03186638|39899299|FG000|Overall Study|Withdrawal by Subject|4|||
16386198|NCT03186638|39899300|FG001|Overall Study|Withdrawal by Subject|4|||
16386199|NCT03186638|39899299|FG000|Overall Study|Withdrawn due to medical problem|3|||
16386200|NCT03186638|39899300|FG001|Overall Study|Withdrawn due to medical problem|2|||
16386201|NCT03186638|39899299|FG000|Overall Study|Lost to Follow-up|1|||
16386202|NCT03186638|39899300|FG001|Overall Study|Lost to Follow-up|0|||
16386203|NCT02534883|39899306|FG000|Overall Study|Early Termination|8|||
16386204|NCT02534883|39899307|FG001|Overall Study|Early Termination|3|||
16386205|NCT00565409|39899310|FG000|Period 1 Open Label|Adverse Event|17|||
16386206|NCT00565409|39899311|FG001|Period 1 Open Label|Adverse Event|0|||
16386207|NCT00565409|39899312|FG002|Period 1 Open Label|Adverse Event|0|||
16386208|NCT00565409|39899313|FG003|Period 1 Open Label|Adverse Event|0|||
16386209|NCT00565409|39899310|FG000|Period 1 Open Label|Death|2|||
16386210|NCT00565409|39899311|FG001|Period 1 Open Label|Death|0|||
16386211|NCT00565409|39899312|FG002|Period 1 Open Label|Death|0|||
16386212|NCT00565409|39899313|FG003|Period 1 Open Label|Death|0|||
16386213|NCT00565409|39899310|FG000|Period 1 Open Label|Lost to Follow-up|1|||
16386214|NCT00565409|39899311|FG001|Period 1 Open Label|Lost to Follow-up|0|||
16386215|NCT00565409|39899312|FG002|Period 1 Open Label|Lost to Follow-up|0|||
16386216|NCT00565409|39899313|FG003|Period 1 Open Label|Lost to Follow-up|0|||
16386217|NCT00565409|39899310|FG000|Period 1 Open Label|Other|21|||
16386218|NCT00565409|39899311|FG001|Period 1 Open Label|Other|0|||
16386219|NCT00565409|39899312|FG002|Period 1 Open Label|Other|0|||
16386220|NCT00565409|39899313|FG003|Period 1 Open Label|Other|0|||
16386221|NCT00565409|39899310|FG000|Period 1 Open Label|Protocol Violation|14|||
16386222|NCT00565409|39899311|FG001|Period 1 Open Label|Protocol Violation|0|||
16386223|NCT00565409|39899312|FG002|Period 1 Open Label|Protocol Violation|0|||
16386224|NCT00565409|39899313|FG003|Period 1 Open Label|Protocol Violation|0|||
16386225|NCT00565409|39899310|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
16386226|NCT00565409|39899311|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
16386227|NCT00565409|39899312|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
16386228|NCT00565409|39899313|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
16386229|NCT00565409|39899310|FG000|Period 1 Open Label|no conclusion of participation record|1|||
16386230|NCT00565409|39899311|FG001|Period 1 Open Label|no conclusion of participation record|0|||
16386231|NCT00565409|39899312|FG002|Period 1 Open Label|no conclusion of participation record|0|||
16386232|NCT00565409|39899313|FG003|Period 1 Open Label|no conclusion of participation record|0|||
16386233|NCT00565409|39899310|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
16386234|NCT00565409|39899311|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
16083798|NCT01074294|38799205|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
16083799|NCT01074294|38799202|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
16083800|NCT01074294|38799203|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
16083801|NCT01074294|38799204|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
16083802|NCT01074294|38799205|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
16083803|NCT04436289|38799206|FG000|Overall Study|Death prior to hospital discharge|8|||
16083804|NCT04436289|38799207|FG001|Overall Study|Death prior to hospital discharge|5|||
16083805|NCT04436289|38799208|FG002|Overall Study|Death prior to hospital discharge|0|||
16083806|NCT04436289|38799209|FG003|Overall Study|Death prior to hospital discharge|1|||
16083807|NCT04436289|38799206|FG000|Overall Study|Withdrawal by Subject|0|||
16083808|NCT04436289|38799207|FG001|Overall Study|Withdrawal by Subject|1|||
16083809|NCT04436289|38799208|FG002|Overall Study|Withdrawal by Subject|4|||
16386235|NCT00565409|39899312|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
16386236|NCT00565409|39899313|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
16386237|NCT00565409|39899310|FG000|Period 2 Double-Blind|Adverse Event|0|||
16386238|NCT00565409|39899311|FG001|Period 2 Double-Blind|Adverse Event|7|||
16386239|NCT00565409|39899312|FG002|Period 2 Double-Blind|Adverse Event|4|||
16386240|NCT00565409|39899313|FG003|Period 2 Double-Blind|Adverse Event|5|||
16083810|NCT04436289|38799209|FG003|Overall Study|Withdrawal by Subject|0|||
16083811|NCT04436289|38799206|FG000|Overall Study|Extended hospital stay|0|||
16300098|NCT00086281|39582057|FG012|Phase 1|Serious Adverse Event|0|||
16300099|NCT00086281|39582058|FG013|Phase 1|Serious Adverse Event|0|||
16083812|NCT04436289|38799207|FG001|Overall Study|Extended hospital stay|1|||
16083813|NCT04436289|38799208|FG002|Overall Study|Extended hospital stay|0|||
16083814|NCT04436289|38799209|FG003|Overall Study|Extended hospital stay|0|||
16300100|NCT00086281|39582059|FG014|Phase 1|Serious Adverse Event|1|||
16083815|NCT04436289|38799206|FG000|Overall Study|Lost to Follow-up|0|||
16083816|NCT04436289|38799207|FG001|Overall Study|Lost to Follow-up|4|||
16083817|NCT04436289|38799208|FG002|Overall Study|Lost to Follow-up|1|||
16083818|NCT04436289|38799209|FG003|Overall Study|Lost to Follow-up|3|||
16083819|NCT04579250|38799210|FG000|Overall Study|Withdrawal by Subject|1|||
16083820|NCT04579250|38799211|FG001|Overall Study|Withdrawal by Subject|1|||
16191771|NCT02768194|39179401|FG004|Period 2|Other (Reason not specified)|0|||
16191772|NCT02768194|39179402|FG005|Period 2|Other (Reason not specified)|0|||
16191773|NCT02768194|39179397|FG000|Period 3|Other (Reason not specified)|0|||
16191774|NCT02768194|39179398|FG001|Period 3|Other (Reason not specified)|1|||
16191775|NCT02768194|39179399|FG002|Period 3|Other (Reason not specified)|0|||
16191776|NCT02768194|39179400|FG003|Period 3|Other (Reason not specified)|0|||
16191777|NCT02768194|39179401|FG004|Period 3|Other (Reason not specified)|0|||
16191778|NCT02768194|39179402|FG005|Period 3|Other (Reason not specified)|0|||
16191779|NCT00028002|39179406|FG000|Overall Study|Withdrawal by Subject|3|||
16191780|NCT00028002|39179406|FG000|Overall Study|Ineligible|8|||
16191781|NCT03165721|39179407|FG000|Overall Study|Refused further treatment|3|||
16191782|NCT03165721|39179408|FG001|Overall Study|Refused further treatment|0|||
16191783|NCT03165721|39179409|FG002|Overall Study|Refused further treatment|0|||
16191784|NCT03165721|39179407|FG000|Overall Study|Physician Decision|1|||
16191785|NCT03165721|39179408|FG001|Overall Study|Physician Decision|0|||
16191786|NCT03165721|39179409|FG002|Overall Study|Physician Decision|0|||
16191787|NCT00115349|39179410|FG000|Overall Study|Study closed due to low enrollment.|11|||
16191788|NCT00115349|39179411|FG001|Overall Study|Study closed due to low enrollment.|9|||
16191789|NCT02410902|39179412|FG000|Overall Study|Adverse Event|2|||
16191790|NCT02410902|39179413|FG001|Overall Study|Adverse Event|3|||
16300101|NCT00086281|39582045|FG000|Phase 2|Adverse Event|0|||
16300102|NCT00086281|39582046|FG001|Phase 2|Adverse Event|0|||
16300103|NCT00086281|39582047|FG002|Phase 2|Adverse Event|0|||
16300104|NCT00086281|39582048|FG003|Phase 2|Adverse Event|0|||
16300105|NCT00086281|39582049|FG004|Phase 2|Adverse Event|0|||
16300106|NCT00086281|39582050|FG005|Phase 2|Adverse Event|0|||
16300107|NCT00086281|39582051|FG006|Phase 2|Adverse Event|0|||
16300108|NCT00086281|39582052|FG007|Phase 2|Adverse Event|0|||
16300109|NCT00086281|39582053|FG008|Phase 2|Adverse Event|0|||
16300110|NCT00086281|39582054|FG009|Phase 2|Adverse Event|0|||
16300111|NCT00086281|39582055|FG010|Phase 2|Adverse Event|0|||
16300112|NCT00086281|39582056|FG011|Phase 2|Adverse Event|0|||
16300113|NCT00086281|39582057|FG012|Phase 2|Adverse Event|1|||
16300114|NCT00086281|39582058|FG013|Phase 2|Adverse Event|1|||
16300115|NCT00086281|39582059|FG014|Phase 2|Adverse Event|0|||
16300116|NCT02466685|39582060|FG000|Overall Study|Adverse Event|5|||
16300117|NCT02466685|39582061|FG001|Overall Study|Adverse Event|2|||
16191791|NCT02410902|39179412|FG000|Overall Study|Lost to Follow-up|4|||
16300118|NCT02466685|39582060|FG000|Overall Study|Lost to Follow-up|1|||
16300119|NCT02466685|39582061|FG001|Overall Study|Lost to Follow-up|1|||
16191792|NCT02410902|39179413|FG001|Overall Study|Lost to Follow-up|1|||
16191793|NCT02410902|39179412|FG000|Overall Study|Protocol Violation|1|||
16191794|NCT02410902|39179413|FG001|Overall Study|Protocol Violation|4|||
16191795|NCT02410902|39179412|FG000|Overall Study|Withdrawal by Subject|6|||
16191796|NCT02410902|39179413|FG001|Overall Study|Withdrawal by Subject|8|||
16191797|NCT02410902|39179412|FG000|Overall Study|Non-Compliance|8|||
16191798|NCT02410902|39179413|FG001|Overall Study|Non-Compliance|2|||
16191799|NCT03666858|39179416|FG000|Cohort 1|Adverse Event|1|||
16191800|NCT03666858|39179417|FG001|Cohort 1|Adverse Event|0|||
16191801|NCT03666858|39179416|FG000|Cohort 2|Adverse Event|0|||
16191802|NCT03666858|39179417|FG001|Cohort 2|Adverse Event|1|||
16191803|NCT00678587|39179418|FG000|Overall Study|Adverse Event|3|||
16191804|NCT00678587|39179419|FG001|Overall Study|Adverse Event|3|||
16191805|NCT00678587|39179418|FG000|Overall Study|Lack of Efficacy|1|||
16191806|NCT00678587|39179419|FG001|Overall Study|Lack of Efficacy|0|||
16191807|NCT00678587|39179418|FG000|Overall Study|Protocol Violation|2|||
16191808|NCT00678587|39179419|FG001|Overall Study|Protocol Violation|1|||
16191809|NCT00678587|39179418|FG000|Overall Study|Study Closed/Terminated|1|||
16191810|NCT00678587|39179419|FG001|Overall Study|Study Closed/Terminated|0|||
16191811|NCT00678587|39179418|FG000|Overall Study|Lost to Follow-up|3|||
16191812|NCT00678587|39179419|FG001|Overall Study|Lost to Follow-up|5|||
16191813|NCT00678587|39179418|FG000|Overall Study|Investigator Discretion|2|||
16191814|NCT00678587|39179419|FG001|Overall Study|Investigator Discretion|6|||
16300120|NCT02466685|39582060|FG000|Overall Study|Withdrawal by Subject|1|||
16300121|NCT02466685|39582061|FG001|Overall Study|Withdrawal by Subject|0|||
16300122|NCT02466685|39582060|FG000|Overall Study|Physician Decision|1|||
16300123|NCT02466685|39582061|FG001|Overall Study|Physician Decision|1|||
16300124|NCT00603837|39582062|FG000|Overall Study|Physician Decision|3|||
16300125|NCT00603837|39582063|FG001|Overall Study|Physician Decision|0|||
16300126|NCT02342639|39582064|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
16191815|NCT00678587|39179418|FG000|Overall Study|Withdrew Consent|8|||
16191816|NCT00678587|39179419|FG001|Overall Study|Withdrew Consent|3|||
16191817|NCT01331239|39179420|FG000|Part II: Core Study|Adverse Event|0|||
16300127|NCT02342639|39582065|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
16300128|NCT02342639|39582064|FG000|Overall Study|Protocol Violation|0|||
16300129|NCT02342639|39582065|FG001|Overall Study|Protocol Violation|2|||
16300130|NCT01106014|39582066|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
16300131|NCT01106014|39582067|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
16300132|NCT01106014|39582066|FG000|Overall Study|Adverse Event|78|||
16300133|NCT01106014|39582067|FG001|Overall Study|Adverse Event|42|||
16300134|NCT01106014|39582066|FG000|Overall Study|Withdrawal by Subject|43|||
16300135|NCT01106014|39582067|FG001|Overall Study|Withdrawal by Subject|37|||
16300136|NCT01106014|39582066|FG000|Overall Study|Administrative reason|7|||
16300137|NCT01106014|39582067|FG001|Overall Study|Administrative reason|6|||
16300138|NCT01106014|39582066|FG000|Overall Study|Lost to Follow-up|2|||
16300139|NCT01106014|39582067|FG001|Overall Study|Lost to Follow-up|3|||
16300140|NCT03340974|39582068|FG000|Completion of Study -Long Term Follow up|Death|8|||
16300141|NCT03340974|39582069|FG001|Completion of Study -Long Term Follow up|Death|5|||
16490015|NCT02207244|40267108|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
16490016|NCT02207244|40267109|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
16490017|NCT02207244|40267110|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
16490018|NCT02207244|40267111|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
16490019|NCT02207244|40267112|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
16191818|NCT01331239|39179421|FG001|Part II: Core Study|Adverse Event|3|||
16490020|NCT02207244|40267102|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16490021|NCT02207244|40267103|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16490022|NCT02207244|40267104|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16490023|NCT02207244|40267105|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16490024|NCT02207244|40267106|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16490025|NCT02207244|40267107|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16490026|NCT02207244|40267108|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16191819|NCT01331239|39179422|FG002|Part II: Core Study|Adverse Event|0|||
16300142|NCT03340974|39582070|FG002|Completion of Study -Long Term Follow up|Death|5|||
16300143|NCT03340974|39582071|FG003|Completion of Study -Long Term Follow up|Death|7|||
16191820|NCT01331239|39179420|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
16191821|NCT01331239|39179421|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
16191822|NCT01331239|39179422|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
16191823|NCT01331239|39179420|FG000|Part II: Core Study|Withdrawal by Subject|0|||
16191824|NCT01331239|39179421|FG001|Part II: Core Study|Withdrawal by Subject|2|||
16191825|NCT01331239|39179422|FG002|Part II: Core Study|Withdrawal by Subject|0|||
16191826|NCT01331239|39179420|FG000|Part II: Core Study|Administrative problems|0|||
16191827|NCT01331239|39179421|FG001|Part II: Core Study|Administrative problems|1|||
16191828|NCT01331239|39179422|FG002|Part II: Core Study|Administrative problems|0|||
16191829|NCT01952730|39179427|FG000|Overall Study|FDA shut down core lab used by study|1|||
16191830|NCT01774344|39179428|FG000|Overall Study|Withdrawal by Subject|3|||
16191831|NCT01774344|39179429|FG001|Overall Study|Withdrawal by Subject|10|||
16191832|NCT01774344|39179428|FG000|Overall Study|Protocol Violation|0|||
16191833|NCT01774344|39179429|FG001|Overall Study|Protocol Violation|1|||
16191834|NCT01774344|39179428|FG000|Overall Study|Lost to Follow-up|4|||
16191835|NCT01774344|39179429|FG001|Overall Study|Lost to Follow-up|10|||
16191836|NCT01774344|39179428|FG000|Overall Study|End of survival follow-up not available|2|||
16191837|NCT01774344|39179429|FG001|Overall Study|End of survival follow-up not available|2|||
16191838|NCT01774344|39179428|FG000|Overall Study|Data collection finished|4|||
16191839|NCT01774344|39179429|FG001|Overall Study|Data collection finished|14|||
16191840|NCT01774344|39179428|FG000|Overall Study|Other|0|||
16191841|NCT01774344|39179429|FG001|Overall Study|Other|1|||
16191842|NCT01774344|39179428|FG000|Overall Study|Did not enter Survival Follow up|49|||
16191843|NCT01774344|39179429|FG001|Overall Study|Did not enter Survival Follow up|83|||
16191844|NCT00625365|39179433|FG000|Overall Study|Withdrawal by Subject|1|||
16191845|NCT00625365|39179433|FG000|Overall Study|No IV access|5|||
16191846|NCT00625365|39179433|FG000|Overall Study|VSD|1|||
16191847|NCT01379534|39179434|FG000|Treatment Phase|Withdrawal by Subject|2|||
16191848|NCT01379534|39179435|FG001|Treatment Phase|Withdrawal by Subject|2|||
16191849|NCT01379534|39179434|FG000|Treatment Phase|Progressive disease|13|||
16191850|NCT01379534|39179435|FG001|Treatment Phase|Progressive disease|22|||
16191851|NCT01379534|39179434|FG000|Treatment Phase|Adverse Event|7|||
16191852|NCT01379534|39179435|FG001|Treatment Phase|Adverse Event|7|||
16191853|NCT01379534|39179434|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
16300144|NCT03340974|39582068|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
16300145|NCT03340974|39582069|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
16300146|NCT03340974|39582070|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
16300147|NCT03340974|39582071|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
16191854|NCT01379534|39179435|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
16191855|NCT01379534|39179434|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
16300148|NCT03340974|39582068|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
16300149|NCT03340974|39582069|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
16300150|NCT03340974|39582070|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
16300151|NCT03340974|39582071|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
16300152|NCT03340974|39582068|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
16300153|NCT03340974|39582069|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
16300154|NCT03340974|39582070|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
16386241|NCT00565409|39899310|FG000|Period 2 Double-Blind|Death|0|||
16386242|NCT00565409|39899311|FG001|Period 2 Double-Blind|Death|2|||
16386243|NCT00565409|39899312|FG002|Period 2 Double-Blind|Death|0|||
16386244|NCT00565409|39899313|FG003|Period 2 Double-Blind|Death|0|||
16386245|NCT00565409|39899310|FG000|Period 2 Double-Blind|Protocol Violation|0|||
16386246|NCT00565409|39899311|FG001|Period 2 Double-Blind|Protocol Violation|4|||
16386247|NCT00565409|39899312|FG002|Period 2 Double-Blind|Protocol Violation|6|||
16386248|NCT00565409|39899313|FG003|Period 2 Double-Blind|Protocol Violation|2|||
16386249|NCT00565409|39899310|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
16386250|NCT00565409|39899311|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
16386251|NCT00565409|39899312|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
16386252|NCT00565409|39899313|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
16386253|NCT00565409|39899310|FG000|Period 2 Double-Blind|Other|0|||
16386254|NCT00565409|39899311|FG001|Period 2 Double-Blind|Other|4|||
16386255|NCT00565409|39899312|FG002|Period 2 Double-Blind|Other|5|||
16386256|NCT00565409|39899313|FG003|Period 2 Double-Blind|Other|9|||
16386257|NCT00565409|39899310|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
16386258|NCT00565409|39899311|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
16386259|NCT00565409|39899312|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
16386260|NCT00565409|39899313|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
16386261|NCT01959529|39899314|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
16386262|NCT01959529|39899315|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
16386263|NCT01959529|39899314|FG000|Overall Study|Lost to Follow-up|4|||
16386264|NCT01959529|39899315|FG001|Overall Study|Lost to Follow-up|1|||
16386265|NCT01959529|39899314|FG000|Overall Study|Other|70|||
16386266|NCT01959529|39899315|FG001|Overall Study|Other|68|||
16386267|NCT01959529|39899314|FG000|Overall Study|Hypoglycaemia|1|||
16191856|NCT01379534|39179435|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
16191857|NCT01379534|39179434|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
16191858|NCT01379534|39179435|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
16191859|NCT01379534|39179434|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
16191860|NCT01379534|39179435|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
16191861|NCT01597557|39179445|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
16191862|NCT01597557|39179446|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
16191863|NCT00740779|39179447|FG000|Overall Study|Adverse Event|4|||
16191864|NCT00740779|39179448|FG001|Overall Study|Adverse Event|6|||
16191865|NCT00740779|39179449|FG002|Overall Study|Adverse Event|3|||
16300155|NCT03340974|39582071|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
16300156|NCT00396565|39582072|FG000|Overall Study|Physician Decision|3|||
16300157|NCT00396565|39582073|FG001|Overall Study|Physician Decision|1|||
16300158|NCT00396565|39582074|FG002|Overall Study|Physician Decision|2|||
16191866|NCT00740779|39179447|FG000|Overall Study|Protocol Violation|1|||
16191867|NCT00740779|39179448|FG001|Overall Study|Protocol Violation|1|||
16191868|NCT00740779|39179449|FG002|Overall Study|Protocol Violation|1|||
16191869|NCT00740779|39179447|FG000|Overall Study|Lack of Efficacy|0|||
16191870|NCT00740779|39179448|FG001|Overall Study|Lack of Efficacy|0|||
16191871|NCT00740779|39179449|FG002|Overall Study|Lack of Efficacy|2|||
16191872|NCT00740779|39179447|FG000|Overall Study|Withdrawal by Subject|2|||
16300159|NCT00396565|39582072|FG000|Overall Study|Adverse Event|5|||
16300160|NCT00396565|39582073|FG001|Overall Study|Adverse Event|13|||
16300161|NCT00396565|39582074|FG002|Overall Study|Adverse Event|3|||
16300162|NCT00396565|39582072|FG000|Overall Study|Withdrawal by Subject|8|||
16300163|NCT00396565|39582073|FG001|Overall Study|Withdrawal by Subject|13|||
16300164|NCT00396565|39582074|FG002|Overall Study|Withdrawal by Subject|1|||
16300165|NCT00396565|39582072|FG000|Overall Study|Lack of Efficacy|32|||
16300166|NCT00396565|39582073|FG001|Overall Study|Lack of Efficacy|64|||
16300167|NCT00396565|39582074|FG002|Overall Study|Lack of Efficacy|11|||
16300168|NCT00843635|39582075|FG000|Overall Study|Adverse Event|2|||
16300169|NCT00843635|39582076|FG001|Overall Study|Adverse Event|2|||
16300170|NCT00843635|39582077|FG002|Overall Study|Adverse Event|0|||
16300171|NCT00866658|39582078|FG000|Overall Study|Adverse Event|5|||
16300172|NCT00866658|39582079|FG001|Overall Study|Adverse Event|14|||
16300173|NCT00866658|39582078|FG000|Overall Study|Lack of Efficacy|2|||
16300174|NCT00866658|39582079|FG001|Overall Study|Lack of Efficacy|1|||
16300175|NCT00866658|39582078|FG000|Overall Study|Withdrawal by Subject|1|||
16300176|NCT00866658|39582079|FG001|Overall Study|Withdrawal by Subject|0|||
16300177|NCT00866658|39582078|FG000|Overall Study|Protocol Violation|1|||
16300178|NCT00866658|39582079|FG001|Overall Study|Protocol Violation|1|||
16300179|NCT00866658|39582078|FG000|Overall Study|Familial and Personal Reasons|4|||
16300180|NCT00866658|39582079|FG001|Overall Study|Familial and Personal Reasons|5|||
16300181|NCT00416884|39582084|FG000|Overall Study|Study terminated due to low accrual|1|||
16300182|NCT03167723|39582100|FG000|Overall Study|Protocol Violation|4|||
16300183|NCT03167723|39582101|FG001|Overall Study|Protocol Violation|6|||
16300184|NCT00371397|39582102|FG000|Session 1|Withdrawal by Subject|1|||
16300185|NCT00371397|39582103|FG001|Session 1|Withdrawal by Subject|0|||
16300186|NCT00371397|39582104|FG002|Session 1|Withdrawal by Subject|0|||
16300187|NCT00371397|39582105|FG003|Session 1|Withdrawal by Subject|0|||
16300188|NCT00371397|39582106|FG004|Session 1|Withdrawal by Subject|0|||
16300189|NCT00371397|39582107|FG005|Session 1|Withdrawal by Subject|0|||
16300190|NCT00371397|39582108|FG006|Session 1|Withdrawal by Subject|0|||
16300191|NCT00371397|39582109|FG007|Session 1|Withdrawal by Subject|1|||
16300192|NCT00371397|39582110|FG008|Session 1|Withdrawal by Subject|0|||
16300193|NCT00371397|39582111|FG009|Session 1|Withdrawal by Subject|0|||
16300194|NCT00371397|39582112|FG010|Session 1|Withdrawal by Subject|0|||
16300195|NCT00371397|39582113|FG011|Session 1|Withdrawal by Subject|0|||
16300196|NCT02309138|39582118|FG000|Overall Study|Withdrawal by Subject|44|||
16300197|NCT02309138|39582119|FG001|Overall Study|Withdrawal by Subject|15|||
16300198|NCT02309138|39582118|FG000|Overall Study|Protocol Violation|4|||
16300199|NCT02309138|39582119|FG001|Overall Study|Protocol Violation|2|||
16083821|NCT04579250|38799212|FG002|Overall Study|Withdrawal by Subject|0|||
16191873|NCT00740779|39179448|FG001|Overall Study|Withdrawal by Subject|4|||
16191874|NCT00740779|39179449|FG002|Overall Study|Withdrawal by Subject|2|||
16191875|NCT00740779|39179447|FG000|Overall Study|Lost to Follow-up|2|||
16300200|NCT02309138|39582118|FG000|Overall Study|delivered before visit 2|0|||
16300201|NCT02309138|39582119|FG001|Overall Study|delivered before visit 2|1|||
16300202|NCT01341782|39582121|FG000|Overall Study|Adverse Event|1|||
16300203|NCT01341782|39582122|FG001|Overall Study|Adverse Event|1|||
16300204|NCT01341782|39582121|FG000|Overall Study|Withdrawal by Subject|6|||
16300205|NCT01341782|39582122|FG001|Overall Study|Withdrawal by Subject|5|||
16300206|NCT01341782|39582121|FG000|Overall Study|Missed 3 consecutive doses|0|||
16300207|NCT01341782|39582122|FG001|Overall Study|Missed 3 consecutive doses|4|||
16300208|NCT01341782|39582121|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
16300209|NCT01341782|39582122|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
16300210|NCT01341782|39582121|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
16300211|NCT01341782|39582122|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
16300212|NCT01341782|39582121|FG000|Overall Study|Other|5|||
16490027|NCT02207244|40267109|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
16083822|NCT04579250|38799210|FG000|Overall Study|Lost to Follow-up|1|||
16083823|NCT04579250|38799211|FG001|Overall Study|Lost to Follow-up|1|||
16083824|NCT04579250|38799212|FG002|Overall Study|Lost to Follow-up|0|||
16083825|NCT04579250|38799210|FG000|Overall Study|Moved from area|0|||
16083826|NCT04579250|38799211|FG001|Overall Study|Moved from area|1|||
16083827|NCT04579250|38799212|FG002|Overall Study|Moved from area|2|||
16083828|NCT01721291|38799219|FG000|Overall Study|Withdrawal by Subject|1|||
16083829|NCT01721291|38799220|FG001|Overall Study|Withdrawal by Subject|0|||
16083830|NCT01721291|38799219|FG000|Overall Study|did not like the treatment|1|||
16083831|NCT01721291|38799220|FG001|Overall Study|did not like the treatment|0|||
16083832|NCT02972359|38799221|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
16083833|NCT02972359|38799221|FG000|Overall Study|Lack of Efficacy|1|||
16083834|NCT02972359|38799221|FG000|Overall Study|Adverse Event|4|||
16083835|NCT02972359|38799221|FG000|Overall Study|Death|1|||
16083836|NCT02972359|38799221|FG000|Overall Study|Withdrawal by Subject|30|||
16083837|NCT02972359|38799221|FG000|Overall Study|Protocol Violation|1|||
16083838|NCT02972359|38799221|FG000|Overall Study|Lost to Follow-up|26|||
16083839|NCT02972359|38799221|FG000|Overall Study|Other reasons|5|||
16083840|NCT02972359|38799221|FG000|Overall Study|Missing|1|||
16083841|NCT03451721|38799222|FG000|Overall Study|Death|1|||
16300213|NCT01341782|39582122|FG001|Overall Study|Other|0|||
16490028|NCT02207244|40267110|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16490029|NCT02207244|40267111|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16490030|NCT02207244|40267112|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
16490031|NCT02207244|40267102|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16490032|NCT02207244|40267103|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16490033|NCT02207244|40267104|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16490034|NCT02207244|40267105|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16490035|NCT02207244|40267106|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16490036|NCT02207244|40267107|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16083842|NCT00448669|38799226|FG000|Overall Study|Lost to Follow-up|52|||
16083843|NCT00448669|38799227|FG001|Overall Study|Lost to Follow-up|63|||
16083844|NCT00448669|38799226|FG000|Overall Study|Withdrawal by Subject|90|||
16083845|NCT00448669|38799227|FG001|Overall Study|Withdrawal by Subject|74|||
16191876|NCT00740779|39179448|FG001|Overall Study|Lost to Follow-up|3|||
16191877|NCT00740779|39179449|FG002|Overall Study|Lost to Follow-up|5|||
16191878|NCT02491073|39179450|FG000|Overall Study|screen failure|1|||
16191879|NCT02491073|39179451|FG001|Overall Study|screen failure|0|||
16191880|NCT01115569|39179452|FG000|Conversion/Titration Phase|Adverse Event|59|||
16191881|NCT01115569|39179453|FG001|Conversion/Titration Phase|Adverse Event|0|||
16191882|NCT01115569|39179452|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
16191883|NCT01115569|39179453|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
16191884|NCT01115569|39179452|FG000|Conversion/Titration Phase|Physician Decision|5|||
16191885|NCT01115569|39179453|FG001|Conversion/Titration Phase|Physician Decision|0|||
16191886|NCT01115569|39179452|FG000|Conversion/Titration Phase|Protocol Violation|68|||
16191887|NCT01115569|39179453|FG001|Conversion/Titration Phase|Protocol Violation|0|||
16191888|NCT01115569|39179452|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
16191889|NCT01115569|39179453|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
16191890|NCT01115569|39179452|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
16191891|NCT01115569|39179453|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
16191892|NCT01115569|39179452|FG000|Maintenance Phase|Adverse Event|0|||
16191893|NCT01115569|39179453|FG001|Maintenance Phase|Adverse Event|43|||
16191894|NCT01115569|39179452|FG000|Maintenance Phase|Lost to Follow-up|0|||
16191895|NCT01115569|39179453|FG001|Maintenance Phase|Lost to Follow-up|8|||
16191896|NCT01115569|39179452|FG000|Maintenance Phase|Physician Decision|0|||
16191897|NCT01115569|39179453|FG001|Maintenance Phase|Physician Decision|3|||
16191898|NCT01115569|39179452|FG000|Maintenance Phase|Protocol Violation|0|||
16191899|NCT01115569|39179453|FG001|Maintenance Phase|Protocol Violation|9|||
16191900|NCT01115569|39179452|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16191901|NCT01115569|39179453|FG001|Maintenance Phase|Withdrawal by Subject|27|||
16191902|NCT01115569|39179452|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
16191903|NCT01115569|39179453|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
16191904|NCT01115569|39179452|FG000|Maintenance Phase|Administrative|0|||
16191905|NCT01115569|39179453|FG001|Maintenance Phase|Administrative|1|||
16191906|NCT04426825|39179454|FG000|Overall Study|Death|17|||
16191907|NCT04426825|39179454|FG000|Overall Study|Lost to Follow-up|1|||
16191908|NCT04426825|39179454|FG000|Overall Study|Study terminated by sponsor|5|||
16191909|NCT02488759|39179455|FG000|Overall Study|Disease progression|73|||
16191910|NCT02488759|39179456|FG001|Overall Study|Disease progression|111|||
16191911|NCT02488759|39179457|FG002|Overall Study|Disease progression|62|||
16191912|NCT02488759|39179458|FG003|Overall Study|Disease progression|7|||
16191913|NCT02488759|39179459|FG004|Overall Study|Disease progression|4|||
16191914|NCT02488759|39179460|FG005|Overall Study|Disease progression|2|||
16300214|NCT01769456|39582126|FG000|Overall Study|Lost to Follow-up|19|||
16300215|NCT01769456|39582126|FG000|Overall Study|Withdrawal by Subject|3|||
16300216|NCT01769456|39582126|FG000|Overall Study|Did not receive PCC intervention|6|||
16300217|NCT01769456|39582126|FG000|Overall Study|Moved out of the area|3|||
16300218|NCT01769456|39582126|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
16300219|NCT01769456|39582126|FG000|Overall Study|Parental request to youth to withdraw|1|||
16300220|NCT03656744|39582131|FG000|Overall Study|Adverse Event|1|||
16191915|NCT02488759|39179455|FG000|Overall Study|Study drug toxicity|11|||
16191916|NCT02488759|39179456|FG001|Overall Study|Study drug toxicity|33|||
16191917|NCT02488759|39179457|FG002|Overall Study|Study drug toxicity|31|||
16191918|NCT02488759|39179458|FG003|Overall Study|Study drug toxicity|0|||
16191919|NCT02488759|39179459|FG004|Overall Study|Study drug toxicity|0|||
16191920|NCT02488759|39179460|FG005|Overall Study|Study drug toxicity|2|||
16191921|NCT02488759|39179455|FG000|Overall Study|Adverse event unrelated to study drug|9|||
16191922|NCT02488759|39179456|FG001|Overall Study|Adverse event unrelated to study drug|11|||
16191923|NCT02488759|39179457|FG002|Overall Study|Adverse event unrelated to study drug|7|||
16191924|NCT02488759|39179458|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16191925|NCT02488759|39179459|FG004|Overall Study|Adverse event unrelated to study drug|1|||
16191926|NCT02488759|39179460|FG005|Overall Study|Adverse event unrelated to study drug|0|||
16191927|NCT02488759|39179455|FG000|Overall Study|Participant request to discontinue study treatment|6|||
16191928|NCT02488759|39179456|FG001|Overall Study|Participant request to discontinue study treatment|8|||
16191929|NCT02488759|39179457|FG002|Overall Study|Participant request to discontinue study treatment|4|||
16191930|NCT02488759|39179458|FG003|Overall Study|Participant request to discontinue study treatment|0|||
16191931|NCT02488759|39179459|FG004|Overall Study|Participant request to discontinue study treatment|0|||
16191932|NCT02488759|39179460|FG005|Overall Study|Participant request to discontinue study treatment|0|||
16191933|NCT02488759|39179455|FG000|Overall Study|Withdrawal by Subject|4|||
16191934|NCT02488759|39179456|FG001|Overall Study|Withdrawal by Subject|0|||
16191935|NCT02488759|39179457|FG002|Overall Study|Withdrawal by Subject|3|||
16191936|NCT02488759|39179458|FG003|Overall Study|Withdrawal by Subject|0|||
16191937|NCT02488759|39179459|FG004|Overall Study|Withdrawal by Subject|0|||
16191938|NCT02488759|39179460|FG005|Overall Study|Withdrawal by Subject|2|||
16191939|NCT02488759|39179455|FG000|Overall Study|Lost to Follow-up|0|||
16191940|NCT02488759|39179456|FG001|Overall Study|Lost to Follow-up|0|||
16191941|NCT02488759|39179457|FG002|Overall Study|Lost to Follow-up|2|||
16300221|NCT03656744|39582132|FG001|Overall Study|Adverse Event|4|||
16300222|NCT03656744|39582133|FG002|Overall Study|Adverse Event|1|||
16300223|NCT03656744|39582131|FG000|Overall Study|Protocol Violation|1|||
16300224|NCT03656744|39582132|FG001|Overall Study|Protocol Violation|0|||
16300225|NCT03656744|39582133|FG002|Overall Study|Protocol Violation|0|||
16300226|NCT03656744|39582131|FG000|Overall Study|Lost to Follow-up|2|||
16300227|NCT03656744|39582132|FG001|Overall Study|Lost to Follow-up|2|||
16300228|NCT03656744|39582133|FG002|Overall Study|Lost to Follow-up|0|||
16300229|NCT03656744|39582131|FG000|Overall Study|Withdrawal by Subject|0|||
16300230|NCT03656744|39582132|FG001|Overall Study|Withdrawal by Subject|1|||
16300231|NCT03656744|39582133|FG002|Overall Study|Withdrawal by Subject|0|||
16300232|NCT03656744|39582131|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
16386268|NCT01959529|39899315|FG001|Overall Study|Hypoglycaemia|1|||
16386269|NCT01959529|39899314|FG000|Overall Study|Lack of glycaemic control|1|||
16386270|NCT01959529|39899315|FG001|Overall Study|Lack of glycaemic control|1|||
16386271|NCT02473471|39899316|FG000|Overall Study|poor oral hygiene|2|||
16386272|NCT02473471|39899316|FG000|Overall Study|Lost to Follow-up|1|||
16386273|NCT01343888|39899317|FG000|Overall Study|Adverse Event|12|||
16386274|NCT01343888|39899318|FG001|Overall Study|Adverse Event|22|||
16386275|NCT01343888|39899319|FG002|Overall Study|Adverse Event|5|||
16386276|NCT01343888|39899317|FG000|Overall Study|Lack of Efficacy|9|||
16386277|NCT01343888|39899318|FG001|Overall Study|Lack of Efficacy|9|||
16386278|NCT01343888|39899319|FG002|Overall Study|Lack of Efficacy|13|||
16386279|NCT01343888|39899317|FG000|Overall Study|Lost to Follow-up|0|||
16386280|NCT01343888|39899318|FG001|Overall Study|Lost to Follow-up|2|||
16386281|NCT01343888|39899319|FG002|Overall Study|Lost to Follow-up|1|||
16386282|NCT01343888|39899317|FG000|Overall Study|Protocol Violation|0|||
16386283|NCT01343888|39899318|FG001|Overall Study|Protocol Violation|2|||
16386284|NCT01343888|39899319|FG002|Overall Study|Protocol Violation|0|||
16386285|NCT01343888|39899317|FG000|Overall Study|Withdrawal by Subject|4|||
16386286|NCT01343888|39899318|FG001|Overall Study|Withdrawal by Subject|4|||
16386287|NCT01343888|39899319|FG002|Overall Study|Withdrawal by Subject|2|||
16386288|NCT01343888|39899317|FG000|Overall Study|other than stated above|0|||
16386289|NCT01343888|39899318|FG001|Overall Study|other than stated above|0|||
16386290|NCT01343888|39899319|FG002|Overall Study|other than stated above|1|||
16386291|NCT00487981|39899325|FG000|Overall Study|Hypothyroidism diagnosis|1|||
16386292|NCT01957865|39899331|FG000|Overall Study|Found HIV negative|0|||
16386293|NCT01957865|39899332|FG001|Overall Study|Found HIV negative|0|||
16386294|NCT01957865|39899333|FG002|Overall Study|Found HIV negative|1|||
16386295|NCT01957865|39899331|FG000|Overall Study|Lost to Follow-up|0|||
16386296|NCT01957865|39899332|FG001|Overall Study|Lost to Follow-up|2|||
16386297|NCT01957865|39899333|FG002|Overall Study|Lost to Follow-up|2|||
16386298|NCT00707993|39899337|FG000|Overall Study|Adverse Event|16|||
16386299|NCT00707993|39899338|FG001|Overall Study|Adverse Event|20|||
16386300|NCT00707993|39899337|FG000|Overall Study|Protocol Violation|4|||
16386301|NCT00707993|39899338|FG001|Overall Study|Protocol Violation|7|||
16083846|NCT00448669|38799226|FG000|Overall Study|Relocated|49|||
16083847|NCT00448669|38799227|FG001|Overall Study|Relocated|36|||
16083848|NCT00448669|38799226|FG000|Overall Study|Were withdrawn by investigator|10|||
16083849|NCT00448669|38799227|FG001|Overall Study|Were withdrawn by investigator|6|||
16083850|NCT00448669|38799226|FG000|Overall Study|Death|2|||
16083851|NCT00448669|38799227|FG001|Overall Study|Death|4|||
16083852|NCT00448669|38799226|FG000|Overall Study|Had other reasons|5|||
16083853|NCT00448669|38799227|FG001|Overall Study|Had other reasons|6|||
16191942|NCT02488759|39179458|FG003|Overall Study|Lost to Follow-up|0|||
16191943|NCT02488759|39179459|FG004|Overall Study|Lost to Follow-up|0|||
16191944|NCT02488759|39179460|FG005|Overall Study|Lost to Follow-up|0|||
16191945|NCT02488759|39179455|FG000|Overall Study|Maximum clinical benefit|3|||
16191946|NCT02488759|39179456|FG001|Overall Study|Maximum clinical benefit|0|||
16191947|NCT02488759|39179457|FG002|Overall Study|Maximum clinical benefit|1|||
16191948|NCT02488759|39179458|FG003|Overall Study|Maximum clinical benefit|0|||
16191949|NCT02488759|39179459|FG004|Overall Study|Maximum clinical benefit|0|||
16191950|NCT02488759|39179460|FG005|Overall Study|Maximum clinical benefit|0|||
16191951|NCT02488759|39179455|FG000|Overall Study|Other reasons|7|||
16191952|NCT02488759|39179456|FG001|Overall Study|Other reasons|32|||
16191953|NCT02488759|39179457|FG002|Overall Study|Other reasons|23|||
16191954|NCT02488759|39179458|FG003|Overall Study|Other reasons|1|||
16191955|NCT02488759|39179459|FG004|Overall Study|Other reasons|1|||
16386302|NCT00707993|39899337|FG000|Overall Study|Lost to Follow-up|0|||
16386303|NCT00707993|39899338|FG001|Overall Study|Lost to Follow-up|4|||
16083854|NCT00448669|38799226|FG000|Overall Study|HIV-infected at enrollment|1|||
16083855|NCT00448669|38799227|FG001|Overall Study|HIV-infected at enrollment|2|||
16083856|NCT00448669|38799226|FG000|Overall Study|Never started drug|9|||
16191956|NCT02488759|39179460|FG005|Overall Study|Other reasons|1|||
16191957|NCT03029650|39179461|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
16191958|NCT03029650|39179462|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
16386304|NCT00707993|39899337|FG000|Overall Study|Withdrawal by Subject|12|||
16386305|NCT00707993|39899338|FG001|Overall Study|Withdrawal by Subject|16|||
16191959|NCT03029650|39179461|FG000|Washout (1 Week)|Physician Decision|0|||
16386306|NCT00707993|39899337|FG000|Overall Study|Hyperglycemic Rescue|55|||
16386307|NCT00707993|39899338|FG001|Overall Study|Hyperglycemic Rescue|47|||
16386308|NCT00707993|39899337|FG000|Overall Study|Other|2|||
16386309|NCT00707993|39899338|FG001|Overall Study|Other|0|||
16386310|NCT00049543|39899339|FG000|Overall Study|still on treatment|2|||
16386311|NCT00049543|39899340|FG001|Overall Study|still on treatment|9|||
16386312|NCT02329743|39899342|FG000|Overall Study|Adverse Event|1|||
16386313|NCT02329743|39899343|FG001|Overall Study|Adverse Event|1|||
16386314|NCT02329743|39899344|FG002|Overall Study|Adverse Event|3|||
16386315|NCT02329743|39899342|FG000|Overall Study|Lost to Follow-up|1|||
16386316|NCT02329743|39899343|FG001|Overall Study|Lost to Follow-up|0|||
16386317|NCT02329743|39899344|FG002|Overall Study|Lost to Follow-up|1|||
16386318|NCT02329743|39899342|FG000|Overall Study|Withdrawal by Subject|4|||
16386319|NCT02329743|39899343|FG001|Overall Study|Withdrawal by Subject|4|||
16386320|NCT02329743|39899344|FG002|Overall Study|Withdrawal by Subject|1|||
16386321|NCT02329743|39899342|FG000|Overall Study|Other|0|||
16386322|NCT02329743|39899343|FG001|Overall Study|Other|2|||
16386323|NCT02329743|39899344|FG002|Overall Study|Other|3|||
16386324|NCT03423121|39899345|FG000|Overall Study|Lost to Follow-up|2|||
16386325|NCT03423121|39899346|FG001|Overall Study|Lost to Follow-up|6|||
16386326|NCT03423121|39899345|FG000|Overall Study|Adverse Event|1|||
16386327|NCT03423121|39899346|FG001|Overall Study|Adverse Event|0|||
16191960|NCT03029650|39179462|FG001|Washout (1 Week)|Physician Decision|1|||
16386328|NCT00060944|39899347|FG000|Overall Study|Adverse Event|12|||
16386329|NCT00060944|39899348|FG001|Overall Study|Adverse Event|10|||
16386330|NCT00060944|39899347|FG000|Overall Study|Death|2|||
16386331|NCT00060944|39899348|FG001|Overall Study|Death|3|||
16386332|NCT00060944|39899347|FG000|Overall Study|Withdrawal by Subject|18|||
16386333|NCT00060944|39899348|FG001|Overall Study|Withdrawal by Subject|5|||
16386334|NCT00060944|39899347|FG000|Overall Study|Disease Progression|93|||
16386335|NCT00060944|39899348|FG001|Overall Study|Disease Progression|94|||
16386336|NCT00060944|39899347|FG000|Overall Study|Lost to Follow-up|1|||
16386337|NCT00060944|39899348|FG001|Overall Study|Lost to Follow-up|0|||
16386338|NCT00060944|39899347|FG000|Overall Study|Subject Ineligible To Continue|2|||
16386339|NCT00060944|39899348|FG001|Overall Study|Subject Ineligible To Continue|1|||
16386340|NCT00060944|39899347|FG000|Overall Study|Treatment Switch|0|||
16386341|NCT00060944|39899348|FG001|Overall Study|Treatment Switch|13|||
16386342|NCT00060944|39899347|FG000|Overall Study|Other|2|||
16386343|NCT00060944|39899348|FG001|Overall Study|Other|4|||
16386344|NCT00060944|39899347|FG000|Overall Study|randomized but not treated|6|||
16386345|NCT00060944|39899348|FG001|Overall Study|randomized but not treated|4|||
16386346|NCT03502681|39899349|FG000|Overall Study|Adverse Event|1|||
16386347|NCT03502681|39899350|FG001|Overall Study|Adverse Event|1|||
16386348|NCT03502681|39899349|FG000|Overall Study|Disease Progression|2|||
16386349|NCT03502681|39899350|FG001|Overall Study|Disease Progression|1|||
16386350|NCT02808429|39899351|FG000|Overall Study|Lost to Follow-up|1|||
16386351|NCT02808429|39899352|FG001|Overall Study|Lost to Follow-up|0|||
16386352|NCT02808429|39899353|FG002|Overall Study|Lost to Follow-up|0|||
16386353|NCT02808429|39899351|FG000|Overall Study|Protocol Violation|0|||
16386354|NCT02808429|39899352|FG001|Overall Study|Protocol Violation|1|||
16386355|NCT02808429|39899353|FG002|Overall Study|Protocol Violation|0|||
16386356|NCT02808429|39899351|FG000|Overall Study|Premature study termination by sponsor|2|||
16386357|NCT02808429|39899352|FG001|Overall Study|Premature study termination by sponsor|0|||
16386358|NCT02808429|39899353|FG002|Overall Study|Premature study termination by sponsor|1|||
16386359|NCT02808429|39899351|FG000|Overall Study|Relocation|0|||
16191961|NCT01849250|39179463|FG000|Overall Study|Withdrawal by Subject|1|||
16386360|NCT02808429|39899352|FG001|Overall Study|Relocation|0|||
16386361|NCT02808429|39899353|FG002|Overall Study|Relocation|1|||
16386362|NCT04592341|39899356|FG000|Overall Study|Physician Decision|5|||
16386363|NCT04592341|39899356|FG000|Overall Study|Study Terminated by Sponsor|5|||
16386364|NCT04592341|39899356|FG000|Overall Study|Withdrawal by Subject|53|||
16386365|NCT04592341|39899356|FG000|Overall Study|Lost to Follow-up|3|||
16386366|NCT04592341|39899356|FG000|Overall Study|Death|1|||
16386367|NCT04592341|39899356|FG000|Overall Study|Adverse Event|5|||
16386368|NCT04592341|39899356|FG000|Overall Study|other|4|||
16386369|NCT00442702|39899358|FG000|Titration Period|Adverse Event|2|||
16300233|NCT03656744|39582132|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
16300234|NCT03656744|39582133|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
16300235|NCT04400682|39582134|FG000|Period 1|Withdrawal by Subject|1|||
16300236|NCT04400682|39582135|FG001|Period 1|Withdrawal by Subject|4|||
16300237|NCT01338870|39582136|FG000|Overall Study|Lost to Follow-up|0|||
16300238|NCT01338870|39582137|FG001|Overall Study|Lost to Follow-up|0|||
16300239|NCT01338870|39582138|FG002|Overall Study|Lost to Follow-up|1|||
16300240|NCT01338870|39582139|FG003|Overall Study|Lost to Follow-up|0|||
16300241|NCT01338870|39582140|FG004|Overall Study|Lost to Follow-up|1|||
16300242|NCT01338870|39582141|FG005|Overall Study|Lost to Follow-up|0|||
16300243|NCT01338870|39582136|FG000|Overall Study|Withdrawal by Subject|2|||
16300244|NCT01338870|39582137|FG001|Overall Study|Withdrawal by Subject|3|||
16300245|NCT01338870|39582138|FG002|Overall Study|Withdrawal by Subject|4|||
16300246|NCT01338870|39582139|FG003|Overall Study|Withdrawal by Subject|0|||
16300247|NCT01338870|39582140|FG004|Overall Study|Withdrawal by Subject|0|||
16300248|NCT01338870|39582141|FG005|Overall Study|Withdrawal by Subject|2|||
16300249|NCT01338870|39582136|FG000|Overall Study|Other|3|||
16300250|NCT01338870|39582137|FG001|Overall Study|Other|3|||
16300251|NCT01338870|39582138|FG002|Overall Study|Other|3|||
16300252|NCT01338870|39582139|FG003|Overall Study|Other|2|||
16300253|NCT01338870|39582140|FG004|Overall Study|Other|0|||
16300254|NCT01338870|39582141|FG005|Overall Study|Other|2|||
16300255|NCT01338870|39582136|FG000|Overall Study|Protocol Violation|0|||
16300256|NCT01338870|39582137|FG001|Overall Study|Protocol Violation|2|||
16300257|NCT01338870|39582138|FG002|Overall Study|Protocol Violation|2|||
16300258|NCT01338870|39582139|FG003|Overall Study|Protocol Violation|2|||
16300259|NCT01338870|39582140|FG004|Overall Study|Protocol Violation|1|||
16300260|NCT01338870|39582141|FG005|Overall Study|Protocol Violation|1|||
16300261|NCT01338870|39582136|FG000|Overall Study|Adverse Event|4|||
16300262|NCT01338870|39582137|FG001|Overall Study|Adverse Event|4|||
16300263|NCT01338870|39582138|FG002|Overall Study|Adverse Event|1|||
16300264|NCT01338870|39582139|FG003|Overall Study|Adverse Event|5|||
16300265|NCT01338870|39582140|FG004|Overall Study|Adverse Event|4|||
16300266|NCT01338870|39582141|FG005|Overall Study|Adverse Event|1|||
16300267|NCT02022748|39582162|FG000|Overall Study|Adverse Event|1|||
16300268|NCT02022748|39582163|FG001|Overall Study|Adverse Event|1|||
16300269|NCT02022748|39582164|FG002|Overall Study|Adverse Event|0|||
16300270|NCT02022748|39582162|FG000|Overall Study|Withdrawal by Subject|0|||
16300271|NCT02022748|39582163|FG001|Overall Study|Withdrawal by Subject|1|||
16300272|NCT02022748|39582164|FG002|Overall Study|Withdrawal by Subject|0|||
16300273|NCT02800642|39582166|FG000|Overall Study|Death|3|||
16300274|NCT02800642|39582166|FG000|Overall Study|Other|10|||
16300275|NCT02800642|39582166|FG000|Overall Study|Physician Decision|2|||
16300276|NCT02800642|39582166|FG000|Overall Study|Adverse Event|6|||
16300277|NCT02800642|39582166|FG000|Overall Study|Withdrawal by Subject|3|||
16300278|NCT02800642|39582166|FG000|Overall Study|Lost to Follow-up|1|||
16300279|NCT00985491|39582172|FG000|Overall Study|Adverse Event|8|||
16300280|NCT00985491|39582172|FG000|Overall Study|device migration|7|||
16300281|NCT00985491|39582172|FG000|Overall Study|Withdrawal by Subject|1|||
16300282|NCT00985491|39582172|FG000|Overall Study|implant failure|3|||
16300283|NCT02383810|39582173|FG000|Overall Study|Physician Decision|1|||
16300284|NCT02383810|39582174|FG001|Overall Study|Physician Decision|1|||
16300285|NCT02383810|39582175|FG002|Overall Study|Physician Decision|0|||
16300286|NCT02383810|39582176|FG003|Overall Study|Physician Decision|0|||
16300287|NCT02383810|39582177|FG004|Overall Study|Physician Decision|0|||
16300288|NCT02383810|39582178|FG005|Overall Study|Physician Decision|0|||
16300289|NCT02383810|39582179|FG006|Overall Study|Physician Decision|0|||
16300290|NCT02383810|39582180|FG007|Overall Study|Physician Decision|0|||
16300291|NCT02383810|39582173|FG000|Overall Study|Withdrawal by Subject|2|||
16300292|NCT02383810|39582174|FG001|Overall Study|Withdrawal by Subject|3|||
16300293|NCT02383810|39582175|FG002|Overall Study|Withdrawal by Subject|3|||
16300294|NCT02383810|39582176|FG003|Overall Study|Withdrawal by Subject|3|||
16300295|NCT02383810|39582177|FG004|Overall Study|Withdrawal by Subject|0|||
16300296|NCT02383810|39582178|FG005|Overall Study|Withdrawal by Subject|0|||
16300297|NCT02383810|39582179|FG006|Overall Study|Withdrawal by Subject|0|||
16300298|NCT02383810|39582180|FG007|Overall Study|Withdrawal by Subject|0|||
16300299|NCT02383810|39582173|FG000|Overall Study|Adverse Event|0|||
16300300|NCT02383810|39582174|FG001|Overall Study|Adverse Event|2|||
16300301|NCT02383810|39582175|FG002|Overall Study|Adverse Event|4|||
16300302|NCT02383810|39582176|FG003|Overall Study|Adverse Event|5|||
16300303|NCT02383810|39582177|FG004|Overall Study|Adverse Event|0|||
16300304|NCT02383810|39582178|FG005|Overall Study|Adverse Event|1|||
16300305|NCT02383810|39582179|FG006|Overall Study|Adverse Event|1|||
16300306|NCT02383810|39582180|FG007|Overall Study|Adverse Event|0|||
16300307|NCT02383810|39582173|FG000|Overall Study|Lost to Follow-up|0|||
16300308|NCT02383810|39582174|FG001|Overall Study|Lost to Follow-up|1|||
16300309|NCT02383810|39582175|FG002|Overall Study|Lost to Follow-up|0|||
16300310|NCT02383810|39582176|FG003|Overall Study|Lost to Follow-up|1|||
16300311|NCT02383810|39582177|FG004|Overall Study|Lost to Follow-up|0|||
16300312|NCT02383810|39582178|FG005|Overall Study|Lost to Follow-up|0|||
16300313|NCT02383810|39582179|FG006|Overall Study|Lost to Follow-up|0|||
16191962|NCT01849250|39179464|FG001|Overall Study|Withdrawal by Subject|0|||
16191963|NCT01849250|39179463|FG000|Overall Study|Not Evaluable|5|||
16191964|NCT01849250|39179464|FG001|Overall Study|Not Evaluable|3|||
16191965|NCT01849250|39179463|FG000|Overall Study|Screen Failure|1|||
16191966|NCT01849250|39179464|FG001|Overall Study|Screen Failure|0|||
16191967|NCT01409031|39179467|FG000|Overall Study|transferred to other hosp|1|||
16191968|NCT01409031|39179468|FG001|Overall Study|transferred to other hosp|0|||
16191969|NCT00926796|39179471|FG000|Overall Study|Did not receive randomized treatment|4|||
16191970|NCT00926796|39179472|FG001|Overall Study|Did not receive randomized treatment|7|||
16191971|NCT00926796|39179471|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
16191972|NCT00926796|39179472|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
16191973|NCT00926796|39179471|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
16191974|NCT00926796|39179472|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
16191975|NCT00926796|39179471|FG000|Overall Study|Adverse Event|7|||
16191976|NCT00926796|39179472|FG001|Overall Study|Adverse Event|14|||
16191977|NCT00926796|39179471|FG000|Overall Study|Lost to Follow-up|22|||
16191978|NCT00926796|39179472|FG001|Overall Study|Lost to Follow-up|13|||
16191979|NCT00926796|39179471|FG000|Overall Study|Protocol Violation|15|||
16191980|NCT00926796|39179472|FG001|Overall Study|Protocol Violation|11|||
16191981|NCT00926796|39179471|FG000|Overall Study|Withdrawal by Subject|1|||
16191982|NCT00926796|39179472|FG001|Overall Study|Withdrawal by Subject|0|||
16191983|NCT02622724|39182251|FG000|Overall Study|Death|51|||
16191984|NCT02622724|39182252|FG001|Overall Study|Death|53|||
16191985|NCT02622724|39182251|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
16191986|NCT02622724|39182252|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
16191987|NCT02622724|39182251|FG000|Overall Study|Early termination of study|38|||
16191988|NCT02622724|39182252|FG001|Overall Study|Early termination of study|43|||
16191989|NCT04191967|39182261|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
16191990|NCT04191967|39182261|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
16191991|NCT00121992|39182262|FG000|Overall Study|Treatment not received|2|||
16191992|NCT00121992|39182263|FG001|Overall Study|Treatment not received|11|||
16191993|NCT04439838|39182267|FG000|Overall Study|Withdrawal by Subject|0|||
16191994|NCT04439838|39182268|FG001|Overall Study|Withdrawal by Subject|0|||
16191995|NCT04439838|39182269|FG002|Overall Study|Withdrawal by Subject|0|||
16191996|NCT04439838|39182270|FG003|Overall Study|Withdrawal by Subject|0|||
16191997|NCT04439838|39182271|FG004|Overall Study|Withdrawal by Subject|0|||
16191998|NCT04439838|39182272|FG005|Overall Study|Withdrawal by Subject|0|||
16191999|NCT04439838|39182273|FG006|Overall Study|Withdrawal by Subject|0|||
16192000|NCT04439838|39182274|FG007|Overall Study|Withdrawal by Subject|0|||
16192001|NCT04439838|39182275|FG008|Overall Study|Withdrawal by Subject|1|||
16192002|NCT04570657|39182278|FG000|Overall Study|Adverse Event|0|||
16192003|NCT04570657|39182279|FG001|Overall Study|Adverse Event|0|||
16192004|NCT04570657|39182280|FG002|Overall Study|Adverse Event|1|||
16192005|NCT04570657|39182278|FG000|Overall Study|Lost to Follow-up|0|||
16192006|NCT04570657|39182279|FG001|Overall Study|Lost to Follow-up|0|||
16192007|NCT04570657|39182280|FG002|Overall Study|Lost to Follow-up|1|||
16192008|NCT04570657|39182278|FG000|Overall Study|Physician Decision|0|||
16192009|NCT04570657|39182279|FG001|Overall Study|Physician Decision|1|||
16192010|NCT04570657|39182280|FG002|Overall Study|Physician Decision|0|||
16192011|NCT04570657|39182278|FG000|Overall Study|Withdrawal by Subject|1|||
16192012|NCT04570657|39182279|FG001|Overall Study|Withdrawal by Subject|2|||
16192013|NCT04570657|39182280|FG002|Overall Study|Withdrawal by Subject|2|||
16192014|NCT02322892|39182283|FG000|Overall Study|Surgery cancelled|1|||
16192015|NCT02322892|39182284|FG001|Overall Study|Surgery cancelled|2|||
16192016|NCT02322892|39182283|FG000|Overall Study|Met exclusion criteria|0|||
16192017|NCT02322892|39182284|FG001|Overall Study|Met exclusion criteria|1|||
16192018|NCT02322892|39182283|FG000|Overall Study|Protocol Violation|1|||
16192019|NCT02322892|39182284|FG001|Overall Study|Protocol Violation|0|||
16192020|NCT00745368|39182285|FG000|Overall Study|Unable to provide sample|3|||
16192021|NCT00968253|39182288|FG000|Overall Study|Death|0|||
16192022|NCT00968253|39182289|FG001|Overall Study|Death|0|||
16300314|NCT02383810|39582180|FG007|Overall Study|Lost to Follow-up|0|||
16300315|NCT02383810|39582173|FG000|Overall Study|other|0|||
16300316|NCT02383810|39582174|FG001|Overall Study|other|0|||
16192023|NCT00968253|39182290|FG002|Overall Study|Death|2|||
16192024|NCT00968253|39182288|FG000|Overall Study|Withdrawal by Subject|0|||
16192025|NCT00968253|39182289|FG001|Overall Study|Withdrawal by Subject|0|||
16192026|NCT00968253|39182290|FG002|Overall Study|Withdrawal by Subject|1|||
16300317|NCT02383810|39582175|FG002|Overall Study|other|0|||
16300318|NCT02383810|39582176|FG003|Overall Study|other|2|||
16083857|NCT00448669|38799227|FG001|Overall Study|Never started drug|7|||
16083858|NCT01376700|38799228|FG000|Overall Study|Sponsor terminated study early|8|||
16083859|NCT01376700|38799228|FG000|Overall Study|Low or high titer inhibitor|8|||
16083860|NCT00676091|38799229|FG000|Infant Series|Parent or legal guardian request|10|||
16083861|NCT00676091|38799230|FG001|Infant Series|Parent or legal guardian request|8|||
16386370|NCT00442702|39899359|FG001|Titration Period|Adverse Event|0|||
16386371|NCT00442702|39899358|FG000|Titration Period|Death|3|||
16386372|NCT00442702|39899359|FG001|Titration Period|Death|2|||
16386373|NCT00442702|39899358|FG000|Titration Period|Insufficient Therapeutic Response|1|||
16386374|NCT00442702|39899359|FG001|Titration Period|Insufficient Therapeutic Response|0|||
16386375|NCT00442702|39899358|FG000|Titration Period|Refused Treatment|4|||
16386376|NCT00442702|39899359|FG001|Titration Period|Refused Treatment|1|||
16386377|NCT00442702|39899358|FG000|Titration Period|Failure to return|1|||
16083862|NCT00676091|38799229|FG000|Infant Series|Protocol Violation|6|||
16083863|NCT00676091|38799230|FG001|Infant Series|Protocol Violation|3|||
16083864|NCT00676091|38799229|FG000|Infant Series|Adverse Event|2|||
16386378|NCT00442702|39899359|FG001|Titration Period|Failure to return|0|||
16386379|NCT00442702|39899358|FG000|Titration Period|Hospitalized in another hospital|1|||
16490037|NCT02207244|40267108|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
16490038|NCT02207244|40267109|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
16490039|NCT02207244|40267110|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
16490040|NCT02207244|40267111|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
16490041|NCT02207244|40267112|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
16490042|NCT02207244|40267102|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16490043|NCT02207244|40267103|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16490044|NCT02207244|40267104|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16490045|NCT02207244|40267105|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16490046|NCT02207244|40267106|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16490047|NCT02207244|40267107|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16490048|NCT02207244|40267108|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
16490049|NCT02207244|40267109|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
16490050|NCT02207244|40267110|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16490051|NCT02207244|40267111|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
16490052|NCT02207244|40267112|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
16490053|NCT02207244|40267102|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16490054|NCT02207244|40267103|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16490055|NCT02207244|40267104|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16490056|NCT02207244|40267105|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16490057|NCT02207244|40267106|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16490058|NCT02207244|40267107|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16490059|NCT02207244|40267108|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
16490060|NCT02207244|40267109|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
16490061|NCT02207244|40267110|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
16490062|NCT02207244|40267111|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
16490063|NCT02207244|40267112|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
16490064|NCT02207244|40267102|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16490065|NCT02207244|40267103|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16490066|NCT02207244|40267104|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16490067|NCT02207244|40267105|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16490068|NCT02207244|40267106|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16490069|NCT02207244|40267107|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16490070|NCT02207244|40267108|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16490071|NCT02207244|40267109|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
16490072|NCT02207244|40267110|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
16490073|NCT02207244|40267111|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16490074|NCT02207244|40267112|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
16490075|NCT02207244|40267102|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16490076|NCT02207244|40267103|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16490077|NCT02207244|40267104|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16490078|NCT02207244|40267105|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16490079|NCT02207244|40267106|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16386380|NCT00442702|39899359|FG001|Titration Period|Hospitalized in another hospital|0|||
16490080|NCT02207244|40267107|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16490081|NCT02207244|40267108|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16083865|NCT00676091|38799230|FG001|Infant Series|Adverse Event|3|||
16083866|NCT00676091|38799229|FG000|Infant Series|Failed to return|1|||
16300319|NCT02383810|39582177|FG004|Overall Study|other|0|||
16300320|NCT02383810|39582178|FG005|Overall Study|other|0|||
16300321|NCT02383810|39582179|FG006|Overall Study|other|0|||
16300322|NCT02383810|39582180|FG007|Overall Study|other|0|||
16300323|NCT02383810|39582173|FG000|Overall Study|subject did not receive study treatment|0|||
16300324|NCT02383810|39582174|FG001|Overall Study|subject did not receive study treatment|1|||
16300325|NCT02383810|39582175|FG002|Overall Study|subject did not receive study treatment|0|||
16300326|NCT02383810|39582176|FG003|Overall Study|subject did not receive study treatment|0|||
16300327|NCT02383810|39582177|FG004|Overall Study|subject did not receive study treatment|0|||
16300328|NCT02383810|39582178|FG005|Overall Study|subject did not receive study treatment|0|||
16300329|NCT02383810|39582179|FG006|Overall Study|subject did not receive study treatment|0|||
16300330|NCT02383810|39582180|FG007|Overall Study|subject did not receive study treatment|0|||
16300331|NCT03017612|39582181|FG000|Overall Study|Adverse Event|2|||
16386381|NCT00442702|39899358|FG000|Evaluation Period|Adverse Event|1|||
16386382|NCT00442702|39899359|FG001|Evaluation Period|Adverse Event|0|||
16386383|NCT00442702|39899358|FG000|Evaluation Period|Death|1|||
16386384|NCT00442702|39899359|FG001|Evaluation Period|Death|1|||
16386385|NCT00442702|39899358|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
16386386|NCT00442702|39899359|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
16386387|NCT00442702|39899358|FG000|Evaluation Period|Refused treatment|1|||
16386388|NCT00442702|39899359|FG001|Evaluation Period|Refused treatment|1|||
16386389|NCT00442702|39899358|FG000|Evaluation Period|Renal transplant|0|||
16386390|NCT00442702|39899359|FG001|Evaluation Period|Renal transplant|1|||
16386391|NCT00442702|39899358|FG000|Evaluation Period|Failure to return|1|||
16386392|NCT00442702|39899359|FG001|Evaluation Period|Failure to return|0|||
16386393|NCT00442702|39899358|FG000|Evaluation Period|Site closure|0|||
16386394|NCT00442702|39899359|FG001|Evaluation Period|Site closure|1|||
16386395|NCT01027650|39899360|FG000|Overall Study|Personal Reasons|0|||
16386396|NCT01027650|39899361|FG001|Overall Study|Personal Reasons|0|||
16386397|NCT01027650|39899362|FG002|Overall Study|Personal Reasons|0|||
16386398|NCT01027650|39899363|FG003|Overall Study|Personal Reasons|0|||
16386399|NCT01027650|39899364|FG004|Overall Study|Personal Reasons|2|||
16386400|NCT01027650|39899365|FG005|Overall Study|Personal Reasons|1|||
16192027|NCT00968253|39182288|FG000|Overall Study|Disease Progression|0|||
16386401|NCT01027650|39899366|FG006|Overall Study|Personal Reasons|0|||
16386402|NCT01027650|39899367|FG007|Overall Study|Personal Reasons|0|||
16386403|NCT01027650|39899360|FG000|Overall Study|Lost to Follow-up|0|||
16386404|NCT01027650|39899361|FG001|Overall Study|Lost to Follow-up|0|||
16490082|NCT02207244|40267109|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16490083|NCT02207244|40267110|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
16490084|NCT02207244|40267111|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16490085|NCT02207244|40267112|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
16490086|NCT02207244|40267102|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16490087|NCT02207244|40267103|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16490088|NCT02207244|40267104|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16490089|NCT02207244|40267105|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16490090|NCT02207244|40267106|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16490091|NCT02207244|40267107|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16490092|NCT02207244|40267108|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16490093|NCT02207244|40267109|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
16490094|NCT02207244|40267110|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16490095|NCT02207244|40267111|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16490096|NCT02207244|40267112|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
16490097|NCT02207244|40267102|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16490098|NCT02207244|40267103|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16490099|NCT02207244|40267104|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16490100|NCT02207244|40267105|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16490101|NCT02207244|40267106|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16490102|NCT02207244|40267107|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16490103|NCT02207244|40267108|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
16490104|NCT02207244|40267109|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16490105|NCT02207244|40267110|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16490106|NCT02207244|40267111|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16490107|NCT02207244|40267112|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
16490108|NCT02207244|40267102|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16490109|NCT02207244|40267103|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16490110|NCT02207244|40267104|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16490111|NCT02207244|40267105|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16490112|NCT02207244|40267106|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16490113|NCT02207244|40267107|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16490114|NCT02207244|40267108|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16490115|NCT02207244|40267109|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16490116|NCT02207244|40267110|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
16490117|NCT02207244|40267111|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
16490118|NCT02207244|40267112|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
16490119|NCT02207244|40267102|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16490120|NCT02207244|40267103|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16490121|NCT02207244|40267104|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16490122|NCT02207244|40267105|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16490123|NCT02207244|40267106|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16490124|NCT02207244|40267107|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16490125|NCT02207244|40267108|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16490126|NCT02207244|40267109|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16490127|NCT02207244|40267110|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
16490128|NCT02207244|40267111|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
16490129|NCT02207244|40267112|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
16490130|NCT02207244|40267102|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16490131|NCT02207244|40267103|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16490132|NCT02207244|40267104|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16490133|NCT02207244|40267105|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16490134|NCT02207244|40267106|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16490135|NCT02207244|40267107|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16490136|NCT02207244|40267108|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16490137|NCT02207244|40267109|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16490138|NCT02207244|40267110|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
16490139|NCT02207244|40267111|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
16490140|NCT02207244|40267112|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
16490141|NCT02207244|40267102|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16490142|NCT02207244|40267103|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16490143|NCT02207244|40267104|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16490144|NCT02207244|40267105|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16300332|NCT02278055|39582182|FG000|Overall Study|Adverse Event|1|||
16192028|NCT00968253|39182289|FG001|Overall Study|Disease Progression|3|||
16192029|NCT00968253|39182290|FG002|Overall Study|Disease Progression|3|||
16192030|NCT00968253|39182288|FG000|Overall Study|Adverse Event|0|||
16192031|NCT00968253|39182289|FG001|Overall Study|Adverse Event|0|||
16192032|NCT00968253|39182290|FG002|Overall Study|Adverse Event|1|||
16192033|NCT00610935|39182291|FG000|Overall Study|Lost to Follow-up|0|||
16192034|NCT00610935|39182292|FG001|Overall Study|Lost to Follow-up|1|||
16192035|NCT00610935|39182291|FG000|Overall Study|Withdrawal by Subject|0|||
16192036|NCT00610935|39182292|FG001|Overall Study|Withdrawal by Subject|2|||
16192037|NCT00610935|39182291|FG000|Overall Study|Sponsor Discontinuation|1|||
16192038|NCT00610935|39182292|FG001|Overall Study|Sponsor Discontinuation|0|||
16192039|NCT00798694|39182293|FG000|Overall Study|Lost to Follow-up|1|||
16192040|NCT00798694|39182294|FG001|Overall Study|Lost to Follow-up|1|||
16192041|NCT00798694|39182293|FG000|Overall Study|Physician Decision|1|||
16192042|NCT00798694|39182294|FG001|Overall Study|Physician Decision|0|||
16192043|NCT00621855|39182295|FG000|Overall Study|Adverse Event|32|||
16192044|NCT00621855|39182296|FG001|Overall Study|Adverse Event|31|||
16192045|NCT00621855|39182297|FG002|Overall Study|Adverse Event|48|||
16490145|NCT02207244|40267106|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16490146|NCT02207244|40267107|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16490147|NCT02207244|40267108|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16490148|NCT02207244|40267109|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16192046|NCT00621855|39182298|FG003|Overall Study|Adverse Event|34|||
16192047|NCT00621855|39182299|FG004|Overall Study|Adverse Event|31|||
16192048|NCT00621855|39182295|FG000|Overall Study|Lost to Follow-up|0|||
16192049|NCT00621855|39182296|FG001|Overall Study|Lost to Follow-up|1|||
16192050|NCT00621855|39182297|FG002|Overall Study|Lost to Follow-up|3|||
16192051|NCT00621855|39182298|FG003|Overall Study|Lost to Follow-up|4|||
16192052|NCT00621855|39182299|FG004|Overall Study|Lost to Follow-up|1|||
16192053|NCT00621855|39182295|FG000|Overall Study|Protocol Violation|16|||
16192054|NCT00621855|39182296|FG001|Overall Study|Protocol Violation|8|||
16192055|NCT00621855|39182297|FG002|Overall Study|Protocol Violation|6|||
16192056|NCT00621855|39182298|FG003|Overall Study|Protocol Violation|7|||
16192057|NCT00621855|39182299|FG004|Overall Study|Protocol Violation|8|||
16192058|NCT00621855|39182295|FG000|Overall Study|Withdrawal by Subject|16|||
16192059|NCT00621855|39182296|FG001|Overall Study|Withdrawal by Subject|11|||
16192060|NCT00621855|39182297|FG002|Overall Study|Withdrawal by Subject|13|||
16192061|NCT00621855|39182298|FG003|Overall Study|Withdrawal by Subject|13|||
16192062|NCT00621855|39182299|FG004|Overall Study|Withdrawal by Subject|9|||
16192063|NCT00621855|39182295|FG000|Overall Study|Other|9|||
16192064|NCT00621855|39182296|FG001|Overall Study|Other|7|||
16192065|NCT00621855|39182297|FG002|Overall Study|Other|6|||
16192066|NCT00621855|39182298|FG003|Overall Study|Other|5|||
16490149|NCT02207244|40267110|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
16490150|NCT02207244|40267111|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
16192067|NCT00621855|39182299|FG004|Overall Study|Other|4|||
16192068|NCT00621855|39182295|FG000|Overall Study|Patients did not receive study drug|3|||
16192069|NCT00621855|39182296|FG001|Overall Study|Patients did not receive study drug|3|||
16192070|NCT00621855|39182297|FG002|Overall Study|Patients did not receive study drug|5|||
16192071|NCT00621855|39182298|FG003|Overall Study|Patients did not receive study drug|4|||
16192072|NCT00621855|39182299|FG004|Overall Study|Patients did not receive study drug|2|||
16192073|NCT01737840|39182300|FG000|Overall Study|Diagnosed with an other pathology|2|||
16192074|NCT01737840|39182301|FG001|Overall Study|Diagnosed with an other pathology|2|||
16192075|NCT04715230|39182302|FG000|Overall Study|Withdrawal by Subject|1|||
16192076|NCT04715230|39182303|FG001|Overall Study|Withdrawal by Subject|0|||
16192077|NCT04715230|39182304|FG002|Overall Study|Withdrawal by Subject|0|||
16192078|NCT04715230|39182302|FG000|Overall Study|Lost to Follow-up|0|||
16192079|NCT04715230|39182303|FG001|Overall Study|Lost to Follow-up|5|||
16192080|NCT04715230|39182304|FG002|Overall Study|Lost to Follow-up|1|||
16192081|NCT01553916|39182305|FG000|Overall Study|Withdrawal by Subject|2|||
16192082|NCT01553916|39182305|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
16192083|NCT02104804|39182306|FG000|Overall Study|Did not take study medication|0|||
16192084|NCT02104804|39182307|FG001|Overall Study|Did not take study medication|1|||
16192085|NCT02104804|39182306|FG000|Overall Study|Study specific discontinuation criteria|6|||
16192086|NCT02104804|39182307|FG001|Overall Study|Study specific discontinuation criteria|1|||
16192087|NCT02104804|39182306|FG000|Overall Study|Other listed|2|||
16192088|NCT02104804|39182307|FG001|Overall Study|Other listed|1|||
16192089|NCT02104804|39182306|FG000|Overall Study|Protocol Violation|0|||
16192090|NCT02104804|39182307|FG001|Overall Study|Protocol Violation|1|||
16192091|NCT02104804|39182306|FG000|Overall Study|Adverse Event|4|||
16192092|NCT02104804|39182307|FG001|Overall Study|Adverse Event|3|||
16192093|NCT02104804|39182306|FG000|Overall Study|Withdrawal by Subject|4|||
16192094|NCT02104804|39182307|FG001|Overall Study|Withdrawal by Subject|12|||
16192095|NCT03105700|39182308|FG000|Overall Study|screen fail|3|||
16490151|NCT02207244|40267112|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
16192096|NCT03105700|39182308|FG000|Overall Study|Lost to Follow-up|4|||
16192097|NCT02618928|39182309|FG000|Overall Study|Failure to Return|28|||
16192098|NCT02618928|39182309|FG000|Overall Study|Insufficient Virological Response|1|||
16192099|NCT02618928|39182309|FG000|Overall Study|Withdrawal by Subject|2|||
16192100|NCT02618928|39182309|FG000|Overall Study|Death|3|||
16192101|NCT02618928|39182309|FG000|Overall Study|Other|11|||
16192102|NCT02618928|39182309|FG000|Overall Study|Missing|6|||
16192103|NCT02618928|39182309|FG000|Overall Study|Treatment Never Started|7|||
16192104|NCT00516269|39182310|FG000|Overall Study|Adverse Event|2|||
16192105|NCT00516269|39182311|FG001|Overall Study|Adverse Event|1|||
16192106|NCT00516269|39182310|FG000|Overall Study|Lost to Follow-up|0|||
16192107|NCT00516269|39182311|FG001|Overall Study|Lost to Follow-up|1|||
16192108|NCT00516269|39182310|FG000|Overall Study|Protocol Violation|0|||
16490152|NCT02207244|40267102|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
16490153|NCT02207244|40267103|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
16490154|NCT02207244|40267104|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
16490155|NCT02207244|40267105|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
16490156|NCT02207244|40267106|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
16490157|NCT02207244|40267107|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
16490158|NCT02207244|40267108|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
16490159|NCT02207244|40267109|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
16192109|NCT00516269|39182311|FG001|Overall Study|Protocol Violation|1|||
16192110|NCT00487084|39182312|FG000|Overall Study|Did not receive intervention|4|||
16192111|NCT00487084|39182313|FG001|Overall Study|Did not receive intervention|3|||
16192112|NCT00487084|39182314|FG002|Overall Study|Did not receive intervention|5|||
16192113|NCT00411788|39182315|FG000|Overall Study|Protocol Violation|1|||
16192114|NCT00411788|39182315|FG000|Overall Study|Adverse Event|1|||
16192115|NCT02043301|39182316|FG000|Overall Study|Discontinued|0|||
16192116|NCT02043301|39182317|FG001|Overall Study|Discontinued|1|||
16192117|NCT02043301|39182318|FG002|Overall Study|Discontinued|0|||
16192118|NCT01511419|39182322|FG000|Dose 2|Physician Decision|1|||
16192119|NCT01511419|39182323|FG001|Dose 2|Physician Decision|0|||
16192120|NCT01525849|39182326|FG000|Overall Study|Lost to Follow-up|3|||
16192121|NCT01525849|39182327|FG001|Overall Study|Lost to Follow-up|2|||
16192122|NCT01525849|39182326|FG000|Overall Study|Withdrawal by Subject|1|||
16192123|NCT01525849|39182327|FG001|Overall Study|Withdrawal by Subject|9|||
16192124|NCT01525849|39182326|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
16192125|NCT01525849|39182327|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
16192126|NCT01525849|39182326|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
16192127|NCT01525849|39182327|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
16192128|NCT03731364|39182332|FG000|Overall Study|Adverse Event|0|||
16192129|NCT03731364|39182333|FG001|Overall Study|Adverse Event|0|||
16192130|NCT03731364|39182334|FG002|Overall Study|Adverse Event|1|||
16490160|NCT02207244|40267110|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
16490161|NCT02207244|40267111|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
16490162|NCT02207244|40267112|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
16490163|NCT02207244|40267102|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
16490164|NCT02207244|40267103|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
16490165|NCT02207244|40267104|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
16490166|NCT02207244|40267105|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
16490167|NCT02207244|40267106|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
16490168|NCT02207244|40267107|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
16490169|NCT02207244|40267108|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
16490170|NCT02207244|40267109|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
16490171|NCT02207244|40267110|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
16490172|NCT02207244|40267111|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
16490173|NCT02207244|40267112|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
16490174|NCT02207244|40267102|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16490175|NCT02207244|40267103|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16490176|NCT02207244|40267104|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16490177|NCT02207244|40267105|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16490178|NCT02207244|40267106|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16490179|NCT02207244|40267107|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16490180|NCT02207244|40267108|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16490181|NCT02207244|40267109|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16490182|NCT02207244|40267110|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16192131|NCT03731364|39182335|FG003|Overall Study|Adverse Event|2|||
16192132|NCT03731364|39182336|FG004|Overall Study|Adverse Event|1|||
16192133|NCT03364608|39182337|FG000|Overall Study|Withdrawal by Subject|4|||
16192134|NCT03364608|39182337|FG000|Overall Study|Protocol Violation|2|||
16490183|NCT02207244|40267111|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
16490184|NCT02207244|40267112|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
16490185|NCT04706091|40267116|FG000|Treatment 2|Withdrawal by Subject|1|||
16490186|NCT04706091|40267117|FG001|Treatment 2|Withdrawal by Subject|0|||
16490187|NCT00224042|40267118|FG000|Overall Study|Adverse Event|2|||
16490188|NCT00224042|40267119|FG001|Overall Study|Adverse Event|1|||
16192135|NCT03364608|39182337|FG000|Overall Study|Lost to Follow-up|2|||
16192136|NCT00543569|39182338|FG000|Overall Study|Death|2|||
16192137|NCT00543569|39182339|FG001|Overall Study|Death|2|||
16192138|NCT00543569|39182340|FG002|Overall Study|Death|3|||
16192139|NCT00543569|39182341|FG003|Overall Study|Death|1|||
16192140|NCT00543569|39182338|FG000|Overall Study|Lost to Follow-up|0|||
16192141|NCT00543569|39182339|FG001|Overall Study|Lost to Follow-up|0|||
16192142|NCT00543569|39182340|FG002|Overall Study|Lost to Follow-up|1|||
16192143|NCT00543569|39182341|FG003|Overall Study|Lost to Follow-up|1|||
16192144|NCT00543569|39182338|FG000|Overall Study|Miscellaneous Reasons|7|||
16192145|NCT00543569|39182339|FG001|Overall Study|Miscellaneous Reasons|3|||
16192146|NCT00543569|39182340|FG002|Overall Study|Miscellaneous Reasons|11|||
16192147|NCT00543569|39182341|FG003|Overall Study|Miscellaneous Reasons|4|||
16192148|NCT00543569|39182338|FG000|Overall Study|Randomized but never received study drug|3|||
16192149|NCT00543569|39182339|FG001|Overall Study|Randomized but never received study drug|3|||
16192150|NCT00543569|39182340|FG002|Overall Study|Randomized but never received study drug|5|||
16192151|NCT00543569|39182341|FG003|Overall Study|Randomized but never received study drug|3|||
16192152|NCT02433379|39182342|FG000|Overall Study|Screen Failures|55|||
16192153|NCT02433379|39182342|FG000|Overall Study|Death|57|||
16192154|NCT02433379|39182342|FG000|Overall Study|Total Withdrawals|209|||
16192155|NCT03571256|39182343|FG000|Overall Study|Adverse Event|3|||
16192156|NCT03571256|39182344|FG001|Overall Study|Adverse Event|0|||
16192157|NCT03571256|39182345|FG002|Overall Study|Adverse Event|1|||
16192158|NCT03571256|39182343|FG000|Overall Study|Withdrawal by Subject|3|||
16192159|NCT03571256|39182344|FG001|Overall Study|Withdrawal by Subject|1|||
16192160|NCT03571256|39182345|FG002|Overall Study|Withdrawal by Subject|1|||
16192161|NCT03571256|39182343|FG000|Overall Study|Other than specified|0|||
16192162|NCT03571256|39182344|FG001|Overall Study|Other than specified|1|||
16192163|NCT03571256|39182345|FG002|Overall Study|Other than specified|1|||
16192164|NCT03571256|39182343|FG000|Overall Study|Protocol Violation|0|||
16192165|NCT03571256|39182344|FG001|Overall Study|Protocol Violation|1|||
16192166|NCT03571256|39182345|FG002|Overall Study|Protocol Violation|1|||
16192167|NCT01449682|39182348|FG000|Overall Study|Death|0|||
16192168|NCT01449682|39182349|FG001|Overall Study|Death|1|||
16192169|NCT01449682|39182348|FG000|Overall Study|Adverse Event|1|||
16192170|NCT01449682|39182349|FG001|Overall Study|Adverse Event|0|||
16192171|NCT01716533|39182352|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
16192172|NCT01716533|39182353|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
16192173|NCT01716533|39182354|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
16192174|NCT01716533|39182355|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
16192175|NCT01716533|39182352|FG000|Overall Study|Withdrawal by Subject|0|||
16192176|NCT01716533|39182353|FG001|Overall Study|Withdrawal by Subject|0|||
16192177|NCT01716533|39182354|FG002|Overall Study|Withdrawal by Subject|0|||
16192178|NCT01716533|39182355|FG003|Overall Study|Withdrawal by Subject|5|||
16386405|NCT01027650|39899362|FG002|Overall Study|Lost to Follow-up|0|||
16386406|NCT01027650|39899363|FG003|Overall Study|Lost to Follow-up|0|||
16386407|NCT01027650|39899364|FG004|Overall Study|Lost to Follow-up|0|||
16386408|NCT01027650|39899365|FG005|Overall Study|Lost to Follow-up|0|||
16386409|NCT01027650|39899366|FG006|Overall Study|Lost to Follow-up|1|||
16386410|NCT01027650|39899367|FG007|Overall Study|Lost to Follow-up|0|||
16386411|NCT01027650|39899360|FG000|Overall Study|Lack of Efficacy|0|||
16386412|NCT01027650|39899361|FG001|Overall Study|Lack of Efficacy|0|||
16386413|NCT01027650|39899362|FG002|Overall Study|Lack of Efficacy|0|||
16386414|NCT01027650|39899363|FG003|Overall Study|Lack of Efficacy|0|||
16386415|NCT01027650|39899364|FG004|Overall Study|Lack of Efficacy|0|||
16386416|NCT01027650|39899365|FG005|Overall Study|Lack of Efficacy|1|||
16386417|NCT01027650|39899366|FG006|Overall Study|Lack of Efficacy|0|||
16386418|NCT01027650|39899367|FG007|Overall Study|Lack of Efficacy|0|||
16386419|NCT01740687|39899368|FG000|Overall Study|Lost to Follow-up|11|||
16386420|NCT01740687|39899368|FG000|Overall Study|Withdrawal by Subject|2|||
16386421|NCT01740687|39899368|FG000|Overall Study|other reason|22|||
16386422|NCT01740687|39899368|FG000|Overall Study|treatment not received|2|||
16386423|NCT03559270|39899369|FG000|Overall Study|Adverse Event|6|||
16386424|NCT03559270|39899370|FG001|Overall Study|Adverse Event|5|||
16490189|NCT00224042|40267118|FG000|Overall Study|Protocol Violation|0|||
16192179|NCT01716533|39182352|FG000|Overall Study|Death|0|||
16192180|NCT01716533|39182353|FG001|Overall Study|Death|0|||
16192181|NCT01716533|39182354|FG002|Overall Study|Death|0|||
16386425|NCT03559270|39899371|FG002|Overall Study|Adverse Event|3|||
16386426|NCT03559270|39899372|FG003|Overall Study|Adverse Event|0|||
16386427|NCT03559270|39899369|FG000|Overall Study|Lack of Efficacy|34|||
16386428|NCT03559270|39899370|FG001|Overall Study|Lack of Efficacy|52|||
16386429|NCT03559270|39899371|FG002|Overall Study|Lack of Efficacy|37|||
16386430|NCT03559270|39899372|FG003|Overall Study|Lack of Efficacy|2|||
16386431|NCT03559270|39899369|FG000|Overall Study|Death|0|||
16386432|NCT03559270|39899370|FG001|Overall Study|Death|2|||
16386433|NCT03559270|39899371|FG002|Overall Study|Death|0|||
16386434|NCT03559270|39899372|FG003|Overall Study|Death|0|||
16386435|NCT03559270|39899369|FG000|Overall Study|Lost to Follow-up|16|||
16386436|NCT03559270|39899370|FG001|Overall Study|Lost to Follow-up|4|||
16386437|NCT03559270|39899371|FG002|Overall Study|Lost to Follow-up|12|||
16386438|NCT03559270|39899372|FG003|Overall Study|Lost to Follow-up|3|||
16386439|NCT03559270|39899369|FG000|Overall Study|Sponsor Decision|38|||
16386440|NCT03559270|39899370|FG001|Overall Study|Sponsor Decision|31|||
16386441|NCT03559270|39899371|FG002|Overall Study|Sponsor Decision|35|||
16386442|NCT03559270|39899372|FG003|Overall Study|Sponsor Decision|18|||
16386443|NCT03559270|39899369|FG000|Overall Study|Withdrawal by Subject|19|||
16386444|NCT03559270|39899370|FG001|Overall Study|Withdrawal by Subject|21|||
16386445|NCT03559270|39899371|FG002|Overall Study|Withdrawal by Subject|18|||
16386446|NCT03559270|39899372|FG003|Overall Study|Withdrawal by Subject|7|||
16386447|NCT03559270|39899369|FG000|Overall Study|Physician Decision|3|||
16386448|NCT03559270|39899370|FG001|Overall Study|Physician Decision|2|||
16386449|NCT03559270|39899371|FG002|Overall Study|Physician Decision|1|||
16386450|NCT03559270|39899372|FG003|Overall Study|Physician Decision|0|||
16386451|NCT03559270|39899369|FG000|Overall Study|Pregnancy|0|||
16386452|NCT03559270|39899370|FG001|Overall Study|Pregnancy|1|||
16386453|NCT03559270|39899371|FG002|Overall Study|Pregnancy|0|||
16386454|NCT03559270|39899372|FG003|Overall Study|Pregnancy|0|||
16386455|NCT03559270|39899369|FG000|Overall Study|Protocol Violation|1|||
16386456|NCT03559270|39899370|FG001|Overall Study|Protocol Violation|0|||
16386457|NCT03559270|39899371|FG002|Overall Study|Protocol Violation|2|||
16386458|NCT03559270|39899372|FG003|Overall Study|Protocol Violation|0|||
16386459|NCT01847443|39899375|FG000|Study Period 1|Withdrawal by Subject|0|||
16386460|NCT01847443|39899376|FG001|Study Period 1|Withdrawal by Subject|1|||
16386461|NCT01847443|39899377|FG002|Study Period 1|Withdrawal by Subject|0|||
16386462|NCT01847443|39899378|FG003|Study Period 1|Withdrawal by Subject|0|||
16386463|NCT01847443|39899375|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
16386464|NCT01847443|39899376|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
16386465|NCT01847443|39899377|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
16386466|NCT01847443|39899378|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
16386467|NCT01847443|39899375|FG000|Washout Period Before Study Period 2|Other reason|1|||
16386468|NCT01847443|39899376|FG001|Washout Period Before Study Period 2|Other reason|0|||
16386469|NCT01847443|39899377|FG002|Washout Period Before Study Period 2|Other reason|0|||
16386470|NCT01847443|39899378|FG003|Washout Period Before Study Period 2|Other reason|0|||
16386471|NCT01847443|39899375|FG000|Washout Period Before Study Period 3|Other reason|1|||
16386472|NCT01847443|39899376|FG001|Washout Period Before Study Period 3|Other reason|0|||
16386473|NCT01847443|39899377|FG002|Washout Period Before Study Period 3|Other reason|0|||
16386474|NCT01847443|39899378|FG003|Washout Period Before Study Period 3|Other reason|0|||
16386475|NCT01847443|39899375|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
16386476|NCT01847443|39899376|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
16386477|NCT01847443|39899377|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
16386478|NCT01847443|39899378|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
16386479|NCT01847443|39899375|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
16386480|NCT01847443|39899376|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
16386481|NCT01847443|39899377|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
16386482|NCT01847443|39899378|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
16386483|NCT03961308|39899383|FG000|Overall Study|Withdrawal by Subject|1|||
16386484|NCT03961308|39899384|FG001|Overall Study|Withdrawal by Subject|0|||
16386485|NCT03961308|39899383|FG000|Overall Study|Other|1|||
16386486|NCT03961308|39899384|FG001|Overall Study|Other|0|||
16386487|NCT03961308|39899383|FG000|Overall Study|Lost to Follow-up|0|||
16386488|NCT03961308|39899384|FG001|Overall Study|Lost to Follow-up|1|||
16386489|NCT03961308|39899383|FG000|Overall Study|Adverse Event|0|||
16386490|NCT03961308|39899384|FG001|Overall Study|Adverse Event|1|||
16386491|NCT02121509|39899385|FG000|Washout Period (35 Days)|Adverse Event|1|||
16386492|NCT02121509|39899386|FG001|Washout Period (35 Days)|Adverse Event|1|||
16386493|NCT02121509|39899387|FG002|Washout Period (35 Days)|Adverse Event|0|||
16386494|NCT02121509|39899388|FG003|Washout Period (35 Days)|Adverse Event|0|||
16386495|NCT02121509|39899385|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
16386496|NCT02121509|39899386|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
16386497|NCT02121509|39899387|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
16386498|NCT02121509|39899388|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
16386499|NCT02121509|39899385|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
16386500|NCT02121509|39899386|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
16386501|NCT02121509|39899387|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
16386502|NCT02121509|39899388|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
16386503|NCT05142306|39899389|FG000|Overall Study|Withdrawal by Subject|0|||
16386504|NCT05142306|39899390|FG001|Overall Study|Withdrawal by Subject|0|||
16386505|NCT05142306|39899391|FG002|Overall Study|Withdrawal by Subject|1|||
16386506|NCT02848092|39899392|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
16386507|NCT02848092|39899393|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
16386508|NCT02848092|39899392|FG000|1-month Post-training Follow-up|Adverse Event|2|||
16386509|NCT02848092|39899393|FG001|1-month Post-training Follow-up|Adverse Event|1|||
16386510|NCT02848092|39899392|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
16386511|NCT02848092|39899393|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
16386512|NCT02848092|39899392|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
16386513|NCT02848092|39899393|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
16386514|NCT02848092|39899392|FG000|1-month Post-training Follow-up|fatigue|0|||
16386515|NCT02848092|39899393|FG001|1-month Post-training Follow-up|fatigue|1|||
16386516|NCT02848092|39899392|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
16386517|NCT02848092|39899393|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
16386518|NCT02848092|39899392|FG000|6-month Post-training Follow-up|Adverse Event|1|||
16386519|NCT02848092|39899393|FG001|6-month Post-training Follow-up|Adverse Event|1|||
16386520|NCT02848092|39899392|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
16386521|NCT02848092|39899393|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
16386522|NCT02848092|39899392|FG000|6-month Post-training Follow-up|frustrated with task|1|||
16386523|NCT02848092|39899393|FG001|6-month Post-training Follow-up|frustrated with task|0|||
16386524|NCT02848092|39899392|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
16386525|NCT02848092|39899393|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
16386526|NCT02848092|39899392|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
16386527|NCT02848092|39899393|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
16386528|NCT01083602|39899396|FG000|Overall Study|Adverse Event|11|||
16386529|NCT01083602|39899396|FG000|Overall Study|New Cancer Therapy|2|||
16386530|NCT01083602|39899396|FG000|Overall Study|Death|1|||
16386531|NCT01083602|39899396|FG000|Overall Study|Withdrawal by Subject|5|||
16386532|NCT01083602|39899396|FG000|Overall Study|Lack of Efficacy|36|||
16386533|NCT00272792|39899403|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
16386534|NCT00272792|39899404|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
16386535|NCT00272792|39899403|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
16386536|NCT00272792|39899404|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
16386537|NCT00272792|39899403|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
16386538|NCT00272792|39899404|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
16386539|NCT00272792|39899403|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
16386540|NCT00272792|39899404|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
16386541|NCT00552071|39899405|FG000|Overall Study|Adverse Event|1|||
16386542|NCT00552071|39899406|FG001|Overall Study|Adverse Event|0|||
16386543|NCT00552071|39899405|FG000|Overall Study|Lack of Efficacy|1|||
16386544|NCT00552071|39899406|FG001|Overall Study|Lack of Efficacy|0|||
16386545|NCT00552071|39899405|FG000|Overall Study|Physician Decision|1|||
16386546|NCT00552071|39899406|FG001|Overall Study|Physician Decision|0|||
16386547|NCT00552071|39899405|FG000|Overall Study|Pregnancy|1|||
16386548|NCT00552071|39899406|FG001|Overall Study|Pregnancy|0|||
16386549|NCT00552071|39899405|FG000|Overall Study|Death|0|||
16386550|NCT00552071|39899406|FG001|Overall Study|Death|1|||
16386551|NCT00552071|39899405|FG000|Overall Study|Withdrawal by Subject|0|||
16386552|NCT00552071|39899406|FG001|Overall Study|Withdrawal by Subject|1|||
16386553|NCT01242514|39899411|FG000|Overall Study|e.g., project closure|1042|||
16386554|NCT01242514|39899412|FG001|Overall Study|e.g., project closure|305|||
16386555|NCT01242514|39899413|FG002|Overall Study|e.g., project closure|171|||
16386556|NCT01242514|39899411|FG000|Overall Study|Subject decision|33|||
16386557|NCT01242514|39899412|FG001|Overall Study|Subject decision|8|||
16386558|NCT01242514|39899413|FG002|Overall Study|Subject decision|2|||
16386559|NCT01242514|39899411|FG000|Overall Study|Severe non-compliance to protocol|5|||
16386560|NCT01242514|39899412|FG001|Overall Study|Severe non-compliance to protocol|2|||
16386561|NCT01242514|39899413|FG002|Overall Study|Severe non-compliance to protocol|1|||
16386562|NCT01242514|39899411|FG000|Overall Study|Lack of therapeutic response|99|||
16386563|NCT01242514|39899412|FG001|Overall Study|Lack of therapeutic response|16|||
16386564|NCT01242514|39899413|FG002|Overall Study|Lack of therapeutic response|10|||
16386565|NCT01242514|39899411|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
16386566|NCT01242514|39899412|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
16386567|NCT01242514|39899413|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
16386568|NCT01242514|39899411|FG000|Overall Study|Lost to Follow-up|14|||
16386569|NCT01242514|39899412|FG001|Overall Study|Lost to Follow-up|5|||
16386570|NCT01242514|39899413|FG002|Overall Study|Lost to Follow-up|4|||
16386571|NCT01242514|39899411|FG000|Overall Study|Adverse Event|129|||
16386572|NCT01242514|39899412|FG001|Overall Study|Adverse Event|18|||
16386573|NCT01242514|39899413|FG002|Overall Study|Adverse Event|19|||
16386574|NCT04781816|39899414|FG000|Overall Study|Adverse Event|0|||
16386575|NCT04781816|39899415|FG001|Overall Study|Adverse Event|1|||
16386576|NCT04781816|39899414|FG000|Overall Study|Withdrawal by Subject|1|||
16386577|NCT04781816|39899415|FG001|Overall Study|Withdrawal by Subject|1|||
16386578|NCT04781816|39899414|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
16386579|NCT04781816|39899415|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
16386580|NCT03605693|39899416|FG000|Overall Study|Lost to Follow-up|4|||
16386581|NCT03605693|39899417|FG001|Overall Study|Lost to Follow-up|0|||
16386582|NCT03605693|39899416|FG000|Overall Study|Physician Decision|1|||
16386583|NCT03605693|39899417|FG001|Overall Study|Physician Decision|0|||
16386584|NCT01206517|39899418|FG000|Overall Study|Withdrawal by Subject|0|||
16386585|NCT01206517|39899419|FG001|Overall Study|Withdrawal by Subject|0|||
16386586|NCT01206517|39899420|FG002|Overall Study|Withdrawal by Subject|2|||
16386587|NCT01206517|39899421|FG003|Overall Study|Withdrawal by Subject|0|||
16386588|NCT01206517|39899422|FG004|Overall Study|Withdrawal by Subject|1|||
16386589|NCT01206517|39899423|FG005|Overall Study|Withdrawal by Subject|0|||
16386590|NCT01541371|39899424|FG000|Overall Study|Withdrawal by Subject|14|||
16386591|NCT01541371|39899424|FG000|Overall Study|Lost to Follow-up|21|||
16386592|NCT01541371|39899424|FG000|Overall Study|Adverse Event|15|||
16386593|NCT01541371|39899424|FG000|Overall Study|Lack of Efficacy|12|||
16386594|NCT01541371|39899424|FG000|Overall Study|Protocol Violation|6|||
16386595|NCT01541371|39899424|FG000|Overall Study|Study medication non-compliance|3|||
16386596|NCT01541371|39899424|FG000|Overall Study|Other|6|||
16386597|NCT01767909|39899425|FG000|Overall Study|Withdrawal by Subject|4|||
16386598|NCT01767909|39899426|FG001|Overall Study|Withdrawal by Subject|7|||
16386599|NCT01767909|39899425|FG000|Overall Study|Adverse Event|3|||
16386600|NCT01767909|39899426|FG001|Overall Study|Adverse Event|1|||
16386601|NCT01767909|39899425|FG000|Overall Study|Withdrawal by Study Partner|3|||
16386602|NCT01767909|39899426|FG001|Overall Study|Withdrawal by Study Partner|1|||
16386603|NCT01767909|39899425|FG000|Overall Study|Non-Compliance|2|||
16386604|NCT01767909|39899426|FG001|Overall Study|Non-Compliance|0|||
16386605|NCT01767909|39899425|FG000|Overall Study|Perceived Lack of Efficacy|1|||
16386606|NCT01767909|39899426|FG001|Overall Study|Perceived Lack of Efficacy|0|||
16386607|NCT01767909|39899425|FG000|Overall Study|Investigator Recommendation|0|||
16386608|NCT01767909|39899426|FG001|Overall Study|Investigator Recommendation|1|||
16386609|NCT01767909|39899425|FG000|Overall Study|Lost to Follow-up|0|||
16386610|NCT01767909|39899426|FG001|Overall Study|Lost to Follow-up|1|||
16386611|NCT01767909|39899425|FG000|Overall Study|LP uncessessful|0|||
16386612|NCT01767909|39899426|FG001|Overall Study|LP uncessessful|1|||
16386613|NCT00436436|39899427|FG000|Overall Study|Progression|4|||
16386614|NCT00436436|39899427|FG000|Overall Study|Adverse Event|2|||
16386615|NCT00436436|39899427|FG000|Overall Study|Death|6|||
16386616|NCT02961244|39899440|FG000|Overall Study|Protocol Violation|0|||
16386617|NCT02961244|39899441|FG001|Overall Study|Protocol Violation|1|||
16386618|NCT02961244|39899440|FG000|Overall Study|Withdrawal by Subject|1|||
16386619|NCT02961244|39899441|FG001|Overall Study|Withdrawal by Subject|2|||
16386620|NCT02961244|39899440|FG000|Overall Study|Surgery plan change after study approval|0|||
16386621|NCT02961244|39899441|FG001|Overall Study|Surgery plan change after study approval|2|||
16386622|NCT02961244|39899440|FG000|Overall Study|Lost to Follow-up|0|||
16386623|NCT02961244|39899441|FG001|Overall Study|Lost to Follow-up|2|||
16386624|NCT02961244|39899440|FG000|Overall Study|İnadequate data|0|||
16386625|NCT02961244|39899441|FG001|Overall Study|İnadequate data|2|||
16386626|NCT00142792|39899443|FG000|Overall Study|Death|0|||
16386627|NCT00142792|39899444|FG001|Overall Study|Death|0|||
16386628|NCT00142792|39899445|FG002|Overall Study|Death|1|||
16386629|NCT00142792|39899443|FG000|Overall Study|Withdrawal by Subject|3|||
16386630|NCT00142792|39899444|FG001|Overall Study|Withdrawal by Subject|2|||
16386631|NCT00142792|39899445|FG002|Overall Study|Withdrawal by Subject|3|||
16386632|NCT00142792|39899443|FG000|Overall Study|Lost to Follow-up|8|||
16386633|NCT00142792|39899444|FG001|Overall Study|Lost to Follow-up|11|||
16386634|NCT00142792|39899445|FG002|Overall Study|Lost to Follow-up|7|||
16386635|NCT00142792|39899443|FG000|Overall Study|No category|1|||
16386636|NCT00142792|39899444|FG001|Overall Study|No category|2|||
16386637|NCT00142792|39899445|FG002|Overall Study|No category|1|||
16386638|NCT01029535|39899446|FG000|Overall Study|Lost to Follow-up|24|||
16386639|NCT01029535|39899446|FG000|Overall Study|Protocol Violation|2|||
16386640|NCT01029535|39899446|FG000|Overall Study|Participant Withdrew Consent|2|||
16386641|NCT01029535|39899446|FG000|Overall Study|Adverse Event|1|||
16386642|NCT01029535|39899446|FG000|Overall Study|Use of Another Treatment|1|||
16386643|NCT01029535|39899446|FG000|Overall Study|Death|1|||
16386644|NCT00967616|39899447|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
16386645|NCT00967616|39899448|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
16386646|NCT00967616|39899447|FG000|Overall Study|Death|0|||
16386647|NCT00967616|39899448|FG001|Overall Study|Death|3|||
16386648|NCT00967616|39899447|FG000|Overall Study|Withdrawal by Subject|8|||
16386649|NCT00967616|39899448|FG001|Overall Study|Withdrawal by Subject|4|||
16386650|NCT00967616|39899447|FG000|Overall Study|Progressive Disease|31|||
16386651|NCT00967616|39899448|FG001|Overall Study|Progressive Disease|18|||
16386652|NCT00967616|39899447|FG000|Overall Study|Other|8|||
16386653|NCT00967616|39899448|FG001|Overall Study|Other|8|||
16386654|NCT00967616|39899447|FG000|Overall Study|Protocol Violation|1|||
16386655|NCT00967616|39899448|FG001|Overall Study|Protocol Violation|0|||
16386656|NCT01444781|39899449|FG000|Overall Study|Lost to Follow-up|0|||
16386657|NCT01444781|39899450|FG001|Overall Study|Lost to Follow-up|3|||
16386658|NCT01444781|39899451|FG002|Overall Study|Lost to Follow-up|1|||
16386659|NCT01444781|39899449|FG000|Overall Study|Withdrawal by Subject|3|||
16386660|NCT01444781|39899450|FG001|Overall Study|Withdrawal by Subject|1|||
16386661|NCT01444781|39899451|FG002|Overall Study|Withdrawal by Subject|2|||
16386662|NCT02949024|39899452|FG000|Overall Study|Withdrawal by Subject|0|||
16386663|NCT02949024|39899453|FG001|Overall Study|Withdrawal by Subject|1|||
16386664|NCT01819272|39899454|FG000|Overall Study|Adverse Event|1|||
16386665|NCT01819272|39899455|FG001|Overall Study|Adverse Event|0|||
16386666|NCT01819272|39899456|FG002|Overall Study|Adverse Event|0|||
16386667|NCT01819272|39899457|FG003|Overall Study|Adverse Event|2|||
16386668|NCT01819272|39899458|FG004|Overall Study|Adverse Event|0|||
16386669|NCT01819272|39899459|FG005|Overall Study|Adverse Event|0|||
16386670|NCT01819272|39899454|FG000|Overall Study|Lost to Follow-up|3|||
16386671|NCT01819272|39899455|FG001|Overall Study|Lost to Follow-up|0|||
16386672|NCT01819272|39899456|FG002|Overall Study|Lost to Follow-up|1|||
16386673|NCT01819272|39899457|FG003|Overall Study|Lost to Follow-up|0|||
16386674|NCT01819272|39899458|FG004|Overall Study|Lost to Follow-up|0|||
16386675|NCT01819272|39899459|FG005|Overall Study|Lost to Follow-up|3|||
16386676|NCT01819272|39899454|FG000|Overall Study|Protocol Violation|0|||
16386677|NCT01819272|39899455|FG001|Overall Study|Protocol Violation|0|||
16386678|NCT01819272|39899456|FG002|Overall Study|Protocol Violation|0|||
16386679|NCT01819272|39899457|FG003|Overall Study|Protocol Violation|1|||
16386680|NCT01819272|39899458|FG004|Overall Study|Protocol Violation|2|||
16386681|NCT01819272|39899459|FG005|Overall Study|Protocol Violation|3|||
16386682|NCT01819272|39899454|FG000|Overall Study|Physician Decision|0|||
16386683|NCT01819272|39899455|FG001|Overall Study|Physician Decision|1|||
16386684|NCT01819272|39899456|FG002|Overall Study|Physician Decision|0|||
16386685|NCT01819272|39899457|FG003|Overall Study|Physician Decision|0|||
16386686|NCT01819272|39899458|FG004|Overall Study|Physician Decision|0|||
16386687|NCT01819272|39899459|FG005|Overall Study|Physician Decision|0|||
16386688|NCT01819272|39899454|FG000|Overall Study|Withdrawal of Consent|0|||
16386689|NCT01819272|39899455|FG001|Overall Study|Withdrawal of Consent|1|||
16386690|NCT01819272|39899456|FG002|Overall Study|Withdrawal of Consent|2|||
16386691|NCT01819272|39899457|FG003|Overall Study|Withdrawal of Consent|1|||
16386692|NCT01819272|39899458|FG004|Overall Study|Withdrawal of Consent|0|||
16386693|NCT01819272|39899459|FG005|Overall Study|Withdrawal of Consent|1|||
16386694|NCT01819272|39899454|FG000|Overall Study|Loss of Glucose Control|2|||
16386695|NCT01819272|39899455|FG001|Overall Study|Loss of Glucose Control|1|||
16386696|NCT01819272|39899456|FG002|Overall Study|Loss of Glucose Control|0|||
16386697|NCT01819272|39899457|FG003|Overall Study|Loss of Glucose Control|1|||
16386698|NCT01819272|39899458|FG004|Overall Study|Loss of Glucose Control|2|||
16386699|NCT01819272|39899459|FG005|Overall Study|Loss of Glucose Control|0|||
16386700|NCT03783780|39899461|FG000|Overall Study|Withdrawn prior to completion|1|||
16386701|NCT00100802|39899462|FG000|Overall Study|Adverse Event|9|||
16386702|NCT00100802|39899462|FG000|Overall Study|Death|1|||
16386703|NCT00100802|39899462|FG000|Overall Study|Lack of Efficacy|47|||
16386704|NCT00100802|39899462|FG000|Overall Study|Physician Decision|5|||
16386705|NCT00100802|39899462|FG000|Overall Study|Protocol Violation|1|||
16386706|NCT00100802|39899462|FG000|Overall Study|Withdrawal by Subject|5|||
16386707|NCT00100802|39899462|FG000|Overall Study|Ineligible|12|||
16386708|NCT03192137|39899463|FG000|Overall Study|Adverse Event|10|||
16386709|NCT03192137|39899464|FG001|Overall Study|Adverse Event|11|||
16386710|NCT03192137|39899463|FG000|Overall Study|Physician Decision|1|||
16386711|NCT03192137|39899464|FG001|Overall Study|Physician Decision|0|||
16386712|NCT03192137|39899463|FG000|Overall Study|Lack of Efficacy|20|||
16386713|NCT03192137|39899464|FG001|Overall Study|Lack of Efficacy|37|||
16386714|NCT03192137|39899463|FG000|Overall Study|Withdrawal by Subject|3|||
16386715|NCT03192137|39899464|FG001|Overall Study|Withdrawal by Subject|3|||
16490190|NCT00224042|40267119|FG001|Overall Study|Protocol Violation|1|||
16490191|NCT00224042|40267118|FG000|Overall Study|Physician Decision|0|||
16192182|NCT01716533|39182355|FG003|Overall Study|Death|2|||
16386716|NCT03192137|39899463|FG000|Overall Study|Protocol Violation|4|||
16386717|NCT03192137|39899464|FG001|Overall Study|Protocol Violation|3|||
16386718|NCT03192137|39899463|FG000|Overall Study|Surgery Cancelled|4|||
16386719|NCT03192137|39899464|FG001|Overall Study|Surgery Cancelled|1|||
16386720|NCT03192137|39899463|FG000|Overall Study|Other - Various Administrative Reasons|8|||
16386721|NCT03192137|39899464|FG001|Overall Study|Other - Various Administrative Reasons|3|||
16386722|NCT02761642|39899468|FG000|Overall Study|Did not Receive Study Treatment|3|||
16386723|NCT02761642|39899468|FG000|Overall Study|Adverse Event|13|||
16386724|NCT02761642|39899468|FG000|Overall Study|Withdrawal by Subject|2|||
16386725|NCT02761642|39899468|FG000|Overall Study|Non-compliant|7|||
16386726|NCT02761642|39899468|FG000|Overall Study|Death|3|||
16386727|NCT02761642|39899468|FG000|Overall Study|Lack of Efficacy|20|||
16386728|NCT02761642|39899468|FG000|Overall Study|Physician Decision|1|||
16386729|NCT02761642|39899468|FG000|Overall Study|Reason Unspecified|21|||
16490192|NCT00224042|40267119|FG001|Overall Study|Physician Decision|1|||
16386730|NCT03545672|39899469|FG000|Overall Study|Uncertain diagnosis|2|||
16386731|NCT03545672|39899470|FG001|Overall Study|Uncertain diagnosis|1|||
16386732|NCT03545672|39899469|FG000|Overall Study|Protocol Violation|2|||
16386733|NCT03545672|39899470|FG001|Overall Study|Protocol Violation|2|||
16386734|NCT03073525|39899471|FG000|Overall Study|Withdrawal by Subject|0|||
16386735|NCT03073525|39899472|FG001|Overall Study|Withdrawal by Subject|0|||
16386736|NCT03073525|39899473|FG002|Overall Study|Withdrawal by Subject|3|||
16386737|NCT00696878|39899474|FG000|Overall Study|Adverse Event|8|||
16386738|NCT00696878|39899474|FG000|Overall Study|Withdrawal by Subject|87|||
16386739|NCT00696878|39899474|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
16386740|NCT00696878|39899474|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
16386741|NCT00696878|39899474|FG000|Overall Study|Trial stopped|32|||
16386742|NCT00696878|39899474|FG000|Overall Study|Other reason (not specified)|55|||
16386743|NCT00976456|39899475|FG000|Overall Study|Adverse Event|17|||
16386744|NCT00976456|39899476|FG001|Overall Study|Adverse Event|22|||
16386745|NCT00976456|39899475|FG000|Overall Study|Death|7|||
16386746|NCT00976456|39899476|FG001|Overall Study|Death|9|||
16386747|NCT00976456|39899475|FG000|Overall Study|Lack of Efficacy|5|||
16386748|NCT00976456|39899476|FG001|Overall Study|Lack of Efficacy|2|||
16386749|NCT00976456|39899475|FG000|Overall Study|Withdrawal by Subject|3|||
16386750|NCT00976456|39899476|FG001|Overall Study|Withdrawal by Subject|1|||
16386751|NCT00976456|39899475|FG000|Overall Study|screening failure, unknown|11|||
16386752|NCT00976456|39899476|FG001|Overall Study|screening failure, unknown|4|||
16386753|NCT02268383|39899479|FG000|Overall Study|Death|12|||
16386754|NCT02268383|39899479|FG000|Overall Study|Lost to Follow-up|2|||
16386755|NCT02268383|39899479|FG000|Overall Study|Withdrawal by Subject|9|||
16386756|NCT02268383|39899479|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
16386757|NCT02268383|39899479|FG000|Overall Study|Protocol deviation|3|||
16386758|NCT02268383|39899479|FG000|Overall Study|Sponsor decision|22|||
16386759|NCT02268383|39899479|FG000|Overall Study|Not reported|12|||
16386760|NCT04778592|39899480|FG000|Overall Study|Adverse Event|1|||
16386761|NCT04778592|39899481|FG001|Overall Study|Adverse Event|2|||
16386762|NCT04778592|39899480|FG000|Overall Study|Withdrawal by Subject|1|||
16386763|NCT04778592|39899481|FG001|Overall Study|Withdrawal by Subject|2|||
16386764|NCT03580044|39899486|FG000|Overall Study|Death|2|||
16386765|NCT03580044|39899487|FG001|Overall Study|Death|1|||
16386766|NCT03580044|39899486|FG000|Overall Study|Withdrawal by Subject|1|||
16386767|NCT03580044|39899487|FG001|Overall Study|Withdrawal by Subject|1|||
16386768|NCT02271529|39899491|FG000|Overall Study|Withdrawal by Subject|1|||
16386769|NCT02131311|39899492|FG000|Overall Study|Adverse Event|2|||
16386770|NCT02131311|39899492|FG000|Overall Study|Protocol Violation|1|||
16386771|NCT02131311|39899492|FG000|Overall Study|Lost to Follow-up|1|||
16386772|NCT01077063|39899493|FG000|Overall Study|Adverse Event|3|||
16386773|NCT01077063|39899494|FG001|Overall Study|Adverse Event|0|||
16386774|NCT01077063|39899493|FG000|Overall Study|Death|1|||
16386775|NCT01077063|39899494|FG001|Overall Study|Death|1|||
16386776|NCT01077063|39899493|FG000|Overall Study|Withdrawal by Subject|0|||
16386777|NCT01077063|39899494|FG001|Overall Study|Withdrawal by Subject|2|||
16386778|NCT02026011|39899497|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
16386779|NCT02026011|39899498|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
16386780|NCT02026011|39899497|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
16386781|NCT02026011|39899498|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
16386782|NCT02026011|39899497|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
16386783|NCT02026011|39899498|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
16386784|NCT02026011|39899497|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
16386785|NCT02026011|39899498|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
16386786|NCT00583219|39899501|FG000|Phase 2|Withdrawal by Subject|1|||
16386787|NCT01240863|39899508|FG000|Open-label Titration Period|Adverse Event|47|||
16386788|NCT01240863|39899509|FG001|Open-label Titration Period|Adverse Event|0|||
16386789|NCT01240863|39899510|FG002|Open-label Titration Period|Adverse Event|0|||
16386790|NCT01240863|39899508|FG000|Open-label Titration Period|Lack of Efficacy|19|||
16386791|NCT01240863|39899509|FG001|Open-label Titration Period|Lack of Efficacy|0|||
16386792|NCT01240863|39899510|FG002|Open-label Titration Period|Lack of Efficacy|0|||
16386793|NCT01240863|39899508|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
16386794|NCT01240863|39899509|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
16386795|NCT01240863|39899510|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
16386796|NCT01240863|39899508|FG000|Open-label Titration Period|Protocol Violation|7|||
16386797|NCT01240863|39899509|FG001|Open-label Titration Period|Protocol Violation|0|||
16386798|NCT01240863|39899510|FG002|Open-label Titration Period|Protocol Violation|0|||
16386799|NCT01240863|39899508|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
16386800|NCT01240863|39899509|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
16386801|NCT01240863|39899510|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
16386802|NCT01240863|39899508|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
16386803|NCT01240863|39899509|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
16386804|NCT01240863|39899510|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
16386805|NCT01240863|39899508|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
16386806|NCT01240863|39899509|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
16386807|NCT01240863|39899510|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
16386808|NCT01240863|39899508|FG000|Open-label Titration Period|Other|7|||
16386809|NCT01240863|39899509|FG001|Open-label Titration Period|Other|0|||
16386810|NCT01240863|39899510|FG002|Open-label Titration Period|Other|0|||
16386811|NCT01240863|39899508|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
16386812|NCT01240863|39899509|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
16386813|NCT01240863|39899510|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
16386814|NCT01240863|39899508|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
16386815|NCT01240863|39899509|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
16386816|NCT01240863|39899510|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
16386817|NCT01240863|39899508|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
16386818|NCT01240863|39899509|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
16386819|NCT01240863|39899510|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
16386820|NCT01240863|39899508|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
16386821|NCT01240863|39899509|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
16386822|NCT01240863|39899510|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
16386823|NCT01240863|39899508|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
16386824|NCT01240863|39899509|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
16386825|NCT01240863|39899510|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
16386826|NCT01240863|39899508|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
16386827|NCT01240863|39899509|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
16386828|NCT01240863|39899510|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
16386829|NCT01240863|39899508|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
16386830|NCT01240863|39899509|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
16386831|NCT01240863|39899510|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
16386832|NCT01240863|39899508|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
16386833|NCT01240863|39899509|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
16386834|NCT01240863|39899510|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
16386835|NCT00786422|39899511|FG000|Rivaroxaban Treatment|Death|2|||
16386836|NCT00786422|39899511|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
16386837|NCT00786422|39899511|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
16386838|NCT00786422|39899511|FG000|Rivaroxaban Treatment|Physician Decision|1|||
16386839|NCT00786422|39899511|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
16386840|NCT00786422|39899511|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
16386841|NCT00786422|39899511|FG000|Rivaroxaban Treatment|Adverse Event|2|||
16386842|NCT00786422|39899511|FG000|Follow-up Period|Death|1|||
16386843|NCT00786422|39899511|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
16386844|NCT00527618|39899512|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
16386845|NCT00527618|39899513|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
16386846|NCT00527618|39899512|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
16386847|NCT00527618|39899513|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
16386848|NCT00527618|39899512|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
16386849|NCT00527618|39899513|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
16386850|NCT00527618|39899512|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
16386851|NCT00527618|39899513|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
16386852|NCT00527618|39899512|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
16386853|NCT00527618|39899513|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
16386854|NCT00527618|39899512|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
16386855|NCT00527618|39899513|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
16386856|NCT02131766|39899514|FG000|Overall Study|Withdrawal by Subject|4|||
16386857|NCT01126190|39899517|FG000|Double-Blind Phase|Death|0|||
16386858|NCT01126190|39899518|FG001|Double-Blind Phase|Death|1|||
16386859|NCT01126190|39899519|FG002|Double-Blind Phase|Death|0|||
16386860|NCT01126190|39899517|FG000|Double-Blind Phase|Adverse Event|1|||
16490193|NCT00224042|40267118|FG000|Overall Study|Did not meet lab incusion criteria|2|||
16490194|NCT00224042|40267119|FG001|Overall Study|Did not meet lab incusion criteria|3|||
16490195|NCT00224042|40267118|FG000|Overall Study|Other|2|||
16386861|NCT01126190|39899518|FG001|Double-Blind Phase|Adverse Event|2|||
16386862|NCT01126190|39899519|FG002|Double-Blind Phase|Adverse Event|0|||
16386863|NCT01126190|39899517|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
16386864|NCT01126190|39899518|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
16386865|NCT01126190|39899519|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
16386866|NCT01126190|39899517|FG000|Double-Blind Phase|Request of Investigator|1|||
16386867|NCT01126190|39899518|FG001|Double-Blind Phase|Request of Investigator|0|||
16386868|NCT01126190|39899519|FG002|Double-Blind Phase|Request of Investigator|0|||
16490196|NCT00224042|40267119|FG001|Overall Study|Other|0|||
16490197|NCT01550289|40267120|FG000|Overall Study|Protocol Violation|1|||
16300333|NCT02278055|39582182|FG000|Overall Study|Lost to Follow-up|1|||
16300334|NCT02278055|39582182|FG000|Overall Study|Withdrawal by Subject|2|||
16300335|NCT02278055|39582182|FG000|Overall Study|Progressive Disease|4|||
16300336|NCT02996487|39582183|FG000|Overall Study|Lost to Follow-up|1|||
16300337|NCT02996487|39582184|FG001|Overall Study|Lost to Follow-up|1|||
16300338|NCT02996487|39582185|FG002|Overall Study|Lost to Follow-up|0|||
16300339|NCT02996487|39582183|FG000|Overall Study|Death|0|||
16300340|NCT02996487|39582184|FG001|Overall Study|Death|1|||
16300341|NCT02996487|39582185|FG002|Overall Study|Death|0|||
16300342|NCT02996487|39582183|FG000|Overall Study|Withdrawal by Subject|2|||
16300343|NCT02996487|39582184|FG001|Overall Study|Withdrawal by Subject|3|||
16300344|NCT02996487|39582185|FG002|Overall Study|Withdrawal by Subject|0|||
16300345|NCT02315196|39582186|FG000|Overall Study|Withdrew consent|9|||
16300346|NCT00117325|39582196|FG000|Overall Study|Adverse Event|3|||
16300347|NCT00117325|39582197|FG001|Overall Study|Adverse Event|3|||
16300348|NCT00117325|39582196|FG000|Overall Study|Lost to Follow-up|1|||
16300349|NCT00117325|39582197|FG001|Overall Study|Lost to Follow-up|1|||
16300350|NCT00117325|39582196|FG000|Overall Study|Protocol Violation|2|||
16300351|NCT00117325|39582197|FG001|Overall Study|Protocol Violation|3|||
16300352|NCT00117325|39582196|FG000|Overall Study|Withdrawal by Subject|3|||
16300353|NCT00117325|39582197|FG001|Overall Study|Withdrawal by Subject|2|||
16300354|NCT00117325|39582196|FG000|Overall Study|Lack of Efficacy|1|||
16300355|NCT00117325|39582197|FG001|Overall Study|Lack of Efficacy|0|||
16300356|NCT00117325|39582196|FG000|Overall Study|Use of prohibited medicine|1|||
16300357|NCT00117325|39582197|FG001|Overall Study|Use of prohibited medicine|2|||
16300358|NCT00117325|39582196|FG000|Overall Study|Early termination|1|||
16300359|NCT00117325|39582197|FG001|Overall Study|Early termination|1|||
16300360|NCT00117325|39582196|FG000|Overall Study|Admisnitrative|1|||
16300361|NCT00117325|39582197|FG001|Overall Study|Admisnitrative|0|||
16300362|NCT04380961|39582198|FG000|Overall Study|Lost to Follow-up|17|||
16300363|NCT04380961|39582199|FG001|Overall Study|Lost to Follow-up|11|||
16300364|NCT04380961|39582198|FG000|Overall Study|Withdrawal by Subject|3|||
16300365|NCT04380961|39582199|FG001|Overall Study|Withdrawal by Subject|0|||
16300366|NCT04380961|39582198|FG000|Overall Study|Death|22|||
16300367|NCT04380961|39582199|FG001|Overall Study|Death|16|||
16300368|NCT04380961|39582198|FG000|Overall Study|Other|1|||
16300369|NCT04380961|39582199|FG001|Overall Study|Other|0|||
16300370|NCT04380961|39582198|FG000|Overall Study|Randomized but Not Treated|1|||
16300371|NCT04380961|39582199|FG001|Overall Study|Randomized but Not Treated|2|||
16300372|NCT03968978|39582202|FG000|Overall Study|Adverse Event|1|||
16300373|NCT03968978|39582203|FG001|Overall Study|Adverse Event|0|||
16300374|NCT00858143|39582204|FG000|Overall Study|Adverse Event|16|||
16300375|NCT00858143|39582204|FG000|Overall Study|Lack of Efficacy|4|||
16300376|NCT00858143|39582204|FG000|Overall Study|Death|7|||
16300377|NCT00858143|39582204|FG000|Overall Study|Other|23|||
16300378|NCT03954834|39582207|FG000|Overall Study|Adverse Event|1|||
16300379|NCT03954834|39582208|FG001|Overall Study|Adverse Event|3|||
16300380|NCT03954834|39582209|FG002|Overall Study|Adverse Event|1|||
16300381|NCT03954834|39582210|FG003|Overall Study|Adverse Event|1|||
16300382|NCT03954834|39582207|FG000|Overall Study|Death|0|||
16300383|NCT03954834|39582208|FG001|Overall Study|Death|0|||
16300384|NCT03954834|39582209|FG002|Overall Study|Death|0|||
16300385|NCT03954834|39582210|FG003|Overall Study|Death|1|||
16300386|NCT03954834|39582207|FG000|Overall Study|Physician Decision|0|||
16300387|NCT03954834|39582208|FG001|Overall Study|Physician Decision|1|||
16300388|NCT03954834|39582209|FG002|Overall Study|Physician Decision|0|||
16300389|NCT03954834|39582210|FG003|Overall Study|Physician Decision|2|||
16300390|NCT03954834|39582207|FG000|Overall Study|Protocol Violation|1|||
16300391|NCT03954834|39582208|FG001|Overall Study|Protocol Violation|0|||
16300392|NCT03954834|39582209|FG002|Overall Study|Protocol Violation|0|||
16300393|NCT03954834|39582210|FG003|Overall Study|Protocol Violation|1|||
16300394|NCT03954834|39582207|FG000|Overall Study|Withdrawal by Subject|2|||
16386869|NCT01126190|39899517|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
16300395|NCT03954834|39582208|FG001|Overall Study|Withdrawal by Subject|3|||
16300396|NCT03954834|39582209|FG002|Overall Study|Withdrawal by Subject|13|||
16300397|NCT03954834|39582210|FG003|Overall Study|Withdrawal by Subject|6|||
16300398|NCT03954834|39582207|FG000|Overall Study|Participant left the country|0|||
16300399|NCT03954834|39582208|FG001|Overall Study|Participant left the country|0|||
16300400|NCT03954834|39582209|FG002|Overall Study|Participant left the country|1|||
16300401|NCT03954834|39582210|FG003|Overall Study|Participant left the country|0|||
16300402|NCT03954834|39582207|FG000|Overall Study|Lost to Follow-up|3|||
16300403|NCT03954834|39582208|FG001|Overall Study|Lost to Follow-up|2|||
16300404|NCT03954834|39582209|FG002|Overall Study|Lost to Follow-up|3|||
16300405|NCT03954834|39582210|FG003|Overall Study|Lost to Follow-up|5|||
16300406|NCT02455518|39582214|FG000|Overall Study|Protocol Violation|0|||
16300407|NCT02455518|39582215|FG001|Overall Study|Protocol Violation|1|||
16300408|NCT02455518|39582216|FG002|Overall Study|Protocol Violation|1|||
16300409|NCT02455518|39582217|FG003|Overall Study|Protocol Violation|3|||
16300410|NCT04710979|39582218|FG000|Overall Study|Lost to Follow-up|2|||
16300411|NCT04710979|39582219|FG001|Overall Study|Lost to Follow-up|4|||
16300412|NCT04710979|39582218|FG000|Overall Study|Withdrawal by Subject|1|||
16300413|NCT04710979|39582219|FG001|Overall Study|Withdrawal by Subject|0|||
16300414|NCT01512160|39582222|FG000|Overall Study|Lost to Follow-up|1|||
16300415|NCT01512160|39582223|FG001|Overall Study|Lost to Follow-up|0|||
16300416|NCT01512160|39582224|FG002|Overall Study|Lost to Follow-up|0|||
16300417|NCT01512160|39582225|FG003|Overall Study|Lost to Follow-up|0|||
16300418|NCT01512160|39582222|FG000|Overall Study|Withdrawal by Subject|1|||
16300419|NCT01512160|39582223|FG001|Overall Study|Withdrawal by Subject|0|||
16300420|NCT01512160|39582224|FG002|Overall Study|Withdrawal by Subject|0|||
16300421|NCT01512160|39582225|FG003|Overall Study|Withdrawal by Subject|1|||
16300422|NCT04576923|39582229|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
16300423|NCT02787408|39582230|FG000|Overall Study|Death|16|||
16300424|NCT02787408|39582230|FG000|Overall Study|Withdrawal by Subject|1|||
16300425|NCT02787408|39582230|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
16300426|NCT01862484|39582231|FG000|Overall Study|Lack of Efficacy|1|||
16300427|NCT01862484|39582232|FG001|Overall Study|Lack of Efficacy|1|||
16300428|NCT01862484|39582231|FG000|Overall Study|Lost to Follow-up|1|||
16300429|NCT01862484|39582232|FG001|Overall Study|Lost to Follow-up|2|||
16300430|NCT01862484|39582231|FG000|Overall Study|Protocol Violation|0|||
16300431|NCT01862484|39582232|FG001|Overall Study|Protocol Violation|2|||
16300432|NCT01862484|39582231|FG000|Overall Study|Withdrawal by Subject|0|||
16300433|NCT01862484|39582232|FG001|Overall Study|Withdrawal by Subject|3|||
16300434|NCT03597464|39582233|FG000|Overall Study|Withdrawal by Subject|4|||
16300435|NCT03597464|39582234|FG001|Overall Study|Withdrawal by Subject|5|||
16300436|NCT03597464|39582233|FG000|Overall Study|Lost to Follow-up|3|||
16300437|NCT03597464|39582234|FG001|Overall Study|Lost to Follow-up|1|||
16300438|NCT03597464|39582233|FG000|Overall Study|Pregnancy|3|||
16300439|NCT03597464|39582234|FG001|Overall Study|Pregnancy|1|||
16300440|NCT03597464|39582233|FG000|Overall Study|Lack of Efficacy|2|||
16300441|NCT03597464|39582234|FG001|Overall Study|Lack of Efficacy|0|||
16300442|NCT03597464|39582233|FG000|Overall Study|Physician Decision|2|||
16300443|NCT03597464|39582234|FG001|Overall Study|Physician Decision|2|||
16300444|NCT03597464|39582233|FG000|Overall Study|Protocol Violation|1|||
16300445|NCT03597464|39582234|FG001|Overall Study|Protocol Violation|1|||
16300446|NCT03597464|39582233|FG000|Overall Study|Adverse Event|0|||
16300447|NCT03597464|39582234|FG001|Overall Study|Adverse Event|2|||
16300448|NCT03597464|39582233|FG000|Overall Study|Death|0|||
16300449|NCT03597464|39582234|FG001|Overall Study|Death|3|||
16300450|NCT00720382|39582235|FG000|Overall Study|Adverse Event|54|||
16300451|NCT00720382|39582236|FG001|Overall Study|Adverse Event|17|||
16300452|NCT00720382|39582235|FG000|Overall Study|Lack of Efficacy|18|||
16300453|NCT00720382|39582236|FG001|Overall Study|Lack of Efficacy|7|||
16300454|NCT00720382|39582235|FG000|Overall Study|Non-Compliance|15|||
16300455|NCT00720382|39582236|FG001|Overall Study|Non-Compliance|5|||
16300456|NCT00720382|39582235|FG000|Overall Study|Withdrawal by Subject|47|||
16300457|NCT00720382|39582236|FG001|Overall Study|Withdrawal by Subject|11|||
16300458|NCT00720382|39582235|FG000|Overall Study|Lost to Follow-up|28|||
16300459|NCT00720382|39582236|FG001|Overall Study|Lost to Follow-up|14|||
16300460|NCT00720382|39582235|FG000|Overall Study|administrative|14|||
16300461|NCT00720382|39582236|FG001|Overall Study|administrative|5|||
16300462|NCT00792935|39582251|FG000|Overall Study|Adverse Event|2|||
16300463|NCT00792935|39582252|FG001|Overall Study|Adverse Event|1|||
16300464|NCT00792935|39582251|FG000|Overall Study|Lost to Follow-up|0|||
16300465|NCT00792935|39582252|FG001|Overall Study|Lost to Follow-up|1|||
16300466|NCT00792935|39582251|FG000|Overall Study|Protocol Violation|2|||
16300467|NCT00792935|39582252|FG001|Overall Study|Protocol Violation|0|||
16300468|NCT00792935|39582251|FG000|Overall Study|Withdrawal by Subject|0|||
16300469|NCT00792935|39582252|FG001|Overall Study|Withdrawal by Subject|1|||
16300470|NCT01709838|39582253|FG000|Overall Study|Withdrawal by Subject|21|||
16300471|NCT01709838|39582253|FG000|Overall Study|Lost to Follow-up|16|||
16300472|NCT01709838|39582253|FG000|Overall Study|Pregnancy|10|||
16300473|NCT01709838|39582253|FG000|Overall Study|Subject/guardian decision|8|||
16386870|NCT01126190|39899518|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
16386871|NCT01126190|39899519|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
16386872|NCT01126190|39899517|FG000|Double-Blind Phase|Non-compliance|1|||
16386873|NCT01126190|39899518|FG001|Double-Blind Phase|Non-compliance|0|||
16386874|NCT01126190|39899519|FG002|Double-Blind Phase|Non-compliance|0|||
16386875|NCT01126190|39899517|FG000|Double-Blind Phase|Lost to Follow-up|1|||
16386876|NCT01126190|39899518|FG001|Double-Blind Phase|Lost to Follow-up|3|||
16386877|NCT01126190|39899519|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16386878|NCT01126190|39899517|FG000|Open-Label Phase|Death|0|||
16386879|NCT01126190|39899518|FG001|Open-Label Phase|Death|0|||
16386880|NCT01126190|39899519|FG002|Open-Label Phase|Death|1|||
16386881|NCT01126190|39899517|FG000|Open-Label Phase|Adverse Event|0|||
16386882|NCT01126190|39899518|FG001|Open-Label Phase|Adverse Event|0|||
16386883|NCT01126190|39899519|FG002|Open-Label Phase|Adverse Event|4|||
16386884|NCT01126190|39899517|FG000|Open-Label Phase|Withdrawal by Subject|0|||
16386885|NCT01126190|39899518|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16386886|NCT01126190|39899519|FG002|Open-Label Phase|Withdrawal by Subject|6|||
16386887|NCT02750930|39899521|FG000|Overall Study|Study closed/terminated|8|||
16300474|NCT01709838|39582253|FG000|Overall Study|Adverse Event|4|||
16300475|NCT01709838|39582253|FG000|Overall Study|Physician Decision|4|||
16300476|NCT01709838|39582253|FG000|Overall Study|Death|3|||
16300477|NCT01709838|39582253|FG000|Overall Study|Protocol Violation|1|||
16300478|NCT02463357|39585382|FG000|Overall Study|Withdrawal by Subject|1|||
16300479|NCT02463357|39585383|FG001|Overall Study|Withdrawal by Subject|0|||
16192183|NCT01716533|39182352|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
16192184|NCT01716533|39182353|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
16192185|NCT01716533|39182354|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
16192186|NCT01716533|39182355|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
16192187|NCT00125190|39182356|FG000|Overall Study|Subject/Parent Decision|7|||
16192188|NCT00125190|39182356|FG000|Overall Study|Non-compliance|2|||
16192189|NCT00125190|39182356|FG000|Overall Study|Adverse Event|1|||
16490198|NCT01550289|40267121|FG001|Overall Study|Protocol Violation|0|||
16300480|NCT02463357|39585384|FG002|Overall Study|Withdrawal by Subject|0|||
16300481|NCT02463357|39585385|FG003|Overall Study|Withdrawal by Subject|0|||
16300482|NCT02463357|39585386|FG004|Overall Study|Withdrawal by Subject|0|||
16300483|NCT02463357|39585382|FG000|Overall Study|Withdrawal by Subject|0|||
16300484|NCT02463357|39585383|FG001|Overall Study|Withdrawal by Subject|0|||
16300485|NCT02463357|39585384|FG002|Overall Study|Withdrawal by Subject|0|||
16300486|NCT02463357|39585385|FG003|Overall Study|Withdrawal by Subject|0|||
16300487|NCT02463357|39585386|FG004|Overall Study|Withdrawal by Subject|1|||
16300488|NCT02125877|39585387|FG000|Overall Study|Physician Decision|1|||
16300489|NCT02125877|39585388|FG001|Overall Study|Physician Decision|0|||
16300490|NCT02125877|39585387|FG000|Overall Study|Death|0|||
16300491|NCT02125877|39585388|FG001|Overall Study|Death|1|||
16300492|NCT02125877|39585387|FG000|Overall Study|Administrative problems|0|||
16300493|NCT02125877|39585388|FG001|Overall Study|Administrative problems|1|||
16300494|NCT02125877|39585387|FG000|Overall Study|Participant/guardian decision|0|||
16300495|NCT02125877|39585388|FG001|Overall Study|Participant/guardian decision|2|||
16300496|NCT02125877|39585387|FG000|Overall Study|Withdrawal by Subject|2|||
16300497|NCT02125877|39585388|FG001|Overall Study|Withdrawal by Subject|1|||
16300498|NCT02125877|39585387|FG000|Overall Study|Protocol deviation|4|||
16300499|NCT02125877|39585388|FG001|Overall Study|Protocol deviation|1|||
16300500|NCT02125877|39585387|FG000|Overall Study|Adverse Event|6|||
16300501|NCT02125877|39585388|FG001|Overall Study|Adverse Event|4|||
16300502|NCT02439970|39585389|FG000|Overall Study|Study Terminated|2|||
16300503|NCT02439970|39585390|FG001|Overall Study|Study Terminated|3|||
16300504|NCT00094861|39585391|FG000|Overall Study|Adverse Event|5|||
16300505|NCT00094861|39585392|FG001|Overall Study|Adverse Event|2|||
16300506|NCT00094861|39585391|FG000|Overall Study|Withdrawal by Subject|5|||
16300507|NCT00094861|39585392|FG001|Overall Study|Withdrawal by Subject|3|||
16300508|NCT00094861|39585391|FG000|Overall Study|Physician Decision|1|||
16300509|NCT00094861|39585392|FG001|Overall Study|Physician Decision|1|||
16300510|NCT00094861|39585391|FG000|Overall Study|Lost to Follow-up|0|||
16300511|NCT00094861|39585392|FG001|Overall Study|Lost to Follow-up|1|||
16300512|NCT00094861|39585391|FG000|Overall Study|Death|4|||
16300513|NCT00094861|39585392|FG001|Overall Study|Death|2|||
16490199|NCT01550289|40267120|FG000|Overall Study|Lost to Follow-up|1|||
16490200|NCT01550289|40267121|FG001|Overall Study|Lost to Follow-up|1|||
16490201|NCT01550289|40267120|FG000|Overall Study|Withdrawal by Subject|11|||
16490202|NCT01550289|40267121|FG001|Overall Study|Withdrawal by Subject|3|||
16192190|NCT00125190|39182356|FG000|Overall Study|Other|1|||
16192191|NCT00125190|39182356|FG000|Overall Study|Lost to Follow-up|4|||
16192192|NCT02130427|39182357|FG000|Overall Study|Imaging results not interpretable|30|||
16192193|NCT02370498|39182363|FG000|Overall Study|Adverse Event|10|||
16192194|NCT02370498|39182364|FG001|Overall Study|Adverse Event|8|||
16192195|NCT02370498|39182363|FG000|Overall Study|Death|263|||
16192196|NCT02370498|39182364|FG001|Overall Study|Death|265|||
16192197|NCT02370498|39182363|FG000|Overall Study|Protocol Violation|1|||
16192198|NCT02370498|39182364|FG001|Overall Study|Protocol Violation|2|||
16192199|NCT02370498|39182363|FG000|Overall Study|Withdrawal by Subject|7|||
16192200|NCT02370498|39182364|FG001|Overall Study|Withdrawal by Subject|12|||
16192201|NCT02370498|39182363|FG000|Overall Study|Sponsor's decision|15|||
16192202|NCT02370498|39182364|FG001|Overall Study|Sponsor's decision|9|||
16192203|NCT01727713|39182365|FG000|Overall Study|Lost to Follow-up|5|||
16192204|NCT01727713|39182365|FG000|Overall Study|Adverse Event|10|||
16192205|NCT01727713|39182365|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
16300514|NCT00094861|39585391|FG000|Overall Study|Other|3|||
16300515|NCT00094861|39585392|FG001|Overall Study|Other|0|||
16300516|NCT01130493|39585435|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
16300517|NCT01130493|39585436|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
16300518|NCT01130493|39585437|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
16300519|NCT01130493|39585435|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
16490203|NCT01442675|40267122|FG000|Overall Study|Protocol Violation|6|||
16490204|NCT01442675|40267122|FG000|Overall Study|Lost to Follow-up|2|||
16490205|NCT01442675|40267122|FG000|Overall Study|Withdrawal by Subject|4|||
16490206|NCT03539081|40267125|FG000|Overall Study|Withdrawal by Subject|2|||
16490207|NCT03539081|40267126|FG001|Overall Study|Withdrawal by Subject|3|||
16490208|NCT03539081|40267127|FG002|Overall Study|Withdrawal by Subject|0|||
16490209|NCT03539081|40267125|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
16490210|NCT03539081|40267126|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
16300520|NCT01130493|39585436|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
16300521|NCT01130493|39585437|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
16300522|NCT01130493|39585435|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
16300523|NCT01130493|39585436|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
16300524|NCT01130493|39585437|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
16300525|NCT01130493|39585435|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
16300526|NCT01130493|39585436|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
16300527|NCT01130493|39585437|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
16300528|NCT01130493|39585435|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
16300529|NCT01130493|39585436|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
16300530|NCT01130493|39585437|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
16300531|NCT01130493|39585435|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
16300532|NCT01130493|39585436|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
16300533|NCT01130493|39585437|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
16300534|NCT01130493|39585435|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
16300535|NCT01130493|39585436|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
16300536|NCT01130493|39585437|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
16300537|NCT01130493|39585435|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
16300538|NCT01130493|39585436|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
16300539|NCT01130493|39585437|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
16300540|NCT01130493|39585435|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
16300541|NCT01130493|39585436|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
16300542|NCT01130493|39585437|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
16300543|NCT01130493|39585435|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
16300544|NCT01130493|39585436|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
16300545|NCT01130493|39585437|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
16300546|NCT01130493|39585435|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
16300547|NCT01130493|39585436|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
16300548|NCT01130493|39585437|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
16300549|NCT01130493|39585435|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
16300550|NCT01130493|39585436|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
16386888|NCT02896257|39899522|FG000|Providers|Without eligible patients|21|||
16490211|NCT03539081|40267127|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
16490212|NCT01854710|40267128|FG000|Overall Study|Withdrawal by Subject|2|||
16490213|NCT01854710|40267129|FG001|Overall Study|Withdrawal by Subject|1|||
16490214|NCT01854710|40267130|FG002|Overall Study|Withdrawal by Subject|0|||
16490215|NCT01854710|40267131|FG003|Overall Study|Withdrawal by Subject|0|||
16490216|NCT01854710|40267132|FG004|Overall Study|Withdrawal by Subject|0|||
16490217|NCT01854710|40267133|FG005|Overall Study|Withdrawal by Subject|0|||
16490218|NCT01854710|40267128|FG000|Overall Study|CRI procedural error|2|||
16490219|NCT01854710|40267129|FG001|Overall Study|CRI procedural error|2|||
16490220|NCT01854710|40267130|FG002|Overall Study|CRI procedural error|2|||
16490221|NCT01854710|40267131|FG003|Overall Study|CRI procedural error|2|||
16490222|NCT01854710|40267132|FG004|Overall Study|CRI procedural error|2|||
16490223|NCT01854710|40267133|FG005|Overall Study|CRI procedural error|2|||
16300551|NCT01130493|39585437|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
16386889|NCT02896257|39899523|FG001|Providers|Without eligible patients|28|||
16386890|NCT02896257|39899522|FG000|Patients|PFT entry criteria not met|43|||
16386891|NCT02896257|39899523|FG001|Patients|PFT entry criteria not met|50|||
16386892|NCT02896257|39899522|FG000|Patients|No capacity to review|8|||
16386893|NCT02896257|39899523|FG001|Patients|No capacity to review|11|||
16386894|NCT02896257|39899522|FG000|Patients|Appointment rescheduled/cancelled|5|||
16386895|NCT02896257|39899523|FG001|Patients|Appointment rescheduled/cancelled|7|||
16386896|NCT02896257|39899522|FG000|Patients|PCP not assigned a clinic|4|||
16386897|NCT02896257|39899523|FG001|Patients|PCP not assigned a clinic|0|||
16386898|NCT02896257|39899522|FG000|Patients|No history of COPD|0|||
16386899|NCT02896257|39899523|FG001|Patients|No history of COPD|1|||
16386900|NCT02896257|39899522|FG000|Patients|Deceased between review and index date|0|||
16386901|NCT02896257|39899523|FG001|Patients|Deceased between review and index date|1|||
16386902|NCT02896257|39899522|FG000|Patients|No ICS Rx upon review|1|||
16386903|NCT02896257|39899523|FG001|Patients|No ICS Rx upon review|1|||
16386904|NCT02896257|39899522|FG000|Patients|Protocol Violation|2|||
16386905|NCT02896257|39899523|FG001|Patients|Protocol Violation|1|||
16386906|NCT02896257|39899522|FG000|Patients|Hospice care|0|||
16386907|NCT02896257|39899523|FG001|Patients|Hospice care|1|||
16386908|NCT01897493|39899524|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
16386909|NCT02737501|39899525|FG000|Randomized Phase|Died|41|||
16386910|NCT02737501|39899526|FG001|Randomized Phase|Died|29|||
16490224|NCT02088047|40267134|FG000|Overall Study|Withdrawal by Subject|1|||
16490225|NCT02088047|40267135|FG001|Overall Study|Withdrawal by Subject|0|||
16300552|NCT01130493|39585435|FG000|Part 2: OLE|Adverse Event|0|||
16300553|NCT01130493|39585436|FG001|Part 2: OLE|Adverse Event|2|||
16300554|NCT01130493|39585437|FG002|Part 2: OLE|Adverse Event|1|||
16300555|NCT01130493|39585435|FG000|Part 2: OLE|Withdrawal by Subject|0|||
16300556|NCT01130493|39585436|FG001|Part 2: OLE|Withdrawal by Subject|1|||
16300557|NCT01130493|39585437|FG002|Part 2: OLE|Withdrawal by Subject|4|||
16300558|NCT02461160|39585439|FG000|Overall Study|Lost to Follow-up|0|||
16192206|NCT01727713|39182365|FG000|Overall Study|Withdrawal by Subject|13|||
16192207|NCT01727713|39182365|FG000|Overall Study|Protocol Deviation|2|||
16192208|NCT00364845|39182370|FG000|Overall Study|Adverse Event|1|||
16192209|NCT00364845|39182371|FG001|Overall Study|Adverse Event|0|||
16192210|NCT00364845|39182370|FG000|Overall Study|Withdrawal by Subject|2|||
16192211|NCT00364845|39182371|FG001|Overall Study|Withdrawal by Subject|1|||
16192212|NCT00364845|39182370|FG000|Overall Study|Physician Decision|8|||
16192213|NCT00364845|39182371|FG001|Overall Study|Physician Decision|8|||
16192214|NCT00364845|39182370|FG000|Overall Study|Lost to Follow-up|0|||
16192215|NCT00364845|39182371|FG001|Overall Study|Lost to Follow-up|1|||
16192216|NCT00364845|39182370|FG000|Overall Study|Death|0|||
16192217|NCT00364845|39182371|FG001|Overall Study|Death|1|||
16192218|NCT00995345|39182382|FG000|Overall Study|Withdrawal by Subject|4|||
16192219|NCT00995345|39182383|FG001|Overall Study|Withdrawal by Subject|2|||
16192220|NCT00995345|39182384|FG002|Overall Study|Withdrawal by Subject|1|||
16300559|NCT02461160|39585440|FG001|Overall Study|Lost to Follow-up|0|||
16300560|NCT02461160|39585441|FG002|Overall Study|Lost to Follow-up|0|||
16300561|NCT02461160|39585442|FG003|Overall Study|Lost to Follow-up|0|||
16300562|NCT02461160|39585443|FG004|Overall Study|Lost to Follow-up|0|||
16300563|NCT02461160|39585444|FG005|Overall Study|Lost to Follow-up|0|||
16300564|NCT02461160|39585445|FG006|Overall Study|Lost to Follow-up|0|||
16300565|NCT02461160|39585446|FG007|Overall Study|Lost to Follow-up|1|||
16300566|NCT02461160|39585447|FG008|Overall Study|Lost to Follow-up|0|||
16300567|NCT02461160|39585448|FG009|Overall Study|Lost to Follow-up|0|||
16300568|NCT02461160|39585449|FG010|Overall Study|Lost to Follow-up|0|||
16300569|NCT02461160|39585450|FG011|Overall Study|Lost to Follow-up|0|||
16300570|NCT02461160|39585451|FG012|Overall Study|Lost to Follow-up|0|||
16192221|NCT00995345|39182385|FG003|Overall Study|Withdrawal by Subject|3|||
16192222|NCT00995345|39182386|FG004|Overall Study|Withdrawal by Subject|1|||
16192223|NCT00995345|39182382|FG000|Overall Study|Adverse Event|3|||
16192224|NCT00995345|39182383|FG001|Overall Study|Adverse Event|1|||
16192225|NCT00995345|39182384|FG002|Overall Study|Adverse Event|2|||
16192226|NCT00995345|39182385|FG003|Overall Study|Adverse Event|0|||
16192227|NCT00995345|39182386|FG004|Overall Study|Adverse Event|1|||
16192228|NCT00995345|39182382|FG000|Overall Study|Lost to Follow-up|2|||
16192229|NCT00995345|39182383|FG001|Overall Study|Lost to Follow-up|2|||
16192230|NCT00995345|39182384|FG002|Overall Study|Lost to Follow-up|2|||
16490226|NCT00230607|40267136|FG000|Overall Study|Other|3|||
16490227|NCT00965718|40270232|FG000|Overall Study|Withdrawal by Subject|4|||
16490228|NCT02289898|40270235|FG000|Overall Study|Death|5|||
16490229|NCT02289898|40270236|FG001|Overall Study|Death|4|||
16490230|NCT02289898|40270237|FG002|Overall Study|Death|3|||
16490231|NCT02289898|40270235|FG000|Overall Study|Physician Decision|2|||
16192231|NCT00995345|39182385|FG003|Overall Study|Lost to Follow-up|1|||
16192232|NCT00995345|39182386|FG004|Overall Study|Lost to Follow-up|0|||
16192233|NCT00995345|39182382|FG000|Overall Study|all other reasons combined|2|||
16192234|NCT00995345|39182383|FG001|Overall Study|all other reasons combined|2|||
16192235|NCT00995345|39182384|FG002|Overall Study|all other reasons combined|2|||
16192236|NCT00995345|39182385|FG003|Overall Study|all other reasons combined|1|||
16192237|NCT00995345|39182386|FG004|Overall Study|all other reasons combined|3|||
16192238|NCT00305006|39182387|FG000|Overall Study|Withdrawal by Subject|1|||
16192239|NCT00305006|39182388|FG001|Overall Study|Withdrawal by Subject|0|||
16192240|NCT00305006|39182387|FG000|Overall Study|Failure to complete pretest|0|||
16192241|NCT00305006|39182388|FG001|Overall Study|Failure to complete pretest|1|||
16192242|NCT01079962|39182389|FG000|Overall Study|Adverse Event|2|||
16192243|NCT01079962|39182390|FG001|Overall Study|Adverse Event|2|||
16192244|NCT01079962|39182389|FG000|Overall Study|Withdrawal by Subject|5|||
16192245|NCT01079962|39182390|FG001|Overall Study|Withdrawal by Subject|7|||
16300571|NCT00230178|39585452|FG000|Overall Study|Adverse Event|1|||
16300572|NCT00230178|39585453|FG001|Overall Study|Adverse Event|5|||
16490232|NCT02289898|40270236|FG001|Overall Study|Physician Decision|5|||
16490233|NCT02289898|40270237|FG002|Overall Study|Physician Decision|2|||
16192246|NCT01079962|39182389|FG000|Overall Study|Protocol Violation|2|||
16192247|NCT01079962|39182390|FG001|Overall Study|Protocol Violation|2|||
16192248|NCT01079962|39182389|FG000|Overall Study|No blood pressure (BP) control|3|||
16192249|NCT01079962|39182390|FG001|Overall Study|No blood pressure (BP) control|0|||
16192250|NCT01079962|39182389|FG000|Overall Study|Inclusion/exclusion criteria|1|||
16192251|NCT01079962|39182390|FG001|Overall Study|Inclusion/exclusion criteria|3|||
16192252|NCT01079962|39182389|FG000|Overall Study|Participant not returning for next visit|1|||
16300573|NCT00230178|39585454|FG002|Overall Study|Adverse Event|2|||
16300574|NCT00230178|39585452|FG000|Overall Study|Withdrawal by Subject|0|||
16300575|NCT00230178|39585453|FG001|Overall Study|Withdrawal by Subject|0|||
16192253|NCT01079962|39182390|FG001|Overall Study|Participant not returning for next visit|0|||
16192254|NCT01079962|39182389|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
16192255|NCT01079962|39182390|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
16192256|NCT02330549|39182391|FG000|Overall Study|Adverse Event|1|||
16192257|NCT02330549|39182392|FG001|Overall Study|Adverse Event|0|||
16192258|NCT02330549|39182391|FG000|Overall Study|Subject withdrew consent|2|||
16192259|NCT02330549|39182392|FG001|Overall Study|Subject withdrew consent|1|||
16192260|NCT02330549|39182391|FG000|Overall Study|Failure to meet randomization criteria|1|||
16192261|NCT02330549|39182392|FG001|Overall Study|Failure to meet randomization criteria|0|||
16192262|NCT00367640|39182393|FG000|Overall Study|Adverse Event|3|||
16192263|NCT00367640|39182394|FG001|Overall Study|Adverse Event|6|||
16192264|NCT00367640|39182395|FG002|Overall Study|Adverse Event|8|||
16192265|NCT00367640|39182396|FG003|Overall Study|Adverse Event|0|||
16192266|NCT00367640|39182393|FG000|Overall Study|Withdrawal by Subject|8|||
16192267|NCT00367640|39182394|FG001|Overall Study|Withdrawal by Subject|11|||
16192268|NCT00367640|39182395|FG002|Overall Study|Withdrawal by Subject|8|||
16192269|NCT00367640|39182396|FG003|Overall Study|Withdrawal by Subject|6|||
16192270|NCT00367640|39182393|FG000|Overall Study|Any other reason not above-mentioned|7|||
16192271|NCT00367640|39182394|FG001|Overall Study|Any other reason not above-mentioned|5|||
16192272|NCT00367640|39182395|FG002|Overall Study|Any other reason not above-mentioned|3|||
16192273|NCT00367640|39182396|FG003|Overall Study|Any other reason not above-mentioned|4|||
16192274|NCT03699631|39182397|FG000|Overall Study|Adverse Event|3|||
16192275|NCT00414960|39182398|FG000|Overall Study|Adverse Event|4|||
16192276|NCT00414960|39182399|FG001|Overall Study|Adverse Event|0|||
16192277|NCT00414960|39182398|FG000|Overall Study|Withdrawal by Subject|3|||
16192278|NCT00414960|39182399|FG001|Overall Study|Withdrawal by Subject|0|||
16192279|NCT00414960|39182398|FG000|Overall Study|Physician Decision|0|||
16192280|NCT00414960|39182399|FG001|Overall Study|Physician Decision|1|||
16192281|NCT04439344|39182400|FG000|Overall Study|Never started threapy|3|||
16192282|NCT04439344|39182400|FG000|Overall Study|Ineligible|3|||
16192283|NCT04439344|39182400|FG000|Overall Study|Adverse Event|13|||
16192284|NCT04439344|39182400|FG000|Overall Study|Death|2|||
16192285|NCT04439344|39182400|FG000|Overall Study|Disease progression|29|||
16192286|NCT04439344|39182400|FG000|Overall Study|Withdrawal by Subject|2|||
16192287|NCT04439344|39182400|FG000|Overall Study|Alternative therapy|1|||
16192288|NCT03245723|39182403|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
16192289|NCT03245723|39182404|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
16192290|NCT03245723|39182403|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
16192291|NCT03245723|39182404|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
16192292|NCT03245723|39182403|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
16192293|NCT03245723|39182404|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
16192294|NCT03245723|39182403|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
16192295|NCT03245723|39182404|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
16192296|NCT01346371|39182408|FG000|Overall Study|Lost to Follow-up|2|||
16192297|NCT01346371|39182409|FG001|Overall Study|Lost to Follow-up|0|||
16192298|NCT01822691|39182413|FG000|Overall Study|Withdrawal by Subject|2|||
16192299|NCT01008995|39182414|FG000|Controlled Period|Adverse Event|1|||
16192300|NCT01008995|39182415|FG001|Controlled Period|Adverse Event|2|||
16192301|NCT01008995|39182416|FG002|Controlled Period|Adverse Event|0|||
16192302|NCT01008995|39182417|FG003|Controlled Period|Adverse Event|0|||
16192303|NCT01008995|39182414|FG000|Controlled Period|Other|2|||
16192304|NCT01008995|39182415|FG001|Controlled Period|Other|1|||
16192305|NCT01008995|39182416|FG002|Controlled Period|Other|0|||
16192306|NCT01008995|39182417|FG003|Controlled Period|Other|0|||
16192307|NCT01008995|39182414|FG000|After Controlled Period|Adverse Event|0|||
16192308|NCT01008995|39182415|FG001|After Controlled Period|Adverse Event|0|||
16192309|NCT01008995|39182416|FG002|After Controlled Period|Adverse Event|1|||
16192310|NCT01008995|39182417|FG003|After Controlled Period|Adverse Event|1|||
16192311|NCT01008995|39182414|FG000|After Controlled Period|Other|0|||
16192312|NCT01008995|39182415|FG001|After Controlled Period|Other|0|||
16192313|NCT01008995|39182416|FG002|After Controlled Period|Other|1|||
16192314|NCT01008995|39182417|FG003|After Controlled Period|Other|0|||
16192315|NCT04937816|39182418|FG000|Overall Study|Study drug stopped, reason missing|5|||
16192316|NCT04937816|39182419|FG001|Overall Study|Study drug stopped, reason missing|3|||
16192317|NCT04937816|39182420|FG002|Overall Study|Study drug stopped, reason missing|4|||
16192318|NCT04937816|39182421|FG003|Overall Study|Study drug stopped, reason missing|6|||
16192319|NCT04937816|39182422|FG004|Overall Study|Study drug stopped, reason missing|1|||
16192320|NCT04937816|39182423|FG005|Overall Study|Study drug stopped, reason missing|0|||
16192321|NCT04937816|39182424|FG006|Overall Study|Study drug stopped, reason missing|0|||
16192322|NCT04937816|39182418|FG000|Overall Study|Other than stated below|173|||
16192323|NCT04937816|39182419|FG001|Overall Study|Other than stated below|143|||
16192324|NCT04937816|39182420|FG002|Overall Study|Other than stated below|125|||
16192325|NCT04937816|39182421|FG003|Overall Study|Other than stated below|44|||
16192326|NCT04937816|39182422|FG004|Overall Study|Other than stated below|45|||
16192327|NCT04937816|39182423|FG005|Overall Study|Other than stated below|28|||
16192328|NCT04937816|39182424|FG006|Overall Study|Other than stated below|31|||
16192329|NCT04937816|39182418|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
16192330|NCT04937816|39182419|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
16192331|NCT04937816|39182420|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
16192332|NCT04937816|39182421|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
16192333|NCT04937816|39182422|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
16192334|NCT04937816|39182423|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
16192335|NCT04937816|39182424|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
16192336|NCT04937816|39182418|FG000|Overall Study|Lost to Follow-up|15|||
16192337|NCT04937816|39182419|FG001|Overall Study|Lost to Follow-up|9|||
16192338|NCT04937816|39182420|FG002|Overall Study|Lost to Follow-up|6|||
16192339|NCT04937816|39182421|FG003|Overall Study|Lost to Follow-up|6|||
16192340|NCT04937816|39182422|FG004|Overall Study|Lost to Follow-up|16|||
16192341|NCT04937816|39182423|FG005|Overall Study|Lost to Follow-up|11|||
16192342|NCT04937816|39182424|FG006|Overall Study|Lost to Follow-up|17|||
16192343|NCT04937816|39182418|FG000|Overall Study|Protocol Violation|15|||
16192344|NCT04937816|39182419|FG001|Overall Study|Protocol Violation|15|||
16192345|NCT04937816|39182420|FG002|Overall Study|Protocol Violation|12|||
16192346|NCT04937816|39182421|FG003|Overall Study|Protocol Violation|30|||
16192347|NCT04937816|39182422|FG004|Overall Study|Protocol Violation|24|||
16192348|NCT04937816|39182423|FG005|Overall Study|Protocol Violation|5|||
16192349|NCT04937816|39182424|FG006|Overall Study|Protocol Violation|5|||
16192350|NCT04937816|39182418|FG000|Overall Study|Adverse Event|303|||
16192351|NCT04937816|39182419|FG001|Overall Study|Adverse Event|267|||
16192352|NCT04937816|39182420|FG002|Overall Study|Adverse Event|273|||
16192353|NCT04937816|39182421|FG003|Overall Study|Adverse Event|553|||
16192354|NCT04937816|39182422|FG004|Overall Study|Adverse Event|575|||
16192355|NCT04937816|39182423|FG005|Overall Study|Adverse Event|343|||
16192356|NCT04937816|39182424|FG006|Overall Study|Adverse Event|337|||
16192357|NCT04937816|39182418|FG000|Overall Study|Not treated|4|||
16192358|NCT04937816|39182419|FG001|Overall Study|Not treated|2|||
16192359|NCT04937816|39182420|FG002|Overall Study|Not treated|2|||
16192360|NCT04937816|39182421|FG003|Overall Study|Not treated|2|||
16192361|NCT04937816|39182422|FG004|Overall Study|Not treated|1|||
16192362|NCT04937816|39182423|FG005|Overall Study|Not treated|4|||
16192363|NCT04937816|39182424|FG006|Overall Study|Not treated|0|||
16192364|NCT03650452|39182430|FG000|Overall Study|Physician Decision|1|||
16192365|NCT03650452|39182431|FG001|Overall Study|Physician Decision|0|||
16192366|NCT03650452|39182430|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
16192367|NCT03650452|39182431|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16192368|NCT03650452|39182430|FG000|Overall Study|Adverse Event|3|||
16192369|NCT03650452|39182431|FG001|Overall Study|Adverse Event|4|||
16192370|NCT03650452|39182430|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
16192371|NCT03650452|39182431|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
16192372|NCT03196505|39182432|FG000|Overall Study|Physician Decision|26|||
16192373|NCT03196505|39182433|FG001|Overall Study|Physician Decision|26|||
16192374|NCT00069576|39182434|FG000|Original Trial|Lost to Follow-up|25|||
16192375|NCT00069576|39182435|FG001|Original Trial|Lost to Follow-up|33|||
16192376|NCT00069576|39182434|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
16192377|NCT00069576|39182435|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
16192378|NCT05013905|39182436|FG000|Overall Study|Adverse Event|1|||
16192379|NCT05013905|39182436|FG000|Overall Study|Lack of Efficacy|1|||
16192380|NCT02817555|39182437|FG000|Overall Study|Death|1|||
16192381|NCT02817555|39182438|FG001|Overall Study|Death|3|||
16192382|NCT02817555|39182437|FG000|Overall Study|moved away|1|||
16192383|NCT02817555|39182438|FG001|Overall Study|moved away|0|||
16192384|NCT02817555|39182437|FG000|Overall Study|transplant|1|||
16192385|NCT02817555|39182438|FG001|Overall Study|transplant|1|||
16192386|NCT02817555|39182437|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
16192387|NCT02817555|39182438|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
16192388|NCT03885726|39182442|FG000|Overall Study|Staffing issues/lost interest|1|||
16192389|NCT03885726|39182442|FG000|Overall Study|Early discharge from hospital|3|||
16192390|NCT00631488|39182449|FG000|Overall Study|Adverse Event|1|||
16192391|NCT00631488|39182450|FG001|Overall Study|Adverse Event|0|||
16192392|NCT00631488|39182451|FG002|Overall Study|Adverse Event|0|||
16192393|NCT00631488|39182449|FG000|Overall Study|Lost to Follow-up|2|||
16192394|NCT00631488|39182450|FG001|Overall Study|Lost to Follow-up|2|||
16192395|NCT00631488|39182451|FG002|Overall Study|Lost to Follow-up|0|||
16192396|NCT00631488|39182449|FG000|Overall Study|Physician Decision|1|||
16192397|NCT00631488|39182450|FG001|Overall Study|Physician Decision|0|||
16192398|NCT00631488|39182451|FG002|Overall Study|Physician Decision|1|||
16192399|NCT00631488|39182449|FG000|Overall Study|Protocol Violation|0|||
16192400|NCT00631488|39182450|FG001|Overall Study|Protocol Violation|0|||
16192401|NCT00631488|39182451|FG002|Overall Study|Protocol Violation|1|||
16192402|NCT01096849|39182452|FG000|Overall Study|Consent Withdrawn|1|||
16192403|NCT01096849|39182453|FG001|Overall Study|Consent Withdrawn|4|||
16192404|NCT01096849|39182454|FG002|Overall Study|Consent Withdrawn|2|||
16192405|NCT01096849|39182452|FG000|Overall Study|Lack of Efficacy|0|||
16192406|NCT01096849|39182453|FG001|Overall Study|Lack of Efficacy|2|||
16192407|NCT01096849|39182454|FG002|Overall Study|Lack of Efficacy|0|||
16192408|NCT01096849|39182452|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
16192409|NCT01096849|39182453|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
16192410|NCT01096849|39182454|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
16192411|NCT01096849|39182452|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
16192412|NCT01096849|39182453|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
16192413|NCT01096849|39182454|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
16192414|NCT01096849|39182452|FG000|Overall Study|Administrative Reasons|0|||
16192415|NCT01096849|39182453|FG001|Overall Study|Administrative Reasons|1|||
16192416|NCT01096849|39182454|FG002|Overall Study|Administrative Reasons|2|||
16192417|NCT01096849|39182452|FG000|Overall Study|Lost to Follow-up|1|||
16192418|NCT01096849|39182453|FG001|Overall Study|Lost to Follow-up|3|||
16192419|NCT01096849|39182454|FG002|Overall Study|Lost to Follow-up|1|||
16192420|NCT02509598|39182456|FG000|Overall Study|Withdrawal by Subject|1|||
16192421|NCT00862849|39182459|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
16192422|NCT00862849|39182460|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
16192423|NCT00862849|39182461|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
16192424|NCT00862849|39182462|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
16192425|NCT00862849|39182463|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
16192426|NCT00862849|39182464|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
16192427|NCT00862849|39182459|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
16192428|NCT00862849|39182460|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
16192429|NCT00862849|39182461|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
16192430|NCT00862849|39182462|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
16192431|NCT00862849|39182463|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
16192432|NCT00862849|39182464|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
16192433|NCT04863014|39182466|FG000|Overall Study|Lost to Follow-up|3|||
16192434|NCT04863014|39182467|FG001|Overall Study|Lost to Follow-up|2|||
16192435|NCT04863014|39182466|FG000|Overall Study|Subject Decision|0|||
16192436|NCT04863014|39182467|FG001|Overall Study|Subject Decision|4|||
16192437|NCT02023164|39182468|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
16192438|NCT02023164|39182469|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
16192439|NCT02108951|39182472|FG000|Overall Study|Lost to Follow-up|1|||
16300576|NCT00230178|39585454|FG002|Overall Study|Withdrawal by Subject|1|||
16300577|NCT00230178|39585452|FG000|Overall Study|Various other reasons|3|||
16300578|NCT00230178|39585453|FG001|Overall Study|Various other reasons|2|||
16300579|NCT00230178|39585454|FG002|Overall Study|Various other reasons|4|||
16300580|NCT04803305|39585458|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
16300581|NCT04803305|39585459|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
16300582|NCT04803305|39585458|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
16300583|NCT04803305|39585459|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
16300584|NCT04803305|39585458|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
16300585|NCT04803305|39585459|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
16300586|NCT04803305|39585458|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
16300587|NCT04803305|39585459|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
16300588|NCT04803305|39585458|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
16300589|NCT04803305|39585459|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
16300590|NCT04803305|39585458|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
16300591|NCT04803305|39585459|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
16300592|NCT04803305|39585458|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
16300593|NCT04803305|39585459|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
16300594|NCT04803305|39585458|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
16300595|NCT04803305|39585459|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
16300596|NCT04305587|39585460|FG000|Overall Study|Withdrawal by Subject|0|||
16300597|NCT04305587|39585461|FG001|Overall Study|Withdrawal by Subject|0|||
16300598|NCT04305587|39585462|FG002|Overall Study|Withdrawal by Subject|0|||
16300599|NCT04305587|39585463|FG003|Overall Study|Withdrawal by Subject|1|||
16300600|NCT04305587|39585464|FG004|Overall Study|Withdrawal by Subject|0|||
16386911|NCT02737501|39899527|FG002|Randomized Phase|Died|0|||
16386912|NCT02737501|39899525|FG000|Randomized Phase|Withdrawal by Subject|16|||
16300601|NCT04305587|39585465|FG005|Overall Study|Withdrawal by Subject|0|||
16300602|NCT04305587|39585466|FG006|Overall Study|Withdrawal by Subject|0|||
16300603|NCT04305587|39585467|FG007|Overall Study|Withdrawal by Subject|0|||
16300604|NCT04305587|39585468|FG008|Overall Study|Withdrawal by Subject|0|||
16300605|NCT00264550|39585469|FG000|Overall Study|Death|0|||
16300606|NCT00264550|39585470|FG001|Overall Study|Death|3|||
16300607|NCT00264550|39585471|FG002|Overall Study|Death|0|||
16300608|NCT00264550|39585472|FG003|Overall Study|Death|0|||
16300609|NCT00264550|39585469|FG000|Overall Study|Lost to Follow-up|3|||
16300610|NCT00264550|39585470|FG001|Overall Study|Lost to Follow-up|1|||
16300611|NCT00264550|39585471|FG002|Overall Study|Lost to Follow-up|1|||
16300612|NCT00264550|39585472|FG003|Overall Study|Lost to Follow-up|1|||
16300613|NCT00264550|39585469|FG000|Overall Study|Adverse Event|23|||
16300614|NCT00264550|39585470|FG001|Overall Study|Adverse Event|18|||
16300615|NCT00264550|39585471|FG002|Overall Study|Adverse Event|9|||
16300616|NCT00264550|39585472|FG003|Overall Study|Adverse Event|14|||
16300617|NCT00264550|39585469|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16300618|NCT00264550|39585470|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
16300619|NCT00264550|39585471|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
16300620|NCT00264550|39585472|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
16300621|NCT00264550|39585469|FG000|Overall Study|Discontinued oral study agent|0|||
16300622|NCT00264550|39585470|FG001|Overall Study|Discontinued oral study agent|1|||
16300623|NCT00264550|39585471|FG002|Overall Study|Discontinued oral study agent|0|||
16300624|NCT00264550|39585472|FG003|Overall Study|Discontinued oral study agent|0|||
16300625|NCT00264550|39585469|FG000|Overall Study|Other|13|||
16300626|NCT00264550|39585470|FG001|Overall Study|Other|7|||
16300627|NCT00264550|39585471|FG002|Overall Study|Other|3|||
16300628|NCT00264550|39585472|FG003|Overall Study|Other|9|||
16300629|NCT00789737|39585480|FG000|Overall Study|Withdrawal by Subject|13|||
16300630|NCT00789737|39585481|FG001|Overall Study|Withdrawal by Subject|22|||
16300631|NCT00789737|39585480|FG000|Overall Study|Lost to Follow-up|10|||
16300632|NCT00789737|39585481|FG001|Overall Study|Lost to Follow-up|14|||
16300633|NCT00789737|39585480|FG000|Overall Study|Adverse Event|8|||
16300634|NCT00789737|39585481|FG001|Overall Study|Adverse Event|8|||
16300635|NCT00789737|39585480|FG000|Overall Study|Protocol Violation|3|||
16300636|NCT00789737|39585481|FG001|Overall Study|Protocol Violation|0|||
16300637|NCT00789737|39585480|FG000|Overall Study|Lack of Efficacy|3|||
16300638|NCT00789737|39585481|FG001|Overall Study|Lack of Efficacy|0|||
16300639|NCT00789737|39585480|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
16300640|NCT00789737|39585481|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
16300641|NCT00789737|39585480|FG000|Overall Study|Other|11|||
16300642|NCT00789737|39585481|FG001|Overall Study|Other|7|||
16300643|NCT01200992|39585482|FG000|Overall Study|Study terminated early|35|||
16300644|NCT01200992|39585483|FG001|Overall Study|Study terminated early|41|||
16300645|NCT01200992|39585482|FG000|Overall Study|Randomized but not treated|2|||
16300646|NCT01200992|39585483|FG001|Overall Study|Randomized but not treated|0|||
16300647|NCT00534404|39585487|FG000|Overall Study|Death|0|||
16300648|NCT00534404|39585488|FG001|Overall Study|Death|0|||
16300649|NCT00534404|39585489|FG002|Overall Study|Death|2|||
16300650|NCT00534404|39585487|FG000|Overall Study|Withdrawal by Subject|8|||
16300651|NCT00534404|39585488|FG001|Overall Study|Withdrawal by Subject|2|||
16300652|NCT00534404|39585489|FG002|Overall Study|Withdrawal by Subject|38|||
16300653|NCT00534404|39585487|FG000|Overall Study|Removed by study staff|2|||
16300654|NCT00534404|39585488|FG001|Overall Study|Removed by study staff|3|||
16300655|NCT00534404|39585489|FG002|Overall Study|Removed by study staff|1|||
16300656|NCT00534404|39585487|FG000|Overall Study|Lost to Follow-up|170|||
16300657|NCT00534404|39585488|FG001|Overall Study|Lost to Follow-up|138|||
16300658|NCT00534404|39585489|FG002|Overall Study|Lost to Follow-up|201|||
16300659|NCT01137071|39585490|FG000|Overall Study|Disease Progression|11|||
16300660|NCT01137071|39585490|FG000|Overall Study|Withdrawal by Subject|2|||
16300661|NCT01137071|39585490|FG000|Overall Study|Wrongly Included|1|||
16300662|NCT01006135|39585493|FG000|Overall Study|Adverse Event|22|||
16300663|NCT01006135|39585493|FG000|Overall Study|Protocol Violation|14|||
16300664|NCT01006135|39585493|FG000|Overall Study|Lost to Follow-up|32|||
16300665|NCT01006135|39585493|FG000|Overall Study|Other|72|||
16300666|NCT00428116|39585494|FG000|Overall Study|Death|1|||
16300667|NCT00428116|39585495|FG001|Overall Study|Death|0|||
16300668|NCT00428116|39585494|FG000|Overall Study|Withdrawal by Subject|1|||
16300669|NCT00428116|39585495|FG001|Overall Study|Withdrawal by Subject|0|||
16300670|NCT00428116|39585494|FG000|Overall Study|Lost to Follow-up|1|||
16300671|NCT00428116|39585495|FG001|Overall Study|Lost to Follow-up|0|||
16300672|NCT00459043|39585496|FG000|Overall Study|Withdrawal by Subject|1|||
16300673|NCT00459043|39585497|FG001|Overall Study|Withdrawal by Subject|0|||
16300674|NCT01547130|39585498|FG000|Overall Study|Lost to Follow-up|9|||
16300675|NCT01547130|39585499|FG001|Overall Study|Lost to Follow-up|5|||
16300676|NCT03696953|39585500|FG000|Overall Study|Withdrawal by Subject|6|||
16300677|NCT03696953|39585501|FG001|Overall Study|Withdrawal by Subject|1|||
16300678|NCT03696953|39585500|FG000|Overall Study|missed GBS swabs|2|||
16300679|NCT03696953|39585501|FG001|Overall Study|missed GBS swabs|2|||
16300680|NCT03696953|39585500|FG000|Overall Study|lost study bottle containing capsules|2|||
16300681|NCT03696953|39585501|FG001|Overall Study|lost study bottle containing capsules|0|||
16300682|NCT03696953|39585500|FG000|Overall Study|Premature birth|1|||
16386913|NCT02737501|39899526|FG001|Randomized Phase|Withdrawal by Subject|6|||
16386914|NCT02737501|39899527|FG002|Randomized Phase|Withdrawal by Subject|0|||
16386915|NCT02737501|39899525|FG000|Randomized Phase|Lost to Follow-up|0|||
16386916|NCT02737501|39899526|FG001|Randomized Phase|Lost to Follow-up|1|||
16386917|NCT02737501|39899527|FG002|Randomized Phase|Lost to Follow-up|0|||
16386918|NCT02737501|39899525|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
16386919|NCT02737501|39899526|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
16386920|NCT02737501|39899527|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
16386921|NCT02737501|39899525|FG000|Randomized Phase|Reason not Specified|1|||
16386922|NCT02737501|39899526|FG001|Randomized Phase|Reason not Specified|1|||
16386923|NCT02737501|39899527|FG002|Randomized Phase|Reason not Specified|0|||
16386924|NCT02737501|39899525|FG000|Randomized Phase|Never Treated|1|||
16386925|NCT02737501|39899526|FG001|Randomized Phase|Never Treated|1|||
16386926|NCT02737501|39899527|FG002|Randomized Phase|Never Treated|0|||
16386927|NCT02737501|39899525|FG000|Crossover Phase|Died|0|||
16386928|NCT02737501|39899526|FG001|Crossover Phase|Died|0|||
16386929|NCT02737501|39899527|FG002|Crossover Phase|Died|22|||
16386930|NCT02737501|39899525|FG000|Crossover Phase|Withdrew Consent|0|||
16386931|NCT02737501|39899526|FG001|Crossover Phase|Withdrew Consent|0|||
16386932|NCT02737501|39899527|FG002|Crossover Phase|Withdrew Consent|9|||
16386933|NCT02737501|39899525|FG000|Crossover Phase|Physician Decision|0|||
16386934|NCT02737501|39899526|FG001|Crossover Phase|Physician Decision|0|||
16386935|NCT02737501|39899527|FG002|Crossover Phase|Physician Decision|1|||
16386936|NCT02737501|39899525|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
16386937|NCT02737501|39899526|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
16386938|NCT02737501|39899527|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
16386939|NCT01812057|39899530|FG000|Overall Study|Protocol Violation|1|||
16386940|NCT01812057|39899531|FG001|Overall Study|Protocol Violation|0|||
16386941|NCT01812057|39899530|FG000|Overall Study|Physician Decision|1|||
16386942|NCT01812057|39899531|FG001|Overall Study|Physician Decision|0|||
16386943|NCT03698279|39899532|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16386944|NCT03698279|39899533|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16386945|NCT03698279|39899534|FG002|Overall Study|Withdrawal by parent/guardian|1|||
16386946|NCT03698279|39899535|FG003|Overall Study|Withdrawal by parent/guardian|1|||
16386947|NCT03698279|39899536|FG004|Overall Study|Withdrawal by parent/guardian|0|||
16386948|NCT03698279|39899537|FG005|Overall Study|Withdrawal by parent/guardian|0|||
16386949|NCT03698279|39899532|FG000|Overall Study|Protocol deviation|1|||
16386950|NCT03698279|39899533|FG001|Overall Study|Protocol deviation|0|||
16386951|NCT03698279|39899534|FG002|Overall Study|Protocol deviation|1|||
16386952|NCT03698279|39899535|FG003|Overall Study|Protocol deviation|0|||
16386953|NCT03698279|39899536|FG004|Overall Study|Protocol deviation|0|||
16386954|NCT03698279|39899537|FG005|Overall Study|Protocol deviation|0|||
16386955|NCT03698279|39899532|FG000|Overall Study|Withdrawal by Subject|0|||
16386956|NCT03698279|39899533|FG001|Overall Study|Withdrawal by Subject|0|||
16386957|NCT03698279|39899534|FG002|Overall Study|Withdrawal by Subject|1|||
16386958|NCT03698279|39899535|FG003|Overall Study|Withdrawal by Subject|0|||
16386959|NCT03698279|39899536|FG004|Overall Study|Withdrawal by Subject|0|||
16386960|NCT03698279|39899537|FG005|Overall Study|Withdrawal by Subject|0|||
16386961|NCT03698279|39899532|FG000|Overall Study|Lost to Follow-up|3|||
16386962|NCT03698279|39899533|FG001|Overall Study|Lost to Follow-up|1|||
16386963|NCT03698279|39899534|FG002|Overall Study|Lost to Follow-up|4|||
16386964|NCT03698279|39899535|FG003|Overall Study|Lost to Follow-up|5|||
16386965|NCT03698279|39899536|FG004|Overall Study|Lost to Follow-up|0|||
16386966|NCT03698279|39899537|FG005|Overall Study|Lost to Follow-up|0|||
16386967|NCT01213082|39899540|FG000|Overall Study|Lost to Follow-up|6|||
16386968|NCT01213082|39899541|FG001|Overall Study|Lost to Follow-up|7|||
16490234|NCT02289898|40270235|FG000|Overall Study|Withdrawal by Subject|0|||
16490235|NCT02289898|40270236|FG001|Overall Study|Withdrawal by Subject|4|||
16386969|NCT01213082|39899542|FG002|Overall Study|Lost to Follow-up|4|||
16386970|NCT01213082|39899540|FG000|Overall Study|Physician Decision|0|||
16386971|NCT01213082|39899541|FG001|Overall Study|Physician Decision|0|||
16386972|NCT01213082|39899542|FG002|Overall Study|Physician Decision|1|||
16386973|NCT00956293|39902482|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
16386974|NCT00956293|39902483|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
16386975|NCT00956293|39902484|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
16386976|NCT00956293|39902482|FG000|Main Period (Pre-randomization)|Death|0|||
16386977|NCT00956293|39902483|FG001|Main Period (Pre-randomization)|Death|0|||
16386978|NCT00956293|39902484|FG002|Main Period (Pre-randomization)|Death|1|||
16386979|NCT00956293|39902482|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
16386980|NCT00956293|39902483|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
16386981|NCT00956293|39902484|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
16386982|NCT00956293|39902482|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
16386983|NCT00956293|39902483|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
16386984|NCT00956293|39902484|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
16386985|NCT00956293|39902482|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
16386986|NCT00956293|39902483|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
16386987|NCT00956293|39902484|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
16386988|NCT00956293|39902482|FG000|Main Period (Pre-randomization)|Graft loss|0|||
16386989|NCT00956293|39902483|FG001|Main Period (Pre-randomization)|Graft loss|0|||
16386990|NCT00956293|39902484|FG002|Main Period (Pre-randomization)|Graft loss|7|||
16386991|NCT00956293|39902482|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
16386992|NCT00956293|39902483|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
16386993|NCT00956293|39902484|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
16386994|NCT00956293|39902482|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
16386995|NCT00956293|39902483|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
16386996|NCT00956293|39902484|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
16386997|NCT00956293|39902482|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
16386998|NCT00956293|39902483|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
16386999|NCT00956293|39902484|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
16387000|NCT00956293|39902482|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
16387001|NCT00956293|39902483|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
16387002|NCT00956293|39902484|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
16387003|NCT00956293|39902482|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
16387004|NCT00956293|39902483|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
16387005|NCT00956293|39902484|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
16387006|NCT00956293|39902482|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
16387007|NCT00956293|39902483|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
16387008|NCT00956293|39902484|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
16387009|NCT00956293|39902482|FG000|Main Period (Randomization)|Adverse Event|0|||
16387010|NCT00956293|39902483|FG001|Main Period (Randomization)|Adverse Event|15|||
16387011|NCT00956293|39902484|FG002|Main Period (Randomization)|Adverse Event|0|||
16387012|NCT00956293|39902482|FG000|Follow-up Period|Follow-up period was terminated.|20|||
16387013|NCT00956293|39902483|FG001|Follow-up Period|Follow-up period was terminated.|32|||
16387014|NCT00956293|39902484|FG002|Follow-up Period|Follow-up period was terminated.|0|||
16387015|NCT01273038|39902485|FG000|Second Intervention (14 Days)|Adverse Event|0|||
16387016|NCT01273038|39902486|FG001|Second Intervention (14 Days)|Adverse Event|1|||
16387017|NCT01273038|39902485|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
16387018|NCT01273038|39902486|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
16387019|NCT01497197|39902487|FG000|Overall Study|Lost to Follow-up|1|||
16387020|NCT01497197|39902488|FG001|Overall Study|Lost to Follow-up|0|||
16387021|NCT01497197|39902487|FG000|Overall Study|Protocol Violation|0|||
16387022|NCT01497197|39902488|FG001|Overall Study|Protocol Violation|2|||
16387023|NCT01497197|39902487|FG000|Overall Study|Withdrawal by Subject|2|||
16387024|NCT01497197|39902488|FG001|Overall Study|Withdrawal by Subject|1|||
16387025|NCT01497197|39902487|FG000|Overall Study|Excessive/lack of response to treatment|1|||
16387026|NCT01497197|39902488|FG001|Overall Study|Excessive/lack of response to treatment|0|||
16387027|NCT01497197|39902487|FG000|Overall Study|Risk of OHSS|1|||
16387028|NCT01497197|39902488|FG001|Overall Study|Risk of OHSS|0|||
16387029|NCT01497197|39902487|FG000|Overall Study|No oocytes retrieved|3|||
16387030|NCT01497197|39902488|FG001|Overall Study|No oocytes retrieved|2|||
16387031|NCT01497197|39902487|FG000|Overall Study|No fertilisation|6|||
16387032|NCT01497197|39902488|FG001|Overall Study|No fertilisation|5|||
16387033|NCT01497197|39902487|FG000|Overall Study|Intention to freeze all embryos|0|||
16387034|NCT01497197|39902488|FG001|Overall Study|Intention to freeze all embryos|1|||
16387035|NCT01497197|39902487|FG000|Overall Study|All embryos discarded|0|||
16387036|NCT01497197|39902488|FG001|Overall Study|All embryos discarded|3|||
16192440|NCT02108951|39182472|FG000|Overall Study|Patient's/guardian's decision|1|||
16192441|NCT02108951|39182472|FG000|Overall Study|Study Terminated by Sponsor|14|||
16387037|NCT01497197|39902487|FG000|Overall Study|Other|3|||
16387038|NCT01497197|39902488|FG001|Overall Study|Other|1|||
16387039|NCT00714948|39902491|FG000|Overall Study|Adverse Event|2|||
16387040|NCT00894387|39902492|FG000|Overall Study|Adverse Event|44|||
16387041|NCT00894387|39902493|FG001|Overall Study|Adverse Event|45|||
16387042|NCT00894387|39902492|FG000|Overall Study|Abnormal Laboratory values|2|||
16387043|NCT00894387|39902493|FG001|Overall Study|Abnormal Laboratory values|2|||
16387044|NCT00894387|39902492|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16387045|NCT00894387|39902493|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16387046|NCT00894387|39902492|FG000|Overall Study|Lost to Follow-up|3|||
16387047|NCT00894387|39902493|FG001|Overall Study|Lost to Follow-up|5|||
16387048|NCT00894387|39902492|FG000|Overall Study|Administrative problems|2|||
16387049|NCT00894387|39902493|FG001|Overall Study|Administrative problems|2|||
16387050|NCT00894387|39902492|FG000|Overall Study|Death|77|||
16387051|NCT00894387|39902493|FG001|Overall Study|Death|76|||
16387052|NCT00894387|39902492|FG000|Overall Study|Protocol Deviation|4|||
16387053|NCT00894387|39902493|FG001|Overall Study|Protocol Deviation|0|||
16192442|NCT02020031|39182474|FG000|Overall Study|Physician Decision|1|||
16192443|NCT02020031|39182475|FG001|Overall Study|Physician Decision|1|||
16387054|NCT00894387|39902492|FG000|Overall Study|Patient's request|25|||
16387055|NCT00894387|39902493|FG001|Overall Study|Patient's request|30|||
16387056|NCT00894387|39902492|FG000|Overall Study|Other (Missing)|5|||
16387057|NCT00894387|39902493|FG001|Overall Study|Other (Missing)|3|||
16387058|NCT00894387|39902492|FG000|Overall Study|Mis-randomized|13|||
16387059|NCT00894387|39902493|FG001|Overall Study|Mis-randomized|9|||
16387060|NCT00894387|39902492|FG000|Overall Study|GCP non-compliance|0|||
16387061|NCT00894387|39902493|FG001|Overall Study|GCP non-compliance|2|||
16387062|NCT00429182|39902494|FG000|Overall Study|Not evaluable, Disease Progression|2|||
16387063|NCT00429182|39902494|FG000|Overall Study|Not eligible|5|||
16387064|NCT01299389|39902495|FG000|Double-blind|Adverse Event|45|||
16387065|NCT01299389|39902496|FG001|Double-blind|Adverse Event|27|||
16387066|NCT01299389|39902497|FG002|Double-blind|Adverse Event|0|||
16387067|NCT01299389|39902498|FG003|Double-blind|Adverse Event|0|||
16387068|NCT01299389|39902495|FG000|Double-blind|Lack of Efficacy|45|||
16387069|NCT01299389|39902496|FG001|Double-blind|Lack of Efficacy|21|||
16387070|NCT01299389|39902497|FG002|Double-blind|Lack of Efficacy|0|||
16387071|NCT01299389|39902498|FG003|Double-blind|Lack of Efficacy|0|||
16387072|NCT01299389|39902495|FG000|Double-blind|Lost to Follow-up|2|||
16387073|NCT01299389|39902496|FG001|Double-blind|Lost to Follow-up|1|||
16387074|NCT01299389|39902497|FG002|Double-blind|Lost to Follow-up|0|||
16387075|NCT01299389|39902498|FG003|Double-blind|Lost to Follow-up|0|||
16387076|NCT01299389|39902495|FG000|Double-blind|Withdrawal by Subject|16|||
16387077|NCT01299389|39902496|FG001|Double-blind|Withdrawal by Subject|13|||
16387078|NCT01299389|39902497|FG002|Double-blind|Withdrawal by Subject|0|||
16387079|NCT01299389|39902498|FG003|Double-blind|Withdrawal by Subject|0|||
16387080|NCT01299389|39902495|FG000|Double-blind|Other|1|||
16387081|NCT01299389|39902496|FG001|Double-blind|Other|1|||
16387082|NCT01299389|39902497|FG002|Double-blind|Other|0|||
16387083|NCT01299389|39902498|FG003|Double-blind|Other|0|||
16387084|NCT01299389|39902495|FG000|Double-blind|"fail to meet study population criteria"|0|||
16387085|NCT01299389|39902496|FG001|Double-blind|"fail to meet study population criteria"|1|||
16387086|NCT01299389|39902497|FG002|Double-blind|"fail to meet study population criteria"|0|||
16387087|NCT01299389|39902498|FG003|Double-blind|"fail to meet study population criteria"|0|||
16387088|NCT01299389|39902495|FG000|Post-observational|Other|0|||
16387089|NCT01299389|39902496|FG001|Post-observational|Other|0|||
16387090|NCT01299389|39902497|FG002|Post-observational|Other|12|||
16387091|NCT01299389|39902498|FG003|Post-observational|Other|6|||
16387092|NCT03519997|39902500|FG000|Overall Study|Adverse Event|4|||
16387093|NCT03519997|39902500|FG000|Overall Study|Withdrawal by Subject|2|||
16387094|NCT03519997|39902500|FG000|Overall Study|Protocol Violation|1|||
16387095|NCT03097289|39902503|FG000|Overall Study|Adverse Event|1|||
16387096|NCT03097289|39902503|FG000|Overall Study|Equipment failure|2|||
16387097|NCT03097289|39902503|FG000|Overall Study|Collected platelet product unusable|3|||
16387098|NCT00939107|39902504|FG000|Overall Study|Lost to Follow-up|14|||
16387099|NCT00939107|39902505|FG001|Overall Study|Lost to Follow-up|12|||
16387100|NCT02834819|39902506|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
16387101|NCT02834819|39902507|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
16387102|NCT03637491|39902508|FG000|Overall Study|Death|9|||
16387103|NCT03637491|39902509|FG001|Overall Study|Death|9|||
16387104|NCT03637491|39902510|FG002|Overall Study|Death|5|||
16387105|NCT03637491|39902511|FG003|Overall Study|Death|3|||
16387106|NCT03637491|39902508|FG000|Overall Study|Lost to Follow-up|0|||
16387107|NCT03637491|39902509|FG001|Overall Study|Lost to Follow-up|1|||
16387108|NCT03637491|39902510|FG002|Overall Study|Lost to Follow-up|0|||
16387109|NCT03637491|39902511|FG003|Overall Study|Lost to Follow-up|1|||
16387110|NCT03637491|39902508|FG000|Overall Study|Study Terminated By Sponsor|0|||
16387111|NCT03637491|39902509|FG001|Overall Study|Study Terminated By Sponsor|2|||
16387112|NCT03637491|39902510|FG002|Overall Study|Study Terminated By Sponsor|1|||
16387113|NCT03637491|39902511|FG003|Overall Study|Study Terminated By Sponsor|0|||
16387114|NCT03637491|39902508|FG000|Overall Study|Withdrawal by Subject|1|||
16387115|NCT03637491|39902509|FG001|Overall Study|Withdrawal by Subject|0|||
16387116|NCT03637491|39902510|FG002|Overall Study|Withdrawal by Subject|1|||
16387117|NCT03637491|39902511|FG003|Overall Study|Withdrawal by Subject|2|||
16490236|NCT02289898|40270237|FG002|Overall Study|Withdrawal by Subject|1|||
16490237|NCT02289898|40270235|FG000|Overall Study|Adverse Event|3|||
16490238|NCT02289898|40270236|FG001|Overall Study|Adverse Event|5|||
16490239|NCT02289898|40270237|FG002|Overall Study|Adverse Event|5|||
16192444|NCT03352414|39182477|FG000|Overall Study|Ineligible by operative criteria|12|||
16387118|NCT00948688|39902512|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
16387119|NCT00948688|39902513|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
16387120|NCT00948688|39902512|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
16387121|NCT00948688|39902513|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
16387122|NCT00948688|39902512|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
16387123|NCT00948688|39902513|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
16387124|NCT04067492|39902514|FG000|Overall Study|Lost to Follow-up|0|||
16387125|NCT04067492|39902515|FG001|Overall Study|Lost to Follow-up|0|||
16387126|NCT04067492|39902516|FG002|Overall Study|Lost to Follow-up|0|||
16387127|NCT04067492|39902517|FG003|Overall Study|Lost to Follow-up|0|||
16490240|NCT02289898|40270235|FG000|Overall Study|Disease progression|34|||
16490241|NCT02289898|40270236|FG001|Overall Study|Disease progression|28|||
16490242|NCT02289898|40270237|FG002|Overall Study|Disease progression|34|||
16490243|NCT02289898|40270235|FG000|Overall Study|Use of another anticancer therapy|0|||
16490244|NCT02289898|40270236|FG001|Overall Study|Use of another anticancer therapy|0|||
16490245|NCT02289898|40270237|FG002|Overall Study|Use of another anticancer therapy|1|||
16300683|NCT03696953|39585501|FG001|Overall Study|Premature birth|4|||
16300684|NCT03696953|39585500|FG000|Overall Study|Gestational hypertension|1|||
16490246|NCT02289898|40270235|FG000|Overall Study|Other|8|||
16490247|NCT02289898|40270236|FG001|Overall Study|Other|7|||
16490248|NCT02289898|40270237|FG002|Overall Study|Other|10|||
16490249|NCT05059600|40270238|FG000|Overall Study|Enrolled but not Treated|10|||
16490250|NCT00793598|40270239|FG000|Overall Study|Patient Request|0|||
16490251|NCT00793598|40270240|FG001|Overall Study|Patient Request|1|||
16490252|NCT00793598|40270241|FG002|Overall Study|Patient Request|0|||
16490253|NCT00793598|40270242|FG003|Overall Study|Patient Request|0|||
16490254|NCT00793598|40270243|FG004|Overall Study|Patient Request|0|||
16490255|NCT00793598|40270244|FG005|Overall Study|Patient Request|0|||
16490256|NCT00793598|40270245|FG006|Overall Study|Patient Request|0|||
16490257|NCT00793598|40270246|FG007|Overall Study|Patient Request|0|||
16490258|NCT00793598|40270239|FG000|Overall Study|Protocol Violation|0|||
16490259|NCT00793598|40270240|FG001|Overall Study|Protocol Violation|0|||
16490260|NCT00793598|40270241|FG002|Overall Study|Protocol Violation|0|||
16490261|NCT00793598|40270242|FG003|Overall Study|Protocol Violation|0|||
16490262|NCT00793598|40270243|FG004|Overall Study|Protocol Violation|0|||
16490263|NCT00793598|40270244|FG005|Overall Study|Protocol Violation|0|||
16490264|NCT00793598|40270245|FG006|Overall Study|Protocol Violation|0|||
16490265|NCT00793598|40270246|FG007|Overall Study|Protocol Violation|1|||
16490266|NCT00793598|40270239|FG000|Overall Study|Subject not dosed|0|||
16490267|NCT00793598|40270240|FG001|Overall Study|Subject not dosed|0|||
16490268|NCT00793598|40270241|FG002|Overall Study|Subject not dosed|0|||
16490269|NCT00793598|40270242|FG003|Overall Study|Subject not dosed|0|||
16490270|NCT00793598|40270243|FG004|Overall Study|Subject not dosed|0|||
16490271|NCT00793598|40270244|FG005|Overall Study|Subject not dosed|1|||
16490272|NCT00793598|40270245|FG006|Overall Study|Subject not dosed|0|||
16490273|NCT00793598|40270246|FG007|Overall Study|Subject not dosed|0|||
16490274|NCT03978520|40270247|FG000|Overall Study|Adverse Event|2|||
16490275|NCT03978520|40270248|FG001|Overall Study|Adverse Event|5|||
16490276|NCT03978520|40270249|FG002|Overall Study|Adverse Event|3|||
16490277|NCT03978520|40270250|FG003|Overall Study|Adverse Event|5|||
16490278|NCT03978520|40270251|FG004|Overall Study|Adverse Event|6|||
16490279|NCT03978520|40270247|FG000|Overall Study|Withdrawal by Subject|10|||
16490280|NCT03978520|40270248|FG001|Overall Study|Withdrawal by Subject|4|||
16490281|NCT03978520|40270249|FG002|Overall Study|Withdrawal by Subject|5|||
16490282|NCT03978520|40270250|FG003|Overall Study|Withdrawal by Subject|6|||
16490283|NCT03978520|40270251|FG004|Overall Study|Withdrawal by Subject|5|||
16490284|NCT03978520|40270247|FG000|Overall Study|Lost to Follow-up|2|||
16490285|NCT03978520|40270248|FG001|Overall Study|Lost to Follow-up|2|||
16490286|NCT03978520|40270249|FG002|Overall Study|Lost to Follow-up|2|||
16490287|NCT03978520|40270250|FG003|Overall Study|Lost to Follow-up|0|||
16490288|NCT03978520|40270251|FG004|Overall Study|Lost to Follow-up|1|||
16490289|NCT03978520|40270247|FG000|Overall Study|COVID-19 infection|0|||
16490290|NCT03978520|40270248|FG001|Overall Study|COVID-19 infection|1|||
16490291|NCT03978520|40270249|FG002|Overall Study|COVID-19 infection|0|||
16490292|NCT03978520|40270250|FG003|Overall Study|COVID-19 infection|0|||
16490293|NCT03978520|40270251|FG004|Overall Study|COVID-19 infection|0|||
16490294|NCT03978520|40270247|FG000|Overall Study|Other, not specified|9|||
16490295|NCT03978520|40270248|FG001|Overall Study|Other, not specified|4|||
16490296|NCT03978520|40270249|FG002|Overall Study|Other, not specified|1|||
16300685|NCT03696953|39585501|FG001|Overall Study|Gestational hypertension|1|||
16300686|NCT03696953|39585500|FG000|Overall Study|Gestational diabetes|2|||
16300687|NCT03696953|39585501|FG001|Overall Study|Gestational diabetes|1|||
16490297|NCT03978520|40270250|FG003|Overall Study|Other, not specified|1|||
16490298|NCT03978520|40270251|FG004|Overall Study|Other, not specified|2|||
16490299|NCT03978520|40270247|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
16490300|NCT03978520|40270248|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
16490301|NCT03978520|40270249|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
16490302|NCT03978520|40270250|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
16490303|NCT03978520|40270251|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
16490304|NCT01025752|40270252|FG000|Overall Study|Lost to Follow-up|7|||
16490305|NCT01025752|40270253|FG001|Overall Study|Lost to Follow-up|10|||
16490306|NCT01025752|40270252|FG000|Overall Study|Physician Decision|1|||
16490307|NCT01025752|40270253|FG001|Overall Study|Physician Decision|3|||
16490308|NCT02706691|40270258|FG000|Overall Study|Adverse Event|1|||
16490309|NCT00630396|40270259|FG000|Overall Study|Death|4|||
16490310|NCT00630396|40270259|FG000|Overall Study|Lost to Follow-up|3|||
16490311|NCT03032705|40270260|FG000|Overall Study|Lost to Follow-up|16|||
16490312|NCT03032705|40270261|FG001|Overall Study|Lost to Follow-up|17|||
16490313|NCT03032705|40270260|FG000|Overall Study|did not quality|6|||
16490314|NCT03032705|40270261|FG001|Overall Study|did not quality|6|||
16192445|NCT03352414|39182478|FG001|Overall Study|Ineligible by operative criteria|10|||
16192446|NCT02245568|39182479|FG000|Overall Study|Study terminated by Sponsor|346|||
16192447|NCT02245568|39182479|FG000|Overall Study|Adverse Event|144|||
16192448|NCT02245568|39182479|FG000|Overall Study|Lack of Efficacy|98|||
16192449|NCT02245568|39182479|FG000|Overall Study|Withdrawal by Caregiver|85|||
16192450|NCT02245568|39182479|FG000|Overall Study|Withdrawal by Subject|77|||
16192451|NCT02245568|39182479|FG000|Overall Study|Withdrawal by Legal Representative|31|||
16192452|NCT02245568|39182479|FG000|Overall Study|Missing (Site closure)|16|||
16192453|NCT02245568|39182479|FG000|Overall Study|Physician Decision|14|||
16192454|NCT02245568|39182479|FG000|Overall Study|Non-compliance with study drug|11|||
16192455|NCT02245568|39182479|FG000|Overall Study|Death|9|||
16192456|NCT02245568|39182479|FG000|Overall Study|Blue staining|6|||
16192457|NCT02245568|39182479|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
16192458|NCT02245568|39182479|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
16300688|NCT03696953|39585500|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
16300689|NCT03696953|39585501|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
16300690|NCT03696953|39585500|FG000|Overall Study|Changed prenatal provider|1|||
16300691|NCT03696953|39585501|FG001|Overall Study|Changed prenatal provider|1|||
16300692|NCT00631657|39585511|FG000|6-Month Treatment Period|Adverse Event|47|||
16300693|NCT00631657|39585512|FG001|6-Month Treatment Period|Adverse Event|0|||
16300694|NCT00631657|39585513|FG002|6-Month Treatment Period|Adverse Event|7|||
16300695|NCT00631657|39585511|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
16300696|NCT00631657|39585512|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
16300697|NCT00631657|39585513|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
16300698|NCT00631657|39585511|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
16300699|NCT00631657|39585512|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
16300700|NCT00631657|39585513|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
16083867|NCT00676091|38799230|FG001|Infant Series|Failed to return|3|||
16192459|NCT02245568|39182479|FG000|Overall Study|Lost to Follow-up|5|||
16300701|NCT00631657|39585511|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
16490315|NCT00727025|40270262|FG000|Overall Study|Physician Decision|23|||
16490316|NCT01918774|40270263|FG000|Overall Study|Lost prior to first CBTw session|4|||
16490317|NCT01918774|40270263|FG000|Overall Study|Lost to Follow-up|1|||
16490318|NCT03766581|40270264|FG000|Randomization|Other reasons|2|||
16490319|NCT03766581|40270265|FG001|Randomization|Other reasons|1|||
16490320|NCT03766581|40270266|FG002|Randomization|Other reasons|0|||
16490321|NCT03766581|40270267|FG003|Randomization|Other reasons|1|||
16490322|NCT03766581|40270268|FG004|Randomization|Other reasons|0|||
16490323|NCT03766581|40270269|FG005|Randomization|Other reasons|0|||
16490324|NCT03766581|40270270|FG006|Randomization|Other reasons|0|||
16490325|NCT03766581|40270271|FG007|Randomization|Other reasons|0|||
16490326|NCT03766581|40270264|FG000|Randomization|Participant no longer meets study criteria|5|||
16490327|NCT03766581|40270265|FG001|Randomization|Participant no longer meets study criteria|3|||
16490328|NCT03766581|40270266|FG002|Randomization|Participant no longer meets study criteria|4|||
16490329|NCT03766581|40270267|FG003|Randomization|Participant no longer meets study criteria|0|||
16490330|NCT03766581|40270268|FG004|Randomization|Participant no longer meets study criteria|2|||
16490331|NCT03766581|40270269|FG005|Randomization|Participant no longer meets study criteria|3|||
16490332|NCT03766581|40270270|FG006|Randomization|Participant no longer meets study criteria|0|||
16490333|NCT03766581|40270271|FG007|Randomization|Participant no longer meets study criteria|1|||
16490334|NCT03766581|40270264|FG000|Randomization|Participant request to discontinue study treatment|1|||
16490335|NCT03766581|40270265|FG001|Randomization|Participant request to discontinue study treatment|0|||
16490336|NCT03766581|40270266|FG002|Randomization|Participant request to discontinue study treatment|0|||
16490337|NCT03766581|40270267|FG003|Randomization|Participant request to discontinue study treatment|0|||
16490338|NCT03766581|40270268|FG004|Randomization|Participant request to discontinue study treatment|1|||
16490339|NCT03766581|40270269|FG005|Randomization|Participant request to discontinue study treatment|2|||
16490340|NCT03766581|40270270|FG006|Randomization|Participant request to discontinue study treatment|0|||
16192460|NCT03158688|39182480|FG000|Overall Study|Withdrawal by Subject|14|||
16192461|NCT03158688|39182481|FG001|Overall Study|Withdrawal by Subject|28|||
16192462|NCT03158688|39182480|FG000|Overall Study|Decision by sponsor|13|||
16192463|NCT03158688|39182481|FG001|Overall Study|Decision by sponsor|37|||
16192464|NCT03158688|39182480|FG000|Overall Study|Lost to Follow-up|4|||
16192465|NCT03158688|39182481|FG001|Overall Study|Lost to Follow-up|3|||
16192466|NCT03158688|39182480|FG000|Overall Study|Death|74|||
16192467|NCT03158688|39182481|FG001|Overall Study|Death|142|||
16192468|NCT01341652|39182484|FG000|Overall Study|Incorrect Random Assignment|0|||
16192469|NCT01341652|39182485|FG001|Overall Study|Incorrect Random Assignment|1|||
16192470|NCT01341652|39182484|FG000|Overall Study|ineligible; presence metastatic disease|0|||
16192471|NCT01341652|39182485|FG001|Overall Study|ineligible; presence metastatic disease|1|||
16192472|NCT01871896|39182488|FG000|Overall Study|Lost to Follow-up|1|||
16192473|NCT01029886|39182490|FG000|Overall Study|Adverse Event|12|||
16192474|NCT01029886|39182491|FG001|Overall Study|Adverse Event|25|||
16192475|NCT01029886|39182490|FG000|Overall Study|Lost to Follow-up|1|||
16192476|NCT01029886|39182491|FG001|Overall Study|Lost to Follow-up|0|||
16192477|NCT01029886|39182490|FG000|Overall Study|Physician Decision|2|||
16192478|NCT01029886|39182491|FG001|Overall Study|Physician Decision|6|||
16192479|NCT01029886|39182490|FG000|Overall Study|Protocol Violation|17|||
16192480|NCT01029886|39182491|FG001|Overall Study|Protocol Violation|5|||
16192481|NCT01029886|39182490|FG000|Overall Study|Withdrawal by Subject|8|||
16192482|NCT01029886|39182491|FG001|Overall Study|Withdrawal by Subject|18|||
16300702|NCT00631657|39585512|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
16192483|NCT01029886|39182490|FG000|Overall Study|Entry Criteria Not Met|13|||
16192484|NCT01029886|39182491|FG001|Overall Study|Entry Criteria Not Met|5|||
16192485|NCT01029886|39182490|FG000|Overall Study|Sponsor Decision|1|||
16192486|NCT01029886|39182491|FG001|Overall Study|Sponsor Decision|0|||
16192487|NCT01029886|39182490|FG000|Overall Study|Loss Glucose Control|7|||
16192488|NCT01029886|39182491|FG001|Overall Study|Loss Glucose Control|1|||
16192489|NCT00532948|39182492|FG000|Overall Study|Protocol Violation|1|||
16192490|NCT00532948|39182493|FG001|Overall Study|Protocol Violation|0|||
16192491|NCT00532948|39182494|FG002|Overall Study|Protocol Violation|0|||
16192492|NCT00532948|39182492|FG000|Overall Study|Death|3|||
16192493|NCT00532948|39182493|FG001|Overall Study|Death|3|||
16192494|NCT00532948|39182494|FG002|Overall Study|Death|4|||
16192495|NCT00532948|39182492|FG000|Overall Study|Violation of selection criteria at entry|0|||
16192496|NCT00532948|39182493|FG001|Overall Study|Violation of selection criteria at entry|1|||
16192497|NCT00532948|39182494|FG002|Overall Study|Violation of selection criteria at entry|0|||
16192498|NCT00532948|39182492|FG000|Overall Study|Failure to return|0|||
16192499|NCT00532948|39182493|FG001|Overall Study|Failure to return|1|||
16192500|NCT00532948|39182494|FG002|Overall Study|Failure to return|0|||
16192501|NCT01469013|39182495|FG000|Part A (Treatment Period)|Adverse Event|1|||
16192502|NCT01469013|39182496|FG001|Part A (Treatment Period)|Adverse Event|0|||
16192503|NCT01469013|39182497|FG002|Part A (Treatment Period)|Adverse Event|0|||
16192504|NCT01469013|39182498|FG003|Part A (Treatment Period)|Adverse Event|0|||
16192505|NCT01469013|39182499|FG004|Part A (Treatment Period)|Adverse Event|1|||
16192506|NCT01469013|39182500|FG005|Part A (Treatment Period)|Adverse Event|0|||
16192507|NCT01469013|39182501|FG006|Part A (Treatment Period)|Adverse Event|0|||
16192508|NCT01469013|39182502|FG007|Part A (Treatment Period)|Adverse Event|0|||
16192509|NCT01469013|39182503|FG008|Part A (Treatment Period)|Adverse Event|0|||
16192510|NCT01469013|39182504|FG009|Part A (Treatment Period)|Adverse Event|0|||
16192511|NCT01469013|39182505|FG010|Part A (Treatment Period)|Adverse Event|0|||
16192512|NCT01469013|39182506|FG011|Part A (Treatment Period)|Adverse Event|0|||
16192513|NCT01469013|39182507|FG012|Part A (Treatment Period)|Adverse Event|0|||
16192514|NCT01469013|39182495|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192515|NCT01469013|39182496|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192516|NCT01469013|39182497|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
16192517|NCT01469013|39182498|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192518|NCT01469013|39182499|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192519|NCT01469013|39182500|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192520|NCT01469013|39182501|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192521|NCT01469013|39182502|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
16387128|NCT04067492|39902518|FG004|Overall Study|Lost to Follow-up|0|||
16387129|NCT04067492|39902519|FG005|Overall Study|Lost to Follow-up|1|||
16192522|NCT01469013|39182503|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192523|NCT01469013|39182504|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192524|NCT01469013|39182505|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192525|NCT01469013|39182506|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192526|NCT01469013|39182507|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
16192527|NCT01469013|39182495|FG000|Part B (Extension Period)|Adverse Event|0|||
16192528|NCT01469013|39182496|FG001|Part B (Extension Period)|Adverse Event|0|||
16192529|NCT01469013|39182497|FG002|Part B (Extension Period)|Adverse Event|0|||
16192530|NCT01469013|39182498|FG003|Part B (Extension Period)|Adverse Event|0|||
16192531|NCT01469013|39182499|FG004|Part B (Extension Period)|Adverse Event|0|||
16192532|NCT01469013|39182500|FG005|Part B (Extension Period)|Adverse Event|2|||
16490341|NCT03766581|40270271|FG007|Randomization|Participant request to discontinue study treatment|0|||
16192533|NCT01469013|39182501|FG006|Part B (Extension Period)|Adverse Event|5|||
16192534|NCT01469013|39182502|FG007|Part B (Extension Period)|Adverse Event|5|||
16192535|NCT01469013|39182503|FG008|Part B (Extension Period)|Adverse Event|3|||
16192536|NCT01469013|39182504|FG009|Part B (Extension Period)|Adverse Event|3|||
16192537|NCT01469013|39182505|FG010|Part B (Extension Period)|Adverse Event|1|||
16192538|NCT01469013|39182506|FG011|Part B (Extension Period)|Adverse Event|6|||
16192539|NCT01469013|39182507|FG012|Part B (Extension Period)|Adverse Event|3|||
16192540|NCT01469013|39182495|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
16192541|NCT01469013|39182496|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
16192542|NCT01469013|39182497|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
16192543|NCT01469013|39182498|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
16192544|NCT01469013|39182499|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
16192545|NCT01469013|39182500|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
16192546|NCT01469013|39182501|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
16192547|NCT01469013|39182502|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
16192548|NCT01469013|39182503|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
16192549|NCT01469013|39182504|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
16192550|NCT01469013|39182505|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
16192551|NCT01469013|39182506|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
16192552|NCT01469013|39182507|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
16192553|NCT03331666|39182508|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
16192554|NCT03331666|39182509|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
16192555|NCT03648476|39182510|FG000|Overall Study|Withdrawal by Subject|2|||
16192556|NCT03648476|39182511|FG001|Overall Study|Withdrawal by Subject|1|||
16387130|NCT04067492|39902514|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
16387131|NCT04067492|39902515|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
16387132|NCT04067492|39902516|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
16083868|NCT00676091|38799229|FG000|Infant Series|Lost to Follow-up|1|||
16387133|NCT04067492|39902517|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
16387134|NCT04067492|39902518|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
16387135|NCT04067492|39902519|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
16192565|NCT01952834|39182517|FG000|Overall Study|Adverse Event|1|||
16192566|NCT00608530|39182518|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
16192567|NCT00608530|39182519|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
16192568|NCT00608530|39182520|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
16192569|NCT00608530|39182521|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
16192570|NCT00608530|39182518|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
16192571|NCT00608530|39182519|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
16192572|NCT00608530|39182520|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
16192573|NCT00608530|39182521|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
16192574|NCT00608530|39182518|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
16192575|NCT00608530|39182519|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
16192576|NCT00608530|39182520|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
16192577|NCT00608530|39182521|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
16192578|NCT00608530|39182518|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
16192579|NCT00608530|39182519|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
16192580|NCT00608530|39182520|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
16192581|NCT00608530|39182521|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
16192582|NCT00608530|39182518|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
16192583|NCT00608530|39182519|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
16192584|NCT00608530|39182520|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
16192585|NCT00608530|39182521|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
16192586|NCT00608530|39182518|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
16192587|NCT00608530|39182519|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
16192588|NCT00608530|39182520|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
16192589|NCT00608530|39182521|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
16192590|NCT00239837|39182522|FG000|Overall Study|Lost to Follow-up|3|||
16192591|NCT00239837|39182523|FG001|Overall Study|Lost to Follow-up|7|||
16192592|NCT02486952|39182524|FG000|Overall Study|Not Started Induction Therapy|3|||
16192593|NCT02486952|39182524|FG000|Overall Study|Adverse Event|1|||
16192594|NCT02486952|39182524|FG000|Overall Study|Death|15|||
16192595|NCT02486952|39182524|FG000|Overall Study|Lack of Efficacy|3|||
16192596|NCT02486952|39182524|FG000|Overall Study|Lost to Follow-up|26|||
16192597|NCT02486952|39182524|FG000|Overall Study|Other|2|||
16192598|NCT01826422|39182528|FG000|Overall Study|Withdrawal by Subject|1|||
16192599|NCT01826422|39182529|FG001|Overall Study|Withdrawal by Subject|3|||
16192600|NCT01515306|39182530|FG000|Overall Study|Adverse Event|3|||
16300703|NCT00631657|39585513|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
16300704|NCT00631657|39585511|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
16300705|NCT00631657|39585512|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
16300706|NCT00631657|39585513|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
16300707|NCT00631657|39585511|FG000|6-Month Treatment Period|Other|16|||
16300708|NCT00631657|39585512|FG001|6-Month Treatment Period|Other|0|||
16300709|NCT00631657|39585513|FG002|6-Month Treatment Period|Other|4|||
16300710|NCT00631657|39585511|FG000|6-Month Treatment Period|Not Treated|2|||
16300711|NCT00631657|39585512|FG001|6-Month Treatment Period|Not Treated|0|||
16300712|NCT00631657|39585513|FG002|6-Month Treatment Period|Not Treated|1|||
16300713|NCT00631657|39585511|FG000|7-Day Discontinuation Period|Not Treated|1|||
16300714|NCT00631657|39585512|FG001|7-Day Discontinuation Period|Not Treated|1|||
16300715|NCT00631657|39585513|FG002|7-Day Discontinuation Period|Not Treated|1|||
16300716|NCT00631657|39585511|FG000|7-Day Discontinuation Period|Other|1|||
16300717|NCT00631657|39585512|FG001|7-Day Discontinuation Period|Other|0|||
16300718|NCT00631657|39585513|FG002|7-Day Discontinuation Period|Other|0|||
16300719|NCT00000620|39585514|FG000|Overall Study|Death|86|||
16300720|NCT00000620|39585515|FG001|Overall Study|Death|67|||
16300721|NCT00000620|39585516|FG002|Overall Study|Death|112|||
16300722|NCT00000620|39585517|FG003|Overall Study|Death|126|||
16300723|NCT00000620|39585518|FG004|Overall Study|Death|64|||
16300724|NCT00000620|39585519|FG005|Overall Study|Death|77|||
16300725|NCT00000620|39585520|FG006|Overall Study|Death|91|||
16300726|NCT00000620|39585521|FG007|Overall Study|Death|95|||
16300727|NCT00000620|39585514|FG000|Overall Study|Lost to Follow-up|14|||
16300728|NCT00000620|39585515|FG001|Overall Study|Lost to Follow-up|14|||
16300729|NCT00000620|39585516|FG002|Overall Study|Lost to Follow-up|14|||
16300730|NCT00000620|39585517|FG003|Overall Study|Lost to Follow-up|14|||
16300731|NCT00000620|39585518|FG004|Overall Study|Lost to Follow-up|15|||
16300732|NCT00000620|39585519|FG005|Overall Study|Lost to Follow-up|15|||
16300733|NCT00000620|39585520|FG006|Overall Study|Lost to Follow-up|13|||
16300734|NCT00000620|39585521|FG007|Overall Study|Lost to Follow-up|14|||
16300735|NCT00000620|39585514|FG000|Overall Study|Withdrawal by Subject|40|||
16300736|NCT00000620|39585515|FG001|Overall Study|Withdrawal by Subject|27|||
16300737|NCT00000620|39585516|FG002|Overall Study|Withdrawal by Subject|28|||
16387136|NCT04067492|39902514|FG000|Overall Study|COVID-19 epidemiological situation|0|||
16300738|NCT00000620|39585517|FG003|Overall Study|Withdrawal by Subject|27|||
16300739|NCT00000620|39585518|FG004|Overall Study|Withdrawal by Subject|30|||
16300740|NCT00000620|39585519|FG005|Overall Study|Withdrawal by Subject|32|||
16300741|NCT00000620|39585520|FG006|Overall Study|Withdrawal by Subject|32|||
16300742|NCT00000620|39585521|FG007|Overall Study|Withdrawal by Subject|21|||
16387137|NCT04067492|39902515|FG001|Overall Study|COVID-19 epidemiological situation|0|||
16387138|NCT04067492|39902516|FG002|Overall Study|COVID-19 epidemiological situation|0|||
16387139|NCT04067492|39902517|FG003|Overall Study|COVID-19 epidemiological situation|1|||
16387140|NCT04067492|39902518|FG004|Overall Study|COVID-19 epidemiological situation|0|||
16387141|NCT04067492|39902519|FG005|Overall Study|COVID-19 epidemiological situation|0|||
16387142|NCT03493958|39902520|FG000|Overall Study|Withdrawal by Subject|6|||
16387143|NCT03493958|39902520|FG000|Overall Study|Lost to Follow-up|7|||
16387144|NCT03493958|39902520|FG000|Overall Study|Did not complete all required study procedures|2|||
16387145|NCT00488514|39902521|FG000|Overall Study|Adverse Event|41|||
16387146|NCT00488514|39902521|FG000|Overall Study|Lost to Follow-up|44|||
16387147|NCT00488514|39902521|FG000|Overall Study|Protocol Violation|32|||
16387148|NCT00488514|39902521|FG000|Overall Study|Withdrawal by Subject|106|||
16387149|NCT00488514|39902521|FG000|Overall Study|Lack of Efficacy|28|||
16387150|NCT00488514|39902521|FG000|Overall Study|Did not meet criteria for treatment|30|||
16387151|NCT00488514|39902521|FG000|Overall Study|Postive drug screen|1|||
16387152|NCT00488514|39902521|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
16387153|NCT00488514|39902521|FG000|Overall Study|Investigator decision|1|||
16387154|NCT00488514|39902521|FG000|Overall Study|Participant had too few migraines|5|||
16387155|NCT00488514|39902521|FG000|Overall Study|Increase in number of migraines|2|||
16387156|NCT00488514|39902521|FG000|Overall Study|Increased use of concomitant medication|1|||
16387157|NCT02709720|39902527|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
16387158|NCT02709720|39902527|FG000|Overall Study|Protocol Violation|1|||
16387159|NCT02709720|39902527|FG000|Overall Study|Not take study medication|1|||
16387160|NCT00972517|39902528|FG000|Overall Study|Adverse Event|0|||
16490342|NCT03766581|40270264|FG000|Randomization|Participant withdrew consent|1|||
16490343|NCT03766581|40270265|FG001|Randomization|Participant withdrew consent|0|||
16192601|NCT01515306|39182531|FG001|Overall Study|Adverse Event|2|||
16300743|NCT00000620|39585514|FG000|Overall Study|missed closeout visit|22|||
16300744|NCT00000620|39585515|FG001|Overall Study|missed closeout visit|28|||
16300745|NCT00000620|39585516|FG002|Overall Study|missed closeout visit|16|||
16300746|NCT00000620|39585517|FG003|Overall Study|missed closeout visit|11|||
16300747|NCT00000620|39585518|FG004|Overall Study|missed closeout visit|26|||
16300748|NCT00000620|39585519|FG005|Overall Study|missed closeout visit|28|||
16387161|NCT00972517|39902529|FG001|Overall Study|Adverse Event|0|||
16387162|NCT00972517|39902530|FG002|Overall Study|Adverse Event|0|||
16387163|NCT00972517|39902531|FG003|Overall Study|Adverse Event|1|||
16387164|NCT00972517|39902532|FG004|Overall Study|Adverse Event|0|||
16387165|NCT00972517|39902533|FG005|Overall Study|Adverse Event|0|||
16387166|NCT00972517|39902528|FG000|Overall Study|Withdrawal by Subject|0|||
16387167|NCT00972517|39902529|FG001|Overall Study|Withdrawal by Subject|1|||
16387168|NCT00972517|39902530|FG002|Overall Study|Withdrawal by Subject|0|||
16387169|NCT00972517|39902531|FG003|Overall Study|Withdrawal by Subject|2|||
16387170|NCT00972517|39902532|FG004|Overall Study|Withdrawal by Subject|1|||
16387171|NCT00972517|39902533|FG005|Overall Study|Withdrawal by Subject|0|||
16387172|NCT01913327|39902536|FG000|Overall Study|Withdrawal by Subject|0|||
16387173|NCT01913327|39902537|FG001|Overall Study|Withdrawal by Subject|1|||
16490344|NCT03766581|40270266|FG002|Randomization|Participant withdrew consent|1|||
16192602|NCT01515306|39182530|FG000|Overall Study|Progressive Disease|19|||
16387174|NCT01944020|39902541|FG000|Overall Study|Withdrawal by Subject|5|||
16387175|NCT01944020|39902542|FG001|Overall Study|Withdrawal by Subject|0|||
16387176|NCT01193101|39902543|FG000|Overall Study|Adverse Event|0|||
16387177|NCT01193101|39902544|FG001|Overall Study|Adverse Event|1|||
16387178|NCT01193101|39902545|FG002|Overall Study|Adverse Event|1|||
16387179|NCT01193101|39902546|FG003|Overall Study|Adverse Event|3|||
16387180|NCT01193101|39902543|FG000|Overall Study|Lack of Efficacy|3|||
16387181|NCT01193101|39902544|FG001|Overall Study|Lack of Efficacy|1|||
16387182|NCT01193101|39902545|FG002|Overall Study|Lack of Efficacy|0|||
16387183|NCT01193101|39902546|FG003|Overall Study|Lack of Efficacy|8|||
16387184|NCT01193101|39902543|FG000|Overall Study|Withdrawal by Subject|2|||
16387185|NCT01193101|39902544|FG001|Overall Study|Withdrawal by Subject|4|||
16387186|NCT01193101|39902545|FG002|Overall Study|Withdrawal by Subject|1|||
16387187|NCT01193101|39902546|FG003|Overall Study|Withdrawal by Subject|1|||
16387188|NCT01193101|39902543|FG000|Overall Study|Administrative problems|0|||
16387189|NCT01193101|39902544|FG001|Overall Study|Administrative problems|0|||
16387190|NCT01193101|39902545|FG002|Overall Study|Administrative problems|1|||
16387191|NCT01193101|39902546|FG003|Overall Study|Administrative problems|0|||
16387192|NCT01193101|39902543|FG000|Overall Study|Abnormal test procedure results|0|||
16387193|NCT01193101|39902544|FG001|Overall Study|Abnormal test procedure results|1|||
16387194|NCT01193101|39902545|FG002|Overall Study|Abnormal test procedure results|0|||
16387195|NCT01193101|39902546|FG003|Overall Study|Abnormal test procedure results|0|||
16387196|NCT03848416|39902547|FG000|Overall Study|Withdrawal by Subject|1|||
16387197|NCT03848416|39902548|FG001|Overall Study|Withdrawal by Subject|0|||
16387198|NCT03848416|39902549|FG002|Overall Study|Withdrawal by Subject|0|||
16387199|NCT03848416|39902547|FG000|Overall Study|Death|0|||
16387200|NCT03848416|39902548|FG001|Overall Study|Death|0|||
16387201|NCT03848416|39902549|FG002|Overall Study|Death|1|||
16387202|NCT01627691|39902550|FG000|Overall Study|Death|11|||
16387203|NCT01627691|39902550|FG000|Overall Study|Lost to Follow-up|3|||
16387204|NCT01627691|39902550|FG000|Overall Study|Withdrawal by Subject|1|||
16387205|NCT01627691|39902550|FG000|Overall Study|Missed the visit|3|||
16387206|NCT04460183|39902553|FG000|Overall Study|Lost to Follow-up|3|||
16387207|NCT04460183|39902554|FG001|Overall Study|Lost to Follow-up|1|||
16387208|NCT04460183|39902553|FG000|Overall Study|Withdrawal by Subject|1|||
16387209|NCT04460183|39902554|FG001|Overall Study|Withdrawal by Subject|0|||
16387210|NCT01428219|39902555|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
16192603|NCT01515306|39182531|FG001|Overall Study|Progressive Disease|9|||
16192604|NCT01515306|39182530|FG000|Overall Study|Withdrawal by Subject|1|||
16192605|NCT01515306|39182531|FG001|Overall Study|Withdrawal by Subject|2|||
16192606|NCT01515306|39182530|FG000|Overall Study|Physician Decision|1|||
16192607|NCT01515306|39182531|FG001|Overall Study|Physician Decision|1|||
16192608|NCT04397718|39185118|FG000|Overall Study|Death|7|||
16192609|NCT04397718|39185119|FG001|Overall Study|Death|11|||
16192610|NCT04397718|39185118|FG000|Overall Study|Lost to Follow-up|0|||
16192611|NCT04397718|39185119|FG001|Overall Study|Lost to Follow-up|4|||
16192612|NCT03150095|39185120|FG000|Overall Study|Death|0|||
16192613|NCT03150095|39185121|FG001|Overall Study|Death|1|||
16387211|NCT01173679|39902556|FG000|Overall Study|Death|1|||
16387212|NCT01977222|39902557|FG000|Overall Study|Withdrawal by Subject|1|||
16387213|NCT04940130|39902558|FG000|Overall Study|Travel|1|||
16387214|NCT04940130|39902559|FG001|Overall Study|Travel|0|||
16490345|NCT03766581|40270267|FG003|Randomization|Participant withdrew consent|2|||
16490346|NCT03766581|40270268|FG004|Randomization|Participant withdrew consent|1|||
16192614|NCT03150095|39185120|FG000|Overall Study|Lost to Follow-up|1|||
16192615|NCT03150095|39185121|FG001|Overall Study|Lost to Follow-up|1|||
16387215|NCT04940130|39902560|FG002|Overall Study|Travel|2|||
16387216|NCT04940130|39902558|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
16387217|NCT04940130|39902559|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
16387218|NCT04940130|39902560|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
16387219|NCT04940130|39902558|FG000|Overall Study|Adverse Event|0|||
16387220|NCT04940130|39902559|FG001|Overall Study|Adverse Event|0|||
16387221|NCT04940130|39902560|FG002|Overall Study|Adverse Event|2|||
16192616|NCT03150095|39185120|FG000|Overall Study|Withdrawal by Subject|4|||
16192617|NCT03150095|39185121|FG001|Overall Study|Withdrawal by Subject|0|||
16387222|NCT04940130|39902558|FG000|Overall Study|Disease progression/treatment failure|0|||
16387223|NCT04940130|39902559|FG001|Overall Study|Disease progression/treatment failure|0|||
16387224|NCT04940130|39902560|FG002|Overall Study|Disease progression/treatment failure|1|||
16387225|NCT04940130|39902558|FG000|Overall Study|Participant refusal|0|||
16192618|NCT03150095|39185120|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
16192619|NCT03150095|39185121|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
16192620|NCT00976950|39185122|FG000|Overall Study|Adverse Event|3|||
16192621|NCT00976950|39185122|FG000|Overall Study|Events with no relationship to Aptivus|3|||
16192622|NCT01232894|39185123|FG000|Overall Study|Lost to Follow-up|0|||
16192623|NCT01232894|39185124|FG001|Overall Study|Lost to Follow-up|1|||
16192624|NCT01232894|39185123|FG000|Overall Study|Death|1|||
16192625|NCT01232894|39185124|FG001|Overall Study|Death|0|||
16192626|NCT01232894|39185123|FG000|Overall Study|Protocol Violation|1|||
16192627|NCT01232894|39185124|FG001|Overall Study|Protocol Violation|1|||
16192628|NCT01232894|39185123|FG000|Overall Study|Withdrawal by Subject|8|||
16192629|NCT01232894|39185124|FG001|Overall Study|Withdrawal by Subject|5|||
16192630|NCT01232894|39185123|FG000|Overall Study|Physician Decision|2|||
16192631|NCT01232894|39185124|FG001|Overall Study|Physician Decision|1|||
16192632|NCT01364233|39185128|FG000|Overall Study|Lost to Follow-up|1|||
16192633|NCT00547378|39185130|FG000|Randomized Cohort|Withdrawal by Subject|7|||
16192634|NCT00547378|39185131|FG001|Randomized Cohort|Withdrawal by Subject|5|||
16300749|NCT00000620|39585520|FG006|Overall Study|missed closeout visit|13|||
16300750|NCT00000620|39585521|FG007|Overall Study|missed closeout visit|16|||
16300751|NCT00901576|39585525|FG000|Second Intervention|Withdrawal by Subject|0|||
16387226|NCT04940130|39902559|FG001|Overall Study|Participant refusal|0|||
16387227|NCT04940130|39902560|FG002|Overall Study|Participant refusal|1|||
16387228|NCT01904721|39902562|FG000|Overall Study|Other Reasons|0|||
16387229|NCT01904721|39902563|FG001|Overall Study|Other Reasons|0|||
16387230|NCT01904721|39902564|FG002|Overall Study|Other Reasons|1|||
16387231|NCT01904721|39902565|FG003|Overall Study|Other Reasons|1|||
16387232|NCT01904721|39902566|FG004|Overall Study|Other Reasons|2|||
16387233|NCT01904721|39902567|FG005|Overall Study|Other Reasons|2|||
16387234|NCT01904721|39902568|FG006|Overall Study|Other Reasons|2|||
16387235|NCT01904721|39902562|FG000|Overall Study|Personal Reasons|0|||
16387236|NCT01904721|39902563|FG001|Overall Study|Personal Reasons|0|||
16387237|NCT01904721|39902564|FG002|Overall Study|Personal Reasons|0|||
16387238|NCT01904721|39902565|FG003|Overall Study|Personal Reasons|0|||
16387239|NCT01904721|39902566|FG004|Overall Study|Personal Reasons|2|||
16387240|NCT01904721|39902567|FG005|Overall Study|Personal Reasons|3|||
16387241|NCT01904721|39902568|FG006|Overall Study|Personal Reasons|3|||
16387242|NCT01904721|39902562|FG000|Overall Study|Lost to Follow-up|0|||
16387243|NCT01904721|39902563|FG001|Overall Study|Lost to Follow-up|0|||
16387244|NCT01904721|39902564|FG002|Overall Study|Lost to Follow-up|0|||
16387245|NCT01904721|39902565|FG003|Overall Study|Lost to Follow-up|0|||
16387246|NCT01904721|39902566|FG004|Overall Study|Lost to Follow-up|1|||
16387247|NCT01904721|39902567|FG005|Overall Study|Lost to Follow-up|3|||
16387248|NCT01904721|39902568|FG006|Overall Study|Lost to Follow-up|1|||
16387249|NCT01904721|39902562|FG000|Overall Study|Lack of Efficacy|0|||
16300752|NCT00901576|39585526|FG001|Second Intervention|Withdrawal by Subject|0|||
16300753|NCT00901576|39585527|FG002|Second Intervention|Withdrawal by Subject|0|||
16300754|NCT00901576|39585528|FG003|Second Intervention|Withdrawal by Subject|1|||
16300755|NCT00901576|39585529|FG004|Second Intervention|Withdrawal by Subject|0|||
16300756|NCT00901576|39585530|FG005|Second Intervention|Withdrawal by Subject|1|||
16300757|NCT00901576|39585525|FG000|Second Intervention|Physician Decision|1|||
16300758|NCT00901576|39585526|FG001|Second Intervention|Physician Decision|0|||
16300759|NCT00901576|39585527|FG002|Second Intervention|Physician Decision|0|||
16300760|NCT00901576|39585528|FG003|Second Intervention|Physician Decision|0|||
16300761|NCT00901576|39585529|FG004|Second Intervention|Physician Decision|0|||
16300762|NCT00901576|39585530|FG005|Second Intervention|Physician Decision|0|||
16300763|NCT00660400|39585531|FG000|Overall Study|Lack of insurance approval|1|||
16300764|NCT00660400|39585531|FG000|Overall Study|Suboptimal organ function|1|||
16300765|NCT00660400|39585531|FG000|Overall Study|Intracranial hemorrhage|1|||
16300766|NCT00660400|39585531|FG000|Overall Study|Withdrawal by Subject|1|||
16300767|NCT01329900|39585534|FG000|Overall Study|Elevated creatinine/renal function|1|||
16300768|NCT02289729|39585537|FG000|Overall Study|Lack of Efficacy|3|||
16300769|NCT02289729|39585537|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
16192635|NCT00547378|39185132|FG002|Randomized Cohort|Withdrawal by Subject|0|||
16192636|NCT00547378|39185130|FG000|Randomized Cohort|Death|0|||
16192637|NCT00547378|39185131|FG001|Randomized Cohort|Death|1|||
16300770|NCT02289729|39585537|FG000|Overall Study|Withdrawal by Subject|1|||
16300771|NCT02289729|39585537|FG000|Overall Study|Death|1|||
16300772|NCT01994291|39585540|FG000|Overall Study|Adverse Event|4|||
16387250|NCT01904721|39902563|FG001|Overall Study|Lack of Efficacy|0|||
16387251|NCT01904721|39902564|FG002|Overall Study|Lack of Efficacy|0|||
16192638|NCT00547378|39185132|FG002|Randomized Cohort|Death|0|||
16387252|NCT01904721|39902565|FG003|Overall Study|Lack of Efficacy|0|||
16387253|NCT01904721|39902566|FG004|Overall Study|Lack of Efficacy|0|||
16387254|NCT01904721|39902567|FG005|Overall Study|Lack of Efficacy|0|||
16387255|NCT01904721|39902568|FG006|Overall Study|Lack of Efficacy|1|||
16387256|NCT01904721|39902562|FG000|Overall Study|Adverse Event|0|||
16387257|NCT01904721|39902563|FG001|Overall Study|Adverse Event|0|||
16387258|NCT01904721|39902564|FG002|Overall Study|Adverse Event|0|||
16387259|NCT01904721|39902565|FG003|Overall Study|Adverse Event|0|||
16387260|NCT01904721|39902566|FG004|Overall Study|Adverse Event|3|||
16387261|NCT01904721|39902567|FG005|Overall Study|Adverse Event|1|||
16387262|NCT01904721|39902568|FG006|Overall Study|Adverse Event|0|||
16387263|NCT00959907|39902569|FG000|Overall Study|Protocol Violation|0|||
16387264|NCT00959907|39902570|FG001|Overall Study|Protocol Violation|1|||
16387265|NCT00959907|39902569|FG000|Overall Study|Adverse Event|1|||
16387266|NCT00959907|39902570|FG001|Overall Study|Adverse Event|0|||
16387267|NCT00959907|39902569|FG000|Overall Study|Withdrawal by Subject|2|||
16387268|NCT00959907|39902570|FG001|Overall Study|Withdrawal by Subject|0|||
16387269|NCT02254291|39902573|FG000|Overall Study|Withdrawal by Subject|0|||
16387270|NCT02254291|39902574|FG001|Overall Study|Withdrawal by Subject|3|||
16387271|NCT02254291|39902575|FG002|Overall Study|Withdrawal by Subject|1|||
16387272|NCT02254291|39902573|FG000|Overall Study|Missing follow-up information|0|||
16387273|NCT02254291|39902574|FG001|Overall Study|Missing follow-up information|0|||
16387274|NCT02254291|39902575|FG002|Overall Study|Missing follow-up information|1|||
16387275|NCT00165789|39902578|FG000|Overall Study|Adverse Event|0|||
16387276|NCT00165789|39902579|FG001|Overall Study|Adverse Event|3|||
16387277|NCT00165789|39902580|FG002|Overall Study|Adverse Event|0|||
16387278|NCT00165789|39902581|FG003|Overall Study|Adverse Event|12|||
16387279|NCT00165789|39902578|FG000|Overall Study|Withdrawal by Subject|0|||
16387280|NCT00165789|39902579|FG001|Overall Study|Withdrawal by Subject|1|||
16387281|NCT00165789|39902580|FG002|Overall Study|Withdrawal by Subject|1|||
16387282|NCT00165789|39902581|FG003|Overall Study|Withdrawal by Subject|2|||
16387283|NCT01463527|39902582|FG000|Overall Study|Protocol Violation|1|||
16387284|NCT01463527|39902583|FG001|Overall Study|Protocol Violation|1|||
16387285|NCT01463527|39902582|FG000|Overall Study|Crying >20% of sedation|5|||
16387286|NCT01463527|39902583|FG001|Overall Study|Crying >20% of sedation|6|||
16387287|NCT01082614|39902584|FG000|Overall Study|Adverse Event|1|||
16387288|NCT01082614|39902585|FG001|Overall Study|Adverse Event|4|||
16387289|NCT01082614|39902584|FG000|Overall Study|Equipment Malfunction|0|||
16387290|NCT01082614|39902585|FG001|Overall Study|Equipment Malfunction|1|||
16387291|NCT01082614|39902584|FG000|Overall Study|Physician Decision|2|||
16387292|NCT01082614|39902585|FG001|Overall Study|Physician Decision|0|||
16387293|NCT01250054|39902586|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
16387294|NCT01250054|39902587|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
16387295|NCT03289143|39902595|FG000|Overall Study|Caregiver Unavailability|1|||
16387296|NCT03289143|39902596|FG001|Overall Study|Caregiver Unavailability|1|||
16387297|NCT03289143|39902597|FG002|Overall Study|Caregiver Unavailability|0|||
16387298|NCT03289143|39902598|FG003|Overall Study|Caregiver Unavailability|0|||
16387299|NCT03289143|39902595|FG000|Overall Study|Research Department Closure|0|||
16387300|NCT03289143|39902596|FG001|Overall Study|Research Department Closure|0|||
16387301|NCT03289143|39902597|FG002|Overall Study|Research Department Closure|1|||
16387302|NCT03289143|39902598|FG003|Overall Study|Research Department Closure|0|||
16387303|NCT03289143|39902595|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
16387304|NCT03289143|39902596|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
16387305|NCT03289143|39902597|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
16387306|NCT03289143|39902598|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
16387307|NCT03289143|39902595|FG000|Overall Study|Medical Monitor Decision|1|||
16387308|NCT03289143|39902596|FG001|Overall Study|Medical Monitor Decision|0|||
16387309|NCT03289143|39902597|FG002|Overall Study|Medical Monitor Decision|0|||
16387310|NCT03289143|39902598|FG003|Overall Study|Medical Monitor Decision|0|||
16387311|NCT03289143|39902595|FG000|Overall Study|Participant Non-Compliance|0|||
16387312|NCT03289143|39902596|FG001|Overall Study|Participant Non-Compliance|0|||
16387313|NCT03289143|39902597|FG002|Overall Study|Participant Non-Compliance|1|||
16387314|NCT03289143|39902598|FG003|Overall Study|Participant Non-Compliance|0|||
16387315|NCT03289143|39902595|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
16387316|NCT03289143|39902596|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
16387317|NCT03289143|39902597|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
16387318|NCT03289143|39902598|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
16387319|NCT03289143|39902595|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
16387320|NCT03289143|39902596|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
16387321|NCT03289143|39902597|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
16387322|NCT03289143|39902598|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
16387323|NCT03289143|39902595|FG000|Overall Study|Caregiver Passed Away|1|||
16387324|NCT03289143|39902596|FG001|Overall Study|Caregiver Passed Away|0|||
16387325|NCT03289143|39902597|FG002|Overall Study|Caregiver Passed Away|0|||
16387326|NCT03289143|39902598|FG003|Overall Study|Caregiver Passed Away|0|||
16192639|NCT00547378|39185130|FG000|Randomized Cohort|Lost to Follow-up|1|||
16300773|NCT01994291|39585541|FG001|Overall Study|Adverse Event|1|||
16387327|NCT03289143|39902595|FG000|Overall Study|Physician Decision|0|||
16387328|NCT03289143|39902596|FG001|Overall Study|Physician Decision|2|||
16387329|NCT03289143|39902597|FG002|Overall Study|Physician Decision|2|||
16387330|NCT03289143|39902598|FG003|Overall Study|Physician Decision|2|||
16387331|NCT03289143|39902595|FG000|Overall Study|Protocol Deviation|2|||
16387332|NCT03289143|39902596|FG001|Overall Study|Protocol Deviation|1|||
16387333|NCT03289143|39902597|FG002|Overall Study|Protocol Deviation|3|||
16387334|NCT03289143|39902598|FG003|Overall Study|Protocol Deviation|1|||
16387335|NCT03289143|39902595|FG000|Overall Study|Study Terminated By Sponsor|101|||
16387336|NCT03289143|39902596|FG001|Overall Study|Study Terminated By Sponsor|75|||
16387337|NCT03289143|39902597|FG002|Overall Study|Study Terminated By Sponsor|100|||
16387338|NCT03289143|39902598|FG003|Overall Study|Study Terminated By Sponsor|69|||
16387339|NCT03289143|39902595|FG000|Overall Study|Withdrawal by Subject|14|||
16387340|NCT03289143|39902596|FG001|Overall Study|Withdrawal by Subject|6|||
16387341|NCT03289143|39902597|FG002|Overall Study|Withdrawal by Subject|14|||
16387342|NCT03289143|39902598|FG003|Overall Study|Withdrawal by Subject|12|||
16387343|NCT03289143|39902595|FG000|Overall Study|Adverse Event|10|||
16387344|NCT03289143|39902596|FG001|Overall Study|Adverse Event|7|||
16387345|NCT03289143|39902597|FG002|Overall Study|Adverse Event|6|||
16387346|NCT03289143|39902598|FG003|Overall Study|Adverse Event|5|||
16387347|NCT03289143|39902595|FG000|Overall Study|Death|2|||
16387348|NCT03289143|39902596|FG001|Overall Study|Death|0|||
16387349|NCT03289143|39902597|FG002|Overall Study|Death|2|||
16387350|NCT03289143|39902598|FG003|Overall Study|Death|1|||
16387351|NCT03289143|39902595|FG000|Overall Study|Lost to Follow-up|2|||
16387352|NCT03289143|39902596|FG001|Overall Study|Lost to Follow-up|1|||
16387353|NCT03289143|39902597|FG002|Overall Study|Lost to Follow-up|1|||
16387354|NCT03289143|39902598|FG003|Overall Study|Lost to Follow-up|0|||
16387355|NCT03289143|39902595|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
16387356|NCT03289143|39902596|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
16387357|NCT03289143|39902597|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
16387358|NCT03289143|39902598|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
16387359|NCT03289143|39902595|FG000|Overall Study|Withdrawal by Caregiver|0|||
16387360|NCT03289143|39902596|FG001|Overall Study|Withdrawal by Caregiver|1|||
16387361|NCT03289143|39902597|FG002|Overall Study|Withdrawal by Caregiver|0|||
16387362|NCT03289143|39902598|FG003|Overall Study|Withdrawal by Caregiver|0|||
16387363|NCT03289143|39902595|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
16387364|NCT03289143|39902596|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
16300774|NCT01994291|39585542|FG002|Overall Study|Adverse Event|3|||
16300775|NCT01994291|39585540|FG000|Overall Study|Lost to Follow-up|1|||
16300776|NCT01994291|39585541|FG001|Overall Study|Lost to Follow-up|1|||
16387365|NCT03289143|39902597|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
16490347|NCT03766581|40270269|FG005|Randomization|Participant withdrew consent|1|||
16300777|NCT01994291|39585542|FG002|Overall Study|Lost to Follow-up|0|||
16300778|NCT01994291|39585540|FG000|Overall Study|Does not meet entrance criteria|1|||
16300779|NCT01994291|39585541|FG001|Overall Study|Does not meet entrance criteria|0|||
16300780|NCT01994291|39585542|FG002|Overall Study|Does not meet entrance criteria|0|||
16300781|NCT01994291|39585540|FG000|Overall Study|Medication error without associated AE|1|||
16300782|NCT01994291|39585541|FG001|Overall Study|Medication error without associated AE|0|||
16300783|NCT01994291|39585542|FG002|Overall Study|Medication error without associated AE|1|||
16300784|NCT01994291|39585540|FG000|Overall Study|Protocol Violation|1|||
16300785|NCT01994291|39585541|FG001|Overall Study|Protocol Violation|0|||
16300786|NCT01994291|39585542|FG002|Overall Study|Protocol Violation|0|||
16300787|NCT01994291|39585540|FG000|Overall Study|Withdrawal by Subject|6|||
16300788|NCT01994291|39585541|FG001|Overall Study|Withdrawal by Subject|3|||
16300789|NCT01994291|39585542|FG002|Overall Study|Withdrawal by Subject|5|||
16300790|NCT01994291|39585540|FG000|Overall Study|Other|1|||
16300791|NCT01994291|39585541|FG001|Overall Study|Other|2|||
16300792|NCT01994291|39585542|FG002|Overall Study|Other|0|||
16300793|NCT02564887|39585543|FG000|Overall Study|Lost to Follow-up|6|||
16300794|NCT02564887|39585544|FG001|Overall Study|Lost to Follow-up|0|||
16300795|NCT00554190|39585547|FG000|Overall Study|Termination forms not completed|10|||
16300796|NCT02123446|39585548|FG000|Washout Period (1 Day)|Physician Decision|1|||
16300797|NCT02123446|39585549|FG001|Washout Period (1 Day)|Physician Decision|0|||
16300798|NCT00576316|39585552|FG000|Overall Study|Adverse Event|9|||
16387366|NCT03289143|39902598|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
16387367|NCT03289143|39902595|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
16387368|NCT03289143|39902596|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
16490348|NCT03766581|40270270|FG006|Randomization|Participant withdrew consent|0|||
16490349|NCT03766581|40270271|FG007|Randomization|Participant withdrew consent|0|||
16490350|NCT03766581|40270264|FG000|Treatment|Adverse Event|82|||
16300799|NCT00576316|39585552|FG000|Overall Study|Withdrawal by Subject|2|||
16300800|NCT00576316|39585552|FG000|Overall Study|Protocol Violation|9|||
16387369|NCT03289143|39902597|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
16387370|NCT03289143|39902598|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
16387371|NCT01276106|39902600|FG000|Overall Study|Adverse Event|3|||
16387372|NCT01276106|39902601|FG001|Overall Study|Adverse Event|3|||
16387373|NCT01276106|39902602|FG002|Overall Study|Adverse Event|11|||
16387374|NCT01276106|39902603|FG003|Overall Study|Adverse Event|3|||
16387375|NCT01276106|39902600|FG000|Overall Study|Withdrawal by Subject|6|||
16387376|NCT01276106|39902601|FG001|Overall Study|Withdrawal by Subject|3|||
16387377|NCT01276106|39902602|FG002|Overall Study|Withdrawal by Subject|1|||
16387378|NCT01276106|39902603|FG003|Overall Study|Withdrawal by Subject|6|||
16387379|NCT01276106|39902600|FG000|Overall Study|Lack of Efficacy|0|||
16387380|NCT01276106|39902601|FG001|Overall Study|Lack of Efficacy|1|||
16387381|NCT01276106|39902602|FG002|Overall Study|Lack of Efficacy|0|||
16387382|NCT01276106|39902603|FG003|Overall Study|Lack of Efficacy|1|||
16387383|NCT01276106|39902600|FG000|Overall Study|Lost to Follow-up|2|||
16387384|NCT01276106|39902601|FG001|Overall Study|Lost to Follow-up|1|||
16387385|NCT01276106|39902602|FG002|Overall Study|Lost to Follow-up|1|||
16387386|NCT01276106|39902603|FG003|Overall Study|Lost to Follow-up|0|||
16387387|NCT01276106|39902600|FG000|Overall Study|Physician Decision|0|||
16387388|NCT01276106|39902601|FG001|Overall Study|Physician Decision|0|||
16387389|NCT01276106|39902602|FG002|Overall Study|Physician Decision|1|||
16387390|NCT01276106|39902603|FG003|Overall Study|Physician Decision|1|||
16387391|NCT01276106|39902600|FG000|Overall Study|Protocol Violation|1|||
16387392|NCT01276106|39902601|FG001|Overall Study|Protocol Violation|1|||
16387393|NCT01276106|39902602|FG002|Overall Study|Protocol Violation|0|||
16387394|NCT01276106|39902603|FG003|Overall Study|Protocol Violation|2|||
16387395|NCT01276106|39902600|FG000|Overall Study|Insufficient therapeutic effects|0|||
16387396|NCT01276106|39902601|FG001|Overall Study|Insufficient therapeutic effects|0|||
16387397|NCT01276106|39902602|FG002|Overall Study|Insufficient therapeutic effects|2|||
16387398|NCT01276106|39902603|FG003|Overall Study|Insufficient therapeutic effects|0|||
16387399|NCT02897115|39902604|FG000|Overall Study|Early termination of study by sponsor|11|||
16387400|NCT02897115|39902605|FG001|Overall Study|Early termination of study by sponsor|8|||
16387401|NCT01816295|39902606|FG000|Double Blind Phase|Adverse Event|11|||
16387402|NCT01816295|39902607|FG001|Double Blind Phase|Adverse Event|8|||
16387403|NCT01816295|39902606|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
16387404|NCT01816295|39902607|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
16387405|NCT01816295|39902606|FG000|Double Blind Phase|Lost to Follow-up|3|||
16300801|NCT01145508|39585553|FG000|Overall Study|Adverse Event|1|||
16300802|NCT01145508|39585554|FG001|Overall Study|Adverse Event|0|||
16300803|NCT01145508|39585553|FG000|Overall Study|Death|1|||
16300804|NCT01145508|39585554|FG001|Overall Study|Death|0|||
16300805|NCT01145508|39585553|FG000|Overall Study|Physician Decision|2|||
16300806|NCT01145508|39585554|FG001|Overall Study|Physician Decision|1|||
16300807|NCT01145508|39585553|FG000|Overall Study|Never started treatment|1|||
16300808|NCT01145508|39585554|FG001|Overall Study|Never started treatment|1|||
16300809|NCT01087489|39585555|FG000|Overall Study|enrolled in another VA study|0|||
16300810|NCT01087489|39585556|FG001|Overall Study|enrolled in another VA study|1|||
16300811|NCT01087489|39585555|FG000|Overall Study|Death|0|||
16300812|NCT01087489|39585556|FG001|Overall Study|Death|1|||
16300813|NCT01087489|39585555|FG000|Overall Study|unable to survey by telephone|0|||
16300814|NCT01087489|39585556|FG001|Overall Study|unable to survey by telephone|1|||
16300815|NCT01822366|39585557|FG000|Overall Study|Lost to Follow-up|5|||
16300816|NCT01822366|39585558|FG001|Overall Study|Lost to Follow-up|1|||
16300817|NCT01822366|39585559|FG002|Overall Study|Lost to Follow-up|5|||
16300818|NCT01822366|39585560|FG003|Overall Study|Lost to Follow-up|1|||
16300819|NCT01822366|39585557|FG000|Overall Study|Withdrawal by Subject|0|||
16300820|NCT01822366|39585558|FG001|Overall Study|Withdrawal by Subject|6|||
16387406|NCT01816295|39902607|FG001|Double Blind Phase|Lost to Follow-up|5|||
16387407|NCT01816295|39902606|FG000|Double Blind Phase|Physician Decision|2|||
16387408|NCT01816295|39902607|FG001|Double Blind Phase|Physician Decision|2|||
16387409|NCT01816295|39902606|FG000|Double Blind Phase|Protocol Violation|17|||
16387410|NCT01816295|39902607|FG001|Double Blind Phase|Protocol Violation|11|||
16300821|NCT01822366|39585559|FG002|Overall Study|Withdrawal by Subject|0|||
16387411|NCT01816295|39902606|FG000|Double Blind Phase|Sponsor Decision|8|||
16387412|NCT01816295|39902607|FG001|Double Blind Phase|Sponsor Decision|8|||
16387413|NCT01816295|39902606|FG000|Double Blind Phase|Withdrawal by Subject|22|||
16387414|NCT01816295|39902607|FG001|Double Blind Phase|Withdrawal by Subject|20|||
16387415|NCT01816295|39902606|FG000|OLE Phase|Adverse Event|17|||
16387416|NCT01816295|39902607|FG001|OLE Phase|Adverse Event|15|||
16387417|NCT01816295|39902606|FG000|OLE Phase|Death|1|||
16387418|NCT01816295|39902607|FG001|OLE Phase|Death|0|||
16387419|NCT01816295|39902606|FG000|OLE Phase|Entry Criteria Not Met|3|||
16387420|NCT01816295|39902607|FG001|OLE Phase|Entry Criteria Not Met|5|||
16387421|NCT01816295|39902606|FG000|OLE Phase|Lost to Follow-up|5|||
16387422|NCT01816295|39902607|FG001|OLE Phase|Lost to Follow-up|5|||
16387423|NCT01816295|39902606|FG000|OLE Phase|Physician Decision|3|||
16387424|NCT01816295|39902607|FG001|OLE Phase|Physician Decision|1|||
16387425|NCT01816295|39902606|FG000|OLE Phase|Protocol Violation|4|||
16387426|NCT01816295|39902607|FG001|OLE Phase|Protocol Violation|4|||
16387427|NCT01816295|39902606|FG000|OLE Phase|Sponsor Decision|7|||
16300822|NCT01822366|39585560|FG003|Overall Study|Withdrawal by Subject|6|||
16300823|NCT01822366|39585557|FG000|Overall Study|Partial Intervention Completion|0|||
16300824|NCT01822366|39585558|FG001|Overall Study|Partial Intervention Completion|15|||
16300825|NCT01822366|39585559|FG002|Overall Study|Partial Intervention Completion|0|||
16300826|NCT01822366|39585560|FG003|Overall Study|Partial Intervention Completion|15|||
16300827|NCT03694327|39585561|FG000|Overall Study|Lost to Follow-up|13|||
16300828|NCT03694327|39585562|FG001|Overall Study|Lost to Follow-up|23|||
16300829|NCT01941498|39585563|FG000|Overall Study|Relocated out of state|1|||
16300830|NCT04386616|39585564|FG000|Overall Study|Death|22|||
16300831|NCT04386616|39585565|FG001|Overall Study|Death|22|||
16300832|NCT04386616|39585566|FG002|Overall Study|Death|21|||
16300833|NCT04386616|39585564|FG000|Overall Study|Lost to Follow-up|5|||
16300834|NCT04386616|39585565|FG001|Overall Study|Lost to Follow-up|8|||
16300835|NCT04386616|39585566|FG002|Overall Study|Lost to Follow-up|6|||
16300836|NCT04386616|39585564|FG000|Overall Study|Withdrawal by Subject|2|||
16300837|NCT04386616|39585565|FG001|Overall Study|Withdrawal by Subject|4|||
16300838|NCT04386616|39585566|FG002|Overall Study|Withdrawal by Subject|1|||
16300839|NCT04386616|39585564|FG000|Overall Study|Adverse Event|1|||
16300840|NCT04386616|39585565|FG001|Overall Study|Adverse Event|1|||
16300841|NCT04386616|39585566|FG002|Overall Study|Adverse Event|0|||
16300842|NCT05022212|39585567|FG000|Overall Study|Lost to Follow-up|0|||
16300843|NCT05022212|39585568|FG001|Overall Study|Lost to Follow-up|2|||
16300844|NCT00796107|39585569|FG000|Overall Study|Lack of Efficacy|1|||
16300845|NCT00796107|39585569|FG000|Overall Study|Progressive Disease|5|||
16300846|NCT00811928|39585577|FG000|Overall Study|AEs and SAEs Including Death|7|||
16300847|NCT00811928|39585578|FG001|Overall Study|AEs and SAEs Including Death|11|||
16300848|NCT00811928|39585577|FG000|Overall Study|Withdrawal by Subject|18|||
16300849|NCT00811928|39585578|FG001|Overall Study|Withdrawal by Subject|12|||
16300850|NCT00811928|39585577|FG000|Overall Study|Did Not Take Study Drug|3|||
16300851|NCT00811928|39585578|FG001|Overall Study|Did Not Take Study Drug|0|||
16300852|NCT00811928|39585577|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
16300853|NCT00811928|39585578|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
16300854|NCT00811928|39585577|FG000|Overall Study|Investigator Decision|2|||
16300855|NCT00811928|39585578|FG001|Overall Study|Investigator Decision|1|||
16300856|NCT00811928|39585577|FG000|Overall Study|Poor Compliance|2|||
16300857|NCT00811928|39585578|FG001|Overall Study|Poor Compliance|5|||
16300858|NCT02542605|39585579|FG000|Part B: Challenge Phase|Sponsor decision|1|||
16300859|NCT02542605|39585580|FG001|Part B: Challenge Phase|Sponsor decision|0|||
16300860|NCT02542605|39585581|FG002|Part B: Challenge Phase|Sponsor decision|0|||
16300861|NCT02542605|39585579|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
16300862|NCT02542605|39585580|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
16300863|NCT02542605|39585581|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
16300864|NCT02114385|39585584|FG000|Overall Study|Withdrawal by Subject|3|||
16300865|NCT02114385|39585585|FG001|Overall Study|Withdrawal by Subject|2|||
16300866|NCT02114385|39585584|FG000|Overall Study|Lost to Follow-up|0|||
16300867|NCT02114385|39585585|FG001|Overall Study|Lost to Follow-up|6|||
16300868|NCT01590797|39585590|FG000|Overall Study|Adverse Event|4|||
16300869|NCT01590797|39585591|FG001|Overall Study|Adverse Event|3|||
16300870|NCT01590797|39585590|FG000|Overall Study|Lack of Efficacy|0|||
16300871|NCT01590797|39585591|FG001|Overall Study|Lack of Efficacy|2|||
16300872|NCT01590797|39585590|FG000|Overall Study|Lost to Follow-up|0|||
16387428|NCT01816295|39902607|FG001|OLE Phase|Sponsor Decision|9|||
16387429|NCT01816295|39902606|FG000|OLE Phase|Withdrawal by Subject|10|||
16083869|NCT00676091|38799230|FG001|Infant Series|Lost to Follow-up|0|||
16300873|NCT01590797|39585591|FG001|Overall Study|Lost to Follow-up|1|||
16300874|NCT01590797|39585590|FG000|Overall Study|Protocol Violation|4|||
16300875|NCT01590797|39585591|FG001|Overall Study|Protocol Violation|1|||
16300876|NCT01590797|39585590|FG000|Overall Study|Withdrawal by Subject|7|||
16300877|NCT01590797|39585591|FG001|Overall Study|Withdrawal by Subject|5|||
16387430|NCT01816295|39902607|FG001|OLE Phase|Withdrawal by Subject|10|||
16387431|NCT01816295|39902606|FG000|OLE Phase|Lack of Efficacy|3|||
16387432|NCT01816295|39902607|FG001|OLE Phase|Lack of Efficacy|7|||
16387433|NCT02639390|39902612|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
16387434|NCT02639390|39902613|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
16387435|NCT01342926|39902619|FG000|Overall Study|Adverse Event|5|||
16387436|NCT01342926|39902620|FG001|Overall Study|Adverse Event|8|||
16387437|NCT01342926|39902621|FG002|Overall Study|Adverse Event|10|||
16387438|NCT01342926|39902622|FG003|Overall Study|Adverse Event|7|||
16387439|NCT01342926|39902619|FG000|Overall Study|Lost to Follow-up|0|||
16387440|NCT01342926|39902620|FG001|Overall Study|Lost to Follow-up|1|||
16387441|NCT01342926|39902621|FG002|Overall Study|Lost to Follow-up|1|||
16387442|NCT01342926|39902622|FG003|Overall Study|Lost to Follow-up|0|||
16387443|NCT01342926|39902619|FG000|Overall Study|Investigator Discretion|2|||
16387444|NCT01342926|39902620|FG001|Overall Study|Investigator Discretion|2|||
16387445|NCT01342926|39902621|FG002|Overall Study|Investigator Discretion|0|||
16387446|NCT01342926|39902622|FG003|Overall Study|Investigator Discretion|0|||
16387447|NCT01342926|39902619|FG000|Overall Study|Withdrawal by Subject|2|||
16387448|NCT01342926|39902620|FG001|Overall Study|Withdrawal by Subject|4|||
16300878|NCT01590797|39585590|FG000|Overall Study|Other Protocol Specified Criteria|2|||
16300879|NCT01590797|39585591|FG001|Overall Study|Other Protocol Specified Criteria|4|||
16300880|NCT03700385|39585593|FG000|Overall Study|Lost to Follow-up|1|||
16300881|NCT02695537|39585594|FG000|Overall Study|Adverse Event|3|||
16300882|NCT02695537|39585594|FG000|Overall Study|Lack of Efficacy|28|||
16387449|NCT01342926|39902621|FG002|Overall Study|Withdrawal by Subject|3|||
16387450|NCT01342926|39902622|FG003|Overall Study|Withdrawal by Subject|5|||
16300883|NCT02695537|39585594|FG000|Overall Study|Withdrawal by Subject|4|||
16300884|NCT02695537|39585594|FG000|Overall Study|Protocol Violation|3|||
16300885|NCT00926783|39585609|FG000|Overall Study|Incomplete CFAE Procedures|3|||
16300886|NCT00926783|39585610|FG001|Overall Study|Incomplete CFAE Procedures|3|||
16300887|NCT00952731|39585611|FG000|Overall Study|Drug supply expired|1|||
16300888|NCT00952731|39585612|FG001|Overall Study|Drug supply expired|0|||
16300889|NCT00340678|39585613|FG000|Overall Study|Lost to Follow-up|1|||
16300890|NCT00340678|39585614|FG001|Overall Study|Lost to Follow-up|0|||
16300891|NCT00340678|39585615|FG002|Overall Study|Lost to Follow-up|0|||
16300892|NCT00340678|39585616|FG003|Overall Study|Lost to Follow-up|0|||
16300893|NCT01141205|39585617|FG000|Overall Study|Physician Decision|1|||
16300894|NCT01141205|39585618|FG001|Overall Study|Physician Decision|1|||
16300895|NCT01141205|39585617|FG000|Overall Study|Lost to Follow-up|1|||
16300896|NCT01141205|39585618|FG001|Overall Study|Lost to Follow-up|0|||
16300897|NCT01141205|39585617|FG000|Overall Study|Withdrawal by Subject|1|||
16300898|NCT01141205|39585618|FG001|Overall Study|Withdrawal by Subject|1|||
16300899|NCT00426361|39585620|FG000|Overall Study|Lost to Follow-up|3|||
16300900|NCT00426361|39585621|FG001|Overall Study|Lost to Follow-up|2|||
16300901|NCT00426361|39585622|FG002|Overall Study|Lost to Follow-up|5|||
16300902|NCT00426361|39585620|FG000|Overall Study|Withdrawal by Subject|1|||
16300903|NCT00426361|39585621|FG001|Overall Study|Withdrawal by Subject|3|||
16300904|NCT00426361|39585622|FG002|Overall Study|Withdrawal by Subject|0|||
16300905|NCT05314816|39585624|FG000|Overall Study|Lost to Follow-up|5|||
16300906|NCT05314816|39585625|FG001|Overall Study|Lost to Follow-up|0|||
16300907|NCT05314816|39585626|FG002|Overall Study|Lost to Follow-up|1|||
16300908|NCT05314816|39585624|FG000|Overall Study|Protocol Violation|13|||
16300909|NCT05314816|39585625|FG001|Overall Study|Protocol Violation|8|||
16300910|NCT05314816|39585626|FG002|Overall Study|Protocol Violation|0|||
16300911|NCT01954745|39585633|FG000|Overall Study|Radiological Progression|11|||
16300912|NCT01954745|39585633|FG000|Overall Study|Clinical Progression|5|||
16387451|NCT01192126|39902626|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
16300913|NCT01954745|39585633|FG000|Overall Study|Adverse Event|2|||
16300914|NCT01954745|39585633|FG000|Overall Study|Death|1|||
16300915|NCT00442962|39585634|FG000|Overall Study|Pregnancy|1|||
16490351|NCT03766581|40270265|FG001|Treatment|Adverse Event|44|||
16387452|NCT01192126|39902627|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
16387453|NCT01192126|39902626|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
16387454|NCT01192126|39902627|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
16387455|NCT02230189|39902628|FG000|Overall Study|Withdrawal by Subject|3|||
16387456|NCT02230189|39902629|FG001|Overall Study|Withdrawal by Subject|0|||
16387457|NCT02230189|39902630|FG002|Overall Study|Withdrawal by Subject|1|||
16387458|NCT02230189|39902628|FG000|Overall Study|Lost to Follow-up|1|||
16387459|NCT02230189|39902629|FG001|Overall Study|Lost to Follow-up|0|||
16300916|NCT00442962|39585634|FG000|Overall Study|Lost to Follow-up|7|||
16300917|NCT02068092|39585638|FG000|Overall Study|Physician Decision|2|||
16300918|NCT02068092|39585638|FG000|Overall Study|Adverse Event|2|||
16300919|NCT02068092|39585638|FG000|Overall Study|Lost to Follow-up|4|||
16300920|NCT02068092|39585638|FG000|Overall Study|Withdrawal by Subject|2|||
16300921|NCT01449812|39585639|FG000|Overall Study|Migrated/moved from study area|1|||
16300922|NCT01449812|39585640|FG001|Overall Study|Migrated/moved from study area|0|||
16300923|NCT01449812|39585641|FG002|Overall Study|Migrated/moved from study area|0|||
16387460|NCT02230189|39902630|FG002|Overall Study|Lost to Follow-up|0|||
16387461|NCT02230189|39902628|FG000|Overall Study|Physician Decision|1|||
16387462|NCT02230189|39902629|FG001|Overall Study|Physician Decision|0|||
16387463|NCT02230189|39902630|FG002|Overall Study|Physician Decision|0|||
16387464|NCT04834726|39902634|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
16387465|NCT04834726|39902635|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
16387466|NCT04834726|39902636|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
16387467|NCT04834726|39902637|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
16387468|NCT04834726|39902638|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
16387469|NCT04834726|39902639|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
16387470|NCT04834726|39902640|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
16387471|NCT04834726|39902641|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
16387472|NCT04834726|39902642|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
16387473|NCT00066690|39902643|FG000|Overall Study|Adverse Event|145|||
16387474|NCT00066690|39902644|FG001|Overall Study|Adverse Event|58|||
16387475|NCT00066690|39902645|FG002|Overall Study|Adverse Event|126|||
16387476|NCT00066690|39902643|FG000|Overall Study|Death|3|||
16387477|NCT00066690|39902644|FG001|Overall Study|Death|0|||
16387478|NCT00066690|39902645|FG002|Overall Study|Death|2|||
16387479|NCT00066690|39902643|FG000|Overall Study|Lack of Efficacy|114|||
16387480|NCT00066690|39902644|FG001|Overall Study|Lack of Efficacy|110|||
16387481|NCT00066690|39902645|FG002|Overall Study|Lack of Efficacy|76|||
16387482|NCT00066690|39902643|FG000|Overall Study|Lost to Follow-up|40|||
16387483|NCT00066690|39902644|FG001|Overall Study|Lost to Follow-up|21|||
16387484|NCT00066690|39902645|FG002|Overall Study|Lost to Follow-up|29|||
16387485|NCT00066690|39902643|FG000|Overall Study|Withdrawal by Subject|50|||
16387486|NCT00066690|39902644|FG001|Overall Study|Withdrawal by Subject|55|||
16387487|NCT00066690|39902645|FG002|Overall Study|Withdrawal by Subject|49|||
16387488|NCT00066690|39902643|FG000|Overall Study|Treatment Ongoing|246|||
16387489|NCT00066690|39902644|FG001|Overall Study|Treatment Ongoing|278|||
16387490|NCT00066690|39902645|FG002|Overall Study|Treatment Ongoing|282|||
16387491|NCT01840943|39902646|FG000|Overall Study|Withdrawal by Subject|5|||
16387492|NCT01840943|39902647|FG001|Overall Study|Withdrawal by Subject|6|||
16387493|NCT01840943|39902646|FG000|Overall Study|Physician Decision|4|||
16387494|NCT01840943|39902647|FG001|Overall Study|Physician Decision|2|||
16387495|NCT01840943|39902646|FG000|Overall Study|Lost to Follow-up|4|||
16387496|NCT01840943|39902647|FG001|Overall Study|Lost to Follow-up|4|||
16387497|NCT01788943|39902648|FG000|Overall Study|Withdrawal by Subject|1|||
16387498|NCT01788943|39902649|FG001|Overall Study|Withdrawal by Subject|0|||
16387499|NCT03092479|39902650|FG000|Overall Study|Lost to Follow-up|3|||
16387500|NCT03092479|39902651|FG001|Overall Study|Lost to Follow-up|2|||
16387501|NCT03092479|39902650|FG000|Overall Study|Withdrawal by Subject|4|||
16387502|NCT03092479|39902651|FG001|Overall Study|Withdrawal by Subject|0|||
16387503|NCT03423602|39902656|FG000|Overall Study|Death|1|||
16387504|NCT03423602|39902656|FG000|Overall Study|Lost to Follow-up|6|||
16387505|NCT03423602|39902656|FG000|Overall Study|Protocol Violation|1|||
16387506|NCT03423602|39902656|FG000|Overall Study|Withdrawal by Subject|4|||
16387507|NCT03218917|39902657|FG000|Overall Study|Adverse Event|3|||
16387508|NCT03218917|39902658|FG001|Overall Study|Adverse Event|3|||
16387509|NCT03218917|39902659|FG002|Overall Study|Adverse Event|2|||
16387510|NCT03218917|39902657|FG000|Overall Study|Subject withdrew consent|2|||
16387511|NCT03218917|39902658|FG001|Overall Study|Subject withdrew consent|4|||
16387512|NCT03218917|39902659|FG002|Overall Study|Subject withdrew consent|10|||
16387513|NCT03218917|39902657|FG000|Overall Study|Physician Decision|0|||
16387514|NCT03218917|39902658|FG001|Overall Study|Physician Decision|1|||
16387515|NCT03218917|39902659|FG002|Overall Study|Physician Decision|1|||
16387516|NCT03218917|39902657|FG000|Overall Study|Lost to Follow-up|1|||
16387517|NCT03218917|39902658|FG001|Overall Study|Lost to Follow-up|0|||
16387518|NCT03218917|39902659|FG002|Overall Study|Lost to Follow-up|0|||
16387519|NCT03218917|39902657|FG000|Overall Study|Reason Missing|0|||
16387520|NCT03218917|39902658|FG001|Overall Study|Reason Missing|2|||
16387521|NCT03218917|39902659|FG002|Overall Study|Reason Missing|0|||
16387522|NCT03218917|39902657|FG000|Overall Study|Death|0|||
16387523|NCT03218917|39902658|FG001|Overall Study|Death|1|||
16387524|NCT03218917|39902659|FG002|Overall Study|Death|0|||
16387525|NCT03218917|39902657|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16387526|NCT03218917|39902658|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16387527|NCT03218917|39902659|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16387528|NCT03110029|39902660|FG000|Overall Study|Withdrawal by Subject|1|||
16387529|NCT03110029|39902661|FG001|Overall Study|Withdrawal by Subject|1|||
16387530|NCT01088503|39902664|FG000|Overall Study|Withdrawal by Subject|118|||
16387531|NCT01088503|39902665|FG001|Overall Study|Withdrawal by Subject|327|||
16387532|NCT01088503|39902666|FG002|Overall Study|Withdrawal by Subject|10|||
16387533|NCT01088503|39902664|FG000|Overall Study|Death|64|||
16387534|NCT01088503|39902665|FG001|Overall Study|Death|358|||
16387535|NCT01088503|39902666|FG002|Overall Study|Death|7|||
16387536|NCT00560508|39902667|FG000|12 Week Double-blind Period|Adverse Event|3|||
16387537|NCT00560508|39902668|FG001|12 Week Double-blind Period|Adverse Event|2|||
16387538|NCT00560508|39902667|FG000|12 Week Double-blind Period|Protocol Violation|1|||
16387539|NCT00560508|39902668|FG001|12 Week Double-blind Period|Protocol Violation|0|||
16387540|NCT00560508|39902667|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
16387541|NCT00560508|39902668|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
16387542|NCT00560508|39902667|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
16387543|NCT00560508|39902668|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
16387544|NCT00560508|39902667|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
16387545|NCT00560508|39902668|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
16387546|NCT00560508|39902667|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
16387547|NCT00560508|39902668|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
16387548|NCT00560508|39902667|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
16387549|NCT00560508|39902668|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
16387550|NCT01076010|39902669|FG000|Overall Study|Death|15|||
16387551|NCT01076010|39902670|FG001|Overall Study|Death|1|||
16387552|NCT01076010|39902671|FG002|Overall Study|Death|0|||
16387553|NCT01076010|39902669|FG000|Overall Study|Adverse Event|7|||
16387554|NCT01076010|39902670|FG001|Overall Study|Adverse Event|2|||
16387555|NCT01076010|39902671|FG002|Overall Study|Adverse Event|0|||
16387556|NCT01076010|39902669|FG000|Overall Study|Progressive disease|90|||
16387557|NCT01076010|39902670|FG001|Overall Study|Progressive disease|30|||
16387558|NCT01076010|39902671|FG002|Overall Study|Progressive disease|1|||
16387559|NCT01076010|39902669|FG000|Overall Study|Lack of Efficacy|4|||
16300924|NCT01449812|39585639|FG000|Overall Study|Withdrawal by Subject|0|||
16300925|NCT01449812|39585640|FG001|Overall Study|Withdrawal by Subject|0|||
16300926|NCT01449812|39585641|FG002|Overall Study|Withdrawal by Subject|1|||
16300927|NCT01449812|39585639|FG000|Overall Study|Lost to Follow-up|1|||
16300928|NCT01449812|39585640|FG001|Overall Study|Lost to Follow-up|0|||
16300929|NCT01449812|39585641|FG002|Overall Study|Lost to Follow-up|0|||
16300930|NCT04480021|39585647|FG000|Overall Study|Lost to Follow-up|3|||
16387560|NCT01076010|39902670|FG001|Overall Study|Lack of Efficacy|0|||
16387561|NCT01076010|39902671|FG002|Overall Study|Lack of Efficacy|0|||
16490352|NCT03766581|40270266|FG002|Treatment|Adverse Event|47|||
16192640|NCT00547378|39185131|FG001|Randomized Cohort|Lost to Follow-up|0|||
16192641|NCT00547378|39185132|FG002|Randomized Cohort|Lost to Follow-up|0|||
16192642|NCT00547378|39185130|FG000|Randomized Cohort|Adverse Event|1|||
16192643|NCT00547378|39185131|FG001|Randomized Cohort|Adverse Event|0|||
16192644|NCT00547378|39185132|FG002|Randomized Cohort|Adverse Event|0|||
16192645|NCT00547378|39185130|FG000|Randomized Cohort|Other reasons|2|||
16192646|NCT00547378|39185131|FG001|Randomized Cohort|Other reasons|0|||
16192647|NCT00547378|39185132|FG002|Randomized Cohort|Other reasons|0|||
16192648|NCT00547378|39185130|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
16192649|NCT00547378|39185131|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
16192650|NCT00547378|39185132|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
16192651|NCT00547378|39185130|FG000|All Implanted Cohort|Adverse Event|4|||
16192652|NCT00547378|39185131|FG001|All Implanted Cohort|Adverse Event|10|||
16300931|NCT04480021|39585648|FG001|Overall Study|Lost to Follow-up|4|||
16300932|NCT03893565|39585653|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
16300933|NCT03893565|39585654|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
16300934|NCT03893565|39585655|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
16387562|NCT01076010|39902669|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
16387563|NCT01076010|39902670|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
16387564|NCT01076010|39902671|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
16387565|NCT01076010|39902669|FG000|Overall Study|Significant Surgical Procedure|0|||
16387566|NCT01076010|39902670|FG001|Overall Study|Significant Surgical Procedure|1|||
16387567|NCT01076010|39902671|FG002|Overall Study|Significant Surgical Procedure|0|||
16387568|NCT01076010|39902669|FG000|Overall Study|Protocol Violation|0|||
16192653|NCT00547378|39185132|FG002|All Implanted Cohort|Adverse Event|17|||
16192654|NCT00547378|39185130|FG000|All Implanted Cohort|Lost to Follow-up|0|||
16192655|NCT00547378|39185131|FG001|All Implanted Cohort|Lost to Follow-up|1|||
16192656|NCT00547378|39185132|FG002|All Implanted Cohort|Lost to Follow-up|14|||
16192657|NCT00547378|39185130|FG000|All Implanted Cohort|Death|3|||
16192658|NCT00547378|39185131|FG001|All Implanted Cohort|Death|1|||
16192659|NCT00547378|39185132|FG002|All Implanted Cohort|Death|4|||
16192660|NCT00547378|39185130|FG000|All Implanted Cohort|Physician Decision|0|||
16192661|NCT00547378|39185131|FG001|All Implanted Cohort|Physician Decision|2|||
16192662|NCT00547378|39185132|FG002|All Implanted Cohort|Physician Decision|6|||
16192663|NCT00547378|39185130|FG000|All Implanted Cohort|Site closure|2|||
16192664|NCT00547378|39185131|FG001|All Implanted Cohort|Site closure|0|||
16192665|NCT00547378|39185132|FG002|All Implanted Cohort|Site closure|1|||
16192666|NCT00547378|39185130|FG000|All Implanted Cohort|Other reasons|1|||
16192667|NCT00547378|39185131|FG001|All Implanted Cohort|Other reasons|0|||
16192668|NCT00547378|39185132|FG002|All Implanted Cohort|Other reasons|1|||
16192669|NCT02935634|39185136|FG000|Randomization|Participant withdrew consent|0|||
16192670|NCT02935634|39185137|FG001|Randomization|Participant withdrew consent|1|||
16192671|NCT02935634|39185138|FG002|Randomization|Participant withdrew consent|0|||
16192672|NCT02935634|39185139|FG003|Randomization|Participant withdrew consent|0|||
16192673|NCT02935634|39185140|FG004|Randomization|Participant withdrew consent|0|||
16192674|NCT02935634|39185141|FG005|Randomization|Participant withdrew consent|0|||
16192675|NCT02935634|39185136|FG000|Randomization|Death|2|||
16192676|NCT02935634|39185137|FG001|Randomization|Death|1|||
16192677|NCT02935634|39185138|FG002|Randomization|Death|1|||
16192678|NCT02935634|39185139|FG003|Randomization|Death|0|||
16192679|NCT02935634|39185140|FG004|Randomization|Death|0|||
16192680|NCT02935634|39185141|FG005|Randomization|Death|0|||
16192681|NCT02935634|39185136|FG000|Randomization|Other reasons|0|||
16192682|NCT02935634|39185137|FG001|Randomization|Other reasons|2|||
16192683|NCT02935634|39185138|FG002|Randomization|Other reasons|2|||
16192684|NCT02935634|39185139|FG003|Randomization|Other reasons|0|||
16192685|NCT02935634|39185140|FG004|Randomization|Other reasons|0|||
16192686|NCT02935634|39185141|FG005|Randomization|Other reasons|0|||
16192687|NCT02935634|39185136|FG000|Treatment: Track 1|Disease progression|15|||
16192688|NCT02935634|39185137|FG001|Treatment: Track 1|Disease progression|17|||
16192689|NCT02935634|39185138|FG002|Treatment: Track 1|Disease progression|28|||
16192690|NCT02935634|39185139|FG003|Treatment: Track 1|Disease progression|4|||
16192691|NCT02935634|39185140|FG004|Treatment: Track 1|Disease progression|6|||
16300935|NCT03893565|39585656|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
16300936|NCT03893565|39585657|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
16300937|NCT03893565|39585658|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
16300938|NCT03893565|39585659|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
16300939|NCT03893565|39585660|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
16300940|NCT03893565|39585661|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
16300941|NCT03893565|39585653|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
16300942|NCT03893565|39585654|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
16300943|NCT03893565|39585655|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
16300944|NCT03893565|39585656|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
16300945|NCT03893565|39585657|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
16300946|NCT03893565|39585658|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
16300947|NCT03893565|39585659|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
16300948|NCT03893565|39585660|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
16300949|NCT03893565|39585661|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
16300950|NCT03893565|39585653|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16300951|NCT03893565|39585654|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
16300952|NCT03893565|39585655|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16300953|NCT03893565|39585656|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
16300954|NCT03893565|39585657|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16192692|NCT02935634|39185141|FG005|Treatment: Track 1|Disease progression|2|||
16192693|NCT02935634|39185136|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
16192694|NCT02935634|39185137|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
16192695|NCT02935634|39185138|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
16192696|NCT02935634|39185139|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
16192697|NCT02935634|39185140|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
16192698|NCT02935634|39185141|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
16192699|NCT02935634|39185136|FG000|Treatment: Track 1|Lost to Follow-up|1|||
16192700|NCT02935634|39185137|FG001|Treatment: Track 1|Lost to Follow-up|0|||
16192701|NCT02935634|39185138|FG002|Treatment: Track 1|Lost to Follow-up|0|||
16192702|NCT02935634|39185139|FG003|Treatment: Track 1|Lost to Follow-up|0|||
16192703|NCT02935634|39185140|FG004|Treatment: Track 1|Lost to Follow-up|0|||
16192704|NCT02935634|39185141|FG005|Treatment: Track 1|Lost to Follow-up|0|||
16300955|NCT03893565|39585658|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16300956|NCT03893565|39585659|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16300957|NCT03893565|39585660|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16300958|NCT03893565|39585661|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16300959|NCT03893565|39585653|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
16300960|NCT03893565|39585654|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
16300961|NCT03893565|39585655|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
16300962|NCT03893565|39585656|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
16300963|NCT03893565|39585657|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
16300964|NCT03893565|39585658|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
16300965|NCT03893565|39585659|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
16300966|NCT03893565|39585660|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
16300967|NCT03893565|39585661|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
16300968|NCT03893565|39585653|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
16300969|NCT03893565|39585654|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
16300970|NCT03893565|39585655|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
16300971|NCT03893565|39585656|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16300972|NCT03893565|39585657|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
16300973|NCT03893565|39585658|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16300974|NCT03893565|39585659|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16300975|NCT03893565|39585660|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16300976|NCT03893565|39585661|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16300977|NCT03893565|39585653|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
16300978|NCT03893565|39585654|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
16346279|NCT04249362|39753276|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 30 March 2023.|34|||
16346280|NCT04249362|39753277|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 30 March 2023.|25|||
16490353|NCT03766581|40270267|FG003|Treatment|Adverse Event|46|||
16490354|NCT03766581|40270268|FG004|Treatment|Adverse Event|50|||
16490355|NCT03766581|40270269|FG005|Treatment|Adverse Event|77|||
16490356|NCT03766581|40270270|FG006|Treatment|Adverse Event|5|||
16490357|NCT03766581|40270271|FG007|Treatment|Adverse Event|2|||
16490358|NCT03766581|40270264|FG000|Treatment|Participant request to discontinue treatment|34|||
16490359|NCT03766581|40270265|FG001|Treatment|Participant request to discontinue treatment|6|||
16490360|NCT03766581|40270266|FG002|Treatment|Participant request to discontinue treatment|10|||
16490361|NCT03766581|40270267|FG003|Treatment|Participant request to discontinue treatment|10|||
16490362|NCT03766581|40270268|FG004|Treatment|Participant request to discontinue treatment|14|||
16490363|NCT03766581|40270269|FG005|Treatment|Participant request to discontinue treatment|15|||
16490364|NCT03766581|40270270|FG006|Treatment|Participant request to discontinue treatment|0|||
16490365|NCT03766581|40270271|FG007|Treatment|Participant request to discontinue treatment|1|||
16490366|NCT03766581|40270264|FG000|Treatment|Participant withdrew consent|11|||
16490367|NCT03766581|40270265|FG001|Treatment|Participant withdrew consent|4|||
16490368|NCT03766581|40270266|FG002|Treatment|Participant withdrew consent|5|||
16490369|NCT03766581|40270267|FG003|Treatment|Participant withdrew consent|5|||
16490370|NCT03766581|40270268|FG004|Treatment|Participant withdrew consent|4|||
16490371|NCT03766581|40270269|FG005|Treatment|Participant withdrew consent|4|||
16490372|NCT03766581|40270270|FG006|Treatment|Participant withdrew consent|0|||
16490373|NCT03766581|40270271|FG007|Treatment|Participant withdrew consent|0|||
16490374|NCT03766581|40270264|FG000|Treatment|Death|1|||
16490375|NCT03766581|40270265|FG001|Treatment|Death|0|||
16490376|NCT03766581|40270266|FG002|Treatment|Death|0|||
16490377|NCT03766581|40270267|FG003|Treatment|Death|0|||
16346281|NCT02466971|39753278|FG000|Overall Study|eligible and never treated|14|||
16346282|NCT02466971|39753279|FG001|Overall Study|eligible and never treated|20|||
16346283|NCT02466971|39753278|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
16346284|NCT02466971|39753279|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
16346285|NCT02466971|39753278|FG000|Overall Study|ineligible and treated|1|||
16346286|NCT02466971|39753279|FG001|Overall Study|ineligible and treated|0|||
16346287|NCT02466971|39753278|FG000|Overall Study|ineligible and never treated|0|||
16346288|NCT02466971|39753279|FG001|Overall Study|ineligible and never treated|1|||
16346289|NCT04249427|39753280|FG000|Overall Study|Adverse Event|3|||
16346290|NCT04249427|39753281|FG001|Overall Study|Adverse Event|1|||
16346291|NCT04249427|39753280|FG000|Overall Study|Lack of Efficacy|0|||
16346292|NCT04249427|39753281|FG001|Overall Study|Lack of Efficacy|1|||
16346293|NCT04249427|39753280|FG000|Overall Study|Withdrawal by Subject|1|||
16346294|NCT04249427|39753281|FG001|Overall Study|Withdrawal by Subject|2|||
16346295|NCT05568797|39753282|FG000|Overall Study|Adverse Event|0|||
16346296|NCT05568797|39753283|FG001|Overall Study|Adverse Event|8|||
16387569|NCT01076010|39902670|FG001|Overall Study|Protocol Violation|1|||
16387570|NCT01076010|39902671|FG002|Overall Study|Protocol Violation|0|||
16387571|NCT01076010|39902669|FG000|Overall Study|Noncompliance|1|||
16387572|NCT01076010|39902670|FG001|Overall Study|Noncompliance|1|||
16387573|NCT01076010|39902671|FG002|Overall Study|Noncompliance|0|||
16387574|NCT01076010|39902669|FG000|Overall Study|Withdrawal by Subject|3|||
16387575|NCT01076010|39902670|FG001|Overall Study|Withdrawal by Subject|0|||
16387576|NCT01076010|39902671|FG002|Overall Study|Withdrawal by Subject|1|||
16387577|NCT01076010|39902669|FG000|Overall Study|Other|5|||
16387578|NCT01076010|39902670|FG001|Overall Study|Other|2|||
16387579|NCT01076010|39902671|FG002|Overall Study|Other|0|||
16387580|NCT01248793|39902672|FG000|Overall Study|Lost to Follow-up|0|||
16387581|NCT01248793|39902673|FG001|Overall Study|Lost to Follow-up|1|||
16387582|NCT01248793|39902672|FG000|Overall Study|Adverse Event|1|||
16387583|NCT01248793|39902673|FG001|Overall Study|Adverse Event|1|||
16387584|NCT01248793|39902672|FG000|Overall Study|Protocol Violation|0|||
16387585|NCT01248793|39902673|FG001|Overall Study|Protocol Violation|1|||
16300979|NCT03893565|39585655|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
16300980|NCT03893565|39585656|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
16300981|NCT03893565|39585657|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
16300982|NCT03893565|39585658|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
16300983|NCT03893565|39585659|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
16300984|NCT03893565|39585660|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
16300985|NCT03893565|39585661|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
16300986|NCT03893565|39585653|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16300987|NCT03893565|39585654|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16300988|NCT03893565|39585655|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16300989|NCT03893565|39585656|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
16300990|NCT03893565|39585657|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16300991|NCT03893565|39585658|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16300992|NCT03893565|39585659|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16300993|NCT03893565|39585660|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16300994|NCT03893565|39585661|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16300995|NCT03893565|39585653|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
16300996|NCT03893565|39585654|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
16300997|NCT03893565|39585655|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
16300998|NCT03893565|39585656|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
16300999|NCT03893565|39585657|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
16301000|NCT03893565|39585658|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
16301001|NCT03893565|39585659|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
16301002|NCT03893565|39585660|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
16301003|NCT03893565|39585661|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
16301004|NCT03893565|39585653|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
16301005|NCT03893565|39585654|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
16301006|NCT03893565|39585655|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
16301007|NCT03893565|39585656|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
16301008|NCT03893565|39585657|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
16301009|NCT03893565|39585658|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
16301010|NCT03893565|39585659|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
16301011|NCT03893565|39585660|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
16301012|NCT03893565|39585661|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
16301013|NCT03893565|39585653|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
16301014|NCT03893565|39585654|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
16301015|NCT03893565|39585655|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
16301016|NCT03893565|39585656|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
16301017|NCT03893565|39585657|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
16301018|NCT03893565|39585658|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
16301019|NCT03893565|39585659|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
16301020|NCT03893565|39585660|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
16301021|NCT03893565|39585661|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
16301022|NCT03893565|39585653|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
16301023|NCT03893565|39585654|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
16387586|NCT01248793|39902672|FG000|Overall Study|Withdrawal by Subject|3|||
16387587|NCT01248793|39902673|FG001|Overall Study|Withdrawal by Subject|3|||
16387588|NCT00742625|39902677|FG000|Remission Induction|Progression|6|||
16387589|NCT00742625|39902677|FG000|Remission Induction|Failed induction|8|||
16387590|NCT00742625|39902677|FG000|Remission Induction|Adverse Event|3|||
16387591|NCT00742625|39902677|FG000|Remission Induction|Death|10|||
16301024|NCT03893565|39585655|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
16301025|NCT03893565|39585656|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
16301026|NCT03893565|39585657|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
16301027|NCT03893565|39585658|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
16301028|NCT03893565|39585659|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
16301029|NCT03893565|39585660|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
16301030|NCT03893565|39585661|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
16301031|NCT03893565|39585653|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
16301032|NCT03893565|39585654|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
16301033|NCT03893565|39585655|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
16301034|NCT03893565|39585656|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
16301035|NCT03893565|39585657|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
16301036|NCT03893565|39585658|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
16301037|NCT03893565|39585659|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
16301038|NCT03893565|39585660|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
16301039|NCT03893565|39585661|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
16301040|NCT03893565|39585653|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16301041|NCT03893565|39585654|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16301042|NCT03893565|39585655|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16301043|NCT03893565|39585656|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16301044|NCT03893565|39585657|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16301045|NCT03893565|39585658|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16301046|NCT03893565|39585659|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16301047|NCT03893565|39585660|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
16301048|NCT03893565|39585661|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
16301049|NCT03893565|39585653|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16301050|NCT03893565|39585654|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16301051|NCT03893565|39585655|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16301052|NCT03893565|39585656|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16301053|NCT03893565|39585657|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16301054|NCT03893565|39585658|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16301055|NCT03893565|39585659|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16301056|NCT03893565|39585660|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
16301057|NCT03893565|39585661|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
16301058|NCT03893565|39585653|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16301059|NCT03893565|39585654|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16301060|NCT03893565|39585655|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16301061|NCT03893565|39585656|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16301062|NCT03893565|39585657|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16301063|NCT03893565|39585658|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16301064|NCT03893565|39585659|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16301065|NCT03893565|39585660|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
16301066|NCT03893565|39585661|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
16301067|NCT03893565|39585653|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
16301068|NCT03893565|39585654|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
16301069|NCT03893565|39585655|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
16301070|NCT03893565|39585656|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
16301071|NCT03893565|39585657|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
16301072|NCT03893565|39585658|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
16301073|NCT03893565|39585659|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
16301074|NCT03893565|39585660|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
16301075|NCT03893565|39585661|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
16301076|NCT04971187|39585662|FG000|Overall Study|Screen failures|2|||
16301077|NCT02252406|39585667|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
16301078|NCT02252406|39585668|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
16301079|NCT02252406|39585667|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
16301080|NCT02252406|39585668|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
16301081|NCT02252406|39585667|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
16301082|NCT02252406|39585668|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
16301083|NCT02252406|39585667|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
16301084|NCT02252406|39585668|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
16301085|NCT02252406|39585667|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
16301086|NCT02252406|39585668|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
16301087|NCT04414618|39585672|FG000|Overall Study|Death|3|||
16301088|NCT04414618|39585673|FG001|Overall Study|Death|3|||
16301089|NCT04414618|39585672|FG000|Overall Study|Withdrawal by Subject|2|||
16301090|NCT04414618|39585673|FG001|Overall Study|Withdrawal by Subject|1|||
16301091|NCT04414618|39585672|FG000|Overall Study|Lost to Follow-up|2|||
16301092|NCT04414618|39585673|FG001|Overall Study|Lost to Follow-up|3|||
16301093|NCT04414618|39585672|FG000|Overall Study|Physician Decision|1|||
16301094|NCT04414618|39585673|FG001|Overall Study|Physician Decision|0|||
16301095|NCT01589497|39585674|FG000|Overall Study|Withdrawal by Subject|0|||
16301096|NCT01589497|39585675|FG001|Overall Study|Withdrawal by Subject|1|||
16301097|NCT01589497|39585676|FG002|Overall Study|Withdrawal by Subject|0|||
16301098|NCT01589497|39585677|FG003|Overall Study|Withdrawal by Subject|1|||
16301099|NCT01589497|39585674|FG000|Overall Study|Death|1|||
16301100|NCT01589497|39585675|FG001|Overall Study|Death|0|||
16301101|NCT01589497|39585676|FG002|Overall Study|Death|0|||
16301102|NCT01589497|39585677|FG003|Overall Study|Death|0|||
16301103|NCT01589497|39585674|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
16301104|NCT01589497|39585675|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
16301105|NCT01589497|39585676|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
16301106|NCT01589497|39585677|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
16301107|NCT00530218|39585689|FG000|Overall Study|CMV Not Detected|13|||
16301108|NCT00530218|39585689|FG000|Overall Study|Death|12|||
16301109|NCT00025259|39585692|FG000|Overall Study|Death|1|||
16301110|NCT00025259|39585693|FG001|Overall Study|Death|3|||
16301111|NCT00025259|39585694|FG002|Overall Study|Death|0|||
16301112|NCT00025259|39585695|FG003|Overall Study|Death|3|||
16301113|NCT00025259|39585696|FG004|Overall Study|Death|0|||
16301114|NCT00025259|39585697|FG005|Overall Study|Death|1|||
16301115|NCT00025259|39585698|FG006|Overall Study|Death|2|||
16301116|NCT00025259|39585692|FG000|Overall Study|Lack of Efficacy|2|||
16301117|NCT00025259|39585693|FG001|Overall Study|Lack of Efficacy|46|||
16301118|NCT00025259|39585694|FG002|Overall Study|Lack of Efficacy|60|||
16301119|NCT00025259|39585695|FG003|Overall Study|Lack of Efficacy|78|||
16301120|NCT00025259|39585696|FG004|Overall Study|Lack of Efficacy|11|||
16301121|NCT00025259|39585697|FG005|Overall Study|Lack of Efficacy|30|||
16301122|NCT00025259|39585698|FG006|Overall Study|Lack of Efficacy|38|||
16301123|NCT00025259|39585692|FG000|Overall Study|Lost to Follow-up|2|||
16301124|NCT00025259|39585693|FG001|Overall Study|Lost to Follow-up|9|||
16301125|NCT00025259|39585694|FG002|Overall Study|Lost to Follow-up|13|||
16301126|NCT00025259|39585695|FG003|Overall Study|Lost to Follow-up|13|||
16301127|NCT00025259|39585696|FG004|Overall Study|Lost to Follow-up|1|||
16301128|NCT00025259|39585697|FG005|Overall Study|Lost to Follow-up|3|||
16301129|NCT00025259|39585698|FG006|Overall Study|Lost to Follow-up|1|||
16301130|NCT00025259|39585692|FG000|Overall Study|Physician Decision|12|||
16301131|NCT00025259|39585693|FG001|Overall Study|Physician Decision|1|||
16301132|NCT00025259|39585694|FG002|Overall Study|Physician Decision|0|||
16301133|NCT00025259|39585695|FG003|Overall Study|Physician Decision|5|||
16301134|NCT00025259|39585696|FG004|Overall Study|Physician Decision|4|||
16301135|NCT00025259|39585697|FG005|Overall Study|Physician Decision|2|||
16301136|NCT00025259|39585698|FG006|Overall Study|Physician Decision|1|||
16301137|NCT00025259|39585692|FG000|Overall Study|Protocol Violation|3|||
16301138|NCT00025259|39585693|FG001|Overall Study|Protocol Violation|2|||
16301139|NCT00025259|39585694|FG002|Overall Study|Protocol Violation|2|||
16301140|NCT00025259|39585695|FG003|Overall Study|Protocol Violation|1|||
16301141|NCT00025259|39585696|FG004|Overall Study|Protocol Violation|2|||
16301142|NCT00025259|39585697|FG005|Overall Study|Protocol Violation|1|||
16301143|NCT00025259|39585698|FG006|Overall Study|Protocol Violation|3|||
16301144|NCT00025259|39585692|FG000|Overall Study|Withdrawal by Subject|9|||
16301145|NCT00025259|39585693|FG001|Overall Study|Withdrawal by Subject|27|||
16301146|NCT00025259|39585694|FG002|Overall Study|Withdrawal by Subject|6|||
16301147|NCT00025259|39585695|FG003|Overall Study|Withdrawal by Subject|14|||
16301148|NCT00025259|39585696|FG004|Overall Study|Withdrawal by Subject|11|||
16301149|NCT00025259|39585697|FG005|Overall Study|Withdrawal by Subject|8|||
16301150|NCT00025259|39585698|FG006|Overall Study|Withdrawal by Subject|3|||
16301151|NCT00025259|39585692|FG000|Overall Study|Ineligible|14|||
16301152|NCT00025259|39585693|FG001|Overall Study|Ineligible|1|||
16301153|NCT00025259|39585694|FG002|Overall Study|Ineligible|0|||
16301154|NCT00025259|39585695|FG003|Overall Study|Ineligible|0|||
16301155|NCT00025259|39585696|FG004|Overall Study|Ineligible|6|||
16301156|NCT00025259|39585697|FG005|Overall Study|Ineligible|0|||
16301157|NCT00025259|39585698|FG006|Overall Study|Ineligible|1|||
16301158|NCT00025259|39585692|FG000|Overall Study|Randomization error|1|||
16301159|NCT00025259|39585693|FG001|Overall Study|Randomization error|0|||
16301160|NCT00025259|39585694|FG002|Overall Study|Randomization error|0|||
16301161|NCT00025259|39585695|FG003|Overall Study|Randomization error|0|||
16301162|NCT00025259|39585696|FG004|Overall Study|Randomization error|1|||
16301163|NCT00025259|39585697|FG005|Overall Study|Randomization error|7|||
16301164|NCT00025259|39585698|FG006|Overall Study|Randomization error|2|||
16301165|NCT00025259|39585692|FG000|Overall Study|Adverse Event|1|||
16301166|NCT00025259|39585693|FG001|Overall Study|Adverse Event|0|||
16301167|NCT00025259|39585694|FG002|Overall Study|Adverse Event|0|||
16301168|NCT00025259|39585695|FG003|Overall Study|Adverse Event|0|||
16301169|NCT00025259|39585696|FG004|Overall Study|Adverse Event|0|||
16301170|NCT00025259|39585697|FG005|Overall Study|Adverse Event|0|||
16301171|NCT00025259|39585698|FG006|Overall Study|Adverse Event|0|||
16301172|NCT01908907|39585701|FG000|Overall Study|Physician Decision|1|||
16301173|NCT01908907|39585702|FG001|Overall Study|Physician Decision|0|||
16301174|NCT01908907|39585701|FG000|Overall Study|Protocol Violation|1|||
16301175|NCT01908907|39585702|FG001|Overall Study|Protocol Violation|0|||
16301176|NCT01332292|39585703|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
16301177|NCT01332292|39585704|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
16301178|NCT01332292|39585703|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
16301179|NCT01332292|39585704|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
16301180|NCT01332292|39585703|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
16301181|NCT01332292|39585704|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
16301182|NCT04693416|39585709|FG000|Overall Study|Lost to Follow-up|13|||
16301183|NCT04693416|39585710|FG001|Overall Study|Lost to Follow-up|0|||
16301184|NCT01876446|39589379|FG000|Overall Study|Death|0|||
16301185|NCT01876446|39589380|FG001|Overall Study|Death|1|||
16301186|NCT01876446|39589379|FG000|Overall Study|Withdrawal by Subject|1|||
16301187|NCT01876446|39589380|FG001|Overall Study|Withdrawal by Subject|2|||
16301188|NCT01876446|39589379|FG000|Overall Study|Physician Decision|1|||
16301189|NCT01876446|39589380|FG001|Overall Study|Physician Decision|3|||
16301190|NCT03316547|39589388|FG000|Overall Study|Death|3|||
16301191|NCT03316547|39589389|FG001|Overall Study|Death|1|||
16301192|NCT03316547|39589388|FG000|Overall Study|Lost to Follow-up|6|||
16301193|NCT03316547|39589389|FG001|Overall Study|Lost to Follow-up|6|||
16301194|NCT03316547|39589388|FG000|Overall Study|Withdrawal by Subject|3|||
16301195|NCT03316547|39589389|FG001|Overall Study|Withdrawal by Subject|2|||
16301196|NCT03316547|39589388|FG000|Overall Study|Transfer to another hospital|6|||
16301197|NCT03316547|39589389|FG001|Overall Study|Transfer to another hospital|4|||
16301198|NCT01475097|39589392|FG000|Overall Study|Protocol Violation|1|||
16301199|NCT01475097|39589393|FG001|Overall Study|Protocol Violation|1|||
16301200|NCT02794870|39589395|FG000|Overall Study|Withdrawal by Subject|2|||
16301201|NCT02794870|39589396|FG001|Overall Study|Withdrawal by Subject|0|||
16301202|NCT03142191|39589402|FG000|Placebo Controlled Period|Death|0|||
16301203|NCT03142191|39589403|FG001|Placebo Controlled Period|Death|1|||
16301204|NCT03142191|39589404|FG002|Placebo Controlled Period|Death|1|||
16301205|NCT03142191|39589405|FG003|Placebo Controlled Period|Death|0|||
16301206|NCT03142191|39589406|FG004|Placebo Controlled Period|Death|0|||
16301207|NCT03142191|39589402|FG000|Placebo Controlled Period|Adverse Event|4|||
16301208|NCT03142191|39589403|FG001|Placebo Controlled Period|Adverse Event|5|||
16301209|NCT03142191|39589404|FG002|Placebo Controlled Period|Adverse Event|1|||
16301210|NCT03142191|39589405|FG003|Placebo Controlled Period|Adverse Event|0|||
16301211|NCT03142191|39589406|FG004|Placebo Controlled Period|Adverse Event|0|||
16301212|NCT03142191|39589402|FG000|Placebo Controlled Period|Progressive Disease|1|||
16301213|NCT03142191|39589403|FG001|Placebo Controlled Period|Progressive Disease|0|||
16301214|NCT03142191|39589404|FG002|Placebo Controlled Period|Progressive Disease|1|||
16301215|NCT03142191|39589405|FG003|Placebo Controlled Period|Progressive Disease|0|||
16301216|NCT03142191|39589406|FG004|Placebo Controlled Period|Progressive Disease|0|||
16301217|NCT03142191|39589402|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
16301218|NCT03142191|39589403|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
16387592|NCT00742625|39902677|FG000|Remission Induction|Refusal|5|||
16490378|NCT03766581|40270268|FG004|Treatment|Death|0|||
16301219|NCT03142191|39589404|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
16301220|NCT03142191|39589405|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
16301221|NCT03142191|39589406|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
16301222|NCT03142191|39589402|FG000|Placebo Controlled Period|Other Reasons|1|||
16301223|NCT03142191|39589403|FG001|Placebo Controlled Period|Other Reasons|0|||
16301224|NCT03142191|39589404|FG002|Placebo Controlled Period|Other Reasons|0|||
16301225|NCT03142191|39589405|FG003|Placebo Controlled Period|Other Reasons|0|||
16301226|NCT03142191|39589406|FG004|Placebo Controlled Period|Other Reasons|0|||
16301227|NCT03142191|39589402|FG000|Active Treatment Extension Period|Death|2|||
16301228|NCT03142191|39589403|FG001|Active Treatment Extension Period|Death|1|||
16301229|NCT03142191|39589404|FG002|Active Treatment Extension Period|Death|1|||
16301230|NCT03142191|39589405|FG003|Active Treatment Extension Period|Death|1|||
16301231|NCT03142191|39589406|FG004|Active Treatment Extension Period|Death|0|||
16301232|NCT03142191|39589402|FG000|Active Treatment Extension Period|Adverse Event|6|||
16301233|NCT03142191|39589403|FG001|Active Treatment Extension Period|Adverse Event|5|||
16490379|NCT03766581|40270269|FG005|Treatment|Death|0|||
16301234|NCT03142191|39589404|FG002|Active Treatment Extension Period|Adverse Event|4|||
16301235|NCT03142191|39589405|FG003|Active Treatment Extension Period|Adverse Event|1|||
16301236|NCT03142191|39589406|FG004|Active Treatment Extension Period|Adverse Event|0|||
16301237|NCT03142191|39589402|FG000|Active Treatment Extension Period|Progressive Disease|10|||
16301238|NCT03142191|39589403|FG001|Active Treatment Extension Period|Progressive Disease|5|||
16490380|NCT03766581|40270270|FG006|Treatment|Death|0|||
16490381|NCT03766581|40270271|FG007|Treatment|Death|0|||
16490382|NCT03766581|40270264|FG000|Treatment|Lost to Follow-up|1|||
16490383|NCT03766581|40270265|FG001|Treatment|Lost to Follow-up|0|||
16490384|NCT03766581|40270266|FG002|Treatment|Lost to Follow-up|0|||
16192705|NCT02935634|39185136|FG000|Treatment: Track 1|Study drug toxicity|2|||
16192706|NCT02935634|39185137|FG001|Treatment: Track 1|Study drug toxicity|1|||
16490385|NCT03766581|40270267|FG003|Treatment|Lost to Follow-up|1|||
16490386|NCT03766581|40270268|FG004|Treatment|Lost to Follow-up|0|||
16490387|NCT03766581|40270269|FG005|Treatment|Lost to Follow-up|0|||
16490388|NCT03766581|40270270|FG006|Treatment|Lost to Follow-up|0|||
16490389|NCT03766581|40270271|FG007|Treatment|Lost to Follow-up|0|||
16490390|NCT03766581|40270264|FG000|Treatment|Poor/Non compliance|2|||
16490391|NCT03766581|40270265|FG001|Treatment|Poor/Non compliance|2|||
16490392|NCT03766581|40270266|FG002|Treatment|Poor/Non compliance|1|||
16490393|NCT03766581|40270267|FG003|Treatment|Poor/Non compliance|1|||
16490394|NCT03766581|40270268|FG004|Treatment|Poor/Non compliance|1|||
16490395|NCT03766581|40270269|FG005|Treatment|Poor/Non compliance|1|||
16490396|NCT03766581|40270270|FG006|Treatment|Poor/Non compliance|0|||
16490397|NCT03766581|40270271|FG007|Treatment|Poor/Non compliance|0|||
16490398|NCT03766581|40270264|FG000|Treatment|Participant no longer meets study criteria|9|||
16490399|NCT03766581|40270265|FG001|Treatment|Participant no longer meets study criteria|1|||
16490400|NCT03766581|40270266|FG002|Treatment|Participant no longer meets study criteria|5|||
16490401|NCT03766581|40270267|FG003|Treatment|Participant no longer meets study criteria|4|||
16490402|NCT03766581|40270268|FG004|Treatment|Participant no longer meets study criteria|4|||
16490403|NCT03766581|40270269|FG005|Treatment|Participant no longer meets study criteria|4|||
16490404|NCT03766581|40270270|FG006|Treatment|Participant no longer meets study criteria|2|||
16490405|NCT03766581|40270271|FG007|Treatment|Participant no longer meets study criteria|0|||
16490406|NCT03766581|40270264|FG000|Treatment|Other reasons|13|||
16490407|NCT03766581|40270265|FG001|Treatment|Other reasons|8|||
16490408|NCT03766581|40270266|FG002|Treatment|Other reasons|3|||
16490409|NCT03766581|40270267|FG003|Treatment|Other reasons|7|||
16490410|NCT03766581|40270268|FG004|Treatment|Other reasons|3|||
16490411|NCT03766581|40270269|FG005|Treatment|Other reasons|3|||
16301239|NCT03142191|39589404|FG002|Active Treatment Extension Period|Progressive Disease|4|||
16301240|NCT03142191|39589405|FG003|Active Treatment Extension Period|Progressive Disease|1|||
16301241|NCT03142191|39589406|FG004|Active Treatment Extension Period|Progressive Disease|2|||
16301242|NCT03142191|39589402|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
16301243|NCT03142191|39589403|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
16301244|NCT03142191|39589404|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
16301245|NCT03142191|39589405|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
16301246|NCT03142191|39589406|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
16490412|NCT03766581|40270270|FG006|Treatment|Other reasons|0|||
16192707|NCT02935634|39185138|FG002|Treatment: Track 1|Study drug toxicity|3|||
16192708|NCT02935634|39185139|FG003|Treatment: Track 1|Study drug toxicity|0|||
16192709|NCT02935634|39185140|FG004|Treatment: Track 1|Study drug toxicity|0|||
16192710|NCT02935634|39185141|FG005|Treatment: Track 1|Study drug toxicity|1|||
16192711|NCT02935634|39185136|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
16301247|NCT03142191|39589402|FG000|Active Treatment Extension Period|Physician Decision|2|||
16301248|NCT03142191|39589403|FG001|Active Treatment Extension Period|Physician Decision|0|||
16301249|NCT03142191|39589404|FG002|Active Treatment Extension Period|Physician Decision|0|||
16192712|NCT02935634|39185137|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
16192713|NCT02935634|39185138|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
16346297|NCT05568797|39753282|FG000|Overall Study|Lost to Follow-up|2|||
16346298|NCT05568797|39753283|FG001|Overall Study|Lost to Follow-up|3|||
16346299|NCT05568797|39753282|FG000|Overall Study|Withdrawal by Subject|1|||
16346300|NCT05568797|39753283|FG001|Overall Study|Withdrawal by Subject|10|||
16346301|NCT05568797|39753282|FG000|Overall Study|Other|2|||
16346302|NCT05568797|39753283|FG001|Overall Study|Other|2|||
16346303|NCT05415462|39753285|FG000|Overall Study|Death|18|||
16346304|NCT05415462|39753286|FG001|Overall Study|Death|10|||
16346305|NCT05415462|39753285|FG000|Overall Study|Lost to Follow-up|72|||
16346306|NCT05415462|39753286|FG001|Overall Study|Lost to Follow-up|64|||
16346307|NCT05415462|39753285|FG000|Overall Study|Physician Decision|5|||
16346308|NCT05415462|39753286|FG001|Overall Study|Physician Decision|5|||
16346309|NCT05415462|39753285|FG000|Overall Study|Protocol Deviation|1|||
16346310|NCT05415462|39753286|FG001|Overall Study|Protocol Deviation|0|||
16346311|NCT05415462|39753285|FG000|Overall Study|Withdrawal by Subject|129|||
16346312|NCT05415462|39753286|FG001|Overall Study|Withdrawal by Subject|101|||
16346313|NCT05415462|39753285|FG000|Overall Study|Other Than Specified|8|||
16346314|NCT05415462|39753286|FG001|Overall Study|Other Than Specified|8|||
16346315|NCT03201965|39753287|FG000|Overall Study|Death|5|||
16346316|NCT03201965|39753288|FG001|Overall Study|Death|27|||
16346317|NCT03201965|39753289|FG002|Overall Study|Death|27|||
16346318|NCT03201965|39753287|FG000|Overall Study|Lost to Follow-up|0|||
16346319|NCT03201965|39753288|FG001|Overall Study|Lost to Follow-up|1|||
16346320|NCT03201965|39753289|FG002|Overall Study|Lost to Follow-up|0|||
16490413|NCT03766581|40270271|FG007|Treatment|Other reasons|0|||
16490414|NCT01626391|40270274|FG000|Overall Study|Physician Decision|1|||
16490415|NCT01626391|40270275|FG001|Overall Study|Physician Decision|0|||
16490416|NCT01626391|40270274|FG000|Overall Study|Withdrawal by Subject|1|||
16490417|NCT01626391|40270275|FG001|Overall Study|Withdrawal by Subject|0|||
16490418|NCT01276353|40270280|FG000|Double-blind|Adverse Event|2|||
16490419|NCT01276353|40270281|FG001|Double-blind|Adverse Event|0|||
16490420|NCT01276353|40270280|FG000|Double-blind|Withdrawal by Subject|1|||
16192714|NCT02935634|39185139|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
16192715|NCT02935634|39185140|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
16192716|NCT02935634|39185141|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
16192717|NCT02935634|39185136|FG000|Treatment: Track 1|Participant withdrew consent|2|||
16192718|NCT02935634|39185137|FG001|Treatment: Track 1|Participant withdrew consent|0|||
16192719|NCT02935634|39185138|FG002|Treatment: Track 1|Participant withdrew consent|1|||
16192720|NCT02935634|39185139|FG003|Treatment: Track 1|Participant withdrew consent|0|||
16192721|NCT02935634|39185140|FG004|Treatment: Track 1|Participant withdrew consent|1|||
16192722|NCT02935634|39185141|FG005|Treatment: Track 1|Participant withdrew consent|0|||
16192723|NCT02935634|39185136|FG000|Treatment: Track 1|Other reasons|0|||
16192724|NCT02935634|39185137|FG001|Treatment: Track 1|Other reasons|0|||
16192725|NCT02935634|39185138|FG002|Treatment: Track 1|Other reasons|2|||
16192726|NCT02935634|39185139|FG003|Treatment: Track 1|Other reasons|0|||
16192727|NCT02935634|39185140|FG004|Treatment: Track 1|Other reasons|0|||
16192728|NCT02935634|39185141|FG005|Treatment: Track 1|Other reasons|0|||
16192729|NCT02935634|39185136|FG000|Treatment: Track 2|Disease progression|13|||
16192730|NCT02935634|39185137|FG001|Treatment: Track 2|Disease progression|26|||
16192731|NCT02935634|39185138|FG002|Treatment: Track 2|Disease progression|20|||
16192732|NCT02935634|39185139|FG003|Treatment: Track 2|Disease progression|5|||
16192733|NCT02935634|39185140|FG004|Treatment: Track 2|Disease progression|1|||
16192734|NCT02935634|39185141|FG005|Treatment: Track 2|Disease progression|4|||
16192735|NCT02935634|39185136|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
16192736|NCT02935634|39185137|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
16192737|NCT02935634|39185138|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
16192738|NCT02935634|39185139|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
16192739|NCT02935634|39185140|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
16192740|NCT02935634|39185141|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
16192741|NCT02935634|39185136|FG000|Treatment: Track 2|Study drug toxicity|7|||
16192742|NCT02935634|39185137|FG001|Treatment: Track 2|Study drug toxicity|3|||
16192743|NCT02935634|39185138|FG002|Treatment: Track 2|Study drug toxicity|0|||
16192744|NCT02935634|39185139|FG003|Treatment: Track 2|Study drug toxicity|0|||
16192745|NCT02935634|39185140|FG004|Treatment: Track 2|Study drug toxicity|0|||
16192746|NCT02935634|39185141|FG005|Treatment: Track 2|Study drug toxicity|0|||
16192747|NCT02935634|39185136|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
16192748|NCT02935634|39185137|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
16192749|NCT02935634|39185138|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
16192750|NCT02935634|39185139|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
16192751|NCT02935634|39185140|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
16192752|NCT02935634|39185141|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
16192753|NCT02935634|39185136|FG000|Treatment: Track 2|Participant withdrew consent|0|||
16192754|NCT02935634|39185137|FG001|Treatment: Track 2|Participant withdrew consent|1|||
16192755|NCT02935634|39185138|FG002|Treatment: Track 2|Participant withdrew consent|1|||
16192756|NCT02935634|39185139|FG003|Treatment: Track 2|Participant withdrew consent|0|||
16192757|NCT02935634|39185140|FG004|Treatment: Track 2|Participant withdrew consent|1|||
16192758|NCT02935634|39185141|FG005|Treatment: Track 2|Participant withdrew consent|0|||
16192759|NCT01115738|39185143|FG000|Overall Study|Death|1|||
16192760|NCT01115738|39185144|FG001|Overall Study|Death|0|||
16387593|NCT00742625|39902677|FG000|Remission Induction|Non protocol treatment|17|||
16387594|NCT00742625|39902677|FG000|Remission Induction|Other, not specified|5|||
16387595|NCT00742625|39902677|FG000|Consolidation|Progression|5|||
16387596|NCT00742625|39902677|FG000|Consolidation|Adverse Event|1|||
16387597|NCT00742625|39902677|FG000|Consolidation|Death|1|||
16387598|NCT00742625|39902677|FG000|Consolidation|Refused|1|||
16387599|NCT00742625|39902677|FG000|Consolidation|Non protocol therapy|13|||
16387600|NCT01171677|39902678|FG000|Overall Study|Withdrawal by Subject|0|||
16387601|NCT01171677|39902679|FG001|Overall Study|Withdrawal by Subject|3|||
16387602|NCT01171677|39902678|FG000|Overall Study|Adverse Event|1|||
16387603|NCT01171677|39902679|FG001|Overall Study|Adverse Event|0|||
16387604|NCT01171677|39902678|FG000|Overall Study|completed <70% IntenSati classes|5|||
16387605|NCT01171677|39902679|FG001|Overall Study|completed <70% IntenSati classes|0|||
16387606|NCT00237042|39902684|FG000|Treatment|Became ineligible post-randomization|0|||
16490421|NCT01276353|40270281|FG001|Double-blind|Withdrawal by Subject|0|||
16490422|NCT01276353|40270280|FG000|Extension|Adverse Event|2|||
16490423|NCT01276353|40270281|FG001|Extension|Adverse Event|5|||
16490424|NCT01276353|40270280|FG000|Extension|Withdrawal by Subject|1|||
16192761|NCT01115738|39185145|FG002|Overall Study|Death|0|||
16301250|NCT03142191|39589405|FG003|Active Treatment Extension Period|Physician Decision|0|||
16301251|NCT03142191|39589406|FG004|Active Treatment Extension Period|Physician Decision|0|||
16301252|NCT03142191|39589402|FG000|Active Treatment Extension Period|Other Reasons|3|||
16301253|NCT03142191|39589403|FG001|Active Treatment Extension Period|Other Reasons|3|||
16301254|NCT03142191|39589404|FG002|Active Treatment Extension Period|Other Reasons|3|||
16301255|NCT03142191|39589405|FG003|Active Treatment Extension Period|Other Reasons|8|||
16192762|NCT01115738|39185143|FG000|Overall Study|Lost to Follow-up|0|||
16192763|NCT01115738|39185144|FG001|Overall Study|Lost to Follow-up|0|||
16192764|NCT01115738|39185145|FG002|Overall Study|Lost to Follow-up|1|||
16192765|NCT01115738|39185143|FG000|Overall Study|Physician Decision|18|||
16192766|NCT01115738|39185144|FG001|Overall Study|Physician Decision|15|||
16192767|NCT01115738|39185145|FG002|Overall Study|Physician Decision|17|||
16192768|NCT01115738|39185143|FG000|Overall Study|Withdrawal by Subject|6|||
16192769|NCT01115738|39185144|FG001|Overall Study|Withdrawal by Subject|6|||
16192770|NCT01115738|39185145|FG002|Overall Study|Withdrawal by Subject|9|||
16192771|NCT01533935|39185148|FG000|Overall Study|Adverse Event|5|||
16192772|NCT01533935|39185149|FG001|Overall Study|Adverse Event|7|||
16192773|NCT01533935|39185150|FG002|Overall Study|Adverse Event|1|||
16192774|NCT01533935|39185151|FG003|Overall Study|Adverse Event|5|||
16192775|NCT01533935|39185152|FG004|Overall Study|Adverse Event|3|||
16192776|NCT01533935|39185148|FG000|Overall Study|Protocol Violation|0|||
16192777|NCT01533935|39185149|FG001|Overall Study|Protocol Violation|2|||
16192778|NCT01533935|39185150|FG002|Overall Study|Protocol Violation|0|||
16192779|NCT01533935|39185151|FG003|Overall Study|Protocol Violation|0|||
16192780|NCT01533935|39185152|FG004|Overall Study|Protocol Violation|0|||
16192781|NCT01533935|39185148|FG000|Overall Study|Lost to Follow-up|0|||
16192782|NCT01533935|39185149|FG001|Overall Study|Lost to Follow-up|0|||
16192783|NCT01533935|39185150|FG002|Overall Study|Lost to Follow-up|1|||
16192784|NCT01533935|39185151|FG003|Overall Study|Lost to Follow-up|0|||
16192785|NCT01533935|39185152|FG004|Overall Study|Lost to Follow-up|0|||
16301256|NCT03142191|39589406|FG004|Active Treatment Extension Period|Other Reasons|3|||
16301257|NCT03142191|39589402|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
16301258|NCT03142191|39589403|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
16192786|NCT01533935|39185148|FG000|Overall Study|Withdrawal by Subject|0|||
16192787|NCT01533935|39185149|FG001|Overall Study|Withdrawal by Subject|4|||
16301259|NCT03142191|39589404|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
16301260|NCT03142191|39589405|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
16301261|NCT03142191|39589406|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
16301262|NCT03907878|39589407|FG000|Treatment Period|Withdrawal by Subject|5|||
16301263|NCT03907878|39589407|FG000|Treatment Period|Adverse Event|4|||
16301264|NCT03907878|39589407|FG000|Treatment Period|Lack of Efficacy|1|||
16301265|NCT03907878|39589407|FG000|Treatment Period|Protocol Violation|1|||
16301266|NCT03907878|39589407|FG000|Follow-up Period|Adverse Event|3|||
16301267|NCT03907878|39589407|FG000|Follow-up Period|Withdrawal by Subject|3|||
16301268|NCT01831258|39589408|FG000|Overall Study|Withdrawal by Subject|2|||
16301269|NCT01831258|39589409|FG001|Overall Study|Withdrawal by Subject|1|||
16301270|NCT01831258|39589408|FG000|Overall Study|Lost to Follow-up|3|||
16301271|NCT01831258|39589409|FG001|Overall Study|Lost to Follow-up|2|||
16301272|NCT01644617|39589412|FG000|Overall Study|Withdrawal by Subject|3|||
16301273|NCT01644617|39589413|FG001|Overall Study|Withdrawal by Subject|4|||
16301274|NCT01644617|39589414|FG002|Overall Study|Withdrawal by Subject|1|||
16301275|NCT01644617|39589412|FG000|Overall Study|Lost to Follow-up|0|||
16301276|NCT01644617|39589413|FG001|Overall Study|Lost to Follow-up|1|||
16301277|NCT01644617|39589414|FG002|Overall Study|Lost to Follow-up|0|||
16301278|NCT01644617|39589412|FG000|Overall Study|Adverse Event|3|||
16301279|NCT01644617|39589413|FG001|Overall Study|Adverse Event|0|||
16301280|NCT01644617|39589414|FG002|Overall Study|Adverse Event|6|||
16301281|NCT04604795|39589415|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
16301282|NCT04604795|39589416|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
16301283|NCT04604795|39589417|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
16301284|NCT04604795|39589418|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
16301285|NCT04604795|39589419|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
16301286|NCT04604795|39589420|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
16301287|NCT04604795|39589421|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
16301288|NCT04604795|39589422|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
16301289|NCT04604795|39589423|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
16301290|NCT04604795|39589424|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
16301291|NCT04604795|39589415|FG000|Part B: Up to Day 14|Adverse Event|0|||
16192788|NCT01533935|39185150|FG002|Overall Study|Withdrawal by Subject|5|||
16301292|NCT04604795|39589416|FG001|Part B: Up to Day 14|Adverse Event|0|||
16192789|NCT01533935|39185151|FG003|Overall Study|Withdrawal by Subject|2|||
16301293|NCT04604795|39589417|FG002|Part B: Up to Day 14|Adverse Event|0|||
16301294|NCT04604795|39589418|FG003|Part B: Up to Day 14|Adverse Event|0|||
16301295|NCT04604795|39589419|FG004|Part B: Up to Day 14|Adverse Event|2|||
16301296|NCT04604795|39589420|FG005|Part B: Up to Day 14|Adverse Event|1|||
16301297|NCT04604795|39589421|FG006|Part B: Up to Day 14|Adverse Event|0|||
16490425|NCT01276353|40270281|FG001|Extension|Withdrawal by Subject|2|||
16490426|NCT01276353|40270280|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
16490427|NCT01276353|40270281|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
16490428|NCT01276353|40270280|FG000|Extension|Physician Decision|1|||
16490429|NCT01276353|40270281|FG001|Extension|Physician Decision|0|||
16490430|NCT01276353|40270280|FG000|Extension|Prohibited concomitant medications|0|||
16490431|NCT01276353|40270281|FG001|Extension|Prohibited concomitant medications|1|||
16490432|NCT02732119|40270288|FG000|Phase I|Adverse Event|1|||
16490433|NCT02732119|40270289|FG001|Phase I|Adverse Event|3|||
16490434|NCT02732119|40270290|FG002|Phase I|Adverse Event|1|||
16490435|NCT02732119|40270291|FG003|Phase I|Adverse Event|0|||
16490436|NCT02732119|40270292|FG004|Phase I|Adverse Event|0|||
16301298|NCT04604795|39589422|FG007|Part B: Up to Day 14|Adverse Event|0|||
16301299|NCT04604795|39589423|FG008|Part B: Up to Day 14|Adverse Event|0|||
16301300|NCT04604795|39589424|FG009|Part B: Up to Day 14|Adverse Event|0|||
16301301|NCT04604795|39589415|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
16301302|NCT04604795|39589416|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
16301303|NCT04604795|39589417|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
16301304|NCT04604795|39589418|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
16301305|NCT04604795|39589419|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
16301306|NCT04604795|39589420|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
16301307|NCT04604795|39589421|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
16301308|NCT04604795|39589422|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
16301309|NCT04604795|39589423|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
16301310|NCT04604795|39589424|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
16301311|NCT04604795|39589415|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
16301312|NCT04604795|39589416|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
16301313|NCT04604795|39589417|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
16301314|NCT04604795|39589418|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
16301315|NCT04604795|39589419|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
16301316|NCT04604795|39589420|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
16301317|NCT04604795|39589421|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
16301318|NCT04604795|39589422|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
16301319|NCT04604795|39589423|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
16301320|NCT04604795|39589424|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
16301321|NCT04604795|39589415|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
16301322|NCT04604795|39589416|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
16301323|NCT04604795|39589417|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
16301324|NCT04604795|39589418|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
16301325|NCT04604795|39589419|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
16301326|NCT04604795|39589420|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
16301327|NCT04604795|39589421|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
16387607|NCT00237042|39902685|FG001|Treatment|Became ineligible post-randomization|1|||
16387608|NCT00237042|39902686|FG002|Treatment|Became ineligible post-randomization|16|||
16490437|NCT02732119|40270288|FG000|Phase I|Progressive disease|7|||
16490438|NCT02732119|40270289|FG001|Phase I|Progressive disease|3|||
16490439|NCT02732119|40270290|FG002|Phase I|Progressive disease|2|||
16490440|NCT02732119|40270291|FG003|Phase I|Progressive disease|0|||
16490441|NCT02732119|40270292|FG004|Phase I|Progressive disease|0|||
16490442|NCT02732119|40270288|FG000|Phase I|Protocol deviation|0|||
16490443|NCT02732119|40270289|FG001|Phase I|Protocol deviation|1|||
16490444|NCT02732119|40270290|FG002|Phase I|Protocol deviation|0|||
16490445|NCT02732119|40270291|FG003|Phase I|Protocol deviation|0|||
16490446|NCT02732119|40270292|FG004|Phase I|Protocol deviation|0|||
16301328|NCT04604795|39589422|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
16301329|NCT04604795|39589423|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
16301330|NCT04604795|39589424|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
16301331|NCT04604795|39589415|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
16301332|NCT04604795|39589416|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
16301333|NCT04604795|39589417|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
16301334|NCT04604795|39589418|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
16301335|NCT04604795|39589419|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
16301336|NCT04604795|39589420|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
16301337|NCT04604795|39589421|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
16301338|NCT04604795|39589422|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
16301339|NCT04604795|39589423|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
16301340|NCT04604795|39589424|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
16301341|NCT03760185|39589426|FG000|Overall Study|Lost to Follow-up|1|||
16301342|NCT03760185|39589427|FG001|Overall Study|Lost to Follow-up|1|||
16301343|NCT05101343|39589428|FG000|Overall Study|Withdrawal by Subject|2|||
16301344|NCT05101343|39589429|FG001|Overall Study|Withdrawal by Subject|1|||
16301345|NCT01783886|39589430|FG000|Overall Study|Lost to Follow-up|0|||
16301346|NCT01783886|39589431|FG001|Overall Study|Lost to Follow-up|3|||
16301347|NCT01783886|39589432|FG002|Overall Study|Lost to Follow-up|0|||
16301348|NCT01783886|39589430|FG000|Overall Study|Protocol deviation|0|||
16301349|NCT01783886|39589431|FG001|Overall Study|Protocol deviation|0|||
16301350|NCT01783886|39589432|FG002|Overall Study|Protocol deviation|2|||
16490447|NCT02732119|40270288|FG000|Phase I|Physician Decision|0|||
16490448|NCT02732119|40270289|FG001|Phase I|Physician Decision|3|||
16490449|NCT02732119|40270290|FG002|Phase I|Physician Decision|4|||
16490450|NCT02732119|40270291|FG003|Phase I|Physician Decision|0|||
16490451|NCT02732119|40270292|FG004|Phase I|Physician Decision|0|||
16490452|NCT02732119|40270288|FG000|Phase II|Adverse Event|0|||
16490453|NCT02732119|40270289|FG001|Phase II|Adverse Event|0|||
16490454|NCT02732119|40270290|FG002|Phase II|Adverse Event|0|||
16490455|NCT02732119|40270291|FG003|Phase II|Adverse Event|3|||
16490456|NCT02732119|40270292|FG004|Phase II|Adverse Event|3|||
16490457|NCT02732119|40270288|FG000|Phase II|Death|0|||
16490458|NCT02732119|40270289|FG001|Phase II|Death|0|||
16490459|NCT02732119|40270290|FG002|Phase II|Death|0|||
16490460|NCT02732119|40270291|FG003|Phase II|Death|1|||
16490461|NCT02732119|40270292|FG004|Phase II|Death|0|||
16490462|NCT02732119|40270288|FG000|Phase II|Progressive dissease|0|||
16490463|NCT02732119|40270289|FG001|Phase II|Progressive dissease|0|||
16490464|NCT02732119|40270290|FG002|Phase II|Progressive dissease|0|||
16490465|NCT02732119|40270291|FG003|Phase II|Progressive dissease|30|||
16490466|NCT02732119|40270292|FG004|Phase II|Progressive dissease|23|||
16490467|NCT02732119|40270288|FG000|Phase II|Study terminated by sponsor|0|||
16490468|NCT02732119|40270289|FG001|Phase II|Study terminated by sponsor|0|||
16490469|NCT02732119|40270290|FG002|Phase II|Study terminated by sponsor|0|||
16490470|NCT02732119|40270291|FG003|Phase II|Study terminated by sponsor|2|||
16490471|NCT02732119|40270292|FG004|Phase II|Study terminated by sponsor|2|||
16490472|NCT02732119|40270288|FG000|Phase II|Other|0|||
16490473|NCT02732119|40270289|FG001|Phase II|Other|0|||
16490474|NCT02732119|40270290|FG002|Phase II|Other|0|||
16490475|NCT02732119|40270291|FG003|Phase II|Other|2|||
16490476|NCT02732119|40270292|FG004|Phase II|Other|0|||
16490477|NCT02732119|40270288|FG000|Phase II|Physician Decision|0|||
16490478|NCT02732119|40270289|FG001|Phase II|Physician Decision|0|||
16490479|NCT02732119|40270290|FG002|Phase II|Physician Decision|0|||
16490480|NCT02732119|40270291|FG003|Phase II|Physician Decision|8|||
16490481|NCT02732119|40270292|FG004|Phase II|Physician Decision|5|||
16301351|NCT01783886|39589430|FG000|Overall Study|Withdrawal of consent by participant|1|||
16301352|NCT01783886|39589431|FG001|Overall Study|Withdrawal of consent by participant|3|||
16301353|NCT01783886|39589432|FG002|Overall Study|Withdrawal of consent by participant|4|||
16301354|NCT01783886|39589430|FG000|Overall Study|Adverse Event|4|||
16301355|NCT01783886|39589431|FG001|Overall Study|Adverse Event|5|||
16490482|NCT00602797|40270295|FG000|Overall Study|Adverse Event|1|||
16490483|NCT03020160|40270299|FG000|Overall Study|Withdrawal by Subject|1|||
16490484|NCT03020160|40270300|FG001|Overall Study|Withdrawal by Subject|0|||
16490485|NCT01594281|40270301|FG000|Interventional Core Phase|Protocol Deviation|1|||
16490486|NCT01594281|40270302|FG001|Interventional Core Phase|Protocol Deviation|0|||
16490487|NCT01594281|40270303|FG002|Interventional Core Phase|Protocol Deviation|0|||
16490488|NCT01594281|40270301|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
16490489|NCT01594281|40270302|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
16490490|NCT01594281|40270303|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
16490491|NCT01594281|40270301|FG000|Interventional Core Phase|Death|1|||
16490492|NCT01594281|40270302|FG001|Interventional Core Phase|Death|1|||
16490493|NCT01594281|40270303|FG002|Interventional Core Phase|Death|2|||
16301356|NCT01783886|39589432|FG002|Overall Study|Adverse Event|4|||
16301357|NCT00345631|39589433|FG000|Overall Study|Withdrawal by Subject|1|||
16301358|NCT00345631|39589434|FG001|Overall Study|Withdrawal by Subject|0|||
16301359|NCT00345631|39589435|FG002|Overall Study|Withdrawal by Subject|1|||
16301360|NCT00345631|39589433|FG000|Overall Study|Adverse Event|0|||
16301361|NCT00345631|39589434|FG001|Overall Study|Adverse Event|1|||
16301362|NCT00345631|39589435|FG002|Overall Study|Adverse Event|0|||
16301363|NCT00345631|39589433|FG000|Overall Study|Lost to Follow-up|3|||
16301364|NCT00345631|39589434|FG001|Overall Study|Lost to Follow-up|7|||
16301365|NCT00345631|39589435|FG002|Overall Study|Lost to Follow-up|4|||
16301366|NCT00345631|39589433|FG000|Overall Study|Other reasons|0|||
16301367|NCT00345631|39589434|FG001|Overall Study|Other reasons|0|||
16301368|NCT00345631|39589435|FG002|Overall Study|Other reasons|1|||
16301369|NCT01653912|39589436|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
16301370|NCT01653912|39589437|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
16301371|NCT01653912|39589438|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
16301372|NCT01653912|39589439|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
16301373|NCT01653912|39589440|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
16301374|NCT01653912|39589441|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
16301375|NCT01653912|39589436|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
16301376|NCT01653912|39589437|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
16301377|NCT01653912|39589438|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
16301378|NCT01653912|39589439|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
16301379|NCT01653912|39589440|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
16301380|NCT01653912|39589441|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
16301381|NCT01653912|39589436|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
16301382|NCT01653912|39589437|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
16301383|NCT01653912|39589438|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
16301384|NCT01653912|39589439|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
16301385|NCT01653912|39589440|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
16301386|NCT01653912|39589441|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
16301387|NCT01653912|39589436|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
16301388|NCT01653912|39589437|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
16301389|NCT01653912|39589438|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
16301390|NCT01653912|39589439|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
16301391|NCT01653912|39589440|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
16301392|NCT01653912|39589441|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
16301393|NCT01653912|39589436|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
16301394|NCT01653912|39589437|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
16301395|NCT01653912|39589438|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
16301396|NCT01653912|39589439|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
16301397|NCT01653912|39589440|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
16301398|NCT01653912|39589441|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
16301399|NCT01653912|39589436|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
16301400|NCT01653912|39589437|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
16301401|NCT01653912|39589438|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
16301402|NCT01653912|39589439|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
16301403|NCT01653912|39589440|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
16301404|NCT01653912|39589441|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
16301405|NCT01653912|39589436|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
16301406|NCT01653912|39589437|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
16301407|NCT01653912|39589438|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
16301408|NCT01653912|39589439|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
16301409|NCT01653912|39589440|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
16301410|NCT01653912|39589441|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
16301411|NCT01559389|39589442|FG000|Overall Study|Withdrawal by Subject|20|||
16301412|NCT01559389|39589443|FG001|Overall Study|Withdrawal by Subject|20|||
16301413|NCT02766283|39589446|FG000|Overall Study|Lost to Follow-up|27|||
16301414|NCT04040192|39589447|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
16301415|NCT04040192|39589448|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
16301416|NCT04040192|39589449|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
16301417|NCT04040192|39589447|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
16301418|NCT04040192|39589448|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
16301419|NCT04040192|39589449|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
16301420|NCT04040192|39589447|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
16301421|NCT04040192|39589448|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
16301422|NCT04040192|39589449|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
16301423|NCT04040192|39589447|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
16301424|NCT04040192|39589448|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
16301425|NCT04040192|39589449|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
16301426|NCT04040192|39589447|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
16301427|NCT04040192|39589448|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
16301428|NCT04040192|39589449|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
16301429|NCT04040192|39589447|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
16301430|NCT04040192|39589448|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
16301431|NCT04040192|39589449|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
16301432|NCT04040192|39589447|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
16301433|NCT04040192|39589448|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
16301434|NCT04040192|39589449|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
16301435|NCT04040192|39589447|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
16301436|NCT04040192|39589448|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
16301437|NCT04040192|39589449|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
16301438|NCT04040192|39589447|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
16301439|NCT04040192|39589448|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
16301440|NCT04040192|39589449|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
16301441|NCT04040192|39589447|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
16301442|NCT04040192|39589448|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
16301443|NCT04040192|39589449|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
16301444|NCT04040192|39589447|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
16301445|NCT04040192|39589448|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
16301446|NCT04040192|39589449|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
16301447|NCT04040192|39589447|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
16301448|NCT04040192|39589448|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
16301449|NCT04040192|39589449|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
16301450|NCT04040192|39589447|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
16301451|NCT04040192|39589448|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
16301452|NCT04040192|39589449|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
16301453|NCT04040192|39589447|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
16301454|NCT04040192|39589448|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
16301455|NCT04040192|39589449|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
16301456|NCT04040192|39589447|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
16301457|NCT04040192|39589448|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
16301458|NCT04040192|39589449|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
16301459|NCT04040192|39589447|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
16301460|NCT04040192|39589448|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
16301461|NCT04040192|39589449|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
16301462|NCT04040192|39589447|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
16301463|NCT04040192|39589448|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
16301464|NCT04040192|39589449|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
16301465|NCT01374269|39589450|FG000|Overall Study|Withdrawal by Subject|4|||
16301466|NCT01374269|39589451|FG001|Overall Study|Withdrawal by Subject|0|||
16301467|NCT01374269|39589450|FG000|Overall Study|Lost to Follow-up|1|||
16301468|NCT01374269|39589451|FG001|Overall Study|Lost to Follow-up|3|||
16301469|NCT01374269|39589450|FG000|Overall Study|closed research|1|||
16301470|NCT01374269|39589451|FG001|Overall Study|closed research|2|||
16301471|NCT03097991|39589452|FG000|Overall Study|Didn't meet study criteria|8|||
16301472|NCT03097991|39589453|FG001|Overall Study|Didn't meet study criteria|0|||
16301473|NCT03097991|39589452|FG000|Overall Study|Withdrawal by Subject|12|||
16301474|NCT03097991|39589453|FG001|Overall Study|Withdrawal by Subject|6|||
16301475|NCT03097991|39589452|FG000|Overall Study|Death of Baby|3|||
16301476|NCT03097991|39589453|FG001|Overall Study|Death of Baby|1|||
16301477|NCT03097991|39589452|FG000|Overall Study|Lost to Follow-up|24|||
16301478|NCT03097991|39589453|FG001|Overall Study|Lost to Follow-up|38|||
16301479|NCT03097991|39589452|FG000|Overall Study|Adverse Event|3|||
16301480|NCT03097991|39589453|FG001|Overall Study|Adverse Event|5|||
16301481|NCT02227446|39589454|FG000|Overall Study|not eligible post randomization|18|||
16301482|NCT02227446|39589455|FG001|Overall Study|not eligible post randomization|29|||
16301483|NCT02227446|39589454|FG000|Overall Study|Withdrawal by Subject|4|||
16301484|NCT02227446|39589455|FG001|Overall Study|Withdrawal by Subject|5|||
16301485|NCT00948155|39589458|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
16301486|NCT00948155|39589459|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
16301487|NCT00948155|39589458|FG000|Washout 14 Days|Lost to Follow-up|1|||
16301488|NCT00948155|39589459|FG001|Washout 14 Days|Lost to Follow-up|2|||
16301489|NCT02052011|39589460|FG000|Overall Study|Lost to Follow-up|3|||
16301490|NCT02052011|39589461|FG001|Overall Study|Lost to Follow-up|0|||
16387609|NCT00237042|39902684|FG000|Treatment|Moved out of state|1|||
16301491|NCT02052011|39589460|FG000|Overall Study|Withdrawal by Subject|1|||
16301492|NCT02052011|39589461|FG001|Overall Study|Withdrawal by Subject|2|||
16301493|NCT04036110|39589462|FG000|Overall Study|Lost to Follow-up|3|||
16301494|NCT04036110|39589463|FG001|Overall Study|Lost to Follow-up|2|||
16301495|NCT04036110|39589464|FG002|Overall Study|Lost to Follow-up|1|||
16301496|NCT04036110|39589462|FG000|Overall Study|Study Suspended|4|||
16301497|NCT04036110|39589463|FG001|Overall Study|Study Suspended|5|||
16301498|NCT04036110|39589464|FG002|Overall Study|Study Suspended|1|||
16301499|NCT01450683|39589466|FG000|Overall Study|Adverse Event|2|||
16301500|NCT02540850|39589480|FG000|Overall Study|Lost to Follow-up|69|||
16301501|NCT02540850|39589481|FG001|Overall Study|Lost to Follow-up|66|||
16301502|NCT02540850|39589482|FG002|Overall Study|Lost to Follow-up|34|||
16301503|NCT02096744|39589494|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
16301504|NCT02096744|39589495|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
16301505|NCT02096744|39589494|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
16301506|NCT02096744|39589495|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
16301507|NCT02096744|39589494|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
16301508|NCT02096744|39589495|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
16301509|NCT00456300|39589496|FG000|Overall Study|Adverse Event|1|||
16301510|NCT00456300|39589497|FG001|Overall Study|Adverse Event|0|||
16301511|NCT02682927|39589498|FG000|Overall Study|Adverse Event|0|||
16301512|NCT02682927|39589499|FG001|Overall Study|Adverse Event|0|||
16301513|NCT02682927|39589500|FG002|Overall Study|Adverse Event|5|||
16301514|NCT02682927|39589501|FG003|Overall Study|Adverse Event|1|||
16301515|NCT02682927|39589502|FG004|Overall Study|Adverse Event|0|||
16301516|NCT02682927|39589503|FG005|Overall Study|Adverse Event|2|||
16301517|NCT02682927|39589498|FG000|Overall Study|Death|0|||
16301518|NCT02682927|39589499|FG001|Overall Study|Death|0|||
16301519|NCT02682927|39589500|FG002|Overall Study|Death|0|||
16301520|NCT02682927|39589501|FG003|Overall Study|Death|1|||
16301521|NCT02682927|39589502|FG004|Overall Study|Death|0|||
16301522|NCT02682927|39589503|FG005|Overall Study|Death|0|||
16301523|NCT02682927|39589498|FG000|Overall Study|Lack of Efficacy|1|||
16301524|NCT02682927|39589499|FG001|Overall Study|Lack of Efficacy|0|||
16301525|NCT02682927|39589500|FG002|Overall Study|Lack of Efficacy|0|||
16301526|NCT02682927|39589501|FG003|Overall Study|Lack of Efficacy|1|||
16301527|NCT02682927|39589502|FG004|Overall Study|Lack of Efficacy|0|||
16301528|NCT02682927|39589503|FG005|Overall Study|Lack of Efficacy|0|||
16301529|NCT02682927|39589498|FG000|Overall Study|Other|0|||
16301530|NCT02682927|39589499|FG001|Overall Study|Other|0|||
16301531|NCT02682927|39589500|FG002|Overall Study|Other|0|||
16301532|NCT02682927|39589501|FG003|Overall Study|Other|2|||
16301533|NCT02682927|39589502|FG004|Overall Study|Other|0|||
16301534|NCT02682927|39589503|FG005|Overall Study|Other|0|||
16301535|NCT02682927|39589498|FG000|Overall Study|Withdrawal by Subject|2|||
16301536|NCT02682927|39589499|FG001|Overall Study|Withdrawal by Subject|0|||
16301537|NCT02682927|39589500|FG002|Overall Study|Withdrawal by Subject|1|||
16301538|NCT02682927|39589501|FG003|Overall Study|Withdrawal by Subject|0|||
16301539|NCT02682927|39589502|FG004|Overall Study|Withdrawal by Subject|1|||
16301540|NCT02682927|39589503|FG005|Overall Study|Withdrawal by Subject|1|||
16301541|NCT01199016|39589504|FG000|Overall Study|No longer meets eligibility criteria|4|||
16301542|NCT01199016|39589504|FG000|Overall Study|Entrance criteria|5|||
16301543|NCT01199016|39589504|FG000|Overall Study|Protocol Violation|9|||
16301544|NCT01199016|39589504|FG000|Overall Study|Other|13|||
16301545|NCT01199016|39589504|FG000|Overall Study|Withdrawal by Subject|21|||
16301546|NCT01199016|39589504|FG000|Overall Study|Lost to Follow-up|25|||
16301547|NCT00625872|39589505|FG000|Overall Study|Withdrawal by Subject|1|||
16301548|NCT00625872|39589506|FG001|Overall Study|Withdrawal by Subject|0|||
16301549|NCT00625872|39589505|FG000|Overall Study|Does not meet inclusion criteria|1|||
16301550|NCT00625872|39589506|FG001|Overall Study|Does not meet inclusion criteria|0|||
16301551|NCT00625872|39589505|FG000|Overall Study|Terminated by sponsor|2|||
16301552|NCT00625872|39589506|FG001|Overall Study|Terminated by sponsor|5|||
16301553|NCT00625872|39589505|FG000|Overall Study|Randomized but not treated|0|||
16301554|NCT00625872|39589506|FG001|Overall Study|Randomized but not treated|1|||
16301555|NCT01973595|39589509|FG000|Washout|Withdrawal by Subject|1|||
16490494|NCT01594281|40270301|FG000|Interventional Core Phase|Lost to Follow-up|1|||
16490495|NCT01594281|40270302|FG001|Interventional Core Phase|Lost to Follow-up|4|||
16301556|NCT01973595|39589510|FG001|Washout|Withdrawal by Subject|0|||
16301557|NCT01973595|39589511|FG002|Washout|Withdrawal by Subject|1|||
16301558|NCT01973595|39589512|FG003|Washout|Withdrawal by Subject|0|||
16301559|NCT02108912|39589513|FG000|Overall Study|Lost to Follow-up|1|||
16301560|NCT02108912|39589514|FG001|Overall Study|Lost to Follow-up|1|||
16301561|NCT02108912|39589513|FG000|Overall Study|lack of transportation|1|||
16301562|NCT02108912|39589514|FG001|Overall Study|lack of transportation|0|||
16301563|NCT02108912|39589513|FG000|Overall Study|high blood pressure|1|||
16301564|NCT02108912|39589514|FG001|Overall Study|high blood pressure|0|||
16301565|NCT00233948|39589518|FG000|Overall Study|Adverse Event|1|||
16301566|NCT00233948|39589519|FG001|Overall Study|Adverse Event|0|||
16301567|NCT00233948|39589520|FG002|Overall Study|Adverse Event|0|||
16387610|NCT00237042|39902685|FG001|Treatment|Moved out of state|1|||
16301568|NCT00233948|39589521|FG003|Overall Study|Adverse Event|0|||
16490496|NCT01594281|40270303|FG002|Interventional Core Phase|Lost to Follow-up|1|||
16490497|NCT01594281|40270301|FG000|Interventional Core Phase|Adverse Event|4|||
16301569|NCT00233948|39589522|FG004|Overall Study|Adverse Event|0|||
16301570|NCT00233948|39589523|FG005|Overall Study|Adverse Event|0|||
16301571|NCT03278626|39589527|FG000|Overall Study|Death|2|||
16301572|NCT03278626|39589527|FG000|Overall Study|Toxicity|1|||
16301573|NCT03278626|39589527|FG000|Overall Study|Disease Progression|2|||
16301574|NCT01085357|39589528|FG000|Overall Study|Adverse Event|1|||
16301575|NCT01085357|39589529|FG001|Overall Study|Adverse Event|1|||
16301576|NCT01085357|39589528|FG000|Overall Study|Subject Decision|4|||
16301577|NCT01085357|39589529|FG001|Overall Study|Subject Decision|3|||
16301578|NCT01085357|39589528|FG000|Overall Study|Investigator Decision|1|||
16301579|NCT01085357|39589529|FG001|Overall Study|Investigator Decision|1|||
16301580|NCT01085357|39589528|FG000|Overall Study|Death|11|||
16301581|NCT01085357|39589529|FG001|Overall Study|Death|1|||
16301582|NCT01085357|39589528|FG000|Overall Study|Lost to Follow-up|2|||
16301583|NCT01085357|39589529|FG001|Overall Study|Lost to Follow-up|0|||
16301584|NCT02257385|39589533|FG000|Overall Study|Adverse Event|12|||
16301585|NCT02257385|39589534|FG001|Overall Study|Adverse Event|8|||
16301586|NCT02257385|39589533|FG000|Overall Study|Lack of Efficacy|1|||
16301587|NCT02257385|39589534|FG001|Overall Study|Lack of Efficacy|2|||
16301588|NCT02257385|39589533|FG000|Overall Study|Protocol Violation|5|||
16301589|NCT02257385|39589534|FG001|Overall Study|Protocol Violation|7|||
16301590|NCT02257385|39589533|FG000|Overall Study|Lost to Follow-up|0|||
16301591|NCT02257385|39589534|FG001|Overall Study|Lost to Follow-up|1|||
16301592|NCT02257385|39589533|FG000|Overall Study|Withdrawal by Subject|4|||
16301593|NCT02257385|39589534|FG001|Overall Study|Withdrawal by Subject|4|||
16301594|NCT03510598|39589538|FG000|Overall Study|Withdrawal by Subject|1|||
16301595|NCT03196635|39589539|FG000|Overall Study|Withdrawal by Subject|1|||
16301596|NCT04007991|39589540|FG000|Overall Study|Withdrawal by Subject|1|||
16301597|NCT04007991|39589541|FG001|Overall Study|Withdrawal by Subject|1|||
16301598|NCT04007991|39589540|FG000|Overall Study|Physician Decision|1|||
16301599|NCT04007991|39589541|FG001|Overall Study|Physician Decision|1|||
16301600|NCT04007991|39589540|FG000|Overall Study|Non-compliance with Study Drug|0|||
16301601|NCT04007991|39589541|FG001|Overall Study|Non-compliance with Study Drug|1|||
16301602|NCT04007991|39589540|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
16301603|NCT04007991|39589541|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
16301604|NCT04007991|39589540|FG000|Overall Study|Adverse event, non-fatal|5|||
16301605|NCT04007991|39589541|FG001|Overall Study|Adverse event, non-fatal|0|||
16301606|NCT04007991|39589540|FG000|Overall Study|Lost to Follow-up|2|||
16301607|NCT04007991|39589541|FG001|Overall Study|Lost to Follow-up|1|||
16301608|NCT00813800|39589542|FG000|Overall Study|Screen Failure after Consent|2|||
16301609|NCT00813800|39589542|FG000|Overall Study|Adverse Event|1|||
16301610|NCT00813800|39589542|FG000|Overall Study|Worsening of depression|2|||
16301611|NCT00813800|39589542|FG000|Overall Study|Physician Decision|1|||
16301612|NCT01434810|39589543|FG000|Overall Study|Did not receive treatment|11|||
16301613|NCT01434810|39589544|FG001|Overall Study|Did not receive treatment|3|||
16301614|NCT01434810|39589543|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
16301615|NCT01434810|39589544|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
16301616|NCT00799825|39589547|FG000|Overall Study|Adverse Event|1|||
16301617|NCT00799825|39589547|FG000|Overall Study|Withdrawal by Subject|6|||
16301618|NCT00799825|39589547|FG000|Overall Study|Lost to Follow-up|38|||
16301619|NCT00799825|39589547|FG000|Overall Study|Pregnancy|3|||
16301620|NCT01756079|39589548|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
16301621|NCT01756079|39589548|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
16301622|NCT01756079|39589548|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
16301623|NCT01756079|39589548|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
16301624|NCT01756079|39589548|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
16301625|NCT04194645|39589551|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301626|NCT04194645|39589552|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301627|NCT04194645|39589553|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301628|NCT04194645|39589554|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301629|NCT04194645|39589555|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301630|NCT04194645|39589556|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301631|NCT04194645|39589557|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301632|NCT04194645|39589558|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301633|NCT04194645|39589559|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301634|NCT04194645|39589560|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
16301635|NCT04194645|39589561|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301636|NCT04194645|39589562|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301637|NCT04194645|39589563|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301638|NCT04194645|39589564|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301639|NCT04194645|39589565|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
16301640|NCT03485352|39589566|FG000|Overall Study|Lost to Follow-up|9|||
16301641|NCT03132155|39589569|FG000|Overall Study|Lack of Efficacy|6|||
16301642|NCT03132155|39589569|FG000|Overall Study|Lost to Follow-up|1|||
16301643|NCT03132155|39589569|FG000|Overall Study|Withdrawal by Subject|1|||
16301644|NCT01625988|39589570|FG000|Overall Study|Lost to Follow-up|5|||
16301645|NCT01625988|39589571|FG001|Overall Study|Lost to Follow-up|6|||
16301646|NCT01625988|39589570|FG000|Overall Study|Withdrawal by Subject|8|||
16301647|NCT01625988|39589571|FG001|Overall Study|Withdrawal by Subject|3|||
16301648|NCT01625988|39589570|FG000|Overall Study|Adverse Event|0|||
16301649|NCT01625988|39589571|FG001|Overall Study|Adverse Event|1|||
16301650|NCT01625988|39589570|FG000|Overall Study|Lack of Efficacy|0|||
16301651|NCT01625988|39589571|FG001|Overall Study|Lack of Efficacy|1|||
16301652|NCT01625988|39589570|FG000|Overall Study|Randomized Inappropriately|1|||
16301653|NCT01625988|39589571|FG001|Overall Study|Randomized Inappropriately|0|||
16301654|NCT01625988|39589570|FG000|Overall Study|Protocol Violation|0|||
16301655|NCT01625988|39589571|FG001|Overall Study|Protocol Violation|2|||
16301656|NCT04233073|39589572|FG000|Overall Study|Death|5|||
16301657|NCT02960490|39589573|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
16301658|NCT02960490|39589574|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
16301659|NCT02960490|39589575|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
16301660|NCT02960490|39589576|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
16301661|NCT02960490|39589577|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
16301662|NCT02960490|39589578|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
16301663|NCT02960490|39589579|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
16301664|NCT02960490|39589580|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
16301665|NCT02960490|39589581|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
16301666|NCT02960490|39589582|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
16301667|NCT02960490|39589573|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
16301668|NCT02960490|39589574|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
16301669|NCT02960490|39589575|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
16301670|NCT02960490|39589576|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
16301671|NCT02960490|39589577|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
16301672|NCT02960490|39589578|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
16301673|NCT02960490|39589579|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
16301674|NCT02960490|39589580|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
16301675|NCT02960490|39589581|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
16301676|NCT02960490|39589582|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
16301677|NCT02960490|39589573|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
16490498|NCT01594281|40270302|FG001|Interventional Core Phase|Adverse Event|4|||
16490499|NCT01594281|40270303|FG002|Interventional Core Phase|Adverse Event|4|||
16301678|NCT02960490|39589574|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
16301679|NCT02960490|39589575|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
16301680|NCT02960490|39589576|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
16301681|NCT02960490|39589577|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
16301682|NCT02960490|39589578|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
16301683|NCT02960490|39589579|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
16301684|NCT02960490|39589580|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
16301685|NCT02960490|39589581|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
16301686|NCT02960490|39589582|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
16301687|NCT02960490|39589573|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
16301688|NCT02960490|39589574|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
16301689|NCT02960490|39589575|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
16301690|NCT02960490|39589576|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
16301691|NCT02960490|39589577|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
16301692|NCT02960490|39589578|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
16301693|NCT02960490|39589579|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
16301694|NCT02960490|39589580|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
16301695|NCT02960490|39589581|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
16301696|NCT02960490|39589582|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
16301697|NCT02960490|39589573|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
16301698|NCT02960490|39589574|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
16301699|NCT02960490|39589575|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
16301700|NCT02960490|39589576|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
16490500|NCT01594281|40270301|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
16490501|NCT01594281|40270302|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
16490502|NCT01594281|40270303|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
16490503|NCT01594281|40270301|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
16301701|NCT02960490|39589577|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
16301702|NCT02960490|39589578|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
16490504|NCT01594281|40270302|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
16490505|NCT01594281|40270303|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
16301703|NCT02960490|39589579|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
16301704|NCT02960490|39589580|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
16301705|NCT02960490|39589581|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
16301706|NCT02960490|39589582|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
16301707|NCT02960490|39589573|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
16301708|NCT02960490|39589574|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
16301709|NCT02960490|39589575|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
16301710|NCT02960490|39589576|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
16301711|NCT02960490|39589577|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
16301712|NCT02960490|39589578|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
16301713|NCT02960490|39589579|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
16301714|NCT02960490|39589580|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
16301715|NCT02960490|39589581|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
16301716|NCT02960490|39589582|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
16301717|NCT02960490|39589573|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
16301718|NCT02960490|39589574|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
16301719|NCT02960490|39589575|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
16301720|NCT02960490|39589576|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
16301721|NCT02960490|39589577|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
16301722|NCT02960490|39589578|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
16301723|NCT02960490|39589579|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
16301724|NCT02960490|39589580|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
16301725|NCT02960490|39589581|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
16301726|NCT02960490|39589582|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
16301727|NCT02960490|39589573|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
16301728|NCT02960490|39589574|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
16301729|NCT02960490|39589575|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
16301730|NCT02960490|39589576|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
16301731|NCT02960490|39589577|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
16301732|NCT02960490|39589578|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
16301733|NCT02960490|39589579|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
16301734|NCT02960490|39589580|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
16301735|NCT02960490|39589581|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
16301736|NCT02960490|39589582|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
16301737|NCT02960490|39589573|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
16301738|NCT02960490|39589574|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
16301739|NCT02960490|39589575|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
16301740|NCT02960490|39589576|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
16301741|NCT02960490|39589577|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
16301742|NCT02960490|39589578|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
16301743|NCT02960490|39589579|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
16301744|NCT02960490|39589580|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
16301745|NCT02960490|39589581|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
16301746|NCT02960490|39589582|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
16301747|NCT02960490|39589573|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
16387611|NCT00237042|39902686|FG002|Treatment|Moved out of state|1|||
16387612|NCT00237042|39902684|FG000|Treatment|Completed no treatment|5|||
16387613|NCT00237042|39902685|FG001|Treatment|Completed no treatment|5|||
16387614|NCT00237042|39902686|FG002|Treatment|Completed no treatment|21|||
16387615|NCT00237042|39902684|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
16387616|NCT00237042|39902685|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
16387617|NCT00237042|39902686|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
16387618|NCT00237042|39902684|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
16387619|NCT00237042|39902685|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
16387620|NCT00237042|39902686|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
16387621|NCT01847755|39902690|FG000|Overall Study|Adverse Event|2|||
16387622|NCT01847755|39902690|FG000|Overall Study|Withdrawal by Subject|2|||
16387623|NCT01847755|39902690|FG000|Overall Study|Physician Decision|1|||
16387624|NCT02465931|39902691|FG000|Overall Study|Lost to Follow-up|9|||
16387625|NCT02465931|39902692|FG001|Overall Study|Lost to Follow-up|11|||
16387626|NCT02465931|39902691|FG000|Overall Study|Protocol Violation|1|||
16387627|NCT02465931|39902692|FG001|Overall Study|Protocol Violation|0|||
16387628|NCT02465931|39902691|FG000|Overall Study|Withdrawal by Subject|1|||
16192790|NCT01533935|39185152|FG004|Overall Study|Withdrawal by Subject|4|||
16387629|NCT02465931|39902692|FG001|Overall Study|Withdrawal by Subject|0|||
16387630|NCT01402869|39902695|FG000|Overall Study|Required Tooth Extraction|0|||
16387631|NCT01402869|39902696|FG001|Overall Study|Required Tooth Extraction|0|||
16387632|NCT01402869|39902697|FG002|Overall Study|Required Tooth Extraction|1|||
16387633|NCT03789292|39902698|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
16387634|NCT03789292|39902699|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
16387635|NCT03789292|39902700|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
16387636|NCT03789292|39902698|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
16387637|NCT03789292|39902699|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
16387638|NCT03789292|39902700|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
16387639|NCT03789292|39902698|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
16387640|NCT03789292|39902699|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
16387641|NCT03789292|39902700|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
16387642|NCT03789292|39902698|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
16387643|NCT03789292|39902699|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
16387644|NCT03789292|39902700|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
16387645|NCT03789292|39902698|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
16387646|NCT03789292|39902699|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
16387647|NCT03789292|39902700|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
16387648|NCT03789292|39902698|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
16387649|NCT03789292|39902699|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
16387650|NCT03789292|39902700|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
16387651|NCT03789292|39902698|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
16387652|NCT03789292|39902699|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
16387653|NCT03789292|39902700|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
16387654|NCT03789292|39902698|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
16387655|NCT03789292|39902699|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
16387656|NCT03789292|39902700|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
16387657|NCT03789292|39902698|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
16387658|NCT03789292|39902699|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
16387659|NCT03789292|39902700|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
16387660|NCT03789292|39902698|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
16387661|NCT03789292|39902699|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
16387662|NCT03789292|39902700|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
16387663|NCT03789292|39902698|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
16387664|NCT03789292|39902699|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
16387665|NCT03789292|39902700|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
16387666|NCT03789292|39902698|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
16387667|NCT03789292|39902699|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
16387668|NCT03789292|39902700|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
16387669|NCT03789292|39902698|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
16387670|NCT03789292|39902699|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
16387671|NCT03789292|39902700|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
16387672|NCT01976299|39902701|FG000|Overall Study|Withdrawal by Subject|3|||
16387673|NCT01976299|39902702|FG001|Overall Study|Withdrawal by Subject|1|||
16387674|NCT01976299|39902701|FG000|Overall Study|Death|4|||
16387675|NCT01976299|39902702|FG001|Overall Study|Death|2|||
16387676|NCT01976299|39902701|FG000|Overall Study|Lost to Follow-up|7|||
16387677|NCT01976299|39902702|FG001|Overall Study|Lost to Follow-up|1|||
16387678|NCT01976299|39902701|FG000|Overall Study|See clarification above in comments|9|||
16387679|NCT01976299|39902702|FG001|Overall Study|See clarification above in comments|2|||
16387680|NCT00856323|39902704|FG000|Overall Study|Withdrawal by Subject|2|||
16387681|NCT01644643|39902705|FG000|Overall Study|Death|1|||
16387682|NCT01644643|39902706|FG001|Overall Study|Death|0|||
16387683|NCT01644643|39902707|FG002|Overall Study|Death|3|||
16387684|NCT01644643|39902708|FG003|Overall Study|Death|3|||
16387685|NCT01644643|39902705|FG000|Overall Study|Lost to Follow-up|0|||
16387686|NCT01644643|39902706|FG001|Overall Study|Lost to Follow-up|0|||
16387687|NCT01644643|39902707|FG002|Overall Study|Lost to Follow-up|0|||
16387688|NCT01644643|39902708|FG003|Overall Study|Lost to Follow-up|4|||
16387689|NCT01644643|39902705|FG000|Overall Study|Withdrawal by Subject|1|||
16387690|NCT01644643|39902706|FG001|Overall Study|Withdrawal by Subject|0|||
16387691|NCT01644643|39902707|FG002|Overall Study|Withdrawal by Subject|2|||
16387692|NCT01644643|39902708|FG003|Overall Study|Withdrawal by Subject|1|||
16387693|NCT01644643|39902705|FG000|Overall Study|Other Eligibility criteria|0|||
16387694|NCT01644643|39902706|FG001|Overall Study|Other Eligibility criteria|0|||
16387695|NCT01644643|39902707|FG002|Overall Study|Other Eligibility criteria|0|||
16387696|NCT01644643|39902708|FG003|Overall Study|Other Eligibility criteria|2|||
16387697|NCT02012218|39902714|FG000|Overall Study|Withdrawal by Subject|1|||
16387698|NCT02012218|39902715|FG001|Overall Study|Withdrawal by Subject|0|||
16387699|NCT02012218|39902716|FG002|Overall Study|Withdrawal by Subject|1|||
16387700|NCT02012218|39902717|FG003|Overall Study|Withdrawal by Subject|1|||
16387701|NCT02012218|39902718|FG004|Overall Study|Withdrawal by Subject|1|||
16387702|NCT02012218|39902714|FG000|Overall Study|Adverse Event|1|||
16387703|NCT02012218|39902715|FG001|Overall Study|Adverse Event|0|||
16387704|NCT02012218|39902716|FG002|Overall Study|Adverse Event|0|||
16387705|NCT02012218|39902717|FG003|Overall Study|Adverse Event|1|||
16387706|NCT02012218|39902718|FG004|Overall Study|Adverse Event|0|||
16387707|NCT02012218|39902714|FG000|Overall Study|Lost to Follow-up|0|||
16387708|NCT02012218|39902715|FG001|Overall Study|Lost to Follow-up|1|||
16387709|NCT02012218|39902716|FG002|Overall Study|Lost to Follow-up|1|||
16387710|NCT02012218|39902717|FG003|Overall Study|Lost to Follow-up|0|||
16387711|NCT02012218|39902718|FG004|Overall Study|Lost to Follow-up|0|||
16387712|NCT02012218|39902714|FG000|Overall Study|Protocol Specified|1|||
16387713|NCT02012218|39902715|FG001|Overall Study|Protocol Specified|0|||
16387714|NCT02012218|39902716|FG002|Overall Study|Protocol Specified|0|||
16387715|NCT02012218|39902717|FG003|Overall Study|Protocol Specified|0|||
16387716|NCT02012218|39902718|FG004|Overall Study|Protocol Specified|0|||
16387717|NCT02012218|39902714|FG000|Overall Study|Protocol Deviation|1|||
16387718|NCT02012218|39902715|FG001|Overall Study|Protocol Deviation|0|||
16387719|NCT02012218|39902716|FG002|Overall Study|Protocol Deviation|0|||
16387720|NCT02012218|39902717|FG003|Overall Study|Protocol Deviation|0|||
16387721|NCT02012218|39902718|FG004|Overall Study|Protocol Deviation|0|||
16387722|NCT01182350|39902719|FG000|Overall Study|Adverse Event|5|||
16387723|NCT01182350|39902720|FG001|Overall Study|Adverse Event|0|||
16387724|NCT01182350|39902721|FG002|Overall Study|Adverse Event|0|||
16301748|NCT02960490|39589574|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
16301749|NCT02960490|39589575|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
16301750|NCT02960490|39589576|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
16301751|NCT02960490|39589577|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
16301752|NCT02960490|39589578|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
16301753|NCT02960490|39589579|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
16301754|NCT02960490|39589580|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
16301755|NCT02960490|39589581|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
16301756|NCT02960490|39589582|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
16301757|NCT02960490|39589573|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
16301758|NCT02960490|39589574|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
16301759|NCT02960490|39589575|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
16301760|NCT02960490|39589576|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
16301761|NCT02960490|39589577|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
16301762|NCT02960490|39589578|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
16301763|NCT02960490|39589579|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
16301764|NCT02960490|39589580|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
16301765|NCT02960490|39589581|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
16301766|NCT02960490|39589582|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
16301767|NCT02960490|39589573|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
16301768|NCT02960490|39589574|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
16301769|NCT02960490|39589575|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
16301770|NCT02960490|39589576|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
16301771|NCT02960490|39589577|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
16301772|NCT02960490|39589578|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
16301773|NCT02960490|39589579|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
16301774|NCT02960490|39589580|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
16301775|NCT02960490|39589581|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
16301776|NCT02960490|39589582|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
16301777|NCT02198963|39589589|FG000|Overall Study|Adverse Event|1|||
16301778|NCT02198963|39589589|FG000|Overall Study|Withdrawal by Subject|6|||
16301779|NCT01121562|39589590|FG000|Overall Study|Objective progression or relapse|8|||
16301780|NCT01121562|39589590|FG000|Overall Study|Withdrawal by Subject|1|||
16301781|NCT01121562|39589590|FG000|Overall Study|Adverse Event|1|||
16301782|NCT01121562|39589590|FG000|Overall Study|Sponsor Decision|1|||
16301783|NCT01121562|39589590|FG000|Overall Study|Met study discontinuation criteria|1|||
16301784|NCT04562155|39589591|FG000|Overall Study|COVID-19 pandemic|0|||
16301785|NCT04562155|39589592|FG001|Overall Study|COVID-19 pandemic|0|||
16301786|NCT04562155|39589593|FG002|Overall Study|COVID-19 pandemic|0|||
16301787|NCT04562155|39589594|FG003|Overall Study|COVID-19 pandemic|1|||
16301788|NCT04562155|39589591|FG000|Overall Study|Adverse Event|7|||
16301789|NCT04562155|39589592|FG001|Overall Study|Adverse Event|3|||
16387725|NCT01182350|39902722|FG003|Overall Study|Adverse Event|0|||
16387726|NCT01182350|39902723|FG004|Overall Study|Adverse Event|0|||
16387727|NCT01182350|39902719|FG000|Overall Study|Disease Progression|15|||
16387728|NCT01182350|39902720|FG001|Overall Study|Disease Progression|12|||
16387729|NCT01182350|39902721|FG002|Overall Study|Disease Progression|0|||
16387730|NCT01182350|39902722|FG003|Overall Study|Disease Progression|1|||
16387731|NCT01182350|39902723|FG004|Overall Study|Disease Progression|0|||
16387732|NCT01182350|39902719|FG000|Overall Study|Death|0|||
16387733|NCT01182350|39902720|FG001|Overall Study|Death|1|||
16387734|NCT01182350|39902721|FG002|Overall Study|Death|1|||
16387735|NCT01182350|39902722|FG003|Overall Study|Death|0|||
16387736|NCT01182350|39902723|FG004|Overall Study|Death|0|||
16387737|NCT01182350|39902719|FG000|Overall Study|Withdrawal by Subject|3|||
16387738|NCT01182350|39902720|FG001|Overall Study|Withdrawal by Subject|1|||
16387739|NCT01182350|39902721|FG002|Overall Study|Withdrawal by Subject|0|||
16387740|NCT01182350|39902722|FG003|Overall Study|Withdrawal by Subject|1|||
16387741|NCT01182350|39902723|FG004|Overall Study|Withdrawal by Subject|0|||
16387742|NCT01182350|39902719|FG000|Overall Study|Alternative Therapy|2|||
16387743|NCT01182350|39902720|FG001|Overall Study|Alternative Therapy|0|||
16387744|NCT01182350|39902721|FG002|Overall Study|Alternative Therapy|1|||
16387745|NCT01182350|39902722|FG003|Overall Study|Alternative Therapy|0|||
16387746|NCT01182350|39902723|FG004|Overall Study|Alternative Therapy|0|||
16387747|NCT01182350|39902719|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
16387748|NCT01182350|39902720|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
16387749|NCT01182350|39902721|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
16301790|NCT04562155|39589593|FG002|Overall Study|Adverse Event|8|||
16301791|NCT04562155|39589594|FG003|Overall Study|Adverse Event|1|||
16301792|NCT04562155|39589591|FG000|Overall Study|Withdrawal by Subject|3|||
16301793|NCT04562155|39589592|FG001|Overall Study|Withdrawal by Subject|6|||
16301794|NCT04562155|39589593|FG002|Overall Study|Withdrawal by Subject|3|||
16301795|NCT04562155|39589594|FG003|Overall Study|Withdrawal by Subject|3|||
16301796|NCT04562155|39589591|FG000|Overall Study|Participant personal reason|1|||
16301797|NCT04562155|39589592|FG001|Overall Study|Participant personal reason|0|||
16301798|NCT04562155|39589593|FG002|Overall Study|Participant personal reason|2|||
16301799|NCT04562155|39589594|FG003|Overall Study|Participant personal reason|1|||
16301800|NCT01715571|39589595|FG000|Overall Study|Lost to Follow-up|8|||
16301801|NCT00402116|39589598|FG000|Overall Study|Jaw infection after surgery-other|1|||
16301802|NCT00402116|39589599|FG001|Overall Study|Jaw infection after surgery-other|0|||
16301803|NCT00402116|39589600|FG002|Overall Study|Jaw infection after surgery-other|0|||
16301804|NCT00402116|39589598|FG000|Overall Study|Withdrawal by Subject|1|||
16301805|NCT00402116|39589599|FG001|Overall Study|Withdrawal by Subject|0|||
16301806|NCT00402116|39589600|FG002|Overall Study|Withdrawal by Subject|5|||
16301807|NCT00402116|39589598|FG000|Overall Study|Treatment completed per protocol|1|||
16301808|NCT00402116|39589599|FG001|Overall Study|Treatment completed per protocol|1|||
16301809|NCT00402116|39589600|FG002|Overall Study|Treatment completed per protocol|2|||
16301810|NCT00402116|39589598|FG000|Overall Study|other complicating disease|0|||
16301811|NCT00402116|39589599|FG001|Overall Study|other complicating disease|0|||
16301812|NCT00402116|39589600|FG002|Overall Study|other complicating disease|2|||
16301813|NCT00402116|39589598|FG000|Overall Study|Disease Progression|0|||
16301814|NCT00402116|39589599|FG001|Overall Study|Disease Progression|4|||
16301815|NCT00402116|39589600|FG002|Overall Study|Disease Progression|38|||
16301816|NCT00402116|39589598|FG000|Overall Study|mistaken thrombocytopenia|0|||
16301817|NCT00402116|39589599|FG001|Overall Study|mistaken thrombocytopenia|0|||
16301818|NCT00402116|39589600|FG002|Overall Study|mistaken thrombocytopenia|1|||
16387750|NCT01182350|39902722|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
16387751|NCT01182350|39902723|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
16387752|NCT01182350|39902719|FG000|Overall Study|Unevaluable for Biopsy|0|||
16387753|NCT01182350|39902720|FG001|Overall Study|Unevaluable for Biopsy|0|||
16387754|NCT01182350|39902721|FG002|Overall Study|Unevaluable for Biopsy|0|||
16387755|NCT01182350|39902722|FG003|Overall Study|Unevaluable for Biopsy|0|||
16387756|NCT01182350|39902723|FG004|Overall Study|Unevaluable for Biopsy|3|||
16387757|NCT00806260|39902724|FG000|Period 1 (1 Day)|Adverse Event|0|||
16490506|NCT01594281|40270301|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
16490507|NCT01594281|40270302|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
16490508|NCT01594281|40270303|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
16490509|NCT00790023|40270304|FG000|Overall Study|Adverse Event|2|||
16490510|NCT00790023|40270305|FG001|Overall Study|Adverse Event|1|||
16490511|NCT00790023|40270306|FG002|Overall Study|Adverse Event|4|||
16490512|NCT00790023|40270304|FG000|Overall Study|Protocol Violation|2|||
16301819|NCT00402116|39589598|FG000|Overall Study|decline related hyponatremia/tumor|0|||
16301820|NCT00402116|39589599|FG001|Overall Study|decline related hyponatremia/tumor|0|||
16301821|NCT00402116|39589600|FG002|Overall Study|decline related hyponatremia/tumor|1|||
16301822|NCT00402116|39589598|FG000|Overall Study|Adverse Event|0|||
16301823|NCT00402116|39589599|FG001|Overall Study|Adverse Event|1|||
16387758|NCT00806260|39902725|FG001|Period 1 (1 Day)|Adverse Event|0|||
16387759|NCT00806260|39902726|FG002|Period 1 (1 Day)|Adverse Event|0|||
16387760|NCT00806260|39902727|FG003|Period 1 (1 Day)|Adverse Event|0|||
16387761|NCT00806260|39902728|FG004|Period 1 (1 Day)|Adverse Event|3|||
16387762|NCT00806260|39902729|FG005|Period 1 (1 Day)|Adverse Event|0|||
16387763|NCT00806260|39902724|FG000|Period 2|Adverse Event|0|||
16387764|NCT00806260|39902725|FG001|Period 2|Adverse Event|0|||
16387765|NCT00806260|39902726|FG002|Period 2|Adverse Event|0|||
16490513|NCT00790023|40270305|FG001|Overall Study|Protocol Violation|4|||
16490514|NCT00790023|40270306|FG002|Overall Study|Protocol Violation|2|||
16490515|NCT00790023|40270304|FG000|Overall Study|Withdrawal by Subject|2|||
16387766|NCT00806260|39902727|FG003|Period 2|Adverse Event|1|||
16301824|NCT00402116|39589600|FG002|Overall Study|Adverse Event|6|||
16301825|NCT00403585|39589604|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
16301826|NCT00403585|39589604|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
16301827|NCT00403585|39589604|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
16301828|NCT04602546|39589610|FG000|Overall Study|Training|2|||
16301829|NCT04602546|39589611|FG001|Overall Study|Training|2|||
16301830|NCT04602546|39589612|FG002|Overall Study|Training|1|||
16301831|NCT04602546|39589613|FG003|Overall Study|Training|2|||
16301832|NCT04602546|39589614|FG004|Overall Study|Training|0|||
16301833|NCT04602546|39589610|FG000|Overall Study|Randomized with disqualified data|2|||
16301834|NCT04602546|39589611|FG001|Overall Study|Randomized with disqualified data|0|||
16301835|NCT04602546|39589612|FG002|Overall Study|Randomized with disqualified data|2|||
16301836|NCT04602546|39589613|FG003|Overall Study|Randomized with disqualified data|5|||
16301837|NCT04602546|39589614|FG004|Overall Study|Randomized with disqualified data|3|||
16301838|NCT00195338|39589615|FG000|Overall Study|Lost to Follow-up|2|||
16301839|NCT00195338|39589615|FG000|Overall Study|Adverse Event|5|||
16301840|NCT00195338|39589615|FG000|Overall Study|Lack of Efficacy|1|||
16301841|NCT00195338|39589615|FG000|Overall Study|Early closure of the site|4|||
16301842|NCT00143390|39589616|FG000|Overall Study|Death|2|||
16301843|NCT00143390|39589617|FG001|Overall Study|Death|0|||
16301844|NCT00143390|39589616|FG000|Overall Study|Not meeting entry criteria|2|||
16301845|NCT00143390|39589617|FG001|Overall Study|Not meeting entry criteria|5|||
16301846|NCT00143390|39589616|FG000|Overall Study|Withdrawal by Subject|4|||
16301847|NCT00143390|39589617|FG001|Overall Study|Withdrawal by Subject|4|||
16301848|NCT00143390|39589616|FG000|Overall Study|Progressive disease|119|||
16301849|NCT00143390|39589617|FG001|Overall Study|Progressive disease|115|||
16301850|NCT00143390|39589616|FG000|Overall Study|Protocol Violation|2|||
16301851|NCT00143390|39589617|FG001|Overall Study|Protocol Violation|0|||
16301852|NCT00143390|39589616|FG000|Overall Study|Study termination|10|||
16301853|NCT00143390|39589617|FG001|Overall Study|Study termination|15|||
16301854|NCT00143390|39589616|FG000|Overall Study|Adverse Event|9|||
16301855|NCT00143390|39589617|FG001|Overall Study|Adverse Event|8|||
16301856|NCT00143390|39589616|FG000|Overall Study|Other|1|||
16301857|NCT00143390|39589617|FG001|Overall Study|Other|2|||
16301858|NCT04759768|39589618|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
16301859|NCT04759768|39589619|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
16301860|NCT04759768|39589618|FG000|Washout (7 Days)|Physician Decision|0|||
16301861|NCT04759768|39589619|FG001|Washout (7 Days)|Physician Decision|1|||
16301862|NCT03323398|39589622|FG000|Overall Study|Other than Specified|0|||
16301863|NCT03323398|39589623|FG001|Overall Study|Other than Specified|1|||
16301864|NCT03323398|39589624|FG002|Overall Study|Other than Specified|2|||
16301865|NCT03323398|39589625|FG003|Overall Study|Other than Specified|0|||
16301866|NCT03323398|39589626|FG004|Overall Study|Other than Specified|0|||
16301867|NCT03323398|39589627|FG005|Overall Study|Other than Specified|0|||
16301868|NCT03323398|39589628|FG006|Overall Study|Other than Specified|1|||
16301869|NCT03323398|39589629|FG007|Overall Study|Other than Specified|0|||
16301870|NCT03323398|39589630|FG008|Overall Study|Other than Specified|2|||
16301871|NCT03323398|39589622|FG000|Overall Study|Lost to Follow-up|1|||
16301872|NCT03323398|39589623|FG001|Overall Study|Lost to Follow-up|2|||
16301873|NCT03323398|39589624|FG002|Overall Study|Lost to Follow-up|1|||
16301874|NCT03323398|39589625|FG003|Overall Study|Lost to Follow-up|0|||
16301875|NCT03323398|39589626|FG004|Overall Study|Lost to Follow-up|0|||
16301876|NCT03323398|39589627|FG005|Overall Study|Lost to Follow-up|0|||
16301877|NCT03323398|39589628|FG006|Overall Study|Lost to Follow-up|0|||
16301878|NCT03323398|39589629|FG007|Overall Study|Lost to Follow-up|0|||
16301879|NCT03323398|39589630|FG008|Overall Study|Lost to Follow-up|0|||
16301880|NCT03323398|39589622|FG000|Overall Study|Death|4|||
16387767|NCT00806260|39902728|FG004|Period 2|Adverse Event|0|||
16301881|NCT03323398|39589623|FG001|Overall Study|Death|6|||
16301882|NCT03323398|39589624|FG002|Overall Study|Death|2|||
16301883|NCT03323398|39589625|FG003|Overall Study|Death|2|||
16301884|NCT03323398|39589626|FG004|Overall Study|Death|1|||
16301885|NCT03323398|39589627|FG005|Overall Study|Death|2|||
16301886|NCT03323398|39589628|FG006|Overall Study|Death|0|||
16301887|NCT03323398|39589629|FG007|Overall Study|Death|0|||
16301888|NCT03323398|39589630|FG008|Overall Study|Death|6|||
16301889|NCT03323398|39589622|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
16387768|NCT00806260|39902729|FG005|Period 2|Adverse Event|0|||
16301890|NCT03323398|39589623|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
16301891|NCT03323398|39589624|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
16301892|NCT03323398|39589625|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
16301893|NCT03323398|39589626|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
16387769|NCT00806260|39902724|FG000|Period 2|Protocol Violation|1|||
16387770|NCT00806260|39902725|FG001|Period 2|Protocol Violation|0|||
16490516|NCT00790023|40270305|FG001|Overall Study|Withdrawal by Subject|0|||
16387771|NCT00806260|39902726|FG002|Period 2|Protocol Violation|1|||
16387772|NCT00806260|39902727|FG003|Period 2|Protocol Violation|0|||
16387773|NCT00806260|39902728|FG004|Period 2|Protocol Violation|0|||
16387774|NCT00806260|39902729|FG005|Period 2|Protocol Violation|0|||
16387775|NCT00806260|39902724|FG000|Period 2|Need to take concomitant medication|1|||
16387776|NCT00806260|39902725|FG001|Period 2|Need to take concomitant medication|0|||
16387777|NCT00806260|39902726|FG002|Period 2|Need to take concomitant medication|0|||
16387778|NCT00806260|39902727|FG003|Period 2|Need to take concomitant medication|0|||
16387779|NCT00806260|39902728|FG004|Period 2|Need to take concomitant medication|0|||
16387780|NCT00806260|39902729|FG005|Period 2|Need to take concomitant medication|0|||
16387781|NCT00806260|39902724|FG000|Period 2|sponsor request|0|||
16387782|NCT00806260|39902725|FG001|Period 2|sponsor request|0|||
16387783|NCT00806260|39902726|FG002|Period 2|sponsor request|1|||
16387784|NCT00806260|39902727|FG003|Period 2|sponsor request|1|||
16387785|NCT00806260|39902728|FG004|Period 2|sponsor request|0|||
16387786|NCT00806260|39902729|FG005|Period 2|sponsor request|0|||
16387787|NCT00806260|39902724|FG000|Period 3|Protocol Violation|0|||
16387788|NCT00806260|39902725|FG001|Period 3|Protocol Violation|1|||
16387789|NCT00806260|39902726|FG002|Period 3|Protocol Violation|1|||
16387790|NCT00806260|39902727|FG003|Period 3|Protocol Violation|0|||
16387791|NCT00806260|39902728|FG004|Period 3|Protocol Violation|0|||
16387792|NCT00806260|39902729|FG005|Period 3|Protocol Violation|0|||
16387793|NCT00806260|39902724|FG000|Period 3|Pregnancy|1|||
16387794|NCT00806260|39902725|FG001|Period 3|Pregnancy|0|||
16387795|NCT00806260|39902726|FG002|Period 3|Pregnancy|0|||
16387796|NCT00806260|39902727|FG003|Period 3|Pregnancy|0|||
16387797|NCT00806260|39902728|FG004|Period 3|Pregnancy|0|||
16387798|NCT00806260|39902729|FG005|Period 3|Pregnancy|0|||
16387799|NCT02712996|39902732|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
16387800|NCT02712996|39902733|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
16387801|NCT01465386|39902736|FG000|Overall Study|Lack of Efficacy|3|||
16387802|NCT01465386|39902736|FG000|Overall Study|Adverse Event|1|||
16387803|NCT01908140|39902737|FG000|Overall Study|Other or Progressive Disease|5|||
16387804|NCT01908140|39902738|FG001|Overall Study|Other or Progressive Disease|12|||
16387805|NCT01908140|39902737|FG000|Overall Study|Lack of Efficacy|7|||
16387806|NCT01908140|39902738|FG001|Overall Study|Lack of Efficacy|5|||
16387807|NCT01908140|39902737|FG000|Overall Study|Withdrawal by Subject|23|||
16387808|NCT01908140|39902738|FG001|Overall Study|Withdrawal by Subject|24|||
16387809|NCT01908140|39902737|FG000|Overall Study|Lost to Follow-up|1|||
16387810|NCT01908140|39902738|FG001|Overall Study|Lost to Follow-up|6|||
16387811|NCT01908140|39902737|FG000|Overall Study|Protocol Violation|8|||
16387812|NCT01908140|39902738|FG001|Overall Study|Protocol Violation|9|||
16387813|NCT01908140|39902737|FG000|Overall Study|Adverse Event|22|||
16387814|NCT01908140|39902738|FG001|Overall Study|Adverse Event|23|||
16387815|NCT04716894|39902739|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
16387816|NCT04716894|39902739|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
16387817|NCT01576783|39902740|FG000|Overall Study|Change in Medical Care|1|||
16387818|NCT01576783|39902741|FG001|Overall Study|Change in Medical Care|0|||
16387819|NCT01576783|39902740|FG000|Overall Study|Lost to Follow-up|14|||
16387820|NCT01576783|39902741|FG001|Overall Study|Lost to Follow-up|16|||
16387821|NCT01576783|39902740|FG000|Overall Study|Withdrawal by Subject|5|||
16387822|NCT01576783|39902741|FG001|Overall Study|Withdrawal by Subject|1|||
16387823|NCT03965403|39902743|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
16387824|NCT03108521|39902745|FG000|Overall Study|Lost to Follow-up|3|||
16387825|NCT03108521|39902746|FG001|Overall Study|Lost to Follow-up|0|||
16387826|NCT03108521|39902745|FG000|Overall Study|Lack of Efficacy|2|||
16387827|NCT03108521|39902746|FG001|Overall Study|Lack of Efficacy|0|||
16387828|NCT03108521|39902745|FG000|Overall Study|Physician Decision|4|||
16387829|NCT03108521|39902746|FG001|Overall Study|Physician Decision|0|||
16490517|NCT00790023|40270306|FG002|Overall Study|Withdrawal by Subject|6|||
16387830|NCT03108521|39902745|FG000|Overall Study|Adverse Event|3|||
16387831|NCT03108521|39902746|FG001|Overall Study|Adverse Event|0|||
16387832|NCT03824392|39902747|FG000|Overall Study|Adverse Event|1|||
16387833|NCT03824392|39902748|FG001|Overall Study|Adverse Event|0|||
16387834|NCT03824392|39902749|FG002|Overall Study|Adverse Event|0|||
16387835|NCT03824392|39902750|FG003|Overall Study|Adverse Event|0|||
16387836|NCT03824392|39902747|FG000|Overall Study|Investigator Decision|0|||
16387837|NCT03824392|39902748|FG001|Overall Study|Investigator Decision|1|||
16387838|NCT03824392|39902749|FG002|Overall Study|Investigator Decision|0|||
16387839|NCT03824392|39902750|FG003|Overall Study|Investigator Decision|0|||
16387840|NCT03824392|39902747|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
16387841|NCT03824392|39902748|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
16387842|NCT03824392|39902749|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
16490518|NCT00790023|40270304|FG000|Overall Study|Lost to Follow-up|0|||
16387843|NCT03824392|39902750|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
16387844|NCT00244621|39902753|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16490519|NCT00790023|40270305|FG001|Overall Study|Lost to Follow-up|0|||
16301894|NCT03323398|39589627|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
16301895|NCT03323398|39589628|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
16301896|NCT03323398|39589629|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
16301897|NCT03323398|39589630|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
16490520|NCT00790023|40270306|FG002|Overall Study|Lost to Follow-up|1|||
16490521|NCT00790023|40270304|FG000|Overall Study|Other|5|||
16490522|NCT00790023|40270305|FG001|Overall Study|Other|5|||
16490523|NCT00790023|40270306|FG002|Overall Study|Other|8|||
16490524|NCT02622321|40270309|FG000|Overall Study|Withdrawal by Subject|2|||
16490525|NCT02622321|40270310|FG001|Overall Study|Withdrawal by Subject|0|||
16490526|NCT02622321|40270311|FG002|Overall Study|Withdrawal by Subject|0|||
16490527|NCT02622321|40270312|FG003|Overall Study|Withdrawal by Subject|0|||
16490528|NCT02622321|40270309|FG000|Overall Study|Death|0|||
16490529|NCT02622321|40270310|FG001|Overall Study|Death|0|||
16490530|NCT02622321|40270311|FG002|Overall Study|Death|1|||
16490531|NCT02622321|40270312|FG003|Overall Study|Death|0|||
16490532|NCT02622321|40270309|FG000|Overall Study|Physician Decision|1|||
16490533|NCT02622321|40270310|FG001|Overall Study|Physician Decision|0|||
16490534|NCT02622321|40270311|FG002|Overall Study|Physician Decision|0|||
16490535|NCT02622321|40270312|FG003|Overall Study|Physician Decision|0|||
16490536|NCT00357968|40270313|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
16490537|NCT00357968|40270314|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
16301898|NCT03323398|39589622|FG000|Overall Study|Withdrawal by Subject|2|||
16301899|NCT03323398|39589623|FG001|Overall Study|Withdrawal by Subject|1|||
16301900|NCT03323398|39589624|FG002|Overall Study|Withdrawal by Subject|3|||
16301901|NCT03323398|39589625|FG003|Overall Study|Withdrawal by Subject|0|||
16301902|NCT03323398|39589626|FG004|Overall Study|Withdrawal by Subject|0|||
16301903|NCT03323398|39589627|FG005|Overall Study|Withdrawal by Subject|1|||
16301904|NCT03323398|39589628|FG006|Overall Study|Withdrawal by Subject|0|||
16301905|NCT03323398|39589629|FG007|Overall Study|Withdrawal by Subject|0|||
16301906|NCT03323398|39589630|FG008|Overall Study|Withdrawal by Subject|0|||
16301907|NCT03323398|39589622|FG000|Overall Study|Participant was Put on Hospice|0|||
16301908|NCT03323398|39589623|FG001|Overall Study|Participant was Put on Hospice|0|||
16301909|NCT03323398|39589624|FG002|Overall Study|Participant was Put on Hospice|0|||
16301910|NCT03323398|39589625|FG003|Overall Study|Participant was Put on Hospice|0|||
16301911|NCT03323398|39589626|FG004|Overall Study|Participant was Put on Hospice|0|||
16301912|NCT03323398|39589627|FG005|Overall Study|Participant was Put on Hospice|0|||
16301913|NCT03323398|39589628|FG006|Overall Study|Participant was Put on Hospice|1|||
16301914|NCT03323398|39589629|FG007|Overall Study|Participant was Put on Hospice|0|||
16301915|NCT03323398|39589630|FG008|Overall Study|Participant was Put on Hospice|0|||
16301916|NCT03323398|39589622|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
16301917|NCT03323398|39589623|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
16301918|NCT03323398|39589624|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
16301919|NCT03323398|39589625|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
16301920|NCT03323398|39589626|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
16301921|NCT03323398|39589627|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
16301922|NCT03323398|39589628|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
16301923|NCT03323398|39589629|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
16301924|NCT03323398|39589630|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
16301925|NCT00552578|39589631|FG000|Overall Study|Lost to Follow-up|1|||
16301926|NCT00552578|39589632|FG001|Overall Study|Lost to Follow-up|1|||
16301927|NCT00445146|39589635|FG000|Overall Study|Withdrew Consent|29|||
16301928|NCT00445146|39589635|FG000|Overall Study|Lack of Efficacy|28|||
16301929|NCT00445146|39589635|FG000|Overall Study|Investigator's Discretion|22|||
16301930|NCT00445146|39589635|FG000|Overall Study|Adverse Event|13|||
16301931|NCT00445146|39589635|FG000|Overall Study|Lost to Follow-up|13|||
16301932|NCT00445146|39589635|FG000|Overall Study|Death|9|||
16301933|NCT00445146|39589635|FG000|Overall Study|Protocol Violation|4|||
16301934|NCT00445146|39589635|FG000|Overall Study|Pregnancy|1|||
16301935|NCT01696279|39589638|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
16301936|NCT01696279|39589639|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
16301937|NCT01696279|39589640|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
16301938|NCT01696279|39589641|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
16301939|NCT01696279|39589638|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
16301940|NCT01696279|39589639|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
16301941|NCT01696279|39589640|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
16301942|NCT01696279|39589641|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
16490538|NCT00357968|40270313|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
16490539|NCT00357968|40270314|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
16490540|NCT00056316|40270315|FG000|Overall Study|Withdrawal by Subject|2|||
16490541|NCT00056316|40270316|FG001|Overall Study|Withdrawal by Subject|2|||
16490542|NCT00056316|40270315|FG000|Overall Study|Death/NH placement of pt|1|||
16490543|NCT00056316|40270316|FG001|Overall Study|Death/NH placement of pt|1|||
16490544|NCT01425281|40270320|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
16490545|NCT01425281|40270321|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
16490546|NCT01425281|40270320|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
16490547|NCT01425281|40270321|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
16490548|NCT01425281|40270320|FG000|At 180-day Clinical Follow-up|Death|0|||
16490549|NCT01425281|40270321|FG001|At 180-day Clinical Follow-up|Death|1|||
16490550|NCT01425281|40270320|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
16490551|NCT01425281|40270321|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
16490552|NCT01425281|40270320|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
16490553|NCT01425281|40270321|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
16490554|NCT01425281|40270320|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
16490555|NCT01425281|40270321|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
16490556|NCT01425281|40270320|FG000|At 2-year Clinical Follow-up|Death|2|||
16490557|NCT01425281|40270321|FG001|At 2-year Clinical Follow-up|Death|0|||
16490558|NCT01425281|40270320|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
16490559|NCT01425281|40270321|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
16490560|NCT01425281|40270320|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
16490561|NCT01425281|40270321|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
16490562|NCT01425281|40270320|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
16490563|NCT01425281|40270321|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
16490564|NCT01425281|40270320|FG000|At 3-year Clinical Follow-up|Death|2|||
16490565|NCT01425281|40270321|FG001|At 3-year Clinical Follow-up|Death|3|||
16490566|NCT01425281|40270320|FG000|At 4-year Clinical Follow-up|Death|7|||
16490567|NCT01425281|40270321|FG001|At 4-year Clinical Follow-up|Death|3|||
16490568|NCT01425281|40270320|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
16490569|NCT01425281|40270321|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
16490570|NCT01425281|40270320|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
16490571|NCT01425281|40270321|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
16490572|NCT01425281|40270320|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
16490573|NCT01425281|40270321|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
16301943|NCT01696279|39589638|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
16301944|NCT01696279|39589639|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
16301945|NCT01696279|39589640|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
16301946|NCT01696279|39589641|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
16301947|NCT01696279|39589638|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
16301948|NCT01696279|39589639|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
16301949|NCT01696279|39589640|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
16301950|NCT01696279|39589641|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
16301951|NCT01696279|39589638|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
16301952|NCT01696279|39589639|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
16301953|NCT01696279|39589640|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
16301954|NCT01696279|39589641|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
16301955|NCT01696279|39589638|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
16301956|NCT01696279|39589639|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
16301957|NCT01696279|39589640|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
16301958|NCT01696279|39589641|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
16301959|NCT01696279|39589638|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
16301960|NCT01696279|39589639|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
16301961|NCT01696279|39589640|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
16301962|NCT01696279|39589641|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
16301963|NCT01696279|39589638|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
16301964|NCT01696279|39589639|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
16301965|NCT01696279|39589640|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
16301966|NCT01696279|39589641|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
16301967|NCT01696279|39589638|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
16301968|NCT01696279|39589639|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
16301969|NCT01696279|39589640|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
16301970|NCT01696279|39589641|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
16301971|NCT01696279|39589638|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
16301972|NCT01696279|39589639|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
16301973|NCT01696279|39589640|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
16301974|NCT01696279|39589641|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
16301975|NCT01696279|39589638|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
16192791|NCT01533935|39185148|FG000|Overall Study|Other reason not defined above|1|||
16301976|NCT01696279|39589639|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
16301977|NCT01696279|39589640|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
16301978|NCT01696279|39589641|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
16301979|NCT01346293|39589642|FG000|Overall Study|Protocol Violation|30|||
16490574|NCT01425281|40270320|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
16490575|NCT01425281|40270321|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
16490576|NCT01425281|40270320|FG000|At 5-year Clinical Follow-up|Death|2|||
16490577|NCT01425281|40270321|FG001|At 5-year Clinical Follow-up|Death|0|||
16490578|NCT01425281|40270320|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
16490579|NCT01425281|40270321|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
16490580|NCT01425281|40270320|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
16490581|NCT01425281|40270321|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
16490582|NCT01425281|40270320|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
16490583|NCT01425281|40270321|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
16301980|NCT01346293|39589643|FG001|Overall Study|Protocol Violation|9|||
16301981|NCT01346293|39589642|FG000|Overall Study|Lost to Follow-up|21|||
16301982|NCT01346293|39589643|FG001|Overall Study|Lost to Follow-up|8|||
16301983|NCT01346293|39589642|FG000|Overall Study|Withdrawal by Subject|15|||
16301984|NCT01346293|39589643|FG001|Overall Study|Withdrawal by Subject|4|||
16301985|NCT01346293|39589642|FG000|Overall Study|Other|1|||
16301986|NCT01346293|39589643|FG001|Overall Study|Other|0|||
16301987|NCT01661062|39589644|FG000|Overall Study|Completed Treatment Off Study|3|||
16301988|NCT01661062|39589644|FG000|Overall Study|Withdrawal by Subject|2|||
16301989|NCT04646005|39589645|FG000|Overall Study|Adverse Event|1|||
16301990|NCT04646005|39589645|FG000|Overall Study|Progressive Disease|60|||
16301991|NCT04646005|39589645|FG000|Overall Study|Death|19|||
16301992|NCT04646005|39589645|FG000|Overall Study|Withdrawal by Subject|9|||
16301993|NCT04646005|39589645|FG000|Overall Study|Study Ongoing|24|||
16301994|NCT00397514|39589646|FG000|Overall Study|Withdrawal by Subject|1|||
16301995|NCT00397514|39589646|FG000|Overall Study|Pacing wire malfunction|1|||
16301996|NCT00397514|39589646|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
16301997|NCT00397514|39589646|FG000|Overall Study|early extubation|2|||
16301998|NCT00397514|39589646|FG000|Overall Study|poor echocardiographic windows|1|||
16301999|NCT01377012|39589648|FG000|Core Study|Study terminated by Sponsor|47|||
16302000|NCT01377012|39589649|FG001|Core Study|Study terminated by Sponsor|54|||
16302001|NCT01377012|39589650|FG002|Core Study|Study terminated by Sponsor|46|||
16302002|NCT01377012|39589648|FG000|Core Study|Technical problems|1|||
16302003|NCT01377012|39589649|FG001|Core Study|Technical problems|0|||
16302004|NCT01377012|39589650|FG002|Core Study|Technical problems|0|||
16302005|NCT01377012|39589648|FG000|Core Study|Withdrawal by Subject|15|||
16302006|NCT01377012|39589649|FG001|Core Study|Withdrawal by Subject|23|||
16302007|NCT01377012|39589650|FG002|Core Study|Withdrawal by Subject|18|||
16302008|NCT01377012|39589648|FG000|Core Study|Protocol Violation|7|||
16302009|NCT01377012|39589649|FG001|Core Study|Protocol Violation|3|||
16302010|NCT01377012|39589650|FG002|Core Study|Protocol Violation|2|||
16302011|NCT01377012|39589648|FG000|Core Study|Pregnancy|0|||
16302012|NCT01377012|39589649|FG001|Core Study|Pregnancy|0|||
16302013|NCT01377012|39589650|FG002|Core Study|Pregnancy|1|||
16302014|NCT01377012|39589648|FG000|Core Study|Physician Decision|5|||
16302015|NCT01377012|39589649|FG001|Core Study|Physician Decision|4|||
16302016|NCT01377012|39589650|FG002|Core Study|Physician Decision|10|||
16302017|NCT01377012|39589648|FG000|Core Study|Non-Compliant with study treatment|0|||
16302018|NCT01377012|39589649|FG001|Core Study|Non-Compliant with study treatment|0|||
16302019|NCT01377012|39589650|FG002|Core Study|Non-Compliant with study treatment|1|||
16302020|NCT01377012|39589648|FG000|Core Study|No Longer require treatment|0|||
16302021|NCT01377012|39589649|FG001|Core Study|No Longer require treatment|0|||
16302022|NCT01377012|39589650|FG002|Core Study|No Longer require treatment|1|||
16302023|NCT01377012|39589648|FG000|Core Study|Lost to Follow-up|7|||
16302024|NCT01377012|39589649|FG001|Core Study|Lost to Follow-up|5|||
16302025|NCT01377012|39589650|FG002|Core Study|Lost to Follow-up|4|||
16302026|NCT01377012|39589648|FG000|Core Study|Lack of Efficacy|41|||
16302027|NCT01377012|39589649|FG001|Core Study|Lack of Efficacy|28|||
16302028|NCT01377012|39589650|FG002|Core Study|Lack of Efficacy|37|||
16302029|NCT01377012|39589648|FG000|Core Study|Death|1|||
16302030|NCT01377012|39589649|FG001|Core Study|Death|1|||
16302031|NCT01377012|39589650|FG002|Core Study|Death|1|||
16302032|NCT01377012|39589648|FG000|Core Study|Adverse Event|10|||
16302033|NCT01377012|39589649|FG001|Core Study|Adverse Event|14|||
16302034|NCT01377012|39589650|FG002|Core Study|Adverse Event|13|||
16302035|NCT01377012|39589648|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
16302036|NCT01377012|39589649|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
16302037|NCT01377012|39589650|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
16302038|NCT01377012|39589648|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
16302039|NCT01377012|39589649|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
16302040|NCT01377012|39589650|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
16302041|NCT01377012|39589648|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
16490584|NCT01663532|40270322|FG000|Overall Study|Lost to Follow-up|9|||
16490585|NCT01663532|40270323|FG001|Overall Study|Lost to Follow-up|10|||
16490586|NCT01663532|40270322|FG000|Overall Study|Adverse Event|7|||
16490587|NCT01663532|40270323|FG001|Overall Study|Adverse Event|13|||
16490588|NCT01663532|40270322|FG000|Overall Study|Met Withdrawal Criteria|7|||
16490589|NCT01663532|40270323|FG001|Overall Study|Met Withdrawal Criteria|6|||
16490590|NCT01663532|40270322|FG000|Overall Study|Physician Decision|1|||
16490591|NCT01663532|40270323|FG001|Overall Study|Physician Decision|1|||
16490592|NCT01663532|40270322|FG000|Overall Study|Withdrawal by Subject|35|||
16490593|NCT01663532|40270323|FG001|Overall Study|Withdrawal by Subject|17|||
16490594|NCT01663532|40270322|FG000|Overall Study|Lack of Efficacy|15|||
16490595|NCT01663532|40270323|FG001|Overall Study|Lack of Efficacy|60|||
16490596|NCT02692703|40270324|FG000|Overall Study|Lost to Follow-up|1|||
16490597|NCT02692703|40270324|FG000|Overall Study|Other|1|||
16490598|NCT03228537|40270325|FG000|Neoadjuvant|Adverse Event|2|||
16490599|NCT03228537|40270325|FG000|Neoadjuvant|Progression/Relapse|4|||
16490600|NCT03228537|40270325|FG000|Neoadjuvant|Death|1|||
16490601|NCT03228537|40270325|FG000|Surgery|Death|1|||
16490602|NCT03228537|40270325|FG000|Surgery|Other - Not Protocol Specified|2|||
16490603|NCT03228537|40270325|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
16490604|NCT03228537|40270325|FG000|Maintenance|Progression/Relapse|10|||
16490605|NCT02151591|40270327|FG000|Overall Study|Lost to Follow-up|6|||
16490606|NCT02151591|40270328|FG001|Overall Study|Lost to Follow-up|3|||
16490607|NCT00598832|40270331|FG000|Overall Study|Lack of Efficacy|3|||
16490608|NCT00598832|40270332|FG001|Overall Study|Lack of Efficacy|7|||
16490609|NCT00598832|40270331|FG000|Overall Study|Adverse Event|6|||
16490610|NCT00598832|40270332|FG001|Overall Study|Adverse Event|2|||
16490611|NCT00598832|40270331|FG000|Overall Study|Withdrawal by Subject|25|||
16192792|NCT01533935|39185149|FG001|Overall Study|Other reason not defined above|0|||
16192793|NCT01533935|39185150|FG002|Overall Study|Other reason not defined above|1|||
16302042|NCT01377012|39589649|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
16302043|NCT01377012|39589650|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
16302044|NCT01377012|39589648|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
16302045|NCT01377012|39589649|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
16302046|NCT01377012|39589650|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
16302047|NCT01377012|39589648|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
16302048|NCT01377012|39589649|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
16302049|NCT01377012|39589650|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
16302050|NCT01377012|39589648|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
16302051|NCT01377012|39589649|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
16302052|NCT01377012|39589650|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
16302053|NCT02473523|39589654|FG000|Overall Study|Death|1|||
16302054|NCT02473523|39589654|FG000|Overall Study|Lost to Follow-up|1|||
16302055|NCT00721227|39589655|FG000|Overall Study|Lost to Follow-up|3|||
16302056|NCT00721227|39589656|FG001|Overall Study|Lost to Follow-up|0|||
16302057|NCT00721227|39589655|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
16302058|NCT00721227|39589656|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
16302059|NCT02359994|39589659|FG000|Overall Population Study|Adverse Event|1|||
16302060|NCT02359994|39589660|FG001|Overall Population Study|Adverse Event|1|||
16302061|NCT02359994|39589659|FG000|Overall Population Study|Death|1|||
16302062|NCT02359994|39589660|FG001|Overall Population Study|Death|5|||
16302063|NCT02359994|39589659|FG000|Overall Population Study|Lost to Follow-up|1|||
16302064|NCT02359994|39589660|FG001|Overall Population Study|Lost to Follow-up|1|||
16302065|NCT02359994|39589659|FG000|Overall Population Study|Withdrawal by Subject|1|||
16302066|NCT02359994|39589660|FG001|Overall Population Study|Withdrawal by Subject|0|||
16302067|NCT02359994|39589659|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
16302068|NCT02359994|39589660|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
16302069|NCT02359994|39589659|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
16302070|NCT02359994|39589660|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
16302071|NCT02359994|39589659|FG000|Extended Oncology 24-Month Survival|Death|19|||
16302072|NCT02359994|39589660|FG001|Extended Oncology 24-Month Survival|Death|21|||
16302073|NCT02359994|39589659|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
16302074|NCT02359994|39589660|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
16490612|NCT00598832|40270332|FG001|Overall Study|Withdrawal by Subject|36|||
16490613|NCT00598832|40270331|FG000|Overall Study|Protocol Violation|0|||
16490614|NCT00598832|40270332|FG001|Overall Study|Protocol Violation|2|||
16490615|NCT00598832|40270331|FG000|Overall Study|Lost to Follow-up|24|||
16490616|NCT00598832|40270332|FG001|Overall Study|Lost to Follow-up|29|||
16490617|NCT00598832|40270331|FG000|Overall Study|Pregnancy|2|||
16490618|NCT00598832|40270332|FG001|Overall Study|Pregnancy|2|||
16490619|NCT00598832|40270331|FG000|Overall Study|Physician Decision|1|||
16490620|NCT00598832|40270332|FG001|Overall Study|Physician Decision|4|||
16490621|NCT00598832|40270331|FG000|Overall Study|Non compliance|1|||
16490622|NCT00598832|40270332|FG001|Overall Study|Non compliance|0|||
16192794|NCT01533935|39185151|FG003|Overall Study|Other reason not defined above|0|||
16302075|NCT01755091|39589664|FG000|Overall Study|Withdrawal by Subject|6|||
16302076|NCT01755091|39589665|FG001|Overall Study|Withdrawal by Subject|1|||
16302077|NCT01755091|39589666|FG002|Overall Study|Withdrawal by Subject|3|||
16302078|NCT01755091|39589664|FG000|Overall Study|Adverse Event|1|||
16302079|NCT01755091|39589665|FG001|Overall Study|Adverse Event|1|||
16302080|NCT01755091|39589666|FG002|Overall Study|Adverse Event|1|||
16302081|NCT01755091|39589664|FG000|Overall Study|Lost to Follow-up|1|||
16302082|NCT01755091|39589665|FG001|Overall Study|Lost to Follow-up|0|||
16302083|NCT01755091|39589666|FG002|Overall Study|Lost to Follow-up|1|||
16302084|NCT01755091|39589664|FG000|Overall Study|Physician Decision|1|||
16302085|NCT01755091|39589665|FG001|Overall Study|Physician Decision|1|||
16302086|NCT01755091|39589666|FG002|Overall Study|Physician Decision|2|||
16302087|NCT01987479|39589670|FG000|Overall Study|Protocol Violation|1|||
16302088|NCT01987479|39589670|FG000|Overall Study|Physician Decision|2|||
16302089|NCT01987479|39589670|FG000|Overall Study|Participant/legal guardian decision|1|||
16302090|NCT01987479|39589670|FG000|Overall Study|Other|5|||
16302091|NCT01987479|39589670|FG000|Overall Study|Lost to Follow-up|1|||
16302092|NCT01987479|39589670|FG000|Overall Study|Adverse Event|7|||
16302093|NCT01893346|39589671|FG000|Overall Study|Lost to Follow-up|0|||
16302094|NCT01893346|39589672|FG001|Overall Study|Lost to Follow-up|1|||
16302095|NCT01893346|39589673|FG002|Overall Study|Lost to Follow-up|0|||
16302096|NCT01893346|39589674|FG003|Overall Study|Lost to Follow-up|0|||
16302097|NCT01893346|39589671|FG000|Overall Study|Protocol Violation|1|||
16302098|NCT01893346|39589672|FG001|Overall Study|Protocol Violation|0|||
16302099|NCT01893346|39589673|FG002|Overall Study|Protocol Violation|0|||
16302100|NCT01893346|39589674|FG003|Overall Study|Protocol Violation|0|||
16302101|NCT01893346|39589671|FG000|Overall Study|Withdrawal by Subject|2|||
16302102|NCT01893346|39589672|FG001|Overall Study|Withdrawal by Subject|0|||
16302103|NCT01893346|39589673|FG002|Overall Study|Withdrawal by Subject|0|||
16302104|NCT01893346|39589674|FG003|Overall Study|Withdrawal by Subject|0|||
16302105|NCT02242045|39589675|FG000|Overall Study|Investigator's Discretion|1|||
16302106|NCT02242045|39589675|FG000|Overall Study|Progressive Disease|2|||
16302107|NCT02242045|39589675|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
16302108|NCT02242045|39589675|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
16302109|NCT00710866|39589684|FG000|Overall Study|Protocol Violation|5|||
16302110|NCT00710866|39589685|FG001|Overall Study|Protocol Violation|4|||
16302111|NCT00710866|39589684|FG000|Overall Study|Withdrawal by Subject|2|||
16302112|NCT00710866|39589685|FG001|Overall Study|Withdrawal by Subject|1|||
16302113|NCT00710866|39589684|FG000|Overall Study|Lost to Follow-up|1|||
16302114|NCT00710866|39589685|FG001|Overall Study|Lost to Follow-up|0|||
16302115|NCT00710866|39589684|FG000|Overall Study|Failed to meet eligibility|1|||
16490623|NCT03311724|40270333|FG000|Overall Study|Physician Decision|0|||
16192795|NCT01533935|39185152|FG004|Overall Study|Other reason not defined above|1|||
16192796|NCT00912015|39185153|FG000|Overall Study|Lack of Efficacy|1|||
16302116|NCT00710866|39589685|FG001|Overall Study|Failed to meet eligibility|1|||
16302117|NCT00243412|39589687|FG000|Overall Study|Death|0|||
16302118|NCT00243412|39589688|FG001|Overall Study|Death|1|||
16302119|NCT00243412|39589687|FG000|Overall Study|Adverse Event|4|||
16302120|NCT00243412|39589688|FG001|Overall Study|Adverse Event|2|||
16302121|NCT00243412|39589687|FG000|Overall Study|Lost to Follow-up|0|||
16302122|NCT00243412|39589688|FG001|Overall Study|Lost to Follow-up|1|||
16302123|NCT00243412|39589687|FG000|Overall Study|Physician Decision|1|||
16302124|NCT00243412|39589688|FG001|Overall Study|Physician Decision|1|||
16302125|NCT00243412|39589687|FG000|Overall Study|Withdrawal by Subject|4|||
16302126|NCT00243412|39589688|FG001|Overall Study|Withdrawal by Subject|5|||
16302127|NCT00243412|39589687|FG000|Overall Study|Other|1|||
16302128|NCT00243412|39589688|FG001|Overall Study|Other|1|||
16302129|NCT02201277|39589689|FG000|Overall Study|Death|3|||
16302130|NCT02201277|39589690|FG001|Overall Study|Death|4|||
16302131|NCT02201277|39589689|FG000|Overall Study|Lost to Follow-up|2|||
16302132|NCT02201277|39589690|FG001|Overall Study|Lost to Follow-up|1|||
16302133|NCT02201277|39589689|FG000|Overall Study|Failed retrieval|1|||
16302134|NCT02201277|39589690|FG001|Overall Study|Failed retrieval|0|||
16302135|NCT02201277|39589689|FG000|Overall Study|Physician Decision|1|||
16302136|NCT02201277|39589690|FG001|Overall Study|Physician Decision|0|||
16302137|NCT05013008|39589708|FG000|Overall Study|Exclusion from mBFAS|5|||
16302138|NCT05013008|39589709|FG001|Overall Study|Exclusion from mBFAS|25|||
16302139|NCT03172494|39589714|FG000|Overall Study|Adverse Event|5|||
16302140|NCT03172494|39589715|FG001|Overall Study|Adverse Event|1|||
16302141|NCT03172494|39589716|FG002|Overall Study|Adverse Event|15|||
16302142|NCT03172494|39589714|FG000|Overall Study|Protocol Violation|3|||
16302143|NCT03172494|39589715|FG001|Overall Study|Protocol Violation|2|||
16302144|NCT03172494|39589716|FG002|Overall Study|Protocol Violation|1|||
16302145|NCT03172494|39589714|FG000|Overall Study|Lack of Efficacy|0|||
16302146|NCT03172494|39589715|FG001|Overall Study|Lack of Efficacy|0|||
16302147|NCT03172494|39589716|FG002|Overall Study|Lack of Efficacy|4|||
16302148|NCT03172494|39589714|FG000|Overall Study|Pregnancy|0|||
16302149|NCT03172494|39589715|FG001|Overall Study|Pregnancy|1|||
16302150|NCT03172494|39589716|FG002|Overall Study|Pregnancy|0|||
16192797|NCT00912015|39185154|FG001|Overall Study|Lack of Efficacy|0|||
16192798|NCT00912015|39185155|FG002|Overall Study|Lack of Efficacy|0|||
16302151|NCT03172494|39589714|FG000|Overall Study|Withdrawal by Subject|10|||
16302152|NCT03172494|39589715|FG001|Overall Study|Withdrawal by Subject|8|||
16302153|NCT03172494|39589716|FG002|Overall Study|Withdrawal by Subject|8|||
16302154|NCT03172494|39589714|FG000|Overall Study|Severe hypoglycaemic episode|0|||
16302155|NCT03172494|39589715|FG001|Overall Study|Severe hypoglycaemic episode|0|||
16302156|NCT03172494|39589716|FG002|Overall Study|Severe hypoglycaemic episode|1|||
16302157|NCT03172494|39589714|FG000|Overall Study|Non-compliance towards treatment|2|||
16302158|NCT03172494|39589715|FG001|Overall Study|Non-compliance towards treatment|0|||
16302159|NCT03172494|39589716|FG002|Overall Study|Non-compliance towards treatment|0|||
16302160|NCT03155945|39589718|FG000|Overall Study|Lost to Follow-up|0|||
16302161|NCT03155945|39589719|FG001|Overall Study|Lost to Follow-up|1|||
16302162|NCT03155945|39589718|FG000|Overall Study|Withdrawal by Subject|0|||
16302163|NCT03155945|39589719|FG001|Overall Study|Withdrawal by Subject|1|||
16302164|NCT03155945|39589718|FG000|Overall Study|Other Reason|0|||
16302165|NCT03155945|39589719|FG001|Overall Study|Other Reason|1|||
16302166|NCT00143247|39589720|FG000|Overall Study|Death|8|||
16302167|NCT00143247|39589720|FG000|Overall Study|Adverse Event|19|||
16302168|NCT00143247|39589720|FG000|Overall Study|Lack of Efficacy|3|||
16302169|NCT00143247|39589720|FG000|Overall Study|Withdrawal by Subject|55|||
16302170|NCT00143247|39589720|FG000|Overall Study|Study terminated by sponsor|31|||
16302171|NCT00143247|39589720|FG000|Overall Study|Protocol Violation|15|||
16192799|NCT00912015|39185156|FG003|Overall Study|Lack of Efficacy|0|||
16192800|NCT00912015|39185153|FG000|Overall Study|Withdrawal by Subject|8|||
16192801|NCT00912015|39185154|FG001|Overall Study|Withdrawal by Subject|8|||
16192802|NCT00912015|39185155|FG002|Overall Study|Withdrawal by Subject|3|||
16192803|NCT00912015|39185156|FG003|Overall Study|Withdrawal by Subject|0|||
16192804|NCT00912015|39185153|FG000|Overall Study|Protocol Violation|1|||
16192805|NCT00912015|39185154|FG001|Overall Study|Protocol Violation|0|||
16192806|NCT00912015|39185155|FG002|Overall Study|Protocol Violation|0|||
16192807|NCT00912015|39185156|FG003|Overall Study|Protocol Violation|1|||
16192808|NCT00912015|39185153|FG000|Overall Study|Adverse Event|6|||
16192809|NCT00912015|39185154|FG001|Overall Study|Adverse Event|0|||
16192810|NCT00912015|39185155|FG002|Overall Study|Adverse Event|0|||
16192811|NCT00912015|39185156|FG003|Overall Study|Adverse Event|1|||
16192812|NCT01000727|39185157|FG000|Overall Study|Lost to Follow-up|41|||
16192813|NCT01000727|39185158|FG001|Overall Study|Lost to Follow-up|43|||
16192814|NCT01000727|39185157|FG000|Overall Study|Withdrawal by Subject|111|||
16192815|NCT01000727|39185158|FG001|Overall Study|Withdrawal by Subject|109|||
16192816|NCT01000727|39185157|FG000|Overall Study|Study closed/terminated|23|||
16192817|NCT01000727|39185158|FG001|Overall Study|Study closed/terminated|24|||
16192818|NCT00138424|39185159|FG000|Overall Study|Physician Decision|0|||
16192819|NCT00138424|39185160|FG001|Overall Study|Physician Decision|1|||
16192820|NCT00138424|39185161|FG002|Overall Study|Physician Decision|0|||
16192821|NCT00138424|39185162|FG003|Overall Study|Physician Decision|0|||
16192822|NCT02512068|39185164|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
16302172|NCT00143247|39589720|FG000|Overall Study|Lost to Follow-up|12|||
16302173|NCT00143247|39589720|FG000|Overall Study|following inaccurate lab adverse event|1|||
16302174|NCT00143247|39589720|FG000|Overall Study|Other|12|||
16302175|NCT01305044|39589721|FG000|Overall Study|Withdrawal by Subject|3|||
16302176|NCT01305044|39589722|FG001|Overall Study|Withdrawal by Subject|6|||
16302177|NCT01609023|39589729|FG000|Overall Study|Lack of Efficacy|3|||
16302178|NCT01609023|39589729|FG000|Overall Study|Withdrawal by Subject|4|||
16302179|NCT01609023|39589729|FG000|Overall Study|Lost to Follow-up|8|||
16302180|NCT01609023|39589729|FG000|Overall Study|Toxicity|3|||
16302181|NCT01609023|39589729|FG000|Overall Study|Disease progression|10|||
16192823|NCT02512068|39185165|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
16192824|NCT02512068|39185164|FG000|Overall Study|Major Protocol Deviation|1|||
16192825|NCT02512068|39185165|FG001|Overall Study|Major Protocol Deviation|0|||
16192826|NCT02512068|39185164|FG000|Overall Study|Voluntary Withdrawal|0|||
16192827|NCT02512068|39185165|FG001|Overall Study|Voluntary Withdrawal|1|||
16302182|NCT01609023|39589729|FG000|Overall Study|Physician Decision|2|||
16302183|NCT01609023|39589729|FG000|Overall Study|Death|2|||
16302184|NCT01609023|39589729|FG000|Overall Study|Personal reasons|1|||
16302185|NCT01696058|39593368|FG000|Overall Study|Adverse Event|21|||
16302186|NCT01696058|39593369|FG001|Overall Study|Adverse Event|11|||
16302187|NCT01696058|39593368|FG000|Overall Study|Lack of Efficacy|2|||
16192828|NCT02512068|39185164|FG000|Overall Study|Lack of Efficacy|0|||
16302188|NCT01696058|39593369|FG001|Overall Study|Lack of Efficacy|3|||
16302189|NCT01696058|39593368|FG000|Overall Study|Protocol Violation|9|||
16192829|NCT02512068|39185165|FG001|Overall Study|Lack of Efficacy|1|||
16192830|NCT02512068|39185164|FG000|Overall Study|Reason Not Specified|3|||
16192831|NCT02512068|39185165|FG001|Overall Study|Reason Not Specified|5|||
16302190|NCT01696058|39593369|FG001|Overall Study|Protocol Violation|3|||
16302191|NCT01696058|39593368|FG000|Overall Study|Lost to Follow-up|2|||
16302192|NCT01696058|39593369|FG001|Overall Study|Lost to Follow-up|5|||
16192832|NCT00848549|39185166|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
16192833|NCT00848549|39185167|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
16192834|NCT00848549|39185166|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
16192835|NCT00848549|39185167|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
16192836|NCT00848549|39185166|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
16192837|NCT00848549|39185167|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
16192838|NCT00848549|39185166|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
16192839|NCT00848549|39185167|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
16192840|NCT00848549|39185166|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
16192841|NCT00848549|39185167|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
16302193|NCT01696058|39593368|FG000|Overall Study|Withdrawal by Subject|4|||
16192842|NCT00848549|39185166|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
16192843|NCT00848549|39185167|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
16192844|NCT00848549|39185166|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
16192845|NCT00848549|39185167|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
16192846|NCT00848549|39185166|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
16192847|NCT00848549|39185167|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
16192848|NCT00848549|39185166|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
16192849|NCT00848549|39185167|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
16192850|NCT00848549|39185166|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
16192851|NCT00848549|39185167|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
16192852|NCT00848549|39185166|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
16192853|NCT00848549|39185167|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
16192854|NCT00848549|39185166|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
16192855|NCT00848549|39185167|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
16192856|NCT00848549|39185166|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
16192857|NCT00848549|39185167|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
16192858|NCT00848549|39185166|FG000|E2090-E044-314 (Extension Study)|Other|5|||
16192859|NCT00848549|39185167|FG001|E2090-E044-314 (Extension Study)|Other|6|||
16192860|NCT01842607|39185168|FG000|Overall Study|Adverse Event|11|||
16192861|NCT01842607|39185168|FG000|Overall Study|Lack of Efficacy|19|||
16192862|NCT01842607|39185168|FG000|Overall Study|Protocol Violation|8|||
16192863|NCT01842607|39185168|FG000|Overall Study|Protocol defined stopping criteria|2|||
16192864|NCT01842607|39185168|FG000|Overall Study|Lost to Follow-up|3|||
16192865|NCT01842607|39185168|FG000|Overall Study|Physician Decision|9|||
16192866|NCT01842607|39185168|FG000|Overall Study|Withdrawal by Subject|14|||
16192867|NCT04664855|39185171|FG000|Overall Study|Withdrawal by Subject|0|||
16192868|NCT04664855|39185172|FG001|Overall Study|Withdrawal by Subject|2|||
16192869|NCT03703375|39185173|FG000|Randomization Period|Withdrawal by Subject|0|||
16192870|NCT03703375|39185174|FG001|Randomization Period|Withdrawal by Subject|0|||
16302194|NCT01696058|39593369|FG001|Overall Study|Withdrawal by Subject|6|||
16302195|NCT01696058|39593368|FG000|Overall Study|Other reason prematurely discontinued|5|||
16302196|NCT01696058|39593369|FG001|Overall Study|Other reason prematurely discontinued|3|||
16302197|NCT02445963|39593370|FG000|Overall Study|Lost to Follow-up|1|||
16302198|NCT02445963|39593371|FG001|Overall Study|Lost to Follow-up|0|||
16302199|NCT02445963|39593372|FG002|Overall Study|Lost to Follow-up|0|||
16302200|NCT02445963|39593373|FG003|Overall Study|Lost to Follow-up|0|||
16302201|NCT02445963|39593370|FG000|Overall Study|Change in employment|1|||
16302202|NCT02445963|39593371|FG001|Overall Study|Change in employment|0|||
16302203|NCT02445963|39593372|FG002|Overall Study|Change in employment|0|||
16302204|NCT02445963|39593373|FG003|Overall Study|Change in employment|0|||
16302205|NCT02445963|39593370|FG000|Overall Study|Symptoms post-vaccination|0|||
16302206|NCT02445963|39593371|FG001|Overall Study|Symptoms post-vaccination|0|||
16302207|NCT02445963|39593372|FG002|Overall Study|Symptoms post-vaccination|1|||
16302208|NCT02445963|39593373|FG003|Overall Study|Symptoms post-vaccination|0|||
16302209|NCT00141778|39593374|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
16302210|NCT00141778|39593375|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
16302211|NCT00141778|39593376|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
16302212|NCT00141778|39593374|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
16302213|NCT00141778|39593375|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
16302214|NCT00141778|39593376|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
16302215|NCT00141778|39593374|FG000|Started Study Medication|Withdrawal by Subject|0|||
16302216|NCT00141778|39593375|FG001|Started Study Medication|Withdrawal by Subject|2|||
16302217|NCT00141778|39593376|FG002|Started Study Medication|Withdrawal by Subject|0|||
16302218|NCT00141778|39593374|FG000|Started Study Medication|Difficulty Swallowing|0|||
16302219|NCT00141778|39593375|FG001|Started Study Medication|Difficulty Swallowing|1|||
16302220|NCT00141778|39593376|FG002|Started Study Medication|Difficulty Swallowing|0|||
16302221|NCT00141778|39593374|FG000|Started Study Medication|Chest Discomfort|0|||
16192871|NCT03703375|39185175|FG002|Randomization Period|Withdrawal by Subject|0|||
16302222|NCT00141778|39593375|FG001|Started Study Medication|Chest Discomfort|0|||
16302223|NCT00141778|39593376|FG002|Started Study Medication|Chest Discomfort|1|||
16302224|NCT00191165|39593377|FG000|Overall Study|Adverse Event|2|||
16302225|NCT00191165|39593378|FG001|Overall Study|Adverse Event|0|||
16302226|NCT00191165|39593377|FG000|Overall Study|Protocol Violation|0|||
16302227|NCT00191165|39593378|FG001|Overall Study|Protocol Violation|1|||
16302228|NCT00191165|39593377|FG000|Overall Study|Participant Moved Away|0|||
16302229|NCT00191165|39593378|FG001|Overall Study|Participant Moved Away|1|||
16302230|NCT00261950|39593384|FG000|Overall Study|Lost to Follow-up|2|||
16302231|NCT00261950|39593384|FG000|Overall Study|Death|6|||
16302232|NCT00261950|39593384|FG000|Overall Study|Withdrawal by Subject|5|||
16302233|NCT00261950|39593384|FG000|Overall Study|Other|1|||
16302234|NCT00261950|39593384|FG000|Overall Study|Physician Decision|1|||
16302235|NCT00261950|39593384|FG000|Overall Study|Protocol specified Criteria|11|||
16302236|NCT02213510|39593385|FG000|Overall Study|Death|0|||
16302237|NCT02213510|39593386|FG001|Overall Study|Death|1|||
16302238|NCT02213510|39593385|FG000|Overall Study|Lost to Follow-up|1|||
16302239|NCT02213510|39593386|FG001|Overall Study|Lost to Follow-up|0|||
16302240|NCT03390426|39593391|FG000|Overall Study|Protocol Violation|0|||
16302241|NCT03390426|39593392|FG001|Overall Study|Protocol Violation|1|||
16302242|NCT02980341|39593399|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
16302243|NCT02980341|39593400|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
16302244|NCT02980341|39593401|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
16302245|NCT02980341|39593402|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
16302246|NCT02980341|39593403|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
16302247|NCT02980341|39593404|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
16302248|NCT02980341|39593405|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
16302249|NCT02980341|39593406|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
16302250|NCT02980341|39593407|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
16302251|NCT02980341|39593408|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
16302252|NCT02980341|39593409|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
16302253|NCT02980341|39593399|FG000|Dose Escalation|Clinical progression|0|||
16302254|NCT02980341|39593400|FG001|Dose Escalation|Clinical progression|0|||
16302255|NCT02980341|39593401|FG002|Dose Escalation|Clinical progression|2|||
16302256|NCT02980341|39593402|FG003|Dose Escalation|Clinical progression|1|||
16302257|NCT02980341|39593403|FG004|Dose Escalation|Clinical progression|0|||
16302258|NCT02980341|39593404|FG005|Dose Escalation|Clinical progression|0|||
16302259|NCT02980341|39593405|FG006|Dose Escalation|Clinical progression|0|||
16302260|NCT02980341|39593406|FG007|Dose Escalation|Clinical progression|0|||
16302261|NCT02980341|39593407|FG008|Dose Escalation|Clinical progression|0|||
16302262|NCT02980341|39593408|FG009|Dose Escalation|Clinical progression|0|||
16302263|NCT02980341|39593409|FG010|Dose Escalation|Clinical progression|0|||
16302264|NCT02980341|39593399|FG000|Dose Escalation|Adverse Event|0|||
16302265|NCT02980341|39593400|FG001|Dose Escalation|Adverse Event|0|||
16302266|NCT02980341|39593401|FG002|Dose Escalation|Adverse Event|1|||
16302267|NCT02980341|39593402|FG003|Dose Escalation|Adverse Event|2|||
16302268|NCT02980341|39593403|FG004|Dose Escalation|Adverse Event|2|||
16302269|NCT02980341|39593404|FG005|Dose Escalation|Adverse Event|0|||
16302270|NCT02980341|39593405|FG006|Dose Escalation|Adverse Event|0|||
16302271|NCT02980341|39593406|FG007|Dose Escalation|Adverse Event|0|||
16302272|NCT02980341|39593407|FG008|Dose Escalation|Adverse Event|0|||
16302273|NCT02980341|39593408|FG009|Dose Escalation|Adverse Event|0|||
16302274|NCT02980341|39593409|FG010|Dose Escalation|Adverse Event|0|||
16302275|NCT02980341|39593399|FG000|Dose Escalation|Withdrawal by Subject|0|||
16302276|NCT02980341|39593400|FG001|Dose Escalation|Withdrawal by Subject|0|||
16302277|NCT02980341|39593401|FG002|Dose Escalation|Withdrawal by Subject|1|||
16302278|NCT02980341|39593402|FG003|Dose Escalation|Withdrawal by Subject|0|||
16387845|NCT00244621|39902754|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
16387846|NCT00244621|39902755|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
16387847|NCT00244621|39902753|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
16387848|NCT00244621|39902754|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
16387849|NCT00244621|39902755|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16387850|NCT00244621|39902753|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
16490624|NCT03311724|40270334|FG001|Overall Study|Physician Decision|0|||
16490625|NCT03311724|40270335|FG002|Overall Study|Physician Decision|0|||
16302279|NCT02980341|39593403|FG004|Dose Escalation|Withdrawal by Subject|0|||
16302280|NCT02980341|39593404|FG005|Dose Escalation|Withdrawal by Subject|0|||
16302281|NCT02980341|39593405|FG006|Dose Escalation|Withdrawal by Subject|0|||
16302282|NCT02980341|39593406|FG007|Dose Escalation|Withdrawal by Subject|0|||
16387851|NCT00244621|39902754|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
16387852|NCT00244621|39902755|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
16490626|NCT03311724|40270336|FG003|Overall Study|Physician Decision|1|||
16302283|NCT02980341|39593407|FG008|Dose Escalation|Withdrawal by Subject|0|||
16302284|NCT02980341|39593408|FG009|Dose Escalation|Withdrawal by Subject|0|||
16302285|NCT02980341|39593409|FG010|Dose Escalation|Withdrawal by Subject|0|||
16490627|NCT03311724|40270333|FG000|Overall Study|Protocol Violation|1|||
16490628|NCT03311724|40270334|FG001|Overall Study|Protocol Violation|0|||
16490629|NCT03311724|40270335|FG002|Overall Study|Protocol Violation|1|||
16490630|NCT03311724|40270336|FG003|Overall Study|Protocol Violation|0|||
16490631|NCT03311724|40270333|FG000|Overall Study|Withdrawal by Subject|1|||
16490632|NCT03311724|40270334|FG001|Overall Study|Withdrawal by Subject|1|||
16490633|NCT03311724|40270335|FG002|Overall Study|Withdrawal by Subject|0|||
16490634|NCT03311724|40270336|FG003|Overall Study|Withdrawal by Subject|0|||
16490635|NCT03311724|40270333|FG000|Overall Study|Lost to Follow-up|1|||
16490636|NCT03311724|40270334|FG001|Overall Study|Lost to Follow-up|0|||
16490637|NCT03311724|40270335|FG002|Overall Study|Lost to Follow-up|0|||
16490638|NCT03311724|40270336|FG003|Overall Study|Lost to Follow-up|0|||
16490639|NCT03311724|40270333|FG000|Overall Study|Sponsor Decision|0|||
16490640|NCT03311724|40270334|FG001|Overall Study|Sponsor Decision|0|||
16490641|NCT03311724|40270335|FG002|Overall Study|Sponsor Decision|1|||
16490642|NCT03311724|40270336|FG003|Overall Study|Sponsor Decision|0|||
16490643|NCT05074667|40270339|FG000|Overall Study|Death|1|||
16490644|NCT05074667|40270339|FG000|Overall Study|Withdrawal by Subject|4|||
16490645|NCT05074667|40270339|FG000|Overall Study|Lost to Follow-up|10|||
16490646|NCT04221009|40270340|FG000|Overall Study|Withdrawal by Subject|4|||
16490647|NCT02220205|40270343|FG000|Overall Study|Withdrawal by Subject|1|||
16490648|NCT02220205|40270344|FG001|Overall Study|Withdrawal by Subject|0|||
16490649|NCT00317356|40270345|FG000|Overall Study|Adverse Event|0|||
16490650|NCT00317356|40270346|FG001|Overall Study|Adverse Event|0|||
16490651|NCT00317356|40270347|FG002|Overall Study|Adverse Event|1|||
16490652|NCT00317356|40270348|FG003|Overall Study|Adverse Event|0|||
16490653|NCT00317356|40270345|FG000|Overall Study|Lack of Efficacy|1|||
16490654|NCT00317356|40270346|FG001|Overall Study|Lack of Efficacy|1|||
16490655|NCT00317356|40270347|FG002|Overall Study|Lack of Efficacy|0|||
16490656|NCT00317356|40270348|FG003|Overall Study|Lack of Efficacy|3|||
16490657|NCT00317356|40270345|FG000|Overall Study|Physician Decision|0|||
16490658|NCT00317356|40270346|FG001|Overall Study|Physician Decision|1|||
16490659|NCT00317356|40270347|FG002|Overall Study|Physician Decision|0|||
16490660|NCT00317356|40270348|FG003|Overall Study|Physician Decision|0|||
16490661|NCT03217175|40270354|FG000|Overall Study|Physician Decision|4|||
16490662|NCT03217175|40270355|FG001|Overall Study|Physician Decision|1|||
16490663|NCT00133952|40270356|FG000|Overall Study|Adverse Event|1|||
16490664|NCT00133952|40270357|FG001|Overall Study|Adverse Event|2|||
16490665|NCT00133952|40270356|FG000|Overall Study|Death|3|||
16490666|NCT00133952|40270357|FG001|Overall Study|Death|2|||
16490667|NCT00133952|40270356|FG000|Overall Study|Lost to Follow-up|9|||
16490668|NCT00133952|40270357|FG001|Overall Study|Lost to Follow-up|14|||
16302286|NCT02980341|39593399|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
16302287|NCT02980341|39593400|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
16302288|NCT02980341|39593401|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
16302289|NCT02980341|39593402|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
16302290|NCT02980341|39593403|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
16302291|NCT02980341|39593404|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
16302292|NCT02980341|39593405|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
16302293|NCT02980341|39593406|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
16490669|NCT00133952|40270356|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
16490670|NCT00133952|40270357|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
16490671|NCT00133952|40270356|FG000|Overall Study|Protocol Violation|1|||
16302294|NCT02980341|39593407|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
16302295|NCT02980341|39593408|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
16302296|NCT02980341|39593409|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
16302297|NCT02980341|39593399|FG000|Dose Escalation|Due to investigator's decision|0|||
16302298|NCT02980341|39593400|FG001|Dose Escalation|Due to investigator's decision|0|||
16490672|NCT00133952|40270357|FG001|Overall Study|Protocol Violation|1|||
16490673|NCT00133952|40270356|FG000|Overall Study|Withdrawal by Subject|20|||
16490674|NCT00133952|40270357|FG001|Overall Study|Withdrawal by Subject|4|||
16490675|NCT00133952|40270356|FG000|Overall Study|Physician Decision|4|||
16490676|NCT00133952|40270357|FG001|Overall Study|Physician Decision|3|||
16490677|NCT00133952|40270356|FG000|Overall Study|Sponsor Decision|0|||
16490678|NCT00133952|40270357|FG001|Overall Study|Sponsor Decision|1|||
16490679|NCT03132220|40270360|FG000|Overall Study|Lost to Follow-up|17|||
16490680|NCT03132220|40270361|FG001|Overall Study|Lost to Follow-up|8|||
16490681|NCT03132220|40270360|FG000|Overall Study|Withdrawal by Subject|1|||
16490682|NCT03132220|40270361|FG001|Overall Study|Withdrawal by Subject|4|||
16490683|NCT03198234|40270362|FG000|Overall Study|Relapse of primary disease|0|||
16490684|NCT03198234|40270363|FG001|Overall Study|Relapse of primary disease|1|||
16490685|NCT03198234|40270364|FG002|Overall Study|Relapse of primary disease|0|||
16490686|NCT00064337|40270365|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
16490687|NCT00064337|40270365|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
16490688|NCT00064337|40270365|FG000|PBSCC or Induction/PBSCC|Progression|3|||
16490689|NCT00064337|40270365|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
16302299|NCT02980341|39593401|FG002|Dose Escalation|Due to investigator's decision|0|||
16302300|NCT02980341|39593402|FG003|Dose Escalation|Due to investigator's decision|0|||
16302301|NCT02980341|39593403|FG004|Dose Escalation|Due to investigator's decision|1|||
16302302|NCT02980341|39593404|FG005|Dose Escalation|Due to investigator's decision|0|||
16302303|NCT02980341|39593405|FG006|Dose Escalation|Due to investigator's decision|0|||
16302304|NCT02980341|39593406|FG007|Dose Escalation|Due to investigator's decision|0|||
16302305|NCT02980341|39593407|FG008|Dose Escalation|Due to investigator's decision|0|||
16302306|NCT02980341|39593408|FG009|Dose Escalation|Due to investigator's decision|0|||
16302307|NCT02980341|39593409|FG010|Dose Escalation|Due to investigator's decision|0|||
16302308|NCT02980341|39593399|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
16302309|NCT02980341|39593400|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
16302310|NCT02980341|39593401|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
16302311|NCT02980341|39593402|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
16302312|NCT02980341|39593403|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
16302313|NCT02980341|39593404|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
16302314|NCT02980341|39593405|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
16302315|NCT02980341|39593406|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
16302316|NCT02980341|39593407|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
16302317|NCT02980341|39593408|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
16302318|NCT02980341|39593409|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
16302319|NCT02980341|39593399|FG000|Dose Finding|Adverse Event|0|||
16302320|NCT02980341|39593400|FG001|Dose Finding|Adverse Event|0|||
16302321|NCT02980341|39593401|FG002|Dose Finding|Adverse Event|0|||
16302322|NCT02980341|39593402|FG003|Dose Finding|Adverse Event|0|||
16302323|NCT02980341|39593403|FG004|Dose Finding|Adverse Event|0|||
16302324|NCT02980341|39593404|FG005|Dose Finding|Adverse Event|3|||
16302325|NCT02980341|39593405|FG006|Dose Finding|Adverse Event|0|||
16302326|NCT02980341|39593406|FG007|Dose Finding|Adverse Event|0|||
16302327|NCT02980341|39593407|FG008|Dose Finding|Adverse Event|0|||
16302328|NCT02980341|39593408|FG009|Dose Finding|Adverse Event|0|||
16302329|NCT02980341|39593409|FG010|Dose Finding|Adverse Event|0|||
16302330|NCT02980341|39593399|FG000|Dose Finding|Withdrawal by Subject|0|||
16302331|NCT02980341|39593400|FG001|Dose Finding|Withdrawal by Subject|0|||
16302332|NCT02980341|39593401|FG002|Dose Finding|Withdrawal by Subject|0|||
16302333|NCT02980341|39593402|FG003|Dose Finding|Withdrawal by Subject|0|||
16302334|NCT02980341|39593403|FG004|Dose Finding|Withdrawal by Subject|0|||
16302335|NCT02980341|39593404|FG005|Dose Finding|Withdrawal by Subject|1|||
16302336|NCT02980341|39593405|FG006|Dose Finding|Withdrawal by Subject|1|||
16302337|NCT02980341|39593406|FG007|Dose Finding|Withdrawal by Subject|0|||
16302338|NCT02980341|39593407|FG008|Dose Finding|Withdrawal by Subject|0|||
16302339|NCT02980341|39593408|FG009|Dose Finding|Withdrawal by Subject|0|||
16302340|NCT02980341|39593409|FG010|Dose Finding|Withdrawal by Subject|0|||
16302341|NCT02980341|39593399|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
16302342|NCT02980341|39593400|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
16302343|NCT02980341|39593401|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
16302344|NCT02980341|39593402|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
16302345|NCT02980341|39593403|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
16302346|NCT02980341|39593404|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
16302347|NCT02980341|39593405|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
16302348|NCT02980341|39593406|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
16302349|NCT02980341|39593407|FG008|Dose Expansion|Progressive disease per RECIST v1.1|23|||
16302350|NCT02980341|39593408|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
16302351|NCT02980341|39593409|FG010|Dose Expansion|Progressive disease per RECIST v1.1|21|||
16302352|NCT02980341|39593399|FG000|Dose Expansion|Clinical progression|0|||
16302353|NCT02980341|39593400|FG001|Dose Expansion|Clinical progression|0|||
16302354|NCT02980341|39593401|FG002|Dose Expansion|Clinical progression|0|||
16302355|NCT02980341|39593402|FG003|Dose Expansion|Clinical progression|0|||
16302356|NCT02980341|39593403|FG004|Dose Expansion|Clinical progression|0|||
16302357|NCT02980341|39593404|FG005|Dose Expansion|Clinical progression|0|||
16302358|NCT02980341|39593405|FG006|Dose Expansion|Clinical progression|0|||
16302359|NCT02980341|39593406|FG007|Dose Expansion|Clinical progression|4|||
16302360|NCT02980341|39593407|FG008|Dose Expansion|Clinical progression|3|||
16302361|NCT02980341|39593408|FG009|Dose Expansion|Clinical progression|1|||
16302362|NCT02980341|39593409|FG010|Dose Expansion|Clinical progression|4|||
16302363|NCT02980341|39593399|FG000|Dose Expansion|Adverse Event|0|||
16302364|NCT02980341|39593400|FG001|Dose Expansion|Adverse Event|0|||
16490690|NCT00064337|40270365|FG000|PBSCC or Induction/PBSCC|Death|2|||
16302365|NCT02980341|39593401|FG002|Dose Expansion|Adverse Event|0|||
16302366|NCT02980341|39593402|FG003|Dose Expansion|Adverse Event|0|||
16302367|NCT02980341|39593403|FG004|Dose Expansion|Adverse Event|0|||
16302368|NCT02980341|39593404|FG005|Dose Expansion|Adverse Event|0|||
16302369|NCT02980341|39593405|FG006|Dose Expansion|Adverse Event|0|||
16302370|NCT02980341|39593406|FG007|Dose Expansion|Adverse Event|3|||
16302371|NCT02980341|39593407|FG008|Dose Expansion|Adverse Event|0|||
16302372|NCT02980341|39593408|FG009|Dose Expansion|Adverse Event|1|||
16302373|NCT02980341|39593409|FG010|Dose Expansion|Adverse Event|3|||
16302374|NCT02980341|39593399|FG000|Dose Expansion|Death|0|||
16302375|NCT02980341|39593400|FG001|Dose Expansion|Death|0|||
16302376|NCT02980341|39593401|FG002|Dose Expansion|Death|0|||
16302377|NCT02980341|39593402|FG003|Dose Expansion|Death|0|||
16302378|NCT02980341|39593403|FG004|Dose Expansion|Death|0|||
16302379|NCT02980341|39593404|FG005|Dose Expansion|Death|0|||
16302380|NCT02980341|39593405|FG006|Dose Expansion|Death|0|||
16302381|NCT02980341|39593406|FG007|Dose Expansion|Death|0|||
16302382|NCT02980341|39593407|FG008|Dose Expansion|Death|2|||
16302383|NCT02980341|39593408|FG009|Dose Expansion|Death|1|||
16302384|NCT02980341|39593409|FG010|Dose Expansion|Death|0|||
16302385|NCT02980341|39593399|FG000|Dose Expansion|Withdrawal by Subject|0|||
16302386|NCT02980341|39593400|FG001|Dose Expansion|Withdrawal by Subject|0|||
16302387|NCT02980341|39593401|FG002|Dose Expansion|Withdrawal by Subject|0|||
16302388|NCT02980341|39593402|FG003|Dose Expansion|Withdrawal by Subject|0|||
16302389|NCT02980341|39593403|FG004|Dose Expansion|Withdrawal by Subject|0|||
16302390|NCT02980341|39593404|FG005|Dose Expansion|Withdrawal by Subject|0|||
16302391|NCT02980341|39593405|FG006|Dose Expansion|Withdrawal by Subject|0|||
16302392|NCT02980341|39593406|FG007|Dose Expansion|Withdrawal by Subject|2|||
16302393|NCT02980341|39593407|FG008|Dose Expansion|Withdrawal by Subject|0|||
16490691|NCT00064337|40270365|FG000|Transplant|Adverse Event|9|||
16490692|NCT00064337|40270365|FG000|Transplant|Not protocol-specified|5|||
16490693|NCT00064337|40270365|FG000|Transplant|Death|3|||
16490694|NCT00064337|40270365|FG000|Transplant|Patient Refusal|2|||
16490695|NCT00064337|40270365|FG000|Transplant|Progression|2|||
16490696|NCT00064337|40270365|FG000|Maintenance|Adverse Event|3|||
16490697|NCT00064337|40270365|FG000|Maintenance|Progression|2|||
16490698|NCT00064337|40270365|FG000|Maintenance|On treatment at time of analysis|2|||
16490699|NCT00064337|40270365|FG000|Maintenance|Not protocol-specified|2|||
16490700|NCT00064337|40270365|FG000|Maintenance|Death|1|||
16490701|NCT04584645|40270366|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
16490702|NCT04584645|40270367|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
16490703|NCT02025621|40270369|FG000|Overall Study|Withdrawal by Subject|1|||
16490704|NCT02025621|40270370|FG001|Overall Study|Withdrawal by Subject|0|||
16302394|NCT02980341|39593408|FG009|Dose Expansion|Withdrawal by Subject|1|||
16302395|NCT02980341|39593409|FG010|Dose Expansion|Withdrawal by Subject|0|||
16302396|NCT02980341|39593399|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
16302397|NCT02980341|39593400|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
16302398|NCT02980341|39593401|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
16302399|NCT02980341|39593402|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
16490705|NCT02025621|40270369|FG000|Overall Study|Death|0|||
16490706|NCT02025621|40270370|FG001|Overall Study|Death|1|||
16302400|NCT02980341|39593403|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
16302401|NCT02980341|39593404|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
16302402|NCT02980341|39593405|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
16302403|NCT02980341|39593406|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
16302404|NCT02980341|39593407|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
16302405|NCT02980341|39593408|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
16302406|NCT02980341|39593409|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
16490707|NCT02025621|40270369|FG000|Overall Study|No longer eligible|10|||
16490708|NCT02025621|40270370|FG001|Overall Study|No longer eligible|15|||
16490709|NCT02025621|40270369|FG000|Overall Study|Surgery initiated before infusion|3|||
16490710|NCT02025621|40270370|FG001|Overall Study|Surgery initiated before infusion|3|||
16490711|NCT02233647|40270373|FG000|Overall Study|Adverse Event|1|||
16490712|NCT03281577|40270374|FG000|Overall Study|Adverse Event|0|||
16490713|NCT03281577|40270375|FG001|Overall Study|Adverse Event|0|||
16490714|NCT03281577|40270376|FG002|Overall Study|Adverse Event|0|||
16490715|NCT03281577|40270377|FG003|Overall Study|Adverse Event|1|||
16490716|NCT03281577|40270374|FG000|Overall Study|Withdrawal by Subject|1|||
16490717|NCT03281577|40270375|FG001|Overall Study|Withdrawal by Subject|0|||
16490718|NCT03281577|40270376|FG002|Overall Study|Withdrawal by Subject|0|||
16490719|NCT03281577|40270377|FG003|Overall Study|Withdrawal by Subject|0|||
16490720|NCT03329573|40270378|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
16490721|NCT03329573|40270379|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
16490722|NCT03329573|40270380|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
16490723|NCT03329573|40270381|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
16490724|NCT03329573|40270378|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
16490725|NCT03329573|40270379|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
16490726|NCT03329573|40270380|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16490727|NCT03329573|40270381|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16490728|NCT03329573|40270378|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
16490729|NCT03329573|40270379|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
16490730|NCT03329573|40270380|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
16490731|NCT03329573|40270381|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
16490732|NCT03329573|40270378|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
16490733|NCT03329573|40270379|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
16490734|NCT03329573|40270380|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
16490735|NCT03329573|40270381|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
16490736|NCT01947582|40270382|FG000|Overall Study|Withdrawal by Subject|1|||
16490737|NCT00370032|40270388|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
16490738|NCT00370032|40270389|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
16490739|NCT00370032|40270388|FG000|Washout Period|Withdrawal by Subject|0|||
16490740|NCT00370032|40270389|FG001|Washout Period|Withdrawal by Subject|1|||
16490741|NCT00370032|40270388|FG000|Washout Period|Lost to Follow-up|0|||
16490742|NCT00370032|40270389|FG001|Washout Period|Lost to Follow-up|1|||
16490743|NCT00370032|40270388|FG000|Washout Period|Adverse Event|1|||
16490744|NCT00370032|40270389|FG001|Washout Period|Adverse Event|0|||
16490745|NCT00370032|40270388|FG000|Follow-up Period|Withdrawal by Subject|1|||
16490746|NCT00370032|40270389|FG001|Follow-up Period|Withdrawal by Subject|0|||
16302407|NCT02980341|39593399|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
16302408|NCT02980341|39593400|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
16302409|NCT02980341|39593401|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
16302410|NCT02980341|39593402|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
16302411|NCT02980341|39593403|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
16302412|NCT02980341|39593404|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
16302413|NCT02980341|39593405|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
16387853|NCT00244621|39902753|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
16387854|NCT00244621|39902754|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
16387855|NCT00244621|39902755|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
16387856|NCT00244621|39902753|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
16387857|NCT00244621|39902754|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
16387858|NCT00244621|39902755|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
16387859|NCT00244621|39902753|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
16387860|NCT00244621|39902754|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
16387861|NCT00244621|39902755|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
16387862|NCT00244621|39902753|FG000|Open-label Treatment Period|Adverse Event|0|||
16387863|NCT00244621|39902754|FG001|Open-label Treatment Period|Adverse Event|0|||
16387864|NCT00244621|39902755|FG002|Open-label Treatment Period|Adverse Event|1|||
16387865|NCT00244621|39902753|FG000|Open-label Treatment Period|Moved abroad|0|||
16387866|NCT00244621|39902754|FG001|Open-label Treatment Period|Moved abroad|0|||
16387867|NCT00244621|39902755|FG002|Open-label Treatment Period|Moved abroad|1|||
16387868|NCT01345929|39902756|FG000|Overall Study|Withdrawal by Subject|9|||
16387869|NCT01345929|39902757|FG001|Overall Study|Withdrawal by Subject|8|||
16387870|NCT01345929|39902756|FG000|Overall Study|Lost to Follow-up|9|||
16387871|NCT01345929|39902757|FG001|Overall Study|Lost to Follow-up|9|||
16387872|NCT01345929|39902756|FG000|Overall Study|Adverse Event|0|||
16387873|NCT01345929|39902757|FG001|Overall Study|Adverse Event|1|||
16387874|NCT01345929|39902756|FG000|Overall Study|Didn't meet eligibility criteria|2|||
16387875|NCT01345929|39902757|FG001|Overall Study|Didn't meet eligibility criteria|0|||
16387876|NCT01345929|39902756|FG000|Overall Study|40,000 CFU/ML|1|||
16387877|NCT01345929|39902757|FG001|Overall Study|40,000 CFU/ML|0|||
16387878|NCT01345929|39902756|FG000|Overall Study|Patient withdrawal|0|||
16387879|NCT01345929|39902757|FG001|Overall Study|Patient withdrawal|1|||
16387880|NCT03904147|39902758|FG000|Overall Study|Death|15|||
16387881|NCT03904147|39902759|FG001|Overall Study|Death|13|||
16387882|NCT03904147|39902760|FG002|Overall Study|Death|15|||
16387883|NCT03904147|39902758|FG000|Overall Study|Withdrawal by Subject|7|||
16387884|NCT03904147|39902759|FG001|Overall Study|Withdrawal by Subject|12|||
16387885|NCT03904147|39902760|FG002|Overall Study|Withdrawal by Subject|1|||
16387886|NCT03904147|39902758|FG000|Overall Study|1Y visit completed after 365 days|1|||
16387887|NCT03904147|39902759|FG001|Overall Study|1Y visit completed after 365 days|1|||
16387888|NCT03904147|39902760|FG002|Overall Study|1Y visit completed after 365 days|0|||
16387889|NCT01493414|39902764|FG000|Overall Study|Adverse Event|405|||
16387890|NCT01493414|39902764|FG000|Overall Study|Disease progression|204|||
16387891|NCT01493414|39902764|FG000|Overall Study|Death|101|||
16387892|NCT01493414|39902764|FG000|Overall Study|Physician Decision|93|||
16387893|NCT01493414|39902764|FG000|Overall Study|Withdrawal by Subject|79|||
16387894|NCT01493414|39902764|FG000|Overall Study|Protocol deviation|27|||
16387895|NCT01493414|39902764|FG000|Overall Study|Administrative problems|25|||
16387896|NCT01493414|39902764|FG000|Overall Study|Lost to Follow-up|16|||
16387897|NCT01154452|39902765|FG000|Phase Ib|Not Treated|1|||
16387898|NCT01154452|39902766|FG001|Phase Ib|Not Treated|0|||
16387899|NCT01154452|39902767|FG002|Phase Ib|Not Treated|0|||
16387900|NCT01154452|39902768|FG003|Phase Ib|Not Treated|0|||
16387901|NCT01154452|39902765|FG000|Phase Ib|Adverse Event|2|||
16387902|NCT01154452|39902766|FG001|Phase Ib|Adverse Event|1|||
16387903|NCT01154452|39902767|FG002|Phase Ib|Adverse Event|0|||
16387904|NCT01154452|39902768|FG003|Phase Ib|Adverse Event|0|||
16387905|NCT01154452|39902765|FG000|Phase II|Withdrawal by Subject|0|||
16387906|NCT01154452|39902766|FG001|Phase II|Withdrawal by Subject|0|||
16387907|NCT01154452|39902767|FG002|Phase II|Withdrawal by Subject|1|||
16387908|NCT01154452|39902768|FG003|Phase II|Withdrawal by Subject|2|||
16387909|NCT01154452|39902765|FG000|Phase II|Adverse Event|0|||
16387910|NCT01154452|39902766|FG001|Phase II|Adverse Event|0|||
16387911|NCT01154452|39902767|FG002|Phase II|Adverse Event|4|||
16387912|NCT01154452|39902768|FG003|Phase II|Adverse Event|4|||
16387913|NCT02297412|39902775|FG000|Overall Study|Canceled|1|||
16387914|NCT02297412|39902776|FG001|Overall Study|Canceled|1|||
16387915|NCT01070979|39902779|FG000|Overall Study|Adverse Event|2|||
16387916|NCT01070979|39902780|FG001|Overall Study|Adverse Event|3|||
16302414|NCT02980341|39593406|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
16302415|NCT02980341|39593407|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
16302416|NCT02980341|39593408|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
16302417|NCT02980341|39593409|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
16490747|NCT01411774|40270391|FG000|Overall Study|Withdrawal by Subject|0|||
16490748|NCT01411774|40270392|FG001|Overall Study|Withdrawal by Subject|3|||
16490749|NCT00371137|40270393|FG000|Overall Study|Adverse Event|20|||
16490750|NCT00371137|40270394|FG001|Overall Study|Adverse Event|35|||
16490751|NCT00371137|40270395|FG002|Overall Study|Adverse Event|42|||
16490752|NCT00371137|40270393|FG000|Overall Study|Withdrawal by Subject|11|||
16490753|NCT00371137|40270394|FG001|Overall Study|Withdrawal by Subject|10|||
16302418|NCT02980341|39593399|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
16302419|NCT02980341|39593400|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
16302420|NCT02980341|39593401|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
16302421|NCT02980341|39593402|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
16302422|NCT02980341|39593403|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
16302423|NCT02980341|39593404|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
16302424|NCT02980341|39593405|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
16302425|NCT02980341|39593406|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
16490754|NCT00371137|40270395|FG002|Overall Study|Withdrawal by Subject|15|||
16490755|NCT00371137|40270393|FG000|Overall Study|Lost to Follow-up|6|||
16490756|NCT00371137|40270394|FG001|Overall Study|Lost to Follow-up|3|||
16490757|NCT00371137|40270395|FG002|Overall Study|Lost to Follow-up|5|||
16490758|NCT00371137|40270393|FG000|Overall Study|Lack of Efficacy|30|||
16490759|NCT00371137|40270394|FG001|Overall Study|Lack of Efficacy|12|||
16490760|NCT00371137|40270395|FG002|Overall Study|Lack of Efficacy|13|||
16490761|NCT00371137|40270393|FG000|Overall Study|Sponsor Decision|2|||
16490762|NCT00371137|40270394|FG001|Overall Study|Sponsor Decision|1|||
16490763|NCT00371137|40270395|FG002|Overall Study|Sponsor Decision|2|||
16490764|NCT00371137|40270393|FG000|Overall Study|Physician Decision|1|||
16490765|NCT00371137|40270394|FG001|Overall Study|Physician Decision|1|||
16490766|NCT00371137|40270395|FG002|Overall Study|Physician Decision|1|||
16490767|NCT00371137|40270393|FG000|Overall Study|Protocol Violation|2|||
16490768|NCT00371137|40270394|FG001|Overall Study|Protocol Violation|1|||
16490769|NCT00371137|40270395|FG002|Overall Study|Protocol Violation|1|||
16490770|NCT01844518|40270398|FG000|Overall Study|Adverse Event|7|||
16490771|NCT01844518|40270399|FG001|Overall Study|Adverse Event|1|||
16490772|NCT01844518|40270398|FG000|Overall Study|Lack of Efficacy|17|||
16490773|NCT01844518|40270399|FG001|Overall Study|Lack of Efficacy|5|||
16490774|NCT01844518|40270398|FG000|Overall Study|Participant's request to discontinue|4|||
16490775|NCT01844518|40270399|FG001|Overall Study|Participant's request to discontinue|1|||
16490776|NCT01844518|40270398|FG000|Overall Study|Poor/Non-compliance|1|||
16490777|NCT01844518|40270399|FG001|Overall Study|Poor/Non-compliance|0|||
16490778|NCT01844518|40270398|FG000|Overall Study|No Longer Met Study Criteria|2|||
16490779|NCT01844518|40270399|FG001|Overall Study|No Longer Met Study Criteria|0|||
16490780|NCT01844518|40270398|FG000|Overall Study|Withdrawal by Subject|9|||
16490781|NCT01844518|40270399|FG001|Overall Study|Withdrawal by Subject|0|||
16490782|NCT01844518|40270398|FG000|Overall Study|Pregnancy|1|||
16490783|NCT01844518|40270399|FG001|Overall Study|Pregnancy|0|||
16490784|NCT00752232|40270400|FG000|Overall Study|Protocol Violation|0|||
16490785|NCT00752232|40270401|FG001|Overall Study|Protocol Violation|0|||
16490786|NCT00752232|40270402|FG002|Overall Study|Protocol Violation|0|||
16490787|NCT00752232|40270403|FG003|Overall Study|Protocol Violation|0|||
16302426|NCT02980341|39593407|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
16490788|NCT00752232|40270404|FG004|Overall Study|Protocol Violation|0|||
16490789|NCT00752232|40270405|FG005|Overall Study|Protocol Violation|1|||
16490790|NCT00752232|40270406|FG006|Overall Study|Protocol Violation|0|||
16490791|NCT00752232|40270400|FG000|Overall Study|Caregiver request|2|||
16490792|NCT00752232|40270401|FG001|Overall Study|Caregiver request|0|||
16490793|NCT00752232|40270402|FG002|Overall Study|Caregiver request|0|||
16490794|NCT00752232|40270403|FG003|Overall Study|Caregiver request|0|||
16490795|NCT00752232|40270404|FG004|Overall Study|Caregiver request|1|||
16490796|NCT00752232|40270405|FG005|Overall Study|Caregiver request|0|||
16490797|NCT00752232|40270406|FG006|Overall Study|Caregiver request|0|||
16490798|NCT00752232|40270400|FG000|Overall Study|Investigator request|0|||
16490799|NCT00752232|40270401|FG001|Overall Study|Investigator request|0|||
16490800|NCT00752232|40270402|FG002|Overall Study|Investigator request|0|||
16490801|NCT00752232|40270403|FG003|Overall Study|Investigator request|0|||
16490802|NCT00752232|40270404|FG004|Overall Study|Investigator request|1|||
16490803|NCT00752232|40270405|FG005|Overall Study|Investigator request|0|||
16490804|NCT00752232|40270406|FG006|Overall Study|Investigator request|0|||
16490805|NCT00752232|40270400|FG000|Overall Study|Subject request|0|||
16490806|NCT00752232|40270401|FG001|Overall Study|Subject request|0|||
16490807|NCT00752232|40270402|FG002|Overall Study|Subject request|1|||
16490808|NCT00752232|40270403|FG003|Overall Study|Subject request|0|||
16490809|NCT00752232|40270404|FG004|Overall Study|Subject request|0|||
16490810|NCT00752232|40270405|FG005|Overall Study|Subject request|0|||
16490811|NCT00752232|40270406|FG006|Overall Study|Subject request|0|||
16490812|NCT00752232|40270400|FG000|Overall Study|Group home admission|0|||
16490813|NCT00752232|40270401|FG001|Overall Study|Group home admission|0|||
16490814|NCT00752232|40270402|FG002|Overall Study|Group home admission|0|||
16490815|NCT00752232|40270403|FG003|Overall Study|Group home admission|1|||
16490816|NCT00752232|40270404|FG004|Overall Study|Group home admission|0|||
16490817|NCT00752232|40270405|FG005|Overall Study|Group home admission|0|||
16490818|NCT00752232|40270406|FG006|Overall Study|Group home admission|0|||
16490819|NCT00752232|40270400|FG000|Overall Study|Caregiver could not attend the subject|0|||
16490820|NCT00752232|40270401|FG001|Overall Study|Caregiver could not attend the subject|0|||
16490821|NCT00752232|40270402|FG002|Overall Study|Caregiver could not attend the subject|0|||
16490822|NCT00752232|40270403|FG003|Overall Study|Caregiver could not attend the subject|0|||
16490823|NCT00752232|40270404|FG004|Overall Study|Caregiver could not attend the subject|1|||
16490824|NCT00752232|40270405|FG005|Overall Study|Caregiver could not attend the subject|0|||
16490825|NCT00752232|40270406|FG006|Overall Study|Caregiver could not attend the subject|0|||
16490826|NCT00612690|40270408|FG000|Overall Study|Lost to Follow-up|72|||
16490827|NCT00612690|40270409|FG001|Overall Study|Lost to Follow-up|98|||
16490828|NCT00612690|40270408|FG000|Overall Study|Withdrawal by Subject|32|||
16490829|NCT00612690|40270409|FG001|Overall Study|Withdrawal by Subject|20|||
16490830|NCT00612690|40270408|FG000|Overall Study|Withdrawal by Site|11|||
16490831|NCT00612690|40270409|FG001|Overall Study|Withdrawal by Site|0|||
16490832|NCT01507298|40270410|FG000|Overall Study|Protocol Violation|0|||
16490833|NCT01507298|40270411|FG001|Overall Study|Protocol Violation|6|||
16490834|NCT01438424|40270412|FG000|Overall Study|Continuing treatment|29|||
16490835|NCT01438424|40270412|FG000|Overall Study|Minimal virologic response|95|||
16490836|NCT01438424|40270412|FG000|Overall Study|Not identified|55|||
16490837|NCT01438424|40270412|FG000|Overall Study|Withdrawal by Subject|104|||
16490838|NCT01438424|40270412|FG000|Overall Study|Progression of chronic hepatitis B|22|||
16490839|NCT01438424|40270412|FG000|Overall Study|Death|22|||
16490840|NCT01438424|40270412|FG000|Overall Study|Adverse Event|17|||
16490841|NCT01438424|40270412|FG000|Overall Study|Lost to Follow-up|17|||
16490842|NCT01438424|40270412|FG000|Overall Study|Abnormal laboratory test result|14|||
16490843|NCT01438424|40270412|FG000|Overall Study|Need for drug prohibited by protocol|14|||
16490844|NCT01438424|40270412|FG000|Overall Study|Pregnancy|7|||
16490845|NCT01438424|40270412|FG000|Overall Study|No longer met inclusion criteria|1|||
16490846|NCT01438424|40270412|FG000|Overall Study|Participant noncompliance|20|||
16490847|NCT00160693|40270413|FG000|Overall Study|Adverse Event|97|||
16490848|NCT00160693|40270413|FG000|Overall Study|Lack of Efficacy|30|||
16490849|NCT00160693|40270413|FG000|Overall Study|Protocol Violation|24|||
16490850|NCT00160693|40270413|FG000|Overall Study|Lost to Follow-up|15|||
16490851|NCT00160693|40270413|FG000|Overall Study|Withdrawal by Subject|54|||
16490852|NCT00160693|40270413|FG000|Overall Study|Study terminated by sponsor|15|||
16490853|NCT02246660|40270414|FG000|Overall Study|Withdrawal by Subject|0|||
16490854|NCT02246660|40270415|FG001|Overall Study|Withdrawal by Subject|1|||
16490855|NCT02246660|40270416|FG002|Overall Study|Withdrawal by Subject|0|||
16490856|NCT02246660|40270414|FG000|Overall Study|Death|0|||
16490857|NCT02246660|40270415|FG001|Overall Study|Death|0|||
16490858|NCT02246660|40270416|FG002|Overall Study|Death|1|||
16192872|NCT03703375|39185176|FG003|Randomization Period|Withdrawal by Subject|1|||
16192873|NCT03703375|39185173|FG000|Randomization Period|Completed safety run-in treatment|7|||
16192874|NCT03703375|39185174|FG001|Randomization Period|Completed safety run-in treatment|0|||
16192875|NCT03703375|39185175|FG002|Randomization Period|Completed safety run-in treatment|0|||
16192876|NCT03703375|39185176|FG003|Randomization Period|Completed safety run-in treatment|0|||
16192877|NCT03703375|39185173|FG000|Treatment Period|Other Reasons|0|||
16490859|NCT00729651|40270417|FG000|Overall Study|Withdrawal by Subject|5|||
16490860|NCT00729651|40270418|FG001|Overall Study|Withdrawal by Subject|6|||
16192878|NCT03703375|39185174|FG001|Treatment Period|Other Reasons|1|||
16192879|NCT03703375|39185175|FG002|Treatment Period|Other Reasons|0|||
16192880|NCT03703375|39185176|FG003|Treatment Period|Other Reasons|3|||
16192881|NCT03703375|39185173|FG000|Treatment Period|Consent Withdrawal|0|||
16192882|NCT03703375|39185174|FG001|Treatment Period|Consent Withdrawal|0|||
16490861|NCT00729651|40270417|FG000|Overall Study|Lost to Follow-up|5|||
16490862|NCT00729651|40270418|FG001|Overall Study|Lost to Follow-up|4|||
16490863|NCT00729651|40270417|FG000|Overall Study|Protocol Violation|0|||
16490864|NCT00729651|40270418|FG001|Overall Study|Protocol Violation|1|||
16192883|NCT03703375|39185175|FG002|Treatment Period|Consent Withdrawal|0|||
16192884|NCT03703375|39185176|FG003|Treatment Period|Consent Withdrawal|1|||
16192885|NCT03703375|39185173|FG000|Treatment Period|Death|1|||
16192886|NCT03703375|39185174|FG001|Treatment Period|Death|0|||
16192887|NCT03703375|39185175|FG002|Treatment Period|Death|1|||
16192888|NCT03703375|39185176|FG003|Treatment Period|Death|2|||
16192889|NCT03703375|39185173|FG000|Treatment Period|Toxicity of Study Treatment|2|||
16192890|NCT03703375|39185174|FG001|Treatment Period|Toxicity of Study Treatment|0|||
16192891|NCT03703375|39185175|FG002|Treatment Period|Toxicity of Study Treatment|4|||
16192892|NCT03703375|39185176|FG003|Treatment Period|Toxicity of Study Treatment|1|||
16192893|NCT03703375|39185173|FG000|Treatment Period|Progression|32|||
16192894|NCT03703375|39185174|FG001|Treatment Period|Progression|1|||
16192895|NCT03703375|39185175|FG002|Treatment Period|Progression|7|||
16192896|NCT03703375|39185176|FG003|Treatment Period|Progression|11|||
16192897|NCT03703375|39185173|FG000|Treatment Period|Completed treatment|7|||
16192898|NCT03703375|39185174|FG001|Treatment Period|Completed treatment|2|||
16192899|NCT03703375|39185175|FG002|Treatment Period|Completed treatment|0|||
16192900|NCT03703375|39185176|FG003|Treatment Period|Completed treatment|0|||
16192901|NCT02531373|39185177|FG000|Overall Study|Lack of Efficacy|0|||
16192902|NCT02531373|39185178|FG001|Overall Study|Lack of Efficacy|0|||
16192903|NCT02531373|39185179|FG002|Overall Study|Lack of Efficacy|0|||
16192904|NCT02531373|39185180|FG003|Overall Study|Lack of Efficacy|0|||
16192905|NCT02531373|39185181|FG004|Overall Study|Lack of Efficacy|3|||
16192906|NCT02531373|39185182|FG005|Overall Study|Lack of Efficacy|2|||
16192907|NCT02531373|39185183|FG006|Overall Study|Lack of Efficacy|4|||
16192908|NCT02531373|39185184|FG007|Overall Study|Lack of Efficacy|8|||
16192909|NCT02531373|39185185|FG008|Overall Study|Lack of Efficacy|5|||
16192910|NCT02531373|39185177|FG000|Overall Study|Lost to Follow-up|0|||
16192911|NCT02531373|39185178|FG001|Overall Study|Lost to Follow-up|0|||
16192912|NCT02531373|39185179|FG002|Overall Study|Lost to Follow-up|0|||
16490865|NCT00729651|40270417|FG000|Overall Study|Adverse Event|7|||
16490866|NCT00729651|40270418|FG001|Overall Study|Adverse Event|3|||
16490867|NCT00729651|40270417|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
16490868|NCT00729651|40270418|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
16490869|NCT00729651|40270417|FG000|Overall Study|Subject's private reason|2|||
16490870|NCT00729651|40270418|FG001|Overall Study|Subject's private reason|0|||
16490871|NCT00733408|40270428|FG000|Overall Study|Adverse Event|4|||
16490872|NCT00001596|40270429|FG000|Overall Study|Death|1|||
16490873|NCT00001596|40270430|FG001|Overall Study|Death|0|||
16490874|NCT00001596|40270429|FG000|Overall Study|Withdrawal by Subject|3|||
16192913|NCT02531373|39185180|FG003|Overall Study|Lost to Follow-up|0|||
16192914|NCT02531373|39185181|FG004|Overall Study|Lost to Follow-up|0|||
16192915|NCT02531373|39185182|FG005|Overall Study|Lost to Follow-up|2|||
16192916|NCT02531373|39185183|FG006|Overall Study|Lost to Follow-up|2|||
16192917|NCT02531373|39185184|FG007|Overall Study|Lost to Follow-up|0|||
16192918|NCT02531373|39185185|FG008|Overall Study|Lost to Follow-up|0|||
16192919|NCT02531373|39185177|FG000|Overall Study|Physician Decision|0|||
16192920|NCT02531373|39185178|FG001|Overall Study|Physician Decision|0|||
16192921|NCT02531373|39185179|FG002|Overall Study|Physician Decision|0|||
16192922|NCT02531373|39185180|FG003|Overall Study|Physician Decision|0|||
16192923|NCT02531373|39185181|FG004|Overall Study|Physician Decision|2|||
16490875|NCT00001596|40270430|FG001|Overall Study|Withdrawal by Subject|1|||
16490876|NCT00001596|40270429|FG000|Overall Study|Study Termination|12|||
16490877|NCT00001596|40270430|FG001|Overall Study|Study Termination|9|||
16490878|NCT00001596|40270429|FG000|Overall Study|Adverse Event|1|||
16490879|NCT00001596|40270430|FG001|Overall Study|Adverse Event|0|||
16490880|NCT00071513|40270432|FG000|Intervention Component|Withdrawal by Subject|2|||
16490881|NCT00071513|40270433|FG001|Intervention Component|Withdrawal by Subject|3|||
16490882|NCT00071513|40270432|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
16192924|NCT02531373|39185182|FG005|Overall Study|Physician Decision|1|||
16192925|NCT02531373|39185183|FG006|Overall Study|Physician Decision|0|||
16192926|NCT02531373|39185184|FG007|Overall Study|Physician Decision|0|||
16192927|NCT02531373|39185185|FG008|Overall Study|Physician Decision|0|||
16192928|NCT02531373|39185177|FG000|Overall Study|Protocol Violation|0|||
16302427|NCT02980341|39593408|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
16302428|NCT02980341|39593409|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
16192929|NCT02531373|39185178|FG001|Overall Study|Protocol Violation|0|||
16192930|NCT02531373|39185179|FG002|Overall Study|Protocol Violation|0|||
16192931|NCT02531373|39185180|FG003|Overall Study|Protocol Violation|0|||
16192932|NCT02531373|39185181|FG004|Overall Study|Protocol Violation|0|||
16192933|NCT02531373|39185182|FG005|Overall Study|Protocol Violation|1|||
16192934|NCT02531373|39185183|FG006|Overall Study|Protocol Violation|1|||
16192935|NCT02531373|39185184|FG007|Overall Study|Protocol Violation|0|||
16192936|NCT02531373|39185185|FG008|Overall Study|Protocol Violation|1|||
16192937|NCT02531373|39185177|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16192938|NCT02531373|39185178|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16192939|NCT02531373|39185179|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16192940|NCT02531373|39185180|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
16192941|NCT02531373|39185181|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
16192942|NCT02531373|39185182|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
16302429|NCT02856802|39593410|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
16302430|NCT02856802|39593411|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
16302431|NCT02856802|39593410|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
16302432|NCT02856802|39593411|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
16387917|NCT01070979|39902781|FG002|Overall Study|Adverse Event|3|||
16490883|NCT00071513|40270433|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
16490884|NCT04851314|40270434|FG000|Overall Study|Unable to complete research set-up procedures|0|||
16192943|NCT02531373|39185183|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
16192944|NCT02531373|39185184|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
16192945|NCT02531373|39185185|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
16192946|NCT02531373|39185177|FG000|Overall Study|Withdrawal by Subject|0|||
16302433|NCT02856802|39593410|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
16302434|NCT02856802|39593411|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
16302435|NCT02856802|39593410|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
16302436|NCT02856802|39593411|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
16302437|NCT02856802|39593410|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
16302438|NCT02856802|39593411|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
16192947|NCT02531373|39185178|FG001|Overall Study|Withdrawal by Subject|0|||
16192948|NCT02531373|39185179|FG002|Overall Study|Withdrawal by Subject|0|||
16192949|NCT02531373|39185180|FG003|Overall Study|Withdrawal by Subject|0|||
16192950|NCT02531373|39185181|FG004|Overall Study|Withdrawal by Subject|3|||
16192951|NCT02531373|39185182|FG005|Overall Study|Withdrawal by Subject|0|||
16192952|NCT02531373|39185183|FG006|Overall Study|Withdrawal by Subject|0|||
16192953|NCT02531373|39185184|FG007|Overall Study|Withdrawal by Subject|0|||
16192954|NCT02531373|39185185|FG008|Overall Study|Withdrawal by Subject|0|||
16192955|NCT00138151|39185188|FG000|Overall Study|Withdrawal by Subject|3|||
16192956|NCT00138151|39185188|FG000|Overall Study|Physician Decision|1|||
16192957|NCT04532294|39185189|FG000|Overall Study|Withdrawal by Subject|0|||
16192958|NCT04532294|39185190|FG001|Overall Study|Withdrawal by Subject|0|||
16192959|NCT04532294|39185191|FG002|Overall Study|Withdrawal by Subject|1|||
16192960|NCT04532294|39185189|FG000|Overall Study|Participants Not Dosed|0|||
16192961|NCT04532294|39185190|FG001|Overall Study|Participants Not Dosed|0|||
16192962|NCT04532294|39185191|FG002|Overall Study|Participants Not Dosed|2|||
16192963|NCT00406783|39185192|FG000|Overall Study|Adverse Event|4|||
16192964|NCT00406783|39185193|FG001|Overall Study|Adverse Event|4|||
16192965|NCT00406783|39185192|FG000|Overall Study|Treatment Failure|2|||
16192966|NCT00406783|39185193|FG001|Overall Study|Treatment Failure|3|||
16192967|NCT00406783|39185192|FG000|Overall Study|Lost to Follow-up|3|||
16192968|NCT00406783|39185193|FG001|Overall Study|Lost to Follow-up|0|||
16192969|NCT00406783|39185192|FG000|Overall Study|Withdrawal by Subject|1|||
16192970|NCT00406783|39185193|FG001|Overall Study|Withdrawal by Subject|4|||
16192971|NCT00406783|39185192|FG000|Overall Study|Protocol Violation|4|||
16192972|NCT00406783|39185193|FG001|Overall Study|Protocol Violation|4|||
16192973|NCT04056455|39185197|FG000|Overall Study|Adverse Event|1|||
16192974|NCT04056455|39185198|FG001|Overall Study|Adverse Event|0|||
16192975|NCT02575079|39185199|FG000|Overall Study|Death|3|||
16192976|NCT02575079|39185200|FG001|Overall Study|Death|0|||
16192977|NCT02575079|39185199|FG000|Overall Study|Withdrawal by Subject|3|||
16192978|NCT02575079|39185200|FG001|Overall Study|Withdrawal by Subject|0|||
16192979|NCT01767194|39185201|FG000|Overall Study|Adverse Event|1|||
16192980|NCT01767194|39185202|FG001|Overall Study|Adverse Event|1|||
16192981|NCT01767194|39185201|FG000|Overall Study|Death|0|||
16192982|NCT01767194|39185202|FG001|Overall Study|Death|1|||
16192983|NCT01767194|39185201|FG000|Overall Study|Lack of Efficacy|12|||
16192984|NCT01767194|39185202|FG001|Overall Study|Lack of Efficacy|11|||
16192985|NCT01767194|39185201|FG000|Overall Study|Physician Decision|2|||
16192986|NCT01767194|39185202|FG001|Overall Study|Physician Decision|23|||
16302439|NCT02856802|39593410|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
16302440|NCT02856802|39593411|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
16302441|NCT01174043|39593416|FG000|Overall Study|Disease progression|5|||
16302442|NCT01174043|39593416|FG000|Overall Study|Adverse Event|3|||
16302443|NCT01174043|39593416|FG000|Overall Study|Death|1|||
16302444|NCT01174043|39593416|FG000|Overall Study|Withdrawal by Subject|2|||
16302445|NCT00801099|39593417|FG000|Overall Study|Lost to Follow-up|101|||
16302446|NCT04015908|39593421|FG000|Overall Study|Lost to Follow-up|0|||
16302447|NCT04015908|39593422|FG001|Overall Study|Lost to Follow-up|1|||
16302448|NCT03449446|39593426|FG000|Overall Study|Randomized but Never Treated|0|||
16302449|NCT03449446|39593427|FG001|Overall Study|Randomized but Never Treated|0|||
16302450|NCT03449446|39593428|FG002|Overall Study|Randomized but Never Treated|1|||
16302451|NCT03449446|39593429|FG003|Overall Study|Randomized but Never Treated|1|||
16302452|NCT03449446|39593430|FG004|Overall Study|Randomized but Never Treated|1|||
16302453|NCT03449446|39593431|FG005|Overall Study|Randomized but Never Treated|0|||
16302454|NCT03449446|39593432|FG006|Overall Study|Randomized but Never Treated|0|||
16302455|NCT03449446|39593426|FG000|Overall Study|Unknown Reason|33|||
16490885|NCT04851314|40270435|FG001|Overall Study|Unable to complete research set-up procedures|2|||
16490886|NCT04851314|40270434|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
16490887|NCT04851314|40270435|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
16490888|NCT00887978|40270436|FG000|Overall Study|Adverse Event|18|||
16490889|NCT00887978|40270437|FG001|Overall Study|Adverse Event|5|||
16490890|NCT00887978|40270436|FG000|Overall Study|Clinical Worsening|4|||
16490891|NCT00887978|40270437|FG001|Overall Study|Clinical Worsening|4|||
16490892|NCT00887978|40270436|FG000|Overall Study|Death|2|||
16490893|NCT00887978|40270437|FG001|Overall Study|Death|3|||
16490894|NCT00887978|40270436|FG000|Overall Study|Withdrawal by Subject|1|||
16192987|NCT01767194|39185201|FG000|Overall Study|Withdrawal by Subject|0|||
16192988|NCT01767194|39185202|FG001|Overall Study|Withdrawal by Subject|1|||
16192989|NCT01767194|39185201|FG000|Overall Study|Ineligible|1|||
16302456|NCT03449446|39593427|FG001|Overall Study|Unknown Reason|1|||
16302457|NCT03449446|39593428|FG002|Overall Study|Unknown Reason|1|||
16302458|NCT03449446|39593429|FG003|Overall Study|Unknown Reason|1|||
16302459|NCT03449446|39593430|FG004|Overall Study|Unknown Reason|2|||
16302460|NCT03449446|39593431|FG005|Overall Study|Unknown Reason|2|||
16302461|NCT03449446|39593432|FG006|Overall Study|Unknown Reason|0|||
16302462|NCT03449446|39593426|FG000|Overall Study|Withdrew Consent|1|||
16302463|NCT03449446|39593427|FG001|Overall Study|Withdrew Consent|3|||
16302464|NCT03449446|39593428|FG002|Overall Study|Withdrew Consent|1|||
16302465|NCT03449446|39593429|FG003|Overall Study|Withdrew Consent|4|||
16302466|NCT03449446|39593430|FG004|Overall Study|Withdrew Consent|4|||
16302467|NCT03449446|39593431|FG005|Overall Study|Withdrew Consent|4|||
16302468|NCT03449446|39593432|FG006|Overall Study|Withdrew Consent|1|||
16302469|NCT03449446|39593426|FG000|Overall Study|Adverse Event|1|||
16302470|NCT03449446|39593427|FG001|Overall Study|Adverse Event|2|||
16302471|NCT03449446|39593428|FG002|Overall Study|Adverse Event|1|||
16302472|NCT03449446|39593429|FG003|Overall Study|Adverse Event|0|||
16302473|NCT03449446|39593430|FG004|Overall Study|Adverse Event|0|||
16302474|NCT03449446|39593431|FG005|Overall Study|Adverse Event|2|||
16302475|NCT03449446|39593432|FG006|Overall Study|Adverse Event|0|||
16302476|NCT03449446|39593426|FG000|Overall Study|Lost to Follow-up|0|||
16302477|NCT03449446|39593427|FG001|Overall Study|Lost to Follow-up|0|||
16302478|NCT03449446|39593428|FG002|Overall Study|Lost to Follow-up|2|||
16302479|NCT03449446|39593429|FG003|Overall Study|Lost to Follow-up|1|||
16302480|NCT03449446|39593430|FG004|Overall Study|Lost to Follow-up|3|||
16302481|NCT03449446|39593431|FG005|Overall Study|Lost to Follow-up|0|||
16302482|NCT03449446|39593432|FG006|Overall Study|Lost to Follow-up|0|||
16302483|NCT03449446|39593426|FG000|Overall Study|Investigator's Discretion|0|||
16302484|NCT03449446|39593427|FG001|Overall Study|Investigator's Discretion|1|||
16302485|NCT03449446|39593428|FG002|Overall Study|Investigator's Discretion|1|||
16302486|NCT03449446|39593429|FG003|Overall Study|Investigator's Discretion|2|||
16302487|NCT03449446|39593430|FG004|Overall Study|Investigator's Discretion|0|||
16302488|NCT03449446|39593431|FG005|Overall Study|Investigator's Discretion|0|||
16302489|NCT03449446|39593432|FG006|Overall Study|Investigator's Discretion|0|||
16302490|NCT03449446|39593426|FG000|Overall Study|Non Compliance with Study Drug|1|||
16302491|NCT03449446|39593427|FG001|Overall Study|Non Compliance with Study Drug|0|||
16302492|NCT03449446|39593428|FG002|Overall Study|Non Compliance with Study Drug|0|||
16302493|NCT03449446|39593429|FG003|Overall Study|Non Compliance with Study Drug|0|||
16302494|NCT03449446|39593430|FG004|Overall Study|Non Compliance with Study Drug|0|||
16302495|NCT03449446|39593431|FG005|Overall Study|Non Compliance with Study Drug|0|||
16302496|NCT03449446|39593432|FG006|Overall Study|Non Compliance with Study Drug|0|||
16302497|NCT03449446|39593426|FG000|Overall Study|Protocol Violation|0|||
16302498|NCT03449446|39593427|FG001|Overall Study|Protocol Violation|0|||
16302499|NCT03449446|39593428|FG002|Overall Study|Protocol Violation|0|||
16302500|NCT03449446|39593429|FG003|Overall Study|Protocol Violation|0|||
16302501|NCT03449446|39593430|FG004|Overall Study|Protocol Violation|1|||
16302502|NCT03449446|39593431|FG005|Overall Study|Protocol Violation|1|||
16302503|NCT03449446|39593432|FG006|Overall Study|Protocol Violation|0|||
16302504|NCT03449446|39593426|FG000|Overall Study|Death|0|||
16302505|NCT03449446|39593427|FG001|Overall Study|Death|0|||
16302506|NCT03449446|39593428|FG002|Overall Study|Death|0|||
16302507|NCT03449446|39593429|FG003|Overall Study|Death|0|||
16302508|NCT03449446|39593430|FG004|Overall Study|Death|1|||
16302509|NCT03449446|39593431|FG005|Overall Study|Death|0|||
16302510|NCT03449446|39593432|FG006|Overall Study|Death|0|||
16302511|NCT00660907|39593433|FG000|Overall Study|Incorrect Enrollment|1|||
16302512|NCT00660907|39593434|FG001|Overall Study|Incorrect Enrollment|1|||
16302513|NCT00660907|39593433|FG000|Overall Study|Adverse Event|33|||
16302514|NCT00660907|39593434|FG001|Overall Study|Adverse Event|19|||
16302515|NCT00660907|39593433|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
16302516|NCT00660907|39593434|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
16302517|NCT00660907|39593433|FG000|Overall Study|Withdrawal by Subject|23|||
16302518|NCT00660907|39593434|FG001|Overall Study|Withdrawal by Subject|32|||
16302519|NCT00660907|39593433|FG000|Overall Study|Lost to Follow-up|3|||
16302520|NCT00660907|39593434|FG001|Overall Study|Lost to Follow-up|3|||
16302521|NCT00660907|39593433|FG000|Overall Study|Poor/Non-Compliance|5|||
16302522|NCT00660907|39593434|FG001|Overall Study|Poor/Non-Compliance|1|||
16302523|NCT00660907|39593433|FG000|Overall Study|Safety|1|||
16302524|NCT00660907|39593434|FG001|Overall Study|Safety|0|||
16302525|NCT00660907|39593433|FG000|Overall Study|Death|1|||
16302526|NCT00660907|39593434|FG001|Overall Study|Death|3|||
16302527|NCT00660907|39593433|FG000|Overall Study|Various|11|||
16302528|NCT00660907|39593434|FG001|Overall Study|Various|8|||
16302529|NCT00704132|39593435|FG000|Overall Study|Clinical Adverse Experience|1|||
16302530|NCT00704132|39593436|FG001|Overall Study|Clinical Adverse Experience|0|||
16302531|NCT00704132|39593435|FG000|Overall Study|Lack of Efficacy|0|||
16302532|NCT00704132|39593436|FG001|Overall Study|Lack of Efficacy|1|||
16302533|NCT00704132|39593435|FG000|Overall Study|Withdrawal by Subject|0|||
16302534|NCT00704132|39593436|FG001|Overall Study|Withdrawal by Subject|1|||
16302535|NCT02290405|39593437|FG000|Overall Study|Withdrawal by Subject|1|||
16302536|NCT02290405|39593438|FG001|Overall Study|Withdrawal by Subject|0|||
16302537|NCT00822692|39593439|FG000|Overall Study|Lost to Follow-up|17|||
16302538|NCT00822692|39593440|FG001|Overall Study|Lost to Follow-up|25|||
16302539|NCT00281957|39593443|FG000|Overall Study|Adverse Event|7|||
16302540|NCT00281957|39593444|FG001|Overall Study|Adverse Event|2|||
16302541|NCT00281957|39593443|FG000|Overall Study|Death|1|||
16302542|NCT00281957|39593444|FG001|Overall Study|Death|0|||
16302543|NCT00281957|39593443|FG000|Overall Study|Progression/relapse|47|||
16302544|NCT00281957|39593444|FG001|Overall Study|Progression/relapse|35|||
16302545|NCT00281957|39593443|FG000|Overall Study|Not protocol specified|8|||
16302546|NCT00281957|39593444|FG001|Overall Study|Not protocol specified|1|||
16302547|NCT00281957|39593443|FG000|Overall Study|Not eligible|1|||
16302548|NCT00281957|39593444|FG001|Overall Study|Not eligible|2|||
16302549|NCT00281957|39593443|FG000|Overall Study|Did not start treatment|3|||
16302550|NCT00281957|39593444|FG001|Overall Study|Did not start treatment|1|||
16302551|NCT00281957|39593443|FG000|Overall Study|Refusal unrelated to adverse events|0|||
16302552|NCT00281957|39593444|FG001|Overall Study|Refusal unrelated to adverse events|1|||
16302553|NCT02017015|39593445|FG000|Overall Study|Adverse Event|9|||
16302554|NCT02017015|39593445|FG000|Overall Study|Withdrawal by Subject|21|||
16302555|NCT02017015|39593445|FG000|Overall Study|Death|4|||
16302556|NCT02017015|39593445|FG000|Overall Study|Progressive Disease|31|||
16302557|NCT02017015|39593445|FG000|Overall Study|Non-compliance with study drug|2|||
16302558|NCT02017015|39593445|FG000|Overall Study|Physician Decision|2|||
16302559|NCT01449370|39593446|FG000|Overall Study|Disease Progression|5|||
16302560|NCT01449370|39593447|FG001|Overall Study|Disease Progression|4|||
16302561|NCT01449370|39593448|FG002|Overall Study|Disease Progression|8|||
16302562|NCT01449370|39593449|FG003|Overall Study|Disease Progression|3|||
16302563|NCT01449370|39593450|FG004|Overall Study|Disease Progression|3|||
16302564|NCT01449370|39593451|FG005|Overall Study|Disease Progression|3|||
16302565|NCT01449370|39593452|FG006|Overall Study|Disease Progression|3|||
16302566|NCT01449370|39593453|FG007|Overall Study|Disease Progression|2|||
16302567|NCT01449370|39593454|FG008|Overall Study|Disease Progression|9|||
16302568|NCT01449370|39593455|FG009|Overall Study|Disease Progression|1|||
16302569|NCT01449370|39593456|FG010|Overall Study|Disease Progression|3|||
16302570|NCT01449370|39593457|FG011|Overall Study|Disease Progression|3|||
16302571|NCT01449370|39593458|FG012|Overall Study|Disease Progression|2|||
16302572|NCT01449370|39593459|FG013|Overall Study|Disease Progression|8|||
16302573|NCT01449370|39593460|FG014|Overall Study|Disease Progression|3|||
16302574|NCT01449370|39593461|FG015|Overall Study|Disease Progression|1|||
16302575|NCT01449370|39593462|FG016|Overall Study|Disease Progression|4|||
16302576|NCT01449370|39593463|FG017|Overall Study|Disease Progression|3|||
16302577|NCT01449370|39593464|FG018|Overall Study|Disease Progression|1|||
16302578|NCT01449370|39593465|FG019|Overall Study|Disease Progression|2|||
16302579|NCT01449370|39593466|FG020|Overall Study|Disease Progression|5|||
16302580|NCT01449370|39593467|FG021|Overall Study|Disease Progression|2|||
16302581|NCT01449370|39593468|FG022|Overall Study|Disease Progression|3|||
16302582|NCT01449370|39593469|FG023|Overall Study|Disease Progression|7|||
16302583|NCT01449370|39593470|FG024|Overall Study|Disease Progression|3|||
16302584|NCT01449370|39593446|FG000|Overall Study|Adverse Event|1|||
16490895|NCT00887978|40270437|FG001|Overall Study|Withdrawal by Subject|2|||
16490896|NCT00887978|40270436|FG000|Overall Study|Lost to Follow-up|0|||
16490897|NCT00887978|40270437|FG001|Overall Study|Lost to Follow-up|1|||
16490898|NCT01366209|40270438|FG000|Overall Study|Adverse Event|6|||
16490899|NCT01366209|40270439|FG001|Overall Study|Adverse Event|7|||
16302585|NCT01449370|39593447|FG001|Overall Study|Adverse Event|2|||
16302586|NCT01449370|39593448|FG002|Overall Study|Adverse Event|0|||
16302587|NCT01449370|39593449|FG003|Overall Study|Adverse Event|1|||
16302588|NCT01449370|39593450|FG004|Overall Study|Adverse Event|0|||
16490900|NCT01366209|40270438|FG000|Overall Study|Withdrawal by Subject|4|||
16302589|NCT01449370|39593451|FG005|Overall Study|Adverse Event|0|||
16302590|NCT01449370|39593452|FG006|Overall Study|Adverse Event|0|||
16192990|NCT01767194|39185202|FG001|Overall Study|Ineligible|1|||
16302591|NCT01449370|39593453|FG007|Overall Study|Adverse Event|0|||
16302592|NCT01449370|39593454|FG008|Overall Study|Adverse Event|1|||
16302593|NCT01449370|39593455|FG009|Overall Study|Adverse Event|1|||
16302594|NCT01449370|39593456|FG010|Overall Study|Adverse Event|0|||
16302595|NCT01449370|39593457|FG011|Overall Study|Adverse Event|0|||
16302596|NCT01449370|39593458|FG012|Overall Study|Adverse Event|0|||
16302597|NCT01449370|39593459|FG013|Overall Study|Adverse Event|2|||
16302598|NCT01449370|39593460|FG014|Overall Study|Adverse Event|0|||
16302599|NCT01449370|39593461|FG015|Overall Study|Adverse Event|1|||
16302600|NCT01449370|39593462|FG016|Overall Study|Adverse Event|0|||
16302601|NCT01449370|39593463|FG017|Overall Study|Adverse Event|0|||
16490901|NCT01366209|40270439|FG001|Overall Study|Withdrawal by Subject|4|||
16490902|NCT01366209|40270438|FG000|Overall Study|Death|12|||
16490903|NCT01366209|40270439|FG001|Overall Study|Death|19|||
16490904|NCT01366209|40270438|FG000|Overall Study|Lung transplantation|6|||
16490905|NCT01366209|40270439|FG001|Overall Study|Lung transplantation|1|||
16490906|NCT01366209|40270438|FG000|Overall Study|Lost to Follow-up|2|||
16490907|NCT01366209|40270439|FG001|Overall Study|Lost to Follow-up|1|||
16490908|NCT01366209|40270438|FG000|Overall Study|Physician Decision|1|||
16490909|NCT01366209|40270439|FG001|Overall Study|Physician Decision|0|||
16490910|NCT01366209|40270438|FG000|Overall Study|Sponsors decision|0|||
16490911|NCT01366209|40270439|FG001|Overall Study|Sponsors decision|1|||
16490912|NCT01366209|40270438|FG000|Overall Study|Withdrew consent|4|||
16490913|NCT01366209|40270439|FG001|Overall Study|Withdrew consent|3|||
16490914|NCT00646776|40270440|FG000|Overall Study|Adverse Event|1|||
16490915|NCT00646776|40270441|FG001|Overall Study|Adverse Event|9|||
16490916|NCT00646776|40270440|FG000|Overall Study|Investigator discretion|0|||
16490917|NCT00646776|40270441|FG001|Overall Study|Investigator discretion|4|||
16490918|NCT03310775|40270448|FG000|Overall Study|Lost to Follow-up|2|||
16490919|NCT03310775|40270449|FG001|Overall Study|Lost to Follow-up|3|||
16490920|NCT03310775|40270448|FG000|Overall Study|aggravation of depression|0|||
16490921|NCT03310775|40270449|FG001|Overall Study|aggravation of depression|1|||
16490922|NCT00618072|40270457|FG000|Overall Study|Lost to Follow-up|2|||
16490923|NCT00618072|40270458|FG001|Overall Study|Lost to Follow-up|0|||
16490924|NCT00618072|40270459|FG002|Overall Study|Lost to Follow-up|3|||
16490925|NCT00618072|40270457|FG000|Overall Study|Physician Decision|0|||
16490926|NCT00618072|40270458|FG001|Overall Study|Physician Decision|1|||
16490927|NCT00618072|40270459|FG002|Overall Study|Physician Decision|1|||
16490928|NCT00855920|40270463|FG000|Overall Study|Protocol Violation|0|||
16490929|NCT00855920|40270464|FG001|Overall Study|Protocol Violation|0|||
16490930|NCT00855920|40270465|FG002|Overall Study|Protocol Violation|2|||
16490931|NCT00855920|40270463|FG000|Overall Study|Adverse Event|2|||
16490932|NCT00855920|40270464|FG001|Overall Study|Adverse Event|1|||
16490933|NCT00855920|40270465|FG002|Overall Study|Adverse Event|1|||
16490934|NCT00855920|40270463|FG000|Overall Study|Lack of Efficacy|2|||
16490935|NCT00855920|40270464|FG001|Overall Study|Lack of Efficacy|2|||
16490936|NCT00855920|40270465|FG002|Overall Study|Lack of Efficacy|2|||
16490937|NCT00855920|40270463|FG000|Overall Study|Withdrawal by Subject|2|||
16490938|NCT00855920|40270464|FG001|Overall Study|Withdrawal by Subject|3|||
16490939|NCT00855920|40270465|FG002|Overall Study|Withdrawal by Subject|2|||
16490940|NCT00855920|40270463|FG000|Overall Study|Lost to Follow-up|1|||
16490941|NCT00855920|40270464|FG001|Overall Study|Lost to Follow-up|0|||
16490942|NCT00855920|40270465|FG002|Overall Study|Lost to Follow-up|2|||
16490943|NCT00855920|40270463|FG000|Overall Study|Death|0|||
16490944|NCT00855920|40270464|FG001|Overall Study|Death|1|||
16490945|NCT00855920|40270465|FG002|Overall Study|Death|0|||
16490946|NCT00855920|40270463|FG000|Overall Study|Decision by the sponsor|0|||
16490947|NCT00855920|40270464|FG001|Overall Study|Decision by the sponsor|1|||
16490948|NCT00855920|40270465|FG002|Overall Study|Decision by the sponsor|1|||
16490949|NCT00855920|40270463|FG000|Overall Study|Other than specified above|1|||
16490950|NCT00855920|40270464|FG001|Overall Study|Other than specified above|1|||
16490951|NCT00855920|40270465|FG002|Overall Study|Other than specified above|1|||
16490952|NCT01007812|40270467|FG000|Period 1, One Week|Lost to Follow-up|0|||
16490953|NCT01007812|40270468|FG001|Period 1, One Week|Lost to Follow-up|1|||
16302602|NCT01449370|39593464|FG018|Overall Study|Adverse Event|1|||
16302603|NCT01449370|39593465|FG019|Overall Study|Adverse Event|1|||
16302604|NCT01449370|39593466|FG020|Overall Study|Adverse Event|0|||
16490954|NCT01007812|40270467|FG000|Period 1, One Week|Discomfort|1|||
16490955|NCT01007812|40270468|FG001|Period 1, One Week|Discomfort|0|||
16490956|NCT03648541|40270469|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
16490957|NCT03648541|40270470|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
16490958|NCT03648541|40270469|FG000|Re-induction Period Only|Lack of Efficacy|7|||
16490959|NCT03648541|40270470|FG001|Re-induction Period Only|Lack of Efficacy|0|||
16490960|NCT03648541|40270469|FG000|Maintenance Period Only|Missing|0|||
16490961|NCT03648541|40270470|FG001|Maintenance Period Only|Missing|1|||
16490962|NCT03648541|40270469|FG000|Maintenance Period Only|Other not listed below|0|||
16490963|NCT03648541|40270470|FG001|Maintenance Period Only|Other not listed below|4|||
16490964|NCT03648541|40270469|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
16302605|NCT01449370|39593467|FG021|Overall Study|Adverse Event|1|||
16302606|NCT01449370|39593468|FG022|Overall Study|Adverse Event|0|||
16490965|NCT03648541|40270470|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
16302607|NCT01449370|39593469|FG023|Overall Study|Adverse Event|1|||
16302608|NCT01449370|39593470|FG024|Overall Study|Adverse Event|3|||
16302609|NCT01449370|39593446|FG000|Overall Study|Participant Decision|0|||
16302610|NCT01449370|39593447|FG001|Overall Study|Participant Decision|0|||
16302611|NCT01449370|39593448|FG002|Overall Study|Participant Decision|0|||
16302612|NCT01449370|39593449|FG003|Overall Study|Participant Decision|0|||
16302613|NCT01449370|39593450|FG004|Overall Study|Participant Decision|0|||
16302614|NCT01449370|39593451|FG005|Overall Study|Participant Decision|0|||
16387918|NCT01070979|39902779|FG000|Overall Study|Lost to Follow-up|2|||
16387919|NCT01070979|39902780|FG001|Overall Study|Lost to Follow-up|1|||
16387920|NCT01070979|39902781|FG002|Overall Study|Lost to Follow-up|1|||
16387921|NCT01070979|39902779|FG000|Overall Study|Protocol Violation|0|||
16387922|NCT01070979|39902780|FG001|Overall Study|Protocol Violation|2|||
16387923|NCT01070979|39902781|FG002|Overall Study|Protocol Violation|6|||
16387924|NCT01070979|39902779|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
16387925|NCT01070979|39902780|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
16387926|NCT01070979|39902781|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
16387927|NCT01070979|39902779|FG000|Overall Study|Withdrawal by Subject|3|||
16387928|NCT01070979|39902780|FG001|Overall Study|Withdrawal by Subject|1|||
16387929|NCT01070979|39902781|FG002|Overall Study|Withdrawal by Subject|1|||
16387930|NCT01070979|39902779|FG000|Overall Study|No study drug taken|0|||
16387931|NCT01070979|39902780|FG001|Overall Study|No study drug taken|1|||
16387932|NCT01070979|39902781|FG002|Overall Study|No study drug taken|0|||
16387933|NCT04102007|39902784|FG000|Overall Study|Adverse Event|4|||
16387934|NCT04102007|39902784|FG000|Overall Study|Lost to Follow-up|3|||
16387935|NCT04102007|39902784|FG000|Overall Study|Withdrawal by Subject|12|||
16387936|NCT04102007|39902784|FG000|Overall Study|Eligibility Violation|5|||
16387937|NCT04102007|39902784|FG000|Overall Study|Lack of Efficacy|6|||
16387938|NCT04102007|39902784|FG000|Overall Study|Protocol Deviation|5|||
16387939|NCT04102007|39902784|FG000|Overall Study|Protocol Compliance|1|||
16387940|NCT04102007|39902784|FG000|Overall Study|Withdrew Treatment|2|||
16387941|NCT04102007|39902784|FG000|Overall Study|Pregnancy|1|||
16387942|NCT01897532|39902785|FG000|Discontinuation From Treatment|Not Treated|7|||
16387943|NCT01897532|39902786|FG001|Discontinuation From Treatment|Not Treated|5|||
16387944|NCT01897532|39902785|FG000|Discontinuation From Treatment|Other reason than specified|196|||
16387945|NCT01897532|39902786|FG001|Discontinuation From Treatment|Other reason than specified|176|||
16387946|NCT01897532|39902785|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
16387947|NCT01897532|39902786|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
16387948|NCT01897532|39902785|FG000|Discontinuation From Treatment|Non compliance|24|||
16387949|NCT01897532|39902786|FG001|Discontinuation From Treatment|Non compliance|15|||
16387950|NCT01897532|39902785|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
16387951|NCT01897532|39902786|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
16387952|NCT01897532|39902785|FG000|Discontinuation From Trial|Not Treated|7|||
16387953|NCT01897532|39902786|FG001|Discontinuation From Trial|Not Treated|5|||
16387954|NCT01897532|39902785|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
16387955|NCT01897532|39902786|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
16387956|NCT04568603|39902792|FG000|Overall Study|Physician Decision|1|||
16387957|NCT02030821|39902793|FG000|Overall Study|Physician Decision|2|||
16387958|NCT02030821|39902794|FG001|Overall Study|Physician Decision|2|||
16387959|NCT02030821|39902795|FG002|Overall Study|Physician Decision|5|||
16387960|NCT02030821|39902796|FG003|Overall Study|Physician Decision|2|||
16387961|NCT00598650|39902800|FG000|Overall Study|Withdrawal by Subject|3|||
16387962|NCT00598650|39902800|FG000|Overall Study|Adverse Event|18|||
16387963|NCT00598650|39902800|FG000|Overall Study|No treatment for 3 weeks|1|||
16387964|NCT00598650|39902800|FG000|Overall Study|Not eligible|1|||
16387965|NCT00598650|39902800|FG000|Overall Study|Prohibited Concomitant Medication|2|||
16387966|NCT00598650|39902800|FG000|Overall Study|Physician Decision|2|||
16387967|NCT00953706|39902801|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
16387968|NCT00953706|39902802|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
16387969|NCT00953706|39902803|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
16387970|NCT00953706|39902804|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
16387971|NCT00953706|39902801|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
16387972|NCT00953706|39902802|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
16387973|NCT00953706|39902803|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
16387974|NCT00953706|39902804|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
16409901|NCT01143051|39981817|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
16490966|NCT03648541|40270469|FG000|Maintenance Period Only|Protocol Violation|0|||
16490967|NCT03648541|40270470|FG001|Maintenance Period Only|Protocol Violation|1|||
16490968|NCT03648541|40270469|FG000|Maintenance Period Only|Lack of Efficacy|0|||
16490969|NCT03648541|40270470|FG001|Maintenance Period Only|Lack of Efficacy|18|||
16490970|NCT03648541|40270469|FG000|Maintenance Period Only|Adverse Event|0|||
16490971|NCT03648541|40270470|FG001|Maintenance Period Only|Adverse Event|4|||
16490972|NCT03648541|40270469|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
16490973|NCT03648541|40270470|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
16490974|NCT03919799|40270471|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
16490975|NCT03919799|40270472|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
16490976|NCT03919799|40270473|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
16490977|NCT03919799|40270474|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
16490978|NCT03919799|40270475|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
16490979|NCT03919799|40270471|FG000|DB Period (28 Weeks)|Adverse Event|1|||
16490980|NCT03919799|40270472|FG001|DB Period (28 Weeks)|Adverse Event|1|||
16490981|NCT03919799|40270473|FG002|DB Period (28 Weeks)|Adverse Event|1|||
16490982|NCT03919799|40270474|FG003|DB Period (28 Weeks)|Adverse Event|0|||
16490983|NCT03919799|40270475|FG004|DB Period (28 Weeks)|Adverse Event|0|||
16490984|NCT03919799|40270471|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
16490985|NCT03919799|40270472|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
16490986|NCT03919799|40270473|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
16490987|NCT03919799|40270474|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
16490988|NCT03919799|40270475|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
16490989|NCT03919799|40270471|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
16490990|NCT03919799|40270472|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
16490991|NCT03919799|40270473|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
16490992|NCT03919799|40270474|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
16490993|NCT03919799|40270475|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
16490994|NCT03919799|40270471|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
16490995|NCT03919799|40270472|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
16490996|NCT03919799|40270473|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
16490997|NCT03919799|40270474|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
16490998|NCT03919799|40270475|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
16490999|NCT00621985|40270481|FG000|Dexamethasone Admission|Adverse Event|1|||
16302615|NCT01449370|39593452|FG006|Overall Study|Participant Decision|0|||
16302616|NCT01449370|39593453|FG007|Overall Study|Participant Decision|1|||
16302617|NCT01449370|39593454|FG008|Overall Study|Participant Decision|1|||
16302618|NCT01449370|39593455|FG009|Overall Study|Participant Decision|0|||
16302619|NCT01449370|39593456|FG010|Overall Study|Participant Decision|0|||
16302620|NCT01449370|39593457|FG011|Overall Study|Participant Decision|0|||
16302621|NCT01449370|39593458|FG012|Overall Study|Participant Decision|1|||
16302622|NCT01449370|39593459|FG013|Overall Study|Participant Decision|1|||
16302623|NCT01449370|39593460|FG014|Overall Study|Participant Decision|0|||
16491000|NCT00283400|40270493|FG000|Overall Study|Withdrawal by Subject|1|||
16491001|NCT00283400|40270494|FG001|Overall Study|Withdrawal by Subject|1|||
16491002|NCT00283400|40270495|FG002|Overall Study|Withdrawal by Subject|0|||
16491003|NCT00283400|40270496|FG003|Overall Study|Withdrawal by Subject|0|||
16491004|NCT00283400|40270493|FG000|Overall Study|Death|1|||
16491005|NCT00283400|40270494|FG001|Overall Study|Death|0|||
16491006|NCT00283400|40270495|FG002|Overall Study|Death|1|||
16491007|NCT00283400|40270496|FG003|Overall Study|Death|0|||
16491008|NCT04015336|40270497|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
16491009|NCT02430311|40270501|FG000|Part A|Adverse Event|0|||
16491010|NCT02430311|40270502|FG001|Part A|Adverse Event|1|||
16302624|NCT01449370|39593461|FG015|Overall Study|Participant Decision|1|||
16302625|NCT01449370|39593462|FG016|Overall Study|Participant Decision|3|||
16302626|NCT01449370|39593463|FG017|Overall Study|Participant Decision|0|||
16302627|NCT01449370|39593464|FG018|Overall Study|Participant Decision|1|||
16302628|NCT01449370|39593465|FG019|Overall Study|Participant Decision|0|||
16302629|NCT01449370|39593466|FG020|Overall Study|Participant Decision|0|||
16302630|NCT01449370|39593467|FG021|Overall Study|Participant Decision|1|||
16302631|NCT01449370|39593468|FG022|Overall Study|Participant Decision|0|||
16302632|NCT01449370|39593469|FG023|Overall Study|Participant Decision|0|||
16302633|NCT01449370|39593470|FG024|Overall Study|Participant Decision|1|||
16302634|NCT01449370|39593446|FG000|Overall Study|Lost to Follow-up|0|||
16302635|NCT01449370|39593447|FG001|Overall Study|Lost to Follow-up|0|||
16302636|NCT01449370|39593448|FG002|Overall Study|Lost to Follow-up|0|||
16302637|NCT01449370|39593449|FG003|Overall Study|Lost to Follow-up|0|||
16302638|NCT01449370|39593450|FG004|Overall Study|Lost to Follow-up|0|||
16491011|NCT02430311|40270501|FG000|Part A|Withdrawal by Subject|1|||
16491012|NCT02430311|40270502|FG001|Part A|Withdrawal by Subject|0|||
16491013|NCT02430311|40270501|FG000|Part B|Meet study-specific withdrawal criteria|6|||
16491014|NCT02430311|40270502|FG001|Part B|Meet study-specific withdrawal criteria|6|||
16302639|NCT01449370|39593451|FG005|Overall Study|Lost to Follow-up|0|||
16302640|NCT01449370|39593452|FG006|Overall Study|Lost to Follow-up|0|||
16491015|NCT02430311|40270501|FG000|Part B|Withdrawal by Subject|2|||
16302641|NCT01449370|39593453|FG007|Overall Study|Lost to Follow-up|0|||
16302642|NCT01449370|39593454|FG008|Overall Study|Lost to Follow-up|0|||
16302643|NCT01449370|39593455|FG009|Overall Study|Lost to Follow-up|0|||
16302644|NCT01449370|39593456|FG010|Overall Study|Lost to Follow-up|0|||
16302645|NCT01449370|39593457|FG011|Overall Study|Lost to Follow-up|0|||
16302646|NCT01449370|39593458|FG012|Overall Study|Lost to Follow-up|0|||
16302647|NCT01449370|39593459|FG013|Overall Study|Lost to Follow-up|0|||
16302648|NCT01449370|39593460|FG014|Overall Study|Lost to Follow-up|0|||
16302649|NCT01449370|39593461|FG015|Overall Study|Lost to Follow-up|0|||
16302650|NCT01449370|39593462|FG016|Overall Study|Lost to Follow-up|0|||
16302651|NCT01449370|39593463|FG017|Overall Study|Lost to Follow-up|0|||
16302652|NCT01449370|39593464|FG018|Overall Study|Lost to Follow-up|0|||
16302653|NCT01449370|39593465|FG019|Overall Study|Lost to Follow-up|0|||
16302654|NCT01449370|39593466|FG020|Overall Study|Lost to Follow-up|1|||
16302655|NCT01449370|39593467|FG021|Overall Study|Lost to Follow-up|0|||
16302656|NCT01449370|39593468|FG022|Overall Study|Lost to Follow-up|0|||
16302657|NCT01449370|39593469|FG023|Overall Study|Lost to Follow-up|0|||
16302658|NCT01449370|39593470|FG024|Overall Study|Lost to Follow-up|0|||
16302659|NCT01449370|39593446|FG000|Overall Study|Other|0|||
16302660|NCT01449370|39593447|FG001|Overall Study|Other|0|||
16302661|NCT01449370|39593448|FG002|Overall Study|Other|0|||
16302662|NCT01449370|39593449|FG003|Overall Study|Other|0|||
16302663|NCT01449370|39593450|FG004|Overall Study|Other|0|||
16302664|NCT01449370|39593451|FG005|Overall Study|Other|0|||
16302665|NCT01449370|39593452|FG006|Overall Study|Other|0|||
16302666|NCT01449370|39593453|FG007|Overall Study|Other|0|||
16302667|NCT01449370|39593454|FG008|Overall Study|Other|1|||
16302668|NCT01449370|39593455|FG009|Overall Study|Other|1|||
16302669|NCT01449370|39593456|FG010|Overall Study|Other|0|||
16491016|NCT02430311|40270502|FG001|Part B|Withdrawal by Subject|2|||
16491017|NCT02430311|40270501|FG000|Part B|Adverse Event|1|||
16491018|NCT02430311|40270502|FG001|Part B|Adverse Event|0|||
16491019|NCT02430311|40270501|FG000|Part B|Death|1|||
16491020|NCT02430311|40270502|FG001|Part B|Death|0|||
16491021|NCT01673867|40270503|FG000|Randomization|Adverse event unrelated to study drug|1|||
16491022|NCT01673867|40270504|FG001|Randomization|Adverse event unrelated to study drug|0|||
16491023|NCT01673867|40270503|FG000|Randomization|Participant request to discontinue study treatment|0|||
16491024|NCT01673867|40270504|FG001|Randomization|Participant request to discontinue study treatment|4|||
16491025|NCT01673867|40270503|FG000|Randomization|Withdrawal by participant|0|||
16491026|NCT01673867|40270504|FG001|Randomization|Withdrawal by participant|12|||
16491027|NCT01673867|40270503|FG000|Randomization|Lost to Follow-up|0|||
16491028|NCT01673867|40270504|FG001|Randomization|Lost to Follow-up|1|||
16491029|NCT01673867|40270503|FG000|Randomization|Participant no longer meets study criteria|4|||
16491030|NCT01673867|40270504|FG001|Randomization|Participant no longer meets study criteria|5|||
16491031|NCT01673867|40270503|FG000|Treatment|Disease Progression|208|||
16491032|NCT01673867|40270504|FG001|Treatment|Disease Progression|178|||
16491033|NCT01673867|40270503|FG000|Treatment|Study Drug Toxicity|23|||
16491034|NCT01673867|40270504|FG001|Treatment|Study Drug Toxicity|43|||
16491035|NCT01673867|40270503|FG000|Treatment|Death|2|||
16491036|NCT01673867|40270504|FG001|Treatment|Death|3|||
16491037|NCT01673867|40270503|FG000|Treatment|Adverse event unrelated to study drug|23|||
16491038|NCT01673867|40270504|FG001|Treatment|Adverse event unrelated to study drug|10|||
16491039|NCT01673867|40270503|FG000|Treatment|Participant request to discontinue study treatment|7|||
16491040|NCT01673867|40270504|FG001|Treatment|Participant request to discontinue study treatment|17|||
16491041|NCT01673867|40270503|FG000|Treatment|Withdrawal by participant|5|||
16491042|NCT01673867|40270504|FG001|Treatment|Withdrawal by participant|5|||
16491043|NCT01673867|40270503|FG000|Treatment|Maximum clinical benefit|1|||
16491044|NCT01673867|40270504|FG001|Treatment|Maximum clinical benefit|10|||
16491045|NCT01673867|40270503|FG000|Treatment|Participant no longer meets study criteria|2|||
16491046|NCT01673867|40270504|FG001|Treatment|Participant no longer meets study criteria|0|||
16302670|NCT01449370|39593457|FG011|Overall Study|Other|0|||
16302671|NCT01449370|39593458|FG012|Overall Study|Other|0|||
16302672|NCT01449370|39593459|FG013|Overall Study|Other|0|||
16302673|NCT01449370|39593460|FG014|Overall Study|Other|0|||
16302674|NCT01449370|39593461|FG015|Overall Study|Other|0|||
16302675|NCT01449370|39593462|FG016|Overall Study|Other|0|||
16302676|NCT01449370|39593463|FG017|Overall Study|Other|0|||
16387975|NCT00953706|39902801|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
16491047|NCT01673867|40270503|FG000|Treatment|Administrative reason by sponsor|3|||
16491048|NCT01673867|40270504|FG001|Treatment|Administrative reason by sponsor|0|||
16491049|NCT01673867|40270503|FG000|Treatment|Other reason|11|||
16491050|NCT01673867|40270504|FG001|Treatment|Other reason|2|||
16491051|NCT00838578|40270507|FG000|Overall Study|Protocol Violation|2|||
16491052|NCT02270957|40270508|FG000|Overall Study|Lack of Efficacy|2|||
16302677|NCT01449370|39593464|FG018|Overall Study|Other|0|||
16302678|NCT01449370|39593465|FG019|Overall Study|Other|0|||
16302679|NCT01449370|39593466|FG020|Overall Study|Other|0|||
16491053|NCT02270957|40270509|FG001|Overall Study|Lack of Efficacy|4|||
16491054|NCT02270957|40270508|FG000|Overall Study|Adverse Event|2|||
16491055|NCT02270957|40270509|FG001|Overall Study|Adverse Event|0|||
16491056|NCT01871532|40270510|FG000|Overall Study|Withdrawal by Subject|1|||
16491057|NCT01871532|40270511|FG001|Overall Study|Withdrawal by Subject|2|||
16491058|NCT02101060|40270512|FG000|Overall Study|Adverse Event|1|||
16491059|NCT02101060|40270513|FG001|Overall Study|Adverse Event|0|||
16491060|NCT02101060|40270512|FG000|Overall Study|Withdrawal by Subject|1|||
16491061|NCT02101060|40270513|FG001|Overall Study|Withdrawal by Subject|1|||
16491062|NCT02101060|40270512|FG000|Overall Study|Lost to Follow-up|3|||
16491063|NCT02101060|40270513|FG001|Overall Study|Lost to Follow-up|3|||
16491064|NCT02254486|40270514|FG000|Overall Study|Adverse Event|1|||
16491065|NCT02254486|40270515|FG001|Overall Study|Adverse Event|1|||
16491066|NCT02254486|40270514|FG000|Overall Study|Lack of Efficacy|1|||
16491067|NCT02254486|40270515|FG001|Overall Study|Lack of Efficacy|0|||
16491068|NCT02254486|40270514|FG000|Overall Study|Lost to Follow-up|2|||
16491069|NCT02254486|40270515|FG001|Overall Study|Lost to Follow-up|4|||
16491070|NCT02254486|40270514|FG000|Overall Study|Protocol Violation|1|||
16491071|NCT02254486|40270515|FG001|Overall Study|Protocol Violation|2|||
16491072|NCT02254486|40270514|FG000|Overall Study|Withdrawal by Subject|17|||
16491073|NCT02254486|40270515|FG001|Overall Study|Withdrawal by Subject|15|||
16491074|NCT02254486|40270514|FG000|Overall Study|GFR<60mL/min|16|||
16491075|NCT02254486|40270515|FG001|Overall Study|GFR<60mL/min|21|||
16491076|NCT02254486|40270514|FG000|Overall Study|Various|12|||
16192991|NCT01767194|39185201|FG000|Overall Study|Refusal by patient/parent|2|||
16192992|NCT01767194|39185202|FG001|Overall Study|Refusal by patient/parent|4|||
16192993|NCT01767194|39185201|FG000|Overall Study|Criteria not met on time for next cycle|0|||
16192994|NCT01767194|39185202|FG001|Overall Study|Criteria not met on time for next cycle|1|||
16192995|NCT00302718|39185207|FG000|Overall Study|Participant left the hospital|1|||
16192996|NCT00302718|39185208|FG001|Overall Study|Participant left the hospital|0|||
16192997|NCT00302718|39185209|FG002|Overall Study|Participant left the hospital|0|||
16192998|NCT00302718|39185210|FG003|Overall Study|Participant left the hospital|1|||
16192999|NCT00302718|39185207|FG000|Overall Study|Withdrawal by Subject|0|||
16193000|NCT00302718|39185208|FG001|Overall Study|Withdrawal by Subject|1|||
16193001|NCT00302718|39185209|FG002|Overall Study|Withdrawal by Subject|0|||
16193002|NCT00302718|39185210|FG003|Overall Study|Withdrawal by Subject|0|||
16193003|NCT00302718|39185207|FG000|Overall Study|Participant left primary care setting|0|||
16193004|NCT00302718|39185208|FG001|Overall Study|Participant left primary care setting|0|||
16193005|NCT00302718|39185209|FG002|Overall Study|Participant left primary care setting|2|||
16193006|NCT00302718|39185210|FG003|Overall Study|Participant left primary care setting|1|||
16193007|NCT02273050|39185211|FG000|Overall Study|Adverse Event|4|||
16193008|NCT02273050|39185212|FG001|Overall Study|Adverse Event|3|||
16193009|NCT02273050|39185213|FG002|Overall Study|Adverse Event|3|||
16193010|NCT02273050|39185211|FG000|Overall Study|Death|0|||
16193011|NCT02273050|39185212|FG001|Overall Study|Death|0|||
16193012|NCT02273050|39185213|FG002|Overall Study|Death|1|||
16302680|NCT01449370|39593467|FG021|Overall Study|Other|0|||
16302681|NCT01449370|39593468|FG022|Overall Study|Other|1|||
16193013|NCT02273050|39185211|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
16193014|NCT02273050|39185212|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
16193015|NCT02273050|39185213|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
16193016|NCT02273050|39185211|FG000|Overall Study|Lack of Efficacy|0|||
16193017|NCT02273050|39185212|FG001|Overall Study|Lack of Efficacy|1|||
16193018|NCT02273050|39185213|FG002|Overall Study|Lack of Efficacy|1|||
16193019|NCT02273050|39185211|FG000|Overall Study|Withdrawal by Subject|17|||
16193020|NCT02273050|39185212|FG001|Overall Study|Withdrawal by Subject|14|||
16302682|NCT01449370|39593469|FG023|Overall Study|Other|1|||
16302683|NCT01449370|39593470|FG024|Overall Study|Other|0|||
16302684|NCT01449370|39593446|FG000|Overall Study|Medication Prohibited by Protocol|0|||
16302685|NCT01449370|39593447|FG001|Overall Study|Medication Prohibited by Protocol|0|||
16387976|NCT00953706|39902802|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
16193021|NCT02273050|39185213|FG002|Overall Study|Withdrawal by Subject|16|||
16193022|NCT02273050|39185211|FG000|Overall Study|Lost to Follow-up|0|||
16193023|NCT02273050|39185212|FG001|Overall Study|Lost to Follow-up|2|||
16193024|NCT02273050|39185213|FG002|Overall Study|Lost to Follow-up|3|||
16193025|NCT02273050|39185211|FG000|Overall Study|Protocol Violation|3|||
16193026|NCT02273050|39185212|FG001|Overall Study|Protocol Violation|1|||
16491077|NCT02254486|40270515|FG001|Overall Study|Various|12|||
16193027|NCT02273050|39185213|FG002|Overall Study|Protocol Violation|4|||
16193028|NCT02234583|39185220|FG000|Overall Study|Adverse Event|172|||
16193029|NCT02234583|39185221|FG001|Overall Study|Adverse Event|156|||
16193030|NCT02234583|39185220|FG000|Overall Study|Withdrawal by Subject|109|||
16491078|NCT00553644|40270521|FG000|Overall Study|Adverse Event|17|||
16491079|NCT00553644|40270521|FG000|Overall Study|Withdrawal by Subject|4|||
16491080|NCT00553644|40270521|FG000|Overall Study|Physician Decision|1|||
16491081|NCT00553644|40270521|FG000|Overall Study|Alternative therapy|6|||
16491082|NCT02495168|40270523|FG000|Overall Study|Other than Specified|18|||
16193031|NCT02234583|39185221|FG001|Overall Study|Withdrawal by Subject|157|||
16193032|NCT02234583|39185220|FG000|Overall Study|Lost to Follow-up|0|||
16193033|NCT02234583|39185221|FG001|Overall Study|Lost to Follow-up|1|||
16193034|NCT02234583|39185220|FG000|Overall Study|Lack of Efficacy|58|||
16193035|NCT02234583|39185221|FG001|Overall Study|Lack of Efficacy|103|||
16193036|NCT02234583|39185220|FG000|Overall Study|Protocol Violation|35|||
16193037|NCT02234583|39185221|FG001|Overall Study|Protocol Violation|42|||
16193038|NCT02234583|39185220|FG000|Overall Study|Other|39|||
16193039|NCT02234583|39185221|FG001|Overall Study|Other|97|||
16193040|NCT01766817|39185222|FG000|Overall Study|Drug-related adverse event|1|||
16193041|NCT01766817|39185223|FG001|Overall Study|Drug-related adverse event|2|||
16193042|NCT01766817|39185224|FG002|Overall Study|Drug-related adverse event|1|||
16193043|NCT01766817|39185222|FG000|Overall Study|Drug-unrelated adverse event|3|||
16193044|NCT01766817|39185223|FG001|Overall Study|Drug-unrelated adverse event|3|||
16193045|NCT01766817|39185224|FG002|Overall Study|Drug-unrelated adverse event|3|||
16193046|NCT01766817|39185222|FG000|Overall Study|Death|1|||
16193047|NCT01766817|39185223|FG001|Overall Study|Death|1|||
16193048|NCT01766817|39185224|FG002|Overall Study|Death|0|||
16193049|NCT01766817|39185222|FG000|Overall Study|Unable to take study drug|0|||
16193050|NCT01766817|39185223|FG001|Overall Study|Unable to take study drug|1|||
16193051|NCT01766817|39185224|FG002|Overall Study|Unable to take study drug|0|||
16193052|NCT01766817|39185222|FG000|Overall Study|Withdrawal by Subject|2|||
16193053|NCT01766817|39185223|FG001|Overall Study|Withdrawal by Subject|0|||
16193054|NCT01766817|39185224|FG002|Overall Study|Withdrawal by Subject|3|||
16193055|NCT01766817|39185222|FG000|Overall Study|Subject non-compliance|0|||
16193056|NCT01766817|39185223|FG001|Overall Study|Subject non-compliance|1|||
16193057|NCT01766817|39185224|FG002|Overall Study|Subject non-compliance|2|||
16193058|NCT01766817|39185222|FG000|Overall Study|Physician Decision|3|||
16193059|NCT01766817|39185223|FG001|Overall Study|Physician Decision|3|||
16193060|NCT01766817|39185224|FG002|Overall Study|Physician Decision|4|||
16193061|NCT01766817|39185222|FG000|Overall Study|Other|1|||
16193062|NCT01766817|39185223|FG001|Overall Study|Other|0|||
16193063|NCT01766817|39185224|FG002|Overall Study|Other|0|||
16193064|NCT01627067|39185225|FG000|Overall Study|Screen Failure|1|||
16193065|NCT00353496|39185226|FG000|Overall Study|Adverse Event|1|||
16193066|NCT00353496|39185227|FG001|Overall Study|Adverse Event|0|||
16193067|NCT00353496|39185226|FG000|Overall Study|Protocol Violation|2|||
16193068|NCT00353496|39185227|FG001|Overall Study|Protocol Violation|2|||
16193069|NCT00353496|39185226|FG000|Overall Study|Withdrawal by Subject|3|||
16193070|NCT00353496|39185227|FG001|Overall Study|Withdrawal by Subject|4|||
16193071|NCT00353496|39185226|FG000|Overall Study|Physician Decision|6|||
16193072|NCT00353496|39185227|FG001|Overall Study|Physician Decision|9|||
16193073|NCT00353496|39185226|FG000|Overall Study|Not otherwise specified|4|||
16193074|NCT00353496|39185227|FG001|Overall Study|Not otherwise specified|2|||
16193075|NCT03509207|39185230|FG000|Overall Study|Death|2|||
16193076|NCT02273752|39185233|FG000|Overall Study|Trial was terminated early|2|||
16193077|NCT00717366|39185234|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
16193078|NCT00717366|39185235|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
16193079|NCT00717366|39185234|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
16193080|NCT00717366|39185235|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
16193081|NCT00717366|39185234|FG000|Core Study Period (20 Weeks)|Death|0|||
16193082|NCT00717366|39185235|FG001|Core Study Period (20 Weeks)|Death|1|||
16193083|NCT00717366|39185234|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
16193084|NCT00717366|39185235|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
16193085|NCT00717366|39185234|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
16302686|NCT01449370|39593448|FG002|Overall Study|Medication Prohibited by Protocol|0|||
16302687|NCT01449370|39593449|FG003|Overall Study|Medication Prohibited by Protocol|0|||
16302688|NCT01449370|39593450|FG004|Overall Study|Medication Prohibited by Protocol|0|||
16302689|NCT01449370|39593451|FG005|Overall Study|Medication Prohibited by Protocol|0|||
16302690|NCT01449370|39593452|FG006|Overall Study|Medication Prohibited by Protocol|0|||
16302691|NCT01449370|39593453|FG007|Overall Study|Medication Prohibited by Protocol|0|||
16302692|NCT01449370|39593454|FG008|Overall Study|Medication Prohibited by Protocol|0|||
16302693|NCT01449370|39593455|FG009|Overall Study|Medication Prohibited by Protocol|0|||
16302694|NCT01449370|39593456|FG010|Overall Study|Medication Prohibited by Protocol|0|||
16302695|NCT01449370|39593457|FG011|Overall Study|Medication Prohibited by Protocol|0|||
16302696|NCT01449370|39593458|FG012|Overall Study|Medication Prohibited by Protocol|0|||
16302697|NCT01449370|39593459|FG013|Overall Study|Medication Prohibited by Protocol|0|||
16302698|NCT01449370|39593460|FG014|Overall Study|Medication Prohibited by Protocol|0|||
16193086|NCT00717366|39185235|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
16193087|NCT00717366|39185234|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
16302699|NCT01449370|39593461|FG015|Overall Study|Medication Prohibited by Protocol|0|||
16193088|NCT00717366|39185235|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
16193089|NCT00717366|39185234|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
16302700|NCT01449370|39593462|FG016|Overall Study|Medication Prohibited by Protocol|0|||
16193090|NCT00717366|39185235|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
16193091|NCT00585923|39185238|FG000|Overall Study|Physician decided not to continue|31|||
16193092|NCT00585923|39185239|FG001|Overall Study|Physician decided not to continue|33|||
16193093|NCT02125331|39185246|FG000|Overall Study|Protocol Violation|1|||
16193094|NCT02125331|39185247|FG001|Overall Study|Protocol Violation|0|||
16193095|NCT02125331|39185246|FG000|Overall Study|technical problem|2|||
16193096|NCT02125331|39185247|FG001|Overall Study|technical problem|0|||
16193097|NCT02125331|39185246|FG000|Overall Study|screen failure|2|||
16193098|NCT02125331|39185247|FG001|Overall Study|screen failure|0|||
16193099|NCT00077610|39185249|FG000|Overall Study|Adverse Event|9|||
16193100|NCT00077610|39185250|FG001|Overall Study|Adverse Event|7|||
16193101|NCT00077610|39185251|FG002|Overall Study|Adverse Event|1|||
16193102|NCT00077610|39185249|FG000|Overall Study|Lost to Follow-up|0|||
16193103|NCT00077610|39185250|FG001|Overall Study|Lost to Follow-up|1|||
16193104|NCT00077610|39185251|FG002|Overall Study|Lost to Follow-up|2|||
16193105|NCT00077610|39185249|FG000|Overall Study|Withdrawal by Subject|4|||
16193106|NCT00077610|39185250|FG001|Overall Study|Withdrawal by Subject|10|||
16193107|NCT00077610|39185251|FG002|Overall Study|Withdrawal by Subject|6|||
16193108|NCT00077610|39185249|FG000|Overall Study|Death|17|||
16193109|NCT00077610|39185250|FG001|Overall Study|Death|13|||
16193110|NCT00077610|39185251|FG002|Overall Study|Death|13|||
16193111|NCT00077610|39185249|FG000|Overall Study|Renal transplant|12|||
16193112|NCT00077610|39185250|FG001|Overall Study|Renal transplant|15|||
16193113|NCT00077610|39185251|FG002|Overall Study|Renal transplant|11|||
16193114|NCT00077610|39185249|FG000|Overall Study|Withdrew from dialysis care|5|||
16193115|NCT00077610|39185250|FG001|Overall Study|Withdrew from dialysis care|0|||
16193116|NCT00077610|39185251|FG002|Overall Study|Withdrew from dialysis care|3|||
16193117|NCT00077610|39185249|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16193118|NCT00077610|39185250|FG001|Overall Study|Insufficient Therapeutic Response|0|||
16193119|NCT00077610|39185251|FG002|Overall Study|Insufficient Therapeutic Response|0|||
16193120|NCT00077610|39185249|FG000|Overall Study|Multiple blood transfusions|0|||
16193121|NCT00077610|39185250|FG001|Overall Study|Multiple blood transfusions|0|||
16193122|NCT00077610|39185251|FG002|Overall Study|Multiple blood transfusions|1|||
16193123|NCT00077610|39185249|FG000|Overall Study|Principal Investigator's decision|1|||
16193124|NCT00077610|39185250|FG001|Overall Study|Principal Investigator's decision|0|||
16193125|NCT00077610|39185251|FG002|Overall Study|Principal Investigator's decision|1|||
16193126|NCT00077610|39185249|FG000|Overall Study|Worsening of health condition|1|||
16193127|NCT00077610|39185250|FG001|Overall Study|Worsening of health condition|1|||
16193128|NCT00077610|39185251|FG002|Overall Study|Worsening of health condition|0|||
16193129|NCT00077610|39185249|FG000|Overall Study|Given Epogen in hospital|1|||
16193130|NCT00077610|39185250|FG001|Overall Study|Given Epogen in hospital|0|||
16193131|NCT00077610|39185251|FG002|Overall Study|Given Epogen in hospital|0|||
16193132|NCT00077610|39185249|FG000|Overall Study|Transferred to other unit|0|||
16193133|NCT00077610|39185250|FG001|Overall Study|Transferred to other unit|0|||
16193134|NCT00077610|39185251|FG002|Overall Study|Transferred to other unit|1|||
16193135|NCT00077610|39185249|FG000|Overall Study|Transferred to nursing home|0|||
16193136|NCT00077610|39185250|FG001|Overall Study|Transferred to nursing home|0|||
16193137|NCT00077610|39185251|FG002|Overall Study|Transferred to nursing home|1|||
16193138|NCT00077610|39185249|FG000|Overall Study|Transfer to satellite unit|1|||
16193139|NCT00077610|39185250|FG001|Overall Study|Transfer to satellite unit|0|||
16193140|NCT00077610|39185251|FG002|Overall Study|Transfer to satellite unit|0|||
16193141|NCT00077610|39185249|FG000|Overall Study|Transfer to other center for surgery|1|||
16193142|NCT00077610|39185250|FG001|Overall Study|Transfer to other center for surgery|0|||
16193143|NCT00077610|39185251|FG002|Overall Study|Transfer to other center for surgery|0|||
16193144|NCT00077610|39185249|FG000|Overall Study|Change in dialysis modality|1|||
16193145|NCT00077610|39185250|FG001|Overall Study|Change in dialysis modality|0|||
16193146|NCT00077610|39185251|FG002|Overall Study|Change in dialysis modality|0|||
16193147|NCT00077610|39185249|FG000|Overall Study|Relocation|0|||
16193148|NCT00077610|39185250|FG001|Overall Study|Relocation|8|||
16193149|NCT00077610|39185251|FG002|Overall Study|Relocation|5|||
16193150|NCT00077610|39185249|FG000|Overall Study|Financial issues|0|||
16193151|NCT00077610|39185250|FG001|Overall Study|Financial issues|1|||
16193152|NCT00077610|39185251|FG002|Overall Study|Financial issues|0|||
16193153|NCT00077610|39185249|FG000|Overall Study|Sponsors decision to withdraw|0|||
16193154|NCT00077610|39185250|FG001|Overall Study|Sponsors decision to withdraw|0|||
16193155|NCT00077610|39185251|FG002|Overall Study|Sponsors decision to withdraw|1|||
16193156|NCT02651194|39185254|FG000|Overall Study|Lost to Follow-up|3|||
16193157|NCT02651194|39185254|FG000|Overall Study|Other|2|||
16193158|NCT01781429|39185257|FG000|Overall Study|Death|0|||
16193159|NCT01781429|39185258|FG001|Overall Study|Death|0|||
16193160|NCT01781429|39185259|FG002|Overall Study|Death|0|||
16193161|NCT01781429|39185260|FG003|Overall Study|Death|0|||
16193162|NCT01781429|39185261|FG004|Overall Study|Death|0|||
16193163|NCT01781429|39185262|FG005|Overall Study|Death|0|||
16193164|NCT01781429|39185263|FG006|Overall Study|Death|0|||
16193165|NCT01781429|39185264|FG007|Overall Study|Death|0|||
16193166|NCT01781429|39185265|FG008|Overall Study|Death|0|||
16193167|NCT01781429|39185266|FG009|Overall Study|Death|1|||
16193168|NCT01781429|39185267|FG010|Overall Study|Death|0|||
16193169|NCT01781429|39185268|FG011|Overall Study|Death|0|||
16193170|NCT01781429|39185269|FG012|Overall Study|Death|1|||
16193171|NCT01781429|39185270|FG013|Overall Study|Death|0|||
16193172|NCT01781429|39185271|FG014|Overall Study|Death|1|||
16193173|NCT01781429|39185272|FG015|Overall Study|Death|0|||
16193174|NCT01781429|39185257|FG000|Overall Study|Withdrawal by Subject|0|||
16193175|NCT01781429|39185258|FG001|Overall Study|Withdrawal by Subject|0|||
16193176|NCT01781429|39185259|FG002|Overall Study|Withdrawal by Subject|0|||
16193177|NCT01781429|39185260|FG003|Overall Study|Withdrawal by Subject|0|||
16193178|NCT01781429|39185261|FG004|Overall Study|Withdrawal by Subject|0|||
16193179|NCT01781429|39185262|FG005|Overall Study|Withdrawal by Subject|0|||
16193180|NCT01781429|39185263|FG006|Overall Study|Withdrawal by Subject|0|||
16193181|NCT01781429|39185264|FG007|Overall Study|Withdrawal by Subject|0|||
16193182|NCT01781429|39185265|FG008|Overall Study|Withdrawal by Subject|1|||
16193183|NCT01781429|39185266|FG009|Overall Study|Withdrawal by Subject|3|||
16193184|NCT01781429|39185267|FG010|Overall Study|Withdrawal by Subject|1|||
16193185|NCT01781429|39185268|FG011|Overall Study|Withdrawal by Subject|1|||
16193186|NCT01781429|39185269|FG012|Overall Study|Withdrawal by Subject|5|||
16193187|NCT01781429|39185270|FG013|Overall Study|Withdrawal by Subject|2|||
16193188|NCT01781429|39185271|FG014|Overall Study|Withdrawal by Subject|3|||
16193189|NCT01781429|39185272|FG015|Overall Study|Withdrawal by Subject|0|||
16193190|NCT01781429|39185257|FG000|Overall Study|Disease Progression|1|||
16193191|NCT01781429|39185258|FG001|Overall Study|Disease Progression|0|||
16193192|NCT01781429|39185259|FG002|Overall Study|Disease Progression|1|||
16193193|NCT01781429|39185260|FG003|Overall Study|Disease Progression|1|||
16193194|NCT01781429|39185261|FG004|Overall Study|Disease Progression|1|||
16193195|NCT01781429|39185262|FG005|Overall Study|Disease Progression|4|||
16193196|NCT01781429|39185263|FG006|Overall Study|Disease Progression|7|||
16193197|NCT01781429|39185264|FG007|Overall Study|Disease Progression|4|||
16193198|NCT01781429|39185265|FG008|Overall Study|Disease Progression|6|||
16193199|NCT01781429|39185266|FG009|Overall Study|Disease Progression|15|||
16193200|NCT01781429|39185267|FG010|Overall Study|Disease Progression|15|||
16193201|NCT01781429|39185268|FG011|Overall Study|Disease Progression|15|||
16193202|NCT01781429|39185269|FG012|Overall Study|Disease Progression|15|||
16193203|NCT01781429|39185270|FG013|Overall Study|Disease Progression|4|||
16193204|NCT01781429|39185271|FG014|Overall Study|Disease Progression|11|||
16193205|NCT01781429|39185272|FG015|Overall Study|Disease Progression|0|||
16193206|NCT01781429|39185257|FG000|Overall Study|Unacceptable Toxicity|0|||
16193207|NCT01781429|39185258|FG001|Overall Study|Unacceptable Toxicity|0|||
16193208|NCT01781429|39185259|FG002|Overall Study|Unacceptable Toxicity|0|||
16193209|NCT01781429|39185260|FG003|Overall Study|Unacceptable Toxicity|0|||
16193210|NCT01781429|39185261|FG004|Overall Study|Unacceptable Toxicity|0|||
16193211|NCT01781429|39185262|FG005|Overall Study|Unacceptable Toxicity|0|||
16193212|NCT01781429|39185263|FG006|Overall Study|Unacceptable Toxicity|0|||
16193213|NCT01781429|39185264|FG007|Overall Study|Unacceptable Toxicity|0|||
16193214|NCT01781429|39185265|FG008|Overall Study|Unacceptable Toxicity|0|||
16193215|NCT01781429|39185266|FG009|Overall Study|Unacceptable Toxicity|0|||
16193216|NCT01781429|39185267|FG010|Overall Study|Unacceptable Toxicity|0|||
16193217|NCT01781429|39185268|FG011|Overall Study|Unacceptable Toxicity|2|||
16193218|NCT01781429|39185269|FG012|Overall Study|Unacceptable Toxicity|0|||
16193219|NCT01781429|39185270|FG013|Overall Study|Unacceptable Toxicity|0|||
16193220|NCT01781429|39185271|FG014|Overall Study|Unacceptable Toxicity|0|||
16193221|NCT01781429|39185272|FG015|Overall Study|Unacceptable Toxicity|0|||
16193222|NCT01781429|39185257|FG000|Overall Study|Patient Condition Changed|0|||
16193223|NCT01781429|39185258|FG001|Overall Study|Patient Condition Changed|0|||
16193224|NCT01781429|39185259|FG002|Overall Study|Patient Condition Changed|0|||
16193225|NCT01781429|39185260|FG003|Overall Study|Patient Condition Changed|0|||
16193226|NCT01781429|39185261|FG004|Overall Study|Patient Condition Changed|0|||
16193227|NCT01781429|39185262|FG005|Overall Study|Patient Condition Changed|0|||
16193228|NCT01781429|39185263|FG006|Overall Study|Patient Condition Changed|0|||
16193229|NCT01781429|39185264|FG007|Overall Study|Patient Condition Changed|0|||
16193230|NCT01781429|39185265|FG008|Overall Study|Patient Condition Changed|0|||
16193231|NCT01781429|39185266|FG009|Overall Study|Patient Condition Changed|4|||
16193232|NCT01781429|39185267|FG010|Overall Study|Patient Condition Changed|0|||
16193233|NCT01781429|39185268|FG011|Overall Study|Patient Condition Changed|1|||
16193234|NCT01781429|39185269|FG012|Overall Study|Patient Condition Changed|0|||
16193235|NCT01781429|39185270|FG013|Overall Study|Patient Condition Changed|1|||
16193236|NCT01781429|39185271|FG014|Overall Study|Patient Condition Changed|0|||
16193237|NCT01781429|39185272|FG015|Overall Study|Patient Condition Changed|0|||
16193238|NCT01781429|39185257|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
16193239|NCT01781429|39185258|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
16193240|NCT01781429|39185259|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
16193241|NCT01781429|39185260|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
16193242|NCT01781429|39185261|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
16193243|NCT01781429|39185262|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
16193244|NCT01781429|39185263|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
16409902|NCT01952665|39981818|FG000|Overall Study|Physician Decision|3|||
16302701|NCT01449370|39593463|FG017|Overall Study|Medication Prohibited by Protocol|0|||
16302702|NCT01449370|39593464|FG018|Overall Study|Medication Prohibited by Protocol|0|||
16302703|NCT01449370|39593465|FG019|Overall Study|Medication Prohibited by Protocol|0|||
16302704|NCT01449370|39593466|FG020|Overall Study|Medication Prohibited by Protocol|0|||
16302705|NCT01449370|39593467|FG021|Overall Study|Medication Prohibited by Protocol|0|||
16302706|NCT01449370|39593468|FG022|Overall Study|Medication Prohibited by Protocol|0|||
16302707|NCT01449370|39593469|FG023|Overall Study|Medication Prohibited by Protocol|1|||
16302708|NCT01449370|39593470|FG024|Overall Study|Medication Prohibited by Protocol|0|||
16491083|NCT02495168|40270524|FG001|Overall Study|Other than Specified|22|||
16491084|NCT02495168|40270525|FG002|Overall Study|Other than Specified|5|||
16491085|NCT02495168|40270523|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
16491086|NCT02495168|40270524|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
16491087|NCT02495168|40270525|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
16491088|NCT02495168|40270523|FG000|Overall Study|Physician Decision|1|||
16491089|NCT02495168|40270524|FG001|Overall Study|Physician Decision|1|||
16491090|NCT02495168|40270525|FG002|Overall Study|Physician Decision|0|||
16491091|NCT02495168|40270523|FG000|Overall Study|Lost to Follow-up|10|||
16491092|NCT02495168|40270524|FG001|Overall Study|Lost to Follow-up|6|||
16491093|NCT02495168|40270525|FG002|Overall Study|Lost to Follow-up|1|||
16491094|NCT02495168|40270523|FG000|Overall Study|Withdrawal by Subject|1|||
16491095|NCT02495168|40270524|FG001|Overall Study|Withdrawal by Subject|4|||
16491096|NCT02495168|40270525|FG002|Overall Study|Withdrawal by Subject|2|||
16491097|NCT02495168|40270523|FG000|Overall Study|Protocol Violation|0|||
16491098|NCT02495168|40270524|FG001|Overall Study|Protocol Violation|10|||
16491099|NCT02495168|40270525|FG002|Overall Study|Protocol Violation|1|||
16491100|NCT02495168|40270523|FG000|Overall Study|Adverse Event|4|||
16491101|NCT02495168|40270524|FG001|Overall Study|Adverse Event|8|||
16491102|NCT02495168|40270525|FG002|Overall Study|Adverse Event|3|||
16491103|NCT02495168|40270523|FG000|Overall Study|Lack of Efficacy|0|||
16491104|NCT02495168|40270524|FG001|Overall Study|Lack of Efficacy|0|||
16491105|NCT02495168|40270525|FG002|Overall Study|Lack of Efficacy|3|||
16491106|NCT02269241|40272529|FG000|Overall Study|Lost to Follow-up|269|||
16491107|NCT02269241|40272529|FG000|Overall Study|Withdrawal by Subject|155|||
16491108|NCT02269241|40272529|FG000|Overall Study|Protocol Violation|1|||
16491109|NCT02269241|40272529|FG000|Overall Study|Physician Decision|7|||
16491110|NCT02269241|40272529|FG000|Overall Study|Pregnancy|15|||
16491111|NCT02269241|40272529|FG000|Overall Study|Wish for pregnancy|5|||
16491112|NCT02269241|40272529|FG000|Overall Study|Development of an exclusion criteria|16|||
16491113|NCT02269241|40272529|FG000|Overall Study|Adverse Event|113|||
16491114|NCT02269241|40272529|FG000|Overall Study|At the specific request of the sponsor|20|||
16491115|NCT02269241|40272529|FG000|Overall Study|Several reasons not classified|53|||
16491116|NCT02269241|40272529|FG000|Overall Study|Screening failures|546|||
16491117|NCT01949506|40272533|FG000|Overall Study|Physician Decision|1|||
16491118|NCT00964860|40272534|FG000|Overall Study|Withdrawal by Subject|0|||
16491119|NCT00964860|40272535|FG001|Overall Study|Withdrawal by Subject|1|||
16491120|NCT01918085|40272536|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
16491121|NCT01918085|40272537|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
16491122|NCT00491075|40272546|FG000|Overall Study|Withdrawal by Subject|1|||
16491123|NCT00491075|40272546|FG000|Overall Study|Physician Decision|1|||
16491124|NCT03470441|40272547|FG000|Overall Study|Death|0|||
16491125|NCT03470441|40272548|FG001|Overall Study|Death|1|||
16491126|NCT03470441|40272549|FG002|Overall Study|Death|1|||
16491127|NCT03470441|40272550|FG003|Overall Study|Death|0|||
16491128|NCT03470441|40272547|FG000|Overall Study|Adverse Event|0|||
16491129|NCT03470441|40272548|FG001|Overall Study|Adverse Event|0|||
16491130|NCT03470441|40272549|FG002|Overall Study|Adverse Event|0|||
16491131|NCT03470441|40272550|FG003|Overall Study|Adverse Event|1|||
16491132|NCT03470441|40272547|FG000|Overall Study|Withdrawal by Subject|1|||
16491133|NCT03470441|40272548|FG001|Overall Study|Withdrawal by Subject|4|||
16491134|NCT03470441|40272549|FG002|Overall Study|Withdrawal by Subject|1|||
16491135|NCT03470441|40272550|FG003|Overall Study|Withdrawal by Subject|3|||
16491136|NCT01907815|40272551|FG000|Overall Study|Withdrawal by Subject|1|||
16491137|NCT01907815|40272552|FG001|Overall Study|Withdrawal by Subject|0|||
16491138|NCT00573469|40272553|FG000|Overall Study|Adverse Event|1|||
16491139|NCT00573469|40272554|FG001|Overall Study|Adverse Event|1|||
16491140|NCT00573469|40272555|FG002|Overall Study|Adverse Event|1|||
16491141|NCT00573469|40272553|FG000|Overall Study|Withdrawal by Subject|0|||
16491142|NCT00573469|40272554|FG001|Overall Study|Withdrawal by Subject|2|||
16491143|NCT00573469|40272555|FG002|Overall Study|Withdrawal by Subject|0|||
16491144|NCT00573469|40272553|FG000|Overall Study|Other|5|||
16491145|NCT00573469|40272554|FG001|Overall Study|Other|1|||
16491146|NCT00573469|40272555|FG002|Overall Study|Other|3|||
16491147|NCT04980040|40272556|FG000|Overall Study|Violated the Inclusion Criteria|260|||
16491148|NCT04980040|40272556|FG000|Overall Study|Violated the Administration & Dosage|225|||
16491149|NCT04980040|40272556|FG000|Overall Study|Lost to Safety-Follow-up|4|||
16491150|NCT04980040|40272556|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
16491151|NCT00982878|40272557|FG000|Overall Study|Physician Decision|1|||
16193245|NCT01781429|39185264|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
16193246|NCT01781429|39185265|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
16193247|NCT01781429|39185266|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
16193248|NCT01781429|39185267|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
16193249|NCT01781429|39185268|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
16193250|NCT01781429|39185269|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
16193251|NCT01781429|39185270|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
16193252|NCT01781429|39185271|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
16302709|NCT01449370|39593446|FG000|Overall Study|Death|0|||
16193253|NCT01781429|39185272|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
16193254|NCT01781429|39185257|FG000|Overall Study|Enrolled, but not treated|0|||
16193255|NCT01781429|39185258|FG001|Overall Study|Enrolled, but not treated|0|||
16193256|NCT01781429|39185259|FG002|Overall Study|Enrolled, but not treated|0|||
16193257|NCT01781429|39185260|FG003|Overall Study|Enrolled, but not treated|0|||
16302710|NCT01449370|39593447|FG001|Overall Study|Death|0|||
16302711|NCT01449370|39593448|FG002|Overall Study|Death|0|||
16302712|NCT01449370|39593449|FG003|Overall Study|Death|0|||
16302713|NCT01449370|39593450|FG004|Overall Study|Death|0|||
16302714|NCT01449370|39593451|FG005|Overall Study|Death|0|||
16193258|NCT01781429|39185261|FG004|Overall Study|Enrolled, but not treated|0|||
16193259|NCT01781429|39185262|FG005|Overall Study|Enrolled, but not treated|0|||
16193260|NCT01781429|39185263|FG006|Overall Study|Enrolled, but not treated|0|||
16193261|NCT01781429|39185264|FG007|Overall Study|Enrolled, but not treated|0|||
16193262|NCT01781429|39185265|FG008|Overall Study|Enrolled, but not treated|0|||
16193263|NCT01781429|39185266|FG009|Overall Study|Enrolled, but not treated|0|||
16193264|NCT01781429|39185267|FG010|Overall Study|Enrolled, but not treated|1|||
16193265|NCT01781429|39185268|FG011|Overall Study|Enrolled, but not treated|0|||
16193266|NCT01781429|39185269|FG012|Overall Study|Enrolled, but not treated|0|||
16193267|NCT01781429|39185270|FG013|Overall Study|Enrolled, but not treated|0|||
16193268|NCT01781429|39185271|FG014|Overall Study|Enrolled, but not treated|0|||
16193269|NCT01781429|39185272|FG015|Overall Study|Enrolled, but not treated|0|||
16193270|NCT00632541|39185278|FG000|Overall Study|Adverse Event|7|||
16193271|NCT02112994|39185279|FG000|Overall Study|Progressive Disease|0|||
16193272|NCT02112994|39185280|FG001|Overall Study|Progressive Disease|0|||
16193273|NCT02112994|39185281|FG002|Overall Study|Progressive Disease|1|||
16193274|NCT02112994|39185279|FG000|Overall Study|Pregnancy|0|||
16193275|NCT02112994|39185280|FG001|Overall Study|Pregnancy|1|||
16193276|NCT02112994|39185281|FG002|Overall Study|Pregnancy|1|||
16193277|NCT02112994|39185279|FG000|Overall Study|Liver Transplant|0|||
16193278|NCT02112994|39185280|FG001|Overall Study|Liver Transplant|1|||
16193279|NCT02112994|39185281|FG002|Overall Study|Liver Transplant|0|||
16193280|NCT02112994|39185279|FG000|Overall Study|Withdrawal by Subject|0|||
16302715|NCT01449370|39593452|FG006|Overall Study|Death|0|||
16302716|NCT01449370|39593453|FG007|Overall Study|Death|0|||
16302717|NCT01449370|39593454|FG008|Overall Study|Death|0|||
16302718|NCT01449370|39593455|FG009|Overall Study|Death|0|||
16302719|NCT01449370|39593456|FG010|Overall Study|Death|0|||
16302720|NCT01449370|39593457|FG011|Overall Study|Death|0|||
16302721|NCT01449370|39593458|FG012|Overall Study|Death|0|||
16302722|NCT01449370|39593459|FG013|Overall Study|Death|0|||
16302723|NCT01449370|39593460|FG014|Overall Study|Death|0|||
16302724|NCT01449370|39593461|FG015|Overall Study|Death|0|||
16302725|NCT01449370|39593462|FG016|Overall Study|Death|0|||
16302726|NCT01449370|39593463|FG017|Overall Study|Death|0|||
16302727|NCT01449370|39593464|FG018|Overall Study|Death|0|||
16302728|NCT01449370|39593465|FG019|Overall Study|Death|0|||
16193281|NCT02112994|39185280|FG001|Overall Study|Withdrawal by Subject|0|||
16193282|NCT02112994|39185281|FG002|Overall Study|Withdrawal by Subject|1|||
16193283|NCT03282357|39185282|FG000|Overall Study|Lost to Follow-up|3|||
16193284|NCT03282357|39185282|FG000|Overall Study|Withdrawal by Subject|4|||
16193285|NCT03282357|39185282|FG000|Overall Study|Adverse Event|1|||
16193286|NCT03282357|39185282|FG000|Overall Study|Other|9|||
16193287|NCT00578864|39185283|FG000|Overall Study|Death|1|||
16193288|NCT00578864|39185284|FG001|Overall Study|Death|0|||
16302729|NCT01449370|39593466|FG020|Overall Study|Death|0|||
16302730|NCT01449370|39593467|FG021|Overall Study|Death|0|||
16302731|NCT01449370|39593468|FG022|Overall Study|Death|0|||
16193289|NCT01328249|39185285|FG000|Overall Study|Adverse Event|3|||
16193290|NCT01328249|39185286|FG001|Overall Study|Adverse Event|0|||
16302732|NCT01449370|39593469|FG023|Overall Study|Death|0|||
16302733|NCT01449370|39593470|FG024|Overall Study|Death|1|||
16302734|NCT00640315|39593471|FG000|Overall Study|Withdrawal by Subject|0|||
16302735|NCT00640315|39593472|FG001|Overall Study|Withdrawal by Subject|1|||
16302736|NCT02886624|39593473|FG000|12-week Post Treatment Follow-up|Death|1|||
16302737|NCT02886624|39593473|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
16302738|NCT00908310|39593476|FG000|Overall Study|Death|37|||
16302739|NCT00908310|39593476|FG000|Overall Study|Withdrawal by Subject|7|||
16302740|NCT00908310|39593476|FG000|Overall Study|Lost to Follow-up|7|||
16302741|NCT00908310|39593476|FG000|Overall Study|Screening failure|5|||
16302742|NCT00908310|39593476|FG000|Overall Study|Other reasons|4|||
16302743|NCT01611857|39593477|FG000|Overall Study|Withdrawal by Subject|0|||
16302744|NCT01611857|39593478|FG001|Overall Study|Withdrawal by Subject|2|||
16302745|NCT00171951|39593480|FG000|Overall Study|Adverse Event|1|||
16302746|NCT00171951|39593480|FG000|Overall Study|Abnormal Laboratory Values|2|||
16302747|NCT00171951|39593480|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16302748|NCT00171951|39593480|FG000|Overall Study|Participants Withdrew Consent|3|||
16302749|NCT00171951|39593480|FG000|Overall Study|New Cancer Therapy|5|||
16302750|NCT00171951|39593480|FG000|Overall Study|Reason not Specified|2|||
16302751|NCT04435184|39593481|FG000|Overall Study|follow-up blood draws missing|3|||
16302752|NCT04435184|39593482|FG001|Overall Study|follow-up blood draws missing|5|||
16302753|NCT01144715|39593485|FG000|Overall Study|Lost to Follow-up|2|||
16302754|NCT01144715|39593486|FG001|Overall Study|Lost to Follow-up|1|||
16302755|NCT01144715|39593485|FG000|Overall Study|Withdrawal by Subject|2|||
16302756|NCT01144715|39593486|FG001|Overall Study|Withdrawal by Subject|1|||
16302757|NCT01144715|39593485|FG000|Overall Study|Adverse Event|0|||
16302758|NCT01144715|39593486|FG001|Overall Study|Adverse Event|1|||
16302759|NCT00384930|39593487|FG000|Overall Study|Adverse Event|5|||
16302760|NCT00384930|39593488|FG001|Overall Study|Adverse Event|4|||
16302761|NCT00384930|39593489|FG002|Overall Study|Adverse Event|12|||
16302762|NCT00384930|39593490|FG003|Overall Study|Adverse Event|11|||
16302763|NCT00384930|39593491|FG004|Overall Study|Adverse Event|14|||
16302764|NCT00384930|39593487|FG000|Overall Study|Entry Criteria Not Met|2|||
16302765|NCT00384930|39593488|FG001|Overall Study|Entry Criteria Not Met|6|||
16302766|NCT00384930|39593489|FG002|Overall Study|Entry Criteria Not Met|7|||
16302767|NCT00384930|39593490|FG003|Overall Study|Entry Criteria Not Met|8|||
16302768|NCT00384930|39593491|FG004|Overall Study|Entry Criteria Not Met|4|||
16302769|NCT00384930|39593487|FG000|Overall Study|Lack of Efficacy|1|||
16302770|NCT00384930|39593488|FG001|Overall Study|Lack of Efficacy|1|||
16302771|NCT00384930|39593489|FG002|Overall Study|Lack of Efficacy|2|||
16302772|NCT00384930|39593490|FG003|Overall Study|Lack of Efficacy|1|||
16302773|NCT00384930|39593491|FG004|Overall Study|Lack of Efficacy|2|||
16302774|NCT00384930|39593487|FG000|Overall Study|Lost to Follow-up|5|||
16409903|NCT01952665|39981819|FG001|Overall Study|Physician Decision|2|||
16491152|NCT03519932|40272558|FG000|First Intervention|Adverse Event|1|||
16491153|NCT03519932|40272559|FG001|First Intervention|Adverse Event|3|||
16491154|NCT03667924|40272566|FG000|Baseline Completed|Lost to Follow-up|0|||
16491155|NCT03667924|40272567|FG001|Baseline Completed|Lost to Follow-up|2|||
16491156|NCT03667924|40272568|FG002|Baseline Completed|Lost to Follow-up|0|||
16491157|NCT03667924|40272566|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
16491158|NCT03667924|40272567|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
16491159|NCT03667924|40272568|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
16491160|NCT03667924|40272566|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
16491161|NCT03667924|40272567|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
16491162|NCT03667924|40272568|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
16491163|NCT03667924|40272566|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
16491164|NCT03667924|40272567|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
16491165|NCT03667924|40272568|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
16491166|NCT03667924|40272566|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
16491167|NCT03667924|40272567|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
16491168|NCT03667924|40272568|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
16491169|NCT03667924|40272566|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
16491170|NCT03667924|40272567|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
16193291|NCT01328249|39185285|FG000|Overall Study|Disease progression|1|||
16193292|NCT01328249|39185286|FG001|Overall Study|Disease progression|0|||
16302775|NCT00384930|39593488|FG001|Overall Study|Lost to Follow-up|3|||
16302776|NCT00384930|39593489|FG002|Overall Study|Lost to Follow-up|0|||
16302777|NCT00384930|39593490|FG003|Overall Study|Lost to Follow-up|4|||
16302778|NCT00384930|39593491|FG004|Overall Study|Lost to Follow-up|6|||
16302779|NCT00384930|39593487|FG000|Overall Study|Physician Decision|0|||
16302780|NCT00384930|39593488|FG001|Overall Study|Physician Decision|1|||
16491171|NCT03667924|40272568|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
16491172|NCT03667924|40272566|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
16491173|NCT03667924|40272567|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
16491174|NCT03667924|40272568|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
16491175|NCT03052725|40272571|FG000|Overall Study|Adverse Event|2|||
16491176|NCT03052725|40272572|FG001|Overall Study|Adverse Event|0|||
16491177|NCT03052725|40272571|FG000|Overall Study|Withdrawal by Subject|3|||
16491178|NCT03052725|40272572|FG001|Overall Study|Withdrawal by Subject|4|||
16491179|NCT03052725|40272571|FG000|Overall Study|Pregnancy|0|||
16491180|NCT03052725|40272572|FG001|Overall Study|Pregnancy|1|||
16491181|NCT03052725|40272571|FG000|Overall Study|Site closure|0|||
16491182|NCT03052725|40272572|FG001|Overall Study|Site closure|1|||
16491183|NCT03052725|40272571|FG000|Overall Study|Study terminated by sponsor|143|||
16491184|NCT03052725|40272572|FG001|Overall Study|Study terminated by sponsor|144|||
16491185|NCT01417234|40272573|FG000|Overall Study|Subject non-compliant|3|||
16491186|NCT02206048|40272574|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
16302781|NCT00384930|39593489|FG002|Overall Study|Physician Decision|1|||
16302782|NCT00384930|39593490|FG003|Overall Study|Physician Decision|0|||
16302783|NCT00384930|39593491|FG004|Overall Study|Physician Decision|1|||
16302784|NCT00384930|39593487|FG000|Overall Study|Protocol Violation|1|||
16302785|NCT00384930|39593488|FG001|Overall Study|Protocol Violation|0|||
16302786|NCT00384930|39593489|FG002|Overall Study|Protocol Violation|1|||
16302787|NCT00384930|39593490|FG003|Overall Study|Protocol Violation|6|||
16302788|NCT00384930|39593491|FG004|Overall Study|Protocol Violation|4|||
16302789|NCT00384930|39593487|FG000|Overall Study|Sponsor Decision|3|||
16491187|NCT01315678|40272577|FG000|Overall Study|Withdrawal by Subject|7|||
16491188|NCT01315678|40272578|FG001|Overall Study|Withdrawal by Subject|3|||
16491189|NCT01315678|40272577|FG000|Overall Study|Adverse Event|3|||
16491190|NCT01315678|40272578|FG001|Overall Study|Adverse Event|1|||
16491191|NCT01315678|40272577|FG000|Overall Study|Lost to Follow-up|1|||
16491192|NCT01315678|40272578|FG001|Overall Study|Lost to Follow-up|0|||
16491193|NCT01315678|40272577|FG000|Overall Study|similar reason to those listed above|3|||
16491194|NCT01315678|40272578|FG001|Overall Study|similar reason to those listed above|2|||
16491195|NCT02130570|40272585|FG000|Overall Study|Death|3|||
16491196|NCT02130570|40272586|FG001|Overall Study|Death|5|||
16491197|NCT02130570|40272585|FG000|Overall Study|Withdrawal by Subject|6|||
16491198|NCT02130570|40272586|FG001|Overall Study|Withdrawal by Subject|3|||
16491199|NCT02130570|40272585|FG000|Overall Study|Part of practice that discontinued study|0|||
16491200|NCT02130570|40272586|FG001|Overall Study|Part of practice that discontinued study|5|||
16491201|NCT01830972|40272587|FG000|Part II|Withdrawal by Subject|2|||
16491202|NCT01830972|40272588|FG001|Part II|Withdrawal by Subject|2|||
16491203|NCT01830972|40272587|FG000|Part III|Withdrawal by Subject|1|||
16491204|NCT01830972|40272588|FG001|Part III|Withdrawal by Subject|0|||
16491205|NCT01830972|40272587|FG000|Part III|Noncompliance|1|||
16491206|NCT01830972|40272588|FG001|Part III|Noncompliance|0|||
16491207|NCT01830972|40272587|FG000|Part IV|Withdrawal by Subject|2|||
16491208|NCT01830972|40272588|FG001|Part IV|Withdrawal by Subject|1|||
16491209|NCT01830972|40272587|FG000|Part IV|Non-Compliance|1|||
16491210|NCT01830972|40272588|FG001|Part IV|Non-Compliance|0|||
16491211|NCT00684593|40272590|FG000|Overall Study|Adverse Event|0|||
16491212|NCT00684593|40272591|FG001|Overall Study|Adverse Event|2|||
16491213|NCT00885105|40272592|FG000|Overall Study|Withdrawal by Subject|0|||
16491214|NCT00885105|40272593|FG001|Overall Study|Withdrawal by Subject|8|||
16491215|NCT00885105|40272592|FG000|Overall Study|Adverse Event|1|||
16491216|NCT00885105|40272593|FG001|Overall Study|Adverse Event|0|||
16491217|NCT00885105|40272592|FG000|Overall Study|Protocol Violation|0|||
16491218|NCT00885105|40272593|FG001|Overall Study|Protocol Violation|2|||
16491219|NCT02181413|40272596|FG000|Overall Study|Adverse Event|7|||
16491220|NCT02181413|40272597|FG001|Overall Study|Adverse Event|24|||
16491221|NCT02181413|40272596|FG000|Overall Study|Progressive Disease|121|||
16491222|NCT02181413|40272597|FG001|Overall Study|Progressive Disease|143|||
16491223|NCT02181413|40272596|FG000|Overall Study|Withdrawal by Subject|5|||
16491224|NCT02181413|40272597|FG001|Overall Study|Withdrawal by Subject|8|||
16491225|NCT02181413|40272596|FG000|Overall Study|Reason Not Specified|19|||
16491226|NCT02181413|40272597|FG001|Overall Study|Reason Not Specified|20|||
16491227|NCT02181413|40272596|FG000|Overall Study|Ongoing Study Treatment|0|||
16491228|NCT02181413|40272597|FG001|Overall Study|Ongoing Study Treatment|1|||
16491229|NCT02181413|40272596|FG000|Overall Study|Lost to Follow-up|0|||
16491230|NCT02181413|40272597|FG001|Overall Study|Lost to Follow-up|1|||
16491231|NCT00687323|40272601|FG000|Overall Study|Death|25|||
16491232|NCT00687323|40272601|FG000|Overall Study|Withdrawal by Subject|1|||
16491233|NCT00687323|40272601|FG000|Overall Study|Excluded from efficacy evaluations|6|||
16491234|NCT00687323|40272601|FG000|Overall Study|Screen failure|148|||
16491235|NCT01654536|40272602|FG000|Overall Study|Lost to Follow-up|5|||
16302790|NCT00384930|39593488|FG001|Overall Study|Sponsor Decision|4|||
16302791|NCT00384930|39593489|FG002|Overall Study|Sponsor Decision|0|||
16302792|NCT00384930|39593490|FG003|Overall Study|Sponsor Decision|5|||
16491236|NCT01654536|40272603|FG001|Overall Study|Lost to Follow-up|5|||
16491237|NCT01654536|40272602|FG000|Overall Study|Physician Decision|12|||
16491238|NCT01654536|40272603|FG001|Overall Study|Physician Decision|8|||
16491239|NCT01654536|40272602|FG000|Overall Study|Withdrawal by Subject|27|||
16491240|NCT01654536|40272603|FG001|Overall Study|Withdrawal by Subject|25|||
16491241|NCT02155608|40272604|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
16491242|NCT02155608|40272605|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
16491243|NCT02155608|40272604|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
16491244|NCT02155608|40272605|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
16491245|NCT00801632|40272607|FG000|Overall Study|Re-transplant|1|||
16491246|NCT01731990|40272617|FG000|Overall Study|Adverse Event|1|||
16491247|NCT01731990|40272618|FG001|Overall Study|Adverse Event|5|||
16491248|NCT01731990|40272617|FG000|Overall Study|Withdrawal by Subject|1|||
16491249|NCT01731990|40272618|FG001|Overall Study|Withdrawal by Subject|1|||
16491250|NCT01731990|40272617|FG000|Overall Study|Protocol deviation|1|||
16491251|NCT01731990|40272618|FG001|Overall Study|Protocol deviation|2|||
16491252|NCT01731990|40272617|FG000|Overall Study|Death|1|||
16491253|NCT01731990|40272618|FG001|Overall Study|Death|0|||
16491254|NCT02014597|40272620|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
16491255|NCT02014597|40272621|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
16491256|NCT00739674|40272622|FG000|Overall Study|Screening failures|19|||
16491257|NCT00739674|40272623|FG001|Overall Study|Screening failures|17|||
16491258|NCT00739674|40272622|FG000|Overall Study|Site 212 removal|19|||
16491259|NCT00739674|40272623|FG001|Overall Study|Site 212 removal|13|||
16491260|NCT00739674|40272622|FG000|Overall Study|No follow-up data|33|||
16491261|NCT00739674|40272623|FG001|Overall Study|No follow-up data|18|||
16491262|NCT00739674|40272622|FG000|Overall Study|Dietician consultation >30 days|1|||
16491263|NCT00739674|40272623|FG001|Overall Study|Dietician consultation >30 days|9|||
16491264|NCT00739674|40272622|FG000|Overall Study|Adverse Event|22|||
16491265|NCT00739674|40272623|FG001|Overall Study|Adverse Event|13|||
16491266|NCT00739674|40272622|FG000|Overall Study|Death|1|||
16491267|NCT00739674|40272623|FG001|Overall Study|Death|0|||
16491268|NCT00739674|40272622|FG000|Overall Study|Lack of Efficacy|1|||
16491269|NCT00739674|40272623|FG001|Overall Study|Lack of Efficacy|0|||
16491270|NCT00739674|40272622|FG000|Overall Study|Lost to Follow-up|52|||
16491271|NCT00739674|40272623|FG001|Overall Study|Lost to Follow-up|30|||
16491272|NCT00739674|40272622|FG000|Overall Study|Protocol Violation|5|||
16491273|NCT00739674|40272623|FG001|Overall Study|Protocol Violation|5|||
16491274|NCT00739674|40272622|FG000|Overall Study|Withdrawal by Subject|9|||
16491275|NCT00739674|40272623|FG001|Overall Study|Withdrawal by Subject|9|||
16491276|NCT00739674|40272622|FG000|Overall Study|Reason missing|2|||
16491277|NCT00739674|40272623|FG001|Overall Study|Reason missing|0|||
16491278|NCT00739674|40272622|FG000|Overall Study|Clinic closed|6|||
16491279|NCT00739674|40272623|FG001|Overall Study|Clinic closed|4|||
16491280|NCT00739674|40272622|FG000|Overall Study|Patient moved|3|||
16491281|NCT00739674|40272623|FG001|Overall Study|Patient moved|2|||
16491282|NCT00739674|40272622|FG000|Overall Study|Non compliant|4|||
16491283|NCT00739674|40272623|FG001|Overall Study|Non compliant|0|||
16491284|NCT00739674|40272622|FG000|Overall Study|Unable to attend visit|3|||
16491285|NCT00739674|40272623|FG001|Overall Study|Unable to attend visit|1|||
16491286|NCT00739674|40272622|FG000|Overall Study|Home monitoring off meds|1|||
16491287|NCT00739674|40272623|FG001|Overall Study|Home monitoring off meds|0|||
16491288|NCT00739674|40272622|FG000|Overall Study|Erectile dysfunction|0|||
16491289|NCT00739674|40272623|FG001|Overall Study|Erectile dysfunction|1|||
16491290|NCT01652703|40272624|FG000|Overall Study|Withdrawal by Subject|0|||
16491291|NCT01652703|40272625|FG001|Overall Study|Withdrawal by Subject|1|||
16491292|NCT01652703|40272626|FG002|Overall Study|Withdrawal by Subject|3|||
16491293|NCT01652703|40272627|FG003|Overall Study|Withdrawal by Subject|1|||
16491294|NCT01652703|40272628|FG004|Overall Study|Withdrawal by Subject|0|||
16491295|NCT01652703|40272629|FG005|Overall Study|Withdrawal by Subject|1|||
16491296|NCT01652703|40272624|FG000|Overall Study|Other|0|||
16491297|NCT01652703|40272625|FG001|Overall Study|Other|0|||
16491298|NCT01652703|40272626|FG002|Overall Study|Other|0|||
16491299|NCT01652703|40272627|FG003|Overall Study|Other|1|||
16491300|NCT01652703|40272628|FG004|Overall Study|Other|1|||
16491301|NCT01652703|40272629|FG005|Overall Study|Other|1|||
16491302|NCT00536198|40272631|FG000|Overall Study|Lost to Follow-up|15|||
16491303|NCT00536198|40272632|FG001|Overall Study|Lost to Follow-up|14|||
16491304|NCT00536198|40272631|FG000|Overall Study|Withdrawal by Subject|16|||
16491305|NCT00536198|40272632|FG001|Overall Study|Withdrawal by Subject|12|||
16491306|NCT00536198|40272631|FG000|Overall Study|Adverse Event|2|||
16491307|NCT00536198|40272632|FG001|Overall Study|Adverse Event|2|||
16491308|NCT00536198|40272631|FG000|Overall Study|Rescue|3|||
16491309|NCT00536198|40272632|FG001|Overall Study|Rescue|9|||
16491310|NCT00536198|40272631|FG000|Overall Study|Pregnancy|1|||
16491311|NCT00536198|40272632|FG001|Overall Study|Pregnancy|1|||
16491312|NCT00536198|40272631|FG000|Overall Study|Protocol Violation|0|||
16491313|NCT00536198|40272632|FG001|Overall Study|Protocol Violation|1|||
16491314|NCT01384760|40272636|FG000|Overall Study|Lost to Follow-up|0|||
16491315|NCT01384760|40272637|FG001|Overall Study|Lost to Follow-up|6|||
16491316|NCT01384760|40272636|FG000|Overall Study|Protocol Violation|16|||
16491317|NCT01384760|40272637|FG001|Overall Study|Protocol Violation|0|||
16491318|NCT04997161|40272638|FG000|Overall Study|Study terminated by sponsor|3|||
16491319|NCT03129100|40272644|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
16491320|NCT03129100|40272645|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
16491321|NCT03129100|40272646|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
16302793|NCT00384930|39593491|FG004|Overall Study|Sponsor Decision|0|||
16302794|NCT00384930|39593487|FG000|Overall Study|Withdrawal by Subject|9|||
16302795|NCT00384930|39593488|FG001|Overall Study|Withdrawal by Subject|7|||
16302796|NCT00384930|39593489|FG002|Overall Study|Withdrawal by Subject|7|||
16302797|NCT00384930|39593490|FG003|Overall Study|Withdrawal by Subject|6|||
16302798|NCT00384930|39593491|FG004|Overall Study|Withdrawal by Subject|16|||
16491322|NCT03129100|40272647|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
16491323|NCT03129100|40272648|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
16491324|NCT03129100|40272649|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
16491325|NCT03129100|40272650|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
16491326|NCT03129100|40272651|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
16491327|NCT03129100|40272652|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
16491328|NCT03129100|40272653|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
16302799|NCT00384930|39593487|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
16491329|NCT03129100|40272654|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
16491330|NCT03129100|40272655|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
16491331|NCT03129100|40272656|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
16491332|NCT03129100|40272657|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
16491333|NCT03129100|40272658|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
16491334|NCT03129100|40272659|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
16491335|NCT03129100|40272660|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
16491336|NCT03129100|40272661|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
16491337|NCT03129100|40272662|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
16491338|NCT03129100|40272663|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
16491339|NCT03129100|40272664|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
16491340|NCT03129100|40272665|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
16491341|NCT03129100|40272666|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
16491342|NCT03129100|40272667|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
16491343|NCT03129100|40272668|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
16491344|NCT03129100|40272669|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
16491345|NCT03129100|40272644|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
16491346|NCT03129100|40272645|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491347|NCT03129100|40272646|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491348|NCT03129100|40272647|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491349|NCT03129100|40272648|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491350|NCT03129100|40272649|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491351|NCT03129100|40272650|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491352|NCT03129100|40272651|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491353|NCT03129100|40272652|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491354|NCT03129100|40272653|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491355|NCT03129100|40272654|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491356|NCT03129100|40272655|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491357|NCT03129100|40272656|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491358|NCT03129100|40272657|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491359|NCT03129100|40272658|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491360|NCT03129100|40272659|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491361|NCT03129100|40272660|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491362|NCT03129100|40272661|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491363|NCT03129100|40272662|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491364|NCT03129100|40272663|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491365|NCT03129100|40272664|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491366|NCT03129100|40272665|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491367|NCT03129100|40272666|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491368|NCT03129100|40272667|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491369|NCT03129100|40272668|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491370|NCT03129100|40272669|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
16491371|NCT03129100|40272644|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
16491372|NCT03129100|40272645|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
16491373|NCT03129100|40272646|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491374|NCT03129100|40272647|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491375|NCT03129100|40272648|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16387977|NCT00953706|39902803|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
16409904|NCT01952665|39981818|FG000|Overall Study|Lost to Follow-up|1|||
16302800|NCT00384930|39593488|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
16193293|NCT01328249|39185285|FG000|Overall Study|Withdrawal by Subject|1|||
16491376|NCT03129100|40272649|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491377|NCT03129100|40272650|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491378|NCT03129100|40272651|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491379|NCT03129100|40272652|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491380|NCT03129100|40272653|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491381|NCT03129100|40272654|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491382|NCT03129100|40272655|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491383|NCT03129100|40272656|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491384|NCT03129100|40272657|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491385|NCT03129100|40272658|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491386|NCT03129100|40272659|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491387|NCT03129100|40272660|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491388|NCT03129100|40272661|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491389|NCT03129100|40272662|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491390|NCT03129100|40272663|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491391|NCT03129100|40272664|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491392|NCT03129100|40272665|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491393|NCT03129100|40272666|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491394|NCT03129100|40272667|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491395|NCT03129100|40272668|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491396|NCT03129100|40272669|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
16491397|NCT03129100|40272644|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
16491398|NCT03129100|40272645|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
16491399|NCT03129100|40272646|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491400|NCT03129100|40272647|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491401|NCT03129100|40272648|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491402|NCT03129100|40272649|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491403|NCT03129100|40272650|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491404|NCT03129100|40272651|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491405|NCT03129100|40272652|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491406|NCT03129100|40272653|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491407|NCT03129100|40272654|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491408|NCT03129100|40272655|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491409|NCT03129100|40272656|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491410|NCT03129100|40272657|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491411|NCT03129100|40272658|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491412|NCT03129100|40272659|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491413|NCT03129100|40272660|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491414|NCT03129100|40272661|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491415|NCT03129100|40272662|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491416|NCT03129100|40272663|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491417|NCT03129100|40272664|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491418|NCT03129100|40272665|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491419|NCT03129100|40272666|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491420|NCT03129100|40272667|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491421|NCT03129100|40272668|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491422|NCT03129100|40272669|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
16491423|NCT03129100|40272644|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491424|NCT03129100|40272645|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
16491425|NCT03129100|40272646|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491426|NCT03129100|40272647|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491427|NCT03129100|40272648|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491428|NCT03129100|40272649|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491429|NCT03129100|40272650|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491430|NCT03129100|40272651|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491431|NCT03129100|40272652|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491432|NCT03129100|40272653|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491433|NCT03129100|40272654|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491434|NCT03129100|40272655|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491435|NCT03129100|40272656|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491436|NCT03129100|40272657|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491437|NCT03129100|40272658|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491438|NCT03129100|40272659|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491439|NCT03129100|40272660|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491440|NCT03129100|40272661|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491441|NCT03129100|40272662|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491442|NCT03129100|40272663|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491443|NCT03129100|40272664|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491444|NCT03129100|40272665|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491445|NCT03129100|40272666|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491446|NCT03129100|40272667|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491447|NCT03129100|40272668|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491448|NCT03129100|40272669|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
16491449|NCT03129100|40272644|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491450|NCT03129100|40272645|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491451|NCT03129100|40272646|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
16491452|NCT03129100|40272647|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
16491453|NCT03129100|40272648|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491454|NCT03129100|40272649|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
16491455|NCT03129100|40272650|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491456|NCT03129100|40272651|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491457|NCT03129100|40272652|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491458|NCT03129100|40272653|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491459|NCT03129100|40272654|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491460|NCT03129100|40272655|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491461|NCT03129100|40272656|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491462|NCT03129100|40272657|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491463|NCT03129100|40272658|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491464|NCT03129100|40272659|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491465|NCT03129100|40272660|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491466|NCT03129100|40272661|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491467|NCT03129100|40272662|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491468|NCT03129100|40272663|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491469|NCT03129100|40272664|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491470|NCT03129100|40272665|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491471|NCT03129100|40272666|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491472|NCT03129100|40272667|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491473|NCT03129100|40272668|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491474|NCT03129100|40272669|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
16491475|NCT03129100|40272644|FG000|Period2 Extension Period (Group A and B)|Death|0|||
16491476|NCT03129100|40272645|FG001|Period2 Extension Period (Group A and B)|Death|0|||
16491477|NCT03129100|40272646|FG002|Period2 Extension Period (Group A and B)|Death|1|||
16491478|NCT03129100|40272647|FG003|Period2 Extension Period (Group A and B)|Death|0|||
16491479|NCT03129100|40272648|FG004|Period2 Extension Period (Group A and B)|Death|0|||
16491480|NCT03129100|40272649|FG005|Period2 Extension Period (Group A and B)|Death|0|||
16491481|NCT03129100|40272650|FG006|Period2 Extension Period (Group A and B)|Death|0|||
16491482|NCT03129100|40272651|FG007|Period2 Extension Period (Group A and B)|Death|0|||
16491483|NCT03129100|40272652|FG008|Period2 Extension Period (Group A and B)|Death|0|||
16491484|NCT03129100|40272653|FG009|Period2 Extension Period (Group A and B)|Death|0|||
16491485|NCT03129100|40272654|FG010|Period2 Extension Period (Group A and B)|Death|0|||
16491486|NCT03129100|40272655|FG011|Period2 Extension Period (Group A and B)|Death|0|||
16491487|NCT03129100|40272656|FG012|Period2 Extension Period (Group A and B)|Death|0|||
16491488|NCT03129100|40272657|FG013|Period2 Extension Period (Group A and B)|Death|0|||
16491489|NCT03129100|40272658|FG014|Period2 Extension Period (Group A and B)|Death|0|||
16491490|NCT03129100|40272659|FG015|Period2 Extension Period (Group A and B)|Death|0|||
16491491|NCT03129100|40272660|FG016|Period2 Extension Period (Group A and B)|Death|0|||
16491492|NCT03129100|40272661|FG017|Period2 Extension Period (Group A and B)|Death|0|||
16491493|NCT03129100|40272662|FG018|Period2 Extension Period (Group A and B)|Death|0|||
16491494|NCT03129100|40272663|FG019|Period2 Extension Period (Group A and B)|Death|0|||
16491495|NCT03129100|40272664|FG020|Period2 Extension Period (Group A and B)|Death|0|||
16491496|NCT03129100|40272665|FG021|Period2 Extension Period (Group A and B)|Death|0|||
16491497|NCT03129100|40272666|FG022|Period2 Extension Period (Group A and B)|Death|0|||
16491498|NCT03129100|40272667|FG023|Period2 Extension Period (Group A and B)|Death|0|||
16491499|NCT03129100|40272668|FG024|Period2 Extension Period (Group A and B)|Death|0|||
16491500|NCT03129100|40272669|FG025|Period2 Extension Period (Group A and B)|Death|0|||
16491501|NCT03129100|40272644|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491502|NCT03129100|40272645|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491503|NCT03129100|40272646|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
16491504|NCT03129100|40272647|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
16491505|NCT03129100|40272648|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
16491506|NCT03129100|40272649|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
16491507|NCT03129100|40272650|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
16491508|NCT03129100|40272651|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491509|NCT03129100|40272652|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16387978|NCT00953706|39902804|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
16491510|NCT03129100|40272653|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16193294|NCT01328249|39185286|FG001|Overall Study|Withdrawal by Subject|1|||
16193295|NCT01328249|39185285|FG000|Overall Study|Moved before end of treatment visit|1|||
16193296|NCT01328249|39185286|FG001|Overall Study|Moved before end of treatment visit|0|||
16193297|NCT01328249|39185285|FG000|Overall Study|Subject choice|1|||
16193298|NCT01328249|39185286|FG001|Overall Study|Subject choice|1|||
16193299|NCT01328249|39185285|FG000|Overall Study|Protocol Violation|0|||
16193300|NCT01328249|39185286|FG001|Overall Study|Protocol Violation|1|||
16302801|NCT00384930|39593489|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
16302802|NCT00384930|39593490|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
16302803|NCT00384930|39593491|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
16302804|NCT04172597|39593492|FG000|Overall Study|Disease Progression|0|||
16302805|NCT04172597|39593493|FG001|Overall Study|Disease Progression|0|||
16302806|NCT04172597|39593494|FG002|Overall Study|Disease Progression|0|||
16302807|NCT04172597|39593495|FG003|Overall Study|Disease Progression|0|||
16302808|NCT04172597|39593496|FG004|Overall Study|Disease Progression|1|||
16302809|NCT02296931|39593507|FG000|Overall Study|Protocol Violation|0|||
16302810|NCT02296931|39593508|FG001|Overall Study|Protocol Violation|2|||
16302811|NCT02046603|39593509|FG000|Overall Study|Other|11|||
16302812|NCT02046603|39593510|FG001|Overall Study|Other|66|||
16302813|NCT02046603|39593509|FG000|Overall Study|Protocol Violation|0|||
16302814|NCT02046603|39593510|FG001|Overall Study|Protocol Violation|1|||
16387979|NCT00953706|39902801|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
16491511|NCT03129100|40272654|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491512|NCT03129100|40272655|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491513|NCT03129100|40272656|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491514|NCT03129100|40272657|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491515|NCT03129100|40272658|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491516|NCT03129100|40272659|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491517|NCT03129100|40272660|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491518|NCT03129100|40272661|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491519|NCT03129100|40272662|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491520|NCT03129100|40272663|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491521|NCT03129100|40272664|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491522|NCT03129100|40272665|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491523|NCT03129100|40272666|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491524|NCT03129100|40272667|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491525|NCT03129100|40272668|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491526|NCT03129100|40272669|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
16491527|NCT03129100|40272644|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491528|NCT03129100|40272645|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491529|NCT03129100|40272646|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
16491530|NCT03129100|40272647|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491531|NCT03129100|40272648|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491532|NCT03129100|40272649|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491533|NCT03129100|40272650|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491534|NCT03129100|40272651|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491535|NCT03129100|40272652|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491536|NCT03129100|40272653|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491537|NCT03129100|40272654|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491538|NCT03129100|40272655|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491539|NCT03129100|40272656|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491540|NCT03129100|40272657|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491541|NCT03129100|40272658|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491542|NCT03129100|40272659|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491543|NCT03129100|40272660|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491544|NCT03129100|40272661|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16302815|NCT02046603|39593509|FG000|Overall Study|Participant/legal guardian decision|1|||
16302816|NCT02046603|39593510|FG001|Overall Study|Participant/legal guardian decision|3|||
16302817|NCT02046603|39593509|FG000|Overall Study|Physician Decision|2|||
16302818|NCT02046603|39593510|FG001|Overall Study|Physician Decision|1|||
16302819|NCT02046603|39593509|FG000|Overall Study|Lost to Follow-up|1|||
16302820|NCT02046603|39593510|FG001|Overall Study|Lost to Follow-up|2|||
16302821|NCT02046603|39593509|FG000|Overall Study|Death|0|||
16302822|NCT02046603|39593510|FG001|Overall Study|Death|1|||
16302823|NCT02046603|39593509|FG000|Overall Study|Adverse Event|0|||
16302824|NCT02046603|39593510|FG001|Overall Study|Adverse Event|1|||
16302825|NCT03516513|39593511|FG000|Overall Study|Withdrawal by Subject|2|||
16302826|NCT03516513|39593512|FG001|Overall Study|Withdrawal by Subject|2|||
16302827|NCT03516513|39593513|FG002|Overall Study|Withdrawal by Subject|0|||
16302828|NCT03516513|39593514|FG003|Overall Study|Withdrawal by Subject|0|||
16302829|NCT00786409|39593515|FG000|Overall Study|Withdrawal by Subject|2|||
16302830|NCT00786409|39593515|FG000|Overall Study|Adverse Event|2|||
16302831|NCT00786409|39593515|FG000|Overall Study|Pregnancy|2|||
16193301|NCT01975272|39185287|FG000|Overall Study|Excluded after protocol amendment|1|||
16193302|NCT01975272|39185288|FG001|Overall Study|Excluded after protocol amendment|1|||
16193303|NCT01975272|39185289|FG002|Overall Study|Excluded after protocol amendment|2|||
16193304|NCT03259490|39185290|FG000|Period 1|Withdrawal by Subject|0|||
16193305|NCT03259490|39185291|FG001|Period 1|Withdrawal by Subject|1|||
16193306|NCT03259490|39185290|FG000|Period 2|Protocol Violation|1|||
16193307|NCT03259490|39185291|FG001|Period 2|Protocol Violation|0|||
16193308|NCT00448760|39185292|FG000|Overall Study|Death|3|||
16193309|NCT04263142|39185293|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
16193310|NCT04263142|39185294|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
16193311|NCT04263142|39185295|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
16193312|NCT04263142|39185296|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
16193313|NCT04263142|39185297|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
16193314|NCT04263142|39185293|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
16193315|NCT04263142|39185294|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
16193316|NCT04263142|39185295|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
16193317|NCT04263142|39185296|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
16193318|NCT04263142|39185297|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
16193319|NCT00137436|39185298|FG000|Overall Study|Adverse Event|13|||
16193320|NCT00137436|39185298|FG000|Overall Study|Death|2|||
16193321|NCT00137436|39185298|FG000|Overall Study|Lack of Efficacy|17|||
16193322|NCT00137436|39185298|FG000|Overall Study|Withdrawal by Subject|6|||
16193323|NCT00137436|39185298|FG000|Overall Study|Other|5|||
16302832|NCT00786409|39593515|FG000|Overall Study|Lost to Follow-up|1|||
16302833|NCT00708227|39593519|FG000|Overall Study|Physician Decision|0|||
16302834|NCT00708227|39593520|FG001|Overall Study|Physician Decision|3|||
16302835|NCT00708227|39593521|FG002|Overall Study|Physician Decision|1|||
16302836|NCT00708227|39593522|FG003|Overall Study|Physician Decision|2|||
16491545|NCT03129100|40272662|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491546|NCT03129100|40272663|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491547|NCT03129100|40272664|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16302837|NCT00708227|39593519|FG000|Overall Study|Withdrawal by Subject|1|||
16302838|NCT00708227|39593520|FG001|Overall Study|Withdrawal by Subject|2|||
16302839|NCT00708227|39593521|FG002|Overall Study|Withdrawal by Subject|0|||
16302840|NCT00708227|39593522|FG003|Overall Study|Withdrawal by Subject|1|||
16302841|NCT00810511|39593526|FG000|Overall Study|Protocol Violation|0|||
16302842|NCT00810511|39593527|FG001|Overall Study|Protocol Violation|1|||
16302843|NCT00810511|39593526|FG000|Overall Study|Lack of Efficacy|9|||
16302844|NCT00810511|39593527|FG001|Overall Study|Lack of Efficacy|1|||
16302845|NCT00810511|39593526|FG000|Overall Study|death in the family|0|||
16302846|NCT00810511|39593527|FG001|Overall Study|death in the family|1|||
16302847|NCT00810511|39593526|FG000|Overall Study|Lost to Follow-up|1|||
16302848|NCT00810511|39593527|FG001|Overall Study|Lost to Follow-up|0|||
16302849|NCT00810511|39593526|FG000|Overall Study|deposits on contact lens|0|||
16302850|NCT00810511|39593527|FG001|Overall Study|deposits on contact lens|1|||
16302851|NCT01885195|39593528|FG000|Overall Study|Adverse Event|29|||
16302852|NCT01885195|39593528|FG000|Overall Study|Death|1|||
16302853|NCT01885195|39593528|FG000|Overall Study|Disease Progression|67|||
16302854|NCT01885195|39593528|FG000|Overall Study|Protocol Deviation|2|||
16302855|NCT01885195|39593528|FG000|Overall Study|Physician Decision|3|||
16302856|NCT01885195|39593528|FG000|Overall Study|Patient/guardian decision|8|||
16302857|NCT00338455|39593529|FG000|Overall Study|Death|2|||
16302858|NCT00338455|39593530|FG001|Overall Study|Death|1|||
16302859|NCT00338455|39593529|FG000|Overall Study|Physician Decision|1|||
16302860|NCT00338455|39593530|FG001|Overall Study|Physician Decision|0|||
16302861|NCT03414684|39593531|FG000|First-course Treatment|Complete response|0|||
16302862|NCT03414684|39593532|FG001|First-course Treatment|Complete response|1|||
16302863|NCT03414684|39593531|FG000|First-course Treatment|Intercurrent illness|1|||
16302864|NCT03414684|39593532|FG001|First-course Treatment|Intercurrent illness|0|||
16302865|NCT03414684|39593531|FG000|First-course Treatment|Progressive Disease|31|||
16302866|NCT03414684|39593532|FG001|First-course Treatment|Progressive Disease|32|||
16302867|NCT03414684|39593531|FG000|First-course Treatment|Adverse Event|1|||
16302868|NCT03414684|39593532|FG001|First-course Treatment|Adverse Event|2|||
16302869|NCT03414684|39593531|FG000|First-course Treatment|Physician Decision|0|||
16302870|NCT03414684|39593532|FG001|First-course Treatment|Physician Decision|1|||
16302871|NCT03414684|39593531|FG000|First-course Treatment|Withdrawal by Subject|0|||
16302872|NCT03414684|39593532|FG001|First-course Treatment|Withdrawal by Subject|1|||
16302873|NCT03414684|39593531|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
16302874|NCT03414684|39593532|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
16302875|NCT03414684|39593531|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
16302876|NCT03414684|39593532|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
16302877|NCT03414684|39593531|FG000|First-course Treatment|Still on treatment|3|||
16302878|NCT03414684|39593532|FG001|First-course Treatment|Still on treatment|0|||
16302879|NCT03414684|39593531|FG000|First-course Treatment|Never started protocol therapy|2|||
16302880|NCT03414684|39593532|FG001|First-course Treatment|Never started protocol therapy|1|||
16302881|NCT03414684|39593531|FG000|Crossover Treatment|Progressive disease|0|||
16302882|NCT03414684|39593532|FG001|Crossover Treatment|Progressive disease|12|||
16491548|NCT03129100|40272665|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491549|NCT03129100|40272666|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16302883|NCT03414684|39593531|FG000|Crossover Treatment|Adverse Event|0|||
16302884|NCT03414684|39593532|FG001|Crossover Treatment|Adverse Event|3|||
16409905|NCT01952665|39981819|FG001|Overall Study|Lost to Follow-up|2|||
16491550|NCT03129100|40272667|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491551|NCT03129100|40272668|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491552|NCT03129100|40272669|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
16491553|NCT03129100|40272644|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491554|NCT03129100|40272645|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491555|NCT03129100|40272646|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
16491556|NCT03129100|40272647|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491557|NCT03129100|40272648|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491558|NCT03129100|40272649|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16302885|NCT03414684|39593531|FG000|Crossover Treatment|Physician Decision|0|||
16302886|NCT03414684|39593532|FG001|Crossover Treatment|Physician Decision|1|||
16302887|NCT03414684|39593531|FG000|Crossover Treatment|Still on treatment|0|||
16302888|NCT03414684|39593532|FG001|Crossover Treatment|Still on treatment|2|||
16302889|NCT01544179|39593533|FG000|Overall Study|Death|50|||
16302890|NCT01544179|39593534|FG001|Overall Study|Death|37|||
16302891|NCT01544179|39593533|FG000|Overall Study|Lost to Follow-up|0|||
16302892|NCT01544179|39593534|FG001|Overall Study|Lost to Follow-up|1|||
16302893|NCT01544179|39593533|FG000|Overall Study|Adverse Event|0|||
16302894|NCT01544179|39593534|FG001|Overall Study|Adverse Event|1|||
16302895|NCT01544179|39593533|FG000|Overall Study|Withdrawal by Subject|12|||
16302896|NCT01544179|39593534|FG001|Overall Study|Withdrawal by Subject|7|||
16302897|NCT01544179|39593533|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
16302898|NCT01544179|39593534|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16302899|NCT01098474|39593535|FG000|Active Phase|Other|0|||
16302900|NCT01098474|39593536|FG001|Active Phase|Other|0|||
16302901|NCT01098474|39593537|FG002|Active Phase|Other|3|||
16302902|NCT01098474|39593538|FG003|Active Phase|Other|0|||
16302903|NCT01098474|39593539|FG004|Active Phase|Other|0|||
16302904|NCT01098474|39593540|FG005|Active Phase|Other|0|||
16302905|NCT01098474|39593535|FG000|Active Phase|Withdrawal by Subject|1|||
16302906|NCT01098474|39593536|FG001|Active Phase|Withdrawal by Subject|1|||
16302907|NCT01098474|39593537|FG002|Active Phase|Withdrawal by Subject|2|||
16302908|NCT01098474|39593538|FG003|Active Phase|Withdrawal by Subject|0|||
16302909|NCT01098474|39593539|FG004|Active Phase|Withdrawal by Subject|0|||
16302910|NCT01098474|39593540|FG005|Active Phase|Withdrawal by Subject|0|||
16302911|NCT01098474|39593535|FG000|Active Phase|Lost to Follow-up|1|||
16302912|NCT01098474|39593536|FG001|Active Phase|Lost to Follow-up|0|||
16302913|NCT01098474|39593537|FG002|Active Phase|Lost to Follow-up|0|||
16302914|NCT01098474|39593538|FG003|Active Phase|Lost to Follow-up|0|||
16302915|NCT01098474|39593539|FG004|Active Phase|Lost to Follow-up|0|||
16302916|NCT01098474|39593540|FG005|Active Phase|Lost to Follow-up|0|||
16302917|NCT01098474|39593535|FG000|Follow Up Phase|Travelled out of study area|0|||
16302918|NCT01098474|39593536|FG001|Follow Up Phase|Travelled out of study area|0|||
16302919|NCT01098474|39593537|FG002|Follow Up Phase|Travelled out of study area|0|||
16302920|NCT01098474|39593538|FG003|Follow Up Phase|Travelled out of study area|0|||
16302921|NCT01098474|39593539|FG004|Follow Up Phase|Travelled out of study area|1|||
16302922|NCT01098474|39593540|FG005|Follow Up Phase|Travelled out of study area|0|||
16302923|NCT01098474|39593535|FG000|Follow Up Phase|Other|0|||
16302924|NCT01098474|39593536|FG001|Follow Up Phase|Other|0|||
16302925|NCT01098474|39593537|FG002|Follow Up Phase|Other|0|||
16302926|NCT01098474|39593538|FG003|Follow Up Phase|Other|0|||
16491559|NCT03129100|40272650|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16302927|NCT01098474|39593539|FG004|Follow Up Phase|Other|0|||
16302928|NCT01098474|39593540|FG005|Follow Up Phase|Other|4|||
16302929|NCT01098474|39593535|FG000|Follow Up Phase|Withdrawal by Subject|0|||
16302930|NCT01098474|39593536|FG001|Follow Up Phase|Withdrawal by Subject|0|||
16302931|NCT01098474|39593537|FG002|Follow Up Phase|Withdrawal by Subject|0|||
16302932|NCT01098474|39593538|FG003|Follow Up Phase|Withdrawal by Subject|2|||
16302933|NCT01098474|39593539|FG004|Follow Up Phase|Withdrawal by Subject|0|||
16302934|NCT01098474|39593540|FG005|Follow Up Phase|Withdrawal by Subject|1|||
16302935|NCT01098474|39593535|FG000|Follow Up Phase|Lost to Follow-up|0|||
16302936|NCT01098474|39593536|FG001|Follow Up Phase|Lost to Follow-up|0|||
16302937|NCT01098474|39593537|FG002|Follow Up Phase|Lost to Follow-up|0|||
16302938|NCT01098474|39593538|FG003|Follow Up Phase|Lost to Follow-up|0|||
16302939|NCT01098474|39593539|FG004|Follow Up Phase|Lost to Follow-up|1|||
16302940|NCT01098474|39593540|FG005|Follow Up Phase|Lost to Follow-up|0|||
16302941|NCT00920790|39593541|FG000|Overall Study|aggravation of general condition|14|||
16302942|NCT01699815|39593542|FG000|Overall Study|Protocol Violation|4|||
16491560|NCT03129100|40272651|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491561|NCT03129100|40272652|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491562|NCT03129100|40272653|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491563|NCT03129100|40272654|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491564|NCT03129100|40272655|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491565|NCT03129100|40272656|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491566|NCT03129100|40272657|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491567|NCT03129100|40272658|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491568|NCT03129100|40272659|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491569|NCT03129100|40272660|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491570|NCT03129100|40272661|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491571|NCT03129100|40272662|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16302943|NCT01699815|39593543|FG001|Overall Study|Protocol Violation|7|||
16302944|NCT01699815|39593542|FG000|Overall Study|record could not be located|1|||
16302945|NCT01699815|39593543|FG001|Overall Study|record could not be located|0|||
16302946|NCT01699815|39593542|FG000|Overall Study|Adverse Event|0|||
16302947|NCT01699815|39593543|FG001|Overall Study|Adverse Event|1|||
16302948|NCT01757275|39593545|FG000|Overall Study|Lost to Follow-up|1|||
16302949|NCT01757275|39593546|FG001|Overall Study|Lost to Follow-up|2|||
16302950|NCT01757275|39593545|FG000|Overall Study|Adverse Event|3|||
16302951|NCT01757275|39593546|FG001|Overall Study|Adverse Event|3|||
16302952|NCT01757275|39593545|FG000|Overall Study|Withdrawal by Subject|2|||
16302953|NCT01757275|39593546|FG001|Overall Study|Withdrawal by Subject|4|||
16302954|NCT01757275|39593545|FG000|Overall Study|Not treated|3|||
16302955|NCT01757275|39593546|FG001|Overall Study|Not treated|4|||
16302956|NCT03573830|39593547|FG000|Overall Study|Dropped without completing treatment|0|||
16302957|NCT03573830|39593548|FG001|Overall Study|Dropped without completing treatment|7|||
16302958|NCT03573830|39593547|FG000|Overall Study|Lost to Follow-up|4|||
16302959|NCT03573830|39593548|FG001|Overall Study|Lost to Follow-up|0|||
16302960|NCT02613182|39593549|FG000|Overall Study|Death|6|||
16302961|NCT02613182|39593549|FG000|Overall Study|Physician Decision|1|||
16302962|NCT02613182|39593549|FG000|Overall Study|Study Terminated by Sponsor|21|||
16302963|NCT02613182|39593549|FG000|Overall Study|Withdrawal by Subject|6|||
16302964|NCT01111825|39593552|FG000|Overall Study|Withdrawal by Subject|0|||
16302965|NCT01111825|39593553|FG001|Overall Study|Withdrawal by Subject|0|||
16302966|NCT01111825|39593554|FG002|Overall Study|Withdrawal by Subject|1|||
16302967|NCT01111825|39593555|FG003|Overall Study|Withdrawal by Subject|0|||
16302968|NCT01111825|39593552|FG000|Overall Study|Lost to Follow-up|0|||
16302969|NCT01111825|39593553|FG001|Overall Study|Lost to Follow-up|0|||
16302970|NCT01111825|39593554|FG002|Overall Study|Lost to Follow-up|3|||
16302971|NCT01111825|39593555|FG003|Overall Study|Lost to Follow-up|1|||
16302972|NCT01111825|39593552|FG000|Overall Study|Adverse Event|2|||
16302973|NCT01111825|39593553|FG001|Overall Study|Adverse Event|1|||
16491572|NCT03129100|40272663|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491573|NCT03129100|40272664|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491574|NCT03129100|40272665|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491575|NCT03129100|40272666|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16302974|NCT01111825|39593554|FG002|Overall Study|Adverse Event|4|||
16302975|NCT01111825|39593555|FG003|Overall Study|Adverse Event|0|||
16302976|NCT01111825|39593552|FG000|Overall Study|Disease Progression|1|||
16302977|NCT01111825|39593553|FG001|Overall Study|Disease Progression|0|||
16302978|NCT01111825|39593554|FG002|Overall Study|Disease Progression|0|||
16302979|NCT01111825|39593555|FG003|Overall Study|Disease Progression|0|||
16302980|NCT01111825|39593552|FG000|Overall Study|Discontinuation by Sponsor|0|||
16302981|NCT01111825|39593553|FG001|Overall Study|Discontinuation by Sponsor|0|||
16302982|NCT01111825|39593554|FG002|Overall Study|Discontinuation by Sponsor|0|||
16302983|NCT01111825|39593555|FG003|Overall Study|Discontinuation by Sponsor|20|||
16302984|NCT00863772|39593557|FG000|Overall Study|Adverse Event|1|||
16302985|NCT00863772|39593558|FG001|Overall Study|Adverse Event|4|||
16302986|NCT00863772|39593559|FG002|Overall Study|Adverse Event|0|||
16302987|NCT00863772|39593557|FG000|Overall Study|Lack of Efficacy|4|||
16302988|NCT00863772|39593558|FG001|Overall Study|Lack of Efficacy|2|||
16302989|NCT00863772|39593559|FG002|Overall Study|Lack of Efficacy|4|||
16491576|NCT03129100|40272667|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491577|NCT03129100|40272668|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16491578|NCT03129100|40272669|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
16302990|NCT00863772|39593557|FG000|Overall Study|Lost to Follow-up|5|||
16302991|NCT00863772|39593558|FG001|Overall Study|Lost to Follow-up|1|||
16302992|NCT00863772|39593559|FG002|Overall Study|Lost to Follow-up|1|||
16302993|NCT00863772|39593557|FG000|Overall Study|Protocol Violation|2|||
16302994|NCT00863772|39593558|FG001|Overall Study|Protocol Violation|0|||
16302995|NCT00863772|39593559|FG002|Overall Study|Protocol Violation|2|||
16302996|NCT00863772|39593557|FG000|Overall Study|Withdrawal by Subject|4|||
16302997|NCT00863772|39593558|FG001|Overall Study|Withdrawal by Subject|7|||
16302998|NCT00863772|39593559|FG002|Overall Study|Withdrawal by Subject|5|||
16302999|NCT00863772|39593557|FG000|Overall Study|Study terminated by sponsor|44|||
16303000|NCT00863772|39593558|FG001|Overall Study|Study terminated by sponsor|45|||
16303001|NCT00863772|39593559|FG002|Overall Study|Study terminated by sponsor|36|||
16303002|NCT00863772|39593557|FG000|Overall Study|Entered extension study|6|||
16303003|NCT00863772|39593558|FG001|Overall Study|Entered extension study|4|||
16303004|NCT00863772|39593559|FG002|Overall Study|Entered extension study|9|||
16303005|NCT00863772|39593557|FG000|Overall Study|Other|1|||
16303006|NCT00863772|39593558|FG001|Overall Study|Other|2|||
16303007|NCT00863772|39593559|FG002|Overall Study|Other|4|||
16303008|NCT00863772|39593557|FG000|Overall Study|Randomized but not Treated|1|||
16303009|NCT00863772|39593558|FG001|Overall Study|Randomized but not Treated|0|||
16303010|NCT00863772|39593559|FG002|Overall Study|Randomized but not Treated|0|||
16303011|NCT00478244|39593562|FG000|Overall Study|Did not receive transplant|1|||
16491579|NCT03129100|40272644|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16303012|NCT04208750|39593563|FG000|Overall Study|Lost to Follow-up|16|||
16303013|NCT04208750|39593564|FG001|Overall Study|Lost to Follow-up|15|||
16303014|NCT02633787|39593565|FG000|Overall Study|Withdrawal by Subject|1|||
16303015|NCT00233402|39593566|FG000|Overall Study|No pathology data|12|||
16303016|NCT00233402|39593567|FG001|Overall Study|No pathology data|9|||
16303017|NCT00233402|39593566|FG000|Overall Study|No Ta/T1|89|||
16303018|NCT00233402|39593567|FG001|Overall Study|No Ta/T1|94|||
16303019|NCT00233402|39593566|FG000|Overall Study|Lost to follow up etc|3|||
16303020|NCT00233402|39593567|FG001|Overall Study|Lost to follow up etc|21|||
16303021|NCT03765788|39593568|FG000|Overall Study|Subject decision|2|||
16303022|NCT03765788|39593569|FG001|Overall Study|Subject decision|3|||
16303023|NCT03765788|39593568|FG000|Overall Study|Physician Decision|2|||
16303024|NCT03765788|39593569|FG001|Overall Study|Physician Decision|4|||
16303025|NCT03765788|39593568|FG000|Overall Study|Death|0|||
16303026|NCT03765788|39593569|FG001|Overall Study|Death|1|||
16303027|NCT03765788|39593568|FG000|Overall Study|Lost to Follow-up|1|||
16303028|NCT03765788|39593569|FG001|Overall Study|Lost to Follow-up|0|||
16303029|NCT02792699|39593570|FG000|Overall Study|Adverse Event|1|||
16303030|NCT02792699|39593571|FG001|Overall Study|Adverse Event|2|||
16303031|NCT02792699|39593572|FG002|Overall Study|Adverse Event|4|||
16303032|NCT02792699|39593570|FG000|Overall Study|Withdrawal by Subject|4|||
16303033|NCT02792699|39593571|FG001|Overall Study|Withdrawal by Subject|4|||
16303034|NCT02792699|39593572|FG002|Overall Study|Withdrawal by Subject|3|||
16303035|NCT02792699|39593570|FG000|Overall Study|Lost to Follow-up|0|||
16303036|NCT02792699|39593571|FG001|Overall Study|Lost to Follow-up|1|||
16303037|NCT02792699|39593572|FG002|Overall Study|Lost to Follow-up|2|||
16303038|NCT02792699|39593570|FG000|Overall Study|Physician Decision|2|||
16303039|NCT02792699|39593571|FG001|Overall Study|Physician Decision|0|||
16303040|NCT02792699|39593572|FG002|Overall Study|Physician Decision|0|||
16303041|NCT02792699|39593570|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
16303042|NCT02792699|39593571|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
16303043|NCT02792699|39593572|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
16303044|NCT02792699|39593570|FG000|Overall Study|Other|1|||
16303045|NCT02792699|39593571|FG001|Overall Study|Other|0|||
16303046|NCT02792699|39593572|FG002|Overall Study|Other|0|||
16303047|NCT02552732|39593573|FG000|Overall Study|Lost to Follow-up|2|||
16303048|NCT02552732|39593573|FG000|Overall Study|Physician Decision|1|||
16303049|NCT02552732|39593573|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
16303050|NCT02552732|39593573|FG000|Overall Study|Withdrawal by Subject|6|||
16303051|NCT03276078|39593574|FG000|Overall Study|Adverse Event|1|||
16303052|NCT01000961|39593575|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
16303053|NCT01000961|39593576|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16303054|NCT01000961|39593575|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
16303055|NCT01000961|39593576|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
16303056|NCT02289456|39593577|FG000|Induction Period|Death|2|||
16303057|NCT02289456|39593577|FG000|Induction Period|Adverse Event|11|||
16491580|NCT03129100|40272645|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491581|NCT03129100|40272646|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
16491582|NCT03129100|40272647|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491583|NCT03129100|40272648|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491584|NCT03129100|40272649|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491585|NCT03129100|40272650|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16303058|NCT02289456|39593577|FG000|Induction Period|Progressive Disease (PD)|4|||
16303059|NCT02289456|39593577|FG000|Induction Period|Symptomatic Deterioration|4|||
16303060|NCT02289456|39593577|FG000|Induction Period|Withdrawal by Subject|2|||
16303061|NCT02289456|39593577|FG000|Induction Period|Miscellaneous|1|||
16303062|NCT02289456|39593577|FG000|Monotherapy Period|Death|1|||
16303063|NCT02289456|39593577|FG000|Monotherapy Period|Adverse Event|1|||
16303064|NCT02289456|39593577|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
16303065|NCT02289456|39593577|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
16303066|NCT02289456|39593577|FG000|Monotherapy Period|Withdrawal by Subject|2|||
16303067|NCT02289456|39593577|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
16303068|NCT02289456|39593577|FG000|Monotherapy Period|Miscellaneous|1|||
16303069|NCT02111603|39593578|FG000|Overall Study|Withdrawal by Subject|1|||
16303070|NCT00258960|39593579|FG000|Overall Study|Death|2|||
16303071|NCT00258960|39593579|FG000|Overall Study|Disease Progression|7|||
16303072|NCT00258960|39593579|FG000|Overall Study|Adverse Event|4|||
16303073|NCT00258960|39593579|FG000|Overall Study|Physician Decision|1|||
16303074|NCT00258960|39593579|FG000|Overall Study|Withdrawal by Subject|1|||
16303075|NCT00258960|39593579|FG000|Overall Study|Mistake|2|||
16303076|NCT02443740|39593582|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
16303077|NCT02443740|39593583|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
16303078|NCT02443740|39593584|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
16303079|NCT02443740|39593585|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
16491586|NCT03129100|40272651|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16303080|NCT02443740|39593586|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
16303081|NCT02443740|39593587|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
16303082|NCT02443740|39593588|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
16303083|NCT02443740|39593589|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
16303084|NCT02443740|39593590|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
16303085|NCT02443740|39593591|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
16303086|NCT02443740|39593592|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
16303087|NCT02443740|39593582|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
16303088|NCT02443740|39593583|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16303089|NCT02443740|39593584|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16303090|NCT02443740|39593585|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16303091|NCT02443740|39593586|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16303092|NCT02443740|39593587|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16303093|NCT02443740|39593588|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
16303094|NCT02443740|39593589|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16303095|NCT02443740|39593590|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16303096|NCT02443740|39593591|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16303097|NCT02443740|39593592|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
16303098|NCT02443740|39593582|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16303099|NCT02443740|39593583|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16303100|NCT02443740|39593584|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16303101|NCT02443740|39593585|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16303102|NCT02443740|39593586|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16303103|NCT02443740|39593587|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
16303104|NCT02443740|39593588|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16303105|NCT02443740|39593589|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16303106|NCT02443740|39593590|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16303107|NCT02443740|39593591|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16303108|NCT02443740|39593592|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
16303109|NCT02925403|39593593|FG000|Overall Study|Lost to Follow-up|0|||
16303110|NCT02925403|39593594|FG001|Overall Study|Lost to Follow-up|1|||
16303111|NCT02203331|39593595|FG000|Overall Study|Pregnancy|1|||
16491587|NCT03129100|40272652|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491588|NCT03129100|40272653|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491589|NCT03129100|40272654|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491590|NCT03129100|40272655|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491591|NCT03129100|40272656|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491592|NCT03129100|40272657|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16303112|NCT02203331|39593596|FG001|Overall Study|Pregnancy|0|||
16303113|NCT02203331|39593597|FG002|Overall Study|Pregnancy|0|||
16303114|NCT02203331|39593598|FG003|Overall Study|Pregnancy|0|||
16303115|NCT02203331|39593599|FG004|Overall Study|Pregnancy|2|||
16303116|NCT02203331|39593600|FG005|Overall Study|Pregnancy|0|||
16303117|NCT02203331|39593595|FG000|Overall Study|Withdrawal by Subject|1|||
16303118|NCT02203331|39593596|FG001|Overall Study|Withdrawal by Subject|0|||
16303119|NCT02203331|39593597|FG002|Overall Study|Withdrawal by Subject|1|||
16303120|NCT02203331|39593598|FG003|Overall Study|Withdrawal by Subject|0|||
16303121|NCT02203331|39593599|FG004|Overall Study|Withdrawal by Subject|0|||
16303122|NCT02203331|39593600|FG005|Overall Study|Withdrawal by Subject|3|||
16303123|NCT02203331|39593595|FG000|Overall Study|Adverse Event|4|||
16303124|NCT02203331|39593596|FG001|Overall Study|Adverse Event|8|||
16303125|NCT02203331|39593597|FG002|Overall Study|Adverse Event|3|||
16303126|NCT02203331|39593598|FG003|Overall Study|Adverse Event|4|||
16303127|NCT02203331|39593599|FG004|Overall Study|Adverse Event|3|||
16303128|NCT02203331|39593600|FG005|Overall Study|Adverse Event|3|||
16303129|NCT02203331|39593595|FG000|Overall Study|Other Reasons|1|||
16303130|NCT02203331|39593596|FG001|Overall Study|Other Reasons|2|||
16303131|NCT02203331|39593597|FG002|Overall Study|Other Reasons|0|||
16303132|NCT02203331|39593598|FG003|Overall Study|Other Reasons|2|||
16303133|NCT02203331|39593599|FG004|Overall Study|Other Reasons|0|||
16303134|NCT02203331|39593600|FG005|Overall Study|Other Reasons|0|||
16303135|NCT02203331|39593595|FG000|Overall Study|Lack of Efficacy|0|||
16303136|NCT02203331|39593596|FG001|Overall Study|Lack of Efficacy|2|||
16303137|NCT02203331|39593597|FG002|Overall Study|Lack of Efficacy|1|||
16303138|NCT02203331|39593598|FG003|Overall Study|Lack of Efficacy|0|||
16303139|NCT02203331|39593599|FG004|Overall Study|Lack of Efficacy|0|||
16303140|NCT02203331|39593600|FG005|Overall Study|Lack of Efficacy|1|||
16303141|NCT02203331|39593595|FG000|Overall Study|Protocol Violation|0|||
16303142|NCT02203331|39593596|FG001|Overall Study|Protocol Violation|2|||
16303143|NCT02203331|39593597|FG002|Overall Study|Protocol Violation|0|||
16303144|NCT02203331|39593598|FG003|Overall Study|Protocol Violation|1|||
16303145|NCT02203331|39593599|FG004|Overall Study|Protocol Violation|1|||
16303146|NCT02203331|39593600|FG005|Overall Study|Protocol Violation|0|||
16303147|NCT02203331|39593595|FG000|Overall Study|Lost to Follow-up|0|||
16303148|NCT02203331|39593596|FG001|Overall Study|Lost to Follow-up|0|||
16303149|NCT02203331|39593597|FG002|Overall Study|Lost to Follow-up|0|||
16303150|NCT02203331|39593598|FG003|Overall Study|Lost to Follow-up|0|||
16303151|NCT02203331|39593599|FG004|Overall Study|Lost to Follow-up|1|||
16303152|NCT02203331|39593600|FG005|Overall Study|Lost to Follow-up|0|||
16303153|NCT02759692|39593601|FG000|Period 1|Test article no longer available|1|||
16303154|NCT02759692|39593602|FG001|Period 1|Test article no longer available|1|||
16303155|NCT02759692|39593601|FG000|Period 1|No longer meets eligibility criteria.|1|||
16303156|NCT02759692|39593602|FG001|Period 1|No longer meets eligibility criteria.|0|||
16303157|NCT02759692|39593601|FG000|Period 1|Miss-Randomized|1|||
16303158|NCT02759692|39593602|FG001|Period 1|Miss-Randomized|1|||
16303159|NCT02759692|39593601|FG000|Period 2|Lost to Follow-up|1|||
16303160|NCT02759692|39593602|FG001|Period 2|Lost to Follow-up|0|||
16303161|NCT02759692|39593601|FG000|Period 2|Test article no longer available|0|||
16303162|NCT02759692|39593602|FG001|Period 2|Test article no longer available|1|||
16303163|NCT01808573|39593603|FG000|Overall Study|Death|212|||
16303164|NCT01808573|39593604|FG001|Overall Study|Death|240|||
16303165|NCT01808573|39593603|FG000|Overall Study|Withdrawal by Subject|12|||
16303166|NCT01808573|39593604|FG001|Overall Study|Withdrawal by Subject|10|||
16491593|NCT03129100|40272658|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491594|NCT03129100|40272659|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491595|NCT03129100|40272660|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491596|NCT03129100|40272661|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491597|NCT03129100|40272662|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491598|NCT03129100|40272663|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491599|NCT03129100|40272664|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491600|NCT03129100|40272665|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491601|NCT03129100|40272666|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491602|NCT03129100|40272667|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491603|NCT03129100|40272668|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491604|NCT03129100|40272669|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
16491605|NCT03129100|40272644|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491606|NCT03129100|40272645|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491607|NCT03129100|40272646|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491608|NCT03129100|40272647|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491609|NCT03129100|40272648|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
16491610|NCT03129100|40272649|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
16491611|NCT03129100|40272650|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
16491612|NCT03129100|40272651|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491613|NCT03129100|40272652|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491614|NCT03129100|40272653|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491615|NCT03129100|40272654|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491616|NCT03129100|40272655|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491617|NCT03129100|40272656|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491618|NCT03129100|40272657|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491619|NCT03129100|40272658|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491620|NCT03129100|40272659|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491621|NCT03129100|40272660|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491622|NCT03129100|40272661|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491623|NCT03129100|40272662|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491624|NCT03129100|40272663|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491625|NCT03129100|40272664|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491626|NCT03129100|40272665|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491627|NCT03129100|40272666|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491628|NCT03129100|40272667|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491629|NCT03129100|40272668|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491630|NCT03129100|40272669|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
16491631|NCT03129100|40272644|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491632|NCT03129100|40272645|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491633|NCT03129100|40272646|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491634|NCT03129100|40272647|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491635|NCT03129100|40272648|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16303167|NCT01808573|39593603|FG000|Overall Study|Lost to Follow-up|3|||
16303168|NCT01808573|39593604|FG001|Overall Study|Lost to Follow-up|0|||
16303169|NCT01808573|39593603|FG000|Overall Study|Discontinuation of study by sponsor|79|||
16303170|NCT01808573|39593604|FG001|Overall Study|Discontinuation of study by sponsor|64|||
16491636|NCT03129100|40272649|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491637|NCT03129100|40272650|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491638|NCT03129100|40272651|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491639|NCT03129100|40272652|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491640|NCT03129100|40272653|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
16491641|NCT03129100|40272654|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491642|NCT03129100|40272655|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491643|NCT03129100|40272656|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491644|NCT03129100|40272657|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491645|NCT03129100|40272658|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491646|NCT03129100|40272659|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491647|NCT03129100|40272660|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491648|NCT03129100|40272661|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491649|NCT03129100|40272662|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491650|NCT03129100|40272663|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16083870|NCT00676091|38799229|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
16491651|NCT03129100|40272664|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491652|NCT03129100|40272665|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491653|NCT03129100|40272666|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491654|NCT03129100|40272667|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491655|NCT03129100|40272668|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491656|NCT03129100|40272669|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
16491657|NCT03129100|40272644|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491658|NCT03129100|40272645|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491659|NCT03129100|40272646|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491660|NCT03129100|40272647|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491661|NCT03129100|40272648|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491662|NCT03129100|40272649|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491663|NCT03129100|40272650|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491664|NCT03129100|40272651|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491665|NCT03129100|40272652|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491666|NCT03129100|40272653|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491667|NCT03129100|40272654|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491668|NCT03129100|40272655|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
16491669|NCT03129100|40272656|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491670|NCT03129100|40272657|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16083871|NCT00676091|38799230|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
16083872|NCT00676091|38799229|FG000|After Infant Series|Adverse Event|0|||
16083873|NCT00676091|38799230|FG001|After Infant Series|Adverse Event|1|||
16083874|NCT00676091|38799229|FG000|After Infant Series|Protocol Violation|0|||
16083875|NCT00676091|38799230|FG001|After Infant Series|Protocol Violation|1|||
16083876|NCT00676091|38799229|FG000|After Infant Series|Failed to return|1|||
16083877|NCT00676091|38799230|FG001|After Infant Series|Failed to return|1|||
16083878|NCT00676091|38799229|FG000|Toddler Dose|Failed to return|2|||
16083879|NCT00676091|38799230|FG001|Toddler Dose|Failed to return|0|||
16083880|NCT00676091|38799229|FG000|Toddler Dose|Parent or legal guardian request|1|||
16083881|NCT00676091|38799230|FG001|Toddler Dose|Parent or legal guardian request|0|||
16083882|NCT02638337|38799233|FG000|Overall Study|Adverse Event|6|||
16083883|NCT02638337|38799234|FG001|Overall Study|Adverse Event|10|||
16083884|NCT02638337|38799233|FG000|Overall Study|Protocol Violation|3|||
16083885|NCT02638337|38799234|FG001|Overall Study|Protocol Violation|0|||
16083886|NCT02638337|38799233|FG000|Overall Study|Withdrawal by Subject|13|||
16083887|NCT02638337|38799234|FG001|Overall Study|Withdrawal by Subject|16|||
16083888|NCT02638337|38799233|FG000|Overall Study|Lost to Follow-up|7|||
16083889|NCT02638337|38799234|FG001|Overall Study|Lost to Follow-up|7|||
16083890|NCT02638337|38799233|FG000|Overall Study|Other - Miscellaneous|4|||
16083891|NCT02638337|38799234|FG001|Overall Study|Other - Miscellaneous|3|||
16083892|NCT01823224|38799235|FG000|Overall Study|Lost to Follow-up|5|||
16083893|NCT01823224|38799236|FG001|Overall Study|Lost to Follow-up|6|||
16083894|NCT01823224|38799235|FG000|Overall Study|didn't qualify|1|||
16083895|NCT01823224|38799236|FG001|Overall Study|didn't qualify|2|||
16083896|NCT01823224|38799235|FG000|Overall Study|pharmacy error|0|||
16083897|NCT01823224|38799236|FG001|Overall Study|pharmacy error|1|||
16083898|NCT01823224|38799235|FG000|Overall Study|missed med dose|0|||
16083899|NCT01823224|38799236|FG001|Overall Study|missed med dose|1|||
16083900|NCT01823224|38799235|FG000|Overall Study|Withdrawal by Subject|0|||
16083901|NCT01823224|38799236|FG001|Overall Study|Withdrawal by Subject|1|||
16083902|NCT01303510|38799239|FG000|Overall Study|Lost to Follow-up|1|||
16083903|NCT01303510|38799240|FG001|Overall Study|Lost to Follow-up|0|||
16193324|NCT01151579|39185301|FG000|Overall Study|Physician Decision|3|||
16193325|NCT01151579|39185302|FG001|Overall Study|Physician Decision|1|||
16193326|NCT01151579|39185301|FG000|Overall Study|Withdrawal by Subject|3|||
16193327|NCT01151579|39185302|FG001|Overall Study|Withdrawal by Subject|2|||
16193328|NCT01151579|39185301|FG000|Overall Study|Not meet inclusion criteria|6|||
16193329|NCT01151579|39185302|FG001|Overall Study|Not meet inclusion criteria|4|||
16193330|NCT01830543|39185305|FG000|Overall Study|Subject Decision|19|||
16193331|NCT01830543|39185306|FG001|Overall Study|Subject Decision|21|||
16193332|NCT01830543|39185307|FG002|Overall Study|Subject Decision|57|||
16193333|NCT01830543|39185305|FG000|Overall Study|Adverse Event|91|||
16193334|NCT01830543|39185306|FG001|Overall Study|Adverse Event|77|||
16193335|NCT01830543|39185307|FG002|Overall Study|Adverse Event|76|||
16193336|NCT01830543|39185305|FG000|Overall Study|Death|20|||
16193337|NCT01830543|39185306|FG001|Overall Study|Death|22|||
16193338|NCT01830543|39185307|FG002|Overall Study|Death|22|||
16193339|NCT01830543|39185305|FG000|Overall Study|Protocol Violation|3|||
16193340|NCT01830543|39185306|FG001|Overall Study|Protocol Violation|7|||
16193341|NCT01830543|39185307|FG002|Overall Study|Protocol Violation|7|||
16193342|NCT01830543|39185305|FG000|Overall Study|Physician Decision|11|||
16193343|NCT01830543|39185306|FG001|Overall Study|Physician Decision|5|||
16193344|NCT01830543|39185307|FG002|Overall Study|Physician Decision|12|||
16193345|NCT01830543|39185305|FG000|Overall Study|Withdrawal by consent|3|||
16193346|NCT01830543|39185306|FG001|Overall Study|Withdrawal by consent|3|||
16193347|NCT01830543|39185307|FG002|Overall Study|Withdrawal by consent|3|||
16193348|NCT01830543|39185305|FG000|Overall Study|Other|12|||
16303171|NCT01808573|39593603|FG000|Overall Study|Randomized in Error|1|||
16303172|NCT01808573|39593604|FG001|Overall Study|Randomized in Error|0|||
16303173|NCT02088697|39593608|FG000|Period I|Physician Decision|1|||
16303174|NCT02088697|39593609|FG001|Period I|Physician Decision|4|||
16303175|NCT02088697|39593608|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
16303176|NCT02088697|39593609|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
16387980|NCT00953706|39902802|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
16387981|NCT00953706|39902803|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
16303177|NCT03645863|39593610|FG000|Overall Study|Withdrawal by Subject|1|||
16387982|NCT00953706|39902804|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
16387983|NCT00953706|39902801|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
16387984|NCT00953706|39902802|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
16387985|NCT00953706|39902803|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
16387986|NCT00953706|39902804|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
16387987|NCT00953706|39902801|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
16387988|NCT00953706|39902802|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
16387989|NCT00953706|39902803|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
16387990|NCT00953706|39902804|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
16387991|NCT00953706|39902801|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
16491671|NCT03129100|40272658|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491672|NCT03129100|40272659|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16303178|NCT03645863|39593611|FG001|Overall Study|Withdrawal by Subject|0|||
16303179|NCT03645863|39593612|FG002|Overall Study|Withdrawal by Subject|0|||
16303180|NCT00324987|39593613|FG000|Overall Study|Adverse Event|2|||
16303181|NCT00324987|39593614|FG001|Overall Study|Adverse Event|1|||
16303182|NCT00324987|39593613|FG000|Overall Study|Withdrawal by Subject|1|||
16303183|NCT00324987|39593614|FG001|Overall Study|Withdrawal by Subject|1|||
16303184|NCT00324987|39593613|FG000|Overall Study|Progression|1|||
16303185|NCT00324987|39593614|FG001|Overall Study|Progression|1|||
16303186|NCT00324987|39593613|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
16303187|NCT00324987|39593614|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
16303188|NCT02905032|39593619|FG000|Overall Study|Withdrawal by Subject|2|||
16303189|NCT02905032|39593620|FG001|Overall Study|Withdrawal by Subject|0|||
16303190|NCT02905032|39593621|FG002|Overall Study|Withdrawal by Subject|0|||
16303191|NCT02905032|39593619|FG000|Overall Study|Protocol Violation|6|||
16303192|NCT02905032|39593620|FG001|Overall Study|Protocol Violation|12|||
16303193|NCT02905032|39593621|FG002|Overall Study|Protocol Violation|0|||
16303194|NCT01184079|39593622|FG000|Overall Study|Lost to Follow-up|14|||
16303195|NCT01184079|39593623|FG001|Overall Study|Lost to Follow-up|2|||
16303196|NCT00461253|39593624|FG000|Overall Study|Death|985|||
16193349|NCT01830543|39185306|FG001|Overall Study|Other|17|||
16193350|NCT01830543|39185307|FG002|Overall Study|Other|37|||
16193351|NCT04146467|39185308|FG000|Overall Study|Adverse Event|0|||
16193352|NCT04146467|39185309|FG001|Overall Study|Adverse Event|1|||
16193353|NCT04146467|39185308|FG000|Overall Study|Lost to Follow-up|0|||
16193354|NCT04146467|39185309|FG001|Overall Study|Lost to Follow-up|2|||
16193355|NCT01069523|39185310|FG000|Overall Study|Withdrawal by Subject|4|||
16303197|NCT00461253|39593625|FG001|Overall Study|Death|0|||
16303198|NCT00461253|39593624|FG000|Overall Study|Protocol Violation|613|||
16303199|NCT00461253|39593625|FG001|Overall Study|Protocol Violation|236|||
16303200|NCT00461253|39593624|FG000|Overall Study|no response|2609|||
16303201|NCT00461253|39593625|FG001|Overall Study|no response|11789|||
16303202|NCT00461253|39593624|FG000|Overall Study|administrative|773|||
16303203|NCT00461253|39593625|FG001|Overall Study|administrative|7773|||
16303204|NCT00450801|39593626|FG000|Overall Study|Death|1|||
16303205|NCT02859142|39593627|FG000|Overall Study|Adverse Event|1|||
16303206|NCT02859142|39593628|FG001|Overall Study|Adverse Event|2|||
16303207|NCT02859142|39593627|FG000|Overall Study|Lost to Follow-up|1|||
16303208|NCT02859142|39593628|FG001|Overall Study|Lost to Follow-up|4|||
16303209|NCT02859142|39593627|FG000|Overall Study|Withdrawal by Subject|2|||
16303210|NCT02859142|39593628|FG001|Overall Study|Withdrawal by Subject|0|||
16303211|NCT02859142|39593627|FG000|Overall Study|Scheduling difficulties|0|||
16303212|NCT02859142|39593628|FG001|Overall Study|Scheduling difficulties|3|||
16303213|NCT04388553|39593629|FG000|Overall Study|Protocol Violation|1|||
16303214|NCT04388553|39593630|FG001|Overall Study|Protocol Violation|0|||
16303215|NCT00064987|39593631|FG000|Overall Study|Physician Decision|3|||
16303216|NCT00064987|39593632|FG001|Overall Study|Physician Decision|0|||
16303217|NCT01851330|39593635|FG000|Overall Study|Lack of Efficacy|10|||
16303218|NCT01851330|39593636|FG001|Overall Study|Lack of Efficacy|9|||
16303219|NCT01851330|39593637|FG002|Overall Study|Lack of Efficacy|2|||
16303220|NCT01851330|39593635|FG000|Overall Study|Lost to Follow-up|1|||
16303221|NCT01851330|39593636|FG001|Overall Study|Lost to Follow-up|6|||
16303222|NCT01851330|39593637|FG002|Overall Study|Lost to Follow-up|9|||
16303223|NCT01851330|39593635|FG000|Overall Study|Withdrew Consent|2|||
16303224|NCT01851330|39593636|FG001|Overall Study|Withdrew Consent|1|||
16303225|NCT01851330|39593637|FG002|Overall Study|Withdrew Consent|0|||
16303226|NCT01851330|39593635|FG000|Overall Study|Investigator's Discretion|0|||
16303227|NCT01851330|39593636|FG001|Overall Study|Investigator's Discretion|0|||
16303228|NCT01851330|39593637|FG002|Overall Study|Investigator's Discretion|1|||
16303229|NCT03567980|39593649|FG000|Overall Study|Adverse Event|1|||
16303230|NCT00970593|39593662|FG000|Overall Study|Adverse Event|1|||
16303231|NCT00970593|39593663|FG001|Overall Study|Adverse Event|1|||
16303232|NCT00970593|39593664|FG002|Overall Study|Adverse Event|0|||
16303233|NCT00970593|39593665|FG003|Overall Study|Adverse Event|0|||
16303234|NCT00970593|39593666|FG004|Overall Study|Adverse Event|0|||
16303235|NCT00970593|39593667|FG005|Overall Study|Adverse Event|0|||
16303236|NCT00970593|39593668|FG006|Overall Study|Adverse Event|0|||
16303237|NCT00970593|39593662|FG000|Overall Study|Discontinuation of study by sponsor|0|||
16303238|NCT00970593|39593663|FG001|Overall Study|Discontinuation of study by sponsor|0|||
16303239|NCT00970593|39593664|FG002|Overall Study|Discontinuation of study by sponsor|5|||
16303240|NCT00970593|39593665|FG003|Overall Study|Discontinuation of study by sponsor|0|||
16303241|NCT00970593|39593666|FG004|Overall Study|Discontinuation of study by sponsor|0|||
16303242|NCT00970593|39593667|FG005|Overall Study|Discontinuation of study by sponsor|0|||
16303243|NCT00970593|39593668|FG006|Overall Study|Discontinuation of study by sponsor|2|||
16303244|NCT00970593|39593662|FG000|Overall Study|Withdrawal by Subject|0|||
16303245|NCT00970593|39593663|FG001|Overall Study|Withdrawal by Subject|0|||
16303246|NCT00970593|39593664|FG002|Overall Study|Withdrawal by Subject|1|||
16303247|NCT00970593|39593665|FG003|Overall Study|Withdrawal by Subject|0|||
16303248|NCT00970593|39593666|FG004|Overall Study|Withdrawal by Subject|0|||
16303249|NCT00970593|39593667|FG005|Overall Study|Withdrawal by Subject|0|||
16303250|NCT00970593|39593668|FG006|Overall Study|Withdrawal by Subject|0|||
16303251|NCT01523002|39593671|FG000|Period 1|Withdrawal by Subject|1|||
16303252|NCT01523002|39593672|FG001|Period 1|Withdrawal by Subject|3|||
16303253|NCT01523002|39593671|FG000|Period 1|Lost to Follow-up|1|||
16303254|NCT01523002|39593672|FG001|Period 1|Lost to Follow-up|0|||
16303255|NCT01523002|39593671|FG000|Period 1|Adverse Event|0|||
16303256|NCT01523002|39593672|FG001|Period 1|Adverse Event|8|||
16303257|NCT01523002|39593671|FG000|Period 2|Withdrawal by Subject|4|||
16303258|NCT01523002|39593672|FG001|Period 2|Withdrawal by Subject|1|||
16303259|NCT01523002|39593671|FG000|Period 2|Adverse Event|2|||
16303260|NCT01523002|39593672|FG001|Period 2|Adverse Event|5|||
16303261|NCT01523002|39593671|FG000|Period 3|Withdrawal by Subject|1|||
16303262|NCT01523002|39593672|FG001|Period 3|Withdrawal by Subject|0|||
16303263|NCT01523002|39593671|FG000|Period 3|Adverse Event|3|||
16303264|NCT01523002|39593672|FG001|Period 3|Adverse Event|0|||
16303265|NCT00303459|39593680|FG000|Overall Study|Death|33|||
16303266|NCT00303459|39593681|FG001|Overall Study|Death|44|||
16303267|NCT00303459|39593680|FG000|Overall Study|Withdrawal of consent|32|||
16303268|NCT00303459|39593681|FG001|Overall Study|Withdrawal of consent|26|||
16303269|NCT00303459|39593680|FG000|Overall Study|Lost to Follow-up|5|||
16303270|NCT00303459|39593681|FG001|Overall Study|Lost to Follow-up|4|||
16303271|NCT00303459|39593680|FG000|Overall Study|Administrative reason|7|||
16303272|NCT00303459|39593681|FG001|Overall Study|Administrative reason|7|||
16303273|NCT00303459|39593680|FG000|Overall Study|Decision by the investigator|5|||
16303274|NCT00303459|39593681|FG001|Overall Study|Decision by the investigator|7|||
16303275|NCT00303459|39593680|FG000|Overall Study|Lung transplantation|1|||
16303276|NCT00303459|39593681|FG001|Overall Study|Lung transplantation|1|||
16303277|NCT00995774|39597825|FG000|Training Period 2|Withdrawal by Subject|2|||
16303278|NCT00995774|39597826|FG001|Training Period 2|Withdrawal by Subject|0|||
16491673|NCT03129100|40272660|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16303279|NCT00061932|39597827|FG000|Overall Study|Withdrawal by Subject|13|||
16491674|NCT03129100|40272661|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491675|NCT03129100|40272662|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491676|NCT03129100|40272663|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491677|NCT03129100|40272664|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491678|NCT03129100|40272665|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491679|NCT03129100|40272666|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491680|NCT03129100|40272667|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491681|NCT03129100|40272668|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491682|NCT03129100|40272669|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
16491683|NCT03129100|40272644|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491684|NCT03129100|40272645|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491685|NCT03129100|40272646|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491686|NCT03129100|40272647|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491687|NCT03129100|40272648|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491688|NCT03129100|40272649|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16193356|NCT01069523|39185311|FG001|Overall Study|Withdrawal by Subject|7|||
16303280|NCT00061932|39597828|FG001|Overall Study|Withdrawal by Subject|4|||
16387992|NCT00953706|39902802|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
16387993|NCT00953706|39902803|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
16387994|NCT00953706|39902804|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
16491689|NCT03129100|40272650|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16193357|NCT03970395|39185312|FG000|Overall Study|Withdrawal by Subject|3|||
16193358|NCT03970395|39185313|FG001|Overall Study|Withdrawal by Subject|4|||
16193359|NCT03970395|39185312|FG000|Overall Study|Lost to Follow-up|4|||
16303281|NCT01597778|39597832|FG000|Overall Study|Death|7|||
16303282|NCT01597778|39597833|FG001|Overall Study|Death|10|||
16303283|NCT01597778|39597832|FG000|Overall Study|Withdrawal by Subject|3|||
16303284|NCT01597778|39597833|FG001|Overall Study|Withdrawal by Subject|4|||
16303285|NCT01597778|39597832|FG000|Overall Study|Adverse Event|1|||
16303286|NCT01597778|39597833|FG001|Overall Study|Adverse Event|1|||
16303287|NCT01597778|39597832|FG000|Overall Study|Protocol Violation|1|||
16303288|NCT01597778|39597833|FG001|Overall Study|Protocol Violation|11|||
16303289|NCT01597778|39597832|FG000|Overall Study|Transplanted off protocol|2|||
16303290|NCT01597778|39597833|FG001|Overall Study|Transplanted off protocol|3|||
16303291|NCT01128543|39597836|FG000|Overall Study|Withdrawal by Subject|3|||
16303292|NCT01128543|39597836|FG000|Overall Study|Protocol Violation|1|||
16193360|NCT03970395|39185313|FG001|Overall Study|Lost to Follow-up|8|||
16193361|NCT02121756|39185316|FG000|Overall Study|Adverse Event|3|||
16193362|NCT02121756|39185317|FG001|Overall Study|Adverse Event|0|||
16193363|NCT02121756|39185316|FG000|Overall Study|Protocol Violation|1|||
16193364|NCT02121756|39185317|FG001|Overall Study|Protocol Violation|1|||
16193365|NCT02121756|39185316|FG000|Overall Study|Physician Decision|2|||
16193366|NCT02121756|39185317|FG001|Overall Study|Physician Decision|1|||
16193367|NCT03622593|39185318|FG000|Overall Study|Withdrawal by Subject|11|||
16193368|NCT03622593|39185319|FG001|Overall Study|Withdrawal by Subject|9|||
16193369|NCT03622593|39185320|FG002|Overall Study|Withdrawal by Subject|13|||
16193370|NCT03622593|39185318|FG000|Overall Study|Death|12|||
16193371|NCT03622593|39185319|FG001|Overall Study|Death|9|||
16193372|NCT03622593|39185320|FG002|Overall Study|Death|10|||
16193373|NCT03622593|39185318|FG000|Overall Study|Lost to Follow-up|11|||
16193374|NCT03622593|39185319|FG001|Overall Study|Lost to Follow-up|5|||
16193375|NCT03622593|39185320|FG002|Overall Study|Lost to Follow-up|8|||
16303293|NCT03016975|39597837|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
16193376|NCT03622593|39185318|FG000|Overall Study|Adverse Event|4|||
16193377|NCT03622593|39185319|FG001|Overall Study|Adverse Event|5|||
16193378|NCT03622593|39185320|FG002|Overall Study|Adverse Event|6|||
16303294|NCT03016975|39597838|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
16303295|NCT03016975|39597839|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
16303296|NCT03016975|39597837|FG000|At 6 Months Follow-up|Death|2|||
16303297|NCT03016975|39597838|FG001|At 6 Months Follow-up|Death|0|||
16303298|NCT03016975|39597839|FG002|At 6 Months Follow-up|Death|0|||
16491690|NCT03129100|40272651|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491691|NCT03129100|40272652|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491692|NCT03129100|40272653|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491693|NCT03129100|40272654|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491694|NCT03129100|40272655|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
16491695|NCT03129100|40272656|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
16491696|NCT03129100|40272657|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
16491697|NCT03129100|40272658|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
16491698|NCT03129100|40272659|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491699|NCT03129100|40272660|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491700|NCT03129100|40272661|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491701|NCT03129100|40272662|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491702|NCT03129100|40272663|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491703|NCT03129100|40272664|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491704|NCT03129100|40272665|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491705|NCT03129100|40272666|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491706|NCT03129100|40272667|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491707|NCT03129100|40272668|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491708|NCT03129100|40272669|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
16491709|NCT03129100|40272644|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491710|NCT03129100|40272645|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491711|NCT03129100|40272646|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491712|NCT03129100|40272647|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491713|NCT03129100|40272648|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491714|NCT03129100|40272649|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491715|NCT03129100|40272650|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491716|NCT03129100|40272651|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491717|NCT03129100|40272652|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491718|NCT03129100|40272653|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491719|NCT03129100|40272654|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16193379|NCT03622593|39185318|FG000|Overall Study|Physician Decision|2|||
16193380|NCT03622593|39185319|FG001|Overall Study|Physician Decision|1|||
16303299|NCT03016975|39597837|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
16303300|NCT03016975|39597838|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
16303301|NCT03016975|39597839|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
16303302|NCT03016975|39597837|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
16303303|NCT03016975|39597838|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
16303304|NCT03016975|39597839|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
16303305|NCT03016975|39597837|FG000|At 6 Months Follow-up|Aborted implant|1|||
16303306|NCT03016975|39597838|FG001|At 6 Months Follow-up|Aborted implant|0|||
16491720|NCT03129100|40272655|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
16491721|NCT03129100|40272656|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491722|NCT03129100|40272657|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
16491723|NCT03129100|40272658|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
16491724|NCT03129100|40272659|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491725|NCT03129100|40272660|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491726|NCT03129100|40272661|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491727|NCT03129100|40272662|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491728|NCT03129100|40272663|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491729|NCT03129100|40272664|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491730|NCT03129100|40272665|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491731|NCT03129100|40272666|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16303307|NCT03016975|39597839|FG002|At 6 Months Follow-up|Aborted implant|0|||
16303308|NCT03016975|39597837|FG000|At 2 Year Follow-up|Death|1|||
16491732|NCT03129100|40272667|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491733|NCT03129100|40272668|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491734|NCT03129100|40272669|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
16491735|NCT03129100|40272644|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491736|NCT03129100|40272645|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491737|NCT03129100|40272646|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491738|NCT03129100|40272647|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491739|NCT03129100|40272648|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491740|NCT03129100|40272649|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491741|NCT03129100|40272650|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491742|NCT03129100|40272651|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491743|NCT03129100|40272652|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491744|NCT03129100|40272653|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491745|NCT03129100|40272654|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491746|NCT03129100|40272655|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491747|NCT03129100|40272656|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491748|NCT03129100|40272657|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491749|NCT03129100|40272658|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491750|NCT03129100|40272659|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
16491751|NCT03129100|40272660|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491752|NCT03129100|40272661|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491753|NCT03129100|40272662|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491754|NCT03129100|40272663|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491755|NCT03129100|40272664|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491756|NCT03129100|40272665|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491757|NCT03129100|40272666|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491758|NCT03129100|40272667|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491759|NCT03129100|40272668|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491760|NCT03129100|40272669|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
16491761|NCT03129100|40272644|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491762|NCT03129100|40272645|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491763|NCT03129100|40272646|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491764|NCT03129100|40272647|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491765|NCT03129100|40272648|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491766|NCT03129100|40272649|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491767|NCT03129100|40272650|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16193381|NCT03622593|39185320|FG002|Overall Study|Physician Decision|6|||
16303309|NCT03016975|39597838|FG001|At 2 Year Follow-up|Death|0|||
16303310|NCT03016975|39597839|FG002|At 2 Year Follow-up|Death|0|||
16303311|NCT03016975|39597837|FG000|At 3 Year Follow-up|Death|1|||
16303312|NCT03016975|39597838|FG001|At 3 Year Follow-up|Death|0|||
16491768|NCT03129100|40272651|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491769|NCT03129100|40272652|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491770|NCT03129100|40272653|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491771|NCT03129100|40272654|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491772|NCT03129100|40272655|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491773|NCT03129100|40272656|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
16491774|NCT03129100|40272657|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16303313|NCT03016975|39597839|FG002|At 3 Year Follow-up|Death|0|||
16303314|NCT03016975|39597837|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
16491775|NCT03129100|40272658|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
16491776|NCT03129100|40272659|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
16491777|NCT03129100|40272660|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491778|NCT03129100|40272661|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491779|NCT03129100|40272662|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491780|NCT03129100|40272663|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491781|NCT03129100|40272664|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491782|NCT03129100|40272665|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491783|NCT03129100|40272666|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491784|NCT03129100|40272667|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491785|NCT03129100|40272668|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491786|NCT03129100|40272669|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
16491787|NCT03129100|40272644|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491788|NCT03129100|40272645|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491789|NCT03129100|40272646|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491790|NCT03129100|40272647|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491791|NCT03129100|40272648|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491792|NCT03129100|40272649|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491793|NCT03129100|40272650|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491794|NCT03129100|40272651|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491795|NCT03129100|40272652|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491796|NCT03129100|40272653|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491797|NCT03129100|40272654|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491798|NCT03129100|40272655|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491799|NCT03129100|40272656|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491800|NCT03129100|40272657|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491801|NCT03129100|40272658|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491802|NCT03129100|40272659|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491803|NCT03129100|40272660|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491804|NCT03129100|40272661|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
16491805|NCT03129100|40272662|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491806|NCT03129100|40272663|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
16491807|NCT03129100|40272664|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491808|NCT03129100|40272665|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491809|NCT03129100|40272666|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491810|NCT03129100|40272667|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491811|NCT03129100|40272668|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491812|NCT03129100|40272669|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
16491813|NCT03129100|40272644|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491814|NCT03129100|40272645|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16083904|NCT03478969|38799241|FG000|Overall Study|Withdrawal by Subject|4|||
16083905|NCT03478969|38799242|FG001|Overall Study|Withdrawal by Subject|7|||
16491815|NCT03129100|40272646|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491816|NCT03129100|40272647|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491817|NCT03129100|40272648|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491818|NCT03129100|40272649|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491819|NCT03129100|40272650|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491820|NCT03129100|40272651|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491821|NCT03129100|40272652|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491822|NCT03129100|40272653|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491823|NCT03129100|40272654|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491824|NCT03129100|40272655|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491825|NCT03129100|40272656|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491826|NCT03129100|40272657|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491827|NCT03129100|40272658|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491828|NCT03129100|40272659|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491829|NCT03129100|40272660|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491830|NCT03129100|40272661|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491831|NCT03129100|40272662|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491832|NCT03129100|40272663|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491833|NCT03129100|40272664|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
16491834|NCT03129100|40272665|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491835|NCT03129100|40272666|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491836|NCT03129100|40272667|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491837|NCT03129100|40272668|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491838|NCT03129100|40272669|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
16491839|NCT03129100|40272644|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
16491840|NCT03129100|40272645|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
16491841|NCT03129100|40272646|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
16491842|NCT03129100|40272647|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
16491843|NCT03129100|40272648|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
16491844|NCT03129100|40272649|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
16491845|NCT03129100|40272650|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
16491846|NCT03129100|40272651|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
16491847|NCT03129100|40272652|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
16491848|NCT03129100|40272653|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
16491849|NCT03129100|40272654|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
16491850|NCT03129100|40272655|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
16491851|NCT03129100|40272656|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
16491852|NCT03129100|40272657|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
16491853|NCT03129100|40272658|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
16491854|NCT03129100|40272659|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
16491855|NCT03129100|40272660|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
16491856|NCT03129100|40272661|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
16491857|NCT03129100|40272662|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
16491858|NCT03129100|40272663|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
16491859|NCT03129100|40272664|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
16491860|NCT03129100|40272665|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
16491861|NCT03129100|40272666|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
16491862|NCT03129100|40272667|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
16491863|NCT03129100|40272668|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
16491864|NCT03129100|40272669|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
16491865|NCT03129100|40272644|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491866|NCT03129100|40272645|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491867|NCT03129100|40272646|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491868|NCT03129100|40272647|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491869|NCT03129100|40272648|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491870|NCT03129100|40272649|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491871|NCT03129100|40272650|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491872|NCT03129100|40272651|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491873|NCT03129100|40272652|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491874|NCT03129100|40272653|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491875|NCT03129100|40272654|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491876|NCT03129100|40272655|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491877|NCT03129100|40272656|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491878|NCT03129100|40272657|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491879|NCT03129100|40272658|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491880|NCT03129100|40272659|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491881|NCT03129100|40272660|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491882|NCT03129100|40272661|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491883|NCT03129100|40272662|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491884|NCT03129100|40272663|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491885|NCT03129100|40272664|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
16491886|NCT03129100|40272665|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491887|NCT03129100|40272666|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491888|NCT03129100|40272667|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491889|NCT03129100|40272668|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491890|NCT03129100|40272669|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
16491891|NCT03129100|40272644|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
16491892|NCT03129100|40272645|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
16491893|NCT03129100|40272646|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
16491894|NCT03129100|40272647|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
16491895|NCT03129100|40272648|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
16491896|NCT03129100|40272649|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
16491897|NCT03129100|40272650|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
16491898|NCT03129100|40272651|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
16491899|NCT03129100|40272652|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
16491900|NCT03129100|40272653|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
16491901|NCT03129100|40272654|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
16491902|NCT03129100|40272655|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
16491903|NCT03129100|40272656|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
16491904|NCT03129100|40272657|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
16491905|NCT03129100|40272658|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
16491906|NCT03129100|40272659|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
16491907|NCT03129100|40272660|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
16491908|NCT03129100|40272661|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
16491909|NCT03129100|40272662|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
16193382|NCT03622593|39185318|FG000|Overall Study|Other|2|||
16491910|NCT03129100|40272663|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
16491911|NCT03129100|40272664|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
16491912|NCT03129100|40272665|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
16491913|NCT03129100|40272666|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
16491914|NCT03129100|40272667|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
16491915|NCT03129100|40272668|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
16491916|NCT03129100|40272669|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
16491917|NCT03129100|40272644|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491918|NCT03129100|40272645|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491919|NCT03129100|40272646|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491920|NCT03129100|40272647|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491921|NCT03129100|40272648|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491922|NCT03129100|40272649|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491923|NCT03129100|40272650|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491924|NCT03129100|40272651|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491925|NCT03129100|40272652|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491926|NCT03129100|40272653|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491927|NCT03129100|40272654|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491928|NCT03129100|40272655|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491929|NCT03129100|40272656|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491930|NCT03129100|40272657|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491931|NCT03129100|40272658|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491932|NCT03129100|40272659|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491933|NCT03129100|40272660|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491934|NCT03129100|40272661|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491935|NCT03129100|40272662|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491936|NCT03129100|40272663|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491937|NCT03129100|40272664|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491938|NCT03129100|40272665|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491939|NCT03129100|40272666|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491940|NCT03129100|40272667|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
16491941|NCT03129100|40272668|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
16491942|NCT03129100|40272669|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
16491943|NCT03129100|40272644|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491944|NCT03129100|40272645|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491945|NCT03129100|40272646|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491946|NCT03129100|40272647|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491947|NCT03129100|40272648|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491948|NCT03129100|40272649|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491949|NCT03129100|40272650|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491950|NCT03129100|40272651|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491951|NCT03129100|40272652|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491952|NCT03129100|40272653|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491953|NCT03129100|40272654|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491954|NCT03129100|40272655|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491955|NCT03129100|40272656|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491956|NCT03129100|40272657|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491957|NCT03129100|40272658|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491958|NCT03129100|40272659|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491959|NCT03129100|40272660|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491960|NCT03129100|40272661|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491961|NCT03129100|40272662|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491962|NCT03129100|40272663|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491963|NCT03129100|40272664|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491964|NCT03129100|40272665|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491965|NCT03129100|40272666|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
16491966|NCT03129100|40272667|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
16491967|NCT03129100|40272668|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
16491968|NCT03129100|40272669|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
16491969|NCT03129100|40272644|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491970|NCT03129100|40272645|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491971|NCT03129100|40272646|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491972|NCT03129100|40272647|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491973|NCT03129100|40272648|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491974|NCT03129100|40272649|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491975|NCT03129100|40272650|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491976|NCT03129100|40272651|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491977|NCT03129100|40272652|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491978|NCT03129100|40272653|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16303315|NCT03016975|39597838|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
16303316|NCT03016975|39597839|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
16303317|NCT03016975|39597837|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
16303318|NCT03016975|39597838|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
16303319|NCT03016975|39597839|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
16303320|NCT01514461|39597840|FG000|Overall Study|Adverse Event|2|||
16491979|NCT03129100|40272654|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491980|NCT03129100|40272655|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491981|NCT03129100|40272656|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491982|NCT03129100|40272657|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491983|NCT03129100|40272658|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491984|NCT03129100|40272659|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16303321|NCT01514461|39597841|FG001|Overall Study|Adverse Event|1|||
16303322|NCT01514461|39597842|FG002|Overall Study|Adverse Event|3|||
16303323|NCT01514461|39597840|FG000|Overall Study|Physician Decision|1|||
16303324|NCT01514461|39597841|FG001|Overall Study|Physician Decision|1|||
16303325|NCT01514461|39597842|FG002|Overall Study|Physician Decision|0|||
16303326|NCT01514461|39597840|FG000|Overall Study|Patient/guardian decision|1|||
16303327|NCT01514461|39597841|FG001|Overall Study|Patient/guardian decision|1|||
16491985|NCT03129100|40272660|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491986|NCT03129100|40272661|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491987|NCT03129100|40272662|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491988|NCT03129100|40272663|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491989|NCT03129100|40272664|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491990|NCT03129100|40272665|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491991|NCT03129100|40272666|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491992|NCT03129100|40272667|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491993|NCT03129100|40272668|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
16491994|NCT03129100|40272669|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
16491995|NCT03129100|40272644|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16491996|NCT03129100|40272645|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16491997|NCT03129100|40272646|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16491998|NCT03129100|40272647|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16491999|NCT03129100|40272648|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492000|NCT03129100|40272649|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492001|NCT03129100|40272650|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492002|NCT03129100|40272651|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492003|NCT03129100|40272652|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492004|NCT03129100|40272653|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492005|NCT03129100|40272654|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492006|NCT03129100|40272655|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492007|NCT03129100|40272656|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492008|NCT03129100|40272657|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492009|NCT03129100|40272658|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492010|NCT03129100|40272659|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492011|NCT03129100|40272660|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492012|NCT03129100|40272661|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492013|NCT03129100|40272662|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492014|NCT03129100|40272663|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492015|NCT03129100|40272664|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492016|NCT03129100|40272665|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492017|NCT03129100|40272666|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492018|NCT03129100|40272667|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492019|NCT03129100|40272668|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
16492020|NCT03129100|40272669|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
16492021|NCT03129100|40272644|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
16492022|NCT03129100|40272645|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
16492023|NCT03129100|40272646|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
16492024|NCT03129100|40272647|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
16492025|NCT03129100|40272648|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
16492026|NCT03129100|40272649|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
16492027|NCT03129100|40272650|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
16492028|NCT03129100|40272651|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
16492029|NCT03129100|40272652|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
16492030|NCT03129100|40272653|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
16492031|NCT03129100|40272654|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
16083906|NCT03478969|38799243|FG002|Overall Study|Withdrawal by Subject|6|||
16083907|NCT03478969|38799241|FG000|Overall Study|Adverse Event|2|||
16083908|NCT03478969|38799242|FG001|Overall Study|Adverse Event|0|||
16083909|NCT03478969|38799243|FG002|Overall Study|Adverse Event|1|||
16083910|NCT03478969|38799241|FG000|Overall Study|Pregnancy|1|||
16083911|NCT03478969|38799242|FG001|Overall Study|Pregnancy|0|||
16083912|NCT03478969|38799243|FG002|Overall Study|Pregnancy|0|||
16083913|NCT03478969|38799241|FG000|Overall Study|Personal Reasons|1|||
16083914|NCT03478969|38799242|FG001|Overall Study|Personal Reasons|0|||
16083915|NCT03478969|38799243|FG002|Overall Study|Personal Reasons|1|||
16083916|NCT03478969|38799241|FG000|Overall Study|Covid-19|1|||
16083917|NCT03478969|38799242|FG001|Overall Study|Covid-19|4|||
16083918|NCT03478969|38799243|FG002|Overall Study|Covid-19|3|||
16083919|NCT03478969|38799241|FG000|Overall Study|Multiple Reasons|0|||
16083920|NCT03478969|38799242|FG001|Overall Study|Multiple Reasons|1|||
16083921|NCT03478969|38799243|FG002|Overall Study|Multiple Reasons|1|||
16083922|NCT03478969|38799241|FG000|Overall Study|Eligibility Criteria|0|||
16083923|NCT03478969|38799242|FG001|Overall Study|Eligibility Criteria|0|||
16083924|NCT03478969|38799243|FG002|Overall Study|Eligibility Criteria|5|||
16083925|NCT03478969|38799241|FG000|Overall Study|Lost to Follow-up|0|||
16083926|NCT03478969|38799242|FG001|Overall Study|Lost to Follow-up|0|||
16083927|NCT03478969|38799243|FG002|Overall Study|Lost to Follow-up|1|||
16083928|NCT03801148|38799245|FG000|Period 1 (2 Days)|Adverse Event|1|||
16083929|NCT03801148|38799246|FG001|Period 1 (2 Days)|Adverse Event|1|||
16083930|NCT03801148|38799247|FG002|Period 1 (2 Days)|Adverse Event|0|||
16083931|NCT03801148|38799248|FG003|Period 1 (2 Days)|Adverse Event|0|||
16083932|NCT03801148|38799245|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
16083933|NCT03801148|38799246|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
16083934|NCT03801148|38799247|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
16083935|NCT03801148|38799248|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
16083936|NCT03801148|38799245|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16083937|NCT03801148|38799246|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16083938|NCT03801148|38799247|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
16083939|NCT03801148|38799248|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16083940|NCT03801148|38799245|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
16083941|NCT03801148|38799246|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
16083942|NCT03801148|38799247|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
16083943|NCT03801148|38799248|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
16083944|NCT02161146|38799249|FG000|Overall Study|Adverse Event|1|||
16083945|NCT02161146|38799250|FG001|Overall Study|Adverse Event|1|||
16083946|NCT02161146|38799251|FG002|Overall Study|Adverse Event|0|||
16083947|NCT02161146|38799252|FG003|Overall Study|Adverse Event|1|||
16083948|NCT02161146|38799253|FG004|Overall Study|Adverse Event|0|||
16083949|NCT02161146|38799249|FG000|Overall Study|Lost to Follow-up|0|||
16083950|NCT02161146|38799250|FG001|Overall Study|Lost to Follow-up|1|||
16083951|NCT02161146|38799251|FG002|Overall Study|Lost to Follow-up|0|||
16083952|NCT02161146|38799252|FG003|Overall Study|Lost to Follow-up|0|||
16083953|NCT02161146|38799253|FG004|Overall Study|Lost to Follow-up|0|||
16083954|NCT02161146|38799249|FG000|Overall Study|Personal Reasons|0|||
16083955|NCT02161146|38799250|FG001|Overall Study|Personal Reasons|1|||
16083956|NCT02161146|38799251|FG002|Overall Study|Personal Reasons|0|||
16083957|NCT02161146|38799252|FG003|Overall Study|Personal Reasons|2|||
16193383|NCT03622593|39185319|FG001|Overall Study|Other|2|||
16492032|NCT03129100|40272655|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
16492033|NCT03129100|40272656|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
16492034|NCT03129100|40272657|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
16492035|NCT03129100|40272658|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
16083958|NCT02161146|38799253|FG004|Overall Study|Personal Reasons|1|||
16083959|NCT02161146|38799249|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16083960|NCT02161146|38799250|FG001|Overall Study|Other Miscellaneous Reasons|1|||
16083961|NCT02161146|38799251|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16083962|NCT02161146|38799252|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16083963|NCT02161146|38799253|FG004|Overall Study|Other Miscellaneous Reasons|0|||
16083964|NCT00093015|38799254|FG000|Overall Study|Withdrawal by Subject|194|||
16083965|NCT00093015|38799255|FG001|Overall Study|Withdrawal by Subject|171|||
16083966|NCT00093015|38799254|FG000|Overall Study|Lost to Follow-up|96|||
16193384|NCT03622593|39185320|FG002|Overall Study|Other|3|||
16083967|NCT00093015|38799255|FG001|Overall Study|Lost to Follow-up|108|||
16083968|NCT00093015|38799254|FG000|Overall Study|Death|375|||
16083969|NCT00093015|38799255|FG001|Overall Study|Death|385|||
16083970|NCT04121546|38799258|FG000|Overall Study|Lost to Follow-up|1|||
16083971|NCT04121546|38799259|FG001|Overall Study|Lost to Follow-up|3|||
16083972|NCT02222493|38799260|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
16083973|NCT02222493|38799261|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
16193385|NCT03622593|39185318|FG000|Overall Study|Protocol Violation|0|||
16193386|NCT03622593|39185319|FG001|Overall Study|Protocol Violation|0|||
16303328|NCT01514461|39597842|FG002|Overall Study|Patient/guardian decision|1|||
16303329|NCT01514461|39597840|FG000|Overall Study|Death|1|||
16303330|NCT01514461|39597841|FG001|Overall Study|Death|0|||
16303331|NCT01514461|39597842|FG002|Overall Study|Death|0|||
16303332|NCT03280381|39597844|FG000|Overall Study|Physician Decision|0|||
16303333|NCT03280381|39597845|FG001|Overall Study|Physician Decision|2|||
16303334|NCT00398866|39597846|FG000|Overall Study|Adverse Event|1|||
16303335|NCT00398866|39597847|FG001|Overall Study|Adverse Event|0|||
16303336|NCT00398866|39597848|FG002|Overall Study|Adverse Event|0|||
16303337|NCT00398866|39597846|FG000|Overall Study|Lack of Efficacy|0|||
16303338|NCT00398866|39597847|FG001|Overall Study|Lack of Efficacy|0|||
16303339|NCT00398866|39597848|FG002|Overall Study|Lack of Efficacy|1|||
16303340|NCT00398866|39597846|FG000|Overall Study|Lost to Follow-up|7|||
16303341|NCT00398866|39597847|FG001|Overall Study|Lost to Follow-up|6|||
16303342|NCT00398866|39597848|FG002|Overall Study|Lost to Follow-up|4|||
16303343|NCT00398866|39597846|FG000|Overall Study|Withdrawal by Subject|5|||
16303344|NCT00398866|39597847|FG001|Overall Study|Withdrawal by Subject|1|||
16303345|NCT00398866|39597848|FG002|Overall Study|Withdrawal by Subject|2|||
16303346|NCT00398866|39597846|FG000|Overall Study|Unable to complete requirements of study|1|||
16303347|NCT00398866|39597847|FG001|Overall Study|Unable to complete requirements of study|1|||
16303348|NCT00398866|39597848|FG002|Overall Study|Unable to complete requirements of study|1|||
16303349|NCT02536846|39597849|FG000|Overall Study|Withdrawal by Subject|1|||
16303350|NCT03247816|39597850|FG000|Overall Study|Adverse Event|12|||
16303351|NCT03247816|39597850|FG000|Overall Study|Physician Decision|3|||
16303352|NCT03247816|39597850|FG000|Overall Study|Lack of Efficacy|1|||
16303353|NCT03247816|39597850|FG000|Overall Study|Lost to Follow-up|10|||
16303354|NCT03247816|39597850|FG000|Overall Study|Missing Feraccru stop date|3|||
16303355|NCT00696787|39597852|FG000|Overall Study|Adverse Event|1|||
16303356|NCT00696787|39597853|FG001|Overall Study|Adverse Event|0|||
16303357|NCT00696787|39597854|FG002|Overall Study|Adverse Event|6|||
16303358|NCT00696787|39597852|FG000|Overall Study|Discontinuation by Sponsor|9|||
16303359|NCT00696787|39597853|FG001|Overall Study|Discontinuation by Sponsor|13|||
16303360|NCT00696787|39597854|FG002|Overall Study|Discontinuation by Sponsor|14|||
16303361|NCT00696787|39597852|FG000|Overall Study|Lack of Efficacy|0|||
16303362|NCT00696787|39597853|FG001|Overall Study|Lack of Efficacy|1|||
16303363|NCT00696787|39597854|FG002|Overall Study|Lack of Efficacy|0|||
16303364|NCT00696787|39597852|FG000|Overall Study|Lost to Follow-up|4|||
16303365|NCT00696787|39597853|FG001|Overall Study|Lost to Follow-up|0|||
16303366|NCT00696787|39597854|FG002|Overall Study|Lost to Follow-up|3|||
16303367|NCT00696787|39597852|FG000|Overall Study|Withdrawal by Subject|0|||
16303368|NCT00696787|39597853|FG001|Overall Study|Withdrawal by Subject|3|||
16303369|NCT00696787|39597854|FG002|Overall Study|Withdrawal by Subject|2|||
16303370|NCT00696787|39597852|FG000|Overall Study|Failed to return|1|||
16303371|NCT00696787|39597853|FG001|Overall Study|Failed to return|3|||
16303372|NCT00696787|39597854|FG002|Overall Study|Failed to return|1|||
16303373|NCT00796757|39597858|FG000|Overall Study|Withdrawal by Subject|14|||
16303374|NCT00796757|39597858|FG000|Overall Study|Death|61|||
16303375|NCT00796757|39597858|FG000|Overall Study|Protocol Violation|1|||
16303376|NCT00796757|39597858|FG000|Overall Study|Participant noncompliance|1|||
16303377|NCT00796757|39597858|FG000|Overall Study|Investigator's decision|2|||
16303378|NCT00796757|39597858|FG000|Overall Study|Other|7|||
16303379|NCT01118975|39597861|FG000|Overall Study|Adverse Event|0|||
16303380|NCT01118975|39597862|FG001|Overall Study|Adverse Event|1|||
16303381|NCT00396812|39597865|FG000|Overall Study|Physician Decision|1|||
16303382|NCT02245412|39597866|FG000|Treatment Period|Death|1|||
16303383|NCT02245412|39597867|FG001|Treatment Period|Death|1|||
16303384|NCT02245412|39597868|FG002|Treatment Period|Death|0|||
16303385|NCT02245412|39597866|FG000|Treatment Period|Physician Decision|1|||
16303386|NCT02245412|39597867|FG001|Treatment Period|Physician Decision|1|||
16303387|NCT02245412|39597868|FG002|Treatment Period|Physician Decision|0|||
16083974|NCT02222493|38799260|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
16193387|NCT03622593|39185320|FG002|Overall Study|Protocol Violation|1|||
16303388|NCT02245412|39597866|FG000|Treatment Period|Withdrawal by Subject|2|||
16303389|NCT02245412|39597867|FG001|Treatment Period|Withdrawal by Subject|1|||
16303390|NCT02245412|39597868|FG002|Treatment Period|Withdrawal by Subject|0|||
16303391|NCT02245412|39597866|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
16303392|NCT02245412|39597867|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
16303393|NCT02245412|39597868|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
16193388|NCT03622593|39185318|FG000|Overall Study|Pregnancy|0|||
16303394|NCT02245412|39597866|FG000|Follow-Up Period|Death|4|||
16303395|NCT02245412|39597867|FG001|Follow-Up Period|Death|2|||
16303396|NCT02245412|39597868|FG002|Follow-Up Period|Death|1|||
16303397|NCT02245412|39597866|FG000|Follow-Up Period|Physician Decision|1|||
16303398|NCT02245412|39597867|FG001|Follow-Up Period|Physician Decision|0|||
16303399|NCT02245412|39597868|FG002|Follow-Up Period|Physician Decision|0|||
16303400|NCT02245412|39597866|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
16303401|NCT02245412|39597867|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
16303402|NCT02245412|39597868|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
16303403|NCT04102189|39597869|FG000|Overall Study|Withdrawal by Subject|1|||
16303404|NCT04102189|39597870|FG001|Overall Study|Withdrawal by Subject|2|||
16303405|NCT04102189|39597869|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16303406|NCT04102189|39597870|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16303407|NCT04102189|39597869|FG000|Overall Study|Lost to Follow-up|1|||
16303408|NCT04102189|39597870|FG001|Overall Study|Lost to Follow-up|0|||
16303409|NCT00761657|39597871|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
16303410|NCT00761657|39597872|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
16303411|NCT00761657|39597873|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
16303412|NCT00761657|39597874|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
16303413|NCT00761657|39597875|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
16303414|NCT00761657|39597876|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
16303415|NCT00761657|39597877|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
16303416|NCT00761657|39597878|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
16303417|NCT00761657|39597879|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
16303418|NCT00761657|39597871|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
16303419|NCT00761657|39597872|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
16303420|NCT00761657|39597873|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
16303421|NCT00761657|39597874|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
16303422|NCT00761657|39597875|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
16303423|NCT00761657|39597876|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
16303424|NCT00761657|39597877|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
16303425|NCT00761657|39597878|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
16303426|NCT00761657|39597879|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
16193389|NCT03622593|39185319|FG001|Overall Study|Pregnancy|0|||
16193390|NCT03622593|39185320|FG002|Overall Study|Pregnancy|1|||
16193391|NCT00683475|39185321|FG000|Overall Study|Withdrawal by Subject|1|||
16193392|NCT00683475|39185322|FG001|Overall Study|Withdrawal by Subject|0|||
16303427|NCT00761657|39597871|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
16303428|NCT00761657|39597872|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
16303429|NCT00761657|39597873|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
16303430|NCT00761657|39597874|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
16303431|NCT00761657|39597875|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
16303432|NCT00761657|39597876|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
16303433|NCT00761657|39597877|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
16303434|NCT00761657|39597878|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
16303435|NCT00761657|39597879|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
16303436|NCT00761657|39597871|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
16303437|NCT00761657|39597872|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
16303438|NCT00761657|39597873|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
16303439|NCT00761657|39597874|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
16303440|NCT00761657|39597875|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
16303441|NCT00761657|39597876|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
16303442|NCT00761657|39597877|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
16492036|NCT03129100|40272659|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
16492037|NCT03129100|40272660|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
16492038|NCT03129100|40272661|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
16492039|NCT03129100|40272662|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
16492040|NCT03129100|40272663|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
16492041|NCT03129100|40272664|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
16492042|NCT03129100|40272665|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
16492043|NCT03129100|40272666|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
16492044|NCT03129100|40272667|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
16492045|NCT03129100|40272668|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
16492046|NCT03129100|40272669|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
16492047|NCT00543140|40272670|FG000|Overall Study|Lost to Follow-up|33|||
16492048|NCT00543140|40272670|FG000|Overall Study|Withdrawal by Subject|13|||
16492049|NCT00543140|40272670|FG000|Overall Study|Protocol Violation|10|||
16303443|NCT00761657|39597878|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
16303444|NCT00761657|39597879|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
16303445|NCT00362336|39597882|FG000|Overall Study|Serious Adverse Event|1|||
16303446|NCT00362336|39597883|FG001|Overall Study|Serious Adverse Event|0|||
16303447|NCT00362336|39597884|FG002|Overall Study|Serious Adverse Event|1|||
16303448|NCT00362336|39597882|FG000|Overall Study|Protocol Violation|0|||
16303449|NCT00362336|39597883|FG001|Overall Study|Protocol Violation|0|||
16193393|NCT00683475|39185321|FG000|Overall Study|Never Treated: Adverse Event|2|||
16492050|NCT00543140|40272670|FG000|Overall Study|Insufficient weight loss|10|||
16492051|NCT00543140|40272670|FG000|Overall Study|SAE leading to explant of SAGB|3|||
16492052|NCT00543140|40272670|FG000|Overall Study|Death|1|||
16303450|NCT00362336|39597884|FG002|Overall Study|Protocol Violation|1|||
16303451|NCT00362336|39597882|FG000|Overall Study|Lost to Follow-up|6|||
16303452|NCT00362336|39597883|FG001|Overall Study|Lost to Follow-up|4|||
16303453|NCT00362336|39597884|FG002|Overall Study|Lost to Follow-up|0|||
16303454|NCT00362336|39597882|FG000|Overall Study|Withdrawal by Subject|3|||
16303455|NCT00362336|39597883|FG001|Overall Study|Withdrawal by Subject|3|||
16303456|NCT00362336|39597884|FG002|Overall Study|Withdrawal by Subject|1|||
16303457|NCT00739063|39597885|FG000|Overall Study|Screen failures|8|||
16303458|NCT03629184|39597886|FG000|Overall Study|Withdrawal by Subject|2|||
16303459|NCT03629184|39597887|FG001|Overall Study|Withdrawal by Subject|1|||
16303460|NCT03629184|39597886|FG000|Overall Study|Physician Decision|1|||
16303461|NCT03629184|39597887|FG001|Overall Study|Physician Decision|0|||
16303462|NCT04043455|39597888|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
16303463|NCT04043455|39597889|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
16303464|NCT04043455|39597890|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
16303465|NCT04043455|39597891|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
16303466|NCT04043455|39597892|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
16303467|NCT04043455|39597893|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
16303468|NCT04043455|39597888|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
16303469|NCT04043455|39597889|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
16303470|NCT04043455|39597890|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
16303471|NCT04043455|39597891|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
16303472|NCT04043455|39597892|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
16303473|NCT04043455|39597893|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
16303474|NCT04043455|39597888|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
16303475|NCT04043455|39597889|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
16303476|NCT04043455|39597890|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
16303477|NCT04043455|39597891|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
16303478|NCT04043455|39597892|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
16303479|NCT04043455|39597893|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
16303480|NCT04043455|39597888|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
16303481|NCT04043455|39597889|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
16303482|NCT04043455|39597890|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
16492053|NCT00543140|40272670|FG000|Overall Study|Subject moved|1|||
16492054|NCT00543140|40272670|FG000|Overall Study|Conversion to different procedure|1|||
16492055|NCT05255068|40272676|FG000|Overall Study|Lost to Follow-up|0|||
16492056|NCT05255068|40272677|FG001|Overall Study|Lost to Follow-up|1|||
16492057|NCT01928394|40272680|FG000|Treatment Period|Disease progression|17|||
16492058|NCT01928394|40272681|FG001|Treatment Period|Disease progression|2|||
16492059|NCT01928394|40272682|FG002|Treatment Period|Disease progression|12|||
16492060|NCT01928394|40272683|FG003|Treatment Period|Disease progression|48|||
16492061|NCT01928394|40272684|FG004|Treatment Period|Disease progression|3|||
16492062|NCT01928394|40272685|FG005|Treatment Period|Disease progression|25|||
16492063|NCT01928394|40272686|FG006|Treatment Period|Disease progression|38|||
16492064|NCT01928394|40272687|FG007|Treatment Period|Disease progression|16|||
16492065|NCT01928394|40272688|FG008|Treatment Period|Disease progression|3|||
16492066|NCT01928394|40272689|FG009|Treatment Period|Disease progression|11|||
16492067|NCT01928394|40272690|FG010|Treatment Period|Disease progression|22|||
16492068|NCT01928394|40272691|FG011|Treatment Period|Disease progression|73|||
16492069|NCT01928394|40272692|FG012|Treatment Period|Disease progression|38|||
16492070|NCT01928394|40272693|FG013|Treatment Period|Disease progression|118|||
16492071|NCT01928394|40272694|FG014|Treatment Period|Disease progression|59|||
16492072|NCT01928394|40272695|FG015|Treatment Period|Disease progression|1|||
16492073|NCT01928394|40272696|FG016|Treatment Period|Disease progression|43|||
16492074|NCT01928394|40272697|FG017|Treatment Period|Disease progression|56|||
16492075|NCT01928394|40272698|FG018|Treatment Period|Disease progression|50|||
16492076|NCT01928394|40272699|FG019|Treatment Period|Disease progression|71|||
16492077|NCT01928394|40272700|FG020|Treatment Period|Disease progression|30|||
16492078|NCT01928394|40272701|FG021|Treatment Period|Disease progression|31|||
16492079|NCT01928394|40272702|FG022|Treatment Period|Disease progression|31|||
16492080|NCT01928394|40272680|FG000|Treatment Period|Study drug toxicity|1|||
16492081|NCT01928394|40272681|FG001|Treatment Period|Study drug toxicity|1|||
16492082|NCT01928394|40272682|FG002|Treatment Period|Study drug toxicity|3|||
16492083|NCT01928394|40272683|FG003|Treatment Period|Study drug toxicity|3|||
16303483|NCT04043455|39597891|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
16303484|NCT04043455|39597892|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
16303485|NCT04043455|39597893|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
16303486|NCT04043455|39597888|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
16303487|NCT04043455|39597889|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
16303488|NCT04043455|39597890|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
16303489|NCT04043455|39597891|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
16303490|NCT04043455|39597892|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
16303491|NCT04043455|39597893|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
16303492|NCT04043455|39597888|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
16303493|NCT04043455|39597889|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
16303494|NCT04043455|39597890|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
16303495|NCT04043455|39597891|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
16303496|NCT04043455|39597892|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
16303497|NCT04043455|39597893|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
16303498|NCT04043455|39597888|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
16303499|NCT04043455|39597889|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
16303500|NCT04043455|39597890|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
16303501|NCT04043455|39597891|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
16303502|NCT04043455|39597892|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
16346321|NCT03201965|39753287|FG000|Overall Study|Withdrawal by Subject|3|||
16492084|NCT01928394|40272684|FG004|Treatment Period|Study drug toxicity|0|||
16492085|NCT01928394|40272685|FG005|Treatment Period|Study drug toxicity|9|||
16492086|NCT01928394|40272686|FG006|Treatment Period|Study drug toxicity|7|||
16492087|NCT01928394|40272687|FG007|Treatment Period|Study drug toxicity|1|||
16492088|NCT01928394|40272688|FG008|Treatment Period|Study drug toxicity|0|||
16193394|NCT00683475|39185322|FG001|Overall Study|Never Treated: Adverse Event|3|||
16193395|NCT00683475|39185321|FG000|Overall Study|Never Treated: Progressive Disease|1|||
16193396|NCT00683475|39185322|FG001|Overall Study|Never Treated: Progressive Disease|0|||
16193397|NCT02625324|39185327|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
16193398|NCT02625324|39185327|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
16193399|NCT02625324|39185327|FG000|6-Month Follow-up Subject Accountability|Death|5|||
16193400|NCT02625324|39185327|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
16193401|NCT02625324|39185327|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
16193402|NCT02625324|39185327|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
16193403|NCT02625324|39185327|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
16193404|NCT02625324|39185327|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
16193405|NCT02625324|39185327|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
16193406|NCT02625324|39185327|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
16193407|NCT02625324|39185327|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
16193408|NCT02625324|39185327|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
16193409|NCT02625324|39185327|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
16193410|NCT02625324|39185327|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
16193411|NCT02625324|39185327|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
16193412|NCT02625324|39185327|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
16193413|NCT02625324|39185327|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
16193414|NCT01725152|39185328|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
16193415|NCT01725152|39185329|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
16193416|NCT01725152|39185328|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
16193417|NCT01725152|39185329|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
16193418|NCT01725152|39185328|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
16193419|NCT01725152|39185329|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
16193420|NCT01725152|39185328|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
16193421|NCT01725152|39185329|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
16193422|NCT01005719|39185330|FG000|Period 1|Adverse Event|0|||
16193423|NCT01005719|39185331|FG001|Period 1|Adverse Event|0|||
16193424|NCT01005719|39185332|FG002|Period 1|Adverse Event|0|||
16193425|NCT01005719|39185333|FG003|Period 1|Adverse Event|1|||
16193426|NCT01005719|39185334|FG004|Period 1|Adverse Event|0|||
16193427|NCT01005719|39185335|FG005|Period 1|Adverse Event|0|||
16193428|NCT01005719|39185330|FG000|Period 1|Delay in completing study procedures|0|||
16193429|NCT01005719|39185331|FG001|Period 1|Delay in completing study procedures|0|||
16193430|NCT01005719|39185332|FG002|Period 1|Delay in completing study procedures|0|||
16193431|NCT01005719|39185333|FG003|Period 1|Delay in completing study procedures|0|||
16303503|NCT04043455|39597893|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
16303504|NCT04043455|39597888|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
16303505|NCT04043455|39597889|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
16303506|NCT04043455|39597890|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
16193432|NCT01005719|39185334|FG004|Period 1|Delay in completing study procedures|0|||
16193433|NCT01005719|39185335|FG005|Period 1|Delay in completing study procedures|1|||
16193434|NCT01005719|39185330|FG000|Period 2|Adverse Event|0|||
16303507|NCT04043455|39597891|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
16303508|NCT04043455|39597892|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
16303509|NCT04043455|39597893|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
16303510|NCT04043455|39597888|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
16303511|NCT04043455|39597889|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
16303512|NCT04043455|39597890|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
16303513|NCT04043455|39597891|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
16303514|NCT04043455|39597892|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
16303515|NCT04043455|39597893|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
16303516|NCT04043455|39597888|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
16303517|NCT04043455|39597889|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
16303518|NCT04043455|39597890|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
16303519|NCT04043455|39597891|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
16303520|NCT04043455|39597892|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
16303521|NCT04043455|39597893|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
16303522|NCT04043455|39597888|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
16303523|NCT04043455|39597889|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
16303524|NCT04043455|39597890|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
16303525|NCT04043455|39597891|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
16303526|NCT04043455|39597892|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
16303527|NCT04043455|39597893|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
16303528|NCT03092219|39597894|FG000|Overall Study|Protocol Violation|7|||
16303529|NCT03092219|39597895|FG001|Overall Study|Protocol Violation|4|||
16303530|NCT02015065|39597896|FG000|Overall Study|Death on study|1|||
16303531|NCT02015065|39597897|FG001|Overall Study|Death on study|2|||
16303532|NCT02015065|39597898|FG002|Overall Study|Death on study|1|||
16303533|NCT00524420|39597912|FG000|Overall Study|Lack of Efficacy|1|||
16303534|NCT00524420|39597913|FG001|Overall Study|Lack of Efficacy|0|||
16303535|NCT01439802|39597916|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
16303536|NCT01439802|39597916|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
16303537|NCT01762800|39597917|FG000|Overall Study|Adverse Event|8|||
16303538|NCT01762800|39597918|FG001|Overall Study|Adverse Event|13|||
16303539|NCT01762800|39597917|FG000|Overall Study|Lack of Efficacy|3|||
16303540|NCT01762800|39597918|FG001|Overall Study|Lack of Efficacy|2|||
16303541|NCT01762800|39597917|FG000|Overall Study|Study Closed/Terminated|0|||
16303542|NCT01762800|39597918|FG001|Overall Study|Study Closed/Terminated|1|||
16303543|NCT01762800|39597917|FG000|Overall Study|Physician Decision|1|||
16303544|NCT01762800|39597918|FG001|Overall Study|Physician Decision|1|||
16303545|NCT01762800|39597917|FG000|Overall Study|Withdrawal by Subject|7|||
16303546|NCT01762800|39597918|FG001|Overall Study|Withdrawal by Subject|4|||
16303547|NCT03328143|39597923|FG000|Overall Study|Declined|3|||
16303548|NCT03328143|39597923|FG000|Overall Study|Required increased sedation|4|||
16303549|NCT03328143|39597923|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
16303550|NCT03328143|39597923|FG000|Overall Study|Surgery cancelled|1|||
16303551|NCT00587860|39597924|FG000|Overall Study|Lost to Follow-up|2|||
16303552|NCT00587860|39597925|FG001|Overall Study|Lost to Follow-up|2|||
16303553|NCT00587860|39597924|FG000|Overall Study|Withdrawal by Subject|3|||
16303554|NCT00587860|39597925|FG001|Overall Study|Withdrawal by Subject|3|||
16303555|NCT00993421|39597926|FG000|Overall Study|Adverse Event|2|||
16303556|NCT00993421|39597927|FG001|Overall Study|Adverse Event|7|||
16303557|NCT00993421|39597928|FG002|Overall Study|Adverse Event|6|||
16303558|NCT00993421|39597929|FG003|Overall Study|Adverse Event|9|||
16303559|NCT00993421|39597930|FG004|Overall Study|Adverse Event|5|||
16303560|NCT00993421|39597931|FG005|Overall Study|Adverse Event|7|||
16303561|NCT00993421|39597932|FG006|Overall Study|Adverse Event|1|||
16303562|NCT00993421|39597926|FG000|Overall Study|Sponsor Decision|36|||
16303563|NCT00993421|39597927|FG001|Overall Study|Sponsor Decision|31|||
16303564|NCT00993421|39597928|FG002|Overall Study|Sponsor Decision|28|||
16303565|NCT00993421|39597929|FG003|Overall Study|Sponsor Decision|30|||
16303566|NCT00993421|39597930|FG004|Overall Study|Sponsor Decision|38|||
16193435|NCT01005719|39185331|FG001|Period 2|Adverse Event|0|||
16193436|NCT01005719|39185332|FG002|Period 2|Adverse Event|0|||
16303567|NCT00993421|39597931|FG005|Overall Study|Sponsor Decision|30|||
16303568|NCT00993421|39597932|FG006|Overall Study|Sponsor Decision|29|||
16303569|NCT00993421|39597926|FG000|Overall Study|Lost to Follow-up|3|||
16303570|NCT00993421|39597927|FG001|Overall Study|Lost to Follow-up|5|||
16303571|NCT00993421|39597928|FG002|Overall Study|Lost to Follow-up|5|||
16303572|NCT00993421|39597929|FG003|Overall Study|Lost to Follow-up|0|||
16303573|NCT00993421|39597930|FG004|Overall Study|Lost to Follow-up|0|||
16303574|NCT00993421|39597931|FG005|Overall Study|Lost to Follow-up|0|||
16303575|NCT00993421|39597932|FG006|Overall Study|Lost to Follow-up|6|||
16492089|NCT01928394|40272689|FG009|Treatment Period|Study drug toxicity|5|||
16492090|NCT01928394|40272690|FG010|Treatment Period|Study drug toxicity|2|||
16492091|NCT01928394|40272691|FG011|Treatment Period|Study drug toxicity|3|||
16492092|NCT01928394|40272692|FG012|Treatment Period|Study drug toxicity|7|||
16492093|NCT01928394|40272693|FG013|Treatment Period|Study drug toxicity|5|||
16492094|NCT01928394|40272694|FG014|Treatment Period|Study drug toxicity|12|||
16492095|NCT01928394|40272695|FG015|Treatment Period|Study drug toxicity|0|||
16492096|NCT01928394|40272696|FG016|Treatment Period|Study drug toxicity|3|||
16492097|NCT01928394|40272697|FG017|Treatment Period|Study drug toxicity|3|||
16492098|NCT01928394|40272698|FG018|Treatment Period|Study drug toxicity|12|||
16492099|NCT01928394|40272699|FG019|Treatment Period|Study drug toxicity|15|||
16492100|NCT01928394|40272700|FG020|Treatment Period|Study drug toxicity|4|||
16492101|NCT01928394|40272701|FG021|Treatment Period|Study drug toxicity|7|||
16492102|NCT01928394|40272702|FG022|Treatment Period|Study drug toxicity|4|||
16492103|NCT01928394|40272680|FG000|Treatment Period|AE unrelated to study drug|0|||
16492104|NCT01928394|40272681|FG001|Treatment Period|AE unrelated to study drug|0|||
16492105|NCT01928394|40272682|FG002|Treatment Period|AE unrelated to study drug|2|||
16492106|NCT01928394|40272683|FG003|Treatment Period|AE unrelated to study drug|3|||
16492107|NCT01928394|40272684|FG004|Treatment Period|AE unrelated to study drug|0|||
16492108|NCT01928394|40272685|FG005|Treatment Period|AE unrelated to study drug|5|||
16492109|NCT01928394|40272686|FG006|Treatment Period|AE unrelated to study drug|1|||
16492110|NCT01928394|40272687|FG007|Treatment Period|AE unrelated to study drug|0|||
16492111|NCT01928394|40272688|FG008|Treatment Period|AE unrelated to study drug|0|||
16492112|NCT01928394|40272689|FG009|Treatment Period|AE unrelated to study drug|2|||
16492113|NCT01928394|40272690|FG010|Treatment Period|AE unrelated to study drug|0|||
16492114|NCT01928394|40272691|FG011|Treatment Period|AE unrelated to study drug|12|||
16492115|NCT01928394|40272692|FG012|Treatment Period|AE unrelated to study drug|6|||
16492116|NCT01928394|40272693|FG013|Treatment Period|AE unrelated to study drug|13|||
16492117|NCT01928394|40272694|FG014|Treatment Period|AE unrelated to study drug|6|||
16492118|NCT01928394|40272695|FG015|Treatment Period|AE unrelated to study drug|1|||
16492119|NCT01928394|40272696|FG016|Treatment Period|AE unrelated to study drug|1|||
16303576|NCT00993421|39597926|FG000|Overall Study|Withdrawal by Subject|3|||
16303577|NCT00993421|39597927|FG001|Overall Study|Withdrawal by Subject|2|||
16303578|NCT00993421|39597928|FG002|Overall Study|Withdrawal by Subject|3|||
16303579|NCT00993421|39597929|FG003|Overall Study|Withdrawal by Subject|3|||
16303580|NCT00993421|39597930|FG004|Overall Study|Withdrawal by Subject|3|||
16303581|NCT00993421|39597931|FG005|Overall Study|Withdrawal by Subject|5|||
16303582|NCT00993421|39597932|FG006|Overall Study|Withdrawal by Subject|3|||
16303583|NCT00993421|39597926|FG000|Overall Study|Death|0|||
16303584|NCT00993421|39597927|FG001|Overall Study|Death|0|||
16492120|NCT01928394|40272697|FG017|Treatment Period|AE unrelated to study drug|6|||
16492121|NCT01928394|40272698|FG018|Treatment Period|AE unrelated to study drug|3|||
16492122|NCT01928394|40272699|FG019|Treatment Period|AE unrelated to study drug|5|||
16303585|NCT00993421|39597928|FG002|Overall Study|Death|0|||
16303586|NCT00993421|39597929|FG003|Overall Study|Death|0|||
16303587|NCT00993421|39597930|FG004|Overall Study|Death|0|||
16303588|NCT00993421|39597931|FG005|Overall Study|Death|0|||
16303589|NCT00993421|39597932|FG006|Overall Study|Death|1|||
16303590|NCT00993421|39597926|FG000|Overall Study|Entry Criteria Exclusion|0|||
16303591|NCT00993421|39597927|FG001|Overall Study|Entry Criteria Exclusion|0|||
16303592|NCT00993421|39597928|FG002|Overall Study|Entry Criteria Exclusion|1|||
16303593|NCT00993421|39597929|FG003|Overall Study|Entry Criteria Exclusion|3|||
16303594|NCT00993421|39597930|FG004|Overall Study|Entry Criteria Exclusion|0|||
16303595|NCT00993421|39597931|FG005|Overall Study|Entry Criteria Exclusion|1|||
16303596|NCT00993421|39597932|FG006|Overall Study|Entry Criteria Exclusion|0|||
16303597|NCT00993421|39597926|FG000|Overall Study|Physician Decision|0|||
16492123|NCT01928394|40272700|FG020|Treatment Period|AE unrelated to study drug|1|||
16492124|NCT01928394|40272701|FG021|Treatment Period|AE unrelated to study drug|1|||
16492125|NCT01928394|40272702|FG022|Treatment Period|AE unrelated to study drug|0|||
16492126|NCT01928394|40272680|FG000|Treatment Period|Participant request to stop therapy|0|||
16492127|NCT01928394|40272681|FG001|Treatment Period|Participant request to stop therapy|0|||
16492128|NCT01928394|40272682|FG002|Treatment Period|Participant request to stop therapy|0|||
16492129|NCT01928394|40272683|FG003|Treatment Period|Participant request to stop therapy|0|||
16492130|NCT01928394|40272684|FG004|Treatment Period|Participant request to stop therapy|0|||
16492131|NCT01928394|40272685|FG005|Treatment Period|Participant request to stop therapy|3|||
16492132|NCT01928394|40272686|FG006|Treatment Period|Participant request to stop therapy|3|||
16492133|NCT01928394|40272687|FG007|Treatment Period|Participant request to stop therapy|0|||
16492134|NCT01928394|40272688|FG008|Treatment Period|Participant request to stop therapy|0|||
16492135|NCT01928394|40272689|FG009|Treatment Period|Participant request to stop therapy|0|||
16492136|NCT01928394|40272690|FG010|Treatment Period|Participant request to stop therapy|3|||
16492137|NCT01928394|40272691|FG011|Treatment Period|Participant request to stop therapy|2|||
16492138|NCT01928394|40272692|FG012|Treatment Period|Participant request to stop therapy|1|||
16492139|NCT01928394|40272693|FG013|Treatment Period|Participant request to stop therapy|2|||
16492140|NCT01928394|40272694|FG014|Treatment Period|Participant request to stop therapy|4|||
16492141|NCT01928394|40272695|FG015|Treatment Period|Participant request to stop therapy|0|||
16492142|NCT01928394|40272696|FG016|Treatment Period|Participant request to stop therapy|1|||
16492143|NCT01928394|40272697|FG017|Treatment Period|Participant request to stop therapy|3|||
16492144|NCT01928394|40272698|FG018|Treatment Period|Participant request to stop therapy|1|||
16492145|NCT01928394|40272699|FG019|Treatment Period|Participant request to stop therapy|1|||
16492146|NCT01928394|40272700|FG020|Treatment Period|Participant request to stop therapy|3|||
16492147|NCT01928394|40272701|FG021|Treatment Period|Participant request to stop therapy|1|||
16492148|NCT01928394|40272702|FG022|Treatment Period|Participant request to stop therapy|3|||
16492149|NCT01928394|40272680|FG000|Treatment Period|Participant withdrew consent|0|||
16492150|NCT01928394|40272681|FG001|Treatment Period|Participant withdrew consent|0|||
16492151|NCT01928394|40272682|FG002|Treatment Period|Participant withdrew consent|1|||
16492152|NCT01928394|40272683|FG003|Treatment Period|Participant withdrew consent|1|||
16492153|NCT01928394|40272684|FG004|Treatment Period|Participant withdrew consent|0|||
16492154|NCT01928394|40272685|FG005|Treatment Period|Participant withdrew consent|1|||
16492155|NCT01928394|40272686|FG006|Treatment Period|Participant withdrew consent|0|||
16492156|NCT01928394|40272687|FG007|Treatment Period|Participant withdrew consent|1|||
16492157|NCT01928394|40272688|FG008|Treatment Period|Participant withdrew consent|0|||
16492158|NCT01928394|40272689|FG009|Treatment Period|Participant withdrew consent|0|||
16492159|NCT01928394|40272690|FG010|Treatment Period|Participant withdrew consent|1|||
16492160|NCT01928394|40272691|FG011|Treatment Period|Participant withdrew consent|1|||
16492161|NCT01928394|40272692|FG012|Treatment Period|Participant withdrew consent|1|||
16492162|NCT01928394|40272693|FG013|Treatment Period|Participant withdrew consent|0|||
16492163|NCT01928394|40272694|FG014|Treatment Period|Participant withdrew consent|2|||
16492164|NCT01928394|40272695|FG015|Treatment Period|Participant withdrew consent|0|||
16492165|NCT01928394|40272696|FG016|Treatment Period|Participant withdrew consent|2|||
16492166|NCT01928394|40272697|FG017|Treatment Period|Participant withdrew consent|1|||
16492167|NCT01928394|40272698|FG018|Treatment Period|Participant withdrew consent|1|||
16492168|NCT01928394|40272699|FG019|Treatment Period|Participant withdrew consent|1|||
16492169|NCT01928394|40272700|FG020|Treatment Period|Participant withdrew consent|0|||
16492170|NCT01928394|40272701|FG021|Treatment Period|Participant withdrew consent|2|||
16492171|NCT01928394|40272702|FG022|Treatment Period|Participant withdrew consent|0|||
16492172|NCT01928394|40272680|FG000|Treatment Period|Poor/non-compliance|0|||
16492173|NCT01928394|40272681|FG001|Treatment Period|Poor/non-compliance|0|||
16492174|NCT01928394|40272682|FG002|Treatment Period|Poor/non-compliance|0|||
16492175|NCT01928394|40272683|FG003|Treatment Period|Poor/non-compliance|1|||
16492176|NCT01928394|40272684|FG004|Treatment Period|Poor/non-compliance|0|||
16492177|NCT01928394|40272685|FG005|Treatment Period|Poor/non-compliance|0|||
16492178|NCT01928394|40272686|FG006|Treatment Period|Poor/non-compliance|0|||
16492179|NCT01928394|40272687|FG007|Treatment Period|Poor/non-compliance|0|||
16492180|NCT01928394|40272688|FG008|Treatment Period|Poor/non-compliance|0|||
16492181|NCT01928394|40272689|FG009|Treatment Period|Poor/non-compliance|0|||
16492182|NCT01928394|40272690|FG010|Treatment Period|Poor/non-compliance|0|||
16492183|NCT01928394|40272691|FG011|Treatment Period|Poor/non-compliance|0|||
16492184|NCT01928394|40272692|FG012|Treatment Period|Poor/non-compliance|1|||
16492185|NCT01928394|40272693|FG013|Treatment Period|Poor/non-compliance|0|||
16492186|NCT01928394|40272694|FG014|Treatment Period|Poor/non-compliance|1|||
16492187|NCT01928394|40272695|FG015|Treatment Period|Poor/non-compliance|0|||
16492188|NCT01928394|40272696|FG016|Treatment Period|Poor/non-compliance|0|||
16492189|NCT01928394|40272697|FG017|Treatment Period|Poor/non-compliance|1|||
16492190|NCT01928394|40272698|FG018|Treatment Period|Poor/non-compliance|0|||
16492191|NCT01928394|40272699|FG019|Treatment Period|Poor/non-compliance|1|||
16492192|NCT01928394|40272700|FG020|Treatment Period|Poor/non-compliance|0|||
16492193|NCT01928394|40272701|FG021|Treatment Period|Poor/non-compliance|0|||
16492194|NCT01928394|40272702|FG022|Treatment Period|Poor/non-compliance|0|||
16492195|NCT01928394|40272680|FG000|Treatment Period|other reason|0|||
16492196|NCT01928394|40272681|FG001|Treatment Period|other reason|0|||
16492197|NCT01928394|40272682|FG002|Treatment Period|other reason|0|||
16492198|NCT01928394|40272683|FG003|Treatment Period|other reason|0|||
16492199|NCT01928394|40272684|FG004|Treatment Period|other reason|0|||
16492200|NCT01928394|40272685|FG005|Treatment Period|other reason|0|||
16492201|NCT01928394|40272686|FG006|Treatment Period|other reason|0|||
16492202|NCT01928394|40272687|FG007|Treatment Period|other reason|0|||
16492203|NCT01928394|40272688|FG008|Treatment Period|other reason|0|||
16492204|NCT01928394|40272689|FG009|Treatment Period|other reason|0|||
16492205|NCT01928394|40272690|FG010|Treatment Period|other reason|1|||
16492206|NCT01928394|40272691|FG011|Treatment Period|other reason|1|||
16492207|NCT01928394|40272692|FG012|Treatment Period|other reason|1|||
16492208|NCT01928394|40272693|FG013|Treatment Period|other reason|0|||
16492209|NCT01928394|40272694|FG014|Treatment Period|other reason|1|||
16492210|NCT01928394|40272695|FG015|Treatment Period|other reason|0|||
16492211|NCT01928394|40272696|FG016|Treatment Period|other reason|0|||
16492212|NCT01928394|40272697|FG017|Treatment Period|other reason|0|||
16492213|NCT01928394|40272698|FG018|Treatment Period|other reason|2|||
16492214|NCT01928394|40272699|FG019|Treatment Period|other reason|2|||
16492215|NCT01928394|40272700|FG020|Treatment Period|other reason|0|||
16492216|NCT01928394|40272701|FG021|Treatment Period|other reason|0|||
16492217|NCT01928394|40272702|FG022|Treatment Period|other reason|0|||
16492218|NCT01928394|40272680|FG000|Treatment Period|Maximum clinical benefit|0|||
16492219|NCT01928394|40272681|FG001|Treatment Period|Maximum clinical benefit|0|||
16303598|NCT00993421|39597927|FG001|Overall Study|Physician Decision|0|||
16303599|NCT00993421|39597928|FG002|Overall Study|Physician Decision|0|||
16303600|NCT00993421|39597929|FG003|Overall Study|Physician Decision|0|||
16303601|NCT00993421|39597930|FG004|Overall Study|Physician Decision|0|||
16303602|NCT00993421|39597931|FG005|Overall Study|Physician Decision|1|||
16492220|NCT01928394|40272682|FG002|Treatment Period|Maximum clinical benefit|0|||
16492221|NCT01928394|40272683|FG003|Treatment Period|Maximum clinical benefit|0|||
16492222|NCT01928394|40272684|FG004|Treatment Period|Maximum clinical benefit|0|||
16492223|NCT01928394|40272685|FG005|Treatment Period|Maximum clinical benefit|0|||
16492224|NCT01928394|40272686|FG006|Treatment Period|Maximum clinical benefit|0|||
16492225|NCT01928394|40272687|FG007|Treatment Period|Maximum clinical benefit|0|||
16492226|NCT01928394|40272688|FG008|Treatment Period|Maximum clinical benefit|0|||
16492227|NCT01928394|40272689|FG009|Treatment Period|Maximum clinical benefit|0|||
16492228|NCT01928394|40272690|FG010|Treatment Period|Maximum clinical benefit|1|||
16492229|NCT01928394|40272691|FG011|Treatment Period|Maximum clinical benefit|1|||
16492230|NCT01928394|40272692|FG012|Treatment Period|Maximum clinical benefit|0|||
16303603|NCT00993421|39597932|FG006|Overall Study|Physician Decision|1|||
16303604|NCT00993421|39597926|FG000|Overall Study|Protocol Violation|0|||
16303605|NCT00993421|39597927|FG001|Overall Study|Protocol Violation|0|||
16303606|NCT00993421|39597928|FG002|Overall Study|Protocol Violation|0|||
16303607|NCT00993421|39597929|FG003|Overall Study|Protocol Violation|0|||
16303608|NCT00993421|39597930|FG004|Overall Study|Protocol Violation|0|||
16303609|NCT00993421|39597931|FG005|Overall Study|Protocol Violation|2|||
16303610|NCT00993421|39597932|FG006|Overall Study|Protocol Violation|1|||
16303611|NCT01473407|39597933|FG000|Overall Study|Physician Decision|1|||
16303612|NCT01473407|39597934|FG001|Overall Study|Physician Decision|4|||
16303613|NCT01473407|39597933|FG000|Overall Study|Lost to Follow-up|10|||
16303614|NCT01473407|39597934|FG001|Overall Study|Lost to Follow-up|4|||
16303615|NCT01473407|39597933|FG000|Overall Study|Adverse Event|8|||
16303616|NCT01473407|39597934|FG001|Overall Study|Adverse Event|8|||
16303617|NCT01473407|39597933|FG000|Overall Study|Randomization Error|3|||
16303618|NCT01473407|39597934|FG001|Overall Study|Randomization Error|1|||
16303619|NCT01473407|39597933|FG000|Overall Study|Withdrawal by Subject|4|||
16303620|NCT01473407|39597934|FG001|Overall Study|Withdrawal by Subject|7|||
16303621|NCT01473407|39597933|FG000|Overall Study|Kidney Transplant|7|||
16303622|NCT01473407|39597934|FG001|Overall Study|Kidney Transplant|6|||
16492231|NCT01928394|40272693|FG013|Treatment Period|Maximum clinical benefit|0|||
16492232|NCT01928394|40272694|FG014|Treatment Period|Maximum clinical benefit|1|||
16492233|NCT01928394|40272695|FG015|Treatment Period|Maximum clinical benefit|0|||
16492234|NCT01928394|40272696|FG016|Treatment Period|Maximum clinical benefit|0|||
16492235|NCT01928394|40272697|FG017|Treatment Period|Maximum clinical benefit|1|||
16492236|NCT01928394|40272698|FG018|Treatment Period|Maximum clinical benefit|1|||
16492237|NCT01928394|40272699|FG019|Treatment Period|Maximum clinical benefit|0|||
16303623|NCT01473407|39597933|FG000|Overall Study|Vacation/Travel|1|||
16303624|NCT01473407|39597934|FG001|Overall Study|Vacation/Travel|1|||
16303625|NCT01473407|39597933|FG000|Overall Study|Elevated Hemoglobin|1|||
16303626|NCT01473407|39597934|FG001|Overall Study|Elevated Hemoglobin|0|||
16303627|NCT01473407|39597933|FG000|Overall Study|Patient Received Aranesp|1|||
16303628|NCT01473407|39597934|FG001|Overall Study|Patient Received Aranesp|0|||
16303629|NCT01473407|39597933|FG000|Overall Study|Patient Lost Green Card Status|1|||
16303630|NCT01473407|39597934|FG001|Overall Study|Patient Lost Green Card Status|0|||
16303631|NCT01473407|39597933|FG000|Overall Study|Temperature Excursion|2|||
16492238|NCT01928394|40272700|FG020|Treatment Period|Maximum clinical benefit|2|||
16492239|NCT01928394|40272701|FG021|Treatment Period|Maximum clinical benefit|0|||
16492240|NCT01928394|40272702|FG022|Treatment Period|Maximum clinical benefit|0|||
16083975|NCT02222493|38799261|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
16083976|NCT02222493|38799260|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
16083977|NCT02222493|38799261|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
16492241|NCT01928394|40272680|FG000|Treatment Period|Lost to Follow-up|0|||
16492242|NCT01928394|40272681|FG001|Treatment Period|Lost to Follow-up|0|||
16083978|NCT02222493|38799260|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
16083979|NCT02222493|38799261|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
16083980|NCT02222493|38799260|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
16083981|NCT02222493|38799261|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
16083982|NCT02222493|38799260|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
16083983|NCT02222493|38799261|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
16083984|NCT02222493|38799260|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
16083985|NCT02222493|38799261|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
16083986|NCT02222493|38799260|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
16083987|NCT02222493|38799261|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
16083988|NCT02222493|38799260|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
16083989|NCT02222493|38799261|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
16083990|NCT02222493|38799260|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
16083991|NCT02222493|38799261|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
16083992|NCT02222493|38799260|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
16083993|NCT02222493|38799261|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
16083994|NCT02222493|38799260|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
16083995|NCT02222493|38799261|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
16083996|NCT02222493|38799260|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
16083997|NCT02222493|38799261|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
16083998|NCT02222493|38799260|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
16083999|NCT02222493|38799261|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
16084000|NCT02222493|38799260|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
16084001|NCT02222493|38799261|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
16084002|NCT02222493|38799260|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
16084003|NCT02222493|38799261|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
16084004|NCT02222493|38799260|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
16084005|NCT02222493|38799261|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
16303632|NCT01473407|39597934|FG001|Overall Study|Temperature Excursion|3|||
16409906|NCT01952665|39981818|FG000|Overall Study|Adverse Event|2|||
16084006|NCT02222493|38799260|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
16409907|NCT01952665|39981819|FG001|Overall Study|Adverse Event|1|||
16409908|NCT01952665|39981818|FG000|Overall Study|Protocol Violation|0|||
16409909|NCT01952665|39981819|FG001|Overall Study|Protocol Violation|1|||
16409910|NCT03158272|39981821|FG000|Overall Study|Disease progression|3|||
16409911|NCT03158272|39981822|FG001|Overall Study|Disease progression|3|||
16409912|NCT03158272|39981823|FG002|Overall Study|Disease progression|4|||
16409913|NCT03158272|39981824|FG003|Overall Study|Disease progression|6|||
16409914|NCT03158272|39981821|FG000|Overall Study|Death|0|||
16409915|NCT03158272|39981822|FG001|Overall Study|Death|0|||
16409916|NCT03158272|39981823|FG002|Overall Study|Death|1|||
16409917|NCT03158272|39981824|FG003|Overall Study|Death|0|||
16409918|NCT03158272|39981821|FG000|Overall Study|Other reasons|0|||
16409919|NCT03158272|39981822|FG001|Overall Study|Other reasons|0|||
16409920|NCT03158272|39981823|FG002|Overall Study|Other reasons|1|||
16409921|NCT03158272|39981824|FG003|Overall Study|Other reasons|0|||
16409922|NCT03158272|39981821|FG000|Overall Study|Adverse event unrelated to the drug|0|||
16409923|NCT03158272|39981822|FG001|Overall Study|Adverse event unrelated to the drug|1|||
16409924|NCT03158272|39981823|FG002|Overall Study|Adverse event unrelated to the drug|0|||
16409925|NCT03158272|39981824|FG003|Overall Study|Adverse event unrelated to the drug|0|||
16409926|NCT03553498|39981828|FG000|Overall Study|Missing primary outcome|1|||
16409927|NCT03553498|39981829|FG001|Overall Study|Missing primary outcome|2|||
16409928|NCT03099148|39981830|FG000|Wash-out|scheduling conflict|0|||
16409929|NCT03099148|39981831|FG001|Wash-out|scheduling conflict|1|||
16409930|NCT03099148|39981832|FG002|Wash-out|scheduling conflict|0|||
16084007|NCT02222493|38799261|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
16084008|NCT02222493|38799260|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
16084009|NCT02222493|38799261|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
16084010|NCT02222493|38799260|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
16084011|NCT02222493|38799261|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
16084012|NCT02222493|38799260|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
16084013|NCT02222493|38799261|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
16084014|NCT02222493|38799260|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
16084015|NCT02222493|38799261|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
16084016|NCT00150813|38799262|FG000|Overall Study|Adverse Event|1|||
16084017|NCT00150813|38799262|FG000|Overall Study|Lack of Efficacy|1|||
16084018|NCT00150813|38799262|FG000|Overall Study|Lost to Follow-up|5|||
16084019|NCT00150813|38799262|FG000|Overall Study|Withdrawal by Subject|5|||
16084020|NCT00150813|38799262|FG000|Overall Study|Remission|3|||
16084021|NCT00150813|38799262|FG000|Overall Study|Planned pregancy|1|||
16084022|NCT00150813|38799262|FG000|Overall Study|Switch to commercially available LEV|2|||
16084023|NCT00611559|38799263|FG000|Overall Study|Lost to Follow-up|0|||
16084024|NCT00611559|38799264|FG001|Overall Study|Lost to Follow-up|1|||
16084025|NCT00611559|38799265|FG002|Overall Study|Lost to Follow-up|0|||
16084026|NCT00611559|38799263|FG000|Overall Study|Protocol Violation|1|||
16084027|NCT00611559|38799264|FG001|Overall Study|Protocol Violation|0|||
16084028|NCT00611559|38799265|FG002|Overall Study|Protocol Violation|1|||
16084029|NCT03764475|38799268|FG000|Overall Study|Adverse Event|11|||
16084030|NCT03764475|38799269|FG001|Overall Study|Adverse Event|2|||
16084031|NCT03764475|38799268|FG000|Overall Study|Lost to Follow-up|24|||
16084032|NCT03764475|38799269|FG001|Overall Study|Lost to Follow-up|10|||
16084033|NCT03764475|38799268|FG000|Overall Study|Withdrawal by Subject|26|||
16084034|NCT03764475|38799269|FG001|Overall Study|Withdrawal by Subject|10|||
16084035|NCT03764475|38799268|FG000|Overall Study|Lack of Efficacy|3|||
16084036|NCT03764475|38799269|FG001|Overall Study|Lack of Efficacy|0|||
16084037|NCT03764475|38799268|FG000|Overall Study|COVID-19 Disruption|2|||
16084038|NCT03764475|38799269|FG001|Overall Study|COVID-19 Disruption|0|||
16084039|NCT02633215|38799270|FG000|Overall Study|Lost to Follow-up|2|||
16084040|NCT02633215|38799271|FG001|Overall Study|Lost to Follow-up|3|||
16084041|NCT00243503|38799272|FG000|Overall Study|Adverse Event|11|||
16084042|NCT00243503|38799272|FG000|Overall Study|Withdrawal by Subject|1|||
16084043|NCT00243503|38799272|FG000|Overall Study|Lack of Efficacy|44|||
16084044|NCT00243503|38799272|FG000|Overall Study|Death|1|||
16084045|NCT00243503|38799272|FG000|Overall Study|Other|1|||
16084046|NCT01767467|38799276|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
16084047|NCT01767467|38799277|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
16084048|NCT01767467|38799276|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
16084049|NCT01767467|38799277|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
16084050|NCT01767467|38799276|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
16084051|NCT01767467|38799277|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
16084052|NCT01767467|38799276|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
16084053|NCT01767467|38799277|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
16084054|NCT01767467|38799276|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
16084055|NCT01767467|38799277|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
16084056|NCT01767467|38799276|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
16084057|NCT01767467|38799277|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
16084058|NCT01767467|38799276|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
16084059|NCT01767467|38799277|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
16084060|NCT01767467|38799276|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
16084061|NCT01767467|38799277|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
16084062|NCT01767467|38799276|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
16084063|NCT01767467|38799277|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
16084064|NCT01767467|38799276|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
16084065|NCT01767467|38799277|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
16084066|NCT01767467|38799276|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
16084067|NCT01767467|38799277|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
16084068|NCT01767467|38799276|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
16084069|NCT01767467|38799277|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
16084070|NCT01767467|38799276|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
16084071|NCT01767467|38799277|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
16084072|NCT01767467|38799276|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
16084073|NCT01767467|38799277|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
16084074|NCT00586313|38799278|FG000|Overall Study|Lack of Efficacy|2|||
16084075|NCT01609218|38799279|FG000|Period 1|Adverse Event|3|||
16084076|NCT01609218|38799280|FG001|Period 1|Adverse Event|5|||
16084077|NCT01609218|38799279|FG000|Period 1|Sponsor Decision|0|||
16084078|NCT01609218|38799280|FG001|Period 1|Sponsor Decision|1|||
16084079|NCT01609218|38799279|FG000|Period 2|Adverse Event|1|||
16084080|NCT01609218|38799280|FG001|Period 2|Adverse Event|0|||
16084081|NCT01530334|38799281|FG000|Overall Study|Adverse Event|3|||
16084082|NCT01530334|38799281|FG000|Overall Study|unknown reason|1|||
16084083|NCT01530334|38799281|FG000|Overall Study|Progressive disease|47|||
16084084|NCT01738438|38799287|FG000|Overall Study|Disease Progression|32|||
16084085|NCT01738438|38799287|FG000|Overall Study|Adverse Event|3|||
16084086|NCT01582100|38802418|FG000|Overall Study|Adverse Event|1|||
16084087|NCT01582100|38802418|FG000|Overall Study|Withdrawal by Subject|1|||
16084088|NCT01750684|38802419|FG000|Overall Study|Death|1|||
16084089|NCT01750684|38802420|FG001|Overall Study|Death|0|||
16084090|NCT01750684|38802419|FG000|Overall Study|Non-compliance with Study Drug|0|||
16084091|NCT01750684|38802420|FG001|Overall Study|Non-compliance with Study Drug|1|||
16084092|NCT01750684|38802419|FG000|Overall Study|Withdrawn by Sponsor|0|||
16084093|NCT01750684|38802420|FG001|Overall Study|Withdrawn by Sponsor|1|||
16084094|NCT01750684|38802419|FG000|Overall Study|Protocol Violation|1|||
16084095|NCT01750684|38802420|FG001|Overall Study|Protocol Violation|0|||
16084096|NCT00642850|38802423|FG000|Overall Study|Death|7|||
16084097|NCT00642850|38802423|FG000|Overall Study|Adverse Event|2|||
16084098|NCT00642850|38802423|FG000|Overall Study|Lack of Efficacy|1|||
16084099|NCT00642850|38802423|FG000|Overall Study|Protocol Violation|2|||
16084100|NCT00642850|38802423|FG000|Overall Study|Kidney transplantation|8|||
16084101|NCT00642850|38802423|FG000|Overall Study|Blood transfusion|6|||
16084102|NCT00642850|38802423|FG000|Overall Study|Other reasons|7|||
16084103|NCT03875313|38802424|FG000|Overall Study|Withdrawal by Subject|1|||
16084104|NCT03875313|38802425|FG001|Overall Study|Withdrawal by Subject|3|||
16084105|NCT03875313|38802426|FG002|Overall Study|Withdrawal by Subject|0|||
16084106|NCT03875313|38802427|FG003|Overall Study|Withdrawal by Subject|0|||
16084107|NCT03875313|38802428|FG004|Overall Study|Withdrawal by Subject|0|||
16084108|NCT03875313|38802424|FG000|Overall Study|Death|0|||
16084109|NCT03875313|38802425|FG001|Overall Study|Death|0|||
16084110|NCT03875313|38802426|FG002|Overall Study|Death|0|||
16084111|NCT03875313|38802427|FG003|Overall Study|Death|0|||
16084112|NCT03875313|38802428|FG004|Overall Study|Death|1|||
16084113|NCT03875313|38802424|FG000|Overall Study|Lost to Follow-up|0|||
16084114|NCT03875313|38802425|FG001|Overall Study|Lost to Follow-up|0|||
16084115|NCT03875313|38802426|FG002|Overall Study|Lost to Follow-up|0|||
16084116|NCT03875313|38802427|FG003|Overall Study|Lost to Follow-up|0|||
16084117|NCT03875313|38802428|FG004|Overall Study|Lost to Follow-up|1|||
16084118|NCT03875313|38802424|FG000|Overall Study|Study Termination by Sponsor|0|||
16084119|NCT03875313|38802425|FG001|Overall Study|Study Termination by Sponsor|1|||
16084120|NCT03875313|38802426|FG002|Overall Study|Study Termination by Sponsor|1|||
16084121|NCT03875313|38802427|FG003|Overall Study|Study Termination by Sponsor|0|||
16084122|NCT03875313|38802428|FG004|Overall Study|Study Termination by Sponsor|1|||
16084123|NCT03875313|38802424|FG000|Overall Study|New Anticancer Treatment|0|||
16084124|NCT03875313|38802425|FG001|Overall Study|New Anticancer Treatment|1|||
16084125|NCT03875313|38802426|FG002|Overall Study|New Anticancer Treatment|2|||
16084126|NCT03875313|38802427|FG003|Overall Study|New Anticancer Treatment|1|||
16084127|NCT03875313|38802428|FG004|Overall Study|New Anticancer Treatment|0|||
16084128|NCT03875313|38802424|FG000|Overall Study|Other, Not Specified|2|||
16084129|NCT03875313|38802425|FG001|Overall Study|Other, Not Specified|11|||
16084130|NCT03875313|38802426|FG002|Overall Study|Other, Not Specified|3|||
16084131|NCT03875313|38802427|FG003|Overall Study|Other, Not Specified|3|||
16084132|NCT03875313|38802428|FG004|Overall Study|Other, Not Specified|1|||
16084133|NCT01619410|38802429|FG000|Overall Study|Lost to Follow-up|7|||
16084134|NCT01619410|38802430|FG001|Overall Study|Lost to Follow-up|4|||
16084135|NCT02561195|38802431|FG000|Vaccination 1 to 3|Adverse Event|4|||
16084136|NCT02561195|38802432|FG001|Vaccination 1 to 3|Adverse Event|5|||
16084137|NCT02561195|38802433|FG002|Vaccination 1 to 3|Adverse Event|0|||
16084138|NCT02561195|38802434|FG003|Vaccination 1 to 3|Adverse Event|3|||
16084139|NCT02561195|38802435|FG004|Vaccination 1 to 3|Adverse Event|4|||
16084140|NCT02561195|38802436|FG005|Vaccination 1 to 3|Adverse Event|0|||
16084141|NCT02561195|38802437|FG006|Vaccination 1 to 3|Adverse Event|0|||
16084142|NCT02561195|38802438|FG007|Vaccination 1 to 3|Adverse Event|0|||
16084143|NCT02561195|38802439|FG008|Vaccination 1 to 3|Adverse Event|0|||
16084144|NCT02561195|38802440|FG009|Vaccination 1 to 3|Adverse Event|0|||
16084145|NCT02561195|38802441|FG010|Vaccination 1 to 3|Adverse Event|0|||
16084146|NCT02561195|38802442|FG011|Vaccination 1 to 3|Adverse Event|0|||
16084147|NCT02561195|38802443|FG012|Vaccination 1 to 3|Adverse Event|0|||
16084148|NCT02561195|38802444|FG013|Vaccination 1 to 3|Adverse Event|0|||
16084149|NCT02561195|38802431|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
16084150|NCT02561195|38802432|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
16084151|NCT02561195|38802433|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
16084152|NCT02561195|38802434|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
16084153|NCT02561195|38802435|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
16084154|NCT02561195|38802436|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
16084155|NCT02561195|38802437|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
16084156|NCT02561195|38802438|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
16084157|NCT02561195|38802439|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
16084158|NCT02561195|38802440|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
16084159|NCT02561195|38802441|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
16084160|NCT02561195|38802442|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
16084161|NCT02561195|38802443|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
16084162|NCT02561195|38802444|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
16084163|NCT02561195|38802431|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16084164|NCT02561195|38802432|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
16084165|NCT02561195|38802433|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16084166|NCT02561195|38802434|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
16084167|NCT02561195|38802435|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
16084168|NCT02561195|38802436|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
16084169|NCT02561195|38802437|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16084170|NCT02561195|38802438|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16084171|NCT02561195|38802439|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16084172|NCT02561195|38802440|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16084173|NCT02561195|38802441|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16084174|NCT02561195|38802442|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16084175|NCT02561195|38802443|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16084176|NCT02561195|38802444|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
16084177|NCT02561195|38802431|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
16084178|NCT02561195|38802432|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
16084179|NCT02561195|38802433|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
16084180|NCT02561195|38802434|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
16084181|NCT02561195|38802435|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
16084182|NCT02561195|38802436|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
16084183|NCT02561195|38802437|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
16084184|NCT02561195|38802438|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
16084185|NCT02561195|38802439|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
16084186|NCT02561195|38802440|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
16084187|NCT02561195|38802441|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
16084188|NCT02561195|38802442|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
16084189|NCT02561195|38802443|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
16084190|NCT02561195|38802444|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
16084191|NCT02561195|38802431|FG000|Vaccination 1 to 3|Other|7|||
16084192|NCT02561195|38802432|FG001|Vaccination 1 to 3|Other|3|||
16084193|NCT02561195|38802433|FG002|Vaccination 1 to 3|Other|1|||
16084194|NCT02561195|38802434|FG003|Vaccination 1 to 3|Other|7|||
16084195|NCT02561195|38802435|FG004|Vaccination 1 to 3|Other|5|||
16084196|NCT02561195|38802436|FG005|Vaccination 1 to 3|Other|1|||
16084197|NCT02561195|38802437|FG006|Vaccination 1 to 3|Other|0|||
16084198|NCT02561195|38802438|FG007|Vaccination 1 to 3|Other|0|||
16084199|NCT02561195|38802439|FG008|Vaccination 1 to 3|Other|0|||
16084200|NCT02561195|38802440|FG009|Vaccination 1 to 3|Other|0|||
16084201|NCT02561195|38802441|FG010|Vaccination 1 to 3|Other|0|||
16084202|NCT02561195|38802442|FG011|Vaccination 1 to 3|Other|0|||
16084203|NCT02561195|38802443|FG012|Vaccination 1 to 3|Other|0|||
16084204|NCT02561195|38802444|FG013|Vaccination 1 to 3|Other|0|||
16084205|NCT02561195|38802431|FG000|Vaccination 1 to 3|Protocol Violation|1|||
16084206|NCT02561195|38802432|FG001|Vaccination 1 to 3|Protocol Violation|0|||
16084207|NCT02561195|38802433|FG002|Vaccination 1 to 3|Protocol Violation|1|||
16084208|NCT02561195|38802434|FG003|Vaccination 1 to 3|Protocol Violation|2|||
16084209|NCT02561195|38802435|FG004|Vaccination 1 to 3|Protocol Violation|5|||
16084210|NCT02561195|38802436|FG005|Vaccination 1 to 3|Protocol Violation|2|||
16084211|NCT02561195|38802437|FG006|Vaccination 1 to 3|Protocol Violation|0|||
16084212|NCT02561195|38802438|FG007|Vaccination 1 to 3|Protocol Violation|0|||
16084213|NCT02561195|38802439|FG008|Vaccination 1 to 3|Protocol Violation|0|||
16084214|NCT02561195|38802440|FG009|Vaccination 1 to 3|Protocol Violation|0|||
16084215|NCT02561195|38802441|FG010|Vaccination 1 to 3|Protocol Violation|0|||
16084216|NCT02561195|38802442|FG011|Vaccination 1 to 3|Protocol Violation|0|||
16084217|NCT02561195|38802443|FG012|Vaccination 1 to 3|Protocol Violation|0|||
16084218|NCT02561195|38802444|FG013|Vaccination 1 to 3|Protocol Violation|0|||
16492243|NCT01928394|40272682|FG002|Treatment Period|Lost to Follow-up|0|||
16492244|NCT01928394|40272683|FG003|Treatment Period|Lost to Follow-up|0|||
16492245|NCT01928394|40272684|FG004|Treatment Period|Lost to Follow-up|0|||
16492246|NCT01928394|40272685|FG005|Treatment Period|Lost to Follow-up|0|||
16084219|NCT02561195|38802431|FG000|Vaccination 1 to 3|Death|2|||
16084220|NCT02561195|38802432|FG001|Vaccination 1 to 3|Death|1|||
16084221|NCT02561195|38802433|FG002|Vaccination 1 to 3|Death|0|||
16084222|NCT02561195|38802434|FG003|Vaccination 1 to 3|Death|2|||
16084223|NCT02561195|38802435|FG004|Vaccination 1 to 3|Death|0|||
16084224|NCT02561195|38802436|FG005|Vaccination 1 to 3|Death|0|||
16084225|NCT02561195|38802437|FG006|Vaccination 1 to 3|Death|0|||
16084226|NCT02561195|38802438|FG007|Vaccination 1 to 3|Death|0|||
16084227|NCT02561195|38802439|FG008|Vaccination 1 to 3|Death|0|||
16084228|NCT02561195|38802440|FG009|Vaccination 1 to 3|Death|0|||
16084229|NCT02561195|38802441|FG010|Vaccination 1 to 3|Death|0|||
16084230|NCT02561195|38802442|FG011|Vaccination 1 to 3|Death|0|||
16084231|NCT02561195|38802443|FG012|Vaccination 1 to 3|Death|0|||
16084232|NCT02561195|38802444|FG013|Vaccination 1 to 3|Death|0|||
16084233|NCT02561195|38802431|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
16084234|NCT02561195|38802432|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
16084235|NCT02561195|38802433|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
16084236|NCT02561195|38802434|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
16084237|NCT02561195|38802435|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
16084238|NCT02561195|38802436|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
16084239|NCT02561195|38802437|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
16084240|NCT02561195|38802438|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
16084241|NCT02561195|38802439|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
16084242|NCT02561195|38802440|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
16084243|NCT02561195|38802441|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
16084244|NCT02561195|38802442|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
16084245|NCT02561195|38802443|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
16084246|NCT02561195|38802444|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
16084247|NCT02561195|38802431|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
16084248|NCT02561195|38802432|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
16084249|NCT02561195|38802433|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
16084250|NCT02561195|38802434|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
16084251|NCT02561195|38802435|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
16084252|NCT02561195|38802436|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
16084253|NCT02561195|38802437|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
16084254|NCT02561195|38802438|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
16084255|NCT02561195|38802439|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
16084256|NCT02561195|38802440|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
16084257|NCT02561195|38802441|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
16084258|NCT02561195|38802442|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
16084259|NCT02561195|38802443|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
16084260|NCT02561195|38802444|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
16084261|NCT02561195|38802431|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16084262|NCT02561195|38802432|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16084263|NCT02561195|38802433|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16084264|NCT02561195|38802434|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16084265|NCT02561195|38802435|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16084266|NCT02561195|38802436|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16084267|NCT02561195|38802437|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16084268|NCT02561195|38802438|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16084269|NCT02561195|38802439|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
16084270|NCT02561195|38802440|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
16084271|NCT02561195|38802441|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
16193437|NCT01005719|39185333|FG003|Period 2|Adverse Event|0|||
16193438|NCT01005719|39185334|FG004|Period 2|Adverse Event|1|||
16193439|NCT01005719|39185335|FG005|Period 2|Adverse Event|1|||
16193440|NCT00115804|39185336|FG000|Overall Study|Adverse Event|2|||
16193441|NCT01944969|39185349|FG000|Overall Study|Adverse Event|1|||
16193442|NCT01944969|39185349|FG000|Overall Study|Lack of Efficacy|1|||
16193443|NCT01944969|39185349|FG000|Overall Study|Non-compliance with IMP|1|||
16193444|NCT01944969|39185349|FG000|Overall Study|Administrative or other reasons|23|||
16193445|NCT01252134|39185350|FG000|Period 1, 8 Hours|Personal Reasons|0|||
16193446|NCT01252134|39185351|FG001|Period 1, 8 Hours|Personal Reasons|1|||
16193447|NCT01252134|39185352|FG002|Period 1, 8 Hours|Personal Reasons|1|||
16193448|NCT01252134|39185353|FG003|Period 1, 8 Hours|Personal Reasons|0|||
16193449|NCT01252134|39185354|FG004|Period 1, 8 Hours|Personal Reasons|0|||
16193450|NCT01252134|39185355|FG005|Period 1, 8 Hours|Personal Reasons|0|||
16193451|NCT01043185|39185356|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
16193452|NCT01043185|39185357|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
16193453|NCT01043185|39185358|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
16193454|NCT01043185|39185359|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
16193455|NCT01043185|39185360|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
16084272|NCT02561195|38802442|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
16084273|NCT02561195|38802443|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
16084274|NCT02561195|38802444|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
16084275|NCT02561195|38802431|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
16193456|NCT01043185|39185361|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
16193457|NCT01043185|39185362|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
16193458|NCT01043185|39185363|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
16193459|NCT01043185|39185364|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
16193460|NCT01043185|39185365|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
16193461|NCT01263691|39185372|FG000|Overall Study|Lost to Follow-up|1|||
16193462|NCT01263691|39185373|FG001|Overall Study|Lost to Follow-up|0|||
16193463|NCT01263691|39185374|FG002|Overall Study|Lost to Follow-up|1|||
16193464|NCT01263691|39185375|FG003|Overall Study|Lost to Follow-up|1|||
16193465|NCT01263691|39185376|FG004|Overall Study|Lost to Follow-up|0|||
16193466|NCT01263691|39185377|FG005|Overall Study|Lost to Follow-up|0|||
16193467|NCT01263691|39185372|FG000|Overall Study|Withdrawal by Subject|1|||
16193468|NCT01263691|39185373|FG001|Overall Study|Withdrawal by Subject|0|||
16193469|NCT01263691|39185374|FG002|Overall Study|Withdrawal by Subject|0|||
16193470|NCT01263691|39185375|FG003|Overall Study|Withdrawal by Subject|0|||
16193471|NCT01263691|39185376|FG004|Overall Study|Withdrawal by Subject|0|||
16193472|NCT01263691|39185377|FG005|Overall Study|Withdrawal by Subject|0|||
16193473|NCT01263691|39185372|FG000|Overall Study|Adverse Event|1|||
16193474|NCT01263691|39185373|FG001|Overall Study|Adverse Event|0|||
16193475|NCT01263691|39185374|FG002|Overall Study|Adverse Event|0|||
16193476|NCT01263691|39185375|FG003|Overall Study|Adverse Event|0|||
16193477|NCT01263691|39185376|FG004|Overall Study|Adverse Event|0|||
16193478|NCT01263691|39185377|FG005|Overall Study|Adverse Event|0|||
16193479|NCT02921919|39185379|FG000|Overall Study|Other|5|||
16193480|NCT02921919|39185380|FG001|Overall Study|Other|6|||
16193481|NCT02921919|39185379|FG000|Overall Study|Lost to Follow-up|0|||
16303633|NCT01473407|39597933|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
16303634|NCT01473407|39597934|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
16193482|NCT02921919|39185380|FG001|Overall Study|Lost to Follow-up|1|||
16193483|NCT02921919|39185379|FG000|Overall Study|Withdrawal by Subject|5|||
16193484|NCT02921919|39185380|FG001|Overall Study|Withdrawal by Subject|1|||
16193485|NCT02921919|39185379|FG000|Overall Study|Disease Progression|47|||
16193486|NCT02921919|39185380|FG001|Overall Study|Disease Progression|38|||
16193487|NCT02921919|39185379|FG000|Overall Study|Physician Decision|3|||
16193488|NCT02921919|39185380|FG001|Overall Study|Physician Decision|2|||
16193489|NCT02921919|39185379|FG000|Overall Study|Adverse Event|6|||
16193490|NCT02921919|39185380|FG001|Overall Study|Adverse Event|4|||
16193491|NCT01056341|39188555|FG000|Overall Study|Treatment Intolerance|0|||
16303635|NCT01473407|39597933|FG000|Overall Study|Sponsor's Decision|10|||
16303636|NCT01473407|39597934|FG001|Overall Study|Sponsor's Decision|10|||
16303637|NCT01473407|39597933|FG000|Overall Study|Site Closure|1|||
16303638|NCT01473407|39597934|FG001|Overall Study|Site Closure|0|||
16303639|NCT01420965|39597937|FG000|Overall Study|Withdrawal by Subject|1|||
16303640|NCT01420965|39597938|FG001|Overall Study|Withdrawal by Subject|0|||
16303641|NCT01420965|39597939|FG002|Overall Study|Withdrawal by Subject|0|||
16303642|NCT01420965|39597937|FG000|Overall Study|Adverse Event|0|||
16492247|NCT01928394|40272686|FG006|Treatment Period|Lost to Follow-up|0|||
16492248|NCT01928394|40272687|FG007|Treatment Period|Lost to Follow-up|0|||
16492249|NCT01928394|40272688|FG008|Treatment Period|Lost to Follow-up|0|||
16492250|NCT01928394|40272689|FG009|Treatment Period|Lost to Follow-up|0|||
16492251|NCT01928394|40272690|FG010|Treatment Period|Lost to Follow-up|0|||
16492252|NCT01928394|40272691|FG011|Treatment Period|Lost to Follow-up|0|||
16492253|NCT01928394|40272692|FG012|Treatment Period|Lost to Follow-up|0|||
16492254|NCT01928394|40272693|FG013|Treatment Period|Lost to Follow-up|0|||
16492255|NCT01928394|40272694|FG014|Treatment Period|Lost to Follow-up|0|||
16303643|NCT01420965|39597938|FG001|Overall Study|Adverse Event|1|||
16303644|NCT01420965|39597939|FG002|Overall Study|Adverse Event|0|||
16303645|NCT03136965|39597940|FG000|Overall Study|Lost to Follow-up|0|||
16303646|NCT03136965|39597941|FG001|Overall Study|Lost to Follow-up|1|||
16303647|NCT03136965|39597942|FG002|Overall Study|Lost to Follow-up|0|||
16303648|NCT03151304|39597946|FG000|Overall Study|Termination of study by Sponsor|23|||
16303649|NCT03151304|39597946|FG000|Overall Study|missing|3|||
16303650|NCT03151304|39597946|FG000|Overall Study|Withdrawal by Subject|8|||
16303651|NCT03151304|39597946|FG000|Overall Study|multiple reasons|30|||
16303652|NCT01371539|39597947|FG000|Period One: One Week|Lost to Follow-up|0|||
16303653|NCT01371539|39597948|FG001|Period One: One Week|Lost to Follow-up|1|||
16303654|NCT01371539|39597947|FG000|Period Two: One Week|Lost to Follow-up|0|||
16303655|NCT01371539|39597948|FG001|Period Two: One Week|Lost to Follow-up|1|||
16492256|NCT01928394|40272695|FG015|Treatment Period|Lost to Follow-up|0|||
16492257|NCT01928394|40272696|FG016|Treatment Period|Lost to Follow-up|0|||
16492258|NCT01928394|40272697|FG017|Treatment Period|Lost to Follow-up|0|||
16492259|NCT01928394|40272698|FG018|Treatment Period|Lost to Follow-up|0|||
16492260|NCT01928394|40272699|FG019|Treatment Period|Lost to Follow-up|0|||
16492261|NCT01928394|40272700|FG020|Treatment Period|Lost to Follow-up|0|||
16193492|NCT01056341|39188556|FG001|Overall Study|Treatment Intolerance|2|||
16193493|NCT01056341|39188557|FG002|Overall Study|Treatment Intolerance|0|||
16193494|NCT01056341|39188558|FG003|Overall Study|Treatment Intolerance|2|||
16193495|NCT01056341|39188559|FG004|Overall Study|Treatment Intolerance|0|||
16193496|NCT01056341|39188555|FG000|Overall Study|Lack of Efficacy|32|||
16193497|NCT01056341|39188556|FG001|Overall Study|Lack of Efficacy|30|||
16193498|NCT01056341|39188557|FG002|Overall Study|Lack of Efficacy|7|||
16303656|NCT01371539|39597947|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
16303657|NCT01371539|39597948|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
16303658|NCT01371539|39597947|FG000|Period Two: One Week|Time/job conflict|0|||
16303659|NCT01371539|39597948|FG001|Period Two: One Week|Time/job conflict|1|||
16303660|NCT00852202|39597952|FG000|Overall Study|Adverse Event|2|||
16303661|NCT00852202|39597953|FG001|Overall Study|Adverse Event|3|||
16303662|NCT00852202|39597954|FG002|Overall Study|Adverse Event|7|||
16303663|NCT00852202|39597952|FG000|Overall Study|Lack of Efficacy|4|||
16303664|NCT00852202|39597953|FG001|Overall Study|Lack of Efficacy|1|||
16303665|NCT00852202|39597954|FG002|Overall Study|Lack of Efficacy|2|||
16303666|NCT00852202|39597952|FG000|Overall Study|Protocol Violation|2|||
16303667|NCT00852202|39597953|FG001|Overall Study|Protocol Violation|2|||
16303668|NCT00852202|39597954|FG002|Overall Study|Protocol Violation|7|||
16303669|NCT00852202|39597952|FG000|Overall Study|Withdrawal by Subject|3|||
16303670|NCT00852202|39597953|FG001|Overall Study|Withdrawal by Subject|1|||
16303671|NCT00852202|39597954|FG002|Overall Study|Withdrawal by Subject|2|||
16303672|NCT00852202|39597952|FG000|Overall Study|Lost to Follow-up|5|||
16303673|NCT00852202|39597953|FG001|Overall Study|Lost to Follow-up|5|||
16303674|NCT00852202|39597954|FG002|Overall Study|Lost to Follow-up|6|||
16303675|NCT00852202|39597952|FG000|Overall Study|pregnancy,moving away and surgery|1|||
16303676|NCT00852202|39597953|FG001|Overall Study|pregnancy,moving away and surgery|0|||
16303677|NCT00852202|39597954|FG002|Overall Study|pregnancy,moving away and surgery|2|||
16303678|NCT02794246|39597960|FG000|Overall Study|Withdrawal by Subject|2|||
16303679|NCT02794246|39597960|FG000|Overall Study|Physician Decision|4|||
16303680|NCT00875797|39597971|FG000|Overall Study|Protocol Violation|6|||
16303681|NCT00875797|39597972|FG001|Overall Study|Protocol Violation|3|||
16084276|NCT02561195|38802432|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
16303682|NCT00352417|39597973|FG000|Overall Study|Adverse Event|1|||
16303683|NCT00352417|39597974|FG001|Overall Study|Adverse Event|0|||
16303684|NCT00352417|39597973|FG000|Overall Study|Protocol Violation|0|||
16303685|NCT00352417|39597974|FG001|Overall Study|Protocol Violation|2|||
16492262|NCT01928394|40272701|FG021|Treatment Period|Lost to Follow-up|0|||
16303686|NCT00352417|39597973|FG000|Overall Study|Withdrawal by Subject|1|||
16303687|NCT00352417|39597974|FG001|Overall Study|Withdrawal by Subject|2|||
16303688|NCT00352417|39597973|FG000|Overall Study|Lost to Follow-up|1|||
16303689|NCT00352417|39597974|FG001|Overall Study|Lost to Follow-up|0|||
16492263|NCT01928394|40272702|FG022|Treatment Period|Lost to Follow-up|1|||
16492264|NCT01928394|40272680|FG000|Treatment Period|Death|0|||
16492265|NCT01928394|40272681|FG001|Treatment Period|Death|0|||
16492266|NCT01928394|40272682|FG002|Treatment Period|Death|0|||
16492267|NCT01928394|40272683|FG003|Treatment Period|Death|0|||
16492268|NCT01928394|40272684|FG004|Treatment Period|Death|0|||
16492269|NCT01928394|40272685|FG005|Treatment Period|Death|0|||
16492270|NCT01928394|40272686|FG006|Treatment Period|Death|0|||
16492271|NCT01928394|40272687|FG007|Treatment Period|Death|0|||
16492272|NCT01928394|40272688|FG008|Treatment Period|Death|0|||
16492273|NCT01928394|40272689|FG009|Treatment Period|Death|0|||
16303690|NCT00352417|39597973|FG000|Overall Study|Schedule Change|2|||
16303691|NCT00352417|39597974|FG001|Overall Study|Schedule Change|1|||
16303692|NCT02374346|39597977|FG000|Overall Study|operated or discharged during weekend|48|||
16303693|NCT02694328|39597980|FG000|Overall Study|Adverse Event|27|||
16303694|NCT02694328|39597981|FG001|Overall Study|Adverse Event|33|||
16303695|NCT02694328|39597980|FG000|Overall Study|Withdrawal by Subject|27|||
16303696|NCT02694328|39597981|FG001|Overall Study|Withdrawal by Subject|23|||
16492274|NCT01928394|40272690|FG010|Treatment Period|Death|0|||
16492275|NCT01928394|40272691|FG011|Treatment Period|Death|0|||
16492276|NCT01928394|40272692|FG012|Treatment Period|Death|0|||
16492277|NCT01928394|40272693|FG013|Treatment Period|Death|1|||
16492278|NCT01928394|40272694|FG014|Treatment Period|Death|2|||
16303697|NCT02694328|39597980|FG000|Overall Study|Lost to Follow-up|26|||
16303698|NCT02694328|39597981|FG001|Overall Study|Lost to Follow-up|22|||
16303699|NCT02694328|39597980|FG000|Overall Study|Noncompliant with study drug|11|||
16492279|NCT01928394|40272695|FG015|Treatment Period|Death|0|||
16492280|NCT01928394|40272696|FG016|Treatment Period|Death|0|||
16303700|NCT02694328|39597981|FG001|Overall Study|Noncompliant with study drug|8|||
16303701|NCT02694328|39597980|FG000|Overall Study|Incarceration|1|||
16303702|NCT02694328|39597981|FG001|Overall Study|Incarceration|1|||
16303703|NCT02694328|39597980|FG000|Overall Study|Lack of Efficacy|1|||
16303704|NCT02694328|39597981|FG001|Overall Study|Lack of Efficacy|2|||
16303705|NCT02694328|39597980|FG000|Overall Study|Pregnancy|1|||
16492281|NCT01928394|40272697|FG017|Treatment Period|Death|0|||
16492282|NCT01928394|40272698|FG018|Treatment Period|Death|0|||
16492283|NCT01928394|40272699|FG019|Treatment Period|Death|0|||
16492284|NCT01928394|40272700|FG020|Treatment Period|Death|0|||
16303706|NCT02694328|39597981|FG001|Overall Study|Pregnancy|1|||
16303707|NCT02694328|39597980|FG000|Overall Study|Protocol Violation|6|||
16303708|NCT02694328|39597981|FG001|Overall Study|Protocol Violation|5|||
16303709|NCT02694328|39597980|FG000|Overall Study|Abnormal Laboratory Value|0|||
16303710|NCT02694328|39597981|FG001|Overall Study|Abnormal Laboratory Value|3|||
16303711|NCT01557517|39597984|FG000|Overall Study|Death|1|||
16303712|NCT01557517|39597985|FG001|Overall Study|Death|0|||
16303713|NCT01557517|39597984|FG000|Overall Study|Refused further treatment|0|||
16303714|NCT01557517|39597985|FG001|Overall Study|Refused further treatment|2|||
16303715|NCT01557517|39597984|FG000|Overall Study|Adverse Event|0|||
16303716|NCT01557517|39597985|FG001|Overall Study|Adverse Event|2|||
16303717|NCT01557517|39597984|FG000|Overall Study|Pt declined before treatment started|1|||
16303718|NCT01557517|39597985|FG001|Overall Study|Pt declined before treatment started|0|||
16303719|NCT00338728|39597986|FG000|Overall Study|Screen Failure|14|||
16303720|NCT03336528|39597987|FG000|Overall Study|Protocol Violation|1|||
16303721|NCT03336528|39597988|FG001|Overall Study|Protocol Violation|1|||
16387995|NCT00953706|39902801|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
16387996|NCT00953706|39902802|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
16303722|NCT03336528|39597987|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
16303723|NCT03336528|39597988|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
16303724|NCT03336528|39597987|FG000|Overall Study|Did not receive study medication|1|||
16303725|NCT03336528|39597988|FG001|Overall Study|Did not receive study medication|2|||
16303726|NCT00663026|39597989|FG000|Overall Study|Lost to Follow-up|1|||
16303727|NCT00663026|39597990|FG001|Overall Study|Lost to Follow-up|0|||
16303728|NCT00663026|39597991|FG002|Overall Study|Lost to Follow-up|0|||
16303729|NCT00663026|39597989|FG000|Overall Study|Other|1|||
16303730|NCT00663026|39597990|FG001|Overall Study|Other|2|||
16303731|NCT00663026|39597991|FG002|Overall Study|Other|0|||
16303732|NCT00663026|39597989|FG000|Overall Study|Adverse Event|0|||
16303733|NCT00663026|39597990|FG001|Overall Study|Adverse Event|2|||
16303734|NCT00663026|39597991|FG002|Overall Study|Adverse Event|3|||
16303735|NCT00663026|39597989|FG000|Overall Study|Caregiver Request|0|||
16303736|NCT00663026|39597990|FG001|Overall Study|Caregiver Request|2|||
16303737|NCT00663026|39597991|FG002|Overall Study|Caregiver Request|0|||
16303738|NCT00663026|39597989|FG000|Overall Study|Withdrawal by Subject|0|||
16303739|NCT00663026|39597990|FG001|Overall Study|Withdrawal by Subject|0|||
16303740|NCT00663026|39597991|FG002|Overall Study|Withdrawal by Subject|1|||
16303741|NCT05093829|39597992|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
16303742|NCT05093829|39597993|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
16303743|NCT05093829|39597994|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
16303744|NCT05093829|39597995|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
16303745|NCT05093829|39597996|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
16303746|NCT03464630|39598000|FG000|Overall Study|Lost to Follow-up|62|||
16303747|NCT03464630|39598001|FG001|Overall Study|Lost to Follow-up|52|||
16387997|NCT00953706|39902803|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
16387998|NCT00953706|39902804|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
16387999|NCT00953706|39902801|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
16388000|NCT00953706|39902802|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
16388001|NCT00953706|39902803|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
16388002|NCT00953706|39902804|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
16388003|NCT00953706|39902801|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
16388004|NCT00953706|39902802|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
16388005|NCT00953706|39902803|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
16388006|NCT00953706|39902804|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
16388007|NCT00953706|39902801|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
16388008|NCT00953706|39902802|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
16388009|NCT00953706|39902803|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
16388010|NCT00953706|39902804|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
16388011|NCT00132301|39902805|FG000|Overall Study|Death|7|||
16388012|NCT00132301|39902806|FG001|Overall Study|Death|6|||
16388013|NCT00132301|39902805|FG000|Overall Study|Withdrawal by Subject|5|||
16388014|NCT00132301|39902806|FG001|Overall Study|Withdrawal by Subject|2|||
16388015|NCT00132301|39902805|FG000|Overall Study|Physician Decision|1|||
16303748|NCT03464630|39598000|FG000|Overall Study|Withdrawal by Subject|16|||
16388016|NCT00132301|39902806|FG001|Overall Study|Physician Decision|1|||
16303749|NCT03464630|39598001|FG001|Overall Study|Withdrawal by Subject|10|||
16303750|NCT03464630|39598000|FG000|Overall Study|Passive Disengagement|8|||
16303751|NCT03464630|39598001|FG001|Overall Study|Passive Disengagement|4|||
16303752|NCT00041132|39598002|FG000|Overall Study|Adverse Event|19|||
16303753|NCT00041132|39598002|FG000|Overall Study|Death|1|||
16303754|NCT00041132|39598002|FG000|Overall Study|Not Eligible|7|||
16303755|NCT00041132|39598002|FG000|Overall Study|Withdrawal by Subject|1|||
16303756|NCT00041132|39598002|FG000|Overall Study|Physician Decision|2|||
16303757|NCT02027428|39598004|FG000|Induction|Never treated|7|||
16303758|NCT02027428|39598005|FG001|Induction|Never treated|0|||
16303759|NCT02027428|39598006|FG002|Induction|Never treated|0|||
16303760|NCT02027428|39598004|FG000|Induction|Progressive disease|77|||
16303761|NCT02027428|39598005|FG001|Induction|Progressive disease|0|||
16303762|NCT02027428|39598006|FG002|Induction|Progressive disease|0|||
16303763|NCT02027428|39598004|FG000|Induction|Adverse Event|51|||
16303764|NCT02027428|39598005|FG001|Induction|Adverse Event|0|||
16303765|NCT02027428|39598006|FG002|Induction|Adverse Event|0|||
16303766|NCT02027428|39598004|FG000|Induction|Withdrawal by Subject|22|||
16303767|NCT02027428|39598005|FG001|Induction|Withdrawal by Subject|0|||
16303768|NCT02027428|39598006|FG002|Induction|Withdrawal by Subject|0|||
16303769|NCT02027428|39598004|FG000|Induction|Death|21|||
16303770|NCT02027428|39598005|FG001|Induction|Death|0|||
16303771|NCT02027428|39598006|FG002|Induction|Death|0|||
16303772|NCT02027428|39598004|FG000|Induction|Symptomatic deterioration|16|||
16303773|NCT02027428|39598005|FG001|Induction|Symptomatic deterioration|0|||
16303774|NCT02027428|39598006|FG002|Induction|Symptomatic deterioration|0|||
16303775|NCT02027428|39598004|FG000|Induction|Study terminated by sponsor|12|||
16303776|NCT02027428|39598005|FG001|Induction|Study terminated by sponsor|0|||
16303777|NCT02027428|39598006|FG002|Induction|Study terminated by sponsor|0|||
16303778|NCT02027428|39598004|FG000|Induction|Protocol Violation|1|||
16303779|NCT02027428|39598005|FG001|Induction|Protocol Violation|0|||
16303780|NCT02027428|39598006|FG002|Induction|Protocol Violation|0|||
16303781|NCT02027428|39598004|FG000|Induction|Miscellaneous|14|||
16303782|NCT02027428|39598005|FG001|Induction|Miscellaneous|0|||
16303783|NCT02027428|39598006|FG002|Induction|Miscellaneous|0|||
16303784|NCT02027428|39598004|FG000|Induction|Induction Treatment Ongoing|4|||
16303785|NCT02027428|39598005|FG001|Induction|Induction Treatment Ongoing|0|||
16303786|NCT02027428|39598006|FG002|Induction|Induction Treatment Ongoing|0|||
16303787|NCT02027428|39598004|FG000|Maintenance|Death|0|||
16303788|NCT02027428|39598005|FG001|Maintenance|Death|3|||
16303789|NCT02027428|39598006|FG002|Maintenance|Death|2|||
16303790|NCT02027428|39598004|FG000|Maintenance|Adverse Event|0|||
16303791|NCT02027428|39598005|FG001|Maintenance|Adverse Event|21|||
16303792|NCT02027428|39598006|FG002|Maintenance|Adverse Event|1|||
16303793|NCT02027428|39598004|FG000|Maintenance|Progressive disease|0|||
16303794|NCT02027428|39598005|FG001|Maintenance|Progressive disease|84|||
16303795|NCT02027428|39598006|FG002|Maintenance|Progressive disease|47|||
16303796|NCT02027428|39598004|FG000|Maintenance|Symptomatic deterioration|0|||
16303797|NCT02027428|39598005|FG001|Maintenance|Symptomatic deterioration|4|||
16303798|NCT02027428|39598006|FG002|Maintenance|Symptomatic deterioration|1|||
16303799|NCT02027428|39598004|FG000|Maintenance|Withdrawal by Subject|0|||
16303800|NCT02027428|39598005|FG001|Maintenance|Withdrawal by Subject|6|||
16303801|NCT02027428|39598006|FG002|Maintenance|Withdrawal by Subject|5|||
16303802|NCT02027428|39598004|FG000|Maintenance|Protocol Violation|0|||
16303803|NCT02027428|39598005|FG001|Maintenance|Protocol Violation|0|||
16303804|NCT02027428|39598006|FG002|Maintenance|Protocol Violation|1|||
16303805|NCT02027428|39598004|FG000|Maintenance|Other|0|||
16303806|NCT02027428|39598005|FG001|Maintenance|Other|6|||
16303807|NCT02027428|39598006|FG002|Maintenance|Other|3|||
16303808|NCT02027428|39598004|FG000|Survival Follow-up|Death|0|||
16303809|NCT02027428|39598005|FG001|Survival Follow-up|Death|78|||
16303810|NCT02027428|39598006|FG002|Survival Follow-up|Death|45|||
16303811|NCT02027428|39598004|FG000|Survival Follow-up|Lost to Follow-up|0|||
16303812|NCT02027428|39598005|FG001|Survival Follow-up|Lost to Follow-up|1|||
16303813|NCT02027428|39598006|FG002|Survival Follow-up|Lost to Follow-up|1|||
16303814|NCT02756611|39598007|FG000|Overall Study|Death|70|||
16303815|NCT02756611|39598007|FG000|Overall Study|Withdrawal by Subject|2|||
16303816|NCT02756611|39598007|FG000|Overall Study|Lost to Follow-up|3|||
16084277|NCT02561195|38802433|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
16084278|NCT02561195|38802434|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
16084279|NCT02561195|38802435|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
16193499|NCT01056341|39188558|FG003|Overall Study|Lack of Efficacy|25|||
16303817|NCT02756611|39598007|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
16303818|NCT02756611|39598007|FG000|Overall Study|Other|10|||
16303819|NCT02075515|39598008|FG000|Overall Study|Serious Adverse Event|1|||
16303820|NCT02075515|39598009|FG001|Overall Study|Serious Adverse Event|1|||
16303821|NCT02075515|39598010|FG002|Overall Study|Serious Adverse Event|1|||
16303822|NCT02075515|39598008|FG000|Overall Study|Non-Serious Adverse Event|0|||
16303823|NCT02075515|39598009|FG001|Overall Study|Non-Serious Adverse Event|1|||
16303824|NCT02075515|39598010|FG002|Overall Study|Non-Serious Adverse Event|0|||
16303825|NCT02075515|39598008|FG000|Overall Study|Withdrawal by Subject|2|||
16303826|NCT02075515|39598009|FG001|Overall Study|Withdrawal by Subject|0|||
16303827|NCT02075515|39598010|FG002|Overall Study|Withdrawal by Subject|1|||
16303828|NCT02075515|39598008|FG000|Overall Study|Lost to Follow-up|1|||
16303829|NCT02075515|39598009|FG001|Overall Study|Lost to Follow-up|3|||
16303830|NCT02075515|39598010|FG002|Overall Study|Lost to Follow-up|6|||
16303831|NCT01461538|39598015|FG000|Overall Study|Death|15|||
16303832|NCT01461538|39598016|FG001|Overall Study|Death|6|||
16303833|NCT01461538|39598017|FG002|Overall Study|Death|2|||
16303834|NCT01461538|39598015|FG000|Overall Study|Study Stopped by Sponsor|2|||
16303835|NCT01461538|39598016|FG001|Overall Study|Study Stopped by Sponsor|1|||
16303836|NCT01461538|39598017|FG002|Overall Study|Study Stopped by Sponsor|0|||
16303837|NCT01461538|39598015|FG000|Overall Study|Withdrawal by Subject|1|||
16303838|NCT01461538|39598016|FG001|Overall Study|Withdrawal by Subject|1|||
16303839|NCT01461538|39598017|FG002|Overall Study|Withdrawal by Subject|0|||
16303840|NCT01632280|39598020|FG000|Overall Study|Withdrawal by Subject|1|||
16303841|NCT01632280|39598021|FG001|Overall Study|Withdrawal by Subject|0|||
16303842|NCT00799058|39598026|FG000|Overall Study|Withdrawal by Subject|2|||
16303843|NCT00799058|39598027|FG001|Overall Study|Withdrawal by Subject|2|||
16303844|NCT00799058|39598028|FG002|Overall Study|Withdrawal by Subject|2|||
16303845|NCT00799058|39598026|FG000|Overall Study|Lost to Follow-up|1|||
16303846|NCT00799058|39598027|FG001|Overall Study|Lost to Follow-up|2|||
16303847|NCT00799058|39598028|FG002|Overall Study|Lost to Follow-up|1|||
16303848|NCT00799058|39598026|FG000|Overall Study|Adverse Event|0|||
16303849|NCT00799058|39598027|FG001|Overall Study|Adverse Event|2|||
16303850|NCT00799058|39598028|FG002|Overall Study|Adverse Event|0|||
16303851|NCT00799058|39598026|FG000|Overall Study|Pregnancy|1|||
16303852|NCT00799058|39598027|FG001|Overall Study|Pregnancy|0|||
16303853|NCT00799058|39598028|FG002|Overall Study|Pregnancy|0|||
16303854|NCT00799058|39598026|FG000|Overall Study|Not adherent|3|||
16303855|NCT00799058|39598027|FG001|Overall Study|Not adherent|2|||
16303856|NCT00799058|39598028|FG002|Overall Study|Not adherent|1|||
16303857|NCT00799058|39598026|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
16303858|NCT00799058|39598027|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
16303859|NCT00799058|39598028|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
16303860|NCT00799058|39598026|FG000|Overall Study|IP dispensing error|1|||
16303861|NCT00799058|39598027|FG001|Overall Study|IP dispensing error|0|||
16303862|NCT00799058|39598028|FG002|Overall Study|IP dispensing error|0|||
16303863|NCT00799058|39598026|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
16303864|NCT00799058|39598027|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
16303865|NCT00799058|39598028|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
16303866|NCT00799058|39598026|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
16303867|NCT00799058|39598027|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
16303868|NCT00799058|39598028|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
16303869|NCT00799058|39598026|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
16303870|NCT00799058|39598027|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
16303871|NCT00799058|39598028|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
16303872|NCT00799058|39598026|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
16303873|NCT00799058|39598027|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
16303874|NCT00799058|39598028|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
16303875|NCT01128179|39598030|FG000|Overall Study|Death|1|||
16303876|NCT01128179|39598031|FG001|Overall Study|Death|0|||
16303877|NCT01128179|39598030|FG000|Overall Study|Protocol Violation|1|||
16303878|NCT01128179|39598031|FG001|Overall Study|Protocol Violation|0|||
16303879|NCT03071276|39598034|FG000|Overall Study|Adverse Event|1|||
16303880|NCT03071276|39598034|FG000|Overall Study|Lack of Efficacy|14|||
16303881|NCT00447876|39598039|FG000|Overall Study|Withdrawal by Subject|1|||
16303882|NCT00447876|39598040|FG001|Overall Study|Withdrawal by Subject|4|||
16303883|NCT00447876|39598039|FG000|Overall Study|Lost to Follow-up|1|||
16303884|NCT00447876|39598040|FG001|Overall Study|Lost to Follow-up|0|||
16303885|NCT00447876|39598039|FG000|Overall Study|Deterioration of symptomology|1|||
16303886|NCT00447876|39598040|FG001|Overall Study|Deterioration of symptomology|0|||
16303887|NCT00359801|39598046|FG000|Overall Study|Lost to Follow-up|72|||
16303888|NCT00359801|39598047|FG001|Overall Study|Lost to Follow-up|58|||
16303889|NCT00359801|39598046|FG000|Overall Study|Withdrawal by Subject|143|||
16303890|NCT00359801|39598047|FG001|Overall Study|Withdrawal by Subject|96|||
16303891|NCT00359801|39598046|FG000|Overall Study|Other|66|||
16303892|NCT00359801|39598047|FG001|Overall Study|Other|46|||
16303893|NCT00359801|39598046|FG000|Overall Study|Final Status Unknown: missing data|7|||
16303894|NCT00359801|39598047|FG001|Overall Study|Final Status Unknown: missing data|4|||
16303895|NCT00359801|39598046|FG000|Overall Study|Sponsor Decision|17|||
16303896|NCT00359801|39598047|FG001|Overall Study|Sponsor Decision|16|||
16303897|NCT01855828|39598048|FG000|Overall Study|Adverse Event|1|||
16303898|NCT01855828|39598048|FG000|Overall Study|Withdrawal by Subject|1|||
16303899|NCT01555671|39598049|FG000|Overall Study|Physician Decision|20|||
16303900|NCT01555671|39598050|FG001|Overall Study|Physician Decision|25|||
16303901|NCT03279692|39598051|FG000|Overall Study|Withdrawal by Subject|1|||
16303902|NCT02439216|39598052|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
16303903|NCT02439216|39598053|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16303904|NCT02439216|39598054|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16303905|NCT02439216|39598055|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16303906|NCT02439216|39598056|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16303907|NCT02439216|39598057|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16303908|NCT02439216|39598058|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16303909|NCT02439216|39598059|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16303910|NCT02439216|39598060|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
16303911|NCT02439216|39598052|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16303912|NCT02439216|39598053|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16303913|NCT02439216|39598054|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16303914|NCT02439216|39598055|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16388017|NCT00132301|39902805|FG000|Overall Study|Lost to Follow-up|5|||
16388018|NCT00132301|39902806|FG001|Overall Study|Lost to Follow-up|3|||
16388019|NCT00132301|39902805|FG000|Overall Study|Other|1|||
16492285|NCT01928394|40272701|FG021|Treatment Period|Death|0|||
16492286|NCT01928394|40272702|FG022|Treatment Period|Death|0|||
16492287|NCT01928394|40272680|FG000|Follow-up Period|Participant withdrew consent|3|||
16492288|NCT01928394|40272681|FG001|Follow-up Period|Participant withdrew consent|0|||
16492289|NCT01928394|40272682|FG002|Follow-up Period|Participant withdrew consent|1|||
16492290|NCT01928394|40272683|FG003|Follow-up Period|Participant withdrew consent|4|||
16492291|NCT01928394|40272684|FG004|Follow-up Period|Participant withdrew consent|0|||
16492292|NCT01928394|40272685|FG005|Follow-up Period|Participant withdrew consent|2|||
16492293|NCT01928394|40272686|FG006|Follow-up Period|Participant withdrew consent|5|||
16492294|NCT01928394|40272687|FG007|Follow-up Period|Participant withdrew consent|1|||
16492295|NCT01928394|40272688|FG008|Follow-up Period|Participant withdrew consent|0|||
16492296|NCT01928394|40272689|FG009|Follow-up Period|Participant withdrew consent|0|||
16492297|NCT01928394|40272690|FG010|Follow-up Period|Participant withdrew consent|5|||
16492298|NCT01928394|40272691|FG011|Follow-up Period|Participant withdrew consent|8|||
16492299|NCT01928394|40272692|FG012|Follow-up Period|Participant withdrew consent|2|||
16492300|NCT01928394|40272693|FG013|Follow-up Period|Participant withdrew consent|12|||
16492301|NCT01928394|40272694|FG014|Follow-up Period|Participant withdrew consent|7|||
16492302|NCT01928394|40272695|FG015|Follow-up Period|Participant withdrew consent|0|||
16492303|NCT01928394|40272696|FG016|Follow-up Period|Participant withdrew consent|5|||
16492304|NCT01928394|40272697|FG017|Follow-up Period|Participant withdrew consent|3|||
16492305|NCT01928394|40272698|FG018|Follow-up Period|Participant withdrew consent|2|||
16492306|NCT01928394|40272699|FG019|Follow-up Period|Participant withdrew consent|7|||
16492307|NCT01928394|40272700|FG020|Follow-up Period|Participant withdrew consent|4|||
16492308|NCT01928394|40272701|FG021|Follow-up Period|Participant withdrew consent|6|||
16492309|NCT01928394|40272702|FG022|Follow-up Period|Participant withdrew consent|2|||
16492310|NCT01928394|40272680|FG000|Follow-up Period|Death|0|||
16492311|NCT01928394|40272681|FG001|Follow-up Period|Death|0|||
16492312|NCT01928394|40272682|FG002|Follow-up Period|Death|2|||
16492313|NCT01928394|40272683|FG003|Follow-up Period|Death|6|||
16492314|NCT01928394|40272684|FG004|Follow-up Period|Death|0|||
16492315|NCT01928394|40272685|FG005|Follow-up Period|Death|6|||
16492316|NCT01928394|40272686|FG006|Follow-up Period|Death|6|||
16492317|NCT01928394|40272687|FG007|Follow-up Period|Death|2|||
16492318|NCT01928394|40272688|FG008|Follow-up Period|Death|1|||
16492319|NCT01928394|40272689|FG009|Follow-up Period|Death|2|||
16492320|NCT01928394|40272690|FG010|Follow-up Period|Death|4|||
16492321|NCT01928394|40272691|FG011|Follow-up Period|Death|12|||
16492322|NCT01928394|40272692|FG012|Follow-up Period|Death|11|||
16492323|NCT01928394|40272693|FG013|Follow-up Period|Death|25|||
16492324|NCT01928394|40272694|FG014|Follow-up Period|Death|18|||
16492325|NCT01928394|40272695|FG015|Follow-up Period|Death|0|||
16492326|NCT01928394|40272696|FG016|Follow-up Period|Death|6|||
16492327|NCT01928394|40272697|FG017|Follow-up Period|Death|5|||
16492328|NCT01928394|40272698|FG018|Follow-up Period|Death|13|||
16492329|NCT01928394|40272699|FG019|Follow-up Period|Death|13|||
16492330|NCT01928394|40272700|FG020|Follow-up Period|Death|5|||
16492331|NCT01928394|40272701|FG021|Follow-up Period|Death|3|||
16193500|NCT01056341|39188559|FG004|Overall Study|Lack of Efficacy|9|||
16492332|NCT01928394|40272702|FG022|Follow-up Period|Death|2|||
16492333|NCT01928394|40272680|FG000|Follow-up Period|other reason|0|||
16492334|NCT01928394|40272681|FG001|Follow-up Period|other reason|0|||
16492335|NCT01928394|40272682|FG002|Follow-up Period|other reason|0|||
16492336|NCT01928394|40272683|FG003|Follow-up Period|other reason|0|||
16492337|NCT01928394|40272684|FG004|Follow-up Period|other reason|0|||
16492338|NCT01928394|40272685|FG005|Follow-up Period|other reason|0|||
16492339|NCT01928394|40272686|FG006|Follow-up Period|other reason|1|||
16492340|NCT01928394|40272687|FG007|Follow-up Period|other reason|3|||
16492341|NCT01928394|40272688|FG008|Follow-up Period|other reason|0|||
16492342|NCT01928394|40272689|FG009|Follow-up Period|other reason|0|||
16492343|NCT01928394|40272690|FG010|Follow-up Period|other reason|2|||
16492344|NCT01928394|40272691|FG011|Follow-up Period|other reason|1|||
16492345|NCT01928394|40272692|FG012|Follow-up Period|other reason|0|||
16492346|NCT01928394|40272693|FG013|Follow-up Period|other reason|1|||
16492347|NCT01928394|40272694|FG014|Follow-up Period|other reason|4|||
16492348|NCT01928394|40272695|FG015|Follow-up Period|other reason|0|||
16492349|NCT01928394|40272696|FG016|Follow-up Period|other reason|2|||
16492350|NCT01928394|40272697|FG017|Follow-up Period|other reason|0|||
16492351|NCT01928394|40272698|FG018|Follow-up Period|other reason|1|||
16492352|NCT01928394|40272699|FG019|Follow-up Period|other reason|1|||
16492353|NCT01928394|40272700|FG020|Follow-up Period|other reason|0|||
16492354|NCT01928394|40272701|FG021|Follow-up Period|other reason|0|||
16492355|NCT01928394|40272702|FG022|Follow-up Period|other reason|1|||
16492356|NCT01928394|40272680|FG000|Follow-up Period|Lost to Follow-up|0|||
16492357|NCT01928394|40272681|FG001|Follow-up Period|Lost to Follow-up|0|||
16492358|NCT01928394|40272682|FG002|Follow-up Period|Lost to Follow-up|0|||
16492359|NCT01928394|40272683|FG003|Follow-up Period|Lost to Follow-up|0|||
16492360|NCT01928394|40272684|FG004|Follow-up Period|Lost to Follow-up|0|||
16492361|NCT01928394|40272685|FG005|Follow-up Period|Lost to Follow-up|0|||
16492362|NCT01928394|40272686|FG006|Follow-up Period|Lost to Follow-up|0|||
16492363|NCT01928394|40272687|FG007|Follow-up Period|Lost to Follow-up|0|||
16492364|NCT01928394|40272688|FG008|Follow-up Period|Lost to Follow-up|0|||
16492365|NCT01928394|40272689|FG009|Follow-up Period|Lost to Follow-up|0|||
16492366|NCT01928394|40272690|FG010|Follow-up Period|Lost to Follow-up|0|||
16492367|NCT01928394|40272691|FG011|Follow-up Period|Lost to Follow-up|1|||
16492368|NCT01928394|40272692|FG012|Follow-up Period|Lost to Follow-up|1|||
16492369|NCT01928394|40272693|FG013|Follow-up Period|Lost to Follow-up|0|||
16492370|NCT01928394|40272694|FG014|Follow-up Period|Lost to Follow-up|1|||
16492371|NCT01928394|40272695|FG015|Follow-up Period|Lost to Follow-up|0|||
16492372|NCT01928394|40272696|FG016|Follow-up Period|Lost to Follow-up|1|||
16492373|NCT01928394|40272697|FG017|Follow-up Period|Lost to Follow-up|0|||
16492374|NCT01928394|40272698|FG018|Follow-up Period|Lost to Follow-up|0|||
16492375|NCT01928394|40272699|FG019|Follow-up Period|Lost to Follow-up|0|||
16492376|NCT01928394|40272700|FG020|Follow-up Period|Lost to Follow-up|0|||
16492377|NCT01928394|40272701|FG021|Follow-up Period|Lost to Follow-up|0|||
16492378|NCT01928394|40272702|FG022|Follow-up Period|Lost to Follow-up|1|||
16492379|NCT00696696|40272707|FG000|Overall Study|Adverse Event|5|||
16492380|NCT00696696|40272707|FG000|Overall Study|Withdrawal by Subject|8|||
16492381|NCT00696696|40272707|FG000|Overall Study|Physician Decision|2|||
16492382|NCT00696696|40272707|FG000|Overall Study|Death|3|||
16492383|NCT01877265|40272708|FG000|Treatment Period 1|Sponsor Decision|0|||
16492384|NCT01877265|40272709|FG001|Treatment Period 1|Sponsor Decision|0|||
16492385|NCT01877265|40272710|FG002|Treatment Period 1|Sponsor Decision|1|||
16492386|NCT01877265|40272711|FG003|Treatment Period 1|Sponsor Decision|0|||
16492387|NCT01877265|40272712|FG004|Treatment Period 1|Sponsor Decision|0|||
16492388|NCT01877265|40272713|FG005|Treatment Period 1|Sponsor Decision|0|||
16492389|NCT01877265|40272708|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
16492390|NCT01877265|40272709|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
16492391|NCT01877265|40272710|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
16492392|NCT01877265|40272711|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
16492393|NCT01877265|40272712|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
16492394|NCT01877265|40272713|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
16492395|NCT01877265|40272708|FG000|Treatment Period 3|Lost to Follow-up|1|||
16492396|NCT01877265|40272709|FG001|Treatment Period 3|Lost to Follow-up|0|||
16492397|NCT01877265|40272710|FG002|Treatment Period 3|Lost to Follow-up|0|||
16492398|NCT01877265|40272711|FG003|Treatment Period 3|Lost to Follow-up|0|||
16492399|NCT01877265|40272712|FG004|Treatment Period 3|Lost to Follow-up|0|||
16492400|NCT01877265|40272713|FG005|Treatment Period 3|Lost to Follow-up|0|||
16492401|NCT02954237|40272716|FG000|Overall Study|Withdrawal by Subject|25|||
16492402|NCT02954237|40272716|FG000|Overall Study|Missed visit|16|||
16492403|NCT02954237|40272716|FG000|Overall Study|Death|2|||
16492404|NCT01892293|40272717|FG000|Overall Study|Apheresed but not treated|4|||
16492405|NCT00023764|40272718|FG000|Overall Study|Other|1|||
16492406|NCT00023764|40272718|FG000|Overall Study|Adverse Event|4|||
16492407|NCT00023764|40272718|FG000|Overall Study|Withdrawal by Subject|1|||
16492408|NCT00023764|40272718|FG000|Overall Study|Progression of disease|6|||
16492409|NCT00023764|40272718|FG000|Overall Study|patient received other treatment|1|||
16492410|NCT00023764|40272718|FG000|Overall Study|delay in obtaining staging images|1|||
16492411|NCT01473836|40272719|FG000|Overall Study|Adverse Event|4|||
16492412|NCT01473836|40272719|FG000|Overall Study|Lack of Efficacy|1|||
16492413|NCT01473836|40272719|FG000|Overall Study|Does not meet entrance criteria|1|||
16492414|NCT03194321|40272720|FG000|Overall Study|Withdrawal by Subject|1|||
16492415|NCT03194321|40272720|FG000|Overall Study|Lost to Follow-up|1|||
16492416|NCT03194321|40272720|FG000|Overall Study|Travel for Follow-up|1|||
16492417|NCT01339429|40272721|FG000|Overall Study|Withdrawal by Subject|1|||
16492418|NCT01339429|40272721|FG000|Overall Study|Physician Decision|3|||
16492419|NCT01414855|40272722|FG000|Overall Study|Death|17|||
16492420|NCT01414855|40272722|FG000|Overall Study|Lost to Follow-up|5|||
16492421|NCT01414855|40272722|FG000|Overall Study|Withdrawal by Subject|7|||
16492422|NCT01005745|40272723|FG000|Overall Study|No TIL growth|1|||
16492423|NCT01005745|40272723|FG000|Overall Study|Disease progressed during TIL growth|3|||
16492424|NCT01005745|40272723|FG000|Overall Study|Death prior to treatment|1|||
16492425|NCT01005745|40272723|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
16492426|NCT01658072|40272724|FG000|Overall Study|Protocol Violation|4|||
16492427|NCT01658072|40272725|FG001|Overall Study|Protocol Violation|2|||
16492428|NCT00217620|40272730|FG000|Overall Study|Adverse Event|2|||
16492429|NCT00217620|40272730|FG000|Overall Study|Progression|31|||
16492430|NCT00217620|40272730|FG000|Overall Study|Not Protocol Specified|4|||
16492431|NCT00217620|40272730|FG000|Overall Study|Ineligible|13|||
16492432|NCT00217620|40272730|FG000|Overall Study|Never received treatment|1|||
16492433|NCT02927431|40272735|FG000|Overall Study|Withdrawal by Subject|0|||
16492434|NCT02927431|40272736|FG001|Overall Study|Withdrawal by Subject|0|||
16492435|NCT02927431|40272737|FG002|Overall Study|Withdrawal by Subject|1|||
16492436|NCT02507505|40272738|FG000|Overall Study|Withdrawal by Subject|13|||
16492437|NCT02507505|40272739|FG001|Overall Study|Withdrawal by Subject|11|||
16492438|NCT02507505|40272738|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
16492439|NCT02507505|40272739|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
16492440|NCT02507505|40272738|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
16492441|NCT02507505|40272739|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
16492442|NCT02507505|40272738|FG000|Overall Study|Death before receipt of anesthesia|0|||
16492443|NCT02507505|40272739|FG001|Overall Study|Death before receipt of anesthesia|1|||
16492444|NCT00644995|40272740|FG000|Overall Study|Lost to Follow-up|1|||
16492445|NCT00644995|40272741|FG001|Overall Study|Lost to Follow-up|4|||
16492446|NCT00644995|40272740|FG000|Overall Study|Refused|1|||
16492447|NCT00644995|40272741|FG001|Overall Study|Refused|0|||
16492448|NCT02820753|40272742|FG000|2 Month|Withdrawal by Subject|3|||
16492449|NCT02820753|40272743|FG001|2 Month|Withdrawal by Subject|3|||
16492450|NCT02820753|40272742|FG000|2 Month|Lost to Follow-up|24|||
16492451|NCT02820753|40272743|FG001|2 Month|Lost to Follow-up|26|||
16492452|NCT02820753|40272742|FG000|2 Month|Stopped per NIH Hold|51|||
16492453|NCT02820753|40272743|FG001|2 Month|Stopped per NIH Hold|13|||
16492454|NCT02820753|40272742|FG000|6 Month|Withdrawal by Subject|2|||
16492455|NCT02820753|40272743|FG001|6 Month|Withdrawal by Subject|2|||
16492456|NCT02820753|40272742|FG000|6 Month|Lost to Follow-up|20|||
16492457|NCT02820753|40272743|FG001|6 Month|Lost to Follow-up|27|||
16492458|NCT02820753|40272742|FG000|6 Month|Stopped per NIH Hold|81|||
16492459|NCT02820753|40272743|FG001|6 Month|Stopped per NIH Hold|81|||
16492460|NCT02820753|40272742|FG000|6 Month|Death|0|||
16492461|NCT02820753|40272743|FG001|6 Month|Death|1|||
16084280|NCT02561195|38802436|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
16492462|NCT04342897|40272744|FG000|Overall Study|Death|7|||
16492463|NCT04342897|40272745|FG001|Overall Study|Death|4|||
16492464|NCT04342897|40272744|FG000|Overall Study|Lost to Follow-up|6|||
16492465|NCT04342897|40272745|FG001|Overall Study|Lost to Follow-up|6|||
16492466|NCT04342897|40272744|FG000|Overall Study|Withdrawal by Subject|1|||
16492467|NCT04342897|40272745|FG001|Overall Study|Withdrawal by Subject|2|||
16492468|NCT04900220|40272752|FG000|Overall Study|Lost to Follow-up|1|||
16492469|NCT04900220|40272753|FG001|Overall Study|Lost to Follow-up|1|||
16492470|NCT03187197|40272754|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
16492471|NCT03187197|40272755|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
16492472|NCT03187197|40272756|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
16492473|NCT03187197|40272754|FG000|Overall Study|Withdrawal by Subject|8|||
16492474|NCT03187197|40272755|FG001|Overall Study|Withdrawal by Subject|63|||
16492475|NCT03187197|40272756|FG002|Overall Study|Withdrawal by Subject|4|||
16492476|NCT03187197|40272754|FG000|Overall Study|Lost to Follow-up|1|||
16492477|NCT03187197|40272755|FG001|Overall Study|Lost to Follow-up|60|||
16492478|NCT03187197|40272756|FG002|Overall Study|Lost to Follow-up|7|||
16492479|NCT03187197|40272754|FG000|Overall Study|Adverse Event|6|||
16492480|NCT03187197|40272755|FG001|Overall Study|Adverse Event|29|||
16492481|NCT03187197|40272756|FG002|Overall Study|Adverse Event|0|||
16084281|NCT02561195|38802437|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
16084282|NCT02561195|38802438|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
16084283|NCT02561195|38802439|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
16084284|NCT02561195|38802440|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
16084285|NCT02561195|38802441|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
16084286|NCT02561195|38802442|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
16084287|NCT02561195|38802443|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
16084288|NCT02561195|38802444|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
16084289|NCT02561195|38802431|FG000|Extension Stage (Vaccination 4)|Death|0|||
16084290|NCT02561195|38802432|FG001|Extension Stage (Vaccination 4)|Death|0|||
16084291|NCT02561195|38802433|FG002|Extension Stage (Vaccination 4)|Death|0|||
16084292|NCT02561195|38802434|FG003|Extension Stage (Vaccination 4)|Death|0|||
16084293|NCT02561195|38802435|FG004|Extension Stage (Vaccination 4)|Death|0|||
16084294|NCT02561195|38802436|FG005|Extension Stage (Vaccination 4)|Death|0|||
16084295|NCT02561195|38802437|FG006|Extension Stage (Vaccination 4)|Death|0|||
16084296|NCT02561195|38802438|FG007|Extension Stage (Vaccination 4)|Death|0|||
16084297|NCT02561195|38802439|FG008|Extension Stage (Vaccination 4)|Death|0|||
16084298|NCT02561195|38802440|FG009|Extension Stage (Vaccination 4)|Death|1|||
16084299|NCT02561195|38802441|FG010|Extension Stage (Vaccination 4)|Death|0|||
16084300|NCT02561195|38802442|FG011|Extension Stage (Vaccination 4)|Death|0|||
16084301|NCT02561195|38802443|FG012|Extension Stage (Vaccination 4)|Death|0|||
16084302|NCT02561195|38802444|FG013|Extension Stage (Vaccination 4)|Death|0|||
16084303|NCT02561195|38802431|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16084304|NCT02561195|38802432|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16084305|NCT02561195|38802433|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16084306|NCT02561195|38802434|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16084307|NCT02561195|38802435|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16084308|NCT02561195|38802436|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16084309|NCT02561195|38802437|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
16084310|NCT02561195|38802438|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
16084311|NCT02561195|38802439|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16084312|NCT02561195|38802440|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
16084313|NCT02561195|38802441|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
16084314|NCT02561195|38802442|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
16084315|NCT02561195|38802443|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
16084316|NCT02561195|38802444|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
16084317|NCT02561195|38802431|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16084318|NCT02561195|38802432|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16084319|NCT02561195|38802433|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16084320|NCT02561195|38802434|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16084321|NCT02561195|38802435|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16084322|NCT02561195|38802436|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16084323|NCT02561195|38802437|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16084324|NCT02561195|38802438|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16084325|NCT02561195|38802439|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16084326|NCT02561195|38802440|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16492482|NCT03187197|40272754|FG000|Overall Study|Death|0|||
16084327|NCT02561195|38802441|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
16084328|NCT02561195|38802442|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
16193501|NCT01056341|39188555|FG000|Overall Study|Other reasons|4|||
16492483|NCT03187197|40272755|FG001|Overall Study|Death|11|||
16492484|NCT03187197|40272756|FG002|Overall Study|Death|0|||
16492485|NCT03187197|40272754|FG000|Overall Study|Administrative problem|1|||
16492486|NCT03187197|40272755|FG001|Overall Study|Administrative problem|1|||
16492487|NCT03187197|40272756|FG002|Overall Study|Administrative problem|0|||
16492488|NCT03187197|40272754|FG000|Overall Study|Reason not listed|2|||
16492489|NCT03187197|40272755|FG001|Overall Study|Reason not listed|54|||
16492490|NCT03187197|40272756|FG002|Overall Study|Reason not listed|1|||
16492491|NCT03187197|40272754|FG000|Overall Study|Missing|1|||
16492492|NCT03187197|40272755|FG001|Overall Study|Missing|32|||
16492493|NCT03187197|40272756|FG002|Overall Study|Missing|3|||
16492494|NCT03187197|40272754|FG000|Overall Study|Status missing|2|||
16492495|NCT03187197|40272755|FG001|Overall Study|Status missing|33|||
16492496|NCT03187197|40272756|FG002|Overall Study|Status missing|3|||
16492497|NCT03187197|40272754|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
16492498|NCT03187197|40272755|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
16303915|NCT02439216|39598056|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16303916|NCT02439216|39598057|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16303917|NCT02439216|39598058|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16303918|NCT02439216|39598059|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
16492499|NCT03187197|40272756|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
16084329|NCT02561195|38802443|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
16492500|NCT02925494|40272757|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
16492501|NCT02925494|40272758|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
16492502|NCT02925494|40272759|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
16492503|NCT02925494|40272760|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
16492504|NCT02925494|40272757|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
16492505|NCT02925494|40272758|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
16492506|NCT02925494|40272759|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
16492507|NCT02925494|40272760|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
16492508|NCT02925494|40272757|FG000|Post-Treatment Follow-Up Period|Other|1|||
16492509|NCT02925494|40272758|FG001|Post-Treatment Follow-Up Period|Other|4|||
16492510|NCT02925494|40272759|FG002|Post-Treatment Follow-Up Period|Other|3|||
16492511|NCT02925494|40272760|FG003|Post-Treatment Follow-Up Period|Other|6|||
16492512|NCT02925494|40272757|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
16492513|NCT02925494|40272758|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
16492514|NCT02925494|40272759|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
16492515|NCT02925494|40272760|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
16492516|NCT02925494|40272757|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
16492517|NCT02925494|40272758|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
16492518|NCT02925494|40272759|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
16492519|NCT02925494|40272760|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
16492520|NCT02925494|40272757|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
16492521|NCT02925494|40272758|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
16492522|NCT02925494|40272759|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
16492523|NCT02925494|40272760|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
16492524|NCT02925494|40272757|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
16492525|NCT02925494|40272758|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
16492526|NCT02925494|40272759|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
16492527|NCT02925494|40272760|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
16492528|NCT00403234|40272761|FG000|Overall Study|Withdrawal by Subject|0|||
16492529|NCT00403234|40272762|FG001|Overall Study|Withdrawal by Subject|1|||
16492530|NCT00403234|40272763|FG002|Overall Study|Withdrawal by Subject|0|||
16492531|NCT00403234|40272764|FG003|Overall Study|Withdrawal by Subject|0|||
16492532|NCT00403234|40272761|FG000|Overall Study|Adverse Event|1|||
16492533|NCT00403234|40272762|FG001|Overall Study|Adverse Event|0|||
16492534|NCT00403234|40272763|FG002|Overall Study|Adverse Event|1|||
16492535|NCT00403234|40272764|FG003|Overall Study|Adverse Event|0|||
16492536|NCT01919723|40272767|FG000|Overall Study|Blood Samples Hemolyzed|2|||
16492537|NCT01919723|40272768|FG001|Overall Study|Blood Samples Hemolyzed|2|||
16084330|NCT02561195|38802444|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
16084331|NCT02561195|38802431|FG000|Extension Stage (Vaccination 4)|Other|0|||
16084332|NCT02561195|38802432|FG001|Extension Stage (Vaccination 4)|Other|0|||
16303919|NCT02439216|39598060|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
16303920|NCT02439216|39598052|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16303921|NCT02439216|39598053|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16303922|NCT02439216|39598054|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16303923|NCT02439216|39598055|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16303924|NCT02439216|39598056|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16303925|NCT02439216|39598057|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16492538|NCT01537393|40272769|FG000|Overall Study|Exclude prior to study|32|||
16492539|NCT01537393|40272770|FG001|Overall Study|Exclude prior to study|44|||
16193502|NCT01056341|39188556|FG001|Overall Study|Other reasons|4|||
16492540|NCT01537393|40272769|FG000|Overall Study|Death|20|||
16492541|NCT01537393|40272770|FG001|Overall Study|Death|32|||
16492542|NCT01537393|40272769|FG000|Overall Study|Withdrawal by Subject|18|||
16492543|NCT01537393|40272770|FG001|Overall Study|Withdrawal by Subject|17|||
16492544|NCT01537393|40272769|FG000|Overall Study|Lost to Follow-up|53|||
16492545|NCT01537393|40272770|FG001|Overall Study|Lost to Follow-up|48|||
16492546|NCT01537393|40272769|FG000|Overall Study|Failure - Regrafted|28|||
16492547|NCT01537393|40272770|FG001|Overall Study|Failure - Regrafted|43|||
16492548|NCT01537393|40272769|FG000|Overall Study|Failure - Not regrafted|2|||
16492549|NCT01537393|40272770|FG001|Overall Study|Failure - Not regrafted|6|||
16492550|NCT01537393|40272769|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
16492551|NCT01537393|40272770|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
16492552|NCT02634320|40272771|FG000|Overall Study|Adverse Event|2|||
16492553|NCT02634320|40272771|FG000|Overall Study|Lost to Follow-up|3|||
16492554|NCT02634320|40272771|FG000|Overall Study|Moved out of area|2|||
16492555|NCT02634320|40272771|FG000|Overall Study|Out of window for study visits|1|||
16492556|NCT02634320|40272771|FG000|Overall Study|Protocol Violation|1|||
16492557|NCT02634320|40272771|FG000|Overall Study|Withdrawal by Subject|5|||
16492558|NCT02634320|40272771|FG000|Overall Study|Lack of Efficacy|2|||
16492559|NCT00127660|40272772|FG000|Overall Study|Protocol Violation|3|||
16492560|NCT00127660|40272773|FG001|Overall Study|Protocol Violation|3|||
16492561|NCT00127660|40272774|FG002|Overall Study|Protocol Violation|5|||
16492562|NCT00127660|40272775|FG003|Overall Study|Protocol Violation|0|||
16492563|NCT00001723|40272776|FG000|Overall Study|Lack of Efficacy|6|||
16492564|NCT00001723|40272777|FG001|Overall Study|Lack of Efficacy|7|||
16492565|NCT00001723|40272776|FG000|Overall Study|Lack of family interest|4|||
16492566|NCT00001723|40272777|FG001|Overall Study|Lack of family interest|5|||
16492567|NCT00001723|40272776|FG000|Overall Study|Lost to Follow-up|2|||
16492568|NCT00001723|40272777|FG001|Overall Study|Lost to Follow-up|2|||
16492569|NCT00001723|40272776|FG000|Overall Study|medication intolerance|1|||
16492570|NCT00001723|40272777|FG001|Overall Study|medication intolerance|2|||
16492571|NCT00429104|40272778|FG000|Overall Study|Protocol Violation|1|||
16492572|NCT01977794|40272779|FG000|Overall Study|Adverse Event|2|||
16492573|NCT01977794|40272780|FG001|Overall Study|Adverse Event|2|||
16492574|NCT01977794|40272779|FG000|Overall Study|Lost to Follow-up|2|||
16492575|NCT01977794|40272780|FG001|Overall Study|Lost to Follow-up|1|||
16492576|NCT01977794|40272779|FG000|Overall Study|Protocol Violation|1|||
16492577|NCT01977794|40272780|FG001|Overall Study|Protocol Violation|0|||
16492578|NCT01977794|40272779|FG000|Overall Study|Death|1|||
16492579|NCT01977794|40272780|FG001|Overall Study|Death|1|||
16492580|NCT01977794|40272779|FG000|Overall Study|Withdrew consent|2|||
16492581|NCT01977794|40272780|FG001|Overall Study|Withdrew consent|1|||
16492582|NCT01977794|40272779|FG000|Overall Study|Other|0|||
16492583|NCT01977794|40272780|FG001|Overall Study|Other|1|||
16492584|NCT02980601|40272781|FG000|Overall Study|Lost to Follow-up|2|||
16492585|NCT02980601|40272782|FG001|Overall Study|Lost to Follow-up|2|||
16492586|NCT02980601|40272781|FG000|Overall Study|Death|0|||
16492587|NCT02980601|40272782|FG001|Overall Study|Death|1|||
16492588|NCT02980601|40272781|FG000|Overall Study|Graft loss|1|||
16492589|NCT02980601|40272782|FG001|Overall Study|Graft loss|0|||
16492590|NCT02980601|40272781|FG000|Overall Study|Failed to sign consent|2|||
16492591|NCT02980601|40272782|FG001|Overall Study|Failed to sign consent|0|||
16492592|NCT01153347|40276248|FG000|Overall Study|Withdrawal by Subject|7|||
16492593|NCT01153347|40276249|FG001|Overall Study|Withdrawal by Subject|7|||
16492594|NCT01153347|40276250|FG002|Overall Study|Withdrawal by Subject|7|||
16492595|NCT01153347|40276251|FG003|Overall Study|Withdrawal by Subject|7|||
16492596|NCT01153347|40276248|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16492597|NCT01153347|40276249|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16492598|NCT01153347|40276250|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
16492599|NCT01153347|40276251|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
16492600|NCT01153347|40276248|FG000|Overall Study|Adverse Event|3|||
16492601|NCT01153347|40276249|FG001|Overall Study|Adverse Event|9|||
16492602|NCT01153347|40276250|FG002|Overall Study|Adverse Event|21|||
16492603|NCT01153347|40276251|FG003|Overall Study|Adverse Event|7|||
16492604|NCT01153347|40276248|FG000|Overall Study|Severe non-compliance to protocol|6|||
16492605|NCT01153347|40276249|FG001|Overall Study|Severe non-compliance to protocol|7|||
16492606|NCT01153347|40276250|FG002|Overall Study|Severe non-compliance to protocol|4|||
16084333|NCT02561195|38802433|FG002|Extension Stage (Vaccination 4)|Other|0|||
16193503|NCT01056341|39188557|FG002|Overall Study|Other reasons|8|||
16492607|NCT01153347|40276251|FG003|Overall Study|Severe non-compliance to protocol|3|||
16492608|NCT01153347|40276248|FG000|Overall Study|Condition under investigation worsened|1|||
16492609|NCT01153347|40276249|FG001|Overall Study|Condition under investigation worsened|1|||
16492610|NCT01153347|40276250|FG002|Overall Study|Condition under investigation worsened|0|||
16492611|NCT01153347|40276251|FG003|Overall Study|Condition under investigation worsened|0|||
16492612|NCT01153347|40276248|FG000|Overall Study|Lack of Efficacy|2|||
16492613|NCT01153347|40276249|FG001|Overall Study|Lack of Efficacy|2|||
16492614|NCT01153347|40276250|FG002|Overall Study|Lack of Efficacy|0|||
16084334|NCT02561195|38802434|FG003|Extension Stage (Vaccination 4)|Other|0|||
16492615|NCT01153347|40276251|FG003|Overall Study|Lack of Efficacy|4|||
16492616|NCT01153347|40276248|FG000|Overall Study|Study-specific withdrawal criteria|4|||
16492617|NCT01153347|40276249|FG001|Overall Study|Study-specific withdrawal criteria|3|||
16492618|NCT01153347|40276250|FG002|Overall Study|Study-specific withdrawal criteria|1|||
16492619|NCT01153347|40276251|FG003|Overall Study|Study-specific withdrawal criteria|2|||
16492620|NCT01153347|40276248|FG000|Overall Study|Lost to Follow-up|4|||
16492621|NCT01153347|40276249|FG001|Overall Study|Lost to Follow-up|9|||
16492622|NCT01153347|40276250|FG002|Overall Study|Lost to Follow-up|11|||
16492623|NCT01153347|40276251|FG003|Overall Study|Lost to Follow-up|8|||
16492624|NCT01153347|40276248|FG000|Overall Study|Other|5|||
16492625|NCT01153347|40276249|FG001|Overall Study|Other|5|||
16492626|NCT01153347|40276250|FG002|Overall Study|Other|4|||
16492627|NCT01153347|40276251|FG003|Overall Study|Other|0|||
16492628|NCT01153347|40276248|FG000|Overall Study|Death|1|||
16492629|NCT01153347|40276249|FG001|Overall Study|Death|0|||
16492630|NCT01153347|40276250|FG002|Overall Study|Death|0|||
16492631|NCT01153347|40276251|FG003|Overall Study|Death|0|||
16492632|NCT00520936|40276253|FG000|Overall Study|Physician Decision|0|||
16492633|NCT00520936|40276254|FG001|Overall Study|Physician Decision|2|||
16492634|NCT00520936|40276255|FG002|Overall Study|Physician Decision|1|||
16492635|NCT00520936|40276256|FG003|Overall Study|Physician Decision|0|||
16492636|NCT00520936|40276257|FG004|Overall Study|Physician Decision|0|||
16492637|NCT00520936|40276258|FG005|Overall Study|Physician Decision|0|||
16492638|NCT00520936|40276259|FG006|Overall Study|Physician Decision|0|||
16492639|NCT00520936|40276260|FG007|Overall Study|Physician Decision|0|||
16492640|NCT00520936|40276253|FG000|Overall Study|Withdrawal by Subject|0|||
16492641|NCT00520936|40276254|FG001|Overall Study|Withdrawal by Subject|0|||
16492642|NCT00520936|40276255|FG002|Overall Study|Withdrawal by Subject|0|||
16492643|NCT00520936|40276256|FG003|Overall Study|Withdrawal by Subject|0|||
16492644|NCT00520936|40276257|FG004|Overall Study|Withdrawal by Subject|0|||
16492645|NCT00520936|40276258|FG005|Overall Study|Withdrawal by Subject|0|||
16492646|NCT00520936|40276259|FG006|Overall Study|Withdrawal by Subject|0|||
16492647|NCT00520936|40276260|FG007|Overall Study|Withdrawal by Subject|1|||
16492648|NCT00520936|40276253|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
16492649|NCT00520936|40276254|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
16492650|NCT00520936|40276255|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
16492651|NCT00520936|40276256|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
16492652|NCT00520936|40276257|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
16492653|NCT00520936|40276258|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
16492654|NCT00520936|40276259|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
16492655|NCT00520936|40276260|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
16492656|NCT00520936|40276253|FG000|Overall Study|Death|0|||
16492657|NCT00520936|40276254|FG001|Overall Study|Death|0|||
16492658|NCT00520936|40276255|FG002|Overall Study|Death|0|||
16492659|NCT00520936|40276256|FG003|Overall Study|Death|0|||
16492660|NCT00520936|40276257|FG004|Overall Study|Death|0|||
16492661|NCT00520936|40276258|FG005|Overall Study|Death|0|||
16492662|NCT00520936|40276259|FG006|Overall Study|Death|1|||
16492663|NCT00520936|40276260|FG007|Overall Study|Death|0|||
16084335|NCT02561195|38802435|FG004|Extension Stage (Vaccination 4)|Other|0|||
16084336|NCT02561195|38802436|FG005|Extension Stage (Vaccination 4)|Other|0|||
16084337|NCT02561195|38802437|FG006|Extension Stage (Vaccination 4)|Other|0|||
16084338|NCT02561195|38802438|FG007|Extension Stage (Vaccination 4)|Other|0|||
16084339|NCT02561195|38802439|FG008|Extension Stage (Vaccination 4)|Other|0|||
16084340|NCT02561195|38802440|FG009|Extension Stage (Vaccination 4)|Other|0|||
16084341|NCT02561195|38802441|FG010|Extension Stage (Vaccination 4)|Other|2|||
16084342|NCT02561195|38802442|FG011|Extension Stage (Vaccination 4)|Other|2|||
16492664|NCT00520936|40276253|FG000|Overall Study|Protocol Violation|0|||
16492665|NCT00520936|40276254|FG001|Overall Study|Protocol Violation|1|||
16492666|NCT00520936|40276255|FG002|Overall Study|Protocol Violation|1|||
16492667|NCT00520936|40276256|FG003|Overall Study|Protocol Violation|0|||
16492668|NCT00520936|40276257|FG004|Overall Study|Protocol Violation|1|||
16492669|NCT00520936|40276258|FG005|Overall Study|Protocol Violation|0|||
16084343|NCT02561195|38802443|FG012|Extension Stage (Vaccination 4)|Other|1|||
16084344|NCT02561195|38802444|FG013|Extension Stage (Vaccination 4)|Other|0|||
16084345|NCT02561195|38802431|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16084346|NCT02561195|38802432|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16084347|NCT02561195|38802433|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16084348|NCT02561195|38802434|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16084349|NCT02561195|38802435|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16084350|NCT02561195|38802436|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16084351|NCT02561195|38802437|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
16084352|NCT02561195|38802438|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16084353|NCT02561195|38802439|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16084354|NCT02561195|38802440|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16084355|NCT02561195|38802441|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
16084356|NCT02561195|38802442|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
16084357|NCT02561195|38802443|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
16084358|NCT02561195|38802444|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
16084359|NCT01079949|38802445|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
16084360|NCT01079949|38802446|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
16084361|NCT01079949|38802445|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
16084362|NCT01079949|38802446|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
16084363|NCT01079949|38802445|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
16084364|NCT01079949|38802446|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
16084365|NCT01079949|38802445|FG000|Overall Study|Randomized but not treated|1|||
16084366|NCT01079949|38802446|FG001|Overall Study|Randomized but not treated|0|||
16084367|NCT02988713|38802451|FG000|Overall Study|Withdrawal by Subject|1|||
16084368|NCT02988713|38802451|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
16084369|NCT03567616|38802452|FG000|Overall Study|Disease progression|4|||
16084370|NCT03567616|38802452|FG000|Overall Study|Withdrawal by Subject|1|||
16084371|NCT03567616|38802452|FG000|Overall Study|Physician Decision|1|||
16084372|NCT03567616|38802452|FG000|Overall Study|Death|1|||
16084373|NCT03567616|38802452|FG000|Overall Study|Adverse Event|1|||
16084374|NCT01068249|38802458|FG000|Overall Study|Death|1|||
16084375|NCT01068249|38802458|FG000|Overall Study|Withdrawal by Subject|3|||
16084376|NCT02844439|38802459|FG000|Overall Study|Withdrawal by Subject|1|||
16084377|NCT02844439|38802459|FG000|Overall Study|Lost to Follow-up|2|||
16084378|NCT02844439|38802459|FG000|Overall Study|Termination by Sponsor|4|||
16084379|NCT02844439|38802459|FG000|Overall Study|Death|28|||
16084380|NCT02844439|38802459|FG000|Overall Study|Other|5|||
16084381|NCT01599793|38802460|FG000|Overall Study|Adverse Event|2|||
16084382|NCT03347396|38802461|FG000|Part A (26 Weeks)|Adverse Event|1|||
16084383|NCT03347396|38802462|FG001|Part A (26 Weeks)|Adverse Event|0|||
16084384|NCT03347396|38802461|FG000|Part A (26 Weeks)|Death|0|||
16084385|NCT03347396|38802462|FG001|Part A (26 Weeks)|Death|1|||
16084386|NCT03347396|38802461|FG000|Part B (149 Weeks)|Adverse Event|1|||
16084387|NCT03347396|38802462|FG001|Part B (149 Weeks)|Adverse Event|1|||
16084388|NCT03347396|38802461|FG000|Part B (149 Weeks)|Death|1|||
16084389|NCT03347396|38802462|FG001|Part B (149 Weeks)|Death|0|||
16084390|NCT00336505|38802465|FG000|Overall Study|Adverse Event|10|||
16084391|NCT00336505|38802466|FG001|Overall Study|Adverse Event|9|||
16084392|NCT00336505|38802465|FG000|Overall Study|Lack of Efficacy|8|||
16084393|NCT00336505|38802466|FG001|Overall Study|Lack of Efficacy|4|||
16084394|NCT00336505|38802465|FG000|Overall Study|Lost to Follow-up|7|||
16084395|NCT00336505|38802466|FG001|Overall Study|Lost to Follow-up|4|||
16084396|NCT00336505|38802465|FG000|Overall Study|Withdrawal by Subject|5|||
16084397|NCT00336505|38802466|FG001|Overall Study|Withdrawal by Subject|3|||
16084398|NCT00336505|38802465|FG000|Overall Study|Other|7|||
16084399|NCT00336505|38802466|FG001|Overall Study|Other|7|||
16084400|NCT05262738|38802467|FG000|Overall Study|Withdrawal by Subject|1|||
16084401|NCT05262738|38802468|FG001|Overall Study|Withdrawal by Subject|0|||
16492670|NCT00520936|40276259|FG006|Overall Study|Protocol Violation|1|||
16492671|NCT00520936|40276260|FG007|Overall Study|Protocol Violation|0|||
16084402|NCT01985334|38802469|FG000|Overall Study|Administrative problems|1|||
16084403|NCT01985334|38802470|FG001|Overall Study|Administrative problems|1|||
16084404|NCT01985334|38802471|FG002|Overall Study|Administrative problems|0|||
16084405|NCT01985334|38802472|FG003|Overall Study|Administrative problems|2|||
16084406|NCT01985334|38802473|FG004|Overall Study|Administrative problems|0|||
16084407|NCT01985334|38802474|FG005|Overall Study|Administrative problems|1|||
16084408|NCT01985334|38802475|FG006|Overall Study|Administrative problems|1|||
16084409|NCT01985334|38802476|FG007|Overall Study|Administrative problems|3|||
16084410|NCT01985334|38802469|FG000|Overall Study|Death|1|||
16084411|NCT01985334|38802470|FG001|Overall Study|Death|0|||
16084412|NCT01985334|38802471|FG002|Overall Study|Death|0|||
16084413|NCT01985334|38802472|FG003|Overall Study|Death|3|||
16084414|NCT01985334|38802473|FG004|Overall Study|Death|0|||
16084415|NCT01985334|38802474|FG005|Overall Study|Death|0|||
16084416|NCT01985334|38802475|FG006|Overall Study|Death|1|||
16084417|NCT01985334|38802476|FG007|Overall Study|Death|2|||
16084418|NCT01985334|38802469|FG000|Overall Study|Worsening of disease|0|||
16084419|NCT01985334|38802470|FG001|Overall Study|Worsening of disease|0|||
16084420|NCT01985334|38802471|FG002|Overall Study|Worsening of disease|0|||
16084421|NCT01985334|38802472|FG003|Overall Study|Worsening of disease|1|||
16492672|NCT01104493|40276261|FG000|Overall Study|Lost to Follow-up|0|||
16492673|NCT01104493|40276262|FG001|Overall Study|Lost to Follow-up|2|||
16492674|NCT01749514|40276263|FG000|Overall Study|Lost to Follow-up|0|||
16492675|NCT01749514|40276264|FG001|Overall Study|Lost to Follow-up|0|||
16492676|NCT01749514|40276265|FG002|Overall Study|Lost to Follow-up|0|||
16492677|NCT01749514|40276266|FG003|Overall Study|Lost to Follow-up|0|||
16492678|NCT01749514|40276267|FG004|Overall Study|Lost to Follow-up|0|||
16303926|NCT02439216|39598058|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
16303927|NCT02439216|39598059|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
16303928|NCT02439216|39598060|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
16303929|NCT02439216|39598052|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16303930|NCT02439216|39598053|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16303931|NCT02439216|39598054|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16303932|NCT02439216|39598055|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16303933|NCT02439216|39598056|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16303934|NCT02439216|39598057|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16303935|NCT02439216|39598058|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16303936|NCT02439216|39598059|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
16303937|NCT02439216|39598060|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
16303938|NCT02439216|39598052|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16303939|NCT02439216|39598053|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16492679|NCT01749514|40276268|FG005|Overall Study|Lost to Follow-up|0|||
16492680|NCT01749514|40276269|FG006|Overall Study|Lost to Follow-up|0|||
16492681|NCT01749514|40276270|FG007|Overall Study|Lost to Follow-up|1|||
16492682|NCT01749514|40276263|FG000|Overall Study|Withdrawal by Subject|0|||
16492683|NCT01749514|40276264|FG001|Overall Study|Withdrawal by Subject|0|||
16492684|NCT01749514|40276265|FG002|Overall Study|Withdrawal by Subject|0|||
16084422|NCT01985334|38802473|FG004|Overall Study|Worsening of disease|0|||
16084423|NCT01985334|38802474|FG005|Overall Study|Worsening of disease|3|||
16492685|NCT01749514|40276266|FG003|Overall Study|Withdrawal by Subject|0|||
16492686|NCT01749514|40276267|FG004|Overall Study|Withdrawal by Subject|0|||
16492687|NCT01749514|40276268|FG005|Overall Study|Withdrawal by Subject|1|||
16492688|NCT01749514|40276269|FG006|Overall Study|Withdrawal by Subject|0|||
16492689|NCT01749514|40276270|FG007|Overall Study|Withdrawal by Subject|1|||
16492690|NCT01749514|40276263|FG000|Overall Study|Not Reported|0|||
16084424|NCT01985334|38802475|FG006|Overall Study|Worsening of disease|0|||
16193504|NCT01056341|39188558|FG003|Overall Study|Other reasons|9|||
16492691|NCT01749514|40276264|FG001|Overall Study|Not Reported|0|||
16492692|NCT01749514|40276265|FG002|Overall Study|Not Reported|0|||
16492693|NCT01749514|40276266|FG003|Overall Study|Not Reported|0|||
16492694|NCT01749514|40276267|FG004|Overall Study|Not Reported|0|||
16193505|NCT01056341|39188559|FG004|Overall Study|Other reasons|5|||
16303940|NCT02439216|39598054|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16303941|NCT02439216|39598055|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16303942|NCT02439216|39598056|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16303943|NCT02439216|39598057|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16303944|NCT02439216|39598058|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
16303945|NCT02439216|39598059|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
16303946|NCT02439216|39598060|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
16303947|NCT04779879|39598067|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
16303948|NCT04779879|39598068|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
16303949|NCT04779879|39598069|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
16303950|NCT04779879|39598070|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
16303951|NCT04779879|39598071|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
16303952|NCT04779879|39598072|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
16303953|NCT04779879|39598067|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
16303954|NCT04779879|39598068|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
16303955|NCT04779879|39598069|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
16303956|NCT04779879|39598070|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
16303957|NCT04779879|39598071|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
16303958|NCT04779879|39598072|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
16303959|NCT04779879|39598067|FG000|Part C: Up to Week 36|Death|0|||
16303960|NCT04779879|39598068|FG001|Part C: Up to Week 36|Death|0|||
16303961|NCT04779879|39598069|FG002|Part C: Up to Week 36|Death|0|||
16303962|NCT04779879|39598070|FG003|Part C: Up to Week 36|Death|0|||
16303963|NCT04779879|39598071|FG004|Part C: Up to Week 36|Death|0|||
16303964|NCT04779879|39598072|FG005|Part C: Up to Week 36|Death|1|||
16303965|NCT04779879|39598067|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
16303966|NCT04779879|39598068|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
16303967|NCT04779879|39598069|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
16303968|NCT04779879|39598070|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
16303969|NCT04779879|39598071|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
16303970|NCT04779879|39598072|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
16303971|NCT03281876|39598073|FG000|Overall Study|Adverse Event|4|||
16303972|NCT03281876|39598074|FG001|Overall Study|Adverse Event|15|||
16303973|NCT03281876|39598073|FG000|Overall Study|Lost to Follow-up|1|||
16303974|NCT03281876|39598074|FG001|Overall Study|Lost to Follow-up|4|||
16303975|NCT03281876|39598073|FG000|Overall Study|Withdrawal by Subject|11|||
16303976|NCT03281876|39598074|FG001|Overall Study|Withdrawal by Subject|15|||
16303977|NCT03281876|39598073|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
16303978|NCT03281876|39598074|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16303979|NCT03281876|39598073|FG000|Overall Study|OTHER|5|||
16303980|NCT03281876|39598074|FG001|Overall Study|OTHER|5|||
16303981|NCT01056289|39598075|FG000|Open-label Phase|Adverse Event|29|||
16303982|NCT01056289|39598076|FG001|Open-label Phase|Adverse Event|0|||
16303983|NCT01056289|39598077|FG002|Open-label Phase|Adverse Event|0|||
16303984|NCT01056289|39598078|FG003|Open-label Phase|Adverse Event|0|||
16303985|NCT01056289|39598075|FG000|Open-label Phase|Lost to Follow-up|30|||
16303986|NCT01056289|39598076|FG001|Open-label Phase|Lost to Follow-up|0|||
16303987|NCT01056289|39598077|FG002|Open-label Phase|Lost to Follow-up|0|||
16303988|NCT01056289|39598078|FG003|Open-label Phase|Lost to Follow-up|0|||
16303989|NCT01056289|39598075|FG000|Open-label Phase|Other|9|||
16303990|NCT01056289|39598076|FG001|Open-label Phase|Other|0|||
16303991|NCT01056289|39598077|FG002|Open-label Phase|Other|0|||
16492695|NCT01749514|40276268|FG005|Overall Study|Not Reported|0|||
16492696|NCT01749514|40276269|FG006|Overall Study|Not Reported|0|||
16492697|NCT01749514|40276270|FG007|Overall Study|Not Reported|5|||
16492698|NCT01056653|40276271|FG000|Overall Study|Lost to Follow-up|0|||
16492699|NCT01056653|40276272|FG001|Overall Study|Lost to Follow-up|0|||
16492700|NCT01056653|40276273|FG002|Overall Study|Lost to Follow-up|2|||
16492701|NCT01833520|40276274|FG000|Overall Study|Lack of Efficacy|3|||
16492702|NCT01833520|40276275|FG001|Overall Study|Lack of Efficacy|3|||
16492703|NCT01833520|40276276|FG002|Overall Study|Lack of Efficacy|8|||
16492704|NCT01833520|40276277|FG003|Overall Study|Lack of Efficacy|3|||
16492705|NCT02670837|40276284|FG000|Overall Study|Death|2|||
16492706|NCT02670837|40276285|FG001|Overall Study|Death|0|||
16492707|NCT02670837|40276286|FG002|Overall Study|Death|0|||
16492708|NCT03761277|40276287|FG000|Enrollment to Implant|Screen Failure|17|||
16492709|NCT03761277|40276287|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
16492710|NCT03761277|40276287|FG000|Enrollment to Implant|Physician Decision|2|||
16492711|NCT03761277|40276287|FG000|Enrollment to Implant|Site Closure|3|||
16492712|NCT03761277|40276287|FG000|Enrollment to Implant|Sponsor Request|2|||
16492713|NCT03761277|40276287|FG000|Post-Implant to 6 Months|Adverse Event|2|||
16492714|NCT03761277|40276287|FG000|Post-Implant to 6 Months|Death|1|||
16492715|NCT03761277|40276287|FG000|Post-Implant to 6 Months|Site Closure|2|||
16303992|NCT01056289|39598078|FG003|Open-label Phase|Other|0|||
16303993|NCT01056289|39598075|FG000|Open-label Phase|Protocol Violation|6|||
16303994|NCT01056289|39598076|FG001|Open-label Phase|Protocol Violation|0|||
16303995|NCT01056289|39598077|FG002|Open-label Phase|Protocol Violation|0|||
16303996|NCT01056289|39598078|FG003|Open-label Phase|Protocol Violation|0|||
16303997|NCT01056289|39598075|FG000|Open-label Phase|Withdrawal by Subject|26|||
16303998|NCT01056289|39598076|FG001|Open-label Phase|Withdrawal by Subject|0|||
16303999|NCT01056289|39598077|FG002|Open-label Phase|Withdrawal by Subject|0|||
16304000|NCT01056289|39598078|FG003|Open-label Phase|Withdrawal by Subject|0|||
16304001|NCT01056289|39598075|FG000|Open-label Phase|Lack of Efficacy|18|||
16304002|NCT01056289|39598076|FG001|Open-label Phase|Lack of Efficacy|0|||
16304003|NCT01056289|39598077|FG002|Open-label Phase|Lack of Efficacy|0|||
16304004|NCT01056289|39598078|FG003|Open-label Phase|Lack of Efficacy|0|||
16304005|NCT01056289|39598075|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
16304006|NCT01056289|39598076|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
16304007|NCT01056289|39598077|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
16304008|NCT01056289|39598078|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
16304009|NCT01056289|39598075|FG000|Double-blind Phase|Adverse Event|0|||
16304010|NCT01056289|39598076|FG001|Double-blind Phase|Adverse Event|1|||
16304011|NCT01056289|39598077|FG002|Double-blind Phase|Adverse Event|2|||
16304012|NCT01056289|39598078|FG003|Double-blind Phase|Adverse Event|1|||
16304013|NCT01056289|39598075|FG000|Double-blind Phase|Lost to Follow-up|0|||
16304014|NCT01056289|39598076|FG001|Double-blind Phase|Lost to Follow-up|2|||
16304015|NCT01056289|39598077|FG002|Double-blind Phase|Lost to Follow-up|2|||
16304016|NCT01056289|39598078|FG003|Double-blind Phase|Lost to Follow-up|2|||
16304017|NCT01056289|39598075|FG000|Double-blind Phase|Other|0|||
16304018|NCT01056289|39598076|FG001|Double-blind Phase|Other|0|||
16304019|NCT01056289|39598077|FG002|Double-blind Phase|Other|1|||
16304020|NCT01056289|39598078|FG003|Double-blind Phase|Other|2|||
16304021|NCT01056289|39598075|FG000|Double-blind Phase|Protocol Violation|0|||
16304022|NCT01056289|39598076|FG001|Double-blind Phase|Protocol Violation|0|||
16304023|NCT01056289|39598077|FG002|Double-blind Phase|Protocol Violation|1|||
16304024|NCT01056289|39598078|FG003|Double-blind Phase|Protocol Violation|1|||
16304025|NCT01056289|39598075|FG000|Double-blind Phase|Withdrawal by Subject|0|||
16304026|NCT01056289|39598076|FG001|Double-blind Phase|Withdrawal by Subject|0|||
16304027|NCT01056289|39598077|FG002|Double-blind Phase|Withdrawal by Subject|4|||
16304028|NCT01056289|39598078|FG003|Double-blind Phase|Withdrawal by Subject|2|||
16304029|NCT01056289|39598075|FG000|Double-blind Phase|Discontinuation symptom|0|||
16304030|NCT01056289|39598076|FG001|Double-blind Phase|Discontinuation symptom|1|||
16304031|NCT01056289|39598077|FG002|Double-blind Phase|Discontinuation symptom|2|||
16304032|NCT01056289|39598078|FG003|Double-blind Phase|Discontinuation symptom|2|||
16304033|NCT01056289|39598075|FG000|Double-blind Phase|Physician Decision|0|||
16304034|NCT01056289|39598076|FG001|Double-blind Phase|Physician Decision|0|||
16304035|NCT01056289|39598077|FG002|Double-blind Phase|Physician Decision|1|||
16304036|NCT01056289|39598078|FG003|Double-blind Phase|Physician Decision|0|||
16304037|NCT00996892|39598079|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
16304038|NCT00996892|39598080|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
16304039|NCT00996892|39598081|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
16304040|NCT00996892|39598082|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
16304041|NCT00996892|39598083|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
16084425|NCT01985334|38802476|FG007|Overall Study|Worsening of disease|1|||
16304042|NCT00996892|39598084|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
16304043|NCT00996892|39598085|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
16304044|NCT00996892|39598086|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
16304045|NCT00996892|39598087|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
16304046|NCT00996892|39598088|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
16304047|NCT00996892|39598089|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
16304048|NCT00996892|39598090|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
16304049|NCT00996892|39598091|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
16304050|NCT00996892|39598092|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
16304051|NCT00996892|39598093|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
16304052|NCT00996892|39598094|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
16304053|NCT00996892|39598095|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
16304054|NCT00996892|39598096|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
16304055|NCT00996892|39598097|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
16304056|NCT00996892|39598098|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
16304057|NCT00996892|39598079|FG000|Dose-Escalation Stage 1|Death|1|||
16304058|NCT00996892|39598080|FG001|Dose-Escalation Stage 1|Death|0|||
16304059|NCT00996892|39598081|FG002|Dose-Escalation Stage 1|Death|0|||
16304060|NCT00996892|39598082|FG003|Dose-Escalation Stage 1|Death|0|||
16304061|NCT00996892|39598083|FG004|Dose-Escalation Stage 1|Death|0|||
16304062|NCT00996892|39598084|FG005|Dose-Escalation Stage 1|Death|1|||
16304063|NCT00996892|39598085|FG006|Dose-Escalation Stage 1|Death|0|||
16304064|NCT00996892|39598086|FG007|Dose-Escalation Stage 1|Death|0|||
16304065|NCT00996892|39598087|FG008|Dose-Escalation Stage 1|Death|0|||
16304066|NCT00996892|39598088|FG009|Dose-Escalation Stage 1|Death|0|||
16304067|NCT00996892|39598089|FG010|Dose-Escalation Stage 1|Death|0|||
16304068|NCT00996892|39598090|FG011|Dose-Escalation Stage 1|Death|0|||
16304069|NCT00996892|39598091|FG012|Dose-Escalation Stage 1|Death|0|||
16304070|NCT00996892|39598092|FG013|Dose-Escalation Stage 1|Death|0|||
16304071|NCT00996892|39598093|FG014|Dose-Escalation Stage 1|Death|0|||
16304072|NCT00996892|39598094|FG015|Dose-Escalation Stage 1|Death|0|||
16304073|NCT00996892|39598095|FG016|Dose-Escalation Stage 1|Death|0|||
16304074|NCT00996892|39598096|FG017|Dose-Escalation Stage 1|Death|0|||
16304075|NCT00996892|39598097|FG018|Dose-Escalation Stage 1|Death|0|||
16304076|NCT00996892|39598098|FG019|Dose-Escalation Stage 1|Death|0|||
16492716|NCT03761277|40276287|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
16492717|NCT03761277|40276287|FG000|6 Months to 12 Months|Physician Decision|2|||
16492718|NCT03761277|40276287|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
16492719|NCT00592384|40276299|FG000|Overall Study|Withdrawal by Subject|5|||
16304077|NCT00996892|39598079|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
16304078|NCT00996892|39598080|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
16304079|NCT00996892|39598081|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
16492720|NCT00592384|40276300|FG001|Overall Study|Withdrawal by Subject|6|||
16492721|NCT01648205|40276303|FG000|Placebo|Pregnancy|1|||
16492722|NCT01648205|40276303|FG000|Placebo|Withdrawal by Subject|1|||
16492723|NCT01648205|40276303|FG000|Placebo|Protocol Violation|2|||
16492724|NCT01648205|40276303|FG000|Ranolazine|Death|1|||
16492725|NCT01648205|40276303|FG000|Ranolazine|Withdrawal by Subject|1|||
16492726|NCT01648205|40276303|FG000|Ranolazine|Protocol Violation|3|||
16492727|NCT02167893|40276305|FG000|Overall Study|Investigator transferred|85|||
16492728|NCT02167893|40276305|FG000|Overall Study|Investigator health reasons|10|||
16492729|NCT02167893|40276305|FG000|Overall Study|Case report forms not collected|68|||
16492730|NCT01835587|40276308|FG000|Overall Study|Disease Recurrence or Relapse|0|||
16492731|NCT01835587|40276309|FG001|Overall Study|Disease Recurrence or Relapse|3|||
16492732|NCT01835587|40276310|FG002|Overall Study|Disease Recurrence or Relapse|0|||
16492733|NCT01835587|40276311|FG003|Overall Study|Disease Recurrence or Relapse|3|||
16492734|NCT01835587|40276308|FG000|Overall Study|Withdrawal by Subject|2|||
16492735|NCT01835587|40276309|FG001|Overall Study|Withdrawal by Subject|0|||
16492736|NCT01835587|40276310|FG002|Overall Study|Withdrawal by Subject|0|||
16492737|NCT01835587|40276311|FG003|Overall Study|Withdrawal by Subject|3|||
16492738|NCT01835587|40276308|FG000|Overall Study|Adverse Event|0|||
16492739|NCT01835587|40276309|FG001|Overall Study|Adverse Event|0|||
16492740|NCT01835587|40276310|FG002|Overall Study|Adverse Event|2|||
16492741|NCT01835587|40276311|FG003|Overall Study|Adverse Event|2|||
16492742|NCT01835587|40276308|FG000|Overall Study|Death|0|||
16492743|NCT01835587|40276309|FG001|Overall Study|Death|0|||
16492744|NCT01835587|40276310|FG002|Overall Study|Death|0|||
16492745|NCT01835587|40276311|FG003|Overall Study|Death|1|||
16492746|NCT01835587|40276308|FG000|Overall Study|Miscellaneous|0|||
16304080|NCT00996892|39598082|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
16304081|NCT00996892|39598083|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
16492747|NCT01835587|40276309|FG001|Overall Study|Miscellaneous|1|||
16304082|NCT00996892|39598084|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
16492748|NCT01835587|40276310|FG002|Overall Study|Miscellaneous|0|||
16492749|NCT01835587|40276311|FG003|Overall Study|Miscellaneous|0|||
16492750|NCT01927367|40276312|FG000|Overall Study|Withdrawal by Subject|7|||
16492751|NCT01927367|40276313|FG001|Overall Study|Withdrawal by Subject|4|||
16492752|NCT01927367|40276312|FG000|Overall Study|No baseline data|0|||
16492753|NCT01927367|40276313|FG001|Overall Study|No baseline data|1|||
16492754|NCT01365910|40276316|FG000|Overall Study|Withdrawal by Subject|7|||
16492755|NCT01365910|40276316|FG000|Overall Study|disease progression|18|||
16492756|NCT01365910|40276316|FG000|Overall Study|Adverse Event|3|||
16492757|NCT01365910|40276316|FG000|Overall Study|other complicating disease|1|||
16492758|NCT01365910|40276316|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
16492759|NCT00546637|40276318|FG000|Overall Study|Adverse Event|46|||
16492760|NCT00546637|40276319|FG001|Overall Study|Adverse Event|20|||
16492761|NCT00546637|40276318|FG000|Overall Study|Lack of Efficacy|5|||
16492762|NCT00546637|40276319|FG001|Overall Study|Lack of Efficacy|5|||
16492763|NCT00546637|40276318|FG000|Overall Study|Lost to Follow-up|2|||
16492764|NCT00546637|40276319|FG001|Overall Study|Lost to Follow-up|2|||
16492765|NCT00546637|40276318|FG000|Overall Study|Other|10|||
16492766|NCT00546637|40276319|FG001|Overall Study|Other|12|||
16492767|NCT00546637|40276318|FG000|Overall Study|Withdrawal by Subject|7|||
16492768|NCT00546637|40276319|FG001|Overall Study|Withdrawal by Subject|9|||
16492769|NCT00546637|40276318|FG000|Overall Study|Randomized, but not treated|3|||
16492770|NCT00546637|40276319|FG001|Overall Study|Randomized, but not treated|1|||
16492771|NCT01513473|40276320|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
16492772|NCT01513473|40276321|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
16492773|NCT01513473|40276320|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
16492774|NCT01513473|40276321|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
16492775|NCT01513473|40276320|FG000|Main Trial (26 Weeks)|Unclassified|0|||
16492776|NCT01513473|40276321|FG001|Main Trial (26 Weeks)|Unclassified|2|||
16492777|NCT01513473|40276320|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
16492778|NCT01513473|40276321|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
16388020|NCT00132301|39902806|FG001|Overall Study|Other|1|||
16492779|NCT01513473|40276320|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
16492780|NCT01513473|40276321|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
16492781|NCT02375113|40276322|FG000|Overall Study|Undisclosed Reason(s).|1|||
16492782|NCT02375113|40276323|FG001|Overall Study|Undisclosed Reason(s).|1|||
16492783|NCT02375113|40276322|FG000|Overall Study|Poor adherence (<70%).|1|||
16492784|NCT02375113|40276323|FG001|Overall Study|Poor adherence (<70%).|0|||
16492785|NCT02375113|40276322|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
16492786|NCT02375113|40276323|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
16492787|NCT00897104|40276331|FG000|Overall Study|Lost to Follow-up|12|||
16492788|NCT00897104|40276332|FG001|Overall Study|Lost to Follow-up|17|||
16492789|NCT00897104|40276333|FG002|Overall Study|Lost to Follow-up|2|||
16409931|NCT03099148|39981833|FG003|Wash-out|scheduling conflict|0|||
16492790|NCT00897104|40276331|FG000|Overall Study|Pregnancy|0|||
16492791|NCT00897104|40276332|FG001|Overall Study|Pregnancy|1|||
16304083|NCT00996892|39598085|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
16304084|NCT00996892|39598086|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
16304085|NCT00996892|39598087|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
16304086|NCT00996892|39598088|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
16304087|NCT00996892|39598089|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
16304088|NCT00996892|39598090|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
16304089|NCT00996892|39598091|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
16304090|NCT00996892|39598092|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
16304091|NCT00996892|39598093|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
16304092|NCT00996892|39598094|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
16304093|NCT00996892|39598095|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
16304094|NCT00996892|39598096|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
16304095|NCT00996892|39598097|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
16304096|NCT00996892|39598098|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
16304097|NCT00996892|39598079|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304098|NCT00996892|39598080|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
16304099|NCT00996892|39598081|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304100|NCT00996892|39598082|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
16304101|NCT00996892|39598083|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
16304102|NCT00996892|39598084|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
16304103|NCT00996892|39598085|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
16304104|NCT00996892|39598086|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304105|NCT00996892|39598087|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304106|NCT00996892|39598088|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304107|NCT00996892|39598089|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304108|NCT00996892|39598090|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304109|NCT00996892|39598091|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304110|NCT00996892|39598092|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304111|NCT00996892|39598093|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304112|NCT00996892|39598094|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304113|NCT00996892|39598095|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304114|NCT00996892|39598096|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304115|NCT00996892|39598097|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304116|NCT00996892|39598098|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
16304117|NCT00996892|39598079|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
16304118|NCT00996892|39598080|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
16304119|NCT00996892|39598081|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
16304120|NCT00996892|39598082|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
16304121|NCT00996892|39598083|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
16304122|NCT00996892|39598084|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
16304123|NCT00996892|39598085|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
16304124|NCT00996892|39598086|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
16304125|NCT00996892|39598087|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
16304126|NCT00996892|39598088|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
16304127|NCT00996892|39598089|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
16304128|NCT00996892|39598090|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
16304129|NCT00996892|39598091|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
16304130|NCT00996892|39598092|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
16304131|NCT00996892|39598093|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
16304132|NCT00996892|39598094|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
16304133|NCT00996892|39598095|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
16304134|NCT00996892|39598096|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
16304135|NCT00996892|39598097|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
16304136|NCT00996892|39598098|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
16304137|NCT00996892|39598079|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
16304138|NCT00996892|39598080|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
16304139|NCT00996892|39598081|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
16304140|NCT00996892|39598082|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
16304141|NCT00996892|39598083|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
16304142|NCT00996892|39598084|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
16304143|NCT00996892|39598085|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
16304144|NCT00996892|39598086|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
16304145|NCT00996892|39598087|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
16304146|NCT00996892|39598088|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
16304147|NCT00996892|39598089|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
16304148|NCT00996892|39598090|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
16304149|NCT00996892|39598091|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
16084426|NCT01985334|38802469|FG000|Overall Study|Other|2|||
16084427|NCT01985334|38802470|FG001|Overall Study|Other|9|||
16084428|NCT01985334|38802471|FG002|Overall Study|Other|7|||
16084429|NCT01985334|38802472|FG003|Overall Study|Other|17|||
16084430|NCT01985334|38802473|FG004|Overall Study|Other|4|||
16084431|NCT01985334|38802474|FG005|Overall Study|Other|8|||
16084432|NCT01985334|38802475|FG006|Overall Study|Other|4|||
16084433|NCT01985334|38802476|FG007|Overall Study|Other|7|||
16084434|NCT01985334|38802469|FG000|Overall Study|Protocol deviation|6|||
16084435|NCT01985334|38802470|FG001|Overall Study|Protocol deviation|31|||
16084436|NCT01985334|38802471|FG002|Overall Study|Protocol deviation|25|||
16084437|NCT01985334|38802472|FG003|Overall Study|Protocol deviation|84|||
16084438|NCT01985334|38802473|FG004|Overall Study|Protocol deviation|17|||
16084439|NCT01985334|38802474|FG005|Overall Study|Protocol deviation|47|||
16084440|NCT01985334|38802475|FG006|Overall Study|Protocol deviation|15|||
16084441|NCT01985334|38802476|FG007|Overall Study|Protocol deviation|42|||
16084442|NCT01985334|38802469|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
16084443|NCT01985334|38802470|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
16084444|NCT01985334|38802471|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
16084445|NCT01985334|38802472|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
16084446|NCT01985334|38802473|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
16084447|NCT01985334|38802474|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
16084448|NCT01985334|38802475|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
16084449|NCT01985334|38802476|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
16084450|NCT01985334|38802469|FG000|Overall Study|Subject withdrawal of consent|3|||
16084451|NCT01985334|38802470|FG001|Overall Study|Subject withdrawal of consent|6|||
16084452|NCT01985334|38802471|FG002|Overall Study|Subject withdrawal of consent|2|||
16084453|NCT01985334|38802472|FG003|Overall Study|Subject withdrawal of consent|28|||
16084454|NCT01985334|38802473|FG004|Overall Study|Subject withdrawal of consent|4|||
16084455|NCT01985334|38802474|FG005|Overall Study|Subject withdrawal of consent|19|||
16084456|NCT01985334|38802475|FG006|Overall Study|Subject withdrawal of consent|0|||
16084457|NCT01985334|38802476|FG007|Overall Study|Subject withdrawal of consent|20|||
16084458|NCT01985334|38802469|FG000|Overall Study|Adverse Event|0|||
16084459|NCT01985334|38802470|FG001|Overall Study|Adverse Event|8|||
16492792|NCT00897104|40276333|FG002|Overall Study|Pregnancy|0|||
16492793|NCT00897104|40276331|FG000|Overall Study|Protocol Violation|0|||
16492794|NCT00897104|40276332|FG001|Overall Study|Protocol Violation|1|||
16492795|NCT00897104|40276333|FG002|Overall Study|Protocol Violation|0|||
16492796|NCT00897104|40276331|FG000|Overall Study|Withdrawal by Subject|23|||
16492797|NCT00897104|40276332|FG001|Overall Study|Withdrawal by Subject|27|||
16492798|NCT00897104|40276333|FG002|Overall Study|Withdrawal by Subject|3|||
16492799|NCT00897104|40276331|FG000|Overall Study|Abnormal Prestudy Labs|2|||
16492800|NCT00897104|40276332|FG001|Overall Study|Abnormal Prestudy Labs|0|||
16492801|NCT00897104|40276333|FG002|Overall Study|Abnormal Prestudy Labs|0|||
16492802|NCT00897104|40276331|FG000|Overall Study|Abnormal Baseline ECG|2|||
16492803|NCT00897104|40276332|FG001|Overall Study|Abnormal Baseline ECG|2|||
16492804|NCT00897104|40276333|FG002|Overall Study|Abnormal Baseline ECG|0|||
16492805|NCT00897104|40276331|FG000|Overall Study|Need for Concom. Med.|0|||
16492806|NCT00897104|40276332|FG001|Overall Study|Need for Concom. Med.|1|||
16492807|NCT00897104|40276333|FG002|Overall Study|Need for Concom. Med.|1|||
16492808|NCT00897104|40276331|FG000|Overall Study|Lack of Migraine Attack|20|||
16492809|NCT00897104|40276332|FG001|Overall Study|Lack of Migraine Attack|22|||
16492810|NCT00897104|40276333|FG002|Overall Study|Lack of Migraine Attack|1|||
16492811|NCT00897104|40276331|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
16492812|NCT00897104|40276332|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
16492813|NCT00897104|40276333|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
16492814|NCT00897104|40276331|FG000|Overall Study|Other|3|||
16492815|NCT00897104|40276332|FG001|Overall Study|Other|0|||
16492816|NCT00897104|40276333|FG002|Overall Study|Other|0|||
16492817|NCT00897104|40276331|FG000|Overall Study|Protocol Violation|1|||
16492818|NCT00897104|40276332|FG001|Overall Study|Protocol Violation|0|||
16492819|NCT00897104|40276333|FG002|Overall Study|Protocol Violation|0|||
16492820|NCT00897104|40276331|FG000|Overall Study|Withdrawal by Subject|0|||
16492821|NCT00897104|40276332|FG001|Overall Study|Withdrawal by Subject|0|||
16492822|NCT00897104|40276333|FG002|Overall Study|Withdrawal by Subject|1|||
16492823|NCT02132130|40276340|FG000|Overall Study|Lost to Follow-up|0|||
16084460|NCT01985334|38802471|FG002|Overall Study|Adverse Event|2|||
16084461|NCT01985334|38802472|FG003|Overall Study|Adverse Event|26|||
16492824|NCT02132130|40276341|FG001|Overall Study|Lost to Follow-up|2|||
16492825|NCT02132130|40276342|FG002|Overall Study|Lost to Follow-up|0|||
16492826|NCT02132130|40276343|FG003|Overall Study|Lost to Follow-up|0|||
16492827|NCT02132130|40276340|FG000|Overall Study|Withdrawal by Subject|0|||
16084462|NCT01985334|38802473|FG004|Overall Study|Adverse Event|3|||
16084463|NCT01985334|38802474|FG005|Overall Study|Adverse Event|18|||
16084464|NCT01985334|38802475|FG006|Overall Study|Adverse Event|3|||
16084465|NCT01985334|38802476|FG007|Overall Study|Adverse Event|15|||
16084466|NCT01985334|38802469|FG000|Overall Study|Other|4|||
16492828|NCT02132130|40276341|FG001|Overall Study|Withdrawal by Subject|0|||
16492829|NCT02132130|40276342|FG002|Overall Study|Withdrawal by Subject|0|||
16492830|NCT02132130|40276343|FG003|Overall Study|Withdrawal by Subject|1|||
16492831|NCT02788357|40276344|FG000|Overall Study|Lost to Follow-up|3|||
16492832|NCT02788357|40276345|FG001|Overall Study|Lost to Follow-up|0|||
16492833|NCT03247530|40276346|FG000|Overall Study|Withdrawal by caregiver|19|||
16492834|NCT03247530|40276347|FG001|Overall Study|Withdrawal by caregiver|8|||
16492835|NCT03247530|40276348|FG002|Overall Study|Withdrawal by caregiver|10|||
16492836|NCT03247530|40276346|FG000|Overall Study|Lost to Follow-up|3|||
16492837|NCT03247530|40276347|FG001|Overall Study|Lost to Follow-up|9|||
16492838|NCT03247530|40276348|FG002|Overall Study|Lost to Follow-up|6|||
16492839|NCT03247530|40276346|FG000|Overall Study|Adverse Event|2|||
16492840|NCT03247530|40276347|FG001|Overall Study|Adverse Event|5|||
16492841|NCT03247530|40276348|FG002|Overall Study|Adverse Event|2|||
16492842|NCT03247530|40276346|FG000|Overall Study|Failure to follow procedure|1|||
16492843|NCT03247530|40276347|FG001|Overall Study|Failure to follow procedure|1|||
16492844|NCT03247530|40276348|FG002|Overall Study|Failure to follow procedure|1|||
16492845|NCT03247530|40276346|FG000|Overall Study|Withdrawal by Subject|1|||
16492846|NCT03247530|40276347|FG001|Overall Study|Withdrawal by Subject|1|||
16492847|NCT03247530|40276348|FG002|Overall Study|Withdrawal by Subject|0|||
16492848|NCT03247530|40276346|FG000|Overall Study|Study medication misuse|0|||
16492849|NCT03247530|40276347|FG001|Overall Study|Study medication misuse|1|||
16492850|NCT03247530|40276348|FG002|Overall Study|Study medication misuse|0|||
16492851|NCT03247530|40276346|FG000|Overall Study|Other, multiple categories|1|||
16492852|NCT03247530|40276347|FG001|Overall Study|Other, multiple categories|3|||
16492853|NCT03247530|40276348|FG002|Overall Study|Other, multiple categories|1|||
16492854|NCT00309387|40276353|FG000|Overall Study|Death|72|||
16492855|NCT00309387|40276354|FG001|Overall Study|Death|73|||
16492856|NCT00309387|40276353|FG000|Overall Study|Lost to Follow-up|70|||
16492857|NCT00309387|40276354|FG001|Overall Study|Lost to Follow-up|86|||
16492858|NCT00617123|40276357|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
16492859|NCT00617123|40276358|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
16492860|NCT00617123|40276357|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
16388021|NCT00132301|39902805|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
16388022|NCT00132301|39902806|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
16388023|NCT00648037|39902807|FG000|Overall Study|Not Treated|1|||
16304150|NCT00996892|39598092|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
16304151|NCT00996892|39598093|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
16492861|NCT00617123|40276358|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
16492862|NCT00617123|40276357|FG000|Referral Screening Period|Adverse Event|0|||
16492863|NCT00617123|40276358|FG001|Referral Screening Period|Adverse Event|1|||
16492864|NCT00617123|40276357|FG000|Study Treatment Period|Withdrawal by Subject|8|||
16492865|NCT00617123|40276358|FG001|Study Treatment Period|Withdrawal by Subject|12|||
16492866|NCT00617123|40276357|FG000|Study Treatment Period|Adverse Event|7|||
16492867|NCT00617123|40276358|FG001|Study Treatment Period|Adverse Event|3|||
16492868|NCT00617123|40276357|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
16492869|NCT00617123|40276358|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
16492870|NCT00617123|40276357|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
16492871|NCT00617123|40276358|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
16304152|NCT00996892|39598094|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
16304153|NCT00996892|39598095|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
16304154|NCT00996892|39598096|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
16304155|NCT00996892|39598097|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
16304156|NCT00996892|39598098|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
16304157|NCT00996892|39598079|FG000|Dose-Escalation Stage 1A|Death|0|||
16388024|NCT00648037|39902807|FG000|Overall Study|Withdrawal by Subject|1|||
16388025|NCT00648037|39902807|FG000|Overall Study|Adverse Event|11|||
16304158|NCT00996892|39598080|FG001|Dose-Escalation Stage 1A|Death|0|||
16388026|NCT00648037|39902807|FG000|Overall Study|Relapse|2|||
16388027|NCT00648037|39902807|FG000|Overall Study|Other|1|||
16388028|NCT00553631|39905518|FG000|Overall Study|Withdrawal by Subject|0|||
16492872|NCT01985867|40276366|FG000|Overall Study|Lost to Follow-up|3|||
16492873|NCT01985867|40276367|FG001|Overall Study|Lost to Follow-up|4|||
16492874|NCT01985867|40276366|FG000|Overall Study|Adverse Event|3|||
16492875|NCT01985867|40276367|FG001|Overall Study|Adverse Event|2|||
16492876|NCT01985867|40276366|FG000|Overall Study|Lack of Efficacy|1|||
16492877|NCT01985867|40276367|FG001|Overall Study|Lack of Efficacy|0|||
16304159|NCT00996892|39598081|FG002|Dose-Escalation Stage 1A|Death|0|||
16388029|NCT00553631|39905519|FG001|Overall Study|Withdrawal by Subject|1|||
16492878|NCT02573311|40276368|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
16492879|NCT02573311|40276369|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
16492880|NCT02573311|40276368|FG000|Disposition for Part 2|Physician Decision|25|||
16388030|NCT00553631|39905518|FG000|Overall Study|Lost to Follow-up|1|||
16388031|NCT00553631|39905519|FG001|Overall Study|Lost to Follow-up|0|||
16388032|NCT00950651|39905520|FG000|Overall Study|Adverse Event|17|||
16388033|NCT00950651|39905521|FG001|Overall Study|Adverse Event|20|||
16388034|NCT00950651|39905520|FG000|Overall Study|Death|1|||
16388035|NCT00950651|39905521|FG001|Overall Study|Death|0|||
16388036|NCT00950651|39905520|FG000|Overall Study|Lack of Efficacy|2|||
16388037|NCT00950651|39905521|FG001|Overall Study|Lack of Efficacy|2|||
16388038|NCT00950651|39905520|FG000|Overall Study|Protocol Violation|3|||
16388039|NCT00950651|39905521|FG001|Overall Study|Protocol Violation|4|||
16388040|NCT00950651|39905520|FG000|Overall Study|Withdrawal by Subject|8|||
16492881|NCT02573311|40276369|FG001|Disposition for Part 2|Physician Decision|7|||
16492882|NCT02573311|40276368|FG000|Disposition for Part 2|Adverse Event|36|||
16492883|NCT02573311|40276369|FG001|Disposition for Part 2|Adverse Event|5|||
16492884|NCT02573311|40276368|FG000|Disposition for Part 2|Lost to Follow-up|76|||
16492885|NCT02573311|40276369|FG001|Disposition for Part 2|Lost to Follow-up|7|||
16492886|NCT02573311|40276368|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
16492887|NCT02573311|40276369|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
16492888|NCT02573311|40276368|FG000|Disposition for Part 2|Investigator decision|0|||
16492889|NCT02573311|40276369|FG001|Disposition for Part 2|Investigator decision|1|||
16304160|NCT00996892|39598082|FG003|Dose-Escalation Stage 1A|Death|0|||
16304161|NCT00996892|39598083|FG004|Dose-Escalation Stage 1A|Death|0|||
16304162|NCT00996892|39598084|FG005|Dose-Escalation Stage 1A|Death|0|||
16304163|NCT00996892|39598085|FG006|Dose-Escalation Stage 1A|Death|0|||
16304164|NCT00996892|39598086|FG007|Dose-Escalation Stage 1A|Death|0|||
16304165|NCT00996892|39598087|FG008|Dose-Escalation Stage 1A|Death|0|||
16304166|NCT00996892|39598088|FG009|Dose-Escalation Stage 1A|Death|2|||
16304167|NCT00996892|39598089|FG010|Dose-Escalation Stage 1A|Death|0|||
16304168|NCT00996892|39598090|FG011|Dose-Escalation Stage 1A|Death|1|||
16304169|NCT00996892|39598091|FG012|Dose-Escalation Stage 1A|Death|1|||
16304170|NCT00996892|39598092|FG013|Dose-Escalation Stage 1A|Death|0|||
16304171|NCT00996892|39598093|FG014|Dose-Escalation Stage 1A|Death|0|||
16304172|NCT00996892|39598094|FG015|Dose-Escalation Stage 1A|Death|0|||
16304173|NCT00996892|39598095|FG016|Dose-Escalation Stage 1A|Death|0|||
16304174|NCT00996892|39598096|FG017|Dose-Escalation Stage 1A|Death|0|||
16304175|NCT00996892|39598097|FG018|Dose-Escalation Stage 1A|Death|0|||
16304176|NCT00996892|39598098|FG019|Dose-Escalation Stage 1A|Death|0|||
16304177|NCT00996892|39598079|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
16304178|NCT00996892|39598080|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
16304179|NCT00996892|39598081|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
16304180|NCT00996892|39598082|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
16304181|NCT00996892|39598083|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
16304182|NCT00996892|39598084|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
16304183|NCT00996892|39598085|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
16304184|NCT00996892|39598086|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
16304185|NCT00996892|39598087|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
16304186|NCT00996892|39598088|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
16304187|NCT00996892|39598089|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
16304188|NCT00996892|39598090|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
16304189|NCT00996892|39598091|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
16304190|NCT00996892|39598092|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
16304191|NCT00996892|39598093|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
16304192|NCT00996892|39598094|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
16304193|NCT00996892|39598095|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
16304194|NCT00996892|39598096|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
16304195|NCT00996892|39598097|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
16304196|NCT00996892|39598098|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
16304197|NCT00996892|39598079|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304198|NCT00996892|39598080|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304199|NCT00996892|39598081|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304200|NCT00996892|39598082|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304201|NCT00996892|39598083|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304202|NCT00996892|39598084|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304203|NCT00996892|39598085|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304204|NCT00996892|39598086|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304205|NCT00996892|39598087|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304206|NCT00996892|39598088|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
16304207|NCT00996892|39598089|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
16388041|NCT00950651|39905521|FG001|Overall Study|Withdrawal by Subject|9|||
16304208|NCT00996892|39598090|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
16388042|NCT01451749|39905522|FG000|Overall Study|Protocol Violation|14|||
16388043|NCT01451749|39905523|FG001|Overall Study|Protocol Violation|7|||
16388044|NCT01451749|39905522|FG000|Overall Study|Lost to Follow-up|15|||
16492890|NCT02573311|40276368|FG000|Disposition for Part 2|Other than specified above|13|||
16304209|NCT00996892|39598091|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
16304210|NCT00996892|39598092|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304211|NCT00996892|39598093|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304212|NCT00996892|39598094|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304213|NCT00996892|39598095|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304214|NCT00996892|39598096|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304215|NCT00996892|39598097|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304216|NCT00996892|39598098|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
16304217|NCT00996892|39598079|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
16304218|NCT00996892|39598080|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
16304219|NCT00996892|39598081|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
16304220|NCT00996892|39598082|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
16304221|NCT00996892|39598083|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
16304222|NCT00996892|39598084|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
16304223|NCT00996892|39598085|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
16304224|NCT00996892|39598086|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
16304225|NCT00996892|39598087|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
16304226|NCT00996892|39598088|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
16304227|NCT00996892|39598089|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
16304228|NCT00996892|39598090|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
16304229|NCT00996892|39598091|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
16304230|NCT00996892|39598092|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
16304231|NCT00996892|39598093|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
16304232|NCT00996892|39598094|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
16304233|NCT00996892|39598095|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
16304234|NCT00996892|39598096|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
16304235|NCT00996892|39598097|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
16304236|NCT00996892|39598098|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
16304237|NCT00996892|39598079|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
16304238|NCT00996892|39598080|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
16304239|NCT00996892|39598081|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
16304240|NCT00996892|39598082|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
16304241|NCT00996892|39598083|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
16304242|NCT00996892|39598084|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
16304243|NCT00996892|39598085|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
16304244|NCT00996892|39598086|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
16304245|NCT00996892|39598087|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
16304246|NCT00996892|39598088|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
16304247|NCT00996892|39598089|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
16304248|NCT00996892|39598090|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
16304249|NCT00996892|39598091|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
16304250|NCT00996892|39598092|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
16304251|NCT00996892|39598093|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
16304252|NCT00996892|39598094|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
16304253|NCT00996892|39598095|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
16304254|NCT00996892|39598096|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
16304255|NCT00996892|39598097|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
16304256|NCT00996892|39598098|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
16304257|NCT00996892|39598079|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
16304258|NCT00996892|39598080|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
16304259|NCT00996892|39598081|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
16304260|NCT00996892|39598082|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
16304261|NCT00996892|39598083|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
16304262|NCT00996892|39598084|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
16304263|NCT00996892|39598085|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
16304264|NCT00996892|39598086|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
16304265|NCT00996892|39598087|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
16304266|NCT00996892|39598088|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
16304267|NCT00996892|39598089|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
16304268|NCT00996892|39598090|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
16304269|NCT00996892|39598091|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
16304270|NCT00996892|39598092|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
16304271|NCT00996892|39598093|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
16304272|NCT00996892|39598094|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
16304273|NCT00996892|39598095|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
16388045|NCT01451749|39905523|FG001|Overall Study|Lost to Follow-up|5|||
16304274|NCT00996892|39598096|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
16304275|NCT00996892|39598097|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
16304276|NCT00996892|39598098|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
16388046|NCT01451749|39905522|FG000|Overall Study|Meet the exclusion criteria,and|1|||
16304277|NCT00996892|39598079|FG000|Expansion Stage 2|Adverse Event|0|||
16304278|NCT00996892|39598080|FG001|Expansion Stage 2|Adverse Event|0|||
16304279|NCT00996892|39598081|FG002|Expansion Stage 2|Adverse Event|0|||
16304280|NCT00996892|39598082|FG003|Expansion Stage 2|Adverse Event|0|||
16304281|NCT00996892|39598083|FG004|Expansion Stage 2|Adverse Event|0|||
16304282|NCT00996892|39598084|FG005|Expansion Stage 2|Adverse Event|0|||
16304283|NCT00996892|39598085|FG006|Expansion Stage 2|Adverse Event|0|||
16304284|NCT00996892|39598086|FG007|Expansion Stage 2|Adverse Event|0|||
16304285|NCT00996892|39598087|FG008|Expansion Stage 2|Adverse Event|0|||
16304286|NCT00996892|39598088|FG009|Expansion Stage 2|Adverse Event|0|||
16304287|NCT00996892|39598089|FG010|Expansion Stage 2|Adverse Event|0|||
16304288|NCT00996892|39598090|FG011|Expansion Stage 2|Adverse Event|0|||
16304289|NCT00996892|39598091|FG012|Expansion Stage 2|Adverse Event|0|||
16304290|NCT00996892|39598092|FG013|Expansion Stage 2|Adverse Event|0|||
16304291|NCT00996892|39598093|FG014|Expansion Stage 2|Adverse Event|0|||
16304292|NCT00996892|39598094|FG015|Expansion Stage 2|Adverse Event|0|||
16304293|NCT00996892|39598095|FG016|Expansion Stage 2|Adverse Event|0|||
16304294|NCT00996892|39598096|FG017|Expansion Stage 2|Adverse Event|0|||
16492891|NCT02573311|40276369|FG001|Disposition for Part 2|Other than specified above|3|||
16492892|NCT00609492|40276370|FG000|Overall Study|Withdrawal by Subject|0|||
16492893|NCT00609492|40276371|FG001|Overall Study|Withdrawal by Subject|2|||
16492894|NCT00609492|40276372|FG002|Overall Study|Withdrawal by Subject|3|||
16492895|NCT00609492|40276370|FG000|Overall Study|Lost to Follow-up|1|||
16492896|NCT00609492|40276371|FG001|Overall Study|Lost to Follow-up|1|||
16492897|NCT00609492|40276372|FG002|Overall Study|Lost to Follow-up|4|||
16492898|NCT03064451|40276375|FG000|Overall Study|Lost to Follow-up|1|||
16492899|NCT03064451|40276375|FG000|Overall Study|Mapping Failure|4|||
16492900|NCT03064451|40276375|FG000|Overall Study|Exited prior to procedure|8|||
16492901|NCT03064451|40276375|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
16492902|NCT01979016|40276379|FG000|Overall Study|Withdrawal by Subject|2|||
16492903|NCT01979016|40276380|FG001|Overall Study|Withdrawal by Subject|0|||
16492904|NCT01979016|40276379|FG000|Overall Study|Adverse Event|0|||
16492905|NCT01979016|40276380|FG001|Overall Study|Adverse Event|1|||
16492906|NCT01085591|40276382|FG000|Overall Study|Adverse Event|0|||
16492907|NCT01085591|40276383|FG001|Overall Study|Adverse Event|1|||
16492908|NCT01085591|40276384|FG002|Overall Study|Adverse Event|3|||
16492909|NCT01085591|40276382|FG000|Overall Study|Physician Decision|1|||
16492910|NCT01085591|40276383|FG001|Overall Study|Physician Decision|0|||
16492911|NCT01085591|40276384|FG002|Overall Study|Physician Decision|1|||
16492912|NCT01085591|40276382|FG000|Overall Study|Withdrawal by Subject|0|||
16492913|NCT01085591|40276383|FG001|Overall Study|Withdrawal by Subject|2|||
16492914|NCT01085591|40276384|FG002|Overall Study|Withdrawal by Subject|1|||
16492915|NCT01085591|40276382|FG000|Overall Study|Lost to Follow-up|0|||
16492916|NCT01085591|40276383|FG001|Overall Study|Lost to Follow-up|1|||
16492917|NCT01085591|40276384|FG002|Overall Study|Lost to Follow-up|1|||
16492918|NCT01085591|40276382|FG000|Overall Study|Protocol Violation|1|||
16492919|NCT01085591|40276383|FG001|Overall Study|Protocol Violation|1|||
16492920|NCT01085591|40276384|FG002|Overall Study|Protocol Violation|1|||
16492921|NCT01085591|40276382|FG000|Overall Study|Other|0|||
16304295|NCT00996892|39598097|FG018|Expansion Stage 2|Adverse Event|3|||
16304296|NCT00996892|39598098|FG019|Expansion Stage 2|Adverse Event|0|||
16492922|NCT01085591|40276383|FG001|Overall Study|Other|1|||
16492923|NCT01085591|40276384|FG002|Overall Study|Other|0|||
16492924|NCT01085591|40276382|FG000|Overall Study|Not Properly Consented|1|||
16492925|NCT01085591|40276383|FG001|Overall Study|Not Properly Consented|0|||
16304297|NCT00996892|39598079|FG000|Expansion Stage 2|Death|0|||
16304298|NCT00996892|39598080|FG001|Expansion Stage 2|Death|0|||
16304299|NCT00996892|39598081|FG002|Expansion Stage 2|Death|0|||
16492926|NCT01085591|40276384|FG002|Overall Study|Not Properly Consented|0|||
16492927|NCT01366521|40276385|FG000|Overall Study|Adverse Event|1|||
16492928|NCT01366521|40276386|FG001|Overall Study|Adverse Event|0|||
16492929|NCT01366521|40276387|FG002|Overall Study|Adverse Event|0|||
16492930|NCT01366521|40276388|FG003|Overall Study|Adverse Event|0|||
16304300|NCT00996892|39598082|FG003|Expansion Stage 2|Death|0|||
16304301|NCT00996892|39598083|FG004|Expansion Stage 2|Death|0|||
16492931|NCT01366521|40276385|FG000|Overall Study|Protocol Violation|0|||
16492932|NCT01366521|40276386|FG001|Overall Study|Protocol Violation|0|||
16492933|NCT01366521|40276387|FG002|Overall Study|Protocol Violation|1|||
16492934|NCT01366521|40276388|FG003|Overall Study|Protocol Violation|0|||
16492935|NCT01366521|40276385|FG000|Overall Study|Physician Decision|0|||
16492936|NCT01366521|40276386|FG001|Overall Study|Physician Decision|0|||
16492937|NCT01366521|40276387|FG002|Overall Study|Physician Decision|1|||
16492938|NCT01366521|40276388|FG003|Overall Study|Physician Decision|0|||
16492939|NCT01366521|40276385|FG000|Overall Study|Withdrawal by Subject|0|||
16492940|NCT01366521|40276386|FG001|Overall Study|Withdrawal by Subject|1|||
16492941|NCT01366521|40276387|FG002|Overall Study|Withdrawal by Subject|0|||
16084467|NCT01985334|38802470|FG001|Overall Study|Other|2|||
16084468|NCT01985334|38802471|FG002|Overall Study|Other|3|||
16084469|NCT01985334|38802472|FG003|Overall Study|Other|10|||
16084470|NCT01985334|38802473|FG004|Overall Study|Other|1|||
16084471|NCT01985334|38802474|FG005|Overall Study|Other|6|||
16084472|NCT01985334|38802475|FG006|Overall Study|Other|2|||
16084473|NCT01985334|38802476|FG007|Overall Study|Other|2|||
16084474|NCT01985334|38802469|FG000|Overall Study|Medication non-compliance|0|||
16084475|NCT01985334|38802470|FG001|Overall Study|Medication non-compliance|4|||
16084476|NCT01985334|38802471|FG002|Overall Study|Medication non-compliance|1|||
16084477|NCT01985334|38802472|FG003|Overall Study|Medication non-compliance|6|||
16084478|NCT01985334|38802473|FG004|Overall Study|Medication non-compliance|2|||
16084479|NCT01985334|38802474|FG005|Overall Study|Medication non-compliance|3|||
16084480|NCT01985334|38802475|FG006|Overall Study|Medication non-compliance|1|||
16084481|NCT01985334|38802476|FG007|Overall Study|Medication non-compliance|3|||
16084482|NCT01985334|38802469|FG000|Overall Study|Use of prohibited treatment|1|||
16084483|NCT01985334|38802470|FG001|Overall Study|Use of prohibited treatment|4|||
16084484|NCT01985334|38802471|FG002|Overall Study|Use of prohibited treatment|1|||
16084485|NCT01985334|38802472|FG003|Overall Study|Use of prohibited treatment|2|||
16084486|NCT01985334|38802473|FG004|Overall Study|Use of prohibited treatment|1|||
16084487|NCT01985334|38802474|FG005|Overall Study|Use of prohibited treatment|6|||
16084488|NCT01985334|38802475|FG006|Overall Study|Use of prohibited treatment|2|||
16084489|NCT01985334|38802476|FG007|Overall Study|Use of prohibited treatment|0|||
16084490|NCT01985334|38802469|FG000|Overall Study|Investigator decision|0|||
16084491|NCT01985334|38802470|FG001|Overall Study|Investigator decision|3|||
16084492|NCT01985334|38802471|FG002|Overall Study|Investigator decision|0|||
16084493|NCT01985334|38802472|FG003|Overall Study|Investigator decision|7|||
16084494|NCT01985334|38802473|FG004|Overall Study|Investigator decision|1|||
16084495|NCT01985334|38802474|FG005|Overall Study|Investigator decision|1|||
16084496|NCT01985334|38802475|FG006|Overall Study|Investigator decision|0|||
16084497|NCT01985334|38802476|FG007|Overall Study|Investigator decision|4|||
16084498|NCT01985334|38802469|FG000|Overall Study|Lost to Follow-up|0|||
16084499|NCT01985334|38802470|FG001|Overall Study|Lost to Follow-up|2|||
16084500|NCT01985334|38802471|FG002|Overall Study|Lost to Follow-up|0|||
16084501|NCT01985334|38802472|FG003|Overall Study|Lost to Follow-up|3|||
16084502|NCT01985334|38802473|FG004|Overall Study|Lost to Follow-up|1|||
16084503|NCT01985334|38802474|FG005|Overall Study|Lost to Follow-up|4|||
16084504|NCT01985334|38802475|FG006|Overall Study|Lost to Follow-up|0|||
16084505|NCT01985334|38802476|FG007|Overall Study|Lost to Follow-up|3|||
16084506|NCT02675244|38802477|FG000|Overall Study|Death|9|||
16084507|NCT02675244|38802478|FG001|Overall Study|Death|6|||
16084508|NCT02675244|38802477|FG000|Overall Study|Withdrawal by Subject|3|||
16084509|NCT02675244|38802478|FG001|Overall Study|Withdrawal by Subject|6|||
16084510|NCT02675244|38802477|FG000|Overall Study|Lost to Follow-up|1|||
16084511|NCT02675244|38802478|FG001|Overall Study|Lost to Follow-up|1|||
16084512|NCT02675244|38802477|FG000|Overall Study|Ongoing at 2 Years|190|||
16084513|NCT02675244|38802478|FG001|Overall Study|Ongoing at 2 Years|185|||
16084514|NCT01957163|38802479|FG000|Overall Study|Adverse Event|5|||
16084515|NCT01957163|38802480|FG001|Overall Study|Adverse Event|2|||
16084516|NCT01957163|38802481|FG002|Overall Study|Adverse Event|4|||
16084517|NCT01957163|38802479|FG000|Overall Study|Lack of Efficacy|5|||
16084518|NCT01957163|38802480|FG001|Overall Study|Lack of Efficacy|4|||
16084519|NCT01957163|38802481|FG002|Overall Study|Lack of Efficacy|9|||
16084520|NCT01957163|38802479|FG000|Overall Study|Protocol Violation|1|||
16084521|NCT01957163|38802480|FG001|Overall Study|Protocol Violation|2|||
16084522|NCT01957163|38802481|FG002|Overall Study|Protocol Violation|0|||
16084523|NCT01957163|38802479|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
16193506|NCT00008138|39188561|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
16084524|NCT01957163|38802480|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
16084525|NCT01957163|38802481|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
16084526|NCT01957163|38802479|FG000|Overall Study|Lost to Follow-up|0|||
16084527|NCT01957163|38802480|FG001|Overall Study|Lost to Follow-up|1|||
16084528|NCT01957163|38802481|FG002|Overall Study|Lost to Follow-up|0|||
16492942|NCT01366521|40276388|FG003|Overall Study|Withdrawal by Subject|0|||
16084529|NCT01957163|38802479|FG000|Overall Study|Withdrawal by Subject|4|||
16492943|NCT00759031|40276391|FG000|First Intervention (1 Day)|Physician Decision|1|||
16492944|NCT00759031|40276392|FG001|First Intervention (1 Day)|Physician Decision|0|||
16492945|NCT00759031|40276391|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
16492946|NCT00759031|40276392|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
16492947|NCT00759031|40276391|FG000|First Intervention (1 Day)|Screening failure|1|||
16304302|NCT00996892|39598084|FG005|Expansion Stage 2|Death|0|||
16492948|NCT00759031|40276392|FG001|First Intervention (1 Day)|Screening failure|0|||
16492949|NCT04502589|40276395|FG000|Overall Study|Physician Decision|1|||
16492950|NCT04502589|40276396|FG001|Overall Study|Physician Decision|0|||
16492951|NCT00211809|40276399|FG000|Overall Study|Lack of Efficacy|1|||
16492952|NCT00211809|40276399|FG000|Overall Study|Lost to Follow-up|2|||
16492953|NCT00211809|40276399|FG000|Overall Study|Pregnancy|1|||
16492954|NCT00211809|40276399|FG000|Overall Study|side effects|2|||
16492955|NCT02056340|40276400|FG000|Overall Study|Lost to Follow-up|5|||
16304303|NCT00996892|39598085|FG006|Expansion Stage 2|Death|0|||
16304304|NCT00996892|39598086|FG007|Expansion Stage 2|Death|0|||
16304305|NCT00996892|39598087|FG008|Expansion Stage 2|Death|0|||
16304306|NCT00996892|39598088|FG009|Expansion Stage 2|Death|0|||
16304307|NCT00996892|39598089|FG010|Expansion Stage 2|Death|0|||
16304308|NCT00996892|39598090|FG011|Expansion Stage 2|Death|0|||
16304309|NCT00996892|39598091|FG012|Expansion Stage 2|Death|0|||
16304310|NCT00996892|39598092|FG013|Expansion Stage 2|Death|0|||
16304311|NCT00996892|39598093|FG014|Expansion Stage 2|Death|0|||
16304312|NCT00996892|39598094|FG015|Expansion Stage 2|Death|0|||
16304313|NCT00996892|39598095|FG016|Expansion Stage 2|Death|0|||
16304314|NCT00996892|39598096|FG017|Expansion Stage 2|Death|0|||
16304315|NCT00996892|39598097|FG018|Expansion Stage 2|Death|2|||
16304316|NCT00996892|39598098|FG019|Expansion Stage 2|Death|0|||
16304317|NCT00996892|39598079|FG000|Expansion Stage 2|Physician Decision|0|||
16304318|NCT00996892|39598080|FG001|Expansion Stage 2|Physician Decision|0|||
16304319|NCT00996892|39598081|FG002|Expansion Stage 2|Physician Decision|0|||
16304320|NCT00996892|39598082|FG003|Expansion Stage 2|Physician Decision|0|||
16304321|NCT00996892|39598083|FG004|Expansion Stage 2|Physician Decision|0|||
16304322|NCT00996892|39598084|FG005|Expansion Stage 2|Physician Decision|0|||
16304323|NCT00996892|39598085|FG006|Expansion Stage 2|Physician Decision|0|||
16304324|NCT00996892|39598086|FG007|Expansion Stage 2|Physician Decision|0|||
16492956|NCT02056340|40276401|FG001|Overall Study|Lost to Follow-up|5|||
16492957|NCT02056340|40276400|FG000|Overall Study|Withdrawal by Subject|2|||
16492958|NCT02056340|40276401|FG001|Overall Study|Withdrawal by Subject|6|||
16492959|NCT04160195|40276402|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
16492960|NCT04160195|40276403|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
16492961|NCT01603355|40276404|FG000|Overall Study|Lack of Efficacy|2|||
16084530|NCT01957163|38802480|FG001|Overall Study|Withdrawal by Subject|2|||
16492962|NCT03915496|40276405|FG000|Overall Study|Adverse Event|2|||
16492963|NCT03915496|40276406|FG001|Overall Study|Adverse Event|1|||
16492964|NCT03915496|40276407|FG002|Overall Study|Adverse Event|2|||
16492965|NCT00390468|40276420|FG000|Overall Study|Protocol Violation|2|||
16084531|NCT01957163|38802481|FG002|Overall Study|Withdrawal by Subject|4|||
16304325|NCT00996892|39598087|FG008|Expansion Stage 2|Physician Decision|0|||
16304326|NCT00996892|39598088|FG009|Expansion Stage 2|Physician Decision|0|||
16304327|NCT00996892|39598089|FG010|Expansion Stage 2|Physician Decision|0|||
16304328|NCT00996892|39598090|FG011|Expansion Stage 2|Physician Decision|0|||
16492966|NCT00390468|40276420|FG000|Overall Study|Lack of Efficacy|1|||
16492967|NCT02324569|40276426|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
16492968|NCT02324569|40276427|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
16492969|NCT02324569|40276426|FG000|Overall Study|Voluntary Withdrawal|3|||
16492970|NCT02324569|40276427|FG001|Overall Study|Voluntary Withdrawal|6|||
16304329|NCT00996892|39598091|FG012|Expansion Stage 2|Physician Decision|0|||
16304330|NCT00996892|39598092|FG013|Expansion Stage 2|Physician Decision|0|||
16304331|NCT00996892|39598093|FG014|Expansion Stage 2|Physician Decision|0|||
16304332|NCT00996892|39598094|FG015|Expansion Stage 2|Physician Decision|0|||
16304333|NCT00996892|39598095|FG016|Expansion Stage 2|Physician Decision|0|||
16492971|NCT02324569|40276426|FG000|Overall Study|Lack of Efficacy|2|||
16304334|NCT00996892|39598096|FG017|Expansion Stage 2|Physician Decision|0|||
16304335|NCT00996892|39598097|FG018|Expansion Stage 2|Physician Decision|1|||
16304336|NCT00996892|39598098|FG019|Expansion Stage 2|Physician Decision|0|||
16304337|NCT00996892|39598079|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
16304338|NCT00996892|39598080|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
16304339|NCT00996892|39598081|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
16304340|NCT00996892|39598082|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
16304341|NCT00996892|39598083|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
16304342|NCT00996892|39598084|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
16304343|NCT00996892|39598085|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
16304344|NCT00996892|39598086|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
16304345|NCT00996892|39598087|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
16304346|NCT00996892|39598088|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
16492972|NCT02324569|40276427|FG001|Overall Study|Lack of Efficacy|3|||
16492973|NCT02324569|40276426|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
16304347|NCT00996892|39598089|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
16492974|NCT02324569|40276427|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
16492975|NCT02324569|40276426|FG000|Overall Study|Inconvenient Schedule|2|||
16304348|NCT00996892|39598090|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
16304349|NCT00996892|39598091|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
16304350|NCT00996892|39598092|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
16304351|NCT00996892|39598093|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
16304352|NCT00996892|39598094|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
16304353|NCT00996892|39598095|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
16304354|NCT00996892|39598096|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
16304355|NCT00996892|39598097|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
16304356|NCT00996892|39598098|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
16304357|NCT00996892|39598079|FG000|Expansion Stage 2|Disease Progression|0|||
16304358|NCT00996892|39598080|FG001|Expansion Stage 2|Disease Progression|0|||
16304359|NCT00996892|39598081|FG002|Expansion Stage 2|Disease Progression|0|||
16492976|NCT02324569|40276427|FG001|Overall Study|Inconvenient Schedule|0|||
16492977|NCT01350414|40276428|FG000|Overall Study|Lost to Follow-up|13|||
16492978|NCT01350414|40276428|FG000|Overall Study|Withdrawal by Subject|4|||
16492979|NCT01350414|40276428|FG000|Overall Study|Physician Decision|2|||
16492980|NCT00720434|40276429|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
16492981|NCT00720434|40276430|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
16492982|NCT00720434|40276431|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
16492983|NCT00720434|40276432|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
16492984|NCT00720434|40276429|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
16492985|NCT00720434|40276430|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
16492986|NCT00720434|40276431|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
16492987|NCT00720434|40276432|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
16492988|NCT00720434|40276429|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
16304360|NCT00996892|39598082|FG003|Expansion Stage 2|Disease Progression|0|||
16304361|NCT00996892|39598083|FG004|Expansion Stage 2|Disease Progression|0|||
16304362|NCT00996892|39598084|FG005|Expansion Stage 2|Disease Progression|0|||
16304363|NCT00996892|39598085|FG006|Expansion Stage 2|Disease Progression|0|||
16304364|NCT00996892|39598086|FG007|Expansion Stage 2|Disease Progression|0|||
16492989|NCT00720434|40276430|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
16304365|NCT00996892|39598087|FG008|Expansion Stage 2|Disease Progression|0|||
16304366|NCT00996892|39598088|FG009|Expansion Stage 2|Disease Progression|0|||
16304367|NCT00996892|39598089|FG010|Expansion Stage 2|Disease Progression|0|||
16084532|NCT01759862|38802482|FG000|Overall Study|Physician Decision|3|||
16304368|NCT00996892|39598090|FG011|Expansion Stage 2|Disease Progression|0|||
16304369|NCT00996892|39598091|FG012|Expansion Stage 2|Disease Progression|0|||
16304370|NCT00996892|39598092|FG013|Expansion Stage 2|Disease Progression|0|||
16304371|NCT00996892|39598093|FG014|Expansion Stage 2|Disease Progression|0|||
16492990|NCT00720434|40276431|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
16492991|NCT00720434|40276432|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
16304372|NCT00996892|39598094|FG015|Expansion Stage 2|Disease Progression|0|||
16304373|NCT00996892|39598095|FG016|Expansion Stage 2|Disease Progression|0|||
16304374|NCT00996892|39598096|FG017|Expansion Stage 2|Disease Progression|0|||
16304375|NCT00996892|39598097|FG018|Expansion Stage 2|Disease Progression|28|||
16304376|NCT00996892|39598098|FG019|Expansion Stage 2|Disease Progression|0|||
16304377|NCT00996892|39598079|FG000|Expansion Stage 2A|Adverse Event|0|||
16304378|NCT00996892|39598080|FG001|Expansion Stage 2A|Adverse Event|0|||
16304379|NCT00996892|39598081|FG002|Expansion Stage 2A|Adverse Event|0|||
16304380|NCT00996892|39598082|FG003|Expansion Stage 2A|Adverse Event|0|||
16304381|NCT00996892|39598083|FG004|Expansion Stage 2A|Adverse Event|0|||
16304382|NCT00996892|39598084|FG005|Expansion Stage 2A|Adverse Event|0|||
16492992|NCT00720434|40276429|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
16492993|NCT00720434|40276430|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
16492994|NCT00720434|40276431|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
16492995|NCT00720434|40276432|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
16492996|NCT00720434|40276429|FG000|Open-Label Period (Week 5-72)|Other|4|||
16492997|NCT00720434|40276430|FG001|Open-Label Period (Week 5-72)|Other|3|||
16492998|NCT00720434|40276431|FG002|Open-Label Period (Week 5-72)|Other|3|||
16492999|NCT00720434|40276432|FG003|Open-Label Period (Week 5-72)|Other|2|||
16493000|NCT00883116|40276433|FG000|Overall Study|Adverse event unrelated to study drug|5|||
16493001|NCT00883116|40276434|FG001|Overall Study|Adverse event unrelated to study drug|10|||
16493002|NCT00883116|40276433|FG000|Overall Study|Death|6|||
16493003|NCT00883116|40276434|FG001|Overall Study|Death|2|||
16493004|NCT00883116|40276433|FG000|Overall Study|Disease progression|130|||
16493005|NCT00883116|40276434|FG001|Overall Study|Disease progression|128|||
16493006|NCT00883116|40276433|FG000|Overall Study|Lost to Follow-up|0|||
16493007|NCT00883116|40276434|FG001|Overall Study|Lost to Follow-up|1|||
16493008|NCT00883116|40276433|FG000|Overall Study|Maximum clinical benefit|13|||
16493009|NCT00883116|40276434|FG001|Overall Study|Maximum clinical benefit|46|||
16493010|NCT00883116|40276433|FG000|Overall Study|Not identified|3|||
16493011|NCT00883116|40276434|FG001|Overall Study|Not identified|6|||
16493012|NCT00883116|40276433|FG000|Overall Study|Study drug toxicity|36|||
16493013|NCT00883116|40276434|FG001|Overall Study|Study drug toxicity|16|||
16493014|NCT00883116|40276433|FG000|Overall Study|Withdrawal by Subject|14|||
16493015|NCT00883116|40276434|FG001|Overall Study|Withdrawal by Subject|8|||
16493016|NCT00883116|40276433|FG000|Overall Study|No longer meets study criteria|2|||
16493017|NCT00883116|40276434|FG001|Overall Study|No longer meets study criteria|2|||
16493018|NCT02117648|40276449|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
16493019|NCT02117648|40276449|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
16493020|NCT02117648|40276449|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
16493021|NCT02117648|40276449|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
16493022|NCT02117648|40276449|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
16493023|NCT02117648|40276449|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
16493024|NCT02117648|40276449|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
16493025|NCT02117648|40276449|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
16493026|NCT02117648|40276449|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
16493027|NCT02117648|40276449|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
16493028|NCT02117648|40276449|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
16493029|NCT02450903|40276450|FG000|Overall Study|Adverse Event|3|||
16493030|NCT02450903|40276450|FG000|Overall Study|Progressive disease|15|||
16493031|NCT02450903|40276450|FG000|Overall Study|Switched to commercial drug|1|||
16493032|NCT02450903|40276450|FG000|Overall Study|Subject/guardian decision|1|||
16493033|NCT01338792|40276451|FG000|Overall Study|Adverse Event|2|||
16493034|NCT01338792|40276451|FG000|Overall Study|Death|1|||
16493035|NCT01338792|40276451|FG000|Overall Study|Withdrawal by Subject|1|||
16493036|NCT00187486|40276452|FG000|Overall Study|Protocol Violation|1|||
16493037|NCT00171730|40276454|FG000|Overall Study|Adverse Event|3|||
16493038|NCT00171730|40276454|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
16493039|NCT00171730|40276454|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
16493040|NCT00171730|40276454|FG000|Overall Study|Withdrawal by Subject|3|||
16493041|NCT03535844|40276455|FG000|Overall Study|Withdrawal by Subject|0|||
16493042|NCT03535844|40276456|FG001|Overall Study|Withdrawal by Subject|1|||
16493043|NCT01634360|40276457|FG000|Overall Study|Adverse Event|10|||
16493044|NCT01634360|40276458|FG001|Overall Study|Adverse Event|34|||
16493045|NCT01634360|40276457|FG000|Overall Study|subject withdrew consent|13|||
16493046|NCT01634360|40276458|FG001|Overall Study|subject withdrew consent|23|||
16493047|NCT01634360|40276457|FG000|Overall Study|Protocol Violation|1|||
16493048|NCT01634360|40276458|FG001|Overall Study|Protocol Violation|1|||
16304383|NCT00996892|39598085|FG006|Expansion Stage 2A|Adverse Event|0|||
16304384|NCT00996892|39598086|FG007|Expansion Stage 2A|Adverse Event|0|||
16304385|NCT00996892|39598087|FG008|Expansion Stage 2A|Adverse Event|0|||
16493049|NCT01634360|40276457|FG000|Overall Study|Lack of Efficacy|4|||
16493050|NCT01634360|40276458|FG001|Overall Study|Lack of Efficacy|14|||
16493051|NCT01634360|40276457|FG000|Overall Study|Other|3|||
16493052|NCT01634360|40276458|FG001|Overall Study|Other|20|||
16493053|NCT01634360|40276457|FG000|Overall Study|Study termination by sponsor|18|||
16493054|NCT01634360|40276458|FG001|Overall Study|Study termination by sponsor|44|||
16493055|NCT00489541|40276460|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
16493056|NCT00489541|40276461|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
16493057|NCT00489541|40276460|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
16493058|NCT00489541|40276461|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
16493059|NCT00489541|40276460|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
16493060|NCT00489541|40276461|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
16493061|NCT00489541|40276460|FG000|12-Month Clinical Follow-up|Death|3|||
16493062|NCT00489541|40276461|FG001|12-Month Clinical Follow-up|Death|2|||
16493063|NCT00489541|40276460|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
16493064|NCT00489541|40276461|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
16493065|NCT00489541|40276460|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
16493066|NCT00489541|40276461|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
16493067|NCT03018704|40276462|FG000|Overall Study|Lost to Follow-up|1|||
16493068|NCT03018704|40276463|FG001|Overall Study|Lost to Follow-up|1|||
16493069|NCT00297830|40276466|FG000|6 Month Visit|Death|1|||
16493070|NCT00297830|40276467|FG001|6 Month Visit|Death|0|||
16493071|NCT00297830|40276468|FG002|6 Month Visit|Death|2|||
16084533|NCT01759862|38802483|FG001|Overall Study|Physician Decision|1|||
16084534|NCT01759862|38802482|FG000|Overall Study|Adverse Event|0|||
16304386|NCT00996892|39598088|FG009|Expansion Stage 2A|Adverse Event|0|||
16493072|NCT00297830|40276466|FG000|6 Month Visit|Withdrawal by Subject|2|||
16493073|NCT00297830|40276467|FG001|6 Month Visit|Withdrawal by Subject|1|||
16493074|NCT00297830|40276468|FG002|6 Month Visit|Withdrawal by Subject|1|||
16493075|NCT00297830|40276466|FG000|6 Month Visit|Adverse Event|0|||
16493076|NCT00297830|40276467|FG001|6 Month Visit|Adverse Event|1|||
16493077|NCT00297830|40276468|FG002|6 Month Visit|Adverse Event|0|||
16493078|NCT00297830|40276466|FG000|12 Month Visit|Lost to Follow-up|1|||
16493079|NCT00297830|40276467|FG001|12 Month Visit|Lost to Follow-up|0|||
16493080|NCT00297830|40276468|FG002|12 Month Visit|Lost to Follow-up|0|||
16493081|NCT00297830|40276466|FG000|12 Month Visit|Adverse Event|0|||
16493082|NCT00297830|40276467|FG001|12 Month Visit|Adverse Event|3|||
16493083|NCT00297830|40276468|FG002|12 Month Visit|Adverse Event|0|||
16493084|NCT00297830|40276466|FG000|12 Month Visit|Withdrawal by Subject|0|||
16493085|NCT00297830|40276467|FG001|12 Month Visit|Withdrawal by Subject|3|||
16493086|NCT00297830|40276468|FG002|12 Month Visit|Withdrawal by Subject|0|||
16493087|NCT02266225|40276469|FG000|Overall Study|Lost to Follow-up|2|||
16493088|NCT02266225|40276469|FG000|Overall Study|Death|1|||
16493089|NCT02266225|40276469|FG000|Overall Study|Withdrawal by Subject|13|||
16493090|NCT02990910|40276470|FG000|Overall Study|Lack of Efficacy|6|||
16493091|NCT02990910|40276471|FG001|Overall Study|Lack of Efficacy|10|||
16493092|NCT00844831|40276476|FG000|Overall Study|Withdrawal by Subject|4|||
16493093|NCT00844831|40276476|FG000|Overall Study|Adverse Event|1|||
16493094|NCT00844831|40276476|FG000|Overall Study|Physician Decision|1|||
16493095|NCT02550106|40276477|FG000|Overall Study|Adverse Event|1|||
16493096|NCT02550106|40276477|FG000|Overall Study|Lack of Efficacy|3|||
16493097|NCT02550106|40276477|FG000|Overall Study|Protocol Violation|6|||
16493098|NCT02550106|40276477|FG000|Overall Study|Withdrawal by Subject|2|||
16493099|NCT00241280|40276482|FG000|Overall Study|Adverse Event|2|||
16493100|NCT00241280|40276483|FG001|Overall Study|Adverse Event|6|||
16493101|NCT00241280|40276482|FG000|Overall Study|Discomfort|11|||
16493102|NCT00241280|40276483|FG001|Overall Study|Discomfort|16|||
16493103|NCT00241280|40276482|FG000|Overall Study|Pregnancy|1|||
16493104|NCT00241280|40276483|FG001|Overall Study|Pregnancy|5|||
16493105|NCT00241280|40276482|FG000|Overall Study|Lost to Follow-up|5|||
16304387|NCT00996892|39598089|FG010|Expansion Stage 2A|Adverse Event|0|||
16304388|NCT00996892|39598090|FG011|Expansion Stage 2A|Adverse Event|0|||
16304389|NCT00996892|39598091|FG012|Expansion Stage 2A|Adverse Event|0|||
16493106|NCT00241280|40276483|FG001|Overall Study|Lost to Follow-up|8|||
16493107|NCT00241280|40276482|FG000|Overall Study|Withdrawal by Subject|7|||
16493108|NCT00241280|40276483|FG001|Overall Study|Withdrawal by Subject|4|||
16493109|NCT00241280|40276482|FG000|Overall Study|Protocol Violation|4|||
16493110|NCT00241280|40276483|FG001|Overall Study|Protocol Violation|10|||
16493111|NCT00241280|40276482|FG000|Overall Study|Relocation|4|||
16493112|NCT00241280|40276483|FG001|Overall Study|Relocation|4|||
16493113|NCT00241280|40276482|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
16493114|NCT00241280|40276483|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
16493115|NCT00241280|40276482|FG000|Overall Study|Unsatisfactory Visual Response|1|||
16493116|NCT00241280|40276483|FG001|Overall Study|Unsatisfactory Visual Response|1|||
16493117|NCT00241280|40276482|FG000|Overall Study|Diabetic|1|||
16304390|NCT00996892|39598092|FG013|Expansion Stage 2A|Adverse Event|0|||
16304391|NCT00996892|39598093|FG014|Expansion Stage 2A|Adverse Event|0|||
16304392|NCT00996892|39598094|FG015|Expansion Stage 2A|Adverse Event|0|||
16388047|NCT01451749|39905523|FG001|Overall Study|Meet the exclusion criteria,and|1|||
16388048|NCT01451749|39905522|FG000|Overall Study|Adverse Event|2|||
16493118|NCT00241280|40276483|FG001|Overall Study|Diabetic|0|||
16304393|NCT00996892|39598095|FG016|Expansion Stage 2A|Adverse Event|0|||
16304394|NCT00996892|39598096|FG017|Expansion Stage 2A|Adverse Event|0|||
16304395|NCT00996892|39598097|FG018|Expansion Stage 2A|Adverse Event|0|||
16304396|NCT00996892|39598098|FG019|Expansion Stage 2A|Adverse Event|8|||
16304397|NCT00996892|39598079|FG000|Expansion Stage 2A|Physician Decision|0|||
16493119|NCT00241280|40276482|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
16304398|NCT00996892|39598080|FG001|Expansion Stage 2A|Physician Decision|0|||
16493120|NCT00241280|40276483|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
16304399|NCT00996892|39598081|FG002|Expansion Stage 2A|Physician Decision|0|||
16304400|NCT00996892|39598082|FG003|Expansion Stage 2A|Physician Decision|0|||
16493121|NCT00241280|40276482|FG000|Overall Study|Dispensed incorrect test article|1|||
16493122|NCT00241280|40276483|FG001|Overall Study|Dispensed incorrect test article|2|||
16493123|NCT00241280|40276482|FG000|Overall Study|Unacceptable Fit|0|||
16493124|NCT00241280|40276483|FG001|Overall Study|Unacceptable Fit|1|||
16493125|NCT00241280|40276482|FG000|Overall Study|Scheduling Conflict|0|||
16493126|NCT00241280|40276483|FG001|Overall Study|Scheduling Conflict|2|||
16493127|NCT00241280|40276482|FG000|Overall Study|History of Ocular Surgery|0|||
16493128|NCT00241280|40276483|FG001|Overall Study|History of Ocular Surgery|1|||
16493129|NCT00241280|40276482|FG000|Overall Study|Coating on Lens|1|||
16493130|NCT00241280|40276483|FG001|Overall Study|Coating on Lens|0|||
16304401|NCT00996892|39598083|FG004|Expansion Stage 2A|Physician Decision|0|||
16304402|NCT00996892|39598084|FG005|Expansion Stage 2A|Physician Decision|0|||
16304403|NCT00996892|39598085|FG006|Expansion Stage 2A|Physician Decision|0|||
16304404|NCT00996892|39598086|FG007|Expansion Stage 2A|Physician Decision|0|||
16304405|NCT00996892|39598087|FG008|Expansion Stage 2A|Physician Decision|0|||
16304406|NCT00996892|39598088|FG009|Expansion Stage 2A|Physician Decision|0|||
16304407|NCT00996892|39598089|FG010|Expansion Stage 2A|Physician Decision|0|||
16304408|NCT00996892|39598090|FG011|Expansion Stage 2A|Physician Decision|0|||
16304409|NCT00996892|39598091|FG012|Expansion Stage 2A|Physician Decision|0|||
16304410|NCT00996892|39598092|FG013|Expansion Stage 2A|Physician Decision|0|||
16304411|NCT00996892|39598093|FG014|Expansion Stage 2A|Physician Decision|0|||
16304412|NCT00996892|39598094|FG015|Expansion Stage 2A|Physician Decision|0|||
16304413|NCT00996892|39598095|FG016|Expansion Stage 2A|Physician Decision|0|||
16304414|NCT00996892|39598096|FG017|Expansion Stage 2A|Physician Decision|0|||
16304415|NCT00996892|39598097|FG018|Expansion Stage 2A|Physician Decision|0|||
16304416|NCT00996892|39598098|FG019|Expansion Stage 2A|Physician Decision|2|||
16304417|NCT00996892|39598079|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
16304418|NCT00996892|39598080|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
16304419|NCT00996892|39598081|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
16304420|NCT00996892|39598082|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
16493131|NCT00241280|40276482|FG000|Overall Study|Excessive Dryness|0|||
16493132|NCT00241280|40276483|FG001|Overall Study|Excessive Dryness|1|||
16493133|NCT02848651|40276486|FG000|Overall Study|Death|85|||
16493134|NCT02848651|40276486|FG000|Overall Study|Lost to Follow-up|1|||
16304421|NCT00996892|39598083|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
16304422|NCT00996892|39598084|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
16304423|NCT00996892|39598085|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
16304424|NCT00996892|39598086|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
16304425|NCT00996892|39598087|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
16304426|NCT00996892|39598088|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
16304427|NCT00996892|39598089|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
16304428|NCT00996892|39598090|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
16304429|NCT00996892|39598091|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
16304430|NCT00996892|39598092|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
16304431|NCT00996892|39598093|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
16304432|NCT00996892|39598094|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
16493135|NCT02848651|40276486|FG000|Overall Study|Non-Compliance|1|||
16493136|NCT02848651|40276486|FG000|Overall Study|Symptomatic Deterioration|1|||
16493137|NCT02848651|40276486|FG000|Overall Study|Physician Decision|4|||
16493138|NCT02848651|40276486|FG000|Overall Study|Withdrawal by Subject|14|||
16493139|NCT04232124|40276494|FG000|Overall Study|Lost to Follow-up|3|||
16493140|NCT00827502|40276512|FG000|Overall Study|randomized but not treated|11|||
16493141|NCT00827502|40276512|FG000|Overall Study|Adverse Event|1|||
16493142|NCT00827502|40276512|FG000|Overall Study|Lost to Follow-up|4|||
16493143|NCT00827502|40276512|FG000|Overall Study|Withdrawal by Subject|5|||
16493144|NCT03428360|40276523|FG000|Overall Study|Informed consent withdrawn|5|||
16493145|NCT03428360|40276523|FG000|Overall Study|Withdrawal by Subject|4|||
16493146|NCT03428360|40276523|FG000|Overall Study|Lost to Follow-up|5|||
16493147|NCT03428360|40276523|FG000|Overall Study|Physician Decision|2|||
16493148|NCT03428360|40276523|FG000|Overall Study|Informed consent withdrawn|5|||
16493149|NCT03428360|40276523|FG000|Overall Study|Study terminated by sponsor|10|||
16493150|NCT03428360|40276523|FG000|Overall Study|Non-compliant with study|1|||
16493151|NCT03428360|40276523|FG000|Overall Study|Non-compliant with study drug|3|||
16493152|NCT03428360|40276523|FG000|Overall Study|Death|3|||
16493153|NCT03428360|40276523|FG000|Overall Study|Adverse Event|1|||
16493154|NCT03428360|40276523|FG000|Overall Study|Not on antiepileptic drug|1|||
16493155|NCT00482612|40276524|FG000|In-treatment Period|No study medication administered|0|||
16493156|NCT00482612|40276525|FG001|In-treatment Period|No study medication administered|0|||
16493157|NCT00482612|40276526|FG002|In-treatment Period|No study medication administered|1|||
16493158|NCT00482612|40276527|FG003|In-treatment Period|No study medication administered|0|||
16493159|NCT00482612|40276524|FG000|Follow-up Period|Other|4|||
16493160|NCT00482612|40276525|FG001|Follow-up Period|Other|2|||
16493161|NCT00482612|40276526|FG002|Follow-up Period|Other|1|||
16493162|NCT00482612|40276527|FG003|Follow-up Period|Other|2|||
16493163|NCT00482612|40276524|FG000|Follow-up Period|Lack of compliance|0|||
16493164|NCT00482612|40276525|FG001|Follow-up Period|Lack of compliance|0|||
16493165|NCT00482612|40276526|FG002|Follow-up Period|Lack of compliance|1|||
16493166|NCT00482612|40276527|FG003|Follow-up Period|Lack of compliance|0|||
16493167|NCT00482612|40276524|FG000|Follow-up Period|Lost to Follow-up|0|||
16493168|NCT00482612|40276525|FG001|Follow-up Period|Lost to Follow-up|4|||
16493169|NCT00482612|40276526|FG002|Follow-up Period|Lost to Follow-up|2|||
16493170|NCT00482612|40276527|FG003|Follow-up Period|Lost to Follow-up|1|||
16304433|NCT00996892|39598095|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
16304434|NCT00996892|39598096|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
16493171|NCT00482612|40276524|FG000|Follow-up Period|Adverse Event|4|||
16493172|NCT00482612|40276525|FG001|Follow-up Period|Adverse Event|7|||
16493173|NCT00482612|40276526|FG002|Follow-up Period|Adverse Event|9|||
16493174|NCT00482612|40276527|FG003|Follow-up Period|Adverse Event|0|||
16493175|NCT00482612|40276524|FG000|Follow-up Period|Lack of Efficacy|2|||
16493176|NCT00482612|40276525|FG001|Follow-up Period|Lack of Efficacy|0|||
16493177|NCT00482612|40276526|FG002|Follow-up Period|Lack of Efficacy|1|||
16493178|NCT00482612|40276527|FG003|Follow-up Period|Lack of Efficacy|0|||
16493179|NCT00482612|40276524|FG000|Follow-up Period|Withdrawal by Subject|3|||
16493180|NCT00482612|40276525|FG001|Follow-up Period|Withdrawal by Subject|5|||
16493181|NCT00482612|40276526|FG002|Follow-up Period|Withdrawal by Subject|7|||
16493182|NCT00482612|40276527|FG003|Follow-up Period|Withdrawal by Subject|2|||
16493183|NCT00482612|40276524|FG000|Follow-up Period|Reasons not related to trial|1|||
16493184|NCT00482612|40276525|FG001|Follow-up Period|Reasons not related to trial|0|||
16493185|NCT00482612|40276526|FG002|Follow-up Period|Reasons not related to trial|1|||
16493186|NCT00482612|40276527|FG003|Follow-up Period|Reasons not related to trial|3|||
16493187|NCT01465997|40276528|FG000|Overall Study|Adverse Event|12|||
16493188|NCT01465997|40276529|FG001|Overall Study|Adverse Event|22|||
16493189|NCT01465997|40276528|FG000|Overall Study|Lack of Efficacy|13|||
16493190|NCT01465997|40276529|FG001|Overall Study|Lack of Efficacy|1|||
16493191|NCT01465997|40276528|FG000|Overall Study|Protocol Violation|1|||
16493192|NCT01465997|40276529|FG001|Overall Study|Protocol Violation|4|||
16493193|NCT01465997|40276528|FG000|Overall Study|Lost to Follow-up|6|||
16493194|NCT01465997|40276529|FG001|Overall Study|Lost to Follow-up|9|||
16493195|NCT01465997|40276528|FG000|Overall Study|Withdrawal by Subject|32|||
16493196|NCT01465997|40276529|FG001|Overall Study|Withdrawal by Subject|35|||
16084535|NCT01759862|38802483|FG001|Overall Study|Adverse Event|1|||
16084536|NCT00605306|38802486|FG000|Overall Study|Adverse Event|0|||
16084537|NCT00605306|38802487|FG001|Overall Study|Adverse Event|1|||
16084538|NCT00112359|38802488|FG000|Overall Study|Unrelated adverse event|16|||
16084539|NCT00112359|38802489|FG001|Overall Study|Unrelated adverse event|8|||
16084540|NCT00112359|38802488|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
16084541|NCT00112359|38802489|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
16084542|NCT00112359|38802488|FG000|Overall Study|Related adverse event|5|||
16084543|NCT00112359|38802489|FG001|Overall Study|Related adverse event|3|||
16084544|NCT00112359|38802488|FG000|Overall Study|Lost to Follow-up|0|||
16084545|NCT00112359|38802489|FG001|Overall Study|Lost to Follow-up|1|||
16084546|NCT00112359|38802488|FG000|Overall Study|Personal/administrative|1|||
16084547|NCT00112359|38802489|FG001|Overall Study|Personal/administrative|1|||
16084548|NCT00112359|38802488|FG000|Overall Study|Other|3|||
16084549|NCT00112359|38802489|FG001|Overall Study|Other|0|||
16084550|NCT00845520|38802490|FG000|Overall Study|Death|1|||
16084551|NCT00845520|38802491|FG001|Overall Study|Death|2|||
16493197|NCT01465997|40276528|FG000|Overall Study|investigator's decision|1|||
16493198|NCT01465997|40276529|FG001|Overall Study|investigator's decision|1|||
16493199|NCT01465997|40276528|FG000|Overall Study|Death|0|||
16493200|NCT01465997|40276529|FG001|Overall Study|Death|1|||
16493201|NCT01465997|40276528|FG000|Overall Study|sponsor's decision|1|||
16493202|NCT01465997|40276529|FG001|Overall Study|sponsor's decision|1|||
16493203|NCT01465997|40276528|FG000|Overall Study|subject withdrew consent|1|||
16493204|NCT01465997|40276529|FG001|Overall Study|subject withdrew consent|0|||
16493205|NCT01465997|40276528|FG000|Overall Study|local lab unblinded site|1|||
16493206|NCT01465997|40276529|FG001|Overall Study|local lab unblinded site|0|||
16493207|NCT01465997|40276528|FG000|Overall Study|withdrew before follow-up|0|||
16493208|NCT01465997|40276529|FG001|Overall Study|withdrew before follow-up|13|||
16493209|NCT01465997|40276528|FG000|Overall Study|decision by site staff|0|||
16493210|NCT01465997|40276529|FG001|Overall Study|decision by site staff|1|||
16493211|NCT01465997|40276528|FG000|Overall Study|subject left participation SP0993|0|||
16493212|NCT01465997|40276529|FG001|Overall Study|subject left participation SP0993|1|||
16493213|NCT01385566|40276535|FG000|Overall Study|Lost to Follow-up|1|||
16493214|NCT01385566|40276536|FG001|Overall Study|Lost to Follow-up|0|||
16493215|NCT01385566|40276537|FG002|Overall Study|Lost to Follow-up|0|||
16493216|NCT01385566|40276538|FG003|Overall Study|Lost to Follow-up|0|||
16493217|NCT01385566|40276539|FG004|Overall Study|Lost to Follow-up|0|||
16493218|NCT01385566|40276540|FG005|Overall Study|Lost to Follow-up|0|||
16493219|NCT01385566|40276535|FG000|Overall Study|Withdrawal by Subject|0|||
16493220|NCT01385566|40276536|FG001|Overall Study|Withdrawal by Subject|0|||
16493221|NCT01385566|40276537|FG002|Overall Study|Withdrawal by Subject|0|||
16493222|NCT01385566|40276538|FG003|Overall Study|Withdrawal by Subject|1|||
16493223|NCT01385566|40276539|FG004|Overall Study|Withdrawal by Subject|0|||
16493224|NCT01385566|40276540|FG005|Overall Study|Withdrawal by Subject|0|||
16493225|NCT00191789|40276541|FG000|Overall Study|Adverse Event|5|||
16493226|NCT00191789|40276541|FG000|Overall Study|Patient: Satisfactory Response|5|||
16493227|NCT00191789|40276541|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
16084552|NCT00845520|38802492|FG002|Overall Study|Death|0|||
16493228|NCT00191789|40276541|FG000|Overall Study|Withdrawal by Subject|4|||
16493229|NCT00191789|40276541|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
16493230|NCT00191789|40276541|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
16084553|NCT00845520|38802490|FG000|Overall Study|Lost to Follow-up|1|||
16084554|NCT00845520|38802491|FG001|Overall Study|Lost to Follow-up|0|||
16084555|NCT00845520|38802492|FG002|Overall Study|Lost to Follow-up|0|||
16084556|NCT00845520|38802490|FG000|Overall Study|Adverse Event|0|||
16084557|NCT00845520|38802491|FG001|Overall Study|Adverse Event|0|||
16084558|NCT00845520|38802492|FG002|Overall Study|Adverse Event|1|||
16493231|NCT00191789|40276541|FG000|Overall Study|Death - Not Study-Drug Related|1|||
16493232|NCT00779467|40276542|FG000|Overall Study|Lack of Efficacy|11|||
16493233|NCT00779467|40276543|FG001|Overall Study|Lack of Efficacy|2|||
16493234|NCT00779467|40276544|FG002|Overall Study|Lack of Efficacy|6|||
16493235|NCT00779467|40276545|FG003|Overall Study|Lack of Efficacy|11|||
16493236|NCT00779467|40276542|FG000|Overall Study|failed inclusion criteria|3|||
16304435|NCT00996892|39598097|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
16304436|NCT00996892|39598098|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
16304437|NCT00996892|39598079|FG000|Expansion Stage 2A|Disease Progression|0|||
16304438|NCT00996892|39598080|FG001|Expansion Stage 2A|Disease Progression|0|||
16304439|NCT00996892|39598081|FG002|Expansion Stage 2A|Disease Progression|0|||
16304440|NCT00996892|39598082|FG003|Expansion Stage 2A|Disease Progression|0|||
16304441|NCT00996892|39598083|FG004|Expansion Stage 2A|Disease Progression|0|||
16304442|NCT00996892|39598084|FG005|Expansion Stage 2A|Disease Progression|0|||
16304443|NCT00996892|39598085|FG006|Expansion Stage 2A|Disease Progression|0|||
16304444|NCT00996892|39598086|FG007|Expansion Stage 2A|Disease Progression|0|||
16304445|NCT00996892|39598087|FG008|Expansion Stage 2A|Disease Progression|0|||
16304446|NCT00996892|39598088|FG009|Expansion Stage 2A|Disease Progression|0|||
16304447|NCT00996892|39598089|FG010|Expansion Stage 2A|Disease Progression|0|||
16304448|NCT00996892|39598090|FG011|Expansion Stage 2A|Disease Progression|0|||
16304449|NCT00996892|39598091|FG012|Expansion Stage 2A|Disease Progression|0|||
16304450|NCT00996892|39598092|FG013|Expansion Stage 2A|Disease Progression|0|||
16304451|NCT00996892|39598093|FG014|Expansion Stage 2A|Disease Progression|0|||
16304452|NCT00996892|39598094|FG015|Expansion Stage 2A|Disease Progression|0|||
16304453|NCT00996892|39598095|FG016|Expansion Stage 2A|Disease Progression|0|||
16304454|NCT00996892|39598096|FG017|Expansion Stage 2A|Disease Progression|0|||
16304455|NCT00996892|39598097|FG018|Expansion Stage 2A|Disease Progression|0|||
16304456|NCT00996892|39598098|FG019|Expansion Stage 2A|Disease Progression|31|||
16304457|NCT01442688|39598099|FG000|First Intervention|Withdrawal by Subject|1|||
16304458|NCT01442688|39598100|FG001|First Intervention|Withdrawal by Subject|0|||
16304459|NCT01442688|39598099|FG000|First Intervention|subject incarcerated|1|||
16304460|NCT01442688|39598100|FG001|First Intervention|subject incarcerated|0|||
16304461|NCT01442688|39598099|FG000|Second Intervention|Adverse Event|1|||
16304462|NCT01442688|39598100|FG001|Second Intervention|Adverse Event|0|||
16304463|NCT03106987|39598101|FG000|Overall Study|Death|37|||
16304464|NCT03106987|39598102|FG001|Overall Study|Death|22|||
16304465|NCT03106987|39598103|FG002|Overall Study|Death|12|||
16304466|NCT03106987|39598104|FG003|Overall Study|Death|8|||
16304467|NCT03106987|39598101|FG000|Overall Study|Lost to Follow-up|2|||
16304468|NCT03106987|39598102|FG001|Overall Study|Lost to Follow-up|0|||
16304469|NCT03106987|39598103|FG002|Overall Study|Lost to Follow-up|2|||
16304470|NCT03106987|39598104|FG003|Overall Study|Lost to Follow-up|2|||
16304471|NCT03106987|39598101|FG000|Overall Study|Withdrawal by Subject|5|||
16304472|NCT03106987|39598102|FG001|Overall Study|Withdrawal by Subject|1|||
16304473|NCT03106987|39598103|FG002|Overall Study|Withdrawal by Subject|4|||
16304474|NCT03106987|39598104|FG003|Overall Study|Withdrawal by Subject|1|||
16304475|NCT01998841|39598105|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
16304476|NCT01998841|39598106|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
16304477|NCT01998841|39598107|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
16304478|NCT01998841|39598108|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
16304479|NCT01998841|39598109|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
16304480|NCT01998841|39598105|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
16304481|NCT01998841|39598106|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
16304482|NCT01998841|39598107|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
16304483|NCT01998841|39598108|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
16304484|NCT01998841|39598109|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
16304485|NCT00550459|39598110|FG000|Overall Study|Adverse Event|0|||
16304486|NCT00550459|39598111|FG001|Overall Study|Adverse Event|2|||
16304487|NCT00550459|39598110|FG000|Overall Study|Withdrawal by Subject|1|||
16084559|NCT01485887|38802493|FG000|Overall Study|Withdrawal by Subject|2|||
16084560|NCT01485887|38802493|FG000|Overall Study|Adverse Event|8|||
16304488|NCT00550459|39598111|FG001|Overall Study|Withdrawal by Subject|1|||
16304489|NCT00582010|39598112|FG000|Overall Study|Death|0|||
16304490|NCT00582010|39598113|FG001|Overall Study|Death|1|||
16304491|NCT01721317|39598114|FG000|Overall Study|Study Closed / Terminated|2|||
16304492|NCT01721317|39598115|FG001|Overall Study|Study Closed / Terminated|2|||
16304493|NCT01721317|39598114|FG000|Overall Study|Physician Decision|0|||
16304494|NCT01721317|39598115|FG001|Overall Study|Physician Decision|1|||
16304495|NCT01721317|39598114|FG000|Overall Study|Withdrawal by Subject|0|||
16304496|NCT01721317|39598115|FG001|Overall Study|Withdrawal by Subject|1|||
16304497|NCT04868500|39598116|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
16304498|NCT04868500|39598117|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
16304499|NCT04868500|39598116|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
16304500|NCT04868500|39598117|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
16304501|NCT00101283|39598118|FG000|Overall Study|Withdrawal by Subject|0|||
16304502|NCT00101283|39598119|FG001|Overall Study|Withdrawal by Subject|1|||
16304503|NCT00101283|39598118|FG000|Overall Study|Insurance Refusal|0|||
16304504|NCT00101283|39598119|FG001|Overall Study|Insurance Refusal|1|||
16304505|NCT00101283|39598118|FG000|Overall Study|Prostate Cancer Recurrence|0|||
16304506|NCT00101283|39598119|FG001|Overall Study|Prostate Cancer Recurrence|1|||
16304507|NCT00591773|39598120|FG000|Overall Study|Adverse Event|9|||
16304508|NCT00591773|39598121|FG001|Overall Study|Adverse Event|9|||
16304509|NCT00591773|39598122|FG002|Overall Study|Adverse Event|6|||
16304510|NCT00591773|39598120|FG000|Overall Study|Protocol Violation|2|||
16304511|NCT00591773|39598121|FG001|Overall Study|Protocol Violation|3|||
16304512|NCT00591773|39598122|FG002|Overall Study|Protocol Violation|0|||
16304513|NCT00591773|39598120|FG000|Overall Study|Lost to Follow-up|1|||
16304514|NCT00591773|39598121|FG001|Overall Study|Lost to Follow-up|4|||
16304515|NCT00591773|39598122|FG002|Overall Study|Lost to Follow-up|1|||
16304516|NCT00591773|39598120|FG000|Overall Study|Withdrawal by Subject|2|||
16304517|NCT00591773|39598121|FG001|Overall Study|Withdrawal by Subject|5|||
16304518|NCT00591773|39598122|FG002|Overall Study|Withdrawal by Subject|3|||
16304519|NCT00591773|39598120|FG000|Overall Study|Lack of Efficacy|1|||
16304520|NCT00591773|39598121|FG001|Overall Study|Lack of Efficacy|2|||
16304521|NCT00591773|39598122|FG002|Overall Study|Lack of Efficacy|2|||
16304522|NCT00591773|39598120|FG000|Overall Study|Other|1|||
16304523|NCT00591773|39598121|FG001|Overall Study|Other|1|||
16304524|NCT00591773|39598122|FG002|Overall Study|Other|4|||
16304525|NCT04248829|39598125|FG000|Overall Study|Disease progression|44|||
16304526|NCT04248829|39598126|FG001|Overall Study|Disease progression|109|||
16304527|NCT04248829|39598125|FG000|Overall Study|Adverse Event|19|||
16304528|NCT04248829|39598126|FG001|Overall Study|Adverse Event|18|||
16304529|NCT04248829|39598125|FG000|Overall Study|Withdrawal by Subject|11|||
16304530|NCT04248829|39598126|FG001|Overall Study|Withdrawal by Subject|2|||
16304531|NCT04248829|39598125|FG000|Overall Study|Lost to Follow-up|0|||
16304532|NCT04248829|39598126|FG001|Overall Study|Lost to Follow-up|1|||
16304533|NCT04248829|39598125|FG000|Overall Study|Death|12|||
16304534|NCT04248829|39598126|FG001|Overall Study|Death|14|||
16304535|NCT04248829|39598125|FG000|Overall Study|Physician Decision|2|||
16304536|NCT04248829|39598126|FG001|Overall Study|Physician Decision|4|||
16304537|NCT04248829|39598125|FG000|Overall Study|Any reason not specifically recorded|0|||
16304538|NCT04248829|39598126|FG001|Overall Study|Any reason not specifically recorded|2|||
16304539|NCT00606632|39598127|FG000|Overall Study|Withdrawal by Subject|13|||
16304540|NCT00606632|39598127|FG000|Overall Study|Miscellaneous reasons|9|||
16304541|NCT00683657|39598129|FG000|Overall Study|Adverse Event|0|||
16304542|NCT00683657|39598130|FG001|Overall Study|Adverse Event|1|||
16304543|NCT00683657|39598129|FG000|Overall Study|Subject Withdrew Consent|1|||
16304544|NCT00683657|39598130|FG001|Overall Study|Subject Withdrew Consent|0|||
16304545|NCT03485365|39598131|FG000|Overall Study|Protocol Violation|0|||
16304546|NCT03485365|39598132|FG001|Overall Study|Protocol Violation|0|||
16304547|NCT03485365|39598133|FG002|Overall Study|Protocol Violation|0|||
16304548|NCT03485365|39598134|FG003|Overall Study|Protocol Violation|1|||
16304549|NCT03485365|39598135|FG004|Overall Study|Protocol Violation|0|||
16304550|NCT03485365|39598136|FG005|Overall Study|Protocol Violation|0|||
16304551|NCT03485365|39598137|FG006|Overall Study|Protocol Violation|1|||
16304552|NCT03485365|39598138|FG007|Overall Study|Protocol Violation|0|||
16304553|NCT03485365|39598139|FG008|Overall Study|Protocol Violation|0|||
16304554|NCT04052620|39598143|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
16304555|NCT04052620|39598144|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
16304556|NCT04052620|39598143|FG000|Overall Study|Withdrawal by Subject|1|||
16304557|NCT04052620|39598144|FG001|Overall Study|Withdrawal by Subject|0|||
16304558|NCT04052620|39598143|FG000|Overall Study|Lost to Follow-up|1|||
16304559|NCT04052620|39598144|FG001|Overall Study|Lost to Follow-up|1|||
16304560|NCT04052620|39598143|FG000|Overall Study|Adverse Event|1|||
16304561|NCT04052620|39598144|FG001|Overall Study|Adverse Event|0|||
16304562|NCT04052620|39598143|FG000|Overall Study|Subject did not meet study Criteria|0|||
16304563|NCT04052620|39598144|FG001|Overall Study|Subject did not meet study Criteria|1|||
16304564|NCT04052620|39598143|FG000|Overall Study|Screened failure, randomized by mistake|0|||
16304565|NCT04052620|39598144|FG001|Overall Study|Screened failure, randomized by mistake|1|||
16304566|NCT04052620|39598143|FG000|Overall Study|Personal reasons|2|||
16304567|NCT04052620|39598144|FG001|Overall Study|Personal reasons|4|||
16304568|NCT04052620|39598143|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
16304569|NCT04052620|39598144|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
16304570|NCT02552121|39598149|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
16304571|NCT02552121|39598150|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16304572|NCT02552121|39598151|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16304573|NCT02552121|39598152|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16304574|NCT02552121|39598153|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16304575|NCT02552121|39598154|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16304576|NCT02552121|39598155|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16304577|NCT02552121|39598156|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
16304578|NCT02552121|39598149|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
16304579|NCT02552121|39598150|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16304580|NCT02552121|39598151|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16304581|NCT02552121|39598152|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16304582|NCT02552121|39598153|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16304583|NCT02552121|39598154|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16304584|NCT02552121|39598155|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16304585|NCT02552121|39598156|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
16304586|NCT02552121|39598149|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16304587|NCT02552121|39598150|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
16304588|NCT02552121|39598151|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16304589|NCT02552121|39598152|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16304590|NCT02552121|39598153|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16304591|NCT02552121|39598154|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16304592|NCT02552121|39598155|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16304593|NCT02552121|39598156|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
16304594|NCT02552121|39598149|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16304595|NCT02552121|39598150|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
16304596|NCT02552121|39598151|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16304597|NCT02552121|39598152|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16304598|NCT02552121|39598153|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16304599|NCT02552121|39598154|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16304600|NCT02552121|39598155|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16304601|NCT02552121|39598156|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
16304602|NCT02552121|39598149|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
16304603|NCT02552121|39598150|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
16304604|NCT02552121|39598151|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
16304605|NCT02552121|39598152|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
16304606|NCT02552121|39598153|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
16304607|NCT02552121|39598154|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
16304608|NCT02552121|39598155|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
16304609|NCT02552121|39598156|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
16304610|NCT02552121|39598149|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16304611|NCT02552121|39598150|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
16304612|NCT02552121|39598151|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16304613|NCT02552121|39598152|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16304614|NCT02552121|39598153|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16304615|NCT02552121|39598154|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16304616|NCT02552121|39598155|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16304617|NCT02552121|39598156|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
16304618|NCT02552121|39598149|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
16304619|NCT02552121|39598150|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
16304620|NCT02552121|39598151|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
16304621|NCT02552121|39598152|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
16304622|NCT02552121|39598153|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
16304623|NCT02552121|39598154|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
16493237|NCT00779467|40276543|FG001|Overall Study|failed inclusion criteria|3|||
16493238|NCT00779467|40276544|FG002|Overall Study|failed inclusion criteria|1|||
16493239|NCT00779467|40276545|FG003|Overall Study|failed inclusion criteria|2|||
16493240|NCT00779467|40276542|FG000|Overall Study|missing data|1|||
16493241|NCT00779467|40276543|FG001|Overall Study|missing data|0|||
16493242|NCT00779467|40276544|FG002|Overall Study|missing data|1|||
16493243|NCT00779467|40276545|FG003|Overall Study|missing data|4|||
16304624|NCT02552121|39598155|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
16304625|NCT02552121|39598156|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
16304626|NCT02552121|39598149|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
16304627|NCT02552121|39598150|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
16304628|NCT02552121|39598151|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
16304629|NCT02552121|39598152|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
16304630|NCT02552121|39598153|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
16304631|NCT02552121|39598154|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
16304632|NCT02552121|39598155|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
16493244|NCT00779467|40276542|FG000|Overall Study|technical issue|0|||
16304633|NCT02552121|39598156|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
16304634|NCT02552121|39598149|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
16304635|NCT02552121|39598150|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
16304636|NCT02552121|39598151|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
16304637|NCT02552121|39598152|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
16304638|NCT02552121|39598153|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
16304639|NCT02552121|39598154|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
16304640|NCT02552121|39598155|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
16304641|NCT02552121|39598156|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
16304642|NCT02552121|39598149|FG000|Part 2: Cohort Expansion|Death|0|||
16304643|NCT02552121|39598150|FG001|Part 2: Cohort Expansion|Death|0|||
16304644|NCT02552121|39598151|FG002|Part 2: Cohort Expansion|Death|1|||
16304645|NCT02552121|39598152|FG003|Part 2: Cohort Expansion|Death|0|||
16304646|NCT02552121|39598153|FG004|Part 2: Cohort Expansion|Death|0|||
16304647|NCT02552121|39598154|FG005|Part 2: Cohort Expansion|Death|0|||
16304648|NCT02552121|39598155|FG006|Part 2: Cohort Expansion|Death|0|||
16304649|NCT02552121|39598156|FG007|Part 2: Cohort Expansion|Death|0|||
16304650|NCT00005957|39598157|FG000|Overall Study|No treated|3|||
16493245|NCT00779467|40276543|FG001|Overall Study|technical issue|0|||
16493246|NCT00779467|40276544|FG002|Overall Study|technical issue|2|||
16493247|NCT00779467|40276545|FG003|Overall Study|technical issue|1|||
16493248|NCT00779467|40276542|FG000|Overall Study|unavailable research staff|0|||
16493249|NCT00779467|40276543|FG001|Overall Study|unavailable research staff|0|||
16493250|NCT00779467|40276544|FG002|Overall Study|unavailable research staff|0|||
16493251|NCT00779467|40276545|FG003|Overall Study|unavailable research staff|1|||
16493252|NCT03208244|40276546|FG000|Overall Study|Death|1|||
16493253|NCT05466682|40276547|FG000|Overall Study|Withdrawal by Subject|0|||
16493254|NCT05466682|40276548|FG001|Overall Study|Withdrawal by Subject|2|||
16493255|NCT05466682|40276547|FG000|Overall Study|Lost to Follow-up|2|||
16493256|NCT05466682|40276548|FG001|Overall Study|Lost to Follow-up|1|||
16493257|NCT01385202|40276549|FG000|Overall Study|Lost to Follow-up|6|||
16493258|NCT01385202|40276549|FG000|Overall Study|Not Eligible|11|||
16493259|NCT01385202|40276549|FG000|Overall Study|Withdrawn|1|||
16493260|NCT02743871|40276550|FG000|Overall Study|Lost to Follow-up|0|||
16493261|NCT02743871|40276551|FG001|Overall Study|Lost to Follow-up|0|||
16493262|NCT02743871|40276552|FG002|Overall Study|Lost to Follow-up|0|||
16493263|NCT02743871|40276553|FG003|Overall Study|Lost to Follow-up|1|||
16493264|NCT02743871|40276554|FG004|Overall Study|Lost to Follow-up|0|||
16493265|NCT02743871|40276555|FG005|Overall Study|Lost to Follow-up|0|||
16493266|NCT02743871|40276556|FG006|Overall Study|Lost to Follow-up|1|||
16493267|NCT02743871|40276557|FG007|Overall Study|Lost to Follow-up|0|||
16493268|NCT02743871|40276558|FG008|Overall Study|Lost to Follow-up|0|||
16493269|NCT02743871|40276559|FG009|Overall Study|Lost to Follow-up|0|||
16493270|NCT02743871|40276560|FG010|Overall Study|Lost to Follow-up|0|||
16493271|NCT02743871|40276561|FG011|Overall Study|Lost to Follow-up|2|||
16493272|NCT02743871|40276562|FG012|Overall Study|Lost to Follow-up|0|||
16493273|NCT02743871|40276563|FG013|Overall Study|Lost to Follow-up|0|||
16493274|NCT02743871|40276550|FG000|Overall Study|Withdrawal by Subject|0|||
16493275|NCT02743871|40276551|FG001|Overall Study|Withdrawal by Subject|0|||
16493276|NCT02743871|40276552|FG002|Overall Study|Withdrawal by Subject|0|||
16493277|NCT02743871|40276553|FG003|Overall Study|Withdrawal by Subject|0|||
16493278|NCT02743871|40276554|FG004|Overall Study|Withdrawal by Subject|0|||
16493279|NCT02743871|40276555|FG005|Overall Study|Withdrawal by Subject|0|||
16493280|NCT02743871|40276556|FG006|Overall Study|Withdrawal by Subject|0|||
16493281|NCT02743871|40276557|FG007|Overall Study|Withdrawal by Subject|0|||
16493282|NCT02743871|40276558|FG008|Overall Study|Withdrawal by Subject|0|||
16493283|NCT02743871|40276559|FG009|Overall Study|Withdrawal by Subject|0|||
16493284|NCT02743871|40276560|FG010|Overall Study|Withdrawal by Subject|1|||
16493285|NCT02743871|40276561|FG011|Overall Study|Withdrawal by Subject|0|||
16493286|NCT02743871|40276562|FG012|Overall Study|Withdrawal by Subject|12|||
16493287|NCT02743871|40276563|FG013|Overall Study|Withdrawal by Subject|6|||
16493288|NCT02743871|40276550|FG000|Overall Study|Adverse Event|1|||
16493289|NCT02743871|40276551|FG001|Overall Study|Adverse Event|0|||
16493290|NCT02743871|40276552|FG002|Overall Study|Adverse Event|0|||
16493291|NCT02743871|40276553|FG003|Overall Study|Adverse Event|0|||
16304651|NCT00005957|39598158|FG001|Overall Study|No treated|9|||
16304652|NCT00005957|39598157|FG000|Overall Study|Crossover to the other arm|5|||
16493292|NCT02743871|40276554|FG004|Overall Study|Adverse Event|0|||
16493293|NCT02743871|40276555|FG005|Overall Study|Adverse Event|0|||
16493294|NCT02743871|40276556|FG006|Overall Study|Adverse Event|0|||
16493295|NCT02743871|40276557|FG007|Overall Study|Adverse Event|0|||
16493296|NCT02743871|40276558|FG008|Overall Study|Adverse Event|0|||
16493297|NCT02743871|40276559|FG009|Overall Study|Adverse Event|0|||
16493298|NCT02743871|40276560|FG010|Overall Study|Adverse Event|0|||
16493299|NCT02743871|40276561|FG011|Overall Study|Adverse Event|0|||
16304653|NCT00005957|39598158|FG001|Overall Study|Crossover to the other arm|19|||
16493300|NCT02743871|40276562|FG012|Overall Study|Adverse Event|0|||
16493301|NCT02743871|40276563|FG013|Overall Study|Adverse Event|0|||
16493302|NCT02743871|40276550|FG000|Overall Study|Other|0|||
16493303|NCT02743871|40276551|FG001|Overall Study|Other|0|||
16388049|NCT01451749|39905523|FG001|Overall Study|Adverse Event|0|||
16388050|NCT01451749|39905522|FG000|Overall Study|Withdrawal by Subject|0|||
16388051|NCT01451749|39905523|FG001|Overall Study|Withdrawal by Subject|1|||
16388052|NCT04021290|39905528|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
16388053|NCT04021290|39905529|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
16388054|NCT04021290|39905530|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
16388055|NCT04021290|39905528|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
16388056|NCT04021290|39905529|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
16388057|NCT04021290|39905530|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
16388058|NCT04021290|39905528|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
16388059|NCT04021290|39905529|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
16388060|NCT04021290|39905530|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
16388061|NCT04021290|39905528|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
16388062|NCT04021290|39905529|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
16388063|NCT04021290|39905530|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
16388064|NCT04021290|39905528|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
16388065|NCT04021290|39905529|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
16388066|NCT04021290|39905530|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
16388067|NCT04021290|39905528|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
16388068|NCT04021290|39905529|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
16388069|NCT04021290|39905530|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
16388070|NCT04021290|39905528|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
16388071|NCT04021290|39905529|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
16388072|NCT04021290|39905530|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
16388073|NCT04021290|39905528|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
16388074|NCT04021290|39905529|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
16388075|NCT04021290|39905530|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
16388076|NCT04021290|39905528|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
16388077|NCT04021290|39905529|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
16388078|NCT04021290|39905530|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
16388079|NCT04021290|39905528|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
16388080|NCT04021290|39905529|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
16388081|NCT04021290|39905530|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
16388082|NCT04021290|39905528|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
16388083|NCT04021290|39905529|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
16388084|NCT04021290|39905530|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
16388085|NCT04021290|39905528|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
16388086|NCT04021290|39905529|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
16388087|NCT04021290|39905530|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
16388088|NCT00441272|39905531|FG000|Overall Study|Study terminated prior to enrollment|25|||
16388089|NCT00441272|39905532|FG001|Overall Study|Study terminated prior to enrollment|25|||
16388090|NCT03389308|39905538|FG000|Overall Study|Withdrawal by Subject|5|||
16388091|NCT03389308|39905538|FG000|Overall Study|Lost to Follow-up|3|||
16388092|NCT03389308|39905538|FG000|Overall Study|Adverse Event|2|||
16388093|NCT03389308|39905538|FG000|Overall Study|Sponsor Request|2|||
16388094|NCT00443118|39905546|FG000|Overall Study|unknown primary outcome|3|||
16388095|NCT00443118|39905547|FG001|Overall Study|unknown primary outcome|1|||
16388096|NCT00443118|39905548|FG002|Overall Study|unknown primary outcome|0|||
16388097|NCT00443118|39905546|FG000|Overall Study|Withdrawal by Subject|1|||
16388098|NCT00443118|39905547|FG001|Overall Study|Withdrawal by Subject|0|||
16388099|NCT00443118|39905548|FG002|Overall Study|Withdrawal by Subject|0|||
16388100|NCT02948582|39905549|FG000|Washout Period 1|Adverse Event|0|||
16388101|NCT02948582|39905550|FG001|Washout Period 1|Adverse Event|2|||
16388102|NCT02948582|39905551|FG002|Washout Period 1|Adverse Event|0|||
16388103|NCT02948582|39905552|FG003|Washout Period 1|Adverse Event|0|||
16388104|NCT02948582|39905553|FG004|Washout Period 1|Adverse Event|0|||
16388105|NCT02948582|39905554|FG005|Washout Period 1|Adverse Event|0|||
16388106|NCT02948582|39905549|FG000|Washout Period 1|Protocol Violation|0|||
16388107|NCT02948582|39905550|FG001|Washout Period 1|Protocol Violation|0|||
16388108|NCT02948582|39905551|FG002|Washout Period 1|Protocol Violation|0|||
16388109|NCT02948582|39905552|FG003|Washout Period 1|Protocol Violation|0|||
16388110|NCT02948582|39905553|FG004|Washout Period 1|Protocol Violation|0|||
16388111|NCT02948582|39905554|FG005|Washout Period 1|Protocol Violation|1|||
16388112|NCT02948582|39905549|FG000|Washout Period 2|Adverse Event|0|||
16388113|NCT02948582|39905550|FG001|Washout Period 2|Adverse Event|1|||
16388114|NCT02948582|39905551|FG002|Washout Period 2|Adverse Event|0|||
16493304|NCT02743871|40276552|FG002|Overall Study|Other|0|||
16493305|NCT02743871|40276553|FG003|Overall Study|Other|0|||
16493306|NCT02743871|40276554|FG004|Overall Study|Other|0|||
16493307|NCT02743871|40276555|FG005|Overall Study|Other|0|||
16388115|NCT02948582|39905552|FG003|Washout Period 2|Adverse Event|0|||
16388116|NCT02948582|39905553|FG004|Washout Period 2|Adverse Event|0|||
16388117|NCT02948582|39905554|FG005|Washout Period 2|Adverse Event|0|||
16388118|NCT02948582|39905549|FG000|Washout Period 2|personal reasons|0|||
16388119|NCT02948582|39905550|FG001|Washout Period 2|personal reasons|0|||
16388120|NCT02948582|39905551|FG002|Washout Period 2|personal reasons|0|||
16388121|NCT02948582|39905552|FG003|Washout Period 2|personal reasons|1|||
16493308|NCT02743871|40276556|FG006|Overall Study|Other|0|||
16304654|NCT00741338|39598159|FG000|Overall Study|Adverse Event|0|||
16304655|NCT00741338|39598160|FG001|Overall Study|Adverse Event|1|||
16304656|NCT00805675|39598163|FG000|Overall Study|Adverse Event|0|||
16304657|NCT00805675|39598164|FG001|Overall Study|Adverse Event|0|||
16493309|NCT02743871|40276557|FG007|Overall Study|Other|0|||
16493310|NCT02743871|40276558|FG008|Overall Study|Other|0|||
16304658|NCT00805675|39598165|FG002|Overall Study|Adverse Event|1|||
16304659|NCT01038297|39598166|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
16493311|NCT02743871|40276559|FG009|Overall Study|Other|0|||
16493312|NCT02743871|40276560|FG010|Overall Study|Other|0|||
16493313|NCT02743871|40276561|FG011|Overall Study|Other|1|||
16493314|NCT02743871|40276562|FG012|Overall Study|Other|1|||
16493315|NCT02743871|40276563|FG013|Overall Study|Other|1|||
16493316|NCT02743871|40276550|FG000|Overall Study|Protocol Violation|0|||
16493317|NCT02743871|40276551|FG001|Overall Study|Protocol Violation|0|||
16493318|NCT02743871|40276552|FG002|Overall Study|Protocol Violation|0|||
16493319|NCT02743871|40276553|FG003|Overall Study|Protocol Violation|0|||
16493320|NCT02743871|40276554|FG004|Overall Study|Protocol Violation|0|||
16493321|NCT02743871|40276555|FG005|Overall Study|Protocol Violation|0|||
16493322|NCT02743871|40276556|FG006|Overall Study|Protocol Violation|0|||
16493323|NCT02743871|40276557|FG007|Overall Study|Protocol Violation|0|||
16493324|NCT02743871|40276558|FG008|Overall Study|Protocol Violation|0|||
16304660|NCT01038297|39598167|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
16304661|NCT01038297|39598168|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
16304662|NCT03519087|39598169|FG000|Clinic Evaluation|Physician Decision|15|||
16304663|NCT03519087|39598170|FG001|Clinic Evaluation|Physician Decision|18|||
16388122|NCT02948582|39905553|FG004|Washout Period 2|personal reasons|0|||
16388123|NCT02948582|39905554|FG005|Washout Period 2|personal reasons|0|||
16304664|NCT03519087|39598171|FG002|Clinic Evaluation|Physician Decision|0|||
16493325|NCT02743871|40276559|FG009|Overall Study|Protocol Violation|0|||
16493326|NCT02743871|40276560|FG010|Overall Study|Protocol Violation|0|||
16493327|NCT02743871|40276561|FG011|Overall Study|Protocol Violation|0|||
16493328|NCT02743871|40276562|FG012|Overall Study|Protocol Violation|2|||
16493329|NCT02743871|40276563|FG013|Overall Study|Protocol Violation|0|||
16304665|NCT03519087|39598172|FG003|Clinic Evaluation|Physician Decision|0|||
16304666|NCT03519087|39598173|FG004|Clinic Evaluation|Physician Decision|0|||
16304667|NCT03519087|39598169|FG000|Clinic Evaluation|Protocol Violation|1|||
16304668|NCT03519087|39598170|FG001|Clinic Evaluation|Protocol Violation|0|||
16304669|NCT03519087|39598171|FG002|Clinic Evaluation|Protocol Violation|0|||
16304670|NCT03519087|39598172|FG003|Clinic Evaluation|Protocol Violation|0|||
16304671|NCT03519087|39598173|FG004|Clinic Evaluation|Protocol Violation|0|||
16304672|NCT03519087|39598169|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
16304673|NCT03519087|39598170|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
16304674|NCT03519087|39598171|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
16304675|NCT03519087|39598172|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
16304676|NCT03519087|39598173|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
16304677|NCT03519087|39598169|FG000|Re-randomization for Treatment|Not appropriate|2|||
16304678|NCT03519087|39598170|FG001|Re-randomization for Treatment|Not appropriate|3|||
16304679|NCT03519087|39598171|FG002|Re-randomization for Treatment|Not appropriate|0|||
16304680|NCT03519087|39598172|FG003|Re-randomization for Treatment|Not appropriate|0|||
16304681|NCT03519087|39598173|FG004|Re-randomization for Treatment|Not appropriate|0|||
16304682|NCT03519087|39598169|FG000|Laboratory Testing|Lost to Follow-up|0|||
16304683|NCT03519087|39598170|FG001|Laboratory Testing|Lost to Follow-up|0|||
16304684|NCT03519087|39598171|FG002|Laboratory Testing|Lost to Follow-up|2|||
16304685|NCT03519087|39598172|FG003|Laboratory Testing|Lost to Follow-up|3|||
16304686|NCT03519087|39598173|FG004|Laboratory Testing|Lost to Follow-up|6|||
16304687|NCT03519087|39598169|FG000|Laboratory Testing|Protocol Violation|0|||
16304688|NCT03519087|39598170|FG001|Laboratory Testing|Protocol Violation|0|||
16304689|NCT03519087|39598171|FG002|Laboratory Testing|Protocol Violation|0|||
16304690|NCT03519087|39598172|FG003|Laboratory Testing|Protocol Violation|1|||
16304691|NCT03519087|39598173|FG004|Laboratory Testing|Protocol Violation|0|||
16304692|NCT00735397|39601179|FG000|Overall Study|Adverse Event|194|||
16304693|NCT00735397|39601179|FG000|Overall Study|Lost to Follow-up|33|||
16304694|NCT00735397|39601179|FG000|Overall Study|Participant choice|252|||
16304695|NCT00735397|39601179|FG000|Overall Study|Inadequate therapeutic effect|202|||
16304696|NCT00735397|39601179|FG000|Overall Study|Administrative/Other|502|||
16304697|NCT01173120|39601180|FG000|Overall Study|Lack of Efficacy|2|||
16304698|NCT01173120|39601180|FG000|Overall Study|Lost to Follow-up|1|||
16304699|NCT01173120|39601180|FG000|Overall Study|Participant Decision|2|||
16304700|NCT01173120|39601180|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
16304701|NCT01173120|39601180|FG000|Overall Study|Switch-Participant Decision|12|||
16304702|NCT01173120|39601180|FG000|Overall Study|Switch-Difficulty With Device|12|||
16304703|NCT02503787|39601181|FG000|Enrollment|Withdrawal by Subject|6|||
16304704|NCT02503787|39601181|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
16304705|NCT02503787|39601181|FG000|Enrollment|Physician Decision|2|||
16304706|NCT02503787|39601181|FG000|Enrollment|Insurance issue|2|||
16304707|NCT02503787|39601181|FG000|Enrollment|Lost to Follow-up|1|||
16304708|NCT02503787|39601181|FG000|Enrollment|Study closure|1|||
16304709|NCT02503787|39601181|FG000|Enrollment|Adverse Event|1|||
16304710|NCT02503787|39601181|FG000|Enrollment|Protocol Violation|1|||
16304711|NCT02503787|39601181|FG000|Enrollment|Inability to implant system|1|||
16304712|NCT02503787|39601181|FG000|Enrollment|Unable to be programmed|1|||
16304713|NCT02503787|39601181|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
16304714|NCT02503787|39601181|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
16304715|NCT02503787|39601181|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
16493330|NCT02323113|40276564|FG000|Overall Study|Adverse Event|3|||
16493331|NCT02323113|40276565|FG001|Overall Study|Adverse Event|3|||
16493332|NCT02323113|40276566|FG002|Overall Study|Adverse Event|2|||
16493333|NCT02323113|40276567|FG003|Overall Study|Adverse Event|5|||
16493334|NCT02323113|40276568|FG004|Overall Study|Adverse Event|8|||
16493335|NCT02323113|40276569|FG005|Overall Study|Adverse Event|3|||
16493336|NCT02323113|40276570|FG006|Overall Study|Adverse Event|6|||
16493337|NCT02323113|40276571|FG007|Overall Study|Adverse Event|0|||
16493338|NCT02323113|40276564|FG000|Overall Study|Progressive Disease|0|||
16493339|NCT02323113|40276565|FG001|Overall Study|Progressive Disease|1|||
16304716|NCT02503787|39601181|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
16304717|NCT02503787|39601181|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
16304718|NCT02503787|39601181|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
16493340|NCT02323113|40276566|FG002|Overall Study|Progressive Disease|1|||
16193507|NCT00008138|39188561|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
16193508|NCT00008138|39188561|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
16193509|NCT00008138|39188561|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
16193510|NCT00008138|39188561|FG000|Interval Debulking|Withdrawal by Subject|2|||
16193511|NCT00008138|39188561|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
16193512|NCT00008138|39188561|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
16193513|NCT00008138|39188561|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
16193514|NCT02723604|39188564|FG000|Overall Study|ineligible|1|||
16193515|NCT02723604|39188564|FG000|Overall Study|never received treatment|1|||
16193516|NCT03456713|39188567|FG000|Overall Study|Lost to Follow-up|1|||
16193517|NCT03456713|39188568|FG001|Overall Study|Lost to Follow-up|0|||
16193518|NCT03456713|39188569|FG002|Overall Study|Lost to Follow-up|0|||
16193519|NCT03456713|39188570|FG003|Overall Study|Lost to Follow-up|0|||
16193520|NCT04507867|39188573|FG000|Overall Study|Death|7|||
16193521|NCT04507867|39188574|FG001|Overall Study|Death|1|||
16193522|NCT00262080|39188576|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
16193523|NCT00262080|39188577|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
16193524|NCT00262080|39188578|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
16193525|NCT00262080|39188576|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
16193526|NCT00262080|39188577|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
16193527|NCT00262080|39188578|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
16193528|NCT00262080|39188576|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
16193529|NCT00262080|39188577|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
16193530|NCT00262080|39188578|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
16193531|NCT00262080|39188576|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
16193532|NCT00262080|39188577|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
16193533|NCT00262080|39188578|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
16193534|NCT00262080|39188576|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
16193535|NCT00262080|39188577|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
16193536|NCT00262080|39188578|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
16193537|NCT00262080|39188576|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
16493341|NCT02323113|40276567|FG003|Overall Study|Progressive Disease|0|||
16493342|NCT02323113|40276568|FG004|Overall Study|Progressive Disease|0|||
16304719|NCT01060072|39601182|FG000|Overall Study|Adverse Event|1|||
16304720|NCT01060072|39601183|FG001|Overall Study|Adverse Event|1|||
16304721|NCT01060072|39601182|FG000|Overall Study|Physician Decision|0|||
16304722|NCT01060072|39601183|FG001|Overall Study|Physician Decision|2|||
16304723|NCT01060072|39601182|FG000|Overall Study|Protocol Violation|0|||
16304724|NCT01060072|39601183|FG001|Overall Study|Protocol Violation|1|||
16304725|NCT01060072|39601182|FG000|Overall Study|Acute cholecystitis|1|||
16304726|NCT01060072|39601183|FG001|Overall Study|Acute cholecystitis|0|||
16304727|NCT01060072|39601182|FG000|Overall Study|Excluded Medications|0|||
16304728|NCT01060072|39601183|FG001|Overall Study|Excluded Medications|1|||
16304729|NCT01232452|39601184|FG000|Overall Study|Adverse Event|17|||
16304730|NCT01232452|39601185|FG001|Overall Study|Adverse Event|15|||
16304731|NCT01232452|39601184|FG000|Overall Study|Withdrawal by Subject|11|||
16304732|NCT01232452|39601185|FG001|Overall Study|Withdrawal by Subject|8|||
16304733|NCT01232452|39601184|FG000|Overall Study|Physician Decision|8|||
16304734|NCT01232452|39601185|FG001|Overall Study|Physician Decision|12|||
16304735|NCT01232452|39601184|FG000|Overall Study|Protocol entry criterion not met|0|||
16304736|NCT01232452|39601185|FG001|Overall Study|Protocol entry criterion not met|2|||
16304737|NCT01232452|39601184|FG000|Overall Study|Sponsor Decision|3|||
16304738|NCT01232452|39601185|FG001|Overall Study|Sponsor Decision|1|||
16304739|NCT01232452|39601184|FG000|Overall Study|Protocol Violation|0|||
16304740|NCT01232452|39601185|FG001|Overall Study|Protocol Violation|1|||
16304741|NCT03180645|39601186|FG000|Overall Study|Adverse Event|0|||
16304742|NCT03180645|39601187|FG001|Overall Study|Adverse Event|1|||
16304743|NCT03180645|39601188|FG002|Overall Study|Adverse Event|2|||
16304744|NCT01994850|39601189|FG000|Overall Study|Physician Decision|1|||
16493343|NCT02323113|40276569|FG005|Overall Study|Progressive Disease|3|||
16493344|NCT02323113|40276570|FG006|Overall Study|Progressive Disease|0|||
16493345|NCT02323113|40276571|FG007|Overall Study|Progressive Disease|0|||
16493346|NCT02323113|40276564|FG000|Overall Study|Symptomatic Deterioration|0|||
16493347|NCT02323113|40276565|FG001|Overall Study|Symptomatic Deterioration|0|||
16493348|NCT02323113|40276566|FG002|Overall Study|Symptomatic Deterioration|1|||
16493349|NCT02323113|40276567|FG003|Overall Study|Symptomatic Deterioration|0|||
16493350|NCT02323113|40276568|FG004|Overall Study|Symptomatic Deterioration|1|||
16493351|NCT02323113|40276569|FG005|Overall Study|Symptomatic Deterioration|0|||
16493352|NCT02323113|40276570|FG006|Overall Study|Symptomatic Deterioration|0|||
16493353|NCT02323113|40276571|FG007|Overall Study|Symptomatic Deterioration|0|||
16493354|NCT02323113|40276564|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
16493355|NCT02323113|40276565|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
16493356|NCT02323113|40276566|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
16493357|NCT02323113|40276567|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
16493358|NCT02323113|40276568|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
16493359|NCT02323113|40276569|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
16493360|NCT02323113|40276570|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
16493361|NCT02323113|40276571|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
16493362|NCT02323113|40276564|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16493363|NCT02323113|40276565|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
16493364|NCT02323113|40276566|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16493365|NCT02323113|40276567|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16493366|NCT02323113|40276568|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16493367|NCT02323113|40276569|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16493368|NCT02323113|40276570|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16493369|NCT02323113|40276571|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
16493370|NCT02196558|40276573|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
16493371|NCT02196558|40276574|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
16493372|NCT02196558|40276575|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
16493373|NCT02196558|40276573|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
16493374|NCT02196558|40276574|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
16493375|NCT02196558|40276575|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
16493376|NCT02196558|40276573|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
16493377|NCT02196558|40276574|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
16493378|NCT02196558|40276575|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
16493379|NCT02196558|40276573|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
16493380|NCT02196558|40276574|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
16304745|NCT01994850|39601189|FG000|Overall Study|Withdrawal by Subject|1|||
16304746|NCT03066258|39601191|FG000|Overall Study|Death|1|||
16493381|NCT02196558|40276575|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
16304747|NCT03066258|39601192|FG001|Overall Study|Death|0|||
16304748|NCT03066258|39601193|FG002|Overall Study|Death|0|||
16304749|NCT03066258|39601194|FG003|Overall Study|Death|0|||
16493382|NCT02196558|40276573|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
16493383|NCT02196558|40276574|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
16493384|NCT02196558|40276575|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
16493385|NCT00660023|40276576|FG000|Overall Study|Adverse Event|2|||
16493386|NCT00660023|40276576|FG000|Overall Study|Death|8|||
16493387|NCT00660023|40276576|FG000|Overall Study|Blood Transfusion|5|||
16493388|NCT00660023|40276576|FG000|Overall Study|Renal Transplantation|3|||
16493389|NCT00660023|40276576|FG000|Overall Study|Withdrawal by Subject|1|||
16493390|NCT00660023|40276576|FG000|Overall Study|Missed Pregnancy Test|1|||
16493391|NCT00660023|40276576|FG000|Overall Study|Other Screening Failure|9|||
16493392|NCT00439244|40276577|FG000|Overall Study|Adverse Event|5|||
16493393|NCT00439244|40276578|FG001|Overall Study|Adverse Event|2|||
16493394|NCT00439244|40276579|FG002|Overall Study|Adverse Event|3|||
16493395|NCT00439244|40276577|FG000|Overall Study|Withdrawal by Subject|3|||
16493396|NCT00439244|40276578|FG001|Overall Study|Withdrawal by Subject|1|||
16493397|NCT00439244|40276579|FG002|Overall Study|Withdrawal by Subject|2|||
16493398|NCT00439244|40276577|FG000|Overall Study|Lost to Follow-up|2|||
16493399|NCT00439244|40276578|FG001|Overall Study|Lost to Follow-up|1|||
16493400|NCT00439244|40276579|FG002|Overall Study|Lost to Follow-up|2|||
16493401|NCT00439244|40276577|FG000|Overall Study|Death|0|||
16493402|NCT00439244|40276578|FG001|Overall Study|Death|1|||
16493403|NCT00439244|40276579|FG002|Overall Study|Death|0|||
16493404|NCT00439244|40276577|FG000|Overall Study|Protocol Violation|0|||
16493405|NCT00439244|40276578|FG001|Overall Study|Protocol Violation|1|||
16493406|NCT00439244|40276579|FG002|Overall Study|Protocol Violation|0|||
16493407|NCT00439244|40276577|FG000|Overall Study|Administrative problems|1|||
16493408|NCT00439244|40276578|FG001|Overall Study|Administrative problems|0|||
16493409|NCT00439244|40276579|FG002|Overall Study|Administrative problems|0|||
16493410|NCT00160251|40276580|FG000|Prior to Amendment 2|Adverse Event|2|||
16493411|NCT00160251|40276581|FG001|Prior to Amendment 2|Adverse Event|1|||
16493412|NCT00160251|40276582|FG002|Prior to Amendment 2|Adverse Event|3|||
16084561|NCT01485887|38802493|FG000|Overall Study|Deterioration of primary disease|1|||
16084562|NCT01485887|38802493|FG000|Overall Study|Primary disease markedly improved|1|||
16493413|NCT00160251|40276583|FG003|Prior to Amendment 2|Adverse Event|1|||
16493414|NCT00160251|40276584|FG004|Prior to Amendment 2|Adverse Event|1|||
16493415|NCT00160251|40276585|FG005|Prior to Amendment 2|Adverse Event|1|||
16493416|NCT00160251|40276586|FG006|Prior to Amendment 2|Adverse Event|1|||
16493417|NCT00160251|40276587|FG007|Prior to Amendment 2|Adverse Event|0|||
16493418|NCT00160251|40276580|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
16493419|NCT00160251|40276581|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
16493420|NCT00160251|40276582|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
16493421|NCT00160251|40276583|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
16493422|NCT00160251|40276584|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
16493423|NCT00160251|40276585|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
16493424|NCT00160251|40276586|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
16493425|NCT00160251|40276587|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
16493426|NCT00160251|40276580|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
16493427|NCT00160251|40276581|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
16493428|NCT00160251|40276582|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
16493429|NCT00160251|40276583|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
16493430|NCT00160251|40276584|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
16493431|NCT00160251|40276585|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
16493432|NCT00160251|40276586|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
16493433|NCT00160251|40276587|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
16493434|NCT00160251|40276580|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
16493435|NCT00160251|40276581|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
16493436|NCT00160251|40276582|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
16493437|NCT00160251|40276583|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
16493438|NCT00160251|40276584|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
16493439|NCT00160251|40276585|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
16493440|NCT00160251|40276586|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
16493441|NCT00160251|40276587|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
16493442|NCT00160251|40276580|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
16493443|NCT00160251|40276581|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
16493444|NCT00160251|40276582|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
16493445|NCT00160251|40276583|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
16493446|NCT00160251|40276584|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
16493447|NCT00160251|40276585|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
16493448|NCT00160251|40276586|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
16493449|NCT00160251|40276587|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
16493450|NCT00160251|40276580|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
16193538|NCT00262080|39188577|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
16493451|NCT00160251|40276581|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
16493452|NCT00160251|40276582|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
16493453|NCT00160251|40276583|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
16084563|NCT00914966|38802494|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
16084564|NCT00914966|38802494|FG000|Step 1: 1500 Units|Physician Decision|1|||
16084565|NCT00914966|38802494|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
16084566|NCT03905642|38802495|FG000|Overall Study|Withdrawal by Subject|3|||
16084567|NCT03905642|38802495|FG000|Overall Study|Pregnancy|1|||
16084568|NCT03905642|38802495|FG000|Overall Study|Adverse Event|1|||
16084569|NCT03905642|38802495|FG000|Overall Study|Lack of Efficacy|1|||
16084570|NCT03905642|38802495|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
16084571|NCT00667017|38802497|FG000|Overall Study|Withdrawal by Subject|1|||
16084572|NCT04060212|38802498|FG000|Overall Study|Withdrawal by Subject|7|||
16084573|NCT02740231|38802499|FG000|Overall Study|Withdrawal by Subject|1|||
16084574|NCT02740231|38802500|FG001|Overall Study|Withdrawal by Subject|1|||
16084575|NCT02740231|38802501|FG002|Overall Study|Withdrawal by Subject|1|||
16084576|NCT02740231|38802502|FG003|Overall Study|Withdrawal by Subject|0|||
16084577|NCT02740231|38802499|FG000|Overall Study|Lack of Efficacy|0|||
16084578|NCT02740231|38802500|FG001|Overall Study|Lack of Efficacy|1|||
16084579|NCT02740231|38802501|FG002|Overall Study|Lack of Efficacy|0|||
16084580|NCT02740231|38802502|FG003|Overall Study|Lack of Efficacy|4|||
16493454|NCT00160251|40276584|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
16493455|NCT00160251|40276585|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
16493456|NCT00160251|40276586|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
16493457|NCT00160251|40276587|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
16493458|NCT00160251|40276580|FG000|Post-amendment 2|Adverse Event|0|||
16493459|NCT00160251|40276581|FG001|Post-amendment 2|Adverse Event|0|||
16493460|NCT00160251|40276582|FG002|Post-amendment 2|Adverse Event|0|||
16493461|NCT00160251|40276583|FG003|Post-amendment 2|Adverse Event|0|||
16493462|NCT00160251|40276584|FG004|Post-amendment 2|Adverse Event|0|||
16493463|NCT00160251|40276585|FG005|Post-amendment 2|Adverse Event|0|||
16493464|NCT00160251|40276586|FG006|Post-amendment 2|Adverse Event|0|||
16493465|NCT00160251|40276587|FG007|Post-amendment 2|Adverse Event|20|||
16493466|NCT00160251|40276580|FG000|Post-amendment 2|Lack of Efficacy|0|||
16493467|NCT00160251|40276581|FG001|Post-amendment 2|Lack of Efficacy|0|||
16493468|NCT00160251|40276582|FG002|Post-amendment 2|Lack of Efficacy|0|||
16493469|NCT00160251|40276583|FG003|Post-amendment 2|Lack of Efficacy|0|||
16493470|NCT00160251|40276584|FG004|Post-amendment 2|Lack of Efficacy|0|||
16493471|NCT00160251|40276585|FG005|Post-amendment 2|Lack of Efficacy|0|||
16084581|NCT02740231|38802499|FG000|Overall Study|Lost to Follow-up|1|||
16084582|NCT02740231|38802500|FG001|Overall Study|Lost to Follow-up|3|||
16084583|NCT02740231|38802501|FG002|Overall Study|Lost to Follow-up|0|||
16084584|NCT02740231|38802502|FG003|Overall Study|Lost to Follow-up|3|||
16084585|NCT02740231|38802499|FG000|Overall Study|Adverse Event|0|||
16084586|NCT02740231|38802500|FG001|Overall Study|Adverse Event|1|||
16084587|NCT02740231|38802501|FG002|Overall Study|Adverse Event|0|||
16084588|NCT02740231|38802502|FG003|Overall Study|Adverse Event|1|||
16084589|NCT04679675|38802503|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
16084590|NCT04679675|38802504|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
16084591|NCT04679675|38802505|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
16084592|NCT04679675|38802506|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
16084593|NCT04679675|38802503|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
16084594|NCT04679675|38802504|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
16084595|NCT04679675|38802505|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
16084596|NCT04679675|38802506|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
16084597|NCT01629589|38802511|FG000|Overall Study|Protocol Violation|4|||
16084598|NCT01629589|38802512|FG001|Overall Study|Protocol Violation|2|||
16084599|NCT01629589|38802511|FG000|Overall Study|Lost to Follow-up|2|||
16084600|NCT01629589|38802512|FG001|Overall Study|Lost to Follow-up|1|||
16084601|NCT01629589|38802511|FG000|Overall Study|Withdrawal by Subject|2|||
16084602|NCT01629589|38802512|FG001|Overall Study|Withdrawal by Subject|3|||
16084603|NCT01629589|38802511|FG000|Overall Study|Did not receive study vaccine|0|||
16084604|NCT01629589|38802512|FG001|Overall Study|Did not receive study vaccine|1|||
16084605|NCT02755805|38802513|FG000|Overall Study|Lost to Follow-up|1|||
16084606|NCT02755805|38802514|FG001|Overall Study|Lost to Follow-up|2|||
16493472|NCT00160251|40276586|FG006|Post-amendment 2|Lack of Efficacy|0|||
16493473|NCT00160251|40276587|FG007|Post-amendment 2|Lack of Efficacy|24|||
16493474|NCT00160251|40276580|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
16084607|NCT02755805|38802513|FG000|Overall Study|Refused assessments|1|||
16084608|NCT02755805|38802514|FG001|Overall Study|Refused assessments|0|||
16304750|NCT03066258|39601195|FG004|Overall Study|Death|1|||
16493475|NCT00160251|40276581|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
16493476|NCT00160251|40276582|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
16493477|NCT00160251|40276583|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
16493478|NCT00160251|40276584|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
16084609|NCT02755805|38802513|FG000|Overall Study|Withdrawal by Subject|0|||
16084610|NCT02755805|38802514|FG001|Overall Study|Withdrawal by Subject|2|||
16084611|NCT02564744|38802515|FG000|Overall Study|Investigator decision|0|||
16084612|NCT02564744|38802516|FG001|Overall Study|Investigator decision|0|||
16084613|NCT02564744|38802517|FG002|Overall Study|Investigator decision|0|||
16084614|NCT02564744|38802518|FG003|Overall Study|Investigator decision|0|||
16084615|NCT02564744|38802519|FG004|Overall Study|Investigator decision|1|||
16084616|NCT02564744|38802515|FG000|Overall Study|Death|10|||
16084617|NCT02564744|38802516|FG001|Overall Study|Death|5|||
16084618|NCT02564744|38802517|FG002|Overall Study|Death|4|||
16084619|NCT02564744|38802518|FG003|Overall Study|Death|16|||
16084620|NCT02564744|38802519|FG004|Overall Study|Death|16|||
16084621|NCT02564744|38802515|FG000|Overall Study|End of study Page Missing|0|||
16084622|NCT02564744|38802516|FG001|Overall Study|End of study Page Missing|0|||
16084623|NCT02564744|38802517|FG002|Overall Study|End of study Page Missing|3|||
16084624|NCT02564744|38802518|FG003|Overall Study|End of study Page Missing|3|||
16084625|NCT02564744|38802519|FG004|Overall Study|End of study Page Missing|0|||
16084626|NCT02564744|38802515|FG000|Overall Study|Subject Withdrew Consent|1|||
16084627|NCT02564744|38802516|FG001|Overall Study|Subject Withdrew Consent|1|||
16084628|NCT02564744|38802517|FG002|Overall Study|Subject Withdrew Consent|1|||
16084629|NCT02564744|38802518|FG003|Overall Study|Subject Withdrew Consent|0|||
16084630|NCT02564744|38802519|FG004|Overall Study|Subject Withdrew Consent|2|||
16084631|NCT02564744|38802515|FG000|Overall Study|Lost to Follow-up|0|||
16084632|NCT02564744|38802516|FG001|Overall Study|Lost to Follow-up|1|||
16084633|NCT02564744|38802517|FG002|Overall Study|Lost to Follow-up|0|||
16084634|NCT02564744|38802518|FG003|Overall Study|Lost to Follow-up|0|||
16084635|NCT02564744|38802519|FG004|Overall Study|Lost to Follow-up|1|||
16084636|NCT02564744|38802515|FG000|Overall Study|Reason not specified|1|||
16084637|NCT02564744|38802516|FG001|Overall Study|Reason not specified|0|||
16084638|NCT02564744|38802517|FG002|Overall Study|Reason not specified|0|||
16084639|NCT02564744|38802518|FG003|Overall Study|Reason not specified|0|||
16084640|NCT02564744|38802519|FG004|Overall Study|Reason not specified|0|||
16084641|NCT03057600|38802524|FG000|Overall Study|Adverse Event|0|||
16084642|NCT03057600|38802525|FG001|Overall Study|Adverse Event|0|||
16084643|NCT03057600|38802526|FG002|Overall Study|Adverse Event|4|||
16084644|NCT03057600|38802527|FG003|Overall Study|Adverse Event|0|||
16084645|NCT03057600|38802524|FG000|Overall Study|Radiologic Disease Progression|8|||
16084646|NCT03057600|38802525|FG001|Overall Study|Radiologic Disease Progression|7|||
16084647|NCT03057600|38802526|FG002|Overall Study|Radiologic Disease Progression|13|||
16084648|NCT03057600|38802527|FG003|Overall Study|Radiologic Disease Progression|10|||
16084649|NCT03057600|38802524|FG000|Overall Study|Symptomatic Deterioration|0|||
16084650|NCT03057600|38802525|FG001|Overall Study|Symptomatic Deterioration|1|||
16084651|NCT03057600|38802526|FG002|Overall Study|Symptomatic Deterioration|1|||
16084652|NCT03057600|38802527|FG003|Overall Study|Symptomatic Deterioration|0|||
16304751|NCT05219448|39601196|FG000|Overall Study|Lost to Follow-up|9|||
16304752|NCT05219448|39601197|FG001|Overall Study|Lost to Follow-up|0|||
16304753|NCT00489827|39601198|FG000|Overall Study|Intraoperative exclusion criteria|1|||
16084653|NCT03057600|38802524|FG000|Overall Study|Investigator Decision|0|||
16084654|NCT03057600|38802525|FG001|Overall Study|Investigator Decision|0|||
16084655|NCT03057600|38802526|FG002|Overall Study|Investigator Decision|1|||
16084656|NCT03057600|38802527|FG003|Overall Study|Investigator Decision|0|||
16084657|NCT03057600|38802524|FG000|Overall Study|Study Termination by Sponsor|0|||
16084658|NCT03057600|38802525|FG001|Overall Study|Study Termination by Sponsor|0|||
16084659|NCT03057600|38802526|FG002|Overall Study|Study Termination by Sponsor|0|||
16084660|NCT03057600|38802527|FG003|Overall Study|Study Termination by Sponsor|2|||
16084661|NCT03057600|38802524|FG000|Overall Study|Withdrawal by Subject|0|||
16084662|NCT03057600|38802525|FG001|Overall Study|Withdrawal by Subject|1|||
16084663|NCT03057600|38802526|FG002|Overall Study|Withdrawal by Subject|0|||
16084664|NCT03057600|38802527|FG003|Overall Study|Withdrawal by Subject|0|||
16084665|NCT03057600|38802524|FG000|Overall Study|Other, Not Specified|1|||
16084666|NCT03057600|38802525|FG001|Overall Study|Other, Not Specified|1|||
16084667|NCT03057600|38802526|FG002|Overall Study|Other, Not Specified|1|||
16084668|NCT03057600|38802527|FG003|Overall Study|Other, Not Specified|1|||
16084669|NCT01952366|38802528|FG000|Overall Study|Death|22|||
16084670|NCT01952366|38802528|FG000|Overall Study|Withdrawal by Subject|9|||
16084671|NCT01000805|38802529|FG000|Overall Study|Adverse Event|21|||
16084672|NCT01000805|38802530|FG001|Overall Study|Adverse Event|9|||
16084673|NCT01000805|38802529|FG000|Overall Study|Lack of Efficacy|5|||
16084674|NCT01000805|38802530|FG001|Overall Study|Lack of Efficacy|16|||
16084675|NCT01000805|38802529|FG000|Overall Study|Lost to Follow-up|16|||
16304754|NCT00489827|39601199|FG001|Overall Study|Intraoperative exclusion criteria|1|||
16304755|NCT00489827|39601198|FG000|Overall Study|Intraoperative exclusion criteria|1|||
16304756|NCT00489827|39601199|FG001|Overall Study|Intraoperative exclusion criteria|1|||
16084676|NCT01000805|38802530|FG001|Overall Study|Lost to Follow-up|21|||
16084677|NCT01000805|38802529|FG000|Overall Study|Physician Decision|0|||
16084678|NCT01000805|38802530|FG001|Overall Study|Physician Decision|1|||
16084679|NCT01000805|38802529|FG000|Overall Study|Protocol Violation|12|||
16084680|NCT01000805|38802530|FG001|Overall Study|Protocol Violation|8|||
16084681|NCT01000805|38802529|FG000|Overall Study|Withdrawal by Subject|16|||
16084682|NCT01000805|38802530|FG001|Overall Study|Withdrawal by Subject|6|||
16084683|NCT01000805|38802529|FG000|Overall Study|Sponsor Decision|0|||
16084684|NCT01000805|38802530|FG001|Overall Study|Sponsor Decision|1|||
16084685|NCT01084694|38802531|FG000|Overall Study|Withdrawal by Subject|2|||
16084686|NCT01084694|38802532|FG001|Overall Study|Withdrawal by Subject|1|||
16084687|NCT01084694|38802531|FG000|Overall Study|Death|2|||
16084688|NCT01084694|38802532|FG001|Overall Study|Death|12|||
16084689|NCT01084694|38802531|FG000|Overall Study|eligibility not maintained|2|||
16084690|NCT01084694|38802532|FG001|Overall Study|eligibility not maintained|7|||
16084691|NCT01212744|38802548|FG000|Overall Study|Withdrawal by Subject|1|||
16084692|NCT01268306|38802549|FG000|Overall Study|Lost to Follow-up|1|||
16084693|NCT00366249|38802550|FG000|Overall Study|Adverse Event|53|||
16084694|NCT00366249|38802551|FG001|Overall Study|Adverse Event|28|||
16084695|NCT00366249|38802550|FG000|Overall Study|Death|0|||
16084696|NCT00366249|38802551|FG001|Overall Study|Death|1|||
16084697|NCT00366249|38802550|FG000|Overall Study|Physician Decision|5|||
16084698|NCT00366249|38802551|FG001|Overall Study|Physician Decision|2|||
16084699|NCT00366249|38802550|FG000|Overall Study|Lost to Follow-up|2|||
16084700|NCT00366249|38802551|FG001|Overall Study|Lost to Follow-up|0|||
16084701|NCT00366249|38802550|FG000|Overall Study|Protocol Violation|1|||
16084702|NCT00366249|38802551|FG001|Overall Study|Protocol Violation|2|||
16084703|NCT00366249|38802550|FG000|Overall Study|Withdrawal by Subject|18|||
16084704|NCT00366249|38802551|FG001|Overall Study|Withdrawal by Subject|4|||
16084705|NCT00366249|38802550|FG000|Overall Study|Lack of Efficacy|21|||
16084706|NCT00366249|38802551|FG001|Overall Study|Lack of Efficacy|21|||
16084707|NCT00366249|38802550|FG000|Overall Study|Most due to osteomylitis status|31|||
16084708|NCT00366249|38802551|FG001|Overall Study|Most due to osteomylitis status|20|||
16084709|NCT04759833|38802555|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
16084710|NCT04759833|38802556|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
16084711|NCT04759833|38802557|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
16084712|NCT04759833|38802558|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
16084713|NCT04759833|38802559|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
16084714|NCT04759833|38802555|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
16084715|NCT04759833|38802556|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
16084716|NCT04759833|38802557|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
16084717|NCT04759833|38802558|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
16084718|NCT04759833|38802559|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
16084719|NCT04759833|38802555|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
16084720|NCT04759833|38802556|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
16084721|NCT04759833|38802557|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
16084722|NCT04759833|38802558|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
16084723|NCT04759833|38802559|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
16084724|NCT04759833|38802555|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
16084725|NCT04759833|38802556|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
16084726|NCT04759833|38802557|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
16084727|NCT04759833|38802558|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
16084728|NCT04759833|38802559|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
16084729|NCT04759833|38802555|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
16084730|NCT04759833|38802556|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
16084731|NCT04759833|38802557|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
16084732|NCT04759833|38802558|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
16084733|NCT04759833|38802559|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
16084734|NCT04759833|38802555|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
16084735|NCT04759833|38802556|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
16084736|NCT04759833|38802557|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
16084737|NCT04759833|38802558|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
16084738|NCT04759833|38802559|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
16084739|NCT04759833|38802555|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
16084740|NCT04759833|38802556|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
16084741|NCT04759833|38802557|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
16084742|NCT04759833|38802558|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
16084743|NCT04759833|38802559|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
16084744|NCT04759833|38802555|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
16304757|NCT02676765|39601205|FG000|Overall Study|Lost to Follow-up|0|||
16493479|NCT00160251|40276585|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
16304758|NCT02676765|39601206|FG001|Overall Study|Lost to Follow-up|1|||
16084745|NCT04759833|38802556|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
16084746|NCT04759833|38802557|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
16084747|NCT04759833|38802558|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
16084748|NCT04759833|38802559|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
16084749|NCT04759833|38802555|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
16084750|NCT04759833|38802556|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
16084751|NCT04759833|38802557|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
16084752|NCT04759833|38802558|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
16084753|NCT04759833|38802559|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
16084754|NCT04759833|38802555|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
16084755|NCT04759833|38802556|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
16084756|NCT04759833|38802557|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
16084757|NCT04759833|38802558|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
16084758|NCT04759833|38802559|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
16084759|NCT04759833|38802555|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
16084760|NCT04759833|38802556|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
16084761|NCT04759833|38802557|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
16084762|NCT04759833|38802558|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
16084763|NCT04759833|38802559|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
16084764|NCT04759833|38802555|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
16084765|NCT04759833|38802556|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
16084766|NCT04759833|38802557|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
16084767|NCT04759833|38802558|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
16084768|NCT04759833|38802559|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
16084769|NCT04759833|38802555|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
16084770|NCT04759833|38802556|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
16084771|NCT04759833|38802557|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
16084772|NCT04759833|38802558|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
16084773|NCT04759833|38802559|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
16084774|NCT02023866|38802561|FG000|Overall Study|Non-compliance|2|||
16084775|NCT02023866|38802561|FG000|Overall Study|Adverse Event|3|||
16084776|NCT02023866|38802561|FG000|Overall Study|Withdrawal by Subject|1|||
16084777|NCT02461628|38802562|FG000|Overall Study|Refused to complete survey|4|||
16084778|NCT02461628|38802563|FG001|Overall Study|Refused to complete survey|7|||
16084779|NCT01719172|38802564|FG000|Overall Study|Lost to Follow-up|1|||
16084780|NCT01719172|38802564|FG000|Overall Study|Death|1|||
16084781|NCT02075554|38802567|FG000|Overall Study|Lost to Follow-up|7|||
16084782|NCT02075554|38802567|FG000|Overall Study|Withdrawal by Subject|5|||
16084783|NCT02075554|38802567|FG000|Overall Study|Physician Decision|3|||
16084784|NCT00887224|38802570|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
16084785|NCT00887224|38802571|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
16084786|NCT00887224|38802572|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
16084787|NCT00887224|38802570|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
16084788|NCT00887224|38802571|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
16084789|NCT00887224|38802572|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
16304759|NCT01890434|39601207|FG000|Overall Study|Adverse Event|8|||
16304760|NCT01890434|39601207|FG000|Overall Study|PCI at external hospital|1|||
16304761|NCT01890434|39601207|FG000|Overall Study|Assessment discrepancy|1|||
16304762|NCT01890434|39601207|FG000|Overall Study|CRC didn't contact participant for FU|1|||
16304763|NCT01890434|39601207|FG000|Overall Study|Could not get whole set of images|1|||
16304764|NCT01890434|39601207|FG000|Overall Study|Decline to return for GSPECT|1|||
16304765|NCT01890434|39601207|FG000|Overall Study|GSPECT at rest was not done|1|||
16388124|NCT02948582|39905549|FG000|Washout Period 4|Adverse Event|1|||
16388125|NCT02948582|39905550|FG001|Washout Period 4|Adverse Event|0|||
16388126|NCT02948582|39905551|FG002|Washout Period 4|Adverse Event|1|||
16304766|NCT01890434|39601207|FG000|Overall Study|Participant didn't complete MRI|1|||
16304767|NCT01890434|39601207|FG000|Overall Study|Uncontactable by phone|1|||
16304768|NCT01890434|39601207|FG000|Overall Study|Moved out of position|1|||
16304769|NCT01890434|39601207|FG000|Overall Study|Unable to contact|1|||
16304770|NCT01890434|39601207|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
16304771|NCT01682811|39601208|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16304772|NCT01682811|39601209|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16304773|NCT01682811|39601210|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16304774|NCT01682811|39601211|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16304775|NCT01682811|39601212|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
16304776|NCT01682811|39601213|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16388127|NCT02948582|39905552|FG003|Washout Period 4|Adverse Event|0|||
16388128|NCT02948582|39905553|FG004|Washout Period 4|Adverse Event|0|||
16493480|NCT00160251|40276586|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
16493481|NCT00160251|40276587|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
16493482|NCT02385045|40276588|FG000|Overall Study|Endoscopy could not be completed|4|||
16493483|NCT03547687|40276589|FG000|Overall Study|Withdrawal by Subject|1|||
16493484|NCT03547687|40276589|FG000|Overall Study|Death|1|||
16193539|NCT00262080|39188578|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
16193540|NCT01357915|39188579|FG000|Overall Study|Lost to Follow-up|3|||
16193541|NCT01357915|39188580|FG001|Overall Study|Lost to Follow-up|0|||
16193542|NCT01963208|39188581|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
16193543|NCT01963208|39188582|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
16193544|NCT01963208|39188583|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
16193545|NCT01963208|39188584|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
16193546|NCT01963208|39188585|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
16493485|NCT00688753|40276590|FG000|Overall Study|Disease progression|55|||
16493486|NCT00688753|40276590|FG000|Overall Study|Missing|1|||
16493487|NCT00688753|40276590|FG000|Overall Study|Death|9|||
16493488|NCT00688753|40276590|FG000|Overall Study|Withdrawal by Subject|3|||
16493489|NCT00688753|40276590|FG000|Overall Study|Adverse Event|20|||
16493490|NCT00688753|40276590|FG000|Overall Study|Protocol Violation|1|||
16493491|NCT00688753|40276590|FG000|Overall Study|Lost to Follow-up|3|||
16493492|NCT00938639|40276593|FG000|Overall Study|Moved away from study area|0|||
16493493|NCT00938639|40276594|FG001|Overall Study|Moved away from study area|1|||
16493494|NCT00938639|40276593|FG000|Overall Study|Lost to Follow-up|1|||
16193547|NCT01963208|39188586|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
16084790|NCT00887224|38802570|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
16084791|NCT00887224|38802571|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
16193548|NCT01963208|39188581|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
16193549|NCT01963208|39188582|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
16193550|NCT01963208|39188583|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
16193551|NCT01963208|39188584|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
16193552|NCT01963208|39188585|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
16193553|NCT01963208|39188586|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
16193554|NCT01963208|39188581|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
16193555|NCT01963208|39188582|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
16193556|NCT01963208|39188583|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
16193557|NCT01963208|39188584|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
16304777|NCT01682811|39601214|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
16304778|NCT01682811|39601208|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
16304779|NCT01682811|39601209|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
16304780|NCT01682811|39601210|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
16304781|NCT01682811|39601211|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
16304782|NCT01682811|39601212|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
16304783|NCT01682811|39601213|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
16304784|NCT01682811|39601214|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
16493495|NCT00938639|40276594|FG001|Overall Study|Lost to Follow-up|2|||
16193558|NCT01963208|39188585|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
16193559|NCT01963208|39188586|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
16493496|NCT00938639|40276593|FG000|Overall Study|Family issues|1|||
16493497|NCT00938639|40276594|FG001|Overall Study|Family issues|1|||
16493498|NCT00938639|40276593|FG000|Overall Study|Participant noncompliance|1|||
16493499|NCT00938639|40276594|FG001|Overall Study|Participant noncompliance|0|||
16388129|NCT02948582|39905554|FG005|Washout Period 4|Adverse Event|0|||
16388130|NCT02389465|39905555|FG000|Overall Study|Lost to Follow-up|1|||
16388131|NCT02389465|39905556|FG001|Overall Study|Lost to Follow-up|3|||
16388132|NCT02389465|39905557|FG002|Overall Study|Lost to Follow-up|3|||
16388133|NCT02389465|39905558|FG003|Overall Study|Lost to Follow-up|0|||
16388134|NCT02389465|39905555|FG000|Overall Study|Physician Decision|0|||
16388135|NCT02389465|39905556|FG001|Overall Study|Physician Decision|0|||
16388136|NCT02389465|39905557|FG002|Overall Study|Physician Decision|0|||
16388137|NCT02389465|39905558|FG003|Overall Study|Physician Decision|1|||
16388138|NCT02389465|39905555|FG000|Overall Study|Withdrawal by Subject|0|||
16388139|NCT02389465|39905556|FG001|Overall Study|Withdrawal by Subject|1|||
16388140|NCT02389465|39905557|FG002|Overall Study|Withdrawal by Subject|2|||
16388141|NCT02389465|39905558|FG003|Overall Study|Withdrawal by Subject|2|||
16388142|NCT01991483|39905561|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
16388143|NCT01991483|39905562|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
16388144|NCT01991483|39905563|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
16388145|NCT01991483|39905564|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
16388146|NCT01991483|39905561|FG000|Dose Level 600 mg|Physician Decision|0|||
16388147|NCT01991483|39905562|FG001|Dose Level 600 mg|Physician Decision|0|||
16388148|NCT01991483|39905563|FG002|Dose Level 600 mg|Physician Decision|1|||
16388149|NCT01991483|39905564|FG003|Dose Level 600 mg|Physician Decision|0|||
16388150|NCT01991483|39905561|FG000|Dose Level 1000 mg|Protocol Violation|0|||
16388151|NCT01991483|39905562|FG001|Dose Level 1000 mg|Protocol Violation|0|||
16388152|NCT01991483|39905563|FG002|Dose Level 1000 mg|Protocol Violation|0|||
16388153|NCT01991483|39905564|FG003|Dose Level 1000 mg|Protocol Violation|1|||
16388154|NCT02505425|39905572|FG000|Overall Study|Lost to Follow-up|41|||
16388155|NCT02505425|39905573|FG001|Overall Study|Lost to Follow-up|61|||
16193560|NCT01963208|39188581|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
16193561|NCT01963208|39188582|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
16304785|NCT01682811|39601208|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
16304786|NCT01682811|39601209|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
16304787|NCT01682811|39601210|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
16304788|NCT01682811|39601211|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
16304789|NCT01682811|39601212|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
16304790|NCT01682811|39601213|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
16304791|NCT01682811|39601214|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
16304792|NCT01682811|39601208|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
16193562|NCT01963208|39188583|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
16193563|NCT01963208|39188584|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
16193564|NCT01963208|39188585|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
16193565|NCT01963208|39188586|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
16193566|NCT01963208|39188581|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
16193567|NCT01963208|39188582|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
16193568|NCT01963208|39188583|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
16193569|NCT01963208|39188584|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
16193570|NCT01963208|39188585|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
16193571|NCT01963208|39188586|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
16193572|NCT01963208|39188581|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
16193573|NCT01963208|39188582|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
16304793|NCT01682811|39601209|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
16304794|NCT01682811|39601210|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
16304795|NCT01682811|39601211|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
16304796|NCT01682811|39601212|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
16304797|NCT01682811|39601213|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
16304798|NCT01682811|39601214|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
16304799|NCT01443728|39601215|FG000|Overall Study|Lost to Follow-up|2|||
16304800|NCT01443728|39601216|FG001|Overall Study|Lost to Follow-up|0|||
16304801|NCT01443728|39601215|FG000|Overall Study|Withdrawal by Subject|1|||
16304802|NCT01443728|39601216|FG001|Overall Study|Withdrawal by Subject|1|||
16193574|NCT01963208|39188583|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
16193575|NCT01963208|39188584|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
16193576|NCT01963208|39188585|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
16193577|NCT01963208|39188586|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
16304803|NCT01443728|39601215|FG000|Overall Study|Adverse Event|0|||
16304804|NCT01443728|39601216|FG001|Overall Study|Adverse Event|2|||
16304805|NCT05373108|39601218|FG000|Overall Study|Withdrawal by Subject|2|||
16304806|NCT00658879|39601222|FG000|Overall Study|Protocol Violation|1|||
16388156|NCT02505425|39905574|FG002|Overall Study|Lost to Follow-up|31|||
16388157|NCT02505425|39905575|FG003|Overall Study|Lost to Follow-up|19|||
16388158|NCT02505425|39905572|FG000|Overall Study|Withdrawal by Subject|39|||
16388159|NCT02505425|39905573|FG001|Overall Study|Withdrawal by Subject|9|||
16388160|NCT02505425|39905574|FG002|Overall Study|Withdrawal by Subject|19|||
16304807|NCT01406574|39601238|FG000|Overall Study|Adverse Event|0|||
16304808|NCT01406574|39601239|FG001|Overall Study|Adverse Event|0|||
16304809|NCT01406574|39601240|FG002|Overall Study|Adverse Event|1|||
16304810|NCT01406574|39601241|FG003|Overall Study|Adverse Event|3|||
16304811|NCT01406574|39601238|FG000|Overall Study|Physician Decision|0|||
16304812|NCT01406574|39601239|FG001|Overall Study|Physician Decision|0|||
16304813|NCT01406574|39601240|FG002|Overall Study|Physician Decision|0|||
16304814|NCT01406574|39601241|FG003|Overall Study|Physician Decision|1|||
16304815|NCT01406574|39601238|FG000|Overall Study|Withdrawal by Subject|0|||
16304816|NCT01406574|39601239|FG001|Overall Study|Withdrawal by Subject|1|||
16304817|NCT01406574|39601240|FG002|Overall Study|Withdrawal by Subject|0|||
16304818|NCT01406574|39601241|FG003|Overall Study|Withdrawal by Subject|0|||
16304819|NCT01406574|39601238|FG000|Overall Study|Definite progression of primary disease|1|||
16304820|NCT01406574|39601239|FG001|Overall Study|Definite progression of primary disease|0|||
16304821|NCT01406574|39601240|FG002|Overall Study|Definite progression of primary disease|0|||
16304822|NCT01406574|39601241|FG003|Overall Study|Definite progression of primary disease|0|||
16304823|NCT02430480|39601242|FG000|Overall Study|Death|1|||
16304824|NCT02430480|39601242|FG000|Overall Study|Anesthesia concerns|1|||
16304825|NCT02430480|39601242|FG000|Overall Study|Progressed on treatment|1|||
16304826|NCT01408043|39601243|FG000|Overall Study|unable to collect cells|1|||
16304827|NCT01570686|39601250|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16304828|NCT01570686|39601251|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16304829|NCT01570686|39601250|FG000|Overall Study|Administrative problems|0|||
16304830|NCT01570686|39601251|FG001|Overall Study|Administrative problems|1|||
16304831|NCT01570686|39601250|FG000|Overall Study|Adverse Event|8|||
16304832|NCT01570686|39601251|FG001|Overall Study|Adverse Event|6|||
16304833|NCT01570686|39601250|FG000|Overall Study|Lost to Follow-up|4|||
16304834|NCT01570686|39601251|FG001|Overall Study|Lost to Follow-up|3|||
16304835|NCT01570686|39601250|FG000|Overall Study|Protocol Deviation|3|||
16304836|NCT01570686|39601251|FG001|Overall Study|Protocol Deviation|0|||
16304837|NCT01570686|39601250|FG000|Overall Study|Withdrawal by Subject|4|||
16304838|NCT01570686|39601251|FG001|Overall Study|Withdrawal by Subject|4|||
16304839|NCT01570686|39601250|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16304840|NCT01570686|39601251|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16304841|NCT01937871|39601252|FG000|Overall Study|Adverse Event|6|||
16304842|NCT01937871|39601253|FG001|Overall Study|Adverse Event|6|||
16304843|NCT01937871|39601254|FG002|Overall Study|Adverse Event|2|||
16304844|NCT01937871|39601252|FG000|Overall Study|Lost to Follow-up|8|||
16304845|NCT01937871|39601253|FG001|Overall Study|Lost to Follow-up|2|||
16304846|NCT01937871|39601254|FG002|Overall Study|Lost to Follow-up|4|||
16304847|NCT01937871|39601252|FG000|Overall Study|Withdrawal by Subject|9|||
16304848|NCT01937871|39601253|FG001|Overall Study|Withdrawal by Subject|6|||
16304849|NCT01937871|39601254|FG002|Overall Study|Withdrawal by Subject|4|||
16304850|NCT01937871|39601252|FG000|Overall Study|Physician Decision|0|||
16304851|NCT01937871|39601253|FG001|Overall Study|Physician Decision|1|||
16304852|NCT01937871|39601254|FG002|Overall Study|Physician Decision|0|||
16304853|NCT01937871|39601252|FG000|Overall Study|Entry Criteria Not Met|1|||
16304854|NCT01937871|39601253|FG001|Overall Study|Entry Criteria Not Met|2|||
16304855|NCT01937871|39601254|FG002|Overall Study|Entry Criteria Not Met|1|||
16304856|NCT02493660|39601264|FG000|Overall Study|Physician Decision|0|||
16304857|NCT02493660|39601265|FG001|Overall Study|Physician Decision|1|||
16304858|NCT02493660|39601264|FG000|Overall Study|Adverse Event|4|||
16304859|NCT02493660|39601265|FG001|Overall Study|Adverse Event|2|||
16304860|NCT02493660|39601264|FG000|Overall Study|Withdrawal by Subject|2|||
16304861|NCT02493660|39601265|FG001|Overall Study|Withdrawal by Subject|3|||
16304862|NCT02493660|39601264|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
16304863|NCT02493660|39601265|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
16304864|NCT02493660|39601264|FG000|Overall Study|Protocol Violation|0|||
16304865|NCT02493660|39601265|FG001|Overall Study|Protocol Violation|1|||
16304866|NCT02493660|39601264|FG000|Overall Study|Death|0|||
16304867|NCT02493660|39601265|FG001|Overall Study|Death|1|||
16304868|NCT02493660|39601264|FG000|Overall Study|Lost to Follow-up|2|||
16304869|NCT02493660|39601265|FG001|Overall Study|Lost to Follow-up|4|||
16304870|NCT00492778|39601271|FG000|Overall Study|Ineligible by Pathology Review|8|||
16304871|NCT00492778|39601272|FG001|Overall Study|Ineligible by Pathology Review|1|||
16304872|NCT00996489|39601275|FG000|Overall Study|Device failure|45|||
16304873|NCT00996489|39601275|FG000|Overall Study|Discontinued|116|||
16304874|NCT02224157|39601276|FG000|Overall Study|Severe non-compliance to protocol|2|||
16304875|NCT02224157|39601277|FG001|Overall Study|Severe non-compliance to protocol|2|||
16304876|NCT02224157|39601276|FG000|Overall Study|Other|13|||
16304877|NCT02224157|39601277|FG001|Overall Study|Other|10|||
16304878|NCT02224157|39601276|FG000|Overall Study|Subject decision|58|||
16304879|NCT02224157|39601277|FG001|Overall Study|Subject decision|50|||
16304880|NCT02224157|39601276|FG000|Overall Study|Prematurely closed site|4|||
16304881|NCT02224157|39601277|FG001|Overall Study|Prematurely closed site|2|||
16304882|NCT02224157|39601276|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
16304883|NCT02224157|39601277|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
16304884|NCT02224157|39601276|FG000|Overall Study|Lost to Follow-up|27|||
16304885|NCT02224157|39601277|FG001|Overall Study|Lost to Follow-up|35|||
16304886|NCT02224157|39601276|FG000|Overall Study|Death|1|||
16304887|NCT02224157|39601277|FG001|Overall Study|Death|1|||
16493500|NCT00320411|40276595|FG000|Overall Study|No investigational product admin.|4|||
16493501|NCT00907777|40276596|FG000|Overall Study|Withdrawal by Subject|0|||
16493502|NCT00907777|40276597|FG001|Overall Study|Withdrawal by Subject|1|||
16493503|NCT02193867|40276598|FG000|Overall Study|Death|2|||
16493504|NCT02193867|40276598|FG000|Overall Study|Sponsor Study Termination|2|||
16493505|NCT02989194|40276599|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
16493506|NCT02989194|40276600|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
16493507|NCT02989194|40276601|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
16493508|NCT02989194|40276599|FG000|Overall Study|Lost to Follow-up|0|||
16493509|NCT02989194|40276600|FG001|Overall Study|Lost to Follow-up|1|||
16493510|NCT02989194|40276601|FG002|Overall Study|Lost to Follow-up|0|||
16493511|NCT02989194|40276599|FG000|Overall Study|Withdrawal by Subject|0|||
16493512|NCT02989194|40276600|FG001|Overall Study|Withdrawal by Subject|1|||
16493513|NCT02989194|40276601|FG002|Overall Study|Withdrawal by Subject|0|||
16493514|NCT03700671|40276604|FG000|Overall Study|Lack of Efficacy|1|||
16493515|NCT03700671|40276605|FG001|Overall Study|Lack of Efficacy|2|||
16493516|NCT01958008|40276606|FG000|Overall Study|Worsening of disease under study|0|||
16304888|NCT02224157|39601276|FG000|Overall Study|Adverse Event|1|||
16304889|NCT02224157|39601277|FG001|Overall Study|Adverse Event|3|||
16304890|NCT02246114|39601278|FG000|Overall Study|miscarriage|1|||
16304891|NCT02246114|39601279|FG001|Overall Study|miscarriage|0|||
16304892|NCT01610492|39601284|FG000|Overall Study|Adverse Event|1|||
16304893|NCT01610492|39601284|FG000|Overall Study|Lack of Efficacy|3|||
16304894|NCT01610492|39601284|FG000|Overall Study|Other: Reached stopping criteria|1|||
16304895|NCT01610492|39601284|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
16304896|NCT03296527|39601287|FG000|Overall Study|Adverse Event|15|||
16304897|NCT03296527|39601288|FG001|Overall Study|Adverse Event|33|||
16304898|NCT03296527|39601287|FG000|Overall Study|Protocol Deviation|4|||
16304899|NCT03296527|39601288|FG001|Overall Study|Protocol Deviation|0|||
16304900|NCT03296527|39601287|FG000|Overall Study|Participant withdrew consent|3|||
16304901|NCT03296527|39601288|FG001|Overall Study|Participant withdrew consent|1|||
16304902|NCT03296527|39601287|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
16304903|NCT03296527|39601288|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
16304904|NCT03296527|39601287|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
16304905|NCT03296527|39601288|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
16304906|NCT03296527|39601287|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
16304907|NCT03296527|39601288|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
16304908|NCT03296527|39601287|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
16304909|NCT03296527|39601288|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
16304910|NCT03296527|39601287|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
16304911|NCT03296527|39601288|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
16304912|NCT02290223|39601289|FG000|6 Months|Lost to Follow-up|9|||
16304913|NCT02290223|39601290|FG001|6 Months|Lost to Follow-up|6|||
16304914|NCT02290223|39601289|FG000|6 Months|Withdrawal by Subject|5|||
16304915|NCT02290223|39601290|FG001|6 Months|Withdrawal by Subject|0|||
16304916|NCT02290223|39601289|FG000|6 Months|deceased (not related to study)|2|||
16304917|NCT02290223|39601290|FG001|6 Months|deceased (not related to study)|0|||
16304918|NCT02290223|39601289|FG000|12 Months|Lost to Follow-up|16|||
16304919|NCT02290223|39601290|FG001|12 Months|Lost to Follow-up|10|||
16304920|NCT02290223|39601289|FG000|12 Months|Refusal|0|||
16304921|NCT02290223|39601290|FG001|12 Months|Refusal|1|||
16304922|NCT01023035|39601299|FG000|Treatment Period|Adverse Event|27|||
16304923|NCT01023035|39601300|FG001|Treatment Period|Adverse Event|32|||
16304924|NCT01023035|39601301|FG002|Treatment Period|Adverse Event|50|||
16304925|NCT01023035|39601299|FG000|Treatment Period|Non-Medical Reasons|19|||
16304926|NCT01023035|39601300|FG001|Treatment Period|Non-Medical Reasons|22|||
16304927|NCT01023035|39601301|FG002|Treatment Period|Non-Medical Reasons|44|||
16304928|NCT01023035|39601299|FG000|Treatment Period|Treatment Failure|26|||
16304929|NCT01023035|39601300|FG001|Treatment Period|Treatment Failure|31|||
16304930|NCT01023035|39601301|FG002|Treatment Period|Treatment Failure|24|||
16304931|NCT01023035|39601299|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
16304932|NCT01023035|39601300|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
16304933|NCT01023035|39601301|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
16304934|NCT01023035|39601299|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
16304935|NCT01023035|39601300|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
16304936|NCT01023035|39601301|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
16493517|NCT01958008|40276607|FG001|Overall Study|Worsening of disease under study|0|||
16493518|NCT01958008|40276608|FG002|Overall Study|Worsening of disease under study|1|||
16493519|NCT01958008|40276609|FG003|Overall Study|Worsening of disease under study|0|||
16493520|NCT01958008|40276606|FG000|Overall Study|Other adverse event|1|||
16304937|NCT05513391|39601302|FG000|Overall Study|Adverse Event|1|||
16304938|NCT05513391|39601303|FG001|Overall Study|Adverse Event|0|||
16304939|NCT05513391|39601302|FG000|Overall Study|Protocol Deviation|0|||
16304940|NCT05513391|39601303|FG001|Overall Study|Protocol Deviation|1|||
16304941|NCT05513391|39601302|FG000|Overall Study|Withdrawal by Subject|3|||
16304942|NCT05513391|39601303|FG001|Overall Study|Withdrawal by Subject|1|||
16304943|NCT05513391|39601302|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
16304944|NCT05513391|39601303|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
16304945|NCT05513391|39601302|FG000|Overall Study|Lost to Follow-up|0|||
16304946|NCT05513391|39601303|FG001|Overall Study|Lost to Follow-up|2|||
16304947|NCT02856555|39601304|FG000|Overall Study|Adverse Event|1|||
16304948|NCT02856555|39601305|FG001|Overall Study|Adverse Event|0|||
16304949|NCT02856555|39601306|FG002|Overall Study|Adverse Event|0|||
16304950|NCT02856555|39601304|FG000|Overall Study|Lost to Follow-up|1|||
16304951|NCT02856555|39601305|FG001|Overall Study|Lost to Follow-up|3|||
16304952|NCT02856555|39601306|FG002|Overall Study|Lost to Follow-up|0|||
16304953|NCT02856555|39601304|FG000|Overall Study|Withdrawal by Subject|3|||
16304954|NCT02856555|39601305|FG001|Overall Study|Withdrawal by Subject|0|||
16304955|NCT02856555|39601306|FG002|Overall Study|Withdrawal by Subject|0|||
16304956|NCT02856555|39601304|FG000|Overall Study|Randomized but Never Treated|0|||
16304957|NCT02856555|39601305|FG001|Overall Study|Randomized but Never Treated|1|||
16304958|NCT02856555|39601306|FG002|Overall Study|Randomized but Never Treated|0|||
16493521|NCT01958008|40276607|FG001|Overall Study|Other adverse event|0|||
16493522|NCT01958008|40276608|FG002|Overall Study|Other adverse event|0|||
16493523|NCT01958008|40276609|FG003|Overall Study|Other adverse event|0|||
16493524|NCT00743340|40276610|FG000|Overall Study|Study medication non-compliance|1|||
16493525|NCT00743340|40276610|FG000|Overall Study|Lost to Follow-up|1|||
16304959|NCT01582152|39601307|FG000|Overall Study|Disease Progression|4|||
16304960|NCT01582152|39601308|FG001|Overall Study|Disease Progression|5|||
16304961|NCT01582152|39601307|FG000|Overall Study|Adverse Event|2|||
16304962|NCT01582152|39601308|FG001|Overall Study|Adverse Event|1|||
16304963|NCT01068262|39601310|FG000|Overall Study|Adverse Event|2|||
16304964|NCT01068262|39601311|FG001|Overall Study|Adverse Event|0|||
16304965|NCT01068262|39601312|FG002|Overall Study|Adverse Event|1|||
16304966|NCT01068262|39601313|FG003|Overall Study|Adverse Event|0|||
16304967|NCT01068262|39601310|FG000|Overall Study|Protocol Violation|1|||
16304968|NCT01068262|39601311|FG001|Overall Study|Protocol Violation|0|||
16304969|NCT01068262|39601312|FG002|Overall Study|Protocol Violation|0|||
16304970|NCT01068262|39601313|FG003|Overall Study|Protocol Violation|0|||
16304971|NCT01068262|39601310|FG000|Overall Study|Withdrawal by Subject|0|||
16304972|NCT01068262|39601311|FG001|Overall Study|Withdrawal by Subject|1|||
16304973|NCT01068262|39601312|FG002|Overall Study|Withdrawal by Subject|0|||
16304974|NCT01068262|39601313|FG003|Overall Study|Withdrawal by Subject|0|||
16304975|NCT00749892|39601317|FG000|Overall Study|Withdrawal by Subject|3|||
16304976|NCT03122886|39601318|FG000|Overall Study|Withdrawal by Subject|1|||
16304977|NCT03122886|39601319|FG001|Overall Study|Withdrawal by Subject|2|||
16304978|NCT02269098|39601320|FG000|Overall Study|Lost to Follow-up|14|||
16304979|NCT02269098|39601321|FG001|Overall Study|Lost to Follow-up|9|||
16304980|NCT01295320|39601322|FG000|Overall Study|Adverse Event|2|||
16304981|NCT01295320|39601322|FG000|Overall Study|Lost to Follow-up|4|||
16304982|NCT01295320|39601322|FG000|Overall Study|Withdrawal by Subject|2|||
16304983|NCT01295320|39601322|FG000|Overall Study|Subject was bedridden|1|||
16304984|NCT01295320|39601322|FG000|Overall Study|Unable to travel|1|||
16304985|NCT04975191|39601325|FG000|Overall Study|Protocol Violation|1|||
16304986|NCT04975191|39601326|FG001|Overall Study|Protocol Violation|2|||
16304987|NCT04975191|39601327|FG002|Overall Study|Protocol Violation|2|||
16304988|NCT04975191|39601328|FG003|Overall Study|Protocol Violation|2|||
16304989|NCT04975191|39601325|FG000|Overall Study|Lost to Follow-up|13|||
16304990|NCT04975191|39601326|FG001|Overall Study|Lost to Follow-up|3|||
16304991|NCT04975191|39601327|FG002|Overall Study|Lost to Follow-up|8|||
16304992|NCT04975191|39601328|FG003|Overall Study|Lost to Follow-up|8|||
16304993|NCT00805467|39601329|FG000|Overall Study|Lack of Efficacy|0|||
16304994|NCT00805467|39601330|FG001|Overall Study|Lack of Efficacy|8|||
16304995|NCT00805467|39601331|FG002|Overall Study|Lack of Efficacy|13|||
16304996|NCT00805467|39601332|FG003|Overall Study|Lack of Efficacy|86|||
16304997|NCT00805467|39601329|FG000|Overall Study|Lost to Follow-up|0|||
16304998|NCT00805467|39601330|FG001|Overall Study|Lost to Follow-up|1|||
16304999|NCT00805467|39601331|FG002|Overall Study|Lost to Follow-up|7|||
16305000|NCT00805467|39601332|FG003|Overall Study|Lost to Follow-up|21|||
16305001|NCT00805467|39601329|FG000|Overall Study|Withdrawal by Subject|0|||
16305002|NCT00805467|39601330|FG001|Overall Study|Withdrawal by Subject|6|||
16305003|NCT00805467|39601331|FG002|Overall Study|Withdrawal by Subject|45|||
16305004|NCT00805467|39601332|FG003|Overall Study|Withdrawal by Subject|50|||
16305005|NCT00805467|39601329|FG000|Overall Study|Protocol Violation|0|||
16493526|NCT00743340|40276610|FG000|Overall Study|Withdrawal from the Study|5|||
16493527|NCT00743340|40276610|FG000|Overall Study|Protocol Violation|1|||
16305006|NCT00805467|39601330|FG001|Overall Study|Protocol Violation|3|||
16305007|NCT00805467|39601331|FG002|Overall Study|Protocol Violation|0|||
16305008|NCT00805467|39601332|FG003|Overall Study|Protocol Violation|5|||
16305009|NCT00805467|39601329|FG000|Overall Study|Adverse Event|0|||
16305010|NCT00805467|39601330|FG001|Overall Study|Adverse Event|13|||
16305011|NCT00805467|39601331|FG002|Overall Study|Adverse Event|26|||
16305012|NCT00805467|39601332|FG003|Overall Study|Adverse Event|57|||
16305013|NCT00805467|39601329|FG000|Overall Study|Death|0|||
16305014|NCT00805467|39601330|FG001|Overall Study|Death|2|||
16305015|NCT00805467|39601331|FG002|Overall Study|Death|7|||
16305016|NCT00805467|39601332|FG003|Overall Study|Death|5|||
16305017|NCT00805467|39601329|FG000|Overall Study|Physician Decision|0|||
16305018|NCT00805467|39601330|FG001|Overall Study|Physician Decision|1|||
16305019|NCT00805467|39601331|FG002|Overall Study|Physician Decision|2|||
16305020|NCT00805467|39601332|FG003|Overall Study|Physician Decision|6|||
16305021|NCT00805467|39601329|FG000|Overall Study|Not reported|0|||
16305022|NCT00805467|39601330|FG001|Overall Study|Not reported|0|||
16305023|NCT00805467|39601331|FG002|Overall Study|Not reported|3|||
16305024|NCT00805467|39601332|FG003|Overall Study|Not reported|7|||
16305025|NCT01495000|39601336|FG000|Overall Study|Lost to Follow-up|2|||
16305026|NCT01495000|39601337|FG001|Overall Study|Lost to Follow-up|2|||
16305027|NCT01495000|39601336|FG000|Overall Study|Protocol Violation|1|||
16305028|NCT01495000|39601337|FG001|Overall Study|Protocol Violation|0|||
16305029|NCT01495000|39601336|FG000|Overall Study|Withdrawal by Subject|10|||
16305030|NCT01495000|39601337|FG001|Overall Study|Withdrawal by Subject|10|||
16305031|NCT03447743|39601338|FG000|Overall Study|Withdrawal by Subject|2|||
16305032|NCT03447743|39601338|FG000|Overall Study|Lost to Follow-up|3|||
16305033|NCT03447743|39601338|FG000|Overall Study|Adverse Event|1|||
16305034|NCT03447743|39601338|FG000|Overall Study|Did not meet criteria to continue|1|||
16305035|NCT02586155|39601350|FG000|Overall Study|Adverse Event|2|||
16305036|NCT02586155|39601351|FG001|Overall Study|Adverse Event|3|||
16305037|NCT02586155|39601350|FG000|Overall Study|Withdrawal by Subject|31|||
16305038|NCT02586155|39601351|FG001|Overall Study|Withdrawal by Subject|24|||
16305039|NCT02586155|39601350|FG000|Overall Study|Lost to Follow-up|7|||
16305040|NCT02586155|39601351|FG001|Overall Study|Lost to Follow-up|13|||
16305041|NCT02586155|39601350|FG000|Overall Study|Death|61|||
16305042|NCT02586155|39601351|FG001|Overall Study|Death|72|||
16305043|NCT02586155|39601350|FG000|Overall Study|Other reasons|26|||
16305044|NCT02586155|39601351|FG001|Overall Study|Other reasons|15|||
16305045|NCT04564092|39601352|FG000|Overall Study|Withdrawal by Subject|1|||
16305046|NCT02047734|39601353|FG000|Overall Study|Adverse Event|18|||
16305047|NCT02047734|39601354|FG001|Overall Study|Adverse Event|13|||
16305048|NCT02047734|39601355|FG002|Overall Study|Adverse Event|13|||
16305049|NCT02047734|39601353|FG000|Overall Study|Lack of Efficacy|4|||
16305050|NCT02047734|39601354|FG001|Overall Study|Lack of Efficacy|5|||
16305051|NCT02047734|39601355|FG002|Overall Study|Lack of Efficacy|1|||
16305052|NCT02047734|39601353|FG000|Overall Study|Protocol Violation|3|||
16305053|NCT02047734|39601354|FG001|Overall Study|Protocol Violation|1|||
16305054|NCT02047734|39601355|FG002|Overall Study|Protocol Violation|1|||
16305055|NCT02047734|39601353|FG000|Overall Study|Lost to Follow-up|1|||
16305056|NCT02047734|39601354|FG001|Overall Study|Lost to Follow-up|4|||
16305057|NCT02047734|39601355|FG002|Overall Study|Lost to Follow-up|0|||
16305058|NCT02047734|39601353|FG000|Overall Study|Death|0|||
16305059|NCT02047734|39601354|FG001|Overall Study|Death|1|||
16305060|NCT02047734|39601355|FG002|Overall Study|Death|0|||
16305061|NCT02047734|39601353|FG000|Overall Study|Withdrawal by Subject|30|||
16305062|NCT02047734|39601354|FG001|Overall Study|Withdrawal by Subject|31|||
16305063|NCT02047734|39601355|FG002|Overall Study|Withdrawal by Subject|19|||
16305064|NCT02047734|39601353|FG000|Overall Study|Physician Decision|7|||
16305065|NCT02047734|39601354|FG001|Overall Study|Physician Decision|6|||
16305066|NCT02047734|39601355|FG002|Overall Study|Physician Decision|5|||
16305067|NCT02047734|39601353|FG000|Overall Study|Miscellaneous|2|||
16305068|NCT02047734|39601354|FG001|Overall Study|Miscellaneous|4|||
16305069|NCT02047734|39601355|FG002|Overall Study|Miscellaneous|6|||
16305070|NCT02047734|39601353|FG000|Overall Study|Did Not Receive Study Drug|2|||
16305071|NCT02047734|39601354|FG001|Overall Study|Did Not Receive Study Drug|4|||
16305072|NCT02047734|39601355|FG002|Overall Study|Did Not Receive Study Drug|1|||
16388161|NCT02505425|39905575|FG003|Overall Study|Withdrawal by Subject|7|||
16305073|NCT01277211|39601356|FG000|Overall Study|Adverse Event|60|||
16305074|NCT01277211|39601357|FG001|Overall Study|Adverse Event|22|||
16305075|NCT01277211|39601356|FG000|Overall Study|Pregnancy|9|||
16305076|NCT01277211|39601357|FG001|Overall Study|Pregnancy|4|||
16305077|NCT01277211|39601356|FG000|Overall Study|Lost to Follow-up|14|||
16305078|NCT01277211|39601357|FG001|Overall Study|Lost to Follow-up|9|||
16305079|NCT01277211|39601356|FG000|Overall Study|Did not wish to continue|17|||
16305080|NCT01277211|39601357|FG001|Overall Study|Did not wish to continue|0|||
16305081|NCT01277211|39601356|FG000|Overall Study|Withdrew Consent|9|||
16305082|NCT01277211|39601357|FG001|Overall Study|Withdrew Consent|9|||
16305083|NCT01277211|39601356|FG000|Overall Study|Non-compliance with protocol|13|||
16305084|NCT01277211|39601357|FG001|Overall Study|Non-compliance with protocol|4|||
16305085|NCT01277211|39601356|FG000|Overall Study|Did not meet protocol eligibility|1|||
16305086|NCT01277211|39601357|FG001|Overall Study|Did not meet protocol eligibility|0|||
16305087|NCT01277211|39601356|FG000|Overall Study|Administrative|3|||
16305088|NCT01277211|39601357|FG001|Overall Study|Administrative|0|||
16305089|NCT01277211|39601356|FG000|Overall Study|Pregnancy wish|0|||
16305090|NCT01277211|39601357|FG001|Overall Study|Pregnancy wish|2|||
16305091|NCT01277211|39601356|FG000|Overall Study|Discontinued prior to treatment|24|||
16305092|NCT01277211|39601357|FG001|Overall Study|Discontinued prior to treatment|13|||
16305093|NCT02865460|39601359|FG000|Overall Study|Adverse Event|1|||
16305094|NCT02865460|39601360|FG001|Overall Study|Adverse Event|0|||
16305095|NCT02865460|39601359|FG000|Overall Study|Withdrawal by Subject|1|||
16305096|NCT02865460|39601360|FG001|Overall Study|Withdrawal by Subject|1|||
16305097|NCT02865460|39601359|FG000|Overall Study|Lost to Follow-up|7|||
16305098|NCT02865460|39601360|FG001|Overall Study|Lost to Follow-up|4|||
16305099|NCT02865460|39601359|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
16305100|NCT02865460|39601360|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
16305101|NCT02620579|39601363|FG000|Overall Study|Physician Decision|0|||
16305102|NCT02620579|39601364|FG001|Overall Study|Physician Decision|0|||
16305103|NCT02620579|39601365|FG002|Overall Study|Physician Decision|0|||
16305104|NCT02620579|39601366|FG003|Overall Study|Physician Decision|1|||
16305105|NCT02620579|39601363|FG000|Overall Study|Withdrawal by Subject|0|||
16305106|NCT02620579|39601364|FG001|Overall Study|Withdrawal by Subject|1|||
16305107|NCT02620579|39601365|FG002|Overall Study|Withdrawal by Subject|1|||
16305108|NCT02620579|39601366|FG003|Overall Study|Withdrawal by Subject|0|||
16305109|NCT02165735|39601367|FG000|Overall Study|Lost to Follow-up|12|||
16305110|NCT02165735|39601368|FG001|Overall Study|Lost to Follow-up|10|||
16305111|NCT02165735|39601367|FG000|Overall Study|Withdrawal by Subject|3|||
16305112|NCT02165735|39601368|FG001|Overall Study|Withdrawal by Subject|0|||
16305113|NCT02165735|39601367|FG000|Overall Study|Participant indicated lack of time|1|||
16305114|NCT02165735|39601368|FG001|Overall Study|Participant indicated lack of time|3|||
16305115|NCT02165735|39601367|FG000|Overall Study|Protocol Violation|0|||
16305116|NCT02165735|39601368|FG001|Overall Study|Protocol Violation|1|||
16305117|NCT03953612|39601369|FG000|Overall Study|Randomized but did not start|1|||
16305118|NCT03953612|39601370|FG001|Overall Study|Randomized but did not start|1|||
16305119|NCT03953612|39601371|FG002|Overall Study|Randomized but did not start|1|||
16305120|NCT03953612|39601369|FG000|Overall Study|Withdrawal by Subject|2|||
16305121|NCT03953612|39601370|FG001|Overall Study|Withdrawal by Subject|1|||
16305122|NCT03953612|39601371|FG002|Overall Study|Withdrawal by Subject|0|||
16305123|NCT00911300|39601372|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
16305124|NCT00911300|39601373|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
16305125|NCT00911300|39601372|FG000|Overall Study|Death|1|||
16305126|NCT00911300|39601373|FG001|Overall Study|Death|0|||
16305127|NCT00911300|39601372|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
16305128|NCT00911300|39601373|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
16305129|NCT00911300|39601372|FG000|Overall Study|Adverse Event|14|||
16305130|NCT00911300|39601373|FG001|Overall Study|Adverse Event|6|||
16305131|NCT00911300|39601372|FG000|Overall Study|Protocol Violation|3|||
16305132|NCT00911300|39601373|FG001|Overall Study|Protocol Violation|2|||
16305133|NCT00911300|39601372|FG000|Overall Study|Consent Withdrawn|4|||
16305134|NCT00911300|39601373|FG001|Overall Study|Consent Withdrawn|12|||
16305135|NCT00911300|39601372|FG000|Overall Study|Coronary Angiography Performed|1|||
16388162|NCT02505425|39905572|FG000|Overall Study|Death|8|||
16493528|NCT00743340|40276610|FG000|Overall Study|Virologic failure|8|||
16493529|NCT00743340|40276610|FG000|Overall Study|Pregnancy|1|||
16193578|NCT01963208|39188581|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
16193579|NCT01963208|39188582|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
16193580|NCT01963208|39188583|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
16193581|NCT01963208|39188584|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
16193582|NCT01963208|39188585|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
16193583|NCT01963208|39188586|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
16193584|NCT01963208|39188581|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
16193585|NCT01963208|39188582|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
16193586|NCT01963208|39188583|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
16193587|NCT01963208|39188584|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
16193588|NCT01963208|39188585|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
16193589|NCT01963208|39188586|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
16193590|NCT01963208|39188581|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
16193591|NCT01963208|39188582|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
16193592|NCT01963208|39188583|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
16305136|NCT00911300|39601373|FG001|Overall Study|Coronary Angiography Performed|0|||
16305137|NCT00911300|39601372|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
16305138|NCT00911300|39601373|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
16305139|NCT00911300|39601372|FG000|Overall Study|Received Commercial Treatment|1|||
16305140|NCT00911300|39601373|FG001|Overall Study|Received Commercial Treatment|0|||
16305141|NCT00911300|39601372|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
16193593|NCT01963208|39188584|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
16193594|NCT01963208|39188585|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
16193595|NCT01963208|39188586|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
16193596|NCT01963208|39188581|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
16193597|NCT01963208|39188582|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
16305142|NCT00911300|39601373|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
16305143|NCT00911300|39601372|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
16305144|NCT00911300|39601373|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
16305145|NCT00911300|39601372|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
16305146|NCT00911300|39601373|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
16305147|NCT00911300|39601372|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
16305148|NCT00911300|39601373|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
16305149|NCT00911300|39601372|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
16305150|NCT00911300|39601373|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
16305151|NCT00911300|39601372|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
16305152|NCT00911300|39601373|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
16305153|NCT00911300|39601372|FG000|Overall Study|International Normalized Ratio Too High|0|||
16305154|NCT00911300|39601373|FG001|Overall Study|International Normalized Ratio Too High|1|||
16305155|NCT00911300|39601372|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
16305156|NCT00911300|39601373|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
16305157|NCT00911300|39601372|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
16305158|NCT00911300|39601373|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
16305159|NCT00911300|39601372|FG000|Overall Study|Physician Decision|0|||
16305160|NCT00911300|39601373|FG001|Overall Study|Physician Decision|1|||
16305161|NCT00911300|39601372|FG000|Overall Study|Treatment Stopped by Mistake|0|||
16305162|NCT00911300|39601373|FG001|Overall Study|Treatment Stopped by Mistake|1|||
16305163|NCT00911300|39601372|FG000|Overall Study|Randomized; No Study Medication Received|0|||
16305164|NCT00911300|39601373|FG001|Overall Study|Randomized; No Study Medication Received|2|||
16305165|NCT02899195|39601374|FG000|Concurrent Durvalumab|Adverse Event|4|||
16305166|NCT02899195|39601374|FG000|Concurrent Durvalumab|Physician Decision|1|||
16305167|NCT02899195|39601374|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
16305168|NCT02899195|39601374|FG000|Concurrent Durvalumab|Progressive Disease|5|||
16305169|NCT02899195|39601374|FG000|Maintenance Durvalumab|Adverse Event|1|||
16305170|NCT02899195|39601374|FG000|Maintenance Durvalumab|Physician Decision|1|||
16305171|NCT02899195|39601374|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
16305172|NCT02899195|39601374|FG000|Maintenance Durvalumab|Progressive Disease|31|||
16305173|NCT00535405|39601375|FG000|Overall Study|Adverse Event|6|||
16305174|NCT00535405|39601376|FG001|Overall Study|Adverse Event|8|||
16305175|NCT00535405|39601377|FG002|Overall Study|Adverse Event|3|||
16305176|NCT00535405|39601378|FG003|Overall Study|Adverse Event|8|||
16305177|NCT00535405|39601379|FG004|Overall Study|Adverse Event|6|||
16305178|NCT00535405|39601375|FG000|Overall Study|Lost to Follow-up|1|||
16305179|NCT00535405|39601376|FG001|Overall Study|Lost to Follow-up|3|||
16305180|NCT00535405|39601377|FG002|Overall Study|Lost to Follow-up|3|||
16305181|NCT00535405|39601378|FG003|Overall Study|Lost to Follow-up|2|||
16305182|NCT00535405|39601379|FG004|Overall Study|Lost to Follow-up|1|||
16305183|NCT00535405|39601375|FG000|Overall Study|Physician Decision|3|||
16305184|NCT00535405|39601376|FG001|Overall Study|Physician Decision|2|||
16305185|NCT00535405|39601377|FG002|Overall Study|Physician Decision|0|||
16305186|NCT00535405|39601378|FG003|Overall Study|Physician Decision|1|||
16305187|NCT00535405|39601379|FG004|Overall Study|Physician Decision|1|||
16305188|NCT00535405|39601375|FG000|Overall Study|Protocol Violation|2|||
16305189|NCT00535405|39601376|FG001|Overall Study|Protocol Violation|2|||
16305190|NCT00535405|39601377|FG002|Overall Study|Protocol Violation|2|||
16305191|NCT00535405|39601378|FG003|Overall Study|Protocol Violation|1|||
16305192|NCT00535405|39601379|FG004|Overall Study|Protocol Violation|0|||
16305193|NCT00535405|39601375|FG000|Overall Study|Withdrawal by Subject|5|||
16305194|NCT00535405|39601376|FG001|Overall Study|Withdrawal by Subject|11|||
16305195|NCT00535405|39601377|FG002|Overall Study|Withdrawal by Subject|10|||
16305196|NCT00535405|39601378|FG003|Overall Study|Withdrawal by Subject|10|||
16305197|NCT00535405|39601379|FG004|Overall Study|Withdrawal by Subject|8|||
16388163|NCT02505425|39905573|FG001|Overall Study|Death|12|||
16388164|NCT02505425|39905574|FG002|Overall Study|Death|0|||
16305198|NCT01245283|39601381|FG000|Overall Study|Lost to Follow-up|14|||
16305199|NCT01245283|39601382|FG001|Overall Study|Lost to Follow-up|11|||
16305200|NCT01245283|39601383|FG002|Overall Study|Lost to Follow-up|11|||
16305201|NCT01098487|39601394|FG000|Overall Study|Adverse Event|22|||
16305202|NCT01098487|39601394|FG000|Overall Study|Lack of Efficacy|11|||
16305203|NCT01098487|39601394|FG000|Overall Study|Withdrawal by Subject|7|||
16305204|NCT01098487|39601394|FG000|Overall Study|Lost to Follow-up|3|||
16305205|NCT01098487|39601394|FG000|Overall Study|Physician Decision|1|||
16305206|NCT03624192|39601401|FG000|Overall Study|Lost to Follow-up|1|||
16305207|NCT03624192|39601402|FG001|Overall Study|Lost to Follow-up|1|||
16305208|NCT02698163|39601403|FG000|Overall Study|Lost to Follow-up|0|||
16388165|NCT02505425|39905575|FG003|Overall Study|Death|0|||
16305209|NCT02698163|39601404|FG001|Overall Study|Lost to Follow-up|1|||
16305210|NCT00789035|39601406|FG000|Overall Study|Adverse Event|0|||
16305211|NCT00789035|39601407|FG001|Overall Study|Adverse Event|2|||
16305212|NCT00789035|39601408|FG002|Overall Study|Adverse Event|0|||
16305213|NCT00789035|39601409|FG003|Overall Study|Adverse Event|1|||
16305214|NCT00789035|39601410|FG004|Overall Study|Adverse Event|3|||
16305215|NCT00789035|39601406|FG000|Overall Study|Lack of Efficacy|3|||
16305216|NCT00789035|39601407|FG001|Overall Study|Lack of Efficacy|0|||
16305217|NCT00789035|39601408|FG002|Overall Study|Lack of Efficacy|0|||
16305218|NCT00789035|39601409|FG003|Overall Study|Lack of Efficacy|0|||
16305219|NCT00789035|39601410|FG004|Overall Study|Lack of Efficacy|2|||
16305220|NCT00789035|39601406|FG000|Overall Study|Protocol Violation|1|||
16305221|NCT00789035|39601407|FG001|Overall Study|Protocol Violation|0|||
16305222|NCT00789035|39601408|FG002|Overall Study|Protocol Violation|0|||
16305223|NCT00789035|39601409|FG003|Overall Study|Protocol Violation|0|||
16305224|NCT00789035|39601410|FG004|Overall Study|Protocol Violation|0|||
16305225|NCT00789035|39601406|FG000|Overall Study|Withdrawal by Subject|0|||
16305226|NCT00789035|39601407|FG001|Overall Study|Withdrawal by Subject|2|||
16305227|NCT00789035|39601408|FG002|Overall Study|Withdrawal by Subject|0|||
16305228|NCT00789035|39601409|FG003|Overall Study|Withdrawal by Subject|0|||
16305229|NCT00789035|39601410|FG004|Overall Study|Withdrawal by Subject|0|||
16305230|NCT00789035|39601406|FG000|Overall Study|Other reason not defined above|2|||
16305231|NCT00789035|39601407|FG001|Overall Study|Other reason not defined above|3|||
16305232|NCT00789035|39601408|FG002|Overall Study|Other reason not defined above|1|||
16305233|NCT00789035|39601409|FG003|Overall Study|Other reason not defined above|0|||
16305234|NCT00789035|39601410|FG004|Overall Study|Other reason not defined above|1|||
16305235|NCT02764151|39601411|FG000|Overall Study|Subject refused further follow-up|0|||
16305236|NCT02764151|39601412|FG001|Overall Study|Subject refused further follow-up|0|||
16305237|NCT02764151|39601413|FG002|Overall Study|Subject refused further follow-up|0|||
16305238|NCT02764151|39601414|FG003|Overall Study|Subject refused further follow-up|1|||
16305239|NCT02764151|39601411|FG000|Overall Study|Other|0|||
16305240|NCT02764151|39601412|FG001|Overall Study|Other|0|||
16305241|NCT02764151|39601413|FG002|Overall Study|Other|0|||
16305242|NCT02764151|39601414|FG003|Overall Study|Other|2|||
16305243|NCT02842073|39601415|FG000|Overall Study|Withdrawal by Subject|1|||
16305244|NCT00191191|39601420|FG000|Overall Study|Entry Criteria Exclusion|2|||
16305245|NCT00191191|39601421|FG001|Overall Study|Entry Criteria Exclusion|0|||
16305246|NCT00191191|39601420|FG000|Overall Study|Treated with Another Systemic Agent|1|||
16305247|NCT00191191|39601421|FG001|Overall Study|Treated with Another Systemic Agent|1|||
16305248|NCT00191191|39601420|FG000|Overall Study|Adverse Event|11|||
16305249|NCT00191191|39601421|FG001|Overall Study|Adverse Event|21|||
16305250|NCT00191191|39601420|FG000|Overall Study|Progressive Disease|84|||
16305251|NCT00191191|39601421|FG001|Overall Study|Progressive Disease|72|||
16305252|NCT00191191|39601420|FG000|Overall Study|Toxicity After Dose Reduction|7|||
16305253|NCT00191191|39601421|FG001|Overall Study|Toxicity After Dose Reduction|8|||
16305254|NCT00191191|39601420|FG000|Overall Study|Family/Caregiver Decision|5|||
16305255|NCT00191191|39601421|FG001|Overall Study|Family/Caregiver Decision|7|||
16305256|NCT00191191|39601420|FG000|Overall Study|Lost to Follow-up|1|||
16305257|NCT00191191|39601421|FG001|Overall Study|Lost to Follow-up|0|||
16305258|NCT00191191|39601420|FG000|Overall Study|Physician Decision|3|||
16305259|NCT00191191|39601421|FG001|Overall Study|Physician Decision|2|||
16305260|NCT00191191|39601420|FG000|Overall Study|Good Clinical Practice Violation|0|||
16305261|NCT00191191|39601421|FG001|Overall Study|Good Clinical Practice Violation|1|||
16305262|NCT00129545|39601422|FG000|Overall Study|Death|5|||
16305263|NCT00129545|39601423|FG001|Overall Study|Death|60|||
16305264|NCT00129545|39601424|FG002|Overall Study|Death|44|||
16305265|NCT00129545|39601422|FG000|Overall Study|Withdrawal by Subject|3|||
16305266|NCT00129545|39601423|FG001|Overall Study|Withdrawal by Subject|18|||
16305267|NCT00129545|39601424|FG002|Overall Study|Withdrawal by Subject|44|||
16305268|NCT00129545|39601422|FG000|Overall Study|Lost to Follow-up|2|||
16305269|NCT00129545|39601423|FG001|Overall Study|Lost to Follow-up|22|||
16305270|NCT00129545|39601424|FG002|Overall Study|Lost to Follow-up|13|||
16305271|NCT00129545|39601422|FG000|Overall Study|Physician Decision|0|||
16305272|NCT00129545|39601423|FG001|Overall Study|Physician Decision|3|||
16305273|NCT00129545|39601424|FG002|Overall Study|Physician Decision|10|||
16305274|NCT00129545|39601422|FG000|Overall Study|Device not implanted|16|||
16305275|NCT00129545|39601423|FG001|Overall Study|Device not implanted|61|||
16084792|NCT00887224|38802572|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
16193598|NCT01963208|39188583|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
16305276|NCT00129545|39601424|FG002|Overall Study|Device not implanted|0|||
16305277|NCT01433055|39601425|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
16305278|NCT01433055|39601426|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
16305279|NCT01433055|39601425|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
16305280|NCT01433055|39601426|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
16305281|NCT04778904|39601427|FG000|Overall Study|Protocol Violation|1|||
16305282|NCT04778904|39601428|FG001|Overall Study|Protocol Violation|0|||
16305283|NCT04778904|39601429|FG002|Overall Study|Protocol Violation|0|||
16305284|NCT04778904|39601430|FG003|Overall Study|Protocol Violation|0|||
16305285|NCT04778904|39601427|FG000|Overall Study|Withdrawal by Subject|0|||
16305286|NCT04778904|39601428|FG001|Overall Study|Withdrawal by Subject|0|||
16305287|NCT04778904|39601429|FG002|Overall Study|Withdrawal by Subject|1|||
16305288|NCT04778904|39601430|FG003|Overall Study|Withdrawal by Subject|0|||
16305289|NCT03267212|39601431|FG000|First Intervention|Lost to Follow-up|0|||
16305290|NCT03267212|39601432|FG001|First Intervention|Lost to Follow-up|2|||
16305291|NCT03267212|39601431|FG000|First Intervention|Withdrawal by Subject|1|||
16305292|NCT03267212|39601432|FG001|First Intervention|Withdrawal by Subject|1|||
16305293|NCT03267212|39601431|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
16305294|NCT03267212|39601432|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
16305295|NCT02929056|39601439|FG000|Overall Study|Lost to Follow-up|0|||
16305296|NCT02929056|39601440|FG001|Overall Study|Lost to Follow-up|1|||
16305297|NCT01198132|39601443|FG000|Overall Study|Withdrawal by Subject|4|||
16305298|NCT01198132|39601444|FG001|Overall Study|Withdrawal by Subject|5|||
16305299|NCT01198132|39601443|FG000|Overall Study|Physician Decision|5|||
16305300|NCT01198132|39601444|FG001|Overall Study|Physician Decision|4|||
16305301|NCT01198132|39601443|FG000|Overall Study|Other Unspecified|3|||
16305302|NCT01198132|39601444|FG001|Overall Study|Other Unspecified|6|||
16305303|NCT01198132|39601443|FG000|Overall Study|Lack of Efficacy|2|||
16305304|NCT01198132|39601444|FG001|Overall Study|Lack of Efficacy|3|||
16305305|NCT01198132|39601443|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
16305306|NCT01198132|39601444|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
16305307|NCT01198132|39601443|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
16305308|NCT01198132|39601444|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
16305309|NCT01198132|39601443|FG000|Overall Study|Adverse Event|0|||
16305310|NCT01198132|39601444|FG001|Overall Study|Adverse Event|1|||
16305311|NCT01198132|39601443|FG000|Overall Study|Protocol Violation|1|||
16305312|NCT01198132|39601444|FG001|Overall Study|Protocol Violation|0|||
16305313|NCT01625091|39601445|FG000|Intervention|Death|1|||
16305314|NCT01625091|39601446|FG001|Intervention|Death|1|||
16305315|NCT01625091|39601445|FG000|Intervention|Withdrawal by Subject|4|||
16305316|NCT01625091|39601446|FG001|Intervention|Withdrawal by Subject|1|||
16305317|NCT01625091|39601445|FG000|Intervention|Adverse Event|0|||
16305318|NCT01625091|39601446|FG001|Intervention|Adverse Event|2|||
16305319|NCT01625091|39601445|FG000|Intervention|Lost to Follow-up|4|||
16305320|NCT01625091|39601446|FG001|Intervention|Lost to Follow-up|4|||
16305321|NCT01625091|39601445|FG000|Intervention|Study termination|2|||
16305322|NCT01625091|39601446|FG001|Intervention|Study termination|3|||
16305323|NCT01625091|39601445|FG000|Post-intervention|Death|0|||
16305324|NCT01625091|39601446|FG001|Post-intervention|Death|1|||
16305325|NCT01625091|39601445|FG000|Post-intervention|Lost to Follow-up|2|||
16305326|NCT01625091|39601446|FG001|Post-intervention|Lost to Follow-up|0|||
16305327|NCT01625091|39601445|FG000|Post-intervention|Study termination|2|||
16305328|NCT01625091|39601446|FG001|Post-intervention|Study termination|1|||
16305329|NCT02181790|39601448|FG000|Overall Study|study terminated|2|||
16305330|NCT02181790|39601449|FG001|Overall Study|study terminated|0|||
16305331|NCT04113018|39601450|FG000|Overall Study|Death|2|||
16305332|NCT04113018|39601450|FG000|Overall Study|Lost to Follow-up|1|||
16305333|NCT04113018|39601450|FG000|Overall Study|Still On Study (on study treatment)|24|||
16305334|NCT04113018|39601450|FG000|Overall Study|Still On Study (in follow up)|12|||
16305335|NCT02215967|39601452|FG000|Overall Study|Patient became ineligible for treatment|0|||
16305336|NCT02215967|39601453|FG001|Overall Study|Patient became ineligible for treatment|0|||
16305337|NCT02215967|39601454|FG002|Overall Study|Patient became ineligible for treatment|0|||
16305338|NCT02215967|39601455|FG003|Overall Study|Patient became ineligible for treatment|3|||
16305339|NCT02215967|39601452|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
16305340|NCT02215967|39601453|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
16305341|NCT02215967|39601454|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
16305342|NCT02215967|39601455|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
16305343|NCT01266031|39604825|FG000|Overall Study|Not treated|0|||
16305344|NCT01266031|39604826|FG001|Overall Study|Not treated|3|||
16305345|NCT01266031|39604827|FG002|Overall Study|Not treated|2|||
16305346|NCT02575833|39604831|FG000|Overall Study|Withdrawal by Subject|0|||
16305347|NCT02575833|39604832|FG001|Overall Study|Withdrawal by Subject|1|||
16305348|NCT02575833|39604831|FG000|Overall Study|Lost to Follow-up|1|||
16305349|NCT02575833|39604832|FG001|Overall Study|Lost to Follow-up|0|||
16305350|NCT00887289|39604833|FG000|Overall Study|Lack of Efficacy|14|||
16305351|NCT00887289|39604833|FG000|Overall Study|Adverse Event|27|||
16305352|NCT00887289|39604833|FG000|Overall Study|Withdrawal by Subject|26|||
16305353|NCT00887289|39604833|FG000|Overall Study|Lost to Follow-up|8|||
16305354|NCT00887289|39604833|FG000|Overall Study|Other|20|||
16305355|NCT00595309|39604836|FG000|Overall Study|Lost to Follow-up|1|||
16305356|NCT00595309|39604836|FG000|Overall Study|planned vaccination against yellow fever|1|||
16305357|NCT00595309|39604836|FG000|Overall Study|acute infection after V0|1|||
16305358|NCT00595309|39604836|FG000|Overall Study|personal reason|1|||
16305359|NCT00580788|39604837|FG000|Overall Study|Adverse Event|0|||
16305360|NCT00580788|39604838|FG001|Overall Study|Adverse Event|0|||
16305361|NCT00580788|39604839|FG002|Overall Study|Adverse Event|0|||
16305362|NCT00580788|39604840|FG003|Overall Study|Adverse Event|1|||
16305363|NCT00927589|39604841|FG000|Overall Study|Death|1|||
16305364|NCT00927589|39604841|FG000|Overall Study|Physician Decision|1|||
16305365|NCT00927589|39604841|FG000|Overall Study|Withdrawal by Subject|3|||
16305366|NCT00927589|39604841|FG000|Overall Study|Adverse Event|2|||
16305367|NCT00927589|39604841|FG000|Overall Study|Disease Progression|8|||
16305368|NCT00927589|39604841|FG000|Overall Study|Non-compliance|1|||
16305369|NCT02618759|39604843|FG000|Overall Study|Lost to Follow-up|0|||
16305370|NCT02618759|39604844|FG001|Overall Study|Lost to Follow-up|1|||
16305371|NCT02618759|39604843|FG000|Overall Study|Withdrawal by Subject|1|||
16305372|NCT02618759|39604844|FG001|Overall Study|Withdrawal by Subject|0|||
16305373|NCT02618759|39604843|FG000|Overall Study|Other Reasons|1|||
16305374|NCT02618759|39604844|FG001|Overall Study|Other Reasons|4|||
16305375|NCT00754650|39604858|FG000|Overall Study|Disease Progression|2|||
16305376|NCT01006122|39604863|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
16305377|NCT01006122|39604864|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
16305378|NCT01006122|39604863|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
16305379|NCT01006122|39604864|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
16305380|NCT01006122|39604863|FG000|First Double-blind Intervention Period|Pregnancy|0|||
16305381|NCT01006122|39604864|FG001|First Double-blind Intervention Period|Pregnancy|1|||
16305382|NCT01006122|39604863|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
16305383|NCT01006122|39604864|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
16305384|NCT01006122|39604863|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
16305385|NCT01006122|39604864|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
16305386|NCT01006122|39604863|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
16305387|NCT01006122|39604864|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
16305388|NCT01006122|39604863|FG000|First Double-blind Intervention Period|Other|3|||
16305389|NCT01006122|39604864|FG001|First Double-blind Intervention Period|Other|0|||
16305390|NCT01006122|39604863|FG000|First Double-blind Intervention Period|Adverse Event|0|||
16305391|NCT01006122|39604864|FG001|First Double-blind Intervention Period|Adverse Event|4|||
16305392|NCT01006122|39604863|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
16305393|NCT01006122|39604864|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
16305394|NCT01006122|39604863|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
16305395|NCT01006122|39604864|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
16305396|NCT01006122|39604863|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
16305397|NCT01006122|39604864|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
16305398|NCT01006122|39604863|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
16305399|NCT01006122|39604864|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
16305400|NCT01006122|39604863|FG000|Second Double-blind Intervention Period|Death|0|||
16305401|NCT01006122|39604864|FG001|Second Double-blind Intervention Period|Death|1|||
16305402|NCT03052751|39604865|FG000|Dosing Period 1|Adverse Event|0|||
16305403|NCT03052751|39604866|FG001|Dosing Period 1|Adverse Event|1|||
16305404|NCT03052751|39604867|FG002|Dosing Period 1|Adverse Event|0|||
16305405|NCT03052751|39604868|FG003|Dosing Period 1|Adverse Event|0|||
16305406|NCT03052751|39604869|FG004|Dosing Period 1|Adverse Event|0|||
16305407|NCT03052751|39604870|FG005|Dosing Period 1|Adverse Event|0|||
16305408|NCT03052751|39604865|FG000|Dosing Period 2|Adverse Event|0|||
16305409|NCT03052751|39604866|FG001|Dosing Period 2|Adverse Event|0|||
16305410|NCT03052751|39604867|FG002|Dosing Period 2|Adverse Event|3|||
16305411|NCT03052751|39604868|FG003|Dosing Period 2|Adverse Event|0|||
16305412|NCT03052751|39604869|FG004|Dosing Period 2|Adverse Event|0|||
16305413|NCT03052751|39604870|FG005|Dosing Period 2|Adverse Event|0|||
16305414|NCT03052751|39604865|FG000|Observation Period|Adverse Event|0|||
16305415|NCT03052751|39604866|FG001|Observation Period|Adverse Event|0|||
16305416|NCT03052751|39604867|FG002|Observation Period|Adverse Event|0|||
16305417|NCT03052751|39604868|FG003|Observation Period|Adverse Event|0|||
16305418|NCT03052751|39604869|FG004|Observation Period|Adverse Event|1|||
16305419|NCT03052751|39604870|FG005|Observation Period|Adverse Event|0|||
16305420|NCT03257865|39604873|FG000|Overall Study|Adverse Event|4|||
16305421|NCT03257865|39604874|FG001|Overall Study|Adverse Event|8|||
16305422|NCT03257865|39604873|FG000|Overall Study|Lack of Efficacy|1|||
16305423|NCT03257865|39604874|FG001|Overall Study|Lack of Efficacy|2|||
16305424|NCT03257865|39604873|FG000|Overall Study|Non-compliance with Study Drug|0|||
16305425|NCT03257865|39604874|FG001|Overall Study|Non-compliance with Study Drug|2|||
16305426|NCT03257865|39604873|FG000|Overall Study|Withdrawal by Subject|23|||
16305427|NCT03257865|39604874|FG001|Overall Study|Withdrawal by Subject|17|||
16305428|NCT03257865|39604873|FG000|Overall Study|Physician Decision|3|||
16305429|NCT03257865|39604874|FG001|Overall Study|Physician Decision|1|||
16305430|NCT03257865|39604873|FG000|Overall Study|Other|0|||
16305431|NCT03257865|39604874|FG001|Overall Study|Other|1|||
16305432|NCT03257865|39604873|FG000|Overall Study|Lost to Follow-up|4|||
16193599|NCT01963208|39188584|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
16305433|NCT03257865|39604874|FG001|Overall Study|Lost to Follow-up|4|||
16305434|NCT02681510|39604876|FG000|Overall Study|Withdrawal by Subject|1|||
16305435|NCT02681510|39604876|FG000|Overall Study|Lost to Follow-up|9|||
16305436|NCT04289363|39604877|FG000|Overall Study|Lost to Follow-up|14|||
16305437|NCT04289363|39604878|FG001|Overall Study|Lost to Follow-up|0|||
16305438|NCT02952586|39604886|FG000|Lead-In Phase (7 Days)|Death|0|||
16305439|NCT02952586|39604887|FG001|Lead-In Phase (7 Days)|Death|1|||
16305440|NCT02952586|39604886|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
16305441|NCT02952586|39604887|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
16305442|NCT02952586|39604886|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
16305443|NCT02952586|39604887|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
16305444|NCT02952586|39604886|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
16305445|NCT02952586|39604887|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
16305446|NCT02952586|39604886|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
16305447|NCT02952586|39604887|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
16305448|NCT02952586|39604886|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
16305449|NCT02952586|39604887|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
16305450|NCT02952586|39604886|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
16305451|NCT02952586|39604887|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
16305452|NCT02952586|39604886|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
16305453|NCT02952586|39604887|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
16305454|NCT02952586|39604886|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
16305455|NCT02952586|39604887|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
16305456|NCT02952586|39604886|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
16305457|NCT02952586|39604887|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
16305458|NCT02952586|39604886|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
16305459|NCT02952586|39604887|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
16305460|NCT02952586|39604886|FG000|CRT for Cisplatin (63 Days)|Death|3|||
16305461|NCT02952586|39604887|FG001|CRT for Cisplatin (63 Days)|Death|8|||
16305462|NCT02952586|39604886|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
16305463|NCT02952586|39604887|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
16305464|NCT02952586|39604886|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
16305465|NCT02952586|39604887|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
16305466|NCT02952586|39604886|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
16305467|NCT02952586|39604887|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
16305468|NCT02952586|39604886|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
16305469|NCT02952586|39604887|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
16305470|NCT02952586|39604886|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
16305471|NCT02952586|39604887|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
16305472|NCT02952586|39604886|FG000|CRT for Cisplatin (63 Days)|Other|1|||
16305473|NCT02952586|39604887|FG001|CRT for Cisplatin (63 Days)|Other|1|||
16305474|NCT02952586|39604886|FG000|CRT for IMRT (63 Days)|Death|5|||
16305475|NCT02952586|39604887|FG001|CRT for IMRT (63 Days)|Death|8|||
16305476|NCT02952586|39604886|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
16305477|NCT02952586|39604887|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
16305478|NCT02952586|39604886|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
16305479|NCT02952586|39604887|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
16305480|NCT02952586|39604886|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
16305481|NCT02952586|39604887|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
16305482|NCT02952586|39604886|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
16305483|NCT02952586|39604887|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
16305484|NCT02952586|39604886|FG000|CRT for IMRT (63 Days)|Other|1|||
16305485|NCT02952586|39604887|FG001|CRT for IMRT (63 Days)|Other|0|||
16305486|NCT02952586|39604886|FG000|Maintenance Phase (12 Months)|Death|17|||
16305487|NCT02952586|39604887|FG001|Maintenance Phase (12 Months)|Death|11|||
16305488|NCT02952586|39604886|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
16305489|NCT02952586|39604887|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
16305490|NCT02952586|39604886|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
16305491|NCT02952586|39604887|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
16305492|NCT02952586|39604886|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
16305493|NCT02952586|39604887|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
16305494|NCT02952586|39604886|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
16305495|NCT02952586|39604887|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
16305496|NCT02952586|39604886|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
16305497|NCT02952586|39604887|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
16305498|NCT02952586|39604886|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
16305499|NCT02952586|39604887|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
16305500|NCT02952586|39604886|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
16305501|NCT02952586|39604887|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
16305502|NCT02952586|39604886|FG000|Maintenance Phase (12 Months)|Other|2|||
16305503|NCT02952586|39604887|FG001|Maintenance Phase (12 Months)|Other|1|||
16305504|NCT02952586|39604886|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
16305505|NCT02952586|39604887|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
16305506|NCT02952586|39604886|FG000|Follow-Up Phase (90 Days)|Death|12|||
16305507|NCT02952586|39604887|FG001|Follow-Up Phase (90 Days)|Death|10|||
16305508|NCT02952586|39604886|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
16305509|NCT02952586|39604887|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
16305510|NCT02952586|39604886|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
16305511|NCT02952586|39604887|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
16493530|NCT00743340|40276610|FG000|Overall Study|Rolled over to other Gilead Study|23|||
16493531|NCT00743340|40276610|FG000|Overall Study|Participant Relocated|1|||
16493532|NCT01906008|40280763|FG000|Overall Study|Lost to Follow-up|2|||
16493533|NCT01906008|40280764|FG001|Overall Study|Lost to Follow-up|0|||
16493534|NCT01906008|40280763|FG000|Overall Study|Oxaliplatin toxicity|2|||
16493535|NCT01906008|40280764|FG001|Overall Study|Oxaliplatin toxicity|0|||
16493536|NCT01906008|40280763|FG000|Overall Study|Protocol Violation|0|||
16493537|NCT01906008|40280764|FG001|Overall Study|Protocol Violation|1|||
16493538|NCT01906008|40280763|FG000|Overall Study|Withdrawal by Subject|1|||
16493539|NCT01906008|40280764|FG001|Overall Study|Withdrawal by Subject|5|||
16493540|NCT01906008|40280763|FG000|Overall Study|Did not start study med|3|||
16493541|NCT01906008|40280764|FG001|Overall Study|Did not start study med|4|||
16493542|NCT01906008|40280763|FG000|Overall Study|Oxaliplatin stops|10|||
16493543|NCT01906008|40280764|FG001|Overall Study|Oxaliplatin stops|8|||
16193600|NCT01963208|39188585|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
16193601|NCT01963208|39188586|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
16193602|NCT01963208|39188581|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
16193603|NCT01963208|39188582|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
16193604|NCT01963208|39188583|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
16193605|NCT01963208|39188584|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
16193606|NCT01963208|39188585|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
16193607|NCT01963208|39188586|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
16193608|NCT01963208|39188581|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
16193609|NCT01963208|39188582|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
16193610|NCT01963208|39188583|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
16193611|NCT01963208|39188584|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
16193612|NCT01963208|39188585|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
16193613|NCT01963208|39188586|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
16193614|NCT01963208|39188581|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
16193615|NCT01963208|39188582|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
16193616|NCT01963208|39188583|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
16193617|NCT01963208|39188584|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
16193618|NCT01963208|39188585|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
16193619|NCT01963208|39188586|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
16193620|NCT01963208|39188581|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
16193621|NCT01963208|39188582|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
16493544|NCT01906008|40280763|FG000|Overall Study|Hospice|1|||
16493545|NCT01906008|40280764|FG001|Overall Study|Hospice|0|||
16305512|NCT02952586|39604886|FG000|Follow-Up Phase (90 Days)|Other|7|||
16305513|NCT02952586|39604887|FG001|Follow-Up Phase (90 Days)|Other|5|||
16305514|NCT02952586|39604886|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
16305515|NCT02952586|39604887|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
16305516|NCT02952586|39604886|FG000|LT Follow-up (up to 45 Months)|Death|51|||
16305517|NCT02952586|39604887|FG001|LT Follow-up (up to 45 Months)|Death|31|||
16305518|NCT02952586|39604886|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
16305519|NCT02952586|39604887|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
16305520|NCT02952586|39604886|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
16305521|NCT02952586|39604887|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
16305522|NCT02952586|39604886|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
16305523|NCT02952586|39604887|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
16305524|NCT02481869|39604888|FG000|Overall Study|Lost to Follow-up|3|||
16305525|NCT02481869|39604889|FG001|Overall Study|Lost to Follow-up|4|||
16305526|NCT02481869|39604888|FG000|Overall Study|Withdrawal by Subject|2|||
16305527|NCT02481869|39604889|FG001|Overall Study|Withdrawal by Subject|0|||
16305528|NCT01308424|39604890|FG000|Baseline Eligibility|Screen Failures|71|||
16388166|NCT04819113|39905579|FG000|Overall Study|Withdrawal by parent/guardian|3|||
16193622|NCT01963208|39188583|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
16305529|NCT01308424|39604891|FG001|Baseline Eligibility|Screen Failures|0|||
16305530|NCT01308424|39604892|FG002|Baseline Eligibility|Screen Failures|0|||
16305531|NCT01308424|39604890|FG000|Randomization|Adverse Event|0|||
16305532|NCT01308424|39604891|FG001|Randomization|Adverse Event|1|||
16493546|NCT01906008|40280763|FG000|Overall Study|Physician Decision|3|||
16305533|NCT01308424|39604892|FG002|Randomization|Adverse Event|1|||
16305534|NCT01308424|39604890|FG000|Randomization|Lost to Follow-up|0|||
16305535|NCT01308424|39604891|FG001|Randomization|Lost to Follow-up|1|||
16305536|NCT01308424|39604892|FG002|Randomization|Lost to Follow-up|0|||
16305537|NCT01308424|39604890|FG000|Randomization|Physician Decision|0|||
16305538|NCT01308424|39604891|FG001|Randomization|Physician Decision|1|||
16305539|NCT01308424|39604892|FG002|Randomization|Physician Decision|1|||
16305540|NCT03775486|39604894|FG000|Initial Therapy Phase|Other reason provided|0|||
16305541|NCT03775486|39604895|FG001|Initial Therapy Phase|Other reason provided|15|||
16305542|NCT03775486|39604894|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
16305543|NCT03775486|39604895|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
16305544|NCT03775486|39604894|FG000|Initial Therapy Phase|Protocol Violation|0|||
16305545|NCT03775486|39604895|FG001|Initial Therapy Phase|Protocol Violation|2|||
16305546|NCT03775486|39604894|FG000|Initial Therapy Phase|Adverse Event|0|||
16305547|NCT03775486|39604895|FG001|Initial Therapy Phase|Adverse Event|34|||
16305548|NCT03775486|39604894|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
16305549|NCT03775486|39604895|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
16305550|NCT03775486|39604894|FG000|Maintenance Phase|Withdrawal by Subject|13|||
16305551|NCT03775486|39604895|FG001|Maintenance Phase|Withdrawal by Subject|12|||
16305552|NCT03775486|39604894|FG000|Maintenance Phase|Death|44|||
16305553|NCT03775486|39604895|FG001|Maintenance Phase|Death|45|||
16305554|NCT01108718|39604896|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
16305555|NCT01108718|39604897|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
16305556|NCT00477633|39604898|FG000|Overall Study|Did not receive treatment|23|||
16305557|NCT00477633|39604898|FG000|Overall Study|Adverse Event|143|||
16305558|NCT00477633|39604898|FG000|Overall Study|Pregnancy|23|||
16305559|NCT00477633|39604898|FG000|Overall Study|Lost to Follow-up|271|||
16305560|NCT00477633|39604898|FG000|Overall Study|Withdrawal by Subject|149|||
16305561|NCT00477633|39604898|FG000|Overall Study|Protocol Violation|25|||
16305562|NCT00477633|39604898|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
16305563|NCT01197534|39604899|FG000|Overall Study|Not reported|16|||
16305564|NCT01197534|39604900|FG001|Overall Study|Not reported|10|||
16305565|NCT01197534|39604901|FG002|Overall Study|Not reported|16|||
16305566|NCT01197534|39604899|FG000|Overall Study|Enrolment in long term extension|57|||
16305567|NCT01197534|39604900|FG001|Overall Study|Enrolment in long term extension|66|||
16305568|NCT01197534|39604901|FG002|Overall Study|Enrolment in long term extension|119|||
16305569|NCT01197534|39604899|FG000|Overall Study|Severe non-compliance to protocol|3|||
16305570|NCT01197534|39604900|FG001|Overall Study|Severe non-compliance to protocol|4|||
16305571|NCT01197534|39604901|FG002|Overall Study|Severe non-compliance to protocol|1|||
16305572|NCT01197534|39604899|FG000|Overall Study|Lack of therapeutic response|9|||
16305573|NCT01197534|39604900|FG001|Overall Study|Lack of therapeutic response|4|||
16305574|NCT01197534|39604901|FG002|Overall Study|Lack of therapeutic response|9|||
16305575|NCT01197534|39604899|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
16305576|NCT01197534|39604900|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
16305577|NCT01197534|39604901|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
16305578|NCT01197534|39604899|FG000|Overall Study|Lost to Follow-up|1|||
16305579|NCT01197534|39604900|FG001|Overall Study|Lost to Follow-up|4|||
16305580|NCT01197534|39604901|FG002|Overall Study|Lost to Follow-up|2|||
16305581|NCT01197534|39604899|FG000|Overall Study|Adverse Event|35|||
16493547|NCT01906008|40280764|FG001|Overall Study|Physician Decision|3|||
16493548|NCT01906008|40280763|FG000|Overall Study|Lack of compliance of study med|5|||
16493549|NCT01906008|40280764|FG001|Overall Study|Lack of compliance of study med|3|||
16493550|NCT01906008|40280763|FG000|Overall Study|Adverse Event|0|||
16493551|NCT01906008|40280764|FG001|Overall Study|Adverse Event|3|||
16493552|NCT02760069|40280765|FG000|Overall Study|Withdrawal by Subject|0|||
16493553|NCT02760069|40280766|FG001|Overall Study|Withdrawal by Subject|1|||
16305582|NCT01197534|39604900|FG001|Overall Study|Adverse Event|36|||
16305583|NCT01197534|39604901|FG002|Overall Study|Adverse Event|24|||
16305584|NCT00742209|39604903|FG000|Overall Study|Adverse Event|11|||
16305585|NCT00742209|39604904|FG001|Overall Study|Adverse Event|4|||
16305586|NCT00742209|39604905|FG002|Overall Study|Adverse Event|17|||
16305587|NCT00742209|39604906|FG003|Overall Study|Adverse Event|16|||
16305588|NCT00742209|39604907|FG004|Overall Study|Adverse Event|13|||
16305589|NCT00742209|39604903|FG000|Overall Study|Participant Withdrew Consent|8|||
16305590|NCT00742209|39604904|FG001|Overall Study|Participant Withdrew Consent|4|||
16305591|NCT00742209|39604905|FG002|Overall Study|Participant Withdrew Consent|14|||
16305592|NCT00742209|39604906|FG003|Overall Study|Participant Withdrew Consent|7|||
16305593|NCT00742209|39604907|FG004|Overall Study|Participant Withdrew Consent|4|||
16305594|NCT00742209|39604903|FG000|Overall Study|Protocol Violation|6|||
16305595|NCT00742209|39604904|FG001|Overall Study|Protocol Violation|5|||
16305596|NCT00742209|39604905|FG002|Overall Study|Protocol Violation|4|||
16305597|NCT00742209|39604906|FG003|Overall Study|Protocol Violation|5|||
16305598|NCT00742209|39604907|FG004|Overall Study|Protocol Violation|3|||
16305599|NCT00742209|39604903|FG000|Overall Study|Lost to Follow-up|3|||
16493554|NCT02760069|40280767|FG002|Overall Study|Withdrawal by Subject|1|||
16493555|NCT02825992|40280768|FG000|Overall Study|Withdrawal by Subject|4|||
16493556|NCT02825992|40280768|FG000|Overall Study|Lost to Follow-up|2|||
16305600|NCT00742209|39604904|FG001|Overall Study|Lost to Follow-up|4|||
16305601|NCT00742209|39604905|FG002|Overall Study|Lost to Follow-up|5|||
16493557|NCT02825992|40280768|FG000|Overall Study|Procedure terminated|2|||
16493558|NCT00203996|40280769|FG000|Overall Study|Lost to Follow-up|0|||
16493559|NCT00203996|40280770|FG001|Overall Study|Lost to Follow-up|0|||
16493560|NCT00203996|40280771|FG002|Overall Study|Lost to Follow-up|0|||
16493561|NCT00203996|40280772|FG003|Overall Study|Lost to Follow-up|1|||
16493562|NCT00203996|40280773|FG004|Overall Study|Lost to Follow-up|0|||
16493563|NCT00203996|40280774|FG005|Overall Study|Lost to Follow-up|0|||
16493564|NCT00203996|40280775|FG006|Overall Study|Lost to Follow-up|0|||
16493565|NCT00203996|40280776|FG007|Overall Study|Lost to Follow-up|0|||
16493566|NCT00203996|40280777|FG008|Overall Study|Lost to Follow-up|0|||
16493567|NCT00203996|40280778|FG009|Overall Study|Lost to Follow-up|0|||
16493568|NCT00203996|40280769|FG000|Overall Study|Protocol Violation|0|||
16493569|NCT00203996|40280770|FG001|Overall Study|Protocol Violation|0|||
16493570|NCT00203996|40280771|FG002|Overall Study|Protocol Violation|0|||
16493571|NCT00203996|40280772|FG003|Overall Study|Protocol Violation|6|||
16493572|NCT00203996|40280773|FG004|Overall Study|Protocol Violation|1|||
16493573|NCT00203996|40280774|FG005|Overall Study|Protocol Violation|0|||
16493574|NCT00203996|40280775|FG006|Overall Study|Protocol Violation|0|||
16493575|NCT00203996|40280776|FG007|Overall Study|Protocol Violation|0|||
16493576|NCT00203996|40280777|FG008|Overall Study|Protocol Violation|0|||
16493577|NCT00203996|40280778|FG009|Overall Study|Protocol Violation|0|||
16493578|NCT00203996|40280769|FG000|Overall Study|Physician Decision|0|||
16493579|NCT00203996|40280770|FG001|Overall Study|Physician Decision|0|||
16493580|NCT00203996|40280771|FG002|Overall Study|Physician Decision|0|||
16493581|NCT00203996|40280772|FG003|Overall Study|Physician Decision|2|||
16493582|NCT00203996|40280773|FG004|Overall Study|Physician Decision|0|||
16493583|NCT00203996|40280774|FG005|Overall Study|Physician Decision|0|||
16493584|NCT00203996|40280775|FG006|Overall Study|Physician Decision|0|||
16493585|NCT00203996|40280776|FG007|Overall Study|Physician Decision|0|||
16493586|NCT00203996|40280777|FG008|Overall Study|Physician Decision|0|||
16493587|NCT00203996|40280778|FG009|Overall Study|Physician Decision|1|||
16493588|NCT00203996|40280769|FG000|Overall Study|CPAP machine malfunction|0|||
16493589|NCT00203996|40280770|FG001|Overall Study|CPAP machine malfunction|0|||
16493590|NCT00203996|40280771|FG002|Overall Study|CPAP machine malfunction|0|||
16493591|NCT00203996|40280772|FG003|Overall Study|CPAP machine malfunction|1|||
16493592|NCT00203996|40280773|FG004|Overall Study|CPAP machine malfunction|0|||
16493593|NCT00203996|40280774|FG005|Overall Study|CPAP machine malfunction|0|||
16493594|NCT00203996|40280775|FG006|Overall Study|CPAP machine malfunction|0|||
16493595|NCT00203996|40280776|FG007|Overall Study|CPAP machine malfunction|0|||
16493596|NCT00203996|40280777|FG008|Overall Study|CPAP machine malfunction|0|||
16493597|NCT00203996|40280778|FG009|Overall Study|CPAP machine malfunction|0|||
16493598|NCT00203996|40280769|FG000|Overall Study|Scheduling issue|0|||
16493599|NCT00203996|40280770|FG001|Overall Study|Scheduling issue|0|||
16493600|NCT00203996|40280771|FG002|Overall Study|Scheduling issue|0|||
16493601|NCT00203996|40280772|FG003|Overall Study|Scheduling issue|0|||
16493602|NCT00203996|40280773|FG004|Overall Study|Scheduling issue|0|||
16493603|NCT00203996|40280774|FG005|Overall Study|Scheduling issue|0|||
16493604|NCT00203996|40280775|FG006|Overall Study|Scheduling issue|0|||
16493605|NCT00203996|40280776|FG007|Overall Study|Scheduling issue|2|||
16493606|NCT00203996|40280777|FG008|Overall Study|Scheduling issue|0|||
16493607|NCT00203996|40280778|FG009|Overall Study|Scheduling issue|0|||
16493608|NCT01714635|40280781|FG000|Overall Study|Discontinued|1|||
16493609|NCT01714635|40280782|FG001|Overall Study|Discontinued|0|||
16305602|NCT00742209|39604906|FG003|Overall Study|Lost to Follow-up|5|||
16305603|NCT00742209|39604907|FG004|Overall Study|Lost to Follow-up|3|||
16305604|NCT00742209|39604903|FG000|Overall Study|Lack of Efficacy|6|||
16305605|NCT00742209|39604904|FG001|Overall Study|Lack of Efficacy|1|||
16305606|NCT00742209|39604905|FG002|Overall Study|Lack of Efficacy|1|||
16305607|NCT00742209|39604906|FG003|Overall Study|Lack of Efficacy|3|||
16305608|NCT00742209|39604907|FG004|Overall Study|Lack of Efficacy|1|||
16493610|NCT01714635|40280783|FG002|Overall Study|Discontinued|2|||
16493611|NCT01714635|40280781|FG000|Overall Study|Missed 6-month exam|1|||
16493612|NCT01714635|40280782|FG001|Overall Study|Missed 6-month exam|0|||
16493613|NCT01714635|40280783|FG002|Overall Study|Missed 6-month exam|0|||
16493614|NCT01340027|40280784|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
16493615|NCT01340027|40280785|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
16493616|NCT01340027|40280786|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
16493617|NCT01340027|40280787|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
16493618|NCT01340027|40280788|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
16493619|NCT01340027|40280789|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
16493620|NCT01340027|40280790|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
16493621|NCT01340027|40280791|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
16493622|NCT01340027|40280792|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
16305609|NCT00742209|39604903|FG000|Overall Study|Investigator Discretion|0|||
16493623|NCT01340027|40280793|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
16493624|NCT01340027|40280794|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
16493625|NCT01340027|40280795|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
16493626|NCT01340027|40280784|FG000|Overall Study|Adverse Event|0|||
16493627|NCT01340027|40280785|FG001|Overall Study|Adverse Event|1|||
16493628|NCT01340027|40280786|FG002|Overall Study|Adverse Event|2|||
16493629|NCT01340027|40280787|FG003|Overall Study|Adverse Event|0|||
16493630|NCT01340027|40280788|FG004|Overall Study|Adverse Event|1|||
16493631|NCT01340027|40280789|FG005|Overall Study|Adverse Event|2|||
16493632|NCT01340027|40280790|FG006|Overall Study|Adverse Event|2|||
16493633|NCT01340027|40280791|FG007|Overall Study|Adverse Event|1|||
16493634|NCT01340027|40280792|FG008|Overall Study|Adverse Event|4|||
16493635|NCT01340027|40280793|FG009|Overall Study|Adverse Event|1|||
16493636|NCT01340027|40280794|FG010|Overall Study|Adverse Event|1|||
16493637|NCT01340027|40280795|FG011|Overall Study|Adverse Event|3|||
16493638|NCT01340027|40280784|FG000|Overall Study|Lack of Efficacy|0|||
16493639|NCT01340027|40280785|FG001|Overall Study|Lack of Efficacy|0|||
16493640|NCT01340027|40280786|FG002|Overall Study|Lack of Efficacy|0|||
16493641|NCT01340027|40280787|FG003|Overall Study|Lack of Efficacy|0|||
16493642|NCT01340027|40280788|FG004|Overall Study|Lack of Efficacy|0|||
16493643|NCT01340027|40280789|FG005|Overall Study|Lack of Efficacy|0|||
16493644|NCT01340027|40280790|FG006|Overall Study|Lack of Efficacy|1|||
16493645|NCT01340027|40280791|FG007|Overall Study|Lack of Efficacy|1|||
16493646|NCT01340027|40280792|FG008|Overall Study|Lack of Efficacy|1|||
16493647|NCT01340027|40280793|FG009|Overall Study|Lack of Efficacy|0|||
16493648|NCT01340027|40280794|FG010|Overall Study|Lack of Efficacy|0|||
16493649|NCT01340027|40280795|FG011|Overall Study|Lack of Efficacy|0|||
16493650|NCT01340027|40280784|FG000|Overall Study|Lost to Follow-up|0|||
16493651|NCT01340027|40280785|FG001|Overall Study|Lost to Follow-up|1|||
16493652|NCT01340027|40280786|FG002|Overall Study|Lost to Follow-up|0|||
16493653|NCT01340027|40280787|FG003|Overall Study|Lost to Follow-up|0|||
16493654|NCT01340027|40280788|FG004|Overall Study|Lost to Follow-up|0|||
16493655|NCT01340027|40280789|FG005|Overall Study|Lost to Follow-up|0|||
16493656|NCT01340027|40280790|FG006|Overall Study|Lost to Follow-up|1|||
16493657|NCT01340027|40280791|FG007|Overall Study|Lost to Follow-up|0|||
16493658|NCT01340027|40280792|FG008|Overall Study|Lost to Follow-up|0|||
16493659|NCT01340027|40280793|FG009|Overall Study|Lost to Follow-up|1|||
16493660|NCT01340027|40280794|FG010|Overall Study|Lost to Follow-up|0|||
16493661|NCT01340027|40280795|FG011|Overall Study|Lost to Follow-up|0|||
16493662|NCT01340027|40280784|FG000|Overall Study|Protocol Violation|1|||
16493663|NCT01340027|40280785|FG001|Overall Study|Protocol Violation|2|||
16493664|NCT01340027|40280786|FG002|Overall Study|Protocol Violation|0|||
16493665|NCT01340027|40280787|FG003|Overall Study|Protocol Violation|0|||
16493666|NCT01340027|40280788|FG004|Overall Study|Protocol Violation|6|||
16493667|NCT01340027|40280789|FG005|Overall Study|Protocol Violation|0|||
16493668|NCT01340027|40280790|FG006|Overall Study|Protocol Violation|0|||
16493669|NCT01340027|40280791|FG007|Overall Study|Protocol Violation|1|||
16493670|NCT01340027|40280792|FG008|Overall Study|Protocol Violation|2|||
16493671|NCT01340027|40280793|FG009|Overall Study|Protocol Violation|2|||
16493672|NCT01340027|40280794|FG010|Overall Study|Protocol Violation|0|||
16493673|NCT01340027|40280795|FG011|Overall Study|Protocol Violation|0|||
16493674|NCT01340027|40280784|FG000|Overall Study|Withdrawal by Subject|4|||
16493675|NCT01340027|40280785|FG001|Overall Study|Withdrawal by Subject|3|||
16493676|NCT01340027|40280786|FG002|Overall Study|Withdrawal by Subject|1|||
16493677|NCT01340027|40280787|FG003|Overall Study|Withdrawal by Subject|3|||
16493678|NCT01340027|40280788|FG004|Overall Study|Withdrawal by Subject|3|||
16493679|NCT01340027|40280789|FG005|Overall Study|Withdrawal by Subject|2|||
16493680|NCT01340027|40280790|FG006|Overall Study|Withdrawal by Subject|3|||
16493681|NCT01340027|40280791|FG007|Overall Study|Withdrawal by Subject|4|||
16493682|NCT01340027|40280792|FG008|Overall Study|Withdrawal by Subject|1|||
16493683|NCT01340027|40280793|FG009|Overall Study|Withdrawal by Subject|2|||
16493684|NCT01340027|40280794|FG010|Overall Study|Withdrawal by Subject|0|||
16493685|NCT01340027|40280795|FG011|Overall Study|Withdrawal by Subject|1|||
16493686|NCT01340027|40280784|FG000|Overall Study|Miscellaneous|0|||
16493687|NCT01340027|40280785|FG001|Overall Study|Miscellaneous|0|||
16493688|NCT01340027|40280786|FG002|Overall Study|Miscellaneous|0|||
16493689|NCT01340027|40280787|FG003|Overall Study|Miscellaneous|1|||
16493690|NCT01340027|40280788|FG004|Overall Study|Miscellaneous|0|||
16493691|NCT01340027|40280789|FG005|Overall Study|Miscellaneous|0|||
16493692|NCT01340027|40280790|FG006|Overall Study|Miscellaneous|0|||
16493693|NCT01340027|40280791|FG007|Overall Study|Miscellaneous|0|||
16493694|NCT01340027|40280792|FG008|Overall Study|Miscellaneous|0|||
16493695|NCT01340027|40280793|FG009|Overall Study|Miscellaneous|0|||
16493696|NCT01340027|40280794|FG010|Overall Study|Miscellaneous|1|||
16493697|NCT01340027|40280795|FG011|Overall Study|Miscellaneous|0|||
16493698|NCT02057406|40280796|FG000|Overall Study|Physician Decision|0|||
16493699|NCT02057406|40280797|FG001|Overall Study|Physician Decision|0|||
16493700|NCT02057406|40280798|FG002|Overall Study|Physician Decision|2|||
16493701|NCT02057406|40280796|FG000|Overall Study|Withdrawal by Subject|0|||
16084793|NCT00887224|38802570|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
16084794|NCT00887224|38802571|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
16084795|NCT00887224|38802572|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
16084796|NCT00887224|38802570|FG000|Open-label Response (OLR) Phase|Other|1|||
16084797|NCT00887224|38802571|FG001|Open-label Response (OLR) Phase|Other|0|||
16084798|NCT00887224|38802572|FG002|Open-label Response (OLR) Phase|Other|0|||
16084799|NCT00887224|38802570|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
16084800|NCT00887224|38802571|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
16084801|NCT00887224|38802572|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
16305610|NCT00742209|39604904|FG001|Overall Study|Investigator Discretion|0|||
16305611|NCT00742209|39604905|FG002|Overall Study|Investigator Discretion|5|||
16305612|NCT00742209|39604906|FG003|Overall Study|Investigator Discretion|1|||
16305613|NCT00742209|39604907|FG004|Overall Study|Investigator Discretion|1|||
16305614|NCT00489255|39604908|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
16305615|NCT00489255|39604909|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
16305616|NCT00489255|39604908|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
16305617|NCT00489255|39604909|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
16305618|NCT00489255|39604908|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
16305619|NCT00489255|39604909|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
16305620|NCT00489255|39604908|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
16305621|NCT00489255|39604909|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
16305622|NCT00489255|39604908|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
16305623|NCT00489255|39604909|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
16305624|NCT00489255|39604908|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
16305625|NCT00489255|39604909|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
16305626|NCT00489255|39604908|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
16305627|NCT00489255|39604909|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
16305628|NCT00489255|39604908|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
16305629|NCT00489255|39604909|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
16305630|NCT00489255|39604908|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
16305631|NCT00489255|39604909|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
16305632|NCT00489255|39604908|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
16305633|NCT00489255|39604909|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
16305634|NCT01560416|39604912|FG000|Randomized Phase|Crossover Participants|7|||
16305635|NCT01560416|39604913|FG001|Randomized Phase|Crossover Participants|0|||
16305636|NCT01256502|39604914|FG000|Overall Study|Had scaffold removed|4|||
16305637|NCT01256502|39604914|FG000|Overall Study|Personal reasons|5|||
16305638|NCT01256502|39604914|FG000|Overall Study|Protocol deviation|1|||
16305639|NCT01399658|39604915|FG000|Overall Study|Ineligible|1|||
16305640|NCT01399658|39604915|FG000|Overall Study|Machine Technical Issue|3|||
16305641|NCT01399658|39604915|FG000|Overall Study|Alternative therapy|1|||
16305642|NCT01399658|39604915|FG000|Overall Study|No reason given|1|||
16305643|NCT03410056|39604919|FG000|Overall Study|Decision by Sponsor|0|||
16305644|NCT03410056|39604920|FG001|Overall Study|Decision by Sponsor|0|||
16305645|NCT03410056|39604921|FG002|Overall Study|Decision by Sponsor|3|||
16305646|NCT03410056|39604922|FG003|Overall Study|Decision by Sponsor|0|||
16305647|NCT03410056|39604923|FG004|Overall Study|Decision by Sponsor|0|||
16305648|NCT03410056|39604924|FG005|Overall Study|Decision by Sponsor|0|||
16305649|NCT03410056|39604925|FG006|Overall Study|Decision by Sponsor|0|||
16305650|NCT03410056|39604919|FG000|Overall Study|Withdrawal by Subject|0|||
16305651|NCT03410056|39604920|FG001|Overall Study|Withdrawal by Subject|2|||
16305652|NCT03410056|39604921|FG002|Overall Study|Withdrawal by Subject|5|||
16305653|NCT03410056|39604922|FG003|Overall Study|Withdrawal by Subject|5|||
16305654|NCT03410056|39604923|FG004|Overall Study|Withdrawal by Subject|0|||
16305655|NCT03410056|39604924|FG005|Overall Study|Withdrawal by Subject|0|||
16305656|NCT03410056|39604925|FG006|Overall Study|Withdrawal by Subject|0|||
16305657|NCT01027702|39604926|FG000|Overall Study|Received subsequent therapy|1|||
16305658|NCT01027702|39604927|FG001|Overall Study|Received subsequent therapy|2|||
16305659|NCT01027702|39604928|FG002|Overall Study|Received subsequent therapy|0|||
16305660|NCT01027702|39604929|FG003|Overall Study|Received subsequent therapy|4|||
16305661|NCT01027702|39604930|FG004|Overall Study|Received subsequent therapy|1|||
16305662|NCT01027702|39604931|FG005|Overall Study|Received subsequent therapy|0|||
16305663|NCT01027702|39604932|FG006|Overall Study|Received subsequent therapy|1|||
16305664|NCT01027702|39604926|FG000|Overall Study|Death|0|||
16305665|NCT01027702|39604927|FG001|Overall Study|Death|0|||
16305666|NCT01027702|39604928|FG002|Overall Study|Death|1|||
16305667|NCT01027702|39604929|FG003|Overall Study|Death|0|||
16305668|NCT01027702|39604930|FG004|Overall Study|Death|0|||
16305669|NCT01027702|39604931|FG005|Overall Study|Death|0|||
16305670|NCT01027702|39604932|FG006|Overall Study|Death|0|||
16305671|NCT00770328|39604933|FG000|Overall Study|Adverse Event|11|||
16305672|NCT00770328|39604934|FG001|Overall Study|Adverse Event|2|||
16305673|NCT00770328|39604933|FG000|Overall Study|Lost to Follow-up|2|||
16305674|NCT00770328|39604934|FG001|Overall Study|Lost to Follow-up|2|||
16084802|NCT00887224|38802570|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
16493702|NCT02057406|40280797|FG001|Overall Study|Withdrawal by Subject|2|||
16493703|NCT02057406|40280798|FG002|Overall Study|Withdrawal by Subject|0|||
16493704|NCT02057406|40280796|FG000|Overall Study|Lost to Follow-up|0|||
16493705|NCT02057406|40280797|FG001|Overall Study|Lost to Follow-up|0|||
16493706|NCT02057406|40280798|FG002|Overall Study|Lost to Follow-up|1|||
16493707|NCT02057406|40280796|FG000|Overall Study|Death|1|||
16493708|NCT02057406|40280797|FG001|Overall Study|Death|0|||
16493709|NCT02057406|40280798|FG002|Overall Study|Death|0|||
16493710|NCT02057406|40280796|FG000|Overall Study|Protocol Violation|0|||
16493711|NCT02057406|40280797|FG001|Overall Study|Protocol Violation|1|||
16493712|NCT02057406|40280798|FG002|Overall Study|Protocol Violation|0|||
16493713|NCT02057406|40280796|FG000|Overall Study|Patient transportation issues|0|||
16493714|NCT02057406|40280797|FG001|Overall Study|Patient transportation issues|0|||
16493715|NCT02057406|40280798|FG002|Overall Study|Patient transportation issues|1|||
16493716|NCT02064868|40280799|FG000|Overall Study|Lost to Follow-up|14|||
16493717|NCT02064868|40280800|FG001|Overall Study|Lost to Follow-up|8|||
16493718|NCT02064868|40280799|FG000|Overall Study|Physician Decision|1|||
16493719|NCT02064868|40280800|FG001|Overall Study|Physician Decision|0|||
16493720|NCT02064868|40280799|FG000|Overall Study|Withdrawal by Subject|14|||
16493721|NCT02064868|40280800|FG001|Overall Study|Withdrawal by Subject|3|||
16493722|NCT02064868|40280799|FG000|Overall Study|Technical Problems or Missing|5|||
16493723|NCT02064868|40280800|FG001|Overall Study|Technical Problems or Missing|2|||
16305675|NCT00616421|39604941|FG000|Overall Study|Withdrawal by Subject|9|||
16305676|NCT00616421|39604942|FG001|Overall Study|Withdrawal by Subject|11|||
16305677|NCT00616421|39604943|FG002|Overall Study|Withdrawal by Subject|8|||
16305678|NCT00616421|39604941|FG000|Overall Study|Lost to Follow-up|12|||
16305679|NCT00616421|39604942|FG001|Overall Study|Lost to Follow-up|26|||
16305680|NCT00616421|39604943|FG002|Overall Study|Lost to Follow-up|30|||
16305681|NCT00616421|39604941|FG000|Overall Study|Inappropriate enrollment|3|||
16305682|NCT00616421|39604942|FG001|Overall Study|Inappropriate enrollment|0|||
16305683|NCT00616421|39604943|FG002|Overall Study|Inappropriate enrollment|1|||
16305684|NCT00616421|39604941|FG000|Overall Study|Administrative reason|1|||
16305685|NCT00616421|39604942|FG001|Overall Study|Administrative reason|0|||
16305686|NCT00616421|39604943|FG002|Overall Study|Administrative reason|0|||
16305687|NCT00616421|39604941|FG000|Overall Study|Protocol Violation|0|||
16305688|NCT00616421|39604942|FG001|Overall Study|Protocol Violation|1|||
16305689|NCT00616421|39604943|FG002|Overall Study|Protocol Violation|2|||
16305690|NCT00616421|39604941|FG000|Overall Study|Unable to classify|1|||
16305691|NCT00616421|39604942|FG001|Overall Study|Unable to classify|0|||
16305692|NCT00616421|39604943|FG002|Overall Study|Unable to classify|0|||
16305693|NCT00306995|39604944|FG000|Study Part I|Withdrawal by Subject|0|||
16493724|NCT04626297|40280801|FG000|Overall Study|Adverse Event|5|||
16493725|NCT04626297|40280802|FG001|Overall Study|Adverse Event|3|||
16493726|NCT04626297|40280801|FG000|Overall Study|Lost to Follow-up|7|||
16493727|NCT04626297|40280802|FG001|Overall Study|Lost to Follow-up|3|||
16493728|NCT04626297|40280801|FG000|Overall Study|Protocol Violation|5|||
16493729|NCT04626297|40280802|FG001|Overall Study|Protocol Violation|1|||
16493730|NCT04626297|40280801|FG000|Overall Study|Withdrawal by Subject|20|||
16493731|NCT04626297|40280802|FG001|Overall Study|Withdrawal by Subject|6|||
16493732|NCT04626297|40280801|FG000|Overall Study|Sponsor decision|2|||
16493733|NCT04626297|40280802|FG001|Overall Study|Sponsor decision|1|||
16493734|NCT04977583|40280803|FG000|Overall Study|Lost to Follow-up|8|||
16493735|NCT04977583|40280804|FG001|Overall Study|Lost to Follow-up|4|||
16493736|NCT04977583|40280805|FG002|Overall Study|Lost to Follow-up|13|||
16493737|NCT04977583|40280803|FG000|Overall Study|Withdrawal by Subject|3|||
16493738|NCT04977583|40280804|FG001|Overall Study|Withdrawal by Subject|2|||
16493739|NCT04977583|40280805|FG002|Overall Study|Withdrawal by Subject|1|||
16493740|NCT03211416|40280806|FG000|Overall Study|Adverse Event|7|||
16493741|NCT03211416|40280806|FG000|Overall Study|Lack of Efficacy|2|||
16493742|NCT03211416|40280806|FG000|Overall Study|Physician Decision|1|||
16493743|NCT01850524|40280807|FG000|Overall Study|Lost to Follow-up|5|||
16493744|NCT01850524|40280808|FG001|Overall Study|Lost to Follow-up|10|||
16493745|NCT01850524|40280807|FG000|Overall Study|Withdrawal by Subject|24|||
16493746|NCT01850524|40280808|FG001|Overall Study|Withdrawal by Subject|22|||
16493747|NCT01850524|40280807|FG000|Overall Study|Reason not Specified|142|||
16493748|NCT01850524|40280808|FG001|Overall Study|Reason not Specified|141|||
16493749|NCT01285310|40280814|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
16493750|NCT01285310|40280815|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
16493751|NCT01285310|40280816|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
16305694|NCT00306995|39604945|FG001|Study Part I|Withdrawal by Subject|0|||
16493752|NCT01285310|40280817|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
16305695|NCT00306995|39604946|FG002|Study Part I|Withdrawal by Subject|0|||
16305696|NCT00306995|39604947|FG003|Study Part I|Withdrawal by Subject|0|||
16305697|NCT00306995|39604948|FG004|Study Part I|Withdrawal by Subject|0|||
16493753|NCT01285310|40280818|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
16493754|NCT01285310|40280814|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
16493755|NCT01285310|40280815|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
16493756|NCT01285310|40280816|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
16493757|NCT01285310|40280817|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
16493758|NCT01285310|40280818|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
16493759|NCT01285310|40280814|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
16493760|NCT01285310|40280815|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
16493761|NCT01285310|40280816|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
16493762|NCT01285310|40280817|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
16493763|NCT01285310|40280818|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
16493764|NCT01285310|40280814|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
16493765|NCT01285310|40280815|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
16493766|NCT01285310|40280816|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
16493767|NCT01285310|40280817|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
16493768|NCT01285310|40280818|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
16493769|NCT01285310|40280814|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
16493770|NCT01285310|40280815|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
16493771|NCT01285310|40280816|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
16493772|NCT01285310|40280817|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
16493773|NCT01285310|40280818|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
16493774|NCT01285310|40280814|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
16493775|NCT01285310|40280815|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
16493776|NCT01285310|40280816|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
16493777|NCT01285310|40280817|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
16493778|NCT01285310|40280818|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
16493779|NCT01285310|40280814|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
16493780|NCT01285310|40280815|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
16493781|NCT01285310|40280816|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
16493782|NCT01285310|40280817|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
16493783|NCT01285310|40280818|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
16493784|NCT01285310|40280814|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
16493785|NCT01285310|40280815|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
16493786|NCT01285310|40280816|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
16493787|NCT01285310|40280817|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
16493788|NCT01285310|40280818|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
16493789|NCT01285310|40280814|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
16493790|NCT01285310|40280815|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
16493791|NCT01285310|40280816|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
16493792|NCT01285310|40280817|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
16493793|NCT01285310|40280818|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
16493794|NCT01285310|40280814|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
16493795|NCT01285310|40280815|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
16493796|NCT01285310|40280816|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
16493797|NCT01285310|40280817|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
16493798|NCT01285310|40280818|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
16493799|NCT01285310|40280814|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
16493800|NCT01285310|40280815|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
16493801|NCT01285310|40280816|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
16493802|NCT01285310|40280817|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
16493803|NCT01285310|40280818|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
16493804|NCT01285310|40280814|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
16493805|NCT01285310|40280815|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
16493806|NCT01285310|40280816|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
16493807|NCT01285310|40280817|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
16493808|NCT01285310|40280818|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
16493809|NCT03555591|40280822|FG000|Overall Study|Protocol Violation|77|||
16493810|NCT00062374|40280824|FG000|Overall Study|Not treated|12|||
16493811|NCT01867424|40280825|FG000|Overall Study|Patient noncompliance|2|||
16493812|NCT01867424|40280826|FG001|Overall Study|Patient noncompliance|1|||
16493813|NCT01829191|40280829|FG000|Overall Study|Relocation|0|||
16493814|NCT01829191|40280830|FG001|Overall Study|Relocation|1|||
16493815|NCT01829191|40280829|FG000|Overall Study|Lens discomfort|0|||
16493816|NCT01829191|40280830|FG001|Overall Study|Lens discomfort|3|||
16493817|NCT01829191|40280829|FG000|Overall Study|Lens handling difficulty|1|||
16084803|NCT00887224|38802571|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
16084804|NCT00887224|38802572|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
16084805|NCT00887224|38802570|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
16084806|NCT00887224|38802571|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
16493818|NCT01829191|40280830|FG001|Overall Study|Lens handling difficulty|4|||
16493819|NCT01829191|40280829|FG000|Overall Study|Protocol Violation|4|||
16493820|NCT01829191|40280830|FG001|Overall Study|Protocol Violation|1|||
16493821|NCT01829191|40280829|FG000|Overall Study|Withdrawal by Subject|2|||
16493822|NCT01829191|40280830|FG001|Overall Study|Withdrawal by Subject|3|||
16493823|NCT01829191|40280829|FG000|Overall Study|Lost to Follow-up|0|||
16493824|NCT01829191|40280830|FG001|Overall Study|Lost to Follow-up|1|||
16493825|NCT01829191|40280829|FG000|Overall Study|Subject was fit for ortho - k|0|||
16493826|NCT01829191|40280830|FG001|Overall Study|Subject was fit for ortho - k|1|||
16493827|NCT04952402|40280836|FG000|Overall Study|Lost to Follow-up|1|||
16493828|NCT04952402|40280837|FG001|Overall Study|Lost to Follow-up|3|||
16493829|NCT04952402|40280836|FG000|Overall Study|Lack Of Venous Access|0|||
16493830|NCT04952402|40280837|FG001|Overall Study|Lack Of Venous Access|1|||
16493831|NCT02728076|40280838|FG000|Overall Study|Physician Decision|4|||
16493832|NCT04605484|40280839|FG000|Overall Study|Lost to Follow-up|0|||
16493833|NCT04605484|40280840|FG001|Overall Study|Lost to Follow-up|1|||
16493834|NCT04605484|40280841|FG002|Overall Study|Lost to Follow-up|1|||
16493835|NCT04605484|40280839|FG000|Overall Study|Other|0|||
16493836|NCT04605484|40280840|FG001|Overall Study|Other|1|||
16493837|NCT04605484|40280841|FG002|Overall Study|Other|0|||
16493838|NCT01581931|40280844|FG000|Washout|Adverse Event|0|||
16493839|NCT01581931|40280845|FG001|Washout|Adverse Event|1|||
16493840|NCT01955733|40280846|FG000|Period 1|Lost to Follow-up|1|||
16493841|NCT01955733|40280847|FG001|Period 1|Lost to Follow-up|0|||
16493842|NCT01955733|40280848|FG002|Period 1|Lost to Follow-up|0|||
16493843|NCT01955733|40280846|FG000|Period 2|Adverse Event|1|||
16493844|NCT01955733|40280847|FG001|Period 2|Adverse Event|0|||
16493845|NCT01955733|40280848|FG002|Period 2|Adverse Event|0|||
16493846|NCT01955733|40280846|FG000|Period 2|Physician Decision|0|||
16493847|NCT01955733|40280847|FG001|Period 2|Physician Decision|0|||
16493848|NCT01955733|40280848|FG002|Period 2|Physician Decision|1|||
16493849|NCT01955733|40280846|FG000|Period 2|Withdrawal by Subject|1|||
16493850|NCT01955733|40280847|FG001|Period 2|Withdrawal by Subject|3|||
16493851|NCT01955733|40280848|FG002|Period 2|Withdrawal by Subject|2|||
16493852|NCT01955733|40280846|FG000|Period 2|Study terminated by sponsor|8|||
16493853|NCT01955733|40280847|FG001|Period 2|Study terminated by sponsor|14|||
16493854|NCT01955733|40280848|FG002|Period 2|Study terminated by sponsor|16|||
16493855|NCT01955733|40280846|FG000|Period 2|Lost to Follow-up|2|||
16493856|NCT01955733|40280847|FG001|Period 2|Lost to Follow-up|0|||
16493857|NCT01955733|40280848|FG002|Period 2|Lost to Follow-up|0|||
16493858|NCT01955733|40280846|FG000|Period 2|Other not defined above|0|||
16493859|NCT01955733|40280847|FG001|Period 2|Other not defined above|2|||
16493860|NCT01955733|40280848|FG002|Period 2|Other not defined above|2|||
16493861|NCT02670083|40280857|FG000|Overall Study|Adverse Event|16|||
16493862|NCT02670083|40280858|FG001|Overall Study|Adverse Event|13|||
16493863|NCT02670083|40280857|FG000|Overall Study|Death|4|||
16493864|NCT02670083|40280858|FG001|Overall Study|Death|6|||
16493865|NCT02670083|40280857|FG000|Overall Study|Lost to Follow-up|2|||
16493866|NCT02670083|40280858|FG001|Overall Study|Lost to Follow-up|2|||
16493867|NCT02670083|40280857|FG000|Overall Study|Multiple Reasons|9|||
16493868|NCT02670083|40280858|FG001|Overall Study|Multiple Reasons|9|||
16493869|NCT02670083|40280857|FG000|Overall Study|Physician Decision|0|||
16493870|NCT02670083|40280858|FG001|Overall Study|Physician Decision|2|||
16493871|NCT02670083|40280857|FG000|Overall Study|Study Terminated By Sponsor|257|||
16493872|NCT02670083|40280858|FG001|Overall Study|Study Terminated By Sponsor|254|||
16493873|NCT02670083|40280857|FG000|Overall Study|Symptomatic Deterioration|0|||
16493874|NCT02670083|40280858|FG001|Overall Study|Symptomatic Deterioration|2|||
16493875|NCT02670083|40280857|FG000|Overall Study|Withdrawal by Subject|32|||
16493876|NCT02670083|40280858|FG001|Overall Study|Withdrawal by Subject|31|||
16493877|NCT02670083|40280857|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16493878|NCT02670083|40280858|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16493879|NCT04294472|40280859|FG000|Overall Study|Adverse Event|0|||
16493880|NCT04294472|40280860|FG001|Overall Study|Adverse Event|1|||
16305698|NCT00306995|39604949|FG005|Study Part I|Withdrawal by Subject|0|||
16493881|NCT04294472|40280861|FG002|Overall Study|Adverse Event|1|||
16493882|NCT04294472|40280859|FG000|Overall Study|Randomized but not treated|0|||
16493883|NCT04294472|40280860|FG001|Overall Study|Randomized but not treated|1|||
16493884|NCT04294472|40280861|FG002|Overall Study|Randomized but not treated|1|||
16493885|NCT00726661|40280866|FG000|Overall Study|Lost to Follow-up|36|||
16493886|NCT00726661|40280867|FG001|Overall Study|Lost to Follow-up|11|||
16493887|NCT00726661|40280866|FG000|Overall Study|Withdrawal by Subject|17|||
16493888|NCT00726661|40280867|FG001|Overall Study|Withdrawal by Subject|13|||
16493889|NCT00726661|40280866|FG000|Overall Study|Trial terminated by sponsor|214|||
16493890|NCT00726661|40280867|FG001|Overall Study|Trial terminated by sponsor|187|||
16493891|NCT00726661|40280866|FG000|Overall Study|Death|475|||
16493892|NCT00726661|40280867|FG001|Overall Study|Death|159|||
16493893|NCT00726661|40280866|FG000|Overall Study|Physician Decision|25|||
16493894|NCT00726661|40280867|FG001|Overall Study|Physician Decision|13|||
16493895|NCT00726661|40280866|FG000|Overall Study|Other|47|||
16493896|NCT00726661|40280867|FG001|Overall Study|Other|35|||
16493897|NCT01482884|40280868|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
16493898|NCT01482884|40280869|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
16493899|NCT01482884|40280868|FG000|Overall Study|Protocol Violation|1|||
16493900|NCT01482884|40280869|FG001|Overall Study|Protocol Violation|0|||
16493901|NCT01482884|40280868|FG000|Overall Study|Lost to Follow-up|2|||
16493902|NCT01482884|40280869|FG001|Overall Study|Lost to Follow-up|2|||
16493903|NCT01482884|40280868|FG000|Overall Study|Lack of Efficacy|0|||
16493904|NCT01482884|40280869|FG001|Overall Study|Lack of Efficacy|1|||
16493905|NCT01482884|40280868|FG000|Overall Study|Adverse Event|2|||
16493906|NCT01482884|40280869|FG001|Overall Study|Adverse Event|1|||
16493907|NCT01482884|40280868|FG000|Overall Study|Withdrawal by Subject|8|||
16493908|NCT01482884|40280869|FG001|Overall Study|Withdrawal by Subject|13|||
16493909|NCT02547649|40280878|FG000|Overall Study|Lost to Follow-up|3|||
16493910|NCT02547649|40280879|FG001|Overall Study|Lost to Follow-up|1|||
16493911|NCT02547649|40280880|FG002|Overall Study|Lost to Follow-up|1|||
16493912|NCT02547649|40280878|FG000|Overall Study|Not vaccinated|0|||
16493913|NCT02547649|40280879|FG001|Overall Study|Not vaccinated|0|||
16493914|NCT02547649|40280880|FG002|Overall Study|Not vaccinated|1|||
16493915|NCT02547649|40280878|FG000|Overall Study|Withdrawal by Subject|0|||
16493916|NCT02547649|40280879|FG001|Overall Study|Withdrawal by Subject|4|||
16493917|NCT02547649|40280880|FG002|Overall Study|Withdrawal by Subject|2|||
16493918|NCT00040664|40280886|FG000|Overall Study|Adverse Event|12|||
16493919|NCT00040664|40280887|FG001|Overall Study|Adverse Event|3|||
16493920|NCT00040664|40280888|FG002|Overall Study|Adverse Event|2|||
16493921|NCT00040664|40280889|FG003|Overall Study|Adverse Event|7|||
16493922|NCT00040664|40280886|FG000|Overall Study|Lack of Efficacy|9|||
16493923|NCT00040664|40280887|FG001|Overall Study|Lack of Efficacy|2|||
16493924|NCT00040664|40280888|FG002|Overall Study|Lack of Efficacy|3|||
16493925|NCT00040664|40280889|FG003|Overall Study|Lack of Efficacy|4|||
16493926|NCT00040664|40280886|FG000|Overall Study|Insufficient CD4 response|1|||
16493927|NCT00040664|40280887|FG001|Overall Study|Insufficient CD4 response|0|||
16493928|NCT00040664|40280888|FG002|Overall Study|Insufficient CD4 response|1|||
16493929|NCT00040664|40280889|FG003|Overall Study|Insufficient CD4 response|0|||
16493930|NCT00040664|40280886|FG000|Overall Study|Lost to Follow-up|4|||
16493931|NCT00040664|40280887|FG001|Overall Study|Lost to Follow-up|2|||
16493932|NCT00040664|40280888|FG002|Overall Study|Lost to Follow-up|0|||
16493933|NCT00040664|40280889|FG003|Overall Study|Lost to Follow-up|2|||
16493934|NCT00040664|40280886|FG000|Overall Study|Protocol Violation|2|||
16493935|NCT00040664|40280887|FG001|Overall Study|Protocol Violation|1|||
16493936|NCT00040664|40280888|FG002|Overall Study|Protocol Violation|0|||
16493937|NCT00040664|40280889|FG003|Overall Study|Protocol Violation|1|||
16493938|NCT00040664|40280886|FG000|Overall Study|Withdrawal by Subject|7|||
16493939|NCT00040664|40280887|FG001|Overall Study|Withdrawal by Subject|0|||
16493940|NCT00040664|40280888|FG002|Overall Study|Withdrawal by Subject|3|||
16493941|NCT00040664|40280889|FG003|Overall Study|Withdrawal by Subject|4|||
16493942|NCT00040664|40280886|FG000|Overall Study|Pregnancy|3|||
16493943|NCT00040664|40280887|FG001|Overall Study|Pregnancy|0|||
16493944|NCT00040664|40280888|FG002|Overall Study|Pregnancy|0|||
16493945|NCT00040664|40280889|FG003|Overall Study|Pregnancy|3|||
16493946|NCT00040664|40280886|FG000|Overall Study|Medication adherence/compliance problems|8|||
16493947|NCT00040664|40280887|FG001|Overall Study|Medication adherence/compliance problems|2|||
16493948|NCT00040664|40280888|FG002|Overall Study|Medication adherence/compliance problems|1|||
16493949|NCT00040664|40280889|FG003|Overall Study|Medication adherence/compliance problems|5|||
16493950|NCT00040664|40280886|FG000|Overall Study|Poor taste|2|||
16493951|NCT00040664|40280887|FG001|Overall Study|Poor taste|0|||
16493952|NCT00040664|40280888|FG002|Overall Study|Poor taste|2|||
16493953|NCT00040664|40280889|FG003|Overall Study|Poor taste|0|||
16493954|NCT00040664|40280886|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
16493955|NCT00040664|40280887|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
16493956|NCT00040664|40280888|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
16493957|NCT00040664|40280889|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
16493958|NCT00040664|40280886|FG000|Overall Study|Change of formulation|2|||
16493959|NCT00040664|40280887|FG001|Overall Study|Change of formulation|2|||
16493960|NCT00040664|40280888|FG002|Overall Study|Change of formulation|0|||
16493961|NCT00040664|40280889|FG003|Overall Study|Change of formulation|0|||
16493962|NCT00040664|40280886|FG000|Overall Study|Non-viability of oral suspension|1|||
16305699|NCT00306995|39604950|FG006|Study Part I|Withdrawal by Subject|1|||
16305700|NCT00306995|39604944|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
16493963|NCT00040664|40280887|FG001|Overall Study|Non-viability of oral suspension|0|||
16493964|NCT00040664|40280888|FG002|Overall Study|Non-viability of oral suspension|1|||
16493965|NCT00040664|40280889|FG003|Overall Study|Non-viability of oral suspension|0|||
16493966|NCT03292588|40280891|FG000|Overall Study|Death|1|||
16493967|NCT03292588|40280892|FG001|Overall Study|Death|0|||
16493968|NCT03292588|40280891|FG000|Overall Study|Lost to Follow-up|12|||
16493969|NCT03292588|40280892|FG001|Overall Study|Lost to Follow-up|16|||
16493970|NCT03292588|40280891|FG000|Overall Study|Physician Decision|0|||
16305701|NCT00306995|39604945|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
16493971|NCT03292588|40280892|FG001|Overall Study|Physician Decision|1|||
16493972|NCT03292588|40280891|FG000|Overall Study|Withdrawal by Subject|4|||
16493973|NCT03292588|40280892|FG001|Overall Study|Withdrawal by Subject|4|||
16493974|NCT03292588|40280891|FG000|Overall Study|Move out of town|1|||
16493975|NCT03292588|40280892|FG001|Overall Study|Move out of town|0|||
16493976|NCT03292588|40280891|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
16493977|NCT03292588|40280892|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
16493978|NCT00563381|40280906|FG000|Overall Study|Adverse Event|264|||
16493979|NCT00563381|40280907|FG001|Overall Study|Adverse Event|292|||
16493980|NCT00563381|40280906|FG000|Overall Study|Protocol Violation|66|||
16493981|NCT00563381|40280907|FG001|Overall Study|Protocol Violation|74|||
16493982|NCT00563381|40280906|FG000|Overall Study|Lost to Follow-up|7|||
16493983|NCT00563381|40280907|FG001|Overall Study|Lost to Follow-up|15|||
16493984|NCT00563381|40280906|FG000|Overall Study|Withdrawal by Subject|192|||
16493985|NCT00563381|40280907|FG001|Overall Study|Withdrawal by Subject|209|||
16493986|NCT00563381|40280906|FG000|Overall Study|Lack of Efficacy|32|||
16493987|NCT00563381|40280907|FG001|Overall Study|Lack of Efficacy|24|||
16493988|NCT00563381|40280906|FG000|Overall Study|Individual different reasons|24|||
16493989|NCT00563381|40280907|FG001|Overall Study|Individual different reasons|34|||
16493990|NCT01798004|40280908|FG000|Overall Study|Death|2|||
16493991|NCT01798004|40280908|FG000|Overall Study|Lack of Efficacy|8|||
16493992|NCT01798004|40280908|FG000|Overall Study|Physician Decision|25|||
16493993|NCT01798004|40280908|FG000|Overall Study|Withdrawal by Subject|4|||
16493994|NCT01798004|40280908|FG000|Overall Study|Ineligible|4|||
16493995|NCT01798004|40280908|FG000|Overall Study|Patient/parent refusal|7|||
16493996|NCT01798004|40280908|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
16493997|NCT01798004|40280908|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
16493998|NCT01828281|40280909|FG000|Overall Study|Withdrawal by Subject|1|||
16493999|NCT01828281|40280910|FG001|Overall Study|Withdrawal by Subject|0|||
16494000|NCT03031678|40280912|FG000|Overall Study|Study closed prior to completion|1|||
16494001|NCT02326025|40280913|FG000|Overall Study|Adverse Event|3|||
16494002|NCT02326025|40280914|FG001|Overall Study|Adverse Event|0|||
16494003|NCT02326025|40280913|FG000|Overall Study|Physician Decision|1|||
16494004|NCT02326025|40280914|FG001|Overall Study|Physician Decision|2|||
16494005|NCT02326025|40280913|FG000|Overall Study|Physician and Participant Decision|1|||
16494006|NCT02326025|40280914|FG001|Overall Study|Physician and Participant Decision|0|||
16494007|NCT02326025|40280913|FG000|Overall Study|Withdrawal by Subject|0|||
16494008|NCT02326025|40280914|FG001|Overall Study|Withdrawal by Subject|2|||
16494009|NCT02326025|40280913|FG000|Overall Study|Protocol Violation|0|||
16494010|NCT02326025|40280914|FG001|Overall Study|Protocol Violation|1|||
16494011|NCT00600483|40280915|FG000|Overall Study|Lost to Follow-up|26|||
16494012|NCT00600483|40280916|FG001|Overall Study|Lost to Follow-up|47|||
16494013|NCT00600483|40280915|FG000|Overall Study|Randomized but not treated|10|||
16494014|NCT00600483|40280916|FG001|Overall Study|Randomized but not treated|0|||
16494015|NCT03982368|40280919|FG000|Overall Study|Adverse Event|6|||
16494016|NCT03982368|40280920|FG001|Overall Study|Adverse Event|4|||
16494017|NCT03982368|40280921|FG002|Overall Study|Adverse Event|3|||
16494018|NCT03982368|40280919|FG000|Overall Study|Lost to Follow-up|2|||
16494019|NCT03982368|40280920|FG001|Overall Study|Lost to Follow-up|1|||
16494020|NCT03982368|40280921|FG002|Overall Study|Lost to Follow-up|0|||
16494021|NCT03982368|40280919|FG000|Overall Study|Withdrawal by Subject|1|||
16494022|NCT03982368|40280920|FG001|Overall Study|Withdrawal by Subject|2|||
16494023|NCT03982368|40280921|FG002|Overall Study|Withdrawal by Subject|0|||
16494024|NCT03982368|40280919|FG000|Overall Study|unknow|4|||
16494025|NCT03982368|40280920|FG001|Overall Study|unknow|0|||
16494026|NCT03982368|40280921|FG002|Overall Study|unknow|2|||
16494027|NCT02501473|40280922|FG000|Overall Study|Study Terminated|2|||
16494028|NCT02501473|40280923|FG001|Overall Study|Study Terminated|3|||
16494029|NCT02501473|40280924|FG002|Overall Study|Study Terminated|7|||
16494030|NCT02501473|40280925|FG003|Overall Study|Study Terminated|9|||
16494031|NCT02501473|40280926|FG004|Overall Study|Study Terminated|2|||
16305702|NCT00306995|39604946|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
16494032|NCT02501473|40280927|FG005|Overall Study|Study Terminated|10|||
16494033|NCT02501473|40280928|FG006|Overall Study|Study Terminated|1|||
16494034|NCT02501473|40280929|FG007|Overall Study|Study Terminated|0|||
16084807|NCT00887224|38802572|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
16305703|NCT00306995|39604947|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
16305704|NCT00306995|39604948|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
16494035|NCT02501473|40280922|FG000|Overall Study|Withdrawal by Subject|0|||
16494036|NCT02501473|40280923|FG001|Overall Study|Withdrawal by Subject|0|||
16494037|NCT02501473|40280924|FG002|Overall Study|Withdrawal by Subject|3|||
16494038|NCT02501473|40280925|FG003|Overall Study|Withdrawal by Subject|3|||
16494039|NCT02501473|40280926|FG004|Overall Study|Withdrawal by Subject|2|||
16494040|NCT02501473|40280927|FG005|Overall Study|Withdrawal by Subject|2|||
16494041|NCT02501473|40280928|FG006|Overall Study|Withdrawal by Subject|0|||
16494042|NCT02501473|40280929|FG007|Overall Study|Withdrawal by Subject|0|||
16494043|NCT02501473|40280922|FG000|Overall Study|Death|0|||
16494044|NCT02501473|40280923|FG001|Overall Study|Death|0|||
16494045|NCT02501473|40280924|FG002|Overall Study|Death|1|||
16494046|NCT02501473|40280925|FG003|Overall Study|Death|1|||
16494047|NCT02501473|40280926|FG004|Overall Study|Death|0|||
16494048|NCT02501473|40280927|FG005|Overall Study|Death|1|||
16494049|NCT02501473|40280928|FG006|Overall Study|Death|0|||
16494050|NCT02501473|40280929|FG007|Overall Study|Death|0|||
16494051|NCT02501473|40280922|FG000|Overall Study|Lost to Follow-up|1|||
16494052|NCT02501473|40280923|FG001|Overall Study|Lost to Follow-up|0|||
16494053|NCT02501473|40280924|FG002|Overall Study|Lost to Follow-up|1|||
16494054|NCT02501473|40280925|FG003|Overall Study|Lost to Follow-up|0|||
16494055|NCT02501473|40280926|FG004|Overall Study|Lost to Follow-up|0|||
16494056|NCT02501473|40280927|FG005|Overall Study|Lost to Follow-up|1|||
16494057|NCT02501473|40280928|FG006|Overall Study|Lost to Follow-up|0|||
16494058|NCT02501473|40280929|FG007|Overall Study|Lost to Follow-up|0|||
16494059|NCT02501473|40280922|FG000|Overall Study|Reason not specified|0|||
16494060|NCT02501473|40280923|FG001|Overall Study|Reason not specified|0|||
16494061|NCT02501473|40280924|FG002|Overall Study|Reason not specified|1|||
16494062|NCT02501473|40280925|FG003|Overall Study|Reason not specified|1|||
16494063|NCT02501473|40280926|FG004|Overall Study|Reason not specified|0|||
16494064|NCT02501473|40280927|FG005|Overall Study|Reason not specified|0|||
16494065|NCT02501473|40280928|FG006|Overall Study|Reason not specified|0|||
16494066|NCT02501473|40280929|FG007|Overall Study|Reason not specified|0|||
16494067|NCT00331682|40280931|FG000|Overall Study|Adverse Event|1|||
16494068|NCT02239978|40280932|FG000|Overall Study|Withdrawal by Subject|2|||
16494069|NCT02239978|40280933|FG001|Overall Study|Withdrawal by Subject|0|||
16494070|NCT00110149|40280934|FG000|Overall Study|Physician Decision|3|||
16494071|NCT03049280|40280935|FG000|Overall Study|Physician Decision|1|||
16084808|NCT00887224|38802570|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
16084809|NCT00887224|38802571|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
16084810|NCT00887224|38802572|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
16084811|NCT00887224|38802570|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
16084812|NCT00887224|38802571|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
16084813|NCT00887224|38802572|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
16084814|NCT00887224|38802570|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
16084815|NCT00887224|38802571|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
16084816|NCT00887224|38802572|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
16084817|NCT00887224|38802570|FG000|Open-label Stability (OLS) Phase|Other|1|||
16084818|NCT00887224|38802571|FG001|Open-label Stability (OLS) Phase|Other|0|||
16084819|NCT00887224|38802572|FG002|Open-label Stability (OLS) Phase|Other|0|||
16084820|NCT00887224|38802570|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
16084821|NCT00887224|38802571|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
16084822|NCT00887224|38802572|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
16084823|NCT00887224|38802570|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
16084824|NCT00887224|38802571|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
16084825|NCT00887224|38802572|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
16084826|NCT00887224|38802570|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
16084827|NCT00887224|38802571|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
16084828|NCT00887224|38802572|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
16305705|NCT00306995|39604949|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
16305706|NCT00306995|39604950|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
16305707|NCT03367156|39604951|FG000|Overall Study|Lack of interest|3|||
16305708|NCT03367156|39604952|FG001|Overall Study|Lack of interest|1|||
16305709|NCT03367156|39604951|FG000|Overall Study|Death|2|||
16305710|NCT03367156|39604952|FG001|Overall Study|Death|0|||
16305711|NCT03367156|39604951|FG000|Overall Study|Lost to Follow-up|2|||
16305712|NCT03367156|39604952|FG001|Overall Study|Lost to Follow-up|1|||
16305713|NCT03367156|39604951|FG000|Overall Study|Became ineligible|1|||
16305714|NCT03367156|39604952|FG001|Overall Study|Became ineligible|2|||
16305715|NCT03367156|39604951|FG000|Overall Study|Hospitalization|1|||
16305716|NCT03367156|39604952|FG001|Overall Study|Hospitalization|0|||
16388167|NCT04819113|39905579|FG000|Overall Study|Lost to Follow-up|1|||
16494072|NCT02483520|40280936|FG000|Overall Study|Lost to Follow-up|3|||
16494073|NCT02483520|40280937|FG001|Overall Study|Lost to Follow-up|4|||
16494074|NCT02483520|40280936|FG000|Overall Study|Withdrawal by Subject|4|||
16084829|NCT00887224|38802570|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
16193623|NCT01963208|39188584|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
16305717|NCT03367156|39604951|FG000|Overall Study|Concerned about Treatment|11|||
16305718|NCT03367156|39604952|FG001|Overall Study|Concerned about Treatment|3|||
16305719|NCT03367156|39604951|FG000|Overall Study|Started new treatment|4|||
16494075|NCT02483520|40280937|FG001|Overall Study|Withdrawal by Subject|14|||
16494076|NCT02483520|40280936|FG000|Overall Study|Hospitalized|2|||
16494077|NCT02483520|40280937|FG001|Overall Study|Hospitalized|3|||
16494078|NCT02483520|40280936|FG000|Overall Study|Moved to LTC|2|||
16494079|NCT02483520|40280937|FG001|Overall Study|Moved to LTC|3|||
16084830|NCT00887224|38802571|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
16084831|NCT00887224|38802572|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
16084832|NCT00887224|38802570|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
16084833|NCT00887224|38802571|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
16084834|NCT00887224|38802572|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
16084835|NCT00887224|38802570|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
16084836|NCT00887224|38802571|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
16084837|NCT00887224|38802572|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
16084838|NCT00887224|38802570|FG000|OL Taper Phase / OL Follow Up|Other|30|||
16084839|NCT00887224|38802571|FG001|OL Taper Phase / OL Follow Up|Other|0|||
16084840|NCT00887224|38802572|FG002|OL Taper Phase / OL Follow Up|Other|0|||
16084841|NCT00887224|38802570|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
16084842|NCT00887224|38802571|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
16084843|NCT00887224|38802572|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
16084844|NCT00887224|38802570|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
16084845|NCT00887224|38802571|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
16084846|NCT00887224|38802572|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
16084847|NCT00887224|38802570|FG000|Double-blind (DB) Phase|Adverse Event|0|||
16084848|NCT00887224|38802571|FG001|Double-blind (DB) Phase|Adverse Event|7|||
16084849|NCT00887224|38802572|FG002|Double-blind (DB) Phase|Adverse Event|2|||
16084850|NCT00887224|38802570|FG000|Double-blind (DB) Phase|Failed to return|0|||
16084851|NCT00887224|38802571|FG001|Double-blind (DB) Phase|Failed to return|2|||
16084852|NCT00887224|38802572|FG002|Double-blind (DB) Phase|Failed to return|2|||
16084853|NCT00887224|38802570|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
16084854|NCT00887224|38802571|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
16084855|NCT00887224|38802572|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
16084856|NCT00887224|38802570|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
16084857|NCT00887224|38802571|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
16084858|NCT00887224|38802572|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
16084859|NCT00887224|38802570|FG000|Double-blind (DB) Phase|Other|0|||
16084860|NCT00887224|38802571|FG001|Double-blind (DB) Phase|Other|2|||
16084861|NCT00887224|38802572|FG002|Double-blind (DB) Phase|Other|0|||
16084862|NCT00887224|38802570|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
16084863|NCT00887224|38802571|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
16084864|NCT00887224|38802572|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
16084865|NCT00887224|38802570|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
16084866|NCT00887224|38802571|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
16084867|NCT00887224|38802572|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
16084868|NCT00887224|38802570|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
16084869|NCT00887224|38802571|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
16409932|NCT03099148|39981830|FG000|Wash-out|Adverse Event|0|||
16084870|NCT00887224|38802572|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
16084871|NCT00887224|38802570|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
16193624|NCT01963208|39188585|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
16193625|NCT01963208|39188586|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
16494080|NCT01524692|40280940|FG000|Overall Study|Withdrawal by Subject|3|||
16494081|NCT02260921|40280941|FG000|Overall Study|Adverse Event|1|||
16494082|NCT02260921|40280942|FG001|Overall Study|Adverse Event|0|||
16494083|NCT02260921|40280941|FG000|Overall Study|Lost to Follow-up|4|||
16193626|NCT00471536|39188587|FG000|Overall Study|Withdrawal by Subject|1|||
16193627|NCT04465396|39188593|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
16193628|NCT04465396|39188594|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
16193629|NCT04465396|39188595|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
16193630|NCT04465396|39188596|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
16193631|NCT00589979|39188597|FG000|Run-In Period|Adverse Event|5|||
16193632|NCT00589979|39188598|FG001|Run-In Period|Adverse Event|0|||
16193633|NCT00589979|39188599|FG002|Run-In Period|Adverse Event|0|||
16193634|NCT00589979|39188597|FG000|Run-In Period|Protocol Violation|3|||
16193635|NCT00589979|39188598|FG001|Run-In Period|Protocol Violation|0|||
16193636|NCT00589979|39188599|FG002|Run-In Period|Protocol Violation|0|||
16193637|NCT00589979|39188597|FG000|Run-In Period|Did not qualify for randomization|54|||
16193638|NCT00589979|39188598|FG001|Run-In Period|Did not qualify for randomization|0|||
16193639|NCT00589979|39188599|FG002|Run-In Period|Did not qualify for randomization|0|||
16193640|NCT00589979|39188597|FG000|Run-In Period|Withdrawal by Subject|10|||
16193641|NCT00589979|39188598|FG001|Run-In Period|Withdrawal by Subject|0|||
16193642|NCT00589979|39188599|FG002|Run-In Period|Withdrawal by Subject|0|||
16193643|NCT00589979|39188597|FG000|Run-In Period|Informed Consent Withdrawn|4|||
16193644|NCT00589979|39188598|FG001|Run-In Period|Informed Consent Withdrawn|0|||
16193645|NCT00589979|39188599|FG002|Run-In Period|Informed Consent Withdrawn|0|||
16193646|NCT00589979|39188597|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
16193647|NCT00589979|39188598|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
16193648|NCT00589979|39188599|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
16193649|NCT00589979|39188597|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
16193650|NCT00589979|39188598|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
16193651|NCT00589979|39188599|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
16193652|NCT00589979|39188597|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
16193653|NCT00589979|39188598|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
16193654|NCT00589979|39188599|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
16193655|NCT00589979|39188597|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
16193656|NCT00589979|39188598|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
16193657|NCT00589979|39188599|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
16193658|NCT00589979|39188597|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
16193659|NCT00589979|39188598|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
16193660|NCT00589979|39188599|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
16193661|NCT00589979|39188597|FG000|Double-Blind Treatment Period 2|Other|0|||
16305720|NCT03367156|39604952|FG001|Overall Study|Started new treatment|1|||
16305721|NCT00958893|39604956|FG000|Overall Study|Study prematurely terminated|4|||
16305722|NCT03717012|39604963|FG000|Overall Study|Due to trial termination|1|||
16305723|NCT03717012|39604964|FG001|Overall Study|Due to trial termination|2|||
16305724|NCT03717012|39604963|FG000|Overall Study|Protocol Violation|0|||
16305725|NCT03717012|39604964|FG001|Overall Study|Protocol Violation|2|||
16305726|NCT03717012|39604963|FG000|Overall Study|Adverse Event|0|||
16305727|NCT03717012|39604964|FG001|Overall Study|Adverse Event|1|||
16305728|NCT03717012|39604963|FG000|Overall Study|Lung transplant|0|||
16305729|NCT03717012|39604964|FG001|Overall Study|Lung transplant|1|||
16305730|NCT02256436|39604965|FG000|Overall Study|Adverse Event|9|||
16305731|NCT02256436|39604966|FG001|Overall Study|Adverse Event|14|||
16193662|NCT00589979|39188598|FG001|Double-Blind Treatment Period 2|Other|0|||
16305732|NCT02256436|39604965|FG000|Overall Study|Death|216|||
16388168|NCT04819113|39905579|FG000|Overall Study|Withdrawn before vaccination|2|||
16388169|NCT02949011|39905580|FG000|Overall Study|Adverse Event|6|||
16388170|NCT02949011|39905581|FG001|Overall Study|Adverse Event|7|||
16388171|NCT02949011|39905582|FG002|Overall Study|Adverse Event|3|||
16388172|NCT02949011|39905580|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
16388173|NCT02949011|39905581|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
16494084|NCT02260921|40280942|FG001|Overall Study|Lost to Follow-up|3|||
16084872|NCT00887224|38802571|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
16193663|NCT00589979|39188599|FG002|Double-Blind Treatment Period 2|Other|1|||
16193664|NCT00589979|39188597|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
16193665|NCT00589979|39188598|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
16193666|NCT00589979|39188599|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
16193667|NCT00589979|39188597|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
16305733|NCT02256436|39604966|FG001|Overall Study|Death|208|||
16305734|NCT02256436|39604965|FG000|Overall Study|Lost to Follow-up|1|||
16494085|NCT02260921|40280941|FG000|Overall Study|Withdraw Consent|4|||
16388174|NCT02949011|39905582|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
16388175|NCT02949011|39905580|FG000|Overall Study|Protocol Deviation|5|||
16388176|NCT02949011|39905581|FG001|Overall Study|Protocol Deviation|3|||
16388177|NCT02949011|39905582|FG002|Overall Study|Protocol Deviation|3|||
16388178|NCT02949011|39905580|FG000|Overall Study|Lack of Efficacy|0|||
16388179|NCT02949011|39905581|FG001|Overall Study|Lack of Efficacy|2|||
16388180|NCT02949011|39905582|FG002|Overall Study|Lack of Efficacy|0|||
16388181|NCT02949011|39905580|FG000|Overall Study|Withdrawal by Subject|13|||
16388182|NCT02949011|39905581|FG001|Overall Study|Withdrawal by Subject|13|||
16388183|NCT02949011|39905582|FG002|Overall Study|Withdrawal by Subject|21|||
16388184|NCT02949011|39905580|FG000|Overall Study|Lost to Follow-up|7|||
16388185|NCT02949011|39905581|FG001|Overall Study|Lost to Follow-up|5|||
16388186|NCT02949011|39905582|FG002|Overall Study|Lost to Follow-up|5|||
16388187|NCT02949011|39905580|FG000|Overall Study|Death|0|||
16388188|NCT02949011|39905581|FG001|Overall Study|Death|0|||
16388189|NCT02949011|39905582|FG002|Overall Study|Death|1|||
16388190|NCT02949011|39905580|FG000|Overall Study|Miscellaneous|2|||
16388191|NCT02949011|39905581|FG001|Overall Study|Miscellaneous|4|||
16388192|NCT02949011|39905582|FG002|Overall Study|Miscellaneous|6|||
16388193|NCT01639469|39905591|FG000|Overall Study|Death|4|||
16388194|NCT01639469|39905592|FG001|Overall Study|Death|2|||
16388195|NCT01639469|39905591|FG000|Overall Study|Lost to Follow-up|1|||
16388196|NCT01639469|39905592|FG001|Overall Study|Lost to Follow-up|1|||
16388197|NCT01436110|39905593|FG000|Overall Study|Lack of Efficacy|23|||
16388198|NCT01436110|39905594|FG001|Overall Study|Lack of Efficacy|14|||
16388199|NCT01436110|39905595|FG002|Overall Study|Lack of Efficacy|9|||
16388200|NCT01436110|39905593|FG000|Overall Study|Withdrawal by Subject|6|||
16388201|NCT01436110|39905594|FG001|Overall Study|Withdrawal by Subject|8|||
16388202|NCT01436110|39905595|FG002|Overall Study|Withdrawal by Subject|4|||
16388203|NCT01436110|39905593|FG000|Overall Study|Adverse Event|2|||
16388204|NCT01436110|39905594|FG001|Overall Study|Adverse Event|1|||
16388205|NCT01436110|39905595|FG002|Overall Study|Adverse Event|2|||
16388206|NCT01436110|39905593|FG000|Overall Study|Physician Decision|3|||
16388207|NCT01436110|39905594|FG001|Overall Study|Physician Decision|1|||
16388208|NCT01436110|39905595|FG002|Overall Study|Physician Decision|1|||
16388209|NCT01436110|39905593|FG000|Overall Study|Lost to Follow-up|1|||
16388210|NCT01436110|39905594|FG001|Overall Study|Lost to Follow-up|1|||
16388211|NCT01436110|39905595|FG002|Overall Study|Lost to Follow-up|3|||
16388212|NCT01436110|39905593|FG000|Overall Study|Protocol Violation|3|||
16388213|NCT01436110|39905594|FG001|Overall Study|Protocol Violation|1|||
16388214|NCT01436110|39905595|FG002|Overall Study|Protocol Violation|1|||
16388215|NCT01436110|39905593|FG000|Overall Study|Did Not Receive Trial Medication|1|||
16388216|NCT01436110|39905594|FG001|Overall Study|Did Not Receive Trial Medication|0|||
16388217|NCT01436110|39905595|FG002|Overall Study|Did Not Receive Trial Medication|3|||
16084873|NCT00887224|38802572|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
16084874|NCT00887224|38802570|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
16388218|NCT03381287|39905596|FG000|Overall Study|Withdrawal by Subject|0|||
16388219|NCT03381287|39905597|FG001|Overall Study|Withdrawal by Subject|1|||
16388220|NCT03381287|39905598|FG002|Overall Study|Withdrawal by Subject|0|||
16388221|NCT03381287|39905599|FG003|Overall Study|Withdrawal by Subject|0|||
16388222|NCT03381287|39905596|FG000|Overall Study|Adverse Event|0|||
16388223|NCT03381287|39905597|FG001|Overall Study|Adverse Event|0|||
16388224|NCT03381287|39905598|FG002|Overall Study|Adverse Event|0|||
16388225|NCT03381287|39905599|FG003|Overall Study|Adverse Event|1|||
16305735|NCT02256436|39604966|FG001|Overall Study|Lost to Follow-up|2|||
16193668|NCT00589979|39188598|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
16193669|NCT00589979|39188599|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
16193670|NCT02868216|39188600|FG000|Overall Study|Death|0|||
16193671|NCT02868216|39188601|FG001|Overall Study|Death|1|||
16193672|NCT02868216|39188600|FG000|Overall Study|coronary artery bypass|1|||
16193673|NCT02868216|39188601|FG001|Overall Study|coronary artery bypass|0|||
16305736|NCT02256436|39604965|FG000|Overall Study|Physician Decision|1|||
16305737|NCT02256436|39604966|FG001|Overall Study|Physician Decision|0|||
16305738|NCT02256436|39604965|FG000|Overall Study|Protocol Violation|0|||
16305739|NCT02256436|39604966|FG001|Overall Study|Protocol Violation|1|||
16193674|NCT02868216|39188600|FG000|Overall Study|Withdrawal by Subject|7|||
16193675|NCT02868216|39188601|FG001|Overall Study|Withdrawal by Subject|5|||
16193676|NCT02034474|39188602|FG000|Overall Study|Adverse Event|3|||
16193677|NCT02034474|39188603|FG001|Overall Study|Adverse Event|2|||
16193678|NCT02034474|39188602|FG000|Overall Study|Withdrawal by Subject|1|||
16193679|NCT02034474|39188603|FG001|Overall Study|Withdrawal by Subject|2|||
16193680|NCT00366548|39188604|FG000|Infant Series|Adverse Event|1|||
16193681|NCT00366548|39188605|FG001|Infant Series|Adverse Event|3|||
16193682|NCT00366548|39188604|FG000|Infant Series|Protocol Violation|0|||
16193683|NCT00366548|39188605|FG001|Infant Series|Protocol Violation|1|||
16193684|NCT00366548|39188604|FG000|Infant Series|Withdrawal by Subject|3|||
16193685|NCT00366548|39188605|FG001|Infant Series|Withdrawal by Subject|1|||
16193686|NCT00366548|39188604|FG000|After Infant Series|Withdrawal by Subject|3|||
16193687|NCT00366548|39188605|FG001|After Infant Series|Withdrawal by Subject|1|||
16193688|NCT00366548|39188604|FG000|After Infant Series|Adverse Event|2|||
16193689|NCT00366548|39188605|FG001|After Infant Series|Adverse Event|0|||
16193690|NCT00366548|39188604|FG000|After Infant Series|Lost to Follow-up|1|||
16193691|NCT00366548|39188605|FG001|After Infant Series|Lost to Follow-up|0|||
16193692|NCT01606761|39188607|FG000|Prior to Week 24|Lost to Follow-up|0|||
16193693|NCT01606761|39188608|FG001|Prior to Week 24|Lost to Follow-up|3|||
16193694|NCT01606761|39188609|FG002|Prior to Week 24|Lost to Follow-up|2|||
16193695|NCT01606761|39188610|FG003|Prior to Week 24|Lost to Follow-up|0|||
16193696|NCT01606761|39188611|FG004|Prior to Week 24|Lost to Follow-up|0|||
16193697|NCT01606761|39188607|FG000|Prior to Week 24|Withdrawal by Subject|12|||
16193698|NCT01606761|39188608|FG001|Prior to Week 24|Withdrawal by Subject|10|||
16305740|NCT02256436|39604965|FG000|Overall Study|Withdrawal by Subject|26|||
16305741|NCT02256436|39604966|FG001|Overall Study|Withdrawal by Subject|10|||
16305742|NCT02256436|39604965|FG000|Overall Study|Transferred to Extension Study|11|||
16305743|NCT02256436|39604966|FG001|Overall Study|Transferred to Extension Study|23|||
16305744|NCT02256436|39604965|FG000|Overall Study|Did Not Continue on Extension Study|8|||
16305745|NCT02256436|39604966|FG001|Overall Study|Did Not Continue on Extension Study|12|||
16305746|NCT02368314|39604967|FG000|Overall Study|Withdrawal by Subject|2|||
16305747|NCT02368314|39604968|FG001|Overall Study|Withdrawal by Subject|1|||
16193699|NCT01606761|39188609|FG002|Prior to Week 24|Withdrawal by Subject|9|||
16193700|NCT01606761|39188610|FG003|Prior to Week 24|Withdrawal by Subject|0|||
16305748|NCT02368314|39604967|FG000|Overall Study|Adverse Event|1|||
16305749|NCT02368314|39604968|FG001|Overall Study|Adverse Event|2|||
16305750|NCT04825912|39604969|FG000|Overall Study|Death|3|||
16305751|NCT04825912|39604969|FG000|Overall Study|Withdrawal by Subject|1|||
16305752|NCT03348163|39604970|FG000|Overall Study|Withdrawal by Subject|2|||
16305753|NCT03348163|39604971|FG001|Overall Study|Withdrawal by Subject|0|||
16305754|NCT02871492|39604972|FG000|Overall Study|Lost to Follow-up|6|||
16305755|NCT02871492|39604973|FG001|Overall Study|Lost to Follow-up|3|||
16305756|NCT02871492|39604974|FG002|Overall Study|Lost to Follow-up|5|||
16305757|NCT02871492|39604972|FG000|Overall Study|Withdrawal by Subject|0|||
16305758|NCT02871492|39604973|FG001|Overall Study|Withdrawal by Subject|0|||
16305759|NCT02871492|39604974|FG002|Overall Study|Withdrawal by Subject|1|||
16305760|NCT04782076|39604983|FG000|Overall Study|Family Emergency|1|||
16305761|NCT03156504|39604987|FG000|Overall Study|Withdrawal by Subject|1|||
16305762|NCT01964976|39604993|FG000|Overall Study|Protocol Violation|31|||
16305763|NCT04146012|39604994|FG000|Overall Study|Study Terminated|30|||
16305764|NCT04146012|39604995|FG001|Overall Study|Study Terminated|15|||
16305765|NCT03076775|39604996|FG000|Overall Study|Lost to Follow-up|1|||
16305766|NCT03076775|39604997|FG001|Overall Study|Lost to Follow-up|0|||
16305767|NCT01200069|39604998|FG000|Overall Study|Withdrawal by Subject|0|||
16305768|NCT01200069|39604999|FG001|Overall Study|Withdrawal by Subject|1|||
16305769|NCT00270855|39605006|FG000|Overall Study|Withdrawal by Subject|8|||
16193701|NCT01606761|39188611|FG004|Prior to Week 24|Withdrawal by Subject|0|||
16494086|NCT02260921|40280942|FG001|Overall Study|Withdraw Consent|1|||
16193702|NCT01606761|39188607|FG000|Prior to Week 24|Adverse Event|11|||
16193703|NCT01606761|39188608|FG001|Prior to Week 24|Adverse Event|18|||
16193704|NCT01606761|39188609|FG002|Prior to Week 24|Adverse Event|22|||
16193705|NCT01606761|39188610|FG003|Prior to Week 24|Adverse Event|0|||
16494087|NCT02260921|40280941|FG000|Overall Study|Death|1|||
16494088|NCT02260921|40280942|FG001|Overall Study|Death|0|||
16494089|NCT02260921|40280941|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
16494090|NCT02260921|40280942|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
16494091|NCT04016285|40280944|FG000|Overall Study|Did not progress to surgery|2|||
16494092|NCT04016285|40280945|FG001|Overall Study|Did not progress to surgery|5|||
16494093|NCT04016285|40280944|FG000|Overall Study|Failed to collect outcome data|5|||
16494094|NCT04016285|40280945|FG001|Overall Study|Failed to collect outcome data|3|||
16494095|NCT01532414|40280949|FG000|Overall Study|Lost to Follow-up|3|||
16494096|NCT01532414|40280950|FG001|Overall Study|Lost to Follow-up|0|||
16494097|NCT01532414|40280951|FG002|Overall Study|Lost to Follow-up|1|||
16494098|NCT01532414|40280949|FG000|Overall Study|Withdrawal by Subject|3|||
16494099|NCT01532414|40280950|FG001|Overall Study|Withdrawal by Subject|0|||
16494100|NCT01532414|40280951|FG002|Overall Study|Withdrawal by Subject|0|||
16494101|NCT01532414|40280949|FG000|Overall Study|No V6 semen sample|0|||
16494102|NCT01532414|40280950|FG001|Overall Study|No V6 semen sample|1|||
16494103|NCT01532414|40280951|FG002|Overall Study|No V6 semen sample|0|||
16494104|NCT01532414|40280949|FG000|Overall Study|Adverse Event|0|||
16494105|NCT01532414|40280950|FG001|Overall Study|Adverse Event|1|||
16494106|NCT01532414|40280951|FG002|Overall Study|Adverse Event|1|||
16494107|NCT01532414|40280949|FG000|Overall Study|Unable to complete 24 hour PK|0|||
16494108|NCT01532414|40280950|FG001|Overall Study|Unable to complete 24 hour PK|0|||
16494109|NCT01532414|40280951|FG002|Overall Study|Unable to complete 24 hour PK|1|||
16494110|NCT01532414|40280949|FG000|Overall Study|Withdrawn by sponsor|1|||
16494111|NCT01532414|40280950|FG001|Overall Study|Withdrawn by sponsor|0|||
16494112|NCT01532414|40280951|FG002|Overall Study|Withdrawn by sponsor|0|||
16494113|NCT03156543|40280953|FG000|Overall Study|Withdrawal by Subject|1|||
16494114|NCT03156543|40280954|FG001|Overall Study|Withdrawal by Subject|0|||
16494115|NCT00967798|40280955|FG000|Overall Study|Withdrawal by Subject|5|||
16494116|NCT00967798|40280956|FG001|Overall Study|Withdrawal by Subject|2|||
16494117|NCT00967798|40280955|FG000|Overall Study|Lost to Follow-up|4|||
16494118|NCT00967798|40280956|FG001|Overall Study|Lost to Follow-up|1|||
16494119|NCT00587639|40280960|FG000|Overall Study|Withdrawal by Subject|1|||
16494120|NCT00420927|40280969|FG000|Period 1|Adverse Event|19|||
16494121|NCT00420927|40280970|FG001|Period 1|Adverse Event|15|||
16494122|NCT00420927|40280971|FG002|Period 1|Adverse Event|0|||
16494123|NCT00420927|40280972|FG003|Period 1|Adverse Event|0|||
16193706|NCT01606761|39188611|FG004|Prior to Week 24|Adverse Event|0|||
16193707|NCT01606761|39188607|FG000|Prior to Week 24|Lack of Efficacy|15|||
16305770|NCT00270855|39605007|FG001|Overall Study|Withdrawal by Subject|8|||
16305771|NCT04439201|39605009|FG000|Overall Study|Ineligible|2|||
16305772|NCT04439201|39605009|FG000|Overall Study|Never start protocol therapy|1|||
16388226|NCT03381287|39905596|FG000|Overall Study|Physician Decision|0|||
16494124|NCT00420927|40280973|FG004|Period 1|Adverse Event|0|||
16494125|NCT00420927|40280974|FG005|Period 1|Adverse Event|0|||
16494126|NCT00420927|40280975|FG006|Period 1|Adverse Event|0|||
16494127|NCT00420927|40280969|FG000|Period 1|Withdrawal by Subject|7|||
16494128|NCT00420927|40280970|FG001|Period 1|Withdrawal by Subject|12|||
16494129|NCT00420927|40280971|FG002|Period 1|Withdrawal by Subject|0|||
16494130|NCT00420927|40280972|FG003|Period 1|Withdrawal by Subject|0|||
16494131|NCT00420927|40280973|FG004|Period 1|Withdrawal by Subject|0|||
16494132|NCT00420927|40280974|FG005|Period 1|Withdrawal by Subject|0|||
16494133|NCT00420927|40280975|FG006|Period 1|Withdrawal by Subject|0|||
16494134|NCT00420927|40280969|FG000|Period 1|Lost to Follow-up|8|||
16494135|NCT00420927|40280970|FG001|Period 1|Lost to Follow-up|6|||
16494136|NCT00420927|40280971|FG002|Period 1|Lost to Follow-up|0|||
16494137|NCT00420927|40280972|FG003|Period 1|Lost to Follow-up|0|||
16494138|NCT00420927|40280973|FG004|Period 1|Lost to Follow-up|0|||
16494139|NCT00420927|40280974|FG005|Period 1|Lost to Follow-up|0|||
16494140|NCT00420927|40280975|FG006|Period 1|Lost to Follow-up|0|||
16494141|NCT00420927|40280969|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
16494142|NCT00420927|40280970|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
16494143|NCT00420927|40280971|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
16494144|NCT00420927|40280972|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
16494145|NCT00420927|40280973|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
16494146|NCT00420927|40280974|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
16494147|NCT00420927|40280975|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
16494148|NCT00420927|40280969|FG000|Period 1|Death|2|||
16494149|NCT00420927|40280970|FG001|Period 1|Death|0|||
16494150|NCT00420927|40280971|FG002|Period 1|Death|0|||
16494151|NCT00420927|40280972|FG003|Period 1|Death|0|||
16494152|NCT00420927|40280973|FG004|Period 1|Death|0|||
16494153|NCT00420927|40280974|FG005|Period 1|Death|0|||
16494154|NCT00420927|40280975|FG006|Period 1|Death|0|||
16494155|NCT00420927|40280969|FG000|Period 1|Subject moved/relocated|0|||
16494156|NCT00420927|40280970|FG001|Period 1|Subject moved/relocated|2|||
16494157|NCT00420927|40280971|FG002|Period 1|Subject moved/relocated|0|||
16494158|NCT00420927|40280972|FG003|Period 1|Subject moved/relocated|0|||
16494159|NCT00420927|40280973|FG004|Period 1|Subject moved/relocated|0|||
16494160|NCT00420927|40280974|FG005|Period 1|Subject moved/relocated|0|||
16494161|NCT00420927|40280975|FG006|Period 1|Subject moved/relocated|0|||
16494162|NCT00420927|40280969|FG000|Period 1|Noncompliant with study drug|1|||
16494163|NCT00420927|40280970|FG001|Period 1|Noncompliant with study drug|1|||
16494164|NCT00420927|40280971|FG002|Period 1|Noncompliant with study drug|0|||
16494165|NCT00420927|40280972|FG003|Period 1|Noncompliant with study drug|0|||
16494166|NCT00420927|40280973|FG004|Period 1|Noncompliant with study drug|0|||
16494167|NCT00420927|40280974|FG005|Period 1|Noncompliant with study drug|0|||
16494168|NCT00420927|40280975|FG006|Period 1|Noncompliant with study drug|0|||
16494169|NCT00420927|40280969|FG000|Period 1|Randomization error|1|||
16494170|NCT00420927|40280970|FG001|Period 1|Randomization error|0|||
16494171|NCT00420927|40280971|FG002|Period 1|Randomization error|0|||
16494172|NCT00420927|40280972|FG003|Period 1|Randomization error|0|||
16494173|NCT00420927|40280973|FG004|Period 1|Randomization error|0|||
16494174|NCT00420927|40280974|FG005|Period 1|Randomization error|0|||
16494175|NCT00420927|40280975|FG006|Period 1|Randomization error|0|||
16494176|NCT00420927|40280969|FG000|Period 1|Suspected tuberculosis/positive test|1|||
16494177|NCT00420927|40280970|FG001|Period 1|Suspected tuberculosis/positive test|1|||
16494178|NCT00420927|40280971|FG002|Period 1|Suspected tuberculosis/positive test|0|||
16494179|NCT00420927|40280972|FG003|Period 1|Suspected tuberculosis/positive test|0|||
16494180|NCT00420927|40280973|FG004|Period 1|Suspected tuberculosis/positive test|0|||
16494181|NCT00420927|40280974|FG005|Period 1|Suspected tuberculosis/positive test|0|||
16494182|NCT00420927|40280975|FG006|Period 1|Suspected tuberculosis/positive test|0|||
16494183|NCT00420927|40280969|FG000|Period 1|Study site closure|0|||
16494184|NCT00420927|40280970|FG001|Period 1|Study site closure|1|||
16494185|NCT00420927|40280971|FG002|Period 1|Study site closure|0|||
16494186|NCT00420927|40280972|FG003|Period 1|Study site closure|0|||
16494187|NCT00420927|40280973|FG004|Period 1|Study site closure|0|||
16494188|NCT00420927|40280974|FG005|Period 1|Study site closure|0|||
16494189|NCT00420927|40280975|FG006|Period 1|Study site closure|0|||
16494190|NCT00420927|40280969|FG000|Period 1|Subject received new diagnosis|0|||
16494191|NCT00420927|40280970|FG001|Period 1|Subject received new diagnosis|2|||
16494192|NCT00420927|40280971|FG002|Period 1|Subject received new diagnosis|0|||
16494193|NCT00420927|40280972|FG003|Period 1|Subject received new diagnosis|0|||
16494194|NCT00420927|40280973|FG004|Period 1|Subject received new diagnosis|0|||
16494195|NCT00420927|40280974|FG005|Period 1|Subject received new diagnosis|0|||
16494196|NCT00420927|40280975|FG006|Period 1|Subject received new diagnosis|0|||
16494197|NCT00420927|40280969|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
16494198|NCT00420927|40280970|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
16494199|NCT00420927|40280971|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
16494200|NCT00420927|40280972|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
16494201|NCT00420927|40280973|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
16494202|NCT00420927|40280974|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
16494203|NCT00420927|40280975|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
16494204|NCT00420927|40280969|FG000|Period 1|Failed to meet entry criteria|8|||
16494205|NCT00420927|40280970|FG001|Period 1|Failed to meet entry criteria|7|||
16494206|NCT00420927|40280971|FG002|Period 1|Failed to meet entry criteria|0|||
16494207|NCT00420927|40280972|FG003|Period 1|Failed to meet entry criteria|0|||
16494208|NCT00420927|40280973|FG004|Period 1|Failed to meet entry criteria|0|||
16494209|NCT00420927|40280974|FG005|Period 1|Failed to meet entry criteria|0|||
16494210|NCT00420927|40280975|FG006|Period 1|Failed to meet entry criteria|0|||
16494211|NCT00420927|40280969|FG000|Period 1|Took prohibited medication|1|||
16494212|NCT00420927|40280970|FG001|Period 1|Took prohibited medication|3|||
16494213|NCT00420927|40280971|FG002|Period 1|Took prohibited medication|0|||
16494214|NCT00420927|40280972|FG003|Period 1|Took prohibited medication|0|||
16494215|NCT00420927|40280973|FG004|Period 1|Took prohibited medication|0|||
16494216|NCT00420927|40280974|FG005|Period 1|Took prohibited medication|0|||
16494217|NCT00420927|40280975|FG006|Period 1|Took prohibited medication|0|||
16494218|NCT00420927|40280969|FG000|Period 2|Adverse Event|0|||
16494219|NCT00420927|40280970|FG001|Period 2|Adverse Event|0|||
16494220|NCT00420927|40280971|FG002|Period 2|Adverse Event|7|||
16494221|NCT00420927|40280972|FG003|Period 2|Adverse Event|3|||
16494222|NCT00420927|40280973|FG004|Period 2|Adverse Event|17|||
16494223|NCT00420927|40280974|FG005|Period 2|Adverse Event|6|||
16494224|NCT00420927|40280975|FG006|Period 2|Adverse Event|20|||
16494225|NCT00420927|40280969|FG000|Period 2|Withdrawal by Subject|0|||
16494226|NCT00420927|40280970|FG001|Period 2|Withdrawal by Subject|0|||
16494227|NCT00420927|40280971|FG002|Period 2|Withdrawal by Subject|1|||
16494228|NCT00420927|40280972|FG003|Period 2|Withdrawal by Subject|3|||
16494229|NCT00420927|40280973|FG004|Period 2|Withdrawal by Subject|11|||
16494230|NCT00420927|40280974|FG005|Period 2|Withdrawal by Subject|2|||
16494231|NCT00420927|40280975|FG006|Period 2|Withdrawal by Subject|12|||
16494232|NCT00420927|40280969|FG000|Period 2|Lost to Follow-up|0|||
16494233|NCT00420927|40280970|FG001|Period 2|Lost to Follow-up|0|||
16494234|NCT00420927|40280971|FG002|Period 2|Lost to Follow-up|2|||
16494235|NCT00420927|40280972|FG003|Period 2|Lost to Follow-up|2|||
16494236|NCT00420927|40280973|FG004|Period 2|Lost to Follow-up|6|||
16494237|NCT00420927|40280974|FG005|Period 2|Lost to Follow-up|3|||
16494238|NCT00420927|40280975|FG006|Period 2|Lost to Follow-up|9|||
16494239|NCT00420927|40280969|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
16494240|NCT00420927|40280970|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
16494241|NCT00420927|40280971|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
16494242|NCT00420927|40280972|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
16494243|NCT00420927|40280973|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
16494244|NCT00420927|40280974|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
16494245|NCT00420927|40280975|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
16494246|NCT00420927|40280969|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
16494247|NCT00420927|40280970|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
16494248|NCT00420927|40280971|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
16494249|NCT00420927|40280972|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
16494250|NCT00420927|40280973|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
16494251|NCT00420927|40280974|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
16494252|NCT00420927|40280975|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
16494253|NCT00420927|40280969|FG000|Period 2|Subject unable to find transportation|0|||
16494254|NCT00420927|40280970|FG001|Period 2|Subject unable to find transportation|0|||
16494255|NCT00420927|40280971|FG002|Period 2|Subject unable to find transportation|0|||
16494256|NCT00420927|40280972|FG003|Period 2|Subject unable to find transportation|0|||
16494257|NCT00420927|40280973|FG004|Period 2|Subject unable to find transportation|0|||
16494258|NCT00420927|40280974|FG005|Period 2|Subject unable to find transportation|0|||
16494259|NCT00420927|40280975|FG006|Period 2|Subject unable to find transportation|1|||
16494260|NCT00420927|40280969|FG000|Period 2|Physician Decision|0|||
16494261|NCT00420927|40280970|FG001|Period 2|Physician Decision|0|||
16494262|NCT00420927|40280971|FG002|Period 2|Physician Decision|0|||
16494263|NCT00420927|40280972|FG003|Period 2|Physician Decision|0|||
16494264|NCT00420927|40280973|FG004|Period 2|Physician Decision|1|||
16494265|NCT00420927|40280974|FG005|Period 2|Physician Decision|1|||
16494266|NCT00420927|40280975|FG006|Period 2|Physician Decision|0|||
16494267|NCT00420927|40280969|FG000|Period 2|Sponsor decision|0|||
16494268|NCT00420927|40280970|FG001|Period 2|Sponsor decision|0|||
16494269|NCT00420927|40280971|FG002|Period 2|Sponsor decision|1|||
16494270|NCT00420927|40280972|FG003|Period 2|Sponsor decision|0|||
16494271|NCT00420927|40280973|FG004|Period 2|Sponsor decision|0|||
16494272|NCT00420927|40280974|FG005|Period 2|Sponsor decision|0|||
16494273|NCT00420927|40280975|FG006|Period 2|Sponsor decision|1|||
16494274|NCT00420927|40280969|FG000|Period 2|Randomization error|0|||
16494275|NCT00420927|40280970|FG001|Period 2|Randomization error|0|||
16494276|NCT00420927|40280971|FG002|Period 2|Randomization error|0|||
16494277|NCT00420927|40280972|FG003|Period 2|Randomization error|0|||
16494278|NCT00420927|40280973|FG004|Period 2|Randomization error|1|||
16494279|NCT00420927|40280974|FG005|Period 2|Randomization error|1|||
16494280|NCT00420927|40280975|FG006|Period 2|Randomization error|0|||
16494281|NCT00420927|40280969|FG000|Period 2|Noncompliant with study drug|0|||
16494282|NCT00420927|40280970|FG001|Period 2|Noncompliant with study drug|0|||
16494283|NCT00420927|40280971|FG002|Period 2|Noncompliant with study drug|0|||
16494284|NCT00420927|40280972|FG003|Period 2|Noncompliant with study drug|1|||
16494285|NCT00420927|40280973|FG004|Period 2|Noncompliant with study drug|0|||
16494286|NCT00420927|40280974|FG005|Period 2|Noncompliant with study drug|0|||
16494287|NCT00420927|40280975|FG006|Period 2|Noncompliant with study drug|2|||
16494288|NCT00420927|40280969|FG000|Period 2|Methotrexate intolerance|0|||
16494289|NCT00420927|40280970|FG001|Period 2|Methotrexate intolerance|0|||
16494290|NCT00420927|40280971|FG002|Period 2|Methotrexate intolerance|0|||
16494291|NCT00420927|40280972|FG003|Period 2|Methotrexate intolerance|0|||
16494292|NCT00420927|40280973|FG004|Period 2|Methotrexate intolerance|0|||
16494293|NCT00420927|40280974|FG005|Period 2|Methotrexate intolerance|0|||
16494294|NCT00420927|40280975|FG006|Period 2|Methotrexate intolerance|1|||
16494295|NCT00420927|40280969|FG000|Period 2|Took prohibited medication|0|||
16494296|NCT00420927|40280970|FG001|Period 2|Took prohibited medication|0|||
16494297|NCT00420927|40280971|FG002|Period 2|Took prohibited medication|0|||
16494298|NCT00420927|40280972|FG003|Period 2|Took prohibited medication|0|||
16494299|NCT00420927|40280973|FG004|Period 2|Took prohibited medication|1|||
16494300|NCT00420927|40280974|FG005|Period 2|Took prohibited medication|0|||
16494301|NCT00420927|40280975|FG006|Period 2|Took prohibited medication|0|||
16494302|NCT04967443|40280976|FG000|Open Label Treatment|Death|1|||
16494303|NCT04967443|40280977|FG001|Open Label Treatment|Death|0|||
16494304|NCT04967443|40280978|FG002|Open Label Treatment|Death|0|||
16494305|NCT04967443|40280979|FG003|Open Label Treatment|Death|0|||
16494306|NCT04967443|40280980|FG004|Open Label Treatment|Death|0|||
16494307|NCT04967443|40280981|FG005|Open Label Treatment|Death|0|||
16494308|NCT04967443|40280982|FG006|Open Label Treatment|Death|0|||
16494309|NCT04967443|40280983|FG007|Open Label Treatment|Death|0|||
16494310|NCT04967443|40280976|FG000|Open Label Treatment|Lost to Follow-up|0|||
16494311|NCT04967443|40280977|FG001|Open Label Treatment|Lost to Follow-up|0|||
16494312|NCT04967443|40280978|FG002|Open Label Treatment|Lost to Follow-up|1|||
16494313|NCT04967443|40280979|FG003|Open Label Treatment|Lost to Follow-up|0|||
16494314|NCT04967443|40280980|FG004|Open Label Treatment|Lost to Follow-up|0|||
16494315|NCT04967443|40280981|FG005|Open Label Treatment|Lost to Follow-up|0|||
16494316|NCT04967443|40280982|FG006|Open Label Treatment|Lost to Follow-up|0|||
16494317|NCT04967443|40280983|FG007|Open Label Treatment|Lost to Follow-up|0|||
16494318|NCT04967443|40280976|FG000|Open Label Treatment|Withdrawal by Subject|0|||
16494319|NCT04967443|40280977|FG001|Open Label Treatment|Withdrawal by Subject|1|||
16494320|NCT04967443|40280978|FG002|Open Label Treatment|Withdrawal by Subject|0|||
16494321|NCT04967443|40280979|FG003|Open Label Treatment|Withdrawal by Subject|1|||
16494322|NCT04967443|40280980|FG004|Open Label Treatment|Withdrawal by Subject|0|||
16494323|NCT04967443|40280981|FG005|Open Label Treatment|Withdrawal by Subject|1|||
16494324|NCT04967443|40280982|FG006|Open Label Treatment|Withdrawal by Subject|2|||
16494325|NCT04967443|40280983|FG007|Open Label Treatment|Withdrawal by Subject|3|||
16494326|NCT04967443|40280976|FG000|Follow-Up|Death|1|||
16494327|NCT04967443|40280977|FG001|Follow-Up|Death|0|||
16494328|NCT04967443|40280978|FG002|Follow-Up|Death|0|||
16494329|NCT04967443|40280979|FG003|Follow-Up|Death|0|||
16494330|NCT04967443|40280980|FG004|Follow-Up|Death|0|||
16494331|NCT04967443|40280981|FG005|Follow-Up|Death|0|||
16494332|NCT04967443|40280982|FG006|Follow-Up|Death|0|||
16494333|NCT04967443|40280983|FG007|Follow-Up|Death|0|||
16494334|NCT04967443|40280976|FG000|Follow-Up|Lost to Follow-up|0|||
16494335|NCT04967443|40280977|FG001|Follow-Up|Lost to Follow-up|0|||
16494336|NCT04967443|40280978|FG002|Follow-Up|Lost to Follow-up|1|||
16494337|NCT04967443|40280979|FG003|Follow-Up|Lost to Follow-up|1|||
16494338|NCT04967443|40280980|FG004|Follow-Up|Lost to Follow-up|0|||
16494339|NCT04967443|40280981|FG005|Follow-Up|Lost to Follow-up|0|||
16494340|NCT04967443|40280982|FG006|Follow-Up|Lost to Follow-up|0|||
16494341|NCT04967443|40280983|FG007|Follow-Up|Lost to Follow-up|0|||
16494342|NCT04967443|40280976|FG000|Follow-Up|Withdrawal by Subject|0|||
16494343|NCT04967443|40280977|FG001|Follow-Up|Withdrawal by Subject|1|||
16494344|NCT04967443|40280978|FG002|Follow-Up|Withdrawal by Subject|0|||
16494345|NCT04967443|40280979|FG003|Follow-Up|Withdrawal by Subject|1|||
16494346|NCT04967443|40280980|FG004|Follow-Up|Withdrawal by Subject|0|||
16494347|NCT04967443|40280981|FG005|Follow-Up|Withdrawal by Subject|1|||
16494348|NCT04967443|40280982|FG006|Follow-Up|Withdrawal by Subject|2|||
16494349|NCT04967443|40280983|FG007|Follow-Up|Withdrawal by Subject|3|||
16084875|NCT00887224|38802571|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
16084876|NCT00887224|38802572|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
16084877|NCT00887224|38802570|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
16084878|NCT00887224|38802571|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
16084879|NCT00887224|38802572|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
16084880|NCT00887224|38802570|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
16084881|NCT00887224|38802571|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
16193708|NCT01606761|39188608|FG001|Prior to Week 24|Lack of Efficacy|14|||
16494350|NCT03934931|40280984|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
16494351|NCT03934931|40280985|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
16494352|NCT03934931|40280986|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
16494353|NCT02028065|40280987|FG000|Randomization Through Start Treatment|Not treated|1|||
16494354|NCT02028065|40280988|FG001|Randomization Through Start Treatment|Not treated|3|||
16084882|NCT00887224|38802572|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
16084883|NCT00887224|38802570|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
16084884|NCT00887224|38802571|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
16084885|NCT00887224|38802572|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
16084886|NCT00887224|38802570|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
16084887|NCT00887224|38802571|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
16084888|NCT00887224|38802572|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
16084889|NCT04492475|38802573|FG000|Overall Study|Enrolled but not treated|8|||
16084890|NCT04492475|38802574|FG001|Overall Study|Enrolled but not treated|8|||
16084891|NCT04492475|38802573|FG000|Overall Study|Withdrawal by Subject|4|||
16084892|NCT04492475|38802574|FG001|Overall Study|Withdrawal by Subject|0|||
16084893|NCT04492475|38802573|FG000|Overall Study|Became ineligible after enrollment|2|||
16084894|NCT04492475|38802574|FG001|Overall Study|Became ineligible after enrollment|0|||
16084895|NCT01057433|38802578|FG000|Overall Study|Adverse Event|1|||
16084896|NCT00989196|38802582|FG000|Treatment Period|Lost to Follow-up|1|||
16084897|NCT00989196|38802583|FG001|Treatment Period|Lost to Follow-up|0|||
16084898|NCT01500200|38802595|FG000|Stage 1|Adverse Event|1|||
16494355|NCT02028065|40280989|FG002|Randomization Through Start Treatment|Not treated|3|||
16494356|NCT02028065|40280987|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
16494357|NCT02028065|40280988|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
16494358|NCT02028065|40280989|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
16494359|NCT02028065|40280987|FG000|Treatment Through Study Completion|Physician Decision|1|||
16494360|NCT02028065|40280988|FG001|Treatment Through Study Completion|Physician Decision|0|||
16494361|NCT02028065|40280989|FG002|Treatment Through Study Completion|Physician Decision|0|||
16494362|NCT02028065|40280987|FG000|Treatment Through Study Completion|Protocol Violation|1|||
16494363|NCT02028065|40280988|FG001|Treatment Through Study Completion|Protocol Violation|4|||
16494364|NCT02028065|40280989|FG002|Treatment Through Study Completion|Protocol Violation|0|||
16494365|NCT02028065|40280987|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
16494366|NCT02028065|40280988|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
16494367|NCT02028065|40280989|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
16494368|NCT02028065|40280987|FG000|Treatment Through Study Completion|Adverse Event|3|||
16494369|NCT02028065|40280988|FG001|Treatment Through Study Completion|Adverse Event|3|||
16494370|NCT02028065|40280989|FG002|Treatment Through Study Completion|Adverse Event|5|||
16494371|NCT00867009|40280993|FG000|Induction Period|Nonserious Adverse Event|5|||
16494372|NCT00867009|40280993|FG000|Induction Period|Serious Adverse Event|10|||
16494373|NCT00867009|40280993|FG000|Induction Period|Death due to serious adverse event|6|||
16494374|NCT00867009|40280993|FG000|Induction Period|Death due to Study Disease|4|||
16494375|NCT00867009|40280993|FG000|Induction Period|Protocol Violation|1|||
16494376|NCT00867009|40280993|FG000|Induction Period|Withdrawal by Subject|8|||
16494377|NCT00867009|40280993|FG000|Induction Period|Physician Decision|3|||
16494378|NCT00867009|40280993|FG000|Induction Period|Progressive Disease (PD)|25|||
16494379|NCT00867009|40280993|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
16494380|NCT00877383|40280998|FG000|Overall Study|Adverse Event|13|||
16084899|NCT01500200|38802596|FG001|Stage 1|Adverse Event|4|||
16084900|NCT01500200|38802597|FG002|Stage 1|Adverse Event|5|||
16084901|NCT01500200|38802598|FG003|Stage 1|Adverse Event|0|||
16494381|NCT00877383|40280999|FG001|Overall Study|Adverse Event|14|||
16494382|NCT00877383|40280998|FG000|Overall Study|Lost to Follow-up|5|||
16084902|NCT01500200|38802599|FG004|Stage 1|Adverse Event|0|||
16084903|NCT01500200|38802600|FG005|Stage 1|Adverse Event|0|||
16305773|NCT04439201|39605009|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
16494383|NCT00877383|40280999|FG001|Overall Study|Lost to Follow-up|3|||
16494384|NCT00877383|40280998|FG000|Overall Study|Subject withdrew consent|3|||
16494385|NCT00877383|40280999|FG001|Overall Study|Subject withdrew consent|12|||
16494386|NCT00877383|40280998|FG000|Overall Study|Subject no longer requires study drug|2|||
16494387|NCT00877383|40280999|FG001|Overall Study|Subject no longer requires study drug|0|||
16494388|NCT00877383|40280998|FG000|Overall Study|Administrative problems|2|||
16494389|NCT00877383|40280999|FG001|Overall Study|Administrative problems|0|||
16494390|NCT00877383|40280998|FG000|Overall Study|Protocol deviation|2|||
16494391|NCT00877383|40280999|FG001|Overall Study|Protocol deviation|6|||
16494392|NCT00877383|40280998|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16494393|NCT00877383|40280999|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16494394|NCT00877383|40280998|FG000|Overall Study|Death|1|||
16494395|NCT00877383|40280999|FG001|Overall Study|Death|2|||
16494396|NCT00456521|40281000|FG000|Overall Study|Adverse Event|150|||
16494397|NCT00456521|40281001|FG001|Overall Study|Adverse Event|25|||
16494398|NCT00456521|40281000|FG000|Overall Study|Withdrawal by Subject|43|||
16494399|NCT00456521|40281001|FG001|Overall Study|Withdrawal by Subject|24|||
16494400|NCT00456521|40281000|FG000|Overall Study|Lost to Follow-up|22|||
16494401|NCT00456521|40281001|FG001|Overall Study|Lost to Follow-up|17|||
16494402|NCT00456521|40281000|FG000|Overall Study|Lack of Efficacy|3|||
16494403|NCT00456521|40281001|FG001|Overall Study|Lack of Efficacy|6|||
16494404|NCT00456521|40281000|FG000|Overall Study|Protocol Violation|4|||
16494405|NCT00456521|40281001|FG001|Overall Study|Protocol Violation|0|||
16494406|NCT00456521|40281000|FG000|Overall Study|Pregnancy|1|||
16494407|NCT00456521|40281001|FG001|Overall Study|Pregnancy|1|||
16494408|NCT00456521|40281000|FG000|Overall Study|Drug non-compliance, moved, other|26|||
16494409|NCT00456521|40281001|FG001|Overall Study|Drug non-compliance, moved, other|11|||
16494410|NCT02268084|40281004|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
16494411|NCT02268084|40281005|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
16494412|NCT02268084|40281004|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
16305774|NCT04439201|39605009|FG000|Overall Study|Mutation status not confirmed|4|||
16305775|NCT04439201|39605009|FG000|Overall Study|Adverse Event|1|||
16305776|NCT04439201|39605009|FG000|Overall Study|Death|7|||
16305777|NCT04439201|39605009|FG000|Overall Study|Withdrawal by Subject|2|||
16305778|NCT04439201|39605009|FG000|Overall Study|Disease progression|20|||
16305779|NCT04439201|39605009|FG000|Overall Study|Alternative therapy|1|||
16305780|NCT04439201|39605009|FG000|Overall Study|Physician Decision|1|||
16305781|NCT02288312|39605010|FG000|Overall Study|Pregnancy|1|||
16305782|NCT02288312|39605011|FG001|Overall Study|Pregnancy|0|||
16305783|NCT02288312|39605012|FG002|Overall Study|Pregnancy|0|||
16305784|NCT02548832|39605017|FG000|Overall Study|Lost to Follow-up|2|||
16494413|NCT02268084|40281005|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
16494414|NCT02329730|40281006|FG000|Overall Study|Protocol Violation|0|||
16494415|NCT02329730|40281007|FG001|Overall Study|Protocol Violation|0|||
16494416|NCT02329730|40281008|FG002|Overall Study|Protocol Violation|0|||
16494417|NCT02329730|40281009|FG003|Overall Study|Protocol Violation|0|||
16494418|NCT02329730|40281010|FG004|Overall Study|Protocol Violation|2|||
16494419|NCT02329730|40281011|FG005|Overall Study|Protocol Violation|2|||
16494420|NCT02329730|40281012|FG006|Overall Study|Protocol Violation|0|||
16494421|NCT02329730|40281013|FG007|Overall Study|Protocol Violation|0|||
16494422|NCT02329730|40281014|FG008|Overall Study|Protocol Violation|0|||
16494423|NCT02329730|40281015|FG009|Overall Study|Protocol Violation|0|||
16494424|NCT02329730|40281016|FG010|Overall Study|Protocol Violation|0|||
16494425|NCT02329730|40281017|FG011|Overall Study|Protocol Violation|0|||
16494426|NCT02329730|40281006|FG000|Overall Study|Withdrawal by Subject|0|||
16494427|NCT02329730|40281007|FG001|Overall Study|Withdrawal by Subject|0|||
16494428|NCT02329730|40281008|FG002|Overall Study|Withdrawal by Subject|0|||
16494429|NCT02329730|40281009|FG003|Overall Study|Withdrawal by Subject|0|||
16494430|NCT02329730|40281010|FG004|Overall Study|Withdrawal by Subject|1|||
16494431|NCT02329730|40281011|FG005|Overall Study|Withdrawal by Subject|0|||
16494432|NCT02329730|40281012|FG006|Overall Study|Withdrawal by Subject|1|||
16494433|NCT02329730|40281013|FG007|Overall Study|Withdrawal by Subject|1|||
16305785|NCT02548832|39605018|FG001|Overall Study|Lost to Follow-up|2|||
16494434|NCT02329730|40281014|FG008|Overall Study|Withdrawal by Subject|1|||
16305786|NCT02548832|39605019|FG002|Overall Study|Lost to Follow-up|2|||
16494435|NCT02329730|40281015|FG009|Overall Study|Withdrawal by Subject|1|||
16494436|NCT02329730|40281016|FG010|Overall Study|Withdrawal by Subject|0|||
16494437|NCT02329730|40281017|FG011|Overall Study|Withdrawal by Subject|0|||
16494438|NCT03715764|40281018|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
16494439|NCT03715764|40281019|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
16494440|NCT03715764|40281018|FG000|3 Month Follow-up|Lost to Follow-up|2|||
16494441|NCT03715764|40281019|FG001|3 Month Follow-up|Lost to Follow-up|2|||
16494442|NCT03715764|40281018|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
16494443|NCT03715764|40281019|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
16494444|NCT03715764|40281018|FG000|6 Month Follow-up|Lost to Follow-up|3|||
16494445|NCT03715764|40281019|FG001|6 Month Follow-up|Lost to Follow-up|0|||
16494446|NCT03715764|40281018|FG000|12 Month Follow-up|Lost to Follow-up|2|||
16494447|NCT03715764|40281019|FG001|12 Month Follow-up|Lost to Follow-up|3|||
16494448|NCT03715764|40281018|FG000|12 Month Follow-up|Pregnancy|0|||
16494449|NCT03715764|40281019|FG001|12 Month Follow-up|Pregnancy|1|||
16494450|NCT03715764|40281018|FG000|12 Month Follow-up|Surgery|2|||
16494451|NCT03715764|40281019|FG001|12 Month Follow-up|Surgery|0|||
16494452|NCT03715764|40281018|FG000|12 Month Follow-up|Wrong address|1|||
16494453|NCT03715764|40281019|FG001|12 Month Follow-up|Wrong address|0|||
16494454|NCT03715764|40281018|FG000|12 Month Follow-up|No symptoms|1|||
16494455|NCT03715764|40281019|FG001|12 Month Follow-up|No symptoms|0|||
16494456|NCT03715764|40281018|FG000|12 Month Follow-up|Changed primary care centre|0|||
16494457|NCT03715764|40281019|FG001|12 Month Follow-up|Changed primary care centre|1|||
16494458|NCT01224431|40281024|FG000|Overall Study|not randomized|0|||
16494459|NCT01224431|40281025|FG001|Overall Study|not randomized|4|||
16494460|NCT01224431|40281024|FG000|Overall Study|no video record|0|||
16494461|NCT01224431|40281025|FG001|Overall Study|no video record|1|||
16084904|NCT01500200|38802595|FG000|Stage 1|Lost to Follow-up|2|||
16305787|NCT01810302|39605020|FG000|Overall Study|Death|1|||
16494462|NCT03557151|40281026|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
16494463|NCT03557151|40281027|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
16494464|NCT03557151|40281026|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
16494465|NCT03557151|40281027|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
16494466|NCT03557151|40281026|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
16494467|NCT03557151|40281027|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
16494468|NCT02603419|40281028|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
16494469|NCT02603419|40281029|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
16494470|NCT02603419|40281030|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
16494471|NCT02603419|40281031|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
16494472|NCT02603419|40281032|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
16494473|NCT02603419|40281033|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
16494474|NCT02603419|40281028|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
16305788|NCT01810302|39605021|FG001|Overall Study|Death|0|||
16305789|NCT01810302|39605020|FG000|Overall Study|Physician Decision|0|||
16305790|NCT01810302|39605021|FG001|Overall Study|Physician Decision|1|||
16305791|NCT01565707|39605022|FG000|Overall Study|Adverse Event|1|||
16305792|NCT01565707|39605023|FG001|Overall Study|Adverse Event|6|||
16305793|NCT01565707|39605024|FG002|Overall Study|Adverse Event|2|||
16305794|NCT01565707|39605025|FG003|Overall Study|Adverse Event|1|||
16305795|NCT01565707|39605022|FG000|Overall Study|Lost to Follow-up|1|||
16305796|NCT01565707|39605023|FG001|Overall Study|Lost to Follow-up|0|||
16305797|NCT01565707|39605024|FG002|Overall Study|Lost to Follow-up|0|||
16305798|NCT01565707|39605025|FG003|Overall Study|Lost to Follow-up|0|||
16305799|NCT01565707|39605022|FG000|Overall Study|Protocol Violation|1|||
16305800|NCT01565707|39605023|FG001|Overall Study|Protocol Violation|0|||
16305801|NCT01565707|39605024|FG002|Overall Study|Protocol Violation|0|||
16305802|NCT01565707|39605025|FG003|Overall Study|Protocol Violation|1|||
16305803|NCT01565707|39605022|FG000|Overall Study|Withdrawal by Subject|3|||
16305804|NCT01565707|39605023|FG001|Overall Study|Withdrawal by Subject|1|||
16305805|NCT01565707|39605024|FG002|Overall Study|Withdrawal by Subject|1|||
16305806|NCT01565707|39605025|FG003|Overall Study|Withdrawal by Subject|1|||
16305807|NCT01565707|39605022|FG000|Overall Study|Randomized but not evaluable|2|||
16305808|NCT01565707|39605023|FG001|Overall Study|Randomized but not evaluable|0|||
16084905|NCT01500200|38802596|FG001|Stage 1|Lost to Follow-up|2|||
16305809|NCT01565707|39605024|FG002|Overall Study|Randomized but not evaluable|0|||
16305810|NCT01565707|39605025|FG003|Overall Study|Randomized but not evaluable|0|||
16494475|NCT02603419|40281029|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
16494476|NCT02603419|40281030|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
16494477|NCT02603419|40281031|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
16494478|NCT02603419|40281032|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
16494479|NCT02603419|40281033|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
16494480|NCT02603419|40281028|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
16494481|NCT02603419|40281029|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
16494482|NCT02603419|40281030|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
16494483|NCT02603419|40281031|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
16494484|NCT02603419|40281032|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
16494485|NCT02603419|40281033|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
16494486|NCT02603419|40281028|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
16494487|NCT02603419|40281029|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
16494488|NCT02603419|40281030|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
16494489|NCT02603419|40281031|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
16494490|NCT02603419|40281032|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
16494491|NCT02603419|40281033|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
16494492|NCT02603419|40281028|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
16494493|NCT02603419|40281029|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
16494494|NCT02603419|40281030|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
16494495|NCT02603419|40281031|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
16494496|NCT02603419|40281032|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
16494497|NCT02603419|40281033|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
16494498|NCT02603419|40281028|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
16494499|NCT02603419|40281029|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
16494500|NCT02603419|40281030|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
16494501|NCT02603419|40281031|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
16494502|NCT02603419|40281032|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
16494503|NCT02603419|40281033|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
16494504|NCT02603419|40281028|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
16494505|NCT02603419|40281029|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
16494506|NCT02603419|40281030|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
16494507|NCT02603419|40281031|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
16494508|NCT02603419|40281032|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
16494509|NCT02603419|40281033|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
16494510|NCT02603419|40281028|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
16494511|NCT02603419|40281029|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
16494512|NCT02603419|40281030|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
16494513|NCT02603419|40281031|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
16494514|NCT02603419|40281032|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
16494515|NCT02603419|40281033|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
16494516|NCT02603419|40281028|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
16494517|NCT02603419|40281029|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
16494518|NCT02603419|40281030|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
16494519|NCT02603419|40281031|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
16494520|NCT02603419|40281032|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
16494521|NCT02603419|40281033|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
16494522|NCT02603419|40281028|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
16494523|NCT02603419|40281029|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
16494524|NCT02603419|40281030|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
16494525|NCT02603419|40281031|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
16494526|NCT02603419|40281032|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
16494527|NCT02603419|40281033|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
16494528|NCT01852110|40281038|FG000|Overall Study|Adverse Event|12|||
16494529|NCT01852110|40281039|FG001|Overall Study|Adverse Event|5|||
16494530|NCT01852110|40281040|FG002|Overall Study|Adverse Event|0|||
16494531|NCT01852110|40281041|FG003|Overall Study|Adverse Event|0|||
16494532|NCT01852110|40281042|FG004|Overall Study|Adverse Event|0|||
16494533|NCT01852110|40281043|FG005|Overall Study|Adverse Event|0|||
16305811|NCT01565707|39605022|FG000|Overall Study|Miscellaneous|1|||
16193709|NCT01606761|39188609|FG002|Prior to Week 24|Lack of Efficacy|8|||
16494534|NCT01852110|40281038|FG000|Overall Study|Lost to Follow-up|1|||
16494535|NCT01852110|40281039|FG001|Overall Study|Lost to Follow-up|3|||
16494536|NCT01852110|40281040|FG002|Overall Study|Lost to Follow-up|0|||
16494537|NCT01852110|40281041|FG003|Overall Study|Lost to Follow-up|0|||
16494538|NCT01852110|40281042|FG004|Overall Study|Lost to Follow-up|0|||
16494539|NCT01852110|40281043|FG005|Overall Study|Lost to Follow-up|0|||
16494540|NCT01852110|40281038|FG000|Overall Study|Non-compliance with Study Drug|2|||
16494541|NCT01852110|40281039|FG001|Overall Study|Non-compliance with Study Drug|1|||
16494542|NCT01852110|40281040|FG002|Overall Study|Non-compliance with Study Drug|0|||
16494543|NCT01852110|40281041|FG003|Overall Study|Non-compliance with Study Drug|0|||
16494544|NCT01852110|40281042|FG004|Overall Study|Non-compliance with Study Drug|0|||
16494545|NCT01852110|40281043|FG005|Overall Study|Non-compliance with Study Drug|0|||
16494546|NCT01852110|40281038|FG000|Overall Study|Physician Decision|1|||
16494547|NCT01852110|40281039|FG001|Overall Study|Physician Decision|0|||
16494548|NCT01852110|40281040|FG002|Overall Study|Physician Decision|0|||
16494549|NCT01852110|40281041|FG003|Overall Study|Physician Decision|0|||
16494550|NCT01852110|40281042|FG004|Overall Study|Physician Decision|0|||
16494551|NCT01852110|40281043|FG005|Overall Study|Physician Decision|0|||
16494552|NCT01852110|40281038|FG000|Overall Study|Protocol Violation|0|||
16494553|NCT01852110|40281039|FG001|Overall Study|Protocol Violation|1|||
16494554|NCT01852110|40281040|FG002|Overall Study|Protocol Violation|0|||
16494555|NCT01852110|40281041|FG003|Overall Study|Protocol Violation|0|||
16494556|NCT01852110|40281042|FG004|Overall Study|Protocol Violation|0|||
16494557|NCT01852110|40281043|FG005|Overall Study|Protocol Violation|0|||
16494558|NCT01852110|40281038|FG000|Overall Study|Study Terminated by Sponsor|30|||
16084906|NCT01500200|38802597|FG002|Stage 1|Lost to Follow-up|1|||
16084907|NCT01500200|38802598|FG003|Stage 1|Lost to Follow-up|0|||
16084908|NCT01500200|38802599|FG004|Stage 1|Lost to Follow-up|0|||
16084909|NCT01500200|38802600|FG005|Stage 1|Lost to Follow-up|0|||
16084910|NCT01500200|38802595|FG000|Stage 1|Withdrawal by Subject|3|||
16084911|NCT01500200|38802596|FG001|Stage 1|Withdrawal by Subject|0|||
16084912|NCT01500200|38802597|FG002|Stage 1|Withdrawal by Subject|0|||
16084913|NCT01500200|38802598|FG003|Stage 1|Withdrawal by Subject|0|||
16084914|NCT01500200|38802599|FG004|Stage 1|Withdrawal by Subject|0|||
16084915|NCT01500200|38802600|FG005|Stage 1|Withdrawal by Subject|0|||
16084916|NCT01500200|38802595|FG000|Stage 1|Noncompliance with Study Drug|1|||
16084917|NCT01500200|38802596|FG001|Stage 1|Noncompliance with Study Drug|0|||
16084918|NCT01500200|38802597|FG002|Stage 1|Noncompliance with Study Drug|0|||
16084919|NCT01500200|38802598|FG003|Stage 1|Noncompliance with Study Drug|0|||
16084920|NCT01500200|38802599|FG004|Stage 1|Noncompliance with Study Drug|0|||
16193710|NCT01606761|39188610|FG003|Prior to Week 24|Lack of Efficacy|0|||
16193711|NCT01606761|39188611|FG004|Prior to Week 24|Lack of Efficacy|0|||
16084921|NCT01500200|38802600|FG005|Stage 1|Noncompliance with Study Drug|0|||
16084922|NCT01500200|38802595|FG000|Stage 1|Physician Decision|1|||
16084923|NCT01500200|38802596|FG001|Stage 1|Physician Decision|0|||
16084924|NCT01500200|38802597|FG002|Stage 1|Physician Decision|0|||
16084925|NCT01500200|38802598|FG003|Stage 1|Physician Decision|0|||
16193712|NCT01606761|39188607|FG000|Prior to Week 24|Physician Decision|0|||
16193713|NCT01606761|39188608|FG001|Prior to Week 24|Physician Decision|3|||
16193714|NCT01606761|39188609|FG002|Prior to Week 24|Physician Decision|1|||
16193715|NCT01606761|39188610|FG003|Prior to Week 24|Physician Decision|0|||
16193716|NCT01606761|39188611|FG004|Prior to Week 24|Physician Decision|0|||
16193717|NCT01606761|39188607|FG000|Prior to Week 24|Other|4|||
16193718|NCT01606761|39188608|FG001|Prior to Week 24|Other|7|||
16193719|NCT01606761|39188609|FG002|Prior to Week 24|Other|5|||
16193720|NCT01606761|39188610|FG003|Prior to Week 24|Other|0|||
16193721|NCT01606761|39188611|FG004|Prior to Week 24|Other|0|||
16193722|NCT01606761|39188607|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
16193723|NCT01606761|39188608|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
16193724|NCT01606761|39188609|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
16193725|NCT01606761|39188610|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
16193726|NCT01606761|39188611|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
16193727|NCT01606761|39188607|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
16193728|NCT01606761|39188608|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
16193729|NCT01606761|39188609|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
16193730|NCT01606761|39188610|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
16494559|NCT01852110|40281039|FG001|Overall Study|Study Terminated by Sponsor|32|||
16494560|NCT01852110|40281040|FG002|Overall Study|Study Terminated by Sponsor|0|||
16494561|NCT01852110|40281041|FG003|Overall Study|Study Terminated by Sponsor|0|||
16494562|NCT01852110|40281042|FG004|Overall Study|Study Terminated by Sponsor|0|||
16494563|NCT01852110|40281043|FG005|Overall Study|Study Terminated by Sponsor|0|||
16494564|NCT01852110|40281038|FG000|Overall Study|Withdrawal by Subject|4|||
16494565|NCT01852110|40281039|FG001|Overall Study|Withdrawal by Subject|4|||
16494566|NCT01852110|40281040|FG002|Overall Study|Withdrawal by Subject|0|||
16494567|NCT01852110|40281041|FG003|Overall Study|Withdrawal by Subject|0|||
16494568|NCT01852110|40281042|FG004|Overall Study|Withdrawal by Subject|0|||
16494569|NCT01852110|40281043|FG005|Overall Study|Withdrawal by Subject|0|||
16494570|NCT04656691|40281044|FG000|Overall Study|Adverse Event|1|||
16305812|NCT01565707|39605023|FG001|Overall Study|Miscellaneous|1|||
16305813|NCT01565707|39605024|FG002|Overall Study|Miscellaneous|0|||
16305814|NCT01565707|39605025|FG003|Overall Study|Miscellaneous|2|||
16305815|NCT02121652|39605030|FG000|Overall Study|Lost to Follow-up|2|||
16305816|NCT02121652|39605031|FG001|Overall Study|Lost to Follow-up|1|||
16305817|NCT02121652|39605030|FG000|Overall Study|Death|1|||
16305818|NCT02121652|39605031|FG001|Overall Study|Death|0|||
16305819|NCT02121652|39605030|FG000|Overall Study|Withdrawal by Subject|3|||
16305820|NCT02121652|39605031|FG001|Overall Study|Withdrawal by Subject|3|||
16305821|NCT00193050|39605032|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
16305822|NCT00193050|39605032|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
16305823|NCT00193050|39605032|FG000|Neoadjuvant Treatment|Physician Decision|2|||
16305824|NCT00193050|39605032|FG000|Neoadjuvant Treatment|Adverse Event|2|||
16305825|NCT00193050|39605032|FG000|Adjuvant|Physician Decision|5|||
16305826|NCT00193050|39605032|FG000|Adjuvant|Intercurrent Hospitalization|3|||
16305827|NCT00193050|39605032|FG000|Adjuvant|Lack of Efficacy|2|||
16305828|NCT01982955|39605033|FG000|Overall Study|Randomized but not treated|0|||
16305829|NCT01982955|39605034|FG001|Overall Study|Randomized but not treated|0|||
16305830|NCT01982955|39605035|FG002|Overall Study|Randomized but not treated|0|||
16305831|NCT01982955|39605036|FG003|Overall Study|Randomized but not treated|1|||
16305832|NCT01982955|39605037|FG004|Overall Study|Randomized but not treated|0|||
16305833|NCT03004183|39605038|FG000|Overall Study|Adverse Event|7|||
16305834|NCT03004183|39605038|FG000|Overall Study|Lost to Follow-up|1|||
16305835|NCT03004183|39605038|FG000|Overall Study|Physician Decision|40|||
16305836|NCT03004183|39605038|FG000|Overall Study|Withdrawal by Subject|1|||
16305837|NCT03004183|39605038|FG000|Overall Study|COVID-19|1|||
16305838|NCT02452476|39605042|FG000|Overall Study|Death|4|||
16305839|NCT02452476|39605043|FG001|Overall Study|Death|7|||
16305840|NCT02452476|39605042|FG000|Overall Study|Lost to Follow-up|1|||
16305841|NCT02452476|39605043|FG001|Overall Study|Lost to Follow-up|1|||
16305842|NCT02452476|39605042|FG000|Overall Study|Physician Decision|1|||
16305843|NCT02452476|39605043|FG001|Overall Study|Physician Decision|1|||
16305844|NCT02452476|39605042|FG000|Overall Study|Not treated|5|||
16305845|NCT02452476|39605043|FG001|Overall Study|Not treated|1|||
16305860|NCT02862730|39605049|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
16305861|NCT02862730|39605050|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
16305862|NCT02862730|39605051|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
16305863|NCT02862730|39605052|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
16305864|NCT02862730|39605053|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
16305865|NCT02862730|39605054|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
16305866|NCT02862730|39605055|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
16305867|NCT02862730|39605049|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
16305868|NCT02862730|39605050|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
16305869|NCT02862730|39605051|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
16305870|NCT02862730|39605052|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
16305871|NCT02862730|39605053|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
16305872|NCT02862730|39605054|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
16305873|NCT02862730|39605055|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
16305874|NCT02862730|39605049|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
16305875|NCT02862730|39605050|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
16305876|NCT02862730|39605051|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
16305877|NCT02862730|39605052|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
16305878|NCT02862730|39605053|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
16305879|NCT02862730|39605054|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
16305880|NCT02862730|39605055|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
16305881|NCT02862730|39605049|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
16305882|NCT02862730|39605050|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
16305883|NCT02862730|39605051|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
16084926|NCT01500200|38802599|FG004|Stage 1|Physician Decision|0|||
16388227|NCT03381287|39905597|FG001|Overall Study|Physician Decision|0|||
16084927|NCT01500200|38802600|FG005|Stage 1|Physician Decision|0|||
16084928|NCT01500200|38802595|FG000|Stage 2|Adverse Event|0|||
16084929|NCT01500200|38802596|FG001|Stage 2|Adverse Event|0|||
16084930|NCT01500200|38802597|FG002|Stage 2|Adverse Event|0|||
16084931|NCT01500200|38802598|FG003|Stage 2|Adverse Event|0|||
16494571|NCT03130257|40281045|FG000|Overall Study|Withdrawal by Subject|1|||
16494572|NCT03130257|40281046|FG001|Overall Study|Withdrawal by Subject|0|||
16494573|NCT03130257|40281047|FG002|Overall Study|Withdrawal by Subject|2|||
16494574|NCT01543698|40281048|FG000|Phase 1b|Disease progression|2|||
16494575|NCT01543698|40281049|FG001|Phase 1b|Disease progression|4|||
16494576|NCT01543698|40281050|FG002|Phase 1b|Disease progression|3|||
16494577|NCT01543698|40281051|FG003|Phase 1b|Disease progression|2|||
16494578|NCT01543698|40281052|FG004|Phase 1b|Disease progression|10|||
16494579|NCT01543698|40281053|FG005|Phase 1b|Disease progression|6|||
16494580|NCT01543698|40281054|FG006|Phase 1b|Disease progression|5|||
16494581|NCT01543698|40281055|FG007|Phase 1b|Disease progression|3|||
16494582|NCT01543698|40281056|FG008|Phase 1b|Disease progression|4|||
16494583|NCT01543698|40281057|FG009|Phase 1b|Disease progression|5|||
16494584|NCT01543698|40281058|FG010|Phase 1b|Disease progression|1|||
16494585|NCT01543698|40281059|FG011|Phase 1b|Disease progression|0|||
16494586|NCT01543698|40281060|FG012|Phase 1b|Disease progression|0|||
16494587|NCT01543698|40281061|FG013|Phase 1b|Disease progression|0|||
16494588|NCT01543698|40281062|FG014|Phase 1b|Disease progression|0|||
16494589|NCT01543698|40281048|FG000|Phase 1b|Death|0|||
16494590|NCT01543698|40281049|FG001|Phase 1b|Death|0|||
16494591|NCT01543698|40281050|FG002|Phase 1b|Death|1|||
16494592|NCT01543698|40281051|FG003|Phase 1b|Death|1|||
16494593|NCT01543698|40281052|FG004|Phase 1b|Death|0|||
16494594|NCT01543698|40281053|FG005|Phase 1b|Death|0|||
16494595|NCT01543698|40281054|FG006|Phase 1b|Death|0|||
16494596|NCT01543698|40281055|FG007|Phase 1b|Death|0|||
16494597|NCT01543698|40281056|FG008|Phase 1b|Death|0|||
16494598|NCT01543698|40281057|FG009|Phase 1b|Death|0|||
16494599|NCT01543698|40281058|FG010|Phase 1b|Death|1|||
16494600|NCT01543698|40281059|FG011|Phase 1b|Death|0|||
16494601|NCT01543698|40281060|FG012|Phase 1b|Death|0|||
16494602|NCT01543698|40281061|FG013|Phase 1b|Death|0|||
16494603|NCT01543698|40281062|FG014|Phase 1b|Death|0|||
16494604|NCT01543698|40281048|FG000|Phase 1b|Withdrawal by Subject|0|||
16494605|NCT01543698|40281049|FG001|Phase 1b|Withdrawal by Subject|1|||
16494606|NCT01543698|40281050|FG002|Phase 1b|Withdrawal by Subject|0|||
16494607|NCT01543698|40281051|FG003|Phase 1b|Withdrawal by Subject|1|||
16494608|NCT01543698|40281052|FG004|Phase 1b|Withdrawal by Subject|0|||
16494609|NCT01543698|40281053|FG005|Phase 1b|Withdrawal by Subject|0|||
16494610|NCT01543698|40281054|FG006|Phase 1b|Withdrawal by Subject|1|||
16494611|NCT01543698|40281055|FG007|Phase 1b|Withdrawal by Subject|0|||
16494612|NCT01543698|40281056|FG008|Phase 1b|Withdrawal by Subject|0|||
16494613|NCT01543698|40281057|FG009|Phase 1b|Withdrawal by Subject|0|||
16494614|NCT01543698|40281058|FG010|Phase 1b|Withdrawal by Subject|0|||
16494615|NCT01543698|40281059|FG011|Phase 1b|Withdrawal by Subject|0|||
16494616|NCT01543698|40281060|FG012|Phase 1b|Withdrawal by Subject|0|||
16494617|NCT01543698|40281061|FG013|Phase 1b|Withdrawal by Subject|0|||
16494618|NCT01543698|40281062|FG014|Phase 1b|Withdrawal by Subject|0|||
16494619|NCT01543698|40281048|FG000|Phase 1b|Adverse Event|1|||
16494620|NCT01543698|40281049|FG001|Phase 1b|Adverse Event|0|||
16494621|NCT01543698|40281050|FG002|Phase 1b|Adverse Event|0|||
16494622|NCT01543698|40281051|FG003|Phase 1b|Adverse Event|1|||
16494623|NCT01543698|40281052|FG004|Phase 1b|Adverse Event|2|||
16494624|NCT01543698|40281053|FG005|Phase 1b|Adverse Event|2|||
16494625|NCT01543698|40281054|FG006|Phase 1b|Adverse Event|0|||
16494626|NCT01543698|40281055|FG007|Phase 1b|Adverse Event|0|||
16494627|NCT01543698|40281056|FG008|Phase 1b|Adverse Event|1|||
16494628|NCT01543698|40281057|FG009|Phase 1b|Adverse Event|1|||
16494629|NCT01543698|40281058|FG010|Phase 1b|Adverse Event|2|||
16494630|NCT01543698|40281059|FG011|Phase 1b|Adverse Event|0|||
16494631|NCT01543698|40281060|FG012|Phase 1b|Adverse Event|0|||
16494632|NCT01543698|40281061|FG013|Phase 1b|Adverse Event|0|||
16494633|NCT01543698|40281062|FG014|Phase 1b|Adverse Event|0|||
16494634|NCT01543698|40281048|FG000|Phase 1b|Administrative problems|1|||
16494635|NCT01543698|40281049|FG001|Phase 1b|Administrative problems|0|||
16494636|NCT01543698|40281050|FG002|Phase 1b|Administrative problems|0|||
16494637|NCT01543698|40281051|FG003|Phase 1b|Administrative problems|0|||
16494638|NCT01543698|40281052|FG004|Phase 1b|Administrative problems|1|||
16494639|NCT01543698|40281053|FG005|Phase 1b|Administrative problems|0|||
16494640|NCT01543698|40281054|FG006|Phase 1b|Administrative problems|0|||
16494641|NCT01543698|40281055|FG007|Phase 1b|Administrative problems|1|||
16494642|NCT01543698|40281056|FG008|Phase 1b|Administrative problems|0|||
16494643|NCT01543698|40281057|FG009|Phase 1b|Administrative problems|0|||
16084932|NCT01500200|38802599|FG004|Stage 2|Adverse Event|5|||
16494644|NCT01543698|40281058|FG010|Phase 1b|Administrative problems|2|||
16494645|NCT01543698|40281059|FG011|Phase 1b|Administrative problems|0|||
16494646|NCT01543698|40281060|FG012|Phase 1b|Administrative problems|0|||
16494647|NCT01543698|40281061|FG013|Phase 1b|Administrative problems|0|||
16494648|NCT01543698|40281062|FG014|Phase 1b|Administrative problems|0|||
16494649|NCT01543698|40281048|FG000|Phase 1b|Protocol Violation|2|||
16494650|NCT01543698|40281049|FG001|Phase 1b|Protocol Violation|0|||
16494651|NCT01543698|40281050|FG002|Phase 1b|Protocol Violation|0|||
16494652|NCT01543698|40281051|FG003|Phase 1b|Protocol Violation|0|||
16494653|NCT01543698|40281052|FG004|Phase 1b|Protocol Violation|0|||
16494654|NCT01543698|40281053|FG005|Phase 1b|Protocol Violation|0|||
16494655|NCT01543698|40281054|FG006|Phase 1b|Protocol Violation|0|||
16494656|NCT01543698|40281055|FG007|Phase 1b|Protocol Violation|0|||
16494657|NCT01543698|40281056|FG008|Phase 1b|Protocol Violation|0|||
16494658|NCT01543698|40281057|FG009|Phase 1b|Protocol Violation|0|||
16494659|NCT01543698|40281058|FG010|Phase 1b|Protocol Violation|0|||
16494660|NCT01543698|40281059|FG011|Phase 1b|Protocol Violation|0|||
16494661|NCT01543698|40281060|FG012|Phase 1b|Protocol Violation|0|||
16494662|NCT01543698|40281061|FG013|Phase 1b|Protocol Violation|0|||
16494663|NCT01543698|40281062|FG014|Phase 1b|Protocol Violation|0|||
16494664|NCT01543698|40281048|FG000|Phase 2|Protocol Violation|0|||
16494665|NCT01543698|40281049|FG001|Phase 2|Protocol Violation|0|||
16494666|NCT01543698|40281050|FG002|Phase 2|Protocol Violation|0|||
16494667|NCT01543698|40281051|FG003|Phase 2|Protocol Violation|0|||
16494668|NCT01543698|40281052|FG004|Phase 2|Protocol Violation|0|||
16494669|NCT01543698|40281053|FG005|Phase 2|Protocol Violation|0|||
16494670|NCT01543698|40281054|FG006|Phase 2|Protocol Violation|0|||
16494671|NCT01543698|40281055|FG007|Phase 2|Protocol Violation|0|||
16494672|NCT01543698|40281056|FG008|Phase 2|Protocol Violation|0|||
16494673|NCT01543698|40281057|FG009|Phase 2|Protocol Violation|0|||
16494674|NCT01543698|40281058|FG010|Phase 2|Protocol Violation|0|||
16494675|NCT01543698|40281059|FG011|Phase 2|Protocol Violation|0|||
16494676|NCT01543698|40281060|FG012|Phase 2|Protocol Violation|1|||
16494677|NCT01543698|40281061|FG013|Phase 2|Protocol Violation|0|||
16494678|NCT01543698|40281062|FG014|Phase 2|Protocol Violation|0|||
16494679|NCT01543698|40281048|FG000|Phase 2|Disease progression|0|||
16494680|NCT01543698|40281049|FG001|Phase 2|Disease progression|0|||
16494681|NCT01543698|40281050|FG002|Phase 2|Disease progression|0|||
16494682|NCT01543698|40281051|FG003|Phase 2|Disease progression|0|||
16494683|NCT01543698|40281052|FG004|Phase 2|Disease progression|0|||
16494684|NCT01543698|40281053|FG005|Phase 2|Disease progression|0|||
16494685|NCT01543698|40281054|FG006|Phase 2|Disease progression|0|||
16494686|NCT01543698|40281055|FG007|Phase 2|Disease progression|0|||
16494687|NCT01543698|40281056|FG008|Phase 2|Disease progression|0|||
16494688|NCT01543698|40281057|FG009|Phase 2|Disease progression|0|||
16494689|NCT01543698|40281058|FG010|Phase 2|Disease progression|0|||
16494690|NCT01543698|40281059|FG011|Phase 2|Disease progression|10|||
16494691|NCT01543698|40281060|FG012|Phase 2|Disease progression|21|||
16494692|NCT01543698|40281061|FG013|Phase 2|Disease progression|30|||
16494693|NCT01543698|40281062|FG014|Phase 2|Disease progression|25|||
16494694|NCT01543698|40281048|FG000|Phase 2|Death|0|||
16494695|NCT01543698|40281049|FG001|Phase 2|Death|0|||
16494696|NCT01543698|40281050|FG002|Phase 2|Death|0|||
16494697|NCT01543698|40281051|FG003|Phase 2|Death|0|||
16494698|NCT01543698|40281052|FG004|Phase 2|Death|0|||
16494699|NCT01543698|40281053|FG005|Phase 2|Death|0|||
16494700|NCT01543698|40281054|FG006|Phase 2|Death|0|||
16494701|NCT01543698|40281055|FG007|Phase 2|Death|0|||
16494702|NCT01543698|40281056|FG008|Phase 2|Death|0|||
16494703|NCT01543698|40281057|FG009|Phase 2|Death|0|||
16494704|NCT01543698|40281058|FG010|Phase 2|Death|0|||
16494705|NCT01543698|40281059|FG011|Phase 2|Death|0|||
16494706|NCT01543698|40281060|FG012|Phase 2|Death|1|||
16494707|NCT01543698|40281061|FG013|Phase 2|Death|1|||
16494708|NCT01543698|40281062|FG014|Phase 2|Death|1|||
16494709|NCT01543698|40281048|FG000|Phase 2|Administrative problems|0|||
16494710|NCT01543698|40281049|FG001|Phase 2|Administrative problems|0|||
16494711|NCT01543698|40281050|FG002|Phase 2|Administrative problems|0|||
16494712|NCT01543698|40281051|FG003|Phase 2|Administrative problems|0|||
16494713|NCT01543698|40281052|FG004|Phase 2|Administrative problems|0|||
16494714|NCT01543698|40281053|FG005|Phase 2|Administrative problems|0|||
16494715|NCT01543698|40281054|FG006|Phase 2|Administrative problems|0|||
16494716|NCT01543698|40281055|FG007|Phase 2|Administrative problems|0|||
16494717|NCT01543698|40281056|FG008|Phase 2|Administrative problems|0|||
16494718|NCT01543698|40281057|FG009|Phase 2|Administrative problems|0|||
16494719|NCT01543698|40281058|FG010|Phase 2|Administrative problems|0|||
16494720|NCT01543698|40281059|FG011|Phase 2|Administrative problems|0|||
16494721|NCT01543698|40281060|FG012|Phase 2|Administrative problems|0|||
16494722|NCT01543698|40281061|FG013|Phase 2|Administrative problems|3|||
16494723|NCT01543698|40281062|FG014|Phase 2|Administrative problems|1|||
16494724|NCT01543698|40281048|FG000|Phase 2|Withdrawal by Subject|0|||
16494725|NCT01543698|40281049|FG001|Phase 2|Withdrawal by Subject|0|||
16494726|NCT01543698|40281050|FG002|Phase 2|Withdrawal by Subject|0|||
16494727|NCT01543698|40281051|FG003|Phase 2|Withdrawal by Subject|0|||
16494728|NCT01543698|40281052|FG004|Phase 2|Withdrawal by Subject|0|||
16494729|NCT01543698|40281053|FG005|Phase 2|Withdrawal by Subject|0|||
16494730|NCT01543698|40281054|FG006|Phase 2|Withdrawal by Subject|0|||
16494731|NCT01543698|40281055|FG007|Phase 2|Withdrawal by Subject|0|||
16494732|NCT01543698|40281056|FG008|Phase 2|Withdrawal by Subject|0|||
16494733|NCT01543698|40281057|FG009|Phase 2|Withdrawal by Subject|0|||
16494734|NCT01543698|40281058|FG010|Phase 2|Withdrawal by Subject|0|||
16494735|NCT01543698|40281059|FG011|Phase 2|Withdrawal by Subject|0|||
16494736|NCT01543698|40281060|FG012|Phase 2|Withdrawal by Subject|0|||
16494737|NCT01543698|40281061|FG013|Phase 2|Withdrawal by Subject|3|||
16494738|NCT01543698|40281062|FG014|Phase 2|Withdrawal by Subject|1|||
16494739|NCT01543698|40281048|FG000|Phase 2|Adverse Event|0|||
16494740|NCT01543698|40281049|FG001|Phase 2|Adverse Event|0|||
16494741|NCT01543698|40281050|FG002|Phase 2|Adverse Event|0|||
16494742|NCT01543698|40281051|FG003|Phase 2|Adverse Event|0|||
16494743|NCT01543698|40281052|FG004|Phase 2|Adverse Event|0|||
16494744|NCT01543698|40281053|FG005|Phase 2|Adverse Event|0|||
16494745|NCT01543698|40281054|FG006|Phase 2|Adverse Event|0|||
16494746|NCT01543698|40281055|FG007|Phase 2|Adverse Event|0|||
16494747|NCT01543698|40281056|FG008|Phase 2|Adverse Event|0|||
16494748|NCT01543698|40281057|FG009|Phase 2|Adverse Event|0|||
16494749|NCT01543698|40281058|FG010|Phase 2|Adverse Event|0|||
16494750|NCT01543698|40281059|FG011|Phase 2|Adverse Event|1|||
16494751|NCT01543698|40281060|FG012|Phase 2|Adverse Event|3|||
16494752|NCT01543698|40281061|FG013|Phase 2|Adverse Event|5|||
16494753|NCT01543698|40281062|FG014|Phase 2|Adverse Event|14|||
16494754|NCT02743520|40281063|FG000|Overall Study|Withdrawal by Subject|1|||
16494755|NCT04118166|40281064|FG000|Overall Study|Adverse Event|1|||
16494756|NCT04840615|40281065|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
16494757|NCT04840615|40281066|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
16494758|NCT04840615|40281067|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
16494759|NCT03055260|40281071|FG000|Overall Study|Withdrawal by Subject|1|||
16494760|NCT03055260|40281072|FG001|Overall Study|Withdrawal by Subject|0|||
16494761|NCT03068130|40281073|FG000|Overall Study|Adverse Event|19|||
16494762|NCT03068130|40281073|FG000|Overall Study|Death|14|||
16494763|NCT03068130|40281073|FG000|Overall Study|Lost to Follow-up|4|||
16494764|NCT03068130|40281073|FG000|Overall Study|Withdrawal by Subject|26|||
16494765|NCT03068130|40281073|FG000|Overall Study|Administrative Reasons|3|||
16494766|NCT03068130|40281073|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
16494767|NCT03068130|40281073|FG000|Overall Study|Study terminated by sponsor|194|||
16494768|NCT00679302|40281074|FG000|Overall Study|Lost to Follow-up|8|||
16494769|NCT00679302|40281075|FG001|Overall Study|Lost to Follow-up|4|||
16494770|NCT01987505|40281076|FG000|Overall Study|Other|9|||
16494771|NCT01987505|40281076|FG000|Overall Study|Withdrawal by Subject|2|||
16494772|NCT01987505|40281076|FG000|Overall Study|Other Reason|2|||
16494773|NCT01987505|40281076|FG000|Overall Study|Lost to Follow-up|15|||
16494774|NCT01987505|40281076|FG000|Overall Study|Investigator Decision|2|||
16494775|NCT01987505|40281076|FG000|Overall Study|Death|4|||
16494776|NCT04868890|40281088|FG000|Overall Study|Death|2|||
16494777|NCT04868890|40281089|FG001|Overall Study|Death|1|||
16494778|NCT04868890|40281088|FG000|Overall Study|Withdrawal by Subject|1|||
16494779|NCT04868890|40281089|FG001|Overall Study|Withdrawal by Subject|5|||
16494780|NCT03266094|40281090|FG000|Overall Study|Lost to Follow-up|1|||
16494781|NCT03266094|40281090|FG000|Overall Study|Withdrawal by Subject|1|||
16494782|NCT00464087|40281091|FG000|Overall Study|No PCI per inclusion criteria|0|||
16494783|NCT00464087|40281092|FG001|Overall Study|No PCI per inclusion criteria|0|||
16494784|NCT00464087|40281093|FG002|Overall Study|No PCI per inclusion criteria|29|||
16494785|NCT04160091|40281099|FG000|Overall Study|Terminated by Sponsor|7|||
16494786|NCT04160091|40281100|FG001|Overall Study|Terminated by Sponsor|3|||
16494787|NCT04160091|40281101|FG002|Overall Study|Terminated by Sponsor|5|||
16494788|NCT04160091|40281102|FG003|Overall Study|Terminated by Sponsor|2|||
16494789|NCT04160091|40281099|FG000|Overall Study|Noncompliance|0|||
16494790|NCT04160091|40281100|FG001|Overall Study|Noncompliance|0|||
16494791|NCT04160091|40281101|FG002|Overall Study|Noncompliance|0|||
16494792|NCT04160091|40281102|FG003|Overall Study|Noncompliance|1|||
16494793|NCT04160091|40281099|FG000|Overall Study|Withdrawal by Subject|0|||
16494794|NCT04160091|40281100|FG001|Overall Study|Withdrawal by Subject|0|||
16494795|NCT04160091|40281101|FG002|Overall Study|Withdrawal by Subject|0|||
16494796|NCT04160091|40281102|FG003|Overall Study|Withdrawal by Subject|1|||
16494797|NCT02782780|40281103|FG000|Overall Study|dropped out after randomization.|7|||
16494798|NCT02782780|40281104|FG001|Overall Study|dropped out after randomization.|5|||
16494799|NCT02782780|40281103|FG000|Overall Study|Protocol Violation|0|||
16494800|NCT02782780|40281104|FG001|Overall Study|Protocol Violation|2|||
16494801|NCT03998189|40281105|FG000|Overall Study|Lack of Efficacy|0|||
16494802|NCT03998189|40281106|FG001|Overall Study|Lack of Efficacy|1|||
16494803|NCT00555321|40281107|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
16494804|NCT00555321|40281108|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
16494805|NCT00555321|40281109|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
16494806|NCT00555321|40281110|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
16494807|NCT00555321|40281111|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
16494808|NCT00555321|40281107|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
16494809|NCT00555321|40281108|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
16494810|NCT00555321|40281109|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
16494811|NCT00555321|40281110|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
16494812|NCT00555321|40281111|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
16494813|NCT00555321|40281107|FG000|Treatment Phase up to 12-months|Death|2|||
16494814|NCT00555321|40281108|FG001|Treatment Phase up to 12-months|Death|1|||
16494815|NCT00555321|40281109|FG002|Treatment Phase up to 12-months|Death|4|||
16494816|NCT00555321|40281110|FG003|Treatment Phase up to 12-months|Death|0|||
16494817|NCT00555321|40281111|FG004|Treatment Phase up to 12-months|Death|0|||
16494818|NCT00555321|40281107|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
16494819|NCT00555321|40281108|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
16494820|NCT00555321|40281109|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
16494821|NCT00555321|40281110|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
16494822|NCT00555321|40281111|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
16494823|NCT00555321|40281107|FG000|Treatment Phase up to 12-months|Other Reason|1|||
16494824|NCT00555321|40281108|FG001|Treatment Phase up to 12-months|Other Reason|3|||
16494825|NCT00555321|40281109|FG002|Treatment Phase up to 12-months|Other Reason|2|||
16494826|NCT00555321|40281110|FG003|Treatment Phase up to 12-months|Other Reason|0|||
16494827|NCT00555321|40281111|FG004|Treatment Phase up to 12-months|Other Reason|0|||
16494828|NCT00555321|40281107|FG000|Treatment Phase up to 12-months|Never treated|2|||
16494829|NCT00555321|40281108|FG001|Treatment Phase up to 12-months|Never treated|3|||
16494830|NCT00555321|40281109|FG002|Treatment Phase up to 12-months|Never treated|1|||
16494831|NCT00555321|40281110|FG003|Treatment Phase up to 12-months|Never treated|0|||
16494832|NCT00555321|40281111|FG004|Treatment Phase up to 12-months|Never treated|4|||
16305884|NCT02862730|39605052|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
16305885|NCT02862730|39605053|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
16305886|NCT02862730|39605054|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
16305887|NCT02862730|39605055|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
16305888|NCT00111241|39605058|FG000|Overall Study|Lost to Follow-up|1|||
16305889|NCT00111241|39605059|FG001|Overall Study|Lost to Follow-up|0|||
16305890|NCT00111241|39605058|FG000|Overall Study|Withdrawal by Subject|4|||
16305891|NCT00111241|39605059|FG001|Overall Study|Withdrawal by Subject|0|||
16305892|NCT00111241|39605058|FG000|Overall Study|Protocol Violation|9|||
16305893|NCT00111241|39605059|FG001|Overall Study|Protocol Violation|8|||
16305894|NCT00111241|39605058|FG000|Overall Study|Adverse Event|1|||
16305895|NCT00111241|39605059|FG001|Overall Study|Adverse Event|0|||
16305896|NCT01911273|39605062|FG000|Overall Study|Progression of Disease|1|||
16305897|NCT01911273|39605063|FG001|Overall Study|Progression of Disease|0|||
16305898|NCT01911273|39605062|FG000|Overall Study|Withdrawal by Subject|0|||
16305899|NCT01911273|39605063|FG001|Overall Study|Withdrawal by Subject|2|||
16305900|NCT02460679|39605065|FG000|Overall Study|Investigator Decision|1|||
16305901|NCT02460679|39605065|FG000|Overall Study|Withdrawal by Subject|4|||
16305902|NCT01750190|39605068|FG000|Overall Study|Adverse Event|47|||
16305903|NCT01750190|39605069|FG001|Overall Study|Adverse Event|19|||
16305904|NCT01750190|39605068|FG000|Overall Study|Death|38|||
16305905|NCT01750190|39605069|FG001|Overall Study|Death|11|||
16305906|NCT01750190|39605068|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
16305907|NCT01750190|39605069|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
16305908|NCT01750190|39605068|FG000|Overall Study|Lost to Follow-up|28|||
16305909|NCT01750190|39605069|FG001|Overall Study|Lost to Follow-up|7|||
16305910|NCT01750190|39605068|FG000|Overall Study|Physician Decision|16|||
16305911|NCT01750190|39605069|FG001|Overall Study|Physician Decision|17|||
16305912|NCT01750190|39605068|FG000|Overall Study|Protocol Violation|6|||
16305913|NCT01750190|39605069|FG001|Overall Study|Protocol Violation|5|||
16305914|NCT01750190|39605068|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
16305915|NCT01750190|39605069|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
16494833|NCT00555321|40281107|FG000|Long-term Extension Phase|Adverse Event|2|||
16494834|NCT00555321|40281108|FG001|Long-term Extension Phase|Adverse Event|5|||
16494835|NCT00555321|40281109|FG002|Long-term Extension Phase|Adverse Event|2|||
16494836|NCT00555321|40281110|FG003|Long-term Extension Phase|Adverse Event|1|||
16305916|NCT01750190|39605068|FG000|Overall Study|Withdrawal by Subject|83|||
16305917|NCT01750190|39605069|FG001|Overall Study|Withdrawal by Subject|89|||
16305918|NCT01750190|39605068|FG000|Overall Study|Kidney Transplant|8|||
16305919|NCT01750190|39605069|FG001|Overall Study|Kidney Transplant|4|||
16305920|NCT01750190|39605068|FG000|Overall Study|Dialysis|22|||
16305921|NCT01750190|39605069|FG001|Overall Study|Dialysis|8|||
16305922|NCT01750190|39605068|FG000|Overall Study|Other than Specified|13|||
16305923|NCT01750190|39605069|FG001|Overall Study|Other than Specified|4|||
16305924|NCT02635984|39605073|FG000|Overall Study|Lost to Follow-up|2|||
16305925|NCT02635984|39605074|FG001|Overall Study|Lost to Follow-up|4|||
16305926|NCT02635984|39605073|FG000|Overall Study|Study Arm Closed|1|||
16305927|NCT02635984|39605074|FG001|Overall Study|Study Arm Closed|0|||
16305928|NCT02016183|39605079|FG000|Overall Study|Case Report Forms Uncollected|13|||
16305929|NCT02016183|39605079|FG000|Overall Study|Protocol Violation|52|||
16305930|NCT02498392|39605080|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
16305931|NCT02498392|39605081|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
16305932|NCT02498392|39605080|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
16305933|NCT02498392|39605081|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
16305934|NCT02498392|39605080|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
16305935|NCT02498392|39605081|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
16305936|NCT02498392|39605080|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
16305937|NCT02498392|39605081|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
16305938|NCT02498392|39605080|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
16305939|NCT02498392|39605081|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
16305940|NCT02498392|39605080|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
16305941|NCT02498392|39605081|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
16305942|NCT00626561|39605082|FG000|Overall Study|Withdrawal by Subject|2|||
16305943|NCT00626561|39605082|FG000|Overall Study|Disease Progression|2|||
16305944|NCT02729909|39605085|FG000|Overall Study|Lost to Follow-up|0|||
16305945|NCT02729909|39605086|FG001|Overall Study|Lost to Follow-up|1|||
16305946|NCT02729909|39605085|FG000|Overall Study|Lack of Efficacy|0|||
16305947|NCT02729909|39605086|FG001|Overall Study|Lack of Efficacy|2|||
16305948|NCT02729909|39605085|FG000|Overall Study|Significant Protocol Deviation|0|||
16305949|NCT02729909|39605086|FG001|Overall Study|Significant Protocol Deviation|2|||
16305950|NCT02729909|39605085|FG000|Overall Study|Voluntary Withdrawal|1|||
16305951|NCT02729909|39605086|FG001|Overall Study|Voluntary Withdrawal|0|||
16305952|NCT04238650|39605087|FG000|Overall Study|Withdrawal by Subject|0|||
16305953|NCT04238650|39605088|FG001|Overall Study|Withdrawal by Subject|1|||
16305954|NCT01320293|39605089|FG000|Overall Study|Lack of Efficacy|1|||
16305955|NCT01320293|39605089|FG000|Overall Study|Adverse Event|1|||
16305956|NCT00711880|39605091|FG000|Overall Study|Adverse Event|11|||
16305957|NCT00711880|39605092|FG001|Overall Study|Adverse Event|2|||
16305958|NCT00711880|39605091|FG000|Overall Study|Patient non-compliance|1|||
16305959|NCT00711880|39605092|FG001|Overall Study|Patient non-compliance|0|||
16305960|NCT00711880|39605091|FG000|Overall Study|Lack of Efficacy|1|||
16305961|NCT00711880|39605092|FG001|Overall Study|Lack of Efficacy|5|||
16305962|NCT00425373|39605093|FG000|Overall Study|Adverse Event|2|||
16305963|NCT00425373|39605094|FG001|Overall Study|Adverse Event|2|||
16305964|NCT00425373|39605095|FG002|Overall Study|Adverse Event|0|||
16305965|NCT00425373|39605096|FG003|Overall Study|Adverse Event|1|||
16305966|NCT00425373|39605097|FG004|Overall Study|Adverse Event|4|||
16305967|NCT00425373|39605098|FG005|Overall Study|Adverse Event|6|||
16305968|NCT00425373|39605099|FG006|Overall Study|Adverse Event|2|||
16305969|NCT00425373|39605100|FG007|Overall Study|Adverse Event|3|||
16305970|NCT00425373|39605101|FG008|Overall Study|Adverse Event|8|||
16305971|NCT00425373|39605093|FG000|Overall Study|Lost to Follow-up|0|||
16305972|NCT00425373|39605094|FG001|Overall Study|Lost to Follow-up|1|||
16305973|NCT00425373|39605095|FG002|Overall Study|Lost to Follow-up|0|||
16305974|NCT00425373|39605096|FG003|Overall Study|Lost to Follow-up|0|||
16305975|NCT00425373|39605097|FG004|Overall Study|Lost to Follow-up|1|||
16305976|NCT00425373|39605098|FG005|Overall Study|Lost to Follow-up|0|||
16305977|NCT00425373|39605099|FG006|Overall Study|Lost to Follow-up|0|||
16305978|NCT00425373|39605100|FG007|Overall Study|Lost to Follow-up|0|||
16305979|NCT00425373|39605101|FG008|Overall Study|Lost to Follow-up|0|||
16305980|NCT00425373|39605093|FG000|Overall Study|Protocol Violation|1|||
16305981|NCT00425373|39605094|FG001|Overall Study|Protocol Violation|0|||
16305982|NCT00425373|39605095|FG002|Overall Study|Protocol Violation|1|||
16305983|NCT00425373|39605096|FG003|Overall Study|Protocol Violation|0|||
16305984|NCT00425373|39605097|FG004|Overall Study|Protocol Violation|0|||
16305985|NCT00425373|39605098|FG005|Overall Study|Protocol Violation|0|||
16305986|NCT00425373|39605099|FG006|Overall Study|Protocol Violation|0|||
16305987|NCT00425373|39605100|FG007|Overall Study|Protocol Violation|5|||
16494837|NCT00555321|40281111|FG004|Long-term Extension Phase|Adverse Event|0|||
16494838|NCT00555321|40281107|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
16494839|NCT00555321|40281108|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
16494840|NCT00555321|40281109|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
16494841|NCT00555321|40281110|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
16494842|NCT00555321|40281111|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
16494843|NCT00555321|40281107|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
16494844|NCT00555321|40281108|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
16494845|NCT00555321|40281109|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
16494846|NCT00555321|40281110|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
16494847|NCT00555321|40281111|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
16305988|NCT00425373|39605101|FG008|Overall Study|Protocol Violation|3|||
16305989|NCT00425373|39605093|FG000|Overall Study|Withdrawal by Subject|2|||
16494848|NCT00555321|40281107|FG000|Long-term Extension Phase|Death|2|||
16494849|NCT00555321|40281108|FG001|Long-term Extension Phase|Death|0|||
16494850|NCT00555321|40281109|FG002|Long-term Extension Phase|Death|0|||
16494851|NCT00555321|40281110|FG003|Long-term Extension Phase|Death|3|||
16494852|NCT00555321|40281111|FG004|Long-term Extension Phase|Death|0|||
16305990|NCT00425373|39605094|FG001|Overall Study|Withdrawal by Subject|0|||
16305991|NCT00425373|39605095|FG002|Overall Study|Withdrawal by Subject|2|||
16305992|NCT00425373|39605096|FG003|Overall Study|Withdrawal by Subject|1|||
16305993|NCT00425373|39605097|FG004|Overall Study|Withdrawal by Subject|4|||
16305994|NCT00425373|39605098|FG005|Overall Study|Withdrawal by Subject|0|||
16305995|NCT00425373|39605099|FG006|Overall Study|Withdrawal by Subject|2|||
16305996|NCT00425373|39605100|FG007|Overall Study|Withdrawal by Subject|2|||
16305997|NCT00425373|39605101|FG008|Overall Study|Withdrawal by Subject|2|||
16305998|NCT00425373|39605093|FG000|Overall Study|Lack of Efficacy|0|||
16305999|NCT00425373|39605094|FG001|Overall Study|Lack of Efficacy|0|||
16306000|NCT00425373|39605095|FG002|Overall Study|Lack of Efficacy|0|||
16306001|NCT00425373|39605096|FG003|Overall Study|Lack of Efficacy|0|||
16306002|NCT00425373|39605097|FG004|Overall Study|Lack of Efficacy|1|||
16306003|NCT00425373|39605098|FG005|Overall Study|Lack of Efficacy|3|||
16306004|NCT00425373|39605099|FG006|Overall Study|Lack of Efficacy|3|||
16306005|NCT00425373|39605100|FG007|Overall Study|Lack of Efficacy|0|||
16306006|NCT00425373|39605101|FG008|Overall Study|Lack of Efficacy|5|||
16306007|NCT01191944|39605102|FG000|Overall Study|Adverse Event|11|||
16306008|NCT01191944|39605103|FG001|Overall Study|Adverse Event|12|||
16306009|NCT01191944|39605102|FG000|Overall Study|Protocol Violation|1|||
16306010|NCT01191944|39605103|FG001|Overall Study|Protocol Violation|2|||
16306011|NCT01191944|39605102|FG000|Overall Study|Withdrawal by Subject|4|||
16306012|NCT01191944|39605103|FG001|Overall Study|Withdrawal by Subject|2|||
16306013|NCT01191944|39605102|FG000|Overall Study|Other|1|||
16306014|NCT01191944|39605103|FG001|Overall Study|Other|3|||
16306015|NCT00699998|39605104|FG000|Overall Study|Withdrawal by Subject|194|||
16306016|NCT00699998|39605105|FG001|Overall Study|Withdrawal by Subject|83|||
16306017|NCT00699998|39605106|FG002|Overall Study|Withdrawal by Subject|202|||
16306018|NCT00699998|39605107|FG003|Overall Study|Withdrawal by Subject|80|||
16306019|NCT00699998|39605104|FG000|Overall Study|Physician Decision|3|||
16306020|NCT00699998|39605105|FG001|Overall Study|Physician Decision|2|||
16306021|NCT00699998|39605106|FG002|Overall Study|Physician Decision|1|||
16306022|NCT00699998|39605107|FG003|Overall Study|Physician Decision|1|||
16306023|NCT00699998|39605104|FG000|Overall Study|Lost to Follow-up|2|||
16306024|NCT00699998|39605105|FG001|Overall Study|Lost to Follow-up|1|||
16306025|NCT00699998|39605106|FG002|Overall Study|Lost to Follow-up|3|||
16306026|NCT00699998|39605107|FG003|Overall Study|Lost to Follow-up|1|||
16306027|NCT04411914|39605108|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
16306028|NCT04411914|39605109|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
16306029|NCT04315506|39605110|FG000|Overall Study|Lost to Follow-up|74|||
16306030|NCT04315506|39605111|FG001|Overall Study|Lost to Follow-up|82|||
16306031|NCT04315506|39605110|FG000|Overall Study|Withdrawal by Subject|8|||
16306032|NCT04315506|39605111|FG001|Overall Study|Withdrawal by Subject|8|||
16306033|NCT04315506|39605110|FG000|Overall Study|Physician Decision|0|||
16306034|NCT04315506|39605111|FG001|Overall Study|Physician Decision|1|||
16306035|NCT01427608|39608753|FG000|Overall Study|Death|1|||
16306036|NCT01427608|39608754|FG001|Overall Study|Death|0|||
16306037|NCT01427608|39608753|FG000|Overall Study|Withdrawal by Subject|7|||
16306038|NCT01427608|39608754|FG001|Overall Study|Withdrawal by Subject|3|||
16306039|NCT01427608|39608753|FG000|Overall Study|Relapsed-all cause|13|||
16306040|NCT01427608|39608754|FG001|Overall Study|Relapsed-all cause|34|||
16306041|NCT01427608|39608753|FG000|Overall Study|Events not attributed to study meds|0|||
16306042|NCT01427608|39608754|FG001|Overall Study|Events not attributed to study meds|1|||
16306043|NCT00633243|39608755|FG000|Overall Study|Withdrawal by Subject|0|||
16306044|NCT00633243|39608756|FG001|Overall Study|Withdrawal by Subject|1|||
16306045|NCT00633243|39608755|FG000|Overall Study|incarceration|0|||
16306046|NCT00633243|39608756|FG001|Overall Study|incarceration|2|||
16306047|NCT00633243|39608755|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
16306048|NCT00633243|39608756|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
16306049|NCT00633243|39608755|FG000|Overall Study|Not comfortable with self-injecting|0|||
16306050|NCT00633243|39608756|FG001|Overall Study|Not comfortable with self-injecting|1|||
16306051|NCT00633243|39608755|FG000|Overall Study|Mental Health--Depression|0|||
16306052|NCT00633243|39608756|FG001|Overall Study|Mental Health--Depression|1|||
16306053|NCT00633243|39608755|FG000|Overall Study|Couldn't tolerate side-effects|1|||
16306054|NCT00633243|39608756|FG001|Overall Study|Couldn't tolerate side-effects|1|||
16306055|NCT02766335|39608757|FG000|Initial Registration|Adverse Event|6|||
16306056|NCT02766335|39608758|FG001|Initial Registration|Adverse Event|3|||
16306057|NCT02766335|39608759|FG002|Initial Registration|Adverse Event|0|||
16306058|NCT02766335|39608757|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
16306059|NCT02766335|39608758|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
16306060|NCT02766335|39608759|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
16306061|NCT02766335|39608757|FG000|Initial Registration|Progression/relapse|49|||
16306062|NCT02766335|39608758|FG001|Initial Registration|Progression/relapse|15|||
16306063|NCT02766335|39608759|FG002|Initial Registration|Progression/relapse|0|||
16306064|NCT02766335|39608757|FG000|Initial Registration|Death|1|||
16306065|NCT02766335|39608758|FG001|Initial Registration|Death|3|||
16306066|NCT02766335|39608759|FG002|Initial Registration|Death|0|||
16306067|NCT02766335|39608757|FG000|Initial Registration|not protocol specified|1|||
16306068|NCT02766335|39608758|FG001|Initial Registration|not protocol specified|9|||
16306069|NCT02766335|39608759|FG002|Initial Registration|not protocol specified|0|||
16306070|NCT02766335|39608757|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
16306071|NCT02766335|39608758|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
16306072|NCT02766335|39608759|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
16306073|NCT02766335|39608757|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
16306074|NCT02766335|39608758|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
16306075|NCT02766335|39608759|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
16306076|NCT03668808|39608760|FG000|First Intervention|Withdrawal by Subject|2|||
16306077|NCT03668808|39608761|FG001|First Intervention|Withdrawal by Subject|2|||
16306078|NCT04152863|39608773|FG000|Overall Study|Death|13|||
16306079|NCT04152863|39608774|FG001|Overall Study|Death|12|||
16306080|NCT04152863|39608775|FG002|Overall Study|Death|7|||
16306081|NCT04152863|39608773|FG000|Overall Study|Physician Decision|1|||
16306082|NCT04152863|39608774|FG001|Overall Study|Physician Decision|1|||
16306083|NCT04152863|39608775|FG002|Overall Study|Physician Decision|1|||
16306084|NCT04152863|39608773|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
16306085|NCT04152863|39608774|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
16306086|NCT04152863|39608775|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
16306087|NCT04152863|39608773|FG000|Overall Study|Withdrawal by Subject|2|||
16306088|NCT04152863|39608774|FG001|Overall Study|Withdrawal by Subject|1|||
16306089|NCT04152863|39608775|FG002|Overall Study|Withdrawal by Subject|3|||
16306090|NCT01333397|39608776|FG000|Overall Study|Lost to Follow-up|1|||
16306091|NCT01333397|39608777|FG001|Overall Study|Lost to Follow-up|0|||
16306092|NCT01333397|39608778|FG002|Overall Study|Lost to Follow-up|0|||
16306093|NCT01333397|39608779|FG003|Overall Study|Lost to Follow-up|1|||
16306094|NCT01333397|39608780|FG004|Overall Study|Lost to Follow-up|0|||
16306095|NCT00307086|39608781|FG000|Overall Study|ineligible|5|||
16306096|NCT00322712|39608782|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
16306097|NCT00998309|39608787|FG000|Overall Study|Protocol Violation|4|||
16306098|NCT00451204|39608788|FG000|Overall Study|Adverse Event|4|||
16306099|NCT00451204|39608789|FG001|Overall Study|Adverse Event|6|||
16306100|NCT00451204|39608788|FG000|Overall Study|Lack of Efficacy|4|||
16306101|NCT00451204|39608789|FG001|Overall Study|Lack of Efficacy|4|||
16306102|NCT00451204|39608788|FG000|Overall Study|Lost to Follow-up|4|||
16306103|NCT00451204|39608789|FG001|Overall Study|Lost to Follow-up|4|||
16306104|NCT00451204|39608788|FG000|Overall Study|Protocol Violation|1|||
16306105|NCT00451204|39608789|FG001|Overall Study|Protocol Violation|0|||
16306106|NCT00451204|39608788|FG000|Overall Study|Patient refusal|8|||
16306107|NCT00451204|39608789|FG001|Overall Study|Patient refusal|4|||
16306108|NCT00451204|39608788|FG000|Overall Study|Other|1|||
16306109|NCT00451204|39608789|FG001|Overall Study|Other|2|||
16306110|NCT01133067|39608790|FG000|Overall Study|Death|136|||
16306111|NCT01133067|39608790|FG000|Overall Study|Lost to Follow-up|3|||
16306112|NCT01284361|39608793|FG000|Overall Study|Withdrawal by Subject|1|||
16306113|NCT01284361|39608793|FG000|Overall Study|Protocol Violation|5|||
16306114|NCT01284361|39608793|FG000|Overall Study|Adverse Event|1|||
16306115|NCT01284361|39608793|FG000|Overall Study|Lost to Follow-up|2|||
16306116|NCT00104572|39608801|FG000|Overall Study|Withdrawal by Subject|3|||
16494853|NCT00555321|40281107|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
16494854|NCT00555321|40281108|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
16494855|NCT00555321|40281109|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
16306117|NCT00104572|39608802|FG001|Overall Study|Withdrawal by Subject|3|||
16306118|NCT00104572|39608803|FG002|Overall Study|Withdrawal by Subject|0|||
16306119|NCT01090414|39608804|FG000|Study 101-99|Progressive Disease|28|||
16306120|NCT01090414|39608805|FG001|Study 101-99|Progressive Disease|48|||
16306121|NCT01090414|39608806|FG002|Study 101-99|Progressive Disease|10|||
16306122|NCT01090414|39608807|FG003|Study 101-99|Progressive Disease|4|||
16306123|NCT01090414|39608804|FG000|Study 101-99|Adverse Event|10|||
16306124|NCT01090414|39608805|FG001|Study 101-99|Adverse Event|28|||
16306125|NCT01090414|39608806|FG002|Study 101-99|Adverse Event|18|||
16306126|NCT01090414|39608807|FG003|Study 101-99|Adverse Event|0|||
16306127|NCT01090414|39608804|FG000|Study 101-99|Investigator Request|1|||
16306128|NCT01090414|39608805|FG001|Study 101-99|Investigator Request|11|||
16494856|NCT00555321|40281110|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
16306129|NCT01090414|39608806|FG002|Study 101-99|Investigator Request|4|||
16306130|NCT01090414|39608807|FG003|Study 101-99|Investigator Request|0|||
16306131|NCT01090414|39608804|FG000|Study 101-99|Death|3|||
16306132|NCT01090414|39608805|FG001|Study 101-99|Death|8|||
16306133|NCT01090414|39608806|FG002|Study 101-99|Death|1|||
16306134|NCT01090414|39608807|FG003|Study 101-99|Death|0|||
16306135|NCT01090414|39608804|FG000|Study 101-99|Sponsor Discontinued Study|0|||
16306136|NCT01090414|39608805|FG001|Study 101-99|Sponsor Discontinued Study|7|||
16306137|NCT01090414|39608806|FG002|Study 101-99|Sponsor Discontinued Study|5|||
16306138|NCT01090414|39608807|FG003|Study 101-99|Sponsor Discontinued Study|0|||
16084933|NCT01500200|38802600|FG005|Stage 2|Adverse Event|4|||
16084934|NCT01063881|38802601|FG000|Overall Study|Adverse Event|12|||
16084935|NCT01063881|38802602|FG001|Overall Study|Adverse Event|2|||
16084936|NCT01063881|38802603|FG002|Overall Study|Adverse Event|0|||
16306139|NCT01090414|39608804|FG000|Study 101-99|Other (Unknown Reasons)|3|||
16306140|NCT01090414|39608805|FG001|Study 101-99|Other (Unknown Reasons)|3|||
16306141|NCT01090414|39608806|FG002|Study 101-99|Other (Unknown Reasons)|0|||
16306142|NCT01090414|39608807|FG003|Study 101-99|Other (Unknown Reasons)|0|||
16306143|NCT01090414|39608804|FG000|Study 101-99|Withdrew Consent|0|||
16306144|NCT01090414|39608805|FG001|Study 101-99|Withdrew Consent|2|||
16306145|NCT01090414|39608806|FG002|Study 101-99|Withdrew Consent|3|||
16306146|NCT01090414|39608807|FG003|Study 101-99|Withdrew Consent|1|||
16306147|NCT01090414|39608804|FG000|Study 101-99|Participant Request|3|||
16306148|NCT01090414|39608805|FG001|Study 101-99|Participant Request|1|||
16306149|NCT01090414|39608806|FG002|Study 101-99|Participant Request|0|||
16306150|NCT01090414|39608807|FG003|Study 101-99|Participant Request|0|||
16306151|NCT01659125|39608808|FG000|Overall Study|Withdrawal by Subject|2|||
16306152|NCT01659125|39608808|FG000|Overall Study|Lost to Follow-up|7|||
16306153|NCT01659125|39608808|FG000|Overall Study|Technical Problem|1|||
16306154|NCT01659125|39608808|FG000|Overall Study|Time Constraints|2|||
16306155|NCT01659125|39608808|FG000|Overall Study|Failed to Start Treatment|2|||
16306156|NCT01026194|39608817|FG000|Period 1：Double Blind Period|Adverse Event|2|||
16306157|NCT01026194|39608818|FG001|Period 1：Double Blind Period|Adverse Event|1|||
16494857|NCT00555321|40281111|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
16494858|NCT00555321|40281107|FG000|Long-term Extension Phase|Other Reason|1|||
16494859|NCT00555321|40281108|FG001|Long-term Extension Phase|Other Reason|0|||
16494860|NCT00555321|40281109|FG002|Long-term Extension Phase|Other Reason|2|||
16306158|NCT01026194|39608817|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
16306159|NCT01026194|39608818|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
16306160|NCT01026194|39608817|FG000|Period 1：Double Blind Period|Physician Decision|0|||
16306161|NCT01026194|39608818|FG001|Period 1：Double Blind Period|Physician Decision|4|||
16306162|NCT01026194|39608817|FG000|Period 2：Open-label Period|Adverse Event|4|||
16306163|NCT01026194|39608818|FG001|Period 2：Open-label Period|Adverse Event|5|||
16306164|NCT01026194|39608817|FG000|Period 2：Open-label Period|Physician Decision|3|||
16306165|NCT01026194|39608818|FG001|Period 2：Open-label Period|Physician Decision|1|||
16306166|NCT01026194|39608817|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
16306167|NCT01026194|39608818|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
16306168|NCT00098774|39608819|FG000|Overall Study|Adverse Event|2|||
16306169|NCT00098774|39608819|FG000|Overall Study|Disease Progression|9|||
16494861|NCT00555321|40281110|FG003|Long-term Extension Phase|Other Reason|0|||
16494862|NCT00555321|40281111|FG004|Long-term Extension Phase|Other Reason|0|||
16494863|NCT02707991|40281112|FG000|Overall Study|Protocol Violation|1|||
16494864|NCT02707991|40281113|FG001|Overall Study|Protocol Violation|0|||
16494865|NCT02707991|40281112|FG000|Overall Study|Became ineligible|0|||
16494866|NCT02707991|40281113|FG001|Overall Study|Became ineligible|1|||
16494867|NCT01053221|40281116|FG000|Overall Study|The study was closed prematurely|5|||
16494868|NCT01053221|40281117|FG001|Overall Study|The study was closed prematurely|9|||
16306170|NCT00098774|39608819|FG000|Overall Study|Withdrawal by Subject|1|||
16306171|NCT00098774|39608819|FG000|Overall Study|Failed (to respond) during induction|4|||
16306172|NCT00098774|39608819|FG000|Overall Study|Physician Decision|2|||
16494869|NCT00290888|40284510|FG000|Overall Study|Physician Decision|3|||
16494870|NCT00290888|40284511|FG001|Overall Study|Physician Decision|1|||
16494871|NCT02599129|40284512|FG000|Overall Study|Lack of Efficacy|2|||
16494872|NCT02599129|40284513|FG001|Overall Study|Lack of Efficacy|2|||
16494873|NCT02599129|40284512|FG000|Overall Study|Lost to Follow-up|1|||
16494874|NCT02599129|40284513|FG001|Overall Study|Lost to Follow-up|0|||
16494875|NCT02599129|40284512|FG000|Overall Study|Withdrawal by Subject|2|||
16494876|NCT02599129|40284513|FG001|Overall Study|Withdrawal by Subject|1|||
16494877|NCT03402386|40284514|FG000|Overall Study|Adverse Event|3|||
16494878|NCT03402386|40284514|FG000|Overall Study|Physician Decision|1|||
16494879|NCT03402386|40284514|FG000|Overall Study|Difficult to control Hb|2|||
16306173|NCT04578535|39608820|FG000|Overall Study|Lost to Follow-up|1|||
16306174|NCT04578535|39608821|FG001|Overall Study|Lost to Follow-up|0|||
16306175|NCT04578535|39608822|FG002|Overall Study|Lost to Follow-up|0|||
16306176|NCT04578535|39608823|FG003|Overall Study|Lost to Follow-up|1|||
16494880|NCT00903695|40284515|FG000|Overall Study|medical exclusion after 1st testing|1|||
16494881|NCT00903695|40284516|FG001|Overall Study|medical exclusion after 1st testing|0|||
16494882|NCT00903695|40284515|FG000|Overall Study|lung cancer|1|||
16494883|NCT00903695|40284516|FG001|Overall Study|lung cancer|0|||
16494884|NCT00004978|40284517|FG000|Overall Study|Death|107|||
16494885|NCT00004978|40284518|FG001|Overall Study|Death|116|||
16494886|NCT00004978|40284517|FG000|Overall Study|Lost to Follow-up|101|||
16494887|NCT00004978|40284518|FG001|Overall Study|Lost to Follow-up|108|||
16494888|NCT00004978|40284517|FG000|Overall Study|Withdrawal by Subject|17|||
16494889|NCT00004978|40284518|FG001|Overall Study|Withdrawal by Subject|26|||
16494890|NCT00004978|40284517|FG000|Overall Study|site closure - not in analysis cohort|19|||
16494891|NCT00004978|40284518|FG001|Overall Study|site closure - not in analysis cohort|20|||
16494892|NCT00617773|40284519|FG000|Overall Study|Physician Decision|1|||
16494893|NCT00617773|40284519|FG000|Overall Study|Lack of compliance with the protocol|1|||
16494894|NCT00617773|40284519|FG000|Overall Study|Withdrawal by Subject|1|||
16494895|NCT00617773|40284519|FG000|Overall Study|Death|1|||
16494896|NCT00617773|40284519|FG000|Overall Study|Progressive disease|19|||
16494897|NCT00617773|40284519|FG000|Overall Study|Protocol Violation|1|||
16494898|NCT00459667|40284521|FG000|Overall Study|Adverse Event|9|||
16494899|NCT00459667|40284522|FG001|Overall Study|Adverse Event|12|||
16494900|NCT00459667|40284523|FG002|Overall Study|Adverse Event|8|||
16494901|NCT00459667|40284521|FG000|Overall Study|Lost to Follow-up|5|||
16494902|NCT00459667|40284522|FG001|Overall Study|Lost to Follow-up|9|||
16494903|NCT00459667|40284523|FG002|Overall Study|Lost to Follow-up|3|||
16494904|NCT00459667|40284521|FG000|Overall Study|Pregnancy|1|||
16494905|NCT00459667|40284522|FG001|Overall Study|Pregnancy|1|||
16494906|NCT00459667|40284523|FG002|Overall Study|Pregnancy|1|||
16494907|NCT00459667|40284521|FG000|Overall Study|Protocol Violation|1|||
16494908|NCT00459667|40284522|FG001|Overall Study|Protocol Violation|0|||
16494909|NCT00459667|40284523|FG002|Overall Study|Protocol Violation|0|||
16494910|NCT00459667|40284521|FG000|Overall Study|Withdrawal by Subject|3|||
16494911|NCT00459667|40284522|FG001|Overall Study|Withdrawal by Subject|5|||
16494912|NCT00459667|40284523|FG002|Overall Study|Withdrawal by Subject|5|||
16494913|NCT00459667|40284521|FG000|Overall Study|Other disease modifying treatment|1|||
16494914|NCT00459667|40284522|FG001|Overall Study|Other disease modifying treatment|2|||
16494915|NCT00459667|40284523|FG002|Overall Study|Other disease modifying treatment|1|||
16084937|NCT01063881|38802601|FG000|Overall Study|Lost to Follow-up|13|||
16084938|NCT01063881|38802602|FG001|Overall Study|Lost to Follow-up|7|||
16084939|NCT01063881|38802603|FG002|Overall Study|Lost to Follow-up|1|||
16084940|NCT01063881|38802601|FG000|Overall Study|Withdrawal by Subject|25|||
16084941|NCT01063881|38802602|FG001|Overall Study|Withdrawal by Subject|1|||
16084942|NCT01063881|38802603|FG002|Overall Study|Withdrawal by Subject|0|||
16084943|NCT01063881|38802601|FG000|Overall Study|Reason for not completed not specified|5|||
16084944|NCT01063881|38802602|FG001|Overall Study|Reason for not completed not specified|1|||
16084945|NCT01063881|38802603|FG002|Overall Study|Reason for not completed not specified|0|||
16084946|NCT02079649|38802609|FG000|Overall Study|Lost to Follow-up|0|||
16084947|NCT02079649|38802610|FG001|Overall Study|Lost to Follow-up|0|||
16084948|NCT02079649|38802611|FG002|Overall Study|Lost to Follow-up|0|||
16084949|NCT02079649|38802612|FG003|Overall Study|Lost to Follow-up|1|||
16084950|NCT02079649|38802609|FG000|Overall Study|Withdrawal by Subject|0|||
16084951|NCT02079649|38802610|FG001|Overall Study|Withdrawal by Subject|0|||
16084952|NCT02079649|38802611|FG002|Overall Study|Withdrawal by Subject|0|||
16084953|NCT02079649|38802612|FG003|Overall Study|Withdrawal by Subject|1|||
16084954|NCT02079649|38802609|FG000|Overall Study|Randomization error (prior to treatment)|1|||
16084955|NCT02079649|38802610|FG001|Overall Study|Randomization error (prior to treatment)|0|||
16084956|NCT02079649|38802611|FG002|Overall Study|Randomization error (prior to treatment)|1|||
16084957|NCT02079649|38802612|FG003|Overall Study|Randomization error (prior to treatment)|0|||
16084958|NCT03113409|38802617|FG000|Overall Study|Withdrawal by Subject|5|||
16084959|NCT03113409|38802618|FG001|Overall Study|Withdrawal by Subject|0|||
16084960|NCT03113409|38802619|FG002|Overall Study|Withdrawal by Subject|0|||
16084961|NCT03675321|38802623|FG000|Overall Study|Lack of Efficacy|2|||
16084962|NCT03675321|38802624|FG001|Overall Study|Lack of Efficacy|2|||
16084963|NCT03675321|38802623|FG000|Overall Study|Withdrawal by Subject|1|||
16084964|NCT03675321|38802624|FG001|Overall Study|Withdrawal by Subject|3|||
16084965|NCT00350792|38802628|FG000|Overall Study|Adverse Event|11|||
16084966|NCT00350792|38802628|FG000|Overall Study|Death from Study Disease|1|||
16084967|NCT00350792|38802628|FG000|Overall Study|Death from Study Drug Toxicity|1|||
16084968|NCT00350792|38802628|FG000|Overall Study|Death Not Study Drug Related|2|||
16494916|NCT00459667|40284521|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
16494917|NCT00459667|40284522|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
16494918|NCT00459667|40284523|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
16494919|NCT00459667|40284521|FG000|Overall Study|No treatment administered|6|||
16494920|NCT00459667|40284522|FG001|Overall Study|No treatment administered|3|||
16494921|NCT00459667|40284523|FG002|Overall Study|No treatment administered|1|||
16494922|NCT01134783|40284524|FG000|Overall Study|Pregnancy|16|||
16494923|NCT01134783|40284525|FG001|Overall Study|Pregnancy|8|||
16084969|NCT00350792|38802628|FG000|Overall Study|Protocol Violation|1|||
16084970|NCT00350792|38802628|FG000|Overall Study|Withdrawal by Subject|4|||
16084971|NCT00350792|38802628|FG000|Overall Study|Physician Decision|2|||
16084972|NCT00350792|38802628|FG000|Overall Study|Lack of Efficacy|11|||
16084973|NCT02928172|38802630|FG000|Overall Study|Device did not record data|1|||
16084974|NCT01046136|38802631|FG000|Overall Study|Withdrawal by Subject|0|||
16084975|NCT01046136|38802632|FG001|Overall Study|Withdrawal by Subject|4|||
16084976|NCT01046136|38802631|FG000|Overall Study|Physician Decision|1|||
16084977|NCT01046136|38802632|FG001|Overall Study|Physician Decision|1|||
16084978|NCT01046136|38802631|FG000|Overall Study|Lost to Follow-up|3|||
16084979|NCT01046136|38802632|FG001|Overall Study|Lost to Follow-up|3|||
16084980|NCT01359150|38802633|FG000|Overall Study|Lack of Efficacy|1|||
16084981|NCT01359150|38802634|FG001|Overall Study|Lack of Efficacy|1|||
16084982|NCT01359150|38802633|FG000|Overall Study|Withdrawal by Subject|1|||
16084983|NCT01359150|38802634|FG001|Overall Study|Withdrawal by Subject|1|||
16084984|NCT01359150|38802633|FG000|Overall Study|Adverse Event|4|||
16084985|NCT01359150|38802634|FG001|Overall Study|Adverse Event|3|||
16084986|NCT01359150|38802633|FG000|Overall Study|Other|1|||
16084987|NCT01359150|38802634|FG001|Overall Study|Other|0|||
16084988|NCT01827839|38802635|FG000|Overall Study|Adverse Event|1|||
16084989|NCT01827839|38802635|FG000|Overall Study|Consent Withdrawal|2|||
16084990|NCT01736475|38802636|FG000|Overall Study|Adverse Event|4|||
16084991|NCT01736475|38802637|FG001|Overall Study|Adverse Event|0|||
16084992|NCT01736475|38802636|FG000|Overall Study|Withdrawal by Subject|2|||
16084993|NCT01736475|38802637|FG001|Overall Study|Withdrawal by Subject|0|||
16084994|NCT01736475|38802636|FG000|Overall Study|Protocol Violation|4|||
16084995|NCT01736475|38802637|FG001|Overall Study|Protocol Violation|0|||
16084996|NCT01736475|38802636|FG000|Overall Study|Other - Screen failure|1|||
16084997|NCT01736475|38802637|FG001|Overall Study|Other - Screen failure|0|||
16084998|NCT01736475|38802636|FG000|Overall Study|Other - Surgical procedure|1|||
16084999|NCT01736475|38802637|FG001|Overall Study|Other - Surgical procedure|0|||
16085000|NCT02765100|38802641|FG000|Overall Study|subject found ineligible after baseline|1|||
16085001|NCT02765100|38802642|FG001|Overall Study|subject found ineligible after baseline|1|||
16085002|NCT02765100|38802641|FG000|Overall Study|Lost to Follow-up|0|||
16085003|NCT02765100|38802642|FG001|Overall Study|Lost to Follow-up|1|||
16085004|NCT01532999|38802643|FG000|Overall Study|Lost to Follow-up|14|||
16085005|NCT01532999|38802644|FG001|Overall Study|Lost to Follow-up|8|||
16085006|NCT01532999|38802643|FG000|Overall Study|Physician Decision|1|||
16085007|NCT01532999|38802644|FG001|Overall Study|Physician Decision|2|||
16085008|NCT01532999|38802643|FG000|Overall Study|Withdrawal by Subject|5|||
16085009|NCT01532999|38802644|FG001|Overall Study|Withdrawal by Subject|0|||
16085010|NCT01532999|38802643|FG000|Overall Study|Relocated|2|||
16085011|NCT01532999|38802644|FG001|Overall Study|Relocated|0|||
16085012|NCT01532999|38802643|FG000|Overall Study|should not have been randomized|1|||
16085013|NCT01532999|38802644|FG001|Overall Study|should not have been randomized|0|||
16085014|NCT01532999|38802643|FG000|Overall Study|substantial noncompliance|2|||
16085015|NCT01532999|38802644|FG001|Overall Study|substantial noncompliance|0|||
16085016|NCT01532999|38802643|FG000|Overall Study|no show for week 9 assessments|6|||
16085017|NCT01532999|38802644|FG001|Overall Study|no show for week 9 assessments|4|||
16085018|NCT01532999|38802643|FG000|Overall Study|Adverse Event|0|||
16085019|NCT01532999|38802644|FG001|Overall Study|Adverse Event|1|||
16085020|NCT01532999|38802643|FG000|Overall Study|incarcerated|0|||
16085021|NCT01532999|38802644|FG001|Overall Study|incarcerated|1|||
16085022|NCT01532999|38802643|FG000|Overall Study|New job|0|||
16085023|NCT01532999|38802644|FG001|Overall Study|New job|2|||
16085024|NCT01854385|38802645|FG000|Pre-Treatment|Withdrawal by Subject|4|||
16085025|NCT01854385|38802645|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
16085026|NCT01854385|38802645|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
16085027|NCT01854385|38802645|FG000|Pre-Treatment|Unable to come for study visits|1|||
16085028|NCT01854385|38802645|FG000|Treatment|Lost to Follow-up|1|||
16085029|NCT02130557|38802648|FG000|Overall Study|Withdrawal by Subject|12|||
16085030|NCT02130557|38802649|FG001|Overall Study|Withdrawal by Subject|12|||
16085031|NCT02130557|38802648|FG000|Overall Study|Investigator Request|0|||
16085032|NCT02130557|38802649|FG001|Overall Study|Investigator Request|2|||
16085033|NCT02130557|38802648|FG000|Overall Study|Deceased|14|||
16085034|NCT02130557|38802649|FG001|Overall Study|Deceased|14|||
16306177|NCT04578535|39608824|FG004|Overall Study|Lost to Follow-up|0|||
16306178|NCT04578535|39608825|FG005|Overall Study|Lost to Follow-up|2|||
16306179|NCT04578535|39608820|FG000|Overall Study|Pregnancy|1|||
16494924|NCT01134783|40284524|FG000|Overall Study|Withdrawal by Subject|15|||
16085035|NCT02130557|38802648|FG000|Overall Study|Lost to Follow-up|6|||
16085036|NCT02130557|38802649|FG001|Overall Study|Lost to Follow-up|7|||
16085037|NCT02130557|38802648|FG000|Overall Study|Other|2|||
16085038|NCT02130557|38802649|FG001|Overall Study|Other|1|||
16085039|NCT02130557|38802648|FG000|Overall Study|Missing|2|||
16085040|NCT02130557|38802649|FG001|Overall Study|Missing|1|||
16085041|NCT00603954|38802650|FG000|Overall Study|Protocol Violation|1|||
16306180|NCT04578535|39608821|FG001|Overall Study|Pregnancy|0|||
16494925|NCT01134783|40284525|FG001|Overall Study|Withdrawal by Subject|9|||
16085042|NCT00603954|38802651|FG001|Overall Study|Protocol Violation|2|||
16085043|NCT03624972|38802652|FG000|Overall Study|Lost to Follow-up|2|||
16085044|NCT03624972|38802653|FG001|Overall Study|Lost to Follow-up|0|||
16085045|NCT03624972|38802654|FG002|Overall Study|Lost to Follow-up|0|||
16494926|NCT01134783|40284524|FG000|Overall Study|Lost to Follow-up|5|||
16494927|NCT01134783|40284525|FG001|Overall Study|Lost to Follow-up|20|||
16494928|NCT01291173|40284526|FG000|Overall Study|Adverse Event|0|||
16494929|NCT01291173|40284527|FG001|Overall Study|Adverse Event|3|||
16494930|NCT01291173|40284528|FG002|Overall Study|Adverse Event|1|||
16494931|NCT01291173|40284529|FG003|Overall Study|Adverse Event|3|||
16494932|NCT01291173|40284526|FG000|Overall Study|Protocol Violation|7|||
16494933|NCT01291173|40284527|FG001|Overall Study|Protocol Violation|2|||
16085046|NCT03624972|38802652|FG000|Overall Study|Withdrawal by Subject|0|||
16085047|NCT03624972|38802653|FG001|Overall Study|Withdrawal by Subject|2|||
16085048|NCT03624972|38802654|FG002|Overall Study|Withdrawal by Subject|0|||
16085049|NCT03041233|38802657|FG000|Overall Study|Death|5|||
16085050|NCT03041233|38802657|FG000|Overall Study|Physician Decision|1|||
16085051|NCT03041233|38802657|FG000|Overall Study|Lost to Follow-up|16|||
16085052|NCT03041233|38802657|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
16085053|NCT03041233|38802657|FG000|Overall Study|Sponsor Request|1|||
16085054|NCT03041233|38802657|FG000|Overall Study|Duplicate subject|1|||
16085055|NCT03041233|38802657|FG000|Overall Study|Re-ablation|1|||
16085056|NCT01075152|38802658|FG000|Overall Study|Withdrawal by Subject|1|||
16085057|NCT01075152|38802659|FG001|Overall Study|Withdrawal by Subject|0|||
16085058|NCT00146172|38802660|FG000|Overall Study|Adverse Event|0|||
16085059|NCT00146172|38802661|FG001|Overall Study|Adverse Event|0|||
16085060|NCT00146172|38802662|FG002|Overall Study|Adverse Event|1|||
16085061|NCT00146172|38802663|FG003|Overall Study|Adverse Event|1|||
16494934|NCT01291173|40284528|FG002|Overall Study|Protocol Violation|2|||
16494935|NCT01291173|40284529|FG003|Overall Study|Protocol Violation|5|||
16494936|NCT01291173|40284526|FG000|Overall Study|Withdrawal by Subject|6|||
16494937|NCT01291173|40284527|FG001|Overall Study|Withdrawal by Subject|4|||
16085062|NCT00146172|38802664|FG004|Overall Study|Adverse Event|0|||
16085063|NCT00146172|38802665|FG005|Overall Study|Adverse Event|2|||
16085064|NCT00146172|38802666|FG006|Overall Study|Adverse Event|3|||
16085065|NCT00146172|38802667|FG007|Overall Study|Adverse Event|10|||
16085066|NCT00146172|38802660|FG000|Overall Study|Lost to Follow-up|0|||
16085067|NCT00146172|38802661|FG001|Overall Study|Lost to Follow-up|0|||
16085068|NCT00146172|38802662|FG002|Overall Study|Lost to Follow-up|0|||
16085069|NCT00146172|38802663|FG003|Overall Study|Lost to Follow-up|0|||
16085070|NCT00146172|38802664|FG004|Overall Study|Lost to Follow-up|0|||
16085071|NCT00146172|38802665|FG005|Overall Study|Lost to Follow-up|0|||
16085072|NCT00146172|38802666|FG006|Overall Study|Lost to Follow-up|0|||
16085073|NCT00146172|38802667|FG007|Overall Study|Lost to Follow-up|1|||
16085074|NCT00146172|38802660|FG000|Overall Study|Disease Progression|2|||
16085075|NCT00146172|38802661|FG001|Overall Study|Disease Progression|4|||
16085076|NCT00146172|38802662|FG002|Overall Study|Disease Progression|2|||
16085077|NCT00146172|38802663|FG003|Overall Study|Disease Progression|5|||
16085078|NCT00146172|38802664|FG004|Overall Study|Disease Progression|2|||
16085079|NCT00146172|38802665|FG005|Overall Study|Disease Progression|2|||
16085080|NCT00146172|38802666|FG006|Overall Study|Disease Progression|1|||
16085081|NCT00146172|38802667|FG007|Overall Study|Disease Progression|22|||
16306181|NCT04578535|39608822|FG002|Overall Study|Pregnancy|0|||
16306182|NCT04578535|39608823|FG003|Overall Study|Pregnancy|0|||
16306183|NCT04578535|39608824|FG004|Overall Study|Pregnancy|0|||
16306184|NCT04578535|39608825|FG005|Overall Study|Pregnancy|0|||
16306185|NCT04578535|39608820|FG000|Overall Study|Withdrawal by Subject|0|||
16306186|NCT04578535|39608821|FG001|Overall Study|Withdrawal by Subject|0|||
16306187|NCT04578535|39608822|FG002|Overall Study|Withdrawal by Subject|0|||
16306188|NCT04578535|39608823|FG003|Overall Study|Withdrawal by Subject|1|||
16306189|NCT04578535|39608824|FG004|Overall Study|Withdrawal by Subject|1|||
16306190|NCT04578535|39608825|FG005|Overall Study|Withdrawal by Subject|5|||
16085082|NCT00146172|38802660|FG000|Overall Study|Death|0|||
16085083|NCT00146172|38802661|FG001|Overall Study|Death|0|||
16085084|NCT00146172|38802662|FG002|Overall Study|Death|0|||
16085085|NCT00146172|38802663|FG003|Overall Study|Death|0|||
16085086|NCT00146172|38802664|FG004|Overall Study|Death|0|||
16085087|NCT00146172|38802665|FG005|Overall Study|Death|0|||
16085088|NCT00146172|38802666|FG006|Overall Study|Death|1|||
16085089|NCT00146172|38802667|FG007|Overall Study|Death|0|||
16085090|NCT00146172|38802660|FG000|Overall Study|Physician Decision|0|||
16193731|NCT01606761|39188611|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
16085091|NCT00146172|38802661|FG001|Overall Study|Physician Decision|0|||
16306191|NCT04578535|39608820|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
16306192|NCT04578535|39608821|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
16494938|NCT01291173|40284528|FG002|Overall Study|Withdrawal by Subject|4|||
16494939|NCT01291173|40284529|FG003|Overall Study|Withdrawal by Subject|2|||
16494940|NCT01291173|40284526|FG000|Overall Study|Lost to Follow-up|4|||
16494941|NCT01291173|40284527|FG001|Overall Study|Lost to Follow-up|6|||
16494942|NCT01291173|40284528|FG002|Overall Study|Lost to Follow-up|3|||
16085092|NCT00146172|38802662|FG002|Overall Study|Physician Decision|0|||
16085093|NCT00146172|38802663|FG003|Overall Study|Physician Decision|0|||
16085094|NCT00146172|38802664|FG004|Overall Study|Physician Decision|0|||
16085095|NCT00146172|38802665|FG005|Overall Study|Physician Decision|0|||
16085096|NCT00146172|38802666|FG006|Overall Study|Physician Decision|0|||
16085097|NCT00146172|38802667|FG007|Overall Study|Physician Decision|1|||
16085098|NCT00146172|38802660|FG000|Overall Study|Withdrawal by Subject|0|||
16085099|NCT00146172|38802661|FG001|Overall Study|Withdrawal by Subject|0|||
16085100|NCT00146172|38802662|FG002|Overall Study|Withdrawal by Subject|0|||
16085101|NCT00146172|38802663|FG003|Overall Study|Withdrawal by Subject|0|||
16085102|NCT00146172|38802664|FG004|Overall Study|Withdrawal by Subject|0|||
16085103|NCT00146172|38802665|FG005|Overall Study|Withdrawal by Subject|1|||
16085104|NCT00146172|38802666|FG006|Overall Study|Withdrawal by Subject|1|||
16085105|NCT00146172|38802667|FG007|Overall Study|Withdrawal by Subject|4|||
16085106|NCT00146172|38802660|FG000|Overall Study|Symptomatic Deterioration|1|||
16085107|NCT00146172|38802661|FG001|Overall Study|Symptomatic Deterioration|0|||
16085108|NCT00146172|38802662|FG002|Overall Study|Symptomatic Deterioration|1|||
16085109|NCT00146172|38802663|FG003|Overall Study|Symptomatic Deterioration|0|||
16085110|NCT00146172|38802664|FG004|Overall Study|Symptomatic Deterioration|1|||
16085111|NCT00146172|38802665|FG005|Overall Study|Symptomatic Deterioration|2|||
16085112|NCT00146172|38802666|FG006|Overall Study|Symptomatic Deterioration|0|||
16085113|NCT00146172|38802667|FG007|Overall Study|Symptomatic Deterioration|2|||
16085114|NCT03709706|38802673|FG000|Overall Study|Adverse Event|0|||
16085115|NCT03709706|38802674|FG001|Overall Study|Adverse Event|1|||
16306193|NCT04578535|39608822|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
16306194|NCT04578535|39608823|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
16306195|NCT04578535|39608824|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
16306196|NCT04578535|39608825|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
16306197|NCT00280735|39608826|FG000|Overall Study|Adverse Event|5|||
16306198|NCT00280735|39608826|FG000|Overall Study|Lack of Efficacy|3|||
16306199|NCT00280735|39608826|FG000|Overall Study|Withdrawal by Subject|8|||
16306200|NCT00280735|39608826|FG000|Overall Study|Intercurrent Illness|2|||
16306201|NCT02652949|39608829|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
16306202|NCT02652949|39608829|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
16306203|NCT02652949|39608829|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
16306204|NCT02652949|39608829|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
16306205|NCT02652949|39608829|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
16306206|NCT02652949|39608829|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
16306207|NCT02652949|39608829|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
16306208|NCT02652949|39608829|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
16306209|NCT02652949|39608829|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
16306210|NCT02652949|39608829|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
16306211|NCT02652949|39608829|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
16306212|NCT02652949|39608829|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
16306213|NCT02652949|39608829|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
16085116|NCT03709706|38802673|FG000|Overall Study|Physician Decision|14|||
16085117|NCT03709706|38802674|FG001|Overall Study|Physician Decision|8|||
16085118|NCT03709706|38802673|FG000|Overall Study|Withdrawal by Subject|2|||
16085119|NCT03709706|38802674|FG001|Overall Study|Withdrawal by Subject|1|||
16085120|NCT03709706|38802673|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
16085121|NCT03709706|38802674|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
16085122|NCT00655824|38802677|FG000|Overall Study|Adverse Event|3|||
16085123|NCT00655824|38802677|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
16085124|NCT00655824|38802677|FG000|Overall Study|Protocol Violation|1|||
16085125|NCT00655824|38802677|FG000|Overall Study|Withdrawal by Subject|4|||
16085126|NCT00655824|38802677|FG000|Overall Study|Deterioration of Trial Disease|2|||
16085127|NCT04019444|38802679|FG000|Overall Study|Withdrawal by Subject|0|||
16085128|NCT04019444|38802680|FG001|Overall Study|Withdrawal by Subject|1|||
16085129|NCT04019444|38802681|FG002|Overall Study|Withdrawal by Subject|0|||
16085130|NCT04019444|38802682|FG003|Overall Study|Withdrawal by Subject|1|||
16306214|NCT02652949|39608829|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
16306215|NCT02652949|39608829|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
16388228|NCT03381287|39905598|FG002|Overall Study|Physician Decision|0|||
16388229|NCT03381287|39905599|FG003|Overall Study|Physician Decision|1|||
16085131|NCT04019444|38802679|FG000|Overall Study|Solicited Event|0|||
16085132|NCT04019444|38802680|FG001|Overall Study|Solicited Event|0|||
16085133|NCT04019444|38802681|FG002|Overall Study|Solicited Event|2|||
16085134|NCT04019444|38802682|FG003|Overall Study|Solicited Event|0|||
16085135|NCT01579916|38802683|FG000|Overall Study|Lost to Follow-up|6|||
16085136|NCT01579916|38802684|FG001|Overall Study|Lost to Follow-up|1|||
16306216|NCT02652949|39608829|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
16306217|NCT02652949|39608829|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
16306218|NCT00715624|39608830|FG000|Overall Study|Adverse Event|12|||
16306219|NCT00715624|39608831|FG001|Overall Study|Adverse Event|37|||
16306220|NCT00715624|39608830|FG000|Overall Study|Lack of Efficacy|11|||
16306221|NCT00715624|39608831|FG001|Overall Study|Lack of Efficacy|11|||
16306222|NCT00715624|39608830|FG000|Overall Study|Lost to Follow-up|1|||
16306223|NCT00715624|39608831|FG001|Overall Study|Lost to Follow-up|2|||
16306224|NCT00715624|39608830|FG000|Overall Study|Protocol Violation|1|||
16306225|NCT00715624|39608831|FG001|Overall Study|Protocol Violation|0|||
16306226|NCT00715624|39608830|FG000|Overall Study|Withdrawal by Subject|11|||
16306227|NCT00715624|39608831|FG001|Overall Study|Withdrawal by Subject|25|||
16306228|NCT00715624|39608830|FG000|Overall Study|Familial and personal reasons|10|||
16306229|NCT00715624|39608831|FG001|Overall Study|Familial and personal reasons|22|||
16306230|NCT00715624|39608830|FG000|Overall Study|Poor compliance|6|||
16306231|NCT00715624|39608831|FG001|Overall Study|Poor compliance|13|||
16306232|NCT00715624|39608830|FG000|Overall Study|Sponsor decision|0|||
16306233|NCT00715624|39608831|FG001|Overall Study|Sponsor decision|4|||
16306234|NCT00715624|39608830|FG000|Overall Study|Incorrect randomization (not treated)|0|||
16306235|NCT00715624|39608831|FG001|Overall Study|Incorrect randomization (not treated)|1|||
16306236|NCT00715624|39608830|FG000|Overall Study|Other|0|||
16306237|NCT00715624|39608831|FG001|Overall Study|Other|1|||
16306238|NCT02006732|39608832|FG000|Overall Study|Adverse Event|10|||
16306239|NCT02006732|39608833|FG001|Overall Study|Adverse Event|7|||
16306240|NCT02006732|39608834|FG002|Overall Study|Adverse Event|4|||
16306241|NCT02006732|39608835|FG003|Overall Study|Adverse Event|2|||
16306242|NCT02006732|39608832|FG000|Overall Study|Lack of Efficacy|6|||
16306243|NCT02006732|39608833|FG001|Overall Study|Lack of Efficacy|3|||
16306244|NCT02006732|39608834|FG002|Overall Study|Lack of Efficacy|1|||
16085137|NCT01579916|38802683|FG000|Overall Study|Withdrawal by Subject|1|||
16085138|NCT01579916|38802684|FG001|Overall Study|Withdrawal by Subject|1|||
16085139|NCT01579916|38802683|FG000|Overall Study|Death|1|||
16085140|NCT01579916|38802684|FG001|Overall Study|Death|0|||
16085141|NCT02931396|38802686|FG000|Overall Study|Lost to Follow-up|3|||
16085142|NCT02931396|38802687|FG001|Overall Study|Lost to Follow-up|0|||
16085143|NCT02931396|38802686|FG000|Overall Study|Withdrawal by Subject|2|||
16085144|NCT02931396|38802687|FG001|Overall Study|Withdrawal by Subject|0|||
16085145|NCT02941549|38802688|FG000|Overall Study|Adverse Event|1|||
16085146|NCT02941549|38802689|FG001|Overall Study|Adverse Event|0|||
16085147|NCT02941549|38802690|FG002|Overall Study|Adverse Event|0|||
16085148|NCT02941549|38802688|FG000|Overall Study|Withdrawal by Subject|2|||
16085149|NCT02941549|38802689|FG001|Overall Study|Withdrawal by Subject|1|||
16085150|NCT02941549|38802690|FG002|Overall Study|Withdrawal by Subject|2|||
16306245|NCT02006732|39608835|FG003|Overall Study|Lack of Efficacy|1|||
16306246|NCT02006732|39608832|FG000|Overall Study|Protocol Violation|1|||
16306247|NCT02006732|39608833|FG001|Overall Study|Protocol Violation|1|||
16306248|NCT02006732|39608834|FG002|Overall Study|Protocol Violation|0|||
16306249|NCT02006732|39608835|FG003|Overall Study|Protocol Violation|0|||
16306250|NCT02006732|39608832|FG000|Overall Study|Lost to Follow-up|0|||
16306251|NCT02006732|39608833|FG001|Overall Study|Lost to Follow-up|1|||
16306252|NCT02006732|39608834|FG002|Overall Study|Lost to Follow-up|0|||
16306253|NCT02006732|39608835|FG003|Overall Study|Lost to Follow-up|0|||
16306254|NCT02006732|39608832|FG000|Overall Study|Withdrawal by Subject|3|||
16306255|NCT02006732|39608833|FG001|Overall Study|Withdrawal by Subject|0|||
16306256|NCT02006732|39608834|FG002|Overall Study|Withdrawal by Subject|4|||
16306257|NCT02006732|39608835|FG003|Overall Study|Withdrawal by Subject|1|||
16306258|NCT01645787|39608836|FG000|Washout (2 Weeks)|Adverse Event|1|||
16306259|NCT01645787|39608837|FG001|Washout (2 Weeks)|Adverse Event|0|||
16306260|NCT04211831|39608842|FG000|Overall Study|Withdrawal by Subject|4|||
16306261|NCT04211831|39608843|FG001|Overall Study|Withdrawal by Subject|1|||
16306262|NCT04211831|39608844|FG002|Overall Study|Withdrawal by Subject|1|||
16306263|NCT04211831|39608842|FG000|Overall Study|Protocol Violation|0|||
16306264|NCT04211831|39608843|FG001|Overall Study|Protocol Violation|0|||
16306265|NCT04211831|39608844|FG002|Overall Study|Protocol Violation|1|||
16306266|NCT04211831|39608842|FG000|Overall Study|Adverse Event|0|||
16306267|NCT04211831|39608843|FG001|Overall Study|Adverse Event|1|||
16306268|NCT04211831|39608844|FG002|Overall Study|Adverse Event|0|||
16306269|NCT04211831|39608842|FG000|Overall Study|Lack of Efficacy|0|||
16306270|NCT04211831|39608843|FG001|Overall Study|Lack of Efficacy|0|||
16306271|NCT04211831|39608844|FG002|Overall Study|Lack of Efficacy|1|||
16085151|NCT01737021|38802693|FG000|Overall Study|Lost to Follow-up|5|||
16085152|NCT01737021|38802694|FG001|Overall Study|Lost to Follow-up|3|||
16306272|NCT04211831|39608842|FG000|Overall Study|Lost to Follow-up|0|||
16306273|NCT04211831|39608843|FG001|Overall Study|Lost to Follow-up|0|||
16306274|NCT04211831|39608844|FG002|Overall Study|Lost to Follow-up|2|||
16306275|NCT04211831|39608842|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
16085153|NCT02408887|38802700|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
16085154|NCT02408887|38802701|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
16306276|NCT04211831|39608843|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
16306277|NCT04211831|39608844|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
16306278|NCT04211831|39608842|FG000|Overall Study|Other|0|||
16193732|NCT01606761|39188607|FG000|Week 24 to Week 52|Adverse Event|0|||
16193733|NCT01606761|39188608|FG001|Week 24 to Week 52|Adverse Event|11|||
16193734|NCT01606761|39188609|FG002|Week 24 to Week 52|Adverse Event|14|||
16193735|NCT01606761|39188610|FG003|Week 24 to Week 52|Adverse Event|3|||
16193736|NCT01606761|39188611|FG004|Week 24 to Week 52|Adverse Event|15|||
16193737|NCT01606761|39188607|FG000|Week 24 to Week 52|Death|0|||
16193738|NCT01606761|39188608|FG001|Week 24 to Week 52|Death|0|||
16193739|NCT01606761|39188609|FG002|Week 24 to Week 52|Death|2|||
16193740|NCT01606761|39188610|FG003|Week 24 to Week 52|Death|1|||
16193741|NCT01606761|39188611|FG004|Week 24 to Week 52|Death|0|||
16193742|NCT01606761|39188607|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
16193743|NCT01606761|39188608|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
16193744|NCT01606761|39188609|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
16193745|NCT01606761|39188610|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
16193746|NCT01606761|39188611|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
16193747|NCT01606761|39188607|FG000|Week 24 to Week 52|Physician Decision|0|||
16193748|NCT01606761|39188608|FG001|Week 24 to Week 52|Physician Decision|1|||
16193749|NCT01606761|39188609|FG002|Week 24 to Week 52|Physician Decision|1|||
16193750|NCT01606761|39188610|FG003|Week 24 to Week 52|Physician Decision|0|||
16193751|NCT01606761|39188611|FG004|Week 24 to Week 52|Physician Decision|0|||
16193752|NCT01606761|39188607|FG000|Week 24 to Week 52|Other|0|||
16193753|NCT01606761|39188608|FG001|Week 24 to Week 52|Other|1|||
16193754|NCT01606761|39188609|FG002|Week 24 to Week 52|Other|5|||
16193755|NCT01606761|39188610|FG003|Week 24 to Week 52|Other|2|||
16193756|NCT01606761|39188611|FG004|Week 24 to Week 52|Other|2|||
16193757|NCT01606761|39188607|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
16193758|NCT01606761|39188608|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
16193759|NCT01606761|39188609|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
16193760|NCT01606761|39188610|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
16193761|NCT01606761|39188611|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
16193762|NCT01606761|39188607|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
16193763|NCT01606761|39188608|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
16193764|NCT01606761|39188609|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
16193765|NCT01606761|39188610|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
16193766|NCT01606761|39188611|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
16193767|NCT01606761|39188607|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
16193768|NCT01606761|39188608|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
16193769|NCT01606761|39188609|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
16193770|NCT01606761|39188610|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
16193771|NCT01606761|39188611|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
16193772|NCT01606761|39188607|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
16193773|NCT01606761|39188608|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
16193774|NCT01606761|39188609|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
16193775|NCT01606761|39188610|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
16193776|NCT01606761|39188611|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
16193777|NCT00296725|39188612|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
16193778|NCT00296725|39188612|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
16193779|NCT00296725|39188612|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
16193780|NCT00712322|39188616|FG000|Overall Study|Protocol deviation|0|||
16193781|NCT00712322|39188617|FG001|Overall Study|Protocol deviation|1|||
16193782|NCT00712322|39188618|FG002|Overall Study|Protocol deviation|0|||
16193783|NCT00788697|39188623|FG000|Overall Study|No study drug administered|12|||
16193784|NCT00788697|39188623|FG000|Overall Study|Training Patients|74|||
16193785|NCT00788697|39188623|FG000|Overall Study|no truth standard procedure available|5|||
16193786|NCT00788697|39188623|FG000|Overall Study|Technically inadequate truth standard|1|||
16193787|NCT00788697|39188623|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
16193788|NCT02683525|39188624|FG000|Overall Study|Lost to Follow-up|1|||
16193789|NCT02683525|39188624|FG000|Overall Study|Physician Decision|1|||
16193790|NCT02683525|39188624|FG000|Overall Study|Disease Progression|6|||
16193791|NCT00937768|39188625|FG000|Overall Study|Refused Further Treatment|3|||
16193792|NCT00937768|39188626|FG001|Overall Study|Refused Further Treatment|2|||
16193793|NCT00937768|39188625|FG000|Overall Study|Disease Progression|1|||
16193794|NCT00937768|39188626|FG001|Overall Study|Disease Progression|1|||
16193795|NCT00937768|39188625|FG000|Overall Study|Alternate Treatment|0|||
16193796|NCT00937768|39188626|FG001|Overall Study|Alternate Treatment|1|||
16193797|NCT00937768|39188625|FG000|Overall Study|No Further Funding|4|||
16193798|NCT00937768|39188626|FG001|Overall Study|No Further Funding|4|||
16193799|NCT01067508|39188627|FG000|Overall Study|Physician Decision|0|||
16193800|NCT01067508|39188628|FG001|Overall Study|Physician Decision|1|||
16193801|NCT01067508|39188627|FG000|Overall Study|Withdrawal by Subject|0|||
16193802|NCT01067508|39188628|FG001|Overall Study|Withdrawal by Subject|1|||
16193803|NCT03493685|39188631|FG000|Overall Study|Death|4|||
16193804|NCT03493685|39188632|FG001|Overall Study|Death|3|||
16193805|NCT03493685|39188631|FG000|Overall Study|Lost to Follow-up|3|||
16193806|NCT03493685|39188632|FG001|Overall Study|Lost to Follow-up|2|||
16306279|NCT04211831|39608843|FG001|Overall Study|Other|1|||
16306280|NCT04211831|39608844|FG002|Overall Study|Other|0|||
16306281|NCT01050530|39608847|FG000|Overall Study|Adverse Event|6|||
16306282|NCT01050530|39608848|FG001|Overall Study|Adverse Event|3|||
16306283|NCT01050530|39608847|FG000|Overall Study|Lack of Efficacy|1|||
16306284|NCT01050530|39608848|FG001|Overall Study|Lack of Efficacy|4|||
16306285|NCT01050530|39608847|FG000|Overall Study|Withdrawal by Subject|0|||
16306286|NCT01050530|39608848|FG001|Overall Study|Withdrawal by Subject|3|||
16306287|NCT01050530|39608847|FG000|Overall Study|Protocol Violation|1|||
16306288|NCT01050530|39608848|FG001|Overall Study|Protocol Violation|0|||
16306289|NCT03971474|39608849|FG000|Overall Study|Adverse Event|11|||
16306290|NCT03971474|39608850|FG001|Overall Study|Adverse Event|7|||
16306291|NCT03971474|39608849|FG000|Overall Study|Refusal unrelated to adverse event|5|||
16306292|NCT03971474|39608850|FG001|Overall Study|Refusal unrelated to adverse event|1|||
16306293|NCT03971474|39608849|FG000|Overall Study|Progression/relapse|40|||
16306294|NCT03971474|39608850|FG001|Overall Study|Progression/relapse|47|||
16306295|NCT03971474|39608849|FG000|Overall Study|Death|6|||
16306296|NCT03971474|39608850|FG001|Overall Study|Death|3|||
16306297|NCT03971474|39608849|FG000|Overall Study|Other - not protocol specified|5|||
16306298|NCT03971474|39608850|FG001|Overall Study|Other - not protocol specified|4|||
16306299|NCT03971474|39608849|FG000|Overall Study|On treatment|0|||
16306300|NCT03971474|39608850|FG001|Overall Study|On treatment|7|||
16306301|NCT00474266|39608855|FG000|Overall Study|Withdrawal by Subject|7|||
16306302|NCT00474266|39608856|FG001|Overall Study|Withdrawal by Subject|20|||
16306303|NCT00474266|39608857|FG002|Overall Study|Withdrawal by Subject|4|||
16306304|NCT00474266|39608858|FG003|Overall Study|Withdrawal by Subject|7|||
16306305|NCT02431364|39608859|FG000|Overall Study|Adverse Event|0|||
16306306|NCT02431364|39608860|FG001|Overall Study|Adverse Event|1|||
16306307|NCT02431364|39608861|FG002|Overall Study|Adverse Event|0|||
16306308|NCT02431364|39608862|FG003|Overall Study|Adverse Event|0|||
16306309|NCT02431364|39608863|FG004|Overall Study|Adverse Event|0|||
16306310|NCT02431364|39608859|FG000|Overall Study|Randomized but never treated|0|||
16306311|NCT02431364|39608860|FG001|Overall Study|Randomized but never treated|0|||
16306312|NCT02431364|39608861|FG002|Overall Study|Randomized but never treated|0|||
16306313|NCT02431364|39608862|FG003|Overall Study|Randomized but never treated|1|||
16306314|NCT02431364|39608863|FG004|Overall Study|Randomized but never treated|0|||
16306315|NCT01659151|39608864|FG000|Overall Study|Inadequate TIL growth|1|||
16306316|NCT00299130|39608865|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
16306317|NCT00299130|39608866|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
16306318|NCT00299130|39608867|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
16306319|NCT00299130|39608865|FG000|Treatment Period (up to 5 Years)|Death|1|||
16306320|NCT00299130|39608866|FG001|Treatment Period (up to 5 Years)|Death|3|||
16306321|NCT00299130|39608867|FG002|Treatment Period (up to 5 Years)|Death|1|||
16306322|NCT00299130|39608865|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
16306323|NCT00299130|39608866|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
16306324|NCT00299130|39608867|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
16306325|NCT00299130|39608865|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
16306326|NCT00299130|39608866|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
16306327|NCT00299130|39608867|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
16306328|NCT00299130|39608865|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
16306329|NCT00299130|39608866|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
16306330|NCT00299130|39608867|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
16306331|NCT00299130|39608865|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
16306332|NCT00299130|39608866|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
16306333|NCT00299130|39608867|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
16306334|NCT00299130|39608865|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
16306335|NCT00299130|39608866|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
16306336|NCT00299130|39608867|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
16306337|NCT00299130|39608865|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
16306338|NCT00299130|39608866|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
16306339|NCT00299130|39608867|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
16306340|NCT00299130|39608865|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
16306341|NCT00299130|39608866|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
16306342|NCT00299130|39608867|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
16306343|NCT00299130|39608865|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
16306344|NCT00299130|39608866|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
16306345|NCT00299130|39608867|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
16306346|NCT00299130|39608865|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
16306347|NCT00299130|39608866|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
16306348|NCT00299130|39608867|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
16306349|NCT00299130|39608865|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
16193807|NCT03493685|39188631|FG000|Overall Study|Physician Decision|2|||
16306350|NCT00299130|39608866|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
16306351|NCT00299130|39608867|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
16306352|NCT00299130|39608865|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
16306353|NCT00299130|39608866|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
16306354|NCT00299130|39608867|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
16306355|NCT00299130|39608865|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
16306356|NCT00299130|39608866|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
16306357|NCT00299130|39608867|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
16306358|NCT00299130|39608865|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
16306359|NCT00299130|39608866|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
16306360|NCT00299130|39608867|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
16306361|NCT00299130|39608865|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
16306362|NCT00299130|39608866|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
16306363|NCT00299130|39608867|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
16306364|NCT00299130|39608865|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
16306365|NCT00299130|39608866|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
16306366|NCT00299130|39608867|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
16306367|NCT04607135|39608872|FG000|Overall Study|Physician Decision|1|||
16306368|NCT04607135|39608872|FG000|Overall Study|Withdrawal by Subject|1|||
16306369|NCT04607135|39608872|FG000|Overall Study|Equipment not working|3|||
16306370|NCT04138043|39608873|FG000|Overall Study|Withdrawal by Subject|0|||
16306371|NCT04138043|39608874|FG001|Overall Study|Withdrawal by Subject|1|||
16306372|NCT02064296|39608878|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
16306373|NCT02064296|39608879|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
16306374|NCT02064296|39608880|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
16306375|NCT02064296|39608878|FG000|Intervention|Withdrawal by Subject|0|||
16306376|NCT02064296|39608879|FG001|Intervention|Withdrawal by Subject|1|||
16306377|NCT02064296|39608880|FG002|Intervention|Withdrawal by Subject|2|||
16306378|NCT05445492|39608881|FG000|Overall Study|Physician Decision|1|||
16306379|NCT02797171|39608882|FG000|Overall Study|Lost to Follow-up|2|||
16306380|NCT02797171|39608883|FG001|Overall Study|Lost to Follow-up|0|||
16306381|NCT02797171|39608884|FG002|Overall Study|Lost to Follow-up|2|||
16306382|NCT02797171|39608885|FG003|Overall Study|Lost to Follow-up|1|||
16306383|NCT02797171|39608886|FG004|Overall Study|Lost to Follow-up|2|||
16306384|NCT02797171|39608887|FG005|Overall Study|Lost to Follow-up|0|||
16306385|NCT02797171|39608882|FG000|Overall Study|Withdrawal by Subject|1|||
16306386|NCT02797171|39608883|FG001|Overall Study|Withdrawal by Subject|1|||
16306387|NCT02797171|39608884|FG002|Overall Study|Withdrawal by Subject|0|||
16306388|NCT02797171|39608885|FG003|Overall Study|Withdrawal by Subject|0|||
16306389|NCT02797171|39608886|FG004|Overall Study|Withdrawal by Subject|0|||
16306390|NCT02797171|39608887|FG005|Overall Study|Withdrawal by Subject|0|||
16306391|NCT02797171|39608882|FG000|Overall Study|Protocol Violation|1|||
16306392|NCT02797171|39608883|FG001|Overall Study|Protocol Violation|0|||
16306393|NCT02797171|39608884|FG002|Overall Study|Protocol Violation|0|||
16306394|NCT02797171|39608885|FG003|Overall Study|Protocol Violation|0|||
16306395|NCT02797171|39608886|FG004|Overall Study|Protocol Violation|0|||
16306396|NCT02797171|39608887|FG005|Overall Study|Protocol Violation|0|||
16306397|NCT02797171|39608882|FG000|Overall Study|Participant unable to adhere|0|||
16306398|NCT02797171|39608883|FG001|Overall Study|Participant unable to adhere|1|||
16306399|NCT02797171|39608884|FG002|Overall Study|Participant unable to adhere|0|||
16306400|NCT02797171|39608885|FG003|Overall Study|Participant unable to adhere|0|||
16306401|NCT02797171|39608886|FG004|Overall Study|Participant unable to adhere|0|||
16306402|NCT02797171|39608887|FG005|Overall Study|Participant unable to adhere|0|||
16306403|NCT02797171|39608882|FG000|Overall Study|Not Randomized|0|||
16306404|NCT02797171|39608883|FG001|Overall Study|Not Randomized|0|||
16306405|NCT02797171|39608884|FG002|Overall Study|Not Randomized|0|||
16306406|NCT02797171|39608885|FG003|Overall Study|Not Randomized|0|||
16306407|NCT02797171|39608886|FG004|Overall Study|Not Randomized|0|||
16306408|NCT02797171|39608887|FG005|Overall Study|Not Randomized|1|||
16306409|NCT01074944|39608888|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
16306410|NCT01074944|39608889|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
16306411|NCT01074944|39608890|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
16306412|NCT01074944|39608891|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
16306413|NCT01074944|39608892|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
16306414|NCT01074944|39608888|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
16306415|NCT01074944|39608889|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
16306416|NCT01074944|39608890|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
16306417|NCT01074944|39608891|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
16306418|NCT01074944|39608892|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
16306419|NCT01074944|39608888|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
16306420|NCT01074944|39608889|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
16306421|NCT01074944|39608890|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
16306422|NCT01074944|39608891|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
16306423|NCT01074944|39608892|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
16306424|NCT01074944|39608888|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
16306425|NCT01074944|39608889|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
16306426|NCT01074944|39608890|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
16306427|NCT01074944|39608891|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
16306428|NCT01074944|39608892|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
16306429|NCT01074944|39608888|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
16306430|NCT01074944|39608889|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
16306431|NCT01074944|39608890|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
16306432|NCT01074944|39608891|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
16306433|NCT01074944|39608892|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
16306434|NCT01074944|39608888|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
16306435|NCT01074944|39608889|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
16306436|NCT01074944|39608890|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
16306437|NCT01074944|39608891|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
16306438|NCT01074944|39608892|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
16306439|NCT01074944|39608888|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
16306440|NCT01074944|39608889|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
16306441|NCT01074944|39608890|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
16306442|NCT01074944|39608891|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
16306443|NCT01074944|39608892|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
16306444|NCT01074944|39608888|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
16306445|NCT01074944|39608889|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
16306446|NCT01074944|39608890|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
16306447|NCT01074944|39608891|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
16306448|NCT01074944|39608892|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
16306449|NCT01074944|39608888|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
16306450|NCT01074944|39608889|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
16306451|NCT01074944|39608890|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
16306452|NCT01074944|39608891|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
16306453|NCT01074944|39608892|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
16306454|NCT01074944|39608888|FG000|Long Term Treatment|Adverse Event|0|||
16306455|NCT01074944|39608889|FG001|Long Term Treatment|Adverse Event|0|||
16306456|NCT01074944|39608890|FG002|Long Term Treatment|Adverse Event|0|||
16306457|NCT01074944|39608891|FG003|Long Term Treatment|Adverse Event|3|||
16306458|NCT01074944|39608892|FG004|Long Term Treatment|Adverse Event|0|||
16306459|NCT01074944|39608888|FG000|Long Term Treatment|Lost to Follow-up|0|||
16306460|NCT01074944|39608889|FG001|Long Term Treatment|Lost to Follow-up|0|||
16306461|NCT01074944|39608890|FG002|Long Term Treatment|Lost to Follow-up|0|||
16306462|NCT01074944|39608891|FG003|Long Term Treatment|Lost to Follow-up|2|||
16306463|NCT01074944|39608892|FG004|Long Term Treatment|Lost to Follow-up|0|||
16306464|NCT01074944|39608888|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
16306465|NCT01074944|39608889|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
16306466|NCT01074944|39608890|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
16306467|NCT01074944|39608891|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
16306468|NCT01074944|39608892|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
16306469|NCT01074944|39608888|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
16306470|NCT01074944|39608889|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
16306471|NCT01074944|39608890|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
16306472|NCT01074944|39608891|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
16306473|NCT01074944|39608892|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
16306474|NCT01074944|39608888|FG000|Long Term Treatment|Withdrawal by Subject|0|||
16306475|NCT01074944|39608889|FG001|Long Term Treatment|Withdrawal by Subject|0|||
16306476|NCT01074944|39608890|FG002|Long Term Treatment|Withdrawal by Subject|0|||
16306477|NCT01074944|39608891|FG003|Long Term Treatment|Withdrawal by Subject|2|||
16306478|NCT01074944|39608892|FG004|Long Term Treatment|Withdrawal by Subject|0|||
16306479|NCT01074944|39608888|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
16306480|NCT01074944|39608889|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
16306481|NCT01074944|39608890|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
16306482|NCT01074944|39608891|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
16306483|NCT01074944|39608892|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
16306484|NCT01074944|39608888|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
16306485|NCT01074944|39608889|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
16306486|NCT01074944|39608890|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
16409933|NCT03099148|39981831|FG001|Wash-out|Adverse Event|1|||
16306487|NCT01074944|39608891|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
16306488|NCT01074944|39608892|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
16306489|NCT02308124|39608893|FG000|Overall Study|Lost to Follow-up|6|||
16306490|NCT02308124|39608894|FG001|Overall Study|Lost to Follow-up|6|||
16306491|NCT02308124|39608895|FG002|Overall Study|Lost to Follow-up|6|||
16306492|NCT02308124|39608893|FG000|Overall Study|Adverse Event|0|||
16306493|NCT02308124|39608894|FG001|Overall Study|Adverse Event|2|||
16306494|NCT02308124|39608895|FG002|Overall Study|Adverse Event|2|||
16306495|NCT03284723|39608901|FG000|Overall Study|Death|0|||
16306496|NCT03284723|39608902|FG001|Overall Study|Death|0|||
16306497|NCT03284723|39608903|FG002|Overall Study|Death|0|||
16306498|NCT03284723|39608904|FG003|Overall Study|Death|1|||
16306499|NCT03284723|39608905|FG004|Overall Study|Death|0|||
16306500|NCT03284723|39608906|FG005|Overall Study|Death|0|||
16306501|NCT03284723|39608907|FG006|Overall Study|Death|1|||
16306502|NCT03284723|39608908|FG007|Overall Study|Death|0|||
16306503|NCT03284723|39608909|FG008|Overall Study|Death|0|||
16306504|NCT03284723|39608910|FG009|Overall Study|Death|2|||
16306505|NCT03284723|39608911|FG010|Overall Study|Death|1|||
16306506|NCT03284723|39608912|FG011|Overall Study|Death|0|||
16306507|NCT03284723|39608901|FG000|Overall Study|Lost to Follow-up|0|||
16306508|NCT03284723|39608902|FG001|Overall Study|Lost to Follow-up|0|||
16306509|NCT03284723|39608903|FG002|Overall Study|Lost to Follow-up|0|||
16306510|NCT03284723|39608904|FG003|Overall Study|Lost to Follow-up|0|||
16306511|NCT03284723|39608905|FG004|Overall Study|Lost to Follow-up|0|||
16306512|NCT03284723|39608906|FG005|Overall Study|Lost to Follow-up|2|||
16306513|NCT03284723|39608907|FG006|Overall Study|Lost to Follow-up|1|||
16306514|NCT03284723|39608908|FG007|Overall Study|Lost to Follow-up|0|||
16306515|NCT03284723|39608909|FG008|Overall Study|Lost to Follow-up|0|||
16306516|NCT03284723|39608910|FG009|Overall Study|Lost to Follow-up|2|||
16306517|NCT03284723|39608911|FG010|Overall Study|Lost to Follow-up|0|||
16306518|NCT03284723|39608912|FG011|Overall Study|Lost to Follow-up|0|||
16306519|NCT03284723|39608901|FG000|Overall Study|Study Terminated By Sponsor|0|||
16306520|NCT03284723|39608902|FG001|Overall Study|Study Terminated By Sponsor|0|||
16306521|NCT03284723|39608903|FG002|Overall Study|Study Terminated By Sponsor|0|||
16306522|NCT03284723|39608904|FG003|Overall Study|Study Terminated By Sponsor|0|||
16306523|NCT03284723|39608905|FG004|Overall Study|Study Terminated By Sponsor|1|||
16306524|NCT03284723|39608906|FG005|Overall Study|Study Terminated By Sponsor|0|||
16306525|NCT03284723|39608907|FG006|Overall Study|Study Terminated By Sponsor|0|||
16306526|NCT03284723|39608908|FG007|Overall Study|Study Terminated By Sponsor|0|||
16306527|NCT03284723|39608909|FG008|Overall Study|Study Terminated By Sponsor|1|||
16306528|NCT03284723|39608910|FG009|Overall Study|Study Terminated By Sponsor|1|||
16306529|NCT03284723|39608911|FG010|Overall Study|Study Terminated By Sponsor|1|||
16306530|NCT03284723|39608912|FG011|Overall Study|Study Terminated By Sponsor|1|||
16306531|NCT03284723|39608901|FG000|Overall Study|Withdrawal by Subject|0|||
16306532|NCT03284723|39608902|FG001|Overall Study|Withdrawal by Subject|0|||
16306533|NCT03284723|39608903|FG002|Overall Study|Withdrawal by Subject|0|||
16306534|NCT03284723|39608904|FG003|Overall Study|Withdrawal by Subject|0|||
16306535|NCT03284723|39608905|FG004|Overall Study|Withdrawal by Subject|5|||
16306536|NCT03284723|39608906|FG005|Overall Study|Withdrawal by Subject|3|||
16306537|NCT03284723|39608907|FG006|Overall Study|Withdrawal by Subject|1|||
16306538|NCT03284723|39608908|FG007|Overall Study|Withdrawal by Subject|0|||
16306539|NCT03284723|39608909|FG008|Overall Study|Withdrawal by Subject|6|||
16306540|NCT03284723|39608910|FG009|Overall Study|Withdrawal by Subject|0|||
16306541|NCT03284723|39608911|FG010|Overall Study|Withdrawal by Subject|3|||
16306542|NCT03284723|39608912|FG011|Overall Study|Withdrawal by Subject|1|||
16306543|NCT03284723|39608901|FG000|Overall Study|Other|1|||
16306544|NCT03284723|39608902|FG001|Overall Study|Other|0|||
16306545|NCT03284723|39608903|FG002|Overall Study|Other|1|||
16306546|NCT03284723|39608904|FG003|Overall Study|Other|0|||
16306547|NCT03284723|39608905|FG004|Overall Study|Other|1|||
16306548|NCT03284723|39608906|FG005|Overall Study|Other|0|||
16306549|NCT03284723|39608907|FG006|Overall Study|Other|0|||
16306550|NCT03284723|39608908|FG007|Overall Study|Other|0|||
16306551|NCT03284723|39608909|FG008|Overall Study|Other|0|||
16306552|NCT03284723|39608910|FG009|Overall Study|Other|0|||
16306553|NCT03284723|39608911|FG010|Overall Study|Other|1|||
16306554|NCT03284723|39608912|FG011|Overall Study|Other|0|||
16306555|NCT03284723|39608901|FG000|Overall Study|Adverse Event|0|||
16306556|NCT03284723|39608902|FG001|Overall Study|Adverse Event|0|||
16306557|NCT03284723|39608903|FG002|Overall Study|Adverse Event|0|||
16306558|NCT03284723|39608904|FG003|Overall Study|Adverse Event|0|||
16306559|NCT03284723|39608905|FG004|Overall Study|Adverse Event|0|||
16306560|NCT03284723|39608906|FG005|Overall Study|Adverse Event|0|||
16306561|NCT03284723|39608907|FG006|Overall Study|Adverse Event|0|||
16306562|NCT03284723|39608908|FG007|Overall Study|Adverse Event|0|||
16306563|NCT03284723|39608909|FG008|Overall Study|Adverse Event|1|||
16306564|NCT03284723|39608910|FG009|Overall Study|Adverse Event|0|||
16306565|NCT03284723|39608911|FG010|Overall Study|Adverse Event|0|||
16306566|NCT03284723|39608912|FG011|Overall Study|Adverse Event|0|||
16306567|NCT01924754|39608913|FG000|Overall Study|Lost to Follow-up|1|||
16306568|NCT01924754|39608914|FG001|Overall Study|Lost to Follow-up|2|||
16306569|NCT01924754|39608915|FG002|Overall Study|Lost to Follow-up|1|||
16306570|NCT01924754|39608913|FG000|Overall Study|Pregnancy|0|||
16306571|NCT01924754|39608914|FG001|Overall Study|Pregnancy|1|||
16306572|NCT01924754|39608915|FG002|Overall Study|Pregnancy|2|||
16306573|NCT03908437|39608920|FG000|Overall Study|Death|0|||
16306574|NCT03908437|39608921|FG001|Overall Study|Death|1|||
16306575|NCT03908437|39608920|FG000|Overall Study|Lost to Follow-up|31|||
16306576|NCT03908437|39608921|FG001|Overall Study|Lost to Follow-up|24|||
16306577|NCT00490841|39608922|FG000|Overall Study|Death|5|||
16306578|NCT00490841|39608922|FG000|Overall Study|Withdrawal by Subject|4|||
16306579|NCT00490841|39608922|FG000|Overall Study|Lost to Follow-up|1|||
16306580|NCT00490841|39608922|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
16306581|NCT02211417|39608923|FG000|Overall Study|Withdrawal by Subject|11|||
16306582|NCT02211417|39608924|FG001|Overall Study|Withdrawal by Subject|8|||
16306583|NCT02211417|39608923|FG000|Overall Study|Protocol Violation|1|||
16306584|NCT02211417|39608924|FG001|Overall Study|Protocol Violation|0|||
16306585|NCT02211417|39608923|FG000|Overall Study|Pregnancy|0|||
16306586|NCT02211417|39608924|FG001|Overall Study|Pregnancy|1|||
16306587|NCT02211417|39608923|FG000|Overall Study|Lost to Follow-up|2|||
16306588|NCT02211417|39608924|FG001|Overall Study|Lost to Follow-up|3|||
16306589|NCT02211417|39608923|FG000|Overall Study|Adverse Event|1|||
16306590|NCT02211417|39608924|FG001|Overall Study|Adverse Event|4|||
16306591|NCT03685344|39608925|FG000|Overall Study|Withdrawal by Subject|1|||
16306592|NCT03685344|39608926|FG001|Overall Study|Withdrawal by Subject|1|||
16306593|NCT03685344|39608927|FG002|Overall Study|Withdrawal by Subject|2|||
16306594|NCT03685344|39608928|FG003|Overall Study|Withdrawal by Subject|0|||
16306595|NCT03685344|39608925|FG000|Overall Study|Physician Decision|1|||
16306596|NCT03685344|39608926|FG001|Overall Study|Physician Decision|1|||
16306597|NCT03685344|39608927|FG002|Overall Study|Physician Decision|5|||
16306598|NCT03685344|39608928|FG003|Overall Study|Physician Decision|0|||
16306599|NCT03685344|39608925|FG000|Overall Study|Death|1|||
16306600|NCT03685344|39608926|FG001|Overall Study|Death|1|||
16306601|NCT03685344|39608927|FG002|Overall Study|Death|0|||
16306602|NCT03685344|39608928|FG003|Overall Study|Death|0|||
16306603|NCT03325608|39608929|FG000|Overall Study|Lost to Follow-up|47|||
16306604|NCT03325608|39608930|FG001|Overall Study|Lost to Follow-up|47|||
16306605|NCT03325608|39608931|FG002|Overall Study|Lost to Follow-up|41|||
16306606|NCT03325608|39608932|FG003|Overall Study|Lost to Follow-up|41|||
16306607|NCT03325608|39608929|FG000|Overall Study|Death|44|||
16306608|NCT03325608|39608930|FG001|Overall Study|Death|0|||
16306609|NCT03325608|39608931|FG002|Overall Study|Death|41|||
16306610|NCT03325608|39608932|FG003|Overall Study|Death|0|||
16306611|NCT03325608|39608929|FG000|Overall Study|Death of Care Recipient|0|||
16306612|NCT03325608|39608930|FG001|Overall Study|Death of Care Recipient|44|||
16306613|NCT03325608|39608931|FG002|Overall Study|Death of Care Recipient|0|||
16306614|NCT03325608|39608932|FG003|Overall Study|Death of Care Recipient|41|||
16306615|NCT03325608|39608929|FG000|Overall Study|Withdrawal by Subject|44|||
16306616|NCT03325608|39608930|FG001|Overall Study|Withdrawal by Subject|44|||
16306617|NCT03325608|39608931|FG002|Overall Study|Withdrawal by Subject|30|||
16306618|NCT03325608|39608932|FG003|Overall Study|Withdrawal by Subject|30|||
16306619|NCT01812109|39608933|FG000|Overall Study|research personnel delay|16|||
16306620|NCT01812109|39608933|FG000|Overall Study|NIRS Unattainable|17|||
16306621|NCT01260701|39608934|FG000|Overall Study|Adverse Event|9|||
16306622|NCT01260701|39608934|FG000|Overall Study|Withdrawal by Subject|2|||
16306623|NCT01260701|39608934|FG000|Overall Study|Progression|53|||
16306624|NCT01260701|39608934|FG000|Overall Study|Death|2|||
16306625|NCT01260701|39608934|FG000|Overall Study|Not protocol specified|3|||
16306626|NCT01260701|39608934|FG000|Overall Study|Under review|1|||
16306627|NCT01260701|39608934|FG000|Overall Study|Ineligible|4|||
16306628|NCT01260701|39608934|FG000|Overall Study|Did not begin protocol therapy|1|||
16306629|NCT02189837|39608935|FG000|Overall Study|Withdrawal by Subject|2|||
16306630|NCT02189837|39608936|FG001|Overall Study|Withdrawal by Subject|1|||
16306631|NCT02189837|39608937|FG002|Overall Study|Withdrawal by Subject|3|||
16306632|NCT02189837|39608938|FG003|Overall Study|Withdrawal by Subject|1|||
16306633|NCT02189837|39608935|FG000|Overall Study|Sponsor Decision|0|||
16306634|NCT02189837|39608936|FG001|Overall Study|Sponsor Decision|0|||
16306635|NCT02189837|39608937|FG002|Overall Study|Sponsor Decision|0|||
16306636|NCT02189837|39608938|FG003|Overall Study|Sponsor Decision|1|||
16306637|NCT03126435|39608947|FG000|Overall Study|Death|90|||
16306638|NCT03126435|39608948|FG001|Overall Study|Death|84|||
16306639|NCT03126435|39608947|FG000|Overall Study|Lost to Follow-up|4|||
16306640|NCT03126435|39608948|FG001|Overall Study|Lost to Follow-up|3|||
16306641|NCT03126435|39608947|FG000|Overall Study|Physician Decision|0|||
16306642|NCT03126435|39608948|FG001|Overall Study|Physician Decision|1|||
16306643|NCT03126435|39608947|FG000|Overall Study|Withdrawal by Subject|6|||
16306644|NCT03126435|39608948|FG001|Overall Study|Withdrawal by Subject|12|||
16306645|NCT03126435|39608947|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
16306646|NCT03126435|39608948|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
16306647|NCT01495702|39608949|FG000|Randomized Phase|Randomized But Not Treated|1|||
16306648|NCT01495702|39608950|FG001|Randomized Phase|Randomized But Not Treated|4|||
16306649|NCT01495702|39608949|FG000|Randomized Phase|Adverse Event|2|||
16306650|NCT01495702|39608950|FG001|Randomized Phase|Adverse Event|2|||
16306651|NCT01495702|39608949|FG000|Randomized Phase|Death|1|||
16306652|NCT01495702|39608950|FG001|Randomized Phase|Death|0|||
16306653|NCT01495702|39608949|FG000|Randomized Phase|Lack of Efficacy|2|||
16306654|NCT01495702|39608950|FG001|Randomized Phase|Lack of Efficacy|0|||
16306655|NCT01495702|39608949|FG000|Randomized Phase|Investigators Discretion|2|||
16306656|NCT01495702|39608950|FG001|Randomized Phase|Investigators Discretion|0|||
16306657|NCT01495702|39608949|FG000|Randomized Phase|Withdrew Consent|10|||
16306658|NCT01495702|39608950|FG001|Randomized Phase|Withdrew Consent|18|||
16306659|NCT01495702|39608949|FG000|Randomized Phase|Lost to Follow-up|4|||
16306660|NCT01495702|39608950|FG001|Randomized Phase|Lost to Follow-up|3|||
16306661|NCT01495702|39608949|FG000|Randomized Phase|Participant Noncompliance|1|||
16306662|NCT01495702|39608950|FG001|Randomized Phase|Participant Noncompliance|0|||
16306663|NCT01495702|39608949|FG000|Randomized Phase|Protocol Violation|3|||
16306664|NCT01495702|39608950|FG001|Randomized Phase|Protocol Violation|1|||
16306665|NCT03380429|39608952|FG000|Overall Study|Physician Decision|0|||
16306666|NCT03380429|39608953|FG001|Overall Study|Physician Decision|1|||
16306667|NCT03380429|39608954|FG002|Overall Study|Physician Decision|0|||
16306668|NCT03380429|39608955|FG003|Overall Study|Physician Decision|1|||
16306669|NCT03380429|39608956|FG004|Overall Study|Physician Decision|1|||
16306670|NCT03380429|39608952|FG000|Overall Study|Withdrawal by Subject|3|||
16306671|NCT03380429|39608953|FG001|Overall Study|Withdrawal by Subject|3|||
16306672|NCT03380429|39608954|FG002|Overall Study|Withdrawal by Subject|5|||
16306673|NCT03380429|39608955|FG003|Overall Study|Withdrawal by Subject|2|||
16306674|NCT03380429|39608956|FG004|Overall Study|Withdrawal by Subject|1|||
16306675|NCT03380429|39608952|FG000|Overall Study|Lost to Follow-up|0|||
16306676|NCT03380429|39608953|FG001|Overall Study|Lost to Follow-up|2|||
16306677|NCT03380429|39608954|FG002|Overall Study|Lost to Follow-up|4|||
16306678|NCT03380429|39608955|FG003|Overall Study|Lost to Follow-up|3|||
16306679|NCT03380429|39608956|FG004|Overall Study|Lost to Follow-up|1|||
16306680|NCT03380429|39608952|FG000|Overall Study|Protocol Violation|1|||
16306681|NCT03380429|39608953|FG001|Overall Study|Protocol Violation|0|||
16306682|NCT03380429|39608954|FG002|Overall Study|Protocol Violation|1|||
16306683|NCT03380429|39608955|FG003|Overall Study|Protocol Violation|0|||
16306684|NCT03380429|39608956|FG004|Overall Study|Protocol Violation|1|||
16306685|NCT03380429|39608952|FG000|Overall Study|Lack of Efficacy|0|||
16306686|NCT03380429|39608953|FG001|Overall Study|Lack of Efficacy|0|||
16306687|NCT03380429|39608954|FG002|Overall Study|Lack of Efficacy|0|||
16306688|NCT03380429|39608955|FG003|Overall Study|Lack of Efficacy|2|||
16306689|NCT03380429|39608956|FG004|Overall Study|Lack of Efficacy|1|||
16306690|NCT03380429|39608952|FG000|Overall Study|Adverse Event|1|||
16306691|NCT03380429|39608953|FG001|Overall Study|Adverse Event|1|||
16306692|NCT03380429|39608954|FG002|Overall Study|Adverse Event|1|||
16306693|NCT03380429|39608955|FG003|Overall Study|Adverse Event|2|||
16306694|NCT03380429|39608956|FG004|Overall Study|Adverse Event|0|||
16306695|NCT00339144|39608958|FG000|Overall Study|Disease progression|5|||
16306696|NCT00339144|39608959|FG001|Overall Study|Disease progression|2|||
16306697|NCT00339144|39608960|FG002|Overall Study|Disease progression|2|||
16306698|NCT00339144|39608958|FG000|Overall Study|Study drug toxicity|3|||
16306699|NCT00339144|39608959|FG001|Overall Study|Study drug toxicity|1|||
16306700|NCT00339144|39608960|FG002|Overall Study|Study drug toxicity|1|||
16306701|NCT00339144|39608958|FG000|Overall Study|Participant's request to discontinuation|1|||
16306702|NCT00339144|39608959|FG001|Overall Study|Participant's request to discontinuation|0|||
16306703|NCT00339144|39608960|FG002|Overall Study|Participant's request to discontinuation|1|||
16306704|NCT00369486|39608961|FG000|4-Week Visit|Missed visit|2|||
16306705|NCT00369486|39608962|FG001|4-Week Visit|Missed visit|2|||
16306706|NCT00369486|39608963|FG002|4-Week Visit|Missed visit|0|||
16306707|NCT00369486|39608964|FG003|4-Week Visit|Missed visit|2|||
16306708|NCT00369486|39608965|FG004|4-Week Visit|Missed visit|1|||
16306709|NCT00369486|39608961|FG000|4-Week Visit|Dropped|0|||
16306710|NCT00369486|39608962|FG001|4-Week Visit|Dropped|0|||
16306711|NCT00369486|39608963|FG002|4-Week Visit|Dropped|1|||
16306712|NCT00369486|39608964|FG003|4-Week Visit|Dropped|0|||
16306713|NCT00369486|39608965|FG004|4-Week Visit|Dropped|0|||
16306714|NCT00369486|39608961|FG000|8-Week Visit|Missed visit|0|||
16306715|NCT00369486|39608962|FG001|8-Week Visit|Missed visit|1|||
16306716|NCT00369486|39608963|FG002|8-Week Visit|Missed visit|0|||
16306717|NCT00369486|39608964|FG003|8-Week Visit|Missed visit|0|||
16306718|NCT00369486|39608965|FG004|8-Week Visit|Missed visit|1|||
16306719|NCT00369486|39608961|FG000|8-Week Visit|Dropped|0|||
16306720|NCT00369486|39608962|FG001|8-Week Visit|Dropped|0|||
16306721|NCT00369486|39608963|FG002|8-Week Visit|Dropped|0|||
16306722|NCT00369486|39608964|FG003|8-Week Visit|Dropped|1|||
16306723|NCT00369486|39608965|FG004|8-Week Visit|Dropped|0|||
16306724|NCT00369486|39608961|FG000|17-Week Visit|Missed visit|0|||
16306725|NCT00369486|39608962|FG001|17-Week Visit|Missed visit|0|||
16306726|NCT00369486|39608963|FG002|17-Week Visit|Missed visit|1|||
16306727|NCT00369486|39608964|FG003|17-Week Visit|Missed visit|1|||
16306728|NCT00369486|39608965|FG004|17-Week Visit|Missed visit|1|||
16306729|NCT00369486|39608961|FG000|34-Week Visit|Dropped|0|||
16306730|NCT00369486|39608962|FG001|34-Week Visit|Dropped|1|||
16306731|NCT00369486|39608963|FG002|34-Week Visit|Dropped|1|||
16306732|NCT00369486|39608964|FG003|34-Week Visit|Dropped|3|||
16306733|NCT00369486|39608965|FG004|34-Week Visit|Dropped|3|||
16306734|NCT02174627|39608966|FG000|Overall Study|Missing|0|||
16306735|NCT02174627|39608967|FG001|Overall Study|Missing|1|||
16306736|NCT02174627|39608966|FG000|Overall Study|Incorrect enrolment before randomization|0|||
16306737|NCT02174627|39608967|FG001|Overall Study|Incorrect enrolment before randomization|1|||
16306738|NCT02174627|39608966|FG000|Overall Study|Participant decision|84|||
16306739|NCT02174627|39608967|FG001|Overall Study|Participant decision|128|||
16306740|NCT01392963|39608968|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
16306741|NCT01392963|39608969|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
16306742|NCT01392963|39608968|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
16306743|NCT01392963|39608969|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
16306744|NCT01392963|39608968|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
16306745|NCT01392963|39608969|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
16306746|NCT02565511|39608970|FG000|Overall Study|Study terminated by Sponsor|35|||
16306747|NCT02565511|39608971|FG001|Overall Study|Study terminated by Sponsor|22|||
16306748|NCT02565511|39608972|FG002|Overall Study|Study terminated by Sponsor|235|||
16306749|NCT02565511|39608973|FG003|Overall Study|Study terminated by Sponsor|156|||
16306750|NCT02565511|39608970|FG000|Overall Study|Withdrawal by Subject|3|||
16306751|NCT02565511|39608971|FG001|Overall Study|Withdrawal by Subject|0|||
16306752|NCT02565511|39608972|FG002|Overall Study|Withdrawal by Subject|12|||
16306753|NCT02565511|39608973|FG003|Overall Study|Withdrawal by Subject|5|||
16306754|NCT02565511|39608970|FG000|Overall Study|Adverse Event|0|||
16306755|NCT02565511|39608971|FG001|Overall Study|Adverse Event|0|||
16306756|NCT02565511|39608972|FG002|Overall Study|Adverse Event|1|||
16306757|NCT02565511|39608973|FG003|Overall Study|Adverse Event|1|||
16306758|NCT02565511|39608970|FG000|Overall Study|Lost to Follow-up|4|||
16306759|NCT02565511|39608971|FG001|Overall Study|Lost to Follow-up|1|||
16306760|NCT02565511|39608972|FG002|Overall Study|Lost to Follow-up|0|||
16306761|NCT02565511|39608973|FG003|Overall Study|Lost to Follow-up|1|||
16306762|NCT02565511|39608970|FG000|Overall Study|Physician Decision|0|||
16306763|NCT02565511|39608971|FG001|Overall Study|Physician Decision|0|||
16306764|NCT02565511|39608972|FG002|Overall Study|Physician Decision|0|||
16306765|NCT02565511|39608973|FG003|Overall Study|Physician Decision|1|||
16306766|NCT02565511|39608970|FG000|Overall Study|Protocol deviation|0|||
16306767|NCT02565511|39608971|FG001|Overall Study|Protocol deviation|0|||
16306768|NCT02565511|39608972|FG002|Overall Study|Protocol deviation|3|||
16306769|NCT02565511|39608973|FG003|Overall Study|Protocol deviation|0|||
16306770|NCT02755649|39608982|FG000|Overall Study|Transitioned into OLE study|99|||
16306771|NCT02755649|39608983|FG001|Overall Study|Transitioned into OLE study|98|||
16306772|NCT02755649|39608984|FG002|Overall Study|Transitioned into OLE study|100|||
16306773|NCT02755649|39608982|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
16306774|NCT02755649|39608983|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
16306775|NCT02755649|39608984|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
16306776|NCT02755649|39608982|FG000|Overall Study|Physician Decision|0|||
16306777|NCT02755649|39608983|FG001|Overall Study|Physician Decision|0|||
16306778|NCT02755649|39608984|FG002|Overall Study|Physician Decision|2|||
16306779|NCT02755649|39608982|FG000|Overall Study|Withdrawal by Subject|0|||
16306780|NCT02755649|39608983|FG001|Overall Study|Withdrawal by Subject|1|||
16306781|NCT02755649|39608984|FG002|Overall Study|Withdrawal by Subject|0|||
16306782|NCT02755649|39608982|FG000|Overall Study|Undecided|1|||
16306783|NCT02755649|39608983|FG001|Overall Study|Undecided|0|||
16306784|NCT02755649|39608984|FG002|Overall Study|Undecided|0|||
16306785|NCT01626690|39609003|FG000|Overall Study|Protocol Violation|1|||
16306786|NCT01626690|39609004|FG001|Overall Study|Protocol Violation|0|||
16306787|NCT01626690|39609003|FG000|Overall Study|Adverse Event|1|||
16306788|NCT01626690|39609004|FG001|Overall Study|Adverse Event|0|||
16306789|NCT04352101|39609005|FG000|Overall Study|Physician Decision|2|||
16306790|NCT04352101|39609006|FG001|Overall Study|Physician Decision|1|||
16306791|NCT01289678|39609012|FG000|Overall Study|Physician Decision|6|||
16306792|NCT03830333|39609014|FG000|Overall Study|Death|0|||
16306793|NCT03830333|39609015|FG001|Overall Study|Death|1|||
16306794|NCT03830333|39609014|FG000|Overall Study|Withdrawal by Subject|5|||
16306795|NCT03830333|39609015|FG001|Overall Study|Withdrawal by Subject|1|||
16306796|NCT03830333|39609014|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
16306797|NCT03830333|39609015|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
16306798|NCT01807065|39609018|FG000|Overall Study|Receive no sip-T due to IV access|1|||
16306799|NCT01807065|39609019|FG001|Overall Study|Receive no sip-T due to IV access|1|||
16306800|NCT02864992|39609020|FG000|Overall Study|still on treatment|15|||
16306801|NCT02864992|39609021|FG001|Overall Study|still on treatment|1|||
16306802|NCT02864992|39609022|FG002|Overall Study|still on treatment|33|||
16306803|NCT00134901|39609023|FG000|Overall Study|Lost to Follow-up|5|||
16306804|NCT00134901|39609024|FG001|Overall Study|Lost to Follow-up|5|||
16306805|NCT00134901|39609023|FG000|Overall Study|discontinued intervention|12|||
16306806|NCT00134901|39609024|FG001|Overall Study|discontinued intervention|10|||
16306807|NCT01478373|39609025|FG000|Treatment Phase|Protocol Violation|1|||
16306808|NCT01478373|39609025|FG000|Survival Phase|Adverse Event|8|||
16306809|NCT01478373|39609025|FG000|Survival Phase|Protocol Violation|1|||
16306810|NCT01478373|39609025|FG000|Survival Phase|crossover to another study|2|||
16306811|NCT01478373|39609025|FG000|Survival Phase|Progressive Disease|27|||
16306812|NCT00853099|39609026|FG000|Double-blind Period|Adverse Event|7|||
16306813|NCT00853099|39609027|FG001|Double-blind Period|Adverse Event|9|||
16306814|NCT00853099|39609028|FG002|Double-blind Period|Adverse Event|13|||
16306815|NCT00853099|39609029|FG003|Double-blind Period|Adverse Event|0|||
16306816|NCT00853099|39609026|FG000|Double-blind Period|Withdrawal by Subject|2|||
16306817|NCT00853099|39609027|FG001|Double-blind Period|Withdrawal by Subject|3|||
16494943|NCT01291173|40284529|FG003|Overall Study|Lost to Follow-up|2|||
16494944|NCT01291173|40284526|FG000|Overall Study|Unable to meet visit schedule|0|||
16085155|NCT02408887|38802700|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
16085156|NCT02408887|38802701|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
16085157|NCT01260896|38802702|FG000|First Intervention|Withdrawn Due to Emesis|2|||
16085158|NCT01260896|38802703|FG001|First Intervention|Withdrawn Due to Emesis|0|||
16085159|NCT03611075|38802711|FG000|Overall Study|Physician Decision|0|||
16494945|NCT01291173|40284527|FG001|Overall Study|Unable to meet visit schedule|0|||
16494946|NCT01291173|40284528|FG002|Overall Study|Unable to meet visit schedule|1|||
16494947|NCT01291173|40284529|FG003|Overall Study|Unable to meet visit schedule|0|||
16494948|NCT01291173|40284526|FG000|Overall Study|Lack of compliance|0|||
16085160|NCT03611075|38802712|FG001|Overall Study|Physician Decision|1|||
16085161|NCT03611075|38802713|FG002|Overall Study|Physician Decision|1|||
16085162|NCT03611075|38802714|FG003|Overall Study|Physician Decision|0|||
16085163|NCT03611075|38802715|FG004|Overall Study|Physician Decision|0|||
16085164|NCT03611075|38802716|FG005|Overall Study|Physician Decision|0|||
16085165|NCT03611075|38802717|FG006|Overall Study|Physician Decision|0|||
16085166|NCT03611075|38802718|FG007|Overall Study|Physician Decision|0|||
16085167|NCT03611075|38802719|FG008|Overall Study|Physician Decision|0|||
16085168|NCT03611075|38802711|FG000|Overall Study|Lost to Follow-up|1|||
16085169|NCT03611075|38802712|FG001|Overall Study|Lost to Follow-up|0|||
16085170|NCT03611075|38802713|FG002|Overall Study|Lost to Follow-up|0|||
16085171|NCT03611075|38802714|FG003|Overall Study|Lost to Follow-up|2|||
16085172|NCT03611075|38802715|FG004|Overall Study|Lost to Follow-up|0|||
16085173|NCT03611075|38802716|FG005|Overall Study|Lost to Follow-up|0|||
16085174|NCT03611075|38802717|FG006|Overall Study|Lost to Follow-up|0|||
16085175|NCT03611075|38802718|FG007|Overall Study|Lost to Follow-up|0|||
16085176|NCT03611075|38802719|FG008|Overall Study|Lost to Follow-up|0|||
16085177|NCT03611075|38802711|FG000|Overall Study|Withdrawal by Subject|0|||
16085178|NCT03611075|38802712|FG001|Overall Study|Withdrawal by Subject|1|||
16085179|NCT03611075|38802713|FG002|Overall Study|Withdrawal by Subject|1|||
16085180|NCT03611075|38802714|FG003|Overall Study|Withdrawal by Subject|1|||
16085181|NCT03611075|38802715|FG004|Overall Study|Withdrawal by Subject|0|||
16085182|NCT03611075|38802716|FG005|Overall Study|Withdrawal by Subject|0|||
16085183|NCT03611075|38802717|FG006|Overall Study|Withdrawal by Subject|1|||
16085184|NCT03611075|38802718|FG007|Overall Study|Withdrawal by Subject|0|||
16085185|NCT03611075|38802719|FG008|Overall Study|Withdrawal by Subject|0|||
16306818|NCT00853099|39609028|FG002|Double-blind Period|Withdrawal by Subject|0|||
16306819|NCT00853099|39609029|FG003|Double-blind Period|Withdrawal by Subject|0|||
16306820|NCT00853099|39609026|FG000|Double-blind Period|Lack of Efficacy|14|||
16306821|NCT00853099|39609027|FG001|Double-blind Period|Lack of Efficacy|17|||
16306822|NCT00853099|39609028|FG002|Double-blind Period|Lack of Efficacy|16|||
16306823|NCT00853099|39609029|FG003|Double-blind Period|Lack of Efficacy|0|||
16494949|NCT01291173|40284527|FG001|Overall Study|Lack of compliance|0|||
16085186|NCT03611075|38802711|FG000|Overall Study|Reason unknown|0|||
16085187|NCT03611075|38802712|FG001|Overall Study|Reason unknown|0|||
16085188|NCT03611075|38802713|FG002|Overall Study|Reason unknown|0|||
16085189|NCT03611075|38802714|FG003|Overall Study|Reason unknown|1|||
16085190|NCT03611075|38802715|FG004|Overall Study|Reason unknown|0|||
16085191|NCT03611075|38802716|FG005|Overall Study|Reason unknown|0|||
16306824|NCT00853099|39609026|FG000|Double-blind Period|Other|0|||
16494950|NCT01291173|40284528|FG002|Overall Study|Lack of compliance|0|||
16494951|NCT01291173|40284529|FG003|Overall Study|Lack of compliance|1|||
16193808|NCT03493685|39188632|FG001|Overall Study|Physician Decision|0|||
16193809|NCT03493685|39188631|FG000|Overall Study|Withdrawal by Subject|7|||
16193810|NCT03493685|39188632|FG001|Overall Study|Withdrawal by Subject|11|||
16193811|NCT02159469|39188633|FG000|Overall Study|Missing Completion status|1|||
16193812|NCT02159469|39188633|FG000|Overall Study|Adverse Event|5|||
16193813|NCT02159469|39188633|FG000|Overall Study|Non-compliance|2|||
16193814|NCT02159469|39188633|FG000|Overall Study|Withdrawal by Subject|9|||
16193815|NCT02159469|39188633|FG000|Overall Study|Lost to Follow-up|1|||
16193816|NCT02159469|39188633|FG000|Overall Study|Sponsor's request|2|||
16193817|NCT02159469|39188633|FG000|Overall Study|Met Stopping Criteria|3|||
16193818|NCT02159469|39188633|FG000|Overall Study|Other|1|||
16193819|NCT02159469|39188633|FG000|Overall Study|Multiple|29|||
16193820|NCT01432262|39188635|FG000|Overall Study|Withdrawal by Subject|2|||
16193821|NCT01432262|39188636|FG001|Overall Study|Withdrawal by Subject|1|||
16193822|NCT04410198|39188639|FG000|Overall Study|Death|10|||
16193823|NCT04410198|39188639|FG000|Overall Study|Withdrawal by Subject|7|||
16193824|NCT04410198|39188639|FG000|Overall Study|Transferred/Relocation|4|||
16193825|NCT04410198|39188639|FG000|Overall Study|Kidney Transplant|9|||
16193826|NCT04410198|39188639|FG000|Overall Study|Adverse Event|4|||
16193827|NCT04410198|39188639|FG000|Overall Study|Physician Decision|2|||
16193828|NCT04410198|39188639|FG000|Overall Study|Other than specified|1|||
16193829|NCT02364947|39188640|FG000|Overall Study|Withdrawal by Subject|10|||
16193830|NCT02364947|39188641|FG001|Overall Study|Withdrawal by Subject|8|||
16193831|NCT02364947|39188642|FG002|Overall Study|Withdrawal by Subject|9|||
16494952|NCT01291173|40284526|FG000|Overall Study|Subject was unblinded|0|||
16494953|NCT01291173|40284527|FG001|Overall Study|Subject was unblinded|0|||
16494954|NCT01291173|40284528|FG002|Overall Study|Subject was unblinded|1|||
16193832|NCT02364947|39188640|FG000|Overall Study|Adverse Event|45|||
16193833|NCT02364947|39188641|FG001|Overall Study|Adverse Event|33|||
16306825|NCT00853099|39609027|FG001|Double-blind Period|Other|0|||
16388230|NCT05111145|39905603|FG000|Overall Study|Commercial drug is available for participant|76|||
16388231|NCT05111145|39905603|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
16494955|NCT01291173|40284529|FG003|Overall Study|Subject was unblinded|0|||
16494956|NCT01291173|40284526|FG000|Overall Study|Excluded therapy|0|||
16306826|NCT00853099|39609028|FG002|Double-blind Period|Other|1|||
16306827|NCT00853099|39609029|FG003|Double-blind Period|Other|0|||
16306828|NCT00853099|39609026|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
16306829|NCT00853099|39609027|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
16306830|NCT00853099|39609028|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
16306831|NCT00853099|39609029|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
16306832|NCT00853099|39609026|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
16306833|NCT00853099|39609027|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
16306834|NCT00853099|39609028|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
16306835|NCT00853099|39609029|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
16306836|NCT00853099|39609026|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
16306837|NCT00853099|39609027|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
16306838|NCT00853099|39609028|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
16306839|NCT00853099|39609029|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
16306840|NCT00853099|39609026|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
16306841|NCT00853099|39609027|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
16306842|NCT00853099|39609028|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
16306843|NCT00853099|39609029|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
16306844|NCT00853099|39609026|FG000|Double-blind + Open-label Periods|Other|0|||
16306845|NCT00853099|39609027|FG001|Double-blind + Open-label Periods|Other|0|||
16494957|NCT01291173|40284527|FG001|Overall Study|Excluded therapy|0|||
16494958|NCT01291173|40284528|FG002|Overall Study|Excluded therapy|1|||
16494959|NCT01291173|40284529|FG003|Overall Study|Excluded therapy|0|||
16306846|NCT00853099|39609028|FG002|Double-blind + Open-label Periods|Other|0|||
16306847|NCT00853099|39609029|FG003|Double-blind + Open-label Periods|Other|6|||
16306848|NCT04071405|39609034|FG000|Overall Study|Protocol Violation|3|||
16306849|NCT03875508|39609035|FG000|Overall Study|Adverse Event|1|||
16306850|NCT03875508|39609035|FG000|Overall Study|Lost to Follow-up|8|||
16306851|NCT03875508|39609035|FG000|Overall Study|Lack of Efficacy|1|||
16306852|NCT03875508|39609035|FG000|Overall Study|Other, not specified|2|||
16494960|NCT00553514|40284530|FG000|Overall Study|Protocol deviation|0|||
16193834|NCT02364947|39188642|FG002|Overall Study|Adverse Event|11|||
16193835|NCT02364947|39188640|FG000|Overall Study|Protocol Violation|1|||
16193836|NCT02364947|39188641|FG001|Overall Study|Protocol Violation|1|||
16494961|NCT00553514|40284531|FG001|Overall Study|Protocol deviation|0|||
16193837|NCT02364947|39188642|FG002|Overall Study|Protocol Violation|1|||
16306853|NCT01228019|39609036|FG000|Overall Study|Dose Violation|70|||
16494962|NCT00553514|40284532|FG002|Overall Study|Protocol deviation|0|||
16193838|NCT02364947|39188640|FG000|Overall Study|Physician Decision|3|||
16193839|NCT02364947|39188641|FG001|Overall Study|Physician Decision|2|||
16494963|NCT00553514|40284533|FG003|Overall Study|Protocol deviation|1|||
16494964|NCT00553514|40284534|FG004|Overall Study|Protocol deviation|0|||
16085192|NCT03611075|38802717|FG006|Overall Study|Reason unknown|1|||
16085193|NCT03611075|38802718|FG007|Overall Study|Reason unknown|0|||
16085194|NCT03611075|38802719|FG008|Overall Study|Reason unknown|0|||
16085195|NCT03653364|38802723|FG000|Overall Study|Withdrawal by Subject|1|||
16085196|NCT03653364|38802723|FG000|Overall Study|Enrolled in Error|1|||
16085197|NCT03653364|38802723|FG000|Overall Study|Death|1|||
16085198|NCT01641900|38802730|FG000|Overall Study|Withdrawal by Subject|2|||
16085199|NCT01641900|38802731|FG001|Overall Study|Withdrawal by Subject|2|||
16494965|NCT00553514|40284530|FG000|Overall Study|Lack of ovarian response|4|||
16085200|NCT00174252|38802733|FG000|Overall Study|Protocol Violation|2|||
16085201|NCT04220775|38802736|FG000|Overall Study|Adverse Event|1|||
16085202|NCT04220775|38802737|FG001|Overall Study|Adverse Event|0|||
16306854|NCT01228019|39609036|FG000|Overall Study|Duplicate enrollment|1|||
16306855|NCT01228019|39609036|FG000|Overall Study|Missing pre-treatment data|72|||
16306856|NCT01228019|39609036|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
16306857|NCT01228019|39609036|FG000|Overall Study|Violation of Entry Criterion|9|||
16306858|NCT02723344|39609041|FG000|Overall Study|Lost to Follow-up|0|||
16306859|NCT02723344|39609042|FG001|Overall Study|Lost to Follow-up|4|||
16306860|NCT03682107|39609043|FG000|Overall Study|Withdrawal by Subject|0|||
16306861|NCT03682107|39609044|FG001|Overall Study|Withdrawal by Subject|1|||
16306862|NCT03682107|39609045|FG002|Overall Study|Withdrawal by Subject|0|||
16306863|NCT03682107|39609046|FG003|Overall Study|Withdrawal by Subject|0|||
16306864|NCT03682107|39609047|FG004|Overall Study|Withdrawal by Subject|0|||
16306865|NCT02072980|39609053|FG000|Period 2, Second Wear|Adverse Event|0|||
16306866|NCT02072980|39609054|FG001|Period 2, Second Wear|Adverse Event|1|||
16306867|NCT02910011|39609055|FG000|Overall Study|Physician Decision|2|||
16306868|NCT00729937|39609056|FG000|Overall Study|Lost to Follow-up|49|||
16306869|NCT00729937|39609057|FG001|Overall Study|Lost to Follow-up|58|||
16306870|NCT00729937|39609058|FG002|Overall Study|Lost to Follow-up|18|||
16306871|NCT00729937|39609059|FG003|Overall Study|Lost to Follow-up|33|||
16306872|NCT00729937|39609060|FG004|Overall Study|Lost to Follow-up|18|||
16306873|NCT00729937|39609061|FG005|Overall Study|Lost to Follow-up|23|||
16306874|NCT00729937|39609056|FG000|Overall Study|Physician Decision|7|||
16306875|NCT00729937|39609057|FG001|Overall Study|Physician Decision|16|||
16306876|NCT00729937|39609058|FG002|Overall Study|Physician Decision|2|||
16306877|NCT00729937|39609059|FG003|Overall Study|Physician Decision|0|||
16306878|NCT00729937|39609060|FG004|Overall Study|Physician Decision|5|||
16306879|NCT00729937|39609061|FG005|Overall Study|Physician Decision|8|||
16306880|NCT00729937|39609056|FG000|Overall Study|Death|1|||
16306881|NCT00729937|39609057|FG001|Overall Study|Death|0|||
16306882|NCT00729937|39609058|FG002|Overall Study|Death|1|||
16306883|NCT00729937|39609059|FG003|Overall Study|Death|0|||
16306884|NCT00729937|39609060|FG004|Overall Study|Death|0|||
16306885|NCT00729937|39609061|FG005|Overall Study|Death|1|||
16306886|NCT00729937|39609056|FG000|Overall Study|Withdrawal by Subject|3|||
16306887|NCT00729937|39609057|FG001|Overall Study|Withdrawal by Subject|5|||
16494966|NCT00553514|40284531|FG001|Overall Study|Lack of ovarian response|5|||
16494967|NCT00553514|40284532|FG002|Overall Study|Lack of ovarian response|5|||
16494968|NCT00553514|40284533|FG003|Overall Study|Lack of ovarian response|5|||
16494969|NCT00553514|40284534|FG004|Overall Study|Lack of ovarian response|6|||
16193840|NCT02364947|39188642|FG002|Overall Study|Physician Decision|5|||
16193841|NCT02364947|39188640|FG000|Overall Study|Death|0|||
16193842|NCT02364947|39188641|FG001|Overall Study|Death|1|||
16193843|NCT02364947|39188642|FG002|Overall Study|Death|0|||
16193844|NCT00418834|39188643|FG000|Overall Study|Adverse Event|16|||
16193845|NCT00418834|39188644|FG001|Overall Study|Adverse Event|9|||
16494970|NCT00553514|40284530|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
16494971|NCT00553514|40284531|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
16494972|NCT00553514|40284532|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
16193846|NCT00418834|39188643|FG000|Overall Study|Lost to Follow-up|0|||
16193847|NCT00418834|39188644|FG001|Overall Study|Lost to Follow-up|1|||
16193848|NCT00418834|39188643|FG000|Overall Study|Protocol Violation|4|||
16193849|NCT00418834|39188644|FG001|Overall Study|Protocol Violation|3|||
16193850|NCT00418834|39188643|FG000|Overall Study|Withdrawal by Subject|3|||
16193851|NCT00418834|39188644|FG001|Overall Study|Withdrawal by Subject|7|||
16193852|NCT00501046|39188645|FG000|Overall Study|Adverse Event|21|||
16306888|NCT00729937|39609058|FG002|Overall Study|Withdrawal by Subject|6|||
16306889|NCT00729937|39609059|FG003|Overall Study|Withdrawal by Subject|0|||
16085203|NCT04220775|38802736|FG000|Overall Study|Disease Progression|1|||
16193853|NCT00501046|39188646|FG001|Overall Study|Adverse Event|25|||
16306890|NCT00729937|39609060|FG004|Overall Study|Withdrawal by Subject|4|||
16085204|NCT04220775|38802737|FG001|Overall Study|Disease Progression|0|||
16306891|NCT00729937|39609061|FG005|Overall Study|Withdrawal by Subject|2|||
16306892|NCT00729937|39609056|FG000|Overall Study|Randomized but not treated|12|||
16306893|NCT00729937|39609057|FG001|Overall Study|Randomized but not treated|6|||
16193854|NCT00501046|39188645|FG000|Overall Study|Death|23|||
16193855|NCT00501046|39188646|FG001|Overall Study|Death|30|||
16193856|NCT00501046|39188645|FG000|Overall Study|Lost to Follow-up|14|||
16494973|NCT00553514|40284533|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
16193857|NCT00501046|39188646|FG001|Overall Study|Lost to Follow-up|13|||
16193858|NCT00501046|39188645|FG000|Overall Study|Physician Decision|7|||
16193859|NCT00501046|39188646|FG001|Overall Study|Physician Decision|2|||
16193860|NCT00501046|39188645|FG000|Overall Study|Pregnancy|0|||
16193861|NCT00501046|39188646|FG001|Overall Study|Pregnancy|3|||
16193862|NCT00501046|39188645|FG000|Overall Study|Protocol Violation|2|||
16193863|NCT00501046|39188646|FG001|Overall Study|Protocol Violation|1|||
16193864|NCT00501046|39188645|FG000|Overall Study|Withdrawal by Subject|84|||
16193865|NCT00501046|39188646|FG001|Overall Study|Withdrawal by Subject|83|||
16193866|NCT00501046|39188645|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
16193867|NCT00501046|39188646|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
16193868|NCT00006604|39188657|FG000|Overall Study|Met study objective - no further FU|1|||
16193869|NCT00006604|39188658|FG001|Overall Study|Met study objective - no further FU|0|||
16193870|NCT00006604|39188659|FG002|Overall Study|Met study objective - no further FU|0|||
16193871|NCT00006604|39188660|FG003|Overall Study|Met study objective - no further FU|0|||
16193872|NCT00006604|39188661|FG004|Overall Study|Met study objective - no further FU|0|||
16193873|NCT00006604|39188662|FG005|Overall Study|Met study objective - no further FU|0|||
16306894|NCT00729937|39609058|FG002|Overall Study|Randomized but not treated|1|||
16306895|NCT00729937|39609059|FG003|Overall Study|Randomized but not treated|0|||
16193874|NCT00006604|39188663|FG006|Overall Study|Met study objective - no further FU|0|||
16193875|NCT00006604|39188664|FG007|Overall Study|Met study objective - no further FU|0|||
16193876|NCT00006604|39188665|FG008|Overall Study|Met study objective - no further FU|0|||
16193877|NCT00006604|39188666|FG009|Overall Study|Met study objective - no further FU|0|||
16193878|NCT00006604|39188667|FG010|Overall Study|Met study objective - no further FU|0|||
16193879|NCT00006604|39188668|FG011|Overall Study|Met study objective - no further FU|0|||
16193880|NCT00006604|39188669|FG012|Overall Study|Met study objective - no further FU|0|||
16306896|NCT00729937|39609060|FG004|Overall Study|Randomized but not treated|1|||
16306897|NCT00729937|39609061|FG005|Overall Study|Randomized but not treated|3|||
16306898|NCT00729937|39609056|FG000|Overall Study|Did not meet eligibility criteria|2|||
16306899|NCT00729937|39609057|FG001|Overall Study|Did not meet eligibility criteria|1|||
16306900|NCT00729937|39609058|FG002|Overall Study|Did not meet eligibility criteria|0|||
16306901|NCT00729937|39609059|FG003|Overall Study|Did not meet eligibility criteria|0|||
16306902|NCT00729937|39609060|FG004|Overall Study|Did not meet eligibility criteria|0|||
16306903|NCT00729937|39609061|FG005|Overall Study|Did not meet eligibility criteria|0|||
16306904|NCT00729937|39609056|FG000|Overall Study|Incarcerated|0|||
16306905|NCT00729937|39609057|FG001|Overall Study|Incarcerated|2|||
16306906|NCT00729937|39609058|FG002|Overall Study|Incarcerated|1|||
16306907|NCT00729937|39609059|FG003|Overall Study|Incarcerated|1|||
16306908|NCT00729937|39609060|FG004|Overall Study|Incarcerated|0|||
16306909|NCT00729937|39609061|FG005|Overall Study|Incarcerated|0|||
16193881|NCT00006604|39188670|FG013|Overall Study|Met study objective - no further FU|0|||
16193882|NCT00006604|39188671|FG014|Overall Study|Met study objective - no further FU|1|||
16193883|NCT00006604|39188672|FG015|Overall Study|Met study objective - no further FU|1|||
16306910|NCT02789137|39609063|FG000|Overall Study|Dropped out/Died|58|||
16306911|NCT02301390|39609064|FG000|Overall Study|Withdrawal by Subject|3|||
16306912|NCT02301390|39609065|FG001|Overall Study|Withdrawal by Subject|5|||
16306913|NCT02301390|39609064|FG000|Overall Study|Protocol Violation|1|||
16306914|NCT02301390|39609065|FG001|Overall Study|Protocol Violation|0|||
16306915|NCT02301390|39609064|FG000|Overall Study|Physician Decision|1|||
16306916|NCT02301390|39609065|FG001|Overall Study|Physician Decision|0|||
16306917|NCT02301390|39609064|FG000|Overall Study|Lost to Follow-up|0|||
16306918|NCT02301390|39609065|FG001|Overall Study|Lost to Follow-up|1|||
16306919|NCT02301390|39609064|FG000|Overall Study|Death|2|||
16306920|NCT02301390|39609065|FG001|Overall Study|Death|2|||
16306921|NCT02301390|39609064|FG000|Overall Study|Procedure not completed|0|||
16306922|NCT02301390|39609065|FG001|Overall Study|Procedure not completed|4|||
16306923|NCT02301390|39609064|FG000|Overall Study|Missed multiple visits|1|||
16306924|NCT02301390|39609065|FG001|Overall Study|Missed multiple visits|1|||
16306925|NCT02301390|39609064|FG000|Overall Study|study terminated|2|||
16306926|NCT02301390|39609065|FG001|Overall Study|study terminated|0|||
16306927|NCT01071915|39609067|FG000|Overall Study|Adverse Event|3|||
16306928|NCT01071915|39609067|FG000|Overall Study|Physician Decision|2|||
16306929|NCT01071915|39609067|FG000|Overall Study|Withdrawal by Subject|2|||
16306930|NCT01071915|39609067|FG000|Overall Study|Miscellaneous Reasons|2|||
16306931|NCT04108299|39609068|FG000|Overall Study|Not interested in participating|2|||
16306932|NCT04108299|39609069|FG001|Overall Study|Not interested in participating|1|||
16193884|NCT00006604|39188673|FG016|Overall Study|Met study objective - no further FU|0|||
16306933|NCT04108299|39609070|FG002|Overall Study|Not interested in participating|2|||
16306934|NCT04108299|39609071|FG003|Overall Study|Not interested in participating|1|||
16306935|NCT03345420|39609079|FG000|Overall Study|Withdrawal by Subject|1|||
16306936|NCT00613171|39609080|FG000|Overall Study|Adverse Event|7|||
16306937|NCT00613171|39609080|FG000|Overall Study|Withdrawal by Subject|3|||
16306938|NCT00613171|39609080|FG000|Overall Study|Reason not Specified|4|||
16306939|NCT03805412|39609093|FG000|Overall Study|Lost to Follow-up|0|||
16306940|NCT03805412|39609094|FG001|Overall Study|Lost to Follow-up|1|||
16306941|NCT02508935|39609095|FG000|Overall Study|Withdrawal by Subject|1|||
16306942|NCT02508935|39609095|FG000|Overall Study|Withdrawal by Caregiver|8|||
16306943|NCT02508935|39609095|FG000|Overall Study|Pain Score <4|1|||
16306944|NCT02508935|39609095|FG000|Overall Study|Emesis|3|||
16306945|NCT02508935|39609095|FG000|Overall Study|Adverse Event|3|||
16306946|NCT02508935|39609095|FG000|Overall Study|Protocol Violation|1|||
16306947|NCT02508935|39609095|FG000|Overall Study|Physician Decision|1|||
16306948|NCT02508935|39609095|FG000|Overall Study|Trial terminated by sponsor|5|||
16306949|NCT04158648|39609096|FG000|Overall Study|Ongoing in the Study|69|||
16306950|NCT04158648|39609096|FG000|Overall Study|Withdrawal by Subject|4|||
16306951|NCT02438683|39612506|FG000|Overall Study|Adverse Event|1|||
16306952|NCT02438683|39612507|FG001|Overall Study|Adverse Event|0|||
16306953|NCT02438683|39612508|FG002|Overall Study|Adverse Event|0|||
16306954|NCT02438683|39612509|FG003|Overall Study|Adverse Event|0|||
16306955|NCT02438683|39612510|FG004|Overall Study|Adverse Event|0|||
16306956|NCT02438683|39612511|FG005|Overall Study|Adverse Event|0|||
16306957|NCT01286753|39612512|FG000|Overall Study|Adverse Event|7|||
16306958|NCT01286753|39612513|FG001|Overall Study|Adverse Event|6|||
16306959|NCT01286753|39612512|FG000|Overall Study|Progression|11|||
16306960|NCT01286753|39612513|FG001|Overall Study|Progression|13|||
16306961|NCT01286753|39612512|FG000|Overall Study|Refused Treatment|1|||
16306962|NCT01286753|39612513|FG001|Overall Study|Refused Treatment|0|||
16306963|NCT01286753|39612512|FG000|Overall Study|Withdrawal of Consent|0|||
16306964|NCT01286753|39612513|FG001|Overall Study|Withdrawal of Consent|2|||
16306965|NCT01286753|39612512|FG000|Overall Study|Discontinued to Join Extension Study|6|||
16306966|NCT01286753|39612513|FG001|Overall Study|Discontinued to Join Extension Study|4|||
16306967|NCT01286753|39612512|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
16306968|NCT01286753|39612513|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
16306969|NCT03541317|39612514|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
16306970|NCT03541317|39612515|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
16306971|NCT03541317|39612516|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
16306972|NCT03541317|39612517|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
16306973|NCT03541317|39612518|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
16306974|NCT03541317|39612519|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
16306975|NCT01197911|39612520|FG000|Overall Study|Adverse Event|0|||
16306976|NCT01197911|39612521|FG001|Overall Study|Adverse Event|0|||
16306977|NCT01197911|39612522|FG002|Overall Study|Adverse Event|1|||
16306978|NCT00758524|39612523|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
16306979|NCT00758524|39612524|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
16306980|NCT00758524|39612525|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
16306981|NCT00758524|39612526|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306982|NCT00758524|39612527|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
16306983|NCT00758524|39612528|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
16306984|NCT00758524|39612529|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306985|NCT00758524|39612530|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306986|NCT00758524|39612531|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306987|NCT00758524|39612532|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306988|NCT00758524|39612533|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306989|NCT00758524|39612534|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306990|NCT00758524|39612535|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306991|NCT00758524|39612536|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306992|NCT00758524|39612537|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306993|NCT00758524|39612538|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16494974|NCT00553514|40284534|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
16494975|NCT00553514|40284530|FG000|Overall Study|Risk of multiple pregnancy|0|||
16494976|NCT00553514|40284531|FG001|Overall Study|Risk of multiple pregnancy|2|||
16494977|NCT00553514|40284532|FG002|Overall Study|Risk of multiple pregnancy|0|||
16494978|NCT00553514|40284533|FG003|Overall Study|Risk of multiple pregnancy|1|||
16494979|NCT00553514|40284534|FG004|Overall Study|Risk of multiple pregnancy|0|||
16306994|NCT00758524|39612539|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
16306995|NCT00758524|39612523|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
16306996|NCT00758524|39612524|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16306997|NCT00758524|39612525|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
16306998|NCT00758524|39612526|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
16306999|NCT00758524|39612527|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
16307000|NCT00758524|39612528|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
16307001|NCT00758524|39612529|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307002|NCT00758524|39612530|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307003|NCT00758524|39612531|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307004|NCT00758524|39612532|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307005|NCT00758524|39612533|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307006|NCT00758524|39612534|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307007|NCT00758524|39612535|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307008|NCT00758524|39612536|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307009|NCT00758524|39612537|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307010|NCT00758524|39612538|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307011|NCT00758524|39612539|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
16307012|NCT00758524|39612523|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
16307013|NCT00758524|39612524|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
16307014|NCT00758524|39612525|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
16307015|NCT00758524|39612526|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
16307016|NCT00758524|39612527|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
16307017|NCT00758524|39612528|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
16307018|NCT00758524|39612529|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307019|NCT00758524|39612530|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307020|NCT00758524|39612531|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307021|NCT00758524|39612532|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307022|NCT00758524|39612533|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307023|NCT00758524|39612534|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307024|NCT00758524|39612535|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307025|NCT00758524|39612536|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307026|NCT00758524|39612537|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307027|NCT00758524|39612538|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307028|NCT00758524|39612539|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
16307029|NCT00758524|39612523|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307030|NCT00758524|39612524|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
16307031|NCT00758524|39612525|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
16307032|NCT00758524|39612526|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307033|NCT00758524|39612527|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
16307034|NCT00758524|39612528|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
16307035|NCT00758524|39612529|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307036|NCT00758524|39612530|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307037|NCT00758524|39612531|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307038|NCT00758524|39612532|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307039|NCT00758524|39612533|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307040|NCT00758524|39612534|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307041|NCT00758524|39612535|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307042|NCT00758524|39612536|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307043|NCT00758524|39612537|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307044|NCT00758524|39612538|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307045|NCT00758524|39612539|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
16307046|NCT00758524|39612523|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307047|NCT00758524|39612524|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307048|NCT00758524|39612525|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
16307049|NCT00758524|39612526|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
16307050|NCT00758524|39612527|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307051|NCT00758524|39612528|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307052|NCT00758524|39612529|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307053|NCT00758524|39612530|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307054|NCT00758524|39612531|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307055|NCT00758524|39612532|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307056|NCT00758524|39612533|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307057|NCT00758524|39612534|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307058|NCT00758524|39612535|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307059|NCT00758524|39612536|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307060|NCT00758524|39612537|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307061|NCT00758524|39612538|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307062|NCT00758524|39612539|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
16307063|NCT00758524|39612523|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307064|NCT00758524|39612524|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307065|NCT00758524|39612525|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307066|NCT00758524|39612526|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307067|NCT00758524|39612527|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
16307068|NCT00758524|39612528|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307069|NCT00758524|39612529|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307070|NCT00758524|39612530|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307071|NCT00758524|39612531|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307072|NCT00758524|39612532|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307073|NCT00758524|39612533|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307074|NCT00758524|39612534|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307075|NCT00758524|39612535|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307076|NCT00758524|39612536|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307077|NCT00758524|39612537|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307078|NCT00758524|39612538|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307079|NCT00758524|39612539|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
16307080|NCT00758524|39612523|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307081|NCT00758524|39612524|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
16307082|NCT00758524|39612525|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307083|NCT00758524|39612526|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307084|NCT00758524|39612527|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307085|NCT00758524|39612528|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307086|NCT00758524|39612529|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307087|NCT00758524|39612530|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307088|NCT00758524|39612531|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16193885|NCT00006604|39188657|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
16193886|NCT00006604|39188658|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
16193887|NCT00006604|39188659|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
16193888|NCT00006604|39188660|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
16193889|NCT00006604|39188661|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
16193890|NCT00006604|39188662|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
16193891|NCT00006604|39188663|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
16193892|NCT00006604|39188664|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
16193893|NCT00006604|39188665|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
16193894|NCT00006604|39188666|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
16193895|NCT00006604|39188667|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
16193896|NCT00006604|39188668|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
16193897|NCT00006604|39188669|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
16193898|NCT00006604|39188670|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
16193899|NCT00006604|39188671|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
16193900|NCT00006604|39188672|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
16193901|NCT00006604|39188673|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
16193902|NCT00006604|39188657|FG000|Overall Study|Death|0|||
16193903|NCT00006604|39188658|FG001|Overall Study|Death|0|||
16193904|NCT00006604|39188659|FG002|Overall Study|Death|0|||
16193905|NCT00006604|39188660|FG003|Overall Study|Death|0|||
16193906|NCT00006604|39188661|FG004|Overall Study|Death|0|||
16193907|NCT00006604|39188662|FG005|Overall Study|Death|0|||
16193908|NCT00006604|39188663|FG006|Overall Study|Death|0|||
16193909|NCT00006604|39188664|FG007|Overall Study|Death|0|||
16193910|NCT00006604|39188665|FG008|Overall Study|Death|0|||
16193911|NCT00006604|39188666|FG009|Overall Study|Death|1|||
16193912|NCT00006604|39188667|FG010|Overall Study|Death|1|||
16193913|NCT00006604|39188668|FG011|Overall Study|Death|1|||
16193914|NCT00006604|39188669|FG012|Overall Study|Death|0|||
16193915|NCT00006604|39188670|FG013|Overall Study|Death|0|||
16193916|NCT00006604|39188671|FG014|Overall Study|Death|0|||
16193917|NCT00006604|39188672|FG015|Overall Study|Death|0|||
16193918|NCT00006604|39188673|FG016|Overall Study|Death|0|||
16193919|NCT00006604|39188657|FG000|Overall Study|Severe debilitation, unable to continue|0|||
16193920|NCT00006604|39188658|FG001|Overall Study|Severe debilitation, unable to continue|0|||
16193921|NCT00006604|39188659|FG002|Overall Study|Severe debilitation, unable to continue|0|||
16193922|NCT00006604|39188660|FG003|Overall Study|Severe debilitation, unable to continue|0|||
16193923|NCT00006604|39188661|FG004|Overall Study|Severe debilitation, unable to continue|0|||
16193924|NCT00006604|39188662|FG005|Overall Study|Severe debilitation, unable to continue|0|||
16193925|NCT00006604|39188663|FG006|Overall Study|Severe debilitation, unable to continue|3|||
16193926|NCT00006604|39188664|FG007|Overall Study|Severe debilitation, unable to continue|0|||
16193927|NCT00006604|39188665|FG008|Overall Study|Severe debilitation, unable to continue|0|||
16193928|NCT00006604|39188666|FG009|Overall Study|Severe debilitation, unable to continue|5|||
16193929|NCT00006604|39188667|FG010|Overall Study|Severe debilitation, unable to continue|0|||
16193930|NCT00006604|39188668|FG011|Overall Study|Severe debilitation, unable to continue|2|||
16193931|NCT00006604|39188669|FG012|Overall Study|Severe debilitation, unable to continue|1|||
16193932|NCT00006604|39188670|FG013|Overall Study|Severe debilitation, unable to continue|0|||
16193933|NCT00006604|39188671|FG014|Overall Study|Severe debilitation, unable to continue|2|||
16193934|NCT00006604|39188672|FG015|Overall Study|Severe debilitation, unable to continue|0|||
16193935|NCT00006604|39188673|FG016|Overall Study|Severe debilitation, unable to continue|0|||
16193936|NCT00006604|39188657|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
16193937|NCT00006604|39188658|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
16193938|NCT00006604|39188659|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
16193939|NCT00006604|39188660|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
16307089|NCT00758524|39612532|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307090|NCT00758524|39612533|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307091|NCT00758524|39612534|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307092|NCT00758524|39612535|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307093|NCT00758524|39612536|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307094|NCT00758524|39612537|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307095|NCT00758524|39612538|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307096|NCT00758524|39612539|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
16307097|NCT00758524|39612523|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307098|NCT00758524|39612524|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
16307099|NCT00758524|39612525|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16494980|NCT00553514|40284530|FG000|Overall Study|Other|1|||
16494981|NCT00553514|40284531|FG001|Overall Study|Other|1|||
16494982|NCT00553514|40284532|FG002|Overall Study|Other|0|||
16494983|NCT00553514|40284533|FG003|Overall Study|Other|0|||
16494984|NCT00553514|40284534|FG004|Overall Study|Other|1|||
16494985|NCT04983264|40284536|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
16494986|NCT04983264|40284537|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
16494987|NCT04983264|40284538|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
16494988|NCT04983264|40284536|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
16494989|NCT04983264|40284537|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
16494990|NCT04983264|40284538|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
16494991|NCT01214629|40284539|FG000|Overall Study|Progressive Disease|1|||
16494992|NCT01214629|40284540|FG001|Overall Study|Progressive Disease|1|||
16494993|NCT01214629|40284541|FG002|Overall Study|Progressive Disease|0|||
16494994|NCT01214629|40284542|FG003|Overall Study|Progressive Disease|1|||
16494995|NCT01214629|40284543|FG004|Overall Study|Progressive Disease|2|||
16494996|NCT01214629|40284544|FG005|Overall Study|Progressive Disease|3|||
16494997|NCT01214629|40284545|FG006|Overall Study|Progressive Disease|1|||
16494998|NCT01214629|40284546|FG007|Overall Study|Progressive Disease|1|||
16494999|NCT01214629|40284547|FG008|Overall Study|Progressive Disease|1|||
16495000|NCT01214629|40284548|FG009|Overall Study|Progressive Disease|5|||
16495001|NCT01214629|40284549|FG010|Overall Study|Progressive Disease|1|||
16495002|NCT01214629|40284539|FG000|Overall Study|Adverse Event|0|||
16495003|NCT01214629|40284540|FG001|Overall Study|Adverse Event|0|||
16495004|NCT01214629|40284541|FG002|Overall Study|Adverse Event|0|||
16495005|NCT01214629|40284542|FG003|Overall Study|Adverse Event|1|||
16495006|NCT01214629|40284543|FG004|Overall Study|Adverse Event|0|||
16307100|NCT00758524|39612526|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307101|NCT00758524|39612527|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307102|NCT00758524|39612528|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307103|NCT00758524|39612529|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307104|NCT00758524|39612530|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307105|NCT00758524|39612531|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307106|NCT00758524|39612532|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307107|NCT00758524|39612533|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307108|NCT00758524|39612534|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307109|NCT00758524|39612535|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16495007|NCT01214629|40284544|FG005|Overall Study|Adverse Event|1|||
16495008|NCT01214629|40284545|FG006|Overall Study|Adverse Event|0|||
16495009|NCT01214629|40284546|FG007|Overall Study|Adverse Event|0|||
16307110|NCT00758524|39612536|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307111|NCT00758524|39612537|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307112|NCT00758524|39612538|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307113|NCT00758524|39612539|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
16307114|NCT00758524|39612523|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307115|NCT00758524|39612524|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307116|NCT00758524|39612525|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307117|NCT00758524|39612526|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307118|NCT00758524|39612527|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307119|NCT00758524|39612528|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307120|NCT00758524|39612529|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307121|NCT00758524|39612530|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307122|NCT00758524|39612531|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
16307123|NCT00758524|39612532|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307124|NCT00758524|39612533|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307125|NCT00758524|39612534|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307126|NCT00758524|39612535|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307127|NCT00758524|39612536|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307128|NCT00758524|39612537|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307129|NCT00758524|39612538|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307130|NCT00758524|39612539|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
16307131|NCT00758524|39612523|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307132|NCT00758524|39612524|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307133|NCT00758524|39612525|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307134|NCT00758524|39612526|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307135|NCT00758524|39612527|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307136|NCT00758524|39612528|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307137|NCT00758524|39612529|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
16307138|NCT00758524|39612530|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307139|NCT00758524|39612531|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307140|NCT00758524|39612532|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307141|NCT00758524|39612533|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307142|NCT00758524|39612534|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307143|NCT00758524|39612535|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307144|NCT00758524|39612536|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307145|NCT00758524|39612537|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307146|NCT00758524|39612538|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307147|NCT00758524|39612539|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
16307148|NCT01597973|39612545|FG000|Overall Study|Found ineligible before study medication started|4|||
16307149|NCT01597973|39612546|FG001|Overall Study|Found ineligible before study medication started|2|||
16307150|NCT01597973|39612545|FG000|Overall Study|Eligible pathogen not confirmed|14|||
16307151|NCT01597973|39612546|FG001|Overall Study|Eligible pathogen not confirmed|15|||
16307152|NCT01597973|39612545|FG000|Overall Study|LAR not authorized to consent|0|||
16307153|NCT01597973|39612546|FG001|Overall Study|LAR not authorized to consent|1|||
16307154|NCT01597973|39612545|FG000|Overall Study|Ineligible due to early seizures|1|||
16307155|NCT01597973|39612546|FG001|Overall Study|Ineligible due to early seizures|0|||
16307156|NCT01597973|39612545|FG000|Overall Study|Ineligible due to non-target infection|1|||
16307157|NCT01597973|39612546|FG001|Overall Study|Ineligible due to non-target infection|1|||
16307158|NCT00247676|39612547|FG000|Overall Study|Death|5|||
16307159|NCT00247676|39612547|FG000|Overall Study|Adverse Event|11|||
16307160|NCT00247676|39612547|FG000|Overall Study|Lack of Efficacy|15|||
16307161|NCT00247676|39612547|FG000|Overall Study|Other|3|||
16307162|NCT00247676|39612547|FG000|Overall Study|Withdrawal by Subject|2|||
16307163|NCT04324021|39612548|FG000|Overall Study|Adverse Event|1|||
16307164|NCT04324021|39612549|FG001|Overall Study|Adverse Event|0|||
16307165|NCT04324021|39612550|FG002|Overall Study|Adverse Event|0|||
16307166|NCT04324021|39612548|FG000|Overall Study|Lack of Efficacy|0|||
16307167|NCT04324021|39612549|FG001|Overall Study|Lack of Efficacy|0|||
16307168|NCT04324021|39612550|FG002|Overall Study|Lack of Efficacy|1|||
16307169|NCT04324021|39612548|FG000|Overall Study|Death|1|||
16495010|NCT01214629|40284547|FG008|Overall Study|Adverse Event|0|||
16495011|NCT01214629|40284548|FG009|Overall Study|Adverse Event|1|||
16307170|NCT04324021|39612549|FG001|Overall Study|Death|1|||
16307171|NCT04324021|39612550|FG002|Overall Study|Death|0|||
16307172|NCT02756208|39612551|FG000|Overall Study|Withdrawal by Subject|1|||
16495012|NCT01214629|40284549|FG010|Overall Study|Adverse Event|0|||
16495013|NCT01214629|40284539|FG000|Overall Study|Physician Decision|0|||
16495014|NCT01214629|40284540|FG001|Overall Study|Physician Decision|0|||
16307173|NCT02756208|39612552|FG001|Overall Study|Withdrawal by Subject|0|||
16307174|NCT02756208|39612553|FG002|Overall Study|Withdrawal by Subject|1|||
16307175|NCT02756208|39612554|FG003|Overall Study|Withdrawal by Subject|3|||
16307176|NCT02756208|39612551|FG000|Overall Study|Lost to Follow-up|3|||
16085205|NCT00277355|38802738|FG000|Overall Study|Withdrawal by Subject|3|||
16085206|NCT00277355|38802739|FG001|Overall Study|Withdrawal by Subject|3|||
16085207|NCT00277355|38802738|FG000|Overall Study|Lost to Follow-up|2|||
16085208|NCT00277355|38802739|FG001|Overall Study|Lost to Follow-up|2|||
16085209|NCT00277355|38802738|FG000|Overall Study|Adverse Event|5|||
16085210|NCT00277355|38802739|FG001|Overall Study|Adverse Event|0|||
16085211|NCT00277355|38802738|FG000|Overall Study|Death|3|||
16085212|NCT00277355|38802739|FG001|Overall Study|Death|0|||
16085213|NCT00277355|38802738|FG000|Overall Study|Physician Decision|1|||
16085214|NCT00277355|38802739|FG001|Overall Study|Physician Decision|0|||
16085215|NCT00745875|38806748|FG000|Overall Study|Continuing study treatment|4|||
16085216|NCT00745875|38806749|FG001|Overall Study|Continuing study treatment|4|||
16085217|NCT01324310|38806750|FG000|Overall Study|Adverse Event|1|||
16085218|NCT01324310|38806750|FG000|Overall Study|Disease Progression|1|||
16085219|NCT00853580|38806751|FG000|Overall Study|Lost to Follow-up|3|||
16085220|NCT00853580|38806752|FG001|Overall Study|Lost to Follow-up|5|||
16085221|NCT00853580|38806751|FG000|Overall Study|Protocol Violation|2|||
16085222|NCT00853580|38806752|FG001|Overall Study|Protocol Violation|1|||
16085223|NCT00853580|38806751|FG000|Overall Study|Withdrawal by Subject|2|||
16085224|NCT00853580|38806752|FG001|Overall Study|Withdrawal by Subject|8|||
16085225|NCT00853580|38806751|FG000|Overall Study|Commenced contraindicated therapy|0|||
16085226|NCT00853580|38806752|FG001|Overall Study|Commenced contraindicated therapy|2|||
16085227|NCT01639131|38806755|FG000|Overall Study|Disease Progression|6|||
16085228|NCT00680771|38806756|FG000|Overall Study|Withdrawal by Subject|1|||
16085229|NCT00680771|38806757|FG001|Overall Study|Withdrawal by Subject|0|||
16085230|NCT00680771|38806756|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
16085231|NCT00680771|38806757|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
16085232|NCT00680771|38806756|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
16085233|NCT00680771|38806757|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
16085234|NCT01596972|38806762|FG000|Overall Study|Physician Decision|1|||
16085235|NCT01596972|38806763|FG001|Overall Study|Physician Decision|9|||
16085236|NCT01596972|38806762|FG000|Overall Study|Lost to Follow-up|0|||
16085237|NCT01596972|38806763|FG001|Overall Study|Lost to Follow-up|4|||
16085238|NCT01596972|38806762|FG000|Overall Study|Withdrawal by Subject|0|||
16085239|NCT01596972|38806763|FG001|Overall Study|Withdrawal by Subject|1|||
16085240|NCT03205566|38806764|FG000|Phase 1|Protocol Violation|1|||
16085241|NCT03205566|38806765|FG001|Phase 1|Protocol Violation|1|||
16085242|NCT03220724|38806766|FG000|Overall Study|Lost to Follow-up|2|||
16085243|NCT03220724|38806767|FG001|Overall Study|Lost to Follow-up|2|||
16085244|NCT03220724|38806768|FG002|Overall Study|Lost to Follow-up|0|||
16085245|NCT03220724|38806769|FG003|Overall Study|Lost to Follow-up|3|||
16193940|NCT00006604|39188661|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
16495015|NCT01214629|40284541|FG002|Overall Study|Physician Decision|0|||
16495016|NCT01214629|40284542|FG003|Overall Study|Physician Decision|0|||
16495017|NCT01214629|40284543|FG004|Overall Study|Physician Decision|0|||
16495018|NCT01214629|40284544|FG005|Overall Study|Physician Decision|0|||
16495019|NCT01214629|40284545|FG006|Overall Study|Physician Decision|0|||
16495020|NCT01214629|40284546|FG007|Overall Study|Physician Decision|0|||
16495021|NCT01214629|40284547|FG008|Overall Study|Physician Decision|0|||
16495022|NCT01214629|40284548|FG009|Overall Study|Physician Decision|0|||
16495023|NCT01214629|40284549|FG010|Overall Study|Physician Decision|1|||
16495024|NCT01214629|40284539|FG000|Overall Study|Withdrawal by Subject|0|||
16495025|NCT01214629|40284540|FG001|Overall Study|Withdrawal by Subject|0|||
16495026|NCT01214629|40284541|FG002|Overall Study|Withdrawal by Subject|0|||
16495027|NCT01214629|40284542|FG003|Overall Study|Withdrawal by Subject|0|||
16495028|NCT01214629|40284543|FG004|Overall Study|Withdrawal by Subject|0|||
16495029|NCT01214629|40284544|FG005|Overall Study|Withdrawal by Subject|0|||
16495030|NCT01214629|40284545|FG006|Overall Study|Withdrawal by Subject|0|||
16495031|NCT01214629|40284546|FG007|Overall Study|Withdrawal by Subject|0|||
16495032|NCT01214629|40284547|FG008|Overall Study|Withdrawal by Subject|0|||
16495033|NCT01214629|40284548|FG009|Overall Study|Withdrawal by Subject|1|||
16495034|NCT01214629|40284549|FG010|Overall Study|Withdrawal by Subject|0|||
16495035|NCT00754624|40284551|FG000|Overall Study|Adverse Event|16|||
16193941|NCT00006604|39188662|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
16307177|NCT02756208|39612552|FG001|Overall Study|Lost to Follow-up|1|||
16495036|NCT00754624|40284551|FG000|Overall Study|Death|1|||
16085246|NCT03220724|38806770|FG004|Overall Study|Lost to Follow-up|1|||
16085247|NCT03220724|38806771|FG005|Overall Study|Lost to Follow-up|0|||
16085248|NCT03220724|38806772|FG006|Overall Study|Lost to Follow-up|2|||
16085249|NCT03220724|38806773|FG007|Overall Study|Lost to Follow-up|1|||
16085250|NCT03220724|38806774|FG008|Overall Study|Lost to Follow-up|0|||
16085251|NCT03220724|38806766|FG000|Overall Study|Withdrawal by Subject|1|||
16085252|NCT03220724|38806767|FG001|Overall Study|Withdrawal by Subject|0|||
16307178|NCT02756208|39612553|FG002|Overall Study|Lost to Follow-up|1|||
16307179|NCT02756208|39612554|FG003|Overall Study|Lost to Follow-up|1|||
16307180|NCT02756208|39612551|FG000|Overall Study|Physician Decision|1|||
16307181|NCT02756208|39612552|FG001|Overall Study|Physician Decision|0|||
16307182|NCT02756208|39612553|FG002|Overall Study|Physician Decision|0|||
16307183|NCT02756208|39612554|FG003|Overall Study|Physician Decision|0|||
16307184|NCT02756208|39612551|FG000|Overall Study|Protocol Violation|0|||
16307185|NCT02756208|39612552|FG001|Overall Study|Protocol Violation|1|||
16307186|NCT02756208|39612553|FG002|Overall Study|Protocol Violation|0|||
16307187|NCT02756208|39612554|FG003|Overall Study|Protocol Violation|0|||
16307188|NCT04542057|39612555|FG000|Overall Study|Death|3|||
16307189|NCT04542057|39612556|FG001|Overall Study|Death|1|||
16307190|NCT04542057|39612555|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
16307191|NCT04542057|39612556|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
16307192|NCT04542057|39612555|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
16307193|NCT04542057|39612556|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
16193942|NCT00006604|39188663|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
16193943|NCT00006604|39188664|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
16307194|NCT04542057|39612555|FG000|Overall Study|Adverse Event|15|||
16307195|NCT04542057|39612556|FG001|Overall Study|Adverse Event|6|||
16307196|NCT04542057|39612555|FG000|Overall Study|COVID-19 adverse event|6|||
16307197|NCT04542057|39612556|FG001|Overall Study|COVID-19 adverse event|4|||
16307198|NCT04542057|39612555|FG000|Overall Study|Lack of Efficacy|2|||
16307199|NCT04542057|39612556|FG001|Overall Study|Lack of Efficacy|5|||
16307200|NCT04542057|39612555|FG000|Overall Study|Study terminated by sponsor|1|||
16307201|NCT04542057|39612556|FG001|Overall Study|Study terminated by sponsor|0|||
16307202|NCT04542057|39612555|FG000|Overall Study|Investigator discretion|2|||
16307203|NCT04542057|39612556|FG001|Overall Study|Investigator discretion|1|||
16307204|NCT04542057|39612555|FG000|Overall Study|Withdrawal by Subject|52|||
16307205|NCT04542057|39612556|FG001|Overall Study|Withdrawal by Subject|30|||
16307206|NCT04542057|39612555|FG000|Overall Study|Lost to Follow-up|8|||
16307207|NCT04542057|39612556|FG001|Overall Study|Lost to Follow-up|11|||
16307208|NCT04542057|39612555|FG000|Overall Study|Other|2|||
16307209|NCT04542057|39612556|FG001|Overall Study|Other|2|||
16307210|NCT01288079|39612562|FG000|Overall Study|Withdrawal by Subject|2|||
16307211|NCT01288079|39612563|FG001|Overall Study|Withdrawal by Subject|4|||
16307212|NCT01288079|39612564|FG002|Overall Study|Withdrawal by Subject|1|||
16307213|NCT01288079|39612565|FG003|Overall Study|Withdrawal by Subject|0|||
16307214|NCT01288079|39612562|FG000|Overall Study|Adverse Event|2|||
16307215|NCT01288079|39612563|FG001|Overall Study|Adverse Event|1|||
16307216|NCT01288079|39612564|FG002|Overall Study|Adverse Event|2|||
16307217|NCT01288079|39612565|FG003|Overall Study|Adverse Event|3|||
16307218|NCT01288079|39612562|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
16307219|NCT01288079|39612563|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
16307220|NCT01288079|39612564|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
16307221|NCT01288079|39612565|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
16307222|NCT01288079|39612562|FG000|Overall Study|Condition under Investigation Worsened|0|||
16307223|NCT01288079|39612563|FG001|Overall Study|Condition under Investigation Worsened|0|||
16307224|NCT01288079|39612564|FG002|Overall Study|Condition under Investigation Worsened|0|||
16307225|NCT01288079|39612565|FG003|Overall Study|Condition under Investigation Worsened|1|||
16307226|NCT01288079|39612562|FG000|Overall Study|Lack of Efficacy|2|||
16495037|NCT00754624|40284551|FG000|Overall Study|Physician Decision|8|||
16495038|NCT00754624|40284551|FG000|Overall Study|Protocol Violation|1|||
16495039|NCT00754624|40284551|FG000|Overall Study|Withdrawal by Subject|28|||
16495040|NCT00754624|40284551|FG000|Overall Study|Various|12|||
16495041|NCT00754624|40284551|FG000|Overall Study|Lost to Follow-up|3|||
16495042|NCT01782495|40284552|FG000|Overall Study|Adverse Event|0|||
16495043|NCT01782495|40284553|FG001|Overall Study|Adverse Event|0|||
16495044|NCT01782495|40284554|FG002|Overall Study|Adverse Event|0|||
16495045|NCT01782495|40284555|FG003|Overall Study|Adverse Event|0|||
16495046|NCT01782495|40284556|FG004|Overall Study|Adverse Event|0|||
16495047|NCT01782495|40284557|FG005|Overall Study|Adverse Event|0|||
16495048|NCT01782495|40284558|FG006|Overall Study|Adverse Event|0|||
16495049|NCT01782495|40284559|FG007|Overall Study|Adverse Event|2|||
16495050|NCT01782495|40284560|FG008|Overall Study|Adverse Event|0|||
16085253|NCT03220724|38806768|FG002|Overall Study|Withdrawal by Subject|1|||
16193944|NCT00006604|39188665|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
16307227|NCT01288079|39612563|FG001|Overall Study|Lack of Efficacy|2|||
16307228|NCT01288079|39612564|FG002|Overall Study|Lack of Efficacy|0|||
16307229|NCT01288079|39612565|FG003|Overall Study|Lack of Efficacy|2|||
16307230|NCT01288079|39612562|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
16307231|NCT01288079|39612563|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
16307232|NCT01288079|39612564|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
16307233|NCT01288079|39612565|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
16495051|NCT01782495|40284561|FG009|Overall Study|Adverse Event|0|||
16495052|NCT01782495|40284562|FG010|Overall Study|Adverse Event|0|||
16495053|NCT01782495|40284552|FG000|Overall Study|Withdrew Consent|0|||
16495054|NCT01782495|40284553|FG001|Overall Study|Withdrew Consent|1|||
16307234|NCT01288079|39612562|FG000|Overall Study|Lost to Follow-up|1|||
16307235|NCT01288079|39612563|FG001|Overall Study|Lost to Follow-up|1|||
16307236|NCT01288079|39612564|FG002|Overall Study|Lost to Follow-up|1|||
16307237|NCT01288079|39612565|FG003|Overall Study|Lost to Follow-up|0|||
16307238|NCT01288079|39612562|FG000|Overall Study|Other or Study Termination|11|||
16307239|NCT01288079|39612563|FG001|Overall Study|Other or Study Termination|15|||
16307240|NCT01288079|39612564|FG002|Overall Study|Other or Study Termination|14|||
16307241|NCT01288079|39612565|FG003|Overall Study|Other or Study Termination|8|||
16307242|NCT01811472|39612566|FG000|Overall Study|Adverse Event|1|||
16307243|NCT01811472|39612567|FG001|Overall Study|Adverse Event|0|||
16307244|NCT01811472|39612568|FG002|Overall Study|Adverse Event|4|||
16307245|NCT01811472|39612566|FG000|Overall Study|Lost to Follow-up|0|||
16307246|NCT01811472|39612567|FG001|Overall Study|Lost to Follow-up|0|||
16307247|NCT01811472|39612568|FG002|Overall Study|Lost to Follow-up|1|||
16307248|NCT01811472|39612566|FG000|Overall Study|Subject/guardian decision|1|||
16307249|NCT01811472|39612567|FG001|Overall Study|Subject/guardian decision|0|||
16307250|NCT01811472|39612568|FG002|Overall Study|Subject/guardian decision|0|||
16307251|NCT01301729|39612569|FG000|Overall Study|Withdrawal by Subject|2|||
16307252|NCT01301729|39612569|FG000|Overall Study|Participant did not Return for Treatment|1|||
16307253|NCT01301729|39612569|FG000|Overall Study|Violated Selection Criteria|1|||
16307254|NCT03571828|39612570|FG000|Overall Study|Withdrawal by Subject|1|||
16307255|NCT03571828|39612571|FG001|Overall Study|Withdrawal by Subject|0|||
16307256|NCT03571828|39612570|FG000|Overall Study|Decision by sponsor|5|||
16307257|NCT03571828|39612571|FG001|Overall Study|Decision by sponsor|1|||
16307258|NCT03571828|39612570|FG000|Overall Study|Death|2|||
16307259|NCT03571828|39612571|FG001|Overall Study|Death|0|||
16307260|NCT02163057|39612572|FG000|Overall Study|Participant Refusal to Continue|2|||
16307261|NCT02163057|39612573|FG001|Overall Study|Participant Refusal to Continue|2|||
16307262|NCT02163057|39612572|FG000|Overall Study|Participant Significant Noncompliance|0|||
16307263|NCT02163057|39612573|FG001|Overall Study|Participant Significant Noncompliance|1|||
16307264|NCT02163057|39612572|FG000|Overall Study|Progression of Disease|1|||
16307265|NCT02163057|39612573|FG001|Overall Study|Progression of Disease|2|||
16307266|NCT05024747|39612574|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
16307267|NCT05024747|39612575|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
16307268|NCT05024747|39612574|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
16307269|NCT05024747|39612575|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
16307270|NCT05024747|39612574|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
16307271|NCT05024747|39612575|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
16307272|NCT02115607|39612582|FG000|Overall Study|Withdrawal by Subject|1|||
16307273|NCT00711243|39612583|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
16307274|NCT00711243|39612584|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
16307275|NCT00711243|39612585|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
16307276|NCT00711243|39612586|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
16193945|NCT00006604|39188666|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
16193946|NCT00006604|39188667|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
16193947|NCT00006604|39188668|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
16193948|NCT00006604|39188669|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
16193949|NCT00006604|39188670|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
16193950|NCT00006604|39188671|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
16193951|NCT00006604|39188672|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
16193952|NCT00006604|39188673|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
16193953|NCT00006604|39188657|FG000|Overall Study|Site closing|0|||
16193954|NCT00006604|39188658|FG001|Overall Study|Site closing|0|||
16193955|NCT00006604|39188659|FG002|Overall Study|Site closing|1|||
16307277|NCT00711243|39612587|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
16307278|NCT00711243|39612588|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
16307279|NCT00711243|39612583|FG000|Reached First Response/4 Cycles|Death|0|||
16307280|NCT00711243|39612584|FG001|Reached First Response/4 Cycles|Death|0|||
16307281|NCT00711243|39612585|FG002|Reached First Response/4 Cycles|Death|0|||
16307282|NCT00711243|39612586|FG003|Reached First Response/4 Cycles|Death|0|||
16307283|NCT00711243|39612587|FG004|Reached First Response/4 Cycles|Death|0|||
16307284|NCT00711243|39612588|FG005|Reached First Response/4 Cycles|Death|2|||
16307285|NCT00711243|39612583|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
16495055|NCT01782495|40284554|FG002|Overall Study|Withdrew Consent|0|||
16495056|NCT01782495|40284555|FG003|Overall Study|Withdrew Consent|0|||
16495057|NCT01782495|40284556|FG004|Overall Study|Withdrew Consent|0|||
16495058|NCT01782495|40284557|FG005|Overall Study|Withdrew Consent|0|||
16495059|NCT01782495|40284558|FG006|Overall Study|Withdrew Consent|0|||
16495060|NCT01782495|40284559|FG007|Overall Study|Withdrew Consent|1|||
16085254|NCT03220724|38806769|FG003|Overall Study|Withdrawal by Subject|0|||
16307286|NCT00711243|39612584|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
16495061|NCT01782495|40284560|FG008|Overall Study|Withdrew Consent|0|||
16307287|NCT00711243|39612585|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
16307288|NCT00711243|39612586|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
16307289|NCT00711243|39612587|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
16307290|NCT00711243|39612588|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
16307291|NCT00711243|39612583|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
16307292|NCT00711243|39612584|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
16307293|NCT00711243|39612585|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
16307294|NCT00711243|39612586|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
16307295|NCT00711243|39612587|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
16307296|NCT00711243|39612588|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
16307297|NCT00711243|39612583|FG000|Treated Cycle 5 After First Response|Death|0|||
16307298|NCT00711243|39612584|FG001|Treated Cycle 5 After First Response|Death|0|||
16307299|NCT00711243|39612585|FG002|Treated Cycle 5 After First Response|Death|0|||
16307300|NCT00711243|39612586|FG003|Treated Cycle 5 After First Response|Death|0|||
16307301|NCT00711243|39612587|FG004|Treated Cycle 5 After First Response|Death|0|||
16307302|NCT00711243|39612588|FG005|Treated Cycle 5 After First Response|Death|2|||
16307303|NCT00711243|39612583|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
16307304|NCT00711243|39612584|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
16307305|NCT00711243|39612585|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
16307306|NCT00711243|39612586|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
16307307|NCT00711243|39612587|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
16085255|NCT03220724|38806770|FG004|Overall Study|Withdrawal by Subject|0|||
16193956|NCT00006604|39188660|FG003|Overall Study|Site closing|1|||
16307308|NCT00711243|39612588|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
16307309|NCT00711243|39612583|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
16307310|NCT00711243|39612584|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
16307311|NCT00711243|39612585|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
16193957|NCT00006604|39188661|FG004|Overall Study|Site closing|0|||
16193958|NCT00006604|39188662|FG005|Overall Study|Site closing|0|||
16193959|NCT00006604|39188663|FG006|Overall Study|Site closing|0|||
16193960|NCT00006604|39188664|FG007|Overall Study|Site closing|1|||
16193961|NCT00006604|39188665|FG008|Overall Study|Site closing|0|||
16193962|NCT00006604|39188666|FG009|Overall Study|Site closing|0|||
16193963|NCT00006604|39188667|FG010|Overall Study|Site closing|0|||
16193964|NCT00006604|39188668|FG011|Overall Study|Site closing|1|||
16193965|NCT00006604|39188669|FG012|Overall Study|Site closing|1|||
16193966|NCT00006604|39188670|FG013|Overall Study|Site closing|1|||
16307312|NCT00711243|39612586|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
16307313|NCT00711243|39612587|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
16307314|NCT00711243|39612588|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
16307315|NCT01276041|39612589|FG000|Overall Study|Adverse Event|2|||
16307316|NCT01276041|39612589|FG000|Overall Study|Protocol Violation|1|||
16307317|NCT01153425|39612590|FG000|Overall Study|Withdrawal by Subject|3|||
16307318|NCT01153425|39612591|FG001|Overall Study|Withdrawal by Subject|3|||
16307319|NCT03404674|39612592|FG000|Overall Study|Inability to Attend Future Visits|0|||
16307320|NCT03404674|39612593|FG001|Overall Study|Inability to Attend Future Visits|1|||
16307321|NCT03404674|39612594|FG002|Overall Study|Inability to Attend Future Visits|1|||
16307322|NCT03404674|39612595|FG003|Overall Study|Inability to Attend Future Visits|0|||
16307323|NCT03404674|39612596|FG004|Overall Study|Inability to Attend Future Visits|0|||
16307324|NCT03404674|39612597|FG005|Overall Study|Inability to Attend Future Visits|0|||
16307325|NCT03404674|39612592|FG000|Overall Study|Behavioral Problems|0|||
16307326|NCT03404674|39612593|FG001|Overall Study|Behavioral Problems|0|||
16307327|NCT03404674|39612594|FG002|Overall Study|Behavioral Problems|1|||
16307328|NCT03404674|39612595|FG003|Overall Study|Behavioral Problems|0|||
16307329|NCT03404674|39612596|FG004|Overall Study|Behavioral Problems|0|||
16307330|NCT03404674|39612597|FG005|Overall Study|Behavioral Problems|0|||
16307331|NCT03404674|39612592|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
16307332|NCT03404674|39612593|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
16307333|NCT03404674|39612594|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
16307334|NCT03404674|39612595|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
16193967|NCT00006604|39188671|FG014|Overall Study|Site closing|0|||
16193968|NCT00006604|39188672|FG015|Overall Study|Site closing|0|||
16193969|NCT00006604|39188673|FG016|Overall Study|Site closing|1|||
16193970|NCT00006604|39188657|FG000|Overall Study|Withdrawal by Subject|1|||
16307335|NCT03404674|39612596|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
16307336|NCT03404674|39612597|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
16307337|NCT02964247|39612621|FG000|Overall Study|Lost to Follow-up|2|||
16307338|NCT02964247|39612622|FG001|Overall Study|Lost to Follow-up|0|||
16409934|NCT03099148|39981832|FG002|Wash-out|Adverse Event|0|||
16085256|NCT03220724|38806771|FG005|Overall Study|Withdrawal by Subject|0|||
16193971|NCT00006604|39188658|FG001|Overall Study|Withdrawal by Subject|0|||
16193972|NCT00006604|39188659|FG002|Overall Study|Withdrawal by Subject|2|||
16495062|NCT01782495|40284561|FG009|Overall Study|Withdrew Consent|0|||
16495063|NCT01782495|40284562|FG010|Overall Study|Withdrew Consent|0|||
16307339|NCT02964247|39612621|FG000|Overall Study|Withdrawal by Subject|1|||
16307340|NCT02964247|39612622|FG001|Overall Study|Withdrawal by Subject|2|||
16307341|NCT01863667|39612627|FG000|Overall Study|Adverse Event|1|||
16307342|NCT01863667|39612628|FG001|Overall Study|Adverse Event|0|||
16307343|NCT01863667|39612627|FG000|Overall Study|Study terminated by Sponsor|30|||
16307344|NCT01863667|39612628|FG001|Overall Study|Study terminated by Sponsor|30|||
16307345|NCT01863667|39612627|FG000|Overall Study|Withdrawal by Subject|2|||
16307346|NCT01863667|39612628|FG001|Overall Study|Withdrawal by Subject|2|||
16307347|NCT03334435|39612635|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
16307348|NCT03334435|39612636|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
16307349|NCT03334435|39612637|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
16307350|NCT03334435|39612638|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
16307351|NCT03334435|39612639|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
16307352|NCT03334435|39612640|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
16307353|NCT03334435|39612641|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
16307354|NCT03334435|39612642|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
16307355|NCT03334435|39612643|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
16307356|NCT03334435|39612644|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
16307357|NCT03334435|39612645|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
16307358|NCT03334435|39612646|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
16307359|NCT03334435|39612647|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
16307360|NCT03334435|39612648|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
16307361|NCT03334435|39612649|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
16307362|NCT03334435|39612635|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
16307363|NCT03334435|39612636|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
16307364|NCT03334435|39612637|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
16307365|NCT03334435|39612638|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
16495064|NCT01018186|40284564|FG000|2-week Run-in Period|Protocol Violation|1|||
16495065|NCT01018186|40284565|FG001|2-week Run-in Period|Protocol Violation|0|||
16307366|NCT03334435|39612639|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
16307367|NCT03334435|39612640|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
16307368|NCT03334435|39612641|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
16307369|NCT03334435|39612642|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
16307370|NCT03334435|39612643|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
16307371|NCT03334435|39612644|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
16307372|NCT03334435|39612645|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
16307373|NCT03334435|39612646|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
16307374|NCT03334435|39612647|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
16495066|NCT01018186|40284566|FG002|2-week Run-in Period|Protocol Violation|0|||
16495067|NCT01018186|40284567|FG003|2-week Run-in Period|Protocol Violation|0|||
16495068|NCT01018186|40284564|FG000|2-week Run-in Period|Lost to Follow-up|2|||
16495069|NCT01018186|40284565|FG001|2-week Run-in Period|Lost to Follow-up|0|||
16495070|NCT01018186|40284566|FG002|2-week Run-in Period|Lost to Follow-up|0|||
16495071|NCT01018186|40284567|FG003|2-week Run-in Period|Lost to Follow-up|0|||
16495072|NCT01018186|40284564|FG000|2-week Run-in Period|Physician Decision|3|||
16495073|NCT01018186|40284565|FG001|2-week Run-in Period|Physician Decision|0|||
16495074|NCT01018186|40284566|FG002|2-week Run-in Period|Physician Decision|0|||
16495075|NCT01018186|40284567|FG003|2-week Run-in Period|Physician Decision|0|||
16495076|NCT01018186|40284564|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
16495077|NCT01018186|40284565|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16495078|NCT01018186|40284566|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16495079|NCT01018186|40284567|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
16495080|NCT01018186|40284564|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
16495081|NCT01018186|40284565|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16495082|NCT01018186|40284566|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16495083|NCT01018186|40284567|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
16085257|NCT03220724|38806772|FG006|Overall Study|Withdrawal by Subject|0|||
16307375|NCT03334435|39612648|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
16307376|NCT03334435|39612649|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
16307377|NCT03334435|39612635|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
16307378|NCT03334435|39612636|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
16307379|NCT03334435|39612637|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
16307380|NCT03334435|39612638|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
16307381|NCT03334435|39612639|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
16307382|NCT03334435|39612640|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
16495084|NCT01018186|40284564|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
16495085|NCT01018186|40284565|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
16495086|NCT01018186|40284566|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
16495087|NCT01018186|40284567|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
16495088|NCT01018186|40284564|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
16495089|NCT01018186|40284565|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
16495090|NCT01018186|40284566|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
16495091|NCT01018186|40284567|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
16495092|NCT01018186|40284564|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
16495093|NCT01018186|40284565|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
16495094|NCT01018186|40284566|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
16495095|NCT01018186|40284567|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
16495096|NCT01018186|40284564|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
16495097|NCT01018186|40284565|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
16495098|NCT01018186|40284566|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
16495099|NCT01018186|40284567|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
16495100|NCT01018186|40284564|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
16495101|NCT01018186|40284565|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
16495102|NCT01018186|40284566|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
16495103|NCT01018186|40284567|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
16495104|NCT01018186|40284564|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
16495105|NCT01018186|40284565|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
16495106|NCT01018186|40284566|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
16495107|NCT01018186|40284567|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
16495108|NCT01018186|40284564|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16495109|NCT01018186|40284565|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
16495110|NCT01018186|40284566|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
16495111|NCT01018186|40284567|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
16307383|NCT03334435|39612641|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
16307384|NCT03334435|39612642|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
16307385|NCT03334435|39612643|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
16307386|NCT03334435|39612644|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
16307387|NCT03334435|39612645|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
16495112|NCT02573350|40284568|FG000|Overall Study|Lost to Follow-up|2|||
16495113|NCT02573350|40284569|FG001|Overall Study|Lost to Follow-up|1|||
16495114|NCT02573350|40284568|FG000|Overall Study|Adverse Event|3|||
16495115|NCT02573350|40284569|FG001|Overall Study|Adverse Event|4|||
16495116|NCT02573350|40284568|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
16495117|NCT02573350|40284569|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
16495118|NCT02573350|40284568|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
16495119|NCT02573350|40284569|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
16307388|NCT03334435|39612646|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
16307389|NCT03334435|39612647|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
16307390|NCT03334435|39612648|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
16495120|NCT02573350|40284568|FG000|Overall Study|Subject withdrew consent to participate|6|||
16495121|NCT02573350|40284569|FG001|Overall Study|Subject withdrew consent to participate|1|||
16495122|NCT02573350|40284568|FG000|Overall Study|Protocol Deviation|1|||
16495123|NCT02573350|40284569|FG001|Overall Study|Protocol Deviation|1|||
16495124|NCT02205814|40284570|FG000|Overall Study|Lost to Follow-up|0|||
16495125|NCT02205814|40284571|FG001|Overall Study|Lost to Follow-up|0|||
16495126|NCT02205814|40284572|FG002|Overall Study|Lost to Follow-up|0|||
16495127|NCT02205814|40284573|FG003|Overall Study|Lost to Follow-up|1|||
16495128|NCT02205814|40284570|FG000|Overall Study|Lack of Efficacy|1|||
16495129|NCT02205814|40284571|FG001|Overall Study|Lack of Efficacy|0|||
16307391|NCT03334435|39612649|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
16307392|NCT03334435|39612635|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
16495130|NCT02205814|40284572|FG002|Overall Study|Lack of Efficacy|1|||
16495131|NCT02205814|40284573|FG003|Overall Study|Lack of Efficacy|1|||
16495132|NCT02205814|40284570|FG000|Overall Study|Physician Decision|0|||
16307393|NCT03334435|39612636|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
16307394|NCT03334435|39612637|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
16495133|NCT02205814|40284571|FG001|Overall Study|Physician Decision|0|||
16495134|NCT02205814|40284572|FG002|Overall Study|Physician Decision|1|||
16495135|NCT02205814|40284573|FG003|Overall Study|Physician Decision|0|||
16495136|NCT02205814|40284570|FG000|Overall Study|Protocol Violation|1|||
16495137|NCT02205814|40284571|FG001|Overall Study|Protocol Violation|0|||
16495138|NCT02205814|40284572|FG002|Overall Study|Protocol Violation|0|||
16495139|NCT02205814|40284573|FG003|Overall Study|Protocol Violation|1|||
16495140|NCT02205814|40284570|FG000|Overall Study|Withdrawal by Subject|0|||
16495141|NCT02205814|40284571|FG001|Overall Study|Withdrawal by Subject|1|||
16495142|NCT02205814|40284572|FG002|Overall Study|Withdrawal by Subject|2|||
16495143|NCT02205814|40284573|FG003|Overall Study|Withdrawal by Subject|1|||
16085258|NCT03220724|38806773|FG007|Overall Study|Withdrawal by Subject|0|||
16085259|NCT03220724|38806774|FG008|Overall Study|Withdrawal by Subject|0|||
16085260|NCT01588951|38806775|FG000|Overall Study|Ineligible in retrospect|0|||
16085261|NCT01588951|38806776|FG001|Overall Study|Ineligible in retrospect|0|||
16085262|NCT01588951|38806777|FG002|Overall Study|Ineligible in retrospect|1|||
16085263|NCT01372085|38806778|FG000|Washout Period 2|Physician Decision|0|||
16085264|NCT01372085|38806779|FG001|Washout Period 2|Physician Decision|0|||
16085265|NCT01372085|38806780|FG002|Washout Period 2|Physician Decision|0|||
16085266|NCT01372085|38806781|FG003|Washout Period 2|Physician Decision|0|||
16085267|NCT01372085|38806782|FG004|Washout Period 2|Physician Decision|1|||
16307395|NCT03334435|39612638|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
16307396|NCT03334435|39612639|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
16307397|NCT03334435|39612640|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
16307398|NCT03334435|39612641|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
16307399|NCT03334435|39612642|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
16307400|NCT03334435|39612643|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
16307401|NCT03334435|39612644|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
16307402|NCT03334435|39612645|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
16307403|NCT03334435|39612646|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
16307404|NCT03334435|39612647|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
16307405|NCT03334435|39612648|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
16307406|NCT03334435|39612649|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
16307407|NCT03334435|39612635|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
16307408|NCT03334435|39612636|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307409|NCT03334435|39612637|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
16307410|NCT03334435|39612638|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
16307411|NCT03334435|39612639|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
16307412|NCT03334435|39612640|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307413|NCT03334435|39612641|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307414|NCT03334435|39612642|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307415|NCT03334435|39612643|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307416|NCT03334435|39612644|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307417|NCT03334435|39612645|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307418|NCT03334435|39612646|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307419|NCT03334435|39612647|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307420|NCT03334435|39612648|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307421|NCT03334435|39612649|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
16307422|NCT03334435|39612635|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307423|NCT03334435|39612636|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307424|NCT03334435|39612637|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307425|NCT03334435|39612638|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
16307426|NCT03334435|39612639|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307427|NCT03334435|39612640|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307428|NCT03334435|39612641|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307429|NCT03334435|39612642|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307430|NCT03334435|39612643|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307431|NCT03334435|39612644|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307432|NCT03334435|39612645|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307433|NCT03334435|39612646|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307434|NCT03334435|39612647|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307435|NCT03334435|39612648|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
16495144|NCT02205814|40284570|FG000|Overall Study|not compliant with study procedures|0|||
16495145|NCT02205814|40284571|FG001|Overall Study|not compliant with study procedures|0|||
16085268|NCT01372085|38806783|FG005|Washout Period 2|Physician Decision|0|||
16085269|NCT01372085|38806784|FG006|Washout Period 2|Physician Decision|0|||
16085270|NCT01372085|38806785|FG007|Washout Period 2|Physician Decision|0|||
16085271|NCT01372085|38806786|FG008|Washout Period 2|Physician Decision|0|||
16085272|NCT01372085|38806787|FG009|Washout Period 2|Physician Decision|0|||
16085273|NCT01372085|38806778|FG000|Washout Period 3|Withdrawal by Subject|0|||
16085274|NCT01372085|38806779|FG001|Washout Period 3|Withdrawal by Subject|0|||
16085275|NCT01372085|38806780|FG002|Washout Period 3|Withdrawal by Subject|0|||
16085276|NCT01372085|38806781|FG003|Washout Period 3|Withdrawal by Subject|0|||
16085277|NCT01372085|38806782|FG004|Washout Period 3|Withdrawal by Subject|0|||
16307436|NCT03334435|39612649|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
16307437|NCT03334435|39612635|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307438|NCT03334435|39612636|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
16307439|NCT03334435|39612637|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
16307440|NCT03334435|39612638|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
16307441|NCT03334435|39612639|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
16307442|NCT03334435|39612640|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307443|NCT03334435|39612641|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307444|NCT03334435|39612642|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307445|NCT03334435|39612643|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307446|NCT03334435|39612644|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307447|NCT03334435|39612645|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307448|NCT03334435|39612646|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307449|NCT03334435|39612647|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307450|NCT03334435|39612648|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307451|NCT03334435|39612649|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
16307452|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
16307453|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
16307454|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
16307455|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
16307456|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
16307457|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
16307458|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
16307459|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
16307460|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
16307461|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
16307462|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
16307463|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
16307464|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
16307465|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
16307466|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
16307467|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
16307468|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
16307469|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
16307470|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
16307471|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
16307472|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
16307473|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
16307474|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
16307475|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
16307476|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
16307477|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
16307478|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
16307479|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
16307480|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
16307481|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
16307482|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
16307483|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
16307484|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
16307485|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
16307486|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
16307487|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
16307488|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
16307489|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
16307490|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
16085278|NCT01372085|38806783|FG005|Washout Period 3|Withdrawal by Subject|2|||
16085279|NCT01372085|38806784|FG006|Washout Period 3|Withdrawal by Subject|0|||
16495146|NCT02205814|40284572|FG002|Overall Study|not compliant with study procedures|1|||
16495147|NCT02205814|40284573|FG003|Overall Study|not compliant with study procedures|0|||
16495148|NCT02468414|40284574|FG000|Overall Study|Early Study Termination by Sponsor|1|||
16495149|NCT02468414|40284575|FG001|Overall Study|Early Study Termination by Sponsor|0|||
16495150|NCT02468414|40284574|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
16495151|NCT02468414|40284575|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
16495152|NCT02468414|40284574|FG000|Overall Study|Screen Failure|1|||
16495153|NCT02468414|40284575|FG001|Overall Study|Screen Failure|0|||
16495154|NCT00396591|40284578|FG000|Overall Study|Disease Progression|13|||
16495155|NCT00396591|40284578|FG000|Overall Study|Adverse Event|2|||
16495156|NCT00396591|40284578|FG000|Overall Study|Participant request|1|||
16495157|NCT00477971|40284580|FG000|Overall Study|Disease progression|6|||
16495158|NCT00477971|40284581|FG001|Overall Study|Disease progression|0|||
16495159|NCT00477971|40284580|FG000|Overall Study|Withdrawal by Subject|3|||
16495160|NCT00477971|40284581|FG001|Overall Study|Withdrawal by Subject|1|||
16495161|NCT00477971|40284580|FG000|Overall Study|Adverse Event|3|||
16495162|NCT00477971|40284581|FG001|Overall Study|Adverse Event|0|||
16495163|NCT00477971|40284580|FG000|Overall Study|Death|2|||
16495164|NCT00477971|40284581|FG001|Overall Study|Death|4|||
16495165|NCT00477971|40284580|FG000|Overall Study|Alternative treatment|3|||
16495166|NCT00477971|40284581|FG001|Overall Study|Alternative treatment|1|||
16495167|NCT04533438|40284583|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
16495168|NCT04533438|40284584|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
16495169|NCT03364023|40284585|FG000|Overall Study|Lost to Follow-up|3|||
16495170|NCT03364023|40284585|FG000|Overall Study|Death|14|||
16495171|NCT00381095|40284586|FG000|Overall Study|Death|3|||
16495172|NCT00381095|40284587|FG001|Overall Study|Death|4|||
16495173|NCT00381095|40284586|FG000|Overall Study|Lack of Efficacy|2|||
16495174|NCT00381095|40284587|FG001|Overall Study|Lack of Efficacy|4|||
16495175|NCT00381095|40284586|FG000|Overall Study|Other|2|||
16495176|NCT00381095|40284587|FG001|Overall Study|Other|2|||
16495177|NCT00381095|40284586|FG000|Overall Study|Protocol Violation|1|||
16495178|NCT00381095|40284587|FG001|Overall Study|Protocol Violation|1|||
16495179|NCT00381095|40284586|FG000|Overall Study|Withdrawal by Subject|3|||
16495180|NCT00381095|40284587|FG001|Overall Study|Withdrawal by Subject|3|||
16495181|NCT00381095|40284586|FG000|Overall Study|Adverse Event|2|||
16495182|NCT00381095|40284587|FG001|Overall Study|Adverse Event|7|||
16495183|NCT00126568|40284600|FG000|Overall Study|Death|2|||
16495184|NCT00418314|40284601|FG000|Overall Study|Withdrawal by Subject|1|||
16495185|NCT00418314|40284602|FG001|Overall Study|Withdrawal by Subject|2|||
16495186|NCT01574326|40284606|FG000|Overall Study|Randomized but not treated|0|||
16495187|NCT01574326|40284607|FG001|Overall Study|Randomized but not treated|1|||
16495188|NCT01574326|40284606|FG000|Overall Study|Withdrawal by Participant|2|||
16495189|NCT01574326|40284607|FG001|Overall Study|Withdrawal by Participant|4|||
16495190|NCT01574326|40284606|FG000|Overall Study|Physician Decision|5|||
16495191|NCT01574326|40284607|FG001|Overall Study|Physician Decision|3|||
16495192|NCT01574326|40284606|FG000|Overall Study|Adverse Event|1|||
16495193|NCT01574326|40284607|FG001|Overall Study|Adverse Event|3|||
16495194|NCT01574326|40284606|FG000|Overall Study|Other: Mainly kidney transplant|8|||
16495195|NCT01574326|40284607|FG001|Overall Study|Other: Mainly kidney transplant|8|||
16495196|NCT00284050|40284610|FG000|Overall Study|Adverse Event|1|||
16495197|NCT00284050|40284611|FG001|Overall Study|Adverse Event|1|||
16495198|NCT00284050|40284612|FG002|Overall Study|Adverse Event|1|||
16495199|NCT00284050|40284610|FG000|Overall Study|Lack of Efficacy|0|||
16495200|NCT00284050|40284611|FG001|Overall Study|Lack of Efficacy|1|||
16495201|NCT00284050|40284612|FG002|Overall Study|Lack of Efficacy|3|||
16495202|NCT00284050|40284610|FG000|Overall Study|Protocol Violation|0|||
16495203|NCT00284050|40284611|FG001|Overall Study|Protocol Violation|1|||
16495204|NCT00284050|40284612|FG002|Overall Study|Protocol Violation|2|||
16495205|NCT00284050|40284610|FG000|Overall Study|Withdrawal by Subject|2|||
16495206|NCT00284050|40284611|FG001|Overall Study|Withdrawal by Subject|2|||
16495207|NCT00284050|40284612|FG002|Overall Study|Withdrawal by Subject|2|||
16495208|NCT00284050|40284610|FG000|Overall Study|Lost to Follow-up|1|||
16495209|NCT00284050|40284611|FG001|Overall Study|Lost to Follow-up|0|||
16495210|NCT00284050|40284612|FG002|Overall Study|Lost to Follow-up|1|||
16495211|NCT00284050|40284610|FG000|Overall Study|Death|1|||
16307491|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
16409935|NCT03099148|39981833|FG003|Wash-out|Adverse Event|0|||
16495212|NCT00284050|40284611|FG001|Overall Study|Death|0|||
16495213|NCT00284050|40284612|FG002|Overall Study|Death|0|||
16495214|NCT01709162|40284613|FG000|Overall Study|Disease progression|3|||
16495215|NCT01709162|40284614|FG001|Overall Study|Disease progression|3|||
16495216|NCT01709162|40284613|FG000|Overall Study|Study drug toxicity|2|||
16495217|NCT01709162|40284614|FG001|Overall Study|Study drug toxicity|0|||
16495218|NCT01709162|40284613|FG000|Overall Study|Administrative reason by sponsor|0|||
16495219|NCT01709162|40284614|FG001|Overall Study|Administrative reason by sponsor|1|||
16495220|NCT01709162|40284613|FG000|Overall Study|Other|1|||
16495221|NCT01709162|40284614|FG001|Overall Study|Other|0|||
16495222|NCT01709162|40284613|FG000|Overall Study|Withdrawal by Subject|0|||
16307492|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
16307493|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
16307494|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
16307495|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
16307496|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
16085280|NCT01372085|38806785|FG007|Washout Period 3|Withdrawal by Subject|0|||
16085281|NCT01372085|38806786|FG008|Washout Period 3|Withdrawal by Subject|0|||
16085282|NCT01372085|38806787|FG009|Washout Period 3|Withdrawal by Subject|0|||
16085283|NCT01988402|38806790|FG000|Overall Study|Adverse Event|1|||
16085284|NCT01988402|38806791|FG001|Overall Study|Adverse Event|2|||
16085285|NCT01988402|38806790|FG000|Overall Study|Withdrawal by Subject|1|||
16085286|NCT01988402|38806791|FG001|Overall Study|Withdrawal by Subject|0|||
16085287|NCT00836498|38806792|FG000|Overall Study|Adverse Event|1|||
16085288|NCT00836498|38806793|FG001|Overall Study|Adverse Event|0|||
16085289|NCT00836498|38806792|FG000|Overall Study|Lost to Follow-up|1|||
16085290|NCT00836498|38806793|FG001|Overall Study|Lost to Follow-up|0|||
16085291|NCT00836498|38806792|FG000|Overall Study|Withdrawal by Subject|2|||
16085292|NCT00836498|38806793|FG001|Overall Study|Withdrawal by Subject|1|||
16085293|NCT02613403|38806796|FG000|Overall Study|Lost to Follow-up|0|||
16085294|NCT02613403|38806797|FG001|Overall Study|Lost to Follow-up|1|||
16085295|NCT02613403|38806798|FG002|Overall Study|Lost to Follow-up|0|||
16085296|NCT02613403|38806799|FG003|Overall Study|Lost to Follow-up|0|||
16085297|NCT02613403|38806800|FG004|Overall Study|Lost to Follow-up|0|||
16085298|NCT02613403|38806796|FG000|Overall Study|Withdrawal by Subject|2|||
16085299|NCT02613403|38806797|FG001|Overall Study|Withdrawal by Subject|0|||
16085300|NCT02613403|38806798|FG002|Overall Study|Withdrawal by Subject|0|||
16085301|NCT02613403|38806799|FG003|Overall Study|Withdrawal by Subject|0|||
16193973|NCT00006604|39188660|FG003|Overall Study|Withdrawal by Subject|0|||
16193974|NCT00006604|39188661|FG004|Overall Study|Withdrawal by Subject|1|||
16193975|NCT00006604|39188662|FG005|Overall Study|Withdrawal by Subject|2|||
16193976|NCT00006604|39188663|FG006|Overall Study|Withdrawal by Subject|2|||
16193977|NCT00006604|39188664|FG007|Overall Study|Withdrawal by Subject|0|||
16193978|NCT00006604|39188665|FG008|Overall Study|Withdrawal by Subject|1|||
16193979|NCT00006604|39188666|FG009|Overall Study|Withdrawal by Subject|3|||
16193980|NCT00006604|39188667|FG010|Overall Study|Withdrawal by Subject|2|||
16193981|NCT00006604|39188668|FG011|Overall Study|Withdrawal by Subject|0|||
16193982|NCT00006604|39188669|FG012|Overall Study|Withdrawal by Subject|1|||
16193983|NCT00006604|39188670|FG013|Overall Study|Withdrawal by Subject|2|||
16193984|NCT00006604|39188671|FG014|Overall Study|Withdrawal by Subject|1|||
16193985|NCT00006604|39188672|FG015|Overall Study|Withdrawal by Subject|0|||
16193986|NCT00006604|39188673|FG016|Overall Study|Withdrawal by Subject|1|||
16193987|NCT00006604|39188657|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
16193988|NCT00006604|39188658|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
16193989|NCT00006604|39188659|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
16193990|NCT00006604|39188660|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
16193991|NCT00006604|39188661|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
16193992|NCT00006604|39188662|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
16193993|NCT00006604|39188663|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
16307497|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
16307498|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
16307499|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
16307500|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
16307501|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
16495223|NCT01709162|40284614|FG001|Overall Study|Withdrawal by Subject|1|||
16307502|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
16307503|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
16307504|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
16307505|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
16307506|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
16495224|NCT03090152|40284615|FG000|Overall Study|Withdrawal by Subject|0|||
16495225|NCT03090152|40284616|FG001|Overall Study|Withdrawal by Subject|2|||
16495226|NCT03090152|40284617|FG002|Overall Study|Withdrawal by Subject|1|||
16495227|NCT03090152|40284615|FG000|Overall Study|Surgery Canceled|1|||
16495228|NCT03090152|40284616|FG001|Overall Study|Surgery Canceled|0|||
16495229|NCT03090152|40284617|FG002|Overall Study|Surgery Canceled|0|||
16307507|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
16495230|NCT03090152|40284615|FG000|Overall Study|Epidural catheter could not be placed|0|||
16085302|NCT02613403|38806800|FG004|Overall Study|Withdrawal by Subject|0|||
16085303|NCT00701701|38806801|FG000|Overall Study|Withdrawal by Subject|0|||
16085304|NCT00701701|38806802|FG001|Overall Study|Withdrawal by Subject|1|||
16193994|NCT00006604|39188664|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
16193995|NCT00006604|39188665|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
16307508|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
16307509|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
16307510|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
16307511|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
16307512|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
16307513|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
16193996|NCT00006604|39188666|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
16193997|NCT00006604|39188667|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
16193998|NCT00006604|39188668|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
16193999|NCT00006604|39188669|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
16194000|NCT00006604|39188670|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
16194001|NCT00006604|39188671|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
16194002|NCT00006604|39188672|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
16194003|NCT00006604|39188673|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
16194004|NCT00006604|39188657|FG000|Overall Study|Lost to Follow-up|0|||
16194005|NCT00006604|39188658|FG001|Overall Study|Lost to Follow-up|0|||
16194006|NCT00006604|39188659|FG002|Overall Study|Lost to Follow-up|0|||
16194007|NCT00006604|39188660|FG003|Overall Study|Lost to Follow-up|0|||
16194008|NCT00006604|39188661|FG004|Overall Study|Lost to Follow-up|0|||
16194009|NCT00006604|39188662|FG005|Overall Study|Lost to Follow-up|0|||
16194010|NCT00006604|39188663|FG006|Overall Study|Lost to Follow-up|0|||
16194011|NCT00006604|39188664|FG007|Overall Study|Lost to Follow-up|1|||
16307514|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
16307515|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
16194012|NCT00006604|39188665|FG008|Overall Study|Lost to Follow-up|0|||
16194013|NCT00006604|39188666|FG009|Overall Study|Lost to Follow-up|2|||
16194014|NCT00006604|39188667|FG010|Overall Study|Lost to Follow-up|0|||
16194015|NCT00006604|39188668|FG011|Overall Study|Lost to Follow-up|0|||
16194016|NCT00006604|39188669|FG012|Overall Study|Lost to Follow-up|0|||
16194017|NCT00006604|39188670|FG013|Overall Study|Lost to Follow-up|0|||
16194018|NCT00006604|39188671|FG014|Overall Study|Lost to Follow-up|0|||
16194019|NCT00006604|39188672|FG015|Overall Study|Lost to Follow-up|1|||
16307516|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
16307517|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
16307518|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
16307519|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
16307520|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
16495231|NCT03090152|40284616|FG001|Overall Study|Epidural catheter could not be placed|2|||
16495232|NCT03090152|40284617|FG002|Overall Study|Epidural catheter could not be placed|0|||
16307521|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
16307522|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
16307523|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
16307524|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
16307525|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
16307526|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
16307527|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307528|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307529|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307530|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307531|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307532|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307533|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307534|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16495233|NCT00576927|40284618|FG000|Clinical Assessment|Lack of Efficacy|24|||
16495234|NCT00576927|40284618|FG000|Clinical Assessment|Death|1|||
16495235|NCT00576927|40284618|FG000|Clinical Assessment|Withdrawal by Subject|10|||
16085305|NCT00701701|38806801|FG000|Overall Study|Adverse Event|0|||
16194020|NCT00006604|39188673|FG016|Overall Study|Lost to Follow-up|3|||
16495236|NCT00576927|40284618|FG000|Clinical Assessment|Physician Decision|1|||
16495237|NCT00576927|40284618|FG000|Baseline|Physician Decision|9|||
16495238|NCT00576927|40284618|FG000|Baseline|Medication Change by PCP of subject|1|||
16495239|NCT00576927|40284618|FG000|Baseline|Withdrawal by Subject|3|||
16495240|NCT00576927|40284618|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
16495241|NCT00576927|40284618|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
16495242|NCT00576927|40284618|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
16194021|NCT00006604|39188657|FG000|Overall Study|Other Reason|0|||
16194022|NCT00006604|39188658|FG001|Overall Study|Other Reason|0|||
16307535|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307536|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307537|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307538|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
16307539|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307540|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
16307541|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
16307542|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307543|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307544|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307545|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
16194023|NCT00006604|39188659|FG002|Overall Study|Other Reason|0|||
16194024|NCT00006604|39188660|FG003|Overall Study|Other Reason|0|||
16194025|NCT00006604|39188661|FG004|Overall Study|Other Reason|0|||
16194026|NCT00006604|39188662|FG005|Overall Study|Other Reason|1|||
16194027|NCT00006604|39188663|FG006|Overall Study|Other Reason|0|||
16194028|NCT00006604|39188664|FG007|Overall Study|Other Reason|0|||
16307546|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307547|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
16307548|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307549|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307550|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307551|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307552|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307553|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307554|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307555|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
16307556|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
16307557|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
16307558|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
16307559|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
16307560|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
16307561|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
16307562|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
16307563|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
16307564|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
16307565|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
16307566|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
16307567|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
16307568|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
16307569|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
16307570|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
16307571|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
16307572|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
16194029|NCT00006604|39188665|FG008|Overall Study|Other Reason|0|||
16307573|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
16307574|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
16307575|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
16307576|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
16307577|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
16307578|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
16307579|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
16307580|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
16307581|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
16307582|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
16307583|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
16307584|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
16307585|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
16307586|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
16307587|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16307588|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16307589|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16194030|NCT00006604|39188666|FG009|Overall Study|Other Reason|1|||
16194031|NCT00006604|39188667|FG010|Overall Study|Other Reason|0|||
16307590|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16307591|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16307592|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
16085306|NCT00701701|38806802|FG001|Overall Study|Adverse Event|1|||
16085307|NCT02185794|38806809|FG000|Overall Study|Enrolled but Never Dosed|1|||
16307593|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16307594|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16307595|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16085308|NCT02185794|38806810|FG001|Overall Study|Enrolled but Never Dosed|6|||
16085309|NCT02185794|38806811|FG002|Overall Study|Enrolled but Never Dosed|3|||
16085310|NCT02185794|38806812|FG003|Overall Study|Enrolled but Never Dosed|1|||
16085311|NCT02185794|38806813|FG004|Overall Study|Enrolled but Never Dosed|1|||
16085312|NCT02185794|38806814|FG005|Overall Study|Enrolled but Never Dosed|0|||
16307596|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16307597|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
16307598|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16307599|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16307600|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
16307601|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
16307602|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
16307603|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
16307604|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
16307605|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
16307606|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
16307607|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
16307608|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
16307609|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
16307610|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
16307611|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
16307612|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
16307613|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
16307614|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
16307615|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
16307616|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
16307617|NCT03334435|39612635|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307618|NCT03334435|39612636|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307619|NCT03334435|39612637|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307620|NCT03334435|39612638|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307621|NCT03334435|39612639|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307622|NCT03334435|39612640|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307623|NCT03334435|39612641|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307624|NCT03334435|39612642|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307625|NCT03334435|39612643|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307626|NCT03334435|39612644|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307627|NCT03334435|39612645|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307628|NCT03334435|39612646|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
16307629|NCT03334435|39612647|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
16307630|NCT03334435|39612648|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
16307631|NCT03334435|39612649|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
16307632|NCT02955212|39612650|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
16307633|NCT02955212|39612651|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
16409936|NCT02133664|39981834|FG000|Overall Study|Lost to Follow-up|2|||
16085313|NCT02185794|38806809|FG000|Overall Study|Investigator's Discretion|1|||
16085314|NCT02185794|38806810|FG001|Overall Study|Investigator's Discretion|0|||
16085315|NCT02185794|38806811|FG002|Overall Study|Investigator's Discretion|1|||
16085316|NCT02185794|38806812|FG003|Overall Study|Investigator's Discretion|2|||
16085317|NCT02185794|38806813|FG004|Overall Study|Investigator's Discretion|2|||
16085318|NCT02185794|38806814|FG005|Overall Study|Investigator's Discretion|15|||
16085319|NCT02185794|38806809|FG000|Overall Study|Withdrew Consent|2|||
16085320|NCT02185794|38806810|FG001|Overall Study|Withdrew Consent|5|||
16085321|NCT02185794|38806811|FG002|Overall Study|Withdrew Consent|10|||
16085322|NCT02185794|38806812|FG003|Overall Study|Withdrew Consent|2|||
16085323|NCT02185794|38806813|FG004|Overall Study|Withdrew Consent|0|||
16085324|NCT02185794|38806814|FG005|Overall Study|Withdrew Consent|0|||
16085325|NCT02185794|38806809|FG000|Overall Study|Lost to Follow-up|1|||
16085326|NCT02185794|38806810|FG001|Overall Study|Lost to Follow-up|2|||
16085327|NCT02185794|38806811|FG002|Overall Study|Lost to Follow-up|2|||
16085328|NCT02185794|38806812|FG003|Overall Study|Lost to Follow-up|3|||
16085329|NCT02185794|38806813|FG004|Overall Study|Lost to Follow-up|0|||
16085330|NCT02185794|38806814|FG005|Overall Study|Lost to Follow-up|1|||
16085331|NCT02399449|38806817|FG000|Overall Study|Withdrawal by Subject|3|||
16085332|NCT02399449|38806818|FG001|Overall Study|Withdrawal by Subject|9|||
16085333|NCT02399449|38806817|FG000|Overall Study|Physician Decision|0|||
16085334|NCT02399449|38806818|FG001|Overall Study|Physician Decision|1|||
16085335|NCT01989689|38806819|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
16085336|NCT01989689|38806820|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
16307634|NCT02955212|39612650|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
16307635|NCT02955212|39612651|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
16307636|NCT02955212|39612650|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
16495243|NCT00576927|40284618|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
16495244|NCT00576927|40284618|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
16495245|NCT03316131|40284619|FG000|Treatment Period 2|Protocol deviation|1|||
16495246|NCT03316131|40284620|FG001|Treatment Period 2|Protocol deviation|0|||
16495247|NCT00416078|40284627|FG000|Overall Study|Death|3|||
16495248|NCT00416078|40284628|FG001|Overall Study|Death|4|||
16495249|NCT00416078|40284627|FG000|Overall Study|Withdrawal by Subject|3|||
16495250|NCT00416078|40284628|FG001|Overall Study|Withdrawal by Subject|2|||
16495251|NCT00416078|40284627|FG000|Overall Study|Physician Decision|1|||
16495252|NCT00416078|40284628|FG001|Overall Study|Physician Decision|0|||
16495253|NCT00416078|40284627|FG000|Overall Study|Lost to Follow-up|4|||
16495254|NCT00416078|40284628|FG001|Overall Study|Lost to Follow-up|2|||
16495255|NCT04492618|40284631|FG000|Overall Study|Withdrawal by Subject|1|||
16495256|NCT00715078|40284632|FG000|Overall Study|Death|29|||
16495257|NCT00715078|40284633|FG001|Overall Study|Death|36|||
16495258|NCT00715078|40284634|FG002|Overall Study|Death|36|||
16495259|NCT00715078|40284632|FG000|Overall Study|Withdrawal by Subject|1|||
16307637|NCT02955212|39612651|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
16307638|NCT02955212|39612650|FG000|Period 1: Double-blind Treatment Period|Other|3|||
16307639|NCT02955212|39612651|FG001|Period 1: Double-blind Treatment Period|Other|2|||
16307640|NCT02955212|39612650|FG000|Period 2: Open-label Extension|Adverse Event|11|||
16307641|NCT02955212|39612651|FG001|Period 2: Open-label Extension|Adverse Event|7|||
16307642|NCT02955212|39612650|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
16307643|NCT02955212|39612651|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
16307644|NCT02955212|39612650|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
16307645|NCT02955212|39612651|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
16307646|NCT02955212|39612650|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
16307647|NCT02955212|39612651|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
16307648|NCT02955212|39612650|FG000|Period 2: Open-label Extension|Other|2|||
16307649|NCT02955212|39612651|FG001|Period 2: Open-label Extension|Other|4|||
16307650|NCT01526057|39612654|FG000|Overall Study|Withdrawal by Subject|3|||
16307651|NCT01526057|39612655|FG001|Overall Study|Withdrawal by Subject|2|||
16307652|NCT01526057|39612656|FG002|Overall Study|Withdrawal by Subject|2|||
16307653|NCT01526057|39612654|FG000|Overall Study|Adverse Event|3|||
16307654|NCT01526057|39612655|FG001|Overall Study|Adverse Event|1|||
16307655|NCT01526057|39612656|FG002|Overall Study|Adverse Event|1|||
16307656|NCT01526057|39612654|FG000|Overall Study|Death|1|||
16307657|NCT01526057|39612655|FG001|Overall Study|Death|0|||
16307658|NCT01526057|39612656|FG002|Overall Study|Death|0|||
16307659|NCT01526057|39612654|FG000|Overall Study|Lost to Follow-up|1|||
16307660|NCT01526057|39612655|FG001|Overall Study|Lost to Follow-up|0|||
16307661|NCT01526057|39612656|FG002|Overall Study|Lost to Follow-up|1|||
16307662|NCT01526057|39612654|FG000|Overall Study|Other|1|||
16307663|NCT01526057|39612655|FG001|Overall Study|Other|0|||
16307664|NCT01526057|39612656|FG002|Overall Study|Other|1|||
16307665|NCT01526057|39612654|FG000|Overall Study|Protocol Violation|0|||
16307666|NCT01526057|39612655|FG001|Overall Study|Protocol Violation|0|||
16307667|NCT01526057|39612656|FG002|Overall Study|Protocol Violation|1|||
16307668|NCT02232984|39612659|FG000|Overall Study|Withdrawal by Subject|5|||
16307669|NCT02232984|39612659|FG000|Overall Study|Death|1|||
16307670|NCT02232984|39612659|FG000|Overall Study|Investigator withdrawal|10|||
16307671|NCT02232984|39612659|FG000|Overall Study|Device implant unsuccessful|53|||
16495260|NCT00715078|40284633|FG001|Overall Study|Withdrawal by Subject|0|||
16495261|NCT00715078|40284634|FG002|Overall Study|Withdrawal by Subject|1|||
16085337|NCT01989689|38806819|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
16194032|NCT00006604|39188668|FG011|Overall Study|Other Reason|0|||
16307672|NCT02232984|39612659|FG000|Overall Study|not disclosed by site|7|||
16307673|NCT02232984|39612659|FG000|Overall Study|Protocol Violation|1|||
16307674|NCT03452943|39612660|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
16307675|NCT03452943|39612661|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
16388232|NCT02185534|39905609|FG000|First Period|Withdrawal by Subject|0|||
16495262|NCT00715078|40284632|FG000|Overall Study|Unable to start due to disease prog.|0|||
16495263|NCT00715078|40284633|FG001|Overall Study|Unable to start due to disease prog.|0|||
16495264|NCT00715078|40284634|FG002|Overall Study|Unable to start due to disease prog.|1|||
16495265|NCT01535053|40284635|FG000|Overall Study|Ineligible|1|||
16495266|NCT01535053|40284636|FG001|Overall Study|Ineligible|2|||
16495267|NCT01320085|40284637|FG000|Overall Study|Disease Progression|26|||
16307676|NCT03452943|39612660|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
16307677|NCT03452943|39612661|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
16307678|NCT03452943|39612660|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
16307679|NCT03452943|39612661|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
16307680|NCT03452943|39612660|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
16307681|NCT03452943|39612661|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
16307682|NCT03452943|39612660|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
16307683|NCT03452943|39612661|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
16307684|NCT03452943|39612660|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
16307685|NCT03452943|39612661|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
16307686|NCT02094300|39612666|FG000|Overall Study|Death|7|||
16307687|NCT02094300|39612666|FG000|Overall Study|Lost to Follow-up|10|||
16307688|NCT02094300|39612666|FG000|Overall Study|Still be eligible for follow-up|3|||
16307689|NCT01168427|39612669|FG000|Overall Study|Patient exited prior to implant|1|||
16307690|NCT03552380|39612670|FG000|Study Treatment|Disease Progression|3|||
16495268|NCT01320085|40284638|FG001|Overall Study|Disease Progression|93|||
16495269|NCT01320085|40284639|FG002|Overall Study|Disease Progression|17|||
16495270|NCT01320085|40284637|FG000|Overall Study|Adverse Event|12|||
16495271|NCT01320085|40284638|FG001|Overall Study|Adverse Event|20|||
16495272|NCT01320085|40284639|FG002|Overall Study|Adverse Event|5|||
16495273|NCT01320085|40284637|FG000|Overall Study|Withdrawal by Subject|2|||
16495274|NCT01320085|40284638|FG001|Overall Study|Withdrawal by Subject|4|||
16495275|NCT01320085|40284639|FG002|Overall Study|Withdrawal by Subject|1|||
16495276|NCT01320085|40284637|FG000|Overall Study|Protocol Deviation|1|||
16495277|NCT01320085|40284638|FG001|Overall Study|Protocol Deviation|0|||
16495278|NCT01320085|40284639|FG002|Overall Study|Protocol Deviation|1|||
16495279|NCT01320085|40284637|FG000|Overall Study|Administrative problems|0|||
16495280|NCT01320085|40284638|FG001|Overall Study|Administrative problems|0|||
16495281|NCT01320085|40284639|FG002|Overall Study|Administrative problems|1|||
16495282|NCT00867568|40284641|FG000|Overall Study|Lack of Efficacy|10|||
16495283|NCT00867568|40284641|FG000|Overall Study|Adverse Event|4|||
16495284|NCT00867568|40284641|FG000|Overall Study|Withdrawal by Subject|1|||
16495285|NCT02617628|40284642|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
16495286|NCT02617628|40284643|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
16495287|NCT00642460|40284644|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
16495288|NCT00642460|40284645|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
16307691|NCT03552380|39612671|FG001|Study Treatment|Disease Progression|4|||
16307692|NCT03552380|39612670|FG000|Study Treatment|Adverse Event|2|||
16495289|NCT00642460|40284646|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
16495290|NCT00642460|40284647|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
16307693|NCT03552380|39612671|FG001|Study Treatment|Adverse Event|2|||
16307694|NCT03552380|39612670|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
16307695|NCT03552380|39612671|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
16307696|NCT03552380|39612670|FG000|Follow up|Death|3|||
16307697|NCT03552380|39612671|FG001|Follow up|Death|4|||
16307698|NCT03552380|39612670|FG000|Follow up|Site IRB terminated|0|||
16307699|NCT03552380|39612671|FG001|Follow up|Site IRB terminated|1|||
16307700|NCT01262872|39612672|FG000|Step 2|Death|0|||
16307701|NCT01262872|39612673|FG001|Step 2|Death|0|||
16307702|NCT01262872|39612674|FG002|Step 2|Death|0|||
16307703|NCT01262872|39612675|FG003|Step 2|Death|1|||
16307704|NCT01262872|39612676|FG004|Step 2|Death|0|||
16307705|NCT01262872|39612677|FG005|Step 2|Death|2|||
16307706|NCT01262872|39612678|FG006|Step 2|Death|2|||
16307707|NCT01262872|39612679|FG007|Step 2|Death|1|||
16307708|NCT01262872|39612672|FG000|Step 2|Protocol Violation|0|||
16307709|NCT01262872|39612673|FG001|Step 2|Protocol Violation|0|||
16307710|NCT01262872|39612674|FG002|Step 2|Protocol Violation|1|||
16307711|NCT01262872|39612675|FG003|Step 2|Protocol Violation|0|||
16307712|NCT01262872|39612676|FG004|Step 2|Protocol Violation|0|||
16307713|NCT01262872|39612677|FG005|Step 2|Protocol Violation|0|||
16307714|NCT01262872|39612678|FG006|Step 2|Protocol Violation|3|||
16307715|NCT01262872|39612679|FG007|Step 2|Protocol Violation|1|||
16495291|NCT00642460|40284648|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
16495292|NCT00642460|40284649|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
16495293|NCT00642460|40284644|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
16307716|NCT01262872|39612672|FG000|Step 2|Withdrawal by Subject|0|||
16307717|NCT01262872|39612673|FG001|Step 2|Withdrawal by Subject|0|||
16307718|NCT01262872|39612674|FG002|Step 2|Withdrawal by Subject|4|||
16307719|NCT01262872|39612675|FG003|Step 2|Withdrawal by Subject|6|||
16307720|NCT01262872|39612676|FG004|Step 2|Withdrawal by Subject|3|||
16307721|NCT01262872|39612677|FG005|Step 2|Withdrawal by Subject|1|||
16307722|NCT01262872|39612678|FG006|Step 2|Withdrawal by Subject|2|||
16307723|NCT01262872|39612679|FG007|Step 2|Withdrawal by Subject|1|||
16307724|NCT01262872|39612672|FG000|Step 2|Migrated/moved from study area|0|||
16307725|NCT01262872|39612673|FG001|Step 2|Migrated/moved from study area|0|||
16307726|NCT01262872|39612674|FG002|Step 2|Migrated/moved from study area|4|||
16307727|NCT01262872|39612675|FG003|Step 2|Migrated/moved from study area|3|||
16307728|NCT01262872|39612676|FG004|Step 2|Migrated/moved from study area|2|||
16307729|NCT01262872|39612677|FG005|Step 2|Migrated/moved from study area|6|||
16495294|NCT00642460|40284645|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
16307730|NCT01262872|39612678|FG006|Step 2|Migrated/moved from study area|2|||
16307731|NCT01262872|39612679|FG007|Step 2|Migrated/moved from study area|3|||
16307732|NCT00065156|39612682|FG000|Overall Study|Adverse Event|37|||
16495295|NCT00642460|40284646|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
16495296|NCT00642460|40284647|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
16495297|NCT00642460|40284648|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
16495298|NCT00642460|40284649|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
16495299|NCT00642460|40284644|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
16495300|NCT00642460|40284645|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
16495301|NCT00642460|40284646|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
16495302|NCT00642460|40284647|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
16495303|NCT00642460|40284648|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
16495304|NCT00642460|40284649|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
16495305|NCT00642460|40284644|FG000|Part II: Open-Label Up to Week 92|Death|0|||
16495306|NCT00642460|40284645|FG001|Part II: Open-Label Up to Week 92|Death|1|||
16495307|NCT00642460|40284646|FG002|Part II: Open-Label Up to Week 92|Death|0|||
16495308|NCT00642460|40284647|FG003|Part II: Open-Label Up to Week 92|Death|2|||
16495309|NCT00642460|40284648|FG004|Part II: Open-Label Up to Week 92|Death|0|||
16495310|NCT00642460|40284649|FG005|Part II: Open-Label Up to Week 92|Death|0|||
16495311|NCT00642460|40284644|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
16495312|NCT00642460|40284645|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
16495313|NCT00642460|40284646|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
16495314|NCT00642460|40284647|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
16495315|NCT00642460|40284648|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
16495316|NCT00642460|40284649|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
16495317|NCT00642460|40284644|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
16495318|NCT00642460|40284645|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
16495319|NCT00642460|40284646|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
16495320|NCT00642460|40284647|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
16495321|NCT00642460|40284648|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
16495322|NCT00642460|40284649|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
16495323|NCT00642460|40284644|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
16495324|NCT00642460|40284645|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
16495325|NCT00642460|40284646|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
16495326|NCT00642460|40284647|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
16495327|NCT00642460|40284648|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
16495328|NCT00642460|40284649|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
16495329|NCT00642460|40284644|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
16495330|NCT00642460|40284645|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
16495331|NCT00642460|40284646|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
16495332|NCT00642460|40284647|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
16495333|NCT00642460|40284648|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
16495334|NCT00642460|40284649|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
16495335|NCT00642460|40284644|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
16495336|NCT00642460|40284645|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
16194033|NCT00006604|39188669|FG012|Overall Study|Other Reason|0|||
16307733|NCT00065156|39612682|FG000|Overall Study|Lack of Efficacy|52|||
16307734|NCT00065156|39612682|FG000|Overall Study|Withdrawal by Subject|8|||
16307735|NCT00065156|39612682|FG000|Overall Study|Lost to Follow-up|1|||
16307736|NCT00065156|39612682|FG000|Overall Study|Death|11|||
16307737|NCT00065156|39612682|FG000|Overall Study|Study Closed by Sponsor|2|||
16307738|NCT00065156|39612682|FG000|Overall Study|Disease Progression|7|||
16307739|NCT00065156|39612682|FG000|Overall Study|Investigator Decision|2|||
16307740|NCT00065156|39612682|FG000|Overall Study|Non-Compliance|2|||
16307741|NCT00065156|39612682|FG000|Overall Study|Loss of Response|1|||
16307742|NCT00065156|39612682|FG000|Overall Study|Secondary Malign Disease|1|||
16307743|NCT00378573|39612686|FG000|Treatment Period|Adverse Event|9|||
16307744|NCT00378573|39612686|FG000|Treatment Period|Physician Decision|1|||
16307745|NCT00378573|39612686|FG000|Treatment Period|Withdrawal by Subject|2|||
16307746|NCT00378573|39612686|FG000|Treatment Period|Disease Progression|4|||
16307747|NCT00378573|39612686|FG000|Treatment Period|Sponsor decision to close study|1|||
16307748|NCT00378573|39612686|FG000|Follow-up|Death|12|||
16307749|NCT00378573|39612686|FG000|Follow-up|Lost to Follow-up|1|||
16307750|NCT00378573|39612686|FG000|Follow-up|Withdrawal by Subject|1|||
16307751|NCT02719184|39612692|FG000|Overall Study|Other than listed|1|||
16307752|NCT02719184|39612693|FG001|Overall Study|Other than listed|12|||
16307753|NCT02719184|39612694|FG002|Overall Study|Other than listed|13|||
16495337|NCT00642460|40284646|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
16495338|NCT00642460|40284647|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
16307754|NCT02719184|39612695|FG003|Overall Study|Other than listed|22|||
16307755|NCT02719184|39612696|FG004|Overall Study|Other than listed|9|||
16307756|NCT02719184|39612692|FG000|Overall Study|Withdrawal by Subject|5|||
16307757|NCT02719184|39612693|FG001|Overall Study|Withdrawal by Subject|3|||
16307758|NCT02719184|39612694|FG002|Overall Study|Withdrawal by Subject|6|||
16307759|NCT02719184|39612695|FG003|Overall Study|Withdrawal by Subject|6|||
16307760|NCT02719184|39612696|FG004|Overall Study|Withdrawal by Subject|0|||
16307761|NCT02719184|39612692|FG000|Overall Study|Lost to Follow-up|0|||
16307762|NCT02719184|39612693|FG001|Overall Study|Lost to Follow-up|4|||
16307763|NCT02719184|39612694|FG002|Overall Study|Lost to Follow-up|1|||
16307764|NCT02719184|39612695|FG003|Overall Study|Lost to Follow-up|3|||
16307765|NCT02719184|39612696|FG004|Overall Study|Lost to Follow-up|0|||
16307766|NCT02719184|39612692|FG000|Overall Study|Protocol Violation|0|||
16307767|NCT02719184|39612693|FG001|Overall Study|Protocol Violation|3|||
16307768|NCT02719184|39612694|FG002|Overall Study|Protocol Violation|0|||
16307769|NCT02719184|39612695|FG003|Overall Study|Protocol Violation|2|||
16307770|NCT02719184|39612696|FG004|Overall Study|Protocol Violation|0|||
16307771|NCT02719184|39612692|FG000|Overall Study|Adverse Event|0|||
16307772|NCT02719184|39612693|FG001|Overall Study|Adverse Event|0|||
16307773|NCT02719184|39612694|FG002|Overall Study|Adverse Event|0|||
16307774|NCT02719184|39612695|FG003|Overall Study|Adverse Event|3|||
16307775|NCT02719184|39612696|FG004|Overall Study|Adverse Event|0|||
16495339|NCT00642460|40284648|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
16495340|NCT00642460|40284649|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
16495341|NCT00642460|40284644|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
16495342|NCT00642460|40284645|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
16495343|NCT00642460|40284646|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
16307776|NCT04342819|39612698|FG000|Overall Study|Declined|4|||
16495344|NCT00642460|40284647|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
16495345|NCT00642460|40284648|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
16495346|NCT00642460|40284649|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
16194034|NCT00006604|39188670|FG013|Overall Study|Other Reason|0|||
16307777|NCT04342819|39612698|FG000|Overall Study|Not meeeting selection criteria|1|||
16307778|NCT03536884|39612700|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
16307779|NCT03536884|39612701|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
16307780|NCT03536884|39612702|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
16307781|NCT03536884|39612703|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
16307782|NCT03536884|39612704|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
16307783|NCT03536884|39612705|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
16307784|NCT03536884|39612706|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
16495347|NCT00642460|40284644|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
16495348|NCT00642460|40284645|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
16495349|NCT00642460|40284646|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
16495350|NCT00642460|40284647|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
16495351|NCT00642460|40284648|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
16495352|NCT00642460|40284649|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
16495353|NCT00642460|40284644|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
16495354|NCT00642460|40284645|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
16495355|NCT00642460|40284646|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
16495356|NCT00642460|40284647|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
16495357|NCT00642460|40284648|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
16495358|NCT00642460|40284649|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
16495359|NCT00642460|40284644|FG000|Part III: Open-Label Up to Week 260|Other|0|||
16495360|NCT00642460|40284645|FG001|Part III: Open-Label Up to Week 260|Other|0|||
16495361|NCT00642460|40284646|FG002|Part III: Open-Label Up to Week 260|Other|0|||
16495362|NCT00642460|40284647|FG003|Part III: Open-Label Up to Week 260|Other|0|||
16495363|NCT00642460|40284648|FG004|Part III: Open-Label Up to Week 260|Other|2|||
16495364|NCT00642460|40284649|FG005|Part III: Open-Label Up to Week 260|Other|2|||
16495365|NCT00642460|40284644|FG000|Part III: Open-Label Up to Week 260|Death|0|||
16495366|NCT00642460|40284645|FG001|Part III: Open-Label Up to Week 260|Death|0|||
16495367|NCT00642460|40284646|FG002|Part III: Open-Label Up to Week 260|Death|0|||
16495368|NCT00642460|40284647|FG003|Part III: Open-Label Up to Week 260|Death|0|||
16495369|NCT00642460|40284648|FG004|Part III: Open-Label Up to Week 260|Death|0|||
16495370|NCT00642460|40284649|FG005|Part III: Open-Label Up to Week 260|Death|3|||
16495371|NCT00642460|40284644|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
16495372|NCT00642460|40284645|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
16495373|NCT00642460|40284646|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
16495374|NCT00642460|40284647|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
16495375|NCT00642460|40284648|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
16495376|NCT00642460|40284649|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
16495377|NCT00642460|40284644|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
16495378|NCT00642460|40284645|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
16495379|NCT00642460|40284646|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
16495380|NCT00642460|40284647|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
16495381|NCT00642460|40284648|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
16495382|NCT00642460|40284649|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
16495383|NCT00143403|40284654|FG000|Overall Study|Adverse Event|3|||
16495384|NCT00143403|40284655|FG001|Overall Study|Adverse Event|8|||
16495385|NCT00143403|40284654|FG000|Overall Study|Death|1|||
16495386|NCT00143403|40284655|FG001|Overall Study|Death|0|||
16495387|NCT00143403|40284654|FG000|Overall Study|Withdrawal by Subject|3|||
16495388|NCT00143403|40284655|FG001|Overall Study|Withdrawal by Subject|12|||
16495389|NCT00143403|40284654|FG000|Overall Study|Relapse|15|||
16495390|NCT00143403|40284655|FG001|Overall Study|Relapse|7|||
16495391|NCT00143403|40284654|FG000|Overall Study|Protocol Violation|2|||
16495392|NCT00143403|40284655|FG001|Overall Study|Protocol Violation|2|||
16495393|NCT00143403|40284654|FG000|Overall Study|specified by site|4|||
16495394|NCT00143403|40284655|FG001|Overall Study|specified by site|9|||
16495395|NCT00143403|40284654|FG000|Overall Study|Randomized Not Treated|7|||
16495396|NCT00143403|40284655|FG001|Overall Study|Randomized Not Treated|8|||
16495397|NCT00728130|40284656|FG000|Overall Study|Withdrawal by Subject|1|||
16495398|NCT00728130|40284656|FG000|Overall Study|Paperwork not completed in time|1|||
16495399|NCT00728130|40284656|FG000|Overall Study|Physician Decision|1|||
16495400|NCT03789318|40284660|FG000|Overall Study|Adverse Event|0|||
16495401|NCT03789318|40284661|FG001|Overall Study|Adverse Event|0|||
16495402|NCT03789318|40284662|FG002|Overall Study|Adverse Event|1|||
16495403|NCT03789318|40284663|FG003|Overall Study|Adverse Event|1|||
16495404|NCT03789318|40284664|FG004|Overall Study|Adverse Event|0|||
16495405|NCT03789318|40284660|FG000|Overall Study|Lost to Follow-up|0|||
16495406|NCT03789318|40284661|FG001|Overall Study|Lost to Follow-up|0|||
16495407|NCT03789318|40284662|FG002|Overall Study|Lost to Follow-up|1|||
16495408|NCT03789318|40284663|FG003|Overall Study|Lost to Follow-up|0|||
16495409|NCT03789318|40284664|FG004|Overall Study|Lost to Follow-up|0|||
16495410|NCT03789318|40284660|FG000|Overall Study|Withdrawal by Subject|0|||
16495411|NCT03789318|40284661|FG001|Overall Study|Withdrawal by Subject|0|||
16495412|NCT03789318|40284662|FG002|Overall Study|Withdrawal by Subject|1|||
16194035|NCT00006604|39188671|FG014|Overall Study|Other Reason|0|||
16388233|NCT02185534|39905610|FG001|First Period|Withdrawal by Subject|0|||
16495413|NCT03789318|40284663|FG003|Overall Study|Withdrawal by Subject|0|||
16495414|NCT03789318|40284664|FG004|Overall Study|Withdrawal by Subject|0|||
16495415|NCT02692716|40284665|FG000|Overall Study|Lost to Follow-up|2|||
16495416|NCT02692716|40284666|FG001|Overall Study|Lost to Follow-up|5|||
16495417|NCT02692716|40284665|FG000|Overall Study|Withdrawal by Subject|3|||
16194036|NCT00006604|39188672|FG015|Overall Study|Other Reason|0|||
16085338|NCT01989689|38806820|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
16307785|NCT03536884|39612707|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
16307786|NCT03536884|39612708|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
16307787|NCT03536884|39612709|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
16307788|NCT03536884|39612710|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
16307789|NCT03536884|39612711|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
16307790|NCT03536884|39612700|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307791|NCT03536884|39612701|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
16495418|NCT02692716|40284666|FG001|Overall Study|Withdrawal by Subject|1|||
16495419|NCT02480114|40284667|FG000|Overall Study|Not completing surveys|3|||
16495420|NCT02480114|40284668|FG001|Overall Study|Not completing surveys|2|||
16495421|NCT02480114|40284667|FG000|Overall Study|Withdrawal by Subject|2|||
16495422|NCT02480114|40284668|FG001|Overall Study|Withdrawal by Subject|4|||
16495423|NCT02480114|40284667|FG000|Overall Study|Disease progression|3|||
16495424|NCT02480114|40284668|FG001|Overall Study|Disease progression|0|||
16495425|NCT02480114|40284667|FG000|Overall Study|Improper completion of survey|1|||
16495426|NCT02480114|40284668|FG001|Overall Study|Improper completion of survey|1|||
16495427|NCT02480114|40284667|FG000|Overall Study|Not eligible|0|||
16495428|NCT02480114|40284668|FG001|Overall Study|Not eligible|1|||
16495429|NCT03855280|40284669|FG000|Treatment Phase|Adverse Event|1|||
16495430|NCT03855280|40284669|FG000|Treatment Phase|Withdrawal by Subject|1|||
16495431|NCT03855280|40284669|FG000|Continuation Phase|Protocol Violation|1|||
16495432|NCT03855280|40284669|FG000|Continuation Phase|Adverse Event|1|||
16495433|NCT03855280|40284669|FG000|Continuation Phase|Sponsor Concluded Study|1|||
16495434|NCT02846779|40284670|FG000|Overall Study|Lost Enrollment|83|||
16495435|NCT02846779|40284671|FG001|Overall Study|Lost Enrollment|82|||
16495436|NCT02846779|40284672|FG002|Overall Study|Lost Enrollment|86|||
16495437|NCT02846779|40284670|FG000|Overall Study|Less than 31 days of follow-up|56|||
16495438|NCT02846779|40284671|FG001|Overall Study|Less than 31 days of follow-up|45|||
16307792|NCT03536884|39612702|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307793|NCT03536884|39612703|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307794|NCT03536884|39612704|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307795|NCT03536884|39612705|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307796|NCT03536884|39612706|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307797|NCT03536884|39612707|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307798|NCT03536884|39612708|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307799|NCT03536884|39612709|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307800|NCT03536884|39612710|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307801|NCT03536884|39612711|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
16307802|NCT03536884|39612700|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
16307803|NCT03536884|39612701|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
16307804|NCT03536884|39612702|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
16307805|NCT03536884|39612703|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
16307806|NCT03536884|39612704|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
16307807|NCT03536884|39612705|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
16307808|NCT03536884|39612706|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
16307809|NCT03536884|39612707|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
16307810|NCT03536884|39612708|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
16307811|NCT03536884|39612709|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
16307812|NCT03536884|39612710|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
16495439|NCT02846779|40284672|FG002|Overall Study|Less than 31 days of follow-up|52|||
16495440|NCT02051608|40284673|FG000|Part 1: Double Blind Treatment|Death|3|||
16495441|NCT02051608|40284674|FG001|Part 1: Double Blind Treatment|Death|3|||
16495442|NCT02051608|40284675|FG002|Part 1: Double Blind Treatment|Death|0|||
16495443|NCT02051608|40284676|FG003|Part 1: Double Blind Treatment|Death|0|||
16495444|NCT02051608|40284673|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
16495445|NCT02051608|40284674|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
16495446|NCT02051608|40284675|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
16495447|NCT02051608|40284676|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
16307813|NCT03536884|39612711|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
16307814|NCT03536884|39612700|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307815|NCT03536884|39612701|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
16307816|NCT03536884|39612702|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307817|NCT03536884|39612703|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307818|NCT03536884|39612704|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307819|NCT03536884|39612705|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307820|NCT03536884|39612706|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307821|NCT03536884|39612707|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307822|NCT03536884|39612708|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307823|NCT03536884|39612709|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307824|NCT03536884|39612710|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307825|NCT03536884|39612711|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
16307826|NCT03536884|39612700|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307827|NCT03536884|39612701|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
16307828|NCT03536884|39612702|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307829|NCT03536884|39612703|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307830|NCT03536884|39612704|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307831|NCT03536884|39612705|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307832|NCT03536884|39612706|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307833|NCT03536884|39612707|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307834|NCT03536884|39612708|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307835|NCT03536884|39612709|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307836|NCT03536884|39612710|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307837|NCT03536884|39612711|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
16307838|NCT03536884|39612700|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16307839|NCT03536884|39612701|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
16307840|NCT03536884|39612702|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16495448|NCT02051608|40284673|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
16495449|NCT02051608|40284674|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
16495450|NCT02051608|40284675|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
16495451|NCT02051608|40284676|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
16495452|NCT02051608|40284673|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
16495453|NCT02051608|40284674|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
16495454|NCT02051608|40284675|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
16495455|NCT02051608|40284676|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
16495456|NCT02051608|40284673|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
16495457|NCT02051608|40284674|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
16495458|NCT02051608|40284675|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
16495459|NCT02051608|40284676|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
16495460|NCT02051608|40284673|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
16495461|NCT02051608|40284674|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
16495462|NCT02051608|40284675|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
16495463|NCT02051608|40284676|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
16495464|NCT02051608|40284673|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
16495465|NCT02051608|40284674|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
16495466|NCT02051608|40284675|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
16495467|NCT02051608|40284676|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
16495468|NCT02051608|40284673|FG000|Part 1: Double Blind Treatment|Other|6|||
16495469|NCT02051608|40284674|FG001|Part 1: Double Blind Treatment|Other|3|||
16495470|NCT02051608|40284675|FG002|Part 1: Double Blind Treatment|Other|0|||
16495471|NCT02051608|40284676|FG003|Part 1: Double Blind Treatment|Other|0|||
16495472|NCT02051608|40284673|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
16495473|NCT02051608|40284674|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
16495474|NCT02051608|40284675|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
16495475|NCT02051608|40284676|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
16495476|NCT02051608|40284673|FG000|Part 2: Open-label Extension|Adverse Event|0|||
16495477|NCT02051608|40284674|FG001|Part 2: Open-label Extension|Adverse Event|0|||
16495478|NCT02051608|40284675|FG002|Part 2: Open-label Extension|Adverse Event|6|||
16495479|NCT02051608|40284676|FG003|Part 2: Open-label Extension|Adverse Event|8|||
16495480|NCT02051608|40284673|FG000|Part 2: Open-label Extension|Death|0|||
16495481|NCT02051608|40284674|FG001|Part 2: Open-label Extension|Death|0|||
16495482|NCT02051608|40284675|FG002|Part 2: Open-label Extension|Death|7|||
16495483|NCT02051608|40284676|FG003|Part 2: Open-label Extension|Death|4|||
16495484|NCT02051608|40284673|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
16495485|NCT02051608|40284674|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
16307841|NCT03536884|39612703|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16307842|NCT03536884|39612704|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16307843|NCT03536884|39612705|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16307844|NCT03536884|39612706|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16307845|NCT03536884|39612707|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16307846|NCT03536884|39612708|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16307847|NCT03536884|39612709|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16307848|NCT03536884|39612710|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16307849|NCT03536884|39612711|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
16307850|NCT03536884|39612700|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
16307851|NCT03536884|39612701|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
16307852|NCT03536884|39612702|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
16307853|NCT03536884|39612703|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
16307854|NCT03536884|39612704|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
16307855|NCT03536884|39612705|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
16307856|NCT03536884|39612706|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
16307857|NCT03536884|39612707|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
16307858|NCT03536884|39612708|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
16307859|NCT03536884|39612709|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
16307860|NCT03536884|39612710|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
16307861|NCT03536884|39612711|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
16307862|NCT03536884|39612700|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
16307863|NCT03536884|39612701|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
16307864|NCT03536884|39612702|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
16307865|NCT03536884|39612703|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
16307866|NCT03536884|39612704|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
16307867|NCT03536884|39612705|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
16307868|NCT03536884|39612706|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
16307869|NCT03536884|39612707|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
16307870|NCT03536884|39612708|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
16307871|NCT03536884|39612709|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
16307872|NCT03536884|39612710|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
16307873|NCT03536884|39612711|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
16307874|NCT03536884|39612700|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
16307875|NCT03536884|39612701|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
16307876|NCT03536884|39612702|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
16307877|NCT03536884|39612703|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
16307878|NCT03536884|39612704|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
16307879|NCT03536884|39612705|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
16307880|NCT03536884|39612706|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
16307881|NCT03536884|39612707|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
16307882|NCT03536884|39612708|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
16495486|NCT02051608|40284675|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
16085339|NCT00109031|38806821|FG000|Overall Study|Adverse Event|0|||
16085340|NCT00109031|38806822|FG001|Overall Study|Adverse Event|0|||
16085341|NCT00109031|38806823|FG002|Overall Study|Adverse Event|1|||
16085342|NCT00109031|38806824|FG003|Overall Study|Adverse Event|0|||
16085343|NCT00109031|38806821|FG000|Overall Study|Withdrawal by Subject|0|||
16085344|NCT00109031|38806822|FG001|Overall Study|Withdrawal by Subject|1|||
16085345|NCT00109031|38806823|FG002|Overall Study|Withdrawal by Subject|0|||
16085346|NCT00109031|38806824|FG003|Overall Study|Withdrawal by Subject|0|||
16085347|NCT00109031|38806821|FG000|Overall Study|Physician Decision|0|||
16085348|NCT00109031|38806822|FG001|Overall Study|Physician Decision|1|||
16085349|NCT00109031|38806823|FG002|Overall Study|Physician Decision|0|||
16085350|NCT00109031|38806824|FG003|Overall Study|Physician Decision|0|||
16085351|NCT00109031|38806821|FG000|Overall Study|Protocol Violation|0|||
16085352|NCT00109031|38806822|FG001|Overall Study|Protocol Violation|0|||
16085353|NCT00109031|38806823|FG002|Overall Study|Protocol Violation|1|||
16085354|NCT00109031|38806824|FG003|Overall Study|Protocol Violation|0|||
16085355|NCT01429285|38806829|FG000|Overall Study|Protocol Violation|9|||
16085356|NCT01429285|38806830|FG001|Overall Study|Protocol Violation|4|||
16085357|NCT01429285|38806829|FG000|Overall Study|Missing Data|5|||
16085358|NCT01429285|38806830|FG001|Overall Study|Missing Data|3|||
16085359|NCT01429285|38806829|FG000|Overall Study|Erroneously Enrolled Twice|8|||
16085360|NCT01429285|38806830|FG001|Overall Study|Erroneously Enrolled Twice|2|||
16085361|NCT04250636|38806831|FG000|Overall Study|Lost to Follow-up|2|||
16085362|NCT00683800|38806839|FG000|Overall Study|Adverse Event|195|||
16085363|NCT00683800|38806840|FG001|Overall Study|Adverse Event|102|||
16085364|NCT00683800|38806839|FG000|Overall Study|Death|0|||
16085365|NCT00683800|38806840|FG001|Overall Study|Death|1|||
16085366|NCT00683800|38806839|FG000|Overall Study|Lost to Follow-up|57|||
16085367|NCT00683800|38806840|FG001|Overall Study|Lost to Follow-up|44|||
16085368|NCT00683800|38806839|FG000|Overall Study|Other|5|||
16085369|NCT00683800|38806840|FG001|Overall Study|Other|2|||
16085370|NCT00683800|38806839|FG000|Overall Study|Protocol Violation|13|||
16085371|NCT00683800|38806840|FG001|Overall Study|Protocol Violation|16|||
16085372|NCT00683800|38806839|FG000|Overall Study|Withdrawal by Subject|66|||
16085373|NCT00683800|38806840|FG001|Overall Study|Withdrawal by Subject|64|||
16085374|NCT00683800|38806839|FG000|Overall Study|Lack of Efficacy|61|||
16085375|NCT00683800|38806840|FG001|Overall Study|Lack of Efficacy|104|||
16085376|NCT00683800|38806839|FG000|Overall Study|Randomized, not treated|35|||
16085377|NCT00683800|38806840|FG001|Overall Study|Randomized, not treated|33|||
16085378|NCT01701401|38806841|FG000|Overall Study|Randomized But Not Treated|3|||
16085379|NCT01701401|38806842|FG001|Overall Study|Randomized But Not Treated|1|||
16085380|NCT01701401|38806843|FG002|Overall Study|Randomized But Not Treated|0|||
16085381|NCT01701401|38806844|FG003|Overall Study|Randomized But Not Treated|1|||
16085382|NCT01701401|38806841|FG000|Overall Study|Lost to Follow-up|5|||
16085383|NCT01701401|38806842|FG001|Overall Study|Lost to Follow-up|5|||
16085384|NCT01701401|38806843|FG002|Overall Study|Lost to Follow-up|1|||
16085385|NCT01701401|38806844|FG003|Overall Study|Lost to Follow-up|3|||
16085386|NCT01701401|38806841|FG000|Overall Study|Withdrew Consent|0|||
16085387|NCT01701401|38806842|FG001|Overall Study|Withdrew Consent|3|||
16085388|NCT01701401|38806843|FG002|Overall Study|Withdrew Consent|1|||
16085389|NCT01701401|38806844|FG003|Overall Study|Withdrew Consent|2|||
16085390|NCT01701401|38806841|FG000|Overall Study|Lack of Efficacy|1|||
16085391|NCT01701401|38806842|FG001|Overall Study|Lack of Efficacy|0|||
16085392|NCT01701401|38806843|FG002|Overall Study|Lack of Efficacy|2|||
16085393|NCT01701401|38806844|FG003|Overall Study|Lack of Efficacy|0|||
16085394|NCT01701401|38806841|FG000|Overall Study|Adverse Event|1|||
16085395|NCT01701401|38806842|FG001|Overall Study|Adverse Event|0|||
16085396|NCT01701401|38806843|FG002|Overall Study|Adverse Event|0|||
16085397|NCT01701401|38806844|FG003|Overall Study|Adverse Event|0|||
16085398|NCT01701401|38806841|FG000|Overall Study|Protocol Violation|0|||
16085399|NCT01701401|38806842|FG001|Overall Study|Protocol Violation|0|||
16085400|NCT01701401|38806843|FG002|Overall Study|Protocol Violation|1|||
16085401|NCT01701401|38806844|FG003|Overall Study|Protocol Violation|0|||
16085402|NCT02646618|38806856|FG000|Overall Study|Lost to Follow-up|10|||
16085403|NCT02646618|38806857|FG001|Overall Study|Lost to Follow-up|14|||
16085404|NCT03905512|38806858|FG000|Overall Study|Withdrawal by Subject|9|||
16085405|NCT03905512|38806859|FG001|Overall Study|Withdrawal by Subject|8|||
16085406|NCT03905512|38806858|FG000|Overall Study|Adverse Event|1|||
16085407|NCT03905512|38806859|FG001|Overall Study|Adverse Event|2|||
16085408|NCT03905512|38806858|FG000|Overall Study|Lost to Follow-up|4|||
16085409|NCT03905512|38806859|FG001|Overall Study|Lost to Follow-up|3|||
16085410|NCT03905512|38806858|FG000|Overall Study|Other than Specified|7|||
16085411|NCT03905512|38806859|FG001|Overall Study|Other than Specified|4|||
16085412|NCT00345046|38806860|FG000|Overall Study|Protocol Violation|1|||
16085413|NCT00345046|38806861|FG001|Overall Study|Protocol Violation|1|||
16085414|NCT00345046|38806862|FG002|Overall Study|Protocol Violation|2|||
16085415|NCT03333109|38806863|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
16085416|NCT03333109|38806864|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
16085417|NCT03333109|38806865|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
16085418|NCT03333109|38806863|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16085419|NCT03333109|38806864|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16085420|NCT03333109|38806865|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
16194037|NCT00006604|39188673|FG016|Overall Study|Other Reason|0|||
16307883|NCT03536884|39612709|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
16085421|NCT03333109|38806863|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
16085422|NCT03333109|38806864|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
16085423|NCT03333109|38806865|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
16085424|NCT03333109|38806863|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
16085425|NCT03333109|38806864|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
16085426|NCT03333109|38806865|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
16085427|NCT03333109|38806863|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
16085428|NCT03333109|38806864|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
16085429|NCT03333109|38806865|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
16085430|NCT03333109|38806863|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
16085431|NCT03333109|38806864|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
16085432|NCT03333109|38806865|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
16085433|NCT03333109|38806863|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
16085434|NCT03333109|38806864|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
16085435|NCT03333109|38806865|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
16085436|NCT03333109|38806863|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
16085437|NCT03333109|38806864|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
16085438|NCT03333109|38806865|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
16085439|NCT00523419|38806876|FG000|Overall Study|Adverse Event|1|||
16085440|NCT00523419|38806876|FG000|Overall Study|Withdrawal by Subject|1|||
16085441|NCT00523419|38806876|FG000|Overall Study|Physician Decision|2|||
16085442|NCT00523419|38806876|FG000|Overall Study|Progressive Disease|22|||
16085443|NCT00523419|38806876|FG000|Overall Study|Death due to Study Disease|4|||
16085444|NCT00523419|38806876|FG000|Overall Study|Death due to Adverse Event|2|||
16085445|NCT03257410|38806880|FG000|Overall Study|Adverse Event|2|||
16085446|NCT03257410|38806881|FG001|Overall Study|Adverse Event|3|||
16085447|NCT03257410|38806880|FG000|Overall Study|Protocol Violation|1|||
16085448|NCT03257410|38806881|FG001|Overall Study|Protocol Violation|2|||
16085449|NCT03257410|38806880|FG000|Overall Study|Lost to Follow-up|1|||
16085450|NCT03257410|38806881|FG001|Overall Study|Lost to Follow-up|0|||
16085451|NCT03257410|38806880|FG000|Overall Study|Withdrawal by Subject|1|||
16085452|NCT03257410|38806881|FG001|Overall Study|Withdrawal by Subject|2|||
16085453|NCT03257410|38806880|FG000|Overall Study|Physician Decision|1|||
16085454|NCT03257410|38806881|FG001|Overall Study|Physician Decision|1|||
16085455|NCT03257410|38806880|FG000|Overall Study|Renal transplantation|2|||
16085456|NCT03257410|38806881|FG001|Overall Study|Renal transplantation|0|||
16085457|NCT03257410|38806880|FG000|Overall Study|Switch to peritoneal dialysis|1|||
16085458|NCT03257410|38806881|FG001|Overall Study|Switch to peritoneal dialysis|0|||
16085459|NCT03257410|38806880|FG000|Overall Study|Death|3|||
16085460|NCT03257410|38806881|FG001|Overall Study|Death|2|||
16085461|NCT03257410|38806880|FG000|Overall Study|Change to another dialysis center|2|||
16085462|NCT03257410|38806881|FG001|Overall Study|Change to another dialysis center|2|||
16085463|NCT03257410|38806880|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
16085464|NCT03257410|38806881|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
16085465|NCT03257410|38806880|FG000|Overall Study|Miscellaneous|2|||
16085466|NCT03257410|38806881|FG001|Overall Study|Miscellaneous|2|||
16085467|NCT03257410|38806880|FG000|Overall Study|Other|0|||
16085468|NCT03257410|38806881|FG001|Overall Study|Other|1|||
16085469|NCT02652442|38806882|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
16085470|NCT02234141|38806883|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
16085471|NCT02234141|38806884|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
16307884|NCT03536884|39612710|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
16307885|NCT03536884|39612711|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
16307886|NCT03536884|39612700|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
16307887|NCT03536884|39612701|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
16307888|NCT03536884|39612702|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
16307889|NCT03536884|39612703|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
16085472|NCT02234141|38806885|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
16085473|NCT02234141|38806886|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
16085474|NCT02234141|38806887|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
16085475|NCT02234141|38806888|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
16085476|NCT02234141|38806889|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
16085477|NCT02234141|38806883|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16085478|NCT02234141|38806884|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
16085479|NCT02234141|38806885|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16085480|NCT02234141|38806886|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16085481|NCT02234141|38806887|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16085482|NCT02234141|38806888|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16085483|NCT02234141|38806889|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
16085484|NCT02234141|38806883|FG000|Treatment Period (24 Weeks)|Death|1|||
16085485|NCT02234141|38806884|FG001|Treatment Period (24 Weeks)|Death|2|||
16085486|NCT02234141|38806885|FG002|Treatment Period (24 Weeks)|Death|0|||
16085487|NCT02234141|38806886|FG003|Treatment Period (24 Weeks)|Death|1|||
16085488|NCT02234141|38806887|FG004|Treatment Period (24 Weeks)|Death|0|||
16085489|NCT02234141|38806888|FG005|Treatment Period (24 Weeks)|Death|0|||
16307890|NCT03536884|39612704|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
16307891|NCT03536884|39612705|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
16307892|NCT03536884|39612706|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
16307893|NCT03536884|39612707|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
16307894|NCT03536884|39612708|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
16307895|NCT03536884|39612709|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
16307896|NCT03536884|39612710|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
16307897|NCT03536884|39612711|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
16307898|NCT03536884|39612700|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
16495487|NCT02051608|40284676|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
16495488|NCT02051608|40284673|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
16495489|NCT02051608|40284674|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
16495490|NCT02051608|40284675|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
16495491|NCT02051608|40284676|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
16495492|NCT02051608|40284673|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
16495493|NCT02051608|40284674|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
16495494|NCT02051608|40284675|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
16495495|NCT02051608|40284676|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
16495496|NCT02051608|40284673|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
16495497|NCT02051608|40284674|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
16495498|NCT02051608|40284675|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
16495499|NCT02051608|40284676|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
16495500|NCT02051608|40284673|FG000|Part 2: Open-label Extension|Physician Decision|0|||
16495501|NCT02051608|40284674|FG001|Part 2: Open-label Extension|Physician Decision|0|||
16495502|NCT02051608|40284675|FG002|Part 2: Open-label Extension|Physician Decision|8|||
16495503|NCT02051608|40284676|FG003|Part 2: Open-label Extension|Physician Decision|5|||
16495504|NCT02051608|40284673|FG000|Part 2: Open-label Extension|Other|0|||
16495505|NCT02051608|40284674|FG001|Part 2: Open-label Extension|Other|0|||
16495506|NCT02051608|40284675|FG002|Part 2: Open-label Extension|Other|9|||
16495507|NCT02051608|40284676|FG003|Part 2: Open-label Extension|Other|9|||
16495508|NCT01585194|40284677|FG000|Overall Study|Withdrawal by Subject|1|||
16495509|NCT01585194|40284677|FG000|Overall Study|Physician Decision|2|||
16495510|NCT01585194|40284677|FG000|Overall Study|Lack of insurance|1|||
16085490|NCT02234141|38806889|FG006|Treatment Period (24 Weeks)|Death|0|||
16085491|NCT02234141|38806883|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
16085492|NCT02234141|38806884|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
16085493|NCT02234141|38806885|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
16085494|NCT02234141|38806886|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
16085495|NCT02234141|38806887|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
16495511|NCT00514540|40284678|FG000|First-Line Chemo|Withdrawal by Subject|1|||
16495512|NCT00514540|40284678|FG000|First-Line Chemo|Protocol Violation|7|||
16495513|NCT00514540|40284678|FG000|Second-Line|Physician/Patient Decision|31|||
16495514|NCT03454893|40284684|FG000|Overall Study|Study Terminated by the Sponsor|5|||
16495515|NCT03454893|40284684|FG000|Overall Study|Did not pass screening|4|||
16495516|NCT01996982|40284685|FG000|Overall Study|PI/team left institution|7|||
16495517|NCT03274440|40284688|FG000|Overall Study|Time commitment too great|1|||
16495518|NCT03274440|40284689|FG001|Overall Study|Time commitment too great|0|||
16495519|NCT03274440|40284690|FG002|Overall Study|Time commitment too great|0|||
16495520|NCT03274440|40284691|FG003|Overall Study|Time commitment too great|1|||
16495521|NCT03274440|40284692|FG004|Overall Study|Time commitment too great|0|||
16495522|NCT03274440|40284693|FG005|Overall Study|Time commitment too great|0|||
16495523|NCT02380677|40284694|FG000|Overall Study|Adverse Event|0|||
16495524|NCT02380677|40284695|FG001|Overall Study|Adverse Event|0|||
16495525|NCT02380677|40284696|FG002|Overall Study|Adverse Event|0|||
16495526|NCT02380677|40284697|FG003|Overall Study|Adverse Event|1|||
16495527|NCT02380677|40284698|FG004|Overall Study|Adverse Event|1|||
16495528|NCT02380677|40284699|FG005|Overall Study|Adverse Event|4|||
16495529|NCT02380677|40284700|FG006|Overall Study|Adverse Event|2|||
16495530|NCT02380677|40284701|FG007|Overall Study|Adverse Event|2|||
16495531|NCT02380677|40284702|FG008|Overall Study|Adverse Event|2|||
16495532|NCT02380677|40284703|FG009|Overall Study|Adverse Event|1|||
16495533|NCT02380677|40284704|FG010|Overall Study|Adverse Event|2|||
16495534|NCT02380677|40284705|FG011|Overall Study|Adverse Event|1|||
16495535|NCT02380677|40284694|FG000|Overall Study|Physician Decision|1|||
16495536|NCT02380677|40284695|FG001|Overall Study|Physician Decision|0|||
16085496|NCT02234141|38806888|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
16307899|NCT03536884|39612701|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
16495537|NCT02380677|40284696|FG002|Overall Study|Physician Decision|1|||
16495538|NCT02380677|40284697|FG003|Overall Study|Physician Decision|1|||
16495539|NCT02380677|40284698|FG004|Overall Study|Physician Decision|0|||
16409937|NCT02133664|39981835|FG001|Overall Study|Lost to Follow-up|1|||
16085497|NCT02234141|38806889|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
16194038|NCT04402008|39188674|FG000|Overall Study|Adverse Event|0|||
16085498|NCT02234141|38806883|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16194039|NCT04402008|39188675|FG001|Overall Study|Adverse Event|0|||
16307900|NCT03536884|39612702|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
16194040|NCT04402008|39188676|FG002|Overall Study|Adverse Event|0|||
16307901|NCT03536884|39612703|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
16307902|NCT03536884|39612704|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
16307903|NCT03536884|39612705|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
16307904|NCT03536884|39612706|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
16307905|NCT03536884|39612707|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
16307906|NCT03536884|39612708|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
16307907|NCT03536884|39612709|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
16307908|NCT03536884|39612710|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
16307909|NCT03536884|39612711|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
16307910|NCT03536884|39612700|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
16307911|NCT03536884|39612701|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
16307912|NCT03536884|39612702|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
16307913|NCT03536884|39612703|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
16307914|NCT03536884|39612704|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
16307915|NCT03536884|39612705|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
16307916|NCT03536884|39612706|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
16307917|NCT03536884|39612707|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
16307918|NCT03536884|39612708|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
16307919|NCT03536884|39612709|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
16307920|NCT03536884|39612710|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
16307921|NCT03536884|39612711|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
16307922|NCT03536884|39612700|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
16307923|NCT03536884|39612701|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
16307924|NCT03536884|39612702|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
16307925|NCT03536884|39612703|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
16307926|NCT03536884|39612704|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
16307927|NCT03536884|39612705|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
16307928|NCT03536884|39612706|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
16307929|NCT03536884|39612707|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
16307930|NCT03536884|39612708|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
16307931|NCT03536884|39612709|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
16307932|NCT03536884|39612710|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
16307933|NCT03536884|39612711|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
16307934|NCT03536884|39612700|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
16307935|NCT03536884|39612701|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
16307936|NCT03536884|39612702|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
16307937|NCT03536884|39612703|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
16307938|NCT03536884|39612704|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
16307939|NCT03536884|39612705|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
16307940|NCT03536884|39612706|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
16307941|NCT03536884|39612707|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
16307942|NCT03536884|39612708|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
16307943|NCT03536884|39612709|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
16307944|NCT03536884|39612710|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
16307945|NCT03536884|39612711|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
16307946|NCT03536884|39612700|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
16307947|NCT03536884|39612701|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
16307948|NCT03536884|39612702|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
16307949|NCT03536884|39612703|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
16307950|NCT03536884|39612704|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
16307951|NCT03536884|39612705|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
16307952|NCT03536884|39612706|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
16307953|NCT03536884|39612707|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
16307954|NCT03536884|39612708|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
16307955|NCT03536884|39612709|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
16307956|NCT03536884|39612710|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
16495540|NCT02380677|40284699|FG005|Overall Study|Physician Decision|0|||
16495541|NCT02380677|40284700|FG006|Overall Study|Physician Decision|0|||
16495542|NCT02380677|40284701|FG007|Overall Study|Physician Decision|0|||
16495543|NCT02380677|40284702|FG008|Overall Study|Physician Decision|0|||
16495544|NCT02380677|40284703|FG009|Overall Study|Physician Decision|0|||
16495545|NCT02380677|40284704|FG010|Overall Study|Physician Decision|0|||
16307957|NCT03536884|39612711|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
16307958|NCT03536884|39612700|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
16307959|NCT03536884|39612701|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
16495546|NCT02380677|40284705|FG011|Overall Study|Physician Decision|0|||
16495547|NCT02380677|40284694|FG000|Overall Study|Lack of Efficacy|0|||
16495548|NCT02380677|40284695|FG001|Overall Study|Lack of Efficacy|1|||
16495549|NCT02380677|40284696|FG002|Overall Study|Lack of Efficacy|2|||
16495550|NCT02380677|40284697|FG003|Overall Study|Lack of Efficacy|0|||
16495551|NCT02380677|40284698|FG004|Overall Study|Lack of Efficacy|4|||
16495552|NCT02380677|40284699|FG005|Overall Study|Lack of Efficacy|1|||
16495553|NCT02380677|40284700|FG006|Overall Study|Lack of Efficacy|1|||
16495554|NCT02380677|40284701|FG007|Overall Study|Lack of Efficacy|2|||
16495555|NCT02380677|40284702|FG008|Overall Study|Lack of Efficacy|2|||
16307960|NCT03536884|39612702|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
16307961|NCT03536884|39612703|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
16307962|NCT03536884|39612704|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
16307963|NCT03536884|39612705|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
16307964|NCT03536884|39612706|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
16307965|NCT03536884|39612707|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
16307966|NCT03536884|39612708|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
16307967|NCT03536884|39612709|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
16307968|NCT03536884|39612710|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
16307969|NCT03536884|39612711|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
16307970|NCT03536884|39612700|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307971|NCT03536884|39612701|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307972|NCT03536884|39612702|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307973|NCT03536884|39612703|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307974|NCT03536884|39612704|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307975|NCT03536884|39612705|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
16307976|NCT03536884|39612706|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307977|NCT03536884|39612707|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307978|NCT03536884|39612708|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307979|NCT03536884|39612709|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307980|NCT03536884|39612710|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307981|NCT03536884|39612711|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
16307982|NCT03536884|39612700|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307983|NCT03536884|39612701|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307984|NCT03536884|39612702|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307985|NCT03536884|39612703|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307986|NCT03536884|39612704|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307987|NCT03536884|39612705|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307988|NCT03536884|39612706|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
16307989|NCT03536884|39612707|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307990|NCT03536884|39612708|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307991|NCT03536884|39612709|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307992|NCT03536884|39612710|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307993|NCT03536884|39612711|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
16307994|NCT03536884|39612700|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16307995|NCT03536884|39612701|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16307996|NCT03536884|39612702|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16085499|NCT02234141|38806884|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
16085500|NCT02234141|38806885|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16085501|NCT02234141|38806886|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16085502|NCT02234141|38806887|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16085503|NCT02234141|38806888|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16085504|NCT02234141|38806889|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
16085505|NCT02234141|38806883|FG000|Long-Term Treatment Period|Death|0|||
16085506|NCT02234141|38806884|FG001|Long-Term Treatment Period|Death|0|||
16085507|NCT02234141|38806885|FG002|Long-Term Treatment Period|Death|0|||
16495556|NCT02380677|40284703|FG009|Overall Study|Lack of Efficacy|0|||
16495557|NCT02380677|40284704|FG010|Overall Study|Lack of Efficacy|2|||
16495558|NCT02380677|40284705|FG011|Overall Study|Lack of Efficacy|1|||
16495559|NCT02380677|40284694|FG000|Overall Study|Withdrawal by Subject|0|||
16495560|NCT02380677|40284695|FG001|Overall Study|Withdrawal by Subject|0|||
16495561|NCT02380677|40284696|FG002|Overall Study|Withdrawal by Subject|0|||
16495562|NCT02380677|40284697|FG003|Overall Study|Withdrawal by Subject|0|||
16495563|NCT02380677|40284698|FG004|Overall Study|Withdrawal by Subject|0|||
16085508|NCT02234141|38806886|FG003|Long-Term Treatment Period|Death|0|||
16085509|NCT02234141|38806887|FG004|Long-Term Treatment Period|Death|0|||
16085510|NCT02234141|38806888|FG005|Long-Term Treatment Period|Death|1|||
16085511|NCT02234141|38806889|FG006|Long-Term Treatment Period|Death|0|||
16085512|NCT02234141|38806883|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
16085513|NCT02234141|38806884|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
16085514|NCT02234141|38806885|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
16085515|NCT02234141|38806886|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
16085516|NCT02234141|38806887|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
16085517|NCT02234141|38806888|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
16085518|NCT02234141|38806889|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
16085519|NCT02234141|38806883|FG000|Long-Term Treatment Period|Adverse Event|4|||
16085520|NCT02234141|38806884|FG001|Long-Term Treatment Period|Adverse Event|0|||
16085521|NCT02234141|38806885|FG002|Long-Term Treatment Period|Adverse Event|5|||
16085522|NCT02234141|38806886|FG003|Long-Term Treatment Period|Adverse Event|0|||
16085523|NCT02234141|38806887|FG004|Long-Term Treatment Period|Adverse Event|1|||
16085524|NCT02234141|38806888|FG005|Long-Term Treatment Period|Adverse Event|1|||
16085525|NCT02234141|38806889|FG006|Long-Term Treatment Period|Adverse Event|1|||
16085526|NCT02234141|38806883|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
16085527|NCT02234141|38806884|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
16085528|NCT02234141|38806885|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
16085529|NCT02234141|38806886|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
16085530|NCT02234141|38806887|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
16085531|NCT02234141|38806888|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
16085532|NCT02234141|38806889|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
16085533|NCT02234141|38806883|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
16085534|NCT02234141|38806884|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
16085535|NCT02234141|38806885|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
16085536|NCT02234141|38806886|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
16085537|NCT02234141|38806887|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
16085538|NCT02234141|38806888|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
16085539|NCT02234141|38806889|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
16085540|NCT01340066|38806890|FG000|Placebo Run in Period|Screen Failures|27|||
16085541|NCT01340066|38806891|FG001|Placebo Run in Period|Screen Failures|0|||
16307997|NCT03536884|39612703|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16307998|NCT03536884|39612704|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16307999|NCT03536884|39612705|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16495564|NCT02380677|40284699|FG005|Overall Study|Withdrawal by Subject|0|||
16495565|NCT02380677|40284700|FG006|Overall Study|Withdrawal by Subject|0|||
16495566|NCT02380677|40284701|FG007|Overall Study|Withdrawal by Subject|0|||
16495567|NCT02380677|40284702|FG008|Overall Study|Withdrawal by Subject|0|||
16495568|NCT02380677|40284703|FG009|Overall Study|Withdrawal by Subject|1|||
16308000|NCT03536884|39612706|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
16308001|NCT03536884|39612707|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16308002|NCT03536884|39612708|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16308003|NCT03536884|39612709|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16308004|NCT03536884|39612710|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16308005|NCT03536884|39612711|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
16308006|NCT03536884|39612700|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
16308007|NCT03536884|39612701|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
16308008|NCT03536884|39612702|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
16308009|NCT03536884|39612703|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
16308010|NCT03536884|39612704|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
16495569|NCT02380677|40284704|FG010|Overall Study|Withdrawal by Subject|0|||
16085542|NCT01340066|38806892|FG002|Placebo Run in Period|Screen Failures|0|||
16085543|NCT01340066|38806890|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
16495570|NCT02380677|40284705|FG011|Overall Study|Withdrawal by Subject|3|||
16495571|NCT02380677|40284694|FG000|Overall Study|Other|0|||
16495572|NCT02380677|40284695|FG001|Overall Study|Other|0|||
16495573|NCT02380677|40284696|FG002|Overall Study|Other|0|||
16495574|NCT02380677|40284697|FG003|Overall Study|Other|1|||
16495575|NCT02380677|40284698|FG004|Overall Study|Other|1|||
16495576|NCT02380677|40284699|FG005|Overall Study|Other|1|||
16194041|NCT04402008|39188677|FG003|Overall Study|Adverse Event|1|||
16194042|NCT04402008|39188678|FG004|Overall Study|Adverse Event|0|||
16194043|NCT04402008|39188679|FG005|Overall Study|Adverse Event|0|||
16194044|NCT04402008|39188680|FG006|Overall Study|Adverse Event|0|||
16308011|NCT03536884|39612705|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
16308012|NCT03536884|39612706|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
16308013|NCT03536884|39612707|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
16308014|NCT03536884|39612708|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
16308015|NCT03536884|39612709|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
16308016|NCT03536884|39612710|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
16308017|NCT03536884|39612711|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
16308018|NCT03536884|39612700|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308019|NCT03536884|39612701|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308020|NCT03536884|39612702|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308021|NCT03536884|39612703|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308022|NCT03536884|39612704|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308023|NCT03536884|39612705|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308024|NCT03536884|39612706|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308025|NCT03536884|39612707|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308026|NCT03536884|39612708|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
16308027|NCT03536884|39612709|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308028|NCT03536884|39612710|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308029|NCT03536884|39612711|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
16308030|NCT03536884|39612700|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
16308031|NCT03536884|39612701|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
16308032|NCT03536884|39612702|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
16308033|NCT03536884|39612703|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
16308034|NCT03536884|39612704|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
16308035|NCT03536884|39612705|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
16308036|NCT03536884|39612706|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
16308037|NCT03536884|39612707|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
16308038|NCT03536884|39612708|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
16308039|NCT03536884|39612709|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
16308040|NCT03536884|39612710|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
16308041|NCT03536884|39612711|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
16308042|NCT03536884|39612700|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
16308043|NCT03536884|39612701|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
16308044|NCT03536884|39612702|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
16308045|NCT03536884|39612703|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
16308046|NCT03536884|39612704|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
16308047|NCT03536884|39612705|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
16308048|NCT03536884|39612706|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
16308049|NCT03536884|39612707|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
16308050|NCT03536884|39612708|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
16308051|NCT03536884|39612709|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
16308052|NCT03536884|39612710|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
16308053|NCT03536884|39612711|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
16308054|NCT03536884|39612700|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16308055|NCT03536884|39612701|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16308056|NCT03536884|39612702|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16308057|NCT03536884|39612703|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16308058|NCT03536884|39612704|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16308059|NCT03536884|39612705|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16308060|NCT03536884|39612706|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16308061|NCT03536884|39612707|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16308062|NCT03536884|39612708|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16308063|NCT03536884|39612709|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16346322|NCT03201965|39753288|FG001|Overall Study|Withdrawal by Subject|13|||
16495577|NCT02380677|40284700|FG006|Overall Study|Other|0|||
16194045|NCT04402008|39188674|FG000|Overall Study|Disease Progression|3|||
16194046|NCT04402008|39188675|FG001|Overall Study|Disease Progression|2|||
16085544|NCT01340066|38806891|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
16085545|NCT01340066|38806892|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
16495578|NCT02380677|40284701|FG007|Overall Study|Other|0|||
16495579|NCT02380677|40284702|FG008|Overall Study|Other|0|||
16495580|NCT02380677|40284703|FG009|Overall Study|Other|0|||
16495581|NCT02380677|40284704|FG010|Overall Study|Other|0|||
16495582|NCT02380677|40284705|FG011|Overall Study|Other|0|||
16495583|NCT01342796|40284706|FG000|Overall Study|Withdrawal by Subject|2|||
16495584|NCT01342796|40284707|FG001|Overall Study|Withdrawal by Subject|0|||
16495585|NCT01342796|40284706|FG000|Overall Study|Lost to Follow-up|0|||
16495586|NCT01342796|40284707|FG001|Overall Study|Lost to Follow-up|3|||
16495587|NCT01342796|40284706|FG000|Overall Study|Inappropriate enrollment|1|||
16495588|NCT01342796|40284707|FG001|Overall Study|Inappropriate enrollment|0|||
16495589|NCT01074450|40284710|FG000|First Intervention|Emesis in Dosing Interval|0|||
16495590|NCT01074450|40284711|FG001|First Intervention|Emesis in Dosing Interval|2|||
16495591|NCT01074450|40284710|FG000|Second Intervention|Protocol Violation|1|||
16495592|NCT01074450|40284711|FG001|Second Intervention|Protocol Violation|0|||
16495593|NCT01074450|40284710|FG000|Second Intervention|Physician Decision|0|||
16495594|NCT01074450|40284711|FG001|Second Intervention|Physician Decision|1|||
16495595|NCT00296374|40284712|FG000|Overall Study|Adverse Event|14|||
16495596|NCT00296374|40284713|FG001|Overall Study|Adverse Event|10|||
16495597|NCT00296374|40284714|FG002|Overall Study|Adverse Event|7|||
16495598|NCT00296374|40284712|FG000|Overall Study|Withdrawal by Subject|3|||
16495599|NCT00296374|40284713|FG001|Overall Study|Withdrawal by Subject|5|||
16495600|NCT00296374|40284714|FG002|Overall Study|Withdrawal by Subject|11|||
16495601|NCT00296374|40284712|FG000|Overall Study|Incorrect enrollment|3|||
16495602|NCT00296374|40284713|FG001|Overall Study|Incorrect enrollment|3|||
16495603|NCT00296374|40284714|FG002|Overall Study|Incorrect enrollment|4|||
16495604|NCT00296374|40284712|FG000|Overall Study|Protocol Violation|1|||
16495605|NCT00296374|40284713|FG001|Overall Study|Protocol Violation|2|||
16495606|NCT00296374|40284714|FG002|Overall Study|Protocol Violation|3|||
16495607|NCT00296374|40284712|FG000|Overall Study|Lost to Follow-up|3|||
16495608|NCT00296374|40284713|FG001|Overall Study|Lost to Follow-up|1|||
16495609|NCT00296374|40284714|FG002|Overall Study|Lost to Follow-up|1|||
16495610|NCT00296374|40284712|FG000|Overall Study|Relocated to another state|1|||
16495611|NCT00296374|40284713|FG001|Overall Study|Relocated to another state|0|||
16495612|NCT00296374|40284714|FG002|Overall Study|Relocated to another state|0|||
16495613|NCT00296374|40284712|FG000|Overall Study|Stopped drug before end of study visit|0|||
16495614|NCT00296374|40284713|FG001|Overall Study|Stopped drug before end of study visit|1|||
16495615|NCT00296374|40284714|FG002|Overall Study|Stopped drug before end of study visit|0|||
16495616|NCT00296374|40284712|FG000|Overall Study|Nephrologist introduced ACE|0|||
16495617|NCT00296374|40284713|FG001|Overall Study|Nephrologist introduced ACE|1|||
16495618|NCT00296374|40284714|FG002|Overall Study|Nephrologist introduced ACE|0|||
16495619|NCT00296374|40284712|FG000|Overall Study|Pregnancy|0|||
16495620|NCT00296374|40284713|FG001|Overall Study|Pregnancy|0|||
16495621|NCT00296374|40284714|FG002|Overall Study|Pregnancy|2|||
16495622|NCT00296374|40284712|FG000|Overall Study|Other|0|||
16495623|NCT00296374|40284713|FG001|Overall Study|Other|0|||
16495624|NCT00296374|40284714|FG002|Overall Study|Other|1|||
16085546|NCT01340066|38806890|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
16085547|NCT01340066|38806891|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
16085548|NCT01340066|38806892|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
16085549|NCT01340066|38806890|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
16085550|NCT01340066|38806891|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
16085551|NCT01340066|38806892|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
16085552|NCT00822900|38806895|FG000|Overall Study|Withdrawal by Subject|14|||
16085553|NCT00822900|38806896|FG001|Overall Study|Withdrawal by Subject|14|||
16085554|NCT00822900|38806895|FG000|Overall Study|Lost to Follow-up|9|||
16085555|NCT00822900|38806896|FG001|Overall Study|Lost to Follow-up|9|||
16085556|NCT00822900|38806895|FG000|Overall Study|Death|83|||
16085557|NCT00822900|38806896|FG001|Overall Study|Death|69|||
16085558|NCT00822900|38806895|FG000|Overall Study|Became a ward of the state|2|||
16085559|NCT00822900|38806896|FG001|Overall Study|Became a ward of the state|1|||
16085560|NCT00727909|38806897|FG000|Overall Study|Withdrawal by Subject|5|||
16085561|NCT00727909|38806898|FG001|Overall Study|Withdrawal by Subject|11|||
16085562|NCT00727909|38806899|FG002|Overall Study|Withdrawal by Subject|8|||
16085563|NCT00727909|38806900|FG003|Overall Study|Withdrawal by Subject|5|||
16085564|NCT00727909|38806897|FG000|Overall Study|Death|0|||
16495625|NCT00166114|40284724|FG000|Overall Study|Protocol Violation|2|||
16495626|NCT00166114|40284725|FG001|Overall Study|Protocol Violation|1|||
16495627|NCT00166114|40284724|FG000|Overall Study|Withdrawal by Subject|10|||
16495628|NCT00166114|40284725|FG001|Overall Study|Withdrawal by Subject|4|||
16495629|NCT00166114|40284724|FG000|Overall Study|Adverse Event|2|||
16085565|NCT00727909|38806898|FG001|Overall Study|Death|0|||
16085566|NCT00727909|38806899|FG002|Overall Study|Death|1|||
16495630|NCT00166114|40284725|FG001|Overall Study|Adverse Event|1|||
16495631|NCT01937559|40284726|FG000|Overall Study|Physician Decision|3|||
16495632|NCT01937559|40284727|FG001|Overall Study|Physician Decision|3|||
16495633|NCT01937559|40284728|FG002|Overall Study|Physician Decision|0|||
16495634|NCT01937559|40284726|FG000|Overall Study|Withdrawal by Subject|6|||
16495635|NCT01937559|40284727|FG001|Overall Study|Withdrawal by Subject|4|||
16495636|NCT01937559|40284728|FG002|Overall Study|Withdrawal by Subject|0|||
16495637|NCT01937559|40284726|FG000|Overall Study|screen fail|2|||
16495638|NCT01937559|40284727|FG001|Overall Study|screen fail|4|||
16495639|NCT01937559|40284728|FG002|Overall Study|screen fail|0|||
16495640|NCT01829230|40284729|FG000|Overall Study|Protocol Violation|0|||
16495641|NCT01829230|40284730|FG001|Overall Study|Protocol Violation|2|||
16495642|NCT01829230|40284729|FG000|Overall Study|Withdrawal by Subject|0|||
16495643|NCT01829230|40284730|FG001|Overall Study|Withdrawal by Subject|1|||
16495644|NCT01829230|40284729|FG000|Overall Study|Lost to Follow-up|1|||
16495645|NCT01829230|40284730|FG001|Overall Study|Lost to Follow-up|1|||
16495646|NCT00837811|40284731|FG000|Overall Study|Adverse Event|4|||
16495647|NCT00837811|40284732|FG001|Overall Study|Adverse Event|6|||
16495648|NCT00837811|40284733|FG002|Overall Study|Adverse Event|0|||
16495649|NCT00837811|40284731|FG000|Overall Study|Death|1|||
16495650|NCT00837811|40284732|FG001|Overall Study|Death|1|||
16495651|NCT00837811|40284733|FG002|Overall Study|Death|0|||
16495652|NCT00837811|40284731|FG000|Overall Study|Lack of Efficacy|0|||
16495653|NCT00837811|40284732|FG001|Overall Study|Lack of Efficacy|11|||
16495654|NCT00837811|40284733|FG002|Overall Study|Lack of Efficacy|0|||
16495655|NCT00837811|40284731|FG000|Overall Study|Lost to Follow-up|1|||
16495656|NCT00837811|40284732|FG001|Overall Study|Lost to Follow-up|3|||
16495657|NCT00837811|40284733|FG002|Overall Study|Lost to Follow-up|0|||
16495658|NCT00837811|40284731|FG000|Overall Study|Physician Decision|0|||
16495659|NCT00837811|40284732|FG001|Overall Study|Physician Decision|2|||
16495660|NCT00837811|40284733|FG002|Overall Study|Physician Decision|1|||
16495661|NCT00837811|40284731|FG000|Overall Study|Withdrawal by Subject|1|||
16495662|NCT00837811|40284732|FG001|Overall Study|Withdrawal by Subject|9|||
16495663|NCT00837811|40284733|FG002|Overall Study|Withdrawal by Subject|0|||
16495664|NCT00837811|40284731|FG000|Overall Study|Sponsor Decision|0|||
16495665|NCT00837811|40284732|FG001|Overall Study|Sponsor Decision|2|||
16495666|NCT00837811|40284733|FG002|Overall Study|Sponsor Decision|0|||
16495667|NCT03462082|40284734|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
16495668|NCT03462082|40284735|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
16495669|NCT03462082|40284736|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
16495670|NCT03462082|40284737|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
16495671|NCT03462082|40284738|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
16495672|NCT03462082|40284739|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
16495673|NCT03462082|40284740|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
16495674|NCT03462082|40284741|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
16495675|NCT00267046|40284745|FG000|Overall Study|Disease progression|4|||
16495676|NCT00267046|40284746|FG001|Overall Study|Disease progression|2|||
16495677|NCT00267046|40284745|FG000|Overall Study|Chemotoxicity|2|||
16495678|NCT00267046|40284746|FG001|Overall Study|Chemotoxicity|0|||
16495679|NCT00267046|40284745|FG000|Overall Study|Open-label palifermin|2|||
16495680|NCT00267046|40284746|FG001|Overall Study|Open-label palifermin|7|||
16495681|NCT00267046|40284745|FG000|Overall Study|Surgery|3|||
16495682|NCT00267046|40284746|FG001|Overall Study|Surgery|1|||
16194047|NCT04402008|39188676|FG002|Overall Study|Disease Progression|3|||
16194048|NCT04402008|39188677|FG003|Overall Study|Disease Progression|3|||
16308064|NCT03536884|39612710|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
16308065|NCT03536884|39612711|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
16308066|NCT03536884|39612700|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16308067|NCT03536884|39612701|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16308068|NCT03536884|39612702|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16308069|NCT03536884|39612703|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16308070|NCT03536884|39612704|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16308071|NCT03536884|39612705|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16308072|NCT03536884|39612706|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16308073|NCT03536884|39612707|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16308074|NCT03536884|39612708|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16409938|NCT02133664|39981834|FG000|Overall Study|Adverse Event|3|||
16495683|NCT00267046|40284745|FG000|Overall Study|Withdrawal by Subject|1|||
16085567|NCT00727909|38806900|FG003|Overall Study|Death|0|||
16495684|NCT00267046|40284746|FG001|Overall Study|Withdrawal by Subject|0|||
16495685|NCT00267046|40284745|FG000|Overall Study|Radiation|0|||
16495686|NCT00267046|40284746|FG001|Overall Study|Radiation|1|||
16495687|NCT01029795|40284753|FG000|Overall Study|Entry Criteria Not Met|2|||
16495688|NCT01029795|40284754|FG001|Overall Study|Entry Criteria Not Met|1|||
16495689|NCT01029795|40284753|FG000|Overall Study|Physician Decision|2|||
16085568|NCT03689946|38806901|FG000|Overall Study|Withdrawal by Subject|3|||
16308075|NCT03536884|39612709|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16308076|NCT03536884|39612710|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
16308077|NCT03536884|39612711|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
16308078|NCT03536884|39612700|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308079|NCT03536884|39612701|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308080|NCT03536884|39612702|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308081|NCT03536884|39612703|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308082|NCT03536884|39612704|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308083|NCT03536884|39612705|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308084|NCT03536884|39612706|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308085|NCT03536884|39612707|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308086|NCT03536884|39612708|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308087|NCT03536884|39612709|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308088|NCT03536884|39612710|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
16308089|NCT03536884|39612711|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
16308090|NCT02861014|39612712|FG000|Primary Analysis|Adverse Event|7|||
16308091|NCT02861014|39612712|FG000|Primary Analysis|Death|1|||
16308092|NCT02861014|39612712|FG000|Primary Analysis|Lack of Efficacy|3|||
16308093|NCT02861014|39612712|FG000|Primary Analysis|Physician Decision|2|||
16308094|NCT02861014|39612712|FG000|Primary Analysis|Pregnancy|4|||
16308095|NCT02861014|39612712|FG000|Primary Analysis|Protocol Violation|2|||
16308096|NCT02861014|39612712|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
16308097|NCT02861014|39612712|FG000|Primary Analysis|Withdrawal by Subject|14|||
16308098|NCT02861014|39612712|FG000|Primary Analysis|Commercial ocrelizumab|3|||
16308099|NCT02861014|39612712|FG000|Safety Follow-up|Adverse Event|1|||
16308100|NCT02861014|39612712|FG000|Safety Follow-up|Pregnancy|1|||
16308101|NCT02861014|39612712|FG000|Safety Follow-up|Withdrawal by Subject|9|||
16308102|NCT02861014|39612712|FG000|Safety Follow-up|Study terminated by sponsor|1|||
16308103|NCT02861014|39612712|FG000|Safety Follow-up|Physician Decision|1|||
16308104|NCT02861014|39612712|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
16308105|NCT02861014|39612712|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
16308106|NCT01459783|39612715|FG000|Baseline to 6 Months|Death|1|||
16308107|NCT01459783|39612716|FG001|Baseline to 6 Months|Death|0|||
16308108|NCT01459783|39612715|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
16308109|NCT01459783|39612716|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
16085569|NCT03689946|38806901|FG000|Overall Study|Lost to Follow-up|3|||
16085570|NCT03689946|38806901|FG000|Overall Study|Data corruption|2|||
16085571|NCT03739866|38806902|FG000|Overall Study|Lost to Follow-up|0|||
16085572|NCT03739866|38806903|FG001|Overall Study|Lost to Follow-up|0|||
16085573|NCT03739866|38806904|FG002|Overall Study|Lost to Follow-up|0|||
16085574|NCT03739866|38806905|FG003|Overall Study|Lost to Follow-up|1|||
16085575|NCT03739866|38806906|FG004|Overall Study|Lost to Follow-up|0|||
16085576|NCT03739866|38806907|FG005|Overall Study|Lost to Follow-up|0|||
16085577|NCT03739866|38806908|FG006|Overall Study|Lost to Follow-up|0|||
16085578|NCT03739866|38806909|FG007|Overall Study|Lost to Follow-up|0|||
16085579|NCT03739866|38806902|FG000|Overall Study|Enrolled but not treated|0|||
16085580|NCT03739866|38806903|FG001|Overall Study|Enrolled but not treated|0|||
16495690|NCT01029795|40284754|FG001|Overall Study|Physician Decision|1|||
16495691|NCT01029795|40284753|FG000|Overall Study|Sponsor Decision|11|||
16495692|NCT01029795|40284754|FG001|Overall Study|Sponsor Decision|17|||
16495693|NCT01029795|40284753|FG000|Overall Study|Withdrawal by Subject|1|||
16495694|NCT01029795|40284754|FG001|Overall Study|Withdrawal by Subject|3|||
16495695|NCT00667368|40284757|FG000|Overall Study|Lost to Follow-up|176|||
16495696|NCT00667368|40284758|FG001|Overall Study|Lost to Follow-up|155|||
16495697|NCT00667368|40284757|FG000|Overall Study|Discontinued early|24|||
16495698|NCT00667368|40284758|FG001|Overall Study|Discontinued early|17|||
16495699|NCT00911820|40284761|FG000|Overall Study|RECIST progression|12|||
16495700|NCT00911820|40284762|FG001|Overall Study|RECIST progression|8|||
16495701|NCT00911820|40284761|FG000|Overall Study|Adverse Event|8|||
16495702|NCT00911820|40284762|FG001|Overall Study|Adverse Event|8|||
16495703|NCT00911820|40284761|FG000|Overall Study|Clinical Progression|7|||
16495704|NCT00911820|40284762|FG001|Overall Study|Clinical Progression|5|||
16495705|NCT00911820|40284761|FG000|Overall Study|Physician Decision|5|||
16495706|NCT00911820|40284762|FG001|Overall Study|Physician Decision|9|||
16495707|NCT00911820|40284761|FG000|Overall Study|Decline in Performance Status|4|||
16495708|NCT00911820|40284762|FG001|Overall Study|Decline in Performance Status|2|||
16495709|NCT00911820|40284761|FG000|Overall Study|Withdrawal by Subject|3|||
16495710|NCT00911820|40284762|FG001|Overall Study|Withdrawal by Subject|4|||
16495711|NCT00911820|40284761|FG000|Overall Study|Death|1|||
16495712|NCT00911820|40284762|FG001|Overall Study|Death|2|||
16495713|NCT00911820|40284761|FG000|Overall Study|Pursue surgery|1|||
16495714|NCT00911820|40284762|FG001|Overall Study|Pursue surgery|1|||
16495715|NCT00911820|40284761|FG000|Overall Study|Pursue Radiation|1|||
16495716|NCT00911820|40284762|FG001|Overall Study|Pursue Radiation|0|||
16495717|NCT00911820|40284761|FG000|Overall Study|Still on Therapy|2|||
16495718|NCT00911820|40284762|FG001|Overall Study|Still on Therapy|2|||
16495719|NCT00911820|40284761|FG000|Overall Study|Pathology Not Confirmed|1|||
16495720|NCT00911820|40284762|FG001|Overall Study|Pathology Not Confirmed|0|||
16495721|NCT00911820|40284761|FG000|Overall Study|Withdraw before Receive Treatment|0|||
16495722|NCT00911820|40284762|FG001|Overall Study|Withdraw before Receive Treatment|2|||
16495723|NCT03716024|40284763|FG000|Overall Study|Randomized, not Treated|7|||
16495724|NCT03716024|40284764|FG001|Overall Study|Randomized, not Treated|8|||
16495725|NCT03716024|40284763|FG000|Overall Study|Adverse Event|1|||
16495726|NCT03716024|40284764|FG001|Overall Study|Adverse Event|2|||
16495727|NCT03716024|40284763|FG000|Overall Study|Treatment Failure|1|||
16495728|NCT03716024|40284764|FG001|Overall Study|Treatment Failure|0|||
16495729|NCT03716024|40284763|FG000|Overall Study|Lost to Follow-up|2|||
16308110|NCT01459783|39612715|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
16495730|NCT03716024|40284764|FG001|Overall Study|Lost to Follow-up|6|||
16495731|NCT03716024|40284763|FG000|Overall Study|Withdrawal by Subject|0|||
16308111|NCT01459783|39612716|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
16308112|NCT01459783|39612715|FG000|6 Months to 12 Months|Death|0|||
16308113|NCT01459783|39612716|FG001|6 Months to 12 Months|Death|1|||
16308114|NCT01459783|39612715|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
16308115|NCT01459783|39612716|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
16308116|NCT01459783|39612715|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
16495732|NCT03716024|40284764|FG001|Overall Study|Withdrawal by Subject|1|||
16495733|NCT03716024|40284763|FG000|Overall Study|Missing Reason|0|||
16495734|NCT03716024|40284764|FG001|Overall Study|Missing Reason|1|||
16495735|NCT04557371|40284765|FG000|Overall Study|Covid-19-related|0|||
16495736|NCT04557371|40284766|FG001|Overall Study|Covid-19-related|1|||
16495737|NCT04557371|40284767|FG002|Overall Study|Covid-19-related|0|||
16495738|NCT04557371|40284765|FG000|Overall Study|Withdrawal by Subject|0|||
16495739|NCT04557371|40284766|FG001|Overall Study|Withdrawal by Subject|1|||
16308117|NCT01459783|39612716|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
16495740|NCT04557371|40284767|FG002|Overall Study|Withdrawal by Subject|0|||
16495741|NCT04557371|40284765|FG000|Overall Study|Adverse Event|1|||
16495742|NCT04557371|40284766|FG001|Overall Study|Adverse Event|0|||
16085581|NCT03739866|38806904|FG002|Overall Study|Enrolled but not treated|1|||
16085582|NCT03739866|38806905|FG003|Overall Study|Enrolled but not treated|0|||
16085583|NCT03739866|38806906|FG004|Overall Study|Enrolled but not treated|1|||
16085584|NCT03739866|38806907|FG005|Overall Study|Enrolled but not treated|0|||
16085585|NCT03739866|38806908|FG006|Overall Study|Enrolled but not treated|0|||
16085586|NCT03739866|38806909|FG007|Overall Study|Enrolled but not treated|0|||
16085587|NCT02432274|38806916|FG000|Overall Study|Death|2|||
16085588|NCT02432274|38806917|FG001|Overall Study|Death|6|||
16308118|NCT01459783|39612715|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
16308119|NCT01459783|39612716|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
16308120|NCT00344448|39612719|FG000|Screening|Withdrawal by Subject|0|||
16308121|NCT00344448|39612720|FG001|Screening|Withdrawal by Subject|1|||
16308122|NCT00344448|39612719|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
16308123|NCT00344448|39612720|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
16308124|NCT00344448|39612719|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
16308125|NCT00344448|39612720|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
16308126|NCT00344448|39612719|FG000|Open Label|Withdrawal by Subject|1|||
16308127|NCT00344448|39612720|FG001|Open Label|Withdrawal by Subject|1|||
16308128|NCT00344448|39612719|FG000|Open Label|Study terminated|1|||
16308129|NCT00344448|39612720|FG001|Open Label|Study terminated|0|||
16308130|NCT01401452|39612721|FG000|Overall Study|Adverse reaction|9|||
16085589|NCT02432274|38806918|FG002|Overall Study|Death|7|||
16085590|NCT02432274|38806919|FG003|Overall Study|Death|0|||
16085591|NCT02432274|38806920|FG004|Overall Study|Death|27|||
16085592|NCT02432274|38806921|FG005|Overall Study|Death|7|||
16085593|NCT02432274|38806922|FG006|Overall Study|Death|9|||
16085594|NCT02432274|38806923|FG007|Overall Study|Death|14|||
16085595|NCT02432274|38806916|FG000|Overall Study|Withdrawal of Consent|0|||
16085596|NCT02432274|38806917|FG001|Overall Study|Withdrawal of Consent|0|||
16085597|NCT02432274|38806918|FG002|Overall Study|Withdrawal of Consent|0|||
16085598|NCT02432274|38806919|FG003|Overall Study|Withdrawal of Consent|0|||
16085599|NCT02432274|38806920|FG004|Overall Study|Withdrawal of Consent|2|||
16085600|NCT02432274|38806921|FG005|Overall Study|Withdrawal of Consent|0|||
16085601|NCT02432274|38806922|FG006|Overall Study|Withdrawal of Consent|1|||
16085602|NCT02432274|38806923|FG007|Overall Study|Withdrawal of Consent|2|||
16085603|NCT00753545|38806927|FG000|Overall Study|Death|98|||
16085604|NCT00753545|38806928|FG001|Overall Study|Death|112|||
16085605|NCT00753545|38806927|FG000|Overall Study|Lost to Follow-up|2|||
16085606|NCT00753545|38806928|FG001|Overall Study|Lost to Follow-up|3|||
16085607|NCT00753545|38806927|FG000|Overall Study|Protocol Violation|1|||
16085608|NCT00753545|38806928|FG001|Overall Study|Protocol Violation|0|||
16085609|NCT00753545|38806927|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
16085610|NCT00753545|38806928|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
16085611|NCT02235298|38806929|FG000|Overall Study|Lost to Follow-up|6|||
16495743|NCT04557371|40284767|FG002|Overall Study|Adverse Event|0|||
16085612|NCT02235298|38806930|FG001|Overall Study|Lost to Follow-up|5|||
16085613|NCT02235298|38806929|FG000|Overall Study|Adverse Event|2|||
16388234|NCT02185534|39905611|FG002|First Period|Withdrawal by Subject|0|||
16495744|NCT00684307|40284774|FG000|Overall Study|Adverse Event|11|||
16495745|NCT00684307|40284775|FG001|Overall Study|Adverse Event|6|||
16495746|NCT00684307|40284776|FG002|Overall Study|Adverse Event|15|||
16495747|NCT00684307|40284777|FG003|Overall Study|Adverse Event|16|||
16495748|NCT00684307|40284778|FG004|Overall Study|Adverse Event|8|||
16495749|NCT00684307|40284774|FG000|Overall Study|Development of increasing Liver Function|0|||
16495750|NCT00684307|40284775|FG001|Overall Study|Development of increasing Liver Function|2|||
16495751|NCT00684307|40284776|FG002|Overall Study|Development of increasing Liver Function|0|||
16495752|NCT00684307|40284777|FG003|Overall Study|Development of increasing Liver Function|1|||
16495753|NCT00684307|40284778|FG004|Overall Study|Development of increasing Liver Function|0|||
16495754|NCT00684307|40284774|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
16495755|NCT00684307|40284775|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
16495756|NCT00684307|40284776|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
16495757|NCT00684307|40284777|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
16495758|NCT00684307|40284778|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
16495759|NCT00684307|40284774|FG000|Overall Study|Incorrect enrolment or randomization|4|||
16495760|NCT00684307|40284775|FG001|Overall Study|Incorrect enrolment or randomization|0|||
16495761|NCT00684307|40284776|FG002|Overall Study|Incorrect enrolment or randomization|0|||
16495762|NCT00684307|40284777|FG003|Overall Study|Incorrect enrolment or randomization|0|||
16495763|NCT00684307|40284778|FG004|Overall Study|Incorrect enrolment or randomization|0|||
16495764|NCT00684307|40284774|FG000|Overall Study|Interupted IP for more than 7 days|0|||
16495765|NCT00684307|40284775|FG001|Overall Study|Interupted IP for more than 7 days|4|||
16495766|NCT00684307|40284776|FG002|Overall Study|Interupted IP for more than 7 days|1|||
16495767|NCT00684307|40284777|FG003|Overall Study|Interupted IP for more than 7 days|3|||
16495768|NCT00684307|40284778|FG004|Overall Study|Interupted IP for more than 7 days|3|||
16495769|NCT00684307|40284774|FG000|Overall Study|Severe non compliance to protocol|1|||
16495770|NCT00684307|40284775|FG001|Overall Study|Severe non compliance to protocol|0|||
16495771|NCT00684307|40284776|FG002|Overall Study|Severe non compliance to protocol|0|||
16495772|NCT00684307|40284777|FG003|Overall Study|Severe non compliance to protocol|1|||
16495773|NCT00684307|40284778|FG004|Overall Study|Severe non compliance to protocol|2|||
16495774|NCT00684307|40284774|FG000|Overall Study|Participant not willing to continue|7|||
16495775|NCT00684307|40284775|FG001|Overall Study|Participant not willing to continue|10|||
16495776|NCT00684307|40284776|FG002|Overall Study|Participant not willing to continue|11|||
16495777|NCT00684307|40284777|FG003|Overall Study|Participant not willing to continue|5|||
16495778|NCT00684307|40284778|FG004|Overall Study|Participant not willing to continue|8|||
16495779|NCT00684307|40284774|FG000|Overall Study|Criteria from the CSR|0|||
16495780|NCT00684307|40284775|FG001|Overall Study|Criteria from the CSR|0|||
16495781|NCT00684307|40284776|FG002|Overall Study|Criteria from the CSR|1|||
16495782|NCT00684307|40284777|FG003|Overall Study|Criteria from the CSR|3|||
16495783|NCT00684307|40284778|FG004|Overall Study|Criteria from the CSR|3|||
16495784|NCT01753856|40284782|FG000|Overall Study|Adverse Event|1|||
16495785|NCT01753856|40284783|FG001|Overall Study|Adverse Event|0|||
16495786|NCT01753856|40284782|FG000|Overall Study|Withdrawal by Subject|0|||
16495787|NCT01753856|40284783|FG001|Overall Study|Withdrawal by Subject|2|||
16495788|NCT01753856|40284782|FG000|Overall Study|Sponsor Decision|2|||
16495789|NCT01753856|40284783|FG001|Overall Study|Sponsor Decision|0|||
16495790|NCT03070782|40284784|FG000|Overall Study|Adverse Event|3|||
16495791|NCT03070782|40284785|FG001|Overall Study|Adverse Event|0|||
16495792|NCT03070782|40284786|FG002|Overall Study|Adverse Event|3|||
16495793|NCT03070782|40284787|FG003|Overall Study|Adverse Event|1|||
16495794|NCT03070782|40284788|FG004|Overall Study|Adverse Event|6|||
16495795|NCT03070782|40284789|FG005|Overall Study|Adverse Event|2|||
16495796|NCT03070782|40284784|FG000|Overall Study|Withdrawal by Subject|2|||
16495797|NCT03070782|40284785|FG001|Overall Study|Withdrawal by Subject|1|||
16495798|NCT03070782|40284786|FG002|Overall Study|Withdrawal by Subject|1|||
16495799|NCT03070782|40284787|FG003|Overall Study|Withdrawal by Subject|0|||
16495800|NCT03070782|40284788|FG004|Overall Study|Withdrawal by Subject|4|||
16495801|NCT03070782|40284789|FG005|Overall Study|Withdrawal by Subject|3|||
16495802|NCT03070782|40284784|FG000|Overall Study|Reason Not Specified|2|||
16495803|NCT03070782|40284785|FG001|Overall Study|Reason Not Specified|0|||
16495804|NCT03070782|40284786|FG002|Overall Study|Reason Not Specified|0|||
16495805|NCT03070782|40284787|FG003|Overall Study|Reason Not Specified|1|||
16495806|NCT03070782|40284788|FG004|Overall Study|Reason Not Specified|2|||
16495807|NCT03070782|40284789|FG005|Overall Study|Reason Not Specified|1|||
16495808|NCT03070782|40284784|FG000|Overall Study|Ineligibility|0|||
16495809|NCT03070782|40284785|FG001|Overall Study|Ineligibility|0|||
16495810|NCT03070782|40284786|FG002|Overall Study|Ineligibility|0|||
16495811|NCT03070782|40284787|FG003|Overall Study|Ineligibility|1|||
16495812|NCT03070782|40284788|FG004|Overall Study|Ineligibility|0|||
16495813|NCT03070782|40284789|FG005|Overall Study|Ineligibility|1|||
16495814|NCT03070782|40284784|FG000|Overall Study|Pregnancy|0|||
16495815|NCT03070782|40284785|FG001|Overall Study|Pregnancy|0|||
16495816|NCT03070782|40284786|FG002|Overall Study|Pregnancy|0|||
16495817|NCT03070782|40284787|FG003|Overall Study|Pregnancy|1|||
16495818|NCT03070782|40284788|FG004|Overall Study|Pregnancy|0|||
16495819|NCT03070782|40284789|FG005|Overall Study|Pregnancy|0|||
16495820|NCT03070782|40284784|FG000|Overall Study|Investigator Judgement|0|||
16495821|NCT03070782|40284785|FG001|Overall Study|Investigator Judgement|0|||
16495822|NCT03070782|40284786|FG002|Overall Study|Investigator Judgement|0|||
16495823|NCT03070782|40284787|FG003|Overall Study|Investigator Judgement|1|||
16495824|NCT03070782|40284788|FG004|Overall Study|Investigator Judgement|0|||
16495825|NCT03070782|40284789|FG005|Overall Study|Investigator Judgement|0|||
16495826|NCT02547454|40284790|FG000|Overall Study|Due to hemodialysis|53|||
16495827|NCT02547454|40284790|FG000|Overall Study|Due to transplantation|1|||
16495828|NCT02547454|40284790|FG000|Overall Study|Due to no further need to treat|4|||
16495829|NCT02547454|40284790|FG000|Overall Study|Death|38|||
16495830|NCT02547454|40284790|FG000|Overall Study|Lost to Follow-up|26|||
16495831|NCT02547454|40284790|FG000|Overall Study|Other|39|||
16495832|NCT02547454|40284790|FG000|Overall Study|No data|11|||
16495833|NCT00578812|40284791|FG000|Overall Study|Not treated|6|||
16495834|NCT00578812|40284792|FG001|Overall Study|Not treated|7|||
16495835|NCT01721330|40284793|FG000|Overall Study|Withdrawal by Subject|0|||
16495836|NCT01721330|40284794|FG001|Overall Study|Withdrawal by Subject|1|||
16495837|NCT02708121|40284795|FG000|Overall Study|Withdrawn by Study Team|1|||
16495838|NCT02708121|40284796|FG001|Overall Study|Withdrawn by Study Team|1|||
16495839|NCT02708121|40284795|FG000|Overall Study|Withdrawal by Subject|0|||
16495840|NCT02708121|40284796|FG001|Overall Study|Withdrawal by Subject|4|||
16495841|NCT02669433|40284797|FG000|Overall Study|Protocol Violation|0|||
16495842|NCT02669433|40284798|FG001|Overall Study|Protocol Violation|4|||
16495843|NCT02669433|40284799|FG002|Overall Study|Protocol Violation|1|||
16495844|NCT02669433|40284797|FG000|Overall Study|Disease Progression|1|||
16495845|NCT02669433|40284798|FG001|Overall Study|Disease Progression|0|||
16495846|NCT02669433|40284799|FG002|Overall Study|Disease Progression|0|||
16495847|NCT02669433|40284797|FG000|Overall Study|Physician Decision|1|||
16495848|NCT02669433|40284798|FG001|Overall Study|Physician Decision|1|||
16495849|NCT02669433|40284799|FG002|Overall Study|Physician Decision|0|||
16495850|NCT02669433|40284797|FG000|Overall Study|Adverse Event|6|||
16495851|NCT02669433|40284798|FG001|Overall Study|Adverse Event|7|||
16495852|NCT02669433|40284799|FG002|Overall Study|Adverse Event|10|||
16495853|NCT02669433|40284797|FG000|Overall Study|Sponsor Termination|1|||
16085614|NCT02235298|38806930|FG001|Overall Study|Adverse Event|2|||
16495854|NCT02669433|40284798|FG001|Overall Study|Sponsor Termination|0|||
16495855|NCT02669433|40284799|FG002|Overall Study|Sponsor Termination|1|||
16085615|NCT02235298|38806929|FG000|Overall Study|Withdrawal by Subject|0|||
16085616|NCT02235298|38806930|FG001|Overall Study|Withdrawal by Subject|1|||
16085617|NCT00857766|38806933|FG000|Overall Study|Adverse Event|13|||
16085618|NCT00857766|38806934|FG001|Overall Study|Adverse Event|12|||
16085619|NCT00857766|38806933|FG000|Overall Study|Protocol Violation|11|||
16085620|NCT00857766|38806934|FG001|Overall Study|Protocol Violation|11|||
16085621|NCT00857766|38806933|FG000|Overall Study|Lost to Follow-up|1|||
16085622|NCT00857766|38806934|FG001|Overall Study|Lost to Follow-up|0|||
16085623|NCT00857766|38806933|FG000|Overall Study|Investigator Discretion|2|||
16085624|NCT00857766|38806934|FG001|Overall Study|Investigator Discretion|3|||
16085625|NCT00857766|38806933|FG000|Overall Study|Participant Withdrew Consent|4|||
16085626|NCT00857766|38806934|FG001|Overall Study|Participant Withdrew Consent|4|||
16085627|NCT02063659|38806935|FG000|Double-Blind Treatment Period|Adverse Event|1|||
16085628|NCT02063659|38806936|FG001|Double-Blind Treatment Period|Adverse Event|2|||
16085629|NCT02063659|38806937|FG002|Double-Blind Treatment Period|Adverse Event|0|||
16085630|NCT02063659|38806938|FG003|Double-Blind Treatment Period|Adverse Event|0|||
16085631|NCT02063659|38806935|FG000|Double-Blind Treatment Period|Physician Decision|1|||
16085632|NCT02063659|38806936|FG001|Double-Blind Treatment Period|Physician Decision|0|||
16085633|NCT02063659|38806937|FG002|Double-Blind Treatment Period|Physician Decision|0|||
16085634|NCT02063659|38806938|FG003|Double-Blind Treatment Period|Physician Decision|0|||
16085635|NCT02063659|38806935|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
16085636|NCT02063659|38806936|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
16085637|NCT02063659|38806937|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
16085638|NCT02063659|38806938|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
16085639|NCT02063659|38806935|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
16495856|NCT02669433|40284797|FG000|Overall Study|Withdrawal by Subject|5|||
16495857|NCT02669433|40284798|FG001|Overall Study|Withdrawal by Subject|1|||
16495858|NCT02669433|40284799|FG002|Overall Study|Withdrawal by Subject|0|||
16085640|NCT02063659|38806936|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
16085641|NCT02063659|38806937|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
16085642|NCT02063659|38806938|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
16085643|NCT02063659|38806935|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
16085644|NCT02063659|38806936|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
16085645|NCT02063659|38806937|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
16085646|NCT02063659|38806938|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
16085647|NCT02063659|38806935|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
16085648|NCT02063659|38806936|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
16085649|NCT02063659|38806937|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
16085650|NCT02063659|38806938|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
16085651|NCT02063659|38806935|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
16085652|NCT02063659|38806936|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
16085653|NCT02063659|38806937|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
16085654|NCT02063659|38806938|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
16085655|NCT02063659|38806935|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
16085656|NCT02063659|38806936|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
16085657|NCT02063659|38806937|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
16085658|NCT02063659|38806938|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
16085659|NCT00822120|38806939|FG000|Initial Registration|Adverse Event|1|||
16085660|NCT00822120|38806940|FG001|Initial Registration|Adverse Event|0|||
16085661|NCT00822120|38806941|FG002|Initial Registration|Adverse Event|0|||
16085662|NCT00822120|38806942|FG003|Initial Registration|Adverse Event|0|||
16085663|NCT00822120|38806943|FG004|Initial Registration|Adverse Event|0|||
16085664|NCT00822120|38806944|FG005|Initial Registration|Adverse Event|0|||
16085665|NCT00822120|38806939|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
16085666|NCT00822120|38806940|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
16085667|NCT00822120|38806941|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
16085668|NCT00822120|38806942|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
16085669|NCT00822120|38806943|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
16085670|NCT00822120|38806944|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
16194049|NCT04402008|39188678|FG004|Overall Study|Disease Progression|4|||
16495859|NCT02669433|40284797|FG000|Overall Study|Withdrawal by Caregiver|1|||
16495860|NCT02669433|40284798|FG001|Overall Study|Withdrawal by Caregiver|0|||
16495861|NCT02669433|40284799|FG002|Overall Study|Withdrawal by Caregiver|2|||
16495862|NCT02669433|40284797|FG000|Overall Study|Death|0|||
16495863|NCT02669433|40284798|FG001|Overall Study|Death|1|||
16495864|NCT02669433|40284799|FG002|Overall Study|Death|1|||
16495865|NCT02585960|40284816|FG000|PK/Safety Assessment Period|Physician Decision|0|||
16495866|NCT02585960|40284817|FG001|PK/Safety Assessment Period|Physician Decision|1|||
16495867|NCT02585960|40284818|FG002|PK/Safety Assessment Period|Physician Decision|0|||
16495868|NCT02585960|40284816|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
16495869|NCT02585960|40284817|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
16085671|NCT00822120|38806939|FG000|Initial Registration|Reasons not Protocol Specified|2|||
16085672|NCT00822120|38806940|FG001|Initial Registration|Reasons not Protocol Specified|0|||
16085673|NCT00822120|38806941|FG002|Initial Registration|Reasons not Protocol Specified|0|||
16085674|NCT00822120|38806942|FG003|Initial Registration|Reasons not Protocol Specified|0|||
16085675|NCT00822120|38806943|FG004|Initial Registration|Reasons not Protocol Specified|0|||
16085676|NCT00822120|38806944|FG005|Initial Registration|Reasons not Protocol Specified|0|||
16085677|NCT00822120|38806939|FG000|Initial Registration|Ineligible|22|||
16085678|NCT00822120|38806940|FG001|Initial Registration|Ineligible|1|||
16085679|NCT00822120|38806941|FG002|Initial Registration|Ineligible|0|||
16085680|NCT00822120|38806942|FG003|Initial Registration|Ineligible|0|||
16085681|NCT00822120|38806943|FG004|Initial Registration|Ineligible|0|||
16085682|NCT00822120|38806944|FG005|Initial Registration|Ineligible|0|||
16085683|NCT00822120|38806939|FG000|PET-directed Therapy|Adverse Event|0|||
16085684|NCT00822120|38806940|FG001|PET-directed Therapy|Adverse Event|0|||
16085685|NCT00822120|38806941|FG002|PET-directed Therapy|Adverse Event|0|||
16085686|NCT00822120|38806942|FG003|PET-directed Therapy|Adverse Event|1|||
16085687|NCT00822120|38806943|FG004|PET-directed Therapy|Adverse Event|0|||
16085688|NCT00822120|38806944|FG005|PET-directed Therapy|Adverse Event|0|||
16085689|NCT00822120|38806939|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
16085690|NCT00822120|38806940|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
16085691|NCT00822120|38806941|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
16085692|NCT00822120|38806942|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
16085693|NCT00822120|38806943|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
16085694|NCT00822120|38806944|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
16085695|NCT00822120|38806939|FG000|PET-directed Therapy|Death|0|||
16085696|NCT00822120|38806940|FG001|PET-directed Therapy|Death|0|||
16085697|NCT00822120|38806941|FG002|PET-directed Therapy|Death|0|||
16085698|NCT00822120|38806942|FG003|PET-directed Therapy|Death|2|||
16085699|NCT00822120|38806943|FG004|PET-directed Therapy|Death|0|||
16495870|NCT02585960|40284818|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
16495871|NCT02585960|40284816|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
16495872|NCT02585960|40284817|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
16085700|NCT00822120|38806944|FG005|PET-directed Therapy|Death|0|||
16085701|NCT00822120|38806939|FG000|PET-directed Therapy|Protocol Violation|0|||
16085702|NCT00822120|38806940|FG001|PET-directed Therapy|Protocol Violation|0|||
16085703|NCT00822120|38806941|FG002|PET-directed Therapy|Protocol Violation|0|||
16495873|NCT02585960|40284818|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
16495874|NCT02585960|40284816|FG000|PK/Safety Assessment Period|Other|4|||
16495875|NCT02585960|40284817|FG001|PK/Safety Assessment Period|Other|4|||
16085704|NCT00822120|38806942|FG003|PET-directed Therapy|Protocol Violation|6|||
16085705|NCT00822120|38806943|FG004|PET-directed Therapy|Protocol Violation|0|||
16085706|NCT00822120|38806944|FG005|PET-directed Therapy|Protocol Violation|0|||
16085707|NCT02823574|38806945|FG000|Randomization|Disease Progression|0|||
16085708|NCT02823574|38806946|FG001|Randomization|Disease Progression|0|||
16085709|NCT02823574|38806947|FG002|Randomization|Disease Progression|1|||
16085710|NCT02823574|38806948|FG003|Randomization|Disease Progression|0|||
16085711|NCT02823574|38806945|FG000|Randomization|AE unrelated to Study Drug|1|||
16085712|NCT02823574|38806946|FG001|Randomization|AE unrelated to Study Drug|0|||
16085713|NCT02823574|38806947|FG002|Randomization|AE unrelated to Study Drug|0|||
16085714|NCT02823574|38806948|FG003|Randomization|AE unrelated to Study Drug|0|||
16085715|NCT02823574|38806945|FG000|Treatment Period|Poor/Non Compliance|1|||
16085716|NCT02823574|38806946|FG001|Treatment Period|Poor/Non Compliance|0|||
16495876|NCT02585960|40284818|FG002|PK/Safety Assessment Period|Other|0|||
16495877|NCT02585960|40284816|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
16085717|NCT02823574|38806947|FG002|Treatment Period|Poor/Non Compliance|0|||
16085718|NCT02823574|38806948|FG003|Treatment Period|Poor/Non Compliance|1|||
16085719|NCT02823574|38806945|FG000|Treatment Period|Maximum Clinical Benefit|8|||
16085720|NCT02823574|38806946|FG001|Treatment Period|Maximum Clinical Benefit|4|||
16085721|NCT02823574|38806947|FG002|Treatment Period|Maximum Clinical Benefit|7|||
16085722|NCT02823574|38806948|FG003|Treatment Period|Maximum Clinical Benefit|1|||
16085723|NCT02823574|38806945|FG000|Treatment Period|Lost to Follow-up|1|||
16085724|NCT02823574|38806946|FG001|Treatment Period|Lost to Follow-up|1|||
16085725|NCT02823574|38806947|FG002|Treatment Period|Lost to Follow-up|0|||
16085726|NCT02823574|38806948|FG003|Treatment Period|Lost to Follow-up|0|||
16085727|NCT02823574|38806945|FG000|Treatment Period|Participant withdrew consent|4|||
16085728|NCT02823574|38806946|FG001|Treatment Period|Participant withdrew consent|0|||
16085729|NCT02823574|38806947|FG002|Treatment Period|Participant withdrew consent|0|||
16085730|NCT02823574|38806948|FG003|Treatment Period|Participant withdrew consent|1|||
16085731|NCT02823574|38806945|FG000|Treatment Period|Participant request to discontinue|5|||
16085732|NCT02823574|38806946|FG001|Treatment Period|Participant request to discontinue|0|||
16194050|NCT04402008|39188679|FG005|Overall Study|Disease Progression|3|||
16495878|NCT02585960|40284817|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
16495879|NCT02585960|40284818|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
16085733|NCT02823574|38806947|FG002|Treatment Period|Participant request to discontinue|3|||
16085734|NCT02823574|38806948|FG003|Treatment Period|Participant request to discontinue|2|||
16085735|NCT02823574|38806945|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
16085736|NCT02823574|38806946|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
16085737|NCT02823574|38806947|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
16085738|NCT02823574|38806948|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
16085739|NCT02823574|38806945|FG000|Treatment Period|Study Drug Toxicity|11|||
16085740|NCT02823574|38806946|FG001|Treatment Period|Study Drug Toxicity|2|||
16085741|NCT02823574|38806947|FG002|Treatment Period|Study Drug Toxicity|14|||
16085742|NCT02823574|38806948|FG003|Treatment Period|Study Drug Toxicity|4|||
16085743|NCT02823574|38806945|FG000|Treatment Period|Disease Progression|113|||
16085744|NCT02823574|38806946|FG001|Treatment Period|Disease Progression|64|||
16085745|NCT02823574|38806947|FG002|Treatment Period|Disease Progression|82|||
16085746|NCT02823574|38806948|FG003|Treatment Period|Disease Progression|43|||
16085747|NCT02823574|38806945|FG000|Treatment Period|Other reasons|5|||
16085748|NCT02823574|38806946|FG001|Treatment Period|Other reasons|9|||
16085749|NCT02823574|38806947|FG002|Treatment Period|Other reasons|3|||
16085750|NCT02823574|38806948|FG003|Treatment Period|Other reasons|6|||
16085751|NCT02823574|38806945|FG000|Treatment Period|Participant no longer meets study criteria|0|||
16085752|NCT02823574|38806946|FG001|Treatment Period|Participant no longer meets study criteria|0|||
16085753|NCT02823574|38806947|FG002|Treatment Period|Participant no longer meets study criteria|1|||
16085754|NCT02823574|38806948|FG003|Treatment Period|Participant no longer meets study criteria|0|||
16085755|NCT02823574|38806945|FG000|Treatment Period|Death|0|||
16085756|NCT02823574|38806946|FG001|Treatment Period|Death|0|||
16085757|NCT02823574|38806947|FG002|Treatment Period|Death|3|||
16085758|NCT02823574|38806948|FG003|Treatment Period|Death|1|||
16085759|NCT01700205|38806949|FG000|Overall Study|Withdrawal by Subject|13|||
16085760|NCT01700205|38806950|FG001|Overall Study|Withdrawal by Subject|13|||
16085761|NCT01700205|38806949|FG000|Overall Study|Protocol Violation|2|||
16085762|NCT01700205|38806950|FG001|Overall Study|Protocol Violation|2|||
16085763|NCT03697603|38806951|FG000|Overall Study|Adverse Event|3|||
16085764|NCT03697603|38806952|FG001|Overall Study|Adverse Event|18|||
16085765|NCT03697603|38806953|FG002|Overall Study|Adverse Event|3|||
16085766|NCT03697603|38806951|FG000|Overall Study|Physician Decision|1|||
16085767|NCT03697603|38806952|FG001|Overall Study|Physician Decision|0|||
16085768|NCT03697603|38806953|FG002|Overall Study|Physician Decision|2|||
16085769|NCT03697603|38806951|FG000|Overall Study|Protocol Violation|3|||
16085770|NCT03697603|38806952|FG001|Overall Study|Protocol Violation|8|||
16085771|NCT03697603|38806953|FG002|Overall Study|Protocol Violation|5|||
16085772|NCT03697603|38806951|FG000|Overall Study|Withdrawal by Subject|5|||
16085773|NCT03697603|38806952|FG001|Overall Study|Withdrawal by Subject|1|||
16085774|NCT03697603|38806953|FG002|Overall Study|Withdrawal by Subject|1|||
16085775|NCT03697603|38806951|FG000|Overall Study|Protocol Violation|0|||
16085776|NCT03697603|38806952|FG001|Overall Study|Protocol Violation|0|||
16085777|NCT03697603|38806953|FG002|Overall Study|Protocol Violation|1|||
16085778|NCT00777049|38806954|FG000|Overall Study|Withdrawal by Subject|1|||
16085779|NCT00777049|38806955|FG001|Overall Study|Withdrawal by Subject|0|||
16085780|NCT00777049|38806954|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
16085781|NCT00777049|38806955|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
16085782|NCT01583166|38806956|FG000|Overall Study|Withdrawal by Subject|4|||
16085783|NCT01583166|38806957|FG001|Overall Study|Withdrawal by Subject|6|||
16085784|NCT00391170|38806959|FG000|Overall Study|Withdrawal by Subject|1|||
16085785|NCT00391170|38806960|FG001|Overall Study|Withdrawal by Subject|0|||
16085786|NCT00391170|38806959|FG000|Overall Study|Adverse Event|3|||
16085787|NCT00391170|38806960|FG001|Overall Study|Adverse Event|2|||
16085788|NCT00391170|38806959|FG000|Overall Study|Physician Decision|2|||
16085789|NCT00391170|38806960|FG001|Overall Study|Physician Decision|2|||
16085790|NCT00875706|38806961|FG000|Overall Study|Withdrawal by Subject|1|||
16085791|NCT00875706|38806962|FG001|Overall Study|Withdrawal by Subject|0|||
16085792|NCT00875706|38806963|FG002|Overall Study|Withdrawal by Subject|0|||
16085793|NCT01964300|38806964|FG000|Overall Study|Ineligible after enrollment|0|||
16085794|NCT01964300|38806965|FG001|Overall Study|Ineligible after enrollment|1|||
16085795|NCT01964300|38806964|FG000|Overall Study|Adverse Event|1|||
16085796|NCT01964300|38806965|FG001|Overall Study|Adverse Event|1|||
16085797|NCT01964300|38806964|FG000|Overall Study|Lack of Efficacy|3|||
16085798|NCT01964300|38806965|FG001|Overall Study|Lack of Efficacy|5|||
16085799|NCT01964300|38806964|FG000|Overall Study|Withdrawal by Subject|0|||
16085800|NCT01964300|38806965|FG001|Overall Study|Withdrawal by Subject|1|||
16085801|NCT01964300|38806964|FG000|Overall Study|To receive alternative therapy|1|||
16085802|NCT01964300|38806965|FG001|Overall Study|To receive alternative therapy|2|||
16085803|NCT01964300|38806964|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
16085804|NCT01964300|38806965|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
16085805|NCT01964300|38806964|FG000|Overall Study|Weight criteria not met|0|||
16085806|NCT01964300|38806965|FG001|Overall Study|Weight criteria not met|1|||
16085807|NCT00372775|38806966|FG000|Overall Study|Adverse Event|8|||
16085808|NCT00372775|38806966|FG000|Overall Study|Death|15|||
16085809|NCT00372775|38806966|FG000|Overall Study|Objective progression or relapse|30|||
16085810|NCT00372775|38806966|FG000|Overall Study|Global deterioration of health status|6|||
16085811|NCT00372775|38806966|FG000|Overall Study|Withdrawal by Subject|1|||
16085812|NCT00372775|38806966|FG000|Overall Study|Other|1|||
16085813|NCT00372775|38806966|FG000|Overall Study|Not Treated|2|||
16085814|NCT01833455|38806967|FG000|Overall Study|Withdrawal by Subject|1|||
16085815|NCT01833455|38806968|FG001|Overall Study|Withdrawal by Subject|0|||
16085816|NCT02189759|38806969|FG000|Overall Study|Lost to Follow-up|0|||
16085817|NCT02189759|38806970|FG001|Overall Study|Lost to Follow-up|0|||
16085818|NCT02189759|38806971|FG002|Overall Study|Lost to Follow-up|2|||
16085819|NCT02189759|38806972|FG003|Overall Study|Lost to Follow-up|5|||
16085820|NCT01673594|38806973|FG000|Overall Study|Adverse Event|3|||
16085821|NCT01673594|38806974|FG001|Overall Study|Adverse Event|1|||
16085822|NCT01673594|38806973|FG000|Overall Study|Lost to Follow-up|1|||
16085823|NCT01673594|38806974|FG001|Overall Study|Lost to Follow-up|0|||
16085824|NCT01673594|38806973|FG000|Overall Study|Physician Decision|2|||
16085825|NCT01673594|38806974|FG001|Overall Study|Physician Decision|4|||
16085826|NCT01673594|38806973|FG000|Overall Study|Withdrawal by Subject|0|||
16085827|NCT01673594|38806974|FG001|Overall Study|Withdrawal by Subject|1|||
16085828|NCT01227421|38806976|FG000|Overall Study|Lost to Follow-up|6|||
16085829|NCT01227421|38806977|FG001|Overall Study|Lost to Follow-up|7|||
16085830|NCT01227421|38806978|FG002|Overall Study|Lost to Follow-up|5|||
16085831|NCT01227421|38806976|FG000|Overall Study|Adverse Event|2|||
16085832|NCT01227421|38806977|FG001|Overall Study|Adverse Event|7|||
16085833|NCT01227421|38806978|FG002|Overall Study|Adverse Event|2|||
16085834|NCT01227421|38806976|FG000|Overall Study|Withdrawal by Subject|1|||
16085835|NCT01227421|38806977|FG001|Overall Study|Withdrawal by Subject|2|||
16085836|NCT01227421|38806978|FG002|Overall Study|Withdrawal by Subject|1|||
16085837|NCT01227421|38806976|FG000|Overall Study|Protocol Violation|1|||
16085838|NCT01227421|38806977|FG001|Overall Study|Protocol Violation|1|||
16085839|NCT01227421|38806978|FG002|Overall Study|Protocol Violation|2|||
16085840|NCT01227421|38806976|FG000|Overall Study|Randomized in error|1|||
16085841|NCT01227421|38806977|FG001|Overall Study|Randomized in error|1|||
16085842|NCT01227421|38806978|FG002|Overall Study|Randomized in error|0|||
16085843|NCT01619059|38806980|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
16085844|NCT01619059|38806981|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
16085845|NCT01619059|38806980|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
16085846|NCT01619059|38806981|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
16085847|NCT01619059|38806980|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
16085848|NCT01619059|38806981|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
16085849|NCT01619059|38806980|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
16085850|NCT01619059|38806981|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
16085851|NCT01619059|38806980|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
16085852|NCT01619059|38806981|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
16085853|NCT01619059|38806980|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
16085854|NCT01619059|38806981|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
16085855|NCT01619059|38806980|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
16085856|NCT01619059|38806981|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
16085857|NCT01619059|38806980|FG000|Long-Term (LT) Treatment Period|Death|1|||
16085858|NCT01619059|38806981|FG001|Long-Term (LT) Treatment Period|Death|0|||
16085859|NCT01619059|38806980|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
16085860|NCT01619059|38806981|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
16085861|NCT01619059|38806980|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
16308131|NCT01401452|39612721|FG000|Overall Study|Lost to Follow-up|12|||
16308132|NCT01401452|39612721|FG000|Overall Study|Lack of Efficacy|30|||
16085862|NCT01619059|38806981|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
16085863|NCT01532648|38806982|FG000|Overall Study|Lost to Follow-up|3|||
16085864|NCT01532648|38806983|FG001|Overall Study|Lost to Follow-up|4|||
16085865|NCT01532648|38806982|FG000|Overall Study|Lack of Efficacy|4|||
16085866|NCT01532648|38806983|FG001|Overall Study|Lack of Efficacy|1|||
16085867|NCT01532648|38806982|FG000|Overall Study|Protocol Violation|1|||
16085868|NCT01532648|38806983|FG001|Overall Study|Protocol Violation|1|||
16085869|NCT01532648|38806982|FG000|Overall Study|Adverse Event|12|||
16085870|NCT01532648|38806983|FG001|Overall Study|Adverse Event|9|||
16085871|NCT01532648|38806982|FG000|Overall Study|Withdrawal by Subject|16|||
16085872|NCT01532648|38806983|FG001|Overall Study|Withdrawal by Subject|2|||
16085873|NCT01170208|38806984|FG000|Overall Study|Withdrawal by Subject|5|||
16085874|NCT01170208|38806985|FG001|Overall Study|Withdrawal by Subject|0|||
16085875|NCT01170208|38806986|FG002|Overall Study|Withdrawal by Subject|1|||
16085876|NCT01170208|38806984|FG000|Overall Study|Protocol Violation|1|||
16085877|NCT01170208|38806985|FG001|Overall Study|Protocol Violation|0|||
16495880|NCT02585960|40284816|FG000|PK/Safety Assessment Period|Screen Failure|0|||
16495881|NCT02585960|40284817|FG001|PK/Safety Assessment Period|Screen Failure|0|||
16495882|NCT02585960|40284818|FG002|PK/Safety Assessment Period|Screen Failure|1|||
16495883|NCT02585960|40284816|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
16495884|NCT02585960|40284817|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
16495885|NCT02585960|40284818|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
16495886|NCT02585960|40284816|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
16495887|NCT02585960|40284817|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
16495888|NCT02585960|40284818|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
16495889|NCT02170051|40284826|FG000|Overall Study|Withdrawal by Subject|10|||
16085878|NCT01170208|38806986|FG002|Overall Study|Protocol Violation|1|||
16495890|NCT02170051|40284827|FG001|Overall Study|Withdrawal by Subject|10|||
16085879|NCT03589768|38806989|FG000|Overall Study|Death|1|||
16085880|NCT03589768|38806990|FG001|Overall Study|Death|0|||
16085881|NCT03589768|38806991|FG002|Overall Study|Death|8|||
16085882|NCT03589768|38806992|FG003|Overall Study|Death|3|||
16085883|NCT03589768|38806989|FG000|Overall Study|Withdrawal by Subject|2|||
16085884|NCT03589768|38806990|FG001|Overall Study|Withdrawal by Subject|0|||
16085885|NCT03589768|38806991|FG002|Overall Study|Withdrawal by Subject|0|||
16085886|NCT03589768|38806992|FG003|Overall Study|Withdrawal by Subject|0|||
16085887|NCT03589768|38806989|FG000|Overall Study|Protocol Violation|1|||
16085888|NCT03589768|38806990|FG001|Overall Study|Protocol Violation|0|||
16085889|NCT03589768|38806991|FG002|Overall Study|Protocol Violation|0|||
16085890|NCT03589768|38806992|FG003|Overall Study|Protocol Violation|0|||
16085891|NCT02260154|38806993|FG000|Overall Study|Screening failure|2|||
16085892|NCT03883828|38806994|FG000|Overall Study|Did not start radiotherapy|1|||
16085893|NCT03883828|38806995|FG001|Overall Study|Did not start radiotherapy|2|||
16085894|NCT03861052|38806996|FG000|Overall Study|Adverse Event|1|||
16085895|NCT03861052|38806997|FG001|Overall Study|Adverse Event|1|||
16085896|NCT03861052|38806998|FG002|Overall Study|Adverse Event|2|||
16085897|NCT03861052|38806999|FG003|Overall Study|Adverse Event|4|||
16085898|NCT03861052|38806996|FG000|Overall Study|Lost to Follow-up|0|||
16085899|NCT03861052|38806997|FG001|Overall Study|Lost to Follow-up|0|||
16085900|NCT03861052|38806998|FG002|Overall Study|Lost to Follow-up|0|||
16085901|NCT03861052|38806999|FG003|Overall Study|Lost to Follow-up|1|||
16495891|NCT02170051|40284826|FG000|Overall Study|Lost to Follow-up|1|||
16495892|NCT02170051|40284827|FG001|Overall Study|Lost to Follow-up|3|||
16495893|NCT01549860|40284828|FG000|Overall Study|Withdrawal by Subject|1|||
16495894|NCT01549860|40284829|FG001|Overall Study|Withdrawal by Subject|0|||
16495895|NCT01549860|40284828|FG000|Overall Study|Physician Decision|1|||
16495896|NCT01549860|40284829|FG001|Overall Study|Physician Decision|1|||
16495897|NCT02370160|40284830|FG000|Overall Study|Death|3|||
16495898|NCT02370160|40284831|FG001|Overall Study|Death|4|||
16495899|NCT02370160|40284832|FG002|Overall Study|Death|1|||
16546307|NCT02237508|40464781|FG008|Overall Study|Withdrawal by Subject|1|||
16546308|NCT02237508|40464782|FG009|Overall Study|Withdrawal by Subject|0|||
16546309|NCT02237508|40464773|FG000|Overall Study|Physician Decision|0|||
16546310|NCT02237508|40464774|FG001|Overall Study|Physician Decision|1|||
16085902|NCT03861052|38806996|FG000|Overall Study|Physician Decision|0|||
16085903|NCT03861052|38806997|FG001|Overall Study|Physician Decision|1|||
16085904|NCT03861052|38806998|FG002|Overall Study|Physician Decision|0|||
16085905|NCT03861052|38806999|FG003|Overall Study|Physician Decision|0|||
16085906|NCT03861052|38806996|FG000|Overall Study|Withdrawal by Subject|2|||
16085907|NCT03861052|38806997|FG001|Overall Study|Withdrawal by Subject|5|||
16085908|NCT03861052|38806998|FG002|Overall Study|Withdrawal by Subject|3|||
16085909|NCT03861052|38806999|FG003|Overall Study|Withdrawal by Subject|0|||
16085910|NCT03861052|38806996|FG000|Overall Study|Relocation to other city|1|||
16085911|NCT03861052|38806997|FG001|Overall Study|Relocation to other city|0|||
16085912|NCT03861052|38806998|FG002|Overall Study|Relocation to other city|0|||
16194051|NCT04402008|39188680|FG006|Overall Study|Disease Progression|10|||
16085913|NCT03861052|38806999|FG003|Overall Study|Relocation to other city|0|||
16085914|NCT02148705|38807000|FG000|Overall Study|Death|2|||
16085915|NCT02148705|38807001|FG001|Overall Study|Death|0|||
16085916|NCT02148705|38807002|FG002|Overall Study|Death|0|||
16085917|NCT02148705|38807000|FG000|Overall Study|Lost to Follow-up|13|||
16085918|NCT02148705|38807001|FG001|Overall Study|Lost to Follow-up|4|||
16085919|NCT02148705|38807002|FG002|Overall Study|Lost to Follow-up|10|||
16085920|NCT02148705|38807000|FG000|Overall Study|Withdrawal by Subject|3|||
16085921|NCT02148705|38807001|FG001|Overall Study|Withdrawal by Subject|0|||
16085922|NCT02148705|38807002|FG002|Overall Study|Withdrawal by Subject|2|||
16085923|NCT02148705|38807000|FG000|Overall Study|Not Treated|0|||
16085924|NCT02148705|38807001|FG001|Overall Study|Not Treated|1|||
16085925|NCT02148705|38807002|FG002|Overall Study|Not Treated|5|||
16085926|NCT03547167|38807003|FG000|Overall Study|Withdrawal by Subject|34|||
16085927|NCT03547167|38807004|FG001|Overall Study|Withdrawal by Subject|12|||
16085928|NCT03547167|38807003|FG000|Overall Study|Screen Failure|0|||
16085929|NCT03547167|38807004|FG001|Overall Study|Screen Failure|1|||
16085930|NCT03547167|38807003|FG000|Overall Study|Lost to Follow-up|59|||
16194052|NCT04402008|39188674|FG000|Overall Study|Withdrawal by Subject|0|||
16388235|NCT02185534|39905612|FG003|First Period|Withdrawal by Subject|1|||
16085931|NCT03547167|38807004|FG001|Overall Study|Lost to Follow-up|15|||
16085932|NCT03547167|38807003|FG000|Overall Study|Death|4|||
16085933|NCT03547167|38807004|FG001|Overall Study|Death|2|||
16085934|NCT00811941|38807011|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
16085935|NCT00811941|38807012|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
16085936|NCT00811941|38807011|FG000|All Treated Patients|Adverse Event|2|||
16085937|NCT00811941|38807012|FG001|All Treated Patients|Adverse Event|43|||
16085938|NCT00811941|38807011|FG000|All Treated Patients|Lack of Efficacy|2|||
16085939|NCT00811941|38807012|FG001|All Treated Patients|Lack of Efficacy|3|||
16085940|NCT00811941|38807011|FG000|All Treated Patients|Non-compliance|1|||
16194053|NCT04402008|39188675|FG001|Overall Study|Withdrawal by Subject|1|||
16308133|NCT01401452|39612721|FG000|Overall Study|Participant developed breast cancer|1|||
16308134|NCT01401452|39612721|FG000|Overall Study|Tx stopped due to financial reasons|1|||
16308135|NCT01401452|39612721|FG000|Overall Study|Tx stopped by psychiatrist|1|||
16308136|NCT01401452|39612721|FG000|Overall Study|No more visits within the 36 wk followup|4|||
16308137|NCT01401452|39612721|FG000|Overall Study|Subject did not come to follow up visits|2|||
16308138|NCT01401452|39612721|FG000|Overall Study|Subject didn't return for routine visits|1|||
16308139|NCT01401452|39612721|FG000|Overall Study|Subject moved to another city|1|||
16308140|NCT01401452|39612721|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
16308141|NCT01401452|39612721|FG000|Overall Study|Psoriatic arthritis|1|||
16308142|NCT01401452|39612721|FG000|Overall Study|Participant stopped Tx|2|||
16308143|NCT01401452|39612721|FG000|Overall Study|Discontinuation for personal reasons|1|||
16308144|NCT01401452|39612721|FG000|Overall Study|Treatment failure|1|||
16308145|NCT01401452|39612721|FG000|Overall Study|Unsatisfactory output|1|||
16308146|NCT01401452|39612721|FG000|Overall Study|Subject withdrew because of Tx success|1|||
16308147|NCT01401452|39612721|FG000|Overall Study|Subject chose to discontinue treatment|1|||
16308148|NCT01401452|39612721|FG000|Overall Study|Participant withdrew consent|1|||
16308149|NCT03213665|39612722|FG000|Overall Study|Adverse Event|1|||
16308150|NCT03213665|39612722|FG000|Overall Study|Physician Decision|2|||
16308151|NCT03213665|39612722|FG000|Overall Study|Withdrawal by Subject|3|||
16308152|NCT03213665|39612722|FG000|Overall Study|Progressive Disease|13|||
16308153|NCT01107197|39612723|FG000|Overall Study|Death|12|||
16308154|NCT01107197|39612724|FG001|Overall Study|Death|10|||
16308155|NCT01107197|39612723|FG000|Overall Study|Lost to Follow-up|5|||
16308156|NCT01107197|39612724|FG001|Overall Study|Lost to Follow-up|8|||
16308157|NCT01107197|39612723|FG000|Overall Study|Withdrawal by Subject|3|||
16308158|NCT01107197|39612724|FG001|Overall Study|Withdrawal by Subject|5|||
16194054|NCT04402008|39188676|FG002|Overall Study|Withdrawal by Subject|0|||
16194055|NCT04402008|39188677|FG003|Overall Study|Withdrawal by Subject|0|||
16194056|NCT04402008|39188678|FG004|Overall Study|Withdrawal by Subject|1|||
16194057|NCT04402008|39188679|FG005|Overall Study|Withdrawal by Subject|0|||
16194058|NCT04402008|39188680|FG006|Overall Study|Withdrawal by Subject|0|||
16194059|NCT04402008|39188674|FG000|Overall Study|Sponsor Decision|0|||
16194060|NCT04402008|39188675|FG001|Overall Study|Sponsor Decision|0|||
16194061|NCT04402008|39188676|FG002|Overall Study|Sponsor Decision|0|||
16194062|NCT04402008|39188677|FG003|Overall Study|Sponsor Decision|0|||
16194063|NCT04402008|39188678|FG004|Overall Study|Sponsor Decision|0|||
16194064|NCT04402008|39188679|FG005|Overall Study|Sponsor Decision|0|||
16194065|NCT04402008|39188680|FG006|Overall Study|Sponsor Decision|3|||
16194066|NCT04402008|39188674|FG000|Overall Study|Death|0|||
16194067|NCT04402008|39188675|FG001|Overall Study|Death|0|||
16194068|NCT04402008|39188676|FG002|Overall Study|Death|0|||
16194069|NCT04402008|39188677|FG003|Overall Study|Death|0|||
16194070|NCT04402008|39188678|FG004|Overall Study|Death|1|||
16194071|NCT04402008|39188679|FG005|Overall Study|Death|0|||
16194072|NCT04402008|39188680|FG006|Overall Study|Death|2|||
16194073|NCT04402008|39188674|FG000|Overall Study|Other|0|||
16194074|NCT04402008|39188675|FG001|Overall Study|Other|0|||
16194075|NCT04402008|39188676|FG002|Overall Study|Other|0|||
16194076|NCT04402008|39188677|FG003|Overall Study|Other|0|||
16194077|NCT04402008|39188678|FG004|Overall Study|Other|0|||
16194078|NCT04402008|39188679|FG005|Overall Study|Other|0|||
16194079|NCT04402008|39188680|FG006|Overall Study|Other|5|||
16194080|NCT02922634|39188683|FG000|Overall Study|Withdrawal by Subject|5|||
16308159|NCT03889886|39612725|FG000|Overall Study|Other|0|||
16194081|NCT02922634|39188683|FG000|Overall Study|Did not have their surgery|5|||
16194082|NCT04167306|39188684|FG000|Overall Study|Lost to Follow-up|2|||
16194083|NCT04167306|39188685|FG001|Overall Study|Lost to Follow-up|2|||
16194084|NCT04167306|39188686|FG002|Overall Study|Lost to Follow-up|5|||
16194085|NCT04167306|39188687|FG003|Overall Study|Lost to Follow-up|5|||
16194086|NCT04167306|39188684|FG000|Overall Study|Adverse Event|13|||
16308160|NCT03889886|39612726|FG001|Overall Study|Other|1|||
16308161|NCT03889886|39612727|FG002|Overall Study|Other|0|||
16308162|NCT03889886|39612728|FG003|Overall Study|Other|1|||
16308163|NCT03889886|39612725|FG000|Overall Study|Withdrawal by Subject|0|||
16194087|NCT04167306|39188685|FG001|Overall Study|Adverse Event|14|||
16194088|NCT04167306|39188686|FG002|Overall Study|Adverse Event|5|||
16194089|NCT04167306|39188687|FG003|Overall Study|Adverse Event|4|||
16194090|NCT04167306|39188684|FG000|Overall Study|Withdrawal by Subject|4|||
16308164|NCT03889886|39612726|FG001|Overall Study|Withdrawal by Subject|0|||
16308165|NCT03889886|39612727|FG002|Overall Study|Withdrawal by Subject|1|||
16308166|NCT03889886|39612728|FG003|Overall Study|Withdrawal by Subject|0|||
16308167|NCT03889886|39612725|FG000|Overall Study|Adverse Event|0|||
16308168|NCT03889886|39612726|FG001|Overall Study|Adverse Event|0|||
16308169|NCT03889886|39612727|FG002|Overall Study|Adverse Event|0|||
16308170|NCT03889886|39612728|FG003|Overall Study|Adverse Event|6|||
16308171|NCT05266053|39612731|FG000|Overall Study|Withdrawal by Subject|8|||
16308172|NCT05266053|39612732|FG001|Overall Study|Withdrawal by Subject|4|||
16308173|NCT00124748|39612737|FG000|Overall Study|Adverse Event|8|||
16308174|NCT00124748|39612738|FG001|Overall Study|Adverse Event|39|||
16308175|NCT00124748|39612737|FG000|Overall Study|Abnormal laboratory Value|2|||
16308176|NCT00124748|39612738|FG001|Overall Study|Abnormal laboratory Value|2|||
16308177|NCT00124748|39612737|FG000|Overall Study|Abnormal Procedure|0|||
16308178|NCT00124748|39612738|FG001|Overall Study|Abnormal Procedure|1|||
16308179|NCT00124748|39612737|FG000|Overall Study|Lack of Efficacy|20|||
16308180|NCT00124748|39612738|FG001|Overall Study|Lack of Efficacy|41|||
16308181|NCT00124748|39612737|FG000|Overall Study|No longer requires study drug|1|||
16308182|NCT00124748|39612738|FG001|Overall Study|No longer requires study drug|1|||
16308183|NCT00124748|39612737|FG000|Overall Study|Protocol Violation|3|||
16308184|NCT00124748|39612738|FG001|Overall Study|Protocol Violation|1|||
16308185|NCT00124748|39612737|FG000|Overall Study|Withdrawal by Subject|5|||
16308186|NCT00124748|39612738|FG001|Overall Study|Withdrawal by Subject|15|||
16308187|NCT00124748|39612737|FG000|Overall Study|Lost to Follow-up|2|||
16308188|NCT00124748|39612738|FG001|Overall Study|Lost to Follow-up|7|||
16308189|NCT00124748|39612737|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
16308190|NCT00124748|39612738|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
16308191|NCT00124748|39612737|FG000|Overall Study|Death|1|||
16308192|NCT00124748|39612738|FG001|Overall Study|Death|3|||
16308193|NCT04583735|39612741|FG000|Double-masked Treatment Period|Adverse Event|0|||
16308194|NCT04583735|39612742|FG001|Double-masked Treatment Period|Adverse Event|1|||
16308195|NCT04583735|39612741|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
16308196|NCT04583735|39612742|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
16308197|NCT04583735|39612741|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
16308198|NCT04583735|39612742|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
16308199|NCT04583735|39612741|FG000|Open-label Treatment Period|Adverse Event|1|||
16308200|NCT04583735|39612742|FG001|Open-label Treatment Period|Adverse Event|1|||
16308201|NCT04583735|39612741|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
16308202|NCT04583735|39612742|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
16308203|NCT04583735|39612741|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
16308204|NCT04583735|39612742|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
16308205|NCT02422797|39612743|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
16308206|NCT02422797|39612744|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
16308207|NCT02422797|39612743|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
16308208|NCT02422797|39612744|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
16308209|NCT02422797|39612743|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
16308210|NCT02422797|39612744|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
16308211|NCT02422797|39612743|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
16308212|NCT02422797|39612744|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
16308213|NCT02422797|39612743|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
16308214|NCT02422797|39612744|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
16308215|NCT02422797|39612743|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
16308216|NCT02422797|39612744|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
16308217|NCT02422797|39612743|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
16495900|NCT04876274|40287723|FG000|Overall Study|Lost to Follow-up|9|||
16495901|NCT04876274|40287724|FG001|Overall Study|Lost to Follow-up|12|||
16495902|NCT00710710|40287726|FG000|Overall Study|Consent withdrawn|2|||
16495903|NCT00710710|40287727|FG001|Overall Study|Consent withdrawn|2|||
16495904|NCT00710710|40287726|FG000|Overall Study|Protocol Violation|0|||
16495905|NCT00710710|40287727|FG001|Overall Study|Protocol Violation|1|||
16495906|NCT00710710|40287726|FG000|Overall Study|Adverse Event|3|||
16495907|NCT00710710|40287727|FG001|Overall Study|Adverse Event|3|||
16495908|NCT00710710|40287726|FG000|Overall Study|Progressive disease|40|||
16495909|NCT00710710|40287727|FG001|Overall Study|Progressive disease|38|||
16495910|NCT02674529|40287728|FG000|Overall Study|Lost to Follow-up|1|||
16495911|NCT02674529|40287729|FG001|Overall Study|Lost to Follow-up|2|||
16495912|NCT02674529|40287728|FG000|Overall Study|Withdrawal by Subject|2|||
16495913|NCT02674529|40287729|FG001|Overall Study|Withdrawal by Subject|1|||
16495914|NCT02674529|40287728|FG000|Overall Study|Physician Decision|0|||
16495915|NCT02674529|40287729|FG001|Overall Study|Physician Decision|1|||
16495916|NCT02674529|40287728|FG000|Overall Study|Protocol Violation|0|||
16495917|NCT02674529|40287729|FG001|Overall Study|Protocol Violation|1|||
16495918|NCT03406104|40287730|FG000|Overall Study|Lost to Follow-up|2|||
16495919|NCT03406104|40287730|FG000|Overall Study|Withdrawal by Subject|2|||
16495920|NCT03406104|40287730|FG000|Overall Study|due to Covid patient did not want to travel|1|||
16495921|NCT03406104|40287730|FG000|Overall Study|Death|2|||
16495922|NCT03633695|40287731|FG000|Overall Study|Lost to Follow-up|4|||
16495923|NCT03633695|40287732|FG001|Overall Study|Lost to Follow-up|5|||
16495924|NCT03633695|40287731|FG000|Overall Study|Discontinued|8|||
16495925|NCT03633695|40287732|FG001|Overall Study|Discontinued|4|||
16495926|NCT03694821|40287733|FG000|Overall Study|Study terminated|4|||
16495927|NCT03694821|40287734|FG001|Overall Study|Study terminated|8|||
16495928|NCT03694821|40287735|FG002|Overall Study|Study terminated|4|||
16194091|NCT04167306|39188685|FG001|Overall Study|Withdrawal by Subject|6|||
16308218|NCT02422797|39612744|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
16308219|NCT02422797|39612743|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
16495929|NCT02279420|40287736|FG000|Overall Study|Lost to Follow-up|23|||
16495930|NCT03291808|40287737|FG000|Overall Study|Lost to Follow-up|6|||
16495931|NCT03291808|40287737|FG000|Overall Study|Research burden|4|||
16495932|NCT00005937|40287738|FG000|Overall Study|Lack of Efficacy|5|||
16308220|NCT02422797|39612744|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
16495933|NCT03334448|40287739|FG000|Washout|Personal Reason|0|||
16308221|NCT02422797|39612743|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
16308222|NCT02422797|39612744|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
16194092|NCT04167306|39188686|FG002|Overall Study|Withdrawal by Subject|8|||
16194093|NCT04167306|39188687|FG003|Overall Study|Withdrawal by Subject|3|||
16194094|NCT04167306|39188684|FG000|Overall Study|covid|1|||
16194095|NCT04167306|39188685|FG001|Overall Study|covid|1|||
16194096|NCT04167306|39188686|FG002|Overall Study|covid|2|||
16194097|NCT04167306|39188687|FG003|Overall Study|covid|1|||
16194098|NCT04167306|39188684|FG000|Overall Study|concomitant medication|0|||
16194099|NCT04167306|39188685|FG001|Overall Study|concomitant medication|0|||
16194100|NCT04167306|39188686|FG002|Overall Study|concomitant medication|0|||
16194101|NCT04167306|39188687|FG003|Overall Study|concomitant medication|1|||
16495934|NCT03334448|40287740|FG001|Washout|Personal Reason|1|||
16495935|NCT03334448|40287741|FG002|Washout|Personal Reason|0|||
16495936|NCT03334448|40287742|FG003|Washout|Personal Reason|0|||
16495937|NCT03334448|40287739|FG000|Washout|Protocol Violation|0|||
16194102|NCT04167306|39188684|FG000|Overall Study|Alcohol treatment|0|||
16194103|NCT04167306|39188685|FG001|Overall Study|Alcohol treatment|4|||
16308223|NCT02422797|39612743|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
16308224|NCT02422797|39612744|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
16308225|NCT02422797|39612743|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
16308226|NCT02422797|39612744|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
16308227|NCT02422797|39612743|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
16308228|NCT02422797|39612744|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
16308229|NCT02422797|39612743|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
16308230|NCT02422797|39612744|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
16308231|NCT02422797|39612743|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
16308232|NCT02422797|39612744|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
16495938|NCT03334448|40287740|FG001|Washout|Protocol Violation|0|||
16495939|NCT03334448|40287741|FG002|Washout|Protocol Violation|0|||
16194104|NCT04167306|39188686|FG002|Overall Study|Alcohol treatment|3|||
16194105|NCT04167306|39188687|FG003|Overall Study|Alcohol treatment|2|||
16194106|NCT04167306|39188684|FG000|Overall Study|non-compliance|0|||
16194107|NCT04167306|39188685|FG001|Overall Study|non-compliance|0|||
16194108|NCT04167306|39188686|FG002|Overall Study|non-compliance|1|||
16194109|NCT04167306|39188687|FG003|Overall Study|non-compliance|0|||
16194110|NCT04167306|39188684|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
16194111|NCT04167306|39188685|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
16194112|NCT04167306|39188686|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
16194113|NCT04167306|39188687|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
16194114|NCT00617409|39188692|FG000|Overall Study|Withdrawal by Subject|4|||
16194115|NCT00617409|39188693|FG001|Overall Study|Withdrawal by Subject|1|||
16194116|NCT00617409|39188694|FG002|Overall Study|Withdrawal by Subject|2|||
16194117|NCT00617409|39188692|FG000|Overall Study|Adverse Event|0|||
16194118|NCT00617409|39188693|FG001|Overall Study|Adverse Event|2|||
16194119|NCT00617409|39188694|FG002|Overall Study|Adverse Event|3|||
16194120|NCT00617409|39188692|FG000|Overall Study|Disease Progression|8|||
16194121|NCT00617409|39188693|FG001|Overall Study|Disease Progression|8|||
16194122|NCT00617409|39188694|FG002|Overall Study|Disease Progression|18|||
16194123|NCT00617409|39188692|FG000|Overall Study|Death|3|||
16194124|NCT00617409|39188693|FG001|Overall Study|Death|5|||
16194125|NCT00617409|39188694|FG002|Overall Study|Death|4|||
16194126|NCT00617409|39188692|FG000|Overall Study|Alternative Therapy|1|||
16194127|NCT00617409|39188693|FG001|Overall Study|Alternative Therapy|2|||
16194128|NCT00617409|39188694|FG002|Overall Study|Alternative Therapy|0|||
16194129|NCT03453151|39188697|FG000|Overall Study|Withdrawal by Subject|1|||
16194130|NCT03453151|39188697|FG000|Overall Study|Physician Decision|3|||
16194131|NCT01201798|39188701|FG000|Overall Study|Adverse Event|2|||
16194132|NCT01201798|39188702|FG001|Overall Study|Adverse Event|0|||
16194133|NCT01201798|39188701|FG000|Overall Study|Lost to Follow-up|3|||
16194134|NCT01201798|39188702|FG001|Overall Study|Lost to Follow-up|5|||
16194135|NCT01201798|39188701|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
16194136|NCT01201798|39188702|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
16194137|NCT01201798|39188701|FG000|Overall Study|Noncompliance|1|||
16194138|NCT01201798|39188702|FG001|Overall Study|Noncompliance|0|||
16194139|NCT01201798|39188701|FG000|Overall Study|Protocol Violation|1|||
16194140|NCT01201798|39188702|FG001|Overall Study|Protocol Violation|1|||
16194141|NCT01201798|39188701|FG000|Overall Study|Treatment Failure|1|||
16194142|NCT01201798|39188702|FG001|Overall Study|Treatment Failure|8|||
16194143|NCT01202227|39188703|FG000|Overall Study|Adverse Event|16|||
16194144|NCT01202227|39188703|FG000|Overall Study|Withdrawal by Subject|2|||
16194145|NCT01202227|39188703|FG000|Overall Study|Lack of Efficacy|1|||
16194146|NCT01617187|39188704|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
16194147|NCT01617187|39188705|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
16273263|NCT01541215|39484477|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
16194148|NCT01617187|39188706|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
16194149|NCT01617187|39188707|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
16194150|NCT01617187|39188704|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
16194151|NCT01617187|39188705|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
16194152|NCT01617187|39188706|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
16194153|NCT01617187|39188707|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
16194154|NCT01617187|39188704|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
16194155|NCT01617187|39188705|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
16194156|NCT01617187|39188706|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
16194157|NCT01617187|39188707|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
16194158|NCT01617187|39188704|FG000|Treatment Through Study Completion|Adverse Event|1|||
16194159|NCT01617187|39188705|FG001|Treatment Through Study Completion|Adverse Event|1|||
16194160|NCT01617187|39188706|FG002|Treatment Through Study Completion|Adverse Event|0|||
16194161|NCT01617187|39188707|FG003|Treatment Through Study Completion|Adverse Event|1|||
16194162|NCT01617187|39188704|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
16194163|NCT01617187|39188705|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
16194164|NCT01617187|39188706|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
16194165|NCT01617187|39188707|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
16194166|NCT01617187|39188704|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
16194167|NCT01617187|39188705|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
16194168|NCT01617187|39188706|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
16194169|NCT01617187|39188707|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
16194170|NCT01617187|39188704|FG000|Treatment Through Study Completion|Protocol Violation|1|||
16194171|NCT01617187|39188705|FG001|Treatment Through Study Completion|Protocol Violation|0|||
16194172|NCT01617187|39188706|FG002|Treatment Through Study Completion|Protocol Violation|0|||
16194173|NCT01617187|39188707|FG003|Treatment Through Study Completion|Protocol Violation|1|||
16194174|NCT01185249|39188710|FG000|Overall Study|Patients discharged or change in status|42|||
16194175|NCT00502307|39188711|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
16194176|NCT00502307|39188712|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
16194177|NCT00502307|39188713|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
16194178|NCT00502307|39188711|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
16194179|NCT00502307|39188712|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
16194180|NCT00502307|39188713|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
16194181|NCT00502307|39188711|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
16194182|NCT00502307|39188712|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
16194183|NCT00502307|39188713|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
16194184|NCT00502307|39188711|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
16194185|NCT00502307|39188712|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
16194186|NCT00502307|39188713|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
16194187|NCT00502307|39188711|FG000|Maintenance Period|Progressive disease|80|||
16194188|NCT00502307|39188712|FG001|Maintenance Period|Progressive disease|0|||
16194189|NCT00502307|39188713|FG002|Maintenance Period|Progressive disease|0|||
16194190|NCT00502307|39188711|FG000|Maintenance Period|Discontinued due to other reasons|68|||
16194191|NCT00502307|39188712|FG001|Maintenance Period|Discontinued due to other reasons|0|||
16194192|NCT00502307|39188713|FG002|Maintenance Period|Discontinued due to other reasons|0|||
16194193|NCT02927873|39188714|FG000|Overall Study|Lost to Follow-up|0|||
16194194|NCT02927873|39188715|FG001|Overall Study|Lost to Follow-up|1|||
16194195|NCT02927873|39188716|FG002|Overall Study|Lost to Follow-up|0|||
16194196|NCT02927873|39188717|FG003|Overall Study|Lost to Follow-up|0|||
16194197|NCT02927873|39188718|FG004|Overall Study|Lost to Follow-up|0|||
16194198|NCT02927873|39188719|FG005|Overall Study|Lost to Follow-up|0|||
16194199|NCT02927873|39188714|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
16194200|NCT02927873|39188715|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
16194201|NCT02927873|39188716|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
16194202|NCT02927873|39188717|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
16194203|NCT02927873|39188718|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
16194204|NCT02927873|39188719|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
16194205|NCT02927873|39188714|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16194206|NCT02927873|39188715|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16194207|NCT02927873|39188716|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16194208|NCT02927873|39188717|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16194209|NCT02927873|39188718|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16194210|NCT02927873|39188719|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16194211|NCT02927873|39188714|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
16194212|NCT02927873|39188715|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
16194213|NCT02927873|39188716|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
16308233|NCT02422797|39612743|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
16308234|NCT02422797|39612744|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
16308235|NCT02422797|39612743|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
16308236|NCT02422797|39612744|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
16308237|NCT02422797|39612743|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
16308238|NCT02422797|39612744|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
16308239|NCT02422797|39612743|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
16308240|NCT02422797|39612744|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
16308241|NCT02422797|39612743|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
16308242|NCT02422797|39612744|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
16308243|NCT02422797|39612743|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
16308244|NCT02422797|39612744|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
16308245|NCT02422797|39612743|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
16308246|NCT02422797|39612744|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
16495940|NCT03334448|40287742|FG003|Washout|Protocol Violation|1|||
16495941|NCT01442493|40287748|FG000|Overall Study|withdrawn from study|3|||
16495942|NCT01442493|40287749|FG001|Overall Study|withdrawn from study|2|||
16495943|NCT00180414|40287754|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
16308247|NCT02524847|39612746|FG000|Overall Study|Adverse Event|4|||
16308248|NCT02524847|39612746|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
16308249|NCT02524847|39612746|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
16308250|NCT02524847|39612746|FG000|Overall Study|Death|1|||
16308251|NCT02524847|39612746|FG000|Overall Study|Reason not Specified|1|||
16388236|NCT02185534|39905613|FG004|First Period|Withdrawal by Subject|0|||
16495944|NCT00180414|40287755|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
16495945|NCT04166435|40287756|FG000|Overall Study|2 patients ineligible for response|2|||
16495946|NCT01401283|40287761|FG000|Overall Study|surgery cancelled|5|||
16194214|NCT02927873|39188717|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
16194215|NCT02927873|39188718|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
16194216|NCT02927873|39188719|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
16194217|NCT02927873|39188714|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
16194218|NCT02927873|39188715|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
16194219|NCT02927873|39188716|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
16194220|NCT02927873|39188717|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
16194221|NCT02927873|39188718|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
16194222|NCT02927873|39188719|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
16194223|NCT02927873|39188714|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
16194224|NCT02927873|39188715|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
16194225|NCT02927873|39188716|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
16194226|NCT02927873|39188717|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
16194227|NCT02927873|39188718|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
16194228|NCT02927873|39188719|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
16194229|NCT00444626|39188720|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
16194230|NCT00444626|39188720|FG000|Initial Treatment Period|Adverse Event|1|||
16194231|NCT00444626|39188720|FG000|Initial Treatment Period|Lost to Follow-up|9|||
16194232|NCT03337152|39188721|FG000|Overall Study|Physician Decision|1|||
16194233|NCT03337152|39188722|FG001|Overall Study|Physician Decision|0|||
16194234|NCT03337152|39188721|FG000|Overall Study|Lost to Follow-up|1|||
16194235|NCT03337152|39188722|FG001|Overall Study|Lost to Follow-up|3|||
16194236|NCT03337152|39188721|FG000|Overall Study|Adverse Event|3|||
16194237|NCT03337152|39188722|FG001|Overall Study|Adverse Event|1|||
16194238|NCT03337152|39188721|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
16194239|NCT03337152|39188722|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
16194240|NCT00771030|39188723|FG000|Overall Study|Adverse Event|0|||
16194241|NCT00771030|39188724|FG001|Overall Study|Adverse Event|1|||
16194242|NCT00771030|39188725|FG002|Overall Study|Adverse Event|0|||
16495947|NCT01401283|40287762|FG001|Overall Study|surgery cancelled|8|||
16495948|NCT01401283|40287761|FG000|Overall Study|preoperative arrhythmia|5|||
16495949|NCT01401283|40287762|FG001|Overall Study|preoperative arrhythmia|0|||
16495950|NCT01401283|40287761|FG000|Overall Study|no central venous access|0|||
16495951|NCT01401283|40287762|FG001|Overall Study|no central venous access|1|||
16495952|NCT01401283|40287761|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
16495953|NCT01401283|40287762|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
16495954|NCT03552198|40287763|FG000|Overall Study|Lost to Follow-up|42|||
16194243|NCT00771030|39188726|FG003|Overall Study|Adverse Event|0|||
16194244|NCT00771030|39188727|FG004|Overall Study|Adverse Event|0|||
16194245|NCT00771030|39188728|FG005|Overall Study|Adverse Event|0|||
16495955|NCT03552198|40287764|FG001|Overall Study|Lost to Follow-up|48|||
16495956|NCT03552198|40287765|FG002|Overall Study|Lost to Follow-up|15|||
16495957|NCT03552198|40287766|FG003|Overall Study|Lost to Follow-up|19|||
16495958|NCT03552198|40287763|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
16495959|NCT03552198|40287764|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
16495960|NCT03552198|40287765|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
16495961|NCT03552198|40287766|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
16495962|NCT03552198|40287763|FG000|Overall Study|Did not receive air alerts|1|||
16495963|NCT03552198|40287764|FG001|Overall Study|Did not receive air alerts|0|||
16495964|NCT03552198|40287765|FG002|Overall Study|Did not receive air alerts|0|||
16495965|NCT03552198|40287766|FG003|Overall Study|Did not receive air alerts|1|||
16495966|NCT00137046|40287768|FG000|Overall Study|Death|2|||
16495967|NCT00137046|40287769|FG001|Overall Study|Death|1|||
16495968|NCT00137046|40287768|FG000|Overall Study|Adverse Event|16|||
16495969|NCT00137046|40287769|FG001|Overall Study|Adverse Event|5|||
16495970|NCT00137046|40287768|FG000|Overall Study|Laboratory Abnormality|2|||
16495971|NCT00137046|40287769|FG001|Overall Study|Laboratory Abnormality|0|||
16495972|NCT00137046|40287768|FG000|Overall Study|Lack of Efficacy|13|||
16495973|NCT00137046|40287769|FG001|Overall Study|Lack of Efficacy|1|||
16495974|NCT00137046|40287768|FG000|Overall Study|Lost to Follow-up|8|||
16495975|NCT00137046|40287769|FG001|Overall Study|Lost to Follow-up|24|||
16495976|NCT00137046|40287768|FG000|Overall Study|Other|23|||
16495977|NCT00137046|40287769|FG001|Overall Study|Other|19|||
16495978|NCT00137046|40287768|FG000|Overall Study|Withdrawal by Subject|33|||
16495979|NCT00137046|40287769|FG001|Overall Study|Withdrawal by Subject|42|||
16194246|NCT00771030|39188729|FG006|Overall Study|Adverse Event|0|||
16495980|NCT00137046|40287768|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
16495981|NCT00137046|40287769|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
16495982|NCT00137046|40287768|FG000|Overall Study|Withdrew prior to study treatment|1|||
16495983|NCT00137046|40287769|FG001|Overall Study|Withdrew prior to study treatment|1|||
16495984|NCT02452398|40287770|FG000|Overall Study|Adverse Event|1|||
16495985|NCT02452398|40287770|FG000|Overall Study|Lost to Follow-up|28|||
16495986|NCT02452398|40287770|FG000|Overall Study|Physician Decision|2|||
16495987|NCT02452398|40287770|FG000|Overall Study|Withdrawal by Subject|6|||
16495988|NCT02452398|40287770|FG000|Overall Study|Moved away|4|||
16495989|NCT03506815|40287771|FG000|Overall Study|Adverse Event|8|||
16495990|NCT03506815|40287772|FG001|Overall Study|Adverse Event|0|||
16495991|NCT03506815|40287771|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
16495992|NCT03506815|40287772|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
16495993|NCT03506815|40287771|FG000|Overall Study|Protocol Violation|1|||
16085941|NCT00811941|38807012|FG001|All Treated Patients|Non-compliance|8|||
16085942|NCT00811941|38807011|FG000|All Treated Patients|Protocol Violation|5|||
16085943|NCT00811941|38807012|FG001|All Treated Patients|Protocol Violation|17|||
16085944|NCT00811941|38807011|FG000|All Treated Patients|Withdrawal by Subject|35|||
16085945|NCT00811941|38807012|FG001|All Treated Patients|Withdrawal by Subject|94|||
16085946|NCT00811941|38807011|FG000|All Treated Patients|Lost to Follow-up|3|||
16085947|NCT00811941|38807012|FG001|All Treated Patients|Lost to Follow-up|12|||
16085948|NCT00811941|38807011|FG000|All Treated Patients|Other Reason|4|||
16085949|NCT00811941|38807012|FG001|All Treated Patients|Other Reason|14|||
16085950|NCT01555138|38807013|FG000|Overall Study|Death|0|||
16085951|NCT01555138|38807014|FG001|Overall Study|Death|1|||
16085952|NCT01555138|38807013|FG000|Overall Study|Lost to Follow-up|1|||
16085953|NCT01555138|38807014|FG001|Overall Study|Lost to Follow-up|0|||
16085954|NCT01555138|38807013|FG000|Overall Study|Abnormal Lab reults|1|||
16085955|NCT01555138|38807014|FG001|Overall Study|Abnormal Lab reults|3|||
16085956|NCT01555138|38807013|FG000|Overall Study|Lack of Efficacy|2|||
16085957|NCT01555138|38807014|FG001|Overall Study|Lack of Efficacy|2|||
16085958|NCT01555138|38807013|FG000|Overall Study|Protocol Violation|5|||
16085959|NCT01555138|38807014|FG001|Overall Study|Protocol Violation|3|||
16085960|NCT01555138|38807013|FG000|Overall Study|Administrative problems|8|||
16085961|NCT01555138|38807014|FG001|Overall Study|Administrative problems|0|||
16085962|NCT01555138|38807013|FG000|Overall Study|Withdrawal by Subject|16|||
16085963|NCT01555138|38807014|FG001|Overall Study|Withdrawal by Subject|15|||
16085964|NCT01555138|38807013|FG000|Overall Study|Adverse Event|14|||
16085965|NCT01555138|38807014|FG001|Overall Study|Adverse Event|14|||
16085966|NCT03520036|38807015|FG000|Overall Study|Adverse Event|1|||
16085967|NCT03520036|38807016|FG001|Overall Study|Adverse Event|2|||
16085968|NCT03520036|38807017|FG002|Overall Study|Adverse Event|0|||
16085969|NCT03520036|38807015|FG000|Overall Study|Protocol Violation|1|||
16085970|NCT03520036|38807016|FG001|Overall Study|Protocol Violation|0|||
16085971|NCT03520036|38807017|FG002|Overall Study|Protocol Violation|0|||
16085972|NCT03520036|38807015|FG000|Overall Study|Withdrawal by Subject|0|||
16085973|NCT03520036|38807016|FG001|Overall Study|Withdrawal by Subject|1|||
16085974|NCT03520036|38807017|FG002|Overall Study|Withdrawal by Subject|4|||
16085975|NCT03520036|38807015|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
16495994|NCT03506815|40287772|FG001|Overall Study|Protocol Violation|0|||
16495995|NCT03506815|40287771|FG000|Overall Study|Elective Surgery|1|||
16495996|NCT03506815|40287772|FG001|Overall Study|Elective Surgery|0|||
16495997|NCT00850564|40287775|FG000|Overall Study|Withdrawal by Subject|2|||
16495998|NCT02049957|40287776|FG000|Overall Study|Progressive Disease|5|||
16495999|NCT02049957|40287777|FG001|Overall Study|Progressive Disease|4|||
16496000|NCT02049957|40287778|FG002|Overall Study|Progressive Disease|2|||
16496001|NCT02049957|40287779|FG003|Overall Study|Progressive Disease|2|||
16496002|NCT02049957|40287780|FG004|Overall Study|Progressive Disease|6|||
16496003|NCT02049957|40287781|FG005|Overall Study|Progressive Disease|35|||
16496004|NCT02049957|40287782|FG006|Overall Study|Progressive Disease|7|||
16496005|NCT02049957|40287783|FG007|Overall Study|Progressive Disease|26|||
16496006|NCT02049957|40287784|FG008|Overall Study|Progressive Disease|6|||
16496007|NCT02049957|40287776|FG000|Overall Study|Adverse Event|1|||
16496008|NCT02049957|40287777|FG001|Overall Study|Adverse Event|1|||
16496009|NCT02049957|40287778|FG002|Overall Study|Adverse Event|1|||
16496010|NCT02049957|40287779|FG003|Overall Study|Adverse Event|0|||
16496011|NCT02049957|40287780|FG004|Overall Study|Adverse Event|0|||
16496012|NCT02049957|40287781|FG005|Overall Study|Adverse Event|5|||
16496013|NCT02049957|40287782|FG006|Overall Study|Adverse Event|0|||
16496014|NCT02049957|40287783|FG007|Overall Study|Adverse Event|6|||
16496015|NCT02049957|40287784|FG008|Overall Study|Adverse Event|1|||
16496016|NCT02049957|40287776|FG000|Overall Study|Study Terminated by Sponsor|0|||
16496017|NCT02049957|40287777|FG001|Overall Study|Study Terminated by Sponsor|1|||
16085976|NCT03520036|38807016|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
16085977|NCT03520036|38807017|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
16085978|NCT01171976|38807018|FG000|Overall Study|Protocol Violation|0|||
16085979|NCT01171976|38807019|FG001|Overall Study|Protocol Violation|0|||
16085980|NCT01171976|38807020|FG002|Overall Study|Protocol Violation|1|||
16085981|NCT01171976|38807018|FG000|Overall Study|Death|2|||
16085982|NCT01171976|38807019|FG001|Overall Study|Death|4|||
16085983|NCT01171976|38807020|FG002|Overall Study|Death|1|||
16085984|NCT01171976|38807018|FG000|Overall Study|Lost to Follow-up|4|||
16496018|NCT02049957|40287778|FG002|Overall Study|Study Terminated by Sponsor|0|||
16496019|NCT02049957|40287779|FG003|Overall Study|Study Terminated by Sponsor|0|||
16496020|NCT02049957|40287780|FG004|Overall Study|Study Terminated by Sponsor|0|||
16496021|NCT02049957|40287781|FG005|Overall Study|Study Terminated by Sponsor|0|||
16496022|NCT02049957|40287782|FG006|Overall Study|Study Terminated by Sponsor|1|||
16496023|NCT02049957|40287783|FG007|Overall Study|Study Terminated by Sponsor|0|||
16496024|NCT02049957|40287784|FG008|Overall Study|Study Terminated by Sponsor|0|||
16496025|NCT02049957|40287776|FG000|Overall Study|Withdrawal by Subject|0|||
16496026|NCT02049957|40287777|FG001|Overall Study|Withdrawal by Subject|0|||
16496027|NCT02049957|40287778|FG002|Overall Study|Withdrawal by Subject|0|||
16496028|NCT02049957|40287779|FG003|Overall Study|Withdrawal by Subject|1|||
16496029|NCT02049957|40287780|FG004|Overall Study|Withdrawal by Subject|0|||
16496030|NCT02049957|40287781|FG005|Overall Study|Withdrawal by Subject|2|||
16496031|NCT02049957|40287782|FG006|Overall Study|Withdrawal by Subject|0|||
16496032|NCT02049957|40287783|FG007|Overall Study|Withdrawal by Subject|3|||
16496033|NCT02049957|40287784|FG008|Overall Study|Withdrawal by Subject|1|||
16496034|NCT02049957|40287776|FG000|Overall Study|Physician Decision|0|||
16496035|NCT02049957|40287777|FG001|Overall Study|Physician Decision|0|||
16496036|NCT02049957|40287778|FG002|Overall Study|Physician Decision|0|||
16496037|NCT02049957|40287779|FG003|Overall Study|Physician Decision|0|||
16496038|NCT02049957|40287780|FG004|Overall Study|Physician Decision|0|||
16496039|NCT02049957|40287781|FG005|Overall Study|Physician Decision|1|||
16496040|NCT02049957|40287782|FG006|Overall Study|Physician Decision|0|||
16496041|NCT02049957|40287783|FG007|Overall Study|Physician Decision|0|||
16496042|NCT02049957|40287784|FG008|Overall Study|Physician Decision|0|||
16496043|NCT01124422|40287785|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
16496044|NCT01124422|40287786|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
16496045|NCT01124422|40287787|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
16496046|NCT01124422|40287785|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
16496047|NCT01124422|40287786|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
16496048|NCT01124422|40287787|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
16496049|NCT01124422|40287785|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
16496050|NCT01124422|40287786|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
16496051|NCT01124422|40287787|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
16496052|NCT01124422|40287785|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
16496053|NCT01124422|40287786|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
16496054|NCT01124422|40287787|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
16496055|NCT01124422|40287785|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
16496056|NCT01124422|40287786|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
16496057|NCT01124422|40287787|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
16496058|NCT01124422|40287785|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
16496059|NCT01124422|40287786|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
16496060|NCT01124422|40287787|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
16496061|NCT01124422|40287785|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
16496062|NCT01124422|40287786|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
16496063|NCT01124422|40287787|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
16496064|NCT01124422|40287785|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
16496065|NCT01124422|40287786|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
16496066|NCT01124422|40287787|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
16496067|NCT01124422|40287785|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
16496068|NCT01124422|40287786|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
16496069|NCT01124422|40287787|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
16496070|NCT01124422|40287785|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
16496071|NCT01124422|40287786|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
16496072|NCT01124422|40287787|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
16496073|NCT02013791|40287788|FG000|Period 1|Lost to Follow-up|0|||
16496074|NCT02013791|40287789|FG001|Period 1|Lost to Follow-up|0|||
16496075|NCT02013791|40287790|FG002|Period 1|Lost to Follow-up|0|||
16496076|NCT02013791|40287791|FG003|Period 1|Lost to Follow-up|1|||
16496077|NCT02013791|40287792|FG004|Period 1|Lost to Follow-up|0|||
16496078|NCT02013791|40287793|FG005|Period 1|Lost to Follow-up|0|||
16496079|NCT02013791|40287794|FG006|Period 1|Lost to Follow-up|1|||
16496080|NCT02013791|40287795|FG007|Period 1|Lost to Follow-up|1|||
16496081|NCT02013791|40287796|FG008|Period 1|Lost to Follow-up|0|||
16496082|NCT02013791|40287788|FG000|Period 1|Other Miscellaneous Reasons|0|||
16496083|NCT02013791|40287789|FG001|Period 1|Other Miscellaneous Reasons|2|||
16496084|NCT02013791|40287790|FG002|Period 1|Other Miscellaneous Reasons|0|||
16496085|NCT02013791|40287791|FG003|Period 1|Other Miscellaneous Reasons|0|||
16496086|NCT02013791|40287792|FG004|Period 1|Other Miscellaneous Reasons|0|||
16496087|NCT02013791|40287793|FG005|Period 1|Other Miscellaneous Reasons|0|||
16496088|NCT02013791|40287794|FG006|Period 1|Other Miscellaneous Reasons|0|||
16496089|NCT02013791|40287795|FG007|Period 1|Other Miscellaneous Reasons|0|||
16496090|NCT02013791|40287796|FG008|Period 1|Other Miscellaneous Reasons|0|||
16496091|NCT01244425|40287799|FG000|Overall Study|Withdrawal by Subject|2|||
16496092|NCT01244425|40287800|FG001|Overall Study|Withdrawal by Subject|2|||
16496093|NCT01244425|40287799|FG000|Overall Study|Adverse Event|1|||
16496094|NCT01244425|40287800|FG001|Overall Study|Adverse Event|1|||
16496095|NCT05227027|40287801|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
16496096|NCT05227027|40287802|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
16496097|NCT01426373|40287803|FG000|Overall Study|Adverse Event|6|||
16496098|NCT01426373|40287803|FG000|Overall Study|Lost to Follow-up|14|||
16308252|NCT02286843|39612747|FG000|Overall Study|Not Treated|4|||
16308253|NCT02286843|39612747|FG000|Overall Study|Protocol Violation|1|||
16308254|NCT02286843|39612747|FG000|Overall Study|Withdrawal by Subject|1|||
16308255|NCT00967330|39612748|FG000|Overall Study|Protocol Violation|3|||
16308256|NCT00967330|39612749|FG001|Overall Study|Protocol Violation|4|||
16308257|NCT00967330|39612748|FG000|Overall Study|Regular|10|||
16308258|NCT00967330|39612749|FG001|Overall Study|Regular|3|||
16308259|NCT00967330|39612748|FG000|Overall Study|Withdrawal by Subject|6|||
16308260|NCT00967330|39612749|FG001|Overall Study|Withdrawal by Subject|0|||
16308261|NCT00967330|39612748|FG000|Overall Study|Lost to Follow-up|1|||
16308262|NCT00967330|39612749|FG001|Overall Study|Lost to Follow-up|1|||
16308263|NCT00967330|39612748|FG000|Overall Study|Death|102|||
16308264|NCT00967330|39612749|FG001|Overall Study|Death|51|||
16308265|NCT00967330|39612748|FG000|Overall Study|Severe protocol deviation|0|||
16308266|NCT00967330|39612749|FG001|Overall Study|Severe protocol deviation|1|||
16308267|NCT04263311|39612750|FG000|Overall Study|Lost to Follow-up|1|||
16308268|NCT04263311|39612751|FG001|Overall Study|Lost to Follow-up|2|||
16308269|NCT04263311|39612750|FG000|Overall Study|Health Issues|1|||
16308270|NCT04263311|39612751|FG001|Overall Study|Health Issues|0|||
16308271|NCT04263311|39612750|FG000|Overall Study|Left the country|1|||
16308272|NCT04263311|39612751|FG001|Overall Study|Left the country|0|||
16308273|NCT04263311|39612750|FG000|Overall Study|Unable to maintain time commitment|1|||
16308274|NCT04263311|39612751|FG001|Overall Study|Unable to maintain time commitment|0|||
16308275|NCT04263311|39612750|FG000|Overall Study|No longer interested|1|||
16308276|NCT04263311|39612751|FG001|Overall Study|No longer interested|0|||
16308277|NCT02413229|39612754|FG000|Overall Study|Adverse Event|0|||
16308278|NCT02413229|39612755|FG001|Overall Study|Adverse Event|0|||
16308279|NCT02413229|39612756|FG002|Overall Study|Adverse Event|0|||
16308280|NCT02413229|39612757|FG003|Overall Study|Adverse Event|1|||
16308281|NCT02413229|39612758|FG004|Overall Study|Adverse Event|0|||
16308282|NCT02413229|39612759|FG005|Overall Study|Adverse Event|0|||
16308283|NCT02413229|39612760|FG006|Overall Study|Adverse Event|0|||
16308284|NCT02413229|39612761|FG007|Overall Study|Adverse Event|1|||
16308285|NCT02413229|39612754|FG000|Overall Study|Lost to Follow-up|0|||
16308286|NCT02413229|39612755|FG001|Overall Study|Lost to Follow-up|0|||
16308287|NCT02413229|39612756|FG002|Overall Study|Lost to Follow-up|1|||
16388237|NCT02185534|39905614|FG005|First Period|Withdrawal by Subject|0|||
16388238|NCT02185534|39905609|FG000|First Washout Period|Withdrawal by Subject|1|||
16194247|NCT04776148|39188730|FG000|Overall Study|Death|172|||
16388239|NCT02185534|39905610|FG001|First Washout Period|Withdrawal by Subject|0|||
16388240|NCT02185534|39905611|FG002|First Washout Period|Withdrawal by Subject|0|||
16388241|NCT02185534|39905612|FG003|First Washout Period|Withdrawal by Subject|0|||
16388242|NCT02185534|39905613|FG004|First Washout Period|Withdrawal by Subject|1|||
16388243|NCT02185534|39905614|FG005|First Washout Period|Withdrawal by Subject|0|||
16388244|NCT02185534|39905609|FG000|First Washout Period|Protocol Violation|0|||
16388245|NCT02185534|39905610|FG001|First Washout Period|Protocol Violation|0|||
16496099|NCT01426373|40287803|FG000|Overall Study|Participant Convenience|10|||
16496100|NCT01426373|40287803|FG000|Overall Study|Miscellaneous Reasons|4|||
16496101|NCT00142584|40287804|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
16496102|NCT00142584|40287805|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
16496103|NCT00142584|40287804|FG000|Overall Study|Withdrawal by Subject|30|||
16496104|NCT00142584|40287805|FG001|Overall Study|Withdrawal by Subject|16|||
16496105|NCT00142584|40287804|FG000|Overall Study|Lost to Follow-up|22|||
16496106|NCT00142584|40287805|FG001|Overall Study|Lost to Follow-up|12|||
16496107|NCT00142584|40287804|FG000|Overall Study|Adverse Event|14|||
16496108|NCT00142584|40287805|FG001|Overall Study|Adverse Event|5|||
16496109|NCT00142584|40287804|FG000|Overall Study|Protocol Violation|4|||
16496110|NCT00142584|40287805|FG001|Overall Study|Protocol Violation|7|||
16496111|NCT00142584|40287804|FG000|Overall Study|Treatment Failure|2|||
16308288|NCT02413229|39612757|FG003|Overall Study|Lost to Follow-up|0|||
16308289|NCT02413229|39612758|FG004|Overall Study|Lost to Follow-up|2|||
16308290|NCT02413229|39612759|FG005|Overall Study|Lost to Follow-up|0|||
16496112|NCT00142584|40287805|FG001|Overall Study|Treatment Failure|0|||
16308291|NCT02413229|39612760|FG006|Overall Study|Lost to Follow-up|0|||
16308292|NCT02413229|39612761|FG007|Overall Study|Lost to Follow-up|0|||
16308293|NCT02413229|39612754|FG000|Overall Study|Withdrawal by Subject|1|||
16308294|NCT02413229|39612755|FG001|Overall Study|Withdrawal by Subject|1|||
16308295|NCT02413229|39612756|FG002|Overall Study|Withdrawal by Subject|0|||
16496113|NCT03473808|40287815|FG000|Overall Study|Withdrawal by Subject|1|||
16496114|NCT03562481|40287816|FG000|First Intervention|Lost to Follow-up|1|||
16496115|NCT03562481|40287817|FG001|First Intervention|Lost to Follow-up|0|||
16496116|NCT00793403|40287818|FG000|Overall Study|Other|73|||
16496117|NCT00368355|40287819|FG000|Overall Study|Adverse Event|1|||
16496118|NCT00368355|40287820|FG001|Overall Study|Adverse Event|0|||
16496119|NCT00368355|40287819|FG000|Overall Study|Death|2|||
16496120|NCT00368355|40287820|FG001|Overall Study|Death|4|||
16496121|NCT00368355|40287819|FG000|Overall Study|Relapse|6|||
16496122|NCT00368355|40287820|FG001|Overall Study|Relapse|10|||
16496123|NCT00368355|40287819|FG000|Overall Study|Subsequent transplant|0|||
16496124|NCT00368355|40287820|FG001|Overall Study|Subsequent transplant|3|||
16496125|NCT00368355|40287819|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
16496126|NCT00368355|40287820|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
16496127|NCT00856284|40287821|FG000|Overall Study|Hyperglycemic rescue|231|||
16496128|NCT00856284|40287822|FG001|Overall Study|Hyperglycemic rescue|201|||
16496129|NCT00856284|40287823|FG002|Overall Study|Hyperglycemic rescue|235|||
16496130|NCT00856284|40287821|FG000|Overall Study|Adverse Event|60|||
16496131|NCT00856284|40287822|FG001|Overall Study|Adverse Event|74|||
16496132|NCT00856284|40287823|FG002|Overall Study|Adverse Event|82|||
16496133|NCT00856284|40287821|FG000|Overall Study|Major protocol deviation|24|||
16496134|NCT00856284|40287822|FG001|Overall Study|Major protocol deviation|16|||
16496135|NCT00856284|40287823|FG002|Overall Study|Major protocol deviation|15|||
16496136|NCT00856284|40287821|FG000|Overall Study|Lost to Follow-up|20|||
16496137|NCT00856284|40287822|FG001|Overall Study|Lost to Follow-up|22|||
16496138|NCT00856284|40287823|FG002|Overall Study|Lost to Follow-up|28|||
16496139|NCT00856284|40287821|FG000|Overall Study|Voluntary withdrawal|48|||
16496140|NCT00856284|40287822|FG001|Overall Study|Voluntary withdrawal|52|||
16496141|NCT00856284|40287823|FG002|Overall Study|Voluntary withdrawal|62|||
16496142|NCT00856284|40287821|FG000|Overall Study|Pregnancy|1|||
16496143|NCT00856284|40287822|FG001|Overall Study|Pregnancy|2|||
16496144|NCT00856284|40287823|FG002|Overall Study|Pregnancy|0|||
16496145|NCT00856284|40287821|FG000|Overall Study|Investigator discretion|9|||
16496146|NCT00856284|40287822|FG001|Overall Study|Investigator discretion|8|||
16496147|NCT00856284|40287823|FG002|Overall Study|Investigator discretion|10|||
16496148|NCT00856284|40287821|FG000|Overall Study|Other|15|||
16496149|NCT00856284|40287822|FG001|Overall Study|Other|17|||
16496150|NCT00856284|40287823|FG002|Overall Study|Other|14|||
16496151|NCT00856284|40287821|FG000|Overall Study|Randomized in error|0|||
16496152|NCT00856284|40287822|FG001|Overall Study|Randomized in error|0|||
16496153|NCT00856284|40287823|FG002|Overall Study|Randomized in error|1|||
16496154|NCT00592839|40287824|FG000|Overall Study|Withdrawal by Subject|1|||
16496155|NCT00592839|40287825|FG001|Overall Study|Withdrawal by Subject|1|||
16496156|NCT00592839|40287826|FG002|Overall Study|Withdrawal by Subject|3|||
16496157|NCT00592839|40287824|FG000|Overall Study|Protocol Violation|1|||
16496158|NCT00592839|40287825|FG001|Overall Study|Protocol Violation|1|||
16496159|NCT00592839|40287826|FG002|Overall Study|Protocol Violation|2|||
16496160|NCT00592839|40287824|FG000|Overall Study|Adverse Event|0|||
16496161|NCT00592839|40287825|FG001|Overall Study|Adverse Event|1|||
16496162|NCT00592839|40287826|FG002|Overall Study|Adverse Event|0|||
16496163|NCT00592839|40287824|FG000|Overall Study|Lost to Follow-up|0|||
16496164|NCT00592839|40287825|FG001|Overall Study|Lost to Follow-up|1|||
16496165|NCT00592839|40287826|FG002|Overall Study|Lost to Follow-up|1|||
16496166|NCT01722071|40287828|FG000|Overall Study|Protocol Violation|1|||
16496167|NCT01722071|40287829|FG001|Overall Study|Protocol Violation|0|||
16496168|NCT00459108|40287830|FG000|Overall Study|Withdrawal by Subject|5|||
16496169|NCT00459108|40287830|FG000|Overall Study|Adverse Event|3|||
16496170|NCT00459108|40287830|FG000|Overall Study|Death|2|||
16496171|NCT00459108|40287830|FG000|Overall Study|Progression|1|||
16496172|NCT03489720|40287831|FG000|Overall Study|Withdrawal by Subject|2|||
16496173|NCT03489720|40287832|FG001|Overall Study|Withdrawal by Subject|0|||
16496174|NCT01824394|40287833|FG000|Overall Study|Early Termination|1|||
16496175|NCT01824394|40287834|FG001|Overall Study|Early Termination|1|||
16496176|NCT01824394|40287835|FG002|Overall Study|Early Termination|3|||
16496177|NCT01824394|40287833|FG000|Overall Study|Withdrawn due to Study Termination|91|||
16085985|NCT01171976|38807019|FG001|Overall Study|Lost to Follow-up|0|||
16085986|NCT01171976|38807020|FG002|Overall Study|Lost to Follow-up|2|||
16085987|NCT01171976|38807018|FG000|Overall Study|Withdrawal by Subject|1|||
16085988|NCT01171976|38807019|FG001|Overall Study|Withdrawal by Subject|5|||
16085989|NCT01171976|38807020|FG002|Overall Study|Withdrawal by Subject|6|||
16085990|NCT01171976|38807018|FG000|Overall Study|Abnormal test result|1|||
16085991|NCT01171976|38807019|FG001|Overall Study|Abnormal test result|0|||
16085992|NCT01171976|38807020|FG002|Overall Study|Abnormal test result|0|||
16085993|NCT01171976|38807018|FG000|Overall Study|Adverse Event|6|||
16085994|NCT01171976|38807019|FG001|Overall Study|Adverse Event|2|||
16085995|NCT01171976|38807020|FG002|Overall Study|Adverse Event|5|||
16085996|NCT00650104|38807021|FG000|Overall Study|Adverse Event|17|||
16085997|NCT00650104|38807021|FG000|Overall Study|Death|2|||
16085998|NCT00650104|38807021|FG000|Overall Study|Withdrawal by Subject|11|||
16085999|NCT00650104|38807021|FG000|Overall Study|Physician Decision|7|||
16086000|NCT00650104|38807021|FG000|Overall Study|Lost to Follow-up|1|||
16086001|NCT00650104|38807021|FG000|Overall Study|Non-compliance|2|||
16086002|NCT00650104|38807021|FG000|Overall Study|Sponsor Terminated Dosing|1|||
16086003|NCT01177670|38807022|FG000|Overall Study|Study Terminated|115|||
16086004|NCT01177670|38807022|FG000|Overall Study|Physician Decision|50|||
16086005|NCT01177670|38807022|FG000|Overall Study|Withdrawal by Subject|4|||
16086006|NCT01561300|38807026|FG000|Run in on Placebo|Adverse Event|1|||
16086007|NCT01561300|38807027|FG001|Run in on Placebo|Adverse Event|0|||
16086008|NCT02605174|38807028|FG000|Overall Study|Adverse Event|0|||
16086009|NCT02605174|38807029|FG001|Overall Study|Adverse Event|0|||
16086010|NCT02605174|38807030|FG002|Overall Study|Adverse Event|1|||
16086011|NCT02605174|38807031|FG003|Overall Study|Adverse Event|0|||
16086012|NCT02605174|38807032|FG004|Overall Study|Adverse Event|4|||
16086013|NCT02605174|38807033|FG005|Overall Study|Adverse Event|0|||
16086014|NCT02605174|38807034|FG006|Overall Study|Adverse Event|0|||
16086015|NCT02605174|38807028|FG000|Overall Study|Lost to Follow-up|20|||
16086016|NCT02605174|38807029|FG001|Overall Study|Lost to Follow-up|7|||
16086017|NCT02605174|38807030|FG002|Overall Study|Lost to Follow-up|27|||
16086018|NCT02605174|38807031|FG003|Overall Study|Lost to Follow-up|10|||
16086019|NCT02605174|38807032|FG004|Overall Study|Lost to Follow-up|20|||
16086020|NCT02605174|38807033|FG005|Overall Study|Lost to Follow-up|10|||
16086021|NCT02605174|38807034|FG006|Overall Study|Lost to Follow-up|29|||
16086022|NCT02605174|38807028|FG000|Overall Study|Protocol Violation|10|||
16086023|NCT02605174|38807029|FG001|Overall Study|Protocol Violation|4|||
16086024|NCT02605174|38807030|FG002|Overall Study|Protocol Violation|14|||
16086025|NCT02605174|38807031|FG003|Overall Study|Protocol Violation|6|||
16086026|NCT02605174|38807032|FG004|Overall Study|Protocol Violation|7|||
16086027|NCT02605174|38807033|FG005|Overall Study|Protocol Violation|7|||
16086028|NCT02605174|38807034|FG006|Overall Study|Protocol Violation|12|||
16086029|NCT02605174|38807028|FG000|Overall Study|Pregnancy|1|||
16086030|NCT02605174|38807029|FG001|Overall Study|Pregnancy|0|||
16086031|NCT02605174|38807030|FG002|Overall Study|Pregnancy|0|||
16086032|NCT02605174|38807031|FG003|Overall Study|Pregnancy|2|||
16086033|NCT02605174|38807032|FG004|Overall Study|Pregnancy|0|||
16086034|NCT02605174|38807033|FG005|Overall Study|Pregnancy|0|||
16086035|NCT02605174|38807034|FG006|Overall Study|Pregnancy|0|||
16086036|NCT02605174|38807028|FG000|Overall Study|Withdrawal by Subject|9|||
16086037|NCT02605174|38807029|FG001|Overall Study|Withdrawal by Subject|6|||
16086038|NCT02605174|38807030|FG002|Overall Study|Withdrawal by Subject|14|||
16086039|NCT02605174|38807031|FG003|Overall Study|Withdrawal by Subject|11|||
16086040|NCT02605174|38807032|FG004|Overall Study|Withdrawal by Subject|6|||
16086041|NCT02605174|38807033|FG005|Overall Study|Withdrawal by Subject|4|||
16086042|NCT02605174|38807034|FG006|Overall Study|Withdrawal by Subject|15|||
16086043|NCT02605174|38807028|FG000|Overall Study|Physician Decision|2|||
16086044|NCT02605174|38807029|FG001|Overall Study|Physician Decision|0|||
16086045|NCT02605174|38807030|FG002|Overall Study|Physician Decision|0|||
16086046|NCT02605174|38807031|FG003|Overall Study|Physician Decision|0|||
16086047|NCT02605174|38807032|FG004|Overall Study|Physician Decision|0|||
16086048|NCT02605174|38807033|FG005|Overall Study|Physician Decision|0|||
16086049|NCT02605174|38807034|FG006|Overall Study|Physician Decision|3|||
16086050|NCT02605174|38807028|FG000|Overall Study|Randomization Failure|22|||
16086051|NCT02605174|38807029|FG001|Overall Study|Randomization Failure|6|||
16086052|NCT02605174|38807030|FG002|Overall Study|Randomization Failure|20|||
16086053|NCT02605174|38807031|FG003|Overall Study|Randomization Failure|7|||
16086054|NCT02605174|38807032|FG004|Overall Study|Randomization Failure|16|||
16086055|NCT02605174|38807033|FG005|Overall Study|Randomization Failure|11|||
16086056|NCT02605174|38807034|FG006|Overall Study|Randomization Failure|30|||
16086057|NCT02744066|38807035|FG000|Overall Study|Withdrawal by parent|0|||
16086058|NCT02744066|38807036|FG001|Overall Study|Withdrawal by parent|1|||
16086059|NCT02744066|38807035|FG000|Overall Study|Discharged from NICU prior to completion|0|||
16086060|NCT02744066|38807036|FG001|Overall Study|Discharged from NICU prior to completion|4|||
16086061|NCT02760654|38807037|FG000|Overall Study|Lost to Follow-up|3|||
16086062|NCT02760654|38807038|FG001|Overall Study|Lost to Follow-up|3|||
16086063|NCT02760654|38807037|FG000|Overall Study|Withdrawal by Subject|4|||
16496178|NCT01824394|40287834|FG001|Overall Study|Withdrawn due to Study Termination|83|||
16496179|NCT01824394|40287835|FG002|Overall Study|Withdrawn due to Study Termination|41|||
16496180|NCT01824394|40287833|FG000|Overall Study|Lost to Follow-up|0|||
16496181|NCT01824394|40287834|FG001|Overall Study|Lost to Follow-up|9|||
16496182|NCT01824394|40287835|FG002|Overall Study|Lost to Follow-up|3|||
16496183|NCT01824394|40287833|FG000|Overall Study|Death|3|||
16496184|NCT01824394|40287834|FG001|Overall Study|Death|2|||
16496185|NCT01824394|40287835|FG002|Overall Study|Death|4|||
16496186|NCT01824394|40287833|FG000|Overall Study|Discontinued Subjects|1|||
16496187|NCT01824394|40287834|FG001|Overall Study|Discontinued Subjects|1|||
16496188|NCT01824394|40287835|FG002|Overall Study|Discontinued Subjects|2|||
16496189|NCT01824394|40287833|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
16496190|NCT01824394|40287834|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
16086064|NCT02760654|38807038|FG001|Overall Study|Withdrawal by Subject|3|||
16086065|NCT00933270|38807041|FG000|Overall Study|Withdrawal by Subject|26|||
16086066|NCT00933270|38807041|FG000|Overall Study|Insufficient Follow-up|10|||
16086067|NCT00933270|38807041|FG000|Overall Study|Lost to Follow-up|14|||
16086068|NCT00933270|38807041|FG000|Overall Study|Adverse Event|1|||
16086069|NCT00933270|38807041|FG000|Overall Study|Missed Visit|2|||
16086070|NCT00933270|38807041|FG000|Overall Study|Death|24|||
16086071|NCT00933270|38807041|FG000|Overall Study|Moved or would not return|10|||
16086072|NCT00960206|38807042|FG000|Overall Study|Death|7|||
16086073|NCT00960206|38807043|FG001|Overall Study|Death|4|||
16086074|NCT00960206|38807044|FG002|Overall Study|Death|1|||
16086075|NCT00960206|38807042|FG000|Overall Study|Unwilling/Unable to return|1|||
16086076|NCT00960206|38807043|FG001|Overall Study|Unwilling/Unable to return|2|||
16194248|NCT04776148|39188731|FG001|Overall Study|Death|188|||
16388246|NCT02185534|39905611|FG002|First Washout Period|Protocol Violation|0|||
16388247|NCT02185534|39905612|FG003|First Washout Period|Protocol Violation|0|||
16388248|NCT02185534|39905613|FG004|First Washout Period|Protocol Violation|0|||
16388249|NCT02185534|39905614|FG005|First Washout Period|Protocol Violation|1|||
16388250|NCT00803361|39905615|FG000|Overall Study|Adverse Event|13|||
16388251|NCT00803361|39905616|FG001|Overall Study|Adverse Event|3|||
16388252|NCT00803361|39905615|FG000|Overall Study|Lack of Efficacy|4|||
16388253|NCT00803361|39905616|FG001|Overall Study|Lack of Efficacy|13|||
16388254|NCT00803361|39905615|FG000|Overall Study|Lost to Follow-up|1|||
16388255|NCT00803361|39905616|FG001|Overall Study|Lost to Follow-up|2|||
16388256|NCT00803361|39905615|FG000|Overall Study|Physician Decision|1|||
16388257|NCT00803361|39905616|FG001|Overall Study|Physician Decision|0|||
16388258|NCT00803361|39905615|FG000|Overall Study|Protocol Violation|2|||
16388259|NCT00803361|39905616|FG001|Overall Study|Protocol Violation|4|||
16388260|NCT00803361|39905615|FG000|Overall Study|Withdrawal by Subject|5|||
16388261|NCT00803361|39905616|FG001|Overall Study|Withdrawal by Subject|6|||
16388262|NCT03547908|39905618|FG000|Overall Study|Still On Study|115|||
16388263|NCT03547908|39905619|FG001|Overall Study|Still On Study|118|||
16388264|NCT03547908|39905618|FG000|Overall Study|Lost to Follow-up|2|||
16388265|NCT03547908|39905619|FG001|Overall Study|Lost to Follow-up|2|||
16388266|NCT03547908|39905618|FG000|Overall Study|Withdrew Consent|2|||
16496191|NCT01824394|40287835|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
16086077|NCT00960206|38807044|FG002|Overall Study|Unwilling/Unable to return|0|||
16086078|NCT00960206|38807042|FG000|Overall Study|Lost to Follow-up|8|||
16388267|NCT03547908|39905619|FG001|Overall Study|Withdrew Consent|1|||
16388268|NCT03547908|39905618|FG000|Overall Study|Adverse Event|1|||
16388269|NCT03547908|39905619|FG001|Overall Study|Adverse Event|0|||
16496192|NCT02433483|40287838|FG000|Overall Study|Unacceptable toxicity|1|||
16194249|NCT04776148|39188730|FG000|Overall Study|Lost to Follow-up|0|||
16194250|NCT04776148|39188731|FG001|Overall Study|Lost to Follow-up|1|||
16194251|NCT04776148|39188730|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16194252|NCT04776148|39188731|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16308296|NCT02413229|39612757|FG003|Overall Study|Withdrawal by Subject|0|||
16308297|NCT02413229|39612758|FG004|Overall Study|Withdrawal by Subject|1|||
16086079|NCT00960206|38807043|FG001|Overall Study|Lost to Follow-up|14|||
16086080|NCT00960206|38807044|FG002|Overall Study|Lost to Follow-up|8|||
16086081|NCT00960206|38807042|FG000|Overall Study|Withdrawal by Subject|2|||
16086082|NCT00960206|38807043|FG001|Overall Study|Withdrawal by Subject|4|||
16086083|NCT00960206|38807044|FG002|Overall Study|Withdrawal by Subject|0|||
16086084|NCT00960206|38807042|FG000|Overall Study|Revision of study component|2|||
16086085|NCT00960206|38807043|FG001|Overall Study|Revision of study component|2|||
16086086|NCT00960206|38807044|FG002|Overall Study|Revision of study component|2|||
16086087|NCT00960206|38807042|FG000|Overall Study|Missing 10 year data|20|||
16086088|NCT00960206|38807043|FG001|Overall Study|Missing 10 year data|1|||
16086089|NCT00960206|38807044|FG002|Overall Study|Missing 10 year data|1|||
16086090|NCT03489369|38807045|FG000|Overall Study|Documented Progressive Disease|3|||
16194253|NCT04776148|39188730|FG000|Overall Study|Withdrawal by Subject|2|||
16194254|NCT04776148|39188731|FG001|Overall Study|Withdrawal by Subject|4|||
16308298|NCT02413229|39612759|FG005|Overall Study|Withdrawal by Subject|0|||
16308299|NCT02413229|39612760|FG006|Overall Study|Withdrawal by Subject|0|||
16308300|NCT02413229|39612761|FG007|Overall Study|Withdrawal by Subject|2|||
16308301|NCT02413229|39612754|FG000|Overall Study|Progressive Disease|0|||
16308302|NCT02413229|39612755|FG001|Overall Study|Progressive Disease|0|||
16388270|NCT03547908|39905618|FG000|Overall Study|Death|1|||
16388271|NCT03547908|39905619|FG001|Overall Study|Death|0|||
16388272|NCT03547908|39905618|FG000|Overall Study|Investigator's Discretion|0|||
16388273|NCT03547908|39905619|FG001|Overall Study|Investigator's Discretion|1|||
16388274|NCT03547908|39905618|FG000|Overall Study|Randomized But Never Treated|1|||
16388275|NCT03547908|39905619|FG001|Overall Study|Randomized But Never Treated|0|||
16308303|NCT02413229|39612756|FG002|Overall Study|Progressive Disease|0|||
16308304|NCT02413229|39612757|FG003|Overall Study|Progressive Disease|0|||
16308305|NCT02413229|39612758|FG004|Overall Study|Progressive Disease|0|||
16308306|NCT02413229|39612759|FG005|Overall Study|Progressive Disease|0|||
16308307|NCT02413229|39612760|FG006|Overall Study|Progressive Disease|0|||
16308308|NCT02413229|39612761|FG007|Overall Study|Progressive Disease|1|||
16308309|NCT00931411|39612763|FG000|First Intervention - 42 Days|Adverse Event|2|||
16308310|NCT00931411|39612764|FG001|First Intervention - 42 Days|Adverse Event|3|||
16308311|NCT00931411|39612763|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
16308312|NCT00931411|39612764|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
16388276|NCT00811720|39905626|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
16308313|NCT00931411|39612763|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
16409939|NCT02133664|39981835|FG001|Overall Study|Adverse Event|6|||
16086091|NCT03489369|38807046|FG001|Overall Study|Documented Progressive Disease|2|||
16086092|NCT03489369|38807047|FG002|Overall Study|Documented Progressive Disease|3|||
16086093|NCT03489369|38807048|FG003|Overall Study|Documented Progressive Disease|6|||
16086094|NCT03489369|38807045|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
16086095|NCT03489369|38807046|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
16086096|NCT03489369|38807047|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
16086097|NCT03489369|38807048|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
16086098|NCT01290341|38807049|FG000|Overall Study|Protocol Violation|7|||
16086099|NCT01290341|38807050|FG001|Overall Study|Protocol Violation|3|||
16086100|NCT01290341|38807049|FG000|Overall Study|Adverse Event|1|||
16086101|NCT01290341|38807050|FG001|Overall Study|Adverse Event|0|||
16086102|NCT01290341|38807049|FG000|Overall Study|Lost to Follow-up|21|||
16086103|NCT01290341|38807050|FG001|Overall Study|Lost to Follow-up|10|||
16086104|NCT01290341|38807049|FG000|Overall Study|Withdrawal by Subject|19|||
16086105|NCT01290341|38807050|FG001|Overall Study|Withdrawal by Subject|5|||
16086106|NCT01290341|38807049|FG000|Overall Study|Negative baseline culture and others|44|||
16086107|NCT01290341|38807050|FG001|Overall Study|Negative baseline culture and others|11|||
16086108|NCT02310581|38807051|FG000|Overall Study|Adverse Event|1|||
16496193|NCT02433483|40287838|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
16496194|NCT00590720|40287839|FG000|Overall Study|Lost to Follow-up|1|||
16086109|NCT02310581|38807052|FG001|Overall Study|Adverse Event|1|||
16496195|NCT00590720|40287840|FG001|Overall Study|Lost to Follow-up|0|||
16496196|NCT00590720|40287839|FG000|Overall Study|Withdrawal by Subject|0|||
16496197|NCT00590720|40287840|FG001|Overall Study|Withdrawal by Subject|1|||
16496198|NCT03358290|40287841|FG000|Overall Study|Study discontinued by Sponsor|0|||
16496199|NCT03358290|40287842|FG001|Overall Study|Study discontinued by Sponsor|1|||
16496200|NCT03358290|40287843|FG002|Overall Study|Study discontinued by Sponsor|1|||
16496201|NCT03358290|40287844|FG003|Overall Study|Study discontinued by Sponsor|0|||
16496202|NCT03358290|40287845|FG004|Overall Study|Study discontinued by Sponsor|0|||
16496203|NCT03358290|40287841|FG000|Overall Study|Adverse Event|0|||
16496204|NCT03358290|40287842|FG001|Overall Study|Adverse Event|0|||
16496205|NCT03358290|40287843|FG002|Overall Study|Adverse Event|1|||
16496206|NCT03358290|40287844|FG003|Overall Study|Adverse Event|2|||
16496207|NCT03358290|40287845|FG004|Overall Study|Adverse Event|0|||
16496208|NCT03358290|40287841|FG000|Overall Study|Withdrawal by Subject|0|||
16496209|NCT03358290|40287842|FG001|Overall Study|Withdrawal by Subject|0|||
16496210|NCT03358290|40287843|FG002|Overall Study|Withdrawal by Subject|0|||
16496211|NCT03358290|40287844|FG003|Overall Study|Withdrawal by Subject|0|||
16496212|NCT03358290|40287845|FG004|Overall Study|Withdrawal by Subject|1|||
16496213|NCT01170091|40287848|FG000|Overall Study|Missing efficacy evaluation|3|||
16496214|NCT01170091|40287848|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
16496215|NCT00750204|40287849|FG000|Overall Study|study halted prematurely|1|||
16496216|NCT00750204|40287850|FG001|Overall Study|study halted prematurely|1|||
16496217|NCT01874054|40287859|FG000|Overall Study|Withdrawal by Subject|3|||
16496218|NCT01874054|40287859|FG000|Overall Study|Study Termination by Sponsor|42|||
16496219|NCT01874054|40287859|FG000|Overall Study|Lost to Follow-up|5|||
16496220|NCT01874054|40287859|FG000|Overall Study|Death|5|||
16496221|NCT01327885|40287860|FG000|Overall Study|Disease progression-according to RECIST|173|||
16496222|NCT01327885|40287861|FG001|Overall Study|Disease progression-according to RECIST|165|||
16496223|NCT01327885|40287860|FG000|Overall Study|Clinical progression|24|||
16496224|NCT01327885|40287861|FG001|Overall Study|Clinical progression|27|||
16496225|NCT01327885|40287860|FG000|Overall Study|Adverse Event|14|||
16496226|NCT01327885|40287861|FG001|Overall Study|Adverse Event|10|||
16496227|NCT01327885|40287860|FG000|Overall Study|Subject choice|5|||
16496228|NCT01327885|40287861|FG001|Overall Study|Subject choice|10|||
16496229|NCT01327885|40287860|FG000|Overall Study|Other|8|||
16496230|NCT01327885|40287861|FG001|Overall Study|Other|6|||
16496231|NCT01327885|40287860|FG000|Overall Study|Withdrawal of consent from study|3|||
16496232|NCT01327885|40287861|FG001|Overall Study|Withdrawal of consent from study|4|||
16496233|NCT01327885|40287860|FG000|Overall Study|Not treated|1|||
16496234|NCT01327885|40287861|FG001|Overall Study|Not treated|1|||
16496235|NCT01327885|40287860|FG000|Overall Study|Administrative decision|0|||
16496236|NCT01327885|40287861|FG001|Overall Study|Administrative decision|1|||
16496237|NCT02425046|40287863|FG000|Overall Study|Lost to Follow-up|52|||
16496238|NCT02425046|40287864|FG001|Overall Study|Lost to Follow-up|50|||
16496239|NCT02425046|40287865|FG002|Overall Study|Lost to Follow-up|56|||
16496240|NCT02425046|40287863|FG000|Overall Study|Withdrawal by Subject|16|||
16496241|NCT02425046|40287864|FG001|Overall Study|Withdrawal by Subject|12|||
16496242|NCT02425046|40287865|FG002|Overall Study|Withdrawal by Subject|0|||
16496243|NCT02835820|40287872|FG000|Overall Study|Baseline Screen Failure|0|||
16496244|NCT02835820|40287873|FG001|Overall Study|Baseline Screen Failure|3|||
16496245|NCT04128267|40287882|FG000|Overall Study|Withdrawal by Subject|6|||
16496246|NCT04128267|40287882|FG000|Overall Study|Death|2|||
16496247|NCT04128267|40287882|FG000|Overall Study|Disease progression|1|||
16086110|NCT02310581|38807053|FG002|Overall Study|Adverse Event|1|||
16086111|NCT02310581|38807054|FG003|Overall Study|Adverse Event|0|||
16086112|NCT02310581|38807051|FG000|Overall Study|Withdrawal by Subject|2|||
16086113|NCT02310581|38807052|FG001|Overall Study|Withdrawal by Subject|1|||
16086114|NCT02310581|38807053|FG002|Overall Study|Withdrawal by Subject|0|||
16086115|NCT02310581|38807054|FG003|Overall Study|Withdrawal by Subject|1|||
16086116|NCT01968967|38807062|FG000|Treatment Period|Other|22|||
16086117|NCT01968967|38807063|FG001|Treatment Period|Other|22|||
16086118|NCT01968967|38807064|FG002|Treatment Period|Other|0|||
16086119|NCT01968967|38807065|FG003|Treatment Period|Other|0|||
16086120|NCT01968967|38807066|FG004|Treatment Period|Other|0|||
16388277|NCT00811720|39905627|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
16388278|NCT00811720|39905626|FG000|All Treated Patients|Adverse Event|20|||
16496248|NCT04128267|40287882|FG000|Overall Study|Participant had other medical issues|4|||
16086121|NCT01968967|38807062|FG000|Treatment Period|Withdrawal by Subject|71|||
16086122|NCT01968967|38807063|FG001|Treatment Period|Withdrawal by Subject|61|||
16086123|NCT01968967|38807064|FG002|Treatment Period|Withdrawal by Subject|0|||
16086124|NCT01968967|38807065|FG003|Treatment Period|Withdrawal by Subject|0|||
16086125|NCT01968967|38807066|FG004|Treatment Period|Withdrawal by Subject|0|||
16086126|NCT01968967|38807062|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
16086127|NCT01968967|38807063|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
16086128|NCT01968967|38807064|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
16086129|NCT01968967|38807065|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
16086130|NCT01968967|38807066|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
16086131|NCT01968967|38807062|FG000|Treatment Period|Lost to Follow-up|26|||
16086132|NCT01968967|38807063|FG001|Treatment Period|Lost to Follow-up|31|||
16086133|NCT01968967|38807064|FG002|Treatment Period|Lost to Follow-up|0|||
16086134|NCT01968967|38807065|FG003|Treatment Period|Lost to Follow-up|0|||
16086135|NCT01968967|38807066|FG004|Treatment Period|Lost to Follow-up|0|||
16086136|NCT01968967|38807062|FG000|Treatment Period|Protocol Violation|1|||
16086137|NCT01968967|38807063|FG001|Treatment Period|Protocol Violation|2|||
16086138|NCT01968967|38807064|FG002|Treatment Period|Protocol Violation|0|||
16086139|NCT01968967|38807065|FG003|Treatment Period|Protocol Violation|0|||
16086140|NCT01968967|38807066|FG004|Treatment Period|Protocol Violation|0|||
16086141|NCT01968967|38807062|FG000|Treatment Period|Adverse Event|9|||
16086142|NCT01968967|38807063|FG001|Treatment Period|Adverse Event|8|||
16086143|NCT01968967|38807064|FG002|Treatment Period|Adverse Event|0|||
16086144|NCT01968967|38807065|FG003|Treatment Period|Adverse Event|0|||
16086145|NCT01968967|38807066|FG004|Treatment Period|Adverse Event|0|||
16086146|NCT01968967|38807062|FG000|Treatment Period|Death|9|||
16086147|NCT01968967|38807063|FG001|Treatment Period|Death|2|||
16086148|NCT01968967|38807064|FG002|Treatment Period|Death|0|||
16086149|NCT01968967|38807065|FG003|Treatment Period|Death|0|||
16086150|NCT01968967|38807066|FG004|Treatment Period|Death|0|||
16086151|NCT01968967|38807062|FG000|Treatment Period|Randomized Not Treated|6|||
16086152|NCT01968967|38807063|FG001|Treatment Period|Randomized Not Treated|5|||
16086153|NCT01968967|38807064|FG002|Treatment Period|Randomized Not Treated|0|||
16086154|NCT01968967|38807065|FG003|Treatment Period|Randomized Not Treated|0|||
16086155|NCT01968967|38807066|FG004|Treatment Period|Randomized Not Treated|0|||
16086156|NCT01968967|38807062|FG000|Extension Period|Withdrew Consent|0|||
16086157|NCT01968967|38807063|FG001|Extension Period|Withdrew Consent|0|||
16086158|NCT01968967|38807064|FG002|Extension Period|Withdrew Consent|2|||
16086159|NCT01968967|38807065|FG003|Extension Period|Withdrew Consent|0|||
16086160|NCT01968967|38807066|FG004|Extension Period|Withdrew Consent|5|||
16086161|NCT01627561|38807067|FG000|Overall Study|Lost to Follow-up|1|||
16086162|NCT01627561|38807068|FG001|Overall Study|Lost to Follow-up|0|||
16086163|NCT01627561|38807067|FG000|Overall Study|Withdrawal by Subject|0|||
16086164|NCT01627561|38807068|FG001|Overall Study|Withdrawal by Subject|1|||
16086165|NCT01627561|38807067|FG000|Overall Study|Migrated/moved from study area|0|||
16086166|NCT01627561|38807068|FG001|Overall Study|Migrated/moved from study area|2|||
16086167|NCT02325466|38807069|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
16086168|NCT02325466|38807070|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
16086169|NCT02325466|38807071|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
16086170|NCT02325466|38807069|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
16086171|NCT02325466|38807070|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
16086172|NCT02325466|38807071|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
16496249|NCT04128267|40287882|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
16086173|NCT02325466|38807069|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
16086174|NCT02325466|38807070|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
16086175|NCT02325466|38807071|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
16086176|NCT02325466|38807069|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
16086177|NCT02325466|38807070|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
16086178|NCT02325466|38807071|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
16086179|NCT02325466|38807069|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
16194255|NCT04776148|39188730|FG000|Overall Study|Ongoing in Study|67|||
16086180|NCT02325466|38807070|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
16086181|NCT02325466|38807071|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
16409940|NCT01269385|39981836|FG000|Overall Study|Adverse Event|1|||
16496250|NCT00434330|40287883|FG000|Overall Study|Adverse Event|0|||
16496251|NCT00434330|40287884|FG001|Overall Study|Adverse Event|0|||
16496252|NCT00434330|40287885|FG002|Overall Study|Adverse Event|1|||
16496253|NCT00434330|40287886|FG003|Overall Study|Adverse Event|0|||
16496254|NCT00434330|40287887|FG004|Overall Study|Adverse Event|0|||
16496255|NCT00434330|40287888|FG005|Overall Study|Adverse Event|0|||
16086182|NCT02325466|38807069|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
16086183|NCT02325466|38807070|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
16194256|NCT04776148|39188731|FG001|Overall Study|Ongoing in Study|45|||
16308314|NCT00931411|39612764|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
16496256|NCT00434330|40287883|FG000|Overall Study|Death|1|||
16496257|NCT00434330|40287884|FG001|Overall Study|Death|0|||
16496258|NCT00434330|40287885|FG002|Overall Study|Death|0|||
16496259|NCT00434330|40287886|FG003|Overall Study|Death|0|||
16496260|NCT00434330|40287887|FG004|Overall Study|Death|1|||
16496261|NCT00434330|40287888|FG005|Overall Study|Death|1|||
16496262|NCT00434330|40287883|FG000|Overall Study|Withdrawal by Subject|0|||
16496263|NCT00434330|40287884|FG001|Overall Study|Withdrawal by Subject|0|||
16496264|NCT00434330|40287885|FG002|Overall Study|Withdrawal by Subject|1|||
16496265|NCT00434330|40287886|FG003|Overall Study|Withdrawal by Subject|1|||
16496266|NCT00434330|40287887|FG004|Overall Study|Withdrawal by Subject|0|||
16496267|NCT00434330|40287888|FG005|Overall Study|Withdrawal by Subject|0|||
16496268|NCT00434330|40287883|FG000|Overall Study|Renal transplant|0|||
16496269|NCT00434330|40287884|FG001|Overall Study|Renal transplant|0|||
16496270|NCT00434330|40287885|FG002|Overall Study|Renal transplant|0|||
16496271|NCT00434330|40287886|FG003|Overall Study|Renal transplant|1|||
16496272|NCT00434330|40287887|FG004|Overall Study|Renal transplant|0|||
16496273|NCT00434330|40287888|FG005|Overall Study|Renal transplant|0|||
16496274|NCT00434330|40287883|FG000|Overall Study|Subject Not Compliant With Study|0|||
16496275|NCT00434330|40287884|FG001|Overall Study|Subject Not Compliant With Study|0|||
16496276|NCT00434330|40287885|FG002|Overall Study|Subject Not Compliant With Study|1|||
16496277|NCT00434330|40287886|FG003|Overall Study|Subject Not Compliant With Study|0|||
16496278|NCT00434330|40287887|FG004|Overall Study|Subject Not Compliant With Study|0|||
16496279|NCT00434330|40287888|FG005|Overall Study|Subject Not Compliant With Study|0|||
16496280|NCT03171415|40287893|FG000|Overall Study|Lost to Follow-up|0|||
16496281|NCT03171415|40287894|FG001|Overall Study|Lost to Follow-up|0|||
16496282|NCT03171415|40287895|FG002|Overall Study|Lost to Follow-up|0|||
16496283|NCT03171415|40287896|FG003|Overall Study|Lost to Follow-up|0|||
16496284|NCT03171415|40287897|FG004|Overall Study|Lost to Follow-up|2|||
16496285|NCT01402544|40287898|FG000|Overall Study|Withdrawal by Subject|6|||
16496286|NCT04140292|40287899|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
16496287|NCT04140292|40287900|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
16496288|NCT03182829|40287902|FG000|Overall Study|Protocol Violation|12|||
16496289|NCT03182829|40287903|FG001|Overall Study|Protocol Violation|12|||
16496290|NCT03182829|40287902|FG000|Overall Study|Other|4|||
16496291|NCT03182829|40287903|FG001|Overall Study|Other|3|||
16496292|NCT01995825|40287904|FG000|Overall Study|Withdrawal by Subject|1|||
16496293|NCT01995825|40287905|FG001|Overall Study|Withdrawal by Subject|0|||
16496294|NCT02407704|40287906|FG000|Overall Study|Lost to Follow-up|0|||
16496295|NCT02407704|40287907|FG001|Overall Study|Lost to Follow-up|0|||
16496296|NCT02407704|40287908|FG002|Overall Study|Lost to Follow-up|0|||
16496297|NCT02407704|40287909|FG003|Overall Study|Lost to Follow-up|2|||
16496298|NCT02407704|40287906|FG000|Overall Study|Protocol Violation|0|||
16496299|NCT02407704|40287907|FG001|Overall Study|Protocol Violation|0|||
16496300|NCT02407704|40287908|FG002|Overall Study|Protocol Violation|0|||
16496301|NCT02407704|40287909|FG003|Overall Study|Protocol Violation|1|||
16496302|NCT02407704|40287906|FG000|Overall Study|Withdrawal by Subject|0|||
16496303|NCT02407704|40287907|FG001|Overall Study|Withdrawal by Subject|0|||
16496304|NCT02407704|40287908|FG002|Overall Study|Withdrawal by Subject|1|||
16496305|NCT02407704|40287909|FG003|Overall Study|Withdrawal by Subject|0|||
16496306|NCT02892760|40287910|FG000|Overall Study|Withdrawal by Subject|3|||
16496307|NCT01344161|40287911|FG000|Overall Study|Lost to Follow-up|4|||
16496308|NCT01344161|40287912|FG001|Overall Study|Lost to Follow-up|1|||
16496309|NCT01344161|40287911|FG000|Overall Study|Pregnancy|0|||
16496310|NCT01344161|40287912|FG001|Overall Study|Pregnancy|1|||
16496311|NCT01344161|40287911|FG000|Overall Study|Protocol Violation|1|||
16496312|NCT01344161|40287912|FG001|Overall Study|Protocol Violation|1|||
16496313|NCT00540514|40287913|FG000|Overall Study|Still on treatment|3|||
16496314|NCT00540514|40287914|FG001|Overall Study|Still on treatment|0|||
16496315|NCT00540514|40287913|FG000|Overall Study|Unacceptable Toxicity|61|||
16496316|NCT00540514|40287914|FG001|Overall Study|Unacceptable Toxicity|62|||
16496317|NCT00540514|40287913|FG000|Overall Study|Adverse Event|20|||
16496318|NCT00540514|40287914|FG001|Overall Study|Adverse Event|24|||
16496319|NCT00540514|40287913|FG000|Overall Study|Physician Decision|86|||
16496320|NCT00540514|40287914|FG001|Overall Study|Physician Decision|99|||
16496321|NCT00540514|40287913|FG000|Overall Study|Protocol Deviation|3|||
16496322|NCT00540514|40287914|FG001|Overall Study|Protocol Deviation|4|||
16496323|NCT00540514|40287913|FG000|Overall Study|Lost to Follow-up|1|||
16496324|NCT00540514|40287914|FG001|Overall Study|Lost to Follow-up|1|||
16496325|NCT00540514|40287913|FG000|Overall Study|Withdrawal by Subject|65|||
16496326|NCT00540514|40287914|FG001|Overall Study|Withdrawal by Subject|67|||
16496327|NCT00540514|40287913|FG000|Overall Study|Excluded prior to treatment|7|||
16496328|NCT00540514|40287914|FG001|Overall Study|Excluded prior to treatment|7|||
16496329|NCT00540514|40287913|FG000|Overall Study|Paclitaxel not available|0|||
16496330|NCT00540514|40287914|FG001|Overall Study|Paclitaxel not available|2|||
16496331|NCT00254540|40287915|FG000|Overall Study|Adverse Event|6|||
16496332|NCT00254540|40287916|FG001|Overall Study|Adverse Event|7|||
16496333|NCT00254540|40287915|FG000|Overall Study|Lack of Efficacy|13|||
16496334|NCT00254540|40287916|FG001|Overall Study|Lack of Efficacy|13|||
16496335|NCT00254540|40287915|FG000|Overall Study|Death|0|||
16496336|NCT00254540|40287916|FG001|Overall Study|Death|1|||
16496337|NCT00254540|40287915|FG000|Overall Study|Laboratory Test Abnormality|0|||
16496338|NCT00254540|40287916|FG001|Overall Study|Laboratory Test Abnormality|1|||
16496339|NCT02200445|40287917|FG000|Overall Study|Lack of Efficacy|1|||
16496340|NCT02200445|40287918|FG001|Overall Study|Lack of Efficacy|2|||
16496341|NCT02200445|40287919|FG002|Overall Study|Lack of Efficacy|2|||
16496342|NCT02200445|40287917|FG000|Overall Study|Adverse Event|0|||
16496343|NCT02200445|40287918|FG001|Overall Study|Adverse Event|2|||
16496344|NCT02200445|40287919|FG002|Overall Study|Adverse Event|0|||
16496345|NCT02557646|40287920|FG000|Overall Study|Adverse Event|40|||
16496346|NCT02557646|40287920|FG000|Overall Study|Death|1|||
16496347|NCT02557646|40287920|FG000|Overall Study|Lack of Efficacy|186|||
16496348|NCT02557646|40287920|FG000|Overall Study|Withdrawal by Subject|18|||
16496349|NCT02557646|40287920|FG000|Overall Study|Lost to Follow-up|17|||
16496350|NCT02557646|40287920|FG000|Overall Study|Other|14|||
16496351|NCT02643082|40287921|FG000|Period 1|Adverse Event|1|||
16496352|NCT02643082|40287922|FG001|Period 1|Adverse Event|0|||
16496353|NCT01059799|40287923|FG000|Overall Study|Adverse Event|2|||
16496354|NCT01059799|40287924|FG001|Overall Study|Adverse Event|3|||
16496355|NCT01059799|40287923|FG000|Overall Study|Lack of Efficacy|1|||
16496356|NCT01059799|40287924|FG001|Overall Study|Lack of Efficacy|0|||
16496357|NCT01059799|40287923|FG000|Overall Study|Protocol Violation|3|||
16496358|NCT01059799|40287924|FG001|Overall Study|Protocol Violation|2|||
16496359|NCT01059799|40287923|FG000|Overall Study|Withdrawal criteria|13|||
16308315|NCT02002221|39612765|FG000|Overall Study|Adverse Event|2|||
16496360|NCT01059799|40287924|FG001|Overall Study|Withdrawal criteria|2|||
16496361|NCT01059799|40287923|FG000|Overall Study|Other|12|||
16496362|NCT01059799|40287924|FG001|Overall Study|Other|3|||
16496363|NCT03061331|40287933|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
16496364|NCT03061331|40287934|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
16496365|NCT00556712|40287937|FG000|Overall Study|Adverse Event|7|||
16496366|NCT00556712|40287938|FG001|Overall Study|Adverse Event|19|||
16496367|NCT00556712|40287937|FG000|Overall Study|Death|5|||
16496368|NCT00556712|40287938|FG001|Overall Study|Death|10|||
16086184|NCT02325466|38807071|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
16086185|NCT02325466|38807069|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
16086186|NCT02325466|38807070|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
16086187|NCT02325466|38807071|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
16086188|NCT02325466|38807069|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
16086189|NCT02325466|38807070|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
16086190|NCT02325466|38807071|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
16086191|NCT02325466|38807069|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
16496369|NCT00556712|40287937|FG000|Overall Study|Progressive Disease|383|||
16496370|NCT00556712|40287938|FG001|Overall Study|Progressive Disease|320|||
16496371|NCT00556712|40287937|FG000|Overall Study|Protocol Violation|3|||
16496372|NCT00556712|40287938|FG001|Overall Study|Protocol Violation|2|||
16496373|NCT00556712|40287937|FG000|Overall Study|Refused Treatment|17|||
16496374|NCT00556712|40287938|FG001|Overall Study|Refused Treatment|16|||
16496375|NCT00556712|40287937|FG000|Overall Study|Failure to Return|2|||
16496376|NCT00556712|40287938|FG001|Overall Study|Failure to Return|3|||
16496377|NCT00556712|40287937|FG000|Overall Study|Other|2|||
16496378|NCT00556712|40287938|FG001|Overall Study|Other|2|||
16496379|NCT00556712|40287937|FG000|Overall Study|Ongoing at Data Cutoff|32|||
16496380|NCT00556712|40287938|FG001|Overall Study|Ongoing at Data Cutoff|66|||
16496381|NCT01113801|40287944|FG000|Overall Study|Adverse Event|4|||
16496382|NCT01113801|40287945|FG001|Overall Study|Adverse Event|0|||
16496383|NCT01113801|40287946|FG002|Overall Study|Adverse Event|2|||
16496384|NCT01113801|40287947|FG003|Overall Study|Adverse Event|6|||
16496385|NCT01113801|40287944|FG000|Overall Study|Death|4|||
16496386|NCT01113801|40287945|FG001|Overall Study|Death|5|||
16496387|NCT01113801|40287946|FG002|Overall Study|Death|3|||
16496388|NCT01113801|40287947|FG003|Overall Study|Death|4|||
16496389|NCT01113801|40287944|FG000|Overall Study|Protocol Violation|0|||
16496390|NCT01113801|40287945|FG001|Overall Study|Protocol Violation|1|||
16496391|NCT01113801|40287946|FG002|Overall Study|Protocol Violation|0|||
16496392|NCT01113801|40287947|FG003|Overall Study|Protocol Violation|0|||
16086192|NCT02325466|38807070|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
16086193|NCT02325466|38807071|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
16086194|NCT00562094|38807083|FG000|Overall Study|Lost to Follow-up|62|||
16086195|NCT01128595|38807088|FG000|Treatment Period 3|Withdrawal by Subject|0|||
16086196|NCT01128595|38807089|FG001|Treatment Period 3|Withdrawal by Subject|1|||
16086197|NCT01128595|38807090|FG002|Treatment Period 3|Withdrawal by Subject|0|||
16086198|NCT01128595|38807091|FG003|Treatment Period 3|Withdrawal by Subject|0|||
16086199|NCT01961609|38807092|FG000|Initiation|Missing|3|||
16086200|NCT01961609|38807093|FG001|Initiation|Missing|2|||
16086201|NCT01961609|38807094|FG002|Initiation|Missing|0|||
16086202|NCT01961609|38807095|FG003|Initiation|Missing|0|||
16086203|NCT01961609|38807092|FG000|Initiation|Protocol deviation|1|||
16086204|NCT01961609|38807093|FG001|Initiation|Protocol deviation|0|||
16086205|NCT01961609|38807094|FG002|Initiation|Protocol deviation|0|||
16086206|NCT01961609|38807095|FG003|Initiation|Protocol deviation|0|||
16086207|NCT01961609|38807092|FG000|Initiation|Death|0|||
16496393|NCT01113801|40287944|FG000|Overall Study|Withdrawal by Subject|9|||
16496394|NCT01113801|40287945|FG001|Overall Study|Withdrawal by Subject|7|||
16496395|NCT01113801|40287946|FG002|Overall Study|Withdrawal by Subject|7|||
16496396|NCT01113801|40287947|FG003|Overall Study|Withdrawal by Subject|8|||
16496397|NCT01113801|40287944|FG000|Overall Study|Physician Decision|2|||
16308316|NCT02002221|39612766|FG001|Overall Study|Adverse Event|1|||
16308317|NCT02002221|39612765|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16308318|NCT02002221|39612766|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16308319|NCT02002221|39612765|FG000|Overall Study|Patient withdrew consent|0|||
16308320|NCT02002221|39612766|FG001|Overall Study|Patient withdrew consent|1|||
16308321|NCT01371747|39612767|FG000|Overall Study|Adverse Event|4|||
16308322|NCT01371747|39612768|FG001|Overall Study|Adverse Event|2|||
16308323|NCT01371747|39612769|FG002|Overall Study|Adverse Event|7|||
16496398|NCT01113801|40287945|FG001|Overall Study|Physician Decision|2|||
16496399|NCT01113801|40287946|FG002|Overall Study|Physician Decision|3|||
16496400|NCT01113801|40287947|FG003|Overall Study|Physician Decision|3|||
16496401|NCT01113801|40287944|FG000|Overall Study|Sponsor Decision|15|||
16194257|NCT01021852|39188732|FG000|Treatment Period 1|Adverse Event|3|||
16194258|NCT01021852|39188733|FG001|Treatment Period 1|Adverse Event|1|||
16194259|NCT01021852|39188734|FG002|Treatment Period 1|Adverse Event|1|||
16194260|NCT01021852|39188735|FG003|Treatment Period 1|Adverse Event|0|||
16194261|NCT01021852|39188736|FG004|Treatment Period 1|Adverse Event|2|||
16194262|NCT01021852|39188737|FG005|Treatment Period 1|Adverse Event|2|||
16194263|NCT01021852|39188738|FG006|Treatment Period 1|Adverse Event|0|||
16194264|NCT01021852|39188739|FG007|Treatment Period 1|Adverse Event|0|||
16194265|NCT01021852|39188732|FG000|Treatment Period 1|Pregnancy|0|||
16194266|NCT01021852|39188733|FG001|Treatment Period 1|Pregnancy|0|||
16194267|NCT01021852|39188734|FG002|Treatment Period 1|Pregnancy|1|||
16194268|NCT01021852|39188735|FG003|Treatment Period 1|Pregnancy|0|||
16194269|NCT01021852|39188736|FG004|Treatment Period 1|Pregnancy|0|||
16194270|NCT01021852|39188737|FG005|Treatment Period 1|Pregnancy|0|||
16194271|NCT01021852|39188738|FG006|Treatment Period 1|Pregnancy|0|||
16194272|NCT01021852|39188739|FG007|Treatment Period 1|Pregnancy|0|||
16194273|NCT01021852|39188732|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16194274|NCT01021852|39188733|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16194275|NCT01021852|39188734|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16194276|NCT01021852|39188735|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16194277|NCT01021852|39188736|FG004|Treatment Period 1|Withdrawal by Subject|1|||
16194278|NCT01021852|39188737|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16194279|NCT01021852|39188738|FG006|Treatment Period 1|Withdrawal by Subject|0|||
16194280|NCT01021852|39188739|FG007|Treatment Period 1|Withdrawal by Subject|1|||
16194281|NCT01021852|39188732|FG000|Treatment Period 1|Not Treated|0|||
16194282|NCT01021852|39188733|FG001|Treatment Period 1|Not Treated|0|||
16194283|NCT01021852|39188734|FG002|Treatment Period 1|Not Treated|0|||
16194284|NCT01021852|39188735|FG003|Treatment Period 1|Not Treated|2|||
16194285|NCT01021852|39188736|FG004|Treatment Period 1|Not Treated|0|||
16194286|NCT01021852|39188737|FG005|Treatment Period 1|Not Treated|0|||
16194287|NCT01021852|39188738|FG006|Treatment Period 1|Not Treated|0|||
16194288|NCT01021852|39188739|FG007|Treatment Period 1|Not Treated|0|||
16194289|NCT01021852|39188732|FG000|Washout Period-Placebo|Adverse Event|0|||
16194290|NCT01021852|39188733|FG001|Washout Period-Placebo|Adverse Event|0|||
16194291|NCT01021852|39188734|FG002|Washout Period-Placebo|Adverse Event|0|||
16194292|NCT01021852|39188735|FG003|Washout Period-Placebo|Adverse Event|1|||
16194293|NCT01021852|39188736|FG004|Washout Period-Placebo|Adverse Event|0|||
16194294|NCT01021852|39188737|FG005|Washout Period-Placebo|Adverse Event|1|||
16194295|NCT01021852|39188738|FG006|Washout Period-Placebo|Adverse Event|0|||
16194296|NCT01021852|39188739|FG007|Washout Period-Placebo|Adverse Event|0|||
16308324|NCT01371747|39612770|FG003|Overall Study|Adverse Event|2|||
16308325|NCT01371747|39612771|FG004|Overall Study|Adverse Event|2|||
16496402|NCT01113801|40287945|FG001|Overall Study|Sponsor Decision|21|||
16496403|NCT01113801|40287946|FG002|Overall Study|Sponsor Decision|20|||
16308326|NCT01371747|39612772|FG005|Overall Study|Adverse Event|2|||
16496404|NCT01113801|40287947|FG003|Overall Study|Sponsor Decision|15|||
16194297|NCT01021852|39188732|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
16194298|NCT01021852|39188733|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
16194299|NCT01021852|39188734|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
16086208|NCT01961609|38807093|FG001|Initiation|Death|1|||
16194300|NCT01021852|39188735|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
16194301|NCT01021852|39188736|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
16194302|NCT01021852|39188737|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
16194303|NCT01021852|39188738|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
16194304|NCT01021852|39188739|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
16194305|NCT01021852|39188732|FG000|Washout Period-Placebo|Protocol Violation|0|||
16194306|NCT01021852|39188733|FG001|Washout Period-Placebo|Protocol Violation|0|||
16194307|NCT01021852|39188734|FG002|Washout Period-Placebo|Protocol Violation|0|||
16194308|NCT01021852|39188735|FG003|Washout Period-Placebo|Protocol Violation|0|||
16194309|NCT01021852|39188736|FG004|Washout Period-Placebo|Protocol Violation|0|||
16194310|NCT01021852|39188737|FG005|Washout Period-Placebo|Protocol Violation|0|||
16194311|NCT01021852|39188738|FG006|Washout Period-Placebo|Protocol Violation|1|||
16194312|NCT01021852|39188739|FG007|Washout Period-Placebo|Protocol Violation|0|||
16194313|NCT01021852|39188732|FG000|Washout Period-No Drug|Adverse Event|1|||
16194314|NCT01021852|39188733|FG001|Washout Period-No Drug|Adverse Event|0|||
16194315|NCT01021852|39188734|FG002|Washout Period-No Drug|Adverse Event|0|||
16194316|NCT01021852|39188735|FG003|Washout Period-No Drug|Adverse Event|0|||
16194317|NCT01021852|39188736|FG004|Washout Period-No Drug|Adverse Event|0|||
16194318|NCT01021852|39188737|FG005|Washout Period-No Drug|Adverse Event|1|||
16194319|NCT01021852|39188738|FG006|Washout Period-No Drug|Adverse Event|0|||
16194320|NCT01021852|39188739|FG007|Washout Period-No Drug|Adverse Event|0|||
16194321|NCT01021852|39188732|FG000|Treatment Period 2|Adverse Event|0|||
16194322|NCT01021852|39188733|FG001|Treatment Period 2|Adverse Event|1|||
16194323|NCT01021852|39188734|FG002|Treatment Period 2|Adverse Event|0|||
16308327|NCT01371747|39612767|FG000|Overall Study|Death|1|||
16308328|NCT01371747|39612768|FG001|Overall Study|Death|0|||
16194324|NCT01021852|39188735|FG003|Treatment Period 2|Adverse Event|0|||
16194325|NCT01021852|39188736|FG004|Treatment Period 2|Adverse Event|1|||
16194326|NCT01021852|39188737|FG005|Treatment Period 2|Adverse Event|0|||
16194327|NCT01021852|39188738|FG006|Treatment Period 2|Adverse Event|1|||
16194328|NCT01021852|39188739|FG007|Treatment Period 2|Adverse Event|0|||
16194329|NCT01021852|39188732|FG000|Treatment Period 2|Lack of Efficacy|0|||
16194330|NCT01021852|39188733|FG001|Treatment Period 2|Lack of Efficacy|0|||
16194331|NCT01021852|39188734|FG002|Treatment Period 2|Lack of Efficacy|0|||
16194332|NCT01021852|39188735|FG003|Treatment Period 2|Lack of Efficacy|0|||
16194333|NCT01021852|39188736|FG004|Treatment Period 2|Lack of Efficacy|0|||
16194334|NCT01021852|39188737|FG005|Treatment Period 2|Lack of Efficacy|1|||
16194335|NCT01021852|39188738|FG006|Treatment Period 2|Lack of Efficacy|0|||
16194336|NCT01021852|39188739|FG007|Treatment Period 2|Lack of Efficacy|0|||
16194337|NCT01021852|39188732|FG000|Treatment Period 2|Physician Decision|0|||
16194338|NCT01021852|39188733|FG001|Treatment Period 2|Physician Decision|0|||
16194339|NCT01021852|39188734|FG002|Treatment Period 2|Physician Decision|1|||
16194340|NCT01021852|39188735|FG003|Treatment Period 2|Physician Decision|0|||
16194341|NCT01021852|39188736|FG004|Treatment Period 2|Physician Decision|0|||
16194342|NCT01021852|39188737|FG005|Treatment Period 2|Physician Decision|0|||
16194343|NCT01021852|39188738|FG006|Treatment Period 2|Physician Decision|0|||
16194344|NCT01021852|39188739|FG007|Treatment Period 2|Physician Decision|0|||
16194345|NCT01021852|39188732|FG000|Treatment Period 2|Protocol Violation|0|||
16194346|NCT01021852|39188733|FG001|Treatment Period 2|Protocol Violation|0|||
16194347|NCT01021852|39188734|FG002|Treatment Period 2|Protocol Violation|0|||
16194348|NCT01021852|39188735|FG003|Treatment Period 2|Protocol Violation|0|||
16194349|NCT01021852|39188736|FG004|Treatment Period 2|Protocol Violation|1|||
16194350|NCT01021852|39188737|FG005|Treatment Period 2|Protocol Violation|0|||
16194351|NCT01021852|39188738|FG006|Treatment Period 2|Protocol Violation|1|||
16194352|NCT01021852|39188739|FG007|Treatment Period 2|Protocol Violation|0|||
16194353|NCT01021852|39188732|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16496405|NCT01113801|40287944|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
16194354|NCT01021852|39188733|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16194355|NCT01021852|39188734|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16194356|NCT01021852|39188735|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16194357|NCT01021852|39188736|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16194358|NCT01021852|39188737|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16496406|NCT01113801|40287945|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
16496407|NCT01113801|40287946|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
16496408|NCT01113801|40287947|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
16496409|NCT02496533|40287948|FG000|Overall Study|Lack of data on outcome|3|||
16496410|NCT02496533|40287949|FG001|Overall Study|Lack of data on outcome|0|||
16194359|NCT01021852|39188738|FG006|Treatment Period 2|Withdrawal by Subject|1|||
16194360|NCT01021852|39188739|FG007|Treatment Period 2|Withdrawal by Subject|2|||
16194361|NCT00575094|39188740|FG000|Overall Study|Adverse Event|2|||
16194362|NCT00575094|39188740|FG000|Overall Study|Withdrawal by Subject|1|||
16194363|NCT00903032|39188741|FG000|Overall Study|Withdrawal by Subject|5|||
16194364|NCT00903032|39188742|FG001|Overall Study|Withdrawal by Subject|3|||
16194365|NCT00903032|39188741|FG000|Overall Study|Lost to Follow-up|2|||
16194366|NCT00903032|39188742|FG001|Overall Study|Lost to Follow-up|2|||
16194367|NCT00423085|39188743|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
16496411|NCT02496533|40287948|FG000|Overall Study|Patient did not complete all measures|0|||
16496412|NCT02496533|40287949|FG001|Overall Study|Patient did not complete all measures|4|||
16496413|NCT02496533|40287948|FG000|Overall Study|Late for radiologic testing|0|||
16496414|NCT02496533|40287949|FG001|Overall Study|Late for radiologic testing|2|||
16496415|NCT01698801|40287951|FG000|Treatment Phase|Adverse Event|4|||
16496416|NCT01698801|40287951|FG000|Treatment Phase|Protocol Violation|1|||
16496417|NCT01698801|40287951|FG000|Treatment Phase|Other|4|||
16496418|NCT01698801|40287951|FG000|Treatment Phase|Withdrawal by Subject|1|||
16496419|NCT01698801|40287951|FG000|Treatment Phase|Disease progression|1|||
16496420|NCT01698801|40287951|FG000|Follow Up Phase|Withdrawal by Subject|1|||
16496421|NCT01698801|40287951|FG000|Follow Up Phase|Death|4|||
16496422|NCT01059825|40287953|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16496423|NCT01059825|40287954|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16496424|NCT01059825|40287955|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16496425|NCT01059825|40287956|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16496426|NCT01059825|40287957|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16496427|NCT01059825|40287958|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
16496428|NCT01059825|40287959|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
16496429|NCT01059825|40287953|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16496430|NCT01059825|40287954|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16496431|NCT01059825|40287955|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16496432|NCT01059825|40287956|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16496433|NCT01059825|40287957|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16496434|NCT01059825|40287958|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
16496435|NCT01059825|40287959|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
16496436|NCT01059825|40287953|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
16496437|NCT01059825|40287954|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
16496438|NCT01059825|40287955|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
16496439|NCT01059825|40287956|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
16496440|NCT01059825|40287957|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
16496441|NCT01059825|40287958|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
16496442|NCT01059825|40287959|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
16496443|NCT01059825|40287953|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16496444|NCT01059825|40287954|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16496445|NCT01059825|40287955|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16496446|NCT01059825|40287956|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16496447|NCT01059825|40287957|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16496448|NCT01059825|40287958|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
16496449|NCT01059825|40287959|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
16496450|NCT01059825|40287953|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
16496451|NCT01059825|40287954|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
16496452|NCT01059825|40287955|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
16496453|NCT01059825|40287956|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
16496454|NCT01059825|40287957|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
16496455|NCT01059825|40287958|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
16496456|NCT01059825|40287959|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
16496457|NCT01059825|40287953|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
16496458|NCT01059825|40287954|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
16496459|NCT01059825|40287955|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
16496460|NCT01059825|40287956|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
16496461|NCT01059825|40287957|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
16496462|NCT01059825|40287958|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
16496463|NCT01059825|40287959|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
16496464|NCT01059825|40287953|FG000|Treatment Period|Lost to Follow-up|2|||
16496465|NCT01059825|40287954|FG001|Treatment Period|Lost to Follow-up|1|||
16496466|NCT01059825|40287955|FG002|Treatment Period|Lost to Follow-up|0|||
16496467|NCT01059825|40287956|FG003|Treatment Period|Lost to Follow-up|1|||
16496468|NCT01059825|40287957|FG004|Treatment Period|Lost to Follow-up|2|||
16496469|NCT01059825|40287958|FG005|Treatment Period|Lost to Follow-up|0|||
16496470|NCT01059825|40287959|FG006|Treatment Period|Lost to Follow-up|0|||
16496471|NCT01059825|40287953|FG000|Treatment Period|Withdrawal by Subject|3|||
16496472|NCT01059825|40287954|FG001|Treatment Period|Withdrawal by Subject|0|||
16496473|NCT01059825|40287955|FG002|Treatment Period|Withdrawal by Subject|1|||
16496474|NCT01059825|40287956|FG003|Treatment Period|Withdrawal by Subject|5|||
16496475|NCT01059825|40287957|FG004|Treatment Period|Withdrawal by Subject|4|||
16496476|NCT01059825|40287958|FG005|Treatment Period|Withdrawal by Subject|1|||
16496477|NCT01059825|40287959|FG006|Treatment Period|Withdrawal by Subject|0|||
16496478|NCT01059825|40287953|FG000|Treatment Period|Other reason not specified|1|||
16546311|NCT02237508|40464775|FG002|Overall Study|Physician Decision|0|||
16496479|NCT01059825|40287954|FG001|Treatment Period|Other reason not specified|2|||
16496480|NCT01059825|40287955|FG002|Treatment Period|Other reason not specified|1|||
16496481|NCT01059825|40287956|FG003|Treatment Period|Other reason not specified|2|||
16496482|NCT01059825|40287957|FG004|Treatment Period|Other reason not specified|0|||
16496483|NCT01059825|40287958|FG005|Treatment Period|Other reason not specified|0|||
16496484|NCT01059825|40287959|FG006|Treatment Period|Other reason not specified|0|||
16496485|NCT01059825|40287953|FG000|Treatment Period|Protocol Violation|0|||
16496486|NCT01059825|40287954|FG001|Treatment Period|Protocol Violation|0|||
16496487|NCT01059825|40287955|FG002|Treatment Period|Protocol Violation|1|||
16496488|NCT01059825|40287956|FG003|Treatment Period|Protocol Violation|1|||
16388279|NCT00811720|39905627|FG001|All Treated Patients|Adverse Event|62|||
16388280|NCT00811720|39905626|FG000|All Treated Patients|Lack of Efficacy|22|||
16496489|NCT01059825|40287957|FG004|Treatment Period|Protocol Violation|1|||
16496490|NCT01059825|40287958|FG005|Treatment Period|Protocol Violation|1|||
16496491|NCT01059825|40287959|FG006|Treatment Period|Protocol Violation|0|||
16496492|NCT01059825|40287953|FG000|Treatment Period|Adverse event related to study drug|1|||
16496493|NCT01059825|40287954|FG001|Treatment Period|Adverse event related to study drug|0|||
16496494|NCT01059825|40287955|FG002|Treatment Period|Adverse event related to study drug|1|||
16194368|NCT00423085|39188744|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
16194369|NCT00423085|39188745|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
16194370|NCT00423085|39188746|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
16194371|NCT00423085|39188743|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
16194372|NCT00423085|39188744|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
16194373|NCT00423085|39188745|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
16194374|NCT00423085|39188746|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16194375|NCT00423085|39188743|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
16194376|NCT00423085|39188744|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
16194377|NCT00423085|39188745|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
16194378|NCT00423085|39188746|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
16194379|NCT00423085|39188743|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
16194380|NCT00423085|39188744|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
16194381|NCT00423085|39188745|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
16194382|NCT00423085|39188746|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
16194383|NCT00423085|39188743|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
16194384|NCT00423085|39188744|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
16194385|NCT00423085|39188745|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
16308329|NCT01371747|39612769|FG002|Overall Study|Death|4|||
16308330|NCT01371747|39612770|FG003|Overall Study|Death|1|||
16308331|NCT01371747|39612771|FG004|Overall Study|Death|2|||
16308332|NCT01371747|39612772|FG005|Overall Study|Death|0|||
16308333|NCT01371747|39612767|FG000|Overall Study|Abnormal Renal Function|0|||
16308334|NCT01371747|39612768|FG001|Overall Study|Abnormal Renal Function|2|||
16308335|NCT01371747|39612769|FG002|Overall Study|Abnormal Renal Function|0|||
16308336|NCT01371747|39612770|FG003|Overall Study|Abnormal Renal Function|1|||
16308337|NCT01371747|39612771|FG004|Overall Study|Abnormal Renal Function|0|||
16308338|NCT01371747|39612772|FG005|Overall Study|Abnormal Renal Function|1|||
16308339|NCT01371747|39612767|FG000|Overall Study|High Serum Potassium Results|1|||
16308340|NCT01371747|39612768|FG001|Overall Study|High Serum Potassium Results|1|||
16308341|NCT01371747|39612769|FG002|Overall Study|High Serum Potassium Results|1|||
16308342|NCT01371747|39612770|FG003|Overall Study|High Serum Potassium Results|2|||
16308343|NCT01371747|39612771|FG004|Overall Study|High Serum Potassium Results|0|||
16086209|NCT01961609|38807094|FG002|Initiation|Death|0|||
16086210|NCT01961609|38807095|FG003|Initiation|Death|0|||
16388281|NCT00811720|39905627|FG001|All Treated Patients|Lack of Efficacy|18|||
16496495|NCT01059825|40287956|FG003|Treatment Period|Adverse event related to study drug|1|||
16496496|NCT01059825|40287957|FG004|Treatment Period|Adverse event related to study drug|0|||
16496497|NCT01059825|40287958|FG005|Treatment Period|Adverse event related to study drug|0|||
16086211|NCT01961609|38807092|FG000|Initiation|Administrative problems|1|||
16086212|NCT01961609|38807093|FG001|Initiation|Administrative problems|0|||
16086213|NCT01961609|38807094|FG002|Initiation|Administrative problems|0|||
16086214|NCT01961609|38807095|FG003|Initiation|Administrative problems|0|||
16086215|NCT01961609|38807092|FG000|Initiation|Withdrawal by Subject|1|||
16086216|NCT01961609|38807093|FG001|Initiation|Withdrawal by Subject|2|||
16086217|NCT01961609|38807094|FG002|Initiation|Withdrawal by Subject|0|||
16086218|NCT01961609|38807095|FG003|Initiation|Withdrawal by Subject|0|||
16086219|NCT01961609|38807092|FG000|Initiation|Lack of Efficacy|2|||
16086220|NCT01961609|38807093|FG001|Initiation|Lack of Efficacy|1|||
16086221|NCT01961609|38807094|FG002|Initiation|Lack of Efficacy|0|||
16086222|NCT01961609|38807095|FG003|Initiation|Lack of Efficacy|0|||
16086223|NCT01961609|38807092|FG000|Initiation|Abnormal lab values|0|||
16086224|NCT01961609|38807093|FG001|Initiation|Abnormal lab values|1|||
16086225|NCT01961609|38807094|FG002|Initiation|Abnormal lab values|0|||
16086226|NCT01961609|38807095|FG003|Initiation|Abnormal lab values|0|||
16086227|NCT01961609|38807092|FG000|Initiation|Adverse Event|3|||
16086228|NCT01961609|38807093|FG001|Initiation|Adverse Event|5|||
16086229|NCT01961609|38807094|FG002|Initiation|Adverse Event|0|||
16086230|NCT01961609|38807095|FG003|Initiation|Adverse Event|0|||
16086231|NCT01961609|38807092|FG000|Initiation|Randomized but not treated|1|||
16086232|NCT01961609|38807093|FG001|Initiation|Randomized but not treated|1|||
16086233|NCT01961609|38807094|FG002|Initiation|Randomized but not treated|0|||
16086234|NCT01961609|38807095|FG003|Initiation|Randomized but not treated|0|||
16086235|NCT01961609|38807092|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
16086236|NCT01961609|38807093|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
16086237|NCT01961609|38807094|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
16086238|NCT01961609|38807095|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
16086239|NCT01961609|38807092|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
16086240|NCT01961609|38807093|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
16086241|NCT01961609|38807094|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
16086242|NCT01961609|38807095|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
16086243|NCT01961609|38807092|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
16086244|NCT01961609|38807093|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
16086245|NCT01961609|38807094|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
16086246|NCT01961609|38807095|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
16086247|NCT01961609|38807092|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
16086248|NCT01961609|38807093|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
16086249|NCT01961609|38807094|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
16086250|NCT01961609|38807095|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
16086251|NCT01961609|38807092|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
16086252|NCT01961609|38807093|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
16086253|NCT01961609|38807094|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
16086254|NCT01961609|38807095|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
16086255|NCT01961609|38807092|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
16086256|NCT01961609|38807093|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
16086257|NCT01961609|38807094|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
16086258|NCT01961609|38807095|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
16086259|NCT01961609|38807092|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
16086260|NCT01961609|38807093|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
16086261|NCT01961609|38807094|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
16086262|NCT01961609|38807095|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
16086263|NCT01961609|38807092|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
16086264|NCT01961609|38807093|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
16086265|NCT01961609|38807094|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
16086266|NCT01961609|38807095|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
16086267|NCT01961609|38807092|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
16388282|NCT00811720|39905626|FG000|All Treated Patients|Non-compliance|0|||
16388283|NCT00811720|39905627|FG001|All Treated Patients|Non-compliance|14|||
16388284|NCT00811720|39905626|FG000|All Treated Patients|Protocol Violation|9|||
16388285|NCT00811720|39905627|FG001|All Treated Patients|Protocol Violation|16|||
16388286|NCT00811720|39905626|FG000|All Treated Patients|Withdrawal by Subject|28|||
16388287|NCT00811720|39905627|FG001|All Treated Patients|Withdrawal by Subject|34|||
16388288|NCT00811720|39905626|FG000|All Treated Patients|Lost to Follow-up|10|||
16388289|NCT00811720|39905627|FG001|All Treated Patients|Lost to Follow-up|16|||
16388290|NCT00811720|39905626|FG000|All Treated Patients|Other Reason|7|||
16388291|NCT00811720|39905627|FG001|All Treated Patients|Other Reason|4|||
16388292|NCT03281629|39905634|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
16388293|NCT03281629|39905635|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
16388294|NCT03281629|39905634|FG000|Overall Study|Death|0|||
16388295|NCT03281629|39905635|FG001|Overall Study|Death|1|||
16086268|NCT01961609|38807093|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
16086269|NCT01961609|38807094|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
16086270|NCT01961609|38807095|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
16086271|NCT01961609|38807092|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
16086272|NCT01961609|38807093|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
16086273|NCT01961609|38807094|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
16086274|NCT01961609|38807095|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
16086275|NCT01961609|38807092|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
16086276|NCT01961609|38807093|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
16086277|NCT01961609|38807094|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
16086278|NCT01961609|38807095|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
16086279|NCT01961609|38807092|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
16086280|NCT01961609|38807093|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
16086281|NCT01961609|38807094|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
16086282|NCT01961609|38807095|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
16086283|NCT03488719|38807098|FG000|Overall Study|Adverse Event|0|||
16086284|NCT03488719|38807099|FG001|Overall Study|Adverse Event|4|||
16086285|NCT03488719|38807100|FG002|Overall Study|Adverse Event|2|||
16086286|NCT03488719|38807098|FG000|Overall Study|Other|0|||
16086287|NCT03488719|38807099|FG001|Overall Study|Other|0|||
16086288|NCT03488719|38807100|FG002|Overall Study|Other|5|||
16086289|NCT00609869|38807102|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
16086290|NCT00609869|38807102|FG000|Overall Study|Severe hematologic toxicity|1|||
16086291|NCT00609869|38807102|FG000|Overall Study|Withdrawal by Subject|1|||
16086292|NCT00609869|38807102|FG000|Overall Study|Seizures|1|||
16086293|NCT00609869|38807102|FG000|Overall Study|Severe tumor flare reaction|1|||
16086294|NCT00609869|38807102|FG000|Overall Study|Hepatitis B infection|1|||
16086295|NCT00609869|38807102|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
16086296|NCT00609869|38807102|FG000|Overall Study|Mantle cell: not evaluable|4|||
16086297|NCT01105975|38807105|FG000|Overall Study|Adverse Event|2|||
16086298|NCT01105975|38807106|FG001|Overall Study|Adverse Event|1|||
16496498|NCT01059825|40287959|FG006|Treatment Period|Adverse event related to study drug|0|||
16496499|NCT01059825|40287953|FG000|Treatment Period|Insufficient clinical response|3|||
16496500|NCT01059825|40287954|FG001|Treatment Period|Insufficient clinical response|0|||
16496501|NCT01059825|40287955|FG002|Treatment Period|Insufficient clinical response|0|||
16496502|NCT01059825|40287956|FG003|Treatment Period|Insufficient clinical response|0|||
16496503|NCT01059825|40287957|FG004|Treatment Period|Insufficient clinical response|0|||
16496504|NCT01059825|40287958|FG005|Treatment Period|Insufficient clinical response|0|||
16496505|NCT01059825|40287959|FG006|Treatment Period|Insufficient clinical response|0|||
16496506|NCT01059825|40287953|FG000|Treatment Period|Adverse event not related to study drug|0|||
16496507|NCT01059825|40287954|FG001|Treatment Period|Adverse event not related to study drug|1|||
16496508|NCT01059825|40287955|FG002|Treatment Period|Adverse event not related to study drug|2|||
16496509|NCT01059825|40287956|FG003|Treatment Period|Adverse event not related to study drug|1|||
16496510|NCT01059825|40287957|FG004|Treatment Period|Adverse event not related to study drug|1|||
16496511|NCT01059825|40287958|FG005|Treatment Period|Adverse event not related to study drug|1|||
16496512|NCT01059825|40287959|FG006|Treatment Period|Adverse event not related to study drug|0|||
16496513|NCT00390858|40287961|FG000|Overall Study|Adverse Event|6|||
16496514|NCT00390858|40287962|FG001|Overall Study|Adverse Event|2|||
16496515|NCT00390858|40287961|FG000|Overall Study|Lack of Efficacy|0|||
16496516|NCT00390858|40287962|FG001|Overall Study|Lack of Efficacy|1|||
16496517|NCT00390858|40287961|FG000|Overall Study|Withdrawal by Subject|3|||
16496518|NCT00390858|40287962|FG001|Overall Study|Withdrawal by Subject|4|||
16496519|NCT02664441|40287963|FG000|Randomization|Withdrawal by Subject|0|||
16496520|NCT02664441|40287964|FG001|Randomization|Withdrawal by Subject|1|||
16496521|NCT02664441|40287963|FG000|36-week Randomized Trial|Adverse Event|2|||
16496522|NCT02664441|40287964|FG001|36-week Randomized Trial|Adverse Event|0|||
16496523|NCT02664441|40287963|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
16496524|NCT02664441|40287964|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
16496525|NCT02664441|40287963|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
16496526|NCT02664441|40287964|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
16496527|NCT02664441|40287963|FG000|18-week Open Label Extension|Adverse Event|1|||
16496528|NCT02664441|40287964|FG001|18-week Open Label Extension|Adverse Event|0|||
16496529|NCT02664441|40287963|FG000|18-week Open Label Extension|Physician Decision|1|||
16496530|NCT02664441|40287964|FG001|18-week Open Label Extension|Physician Decision|0|||
16496531|NCT02664441|40287963|FG000|18-week Open Label Extension|Death|1|||
16496532|NCT02664441|40287964|FG001|18-week Open Label Extension|Death|0|||
16496533|NCT02664441|40287963|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
16496534|NCT02664441|40287964|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
16496535|NCT05131646|40287965|FG000|Overall Study|Withdrawal by Subject|1|||
16496536|NCT05131646|40287966|FG001|Overall Study|Withdrawal by Subject|0|||
16496537|NCT05131646|40287967|FG002|Overall Study|Withdrawal by Subject|0|||
16496538|NCT02899988|40287968|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
16496539|NCT02899988|40287969|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
16496540|NCT02899988|40287970|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16496541|NCT02899988|40287971|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16496542|NCT02899988|40287972|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16496543|NCT02899988|40287973|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16496544|NCT02899988|40287974|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16496545|NCT02899988|40287975|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16496546|NCT02899988|40287976|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16496547|NCT02899988|40287977|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16496548|NCT02899988|40287978|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16496549|NCT02899988|40287968|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
16086299|NCT01105975|38807107|FG002|Overall Study|Adverse Event|5|||
16496550|NCT02899988|40287969|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
16496551|NCT02899988|40287970|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
16496552|NCT02899988|40287971|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
16496553|NCT02899988|40287972|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
16496554|NCT02899988|40287973|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
16496555|NCT02899988|40287974|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
16496556|NCT02899988|40287975|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
16496557|NCT02899988|40287976|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
16496558|NCT02899988|40287977|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
16496559|NCT02899988|40287978|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
16496560|NCT02899988|40287968|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
16496561|NCT02899988|40287969|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
16496562|NCT02899988|40287970|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
16496563|NCT02899988|40287971|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
16496564|NCT02899988|40287972|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
16496565|NCT02899988|40287973|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
16496566|NCT02899988|40287974|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
16496567|NCT02899988|40287975|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
16496568|NCT02899988|40287976|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
16496569|NCT02899988|40287977|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
16496570|NCT02899988|40287978|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
16496571|NCT02899988|40287968|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
16496572|NCT02899988|40287969|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
16496573|NCT02899988|40287970|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
16496574|NCT02899988|40287971|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
16496575|NCT02899988|40287972|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
16496576|NCT02899988|40287973|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
16496577|NCT02899988|40287974|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
16496578|NCT02899988|40287975|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
16496579|NCT02899988|40287976|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
16496580|NCT02899988|40287977|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
16496581|NCT02899988|40287978|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
16086300|NCT01105975|38807108|FG003|Overall Study|Adverse Event|1|||
16086301|NCT01105975|38807109|FG004|Overall Study|Adverse Event|0|||
16086302|NCT01105975|38807110|FG005|Overall Study|Adverse Event|1|||
16086303|NCT01105975|38807111|FG006|Overall Study|Adverse Event|2|||
16086304|NCT01105975|38807112|FG007|Overall Study|Adverse Event|4|||
16086305|NCT01105975|38807113|FG008|Overall Study|Adverse Event|1|||
16086306|NCT01105975|38807114|FG009|Overall Study|Adverse Event|4|||
16086307|NCT01105975|38807105|FG000|Overall Study|Withdrawal by Subject|2|||
16086308|NCT01105975|38807106|FG001|Overall Study|Withdrawal by Subject|2|||
16086309|NCT01105975|38807107|FG002|Overall Study|Withdrawal by Subject|2|||
16086310|NCT01105975|38807108|FG003|Overall Study|Withdrawal by Subject|0|||
16086311|NCT01105975|38807109|FG004|Overall Study|Withdrawal by Subject|4|||
16086312|NCT01105975|38807110|FG005|Overall Study|Withdrawal by Subject|1|||
16086313|NCT01105975|38807111|FG006|Overall Study|Withdrawal by Subject|2|||
16086314|NCT01105975|38807112|FG007|Overall Study|Withdrawal by Subject|1|||
16086315|NCT01105975|38807113|FG008|Overall Study|Withdrawal by Subject|0|||
16086316|NCT01105975|38807114|FG009|Overall Study|Withdrawal by Subject|3|||
16086317|NCT01105975|38807105|FG000|Overall Study|Lost to Follow-up|1|||
16086318|NCT01105975|38807106|FG001|Overall Study|Lost to Follow-up|0|||
16086319|NCT01105975|38807107|FG002|Overall Study|Lost to Follow-up|0|||
16086320|NCT01105975|38807108|FG003|Overall Study|Lost to Follow-up|1|||
16086321|NCT01105975|38807109|FG004|Overall Study|Lost to Follow-up|1|||
16086322|NCT01105975|38807110|FG005|Overall Study|Lost to Follow-up|0|||
16086323|NCT01105975|38807111|FG006|Overall Study|Lost to Follow-up|0|||
16086324|NCT01105975|38807112|FG007|Overall Study|Lost to Follow-up|0|||
16086325|NCT01105975|38807113|FG008|Overall Study|Lost to Follow-up|1|||
16086326|NCT01105975|38807114|FG009|Overall Study|Lost to Follow-up|0|||
16086327|NCT01105975|38807105|FG000|Overall Study|Physician Decision|0|||
16086328|NCT01105975|38807106|FG001|Overall Study|Physician Decision|0|||
16086329|NCT01105975|38807107|FG002|Overall Study|Physician Decision|0|||
16086330|NCT01105975|38807108|FG003|Overall Study|Physician Decision|0|||
16086331|NCT01105975|38807109|FG004|Overall Study|Physician Decision|0|||
16086332|NCT01105975|38807110|FG005|Overall Study|Physician Decision|0|||
16086333|NCT01105975|38807111|FG006|Overall Study|Physician Decision|2|||
16086334|NCT01105975|38807112|FG007|Overall Study|Physician Decision|0|||
16086335|NCT01105975|38807113|FG008|Overall Study|Physician Decision|0|||
16086336|NCT01105975|38807114|FG009|Overall Study|Physician Decision|0|||
16086337|NCT01105975|38807105|FG000|Overall Study|Protocol Violation|0|||
16086338|NCT01105975|38807106|FG001|Overall Study|Protocol Violation|2|||
16086339|NCT01105975|38807107|FG002|Overall Study|Protocol Violation|2|||
16496582|NCT02899988|40287968|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
16496583|NCT02899988|40287969|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
16496584|NCT02899988|40287970|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
16496585|NCT02899988|40287971|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
16496586|NCT02899988|40287972|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
16086340|NCT01105975|38807108|FG003|Overall Study|Protocol Violation|0|||
16086341|NCT01105975|38807109|FG004|Overall Study|Protocol Violation|1|||
16086342|NCT01105975|38807110|FG005|Overall Study|Protocol Violation|1|||
16086343|NCT01105975|38807111|FG006|Overall Study|Protocol Violation|1|||
16086344|NCT01105975|38807112|FG007|Overall Study|Protocol Violation|1|||
16086345|NCT01105975|38807113|FG008|Overall Study|Protocol Violation|2|||
16496587|NCT02899988|40287973|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
16496588|NCT02899988|40287974|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
16496589|NCT02899988|40287975|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
16496590|NCT02899988|40287976|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
16496591|NCT02899988|40287977|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
16496592|NCT02899988|40287978|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
16086346|NCT01105975|38807114|FG009|Overall Study|Protocol Violation|2|||
16086347|NCT01105975|38807105|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16086348|NCT01105975|38807106|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16086349|NCT01105975|38807107|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16086350|NCT01105975|38807108|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16086351|NCT01105975|38807109|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16086352|NCT01105975|38807110|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
16086353|NCT01105975|38807111|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16496593|NCT02899988|40287968|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
16496594|NCT02899988|40287969|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
16496595|NCT02899988|40287970|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
16496596|NCT02899988|40287971|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
16496597|NCT02899988|40287972|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
16496598|NCT02899988|40287973|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
16496599|NCT02899988|40287974|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
16496600|NCT02899988|40287975|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
16496601|NCT02899988|40287976|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
16496602|NCT02899988|40287977|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
16496603|NCT02899988|40287978|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
16496604|NCT01962207|40287983|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
16496605|NCT01962207|40287984|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
16496606|NCT01962207|40287985|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
16496607|NCT01962207|40287986|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
16496608|NCT01962207|40287983|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
16496609|NCT01962207|40287984|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
16496610|NCT01962207|40287985|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
16496611|NCT01962207|40287986|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
16496612|NCT01962207|40287983|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
16496613|NCT01962207|40287984|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
16496614|NCT01962207|40287985|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
16496615|NCT01962207|40287986|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
16496616|NCT01962207|40287983|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
16496617|NCT01962207|40287984|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
16496618|NCT01962207|40287985|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
16496619|NCT01962207|40287986|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
16496620|NCT01962207|40287983|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
16496621|NCT01962207|40287984|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
16496622|NCT01962207|40287985|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
16496623|NCT01962207|40287986|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
16496624|NCT01962207|40287983|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
16496625|NCT01962207|40287984|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
16496626|NCT01962207|40287985|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
16496627|NCT01962207|40287986|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
16496628|NCT02268864|40287987|FG000|Overall Study|Withdrawal by Subject|2|||
16496629|NCT02268864|40287988|FG001|Overall Study|Withdrawal by Subject|0|||
16496630|NCT02268864|40287989|FG002|Overall Study|Withdrawal by Subject|0|||
16496631|NCT02268864|40287987|FG000|Overall Study|Death|0|||
16496632|NCT02268864|40287988|FG001|Overall Study|Death|1|||
16496633|NCT02268864|40287989|FG002|Overall Study|Death|0|||
16496634|NCT03655691|40287992|FG000|Overall Study|Adverse Event|0|||
16496635|NCT03655691|40287993|FG001|Overall Study|Adverse Event|0|||
16496636|NCT03655691|40287994|FG002|Overall Study|Adverse Event|1|||
16496637|NCT03655691|40287992|FG000|Overall Study|Lost to Follow-up|1|||
16086354|NCT01105975|38807112|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16086355|NCT01105975|38807113|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
16086356|NCT01105975|38807114|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16086357|NCT00463229|38807117|FG000|Overall Study|Lost to Follow-up|5|||
16086358|NCT00463229|38807118|FG001|Overall Study|Lost to Follow-up|7|||
16086359|NCT00463229|38807117|FG000|Overall Study|Death|4|||
16086360|NCT00463229|38807118|FG001|Overall Study|Death|3|||
16086361|NCT02236611|38807121|FG000|Overall Study|Adverse Event|10|||
16086362|NCT02236611|38807122|FG001|Overall Study|Adverse Event|16|||
16496638|NCT03655691|40287993|FG001|Overall Study|Lost to Follow-up|1|||
16496639|NCT03655691|40287994|FG002|Overall Study|Lost to Follow-up|2|||
16194386|NCT00423085|39188746|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
16194387|NCT00423085|39188743|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
16194388|NCT00423085|39188744|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
16194389|NCT00423085|39188745|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
16194390|NCT00423085|39188746|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
16194391|NCT00423085|39188743|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
16194392|NCT00423085|39188744|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
16194393|NCT00423085|39188745|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
16194394|NCT00423085|39188746|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
16194395|NCT00423085|39188743|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
16194396|NCT00423085|39188744|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
16194397|NCT00423085|39188745|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
16194398|NCT00423085|39188746|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
16194399|NCT00423085|39188743|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
16194400|NCT00423085|39188744|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
16194401|NCT00423085|39188745|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
16194402|NCT00423085|39188746|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
16194403|NCT00423085|39188743|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
16194404|NCT00423085|39188744|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
16194405|NCT00423085|39188745|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
16194406|NCT00423085|39188746|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
16194407|NCT00423085|39188743|FG000|52-Week Open-Label Extension Phase|Death|0|||
16194408|NCT00423085|39188744|FG001|52-Week Open-Label Extension Phase|Death|0|||
16194409|NCT00423085|39188745|FG002|52-Week Open-Label Extension Phase|Death|0|||
16194410|NCT00423085|39188746|FG003|52-Week Open-Label Extension Phase|Death|2|||
16194411|NCT02586233|39188747|FG000|Overall Study|Randomized but did not receive treatment|0|||
16194412|NCT02586233|39188748|FG001|Overall Study|Randomized but did not receive treatment|1|||
16194413|NCT02586233|39188749|FG002|Overall Study|Randomized but did not receive treatment|0|||
16194414|NCT02586233|39188750|FG003|Overall Study|Randomized but did not receive treatment|0|||
16194415|NCT02586233|39188751|FG004|Overall Study|Randomized but did not receive treatment|0|||
16194416|NCT02586233|39188752|FG005|Overall Study|Randomized but did not receive treatment|2|||
16194417|NCT02586233|39188753|FG006|Overall Study|Randomized but did not receive treatment|2|||
16194418|NCT02586233|39188747|FG000|Overall Study|Death|0|||
16194419|NCT02586233|39188748|FG001|Overall Study|Death|1|||
16194420|NCT02586233|39188749|FG002|Overall Study|Death|0|||
16194421|NCT02586233|39188750|FG003|Overall Study|Death|0|||
16194422|NCT02586233|39188751|FG004|Overall Study|Death|2|||
16194423|NCT02586233|39188752|FG005|Overall Study|Death|0|||
16194424|NCT02586233|39188753|FG006|Overall Study|Death|0|||
16194425|NCT02176291|39188756|FG000|Overall Study|Death|1|||
16194426|NCT02176291|39188757|FG001|Overall Study|Death|0|||
16194427|NCT02176291|39188756|FG000|Overall Study|non compliance with protocol|2|||
16194428|NCT02176291|39188757|FG001|Overall Study|non compliance with protocol|0|||
16194429|NCT02176291|39188756|FG000|Overall Study|Withdrawal by Subject|2|||
16194430|NCT02176291|39188757|FG001|Overall Study|Withdrawal by Subject|0|||
16194431|NCT03009539|39188760|FG000|Overall Study|Lost to Follow-up|132|||
16194432|NCT03009539|39188761|FG001|Overall Study|Lost to Follow-up|113|||
16194433|NCT03009539|39188762|FG002|Overall Study|Lost to Follow-up|132|||
16194434|NCT03009539|39188763|FG003|Overall Study|Lost to Follow-up|113|||
16194435|NCT00882999|39188764|FG000|Overall Study|Adverse Event|0|||
16194436|NCT00882999|39188765|FG001|Overall Study|Adverse Event|0|||
16194437|NCT00882999|39188766|FG002|Overall Study|Adverse Event|0|||
16194438|NCT00882999|39188767|FG003|Overall Study|Adverse Event|0|||
16194439|NCT00882999|39188768|FG004|Overall Study|Adverse Event|1|||
16194440|NCT00882999|39188769|FG005|Overall Study|Adverse Event|0|||
16194441|NCT00882999|39188770|FG006|Overall Study|Adverse Event|0|||
16194442|NCT00882999|39188764|FG000|Overall Study|Death|0|||
16194443|NCT00882999|39188765|FG001|Overall Study|Death|1|||
16194444|NCT00882999|39188766|FG002|Overall Study|Death|0|||
16194445|NCT00882999|39188767|FG003|Overall Study|Death|0|||
16194446|NCT00882999|39188768|FG004|Overall Study|Death|0|||
16194447|NCT00882999|39188769|FG005|Overall Study|Death|0|||
16194448|NCT00882999|39188770|FG006|Overall Study|Death|0|||
16194449|NCT00882999|39188764|FG000|Overall Study|Withdrawal by Subject|7|||
16194450|NCT00882999|39188765|FG001|Overall Study|Withdrawal by Subject|6|||
16194451|NCT00882999|39188766|FG002|Overall Study|Withdrawal by Subject|3|||
16194452|NCT00882999|39188767|FG003|Overall Study|Withdrawal by Subject|3|||
16194453|NCT00882999|39188768|FG004|Overall Study|Withdrawal by Subject|6|||
16194454|NCT00882999|39188769|FG005|Overall Study|Withdrawal by Subject|5|||
16308344|NCT01371747|39612772|FG005|Overall Study|High Serum Potassium Results|2|||
16194455|NCT00882999|39188770|FG006|Overall Study|Withdrawal by Subject|5|||
16194456|NCT00882999|39188764|FG000|Overall Study|Lost to Follow-up|0|||
16194457|NCT00882999|39188765|FG001|Overall Study|Lost to Follow-up|1|||
16194458|NCT00882999|39188766|FG002|Overall Study|Lost to Follow-up|1|||
16194459|NCT00882999|39188767|FG003|Overall Study|Lost to Follow-up|2|||
16194460|NCT00882999|39188768|FG004|Overall Study|Lost to Follow-up|1|||
16194461|NCT00882999|39188769|FG005|Overall Study|Lost to Follow-up|1|||
16194462|NCT00882999|39188770|FG006|Overall Study|Lost to Follow-up|2|||
16194463|NCT00882999|39188764|FG000|Overall Study|Physician Decision|1|||
16194464|NCT00882999|39188765|FG001|Overall Study|Physician Decision|0|||
16194465|NCT00882999|39188766|FG002|Overall Study|Physician Decision|0|||
16194466|NCT00882999|39188767|FG003|Overall Study|Physician Decision|0|||
16194467|NCT00882999|39188768|FG004|Overall Study|Physician Decision|0|||
16194468|NCT00882999|39188769|FG005|Overall Study|Physician Decision|1|||
16388296|NCT03281629|39905634|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
16388297|NCT03281629|39905635|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
16388298|NCT03745768|39905636|FG000|Overall Study|discontinued study|2|||
16388299|NCT03745768|39905637|FG001|Overall Study|discontinued study|0|||
16388300|NCT01541865|39905640|FG000|Overall Study|Lost to Follow-up|11|||
16388301|NCT01541865|39905640|FG000|Overall Study|Withdrawal by Subject|9|||
16388302|NCT01541865|39905640|FG000|Overall Study|Adverse Event|1|||
16388303|NCT01541865|39905640|FG000|Overall Study|Protocol Violation|1|||
16388304|NCT03273907|39905642|FG000|Overall Study|Death|1|||
16388305|NCT03273907|39905642|FG000|Overall Study|Lost to Follow-up|4|||
16496640|NCT03655691|40287992|FG000|Overall Study|Protocol Violation|0|||
16496641|NCT03655691|40287993|FG001|Overall Study|Protocol Violation|1|||
16496642|NCT03655691|40287994|FG002|Overall Study|Protocol Violation|0|||
16496643|NCT03655691|40287992|FG000|Overall Study|Withdrawal by Subject|1|||
16496644|NCT03655691|40287993|FG001|Overall Study|Withdrawal by Subject|1|||
16496645|NCT03655691|40287994|FG002|Overall Study|Withdrawal by Subject|0|||
16496646|NCT03045328|40287995|FG000|Overall Study|Withdrawal by Subject|2|||
16496647|NCT02154490|40287996|FG000|Overall Study|No tissue submitted|23|||
16496648|NCT02154490|40287996|FG000|Overall Study|No biomarker results|167|||
16496649|NCT02154490|40287996|FG000|Overall Study|Not assigned to a sub-study|270|||
16496650|NCT02154490|40287996|FG000|Overall Study|Did not register to a sub-study|749|||
16496651|NCT03902574|40287997|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
16496652|NCT03902574|40287998|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
16496653|NCT03902574|40287999|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
16496654|NCT02107482|40288000|FG000|Overall Study|inconveinence|2|||
16496655|NCT02107482|40288000|FG000|Overall Study|Lost to Follow-up|1|||
16496656|NCT02107482|40288000|FG000|Overall Study|Lack of Efficacy|1|||
16388306|NCT03273907|39905642|FG000|Overall Study|Withdrawal by Subject|2|||
16388307|NCT03273907|39905642|FG000|Overall Study|COVID 19|2|||
16388308|NCT01558596|39905648|FG000|Overall Study|Withdrawal by Subject|1|||
16388309|NCT01558596|39905649|FG001|Overall Study|Withdrawal by Subject|0|||
16388310|NCT01558596|39905648|FG000|Overall Study|surgery elsewhere or cancelled|1|||
16388311|NCT01558596|39905649|FG001|Overall Study|surgery elsewhere or cancelled|1|||
16388312|NCT01558596|39905648|FG000|Overall Study|Protocol Violation|1|||
16496657|NCT00459953|40288004|FG000|Overall Study|not analyzed-household member in study|1|||
16496658|NCT00459953|40288005|FG001|Overall Study|not analyzed-household member in study|1|||
16086363|NCT02236611|38807121|FG000|Overall Study|Lack of Efficacy|4|||
16086364|NCT02236611|38807122|FG001|Overall Study|Lack of Efficacy|7|||
16086365|NCT02236611|38807121|FG000|Overall Study|Lost to Follow-up|0|||
16086366|NCT02236611|38807122|FG001|Overall Study|Lost to Follow-up|2|||
16086367|NCT02236611|38807121|FG000|Overall Study|Protocol deviation|3|||
16086368|NCT02236611|38807122|FG001|Overall Study|Protocol deviation|5|||
16086369|NCT02236611|38807121|FG000|Overall Study|Withdrew consent|9|||
16086370|NCT02236611|38807122|FG001|Overall Study|Withdrew consent|4|||
16086371|NCT02767765|38807123|FG000|Overall Study|Adverse Event|4|||
16086372|NCT02767765|38807123|FG000|Overall Study|Death|1|||
16086373|NCT02767765|38807123|FG000|Overall Study|Insufficient response|1|||
16194469|NCT00882999|39188770|FG006|Overall Study|Physician Decision|1|||
16194470|NCT00879814|39188771|FG000|Overall Study|Adverse Event|0|||
16388313|NCT01558596|39905649|FG001|Overall Study|Protocol Violation|0|||
16388314|NCT03759600|39905650|FG000|Overall Study|Adverse Event|2|||
16496659|NCT00276744|40288007|FG000|PART A|Reason unknown|98|||
16086374|NCT02767765|38807123|FG000|Overall Study|Lost to Follow-up|2|||
16388315|NCT03759600|39905650|FG000|Overall Study|Progressive Disease|15|||
16496660|NCT00545168|40288008|FG000|Overall Study|Lost to Follow-up|5|||
16496661|NCT00545168|40288009|FG001|Overall Study|Lost to Follow-up|5|||
16496662|NCT00545168|40288010|FG002|Overall Study|Lost to Follow-up|5|||
16496663|NCT00545168|40288008|FG000|Overall Study|Withdrawal by Subject|9|||
16496664|NCT00545168|40288009|FG001|Overall Study|Withdrawal by Subject|0|||
16496665|NCT00545168|40288010|FG002|Overall Study|Withdrawal by Subject|13|||
16086375|NCT02767765|38807123|FG000|Overall Study|Investigator decision|1|||
16086376|NCT02767765|38807123|FG000|Overall Study|Non-Compliance|1|||
16308345|NCT01371747|39612767|FG000|Overall Study|Low Serum Potassium Results|1|||
16496666|NCT00545168|40288008|FG000|Overall Study|Protocol Violation|1|||
16496667|NCT00545168|40288009|FG001|Overall Study|Protocol Violation|0|||
16496668|NCT00545168|40288010|FG002|Overall Study|Protocol Violation|1|||
16388316|NCT03759600|39905650|FG000|Overall Study|Site Terminated by Sponsor|3|||
16388317|NCT02852967|39905651|FG000|Overall Study|Adverse Event|3|||
16388318|NCT02852967|39905652|FG001|Overall Study|Adverse Event|1|||
16388319|NCT02852967|39905653|FG002|Overall Study|Adverse Event|0|||
16388320|NCT02852967|39905654|FG003|Overall Study|Adverse Event|1|||
16388321|NCT02852967|39905655|FG004|Overall Study|Adverse Event|0|||
16388322|NCT02852967|39905651|FG000|Overall Study|Death|1|||
16388323|NCT02852967|39905652|FG001|Overall Study|Death|0|||
16388324|NCT02852967|39905653|FG002|Overall Study|Death|0|||
16388325|NCT02852967|39905654|FG003|Overall Study|Death|0|||
16388326|NCT02852967|39905655|FG004|Overall Study|Death|0|||
16388327|NCT02852967|39905651|FG000|Overall Study|Lost to Follow-up|1|||
16388328|NCT02852967|39905652|FG001|Overall Study|Lost to Follow-up|2|||
16388329|NCT02852967|39905653|FG002|Overall Study|Lost to Follow-up|3|||
16388330|NCT02852967|39905654|FG003|Overall Study|Lost to Follow-up|4|||
16388331|NCT02852967|39905655|FG004|Overall Study|Lost to Follow-up|4|||
16388332|NCT02852967|39905651|FG000|Overall Study|Withdrawal by Subject|6|||
16388333|NCT02852967|39905652|FG001|Overall Study|Withdrawal by Subject|12|||
16388334|NCT02852967|39905653|FG002|Overall Study|Withdrawal by Subject|7|||
16388335|NCT02852967|39905654|FG003|Overall Study|Withdrawal by Subject|10|||
16388336|NCT02852967|39905655|FG004|Overall Study|Withdrawal by Subject|10|||
16388337|NCT02852967|39905651|FG000|Overall Study|SAE|0|||
16388338|NCT02852967|39905652|FG001|Overall Study|SAE|0|||
16388339|NCT02852967|39905653|FG002|Overall Study|SAE|0|||
16388340|NCT02852967|39905654|FG003|Overall Study|SAE|3|||
16388341|NCT02852967|39905655|FG004|Overall Study|SAE|0|||
16388342|NCT02852967|39905651|FG000|Overall Study|Elevated Liver Enzymes|2|||
16388343|NCT02852967|39905652|FG001|Overall Study|Elevated Liver Enzymes|0|||
16388344|NCT02852967|39905653|FG002|Overall Study|Elevated Liver Enzymes|0|||
16388345|NCT02852967|39905654|FG003|Overall Study|Elevated Liver Enzymes|2|||
16388346|NCT02852967|39905655|FG004|Overall Study|Elevated Liver Enzymes|2|||
16388347|NCT02852967|39905651|FG000|Overall Study|Physician Decision|0|||
16388348|NCT02852967|39905652|FG001|Overall Study|Physician Decision|0|||
16388349|NCT02852967|39905653|FG002|Overall Study|Physician Decision|0|||
16388350|NCT02852967|39905654|FG003|Overall Study|Physician Decision|1|||
16388351|NCT02852967|39905655|FG004|Overall Study|Physician Decision|0|||
16388352|NCT02852967|39905651|FG000|Overall Study|Lack of Efficacy|0|||
16388353|NCT02852967|39905652|FG001|Overall Study|Lack of Efficacy|1|||
16388354|NCT02852967|39905653|FG002|Overall Study|Lack of Efficacy|0|||
16388355|NCT02852967|39905654|FG003|Overall Study|Lack of Efficacy|0|||
16388356|NCT02852967|39905655|FG004|Overall Study|Lack of Efficacy|0|||
16388357|NCT02852967|39905651|FG000|Overall Study|Non-compliance|0|||
16388358|NCT02852967|39905652|FG001|Overall Study|Non-compliance|0|||
16388359|NCT02852967|39905653|FG002|Overall Study|Non-compliance|1|||
16388360|NCT02852967|39905654|FG003|Overall Study|Non-compliance|1|||
16388361|NCT02852967|39905655|FG004|Overall Study|Non-compliance|0|||
16388362|NCT02852967|39905651|FG000|Overall Study|Dispensing Drug Violation|0|||
16388363|NCT02852967|39905652|FG001|Overall Study|Dispensing Drug Violation|0|||
16388364|NCT02852967|39905653|FG002|Overall Study|Dispensing Drug Violation|1|||
16388365|NCT02852967|39905654|FG003|Overall Study|Dispensing Drug Violation|0|||
16388366|NCT02852967|39905655|FG004|Overall Study|Dispensing Drug Violation|0|||
16388367|NCT02852967|39905651|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
16388368|NCT02852967|39905652|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
16388369|NCT02852967|39905653|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
16388370|NCT02852967|39905654|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
16388371|NCT02852967|39905655|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
16388372|NCT00305877|39905656|FG000|Overall Study|Lack of Efficacy|6|||
16086377|NCT02767765|38807123|FG000|Overall Study|Withdrawal by Subject|1|||
16388373|NCT00305877|39905657|FG001|Overall Study|Lack of Efficacy|9|||
16388374|NCT00305877|39905656|FG000|Overall Study|Adverse Event|9|||
16388375|NCT00305877|39905657|FG001|Overall Study|Adverse Event|14|||
16388376|NCT00305877|39905656|FG000|Overall Study|Death|0|||
16388377|NCT00305877|39905657|FG001|Overall Study|Death|1|||
16388378|NCT00305877|39905656|FG000|Overall Study|Withdrawal by Subject|4|||
16388379|NCT00305877|39905657|FG001|Overall Study|Withdrawal by Subject|2|||
16388380|NCT00305877|39905656|FG000|Overall Study|Physician Decision|1|||
16388381|NCT00305877|39905657|FG001|Overall Study|Physician Decision|1|||
16388382|NCT00305877|39905656|FG000|Overall Study|Never start treatment|2|||
16388383|NCT00305877|39905657|FG001|Overall Study|Never start treatment|5|||
16388384|NCT00305877|39905656|FG000|Overall Study|Ineligible|2|||
16388385|NCT00305877|39905657|FG001|Overall Study|Ineligible|1|||
16388386|NCT00305877|39905656|FG000|Overall Study|Transportation issue with daily RT|0|||
16388387|NCT00305877|39905657|FG001|Overall Study|Transportation issue with daily RT|1|||
16388388|NCT00661830|39905662|FG000|Overall Study|Death|37|||
16388389|NCT00661830|39905663|FG001|Overall Study|Death|33|||
16388390|NCT00661830|39905662|FG000|Overall Study|Lost to Follow-up|1|||
16388391|NCT00661830|39905663|FG001|Overall Study|Lost to Follow-up|3|||
16388392|NCT00661830|39905662|FG000|Overall Study|Withdrawal by Subject|1|||
16388393|NCT00661830|39905663|FG001|Overall Study|Withdrawal by Subject|1|||
16388394|NCT00661830|39905662|FG000|Overall Study|Other reason|1|||
16388395|NCT00661830|39905663|FG001|Overall Study|Other reason|5|||
16388396|NCT01396187|39905664|FG000|Overall Study|Adverse Event|0|||
16388397|NCT01396187|39905665|FG001|Overall Study|Adverse Event|1|||
16388398|NCT01396187|39905666|FG002|Overall Study|Adverse Event|0|||
16388399|NCT01396187|39905667|FG003|Overall Study|Adverse Event|0|||
16388400|NCT01396187|39905668|FG004|Overall Study|Adverse Event|0|||
16388401|NCT01396187|39905664|FG000|Overall Study|Withdrawal by Subject|0|||
16388402|NCT01396187|39905665|FG001|Overall Study|Withdrawal by Subject|1|||
16388403|NCT01396187|39905666|FG002|Overall Study|Withdrawal by Subject|1|||
16388404|NCT01396187|39905667|FG003|Overall Study|Withdrawal by Subject|0|||
16388405|NCT01396187|39905668|FG004|Overall Study|Withdrawal by Subject|0|||
16388406|NCT01396187|39905664|FG000|Overall Study|Other|1|||
16388407|NCT01396187|39905665|FG001|Overall Study|Other|1|||
16388408|NCT01396187|39905666|FG002|Overall Study|Other|0|||
16388409|NCT01396187|39905667|FG003|Overall Study|Other|0|||
16388410|NCT01396187|39905668|FG004|Overall Study|Other|1|||
16388411|NCT00087698|39905669|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
16388412|NCT00087698|39905669|FG000|Overall Study|Death from Other Causes|3|||
16388413|NCT00087698|39905669|FG000|Overall Study|Adverse Event|4|||
16388414|NCT00087698|39905669|FG000|Overall Study|Withdrawal by Subject|4|||
16388415|NCT00087698|39905669|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
16388416|NCT00087698|39905669|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
16388417|NCT00087698|39905669|FG000|Overall Study|Clinical Relapse|1|||
16388418|NCT00087698|39905669|FG000|Overall Study|Death from Study Disease|2|||
16388419|NCT00087698|39905669|FG000|Overall Study|Death from Study Drug Toxicity|2|||
16388420|NCT00087698|39905669|FG000|Overall Study|Protocol Violation|1|||
16388421|NCT03894891|39905670|FG000|Overall Study|Withdrawal by Subject|1|||
16388422|NCT03894891|39905670|FG000|Overall Study|Completed protocol treatment per protocol|5|||
16388423|NCT02041299|39905671|FG000|Overall Study|Adverse Event|9|||
16388424|NCT02041299|39905672|FG001|Overall Study|Adverse Event|3|||
16388425|NCT02041299|39905671|FG000|Overall Study|Lost to Follow-up|4|||
16388426|NCT02041299|39905672|FG001|Overall Study|Lost to Follow-up|1|||
16388427|NCT02041299|39905671|FG000|Overall Study|Physician Decision|1|||
16388428|NCT02041299|39905672|FG001|Overall Study|Physician Decision|1|||
16388429|NCT02041299|39905671|FG000|Overall Study|Withdrawal by Subject|13|||
16388430|NCT02041299|39905672|FG001|Overall Study|Withdrawal by Subject|7|||
16388431|NCT02041299|39905671|FG000|Overall Study|Protocol Violation|11|||
16388432|NCT02041299|39905672|FG001|Overall Study|Protocol Violation|4|||
16388433|NCT02041299|39905671|FG000|Overall Study|Termination of the study|7|||
16388434|NCT02041299|39905672|FG001|Overall Study|Termination of the study|3|||
16388435|NCT02041299|39905671|FG000|Overall Study|Required bone marrow transplant|0|||
16388436|NCT02041299|39905672|FG001|Overall Study|Required bone marrow transplant|1|||
16388437|NCT02041299|39905671|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
16388438|NCT02041299|39905672|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
16388439|NCT00473889|39905674|FG000|Overall Study|Did not receive study medication|1|||
16388440|NCT00473889|39905675|FG001|Overall Study|Did not receive study medication|4|||
16388441|NCT00473889|39905674|FG000|Overall Study|Adverse Event|30|||
16388442|NCT00473889|39905675|FG001|Overall Study|Adverse Event|17|||
16388443|NCT00473889|39905674|FG000|Overall Study|Protocol Violation|4|||
16388444|NCT00473889|39905675|FG001|Overall Study|Protocol Violation|2|||
16388445|NCT00473889|39905674|FG000|Overall Study|Lack of Efficacy|28|||
16388446|NCT00473889|39905675|FG001|Overall Study|Lack of Efficacy|29|||
16388447|NCT00473889|39905674|FG000|Overall Study|Lost to Follow-up|2|||
16388448|NCT00473889|39905675|FG001|Overall Study|Lost to Follow-up|1|||
16388449|NCT00473889|39905674|FG000|Overall Study|Physician Decision|10|||
16388450|NCT00473889|39905675|FG001|Overall Study|Physician Decision|5|||
16388451|NCT00473889|39905674|FG000|Overall Study|Trial Terminated|3|||
16388452|NCT00473889|39905675|FG001|Overall Study|Trial Terminated|6|||
16388453|NCT00473889|39905674|FG000|Overall Study|Withdrawal by Subject|5|||
16388454|NCT00473889|39905675|FG001|Overall Study|Withdrawal by Subject|0|||
16388455|NCT00889707|39905676|FG000|Overall Study|Adverse Event|1|||
16388456|NCT00889707|39905677|FG001|Overall Study|Adverse Event|0|||
16388457|NCT00889707|39905676|FG000|Overall Study|Withdrawal by Subject|4|||
16388458|NCT00889707|39905677|FG001|Overall Study|Withdrawal by Subject|3|||
16388459|NCT00889707|39905676|FG000|Overall Study|Lost to Follow-up|0|||
16388460|NCT00889707|39905677|FG001|Overall Study|Lost to Follow-up|2|||
16388461|NCT00889707|39905676|FG000|Overall Study|Lack of Efficacy|2|||
16388462|NCT00889707|39905677|FG001|Overall Study|Lack of Efficacy|5|||
16388463|NCT02651116|39905678|FG000|Overall Study|Adverse Event|0|||
16388464|NCT02651116|39905679|FG001|Overall Study|Adverse Event|1|||
16388465|NCT02651116|39905678|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
16388466|NCT02651116|39905679|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
16388467|NCT03768427|39905680|FG000|Overall Study|Death|0|||
16388468|NCT03768427|39905681|FG001|Overall Study|Death|0|||
16388469|NCT03768427|39905682|FG002|Overall Study|Death|1|||
16388470|NCT03768427|39905683|FG003|Overall Study|Death|0|||
16388471|NCT03768427|39905680|FG000|Overall Study|Lost to Follow-up|2|||
16388472|NCT03768427|39905681|FG001|Overall Study|Lost to Follow-up|0|||
16388473|NCT03768427|39905682|FG002|Overall Study|Lost to Follow-up|0|||
16388474|NCT03768427|39905683|FG003|Overall Study|Lost to Follow-up|0|||
16388475|NCT03768427|39905680|FG000|Overall Study|Physician Decision|3|||
16388476|NCT03768427|39905681|FG001|Overall Study|Physician Decision|2|||
16388477|NCT03768427|39905682|FG002|Overall Study|Physician Decision|4|||
16388478|NCT03768427|39905683|FG003|Overall Study|Physician Decision|4|||
16388479|NCT03768427|39905680|FG000|Overall Study|Withdrawal by Subject|7|||
16388480|NCT03768427|39905681|FG001|Overall Study|Withdrawal by Subject|2|||
16388481|NCT03768427|39905682|FG002|Overall Study|Withdrawal by Subject|6|||
16388482|NCT03768427|39905683|FG003|Overall Study|Withdrawal by Subject|7|||
16388483|NCT02071771|39905684|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
16496669|NCT00545168|40288008|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
16194471|NCT00879814|39188772|FG001|Overall Study|Adverse Event|1|||
16194472|NCT00879814|39188773|FG002|Overall Study|Adverse Event|0|||
16194473|NCT00879814|39188774|FG003|Overall Study|Adverse Event|0|||
16308346|NCT01371747|39612768|FG001|Overall Study|Low Serum Potassium Results|1|||
16308347|NCT01371747|39612769|FG002|Overall Study|Low Serum Potassium Results|1|||
16308348|NCT01371747|39612770|FG003|Overall Study|Low Serum Potassium Results|1|||
16308349|NCT01371747|39612771|FG004|Overall Study|Low Serum Potassium Results|0|||
16308350|NCT01371747|39612772|FG005|Overall Study|Low Serum Potassium Results|3|||
16308351|NCT01371747|39612767|FG000|Overall Study|Protocol Violation|0|||
16308352|NCT01371747|39612768|FG001|Overall Study|Protocol Violation|0|||
16496670|NCT00545168|40288009|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
16496671|NCT00545168|40288010|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
16496672|NCT02157298|40288017|FG000|Overall Study|Adverse Event|1|||
16496673|NCT02157298|40288018|FG001|Overall Study|Adverse Event|0|||
16496674|NCT02157298|40288017|FG000|Overall Study|Subject no longer meets study criteria|1|||
16496675|NCT02157298|40288018|FG001|Overall Study|Subject no longer meets study criteria|2|||
16496676|NCT02157298|40288017|FG000|Overall Study|Poor/Non-compliance|1|||
16496677|NCT02157298|40288018|FG001|Overall Study|Poor/Non-compliance|0|||
16496678|NCT02157298|40288017|FG000|Overall Study|Withdrawal by Subject|1|||
16194474|NCT00879814|39188771|FG000|Overall Study|Lost to Follow-up|1|||
16308353|NCT01371747|39612769|FG002|Overall Study|Protocol Violation|1|||
16308354|NCT01371747|39612770|FG003|Overall Study|Protocol Violation|0|||
16308355|NCT01371747|39612771|FG004|Overall Study|Protocol Violation|0|||
16308356|NCT01371747|39612772|FG005|Overall Study|Protocol Violation|0|||
16194475|NCT00879814|39188772|FG001|Overall Study|Lost to Follow-up|0|||
16194476|NCT00879814|39188773|FG002|Overall Study|Lost to Follow-up|0|||
16194477|NCT00879814|39188774|FG003|Overall Study|Lost to Follow-up|2|||
16194478|NCT00879814|39188771|FG000|Overall Study|Participant Failed to Return|0|||
16194479|NCT00879814|39188772|FG001|Overall Study|Participant Failed to Return|0|||
16194480|NCT00879814|39188773|FG002|Overall Study|Participant Failed to Return|0|||
16308357|NCT01371747|39612767|FG000|Overall Study|Non-Compliance|3|||
16308358|NCT01371747|39612768|FG001|Overall Study|Non-Compliance|4|||
16308359|NCT01371747|39612769|FG002|Overall Study|Non-Compliance|3|||
16308360|NCT01371747|39612770|FG003|Overall Study|Non-Compliance|0|||
16388484|NCT02071771|39905685|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
16308361|NCT01371747|39612771|FG004|Overall Study|Non-Compliance|0|||
16308362|NCT01371747|39612772|FG005|Overall Study|Non-Compliance|1|||
16388485|NCT02071771|39905684|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
16308363|NCT01371747|39612767|FG000|Overall Study|Physician Decision|0|||
16388486|NCT02071771|39905685|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
16496679|NCT02157298|40288018|FG001|Overall Study|Withdrawal by Subject|0|||
16496680|NCT00461682|40288019|FG000|Overall Study|Protocol Violation|1|||
16496681|NCT00848081|40288020|FG000|Overall Study|Adverse Event|6|||
16496682|NCT00848081|40288021|FG001|Overall Study|Adverse Event|7|||
16496683|NCT00848081|40288020|FG000|Overall Study|Protocol Violation|8|||
16496684|NCT00848081|40288021|FG001|Overall Study|Protocol Violation|5|||
16496685|NCT00848081|40288020|FG000|Overall Study|Lost to Follow-up|1|||
16496686|NCT00848081|40288021|FG001|Overall Study|Lost to Follow-up|0|||
16496687|NCT00848081|40288020|FG000|Overall Study|Physician Decision|0|||
16496688|NCT00848081|40288021|FG001|Overall Study|Physician Decision|3|||
16496689|NCT00848081|40288020|FG000|Overall Study|Withdrawal by Subject|5|||
16496690|NCT00848081|40288021|FG001|Overall Study|Withdrawal by Subject|3|||
16496691|NCT02279173|40288026|FG000|Overall Study|Protocol-specified Criteria|67|||
16496692|NCT02279173|40288026|FG000|Overall Study|Withdrawal by Subject|20|||
16496693|NCT02279173|40288026|FG000|Overall Study|Decision by Sponsor|4|||
16496694|NCT02279173|40288026|FG000|Overall Study|Lost to Follow-up|3|||
16496695|NCT00996216|40288027|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
16496696|NCT00996216|40288027|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
16496697|NCT00996216|40288027|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
16496698|NCT03042533|40288030|FG000|Overall Study|MD left program|1|||
16496699|NCT03042533|40288031|FG001|Overall Study|MD left program|4|||
16496700|NCT03042533|40288032|FG002|Overall Study|MD left program|1|||
16496701|NCT00638378|40288035|FG000|Overall Study|Death|2|||
16496702|NCT00638378|40288035|FG000|Overall Study|Adverse Event|1|||
16496703|NCT00638378|40288035|FG000|Overall Study|Disease progression|15|||
16496704|NCT00638378|40288035|FG000|Overall Study|Physician Decision|4|||
16086378|NCT00918203|38807124|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
16086379|NCT00918203|38807125|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
16086380|NCT00918203|38807126|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
16086381|NCT00918203|38807124|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
16086382|NCT00918203|38807125|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
16086383|NCT00918203|38807126|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
16496705|NCT01957553|40288036|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
16496706|NCT01957553|40288037|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
16496707|NCT01957553|40288036|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
16496708|NCT01957553|40288037|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
16086384|NCT00918203|38807124|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
16086385|NCT00918203|38807125|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
16086386|NCT00918203|38807126|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
16086387|NCT00918203|38807124|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
16086388|NCT00918203|38807125|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
16086389|NCT00918203|38807126|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
16086390|NCT02816398|38807127|FG000|Overall Study|Death|5|||
16086391|NCT02816398|38807127|FG000|Overall Study|Lack of Efficacy|8|||
16496709|NCT01957553|40288036|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
16496710|NCT01957553|40288037|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
16496711|NCT01957553|40288036|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
16496712|NCT01957553|40288037|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
16496713|NCT01957553|40288036|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
16496714|NCT01957553|40288037|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
16496715|NCT01957553|40288036|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
16496716|NCT01957553|40288037|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
16496717|NCT01957553|40288036|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
16496718|NCT01957553|40288037|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
16496719|NCT01957553|40288036|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
16496720|NCT01957553|40288037|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
16496721|NCT01957553|40288036|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
16496722|NCT01957553|40288037|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
16496723|NCT00460408|40291107|FG000|Overall Study|Adverse Event|1|||
16496724|NCT00460408|40291108|FG001|Overall Study|Adverse Event|0|||
16496725|NCT00460408|40291109|FG002|Overall Study|Adverse Event|0|||
16496726|NCT00460408|40291110|FG003|Overall Study|Adverse Event|0|||
16496727|NCT00460408|40291107|FG000|Overall Study|Death|7|||
16496728|NCT00460408|40291108|FG001|Overall Study|Death|0|||
16496729|NCT00460408|40291109|FG002|Overall Study|Death|0|||
16496730|NCT00460408|40291110|FG003|Overall Study|Death|0|||
16496731|NCT00460408|40291107|FG000|Overall Study|Lost to Follow-up|11|||
16086392|NCT02816398|38807127|FG000|Overall Study|Lost to Follow-up|1|||
16086393|NCT01437319|38807130|FG000|Phase I|Lost to Follow-up|2|||
16086394|NCT01437319|38807131|FG001|Phase I|Lost to Follow-up|0|||
16496732|NCT00460408|40291108|FG001|Overall Study|Lost to Follow-up|0|||
16496733|NCT00460408|40291109|FG002|Overall Study|Lost to Follow-up|1|||
16496734|NCT00460408|40291110|FG003|Overall Study|Lost to Follow-up|0|||
16496735|NCT00460408|40291107|FG000|Overall Study|Withdrawal by Subject|31|||
16086395|NCT01437319|38807132|FG002|Phase I|Lost to Follow-up|0|||
16086396|NCT01437319|38807130|FG000|Phase I|Protocol Violation|1|||
16086397|NCT01437319|38807131|FG001|Phase I|Protocol Violation|0|||
16086398|NCT01437319|38807132|FG002|Phase I|Protocol Violation|0|||
16086399|NCT01437319|38807130|FG000|Phase I|Study related symptoms/complaints|27|||
16086400|NCT01437319|38807131|FG001|Phase I|Study related symptoms/complaints|0|||
16086401|NCT01437319|38807132|FG002|Phase I|Study related symptoms/complaints|0|||
16086402|NCT01437319|38807130|FG000|Phase I|Withdrawal by Subject|25|||
16086403|NCT01437319|38807131|FG001|Phase I|Withdrawal by Subject|0|||
16086404|NCT01437319|38807132|FG002|Phase I|Withdrawal by Subject|0|||
16086405|NCT01437319|38807130|FG000|Phase II|Withdrawal by Subject|0|||
16086406|NCT01437319|38807131|FG001|Phase II|Withdrawal by Subject|8|||
16086407|NCT01437319|38807132|FG002|Phase II|Withdrawal by Subject|16|||
16086408|NCT01437319|38807130|FG000|Phase II|Lost to Follow-up|0|||
16086409|NCT01437319|38807131|FG001|Phase II|Lost to Follow-up|7|||
16086410|NCT01437319|38807132|FG002|Phase II|Lost to Follow-up|2|||
16086411|NCT01437319|38807130|FG000|Phase II|Study related symptoms/complaints|0|||
16086412|NCT01437319|38807131|FG001|Phase II|Study related symptoms/complaints|28|||
16086413|NCT01437319|38807132|FG002|Phase II|Study related symptoms/complaints|19|||
16086414|NCT01437319|38807130|FG000|Phase II|Protocol Violation|0|||
16086415|NCT01437319|38807131|FG001|Phase II|Protocol Violation|1|||
16086416|NCT01437319|38807132|FG002|Phase II|Protocol Violation|0|||
16086417|NCT00210106|38807135|FG000|Overall Study|Death|1|||
16308364|NCT01371747|39612768|FG001|Overall Study|Physician Decision|0|||
16308365|NCT01371747|39612769|FG002|Overall Study|Physician Decision|0|||
16308366|NCT01371747|39612770|FG003|Overall Study|Physician Decision|0|||
16086418|NCT00210106|38807135|FG000|Overall Study|Protocol Violation|13|||
16086419|NCT04211766|38810382|FG000|Overall Study|Withdrawal by Subject|5|||
16086420|NCT04211766|38810383|FG001|Overall Study|Withdrawal by Subject|1|||
16086421|NCT03170882|38810385|FG000|Overall Study|Death|17|||
16086422|NCT03170882|38810386|FG001|Overall Study|Death|29|||
16086423|NCT03170882|38810385|FG000|Overall Study|Lost to Follow-up|0|||
16086424|NCT03170882|38810386|FG001|Overall Study|Lost to Follow-up|1|||
16086425|NCT03170882|38810385|FG000|Overall Study|Withdrawal by Subject|4|||
16086426|NCT03170882|38810386|FG001|Overall Study|Withdrawal by Subject|7|||
16086427|NCT03170882|38810385|FG000|Overall Study|Reason not Specified|28|||
16086428|NCT03170882|38810386|FG001|Overall Study|Reason not Specified|36|||
16086429|NCT01185600|38810387|FG000|Overall Study|Adverse Event|1|||
16086430|NCT01185600|38810388|FG001|Overall Study|Adverse Event|1|||
16086431|NCT01185600|38810387|FG000|Overall Study|Death|0|||
16086432|NCT01185600|38810388|FG001|Overall Study|Death|1|||
16086433|NCT01185600|38810387|FG000|Overall Study|Lost to Follow-up|0|||
16086434|NCT01185600|38810388|FG001|Overall Study|Lost to Follow-up|5|||
16086435|NCT01185600|38810387|FG000|Overall Study|Physician Decision|29|||
16086436|NCT01185600|38810388|FG001|Overall Study|Physician Decision|35|||
16086437|NCT01185600|38810387|FG000|Overall Study|Withdrawal by Subject|1|||
16086438|NCT01185600|38810388|FG001|Overall Study|Withdrawal by Subject|1|||
16086439|NCT01185600|38810387|FG000|Overall Study|Hold by DSMB|1|||
16086440|NCT01185600|38810388|FG001|Overall Study|Hold by DSMB|2|||
16086441|NCT02158806|38810389|FG000|Overall Study|Death|2|||
16086442|NCT02158806|38810390|FG001|Overall Study|Death|0|||
16086443|NCT02158806|38810389|FG000|Overall Study|Withdrawal by Subject|2|||
16086444|NCT02158806|38810390|FG001|Overall Study|Withdrawal by Subject|0|||
16086445|NCT02158806|38810389|FG000|Overall Study|Lost to Follow-up|0|||
16086446|NCT02158806|38810390|FG001|Overall Study|Lost to Follow-up|3|||
16086447|NCT02158806|38810389|FG000|Overall Study|Moved out of area|0|||
16086448|NCT02158806|38810390|FG001|Overall Study|Moved out of area|1|||
16086449|NCT02158806|38810389|FG000|Overall Study|Transferred to palliative care|0|||
16086450|NCT02158806|38810390|FG001|Overall Study|Transferred to palliative care|1|||
16086451|NCT02538900|38810395|FG000|Overall Study|Death|2|||
16086452|NCT02538900|38810396|FG001|Overall Study|Death|2|||
16086453|NCT02538900|38810397|FG002|Overall Study|Death|2|||
16086454|NCT02538900|38810395|FG000|Overall Study|Withdrawal by Subject|18|||
16086455|NCT02538900|38810396|FG001|Overall Study|Withdrawal by Subject|16|||
16086456|NCT02538900|38810397|FG002|Overall Study|Withdrawal by Subject|15|||
16086457|NCT00582972|38810398|FG000|Overall Study|Protocol Violation|2|||
16086458|NCT00309166|38810409|FG000|Overall Study|Adverse event, non-fatal|1|||
16086459|NCT00309166|38810410|FG001|Overall Study|Adverse event, non-fatal|0|||
16194481|NCT00879814|39188774|FG003|Overall Study|Participant Failed to Return|1|||
16194482|NCT00879814|39188771|FG000|Overall Study|Withdrawal by Subject|3|||
16308367|NCT01371747|39612771|FG004|Overall Study|Physician Decision|1|||
16086460|NCT00309166|38810409|FG000|Overall Study|Withdrawal by Subject|4|||
16086461|NCT00309166|38810410|FG001|Overall Study|Withdrawal by Subject|3|||
16086462|NCT03547154|38810411|FG000|Overall Study|Disease Progression/Recurrence|6|||
16086463|NCT03547154|38810412|FG001|Overall Study|Disease Progression/Recurrence|14|||
16086464|NCT03547154|38810411|FG000|Overall Study|Adverse Event|26|||
16086465|NCT03547154|38810412|FG001|Overall Study|Adverse Event|31|||
16086466|NCT03547154|38810411|FG000|Overall Study|Protocol Violation|6|||
16086467|NCT03547154|38810412|FG001|Overall Study|Protocol Violation|1|||
16086468|NCT03547154|38810411|FG000|Overall Study|Physician Decision|4|||
16086469|NCT03547154|38810412|FG001|Overall Study|Physician Decision|3|||
16086470|NCT03547154|38810411|FG000|Overall Study|Insufficient Therapeutic Response|13|||
16086471|NCT03547154|38810412|FG001|Overall Study|Insufficient Therapeutic Response|10|||
16086472|NCT03547154|38810411|FG000|Overall Study|Withdrawal by Subject|10|||
16086473|NCT03547154|38810412|FG001|Overall Study|Withdrawal by Subject|6|||
16086474|NCT03547154|38810411|FG000|Overall Study|Not Selected|0|||
16086475|NCT03547154|38810412|FG001|Overall Study|Not Selected|1|||
16086476|NCT03547154|38810411|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
16086477|NCT03547154|38810412|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
16086478|NCT00866619|38810413|FG000|Overall Study|Adverse Event|112|||
16308368|NCT01371747|39612772|FG005|Overall Study|Physician Decision|0|||
16308369|NCT01371747|39612767|FG000|Overall Study|Withdrawal by Subject|6|||
16308370|NCT01371747|39612768|FG001|Overall Study|Withdrawal by Subject|12|||
16308371|NCT01371747|39612769|FG002|Overall Study|Withdrawal by Subject|5|||
16086479|NCT00866619|38810414|FG001|Overall Study|Adverse Event|106|||
16086480|NCT00866619|38810415|FG002|Overall Study|Adverse Event|47|||
16086481|NCT00866619|38810416|FG003|Overall Study|Adverse Event|44|||
16086482|NCT00866619|38810413|FG000|Overall Study|Protocol Violation|2|||
16086483|NCT00866619|38810414|FG001|Overall Study|Protocol Violation|39|||
16086484|NCT00866619|38810415|FG002|Overall Study|Protocol Violation|2|||
16086485|NCT00866619|38810416|FG003|Overall Study|Protocol Violation|17|||
16086486|NCT00866619|38810413|FG000|Overall Study|Withdrawal by Subject|587|||
16086487|NCT00866619|38810414|FG001|Overall Study|Withdrawal by Subject|295|||
16086488|NCT00866619|38810415|FG002|Overall Study|Withdrawal by Subject|272|||
16086489|NCT00866619|38810416|FG003|Overall Study|Withdrawal by Subject|144|||
16086490|NCT00866619|38810413|FG000|Overall Study|Lost to Follow-up|1145|||
16086491|NCT00866619|38810414|FG001|Overall Study|Lost to Follow-up|830|||
16086492|NCT00866619|38810415|FG002|Overall Study|Lost to Follow-up|568|||
16086493|NCT00866619|38810416|FG003|Overall Study|Lost to Follow-up|425|||
16086494|NCT03539952|38810417|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
16086495|NCT03539952|38810418|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
16086496|NCT03539952|38810417|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
16086497|NCT03539952|38810418|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
16086498|NCT03539952|38810417|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
16086499|NCT03539952|38810418|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
16086500|NCT03539952|38810417|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
16086501|NCT03539952|38810418|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
16086502|NCT03539952|38810417|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
16086503|NCT03539952|38810418|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
16086504|NCT03539952|38810417|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
16086505|NCT03539952|38810418|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
16086506|NCT03539952|38810417|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
16086507|NCT03539952|38810418|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
16086508|NCT00604669|38810421|FG000|Overall Study|lack of information in chart|7|||
16086509|NCT01328496|38810423|FG000|Overall Study|Significant Change in Health Status|1|||
16086510|NCT01328496|38810424|FG001|Overall Study|Significant Change in Health Status|0|||
16086511|NCT00360269|38810425|FG000|Overall Study|Lost to Follow-up|7|||
16086512|NCT00360269|38810426|FG001|Overall Study|Lost to Follow-up|9|||
16086513|NCT00360269|38810425|FG000|Overall Study|Physician Decision|1|||
16086514|NCT00360269|38810426|FG001|Overall Study|Physician Decision|2|||
16086515|NCT00360269|38810425|FG000|Overall Study|Adverse Event|1|||
16086516|NCT00360269|38810426|FG001|Overall Study|Adverse Event|0|||
16086517|NCT00360269|38810425|FG000|Overall Study|Withdrawal by Subject|1|||
16086518|NCT00360269|38810426|FG001|Overall Study|Withdrawal by Subject|1|||
16086519|NCT03184987|38810432|FG000|Overall Study|Withdrawal by Subject|0|||
16086520|NCT03184987|38810433|FG001|Overall Study|Withdrawal by Subject|1|||
16086521|NCT03184987|38810434|FG002|Overall Study|Withdrawal by Subject|2|||
16086522|NCT03184987|38810432|FG000|Overall Study|Physician Decision|0|||
16086523|NCT03184987|38810433|FG001|Overall Study|Physician Decision|0|||
16086524|NCT03184987|38810434|FG002|Overall Study|Physician Decision|1|||
16086525|NCT03184987|38810432|FG000|Overall Study|Adverse Event|1|||
16086526|NCT03184987|38810433|FG001|Overall Study|Adverse Event|0|||
16086527|NCT03184987|38810434|FG002|Overall Study|Adverse Event|1|||
16308372|NCT01371747|39612770|FG003|Overall Study|Withdrawal by Subject|2|||
16308373|NCT01371747|39612771|FG004|Overall Study|Withdrawal by Subject|2|||
16086528|NCT00312208|38810436|FG000|Overall Study|Adverse Event|97|||
16086529|NCT00312208|38810437|FG001|Overall Study|Adverse Event|61|||
16308374|NCT01371747|39612772|FG005|Overall Study|Withdrawal by Subject|4|||
16308375|NCT01371747|39612767|FG000|Overall Study|Other Reasons|2|||
16086530|NCT00312208|38810436|FG000|Overall Study|Protocol Violation|5|||
16086531|NCT00312208|38810437|FG001|Overall Study|Protocol Violation|3|||
16086532|NCT00312208|38810436|FG000|Overall Study|Death|2|||
16086533|NCT00312208|38810437|FG001|Overall Study|Death|1|||
16086534|NCT00312208|38810436|FG000|Overall Study|Lack of Efficacy|7|||
16308376|NCT01371747|39612768|FG001|Overall Study|Other Reasons|1|||
16308377|NCT01371747|39612769|FG002|Overall Study|Other Reasons|2|||
16308378|NCT01371747|39612770|FG003|Overall Study|Other Reasons|0|||
16308379|NCT01371747|39612771|FG004|Overall Study|Other Reasons|0|||
16308380|NCT01371747|39612772|FG005|Overall Study|Other Reasons|1|||
16308381|NCT03644342|39612773|FG000|Overall Study|Adverse Event|2|||
16308382|NCT03644342|39612774|FG001|Overall Study|Adverse Event|0|||
16308383|NCT03644342|39612773|FG000|Overall Study|Protocol Violation|0|||
16308384|NCT03644342|39612774|FG001|Overall Study|Protocol Violation|1|||
16308385|NCT00266630|39612775|FG000|Overall Study|Adverse Event|8|||
16308386|NCT00266630|39612776|FG001|Overall Study|Adverse Event|6|||
16308387|NCT00266630|39612775|FG000|Overall Study|Lack of Efficacy|1|||
16308388|NCT00266630|39612776|FG001|Overall Study|Lack of Efficacy|4|||
16308389|NCT00266630|39612775|FG000|Overall Study|Entry Criteria not met|1|||
16308390|NCT00266630|39612776|FG001|Overall Study|Entry Criteria not met|0|||
16308391|NCT00266630|39612775|FG000|Overall Study|Protocol Violation|1|||
16308392|NCT00266630|39612776|FG001|Overall Study|Protocol Violation|3|||
16308393|NCT00266630|39612775|FG000|Overall Study|Physician Decision|1|||
16086535|NCT00312208|38810437|FG001|Overall Study|Lack of Efficacy|4|||
16086536|NCT00312208|38810436|FG000|Overall Study|Lost to Follow-up|3|||
16086537|NCT00312208|38810437|FG001|Overall Study|Lost to Follow-up|5|||
16086538|NCT00312208|38810436|FG000|Overall Study|Withdrawal by Subject|53|||
16086539|NCT00312208|38810437|FG001|Overall Study|Withdrawal by Subject|42|||
16086540|NCT00312208|38810436|FG000|Overall Study|Other|5|||
16086541|NCT00312208|38810437|FG001|Overall Study|Other|7|||
16086542|NCT02597920|38810438|FG000|Overall Study|Worsening of other pre-existing disease|0|||
16086543|NCT02597920|38810439|FG001|Overall Study|Worsening of other pre-existing disease|1|||
16086544|NCT02597920|38810440|FG002|Overall Study|Worsening of other pre-existing disease|0|||
16086545|NCT02597920|38810438|FG000|Overall Study|Other adverse event|20|||
16086546|NCT02597920|38810439|FG001|Overall Study|Other adverse event|30|||
16086547|NCT02597920|38810440|FG002|Overall Study|Other adverse event|0|||
16086548|NCT02597920|38810438|FG000|Overall Study|Lost to Follow-up|7|||
16086549|NCT02597920|38810439|FG001|Overall Study|Lost to Follow-up|9|||
16086550|NCT02597920|38810440|FG002|Overall Study|Lost to Follow-up|0|||
16086551|NCT02597920|38810438|FG000|Overall Study|Refuse to continue in the study|3|||
16086552|NCT02597920|38810439|FG001|Overall Study|Refuse to continue in the study|13|||
16086553|NCT02597920|38810440|FG002|Overall Study|Refuse to continue in the study|1|||
16086554|NCT02597920|38810438|FG000|Overall Study|Other than specified|10|||
16086555|NCT02597920|38810439|FG001|Overall Study|Other than specified|31|||
16086556|NCT02597920|38810440|FG002|Overall Study|Other than specified|5|||
16086557|NCT02597920|38810438|FG000|Overall Study|Other|1|||
16086558|NCT02597920|38810439|FG001|Overall Study|Other|0|||
16086559|NCT02597920|38810440|FG002|Overall Study|Other|0|||
16086560|NCT02000752|38810441|FG000|Overall Study|Dystocic delivery|19|||
16086561|NCT02000752|38810442|FG001|Overall Study|Dystocic delivery|8|||
16086562|NCT02000752|38810441|FG000|Overall Study|Shift Changes|12|||
16086563|NCT02000752|38810442|FG001|Overall Study|Shift Changes|5|||
16086564|NCT01091168|38810444|FG000|Overall Study|Progressive disease|250|||
16086565|NCT01091168|38810445|FG001|Overall Study|Progressive disease|234|||
16086566|NCT01091168|38810444|FG000|Overall Study|Adverse Event|21|||
16086567|NCT01091168|38810445|FG001|Overall Study|Adverse Event|24|||
16086568|NCT01091168|38810444|FG000|Overall Study|Lost to Follow-up|0|||
16086569|NCT01091168|38810445|FG001|Overall Study|Lost to Follow-up|1|||
16086570|NCT01091168|38810444|FG000|Overall Study|Physician, patient's decision, other|27|||
16086571|NCT01091168|38810445|FG001|Overall Study|Physician, patient's decision, other|37|||
16086572|NCT01218659|38810446|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
16086573|NCT01218659|38810447|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
16086574|NCT01218659|38810448|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
16086575|NCT01218659|38810446|FG000|18-Month Randomized Period|Did not receive study drug|0|||
16086576|NCT01218659|38810447|FG001|18-Month Randomized Period|Did not receive study drug|3|||
16308394|NCT00266630|39612776|FG001|Overall Study|Physician Decision|2|||
16308395|NCT00266630|39612775|FG000|Overall Study|Withdrawal by Subject|10|||
16308396|NCT00266630|39612776|FG001|Overall Study|Withdrawal by Subject|2|||
16308397|NCT00266630|39612775|FG000|Overall Study|Lost to Follow-up|1|||
16308398|NCT00266630|39612776|FG001|Overall Study|Lost to Follow-up|0|||
16308399|NCT00266630|39612775|FG000|Overall Study|Other|19|||
16308400|NCT00266630|39612776|FG001|Overall Study|Other|11|||
16086577|NCT01218659|38810448|FG002|18-Month Randomized Period|Did not receive study drug|0|||
16086578|NCT01218659|38810446|FG000|12-Month OLE|Withdrawal by Subject|0|||
16086579|NCT01218659|38810447|FG001|12-Month OLE|Withdrawal by Subject|0|||
16086580|NCT01218659|38810448|FG002|12-Month OLE|Withdrawal by Subject|2|||
16086581|NCT01218659|38810446|FG000|12-Month OLE|Physician Decision|0|||
16086582|NCT01218659|38810447|FG001|12-Month OLE|Physician Decision|0|||
16086583|NCT01218659|38810448|FG002|12-Month OLE|Physician Decision|1|||
16086584|NCT01218659|38810446|FG000|12-Month OLE|Lost to Follow-up|0|||
16086585|NCT01218659|38810447|FG001|12-Month OLE|Lost to Follow-up|0|||
16308401|NCT00349973|39612779|FG000|Overall Study|Adverse Event|3|||
16308402|NCT00349973|39612780|FG001|Overall Study|Adverse Event|3|||
16086586|NCT01218659|38810448|FG002|12-Month OLE|Lost to Follow-up|1|||
16086587|NCT01218659|38810446|FG000|12-Month OLE|Pregnancy|0|||
16086588|NCT01218659|38810447|FG001|12-Month OLE|Pregnancy|0|||
16086589|NCT01218659|38810448|FG002|12-Month OLE|Pregnancy|1|||
16086590|NCT01218659|38810446|FG000|12-Month OLE|Lack of Efficacy|0|||
16086591|NCT01218659|38810447|FG001|12-Month OLE|Lack of Efficacy|0|||
16086592|NCT01218659|38810448|FG002|12-Month OLE|Lack of Efficacy|1|||
16086593|NCT01218659|38810446|FG000|12-Month OLE|Declined to participate in the OLE|0|||
16086594|NCT01218659|38810447|FG001|12-Month OLE|Declined to participate in the OLE|0|||
16086595|NCT01218659|38810448|FG002|12-Month OLE|Declined to participate in the OLE|4|||
16086596|NCT04652869|38810449|FG000|Overall Study|Withdrawal by Subject|0|||
16086597|NCT04652869|38810450|FG001|Overall Study|Withdrawal by Subject|2|||
16086598|NCT04652869|38810451|FG002|Overall Study|Withdrawal by Subject|0|||
16086599|NCT02167451|38810452|FG000|Overall Study|Withdrawal by Subject|1|||
16086600|NCT00645411|38810457|FG000|Overall Study|Adverse Event|0|||
16086601|NCT00645411|38810458|FG001|Overall Study|Adverse Event|0|||
16086602|NCT00645411|38810459|FG002|Overall Study|Adverse Event|0|||
16086603|NCT00645411|38810460|FG003|Overall Study|Adverse Event|2|||
16086604|NCT00645411|38810457|FG000|Overall Study|Withdrawal by Subject|2|||
16086605|NCT00645411|38810458|FG001|Overall Study|Withdrawal by Subject|1|||
16086606|NCT00645411|38810459|FG002|Overall Study|Withdrawal by Subject|19|||
16086607|NCT00645411|38810460|FG003|Overall Study|Withdrawal by Subject|21|||
16086608|NCT00645411|38810457|FG000|Overall Study|Lost to Follow-up|10|||
16086609|NCT00645411|38810458|FG001|Overall Study|Lost to Follow-up|5|||
16086610|NCT00645411|38810459|FG002|Overall Study|Lost to Follow-up|124|||
16086611|NCT00645411|38810460|FG003|Overall Study|Lost to Follow-up|75|||
16086612|NCT00645411|38810457|FG000|Overall Study|Protocol Violation|1|||
16086613|NCT00645411|38810458|FG001|Overall Study|Protocol Violation|0|||
16086614|NCT00645411|38810459|FG002|Overall Study|Protocol Violation|1|||
16086615|NCT00645411|38810460|FG003|Overall Study|Protocol Violation|0|||
16086616|NCT00645411|38810457|FG000|Overall Study|Inappropriate enrollment|0|||
16086617|NCT00645411|38810458|FG001|Overall Study|Inappropriate enrollment|0|||
16086618|NCT00645411|38810459|FG002|Overall Study|Inappropriate enrollment|4|||
16086619|NCT00645411|38810460|FG003|Overall Study|Inappropriate enrollment|1|||
16086620|NCT00645411|38810457|FG000|Overall Study|Unable to classify|0|||
16086621|NCT00645411|38810458|FG001|Overall Study|Unable to classify|0|||
16086622|NCT00645411|38810459|FG002|Overall Study|Unable to classify|3|||
16086623|NCT00645411|38810460|FG003|Overall Study|Unable to classify|4|||
16086624|NCT03206970|38810467|FG000|Overall Study|Death|21|||
16086625|NCT03206970|38810467|FG000|Overall Study|Withdrawal by Subject|13|||
16086626|NCT03206970|38810467|FG000|Overall Study|Lost to Follow-up|3|||
16086627|NCT03206970|38810467|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
16086628|NCT01880736|38810468|FG000|Overall Study|Adverse Event|0|||
16086629|NCT01880736|38810469|FG001|Overall Study|Adverse Event|0|||
16086630|NCT01880736|38810470|FG002|Overall Study|Adverse Event|0|||
16086631|NCT01880736|38810471|FG003|Overall Study|Adverse Event|1|||
16086632|NCT01880736|38810468|FG000|Overall Study|Withdrawal Criteria|1|||
16086633|NCT01880736|38810469|FG001|Overall Study|Withdrawal Criteria|2|||
16086634|NCT01880736|38810470|FG002|Overall Study|Withdrawal Criteria|1|||
16086635|NCT01880736|38810471|FG003|Overall Study|Withdrawal Criteria|5|||
16086636|NCT03335488|38810472|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
16086637|NCT03335488|38810473|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
16086638|NCT03335488|38810472|FG000|Safety Extension Period|Adverse Event|1|||
16086639|NCT03335488|38810473|FG001|Safety Extension Period|Adverse Event|0|||
16086640|NCT03335488|38810472|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
16086641|NCT03335488|38810473|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
16086642|NCT01779050|38810474|FG000|Overall Study|Withdrawal by Subject|1|||
16086643|NCT01779050|38810475|FG001|Overall Study|Withdrawal by Subject|0|||
16086644|NCT00491894|38810476|FG000|Overall Study|Adverse Event|14|||
16086645|NCT00491894|38810476|FG000|Overall Study|Withdrawal by Subject|5|||
16086646|NCT00491894|38810476|FG000|Overall Study|Death|3|||
16086647|NCT00491894|38810476|FG000|Overall Study|Lost to Follow-up|3|||
16086648|NCT00491894|38810476|FG000|Overall Study|Lack of Efficacy|2|||
16086649|NCT00491894|38810476|FG000|Overall Study|Other-Failed to meet any criteria|2|||
16086650|NCT00491894|38810476|FG000|Overall Study|Physician Decision|2|||
16086651|NCT00491894|38810476|FG000|Overall Study|Protocol Violation|2|||
16086652|NCT00491894|38810476|FG000|Overall Study|Other-Intake of prohibited medication|1|||
16086653|NCT02722434|38810477|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
16086654|NCT02722434|38810478|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
16086655|NCT02722434|38810477|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
16086656|NCT02722434|38810478|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
16086657|NCT01034306|38810479|FG000|Overall Study|Adverse Event|1|||
16086658|NCT01034306|38810480|FG001|Overall Study|Adverse Event|0|||
16086659|NCT01034306|38810479|FG000|Overall Study|Lost to Follow-up|0|||
16086660|NCT01034306|38810480|FG001|Overall Study|Lost to Follow-up|1|||
16086661|NCT01034306|38810479|FG000|Overall Study|Withdrawal by Subject|2|||
16086662|NCT01034306|38810480|FG001|Overall Study|Withdrawal by Subject|2|||
16086663|NCT01034306|38810479|FG000|Overall Study|hospitalized and decided to stop|1|||
16086664|NCT01034306|38810480|FG001|Overall Study|hospitalized and decided to stop|0|||
16086665|NCT01034306|38810479|FG000|Overall Study|Noncomplience|1|||
16086666|NCT01034306|38810480|FG001|Overall Study|Noncomplience|0|||
16086667|NCT01092416|38810481|FG000|Enrollment|Atherectomy device not inserted|3|||
16086668|NCT01092416|38810481|FG000|30-Day Follow-up|Death|2|||
16086669|NCT01092416|38810481|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
16086670|NCT01092416|38810481|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
16086671|NCT01092416|38810481|FG000|12-Month Follow-up|Death|16|||
16086672|NCT01092416|38810481|FG000|12-Month Follow-up|Lost to Follow-up|4|||
16086673|NCT01092416|38810481|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
16086674|NCT01092416|38810481|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
16086675|NCT01092416|38810481|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
16086676|NCT00705406|38810486|FG000|Overall Study|Lost to Follow-up|3|||
16086677|NCT00705406|38810487|FG001|Overall Study|Lost to Follow-up|3|||
16086678|NCT00705406|38810486|FG000|Overall Study|Did not receive study drug|1|||
16086679|NCT00705406|38810487|FG001|Overall Study|Did not receive study drug|2|||
16086680|NCT03909100|38810490|FG000|Overall Study|Protocol Deviation|2|||
16086681|NCT03909100|38810490|FG000|Overall Study|Technical Problems|4|||
16086682|NCT03909100|38810490|FG000|Overall Study|Withdrawal by Subject|4|||
16086683|NCT03909100|38810490|FG000|Overall Study|Lost to Follow-up|1|||
16086684|NCT03909100|38810490|FG000|Overall Study|Reason not Specified|4|||
16086685|NCT00722046|38810493|FG000|Overall Study|Adverse Event|0|||
16086686|NCT00722046|38810494|FG001|Overall Study|Adverse Event|1|||
16086687|NCT00722046|38810495|FG002|Overall Study|Adverse Event|2|||
16086688|NCT00722046|38810496|FG003|Overall Study|Adverse Event|1|||
16086689|NCT00722046|38810497|FG004|Overall Study|Adverse Event|2|||
16086690|NCT00722046|38810498|FG005|Overall Study|Adverse Event|1|||
16086691|NCT00722046|38810499|FG006|Overall Study|Adverse Event|0|||
16086692|NCT00722046|38810493|FG000|Overall Study|Death|0|||
16086693|NCT00722046|38810494|FG001|Overall Study|Death|1|||
16086694|NCT00722046|38810495|FG002|Overall Study|Death|0|||
16086695|NCT00722046|38810496|FG003|Overall Study|Death|0|||
16086696|NCT00722046|38810497|FG004|Overall Study|Death|0|||
16086697|NCT00722046|38810498|FG005|Overall Study|Death|0|||
16086698|NCT00722046|38810499|FG006|Overall Study|Death|2|||
16086699|NCT00722046|38810493|FG000|Overall Study|Protocol Violation|1|||
16086700|NCT00722046|38810494|FG001|Overall Study|Protocol Violation|0|||
16086701|NCT00722046|38810495|FG002|Overall Study|Protocol Violation|0|||
16086702|NCT00722046|38810496|FG003|Overall Study|Protocol Violation|0|||
16086703|NCT00722046|38810497|FG004|Overall Study|Protocol Violation|0|||
16086704|NCT00722046|38810498|FG005|Overall Study|Protocol Violation|1|||
16086705|NCT00722046|38810499|FG006|Overall Study|Protocol Violation|0|||
16086706|NCT00722046|38810493|FG000|Overall Study|Withdrawal by Subject|3|||
16086707|NCT00722046|38810494|FG001|Overall Study|Withdrawal by Subject|3|||
16086708|NCT00722046|38810495|FG002|Overall Study|Withdrawal by Subject|4|||
16086709|NCT00722046|38810496|FG003|Overall Study|Withdrawal by Subject|4|||
16086710|NCT00722046|38810497|FG004|Overall Study|Withdrawal by Subject|4|||
16086711|NCT00722046|38810498|FG005|Overall Study|Withdrawal by Subject|7|||
16086712|NCT00722046|38810499|FG006|Overall Study|Withdrawal by Subject|3|||
16086713|NCT00722046|38810493|FG000|Overall Study|Randomized, but not treated|1|||
16086714|NCT00722046|38810494|FG001|Overall Study|Randomized, but not treated|1|||
16086715|NCT00722046|38810495|FG002|Overall Study|Randomized, but not treated|0|||
16086716|NCT00722046|38810496|FG003|Overall Study|Randomized, but not treated|2|||
16086717|NCT00722046|38810497|FG004|Overall Study|Randomized, but not treated|0|||
16086718|NCT00722046|38810498|FG005|Overall Study|Randomized, but not treated|0|||
16086719|NCT00722046|38810499|FG006|Overall Study|Randomized, but not treated|0|||
16086720|NCT00722046|38810493|FG000|Overall Study|Other|0|||
16086721|NCT00722046|38810494|FG001|Overall Study|Other|0|||
16086722|NCT00722046|38810495|FG002|Overall Study|Other|1|||
16086723|NCT00722046|38810496|FG003|Overall Study|Other|1|||
16308403|NCT00349973|39612779|FG000|Overall Study|Withdrawal by Subject|1|||
16086724|NCT00722046|38810497|FG004|Overall Study|Other|3|||
16086725|NCT00722046|38810498|FG005|Overall Study|Other|2|||
16086726|NCT00722046|38810499|FG006|Overall Study|Other|1|||
16086727|NCT01728324|38810502|FG000|Termination of DBV|Adverse Event|14|||
16086728|NCT01728324|38810503|FG001|Termination of DBV|Adverse Event|13|||
16086729|NCT01728324|38810504|FG002|Termination of DBV|Adverse Event|4|||
16086730|NCT01728324|38810502|FG000|Termination of DBV|Lack of Efficacy|14|||
16086731|NCT01728324|38810503|FG001|Termination of DBV|Lack of Efficacy|12|||
16086732|NCT01728324|38810504|FG002|Termination of DBV|Lack of Efficacy|8|||
16086733|NCT01728324|38810502|FG000|Termination of DBV|Withdrawal by Subject|9|||
16086734|NCT01728324|38810503|FG001|Termination of DBV|Withdrawal by Subject|6|||
16086735|NCT01728324|38810504|FG002|Termination of DBV|Withdrawal by Subject|2|||
16086736|NCT01728324|38810502|FG000|Termination of DBV|Other than stated|1|||
16086737|NCT01728324|38810503|FG001|Termination of DBV|Other than stated|3|||
16308404|NCT00349973|39612780|FG001|Overall Study|Withdrawal by Subject|0|||
16308405|NCT01753999|39612784|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
16086738|NCT01728324|38810504|FG002|Termination of DBV|Other than stated|0|||
16086739|NCT01728324|38810502|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
16086740|NCT01728324|38810503|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
16086741|NCT01728324|38810504|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
16086742|NCT01728324|38810502|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
16086743|NCT01728324|38810503|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
16086744|NCT01728324|38810504|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
16086745|NCT01728324|38810502|FG000|Termination of FDV|Adverse Event|14|||
16086746|NCT01728324|38810503|FG001|Termination of FDV|Adverse Event|13|||
16086747|NCT01728324|38810504|FG002|Termination of FDV|Adverse Event|4|||
16086748|NCT01728324|38810502|FG000|Termination of FDV|Lack of Efficacy|14|||
16086749|NCT01728324|38810503|FG001|Termination of FDV|Lack of Efficacy|12|||
16086750|NCT01728324|38810504|FG002|Termination of FDV|Lack of Efficacy|8|||
16086751|NCT01728324|38810502|FG000|Termination of FDV|Withdrawal by Subject|9|||
16086752|NCT01728324|38810503|FG001|Termination of FDV|Withdrawal by Subject|6|||
16086753|NCT01728324|38810504|FG002|Termination of FDV|Withdrawal by Subject|2|||
16086754|NCT01728324|38810502|FG000|Termination of FDV|Other than stated|1|||
16086755|NCT01728324|38810503|FG001|Termination of FDV|Other than stated|3|||
16086756|NCT01728324|38810504|FG002|Termination of FDV|Other than stated|0|||
16086757|NCT01728324|38810502|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
16086758|NCT01728324|38810503|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
16086759|NCT01728324|38810504|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
16086760|NCT01728324|38810502|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
16086761|NCT01728324|38810503|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
16086762|NCT01728324|38810504|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
16086763|NCT01728324|38810502|FG000|Termination of RBV|Adverse Event|15|||
16086764|NCT01728324|38810503|FG001|Termination of RBV|Adverse Event|16|||
16086765|NCT01728324|38810504|FG002|Termination of RBV|Adverse Event|5|||
16086766|NCT01728324|38810502|FG000|Termination of RBV|Lack of Efficacy|14|||
16086767|NCT01728324|38810503|FG001|Termination of RBV|Lack of Efficacy|11|||
16086768|NCT01728324|38810504|FG002|Termination of RBV|Lack of Efficacy|7|||
16086769|NCT01728324|38810502|FG000|Termination of RBV|Withdrawal by Subject|9|||
16086770|NCT01728324|38810503|FG001|Termination of RBV|Withdrawal by Subject|5|||
16086771|NCT01728324|38810504|FG002|Termination of RBV|Withdrawal by Subject|2|||
16086772|NCT01728324|38810502|FG000|Termination of RBV|Other than stated|1|||
16086773|NCT01728324|38810503|FG001|Termination of RBV|Other than stated|3|||
16086774|NCT01728324|38810504|FG002|Termination of RBV|Other than stated|1|||
16086775|NCT01728324|38810502|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
16086776|NCT01728324|38810503|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
16086777|NCT01728324|38810504|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
16086778|NCT01728324|38810502|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
16086779|NCT01728324|38810503|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
16086780|NCT01728324|38810504|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
16086781|NCT01613417|38810505|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
16086782|NCT01613417|38810506|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
16086783|NCT02593149|38810513|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
16086784|NCT02593149|38810514|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
16086785|NCT02593149|38810513|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
16086786|NCT02593149|38810514|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
16086787|NCT01399099|38810515|FG000|Overall Study|Lost to Follow-up|11|||
16086788|NCT01399099|38810515|FG000|Overall Study|Physician Decision|1|||
16086789|NCT01399099|38810515|FG000|Overall Study|Protocol Violation|1|||
16086790|NCT01399099|38810515|FG000|Overall Study|Skin Irritation|13|||
16086791|NCT01399099|38810515|FG000|Overall Study|Infection|1|||
16086792|NCT01399099|38810515|FG000|Overall Study|Miscellaneous|4|||
16086793|NCT03041090|38810518|FG000|Overall Study|technical error|0|||
16086794|NCT03041090|38810519|FG001|Overall Study|technical error|3|||
16086795|NCT00736502|38810520|FG000|Overall Study|Adverse Event|22|||
16086796|NCT00736502|38810520|FG000|Overall Study|Lack of Efficacy|16|||
16086797|NCT00736502|38810520|FG000|Overall Study|Lost to Follow-up|27|||
16086798|NCT02470806|38810526|FG000|Overall Study|Lost to Follow-up|1|||
16086799|NCT02470806|38810527|FG001|Overall Study|Lost to Follow-up|1|||
16086800|NCT02470806|38810526|FG000|Overall Study|Adverse Event|5|||
16086801|NCT02470806|38810527|FG001|Overall Study|Adverse Event|2|||
16086802|NCT02470806|38810526|FG000|Overall Study|Protocol Violation|4|||
16086803|NCT02470806|38810527|FG001|Overall Study|Protocol Violation|11|||
16086804|NCT02470806|38810526|FG000|Overall Study|Physician Decision|0|||
16086805|NCT02470806|38810527|FG001|Overall Study|Physician Decision|3|||
16086806|NCT02470806|38810526|FG000|Overall Study|Withdrawal by Subject|3|||
16086807|NCT02470806|38810527|FG001|Overall Study|Withdrawal by Subject|10|||
16086808|NCT02470806|38810526|FG000|Overall Study|Lack of Efficacy|5|||
16086809|NCT02470806|38810527|FG001|Overall Study|Lack of Efficacy|15|||
16086810|NCT02386098|38810528|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
16086811|NCT02386098|38810529|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
16086812|NCT02386098|38810530|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
16194483|NCT00879814|39188772|FG001|Overall Study|Withdrawal by Subject|1|||
16194484|NCT00879814|39188773|FG002|Overall Study|Withdrawal by Subject|1|||
16194485|NCT00879814|39188774|FG003|Overall Study|Withdrawal by Subject|2|||
16194486|NCT00879814|39188771|FG000|Overall Study|Physician Decision|0|||
16194487|NCT00879814|39188772|FG001|Overall Study|Physician Decision|0|||
16194488|NCT00879814|39188773|FG002|Overall Study|Physician Decision|1|||
16194489|NCT00879814|39188774|FG003|Overall Study|Physician Decision|0|||
16194490|NCT00879814|39188771|FG000|Overall Study|Other|0|||
16194491|NCT00879814|39188772|FG001|Overall Study|Other|0|||
16194492|NCT00879814|39188773|FG002|Overall Study|Other|1|||
16194493|NCT00879814|39188774|FG003|Overall Study|Other|0|||
16194494|NCT00568958|39188775|FG000|Allocation|Withdrawal by Subject|7|||
16194495|NCT00568958|39188776|FG001|Allocation|Withdrawal by Subject|3|||
16194496|NCT00568958|39188775|FG000|Allocation|Physician Decision|2|||
16194497|NCT00568958|39188776|FG001|Allocation|Physician Decision|0|||
16194498|NCT00568958|39188775|FG000|Follow-Up|Withdrawal by Subject|6|||
16194499|NCT00568958|39188776|FG001|Follow-Up|Withdrawal by Subject|6|||
16194500|NCT00568958|39188775|FG000|Follow-Up|Physician Decision|1|||
16194501|NCT00568958|39188776|FG001|Follow-Up|Physician Decision|1|||
16194502|NCT00568958|39188775|FG000|Follow-Up|Family Emergency|1|||
16194503|NCT00568958|39188776|FG001|Follow-Up|Family Emergency|0|||
16194504|NCT00568958|39188775|FG000|Follow-Up|Adverse Event|1|||
16194505|NCT00568958|39188776|FG001|Follow-Up|Adverse Event|0|||
16194506|NCT00786032|39188777|FG000|Overall Study|Death|4|||
16194507|NCT00786032|39188777|FG000|Overall Study|Withdrawal by Subject|14|||
16194508|NCT00786032|39188777|FG000|Overall Study|Did not complete in the timeframe|6|||
16194509|NCT00905307|39188778|FG000|Overall Study|Switched to Open Label Rescue|7|||
16194510|NCT00905307|39188779|FG001|Overall Study|Switched to Open Label Rescue|17|||
16194511|NCT00905307|39188780|FG002|Overall Study|Switched to Open Label Rescue|11|||
16194512|NCT00905307|39188781|FG003|Overall Study|Switched to Open Label Rescue|11|||
16194513|NCT00905307|39188782|FG004|Overall Study|Switched to Open Label Rescue|4|||
16194514|NCT00905307|39188783|FG005|Overall Study|Switched to Open Label Rescue|15|||
16194515|NCT00905307|39188778|FG000|Overall Study|Lost to Follow-up|0|||
16194516|NCT00905307|39188779|FG001|Overall Study|Lost to Follow-up|0|||
16194517|NCT00905307|39188780|FG002|Overall Study|Lost to Follow-up|0|||
16194518|NCT00905307|39188781|FG003|Overall Study|Lost to Follow-up|0|||
16194519|NCT00905307|39188782|FG004|Overall Study|Lost to Follow-up|1|||
16194520|NCT00905307|39188783|FG005|Overall Study|Lost to Follow-up|1|||
16194521|NCT00905307|39188778|FG000|Overall Study|Adverse Event|3|||
16194522|NCT00905307|39188779|FG001|Overall Study|Adverse Event|4|||
16194523|NCT00905307|39188780|FG002|Overall Study|Adverse Event|5|||
16194524|NCT00905307|39188781|FG003|Overall Study|Adverse Event|11|||
16194525|NCT00905307|39188782|FG004|Overall Study|Adverse Event|3|||
16194526|NCT00905307|39188783|FG005|Overall Study|Adverse Event|5|||
16194527|NCT00905307|39188778|FG000|Overall Study|Withdrawal by Subject|5|||
16194528|NCT00905307|39188779|FG001|Overall Study|Withdrawal by Subject|13|||
16194529|NCT00905307|39188780|FG002|Overall Study|Withdrawal by Subject|15|||
16194530|NCT00905307|39188781|FG003|Overall Study|Withdrawal by Subject|11|||
16496736|NCT00460408|40291108|FG001|Overall Study|Withdrawal by Subject|0|||
16496737|NCT00460408|40291109|FG002|Overall Study|Withdrawal by Subject|0|||
16496738|NCT00460408|40291110|FG003|Overall Study|Withdrawal by Subject|0|||
16194531|NCT00905307|39188782|FG004|Overall Study|Withdrawal by Subject|4|||
16194532|NCT00905307|39188783|FG005|Overall Study|Withdrawal by Subject|13|||
16194533|NCT00905307|39188778|FG000|Overall Study|Protocol Violation|1|||
16194534|NCT00905307|39188779|FG001|Overall Study|Protocol Violation|0|||
16194535|NCT00905307|39188780|FG002|Overall Study|Protocol Violation|1|||
16194536|NCT00905307|39188781|FG003|Overall Study|Protocol Violation|0|||
16194537|NCT00905307|39188782|FG004|Overall Study|Protocol Violation|0|||
16194538|NCT00905307|39188783|FG005|Overall Study|Protocol Violation|0|||
16194539|NCT00905307|39188778|FG000|Overall Study|Lack of Efficacy|6|||
16194540|NCT00905307|39188779|FG001|Overall Study|Lack of Efficacy|3|||
16496739|NCT00460408|40291107|FG000|Overall Study|Insufficient clinical response|5|||
16496740|NCT00460408|40291108|FG001|Overall Study|Insufficient clinical response|1|||
16496741|NCT00460408|40291109|FG002|Overall Study|Insufficient clinical response|5|||
16194541|NCT00905307|39188780|FG002|Overall Study|Lack of Efficacy|5|||
16194542|NCT00905307|39188781|FG003|Overall Study|Lack of Efficacy|4|||
16194543|NCT00905307|39188782|FG004|Overall Study|Lack of Efficacy|4|||
16194544|NCT00905307|39188783|FG005|Overall Study|Lack of Efficacy|8|||
16194545|NCT04657016|39188784|FG000|Overall Study|Adverse Event|2|||
16194546|NCT04657016|39188785|FG001|Overall Study|Adverse Event|4|||
16496742|NCT00460408|40291110|FG003|Overall Study|Insufficient clinical response|0|||
16496743|NCT00460408|40291107|FG000|Overall Study|Other|12|||
16194547|NCT04657016|39188784|FG000|Overall Study|Death|1|||
16194548|NCT04657016|39188785|FG001|Overall Study|Death|1|||
16194549|NCT04657016|39188784|FG000|Overall Study|Lost to Follow-up|24|||
16194550|NCT04657016|39188785|FG001|Overall Study|Lost to Follow-up|12|||
16194551|NCT04657016|39188784|FG000|Overall Study|Physician Decision|1|||
16194552|NCT04657016|39188785|FG001|Overall Study|Physician Decision|2|||
16194553|NCT04657016|39188784|FG000|Overall Study|Pregnancy|2|||
16194554|NCT04657016|39188785|FG001|Overall Study|Pregnancy|2|||
16194555|NCT04657016|39188784|FG000|Overall Study|Protocol Deviation|1|||
16496744|NCT00460408|40291108|FG001|Overall Study|Other|2|||
16496745|NCT00460408|40291109|FG002|Overall Study|Other|0|||
16496746|NCT00460408|40291110|FG003|Overall Study|Other|0|||
16496747|NCT04350788|40291111|FG000|Overall Study|Lost to Follow-up|6|||
16496748|NCT04350788|40291112|FG001|Overall Study|Lost to Follow-up|2|||
16496749|NCT04350788|40291111|FG000|Overall Study|Withdrawal by Subject|2|||
16496750|NCT04350788|40291112|FG001|Overall Study|Withdrawal by Subject|4|||
16496751|NCT04350788|40291111|FG000|Overall Study|Protocol Violation|4|||
16496752|NCT04350788|40291112|FG001|Overall Study|Protocol Violation|0|||
16496753|NCT01943292|40291113|FG000|Overall Study|Withdrawal by Subject|1|||
16496754|NCT01943292|40291114|FG001|Overall Study|Withdrawal by Subject|0|||
16496755|NCT01943292|40291115|FG002|Overall Study|Withdrawal by Subject|0|||
16496756|NCT03527966|40291117|FG000|Overall Study|Lost to Follow-up|3|||
16496757|NCT03527966|40291118|FG001|Overall Study|Lost to Follow-up|0|||
16496758|NCT02759471|40291128|FG000|Overall Study|discomfort|2|||
16496759|NCT01324999|40291129|FG000|Overall Study|Adverse Event|3|||
16496760|NCT01324999|40291129|FG000|Overall Study|Withdrawal by Subject|2|||
16496761|NCT01164956|40291130|FG000|Overall Study|Side Effects|1|||
16496762|NCT01164956|40291131|FG001|Overall Study|Side Effects|0|||
16496763|NCT01164956|40291132|FG002|Overall Study|Side Effects|1|||
16496764|NCT02302222|40291133|FG000|Overall Study|Physician Decision|0|||
16496765|NCT02302222|40291134|FG001|Overall Study|Physician Decision|4|||
16496766|NCT02302222|40291133|FG000|Overall Study|Lost to Follow-up|1|||
16496767|NCT02302222|40291134|FG001|Overall Study|Lost to Follow-up|0|||
16496768|NCT02302222|40291133|FG000|Overall Study|Treatment discontinued before day 5|0|||
16496769|NCT02302222|40291134|FG001|Overall Study|Treatment discontinued before day 5|1|||
16496770|NCT02302222|40291133|FG000|Overall Study|Withdrawn prior to any treatment|0|||
16496771|NCT02302222|40291134|FG001|Overall Study|Withdrawn prior to any treatment|1|||
16496772|NCT00103142|40291135|FG000|Overall Study|Adverse Event|1|||
16496773|NCT00103142|40291136|FG001|Overall Study|Adverse Event|0|||
16496774|NCT00103142|40291135|FG000|Overall Study|Progression of disease|2|||
16496775|NCT00103142|40291136|FG001|Overall Study|Progression of disease|1|||
16496776|NCT03128892|40291144|FG000|Overall Study|Withdrawal by Subject|2|||
16496777|NCT03128892|40291144|FG000|Overall Study|Physician Decision|1|||
16496778|NCT02485574|40291145|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
16496779|NCT00742001|40291146|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
16496780|NCT00742001|40291147|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
16496781|NCT00742001|40291148|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
16496782|NCT02446990|40291149|FG000|Overall Study|Death|485|||
16496783|NCT02446990|40291150|FG001|Overall Study|Death|458|||
16496784|NCT02446990|40291149|FG000|Overall Study|Lost to Follow-up|3|||
16496785|NCT02446990|40291150|FG001|Overall Study|Lost to Follow-up|1|||
16496786|NCT02446990|40291149|FG000|Overall Study|Physician Decision|1|||
16496787|NCT02446990|40291150|FG001|Overall Study|Physician Decision|0|||
16496788|NCT02446990|40291149|FG000|Overall Study|Withdrawal by Subject|231|||
16496789|NCT02446990|40291150|FG001|Overall Study|Withdrawal by Subject|199|||
16496790|NCT04711902|40291151|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
16496791|NCT04711902|40291152|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
16496792|NCT04711902|40291153|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
16496793|NCT04711902|40291154|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
16496794|NCT04711902|40291155|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
16496795|NCT04711902|40291156|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
16496796|NCT00674700|40291157|FG000|Year 1|Adverse Event|17|||
16496797|NCT00674700|40291158|FG001|Year 1|Adverse Event|20|||
16496798|NCT00674700|40291159|FG002|Year 1|Adverse Event|5|||
16496799|NCT00674700|40291157|FG000|Year 1|Withdrawal by Subject|7|||
16496800|NCT00674700|40291158|FG001|Year 1|Withdrawal by Subject|7|||
16496801|NCT00674700|40291159|FG002|Year 1|Withdrawal by Subject|6|||
16496802|NCT00674700|40291157|FG000|Year 1|Any other reason not above-mentioned|7|||
16194556|NCT04657016|39188785|FG001|Overall Study|Protocol Deviation|0|||
16496803|NCT00674700|40291158|FG001|Year 1|Any other reason not above-mentioned|7|||
16496804|NCT00674700|40291159|FG002|Year 1|Any other reason not above-mentioned|6|||
16496805|NCT00674700|40291157|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
16496806|NCT00674700|40291158|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
16496807|NCT00674700|40291159|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
16496808|NCT00674700|40291157|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
16496809|NCT00674700|40291158|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
16496810|NCT00674700|40291159|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
16496811|NCT00674700|40291157|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
16496812|NCT00674700|40291158|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
16496813|NCT00674700|40291159|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
16194557|NCT04657016|39188784|FG000|Overall Study|Withdrawal by Subject|28|||
16194558|NCT04657016|39188785|FG001|Overall Study|Withdrawal by Subject|14|||
16194559|NCT04657016|39188784|FG000|Overall Study|Other - as reported by the investigator|6|||
16194560|NCT04657016|39188785|FG001|Overall Study|Other - as reported by the investigator|0|||
16194561|NCT02142894|39188786|FG000|Overall Study|Protocol Violation|8|||
16194562|NCT00838916|39188787|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
16194563|NCT00838916|39188788|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
16194564|NCT00838916|39188787|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
16194565|NCT00838916|39188788|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
16496814|NCT01831544|40291160|FG000|Overall Study|Death|1|||
16496815|NCT01831544|40291160|FG000|Overall Study|Still on original MVAD device|2|||
16496816|NCT02345850|40291164|FG000|Overall Study|Not transplanted|10|||
16496817|NCT02345850|40291165|FG001|Overall Study|Not transplanted|5|||
16496818|NCT02345850|40291166|FG002|Overall Study|Not transplanted|4|||
16496819|NCT02345850|40291164|FG000|Overall Study|Lost to Follow-up|2|||
16496820|NCT02345850|40291165|FG001|Overall Study|Lost to Follow-up|3|||
16496821|NCT02345850|40291166|FG002|Overall Study|Lost to Follow-up|2|||
16496822|NCT02345850|40291164|FG000|Overall Study|Withdrawal by Subject|1|||
16496823|NCT02345850|40291165|FG001|Overall Study|Withdrawal by Subject|0|||
16496824|NCT02345850|40291166|FG002|Overall Study|Withdrawal by Subject|0|||
16194566|NCT00838916|39188787|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
16194567|NCT00838916|39188788|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
16194568|NCT00838916|39188787|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
16194569|NCT00838916|39188788|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
16194570|NCT00838916|39188787|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
16194571|NCT00838916|39188788|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
16194572|NCT00838916|39188787|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
16194573|NCT00838916|39188788|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
16194574|NCT00838916|39188787|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
16194575|NCT00838916|39188788|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
16194576|NCT00838916|39188787|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
16194577|NCT00838916|39188788|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
16194578|NCT00838916|39188787|FG000|Treatment Period (156 Weeks)|Missing|3|||
16194579|NCT00838916|39188788|FG001|Treatment Period (156 Weeks)|Missing|1|||
16194580|NCT00838916|39188787|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
16194581|NCT00838916|39188788|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
16194582|NCT00838916|39188787|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
16194583|NCT00838916|39188788|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
16194584|NCT00838916|39188787|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
16194585|NCT00838916|39188788|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
16194586|NCT00838916|39188787|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
16194587|NCT00838916|39188788|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
16194588|NCT00838916|39188787|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
16194589|NCT00838916|39188788|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
16194590|NCT00838916|39188787|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
16194591|NCT00838916|39188788|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
16194592|NCT00838916|39188787|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
16194593|NCT00838916|39188788|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
16194594|NCT00838916|39188787|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
16194595|NCT00838916|39188788|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
16194596|NCT00838916|39188787|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
16194597|NCT00838916|39188788|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
16194598|NCT00838916|39188787|FG000|Follow-up Period (8 Weeks)|Missing|3|||
16194599|NCT00838916|39188788|FG001|Follow-up Period (8 Weeks)|Missing|0|||
16194600|NCT04580394|39188789|FG000|First Intervention|Incorrectly Randomized|1|||
16194601|NCT04580394|39188789|FG000|First Intervention|Physician Decision|1|||
16194602|NCT04580394|39188789|FG000|First Intervention|Lost to Follow-up|1|||
16194603|NCT04580394|39188789|FG000|Washout (One Week)|Withdrawal by Subject|1|||
16194604|NCT04580394|39188789|FG000|Washout (One Week)|Adverse Event|1|||
16194605|NCT04580394|39188789|FG000|Washout (One Week)|Withdrawal by Subject|2|||
16194606|NCT04580394|39188789|FG000|Third Intervention|Adverse Event|1|||
16194607|NCT04580394|39188789|FG000|Third Intervention|Withdrawal by Subject|1|||
16194608|NCT04580394|39188789|FG000|Washout (One Week)|Withdrawal by Subject|2|||
16194609|NCT02417233|39188790|FG000|Overall Study|Death|4|||
16194610|NCT02417233|39188791|FG001|Overall Study|Death|10|||
16194611|NCT02417233|39188792|FG002|Overall Study|Death|14|||
16194612|NCT02417233|39188790|FG000|Overall Study|Lost to Follow-up|27|||
16194613|NCT02417233|39188791|FG001|Overall Study|Lost to Follow-up|39|||
16194614|NCT02417233|39188792|FG002|Overall Study|Lost to Follow-up|34|||
16194615|NCT02417233|39188790|FG000|Overall Study|Protocol Violation|2|||
16388487|NCT00692003|39905688|FG000|Overall Study|Sponsor Decision|5|||
16496825|NCT01986985|40291167|FG000|Overall Study|Withdrawal by Subject|4|||
16496826|NCT01986985|40291167|FG000|Overall Study|Scan not completed due to malfunction|3|||
16194616|NCT02417233|39188791|FG001|Overall Study|Protocol Violation|0|||
16194617|NCT02417233|39188792|FG002|Overall Study|Protocol Violation|2|||
16308406|NCT01753999|39612785|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
16308407|NCT01753999|39612784|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
16308408|NCT01753999|39612785|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
16308409|NCT01753999|39612784|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
16308410|NCT01753999|39612785|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
16308411|NCT01753999|39612784|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
16308412|NCT01753999|39612785|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
16308413|NCT01753999|39612784|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
16308414|NCT01753999|39612785|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
16308415|NCT01753999|39612784|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
16308416|NCT01753999|39612785|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
16308417|NCT02685735|39612788|FG000|Overall Study|Missing construct or pain data|23|||
16308418|NCT02685735|39612789|FG001|Overall Study|Missing construct or pain data|22|||
16308419|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #1|24|||
16308420|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #1|0|||
16308421|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
16308422|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
16308423|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16308424|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16308425|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
16308426|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
16308427|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
16308428|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
16308429|NCT03888066|39612790|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16308430|NCT03888066|39612791|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16308431|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16308432|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16308433|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
16308434|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
16308435|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16308436|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16308437|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
16308438|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16308439|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #2|5|||
16308440|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #2|0|||
16308441|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
16308442|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
16388488|NCT00692003|39905689|FG001|Overall Study|Sponsor Decision|1|||
16388489|NCT02013609|39905692|FG000|Overall Study|Withdrawal by Subject|9|||
16388490|NCT02013609|39905692|FG000|Overall Study|Lost to Follow-up|3|||
16308443|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
16308444|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
16308445|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
16308446|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
16308447|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #3|11|||
16308448|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #3|0|||
16308449|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
16308450|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
16388491|NCT02013609|39905692|FG000|Overall Study|Adverse Event|3|||
16388492|NCT02013609|39905692|FG000|Overall Study|Met Withdrawal Criteria|3|||
16388493|NCT03745638|39905693|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
16388494|NCT03745638|39905694|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
16388495|NCT03745638|39905695|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
16388496|NCT03745638|39905696|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16388497|NCT03745638|39905697|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16388498|NCT03745638|39905698|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16496827|NCT00249444|40291170|FG000|Overall Study|Lost to Follow-up|2|||
16496828|NCT00249444|40291171|FG001|Overall Study|Lost to Follow-up|2|||
16086813|NCT02386098|38810531|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
16086814|NCT02386098|38810532|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
16086815|NCT02386098|38810528|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
16496829|NCT00249444|40291170|FG000|Overall Study|non-compliant|9|||
16496830|NCT00249444|40291171|FG001|Overall Study|non-compliant|11|||
16496831|NCT00249444|40291170|FG000|Overall Study|Adverse Event|1|||
16496832|NCT00249444|40291171|FG001|Overall Study|Adverse Event|1|||
16496833|NCT00249444|40291170|FG000|Overall Study|life event|0|||
16194618|NCT02417233|39188790|FG000|Overall Study|Withdrawal by Subject|2|||
16194619|NCT02417233|39188791|FG001|Overall Study|Withdrawal by Subject|1|||
16194620|NCT02417233|39188792|FG002|Overall Study|Withdrawal by Subject|8|||
16194621|NCT02417233|39188790|FG000|Overall Study|Relocation out of study area|1|||
16194622|NCT02417233|39188791|FG001|Overall Study|Relocation out of study area|0|||
16194623|NCT02417233|39188792|FG002|Overall Study|Relocation out of study area|1|||
16194624|NCT02417233|39188790|FG000|Overall Study|Mentally unstable|0|||
16308451|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
16308452|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
16308453|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16496834|NCT00249444|40291171|FG001|Overall Study|life event|1|||
16496835|NCT02887521|40291174|FG000|Overall Study|Withdrawal by Subject|0|||
16496836|NCT02887521|40291175|FG001|Overall Study|Withdrawal by Subject|3|||
16496837|NCT00937157|40291176|FG000|Overall Study|Pregnancy|1|||
16496838|NCT00937157|40291176|FG000|Overall Study|Lost to Follow-up|3|||
16496839|NCT01218204|40291177|FG000|Part B Washout|Adverse Event|0|||
16496840|NCT01218204|40291178|FG001|Part B Washout|Adverse Event|1|||
16496841|NCT01218204|40291179|FG002|Part B Washout|Adverse Event|0|||
16496842|NCT01218204|40291180|FG003|Part B Washout|Adverse Event|0|||
16496843|NCT01218204|40291177|FG000|Part B Washout|Lost to Follow-up|0|||
16496844|NCT01218204|40291178|FG001|Part B Washout|Lost to Follow-up|2|||
16496845|NCT01218204|40291179|FG002|Part B Washout|Lost to Follow-up|0|||
16496846|NCT01218204|40291180|FG003|Part B Washout|Lost to Follow-up|0|||
16496847|NCT01218204|40291177|FG000|Part B Washout|Physician Decision|0|||
16496848|NCT01218204|40291178|FG001|Part B Washout|Physician Decision|14|||
16496849|NCT01218204|40291179|FG002|Part B Washout|Physician Decision|0|||
16496850|NCT01218204|40291180|FG003|Part B Washout|Physician Decision|0|||
16496851|NCT01218204|40291177|FG000|Part B Washout|Withdrawal by Subject|0|||
16496852|NCT01218204|40291178|FG001|Part B Washout|Withdrawal by Subject|14|||
16496853|NCT01218204|40291179|FG002|Part B Washout|Withdrawal by Subject|0|||
16496854|NCT01218204|40291180|FG003|Part B Washout|Withdrawal by Subject|0|||
16496855|NCT01218204|40291177|FG000|Part B Washout|Reached defined stopping criteria|0|||
16496856|NCT01218204|40291178|FG001|Part B Washout|Reached defined stopping criteria|2|||
16496857|NCT01218204|40291179|FG002|Part B Washout|Reached defined stopping criteria|0|||
16496858|NCT01218204|40291180|FG003|Part B Washout|Reached defined stopping criteria|0|||
16308454|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16308455|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #4|3|||
16308456|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #4|0|||
16308457|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
16308458|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
16308459|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
16308460|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
16308461|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
16308462|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
16308463|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
16308464|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
16308465|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
16308466|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16308467|NCT03888066|39612790|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
16308468|NCT03888066|39612791|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
16308469|NCT03888066|39612790|FG000|Run-in Phase|AE (Adverse Event)|17|||
16308470|NCT03888066|39612791|FG001|Run-in Phase|AE (Adverse Event)|0|||
16308471|NCT03888066|39612790|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
16308472|NCT03888066|39612791|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
16308473|NCT03888066|39612790|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16308474|NCT03888066|39612791|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16308475|NCT03888066|39612790|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
16308476|NCT03888066|39612791|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16308477|NCT03888066|39612790|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
16308478|NCT03888066|39612791|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
16496859|NCT01218204|40291177|FG000|Part B Washout|Did not meet continuation criteria|0|||
16496860|NCT01218204|40291178|FG001|Part B Washout|Did not meet continuation criteria|112|||
16496861|NCT01218204|40291179|FG002|Part B Washout|Did not meet continuation criteria|0|||
16194625|NCT02417233|39188791|FG001|Overall Study|Mentally unstable|1|||
16496862|NCT01218204|40291180|FG003|Part B Washout|Did not meet continuation criteria|0|||
16194626|NCT02417233|39188792|FG002|Overall Study|Mentally unstable|0|||
16308479|NCT03888066|39612790|FG000|Run-in Phase|Withdrawal by Subject|43|||
16308480|NCT03888066|39612791|FG001|Run-in Phase|Withdrawal by Subject|0|||
16308481|NCT03888066|39612790|FG000|Run-in Phase|AE; Physician Decision|1|||
16388499|NCT03745638|39905699|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16388500|NCT03745638|39905693|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
16388501|NCT03745638|39905694|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16388502|NCT03745638|39905695|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16388503|NCT03745638|39905696|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16388504|NCT03745638|39905697|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16388505|NCT03745638|39905698|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16388506|NCT03745638|39905699|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16388507|NCT03745638|39905693|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
16388508|NCT03745638|39905694|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
16388509|NCT03745638|39905695|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
16388510|NCT03745638|39905696|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16388511|NCT03745638|39905697|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16388512|NCT03745638|39905698|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16388513|NCT03745638|39905699|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16409941|NCT01269385|39981837|FG001|Overall Study|Adverse Event|1|||
16496863|NCT01218204|40291177|FG000|Part B Run-in|Adverse Event|0|||
16496864|NCT01218204|40291178|FG001|Part B Run-in|Adverse Event|0|||
16496865|NCT01218204|40291179|FG002|Part B Run-in|Adverse Event|1|||
16308482|NCT03888066|39612791|FG001|Run-in Phase|AE; Physician Decision|0|||
16308483|NCT03888066|39612790|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
16308484|NCT03888066|39612791|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
16308485|NCT03888066|39612790|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
16308486|NCT03888066|39612791|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
16308487|NCT03888066|39612790|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
16308488|NCT03888066|39612791|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
16308489|NCT03888066|39612790|FG000|Run-in Phase|Death|1|||
16308490|NCT03888066|39612791|FG001|Run-in Phase|Death|0|||
16308491|NCT03888066|39612790|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
16308492|NCT03888066|39612791|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
16496866|NCT01218204|40291180|FG003|Part B Run-in|Adverse Event|0|||
16496867|NCT01218204|40291177|FG000|Part B Run-in|Protocol Violation|0|||
16496868|NCT01218204|40291178|FG001|Part B Run-in|Protocol Violation|0|||
16496869|NCT01218204|40291179|FG002|Part B Run-in|Protocol Violation|2|||
16496870|NCT01218204|40291180|FG003|Part B Run-in|Protocol Violation|0|||
16496871|NCT01218204|40291177|FG000|Part B Run-in|Withdrawal by Subject|0|||
16496872|NCT01218204|40291178|FG001|Part B Run-in|Withdrawal by Subject|0|||
16496873|NCT01218204|40291179|FG002|Part B Run-in|Withdrawal by Subject|3|||
16496874|NCT01218204|40291180|FG003|Part B Run-in|Withdrawal by Subject|0|||
16496875|NCT01218204|40291177|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
16496876|NCT01218204|40291178|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
16496877|NCT01218204|40291179|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
16496878|NCT01218204|40291180|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
16496879|NCT01218204|40291177|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
16496880|NCT01218204|40291178|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
16496881|NCT01218204|40291179|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
16496882|NCT01218204|40291180|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
16496883|NCT01601626|40291181|FG000|Overall Study|Death|1|||
16496884|NCT01601626|40291182|FG001|Overall Study|Death|1|||
16496885|NCT01601626|40291183|FG002|Overall Study|Death|1|||
16496886|NCT01601626|40291181|FG000|Overall Study|Lost to Follow-up|1|||
16496887|NCT01601626|40291182|FG001|Overall Study|Lost to Follow-up|2|||
16496888|NCT01601626|40291183|FG002|Overall Study|Lost to Follow-up|0|||
16496889|NCT01601626|40291181|FG000|Overall Study|Unable to Get to Clinic|0|||
16496890|NCT01601626|40291182|FG001|Overall Study|Unable to Get to Clinic|1|||
16496891|NCT01601626|40291183|FG002|Overall Study|Unable to Get to Clinic|0|||
16496892|NCT01601626|40291181|FG000|Overall Study|Withdrawal by Subject|0|||
16496893|NCT01601626|40291182|FG001|Overall Study|Withdrawal by Subject|1|||
16496894|NCT01601626|40291183|FG002|Overall Study|Withdrawal by Subject|1|||
16496895|NCT01601626|40291181|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
16496896|NCT01601626|40291182|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
16496897|NCT01601626|40291183|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
16496898|NCT01064401|40291184|FG000|Overall Study|Adverse Event|47|||
16496899|NCT01064401|40291185|FG001|Overall Study|Adverse Event|56|||
16496900|NCT01064401|40291184|FG000|Overall Study|Lack of Efficacy|46|||
16496901|NCT01064401|40291185|FG001|Overall Study|Lack of Efficacy|23|||
16496902|NCT01064401|40291184|FG000|Overall Study|Lost to Follow-up|12|||
16496903|NCT01064401|40291185|FG001|Overall Study|Lost to Follow-up|9|||
16496904|NCT01064401|40291184|FG000|Overall Study|Consent Withdrawn|98|||
16496905|NCT01064401|40291185|FG001|Overall Study|Consent Withdrawn|80|||
16496906|NCT01064401|40291184|FG000|Overall Study|Investigator Decision|4|||
16496907|NCT01064401|40291185|FG001|Overall Study|Investigator Decision|6|||
16496908|NCT01064401|40291184|FG000|Overall Study|Death|4|||
16496909|NCT01064401|40291185|FG001|Overall Study|Death|0|||
16496910|NCT01064401|40291184|FG000|Overall Study|Pregnancy|4|||
16496911|NCT01064401|40291185|FG001|Overall Study|Pregnancy|7|||
16496912|NCT01064401|40291184|FG000|Overall Study|Noncompliance|7|||
16496913|NCT01064401|40291185|FG001|Overall Study|Noncompliance|8|||
16496914|NCT01064401|40291184|FG000|Overall Study|Site Closure|4|||
16496915|NCT01064401|40291185|FG001|Overall Study|Site Closure|5|||
16496916|NCT01064401|40291184|FG000|Overall Study|Other|2|||
16496917|NCT01064401|40291185|FG001|Overall Study|Other|1|||
16496918|NCT03051607|40291189|FG000|Overall Study|Adverse Event|66|||
16496919|NCT01414075|40291190|FG000|Overall Study|Adverse Event|1|||
16496920|NCT01414075|40291191|FG001|Overall Study|Adverse Event|0|||
16496921|NCT01414075|40291192|FG002|Overall Study|Adverse Event|1|||
16496922|NCT01414075|40291193|FG003|Overall Study|Adverse Event|0|||
16496923|NCT01414075|40291190|FG000|Overall Study|Death|1|||
16496924|NCT01414075|40291191|FG001|Overall Study|Death|0|||
16496925|NCT01414075|40291192|FG002|Overall Study|Death|0|||
16496926|NCT01414075|40291193|FG003|Overall Study|Death|1|||
16496927|NCT01414075|40291190|FG000|Overall Study|Withdrawal by Subject|0|||
16496928|NCT01414075|40291191|FG001|Overall Study|Withdrawal by Subject|0|||
16496929|NCT01414075|40291192|FG002|Overall Study|Withdrawal by Subject|0|||
16496930|NCT01414075|40291193|FG003|Overall Study|Withdrawal by Subject|1|||
16496931|NCT01414075|40291190|FG000|Overall Study|Other than specified|1|||
16496932|NCT01414075|40291191|FG001|Overall Study|Other than specified|0|||
16496933|NCT01414075|40291192|FG002|Overall Study|Other than specified|1|||
16496934|NCT01414075|40291193|FG003|Overall Study|Other than specified|0|||
16496935|NCT02772081|40291204|FG000|Overall Study|Physician Decision|1|||
16496936|NCT02772081|40291205|FG001|Overall Study|Physician Decision|1|||
16496937|NCT02772081|40291204|FG000|Overall Study|Death|1|||
16496938|NCT02772081|40291205|FG001|Overall Study|Death|1|||
16496939|NCT02289079|40291209|FG000|Overall Study|Physician Decision|2|||
16496940|NCT02289079|40291210|FG001|Overall Study|Physician Decision|0|||
16496941|NCT02289079|40291209|FG000|Overall Study|Lost to Follow-up|0|||
16496942|NCT02289079|40291210|FG001|Overall Study|Lost to Follow-up|1|||
16496943|NCT03824912|40291212|FG000|Overall Study|Lost to Follow-up|18|||
16496944|NCT03824912|40291213|FG001|Overall Study|Lost to Follow-up|15|||
16496945|NCT03824912|40291214|FG002|Overall Study|Lost to Follow-up|8|||
16496946|NCT03824912|40291212|FG000|Overall Study|Negative Baseline Culture Result|118|||
16496947|NCT03824912|40291213|FG001|Overall Study|Negative Baseline Culture Result|112|||
16496948|NCT03824912|40291214|FG002|Overall Study|Negative Baseline Culture Result|57|||
16496949|NCT03824912|40291212|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16496950|NCT03824912|40291213|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16496951|NCT03824912|40291214|FG002|Overall Study|Non-Compliance with Study Drug|1|||
16496952|NCT03824912|40291212|FG000|Overall Study|Protocol Violation|1|||
16496953|NCT03824912|40291213|FG001|Overall Study|Protocol Violation|4|||
16496954|NCT03824912|40291214|FG002|Overall Study|Protocol Violation|1|||
16496955|NCT03824912|40291212|FG000|Overall Study|Withdrawal by Subject|3|||
16496956|NCT03824912|40291213|FG001|Overall Study|Withdrawal by Subject|2|||
16496957|NCT03824912|40291214|FG002|Overall Study|Withdrawal by Subject|1|||
16496958|NCT03824912|40291212|FG000|Overall Study|Participation in another study|0|||
16496959|NCT03824912|40291213|FG001|Overall Study|Participation in another study|1|||
16496960|NCT03824912|40291214|FG002|Overall Study|Participation in another study|0|||
16496961|NCT01031069|40291215|FG000|Overall Study|Serious Adverse Event|0|||
16496962|NCT01031069|40291216|FG001|Overall Study|Serious Adverse Event|1|||
16496963|NCT01031069|40291217|FG002|Overall Study|Serious Adverse Event|0|||
16308493|NCT03888066|39612790|FG000|Run-in Phase|Physician Decision|1|||
16308494|NCT03888066|39612791|FG001|Run-in Phase|Physician Decision|0|||
16308495|NCT03888066|39612790|FG000|Run-in Phase|Protocol Violation|13|||
16308496|NCT03888066|39612791|FG001|Run-in Phase|Protocol Violation|0|||
16308497|NCT03888066|39612790|FG000|Run-in Phase|Sponsor Request|34|||
16308498|NCT03888066|39612791|FG001|Run-in Phase|Sponsor Request|0|||
16308499|NCT03888066|39612790|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
16308500|NCT03888066|39612791|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
16308501|NCT03888066|39612790|FG000|Run-in Phase|Withdrawal Of Consent|1|||
16308502|NCT03888066|39612791|FG001|Run-in Phase|Withdrawal Of Consent|0|||
16308503|NCT03888066|39612790|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
16308504|NCT03888066|39612791|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
16308505|NCT03888066|39612790|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
16308506|NCT03888066|39612791|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
16308507|NCT03888066|39612790|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
16308508|NCT03888066|39612791|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
16308509|NCT03888066|39612790|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
16308510|NCT03888066|39612791|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
16308511|NCT03888066|39612790|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
16308512|NCT03888066|39612791|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
16308513|NCT03888066|39612790|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
16308514|NCT03888066|39612791|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
16308515|NCT03888066|39612790|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
16308516|NCT03888066|39612791|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
16308517|NCT03888066|39612790|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
16308518|NCT03888066|39612791|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
16308519|NCT03888066|39612790|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
16308520|NCT03888066|39612791|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
16308521|NCT03888066|39612790|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
16496964|NCT01031069|40291218|FG003|Overall Study|Serious Adverse Event|0|||
16496965|NCT01031069|40291215|FG000|Overall Study|Withdrawal by Subject|2|||
16496966|NCT01031069|40291216|FG001|Overall Study|Withdrawal by Subject|3|||
16496967|NCT01031069|40291217|FG002|Overall Study|Withdrawal by Subject|18|||
16496968|NCT01031069|40291218|FG003|Overall Study|Withdrawal by Subject|18|||
16496969|NCT01031069|40291215|FG000|Overall Study|Migrated/moved from study area|1|||
16496970|NCT01031069|40291216|FG001|Overall Study|Migrated/moved from study area|2|||
16496971|NCT01031069|40291217|FG002|Overall Study|Migrated/moved from study area|1|||
16496972|NCT01031069|40291218|FG003|Overall Study|Migrated/moved from study area|1|||
16496973|NCT01031069|40291215|FG000|Overall Study|Lost to Follow-up|9|||
16496974|NCT01031069|40291216|FG001|Overall Study|Lost to Follow-up|5|||
16496975|NCT01031069|40291217|FG002|Overall Study|Lost to Follow-up|21|||
16496976|NCT01031069|40291218|FG003|Overall Study|Lost to Follow-up|15|||
16496977|NCT01031069|40291215|FG000|Overall Study|Other|0|||
16496978|NCT01031069|40291216|FG001|Overall Study|Other|0|||
16496979|NCT01031069|40291217|FG002|Overall Study|Other|1|||
16496980|NCT01031069|40291218|FG003|Overall Study|Other|0|||
16496981|NCT01806545|40291219|FG000|Overall Study|Adverse Event|2|||
16496982|NCT01806545|40291220|FG001|Overall Study|Adverse Event|3|||
16496983|NCT01806545|40291219|FG000|Overall Study|Lost to Follow-up|1|||
16496984|NCT01806545|40291220|FG001|Overall Study|Lost to Follow-up|0|||
16496985|NCT01806545|40291219|FG000|Overall Study|Withdrawal by Subject|3|||
16496986|NCT01806545|40291220|FG001|Overall Study|Withdrawal by Subject|2|||
16496987|NCT00732615|40291221|FG000|Overall Study|Withdrawal by Subject|3|||
16496988|NCT00732615|40291222|FG001|Overall Study|Withdrawal by Subject|1|||
16496989|NCT00732615|40291221|FG000|Overall Study|Lost to Follow-up|0|||
16496990|NCT00732615|40291222|FG001|Overall Study|Lost to Follow-up|1|||
16496991|NCT00732615|40291221|FG000|Overall Study|Adverse Event|0|||
16496992|NCT00732615|40291222|FG001|Overall Study|Adverse Event|2|||
16496993|NCT00732615|40291221|FG000|Overall Study|Physician Decision|3|||
16496994|NCT00732615|40291222|FG001|Overall Study|Physician Decision|0|||
16496995|NCT00732615|40291221|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
16496996|NCT00732615|40291222|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
16496997|NCT00865124|40291223|FG000|Overall Study|Physician Decision|2|||
16496998|NCT00865124|40291224|FG001|Overall Study|Physician Decision|1|||
16496999|NCT00865124|40291225|FG002|Overall Study|Physician Decision|0|||
16497000|NCT00865124|40291223|FG000|Overall Study|Withdrawn consent|2|||
16497001|NCT00865124|40291224|FG001|Overall Study|Withdrawn consent|0|||
16308522|NCT03888066|39612791|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
16497002|NCT00865124|40291225|FG002|Overall Study|Withdrawn consent|0|||
16497003|NCT04044716|40291226|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
16497004|NCT04044716|40291227|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
16497005|NCT04044716|40291228|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
16497006|NCT04044716|40291226|FG000|Overall Study|Lost to Follow-up|2|||
16497007|NCT04044716|40291227|FG001|Overall Study|Lost to Follow-up|3|||
16308523|NCT03888066|39612790|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
16308524|NCT03888066|39612791|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
16308525|NCT03888066|39612790|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
16308526|NCT03888066|39612791|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
16308527|NCT01957397|39612793|FG000|Test Period 1|sudden leakage/small bag|1|||
16308528|NCT01957397|39612794|FG001|Test Period 1|sudden leakage/small bag|1|||
16308529|NCT01957397|39612793|FG000|Test Period 1|Withdrawal by Subject|1|||
16388514|NCT03745638|39905693|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
16388515|NCT03745638|39905694|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
16388516|NCT03745638|39905695|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16388517|NCT03745638|39905696|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16388518|NCT03745638|39905697|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16388519|NCT03745638|39905698|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16388520|NCT03745638|39905699|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16388521|NCT03745638|39905693|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
16388522|NCT03745638|39905694|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
16388523|NCT03745638|39905695|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
16388524|NCT03745638|39905696|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
16388525|NCT03745638|39905697|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
16388526|NCT03745638|39905698|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
16388527|NCT03745638|39905699|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
16388528|NCT03745638|39905693|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16388529|NCT03745638|39905694|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
16388530|NCT03745638|39905695|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16388531|NCT03745638|39905696|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16388532|NCT03745638|39905697|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16388533|NCT03745638|39905698|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16388534|NCT03745638|39905699|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16388535|NCT03745638|39905693|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
16388536|NCT03745638|39905694|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
16388537|NCT03745638|39905695|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
16388538|NCT03745638|39905696|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16388539|NCT03745638|39905697|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16388540|NCT03745638|39905698|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16388541|NCT03745638|39905699|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16388542|NCT03745638|39905693|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
16388543|NCT03745638|39905694|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
16388544|NCT03745638|39905695|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
16388545|NCT03745638|39905696|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
16388546|NCT03745638|39905697|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
16388547|NCT03745638|39905698|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
16388548|NCT03745638|39905699|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
16388549|NCT03745638|39905693|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16388550|NCT03745638|39905694|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16388551|NCT03745638|39905695|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16388552|NCT03745638|39905696|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16388553|NCT03745638|39905697|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16388554|NCT03745638|39905698|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
16388555|NCT03745638|39905699|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
16388556|NCT03745638|39905693|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16388557|NCT03745638|39905694|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16388558|NCT03745638|39905695|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16388559|NCT03745638|39905696|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
16388560|NCT03745638|39905697|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16388561|NCT03745638|39905698|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
16388562|NCT03745638|39905699|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
16388563|NCT03745638|39905693|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16388564|NCT03745638|39905694|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16388565|NCT03745638|39905695|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16388566|NCT03745638|39905696|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
16388567|NCT03745638|39905697|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
16388568|NCT03745638|39905698|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
16308530|NCT01957397|39612794|FG001|Test Period 1|Withdrawal by Subject|0|||
16308531|NCT01957397|39612793|FG000|Test Period 2|Adverse Event|0|||
16308532|NCT01957397|39612794|FG001|Test Period 2|Adverse Event|1|||
16308533|NCT01957397|39612793|FG000|Test Period 3|Adverse Event|1|||
16308534|NCT01957397|39612794|FG001|Test Period 3|Adverse Event|2|||
16308535|NCT01957397|39612793|FG000|Test Period 3|the adhesive did not work|1|||
16308536|NCT01957397|39612794|FG001|Test Period 3|the adhesive did not work|0|||
16308537|NCT02492867|39612795|FG000|Overall Study|Alternate therapy|1|||
16308538|NCT02492867|39612795|FG000|Overall Study|Withdrawal by Subject|2|||
16308539|NCT02492867|39612795|FG000|Overall Study|Disease progression after treatment started|1|||
16308540|NCT02492867|39612795|FG000|Overall Study|Death|1|||
16308541|NCT02348112|39612800|FG000|Overall Study|Withdrawal by Subject|32|||
16308542|NCT02348112|39612801|FG001|Overall Study|Withdrawal by Subject|29|||
16308543|NCT02348112|39612800|FG000|Overall Study|Lost to Follow-up|24|||
16308544|NCT02348112|39612801|FG001|Overall Study|Lost to Follow-up|20|||
16308545|NCT02348112|39612800|FG000|Overall Study|Physician Decision|17|||
16388569|NCT03745638|39905699|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
16388570|NCT03745638|39905693|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16388571|NCT03745638|39905694|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16388572|NCT03745638|39905695|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16388573|NCT03745638|39905696|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16388574|NCT03745638|39905697|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
16388575|NCT03745638|39905698|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
16388576|NCT03745638|39905699|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16388577|NCT03745638|39905693|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16086816|NCT02386098|38810529|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
16308546|NCT02348112|39612801|FG001|Overall Study|Physician Decision|15|||
16308547|NCT02348112|39612800|FG000|Overall Study|Site closed due to PI leaving|0|||
16308548|NCT02348112|39612801|FG001|Overall Study|Site closed due to PI leaving|30|||
16308549|NCT02348112|39612800|FG000|Overall Study|Sponsor withdrawal|0|||
16308550|NCT02348112|39612801|FG001|Overall Study|Sponsor withdrawal|7|||
16308551|NCT02348112|39612800|FG000|Overall Study|Death|0|||
16388578|NCT03745638|39905694|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16308552|NCT02348112|39612801|FG001|Overall Study|Death|1|||
16308553|NCT02892149|39612807|FG000|Overall Study|Death|262|||
16308554|NCT02892149|39612808|FG001|Overall Study|Death|278|||
16308555|NCT02892149|39612807|FG000|Overall Study|Withdrawal by Subject|53|||
16308556|NCT02892149|39612808|FG001|Overall Study|Withdrawal by Subject|47|||
16308557|NCT02892149|39612807|FG000|Overall Study|Lost to Follow-up|37|||
16308558|NCT02892149|39612808|FG001|Overall Study|Lost to Follow-up|31|||
16308559|NCT02324582|39612809|FG000|Overall Study|Screen Failures|0|||
16308560|NCT02324582|39612810|FG001|Overall Study|Screen Failures|5|||
16308561|NCT02201784|39612811|FG000|Overall Study|Failure to achieve adequate block|2|||
16308562|NCT02201784|39612812|FG001|Overall Study|Failure to achieve adequate block|0|||
16308563|NCT02135614|39612815|FG000|Overall Study|Randomized but Not Treated|2|||
16308564|NCT02135614|39612816|FG001|Overall Study|Randomized but Not Treated|1|||
16308565|NCT02135614|39612815|FG000|Overall Study|Adverse Event|0|||
16308566|NCT02135614|39612816|FG001|Overall Study|Adverse Event|1|||
16308567|NCT02135614|39612815|FG000|Overall Study|Death|1|||
16308568|NCT02135614|39612816|FG001|Overall Study|Death|0|||
16308569|NCT02135614|39612815|FG000|Overall Study|Investigator's Discretion|0|||
16308570|NCT02135614|39612816|FG001|Overall Study|Investigator's Discretion|1|||
16308571|NCT02135614|39612815|FG000|Overall Study|Withdrew Consent|2|||
16308572|NCT02135614|39612816|FG001|Overall Study|Withdrew Consent|2|||
16308573|NCT02135614|39612815|FG000|Overall Study|Lost to Follow-up|3|||
16308574|NCT02135614|39612816|FG001|Overall Study|Lost to Follow-up|0|||
16308575|NCT01821807|39612817|FG000|Overall Study|Lost to Follow-up|3|||
16308576|NCT01821807|39612818|FG001|Overall Study|Lost to Follow-up|1|||
16308577|NCT04981717|39612820|FG000|Overall Study|Protocol Violation|0|||
16308578|NCT04981717|39612821|FG001|Overall Study|Protocol Violation|3|||
16308579|NCT04981717|39612820|FG000|Overall Study|Adverse Event|1|||
16308580|NCT04981717|39612821|FG001|Overall Study|Adverse Event|3|||
16308581|NCT04981717|39612820|FG000|Overall Study|Pregnancy|1|||
16308582|NCT04981717|39612821|FG001|Overall Study|Pregnancy|0|||
16308583|NCT04981717|39612820|FG000|Overall Study|Physician Decision|1|||
16308584|NCT04981717|39612821|FG001|Overall Study|Physician Decision|0|||
16308585|NCT04981717|39612820|FG000|Overall Study|Sponsor Request|157|||
16308586|NCT04981717|39612821|FG001|Overall Study|Sponsor Request|172|||
16308587|NCT04981717|39612820|FG000|Overall Study|Lost to Follow-up|4|||
16308588|NCT04981717|39612821|FG001|Overall Study|Lost to Follow-up|5|||
16308589|NCT04981717|39612820|FG000|Overall Study|Withdrawal by Subject|50|||
16308590|NCT04981717|39612821|FG001|Overall Study|Withdrawal by Subject|37|||
16308591|NCT00153179|39612822|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
16308592|NCT00153179|39612823|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
16308593|NCT00153179|39612824|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
16308594|NCT00153179|39612825|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
16308595|NCT03845296|39612826|FG000|Overall Study|On Treatment|2|||
16308596|NCT03845296|39612827|FG001|Overall Study|On Treatment|1|||
16308597|NCT03845296|39612826|FG000|Overall Study|Adverse Event|4|||
16308598|NCT03845296|39612827|FG001|Overall Study|Adverse Event|11|||
16308599|NCT03845296|39612826|FG000|Overall Study|Refusal unrelated to adverse event|0|||
16308600|NCT03845296|39612827|FG001|Overall Study|Refusal unrelated to adverse event|1|||
16308601|NCT03845296|39612826|FG000|Overall Study|Progression/relapse|14|||
16308602|NCT03845296|39612827|FG001|Overall Study|Progression/relapse|18|||
16308603|NCT03845296|39612826|FG000|Overall Study|Death|4|||
16308604|NCT03845296|39612827|FG001|Overall Study|Death|0|||
16308605|NCT03845296|39612826|FG000|Overall Study|Other - not protocol specified|1|||
16308606|NCT03845296|39612827|FG001|Overall Study|Other - not protocol specified|3|||
16308607|NCT00946920|39612828|FG000|Overall Study|Withdrawal by Subject|28|||
16308608|NCT00946920|39612829|FG001|Overall Study|Withdrawal by Subject|15|||
16308609|NCT00946920|39612828|FG000|Overall Study|Lost to Follow-up|2|||
16308610|NCT00946920|39612829|FG001|Overall Study|Lost to Follow-up|2|||
16308611|NCT00946920|39612828|FG000|Overall Study|Physician Decision|5|||
16308612|NCT00946920|39612829|FG001|Overall Study|Physician Decision|2|||
16308613|NCT00946920|39612828|FG000|Overall Study|Adverse Event|41|||
16308614|NCT00946920|39612829|FG001|Overall Study|Adverse Event|14|||
16308615|NCT00946920|39612828|FG000|Overall Study|Protocol Violation|16|||
16308616|NCT00946920|39612829|FG001|Overall Study|Protocol Violation|8|||
16308617|NCT00946920|39612828|FG000|Overall Study|Miscellaneous reasons|18|||
16308618|NCT00946920|39612829|FG001|Overall Study|Miscellaneous reasons|3|||
16308619|NCT02717455|39612834|FG000|Overall Study|Adverse Event|1|||
16308620|NCT02717455|39612835|FG001|Overall Study|Adverse Event|0|||
16308621|NCT02717455|39612836|FG002|Overall Study|Adverse Event|0|||
16308622|NCT02717455|39612837|FG003|Overall Study|Adverse Event|2|||
16308623|NCT02717455|39612838|FG004|Overall Study|Adverse Event|2|||
16308624|NCT02717455|39612839|FG005|Overall Study|Adverse Event|2|||
16308625|NCT02717455|39612834|FG000|Overall Study|Withdrawal by Subject|1|||
16308626|NCT02717455|39612835|FG001|Overall Study|Withdrawal by Subject|1|||
16308627|NCT02717455|39612836|FG002|Overall Study|Withdrawal by Subject|0|||
16308628|NCT02717455|39612837|FG003|Overall Study|Withdrawal by Subject|2|||
16308629|NCT02717455|39612838|FG004|Overall Study|Withdrawal by Subject|2|||
16308630|NCT02717455|39612839|FG005|Overall Study|Withdrawal by Subject|1|||
16308631|NCT02717455|39612834|FG000|Overall Study|Death|1|||
16308632|NCT02717455|39612835|FG001|Overall Study|Death|0|||
16308633|NCT02717455|39612836|FG002|Overall Study|Death|0|||
16308634|NCT02717455|39612837|FG003|Overall Study|Death|0|||
16308635|NCT02717455|39612838|FG004|Overall Study|Death|1|||
16308636|NCT02717455|39612839|FG005|Overall Study|Death|0|||
16308637|NCT02717455|39612834|FG000|Overall Study|Did not receive study drug|0|||
16308638|NCT02717455|39612835|FG001|Overall Study|Did not receive study drug|0|||
16308639|NCT02717455|39612836|FG002|Overall Study|Did not receive study drug|0|||
16308640|NCT02717455|39612837|FG003|Overall Study|Did not receive study drug|1|||
16308641|NCT02717455|39612838|FG004|Overall Study|Did not receive study drug|0|||
16308642|NCT02717455|39612839|FG005|Overall Study|Did not receive study drug|1|||
16308643|NCT02717455|39612834|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
16308644|NCT02717455|39612835|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
16308645|NCT02717455|39612836|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
16308646|NCT02717455|39612837|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
16308647|NCT02717455|39612838|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
16308648|NCT02717455|39612839|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
16308649|NCT02717455|39612834|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
16308650|NCT02717455|39612835|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
16308651|NCT02717455|39612836|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
16308652|NCT02717455|39612837|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
16308653|NCT02717455|39612838|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
16308654|NCT02717455|39612839|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
16308655|NCT00908544|39612840|FG000|Overall Study|Withdrawal by Subject|2|||
16308656|NCT00908544|39612841|FG001|Overall Study|Withdrawal by Subject|4|||
16308657|NCT00908544|39612840|FG000|Overall Study|Lack of Efficacy|0|||
16308658|NCT00908544|39612841|FG001|Overall Study|Lack of Efficacy|1|||
16308659|NCT00908544|39612840|FG000|Overall Study|Pregnancy|1|||
16308660|NCT00908544|39612841|FG001|Overall Study|Pregnancy|0|||
16308661|NCT00908544|39612840|FG000|Overall Study|Relocation abroad|1|||
16308662|NCT00908544|39612841|FG001|Overall Study|Relocation abroad|1|||
16308663|NCT00908544|39612840|FG000|Overall Study|Unable to visit sutdy center|1|||
16308664|NCT00908544|39612841|FG001|Overall Study|Unable to visit sutdy center|0|||
16308665|NCT00185588|39612842|FG000|Overall Study|Adverse Event|3|||
16308666|NCT00185588|39612843|FG001|Overall Study|Adverse Event|1|||
16308667|NCT00185588|39612844|FG002|Overall Study|Adverse Event|4|||
16308668|NCT00185588|39612845|FG003|Overall Study|Adverse Event|2|||
16308669|NCT00185588|39612842|FG000|Overall Study|Lost to Follow-up|0|||
16308670|NCT00185588|39612843|FG001|Overall Study|Lost to Follow-up|0|||
16308671|NCT00185588|39612844|FG002|Overall Study|Lost to Follow-up|1|||
16308672|NCT00185588|39612845|FG003|Overall Study|Lost to Follow-up|2|||
16308673|NCT00185588|39612842|FG000|Overall Study|Withdrawal by Subject|0|||
16308674|NCT00185588|39612843|FG001|Overall Study|Withdrawal by Subject|1|||
16308675|NCT00185588|39612844|FG002|Overall Study|Withdrawal by Subject|0|||
16308676|NCT00185588|39612845|FG003|Overall Study|Withdrawal by Subject|0|||
16308677|NCT00185588|39612842|FG000|Overall Study|Physician Decision|0|||
16308678|NCT00185588|39612843|FG001|Overall Study|Physician Decision|0|||
16308679|NCT00185588|39612844|FG002|Overall Study|Physician Decision|1|||
16308680|NCT00185588|39612845|FG003|Overall Study|Physician Decision|0|||
16308681|NCT04720053|39612851|FG000|Overall Study|Lost to Follow-up|12|||
16308682|NCT04747470|39612852|FG000|Overall Study|Death|0|||
16308683|NCT04747470|39612853|FG001|Overall Study|Death|3|||
16308684|NCT04747470|39612854|FG002|Overall Study|Death|2|||
16308685|NCT04747470|39612855|FG003|Overall Study|Death|2|||
16308686|NCT04747470|39612856|FG004|Overall Study|Death|2|||
16308687|NCT04747470|39612857|FG005|Overall Study|Death|0|||
16308688|NCT04747470|39612858|FG006|Overall Study|Death|0|||
16308689|NCT04747470|39612859|FG007|Overall Study|Death|0|||
16308690|NCT04747470|39612860|FG008|Overall Study|Death|0|||
16308691|NCT04747470|39612861|FG009|Overall Study|Death|0|||
16308692|NCT04747470|39612862|FG010|Overall Study|Death|0|||
16308693|NCT04747470|39612852|FG000|Overall Study|Withdrew Consent|0|||
16308694|NCT04747470|39612853|FG001|Overall Study|Withdrew Consent|0|||
16308695|NCT04747470|39612854|FG002|Overall Study|Withdrew Consent|0|||
16308696|NCT04747470|39612855|FG003|Overall Study|Withdrew Consent|1|||
16308697|NCT04747470|39612856|FG004|Overall Study|Withdrew Consent|0|||
16308698|NCT04747470|39612857|FG005|Overall Study|Withdrew Consent|0|||
16308699|NCT04747470|39612858|FG006|Overall Study|Withdrew Consent|0|||
16308700|NCT04747470|39612859|FG007|Overall Study|Withdrew Consent|0|||
16497008|NCT04044716|40291228|FG002|Overall Study|Lost to Follow-up|0|||
16497009|NCT02064894|40291235|FG000|Overall Study|Withdrawal by Subject|43|||
16497010|NCT02064894|40291236|FG001|Overall Study|Withdrawal by Subject|102|||
16497011|NCT02064894|40291237|FG002|Overall Study|Withdrawal by Subject|115|||
16497012|NCT04517253|40291238|FG000|Overall Study|Adverse Event|1|||
16497013|NCT04517253|40291239|FG001|Overall Study|Adverse Event|0|||
16497014|NCT04517253|40291240|FG002|Overall Study|Adverse Event|0|||
16497015|NCT04517253|40291238|FG000|Overall Study|Death|0|||
16497016|NCT04517253|40291239|FG001|Overall Study|Death|1|||
16497017|NCT04517253|40291240|FG002|Overall Study|Death|0|||
16497018|NCT03235154|40291241|FG000|Overall Study|Withdrawal by Subject|1|||
16497019|NCT03235154|40291241|FG000|Overall Study|Adverse Event|1|||
16497020|NCT03235154|40291241|FG000|Overall Study|Lost to Follow-up|2|||
16497021|NCT04343261|40291242|FG000|Overall Study|Adverse Event|1|||
16497022|NCT04343261|40291242|FG000|Overall Study|received inadequate amount of antibodies|7|||
16497023|NCT01438957|40291243|FG000|Overall Study|Physician Decision|1|||
16497024|NCT01438957|40291244|FG001|Overall Study|Physician Decision|1|||
16497025|NCT01438957|40291245|FG002|Overall Study|Physician Decision|0|||
16497026|NCT01438957|40291246|FG003|Overall Study|Physician Decision|1|||
16497027|NCT01438957|40291247|FG004|Overall Study|Physician Decision|0|||
16497028|NCT00450450|40291248|FG000|Overall Study|Death|1|||
16497029|NCT00450450|40291249|FG001|Overall Study|Death|3|||
16497030|NCT00450450|40291248|FG000|Overall Study|Relapse|2|||
16497031|NCT00450450|40291249|FG001|Overall Study|Relapse|0|||
16497032|NCT00450450|40291248|FG000|Overall Study|Missing Data|2|||
16497033|NCT00450450|40291249|FG001|Overall Study|Missing Data|0|||
16497034|NCT03158051|40291250|FG000|Overall Study|Lost to Follow-up|41|||
16497035|NCT03158051|40291251|FG001|Overall Study|Lost to Follow-up|47|||
16497036|NCT03158051|40291250|FG000|Overall Study|Physician Decision|6|||
16497037|NCT03158051|40291251|FG001|Overall Study|Physician Decision|7|||
16497038|NCT03158051|40291250|FG000|Overall Study|Withdrawal by Subject|24|||
16497039|NCT03158051|40291251|FG001|Overall Study|Withdrawal by Subject|15|||
16497040|NCT03158051|40291250|FG000|Overall Study|Death|0|||
16497041|NCT03158051|40291251|FG001|Overall Study|Death|1|||
16497042|NCT03227029|40291252|FG000|Overall Study|Child Wheezed (no treatment)|0|||
16497043|NCT03227029|40291253|FG001|Overall Study|Child Wheezed (no treatment)|1|||
16497044|NCT03227029|40291254|FG002|Overall Study|Child Wheezed (no treatment)|0|||
16497045|NCT03227029|40291252|FG000|Overall Study|No post RSV season visit due to COVID|3|||
16497046|NCT03227029|40291253|FG001|Overall Study|No post RSV season visit due to COVID|3|||
16497047|NCT03227029|40291254|FG002|Overall Study|No post RSV season visit due to COVID|2|||
16497048|NCT03227029|40291252|FG000|Overall Study|Not able to get to clinic|0|||
16497049|NCT03227029|40291253|FG001|Overall Study|Not able to get to clinic|0|||
16497050|NCT03227029|40291254|FG002|Overall Study|Not able to get to clinic|1|||
16497051|NCT03227029|40291252|FG000|Overall Study|Withdrawal by Subject|1|||
16497052|NCT03227029|40291253|FG001|Overall Study|Withdrawal by Subject|0|||
16497053|NCT03227029|40291254|FG002|Overall Study|Withdrawal by Subject|0|||
16497054|NCT03227029|40291252|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
16497055|NCT03227029|40291253|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
16497056|NCT03227029|40291254|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
16497057|NCT01508650|40291255|FG000|Overall Study|Lost to Follow-up|0|||
16497058|NCT01508650|40291256|FG001|Overall Study|Lost to Follow-up|3|||
16497059|NCT00936910|40291257|FG000|Overall Study|Lack of Efficacy|3|||
16497060|NCT02700815|40291259|FG000|Overall Study|Adverse Event|0|||
16497061|NCT02700815|40291260|FG001|Overall Study|Adverse Event|6|||
16497062|NCT02700815|40291261|FG002|Overall Study|Adverse Event|2|||
16497063|NCT02700815|40291262|FG003|Overall Study|Adverse Event|3|||
16497064|NCT02700815|40291259|FG000|Overall Study|Lack of Efficacy|0|||
16497065|NCT02700815|40291260|FG001|Overall Study|Lack of Efficacy|0|||
16497066|NCT02700815|40291261|FG002|Overall Study|Lack of Efficacy|1|||
16497067|NCT02700815|40291262|FG003|Overall Study|Lack of Efficacy|2|||
16497068|NCT02700815|40291259|FG000|Overall Study|Lost to Follow-up|1|||
16497069|NCT02700815|40291260|FG001|Overall Study|Lost to Follow-up|0|||
16497070|NCT02700815|40291261|FG002|Overall Study|Lost to Follow-up|0|||
16497071|NCT02700815|40291262|FG003|Overall Study|Lost to Follow-up|1|||
16497072|NCT02700815|40291259|FG000|Overall Study|Refusal to continue medication|0|||
16497073|NCT02700815|40291260|FG001|Overall Study|Refusal to continue medication|1|||
16497074|NCT02700815|40291261|FG002|Overall Study|Refusal to continue medication|0|||
16308701|NCT04747470|39612860|FG008|Overall Study|Withdrew Consent|0|||
16497075|NCT02700815|40291262|FG003|Overall Study|Refusal to continue medication|1|||
16497076|NCT02700815|40291259|FG000|Overall Study|Withdrawal by Subject|0|||
16497077|NCT02700815|40291260|FG001|Overall Study|Withdrawal by Subject|0|||
16497078|NCT02700815|40291261|FG002|Overall Study|Withdrawal by Subject|1|||
16308702|NCT04747470|39612861|FG009|Overall Study|Withdrew Consent|0|||
16086817|NCT02386098|38810530|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
16086818|NCT02386098|38810531|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
16086819|NCT02386098|38810532|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
16086820|NCT02386098|38810528|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
16086821|NCT02386098|38810529|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
16086822|NCT02386098|38810530|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
16086823|NCT02386098|38810531|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
16086824|NCT02386098|38810532|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
16086825|NCT02386098|38810528|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
16086826|NCT02386098|38810529|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
16086827|NCT02386098|38810530|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
16086828|NCT02386098|38810531|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
16086829|NCT02386098|38810532|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
16086830|NCT02386098|38810528|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
16086831|NCT02386098|38810529|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
16086832|NCT02386098|38810530|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
16086833|NCT02386098|38810531|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
16086834|NCT02386098|38810532|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
16086835|NCT02386098|38810528|FG000|Stage 1 (96 Weeks)|Other|1|||
16086836|NCT02386098|38810529|FG001|Stage 1 (96 Weeks)|Other|0|||
16086837|NCT02386098|38810530|FG002|Stage 1 (96 Weeks)|Other|0|||
16086838|NCT02386098|38810531|FG003|Stage 1 (96 Weeks)|Other|0|||
16086839|NCT02386098|38810532|FG004|Stage 1 (96 Weeks)|Other|0|||
16086840|NCT02386098|38810528|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
16086841|NCT02386098|38810529|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
16086842|NCT02386098|38810530|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
16086843|NCT02386098|38810531|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
16086844|NCT02386098|38810532|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
16086845|NCT03292406|38810533|FG000|Overall Study|Progressive Disease|6|||
16086846|NCT03292406|38810534|FG001|Overall Study|Progressive Disease|3|||
16086847|NCT03292406|38810535|FG002|Overall Study|Progressive Disease|4|||
16086848|NCT03292406|38810533|FG000|Overall Study|Adverse Event|7|||
16308703|NCT04747470|39612862|FG010|Overall Study|Withdrew Consent|0|||
16308704|NCT04747470|39612852|FG000|Overall Study|Study Terminated by Sponsor|0|||
16308705|NCT04747470|39612853|FG001|Overall Study|Study Terminated by Sponsor|0|||
16308706|NCT04747470|39612854|FG002|Overall Study|Study Terminated by Sponsor|1|||
16308707|NCT04747470|39612855|FG003|Overall Study|Study Terminated by Sponsor|0|||
16308708|NCT04747470|39612856|FG004|Overall Study|Study Terminated by Sponsor|2|||
16497079|NCT02700815|40291262|FG003|Overall Study|Withdrawal by Subject|0|||
16497080|NCT00969150|40291267|FG000|Overall Study|Adverse Event|4|||
16497081|NCT00969150|40291268|FG001|Overall Study|Adverse Event|14|||
16497082|NCT00969150|40291267|FG000|Overall Study|Lack of Efficacy|1|||
16497083|NCT00969150|40291268|FG001|Overall Study|Lack of Efficacy|1|||
16497084|NCT00969150|40291267|FG000|Overall Study|Protocol Violation|9|||
16497085|NCT00969150|40291268|FG001|Overall Study|Protocol Violation|12|||
16497086|NCT00969150|40291267|FG000|Overall Study|Withdrawal by Subject|13|||
16497087|NCT00969150|40291268|FG001|Overall Study|Withdrawal by Subject|9|||
16497088|NCT00969150|40291267|FG000|Overall Study|Lost to Follow-up|5|||
16086849|NCT03292406|38810534|FG001|Overall Study|Adverse Event|1|||
16086850|NCT03292406|38810535|FG002|Overall Study|Adverse Event|4|||
16086851|NCT03292406|38810533|FG000|Overall Study|Withdrawal by Subject|0|||
16086852|NCT03292406|38810534|FG001|Overall Study|Withdrawal by Subject|7|||
16497089|NCT00969150|40291268|FG001|Overall Study|Lost to Follow-up|4|||
16497090|NCT00969150|40291267|FG000|Overall Study|Other reasons|1|||
16497091|NCT00969150|40291268|FG001|Overall Study|Other reasons|0|||
16497092|NCT01119131|40291271|FG000|Overall Study|Adverse Event|1|||
16497093|NCT01119131|40291272|FG001|Overall Study|Adverse Event|1|||
16497094|NCT01119131|40291273|FG002|Overall Study|Adverse Event|1|||
16497095|NCT01119131|40291271|FG000|Overall Study|Non-Compliance|1|||
16497096|NCT01119131|40291272|FG001|Overall Study|Non-Compliance|0|||
16497097|NCT01119131|40291273|FG002|Overall Study|Non-Compliance|4|||
16497098|NCT01119131|40291271|FG000|Overall Study|Physician Decision|0|||
16497099|NCT01119131|40291272|FG001|Overall Study|Physician Decision|0|||
16497100|NCT01119131|40291273|FG002|Overall Study|Physician Decision|1|||
16086853|NCT03292406|38810535|FG002|Overall Study|Withdrawal by Subject|2|||
16086854|NCT03292406|38810533|FG000|Overall Study|Protocol Violation|0|||
16086855|NCT03292406|38810534|FG001|Overall Study|Protocol Violation|1|||
16308709|NCT04747470|39612857|FG005|Overall Study|Study Terminated by Sponsor|0|||
16308710|NCT04747470|39612858|FG006|Overall Study|Study Terminated by Sponsor|0|||
16308711|NCT04747470|39612859|FG007|Overall Study|Study Terminated by Sponsor|0|||
16308712|NCT04747470|39612860|FG008|Overall Study|Study Terminated by Sponsor|0|||
16308713|NCT04747470|39612861|FG009|Overall Study|Study Terminated by Sponsor|0|||
16308714|NCT04747470|39612862|FG010|Overall Study|Study Terminated by Sponsor|0|||
16308715|NCT03499067|39612863|FG000|First Intervention|Physician Decision|2|||
16308716|NCT03499067|39612864|FG001|First Intervention|Physician Decision|1|||
16308717|NCT03499067|39612863|FG000|First Intervention|Withdrawal by Subject|3|||
16086856|NCT03292406|38810535|FG002|Overall Study|Protocol Violation|1|||
16086857|NCT03292406|38810533|FG000|Overall Study|Other|0|||
16086858|NCT03292406|38810534|FG001|Overall Study|Other|1|||
16086859|NCT03292406|38810535|FG002|Overall Study|Other|2|||
16086860|NCT02252042|38810537|FG000|Overall Study|Adverse Event|9|||
16086861|NCT02252042|38810538|FG001|Overall Study|Adverse Event|6|||
16086862|NCT02252042|38810537|FG000|Overall Study|Death|209|||
16086863|NCT02252042|38810538|FG001|Overall Study|Death|217|||
16086864|NCT02252042|38810537|FG000|Overall Study|Physician Decision|0|||
16086865|NCT02252042|38810538|FG001|Overall Study|Physician Decision|2|||
16086866|NCT02252042|38810537|FG000|Overall Study|Transferred to Extension Study|7|||
16086867|NCT02252042|38810538|FG001|Overall Study|Transferred to Extension Study|1|||
16086868|NCT02252042|38810537|FG000|Overall Study|Did Not Continue on Extension Study|7|||
16086869|NCT02252042|38810538|FG001|Overall Study|Did Not Continue on Extension Study|2|||
16086870|NCT02252042|38810537|FG000|Overall Study|Withdrawal by Subject|15|||
16086871|NCT02252042|38810538|FG001|Overall Study|Withdrawal by Subject|20|||
16086872|NCT00380250|38810539|FG000|Overall Study|Withdrawal by Subject|39|||
16086873|NCT00380250|38810540|FG001|Overall Study|Withdrawal by Subject|28|||
16086874|NCT00380250|38810539|FG000|Overall Study|Adverse Event|20|||
16086875|NCT00380250|38810540|FG001|Overall Study|Adverse Event|9|||
16086876|NCT00380250|38810539|FG000|Overall Study|Lack of Efficacy|10|||
16086877|NCT00380250|38810540|FG001|Overall Study|Lack of Efficacy|8|||
16086878|NCT00380250|38810539|FG000|Overall Study|Protocol Violation|15|||
16086879|NCT00380250|38810540|FG001|Overall Study|Protocol Violation|5|||
16086880|NCT00380250|38810539|FG000|Overall Study|Lost to Follow-up|14|||
16086881|NCT00380250|38810540|FG001|Overall Study|Lost to Follow-up|5|||
16086882|NCT00380250|38810539|FG000|Overall Study|Physician Decision|1|||
16086883|NCT00380250|38810540|FG001|Overall Study|Physician Decision|0|||
16086884|NCT00070317|38810543|FG000|Overall Study|Inevaluable (Never Treated)|1|||
16086885|NCT00070317|38810543|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
16086886|NCT00070317|38810543|FG000|Overall Study|Ineligible required test not done|1|||
16086887|NCT00070317|38810543|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
16086888|NCT00070317|38810543|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
16086889|NCT01074242|38810548|FG000|Overall Study|Case report before date of contract|40|||
16086890|NCT01074242|38810548|FG000|Overall Study|Lost to Follow-up|1|||
16086891|NCT01074242|38810548|FG000|Overall Study|Case report unclear|6|||
16086892|NCT01074242|38810548|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
16086893|NCT01074242|38810548|FG000|Overall Study|Duplicate Case Report Form|5|||
16086894|NCT01604824|38810549|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
16086895|NCT01604824|38810550|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
16086896|NCT01604824|38810551|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
16086897|NCT01604824|38810552|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
16086898|NCT01604824|38810553|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
16086899|NCT01604824|38810554|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
16086900|NCT01604824|38810549|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
16086901|NCT01604824|38810550|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
16086902|NCT01604824|38810551|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
16086903|NCT01604824|38810552|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
16086904|NCT01604824|38810553|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
16086905|NCT01604824|38810554|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
16086906|NCT01634165|38810555|FG000|Period 2|Adverse Event|0|||
16086907|NCT01634165|38810556|FG001|Period 2|Adverse Event|1|||
16086908|NCT01634165|38810557|FG002|Period 2|Adverse Event|0|||
16086909|NCT01634165|38810558|FG003|Period 2|Adverse Event|0|||
16086910|NCT00246805|38810559|FG000|Phase 1|Lost to Follow-up|1|||
16086911|NCT00246805|38810560|FG001|Phase 1|Lost to Follow-up|0|||
16086912|NCT00491400|38810561|FG000|Overall Study|Withdrawal by Subject|5|||
16194627|NCT04504032|39188793|FG000|Overall Study|Adverse Event|1|||
16194628|NCT04504032|39188794|FG001|Overall Study|Adverse Event|2|||
16194629|NCT04504032|39188793|FG000|Overall Study|Lost to Follow-up|6|||
16194630|NCT04504032|39188794|FG001|Overall Study|Lost to Follow-up|9|||
16194631|NCT04504032|39188793|FG000|Overall Study|Protocol Violation|2|||
16497101|NCT04007094|40291274|FG000|Overall Study|Lost to Follow-up|1|||
16497102|NCT04007094|40291275|FG001|Overall Study|Lost to Follow-up|1|||
16086913|NCT00491400|38810562|FG001|Overall Study|Withdrawal by Subject|4|||
16086914|NCT01499849|38810563|FG000|Overall Study|Adverse Event|28|||
16086915|NCT01499849|38810564|FG001|Overall Study|Adverse Event|32|||
16086916|NCT01499849|38810563|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
16086917|NCT01499849|38810564|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
16086918|NCT01499849|38810563|FG000|Overall Study|Withdrawal by Subject|43|||
16086919|NCT01499849|38810564|FG001|Overall Study|Withdrawal by Subject|43|||
16086920|NCT01499849|38810563|FG000|Overall Study|Death|5|||
16497103|NCT02953314|40291279|FG000|Overall Study|Adverse Event|0|||
16086921|NCT01499849|38810564|FG001|Overall Study|Death|7|||
16086922|NCT01499849|38810563|FG000|Overall Study|Disease Progression|11|||
16194632|NCT04504032|39188794|FG001|Overall Study|Protocol Violation|0|||
16194633|NCT04504032|39188793|FG000|Overall Study|Study terminated by sponsor|1|||
16194634|NCT04504032|39188794|FG001|Overall Study|Study terminated by sponsor|2|||
16194635|NCT04504032|39188793|FG000|Overall Study|Withdrawal by Subject|9|||
16194636|NCT04504032|39188794|FG001|Overall Study|Withdrawal by Subject|11|||
16194637|NCT04504032|39188793|FG000|Overall Study|Disease progression prior to dosing|15|||
16194638|NCT04504032|39188794|FG001|Overall Study|Disease progression prior to dosing|3|||
16194639|NCT04504032|39188793|FG000|Overall Study|Drug supply issues|1|||
16194640|NCT04504032|39188794|FG001|Overall Study|Drug supply issues|1|||
16194641|NCT04504032|39188793|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
16194642|NCT04504032|39188794|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
16194643|NCT03855137|39188801|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
16194644|NCT03855137|39188802|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
16194645|NCT03855137|39188803|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
16194646|NCT03855137|39188801|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
16194647|NCT03855137|39188802|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
16194648|NCT03855137|39188803|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
16194649|NCT03855137|39188801|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
16194650|NCT03855137|39188802|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
16194651|NCT03855137|39188803|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
16194652|NCT03855137|39188801|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
16194653|NCT03855137|39188802|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
16194654|NCT03855137|39188803|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
16497104|NCT02953314|40291280|FG001|Overall Study|Adverse Event|1|||
16497105|NCT02953314|40291279|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
16194655|NCT03855137|39188801|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
16194656|NCT03855137|39188802|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
16194657|NCT03855137|39188803|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
16194658|NCT03855137|39188801|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
16194659|NCT03855137|39188802|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
16194660|NCT03855137|39188803|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
16497106|NCT02953314|40291280|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
16497107|NCT00661622|40291281|FG000|Overall Study|Protocol Violation|1|||
16497108|NCT00661622|40291282|FG001|Overall Study|Protocol Violation|0|||
16497109|NCT02733991|40291285|FG000|Overall Study|Adverse Event|1|||
16308718|NCT03499067|39612864|FG001|First Intervention|Withdrawal by Subject|6|||
16308719|NCT00503698|39615546|FG000|Overall Study|Protocol Violation|5|||
16308720|NCT00503698|39615547|FG001|Overall Study|Protocol Violation|6|||
16308721|NCT00503698|39615546|FG000|Overall Study|Adverse Event|52|||
16308722|NCT00503698|39615547|FG001|Overall Study|Adverse Event|41|||
16308723|NCT00503698|39615546|FG000|Overall Study|Death|1|||
16308724|NCT00503698|39615547|FG001|Overall Study|Death|0|||
16308725|NCT00503698|39615546|FG000|Overall Study|Lack of Efficacy|3|||
16308726|NCT00503698|39615547|FG001|Overall Study|Lack of Efficacy|4|||
16388579|NCT03745638|39905695|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16194661|NCT03855137|39188801|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
16194662|NCT03855137|39188802|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
16194663|NCT03855137|39188803|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
16497110|NCT02733991|40291286|FG001|Overall Study|Adverse Event|0|||
16497111|NCT02733991|40291285|FG000|Overall Study|Withdrawal by Subject|0|||
16497112|NCT02733991|40291286|FG001|Overall Study|Withdrawal by Subject|5|||
16497113|NCT02763189|40291294|FG000|Overall Study|Device failure|0|||
16497114|NCT02763189|40291295|FG001|Overall Study|Device failure|2|||
16497115|NCT03226392|40291296|FG000|Overall Study|Protocol Deviation|1|||
16194664|NCT03855137|39188801|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
16194665|NCT03855137|39188802|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
16194666|NCT03855137|39188803|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
16308727|NCT00503698|39615546|FG000|Overall Study|Trial terminated|216|||
16497116|NCT03226392|40291297|FG001|Overall Study|Protocol Deviation|0|||
16497117|NCT03226392|40291296|FG000|Overall Study|Physician Decision|1|||
16497118|NCT03226392|40291297|FG001|Overall Study|Physician Decision|0|||
16194667|NCT03855137|39188801|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
16194668|NCT03855137|39188802|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
16194669|NCT03855137|39188803|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
16194670|NCT03855137|39188801|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
16194671|NCT03855137|39188802|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
16194672|NCT03855137|39188803|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
16194673|NCT03298412|39188804|FG000|Run-in Period|Other, Not Specified|1|||
16194674|NCT03298412|39188804|FG000|Run-in Period|Disease Progression|1|||
16194675|NCT03298412|39188804|FG000|Run-in Period|Ineligibility Determined|1|||
16194676|NCT03298412|39188804|FG000|Run-in Period|Decision by Sponsor|6|||
16194677|NCT01259856|39188805|FG000|Overall Study|Adverse Event|12|||
16194678|NCT01259856|39188806|FG001|Overall Study|Adverse Event|9|||
16194679|NCT01259856|39188805|FG000|Overall Study|Death|0|||
16194680|NCT01259856|39188806|FG001|Overall Study|Death|1|||
16194681|NCT01259856|39188805|FG000|Overall Study|Lack of Efficacy|3|||
16194682|NCT01259856|39188806|FG001|Overall Study|Lack of Efficacy|1|||
16194683|NCT01259856|39188805|FG000|Overall Study|Lost to Follow-up|1|||
16194684|NCT01259856|39188806|FG001|Overall Study|Lost to Follow-up|1|||
16194685|NCT01259856|39188805|FG000|Overall Study|Physician Decision|2|||
16194686|NCT01259856|39188806|FG001|Overall Study|Physician Decision|1|||
16194687|NCT01259856|39188805|FG000|Overall Study|Withdrawal by Subject|9|||
16194688|NCT01259856|39188806|FG001|Overall Study|Withdrawal by Subject|10|||
16194689|NCT01259856|39188805|FG000|Overall Study|Treatment never started|0|||
16194690|NCT01259856|39188806|FG001|Overall Study|Treatment never started|6|||
16194691|NCT01259856|39188805|FG000|Overall Study|Study closure by sponsor|40|||
16194692|NCT01259856|39188806|FG001|Overall Study|Study closure by sponsor|41|||
16194693|NCT01259856|39188805|FG000|Overall Study|Patient developed other disease|0|||
16194694|NCT01259856|39188806|FG001|Overall Study|Patient developed other disease|1|||
16194695|NCT01259856|39188805|FG000|Overall Study|Transfer to another study|0|||
16194696|NCT01259856|39188806|FG001|Overall Study|Transfer to another study|1|||
16194697|NCT01259856|39188805|FG000|Overall Study|Unknown/missing|2|||
16194698|NCT01259856|39188806|FG001|Overall Study|Unknown/missing|2|||
16194699|NCT01603641|39188809|FG000|Overall Study|Did not Receive Treatment|3|||
16194700|NCT01603641|39188809|FG000|Overall Study|Adverse Event|1|||
16194701|NCT01603641|39188809|FG000|Overall Study|Lack of Efficacy|1|||
16194702|NCT01603641|39188809|FG000|Overall Study|Lost to Follow-up|6|||
16194703|NCT01603641|39188809|FG000|Overall Study|Personal Reasons|18|||
16194704|NCT01603641|39188809|FG000|Overall Study|Other Miscellaneous Reasons|6|||
16194705|NCT00074412|39188810|FG000|Overall Study|Death|30|||
16194706|NCT00074412|39188811|FG001|Overall Study|Death|26|||
16194707|NCT00074412|39188810|FG000|Overall Study|Lost to Follow-up|52|||
16308728|NCT00503698|39615547|FG001|Overall Study|Trial terminated|253|||
16497119|NCT03226392|40291296|FG000|Overall Study|Lost to Follow-up|1|||
16497120|NCT03226392|40291297|FG001|Overall Study|Lost to Follow-up|0|||
16497121|NCT03226392|40291296|FG000|Overall Study|Adverse Event|1|||
16497122|NCT03226392|40291297|FG001|Overall Study|Adverse Event|0|||
16497123|NCT03226392|40291296|FG000|Overall Study|Technical Problems|0|||
16497124|NCT03226392|40291297|FG001|Overall Study|Technical Problems|2|||
16497125|NCT03226392|40291296|FG000|Overall Study|Subject/Guardian Decision|7|||
16497126|NCT03226392|40291297|FG001|Overall Study|Subject/Guardian Decision|6|||
16497127|NCT00524368|40291301|FG000|Overall Study|Adverse Event|10|||
16497128|NCT00524368|40291302|FG001|Overall Study|Adverse Event|12|||
16497129|NCT00524368|40291301|FG000|Overall Study|Lost to Follow-up|9|||
16497130|NCT00524368|40291302|FG001|Overall Study|Lost to Follow-up|13|||
16497131|NCT00524368|40291301|FG000|Overall Study|Withdrawal by Subject|4|||
16497132|NCT00524368|40291302|FG001|Overall Study|Withdrawal by Subject|5|||
16497133|NCT00524368|40291301|FG000|Overall Study|Non-compliant|8|||
16497134|NCT00524368|40291302|FG001|Overall Study|Non-compliant|9|||
16497135|NCT00524368|40291301|FG000|Overall Study|Reached a Virologic Endpoint|3|||
16497136|NCT00524368|40291302|FG001|Overall Study|Reached a Virologic Endpoint|2|||
16497137|NCT00524368|40291301|FG000|Overall Study|Sponsor's Decision|2|||
16086923|NCT01499849|38810564|FG001|Overall Study|Disease Progression|10|||
16086924|NCT01499849|38810563|FG000|Overall Study|Protocol Violation|11|||
16497138|NCT00524368|40291302|FG001|Overall Study|Sponsor's Decision|0|||
16497139|NCT00524368|40291301|FG000|Overall Study|Ineligible to Continue the study|2|||
16194708|NCT00074412|39188811|FG001|Overall Study|Lost to Follow-up|58|||
16194709|NCT00701727|39188823|FG000|First Treatment Period|Adverse Event|0|||
16194710|NCT00701727|39188824|FG001|First Treatment Period|Adverse Event|0|||
16194711|NCT00701727|39188823|FG000|First Treatment Period|Withdrawal by Subject|1|||
16497140|NCT00524368|40291302|FG001|Overall Study|Ineligible to Continue the study|5|||
16497141|NCT00524368|40291301|FG000|Overall Study|Other|3|||
16497142|NCT00524368|40291302|FG001|Overall Study|Other|2|||
16497143|NCT02373202|40291303|FG000|Overall Study|Adverse Event|2|||
16497144|NCT02373202|40291304|FG001|Overall Study|Adverse Event|5|||
16497145|NCT02373202|40291305|FG002|Overall Study|Adverse Event|2|||
16497146|NCT02373202|40291306|FG003|Overall Study|Adverse Event|1|||
16497147|NCT02373202|40291303|FG000|Overall Study|Lack of Efficacy|0|||
16497148|NCT02373202|40291304|FG001|Overall Study|Lack of Efficacy|0|||
16497149|NCT02373202|40291305|FG002|Overall Study|Lack of Efficacy|1|||
16497150|NCT02373202|40291306|FG003|Overall Study|Lack of Efficacy|0|||
16497151|NCT02373202|40291303|FG000|Overall Study|Other|0|||
16497152|NCT02373202|40291304|FG001|Overall Study|Other|1|||
16497153|NCT02373202|40291305|FG002|Overall Study|Other|0|||
16497154|NCT02373202|40291306|FG003|Overall Study|Other|0|||
16497155|NCT02066233|40291307|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
16497156|NCT02066233|40291308|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
16497157|NCT01313767|40291316|FG000|Overall Study|Adverse Event|1|||
16497158|NCT01313767|40291317|FG001|Overall Study|Adverse Event|0|||
16497159|NCT01313767|40291316|FG000|Overall Study|Lost to Follow-up|1|||
16497160|NCT01313767|40291317|FG001|Overall Study|Lost to Follow-up|0|||
16497161|NCT01313767|40291316|FG000|Overall Study|Withdrawal by Subject|2|||
16497162|NCT01313767|40291317|FG001|Overall Study|Withdrawal by Subject|1|||
16497163|NCT01313767|40291316|FG000|Overall Study|Protocol Violation|3|||
16497164|NCT01313767|40291317|FG001|Overall Study|Protocol Violation|1|||
16497165|NCT01413191|40291323|FG000|Overall Study|Lost to Follow-up|5|||
16497166|NCT01413191|40291323|FG000|Overall Study|Disease Progression|5|||
16497167|NCT01413191|40291323|FG000|Overall Study|Death|1|||
16194712|NCT00701727|39188824|FG001|First Treatment Period|Withdrawal by Subject|0|||
16194713|NCT00701727|39188823|FG000|First Treatment Period|sponsor decision|0|||
16194714|NCT00701727|39188824|FG001|First Treatment Period|sponsor decision|1|||
16194715|NCT00701727|39188823|FG000|First Treatment Period|Lost to Follow-up|0|||
16194716|NCT00701727|39188824|FG001|First Treatment Period|Lost to Follow-up|1|||
16194717|NCT00701727|39188823|FG000|Second Treatment Period|Withdrawal by Subject|2|||
16308729|NCT00503698|39615546|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
16308730|NCT00503698|39615547|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
16308731|NCT00503698|39615546|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
16308732|NCT00503698|39615547|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
16308733|NCT00503698|39615546|FG000|Overall Study|Any condition in exclusion criteria|4|||
16308734|NCT00503698|39615547|FG001|Overall Study|Any condition in exclusion criteria|6|||
16308735|NCT00503698|39615546|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
16308736|NCT00503698|39615547|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
16308737|NCT00503698|39615546|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
16308738|NCT00503698|39615547|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
16308739|NCT00503698|39615546|FG000|Overall Study|Critically ill|2|||
16308740|NCT00503698|39615547|FG001|Overall Study|Critically ill|0|||
16308741|NCT00503698|39615546|FG000|Overall Study|Unclassified|48|||
16308742|NCT00503698|39615547|FG001|Overall Study|Unclassified|32|||
16308743|NCT00503698|39615546|FG000|Overall Study|Not exposed to trial drug|11|||
16308744|NCT00503698|39615547|FG001|Overall Study|Not exposed to trial drug|6|||
16308745|NCT04841577|39615548|FG000|Overall Study|Adverse Event|5|||
16308746|NCT04841577|39615549|FG001|Overall Study|Adverse Event|10|||
16308747|NCT04841577|39615548|FG000|Overall Study|Lost to Follow-up|8|||
16308748|NCT04841577|39615549|FG001|Overall Study|Lost to Follow-up|7|||
16308749|NCT04841577|39615548|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
16308750|NCT04841577|39615549|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
16308751|NCT04841577|39615548|FG000|Overall Study|Other|0|||
16308752|NCT04841577|39615549|FG001|Overall Study|Other|1|||
16308753|NCT02500043|39615550|FG000|Overall Study|Randomized, but not Treated|2|||
16308754|NCT02500043|39615551|FG001|Overall Study|Randomized, but not Treated|2|||
16308755|NCT02500043|39615550|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
16308756|NCT02500043|39615551|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
16308757|NCT02500043|39615550|FG000|Overall Study|Adverse Event|33|||
16308758|NCT02500043|39615551|FG001|Overall Study|Adverse Event|11|||
16308759|NCT02500043|39615550|FG000|Overall Study|Clinical Progression|54|||
16308760|NCT02500043|39615551|FG001|Overall Study|Clinical Progression|35|||
16308761|NCT02500043|39615550|FG000|Overall Study|Radiological Progression|192|||
16308762|NCT02500043|39615551|FG001|Overall Study|Radiological Progression|110|||
16308763|NCT02500043|39615550|FG000|Overall Study|Physician's Decision|11|||
16308764|NCT02500043|39615551|FG001|Overall Study|Physician's Decision|3|||
16497168|NCT01195415|40291324|FG000|Overall Study|No repeat biopsy due to progression|2|||
16497169|NCT02282020|40291325|FG000|Overall Study|Objective Disease Progression|128|||
16308765|NCT02500043|39615550|FG000|Overall Study|Withdrawal by Subject|14|||
16308766|NCT02500043|39615551|FG001|Overall Study|Withdrawal by Subject|4|||
16497170|NCT02282020|40291326|FG001|Overall Study|Objective Disease Progression|30|||
16086925|NCT01499849|38810564|FG001|Overall Study|Protocol Violation|11|||
16497171|NCT02282020|40291325|FG000|Overall Study|Adverse Event|18|||
16497172|NCT02282020|40291326|FG001|Overall Study|Adverse Event|15|||
16308767|NCT02500043|39615550|FG000|Overall Study|Death|11|||
16308768|NCT02500043|39615551|FG001|Overall Study|Death|2|||
16308769|NCT02500043|39615550|FG000|Overall Study|Protocol Deviation|1|||
16308770|NCT02500043|39615551|FG001|Overall Study|Protocol Deviation|0|||
16308771|NCT02094417|39615552|FG000|Overall Study|Adverse Event|0|||
16308772|NCT02094417|39615553|FG001|Overall Study|Adverse Event|0|||
16388580|NCT03745638|39905696|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16388581|NCT03745638|39905697|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16388582|NCT03745638|39905698|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
16388583|NCT03745638|39905699|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16388584|NCT03745638|39905693|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16388585|NCT03745638|39905694|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16388586|NCT03745638|39905695|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16388587|NCT03745638|39905696|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
16388588|NCT03745638|39905697|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
16388589|NCT03745638|39905698|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
16388590|NCT03745638|39905699|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
16388591|NCT03745638|39905693|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
16388592|NCT03745638|39905694|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
16388593|NCT03745638|39905695|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
16388594|NCT03745638|39905696|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
16388595|NCT03745638|39905697|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
16388596|NCT03745638|39905698|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
16388597|NCT03745638|39905699|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
16388598|NCT02175277|39905700|FG000|Overall Study|Protocol-specified Criteria|1|||
16388599|NCT02479880|39905701|FG000|Overall Study|Study Terminated by Sponsor|13|||
16308773|NCT02094417|39615554|FG002|Overall Study|Adverse Event|0|||
16308774|NCT02094417|39615555|FG003|Overall Study|Adverse Event|1|||
16388600|NCT02479880|39905702|FG001|Overall Study|Study Terminated by Sponsor|12|||
16388601|NCT02479880|39905701|FG000|Overall Study|Pregnancy|0|||
16388602|NCT02479880|39905702|FG001|Overall Study|Pregnancy|1|||
16388603|NCT00881894|39905703|FG000|Overall Study|Consent withdrawn|0|||
16388604|NCT00881894|39905704|FG001|Overall Study|Consent withdrawn|1|||
16388605|NCT00881894|39905703|FG000|Overall Study|Other reasons for premature termination|1|||
16388606|NCT00881894|39905704|FG001|Overall Study|Other reasons for premature termination|2|||
16388607|NCT00698828|39905705|FG000|Overall Study|Adverse Event|3|||
16388608|NCT00698828|39905706|FG001|Overall Study|Adverse Event|4|||
16388609|NCT00698828|39905707|FG002|Overall Study|Adverse Event|4|||
16388610|NCT00698828|39905705|FG000|Overall Study|Death|0|||
16388611|NCT00698828|39905706|FG001|Overall Study|Death|0|||
16388612|NCT00698828|39905707|FG002|Overall Study|Death|1|||
16388613|NCT00698828|39905705|FG000|Overall Study|Exacerbation of COPD|1|||
16388614|NCT00698828|39905706|FG001|Overall Study|Exacerbation of COPD|3|||
16388615|NCT00698828|39905707|FG002|Overall Study|Exacerbation of COPD|0|||
16388616|NCT00698828|39905705|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
16388617|NCT00698828|39905706|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
16388618|NCT00698828|39905707|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
16388619|NCT00698828|39905705|FG000|Overall Study|Investigator/Sponsor decision|1|||
16388620|NCT00698828|39905706|FG001|Overall Study|Investigator/Sponsor decision|0|||
16388621|NCT00698828|39905707|FG002|Overall Study|Investigator/Sponsor decision|2|||
16308775|NCT02094417|39615552|FG000|Overall Study|Eligibility criteria|0|||
16308776|NCT02094417|39615553|FG001|Overall Study|Eligibility criteria|1|||
16497173|NCT02282020|40291325|FG000|Overall Study|Withdrawal by Subject|7|||
16497174|NCT02282020|40291326|FG001|Overall Study|Withdrawal by Subject|10|||
16497175|NCT02282020|40291325|FG000|Overall Study|Miscellaneous|5|||
16497176|NCT02282020|40291326|FG001|Overall Study|Miscellaneous|19|||
16497177|NCT02282020|40291325|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
16497178|NCT02282020|40291326|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
16497179|NCT02282020|40291325|FG000|Overall Study|Developed Discontinuation Criteria|0|||
16497180|NCT02282020|40291326|FG001|Overall Study|Developed Discontinuation Criteria|2|||
16497181|NCT02282020|40291325|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
16497182|NCT02282020|40291326|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
16497183|NCT00533845|40291333|FG000|Overall Study|Physician Decision|1|||
16497184|NCT00533845|40291334|FG001|Overall Study|Physician Decision|0|||
16497185|NCT04501666|40291337|FG000|Overall Study|Physician Decision|0|||
16497186|NCT04501666|40291338|FG001|Overall Study|Physician Decision|1|||
16497187|NCT04501666|40291337|FG000|Overall Study|Adverse Event|12|||
16497188|NCT04501666|40291338|FG001|Overall Study|Adverse Event|4|||
16086926|NCT01499849|38810563|FG000|Overall Study|Physician Decision|20|||
16194718|NCT00701727|39188824|FG001|Second Treatment Period|Withdrawal by Subject|0|||
16308777|NCT02094417|39615554|FG002|Overall Study|Eligibility criteria|0|||
16308778|NCT02094417|39615555|FG003|Overall Study|Eligibility criteria|0|||
16388622|NCT00698828|39905705|FG000|Overall Study|Lost to Follow-up|1|||
16388623|NCT00698828|39905706|FG001|Overall Study|Lost to Follow-up|1|||
16388624|NCT00698828|39905707|FG002|Overall Study|Lost to Follow-up|0|||
16308779|NCT02094417|39615552|FG000|Overall Study|No responder|4|||
16308780|NCT02094417|39615553|FG001|Overall Study|No responder|4|||
16308781|NCT02094417|39615554|FG002|Overall Study|No responder|4|||
16308782|NCT02094417|39615555|FG003|Overall Study|No responder|3|||
16497189|NCT04501666|40291337|FG000|Overall Study|Subject's request|10|||
16497190|NCT04501666|40291338|FG001|Overall Study|Subject's request|6|||
16497191|NCT04501666|40291337|FG000|Overall Study|Protocol Deviation|2|||
16497192|NCT04501666|40291338|FG001|Overall Study|Protocol Deviation|1|||
16497193|NCT04501666|40291337|FG000|Overall Study|Other-- site permanently closing|0|||
16497194|NCT04501666|40291338|FG001|Overall Study|Other-- site permanently closing|1|||
16497195|NCT02663674|40291339|FG000|Overall Study|Lost to Follow-up|5|||
16497196|NCT02663674|40291340|FG001|Overall Study|Lost to Follow-up|4|||
16497197|NCT02663674|40291339|FG000|Overall Study|Withdrawal by Subject|1|||
16497198|NCT02663674|40291340|FG001|Overall Study|Withdrawal by Subject|4|||
16497199|NCT02663674|40291339|FG000|Overall Study|Physician Decision|1|||
16497200|NCT02663674|40291340|FG001|Overall Study|Physician Decision|1|||
16497201|NCT02663674|40291339|FG000|Overall Study|Other Event (Health Related)|0|||
16308783|NCT02094417|39615552|FG000|Overall Study|Unable to conduct observations or assess|0|||
16308784|NCT02094417|39615553|FG001|Overall Study|Unable to conduct observations or assess|1|||
16308785|NCT02094417|39615554|FG002|Overall Study|Unable to conduct observations or assess|0|||
16308786|NCT02094417|39615555|FG003|Overall Study|Unable to conduct observations or assess|0|||
16308787|NCT02094417|39615552|FG000|Overall Study|Withdrawal by Subject|1|||
16308788|NCT02094417|39615553|FG001|Overall Study|Withdrawal by Subject|2|||
16308789|NCT02094417|39615554|FG002|Overall Study|Withdrawal by Subject|1|||
16308790|NCT02094417|39615555|FG003|Overall Study|Withdrawal by Subject|3|||
16308791|NCT01127256|39615557|FG000|Overall Study|Adverse Event|13|||
16308792|NCT01127256|39615558|FG001|Overall Study|Adverse Event|13|||
16308793|NCT01127256|39615557|FG000|Overall Study|Lack of Efficacy|4|||
16308794|NCT01127256|39615558|FG001|Overall Study|Lack of Efficacy|0|||
16308795|NCT01127256|39615557|FG000|Overall Study|Lost to Follow-up|16|||
16308796|NCT01127256|39615558|FG001|Overall Study|Lost to Follow-up|17|||
16308797|NCT01127256|39615557|FG000|Overall Study|Withdrawal by Subject|5|||
16308798|NCT01127256|39615558|FG001|Overall Study|Withdrawal by Subject|9|||
16308799|NCT01127256|39615557|FG000|Overall Study|Protocol Violation|1|||
16308800|NCT01127256|39615558|FG001|Overall Study|Protocol Violation|0|||
16308801|NCT03293680|39615559|FG000|Overall Study|Death|1|||
16308802|NCT03293680|39615559|FG000|Overall Study|Did not meet inclusion criteria|8|||
16308803|NCT03593395|39615560|FG000|Overall Study|Lost to Follow-up|48|||
16308804|NCT03593395|39615561|FG001|Overall Study|Lost to Follow-up|3|||
16308805|NCT03593395|39615560|FG000|Overall Study|Withdrawal by Subject|5|||
16308806|NCT03593395|39615561|FG001|Overall Study|Withdrawal by Subject|24|||
16308807|NCT03593395|39615560|FG000|Overall Study|Death|2|||
16308808|NCT03593395|39615561|FG001|Overall Study|Death|3|||
16308809|NCT03593395|39615560|FG000|Overall Study|Physician Decision|0|||
16308810|NCT03593395|39615561|FG001|Overall Study|Physician Decision|6|||
16308811|NCT03593395|39615560|FG000|Overall Study|Participant Relocated|19|||
16308812|NCT03593395|39615561|FG001|Overall Study|Participant Relocated|3|||
16388625|NCT00698828|39905705|FG000|Overall Study|Withdrew consent|0|||
16388626|NCT00698828|39905706|FG001|Overall Study|Withdrew consent|7|||
16497202|NCT02663674|40291340|FG001|Overall Study|Other Event (Health Related)|1|||
16497203|NCT00842712|40291341|FG000|Safety Run-in Part|Adverse Event|0|||
16086927|NCT01499849|38810564|FG001|Overall Study|Physician Decision|19|||
16308813|NCT03593395|39615560|FG000|Overall Study|No Information|1|||
16308814|NCT03593395|39615561|FG001|Overall Study|No Information|7|||
16308815|NCT04753216|39615562|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
16388627|NCT00698828|39905707|FG002|Overall Study|Withdrew consent|4|||
16497204|NCT00842712|40291342|FG001|Safety Run-in Part|Adverse Event|1|||
16497205|NCT00842712|40291343|FG002|Safety Run-in Part|Adverse Event|0|||
16308816|NCT04753216|39615562|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
16308817|NCT04753216|39615562|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
16308818|NCT03594071|39615564|FG000|Overall Study|Re-operation|3|||
16308819|NCT03594071|39615564|FG000|Overall Study|Missed visit|2|||
16308820|NCT03154125|39615569|FG000|Overall Study|Lost to Follow-up|11|||
16308821|NCT03154125|39615570|FG001|Overall Study|Lost to Follow-up|11|||
16308822|NCT03154125|39615571|FG002|Overall Study|Lost to Follow-up|0|||
16308823|NCT03154125|39615569|FG000|Overall Study|Withdrawal by Subject|49|||
16308824|NCT03154125|39615570|FG001|Overall Study|Withdrawal by Subject|55|||
16388628|NCT00698828|39905705|FG000|Overall Study|Withdrew consent (not treated)|2|||
16388629|NCT00698828|39905706|FG001|Overall Study|Withdrew consent (not treated)|0|||
16388630|NCT00698828|39905707|FG002|Overall Study|Withdrew consent (not treated)|0|||
16308825|NCT03154125|39615571|FG002|Overall Study|Withdrawal by Subject|8|||
16308826|NCT03154125|39615569|FG000|Overall Study|Physician Decision|13|||
16308827|NCT03154125|39615570|FG001|Overall Study|Physician Decision|6|||
16308828|NCT03154125|39615571|FG002|Overall Study|Physician Decision|0|||
16308829|NCT03154125|39615569|FG000|Overall Study|Protocol Violation|3|||
16308830|NCT03154125|39615570|FG001|Overall Study|Protocol Violation|5|||
16308831|NCT03154125|39615571|FG002|Overall Study|Protocol Violation|0|||
16308832|NCT00356525|39615572|FG000|Overall Study|Progressive Disease|8|||
16308833|NCT00356525|39615573|FG001|Overall Study|Progressive Disease|5|||
16308834|NCT00356525|39615574|FG002|Overall Study|Progressive Disease|4|||
16308835|NCT00356525|39615575|FG003|Overall Study|Progressive Disease|2|||
16308836|NCT00356525|39615572|FG000|Overall Study|Adverse Event|1|||
16308837|NCT00356525|39615573|FG001|Overall Study|Adverse Event|3|||
16308838|NCT00356525|39615574|FG002|Overall Study|Adverse Event|1|||
16308839|NCT00356525|39615575|FG003|Overall Study|Adverse Event|1|||
16308840|NCT00356525|39615572|FG000|Overall Study|Lost to Follow-up|1|||
16308841|NCT00356525|39615573|FG001|Overall Study|Lost to Follow-up|0|||
16308842|NCT00356525|39615574|FG002|Overall Study|Lost to Follow-up|0|||
16308843|NCT00356525|39615575|FG003|Overall Study|Lost to Follow-up|0|||
16308844|NCT00356525|39615572|FG000|Overall Study|Physician Decision|2|||
16308845|NCT00356525|39615573|FG001|Overall Study|Physician Decision|2|||
16308846|NCT00356525|39615574|FG002|Overall Study|Physician Decision|2|||
16308847|NCT00356525|39615575|FG003|Overall Study|Physician Decision|1|||
16308848|NCT00356525|39615572|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
16308849|NCT00356525|39615573|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
16308850|NCT00356525|39615574|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
16308851|NCT00356525|39615575|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
16308852|NCT00356525|39615572|FG000|Overall Study|Withdrawal by Subject|1|||
16308853|NCT00356525|39615573|FG001|Overall Study|Withdrawal by Subject|1|||
16308854|NCT00356525|39615574|FG002|Overall Study|Withdrawal by Subject|0|||
16308855|NCT00356525|39615575|FG003|Overall Study|Withdrawal by Subject|3|||
16308856|NCT00356525|39615572|FG000|Overall Study|Death|0|||
16308857|NCT00356525|39615573|FG001|Overall Study|Death|0|||
16308858|NCT00356525|39615574|FG002|Overall Study|Death|0|||
16308859|NCT00356525|39615575|FG003|Overall Study|Death|1|||
16308860|NCT00356525|39615572|FG000|Overall Study|Sponsor Decision|0|||
16308861|NCT00356525|39615573|FG001|Overall Study|Sponsor Decision|0|||
16308862|NCT00356525|39615574|FG002|Overall Study|Sponsor Decision|0|||
16308863|NCT00356525|39615575|FG003|Overall Study|Sponsor Decision|1|||
16308864|NCT01372748|39615576|FG000|Overall Study|Lost to Follow-up|16|||
16308865|NCT01372748|39615577|FG001|Overall Study|Lost to Follow-up|34|||
16308866|NCT01372748|39615576|FG000|Overall Study|Withdrawal by Subject|7|||
16308867|NCT01372748|39615577|FG001|Overall Study|Withdrawal by Subject|5|||
16308868|NCT00289848|39615578|FG000|Overall Study|Adverse Event|6|||
16388631|NCT01331681|39905711|FG000|Overall Study|Adverse Event|10|||
16388632|NCT01331681|39905712|FG001|Overall Study|Adverse Event|13|||
16388633|NCT01331681|39905713|FG002|Overall Study|Adverse Event|10|||
16388634|NCT01331681|39905711|FG000|Overall Study|Death|6|||
16388635|NCT01331681|39905712|FG001|Overall Study|Death|6|||
16388636|NCT01331681|39905713|FG002|Overall Study|Death|2|||
16388637|NCT01331681|39905711|FG000|Overall Study|Lack of Efficacy|0|||
16388638|NCT01331681|39905712|FG001|Overall Study|Lack of Efficacy|1|||
16388639|NCT01331681|39905713|FG002|Overall Study|Lack of Efficacy|0|||
16308869|NCT00289848|39615579|FG001|Overall Study|Adverse Event|4|||
16308870|NCT00289848|39615578|FG000|Overall Study|Death|1|||
16308871|NCT00289848|39615579|FG001|Overall Study|Death|0|||
16308872|NCT00289848|39615578|FG000|Overall Study|Lack of Efficacy|20|||
16308873|NCT00289848|39615579|FG001|Overall Study|Lack of Efficacy|24|||
16388640|NCT01331681|39905711|FG000|Overall Study|Withdrawal by Subject|12|||
16308874|NCT00289848|39615578|FG000|Overall Study|Lost to Follow-up|3|||
16308875|NCT00289848|39615579|FG001|Overall Study|Lost to Follow-up|1|||
16308876|NCT00289848|39615578|FG000|Overall Study|Protocol Violation|5|||
16308877|NCT00289848|39615579|FG001|Overall Study|Protocol Violation|2|||
16308878|NCT00289848|39615578|FG000|Overall Study|Withdrawal by Subject|5|||
16308879|NCT00289848|39615579|FG001|Overall Study|Withdrawal by Subject|11|||
16308880|NCT00289848|39615578|FG000|Overall Study|Patient Moved|6|||
16308881|NCT00289848|39615579|FG001|Overall Study|Patient Moved|2|||
16497206|NCT00842712|40291344|FG003|Safety Run-in Part|Adverse Event|0|||
16497207|NCT00842712|40291345|FG004|Safety Run-in Part|Adverse Event|0|||
16497208|NCT00842712|40291346|FG005|Safety Run-in Part|Adverse Event|0|||
16497209|NCT00842712|40291347|FG006|Safety Run-in Part|Adverse Event|0|||
16497210|NCT00842712|40291341|FG000|Safety Run-in Part|Progressive disease|3|||
16497211|NCT00842712|40291342|FG001|Safety Run-in Part|Progressive disease|1|||
16497212|NCT00842712|40291343|FG002|Safety Run-in Part|Progressive disease|0|||
16497213|NCT00842712|40291344|FG003|Safety Run-in Part|Progressive disease|1|||
16497214|NCT00842712|40291345|FG004|Safety Run-in Part|Progressive disease|0|||
16497215|NCT00842712|40291346|FG005|Safety Run-in Part|Progressive disease|0|||
16497216|NCT00842712|40291347|FG006|Safety Run-in Part|Progressive disease|0|||
16497217|NCT00842712|40291341|FG000|Randomized Part|Randomized but not treated|0|||
16497218|NCT00842712|40291342|FG001|Randomized Part|Randomized but not treated|0|||
16497219|NCT00842712|40291343|FG002|Randomized Part|Randomized but not treated|0|||
16497220|NCT00842712|40291344|FG003|Randomized Part|Randomized but not treated|0|||
16497221|NCT00842712|40291345|FG004|Randomized Part|Randomized but not treated|0|||
16497222|NCT00842712|40291346|FG005|Randomized Part|Randomized but not treated|1|||
16497223|NCT00842712|40291347|FG006|Randomized Part|Randomized but not treated|4|||
16497224|NCT00842712|40291341|FG000|Randomized Part|Ongoing at cut-off date|0|||
16497225|NCT00842712|40291342|FG001|Randomized Part|Ongoing at cut-off date|0|||
16497226|NCT00842712|40291343|FG002|Randomized Part|Ongoing at cut-off date|0|||
16497227|NCT00842712|40291344|FG003|Randomized Part|Ongoing at cut-off date|0|||
16497228|NCT00842712|40291345|FG004|Randomized Part|Ongoing at cut-off date|0|||
16497229|NCT00842712|40291346|FG005|Randomized Part|Ongoing at cut-off date|0|||
16497230|NCT00842712|40291347|FG006|Randomized Part|Ongoing at cut-off date|2|||
16497231|NCT02005445|40291354|FG000|Overall Study|Dual study enrollment|0|||
16497232|NCT02005445|40291355|FG001|Overall Study|Dual study enrollment|1|||
16497233|NCT04532164|40291356|FG000|Overall Study|Adverse Event|1|||
16497234|NCT04532164|40291356|FG000|Overall Study|Protocol Violation|5|||
16497235|NCT04532164|40291356|FG000|Overall Study|Lost to Follow-up|1|||
16497236|NCT04532164|40291356|FG000|Overall Study|Found to be Ineligible|3|||
16497237|NCT04532164|40291356|FG000|Overall Study|Withdrawal by Subject|14|||
16497238|NCT02041286|40291357|FG000|Overall Study|Adverse Event|1|||
16497239|NCT02548650|40291358|FG000|Triple Therapy|Adverse Event|1|||
16497240|NCT02548650|40291359|FG001|Triple Therapy|Adverse Event|0|||
16497241|NCT02548650|40291358|FG000|Triple Therapy|Withdrawal by Subject|0|||
16497242|NCT02548650|40291359|FG001|Triple Therapy|Withdrawal by Subject|4|||
16497243|NCT02548650|40291358|FG000|Double Therapy|Adverse Event|1|||
16497244|NCT02548650|40291359|FG001|Double Therapy|Adverse Event|1|||
16497245|NCT02548650|40291358|FG000|Double Therapy|Withdrawal by Subject|0|||
16497246|NCT02548650|40291359|FG001|Double Therapy|Withdrawal by Subject|1|||
16497247|NCT00770289|40291364|FG000|Overall Study|Other|6|||
16497248|NCT04271605|40291365|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
16497249|NCT00881712|40291366|FG000|Overall Study|Death|1|||
16497250|NCT00881712|40291367|FG001|Overall Study|Death|0|||
16497251|NCT00881712|40291368|FG002|Overall Study|Death|0|||
16497252|NCT00881712|40291366|FG000|Overall Study|Withdrawal by Subject|1|||
16497253|NCT00881712|40291367|FG001|Overall Study|Withdrawal by Subject|0|||
16497254|NCT00881712|40291368|FG002|Overall Study|Withdrawal by Subject|0|||
16497255|NCT05035550|40291374|FG000|Overall Study|Withdrawal by Subject|3|||
16497256|NCT05035550|40291375|FG001|Overall Study|Withdrawal by Subject|0|||
16497257|NCT02642614|40291380|FG000|Overall Study|Adverse Event|1|||
16497258|NCT02642614|40291381|FG001|Overall Study|Adverse Event|1|||
16497259|NCT02642614|40291382|FG002|Overall Study|Adverse Event|2|||
16497260|NCT02642614|40291383|FG003|Overall Study|Adverse Event|2|||
16497261|NCT02642614|40291380|FG000|Overall Study|Lost to Follow-up|1|||
16497262|NCT02642614|40291381|FG001|Overall Study|Lost to Follow-up|0|||
16497263|NCT02642614|40291382|FG002|Overall Study|Lost to Follow-up|0|||
16497264|NCT02642614|40291383|FG003|Overall Study|Lost to Follow-up|0|||
16497265|NCT02642614|40291380|FG000|Overall Study|Withdrawal by Subject|1|||
16497266|NCT02642614|40291381|FG001|Overall Study|Withdrawal by Subject|1|||
16497267|NCT02642614|40291382|FG002|Overall Study|Withdrawal by Subject|0|||
16497268|NCT02642614|40291383|FG003|Overall Study|Withdrawal by Subject|0|||
16497269|NCT00531050|40291384|FG000|Part 1: Period 1|Adverse Event|0|||
16497270|NCT00531050|40291385|FG001|Part 1: Period 1|Adverse Event|1|||
16497271|NCT00531050|40291386|FG002|Part 1: Period 1|Adverse Event|0|||
16497272|NCT00531050|40291387|FG003|Part 1: Period 1|Adverse Event|0|||
16497273|NCT00531050|40291388|FG004|Part 1: Period 1|Adverse Event|0|||
16497274|NCT00531050|40291389|FG005|Part 1: Period 1|Adverse Event|0|||
16497275|NCT00531050|40291384|FG000|Part 1: Period 1|Protocol Deviation|0|||
16497276|NCT00531050|40291385|FG001|Part 1: Period 1|Protocol Deviation|0|||
16497277|NCT00531050|40291386|FG002|Part 1: Period 1|Protocol Deviation|0|||
16497278|NCT00531050|40291387|FG003|Part 1: Period 1|Protocol Deviation|1|||
16497279|NCT00531050|40291388|FG004|Part 1: Period 1|Protocol Deviation|0|||
16497280|NCT00531050|40291389|FG005|Part 1: Period 1|Protocol Deviation|0|||
16497281|NCT00531050|40291384|FG000|Part 1: Period 3|Adverse Event|1|||
16497282|NCT00531050|40291385|FG001|Part 1: Period 3|Adverse Event|0|||
16497283|NCT00531050|40291386|FG002|Part 1: Period 3|Adverse Event|0|||
16497284|NCT00531050|40291387|FG003|Part 1: Period 3|Adverse Event|0|||
16497285|NCT00531050|40291388|FG004|Part 1: Period 3|Adverse Event|0|||
16497286|NCT00531050|40291389|FG005|Part 1: Period 3|Adverse Event|0|||
16497287|NCT00531050|40291384|FG000|Part 2: Period 1|Adverse Event|0|||
16497288|NCT00531050|40291385|FG001|Part 2: Period 1|Adverse Event|0|||
16497289|NCT00531050|40291386|FG002|Part 2: Period 1|Adverse Event|0|||
16497290|NCT00531050|40291387|FG003|Part 2: Period 1|Adverse Event|0|||
16497291|NCT00531050|40291388|FG004|Part 2: Period 1|Adverse Event|0|||
16497292|NCT00531050|40291389|FG005|Part 2: Period 1|Adverse Event|1|||
16497293|NCT00531050|40291384|FG000|Part 2: Period 3|Abnormal test procedure|1|||
16497294|NCT00531050|40291385|FG001|Part 2: Period 3|Abnormal test procedure|0|||
16497295|NCT00531050|40291386|FG002|Part 2: Period 3|Abnormal test procedure|0|||
16497296|NCT00531050|40291387|FG003|Part 2: Period 3|Abnormal test procedure|0|||
16497297|NCT00531050|40291388|FG004|Part 2: Period 3|Abnormal test procedure|0|||
16497298|NCT00531050|40291389|FG005|Part 2: Period 3|Abnormal test procedure|1|||
16497299|NCT03958955|40295304|FG000|Overall Study|Adverse Event|1|||
16497300|NCT00512707|40295305|FG000|Overall Study|Lost to Follow-up|5|||
16497301|NCT00512707|40295306|FG001|Overall Study|Lost to Follow-up|11|||
16497302|NCT00512707|40295305|FG000|Overall Study|Developed skin irritation|2|||
16497303|NCT00512707|40295306|FG001|Overall Study|Developed skin irritation|1|||
16497304|NCT00512707|40295305|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
16497305|NCT00512707|40295306|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
16497306|NCT00512707|40295305|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
16308882|NCT00289848|39615578|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
16308883|NCT00289848|39615579|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
16308884|NCT01870778|39615584|FG000|Overall Study|Withdrawal by Subject|8|||
16308885|NCT01870778|39615585|FG001|Overall Study|Withdrawal by Subject|7|||
16308886|NCT01870778|39615584|FG000|Overall Study|Lost to Follow-up|0|||
16308887|NCT01870778|39615585|FG001|Overall Study|Lost to Follow-up|2|||
16388641|NCT01331681|39905712|FG001|Overall Study|Withdrawal by Subject|8|||
16388642|NCT01331681|39905713|FG002|Overall Study|Withdrawal by Subject|15|||
16388643|NCT01331681|39905711|FG000|Overall Study|Protocol Violation|1|||
16388644|NCT01331681|39905712|FG001|Overall Study|Protocol Violation|1|||
16388645|NCT01331681|39905713|FG002|Overall Study|Protocol Violation|0|||
16388646|NCT01331681|39905711|FG000|Overall Study|Lost to Follow-up|2|||
16388647|NCT01331681|39905712|FG001|Overall Study|Lost to Follow-up|4|||
16388648|NCT01331681|39905713|FG002|Overall Study|Lost to Follow-up|1|||
16086928|NCT01499849|38810563|FG000|Overall Study|Lack of Efficacy|3|||
16308888|NCT00462904|39615586|FG000|Overall Study|Lost to Follow-up|1|||
16308889|NCT00100828|39615587|FG000|Overall Study|Physician Decision|6|||
16308890|NCT00711087|39615594|FG000|Overall Study|Lost to Follow-up|1|||
16308891|NCT00711087|39615595|FG001|Overall Study|Lost to Follow-up|0|||
16308892|NCT04619004|39615596|FG000|Overall Study|Death|114|||
16308893|NCT04619004|39615597|FG001|Overall Study|Death|28|||
16308894|NCT04619004|39615596|FG000|Overall Study|Lost to Follow-up|1|||
16308895|NCT04619004|39615597|FG001|Overall Study|Lost to Follow-up|1|||
16308896|NCT04619004|39615596|FG000|Overall Study|Withdrawal by Subject|24|||
16308897|NCT04619004|39615597|FG001|Overall Study|Withdrawal by Subject|7|||
16308898|NCT04619004|39615596|FG000|Overall Study|Other - Not specified|0|||
16308899|NCT04619004|39615597|FG001|Overall Study|Other - Not specified|1|||
16308900|NCT01924689|39615598|FG000|Overall Study|Death|0|||
16308901|NCT01924689|39615599|FG001|Overall Study|Death|1|||
16308902|NCT01924689|39615600|FG002|Overall Study|Death|0|||
16308903|NCT01924689|39615601|FG003|Overall Study|Death|1|||
16308904|NCT01924689|39615602|FG004|Overall Study|Death|0|||
16308905|NCT01924689|39615603|FG005|Overall Study|Death|0|||
16308906|NCT01924689|39615598|FG000|Overall Study|Disease progression|0|||
16308907|NCT01924689|39615599|FG001|Overall Study|Disease progression|0|||
16388649|NCT01331681|39905711|FG000|Overall Study|Physician Decision|2|||
16388650|NCT01331681|39905712|FG001|Overall Study|Physician Decision|0|||
16388651|NCT01331681|39905713|FG002|Overall Study|Physician Decision|4|||
16497307|NCT00512707|40295306|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
16497308|NCT01846611|40295307|FG000|Overall Study|Lost to Follow-up|4|||
16086929|NCT01499849|38810564|FG001|Overall Study|Lack of Efficacy|4|||
16388652|NCT01331681|39905711|FG000|Overall Study|Therapeutic procedure required|1|||
16497309|NCT01846611|40295308|FG001|Overall Study|Lost to Follow-up|6|||
16497310|NCT01846611|40295307|FG000|Overall Study|Withdrawal by Subject|15|||
16497311|NCT01846611|40295308|FG001|Overall Study|Withdrawal by Subject|19|||
16308908|NCT01924689|39615600|FG002|Overall Study|Disease progression|2|||
16308909|NCT01924689|39615601|FG003|Overall Study|Disease progression|0|||
16308910|NCT01924689|39615602|FG004|Overall Study|Disease progression|3|||
16308911|NCT01924689|39615603|FG005|Overall Study|Disease progression|2|||
16308912|NCT01924689|39615598|FG000|Overall Study|New therapy or study|3|||
16497312|NCT01846611|40295307|FG000|Overall Study|Other|19|||
16497313|NCT01846611|40295308|FG001|Overall Study|Other|18|||
16497314|NCT03654651|40295311|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
16497315|NCT03654651|40295312|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
16497316|NCT01001377|40295314|FG000|Overall Study|Ineligibility determined|2|||
16497317|NCT01001377|40295315|FG001|Overall Study|Ineligibility determined|0|||
16497318|NCT01001377|40295314|FG000|Overall Study|Withdrawal by Subject|19|||
16497319|NCT01001377|40295315|FG001|Overall Study|Withdrawal by Subject|20|||
16497320|NCT01001377|40295314|FG000|Overall Study|Lost to Follow-up|14|||
16497321|NCT01001377|40295315|FG001|Overall Study|Lost to Follow-up|17|||
16497322|NCT01001377|40295314|FG000|Overall Study|Death|391|||
16497323|NCT01001377|40295315|FG001|Overall Study|Death|384|||
16497324|NCT01846507|40295318|FG000|Overall Study|Lost to Follow-up|4|||
16497325|NCT01846507|40295318|FG000|Overall Study|Protocol Violation|1|||
16497326|NCT01846507|40295318|FG000|Overall Study|Missing data|2|||
16497327|NCT01751867|40295321|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
16497328|NCT01751867|40295322|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
16497329|NCT01751867|40295321|FG000|Overall Study|Diease Progression|4|||
16497330|NCT01751867|40295322|FG001|Overall Study|Diease Progression|18|||
16497331|NCT01751867|40295321|FG000|Overall Study|Adverse Event|8|||
16497332|NCT01751867|40295322|FG001|Overall Study|Adverse Event|15|||
16497333|NCT01751867|40295321|FG000|Overall Study|Poor Compliance|0|||
16497334|NCT01751867|40295322|FG001|Overall Study|Poor Compliance|5|||
16497335|NCT01751867|40295321|FG000|Overall Study|Withdrawal by Subject|3|||
16497336|NCT01751867|40295322|FG001|Overall Study|Withdrawal by Subject|1|||
16497337|NCT01751867|40295321|FG000|Overall Study|Physician Decision|4|||
16497338|NCT01751867|40295322|FG001|Overall Study|Physician Decision|7|||
16497339|NCT01751867|40295321|FG000|Overall Study|Protocol Violation|0|||
16497340|NCT01751867|40295322|FG001|Overall Study|Protocol Violation|2|||
16497341|NCT01751867|40295321|FG000|Overall Study|Death|0|||
16497342|NCT01751867|40295322|FG001|Overall Study|Death|5|||
16497343|NCT01751867|40295321|FG000|Overall Study|Other|11|||
16497344|NCT01751867|40295322|FG001|Overall Study|Other|37|||
16497345|NCT01751867|40295321|FG000|Overall Study|Randomized but not treated.|2|||
16497346|NCT01751867|40295322|FG001|Overall Study|Randomized but not treated.|1|||
16497347|NCT00380978|40295324|FG000|Overall Study|Refused allocated intervention|0|||
16497348|NCT00380978|40295325|FG001|Overall Study|Refused allocated intervention|6|||
16497349|NCT00380978|40295324|FG000|Overall Study|Wrong study envelope|0|||
16497350|NCT00380978|40295325|FG001|Overall Study|Wrong study envelope|2|||
16497351|NCT00380978|40295324|FG000|Overall Study|Allocation prior to analgesia request|1|||
16497352|NCT00380978|40295325|FG001|Overall Study|Allocation prior to analgesia request|2|||
16497353|NCT00380978|40295324|FG000|Overall Study|Parous patient|1|||
16497354|NCT00380978|40295325|FG001|Overall Study|Parous patient|0|||
16497355|NCT02357901|40295326|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
16497356|NCT02357901|40295327|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
16497357|NCT02357901|40295328|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
16497358|NCT02357901|40295329|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
16497359|NCT02357901|40295326|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
16497360|NCT02357901|40295327|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
16497361|NCT02357901|40295328|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
16497362|NCT02357901|40295329|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
16497363|NCT02357901|40295326|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
16497364|NCT02357901|40295327|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
16497365|NCT02357901|40295328|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
16497366|NCT02357901|40295329|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
16497367|NCT02357901|40295326|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
16497368|NCT02357901|40295327|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
16497369|NCT02357901|40295328|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
16497370|NCT02357901|40295329|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
16497371|NCT02357901|40295326|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
16497372|NCT02357901|40295327|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
16497373|NCT02357901|40295328|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
16497374|NCT02357901|40295329|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
16497375|NCT02357901|40295326|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
16497376|NCT02357901|40295327|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
16497377|NCT02357901|40295328|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
16497378|NCT02357901|40295329|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
16497379|NCT02357901|40295326|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
16497380|NCT02357901|40295327|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
16497381|NCT02357901|40295328|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
16497382|NCT02357901|40295329|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
16497383|NCT02357901|40295326|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
16308913|NCT01924689|39615599|FG001|Overall Study|New therapy or study|2|||
16308914|NCT01924689|39615600|FG002|Overall Study|New therapy or study|1|||
16308915|NCT01924689|39615601|FG003|Overall Study|New therapy or study|4|||
16308916|NCT01924689|39615602|FG004|Overall Study|New therapy or study|2|||
16308917|NCT01924689|39615603|FG005|Overall Study|New therapy or study|0|||
16308918|NCT01924689|39615598|FG000|Overall Study|Withdrawal of consent|0|||
16308919|NCT01924689|39615599|FG001|Overall Study|Withdrawal of consent|0|||
16308920|NCT01924689|39615600|FG002|Overall Study|Withdrawal of consent|1|||
16308921|NCT01924689|39615601|FG003|Overall Study|Withdrawal of consent|1|||
16308922|NCT01924689|39615602|FG004|Overall Study|Withdrawal of consent|0|||
16308923|NCT01924689|39615603|FG005|Overall Study|Withdrawal of consent|0|||
16308924|NCT01924689|39615598|FG000|Overall Study|Other|0|||
16308925|NCT01924689|39615599|FG001|Overall Study|Other|0|||
16308926|NCT01924689|39615600|FG002|Overall Study|Other|0|||
16308927|NCT01924689|39615601|FG003|Overall Study|Other|0|||
16308928|NCT01924689|39615602|FG004|Overall Study|Other|1|||
16308929|NCT01924689|39615603|FG005|Overall Study|Other|0|||
16308930|NCT01009814|39615619|FG000|Overall Study|No longer met study criteria|1|||
16308931|NCT01009814|39615620|FG001|Overall Study|No longer met study criteria|1|||
16308932|NCT01009814|39615621|FG002|Overall Study|No longer met study criteria|0|||
16308933|NCT01009814|39615622|FG003|Overall Study|No longer met study criteria|0|||
16308934|NCT01009814|39615623|FG004|Overall Study|No longer met study criteria|0|||
16308935|NCT03993379|39615624|FG000|Overall Study|The study was terminated early due to business decision.|0|||
16308936|NCT03993379|39615625|FG001|Overall Study|The study was terminated early due to business decision.|2|||
16308937|NCT03993379|39615626|FG002|Overall Study|The study was terminated early due to business decision.|0|||
16308938|NCT03993379|39615627|FG003|Overall Study|The study was terminated early due to business decision.|0|||
16308939|NCT03993379|39615624|FG000|Overall Study|Withdrawal by Subject|0|||
16308940|NCT03993379|39615625|FG001|Overall Study|Withdrawal by Subject|1|||
16308941|NCT03993379|39615626|FG002|Overall Study|Withdrawal by Subject|0|||
16308942|NCT03993379|39615627|FG003|Overall Study|Withdrawal by Subject|0|||
16308943|NCT00866359|39615628|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
16308944|NCT00866359|39615629|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
16308945|NCT00866359|39615630|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
16308946|NCT00866359|39615631|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
16308947|NCT00866359|39615628|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
16308948|NCT00866359|39615629|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
16308949|NCT00866359|39615630|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
16308950|NCT00866359|39615631|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
16308951|NCT00866359|39615628|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
16308952|NCT00866359|39615629|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
16308953|NCT00866359|39615630|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
16308954|NCT00866359|39615631|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
16308955|NCT00866359|39615628|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
16308956|NCT00866359|39615629|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
16308957|NCT00866359|39615630|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
16308958|NCT00866359|39615631|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
16308959|NCT00866359|39615628|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
16308960|NCT00866359|39615629|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
16308961|NCT00866359|39615630|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
16308962|NCT00866359|39615631|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
16308963|NCT00866359|39615628|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
16308964|NCT00866359|39615629|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
16308965|NCT00866359|39615630|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
16308966|NCT00866359|39615631|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
16308967|NCT00312338|39615634|FG000|Overall Study|Adverse Event|7|||
16308968|NCT00312338|39615635|FG001|Overall Study|Adverse Event|2|||
16308969|NCT00312338|39615634|FG000|Overall Study|Lost to Follow-up|9|||
16308970|NCT00312338|39615635|FG001|Overall Study|Lost to Follow-up|1|||
16308971|NCT00312338|39615634|FG000|Overall Study|Withdrawal by Subject|4|||
16308972|NCT00312338|39615635|FG001|Overall Study|Withdrawal by Subject|0|||
16308973|NCT00312338|39615634|FG000|Overall Study|Subsequent infection|2|||
16308974|NCT00312338|39615635|FG001|Overall Study|Subsequent infection|0|||
16308975|NCT01396512|39615636|FG000|Overall Study|Withdrawal by Subject|0|||
16308976|NCT01396512|39615637|FG001|Overall Study|Withdrawal by Subject|1|||
16497384|NCT02357901|40295327|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
16546312|NCT02237508|40464776|FG003|Overall Study|Physician Decision|0|||
16194719|NCT04387136|39188825|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
16308977|NCT00925704|39615641|FG000|First Intervention|Withdrew consent|0|||
16308978|NCT00925704|39615642|FG001|First Intervention|Withdrew consent|0|||
16308979|NCT00925704|39615643|FG002|First Intervention|Withdrew consent|0|||
16308980|NCT00925704|39615644|FG003|First Intervention|Withdrew consent|1|||
16308981|NCT00925704|39615645|FG004|First Intervention|Withdrew consent|1|||
16308982|NCT00925704|39615646|FG005|First Intervention|Withdrew consent|0|||
16497385|NCT02357901|40295328|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
16497386|NCT02357901|40295329|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
16497387|NCT02357901|40295326|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
16497388|NCT02357901|40295327|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
16497389|NCT02357901|40295328|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
16497390|NCT02357901|40295329|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
16497391|NCT02357901|40295326|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
16497392|NCT02357901|40295327|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
16497393|NCT02357901|40295328|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
16497394|NCT02357901|40295329|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
16497395|NCT02357901|40295326|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
16497396|NCT02357901|40295327|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
16497397|NCT02357901|40295328|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
16497398|NCT02357901|40295329|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
16497399|NCT01599234|40295332|FG000|Overall Study|Adverse Event|9|||
16497400|NCT01599234|40295333|FG001|Overall Study|Adverse Event|5|||
16497401|NCT01599234|40295332|FG000|Overall Study|Withdrawal by Subject|2|||
16497402|NCT01599234|40295333|FG001|Overall Study|Withdrawal by Subject|1|||
16497403|NCT01599234|40295332|FG000|Overall Study|Lost to Follow-up|1|||
16497404|NCT01599234|40295333|FG001|Overall Study|Lost to Follow-up|2|||
16497405|NCT01599234|40295332|FG000|Overall Study|Lack of Efficacy|2|||
16497406|NCT01599234|40295333|FG001|Overall Study|Lack of Efficacy|4|||
16497407|NCT01599234|40295332|FG000|Overall Study|Unable to operate spray|1|||
16497408|NCT01599234|40295333|FG001|Overall Study|Unable to operate spray|0|||
16497409|NCT01599234|40295332|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
16497410|NCT01599234|40295333|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
16497411|NCT01599234|40295332|FG000|Overall Study|Death|1|||
16497412|NCT01599234|40295333|FG001|Overall Study|Death|0|||
16497413|NCT01599234|40295332|FG000|Overall Study|Patient would not stop driving|1|||
16497414|NCT01599234|40295333|FG001|Overall Study|Patient would not stop driving|0|||
16497415|NCT01599234|40295332|FG000|Overall Study|Contra-indication discovered|0|||
16497416|NCT01599234|40295333|FG001|Overall Study|Contra-indication discovered|1|||
16497417|NCT01599234|40295332|FG000|Overall Study|Pregnancy|0|||
16497418|NCT01599234|40295333|FG001|Overall Study|Pregnancy|1|||
16497419|NCT01948050|40295335|FG000|Overall Study|Withdrawal by Subject|0|||
16497420|NCT01948050|40295336|FG001|Overall Study|Withdrawal by Subject|1|||
16497421|NCT04059094|40295337|FG000|Overall Study|Adverse Event|0|||
16497422|NCT04059094|40295338|FG001|Overall Study|Adverse Event|0|||
16497423|NCT04059094|40295339|FG002|Overall Study|Adverse Event|0|||
16497424|NCT04059094|40295340|FG003|Overall Study|Adverse Event|0|||
16497425|NCT04059094|40295341|FG004|Overall Study|Adverse Event|1|||
16497426|NCT04059094|40295337|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
16497427|NCT04059094|40295338|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
16497428|NCT04059094|40295339|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
16497429|NCT04059094|40295340|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
16497430|NCT04059094|40295341|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
16497431|NCT02999854|40295342|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
16497432|NCT02999854|40295343|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
16497433|NCT02999854|40295342|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
16497434|NCT02999854|40295343|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
16497435|NCT02999854|40295342|FG000|Active Study Phase (up to 18 Months)|Death|7|||
16497436|NCT02999854|40295343|FG001|Active Study Phase (up to 18 Months)|Death|5|||
16497437|NCT02999854|40295342|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
16497438|NCT02999854|40295343|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
16086930|NCT01499849|38810563|FG000|Overall Study|Lost to Follow-up|6|||
16308983|NCT00925704|39615641|FG000|Second Intervention|Withdrawal by Subject|1|||
16308984|NCT00925704|39615642|FG001|Second Intervention|Withdrawal by Subject|0|||
16308985|NCT00925704|39615643|FG002|Second Intervention|Withdrawal by Subject|0|||
16308986|NCT00925704|39615644|FG003|Second Intervention|Withdrawal by Subject|0|||
16308987|NCT00925704|39615645|FG004|Second Intervention|Withdrawal by Subject|1|||
16308988|NCT00925704|39615646|FG005|Second Intervention|Withdrawal by Subject|0|||
16308989|NCT00925704|39615641|FG000|Third Intervention|Withdrew consent|0|||
16308990|NCT00925704|39615642|FG001|Third Intervention|Withdrew consent|0|||
16308991|NCT00925704|39615643|FG002|Third Intervention|Withdrew consent|0|||
16308992|NCT00925704|39615644|FG003|Third Intervention|Withdrew consent|0|||
16308993|NCT00925704|39615645|FG004|Third Intervention|Withdrew consent|0|||
16308994|NCT00925704|39615646|FG005|Third Intervention|Withdrew consent|1|||
16308995|NCT03301649|39615647|FG000|Overall Study|Need alternate therapy due to live lice|17|||
16308996|NCT03301649|39615648|FG001|Overall Study|Need alternate therapy due to live lice|25|||
16497439|NCT02999854|40295342|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
16497440|NCT02999854|40295343|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
16497441|NCT02999854|40295342|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
16497442|NCT02999854|40295343|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
16497443|NCT02999854|40295342|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
16497444|NCT02999854|40295343|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
16497445|NCT02999854|40295342|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
16497446|NCT02999854|40295343|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
16497447|NCT01314443|40295344|FG000|Overall Study|Withdrawal by Subject|2|||
16497448|NCT01314443|40295345|FG001|Overall Study|Withdrawal by Subject|1|||
16497449|NCT01314443|40295346|FG002|Overall Study|Withdrawal by Subject|1|||
16497450|NCT01314443|40295347|FG003|Overall Study|Withdrawal by Subject|1|||
16497451|NCT01314443|40295344|FG000|Overall Study|Protocol Violation|2|||
16497452|NCT01314443|40295345|FG001|Overall Study|Protocol Violation|2|||
16497453|NCT01314443|40295346|FG002|Overall Study|Protocol Violation|1|||
16497454|NCT01314443|40295347|FG003|Overall Study|Protocol Violation|1|||
16497455|NCT02673489|40295351|FG000|Treatment Period|Lost to Follow-up|3|||
16497456|NCT02673489|40295352|FG001|Treatment Period|Lost to Follow-up|0|||
16497457|NCT02673489|40295351|FG000|Treatment Period|Participant request to discontinue|1|||
16497458|NCT02673489|40295352|FG001|Treatment Period|Participant request to discontinue|1|||
16497459|NCT02673489|40295351|FG000|Treatment Period|Participant moved to another province|1|||
16497460|NCT02673489|40295352|FG001|Treatment Period|Participant moved to another province|0|||
16497461|NCT02673489|40295351|FG000|Treatment Period|Participant was incarcerated|0|||
16497462|NCT02673489|40295352|FG001|Treatment Period|Participant was incarcerated|1|||
16497463|NCT02673489|40295351|FG000|Treatment Period|Adverse Event|0|||
16497464|NCT02673489|40295352|FG001|Treatment Period|Adverse Event|1|||
16497465|NCT02673489|40295351|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
16497466|NCT02673489|40295352|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
16497467|NCT02673489|40295351|FG000|Follow Up Period|Unable to return for follow-up|0|||
16388653|NCT01331681|39905712|FG001|Overall Study|Therapeutic procedure required|0|||
16388654|NCT01331681|39905713|FG002|Overall Study|Therapeutic procedure required|0|||
16388655|NCT01331681|39905711|FG000|Overall Study|Sponsor decision|1|||
16388656|NCT01331681|39905712|FG001|Overall Study|Sponsor decision|1|||
16388657|NCT01331681|39905713|FG002|Overall Study|Sponsor decision|0|||
16388658|NCT01331681|39905711|FG000|Overall Study|Switching to other therapy|0|||
16388659|NCT01331681|39905712|FG001|Overall Study|Switching to other therapy|0|||
16308997|NCT03301649|39615649|FG002|Overall Study|Need alternate therapy due to live lice|81|||
16308998|NCT03301649|39615647|FG000|Overall Study|Lost to Follow-up|11|||
16308999|NCT03301649|39615648|FG001|Overall Study|Lost to Follow-up|11|||
16309000|NCT03301649|39615649|FG002|Overall Study|Lost to Follow-up|3|||
16309001|NCT03301649|39615647|FG000|Overall Study|Protocol Violation|0|||
16309002|NCT03301649|39615648|FG001|Overall Study|Protocol Violation|1|||
16309003|NCT03301649|39615649|FG002|Overall Study|Protocol Violation|1|||
16309004|NCT03301649|39615647|FG000|Overall Study|Withdrawal by Subject|10|||
16309005|NCT03301649|39615648|FG001|Overall Study|Withdrawal by Subject|4|||
16388660|NCT01331681|39905713|FG002|Overall Study|Switching to other therapy|1|||
16388661|NCT01331681|39905711|FG000|Overall Study|Not Received Study Treatment|0|||
16497468|NCT02673489|40295352|FG001|Follow Up Period|Unable to return for follow-up|1|||
16194720|NCT04387136|39188826|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
16194721|NCT02345252|39188834|FG000|Double-Blind Phase|Adverse Event|2|||
16497469|NCT00467259|40295357|FG000|Overall Study|Adverse Event|24|||
16497470|NCT00467259|40295358|FG001|Overall Study|Adverse Event|90|||
16497471|NCT00467259|40295357|FG000|Overall Study|Protocol Violation|1|||
16497472|NCT00467259|40295358|FG001|Overall Study|Protocol Violation|7|||
16497473|NCT00467259|40295357|FG000|Overall Study|Withdrawal by Subject|34|||
16497474|NCT00467259|40295358|FG001|Overall Study|Withdrawal by Subject|108|||
16497475|NCT00467259|40295357|FG000|Overall Study|Physician Decision|0|||
16497476|NCT00467259|40295358|FG001|Overall Study|Physician Decision|2|||
16497477|NCT00467259|40295357|FG000|Overall Study|Lost to Follow-up|14|||
16497478|NCT00467259|40295358|FG001|Overall Study|Lost to Follow-up|34|||
16497479|NCT00467259|40295357|FG000|Overall Study|Site Closed|2|||
16497480|NCT00467259|40295358|FG001|Overall Study|Site Closed|1|||
16497481|NCT02744391|40295361|FG000|Overall Study|Lost to Follow-up|9|||
16497482|NCT02744391|40295361|FG000|Overall Study|Physician Decision|2|||
16497483|NCT02744391|40295361|FG000|Overall Study|Withdrawal by Subject|3|||
16497484|NCT00894322|40295364|FG000|Overall Study|Withdrawal by Subject|1|||
16497485|NCT00894322|40295365|FG001|Overall Study|Withdrawal by Subject|0|||
16194722|NCT02345252|39188835|FG001|Double-Blind Phase|Adverse Event|3|||
16309006|NCT03301649|39615649|FG002|Overall Study|Withdrawal by Subject|0|||
16497486|NCT00894322|40295366|FG002|Overall Study|Withdrawal by Subject|0|||
16497487|NCT00975481|40295367|FG000|Second Intervention Period|Adverse Event|2|||
16497488|NCT00975481|40295368|FG001|Second Intervention Period|Adverse Event|1|||
16388662|NCT01331681|39905712|FG001|Overall Study|Not Received Study Treatment|0|||
16388663|NCT01331681|39905713|FG002|Overall Study|Not Received Study Treatment|2|||
16388664|NCT00375674|39905714|FG000|Overall Study|Other|26|||
16388665|NCT00375674|39905715|FG001|Overall Study|Other|18|||
16388666|NCT00375674|39905714|FG000|Overall Study|Death|67|||
16388667|NCT00375674|39905715|FG001|Overall Study|Death|76|||
16388668|NCT00375674|39905714|FG000|Overall Study|Participants refused further follow-up|31|||
16388669|NCT00375674|39905715|FG001|Overall Study|Participants refused further follow-up|30|||
16309007|NCT03301649|39615647|FG000|Overall Study|Other than specified|5|||
16309008|NCT03301649|39615648|FG001|Overall Study|Other than specified|3|||
16309009|NCT03301649|39615649|FG002|Overall Study|Other than specified|0|||
16309010|NCT02454933|39615650|FG000|Overall Study|Progressive disease|10|||
16388670|NCT00375674|39905714|FG000|Overall Study|Lost to Follow-up|17|||
16388671|NCT00375674|39905715|FG001|Overall Study|Lost to Follow-up|15|||
16388672|NCT00375674|39905714|FG000|Overall Study|Enrolled but not treated|3|||
16388673|NCT00375674|39905715|FG001|Overall Study|Enrolled but not treated|2|||
16309011|NCT02454933|39615651|FG001|Overall Study|Progressive disease|7|||
16309012|NCT02454933|39615650|FG000|Overall Study|Adverse Event|1|||
16309013|NCT02454933|39615651|FG001|Overall Study|Adverse Event|1|||
16309014|NCT02454933|39615650|FG000|Overall Study|Withdrawal by Subject|0|||
16086931|NCT01499849|38810564|FG001|Overall Study|Lost to Follow-up|3|||
16388674|NCT03654274|39905716|FG000|Overall Study|Adverse Event|19|||
16497489|NCT00975481|40295369|FG002|Second Intervention Period|Adverse Event|0|||
16086932|NCT01499849|38810563|FG000|Overall Study|Other Reasons|27|||
16086933|NCT01499849|38810564|FG001|Overall Study|Other Reasons|30|||
16086934|NCT02701296|38810567|FG000|Overall Study|Incomplete Data|0|||
16086935|NCT02701296|38810568|FG001|Overall Study|Incomplete Data|2|||
16086936|NCT04820491|38810572|FG000|Overall Study|Withdrawal by Subject|1|||
16086937|NCT04820491|38810573|FG001|Overall Study|Withdrawal by Subject|0|||
16086938|NCT01313663|38810574|FG000|Overall Study|Study Closed/Terminated|2|||
16086939|NCT01313663|38810575|FG001|Overall Study|Study Closed/Terminated|4|||
16086940|NCT01313663|38810574|FG000|Overall Study|Lost to Follow-up|0|||
16086941|NCT01313663|38810575|FG001|Overall Study|Lost to Follow-up|1|||
16086942|NCT01313663|38810574|FG000|Overall Study|Physician Decision|0|||
16086943|NCT01313663|38810575|FG001|Overall Study|Physician Decision|2|||
16086944|NCT01313663|38810574|FG000|Overall Study|Withdrawal by Subject|2|||
16086945|NCT01313663|38810575|FG001|Overall Study|Withdrawal by Subject|1|||
16086946|NCT01256359|38810577|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
16086947|NCT01256359|38810578|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
16086948|NCT01256359|38810577|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
16086949|NCT01256359|38810578|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
16086950|NCT00890591|38810581|FG000|Overall Study|Lack of Efficacy|20|||
16086951|NCT01998958|38810582|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086952|NCT01998958|38810583|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
16086953|NCT01998958|38810584|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086954|NCT01998958|38810585|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16309015|NCT02454933|39615651|FG001|Overall Study|Withdrawal by Subject|3|||
16309016|NCT02454933|39615650|FG000|Overall Study|Lost to Follow-up|1|||
16086955|NCT01998958|38810586|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086956|NCT01998958|38810587|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086957|NCT01998958|38810588|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086958|NCT01998958|38810589|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086959|NCT01998958|38810590|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086960|NCT01998958|38810591|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086961|NCT01998958|38810592|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086962|NCT01998958|38810593|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086963|NCT01998958|38810594|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086964|NCT01998958|38810595|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086965|NCT01998958|38810596|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086966|NCT01998958|38810597|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086967|NCT01998958|38810598|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086968|NCT01998958|38810599|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16309017|NCT02454933|39615651|FG001|Overall Study|Lost to Follow-up|0|||
16309018|NCT01866826|39615654|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
16309019|NCT01866826|39615655|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
16309020|NCT01866826|39615654|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
16309021|NCT01866826|39615655|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
16388675|NCT03654274|39905717|FG001|Overall Study|Adverse Event|23|||
16497490|NCT00975481|40295370|FG003|Second Intervention Period|Adverse Event|0|||
16309022|NCT01866826|39615654|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
16497491|NCT00975481|40295371|FG004|Second Intervention Period|Adverse Event|0|||
16309023|NCT01866826|39615655|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
16388676|NCT03654274|39905718|FG002|Overall Study|Adverse Event|24|||
16497492|NCT00975481|40295372|FG005|Second Intervention Period|Adverse Event|0|||
16497493|NCT00975481|40295367|FG000|Second Intervention Period|Withdrawal by Subject|0|||
16497494|NCT00975481|40295368|FG001|Second Intervention Period|Withdrawal by Subject|0|||
16388677|NCT03654274|39905716|FG000|Overall Study|Protocol Deviation|0|||
16388678|NCT03654274|39905717|FG001|Overall Study|Protocol Deviation|2|||
16388679|NCT03654274|39905718|FG002|Overall Study|Protocol Deviation|0|||
16388680|NCT03654274|39905716|FG000|Overall Study|Lost to Follow-up|8|||
16388681|NCT03654274|39905717|FG001|Overall Study|Lost to Follow-up|6|||
16388682|NCT03654274|39905718|FG002|Overall Study|Lost to Follow-up|5|||
16388683|NCT03654274|39905716|FG000|Overall Study|Withdrawal by Subject|46|||
16388684|NCT03654274|39905717|FG001|Overall Study|Withdrawal by Subject|25|||
16388685|NCT03654274|39905718|FG002|Overall Study|Withdrawal by Subject|33|||
16388686|NCT03654274|39905716|FG000|Overall Study|Lack of Efficacy|4|||
16388687|NCT03654274|39905717|FG001|Overall Study|Lack of Efficacy|5|||
16388688|NCT03654274|39905718|FG002|Overall Study|Lack of Efficacy|7|||
16497495|NCT00975481|40295369|FG002|Second Intervention Period|Withdrawal by Subject|1|||
16497496|NCT00975481|40295370|FG003|Second Intervention Period|Withdrawal by Subject|0|||
16497497|NCT00975481|40295371|FG004|Second Intervention Period|Withdrawal by Subject|0|||
16497498|NCT00975481|40295372|FG005|Second Intervention Period|Withdrawal by Subject|0|||
16497499|NCT00975481|40295367|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
16497500|NCT00975481|40295368|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
16497501|NCT00975481|40295369|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
16497502|NCT00975481|40295370|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
16497503|NCT00975481|40295371|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
16086969|NCT01998958|38810600|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086970|NCT01998958|38810601|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086971|NCT01998958|38810602|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086972|NCT01998958|38810603|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086973|NCT01998958|38810604|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086974|NCT01998958|38810605|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086975|NCT01998958|38810606|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086976|NCT01998958|38810607|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16497504|NCT00975481|40295372|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
16497505|NCT00975481|40295367|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
16497506|NCT00975481|40295368|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
16497507|NCT00975481|40295369|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
16497508|NCT00975481|40295370|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
16497509|NCT00975481|40295371|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
16497510|NCT00975481|40295372|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
16497511|NCT02511184|40295373|FG000|Overall Study|Death|1|||
16497512|NCT02511184|40295374|FG001|Overall Study|Death|0|||
16497513|NCT02511184|40295373|FG000|Overall Study|Lost to Follow-up|0|||
16497514|NCT02511184|40295374|FG001|Overall Study|Lost to Follow-up|1|||
16497515|NCT02511184|40295373|FG000|Overall Study|Study terminated by sponsor|1|||
16497516|NCT02511184|40295374|FG001|Overall Study|Study terminated by sponsor|5|||
16497517|NCT02511184|40295373|FG000|Overall Study|Withdrawal by Subject|0|||
16497518|NCT02511184|40295374|FG001|Overall Study|Withdrawal by Subject|1|||
16497519|NCT04326231|40295384|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
16497520|NCT01396148|40295385|FG000|Overall Study|Patient Decision|1|||
16497521|NCT00082355|40295386|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
16497522|NCT00082355|40295386|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
16497523|NCT00082355|40295386|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
16497524|NCT00847704|40295388|FG000|Overall Study|Withdrawal by Subject|1|||
16497525|NCT02057198|40295395|FG000|Overall Study|Death|0|||
16497526|NCT02057198|40295396|FG001|Overall Study|Death|0|||
16497527|NCT02057198|40295397|FG002|Overall Study|Death|1|||
16497528|NCT02057198|40295395|FG000|Overall Study|Discharged early; lost to followup|0|||
16497529|NCT02057198|40295396|FG001|Overall Study|Discharged early; lost to followup|1|||
16497530|NCT02057198|40295397|FG002|Overall Study|Discharged early; lost to followup|0|||
16497531|NCT00309842|40295398|FG000|Overall Study|Lost to Follow-up|1|||
16497532|NCT03585504|40295399|FG000|Overall Study|Lost to Follow-up|26|||
16497533|NCT03585504|40295400|FG001|Overall Study|Lost to Follow-up|29|||
16497534|NCT03036072|40295401|FG000|Overall Study|Death|0|||
16497535|NCT03036072|40295402|FG001|Overall Study|Death|1|||
16497536|NCT03036072|40295401|FG000|Overall Study|Withdrawal by Subject|0|||
16086977|NCT01998958|38810608|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16388689|NCT03654274|39905716|FG000|Overall Study|Pregnancy|2|||
16388690|NCT03654274|39905717|FG001|Overall Study|Pregnancy|2|||
16388691|NCT03654274|39905718|FG002|Overall Study|Pregnancy|1|||
16388692|NCT03654274|39905716|FG000|Overall Study|Other|27|||
16497537|NCT03036072|40295402|FG001|Overall Study|Withdrawal by Subject|1|||
16497538|NCT03036072|40295401|FG000|Overall Study|Physician Decision|0|||
16497539|NCT03036072|40295402|FG001|Overall Study|Physician Decision|1|||
16497540|NCT03510884|40295403|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
16497541|NCT03510884|40295404|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
16497542|NCT03510884|40295405|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
16497543|NCT03510884|40295406|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
16497544|NCT03510884|40295403|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
16497545|NCT03510884|40295404|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
16497546|NCT03510884|40295405|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
16497547|NCT03510884|40295406|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
16497548|NCT03510884|40295403|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
16497549|NCT03510884|40295404|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
16497550|NCT03510884|40295405|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
16497551|NCT03510884|40295406|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
16497552|NCT03510884|40295403|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
16497553|NCT03510884|40295404|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
16497554|NCT03510884|40295405|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
16497555|NCT03510884|40295406|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
16497556|NCT03510884|40295403|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
16497557|NCT03510884|40295404|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
16497558|NCT03510884|40295405|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
16497559|NCT03510884|40295406|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
16497560|NCT03510884|40295403|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
16497561|NCT03510884|40295404|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
16497562|NCT03510884|40295405|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
16497563|NCT03510884|40295406|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
16497564|NCT03510884|40295403|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
16497565|NCT03510884|40295404|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
16497566|NCT03510884|40295405|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
16497567|NCT03510884|40295406|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
16497568|NCT03510884|40295403|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
16497569|NCT03510884|40295404|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
16497570|NCT03510884|40295405|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
16497571|NCT03510884|40295406|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
16497572|NCT03510884|40295403|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
16497573|NCT03510884|40295404|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
16497574|NCT03510884|40295405|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
16497575|NCT03510884|40295406|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
16497576|NCT03510884|40295403|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
16497577|NCT03510884|40295404|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
16497578|NCT03510884|40295405|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
16497579|NCT03510884|40295406|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
16497580|NCT00423150|40295409|FG000|Overall Study|Adverse Event|11|||
16497581|NCT00423150|40295409|FG000|Overall Study|Progression of disease being studied|69|||
16497582|NCT00423150|40295409|FG000|Overall Study|Withdrawal by Subject|1|||
16497583|NCT00423150|40295409|FG000|Overall Study|Non-compliance with protocol|1|||
16497584|NCT00423150|40295409|FG000|Overall Study|Administrative|4|||
16497585|NCT01922089|40295410|FG000|Overall Study|Adverse Event|18|||
16497586|NCT01922089|40295411|FG001|Overall Study|Adverse Event|13|||
16497587|NCT01922089|40295410|FG000|Overall Study|Protocol Deviation|10|||
16497588|NCT01922089|40295411|FG001|Overall Study|Protocol Deviation|7|||
16497589|NCT01922089|40295410|FG000|Overall Study|Withdrawal by Subject|3|||
16497590|NCT01922089|40295411|FG001|Overall Study|Withdrawal by Subject|4|||
16497591|NCT01922089|40295410|FG000|Overall Study|administrative problems|4|||
16497592|NCT01922089|40295411|FG001|Overall Study|administrative problems|1|||
16497593|NCT01922089|40295410|FG000|Overall Study|Physician Decision|2|||
16497594|NCT01922089|40295411|FG001|Overall Study|Physician Decision|3|||
16497595|NCT01922089|40295410|FG000|Overall Study|Death|2|||
16497596|NCT01922089|40295411|FG001|Overall Study|Death|1|||
16388693|NCT03654274|39905717|FG001|Overall Study|Other|29|||
16388694|NCT03654274|39905718|FG002|Overall Study|Other|32|||
16388695|NCT03654274|39905716|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
16388696|NCT03654274|39905717|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
16388697|NCT03654274|39905718|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
16497597|NCT01922089|40295410|FG000|Overall Study|Lost to Follow-up|0|||
16497598|NCT01922089|40295411|FG001|Overall Study|Lost to Follow-up|1|||
16497599|NCT02436889|40295412|FG000|Overall Study|No improvement in symptoms|1|||
16497600|NCT02436889|40295413|FG001|Overall Study|No improvement in symptoms|0|||
16497601|NCT02436889|40295412|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
16497602|NCT02436889|40295413|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
16497603|NCT00708162|40295422|FG000|Randomized Phase|Randomized but Not Treated|7|||
16497604|NCT00708162|40295423|FG001|Randomized Phase|Randomized but Not Treated|5|||
16497605|NCT00708162|40295422|FG000|Randomized Phase|Participant Noncompliance|40|||
16497606|NCT00708162|40295423|FG001|Randomized Phase|Participant Noncompliance|32|||
16497607|NCT00708162|40295422|FG000|Randomized Phase|Lost to Follow-up|34|||
16497608|NCT00708162|40295423|FG001|Randomized Phase|Lost to Follow-up|34|||
16309024|NCT03639779|39615656|FG000|Overall Study|Lost to Follow-up|1|||
16309025|NCT00709995|39615665|FG000|Overall Study|Adverse Event|4|||
16309026|NCT00709995|39615666|FG001|Overall Study|Adverse Event|2|||
16497609|NCT00708162|40295422|FG000|Randomized Phase|Withdrew Consent|31|||
16497610|NCT00708162|40295423|FG001|Randomized Phase|Withdrew Consent|22|||
16497611|NCT00708162|40295422|FG000|Randomized Phase|Lack of Efficacy|14|||
16497612|NCT00708162|40295423|FG001|Randomized Phase|Lack of Efficacy|19|||
16497613|NCT00708162|40295422|FG000|Randomized Phase|Protocol Violation|10|||
16497614|NCT00708162|40295423|FG001|Randomized Phase|Protocol Violation|11|||
16497615|NCT00708162|40295422|FG000|Randomized Phase|Adverse Event|8|||
16194723|NCT02345252|39188834|FG000|Double-Blind Phase|Death|1|||
16309027|NCT00709995|39615665|FG000|Overall Study|Withdrawal by Subject|1|||
16309028|NCT00709995|39615666|FG001|Overall Study|Withdrawal by Subject|3|||
16309029|NCT02500589|39615669|FG000|Overall Study|Withdrawal by Subject|11|||
16309030|NCT02500589|39615670|FG001|Overall Study|Withdrawal by Subject|14|||
16309031|NCT02500589|39615669|FG000|Overall Study|Lost to Follow-up|10|||
16309032|NCT02500589|39615670|FG001|Overall Study|Lost to Follow-up|12|||
16309033|NCT02500589|39615669|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
16309034|NCT02500589|39615670|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
16309035|NCT02500589|39615669|FG000|Overall Study|Death|7|||
16309036|NCT02500589|39615670|FG001|Overall Study|Death|5|||
16309037|NCT03910673|39615671|FG000|Overall Study|Adverse Event|0|||
16309038|NCT03910673|39615672|FG001|Overall Study|Adverse Event|0|||
16309039|NCT03910673|39615673|FG002|Overall Study|Adverse Event|0|||
16309040|NCT03910673|39615674|FG003|Overall Study|Adverse Event|2|||
16309041|NCT03910673|39615675|FG004|Overall Study|Adverse Event|0|||
16309042|NCT01213966|39615676|FG000|Overall Study|Protocol Violation|1|||
16309043|NCT01213966|39615677|FG001|Overall Study|Protocol Violation|0|||
16309044|NCT01213966|39615678|FG002|Overall Study|Protocol Violation|3|||
16309045|NCT01213966|39615679|FG003|Overall Study|Protocol Violation|1|||
16388698|NCT00363142|39905720|FG000|Overall Study|Adverse Event|2|||
16388699|NCT00363142|39905721|FG001|Overall Study|Adverse Event|0|||
16388700|NCT00363142|39905720|FG000|Overall Study|Lack of Efficacy|0|||
16388701|NCT00363142|39905721|FG001|Overall Study|Lack of Efficacy|1|||
16388702|NCT00363142|39905720|FG000|Overall Study|Lost to Follow-up|1|||
16388703|NCT00363142|39905721|FG001|Overall Study|Lost to Follow-up|0|||
16388704|NCT00363142|39905720|FG000|Overall Study|Non-compliance|1|||
16388705|NCT00363142|39905721|FG001|Overall Study|Non-compliance|1|||
16388706|NCT00363142|39905720|FG000|Overall Study|Withdrawal by Subject|3|||
16388707|NCT00363142|39905721|FG001|Overall Study|Withdrawal by Subject|1|||
16388708|NCT04245709|39905724|FG000|Overall Study|Adverse Event|13|||
16388709|NCT04245709|39905724|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
16388710|NCT00776789|39905727|FG000|Overall Study|Consent refusal|2|||
16388711|NCT00776789|39905728|FG001|Overall Study|Consent refusal|2|||
16388712|NCT00776789|39905727|FG000|Overall Study|Poor quality video|1|||
16388713|NCT00776789|39905728|FG001|Overall Study|Poor quality video|1|||
16388714|NCT00110214|39905736|FG000|Overall Study|Never started treatment|21|||
16388715|NCT00110214|39905737|FG001|Overall Study|Never started treatment|20|||
16388716|NCT00110214|39905736|FG000|Overall Study|Disease progression or death|260|||
16388717|NCT00110214|39905737|FG001|Overall Study|Disease progression or death|151|||
16388718|NCT00110214|39905736|FG000|Overall Study|Adverse Event|115|||
16388719|NCT00110214|39905737|FG001|Overall Study|Adverse Event|192|||
16388720|NCT00110214|39905736|FG000|Overall Study|Refused further treatment|52|||
16388721|NCT00110214|39905737|FG001|Overall Study|Refused further treatment|65|||
16388722|NCT00110214|39905736|FG000|Overall Study|Other (not specified)|61|||
16388723|NCT00110214|39905737|FG001|Overall Study|Other (not specified)|75|||
16388724|NCT01016132|39905739|FG000|Overall Study|Discomfort|1|||
16388725|NCT01490918|39905740|FG000|Overall Study|Lost to Follow-up|2|||
16388726|NCT01490918|39905741|FG001|Overall Study|Lost to Follow-up|1|||
16388727|NCT01490918|39905742|FG002|Overall Study|Lost to Follow-up|0|||
16309046|NCT01827111|39615681|FG000|Overall Study|Disease Progression|1|||
16309047|NCT01742897|39615682|FG000|Overall Study|Adverse Event|3|||
16309048|NCT01742897|39615682|FG000|Overall Study|Withdrawal by Subject|1|||
16309049|NCT01742897|39615682|FG000|Overall Study|Other|1|||
16497616|NCT00708162|40295423|FG001|Randomized Phase|Adverse Event|12|||
16497617|NCT00708162|40295422|FG000|Randomized Phase|Investigator's Discretion|7|||
16497618|NCT00708162|40295423|FG001|Randomized Phase|Investigator's Discretion|10|||
16497619|NCT00708162|40295422|FG000|Randomized Phase|Death|2|||
16497620|NCT00708162|40295423|FG001|Randomized Phase|Death|9|||
16497621|NCT00708162|40295422|FG000|Randomized Phase|Pregnancy|3|||
16497622|NCT00708162|40295423|FG001|Randomized Phase|Pregnancy|0|||
16497623|NCT00708162|40295422|FG000|Open-Label Phase|Lost to Follow-up|10|||
16497624|NCT00708162|40295423|FG001|Open-Label Phase|Lost to Follow-up|8|||
16497625|NCT00708162|40295422|FG000|Open-Label Phase|Withdrew Consent|12|||
16497626|NCT00708162|40295423|FG001|Open-Label Phase|Withdrew Consent|6|||
16497627|NCT00708162|40295422|FG000|Open-Label Phase|Participant Noncompliance|7|||
16497628|NCT00708162|40295423|FG001|Open-Label Phase|Participant Noncompliance|7|||
16497629|NCT00708162|40295422|FG000|Open-Label Phase|Lack of Efficacy|7|||
16497630|NCT00708162|40295423|FG001|Open-Label Phase|Lack of Efficacy|4|||
16497631|NCT00708162|40295422|FG000|Open-Label Phase|Investigator's Discretion|3|||
16497632|NCT00708162|40295423|FG001|Open-Label Phase|Investigator's Discretion|2|||
16497633|NCT00708162|40295422|FG000|Open-Label Phase|Death|3|||
16497634|NCT00708162|40295423|FG001|Open-Label Phase|Death|1|||
16497635|NCT00708162|40295422|FG000|Open-Label Phase|Adverse Event|1|||
16497636|NCT00708162|40295423|FG001|Open-Label Phase|Adverse Event|2|||
16497637|NCT00708162|40295422|FG000|Open-Label Phase|Other|1|||
16497638|NCT00708162|40295423|FG001|Open-Label Phase|Other|0|||
16497639|NCT03021265|40295424|FG000|Overall Study|Adverse Event|29|||
16194724|NCT02345252|39188835|FG001|Double-Blind Phase|Death|2|||
16194725|NCT02345252|39188834|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16194726|NCT02345252|39188835|FG001|Double-Blind Phase|Lack of Efficacy|0|||
16194727|NCT02345252|39188834|FG000|Double-Blind Phase|Investigator's Discretion|4|||
16194728|NCT02345252|39188835|FG001|Double-Blind Phase|Investigator's Discretion|6|||
16194729|NCT02345252|39188834|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
16194730|NCT02345252|39188835|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
16194731|NCT02345252|39188834|FG000|Double-Blind Phase|Protocol Violation|2|||
16194732|NCT02345252|39188835|FG001|Double-Blind Phase|Protocol Violation|1|||
16194733|NCT02345252|39188834|FG000|Double-Blind Phase|Withdrew Consent|21|||
16194734|NCT02345252|39188835|FG001|Double-Blind Phase|Withdrew Consent|23|||
16194735|NCT02345252|39188834|FG000|Double-Blind Phase|Lost to Follow-up|8|||
16194736|NCT02345252|39188835|FG001|Double-Blind Phase|Lost to Follow-up|10|||
16194737|NCT02345252|39188834|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
16194738|NCT02345252|39188835|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
16194739|NCT01093755|39188838|FG000|Overall Study|Withdrawal by Subject|3|||
16194740|NCT01093755|39188839|FG001|Overall Study|Withdrawal by Subject|4|||
16194741|NCT00358917|39188840|FG000|Overall Study|Adverse Event|14|||
16194742|NCT00358917|39188841|FG001|Overall Study|Adverse Event|21|||
16194743|NCT00358917|39188840|FG000|Overall Study|Withdrawal by Subject|5|||
16194744|NCT00358917|39188841|FG001|Overall Study|Withdrawal by Subject|7|||
16194745|NCT00358917|39188840|FG000|Overall Study|Lost to Follow-up|20|||
16194746|NCT00358917|39188841|FG001|Overall Study|Lost to Follow-up|17|||
16194747|NCT00358917|39188840|FG000|Overall Study|Noncompliance|12|||
16194748|NCT00358917|39188841|FG001|Overall Study|Noncompliance|11|||
16194749|NCT00358917|39188840|FG000|Overall Study|Death|2|||
16194750|NCT00358917|39188841|FG001|Overall Study|Death|3|||
16497640|NCT03021265|40295424|FG000|Overall Study|Lack of Efficacy|3|||
16497641|NCT03021265|40295424|FG000|Overall Study|Improved|17|||
16497642|NCT03021265|40295424|FG000|Overall Study|Lost to Follow-up|67|||
16497643|NCT03021265|40295424|FG000|Overall Study|No reason given|2|||
16497644|NCT03021265|40295424|FG000|Overall Study|No visit since the first visit|4|||
16497645|NCT00003479|40295427|FG000|Overall Study|Not evaluable|3|||
16497646|NCT00330616|40295428|FG000|Overall Study|Adverse Event|13|||
16497647|NCT00330616|40295428|FG000|Overall Study|Lack of Efficacy|1|||
16497648|NCT00330616|40295428|FG000|Overall Study|Lost to Follow-up|2|||
16497649|NCT00330616|40295428|FG000|Overall Study|Withdrawal by Subject|4|||
16497650|NCT00330616|40295428|FG000|Overall Study|Other|1|||
16497651|NCT00386776|40295429|FG000|Overall Study|Withdrawal by Subject|8|||
16497652|NCT00293254|40295430|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
16497653|NCT00293254|40295431|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
16497654|NCT00293254|40295430|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
16497655|NCT00293254|40295431|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
16497656|NCT00293254|40295430|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
16497657|NCT00293254|40295431|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
16497658|NCT00293254|40295430|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
16497659|NCT00293254|40295431|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
16497660|NCT00293254|40295430|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
16194751|NCT00358917|39188840|FG000|Overall Study|Virologic failure|11|||
16194752|NCT00358917|39188841|FG001|Overall Study|Virologic failure|8|||
16194753|NCT00358917|39188840|FG000|Overall Study|Unable to Continue Participation|2|||
16194754|NCT00358917|39188841|FG001|Overall Study|Unable to Continue Participation|2|||
16194755|NCT01575197|39188842|FG000|Overall Study|Migration out of study area|1|||
16409942|NCT01269385|39981838|FG002|Overall Study|Adverse Event|0|||
16497661|NCT00293254|40295431|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
16497662|NCT00293254|40295430|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
16497663|NCT00293254|40295431|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
16497664|NCT00293254|40295430|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
16497665|NCT00293254|40295431|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
16497666|NCT00293254|40295430|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
16497667|NCT00293254|40295431|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
16497668|NCT00293254|40295430|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
16497669|NCT00293254|40295431|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
16497670|NCT00293254|40295430|FG000|Extension - Double-Blind Week 49-156|Death|4|||
16497671|NCT00293254|40295431|FG001|Extension - Double-Blind Week 49-156|Death|1|||
16497672|NCT00293254|40295430|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
16497673|NCT00293254|40295431|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
16497674|NCT00293254|40295430|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
16497675|NCT00293254|40295431|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
16497676|NCT00293254|40295430|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
16497677|NCT00293254|40295431|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
16497678|NCT00293254|40295430|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
16497679|NCT00293254|40295431|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
16497680|NCT00293254|40295430|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
16497681|NCT00293254|40295431|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
16497682|NCT00293254|40295430|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
16497683|NCT00293254|40295431|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
16497684|NCT00293254|40295430|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
16497685|NCT00293254|40295431|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
16497686|NCT00293254|40295430|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
16497687|NCT00293254|40295431|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
16086978|NCT01998958|38810609|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086979|NCT01998958|38810610|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086980|NCT01998958|38810611|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16388728|NCT01490918|39905740|FG000|Overall Study|Withdrawal by Subject|7|||
16388729|NCT01490918|39905741|FG001|Overall Study|Withdrawal by Subject|8|||
16388730|NCT01490918|39905742|FG002|Overall Study|Withdrawal by Subject|3|||
16388731|NCT01490918|39905740|FG000|Overall Study|Adverse Event|0|||
16388732|NCT01490918|39905741|FG001|Overall Study|Adverse Event|0|||
16388733|NCT01490918|39905742|FG002|Overall Study|Adverse Event|1|||
16388734|NCT01490918|39905740|FG000|Overall Study|other cause|4|||
16388735|NCT01490918|39905741|FG001|Overall Study|other cause|5|||
16388736|NCT01490918|39905742|FG002|Overall Study|other cause|8|||
16388737|NCT01479764|39905743|FG000|Randomized|Adverse Event|1|||
16388738|NCT01479764|39905744|FG001|Randomized|Adverse Event|1|||
16388739|NCT01479764|39905743|FG000|Randomized|Withdrawal by Subject|1|||
16388740|NCT01479764|39905744|FG001|Randomized|Withdrawal by Subject|0|||
16388741|NCT01479764|39905743|FG000|Treated|Lost to Follow-up|0|||
16388742|NCT01479764|39905744|FG001|Treated|Lost to Follow-up|2|||
16086981|NCT01998958|38810612|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086982|NCT01998958|38810613|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
16086983|NCT01998958|38810582|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086984|NCT01998958|38810583|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
16086985|NCT01998958|38810584|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086986|NCT01998958|38810585|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086987|NCT01998958|38810586|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086988|NCT01998958|38810587|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086989|NCT01998958|38810588|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16194756|NCT01575197|39188843|FG001|Overall Study|Migration out of study area|5|||
16194757|NCT01575197|39188844|FG002|Overall Study|Migration out of study area|4|||
16194758|NCT01575197|39188842|FG000|Overall Study|SAE|0|||
16194759|NCT01575197|39188843|FG001|Overall Study|SAE|1|||
16194760|NCT01575197|39188844|FG002|Overall Study|SAE|0|||
16194761|NCT01575197|39188842|FG000|Overall Study|Lost to Follow-up|0|||
16194762|NCT01575197|39188843|FG001|Overall Study|Lost to Follow-up|1|||
16194763|NCT01575197|39188844|FG002|Overall Study|Lost to Follow-up|0|||
16194764|NCT01575197|39188842|FG000|Overall Study|Withdrawal by Subject|0|||
16086990|NCT01998958|38810589|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086991|NCT01998958|38810590|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16194765|NCT01575197|39188843|FG001|Overall Study|Withdrawal by Subject|1|||
16194766|NCT01575197|39188844|FG002|Overall Study|Withdrawal by Subject|1|||
16194767|NCT01575197|39188842|FG000|Overall Study|Protocol Violation|2|||
16388743|NCT03500211|39905745|FG000|Overall Study|Withdrawal by Subject|1|||
16388744|NCT03500211|39905746|FG001|Overall Study|Withdrawal by Subject|1|||
16388745|NCT00532844|39905750|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
16388746|NCT00532844|39905751|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
16194768|NCT01575197|39188843|FG001|Overall Study|Protocol Violation|1|||
16194769|NCT01575197|39188844|FG002|Overall Study|Protocol Violation|1|||
16194770|NCT02349789|39188845|FG000|Overall Study|Withdrawal by Subject|2|||
16194771|NCT02626533|39188846|FG000|Overall Study|Protocol Violation|14|||
16194772|NCT02626533|39188846|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
16194773|NCT02626533|39188846|FG000|Overall Study|Withdrawal by Subject|1|||
16194774|NCT03076190|39188847|FG000|Overall Study|Lost to Follow-up|9|||
16194775|NCT03076190|39188848|FG001|Overall Study|Lost to Follow-up|34|||
16194776|NCT03076190|39188847|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
16194777|NCT03076190|39188848|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
16194778|NCT03448224|39188849|FG000|Overall Study|Provided same answer to every question|1|||
16497688|NCT00293254|40295430|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
16497689|NCT00293254|40295431|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
16497690|NCT00293254|40295430|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
16497691|NCT00293254|40295431|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
16497692|NCT00293254|40295430|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
16497693|NCT00293254|40295431|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
16497694|NCT00293254|40295430|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
16497695|NCT00293254|40295431|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
16497696|NCT00293254|40295430|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
16497697|NCT00293254|40295431|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
16497698|NCT00293254|40295430|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
16194779|NCT03448224|39188850|FG001|Overall Study|Provided same answer to every question|0|||
16194780|NCT04032171|39188851|FG000|Overall Study|Study Termination|1|||
16194781|NCT04032171|39188852|FG001|Overall Study|Study Termination|0|||
16194782|NCT03151148|39188861|FG000|Overall Study|Lost to Follow-up|1|||
16194783|NCT03151148|39188862|FG001|Overall Study|Lost to Follow-up|0|||
16194784|NCT03151148|39188861|FG000|Overall Study|Withdrawal by Subject|1|||
16194785|NCT03151148|39188862|FG001|Overall Study|Withdrawal by Subject|0|||
16194786|NCT00352755|39188863|FG000|Overall Study|Physician Decision|1|||
16194787|NCT00352755|39188863|FG000|Overall Study|Adverse Event|1|||
16194788|NCT01072539|39188867|FG000|Overall Study|Treated prior to the Site Initiation|1|||
16194789|NCT01072539|39188867|FG000|Overall Study|Protocol Violation|2|||
16194790|NCT01626352|39188868|FG000|Overall Study|Disease Progression|3|||
16194791|NCT01626352|39188868|FG000|Overall Study|Intercurrent Illness|2|||
16194792|NCT01626352|39188868|FG000|Overall Study|Death|2|||
16194793|NCT01626352|39188868|FG000|Overall Study|Withdrawal by Subject|1|||
16194794|NCT01626352|39188868|FG000|Overall Study|Non-Compliance|1|||
16194795|NCT01626352|39188868|FG000|Overall Study|Never Treated|1|||
16194796|NCT01588353|39188869|FG000|Step2|Withdrawal by Subject|0|||
16194797|NCT01588353|39188870|FG001|Step2|Withdrawal by Subject|1|||
16194798|NCT01588353|39188871|FG002|Step2|Withdrawal by Subject|0|||
16194799|NCT01588353|39188869|FG000|Step3|Adverse Event|0|||
16194800|NCT01588353|39188870|FG001|Step3|Adverse Event|0|||
16194801|NCT01588353|39188871|FG002|Step3|Adverse Event|2|||
16194802|NCT03025217|39188877|FG000|Overall Study|Pregnancy|1|||
16194803|NCT03025217|39188877|FG000|Overall Study|Lost to Follow-up|1|||
16194804|NCT03025217|39188877|FG000|Overall Study|Not eligible, poor English|2|||
16194805|NCT03591146|39188878|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
16194806|NCT03591146|39188879|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
16194807|NCT03591146|39188880|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
16194808|NCT03591146|39188881|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
16194809|NCT03591146|39188882|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
16194810|NCT03591146|39188878|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
16194811|NCT03591146|39188879|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
16194812|NCT03591146|39188880|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
16194813|NCT03591146|39188881|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
16194814|NCT03591146|39188882|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
16194815|NCT03591146|39188878|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
16194816|NCT03591146|39188879|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
16194817|NCT03591146|39188880|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
16497699|NCT00293254|40295431|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
16497700|NCT00293254|40295430|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
16497701|NCT00293254|40295431|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
16497702|NCT00293254|40295430|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
16497703|NCT00293254|40295431|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
16497704|NCT00293254|40295430|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
16497705|NCT00293254|40295431|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
16497706|NCT00619801|40295432|FG000|Overall Study|Lack of Efficacy|0|||
16194818|NCT03591146|39188881|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
16194819|NCT03591146|39188882|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
16497707|NCT00619801|40295433|FG001|Overall Study|Lack of Efficacy|1|||
16497708|NCT00619801|40295432|FG000|Overall Study|Withdrawal by Subject|1|||
16497709|NCT00619801|40295433|FG001|Overall Study|Withdrawal by Subject|1|||
16497710|NCT00619801|40295432|FG000|Overall Study|Loss of efficacy|0|||
16497711|NCT00619801|40295433|FG001|Overall Study|Loss of efficacy|1|||
16497712|NCT00656474|40295439|FG000|Overall Study|Other Reason|1|||
16497713|NCT02598076|40295440|FG000|Overall Study|Lost to Follow-up|2|||
16497714|NCT02598076|40295441|FG001|Overall Study|Lost to Follow-up|3|||
16497715|NCT00580606|40295442|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
16497716|NCT00580606|40295443|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
16194820|NCT03591146|39188878|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
16194821|NCT03591146|39188879|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
16194822|NCT03591146|39188880|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
16194823|NCT03591146|39188881|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
16194824|NCT03591146|39188882|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
16194825|NCT00592852|39188887|FG000|Overall Study|Non-compliance|1|||
16194826|NCT00592852|39188887|FG000|Overall Study|Adverse Event|3|||
16194827|NCT00592852|39188887|FG000|Overall Study|Found ineligible|1|||
16194828|NCT00592852|39188887|FG000|Overall Study|Withdrawal by Subject|1|||
16223377|NCT04594213|39298663|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
16223378|NCT04594213|39298664|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
16223379|NCT04594213|39298665|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
16223380|NCT04594213|39298666|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
16223381|NCT04594213|39298661|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
16223382|NCT04594213|39298662|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
16223383|NCT04594213|39298663|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
16223384|NCT04594213|39298664|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
16223385|NCT04594213|39298665|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
16223386|NCT04594213|39298666|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
16223387|NCT04594213|39298661|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
16223388|NCT04594213|39298662|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
16223389|NCT04594213|39298663|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
16223390|NCT04594213|39298664|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
16223391|NCT04594213|39298665|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
16223392|NCT04594213|39298666|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
16223393|NCT04594213|39298661|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
16223394|NCT04594213|39298662|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
16223395|NCT04594213|39298663|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
16223396|NCT04594213|39298664|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
16223397|NCT04594213|39298665|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
16223398|NCT04594213|39298666|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
16223399|NCT04594213|39298661|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
16223400|NCT04594213|39298662|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
16223401|NCT04594213|39298663|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
16223402|NCT04594213|39298664|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
16223403|NCT04594213|39298665|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
16223404|NCT04594213|39298666|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
16223405|NCT02516605|39298667|FG000|Overall Study|Protocol Violation|0|||
16223406|NCT02516605|39298668|FG001|Overall Study|Protocol Violation|0|||
16223407|NCT02516605|39298669|FG002|Overall Study|Protocol Violation|0|||
16223408|NCT02516605|39298670|FG003|Overall Study|Protocol Violation|0|||
16223409|NCT02516605|39298671|FG004|Overall Study|Protocol Violation|1|||
16223410|NCT02516605|39298667|FG000|Overall Study|Withdrawal by Subject|0|||
16223411|NCT02516605|39298668|FG001|Overall Study|Withdrawal by Subject|0|||
16223412|NCT02516605|39298669|FG002|Overall Study|Withdrawal by Subject|0|||
16223413|NCT02516605|39298670|FG003|Overall Study|Withdrawal by Subject|1|||
16223414|NCT02516605|39298671|FG004|Overall Study|Withdrawal by Subject|0|||
16223415|NCT02943577|39298674|FG000|Overall Study|Protocol Violation|0|||
16223416|NCT02943577|39298675|FG001|Overall Study|Protocol Violation|1|||
16223417|NCT02943577|39298674|FG000|Overall Study|Adverse Event|3|||
16223418|NCT02943577|39298675|FG001|Overall Study|Adverse Event|2|||
16223419|NCT02943577|39298674|FG000|Overall Study|Lost to Follow-up|0|||
16223420|NCT02943577|39298675|FG001|Overall Study|Lost to Follow-up|1|||
16223421|NCT02943577|39298674|FG000|Overall Study|Withdrawal by Subject|1|||
16223422|NCT02943577|39298675|FG001|Overall Study|Withdrawal by Subject|1|||
16223423|NCT02943577|39298674|FG000|Overall Study|Pregnancy|1|||
16223424|NCT02943577|39298675|FG001|Overall Study|Pregnancy|0|||
16223425|NCT01277757|39298679|FG000|Overall Study|Disease Progression|1|||
16223426|NCT01277757|39298679|FG000|Overall Study|Withdrawal by Subject|1|||
16223427|NCT02275780|39298682|FG000|Base Study: 96 Weeks|Adverse Event|6|||
16223428|NCT02275780|39298683|FG001|Base Study: 96 Weeks|Adverse Event|14|||
16497717|NCT00580606|40295442|FG000|Open Label (OL)|Withdrawal by Subject|4|||
16497718|NCT00580606|40295443|FG001|Open Label (OL)|Withdrawal by Subject|6|||
16497719|NCT00580606|40295442|FG000|Open Label (OL)|Dosing Symptoms|0|||
16497720|NCT00580606|40295443|FG001|Open Label (OL)|Dosing Symptoms|1|||
16497721|NCT00580606|40295442|FG000|Open Label (OL)|Lost to Follow-up|0|||
16497722|NCT00580606|40295443|FG001|Open Label (OL)|Lost to Follow-up|1|||
16497723|NCT00580606|40295442|FG000|Open Label (OL)|Pregnancy|0|||
16497724|NCT00580606|40295443|FG001|Open Label (OL)|Pregnancy|1|||
16497725|NCT00580606|40295442|FG000|Open Label (OL)|Non-compliance|2|||
16497726|NCT00580606|40295443|FG001|Open Label (OL)|Non-compliance|0|||
16497727|NCT00580606|40295442|FG000|Open Label (OL)|Physician Decision|1|||
16086992|NCT01998958|38810591|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086993|NCT01998958|38810592|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086994|NCT01998958|38810593|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086995|NCT01998958|38810594|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086996|NCT01998958|38810595|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086997|NCT01998958|38810596|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086998|NCT01998958|38810597|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16086999|NCT01998958|38810598|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087000|NCT01998958|38810599|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087001|NCT01998958|38810600|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087002|NCT01998958|38810601|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087003|NCT01998958|38810602|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087004|NCT01998958|38810603|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087005|NCT01998958|38810604|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087006|NCT01998958|38810605|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087007|NCT01998958|38810606|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087008|NCT01998958|38810607|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087009|NCT01998958|38810608|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087010|NCT01998958|38810609|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087011|NCT01998958|38810610|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087012|NCT01998958|38810611|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087013|NCT01998958|38810612|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087014|NCT01998958|38810613|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
16087015|NCT01998958|38810582|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
16087016|NCT01998958|38810583|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
16087017|NCT01998958|38810584|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
16087018|NCT01998958|38810585|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
16087019|NCT01998958|38810586|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
16087020|NCT01998958|38810587|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
16087021|NCT01998958|38810588|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
16087022|NCT01998958|38810589|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
16087023|NCT01998958|38810590|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
16087024|NCT01998958|38810591|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
16087025|NCT01998958|38810592|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
16087026|NCT01998958|38810593|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
16087027|NCT01998958|38810594|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
16087028|NCT01998958|38810595|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
16087029|NCT01998958|38810596|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
16087030|NCT01998958|38810597|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
16087031|NCT01998958|38810598|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
16087032|NCT01998958|38810599|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
16087033|NCT01998958|38810600|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
16087034|NCT01998958|38810601|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
16087035|NCT01998958|38810602|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
16087036|NCT01998958|38810603|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
16087037|NCT01998958|38810604|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
16087038|NCT01998958|38810605|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
16087039|NCT01998958|38810606|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
16087040|NCT01998958|38810607|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
16087041|NCT01998958|38810608|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
16087042|NCT01998958|38810609|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
16087043|NCT01998958|38810610|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
16087044|NCT01998958|38810611|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
16087045|NCT01998958|38810612|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
16087046|NCT01998958|38810613|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
16087047|NCT01998958|38810582|FG000|Period 1 (Panel A and B)|Other|1|||
16087048|NCT01998958|38810583|FG001|Period 1 (Panel A and B)|Other|0|||
16087049|NCT01998958|38810584|FG002|Period 1 (Panel A and B)|Other|0|||
16087050|NCT01998958|38810585|FG003|Period 1 (Panel A and B)|Other|0|||
16087051|NCT01998958|38810586|FG004|Period 1 (Panel A and B)|Other|0|||
16087052|NCT01998958|38810587|FG005|Period 1 (Panel A and B)|Other|0|||
16087053|NCT01998958|38810588|FG006|Period 1 (Panel A and B)|Other|0|||
16087054|NCT01998958|38810589|FG007|Period 1 (Panel A and B)|Other|0|||
16087055|NCT01998958|38810590|FG008|Period 1 (Panel A and B)|Other|0|||
16194829|NCT02953782|39193175|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
16497728|NCT00580606|40295443|FG001|Open Label (OL)|Physician Decision|1|||
16497729|NCT00580606|40295442|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
16194830|NCT02953782|39193176|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
16194831|NCT02953782|39193177|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
16194832|NCT02953782|39193178|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
16194833|NCT02953782|39193179|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
16194834|NCT02953782|39193180|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
16194835|NCT02953782|39193181|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
16194836|NCT02953782|39193182|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
16194837|NCT02953782|39193175|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
16194838|NCT02953782|39193176|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
16194839|NCT02953782|39193177|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
16194840|NCT02953782|39193178|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
16194841|NCT02953782|39193179|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
16194842|NCT02953782|39193180|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
16194843|NCT02953782|39193181|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
16194844|NCT02953782|39193182|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
16194845|NCT02953782|39193175|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
16194846|NCT02953782|39193176|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
16194847|NCT02953782|39193177|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
16194848|NCT02953782|39193178|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
16194849|NCT02953782|39193179|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
16194850|NCT02953782|39193180|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
16194851|NCT02953782|39193181|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
16194852|NCT02953782|39193182|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
16194853|NCT02953782|39193175|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
16194854|NCT02953782|39193176|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
16194855|NCT02953782|39193177|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
16194856|NCT02953782|39193178|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
16194857|NCT02953782|39193179|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
16194858|NCT02953782|39193180|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
16194859|NCT02953782|39193181|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
16194860|NCT02953782|39193182|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
16194861|NCT02953782|39193175|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
16194862|NCT02953782|39193176|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
16194863|NCT02953782|39193177|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
16194864|NCT02953782|39193178|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
16194865|NCT02953782|39193179|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
16194866|NCT02953782|39193180|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
16194867|NCT02953782|39193181|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
16194868|NCT02953782|39193182|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
16194869|NCT02953782|39193175|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
16194870|NCT02953782|39193176|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
16194871|NCT02953782|39193177|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
16194872|NCT02953782|39193178|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
16194873|NCT02953782|39193179|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
16194874|NCT02953782|39193180|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
16194875|NCT02953782|39193181|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
16194876|NCT02953782|39193182|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
16194877|NCT02953782|39193175|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
16194878|NCT02953782|39193176|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
16194879|NCT02953782|39193177|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
16194880|NCT02953782|39193178|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
16194881|NCT02953782|39193179|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
16194882|NCT02953782|39193180|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
16194883|NCT02953782|39193181|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
16194884|NCT02953782|39193182|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
16194885|NCT02953782|39193175|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
16497730|NCT00580606|40295443|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
16497731|NCT00642941|40295448|FG000|Overall Study|Physician Decision|3|||
16497732|NCT00642941|40295449|FG001|Overall Study|Physician Decision|1|||
16497733|NCT00642941|40295450|FG002|Overall Study|Physician Decision|0|||
16497734|NCT00642941|40295451|FG003|Overall Study|Physician Decision|0|||
16497735|NCT00642941|40295452|FG004|Overall Study|Physician Decision|0|||
16087056|NCT01998958|38810591|FG009|Period 1 (Panel A and B)|Other|0|||
16087057|NCT01998958|38810592|FG010|Period 1 (Panel A and B)|Other|0|||
16194886|NCT02953782|39193176|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
16194887|NCT02953782|39193177|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
16194888|NCT02953782|39193178|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
16194889|NCT02953782|39193179|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
16194890|NCT02953782|39193180|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
16194891|NCT02953782|39193181|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
16194892|NCT02953782|39193182|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
16194893|NCT00793819|39193185|FG000|Overall Study|Adverse Event|8|||
16194894|NCT00793819|39193186|FG001|Overall Study|Adverse Event|4|||
16194895|NCT00793819|39193185|FG000|Overall Study|Lack of Efficacy|1|||
16194896|NCT00793819|39193186|FG001|Overall Study|Lack of Efficacy|1|||
16194897|NCT00793819|39193185|FG000|Overall Study|Withdrawal by Subject|4|||
16194898|NCT00793819|39193186|FG001|Overall Study|Withdrawal by Subject|3|||
16194899|NCT00793819|39193185|FG000|Overall Study|Lost to Follow-up|1|||
16194900|NCT00793819|39193186|FG001|Overall Study|Lost to Follow-up|1|||
16194901|NCT00436566|39193191|FG000|Overall Study|Withdrawal by Subject|2|||
16194902|NCT00436566|39193191|FG000|Overall Study|Protocol Violation|1|||
16194903|NCT02431468|39193200|FG000|Overall Study|Adverse Event|2|||
16194904|NCT02431468|39193201|FG001|Overall Study|Adverse Event|4|||
16194905|NCT02431468|39193202|FG002|Overall Study|Adverse Event|5|||
16194906|NCT02431468|39193200|FG000|Overall Study|Withdrawal by Subject|4|||
16194907|NCT02431468|39193201|FG001|Overall Study|Withdrawal by Subject|12|||
16194908|NCT02431468|39193202|FG002|Overall Study|Withdrawal by Subject|2|||
16194909|NCT02431468|39193200|FG000|Overall Study|noncompliance, investigator termination,|2|||
16194910|NCT02431468|39193201|FG001|Overall Study|noncompliance, investigator termination,|2|||
16194911|NCT02431468|39193202|FG002|Overall Study|noncompliance, investigator termination,|2|||
16194912|NCT03053427|39193203|FG000|Overall Study|Adverse Event|4|||
16194913|NCT03053427|39193204|FG001|Overall Study|Adverse Event|4|||
16194914|NCT03053427|39193203|FG000|Overall Study|Lack of Efficacy|1|||
16194915|NCT03053427|39193204|FG001|Overall Study|Lack of Efficacy|3|||
16194916|NCT03053427|39193203|FG000|Overall Study|Lost to Follow-up|2|||
16194917|NCT03053427|39193204|FG001|Overall Study|Lost to Follow-up|2|||
16194918|NCT03053427|39193203|FG000|Overall Study|Worsening of the target disease|0|||
16194919|NCT03053427|39193204|FG001|Overall Study|Worsening of the target disease|1|||
16194920|NCT03053427|39193203|FG000|Overall Study|Protocol Deviation|3|||
16194921|NCT03053427|39193204|FG001|Overall Study|Protocol Deviation|3|||
16194922|NCT03053427|39193203|FG000|Overall Study|Withdrawal by Subject|3|||
16194923|NCT03053427|39193204|FG001|Overall Study|Withdrawal by Subject|2|||
16194924|NCT03053427|39193203|FG000|Overall Study|Miscellaneous|0|||
16194925|NCT03053427|39193204|FG001|Overall Study|Miscellaneous|1|||
16194926|NCT00645567|39193205|FG000|Overall Study|Adverse Event|1|||
16194927|NCT01982773|39193206|FG000|Overall Study|Withdrawal by Subject|1|||
16194928|NCT01982773|39193207|FG001|Overall Study|Withdrawal by Subject|3|||
16194929|NCT01982773|39193206|FG000|Overall Study|Lost to Follow-up|7|||
16194930|NCT01982773|39193207|FG001|Overall Study|Lost to Follow-up|1|||
16194931|NCT02163993|39193208|FG000|Treatment Period|Adverse Event|0|||
16194932|NCT02163993|39193209|FG001|Treatment Period|Adverse Event|1|||
16194933|NCT02163993|39193210|FG002|Treatment Period|Adverse Event|0|||
16194934|NCT02163993|39193211|FG003|Treatment Period|Adverse Event|0|||
16194935|NCT02163993|39193212|FG004|Treatment Period|Adverse Event|1|||
16194936|NCT02163993|39193208|FG000|Treatment Period|Lost to Follow-up|2|||
16194937|NCT02163993|39193209|FG001|Treatment Period|Lost to Follow-up|3|||
16194938|NCT02163993|39193210|FG002|Treatment Period|Lost to Follow-up|1|||
16194939|NCT02163993|39193211|FG003|Treatment Period|Lost to Follow-up|3|||
16194940|NCT02163993|39193212|FG004|Treatment Period|Lost to Follow-up|1|||
16194941|NCT02163993|39193208|FG000|Treatment Period|Physician Decision|1|||
16194942|NCT02163993|39193209|FG001|Treatment Period|Physician Decision|0|||
16194943|NCT02163993|39193210|FG002|Treatment Period|Physician Decision|0|||
16194944|NCT02163993|39193211|FG003|Treatment Period|Physician Decision|0|||
16309050|NCT00856492|39615686|FG000|Overall Study|Ineligible or withdrew consent|1|||
16194945|NCT02163993|39193212|FG004|Treatment Period|Physician Decision|0|||
16194946|NCT02163993|39193208|FG000|Treatment Period|Protocol Violation|2|||
16194947|NCT02163993|39193209|FG001|Treatment Period|Protocol Violation|1|||
16194948|NCT02163993|39193210|FG002|Treatment Period|Protocol Violation|0|||
16309051|NCT00856492|39615687|FG001|Overall Study|Ineligible or withdrew consent|1|||
16309052|NCT00856492|39615688|FG002|Overall Study|Ineligible or withdrew consent|2|||
16194949|NCT02163993|39193211|FG003|Treatment Period|Protocol Violation|1|||
16194950|NCT02163993|39193212|FG004|Treatment Period|Protocol Violation|2|||
16194951|NCT02163993|39193208|FG000|Treatment Period|Withdrawal by Subject|6|||
16194952|NCT02163993|39193209|FG001|Treatment Period|Withdrawal by Subject|4|||
16194953|NCT02163993|39193210|FG002|Treatment Period|Withdrawal by Subject|1|||
16194954|NCT02163993|39193211|FG003|Treatment Period|Withdrawal by Subject|4|||
16194955|NCT02163993|39193212|FG004|Treatment Period|Withdrawal by Subject|1|||
16194956|NCT02163993|39193208|FG000|Treatment Period|Not treated|1|||
16194957|NCT02163993|39193209|FG001|Treatment Period|Not treated|0|||
16194958|NCT02163993|39193210|FG002|Treatment Period|Not treated|0|||
16194959|NCT02163993|39193211|FG003|Treatment Period|Not treated|1|||
16194960|NCT02163993|39193212|FG004|Treatment Period|Not treated|2|||
16194961|NCT02163993|39193208|FG000|Post-treatment Period|Adverse Event|0|||
16194962|NCT02163993|39193209|FG001|Post-treatment Period|Adverse Event|0|||
16194963|NCT02163993|39193210|FG002|Post-treatment Period|Adverse Event|1|||
16194964|NCT02163993|39193211|FG003|Post-treatment Period|Adverse Event|0|||
16194965|NCT02163993|39193212|FG004|Post-treatment Period|Adverse Event|0|||
16194966|NCT02163993|39193208|FG000|Post-treatment Period|Lost to Follow-up|2|||
16194967|NCT02163993|39193209|FG001|Post-treatment Period|Lost to Follow-up|2|||
16194968|NCT02163993|39193210|FG002|Post-treatment Period|Lost to Follow-up|3|||
16194969|NCT02163993|39193211|FG003|Post-treatment Period|Lost to Follow-up|1|||
16194970|NCT02163993|39193212|FG004|Post-treatment Period|Lost to Follow-up|0|||
16194971|NCT02163993|39193208|FG000|Post-treatment Period|Protocol Violation|0|||
16194972|NCT02163993|39193209|FG001|Post-treatment Period|Protocol Violation|0|||
16194973|NCT02163993|39193210|FG002|Post-treatment Period|Protocol Violation|0|||
16194974|NCT02163993|39193211|FG003|Post-treatment Period|Protocol Violation|0|||
16194975|NCT02163993|39193212|FG004|Post-treatment Period|Protocol Violation|1|||
16194976|NCT02163993|39193208|FG000|Post-treatment Period|Withdrawal by Subject|2|||
16194977|NCT02163993|39193209|FG001|Post-treatment Period|Withdrawal by Subject|4|||
16194978|NCT02163993|39193210|FG002|Post-treatment Period|Withdrawal by Subject|0|||
16194979|NCT02163993|39193211|FG003|Post-treatment Period|Withdrawal by Subject|1|||
16194980|NCT02163993|39193212|FG004|Post-treatment Period|Withdrawal by Subject|2|||
16194981|NCT04501679|39193213|FG000|Overall Study|Pregnancy|0|||
16194982|NCT04501679|39193214|FG001|Overall Study|Pregnancy|1|||
16194983|NCT04501679|39193213|FG000|Overall Study|Adverse Event|4|||
16194984|NCT04501679|39193214|FG001|Overall Study|Adverse Event|2|||
16194985|NCT04501679|39193213|FG000|Overall Study|Withdrawal by Subject|2|||
16194986|NCT04501679|39193214|FG001|Overall Study|Withdrawal by Subject|0|||
16194987|NCT04501679|39193213|FG000|Overall Study|Physician Decision|1|||
16194988|NCT04501679|39193214|FG001|Overall Study|Physician Decision|0|||
16194989|NCT04501679|39193213|FG000|Overall Study|Lost to Follow-up|2|||
16194990|NCT04501679|39193214|FG001|Overall Study|Lost to Follow-up|0|||
16194991|NCT03225716|39193215|FG000|Overall Study|Withdrawal by Subject|2|||
16194992|NCT03225716|39193216|FG001|Overall Study|Withdrawal by Subject|2|||
16194993|NCT03225716|39193217|FG002|Overall Study|Withdrawal by Subject|0|||
16194994|NCT03225716|39193215|FG000|Overall Study|Lack of Efficacy|1|||
16194995|NCT03225716|39193216|FG001|Overall Study|Lack of Efficacy|0|||
16194996|NCT03225716|39193217|FG002|Overall Study|Lack of Efficacy|0|||
16194997|NCT03225716|39193215|FG000|Overall Study|Adverse Event|2|||
16194998|NCT03225716|39193216|FG001|Overall Study|Adverse Event|0|||
16194999|NCT03225716|39193217|FG002|Overall Study|Adverse Event|1|||
16195000|NCT03225716|39193215|FG000|Overall Study|Study early termination by Sponsor|0|||
16195001|NCT03225716|39193216|FG001|Overall Study|Study early termination by Sponsor|0|||
16195002|NCT03225716|39193217|FG002|Overall Study|Study early termination by Sponsor|2|||
16195003|NCT02112916|39193218|FG000|Overall Study|Adverse Event|6|||
16195004|NCT02112916|39193219|FG001|Overall Study|Adverse Event|9|||
16195005|NCT02112916|39193220|FG002|Overall Study|Adverse Event|3|||
16195006|NCT02112916|39193221|FG003|Overall Study|Adverse Event|2|||
16195007|NCT02112916|39193218|FG000|Overall Study|Death|9|||
16195008|NCT02112916|39193219|FG001|Overall Study|Death|9|||
16195009|NCT02112916|39193220|FG002|Overall Study|Death|3|||
16195010|NCT02112916|39193221|FG003|Overall Study|Death|4|||
16195011|NCT02112916|39193218|FG000|Overall Study|Lost to Follow-up|1|||
16309053|NCT00625820|39615689|FG000|Overall Study|Withdrawal by Subject|1|||
16195012|NCT02112916|39193219|FG001|Overall Study|Lost to Follow-up|0|||
16195013|NCT02112916|39193220|FG002|Overall Study|Lost to Follow-up|0|||
16195014|NCT02112916|39193221|FG003|Overall Study|Lost to Follow-up|0|||
16195015|NCT02112916|39193218|FG000|Overall Study|Physician Decision|94|||
16195016|NCT02112916|39193219|FG001|Overall Study|Physician Decision|72|||
16195017|NCT02112916|39193220|FG002|Overall Study|Physician Decision|24|||
16195018|NCT02112916|39193221|FG003|Overall Study|Physician Decision|15|||
16309054|NCT01275729|39615690|FG000|Overall Study|Death|3|||
16309055|NCT01275729|39615690|FG000|Overall Study|Withdrawal by Subject|1|||
16309056|NCT00768248|39615691|FG000|Overall Study|Research coordinator didn't collect data|1|||
16409943|NCT01269385|39981839|FG003|Overall Study|Adverse Event|0|||
16195019|NCT02112916|39193218|FG000|Overall Study|Withdrawal by Subject|5|||
16195020|NCT02112916|39193219|FG001|Overall Study|Withdrawal by Subject|3|||
16195021|NCT02112916|39193220|FG002|Overall Study|Withdrawal by Subject|1|||
16195022|NCT02112916|39193221|FG003|Overall Study|Withdrawal by Subject|1|||
16195023|NCT02112916|39193218|FG000|Overall Study|Ineligible|4|||
16195024|NCT02112916|39193219|FG001|Overall Study|Ineligible|8|||
16195025|NCT02112916|39193220|FG002|Overall Study|Ineligible|3|||
16195026|NCT02112916|39193221|FG003|Overall Study|Ineligible|8|||
16195027|NCT02112916|39193218|FG000|Overall Study|Inevaluable|6|||
16195028|NCT02112916|39193219|FG001|Overall Study|Inevaluable|4|||
16195029|NCT02112916|39193220|FG002|Overall Study|Inevaluable|5|||
16195030|NCT02112916|39193221|FG003|Overall Study|Inevaluable|5|||
16195031|NCT02112916|39193218|FG000|Overall Study|Refusal of further protocol therapy|19|||
16195032|NCT02112916|39193219|FG001|Overall Study|Refusal of further protocol therapy|16|||
16195033|NCT02112916|39193220|FG002|Overall Study|Refusal of further protocol therapy|1|||
16195034|NCT02112916|39193221|FG003|Overall Study|Refusal of further protocol therapy|7|||
16195035|NCT02112916|39193218|FG000|Overall Study|Development of SMN|1|||
16195036|NCT02112916|39193219|FG001|Overall Study|Development of SMN|0|||
16195037|NCT02112916|39193220|FG002|Overall Study|Development of SMN|0|||
16195038|NCT02112916|39193221|FG003|Overall Study|Development of SMN|1|||
16195039|NCT02112916|39193218|FG000|Overall Study|Relapse/Progression|10|||
16195040|NCT02112916|39193219|FG001|Overall Study|Relapse/Progression|18|||
16195041|NCT02112916|39193220|FG002|Overall Study|Relapse/Progression|15|||
16195042|NCT02112916|39193221|FG003|Overall Study|Relapse/Progression|2|||
16195043|NCT02112916|39193218|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
16195044|NCT02112916|39193219|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
16497736|NCT00642941|40295453|FG005|Overall Study|Physician Decision|0|||
16497737|NCT00642941|40295454|FG006|Overall Study|Physician Decision|1|||
16497738|NCT00642941|40295455|FG007|Overall Study|Physician Decision|0|||
16497739|NCT00642941|40295456|FG008|Overall Study|Physician Decision|0|||
16497740|NCT00642941|40295457|FG009|Overall Study|Physician Decision|1|||
16497741|NCT00642941|40295458|FG010|Overall Study|Physician Decision|0|||
16497742|NCT00642941|40295459|FG011|Overall Study|Physician Decision|1|||
16497743|NCT00642941|40295448|FG000|Overall Study|Death|4|||
16497744|NCT00642941|40295449|FG001|Overall Study|Death|0|||
16388747|NCT00532844|39905750|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
16388748|NCT00532844|39905751|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
16388749|NCT00532844|39905750|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
16388750|NCT00532844|39905751|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
16497745|NCT00642941|40295450|FG002|Overall Study|Death|1|||
16497746|NCT00642941|40295451|FG003|Overall Study|Death|1|||
16497747|NCT00642941|40295452|FG004|Overall Study|Death|2|||
16497748|NCT00642941|40295453|FG005|Overall Study|Death|1|||
16497749|NCT00642941|40295454|FG006|Overall Study|Death|0|||
16087058|NCT01998958|38810593|FG011|Period 1 (Panel A and B)|Other|0|||
16195045|NCT02112916|39193220|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
16497750|NCT00642941|40295455|FG007|Overall Study|Death|0|||
16497751|NCT00642941|40295456|FG008|Overall Study|Death|0|||
16497752|NCT00642941|40295457|FG009|Overall Study|Death|0|||
16497753|NCT00642941|40295458|FG010|Overall Study|Death|0|||
16497754|NCT00642941|40295459|FG011|Overall Study|Death|1|||
16497755|NCT00642941|40295448|FG000|Overall Study|Study closed by Sponsor|0|||
16497756|NCT00642941|40295449|FG001|Overall Study|Study closed by Sponsor|1|||
16497757|NCT00642941|40295450|FG002|Overall Study|Study closed by Sponsor|0|||
16497758|NCT00642941|40295451|FG003|Overall Study|Study closed by Sponsor|0|||
16497759|NCT00642941|40295452|FG004|Overall Study|Study closed by Sponsor|0|||
16497760|NCT00642941|40295453|FG005|Overall Study|Study closed by Sponsor|0|||
16497761|NCT00642941|40295454|FG006|Overall Study|Study closed by Sponsor|0|||
16497762|NCT00642941|40295455|FG007|Overall Study|Study closed by Sponsor|0|||
16497763|NCT00642941|40295456|FG008|Overall Study|Study closed by Sponsor|0|||
16497764|NCT00642941|40295457|FG009|Overall Study|Study closed by Sponsor|0|||
16497765|NCT00642941|40295458|FG010|Overall Study|Study closed by Sponsor|0|||
16497766|NCT00642941|40295459|FG011|Overall Study|Study closed by Sponsor|0|||
16497767|NCT00642941|40295448|FG000|Overall Study|Withdrawal by Subject|1|||
16497768|NCT00642941|40295449|FG001|Overall Study|Withdrawal by Subject|0|||
16497769|NCT00642941|40295450|FG002|Overall Study|Withdrawal by Subject|0|||
16497770|NCT00642941|40295451|FG003|Overall Study|Withdrawal by Subject|2|||
16497771|NCT00642941|40295452|FG004|Overall Study|Withdrawal by Subject|0|||
16497772|NCT00642941|40295453|FG005|Overall Study|Withdrawal by Subject|0|||
16195046|NCT02112916|39193221|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
16195047|NCT02112916|39193218|FG000|Overall Study|Still on Therapy|44|||
16497773|NCT00642941|40295454|FG006|Overall Study|Withdrawal by Subject|2|||
16497774|NCT00642941|40295455|FG007|Overall Study|Withdrawal by Subject|0|||
16388751|NCT00532844|39905750|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
16497775|NCT00642941|40295456|FG008|Overall Study|Withdrawal by Subject|1|||
16546313|NCT02237508|40464777|FG004|Overall Study|Physician Decision|0|||
16497776|NCT00642941|40295457|FG009|Overall Study|Withdrawal by Subject|0|||
16497777|NCT00642941|40295458|FG010|Overall Study|Withdrawal by Subject|0|||
16497778|NCT00642941|40295459|FG011|Overall Study|Withdrawal by Subject|1|||
16497779|NCT00642941|40295448|FG000|Overall Study|Protocol Violation|0|||
16497780|NCT00642941|40295449|FG001|Overall Study|Protocol Violation|0|||
16497781|NCT00642941|40295450|FG002|Overall Study|Protocol Violation|0|||
16497782|NCT00642941|40295451|FG003|Overall Study|Protocol Violation|0|||
16497783|NCT00642941|40295452|FG004|Overall Study|Protocol Violation|0|||
16497784|NCT00642941|40295453|FG005|Overall Study|Protocol Violation|0|||
16497785|NCT00642941|40295454|FG006|Overall Study|Protocol Violation|1|||
16497786|NCT00642941|40295455|FG007|Overall Study|Protocol Violation|0|||
16497787|NCT00642941|40295456|FG008|Overall Study|Protocol Violation|0|||
16497788|NCT00642941|40295457|FG009|Overall Study|Protocol Violation|0|||
16497789|NCT00642941|40295458|FG010|Overall Study|Protocol Violation|0|||
16497790|NCT00642941|40295459|FG011|Overall Study|Protocol Violation|0|||
16497791|NCT00642941|40295448|FG000|Overall Study|Adverse Event|1|||
16497792|NCT00642941|40295449|FG001|Overall Study|Adverse Event|1|||
16497793|NCT00642941|40295450|FG002|Overall Study|Adverse Event|0|||
16497794|NCT00642941|40295451|FG003|Overall Study|Adverse Event|0|||
16497795|NCT00642941|40295452|FG004|Overall Study|Adverse Event|0|||
16497796|NCT00642941|40295453|FG005|Overall Study|Adverse Event|0|||
16497797|NCT00642941|40295454|FG006|Overall Study|Adverse Event|1|||
16497798|NCT00642941|40295455|FG007|Overall Study|Adverse Event|1|||
16497799|NCT00642941|40295456|FG008|Overall Study|Adverse Event|0|||
16497800|NCT00642941|40295457|FG009|Overall Study|Adverse Event|1|||
16497801|NCT00642941|40295458|FG010|Overall Study|Adverse Event|0|||
16497802|NCT00642941|40295459|FG011|Overall Study|Adverse Event|0|||
16497803|NCT00642941|40295448|FG000|Overall Study|Other|1|||
16497804|NCT00642941|40295449|FG001|Overall Study|Other|1|||
16497805|NCT00642941|40295450|FG002|Overall Study|Other|1|||
16497806|NCT00642941|40295451|FG003|Overall Study|Other|1|||
16497807|NCT00642941|40295452|FG004|Overall Study|Other|0|||
16497808|NCT00642941|40295453|FG005|Overall Study|Other|1|||
16497809|NCT00642941|40295454|FG006|Overall Study|Other|0|||
16497810|NCT00642941|40295455|FG007|Overall Study|Other|1|||
16497811|NCT00642941|40295456|FG008|Overall Study|Other|0|||
16497812|NCT00642941|40295457|FG009|Overall Study|Other|0|||
16497813|NCT00642941|40295458|FG010|Overall Study|Other|0|||
16497814|NCT00642941|40295459|FG011|Overall Study|Other|1|||
16497815|NCT00642941|40295448|FG000|Overall Study|Disease progression|60|||
16497816|NCT00642941|40295449|FG001|Overall Study|Disease progression|50|||
16497817|NCT00642941|40295450|FG002|Overall Study|Disease progression|5|||
16497818|NCT00642941|40295451|FG003|Overall Study|Disease progression|36|||
16497819|NCT00642941|40295452|FG004|Overall Study|Disease progression|23|||
16497820|NCT00642941|40295453|FG005|Overall Study|Disease progression|39|||
16497821|NCT00642941|40295454|FG006|Overall Study|Disease progression|18|||
16497822|NCT00642941|40295455|FG007|Overall Study|Disease progression|12|||
16497823|NCT00642941|40295456|FG008|Overall Study|Disease progression|10|||
16497824|NCT00642941|40295457|FG009|Overall Study|Disease progression|7|||
16497825|NCT00642941|40295458|FG010|Overall Study|Disease progression|12|||
16087059|NCT01998958|38810594|FG012|Period 1 (Panel A and B)|Other|0|||
16087060|NCT01998958|38810595|FG013|Period 1 (Panel A and B)|Other|0|||
16087061|NCT01998958|38810596|FG014|Period 1 (Panel A and B)|Other|0|||
16087062|NCT01998958|38810597|FG015|Period 1 (Panel A and B)|Other|0|||
16087063|NCT01998958|38810598|FG016|Period 1 (Panel A and B)|Other|0|||
16087064|NCT01998958|38810599|FG017|Period 1 (Panel A and B)|Other|0|||
16087065|NCT01998958|38810600|FG018|Period 1 (Panel A and B)|Other|0|||
16087066|NCT01998958|38810601|FG019|Period 1 (Panel A and B)|Other|0|||
16087067|NCT01998958|38810602|FG020|Period 1 (Panel A and B)|Other|0|||
16087068|NCT01998958|38810603|FG021|Period 1 (Panel A and B)|Other|0|||
16087069|NCT01998958|38810604|FG022|Period 1 (Panel A and B)|Other|0|||
16087070|NCT01998958|38810605|FG023|Period 1 (Panel A and B)|Other|0|||
16087071|NCT01998958|38810606|FG024|Period 1 (Panel A and B)|Other|0|||
16087072|NCT01998958|38810607|FG025|Period 1 (Panel A and B)|Other|0|||
16087073|NCT01998958|38810608|FG026|Period 1 (Panel A and B)|Other|0|||
16087074|NCT01998958|38810609|FG027|Period 1 (Panel A and B)|Other|0|||
16087075|NCT01998958|38810610|FG028|Period 1 (Panel A and B)|Other|0|||
16195048|NCT02112916|39193219|FG001|Overall Study|Still on Therapy|47|||
16309057|NCT00768248|39615692|FG001|Overall Study|Research coordinator didn't collect data|1|||
16497826|NCT00642941|40295459|FG011|Overall Study|Disease progression|7|||
16497827|NCT00884312|40295464|FG000|Overall Study|Non-fatal Progressive Disease|0|||
16497828|NCT00884312|40295465|FG001|Overall Study|Non-fatal Progressive Disease|8|||
16497829|NCT00884312|40295464|FG000|Overall Study|Fatal Progressive Disease|0|||
16497830|NCT00884312|40295465|FG001|Overall Study|Fatal Progressive Disease|1|||
16497831|NCT00884312|40295464|FG000|Overall Study|Non-fatal Adverse Event|1|||
16497832|NCT00884312|40295465|FG001|Overall Study|Non-fatal Adverse Event|0|||
16497833|NCT00884312|40295464|FG000|Overall Study|Fatal Adverse Event|1|||
16497834|NCT00884312|40295465|FG001|Overall Study|Fatal Adverse Event|4|||
16087076|NCT01998958|38810611|FG029|Period 1 (Panel A and B)|Other|0|||
16087077|NCT01998958|38810612|FG030|Period 1 (Panel A and B)|Other|0|||
16497835|NCT00884312|40295464|FG000|Overall Study|Withdrawal by Subject|0|||
16497836|NCT00884312|40295465|FG001|Overall Study|Withdrawal by Subject|6|||
16497837|NCT00884312|40295464|FG000|Overall Study|Physician Decision|0|||
16497838|NCT00884312|40295465|FG001|Overall Study|Physician Decision|1|||
16497839|NCT00884312|40295464|FG000|Overall Study|Other|0|||
16497840|NCT00884312|40295465|FG001|Overall Study|Other|4|||
16497841|NCT00884312|40295464|FG000|Overall Study|Did Not Receive Study Drug|0|||
16497842|NCT00884312|40295465|FG001|Overall Study|Did Not Receive Study Drug|1|||
16497843|NCT00449540|40295466|FG000|Pretreatment Phase|No migraine experienced|66|||
16497844|NCT00449540|40295467|FG001|Pretreatment Phase|No migraine experienced|0|||
16497845|NCT00449540|40295468|FG002|Pretreatment Phase|No migraine experienced|0|||
16497846|NCT00449540|40295466|FG000|Treatment Phase|did not experience or treat migraine|0|||
16497847|NCT00449540|40295467|FG001|Treatment Phase|did not experience or treat migraine|20|||
16497848|NCT00449540|40295468|FG002|Treatment Phase|did not experience or treat migraine|17|||
16497849|NCT03266107|40295469|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
16497850|NCT03266107|40295469|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
16497851|NCT03266107|40295469|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
16497852|NCT03266107|40295469|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
16497853|NCT03241342|40295470|FG000|Overall Study|Adverse Event|5|||
16497854|NCT03241342|40295471|FG001|Overall Study|Adverse Event|8|||
16497855|NCT03241342|40295472|FG002|Overall Study|Adverse Event|4|||
16497856|NCT03241342|40295470|FG000|Overall Study|Lack of Efficacy|0|||
16497857|NCT03241342|40295471|FG001|Overall Study|Lack of Efficacy|0|||
16497858|NCT03241342|40295472|FG002|Overall Study|Lack of Efficacy|1|||
16497859|NCT03241342|40295470|FG000|Overall Study|noncompliance with study drug|2|||
16497860|NCT03241342|40295471|FG001|Overall Study|noncompliance with study drug|1|||
16497861|NCT03241342|40295472|FG002|Overall Study|noncompliance with study drug|1|||
16497862|NCT03241342|40295470|FG000|Overall Study|sponsor decision|0|||
16497863|NCT03241342|40295471|FG001|Overall Study|sponsor decision|1|||
16497864|NCT03241342|40295472|FG002|Overall Study|sponsor decision|2|||
16497865|NCT03241342|40295470|FG000|Overall Study|not reported|15|||
16497866|NCT03241342|40295471|FG001|Overall Study|not reported|21|||
16497867|NCT03241342|40295472|FG002|Overall Study|not reported|19|||
16497868|NCT01408914|40295473|FG000|Overall Study|Could not complete tx in protocol period|5|||
16497869|NCT01408914|40295474|FG001|Overall Study|Could not complete tx in protocol period|5|||
16497870|NCT01408914|40295475|FG002|Overall Study|Could not complete tx in protocol period|6|||
16497871|NCT01408914|40295473|FG000|Overall Study|Lost to Follow-up|4|||
16497872|NCT01408914|40295474|FG001|Overall Study|Lost to Follow-up|1|||
16497873|NCT01408914|40295475|FG002|Overall Study|Lost to Follow-up|2|||
16497874|NCT01408914|40295473|FG000|Overall Study|Physician Decision|1|||
16497875|NCT01408914|40295474|FG001|Overall Study|Physician Decision|1|||
16497876|NCT01408914|40295475|FG002|Overall Study|Physician Decision|0|||
16497877|NCT01408914|40295473|FG000|Overall Study|Withdrawal by Subject|1|||
16497878|NCT01408914|40295474|FG001|Overall Study|Withdrawal by Subject|0|||
16497879|NCT01408914|40295475|FG002|Overall Study|Withdrawal by Subject|1|||
16497880|NCT01408914|40295473|FG000|Overall Study|Moved out of study jurisdiction|1|||
16497881|NCT01408914|40295474|FG001|Overall Study|Moved out of study jurisdiction|1|||
16497882|NCT01408914|40295475|FG002|Overall Study|Moved out of study jurisdiction|0|||
16497883|NCT01408914|40295473|FG000|Overall Study|Late exclusion|0|||
16497884|NCT01408914|40295474|FG001|Overall Study|Late exclusion|3|||
16497885|NCT01408914|40295475|FG002|Overall Study|Late exclusion|3|||
16497886|NCT01408914|40295473|FG000|Overall Study|Change in local TB/HIV norms|0|||
16497887|NCT01408914|40295474|FG001|Overall Study|Change in local TB/HIV norms|1|||
16497888|NCT01408914|40295475|FG002|Overall Study|Change in local TB/HIV norms|1|||
16497889|NCT01702454|40295476|FG000|Overall Study|Consent withdrawal|0|||
16497890|NCT01702454|40295477|FG001|Overall Study|Consent withdrawal|1|||
16497891|NCT01702454|40295476|FG000|Overall Study|Migrated/moved from study area|0|||
16497892|NCT01702454|40295477|FG001|Overall Study|Migrated/moved from study area|1|||
16497893|NCT01702454|40295476|FG000|Overall Study|Lost to Follow-up|3|||
16497894|NCT01702454|40295477|FG001|Overall Study|Lost to Follow-up|6|||
16497895|NCT01338493|40295478|FG000|Enrolled|Withdrawal by Subject|1|||
16497896|NCT01338493|40295478|FG000|Enrolled|Patient not implanted|4|||
16388752|NCT00532844|39905751|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
16497897|NCT01338493|40295478|FG000|Discharge|Death|1|||
16497898|NCT01338493|40295478|FG000|Discharge|Missed visit|1|||
16497899|NCT01338493|40295478|FG000|6 Months Follow up|Lost to Follow-up|11|||
16497900|NCT01338493|40295478|FG000|6 Months Follow up|Missed visit|8|||
16497901|NCT01338493|40295478|FG000|12 Months Follow up|Lost to Follow-up|9|||
16497902|NCT01892501|40295479|FG000|Overall Study|Protocol Violation|2|||
16497903|NCT01892501|40295479|FG000|Overall Study|Puncture not carried out|9|||
16497904|NCT01892501|40295479|FG000|Overall Study|Radiological monitoring not carried out|5|||
16497905|NCT01892501|40295479|FG000|Overall Study|Non-contributory histological result|12|||
16497906|NCT01409564|40295484|FG000|Overall Study|low medication compliance|4|||
16497907|NCT01409564|40295485|FG001|Overall Study|low medication compliance|3|||
16497908|NCT01409564|40295484|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
16497909|NCT01409564|40295485|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
16497910|NCT04814433|40295486|FG000|Overall Study|Survey not returned|4|||
16497911|NCT04814433|40295487|FG001|Overall Study|Survey not returned|8|||
16497912|NCT04814433|40295488|FG002|Overall Study|Survey not returned|4|||
16497913|NCT04814433|40295489|FG003|Overall Study|Survey not returned|5|||
16497914|NCT01957644|40295490|FG000|Overall Study|Adverse Event|4|||
16497915|NCT01957644|40295491|FG001|Overall Study|Adverse Event|2|||
16497916|NCT01957644|40295492|FG002|Overall Study|Adverse Event|0|||
16497917|NCT01957644|40295493|FG003|Overall Study|Adverse Event|0|||
16497918|NCT01957644|40295494|FG004|Overall Study|Adverse Event|1|||
16497919|NCT01957644|40295490|FG000|Overall Study|Progressive disease / relapse|0|||
16497920|NCT01957644|40295491|FG001|Overall Study|Progressive disease / relapse|1|||
16497921|NCT01957644|40295492|FG002|Overall Study|Progressive disease / relapse|0|||
16497922|NCT01957644|40295493|FG003|Overall Study|Progressive disease / relapse|1|||
16497923|NCT01957644|40295494|FG004|Overall Study|Progressive disease / relapse|0|||
16497924|NCT01957644|40295490|FG000|Overall Study|Other reason|1|||
16497925|NCT01957644|40295491|FG001|Overall Study|Other reason|2|||
16497926|NCT01957644|40295492|FG002|Overall Study|Other reason|1|||
16497927|NCT01957644|40295493|FG003|Overall Study|Other reason|1|||
16497928|NCT01957644|40295494|FG004|Overall Study|Other reason|0|||
16497929|NCT01957644|40295490|FG000|Overall Study|Withdrawal by Subject|1|||
16497930|NCT01957644|40295491|FG001|Overall Study|Withdrawal by Subject|0|||
16497931|NCT01957644|40295492|FG002|Overall Study|Withdrawal by Subject|0|||
16497932|NCT01957644|40295493|FG003|Overall Study|Withdrawal by Subject|0|||
16497933|NCT01957644|40295494|FG004|Overall Study|Withdrawal by Subject|0|||
16497934|NCT01957644|40295490|FG000|Overall Study|Protocol Violation|0|||
16497935|NCT01957644|40295491|FG001|Overall Study|Protocol Violation|1|||
16497936|NCT01957644|40295492|FG002|Overall Study|Protocol Violation|0|||
16497937|NCT01957644|40295493|FG003|Overall Study|Protocol Violation|0|||
16497938|NCT01957644|40295494|FG004|Overall Study|Protocol Violation|0|||
16497939|NCT02415127|40295495|FG000|Overall Study|Adverse Event|1|||
16497940|NCT02415127|40295496|FG001|Overall Study|Adverse Event|0|||
16497941|NCT02902965|40295499|FG000|Overall Study|Withdrawal by Subject|10|||
16497942|NCT02709785|40295502|FG000|Overall Study|Withdrawal by Subject|1|||
16497943|NCT02709785|40295503|FG001|Overall Study|Withdrawal by Subject|2|||
16497944|NCT02709785|40295504|FG002|Overall Study|Withdrawal by Subject|1|||
16497945|NCT00931762|40295505|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
16497946|NCT00931762|40295505|FG000|Overall Study|Administrative Problems|5|||
16497947|NCT00931762|40295505|FG000|Overall Study|Death|1|||
16497948|NCT00931762|40295505|FG000|Overall Study|Disease Progression|3|||
16497949|NCT00931762|40295505|FG000|Overall Study|Adverse Event (s)|11|||
16497950|NCT00931762|40295505|FG000|Overall Study|Subject withdrew consent|13|||
16497951|NCT01059786|40295506|FG000|Overall Study|Did not receive 6 cycles.|0|||
16497952|NCT01059786|40295507|FG001|Overall Study|Did not receive 6 cycles.|0|||
16497953|NCT01059786|40295508|FG002|Overall Study|Did not receive 6 cycles.|4|||
16497954|NCT01059786|40295509|FG003|Overall Study|Did not receive 6 cycles.|1|||
16497955|NCT01059786|40295510|FG004|Overall Study|Did not receive 6 cycles.|0|||
16497956|NCT01386554|40295512|FG000|Overall Study|Lost to Follow-up|0|||
16497957|NCT01386554|40295513|FG001|Overall Study|Lost to Follow-up|0|||
16497958|NCT01386554|40295514|FG002|Overall Study|Lost to Follow-up|1|||
16497959|NCT01386554|40295512|FG000|Overall Study|Adverse Event|2|||
16497960|NCT01386554|40295513|FG001|Overall Study|Adverse Event|5|||
16497961|NCT01386554|40295514|FG002|Overall Study|Adverse Event|2|||
16497962|NCT01386554|40295512|FG000|Overall Study|Progressive disease|1|||
16497963|NCT01386554|40295513|FG001|Overall Study|Progressive disease|2|||
16195049|NCT02112916|39193220|FG002|Overall Study|Still on Therapy|3|||
16195050|NCT02112916|39193221|FG003|Overall Study|Still on Therapy|2|||
16195051|NCT02112916|39193218|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
16195052|NCT02112916|39193219|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
16195053|NCT02112916|39193220|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
16388753|NCT00532844|39905750|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
16388754|NCT00532844|39905751|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
16497964|NCT01386554|40295514|FG002|Overall Study|Progressive disease|2|||
16497965|NCT01386554|40295512|FG000|Overall Study|Administration of live vaccines|0|||
16497966|NCT01386554|40295513|FG001|Overall Study|Administration of live vaccines|1|||
16497967|NCT01386554|40295514|FG002|Overall Study|Administration of live vaccines|0|||
16497968|NCT01386554|40295512|FG000|Overall Study|Investigator discretion|0|||
16497969|NCT01386554|40295513|FG001|Overall Study|Investigator discretion|0|||
16497970|NCT01386554|40295514|FG002|Overall Study|Investigator discretion|1|||
16497971|NCT01386554|40295512|FG000|Overall Study|Reason not collected|0|||
16497972|NCT01386554|40295513|FG001|Overall Study|Reason not collected|1|||
16497973|NCT01386554|40295514|FG002|Overall Study|Reason not collected|0|||
16497974|NCT02509156|40295515|FG000|Randomized Phase|Death|1|||
16497975|NCT02509156|40295516|FG001|Randomized Phase|Death|0|||
16497976|NCT02509156|40295515|FG000|Randomized Phase|Withdrawal by Subject|1|||
16497977|NCT02509156|40295516|FG001|Randomized Phase|Withdrawal by Subject|1|||
16497978|NCT01949051|40295517|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
16388755|NCT00524121|39905758|FG000|Overall Study|Disease progression|6|||
16195054|NCT02112916|39193221|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
16195055|NCT02112916|39193218|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
16195056|NCT02112916|39193219|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
16195057|NCT02112916|39193220|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
16195058|NCT02112916|39193221|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
16195059|NCT00356863|39193224|FG000|Overall Study|Death|16|||
16195060|NCT00356863|39193225|FG001|Overall Study|Death|32|||
16195061|NCT00356863|39193224|FG000|Overall Study|Lost to Follow-up|76|||
16195062|NCT00356863|39193225|FG001|Overall Study|Lost to Follow-up|43|||
16195063|NCT00288860|39193226|FG000|Overall Study|Did not complete intake|4|||
16195064|NCT00288860|39193227|FG001|Overall Study|Did not complete intake|8|||
16195065|NCT00288860|39193226|FG000|Overall Study|Death|4|||
16195066|NCT00288860|39193227|FG001|Overall Study|Death|3|||
16195067|NCT00288860|39193226|FG000|Overall Study|Withdrawal by Subject|20|||
16195068|NCT00288860|39193227|FG001|Overall Study|Withdrawal by Subject|15|||
16195069|NCT00288860|39193226|FG000|Overall Study|Lost to Follow-up|74|||
16195070|NCT00288860|39193227|FG001|Overall Study|Lost to Follow-up|71|||
16195071|NCT04494633|39193228|FG000|Overall Study|Lost to Follow-up|5|||
16195072|NCT04494633|39193229|FG001|Overall Study|Lost to Follow-up|3|||
16195073|NCT04494633|39193228|FG000|Overall Study|Protocol Violation|1|||
16195074|NCT04494633|39193229|FG001|Overall Study|Protocol Violation|1|||
16195075|NCT04321252|39193230|FG000|Overall Study|Withdrawal by Subject|0|||
16195076|NCT04321252|39193231|FG001|Overall Study|Withdrawal by Subject|0|||
16195077|NCT04321252|39193232|FG002|Overall Study|Withdrawal by Subject|0|||
16195078|NCT04321252|39193233|FG003|Overall Study|Withdrawal by Subject|0|||
16195079|NCT04321252|39193234|FG004|Overall Study|Withdrawal by Subject|0|||
16195080|NCT04321252|39193235|FG005|Overall Study|Withdrawal by Subject|1|||
16195081|NCT04321252|39193236|FG006|Overall Study|Withdrawal by Subject|0|||
16195082|NCT04321252|39193237|FG007|Overall Study|Withdrawal by Subject|0|||
16195083|NCT04321252|39193238|FG008|Overall Study|Withdrawal by Subject|0|||
16195084|NCT02065622|39193239|FG000|Induction Study|Adverse Event|13|||
16195085|NCT02065622|39193240|FG001|Induction Study|Adverse Event|19|||
16195086|NCT02065622|39193241|FG002|Induction Study|Adverse Event|0|||
16195087|NCT02065622|39193242|FG003|Induction Study|Adverse Event|0|||
16195088|NCT02065622|39193243|FG004|Induction Study|Adverse Event|0|||
16195089|NCT02065622|39193239|FG000|Induction Study|Withdrawal by Subject|3|||
16195090|NCT02065622|39193240|FG001|Induction Study|Withdrawal by Subject|5|||
16195091|NCT02065622|39193241|FG002|Induction Study|Withdrawal by Subject|0|||
16195092|NCT02065622|39193242|FG003|Induction Study|Withdrawal by Subject|0|||
16195093|NCT02065622|39193243|FG004|Induction Study|Withdrawal by Subject|0|||
16195094|NCT02065622|39193239|FG000|Induction Study|Lost to Follow-up|1|||
16195095|NCT02065622|39193240|FG001|Induction Study|Lost to Follow-up|0|||
16195096|NCT02065622|39193241|FG002|Induction Study|Lost to Follow-up|0|||
16195097|NCT02065622|39193242|FG003|Induction Study|Lost to Follow-up|0|||
16195098|NCT02065622|39193243|FG004|Induction Study|Lost to Follow-up|0|||
16195099|NCT02065622|39193239|FG000|Induction Study|Lack of Efficacy|22|||
16195100|NCT02065622|39193240|FG001|Induction Study|Lack of Efficacy|27|||
16195101|NCT02065622|39193241|FG002|Induction Study|Lack of Efficacy|0|||
16195102|NCT02065622|39193242|FG003|Induction Study|Lack of Efficacy|0|||
16388756|NCT00524121|39905758|FG000|Overall Study|Adverse Event|4|||
16388757|NCT00524121|39905758|FG000|Overall Study|Patient refused|2|||
16388758|NCT00524121|39905758|FG000|Overall Study|Other|1|||
16388759|NCT00524121|39905758|FG000|Overall Study|Death|1|||
16388760|NCT00524121|39905758|FG000|Overall Study|Not treated (became ineligible)|4|||
16388761|NCT00524121|39905758|FG000|Overall Study|Not treated (changed mind)|1|||
16087078|NCT01998958|38810613|FG031|Period 1 (Panel A and B)|Other|0|||
16087079|NCT01998958|38810582|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
16195103|NCT02065622|39193243|FG004|Induction Study|Lack of Efficacy|0|||
16195104|NCT02065622|39193239|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
16388762|NCT01349673|39905761|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
16388763|NCT01349673|39905761|FG000|Overall Study|No Longer Qualified For Study|1|||
16195105|NCT02065622|39193240|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
16195106|NCT02065622|39193241|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
16195107|NCT02065622|39193242|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
16195108|NCT02065622|39193243|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
16388764|NCT01349673|39905761|FG000|Overall Study|Site Closure|10|||
16388765|NCT01349673|39905761|FG000|Overall Study|Withdrawal by Subject|21|||
16195109|NCT02065622|39193239|FG000|Induction Study|Subject Noncompliance|1|||
16195110|NCT02065622|39193240|FG001|Induction Study|Subject Noncompliance|1|||
16195111|NCT02065622|39193241|FG002|Induction Study|Subject Noncompliance|0|||
16497979|NCT01949051|40295518|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
16497980|NCT01949051|40295519|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
16497981|NCT01949051|40295520|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
16497982|NCT01949051|40295521|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
16497983|NCT01949051|40295522|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
16497984|NCT01949051|40295517|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
16497985|NCT01949051|40295518|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16497986|NCT01949051|40295519|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16195112|NCT02065622|39193242|FG003|Induction Study|Subject Noncompliance|0|||
16195113|NCT02065622|39193243|FG004|Induction Study|Subject Noncompliance|0|||
16195114|NCT02065622|39193239|FG000|Induction Study|Other, Not Specified|3|||
16195115|NCT02065622|39193240|FG001|Induction Study|Other, Not Specified|2|||
16195116|NCT02065622|39193241|FG002|Induction Study|Other, Not Specified|0|||
16195117|NCT02065622|39193242|FG003|Induction Study|Other, Not Specified|0|||
16195118|NCT02065622|39193243|FG004|Induction Study|Other, Not Specified|0|||
16195119|NCT02065622|39193239|FG000|Maintenance Study|Adverse Event|0|||
16195120|NCT02065622|39193240|FG001|Maintenance Study|Adverse Event|0|||
16195121|NCT02065622|39193241|FG002|Maintenance Study|Adverse Event|25|||
16497987|NCT01949051|40295520|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16497988|NCT01949051|40295521|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16497989|NCT01949051|40295522|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16497990|NCT01949051|40295517|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
16497991|NCT01949051|40295518|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
16497992|NCT01949051|40295519|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
16497993|NCT01949051|40295520|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
16497994|NCT01949051|40295521|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
16497995|NCT01949051|40295522|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
16497996|NCT01949051|40295517|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
16497997|NCT01949051|40295518|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
16497998|NCT01949051|40295519|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
16497999|NCT01949051|40295520|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
16498000|NCT01949051|40295521|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
16498001|NCT01949051|40295522|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
16498002|NCT01949051|40295517|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
16498003|NCT01949051|40295518|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
16498004|NCT01949051|40295519|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
16498005|NCT01949051|40295520|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
16498006|NCT01949051|40295521|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
16498007|NCT01949051|40295522|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
16498008|NCT01896531|40295523|FG000|Overall Study|Death|57|||
16498009|NCT01896531|40295524|FG001|Overall Study|Death|59|||
16498010|NCT01896531|40295523|FG000|Overall Study|Lost to Follow-up|3|||
16498011|NCT01896531|40295524|FG001|Overall Study|Lost to Follow-up|0|||
16498012|NCT01896531|40295523|FG000|Overall Study|Non-compliance|0|||
16498013|NCT01896531|40295524|FG001|Overall Study|Non-compliance|1|||
16498014|NCT01896531|40295523|FG000|Overall Study|Study Ended by Sponsor|7|||
16498015|NCT01896531|40295524|FG001|Overall Study|Study Ended by Sponsor|20|||
16498016|NCT01896531|40295523|FG000|Overall Study|Withdrawal by Subject|3|||
16498017|NCT01896531|40295524|FG001|Overall Study|Withdrawal by Subject|2|||
16498018|NCT01896531|40295523|FG000|Overall Study|Death Prior to Treatment|1|||
16498019|NCT01896531|40295524|FG001|Overall Study|Death Prior to Treatment|0|||
16498020|NCT02728895|40295525|FG000|Overall Study|Other|1|||
16498021|NCT02728895|40295526|FG001|Overall Study|Other|2|||
16498022|NCT02728895|40295525|FG000|Overall Study|Withdrawal by Subject|0|||
16498023|NCT02728895|40295526|FG001|Overall Study|Withdrawal by Subject|3|||
16498024|NCT00680043|40295527|FG000|Overall Study|Withdrawal by Subject|1|||
16498025|NCT00680043|40295528|FG001|Overall Study|Withdrawal by Subject|0|||
16498026|NCT00680043|40295529|FG002|Overall Study|Withdrawal by Subject|0|||
16195122|NCT02065622|39193242|FG003|Maintenance Study|Adverse Event|22|||
16195123|NCT02065622|39193243|FG004|Maintenance Study|Adverse Event|11|||
16498027|NCT00680043|40295527|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
16498028|NCT00680043|40295528|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
16498029|NCT00680043|40295529|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
16498030|NCT00680043|40295527|FG000|Overall Study|Renal Transplant|1|||
16498031|NCT00680043|40295528|FG001|Overall Study|Renal Transplant|0|||
16498032|NCT00680043|40295529|FG002|Overall Study|Renal Transplant|4|||
16498033|NCT03342690|40295534|FG000|Overall Study|Missing Information|9|||
16498034|NCT03342690|40295534|FG000|Overall Study|Protocol Violation|16|||
16195124|NCT02065622|39193239|FG000|Maintenance Study|Withdrawal by Subject|0|||
16498035|NCT00268996|40295558|FG000|Overall Study|Adverse Event|11|||
16498036|NCT00268996|40295559|FG001|Overall Study|Adverse Event|7|||
16498037|NCT00268996|40295558|FG000|Overall Study|Lost to Follow-up|3|||
16498038|NCT00268996|40295559|FG001|Overall Study|Lost to Follow-up|1|||
16388766|NCT01349673|39905761|FG000|Overall Study|Lost to Follow-up|6|||
16388767|NCT01349673|39905761|FG000|Overall Study|Adverse Event|17|||
16388768|NCT01349673|39905761|FG000|Overall Study|Study Terminated By Sponsor|50|||
16498039|NCT00268996|40295558|FG000|Overall Study|Withdrawal by Subject|5|||
16388769|NCT01349673|39905761|FG000|Overall Study|Lack of Efficacy|8|||
16388770|NCT03465722|39905764|FG000|Overall Study|Withdrawal by Subject|21|||
16498040|NCT00268996|40295559|FG001|Overall Study|Withdrawal by Subject|11|||
16498041|NCT00268996|40295558|FG000|Overall Study|Non-compliance|1|||
16498042|NCT00268996|40295559|FG001|Overall Study|Non-compliance|0|||
16498043|NCT00268996|40295558|FG000|Overall Study|Other|1|||
16309058|NCT02860546|39615693|FG000|Overall Study|Clinical Progression|6|||
16309059|NCT02860546|39615693|FG000|Overall Study|Radiological Progression|12|||
16309060|NCT01176513|39615694|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
16309061|NCT00235755|39615695|FG000|4-Week Titration Phase|Adverse Event|6|||
16309062|NCT00235755|39615696|FG001|4-Week Titration Phase|Adverse Event|14|||
16309063|NCT00235755|39615697|FG002|4-Week Titration Phase|Adverse Event|20|||
16309064|NCT00235755|39615695|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
16309065|NCT00235755|39615696|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
16309066|NCT00235755|39615697|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
16388771|NCT03465722|39905765|FG001|Overall Study|Withdrawal by Subject|14|||
16388772|NCT03465722|39905764|FG000|Overall Study|Death|89|||
16498044|NCT00268996|40295559|FG001|Overall Study|Other|1|||
16498045|NCT02554812|40295560|FG000|Overall Study|Adverse Event|2|||
16498046|NCT02554812|40295561|FG001|Overall Study|Adverse Event|5|||
16498047|NCT02554812|40295562|FG002|Overall Study|Adverse Event|3|||
16498048|NCT02554812|40295563|FG003|Overall Study|Adverse Event|0|||
16498049|NCT02554812|40295564|FG004|Overall Study|Adverse Event|5|||
16498050|NCT02554812|40295565|FG005|Overall Study|Adverse Event|0|||
16498051|NCT02554812|40295566|FG006|Overall Study|Adverse Event|1|||
16498052|NCT02554812|40295567|FG007|Overall Study|Adverse Event|6|||
16498053|NCT02554812|40295568|FG008|Overall Study|Adverse Event|2|||
16498054|NCT02554812|40295569|FG009|Overall Study|Adverse Event|2|||
16498055|NCT02554812|40295570|FG010|Overall Study|Adverse Event|1|||
16498056|NCT02554812|40295571|FG011|Overall Study|Adverse Event|2|||
16498057|NCT02554812|40295572|FG012|Overall Study|Adverse Event|0|||
16498058|NCT02554812|40295573|FG013|Overall Study|Adverse Event|3|||
16498059|NCT02554812|40295574|FG014|Overall Study|Adverse Event|2|||
16498060|NCT02554812|40295575|FG015|Overall Study|Adverse Event|1|||
16498061|NCT02554812|40295576|FG016|Overall Study|Adverse Event|0|||
16498062|NCT02554812|40295577|FG017|Overall Study|Adverse Event|1|||
16388773|NCT03465722|39905765|FG001|Overall Study|Death|87|||
16498063|NCT02554812|40295578|FG018|Overall Study|Adverse Event|0|||
16498064|NCT02554812|40295579|FG019|Overall Study|Adverse Event|0|||
16498065|NCT02554812|40295580|FG020|Overall Study|Adverse Event|0|||
16498066|NCT02554812|40295581|FG021|Overall Study|Adverse Event|2|||
16195125|NCT02065622|39193240|FG001|Maintenance Study|Withdrawal by Subject|0|||
16195126|NCT02065622|39193241|FG002|Maintenance Study|Withdrawal by Subject|11|||
16195127|NCT02065622|39193242|FG003|Maintenance Study|Withdrawal by Subject|5|||
16195128|NCT02065622|39193243|FG004|Maintenance Study|Withdrawal by Subject|7|||
16195129|NCT02065622|39193239|FG000|Maintenance Study|Lost to Follow-up|0|||
16195130|NCT02065622|39193240|FG001|Maintenance Study|Lost to Follow-up|0|||
16195131|NCT02065622|39193241|FG002|Maintenance Study|Lost to Follow-up|4|||
16195132|NCT02065622|39193242|FG003|Maintenance Study|Lost to Follow-up|1|||
16195133|NCT02065622|39193243|FG004|Maintenance Study|Lost to Follow-up|1|||
16195134|NCT02065622|39193239|FG000|Maintenance Study|Lack of Efficacy|0|||
16498067|NCT02554812|40295582|FG022|Overall Study|Adverse Event|1|||
16195135|NCT02065622|39193240|FG001|Maintenance Study|Lack of Efficacy|0|||
16309067|NCT00235755|39615695|FG000|4-Week Titration Phase|Protocol Violation|2|||
16388774|NCT03465722|39905764|FG000|Overall Study|Lost to Follow-up|5|||
16388775|NCT03465722|39905765|FG001|Overall Study|Lost to Follow-up|3|||
16498068|NCT02554812|40295583|FG023|Overall Study|Adverse Event|1|||
16498069|NCT02554812|40295584|FG024|Overall Study|Adverse Event|1|||
16498070|NCT02554812|40295585|FG025|Overall Study|Adverse Event|2|||
16498071|NCT02554812|40295586|FG026|Overall Study|Adverse Event|1|||
16498072|NCT02554812|40295560|FG000|Overall Study|Death|1|||
16498073|NCT02554812|40295561|FG001|Overall Study|Death|2|||
16498074|NCT02554812|40295562|FG002|Overall Study|Death|2|||
16498075|NCT02554812|40295563|FG003|Overall Study|Death|2|||
16498076|NCT02554812|40295564|FG004|Overall Study|Death|0|||
16498077|NCT02554812|40295565|FG005|Overall Study|Death|1|||
16498078|NCT02554812|40295566|FG006|Overall Study|Death|1|||
16498079|NCT02554812|40295567|FG007|Overall Study|Death|1|||
16498080|NCT02554812|40295568|FG008|Overall Study|Death|0|||
16498081|NCT02554812|40295569|FG009|Overall Study|Death|0|||
16498082|NCT02554812|40295570|FG010|Overall Study|Death|0|||
16498083|NCT02554812|40295571|FG011|Overall Study|Death|0|||
16498084|NCT02554812|40295572|FG012|Overall Study|Death|0|||
16498085|NCT02554812|40295573|FG013|Overall Study|Death|0|||
16498086|NCT02554812|40295574|FG014|Overall Study|Death|1|||
16498087|NCT02554812|40295575|FG015|Overall Study|Death|1|||
16498088|NCT02554812|40295576|FG016|Overall Study|Death|1|||
16498089|NCT02554812|40295577|FG017|Overall Study|Death|0|||
16498090|NCT02554812|40295578|FG018|Overall Study|Death|1|||
16498091|NCT02554812|40295579|FG019|Overall Study|Death|2|||
16498092|NCT02554812|40295580|FG020|Overall Study|Death|0|||
16498093|NCT02554812|40295581|FG021|Overall Study|Death|1|||
16498094|NCT02554812|40295582|FG022|Overall Study|Death|1|||
16498095|NCT02554812|40295583|FG023|Overall Study|Death|0|||
16498096|NCT02554812|40295584|FG024|Overall Study|Death|0|||
16498097|NCT02554812|40295585|FG025|Overall Study|Death|0|||
16498098|NCT02554812|40295586|FG026|Overall Study|Death|0|||
16498099|NCT02554812|40295560|FG000|Overall Study|Lost to Follow-up|0|||
16498100|NCT02554812|40295561|FG001|Overall Study|Lost to Follow-up|1|||
16498101|NCT02554812|40295562|FG002|Overall Study|Lost to Follow-up|0|||
16498102|NCT02554812|40295563|FG003|Overall Study|Lost to Follow-up|0|||
16498103|NCT02554812|40295564|FG004|Overall Study|Lost to Follow-up|0|||
16498104|NCT02554812|40295565|FG005|Overall Study|Lost to Follow-up|0|||
16498105|NCT02554812|40295566|FG006|Overall Study|Lost to Follow-up|0|||
16498106|NCT02554812|40295567|FG007|Overall Study|Lost to Follow-up|0|||
16498107|NCT02554812|40295568|FG008|Overall Study|Lost to Follow-up|0|||
16498108|NCT02554812|40295569|FG009|Overall Study|Lost to Follow-up|0|||
16498109|NCT02554812|40295570|FG010|Overall Study|Lost to Follow-up|0|||
16498110|NCT02554812|40295571|FG011|Overall Study|Lost to Follow-up|0|||
16498111|NCT02554812|40295572|FG012|Overall Study|Lost to Follow-up|0|||
16498112|NCT02554812|40295573|FG013|Overall Study|Lost to Follow-up|0|||
16498113|NCT02554812|40295574|FG014|Overall Study|Lost to Follow-up|0|||
16498114|NCT02554812|40295575|FG015|Overall Study|Lost to Follow-up|0|||
16498115|NCT02554812|40295576|FG016|Overall Study|Lost to Follow-up|0|||
16498116|NCT02554812|40295577|FG017|Overall Study|Lost to Follow-up|0|||
16498117|NCT02554812|40295578|FG018|Overall Study|Lost to Follow-up|0|||
16498118|NCT02554812|40295579|FG019|Overall Study|Lost to Follow-up|0|||
16498119|NCT02554812|40295580|FG020|Overall Study|Lost to Follow-up|0|||
16498120|NCT02554812|40295581|FG021|Overall Study|Lost to Follow-up|0|||
16498121|NCT02554812|40295582|FG022|Overall Study|Lost to Follow-up|0|||
16498122|NCT02554812|40295583|FG023|Overall Study|Lost to Follow-up|0|||
16498123|NCT02554812|40295584|FG024|Overall Study|Lost to Follow-up|0|||
16498124|NCT02554812|40295585|FG025|Overall Study|Lost to Follow-up|0|||
16498125|NCT02554812|40295586|FG026|Overall Study|Lost to Follow-up|0|||
16498126|NCT02554812|40295560|FG000|Overall Study|Global deterioration of health status|4|||
16498127|NCT02554812|40295561|FG001|Overall Study|Global deterioration of health status|3|||
16498128|NCT02554812|40295562|FG002|Overall Study|Global deterioration of health status|3|||
16498129|NCT02554812|40295563|FG003|Overall Study|Global deterioration of health status|2|||
16498130|NCT02554812|40295564|FG004|Overall Study|Global deterioration of health status|5|||
16498131|NCT02554812|40295565|FG005|Overall Study|Global deterioration of health status|0|||
16498132|NCT02554812|40295566|FG006|Overall Study|Global deterioration of health status|2|||
16498133|NCT02554812|40295567|FG007|Overall Study|Global deterioration of health status|1|||
16498134|NCT02554812|40295568|FG008|Overall Study|Global deterioration of health status|1|||
16498135|NCT02554812|40295569|FG009|Overall Study|Global deterioration of health status|1|||
16498136|NCT02554812|40295570|FG010|Overall Study|Global deterioration of health status|2|||
16498137|NCT02554812|40295571|FG011|Overall Study|Global deterioration of health status|1|||
16498138|NCT02554812|40295572|FG012|Overall Study|Global deterioration of health status|0|||
16195136|NCT02065622|39193241|FG002|Maintenance Study|Lack of Efficacy|70|||
16195137|NCT02065622|39193242|FG003|Maintenance Study|Lack of Efficacy|55|||
16195138|NCT02065622|39193243|FG004|Maintenance Study|Lack of Efficacy|19|||
16498139|NCT02554812|40295573|FG013|Overall Study|Global deterioration of health status|0|||
16498140|NCT02554812|40295574|FG014|Overall Study|Global deterioration of health status|0|||
16498141|NCT02554812|40295575|FG015|Overall Study|Global deterioration of health status|1|||
16195139|NCT02065622|39193239|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
16195140|NCT02065622|39193240|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
16498142|NCT02554812|40295576|FG016|Overall Study|Global deterioration of health status|0|||
16498143|NCT02554812|40295577|FG017|Overall Study|Global deterioration of health status|0|||
16498144|NCT02554812|40295578|FG018|Overall Study|Global deterioration of health status|0|||
16498145|NCT02554812|40295579|FG019|Overall Study|Global deterioration of health status|0|||
16498146|NCT02554812|40295580|FG020|Overall Study|Global deterioration of health status|0|||
16498147|NCT02554812|40295581|FG021|Overall Study|Global deterioration of health status|0|||
16498148|NCT02554812|40295582|FG022|Overall Study|Global deterioration of health status|0|||
16498149|NCT02554812|40295583|FG023|Overall Study|Global deterioration of health status|0|||
16498150|NCT02554812|40295584|FG024|Overall Study|Global deterioration of health status|0|||
16498151|NCT02554812|40295585|FG025|Overall Study|Global deterioration of health status|0|||
16498152|NCT02554812|40295586|FG026|Overall Study|Global deterioration of health status|0|||
16498153|NCT02554812|40295560|FG000|Overall Study|Progressive disease|20|||
16498154|NCT02554812|40295561|FG001|Overall Study|Progressive disease|16|||
16498155|NCT02554812|40295562|FG002|Overall Study|Progressive disease|19|||
16498156|NCT02554812|40295563|FG003|Overall Study|Progressive disease|18|||
16498157|NCT02554812|40295564|FG004|Overall Study|Progressive disease|21|||
16498158|NCT02554812|40295565|FG005|Overall Study|Progressive disease|15|||
16498159|NCT02554812|40295566|FG006|Overall Study|Progressive disease|6|||
16498160|NCT02554812|40295567|FG007|Overall Study|Progressive disease|13|||
16498161|NCT02554812|40295568|FG008|Overall Study|Progressive disease|6|||
16498162|NCT02554812|40295569|FG009|Overall Study|Progressive disease|6|||
16498163|NCT02554812|40295570|FG010|Overall Study|Progressive disease|8|||
16498164|NCT02554812|40295571|FG011|Overall Study|Progressive disease|8|||
16498165|NCT02554812|40295572|FG012|Overall Study|Progressive disease|6|||
16498166|NCT02554812|40295573|FG013|Overall Study|Progressive disease|10|||
16498167|NCT02554812|40295574|FG014|Overall Study|Progressive disease|20|||
16498168|NCT02554812|40295575|FG015|Overall Study|Progressive disease|6|||
16498169|NCT02554812|40295576|FG016|Overall Study|Progressive disease|3|||
16498170|NCT02554812|40295577|FG017|Overall Study|Progressive disease|3|||
16498171|NCT02554812|40295578|FG018|Overall Study|Progressive disease|11|||
16498172|NCT02554812|40295579|FG019|Overall Study|Progressive disease|7|||
16498173|NCT02554812|40295580|FG020|Overall Study|Progressive disease|11|||
16498174|NCT02554812|40295581|FG021|Overall Study|Progressive disease|6|||
16498175|NCT02554812|40295582|FG022|Overall Study|Progressive disease|9|||
16498176|NCT02554812|40295583|FG023|Overall Study|Progressive disease|9|||
16498177|NCT02554812|40295584|FG024|Overall Study|Progressive disease|4|||
16498178|NCT02554812|40295585|FG025|Overall Study|Progressive disease|5|||
16498179|NCT02554812|40295586|FG026|Overall Study|Progressive disease|5|||
16498180|NCT02554812|40295560|FG000|Overall Study|Other|0|||
16498181|NCT02554812|40295561|FG001|Overall Study|Other|0|||
16498182|NCT02554812|40295562|FG002|Overall Study|Other|2|||
16498183|NCT02554812|40295563|FG003|Overall Study|Other|3|||
16498184|NCT02554812|40295564|FG004|Overall Study|Other|2|||
16498185|NCT02554812|40295565|FG005|Overall Study|Other|1|||
16498186|NCT02554812|40295566|FG006|Overall Study|Other|0|||
16498187|NCT02554812|40295567|FG007|Overall Study|Other|0|||
16498188|NCT02554812|40295568|FG008|Overall Study|Other|1|||
16498189|NCT02554812|40295569|FG009|Overall Study|Other|1|||
16498190|NCT02554812|40295570|FG010|Overall Study|Other|0|||
16498191|NCT02554812|40295571|FG011|Overall Study|Other|0|||
16498192|NCT02554812|40295572|FG012|Overall Study|Other|1|||
16498193|NCT02554812|40295573|FG013|Overall Study|Other|0|||
16498194|NCT02554812|40295574|FG014|Overall Study|Other|1|||
16498195|NCT02554812|40295575|FG015|Overall Study|Other|0|||
16498196|NCT02554812|40295576|FG016|Overall Study|Other|0|||
16498197|NCT02554812|40295577|FG017|Overall Study|Other|0|||
16498198|NCT02554812|40295578|FG018|Overall Study|Other|0|||
16498199|NCT02554812|40295579|FG019|Overall Study|Other|0|||
16498200|NCT02554812|40295580|FG020|Overall Study|Other|0|||
16498201|NCT02554812|40295581|FG021|Overall Study|Other|2|||
16498202|NCT02554812|40295582|FG022|Overall Study|Other|0|||
16498203|NCT02554812|40295583|FG023|Overall Study|Other|0|||
16498204|NCT02554812|40295584|FG024|Overall Study|Other|0|||
16498205|NCT02554812|40295585|FG025|Overall Study|Other|0|||
16498206|NCT02554812|40295586|FG026|Overall Study|Other|0|||
16498207|NCT02554812|40295560|FG000|Overall Study|Withdrawal by Subject|1|||
16498208|NCT02554812|40295561|FG001|Overall Study|Withdrawal by Subject|0|||
16498209|NCT02554812|40295562|FG002|Overall Study|Withdrawal by Subject|0|||
16498210|NCT02554812|40295563|FG003|Overall Study|Withdrawal by Subject|2|||
16498211|NCT02554812|40295564|FG004|Overall Study|Withdrawal by Subject|2|||
16498212|NCT02554812|40295565|FG005|Overall Study|Withdrawal by Subject|3|||
16498213|NCT02554812|40295566|FG006|Overall Study|Withdrawal by Subject|0|||
16498214|NCT02554812|40295567|FG007|Overall Study|Withdrawal by Subject|0|||
16498215|NCT02554812|40295568|FG008|Overall Study|Withdrawal by Subject|1|||
16498216|NCT02554812|40295569|FG009|Overall Study|Withdrawal by Subject|1|||
16498217|NCT02554812|40295570|FG010|Overall Study|Withdrawal by Subject|0|||
16498218|NCT02554812|40295571|FG011|Overall Study|Withdrawal by Subject|1|||
16498219|NCT02554812|40295572|FG012|Overall Study|Withdrawal by Subject|1|||
16498220|NCT02554812|40295573|FG013|Overall Study|Withdrawal by Subject|1|||
16498221|NCT02554812|40295574|FG014|Overall Study|Withdrawal by Subject|1|||
16498222|NCT02554812|40295575|FG015|Overall Study|Withdrawal by Subject|1|||
16498223|NCT02554812|40295576|FG016|Overall Study|Withdrawal by Subject|3|||
16498224|NCT02554812|40295577|FG017|Overall Study|Withdrawal by Subject|1|||
16498225|NCT02554812|40295578|FG018|Overall Study|Withdrawal by Subject|0|||
16498226|NCT02554812|40295579|FG019|Overall Study|Withdrawal by Subject|2|||
16498227|NCT02554812|40295580|FG020|Overall Study|Withdrawal by Subject|0|||
16498228|NCT02554812|40295581|FG021|Overall Study|Withdrawal by Subject|1|||
16498229|NCT02554812|40295582|FG022|Overall Study|Withdrawal by Subject|0|||
16309068|NCT00235755|39615696|FG001|4-Week Titration Phase|Protocol Violation|2|||
16309069|NCT00235755|39615697|FG002|4-Week Titration Phase|Protocol Violation|1|||
16309070|NCT00235755|39615695|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
16309071|NCT00235755|39615696|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
16498230|NCT02554812|40295583|FG023|Overall Study|Withdrawal by Subject|1|||
16498231|NCT02554812|40295584|FG024|Overall Study|Withdrawal by Subject|0|||
16498232|NCT02554812|40295585|FG025|Overall Study|Withdrawal by Subject|0|||
16498233|NCT02554812|40295586|FG026|Overall Study|Withdrawal by Subject|1|||
16498234|NCT02554812|40295560|FG000|Overall Study|Physician Decision|1|||
16498235|NCT02554812|40295561|FG001|Overall Study|Physician Decision|0|||
16498236|NCT02554812|40295562|FG002|Overall Study|Physician Decision|0|||
16498237|NCT02554812|40295563|FG003|Overall Study|Physician Decision|1|||
16498238|NCT02554812|40295564|FG004|Overall Study|Physician Decision|0|||
16498239|NCT02554812|40295565|FG005|Overall Study|Physician Decision|1|||
16498240|NCT02554812|40295566|FG006|Overall Study|Physician Decision|0|||
16498241|NCT02554812|40295567|FG007|Overall Study|Physician Decision|0|||
16498242|NCT02554812|40295568|FG008|Overall Study|Physician Decision|0|||
16498243|NCT02554812|40295569|FG009|Overall Study|Physician Decision|0|||
16498244|NCT02554812|40295570|FG010|Overall Study|Physician Decision|1|||
16498245|NCT02554812|40295571|FG011|Overall Study|Physician Decision|0|||
16498246|NCT02554812|40295572|FG012|Overall Study|Physician Decision|0|||
16498247|NCT02554812|40295573|FG013|Overall Study|Physician Decision|0|||
16498248|NCT02554812|40295574|FG014|Overall Study|Physician Decision|0|||
16498249|NCT02554812|40295575|FG015|Overall Study|Physician Decision|0|||
16498250|NCT02554812|40295576|FG016|Overall Study|Physician Decision|1|||
16309072|NCT00235755|39615697|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
16309073|NCT00235755|39615695|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
16309074|NCT00235755|39615696|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
16309075|NCT00235755|39615697|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
16309076|NCT00235755|39615695|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
16309077|NCT00235755|39615696|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
16309078|NCT00235755|39615697|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
16309079|NCT00235755|39615695|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
16309080|NCT00235755|39615696|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
16498251|NCT02554812|40295577|FG017|Overall Study|Physician Decision|1|||
16498252|NCT02554812|40295578|FG018|Overall Study|Physician Decision|0|||
16498253|NCT02554812|40295579|FG019|Overall Study|Physician Decision|1|||
16498254|NCT02554812|40295580|FG020|Overall Study|Physician Decision|1|||
16498255|NCT02554812|40295581|FG021|Overall Study|Physician Decision|0|||
16498256|NCT02554812|40295582|FG022|Overall Study|Physician Decision|1|||
16498257|NCT02554812|40295583|FG023|Overall Study|Physician Decision|0|||
16498258|NCT02554812|40295584|FG024|Overall Study|Physician Decision|0|||
16498259|NCT02554812|40295585|FG025|Overall Study|Physician Decision|0|||
16498260|NCT02554812|40295586|FG026|Overall Study|Physician Decision|0|||
16498261|NCT02554812|40295560|FG000|Overall Study|Study terminated by sponsor|0|||
16498262|NCT02554812|40295561|FG001|Overall Study|Study terminated by sponsor|0|||
16498263|NCT02554812|40295562|FG002|Overall Study|Study terminated by sponsor|0|||
16498264|NCT02554812|40295563|FG003|Overall Study|Study terminated by sponsor|0|||
16498265|NCT02554812|40295564|FG004|Overall Study|Study terminated by sponsor|0|||
16498266|NCT02554812|40295565|FG005|Overall Study|Study terminated by sponsor|0|||
16498267|NCT02554812|40295566|FG006|Overall Study|Study terminated by sponsor|0|||
16498268|NCT02554812|40295567|FG007|Overall Study|Study terminated by sponsor|0|||
16498269|NCT02554812|40295568|FG008|Overall Study|Study terminated by sponsor|0|||
16498270|NCT02554812|40295569|FG009|Overall Study|Study terminated by sponsor|0|||
16498271|NCT02554812|40295570|FG010|Overall Study|Study terminated by sponsor|0|||
16498272|NCT02554812|40295571|FG011|Overall Study|Study terminated by sponsor|0|||
16498273|NCT02554812|40295572|FG012|Overall Study|Study terminated by sponsor|0|||
16498274|NCT02554812|40295573|FG013|Overall Study|Study terminated by sponsor|0|||
16498275|NCT02554812|40295574|FG014|Overall Study|Study terminated by sponsor|0|||
16498276|NCT02554812|40295575|FG015|Overall Study|Study terminated by sponsor|0|||
16498277|NCT02554812|40295576|FG016|Overall Study|Study terminated by sponsor|0|||
16498278|NCT02554812|40295577|FG017|Overall Study|Study terminated by sponsor|0|||
16498279|NCT02554812|40295578|FG018|Overall Study|Study terminated by sponsor|0|||
16498280|NCT02554812|40295579|FG019|Overall Study|Study terminated by sponsor|0|||
16498281|NCT02554812|40295580|FG020|Overall Study|Study terminated by sponsor|0|||
16498282|NCT02554812|40295581|FG021|Overall Study|Study terminated by sponsor|0|||
16498283|NCT02554812|40295582|FG022|Overall Study|Study terminated by sponsor|0|||
16498284|NCT02554812|40295583|FG023|Overall Study|Study terminated by sponsor|0|||
16498285|NCT02554812|40295584|FG024|Overall Study|Study terminated by sponsor|1|||
16498286|NCT02554812|40295585|FG025|Overall Study|Study terminated by sponsor|0|||
16498287|NCT02554812|40295586|FG026|Overall Study|Study terminated by sponsor|0|||
16498288|NCT02554812|40295560|FG000|Overall Study|No longer meets eligibility criteria|0|||
16498289|NCT02554812|40295561|FG001|Overall Study|No longer meets eligibility criteria|1|||
16498290|NCT02554812|40295562|FG002|Overall Study|No longer meets eligibility criteria|0|||
16498291|NCT02554812|40295563|FG003|Overall Study|No longer meets eligibility criteria|0|||
16498292|NCT02554812|40295564|FG004|Overall Study|No longer meets eligibility criteria|0|||
16498293|NCT02554812|40295565|FG005|Overall Study|No longer meets eligibility criteria|0|||
16498294|NCT02554812|40295566|FG006|Overall Study|No longer meets eligibility criteria|0|||
16498295|NCT02554812|40295567|FG007|Overall Study|No longer meets eligibility criteria|0|||
16498296|NCT02554812|40295568|FG008|Overall Study|No longer meets eligibility criteria|0|||
16498297|NCT02554812|40295569|FG009|Overall Study|No longer meets eligibility criteria|0|||
16498298|NCT02554812|40295570|FG010|Overall Study|No longer meets eligibility criteria|0|||
16498299|NCT02554812|40295571|FG011|Overall Study|No longer meets eligibility criteria|0|||
16498300|NCT02554812|40295572|FG012|Overall Study|No longer meets eligibility criteria|0|||
16498301|NCT02554812|40295573|FG013|Overall Study|No longer meets eligibility criteria|0|||
16498302|NCT02554812|40295574|FG014|Overall Study|No longer meets eligibility criteria|0|||
16498303|NCT02554812|40295575|FG015|Overall Study|No longer meets eligibility criteria|0|||
16498304|NCT02554812|40295576|FG016|Overall Study|No longer meets eligibility criteria|0|||
16498305|NCT02554812|40295577|FG017|Overall Study|No longer meets eligibility criteria|0|||
16498306|NCT02554812|40295578|FG018|Overall Study|No longer meets eligibility criteria|0|||
16498307|NCT02554812|40295579|FG019|Overall Study|No longer meets eligibility criteria|0|||
16498308|NCT02554812|40295580|FG020|Overall Study|No longer meets eligibility criteria|0|||
16498309|NCT02554812|40295581|FG021|Overall Study|No longer meets eligibility criteria|0|||
16498310|NCT02554812|40295582|FG022|Overall Study|No longer meets eligibility criteria|0|||
16498311|NCT02554812|40295583|FG023|Overall Study|No longer meets eligibility criteria|0|||
16498312|NCT02554812|40295584|FG024|Overall Study|No longer meets eligibility criteria|0|||
16498313|NCT02554812|40295585|FG025|Overall Study|No longer meets eligibility criteria|0|||
16498314|NCT02554812|40295586|FG026|Overall Study|No longer meets eligibility criteria|0|||
16498315|NCT03138889|40295587|FG000|Overall Study|Withdrawal by Subject|5|||
16498316|NCT03138889|40295588|FG001|Overall Study|Withdrawal by Subject|5|||
16498317|NCT03138889|40295589|FG002|Overall Study|Withdrawal by Subject|0|||
16498318|NCT03138889|40295590|FG003|Overall Study|Withdrawal by Subject|2|||
16498319|NCT03138889|40295591|FG004|Overall Study|Withdrawal by Subject|1|||
16498320|NCT03138889|40295592|FG005|Overall Study|Withdrawal by Subject|3|||
16498321|NCT03138889|40295593|FG006|Overall Study|Withdrawal by Subject|0|||
16498322|NCT03138889|40295594|FG007|Overall Study|Withdrawal by Subject|1|||
16498323|NCT00759863|40295595|FG000|Overall Study|Death, moved, or lost contact|20|||
16498324|NCT00759863|40295596|FG001|Overall Study|Death, moved, or lost contact|18|||
16498325|NCT00558025|40295597|FG000|Overall Study|Adverse Event|1|||
16498326|NCT00558025|40295598|FG001|Overall Study|Adverse Event|1|||
16498327|NCT00558025|40295597|FG000|Overall Study|Withdrawal by Subject|2|||
16498328|NCT00558025|40295598|FG001|Overall Study|Withdrawal by Subject|2|||
16498329|NCT00558025|40295597|FG000|Overall Study|Protocol Violation|1|||
16498330|NCT00558025|40295598|FG001|Overall Study|Protocol Violation|0|||
16498331|NCT02671422|40295599|FG000|Overall Study|Lost to Follow-up|1|||
16498332|NCT02671422|40295599|FG000|Overall Study|Adverse Event|68|||
16498333|NCT02671422|40295599|FG000|Overall Study|Lack of Efficacy|1|||
16498334|NCT02671422|40295599|FG000|Overall Study|Lost to Follow-up|4|||
16498335|NCT02671422|40295599|FG000|Overall Study|Withdrawal by Subject|7|||
16498336|NCT02671422|40295599|FG000|Overall Study|Progressive Disease|156|||
16498337|NCT02671422|40295599|FG000|Overall Study|Worsening of Disease|4|||
16498338|NCT02671422|40295599|FG000|Overall Study|Sponsor decision|5|||
16498339|NCT02671422|40295599|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
16498340|NCT02671422|40295599|FG000|Overall Study|Not treated with Vargatef®|3|||
16498341|NCT02671422|40295599|FG000|Overall Study|Other not defined above|3|||
16498342|NCT02111850|40295602|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16498343|NCT02111850|40295603|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16498344|NCT02111850|40295604|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16498345|NCT02111850|40295605|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16498346|NCT02111850|40295606|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
16498347|NCT02111850|40295607|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16498348|NCT02111850|40295608|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16498349|NCT02111850|40295609|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16498350|NCT02111850|40295610|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16498351|NCT02111850|40295611|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16195141|NCT02065622|39193241|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
16309081|NCT00235755|39615697|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
16309082|NCT00235755|39615695|FG000|12-Week Maintenance Phase|Adverse Event|8|||
16309083|NCT00235755|39615696|FG001|12-Week Maintenance Phase|Adverse Event|12|||
16309084|NCT00235755|39615697|FG002|12-Week Maintenance Phase|Adverse Event|26|||
16309085|NCT00235755|39615695|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
16223429|NCT02275780|39298682|FG000|Base Study: 96 Weeks|Death|3|||
16309086|NCT00235755|39615696|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
16498352|NCT02111850|40295612|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
16498353|NCT02864953|40295613|FG000|Overall Study|Adverse Event|22|||
16498354|NCT02864953|40295614|FG001|Overall Study|Adverse Event|19|||
16195142|NCT02065622|39193242|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
16195143|NCT02065622|39193243|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
16195144|NCT02065622|39193239|FG000|Maintenance Study|Subject Non-Compliance|0|||
16195145|NCT02065622|39193240|FG001|Maintenance Study|Subject Non-Compliance|0|||
16498355|NCT02864953|40295613|FG000|Overall Study|Withdrawal by Subject|1|||
16498356|NCT02864953|40295614|FG001|Overall Study|Withdrawal by Subject|0|||
16498357|NCT02864953|40295613|FG000|Overall Study|Physician Decision|4|||
16498358|NCT02864953|40295614|FG001|Overall Study|Physician Decision|2|||
16498359|NCT02864953|40295613|FG000|Overall Study|Death|3|||
16498360|NCT02864953|40295614|FG001|Overall Study|Death|13|||
16498361|NCT02864953|40295613|FG000|Overall Study|Reason not specified|14|||
16498362|NCT02864953|40295614|FG001|Overall Study|Reason not specified|12|||
16498363|NCT02864953|40295613|FG000|Overall Study|Withdrew Prior to Dosing|9|||
16498364|NCT02864953|40295614|FG001|Overall Study|Withdrew Prior to Dosing|8|||
16498365|NCT04053023|40295615|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
16498366|NCT04053023|40295616|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
16498367|NCT04481750|40295617|FG000|Period 1 (Fasted)|Adverse Event|0|||
16498368|NCT04481750|40295618|FG001|Period 1 (Fasted)|Adverse Event|0|||
16498369|NCT04481750|40295619|FG002|Period 1 (Fasted)|Adverse Event|1|||
16498370|NCT04481750|40295620|FG003|Period 1 (Fasted)|Adverse Event|0|||
16498371|NCT04481750|40295621|FG004|Period 1 (Fasted)|Adverse Event|0|||
16498372|NCT04481750|40295622|FG005|Period 1 (Fasted)|Adverse Event|0|||
16498373|NCT04481750|40295623|FG006|Period 1 (Fasted)|Adverse Event|0|||
16498374|NCT04481750|40295624|FG007|Period 1 (Fasted)|Adverse Event|0|||
16498375|NCT04481750|40295625|FG008|Period 1 (Fasted)|Adverse Event|0|||
16498376|NCT04481750|40295626|FG009|Period 1 (Fasted)|Adverse Event|0|||
16498377|NCT04481750|40295627|FG010|Period 1 (Fasted)|Adverse Event|0|||
16498378|NCT00137423|40295628|FG000|Overall Study|Adverse Event|7|||
16498379|NCT00137423|40295629|FG001|Overall Study|Adverse Event|9|||
16498380|NCT00137423|40295628|FG000|Overall Study|consent withdrawn|1|||
16498381|NCT00137423|40295629|FG001|Overall Study|consent withdrawn|1|||
16498382|NCT00137423|40295628|FG000|Overall Study|Lack of Efficacy|31|||
16498383|NCT00137423|40295629|FG001|Overall Study|Lack of Efficacy|33|||
16498384|NCT00137423|40295628|FG000|Overall Study|Death|0|||
16498385|NCT00137423|40295629|FG001|Overall Study|Death|1|||
16498386|NCT02891850|40295632|FG000|Overall Study|Adverse Event|3|||
16498387|NCT02891850|40295633|FG001|Overall Study|Adverse Event|0|||
16498388|NCT02891850|40295632|FG000|Overall Study|Death|0|||
16498389|NCT02891850|40295633|FG001|Overall Study|Death|4|||
16498390|NCT02891850|40295632|FG000|Overall Study|Physician Decision|1|||
16498391|NCT02891850|40295633|FG001|Overall Study|Physician Decision|0|||
16498392|NCT02891850|40295632|FG000|Overall Study|Pregnancy|1|||
16498393|NCT02891850|40295633|FG001|Overall Study|Pregnancy|0|||
16498394|NCT02891850|40295632|FG000|Overall Study|Withdrawal by Subject|2|||
16498395|NCT02891850|40295633|FG001|Overall Study|Withdrawal by Subject|3|||
16498396|NCT01013701|40295634|FG000|Overall Study|study prematurely terminated|7|||
16498397|NCT02625259|40295635|FG000|First Intervention (Day 1)|Other|0|||
16498398|NCT02625259|40295636|FG001|First Intervention (Day 1)|Other|0|||
16498399|NCT02625259|40295637|FG002|First Intervention (Day 1)|Other|1|||
16498400|NCT02625259|40295638|FG003|First Intervention (Day 1)|Other|0|||
16498401|NCT02625259|40295639|FG004|First Intervention (Day 1)|Other|0|||
16498402|NCT02625259|40295635|FG000|First Intervention (Day 1)|Adverse Event|2|||
16498403|NCT02625259|40295636|FG001|First Intervention (Day 1)|Adverse Event|1|||
16498404|NCT02625259|40295637|FG002|First Intervention (Day 1)|Adverse Event|0|||
16498405|NCT02625259|40295638|FG003|First Intervention (Day 1)|Adverse Event|0|||
16498406|NCT02625259|40295639|FG004|First Intervention (Day 1)|Adverse Event|0|||
16498407|NCT02625259|40295635|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
16498408|NCT02625259|40295636|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
16498409|NCT02625259|40295637|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
16498410|NCT02625259|40295638|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
16498411|NCT02625259|40295639|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
16498412|NCT00410046|40295640|FG000|Overall Study|Adverse Event|3|||
16498413|NCT00410046|40295640|FG000|Overall Study|Withdrawal by Subject|1|||
16498414|NCT00410046|40295640|FG000|Overall Study|Lost to Follow-up|1|||
16498415|NCT00748033|40298815|FG000|Overall Study|Adverse Event|0|||
16498416|NCT00748033|40298816|FG001|Overall Study|Adverse Event|1|||
16195146|NCT02065622|39193241|FG002|Maintenance Study|Subject Non-Compliance|1|||
16195147|NCT02065622|39193242|FG003|Maintenance Study|Subject Non-Compliance|3|||
16498417|NCT02810392|40298817|FG000|Overall Study|Subject too ill to continue|1|||
16498418|NCT02810392|40298818|FG001|Overall Study|Subject too ill to continue|0|||
16498419|NCT02810392|40298817|FG000|Overall Study|COVID 19 research restrictions|0|||
16498420|NCT02810392|40298818|FG001|Overall Study|COVID 19 research restrictions|1|||
16498421|NCT04690751|40298819|FG000|Overall Study|Protocol Violation|0|||
16498422|NCT04690751|40298820|FG001|Overall Study|Protocol Violation|1|||
16498423|NCT04690751|40298821|FG002|Overall Study|Protocol Violation|0|||
16498424|NCT04690751|40298822|FG003|Overall Study|Protocol Violation|1|||
16498425|NCT04690751|40298823|FG004|Overall Study|Protocol Violation|2|||
16498426|NCT04690751|40298824|FG005|Overall Study|Protocol Violation|0|||
16498427|NCT04690751|40298819|FG000|Overall Study|Adverse Event|0|||
16498428|NCT04690751|40298820|FG001|Overall Study|Adverse Event|0|||
16498429|NCT04690751|40298821|FG002|Overall Study|Adverse Event|1|||
16498430|NCT04690751|40298822|FG003|Overall Study|Adverse Event|0|||
16498431|NCT04690751|40298823|FG004|Overall Study|Adverse Event|0|||
16498432|NCT04690751|40298824|FG005|Overall Study|Adverse Event|0|||
16498433|NCT04690751|40298819|FG000|Overall Study|Positive urine drug screen test|0|||
16498434|NCT04690751|40298820|FG001|Overall Study|Positive urine drug screen test|0|||
16498435|NCT04690751|40298821|FG002|Overall Study|Positive urine drug screen test|0|||
16498436|NCT04690751|40298822|FG003|Overall Study|Positive urine drug screen test|0|||
16498437|NCT04690751|40298823|FG004|Overall Study|Positive urine drug screen test|1|||
16498438|NCT04690751|40298824|FG005|Overall Study|Positive urine drug screen test|0|||
16498439|NCT02392247|40298825|FG000|Overall Study|Withdrawal by Subject|1|||
16498440|NCT02392247|40298825|FG000|Overall Study|Surgery cancelled; no data|1|||
16498441|NCT00225251|40298828|FG000|Overall Study|Withdrawal by Subject|1|||
16498442|NCT00225251|40298829|FG001|Overall Study|Withdrawal by Subject|1|||
16498443|NCT03362190|40298830|FG000|Overall Study|Adverse Event|0|||
16498444|NCT03362190|40298831|FG001|Overall Study|Adverse Event|0|||
16498445|NCT03362190|40298832|FG002|Overall Study|Adverse Event|0|||
16498446|NCT03362190|40298833|FG003|Overall Study|Adverse Event|1|||
16087080|NCT01998958|38810583|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
16087081|NCT01998958|38810584|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
16087082|NCT01998958|38810585|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
16498447|NCT03362190|40298830|FG000|Overall Study|Withdrawal by Subject|0|||
16498448|NCT03362190|40298831|FG001|Overall Study|Withdrawal by Subject|0|||
16498449|NCT03362190|40298832|FG002|Overall Study|Withdrawal by Subject|0|||
16498450|NCT03362190|40298833|FG003|Overall Study|Withdrawal by Subject|1|||
16498451|NCT01106898|40298837|FG000|Overall Study|Adverse Event|6|||
16498452|NCT01928329|40298841|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
16498453|NCT01928329|40298842|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
16498454|NCT01928329|40298841|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
16498455|NCT01928329|40298842|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
16498456|NCT01928329|40298841|FG000|Overall Study|Adverse Event|5|||
16498457|NCT01928329|40298842|FG001|Overall Study|Adverse Event|3|||
16498458|NCT01928329|40298841|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
16498459|NCT01928329|40298842|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
16498460|NCT01928329|40298841|FG000|Overall Study|Withdrawal by Subject|1|||
16498461|NCT01928329|40298842|FG001|Overall Study|Withdrawal by Subject|5|||
16498462|NCT01928329|40298841|FG000|Overall Study|Physician Decision|1|||
16498463|NCT01928329|40298842|FG001|Overall Study|Physician Decision|1|||
16498464|NCT00157950|40298847|FG000|Overall Study|Death|1|||
16087083|NCT01998958|38810586|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
16087084|NCT01998958|38810587|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
16195148|NCT02065622|39193243|FG004|Maintenance Study|Subject Non-Compliance|2|||
16195149|NCT02065622|39193239|FG000|Maintenance Study|Other, Not Specified|0|||
16309087|NCT00235755|39615697|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
16309088|NCT00235755|39615695|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
16309089|NCT00235755|39615696|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
16309090|NCT00235755|39615697|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
16309091|NCT00235755|39615695|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
16309092|NCT00235755|39615696|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
16309093|NCT00235755|39615697|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
16309094|NCT00235755|39615695|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
16309095|NCT00235755|39615696|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
16309096|NCT00235755|39615697|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
16309097|NCT00235755|39615695|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
16309098|NCT00235755|39615696|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
16309099|NCT00235755|39615697|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
16309100|NCT02932462|39615698|FG000|Overall Study|Adverse Event|1|||
16309101|NCT02932462|39615699|FG001|Overall Study|Adverse Event|2|||
16309102|NCT02932462|39615698|FG000|Overall Study|Lost to Follow-up|4|||
16309103|NCT02932462|39615699|FG001|Overall Study|Lost to Follow-up|1|||
16309104|NCT02932462|39615698|FG000|Overall Study|Protocol Violation|0|||
16309105|NCT02932462|39615699|FG001|Overall Study|Protocol Violation|5|||
16309106|NCT02932462|39615698|FG000|Overall Study|Withdrawal by Subject|1|||
16309107|NCT02932462|39615699|FG001|Overall Study|Withdrawal by Subject|4|||
16498465|NCT00157950|40298848|FG001|Overall Study|Death|0|||
16498466|NCT00453544|40298851|FG000|Overall Study|Withdrawal by Subject|1|||
16498467|NCT00453544|40298852|FG001|Overall Study|Withdrawal by Subject|0|||
16087085|NCT01998958|38810588|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
16087086|NCT01998958|38810589|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
16087087|NCT01998958|38810590|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
16087088|NCT01998958|38810591|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
16087089|NCT01998958|38810592|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
16087090|NCT01998958|38810593|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
16087091|NCT01998958|38810594|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
16087092|NCT01998958|38810595|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
16309108|NCT02932462|39615698|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16309109|NCT02932462|39615699|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16309110|NCT02932462|39615698|FG000|Overall Study|Progressive Disease|1|||
16309111|NCT02932462|39615699|FG001|Overall Study|Progressive Disease|0|||
16309112|NCT02387840|39615700|FG000|Overall Study|Death|0|||
16309113|NCT02387840|39615701|FG001|Overall Study|Death|0|||
16309114|NCT02387840|39615702|FG002|Overall Study|Death|0|||
16309115|NCT02387840|39615703|FG003|Overall Study|Death|0|||
16309116|NCT02387840|39615704|FG004|Overall Study|Death|0|||
16309117|NCT02387840|39615705|FG005|Overall Study|Death|1|||
16388776|NCT03465722|39905764|FG000|Overall Study|Administrative/Other|33|||
16498468|NCT00453544|40298853|FG002|Overall Study|Withdrawal by Subject|0|||
16498469|NCT00453544|40298854|FG003|Overall Study|Withdrawal by Subject|0|||
16498470|NCT00453544|40298851|FG000|Overall Study|Primary outcome measure not completed|1|||
16498471|NCT00453544|40298852|FG001|Overall Study|Primary outcome measure not completed|1|||
16498472|NCT00453544|40298853|FG002|Overall Study|Primary outcome measure not completed|0|||
16498473|NCT00453544|40298854|FG003|Overall Study|Primary outcome measure not completed|1|||
16498474|NCT01287897|40298857|FG000|Overall Study|Adverse Event|5|||
16498475|NCT01287897|40298858|FG001|Overall Study|Adverse Event|3|||
16498476|NCT01287897|40298859|FG002|Overall Study|Adverse Event|6|||
16498477|NCT01287897|40298860|FG003|Overall Study|Adverse Event|4|||
16498478|NCT01287897|40298857|FG000|Overall Study|Lack of Efficacy|2|||
16498479|NCT01287897|40298858|FG001|Overall Study|Lack of Efficacy|0|||
16498480|NCT01287897|40298859|FG002|Overall Study|Lack of Efficacy|0|||
16498481|NCT01287897|40298860|FG003|Overall Study|Lack of Efficacy|0|||
16498482|NCT01287897|40298857|FG000|Overall Study|Protocol Violation|1|||
16498483|NCT01287897|40298858|FG001|Overall Study|Protocol Violation|1|||
16498484|NCT01287897|40298859|FG002|Overall Study|Protocol Violation|0|||
16498485|NCT01287897|40298860|FG003|Overall Study|Protocol Violation|1|||
16498486|NCT01287897|40298857|FG000|Overall Study|Lost to Follow-up|0|||
16498487|NCT01287897|40298858|FG001|Overall Study|Lost to Follow-up|0|||
16498488|NCT01287897|40298859|FG002|Overall Study|Lost to Follow-up|2|||
16498489|NCT01287897|40298860|FG003|Overall Study|Lost to Follow-up|0|||
16498490|NCT01287897|40298857|FG000|Overall Study|Withdrawal by Subject|1|||
16498491|NCT01287897|40298858|FG001|Overall Study|Withdrawal by Subject|5|||
16498492|NCT01287897|40298859|FG002|Overall Study|Withdrawal by Subject|3|||
16498493|NCT01287897|40298860|FG003|Overall Study|Withdrawal by Subject|2|||
16498494|NCT01287897|40298857|FG000|Overall Study|Not consented properly|0|||
16498495|NCT01287897|40298858|FG001|Overall Study|Not consented properly|1|||
16223430|NCT02275780|39298683|FG001|Base Study: 96 Weeks|Death|1|||
16223431|NCT02275780|39298682|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
16223432|NCT02275780|39298683|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
16223433|NCT02275780|39298682|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
16223434|NCT02275780|39298683|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
16223435|NCT02275780|39298682|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
16223436|NCT02275780|39298683|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
16223437|NCT02275780|39298682|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
16223438|NCT02275780|39298683|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
16223439|NCT02275780|39298682|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
16223440|NCT02275780|39298683|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
16223441|NCT02275780|39298682|FG000|Base Study: 96 Weeks|Physician Decision|2|||
16223442|NCT02275780|39298683|FG001|Base Study: 96 Weeks|Physician Decision|4|||
16223443|NCT02275780|39298682|FG000|Base Study: 96 Weeks|Pregnancy|2|||
16223444|NCT02275780|39298683|FG001|Base Study: 96 Weeks|Pregnancy|1|||
16223445|NCT02275780|39298682|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
16223446|NCT02275780|39298683|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
16223447|NCT02275780|39298682|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
16223448|NCT02275780|39298683|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
16223449|NCT02275780|39298682|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
16223450|NCT02275780|39298683|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
16223451|NCT02275780|39298682|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
16223452|NCT02275780|39298683|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
16223453|NCT02275780|39298682|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
16223454|NCT02275780|39298683|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
16223455|NCT02275780|39298682|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
16223456|NCT02275780|39298683|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
16087093|NCT01998958|38810596|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
16087094|NCT01998958|38810597|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
16087095|NCT01998958|38810598|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
16087096|NCT01998958|38810599|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
16087097|NCT01998958|38810600|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
16087098|NCT01998958|38810601|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
16087099|NCT01998958|38810602|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
16087100|NCT01998958|38810603|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
16087101|NCT01998958|38810604|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
16087102|NCT01998958|38810605|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
16087103|NCT01998958|38810606|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
16087104|NCT01998958|38810607|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
16087105|NCT01998958|38810608|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
16087106|NCT01998958|38810609|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
16087107|NCT01998958|38810610|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
16087108|NCT01998958|38810611|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
16087109|NCT01998958|38810612|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
16087110|NCT01998958|38810613|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
16087111|NCT01998958|38810582|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087112|NCT01998958|38810583|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087113|NCT01998958|38810584|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087114|NCT01998958|38810585|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087115|NCT01998958|38810586|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087116|NCT01998958|38810587|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087117|NCT01998958|38810588|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087118|NCT01998958|38810589|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087119|NCT01998958|38810590|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087120|NCT01998958|38810591|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087121|NCT01998958|38810592|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087122|NCT01998958|38810593|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087123|NCT01998958|38810594|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087124|NCT01998958|38810595|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087125|NCT01998958|38810596|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
16087126|NCT01998958|38810597|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087127|NCT01998958|38810598|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087128|NCT01998958|38810599|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087129|NCT01998958|38810600|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
16087130|NCT01998958|38810601|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087131|NCT01998958|38810602|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087132|NCT01998958|38810603|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16498496|NCT01287897|40298859|FG002|Overall Study|Not consented properly|0|||
16498497|NCT01287897|40298860|FG003|Overall Study|Not consented properly|0|||
16498498|NCT01287897|40298857|FG000|Overall Study|Not meeting entrance criteria|1|||
16087133|NCT01998958|38810604|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087134|NCT01998958|38810605|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087135|NCT01998958|38810606|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087136|NCT01998958|38810607|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087137|NCT01998958|38810608|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087138|NCT01998958|38810609|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087139|NCT01998958|38810610|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087140|NCT01998958|38810611|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087141|NCT01998958|38810612|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087142|NCT01998958|38810613|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
16087143|NCT01998958|38810582|FG000|Open Label Phase (Optional)|Adverse Event|0|||
16087144|NCT01998958|38810583|FG001|Open Label Phase (Optional)|Adverse Event|0|||
16087145|NCT01998958|38810584|FG002|Open Label Phase (Optional)|Adverse Event|0|||
16388777|NCT03465722|39905765|FG001|Overall Study|Administrative/Other|32|||
16388778|NCT03465722|39905764|FG000|Overall Study|Not treated|1|||
16388779|NCT03465722|39905765|FG001|Overall Study|Not treated|2|||
16388780|NCT03465722|39905764|FG000|Overall Study|Sponsor decision|91|||
16388781|NCT03465722|39905765|FG001|Overall Study|Sponsor decision|98|||
16388782|NCT01824290|39905770|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
16388783|NCT01824290|39905771|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
16498499|NCT01287897|40298858|FG001|Overall Study|Not meeting entrance criteria|1|||
16087146|NCT01998958|38810585|FG003|Open Label Phase (Optional)|Adverse Event|0|||
16087147|NCT01998958|38810586|FG004|Open Label Phase (Optional)|Adverse Event|0|||
16087148|NCT01998958|38810587|FG005|Open Label Phase (Optional)|Adverse Event|0|||
16087149|NCT01998958|38810588|FG006|Open Label Phase (Optional)|Adverse Event|0|||
16087150|NCT01998958|38810589|FG007|Open Label Phase (Optional)|Adverse Event|0|||
16087151|NCT01998958|38810590|FG008|Open Label Phase (Optional)|Adverse Event|0|||
16498500|NCT01287897|40298859|FG002|Overall Study|Not meeting entrance criteria|0|||
16388784|NCT01824290|39905772|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
16498501|NCT01287897|40298860|FG003|Overall Study|Not meeting entrance criteria|0|||
16087152|NCT01998958|38810591|FG009|Open Label Phase (Optional)|Adverse Event|0|||
16087153|NCT01998958|38810592|FG010|Open Label Phase (Optional)|Adverse Event|0|||
16087154|NCT01998958|38810593|FG011|Open Label Phase (Optional)|Adverse Event|0|||
16309118|NCT01640249|39615718|FG000|Period 1|Withdrawal by Subject|1|||
16309119|NCT01640249|39615719|FG001|Period 1|Withdrawal by Subject|0|||
16309120|NCT01640249|39615720|FG002|Period 1|Withdrawal by Subject|0|||
16309121|NCT01640249|39615721|FG003|Period 1|Withdrawal by Subject|0|||
16309122|NCT01640249|39615722|FG004|Period 1|Withdrawal by Subject|0|||
16087155|NCT01998958|38810594|FG012|Open Label Phase (Optional)|Adverse Event|0|||
16087156|NCT01998958|38810595|FG013|Open Label Phase (Optional)|Adverse Event|0|||
16087157|NCT01998958|38810596|FG014|Open Label Phase (Optional)|Adverse Event|0|||
16087158|NCT01998958|38810597|FG015|Open Label Phase (Optional)|Adverse Event|0|||
16087159|NCT01998958|38810598|FG016|Open Label Phase (Optional)|Adverse Event|0|||
16087160|NCT01998958|38810599|FG017|Open Label Phase (Optional)|Adverse Event|0|||
16087161|NCT01998958|38810600|FG018|Open Label Phase (Optional)|Adverse Event|0|||
16087162|NCT01998958|38810601|FG019|Open Label Phase (Optional)|Adverse Event|0|||
16087163|NCT01998958|38810602|FG020|Open Label Phase (Optional)|Adverse Event|0|||
16087164|NCT01998958|38810603|FG021|Open Label Phase (Optional)|Adverse Event|0|||
16087165|NCT01998958|38810604|FG022|Open Label Phase (Optional)|Adverse Event|0|||
16087166|NCT01998958|38810605|FG023|Open Label Phase (Optional)|Adverse Event|1|||
16087167|NCT01998958|38810606|FG024|Open Label Phase (Optional)|Adverse Event|0|||
16087168|NCT01998958|38810607|FG025|Open Label Phase (Optional)|Adverse Event|0|||
16309123|NCT01640249|39615723|FG005|Period 1|Withdrawal by Subject|1|||
16087169|NCT01998958|38810608|FG026|Open Label Phase (Optional)|Adverse Event|0|||
16087170|NCT01998958|38810609|FG027|Open Label Phase (Optional)|Adverse Event|0|||
16087171|NCT01998958|38810610|FG028|Open Label Phase (Optional)|Adverse Event|0|||
16087172|NCT01998958|38810611|FG029|Open Label Phase (Optional)|Adverse Event|0|||
16087173|NCT01998958|38810612|FG030|Open Label Phase (Optional)|Adverse Event|0|||
16087174|NCT01998958|38810613|FG031|Open Label Phase (Optional)|Adverse Event|0|||
16087175|NCT01998958|38810582|FG000|Open Label Phase (Optional)|Other|0|||
16087176|NCT01998958|38810583|FG001|Open Label Phase (Optional)|Other|0|||
16087177|NCT01998958|38810584|FG002|Open Label Phase (Optional)|Other|0|||
16087178|NCT01998958|38810585|FG003|Open Label Phase (Optional)|Other|0|||
16087179|NCT01998958|38810586|FG004|Open Label Phase (Optional)|Other|0|||
16087180|NCT01998958|38810587|FG005|Open Label Phase (Optional)|Other|0|||
16087181|NCT01998958|38810588|FG006|Open Label Phase (Optional)|Other|0|||
16087182|NCT01998958|38810589|FG007|Open Label Phase (Optional)|Other|0|||
16087183|NCT01998958|38810590|FG008|Open Label Phase (Optional)|Other|0|||
16087184|NCT01998958|38810591|FG009|Open Label Phase (Optional)|Other|0|||
16087185|NCT01998958|38810592|FG010|Open Label Phase (Optional)|Other|0|||
16087186|NCT01998958|38810593|FG011|Open Label Phase (Optional)|Other|0|||
16087187|NCT01998958|38810594|FG012|Open Label Phase (Optional)|Other|0|||
16087188|NCT01998958|38810595|FG013|Open Label Phase (Optional)|Other|0|||
16087189|NCT01998958|38810596|FG014|Open Label Phase (Optional)|Other|0|||
16087190|NCT01998958|38810597|FG015|Open Label Phase (Optional)|Other|0|||
16087191|NCT01998958|38810598|FG016|Open Label Phase (Optional)|Other|0|||
16087192|NCT01998958|38810599|FG017|Open Label Phase (Optional)|Other|0|||
16087193|NCT01998958|38810600|FG018|Open Label Phase (Optional)|Other|0|||
16087194|NCT01998958|38810601|FG019|Open Label Phase (Optional)|Other|0|||
16087195|NCT01998958|38810602|FG020|Open Label Phase (Optional)|Other|0|||
16087196|NCT01998958|38810603|FG021|Open Label Phase (Optional)|Other|0|||
16087197|NCT01998958|38810604|FG022|Open Label Phase (Optional)|Other|5|||
16087198|NCT01998958|38810605|FG023|Open Label Phase (Optional)|Other|1|||
16087199|NCT01998958|38810606|FG024|Open Label Phase (Optional)|Other|0|||
16087200|NCT01998958|38810607|FG025|Open Label Phase (Optional)|Other|0|||
16309124|NCT01640249|39615724|FG006|Period 1|Withdrawal by Subject|0|||
16309125|NCT01547390|39615725|FG000|Overall Study|Withdrawal by Subject|10|||
16309126|NCT01547390|39615726|FG001|Overall Study|Withdrawal by Subject|7|||
16309127|NCT01547390|39615725|FG000|Overall Study|termination of pregnancy|0|||
16309128|NCT01547390|39615726|FG001|Overall Study|termination of pregnancy|1|||
16309129|NCT01547390|39615725|FG000|Overall Study|Lost to Follow-up|0|||
16309130|NCT01547390|39615726|FG001|Overall Study|Lost to Follow-up|2|||
16309131|NCT01547390|39615725|FG000|Overall Study|Adverse Event|3|||
16309132|NCT01547390|39615726|FG001|Overall Study|Adverse Event|0|||
16309133|NCT04700137|39615733|FG000|Overall Study|Lost to Follow-up|1|||
16309134|NCT04700137|39615734|FG001|Overall Study|Lost to Follow-up|6|||
16309135|NCT04700137|39615735|FG002|Overall Study|Lost to Follow-up|1|||
16309136|NCT04700137|39615736|FG003|Overall Study|Lost to Follow-up|1|||
16309137|NCT04700137|39615733|FG000|Overall Study|Withdrawal by Subject|0|||
16087201|NCT01998958|38810608|FG026|Open Label Phase (Optional)|Other|0|||
16498502|NCT01287897|40298857|FG000|Overall Study|Other|1|||
16087202|NCT01998958|38810609|FG027|Open Label Phase (Optional)|Other|0|||
16087203|NCT01998958|38810610|FG028|Open Label Phase (Optional)|Other|0|||
16087204|NCT01998958|38810611|FG029|Open Label Phase (Optional)|Other|0|||
16087205|NCT01998958|38810612|FG030|Open Label Phase (Optional)|Other|0|||
16087206|NCT01998958|38810613|FG031|Open Label Phase (Optional)|Other|0|||
16087207|NCT01998958|38810582|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087208|NCT01998958|38810583|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
16309138|NCT04700137|39615734|FG001|Overall Study|Withdrawal by Subject|0|||
16087209|NCT01998958|38810584|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087210|NCT01998958|38810585|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087211|NCT01998958|38810586|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087212|NCT01998958|38810587|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087213|NCT01998958|38810588|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087214|NCT01998958|38810589|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087215|NCT01998958|38810590|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087216|NCT01998958|38810591|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087217|NCT01998958|38810592|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087218|NCT01998958|38810593|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087219|NCT01998958|38810594|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087220|NCT01998958|38810595|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087221|NCT01998958|38810596|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087222|NCT01998958|38810597|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087223|NCT01998958|38810598|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087224|NCT01998958|38810599|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087225|NCT01998958|38810600|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087226|NCT01998958|38810601|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087227|NCT01998958|38810602|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087228|NCT01998958|38810603|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087229|NCT01998958|38810604|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
16087230|NCT01998958|38810605|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087231|NCT01998958|38810606|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087232|NCT01998958|38810607|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087233|NCT01998958|38810608|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
16195150|NCT02065622|39193240|FG001|Maintenance Study|Other, Not Specified|0|||
16195151|NCT02065622|39193241|FG002|Maintenance Study|Other, Not Specified|6|||
16195152|NCT02065622|39193242|FG003|Maintenance Study|Other, Not Specified|14|||
16309139|NCT04700137|39615735|FG002|Overall Study|Withdrawal by Subject|1|||
16498503|NCT01287897|40298858|FG001|Overall Study|Other|0|||
16498504|NCT01287897|40298859|FG002|Overall Study|Other|1|||
16498505|NCT01287897|40298860|FG003|Overall Study|Other|0|||
16498506|NCT02188589|40298864|FG000|Overall Study|Withdrawal by Subject|5|||
16498507|NCT04984993|40298869|FG000|Overall Study|Withdrawal by Subject|8|||
16498508|NCT04984993|40298870|FG001|Overall Study|Withdrawal by Subject|2|||
16498509|NCT04984993|40298869|FG000|Overall Study|Lost to Follow-up|2|||
16498510|NCT04984993|40298870|FG001|Overall Study|Lost to Follow-up|2|||
16498511|NCT04984993|40298869|FG000|Overall Study|Both patients moved to another country|4|||
16498512|NCT04984993|40298870|FG001|Overall Study|Both patients moved to another country|0|||
16087234|NCT01998958|38810609|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
16195153|NCT02065622|39193243|FG004|Maintenance Study|Other, Not Specified|2|||
16195154|NCT02065622|39193239|FG000|Maintenance Study|Unknown Reason|0|||
16498513|NCT01505868|40298875|FG000|Overall Study|Withdrawal by Subject|1|||
16498514|NCT01505868|40298876|FG001|Overall Study|Withdrawal by Subject|0|||
16498515|NCT01505868|40298877|FG002|Overall Study|Withdrawal by Subject|0|||
16498516|NCT01505868|40298878|FG003|Overall Study|Withdrawal by Subject|0|||
16498517|NCT01505868|40298879|FG004|Overall Study|Withdrawal by Subject|0|||
16195155|NCT02065622|39193240|FG001|Maintenance Study|Unknown Reason|0|||
16195156|NCT02065622|39193241|FG002|Maintenance Study|Unknown Reason|0|||
16498518|NCT03518073|40298880|FG000|Overall Study|Adverse Event|2|||
16498519|NCT03518073|40298881|FG001|Overall Study|Adverse Event|4|||
16498520|NCT03518073|40298882|FG002|Overall Study|Adverse Event|2|||
16498521|NCT03518073|40298880|FG000|Overall Study|Death|2|||
16498522|NCT03518073|40298881|FG001|Overall Study|Death|1|||
16498523|NCT03518073|40298882|FG002|Overall Study|Death|3|||
16498524|NCT03518073|40298880|FG000|Overall Study|Lost to Follow-up|1|||
16498525|NCT03518073|40298881|FG001|Overall Study|Lost to Follow-up|0|||
16498526|NCT03518073|40298882|FG002|Overall Study|Lost to Follow-up|1|||
16498527|NCT03518073|40298880|FG000|Overall Study|Physician Decision|5|||
16498528|NCT03518073|40298881|FG001|Overall Study|Physician Decision|0|||
16498529|NCT03518073|40298882|FG002|Overall Study|Physician Decision|2|||
16498530|NCT03518073|40298880|FG000|Overall Study|Progressive disease|1|||
16498531|NCT03518073|40298881|FG001|Overall Study|Progressive disease|1|||
16309140|NCT04700137|39615736|FG003|Overall Study|Withdrawal by Subject|0|||
16309141|NCT04700137|39615733|FG000|Overall Study|Death|0|||
16309142|NCT04700137|39615734|FG001|Overall Study|Death|0|||
16309143|NCT04700137|39615735|FG002|Overall Study|Death|1|||
16309144|NCT04700137|39615736|FG003|Overall Study|Death|0|||
16309145|NCT03772717|39615742|FG000|Overall Study|Withdrawal by Subject|2|||
16309146|NCT00262028|39615743|FG000|Overall Study|Withdrawal by Subject|6|||
16309147|NCT00262028|39615744|FG001|Overall Study|Withdrawal by Subject|3|||
16309148|NCT00262028|39615745|FG002|Overall Study|Withdrawal by Subject|6|||
16309149|NCT00262028|39615746|FG003|Overall Study|Withdrawal by Subject|5|||
16309150|NCT00262028|39615747|FG004|Overall Study|Withdrawal by Subject|2|||
16498532|NCT03518073|40298882|FG002|Overall Study|Progressive disease|1|||
16498533|NCT03518073|40298880|FG000|Overall Study|Protocol Violation|1|||
16498534|NCT03518073|40298881|FG001|Overall Study|Protocol Violation|0|||
16498535|NCT03518073|40298882|FG002|Overall Study|Protocol Violation|0|||
16498536|NCT03518073|40298880|FG000|Overall Study|Withdrawal by Subject|30|||
16498537|NCT03518073|40298881|FG001|Overall Study|Withdrawal by Subject|34|||
16498538|NCT03518073|40298882|FG002|Overall Study|Withdrawal by Subject|29|||
16498539|NCT03518073|40298880|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
16498540|NCT03518073|40298881|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
16498541|NCT03518073|40298882|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
16498542|NCT03518073|40298880|FG000|Overall Study|Covid-19|1|||
16498543|NCT03518073|40298881|FG001|Overall Study|Covid-19|2|||
16309151|NCT00262028|39615748|FG005|Overall Study|Withdrawal by Subject|3|||
16309152|NCT00262028|39615749|FG006|Overall Study|Withdrawal by Subject|5|||
16498544|NCT03518073|40298882|FG002|Overall Study|Covid-19|1|||
16309153|NCT00262028|39615750|FG007|Overall Study|Withdrawal by Subject|7|||
16309154|NCT00262028|39615751|FG008|Overall Study|Withdrawal by Subject|2|||
16309155|NCT00262028|39615743|FG000|Overall Study|Lost to Follow-up|7|||
16309156|NCT00262028|39615744|FG001|Overall Study|Lost to Follow-up|7|||
16309157|NCT00262028|39615745|FG002|Overall Study|Lost to Follow-up|5|||
16309158|NCT00262028|39615746|FG003|Overall Study|Lost to Follow-up|5|||
16309159|NCT00262028|39615747|FG004|Overall Study|Lost to Follow-up|4|||
16309160|NCT00262028|39615748|FG005|Overall Study|Lost to Follow-up|3|||
16309161|NCT00262028|39615749|FG006|Overall Study|Lost to Follow-up|3|||
16309162|NCT00262028|39615750|FG007|Overall Study|Lost to Follow-up|5|||
16309163|NCT00262028|39615751|FG008|Overall Study|Lost to Follow-up|6|||
16309164|NCT00262028|39615743|FG000|Overall Study|Administrative Reason|11|||
16309165|NCT00262028|39615744|FG001|Overall Study|Administrative Reason|14|||
16309166|NCT00262028|39615745|FG002|Overall Study|Administrative Reason|9|||
16309167|NCT00262028|39615746|FG003|Overall Study|Administrative Reason|12|||
16309168|NCT00262028|39615747|FG004|Overall Study|Administrative Reason|6|||
16309169|NCT00262028|39615748|FG005|Overall Study|Administrative Reason|7|||
16309170|NCT00262028|39615749|FG006|Overall Study|Administrative Reason|4|||
16309171|NCT00262028|39615750|FG007|Overall Study|Administrative Reason|6|||
16309172|NCT00262028|39615751|FG008|Overall Study|Administrative Reason|10|||
16309173|NCT00262028|39615743|FG000|Overall Study|Protocol Violation|0|||
16309174|NCT00262028|39615744|FG001|Overall Study|Protocol Violation|0|||
16309175|NCT00262028|39615745|FG002|Overall Study|Protocol Violation|0|||
16498545|NCT03414424|40298883|FG000|Overall Study|Screened out after consent|0|||
16498546|NCT03414424|40298884|FG001|Overall Study|Screened out after consent|2|||
16195157|NCT02065622|39193242|FG003|Maintenance Study|Unknown Reason|1|||
16195158|NCT02065622|39193243|FG004|Maintenance Study|Unknown Reason|0|||
16195159|NCT01608724|39193244|FG000|Overall Study|Withdrawal by Subject|131|||
16309176|NCT00262028|39615746|FG003|Overall Study|Protocol Violation|1|||
16309177|NCT00262028|39615747|FG004|Overall Study|Protocol Violation|0|||
16309178|NCT00262028|39615748|FG005|Overall Study|Protocol Violation|0|||
16309179|NCT00262028|39615749|FG006|Overall Study|Protocol Violation|0|||
16498547|NCT03414424|40298883|FG000|Overall Study|Lost to Follow-up|0|||
16309180|NCT00262028|39615750|FG007|Overall Study|Protocol Violation|0|||
16309181|NCT00262028|39615751|FG008|Overall Study|Protocol Violation|0|||
16309182|NCT00262028|39615743|FG000|Overall Study|Unable to classify|0|||
16309183|NCT00262028|39615744|FG001|Overall Study|Unable to classify|3|||
16309184|NCT00262028|39615745|FG002|Overall Study|Unable to classify|0|||
16309185|NCT00262028|39615746|FG003|Overall Study|Unable to classify|0|||
16309186|NCT00262028|39615747|FG004|Overall Study|Unable to classify|0|||
16309187|NCT00262028|39615748|FG005|Overall Study|Unable to classify|0|||
16309188|NCT00262028|39615749|FG006|Overall Study|Unable to classify|0|||
16309189|NCT00262028|39615750|FG007|Overall Study|Unable to classify|0|||
16309190|NCT00262028|39615751|FG008|Overall Study|Unable to classify|1|||
16309191|NCT03905694|39615758|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
16309192|NCT03817190|39615759|FG000|Overall Study|Early Termination|13|||
16309193|NCT03817190|39615760|FG001|Overall Study|Early Termination|20|||
16309194|NCT03817190|39615759|FG000|Overall Study|Adverse Event|10|||
16309195|NCT03817190|39615760|FG001|Overall Study|Adverse Event|17|||
16309196|NCT03817190|39615759|FG000|Overall Study|Withdrawal by Subject|12|||
16309197|NCT03817190|39615760|FG001|Overall Study|Withdrawal by Subject|8|||
16309198|NCT03817190|39615759|FG000|Overall Study|Lost to Follow-up|11|||
16309199|NCT03817190|39615760|FG001|Overall Study|Lost to Follow-up|7|||
16309200|NCT03817190|39615759|FG000|Overall Study|Lack of Efficacy|7|||
16309201|NCT03817190|39615760|FG001|Overall Study|Lack of Efficacy|5|||
16309202|NCT03817190|39615759|FG000|Overall Study|Investigator Decision|5|||
16498548|NCT03414424|40298884|FG001|Overall Study|Lost to Follow-up|1|||
16498549|NCT01519960|40298892|FG000|Overall Study|Withdrawal from the study|26|||
16498550|NCT01519960|40298893|FG001|Overall Study|Withdrawal from the study|22|||
16498551|NCT01519960|40298894|FG002|Overall Study|Withdrawal from the study|5|||
16498552|NCT01614067|40298895|FG000|Overall Study|Pregnancy|1|||
16498553|NCT01614067|40298896|FG001|Overall Study|Pregnancy|0|||
16498554|NCT01614067|40298895|FG000|Overall Study|Physician Decision|6|||
16498555|NCT01614067|40298896|FG001|Overall Study|Physician Decision|5|||
16498556|NCT01614067|40298895|FG000|Overall Study|Withdrawal by Subject|0|||
16498557|NCT01614067|40298896|FG001|Overall Study|Withdrawal by Subject|1|||
16498558|NCT01614067|40298895|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
16498559|NCT01614067|40298896|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
16498560|NCT03010254|40298897|FG000|Overall Study|Adverse Event|0|||
16498561|NCT03010254|40298898|FG001|Overall Study|Adverse Event|1|||
16498562|NCT03010254|40298897|FG000|Overall Study|Lost to Follow-up|4|||
16498563|NCT03010254|40298898|FG001|Overall Study|Lost to Follow-up|0|||
16498564|NCT03010254|40298897|FG000|Overall Study|Withdrawal by Subject|1|||
16498565|NCT03010254|40298898|FG001|Overall Study|Withdrawal by Subject|1|||
16498566|NCT03010254|40298897|FG000|Overall Study|Other|2|||
16498567|NCT03010254|40298898|FG001|Overall Study|Other|3|||
16498568|NCT03204305|40298899|FG000|Overall Study|Lost to Follow-up|6|||
16498569|NCT03204305|40298900|FG001|Overall Study|Lost to Follow-up|4|||
16498570|NCT03204305|40298901|FG002|Overall Study|Lost to Follow-up|0|||
16309203|NCT03817190|39615760|FG001|Overall Study|Investigator Decision|1|||
16309204|NCT03817190|39615759|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
16309205|NCT03817190|39615760|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
16388785|NCT01824290|39905773|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
16388786|NCT01824290|39905770|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
16388787|NCT01824290|39905771|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
16388788|NCT01824290|39905772|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
16388789|NCT01824290|39905773|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
16388790|NCT01824290|39905770|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
16388791|NCT01824290|39905771|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
16388792|NCT01824290|39905772|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
16388793|NCT01824290|39905773|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
16388794|NCT01824290|39905770|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
16388795|NCT01824290|39905771|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
16388796|NCT01824290|39905772|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
16498571|NCT03204305|40298902|FG003|Overall Study|Lost to Follow-up|0|||
16309206|NCT03817190|39615759|FG000|Overall Study|Lack of Contact|1|||
16309207|NCT03817190|39615760|FG001|Overall Study|Lack of Contact|0|||
16309208|NCT03817190|39615759|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
16309209|NCT03817190|39615760|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
16309210|NCT03055624|39615761|FG000|Overall Study|Study closed|9|||
16309211|NCT00417170|39615762|FG000|Overall Study|Adverse Event|1|||
16498572|NCT03204305|40298899|FG000|Overall Study|Physician Decision|1|||
16498573|NCT03204305|40298900|FG001|Overall Study|Physician Decision|0|||
16309212|NCT00417170|39615763|FG001|Overall Study|Adverse Event|1|||
16388797|NCT01824290|39905773|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
16388798|NCT01824290|39905770|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
16388799|NCT01824290|39905771|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
16388800|NCT01824290|39905772|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
16388801|NCT01824290|39905773|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
16388802|NCT01824290|39905770|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
16388803|NCT01824290|39905771|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
16388804|NCT01824290|39905772|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
16388805|NCT01824290|39905773|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
16388806|NCT04154605|39905774|FG000|Overall Study|Procedure Canceled|1|||
16388807|NCT04154605|39905775|FG001|Overall Study|Procedure Canceled|1|||
16388808|NCT04154605|39905774|FG000|Overall Study|Missed follow up|1|||
16388809|NCT04154605|39905775|FG001|Overall Study|Missed follow up|1|||
16388810|NCT04154605|39905774|FG000|Overall Study|Withdrawal by Subject|1|||
16498574|NCT03204305|40298901|FG002|Overall Study|Physician Decision|0|||
16498575|NCT03204305|40298902|FG003|Overall Study|Physician Decision|0|||
16498576|NCT03204305|40298899|FG000|Overall Study|failure to place arterial line|2|||
16498577|NCT03204305|40298900|FG001|Overall Study|failure to place arterial line|1|||
16498578|NCT03204305|40298901|FG002|Overall Study|failure to place arterial line|0|||
16498579|NCT03204305|40298902|FG003|Overall Study|failure to place arterial line|0|||
16498580|NCT03204305|40298899|FG000|Overall Study|Withdrawal by Subject|2|||
16498581|NCT03204305|40298900|FG001|Overall Study|Withdrawal by Subject|0|||
16498582|NCT03204305|40298901|FG002|Overall Study|Withdrawal by Subject|0|||
16498583|NCT03204305|40298902|FG003|Overall Study|Withdrawal by Subject|0|||
16498584|NCT03020407|40298903|FG000|Overall Study|Withdrawal by Subject|2|||
16498585|NCT03020407|40298904|FG001|Overall Study|Withdrawal by Subject|1|||
16498586|NCT03020407|40298903|FG000|Overall Study|Lost to Follow-up|2|||
16498587|NCT03020407|40298904|FG001|Overall Study|Lost to Follow-up|3|||
16498588|NCT03020407|40298903|FG000|Overall Study|Protocol Violation|0|||
16498589|NCT03020407|40298904|FG001|Overall Study|Protocol Violation|1|||
16498590|NCT01961323|40298905|FG000|Overall Study|Withdrawal by Subject|7|||
16498591|NCT01961323|40298905|FG000|Overall Study|Lost to Follow-up|8|||
16498592|NCT01961323|40298905|FG000|Overall Study|screen failure|34|||
16498593|NCT01244906|40298906|FG000|Overall Study|Death|2|||
16498594|NCT01244906|40298906|FG000|Overall Study|Progression of disease post treatment|6|||
16498595|NCT02485301|40298907|FG000|Overall Study|Serious Adverse Events|2|||
16498596|NCT02485301|40298908|FG001|Overall Study|Serious Adverse Events|1|||
16498597|NCT02485301|40298907|FG000|Overall Study|Protocol Violation|0|||
16498598|NCT02485301|40298908|FG001|Overall Study|Protocol Violation|1|||
16498599|NCT02485301|40298907|FG000|Overall Study|Withdrawal by Subject|6|||
16498600|NCT02485301|40298908|FG001|Overall Study|Withdrawal by Subject|7|||
16498601|NCT02485301|40298907|FG000|Overall Study|Migrated/moved from study area|10|||
16498602|NCT02485301|40298908|FG001|Overall Study|Migrated/moved from study area|19|||
16498603|NCT02485301|40298907|FG000|Overall Study|Lost to Follow-up|17|||
16498604|NCT02485301|40298908|FG001|Overall Study|Lost to Follow-up|17|||
16498605|NCT02485301|40298907|FG000|Overall Study|Other|3|||
16498606|NCT02485301|40298908|FG001|Overall Study|Other|4|||
16498607|NCT00909389|40298911|FG000|Overall Study|Adverse Event|6|||
16498608|NCT00909389|40298911|FG000|Overall Study|Death|4|||
16498609|NCT00909389|40298911|FG000|Overall Study|Poor Compliance|16|||
16498610|NCT00909389|40298911|FG000|Overall Study|Lost to Follow-up|4|||
16498611|NCT00909389|40298911|FG000|Overall Study|No Information|103|||
16498612|NCT00105482|40298912|FG000|Overall Study|Adverse Event|1|||
16498613|NCT00105482|40298913|FG001|Overall Study|Adverse Event|1|||
16498614|NCT00105482|40298912|FG000|Overall Study|Lost to Follow-up|26|||
16498615|NCT00105482|40298913|FG001|Overall Study|Lost to Follow-up|17|||
16498616|NCT00105482|40298912|FG000|Overall Study|Withdrawal by Subject|0|||
16498617|NCT00105482|40298913|FG001|Overall Study|Withdrawal by Subject|1|||
16498618|NCT00105482|40298912|FG000|Overall Study|Lost Interest|29|||
16388811|NCT04154605|39905775|FG001|Overall Study|Withdrawal by Subject|0|||
16195160|NCT01608724|39193244|FG000|Overall Study|Lost to Follow-up|41|||
16309213|NCT00417170|39615762|FG000|Overall Study|Withdrawal by Subject|1|||
16309214|NCT00417170|39615763|FG001|Overall Study|Withdrawal by Subject|1|||
16309215|NCT00417170|39615762|FG000|Overall Study|Lost to Follow-up|0|||
16309216|NCT00417170|39615763|FG001|Overall Study|Lost to Follow-up|1|||
16309217|NCT00470535|39615764|FG000|Overall Study|Disease Progression|13|||
16309218|NCT00470535|39615764|FG000|Overall Study|Withdrawal by Subject|1|||
16309219|NCT00470535|39615764|FG000|Overall Study|Adverse Event|1|||
16309220|NCT00470535|39615764|FG000|Overall Study|Death|1|||
16309221|NCT00470535|39615764|FG000|Overall Study|Other|2|||
16309222|NCT01207583|39615769|FG000|Overall Study|Withdrawal by Subject|0|||
16309223|NCT01207583|39615770|FG001|Overall Study|Withdrawal by Subject|3|||
16309224|NCT01207583|39615771|FG002|Overall Study|Withdrawal by Subject|1|||
16309225|NCT01207583|39615769|FG000|Overall Study|Participant failed to return|1|||
16309226|NCT01207583|39615770|FG001|Overall Study|Participant failed to return|0|||
16309227|NCT01207583|39615771|FG002|Overall Study|Participant failed to return|0|||
16309228|NCT01207583|39615769|FG000|Overall Study|Lost to Follow-up|0|||
16388812|NCT01306643|39905781|FG000|Overall Study|Adverse Event|5|||
16388813|NCT01306643|39905781|FG000|Overall Study|Disease Progression|7|||
16195161|NCT01608724|39193244|FG000|Overall Study|Study-specific discontinuation criteria|32|||
16388814|NCT01306643|39905781|FG000|Overall Study|Other: Change in Eligibility Status|1|||
16388815|NCT01008618|39905784|FG000|Period 1 (Titration Period)|Physician Decision|2|||
16388816|NCT01008618|39905785|FG001|Period 1 (Titration Period)|Physician Decision|0|||
16388817|NCT01008618|39905786|FG002|Period 1 (Titration Period)|Physician Decision|0|||
16388818|NCT01008618|39905784|FG000|Period 1 (Titration Period)|Adverse Event|33|||
16388819|NCT01008618|39905785|FG001|Period 1 (Titration Period)|Adverse Event|0|||
16388820|NCT01008618|39905786|FG002|Period 1 (Titration Period)|Adverse Event|0|||
16388821|NCT01008618|39905784|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
16388822|NCT01008618|39905785|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
16388823|NCT01008618|39905786|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
16388824|NCT01008618|39905784|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
16498619|NCT00105482|40298913|FG001|Overall Study|Lost Interest|32|||
16498620|NCT00105482|40298912|FG000|Overall Study|Scheduling Conflict|2|||
16498621|NCT00105482|40298913|FG001|Overall Study|Scheduling Conflict|3|||
16498622|NCT00105482|40298912|FG000|Overall Study|Withdrawn by PI|1|||
16498623|NCT00105482|40298913|FG001|Overall Study|Withdrawn by PI|1|||
16309229|NCT01207583|39615770|FG001|Overall Study|Lost to Follow-up|2|||
16309230|NCT01207583|39615771|FG002|Overall Study|Lost to Follow-up|0|||
16309231|NCT02964312|39615777|FG000|Overall Study|Lost to Follow-up|28|||
16309232|NCT02964312|39615777|FG000|Overall Study|Withdrawal by Subject|11|||
16309233|NCT02964312|39615777|FG000|Overall Study|Lack of Efficacy|10|||
16309234|NCT02964312|39615777|FG000|Overall Study|Did not consent to long-term FU|14|||
16309235|NCT02964312|39615777|FG000|Overall Study|Death|1|||
16309236|NCT01662492|39615787|FG000|Overall Study|Other miscellaneous reasons.|1|||
16309237|NCT01662492|39615788|FG001|Overall Study|Other miscellaneous reasons.|0|||
16309238|NCT01662492|39615789|FG002|Overall Study|Other miscellaneous reasons.|1|||
16309239|NCT01662492|39615787|FG000|Overall Study|Withdrawal by Subject|0|||
16388825|NCT01008618|39905785|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
16388826|NCT01008618|39905786|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
16388827|NCT01008618|39905784|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
16388828|NCT01008618|39905785|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
16388829|NCT01008618|39905786|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
16498624|NCT01411228|40298914|FG000|Overall Study|Lost to Follow-up|0|||
16498625|NCT01411228|40298915|FG001|Overall Study|Lost to Follow-up|0|||
16498626|NCT01411228|40298916|FG002|Overall Study|Lost to Follow-up|1|||
16388830|NCT01008618|39905784|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
16388831|NCT01008618|39905785|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
16388832|NCT01008618|39905786|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
16388833|NCT01008618|39905784|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
16388834|NCT01008618|39905785|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
16388835|NCT01008618|39905786|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
16388836|NCT01008618|39905784|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
16388837|NCT01008618|39905785|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
16388838|NCT01008618|39905786|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
16388839|NCT01008618|39905784|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
16388840|NCT01008618|39905785|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
16388841|NCT01008618|39905786|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
16388842|NCT01008618|39905784|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
16388843|NCT01008618|39905785|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
16388844|NCT01008618|39905786|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
16388845|NCT01008618|39905784|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
16388846|NCT01008618|39905785|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
16388847|NCT01008618|39905786|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
16388848|NCT01008618|39905784|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
16388849|NCT01008618|39905785|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
16388850|NCT01008618|39905786|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
16388851|NCT05219253|39905789|FG000|Overall Study|Withdrawal by Subject|1|||
16388852|NCT05219253|39905790|FG001|Overall Study|Withdrawal by Subject|2|||
16388853|NCT00730756|39905800|FG000|Overall Study|Adverse Event|2|||
16388854|NCT00730756|39905801|FG001|Overall Study|Adverse Event|0|||
16388855|NCT00730756|39905800|FG000|Overall Study|Lack of Efficacy|1|||
16309240|NCT01662492|39615788|FG001|Overall Study|Withdrawal by Subject|0|||
16388856|NCT00730756|39905801|FG001|Overall Study|Lack of Efficacy|1|||
16388857|NCT00730756|39905800|FG000|Overall Study|Protocol Deviation|1|||
16498627|NCT01411228|40298914|FG000|Overall Study|Withdrawal by Subject|1|||
16498628|NCT01411228|40298915|FG001|Overall Study|Withdrawal by Subject|0|||
16498629|NCT01411228|40298916|FG002|Overall Study|Withdrawal by Subject|0|||
16498630|NCT01252940|40298920|FG000|Main Study Phase|Randomized but not treated|4|||
16388858|NCT00730756|39905801|FG001|Overall Study|Protocol Deviation|2|||
16388859|NCT00730756|39905800|FG000|Overall Study|Lost to Follow-up|0|||
16388860|NCT00730756|39905801|FG001|Overall Study|Lost to Follow-up|1|||
16388861|NCT00730756|39905800|FG000|Overall Study|Withdrew Consent|0|||
16498631|NCT01252940|40298921|FG001|Main Study Phase|Randomized but not treated|2|||
16498632|NCT01252940|40298920|FG000|Main Study Phase|Adverse Event|3|||
16498633|NCT01252940|40298921|FG001|Main Study Phase|Adverse Event|1|||
16309241|NCT01662492|39615789|FG002|Overall Study|Withdrawal by Subject|1|||
16498634|NCT01252940|40298920|FG000|Main Study Phase|Lack of Efficacy|1|||
16498635|NCT01252940|40298921|FG001|Main Study Phase|Lack of Efficacy|0|||
16498636|NCT01252940|40298920|FG000|Main Study Phase|Lost to Follow-up|6|||
16498637|NCT01252940|40298921|FG001|Main Study Phase|Lost to Follow-up|1|||
16498638|NCT01252940|40298920|FG000|Main Study Phase|Physician Decision|1|||
16498639|NCT01252940|40298921|FG001|Main Study Phase|Physician Decision|0|||
16498640|NCT01252940|40298920|FG000|Main Study Phase|Protocol Violation|4|||
16498641|NCT01252940|40298921|FG001|Main Study Phase|Protocol Violation|2|||
16498642|NCT01252940|40298920|FG000|Main Study Phase|Withdrawal by Subject|6|||
16498643|NCT01252940|40298921|FG001|Main Study Phase|Withdrawal by Subject|5|||
16498644|NCT01252940|40298920|FG000|Main Study Phase|Subject Non-compliance|1|||
16498645|NCT01252940|40298921|FG001|Main Study Phase|Subject Non-compliance|1|||
16498646|NCT01252940|40298920|FG000|Extension Phase|Adverse Event|2|||
16498647|NCT01252940|40298921|FG001|Extension Phase|Adverse Event|1|||
16309242|NCT01662492|39615787|FG000|Overall Study|Protocol Violation|1|||
16309243|NCT01662492|39615788|FG001|Overall Study|Protocol Violation|0|||
16309244|NCT01662492|39615789|FG002|Overall Study|Protocol Violation|0|||
16309245|NCT01662492|39615787|FG000|Overall Study|Lost to Follow-up|0|||
16309246|NCT01662492|39615788|FG001|Overall Study|Lost to Follow-up|0|||
16309247|NCT01662492|39615789|FG002|Overall Study|Lost to Follow-up|2|||
16309248|NCT01662492|39615787|FG000|Overall Study|Lack of Efficacy|1|||
16309249|NCT01662492|39615788|FG001|Overall Study|Lack of Efficacy|1|||
16388862|NCT00730756|39905801|FG001|Overall Study|Withdrew Consent|1|||
16388863|NCT00420381|39908416|FG000|Overall Study|Protocol Violation|1|||
16388864|NCT00846846|39908417|FG000|Overall Study|Death|56|||
16388865|NCT00846846|39908417|FG000|Overall Study|Withdrawal by Subject|19|||
16388866|NCT01544348|39908418|FG000|Overall Study|Lost to Follow-up|1|||
16388867|NCT01544348|39908419|FG001|Overall Study|Lost to Follow-up|0|||
16388868|NCT01544348|39908420|FG002|Overall Study|Lost to Follow-up|0|||
16388869|NCT01544348|39908421|FG003|Overall Study|Lost to Follow-up|0|||
16388870|NCT01544348|39908422|FG004|Overall Study|Lost to Follow-up|0|||
16388871|NCT01544348|39908423|FG005|Overall Study|Lost to Follow-up|0|||
16388872|NCT01544348|39908424|FG006|Overall Study|Lost to Follow-up|1|||
16388873|NCT01544348|39908425|FG007|Overall Study|Lost to Follow-up|0|||
16388874|NCT01544348|39908418|FG000|Overall Study|Withdrawal by Subject|1|||
16388875|NCT01544348|39908419|FG001|Overall Study|Withdrawal by Subject|0|||
16388876|NCT01544348|39908420|FG002|Overall Study|Withdrawal by Subject|0|||
16388877|NCT01544348|39908421|FG003|Overall Study|Withdrawal by Subject|0|||
16388878|NCT01544348|39908422|FG004|Overall Study|Withdrawal by Subject|1|||
16388879|NCT01544348|39908423|FG005|Overall Study|Withdrawal by Subject|2|||
16388880|NCT01544348|39908424|FG006|Overall Study|Withdrawal by Subject|1|||
16388881|NCT01544348|39908425|FG007|Overall Study|Withdrawal by Subject|0|||
16388882|NCT01544348|39908418|FG000|Overall Study|Physician Decision|0|||
16388883|NCT01544348|39908419|FG001|Overall Study|Physician Decision|0|||
16388884|NCT01544348|39908420|FG002|Overall Study|Physician Decision|0|||
16388885|NCT01544348|39908421|FG003|Overall Study|Physician Decision|0|||
16388886|NCT01544348|39908422|FG004|Overall Study|Physician Decision|0|||
16388887|NCT01544348|39908423|FG005|Overall Study|Physician Decision|1|||
16388888|NCT01544348|39908424|FG006|Overall Study|Physician Decision|0|||
16388889|NCT01544348|39908425|FG007|Overall Study|Physician Decision|0|||
16388890|NCT03782064|39908426|FG000|Overall Study|Lack of Efficacy|2|||
16388891|NCT03782064|39908426|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
16388892|NCT00856609|39908427|FG000|Overall Study|Adverse Event|1|||
16388893|NCT00856609|39908428|FG001|Overall Study|Adverse Event|0|||
16388894|NCT02347085|39908429|FG000|Overall Study|Adverse Event|2|||
16388895|NCT02347085|39908429|FG000|Overall Study|Lack of Efficacy|1|||
16388896|NCT02347085|39908429|FG000|Overall Study|Withdrawal by Subject|4|||
16388897|NCT02347085|39908429|FG000|Overall Study|Lost to Follow-up|1|||
16388898|NCT02347085|39908429|FG000|Overall Study|Protocol Criteria|2|||
16388899|NCT01535287|39908430|FG000|Overall Study|drug not prepared in time|5|||
16388900|NCT01535287|39908431|FG001|Overall Study|drug not prepared in time|6|||
16388901|NCT04828707|39908436|FG000|Overall Study|Lost to Follow-up|3|||
16388902|NCT04828707|39908437|FG001|Overall Study|Lost to Follow-up|2|||
16388903|NCT04828707|39908436|FG000|Overall Study|Withdrawal by Subject|2|||
16388904|NCT04828707|39908437|FG001|Overall Study|Withdrawal by Subject|1|||
16388905|NCT01261975|39908438|FG000|Overall Study|Surgical complication|1|||
16388906|NCT00592631|39908439|FG000|Overall Study|Lost to Follow-up|0|||
16388907|NCT00592631|39908440|FG001|Overall Study|Lost to Follow-up|2|||
16388908|NCT01531998|39908445|FG000|Overall Study|Withdrawal by Subject|3|||
16388909|NCT04858425|39908448|FG000|Overall Study|Adverse Event|2|||
16388910|NCT04858425|39908449|FG001|Overall Study|Adverse Event|2|||
16388911|NCT04858425|39908448|FG000|Overall Study|Withdrawal by Subject|3|||
16498648|NCT01252940|40298920|FG000|Extension Phase|Lack of Efficacy|1|||
16498649|NCT01252940|40298921|FG001|Extension Phase|Lack of Efficacy|0|||
16309250|NCT01662492|39615789|FG002|Overall Study|Lack of Efficacy|2|||
16309251|NCT00314951|39615790|FG000|Treatment|Didn't meet criteria for mITT population|16|||
16498650|NCT01252940|40298920|FG000|Extension Phase|Lost to Follow-up|5|||
16309252|NCT00314951|39615791|FG001|Treatment|Didn't meet criteria for mITT population|11|||
16309253|NCT00314951|39615790|FG000|Follow-up|mITT failure|44|||
16388912|NCT04858425|39908449|FG001|Overall Study|Withdrawal by Subject|1|||
16087235|NCT01998958|38810610|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087236|NCT01998958|38810611|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087237|NCT01998958|38810612|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087238|NCT01998958|38810613|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
16087239|NCT01998958|38810582|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087240|NCT01998958|38810583|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087241|NCT01998958|38810584|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087242|NCT01998958|38810585|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087243|NCT01998958|38810586|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087244|NCT01998958|38810587|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087245|NCT01998958|38810588|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087246|NCT01998958|38810589|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087247|NCT01998958|38810590|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087248|NCT01998958|38810591|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087249|NCT01998958|38810592|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087250|NCT01998958|38810593|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087251|NCT01998958|38810594|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087252|NCT01998958|38810595|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087253|NCT01998958|38810596|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087254|NCT01998958|38810597|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087255|NCT01998958|38810598|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087256|NCT01998958|38810599|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
16309254|NCT00314951|39615791|FG001|Follow-up|mITT failure|34|||
16388913|NCT04858425|39908448|FG000|Overall Study|Lost to Follow-up|4|||
16388914|NCT04858425|39908449|FG001|Overall Study|Lost to Follow-up|2|||
16388915|NCT04858425|39908448|FG000|Overall Study|Lost to Follow-up|1|||
16388916|NCT04858425|39908449|FG001|Overall Study|Lost to Follow-up|0|||
16388917|NCT02477527|39908450|FG000|Overall Study|Lost to Follow-up|2|||
16388918|NCT02477527|39908450|FG000|Overall Study|Withdrawal by Subject|1|||
16388919|NCT02477527|39908450|FG000|Overall Study|Screen Failure|3|||
16388920|NCT00800982|39908451|FG000|Overall Study|Lost to Follow-up|1|||
16388921|NCT00800982|39908452|FG001|Overall Study|Lost to Follow-up|2|||
16388922|NCT00800982|39908451|FG000|Overall Study|Withdrawal by Subject|0|||
16388923|NCT00800982|39908452|FG001|Overall Study|Withdrawal by Subject|1|||
16388924|NCT00800982|39908451|FG000|Overall Study|Patient moved out of state|1|||
16388925|NCT00800982|39908452|FG001|Overall Study|Patient moved out of state|0|||
16388926|NCT01612676|39908454|FG000|Overall Study|Adverse Event|2|||
16388927|NCT01612676|39908455|FG001|Overall Study|Adverse Event|3|||
16388928|NCT01612676|39908456|FG002|Overall Study|Adverse Event|1|||
16498651|NCT01252940|40298921|FG001|Extension Phase|Lost to Follow-up|0|||
16309255|NCT03559556|39615792|FG000|Overall Study|Withdrawal by Subject|1|||
16309256|NCT02107131|39615793|FG000|Overall Study|Lost to Follow-up|4|||
16309257|NCT02107131|39615794|FG001|Overall Study|Lost to Follow-up|4|||
16309258|NCT02107131|39615793|FG000|Overall Study|Physician Decision|1|||
16309259|NCT02107131|39615794|FG001|Overall Study|Physician Decision|0|||
16309260|NCT02107131|39615793|FG000|Overall Study|Withdrawal by Subject|2|||
16309261|NCT02107131|39615794|FG001|Overall Study|Withdrawal by Subject|0|||
16309262|NCT02107131|39615793|FG000|Overall Study|mental instability|1|||
16388929|NCT01612676|39908457|FG003|Overall Study|Adverse Event|3|||
16498652|NCT01252940|40298920|FG000|Extension Phase|Physician Decision|0|||
16498653|NCT01252940|40298921|FG001|Extension Phase|Physician Decision|1|||
16498654|NCT01252940|40298920|FG000|Extension Phase|Subject Non-compliance|1|||
16498655|NCT01252940|40298921|FG001|Extension Phase|Subject Non-compliance|0|||
16498656|NCT01252940|40298920|FG000|Extension Phase|Withdrawal by Subject|1|||
16498657|NCT01252940|40298921|FG001|Extension Phase|Withdrawal by Subject|1|||
16309263|NCT02107131|39615794|FG001|Overall Study|mental instability|0|||
16388930|NCT01612676|39908454|FG000|Overall Study|Protocol Violation|0|||
16388931|NCT01612676|39908455|FG001|Overall Study|Protocol Violation|1|||
16388932|NCT01612676|39908456|FG002|Overall Study|Protocol Violation|0|||
16498658|NCT01111149|40298922|FG000|Overall Study|Protocol Violation|1|||
16498659|NCT01111149|40298923|FG001|Overall Study|Protocol Violation|1|||
16309264|NCT02107131|39615793|FG000|Overall Study|Death|0|||
16309265|NCT02107131|39615794|FG001|Overall Study|Death|1|||
16309266|NCT02107131|39615793|FG000|Overall Study|Protocol Violation|0|||
16388933|NCT01612676|39908457|FG003|Overall Study|Protocol Violation|0|||
16498660|NCT01111149|40298924|FG002|Overall Study|Protocol Violation|2|||
16388934|NCT00310375|39908458|FG000|Primary Reporting Phase|Adverse Event|28|||
16388935|NCT00310375|39908459|FG001|Primary Reporting Phase|Adverse Event|22|||
16498661|NCT01111149|40298922|FG000|Overall Study|Withdrawal by Subject|1|||
16087257|NCT01998958|38810600|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087258|NCT01998958|38810601|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087259|NCT01998958|38810602|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087260|NCT01998958|38810603|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
16087261|NCT01998958|38810604|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
16087262|NCT01998958|38810605|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087263|NCT01998958|38810606|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087264|NCT01998958|38810607|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087265|NCT01998958|38810608|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087266|NCT01998958|38810609|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087267|NCT01998958|38810610|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
16195162|NCT01608724|39193244|FG000|Overall Study|Adverse Event|29|||
16498662|NCT01111149|40298923|FG001|Overall Study|Withdrawal by Subject|0|||
16498663|NCT01111149|40298924|FG002|Overall Study|Withdrawal by Subject|2|||
16498664|NCT00818662|40298925|FG000|Overall Study|Adverse Event|5|||
16498665|NCT00818662|40298926|FG001|Overall Study|Adverse Event|14|||
16498666|NCT00818662|40298927|FG002|Overall Study|Adverse Event|4|||
16498667|NCT00818662|40298928|FG003|Overall Study|Adverse Event|3|||
16498668|NCT00818662|40298925|FG000|Overall Study|Withdrawal by Subject|5|||
16498669|NCT00818662|40298926|FG001|Overall Study|Withdrawal by Subject|4|||
16498670|NCT00818662|40298927|FG002|Overall Study|Withdrawal by Subject|2|||
16195163|NCT01608724|39193244|FG000|Overall Study|Protocol Violation|6|||
16195164|NCT01608724|39193244|FG000|Overall Study|bood sugar too high, etc.|3|||
16195165|NCT01608724|39193244|FG000|Overall Study|Safety reasons|1|||
16388936|NCT00310375|39908460|FG002|Primary Reporting Phase|Adverse Event|0|||
16498671|NCT00818662|40298928|FG003|Overall Study|Withdrawal by Subject|2|||
16498672|NCT00818662|40298925|FG000|Overall Study|Death|1|||
16498673|NCT00818662|40298926|FG001|Overall Study|Death|3|||
16498674|NCT00818662|40298927|FG002|Overall Study|Death|0|||
16498675|NCT00818662|40298928|FG003|Overall Study|Death|0|||
16498676|NCT00818662|40298925|FG000|Overall Study|Physician Decision|1|||
16498677|NCT00818662|40298926|FG001|Overall Study|Physician Decision|0|||
16498678|NCT00818662|40298927|FG002|Overall Study|Physician Decision|0|||
16498679|NCT00818662|40298928|FG003|Overall Study|Physician Decision|0|||
16388937|NCT00310375|39908458|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
16388938|NCT00310375|39908459|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
16498680|NCT00818662|40298925|FG000|Overall Study|Lost to Follow-up|0|||
16498681|NCT00818662|40298926|FG001|Overall Study|Lost to Follow-up|0|||
16498682|NCT00818662|40298927|FG002|Overall Study|Lost to Follow-up|0|||
16498683|NCT00818662|40298928|FG003|Overall Study|Lost to Follow-up|1|||
16498684|NCT00818662|40298925|FG000|Overall Study|Unwilling or Unable to Participate|4|||
16498685|NCT00818662|40298926|FG001|Overall Study|Unwilling or Unable to Participate|6|||
16498686|NCT00818662|40298927|FG002|Overall Study|Unwilling or Unable to Participate|2|||
16195166|NCT01561560|39193247|FG000|First Two Weeks of Wear|Time/job conflict|0|||
16195167|NCT01561560|39193248|FG001|First Two Weeks of Wear|Time/job conflict|1|||
16195168|NCT01561560|39193247|FG000|First Two Weeks of Wear|Adverse Event|0|||
16195169|NCT01561560|39193248|FG001|First Two Weeks of Wear|Adverse Event|1|||
16195170|NCT01561560|39193247|FG000|Second Two Weeks of Wear|Adverse Event|0|||
16195171|NCT01561560|39193248|FG001|Second Two Weeks of Wear|Adverse Event|1|||
16195172|NCT01969799|39193250|FG000|Overall Study|Adverse Event|0|||
16195173|NCT01969799|39193251|FG001|Overall Study|Adverse Event|1|||
16195174|NCT01969799|39193250|FG000|Overall Study|Death|16|||
16195175|NCT01969799|39193251|FG001|Overall Study|Death|11|||
16195176|NCT01969799|39193250|FG000|Overall Study|Lost to Follow-up|0|||
16195177|NCT01969799|39193251|FG001|Overall Study|Lost to Follow-up|2|||
16195178|NCT01969799|39193250|FG000|Overall Study|Physician Decision|1|||
16195179|NCT01969799|39193251|FG001|Overall Study|Physician Decision|0|||
16195180|NCT04311177|39193252|FG000|Overall Study|Adverse Event|3|||
16195181|NCT04311177|39193253|FG001|Overall Study|Adverse Event|1|||
16195182|NCT04311177|39193252|FG000|Overall Study|Physician Decision|4|||
16195183|NCT04311177|39193253|FG001|Overall Study|Physician Decision|3|||
16195184|NCT04311177|39193252|FG000|Overall Study|Withdrawal by Subject|1|||
16195185|NCT04311177|39193253|FG001|Overall Study|Withdrawal by Subject|0|||
16195186|NCT01718509|39193256|FG000|Overall Study|Lost to Follow-up|18|||
16498687|NCT00818662|40298928|FG003|Overall Study|Unwilling or Unable to Participate|4|||
16498688|NCT00818662|40298925|FG000|Overall Study|Protocol Violation|1|||
16498689|NCT00818662|40298926|FG001|Overall Study|Protocol Violation|1|||
16498690|NCT00818662|40298927|FG002|Overall Study|Protocol Violation|0|||
16498691|NCT00818662|40298928|FG003|Overall Study|Protocol Violation|0|||
16498692|NCT00818662|40298925|FG000|Overall Study|Requires a Prohibited Medication|1|||
16498693|NCT00818662|40298926|FG001|Overall Study|Requires a Prohibited Medication|0|||
16087268|NCT01998958|38810611|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
16087269|NCT01998958|38810612|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
16195187|NCT01718509|39193257|FG001|Overall Study|Lost to Follow-up|15|||
16195188|NCT01718509|39193256|FG000|Overall Study|Withdrawal by Subject|7|||
16498694|NCT00818662|40298927|FG002|Overall Study|Requires a Prohibited Medication|0|||
16498695|NCT00818662|40298928|FG003|Overall Study|Requires a Prohibited Medication|0|||
16498696|NCT00818662|40298925|FG000|Overall Study|Safety Risk|1|||
16498697|NCT00818662|40298926|FG001|Overall Study|Safety Risk|1|||
16498698|NCT00818662|40298927|FG002|Overall Study|Safety Risk|0|||
16498699|NCT00818662|40298928|FG003|Overall Study|Safety Risk|1|||
16498700|NCT00818662|40298925|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
16498701|NCT00818662|40298926|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
16498702|NCT00818662|40298927|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
16498703|NCT00818662|40298928|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
16498704|NCT00818662|40298925|FG000|Overall Study|Participant's health declined|0|||
16498705|NCT00818662|40298926|FG001|Overall Study|Participant's health declined|0|||
16498706|NCT00818662|40298927|FG002|Overall Study|Participant's health declined|0|||
16498707|NCT00818662|40298928|FG003|Overall Study|Participant's health declined|1|||
16498708|NCT00818662|40298925|FG000|Overall Study|Caregiver to pursue other treatment|0|||
16498709|NCT00818662|40298926|FG001|Overall Study|Caregiver to pursue other treatment|1|||
16498710|NCT00818662|40298927|FG002|Overall Study|Caregiver to pursue other treatment|0|||
16498711|NCT00818662|40298928|FG003|Overall Study|Caregiver to pursue other treatment|0|||
16498712|NCT00818662|40298925|FG000|Overall Study|Moving out of state|0|||
16498713|NCT00818662|40298926|FG001|Overall Study|Moving out of state|0|||
16498714|NCT00818662|40298927|FG002|Overall Study|Moving out of state|0|||
16498715|NCT00818662|40298928|FG003|Overall Study|Moving out of state|1|||
16498716|NCT00818662|40298925|FG000|Overall Study|Declined move to another study site|1|||
16498717|NCT00818662|40298926|FG001|Overall Study|Declined move to another study site|0|||
16498718|NCT00818662|40298927|FG002|Overall Study|Declined move to another study site|0|||
16498719|NCT00818662|40298928|FG003|Overall Study|Declined move to another study site|0|||
16498720|NCT00818662|40298925|FG000|Overall Study|Change in living situation|0|||
16498721|NCT00818662|40298926|FG001|Overall Study|Change in living situation|0|||
16498722|NCT00818662|40298927|FG002|Overall Study|Change in living situation|0|||
16498723|NCT00818662|40298928|FG003|Overall Study|Change in living situation|1|||
16498724|NCT00818662|40298925|FG000|Overall Study|Study partner decision|0|||
16498725|NCT00818662|40298926|FG001|Overall Study|Study partner decision|0|||
16388939|NCT00310375|39908460|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
16388940|NCT00310375|39908458|FG000|Primary Reporting Phase|Pregnancy|2|||
16388941|NCT00310375|39908459|FG001|Primary Reporting Phase|Pregnancy|2|||
16388942|NCT00310375|39908460|FG002|Primary Reporting Phase|Pregnancy|0|||
16388943|NCT00310375|39908458|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
16388944|NCT00310375|39908459|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
16388945|NCT00310375|39908460|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
16388946|NCT00310375|39908458|FG000|Primary Reporting Phase|Protocol Violation|8|||
16388947|NCT00310375|39908459|FG001|Primary Reporting Phase|Protocol Violation|5|||
16388948|NCT00310375|39908460|FG002|Primary Reporting Phase|Protocol Violation|0|||
16388949|NCT00310375|39908458|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
16388950|NCT00310375|39908459|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
16388951|NCT00310375|39908460|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
16388952|NCT00310375|39908458|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
16388953|NCT00310375|39908459|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
16388954|NCT00310375|39908460|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
16388955|NCT00310375|39908458|FG000|Primary Reporting Phase|Physician Decision|5|||
16388956|NCT00310375|39908459|FG001|Primary Reporting Phase|Physician Decision|3|||
16498726|NCT00818662|40298927|FG002|Overall Study|Study partner decision|0|||
16498727|NCT00818662|40298928|FG003|Overall Study|Study partner decision|1|||
16498728|NCT00818662|40298925|FG000|Overall Study|Admitted to long term nursing care|0|||
16498729|NCT00818662|40298926|FG001|Overall Study|Admitted to long term nursing care|1|||
16498730|NCT00818662|40298927|FG002|Overall Study|Admitted to long term nursing care|0|||
16498731|NCT00818662|40298928|FG003|Overall Study|Admitted to long term nursing care|0|||
16498732|NCT02631850|40298931|FG000|Treatment Period|Lost to Follow-up|0|||
16498733|NCT02631850|40298932|FG001|Treatment Period|Lost to Follow-up|1|||
16498734|NCT02631850|40298933|FG002|Treatment Period|Lost to Follow-up|0|||
16498735|NCT02631850|40298934|FG003|Treatment Period|Lost to Follow-up|0|||
16498736|NCT02631850|40298931|FG000|Treatment Period|Protocol Violation|1|||
16498737|NCT02631850|40298932|FG001|Treatment Period|Protocol Violation|0|||
16498738|NCT02631850|40298933|FG002|Treatment Period|Protocol Violation|0|||
16498739|NCT02631850|40298934|FG003|Treatment Period|Protocol Violation|0|||
16309267|NCT02107131|39615794|FG001|Overall Study|Protocol Violation|4|||
16388957|NCT00310375|39908460|FG002|Primary Reporting Phase|Physician Decision|0|||
16388958|NCT00310375|39908458|FG000|Primary Reporting Phase|Request of the sponsor|2|||
16498740|NCT02631850|40298931|FG000|Treatment Period|Withdrawal by Subject|0|||
16498741|NCT02631850|40298932|FG001|Treatment Period|Withdrawal by Subject|5|||
16498742|NCT02631850|40298933|FG002|Treatment Period|Withdrawal by Subject|2|||
16498743|NCT02631850|40298934|FG003|Treatment Period|Withdrawal by Subject|2|||
16498744|NCT02631850|40298931|FG000|Treatment Period|Adverse Event|1|||
16498745|NCT02631850|40298932|FG001|Treatment Period|Adverse Event|0|||
16498746|NCT02631850|40298933|FG002|Treatment Period|Adverse Event|2|||
16498747|NCT02631850|40298934|FG003|Treatment Period|Adverse Event|3|||
16498748|NCT02631850|40298931|FG000|Treatment Period|Family medical issue|1|||
16498749|NCT02631850|40298932|FG001|Treatment Period|Family medical issue|0|||
16498750|NCT02631850|40298933|FG002|Treatment Period|Family medical issue|0|||
16498751|NCT02631850|40298934|FG003|Treatment Period|Family medical issue|0|||
16195189|NCT01718509|39193257|FG001|Overall Study|Withdrawal by Subject|13|||
16195190|NCT01718509|39193256|FG000|Overall Study|Adverse Event|5|||
16195191|NCT01718509|39193257|FG001|Overall Study|Adverse Event|7|||
16195192|NCT01718509|39193256|FG000|Overall Study|Other|13|||
16195193|NCT01718509|39193257|FG001|Overall Study|Other|11|||
16195194|NCT01718509|39193256|FG000|Overall Study|Protocol Violation|4|||
16195195|NCT01718509|39193257|FG001|Overall Study|Protocol Violation|2|||
16195196|NCT01718509|39193256|FG000|Overall Study|Lack of Efficacy|1|||
16195197|NCT01718509|39193257|FG001|Overall Study|Lack of Efficacy|0|||
16195198|NCT00574119|39193258|FG000|Overall Study|Adverse Event|1|||
16195199|NCT00574119|39193258|FG000|Overall Study|Protocol Violation|1|||
16195200|NCT00574119|39193258|FG000|Overall Study|Withdrawal by Subject|1|||
16195201|NCT00574119|39193258|FG000|Overall Study|Physician Decision|1|||
16195202|NCT02297438|39193264|FG000|Overall Study|Death|79|||
16195203|NCT02297438|39193265|FG001|Overall Study|Death|86|||
16195204|NCT02297438|39193264|FG000|Overall Study|Lost to Follow-up|9|||
16195205|NCT02297438|39193265|FG001|Overall Study|Lost to Follow-up|7|||
16195206|NCT02297438|39193264|FG000|Overall Study|Withdrawal by Subject|7|||
16195207|NCT02297438|39193265|FG001|Overall Study|Withdrawal by Subject|0|||
16388959|NCT00310375|39908459|FG001|Primary Reporting Phase|Request of the sponsor|2|||
16388960|NCT00310375|39908460|FG002|Primary Reporting Phase|Request of the sponsor|0|||
16388961|NCT00310375|39908458|FG000|Primary Reporting Phase|Failed to return|1|||
16498752|NCT02631850|40298931|FG000|6 Month Follow up|Lost to Follow-up|5|||
16087270|NCT01998958|38810613|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
16498753|NCT02631850|40298932|FG001|6 Month Follow up|Lost to Follow-up|8|||
16498754|NCT02631850|40298933|FG002|6 Month Follow up|Lost to Follow-up|3|||
16498755|NCT02631850|40298934|FG003|6 Month Follow up|Lost to Follow-up|5|||
16498756|NCT02631850|40298931|FG000|6 Month Follow up|Withdrawal by Subject|1|||
16498757|NCT02631850|40298932|FG001|6 Month Follow up|Withdrawal by Subject|0|||
16498758|NCT02631850|40298933|FG002|6 Month Follow up|Withdrawal by Subject|0|||
16498759|NCT02631850|40298934|FG003|6 Month Follow up|Withdrawal by Subject|2|||
16498760|NCT02631850|40298931|FG000|6 Month Follow up|Adverse Event|1|||
16498761|NCT02631850|40298932|FG001|6 Month Follow up|Adverse Event|4|||
16498762|NCT02631850|40298933|FG002|6 Month Follow up|Adverse Event|1|||
16498763|NCT02631850|40298934|FG003|6 Month Follow up|Adverse Event|3|||
16498764|NCT02631850|40298931|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
16498765|NCT02631850|40298932|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
16498766|NCT02631850|40298933|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
16498767|NCT02631850|40298934|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
16498768|NCT04577118|40298935|FG000|Overall Study|Withdrawal by Subject|4|||
16498769|NCT01191801|40298936|FG000|Overall Study|Death|36|||
16498770|NCT01191801|40298937|FG001|Overall Study|Death|12|||
16498771|NCT01191801|40298936|FG000|Overall Study|Lack of Efficacy|176|||
16498772|NCT01191801|40298937|FG001|Overall Study|Lack of Efficacy|258|||
16498773|NCT01191801|40298936|FG000|Overall Study|Adverse Event|9|||
16498774|NCT01191801|40298937|FG001|Overall Study|Adverse Event|8|||
16498775|NCT01191801|40298936|FG000|Overall Study|Protocol Violation|2|||
16498776|NCT01191801|40298937|FG001|Overall Study|Protocol Violation|4|||
16498777|NCT01191801|40298936|FG000|Overall Study|Physician Decision|47|||
16498778|NCT01191801|40298937|FG001|Overall Study|Physician Decision|24|||
16498779|NCT01191801|40298936|FG000|Overall Study|Withdrawal by Subject|1|||
16498780|NCT01191801|40298937|FG001|Overall Study|Withdrawal by Subject|4|||
16498781|NCT01191801|40298936|FG000|Overall Study|Not Provided|45|||
16498782|NCT01191801|40298937|FG001|Overall Study|Not Provided|27|||
16498783|NCT00553150|40298938|FG000|Overall Study|Withdrawal by Subject|0|||
16498784|NCT00553150|40298939|FG001|Overall Study|Withdrawal by Subject|0|||
16195208|NCT02297438|39193264|FG000|Overall Study|Other|9|||
16195209|NCT02297438|39193265|FG001|Overall Study|Other|5|||
16195210|NCT02297438|39193264|FG000|Overall Study|Ongoing|65|||
16195211|NCT02297438|39193265|FG001|Overall Study|Ongoing|73|||
16195212|NCT04533815|39193266|FG000|Overall Study|Adverse Event|2|||
16498785|NCT00553150|40298940|FG002|Overall Study|Withdrawal by Subject|0|||
16498786|NCT00553150|40298941|FG003|Overall Study|Withdrawal by Subject|2|||
16498787|NCT00553150|40298938|FG000|Overall Study|Protocol Violation|0|||
16498788|NCT00553150|40298939|FG001|Overall Study|Protocol Violation|0|||
16388962|NCT00310375|39908459|FG001|Primary Reporting Phase|Failed to return|3|||
16388963|NCT00310375|39908460|FG002|Primary Reporting Phase|Failed to return|0|||
16388964|NCT00310375|39908458|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
16388965|NCT00310375|39908459|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
16388966|NCT00310375|39908460|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
16388967|NCT00310375|39908458|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
16388968|NCT00310375|39908459|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
16388969|NCT00310375|39908460|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
16309268|NCT04728802|39615795|FG000|Overall Study|Withdrawal by Subject|4|||
16309269|NCT04728802|39615796|FG001|Overall Study|Withdrawal by Subject|20|||
16309270|NCT04728802|39615795|FG000|Overall Study|Physician Decision|7|||
16309271|NCT04728802|39615796|FG001|Overall Study|Physician Decision|7|||
16309272|NCT04728802|39615795|FG000|Overall Study|Protocol Violation|10|||
16309273|NCT04728802|39615796|FG001|Overall Study|Protocol Violation|4|||
16309274|NCT04728802|39615795|FG000|Overall Study|Transfer|1|||
16309275|NCT04728802|39615796|FG001|Overall Study|Transfer|0|||
16309276|NCT04728802|39615795|FG000|Overall Study|Death|4|||
16309277|NCT04728802|39615796|FG001|Overall Study|Death|5|||
16309278|NCT04728802|39615795|FG000|Overall Study|Other|3|||
16309279|NCT04728802|39615796|FG001|Overall Study|Other|0|||
16309280|NCT03565900|39615797|FG000|Overall Study|Disposition Unknown|4|||
16309281|NCT03565900|39615798|FG001|Overall Study|Disposition Unknown|1|||
16195213|NCT04533815|39193266|FG000|Overall Study|Site withdrew|5|||
16309282|NCT03565900|39615797|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
16388970|NCT00310375|39908458|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
16388971|NCT00310375|39908459|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
16195214|NCT02662985|39193267|FG000|Treatment Period 1|Adverse Event|0|||
16309283|NCT03565900|39615798|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
16309284|NCT03565900|39615797|FG000|Overall Study|Withdrawal by Subject|4|||
16388972|NCT00310375|39908460|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
16309285|NCT03565900|39615798|FG001|Overall Study|Withdrawal by Subject|5|||
16309286|NCT03565900|39615797|FG000|Overall Study|Randomized By Mistake|0|||
16309287|NCT03565900|39615798|FG001|Overall Study|Randomized By Mistake|2|||
16309288|NCT03565900|39615797|FG000|Overall Study|Physician Decision|7|||
16309289|NCT03565900|39615798|FG001|Overall Study|Physician Decision|11|||
16309290|NCT03565900|39615797|FG000|Overall Study|Death|9|||
16309291|NCT03565900|39615798|FG001|Overall Study|Death|7|||
16309292|NCT04428034|39615799|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
16309293|NCT01326845|39615802|FG000|Overall Study|Administrative Problems|5|||
16309294|NCT01326845|39615803|FG001|Overall Study|Administrative Problems|2|||
16309295|NCT01326845|39615802|FG000|Overall Study|Adverse Event|1|||
16309296|NCT01326845|39615803|FG001|Overall Study|Adverse Event|0|||
16309297|NCT01326845|39615802|FG000|Overall Study|Misisng|1|||
16309298|NCT01326845|39615803|FG001|Overall Study|Misisng|3|||
16309299|NCT01524978|39615805|FG000|Overall Study|Other|16|||
16388973|NCT00310375|39908458|FG000|Primary Reporting Phase|Site closure|3|||
16388974|NCT00310375|39908459|FG001|Primary Reporting Phase|Site closure|0|||
16388975|NCT00310375|39908460|FG002|Primary Reporting Phase|Site closure|0|||
16388976|NCT00310375|39908458|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
16388977|NCT00310375|39908459|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
16388978|NCT00310375|39908460|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
16388979|NCT00310375|39908458|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
16388980|NCT00310375|39908459|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
16388981|NCT00310375|39908460|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
16388982|NCT00310375|39908458|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
16388983|NCT00310375|39908459|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
16388984|NCT00310375|39908460|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
16388985|NCT00310375|39908458|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
16388986|NCT00310375|39908459|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
16388987|NCT00310375|39908460|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
16388988|NCT02549989|39908461|FG000|Overall Study|Adverse Event|4|||
16388989|NCT02549989|39908461|FG000|Overall Study|Death|1|||
16388990|NCT02549989|39908461|FG000|Overall Study|Lack of Efficacy|19|||
16388991|NCT02549989|39908461|FG000|Overall Study|Withdrawal by Subject|3|||
16388992|NCT01963767|39908464|FG000|Overall Study|Withdrawal by Subject|4|||
16388993|NCT01963767|39908465|FG001|Overall Study|Withdrawal by Subject|2|||
16388994|NCT01963767|39908464|FG000|Overall Study|Adverse Event|2|||
16498789|NCT00553150|40298940|FG002|Overall Study|Protocol Violation|0|||
16498790|NCT00553150|40298941|FG003|Overall Study|Protocol Violation|1|||
16498791|NCT00553150|40298938|FG000|Overall Study|Ineligible|0|||
16498792|NCT00553150|40298939|FG001|Overall Study|Ineligible|0|||
16498793|NCT00553150|40298940|FG002|Overall Study|Ineligible|0|||
16498794|NCT00553150|40298941|FG003|Overall Study|Ineligible|1|||
16498795|NCT01905657|40298942|FG000|Overall Study|Adverse Event|23|||
16498796|NCT01905657|40298943|FG001|Overall Study|Adverse Event|17|||
16498797|NCT01905657|40298944|FG002|Overall Study|Adverse Event|18|||
16498798|NCT01905657|40298942|FG000|Overall Study|Clinical Progression|103|||
16498799|NCT01905657|40298943|FG001|Overall Study|Clinical Progression|78|||
16087271|NCT01998958|38810582|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087272|NCT01998958|38810583|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087273|NCT01998958|38810584|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087274|NCT01998958|38810585|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087275|NCT01998958|38810586|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087276|NCT01998958|38810587|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087277|NCT01998958|38810588|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087278|NCT01998958|38810589|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087279|NCT01998958|38810590|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087280|NCT01998958|38810591|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087281|NCT01998958|38810592|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16388995|NCT01963767|39908465|FG001|Overall Study|Adverse Event|0|||
16388996|NCT01147393|39908466|FG000|Dose Level 1|Dose limiting Toxicity|2|||
16498800|NCT01905657|40298944|FG002|Overall Study|Clinical Progression|59|||
16309300|NCT01524978|39615806|FG001|Overall Study|Other|2|||
16309301|NCT01524978|39615807|FG002|Overall Study|Other|1|||
16309302|NCT01524978|39615808|FG003|Overall Study|Other|2|||
16309303|NCT01524978|39615809|FG004|Overall Study|Other|1|||
16309304|NCT01524978|39615810|FG005|Overall Study|Other|3|||
16498801|NCT01905657|40298942|FG000|Overall Study|Death|40|||
16498802|NCT01905657|40298943|FG001|Overall Study|Death|43|||
16498803|NCT01905657|40298944|FG002|Overall Study|Death|47|||
16309305|NCT01524978|39615811|FG006|Overall Study|Other|17|||
16309306|NCT01524978|39615812|FG007|Overall Study|Other|1|||
16309307|NCT01524978|39615813|FG008|Overall Study|Other|2|||
16309308|NCT01524978|39615814|FG009|Overall Study|Other|2|||
16309309|NCT01524978|39615815|FG010|Overall Study|Other|5|||
16309310|NCT01524978|39615805|FG000|Overall Study|Withdrawal by Subject|12|||
16309311|NCT01524978|39615806|FG001|Overall Study|Withdrawal by Subject|0|||
16309312|NCT01524978|39615807|FG002|Overall Study|Withdrawal by Subject|1|||
16309313|NCT01524978|39615808|FG003|Overall Study|Withdrawal by Subject|1|||
16309314|NCT01524978|39615809|FG004|Overall Study|Withdrawal by Subject|3|||
16309315|NCT01524978|39615810|FG005|Overall Study|Withdrawal by Subject|1|||
16309316|NCT01524978|39615811|FG006|Overall Study|Withdrawal by Subject|6|||
16309317|NCT01524978|39615812|FG007|Overall Study|Withdrawal by Subject|2|||
16309318|NCT01524978|39615813|FG008|Overall Study|Withdrawal by Subject|4|||
16309319|NCT01524978|39615814|FG009|Overall Study|Withdrawal by Subject|0|||
16309320|NCT01524978|39615815|FG010|Overall Study|Withdrawal by Subject|5|||
16309321|NCT01524978|39615805|FG000|Overall Study|Lost to Follow-up|0|||
16309322|NCT01524978|39615806|FG001|Overall Study|Lost to Follow-up|0|||
16309323|NCT01524978|39615807|FG002|Overall Study|Lost to Follow-up|3|||
16309324|NCT01524978|39615808|FG003|Overall Study|Lost to Follow-up|0|||
16309325|NCT01524978|39615809|FG004|Overall Study|Lost to Follow-up|1|||
16309326|NCT01524978|39615810|FG005|Overall Study|Lost to Follow-up|1|||
16309327|NCT01524978|39615811|FG006|Overall Study|Lost to Follow-up|2|||
16309328|NCT01524978|39615812|FG007|Overall Study|Lost to Follow-up|0|||
16309329|NCT01524978|39615813|FG008|Overall Study|Lost to Follow-up|1|||
16309330|NCT01524978|39615814|FG009|Overall Study|Lost to Follow-up|1|||
16309331|NCT01524978|39615815|FG010|Overall Study|Lost to Follow-up|1|||
16309332|NCT01524978|39615805|FG000|Overall Study|Death|34|||
16309333|NCT01524978|39615806|FG001|Overall Study|Death|2|||
16388997|NCT01147393|39908466|FG000|Dose Level -1|Dose Limited Toxicity|1|||
16388998|NCT03306433|39908467|FG000|Overall Study|Lost to Follow-up|3|||
16388999|NCT03306433|39908467|FG000|Overall Study|Patient did not have teeth extracted|1|||
16389000|NCT03306433|39908467|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
16389001|NCT01669902|39908474|FG000|Overall Study|Adverse Event|11|||
16389002|NCT01669902|39908474|FG000|Overall Study|Lack of Efficacy|10|||
16389003|NCT01669902|39908474|FG000|Overall Study|Other|8|||
16389004|NCT03801928|39908475|FG000|Overall Study|Adverse Event|1|||
16389005|NCT03801928|39908476|FG001|Overall Study|Adverse Event|0|||
16389006|NCT03801928|39908477|FG002|Overall Study|Adverse Event|1|||
16389007|NCT03801928|39908478|FG003|Overall Study|Adverse Event|2|||
16389008|NCT03801928|39908479|FG004|Overall Study|Adverse Event|0|||
16389009|NCT03801928|39908480|FG005|Overall Study|Adverse Event|2|||
16389010|NCT03801928|39908475|FG000|Overall Study|Lack of Efficacy|0|||
16309334|NCT01524978|39615807|FG002|Overall Study|Death|5|||
16309335|NCT01524978|39615808|FG003|Overall Study|Death|24|||
16309336|NCT01524978|39615809|FG004|Overall Study|Death|4|||
16309337|NCT01524978|39615810|FG005|Overall Study|Death|4|||
16389011|NCT03801928|39908476|FG001|Overall Study|Lack of Efficacy|0|||
16309338|NCT01524978|39615811|FG006|Overall Study|Death|1|||
16309339|NCT01524978|39615812|FG007|Overall Study|Death|9|||
16389012|NCT03801928|39908477|FG002|Overall Study|Lack of Efficacy|1|||
16389013|NCT03801928|39908478|FG003|Overall Study|Lack of Efficacy|0|||
16389014|NCT03801928|39908479|FG004|Overall Study|Lack of Efficacy|0|||
16389015|NCT03801928|39908480|FG005|Overall Study|Lack of Efficacy|0|||
16389016|NCT03801928|39908475|FG000|Overall Study|Lost to Follow-up|5|||
16389017|NCT03801928|39908476|FG001|Overall Study|Lost to Follow-up|1|||
16389018|NCT03801928|39908477|FG002|Overall Study|Lost to Follow-up|1|||
16389019|NCT03801928|39908478|FG003|Overall Study|Lost to Follow-up|4|||
16389020|NCT03801928|39908479|FG004|Overall Study|Lost to Follow-up|4|||
16389021|NCT03801928|39908480|FG005|Overall Study|Lost to Follow-up|2|||
16389022|NCT03801928|39908475|FG000|Overall Study|Withdrawal by Subject|0|||
16389023|NCT03801928|39908476|FG001|Overall Study|Withdrawal by Subject|0|||
16389024|NCT03801928|39908477|FG002|Overall Study|Withdrawal by Subject|2|||
16389025|NCT03801928|39908478|FG003|Overall Study|Withdrawal by Subject|1|||
16389026|NCT03801928|39908479|FG004|Overall Study|Withdrawal by Subject|0|||
16389027|NCT03801928|39908480|FG005|Overall Study|Withdrawal by Subject|0|||
16389028|NCT03801928|39908475|FG000|Overall Study|Other|0|||
16389029|NCT03801928|39908476|FG001|Overall Study|Other|2|||
16389030|NCT03801928|39908477|FG002|Overall Study|Other|0|||
16389031|NCT03801928|39908478|FG003|Overall Study|Other|1|||
16389032|NCT03801928|39908479|FG004|Overall Study|Other|0|||
16389033|NCT03801928|39908480|FG005|Overall Study|Other|1|||
16389034|NCT03710889|39908481|FG000|Overall Study|Adverse Event|2|||
16389035|NCT03710889|39908481|FG000|Overall Study|Protocol Deviation|1|||
16389036|NCT00980148|39908482|FG000|Overall Study|Discharged from facility|89|||
16389037|NCT00980148|39908483|FG001|Overall Study|Discharged from facility|96|||
16389038|NCT00980148|39908482|FG000|Overall Study|Received other antichlamydia treatment|20|||
16389039|NCT00980148|39908483|FG001|Overall Study|Received other antichlamydia treatment|14|||
16389040|NCT00980148|39908482|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
16389041|NCT00980148|39908483|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
16389042|NCT00980148|39908482|FG000|Overall Study|Various other reasons|8|||
16389043|NCT00980148|39908483|FG001|Overall Study|Various other reasons|9|||
16389044|NCT05173974|39908484|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
16389045|NCT05173974|39908485|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
16389046|NCT05173974|39908486|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
16389047|NCT05173974|39908487|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
16389048|NCT05173974|39908484|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
16389049|NCT05173974|39908485|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
16389050|NCT05173974|39908486|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
16389051|NCT05173974|39908487|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
16389052|NCT01581684|39908490|FG000|Overall Study|Other reason not defined|0|||
16389053|NCT01581684|39908491|FG001|Overall Study|Other reason not defined|0|||
16389054|NCT01581684|39908492|FG002|Overall Study|Other reason not defined|0|||
16389055|NCT01581684|39908493|FG003|Overall Study|Other reason not defined|0|||
16389056|NCT01581684|39908494|FG004|Overall Study|Other reason not defined|0|||
16389057|NCT01581684|39908495|FG005|Overall Study|Other reason not defined|0|||
16389058|NCT01581684|39908496|FG006|Overall Study|Other reason not defined|0|||
16389059|NCT01581684|39908497|FG007|Overall Study|Other reason not defined|0|||
16389060|NCT01581684|39908498|FG008|Overall Study|Other reason not defined|1|||
16389061|NCT01581684|39908499|FG009|Overall Study|Other reason not defined|0|||
16389062|NCT03338400|39908500|FG000|Overall Study|Lost to Follow-up|1|||
16389063|NCT03338400|39908501|FG001|Overall Study|Lost to Follow-up|2|||
16389064|NCT03082677|39908502|FG000|Overall Study|Not Treated|2|||
16389065|NCT02315703|39908505|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
16389066|NCT02315703|39908506|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
16389067|NCT02315703|39908507|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
16389068|NCT02315703|39908508|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
16389069|NCT02315703|39908509|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
16389070|NCT02315703|39908510|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
16389071|NCT02315703|39908511|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
16498804|NCT01905657|40298942|FG000|Overall Study|Excluded Medication|13|||
16498805|NCT01905657|40298943|FG001|Overall Study|Excluded Medication|16|||
16498806|NCT01905657|40298944|FG002|Overall Study|Excluded Medication|9|||
16498807|NCT01905657|40298942|FG000|Overall Study|Lost to Follow-up|1|||
16498808|NCT01905657|40298943|FG001|Overall Study|Lost to Follow-up|2|||
16498809|NCT01905657|40298944|FG002|Overall Study|Lost to Follow-up|1|||
16498810|NCT01905657|40298942|FG000|Overall Study|Physician Decision|5|||
16498811|NCT01905657|40298943|FG001|Overall Study|Physician Decision|8|||
16498812|NCT01905657|40298944|FG002|Overall Study|Physician Decision|12|||
16498813|NCT01905657|40298942|FG000|Overall Study|Protocol Violation|2|||
16498814|NCT01905657|40298943|FG001|Overall Study|Protocol Violation|1|||
16498815|NCT01905657|40298944|FG002|Overall Study|Protocol Violation|1|||
16498816|NCT01905657|40298942|FG000|Overall Study|Screen Failure|0|||
16498817|NCT01905657|40298943|FG001|Overall Study|Screen Failure|1|||
16498818|NCT01905657|40298944|FG002|Overall Study|Screen Failure|0|||
16498819|NCT01905657|40298942|FG000|Overall Study|Withdrawal by Subject|15|||
16498820|NCT01905657|40298943|FG001|Overall Study|Withdrawal by Subject|21|||
16498821|NCT01905657|40298944|FG002|Overall Study|Withdrawal by Subject|53|||
16498822|NCT01905657|40298942|FG000|Overall Study|Sponsor Decision|1|||
16498823|NCT01905657|40298943|FG001|Overall Study|Sponsor Decision|0|||
16498824|NCT01905657|40298944|FG002|Overall Study|Sponsor Decision|0|||
16498825|NCT04007523|40298950|FG000|Overall Study|Withdrawal by Subject|0|||
16498826|NCT04007523|40298951|FG001|Overall Study|Withdrawal by Subject|1|||
16498827|NCT04007523|40298952|FG002|Overall Study|Withdrawal by Subject|1|||
16498828|NCT04007523|40298953|FG003|Overall Study|Withdrawal by Subject|0|||
16498829|NCT04007523|40298950|FG000|Overall Study|ICU Transfer|0|||
16498830|NCT04007523|40298951|FG001|Overall Study|ICU Transfer|1|||
16498831|NCT04007523|40298952|FG002|Overall Study|ICU Transfer|0|||
16498832|NCT04007523|40298953|FG003|Overall Study|ICU Transfer|0|||
16498833|NCT04007523|40298950|FG000|Overall Study|COVID hospital closure|0|||
16498834|NCT04007523|40298951|FG001|Overall Study|COVID hospital closure|0|||
16498835|NCT04007523|40298952|FG002|Overall Study|COVID hospital closure|1|||
16498836|NCT04007523|40298953|FG003|Overall Study|COVID hospital closure|2|||
16498837|NCT04007523|40298950|FG000|Overall Study|Surgery cancelled|0|||
16498838|NCT04007523|40298951|FG001|Overall Study|Surgery cancelled|0|||
16389072|NCT02315703|39908512|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
16389073|NCT02315703|39908505|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
16389074|NCT02315703|39908506|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
16389075|NCT02315703|39908507|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
16389076|NCT02315703|39908508|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
16389077|NCT02315703|39908509|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
16389078|NCT02315703|39908510|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
16389079|NCT02315703|39908511|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
16389080|NCT02315703|39908512|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
16389081|NCT02315703|39908505|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
16389082|NCT02315703|39908506|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
16389083|NCT02315703|39908507|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
16389084|NCT02315703|39908508|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
16389085|NCT02315703|39908509|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
16389086|NCT02315703|39908510|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
16389087|NCT02315703|39908511|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
16389088|NCT02315703|39908512|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
16389089|NCT02315703|39908505|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
16389090|NCT02315703|39908506|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
16389091|NCT02315703|39908507|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
16389092|NCT02315703|39908508|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
16389093|NCT02315703|39908509|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
16389094|NCT02315703|39908510|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
16389095|NCT02315703|39908511|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
16498839|NCT04007523|40298952|FG002|Overall Study|Surgery cancelled|1|||
16389096|NCT02315703|39908512|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
16498840|NCT04007523|40298953|FG003|Overall Study|Surgery cancelled|1|||
16498841|NCT01881776|40298956|FG000|Overall Study|Lost to Follow-up|1|||
16498842|NCT01881776|40298957|FG001|Overall Study|Lost to Follow-up|2|||
16498843|NCT01881776|40298958|FG002|Overall Study|Lost to Follow-up|1|||
16498844|NCT01881776|40298956|FG000|Overall Study|Protocol Violation|0|||
16389097|NCT02315703|39908505|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
16389098|NCT02315703|39908506|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
16309340|NCT01524978|39615813|FG008|Overall Study|Death|5|||
16309341|NCT01524978|39615814|FG009|Overall Study|Death|6|||
16309342|NCT01524978|39615815|FG010|Overall Study|Death|17|||
16309343|NCT02661217|39615816|FG000|Overall Study|Physician Decision|12|||
16309344|NCT02661217|39615817|FG001|Overall Study|Physician Decision|15|||
16309345|NCT02661217|39615816|FG000|Overall Study|Lost to Follow-up|1|||
16309346|NCT02661217|39615817|FG001|Overall Study|Lost to Follow-up|4|||
16309347|NCT02661217|39615816|FG000|Overall Study|Protocol Deviation|0|||
16309348|NCT02661217|39615817|FG001|Overall Study|Protocol Deviation|4|||
16309349|NCT02661217|39615816|FG000|Overall Study|Non-compliance with study treatment|5|||
16309350|NCT02661217|39615817|FG001|Overall Study|Non-compliance with study treatment|5|||
16309351|NCT02661217|39615816|FG000|Overall Study|Death|21|||
16309352|NCT02661217|39615817|FG001|Overall Study|Death|15|||
16309353|NCT02661217|39615816|FG000|Overall Study|Adverse Event|10|||
16389099|NCT02315703|39908507|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
16389100|NCT02315703|39908508|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
16389101|NCT02315703|39908509|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
16389102|NCT02315703|39908510|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
16389103|NCT02315703|39908511|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
16389104|NCT02315703|39908512|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
16389105|NCT02315703|39908505|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
16389106|NCT02315703|39908506|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
16389107|NCT02315703|39908507|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
16389108|NCT02315703|39908508|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
16389109|NCT02315703|39908509|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
16389110|NCT02315703|39908510|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
16389111|NCT02315703|39908511|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
16389112|NCT02315703|39908512|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
16389113|NCT02315703|39908505|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
16389114|NCT02315703|39908506|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
16389115|NCT02315703|39908507|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
16309354|NCT02661217|39615817|FG001|Overall Study|Adverse Event|8|||
16309355|NCT02661217|39615816|FG000|Overall Study|Withdrawal by Subject|15|||
16389116|NCT02315703|39908508|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
16389117|NCT02315703|39908509|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
16389118|NCT02315703|39908510|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
16389119|NCT02315703|39908511|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
16389120|NCT02315703|39908512|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
16389121|NCT02315703|39908505|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
16389122|NCT02315703|39908506|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
16389123|NCT02315703|39908507|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
16389124|NCT02315703|39908508|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
16389125|NCT02315703|39908509|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
16389126|NCT02315703|39908510|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
16389127|NCT02315703|39908511|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
16389128|NCT02315703|39908512|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
16389129|NCT02315703|39908505|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
16389130|NCT02315703|39908506|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
16389131|NCT02315703|39908507|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
16389132|NCT02315703|39908508|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
16389133|NCT02315703|39908509|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
16309356|NCT02661217|39615817|FG001|Overall Study|Withdrawal by Subject|19|||
16309357|NCT02661217|39615816|FG000|Overall Study|Did not enter follow-up epoch|7|||
16309358|NCT02661217|39615817|FG001|Overall Study|Did not enter follow-up epoch|10|||
16309359|NCT02661217|39615816|FG000|Overall Study|Death - no study drug received|1|||
16389134|NCT02315703|39908510|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
16389135|NCT02315703|39908511|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
16389136|NCT02315703|39908512|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
16389137|NCT00678288|39908514|FG000|Overall Study|Adverse Event|0|||
16389138|NCT00678288|39908515|FG001|Overall Study|Adverse Event|2|||
16389139|NCT00678288|39908514|FG000|Overall Study|Withdrawal by Subject|1|||
16389140|NCT00678288|39908515|FG001|Overall Study|Withdrawal by Subject|1|||
16389141|NCT00678288|39908514|FG000|Overall Study|Study terminated by the sponsor|2|||
16389142|NCT00678288|39908515|FG001|Overall Study|Study terminated by the sponsor|0|||
16389143|NCT00678288|39908514|FG000|Overall Study|Not compliant with study medication|0|||
16389144|NCT00678288|39908515|FG001|Overall Study|Not compliant with study medication|1|||
16389145|NCT00678288|39908514|FG000|Overall Study|Switch to commercial drug|0|||
16389146|NCT00678288|39908515|FG001|Overall Study|Switch to commercial drug|1|||
16389147|NCT00678288|39908514|FG000|Overall Study|Reason not reported|1|||
16389148|NCT00678288|39908515|FG001|Overall Study|Reason not reported|0|||
16389149|NCT00678288|39908514|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
16389150|NCT00678288|39908515|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
16389151|NCT00937495|39908522|FG000|Overall Study|Protocol Violation|2|||
16389152|NCT00347932|39908523|FG000|Overall Study|Adverse Event|4|||
16389153|NCT00347932|39908524|FG001|Overall Study|Adverse Event|5|||
16389154|NCT00347932|39908523|FG000|Overall Study|Lack of Efficacy|3|||
16389155|NCT00347932|39908524|FG001|Overall Study|Lack of Efficacy|14|||
16389156|NCT00347932|39908523|FG000|Overall Study|Lost to Follow-up|10|||
16389157|NCT00347932|39908524|FG001|Overall Study|Lost to Follow-up|9|||
16389158|NCT00347932|39908523|FG000|Overall Study|Withdrawal by Subject|10|||
16389159|NCT00347932|39908524|FG001|Overall Study|Withdrawal by Subject|16|||
16389160|NCT00347932|39908523|FG000|Overall Study|Did not meet inclusion criteria|4|||
16389161|NCT00347932|39908524|FG001|Overall Study|Did not meet inclusion criteria|8|||
16389162|NCT02756403|39908528|FG000|Overall Study|Unable to swallow medication|0|||
16389163|NCT02756403|39908529|FG001|Overall Study|Unable to swallow medication|1|||
16389164|NCT02756403|39908530|FG002|Overall Study|Unable to swallow medication|1|||
16389165|NCT02756403|39908531|FG003|Overall Study|Unable to swallow medication|1|||
16389166|NCT02756403|39908528|FG000|Overall Study|Did not complete Procedure|0|||
16389167|NCT02756403|39908529|FG001|Overall Study|Did not complete Procedure|1|||
16389168|NCT02756403|39908530|FG002|Overall Study|Did not complete Procedure|0|||
16389169|NCT02756403|39908531|FG003|Overall Study|Did not complete Procedure|0|||
16389170|NCT02756403|39908528|FG000|Overall Study|Changed Mind About Procedure|0|||
16389171|NCT02756403|39908529|FG001|Overall Study|Changed Mind About Procedure|0|||
16389172|NCT02756403|39908530|FG002|Overall Study|Changed Mind About Procedure|1|||
16389173|NCT02756403|39908531|FG003|Overall Study|Changed Mind About Procedure|0|||
16389174|NCT02756403|39908528|FG000|Overall Study|Protocol Violation|0|||
16389175|NCT02756403|39908529|FG001|Overall Study|Protocol Violation|1|||
16389176|NCT02756403|39908530|FG002|Overall Study|Protocol Violation|0|||
16389177|NCT02756403|39908531|FG003|Overall Study|Protocol Violation|1|||
16389178|NCT01534481|39908532|FG000|Overall Study|Lost to Follow-up|29|||
16389179|NCT01534481|39908533|FG001|Overall Study|Lost to Follow-up|24|||
16389180|NCT01534481|39908532|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
16389181|NCT01534481|39908533|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
16389182|NCT01082081|39908534|FG000|Overall Study|Lost to Follow-up|0|||
16389183|NCT01082081|39908535|FG001|Overall Study|Lost to Follow-up|0|||
16389184|NCT01082081|39908536|FG002|Overall Study|Lost to Follow-up|1|||
16389185|NCT01082081|39908534|FG000|Overall Study|Withdrawal by Subject|0|||
16389186|NCT01082081|39908535|FG001|Overall Study|Withdrawal by Subject|0|||
16389187|NCT01082081|39908536|FG002|Overall Study|Withdrawal by Subject|1|||
16389188|NCT01082081|39908534|FG000|Overall Study|Other Reason|0|||
16389189|NCT01082081|39908535|FG001|Overall Study|Other Reason|1|||
16389190|NCT01082081|39908536|FG002|Overall Study|Other Reason|0|||
16389191|NCT04403919|39908539|FG000|Overall Study|Lost to Follow-up|0|||
16389192|NCT04403919|39908540|FG001|Overall Study|Lost to Follow-up|0|||
16389193|NCT04403919|39908541|FG002|Overall Study|Lost to Follow-up|0|||
16389194|NCT04403919|39908542|FG003|Overall Study|Lost to Follow-up|1|||
16389195|NCT00590122|39908543|FG000|Overall Study|swallowed oral dissolving dose|1|||
16389196|NCT00590122|39908544|FG001|Overall Study|swallowed oral dissolving dose|0|||
16389197|NCT01119287|39908545|FG000|Overall Study|Patient Decision, not related to AE|0|||
16389198|NCT01119287|39908546|FG001|Overall Study|Patient Decision, not related to AE|0|||
16389199|NCT01119287|39908547|FG002|Overall Study|Patient Decision, not related to AE|2|||
16389200|NCT01119287|39908548|FG003|Overall Study|Patient Decision, not related to AE|2|||
16389201|NCT01119287|39908549|FG004|Overall Study|Patient Decision, not related to AE|1|||
16389202|NCT01119287|39908550|FG005|Overall Study|Patient Decision, not related to AE|0|||
16389203|NCT00570713|39908551|FG000|Overall Study|Adverse Event|16|||
16389204|NCT00570713|39908552|FG001|Overall Study|Adverse Event|9|||
16389205|NCT00570713|39908551|FG000|Overall Study|Death|7|||
16389206|NCT00570713|39908552|FG001|Overall Study|Death|7|||
16389207|NCT00570713|39908551|FG000|Overall Study|Lack of Efficacy|40|||
16389208|NCT00570713|39908552|FG001|Overall Study|Lack of Efficacy|49|||
16389209|NCT00570713|39908551|FG000|Overall Study|Physician Decision|2|||
16389210|NCT00570713|39908552|FG001|Overall Study|Physician Decision|2|||
16389211|NCT00570713|39908551|FG000|Overall Study|Withdrawal by Subject|3|||
16389212|NCT00570713|39908552|FG001|Overall Study|Withdrawal by Subject|3|||
16389213|NCT00570713|39908551|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
16389214|NCT00570713|39908552|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
16389215|NCT04162470|39908554|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
16389216|NCT01354223|39908557|FG000|Overall Study|Withdrawal by Subject|3|||
16389217|NCT01354223|39908558|FG001|Overall Study|Withdrawal by Subject|1|||
16389218|NCT04389866|39908559|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
16389219|NCT04389866|39908560|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
16389220|NCT00186628|39908565|FG000|Overall Study|Death|2|||
16389221|NCT00186628|39908565|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
16389222|NCT00912782|39908573|FG000|Overall Study|Death|2|||
16389223|NCT00912782|39908574|FG001|Overall Study|Death|1|||
16389224|NCT00912782|39908573|FG000|Overall Study|Lost to Follow-up|0|||
16498845|NCT01881776|40298957|FG001|Overall Study|Protocol Violation|2|||
16498846|NCT01881776|40298958|FG002|Overall Study|Protocol Violation|1|||
16498847|NCT02377466|40298959|FG000|Overall Study|Other: Randomized and not treated|0|||
16498848|NCT02377466|40298960|FG001|Overall Study|Other: Randomized and not treated|2|||
16498849|NCT01572909|40298961|FG000|Overall Study|Adverse Event|7|||
16498850|NCT01572909|40298962|FG001|Overall Study|Adverse Event|2|||
16498851|NCT01572909|40298961|FG000|Overall Study|Death|3|||
16498852|NCT01572909|40298962|FG001|Overall Study|Death|1|||
16498853|NCT01572909|40298961|FG000|Overall Study|Lost to Follow-up|8|||
16498854|NCT01572909|40298962|FG001|Overall Study|Lost to Follow-up|7|||
16498855|NCT01572909|40298961|FG000|Overall Study|Physician Decision|1|||
16498856|NCT01572909|40298962|FG001|Overall Study|Physician Decision|1|||
16498857|NCT01572909|40298961|FG000|Overall Study|Technical Issues|1|||
16498858|NCT01572909|40298962|FG001|Overall Study|Technical Issues|0|||
16498859|NCT01572909|40298961|FG000|Overall Study|Withdrawal by Subject|12|||
16498860|NCT01572909|40298962|FG001|Overall Study|Withdrawal by Subject|11|||
16498861|NCT01572909|40298961|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
16498862|NCT01572909|40298962|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
16498863|NCT04483011|40298963|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
16498864|NCT04483011|40298964|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
16498865|NCT03045081|40298970|FG000|Overall Study|Withdrawal by Subject|6|||
16498866|NCT03045081|40298971|FG001|Overall Study|Withdrawal by Subject|11|||
16498867|NCT00195676|40298972|FG000|Period O - Open-label Treatment|Adverse Event|82|||
16498868|NCT00195676|40298972|FG000|Period O - Open-label Treatment|Death|6|||
16498869|NCT00195676|40298972|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
16498870|NCT00195676|40298972|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
16498871|NCT00195676|40298972|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
16498872|NCT00195676|40298972|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
16498873|NCT00195676|40298972|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
16498874|NCT00195676|40298972|FG000|Period O - Open-label Treatment|Other reasons|68|||
16498875|NCT00195676|40298972|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
16498876|NCT00195676|40298972|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
16498877|NCT00195676|40298972|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
16498878|NCT00195676|40298972|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
16498879|NCT00195676|40298972|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
16498880|NCT00195676|40298972|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
16498881|NCT00195676|40298972|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
16498882|NCT00195676|40298972|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
16498883|NCT00195676|40298972|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
16498884|NCT00195676|40298972|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
16498885|NCT00195676|40298972|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
16498886|NCT00195676|40298972|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
16498887|NCT00195676|40298972|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
16498888|NCT05286307|40298975|FG000|Overall Study|Incomplete outcome assessments|2|||
16498889|NCT05286307|40298976|FG001|Overall Study|Incomplete outcome assessments|1|||
16498890|NCT05286307|40298975|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
16498891|NCT05286307|40298976|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
16498892|NCT05286307|40298975|FG000|Overall Study|Lost to follow up at 6 months|25|||
16498893|NCT05286307|40298976|FG001|Overall Study|Lost to follow up at 6 months|35|||
16498894|NCT05286307|40298975|FG000|Overall Study|Study medication not available|1|||
16498895|NCT05286307|40298976|FG001|Overall Study|Study medication not available|1|||
16498896|NCT01463878|40298977|FG000|Overall Study|no longer met criteria for tube feed|2|||
16195215|NCT02662985|39193268|FG001|Treatment Period 1|Adverse Event|2|||
16195216|NCT02662985|39193267|FG000|Treatment Period 1|Protocol Violation|0|||
16498897|NCT01463878|40298978|FG001|Overall Study|no longer met criteria for tube feed|2|||
16498898|NCT01083576|40298981|FG000|Overall Study|Treatment Failure|6|||
16389225|NCT00912782|39908574|FG001|Overall Study|Lost to Follow-up|1|||
16389226|NCT00912782|39908573|FG000|Overall Study|Did not receive vascular access type|1|||
16498899|NCT01083576|40298982|FG001|Overall Study|Treatment Failure|1|||
16498900|NCT00362115|40298983|FG000|Overall Study|Adverse Event|0|||
16498901|NCT00362115|40298984|FG001|Overall Study|Adverse Event|1|||
16498902|NCT00362115|40298985|FG002|Overall Study|Adverse Event|1|||
16498903|NCT00362115|40298986|FG003|Overall Study|Adverse Event|1|||
16498904|NCT00362115|40298987|FG004|Overall Study|Adverse Event|2|||
16498905|NCT00362115|40298988|FG005|Overall Study|Adverse Event|2|||
16498906|NCT00362115|40298989|FG006|Overall Study|Adverse Event|1|||
16498907|NCT00362115|40298983|FG000|Overall Study|Protocol Violation|0|||
16498908|NCT00362115|40298984|FG001|Overall Study|Protocol Violation|0|||
16498909|NCT00362115|40298985|FG002|Overall Study|Protocol Violation|0|||
16498910|NCT00362115|40298986|FG003|Overall Study|Protocol Violation|0|||
16498911|NCT00362115|40298987|FG004|Overall Study|Protocol Violation|0|||
16498912|NCT00362115|40298988|FG005|Overall Study|Protocol Violation|1|||
16498913|NCT00362115|40298989|FG006|Overall Study|Protocol Violation|0|||
16498914|NCT00362115|40298983|FG000|Overall Study|Lost to Follow-up|0|||
16498915|NCT00362115|40298984|FG001|Overall Study|Lost to Follow-up|1|||
16498916|NCT00362115|40298985|FG002|Overall Study|Lost to Follow-up|0|||
16498917|NCT00362115|40298986|FG003|Overall Study|Lost to Follow-up|0|||
16498918|NCT00362115|40298987|FG004|Overall Study|Lost to Follow-up|2|||
16498919|NCT00362115|40298988|FG005|Overall Study|Lost to Follow-up|0|||
16498920|NCT00362115|40298989|FG006|Overall Study|Lost to Follow-up|1|||
16498921|NCT00362115|40298983|FG000|Overall Study|Withdrawal by Subject|1|||
16498922|NCT00362115|40298984|FG001|Overall Study|Withdrawal by Subject|3|||
16498923|NCT00362115|40298985|FG002|Overall Study|Withdrawal by Subject|1|||
16498924|NCT00362115|40298986|FG003|Overall Study|Withdrawal by Subject|0|||
16498925|NCT00362115|40298987|FG004|Overall Study|Withdrawal by Subject|1|||
16498926|NCT00362115|40298988|FG005|Overall Study|Withdrawal by Subject|3|||
16498927|NCT00362115|40298989|FG006|Overall Study|Withdrawal by Subject|4|||
16498928|NCT00362115|40298983|FG000|Overall Study|Lack of Efficacy|1|||
16498929|NCT00362115|40298984|FG001|Overall Study|Lack of Efficacy|0|||
16498930|NCT00362115|40298985|FG002|Overall Study|Lack of Efficacy|5|||
16498931|NCT00362115|40298986|FG003|Overall Study|Lack of Efficacy|2|||
16498932|NCT00362115|40298987|FG004|Overall Study|Lack of Efficacy|2|||
16498933|NCT00362115|40298988|FG005|Overall Study|Lack of Efficacy|0|||
16498934|NCT00362115|40298989|FG006|Overall Study|Lack of Efficacy|3|||
16498935|NCT00362115|40298983|FG000|Overall Study|Physician Decision|0|||
16498936|NCT00362115|40298984|FG001|Overall Study|Physician Decision|0|||
16498937|NCT00362115|40298985|FG002|Overall Study|Physician Decision|0|||
16498938|NCT00362115|40298986|FG003|Overall Study|Physician Decision|0|||
16498939|NCT00362115|40298987|FG004|Overall Study|Physician Decision|0|||
16498940|NCT00362115|40298988|FG005|Overall Study|Physician Decision|0|||
16498941|NCT00362115|40298989|FG006|Overall Study|Physician Decision|3|||
16498942|NCT00362115|40298983|FG000|Overall Study|Other|0|||
16498943|NCT00362115|40298984|FG001|Overall Study|Other|1|||
16498944|NCT00362115|40298985|FG002|Overall Study|Other|0|||
16498945|NCT00362115|40298986|FG003|Overall Study|Other|1|||
16498946|NCT00362115|40298987|FG004|Overall Study|Other|0|||
16498947|NCT00362115|40298988|FG005|Overall Study|Other|1|||
16498948|NCT00362115|40298989|FG006|Overall Study|Other|0|||
16498949|NCT02339740|40298990|FG000|Overall Study|Death|1|||
16498950|NCT02339740|40298991|FG001|Overall Study|Death|0|||
16498951|NCT02339740|40298990|FG000|Overall Study|Physician Decision|0|||
16498952|NCT02339740|40298991|FG001|Overall Study|Physician Decision|2|||
16498953|NCT02339740|40298990|FG000|Overall Study|Withdrawal by Subject|5|||
16498954|NCT02339740|40298991|FG001|Overall Study|Withdrawal by Subject|1|||
16498955|NCT02339740|40298990|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
16498956|NCT02339740|40298991|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
16498957|NCT02335489|40298992|FG000|Overall Study|Sponsor terminated study|4|||
16498958|NCT02335489|40298992|FG000|Overall Study|Lost to Follow-up|1|||
16498959|NCT02335489|40298992|FG000|Overall Study|Withdrawal by Subject|2|||
16498960|NCT02335489|40298992|FG000|Overall Study|Physician Decision|2|||
16498961|NCT02335489|40298992|FG000|Overall Study|Lack of Efficacy|1|||
16498962|NCT02730455|40298993|FG000|Overall Study|Death|5|||
16498963|NCT02730455|40298994|FG001|Overall Study|Death|6|||
16498964|NCT02730455|40298995|FG002|Overall Study|Death|4|||
16498965|NCT02730455|40298993|FG000|Overall Study|Consent withdrawn|2|||
16498966|NCT02730455|40298994|FG001|Overall Study|Consent withdrawn|4|||
16498967|NCT02730455|40298995|FG002|Overall Study|Consent withdrawn|1|||
16498968|NCT02730455|40298993|FG000|Overall Study|Lost to Follow-up|3|||
16498969|NCT02730455|40298994|FG001|Overall Study|Lost to Follow-up|1|||
16498970|NCT02730455|40298995|FG002|Overall Study|Lost to Follow-up|4|||
16498971|NCT02730455|40298993|FG000|Overall Study|Other|1|||
16498972|NCT02730455|40298994|FG001|Overall Study|Other|1|||
16498973|NCT02730455|40298995|FG002|Overall Study|Other|2|||
16498974|NCT02730455|40298993|FG000|Overall Study|Other|2|||
16498975|NCT02730455|40298994|FG001|Overall Study|Other|2|||
16498976|NCT02730455|40298995|FG002|Overall Study|Other|0|||
16498977|NCT02769247|40298996|FG000|Overall Study|Withdrawal by Subject|1|||
16498978|NCT02769247|40298997|FG001|Overall Study|Withdrawal by Subject|0|||
16498979|NCT02769247|40298998|FG002|Overall Study|Withdrawal by Subject|0|||
16389227|NCT00912782|39908574|FG001|Overall Study|Did not receive vascular access type|2|||
16389228|NCT00912782|39908573|FG000|Overall Study|Relocated before study completion|0|||
16389229|NCT00912782|39908574|FG001|Overall Study|Relocated before study completion|1|||
16389230|NCT01151020|39908582|FG000|Overall Study|Death|25|||
16389231|NCT01151020|39908582|FG000|Overall Study|Conversion to open repair|1|||
16389232|NCT01151020|39908582|FG000|Overall Study|Lost to Follow-up|4|||
16389233|NCT01151020|39908582|FG000|Overall Study|Withdrawal by Subject|22|||
16389234|NCT01151020|39908582|FG000|Overall Study|Patients did not receive the device|2|||
16389235|NCT00837161|39908584|FG000|Overall Study|refused hysterectomy|2|||
16389236|NCT02332187|39908590|FG000|Overall Study|Withdrawal by Subject|2|||
16389237|NCT02332187|39908591|FG001|Overall Study|Withdrawal by Subject|2|||
16389238|NCT02332187|39908590|FG000|Overall Study|Adverse Event|0|||
16389239|NCT02332187|39908591|FG001|Overall Study|Adverse Event|1|||
16498980|NCT02769247|40298999|FG003|Overall Study|Withdrawal by Subject|1|||
16498981|NCT02769247|40298996|FG000|Overall Study|Protocol Violation|0|||
16498982|NCT02769247|40298997|FG001|Overall Study|Protocol Violation|0|||
16498983|NCT02769247|40298998|FG002|Overall Study|Protocol Violation|1|||
16498984|NCT02769247|40298999|FG003|Overall Study|Protocol Violation|0|||
16498985|NCT02769247|40298996|FG000|Overall Study|Physician Decision|1|||
16498986|NCT02769247|40298997|FG001|Overall Study|Physician Decision|0|||
16498987|NCT02769247|40298998|FG002|Overall Study|Physician Decision|0|||
16389240|NCT00645840|39908592|FG000|Overall Study|Protocol Violation|3|||
16389241|NCT00636181|39908594|FG000|Overall Study|Withdrawal by Subject|8|||
16389242|NCT00636181|39908595|FG001|Overall Study|Withdrawal by Subject|6|||
16389243|NCT00636181|39908596|FG002|Overall Study|Withdrawal by Subject|10|||
16389244|NCT01657370|39908597|FG000|Overall Study|Withdrawal by Subject|0|||
16389245|NCT01657370|39908598|FG001|Overall Study|Withdrawal by Subject|0|||
16389246|NCT01657370|39908599|FG002|Overall Study|Withdrawal by Subject|1|||
16389247|NCT01657370|39908600|FG003|Overall Study|Withdrawal by Subject|0|||
16389248|NCT01657370|39908601|FG004|Overall Study|Withdrawal by Subject|0|||
16389249|NCT01657370|39908602|FG005|Overall Study|Withdrawal by Subject|1|||
16389250|NCT01657370|39908597|FG000|Overall Study|Physician Decision|2|||
16389251|NCT01657370|39908598|FG001|Overall Study|Physician Decision|3|||
16389252|NCT01657370|39908599|FG002|Overall Study|Physician Decision|1|||
16389253|NCT01657370|39908600|FG003|Overall Study|Physician Decision|2|||
16498988|NCT02769247|40298999|FG003|Overall Study|Physician Decision|0|||
16389254|NCT01657370|39908601|FG004|Overall Study|Physician Decision|5|||
16389255|NCT01657370|39908602|FG005|Overall Study|Physician Decision|0|||
16389256|NCT01657370|39908597|FG000|Overall Study|Lack of Qualifying Event|1|||
16389257|NCT01657370|39908598|FG001|Overall Study|Lack of Qualifying Event|0|||
16389258|NCT01657370|39908599|FG002|Overall Study|Lack of Qualifying Event|3|||
16389259|NCT01657370|39908600|FG003|Overall Study|Lack of Qualifying Event|2|||
16389260|NCT01657370|39908601|FG004|Overall Study|Lack of Qualifying Event|1|||
16389261|NCT01657370|39908602|FG005|Overall Study|Lack of Qualifying Event|2|||
16389262|NCT01657370|39908597|FG000|Overall Study|Adverse Event|0|||
16389263|NCT01657370|39908598|FG001|Overall Study|Adverse Event|0|||
16389264|NCT01657370|39908599|FG002|Overall Study|Adverse Event|0|||
16389265|NCT01657370|39908600|FG003|Overall Study|Adverse Event|0|||
16389266|NCT01657370|39908601|FG004|Overall Study|Adverse Event|1|||
16389267|NCT01657370|39908602|FG005|Overall Study|Adverse Event|0|||
16389268|NCT01657370|39908597|FG000|Overall Study|Protocol Violation|1|||
16389269|NCT01657370|39908598|FG001|Overall Study|Protocol Violation|1|||
16389270|NCT01657370|39908599|FG002|Overall Study|Protocol Violation|1|||
16389271|NCT01657370|39908600|FG003|Overall Study|Protocol Violation|1|||
16389272|NCT01657370|39908601|FG004|Overall Study|Protocol Violation|0|||
16389273|NCT01657370|39908602|FG005|Overall Study|Protocol Violation|0|||
16389274|NCT01657370|39908597|FG000|Overall Study|Lost to Follow-up|2|||
16389275|NCT01657370|39908598|FG001|Overall Study|Lost to Follow-up|0|||
16389276|NCT01657370|39908599|FG002|Overall Study|Lost to Follow-up|1|||
16389277|NCT01657370|39908600|FG003|Overall Study|Lost to Follow-up|0|||
16389278|NCT01657370|39908601|FG004|Overall Study|Lost to Follow-up|0|||
16389279|NCT01657370|39908602|FG005|Overall Study|Lost to Follow-up|1|||
16389280|NCT00783432|39908606|FG000|Overall Study|Adverse Event|22|||
16389281|NCT00783432|39908607|FG001|Overall Study|Adverse Event|17|||
16389282|NCT00783432|39908606|FG000|Overall Study|Lack of Efficacy|20|||
16389283|NCT00783432|39908607|FG001|Overall Study|Lack of Efficacy|21|||
16498989|NCT03804879|40299000|FG000|Overall Study|Adverse Event|3|||
16389284|NCT00783432|39908606|FG000|Overall Study|Lost to Follow-up|11|||
16498990|NCT03804879|40299001|FG001|Overall Study|Adverse Event|0|||
16389285|NCT00783432|39908607|FG001|Overall Study|Lost to Follow-up|6|||
16389286|NCT00783432|39908606|FG000|Overall Study|Withdrawal by Subject|23|||
16389287|NCT00783432|39908607|FG001|Overall Study|Withdrawal by Subject|20|||
16498991|NCT03804879|40299000|FG000|Overall Study|Study Terminated By Sponsor|10|||
16498992|NCT03804879|40299001|FG001|Overall Study|Study Terminated By Sponsor|12|||
16498993|NCT03804879|40299000|FG000|Overall Study|Withdrawal by Subject|3|||
16498994|NCT03804879|40299001|FG001|Overall Study|Withdrawal by Subject|1|||
16498995|NCT03635957|40299002|FG000|Run-In Period|Lost to Follow-up|1|||
16498996|NCT03635957|40299002|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
16498997|NCT02457910|40299003|FG000|Overall Study|Withdrawal by Subject|0|||
16498998|NCT02457910|40299004|FG001|Overall Study|Withdrawal by Subject|0|||
16498999|NCT02457910|40299005|FG002|Overall Study|Withdrawal by Subject|0|||
16499000|NCT02457910|40299006|FG003|Overall Study|Withdrawal by Subject|0|||
16499001|NCT02457910|40299007|FG004|Overall Study|Withdrawal by Subject|0|||
16499002|NCT02457910|40299008|FG005|Overall Study|Withdrawal by Subject|1|||
16499003|NCT02457910|40299003|FG000|Overall Study|Adverse Event|0|||
16499004|NCT02457910|40299004|FG001|Overall Study|Adverse Event|2|||
16499005|NCT02457910|40299005|FG002|Overall Study|Adverse Event|1|||
16499006|NCT02457910|40299006|FG003|Overall Study|Adverse Event|1|||
16499007|NCT02457910|40299007|FG004|Overall Study|Adverse Event|1|||
16499008|NCT02457910|40299008|FG005|Overall Study|Adverse Event|3|||
16499009|NCT02457910|40299003|FG000|Overall Study|Disease progression|3|||
16499010|NCT02457910|40299004|FG001|Overall Study|Disease progression|3|||
16499011|NCT02457910|40299005|FG002|Overall Study|Disease progression|1|||
16499012|NCT02457910|40299006|FG003|Overall Study|Disease progression|1|||
16499013|NCT02457910|40299007|FG004|Overall Study|Disease progression|4|||
16499014|NCT02457910|40299008|FG005|Overall Study|Disease progression|6|||
16499015|NCT02457910|40299003|FG000|Overall Study|Other complicating illness|0|||
16499016|NCT02457910|40299004|FG001|Overall Study|Other complicating illness|0|||
16499017|NCT02457910|40299005|FG002|Overall Study|Other complicating illness|0|||
16499018|NCT02457910|40299006|FG003|Overall Study|Other complicating illness|0|||
16499019|NCT02457910|40299007|FG004|Overall Study|Other complicating illness|0|||
16499020|NCT02457910|40299008|FG005|Overall Study|Other complicating illness|1|||
16499021|NCT02457910|40299003|FG000|Overall Study|Death|0|||
16499022|NCT02457910|40299004|FG001|Overall Study|Death|0|||
16499023|NCT02457910|40299005|FG002|Overall Study|Death|1|||
16499024|NCT02457910|40299006|FG003|Overall Study|Death|0|||
16499025|NCT02457910|40299007|FG004|Overall Study|Death|0|||
16499026|NCT02457910|40299008|FG005|Overall Study|Death|0|||
16499027|NCT01686633|40299011|FG000|Overall Study|Lack of Efficacy|33|||
16499028|NCT01686633|40299012|FG001|Overall Study|Lack of Efficacy|13|||
16499029|NCT01686633|40299013|FG002|Overall Study|Lack of Efficacy|11|||
16499030|NCT01686633|40299011|FG000|Overall Study|Withdrawal by Subject|8|||
16499031|NCT01686633|40299012|FG001|Overall Study|Withdrawal by Subject|8|||
16499032|NCT01686633|40299013|FG002|Overall Study|Withdrawal by Subject|5|||
16499033|NCT01686633|40299011|FG000|Overall Study|Physician Decision|3|||
16499034|NCT01686633|40299012|FG001|Overall Study|Physician Decision|4|||
16499035|NCT01686633|40299013|FG002|Overall Study|Physician Decision|4|||
16499036|NCT01686633|40299011|FG000|Overall Study|Adverse Event|4|||
16499037|NCT01686633|40299012|FG001|Overall Study|Adverse Event|3|||
16499038|NCT01686633|40299013|FG002|Overall Study|Adverse Event|3|||
16499039|NCT01686633|40299011|FG000|Overall Study|Protocol Violation|2|||
16499040|NCT01686633|40299012|FG001|Overall Study|Protocol Violation|3|||
16499041|NCT01686633|40299013|FG002|Overall Study|Protocol Violation|0|||
16499042|NCT01686633|40299011|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
16499043|NCT01686633|40299012|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
16499044|NCT01686633|40299013|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
16499045|NCT01686633|40299011|FG000|Overall Study|Lost to Follow-up|0|||
16499046|NCT01686633|40299012|FG001|Overall Study|Lost to Follow-up|1|||
16499047|NCT01686633|40299013|FG002|Overall Study|Lost to Follow-up|1|||
16499048|NCT00799487|40299020|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
16499049|NCT00799487|40299021|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
16499050|NCT00799487|40299022|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
16499051|NCT00799487|40299020|FG000|Dose Adjustment Period|Adverse Event|2|||
16499052|NCT00799487|40299021|FG001|Dose Adjustment Period|Adverse Event|0|||
16499053|NCT00799487|40299022|FG002|Dose Adjustment Period|Adverse Event|0|||
16499054|NCT00799487|40299020|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
16499055|NCT00799487|40299021|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
16499056|NCT00799487|40299022|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
16499057|NCT00799487|40299020|FG000|Dose Adjustment Period|Investigator Discretion|2|||
16499058|NCT00799487|40299021|FG001|Dose Adjustment Period|Investigator Discretion|0|||
16499059|NCT00799487|40299022|FG002|Dose Adjustment Period|Investigator Discretion|0|||
16499060|NCT00799487|40299020|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
16499061|NCT00799487|40299021|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
16499062|NCT00799487|40299022|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
16499063|NCT00799487|40299020|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
16499064|NCT00799487|40299021|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
16499065|NCT00799487|40299022|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
16499066|NCT00799487|40299020|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
16389288|NCT00783432|39908606|FG000|Overall Study|subject moved|3|||
16389289|NCT00783432|39908607|FG001|Overall Study|subject moved|5|||
16389290|NCT00783432|39908606|FG000|Overall Study|Protocol Violation|6|||
16389291|NCT00783432|39908607|FG001|Overall Study|Protocol Violation|9|||
16389292|NCT00628446|39908616|FG000|Overall Study|Lost to Follow-up|3|||
16389293|NCT00628446|39908616|FG000|Overall Study|Withdrawal by Subject|1|||
16389294|NCT00628446|39908616|FG000|Overall Study|Protocol Violation|3|||
16389295|NCT00856635|39908617|FG000|Overall Study|Lost to Follow-up|2|||
16389296|NCT00856635|39908618|FG001|Overall Study|Lost to Follow-up|5|||
16389297|NCT00856635|39908617|FG000|Overall Study|Pregnancy|1|||
16389298|NCT00856635|39908618|FG001|Overall Study|Pregnancy|0|||
16389299|NCT00856635|39908617|FG000|Overall Study|Withdrawal by Subject|3|||
16389300|NCT00856635|39908618|FG001|Overall Study|Withdrawal by Subject|1|||
16389301|NCT00856635|39908617|FG000|Overall Study|Serious Adverse Event|1|||
16389302|NCT00856635|39908618|FG001|Overall Study|Serious Adverse Event|0|||
16389303|NCT00856635|39908617|FG000|Overall Study|Other|1|||
16389304|NCT00856635|39908618|FG001|Overall Study|Other|0|||
16389305|NCT00856635|39908617|FG000|Overall Study|Discontinued at Randomization|2|||
16389306|NCT00856635|39908618|FG001|Overall Study|Discontinued at Randomization|2|||
16389307|NCT03328832|39908619|FG000|Overall Study|Lost to Follow-up|0|||
16389308|NCT03328832|39908620|FG001|Overall Study|Lost to Follow-up|1|||
16389309|NCT00374595|39908624|FG000|Overall Study|Death|23|||
16389310|NCT00374595|39908624|FG000|Overall Study|Withdrawal by Subject|39|||
16389311|NCT00374595|39908624|FG000|Overall Study|Lost to Follow-up|3|||
16389312|NCT00374595|39908624|FG000|Overall Study|too much time commitment|1|||
16389313|NCT00374595|39908624|FG000|Overall Study|transfer care to other clinical site|1|||
16389314|NCT00374595|39908624|FG000|Overall Study|relocation|3|||
16389315|NCT01130337|39908627|FG000|Overall Study|Withdrawal by Subject|3|||
16389316|NCT01130337|39908627|FG000|Overall Study|Principal investigator decision|1|||
16389317|NCT01130337|39908627|FG000|Overall Study|Death|1|||
16389318|NCT01130337|39908627|FG000|Overall Study|Disease progression|1|||
16389319|NCT01130337|39908627|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
16389320|NCT01130337|39908627|FG000|Overall Study|Surgical resection (R2)|1|||
16389321|NCT01102491|39908628|FG000|Overall Study|Protocol Violation|11|||
16389322|NCT01102491|39908629|FG001|Overall Study|Protocol Violation|12|||
16389323|NCT02765399|39908630|FG000|Overall Study|Nausea|1|||
16389324|NCT02765399|39908631|FG001|Overall Study|Nausea|0|||
16389325|NCT01978145|39908632|FG000|Treatment Period 1|Adverse Event|1|||
16389326|NCT01978145|39908633|FG001|Treatment Period 1|Adverse Event|9|||
16389327|NCT01978145|39908632|FG000|Treatment Period 1|Physician Decision|1|||
16389328|NCT01978145|39908633|FG001|Treatment Period 1|Physician Decision|0|||
16389329|NCT01978145|39908632|FG000|Treatment Period 1|Withdrawal by Subject|5|||
16389330|NCT01978145|39908633|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16389331|NCT01978145|39908632|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
16389332|NCT01978145|39908633|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
16389333|NCT01978145|39908632|FG000|Washout Period 1|Adverse Event|0|||
16389334|NCT01978145|39908633|FG001|Washout Period 1|Adverse Event|1|||
16389335|NCT01978145|39908632|FG000|Washout Period 1|Withdrawal by Subject|1|||
16389336|NCT01978145|39908633|FG001|Washout Period 1|Withdrawal by Subject|1|||
16389337|NCT01978145|39908632|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
16389338|NCT01978145|39908633|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
16389339|NCT01978145|39908632|FG000|Treatment Period 2|Adverse Event|3|||
16389340|NCT01978145|39908633|FG001|Treatment Period 2|Adverse Event|3|||
16389341|NCT01978145|39908632|FG000|Treatment Period 2|Protocol Violation|0|||
16389342|NCT01978145|39908633|FG001|Treatment Period 2|Protocol Violation|1|||
16389343|NCT01978145|39908632|FG000|Treatment Period 2|Lost to Follow-up|1|||
16389344|NCT01978145|39908633|FG001|Treatment Period 2|Lost to Follow-up|1|||
16389345|NCT01978145|39908632|FG000|Treatment Period 2|Withdrawal by Subject|7|||
16389346|NCT01978145|39908633|FG001|Treatment Period 2|Withdrawal by Subject|4|||
16389347|NCT01978145|39908632|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
16389348|NCT01978145|39908633|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
16389349|NCT02078752|39908637|FG000|Overall Study|Death|0|||
16389350|NCT02078752|39908638|FG001|Overall Study|Death|3|||
16389351|NCT02078752|39908639|FG002|Overall Study|Death|0|||
16389352|NCT02078752|39908640|FG003|Overall Study|Death|0|||
16389353|NCT02078752|39908641|FG004|Overall Study|Death|0|||
16389354|NCT02078752|39908642|FG005|Overall Study|Death|1|||
16389355|NCT02078752|39908643|FG006|Overall Study|Death|0|||
16389356|NCT02078752|39908644|FG007|Overall Study|Death|1|||
16389357|NCT02078752|39908645|FG008|Overall Study|Death|0|||
16389358|NCT02078752|39908646|FG009|Overall Study|Death|4|||
16389359|NCT02078752|39908637|FG000|Overall Study|Lost to Follow-up|1|||
16087282|NCT01998958|38810593|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087283|NCT01998958|38810594|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087284|NCT01998958|38810595|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087285|NCT01998958|38810596|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087286|NCT01998958|38810597|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087287|NCT01998958|38810598|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087288|NCT01998958|38810599|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087289|NCT01998958|38810600|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087290|NCT01998958|38810601|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087291|NCT01998958|38810602|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087292|NCT01998958|38810603|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
16087293|NCT01998958|38810604|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
16087294|NCT01998958|38810605|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
16087295|NCT01998958|38810606|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087296|NCT01998958|38810607|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087297|NCT01998958|38810608|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087298|NCT01998958|38810609|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087299|NCT01998958|38810610|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087300|NCT01998958|38810611|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087301|NCT01998958|38810612|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087302|NCT01998958|38810613|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
16087303|NCT03035942|38810615|FG000|Overall Study|Adverse Event|8|||
16087304|NCT03035942|38810616|FG001|Overall Study|Adverse Event|4|||
16087305|NCT03035942|38810617|FG002|Overall Study|Adverse Event|5|||
16087306|NCT00895245|38810618|FG000|Overall Study|Lack of Efficacy|6|||
16087307|NCT03960645|38810619|FG000|Overall Study|Protocol Violation|1|||
16087308|NCT03960645|38810620|FG001|Overall Study|Protocol Violation|0|||
16087309|NCT02284113|38810621|FG000|Overall Study|Adverse Event|1|||
16087310|NCT02284113|38810622|FG001|Overall Study|Adverse Event|0|||
16087311|NCT02284113|38810621|FG000|Overall Study|non-compliance|0|||
16087312|NCT02284113|38810622|FG001|Overall Study|non-compliance|1|||
16087313|NCT02284113|38810621|FG000|Overall Study|Withdrawal by Subject|0|||
16087314|NCT02284113|38810622|FG001|Overall Study|Withdrawal by Subject|1|||
16087315|NCT02284113|38810621|FG000|Overall Study|not provided|0|||
16087316|NCT02284113|38810622|FG001|Overall Study|not provided|1|||
16087317|NCT02284113|38810621|FG000|Overall Study|surgery cancelled|2|||
16087318|NCT02284113|38810622|FG001|Overall Study|surgery cancelled|0|||
16087319|NCT03735849|38810626|FG000|Overall Study|Lost to Follow-up|1|||
16087320|NCT03735849|38810627|FG001|Overall Study|Lost to Follow-up|0|||
16087321|NCT03735849|38810628|FG002|Overall Study|Lost to Follow-up|0|||
16087322|NCT03735849|38810626|FG000|Overall Study|Participant unable to adhere to visit|1|||
16087323|NCT03735849|38810627|FG001|Overall Study|Participant unable to adhere to visit|0|||
16087324|NCT03735849|38810628|FG002|Overall Study|Participant unable to adhere to visit|0|||
16087325|NCT03735849|38810626|FG000|Overall Study|Not Randomized|0|||
16087326|NCT03735849|38810627|FG001|Overall Study|Not Randomized|0|||
16087327|NCT03735849|38810628|FG002|Overall Study|Not Randomized|4|||
16087328|NCT02807857|38810629|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
16087329|NCT02807857|38810629|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
16087330|NCT02807857|38810629|FG000|Follow-Up Set|Withdrawal by Subject|8|||
16087331|NCT02807857|38810629|FG000|Follow-Up Set|Lost to Follow-up|7|||
16087332|NCT02807857|38810629|FG000|Follow-Up Set|Physician Decision|6|||
16087333|NCT02807857|38810629|FG000|Follow-Up Set|Adverse Event|3|||
16087334|NCT02807857|38810629|FG000|Follow-Up Set|Death|27|||
16087335|NCT02807857|38810629|FG000|Follow-Up Set|Relocation|2|||
16087336|NCT03500549|38810630|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
16087337|NCT03500549|38810631|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
16087338|NCT03500549|38810630|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
16087339|NCT03500549|38810631|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
16087340|NCT01160354|38810635|FG000|Overall Study|Death|0|||
16087341|NCT01160354|38810636|FG001|Overall Study|Death|1|||
16087342|NCT01160354|38810637|FG002|Overall Study|Death|1|||
16087343|NCT02066636|38810638|FG000|Overall Study|Disease progression|51|||
16087344|NCT02066636|38810639|FG001|Overall Study|Disease progression|60|||
16087345|NCT02066636|38810640|FG002|Overall Study|Disease progression|700|||
16087346|NCT02066636|38810638|FG000|Overall Study|Study drug toxicity|13|||
16087347|NCT02066636|38810639|FG001|Overall Study|Study drug toxicity|2|||
16087348|NCT02066636|38810640|FG002|Overall Study|Study drug toxicity|58|||
16087349|NCT02066636|38810638|FG000|Overall Study|Death|4|||
16087350|NCT02066636|38810639|FG001|Overall Study|Death|2|||
16087351|NCT02066636|38810640|FG002|Overall Study|Death|158|||
16087352|NCT02066636|38810638|FG000|Overall Study|Adverse event unrelated to study drug|6|||
16087353|NCT02066636|38810639|FG001|Overall Study|Adverse event unrelated to study drug|4|||
16087354|NCT02066636|38810640|FG002|Overall Study|Adverse event unrelated to study drug|45|||
16087355|NCT02066636|38810638|FG000|Overall Study|Participant request to discontinue treatment|12|||
16087356|NCT02066636|38810639|FG001|Overall Study|Participant request to discontinue treatment|12|||
16499067|NCT00799487|40299021|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
16499068|NCT00799487|40299022|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
16499069|NCT00799487|40299020|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
16499070|NCT00799487|40299021|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
16499071|NCT00799487|40299022|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
16499072|NCT00799487|40299020|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
16499073|NCT00799487|40299021|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
16499074|NCT00799487|40299022|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
16499075|NCT00799487|40299020|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
16499076|NCT00799487|40299021|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
16499077|NCT00799487|40299022|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
16499078|NCT00799487|40299020|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
16499079|NCT00799487|40299021|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
16499080|NCT00799487|40299022|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
16499081|NCT00799487|40299020|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
16499082|NCT00799487|40299021|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
16499083|NCT00799487|40299022|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
16499084|NCT00730912|40299028|FG000|Overall Study|Discontinued|0|||
16499085|NCT00730912|40299029|FG001|Overall Study|Discontinued|0|||
16499086|NCT00730912|40299030|FG002|Overall Study|Discontinued|1|||
16499087|NCT01110707|40299033|FG000|Overall Study|Protocol Violation|0|||
16499088|NCT01110707|40299034|FG001|Overall Study|Protocol Violation|3|||
16499089|NCT00412854|40299035|FG000|Overall Study|Withdrawn due to adverse events|1|||
16499090|NCT00412854|40299036|FG001|Overall Study|Withdrawn due to adverse events|5|||
16499091|NCT00412854|40299035|FG000|Overall Study|Withdrawn for other reasons|13|||
16499092|NCT00412854|40299036|FG001|Overall Study|Withdrawn for other reasons|11|||
16499093|NCT01484873|40299037|FG000|Overall Study|Withdrawal by Subject|2|||
16499094|NCT00662363|40299038|FG000|Overall Study|Withdrawal by Subject|6|||
16499095|NCT00662363|40299039|FG001|Overall Study|Withdrawal by Subject|5|||
16499096|NCT00662363|40299038|FG000|Overall Study|Adverse Event|0|||
16499097|NCT00662363|40299039|FG001|Overall Study|Adverse Event|3|||
16499098|NCT00662363|40299038|FG000|Overall Study|Discharged early from rehab|4|||
16499099|NCT00662363|40299039|FG001|Overall Study|Discharged early from rehab|1|||
16499100|NCT00662363|40299038|FG000|Overall Study|Protocol Violation|1|||
16499101|NCT00662363|40299039|FG001|Overall Study|Protocol Violation|1|||
16499102|NCT02288559|40299040|FG000|Overall Study|Adverse Event|1|||
16499103|NCT02288559|40299041|FG001|Overall Study|Adverse Event|1|||
16499104|NCT02288559|40299042|FG002|Overall Study|Adverse Event|5|||
16499105|NCT02288559|40299043|FG003|Overall Study|Adverse Event|0|||
16499106|NCT02288559|40299040|FG000|Overall Study|Death|0|||
16499107|NCT02288559|40299041|FG001|Overall Study|Death|0|||
16499108|NCT02288559|40299042|FG002|Overall Study|Death|1|||
16499109|NCT02288559|40299043|FG003|Overall Study|Death|0|||
16499110|NCT02288559|40299040|FG000|Overall Study|Lost to Follow-up|0|||
16499111|NCT02288559|40299041|FG001|Overall Study|Lost to Follow-up|0|||
16499112|NCT02288559|40299042|FG002|Overall Study|Lost to Follow-up|0|||
16499113|NCT02288559|40299043|FG003|Overall Study|Lost to Follow-up|1|||
16499114|NCT02288559|40299040|FG000|Overall Study|Withdrawal by Subject|0|||
16499115|NCT02288559|40299041|FG001|Overall Study|Withdrawal by Subject|0|||
16499116|NCT02288559|40299042|FG002|Overall Study|Withdrawal by Subject|2|||
16499117|NCT02288559|40299043|FG003|Overall Study|Withdrawal by Subject|1|||
16499118|NCT02288559|40299040|FG000|Overall Study|Reason Not Specified|0|||
16499119|NCT02288559|40299041|FG001|Overall Study|Reason Not Specified|0|||
16499120|NCT02288559|40299042|FG002|Overall Study|Reason Not Specified|3|||
16499121|NCT02288559|40299043|FG003|Overall Study|Reason Not Specified|0|||
16499122|NCT02062879|40299044|FG000|Overall Study|Withdrawal by Subject|4|||
16499123|NCT02062879|40299045|FG001|Overall Study|Withdrawal by Subject|1|||
16499124|NCT01286012|40299046|FG000|Overall Study|Adverse Event|3|||
16499125|NCT01286012|40299047|FG001|Overall Study|Adverse Event|3|||
16499126|NCT01286012|40299046|FG000|Overall Study|Death|2|||
16499127|NCT01286012|40299047|FG001|Overall Study|Death|3|||
16499128|NCT01286012|40299046|FG000|Overall Study|Protocol Violation|1|||
16499129|NCT01286012|40299047|FG001|Overall Study|Protocol Violation|1|||
16499130|NCT01286012|40299046|FG000|Overall Study|Withdrawal by Subject|4|||
16499131|NCT01286012|40299047|FG001|Overall Study|Withdrawal by Subject|4|||
16309360|NCT02661217|39615817|FG001|Overall Study|Death - no study drug received|2|||
16499132|NCT01286012|40299046|FG000|Overall Study|Physician Decision|2|||
16499133|NCT01286012|40299047|FG001|Overall Study|Physician Decision|0|||
16499134|NCT01286012|40299046|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
16499135|NCT01286012|40299047|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
16499136|NCT01529346|40299048|FG000|Overall Study|Lost to Follow-up|2|||
16499137|NCT01529346|40299049|FG001|Overall Study|Lost to Follow-up|0|||
16499138|NCT01529346|40299050|FG002|Overall Study|Lost to Follow-up|1|||
16499139|NCT01529346|40299051|FG003|Overall Study|Lost to Follow-up|0|||
16499140|NCT01529346|40299052|FG004|Overall Study|Lost to Follow-up|0|||
16309361|NCT02661217|39615816|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
16309362|NCT02661217|39615817|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
16309363|NCT01125917|39615820|FG000|Overall Study|Adverse Event|43|||
16499141|NCT01529346|40299048|FG000|Overall Study|Other|0|||
16499142|NCT01529346|40299049|FG001|Overall Study|Other|1|||
16499143|NCT01529346|40299050|FG002|Overall Study|Other|1|||
16499144|NCT01529346|40299051|FG003|Overall Study|Other|0|||
16499145|NCT01529346|40299052|FG004|Overall Study|Other|0|||
16499146|NCT01585428|40299053|FG000|Overall Study|Death during treatment|1|||
16499147|NCT01585428|40299054|FG001|Overall Study|Death during treatment|0|||
16087357|NCT02066636|38810640|FG002|Overall Study|Participant request to discontinue treatment|70|||
16087358|NCT02066636|38810638|FG000|Overall Study|Participant withdrew consent|10|||
16087359|NCT02066636|38810639|FG001|Overall Study|Participant withdrew consent|18|||
16087360|NCT02066636|38810640|FG002|Overall Study|Participant withdrew consent|61|||
16087361|NCT02066636|38810638|FG000|Overall Study|Lost to Follow-up|0|||
16087362|NCT02066636|38810639|FG001|Overall Study|Lost to Follow-up|2|||
16087363|NCT02066636|38810640|FG002|Overall Study|Lost to Follow-up|2|||
16087364|NCT02066636|38810638|FG000|Overall Study|Maximum clinical benefit|2|||
16499148|NCT00003492|40299059|FG000|Overall Study|Not evaluable|6|||
16499149|NCT00759954|40299065|FG000|Overall Study|Personal reason|1|||
16087365|NCT02066636|38810639|FG001|Overall Study|Maximum clinical benefit|2|||
16087366|NCT02066636|38810640|FG002|Overall Study|Maximum clinical benefit|3|||
16087367|NCT02066636|38810638|FG000|Overall Study|Poor/non-compliance|2|||
16087368|NCT02066636|38810639|FG001|Overall Study|Poor/non-compliance|1|||
16087369|NCT02066636|38810640|FG002|Overall Study|Poor/non-compliance|1|||
16087370|NCT02066636|38810638|FG000|Overall Study|Participant no loner meets study criteria|3|||
16087371|NCT02066636|38810639|FG001|Overall Study|Participant no loner meets study criteria|2|||
16087372|NCT02066636|38810640|FG002|Overall Study|Participant no loner meets study criteria|28|||
16499150|NCT00759954|40299066|FG001|Overall Study|Personal reason|0|||
16087373|NCT02066636|38810638|FG000|Overall Study|Administrative reasons by sponsor|8|||
16087374|NCT02066636|38810639|FG001|Overall Study|Administrative reasons by sponsor|5|||
16087375|NCT02066636|38810640|FG002|Overall Study|Administrative reasons by sponsor|0|||
16087376|NCT02066636|38810638|FG000|Overall Study|Other reasons|16|||
16309364|NCT01125917|39615820|FG000|Overall Study|Lost to Follow-up|23|||
16309365|NCT01125917|39615820|FG000|Overall Study|Withdrawal by Subject|31|||
16309366|NCT01125917|39615820|FG000|Overall Study|Administrative|223|||
16309367|NCT01125917|39615820|FG000|Overall Study|Lack of Efficacy|19|||
16309368|NCT00365794|39615821|FG000|Overall Study|Withdrawal by Subject|2|||
16087377|NCT02066636|38810639|FG001|Overall Study|Other reasons|15|||
16087378|NCT02066636|38810640|FG002|Overall Study|Other reasons|50|||
16087379|NCT00580866|38810641|FG000|Overall Study|Lost to Follow-up|2|||
16087380|NCT00580866|38810642|FG001|Overall Study|Lost to Follow-up|2|||
16087381|NCT01128959|38810645|FG000|Lead in Period|Adverse Event|3|||
16087382|NCT01128959|38810645|FG000|Treatment Period|Adverse Event|3|||
16087383|NCT01128959|38810645|FG000|Treatment Period|Withdrawal by Subject|1|||
16087384|NCT01471691|38810646|FG000|Overall Study|Lack of Efficacy|0|||
16087385|NCT01471691|38810647|FG001|Overall Study|Lack of Efficacy|1|||
16087386|NCT00949117|38810648|FG000|Overall Study|Lack of Efficacy|2|||
16087387|NCT00949117|38810649|FG001|Overall Study|Lack of Efficacy|3|||
16087388|NCT00949117|38810648|FG000|Overall Study|Protocol Violation|1|||
16087389|NCT00949117|38810649|FG001|Overall Study|Protocol Violation|1|||
16087390|NCT00949117|38810648|FG000|Overall Study|Adverse Event|0|||
16087391|NCT00949117|38810649|FG001|Overall Study|Adverse Event|1|||
16087392|NCT00747006|38810653|FG000|Overall Study|Adverse Event|1|||
16087393|NCT00747006|38810654|FG001|Overall Study|Adverse Event|0|||
16087394|NCT00747006|38810655|FG002|Overall Study|Adverse Event|0|||
16087395|NCT00747006|38810653|FG000|Overall Study|Lost to Follow-up|0|||
16087396|NCT00747006|38810654|FG001|Overall Study|Lost to Follow-up|1|||
16087397|NCT00747006|38810655|FG002|Overall Study|Lost to Follow-up|0|||
16087398|NCT00747006|38810653|FG000|Overall Study|Physician Decision|2|||
16087399|NCT00747006|38810654|FG001|Overall Study|Physician Decision|0|||
16087400|NCT00747006|38810655|FG002|Overall Study|Physician Decision|1|||
16087401|NCT01773993|38810656|FG000|Overall Study|No Visit After Treatment|35|||
16087402|NCT01766206|38810658|FG000|Overall Study|Withdrawal by Subject|22|||
16309369|NCT00226499|39615822|FG000|Overall Study|Adverse Event|10|||
16087403|NCT01766206|38810658|FG000|Overall Study|Lost to Follow-up|10|||
16087404|NCT01766206|38810658|FG000|Overall Study|Inappropriate enrollment|18|||
16087405|NCT01766206|38810658|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
16087406|NCT03577106|38810661|FG000|Overall Study|Withdrawal by Subject|3|||
16087407|NCT02334215|38810662|FG000|Overall Study|Death|1|||
16087408|NCT02334215|38810663|FG001|Overall Study|Death|1|||
16087409|NCT02334215|38810664|FG002|Overall Study|Death|0|||
16087410|NCT02334215|38810662|FG000|Overall Study|Lost to Follow-up|1|||
16087411|NCT02334215|38810663|FG001|Overall Study|Lost to Follow-up|0|||
16087412|NCT02334215|38810664|FG002|Overall Study|Lost to Follow-up|4|||
16499151|NCT00759954|40299065|FG000|Overall Study|Adverse Event|1|||
16499152|NCT00759954|40299066|FG001|Overall Study|Adverse Event|2|||
16499153|NCT01387347|40299067|FG000|Overall Study|Lost to Follow-up|2|||
16087413|NCT02334215|38810662|FG000|Overall Study|Withdrawal by Subject|2|||
16087414|NCT02334215|38810663|FG001|Overall Study|Withdrawal by Subject|2|||
16087415|NCT02334215|38810664|FG002|Overall Study|Withdrawal by Subject|1|||
16087416|NCT02334215|38810662|FG000|Overall Study|Not released from incarceration on time|3|||
16087417|NCT02334215|38810663|FG001|Overall Study|Not released from incarceration on time|3|||
16087418|NCT02334215|38810664|FG002|Overall Study|Not released from incarceration on time|3|||
16087419|NCT02334215|38810662|FG000|Overall Study|Incarcerated|0|||
16087420|NCT02334215|38810663|FG001|Overall Study|Incarcerated|0|||
16087421|NCT02334215|38810664|FG002|Overall Study|Incarcerated|7|||
16087422|NCT01972776|38810665|FG000|Part 1|Withdrawal by Subject|0|||
16087423|NCT01972776|38810666|FG001|Part 1|Withdrawal by Subject|0|||
16087424|NCT01972776|38810667|FG002|Part 1|Withdrawal by Subject|1|||
16087425|NCT01972776|38810668|FG003|Part 1|Withdrawal by Subject|0|||
16087426|NCT01972776|38810669|FG004|Part 1|Withdrawal by Subject|0|||
16087427|NCT01972776|38810670|FG005|Part 1|Withdrawal by Subject|0|||
16087428|NCT01972776|38810665|FG000|Part 1|Adverse Event|0|||
16087429|NCT01972776|38810666|FG001|Part 1|Adverse Event|0|||
16087430|NCT01972776|38810667|FG002|Part 1|Adverse Event|1|||
16087431|NCT01972776|38810668|FG003|Part 1|Adverse Event|1|||
16087432|NCT01972776|38810669|FG004|Part 1|Adverse Event|0|||
16087433|NCT01972776|38810670|FG005|Part 1|Adverse Event|0|||
16087434|NCT01972776|38810665|FG000|Part 2|Adverse Event|0|||
16087435|NCT01972776|38810666|FG001|Part 2|Adverse Event|0|||
16087436|NCT01972776|38810667|FG002|Part 2|Adverse Event|0|||
16087437|NCT01972776|38810668|FG003|Part 2|Adverse Event|0|||
16087438|NCT01972776|38810669|FG004|Part 2|Adverse Event|3|||
16087439|NCT01972776|38810670|FG005|Part 2|Adverse Event|0|||
16087440|NCT01972776|38810665|FG000|Part 2|Administrative problems|0|||
16087441|NCT01972776|38810666|FG001|Part 2|Administrative problems|0|||
16087442|NCT01972776|38810667|FG002|Part 2|Administrative problems|0|||
16087443|NCT01972776|38810668|FG003|Part 2|Administrative problems|0|||
16087444|NCT01972776|38810669|FG004|Part 2|Administrative problems|10|||
16087445|NCT01972776|38810670|FG005|Part 2|Administrative problems|7|||
16087446|NCT02892019|38810671|FG000|Overall Study|randomized but not treated|0|||
16087447|NCT02892019|38810672|FG001|Overall Study|randomized but not treated|1|||
16087448|NCT02892019|38810671|FG000|Overall Study|Withdrawal by Subject|0|||
16087449|NCT02892019|38810672|FG001|Overall Study|Withdrawal by Subject|1|||
16087450|NCT02892019|38810671|FG000|Overall Study|Adverse Event|1|||
16087451|NCT02892019|38810672|FG001|Overall Study|Adverse Event|1|||
16087452|NCT03476798|38810676|FG000|Overall Study|Death|1|||
16087453|NCT03476798|38810676|FG000|Overall Study|Withdrawal by Subject|2|||
16087454|NCT03476798|38810676|FG000|Overall Study|Protocol Violation|2|||
16087455|NCT02455557|38810677|FG000|Overall Study|Withdrawal by Subject|2|||
16087456|NCT00403494|38810680|FG000|Overall Study|Adverse Event|10|||
16087457|NCT00403494|38810681|FG001|Overall Study|Adverse Event|8|||
16087458|NCT00403494|38810680|FG000|Overall Study|Withdrew Consent|3|||
16087459|NCT00403494|38810681|FG001|Overall Study|Withdrew Consent|2|||
16087460|NCT00403494|38810680|FG000|Overall Study|Inappropriately enrolled|0|||
16087461|NCT00403494|38810681|FG001|Overall Study|Inappropriately enrolled|1|||
16087462|NCT00403494|38810680|FG000|Overall Study|Lost to Follow-up|0|||
16087463|NCT00403494|38810681|FG001|Overall Study|Lost to Follow-up|2|||
16087464|NCT00403494|38810680|FG000|Overall Study|Protocol noncompliance|0|||
16087465|NCT00403494|38810681|FG001|Overall Study|Protocol noncompliance|1|||
16087466|NCT00403494|38810680|FG000|Overall Study|Death|1|||
16087467|NCT00403494|38810681|FG001|Overall Study|Death|0|||
16087468|NCT00403494|38810680|FG000|Overall Study|Sponsor Request|1|||
16087469|NCT00403494|38810681|FG001|Overall Study|Sponsor Request|0|||
16087470|NCT01695954|38810682|FG000|Overall Study|Withdrawal by Subject|4|||
16087471|NCT01695954|38810683|FG001|Overall Study|Withdrawal by Subject|0|||
16087472|NCT01695954|38810682|FG000|Overall Study|Adverse Event|0|||
16087473|NCT01695954|38810683|FG001|Overall Study|Adverse Event|2|||
16087474|NCT00442104|38813595|FG000|Overall Study|Adverse Event|5|||
16087475|NCT00442104|38813595|FG000|Overall Study|Death|2|||
16087476|NCT00442104|38813595|FG000|Overall Study|Lost to Follow-up|3|||
16087477|NCT00442104|38813595|FG000|Overall Study|Withdrawal by Subject|5|||
16087478|NCT00442104|38813595|FG000|Overall Study|Insufficient Clinical Response|10|||
16087479|NCT00442104|38813595|FG000|Overall Study|Other|21|||
16087480|NCT00442104|38813595|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
16087481|NCT05270460|38813596|FG000|Overall Study|Adverse Event|0|||
16087482|NCT05270460|38813597|FG001|Overall Study|Adverse Event|1|||
16087483|NCT05270460|38813598|FG002|Overall Study|Adverse Event|0|||
16087484|NCT05270460|38813596|FG000|Overall Study|Early Termination|0|||
16087485|NCT05270460|38813597|FG001|Overall Study|Early Termination|1|||
16087486|NCT05270460|38813598|FG002|Overall Study|Early Termination|0|||
16087487|NCT02159352|38813599|FG000|Overall Study|Adverse Event|3|||
16087488|NCT02159352|38813600|FG001|Overall Study|Adverse Event|1|||
16087489|NCT02159352|38813599|FG000|Overall Study|Withdrawal by Subject|0|||
16087490|NCT02159352|38813600|FG001|Overall Study|Withdrawal by Subject|1|||
16087491|NCT03132636|38813601|FG000|Overall Study|Adverse Event|1|||
16087492|NCT03132636|38813602|FG001|Overall Study|Adverse Event|2|||
16087493|NCT03132636|38813601|FG000|Overall Study|Death|4|||
16087494|NCT03132636|38813602|FG001|Overall Study|Death|7|||
16087495|NCT03132636|38813601|FG000|Overall Study|Lost to Follow-up|3|||
16087496|NCT03132636|38813602|FG001|Overall Study|Lost to Follow-up|2|||
16087497|NCT03132636|38813601|FG000|Overall Study|Non compliance with protocol by participant|1|||
16087498|NCT03132636|38813602|FG001|Overall Study|Non compliance with protocol by participant|1|||
16087499|NCT03132636|38813601|FG000|Overall Study|Subject decision|1|||
16087500|NCT03132636|38813602|FG001|Overall Study|Subject decision|9|||
16087501|NCT03132636|38813601|FG000|Overall Study|Sponsor decision|0|||
16087502|NCT03132636|38813602|FG001|Overall Study|Sponsor decision|1|||
16087503|NCT03132636|38813601|FG000|Overall Study|Physician Decision|1|||
16087504|NCT03132636|38813602|FG001|Overall Study|Physician Decision|0|||
16087505|NCT03132636|38813601|FG000|Overall Study|Progressive disease|33|||
16087506|NCT03132636|38813602|FG001|Overall Study|Progressive disease|36|||
16087507|NCT03132636|38813601|FG000|Overall Study|Withdrawal of consent|2|||
16087508|NCT03132636|38813602|FG001|Overall Study|Withdrawal of consent|5|||
16087509|NCT03132636|38813601|FG000|Overall Study|Did not re-consent|1|||
16087510|NCT03132636|38813602|FG001|Overall Study|Did not re-consent|0|||
16087511|NCT03132636|38813601|FG000|Overall Study|Lost insurance coverage|1|||
16087512|NCT03132636|38813602|FG001|Overall Study|Lost insurance coverage|0|||
16087513|NCT03132636|38813601|FG000|Overall Study|Related to radiological outcomes|0|||
16087514|NCT03132636|38813602|FG001|Overall Study|Related to radiological outcomes|1|||
16087515|NCT03132636|38813601|FG000|Overall Study|Unable to come to site for continued visits|0|||
16087516|NCT03132636|38813602|FG001|Overall Study|Unable to come to site for continued visits|1|||
16087517|NCT02824198|38813603|FG000|Overall Study|Non-compliance with the protocol|5|||
16087518|NCT02824198|38813604|FG001|Overall Study|Non-compliance with the protocol|1|||
16087519|NCT02824198|38813603|FG000|Overall Study|Lost to Follow-up|5|||
16087520|NCT02824198|38813604|FG001|Overall Study|Lost to Follow-up|2|||
16087521|NCT02824198|38813603|FG000|Overall Study|Withdrawal by Subject|5|||
16087522|NCT02824198|38813604|FG001|Overall Study|Withdrawal by Subject|0|||
16087523|NCT01822756|38813605|FG000|Overall Study|Adverse Event|0|||
16087524|NCT01822756|38813606|FG001|Overall Study|Adverse Event|0|||
16087525|NCT01822756|38813607|FG002|Overall Study|Adverse Event|0|||
16087526|NCT01822756|38813608|FG003|Overall Study|Adverse Event|2|||
16087527|NCT01822756|38813609|FG004|Overall Study|Adverse Event|0|||
16087528|NCT01822756|38813605|FG000|Overall Study|Disease progression|11|||
16087529|NCT01822756|38813606|FG001|Overall Study|Disease progression|1|||
16087530|NCT01822756|38813607|FG002|Overall Study|Disease progression|7|||
16087531|NCT01822756|38813608|FG003|Overall Study|Disease progression|2|||
16087532|NCT01822756|38813609|FG004|Overall Study|Disease progression|6|||
16087533|NCT01822756|38813605|FG000|Overall Study|Death|2|||
16087534|NCT01822756|38813606|FG001|Overall Study|Death|2|||
16087535|NCT01822756|38813607|FG002|Overall Study|Death|1|||
16087536|NCT01822756|38813608|FG003|Overall Study|Death|0|||
16087537|NCT01822756|38813609|FG004|Overall Study|Death|0|||
16087538|NCT01822756|38813605|FG000|Overall Study|Lost to Follow-up|1|||
16087539|NCT01822756|38813606|FG001|Overall Study|Lost to Follow-up|0|||
16087540|NCT01822756|38813607|FG002|Overall Study|Lost to Follow-up|1|||
16087541|NCT01822756|38813608|FG003|Overall Study|Lost to Follow-up|0|||
16087542|NCT01822756|38813609|FG004|Overall Study|Lost to Follow-up|1|||
16087543|NCT01822756|38813605|FG000|Overall Study|Physician Decision|0|||
16087544|NCT01822756|38813606|FG001|Overall Study|Physician Decision|1|||
16087545|NCT01822756|38813607|FG002|Overall Study|Physician Decision|0|||
16087546|NCT01822756|38813608|FG003|Overall Study|Physician Decision|0|||
16309370|NCT00226499|39615823|FG001|Overall Study|Adverse Event|6|||
16087547|NCT01822756|38813609|FG004|Overall Study|Physician Decision|0|||
16087548|NCT01822756|38813605|FG000|Overall Study|disease progression & patient preference|2|||
16087549|NCT01822756|38813606|FG001|Overall Study|disease progression & patient preference|0|||
16087550|NCT01822756|38813607|FG002|Overall Study|disease progression & patient preference|1|||
16087551|NCT01822756|38813608|FG003|Overall Study|disease progression & patient preference|0|||
16087552|NCT01822756|38813609|FG004|Overall Study|disease progression & patient preference|0|||
16087553|NCT01898299|38813612|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
16087554|NCT01898299|38813613|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
16087555|NCT00513071|38813614|FG000|Overall Study|Adverse Event|1|||
16087556|NCT00513071|38813614|FG000|Overall Study|Withdrawal by Subject|1|||
16087557|NCT00513071|38813614|FG000|Overall Study|Physician Decision|3|||
16087558|NCT03987074|38813617|FG000|Overall Study|Withdrew Consent|1|||
16087559|NCT03987074|38813618|FG001|Overall Study|Withdrew Consent|1|||
16087560|NCT03987074|38813619|FG002|Overall Study|Withdrew Consent|0|||
16087561|NCT03987074|38813620|FG003|Overall Study|Withdrew Consent|2|||
16087562|NCT03987074|38813621|FG004|Overall Study|Withdrew Consent|1|||
16087563|NCT03987074|38813617|FG000|Overall Study|Adverse Event|2|||
16087564|NCT03987074|38813618|FG001|Overall Study|Adverse Event|1|||
16087565|NCT03987074|38813619|FG002|Overall Study|Adverse Event|0|||
16087566|NCT03987074|38813620|FG003|Overall Study|Adverse Event|0|||
16087567|NCT03987074|38813621|FG004|Overall Study|Adverse Event|1|||
16087568|NCT03987074|38813617|FG000|Overall Study|Lost to Follow-up|0|||
16087569|NCT03987074|38813618|FG001|Overall Study|Lost to Follow-up|0|||
16087570|NCT03987074|38813619|FG002|Overall Study|Lost to Follow-up|1|||
16087571|NCT03987074|38813620|FG003|Overall Study|Lost to Follow-up|1|||
16087572|NCT03987074|38813621|FG004|Overall Study|Lost to Follow-up|0|||
16087573|NCT03987074|38813617|FG000|Overall Study|Investigator's Discretion|0|||
16087574|NCT03987074|38813618|FG001|Overall Study|Investigator's Discretion|0|||
16087575|NCT03987074|38813619|FG002|Overall Study|Investigator's Discretion|0|||
16087576|NCT03987074|38813620|FG003|Overall Study|Investigator's Discretion|1|||
16087577|NCT03987074|38813621|FG004|Overall Study|Investigator's Discretion|0|||
16087578|NCT01394276|38813622|FG000|Overall Study|Related Adverse event (AEs)|15|||
16087579|NCT01394276|38813622|FG000|Overall Study|Not related AEs|9|||
16087580|NCT01394276|38813622|FG000|Overall Study|Remission of disease|2|||
16087581|NCT01394276|38813622|FG000|Overall Study|Insufficient therapeutic effect|17|||
16087582|NCT01394276|38813622|FG000|Overall Study|Insufficient compliance|9|||
16087583|NCT01394276|38813622|FG000|Overall Study|Lost to Follow-up|5|||
16087584|NCT01394276|38813622|FG000|Overall Study|Participant moved to another site|1|||
16087585|NCT01394276|38813622|FG000|Overall Study|Pregnancy|1|||
16087586|NCT01394276|38813622|FG000|Overall Study|unavailability of drug at the Hospital|2|||
16087587|NCT01394276|38813622|FG000|Overall Study|Symptoms of concurrent diseases|1|||
16087588|NCT00526994|38813623|FG000|Overall Study|Lost to Follow-up|98|||
16087589|NCT00526994|38813624|FG001|Overall Study|Lost to Follow-up|108|||
16087590|NCT00526994|38813625|FG002|Overall Study|Lost to Follow-up|96|||
16087591|NCT00526994|38813623|FG000|Overall Study|Death|4|||
16087592|NCT00526994|38813624|FG001|Overall Study|Death|3|||
16087593|NCT00526994|38813625|FG002|Overall Study|Death|3|||
16087594|NCT00526994|38813623|FG000|Overall Study|Withdrawal by Subject|2|||
16087595|NCT00526994|38813624|FG001|Overall Study|Withdrawal by Subject|7|||
16087596|NCT00526994|38813625|FG002|Overall Study|Withdrawal by Subject|5|||
16087597|NCT00526994|38813623|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
16087598|NCT00526994|38813624|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
16087599|NCT00526994|38813625|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
16087600|NCT02202317|38813626|FG000|Overall Study|Lost to Follow-up|1|||
16087601|NCT00705159|38813627|FG000|Overall Study|Withdrawal by Subject|0|||
16087602|NCT00705159|38813628|FG001|Overall Study|Withdrawal by Subject|1|||
16087603|NCT00705159|38813629|FG002|Overall Study|Withdrawal by Subject|1|||
16087604|NCT00705159|38813630|FG003|Overall Study|Withdrawal by Subject|1|||
16087605|NCT00705159|38813627|FG000|Overall Study|Protocol Violation|0|||
16087606|NCT00705159|38813628|FG001|Overall Study|Protocol Violation|1|||
16087607|NCT00705159|38813629|FG002|Overall Study|Protocol Violation|0|||
16087608|NCT00705159|38813630|FG003|Overall Study|Protocol Violation|0|||
16087609|NCT00705159|38813627|FG000|Overall Study|Adverse Event|0|||
16087610|NCT00705159|38813628|FG001|Overall Study|Adverse Event|0|||
16087611|NCT00705159|38813629|FG002|Overall Study|Adverse Event|1|||
16087612|NCT00705159|38813630|FG003|Overall Study|Adverse Event|0|||
16087613|NCT00705159|38813627|FG000|Overall Study|Lost to Follow-up|0|||
16087614|NCT00705159|38813628|FG001|Overall Study|Lost to Follow-up|0|||
16087615|NCT00705159|38813629|FG002|Overall Study|Lost to Follow-up|3|||
16087616|NCT00705159|38813630|FG003|Overall Study|Lost to Follow-up|2|||
16087617|NCT00705159|38813627|FG000|Overall Study|Screen Failure|0|||
16087618|NCT00705159|38813628|FG001|Overall Study|Screen Failure|0|||
16087619|NCT00705159|38813629|FG002|Overall Study|Screen Failure|0|||
16087620|NCT00705159|38813630|FG003|Overall Study|Screen Failure|1|||
16087621|NCT01263496|38813632|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
16087622|NCT01263496|38813633|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16087623|NCT01263496|38813634|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16087624|NCT01263496|38813635|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16087625|NCT01263496|38813636|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16309371|NCT00226499|39615824|FG002|Overall Study|Adverse Event|3|||
16087626|NCT01263496|38813637|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16087627|NCT01263496|38813638|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16087628|NCT01263496|38813639|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16087629|NCT01263496|38813640|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
16087630|NCT01263496|38813632|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16087631|NCT01263496|38813633|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16087632|NCT01263496|38813634|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16087633|NCT01263496|38813635|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
16087634|NCT01263496|38813636|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
16087635|NCT01263496|38813637|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16087636|NCT01263496|38813638|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16087637|NCT01263496|38813639|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16087638|NCT01263496|38813640|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16087639|NCT01263496|38813632|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
16087640|NCT01263496|38813633|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
16087641|NCT01263496|38813634|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
16087642|NCT01263496|38813635|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
16087643|NCT01263496|38813636|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
16087644|NCT01263496|38813637|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
16087645|NCT01263496|38813638|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
16087646|NCT01263496|38813639|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
16087647|NCT01263496|38813640|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
16087648|NCT01263496|38813632|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16087649|NCT01263496|38813633|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
16087650|NCT01263496|38813634|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16087651|NCT01263496|38813635|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16087652|NCT01263496|38813636|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16087653|NCT01263496|38813637|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16087654|NCT01263496|38813638|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16087655|NCT01263496|38813639|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16087656|NCT01263496|38813640|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16087657|NCT01263496|38813632|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16087658|NCT01263496|38813633|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16087659|NCT01263496|38813634|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
16087660|NCT01263496|38813635|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16087661|NCT01263496|38813636|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
16087662|NCT01263496|38813637|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16087663|NCT01263496|38813638|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16087664|NCT01263496|38813639|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
16087665|NCT01263496|38813640|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16087666|NCT01263496|38813632|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
16087667|NCT01263496|38813633|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
16087668|NCT01263496|38813634|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
16087669|NCT01263496|38813635|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
16087670|NCT01263496|38813636|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
16087671|NCT01263496|38813637|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
16087672|NCT01263496|38813638|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
16087673|NCT01263496|38813639|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
16087674|NCT01263496|38813640|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
16087675|NCT01263496|38813632|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16087676|NCT01263496|38813633|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16087677|NCT01263496|38813634|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16087678|NCT01263496|38813635|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16087679|NCT01263496|38813636|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16087680|NCT01263496|38813637|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16499154|NCT01387347|40299068|FG001|Overall Study|Lost to Follow-up|1|||
16499155|NCT01506479|40299073|FG000|Overall Study|Lost to Follow-up|1|||
16499156|NCT01506479|40299074|FG001|Overall Study|Lost to Follow-up|2|||
16499157|NCT01506479|40299075|FG002|Overall Study|Lost to Follow-up|2|||
16499158|NCT01506479|40299073|FG000|Overall Study|Withdrawal by Subject|1|||
16499159|NCT01506479|40299074|FG001|Overall Study|Withdrawal by Subject|2|||
16499160|NCT01506479|40299075|FG002|Overall Study|Withdrawal by Subject|1|||
16499161|NCT01506479|40299073|FG000|Overall Study|Missing assessment|1|||
16499162|NCT01506479|40299074|FG001|Overall Study|Missing assessment|0|||
16499163|NCT01506479|40299075|FG002|Overall Study|Missing assessment|0|||
16499164|NCT01506479|40299073|FG000|Overall Study|Adverse Event|0|||
16499165|NCT01506479|40299074|FG001|Overall Study|Adverse Event|1|||
16499166|NCT01506479|40299075|FG002|Overall Study|Adverse Event|0|||
16499167|NCT03944954|40299077|FG000|Overall Study|Withdrawal by Subject|22|||
16499168|NCT03944954|40299078|FG001|Overall Study|Withdrawal by Subject|4|||
16499169|NCT03944954|40299077|FG000|Overall Study|Lost to Follow-up|18|||
16499170|NCT03944954|40299078|FG001|Overall Study|Lost to Follow-up|0|||
16499171|NCT03944954|40299077|FG000|Overall Study|Failed Medical Screening|7|||
16499172|NCT03944954|40299078|FG001|Overall Study|Failed Medical Screening|0|||
16499173|NCT01502423|40299079|FG000|Overall Study|Withdrawal by Subject|0|||
16499174|NCT01502423|40299080|FG001|Overall Study|Withdrawal by Subject|1|||
16499175|NCT01499667|40299081|FG000|Overall Study|administrative problems|4|||
16499176|NCT01499667|40299082|FG001|Overall Study|administrative problems|5|||
16546314|NCT02237508|40464778|FG005|Overall Study|Physician Decision|0|||
16087681|NCT01263496|38813638|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16087682|NCT01263496|38813639|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
16087683|NCT01263496|38813640|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16087684|NCT02309294|38813643|FG000|Overall Study|Withdrawal by Subject|2|||
16087685|NCT00790569|38813644|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
16087686|NCT00790569|38813645|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
16087687|NCT00790569|38813646|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
16309372|NCT00226499|39615822|FG000|Overall Study|Others|1064|||
16499177|NCT01499667|40299083|FG002|Overall Study|administrative problems|5|||
16499178|NCT01499667|40299081|FG000|Overall Study|Protocol Violation|1|||
16499179|NCT01499667|40299082|FG001|Overall Study|Protocol Violation|3|||
16499180|NCT01499667|40299083|FG002|Overall Study|Protocol Violation|2|||
16499181|NCT01499667|40299081|FG000|Overall Study|Adverse Event|0|||
16499182|NCT01499667|40299082|FG001|Overall Study|Adverse Event|2|||
16499183|NCT01499667|40299083|FG002|Overall Study|Adverse Event|2|||
16499184|NCT01499667|40299081|FG000|Overall Study|Withdrawal by Subject|2|||
16499185|NCT01499667|40299082|FG001|Overall Study|Withdrawal by Subject|1|||
16499186|NCT01499667|40299083|FG002|Overall Study|Withdrawal by Subject|1|||
16499187|NCT01499667|40299081|FG000|Overall Study|Lack of Efficacy|2|||
16499188|NCT01499667|40299082|FG001|Overall Study|Lack of Efficacy|0|||
16499189|NCT01499667|40299083|FG002|Overall Study|Lack of Efficacy|0|||
16499190|NCT00513474|40299085|FG000|Overall Study|Death|6|||
16499191|NCT00513474|40299086|FG001|Overall Study|Death|9|||
16499192|NCT00513474|40299085|FG000|Overall Study|Participant Withdrew Consent|1|||
16499193|NCT00513474|40299086|FG001|Overall Study|Participant Withdrew Consent|0|||
16499194|NCT01288469|40299092|FG000|Overall Study|Adverse Event|4|||
16499195|NCT01288469|40299093|FG001|Overall Study|Adverse Event|1|||
16499196|NCT01288469|40299094|FG002|Overall Study|Adverse Event|1|||
16499197|NCT01288469|40299092|FG000|Overall Study|Poor compliance to protocol|0|||
16499198|NCT01288469|40299093|FG001|Overall Study|Poor compliance to protocol|1|||
16499199|NCT01288469|40299094|FG002|Overall Study|Poor compliance to protocol|0|||
16499200|NCT01288469|40299092|FG000|Overall Study|Participant Moved|1|||
16499201|NCT01288469|40299093|FG001|Overall Study|Participant Moved|0|||
16499202|NCT01288469|40299094|FG002|Overall Study|Participant Moved|0|||
16499203|NCT01288469|40299092|FG000|Overall Study|Consent withdrawn by subject|1|||
16499204|NCT01288469|40299093|FG001|Overall Study|Consent withdrawn by subject|1|||
16499205|NCT01288469|40299094|FG002|Overall Study|Consent withdrawn by subject|1|||
16499206|NCT01288469|40299092|FG000|Overall Study|Exclusion criteria finally met|1|||
16499207|NCT01288469|40299093|FG001|Overall Study|Exclusion criteria finally met|0|||
16499208|NCT01288469|40299094|FG002|Overall Study|Exclusion criteria finally met|0|||
16499209|NCT01414114|40299095|FG000|Overall Study|Adverse Event|2|||
16499210|NCT01414114|40299095|FG000|Overall Study|Withdrawal by Subject|1|||
16499211|NCT01414114|40299095|FG000|Overall Study|Other|2|||
16499212|NCT02927080|40299096|FG000|Overall Study|Withdrawal by Subject|0|||
16499213|NCT02927080|40299097|FG001|Overall Study|Withdrawal by Subject|0|||
16499214|NCT02927080|40299098|FG002|Overall Study|Withdrawal by Subject|0|||
16499215|NCT02927080|40299099|FG003|Overall Study|Withdrawal by Subject|0|||
16499216|NCT02927080|40299100|FG004|Overall Study|Withdrawal by Subject|1|||
16499217|NCT02927080|40299101|FG005|Overall Study|Withdrawal by Subject|0|||
16499218|NCT02927080|40299102|FG006|Overall Study|Withdrawal by Subject|1|||
16499219|NCT02927080|40299103|FG007|Overall Study|Withdrawal by Subject|1|||
16499220|NCT02927080|40299104|FG008|Overall Study|Withdrawal by Subject|0|||
16499221|NCT02927080|40299105|FG009|Overall Study|Withdrawal by Subject|2|||
16499222|NCT02927080|40299096|FG000|Overall Study|Willingness to comply with protocol|0|||
16499223|NCT02927080|40299097|FG001|Overall Study|Willingness to comply with protocol|0|||
16499224|NCT02927080|40299098|FG002|Overall Study|Willingness to comply with protocol|0|||
16499225|NCT02927080|40299099|FG003|Overall Study|Willingness to comply with protocol|0|||
16499226|NCT02927080|40299100|FG004|Overall Study|Willingness to comply with protocol|0|||
16499227|NCT02927080|40299101|FG005|Overall Study|Willingness to comply with protocol|0|||
16499228|NCT02927080|40299102|FG006|Overall Study|Willingness to comply with protocol|0|||
16499229|NCT02927080|40299103|FG007|Overall Study|Willingness to comply with protocol|0|||
16499230|NCT02927080|40299104|FG008|Overall Study|Willingness to comply with protocol|0|||
16499231|NCT02927080|40299105|FG009|Overall Study|Willingness to comply with protocol|1|||
16499232|NCT02927080|40299096|FG000|Overall Study|Study terminated by Sponsor|0|||
16499233|NCT02927080|40299097|FG001|Overall Study|Study terminated by Sponsor|0|||
16499234|NCT02927080|40299098|FG002|Overall Study|Study terminated by Sponsor|0|||
16499235|NCT02927080|40299099|FG003|Overall Study|Study terminated by Sponsor|0|||
16499236|NCT02927080|40299100|FG004|Overall Study|Study terminated by Sponsor|0|||
16499237|NCT02927080|40299101|FG005|Overall Study|Study terminated by Sponsor|0|||
16499238|NCT02927080|40299102|FG006|Overall Study|Study terminated by Sponsor|6|||
16499239|NCT02927080|40299103|FG007|Overall Study|Study terminated by Sponsor|7|||
16309373|NCT00226499|39615823|FG001|Overall Study|Others|1066|||
16499240|NCT02927080|40299104|FG008|Overall Study|Study terminated by Sponsor|2|||
16499241|NCT02927080|40299105|FG009|Overall Study|Study terminated by Sponsor|3|||
16499242|NCT02927080|40299096|FG000|Overall Study|Adverse Event|0|||
16087688|NCT00790569|38813644|FG000|End of Treatment (6 Month Interview)|Death|0|||
16087689|NCT00790569|38813645|FG001|End of Treatment (6 Month Interview)|Death|2|||
16499243|NCT02927080|40299097|FG001|Overall Study|Adverse Event|1|||
16499244|NCT02927080|40299098|FG002|Overall Study|Adverse Event|0|||
16499245|NCT02927080|40299099|FG003|Overall Study|Adverse Event|0|||
16499246|NCT02927080|40299100|FG004|Overall Study|Adverse Event|0|||
16499247|NCT02927080|40299101|FG005|Overall Study|Adverse Event|0|||
16499248|NCT02927080|40299102|FG006|Overall Study|Adverse Event|0|||
16499249|NCT02927080|40299103|FG007|Overall Study|Adverse Event|1|||
16499250|NCT02927080|40299104|FG008|Overall Study|Adverse Event|0|||
16499251|NCT02927080|40299105|FG009|Overall Study|Adverse Event|1|||
16499252|NCT02927080|40299096|FG000|Overall Study|Other|0|||
16499253|NCT02927080|40299097|FG001|Overall Study|Other|0|||
16499254|NCT02927080|40299098|FG002|Overall Study|Other|0|||
16499255|NCT02927080|40299099|FG003|Overall Study|Other|0|||
16499256|NCT02927080|40299100|FG004|Overall Study|Other|0|||
16499257|NCT02927080|40299101|FG005|Overall Study|Other|0|||
16087690|NCT00790569|38813646|FG002|End of Treatment (6 Month Interview)|Death|1|||
16087691|NCT00790569|38813644|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
16087692|NCT00790569|38813645|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
16087693|NCT00790569|38813646|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
16087694|NCT00790569|38813644|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
16087695|NCT00790569|38813645|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
16087696|NCT00790569|38813646|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
16087697|NCT00790569|38813644|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
16195217|NCT02662985|39193268|FG001|Treatment Period 1|Protocol Violation|1|||
16309374|NCT00226499|39615824|FG002|Overall Study|Others|356|||
16309375|NCT00370552|39615825|FG000|Overall Study|Adverse Event|2|||
16499258|NCT02927080|40299102|FG006|Overall Study|Other|1|||
16499259|NCT02927080|40299103|FG007|Overall Study|Other|0|||
16499260|NCT02927080|40299104|FG008|Overall Study|Other|1|||
16499261|NCT02927080|40299105|FG009|Overall Study|Other|0|||
16309376|NCT00370552|39615826|FG001|Overall Study|Adverse Event|2|||
16309377|NCT00370552|39615827|FG002|Overall Study|Adverse Event|2|||
16309378|NCT00370552|39615825|FG000|Overall Study|Disease progression|23|||
16309379|NCT00370552|39615826|FG001|Overall Study|Disease progression|23|||
16309380|NCT00370552|39615827|FG002|Overall Study|Disease progression|15|||
16309381|NCT00370552|39615825|FG000|Overall Study|Maximum clinical benefit|3|||
16309382|NCT00370552|39615826|FG001|Overall Study|Maximum clinical benefit|5|||
16309383|NCT00370552|39615827|FG002|Overall Study|Maximum clinical benefit|5|||
16309384|NCT00370552|39615825|FG000|Overall Study|Poor or noncompliance|0|||
16195218|NCT02662985|39193267|FG000|Treatment Period 1|Physician Decision|1|||
16309385|NCT00370552|39615826|FG001|Overall Study|Poor or noncompliance|0|||
16309386|NCT00370552|39615827|FG002|Overall Study|Poor or noncompliance|1|||
16309387|NCT00370552|39615825|FG000|Overall Study|Study drug toxicity|11|||
16309388|NCT00370552|39615826|FG001|Overall Study|Study drug toxicity|8|||
16309389|NCT00370552|39615827|FG002|Overall Study|Study drug toxicity|6|||
16309390|NCT00370552|39615825|FG000|Overall Study|Withdrawal by Subject|2|||
16309391|NCT00370552|39615826|FG001|Overall Study|Withdrawal by Subject|0|||
16309392|NCT00370552|39615827|FG002|Overall Study|Withdrawal by Subject|1|||
16309393|NCT00370552|39615825|FG000|Overall Study|Still on treatment|1|||
16309394|NCT00370552|39615826|FG001|Overall Study|Still on treatment|3|||
16309395|NCT00370552|39615827|FG002|Overall Study|Still on treatment|2|||
16389360|NCT02078752|39908638|FG001|Overall Study|Lost to Follow-up|0|||
16389361|NCT02078752|39908639|FG002|Overall Study|Lost to Follow-up|0|||
16389362|NCT02078752|39908640|FG003|Overall Study|Lost to Follow-up|1|||
16499262|NCT00065507|40299106|FG000|Overall Study|Death|16|||
16499263|NCT00065507|40299107|FG001|Overall Study|Death|17|||
16309396|NCT00370552|39615825|FG000|Overall Study|Never treated|1|||
16309397|NCT00370552|39615826|FG001|Overall Study|Never treated|0|||
16309398|NCT00370552|39615827|FG002|Overall Study|Never treated|0|||
16309399|NCT00370552|39615825|FG000|Overall Study|Physician Decision|1|||
16309400|NCT00370552|39615826|FG001|Overall Study|Physician Decision|1|||
16309401|NCT00370552|39615827|FG002|Overall Study|Physician Decision|0|||
16309402|NCT00370552|39615825|FG000|Overall Study|Investigator decision|2|||
16309403|NCT00370552|39615826|FG001|Overall Study|Investigator decision|1|||
16389363|NCT02078752|39908641|FG004|Overall Study|Lost to Follow-up|0|||
16389364|NCT02078752|39908642|FG005|Overall Study|Lost to Follow-up|0|||
16309404|NCT00370552|39615827|FG002|Overall Study|Investigator decision|0|||
16309405|NCT00370552|39615825|FG000|Overall Study|High risk of allergic reaction|0|||
16499264|NCT00065507|40299106|FG000|Overall Study|Adverse Event|4|||
16499265|NCT00065507|40299107|FG001|Overall Study|Adverse Event|3|||
16499266|NCT00065507|40299106|FG000|Overall Study|Lack of Efficacy|0|||
16499267|NCT00065507|40299107|FG001|Overall Study|Lack of Efficacy|6|||
16499268|NCT00065507|40299106|FG000|Overall Study|Poor/Non-compliance|3|||
16499269|NCT00065507|40299107|FG001|Overall Study|Poor/Non-compliance|2|||
16309406|NCT00370552|39615826|FG001|Overall Study|High risk of allergic reaction|1|||
16309407|NCT00370552|39615827|FG002|Overall Study|High risk of allergic reaction|0|||
16309408|NCT00370552|39615825|FG000|Overall Study|Planned radiation for palliation|0|||
16499270|NCT00065507|40299106|FG000|Overall Study|Lost to Follow-up|3|||
16499271|NCT00065507|40299107|FG001|Overall Study|Lost to Follow-up|0|||
16499272|NCT00065507|40299106|FG000|Overall Study|Subject Withdrew Consent|2|||
16499273|NCT00065507|40299107|FG001|Overall Study|Subject Withdrew Consent|1|||
16499274|NCT00065507|40299106|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
16499275|NCT00065507|40299107|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
16499276|NCT03649711|40299108|FG000|Overall Study|Adverse Event|0|||
16499277|NCT03649711|40299109|FG001|Overall Study|Adverse Event|1|||
16499278|NCT03649711|40299110|FG002|Overall Study|Adverse Event|0|||
16499279|NCT03649711|40299108|FG000|Overall Study|Kidney Transplant|1|||
16309409|NCT00370552|39615826|FG001|Overall Study|Planned radiation for palliation|1|||
16389365|NCT02078752|39908643|FG006|Overall Study|Lost to Follow-up|0|||
16389366|NCT02078752|39908644|FG007|Overall Study|Lost to Follow-up|0|||
16389367|NCT02078752|39908645|FG008|Overall Study|Lost to Follow-up|0|||
16389368|NCT02078752|39908646|FG009|Overall Study|Lost to Follow-up|0|||
16389369|NCT02078752|39908637|FG000|Overall Study|Withdrawal by Subject|1|||
16389370|NCT02078752|39908638|FG001|Overall Study|Withdrawal by Subject|1|||
16389371|NCT02078752|39908639|FG002|Overall Study|Withdrawal by Subject|1|||
16389372|NCT02078752|39908640|FG003|Overall Study|Withdrawal by Subject|1|||
16389373|NCT02078752|39908641|FG004|Overall Study|Withdrawal by Subject|0|||
16389374|NCT02078752|39908642|FG005|Overall Study|Withdrawal by Subject|3|||
16309410|NCT00370552|39615827|FG002|Overall Study|Planned radiation for palliation|0|||
16309411|NCT00652340|39615828|FG000|Overall Study|Had not progressed.|4|||
16309412|NCT00652340|39615829|FG001|Overall Study|Had not progressed.|3|||
16309413|NCT00654095|39615835|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
16389375|NCT02078752|39908643|FG006|Overall Study|Withdrawal by Subject|2|||
16499280|NCT03649711|40299109|FG001|Overall Study|Kidney Transplant|0|||
16499281|NCT03649711|40299110|FG002|Overall Study|Kidney Transplant|0|||
16309414|NCT00654095|39615835|FG000|Overall Study|Elevated triglyceride level (2)|1|||
16389376|NCT02078752|39908644|FG007|Overall Study|Withdrawal by Subject|1|||
16389377|NCT02078752|39908645|FG008|Overall Study|Withdrawal by Subject|0|||
16389378|NCT02078752|39908646|FG009|Overall Study|Withdrawal by Subject|1|||
16389379|NCT02078752|39908637|FG000|Overall Study|Other|0|||
16389380|NCT02078752|39908638|FG001|Overall Study|Other|3|||
16389381|NCT02078752|39908639|FG002|Overall Study|Other|0|||
16389382|NCT02078752|39908640|FG003|Overall Study|Other|0|||
16389383|NCT02078752|39908641|FG004|Overall Study|Other|1|||
16389384|NCT02078752|39908642|FG005|Overall Study|Other|0|||
16389385|NCT02078752|39908643|FG006|Overall Study|Other|0|||
16389386|NCT02078752|39908644|FG007|Overall Study|Other|1|||
16389387|NCT02078752|39908645|FG008|Overall Study|Other|0|||
16389388|NCT02078752|39908646|FG009|Overall Study|Other|0|||
16389389|NCT02078752|39908637|FG000|Overall Study|Study terminated by sponsor|0|||
16389390|NCT02078752|39908638|FG001|Overall Study|Study terminated by sponsor|0|||
16389391|NCT02078752|39908639|FG002|Overall Study|Study terminated by sponsor|0|||
16499282|NCT00156533|40299113|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
16499283|NCT00156533|40299114|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
16499284|NCT00156533|40299115|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
16499285|NCT00156533|40299116|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
16499286|NCT00156533|40299113|FG000|Overall Study|Withdrawal by Subject|1|||
16499287|NCT00156533|40299114|FG001|Overall Study|Withdrawal by Subject|0|||
16499288|NCT00156533|40299115|FG002|Overall Study|Withdrawal by Subject|0|||
16499289|NCT00156533|40299116|FG003|Overall Study|Withdrawal by Subject|1|||
16499290|NCT00156533|40299113|FG000|Overall Study|Failed Screening|1|||
16499291|NCT00156533|40299114|FG001|Overall Study|Failed Screening|0|||
16499292|NCT00156533|40299115|FG002|Overall Study|Failed Screening|1|||
16499293|NCT00156533|40299116|FG003|Overall Study|Failed Screening|1|||
16309415|NCT00654095|39615835|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
16309416|NCT00654095|39615835|FG000|Overall Study|Adverse Event|11|||
16309417|NCT00654095|39615835|FG000|Overall Study|Withdrawal by Subject|5|||
16309418|NCT00654095|39615835|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
16309419|NCT00654095|39615835|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
16309420|NCT00654095|39615835|FG000|Overall Study|Did not meet inclusion criteria|1|||
16309421|NCT01522456|39615836|FG000|Overall Study|Adverse Event|2|||
16309422|NCT01522456|39615836|FG000|Overall Study|Lost to Follow-up|2|||
16309423|NCT01522456|39615836|FG000|Overall Study|Withdrawal by Subject|2|||
16309424|NCT01522456|39615836|FG000|Overall Study|Pregnancy|1|||
16309425|NCT01522456|39615836|FG000|Overall Study|Tolerability Assessment|1|||
16309426|NCT00196326|39615842|FG000|Overall Study|Did not meet protocol requirements|64|||
16309427|NCT00196326|39615842|FG000|Overall Study|Non-compliance with the protocol|81|||
16309428|NCT00196326|39615842|FG000|Overall Study|Physician Decision|3|||
16309429|NCT00196326|39615842|FG000|Overall Study|Withdrawal by Subject|225|||
16309430|NCT00196326|39615842|FG000|Overall Study|Adverse Event|253|||
16309431|NCT00196326|39615842|FG000|Overall Study|Pregnancy|34|||
16309432|NCT00196326|39615842|FG000|Overall Study|Lost to Follow-up|304|||
16309433|NCT00196326|39615842|FG000|Overall Study|Other|22|||
16309434|NCT00444587|39615843|FG000|Overall Study|Death|2|||
16309435|NCT00444587|39615844|FG001|Overall Study|Death|1|||
16389392|NCT02078752|39908640|FG003|Overall Study|Study terminated by sponsor|0|||
16389393|NCT02078752|39908641|FG004|Overall Study|Study terminated by sponsor|0|||
16499294|NCT01980875|40299117|FG000|Overall Study|Withdrew Consent|1|||
16309436|NCT00444587|39615843|FG000|Overall Study|Progression of the disease|73|||
16309437|NCT00444587|39615844|FG001|Overall Study|Progression of the disease|8|||
16389394|NCT02078752|39908642|FG005|Overall Study|Study terminated by sponsor|0|||
16389395|NCT02078752|39908643|FG006|Overall Study|Study terminated by sponsor|0|||
16389396|NCT02078752|39908644|FG007|Overall Study|Study terminated by sponsor|0|||
16309438|NCT00444587|39615843|FG000|Overall Study|Refused treatment/did not cooperate|4|||
16309439|NCT00444587|39615844|FG001|Overall Study|Refused treatment/did not cooperate|1|||
16309440|NCT00444587|39615843|FG000|Overall Study|Investigator decision|3|||
16309441|NCT00444587|39615844|FG001|Overall Study|Investigator decision|0|||
16309442|NCT00444587|39615843|FG000|Overall Study|Protocol Violation|1|||
16309443|NCT00444587|39615844|FG001|Overall Study|Protocol Violation|0|||
16309444|NCT00444587|39615843|FG000|Overall Study|Missing|0|||
16309445|NCT00444587|39615844|FG001|Overall Study|Missing|5|||
16309446|NCT00451178|39615847|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
16309447|NCT00451178|39615848|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
16309448|NCT00451178|39615847|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
16309449|NCT00451178|39615848|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
16309450|NCT00451178|39615847|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
16309451|NCT00451178|39615848|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
16309452|NCT00451178|39615847|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
16309453|NCT00451178|39615848|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
16309454|NCT00451178|39615847|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
16309455|NCT00451178|39615848|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
16309456|NCT00451178|39615847|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
16309457|NCT00451178|39615848|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
16309458|NCT00451178|39615847|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
16309459|NCT00451178|39615848|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
16309460|NCT00451178|39615847|FG000|Prior to Maintenance Therapy|PD|2|||
16309461|NCT00451178|39615848|FG001|Prior to Maintenance Therapy|PD|0|||
16309462|NCT00451178|39615847|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
16309463|NCT00451178|39615848|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
16309464|NCT00451178|39615847|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
16309465|NCT00451178|39615848|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
16309466|NCT00451178|39615847|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
16309467|NCT00451178|39615848|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
16309468|NCT00451178|39615847|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
16309469|NCT00451178|39615848|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
16309470|NCT00451178|39615847|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
16309471|NCT00451178|39615848|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
16309472|NCT00451178|39615847|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
16309473|NCT00451178|39615848|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
16309474|NCT00451178|39615847|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
16309475|NCT00451178|39615848|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
16309476|NCT01720225|39615849|FG000|Overall Study|Withdrawal by Subject|0|||
16309477|NCT01720225|39615850|FG001|Overall Study|Withdrawal by Subject|1|||
16309478|NCT01720225|39615849|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
16309479|NCT01720225|39615850|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
16309480|NCT03280264|39619030|FG000|Overall Study|Adverse Event|1|||
16309481|NCT03280264|39619030|FG000|Overall Study|Physician Decision|1|||
16309482|NCT03280264|39619030|FG000|Overall Study|Withdrawal by Subject|1|||
16309483|NCT01786993|39619031|FG000|Overall Study|Death|6|||
16309484|NCT01786993|39619032|FG001|Overall Study|Death|7|||
16309485|NCT01786993|39619031|FG000|Overall Study|Withdrawal by Subject|3|||
16309486|NCT01786993|39619032|FG001|Overall Study|Withdrawal by Subject|2|||
16309487|NCT01786993|39619031|FG000|Overall Study|Lost to Follow-up|0|||
16309488|NCT01786993|39619032|FG001|Overall Study|Lost to Follow-up|1|||
16309489|NCT01786993|39619031|FG000|Overall Study|Subject Non-Compliance|1|||
16309490|NCT01786993|39619032|FG001|Overall Study|Subject Non-Compliance|0|||
16389397|NCT02078752|39908645|FG008|Overall Study|Study terminated by sponsor|0|||
16389398|NCT02078752|39908646|FG009|Overall Study|Study terminated by sponsor|5|||
16389399|NCT02903823|39908647|FG000|Overall Study|Physician Decision|5|||
16389400|NCT02903823|39908647|FG000|Overall Study|Could not advance catheter|1|||
16389401|NCT02903823|39908647|FG000|Overall Study|Catheter dislodgement|1|||
16389402|NCT01775553|39908648|FG000|Overall Study|Adverse Event|1|||
16389403|NCT01775553|39908648|FG000|Overall Study|Disease Progression|12|||
16389404|NCT00200967|39908649|FG000|First Treatment Period|Withdrawal by Subject|5|||
16389405|NCT00200967|39908650|FG001|First Treatment Period|Withdrawal by Subject|1|||
16309491|NCT01786993|39619031|FG000|Overall Study|System Explant|1|||
16309492|NCT01786993|39619032|FG001|Overall Study|System Explant|0|||
16389406|NCT00200967|39908649|FG000|First Treatment Period|Pregnancy|1|||
16499295|NCT01980875|40299118|FG001|Overall Study|Withdrew Consent|1|||
16499296|NCT01980875|40299119|FG002|Overall Study|Withdrew Consent|1|||
16499297|NCT01980875|40299117|FG000|Overall Study|Study Terminated by Sponsor|7|||
16499298|NCT01980875|40299118|FG001|Overall Study|Study Terminated by Sponsor|24|||
16499299|NCT01980875|40299119|FG002|Overall Study|Study Terminated by Sponsor|22|||
16499300|NCT01980875|40299117|FG000|Overall Study|Lost to Follow-up|0|||
16499301|NCT01980875|40299118|FG001|Overall Study|Lost to Follow-up|0|||
16389407|NCT00200967|39908650|FG001|First Treatment Period|Pregnancy|0|||
16309493|NCT01786993|39619031|FG000|Overall Study|Hospice Admission|1|||
16309494|NCT01786993|39619032|FG001|Overall Study|Hospice Admission|0|||
16309495|NCT00972595|39619036|FG000|Period 1|Adverse Event|1|||
16309496|NCT00972595|39619037|FG001|Period 1|Adverse Event|0|||
16309497|NCT00584454|39619038|FG000|Overall Study|Adverse Event|1|||
16309498|NCT00584454|39619038|FG000|Overall Study|Relocation|1|||
16309499|NCT00584454|39619038|FG000|Overall Study|Clinical Hold|2|||
16309500|NCT02899962|39619039|FG000|Open-label Phase|Adverse Event|2|||
16309501|NCT02899962|39619040|FG001|Open-label Phase|Adverse Event|0|||
16309502|NCT02899962|39619041|FG002|Open-label Phase|Adverse Event|0|||
16309503|NCT02899962|39619039|FG000|Open-label Phase|Lost to Follow-up|9|||
16309504|NCT02899962|39619040|FG001|Open-label Phase|Lost to Follow-up|0|||
16309505|NCT02899962|39619041|FG002|Open-label Phase|Lost to Follow-up|0|||
16309506|NCT02899962|39619039|FG000|Open-label Phase|Other reasons|9|||
16309507|NCT02899962|39619040|FG001|Open-label Phase|Other reasons|0|||
16309508|NCT02899962|39619041|FG002|Open-label Phase|Other reasons|0|||
16309509|NCT02899962|39619039|FG000|Open-label Phase|Withdrawal by Subject|7|||
16309510|NCT02899962|39619040|FG001|Open-label Phase|Withdrawal by Subject|0|||
16309511|NCT02899962|39619041|FG002|Open-label Phase|Withdrawal by Subject|0|||
16309512|NCT02899962|39619039|FG000|Maintenance Phase|Adverse Event|0|||
16309513|NCT02899962|39619040|FG001|Maintenance Phase|Adverse Event|2|||
16309514|NCT02899962|39619041|FG002|Maintenance Phase|Adverse Event|1|||
16309515|NCT02899962|39619039|FG000|Maintenance Phase|Death|0|||
16309516|NCT02899962|39619040|FG001|Maintenance Phase|Death|0|||
16309517|NCT02899962|39619041|FG002|Maintenance Phase|Death|1|||
16309518|NCT02899962|39619039|FG000|Maintenance Phase|Lack of Efficacy|0|||
16309519|NCT02899962|39619040|FG001|Maintenance Phase|Lack of Efficacy|20|||
16309520|NCT02899962|39619041|FG002|Maintenance Phase|Lack of Efficacy|16|||
16309521|NCT02899962|39619039|FG000|Maintenance Phase|Lost to Follow-up|0|||
16309522|NCT02899962|39619040|FG001|Maintenance Phase|Lost to Follow-up|12|||
16309523|NCT02899962|39619041|FG002|Maintenance Phase|Lost to Follow-up|14|||
16309524|NCT02899962|39619039|FG000|Maintenance Phase|Other reasons|0|||
16309525|NCT02899962|39619040|FG001|Maintenance Phase|Other reasons|9|||
16309526|NCT02899962|39619041|FG002|Maintenance Phase|Other reasons|13|||
16309527|NCT02899962|39619039|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
16309528|NCT02899962|39619040|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
16309529|NCT02899962|39619041|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
16309530|NCT02899962|39619039|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
16309531|NCT02899962|39619040|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
16309532|NCT02899962|39619041|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
16499302|NCT01980875|40299119|FG002|Overall Study|Lost to Follow-up|1|||
16499303|NCT02233309|40299120|FG000|Overall Study|Physician Decision|5|||
16499304|NCT04461015|40299121|FG000|Overall Study|IV access lost during the study|0|||
16499305|NCT04461015|40299122|FG001|Overall Study|IV access lost during the study|1|||
16499306|NCT04461015|40299121|FG000|Overall Study|Withdrawal by Subject|0|||
16499307|NCT04461015|40299122|FG001|Overall Study|Withdrawal by Subject|1|||
16499308|NCT00541034|40299123|FG000|Overall Study|Non-Compliance|3|||
16499309|NCT02865187|40299131|FG000|Overall Study|Lost to Follow-up|12|||
16499310|NCT02865187|40299132|FG001|Overall Study|Lost to Follow-up|7|||
16499311|NCT02865187|40299131|FG000|Overall Study|Adverse Event|1|||
16499312|NCT02865187|40299132|FG001|Overall Study|Adverse Event|0|||
16499313|NCT02259582|40299133|FG000|Overall Study|Physician Decision|0|||
16499314|NCT02259582|40299134|FG001|Overall Study|Physician Decision|1|||
16499315|NCT02259582|40299135|FG002|Overall Study|Physician Decision|0|||
16499316|NCT02259582|40299133|FG000|Overall Study|Death|0|||
16499317|NCT02259582|40299134|FG001|Overall Study|Death|0|||
16499318|NCT02259582|40299135|FG002|Overall Study|Death|1|||
16499319|NCT02259582|40299133|FG000|Overall Study|Adverse Event|1|||
16087698|NCT00790569|38813645|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
16087699|NCT00790569|38813646|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
16087700|NCT00790569|38813644|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
16087701|NCT00790569|38813645|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
16087702|NCT00790569|38813646|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
16087703|NCT00738400|38813647|FG000|Overall Study|Adverse Event|3|||
16087704|NCT00738400|38813648|FG001|Overall Study|Adverse Event|1|||
16087705|NCT00738400|38813647|FG000|Overall Study|Withdrawal by Subject|0|||
16087706|NCT00738400|38813648|FG001|Overall Study|Withdrawal by Subject|1|||
16087707|NCT00738400|38813647|FG000|Overall Study|Lack of Efficacy|0|||
16309533|NCT02899962|39619039|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16499320|NCT02259582|40299134|FG001|Overall Study|Adverse Event|0|||
16499321|NCT02259582|40299135|FG002|Overall Study|Adverse Event|1|||
16309534|NCT02899962|39619040|FG001|Maintenance Phase|Withdrawal by Subject|30|||
16087708|NCT00738400|38813648|FG001|Overall Study|Lack of Efficacy|1|||
16309535|NCT02899962|39619041|FG002|Maintenance Phase|Withdrawal by Subject|36|||
16309536|NCT01130532|39619042|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
16309537|NCT01130532|39619043|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
16309538|NCT01130532|39619044|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
16309539|NCT01130532|39619045|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
16309540|NCT01130532|39619042|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
16309541|NCT01130532|39619043|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
16309542|NCT01130532|39619044|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
16309543|NCT01130532|39619045|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
16309544|NCT01130532|39619042|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
16499322|NCT02259582|40299133|FG000|Overall Study|Withdrawal by Subject|0|||
16499323|NCT02259582|40299134|FG001|Overall Study|Withdrawal by Subject|0|||
16499324|NCT02259582|40299135|FG002|Overall Study|Withdrawal by Subject|1|||
16499325|NCT02259582|40299133|FG000|Overall Study|Disease progression|14|||
16499326|NCT02259582|40299134|FG001|Overall Study|Disease progression|15|||
16499327|NCT02259582|40299135|FG002|Overall Study|Disease progression|17|||
16499328|NCT02259582|40299133|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
16499329|NCT02259582|40299134|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
16499330|NCT02259582|40299135|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
16499331|NCT03187262|40299136|FG000|Induction|Lack of Efficacy|2|||
16499332|NCT03187262|40299136|FG000|Induction|Progressive Disease|4|||
16499333|NCT03187262|40299136|FG000|Consolidation|Progressive Disease|5|||
16499334|NCT02961751|40299143|FG000|Overall Study|Lost to Follow-up|11|||
16499335|NCT02961751|40299143|FG000|Overall Study|Physician Decision|2|||
16087709|NCT00738400|38813647|FG000|Overall Study|Lost to Follow-up|0|||
16087710|NCT00738400|38813648|FG001|Overall Study|Lost to Follow-up|3|||
16087711|NCT00738400|38813647|FG000|Overall Study|Protocol Violation|1|||
16087712|NCT00738400|38813648|FG001|Overall Study|Protocol Violation|0|||
16087713|NCT00738400|38813647|FG000|Overall Study|Non-compliant with study medication|0|||
16087714|NCT00738400|38813648|FG001|Overall Study|Non-compliant with study medication|1|||
16087715|NCT02338999|38813649|FG000|First Intervention|Withdrawal by Subject|3|||
16087716|NCT02338999|38813650|FG001|First Intervention|Withdrawal by Subject|1|||
16087717|NCT02338999|38813649|FG000|Washout Period|Withdrawal by Subject|0|||
16087718|NCT02338999|38813650|FG001|Washout Period|Withdrawal by Subject|2|||
16087719|NCT02338999|38813649|FG000|Second Intervention|Withdrawal by Subject|0|||
16087720|NCT02338999|38813650|FG001|Second Intervention|Withdrawal by Subject|2|||
16087721|NCT03244800|38813655|FG000|Overall Study|Adverse Event|0|||
16087722|NCT03244800|38813656|FG001|Overall Study|Adverse Event|1|||
16087723|NCT03244800|38813657|FG002|Overall Study|Adverse Event|0|||
16087724|NCT03244800|38813658|FG003|Overall Study|Adverse Event|1|||
16087725|NCT03244800|38813655|FG000|Overall Study|Withdrew treatment|0|||
16087726|NCT03244800|38813656|FG001|Overall Study|Withdrew treatment|0|||
16087727|NCT03244800|38813657|FG002|Overall Study|Withdrew treatment|0|||
16087728|NCT03244800|38813658|FG003|Overall Study|Withdrew treatment|1|||
16087729|NCT01478594|38813659|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
16087730|NCT01478594|38813660|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
16087731|NCT01478594|38813659|FG000|Overall Study|Death|45|||
16087732|NCT01478594|38813660|FG001|Overall Study|Death|18|||
16087733|NCT01478594|38813659|FG000|Overall Study|Lost to Follow-up|3|||
16087734|NCT01478594|38813660|FG001|Overall Study|Lost to Follow-up|1|||
16087735|NCT01478594|38813659|FG000|Overall Study|Withdrawal by Subject|9|||
16087736|NCT01478594|38813660|FG001|Overall Study|Withdrawal by Subject|3|||
16087737|NCT01478594|38813659|FG000|Overall Study|Study Closed by Sponsor|8|||
16087738|NCT01478594|38813660|FG001|Overall Study|Study Closed by Sponsor|5|||
16087739|NCT00022672|38813663|FG000|Main Phase: 24 Months|Adverse Event|6|||
16087740|NCT00022672|38813664|FG001|Main Phase: 24 Months|Adverse Event|0|||
16087741|NCT00022672|38813663|FG000|Main Phase: 24 Months|Death|0|||
16087742|NCT00022672|38813664|FG001|Main Phase: 24 Months|Death|3|||
16087743|NCT00022672|38813663|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
16087744|NCT00022672|38813664|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
16087745|NCT00022672|38813663|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
16087746|NCT00022672|38813664|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
16087747|NCT00022672|38813663|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
16087748|NCT00022672|38813664|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
16087749|NCT00022672|38813663|FG000|Main Phase: 24 Months|Refused Treatment|3|||
16309545|NCT01130532|39619043|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
16309546|NCT01130532|39619044|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
16499336|NCT02961751|40299143|FG000|Overall Study|Not Eligible at Enrollment|1|||
16087750|NCT00022672|38813664|FG001|Main Phase: 24 Months|Refused Treatment|4|||
16087751|NCT00022672|38813663|FG000|Main Phase: 24 Months|Failure to Return|1|||
16087752|NCT00022672|38813664|FG001|Main Phase: 24 Months|Failure to Return|1|||
16087753|NCT00022672|38813663|FG000|Main Phase: 24 Months|Other|1|||
16087754|NCT00022672|38813664|FG001|Main Phase: 24 Months|Other|0|||
16087755|NCT00022672|38813663|FG000|Extension Phase|Adverse Event|1|||
16087756|NCT00022672|38813664|FG001|Extension Phase|Adverse Event|3|||
16087757|NCT00022672|38813663|FG000|Extension Phase|Death|0|||
16499337|NCT02961751|40299143|FG000|Overall Study|Protocol Violation|1|||
16499338|NCT01867021|40299144|FG000|Overall Study|Adverse Event|0|||
16499339|NCT01867021|40299145|FG001|Overall Study|Adverse Event|1|||
16087758|NCT00022672|38813664|FG001|Extension Phase|Death|1|||
16087759|NCT00022672|38813663|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
16087760|NCT00022672|38813664|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
16087761|NCT00022672|38813663|FG000|Extension Phase|Refused Treatment|0|||
16087762|NCT00022672|38813664|FG001|Extension Phase|Refused Treatment|2|||
16087763|NCT00022672|38813663|FG000|Extension Phase|Other|1|||
16195219|NCT02662985|39193268|FG001|Treatment Period 1|Physician Decision|0|||
16087764|NCT00022672|38813664|FG001|Extension Phase|Other|1|||
16087765|NCT00939510|38813667|FG000|Overall Study|Withdrawal by Subject|1|||
16087766|NCT00689351|38813668|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
16087767|NCT00689351|38813669|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
16087768|NCT00689351|38813668|FG000|Infant Series of Dosing|Adverse Event|1|||
16087769|NCT00689351|38813669|FG001|Infant Series of Dosing|Adverse Event|0|||
16087770|NCT00689351|38813668|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
16087771|NCT00689351|38813669|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
16087772|NCT00689351|38813668|FG000|After Infant Series|Parent/legal guardian request|1|||
16087773|NCT00689351|38813669|FG001|After Infant Series|Parent/legal guardian request|0|||
16087774|NCT00452452|38813670|FG000|Overall Study|Protocol Violation|0|||
16087775|NCT00452452|38813671|FG001|Overall Study|Protocol Violation|0|||
16087776|NCT00452452|38813672|FG002|Overall Study|Protocol Violation|1|||
16087777|NCT00452452|38813670|FG000|Overall Study|Withdrawal by Subject|1|||
16087778|NCT00452452|38813671|FG001|Overall Study|Withdrawal by Subject|0|||
16087779|NCT00452452|38813672|FG002|Overall Study|Withdrawal by Subject|0|||
16087780|NCT00452452|38813670|FG000|Overall Study|Lost to Follow-up|1|||
16087781|NCT00452452|38813671|FG001|Overall Study|Lost to Follow-up|0|||
16087782|NCT00452452|38813672|FG002|Overall Study|Lost to Follow-up|0|||
16087783|NCT01218009|38813673|FG000|Overall Study|Protocol Violation|2|||
16087784|NCT01218009|38813674|FG001|Overall Study|Protocol Violation|1|||
16087785|NCT01218009|38813673|FG000|Overall Study|Withdrawal by Subject|3|||
16087786|NCT01218009|38813674|FG001|Overall Study|Withdrawal by Subject|1|||
16087787|NCT01218009|38813673|FG000|Overall Study|Sponsor terminated study|161|||
16309547|NCT01130532|39619045|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
16309548|NCT01130532|39619042|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
16309549|NCT01130532|39619043|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
16309550|NCT01130532|39619044|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
16309551|NCT01130532|39619045|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
16309552|NCT01130532|39619042|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
16087788|NCT01218009|38813674|FG001|Overall Study|Sponsor terminated study|163|||
16087789|NCT01549951|38813675|FG000|Overall Study|Adverse Event|15|||
16087790|NCT01549951|38813675|FG000|Overall Study|Withdrawal by Subject|2|||
16087791|NCT01549951|38813675|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
16087792|NCT01549951|38813675|FG000|Overall Study|Progressive disease|29|||
16087793|NCT01549951|38813675|FG000|Overall Study|Symptomatic deterioration|1|||
16309553|NCT01130532|39619043|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
16309554|NCT01130532|39619044|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
16499340|NCT01867021|40299144|FG000|Overall Study|Not Eligible|0|||
16087794|NCT01549951|38813675|FG000|Overall Study|Other|2|||
16087795|NCT04867382|38813676|FG000|Overall Study|Did not complete the survey|2|||
16087796|NCT04867382|38813677|FG001|Overall Study|Did not complete the survey|1|||
16087797|NCT03205488|38813678|FG000|Overall Study|Adverse Event|1|||
16087798|NCT03205488|38813679|FG001|Overall Study|Adverse Event|2|||
16309555|NCT01130532|39619045|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
16195220|NCT02662985|39193267|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16195221|NCT02662985|39193268|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16499341|NCT01867021|40299145|FG001|Overall Study|Not Eligible|1|||
16499342|NCT01867021|40299144|FG000|Overall Study|Death|1|||
16499343|NCT01867021|40299145|FG001|Overall Study|Death|0|||
16499344|NCT01867021|40299144|FG000|Overall Study|Lost to Follow-up|0|||
16499345|NCT01867021|40299145|FG001|Overall Study|Lost to Follow-up|2|||
16499346|NCT01867021|40299144|FG000|Overall Study|Withdrawal by Subject|1|||
16499347|NCT01867021|40299145|FG001|Overall Study|Withdrawal by Subject|6|||
16499348|NCT00429273|40299146|FG000|Overall Study|Lost to Follow-up|1|||
16499349|NCT00429273|40299147|FG001|Overall Study|Lost to Follow-up|2|||
16499350|NCT00429273|40299148|FG002|Overall Study|Lost to Follow-up|2|||
16499351|NCT00429273|40299146|FG000|Overall Study|Physician Decision|6|||
16499352|NCT00429273|40299147|FG001|Overall Study|Physician Decision|5|||
16499353|NCT00429273|40299148|FG002|Overall Study|Physician Decision|5|||
16499354|NCT00429273|40299146|FG000|Overall Study|Adverse Event|1|||
16499355|NCT00429273|40299147|FG001|Overall Study|Adverse Event|1|||
16499356|NCT00429273|40299148|FG002|Overall Study|Adverse Event|2|||
16499357|NCT01500629|40302827|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
16499358|NCT01500629|40302828|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
16499359|NCT00498602|40302829|FG000|Overall Study|Death|0|||
16499360|NCT00498602|40302830|FG001|Overall Study|Death|0|||
16499361|NCT00498602|40302831|FG002|Overall Study|Death|0|||
16499362|NCT00498602|40302832|FG003|Overall Study|Death|0|||
16499363|NCT00498602|40302833|FG004|Overall Study|Death|0|||
16499364|NCT00498602|40302834|FG005|Overall Study|Death|1|||
16499365|NCT00498602|40302835|FG006|Overall Study|Death|0|||
16499366|NCT00498602|40302829|FG000|Overall Study|Lack of Efficacy|1|||
16499367|NCT00498602|40302830|FG001|Overall Study|Lack of Efficacy|0|||
16499368|NCT00498602|40302831|FG002|Overall Study|Lack of Efficacy|0|||
16499369|NCT00498602|40302832|FG003|Overall Study|Lack of Efficacy|0|||
16499370|NCT00498602|40302833|FG004|Overall Study|Lack of Efficacy|0|||
16499371|NCT00498602|40302834|FG005|Overall Study|Lack of Efficacy|0|||
16499372|NCT00498602|40302835|FG006|Overall Study|Lack of Efficacy|0|||
16499373|NCT00498602|40302829|FG000|Overall Study|Lost to Follow-up|0|||
16499374|NCT00498602|40302830|FG001|Overall Study|Lost to Follow-up|2|||
16499375|NCT00498602|40302831|FG002|Overall Study|Lost to Follow-up|0|||
16499376|NCT00498602|40302832|FG003|Overall Study|Lost to Follow-up|2|||
16499377|NCT00498602|40302833|FG004|Overall Study|Lost to Follow-up|0|||
16499378|NCT00498602|40302834|FG005|Overall Study|Lost to Follow-up|0|||
16499379|NCT00498602|40302835|FG006|Overall Study|Lost to Follow-up|0|||
16499380|NCT00498602|40302829|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
16499381|NCT00498602|40302830|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
16499382|NCT00498602|40302831|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
16499383|NCT00498602|40302832|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
16499384|NCT00498602|40302833|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
16499385|NCT00498602|40302834|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
16499386|NCT00498602|40302835|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
16499387|NCT00498602|40302829|FG000|Overall Study|AE not related to Study Drug|1|||
16499388|NCT00498602|40302830|FG001|Overall Study|AE not related to Study Drug|3|||
16499389|NCT00498602|40302831|FG002|Overall Study|AE not related to Study Drug|0|||
16499390|NCT00498602|40302832|FG003|Overall Study|AE not related to Study Drug|0|||
16499391|NCT00498602|40302833|FG004|Overall Study|AE not related to Study Drug|2|||
16499392|NCT00498602|40302834|FG005|Overall Study|AE not related to Study Drug|2|||
16499393|NCT00498602|40302835|FG006|Overall Study|AE not related to Study Drug|1|||
16499394|NCT00498602|40302829|FG000|Overall Study|Caregiver Request|2|||
16499395|NCT00498602|40302830|FG001|Overall Study|Caregiver Request|2|||
16499396|NCT00498602|40302831|FG002|Overall Study|Caregiver Request|2|||
16499397|NCT00498602|40302832|FG003|Overall Study|Caregiver Request|0|||
16499398|NCT00498602|40302833|FG004|Overall Study|Caregiver Request|1|||
16499399|NCT00498602|40302834|FG005|Overall Study|Caregiver Request|2|||
16499400|NCT00498602|40302835|FG006|Overall Study|Caregiver Request|0|||
16499401|NCT00498602|40302829|FG000|Overall Study|Investigator Request|0|||
16499402|NCT00498602|40302830|FG001|Overall Study|Investigator Request|0|||
16499403|NCT00498602|40302831|FG002|Overall Study|Investigator Request|1|||
16499404|NCT00498602|40302832|FG003|Overall Study|Investigator Request|0|||
16499405|NCT00498602|40302833|FG004|Overall Study|Investigator Request|0|||
16499406|NCT00498602|40302834|FG005|Overall Study|Investigator Request|0|||
16499407|NCT00498602|40302835|FG006|Overall Study|Investigator Request|0|||
16499408|NCT00498602|40302829|FG000|Overall Study|Subject Request|3|||
16499409|NCT00498602|40302830|FG001|Overall Study|Subject Request|0|||
16499410|NCT00498602|40302831|FG002|Overall Study|Subject Request|1|||
16499411|NCT00498602|40302832|FG003|Overall Study|Subject Request|1|||
16499412|NCT00498602|40302833|FG004|Overall Study|Subject Request|1|||
16499413|NCT00498602|40302834|FG005|Overall Study|Subject Request|4|||
16499414|NCT00498602|40302835|FG006|Overall Study|Subject Request|1|||
16499415|NCT00498602|40302829|FG000|Overall Study|Other|2|||
16195222|NCT02662985|39193267|FG000|Treatment Period 2|Lack of Efficacy|0|||
16195223|NCT02662985|39193268|FG001|Treatment Period 2|Lack of Efficacy|1|||
16195224|NCT02662985|39193267|FG000|Treatment Period 2|Lost to Follow-up|1|||
16195225|NCT02662985|39193268|FG001|Treatment Period 2|Lost to Follow-up|0|||
16195226|NCT02662985|39193267|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
16195227|NCT02662985|39193268|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
16195228|NCT02662985|39193267|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
16195229|NCT02662985|39193268|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
16195230|NCT02662985|39193267|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
16195231|NCT02662985|39193268|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
16195232|NCT02662985|39193267|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
16195233|NCT02662985|39193268|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
16195234|NCT02662985|39193267|FG000|Treatment Period 3 (Extension Period)|Death|0|||
16195235|NCT02662985|39193268|FG001|Treatment Period 3 (Extension Period)|Death|1|||
16195236|NCT04587453|39193269|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
16195237|NCT04587453|39193270|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
16195238|NCT01361919|39193277|FG000|Overall Study|technical issues|10|||
16195239|NCT01361919|39193278|FG001|Overall Study|technical issues|12|||
16195240|NCT01361919|39193279|FG002|Overall Study|technical issues|10|||
16195241|NCT02358369|39193280|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
16195242|NCT02358369|39193281|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
16195243|NCT02358369|39193282|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
16195244|NCT02358369|39193283|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
16195245|NCT02358369|39193284|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
16195246|NCT02358369|39193280|FG000|Treatment Period A/B|Adverse Event|0|||
16195247|NCT02358369|39193281|FG001|Treatment Period A/B|Adverse Event|0|||
16195248|NCT02358369|39193282|FG002|Treatment Period A/B|Adverse Event|1|||
16195249|NCT02358369|39193283|FG003|Treatment Period A/B|Adverse Event|2|||
16309556|NCT01130532|39619042|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
16499416|NCT00498602|40302830|FG001|Overall Study|Other|3|||
16499417|NCT00498602|40302831|FG002|Overall Study|Other|1|||
16499418|NCT00498602|40302832|FG003|Overall Study|Other|0|||
16499419|NCT00498602|40302833|FG004|Overall Study|Other|0|||
16499420|NCT00498602|40302834|FG005|Overall Study|Other|3|||
16499421|NCT00498602|40302835|FG006|Overall Study|Other|0|||
16499422|NCT00518986|40302836|FG000|Overall Study|Adverse Event|12|||
16499423|NCT00518986|40302837|FG001|Overall Study|Adverse Event|7|||
16499424|NCT00518986|40302836|FG000|Overall Study|Lack of Efficacy|0|||
16499425|NCT00518986|40302837|FG001|Overall Study|Lack of Efficacy|2|||
16499426|NCT00518986|40302836|FG000|Overall Study|Lost to Follow-up|3|||
16499427|NCT00518986|40302837|FG001|Overall Study|Lost to Follow-up|2|||
16499428|NCT00518986|40302836|FG000|Overall Study|Physician Decision|0|||
16499429|NCT00518986|40302837|FG001|Overall Study|Physician Decision|3|||
16499430|NCT00518986|40302836|FG000|Overall Study|Protocol Violation|5|||
16499431|NCT00518986|40302837|FG001|Overall Study|Protocol Violation|7|||
16499432|NCT00518986|40302836|FG000|Overall Study|Withdrawal by Subject|4|||
16499433|NCT00518986|40302837|FG001|Overall Study|Withdrawal by Subject|4|||
16499434|NCT00518986|40302836|FG000|Overall Study|Non-Specific|2|||
16499435|NCT00518986|40302837|FG001|Overall Study|Non-Specific|1|||
16499436|NCT00665847|40302839|FG000|Overall Study|Adverse Event|8|||
16499437|NCT00665847|40302839|FG000|Overall Study|Withdrawal by Subject|2|||
16499438|NCT00665847|40302839|FG000|Overall Study|Subject non-compliant|8|||
16499439|NCT00665847|40302839|FG000|Overall Study|Subject reached a virologic endpoint|4|||
16499440|NCT00665847|40302839|FG000|Overall Study|Resistance to TMC125|1|||
16499441|NCT00665847|40302839|FG000|Overall Study|Subject ineligible to continue the trial|1|||
16499442|NCT00665847|40302839|FG000|Overall Study|Switch to Commercial Medication|1|||
16499443|NCT00469092|40302843|FG000|Overall Study|Adverse Event|5|||
16499444|NCT00469092|40302844|FG001|Overall Study|Adverse Event|4|||
16499445|NCT00469092|40302843|FG000|Overall Study|Lack of Efficacy|1|||
16499446|NCT00469092|40302844|FG001|Overall Study|Lack of Efficacy|0|||
16499447|NCT00469092|40302843|FG000|Overall Study|Lost to Follow-up|1|||
16499448|NCT00469092|40302844|FG001|Overall Study|Lost to Follow-up|2|||
16499449|NCT00469092|40302843|FG000|Overall Study|Protocol Violation|3|||
16499450|NCT00469092|40302844|FG001|Overall Study|Protocol Violation|3|||
16309557|NCT01130532|39619043|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
16309558|NCT01130532|39619044|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
16499451|NCT00469092|40302843|FG000|Overall Study|Withdrawal by Subject|4|||
16499452|NCT00469092|40302844|FG001|Overall Study|Withdrawal by Subject|4|||
16499453|NCT00469092|40302843|FG000|Overall Study|Withdrawal Criteria|3|||
16499454|NCT00469092|40302844|FG001|Overall Study|Withdrawal Criteria|4|||
16499455|NCT00469092|40302843|FG000|Overall Study|Incorrectly Randomised|4|||
16309559|NCT01130532|39619045|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
16499456|NCT00469092|40302844|FG001|Overall Study|Incorrectly Randomised|3|||
16499457|NCT00469092|40302843|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
16309560|NCT01130532|39619042|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
16309561|NCT01130532|39619043|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
16499458|NCT00469092|40302844|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
16499459|NCT00469092|40302843|FG000|Overall Study|Use of lipid lowering drug|1|||
16499460|NCT00469092|40302844|FG001|Overall Study|Use of lipid lowering drug|0|||
16499461|NCT00469092|40302843|FG000|Overall Study|Hypoglycaemic Episodes|1|||
16499462|NCT00469092|40302844|FG001|Overall Study|Hypoglycaemic Episodes|1|||
16499463|NCT00469092|40302843|FG000|Overall Study|Abnormal lab value|1|||
16499464|NCT00469092|40302844|FG001|Overall Study|Abnormal lab value|0|||
16499465|NCT00469092|40302843|FG000|Overall Study|Use of Corticosteroid|1|||
16499466|NCT00469092|40302844|FG001|Overall Study|Use of Corticosteroid|0|||
16499467|NCT02998840|40302845|FG000|Overall Study|Lost to Follow-up|1|||
16309562|NCT01130532|39619044|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
16309563|NCT01130532|39619045|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
16499468|NCT02998840|40302846|FG001|Overall Study|Lost to Follow-up|1|||
16499469|NCT02998840|40302847|FG002|Overall Study|Lost to Follow-up|2|||
16499470|NCT02998840|40302848|FG003|Overall Study|Lost to Follow-up|3|||
16499471|NCT02998840|40302845|FG000|Overall Study|Withdrawal by Subject|1|||
16499472|NCT02998840|40302846|FG001|Overall Study|Withdrawal by Subject|1|||
16499473|NCT02998840|40302847|FG002|Overall Study|Withdrawal by Subject|0|||
16499474|NCT02998840|40302848|FG003|Overall Study|Withdrawal by Subject|1|||
16499475|NCT02998840|40302845|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
16499476|NCT02998840|40302846|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
16499477|NCT02998840|40302847|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
16499478|NCT02998840|40302848|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
16499479|NCT00232817|40302850|FG000|Overall Study|Protocol Violation|2|||
16499480|NCT00232817|40302851|FG001|Overall Study|Protocol Violation|1|||
16499481|NCT03261947|40302856|FG000|Overall Study|Death|10|||
16309564|NCT01130532|39619042|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
16499482|NCT03261947|40302857|FG001|Overall Study|Death|13|||
16309565|NCT01130532|39619043|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
16309566|NCT01130532|39619044|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
16309567|NCT01130532|39619045|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
16309568|NCT01130532|39619042|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
16309569|NCT01130532|39619043|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
16309570|NCT01130532|39619044|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
16309571|NCT01130532|39619045|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
16309572|NCT01130532|39619042|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
16309573|NCT01130532|39619043|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
16309574|NCT01130532|39619044|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
16309575|NCT01130532|39619045|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
16309576|NCT01130532|39619042|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
16309577|NCT01130532|39619043|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
16309578|NCT01130532|39619044|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
16309579|NCT01130532|39619045|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
16309580|NCT00214383|39619048|FG000|Overall Study|Lost to Follow-up|16|||
16309581|NCT00214383|39619049|FG001|Overall Study|Lost to Follow-up|26|||
16309582|NCT02857816|39619050|FG000|Overall Study|Screen Failure|33|||
16309583|NCT02857816|39619050|FG000|Overall Study|Withdrawal by Subject|4|||
16309584|NCT02857816|39619050|FG000|Overall Study|Lost to Follow-up|1|||
16309585|NCT00261443|39619051|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
16309586|NCT00261443|39619052|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
16309587|NCT00261443|39619053|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
16309588|NCT00261443|39619051|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
16309589|NCT00261443|39619052|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
16309590|NCT00261443|39619053|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
16309591|NCT00261443|39619051|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
16309592|NCT00261443|39619052|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
16309593|NCT00261443|39619053|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
16309594|NCT00261443|39619051|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
16309595|NCT00261443|39619052|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
16309596|NCT00261443|39619053|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
16309597|NCT00261443|39619051|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
16309598|NCT00261443|39619052|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
16309599|NCT00261443|39619053|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
16309600|NCT00261443|39619051|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
16309601|NCT00261443|39619052|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
16499483|NCT03261947|40302858|FG002|Overall Study|Death|17|||
16499484|NCT03261947|40302859|FG003|Overall Study|Death|12|||
16499485|NCT03261947|40302860|FG004|Overall Study|Death|8|||
16499486|NCT03261947|40302856|FG000|Overall Study|Lost to Follow-up|0|||
16309602|NCT00261443|39619053|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
16309603|NCT00261443|39619051|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
16309604|NCT00261443|39619052|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
16309605|NCT00261443|39619053|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
16309606|NCT00261443|39619051|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
16309607|NCT00261443|39619052|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
16309608|NCT00261443|39619053|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
16309609|NCT00261443|39619051|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
16309610|NCT00261443|39619052|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
16309611|NCT00261443|39619053|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
16309612|NCT00261443|39619051|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
16309613|NCT00261443|39619052|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
16309614|NCT00261443|39619053|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
16309615|NCT00261443|39619051|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
16309616|NCT00261443|39619052|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
16309617|NCT00261443|39619053|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
16499487|NCT03261947|40302857|FG001|Overall Study|Lost to Follow-up|0|||
16499488|NCT03261947|40302858|FG002|Overall Study|Lost to Follow-up|2|||
16499489|NCT03261947|40302859|FG003|Overall Study|Lost to Follow-up|1|||
16499490|NCT03261947|40302860|FG004|Overall Study|Lost to Follow-up|0|||
16499491|NCT03261947|40302856|FG000|Overall Study|Withdrawal by Subject|0|||
16499492|NCT03261947|40302857|FG001|Overall Study|Withdrawal by Subject|0|||
16499493|NCT03261947|40302858|FG002|Overall Study|Withdrawal by Subject|3|||
16499494|NCT03261947|40302859|FG003|Overall Study|Withdrawal by Subject|0|||
16499495|NCT03261947|40302860|FG004|Overall Study|Withdrawal by Subject|1|||
16499496|NCT03261947|40302856|FG000|Overall Study|Site Terminated by Sponsor|0|||
16499497|NCT03261947|40302857|FG001|Overall Study|Site Terminated by Sponsor|0|||
16499498|NCT03261947|40302858|FG002|Overall Study|Site Terminated by Sponsor|4|||
16499499|NCT03261947|40302859|FG003|Overall Study|Site Terminated by Sponsor|7|||
16499500|NCT03261947|40302860|FG004|Overall Study|Site Terminated by Sponsor|5|||
16499501|NCT03261947|40302856|FG000|Overall Study|Reason not Specified|2|||
16499502|NCT03261947|40302857|FG001|Overall Study|Reason not Specified|0|||
16499503|NCT03261947|40302858|FG002|Overall Study|Reason not Specified|4|||
16499504|NCT03261947|40302859|FG003|Overall Study|Reason not Specified|1|||
16499505|NCT03261947|40302860|FG004|Overall Study|Reason not Specified|3|||
16499506|NCT00616655|40302861|FG000|Overall Study|Adverse Event|10|||
16499507|NCT00616655|40302862|FG001|Overall Study|Adverse Event|7|||
16499508|NCT00616655|40302863|FG002|Overall Study|Adverse Event|12|||
16499509|NCT00616655|40302861|FG000|Overall Study|Lack of Efficacy|5|||
16499510|NCT00616655|40302862|FG001|Overall Study|Lack of Efficacy|5|||
16499511|NCT00616655|40302863|FG002|Overall Study|Lack of Efficacy|5|||
16499512|NCT00616655|40302861|FG000|Overall Study|Lost to Follow-up|3|||
16499513|NCT00616655|40302862|FG001|Overall Study|Lost to Follow-up|12|||
16499514|NCT00616655|40302863|FG002|Overall Study|Lost to Follow-up|10|||
16499515|NCT00616655|40302861|FG000|Overall Study|Protocol Violation|2|||
16309618|NCT00261443|39619051|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
16499516|NCT00616655|40302862|FG001|Overall Study|Protocol Violation|4|||
16499517|NCT00616655|40302863|FG002|Overall Study|Protocol Violation|3|||
16499518|NCT00616655|40302861|FG000|Overall Study|Withdrawal by Subject|9|||
16499519|NCT00616655|40302862|FG001|Overall Study|Withdrawal by Subject|7|||
16309619|NCT00261443|39619052|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
16309620|NCT00261443|39619053|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
16309621|NCT00261443|39619051|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
16499520|NCT00616655|40302863|FG002|Overall Study|Withdrawal by Subject|11|||
16499521|NCT00616655|40302861|FG000|Overall Study|Does not meet in/ex criteria|0|||
16309622|NCT00261443|39619052|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
16309623|NCT00261443|39619053|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
16309624|NCT00261443|39619051|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
16309625|NCT00261443|39619052|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
16309626|NCT00261443|39619053|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
16309627|NCT00261443|39619051|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
16309628|NCT00261443|39619052|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
16309629|NCT00261443|39619053|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
16389408|NCT00200967|39908649|FG000|Wash-out Period|Lost to Follow-up|0|||
16499522|NCT00616655|40302862|FG001|Overall Study|Does not meet in/ex criteria|0|||
16499523|NCT00616655|40302863|FG002|Overall Study|Does not meet in/ex criteria|2|||
16499524|NCT00616655|40302861|FG000|Overall Study|Other|6|||
16499525|NCT00616655|40302862|FG001|Overall Study|Other|6|||
16499526|NCT00616655|40302863|FG002|Overall Study|Other|5|||
16499527|NCT00391274|40302864|FG000|Overall Study|Death Due to Study Disease|55|||
16499528|NCT00391274|40302865|FG001|Overall Study|Death Due to Study Disease|45|||
16499529|NCT00391274|40302864|FG000|Overall Study|Lost to Follow-up|0|||
16309630|NCT00261443|39619051|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
16309631|NCT00261443|39619052|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
16309632|NCT00261443|39619053|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
16309633|NCT00261443|39619051|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
16309634|NCT00261443|39619052|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
16309635|NCT00261443|39619053|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
16309636|NCT00261443|39619051|FG000|3: Assessment of Relapse|Adverse Event|0|||
16309637|NCT00261443|39619052|FG001|3: Assessment of Relapse|Adverse Event|15|||
16309638|NCT00261443|39619053|FG002|3: Assessment of Relapse|Adverse Event|19|||
16309639|NCT00261443|39619051|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
16309640|NCT00261443|39619052|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
16309641|NCT00261443|39619053|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
16309642|NCT00261443|39619051|FG000|3: Assessment of Relapse|Death|0|||
16309643|NCT00261443|39619052|FG001|3: Assessment of Relapse|Death|0|||
16309644|NCT00261443|39619053|FG002|3: Assessment of Relapse|Death|1|||
16309645|NCT00261443|39619051|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
16309646|NCT00261443|39619052|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
16309647|NCT00261443|39619053|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
16309648|NCT00261443|39619051|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
16309649|NCT00261443|39619052|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
16309650|NCT00261443|39619053|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
16309651|NCT00261443|39619051|FG000|3: Assessment of Relapse|Pregnancy|0|||
16309652|NCT00261443|39619052|FG001|3: Assessment of Relapse|Pregnancy|2|||
16309653|NCT00261443|39619053|FG002|3: Assessment of Relapse|Pregnancy|1|||
16309654|NCT00261443|39619051|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
16499530|NCT00391274|40302865|FG001|Overall Study|Lost to Follow-up|3|||
16499531|NCT00391274|40302864|FG000|Overall Study|Physician Decision|4|||
16309655|NCT00261443|39619052|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
16309656|NCT00261443|39619053|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
16309657|NCT00261443|39619051|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
16309658|NCT00261443|39619052|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
16499532|NCT00391274|40302865|FG001|Overall Study|Physician Decision|2|||
16309659|NCT00261443|39619053|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
16309660|NCT00261443|39619051|FG000|3: Assessment of Relapse|Other Reasons|0|||
16309661|NCT00261443|39619052|FG001|3: Assessment of Relapse|Other Reasons|4|||
16309662|NCT00261443|39619053|FG002|3: Assessment of Relapse|Other Reasons|3|||
16309663|NCT00261443|39619051|FG000|4: Extension Phase|Adverse Event|0|||
16309664|NCT00261443|39619052|FG001|4: Extension Phase|Adverse Event|1|||
16309665|NCT00261443|39619053|FG002|4: Extension Phase|Adverse Event|0|||
16309666|NCT00261443|39619051|FG000|4: Extension Phase|Withdrawal by Subject|0|||
16309667|NCT00261443|39619052|FG001|4: Extension Phase|Withdrawal by Subject|1|||
16309668|NCT00261443|39619053|FG002|4: Extension Phase|Withdrawal by Subject|2|||
16309669|NCT00261443|39619051|FG000|4: Extension Phase|Lost to Follow-up|0|||
16309670|NCT00261443|39619052|FG001|4: Extension Phase|Lost to Follow-up|1|||
16309671|NCT00261443|39619053|FG002|4: Extension Phase|Lost to Follow-up|0|||
16309672|NCT01569295|39619057|FG000|Overall Study|Progressive Disease|75|||
16309673|NCT01569295|39619058|FG001|Overall Study|Progressive Disease|139|||
16309674|NCT01569295|39619057|FG000|Overall Study|Adverse Event|39|||
16499533|NCT00391274|40302864|FG000|Overall Study|Withdrawal by Subject|0|||
16499534|NCT00391274|40302865|FG001|Overall Study|Withdrawal by Subject|3|||
16499535|NCT00391274|40302864|FG000|Overall Study|Death Due to Adverse Event|1|||
16499536|NCT00391274|40302865|FG001|Overall Study|Death Due to Adverse Event|3|||
16499537|NCT00391274|40302864|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
16499538|NCT00391274|40302865|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
16309675|NCT01569295|39619058|FG001|Overall Study|Adverse Event|14|||
16309676|NCT01569295|39619057|FG000|Overall Study|Withdrawal by Subject|25|||
16499539|NCT00391274|40302864|FG000|Overall Study|Death Not Study Related|0|||
16499540|NCT00391274|40302865|FG001|Overall Study|Death Not Study Related|1|||
16499541|NCT01963403|40302866|FG000|Overall Study|Lost to Follow-up|2|||
16499542|NCT01963403|40302867|FG001|Overall Study|Lost to Follow-up|3|||
16499543|NCT01963403|40302866|FG000|Overall Study|Implant removal|0|||
16499544|NCT01963403|40302867|FG001|Overall Study|Implant removal|1|||
16499545|NCT02150954|40302868|FG000|Overall Study|Protocol Violation|1|||
16087799|NCT03205488|38813680|FG002|Overall Study|Adverse Event|4|||
16309677|NCT01569295|39619058|FG001|Overall Study|Withdrawal by Subject|12|||
16309678|NCT01569295|39619057|FG000|Overall Study|Death|19|||
16499546|NCT02150954|40302869|FG001|Overall Study|Protocol Violation|0|||
16499547|NCT00993291|40302872|FG000|Overall Study|Withdrawal by Subject|1|||
16499548|NCT01946425|40302873|FG000|Overall Study|Protocol Violation|1|||
16499549|NCT01946425|40302874|FG001|Overall Study|Protocol Violation|0|||
16499550|NCT01946425|40302873|FG000|Overall Study|Withdrawal by Subject|1|||
16499551|NCT01946425|40302874|FG001|Overall Study|Withdrawal by Subject|0|||
16499552|NCT01408030|40302875|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
16499553|NCT01408030|40302876|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
16309679|NCT01569295|39619058|FG001|Overall Study|Death|15|||
16499554|NCT01408030|40302877|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
16087800|NCT03205488|38813678|FG000|Overall Study|Protocol Violation|0|||
16087801|NCT03205488|38813679|FG001|Overall Study|Protocol Violation|0|||
16309680|NCT01569295|39619057|FG000|Overall Study|Physician Decision|13|||
16309681|NCT01569295|39619058|FG001|Overall Study|Physician Decision|18|||
16499555|NCT01408030|40302878|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
16087802|NCT03205488|38813680|FG002|Overall Study|Protocol Violation|1|||
16087803|NCT02874534|38813686|FG000|Overall Study|Withdrawal by Subject|5|||
16087804|NCT02874534|38813687|FG001|Overall Study|Withdrawal by Subject|8|||
16087805|NCT02874534|38813686|FG000|Overall Study|Lost to Follow-up|2|||
16087806|NCT02874534|38813687|FG001|Overall Study|Lost to Follow-up|2|||
16087807|NCT02874534|38813686|FG000|Overall Study|Ongoing in study|1|||
16087808|NCT02874534|38813687|FG001|Overall Study|Ongoing in study|1|||
16087809|NCT03379259|38813692|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
16087810|NCT03379259|38813693|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
16087811|NCT03379259|38813694|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
16087812|NCT03379259|38813695|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
16087813|NCT03379259|38813696|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
16087814|NCT03379259|38813697|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
16087815|NCT03379259|38813692|FG000|Overall Study|Death|0|||
16087816|NCT03379259|38813693|FG001|Overall Study|Death|1|||
16087817|NCT03379259|38813694|FG002|Overall Study|Death|2|||
16087818|NCT03379259|38813695|FG003|Overall Study|Death|1|||
16087819|NCT03379259|38813696|FG004|Overall Study|Death|4|||
16087820|NCT03379259|38813697|FG005|Overall Study|Death|2|||
16087821|NCT03379259|38813692|FG000|Overall Study|Withdrawal by Subject|0|||
16087822|NCT03379259|38813693|FG001|Overall Study|Withdrawal by Subject|0|||
16087823|NCT03379259|38813694|FG002|Overall Study|Withdrawal by Subject|1|||
16087824|NCT03379259|38813695|FG003|Overall Study|Withdrawal by Subject|0|||
16087825|NCT03379259|38813696|FG004|Overall Study|Withdrawal by Subject|2|||
16087826|NCT03379259|38813697|FG005|Overall Study|Withdrawal by Subject|0|||
16087827|NCT03379259|38813692|FG000|Overall Study|Study terminated by sponsor|0|||
16087828|NCT03379259|38813693|FG001|Overall Study|Study terminated by sponsor|0|||
16087829|NCT03379259|38813694|FG002|Overall Study|Study terminated by sponsor|0|||
16087830|NCT03379259|38813695|FG003|Overall Study|Study terminated by sponsor|1|||
16087831|NCT03379259|38813696|FG004|Overall Study|Study terminated by sponsor|1|||
16087832|NCT03379259|38813697|FG005|Overall Study|Study terminated by sponsor|4|||
16087833|NCT03379259|38813692|FG000|Overall Study|Disease progression|0|||
16087834|NCT03379259|38813693|FG001|Overall Study|Disease progression|0|||
16087835|NCT03379259|38813694|FG002|Overall Study|Disease progression|0|||
16087836|NCT03379259|38813695|FG003|Overall Study|Disease progression|1|||
16087837|NCT03379259|38813696|FG004|Overall Study|Disease progression|0|||
16087838|NCT03379259|38813697|FG005|Overall Study|Disease progression|1|||
16087839|NCT03379259|38813692|FG000|Overall Study|Lost to Follow-up|0|||
16087840|NCT03379259|38813693|FG001|Overall Study|Lost to Follow-up|0|||
16087841|NCT03379259|38813694|FG002|Overall Study|Lost to Follow-up|0|||
16087842|NCT03379259|38813695|FG003|Overall Study|Lost to Follow-up|0|||
16087843|NCT03379259|38813696|FG004|Overall Study|Lost to Follow-up|1|||
16087844|NCT03379259|38813697|FG005|Overall Study|Lost to Follow-up|0|||
16087845|NCT03379259|38813692|FG000|Overall Study|Deteriorating condition|0|||
16087846|NCT03379259|38813693|FG001|Overall Study|Deteriorating condition|0|||
16087847|NCT03379259|38813694|FG002|Overall Study|Deteriorating condition|0|||
16087848|NCT03379259|38813695|FG003|Overall Study|Deteriorating condition|0|||
16087849|NCT03379259|38813696|FG004|Overall Study|Deteriorating condition|1|||
16087850|NCT03379259|38813697|FG005|Overall Study|Deteriorating condition|0|||
16087851|NCT01240590|38813701|FG000|Phase I|Refused further treatment|0|||
16087852|NCT01240590|38813702|FG001|Phase I|Refused further treatment|0|||
16499556|NCT01408030|40302875|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
16087853|NCT01240590|38813703|FG002|Phase I|Refused further treatment|3|||
16087854|NCT01240590|38813704|FG003|Phase I|Refused further treatment|0|||
16087855|NCT01240590|38813705|FG004|Phase I|Refused further treatment|0|||
16087856|NCT01240590|38813701|FG000|Phase II|Refused further treatment|0|||
16087857|NCT01240590|38813702|FG001|Phase II|Refused further treatment|0|||
16087858|NCT01240590|38813703|FG002|Phase II|Refused further treatment|0|||
16087859|NCT01240590|38813704|FG003|Phase II|Refused further treatment|2|||
16499557|NCT01408030|40302876|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
16546315|NCT02237508|40464779|FG006|Overall Study|Physician Decision|0|||
16087860|NCT01240590|38813705|FG004|Phase II|Refused further treatment|1|||
16087861|NCT03026166|38813708|FG000|Overall Study|Death|22|||
16309682|NCT01569295|39619057|FG000|Overall Study|Study Terminated by Sponsor|24|||
16309683|NCT01569295|39619058|FG001|Overall Study|Study Terminated by Sponsor|2|||
16309684|NCT01569295|39619057|FG000|Overall Study|Other Reason not Specified|3|||
16499558|NCT01408030|40302877|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
16499559|NCT01408030|40302878|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
16499560|NCT01408030|40302875|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
16499561|NCT01408030|40302876|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
16499562|NCT01408030|40302877|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
16499563|NCT01408030|40302878|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
16499564|NCT01408030|40302875|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
16499565|NCT01408030|40302876|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
16499566|NCT01408030|40302877|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
16499567|NCT01408030|40302878|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
16499568|NCT01408030|40302875|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
16499569|NCT01408030|40302876|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
16499570|NCT01408030|40302877|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
16499571|NCT01408030|40302878|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
16499572|NCT01408030|40302875|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
16499573|NCT01408030|40302876|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
16499574|NCT01408030|40302877|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
16499575|NCT01408030|40302878|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
16499576|NCT01408030|40302875|FG000|Observation Phase (Off Drug)|Other|1|||
16499577|NCT01408030|40302876|FG001|Observation Phase (Off Drug)|Other|1|||
16499578|NCT01408030|40302877|FG002|Observation Phase (Off Drug)|Other|1|||
16499579|NCT01408030|40302878|FG003|Observation Phase (Off Drug)|Other|1|||
16309685|NCT01569295|39619058|FG001|Overall Study|Other Reason not Specified|5|||
16309686|NCT01569295|39619057|FG000|Overall Study|Non-Compliance with Study Drug|6|||
16309687|NCT01569295|39619058|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16309688|NCT01569295|39619057|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
16499580|NCT00271609|40302879|FG000|Overall Study|Adverse Event|11|||
16309689|NCT01569295|39619058|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
16309690|NCT01569295|39619057|FG000|Overall Study|Lost to Follow-up|1|||
16309691|NCT01569295|39619058|FG001|Overall Study|Lost to Follow-up|1|||
16309692|NCT03170362|39619059|FG000|Overall Study|Death|2|||
16309693|NCT03170362|39619060|FG001|Overall Study|Death|2|||
16309694|NCT03170362|39619059|FG000|Overall Study|Withdrawal by Subject|23|||
16309695|NCT03170362|39619060|FG001|Overall Study|Withdrawal by Subject|22|||
16087862|NCT03026166|38813709|FG001|Overall Study|Death|7|||
16087863|NCT03026166|38813708|FG000|Overall Study|Physician Decision|2|||
16309696|NCT03170362|39619059|FG000|Overall Study|Lost to Follow-up|187|||
16309697|NCT03170362|39619060|FG001|Overall Study|Lost to Follow-up|167|||
16309698|NCT04054765|39619064|FG000|Baseline|Withdrawal by Subject|5|||
16309699|NCT04054765|39619065|FG001|Baseline|Withdrawal by Subject|3|||
16309700|NCT04054765|39619064|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
16499581|NCT00271609|40302880|FG001|Overall Study|Adverse Event|3|||
16499582|NCT00271609|40302879|FG000|Overall Study|Withdrawal by Subject|2|||
16499583|NCT00271609|40302880|FG001|Overall Study|Withdrawal by Subject|0|||
16499584|NCT00422591|40302881|FG000|Overall Study|Physician Decision|4|||
16499585|NCT00422591|40302881|FG000|Overall Study|Withdrawal by Subject|2|||
16499586|NCT02904512|40302882|FG000|Overall Study|Withdrawal by Subject|1|||
16499587|NCT02904512|40302883|FG001|Overall Study|Withdrawal by Subject|0|||
16499588|NCT02904512|40302882|FG000|Overall Study|Transferred to ICU|1|||
16499589|NCT02904512|40302883|FG001|Overall Study|Transferred to ICU|0|||
16499590|NCT02904512|40302882|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
16499591|NCT02904512|40302883|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
16499592|NCT03303079|40302884|FG000|Overall Study|Adverse Event|0|||
16499593|NCT03303079|40302885|FG001|Overall Study|Adverse Event|1|||
16499594|NCT03303079|40302886|FG002|Overall Study|Adverse Event|3|||
16499595|NCT03303079|40302884|FG000|Overall Study|Protocol Violation|5|||
16499596|NCT03303079|40302885|FG001|Overall Study|Protocol Violation|4|||
16499597|NCT03303079|40302886|FG002|Overall Study|Protocol Violation|7|||
16499598|NCT03303079|40302884|FG000|Overall Study|Withdrawal by Subject|2|||
16499599|NCT03303079|40302885|FG001|Overall Study|Withdrawal by Subject|4|||
16499600|NCT03303079|40302886|FG002|Overall Study|Withdrawal by Subject|2|||
16499601|NCT03303079|40302884|FG000|Overall Study|Other than specified|0|||
16499602|NCT03303079|40302885|FG001|Overall Study|Other than specified|2|||
16499603|NCT03303079|40302886|FG002|Overall Study|Other than specified|0|||
16087864|NCT03026166|38813709|FG001|Overall Study|Physician Decision|0|||
16087865|NCT03026166|38813708|FG000|Overall Study|Withdrawal by Subject|1|||
16087866|NCT03026166|38813709|FG001|Overall Study|Withdrawal by Subject|2|||
16309701|NCT04054765|39619065|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
16499604|NCT02946047|40302889|FG000|Overall Study|Adverse Event|1|||
16499605|NCT02946047|40302890|FG001|Overall Study|Adverse Event|0|||
16499606|NCT02946047|40302891|FG002|Overall Study|Adverse Event|0|||
16499607|NCT02946047|40302892|FG003|Overall Study|Adverse Event|0|||
16499608|NCT05620563|40302896|FG000|Overall Study|Adverse Event|3|||
16499609|NCT05620563|40302897|FG001|Overall Study|Adverse Event|1|||
16499610|NCT05620563|40302896|FG000|Overall Study|Lost to Follow-up|0|||
16309702|NCT04054765|39619064|FG000|3-month Follow up|Withdrawal by Subject|0|||
16309703|NCT04054765|39619065|FG001|3-month Follow up|Withdrawal by Subject|3|||
16309704|NCT04054765|39619064|FG000|6-month Follow up|Lost to Follow-up|32|||
16309705|NCT04054765|39619065|FG001|6-month Follow up|Lost to Follow-up|32|||
16309706|NCT02601014|39619066|FG000|Overall Study|Adverse Event|3|||
16309707|NCT02601014|39619067|FG001|Overall Study|Adverse Event|3|||
16499611|NCT05620563|40302897|FG001|Overall Study|Lost to Follow-up|2|||
16499612|NCT05620563|40302896|FG000|Overall Study|Protocol Deviation|1|||
16499613|NCT05620563|40302897|FG001|Overall Study|Protocol Deviation|2|||
16499614|NCT05620563|40302896|FG000|Overall Study|Withdrawal by Subject|3|||
16499615|NCT05620563|40302897|FG001|Overall Study|Withdrawal by Subject|3|||
16499616|NCT05620563|40302896|FG000|Overall Study|Physician Decision|0|||
16499617|NCT05620563|40302897|FG001|Overall Study|Physician Decision|1|||
16499618|NCT04741074|40302898|FG000|Overall Study|Withdrawal by Subject|1|||
16499619|NCT04741074|40302899|FG001|Overall Study|Withdrawal by Subject|1|||
16499620|NCT04741074|40302898|FG000|Overall Study|Study terminated prematurely|1|||
16499621|NCT04741074|40302899|FG001|Overall Study|Study terminated prematurely|0|||
16499622|NCT02153112|40302900|FG000|Overall Study|Adverse Event|0|||
16499623|NCT02153112|40302901|FG001|Overall Study|Adverse Event|0|||
16499624|NCT02153112|40302902|FG002|Overall Study|Adverse Event|1|||
16499625|NCT02153112|40302903|FG003|Overall Study|Adverse Event|0|||
16499626|NCT02153112|40302904|FG004|Overall Study|Adverse Event|0|||
16499627|NCT02153112|40302905|FG005|Overall Study|Adverse Event|0|||
16499628|NCT02153112|40302906|FG006|Overall Study|Adverse Event|0|||
16499629|NCT02153112|40302907|FG007|Overall Study|Adverse Event|0|||
16499630|NCT02153112|40302908|FG008|Overall Study|Adverse Event|0|||
16309708|NCT02601014|39619066|FG000|Overall Study|Death|3|||
16309709|NCT02601014|39619067|FG001|Overall Study|Death|1|||
16309710|NCT02601014|39619066|FG000|Overall Study|Disease progression|4|||
16309711|NCT02601014|39619067|FG001|Overall Study|Disease progression|8|||
16309712|NCT02854527|39619068|FG000|Overall Study|Adverse Event|0|||
16309713|NCT02854527|39619069|FG001|Overall Study|Adverse Event|0|||
16309714|NCT02854527|39619070|FG002|Overall Study|Adverse Event|0|||
16309715|NCT02854527|39619071|FG003|Overall Study|Adverse Event|0|||
16309716|NCT02854527|39619072|FG004|Overall Study|Adverse Event|1|||
16309717|NCT02854527|39619073|FG005|Overall Study|Adverse Event|0|||
16309718|NCT02854527|39619074|FG006|Overall Study|Adverse Event|0|||
16309719|NCT02854527|39619075|FG007|Overall Study|Adverse Event|0|||
16309720|NCT02854527|39619076|FG008|Overall Study|Adverse Event|0|||
16309721|NCT02854527|39619077|FG009|Overall Study|Adverse Event|0|||
16309722|NCT02854527|39619068|FG000|Overall Study|Lost to Follow-up|0|||
16309723|NCT02854527|39619069|FG001|Overall Study|Lost to Follow-up|0|||
16499631|NCT02153112|40302909|FG009|Overall Study|Adverse Event|0|||
16499632|NCT02153112|40302900|FG000|Overall Study|Lost to Follow-up|1|||
16499633|NCT02153112|40302901|FG001|Overall Study|Lost to Follow-up|1|||
16499634|NCT02153112|40302902|FG002|Overall Study|Lost to Follow-up|0|||
16499635|NCT02153112|40302903|FG003|Overall Study|Lost to Follow-up|0|||
16499636|NCT02153112|40302904|FG004|Overall Study|Lost to Follow-up|2|||
16499637|NCT02153112|40302905|FG005|Overall Study|Lost to Follow-up|1|||
16499638|NCT02153112|40302906|FG006|Overall Study|Lost to Follow-up|1|||
16499639|NCT02153112|40302907|FG007|Overall Study|Lost to Follow-up|0|||
16499640|NCT02153112|40302908|FG008|Overall Study|Lost to Follow-up|1|||
16499641|NCT02153112|40302909|FG009|Overall Study|Lost to Follow-up|1|||
16499642|NCT02153112|40302900|FG000|Overall Study|Withdrawal by Subject|3|||
16499643|NCT02153112|40302901|FG001|Overall Study|Withdrawal by Subject|1|||
16499644|NCT02153112|40302902|FG002|Overall Study|Withdrawal by Subject|2|||
16499645|NCT02153112|40302903|FG003|Overall Study|Withdrawal by Subject|2|||
16499646|NCT02153112|40302904|FG004|Overall Study|Withdrawal by Subject|1|||
16499647|NCT02153112|40302905|FG005|Overall Study|Withdrawal by Subject|1|||
16499648|NCT02153112|40302906|FG006|Overall Study|Withdrawal by Subject|7|||
16499649|NCT02153112|40302907|FG007|Overall Study|Withdrawal by Subject|2|||
16499650|NCT02153112|40302908|FG008|Overall Study|Withdrawal by Subject|13|||
16499651|NCT02153112|40302909|FG009|Overall Study|Withdrawal by Subject|12|||
16499652|NCT02153112|40302900|FG000|Overall Study|Reason not Specified|0|||
16499653|NCT02153112|40302901|FG001|Overall Study|Reason not Specified|0|||
16499654|NCT02153112|40302902|FG002|Overall Study|Reason not Specified|0|||
16309724|NCT02854527|39619070|FG002|Overall Study|Lost to Follow-up|0|||
16499655|NCT02153112|40302903|FG003|Overall Study|Reason not Specified|0|||
16499656|NCT02153112|40302904|FG004|Overall Study|Reason not Specified|0|||
16499657|NCT02153112|40302905|FG005|Overall Study|Reason not Specified|0|||
16499658|NCT02153112|40302906|FG006|Overall Study|Reason not Specified|0|||
16499659|NCT02153112|40302907|FG007|Overall Study|Reason not Specified|0|||
16499660|NCT02153112|40302908|FG008|Overall Study|Reason not Specified|1|||
16499661|NCT02153112|40302909|FG009|Overall Study|Reason not Specified|1|||
16499662|NCT03641651|40302911|FG000|Overall Study|organizational issues at one study site|1|||
16499663|NCT05014412|40302912|FG000|Overall Study|Death|11|||
16499664|NCT05014412|40302913|FG001|Overall Study|Death|7|||
16499665|NCT05014412|40302914|FG002|Overall Study|Death|4|||
16499666|NCT05014412|40302915|FG003|Overall Study|Death|7|||
16499667|NCT05014412|40302912|FG000|Overall Study|Withdrawal by Subject|1|||
16499668|NCT05014412|40302913|FG001|Overall Study|Withdrawal by Subject|1|||
16499669|NCT05014412|40302914|FG002|Overall Study|Withdrawal by Subject|1|||
16499670|NCT05014412|40302915|FG003|Overall Study|Withdrawal by Subject|2|||
16499671|NCT05014412|40302912|FG000|Overall Study|Ongoing|21|||
16499672|NCT05014412|40302913|FG001|Overall Study|Ongoing|4|||
16499673|NCT05014412|40302914|FG002|Overall Study|Ongoing|6|||
16499674|NCT05014412|40302915|FG003|Overall Study|Ongoing|20|||
16499675|NCT00511667|40302916|FG000|Overall Study|Adverse Event|1|||
16499676|NCT00511667|40302917|FG001|Overall Study|Adverse Event|0|||
16499677|NCT00511667|40302916|FG000|Overall Study|Protocol Violation|1|||
16499678|NCT00511667|40302917|FG001|Overall Study|Protocol Violation|1|||
16499679|NCT00511667|40302916|FG000|Overall Study|Withdrawal by Subject|2|||
16499680|NCT00511667|40302917|FG001|Overall Study|Withdrawal by Subject|0|||
16499681|NCT00511667|40302916|FG000|Overall Study|Site terminated|6|||
16499682|NCT00511667|40302917|FG001|Overall Study|Site terminated|1|||
16499683|NCT00511667|40302916|FG000|Overall Study|Other|2|||
16499684|NCT00511667|40302917|FG001|Overall Study|Other|1|||
16499685|NCT02036502|40302924|FG000|Part 1:Dose Determination/Escalation|Death|3|||
16499686|NCT02036502|40302925|FG001|Part 1:Dose Determination/Escalation|Death|2|||
16499687|NCT02036502|40302926|FG002|Part 1:Dose Determination/Escalation|Death|0|||
16499688|NCT02036502|40302927|FG003|Part 1:Dose Determination/Escalation|Death|0|||
16499689|NCT02036502|40302928|FG004|Part 1:Dose Determination/Escalation|Death|0|||
16499690|NCT02036502|40302929|FG005|Part 1:Dose Determination/Escalation|Death|0|||
16499691|NCT02036502|40302930|FG006|Part 1:Dose Determination/Escalation|Death|0|||
16499692|NCT02036502|40302931|FG007|Part 1:Dose Determination/Escalation|Death|0|||
16499693|NCT02036502|40302924|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
16499694|NCT02036502|40302925|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16499695|NCT02036502|40302926|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16499696|NCT02036502|40302927|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16499697|NCT02036502|40302928|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16499698|NCT02036502|40302929|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16499699|NCT02036502|40302930|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16499700|NCT02036502|40302931|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
16499701|NCT02036502|40302924|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16499702|NCT02036502|40302925|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
16499703|NCT02036502|40302926|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16087867|NCT03026166|38813708|FG000|Overall Study|Lost to Follow-up|1|||
16087868|NCT03026166|38813709|FG001|Overall Study|Lost to Follow-up|0|||
16087869|NCT03026166|38813708|FG000|Overall Study|Study Terminated by Sponsor|3|||
16087870|NCT03026166|38813709|FG001|Overall Study|Study Terminated by Sponsor|3|||
16087871|NCT03026166|38813708|FG000|Overall Study|Other|1|||
16087872|NCT03026166|38813709|FG001|Overall Study|Other|0|||
16087873|NCT05405244|38813713|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
16087874|NCT05405244|38813714|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
16087875|NCT05405244|38813713|FG000|Washout (2 Weeks)|Adverse Event|2|||
16087876|NCT05405244|38813714|FG001|Washout (2 Weeks)|Adverse Event|0|||
16499704|NCT02036502|40302927|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16499705|NCT02036502|40302928|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16499706|NCT02036502|40302929|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16499707|NCT02036502|40302930|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16499708|NCT02036502|40302931|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
16499709|NCT02036502|40302924|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
16499710|NCT02036502|40302925|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
16499711|NCT02036502|40302926|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
16087877|NCT05405244|38813713|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
16499712|NCT02036502|40302927|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
16499713|NCT02036502|40302928|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
16499714|NCT02036502|40302929|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
16499715|NCT02036502|40302930|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
16499716|NCT02036502|40302931|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
16499717|NCT02036502|40302924|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
16499718|NCT02036502|40302925|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
16499719|NCT02036502|40302926|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
16195250|NCT02358369|39193284|FG004|Treatment Period A/B|Adverse Event|0|||
16309725|NCT02854527|39619071|FG003|Overall Study|Lost to Follow-up|1|||
16499720|NCT02036502|40302927|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
16309726|NCT02854527|39619072|FG004|Overall Study|Lost to Follow-up|0|||
16499721|NCT02036502|40302928|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
16499722|NCT02036502|40302929|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
16499723|NCT02036502|40302930|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
16499724|NCT02036502|40302931|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
16087878|NCT05405244|38813714|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
16087879|NCT00071799|38813715|FG000|Overall Study|Adverse Event|19|||
16087880|NCT00071799|38813716|FG001|Overall Study|Adverse Event|10|||
16087881|NCT00071799|38813715|FG000|Overall Study|Protocol Violation|1|||
16087882|NCT00071799|38813716|FG001|Overall Study|Protocol Violation|7|||
16087883|NCT00071799|38813715|FG000|Overall Study|Lost to Follow-up|1|||
16087884|NCT00071799|38813716|FG001|Overall Study|Lost to Follow-up|1|||
16087885|NCT00071799|38813715|FG000|Overall Study|Withdrawal by Subject|15|||
16087886|NCT00071799|38813716|FG001|Overall Study|Withdrawal by Subject|37|||
16087887|NCT00071799|38813715|FG000|Overall Study|Physician Decision|0|||
16087888|NCT00071799|38813716|FG001|Overall Study|Physician Decision|2|||
16087889|NCT00071799|38813715|FG000|Overall Study|Lack of Efficacy|11|||
16087890|NCT00071799|38813716|FG001|Overall Study|Lack of Efficacy|18|||
16087891|NCT00071799|38813715|FG000|Overall Study|Disease Progression|23|||
16087892|NCT00071799|38813716|FG001|Overall Study|Disease Progression|20|||
16087893|NCT00071799|38813715|FG000|Overall Study|Different Central+Local Pathology Review|0|||
16087894|NCT00071799|38813716|FG001|Overall Study|Different Central+Local Pathology Review|1|||
16087895|NCT00071799|38813715|FG000|Overall Study|Not Documented|0|||
16087896|NCT00071799|38813716|FG001|Overall Study|Not Documented|2|||
16087897|NCT02255474|38813719|FG000|Overall Study|Lost to Follow-up|1|||
16087898|NCT02255474|38813720|FG001|Overall Study|Lost to Follow-up|1|||
16087899|NCT02255474|38813721|FG002|Overall Study|Lost to Follow-up|3|||
16087900|NCT02255474|38813719|FG000|Overall Study|Withdrawal by Subject|1|||
16087901|NCT02255474|38813720|FG001|Overall Study|Withdrawal by Subject|1|||
16087902|NCT02255474|38813721|FG002|Overall Study|Withdrawal by Subject|0|||
16087903|NCT01147471|38813722|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
16087904|NCT01147471|38813723|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
16087905|NCT01147471|38813722|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
16087906|NCT01147471|38813723|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
16087907|NCT01147471|38813722|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
16087908|NCT01147471|38813723|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
16087909|NCT01147471|38813722|FG000|3 Month Follow Up|Lost to Follow-up|1|||
16087910|NCT01147471|38813723|FG001|3 Month Follow Up|Lost to Follow-up|1|||
16087911|NCT01147471|38813722|FG000|3 Month Follow Up|Physician Decision|0|||
16087912|NCT01147471|38813723|FG001|3 Month Follow Up|Physician Decision|1|||
16087913|NCT01147471|38813722|FG000|6 Month Follow Up|Lost to Follow-up|4|||
16087914|NCT01147471|38813723|FG001|6 Month Follow Up|Lost to Follow-up|2|||
16087915|NCT00655499|38813724|FG000|Overall Study|not eligible|4|||
16087916|NCT01812759|38813725|FG000|Overall Study|Physician Decision|0|||
16087917|NCT01812759|38813726|FG001|Overall Study|Physician Decision|0|||
16087918|NCT01812759|38813727|FG002|Overall Study|Physician Decision|1|||
16087919|NCT03066609|38813728|FG000|INDUCTION|Pregnancy|0|||
16087920|NCT03066609|38813729|FG001|INDUCTION|Pregnancy|0|||
16087921|NCT03066609|38813730|FG002|INDUCTION|Pregnancy|1|||
16087922|NCT03066609|38813731|FG003|INDUCTION|Pregnancy|0|||
16087923|NCT03066609|38813728|FG000|INDUCTION|Lack of Efficacy|0|||
16087924|NCT03066609|38813729|FG001|INDUCTION|Lack of Efficacy|0|||
16309727|NCT02854527|39619073|FG005|Overall Study|Lost to Follow-up|0|||
16309728|NCT02854527|39619074|FG006|Overall Study|Lost to Follow-up|0|||
16309729|NCT02854527|39619075|FG007|Overall Study|Lost to Follow-up|0|||
16499725|NCT02036502|40302924|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16499726|NCT02036502|40302925|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16499727|NCT02036502|40302926|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
16499728|NCT02036502|40302927|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16499729|NCT02036502|40302928|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16499730|NCT02036502|40302929|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16499731|NCT02036502|40302930|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16499732|NCT02036502|40302931|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
16499733|NCT02036502|40302924|FG000|Part 2:Dose Confirmation|Death|0|||
16499734|NCT02036502|40302925|FG001|Part 2:Dose Confirmation|Death|0|||
16499735|NCT02036502|40302926|FG002|Part 2:Dose Confirmation|Death|1|||
16499736|NCT02036502|40302927|FG003|Part 2:Dose Confirmation|Death|0|||
16499737|NCT02036502|40302928|FG004|Part 2:Dose Confirmation|Death|0|||
16499738|NCT02036502|40302929|FG005|Part 2:Dose Confirmation|Death|0|||
16087925|NCT03066609|38813730|FG002|INDUCTION|Lack of Efficacy|1|||
16087926|NCT03066609|38813731|FG003|INDUCTION|Lack of Efficacy|0|||
16087927|NCT03066609|38813728|FG000|INDUCTION|Adverse Event|2|||
16087928|NCT03066609|38813729|FG001|INDUCTION|Adverse Event|2|||
16087929|NCT03066609|38813730|FG002|INDUCTION|Adverse Event|0|||
16087930|NCT03066609|38813731|FG003|INDUCTION|Adverse Event|0|||
16499739|NCT02036502|40302930|FG006|Part 2:Dose Confirmation|Death|0|||
16499740|NCT02036502|40302931|FG007|Part 2:Dose Confirmation|Death|0|||
16546316|NCT02237508|40464780|FG007|Overall Study|Physician Decision|0|||
16087931|NCT03066609|38813728|FG000|MAINTENANCE|Adverse Event|0|||
16087932|NCT03066609|38813729|FG001|MAINTENANCE|Adverse Event|0|||
16087933|NCT03066609|38813730|FG002|MAINTENANCE|Adverse Event|0|||
16087934|NCT03066609|38813731|FG003|MAINTENANCE|Adverse Event|1|||
16087935|NCT03066609|38813728|FG000|MAINTENANCE|Withdrawal by Subject|4|||
16087936|NCT03066609|38813729|FG001|MAINTENANCE|Withdrawal by Subject|2|||
16087937|NCT03066609|38813730|FG002|MAINTENANCE|Withdrawal by Subject|1|||
16087938|NCT03066609|38813731|FG003|MAINTENANCE|Withdrawal by Subject|1|||
16087939|NCT03066609|38813728|FG000|MAINTENANCE|Lost to Follow-up|0|||
16087940|NCT03066609|38813729|FG001|MAINTENANCE|Lost to Follow-up|1|||
16087941|NCT03066609|38813730|FG002|MAINTENANCE|Lost to Follow-up|1|||
16087942|NCT03066609|38813731|FG003|MAINTENANCE|Lost to Follow-up|0|||
16087943|NCT03066609|38813728|FG000|MAINTENANCE|Pregnancy|1|||
16087944|NCT03066609|38813729|FG001|MAINTENANCE|Pregnancy|0|||
16087945|NCT03066609|38813730|FG002|MAINTENANCE|Pregnancy|0|||
16087946|NCT03066609|38813731|FG003|MAINTENANCE|Pregnancy|0|||
16087947|NCT03066609|38813728|FG000|MAINTENANCE|Lack of Efficacy|2|||
16087948|NCT03066609|38813729|FG001|MAINTENANCE|Lack of Efficacy|1|||
16087949|NCT03066609|38813730|FG002|MAINTENANCE|Lack of Efficacy|0|||
16087950|NCT03066609|38813731|FG003|MAINTENANCE|Lack of Efficacy|1|||
16087951|NCT03066609|38813728|FG000|OVERALL STUDY|Adverse Event|2|||
16087952|NCT03066609|38813729|FG001|OVERALL STUDY|Adverse Event|2|||
16087953|NCT03066609|38813730|FG002|OVERALL STUDY|Adverse Event|0|||
16087954|NCT03066609|38813731|FG003|OVERALL STUDY|Adverse Event|1|||
16087955|NCT03066609|38813728|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
16087956|NCT03066609|38813729|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
16087957|NCT03066609|38813730|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
16087958|NCT03066609|38813731|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
16087959|NCT03066609|38813728|FG000|OVERALL STUDY|Lost to Follow-up|1|||
16087960|NCT03066609|38813729|FG001|OVERALL STUDY|Lost to Follow-up|1|||
16087961|NCT03066609|38813730|FG002|OVERALL STUDY|Lost to Follow-up|1|||
16087962|NCT03066609|38813731|FG003|OVERALL STUDY|Lost to Follow-up|1|||
16087963|NCT03066609|38813728|FG000|OVERALL STUDY|Pregnancy|1|||
16087964|NCT03066609|38813729|FG001|OVERALL STUDY|Pregnancy|0|||
16087965|NCT03066609|38813730|FG002|OVERALL STUDY|Pregnancy|1|||
16087966|NCT03066609|38813731|FG003|OVERALL STUDY|Pregnancy|0|||
16087967|NCT03066609|38813728|FG000|OVERALL STUDY|Lack of Efficacy|2|||
16087968|NCT03066609|38813729|FG001|OVERALL STUDY|Lack of Efficacy|1|||
16087969|NCT03066609|38813730|FG002|OVERALL STUDY|Lack of Efficacy|1|||
16087970|NCT03066609|38813731|FG003|OVERALL STUDY|Lack of Efficacy|1|||
16087971|NCT03066609|38813728|FG000|OVERALL STUDY|discontinued follow up|0|||
16499741|NCT02036502|40302924|FG000|Part 2:Dose Confirmation|Not treated|0|||
16499742|NCT02036502|40302925|FG001|Part 2:Dose Confirmation|Not treated|0|||
16499743|NCT02036502|40302926|FG002|Part 2:Dose Confirmation|Not treated|0|||
16499744|NCT02036502|40302927|FG003|Part 2:Dose Confirmation|Not treated|1|||
16499745|NCT02036502|40302928|FG004|Part 2:Dose Confirmation|Not treated|0|||
16499746|NCT02036502|40302929|FG005|Part 2:Dose Confirmation|Not treated|0|||
16499747|NCT02036502|40302930|FG006|Part 2:Dose Confirmation|Not treated|0|||
16499748|NCT02036502|40302931|FG007|Part 2:Dose Confirmation|Not treated|0|||
16499749|NCT02036502|40302924|FG000|Part 3:Dose Expansion|Adverse Event|0|||
16499750|NCT02036502|40302925|FG001|Part 3:Dose Expansion|Adverse Event|0|||
16499751|NCT02036502|40302926|FG002|Part 3:Dose Expansion|Adverse Event|0|||
16499752|NCT02036502|40302927|FG003|Part 3:Dose Expansion|Adverse Event|0|||
16499753|NCT02036502|40302928|FG004|Part 3:Dose Expansion|Adverse Event|0|||
16499754|NCT02036502|40302929|FG005|Part 3:Dose Expansion|Adverse Event|4|||
16499755|NCT02036502|40302930|FG006|Part 3:Dose Expansion|Adverse Event|0|||
16087972|NCT03066609|38813729|FG001|OVERALL STUDY|discontinued follow up|2|||
16087973|NCT03066609|38813730|FG002|OVERALL STUDY|discontinued follow up|0|||
16087974|NCT03066609|38813731|FG003|OVERALL STUDY|discontinued follow up|0|||
16087975|NCT01353274|38813732|FG000|Overall Study|No case report form (CRF) collected|28|||
16087976|NCT00590759|38813737|FG000|Overall Study|Death|52|||
16087977|NCT00590759|38813737|FG000|Overall Study|Lost to Follow-up|28|||
16087978|NCT00681109|38813742|FG000|Overall Study|Lost to Follow-up|2|||
16087979|NCT00681109|38813743|FG001|Overall Study|Lost to Follow-up|6|||
16087980|NCT00681109|38813744|FG002|Overall Study|Lost to Follow-up|0|||
16087981|NCT00686595|38813745|FG000|Overall Study|Adverse Event|3|||
16087982|NCT00686595|38813745|FG000|Overall Study|Protocol Violation|1|||
16087983|NCT00686595|38813745|FG000|Overall Study|Lost to Follow-up|1|||
16087984|NCT00686595|38813745|FG000|Overall Study|Lack of Efficacy|1|||
16087985|NCT00686595|38813745|FG000|Overall Study|Poor Compliance|1|||
16087986|NCT03138499|38813746|FG000|Overall Study|Lost to Follow-up|1|||
16087987|NCT03138499|38813747|FG001|Overall Study|Lost to Follow-up|0|||
16087988|NCT03138499|38813746|FG000|Overall Study|Participants withdrew consent|1|||
16087989|NCT03138499|38813747|FG001|Overall Study|Participants withdrew consent|0|||
16499756|NCT02036502|40302931|FG007|Part 3:Dose Expansion|Adverse Event|2|||
16499757|NCT02036502|40302924|FG000|Part 3:Dose Expansion|Death|0|||
16499758|NCT02036502|40302925|FG001|Part 3:Dose Expansion|Death|0|||
16499759|NCT02036502|40302926|FG002|Part 3:Dose Expansion|Death|0|||
16499760|NCT02036502|40302927|FG003|Part 3:Dose Expansion|Death|0|||
16499761|NCT02036502|40302928|FG004|Part 3:Dose Expansion|Death|0|||
16499762|NCT02036502|40302929|FG005|Part 3:Dose Expansion|Death|24|||
16499763|NCT02036502|40302930|FG006|Part 3:Dose Expansion|Death|0|||
16499764|NCT02036502|40302931|FG007|Part 3:Dose Expansion|Death|3|||
16499765|NCT02036502|40302924|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
16499766|NCT02036502|40302925|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
16499767|NCT02036502|40302926|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
16499768|NCT02036502|40302927|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
16499769|NCT02036502|40302928|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
16499770|NCT02036502|40302929|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
16499771|NCT02036502|40302930|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
16499772|NCT02036502|40302931|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
16499773|NCT02036502|40302924|FG000|Part 3:Dose Expansion|Physician Decision|0|||
16499774|NCT02036502|40302925|FG001|Part 3:Dose Expansion|Physician Decision|0|||
16499775|NCT02036502|40302926|FG002|Part 3:Dose Expansion|Physician Decision|0|||
16499776|NCT02036502|40302927|FG003|Part 3:Dose Expansion|Physician Decision|0|||
16499777|NCT02036502|40302928|FG004|Part 3:Dose Expansion|Physician Decision|0|||
16499778|NCT02036502|40302929|FG005|Part 3:Dose Expansion|Physician Decision|1|||
16499779|NCT02036502|40302930|FG006|Part 3:Dose Expansion|Physician Decision|0|||
16499780|NCT02036502|40302931|FG007|Part 3:Dose Expansion|Physician Decision|0|||
16499781|NCT02036502|40302924|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
16087990|NCT03138499|38813746|FG000|Overall Study|Participant discontinued study before treatment|0|||
16087991|NCT03138499|38813747|FG001|Overall Study|Participant discontinued study before treatment|1|||
16087992|NCT03138499|38813746|FG000|Overall Study|Disease Progression|2|||
16087993|NCT03138499|38813747|FG001|Overall Study|Disease Progression|6|||
16499782|NCT02036502|40302925|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
16499783|NCT02036502|40302926|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
16499784|NCT02036502|40302927|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
16499785|NCT02036502|40302928|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
16499786|NCT02036502|40302929|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
16499787|NCT02036502|40302930|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
16499788|NCT02036502|40302931|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
16499789|NCT02036502|40302924|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16499790|NCT02036502|40302925|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16499791|NCT02036502|40302926|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16499792|NCT02036502|40302927|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16499793|NCT02036502|40302928|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16499794|NCT02036502|40302929|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
16499795|NCT02036502|40302930|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
16499796|NCT02036502|40302931|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
16499797|NCT02036502|40302924|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
16087994|NCT03138499|38813746|FG000|Overall Study|Study drug toxicity|2|||
16087995|NCT03138499|38813747|FG001|Overall Study|Study drug toxicity|2|||
16087996|NCT03138499|38813746|FG000|Overall Study|Participant request to discontinue study treatment|1|||
16087997|NCT03138499|38813747|FG001|Overall Study|Participant request to discontinue study treatment|1|||
16087998|NCT03138499|38813746|FG000|Overall Study|Other reasons|2|||
16087999|NCT03138499|38813747|FG001|Overall Study|Other reasons|0|||
16088000|NCT03802994|38813748|FG000|Overall Study|Lost to Follow-up|0|||
16088001|NCT03802994|38813749|FG001|Overall Study|Lost to Follow-up|2|||
16088002|NCT03802994|38813750|FG002|Overall Study|Lost to Follow-up|3|||
16088003|NCT03802994|38813751|FG003|Overall Study|Lost to Follow-up|2|||
16088004|NCT03802994|38813752|FG004|Overall Study|Lost to Follow-up|2|||
16088005|NCT02196259|38813753|FG000|Overall Study|Researcher choice|0|||
16088006|NCT02196259|38813754|FG001|Overall Study|Researcher choice|0|||
16088007|NCT02196259|38813755|FG002|Overall Study|Researcher choice|1|||
16088008|NCT02196259|38813753|FG000|Overall Study|Partial data analysis|0|||
16088009|NCT02196259|38813754|FG001|Overall Study|Partial data analysis|3|||
16499798|NCT02036502|40302925|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
16088010|NCT02196259|38813755|FG002|Overall Study|Partial data analysis|0|||
16499799|NCT02036502|40302926|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
16499800|NCT02036502|40302927|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
16499801|NCT02036502|40302928|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
16499802|NCT02036502|40302929|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
16499803|NCT02036502|40302930|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
16499804|NCT02036502|40302931|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
16088011|NCT01218594|38813758|FG000|Overall Study|Death|1|||
16088012|NCT01218594|38813758|FG000|Overall Study|Withdrawal by Subject|3|||
16088013|NCT01218594|38813758|FG000|Overall Study|Adverse Event|2|||
16088014|NCT01218594|38813758|FG000|Overall Study|Physician Decision|6|||
16088015|NCT02095678|38813759|FG000|Overall Study|Withdrawal by Subject|0|||
16499805|NCT02036502|40302924|FG000|Part 3:Dose Expansion|Not Treated|0|||
16499806|NCT02036502|40302925|FG001|Part 3:Dose Expansion|Not Treated|0|||
16499807|NCT02036502|40302926|FG002|Part 3:Dose Expansion|Not Treated|0|||
16499808|NCT02036502|40302927|FG003|Part 3:Dose Expansion|Not Treated|0|||
16499809|NCT02036502|40302928|FG004|Part 3:Dose Expansion|Not Treated|0|||
16499810|NCT02036502|40302929|FG005|Part 3:Dose Expansion|Not Treated|2|||
16499811|NCT02036502|40302930|FG006|Part 3:Dose Expansion|Not Treated|0|||
16499812|NCT02036502|40302931|FG007|Part 3:Dose Expansion|Not Treated|0|||
16499813|NCT00529542|40302932|FG000|Overall Study|Withdrawal by Subject|1|||
16499814|NCT00529542|40302933|FG001|Overall Study|Withdrawal by Subject|0|||
16499815|NCT00529542|40302932|FG000|Overall Study|Lost to Follow-up|0|||
16499816|NCT00529542|40302933|FG001|Overall Study|Lost to Follow-up|1|||
16499817|NCT03686384|40302937|FG000|Overall Study|Lack of Efficacy|4|||
16499818|NCT03686384|40302938|FG001|Overall Study|Lack of Efficacy|13|||
16499819|NCT03686384|40302937|FG000|Overall Study|Lost to Follow-up|3|||
16499820|NCT03686384|40302938|FG001|Overall Study|Lost to Follow-up|0|||
16499821|NCT03686384|40302937|FG000|Overall Study|Physician Decision|0|||
16499822|NCT03686384|40302938|FG001|Overall Study|Physician Decision|1|||
16499823|NCT03686384|40302937|FG000|Overall Study|Took prohibited medication|0|||
16499824|NCT03686384|40302938|FG001|Overall Study|Took prohibited medication|1|||
16499825|NCT01594125|40302942|FG000|Overall Study|Withdrawal by Subject|1|||
16499826|NCT01594125|40302943|FG001|Overall Study|Withdrawal by Subject|0|||
16499827|NCT01594125|40302944|FG002|Overall Study|Withdrawal by Subject|0|||
16499828|NCT01594125|40302945|FG003|Overall Study|Withdrawal by Subject|1|||
16499829|NCT01594125|40302946|FG004|Overall Study|Withdrawal by Subject|0|||
16499830|NCT01594125|40302942|FG000|Overall Study|Progressive Disease|3|||
16499831|NCT01594125|40302943|FG001|Overall Study|Progressive Disease|12|||
16499832|NCT01594125|40302944|FG002|Overall Study|Progressive Disease|3|||
16499833|NCT01594125|40302945|FG003|Overall Study|Progressive Disease|3|||
16499834|NCT01594125|40302946|FG004|Overall Study|Progressive Disease|7|||
16499835|NCT01485640|40302947|FG000|Overall Study|Adverse Event|10|||
16499836|NCT01485640|40302947|FG000|Overall Study|Lack of Efficacy|2|||
16499837|NCT01485640|40302947|FG000|Overall Study|Protocol Violation|1|||
16499838|NCT01485640|40302947|FG000|Overall Study|Withdrawal by Subject|14|||
16499839|NCT01485640|40302947|FG000|Overall Study|Terminated by Sponsor|95|||
16499840|NCT01404325|40302948|FG000|Overall Study|Lost to Follow-up|1|||
16088016|NCT02095678|38813760|FG001|Overall Study|Withdrawal by Subject|1|||
16088017|NCT02095678|38813759|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
16088018|NCT02095678|38813760|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
16088019|NCT02095678|38813759|FG000|Overall Study|lesion impacted by previous treatment|1|||
16088020|NCT02095678|38813760|FG001|Overall Study|lesion impacted by previous treatment|1|||
16088021|NCT02095678|38813759|FG000|Overall Study|No Confirmed Diagnosis|0|||
16088022|NCT02095678|38813760|FG001|Overall Study|No Confirmed Diagnosis|3|||
16088023|NCT02095678|38813759|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
16088024|NCT02095678|38813760|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
16088025|NCT02095678|38813759|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
16088026|NCT02095678|38813760|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
16088027|NCT03418545|38813761|FG000|Overall Study|Withdrawal by Participant|2|||
16088028|NCT03418545|38813762|FG001|Overall Study|Withdrawal by Participant|4|||
16088029|NCT03418545|38813761|FG000|Overall Study|Lost to Follow-up|3|||
16088030|NCT03418545|38813762|FG001|Overall Study|Lost to Follow-up|5|||
16088031|NCT03418545|38813761|FG000|Overall Study|Reason Not Specified|0|||
16088032|NCT03418545|38813762|FG001|Overall Study|Reason Not Specified|1|||
16088033|NCT03418545|38813761|FG000|Overall Study|Missing Completion Status|0|||
16088034|NCT03418545|38813762|FG001|Overall Study|Missing Completion Status|1|||
16088035|NCT00065182|38813763|FG000|Overall Study|Adverse Event|24|||
16088036|NCT00065182|38813764|FG001|Overall Study|Adverse Event|17|||
16088037|NCT00065182|38813763|FG000|Overall Study|Lost to Follow-up|0|||
16088038|NCT00065182|38813764|FG001|Overall Study|Lost to Follow-up|4|||
16499841|NCT01404325|40302949|FG001|Overall Study|Lost to Follow-up|0|||
16499842|NCT01404325|40302948|FG000|Overall Study|Death|2|||
16499843|NCT01404325|40302949|FG001|Overall Study|Death|0|||
16499844|NCT01404325|40302948|FG000|Overall Study|Graft loss/Retransplantation|1|||
16088039|NCT00065182|38813763|FG000|Overall Study|Protocol Violation|3|||
16088040|NCT00065182|38813764|FG001|Overall Study|Protocol Violation|4|||
16088041|NCT00065182|38813763|FG000|Overall Study|Serious adverse events (SAE)|1|||
16088042|NCT00065182|38813764|FG001|Overall Study|Serious adverse events (SAE)|0|||
16088043|NCT00065182|38813763|FG000|Overall Study|Sponsor Decision|11|||
16088044|NCT00065182|38813764|FG001|Overall Study|Sponsor Decision|7|||
16499845|NCT01404325|40302949|FG001|Overall Study|Graft loss/Retransplantation|0|||
16499846|NCT01404325|40302948|FG000|Overall Study|non-specified reason|0|||
16499847|NCT01404325|40302949|FG001|Overall Study|non-specified reason|2|||
16499848|NCT03089606|40302950|FG000|Overall Study|Progression after Cycle 1|1|||
16499849|NCT01349790|40302951|FG000|Overall Study|Investigator Judgement|3|||
16499850|NCT01349790|40302951|FG000|Overall Study|Death|2|||
16499851|NCT01349790|40302951|FG000|Overall Study|Withdrawal by Patient|2|||
16499852|NCT01349790|40302951|FG000|Overall Study|Adverse Event|1|||
16088045|NCT00065182|38813763|FG000|Overall Study|Withdrawal by Subject|8|||
16088046|NCT00065182|38813764|FG001|Overall Study|Withdrawal by Subject|3|||
16499853|NCT01349790|40302951|FG000|Overall Study|Lost to Follow-up|1|||
16499854|NCT00503009|40302954|FG000|Overall Study|Protocol Violation|1|||
16499855|NCT00503009|40302955|FG001|Overall Study|Protocol Violation|0|||
16088047|NCT00065182|38813763|FG000|Overall Study|No clinical benefit|1|||
16088048|NCT00065182|38813764|FG001|Overall Study|No clinical benefit|0|||
16088049|NCT00065182|38813763|FG000|Overall Study|Death|0|||
16088050|NCT00065182|38813764|FG001|Overall Study|Death|1|||
16088051|NCT00065182|38813763|FG000|Overall Study|Decline in Status|0|||
16088052|NCT00065182|38813764|FG001|Overall Study|Decline in Status|1|||
16088053|NCT00666705|38813765|FG000|Overall Study|Withdrawal by Subject|1|||
16088054|NCT00019604|38813781|FG000|Overall Study|Death|1|||
16088055|NCT00019604|38813781|FG000|Overall Study|Progressive disease|23|||
16088056|NCT00019604|38813781|FG000|Overall Study|Refused treatment|1|||
16088057|NCT00019604|38813781|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
16088058|NCT00019604|38813781|FG000|Overall Study|Going to have liver transplant|1|||
16088059|NCT00019604|38813781|FG000|Overall Study|Move to a different study|1|||
16088060|NCT00019604|38813781|FG000|Overall Study|Non compliant on systemic CH|1|||
16088061|NCT00019604|38813781|FG000|Overall Study|Non compliant|1|||
16088062|NCT00019604|38813781|FG000|Overall Study|Resectable disease|1|||
16088063|NCT00019604|38813781|FG000|Overall Study|Started new chemo regimen|1|||
16088064|NCT00019604|38813781|FG000|Overall Study|Pt going to immunotherapy study|1|||
16088065|NCT00019604|38813781|FG000|Overall Study|Too much disease|1|||
16499856|NCT00503009|40302956|FG002|Overall Study|Protocol Violation|1|||
16499857|NCT00503009|40302954|FG000|Overall Study|Withdrawal by Subject|0|||
16088066|NCT00019604|38813781|FG000|Overall Study|Unable to evaluate|1|||
16088067|NCT00019604|38813781|FG000|Overall Study|Details for other not available|4|||
16088068|NCT01918033|38813782|FG000|Overall Study|Adverse Event|1|||
16088069|NCT01918033|38813783|FG001|Overall Study|Adverse Event|0|||
16088070|NCT01918033|38813784|FG002|Overall Study|Adverse Event|2|||
16088071|NCT01918033|38813782|FG000|Overall Study|Lost to Follow-up|0|||
16088072|NCT01918033|38813783|FG001|Overall Study|Lost to Follow-up|1|||
16088073|NCT01918033|38813784|FG002|Overall Study|Lost to Follow-up|0|||
16088074|NCT01918033|38813782|FG000|Overall Study|Protocol Violation|2|||
16088075|NCT01918033|38813783|FG001|Overall Study|Protocol Violation|0|||
16088076|NCT01918033|38813784|FG002|Overall Study|Protocol Violation|1|||
16088077|NCT01918033|38813782|FG000|Overall Study|Withdrawal by Subject|2|||
16088078|NCT01918033|38813783|FG001|Overall Study|Withdrawal by Subject|1|||
16088079|NCT01918033|38813784|FG002|Overall Study|Withdrawal by Subject|0|||
16088080|NCT00597376|38813785|FG000|Overall Study|Withdrawal by Subject|4|||
16088081|NCT00597376|38813786|FG001|Overall Study|Withdrawal by Subject|3|||
16088082|NCT00597376|38813785|FG000|Overall Study|Adverse Event|4|||
16088083|NCT00597376|38813786|FG001|Overall Study|Adverse Event|1|||
16088084|NCT03403036|38813787|FG000|Overall Study|Lack of Efficacy|5|||
16088085|NCT00571649|38813788|FG000|Treatment Period|Adverse Event|438|||
16088086|NCT00571649|38813789|FG001|Treatment Period|Adverse Event|385|||
16088087|NCT00571649|38813788|FG000|Treatment Period|Clinical endpoint reached|50|||
16088088|NCT00571649|38813789|FG001|Treatment Period|Clinical endpoint reached|56|||
16088089|NCT00571649|38813788|FG000|Treatment Period|Withdrawal by Subject|285|||
16088090|NCT00571649|38813789|FG001|Treatment Period|Withdrawal by Subject|255|||
16088091|NCT00571649|38813788|FG000|Treatment Period|Death|76|||
16088092|NCT00571649|38813789|FG001|Treatment Period|Death|59|||
16088093|NCT00571649|38813788|FG000|Treatment Period|Physician Decision|8|||
16088094|NCT00571649|38813789|FG001|Treatment Period|Physician Decision|9|||
16088095|NCT00571649|38813788|FG000|Treatment Period|Lost to Follow-up|43|||
16088096|NCT00571649|38813789|FG001|Treatment Period|Lost to Follow-up|41|||
16088097|NCT00571649|38813788|FG000|Treatment Period|Non-compliant with study medication|88|||
16088098|NCT00571649|38813789|FG001|Treatment Period|Non-compliant with study medication|89|||
16088099|NCT00571649|38813788|FG000|Treatment Period|Patient convenience|11|||
16088100|NCT00571649|38813789|FG001|Treatment Period|Patient convenience|13|||
16088101|NCT00571649|38813788|FG000|Treatment Period|Protocol Violation|90|||
16088102|NCT00571649|38813789|FG001|Treatment Period|Protocol Violation|92|||
16088103|NCT00571649|38813788|FG000|Treatment Period|Technical problems|3|||
16499858|NCT00503009|40302955|FG001|Overall Study|Withdrawal by Subject|1|||
16499859|NCT00503009|40302956|FG002|Overall Study|Withdrawal by Subject|1|||
16499860|NCT00503009|40302954|FG000|Overall Study|Physician Decision|0|||
16499861|NCT00503009|40302955|FG001|Overall Study|Physician Decision|1|||
16499862|NCT00503009|40302956|FG002|Overall Study|Physician Decision|1|||
16499863|NCT03341533|40302957|FG000|Overall Study|Withdrawal by Subject|1|||
16499864|NCT03341533|40302958|FG001|Overall Study|Withdrawal by Subject|1|||
16088104|NCT00571649|38813789|FG001|Treatment Period|Technical problems|5|||
16088105|NCT00571649|38813788|FG000|Follow-up Period|Adverse Event|46|||
16088106|NCT00571649|38813789|FG001|Follow-up Period|Adverse Event|40|||
16499865|NCT03341533|40302957|FG000|Overall Study|Not eligible after randomization|2|||
16499866|NCT03341533|40302958|FG001|Overall Study|Not eligible after randomization|1|||
16088107|NCT00571649|38813788|FG000|Follow-up Period|Clinical endpoint reached|5|||
16088108|NCT00571649|38813789|FG001|Follow-up Period|Clinical endpoint reached|2|||
16088109|NCT00571649|38813788|FG000|Follow-up Period|Withdrawal by Subject|119|||
16088110|NCT00571649|38813789|FG001|Follow-up Period|Withdrawal by Subject|115|||
16499867|NCT00773292|40302961|FG000|Treatment 48 Weeks|Adverse Event|1|||
16088111|NCT00571649|38813788|FG000|Follow-up Period|Death|132|||
16088112|NCT00571649|38813789|FG001|Follow-up Period|Death|133|||
16088113|NCT00571649|38813788|FG000|Follow-up Period|Physician Decision|7|||
16088114|NCT00571649|38813789|FG001|Follow-up Period|Physician Decision|13|||
16088115|NCT00571649|38813788|FG000|Follow-up Period|Lost to Follow-up|95|||
16088116|NCT00571649|38813789|FG001|Follow-up Period|Lost to Follow-up|92|||
16088117|NCT00571649|38813788|FG000|Follow-up Period|Patient convenience|136|||
16088118|NCT00571649|38813789|FG001|Follow-up Period|Patient convenience|121|||
16088119|NCT00571649|38813788|FG000|Follow-up Period|Protocol Violation|5|||
16088120|NCT00571649|38813789|FG001|Follow-up Period|Protocol Violation|12|||
16088121|NCT00918333|38813790|FG000|Overall Study|Drug not taken per protocol|1|||
16088122|NCT00918333|38813791|FG001|Overall Study|Drug not taken per protocol|0|||
16088123|NCT00918333|38813790|FG000|Overall Study|Inadequate amount of drugs provided|1|||
16088124|NCT00918333|38813791|FG001|Overall Study|Inadequate amount of drugs provided|4|||
16088125|NCT00918333|38813790|FG000|Overall Study|Ineligible|1|||
16088126|NCT00918333|38813791|FG001|Overall Study|Ineligible|0|||
16088127|NCT00918333|38813790|FG000|Overall Study|Withdrawal by Subject|0|||
16088128|NCT00918333|38813791|FG001|Overall Study|Withdrawal by Subject|1|||
16088129|NCT00467272|38813792|FG000|Overall Study|Pneumonia|2|||
16088130|NCT00467272|38813792|FG000|Overall Study|Thrombophlebitis|1|||
16088131|NCT01670526|38813793|FG000|Overall Study|Withdrawal by Subject|3|||
16088132|NCT01670526|38813794|FG001|Overall Study|Withdrawal by Subject|1|||
16088133|NCT01670526|38813793|FG000|Overall Study|Lost to Follow-up|9|||
16088134|NCT01670526|38813794|FG001|Overall Study|Lost to Follow-up|5|||
16088135|NCT00667732|38813796|FG000|Run -In (8 Weeks)|Adverse Event|4|||
16088136|NCT00667732|38813797|FG001|Run -In (8 Weeks)|Adverse Event|0|||
16088137|NCT00667732|38813798|FG002|Run -In (8 Weeks)|Adverse Event|0|||
16088138|NCT00667732|38813796|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
16088139|NCT00667732|38813797|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
16088140|NCT00667732|38813798|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
16088141|NCT00667732|38813796|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
16088142|NCT00667732|38813797|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
16088143|NCT00667732|38813798|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
16088144|NCT00569166|38813799|FG000|Overall Study|Withdrawal by Subject|7|||
16088145|NCT00569166|38813800|FG001|Overall Study|Withdrawal by Subject|5|||
16088146|NCT00569166|38813801|FG002|Overall Study|Withdrawal by Subject|3|||
16088147|NCT00569166|38813799|FG000|Overall Study|Lost to Follow-up|2|||
16088148|NCT00569166|38813800|FG001|Overall Study|Lost to Follow-up|1|||
16088149|NCT00569166|38813801|FG002|Overall Study|Lost to Follow-up|1|||
16088150|NCT00391898|38813807|FG000|Overall Study|Adverse Event|3|||
16088151|NCT00391898|38813808|FG001|Overall Study|Adverse Event|0|||
16088152|NCT00391898|38813807|FG000|Overall Study|Other|8|||
16088153|NCT00391898|38813808|FG001|Overall Study|Other|10|||
16088154|NCT01523392|38813809|FG000|Treatment Period 1|Withdrawal by Subject|2|||
16088155|NCT01523392|38813810|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16088156|NCT01523392|38813809|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
16088157|NCT01523392|38813810|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
16088158|NCT01523392|38813809|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
16088159|NCT01523392|38813810|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
16088160|NCT02575365|38813811|FG000|Overall Study|Lost to Follow-up|4|||
16088161|NCT02789020|38813812|FG000|Overall Study|Withdrawal by Subject|6|||
16088162|NCT02789020|38813813|FG001|Overall Study|Withdrawal by Subject|5|||
16088163|NCT00371345|38813814|FG000|Overall Study|Disease Progression|21|||
16088164|NCT00371345|38813815|FG001|Overall Study|Disease Progression|35|||
16088165|NCT00371345|38813814|FG000|Overall Study|Study Drug Toxicity|1|||
16088166|NCT00371345|38813815|FG001|Overall Study|Study Drug Toxicity|7|||
16088167|NCT00371345|38813814|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
16088168|NCT00371345|38813815|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
16088169|NCT00371345|38813814|FG000|Overall Study|Participant Request|1|||
16309730|NCT02854527|39619076|FG008|Overall Study|Lost to Follow-up|0|||
16309731|NCT02854527|39619077|FG009|Overall Study|Lost to Follow-up|0|||
16309732|NCT00618371|39619078|FG000|Overall Study|Withdrawal by Subject|2|||
16088170|NCT00371345|38813815|FG001|Overall Study|Participant Request|1|||
16088171|NCT00371345|38813814|FG000|Overall Study|Participant Withdrew Consent|0|||
16088172|NCT00371345|38813815|FG001|Overall Study|Participant Withdrew Consent|1|||
16088173|NCT04248868|38813816|FG000|Overall Study|Death|1|||
16309733|NCT02738138|39619079|FG000|Overall Study|Adverse Event|0|||
16088174|NCT04248868|38813816|FG000|Overall Study|Lost to Follow-up|3|||
16088175|NCT04248868|38813816|FG000|Overall Study|Protocol Violation|2|||
16088176|NCT00761267|38813817|FG000|Overall Study|Death|1|||
16088177|NCT00761267|38813818|FG001|Overall Study|Death|2|||
16088178|NCT00761267|38813819|FG002|Overall Study|Death|5|||
16088179|NCT00761267|38813817|FG000|Overall Study|Lost to Follow-up|0|||
16088180|NCT00761267|38813818|FG001|Overall Study|Lost to Follow-up|0|||
16088181|NCT00761267|38813819|FG002|Overall Study|Lost to Follow-up|1|||
16088182|NCT00761267|38813817|FG000|Overall Study|Randomized but not treated|1|||
16088183|NCT00761267|38813818|FG001|Overall Study|Randomized but not treated|1|||
16088184|NCT00761267|38813819|FG002|Overall Study|Randomized but not treated|0|||
16088185|NCT00761267|38813817|FG000|Overall Study|Withdrawal by Subject|0|||
16088186|NCT00761267|38813818|FG001|Overall Study|Withdrawal by Subject|1|||
16088187|NCT00761267|38813819|FG002|Overall Study|Withdrawal by Subject|0|||
16088188|NCT04705051|38813822|FG000|Overall Study|Enrolled but not treated|1|||
16088189|NCT04705051|38813822|FG000|Overall Study|Study terminated by sponsor|23|||
16088190|NCT00776009|38813823|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
16088191|NCT00776009|38813824|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
16088192|NCT00776009|38813825|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
16088193|NCT00776009|38813826|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
16088194|NCT00776009|38813827|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
16088195|NCT00776009|38813828|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
16088196|NCT00776009|38813823|FG000|Period 1: First Intervention|Protocol Violation|0|||
16088197|NCT00776009|38813824|FG001|Period 1: First Intervention|Protocol Violation|1|||
16088198|NCT00776009|38813825|FG002|Period 1: First Intervention|Protocol Violation|0|||
16088199|NCT00776009|38813826|FG003|Period 1: First Intervention|Protocol Violation|0|||
16088200|NCT00776009|38813827|FG004|Period 1: First Intervention|Protocol Violation|1|||
16088201|NCT00776009|38813828|FG005|Period 1: First Intervention|Protocol Violation|0|||
16088202|NCT00776009|38813823|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
16088203|NCT00776009|38813824|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
16088204|NCT00776009|38813825|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
16088205|NCT00776009|38813826|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
16088206|NCT00776009|38813827|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
16088207|NCT00776009|38813828|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
16088208|NCT00776009|38813823|FG000|Period 2: Second Intervention|Protocol Violation|1|||
16088209|NCT00776009|38813824|FG001|Period 2: Second Intervention|Protocol Violation|0|||
16088210|NCT00776009|38813825|FG002|Period 2: Second Intervention|Protocol Violation|1|||
16088211|NCT00776009|38813826|FG003|Period 2: Second Intervention|Protocol Violation|0|||
16499868|NCT00773292|40302961|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
16499869|NCT00535223|40302962|FG000|Overall Study|Withdrawal by Subject|4|||
16499870|NCT00535223|40302963|FG001|Overall Study|Withdrawal by Subject|1|||
16499871|NCT02484729|40302964|FG000|Overall Study|Failure of IntelliCap Error|0|||
16499872|NCT02484729|40302965|FG001|Overall Study|Failure of IntelliCap Error|0|||
16499873|NCT02484729|40302966|FG002|Overall Study|Failure of IntelliCap Error|0|||
16499874|NCT02484729|40302967|FG003|Overall Study|Failure of IntelliCap Error|0|||
16499875|NCT02484729|40302968|FG004|Overall Study|Failure of IntelliCap Error|0|||
16499876|NCT02484729|40302969|FG005|Overall Study|Failure of IntelliCap Error|0|||
16499877|NCT02484729|40302970|FG006|Overall Study|Failure of IntelliCap Error|0|||
16499878|NCT02484729|40302971|FG007|Overall Study|Failure of IntelliCap Error|0|||
16499879|NCT02484729|40302972|FG008|Overall Study|Failure of IntelliCap Error|0|||
16499880|NCT02484729|40302973|FG009|Overall Study|Failure of IntelliCap Error|1|||
16499881|NCT00927784|40302974|FG000|Overall Study|Death|1|||
16499882|NCT00927784|40302975|FG001|Overall Study|Death|0|||
16499883|NCT00927784|40302974|FG000|Overall Study|Withdrawal by Subject|1|||
16499884|NCT00927784|40302975|FG001|Overall Study|Withdrawal by Subject|0|||
16088212|NCT00776009|38813827|FG004|Period 2: Second Intervention|Protocol Violation|0|||
16088213|NCT00776009|38813828|FG005|Period 2: Second Intervention|Protocol Violation|0|||
16088214|NCT00776009|38813823|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
16088215|NCT00776009|38813824|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
16088216|NCT00776009|38813825|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
16088217|NCT00776009|38813826|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
16088218|NCT00776009|38813827|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
16088219|NCT00776009|38813828|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
16088220|NCT02923349|38813833|FG000|Overall Study|Other|1|||
16088221|NCT02923349|38813834|FG001|Overall Study|Other|2|||
16088222|NCT02923349|38813835|FG002|Overall Study|Other|4|||
16088223|NCT02923349|38813836|FG003|Overall Study|Other|1|||
16088224|NCT02923349|38813837|FG004|Overall Study|Other|3|||
16088225|NCT02923349|38813838|FG005|Overall Study|Other|0|||
16088226|NCT02923349|38813839|FG006|Overall Study|Other|1|||
16088227|NCT02923349|38813833|FG000|Overall Study|Withdrawal by Subject|2|||
16088228|NCT02923349|38813834|FG001|Overall Study|Withdrawal by Subject|2|||
16088229|NCT02923349|38813835|FG002|Overall Study|Withdrawal by Subject|8|||
16088230|NCT02923349|38813836|FG003|Overall Study|Withdrawal by Subject|10|||
16088231|NCT02923349|38813837|FG004|Overall Study|Withdrawal by Subject|12|||
16088232|NCT02923349|38813838|FG005|Overall Study|Withdrawal by Subject|3|||
16499885|NCT02738450|40302976|FG000|Overall Study|Withdrawal by Subject|0|||
16499886|NCT02738450|40302977|FG001|Overall Study|Withdrawal by Subject|2|||
16499887|NCT02738450|40302978|FG002|Overall Study|Withdrawal by Subject|0|||
16088233|NCT02923349|38813839|FG006|Overall Study|Withdrawal by Subject|0|||
16088234|NCT02923349|38813833|FG000|Overall Study|Physician Decision|0|||
16088235|NCT02923349|38813834|FG001|Overall Study|Physician Decision|0|||
16088236|NCT02923349|38813835|FG002|Overall Study|Physician Decision|0|||
16088237|NCT02923349|38813836|FG003|Overall Study|Physician Decision|1|||
16088238|NCT02923349|38813837|FG004|Overall Study|Physician Decision|1|||
16088239|NCT02923349|38813838|FG005|Overall Study|Physician Decision|0|||
16088240|NCT02923349|38813839|FG006|Overall Study|Physician Decision|2|||
16088241|NCT02923349|38813833|FG000|Overall Study|Lost to Follow-up|0|||
16088242|NCT02923349|38813834|FG001|Overall Study|Lost to Follow-up|0|||
16088243|NCT02923349|38813835|FG002|Overall Study|Lost to Follow-up|3|||
16088244|NCT02923349|38813836|FG003|Overall Study|Lost to Follow-up|0|||
16088245|NCT02923349|38813837|FG004|Overall Study|Lost to Follow-up|1|||
16088246|NCT02923349|38813838|FG005|Overall Study|Lost to Follow-up|1|||
16088247|NCT02923349|38813839|FG006|Overall Study|Lost to Follow-up|0|||
16088248|NCT02923349|38813833|FG000|Overall Study|Death|1|||
16088249|NCT02923349|38813834|FG001|Overall Study|Death|0|||
16088250|NCT02923349|38813835|FG002|Overall Study|Death|2|||
16088251|NCT02923349|38813836|FG003|Overall Study|Death|4|||
16088252|NCT02923349|38813837|FG004|Overall Study|Death|2|||
16088253|NCT02923349|38813838|FG005|Overall Study|Death|3|||
16088254|NCT02923349|38813839|FG006|Overall Study|Death|0|||
16088255|NCT02628626|38813840|FG000|Overall Study|Withdrawal by Subject|2|||
16088256|NCT02628626|38813841|FG001|Overall Study|Withdrawal by Subject|2|||
16088257|NCT03938272|38813842|FG000|Overall Study|Withdrawal by Subject|1|||
16088258|NCT03938272|38813843|FG001|Overall Study|Withdrawal by Subject|0|||
16088259|NCT03938272|38813842|FG000|Overall Study|Physician Decision|0|||
16088260|NCT03938272|38813843|FG001|Overall Study|Physician Decision|2|||
16088261|NCT03938272|38813842|FG000|Overall Study|Study termination by sponsor|10|||
16088262|NCT03938272|38813843|FG001|Overall Study|Study termination by sponsor|8|||
16088263|NCT00536120|38813844|FG000|Overall Study|Lost to Follow-up|1|||
16088264|NCT00536120|38813845|FG001|Overall Study|Lost to Follow-up|0|||
16088265|NCT00536120|38813844|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
16088266|NCT00536120|38813845|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
16088267|NCT00536120|38813844|FG000|Overall Study|Non-compliance|1|||
16088268|NCT00536120|38813845|FG001|Overall Study|Non-compliance|0|||
16088269|NCT00536120|38813844|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
16088270|NCT00536120|38813845|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
16088271|NCT00536120|38813844|FG000|Overall Study|Steroid Use|0|||
16088272|NCT00536120|38813845|FG001|Overall Study|Steroid Use|2|||
16088273|NCT00536120|38813844|FG000|Overall Study|Missed Study Visit|0|||
16088274|NCT00536120|38813845|FG001|Overall Study|Missed Study Visit|1|||
16088275|NCT02797132|38813853|FG000|Part A (15 Days)|Adverse Event|1|||
16088276|NCT02797132|38813853|FG000|Part B (24 Weeks)|Adverse Event|3|||
16088277|NCT01436175|38813854|FG000|Overall Study|Adverse Event|111|||
16088278|NCT01436175|38813854|FG000|Overall Study|Protocol Violation|49|||
16088279|NCT01436175|38813854|FG000|Overall Study|Withdrawal by Subject|108|||
16088280|NCT01436175|38813854|FG000|Overall Study|Lost to Follow-up|89|||
16088281|NCT01436175|38813854|FG000|Overall Study|Lack of Efficacy|24|||
16088282|NCT01436175|38813854|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
16088283|NCT01436175|38813854|FG000|Overall Study|Other|826|||
16088284|NCT03732807|38813855|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
16309734|NCT02738138|39619080|FG001|Overall Study|Adverse Event|1|||
16309735|NCT02738138|39619079|FG000|Overall Study|Lost to Follow-up|2|||
16309736|NCT02738138|39619080|FG001|Overall Study|Lost to Follow-up|0|||
16309737|NCT02738138|39619079|FG000|Overall Study|Other - not further specified|1|||
16309738|NCT02738138|39619080|FG001|Overall Study|Other - not further specified|0|||
16309739|NCT02038010|39619081|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
16309740|NCT02038010|39619082|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
16309741|NCT02038010|39619083|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
16389409|NCT00200967|39908650|FG001|Wash-out Period|Lost to Follow-up|1|||
16389410|NCT00200967|39908649|FG000|Second Treatment Period|Withdrawal by Subject|1|||
16389411|NCT00200967|39908650|FG001|Second Treatment Period|Withdrawal by Subject|2|||
16389412|NCT00200967|39908649|FG000|Run-out Period|Lost to Follow-up|1|||
16389413|NCT00200967|39908650|FG001|Run-out Period|Lost to Follow-up|0|||
16088285|NCT03732807|38813856|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
16088286|NCT03732807|38813857|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
16088287|NCT03732807|38813858|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
16088288|NCT03732807|38813859|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
16088289|NCT03732807|38813860|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
16088290|NCT03732807|38813861|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
16088291|NCT03732807|38813855|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
16088292|NCT03732807|38813856|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
16088293|NCT03732807|38813857|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
16088294|NCT03732807|38813858|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
16088295|NCT03732807|38813859|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
16088296|NCT03732807|38813860|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
16088297|NCT03732807|38813861|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
16389414|NCT00886769|39908653|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
16389415|NCT00886769|39908654|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
16088298|NCT03732807|38813855|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
16088299|NCT03732807|38813856|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
16088300|NCT03732807|38813857|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
16088301|NCT03732807|38813858|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
16088302|NCT03732807|38813859|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
16088303|NCT03732807|38813860|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
16088304|NCT03732807|38813861|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
16088305|NCT03732807|38813855|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
16088306|NCT03732807|38813856|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
16088307|NCT03732807|38813857|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
16088308|NCT03732807|38813858|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
16088309|NCT03732807|38813859|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
16309742|NCT02038010|39619084|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
16309743|NCT02038010|39619081|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
16309744|NCT02038010|39619082|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
16309745|NCT02038010|39619083|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
16309746|NCT02038010|39619084|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
16309747|NCT02038010|39619081|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
16309748|NCT02038010|39619082|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
16309749|NCT02038010|39619083|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
16309750|NCT02038010|39619084|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
16309751|NCT02038010|39619081|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
16309752|NCT02038010|39619082|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
16309753|NCT02038010|39619083|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
16309754|NCT02038010|39619084|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
16309755|NCT02038010|39619081|FG000|Follow Up|Death|4|||
16309756|NCT02038010|39619082|FG001|Follow Up|Death|3|||
16309757|NCT02038010|39619083|FG002|Follow Up|Death|0|||
16309758|NCT02038010|39619084|FG003|Follow Up|Death|0|||
16309759|NCT02038010|39619081|FG000|Follow Up|Other|3|||
16309760|NCT02038010|39619082|FG001|Follow Up|Other|0|||
16309761|NCT02038010|39619083|FG002|Follow Up|Other|0|||
16309762|NCT02038010|39619084|FG003|Follow Up|Other|0|||
16309763|NCT03200717|39619085|FG000|Overall Study|Progressive disease|24|||
16309764|NCT03200717|39619086|FG001|Overall Study|Progressive disease|5|||
16309765|NCT03200717|39619085|FG000|Overall Study|Adverse Event|11|||
16309766|NCT03200717|39619086|FG001|Overall Study|Adverse Event|8|||
16499888|NCT00643682|40302979|FG000|Overall Study|did not keep appointment|522|||
16499889|NCT00643682|40302980|FG001|Overall Study|did not keep appointment|509|||
16499890|NCT03070392|40302983|FG000|Overall Study|Not Treated|7|||
16499891|NCT03070392|40302984|FG001|Overall Study|Not Treated|0|||
16499892|NCT03070392|40302985|FG002|Overall Study|Not Treated|3|||
16499893|NCT03070392|40302986|FG003|Overall Study|Not Treated|12|||
16499894|NCT03070392|40302983|FG000|Overall Study|Death|3|||
16499895|NCT03070392|40302984|FG001|Overall Study|Death|0|||
16499896|NCT03070392|40302985|FG002|Overall Study|Death|0|||
16499897|NCT03070392|40302986|FG003|Overall Study|Death|1|||
16499898|NCT03070392|40302983|FG000|Overall Study|Withdrawal by Subject|7|||
16499899|NCT03070392|40302984|FG001|Overall Study|Withdrawal by Subject|0|||
16499900|NCT03070392|40302985|FG002|Overall Study|Withdrawal by Subject|0|||
16499901|NCT03070392|40302986|FG003|Overall Study|Withdrawal by Subject|3|||
16499902|NCT03070392|40302983|FG000|Overall Study|Physician Decision|1|||
16499903|NCT03070392|40302984|FG001|Overall Study|Physician Decision|0|||
16499904|NCT03070392|40302985|FG002|Overall Study|Physician Decision|0|||
16499905|NCT03070392|40302986|FG003|Overall Study|Physician Decision|2|||
16499906|NCT03070392|40302983|FG000|Overall Study|Progressive Disease|154|||
16309767|NCT03200717|39619085|FG000|Overall Study|Physician Decision|3|||
16309768|NCT03200717|39619086|FG001|Overall Study|Physician Decision|2|||
16309769|NCT03200717|39619085|FG000|Overall Study|Death|2|||
16309770|NCT03200717|39619086|FG001|Overall Study|Death|0|||
16309771|NCT03200717|39619085|FG000|Overall Study|Subject/Guardian Decision|1|||
16309772|NCT03200717|39619086|FG001|Overall Study|Subject/Guardian Decision|0|||
16309773|NCT03093259|39619087|FG000|Overall Study|Adverse Event|1|||
16499907|NCT03070392|40302984|FG001|Overall Study|Progressive Disease|6|||
16499908|NCT03070392|40302985|FG002|Overall Study|Progressive Disease|2|||
16499909|NCT03070392|40302986|FG003|Overall Study|Progressive Disease|70|||
16499910|NCT03070392|40302983|FG000|Overall Study|Adverse Event|6|||
16499911|NCT03070392|40302984|FG001|Overall Study|Adverse Event|1|||
16499912|NCT03070392|40302985|FG002|Overall Study|Adverse Event|1|||
16499913|NCT03070392|40302986|FG003|Overall Study|Adverse Event|3|||
16499914|NCT03070392|40302983|FG000|Overall Study|Alternate anticancer treatment|1|||
16499915|NCT03070392|40302984|FG001|Overall Study|Alternate anticancer treatment|0|||
16499916|NCT03070392|40302985|FG002|Overall Study|Alternate anticancer treatment|0|||
16499917|NCT03070392|40302986|FG003|Overall Study|Alternate anticancer treatment|1|||
16309774|NCT03093259|39619088|FG001|Overall Study|Adverse Event|0|||
16309775|NCT03093259|39619087|FG000|Overall Study|Withdrawal by Subject|1|||
16309776|NCT03093259|39619088|FG001|Overall Study|Withdrawal by Subject|0|||
16389416|NCT02776683|39908657|FG000|Pre-switch Period|Protocol Violation|1|||
16389417|NCT02776683|39908658|FG001|Pre-switch Period|Protocol Violation|0|||
16389418|NCT02776683|39908657|FG000|Pre-switch Period|Adverse Event|21|||
16389419|NCT02776683|39908658|FG001|Pre-switch Period|Adverse Event|0|||
16389420|NCT02776683|39908657|FG000|Pre-switch Period|Withdrawal by Subject|9|||
16389421|NCT02776683|39908658|FG001|Pre-switch Period|Withdrawal by Subject|0|||
16389422|NCT02776683|39908657|FG000|Pre-switch Period|Physician Decision|7|||
16389423|NCT02776683|39908658|FG001|Pre-switch Period|Physician Decision|0|||
16389424|NCT02776683|39908657|FG000|Pre-switch Period|Progressive disease|39|||
16389425|NCT02776683|39908658|FG001|Pre-switch Period|Progressive disease|0|||
16389426|NCT02776683|39908657|FG000|Pre-switch Period|Other than listed|3|||
16499918|NCT03070392|40302983|FG000|Overall Study|Ongoing|73|||
16499919|NCT03070392|40302984|FG001|Overall Study|Ongoing|0|||
16309777|NCT00443729|39619089|FG000|Overall Study|Never Treated|0|||
16309778|NCT00443729|39619090|FG001|Overall Study|Never Treated|1|||
16309779|NCT00443729|39619089|FG000|Overall Study|Lack of Efficacy|4|||
16309780|NCT00443729|39619090|FG001|Overall Study|Lack of Efficacy|2|||
16309781|NCT00443729|39619089|FG000|Overall Study|Lost to Follow-up|0|||
16309782|NCT00443729|39619090|FG001|Overall Study|Lost to Follow-up|1|||
16309783|NCT00443729|39619089|FG000|Overall Study|Physician Decision|2|||
16309784|NCT00443729|39619090|FG001|Overall Study|Physician Decision|1|||
16309785|NCT00443729|39619089|FG000|Overall Study|Protocol Violation|1|||
16309786|NCT00443729|39619090|FG001|Overall Study|Protocol Violation|1|||
16309787|NCT00443729|39619089|FG000|Overall Study|Withdrawal by Subject|3|||
16309788|NCT00443729|39619090|FG001|Overall Study|Withdrawal by Subject|1|||
16309789|NCT04688671|39619093|FG000|Overall Study|Adverse Event|3|||
16309790|NCT04688671|39619094|FG001|Overall Study|Adverse Event|1|||
16309791|NCT04688671|39619093|FG000|Overall Study|Withdrawal by Subject|3|||
16309792|NCT04688671|39619094|FG001|Overall Study|Withdrawal by Subject|1|||
16309793|NCT04688671|39619093|FG000|Overall Study|Lack of Efficacy|1|||
16309794|NCT04688671|39619094|FG001|Overall Study|Lack of Efficacy|1|||
16309795|NCT04688671|39619093|FG000|Overall Study|Protocol Violation|1|||
16309796|NCT04688671|39619094|FG001|Overall Study|Protocol Violation|0|||
16309797|NCT04688671|39619093|FG000|Overall Study|Lost to Follow-up|0|||
16309798|NCT04688671|39619094|FG001|Overall Study|Lost to Follow-up|1|||
16309799|NCT02040805|39619095|FG000|Overall Study|Lost to Follow-up|14|||
16309800|NCT02040805|39619096|FG001|Overall Study|Lost to Follow-up|9|||
16309801|NCT02040805|39619095|FG000|Overall Study|Withdrawal by Subject|28|||
16309802|NCT02040805|39619096|FG001|Overall Study|Withdrawal by Subject|41|||
16309803|NCT00545714|39619097|FG000|Induction Phase (6 Months)|Physician Decision|3|||
16309804|NCT00545714|39619097|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
16389427|NCT02776683|39908658|FG001|Pre-switch Period|Other than listed|0|||
16389428|NCT02776683|39908657|FG000|Post-switch Period|Adverse Event|0|||
16389429|NCT02776683|39908658|FG001|Post-switch Period|Adverse Event|3|||
16499920|NCT03070392|40302985|FG002|Overall Study|Ongoing|0|||
16499921|NCT03070392|40302986|FG003|Overall Study|Ongoing|11|||
16309805|NCT00545714|39619097|FG000|Induction Phase (6 Months)|Disease Progression|1|||
16309806|NCT00545714|39619097|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
16309807|NCT00545714|39619097|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
16309808|NCT00545714|39619097|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
16309809|NCT00545714|39619097|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
16389430|NCT02776683|39908657|FG000|Post-switch Period|Withdrawal by Subject|0|||
16309810|NCT00545714|39619097|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
16499922|NCT00695396|40302987|FG000|Overall Study|Study Closed Prematurely|5|||
16499923|NCT00695396|40302988|FG001|Overall Study|Study Closed Prematurely|6|||
16499924|NCT00695396|40302989|FG002|Overall Study|Study Closed Prematurely|8|||
16499925|NCT00695396|40302987|FG000|Overall Study|Withdrawal by Subject|2|||
16499926|NCT00695396|40302988|FG001|Overall Study|Withdrawal by Subject|2|||
16499927|NCT00695396|40302989|FG002|Overall Study|Withdrawal by Subject|0|||
16499928|NCT01084174|40302991|FG000|Overall Study|gastrointestinal symptoms|1|||
16499929|NCT01084174|40302992|FG001|Overall Study|gastrointestinal symptoms|1|||
16499930|NCT01084174|40302991|FG000|Overall Study|Eosinophilic esophagitis|0|||
16499931|NCT01084174|40302992|FG001|Overall Study|Eosinophilic esophagitis|1|||
16499932|NCT01084174|40302991|FG000|Overall Study|Anaphylaxis|0|||
16499933|NCT01084174|40302992|FG001|Overall Study|Anaphylaxis|1|||
16499934|NCT01084174|40302991|FG000|Overall Study|Participant noncompliance|0|||
16309811|NCT00545714|39619097|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
16309812|NCT00545714|39619097|FG000|Maintenance Phase (36 Months)|Death|2|||
16309813|NCT01564537|39619098|FG000|Overall Study|Site Terminated by Sponsor|1|||
16309814|NCT01564537|39619099|FG001|Overall Study|Site Terminated by Sponsor|0|||
16309815|NCT01564537|39619098|FG000|Overall Study|Withdrawal by Subject|12|||
16309816|NCT01564537|39619099|FG001|Overall Study|Withdrawal by Subject|14|||
16309817|NCT01564537|39619098|FG000|Overall Study|Lost to Follow-up|7|||
16309818|NCT01564537|39619099|FG001|Overall Study|Lost to Follow-up|3|||
16309819|NCT01564537|39619098|FG000|Overall Study|Reason not specified|81|||
16309820|NCT01564537|39619099|FG001|Overall Study|Reason not specified|82|||
16309821|NCT00116779|39619100|FG000|Overall Study|Adverse Event|4|||
16309822|NCT00116779|39619101|FG001|Overall Study|Adverse Event|2|||
16309823|NCT00116779|39619100|FG000|Overall Study|Protocol Violation|1|||
16309824|NCT00116779|39619101|FG001|Overall Study|Protocol Violation|4|||
16309825|NCT00116779|39619100|FG000|Overall Study|Withdrawal by Subject|4|||
16309826|NCT00116779|39619101|FG001|Overall Study|Withdrawal by Subject|1|||
16499935|NCT01084174|40302992|FG001|Overall Study|Participant noncompliance|1|||
16499936|NCT01361464|40302993|FG000|Overall Study|Death|1|||
16499937|NCT01361464|40302993|FG000|Overall Study|Withdrawal by Subject|2|||
16499938|NCT00503308|40302999|FG000|Overall Study|Protocol Violation|2|||
16499939|NCT00503308|40303000|FG001|Overall Study|Protocol Violation|1|||
16499940|NCT02659631|40303002|FG000|Overall Study|Lost to Follow-up|0|||
16499941|NCT02659631|40303003|FG001|Overall Study|Lost to Follow-up|0|||
16499942|NCT02659631|40303004|FG002|Overall Study|Lost to Follow-up|2|||
16499943|NCT02659631|40303005|FG003|Overall Study|Lost to Follow-up|0|||
16499944|NCT02659631|40303006|FG004|Overall Study|Lost to Follow-up|0|||
16309827|NCT00116779|39619100|FG000|Overall Study|Inadequate testosterone suppression|7|||
16309828|NCT00116779|39619101|FG001|Overall Study|Inadequate testosterone suppression|9|||
16309829|NCT00116779|39619100|FG000|Overall Study|Physician Decision|3|||
16309830|NCT00116779|39619101|FG001|Overall Study|Physician Decision|1|||
16309831|NCT00116779|39619100|FG000|Overall Study|Elevated PSA levels|2|||
16309832|NCT00116779|39619101|FG001|Overall Study|Elevated PSA levels|2|||
16309833|NCT01112059|39619102|FG000|Overall Study|Withdrawal by Subject|1|||
16309834|NCT01112059|39619103|FG001|Overall Study|Withdrawal by Subject|0|||
16309835|NCT02328014|39619104|FG000|Overall Study|Adverse Event|1|||
16309836|NCT02328014|39619105|FG001|Overall Study|Adverse Event|0|||
16309837|NCT02328014|39619106|FG002|Overall Study|Adverse Event|0|||
16309838|NCT02328014|39619107|FG003|Overall Study|Adverse Event|1|||
16309839|NCT02328014|39619104|FG000|Overall Study|Death|0|||
16309840|NCT02328014|39619105|FG001|Overall Study|Death|0|||
16309841|NCT02328014|39619106|FG002|Overall Study|Death|0|||
16309842|NCT02328014|39619107|FG003|Overall Study|Death|4|||
16309843|NCT02328014|39619104|FG000|Overall Study|Physician Decision|0|||
16309844|NCT02328014|39619105|FG001|Overall Study|Physician Decision|0|||
16309845|NCT02328014|39619106|FG002|Overall Study|Physician Decision|0|||
16309846|NCT02328014|39619107|FG003|Overall Study|Physician Decision|1|||
16309847|NCT02328014|39619104|FG000|Overall Study|Disease Progression|1|||
16309848|NCT02328014|39619105|FG001|Overall Study|Disease Progression|0|||
16309849|NCT02328014|39619106|FG002|Overall Study|Disease Progression|1|||
16309850|NCT02328014|39619107|FG003|Overall Study|Disease Progression|3|||
16309851|NCT02328014|39619104|FG000|Overall Study|Study Terminated by Sponsor|4|||
16309852|NCT02328014|39619105|FG001|Overall Study|Study Terminated by Sponsor|1|||
16309853|NCT02328014|39619106|FG002|Overall Study|Study Terminated by Sponsor|1|||
16499945|NCT02659631|40303007|FG005|Overall Study|Lost to Follow-up|1|||
16309854|NCT02328014|39619107|FG003|Overall Study|Study Terminated by Sponsor|0|||
16309855|NCT02328014|39619104|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
16309856|NCT02328014|39619105|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
16309857|NCT02328014|39619106|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
16389431|NCT02776683|39908658|FG001|Post-switch Period|Withdrawal by Subject|2|||
16499946|NCT02659631|40303008|FG006|Overall Study|Lost to Follow-up|0|||
16499947|NCT02659631|40303009|FG007|Overall Study|Lost to Follow-up|0|||
16499948|NCT02659631|40303010|FG008|Overall Study|Lost to Follow-up|0|||
16499949|NCT02659631|40303011|FG009|Overall Study|Lost to Follow-up|0|||
16309858|NCT02328014|39619107|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
16499950|NCT02659631|40303002|FG000|Overall Study|Withdrawal prior to treatment|0|||
16389432|NCT02776683|39908657|FG000|Post-switch Period|Physician Decision|0|||
16389433|NCT02776683|39908658|FG001|Post-switch Period|Physician Decision|3|||
16389434|NCT02776683|39908657|FG000|Post-switch Period|Progressive disease|0|||
16389435|NCT02776683|39908658|FG001|Post-switch Period|Progressive disease|20|||
16389436|NCT02776683|39908657|FG000|Post-switch Period|Other than listed|0|||
16389437|NCT02776683|39908658|FG001|Post-switch Period|Other than listed|15|||
16389438|NCT00551031|39908661|FG000|Overall Study|Adverse Event|0|||
16389439|NCT00551031|39908662|FG001|Overall Study|Adverse Event|1|||
16389440|NCT00551031|39908663|FG002|Overall Study|Adverse Event|0|||
16499951|NCT02659631|40303003|FG001|Overall Study|Withdrawal prior to treatment|0|||
16499952|NCT02659631|40303004|FG002|Overall Study|Withdrawal prior to treatment|0|||
16499953|NCT02659631|40303005|FG003|Overall Study|Withdrawal prior to treatment|0|||
16499954|NCT02659631|40303006|FG004|Overall Study|Withdrawal prior to treatment|1|||
16499955|NCT02659631|40303007|FG005|Overall Study|Withdrawal prior to treatment|0|||
16499956|NCT02659631|40303008|FG006|Overall Study|Withdrawal prior to treatment|0|||
16499957|NCT02659631|40303009|FG007|Overall Study|Withdrawal prior to treatment|0|||
16499958|NCT02659631|40303010|FG008|Overall Study|Withdrawal prior to treatment|0|||
16499959|NCT02659631|40303011|FG009|Overall Study|Withdrawal prior to treatment|0|||
16499960|NCT02659631|40303002|FG000|Overall Study|Participant refused further follow-up|0|||
16499961|NCT02659631|40303003|FG001|Overall Study|Participant refused further follow-up|0|||
16499962|NCT02659631|40303004|FG002|Overall Study|Participant refused further follow-up|0|||
16499963|NCT02659631|40303005|FG003|Overall Study|Participant refused further follow-up|1|||
16499964|NCT02659631|40303006|FG004|Overall Study|Participant refused further follow-up|0|||
16499965|NCT02659631|40303007|FG005|Overall Study|Participant refused further follow-up|0|||
16499966|NCT02659631|40303008|FG006|Overall Study|Participant refused further follow-up|0|||
16499967|NCT02659631|40303009|FG007|Overall Study|Participant refused further follow-up|0|||
16499968|NCT02659631|40303010|FG008|Overall Study|Participant refused further follow-up|1|||
16499969|NCT02659631|40303011|FG009|Overall Study|Participant refused further follow-up|0|||
16499970|NCT02659631|40303002|FG000|Overall Study|Death (follow-up phase)|1|||
16499971|NCT02659631|40303003|FG001|Overall Study|Death (follow-up phase)|2|||
16499972|NCT02659631|40303004|FG002|Overall Study|Death (follow-up phase)|1|||
16499973|NCT02659631|40303005|FG003|Overall Study|Death (follow-up phase)|1|||
16499974|NCT02659631|40303006|FG004|Overall Study|Death (follow-up phase)|3|||
16499975|NCT02659631|40303007|FG005|Overall Study|Death (follow-up phase)|2|||
16499976|NCT02659631|40303008|FG006|Overall Study|Death (follow-up phase)|0|||
16499977|NCT02659631|40303009|FG007|Overall Study|Death (follow-up phase)|3|||
16499978|NCT02659631|40303010|FG008|Overall Study|Death (follow-up phase)|1|||
16499979|NCT02659631|40303011|FG009|Overall Study|Death (follow-up phase)|0|||
16499980|NCT02659631|40303002|FG000|Overall Study|Death (treatment phase)|0|||
16499981|NCT02659631|40303003|FG001|Overall Study|Death (treatment phase)|0|||
16499982|NCT02659631|40303004|FG002|Overall Study|Death (treatment phase)|0|||
16499983|NCT02659631|40303005|FG003|Overall Study|Death (treatment phase)|0|||
16499984|NCT02659631|40303006|FG004|Overall Study|Death (treatment phase)|1|||
16499985|NCT02659631|40303007|FG005|Overall Study|Death (treatment phase)|0|||
16499986|NCT02659631|40303008|FG006|Overall Study|Death (treatment phase)|1|||
16499987|NCT02659631|40303009|FG007|Overall Study|Death (treatment phase)|0|||
16499988|NCT02659631|40303010|FG008|Overall Study|Death (treatment phase)|0|||
16499989|NCT02659631|40303011|FG009|Overall Study|Death (treatment phase)|0|||
16499990|NCT02528643|40303014|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
16499991|NCT02528643|40303015|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
16499992|NCT02528643|40303014|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
16499993|NCT02528643|40303015|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
16499994|NCT02528643|40303014|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
16499995|NCT02528643|40303015|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
16499996|NCT02528643|40303014|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
16499997|NCT02528643|40303015|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
16499998|NCT02528643|40303014|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
16499999|NCT02528643|40303015|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
16500000|NCT02528643|40303014|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
16500001|NCT02528643|40303015|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
16500002|NCT02528643|40303014|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
16500003|NCT02528643|40303015|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
16500004|NCT00383149|40303016|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
16500005|NCT00383149|40303016|FG000|Overall Study|Death|2|||
16500006|NCT00383149|40303016|FG000|Overall Study|Disease Progression|38|||
16500007|NCT00383149|40303016|FG000|Overall Study|Lost to Follow-up|1|||
16500008|NCT00383149|40303016|FG000|Overall Study|Other|1|||
16500009|NCT00383149|40303016|FG000|Overall Study|Study Drug Toxicity|4|||
16500010|NCT00383149|40303016|FG000|Overall Study|Request to Discontinue Treatment|4|||
16500011|NCT00383149|40303016|FG000|Overall Study|Participant Withdrew Consent|1|||
16500012|NCT02063854|40303018|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
16389441|NCT00551031|39908664|FG003|Overall Study|Adverse Event|0|||
16389442|NCT00551031|39908665|FG004|Overall Study|Adverse Event|0|||
16389443|NCT00551031|39908661|FG000|Overall Study|Protocol Violation|1|||
16500013|NCT02063854|40303019|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
16500014|NCT02063854|40303020|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
16088310|NCT03732807|38813860|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
16088311|NCT03732807|38813861|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
16309859|NCT02328014|39619104|FG000|Overall Study|Withdrawal by Subject|0|||
16309860|NCT02328014|39619105|FG001|Overall Study|Withdrawal by Subject|0|||
16309861|NCT02328014|39619106|FG002|Overall Study|Withdrawal by Subject|0|||
16309862|NCT02328014|39619107|FG003|Overall Study|Withdrawal by Subject|1|||
16309863|NCT00838526|39619108|FG000|Overall Study|Adverse Event|3|||
16309864|NCT00838526|39619109|FG001|Overall Study|Adverse Event|12|||
16309865|NCT00838526|39619108|FG000|Overall Study|Lost to Follow-up|4|||
16309866|NCT00838526|39619109|FG001|Overall Study|Lost to Follow-up|12|||
16309867|NCT00838526|39619108|FG000|Overall Study|Withdrawal by Subject|4|||
16309868|NCT00838526|39619109|FG001|Overall Study|Withdrawal by Subject|5|||
16309869|NCT00838526|39619108|FG000|Overall Study|Lack of Efficacy|2|||
16309870|NCT00838526|39619109|FG001|Overall Study|Lack of Efficacy|3|||
16309871|NCT00838526|39619108|FG000|Overall Study|Other|11|||
16309872|NCT00838526|39619109|FG001|Overall Study|Other|7|||
16309873|NCT01149863|39619110|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
16309874|NCT00577863|39619116|FG000|Overall Study|Adverse Event|4|||
16309875|NCT00577863|39619117|FG001|Overall Study|Adverse Event|2|||
16309876|NCT00577863|39619116|FG000|Overall Study|Death|1|||
16309877|NCT00577863|39619117|FG001|Overall Study|Death|0|||
16309878|NCT00577863|39619116|FG000|Overall Study|Lost to Follow-up|2|||
16309879|NCT00577863|39619117|FG001|Overall Study|Lost to Follow-up|2|||
16309880|NCT00577863|39619116|FG000|Overall Study|Entry Criteria Exclusion|1|||
16309881|NCT00577863|39619117|FG001|Overall Study|Entry Criteria Exclusion|0|||
16309882|NCT00577863|39619116|FG000|Overall Study|Withdrawal by Subject|0|||
16309883|NCT00577863|39619117|FG001|Overall Study|Withdrawal by Subject|2|||
16309884|NCT00577863|39619116|FG000|Overall Study|Sponsor Decision|2|||
16309885|NCT00577863|39619117|FG001|Overall Study|Sponsor Decision|7|||
16309886|NCT00577863|39619116|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
16309887|NCT00577863|39619117|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
16309888|NCT04067050|39619122|FG000|One Month|Lost to Follow-up|4|||
16309889|NCT04067050|39619123|FG001|One Month|Lost to Follow-up|0|||
16309890|NCT04067050|39619122|FG000|Two Month|Lost to Follow-up|1|||
16309891|NCT04067050|39619123|FG001|Two Month|Lost to Follow-up|0|||
16309892|NCT04067050|39619122|FG000|Two Month|Adverse Event|1|||
16309893|NCT04067050|39619123|FG001|Two Month|Adverse Event|0|||
16309894|NCT01368497|39619124|FG000|Overall Study|Lost to Follow-up|2|||
16309895|NCT03657797|39619131|FG000|Overall Study|Lost to Follow-up|0|||
16309896|NCT03657797|39619132|FG001|Overall Study|Lost to Follow-up|1|||
16309897|NCT03657797|39619133|FG002|Overall Study|Lost to Follow-up|1|||
16309898|NCT03657797|39619134|FG003|Overall Study|Lost to Follow-up|0|||
16309899|NCT03657797|39619131|FG000|Overall Study|Physician Decision|0|||
16500015|NCT02063854|40303021|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
16500016|NCT02063854|40303022|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
16500017|NCT02063854|40303023|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
16500018|NCT02063854|40303024|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
16500019|NCT02063854|40303018|FG000|Overall Study|Major Protocol Deviation|0|||
16500020|NCT02063854|40303019|FG001|Overall Study|Major Protocol Deviation|0|||
16500021|NCT02063854|40303020|FG002|Overall Study|Major Protocol Deviation|3|||
16500022|NCT02063854|40303021|FG003|Overall Study|Major Protocol Deviation|0|||
16500023|NCT02063854|40303022|FG004|Overall Study|Major Protocol Deviation|0|||
16500024|NCT02063854|40303023|FG005|Overall Study|Major Protocol Deviation|0|||
16500025|NCT02063854|40303024|FG006|Overall Study|Major Protocol Deviation|0|||
16500026|NCT02063854|40303018|FG000|Overall Study|Voluntary Withdrawal|2|||
16500027|NCT02063854|40303019|FG001|Overall Study|Voluntary Withdrawal|0|||
16500028|NCT02063854|40303020|FG002|Overall Study|Voluntary Withdrawal|8|||
16500029|NCT02063854|40303021|FG003|Overall Study|Voluntary Withdrawal|1|||
16309900|NCT03657797|39619132|FG001|Overall Study|Physician Decision|1|||
16309901|NCT03657797|39619133|FG002|Overall Study|Physician Decision|0|||
16309902|NCT03657797|39619134|FG003|Overall Study|Physician Decision|0|||
16309903|NCT03657797|39619131|FG000|Overall Study|Withdrawal by Subject|0|||
16309904|NCT03657797|39619132|FG001|Overall Study|Withdrawal by Subject|1|||
16389444|NCT00551031|39908662|FG001|Overall Study|Protocol Violation|1|||
16389445|NCT00551031|39908663|FG002|Overall Study|Protocol Violation|0|||
16389446|NCT00551031|39908664|FG003|Overall Study|Protocol Violation|0|||
16500030|NCT02063854|40303022|FG004|Overall Study|Voluntary Withdrawal|3|||
16309905|NCT03657797|39619133|FG002|Overall Study|Withdrawal by Subject|2|||
16309906|NCT03657797|39619134|FG003|Overall Study|Withdrawal by Subject|0|||
16309907|NCT03657797|39619131|FG000|Overall Study|Adverse Event|0|||
16309908|NCT03657797|39619132|FG001|Overall Study|Adverse Event|0|||
16389447|NCT00551031|39908665|FG004|Overall Study|Protocol Violation|0|||
16309909|NCT03657797|39619133|FG002|Overall Study|Adverse Event|2|||
16309910|NCT03657797|39619134|FG003|Overall Study|Adverse Event|0|||
16309911|NCT01214655|39619135|FG000|Part A|Progressive Disease|7|||
16309912|NCT01214655|39619136|FG001|Part A|Progressive Disease|0|||
16500031|NCT02063854|40303023|FG005|Overall Study|Voluntary Withdrawal|6|||
16500032|NCT02063854|40303024|FG006|Overall Study|Voluntary Withdrawal|1|||
16500033|NCT02063854|40303018|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
16500034|NCT02063854|40303019|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
16309913|NCT01214655|39619137|FG002|Part A|Progressive Disease|0|||
16309914|NCT01214655|39619135|FG000|Part A|Physician Decision|1|||
16309915|NCT01214655|39619136|FG001|Part A|Physician Decision|0|||
16309916|NCT01214655|39619137|FG002|Part A|Physician Decision|0|||
16500035|NCT02063854|40303020|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
16500036|NCT02063854|40303021|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
16500037|NCT02063854|40303022|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
16500038|NCT02063854|40303023|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
16500039|NCT02063854|40303024|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
16500040|NCT02063854|40303018|FG000|Overall Study|Reason Not Specified|1|||
16309917|NCT01214655|39619135|FG000|Part B|Progressive disease|0|||
16309918|NCT01214655|39619136|FG001|Part B|Progressive disease|10|||
16309919|NCT01214655|39619137|FG002|Part B|Progressive disease|0|||
16309920|NCT01214655|39619135|FG000|Part B|Death|0|||
16309921|NCT01214655|39619136|FG001|Part B|Death|1|||
16309922|NCT01214655|39619137|FG002|Part B|Death|0|||
16309923|NCT01214655|39619135|FG000|Part B|Withdrawal by Subject|0|||
16309924|NCT01214655|39619136|FG001|Part B|Withdrawal by Subject|2|||
16309925|NCT01214655|39619137|FG002|Part B|Withdrawal by Subject|0|||
16309926|NCT01214655|39619135|FG000|Part C|Progressive Disease|0|||
16309927|NCT01214655|39619136|FG001|Part C|Progressive Disease|0|||
16309928|NCT01214655|39619137|FG002|Part C|Progressive Disease|5|||
16500041|NCT02063854|40303019|FG001|Overall Study|Reason Not Specified|0|||
16500042|NCT02063854|40303020|FG002|Overall Study|Reason Not Specified|0|||
16500043|NCT02063854|40303021|FG003|Overall Study|Reason Not Specified|0|||
16500044|NCT02063854|40303022|FG004|Overall Study|Reason Not Specified|0|||
16500045|NCT02063854|40303023|FG005|Overall Study|Reason Not Specified|0|||
16500046|NCT02063854|40303024|FG006|Overall Study|Reason Not Specified|0|||
16500047|NCT02063854|40303018|FG000|Overall Study|Did Not Receive Study Drug|0|||
16500048|NCT02063854|40303019|FG001|Overall Study|Did Not Receive Study Drug|0|||
16500049|NCT02063854|40303020|FG002|Overall Study|Did Not Receive Study Drug|0|||
16500050|NCT02063854|40303021|FG003|Overall Study|Did Not Receive Study Drug|0|||
16500051|NCT02063854|40303022|FG004|Overall Study|Did Not Receive Study Drug|0|||
16500052|NCT02063854|40303023|FG005|Overall Study|Did Not Receive Study Drug|1|||
16500053|NCT02063854|40303024|FG006|Overall Study|Did Not Receive Study Drug|0|||
16500054|NCT00788151|40303025|FG000|Overall Study|Other adverse event|0|||
16500055|NCT00788151|40303026|FG001|Overall Study|Other adverse event|2|||
16500056|NCT00788151|40303025|FG000|Overall Study|Protocol Violation|0|||
16500057|NCT00788151|40303026|FG001|Overall Study|Protocol Violation|1|||
16500058|NCT00788151|40303025|FG000|Overall Study|Withdrawal by Subject|13|||
16500059|NCT00788151|40303026|FG001|Overall Study|Withdrawal by Subject|6|||
16500060|NCT00788151|40303025|FG000|Overall Study|Enrolled but not treated|1|||
16500061|NCT00788151|40303026|FG001|Overall Study|Enrolled but not treated|1|||
16500062|NCT04779489|40303029|FG000|Overall Study|Physician Decision|1|||
16500063|NCT02743806|40303033|FG000|Overall Study|Adverse Event|9|||
16500064|NCT02743806|40303033|FG000|Overall Study|Lost to Follow-up|8|||
16500065|NCT02743806|40303033|FG000|Overall Study|Voluntary Withdrawal|54|||
16500066|NCT02743806|40303033|FG000|Overall Study|Study Termination|65|||
16500067|NCT02743806|40303033|FG000|Overall Study|Pregnancy|6|||
16500068|NCT02743806|40303033|FG000|Overall Study|No Longer Clinically Benefiting|27|||
16500069|NCT02743806|40303033|FG000|Overall Study|Reason Not Specified|12|||
16500070|NCT03251079|40303034|FG000|Overall Study|Withdrawal by Subject|1|||
16389448|NCT00551031|39908661|FG000|Overall Study|Lost to Follow-up|0|||
16389449|NCT00551031|39908662|FG001|Overall Study|Lost to Follow-up|1|||
16500071|NCT00202644|40303035|FG000|Overall Study|Adverse Event|12|||
16500072|NCT00202644|40303036|FG001|Overall Study|Adverse Event|13|||
16500073|NCT00202644|40303035|FG000|Overall Study|Withdrawal by Subject|8|||
16500074|NCT00202644|40303036|FG001|Overall Study|Withdrawal by Subject|6|||
16500075|NCT00202644|40303035|FG000|Overall Study|Lack of Efficacy|6|||
16500076|NCT00202644|40303036|FG001|Overall Study|Lack of Efficacy|6|||
16500077|NCT00202644|40303035|FG000|Overall Study|Lost to Follow-up|0|||
16500078|NCT00202644|40303036|FG001|Overall Study|Lost to Follow-up|1|||
16500079|NCT00202644|40303035|FG000|Overall Study|Other|9|||
16500080|NCT00202644|40303036|FG001|Overall Study|Other|1|||
16500081|NCT01254227|40303039|FG000|Overall Study|Withdrawal by Subject|6|||
16309929|NCT01214655|39619135|FG000|Part C|Death|0|||
16309930|NCT01214655|39619136|FG001|Part C|Death|0|||
16309931|NCT01214655|39619137|FG002|Part C|Death|1|||
16309932|NCT01214655|39619135|FG000|Part C|Physician Decision|0|||
16309933|NCT01214655|39619136|FG001|Part C|Physician Decision|0|||
16309934|NCT01214655|39619137|FG002|Part C|Physician Decision|1|||
16309935|NCT00445432|39619138|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
16309936|NCT00445432|39619139|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
16309937|NCT00445432|39619140|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
16309938|NCT00445432|39619141|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
16500082|NCT01254227|40303039|FG000|Overall Study|Lost to Follow-up|6|||
16500083|NCT01254227|40303039|FG000|Overall Study|Adverse Event|5|||
16500084|NCT01254227|40303039|FG000|Overall Study|Abnormal test procedure result|5|||
16500085|NCT01254227|40303039|FG000|Overall Study|Administrative problems|2|||
16500086|NCT01254227|40303039|FG000|Overall Study|Death|1|||
16500087|NCT01254227|40303039|FG000|Overall Study|Protocol deviation|1|||
16500088|NCT00085631|40303040|FG000|Overall Study|Missing Data|4|||
16500089|NCT00085631|40303041|FG001|Overall Study|Missing Data|11|||
16500090|NCT00085631|40303042|FG002|Overall Study|Missing Data|7|||
16500091|NCT04080297|40303043|FG000|Overall Study|Adverse Event|1|||
16500092|NCT04080297|40303044|FG001|Overall Study|Adverse Event|3|||
16500093|NCT04080297|40303043|FG000|Overall Study|concurrent illness|1|||
16500094|NCT04080297|40303044|FG001|Overall Study|concurrent illness|0|||
16500095|NCT01853046|40303045|FG000|Overall Study|Withdrawal by Subject|1|||
16500096|NCT01853046|40303046|FG001|Overall Study|Withdrawal by Subject|1|||
16500097|NCT01853046|40303045|FG000|Overall Study|Adverse Event|4|||
16500098|NCT01853046|40303046|FG001|Overall Study|Adverse Event|2|||
16500099|NCT01853046|40303045|FG000|Overall Study|Disease progression|13|||
16500100|NCT01853046|40303046|FG001|Overall Study|Disease progression|3|||
16500101|NCT00455429|40303057|FG000|Overall Study|Study Terminated by Sponsor|0|||
16500102|NCT00455429|40303058|FG001|Overall Study|Study Terminated by Sponsor|0|||
16500103|NCT00455429|40303059|FG002|Overall Study|Study Terminated by Sponsor|0|||
16500104|NCT00455429|40303060|FG003|Overall Study|Study Terminated by Sponsor|3|||
16500105|NCT00455429|40303057|FG000|Overall Study|Lost to Follow-up|1|||
16500106|NCT00455429|40303058|FG001|Overall Study|Lost to Follow-up|0|||
16500107|NCT00455429|40303059|FG002|Overall Study|Lost to Follow-up|0|||
16500108|NCT00455429|40303060|FG003|Overall Study|Lost to Follow-up|3|||
16500109|NCT00455429|40303057|FG000|Overall Study|Withdrawal by Subject|0|||
16500110|NCT00455429|40303058|FG001|Overall Study|Withdrawal by Subject|1|||
16500111|NCT00455429|40303059|FG002|Overall Study|Withdrawal by Subject|1|||
16500112|NCT00455429|40303060|FG003|Overall Study|Withdrawal by Subject|0|||
16500113|NCT00455429|40303057|FG000|Overall Study|Lack of Efficacy|0|||
16500114|NCT00455429|40303058|FG001|Overall Study|Lack of Efficacy|1|||
16500115|NCT00455429|40303059|FG002|Overall Study|Lack of Efficacy|0|||
16500116|NCT00455429|40303060|FG003|Overall Study|Lack of Efficacy|1|||
16500117|NCT00455429|40303057|FG000|Overall Study|Adverse Event|0|||
16500118|NCT00455429|40303058|FG001|Overall Study|Adverse Event|1|||
16500119|NCT00455429|40303059|FG002|Overall Study|Adverse Event|0|||
16500120|NCT00455429|40303060|FG003|Overall Study|Adverse Event|3|||
16309939|NCT00445432|39619138|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
16309940|NCT00445432|39619139|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
16309941|NCT00445432|39619140|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
16309942|NCT00445432|39619141|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
16309943|NCT00445432|39619138|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
16309944|NCT00445432|39619139|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
16309945|NCT00445432|39619140|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
16088312|NCT03732807|38813855|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
16088313|NCT03732807|38813856|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
16309946|NCT00445432|39619141|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
16389450|NCT00551031|39908663|FG002|Overall Study|Lost to Follow-up|0|||
16389451|NCT00551031|39908664|FG003|Overall Study|Lost to Follow-up|1|||
16500121|NCT00455429|40303057|FG000|Overall Study|Randomly assigned but not treated|0|||
16500122|NCT00455429|40303058|FG001|Overall Study|Randomly assigned but not treated|0|||
16500123|NCT00455429|40303059|FG002|Overall Study|Randomly assigned but not treated|0|||
16500124|NCT00455429|40303060|FG003|Overall Study|Randomly assigned but not treated|2|||
16500125|NCT00455429|40303057|FG000|Overall Study|Personal Reason|1|||
16500126|NCT00455429|40303058|FG001|Overall Study|Personal Reason|0|||
16500127|NCT00455429|40303059|FG002|Overall Study|Personal Reason|0|||
16500128|NCT00455429|40303060|FG003|Overall Study|Personal Reason|0|||
16500129|NCT00455429|40303057|FG000|Overall Study|Non-compliance|0|||
16500130|NCT00455429|40303058|FG001|Overall Study|Non-compliance|0|||
16500131|NCT00455429|40303059|FG002|Overall Study|Non-compliance|0|||
16500132|NCT00455429|40303060|FG003|Overall Study|Non-compliance|1|||
16500133|NCT00455429|40303057|FG000|Overall Study|Other|0|||
16500134|NCT00455429|40303058|FG001|Overall Study|Other|2|||
16500135|NCT00455429|40303059|FG002|Overall Study|Other|0|||
16500136|NCT00455429|40303060|FG003|Overall Study|Other|1|||
16500137|NCT03232281|40303061|FG000|Overall Study|Adverse Event|1|||
16500138|NCT03232281|40303062|FG001|Overall Study|Adverse Event|1|||
16500139|NCT03232281|40303061|FG000|Overall Study|Withdrawal by Subject|5|||
16500140|NCT03232281|40303062|FG001|Overall Study|Withdrawal by Subject|4|||
16500141|NCT03232281|40303061|FG000|Overall Study|Protocol Deviation|1|||
16500142|NCT03232281|40303062|FG001|Overall Study|Protocol Deviation|1|||
16500143|NCT00549302|40303063|FG000|Double-Blind|Death|2|||
16500144|NCT00549302|40303064|FG001|Double-Blind|Death|9|||
16500145|NCT00549302|40303065|FG002|Double-Blind|Death|0|||
16500146|NCT00549302|40303063|FG000|Double-Blind|Adverse Event|3|||
16500147|NCT00549302|40303064|FG001|Double-Blind|Adverse Event|16|||
16500148|NCT00549302|40303065|FG002|Double-Blind|Adverse Event|0|||
16500149|NCT00549302|40303063|FG000|Double-Blind|Withdrawal by Subject|3|||
16500150|NCT00549302|40303064|FG001|Double-Blind|Withdrawal by Subject|8|||
16500151|NCT00549302|40303065|FG002|Double-Blind|Withdrawal by Subject|0|||
16500152|NCT00549302|40303063|FG000|Double-Blind|Investigator Decision|1|||
16500153|NCT00549302|40303064|FG001|Double-Blind|Investigator Decision|5|||
16500154|NCT00549302|40303065|FG002|Double-Blind|Investigator Decision|0|||
16500155|NCT00549302|40303063|FG000|Double-Blind|Sponsor Decision|0|||
16500156|NCT00549302|40303064|FG001|Double-Blind|Sponsor Decision|1|||
16500157|NCT00549302|40303065|FG002|Double-Blind|Sponsor Decision|0|||
16500158|NCT00549302|40303063|FG000|Double-Blind|Lost to Follow-up|1|||
16500159|NCT00549302|40303064|FG001|Double-Blind|Lost to Follow-up|2|||
16500160|NCT00549302|40303065|FG002|Double-Blind|Lost to Follow-up|0|||
16500161|NCT00549302|40303063|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
16500162|NCT00549302|40303064|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
16195251|NCT02358369|39193280|FG000|Treatment Period A/B|Death|0|||
16195252|NCT02358369|39193281|FG001|Treatment Period A/B|Death|0|||
16195253|NCT02358369|39193282|FG002|Treatment Period A/B|Death|1|||
16195254|NCT02358369|39193283|FG003|Treatment Period A/B|Death|0|||
16195255|NCT02358369|39193284|FG004|Treatment Period A/B|Death|0|||
16195256|NCT02358369|39193280|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
16195257|NCT02358369|39193281|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
16195258|NCT02358369|39193282|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
16195259|NCT02358369|39193283|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
16195260|NCT02358369|39193284|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
16195261|NCT02358369|39193280|FG000|Treatment Period C|Adverse Event|0|||
16195262|NCT02358369|39193281|FG001|Treatment Period C|Adverse Event|0|||
16195263|NCT02358369|39193282|FG002|Treatment Period C|Adverse Event|0|||
16195264|NCT02358369|39193283|FG003|Treatment Period C|Adverse Event|0|||
16195265|NCT02358369|39193284|FG004|Treatment Period C|Adverse Event|7|||
16195266|NCT00448916|39193285|FG000|Overall Study|Adverse Event|2|||
16195267|NCT00448916|39193286|FG001|Overall Study|Adverse Event|2|||
16195268|NCT00448916|39193287|FG002|Overall Study|Adverse Event|3|||
16195269|NCT00448916|39193288|FG003|Overall Study|Adverse Event|2|||
16195270|NCT00448916|39193285|FG000|Overall Study|Lack of Efficacy|1|||
16195271|NCT00448916|39193286|FG001|Overall Study|Lack of Efficacy|0|||
16195272|NCT00448916|39193287|FG002|Overall Study|Lack of Efficacy|2|||
16195273|NCT00448916|39193288|FG003|Overall Study|Lack of Efficacy|1|||
16195274|NCT00448916|39193285|FG000|Overall Study|Withdrawal by Subject|3|||
16195275|NCT00448916|39193286|FG001|Overall Study|Withdrawal by Subject|3|||
16195276|NCT00448916|39193287|FG002|Overall Study|Withdrawal by Subject|1|||
16195277|NCT00448916|39193288|FG003|Overall Study|Withdrawal by Subject|1|||
16195278|NCT00448916|39193285|FG000|Overall Study|Other|1|||
16195279|NCT00448916|39193286|FG001|Overall Study|Other|0|||
16195280|NCT00448916|39193287|FG002|Overall Study|Other|0|||
16195281|NCT00448916|39193288|FG003|Overall Study|Other|0|||
16195282|NCT00448916|39193285|FG000|Overall Study|Lost to Follow-up|0|||
16195283|NCT00448916|39193286|FG001|Overall Study|Lost to Follow-up|1|||
16195284|NCT00448916|39193287|FG002|Overall Study|Lost to Follow-up|0|||
16500163|NCT00549302|40303065|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
16500164|NCT00549302|40303063|FG000|Double-Blind|New condition or starts new therapy|0|||
16500165|NCT00549302|40303064|FG001|Double-Blind|New condition or starts new therapy|2|||
16500166|NCT00549302|40303065|FG002|Double-Blind|New condition or starts new therapy|0|||
16500167|NCT00549302|40303063|FG000|Open-Label|Adverse Event|0|||
16500168|NCT00549302|40303064|FG001|Open-Label|Adverse Event|0|||
16500169|NCT00549302|40303065|FG002|Open-Label|Adverse Event|11|||
16500170|NCT00549302|40303063|FG000|Open-Label|Death|0|||
16088314|NCT03732807|38813857|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
16195285|NCT00448916|39193288|FG003|Overall Study|Lost to Follow-up|1|||
16195286|NCT00448916|39193285|FG000|Overall Study|Protocol Violation|0|||
16195287|NCT00448916|39193286|FG001|Overall Study|Protocol Violation|0|||
16195288|NCT00448916|39193287|FG002|Overall Study|Protocol Violation|0|||
16195289|NCT00448916|39193288|FG003|Overall Study|Protocol Violation|1|||
16389452|NCT00551031|39908665|FG004|Overall Study|Lost to Follow-up|1|||
16500171|NCT00549302|40303064|FG001|Open-Label|Death|0|||
16500172|NCT00549302|40303065|FG002|Open-Label|Death|40|||
16500173|NCT00549302|40303063|FG000|Open-Label|Investigator Decision|0|||
16195290|NCT00310388|39193291|FG000|Primary Reporting Phase|Adverse Event|101|||
16195291|NCT00310388|39193292|FG001|Primary Reporting Phase|Adverse Event|0|||
16195292|NCT00310388|39193291|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
16195293|NCT00310388|39193292|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
16195294|NCT00310388|39193291|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
16195295|NCT00310388|39193292|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
16195296|NCT00310388|39193291|FG000|Primary Reporting Phase|Protocol Violation|10|||
16195297|NCT00310388|39193292|FG001|Primary Reporting Phase|Protocol Violation|0|||
16195298|NCT00310388|39193291|FG000|Primary Reporting Phase|Pregnancy|3|||
16195299|NCT00310388|39193292|FG001|Primary Reporting Phase|Pregnancy|0|||
16195300|NCT00310388|39193291|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
16309947|NCT00445432|39619138|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
16309948|NCT00445432|39619139|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
16309949|NCT00445432|39619140|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
16500174|NCT00549302|40303064|FG001|Open-Label|Investigator Decision|0|||
16500175|NCT00549302|40303065|FG002|Open-Label|Investigator Decision|5|||
16500176|NCT00549302|40303063|FG000|Open-Label|Lost to Follow-up|0|||
16389453|NCT00551031|39908661|FG000|Overall Study|Withdrawal by Subject|0|||
16389454|NCT00551031|39908662|FG001|Overall Study|Withdrawal by Subject|4|||
16389455|NCT00551031|39908663|FG002|Overall Study|Withdrawal by Subject|1|||
16389456|NCT00551031|39908664|FG003|Overall Study|Withdrawal by Subject|2|||
16389457|NCT00551031|39908665|FG004|Overall Study|Withdrawal by Subject|0|||
16389458|NCT00551031|39908661|FG000|Overall Study|Serious Adverse Event|0|||
16389459|NCT00551031|39908662|FG001|Overall Study|Serious Adverse Event|2|||
16389460|NCT00551031|39908663|FG002|Overall Study|Serious Adverse Event|1|||
16389461|NCT00551031|39908664|FG003|Overall Study|Serious Adverse Event|0|||
16389462|NCT00551031|39908665|FG004|Overall Study|Serious Adverse Event|0|||
16389463|NCT00551031|39908661|FG000|Overall Study|Did not receive vaccine|1|||
16309950|NCT00445432|39619141|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
16309951|NCT00445432|39619138|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
16309952|NCT00445432|39619139|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
16309953|NCT00445432|39619140|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
16500177|NCT00549302|40303064|FG001|Open-Label|Lost to Follow-up|0|||
16500178|NCT00549302|40303065|FG002|Open-Label|Lost to Follow-up|2|||
16389464|NCT00551031|39908662|FG001|Overall Study|Did not receive vaccine|2|||
16389465|NCT00551031|39908663|FG002|Overall Study|Did not receive vaccine|0|||
16389466|NCT00551031|39908664|FG003|Overall Study|Did not receive vaccine|0|||
16389467|NCT00551031|39908665|FG004|Overall Study|Did not receive vaccine|0|||
16500179|NCT00549302|40303063|FG000|Open-Label|Other|0|||
16500180|NCT00549302|40303064|FG001|Open-Label|Other|0|||
16500181|NCT00549302|40303065|FG002|Open-Label|Other|3|||
16500182|NCT00549302|40303063|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
16500183|NCT00549302|40303064|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
16500184|NCT00549302|40303065|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
16389468|NCT02954458|39908666|FG000|Overall Study|Adverse Event|0|||
16389469|NCT02954458|39908667|FG001|Overall Study|Adverse Event|0|||
16389470|NCT02954458|39908668|FG002|Overall Study|Adverse Event|0|||
16389471|NCT02954458|39908669|FG003|Overall Study|Adverse Event|1|||
16389472|NCT02954458|39908666|FG000|Overall Study|Withdrawal by Subject|0|||
16389473|NCT02954458|39908667|FG001|Overall Study|Withdrawal by Subject|0|||
16389474|NCT02954458|39908668|FG002|Overall Study|Withdrawal by Subject|0|||
16389475|NCT02954458|39908669|FG003|Overall Study|Withdrawal by Subject|1|||
16389476|NCT02954458|39908666|FG000|Overall Study|Physician Decision|0|||
16389477|NCT02954458|39908667|FG001|Overall Study|Physician Decision|0|||
16389478|NCT02954458|39908668|FG002|Overall Study|Physician Decision|1|||
16389479|NCT02954458|39908669|FG003|Overall Study|Physician Decision|1|||
16389480|NCT02954458|39908666|FG000|Overall Study|Lost to Follow-up|1|||
16500185|NCT00549302|40303063|FG000|Open-Label|Withdrawal by Subject|0|||
16500186|NCT00549302|40303064|FG001|Open-Label|Withdrawal by Subject|0|||
16309954|NCT00445432|39619141|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
16309955|NCT00445432|39619138|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
16500187|NCT00549302|40303065|FG002|Open-Label|Withdrawal by Subject|6|||
16500188|NCT01034462|40303066|FG000|Overall Study|Adverse Event|7|||
16500189|NCT01034462|40303067|FG001|Overall Study|Adverse Event|17|||
16500190|NCT01034462|40303066|FG000|Overall Study|Lack of Efficacy|4|||
16500191|NCT01034462|40303067|FG001|Overall Study|Lack of Efficacy|4|||
16500192|NCT01034462|40303066|FG000|Overall Study|Protocol Violation|10|||
16500193|NCT01034462|40303067|FG001|Overall Study|Protocol Violation|7|||
16500194|NCT01034462|40303066|FG000|Overall Study|Withdrawal by Subject|9|||
16500195|NCT01034462|40303067|FG001|Overall Study|Withdrawal by Subject|8|||
16500196|NCT01034462|40303066|FG000|Overall Study|Lost to Follow-up|14|||
16500197|NCT01034462|40303067|FG001|Overall Study|Lost to Follow-up|16|||
16500198|NCT01034462|40303066|FG000|Overall Study|Other reasons|1|||
16500199|NCT01034462|40303067|FG001|Overall Study|Other reasons|2|||
16500200|NCT02733367|40303070|FG000|Overall Study|Withdrawal by Subject|6|||
16500201|NCT00323115|40303071|FG000|Vaccine Administration|Adverse Event|1|||
16500202|NCT00323115|40303071|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
16500203|NCT00462761|40303072|FG000|Overall Study|Adverse Event|6|||
16500204|NCT00462761|40303072|FG000|Overall Study|Withdrawal by Subject|9|||
16500205|NCT00462761|40303072|FG000|Overall Study|Physician Decision|5|||
16500206|NCT00462761|40303072|FG000|Overall Study|Disease progression|43|||
16500207|NCT00462761|40303072|FG000|Overall Study|Death|12|||
16500208|NCT00462761|40303072|FG000|Overall Study|Other|1|||
16500209|NCT02278263|40303073|FG000|Overall Study|Protocol Violation|7|||
16500210|NCT02278263|40303074|FG001|Overall Study|Protocol Violation|0|||
16500211|NCT02278263|40303075|FG002|Overall Study|Protocol Violation|9|||
16500212|NCT01349803|40303076|FG000|Overall Study|Adverse Event|0|||
16500213|NCT01349803|40303077|FG001|Overall Study|Adverse Event|0|||
16309956|NCT00445432|39619139|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
16309957|NCT00445432|39619140|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
16309958|NCT00445432|39619141|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
16500214|NCT01349803|40303078|FG002|Overall Study|Adverse Event|0|||
16500215|NCT01349803|40303079|FG003|Overall Study|Adverse Event|2|||
16500216|NCT01349803|40303076|FG000|Overall Study|Withdrawal by Subject|1|||
16500217|NCT01349803|40303077|FG001|Overall Study|Withdrawal by Subject|0|||
16500218|NCT01349803|40303078|FG002|Overall Study|Withdrawal by Subject|0|||
16500219|NCT01349803|40303079|FG003|Overall Study|Withdrawal by Subject|0|||
16500220|NCT01349803|40303076|FG000|Overall Study|Protocol-specified criteria|0|||
16500221|NCT01349803|40303077|FG001|Overall Study|Protocol-specified criteria|1|||
16500222|NCT01349803|40303078|FG002|Overall Study|Protocol-specified criteria|3|||
16500223|NCT01349803|40303079|FG003|Overall Study|Protocol-specified criteria|0|||
16500224|NCT01358357|40303080|FG000|Open Label Phase|Adverse Event|0|||
16500225|NCT01358357|40303081|FG001|Open Label Phase|Adverse Event|0|||
16500226|NCT01358357|40303082|FG002|Open Label Phase|Adverse Event|59|||
16500227|NCT01358357|40303080|FG000|Open Label Phase|Lack of Efficacy|0|||
16500228|NCT01358357|40303081|FG001|Open Label Phase|Lack of Efficacy|0|||
16500229|NCT01358357|40303082|FG002|Open Label Phase|Lack of Efficacy|107|||
16500230|NCT01358357|40303080|FG000|Open Label Phase|Lost to Follow-up|0|||
16500231|NCT01358357|40303081|FG001|Open Label Phase|Lost to Follow-up|0|||
16500232|NCT01358357|40303082|FG002|Open Label Phase|Lost to Follow-up|76|||
16500233|NCT01358357|40303080|FG000|Open Label Phase|Protocol Violation|0|||
16500234|NCT01358357|40303081|FG001|Open Label Phase|Protocol Violation|0|||
16500235|NCT01358357|40303082|FG002|Open Label Phase|Protocol Violation|45|||
16500236|NCT01358357|40303080|FG000|Open Label Phase|Withdrawal by Subject|0|||
16500237|NCT01358357|40303081|FG001|Open Label Phase|Withdrawal by Subject|0|||
16500238|NCT01358357|40303082|FG002|Open Label Phase|Withdrawal by Subject|112|||
16500239|NCT01358357|40303080|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
16500240|NCT01358357|40303081|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
16500241|NCT01358357|40303082|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
16500242|NCT01358357|40303080|FG000|Open Label Phase|Terminated at study completion|0|||
16500243|NCT01358357|40303081|FG001|Open Label Phase|Terminated at study completion|0|||
16500244|NCT01358357|40303082|FG002|Open Label Phase|Terminated at study completion|5|||
16500245|NCT01358357|40303080|FG000|Open Label Phase|Mood episode|0|||
16500246|NCT01358357|40303081|FG001|Open Label Phase|Mood episode|0|||
16500247|NCT01358357|40303082|FG002|Open Label Phase|Mood episode|42|||
16500248|NCT01358357|40303080|FG000|Double-Blind Phase|Adverse Event|8|||
16500249|NCT01358357|40303081|FG001|Double-Blind Phase|Adverse Event|5|||
16500250|NCT01358357|40303082|FG002|Double-Blind Phase|Adverse Event|0|||
16500251|NCT01358357|40303080|FG000|Double-Blind Phase|Lost to Follow-up|5|||
16500252|NCT01358357|40303081|FG001|Double-Blind Phase|Lost to Follow-up|7|||
16500253|NCT01358357|40303082|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16500254|NCT01358357|40303080|FG000|Double-Blind Phase|Protocol Violation|1|||
16500255|NCT01358357|40303081|FG001|Double-Blind Phase|Protocol Violation|11|||
16500256|NCT01358357|40303082|FG002|Double-Blind Phase|Protocol Violation|0|||
16309959|NCT00445432|39619138|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
16500257|NCT01358357|40303080|FG000|Double-Blind Phase|Protocol Violation|16|||
16500258|NCT01358357|40303081|FG001|Double-Blind Phase|Protocol Violation|12|||
16500259|NCT01358357|40303082|FG002|Double-Blind Phase|Protocol Violation|0|||
16500260|NCT01358357|40303080|FG000|Double-Blind Phase|Terminated at study completion|2|||
16500261|NCT01358357|40303081|FG001|Double-Blind Phase|Terminated at study completion|0|||
16500262|NCT01358357|40303082|FG002|Double-Blind Phase|Terminated at study completion|0|||
16500263|NCT01358357|40303080|FG000|Double-Blind Phase|Recurrence of mood event|48|||
16500264|NCT01358357|40303081|FG001|Double-Blind Phase|Recurrence of mood event|64|||
16500265|NCT01358357|40303082|FG002|Double-Blind Phase|Recurrence of mood event|0|||
16500266|NCT01358357|40303080|FG000|Double-Blind Phase|Administrative|0|||
16500267|NCT01358357|40303081|FG001|Double-Blind Phase|Administrative|1|||
16500268|NCT01358357|40303082|FG002|Double-Blind Phase|Administrative|0|||
16500269|NCT02169739|40303084|FG000|Overall Study|Lost to Follow-up|0|||
16500270|NCT02169739|40303085|FG001|Overall Study|Lost to Follow-up|4|||
16500271|NCT03559257|40303086|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
16500272|NCT03559257|40303087|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
16500273|NCT03559257|40303086|FG000|Double Blind Treatment Period|Protocol Violation|1|||
16500274|NCT03559257|40303087|FG001|Double Blind Treatment Period|Protocol Violation|4|||
16500275|NCT03559257|40303086|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
16500276|NCT03559257|40303087|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
16500277|NCT03559257|40303086|FG000|Double Blind Treatment Period|Adverse Event|0|||
16500278|NCT03559257|40303087|FG001|Double Blind Treatment Period|Adverse Event|1|||
16500279|NCT03559257|40303086|FG000|Double Blind Treatment Period|Screen Failure|0|||
16500280|NCT03559257|40303087|FG001|Double Blind Treatment Period|Screen Failure|1|||
16500281|NCT03559257|40303086|FG000|Open-label Treatment Period|Adverse Event|1|||
16500282|NCT03559257|40303087|FG001|Open-label Treatment Period|Adverse Event|4|||
16500283|NCT03559257|40303086|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
16500284|NCT03559257|40303087|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
16500285|NCT03559257|40303086|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
16500286|NCT03559257|40303087|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
16500287|NCT03559257|40303086|FG000|Open-label Treatment Period|Protocol Violation|2|||
16500288|NCT03559257|40303087|FG001|Open-label Treatment Period|Protocol Violation|0|||
16088315|NCT03732807|38813858|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
16088316|NCT03732807|38813859|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
16088317|NCT03732807|38813860|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
16088318|NCT03732807|38813861|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
16088319|NCT03732807|38813855|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
16088320|NCT03732807|38813856|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
16088321|NCT03732807|38813857|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
16088322|NCT03732807|38813858|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
16088323|NCT03732807|38813859|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
16088324|NCT03732807|38813860|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
16088325|NCT03732807|38813861|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
16088326|NCT03732807|38813855|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
16088327|NCT03732807|38813856|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
16195301|NCT00310388|39193292|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
16195302|NCT00310388|39193291|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
16500289|NCT03559257|40303086|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
16500290|NCT03559257|40303087|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
16546317|NCT02237508|40464781|FG008|Overall Study|Physician Decision|0|||
16195303|NCT00310388|39193292|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
16195304|NCT00310388|39193291|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
16195305|NCT00310388|39193292|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
16195306|NCT00310388|39193291|FG000|Primary Reporting Phase|Physician Decision|2|||
16195307|NCT00310388|39193292|FG001|Primary Reporting Phase|Physician Decision|0|||
16195308|NCT00310388|39193291|FG000|Primary Reporting Phase|Request of the sponsor|19|||
16195309|NCT00310388|39193292|FG001|Primary Reporting Phase|Request of the sponsor|0|||
16195310|NCT00310388|39193291|FG000|Primary Reporting Phase|Failed to return|8|||
16195311|NCT00310388|39193292|FG001|Primary Reporting Phase|Failed to return|0|||
16195312|NCT00310388|39193291|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
16195313|NCT00310388|39193292|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
16195314|NCT00310388|39193291|FG000|Primary Reporting Phase|Participant request|2|||
16195315|NCT00310388|39193292|FG001|Primary Reporting Phase|Participant request|0|||
16195316|NCT00310388|39193291|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
16195317|NCT00310388|39193292|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
16500291|NCT03559257|40303086|FG000|Open-label Treatment Period|Physician Decision|0|||
16500292|NCT03559257|40303087|FG001|Open-label Treatment Period|Physician Decision|1|||
16500293|NCT01365507|40303090|FG000|Overall Study|Withdrawal Criteria|8|||
16500294|NCT01365507|40303091|FG001|Overall Study|Withdrawal Criteria|5|||
16195318|NCT00310388|39193291|FG000|Primary Reporting Phase|Discontinuation of study|1|||
16195319|NCT00310388|39193292|FG001|Primary Reporting Phase|Discontinuation of study|0|||
16195320|NCT00310388|39193291|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
16195321|NCT00310388|39193292|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
16195322|NCT00310388|39193291|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
16195323|NCT00310388|39193292|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
16195324|NCT00310388|39193291|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
16195325|NCT00310388|39193292|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
16195326|NCT00310388|39193291|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
16195327|NCT00310388|39193292|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
16195328|NCT00310388|39193291|FG000|Primary Reporting Phase|Participant passed away|1|||
16195329|NCT00310388|39193292|FG001|Primary Reporting Phase|Participant passed away|0|||
16195330|NCT00310388|39193291|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
16195331|NCT00310388|39193292|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
16195332|NCT00310388|39193291|FG000|Primary Reporting Phase|Missing|1|||
16195333|NCT00310388|39193292|FG001|Primary Reporting Phase|Missing|0|||
16195334|NCT00310388|39193291|FG000|Primary Reporting Phase|Other|1|||
16195335|NCT00310388|39193292|FG001|Primary Reporting Phase|Other|0|||
16195336|NCT00310388|39193291|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
16195337|NCT00310388|39193292|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
16195338|NCT00310388|39193291|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
16500295|NCT01365507|40303090|FG000|Overall Study|Unclassified|1|||
16500296|NCT01365507|40303091|FG001|Overall Study|Unclassified|4|||
16500297|NCT02140567|40303092|FG000|Overall Study|Problems with recording equipment|6|||
16500298|NCT01372501|40303095|FG000|Overall Study|Adverse Event|4|||
16195339|NCT00310388|39193292|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
16195340|NCT00310388|39193291|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
16195341|NCT00310388|39193292|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
16195342|NCT00310388|39193291|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
16195343|NCT00310388|39193292|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
16195344|NCT02939937|39193293|FG000|Overall Study|Adverse Event|5|||
16195345|NCT02939937|39193294|FG001|Overall Study|Adverse Event|0|||
16195346|NCT02939937|39193293|FG000|Overall Study|Lost to Follow-up|1|||
16195347|NCT02939937|39193294|FG001|Overall Study|Lost to Follow-up|3|||
16195348|NCT01875367|39193295|FG000|Overall Study|Not complete at least 2 questionaries|4|||
16195349|NCT01875367|39193296|FG001|Overall Study|Not complete at least 2 questionaries|2|||
16195350|NCT01875367|39193295|FG000|Overall Study|Not receive study treatment|1|||
16195351|NCT01875367|39193296|FG001|Overall Study|Not receive study treatment|0|||
16195352|NCT04348591|39193297|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
16195353|NCT04348591|39193298|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
16195354|NCT04348591|39193297|FG000|Imaging Session (120 Min)|Physician Decision|0|||
16195355|NCT04348591|39193298|FG001|Imaging Session (120 Min)|Physician Decision|1|||
16195356|NCT04348591|39193297|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
16195357|NCT04348591|39193298|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
16195358|NCT01104558|39193304|FG000|Overall Study|Protocol Violation|6|||
16195359|NCT01104558|39193304|FG000|Overall Study|Missing of primary efficacy assessment|10|||
16195360|NCT01104558|39193304|FG000|Overall Study|Missing of genetic analysis results|1|||
16500299|NCT01372501|40303095|FG000|Overall Study|Device migration|1|||
16195361|NCT03806179|39193305|FG000|Overall Study|Progressive disease|0|||
16195362|NCT03806179|39193306|FG001|Overall Study|Progressive disease|2|||
16500300|NCT02882854|40303100|FG000|Overall Study|Lost to Follow-up|1|||
16195363|NCT00441441|39193315|FG000|Overall Study|Adverse Event|2|||
16195364|NCT00441441|39193316|FG001|Overall Study|Adverse Event|1|||
16195365|NCT00441441|39193315|FG000|Overall Study|Protocol Violation|4|||
16195366|NCT00441441|39193316|FG001|Overall Study|Protocol Violation|6|||
16195367|NCT00441441|39193315|FG000|Overall Study|Exacerbation of asthma|1|||
16500301|NCT02882854|40303101|FG001|Overall Study|Lost to Follow-up|2|||
16195368|NCT00441441|39193316|FG001|Overall Study|Exacerbation of asthma|2|||
16500302|NCT02882854|40303100|FG000|Overall Study|Physician Decision|0|||
16500303|NCT02882854|40303101|FG001|Overall Study|Physician Decision|1|||
16500304|NCT00588848|40303102|FG000|Overall Study|Physician Decision|0|||
16500305|NCT00588848|40303103|FG001|Overall Study|Physician Decision|3|||
16500306|NCT00100815|40303104|FG000|Overall Study|Progression|24|||
16500307|NCT00100815|40303104|FG000|Overall Study|Adverse Event|18|||
16500308|NCT00100815|40303104|FG000|Overall Study|Death|4|||
16500309|NCT00100815|40303104|FG000|Overall Study|Other|3|||
16500310|NCT03325075|40303105|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
16500311|NCT03325075|40303106|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
16500312|NCT03325075|40303107|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
16500313|NCT03325075|40303108|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
16500314|NCT03325075|40303105|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
16500315|NCT03325075|40303106|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
16500316|NCT03325075|40303107|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
16500317|NCT03325075|40303108|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
16500318|NCT03325075|40303105|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
16500319|NCT03325075|40303106|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
16500320|NCT03325075|40303107|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
16500321|NCT03325075|40303108|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
16500322|NCT03336333|40303109|FG000|Overall Study|Remained on study at time of data cut-off|202|||
16500323|NCT03336333|40303110|FG001|Overall Study|Remained on study at time of data cut-off|219|||
16500324|NCT03336333|40303111|FG002|Overall Study|Remained on study at time of data cut-off|102|||
16500325|NCT03336333|40303109|FG000|Overall Study|Death|14|||
16500326|NCT03336333|40303110|FG001|Overall Study|Death|16|||
16500327|NCT03336333|40303111|FG002|Overall Study|Death|8|||
16500328|NCT03336333|40303109|FG000|Overall Study|Withdrawal by Subject|16|||
16500329|NCT03336333|40303110|FG001|Overall Study|Withdrawal by Subject|5|||
16500330|NCT03336333|40303111|FG002|Overall Study|Withdrawal by Subject|1|||
16500331|NCT03336333|40303109|FG000|Overall Study|Physician Decision|5|||
16500332|NCT03336333|40303110|FG001|Overall Study|Physician Decision|1|||
16500333|NCT03336333|40303111|FG002|Overall Study|Physician Decision|0|||
16500334|NCT03336333|40303109|FG000|Overall Study|Lost to Follow-up|1|||
16500335|NCT03336333|40303110|FG001|Overall Study|Lost to Follow-up|0|||
16500336|NCT03336333|40303111|FG002|Overall Study|Lost to Follow-up|0|||
16500337|NCT00227903|40303112|FG000|Overall Study|Withdrawal by Subject|2|||
16389481|NCT02954458|39908667|FG001|Overall Study|Lost to Follow-up|0|||
16500338|NCT00227903|40303113|FG001|Overall Study|Withdrawal by Subject|5|||
16500339|NCT00227903|40303112|FG000|Overall Study|Subject moved out of area|1|||
16500340|NCT00227903|40303113|FG001|Overall Study|Subject moved out of area|2|||
16500341|NCT00227903|40303112|FG000|Overall Study|Lost to Follow-up|1|||
16500342|NCT00227903|40303113|FG001|Overall Study|Lost to Follow-up|3|||
16500343|NCT00227903|40303112|FG000|Overall Study|Miscarriage|1|||
16088328|NCT03732807|38813857|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
16088329|NCT03732807|38813858|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
16195369|NCT00441441|39193315|FG000|Overall Study|Withdrawal by Subject|1|||
16195370|NCT00441441|39193316|FG001|Overall Study|Withdrawal by Subject|2|||
16195371|NCT00441441|39193315|FG000|Overall Study|Other|3|||
16500344|NCT00227903|40303113|FG001|Overall Study|Miscarriage|0|||
16500345|NCT02738151|40303114|FG000|Overall Study|Randomized but not treated|4|||
16500346|NCT02738151|40303115|FG001|Overall Study|Randomized but not treated|1|||
16500347|NCT02738151|40303114|FG000|Overall Study|Adverse Event|4|||
16500348|NCT02738151|40303115|FG001|Overall Study|Adverse Event|5|||
16500349|NCT02738151|40303114|FG000|Overall Study|Hypoglycemia|0|||
16500350|NCT02738151|40303115|FG001|Overall Study|Hypoglycemia|1|||
16500351|NCT02738151|40303114|FG000|Overall Study|Poor Compliance to Protocol|4|||
16195372|NCT00441441|39193316|FG001|Overall Study|Other|3|||
16195373|NCT03498287|39193317|FG000|Overall Study|Withdrawal by Subject|3|||
16195374|NCT03498287|39193318|FG001|Overall Study|Withdrawal by Subject|0|||
16195375|NCT03498287|39193317|FG000|Overall Study|Protocol Violation|0|||
16195376|NCT03498287|39193318|FG001|Overall Study|Protocol Violation|4|||
16195377|NCT03498287|39193317|FG000|Overall Study|Adverse Event|0|||
16195378|NCT03498287|39193318|FG001|Overall Study|Adverse Event|1|||
16195379|NCT00929734|39193320|FG000|Overall Study|Lost to Follow-up|2|||
16195380|NCT00929734|39193321|FG001|Overall Study|Lost to Follow-up|1|||
16195381|NCT00929734|39193320|FG000|Overall Study|Withdrawal by Subject|0|||
16195382|NCT00929734|39193321|FG001|Overall Study|Withdrawal by Subject|2|||
16195383|NCT02918266|39193322|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
16195384|NCT02918266|39193323|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
16195385|NCT02918266|39193324|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
16195386|NCT02918266|39193325|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
16195387|NCT02918266|39193326|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
16195388|NCT02918266|39193327|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
16195389|NCT02918266|39193328|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
16195390|NCT02918266|39193329|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
16195391|NCT02918266|39193330|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
16195392|NCT02918266|39193331|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
16195393|NCT02918266|39193332|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
16500352|NCT02738151|40303115|FG001|Overall Study|Poor Compliance to Protocol|3|||
16500353|NCT02738151|40303114|FG000|Overall Study|Other than specified above|11|||
16500354|NCT02738151|40303115|FG001|Overall Study|Other than specified above|21|||
16500355|NCT04772755|40303116|FG000|Overall Study|Withdrawal by Subject|1|||
16195394|NCT01111539|39193333|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
16195395|NCT01111539|39193334|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16195396|NCT01111539|39193335|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16195397|NCT01111539|39193336|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16195398|NCT01111539|39193337|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
16500356|NCT04772755|40303117|FG001|Overall Study|Withdrawal by Subject|0|||
16195399|NCT01111539|39193333|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
16195400|NCT01111539|39193334|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16195401|NCT01111539|39193335|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16195402|NCT01111539|39193336|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16195403|NCT01111539|39193337|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
16195404|NCT01111539|39193333|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
16195405|NCT01111539|39193334|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16195406|NCT01111539|39193335|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16195407|NCT01111539|39193336|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16195408|NCT01111539|39193337|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
16195409|NCT01111539|39193333|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
16195410|NCT01111539|39193334|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
16195411|NCT01111539|39193335|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
16195412|NCT01111539|39193336|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
16195413|NCT01111539|39193337|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
16195414|NCT01111539|39193333|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
16195415|NCT01111539|39193334|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
16195416|NCT01111539|39193335|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
16195417|NCT01111539|39193336|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
16195418|NCT01111539|39193337|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
16195419|NCT01111539|39193333|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
16195420|NCT01111539|39193334|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16195421|NCT01111539|39193335|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16195422|NCT01111539|39193336|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16195423|NCT01111539|39193337|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
16309960|NCT00445432|39619139|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
16309961|NCT00445432|39619140|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
16309962|NCT00445432|39619141|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
16500357|NCT04772755|40303116|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
16500358|NCT04772755|40303117|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
16309963|NCT02687451|39619146|FG000|Overall Study|Withdrawal by Subject|1|||
16309964|NCT02687451|39619147|FG001|Overall Study|Withdrawal by Subject|0|||
16309965|NCT02687451|39619148|FG002|Overall Study|Withdrawal by Subject|0|||
16389482|NCT02954458|39908668|FG002|Overall Study|Lost to Follow-up|0|||
16389483|NCT02954458|39908669|FG003|Overall Study|Lost to Follow-up|1|||
16389484|NCT02954458|39908666|FG000|Overall Study|Death|0|||
16389485|NCT02954458|39908667|FG001|Overall Study|Death|0|||
16389486|NCT02954458|39908668|FG002|Overall Study|Death|0|||
16389487|NCT02954458|39908669|FG003|Overall Study|Death|1|||
16389488|NCT02954458|39908666|FG000|Overall Study|Other|0|||
16389489|NCT02954458|39908667|FG001|Overall Study|Other|0|||
16389490|NCT02954458|39908668|FG002|Overall Study|Other|0|||
16389491|NCT02954458|39908669|FG003|Overall Study|Other|7|||
16389492|NCT01696773|39908670|FG000|Days 15-27, Washout|Adverse Event|1|||
16389493|NCT01696773|39908671|FG001|Days 15-27, Washout|Adverse Event|0|||
16389494|NCT02931838|39908672|FG000|Overall Study|Reason not provided by investigator|1|||
16389495|NCT02931838|39908673|FG001|Overall Study|Reason not provided by investigator|0|||
16500359|NCT00674661|40303118|FG000|Overall Study|Other|5|||
16500360|NCT00674661|40303119|FG001|Overall Study|Other|7|||
16309966|NCT02687451|39619149|FG003|Overall Study|Withdrawal by Subject|0|||
16309967|NCT02687451|39619150|FG004|Overall Study|Withdrawal by Subject|0|||
16309968|NCT02687451|39619151|FG005|Overall Study|Withdrawal by Subject|1|||
16309969|NCT02394600|39619161|FG000|Overall Study|Adverse Event|3|||
16309970|NCT02394600|39619162|FG001|Overall Study|Adverse Event|0|||
16389496|NCT02931838|39908674|FG002|Overall Study|Reason not provided by investigator|1|||
16389497|NCT02931838|39908675|FG003|Overall Study|Reason not provided by investigator|0|||
16389498|NCT02931838|39908676|FG004|Overall Study|Reason not provided by investigator|0|||
16389499|NCT02931838|39908677|FG005|Overall Study|Reason not provided by investigator|0|||
16500361|NCT00674661|40303118|FG000|Overall Study|Lost to Follow-up|6|||
16500362|NCT00674661|40303119|FG001|Overall Study|Lost to Follow-up|3|||
16500363|NCT00674661|40303118|FG000|Overall Study|Withdrawal by Subject|0|||
16500364|NCT00674661|40303119|FG001|Overall Study|Withdrawal by Subject|5|||
16500365|NCT03277105|40303120|FG000|Overall Study|Death|129|||
16500366|NCT03277105|40303121|FG001|Overall Study|Death|124|||
16500367|NCT03277105|40303120|FG000|Overall Study|Lost to Follow-up|2|||
16500368|NCT03277105|40303121|FG001|Overall Study|Lost to Follow-up|4|||
16500369|NCT03277105|40303120|FG000|Overall Study|Withdrawal by Subject|10|||
16500370|NCT03277105|40303121|FG001|Overall Study|Withdrawal by Subject|10|||
16500371|NCT03277105|40303120|FG000|Overall Study|Other|118|||
16389500|NCT02931838|39908672|FG000|Overall Study|Poor/non-compliance|0|||
16389501|NCT02931838|39908673|FG001|Overall Study|Poor/non-compliance|0|||
16500372|NCT03277105|40303121|FG001|Overall Study|Other|125|||
16500373|NCT01462084|40303122|FG000|Overall Study|Withdrawal by Subject|1|||
16500374|NCT01462084|40303123|FG001|Overall Study|Withdrawal by Subject|0|||
16500375|NCT01462084|40303122|FG000|Overall Study|Protocol Violation|1|||
16500376|NCT01462084|40303123|FG001|Overall Study|Protocol Violation|1|||
16500377|NCT01589445|40303124|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
16500378|NCT01589445|40303124|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
16500379|NCT01589445|40303124|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
16500380|NCT01589445|40303124|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
16500381|NCT01589445|40303124|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
16500382|NCT01589445|40303124|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
16500383|NCT01589445|40303124|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
16500384|NCT01589445|40303124|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
16500385|NCT01589445|40303124|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
16500386|NCT01589445|40303124|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
16500387|NCT01394523|40306221|FG000|Overall Study|Unable to place block|1|||
16500388|NCT01394523|40306222|FG001|Overall Study|Unable to place block|0|||
16500389|NCT01394523|40306223|FG002|Overall Study|Unable to place block|0|||
16500390|NCT02066467|40306224|FG000|Overall Study|Did not undergo implant procedure|24|||
16500391|NCT02066467|40306224|FG000|Overall Study|Attempted to implant withoput success|43|||
16500392|NCT02066467|40306224|FG000|Overall Study|Consent ineligible|1|||
16500393|NCT02066467|40306224|FG000|Overall Study|Death|54|||
16500394|NCT02066467|40306224|FG000|Overall Study|Lost to Follow-up|51|||
16500395|NCT02066467|40306224|FG000|Overall Study|Adverse Event|20|||
16500396|NCT02066467|40306224|FG000|Overall Study|Withdrawal by Subject|16|||
16500397|NCT02066467|40306224|FG000|Overall Study|Physician Decision|2|||
16500398|NCT02066467|40306224|FG000|Overall Study|Not defined|4|||
16500399|NCT01525550|40306227|FG000|Overall Study|Lost to Follow-up|8|||
16500400|NCT01525550|40306228|FG001|Overall Study|Lost to Follow-up|2|||
16500401|NCT01525550|40306227|FG000|Overall Study|Death|19|||
16500402|NCT01525550|40306228|FG001|Overall Study|Death|28|||
16500403|NCT01525550|40306227|FG000|Overall Study|Other|0|||
16500404|NCT01525550|40306228|FG001|Overall Study|Other|4|||
16500405|NCT01525550|40306227|FG000|Overall Study|Sponsor's Decision|30|||
16500406|NCT01525550|40306228|FG001|Overall Study|Sponsor's Decision|11|||
16500407|NCT01525550|40306227|FG000|Overall Study|Withdrawal by Subject|4|||
16500408|NCT01525550|40306228|FG001|Overall Study|Withdrawal by Subject|0|||
16500409|NCT02981342|40306229|FG000|Overall Study|Adverse Event|0|||
16500410|NCT02981342|40306230|FG001|Overall Study|Adverse Event|0|||
16500411|NCT02981342|40306231|FG002|Overall Study|Adverse Event|0|||
16500412|NCT02981342|40306232|FG003|Overall Study|Adverse Event|1|||
16500413|NCT02981342|40306229|FG000|Overall Study|Death|0|||
16500414|NCT02981342|40306230|FG001|Overall Study|Death|9|||
16500415|NCT02981342|40306231|FG002|Overall Study|Death|9|||
16500416|NCT02981342|40306232|FG003|Overall Study|Death|4|||
16500417|NCT02981342|40306229|FG000|Overall Study|Withdrawal by Subject|0|||
16500418|NCT02981342|40306230|FG001|Overall Study|Withdrawal by Subject|0|||
16500419|NCT02981342|40306231|FG002|Overall Study|Withdrawal by Subject|3|||
16500420|NCT02981342|40306232|FG003|Overall Study|Withdrawal by Subject|1|||
16500421|NCT02981342|40306229|FG000|Overall Study|Study closed by sponsor|0|||
16500422|NCT02981342|40306230|FG001|Overall Study|Study closed by sponsor|0|||
16500423|NCT02981342|40306231|FG002|Overall Study|Study closed by sponsor|1|||
16500424|NCT02981342|40306232|FG003|Overall Study|Study closed by sponsor|1|||
16500425|NCT02981342|40306229|FG000|Overall Study|Randomized, Never Treated|0|||
16500426|NCT02981342|40306230|FG001|Overall Study|Randomized, Never Treated|1|||
16500427|NCT02981342|40306231|FG002|Overall Study|Randomized, Never Treated|0|||
16500428|NCT02981342|40306232|FG003|Overall Study|Randomized, Never Treated|7|||
16500429|NCT02981342|40306229|FG000|Overall Study|Lost to Follow-up|0|||
16500430|NCT02981342|40306230|FG001|Overall Study|Lost to Follow-up|1|||
16500431|NCT02981342|40306231|FG002|Overall Study|Lost to Follow-up|0|||
16500432|NCT02981342|40306232|FG003|Overall Study|Lost to Follow-up|0|||
16500433|NCT02542631|40306236|FG000|Overall Study|Adverse Event|1|||
16500434|NCT02542631|40306237|FG001|Overall Study|Adverse Event|1|||
16500435|NCT02542631|40306236|FG000|Overall Study|Sponsor Termination|1|||
16500436|NCT02542631|40306237|FG001|Overall Study|Sponsor Termination|0|||
16500437|NCT02542631|40306236|FG000|Overall Study|Withdrawal by Subject|11|||
16500438|NCT02542631|40306237|FG001|Overall Study|Withdrawal by Subject|16|||
16500439|NCT02542631|40306236|FG000|Overall Study|Protocol Violation|1|||
16500440|NCT02542631|40306237|FG001|Overall Study|Protocol Violation|1|||
16500441|NCT02542631|40306236|FG000|Overall Study|Physician Decision|6|||
16500442|NCT02542631|40306237|FG001|Overall Study|Physician Decision|4|||
16500443|NCT02542631|40306236|FG000|Overall Study|Lost to Follow-up|6|||
16500444|NCT02542631|40306237|FG001|Overall Study|Lost to Follow-up|5|||
16500445|NCT02542631|40306236|FG000|Overall Study|Death|1|||
16500446|NCT02542631|40306237|FG001|Overall Study|Death|2|||
16500447|NCT02542631|40306236|FG000|Overall Study|Other|2|||
16500448|NCT02542631|40306237|FG001|Overall Study|Other|1|||
16500449|NCT02542631|40306236|FG000|Overall Study|Used Prohibited Medication|2|||
16500450|NCT02542631|40306237|FG001|Overall Study|Used Prohibited Medication|1|||
16389502|NCT02931838|39908674|FG002|Overall Study|Poor/non-compliance|1|||
16389503|NCT02931838|39908675|FG003|Overall Study|Poor/non-compliance|0|||
16389504|NCT02931838|39908676|FG004|Overall Study|Poor/non-compliance|0|||
16389505|NCT02931838|39908677|FG005|Overall Study|Poor/non-compliance|0|||
16389506|NCT02931838|39908672|FG000|Overall Study|Lack of Efficacy|5|||
16389507|NCT02931838|39908673|FG001|Overall Study|Lack of Efficacy|4|||
16389508|NCT02931838|39908674|FG002|Overall Study|Lack of Efficacy|0|||
16389509|NCT02931838|39908675|FG003|Overall Study|Lack of Efficacy|0|||
16389510|NCT02931838|39908676|FG004|Overall Study|Lack of Efficacy|0|||
16389511|NCT02931838|39908677|FG005|Overall Study|Lack of Efficacy|1|||
16389512|NCT02931838|39908672|FG000|Overall Study|Lost to Follow-up|1|||
16389513|NCT02931838|39908673|FG001|Overall Study|Lost to Follow-up|0|||
16309971|NCT02394600|39619161|FG000|Overall Study|Lost to Follow-up|0|||
16309972|NCT02394600|39619162|FG001|Overall Study|Lost to Follow-up|1|||
16309973|NCT02394600|39619161|FG000|Overall Study|Withdrawal by Subject|0|||
16309974|NCT02394600|39619162|FG001|Overall Study|Withdrawal by Subject|1|||
16309975|NCT02394600|39619161|FG000|Overall Study|Protocol Violation|1|||
16309976|NCT02394600|39619162|FG001|Overall Study|Protocol Violation|0|||
16309977|NCT02654054|39619163|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
16309978|NCT02654054|39619164|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
16309979|NCT02654054|39619165|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
16309980|NCT02654054|39619163|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
16309981|NCT02654054|39619164|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16309982|NCT02654054|39619165|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
16309983|NCT02654054|39619163|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
16309984|NCT02654054|39619164|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
16309985|NCT02654054|39619165|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
16309986|NCT02654054|39619163|FG000|Post-Treatment Follow-Up Period|Other|1|||
16309987|NCT02654054|39619164|FG001|Post-Treatment Follow-Up Period|Other|0|||
16309988|NCT02654054|39619165|FG002|Post-Treatment Follow-Up Period|Other|4|||
16309989|NCT02654054|39619163|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
16309990|NCT02654054|39619164|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
16389514|NCT02931838|39908674|FG002|Overall Study|Lost to Follow-up|1|||
16389515|NCT02931838|39908675|FG003|Overall Study|Lost to Follow-up|1|||
16389516|NCT02931838|39908676|FG004|Overall Study|Lost to Follow-up|2|||
16389517|NCT02931838|39908677|FG005|Overall Study|Lost to Follow-up|0|||
16389518|NCT02931838|39908672|FG000|Overall Study|Subject request to discontinue treatment|4|||
16389519|NCT02931838|39908673|FG001|Overall Study|Subject request to discontinue treatment|3|||
16389520|NCT02931838|39908674|FG002|Overall Study|Subject request to discontinue treatment|3|||
16389521|NCT02931838|39908675|FG003|Overall Study|Subject request to discontinue treatment|0|||
16389522|NCT02931838|39908676|FG004|Overall Study|Subject request to discontinue treatment|1|||
16309991|NCT02654054|39619165|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
16309992|NCT00182325|39619166|FG000|Overall Study|Lost to Follow-up|7|||
16309993|NCT00182325|39619167|FG001|Overall Study|Lost to Follow-up|7|||
16389523|NCT02931838|39908677|FG005|Overall Study|Subject request to discontinue treatment|0|||
16389524|NCT02931838|39908672|FG000|Overall Study|Withdrawal by Subject|1|||
16088330|NCT03732807|38813859|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
16088331|NCT03732807|38813860|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
16389525|NCT02931838|39908673|FG001|Overall Study|Withdrawal by Subject|2|||
16389526|NCT02931838|39908674|FG002|Overall Study|Withdrawal by Subject|0|||
16389527|NCT02931838|39908675|FG003|Overall Study|Withdrawal by Subject|1|||
16389528|NCT02931838|39908676|FG004|Overall Study|Withdrawal by Subject|0|||
16389529|NCT02931838|39908677|FG005|Overall Study|Withdrawal by Subject|0|||
16389530|NCT02931838|39908672|FG000|Overall Study|Adverse Event|2|||
16389531|NCT02931838|39908673|FG001|Overall Study|Adverse Event|1|||
16389532|NCT02931838|39908674|FG002|Overall Study|Adverse Event|2|||
16389533|NCT02931838|39908675|FG003|Overall Study|Adverse Event|1|||
16389534|NCT02931838|39908676|FG004|Overall Study|Adverse Event|3|||
16389535|NCT02931838|39908677|FG005|Overall Study|Adverse Event|1|||
16389536|NCT02973997|39908680|FG000|Overall Study|Withdrawal by Subject|4|||
16389537|NCT02973997|39908681|FG001|Overall Study|Withdrawal by Subject|0|||
16389538|NCT02973997|39908680|FG000|Overall Study|Adverse Event|4|||
16389539|NCT02973997|39908681|FG001|Overall Study|Adverse Event|1|||
16389540|NCT02973997|39908680|FG000|Overall Study|Disease Progression|11|||
16389541|NCT02973997|39908681|FG001|Overall Study|Disease Progression|20|||
16389542|NCT02973997|39908680|FG000|Overall Study|Alternative Therapy|3|||
16389543|NCT02973997|39908681|FG001|Overall Study|Alternative Therapy|0|||
16389544|NCT02973997|39908680|FG000|Overall Study|Other complicating disease|0|||
16389545|NCT02973997|39908681|FG001|Overall Study|Other complicating disease|1|||
16389546|NCT02973997|39908680|FG000|Overall Study|Death|0|||
16389547|NCT02973997|39908681|FG001|Overall Study|Death|1|||
16389548|NCT03289533|39908684|FG000|Overall Study|Death|12|||
16389549|NCT03289533|39908684|FG000|Overall Study|Terminated from study by sponsor|10|||
16500451|NCT00333866|40306240|FG000|Overall Study|Adverse Event|23|||
16500452|NCT00333866|40306241|FG001|Overall Study|Adverse Event|37|||
16500453|NCT00333866|40306242|FG002|Overall Study|Adverse Event|38|||
16500454|NCT00333866|40306243|FG003|Overall Study|Adverse Event|47|||
16500455|NCT00333866|40306240|FG000|Overall Study|Other|3|||
16500456|NCT00333866|40306241|FG001|Overall Study|Other|2|||
16500457|NCT00333866|40306242|FG002|Overall Study|Other|2|||
16500458|NCT00333866|40306243|FG003|Overall Study|Other|2|||
16500459|NCT00333866|40306240|FG000|Overall Study|Lack of Efficacy|8|||
16500460|NCT00333866|40306241|FG001|Overall Study|Lack of Efficacy|6|||
16500461|NCT00333866|40306242|FG002|Overall Study|Lack of Efficacy|3|||
16500462|NCT00333866|40306243|FG003|Overall Study|Lack of Efficacy|5|||
16500463|NCT00333866|40306240|FG000|Overall Study|Lost to Follow-up|1|||
16500464|NCT00333866|40306241|FG001|Overall Study|Lost to Follow-up|2|||
16500465|NCT00333866|40306242|FG002|Overall Study|Lost to Follow-up|2|||
16500466|NCT00333866|40306243|FG003|Overall Study|Lost to Follow-up|2|||
16500467|NCT00333866|40306240|FG000|Overall Study|Withdrawal by Subject|8|||
16500468|NCT00333866|40306241|FG001|Overall Study|Withdrawal by Subject|14|||
16500469|NCT00333866|40306242|FG002|Overall Study|Withdrawal by Subject|4|||
16500470|NCT00333866|40306243|FG003|Overall Study|Withdrawal by Subject|9|||
16500471|NCT00333866|40306240|FG000|Overall Study|Randomized but not Treated|5|||
16500472|NCT00333866|40306241|FG001|Overall Study|Randomized but not Treated|3|||
16500473|NCT00333866|40306242|FG002|Overall Study|Randomized but not Treated|2|||
16500474|NCT00333866|40306243|FG003|Overall Study|Randomized but not Treated|1|||
16500475|NCT01991067|40306244|FG000|Overall Study|Lost to Follow-up|6|||
16500476|NCT01991067|40306245|FG001|Overall Study|Lost to Follow-up|5|||
16500477|NCT00488345|40306246|FG000|Overall Study|Adverse Event|0|||
16500478|NCT00488345|40306247|FG001|Overall Study|Adverse Event|1|||
16500479|NCT00488345|40306248|FG002|Overall Study|Adverse Event|1|||
16500480|NCT00488345|40306246|FG000|Overall Study|Unable to administer antibiotics at home|0|||
16500481|NCT00488345|40306247|FG001|Overall Study|Unable to administer antibiotics at home|1|||
16500482|NCT00488345|40306248|FG002|Overall Study|Unable to administer antibiotics at home|0|||
16500483|NCT00488345|40306246|FG000|Overall Study|Institutional Review Board review|0|||
16500484|NCT00488345|40306247|FG001|Overall Study|Institutional Review Board review|0|||
16500485|NCT00488345|40306248|FG002|Overall Study|Institutional Review Board review|1|||
16500486|NCT00488345|40306246|FG000|Overall Study|Surgical team recommendation|0|||
16500487|NCT00488345|40306247|FG001|Overall Study|Surgical team recommendation|1|||
16500488|NCT00488345|40306248|FG002|Overall Study|Surgical team recommendation|0|||
16500489|NCT00488345|40306246|FG000|Overall Study|Parent/legal guardian request|0|||
16500490|NCT00488345|40306247|FG001|Overall Study|Parent/legal guardian request|1|||
16500491|NCT00488345|40306248|FG002|Overall Study|Parent/legal guardian request|1|||
16500492|NCT03263442|40306249|FG000|Inpatient Phase|Death|1|||
16500493|NCT03263442|40306250|FG001|Inpatient Phase|Death|0|||
16500494|NCT03263442|40306249|FG000|Inpatient Phase|Withdrawal by Subject|1|||
16500495|NCT03263442|40306250|FG001|Inpatient Phase|Withdrawal by Subject|0|||
16500496|NCT03263442|40306249|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
16389550|NCT01977898|39908687|FG000|Overall Study|Non functioning catheter|1|||
16389551|NCT01977898|39908688|FG001|Overall Study|Non functioning catheter|1|||
16389552|NCT00363311|39911737|FG000|Overall Study|Adverse Event|6|||
16389553|NCT00363311|39911738|FG001|Overall Study|Adverse Event|4|||
16389554|NCT00363311|39911737|FG000|Overall Study|Lost to Follow-up|3|||
16389555|NCT00363311|39911738|FG001|Overall Study|Lost to Follow-up|0|||
16389556|NCT00363311|39911737|FG000|Overall Study|Protocol Violation|1|||
16389557|NCT00363311|39911738|FG001|Overall Study|Protocol Violation|2|||
16389558|NCT00363311|39911737|FG000|Overall Study|Withdrawal by Subject|12|||
16389559|NCT00363311|39911738|FG001|Overall Study|Withdrawal by Subject|6|||
16389560|NCT00363311|39911737|FG000|Overall Study|Physician Decision|1|||
16389561|NCT00363311|39911738|FG001|Overall Study|Physician Decision|1|||
16389562|NCT00363311|39911737|FG000|Overall Study|Sponsor Terminated Study|2|||
16389563|NCT00363311|39911738|FG001|Overall Study|Sponsor Terminated Study|2|||
16389564|NCT00363311|39911737|FG000|Overall Study|Disease Progression|46|||
16389565|NCT00363311|39911738|FG001|Overall Study|Disease Progression|26|||
16389566|NCT00363311|39911737|FG000|Overall Study|Non-Compliance|1|||
16389567|NCT00363311|39911738|FG001|Overall Study|Non-Compliance|1|||
16389568|NCT00363311|39911737|FG000|Overall Study|Participant Refused Biopsy|1|||
16389569|NCT00363311|39911738|FG001|Overall Study|Participant Refused Biopsy|0|||
16389570|NCT00363311|39911737|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
16389571|NCT00363311|39911738|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
16389572|NCT00363311|39911737|FG000|Overall Study|Participant Opted for Treatment|1|||
16389573|NCT00363311|39911738|FG001|Overall Study|Participant Opted for Treatment|0|||
16389574|NCT00363311|39911737|FG000|Overall Study|Participant Moved to Another Country|1|||
16389575|NCT00363311|39911738|FG001|Overall Study|Participant Moved to Another Country|0|||
16389576|NCT00363311|39911737|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
16389577|NCT00363311|39911738|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
16389578|NCT00363311|39911737|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
16389579|NCT00363311|39911738|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
16389580|NCT00363311|39911737|FG000|Overall Study|Participant Moved to Louisiana|0|||
16389581|NCT00363311|39911738|FG001|Overall Study|Participant Moved to Louisiana|1|||
16389582|NCT03549338|39911739|FG000|Overall Study|Progressive Disease|1|||
16389583|NCT03549338|39911740|FG001|Overall Study|Progressive Disease|0|||
16389584|NCT03549338|39911741|FG002|Overall Study|Progressive Disease|0|||
16389585|NCT03549338|39911739|FG000|Overall Study|Clinical Progression|0|||
16389586|NCT03549338|39911740|FG001|Overall Study|Clinical Progression|1|||
16389587|NCT03549338|39911741|FG002|Overall Study|Clinical Progression|0|||
16389588|NCT01724216|39911743|FG000|Overall Study|Scan was not completed|1|||
16389589|NCT01123148|39911744|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
16389590|NCT01123148|39911744|FG000|Overall Study|Didn't meet milestone criteria|1|||
16389591|NCT01340664|39911751|FG000|Overall Study|Adverse Event|0|||
16389592|NCT01340664|39911752|FG001|Overall Study|Adverse Event|1|||
16389593|NCT01340664|39911753|FG002|Overall Study|Adverse Event|7|||
16389594|NCT01340664|39911751|FG000|Overall Study|Lost to Follow-up|2|||
16389595|NCT01340664|39911752|FG001|Overall Study|Lost to Follow-up|0|||
16389596|NCT01340664|39911753|FG002|Overall Study|Lost to Follow-up|2|||
16389597|NCT01340664|39911751|FG000|Overall Study|Withdrawal by Subject|2|||
16389598|NCT01340664|39911752|FG001|Overall Study|Withdrawal by Subject|4|||
16389599|NCT01340664|39911753|FG002|Overall Study|Withdrawal by Subject|0|||
16389600|NCT01340664|39911751|FG000|Overall Study|Glycemic withdrawal criteria|2|||
16389601|NCT01340664|39911752|FG001|Overall Study|Glycemic withdrawal criteria|0|||
16389602|NCT01340664|39911753|FG002|Overall Study|Glycemic withdrawal criteria|0|||
16389603|NCT01340664|39911751|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
16389604|NCT01340664|39911752|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
16389605|NCT01340664|39911753|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
16389606|NCT01340664|39911751|FG000|Overall Study|Other|1|||
16389607|NCT01340664|39911752|FG001|Overall Study|Other|2|||
16389608|NCT01340664|39911753|FG002|Overall Study|Other|2|||
16389609|NCT00756275|39911754|FG000|Overall Study|Lost to Follow-up|25|||
16389610|NCT00756275|39911755|FG001|Overall Study|Lost to Follow-up|21|||
16389611|NCT00756275|39911754|FG000|Overall Study|Withdrawal by Subject|4|||
16389612|NCT00756275|39911755|FG001|Overall Study|Withdrawal by Subject|7|||
16389613|NCT00539240|39911756|FG000|Overall Study|Withdrawal by Subject|0|||
16389614|NCT00539240|39911757|FG001|Overall Study|Withdrawal by Subject|2|||
16389615|NCT00539240|39911758|FG002|Overall Study|Withdrawal by Subject|0|||
16389616|NCT00539240|39911756|FG000|Overall Study|Protocol Violation|1|||
16389617|NCT00539240|39911757|FG001|Overall Study|Protocol Violation|1|||
16389618|NCT00539240|39911758|FG002|Overall Study|Protocol Violation|4|||
16389619|NCT00539240|39911756|FG000|Overall Study|Lost to Follow-up|2|||
16389620|NCT00539240|39911757|FG001|Overall Study|Lost to Follow-up|3|||
16389621|NCT00539240|39911758|FG002|Overall Study|Lost to Follow-up|1|||
16389622|NCT00539240|39911756|FG000|Overall Study|Adverse Event|3|||
16389623|NCT00539240|39911757|FG001|Overall Study|Adverse Event|1|||
16389624|NCT00539240|39911758|FG002|Overall Study|Adverse Event|10|||
16389625|NCT02375373|39911760|FG000|Overall Study|Withdrawal by Subject|11|||
16389626|NCT01856322|39911761|FG000|Overall Study|off study due to lack of accrual|0|||
16389627|NCT01856322|39911762|FG001|Overall Study|off study due to lack of accrual|0|||
16389628|NCT01856322|39911763|FG002|Overall Study|off study due to lack of accrual|3|||
16546318|NCT02237508|40464782|FG009|Overall Study|Physician Decision|0|||
16389629|NCT02151786|39911764|FG000|Overall Study|Unavailability of Case Report Form|26|||
16389630|NCT02151786|39911764|FG000|Overall Study|Outside the Contract Period|1|||
16389631|NCT02151786|39911764|FG000|Overall Study|Randomized, not Treated|1|||
16389632|NCT02151786|39911764|FG000|Overall Study|Unavailability of Information|8|||
16500497|NCT03263442|40306250|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
16500498|NCT03263442|40306249|FG000|1-month Follow-Up|Lost to Follow-up|1|||
16500499|NCT03263442|40306250|FG001|1-month Follow-Up|Lost to Follow-up|0|||
16500500|NCT03263442|40306249|FG000|3-month Follow-Up|Lost to Follow-up|1|||
16500501|NCT03263442|40306250|FG001|3-month Follow-Up|Lost to Follow-up|3|||
16500502|NCT03263442|40306249|FG000|6-month Follow-Up|Lost to Follow-up|2|||
16500503|NCT03263442|40306250|FG001|6-month Follow-Up|Lost to Follow-up|2|||
16500504|NCT00589914|40306260|FG000|Overall Study|Adverse Event|19|||
16500505|NCT00589914|40306261|FG001|Overall Study|Adverse Event|10|||
16500506|NCT00589914|40306260|FG000|Overall Study|Death|2|||
16389633|NCT00295646|39911765|FG000|Overall Study|Protocol Violation|18|||
16389634|NCT00295646|39911766|FG001|Overall Study|Protocol Violation|20|||
16389635|NCT00295646|39911767|FG002|Overall Study|Protocol Violation|20|||
16389636|NCT00295646|39911768|FG003|Overall Study|Protocol Violation|18|||
16389637|NCT00295646|39911765|FG000|Overall Study|Withdrawal by Subject|8|||
16389638|NCT00295646|39911766|FG001|Overall Study|Withdrawal by Subject|9|||
16389639|NCT00295646|39911767|FG002|Overall Study|Withdrawal by Subject|11|||
16389640|NCT00295646|39911768|FG003|Overall Study|Withdrawal by Subject|14|||
16389641|NCT00295646|39911765|FG000|Overall Study|Lost to Follow-up|0|||
16389642|NCT00295646|39911766|FG001|Overall Study|Lost to Follow-up|5|||
16389643|NCT00295646|39911767|FG002|Overall Study|Lost to Follow-up|1|||
16389644|NCT00295646|39911768|FG003|Overall Study|Lost to Follow-up|5|||
16389645|NCT00295646|39911765|FG000|Overall Study|Death|9|||
16389646|NCT00295646|39911766|FG001|Overall Study|Death|7|||
16389647|NCT00295646|39911767|FG002|Overall Study|Death|18|||
16389648|NCT00295646|39911768|FG003|Overall Study|Death|8|||
16389649|NCT00421148|39911772|FG000|Overall Study|Lost to Follow-up|0|||
16389650|NCT00421148|39911773|FG001|Overall Study|Lost to Follow-up|0|||
16389651|NCT00421148|39911774|FG002|Overall Study|Lost to Follow-up|0|||
16389652|NCT00421148|39911775|FG003|Overall Study|Lost to Follow-up|0|||
16389653|NCT00421148|39911776|FG004|Overall Study|Lost to Follow-up|0|||
16389654|NCT00421148|39911777|FG005|Overall Study|Lost to Follow-up|0|||
16389655|NCT00421148|39911778|FG006|Overall Study|Lost to Follow-up|0|||
16389656|NCT00421148|39911779|FG007|Overall Study|Lost to Follow-up|0|||
16389657|NCT00421148|39911780|FG008|Overall Study|Lost to Follow-up|0|||
16389658|NCT00421148|39911781|FG009|Overall Study|Lost to Follow-up|0|||
16389659|NCT00421148|39911782|FG010|Overall Study|Lost to Follow-up|0|||
16389660|NCT00421148|39911783|FG011|Overall Study|Lost to Follow-up|0|||
16389661|NCT00421148|39911784|FG012|Overall Study|Lost to Follow-up|0|||
16389662|NCT00421148|39911785|FG013|Overall Study|Lost to Follow-up|0|||
16389663|NCT00421148|39911786|FG014|Overall Study|Lost to Follow-up|0|||
16389664|NCT00421148|39911787|FG015|Overall Study|Lost to Follow-up|0|||
16389665|NCT00421148|39911788|FG016|Overall Study|Lost to Follow-up|0|||
16389666|NCT00421148|39911789|FG017|Overall Study|Lost to Follow-up|1|||
16389667|NCT00421148|39911790|FG018|Overall Study|Lost to Follow-up|0|||
16389668|NCT00421148|39911791|FG019|Overall Study|Lost to Follow-up|0|||
16389669|NCT00421148|39911772|FG000|Overall Study|Withdrawal by Subject|0|||
16389670|NCT00421148|39911773|FG001|Overall Study|Withdrawal by Subject|0|||
16389671|NCT00421148|39911774|FG002|Overall Study|Withdrawal by Subject|0|||
16389672|NCT00421148|39911775|FG003|Overall Study|Withdrawal by Subject|0|||
16389673|NCT00421148|39911776|FG004|Overall Study|Withdrawal by Subject|0|||
16389674|NCT00421148|39911777|FG005|Overall Study|Withdrawal by Subject|0|||
16389675|NCT00421148|39911778|FG006|Overall Study|Withdrawal by Subject|0|||
16389676|NCT00421148|39911779|FG007|Overall Study|Withdrawal by Subject|0|||
16389677|NCT00421148|39911780|FG008|Overall Study|Withdrawal by Subject|0|||
16389678|NCT00421148|39911781|FG009|Overall Study|Withdrawal by Subject|0|||
16389679|NCT00421148|39911782|FG010|Overall Study|Withdrawal by Subject|0|||
16389680|NCT00421148|39911783|FG011|Overall Study|Withdrawal by Subject|0|||
16389681|NCT00421148|39911784|FG012|Overall Study|Withdrawal by Subject|0|||
16389682|NCT00421148|39911785|FG013|Overall Study|Withdrawal by Subject|0|||
16389683|NCT00421148|39911786|FG014|Overall Study|Withdrawal by Subject|0|||
16389684|NCT00421148|39911787|FG015|Overall Study|Withdrawal by Subject|0|||
16389685|NCT00421148|39911788|FG016|Overall Study|Withdrawal by Subject|0|||
16389686|NCT00421148|39911789|FG017|Overall Study|Withdrawal by Subject|1|||
16389687|NCT00421148|39911790|FG018|Overall Study|Withdrawal by Subject|0|||
16500507|NCT00589914|40306261|FG001|Overall Study|Death|0|||
16500508|NCT00589914|40306260|FG000|Overall Study|Lack of Efficacy|40|||
16389688|NCT00421148|39911791|FG019|Overall Study|Withdrawal by Subject|0|||
16389689|NCT00421148|39911772|FG000|Overall Study|Protocol Violation|0|||
16389690|NCT00421148|39911773|FG001|Overall Study|Protocol Violation|0|||
16389691|NCT00421148|39911774|FG002|Overall Study|Protocol Violation|0|||
16500509|NCT00589914|40306261|FG001|Overall Study|Lack of Efficacy|43|||
16389692|NCT00421148|39911775|FG003|Overall Study|Protocol Violation|0|||
16389693|NCT00421148|39911776|FG004|Overall Study|Protocol Violation|0|||
16389694|NCT00421148|39911777|FG005|Overall Study|Protocol Violation|1|||
16389695|NCT00421148|39911778|FG006|Overall Study|Protocol Violation|0|||
16389696|NCT00421148|39911779|FG007|Overall Study|Protocol Violation|0|||
16389697|NCT00421148|39911780|FG008|Overall Study|Protocol Violation|0|||
16389698|NCT00421148|39911781|FG009|Overall Study|Protocol Violation|0|||
16389699|NCT00421148|39911782|FG010|Overall Study|Protocol Violation|0|||
16389700|NCT00421148|39911783|FG011|Overall Study|Protocol Violation|0|||
16389701|NCT00421148|39911784|FG012|Overall Study|Protocol Violation|0|||
16389702|NCT00421148|39911785|FG013|Overall Study|Protocol Violation|0|||
16389703|NCT00421148|39911786|FG014|Overall Study|Protocol Violation|0|||
16389704|NCT00421148|39911787|FG015|Overall Study|Protocol Violation|0|||
16389705|NCT00421148|39911788|FG016|Overall Study|Protocol Violation|0|||
16389706|NCT00421148|39911789|FG017|Overall Study|Protocol Violation|0|||
16389707|NCT00421148|39911790|FG018|Overall Study|Protocol Violation|1|||
16500510|NCT00589914|40306260|FG000|Overall Study|Lost to Follow-up|11|||
16500511|NCT00589914|40306261|FG001|Overall Study|Lost to Follow-up|18|||
16500512|NCT00589914|40306260|FG000|Overall Study|Pregnancy|1|||
16500513|NCT00589914|40306261|FG001|Overall Study|Pregnancy|0|||
16500514|NCT00589914|40306260|FG000|Overall Study|Withdrawal by Subject|55|||
16309994|NCT00182325|39619166|FG000|Overall Study|Miscarriage|5|||
16309995|NCT00182325|39619167|FG001|Overall Study|Miscarriage|3|||
16500515|NCT00589914|40306261|FG001|Overall Study|Withdrawal by Subject|49|||
16500516|NCT00589914|40306260|FG000|Overall Study|Other|22|||
16500517|NCT00589914|40306261|FG001|Overall Study|Other|17|||
16500518|NCT01156311|40306262|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
16500519|NCT01156311|40306263|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
16500520|NCT01156311|40306264|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
16500521|NCT01156311|40306265|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
16500522|NCT01156311|40306262|FG000|2-Month Monotherapy Period|Physician Decision|0|||
16500523|NCT01156311|40306263|FG001|2-Month Monotherapy Period|Physician Decision|1|||
16500524|NCT01156311|40306264|FG002|2-Month Monotherapy Period|Physician Decision|0|||
16500525|NCT01156311|40306265|FG003|2-Month Monotherapy Period|Physician Decision|0|||
16500526|NCT01156311|40306262|FG000|2-Month Monotherapy Period|Other|1|||
16500527|NCT01156311|40306263|FG001|2-Month Monotherapy Period|Other|0|||
16500528|NCT01156311|40306264|FG002|2-Month Monotherapy Period|Other|0|||
16500529|NCT01156311|40306265|FG003|2-Month Monotherapy Period|Other|0|||
16500530|NCT01156311|40306262|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
16500531|NCT01156311|40306263|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
16500532|NCT01156311|40306264|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
16309996|NCT00182325|39619166|FG000|Overall Study|Did not complete survey|22|||
16309997|NCT00182325|39619167|FG001|Overall Study|Did not complete survey|43|||
16309998|NCT02414958|39619168|FG000|Overall Study|Adverse Event|6|||
16309999|NCT02414958|39619169|FG001|Overall Study|Adverse Event|6|||
16310000|NCT02414958|39619170|FG002|Overall Study|Adverse Event|3|||
16310001|NCT02414958|39619168|FG000|Overall Study|Protocol Violation|10|||
16310002|NCT02414958|39619169|FG001|Overall Study|Protocol Violation|3|||
16500533|NCT01156311|40306265|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
16310003|NCT02414958|39619170|FG002|Overall Study|Protocol Violation|1|||
16310004|NCT02414958|39619168|FG000|Overall Study|Lost to Follow-up|7|||
16310005|NCT02414958|39619169|FG001|Overall Study|Lost to Follow-up|4|||
16310006|NCT02414958|39619170|FG002|Overall Study|Lost to Follow-up|0|||
16310007|NCT02414958|39619168|FG000|Overall Study|Withdrawal by Subject|5|||
16310008|NCT02414958|39619169|FG001|Overall Study|Withdrawal by Subject|3|||
16310009|NCT02414958|39619170|FG002|Overall Study|Withdrawal by Subject|5|||
16310010|NCT02414958|39619168|FG000|Overall Study|Other than specified|4|||
16310011|NCT02414958|39619169|FG001|Overall Study|Other than specified|4|||
16310012|NCT02414958|39619170|FG002|Overall Study|Other than specified|5|||
16310013|NCT02389829|39619177|FG000|Overall Study|Lost to Follow-up|0|||
16310014|NCT02389829|39619178|FG001|Overall Study|Lost to Follow-up|1|||
16310015|NCT01565889|39619185|FG000|Part A|Withdrawal by Subject|1|||
16310016|NCT01565889|39619186|FG001|Part A|Withdrawal by Subject|0|||
16310017|NCT01565889|39619187|FG002|Part A|Withdrawal by Subject|0|||
16310018|NCT01565889|39619188|FG003|Part A|Withdrawal by Subject|0|||
16310019|NCT01565889|39619189|FG004|Part A|Withdrawal by Subject|0|||
16310020|NCT01565889|39619190|FG005|Part A|Withdrawal by Subject|0|||
16310021|NCT01565889|39619185|FG000|Part B|Withdrawal by Subject|0|||
16389708|NCT00421148|39911791|FG019|Overall Study|Protocol Violation|0|||
16389709|NCT02779777|39911794|FG000|Overall Study|Disease Progression|1|||
16088332|NCT03732807|38813861|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
16310022|NCT01565889|39619186|FG001|Part B|Withdrawal by Subject|0|||
16310023|NCT01565889|39619187|FG002|Part B|Withdrawal by Subject|0|||
16389710|NCT02779777|39911795|FG001|Overall Study|Disease Progression|0|||
16500534|NCT01156311|40306262|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
16546319|NCT02237508|40464773|FG000|Overall Study|Protocol Violation|0|||
16310024|NCT01565889|39619188|FG003|Part B|Withdrawal by Subject|0|||
16310025|NCT01565889|39619189|FG004|Part B|Withdrawal by Subject|0|||
16310026|NCT01565889|39619190|FG005|Part B|Withdrawal by Subject|1|||
16389711|NCT02779777|39911796|FG002|Overall Study|Disease Progression|0|||
16389712|NCT02779777|39911794|FG000|Overall Study|Adverse Event|3|||
16389713|NCT02779777|39911795|FG001|Overall Study|Adverse Event|1|||
16389714|NCT02779777|39911796|FG002|Overall Study|Adverse Event|0|||
16389715|NCT02779777|39911794|FG000|Overall Study|Physician Decision|9|||
16389716|NCT02779777|39911795|FG001|Overall Study|Physician Decision|0|||
16389717|NCT02779777|39911796|FG002|Overall Study|Physician Decision|1|||
16389718|NCT02779777|39911794|FG000|Overall Study|Withdrawal by Subject|1|||
16389719|NCT02779777|39911795|FG001|Overall Study|Withdrawal by Subject|0|||
16389720|NCT02779777|39911796|FG002|Overall Study|Withdrawal by Subject|0|||
16389721|NCT02580877|39911797|FG000|Overall Study|Withdrawal by Subject|1|||
16389722|NCT02580877|39911798|FG001|Overall Study|Withdrawal by Subject|3|||
16389723|NCT02580877|39911797|FG000|Overall Study|Adverse Event|0|||
16389724|NCT02580877|39911798|FG001|Overall Study|Adverse Event|1|||
16389725|NCT01635998|39911801|FG000|Overall Study|Death|1|||
16389726|NCT01635998|39911802|FG001|Overall Study|Death|1|||
16389727|NCT01635998|39911801|FG000|Overall Study|Lost to Follow-up|2|||
16389728|NCT01635998|39911802|FG001|Overall Study|Lost to Follow-up|1|||
16389729|NCT01635998|39911801|FG000|Overall Study|Withdrawal by Subject|1|||
16389730|NCT01635998|39911802|FG001|Overall Study|Withdrawal by Subject|5|||
16389731|NCT03369665|39911807|FG000|Overall Study|Adverse Event|3|||
16389732|NCT03369665|39911807|FG000|Overall Study|Lost to Follow-up|7|||
16389733|NCT03369665|39911807|FG000|Overall Study|Withdrawal by Subject|15|||
16389734|NCT03369665|39911807|FG000|Overall Study|Progression Disease|2|||
16389735|NCT03369665|39911807|FG000|Overall Study|Not classified|3|||
16389736|NCT00335738|39911808|FG000|Overall Study|Physician Decision|6|||
16389737|NCT00335738|39911809|FG001|Overall Study|Physician Decision|0|||
16389738|NCT00335738|39911808|FG000|Overall Study|Withdrawal by Subject|2|||
16389739|NCT00335738|39911809|FG001|Overall Study|Withdrawal by Subject|0|||
16389740|NCT00335738|39911808|FG000|Overall Study|Ineligible|3|||
16389741|NCT00335738|39911809|FG001|Overall Study|Ineligible|4|||
16389742|NCT03008070|39911810|FG000|Overall Study|Adverse Event|3|||
16389743|NCT03008070|39911811|FG001|Overall Study|Adverse Event|3|||
16389744|NCT03008070|39911812|FG002|Overall Study|Adverse Event|3|||
16389745|NCT03008070|39911810|FG000|Overall Study|Lost to Follow-up|1|||
16389746|NCT03008070|39911811|FG001|Overall Study|Lost to Follow-up|1|||
16389747|NCT03008070|39911812|FG002|Overall Study|Lost to Follow-up|0|||
16389748|NCT03008070|39911810|FG000|Overall Study|Non compliance|0|||
16389749|NCT03008070|39911811|FG001|Overall Study|Non compliance|1|||
16389750|NCT03008070|39911812|FG002|Overall Study|Non compliance|1|||
16389751|NCT03008070|39911810|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
16389752|NCT03008070|39911811|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
16389753|NCT03008070|39911812|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
16389754|NCT03008070|39911810|FG000|Overall Study|Withdrawal by Subject|2|||
16389755|NCT03008070|39911811|FG001|Overall Study|Withdrawal by Subject|0|||
16389756|NCT03008070|39911812|FG002|Overall Study|Withdrawal by Subject|1|||
16389757|NCT03008070|39911810|FG000|Overall Study|Use of prohibited drug|0|||
16389758|NCT03008070|39911811|FG001|Overall Study|Use of prohibited drug|0|||
16389759|NCT03008070|39911812|FG002|Overall Study|Use of prohibited drug|2|||
16389760|NCT04419467|39911813|FG000|Overall Study|Not treated with IP|0|||
16389761|NCT04419467|39911814|FG001|Overall Study|Not treated with IP|0|||
16389762|NCT04419467|39911815|FG002|Overall Study|Not treated with IP|2|||
16389763|NCT04419467|39911813|FG000|Overall Study|Adverse Event|0|||
16389764|NCT04419467|39911814|FG001|Overall Study|Adverse Event|2|||
16389765|NCT04419467|39911815|FG002|Overall Study|Adverse Event|0|||
16389766|NCT04419467|39911813|FG000|Overall Study|Death|1|||
16389767|NCT04419467|39911814|FG001|Overall Study|Death|0|||
16389768|NCT04419467|39911815|FG002|Overall Study|Death|0|||
16389769|NCT04419467|39911813|FG000|Overall Study|Lost to Follow-up|0|||
16389770|NCT04419467|39911814|FG001|Overall Study|Lost to Follow-up|1|||
16389771|NCT04419467|39911815|FG002|Overall Study|Lost to Follow-up|2|||
16389772|NCT04419467|39911813|FG000|Overall Study|Withdrawal by Subject|0|||
16389773|NCT04419467|39911814|FG001|Overall Study|Withdrawal by Subject|0|||
16389774|NCT04419467|39911815|FG002|Overall Study|Withdrawal by Subject|4|||
16389775|NCT04419467|39911813|FG000|Overall Study|Pandemic related|0|||
16389776|NCT04419467|39911814|FG001|Overall Study|Pandemic related|0|||
16389777|NCT04419467|39911815|FG002|Overall Study|Pandemic related|1|||
16389778|NCT04419467|39911813|FG000|Overall Study|Reason not known|1|||
16389779|NCT04419467|39911814|FG001|Overall Study|Reason not known|0|||
16389780|NCT04419467|39911815|FG002|Overall Study|Reason not known|0|||
16389781|NCT04232943|39911816|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
16389782|NCT04232943|39911817|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
16389783|NCT04232943|39911818|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
16389784|NCT04232943|39911816|FG000|Overall Study|Withdrawal by Subject|1|||
16500535|NCT01156311|40306263|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
16500536|NCT01156311|40306264|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
16500537|NCT01156311|40306265|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
16500538|NCT01156311|40306262|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
16500539|NCT01156311|40306263|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
16500540|NCT01156311|40306264|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
16500541|NCT01156311|40306265|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
16500542|NCT01156311|40306262|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
16500543|NCT01156311|40306263|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
16500544|NCT01156311|40306264|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
16500545|NCT01156311|40306265|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
16500546|NCT01156311|40306262|FG000|6-month Add-on Therapy Period|Other|0|||
16500547|NCT01156311|40306263|FG001|6-month Add-on Therapy Period|Other|0|||
16500548|NCT01156311|40306264|FG002|6-month Add-on Therapy Period|Other|1|||
16500549|NCT01156311|40306265|FG003|6-month Add-on Therapy Period|Other|2|||
16500550|NCT03538158|40306269|FG000|Overall Study|Lost to Follow-up|13|||
16500551|NCT03538158|40306270|FG001|Overall Study|Lost to Follow-up|7|||
16500552|NCT03538158|40306269|FG000|Overall Study|Withdrawal by Subject|2|||
16500553|NCT03538158|40306270|FG001|Overall Study|Withdrawal by Subject|1|||
16500554|NCT03287804|40306272|FG000|Overall Study|Death|1|||
16500555|NCT03287804|40306272|FG000|Overall Study|Physician Decision|2|||
16500556|NCT03287804|40306272|FG000|Overall Study|Progressive disease|8|||
16500557|NCT00951665|40306273|FG000|Phase 1b|Adverse Event|2|||
16500558|NCT00951665|40306274|FG001|Phase 1b|Adverse Event|1|||
16500559|NCT00951665|40306275|FG002|Phase 1b|Adverse Event|0|||
16500560|NCT00951665|40306276|FG003|Phase 1b|Adverse Event|1|||
16500561|NCT00951665|40306277|FG004|Phase 1b|Adverse Event|0|||
16500562|NCT00951665|40306278|FG005|Phase 1b|Adverse Event|0|||
16500563|NCT00951665|40306273|FG000|Phase 1b|Death|1|||
16500564|NCT00951665|40306274|FG001|Phase 1b|Death|0|||
16500565|NCT00951665|40306275|FG002|Phase 1b|Death|2|||
16500566|NCT00951665|40306276|FG003|Phase 1b|Death|0|||
16500567|NCT00951665|40306277|FG004|Phase 1b|Death|0|||
16500568|NCT00951665|40306278|FG005|Phase 1b|Death|0|||
16500569|NCT00951665|40306273|FG000|Phase 1b|Physician Decision|4|||
16500570|NCT00951665|40306274|FG001|Phase 1b|Physician Decision|0|||
16500571|NCT00951665|40306275|FG002|Phase 1b|Physician Decision|1|||
16500572|NCT00951665|40306276|FG003|Phase 1b|Physician Decision|0|||
16500573|NCT00951665|40306277|FG004|Phase 1b|Physician Decision|0|||
16500574|NCT00951665|40306278|FG005|Phase 1b|Physician Decision|0|||
16500575|NCT00951665|40306273|FG000|Phase 1b|Withdrawal by Subject|0|||
16500576|NCT00951665|40306274|FG001|Phase 1b|Withdrawal by Subject|1|||
16500577|NCT00951665|40306275|FG002|Phase 1b|Withdrawal by Subject|0|||
16500578|NCT00951665|40306276|FG003|Phase 1b|Withdrawal by Subject|0|||
16500579|NCT00951665|40306277|FG004|Phase 1b|Withdrawal by Subject|0|||
16500580|NCT00951665|40306278|FG005|Phase 1b|Withdrawal by Subject|0|||
16500581|NCT00951665|40306273|FG000|Phase 1b|Disease Progression|13|||
16500582|NCT00951665|40306274|FG001|Phase 1b|Disease Progression|2|||
16500583|NCT00951665|40306275|FG002|Phase 1b|Disease Progression|14|||
16500584|NCT00951665|40306276|FG003|Phase 1b|Disease Progression|0|||
16500585|NCT00951665|40306277|FG004|Phase 1b|Disease Progression|0|||
16500586|NCT00951665|40306278|FG005|Phase 1b|Disease Progression|0|||
16500587|NCT00951665|40306273|FG000|Phase 1b|Protocol Violation|2|||
16500588|NCT00951665|40306274|FG001|Phase 1b|Protocol Violation|0|||
16500589|NCT00951665|40306275|FG002|Phase 1b|Protocol Violation|0|||
16500590|NCT00951665|40306276|FG003|Phase 1b|Protocol Violation|0|||
16500591|NCT00951665|40306277|FG004|Phase 1b|Protocol Violation|0|||
16500592|NCT00951665|40306278|FG005|Phase 1b|Protocol Violation|0|||
16500593|NCT00951665|40306273|FG000|Phase 2a|Adverse Event|0|||
16500594|NCT00951665|40306274|FG001|Phase 2a|Adverse Event|0|||
16500595|NCT00951665|40306275|FG002|Phase 2a|Adverse Event|0|||
16500596|NCT00951665|40306276|FG003|Phase 2a|Adverse Event|0|||
16500597|NCT00951665|40306277|FG004|Phase 2a|Adverse Event|2|||
16500598|NCT00951665|40306278|FG005|Phase 2a|Adverse Event|0|||
16500599|NCT00951665|40306273|FG000|Phase 2a|Death|0|||
16500600|NCT00951665|40306274|FG001|Phase 2a|Death|0|||
16500601|NCT00951665|40306275|FG002|Phase 2a|Death|0|||
16500602|NCT00951665|40306276|FG003|Phase 2a|Death|0|||
16500603|NCT00951665|40306277|FG004|Phase 2a|Death|1|||
16500604|NCT00951665|40306278|FG005|Phase 2a|Death|1|||
16500605|NCT00951665|40306273|FG000|Phase 2a|Lost to Follow-up|0|||
16500606|NCT00951665|40306274|FG001|Phase 2a|Lost to Follow-up|0|||
16500607|NCT00951665|40306275|FG002|Phase 2a|Lost to Follow-up|0|||
16500608|NCT00951665|40306276|FG003|Phase 2a|Lost to Follow-up|0|||
16500609|NCT00951665|40306277|FG004|Phase 2a|Lost to Follow-up|1|||
16500610|NCT00951665|40306278|FG005|Phase 2a|Lost to Follow-up|0|||
16500611|NCT00951665|40306273|FG000|Phase 2a|Physician Decision|0|||
16500612|NCT00951665|40306274|FG001|Phase 2a|Physician Decision|0|||
16500613|NCT00951665|40306275|FG002|Phase 2a|Physician Decision|0|||
16500614|NCT00951665|40306276|FG003|Phase 2a|Physician Decision|0|||
16500615|NCT00951665|40306277|FG004|Phase 2a|Physician Decision|0|||
16500616|NCT00951665|40306278|FG005|Phase 2a|Physician Decision|1|||
16500617|NCT00951665|40306273|FG000|Phase 2a|Withdrawal by Subject|0|||
16500618|NCT00951665|40306274|FG001|Phase 2a|Withdrawal by Subject|0|||
16500619|NCT00951665|40306275|FG002|Phase 2a|Withdrawal by Subject|0|||
16500620|NCT00951665|40306276|FG003|Phase 2a|Withdrawal by Subject|0|||
16500621|NCT00951665|40306277|FG004|Phase 2a|Withdrawal by Subject|2|||
16500622|NCT00951665|40306278|FG005|Phase 2a|Withdrawal by Subject|0|||
16500623|NCT00951665|40306273|FG000|Phase 2a|Disease Progression|0|||
16500624|NCT00951665|40306274|FG001|Phase 2a|Disease Progression|0|||
16500625|NCT00951665|40306275|FG002|Phase 2a|Disease Progression|0|||
16500626|NCT00951665|40306276|FG003|Phase 2a|Disease Progression|0|||
16500627|NCT00951665|40306277|FG004|Phase 2a|Disease Progression|6|||
16500628|NCT00951665|40306278|FG005|Phase 2a|Disease Progression|5|||
16500629|NCT00623727|40306279|FG000|Double Blind (DB)|Adverse Event|1|||
16500630|NCT00623727|40306280|FG001|Double Blind (DB)|Adverse Event|3|||
16500631|NCT00623727|40306279|FG000|Double Blind (DB)|Physician Decision|0|||
16500632|NCT00623727|40306280|FG001|Double Blind (DB)|Physician Decision|1|||
16500633|NCT00623727|40306279|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
16500634|NCT00623727|40306280|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
16500635|NCT00623727|40306279|FG000|Double Blind (DB)|Lack of Efficacy|2|||
16500636|NCT00623727|40306280|FG001|Double Blind (DB)|Lack of Efficacy|2|||
16500637|NCT00623727|40306279|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
16500638|NCT00623727|40306280|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
16500639|NCT00623727|40306279|FG000|Double Blind (DB)|Lost to Follow-up|1|||
16500640|NCT00623727|40306280|FG001|Double Blind (DB)|Lost to Follow-up|1|||
16500641|NCT00623727|40306279|FG000|Double Blind (DB)|Protocol Violation|2|||
16500642|NCT00623727|40306280|FG001|Double Blind (DB)|Protocol Violation|2|||
16500643|NCT00623727|40306279|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
16500644|NCT00623727|40306280|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
16500645|NCT00623727|40306279|FG000|Open Label Follow-up|Study termination|0|||
16500646|NCT00623727|40306280|FG001|Open Label Follow-up|Study termination|6|||
16500647|NCT00623727|40306279|FG000|Open Label Follow-up|Participant convenience|0|||
16500648|NCT00623727|40306280|FG001|Open Label Follow-up|Participant convenience|1|||
16500649|NCT02551731|40306281|FG000|Overall Study|Withdrawal by Subject|2|||
16500650|NCT02750592|40306282|FG000|Overall Study|Adverse Event|3|||
16500651|NCT02750592|40306282|FG000|Overall Study|Lack of Efficacy|2|||
16500652|NCT02956486|40306283|FG000|Core Phase|Adverse Event|51|||
16500653|NCT02956486|40306284|FG001|Core Phase|Adverse Event|88|||
16500654|NCT02956486|40306285|FG002|Core Phase|Adverse Event|0|||
16500655|NCT02956486|40306283|FG000|Core Phase|Lost to Follow-up|8|||
16500656|NCT02956486|40306284|FG001|Core Phase|Lost to Follow-up|6|||
16500657|NCT02956486|40306285|FG002|Core Phase|Lost to Follow-up|0|||
16500658|NCT02956486|40306283|FG000|Core Phase|Inadequate therapeutic effect|4|||
16500659|NCT02956486|40306284|FG001|Core Phase|Inadequate therapeutic effect|5|||
16500660|NCT02956486|40306285|FG002|Core Phase|Inadequate therapeutic effect|0|||
16500661|NCT02956486|40306283|FG000|Core Phase|Withdrawal by Subject|101|||
16500662|NCT02956486|40306284|FG001|Core Phase|Withdrawal by Subject|104|||
16500663|NCT02956486|40306285|FG002|Core Phase|Withdrawal by Subject|0|||
16500664|NCT02956486|40306283|FG000|Core Phase|Study terminated by sponsor|888|||
16500665|NCT02956486|40306284|FG001|Core Phase|Study terminated by sponsor|848|||
16500666|NCT02956486|40306285|FG002|Core Phase|Study terminated by sponsor|0|||
16500667|NCT02956486|40306283|FG000|Core Phase|Other|27|||
16500668|NCT02956486|40306284|FG001|Core Phase|Other|18|||
16500669|NCT02956486|40306285|FG002|Core Phase|Other|0|||
16500670|NCT02956486|40306283|FG000|Core Phase|Not treated|0|||
16500671|NCT02956486|40306284|FG001|Core Phase|Not treated|3|||
16500672|NCT02956486|40306285|FG002|Core Phase|Not treated|0|||
16500673|NCT02956486|40306283|FG000|Extension Phase|Adverse Event|0|||
16500674|NCT02956486|40306284|FG001|Extension Phase|Adverse Event|0|||
16500675|NCT02956486|40306285|FG002|Extension Phase|Adverse Event|2|||
16500676|NCT02956486|40306283|FG000|Extension Phase|Study terminated by sponsor|0|||
16500677|NCT02956486|40306284|FG001|Extension Phase|Study terminated by sponsor|0|||
16500678|NCT02956486|40306285|FG002|Extension Phase|Study terminated by sponsor|16|||
16500679|NCT02956486|40306283|FG000|Extension Phase|Not Treated|0|||
16500680|NCT02956486|40306284|FG001|Extension Phase|Not Treated|0|||
16500681|NCT02956486|40306285|FG002|Extension Phase|Not Treated|1|||
16500682|NCT00463346|40306286|FG000|Overall Study|Withdrawal by Subject|3|||
16500683|NCT00463346|40306287|FG001|Overall Study|Withdrawal by Subject|3|||
16500684|NCT03761147|40306289|FG000|Overall Study|Withdrawal by Subject|6|||
16500685|NCT03761147|40306290|FG001|Overall Study|Withdrawal by Subject|1|||
16500686|NCT03761147|40306289|FG000|Overall Study|Adverse Event|1|||
16500687|NCT03761147|40306290|FG001|Overall Study|Adverse Event|3|||
16500688|NCT01026792|40306291|FG000|Overall Study|Protocol Violation|1|||
16500689|NCT01712854|40306292|FG000|Overall Study|Physician Decision|1|||
16500690|NCT00561080|40306295|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
16546320|NCT02237508|40464774|FG001|Overall Study|Protocol Violation|0|||
16500691|NCT00561080|40306296|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
16500692|NCT00561080|40306297|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
16500693|NCT00561080|40306295|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
16500694|NCT00561080|40306296|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
16500695|NCT00561080|40306297|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
16500696|NCT00561080|40306295|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
16500697|NCT00561080|40306296|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
16500698|NCT00561080|40306297|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
16500699|NCT00561080|40306295|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
16500700|NCT00561080|40306296|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
16500701|NCT00561080|40306297|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
16500702|NCT00561080|40306295|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
16500703|NCT00561080|40306296|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
16500704|NCT00561080|40306297|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
16500705|NCT00561080|40306295|FG000|Vaccination Period (up to Month 4)|Other|0|||
16500706|NCT00561080|40306296|FG001|Vaccination Period (up to Month 4)|Other|2|||
16500707|NCT00561080|40306297|FG002|Vaccination Period (up to Month 4)|Other|1|||
16500708|NCT00561080|40306295|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
16088333|NCT03732807|38813855|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
16088334|NCT03732807|38813856|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
16088335|NCT03732807|38813857|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
16088336|NCT03732807|38813858|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
16088337|NCT03732807|38813859|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
16088338|NCT03732807|38813860|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
16088339|NCT03732807|38813861|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
16088340|NCT03732807|38813855|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
16088341|NCT03732807|38813856|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
16088342|NCT03732807|38813857|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
16088343|NCT03732807|38813858|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
16088344|NCT03732807|38813859|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
16088345|NCT03732807|38813860|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
16088346|NCT03732807|38813861|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
16088347|NCT03732807|38813855|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
16088348|NCT03732807|38813856|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
16088349|NCT03732807|38813857|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
16088350|NCT03732807|38813858|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
16088351|NCT03732807|38813859|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
16088352|NCT03732807|38813860|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
16310027|NCT01565889|39619185|FG000|Part B|Lack of Efficacy|0|||
16310028|NCT01565889|39619186|FG001|Part B|Lack of Efficacy|0|||
16310029|NCT01565889|39619187|FG002|Part B|Lack of Efficacy|0|||
16310030|NCT01565889|39619188|FG003|Part B|Lack of Efficacy|0|||
16500709|NCT00561080|40306296|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
16500710|NCT00561080|40306297|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
16500711|NCT00561080|40306295|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
16500712|NCT00561080|40306296|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
16500713|NCT00561080|40306297|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
16500714|NCT00561080|40306295|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
16500715|NCT00561080|40306296|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
16500716|NCT00561080|40306297|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
16500717|NCT00561080|40306295|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
16500718|NCT00561080|40306296|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
16500719|NCT00561080|40306297|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
16500720|NCT00056407|40306298|FG000|Overall Study|Adverse Event|282|||
16500721|NCT00056407|40306299|FG001|Overall Study|Adverse Event|364|||
16500722|NCT00056407|40306298|FG000|Overall Study|Withdrawal by Subject|377|||
16500723|NCT00056407|40306299|FG001|Overall Study|Withdrawal by Subject|361|||
16500724|NCT00056407|40306298|FG000|Overall Study|Lost to Follow-up|123|||
16500725|NCT00056407|40306299|FG001|Overall Study|Lost to Follow-up|113|||
16500726|NCT00056407|40306298|FG000|Overall Study|Protocol Violation|104|||
16310031|NCT01565889|39619189|FG004|Part B|Lack of Efficacy|0|||
16310032|NCT01565889|39619190|FG005|Part B|Lack of Efficacy|2|||
16500727|NCT00056407|40306299|FG001|Overall Study|Protocol Violation|95|||
16500728|NCT00056407|40306298|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
16500729|NCT00056407|40306299|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
16500730|NCT00056407|40306298|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
16088353|NCT03732807|38813861|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
16310033|NCT01565889|39619185|FG000|Part B|Lost to Follow-up|0|||
16310034|NCT01565889|39619186|FG001|Part B|Lost to Follow-up|0|||
16500731|NCT00056407|40306299|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
16088354|NCT03732807|38813855|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
16088355|NCT03732807|38813856|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
16088356|NCT03732807|38813857|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
16088357|NCT03732807|38813858|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
16088358|NCT03732807|38813859|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
16088359|NCT03732807|38813860|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
16088360|NCT03732807|38813861|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
16195424|NCT01111539|39193333|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
16195425|NCT01111539|39193334|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
16500732|NCT00056407|40306298|FG000|Overall Study|Missing|25|||
16500733|NCT00056407|40306299|FG001|Overall Study|Missing|34|||
16500734|NCT01189812|40306300|FG000|Overall Study|Withdrawal by Subject|2|||
16195426|NCT01111539|39193335|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
16195427|NCT01111539|39193336|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
16195428|NCT01111539|39193337|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
16195429|NCT01111539|39193333|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16195430|NCT01111539|39193334|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16195431|NCT01111539|39193335|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
16195432|NCT01111539|39193336|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16195433|NCT01111539|39193337|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
16195434|NCT01111539|39193333|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16195435|NCT01111539|39193334|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16195436|NCT01111539|39193335|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
16195437|NCT01111539|39193336|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16195438|NCT01111539|39193337|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
16195439|NCT01111539|39193333|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
16195440|NCT01111539|39193334|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
16195441|NCT01111539|39193335|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
16500735|NCT01189812|40306301|FG001|Overall Study|Withdrawal by Subject|3|||
16500736|NCT01189812|40306300|FG000|Overall Study|Adverse Event|1|||
16500737|NCT01189812|40306301|FG001|Overall Study|Adverse Event|0|||
16500738|NCT01189812|40306300|FG000|Overall Study|Out of Window|4|||
16500739|NCT01189812|40306301|FG001|Overall Study|Out of Window|3|||
16500740|NCT01189812|40306300|FG000|Overall Study|Moved out of State|1|||
16500741|NCT01189812|40306301|FG001|Overall Study|Moved out of State|2|||
16500742|NCT04256785|40306302|FG000|Overall Study|Adverse Event|8|||
16500743|NCT04256785|40306303|FG001|Overall Study|Adverse Event|6|||
16500744|NCT04256785|40306302|FG000|Overall Study|Lack of Efficacy|3|||
16500745|NCT04256785|40306303|FG001|Overall Study|Lack of Efficacy|4|||
16500746|NCT04256785|40306302|FG000|Overall Study|Lost to Follow-up|7|||
16500747|NCT04256785|40306303|FG001|Overall Study|Lost to Follow-up|7|||
16500748|NCT04256785|40306302|FG000|Overall Study|Protocol Violation|1|||
16195442|NCT01111539|39193336|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
16195443|NCT01111539|39193337|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
16195444|NCT01111539|39193333|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
16195445|NCT01111539|39193334|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
16195446|NCT01111539|39193335|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
16195447|NCT01111539|39193336|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
16195448|NCT01111539|39193337|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
16195449|NCT01111539|39193333|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
16195450|NCT01111539|39193334|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
16310035|NCT01565889|39619187|FG002|Part B|Lost to Follow-up|0|||
16500749|NCT04256785|40306303|FG001|Overall Study|Protocol Violation|0|||
16500750|NCT04256785|40306302|FG000|Overall Study|Withdrawal by Subject|4|||
16500751|NCT04256785|40306303|FG001|Overall Study|Withdrawal by Subject|1|||
16500752|NCT04256785|40306302|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
16500753|NCT04256785|40306303|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
16500754|NCT00708643|40306306|FG000|Overall Study|Adverse Event|0|||
16500755|NCT00708643|40306307|FG001|Overall Study|Adverse Event|1|||
16500756|NCT00010374|40306314|FG000|Overall Study|False positive phrenic nerve test|1|||
16500757|NCT01998633|40306316|FG000|Overall Study|Death|1|||
16500758|NCT01647282|40306317|FG000|Overall Study|Physician Decision|7|||
16500759|NCT01647282|40306318|FG001|Overall Study|Physician Decision|5|||
16500760|NCT02289690|40306323|FG000|Overall Study|Adverse Event Related to Progression|0|||
16500761|NCT02289690|40306324|FG001|Overall Study|Adverse Event Related to Progression|1|||
16500762|NCT02289690|40306325|FG002|Overall Study|Adverse Event Related to Progression|1|||
16500763|NCT02289690|40306326|FG003|Overall Study|Adverse Event Related to Progression|0|||
16546321|NCT02237508|40464775|FG002|Overall Study|Protocol Violation|1|||
16500764|NCT02289690|40306327|FG004|Overall Study|Adverse Event Related to Progression|1|||
16500765|NCT02289690|40306328|FG005|Overall Study|Adverse Event Related to Progression|0|||
16500766|NCT02289690|40306329|FG006|Overall Study|Adverse Event Related to Progression|1|||
16500767|NCT02289690|40306330|FG007|Overall Study|Adverse Event Related to Progression|0|||
16500768|NCT02289690|40306331|FG008|Overall Study|Adverse Event Related to Progression|0|||
16500769|NCT02289690|40306332|FG009|Overall Study|Adverse Event Related to Progression|0|||
16500770|NCT02289690|40306323|FG000|Overall Study|Withdrawal by Subject|1|||
16500771|NCT02289690|40306324|FG001|Overall Study|Withdrawal by Subject|0|||
16500772|NCT02289690|40306325|FG002|Overall Study|Withdrawal by Subject|0|||
16500773|NCT02289690|40306326|FG003|Overall Study|Withdrawal by Subject|0|||
16500774|NCT02289690|40306327|FG004|Overall Study|Withdrawal by Subject|1|||
16500775|NCT02289690|40306328|FG005|Overall Study|Withdrawal by Subject|1|||
16500776|NCT02289690|40306329|FG006|Overall Study|Withdrawal by Subject|0|||
16500777|NCT02289690|40306330|FG007|Overall Study|Withdrawal by Subject|0|||
16500778|NCT02289690|40306331|FG008|Overall Study|Withdrawal by Subject|4|||
16500779|NCT02289690|40306332|FG009|Overall Study|Withdrawal by Subject|2|||
16500780|NCT02289690|40306323|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
16500781|NCT02289690|40306324|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
16500782|NCT02289690|40306325|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
16500783|NCT02289690|40306326|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
16500784|NCT02289690|40306327|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
16500785|NCT02289690|40306328|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
16500786|NCT02289690|40306329|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
16088361|NCT03732807|38813855|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
16088362|NCT03732807|38813856|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
16389785|NCT04232943|39911817|FG001|Overall Study|Withdrawal by Subject|1|||
16389786|NCT04232943|39911818|FG002|Overall Study|Withdrawal by Subject|0|||
16389787|NCT03257358|39911821|FG000|Overall Study|Adverse Event|25|||
16389788|NCT03257358|39911822|FG001|Overall Study|Adverse Event|12|||
16389789|NCT03257358|39911821|FG000|Overall Study|Lack of Efficacy|1|||
16500787|NCT02289690|40306330|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
16500788|NCT02289690|40306331|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
16500789|NCT02289690|40306332|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
16500790|NCT02289690|40306323|FG000|Overall Study|Lost to Follow-up|0|||
16500791|NCT02289690|40306324|FG001|Overall Study|Lost to Follow-up|0|||
16500792|NCT02289690|40306325|FG002|Overall Study|Lost to Follow-up|0|||
16500793|NCT02289690|40306326|FG003|Overall Study|Lost to Follow-up|0|||
16500794|NCT02289690|40306327|FG004|Overall Study|Lost to Follow-up|0|||
16500795|NCT02289690|40306328|FG005|Overall Study|Lost to Follow-up|0|||
16500796|NCT02289690|40306329|FG006|Overall Study|Lost to Follow-up|0|||
16500797|NCT02289690|40306330|FG007|Overall Study|Lost to Follow-up|1|||
16500798|NCT02289690|40306331|FG008|Overall Study|Lost to Follow-up|0|||
16500799|NCT02289690|40306332|FG009|Overall Study|Lost to Follow-up|2|||
16500800|NCT02289690|40306323|FG000|Overall Study|Death|0|||
16500801|NCT02289690|40306324|FG001|Overall Study|Death|0|||
16500802|NCT02289690|40306325|FG002|Overall Study|Death|0|||
16500803|NCT02289690|40306326|FG003|Overall Study|Death|0|||
16500804|NCT02289690|40306327|FG004|Overall Study|Death|0|||
16500805|NCT02289690|40306328|FG005|Overall Study|Death|0|||
16500806|NCT02289690|40306329|FG006|Overall Study|Death|0|||
16500807|NCT02289690|40306330|FG007|Overall Study|Death|49|||
16500808|NCT02289690|40306331|FG008|Overall Study|Death|45|||
16500809|NCT02289690|40306332|FG009|Overall Study|Death|41|||
16500810|NCT02289690|40306323|FG000|Overall Study|Sponsor Discontinued Study|0|||
16500811|NCT02289690|40306324|FG001|Overall Study|Sponsor Discontinued Study|0|||
16500812|NCT02289690|40306325|FG002|Overall Study|Sponsor Discontinued Study|0|||
16500813|NCT02289690|40306326|FG003|Overall Study|Sponsor Discontinued Study|0|||
16500814|NCT02289690|40306327|FG004|Overall Study|Sponsor Discontinued Study|0|||
16500815|NCT02289690|40306328|FG005|Overall Study|Sponsor Discontinued Study|0|||
16500816|NCT02289690|40306329|FG006|Overall Study|Sponsor Discontinued Study|0|||
16500817|NCT02289690|40306330|FG007|Overall Study|Sponsor Discontinued Study|9|||
16500818|NCT02289690|40306331|FG008|Overall Study|Sponsor Discontinued Study|7|||
16500819|NCT02289690|40306332|FG009|Overall Study|Sponsor Discontinued Study|15|||
16500820|NCT02289690|40306323|FG000|Overall Study|Other|0|||
16500821|NCT02289690|40306324|FG001|Overall Study|Other|0|||
16500822|NCT02289690|40306325|FG002|Overall Study|Other|0|||
16500823|NCT02289690|40306326|FG003|Overall Study|Other|1|||
16500824|NCT02289690|40306327|FG004|Overall Study|Other|1|||
16500825|NCT02289690|40306328|FG005|Overall Study|Other|0|||
16500826|NCT02289690|40306329|FG006|Overall Study|Other|1|||
16500827|NCT02289690|40306330|FG007|Overall Study|Other|2|||
16500828|NCT02289690|40306331|FG008|Overall Study|Other|3|||
16500829|NCT02289690|40306332|FG009|Overall Study|Other|1|||
16500830|NCT01165554|40306333|FG000|Overall Study|Withdrawal by Subject|23|||
16500831|NCT03164928|40306335|FG000|Overall Study|Lost to Follow-up|1|||
16500832|NCT03164928|40306336|FG001|Overall Study|Lost to Follow-up|0|||
16500833|NCT03566823|40306337|FG000|Overall Study|Lack of Efficacy|0|||
16500834|NCT03566823|40306338|FG001|Overall Study|Lack of Efficacy|1|||
16500835|NCT03566823|40306339|FG002|Overall Study|Lack of Efficacy|0|||
16500836|NCT03566823|40306337|FG000|Overall Study|Withdrawal by Subject|1|||
16500837|NCT03566823|40306338|FG001|Overall Study|Withdrawal by Subject|2|||
16500838|NCT03566823|40306339|FG002|Overall Study|Withdrawal by Subject|0|||
16500839|NCT03566823|40306337|FG000|Overall Study|Adverse Event|1|||
16500840|NCT03566823|40306338|FG001|Overall Study|Adverse Event|0|||
16500841|NCT03566823|40306339|FG002|Overall Study|Adverse Event|2|||
16500842|NCT01333059|40306340|FG000|Overall Study|Physician Decision|3|||
16500843|NCT01333059|40306341|FG001|Overall Study|Physician Decision|3|||
16500844|NCT01333059|40306340|FG000|Overall Study|Protocol Violation|3|||
16500845|NCT01333059|40306341|FG001|Overall Study|Protocol Violation|0|||
16500846|NCT00255047|40306342|FG000|Overall Study|Serious Adverse Events|2|||
16500847|NCT00255047|40306343|FG001|Overall Study|Serious Adverse Events|1|||
16500848|NCT00255047|40306344|FG002|Overall Study|Serious Adverse Events|2|||
16500849|NCT00255047|40306345|FG003|Overall Study|Serious Adverse Events|1|||
16500850|NCT00255047|40306342|FG000|Overall Study|Adverse Event|0|||
16500851|NCT00255047|40306343|FG001|Overall Study|Adverse Event|3|||
16500852|NCT00255047|40306344|FG002|Overall Study|Adverse Event|2|||
16500853|NCT00255047|40306345|FG003|Overall Study|Adverse Event|1|||
16500854|NCT00255047|40306342|FG000|Overall Study|Protocol Violation|13|||
16500855|NCT00255047|40306343|FG001|Overall Study|Protocol Violation|13|||
16500856|NCT00255047|40306344|FG002|Overall Study|Protocol Violation|16|||
16500857|NCT00255047|40306345|FG003|Overall Study|Protocol Violation|20|||
16500858|NCT00255047|40306342|FG000|Overall Study|Lost to Follow-up|9|||
16500859|NCT00255047|40306343|FG001|Overall Study|Lost to Follow-up|8|||
16500860|NCT00255047|40306344|FG002|Overall Study|Lost to Follow-up|5|||
16500861|NCT00255047|40306345|FG003|Overall Study|Lost to Follow-up|6|||
16500862|NCT00255047|40306342|FG000|Overall Study|Withdrawal by Subject|24|||
16500863|NCT00255047|40306343|FG001|Overall Study|Withdrawal by Subject|23|||
16500864|NCT00255047|40306344|FG002|Overall Study|Withdrawal by Subject|25|||
16500865|NCT00255047|40306345|FG003|Overall Study|Withdrawal by Subject|18|||
16500866|NCT01705652|40306349|FG000|Overall Study|Adverse Event|1|||
16500867|NCT01705652|40306350|FG001|Overall Study|Adverse Event|0|||
16500868|NCT01705652|40306349|FG000|Overall Study|Withdrawal by Subject|1|||
16500869|NCT01705652|40306350|FG001|Overall Study|Withdrawal by Subject|2|||
16500870|NCT01705652|40306349|FG000|Overall Study|non-compliance|1|||
16500871|NCT01705652|40306350|FG001|Overall Study|non-compliance|1|||
16500872|NCT02355691|40306356|FG000|Overall Study|Loss of Research Personnel|7|||
16500873|NCT02355691|40306357|FG001|Overall Study|Loss of Research Personnel|9|||
16500874|NCT05089682|40306358|FG000|Overall Study|Withdrawal by Subject|2|||
16500875|NCT01466348|40306359|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
16500876|NCT01466348|40306360|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
16088363|NCT03732807|38813857|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
16500877|NCT02436356|40306361|FG000|Overall Study|Excluded by MRI Screening|0|||
16500878|NCT02436356|40306362|FG001|Overall Study|Excluded by MRI Screening|0|||
16500879|NCT02436356|40306363|FG002|Overall Study|Excluded by MRI Screening|2|||
16500880|NCT02436356|40306361|FG000|Overall Study|Lost to Follow-up|0|||
16500881|NCT02436356|40306362|FG001|Overall Study|Lost to Follow-up|1|||
16500882|NCT02436356|40306363|FG002|Overall Study|Lost to Follow-up|0|||
16500883|NCT02436356|40306361|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
16500884|NCT02436356|40306362|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
16500885|NCT02436356|40306363|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
16500886|NCT02436356|40306361|FG000|Overall Study|Excluded due to other medical conditions|3|||
16500887|NCT02436356|40306362|FG001|Overall Study|Excluded due to other medical conditions|0|||
16500888|NCT02436356|40306363|FG002|Overall Study|Excluded due to other medical conditions|0|||
16500889|NCT02436356|40306361|FG000|Overall Study|Withdrawal by Subject|1|||
16500890|NCT02436356|40306362|FG001|Overall Study|Withdrawal by Subject|0|||
16500891|NCT02436356|40306363|FG002|Overall Study|Withdrawal by Subject|0|||
16500892|NCT00597766|40306370|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
16500893|NCT00597766|40306371|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
16500894|NCT00597766|40306372|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
16500895|NCT00597766|40306370|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
16500896|NCT00597766|40306371|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
16500897|NCT00597766|40306372|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
16500898|NCT01729754|40306373|FG000|Part 1|Adverse Event|2|||
16500899|NCT01729754|40306374|FG001|Part 1|Adverse Event|0|||
16500900|NCT01729754|40306375|FG002|Part 1|Adverse Event|0|||
16500901|NCT01729754|40306376|FG003|Part 1|Adverse Event|1|||
16500902|NCT01729754|40306377|FG004|Part 1|Adverse Event|0|||
16500903|NCT01729754|40306378|FG005|Part 1|Adverse Event|0|||
16500904|NCT01729754|40306379|FG006|Part 1|Adverse Event|2|||
16500905|NCT01729754|40306380|FG007|Part 1|Adverse Event|0|||
16500906|NCT01729754|40306381|FG008|Part 1|Adverse Event|0|||
16500907|NCT01729754|40306382|FG009|Part 1|Adverse Event|5|||
16500908|NCT01729754|40306373|FG000|Part 1|Lack of Efficacy|1|||
16500909|NCT01729754|40306374|FG001|Part 1|Lack of Efficacy|0|||
16500910|NCT01729754|40306375|FG002|Part 1|Lack of Efficacy|0|||
16500911|NCT01729754|40306376|FG003|Part 1|Lack of Efficacy|0|||
16500912|NCT01729754|40306377|FG004|Part 1|Lack of Efficacy|0|||
16500913|NCT01729754|40306378|FG005|Part 1|Lack of Efficacy|0|||
16500914|NCT01729754|40306379|FG006|Part 1|Lack of Efficacy|2|||
16500915|NCT01729754|40306380|FG007|Part 1|Lack of Efficacy|0|||
16500916|NCT01729754|40306381|FG008|Part 1|Lack of Efficacy|0|||
16500917|NCT01729754|40306382|FG009|Part 1|Lack of Efficacy|0|||
16500918|NCT01729754|40306373|FG000|Part 1|Lost to Follow-up|1|||
16500919|NCT01729754|40306374|FG001|Part 1|Lost to Follow-up|0|||
16500920|NCT01729754|40306375|FG002|Part 1|Lost to Follow-up|0|||
16500921|NCT01729754|40306376|FG003|Part 1|Lost to Follow-up|2|||
16500922|NCT01729754|40306377|FG004|Part 1|Lost to Follow-up|0|||
16500923|NCT01729754|40306378|FG005|Part 1|Lost to Follow-up|0|||
16500924|NCT01729754|40306379|FG006|Part 1|Lost to Follow-up|3|||
16500925|NCT01729754|40306380|FG007|Part 1|Lost to Follow-up|0|||
16500926|NCT01729754|40306381|FG008|Part 1|Lost to Follow-up|0|||
16500927|NCT01729754|40306382|FG009|Part 1|Lost to Follow-up|3|||
16500928|NCT01729754|40306373|FG000|Part 1|Non-compliance with Study Drug|1|||
16500929|NCT01729754|40306374|FG001|Part 1|Non-compliance with Study Drug|0|||
16500930|NCT01729754|40306375|FG002|Part 1|Non-compliance with Study Drug|0|||
16500931|NCT01729754|40306376|FG003|Part 1|Non-compliance with Study Drug|0|||
16500932|NCT01729754|40306377|FG004|Part 1|Non-compliance with Study Drug|0|||
16500933|NCT01729754|40306378|FG005|Part 1|Non-compliance with Study Drug|0|||
16500934|NCT01729754|40306379|FG006|Part 1|Non-compliance with Study Drug|0|||
16500935|NCT01729754|40306380|FG007|Part 1|Non-compliance with Study Drug|0|||
16500936|NCT01729754|40306381|FG008|Part 1|Non-compliance with Study Drug|0|||
16500937|NCT01729754|40306382|FG009|Part 1|Non-compliance with Study Drug|0|||
16500938|NCT01729754|40306373|FG000|Part 1|Physician Decision|0|||
16500939|NCT01729754|40306374|FG001|Part 1|Physician Decision|0|||
16500940|NCT01729754|40306375|FG002|Part 1|Physician Decision|0|||
16500941|NCT01729754|40306376|FG003|Part 1|Physician Decision|0|||
16500942|NCT01729754|40306377|FG004|Part 1|Physician Decision|0|||
16500943|NCT01729754|40306378|FG005|Part 1|Physician Decision|0|||
16389790|NCT03257358|39911822|FG001|Overall Study|Lack of Efficacy|1|||
16195451|NCT01111539|39193335|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
16195452|NCT01111539|39193336|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
16195453|NCT01111539|39193337|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
16500944|NCT01729754|40306379|FG006|Part 1|Physician Decision|0|||
16500945|NCT01729754|40306380|FG007|Part 1|Physician Decision|0|||
16500946|NCT01729754|40306381|FG008|Part 1|Physician Decision|0|||
16500947|NCT01729754|40306382|FG009|Part 1|Physician Decision|4|||
16500948|NCT01729754|40306373|FG000|Part 1|Pregnancy|0|||
16500949|NCT01729754|40306374|FG001|Part 1|Pregnancy|0|||
16500950|NCT01729754|40306375|FG002|Part 1|Pregnancy|0|||
16500951|NCT01729754|40306376|FG003|Part 1|Pregnancy|1|||
16500952|NCT01729754|40306377|FG004|Part 1|Pregnancy|0|||
16500953|NCT01729754|40306378|FG005|Part 1|Pregnancy|0|||
16500954|NCT01729754|40306379|FG006|Part 1|Pregnancy|0|||
16500955|NCT01729754|40306380|FG007|Part 1|Pregnancy|0|||
16500956|NCT01729754|40306381|FG008|Part 1|Pregnancy|0|||
16500957|NCT01729754|40306382|FG009|Part 1|Pregnancy|1|||
16500958|NCT01729754|40306373|FG000|Part 1|Progressive Disease|0|||
16500959|NCT01729754|40306374|FG001|Part 1|Progressive Disease|0|||
16500960|NCT01729754|40306375|FG002|Part 1|Progressive Disease|0|||
16500961|NCT01729754|40306376|FG003|Part 1|Progressive Disease|0|||
16500962|NCT01729754|40306377|FG004|Part 1|Progressive Disease|0|||
16500963|NCT01729754|40306378|FG005|Part 1|Progressive Disease|0|||
16500964|NCT01729754|40306379|FG006|Part 1|Progressive Disease|0|||
16500965|NCT01729754|40306380|FG007|Part 1|Progressive Disease|0|||
16500966|NCT01729754|40306381|FG008|Part 1|Progressive Disease|0|||
16500967|NCT01729754|40306382|FG009|Part 1|Progressive Disease|1|||
16500968|NCT01729754|40306373|FG000|Part 1|Protocol Violation|2|||
16195454|NCT01111539|39193333|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
16195455|NCT01111539|39193334|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
16195456|NCT01111539|39193335|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
16195457|NCT01111539|39193336|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
16500969|NCT01729754|40306374|FG001|Part 1|Protocol Violation|0|||
16500970|NCT01729754|40306375|FG002|Part 1|Protocol Violation|0|||
16195458|NCT01111539|39193337|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
16195459|NCT01111539|39193333|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16195460|NCT01111539|39193334|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16195461|NCT01111539|39193335|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16195462|NCT01111539|39193336|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
16195463|NCT01111539|39193337|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
16195464|NCT02106455|39193338|FG000|Overall Study|Case Report Form Uncollected|6|||
16195465|NCT02106455|39193338|FG000|Overall Study|Protocol Deviation|2|||
16195466|NCT00788775|39193340|FG000|Overall Study|Progressive Disease|8|||
16195467|NCT00788775|39193341|FG001|Overall Study|Progressive Disease|6|||
16195468|NCT00788775|39193340|FG000|Overall Study|Withdrawal by Subject|0|||
16195469|NCT00788775|39193341|FG001|Overall Study|Withdrawal by Subject|2|||
16195470|NCT00788775|39193340|FG000|Overall Study|Patient Non-Compliance|1|||
16195471|NCT00788775|39193341|FG001|Overall Study|Patient Non-Compliance|0|||
16195472|NCT00788775|39193340|FG000|Overall Study|Patient's measurable disease resected.|1|||
16195473|NCT00788775|39193341|FG001|Overall Study|Patient's measurable disease resected.|0|||
16195474|NCT00878215|39193342|FG000|Overall Study|Determined to be ineligible|0|||
16195475|NCT00878215|39193343|FG001|Overall Study|Determined to be ineligible|10|||
16195476|NCT00878215|39193344|FG002|Overall Study|Determined to be ineligible|0|||
16195477|NCT00878215|39193345|FG003|Overall Study|Determined to be ineligible|0|||
16500971|NCT01729754|40306376|FG003|Part 1|Protocol Violation|1|||
16500972|NCT01729754|40306377|FG004|Part 1|Protocol Violation|0|||
16195478|NCT02227108|39193351|FG000|Overall Study|Did not receive treatment|2|||
16195479|NCT02227108|39193351|FG000|Overall Study|Other|3|||
16310036|NCT01565889|39619188|FG003|Part B|Lost to Follow-up|0|||
16389791|NCT03257358|39911821|FG000|Overall Study|Lost to Follow-up|12|||
16500973|NCT01729754|40306378|FG005|Part 1|Protocol Violation|0|||
16500974|NCT01729754|40306379|FG006|Part 1|Protocol Violation|1|||
16500975|NCT01729754|40306380|FG007|Part 1|Protocol Violation|0|||
16500976|NCT01729754|40306381|FG008|Part 1|Protocol Violation|0|||
16500977|NCT01729754|40306382|FG009|Part 1|Protocol Violation|0|||
16500978|NCT01729754|40306373|FG000|Part 1|Withdrawal by Subject|5|||
16500979|NCT01729754|40306374|FG001|Part 1|Withdrawal by Subject|0|||
16500980|NCT01729754|40306375|FG002|Part 1|Withdrawal by Subject|0|||
16500981|NCT01729754|40306376|FG003|Part 1|Withdrawal by Subject|7|||
16500982|NCT01729754|40306377|FG004|Part 1|Withdrawal by Subject|0|||
16500983|NCT01729754|40306378|FG005|Part 1|Withdrawal by Subject|0|||
16500984|NCT01729754|40306379|FG006|Part 1|Withdrawal by Subject|5|||
16500985|NCT01729754|40306380|FG007|Part 1|Withdrawal by Subject|0|||
16500986|NCT01729754|40306381|FG008|Part 1|Withdrawal by Subject|0|||
16500987|NCT01729754|40306382|FG009|Part 1|Withdrawal by Subject|6|||
16500988|NCT01729754|40306373|FG000|Part 1|Other Protocol Specified Criteria|2|||
16195480|NCT02227108|39193351|FG000|Overall Study|Progressive disease|17|||
16195481|NCT02227108|39193351|FG000|Overall Study|Initiation of alternative therapy|2|||
16195482|NCT02227108|39193351|FG000|Overall Study|Investigator discretion|1|||
16500989|NCT01729754|40306374|FG001|Part 1|Other Protocol Specified Criteria|0|||
16500990|NCT01729754|40306375|FG002|Part 1|Other Protocol Specified Criteria|0|||
16500991|NCT01729754|40306376|FG003|Part 1|Other Protocol Specified Criteria|0|||
16500992|NCT01729754|40306377|FG004|Part 1|Other Protocol Specified Criteria|0|||
16500993|NCT01729754|40306378|FG005|Part 1|Other Protocol Specified Criteria|0|||
16500994|NCT01729754|40306379|FG006|Part 1|Other Protocol Specified Criteria|1|||
16500995|NCT01729754|40306380|FG007|Part 1|Other Protocol Specified Criteria|0|||
16500996|NCT01729754|40306381|FG008|Part 1|Other Protocol Specified Criteria|0|||
16500997|NCT01729754|40306382|FG009|Part 1|Other Protocol Specified Criteria|4|||
16500998|NCT01729754|40306373|FG000|Part 2|Adverse Event|2|||
16500999|NCT01729754|40306374|FG001|Part 2|Adverse Event|0|||
16501000|NCT01729754|40306375|FG002|Part 2|Adverse Event|0|||
16501001|NCT01729754|40306376|FG003|Part 2|Adverse Event|0|||
16501002|NCT01729754|40306377|FG004|Part 2|Adverse Event|0|||
16501003|NCT01729754|40306378|FG005|Part 2|Adverse Event|0|||
16501004|NCT01729754|40306379|FG006|Part 2|Adverse Event|0|||
16501005|NCT01729754|40306380|FG007|Part 2|Adverse Event|0|||
16501006|NCT01729754|40306381|FG008|Part 2|Adverse Event|1|||
16195483|NCT02227108|39193351|FG000|Overall Study|Adverse Event|6|||
16195484|NCT00986427|39193352|FG000|Overall Study|Lost to Follow-up|2|||
16310037|NCT01565889|39619189|FG004|Part B|Lost to Follow-up|0|||
16310038|NCT01565889|39619190|FG005|Part B|Lost to Follow-up|1|||
16501007|NCT01729754|40306382|FG009|Part 2|Adverse Event|2|||
16501008|NCT01729754|40306373|FG000|Part 2|Lack of Efficacy|0|||
16501009|NCT01729754|40306374|FG001|Part 2|Lack of Efficacy|0|||
16501010|NCT01729754|40306375|FG002|Part 2|Lack of Efficacy|0|||
16501011|NCT01729754|40306376|FG003|Part 2|Lack of Efficacy|0|||
16389792|NCT03257358|39911822|FG001|Overall Study|Lost to Follow-up|4|||
16389793|NCT03257358|39911821|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
16389794|NCT03257358|39911822|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
16389795|NCT03257358|39911821|FG000|Overall Study|Physician Decision|2|||
16389796|NCT03257358|39911822|FG001|Overall Study|Physician Decision|2|||
16389797|NCT03257358|39911821|FG000|Overall Study|Protocol Violation|5|||
16501012|NCT01729754|40306377|FG004|Part 2|Lack of Efficacy|0|||
16310039|NCT01119859|39619195|FG000|Overall Study|Adverse Event|9|||
16310040|NCT01119859|39619196|FG001|Overall Study|Adverse Event|10|||
16310041|NCT01119859|39619195|FG000|Overall Study|Death|2|||
16310042|NCT01119859|39619196|FG001|Overall Study|Death|0|||
16310043|NCT01119859|39619195|FG000|Overall Study|Insufficient therapeutic response|7|||
16310044|NCT01119859|39619196|FG001|Overall Study|Insufficient therapeutic response|14|||
16310045|NCT01119859|39619195|FG000|Overall Study|Refused treatment|3|||
16310046|NCT01119859|39619196|FG001|Overall Study|Refused treatment|6|||
16310047|NCT01119859|39619195|FG000|Overall Study|Failure to return|3|||
16310048|NCT01119859|39619196|FG001|Overall Study|Failure to return|0|||
16310049|NCT02533180|39619197|FG000|Overall Study|Death|0|||
16310050|NCT02533180|39619198|FG001|Overall Study|Death|2|||
16310051|NCT02533180|39619197|FG000|Overall Study|Lost to Follow-up|0|||
16310052|NCT02533180|39619198|FG001|Overall Study|Lost to Follow-up|1|||
16501013|NCT01729754|40306378|FG005|Part 2|Lack of Efficacy|0|||
16501014|NCT01729754|40306379|FG006|Part 2|Lack of Efficacy|0|||
16088364|NCT03732807|38813858|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
16389798|NCT03257358|39911822|FG001|Overall Study|Protocol Violation|3|||
16501015|NCT01729754|40306380|FG007|Part 2|Lack of Efficacy|0|||
16501016|NCT01729754|40306381|FG008|Part 2|Lack of Efficacy|2|||
16501017|NCT01729754|40306382|FG009|Part 2|Lack of Efficacy|2|||
16501018|NCT01729754|40306373|FG000|Part 2|Lost to Follow-up|0|||
16501019|NCT01729754|40306374|FG001|Part 2|Lost to Follow-up|0|||
16501020|NCT01729754|40306375|FG002|Part 2|Lost to Follow-up|0|||
16501021|NCT01729754|40306376|FG003|Part 2|Lost to Follow-up|2|||
16501022|NCT01729754|40306377|FG004|Part 2|Lost to Follow-up|0|||
16195485|NCT00986427|39193353|FG001|Overall Study|Lost to Follow-up|0|||
16310053|NCT02533180|39619197|FG000|Overall Study|Physician Decision|0|||
16501023|NCT01729754|40306378|FG005|Part 2|Lost to Follow-up|0|||
16501024|NCT01729754|40306379|FG006|Part 2|Lost to Follow-up|0|||
16501025|NCT01729754|40306380|FG007|Part 2|Lost to Follow-up|1|||
16310054|NCT02533180|39619198|FG001|Overall Study|Physician Decision|1|||
16310055|NCT02533180|39619197|FG000|Overall Study|Withdrawal by Subject|2|||
16310056|NCT02533180|39619198|FG001|Overall Study|Withdrawal by Subject|5|||
16310057|NCT02533180|39619197|FG000|Overall Study|Screen Failure|37|||
16310058|NCT02533180|39619198|FG001|Overall Study|Screen Failure|0|||
16310059|NCT02533180|39619197|FG000|Overall Study|Protocol Deviation|0|||
16310060|NCT02533180|39619198|FG001|Overall Study|Protocol Deviation|1|||
16310061|NCT02533180|39619197|FG000|Overall Study|Non-compliance|0|||
16310062|NCT02533180|39619198|FG001|Overall Study|Non-compliance|1|||
16310063|NCT03238651|39619199|FG000|Overall Study|Other|0|||
16310064|NCT03238651|39619200|FG001|Overall Study|Other|0|||
16310065|NCT03238651|39619201|FG002|Overall Study|Other|0|||
16310066|NCT03238651|39619202|FG003|Overall Study|Other|0|||
16310067|NCT03238651|39619203|FG004|Overall Study|Other|1|||
16501026|NCT01729754|40306381|FG008|Part 2|Lost to Follow-up|0|||
16501027|NCT01729754|40306382|FG009|Part 2|Lost to Follow-up|2|||
16501028|NCT01729754|40306373|FG000|Part 2|Non-Compliance with Study Drug|0|||
16501029|NCT01729754|40306374|FG001|Part 2|Non-Compliance with Study Drug|0|||
16501030|NCT01729754|40306375|FG002|Part 2|Non-Compliance with Study Drug|0|||
16501031|NCT01729754|40306376|FG003|Part 2|Non-Compliance with Study Drug|0|||
16501032|NCT01729754|40306377|FG004|Part 2|Non-Compliance with Study Drug|0|||
16501033|NCT01729754|40306378|FG005|Part 2|Non-Compliance with Study Drug|0|||
16501034|NCT01729754|40306379|FG006|Part 2|Non-Compliance with Study Drug|0|||
16501035|NCT01729754|40306380|FG007|Part 2|Non-Compliance with Study Drug|0|||
16501036|NCT01729754|40306381|FG008|Part 2|Non-Compliance with Study Drug|0|||
16501037|NCT01729754|40306382|FG009|Part 2|Non-Compliance with Study Drug|1|||
16501038|NCT01729754|40306373|FG000|Part 2|Pregnancy|0|||
16501039|NCT01729754|40306374|FG001|Part 2|Pregnancy|0|||
16501040|NCT01729754|40306375|FG002|Part 2|Pregnancy|0|||
16501041|NCT01729754|40306376|FG003|Part 2|Pregnancy|1|||
16501042|NCT01729754|40306377|FG004|Part 2|Pregnancy|0|||
16501043|NCT01729754|40306378|FG005|Part 2|Pregnancy|0|||
16501044|NCT01729754|40306379|FG006|Part 2|Pregnancy|0|||
16501045|NCT01729754|40306380|FG007|Part 2|Pregnancy|0|||
16501046|NCT01729754|40306381|FG008|Part 2|Pregnancy|0|||
16501047|NCT01729754|40306382|FG009|Part 2|Pregnancy|1|||
16501048|NCT01729754|40306373|FG000|Part 2|Withdrawal by Subject|3|||
16501049|NCT01729754|40306374|FG001|Part 2|Withdrawal by Subject|0|||
16501050|NCT01729754|40306375|FG002|Part 2|Withdrawal by Subject|0|||
16501051|NCT01729754|40306376|FG003|Part 2|Withdrawal by Subject|2|||
16501052|NCT01729754|40306377|FG004|Part 2|Withdrawal by Subject|0|||
16501053|NCT01729754|40306378|FG005|Part 2|Withdrawal by Subject|0|||
16501054|NCT01729754|40306379|FG006|Part 2|Withdrawal by Subject|0|||
16501055|NCT01729754|40306380|FG007|Part 2|Withdrawal by Subject|1|||
16501056|NCT01729754|40306381|FG008|Part 2|Withdrawal by Subject|1|||
16501057|NCT01729754|40306382|FG009|Part 2|Withdrawal by Subject|4|||
16501058|NCT01729754|40306373|FG000|Part 2|Other Protocol Specified Criteria|1|||
16501059|NCT01729754|40306374|FG001|Part 2|Other Protocol Specified Criteria|0|||
16501060|NCT01729754|40306375|FG002|Part 2|Other Protocol Specified Criteria|0|||
16501061|NCT01729754|40306376|FG003|Part 2|Other Protocol Specified Criteria|0|||
16501062|NCT01729754|40306377|FG004|Part 2|Other Protocol Specified Criteria|0|||
16501063|NCT01729754|40306378|FG005|Part 2|Other Protocol Specified Criteria|0|||
16501064|NCT01729754|40306379|FG006|Part 2|Other Protocol Specified Criteria|0|||
16501065|NCT01729754|40306380|FG007|Part 2|Other Protocol Specified Criteria|1|||
16501066|NCT01729754|40306381|FG008|Part 2|Other Protocol Specified Criteria|0|||
16501067|NCT01729754|40306382|FG009|Part 2|Other Protocol Specified Criteria|0|||
16501068|NCT01729754|40306373|FG000|Part 3|Adverse Event|0|||
16501069|NCT01729754|40306374|FG001|Part 3|Adverse Event|0|||
16501070|NCT01729754|40306375|FG002|Part 3|Adverse Event|1|||
16501071|NCT01729754|40306376|FG003|Part 3|Adverse Event|0|||
16501072|NCT01729754|40306377|FG004|Part 3|Adverse Event|0|||
16501073|NCT01729754|40306378|FG005|Part 3|Adverse Event|5|||
16501074|NCT01729754|40306379|FG006|Part 3|Adverse Event|0|||
16501075|NCT01729754|40306380|FG007|Part 3|Adverse Event|0|||
16195486|NCT00986427|39193352|FG000|Overall Study|Lack of Efficacy|1|||
16195487|NCT00986427|39193353|FG001|Overall Study|Lack of Efficacy|0|||
16195488|NCT00986427|39193352|FG000|Overall Study|Withdrawal by Subject|1|||
16195489|NCT00986427|39193353|FG001|Overall Study|Withdrawal by Subject|0|||
16195490|NCT00782418|39193354|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
16195491|NCT00782418|39193355|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
16195492|NCT00782418|39193356|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
16195493|NCT00782418|39193357|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
16195494|NCT00782418|39193358|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
16195495|NCT00782418|39193359|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
16195496|NCT00782418|39193360|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
16195497|NCT00782418|39193354|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
16310068|NCT03238651|39619199|FG000|Overall Study|Progressive Disease|2|||
16310069|NCT03238651|39619200|FG001|Overall Study|Progressive Disease|2|||
16195498|NCT00782418|39193355|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
16195499|NCT00782418|39193356|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
16310070|NCT03238651|39619201|FG002|Overall Study|Progressive Disease|2|||
16310071|NCT03238651|39619202|FG003|Overall Study|Progressive Disease|2|||
16310072|NCT03238651|39619203|FG004|Overall Study|Progressive Disease|0|||
16310073|NCT03238651|39619199|FG000|Overall Study|Withdrawal by Subject|0|||
16310074|NCT03238651|39619200|FG001|Overall Study|Withdrawal by Subject|1|||
16310075|NCT03238651|39619201|FG002|Overall Study|Withdrawal by Subject|0|||
16389799|NCT03257358|39911821|FG000|Overall Study|Technical problems|4|||
16389800|NCT03257358|39911822|FG001|Overall Study|Technical problems|1|||
16389801|NCT03257358|39911821|FG000|Overall Study|Withdrawal by Subject|8|||
16389802|NCT03257358|39911822|FG001|Overall Study|Withdrawal by Subject|3|||
16389803|NCT03257358|39911821|FG000|Overall Study|Withdrawal of informed consent|9|||
16389804|NCT03257358|39911822|FG001|Overall Study|Withdrawal of informed consent|5|||
16389805|NCT03257358|39911821|FG000|Overall Study|New therapy for study indication|1|||
16389806|NCT03257358|39911822|FG001|Overall Study|New therapy for study indication|0|||
16389807|NCT03257358|39911821|FG000|Overall Study|No longer requires treatment|0|||
16389808|NCT03257358|39911822|FG001|Overall Study|No longer requires treatment|1|||
16310076|NCT03238651|39619202|FG003|Overall Study|Withdrawal by Subject|1|||
16310077|NCT03238651|39619203|FG004|Overall Study|Withdrawal by Subject|0|||
16310078|NCT03238651|39619199|FG000|Overall Study|Adverse Event|1|||
16501076|NCT01729754|40306381|FG008|Part 3|Adverse Event|0|||
16501077|NCT01729754|40306382|FG009|Part 3|Adverse Event|3|||
16310079|NCT03238651|39619200|FG001|Overall Study|Adverse Event|3|||
16389809|NCT00670930|39911823|FG000|Overall Study|Adminstrative Problem|0|||
16310080|NCT03238651|39619201|FG002|Overall Study|Adverse Event|2|||
16389810|NCT00670930|39911824|FG001|Overall Study|Adminstrative Problem|1|||
16501078|NCT01729754|40306373|FG000|Part 3|Death|0|||
16501079|NCT01729754|40306374|FG001|Part 3|Death|0|||
16501080|NCT01729754|40306375|FG002|Part 3|Death|0|||
16310081|NCT03238651|39619202|FG003|Overall Study|Adverse Event|0|||
16310082|NCT03238651|39619203|FG004|Overall Study|Adverse Event|0|||
16310083|NCT00610129|39619204|FG000|Overall Study|Not treated since patients ineligible|3|||
16310084|NCT02287922|39619205|FG000|Overall Study|Adverse Event|1|||
16310085|NCT02287922|39619206|FG001|Overall Study|Adverse Event|1|||
16310086|NCT02287922|39619207|FG002|Overall Study|Adverse Event|3|||
16310087|NCT02287922|39619208|FG003|Overall Study|Adverse Event|4|||
16310088|NCT02287922|39619205|FG000|Overall Study|Withdrawal by Subject|1|||
16310089|NCT02287922|39619206|FG001|Overall Study|Withdrawal by Subject|1|||
16310090|NCT02287922|39619207|FG002|Overall Study|Withdrawal by Subject|1|||
16310091|NCT02287922|39619208|FG003|Overall Study|Withdrawal by Subject|2|||
16310092|NCT02287922|39619205|FG000|Overall Study|Lost to Follow-up|0|||
16310093|NCT02287922|39619206|FG001|Overall Study|Lost to Follow-up|0|||
16310094|NCT02287922|39619207|FG002|Overall Study|Lost to Follow-up|1|||
16310095|NCT02287922|39619208|FG003|Overall Study|Lost to Follow-up|0|||
16310096|NCT02287922|39619205|FG000|Overall Study|Sponsor's decision|0|||
16310097|NCT02287922|39619206|FG001|Overall Study|Sponsor's decision|0|||
16310098|NCT02287922|39619207|FG002|Overall Study|Sponsor's decision|0|||
16310099|NCT02287922|39619208|FG003|Overall Study|Sponsor's decision|1|||
16310100|NCT02287922|39619205|FG000|Overall Study|Other|1|||
16310101|NCT02287922|39619206|FG001|Overall Study|Other|0|||
16310102|NCT02287922|39619207|FG002|Overall Study|Other|2|||
16310103|NCT02287922|39619208|FG003|Overall Study|Other|0|||
16310104|NCT01256879|39619209|FG000|Overall Study|Withdrawal by Subject|1|||
16310105|NCT00682786|39619210|FG000|Overall Study|Withdrawal by Subject|2|||
16310106|NCT00682786|39619211|FG001|Overall Study|Withdrawal by Subject|2|||
16310107|NCT00682786|39619210|FG000|Overall Study|Did not receive irinotecan|0|||
16310108|NCT00682786|39619211|FG001|Overall Study|Did not receive irinotecan|1|||
16310109|NCT01154231|39619212|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
16310110|NCT01154231|39619212|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
16310111|NCT03359850|39619214|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
16310112|NCT03359850|39619215|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
16310113|NCT03359850|39619214|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
16310114|NCT03359850|39619215|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
16310115|NCT03359850|39619214|FG000|Extension Phase (Up to 28 Months)|Death|2|||
16310116|NCT03359850|39619215|FG001|Extension Phase (Up to 28 Months)|Death|4|||
16310117|NCT03359850|39619214|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
16310118|NCT03359850|39619215|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
16310119|NCT03359850|39619214|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
16310120|NCT03359850|39619215|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
16310121|NCT03839628|39619217|FG000|Overall Study|Withdrawal by Subject|1|||
16310122|NCT00075816|39619220|FG000|Overall Study|Did not undergo transplantation|14|||
16310123|NCT00075816|39619221|FG001|Overall Study|Did not undergo transplantation|11|||
16310124|NCT00765102|39619224|FG000|Overall Study|Progressive disease|18|||
16310125|NCT00765102|39619224|FG000|Overall Study|Adverse Event|6|||
16310126|NCT00765102|39619224|FG000|Overall Study|Physician Decision|4|||
16310127|NCT00765102|39619224|FG000|Overall Study|Withdrawal by Subject|2|||
16310128|NCT00765102|39619224|FG000|Overall Study|Protocol Violation|1|||
16310129|NCT04135937|39619225|FG000|Overall Study|Lost to Follow-up|2|||
16310130|NCT04135937|39619225|FG000|Overall Study|Withdrawal by Subject|1|||
16310131|NCT03736031|39619229|FG000|Overall Study|Death|2|||
16310132|NCT03736031|39619230|FG001|Overall Study|Death|4|||
16310133|NCT03736031|39619229|FG000|Overall Study|Lost to Follow-up|21|||
16310134|NCT03736031|39619230|FG001|Overall Study|Lost to Follow-up|2|||
16310135|NCT03736031|39619229|FG000|Overall Study|Withdrawal by Subject|9|||
16310136|NCT03736031|39619230|FG001|Overall Study|Withdrawal by Subject|0|||
16310137|NCT01709500|39619231|FG000|Overall Study|Randomized but not treated|0|||
16310138|NCT01709500|39619232|FG001|Overall Study|Randomized but not treated|1|||
16310139|NCT01709500|39619231|FG000|Overall Study|Adverse Event|5|||
16310140|NCT01709500|39619232|FG001|Overall Study|Adverse Event|1|||
16310141|NCT01709500|39619231|FG000|Overall Study|Poor compliance to protocol|2|||
16310142|NCT01709500|39619232|FG001|Overall Study|Poor compliance to protocol|1|||
16310143|NCT01709500|39619231|FG000|Overall Study|Other|3|||
16310144|NCT01709500|39619232|FG001|Overall Study|Other|1|||
16310145|NCT01709500|39619231|FG000|Overall Study|Related to IMP administration|1|||
16310146|NCT01709500|39619232|FG001|Overall Study|Related to IMP administration|0|||
16310147|NCT01709500|39619231|FG000|Overall Study|Treatment ongoing|156|||
16310148|NCT01709500|39619232|FG001|Overall Study|Treatment ongoing|78|||
16310149|NCT00638508|39619233|FG000|Overall Study|Physician Decision|5|||
16310150|NCT00638508|39619234|FG001|Overall Study|Physician Decision|2|||
16310151|NCT00615199|39619246|FG000|Overall Study|Adverse Event|3|||
16310152|NCT00615199|39619247|FG001|Overall Study|Adverse Event|1|||
16310153|NCT00615199|39619248|FG002|Overall Study|Adverse Event|1|||
16310154|NCT00615199|39619249|FG003|Overall Study|Adverse Event|0|||
16310155|NCT00615199|39619246|FG000|Overall Study|Lack of Efficacy|2|||
16310156|NCT00615199|39619247|FG001|Overall Study|Lack of Efficacy|0|||
16310157|NCT00615199|39619248|FG002|Overall Study|Lack of Efficacy|0|||
16310158|NCT00615199|39619249|FG003|Overall Study|Lack of Efficacy|1|||
16501081|NCT01729754|40306376|FG003|Part 3|Death|0|||
16501082|NCT01729754|40306377|FG004|Part 3|Death|0|||
16501083|NCT01729754|40306378|FG005|Part 3|Death|2|||
16501084|NCT01729754|40306379|FG006|Part 3|Death|0|||
16501085|NCT01729754|40306380|FG007|Part 3|Death|0|||
16501086|NCT01729754|40306381|FG008|Part 3|Death|0|||
16501087|NCT01729754|40306382|FG009|Part 3|Death|0|||
16501088|NCT01729754|40306373|FG000|Part 3|Lack of Efficacy|0|||
16501089|NCT01729754|40306374|FG001|Part 3|Lack of Efficacy|0|||
16501090|NCT01729754|40306375|FG002|Part 3|Lack of Efficacy|0|||
16501091|NCT01729754|40306376|FG003|Part 3|Lack of Efficacy|0|||
16501092|NCT01729754|40306377|FG004|Part 3|Lack of Efficacy|2|||
16501093|NCT01729754|40306378|FG005|Part 3|Lack of Efficacy|0|||
16501094|NCT01729754|40306379|FG006|Part 3|Lack of Efficacy|0|||
16501095|NCT01729754|40306380|FG007|Part 3|Lack of Efficacy|0|||
16501096|NCT01729754|40306381|FG008|Part 3|Lack of Efficacy|0|||
16501097|NCT01729754|40306382|FG009|Part 3|Lack of Efficacy|4|||
16501098|NCT01729754|40306373|FG000|Part 3|Lost to Follow-up|0|||
16501099|NCT01729754|40306374|FG001|Part 3|Lost to Follow-up|1|||
16501100|NCT01729754|40306375|FG002|Part 3|Lost to Follow-up|2|||
16501101|NCT01729754|40306376|FG003|Part 3|Lost to Follow-up|0|||
16501102|NCT01729754|40306377|FG004|Part 3|Lost to Follow-up|0|||
16501103|NCT01729754|40306378|FG005|Part 3|Lost to Follow-up|3|||
16501104|NCT01729754|40306379|FG006|Part 3|Lost to Follow-up|0|||
16501105|NCT01729754|40306380|FG007|Part 3|Lost to Follow-up|0|||
16501106|NCT01729754|40306381|FG008|Part 3|Lost to Follow-up|1|||
16501107|NCT01729754|40306382|FG009|Part 3|Lost to Follow-up|0|||
16501108|NCT01729754|40306373|FG000|Part 3|Physician Decision|0|||
16501109|NCT01729754|40306374|FG001|Part 3|Physician Decision|0|||
16501110|NCT01729754|40306375|FG002|Part 3|Physician Decision|1|||
16501111|NCT01729754|40306376|FG003|Part 3|Physician Decision|0|||
16501112|NCT01729754|40306377|FG004|Part 3|Physician Decision|0|||
16501113|NCT01729754|40306378|FG005|Part 3|Physician Decision|0|||
16501114|NCT01729754|40306379|FG006|Part 3|Physician Decision|0|||
16501115|NCT01729754|40306380|FG007|Part 3|Physician Decision|0|||
16501116|NCT01729754|40306381|FG008|Part 3|Physician Decision|0|||
16501117|NCT01729754|40306382|FG009|Part 3|Physician Decision|0|||
16501118|NCT01729754|40306373|FG000|Part 3|Withdrawal by Subject|0|||
16501119|NCT01729754|40306374|FG001|Part 3|Withdrawal by Subject|4|||
16501120|NCT01729754|40306375|FG002|Part 3|Withdrawal by Subject|1|||
16501121|NCT01729754|40306376|FG003|Part 3|Withdrawal by Subject|0|||
16501122|NCT01729754|40306377|FG004|Part 3|Withdrawal by Subject|2|||
16501123|NCT01729754|40306378|FG005|Part 3|Withdrawal by Subject|1|||
16501124|NCT01729754|40306379|FG006|Part 3|Withdrawal by Subject|0|||
16501125|NCT01729754|40306380|FG007|Part 3|Withdrawal by Subject|2|||
16501126|NCT01729754|40306381|FG008|Part 3|Withdrawal by Subject|0|||
16501127|NCT01729754|40306382|FG009|Part 3|Withdrawal by Subject|0|||
16501128|NCT01729754|40306373|FG000|Part 3|Other Protocol Specified Criteria|0|||
16501129|NCT01729754|40306374|FG001|Part 3|Other Protocol Specified Criteria|0|||
16195500|NCT00782418|39193357|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
16310159|NCT00615199|39619246|FG000|Overall Study|Lost to Follow-up|1|||
16310160|NCT00615199|39619247|FG001|Overall Study|Lost to Follow-up|0|||
16310161|NCT00615199|39619248|FG002|Overall Study|Lost to Follow-up|0|||
16310162|NCT00615199|39619249|FG003|Overall Study|Lost to Follow-up|0|||
16310163|NCT00615199|39619246|FG000|Overall Study|Other|0|||
16310164|NCT00615199|39619247|FG001|Overall Study|Other|0|||
16310165|NCT00615199|39619248|FG002|Overall Study|Other|0|||
16389811|NCT00670930|39911823|FG000|Overall Study|Lost to Follow-up|1|||
16389812|NCT00670930|39911824|FG001|Overall Study|Lost to Follow-up|0|||
16389813|NCT00997984|39911825|FG000|Overall Study|Adverse Event|1|||
16389814|NCT00997984|39911826|FG001|Overall Study|Adverse Event|8|||
16389815|NCT00997984|39911827|FG002|Overall Study|Adverse Event|8|||
16389816|NCT00997984|39911825|FG000|Overall Study|Protocol Violation|1|||
16389817|NCT00997984|39911826|FG001|Overall Study|Protocol Violation|3|||
16389818|NCT00997984|39911827|FG002|Overall Study|Protocol Violation|0|||
16389819|NCT00997984|39911825|FG000|Overall Study|Withdrawal by Subject|6|||
16389820|NCT00997984|39911826|FG001|Overall Study|Withdrawal by Subject|9|||
16389821|NCT00997984|39911827|FG002|Overall Study|Withdrawal by Subject|5|||
16389822|NCT00997984|39911825|FG000|Overall Study|Lost to Follow-up|8|||
16389823|NCT00997984|39911826|FG001|Overall Study|Lost to Follow-up|5|||
16389824|NCT00997984|39911827|FG002|Overall Study|Lost to Follow-up|4|||
16389825|NCT00997984|39911825|FG000|Overall Study|Lack of Efficacy|20|||
16389826|NCT00997984|39911826|FG001|Overall Study|Lack of Efficacy|6|||
16389827|NCT00997984|39911827|FG002|Overall Study|Lack of Efficacy|3|||
16389828|NCT00997984|39911825|FG000|Overall Study|Met exclusion criteria|1|||
16389829|NCT00997984|39911826|FG001|Overall Study|Met exclusion criteria|0|||
16389830|NCT00997984|39911827|FG002|Overall Study|Met exclusion criteria|0|||
16389831|NCT00997984|39911825|FG000|Overall Study|non-compliance|0|||
16389832|NCT00997984|39911826|FG001|Overall Study|non-compliance|2|||
16389833|NCT00997984|39911827|FG002|Overall Study|non-compliance|3|||
16389834|NCT00997984|39911825|FG000|Overall Study|Wrong medication dispensed|0|||
16389835|NCT00997984|39911826|FG001|Overall Study|Wrong medication dispensed|1|||
16389836|NCT00997984|39911827|FG002|Overall Study|Wrong medication dispensed|0|||
16389837|NCT00997984|39911825|FG000|Overall Study|Suicidal ideation|0|||
16389838|NCT00997984|39911826|FG001|Overall Study|Suicidal ideation|0|||
16389839|NCT00997984|39911827|FG002|Overall Study|Suicidal ideation|1|||
16389840|NCT00997984|39911825|FG000|Overall Study|Work schedule|0|||
16389841|NCT00997984|39911826|FG001|Overall Study|Work schedule|0|||
16389842|NCT00997984|39911827|FG002|Overall Study|Work schedule|2|||
16389843|NCT02927795|39911833|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
16389844|NCT02927795|39911833|FG000|Overall Study|Not Treated|4|||
16389845|NCT02720523|39911834|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
16389846|NCT02720523|39911835|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
16389847|NCT02720523|39911836|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
16389848|NCT02720523|39911837|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
16389849|NCT02720523|39911838|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
16389850|NCT02720523|39911839|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
16389851|NCT02720523|39911840|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
16389852|NCT02720523|39911834|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
16389853|NCT02720523|39911835|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
16389854|NCT02720523|39911836|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
16389855|NCT02720523|39911837|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
16501130|NCT01729754|40306375|FG002|Part 3|Other Protocol Specified Criteria|0|||
16501131|NCT01729754|40306376|FG003|Part 3|Other Protocol Specified Criteria|0|||
16501132|NCT01729754|40306377|FG004|Part 3|Other Protocol Specified Criteria|0|||
16501133|NCT01729754|40306378|FG005|Part 3|Other Protocol Specified Criteria|2|||
16501134|NCT01729754|40306379|FG006|Part 3|Other Protocol Specified Criteria|0|||
16501135|NCT01729754|40306380|FG007|Part 3|Other Protocol Specified Criteria|1|||
16501136|NCT01729754|40306381|FG008|Part 3|Other Protocol Specified Criteria|0|||
16501137|NCT01729754|40306382|FG009|Part 3|Other Protocol Specified Criteria|0|||
16501138|NCT01750242|40306386|FG000|Overall Study|Unreadable Images|3|||
16501139|NCT00228917|40306389|FG000|Overall Study|Migrated/moved from study area|0|||
16501140|NCT00228917|40306390|FG001|Overall Study|Migrated/moved from study area|0|||
16501141|NCT00228917|40306391|FG002|Overall Study|Migrated/moved from study area|0|||
16501142|NCT00228917|40306392|FG003|Overall Study|Migrated/moved from study area|0|||
16501143|NCT00228917|40306393|FG004|Overall Study|Migrated/moved from study area|0|||
16310166|NCT00615199|39619249|FG003|Overall Study|Other|1|||
16310167|NCT00615199|39619246|FG000|Overall Study|Withdrawal by Subject|2|||
16310168|NCT00615199|39619247|FG001|Overall Study|Withdrawal by Subject|1|||
16310169|NCT00615199|39619248|FG002|Overall Study|Withdrawal by Subject|0|||
16389856|NCT02720523|39911838|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
16546322|NCT02237508|40464776|FG003|Overall Study|Protocol Violation|0|||
16310170|NCT00615199|39619249|FG003|Overall Study|Withdrawal by Subject|0|||
16389857|NCT02720523|39911839|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
16389858|NCT02720523|39911840|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
16310171|NCT01418378|39619250|FG000|Overall Study|Death|1|||
16310172|NCT01418378|39619251|FG001|Overall Study|Death|2|||
16310173|NCT01418378|39619250|FG000|Overall Study|Physician Decision|0|||
16310174|NCT01418378|39619251|FG001|Overall Study|Physician Decision|1|||
16310175|NCT01418378|39619250|FG000|Overall Study|ligament imbalance|0|||
16310176|NCT01418378|39619251|FG001|Overall Study|ligament imbalance|1|||
16310177|NCT01418378|39619250|FG000|Overall Study|developed chronic myopathy|0|||
16310178|NCT01418378|39619251|FG001|Overall Study|developed chronic myopathy|1|||
16310179|NCT03633825|39619255|FG000|Enrollment|Did not post on network|5066|||
16310180|NCT03633825|39619256|FG001|Enrollment|Did not post on network|5080|||
16310181|NCT03633825|39619255|FG000|Enrollment|Post not classified as crisis|13967|||
16310182|NCT03633825|39619256|FG001|Enrollment|Post not classified as crisis|13757|||
16310183|NCT03633825|39619255|FG000|Follow up|Lost to Follow-up|478|||
16310184|NCT03633825|39619256|FG001|Follow up|Lost to Follow-up|450|||
16310185|NCT01342081|39619257|FG000|Overall Study|Did not receive allocated intervention|0|||
16310186|NCT01342081|39619258|FG001|Overall Study|Did not receive allocated intervention|0|||
16310187|NCT01342081|39619259|FG002|Overall Study|Did not receive allocated intervention|1|||
16310188|NCT01342081|39619257|FG000|Overall Study|Adverse Event|1|||
16310189|NCT01342081|39619258|FG001|Overall Study|Adverse Event|0|||
16310190|NCT01342081|39619259|FG002|Overall Study|Adverse Event|0|||
16310191|NCT01342081|39619257|FG000|Overall Study|Physician Decision|0|||
16310192|NCT01342081|39619258|FG001|Overall Study|Physician Decision|1|||
16310193|NCT01342081|39619259|FG002|Overall Study|Physician Decision|0|||
16310194|NCT01342081|39619257|FG000|Overall Study|Withdrawal by Subject|1|||
16310195|NCT01342081|39619258|FG001|Overall Study|Withdrawal by Subject|1|||
16310196|NCT01342081|39619259|FG002|Overall Study|Withdrawal by Subject|0|||
16310197|NCT02009722|39619270|FG000|Overall Study|Protocol Violation|1|||
16389859|NCT02720523|39911834|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
16389860|NCT02720523|39911835|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
16389861|NCT02720523|39911836|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
16389862|NCT02720523|39911837|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
16389863|NCT02720523|39911838|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
16389864|NCT02720523|39911839|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
16501144|NCT00228917|40306394|FG005|Overall Study|Migrated/moved from study area|2|||
16501145|NCT00228917|40306395|FG006|Overall Study|Migrated/moved from study area|0|||
16501146|NCT00228917|40306396|FG007|Overall Study|Migrated/moved from study area|0|||
16501147|NCT00450333|40306397|FG000|Overall Study|Study terminated|47|||
16501148|NCT00450333|40306398|FG001|Overall Study|Study terminated|54|||
16501149|NCT00450333|40306399|FG002|Overall Study|Study terminated|16|||
16501150|NCT00450333|40306400|FG003|Overall Study|Study terminated|21|||
16501151|NCT00450333|40306397|FG000|Overall Study|Adverse Event|1|||
16501152|NCT00450333|40306398|FG001|Overall Study|Adverse Event|7|||
16310198|NCT02009722|39619271|FG001|Overall Study|Protocol Violation|2|||
16310199|NCT02009722|39619270|FG000|Overall Study|Did not receive intervention|0|||
16310200|NCT02009722|39619271|FG001|Overall Study|Did not receive intervention|1|||
16310201|NCT01062425|39619272|FG000|Overall Study|Protocol Violation|3|||
16310202|NCT01062425|39619273|FG001|Overall Study|Protocol Violation|6|||
16310203|NCT01753570|39619274|FG000|Overall Study|Adverse Event|1|||
16310204|NCT01753570|39619275|FG001|Overall Study|Adverse Event|0|||
16310205|NCT01753570|39619276|FG002|Overall Study|Adverse Event|1|||
16310206|NCT01753570|39619274|FG000|Overall Study|Physician Decision|0|||
16501153|NCT00450333|40306399|FG002|Overall Study|Adverse Event|2|||
16389865|NCT02720523|39911840|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
16389866|NCT02720523|39911834|FG000|Period 1: Placebo-controlled Period|Other|0|||
16389867|NCT02720523|39911835|FG001|Period 1: Placebo-controlled Period|Other|0|||
16389868|NCT02720523|39911836|FG002|Period 1: Placebo-controlled Period|Other|1|||
16389869|NCT02720523|39911837|FG003|Period 1: Placebo-controlled Period|Other|1|||
16501154|NCT00450333|40306400|FG003|Overall Study|Adverse Event|2|||
16501155|NCT00450333|40306397|FG000|Overall Study|Protocol Violation|1|||
16501156|NCT00450333|40306398|FG001|Overall Study|Protocol Violation|0|||
16501157|NCT00450333|40306399|FG002|Overall Study|Protocol Violation|1|||
16501158|NCT00450333|40306400|FG003|Overall Study|Protocol Violation|0|||
16501159|NCT00450333|40306397|FG000|Overall Study|Withdrawal by Subject|1|||
16501160|NCT00450333|40306398|FG001|Overall Study|Withdrawal by Subject|0|||
16501161|NCT00450333|40306399|FG002|Overall Study|Withdrawal by Subject|3|||
16501162|NCT00450333|40306400|FG003|Overall Study|Withdrawal by Subject|0|||
16501163|NCT00450333|40306397|FG000|Overall Study|Kidney transplant|1|||
16501164|NCT00450333|40306398|FG001|Overall Study|Kidney transplant|0|||
16501165|NCT00450333|40306399|FG002|Overall Study|Kidney transplant|1|||
16501166|NCT00450333|40306400|FG003|Overall Study|Kidney transplant|3|||
16310207|NCT01753570|39619275|FG001|Overall Study|Physician Decision|1|||
16310208|NCT01753570|39619276|FG002|Overall Study|Physician Decision|0|||
16310209|NCT01753570|39619274|FG000|Overall Study|Withdrawal by Subject|1|||
16310210|NCT01753570|39619275|FG001|Overall Study|Withdrawal by Subject|4|||
16501167|NCT00450333|40306397|FG000|Overall Study|Death|3|||
16501168|NCT00450333|40306398|FG001|Overall Study|Death|2|||
16501169|NCT00450333|40306399|FG002|Overall Study|Death|2|||
16389870|NCT02720523|39911838|FG004|Period 1: Placebo-controlled Period|Other|0|||
16389871|NCT02720523|39911839|FG005|Period 1: Placebo-controlled Period|Other|0|||
16389872|NCT02720523|39911840|FG006|Period 1: Placebo-controlled Period|Other|0|||
16389873|NCT02720523|39911834|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
16389874|NCT02720523|39911835|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
16389875|NCT02720523|39911836|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
16389876|NCT02720523|39911837|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
16501170|NCT00450333|40306400|FG003|Overall Study|Death|2|||
16501171|NCT00887354|40306401|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
16501172|NCT00887354|40306402|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
16501173|NCT00887354|40306401|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
16310211|NCT01753570|39619276|FG002|Overall Study|Withdrawal by Subject|0|||
16310212|NCT02762929|39619278|FG000|Overall Study|Adverse Event|0|||
16501174|NCT00887354|40306402|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
16501175|NCT00887354|40306401|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
16501176|NCT00887354|40306402|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
16310213|NCT02762929|39619279|FG001|Overall Study|Adverse Event|0|||
16310214|NCT02762929|39619280|FG002|Overall Study|Adverse Event|0|||
16310215|NCT02762929|39619281|FG003|Overall Study|Adverse Event|1|||
16310216|NCT02762929|39619282|FG004|Overall Study|Adverse Event|0|||
16310217|NCT02762929|39619283|FG005|Overall Study|Adverse Event|0|||
16310218|NCT02762929|39619278|FG000|Overall Study|Lost to Follow-up|1|||
16310219|NCT02762929|39619279|FG001|Overall Study|Lost to Follow-up|2|||
16310220|NCT02762929|39619280|FG002|Overall Study|Lost to Follow-up|0|||
16310221|NCT02762929|39619281|FG003|Overall Study|Lost to Follow-up|1|||
16310222|NCT02762929|39619282|FG004|Overall Study|Lost to Follow-up|0|||
16310223|NCT02762929|39619283|FG005|Overall Study|Lost to Follow-up|0|||
16310224|NCT02762929|39619278|FG000|Overall Study|Withdrawal by Subject|0|||
16310225|NCT02762929|39619279|FG001|Overall Study|Withdrawal by Subject|1|||
16310226|NCT02762929|39619280|FG002|Overall Study|Withdrawal by Subject|0|||
16501177|NCT00887354|40306401|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
16501178|NCT00887354|40306402|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
16501179|NCT00887354|40306401|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
16501180|NCT00887354|40306402|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
16501181|NCT00887354|40306401|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
16501182|NCT00887354|40306402|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
16501183|NCT00887354|40306401|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
16501184|NCT00887354|40306402|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
16501185|NCT00887354|40306401|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
16501186|NCT00887354|40306402|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
16501187|NCT00887354|40306401|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
16501188|NCT00887354|40306402|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
16501189|NCT00887354|40306401|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
16501190|NCT00887354|40306402|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
16501191|NCT00887354|40306401|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
16501192|NCT00887354|40306402|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
16501193|NCT00887354|40306401|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
16310227|NCT02762929|39619281|FG003|Overall Study|Withdrawal by Subject|0|||
16310228|NCT02762929|39619282|FG004|Overall Study|Withdrawal by Subject|0|||
16310229|NCT02762929|39619283|FG005|Overall Study|Withdrawal by Subject|0|||
16310230|NCT02762929|39619278|FG000|Overall Study|exclusionary medication disclosed late|0|||
16501194|NCT00887354|40306402|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
16310231|NCT02762929|39619279|FG001|Overall Study|exclusionary medication disclosed late|0|||
16310232|NCT02762929|39619280|FG002|Overall Study|exclusionary medication disclosed late|0|||
16310233|NCT02762929|39619281|FG003|Overall Study|exclusionary medication disclosed late|1|||
16310234|NCT02762929|39619282|FG004|Overall Study|exclusionary medication disclosed late|0|||
16310235|NCT02762929|39619283|FG005|Overall Study|exclusionary medication disclosed late|0|||
16310236|NCT04173507|39619284|FG000|Overall Study|On Treatment|3|||
16310237|NCT04173507|39619284|FG000|Overall Study|Adverse Event|3|||
16310238|NCT04173507|39619284|FG000|Overall Study|Progression/Relapse|34|||
16310239|NCT04173507|39619284|FG000|Overall Study|Death|2|||
16310240|NCT00459355|39619285|FG000|Overall Study|Subject no longer met inc criteria|20|||
16310241|NCT00459355|39619286|FG001|Overall Study|Subject no longer met inc criteria|18|||
16310242|NCT00955617|39619287|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
16310243|NCT00955617|39619288|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
16310244|NCT00955617|39619287|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
16310245|NCT00955617|39619288|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
16310246|NCT00955617|39619287|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
16310247|NCT00955617|39619288|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
16310248|NCT00955617|39619287|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
16310249|NCT00955617|39619288|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
16310250|NCT00276484|39619289|FG000|Overall Study|Adverse Event|4|||
16310251|NCT00276484|39619290|FG001|Overall Study|Adverse Event|7|||
16310252|NCT00276484|39619289|FG000|Overall Study|Lost to Follow-up|1|||
16310253|NCT00276484|39619290|FG001|Overall Study|Lost to Follow-up|1|||
16310254|NCT00276484|39619289|FG000|Overall Study|Protocol Violation|0|||
16310255|NCT00276484|39619290|FG001|Overall Study|Protocol Violation|1|||
16310256|NCT00276484|39619289|FG000|Overall Study|Withdrawal by Subject|4|||
16310257|NCT00276484|39619290|FG001|Overall Study|Withdrawal by Subject|3|||
16310258|NCT00276484|39619289|FG000|Overall Study|Could not take time off work|0|||
16310259|NCT00276484|39619290|FG001|Overall Study|Could not take time off work|1|||
16310260|NCT02370238|39619291|FG000|Overall Study|Death|42|||
16310261|NCT02370238|39619292|FG001|Overall Study|Death|35|||
16310262|NCT02370238|39619291|FG000|Overall Study|Lost to Follow-up|1|||
16310263|NCT02370238|39619292|FG001|Overall Study|Lost to Follow-up|3|||
16310264|NCT02370238|39619291|FG000|Overall Study|Withdrawal by Subject|2|||
16310265|NCT02370238|39619292|FG001|Overall Study|Withdrawal by Subject|6|||
16310266|NCT02370238|39619291|FG000|Overall Study|Other|2|||
16310267|NCT02370238|39619292|FG001|Overall Study|Other|1|||
16310268|NCT03411863|39619293|FG000|Overall Study|Withdrawal by Subject|3|||
16310269|NCT03411863|39619294|FG001|Overall Study|Withdrawal by Subject|1|||
16310270|NCT03411863|39619293|FG000|Overall Study|Physician Decision|0|||
16310271|NCT03411863|39619294|FG001|Overall Study|Physician Decision|1|||
16310272|NCT00668317|39619295|FG000|Overall Study|Adverse Event|2|||
16310273|NCT00808210|39619296|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
16310274|NCT00808210|39619297|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
16310275|NCT00808210|39619296|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
16310276|NCT00808210|39619297|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
16310277|NCT00808210|39619296|FG000|Double-Blind TX Period|Adverse Event|0|||
16310278|NCT00808210|39619297|FG001|Double-Blind TX Period|Adverse Event|1|||
16310279|NCT00808210|39619296|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
16310280|NCT00808210|39619297|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
16310281|NCT00808210|39619296|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
16310282|NCT00808210|39619297|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
16310283|NCT00808210|39619296|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
16310284|NCT00808210|39619297|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
16310285|NCT02235454|39619298|FG000|Overall Study|Withdrawal by Subject|2|||
16310286|NCT01349192|39619299|FG000|Overall Study|Protocol Violation|0|||
16310287|NCT01349192|39619300|FG001|Overall Study|Protocol Violation|1|||
16310288|NCT01349192|39619299|FG000|Overall Study|Withdrawal by Subject|0|||
16310289|NCT01349192|39619300|FG001|Overall Study|Withdrawal by Subject|2|||
16310290|NCT01349192|39619299|FG000|Overall Study|Lost to Follow-up|1|||
16310291|NCT01349192|39619300|FG001|Overall Study|Lost to Follow-up|3|||
16310292|NCT01349192|39619299|FG000|Overall Study|Failure to adhere to Protocol|2|||
16310293|NCT01349192|39619300|FG001|Overall Study|Failure to adhere to Protocol|0|||
16310294|NCT02566889|39619301|FG000|Overall Study|Withdrawal by Subject|3|||
16310295|NCT02566889|39619302|FG001|Overall Study|Withdrawal by Subject|1|||
16310296|NCT02566889|39619301|FG000|Overall Study|Adverse Event|4|||
16501195|NCT00887354|40306401|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
16310297|NCT02566889|39619302|FG001|Overall Study|Adverse Event|2|||
16310298|NCT02566889|39619301|FG000|Overall Study|Other|6|||
16310299|NCT02566889|39619302|FG001|Overall Study|Other|2|||
16310300|NCT01321879|39619303|FG000|Overall Study|Lack of Efficacy|5|||
16310301|NCT01321879|39619303|FG000|Overall Study|Adverse Event|5|||
16501196|NCT00887354|40306402|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
16310302|NCT01321879|39619303|FG000|Overall Study|Death|3|||
16501197|NCT00887354|40306401|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
16501198|NCT00887354|40306402|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
16501199|NCT00887354|40306401|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
16501200|NCT00887354|40306402|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
16501201|NCT02672423|40306403|FG000|Period 1|Adverse Event|0|||
16501202|NCT02672423|40306404|FG001|Period 1|Adverse Event|0|||
16501203|NCT02672423|40306405|FG002|Period 1|Adverse Event|0|||
16195501|NCT00782418|39193358|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
16195502|NCT00782418|39193359|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
16195503|NCT00782418|39193360|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
16195504|NCT03115476|39193361|FG000|LP0084-1369|Death|1|||
16195505|NCT03115476|39193362|FG001|LP0084-1369|Death|0|||
16195506|NCT03115476|39193363|FG002|LP0084-1369|Death|2|||
16501204|NCT02672423|40306406|FG003|Period 1|Adverse Event|0|||
16501205|NCT02672423|40306407|FG004|Period 1|Adverse Event|1|||
16501206|NCT02672423|40306408|FG005|Period 1|Adverse Event|0|||
16501207|NCT02672423|40306409|FG006|Period 1|Adverse Event|0|||
16501208|NCT02672423|40306410|FG007|Period 1|Adverse Event|0|||
16501209|NCT02672423|40306411|FG008|Period 1|Adverse Event|0|||
16501210|NCT02672423|40306412|FG009|Period 1|Adverse Event|0|||
16501211|NCT02672423|40306403|FG000|Period 2|Withdrawal by Subject|0|||
16501212|NCT02672423|40306404|FG001|Period 2|Withdrawal by Subject|0|||
16501213|NCT02672423|40306405|FG002|Period 2|Withdrawal by Subject|1|||
16501214|NCT02672423|40306406|FG003|Period 2|Withdrawal by Subject|0|||
16501215|NCT02672423|40306407|FG004|Period 2|Withdrawal by Subject|0|||
16501216|NCT02672423|40306408|FG005|Period 2|Withdrawal by Subject|0|||
16501217|NCT02672423|40306409|FG006|Period 2|Withdrawal by Subject|0|||
16501218|NCT02672423|40306410|FG007|Period 2|Withdrawal by Subject|0|||
16501219|NCT02672423|40306411|FG008|Period 2|Withdrawal by Subject|0|||
16501220|NCT02672423|40306412|FG009|Period 2|Withdrawal by Subject|0|||
16501221|NCT02672423|40306403|FG000|Period 3|Withdrawal by Subject|0|||
16501222|NCT02672423|40306404|FG001|Period 3|Withdrawal by Subject|0|||
16501223|NCT02672423|40306405|FG002|Period 3|Withdrawal by Subject|0|||
16501224|NCT02672423|40306406|FG003|Period 3|Withdrawal by Subject|0|||
16501225|NCT02672423|40306407|FG004|Period 3|Withdrawal by Subject|0|||
16501226|NCT02672423|40306408|FG005|Period 3|Withdrawal by Subject|0|||
16501227|NCT02672423|40306409|FG006|Period 3|Withdrawal by Subject|0|||
16501228|NCT02672423|40306410|FG007|Period 3|Withdrawal by Subject|1|||
16501229|NCT02672423|40306411|FG008|Period 3|Withdrawal by Subject|0|||
16501230|NCT02672423|40306412|FG009|Period 3|Withdrawal by Subject|0|||
16501231|NCT02672423|40306403|FG000|Period 3|Physician Decision|0|||
16501232|NCT02672423|40306404|FG001|Period 3|Physician Decision|0|||
16501233|NCT02672423|40306405|FG002|Period 3|Physician Decision|0|||
16501234|NCT02672423|40306406|FG003|Period 3|Physician Decision|0|||
16501235|NCT02672423|40306407|FG004|Period 3|Physician Decision|0|||
16501236|NCT02672423|40306408|FG005|Period 3|Physician Decision|1|||
16501237|NCT02672423|40306409|FG006|Period 3|Physician Decision|0|||
16501238|NCT02672423|40306410|FG007|Period 3|Physician Decision|0|||
16501239|NCT02672423|40306411|FG008|Period 3|Physician Decision|0|||
16501240|NCT02672423|40306412|FG009|Period 3|Physician Decision|0|||
16195507|NCT03115476|39193361|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
16195508|NCT03115476|39193362|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
16195509|NCT03115476|39193363|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
16195510|NCT03629041|39193364|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
16195511|NCT03629041|39193365|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
16501241|NCT02255981|40306415|FG000|Overall Study|Lost to Follow-up|3|||
16501242|NCT02255981|40306415|FG000|Overall Study|Withdrawal by Subject|1|||
16501243|NCT01770379|40306417|FG000|Overall Study|Technical issues|1|||
16501244|NCT01770379|40306418|FG001|Overall Study|Technical issues|0|||
16501245|NCT01770379|40306419|FG002|Overall Study|Technical issues|0|||
16501246|NCT01770379|40306417|FG000|Overall Study|Withdrawal by Subject|7|||
16501247|NCT01770379|40306418|FG001|Overall Study|Withdrawal by Subject|10|||
16501248|NCT01770379|40306419|FG002|Overall Study|Withdrawal by Subject|7|||
16501249|NCT01770379|40306417|FG000|Overall Study|study terminated by sponsor|22|||
16501250|NCT01770379|40306418|FG001|Overall Study|study terminated by sponsor|23|||
16088365|NCT03732807|38813859|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
16501251|NCT01770379|40306419|FG002|Overall Study|study terminated by sponsor|22|||
16501252|NCT01770379|40306417|FG000|Overall Study|Protocol Violation|0|||
16501253|NCT01770379|40306418|FG001|Overall Study|Protocol Violation|1|||
16501254|NCT01770379|40306419|FG002|Overall Study|Protocol Violation|1|||
16501255|NCT01770379|40306417|FG000|Overall Study|Physician Decision|0|||
16501256|NCT01770379|40306418|FG001|Overall Study|Physician Decision|1|||
16501257|NCT01770379|40306419|FG002|Overall Study|Physician Decision|2|||
16501258|NCT01770379|40306417|FG000|Overall Study|Lost to Follow-up|0|||
16501259|NCT01770379|40306418|FG001|Overall Study|Lost to Follow-up|0|||
16501260|NCT01770379|40306419|FG002|Overall Study|Lost to Follow-up|2|||
16501261|NCT01770379|40306417|FG000|Overall Study|Lack of Efficacy|8|||
16501262|NCT01770379|40306418|FG001|Overall Study|Lack of Efficacy|6|||
16501263|NCT01770379|40306419|FG002|Overall Study|Lack of Efficacy|6|||
16501264|NCT01770379|40306417|FG000|Overall Study|Adverse Event|1|||
16501265|NCT01770379|40306418|FG001|Overall Study|Adverse Event|3|||
16389877|NCT02720523|39911838|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
16501266|NCT01770379|40306419|FG002|Overall Study|Adverse Event|2|||
16501267|NCT03480750|40306422|FG000|Overall Study|Withdrawal by Subject|0|||
16501268|NCT03480750|40306423|FG001|Overall Study|Withdrawal by Subject|1|||
16501269|NCT03480750|40306424|FG002|Overall Study|Withdrawal by Subject|0|||
16501270|NCT03480750|40306425|FG003|Overall Study|Withdrawal by Subject|0|||
16501271|NCT03480750|40306426|FG004|Overall Study|Withdrawal by Subject|0|||
16501272|NCT03480750|40306427|FG005|Overall Study|Withdrawal by Subject|0|||
16501273|NCT03480750|40306422|FG000|Overall Study|The interruption in Trientine shippment|0|||
16501274|NCT03480750|40306423|FG001|Overall Study|The interruption in Trientine shippment|0|||
16501275|NCT03480750|40306424|FG002|Overall Study|The interruption in Trientine shippment|0|||
16501276|NCT03480750|40306425|FG003|Overall Study|The interruption in Trientine shippment|0|||
16501277|NCT03480750|40306426|FG004|Overall Study|The interruption in Trientine shippment|0|||
16501278|NCT03480750|40306427|FG005|Overall Study|The interruption in Trientine shippment|1|||
16501279|NCT03973918|40306429|FG000|Overall Study|Adverse Event|0|||
16501280|NCT03973918|40306430|FG001|Overall Study|Adverse Event|0|||
16501281|NCT03973918|40306431|FG002|Overall Study|Adverse Event|0|||
16501282|NCT03973918|40306432|FG003|Overall Study|Adverse Event|1|||
16501283|NCT03973918|40306429|FG000|Overall Study|pt still on treatment|0|||
16501284|NCT03973918|40306430|FG001|Overall Study|pt still on treatment|1|||
16501285|NCT03973918|40306431|FG002|Overall Study|pt still on treatment|0|||
16501286|NCT03973918|40306432|FG003|Overall Study|pt still on treatment|0|||
16501287|NCT01472081|40306435|FG000|Overall Study|Continuing treatment at time of analysis|1|||
16501288|NCT01472081|40306436|FG001|Overall Study|Continuing treatment at time of analysis|4|||
16501289|NCT01472081|40306437|FG002|Overall Study|Continuing treatment at time of analysis|1|||
16501290|NCT01472081|40306438|FG003|Overall Study|Continuing treatment at time of analysis|8|||
16310303|NCT01321879|39619303|FG000|Overall Study|Withdrawal by Subject|1|||
16501291|NCT01472081|40306439|FG004|Overall Study|Continuing treatment at time of analysis|9|||
16501292|NCT01472081|40306440|FG005|Overall Study|Continuing treatment at time of analysis|0|||
16501293|NCT01472081|40306435|FG000|Overall Study|Disease Progression|4|||
16501294|NCT01472081|40306436|FG001|Overall Study|Disease Progression|10|||
16501295|NCT01472081|40306437|FG002|Overall Study|Disease Progression|12|||
16501296|NCT01472081|40306438|FG003|Overall Study|Disease Progression|31|||
16501297|NCT01472081|40306439|FG004|Overall Study|Disease Progression|22|||
16501298|NCT01472081|40306440|FG005|Overall Study|Disease Progression|3|||
16501299|NCT01472081|40306435|FG000|Overall Study|Study drug toxicity|2|||
16501300|NCT01472081|40306436|FG001|Overall Study|Study drug toxicity|9|||
16501301|NCT01472081|40306437|FG002|Overall Study|Study drug toxicity|4|||
16501302|NCT01472081|40306438|FG003|Overall Study|Study drug toxicity|6|||
16501303|NCT01472081|40306439|FG004|Overall Study|Study drug toxicity|13|||
16501304|NCT01472081|40306440|FG005|Overall Study|Study drug toxicity|2|||
16501305|NCT01472081|40306435|FG000|Overall Study|Death|0|||
16501306|NCT01472081|40306436|FG001|Overall Study|Death|0|||
16501307|NCT01472081|40306437|FG002|Overall Study|Death|0|||
16501308|NCT01472081|40306438|FG003|Overall Study|Death|0|||
16501309|NCT01472081|40306439|FG004|Overall Study|Death|1|||
16088366|NCT03732807|38813860|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
16088367|NCT03732807|38813861|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
16088368|NCT03732807|38813855|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
16088369|NCT03732807|38813856|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
16088370|NCT03732807|38813857|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
16088371|NCT03732807|38813858|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
16088372|NCT03732807|38813859|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
16088373|NCT03732807|38813860|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
16088374|NCT03732807|38813861|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
16088375|NCT03732807|38813855|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
16088376|NCT03732807|38813856|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
16088377|NCT03732807|38813857|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
16088378|NCT03732807|38813858|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
16088379|NCT03732807|38813859|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
16088380|NCT03732807|38813860|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
16088381|NCT03732807|38813861|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
16088382|NCT00724126|38813866|FG000|Overall Study|Adverse Event|2|||
16088383|NCT00724126|38813867|FG001|Overall Study|Adverse Event|0|||
16088384|NCT00724126|38813866|FG000|Overall Study|Withdrawal by Subject|8|||
16088385|NCT00724126|38813867|FG001|Overall Study|Withdrawal by Subject|6|||
16501310|NCT01472081|40306440|FG005|Overall Study|Death|0|||
16501311|NCT01472081|40306435|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
16501312|NCT01472081|40306436|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
16088386|NCT00724126|38813866|FG000|Overall Study|Lost to Follow-up|6|||
16088387|NCT00724126|38813867|FG001|Overall Study|Lost to Follow-up|6|||
16088388|NCT00724126|38813866|FG000|Overall Study|Noncompliance|2|||
16088389|NCT00724126|38813867|FG001|Overall Study|Noncompliance|1|||
16088390|NCT00724126|38813866|FG000|Overall Study|Subject randomized although ineligible|1|||
16088391|NCT00724126|38813867|FG001|Overall Study|Subject randomized although ineligible|1|||
16088392|NCT00724126|38813866|FG000|Overall Study|Subject had to leave vicinity of site|0|||
16088393|NCT00724126|38813867|FG001|Overall Study|Subject had to leave vicinity of site|1|||
16088394|NCT00595959|38813869|FG000|Overall Study|Withdrawal by Subject|1|||
16088395|NCT00595959|38813869|FG000|Overall Study|Lost to Follow-up|1|||
16088396|NCT00734578|38813871|FG000|Overall Study|Adverse Event|4|||
16088397|NCT00734578|38813872|FG001|Overall Study|Adverse Event|6|||
16088398|NCT00734578|38813873|FG002|Overall Study|Adverse Event|1|||
16088399|NCT00734578|38813871|FG000|Overall Study|Protocol Violation|8|||
16088400|NCT00734578|38813872|FG001|Overall Study|Protocol Violation|6|||
16088401|NCT00734578|38813873|FG002|Overall Study|Protocol Violation|3|||
16088402|NCT00734578|38813871|FG000|Overall Study|Withdrawal by Subject|7|||
16088403|NCT00734578|38813872|FG001|Overall Study|Withdrawal by Subject|8|||
16088404|NCT00734578|38813873|FG002|Overall Study|Withdrawal by Subject|11|||
16088405|NCT00734578|38813871|FG000|Overall Study|Lost to Follow-up|9|||
16088406|NCT00734578|38813872|FG001|Overall Study|Lost to Follow-up|3|||
16088407|NCT00734578|38813873|FG002|Overall Study|Lost to Follow-up|5|||
16088408|NCT00734578|38813871|FG000|Overall Study|Lack of Efficacy|3|||
16310304|NCT01518322|39619304|FG000|Overall Study|FeNO measurement was missing|13|||
16088409|NCT00734578|38813872|FG001|Overall Study|Lack of Efficacy|2|||
16088410|NCT00734578|38813873|FG002|Overall Study|Lack of Efficacy|5|||
16501313|NCT01472081|40306437|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
16501314|NCT01472081|40306438|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
16501315|NCT01472081|40306439|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
16501316|NCT01472081|40306440|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
16501317|NCT01472081|40306435|FG000|Overall Study|Withdrawal by Subject|0|||
16501318|NCT01472081|40306436|FG001|Overall Study|Withdrawal by Subject|0|||
16501319|NCT01472081|40306437|FG002|Overall Study|Withdrawal by Subject|0|||
16501320|NCT01472081|40306438|FG003|Overall Study|Withdrawal by Subject|0|||
16501321|NCT01472081|40306439|FG004|Overall Study|Withdrawal by Subject|0|||
16501322|NCT01472081|40306440|FG005|Overall Study|Withdrawal by Subject|1|||
16501323|NCT01472081|40306435|FG000|Overall Study|Poor/non-compliance|0|||
16501324|NCT01472081|40306436|FG001|Overall Study|Poor/non-compliance|0|||
16501325|NCT01472081|40306437|FG002|Overall Study|Poor/non-compliance|1|||
16501326|NCT01472081|40306438|FG003|Overall Study|Poor/non-compliance|0|||
16501327|NCT01472081|40306439|FG004|Overall Study|Poor/non-compliance|1|||
16501328|NCT01472081|40306440|FG005|Overall Study|Poor/non-compliance|0|||
16501329|NCT01472081|40306435|FG000|Overall Study|No longer meets study criteria|0|||
16501330|NCT01472081|40306436|FG001|Overall Study|No longer meets study criteria|0|||
16501331|NCT01472081|40306437|FG002|Overall Study|No longer meets study criteria|1|||
16501332|NCT01472081|40306438|FG003|Overall Study|No longer meets study criteria|0|||
16501333|NCT01472081|40306439|FG004|Overall Study|No longer meets study criteria|0|||
16501334|NCT01472081|40306440|FG005|Overall Study|No longer meets study criteria|0|||
16501335|NCT01472081|40306435|FG000|Overall Study|Subject request to discontinue treatment|0|||
16501336|NCT01472081|40306436|FG001|Overall Study|Subject request to discontinue treatment|3|||
16501337|NCT01472081|40306437|FG002|Overall Study|Subject request to discontinue treatment|1|||
16501338|NCT01472081|40306438|FG003|Overall Study|Subject request to discontinue treatment|1|||
16501339|NCT01472081|40306439|FG004|Overall Study|Subject request to discontinue treatment|0|||
16501340|NCT01472081|40306440|FG005|Overall Study|Subject request to discontinue treatment|0|||
16501341|NCT02746874|40306443|FG000|Overall Study|Withdrawal by Subject|0|||
16501342|NCT02746874|40306444|FG001|Overall Study|Withdrawal by Subject|1|||
16501343|NCT02746874|40306443|FG000|Overall Study|Surgery Date Changed|0|||
16501344|NCT02746874|40306444|FG001|Overall Study|Surgery Date Changed|2|||
16501345|NCT04200456|40306445|FG000|Overall Study|Physician Decision|0|||
16501346|NCT04200456|40306446|FG001|Overall Study|Physician Decision|1|||
16501347|NCT04200456|40306445|FG000|Overall Study|Withdrawal by Subject|2|||
16501348|NCT04200456|40306446|FG001|Overall Study|Withdrawal by Subject|2|||
16501349|NCT04200456|40306445|FG000|Overall Study|Lack of Efficacy|1|||
16501350|NCT04200456|40306446|FG001|Overall Study|Lack of Efficacy|1|||
16501351|NCT04200456|40306445|FG000|Overall Study|Adverse event, non-fatal|0|||
16501352|NCT04200456|40306446|FG001|Overall Study|Adverse event, non-fatal|1|||
16501353|NCT04200456|40306445|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
16501354|NCT04200456|40306446|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
16501355|NCT02699554|40306447|FG000|Overall Study|Lost to Follow-up|9|||
16501356|NCT02081690|40306450|FG000|Overall Study|Death|3|||
16501357|NCT02081690|40306450|FG000|Overall Study|Physician Decision|3|||
16501358|NCT02081690|40306450|FG000|Overall Study|Withdrawal by Subject|1|||
16501359|NCT01514760|40306454|FG000|Overall Study|Lost to Follow-up|2|||
16501360|NCT01549392|40306456|FG000|Overall Study|Withdrawal by Subject|1|||
16501361|NCT01549392|40306457|FG001|Overall Study|Withdrawal by Subject|0|||
16501362|NCT01752907|40306458|FG000|Overall Study|Withdrawal by Subject|4|||
16501363|NCT01752907|40306459|FG001|Overall Study|Withdrawal by Subject|10|||
16501364|NCT01752907|40306458|FG000|Overall Study|Lost to Follow-up|2|||
16501365|NCT01752907|40306459|FG001|Overall Study|Lost to Follow-up|1|||
16501366|NCT01752907|40306458|FG000|Overall Study|Decision by Sponsor|6|||
16501367|NCT01752907|40306459|FG001|Overall Study|Decision by Sponsor|9|||
16501368|NCT03447990|40306460|FG000|Overall Study|Withdrawal by Subject|0|||
16501369|NCT03447990|40306461|FG001|Overall Study|Withdrawal by Subject|0|||
16501370|NCT03447990|40306462|FG002|Overall Study|Withdrawal by Subject|0|||
16501371|NCT03447990|40306463|FG003|Overall Study|Withdrawal by Subject|0|||
16501372|NCT03447990|40306464|FG004|Overall Study|Withdrawal by Subject|0|||
16501373|NCT03447990|40306465|FG005|Overall Study|Withdrawal by Subject|0|||
16501374|NCT03447990|40306466|FG006|Overall Study|Withdrawal by Subject|1|||
16501375|NCT01980992|40306467|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
16501376|NCT01980992|40306468|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
16088411|NCT00734578|38813871|FG000|Overall Study|Randomized in error|1|||
16088412|NCT00734578|38813872|FG001|Overall Study|Randomized in error|0|||
16088413|NCT00734578|38813873|FG002|Overall Study|Randomized in error|0|||
16088414|NCT00734578|38813871|FG000|Overall Study|Exclusion criteria|1|||
16501377|NCT01980992|40306467|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
16501378|NCT01980992|40306468|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
16501379|NCT01980992|40306467|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
16501380|NCT01980992|40306468|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
16088415|NCT00734578|38813872|FG001|Overall Study|Exclusion criteria|0|||
16088416|NCT00734578|38813873|FG002|Overall Study|Exclusion criteria|0|||
16501381|NCT01980992|40306467|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
16501382|NCT01980992|40306468|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
16501383|NCT01980992|40306467|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
16501384|NCT01980992|40306468|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
16088417|NCT01079806|38813874|FG000|Day 1 to Week 96|Adverse Event|0|||
16088418|NCT01079806|38813875|FG001|Day 1 to Week 96|Adverse Event|3|||
16088419|NCT01079806|38813874|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
16088420|NCT01079806|38813875|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
16088421|NCT01079806|38813874|FG000|Day 1 to Week 96|Pregnancy|0|||
16088422|NCT01079806|38813875|FG001|Day 1 to Week 96|Pregnancy|1|||
16088423|NCT01079806|38813874|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
16088424|NCT01079806|38813875|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
16088425|NCT01079806|38813874|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
16088426|NCT01079806|38813875|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
16088427|NCT01079806|38813874|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
16088428|NCT01079806|38813875|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
16088429|NCT01079806|38813874|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
16088430|NCT01079806|38813875|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
16088431|NCT01079806|38813874|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
16088432|NCT01079806|38813875|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
16088433|NCT01079806|38813874|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
16088434|NCT01079806|38813875|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
16088435|NCT01079806|38813874|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
16088436|NCT01079806|38813875|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
16088437|NCT01450007|38813876|FG000|Overall Study|Late exclusion before treatment|2|||
16088438|NCT01450007|38813877|FG001|Overall Study|Late exclusion before treatment|3|||
16088439|NCT01450007|38813878|FG002|Overall Study|Late exclusion before treatment|2|||
16088440|NCT01450007|38813876|FG000|Overall Study|Protocol Violation|0|||
16088441|NCT01450007|38813877|FG001|Overall Study|Protocol Violation|1|||
16088442|NCT01450007|38813878|FG002|Overall Study|Protocol Violation|1|||
16088443|NCT01450007|38813876|FG000|Overall Study|Adverse Event|0|||
16088444|NCT01450007|38813877|FG001|Overall Study|Adverse Event|1|||
16088445|NCT01450007|38813878|FG002|Overall Study|Adverse Event|0|||
16088446|NCT01332266|38813884|FG000|Phase 1b|Death|3|||
16088447|NCT01332266|38813885|FG001|Phase 1b|Death|3|||
16088448|NCT01332266|38813886|FG002|Phase 1b|Death|2|||
16088449|NCT01332266|38813887|FG003|Phase 1b|Death|0|||
16088450|NCT01332266|38813888|FG004|Phase 1b|Death|0|||
16088451|NCT01332266|38813884|FG000|Phase 1b|Lost to Follow-up|0|||
16088452|NCT01332266|38813885|FG001|Phase 1b|Lost to Follow-up|1|||
16088453|NCT01332266|38813886|FG002|Phase 1b|Lost to Follow-up|0|||
16088454|NCT01332266|38813887|FG003|Phase 1b|Lost to Follow-up|0|||
16088455|NCT01332266|38813888|FG004|Phase 1b|Lost to Follow-up|0|||
16088456|NCT01332266|38813884|FG000|Phase 1b|Withdrawal by Subject|1|||
16088457|NCT01332266|38813885|FG001|Phase 1b|Withdrawal by Subject|1|||
16088458|NCT01332266|38813886|FG002|Phase 1b|Withdrawal by Subject|1|||
16088459|NCT01332266|38813887|FG003|Phase 1b|Withdrawal by Subject|0|||
16088460|NCT01332266|38813888|FG004|Phase 1b|Withdrawal by Subject|0|||
16088461|NCT01332266|38813884|FG000|Phase 2|Death|0|||
16088462|NCT01332266|38813885|FG001|Phase 2|Death|0|||
16088463|NCT01332266|38813886|FG002|Phase 2|Death|0|||
16088464|NCT01332266|38813887|FG003|Phase 2|Death|33|||
16088465|NCT01332266|38813888|FG004|Phase 2|Death|36|||
16088466|NCT01332266|38813884|FG000|Phase 2|Lost to Follow-up|0|||
16088467|NCT01332266|38813885|FG001|Phase 2|Lost to Follow-up|0|||
16088468|NCT01332266|38813886|FG002|Phase 2|Lost to Follow-up|0|||
16088469|NCT01332266|38813887|FG003|Phase 2|Lost to Follow-up|2|||
16088470|NCT01332266|38813888|FG004|Phase 2|Lost to Follow-up|0|||
16088471|NCT01332266|38813884|FG000|Phase 2|Physician Decision|0|||
16088472|NCT01332266|38813885|FG001|Phase 2|Physician Decision|0|||
16088473|NCT01332266|38813886|FG002|Phase 2|Physician Decision|0|||
16088474|NCT01332266|38813887|FG003|Phase 2|Physician Decision|3|||
16088475|NCT01332266|38813888|FG004|Phase 2|Physician Decision|1|||
16088476|NCT01332266|38813884|FG000|Phase 2|Symptomatic deterioration|0|||
16088477|NCT01332266|38813885|FG001|Phase 2|Symptomatic deterioration|0|||
16088478|NCT01332266|38813886|FG002|Phase 2|Symptomatic deterioration|0|||
16088479|NCT01332266|38813887|FG003|Phase 2|Symptomatic deterioration|0|||
16088480|NCT01332266|38813888|FG004|Phase 2|Symptomatic deterioration|1|||
16088481|NCT01332266|38813884|FG000|Phase 2|Progression Disease|0|||
16088482|NCT01332266|38813885|FG001|Phase 2|Progression Disease|0|||
16088483|NCT01332266|38813886|FG002|Phase 2|Progression Disease|0|||
16088484|NCT01332266|38813887|FG003|Phase 2|Progression Disease|2|||
16088485|NCT01332266|38813888|FG004|Phase 2|Progression Disease|1|||
16088486|NCT01332266|38813884|FG000|Phase 2|Withdrawal by Subject|0|||
16389878|NCT02720523|39911839|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
16389879|NCT02720523|39911840|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
16389880|NCT02720523|39911834|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
16389881|NCT02720523|39911835|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
16389882|NCT02720523|39911836|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
16389883|NCT02720523|39911837|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
16389884|NCT02720523|39911838|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
16389885|NCT02720523|39911839|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
16389886|NCT02720523|39911840|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
16389887|NCT02720523|39911834|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
16389888|NCT02720523|39911835|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
16389889|NCT02720523|39911836|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
16389890|NCT02720523|39911837|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
16389891|NCT02720523|39911838|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
16389892|NCT02720523|39911839|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
16389893|NCT02720523|39911840|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
16389894|NCT02720523|39911834|FG000|Period 2: Long-term Extension Period|Other|0|||
16389895|NCT02720523|39911835|FG001|Period 2: Long-term Extension Period|Other|0|||
16389896|NCT02720523|39911836|FG002|Period 2: Long-term Extension Period|Other|0|||
16389897|NCT02720523|39911837|FG003|Period 2: Long-term Extension Period|Other|0|||
16389898|NCT02720523|39911838|FG004|Period 2: Long-term Extension Period|Other|2|||
16389899|NCT02720523|39911839|FG005|Period 2: Long-term Extension Period|Other|0|||
16389900|NCT02720523|39911840|FG006|Period 2: Long-term Extension Period|Other|3|||
16389901|NCT03810014|39911841|FG000|Overall Study|Pregnancy|2|||
16389902|NCT03810014|39911842|FG001|Overall Study|Pregnancy|2|||
16389903|NCT03810014|39911843|FG002|Overall Study|Pregnancy|0|||
16389904|NCT03810014|39911844|FG003|Overall Study|Pregnancy|2|||
16389905|NCT03382912|39911849|FG000|Overall Study|Physician Decision|0|||
16389906|NCT03382912|39911850|FG001|Overall Study|Physician Decision|1|||
16389907|NCT03382912|39911849|FG000|Overall Study|Sponsor Decision|6|||
16389908|NCT03382912|39911850|FG001|Overall Study|Sponsor Decision|6|||
16389909|NCT03382912|39911849|FG000|Overall Study|Withdrawal by Subject|0|||
16389910|NCT03382912|39911850|FG001|Overall Study|Withdrawal by Subject|5|||
16389911|NCT02820844|39911851|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
16501385|NCT01980992|40306467|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
16501386|NCT01980992|40306468|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
16501387|NCT02588833|40306469|FG000|Part 1|Withdrawal by Subject|1|||
16501388|NCT02588833|40306470|FG001|Part 1|Withdrawal by Subject|0|||
16501389|NCT02588833|40306469|FG000|Part 2A|Physician Decision|0|||
16501390|NCT02588833|40306470|FG001|Part 2A|Physician Decision|1|||
16501391|NCT02588833|40306469|FG000|Part 2A|Withdrawal by Subject|0|||
16501392|NCT02588833|40306470|FG001|Part 2A|Withdrawal by Subject|1|||
16501393|NCT02588833|40306469|FG000|Part 2B|Adverse Event|0|||
16501394|NCT02588833|40306470|FG001|Part 2B|Adverse Event|1|||
16501395|NCT02588833|40306469|FG000|Part 2C|Adverse Event|0|||
16501396|NCT02588833|40306470|FG001|Part 2C|Adverse Event|1|||
16501397|NCT02588833|40306469|FG000|Part 2C|Withdrawal by Subject|0|||
16501398|NCT02588833|40306470|FG001|Part 2C|Withdrawal by Subject|1|||
16501399|NCT02588833|40306469|FG000|Part 3 (Safety Follow-up)|Other|0|||
16501400|NCT02588833|40306470|FG001|Part 3 (Safety Follow-up)|Other|2|||
16501401|NCT01994629|40306471|FG000|Overall Study|Withdrawal by Subject|1|||
16501402|NCT01994629|40306472|FG001|Overall Study|Withdrawal by Subject|0|||
16501403|NCT01994629|40306471|FG000|Overall Study|Lost to Follow-up|0|||
16501404|NCT01994629|40306472|FG001|Overall Study|Lost to Follow-up|3|||
16501405|NCT00481195|40306473|FG000|Overall Study|Adverse Event|16|||
16501406|NCT00481195|40306474|FG001|Overall Study|Adverse Event|11|||
16501407|NCT00481195|40306473|FG000|Overall Study|Lack of Efficacy|1|||
16501408|NCT00481195|40306474|FG001|Overall Study|Lack of Efficacy|3|||
16501409|NCT00481195|40306473|FG000|Overall Study|Lost to Follow-up|4|||
16501410|NCT00481195|40306474|FG001|Overall Study|Lost to Follow-up|6|||
16501411|NCT00481195|40306473|FG000|Overall Study|Physician Decision|3|||
16501412|NCT00481195|40306474|FG001|Overall Study|Physician Decision|1|||
16501413|NCT00481195|40306473|FG000|Overall Study|Protocol Violation|10|||
16501414|NCT00481195|40306474|FG001|Overall Study|Protocol Violation|7|||
16088487|NCT01332266|38813885|FG001|Phase 2|Withdrawal by Subject|0|||
16088488|NCT01332266|38813886|FG002|Phase 2|Withdrawal by Subject|0|||
16088489|NCT01332266|38813887|FG003|Phase 2|Withdrawal by Subject|2|||
16088490|NCT01332266|38813888|FG004|Phase 2|Withdrawal by Subject|2|||
16088491|NCT00599196|38813891|FG000|Overall Study|Lack of Efficacy|22|||
16088492|NCT00599196|38813891|FG000|Overall Study|Adverse Event|93|||
16088493|NCT00599196|38813891|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
16088494|NCT00599196|38813891|FG000|Overall Study|Subject withdrew consent|43|||
16088495|NCT00599196|38813891|FG000|Overall Study|Study ended per sponsor|197|||
16088496|NCT00599196|38813891|FG000|Overall Study|Lost to Follow-up|17|||
16088497|NCT00599196|38813891|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
16389912|NCT02820844|39911852|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
16389913|NCT02820844|39911853|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
16389914|NCT02820844|39911854|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
16389915|NCT02820844|39911855|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
16389916|NCT02820844|39911856|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
16389917|NCT02820844|39911851|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
16501415|NCT00481195|40306473|FG000|Overall Study|Withdrawal by Subject|3|||
16088498|NCT00599196|38813891|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
16088499|NCT00599196|38813891|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
16088500|NCT00599196|38813891|FG000|Overall Study|Other: Pt Moved To Australia|1|||
16088501|NCT00599196|38813891|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
16088502|NCT00599196|38813891|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
16088503|NCT01029704|38816675|FG000|Overall Study|Adverse Event|0|||
16088504|NCT01029704|38816676|FG001|Overall Study|Adverse Event|0|||
16088505|NCT01029704|38816677|FG002|Overall Study|Adverse Event|0|||
16088506|NCT01029704|38816678|FG003|Overall Study|Adverse Event|0|||
16088507|NCT01029704|38816679|FG004|Overall Study|Adverse Event|0|||
16088508|NCT01029704|38816680|FG005|Overall Study|Adverse Event|0|||
16088509|NCT01029704|38816681|FG006|Overall Study|Adverse Event|1|||
16088510|NCT01029704|38816682|FG007|Overall Study|Adverse Event|1|||
16088511|NCT01029704|38816683|FG008|Overall Study|Adverse Event|0|||
16088512|NCT01029704|38816675|FG000|Overall Study|Withdrawal by Subject|0|||
16088513|NCT01029704|38816676|FG001|Overall Study|Withdrawal by Subject|0|||
16088514|NCT01029704|38816677|FG002|Overall Study|Withdrawal by Subject|0|||
16088515|NCT01029704|38816678|FG003|Overall Study|Withdrawal by Subject|0|||
16088516|NCT01029704|38816679|FG004|Overall Study|Withdrawal by Subject|2|||
16088517|NCT01029704|38816680|FG005|Overall Study|Withdrawal by Subject|1|||
16088518|NCT01029704|38816681|FG006|Overall Study|Withdrawal by Subject|1|||
16088519|NCT01029704|38816682|FG007|Overall Study|Withdrawal by Subject|1|||
16088520|NCT01029704|38816683|FG008|Overall Study|Withdrawal by Subject|0|||
16088521|NCT01029704|38816675|FG000|Overall Study|Lost to Follow-up|0|||
16088522|NCT01029704|38816676|FG001|Overall Study|Lost to Follow-up|0|||
16088523|NCT01029704|38816677|FG002|Overall Study|Lost to Follow-up|0|||
16088524|NCT01029704|38816678|FG003|Overall Study|Lost to Follow-up|0|||
16088525|NCT01029704|38816679|FG004|Overall Study|Lost to Follow-up|0|||
16088526|NCT01029704|38816680|FG005|Overall Study|Lost to Follow-up|0|||
16088527|NCT01029704|38816681|FG006|Overall Study|Lost to Follow-up|1|||
16088528|NCT01029704|38816682|FG007|Overall Study|Lost to Follow-up|1|||
16088529|NCT01029704|38816683|FG008|Overall Study|Lost to Follow-up|1|||
16088530|NCT01029704|38816675|FG000|Overall Study|Lack of Efficacy|0|||
16088531|NCT01029704|38816676|FG001|Overall Study|Lack of Efficacy|0|||
16088532|NCT01029704|38816677|FG002|Overall Study|Lack of Efficacy|0|||
16088533|NCT01029704|38816678|FG003|Overall Study|Lack of Efficacy|0|||
16501416|NCT00481195|40306474|FG001|Overall Study|Withdrawal by Subject|9|||
16501417|NCT00481195|40306473|FG000|Overall Study|Miscellaneous|2|||
16501418|NCT00481195|40306474|FG001|Overall Study|Miscellaneous|2|||
16501419|NCT02611778|40306477|FG000|Overall Study|Withdrawal by Subject|2|||
16501420|NCT02611778|40306478|FG001|Overall Study|Withdrawal by Subject|8|||
16501421|NCT02611778|40306477|FG000|Overall Study|Adverse Event|1|||
16501422|NCT02611778|40306478|FG001|Overall Study|Adverse Event|2|||
16501423|NCT02611778|40306477|FG000|Overall Study|Death|2|||
16501424|NCT02611778|40306478|FG001|Overall Study|Death|1|||
16501425|NCT02611778|40306477|FG000|Overall Study|Protocol Violation|1|||
16501426|NCT02611778|40306478|FG001|Overall Study|Protocol Violation|0|||
16501427|NCT02611778|40306477|FG000|Overall Study|Lost to Follow-up|3|||
16501428|NCT02611778|40306478|FG001|Overall Study|Lost to Follow-up|1|||
16501429|NCT02611778|40306477|FG000|Overall Study|Need for alternative treatment|1|||
16501430|NCT02611778|40306478|FG001|Overall Study|Need for alternative treatment|0|||
16501431|NCT02611778|40306477|FG000|Overall Study|Other Reason|2|||
16501432|NCT02611778|40306478|FG001|Overall Study|Other Reason|1|||
16501433|NCT01356966|40306479|FG000|Overall Study|Withdrawal by Subject|1|||
16501434|NCT01356966|40306480|FG001|Overall Study|Withdrawal by Subject|2|||
16501435|NCT01356966|40306479|FG000|Overall Study|Physician Decision|1|||
16501436|NCT01356966|40306480|FG001|Overall Study|Physician Decision|0|||
16501437|NCT03065244|40306489|FG000|Overall Study|Lost to Follow-up|1|||
16088534|NCT01029704|38816679|FG004|Overall Study|Lack of Efficacy|2|||
16088535|NCT01029704|38816680|FG005|Overall Study|Lack of Efficacy|3|||
16088536|NCT01029704|38816681|FG006|Overall Study|Lack of Efficacy|1|||
16088537|NCT01029704|38816682|FG007|Overall Study|Lack of Efficacy|2|||
16088538|NCT01029704|38816683|FG008|Overall Study|Lack of Efficacy|0|||
16088539|NCT01029704|38816675|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
16088540|NCT01029704|38816676|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
16088541|NCT01029704|38816677|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
16088542|NCT01029704|38816678|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
16088543|NCT01029704|38816679|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
16088544|NCT01029704|38816680|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
16088545|NCT01029704|38816681|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
16088546|NCT01029704|38816682|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
16088547|NCT01029704|38816683|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
16088548|NCT03683576|38816684|FG000|Overall Study|Withdrawal by Subject|2|||
16088549|NCT03683576|38816685|FG001|Overall Study|Withdrawal by Subject|0|||
16088550|NCT03683576|38816686|FG002|Overall Study|Withdrawal by Subject|8|||
16088551|NCT03683576|38816687|FG003|Overall Study|Withdrawal by Subject|3|||
16088552|NCT03683576|38816684|FG000|Overall Study|Adverse Event|3|||
16088553|NCT03683576|38816685|FG001|Overall Study|Adverse Event|0|||
16088554|NCT03683576|38816686|FG002|Overall Study|Adverse Event|0|||
16088555|NCT03683576|38816687|FG003|Overall Study|Adverse Event|4|||
16088556|NCT03683576|38816684|FG000|Overall Study|Lack of Efficacy|1|||
16088557|NCT03683576|38816685|FG001|Overall Study|Lack of Efficacy|0|||
16088558|NCT03683576|38816686|FG002|Overall Study|Lack of Efficacy|1|||
16088559|NCT03683576|38816687|FG003|Overall Study|Lack of Efficacy|1|||
16088560|NCT03683576|38816684|FG000|Overall Study|Lost to Follow-up|0|||
16088561|NCT03683576|38816685|FG001|Overall Study|Lost to Follow-up|1|||
16088562|NCT03683576|38816686|FG002|Overall Study|Lost to Follow-up|2|||
16088563|NCT03683576|38816687|FG003|Overall Study|Lost to Follow-up|0|||
16088564|NCT03683576|38816684|FG000|Overall Study|Other, Not Specified|0|||
16088565|NCT03683576|38816685|FG001|Overall Study|Other, Not Specified|2|||
16088566|NCT03683576|38816686|FG002|Overall Study|Other, Not Specified|0|||
16088567|NCT03683576|38816687|FG003|Overall Study|Other, Not Specified|0|||
16088568|NCT03683576|38816684|FG000|Overall Study|Protocol Violation|0|||
16088569|NCT03683576|38816685|FG001|Overall Study|Protocol Violation|1|||
16088570|NCT03683576|38816686|FG002|Overall Study|Protocol Violation|1|||
16088571|NCT03683576|38816687|FG003|Overall Study|Protocol Violation|0|||
16088572|NCT00321672|38816690|FG000|Overall Study|Withdrawal by Subject|5|||
16088573|NCT00321672|38816691|FG001|Overall Study|Withdrawal by Subject|1|||
16088574|NCT00321672|38816692|FG002|Overall Study|Withdrawal by Subject|2|||
16088575|NCT00321672|38816693|FG003|Overall Study|Withdrawal by Subject|0|||
16088576|NCT00321672|38816690|FG000|Overall Study|Noncompliance|1|||
16088577|NCT00321672|38816691|FG001|Overall Study|Noncompliance|2|||
16088578|NCT00321672|38816692|FG002|Overall Study|Noncompliance|1|||
16088579|NCT00321672|38816693|FG003|Overall Study|Noncompliance|0|||
16088580|NCT00321672|38816690|FG000|Overall Study|Adverse Event|1|||
16088581|NCT00321672|38816691|FG001|Overall Study|Adverse Event|1|||
16088582|NCT00321672|38816692|FG002|Overall Study|Adverse Event|0|||
16088583|NCT00321672|38816693|FG003|Overall Study|Adverse Event|0|||
16088584|NCT00321672|38816690|FG000|Overall Study|Lack of Efficacy|1|||
16088585|NCT00321672|38816691|FG001|Overall Study|Lack of Efficacy|1|||
16088586|NCT00321672|38816692|FG002|Overall Study|Lack of Efficacy|0|||
16088587|NCT00321672|38816693|FG003|Overall Study|Lack of Efficacy|0|||
16088588|NCT00321672|38816690|FG000|Overall Study|Lost to Follow-up|2|||
16088589|NCT00321672|38816691|FG001|Overall Study|Lost to Follow-up|0|||
16088590|NCT00321672|38816692|FG002|Overall Study|Lost to Follow-up|4|||
16088591|NCT00321672|38816693|FG003|Overall Study|Lost to Follow-up|2|||
16088592|NCT00321672|38816690|FG000|Overall Study|Death|1|||
16088593|NCT00321672|38816691|FG001|Overall Study|Death|0|||
16088594|NCT00321672|38816692|FG002|Overall Study|Death|0|||
16088595|NCT00321672|38816693|FG003|Overall Study|Death|0|||
16088596|NCT00321672|38816690|FG000|Overall Study|Too far to travel for visits|1|||
16088597|NCT00321672|38816691|FG001|Overall Study|Too far to travel for visits|0|||
16088598|NCT00321672|38816692|FG002|Overall Study|Too far to travel for visits|0|||
16088599|NCT00321672|38816693|FG003|Overall Study|Too far to travel for visits|0|||
16088600|NCT00321672|38816690|FG000|Overall Study|Incarcerated|0|||
16088601|NCT00321672|38816691|FG001|Overall Study|Incarcerated|0|||
16088602|NCT00321672|38816692|FG002|Overall Study|Incarcerated|2|||
16088603|NCT00321672|38816693|FG003|Overall Study|Incarcerated|0|||
16088604|NCT00321672|38816690|FG000|Overall Study|Moved out of state|0|||
16088605|NCT00321672|38816691|FG001|Overall Study|Moved out of state|1|||
16310305|NCT02847260|39619306|FG000|Overall Study|Adverse Event|3|||
16088606|NCT00321672|38816692|FG002|Overall Study|Moved out of state|1|||
16088607|NCT00321672|38816693|FG003|Overall Study|Moved out of state|0|||
16088608|NCT00321672|38816690|FG000|Overall Study|Protocol Violation|0|||
16088609|NCT00321672|38816691|FG001|Overall Study|Protocol Violation|0|||
16088610|NCT00321672|38816692|FG002|Overall Study|Protocol Violation|1|||
16088611|NCT00321672|38816693|FG003|Overall Study|Protocol Violation|0|||
16088612|NCT00321672|38816690|FG000|Overall Study|Diagnosis of testicular cancer|0|||
16088613|NCT00321672|38816691|FG001|Overall Study|Diagnosis of testicular cancer|1|||
16088614|NCT00321672|38816692|FG002|Overall Study|Diagnosis of testicular cancer|0|||
16088615|NCT00321672|38816693|FG003|Overall Study|Diagnosis of testicular cancer|0|||
16088616|NCT00321672|38816690|FG000|Overall Study|Extensive travel required for new job|0|||
16088617|NCT00321672|38816691|FG001|Overall Study|Extensive travel required for new job|1|||
16088618|NCT00321672|38816692|FG002|Overall Study|Extensive travel required for new job|0|||
16088619|NCT00321672|38816693|FG003|Overall Study|Extensive travel required for new job|0|||
16088620|NCT02040870|38816698|FG000|Overall Study|Completed treatment phase|6|||
16088621|NCT02040870|38816698|FG000|Overall Study|Adverse Event|7|||
16088622|NCT02040870|38816698|FG000|Overall Study|Progressive disease|58|||
16088623|NCT02040870|38816698|FG000|Overall Study|Physician Decision|6|||
16088624|NCT02040870|38816698|FG000|Overall Study|Subject/guardian decision|10|||
16088625|NCT02040870|38816698|FG000|Overall Study|Lost to Follow-up|3|||
16088626|NCT02040870|38816698|FG000|Overall Study|Death|13|||
16088627|NCT01419184|38816702|FG000|Overall Study|Site data not available|3|||
16088628|NCT01419184|38816703|FG001|Overall Study|Site data not available|2|||
16088629|NCT01419184|38816702|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
16088630|NCT01419184|38816703|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
16088631|NCT01419184|38816702|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
16088632|NCT01419184|38816703|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
16088633|NCT01419184|38816702|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
16088634|NCT01419184|38816703|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
16088635|NCT01419184|38816702|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
16088636|NCT01419184|38816703|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
16088637|NCT01419184|38816702|FG000|Overall Study|Participant randomized, not treated|1|||
16088638|NCT01419184|38816703|FG001|Overall Study|Participant randomized, not treated|0|||
16088639|NCT01579318|38816708|FG000|Overall Study|Disease Progression|1|||
16088640|NCT00337610|38816709|FG000|Overall Study|Adverse Event|2|||
16088641|NCT00337610|38816710|FG001|Overall Study|Adverse Event|2|||
16088642|NCT00337610|38816709|FG000|Overall Study|Death|0|||
16088643|NCT00337610|38816710|FG001|Overall Study|Death|1|||
16088644|NCT00337610|38816709|FG000|Overall Study|Lack of Efficacy|6|||
16088645|NCT00337610|38816710|FG001|Overall Study|Lack of Efficacy|3|||
16088646|NCT00337610|38816709|FG000|Overall Study|Lost to Follow-up|3|||
16389918|NCT02820844|39911852|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
16501438|NCT03065244|40306490|FG001|Overall Study|Lost to Follow-up|1|||
16088647|NCT00337610|38816710|FG001|Overall Study|Lost to Follow-up|3|||
16088648|NCT00337610|38816709|FG000|Overall Study|Withdrawal by Subject|6|||
16088649|NCT00337610|38816710|FG001|Overall Study|Withdrawal by Subject|5|||
16088650|NCT02372799|38816711|FG000|Treatment Period|Adverse Event|3|||
16088651|NCT02372799|38816712|FG001|Treatment Period|Adverse Event|10|||
16088652|NCT02372799|38816713|FG002|Treatment Period|Adverse Event|6|||
16088653|NCT02372799|38816711|FG000|Treatment Period|Insufficient therapeutic response|2|||
16088654|NCT02372799|38816712|FG001|Treatment Period|Insufficient therapeutic response|2|||
16088655|NCT02372799|38816713|FG002|Treatment Period|Insufficient therapeutic response|0|||
16088656|NCT02372799|38816711|FG000|Treatment Period|Withdrawal by Subject|10|||
16088657|NCT02372799|38816712|FG001|Treatment Period|Withdrawal by Subject|10|||
16088658|NCT02372799|38816713|FG002|Treatment Period|Withdrawal by Subject|2|||
16088659|NCT02372799|38816711|FG000|Treatment Period|Lost to Follow-up|11|||
16088660|NCT02372799|38816712|FG001|Treatment Period|Lost to Follow-up|5|||
16088661|NCT02372799|38816713|FG002|Treatment Period|Lost to Follow-up|3|||
16088662|NCT02372799|38816711|FG000|Treatment Period|Protocol Violation|3|||
16088663|NCT02372799|38816712|FG001|Treatment Period|Protocol Violation|0|||
16088664|NCT02372799|38816713|FG002|Treatment Period|Protocol Violation|0|||
16088665|NCT02372799|38816711|FG000|Treatment Period|Non-compliance with study drug|4|||
16088666|NCT02372799|38816712|FG001|Treatment Period|Non-compliance with study drug|4|||
16088667|NCT02372799|38816713|FG002|Treatment Period|Non-compliance with study drug|4|||
16088668|NCT02372799|38816711|FG000|Treatment Period|Miscellaneous Reasons|1|||
16088669|NCT02372799|38816712|FG001|Treatment Period|Miscellaneous Reasons|1|||
16088670|NCT02372799|38816713|FG002|Treatment Period|Miscellaneous Reasons|0|||
16088671|NCT02372799|38816711|FG000|Down-taper Period|Lost to Follow-up|1|||
16088672|NCT02372799|38816712|FG001|Down-taper Period|Lost to Follow-up|2|||
16088673|NCT02372799|38816713|FG002|Down-taper Period|Lost to Follow-up|2|||
16088674|NCT00390884|38816714|FG000|Overall Study|Withdrawal by Subject|2|||
16088675|NCT00390884|38816715|FG001|Overall Study|Withdrawal by Subject|2|||
16501439|NCT03065244|40306489|FG000|Overall Study|Diagnosed with a different disease|1|||
16088676|NCT02052440|38816716|FG000|Overall Study|Withdrawal by Subject|0|||
16088677|NCT02052440|38816717|FG001|Overall Study|Withdrawal by Subject|1|||
16088678|NCT01885559|38816718|FG000|Overall Study|Lost to Follow-up|15|||
16088679|NCT01885559|38816719|FG001|Overall Study|Lost to Follow-up|16|||
16088680|NCT01885559|38816718|FG000|Overall Study|Less than full participation|9|||
16088681|NCT01885559|38816719|FG001|Overall Study|Less than full participation|19|||
16088682|NCT01885559|38816718|FG000|Overall Study|Protocol Violation|0|||
16088683|NCT01885559|38816719|FG001|Overall Study|Protocol Violation|1|||
16088684|NCT03490032|38816720|FG000|Overall Study|family issue (child custody)|1|||
16088685|NCT03490032|38816721|FG001|Overall Study|family issue (child custody)|0|||
16088686|NCT03490032|38816722|FG002|Overall Study|family issue (child custody)|0|||
16088687|NCT00622700|38816723|FG000|Core Treatment Period|Randomized but Not Treated|0|||
16088688|NCT00622700|38816724|FG001|Core Treatment Period|Randomized but Not Treated|2|||
16088689|NCT00622700|38816725|FG002|Core Treatment Period|Randomized but Not Treated|2|||
16088690|NCT00622700|38816726|FG003|Core Treatment Period|Randomized but Not Treated|0|||
16088691|NCT00622700|38816727|FG004|Core Treatment Period|Randomized but Not Treated|0|||
16088692|NCT00622700|38816728|FG005|Core Treatment Period|Randomized but Not Treated|0|||
16088693|NCT00622700|38816729|FG006|Core Treatment Period|Randomized but Not Treated|0|||
16088694|NCT00622700|38816723|FG000|Core Treatment Period|Adverse Event|18|||
16088695|NCT00622700|38816724|FG001|Core Treatment Period|Adverse Event|25|||
16088696|NCT00622700|38816725|FG002|Core Treatment Period|Adverse Event|18|||
16088697|NCT00622700|38816726|FG003|Core Treatment Period|Adverse Event|0|||
16088698|NCT00622700|38816727|FG004|Core Treatment Period|Adverse Event|0|||
16088699|NCT00622700|38816728|FG005|Core Treatment Period|Adverse Event|0|||
16088700|NCT00622700|38816729|FG006|Core Treatment Period|Adverse Event|0|||
16088701|NCT00622700|38816723|FG000|Core Treatment Period|Lack of Efficacy|19|||
16088702|NCT00622700|38816724|FG001|Core Treatment Period|Lack of Efficacy|6|||
16088703|NCT00622700|38816725|FG002|Core Treatment Period|Lack of Efficacy|12|||
16088704|NCT00622700|38816726|FG003|Core Treatment Period|Lack of Efficacy|0|||
16088705|NCT00622700|38816727|FG004|Core Treatment Period|Lack of Efficacy|0|||
16088706|NCT00622700|38816728|FG005|Core Treatment Period|Lack of Efficacy|0|||
16088707|NCT00622700|38816729|FG006|Core Treatment Period|Lack of Efficacy|0|||
16088708|NCT00622700|38816723|FG000|Core Treatment Period|Lost to Follow-up|1|||
16088709|NCT00622700|38816724|FG001|Core Treatment Period|Lost to Follow-up|1|||
16195512|NCT03629041|39193366|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
16195513|NCT03629041|39193367|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
16195514|NCT02175771|39193368|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
16195515|NCT02175771|39193369|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16195516|NCT02175771|39193370|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16195517|NCT02175771|39193371|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16195518|NCT02175771|39193372|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16195519|NCT02175771|39193373|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16195520|NCT02175771|39193374|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16195521|NCT02175771|39193375|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16195522|NCT02175771|39193376|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16195523|NCT02175771|39193368|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
16195524|NCT02175771|39193369|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16195525|NCT02175771|39193370|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16195526|NCT02175771|39193371|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16195527|NCT02175771|39193372|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16195528|NCT02175771|39193373|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16195529|NCT02175771|39193374|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16195530|NCT02175771|39193375|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16195531|NCT02175771|39193376|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16195532|NCT02175771|39193368|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
16195533|NCT02175771|39193369|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16195534|NCT02175771|39193370|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16195535|NCT02175771|39193371|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16195536|NCT02175771|39193372|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16195537|NCT02175771|39193373|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16195538|NCT02175771|39193374|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16195539|NCT02175771|39193375|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16195540|NCT02175771|39193376|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16195541|NCT02175771|39193368|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
16195542|NCT02175771|39193369|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
16195543|NCT02175771|39193370|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
16195544|NCT02175771|39193371|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
16195545|NCT02175771|39193372|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
16195546|NCT02175771|39193373|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
16195547|NCT02175771|39193374|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
16195548|NCT02175771|39193375|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
16195549|NCT02175771|39193376|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
16195550|NCT02175771|39193368|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
16195551|NCT02175771|39193369|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16195552|NCT02175771|39193370|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16088710|NCT00622700|38816725|FG002|Core Treatment Period|Lost to Follow-up|1|||
16088711|NCT00622700|38816726|FG003|Core Treatment Period|Lost to Follow-up|0|||
16088712|NCT00622700|38816727|FG004|Core Treatment Period|Lost to Follow-up|0|||
16088713|NCT00622700|38816728|FG005|Core Treatment Period|Lost to Follow-up|0|||
16088714|NCT00622700|38816729|FG006|Core Treatment Period|Lost to Follow-up|0|||
16088715|NCT00622700|38816723|FG000|Core Treatment Period|Death|1|||
16088716|NCT00622700|38816724|FG001|Core Treatment Period|Death|0|||
16088717|NCT00622700|38816725|FG002|Core Treatment Period|Death|0|||
16088718|NCT00622700|38816726|FG003|Core Treatment Period|Death|0|||
16088719|NCT00622700|38816727|FG004|Core Treatment Period|Death|0|||
16088720|NCT00622700|38816728|FG005|Core Treatment Period|Death|0|||
16088721|NCT00622700|38816729|FG006|Core Treatment Period|Death|0|||
16088722|NCT00622700|38816723|FG000|Core Treatment Period|Progressive Disease|3|||
16088723|NCT00622700|38816724|FG001|Core Treatment Period|Progressive Disease|1|||
16088724|NCT00622700|38816725|FG002|Core Treatment Period|Progressive Disease|0|||
16088725|NCT00622700|38816726|FG003|Core Treatment Period|Progressive Disease|0|||
16088726|NCT00622700|38816727|FG004|Core Treatment Period|Progressive Disease|0|||
16088727|NCT00622700|38816728|FG005|Core Treatment Period|Progressive Disease|0|||
16088728|NCT00622700|38816729|FG006|Core Treatment Period|Progressive Disease|0|||
16088729|NCT00622700|38816723|FG000|Core Treatment Period|Withdrawal by Subject|12|||
16088730|NCT00622700|38816724|FG001|Core Treatment Period|Withdrawal by Subject|18|||
16088731|NCT00622700|38816725|FG002|Core Treatment Period|Withdrawal by Subject|15|||
16088732|NCT00622700|38816726|FG003|Core Treatment Period|Withdrawal by Subject|0|||
16088733|NCT00622700|38816727|FG004|Core Treatment Period|Withdrawal by Subject|0|||
16088734|NCT00622700|38816728|FG005|Core Treatment Period|Withdrawal by Subject|0|||
16088735|NCT00622700|38816729|FG006|Core Treatment Period|Withdrawal by Subject|0|||
16088736|NCT00622700|38816723|FG000|Core Treatment Period|Other than specified above|2|||
16088737|NCT00622700|38816724|FG001|Core Treatment Period|Other than specified above|2|||
16088738|NCT00622700|38816725|FG002|Core Treatment Period|Other than specified above|5|||
16088739|NCT00622700|38816726|FG003|Core Treatment Period|Other than specified above|0|||
16088740|NCT00622700|38816727|FG004|Core Treatment Period|Other than specified above|0|||
16088741|NCT00622700|38816728|FG005|Core Treatment Period|Other than specified above|0|||
16088742|NCT00622700|38816729|FG006|Core Treatment Period|Other than specified above|0|||
16088743|NCT00622700|38816723|FG000|Extension Treatment Period|Adverse Event|0|||
16088744|NCT00622700|38816724|FG001|Extension Treatment Period|Adverse Event|0|||
16088745|NCT00622700|38816725|FG002|Extension Treatment Period|Adverse Event|0|||
16088746|NCT00622700|38816726|FG003|Extension Treatment Period|Adverse Event|5|||
16088747|NCT00622700|38816727|FG004|Extension Treatment Period|Adverse Event|9|||
16088748|NCT00622700|38816728|FG005|Extension Treatment Period|Adverse Event|6|||
16088749|NCT00622700|38816729|FG006|Extension Treatment Period|Adverse Event|8|||
16088750|NCT00622700|38816723|FG000|Extension Treatment Period|Lack of Efficacy|0|||
16088751|NCT00622700|38816724|FG001|Extension Treatment Period|Lack of Efficacy|0|||
16088752|NCT00622700|38816725|FG002|Extension Treatment Period|Lack of Efficacy|0|||
16088753|NCT00622700|38816726|FG003|Extension Treatment Period|Lack of Efficacy|2|||
16088754|NCT00622700|38816727|FG004|Extension Treatment Period|Lack of Efficacy|8|||
16088755|NCT00622700|38816728|FG005|Extension Treatment Period|Lack of Efficacy|1|||
16088756|NCT00622700|38816729|FG006|Extension Treatment Period|Lack of Efficacy|9|||
16088757|NCT00622700|38816723|FG000|Extension Treatment Period|Protocol Violation|0|||
16088758|NCT00622700|38816724|FG001|Extension Treatment Period|Protocol Violation|0|||
16088759|NCT00622700|38816725|FG002|Extension Treatment Period|Protocol Violation|0|||
16088760|NCT00622700|38816726|FG003|Extension Treatment Period|Protocol Violation|0|||
16088761|NCT00622700|38816727|FG004|Extension Treatment Period|Protocol Violation|0|||
16088762|NCT00622700|38816728|FG005|Extension Treatment Period|Protocol Violation|2|||
16088763|NCT00622700|38816729|FG006|Extension Treatment Period|Protocol Violation|0|||
16088764|NCT00622700|38816723|FG000|Extension Treatment Period|Lost to Follow-up|0|||
16088765|NCT00622700|38816724|FG001|Extension Treatment Period|Lost to Follow-up|0|||
16088766|NCT00622700|38816725|FG002|Extension Treatment Period|Lost to Follow-up|0|||
16088767|NCT00622700|38816726|FG003|Extension Treatment Period|Lost to Follow-up|0|||
16088768|NCT00622700|38816727|FG004|Extension Treatment Period|Lost to Follow-up|1|||
16088769|NCT00622700|38816728|FG005|Extension Treatment Period|Lost to Follow-up|0|||
16088770|NCT00622700|38816729|FG006|Extension Treatment Period|Lost to Follow-up|0|||
16088771|NCT00622700|38816723|FG000|Extension Treatment Period|Progressive Disease|0|||
16088772|NCT00622700|38816724|FG001|Extension Treatment Period|Progressive Disease|0|||
16088773|NCT00622700|38816725|FG002|Extension Treatment Period|Progressive Disease|0|||
16088774|NCT00622700|38816726|FG003|Extension Treatment Period|Progressive Disease|1|||
16088775|NCT00622700|38816727|FG004|Extension Treatment Period|Progressive Disease|2|||
16088776|NCT00622700|38816728|FG005|Extension Treatment Period|Progressive Disease|0|||
16088777|NCT00622700|38816729|FG006|Extension Treatment Period|Progressive Disease|2|||
16088778|NCT00622700|38816723|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
16088779|NCT00622700|38816724|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
16088780|NCT00622700|38816725|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
16088781|NCT00622700|38816726|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
16088782|NCT00622700|38816727|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
16195553|NCT02175771|39193371|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16195554|NCT02175771|39193372|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16501440|NCT03065244|40306490|FG001|Overall Study|Diagnosed with a different disease|1|||
16501441|NCT03065244|40306489|FG000|Overall Study|Protocol Violation|0|||
16501442|NCT03065244|40306490|FG001|Overall Study|Protocol Violation|1|||
16195555|NCT02175771|39193373|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16195556|NCT02175771|39193374|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16501443|NCT03065244|40306489|FG000|Overall Study|Withdrawal by Subject|1|||
16501444|NCT03065244|40306490|FG001|Overall Study|Withdrawal by Subject|1|||
16501445|NCT02877082|40306491|FG000|Overall Study|Trial was closed early|5|||
16501446|NCT02136576|40306493|FG000|Overall Study|Lost to Follow-up|2|||
16501447|NCT02136576|40306494|FG001|Overall Study|Lost to Follow-up|0|||
16195557|NCT02175771|39193375|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16195558|NCT02175771|39193376|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16501448|NCT02136576|40306495|FG002|Overall Study|Lost to Follow-up|0|||
16501449|NCT03338855|40306498|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
16501450|NCT03338855|40306499|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
16501451|NCT02802592|40306501|FG000|Overall Study|Study terminated due to loss of funding|4|||
16501452|NCT00613938|40306506|FG000|Overall Study|Withdrawal by Subject|2|||
16501453|NCT00613938|40306507|FG001|Overall Study|Withdrawal by Subject|4|||
16501454|NCT00613938|40306508|FG002|Overall Study|Withdrawal by Subject|9|||
16501455|NCT00613938|40306509|FG003|Overall Study|Withdrawal by Subject|9|||
16501456|NCT00613938|40306506|FG000|Overall Study|Adverse Event|1|||
16501457|NCT00613938|40306507|FG001|Overall Study|Adverse Event|4|||
16501458|NCT00613938|40306508|FG002|Overall Study|Adverse Event|8|||
16501459|NCT00613938|40306509|FG003|Overall Study|Adverse Event|5|||
16501460|NCT00613938|40306506|FG000|Overall Study|Lack of Efficacy|16|||
16501461|NCT00613938|40306507|FG001|Overall Study|Lack of Efficacy|18|||
16501462|NCT00613938|40306508|FG002|Overall Study|Lack of Efficacy|5|||
16501463|NCT00613938|40306509|FG003|Overall Study|Lack of Efficacy|9|||
16501464|NCT00613938|40306506|FG000|Overall Study|Other|1|||
16501465|NCT00613938|40306507|FG001|Overall Study|Other|2|||
16501466|NCT00613938|40306508|FG002|Overall Study|Other|1|||
16501467|NCT00613938|40306509|FG003|Overall Study|Other|3|||
16501468|NCT03519347|40306514|FG000|Interventional Crossover Period 1|Death|0|||
16501469|NCT03519347|40306515|FG001|Interventional Crossover Period 1|Death|0|||
16501470|NCT03519347|40306516|FG002|Interventional Crossover Period 1|Death|0|||
16501471|NCT03519347|40306517|FG003|Interventional Crossover Period 1|Death|1|||
16501472|NCT00224055|40306518|FG000|Overall Study|Adverse Event|9|||
16501473|NCT00224055|40306519|FG001|Overall Study|Adverse Event|3|||
16501474|NCT00224055|40306518|FG000|Overall Study|Lost to Follow-up|1|||
16501475|NCT00224055|40306519|FG001|Overall Study|Lost to Follow-up|2|||
16501476|NCT00224055|40306518|FG000|Overall Study|Protocol Violation|1|||
16501477|NCT00224055|40306519|FG001|Overall Study|Protocol Violation|1|||
16501478|NCT00224055|40306518|FG000|Overall Study|Inclusion Violation|3|||
16501479|NCT00224055|40306519|FG001|Overall Study|Inclusion Violation|6|||
16501480|NCT00224055|40306518|FG000|Overall Study|Withdrawal by Subject|0|||
16501481|NCT00224055|40306519|FG001|Overall Study|Withdrawal by Subject|2|||
16501482|NCT00224055|40306518|FG000|Overall Study|Other|1|||
16501483|NCT00224055|40306519|FG001|Overall Study|Other|0|||
16501484|NCT02081079|40306526|FG000|Overall Study|Lack of Efficacy|3|||
16501485|NCT02081079|40306527|FG001|Overall Study|Lack of Efficacy|2|||
16501486|NCT02081079|40306526|FG000|Overall Study|Lost to Follow-up|1|||
16501487|NCT02081079|40306527|FG001|Overall Study|Lost to Follow-up|0|||
16501488|NCT00356369|40306528|FG000|Active Phase|Withdrawal by Subject|2|||
16501489|NCT00356369|40306529|FG001|Active Phase|Withdrawal by Subject|1|||
16501490|NCT03909295|40306530|FG000|Overall Study|Adverse Event|2|||
16501491|NCT03909295|40306530|FG000|Overall Study|Study terminated by sponsor|50|||
16501492|NCT01998737|40310127|FG000|Overall Study|Corrupted database|23|||
16501493|NCT01998737|40310128|FG001|Overall Study|Corrupted database|0|||
16501494|NCT00475176|40310129|FG000|Overall Study|Adverse Event|2|||
16501495|NCT00475176|40310129|FG000|Overall Study|Withdrawal by Subject|1|||
16501496|NCT00475176|40310129|FG000|Overall Study|Protocol Violation|1|||
16501497|NCT03630120|40310130|FG000|Overall Study|Disease progression|0|||
16501498|NCT03630120|40310131|FG001|Overall Study|Disease progression|1|||
16501499|NCT03630120|40310132|FG002|Overall Study|Disease progression|1|||
16501500|NCT03630120|40310133|FG003|Overall Study|Disease progression|1|||
16501501|NCT01199289|40310140|FG000|Overall Study|Ineligibility determined|2|||
16501502|NCT01199289|40310141|FG001|Overall Study|Ineligibility determined|1|||
16501503|NCT01199289|40310142|FG002|Overall Study|Ineligibility determined|0|||
16501504|NCT01199289|40310143|FG003|Overall Study|Ineligibility determined|0|||
16501505|NCT01199289|40310140|FG000|Overall Study|Protocol Violation|1|||
16501506|NCT01199289|40310141|FG001|Overall Study|Protocol Violation|0|||
16501507|NCT01199289|40310142|FG002|Overall Study|Protocol Violation|0|||
16501508|NCT01199289|40310143|FG003|Overall Study|Protocol Violation|1|||
16501509|NCT01199289|40310140|FG000|Overall Study|Noncompliance|1|||
16501510|NCT01199289|40310141|FG001|Overall Study|Noncompliance|0|||
16501511|NCT01199289|40310142|FG002|Overall Study|Noncompliance|2|||
16501512|NCT01199289|40310143|FG003|Overall Study|Noncompliance|0|||
16501513|NCT01199289|40310140|FG000|Overall Study|Adverse Event|0|||
16501514|NCT01199289|40310141|FG001|Overall Study|Adverse Event|3|||
16501515|NCT01199289|40310142|FG002|Overall Study|Adverse Event|1|||
16501516|NCT01199289|40310143|FG003|Overall Study|Adverse Event|4|||
16501517|NCT01199289|40310140|FG000|Overall Study|Full consent withdrawn|2|||
16501518|NCT01199289|40310141|FG001|Overall Study|Full consent withdrawn|2|||
16501519|NCT01199289|40310142|FG002|Overall Study|Full consent withdrawn|2|||
16501520|NCT01199289|40310143|FG003|Overall Study|Full consent withdrawn|3|||
16501521|NCT01199289|40310140|FG000|Overall Study|Administrative decision|0|||
16088783|NCT00622700|38816728|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
16088784|NCT00622700|38816729|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
16088785|NCT00622700|38816723|FG000|Extension Treatment Period|Missing|0|||
16501522|NCT01199289|40310141|FG001|Overall Study|Administrative decision|0|||
16501523|NCT01199289|40310142|FG002|Overall Study|Administrative decision|0|||
16501524|NCT01199289|40310143|FG003|Overall Study|Administrative decision|1|||
16501525|NCT01199289|40310140|FG000|Overall Study|Lost to Follow-up|0|||
16501526|NCT01199289|40310141|FG001|Overall Study|Lost to Follow-up|0|||
16501527|NCT01199289|40310142|FG002|Overall Study|Lost to Follow-up|0|||
16501528|NCT01199289|40310143|FG003|Overall Study|Lost to Follow-up|1|||
16501529|NCT01199289|40310140|FG000|Overall Study|Protocol-specified criteria|3|||
16501530|NCT01199289|40310141|FG001|Overall Study|Protocol-specified criteria|0|||
16501531|NCT01199289|40310142|FG002|Overall Study|Protocol-specified criteria|0|||
16501532|NCT01199289|40310143|FG003|Overall Study|Protocol-specified criteria|1|||
16501533|NCT01199289|40310140|FG000|Overall Study|Pregnancy|0|||
16195559|NCT02175771|39193368|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
16195560|NCT02175771|39193369|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16501534|NCT01199289|40310141|FG001|Overall Study|Pregnancy|1|||
16501535|NCT01199289|40310142|FG002|Overall Study|Pregnancy|0|||
16501536|NCT01199289|40310143|FG003|Overall Study|Pregnancy|1|||
16501537|NCT01894152|40310152|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
16501538|NCT01558752|40310156|FG000|Overall Study|Physician Decision|2|||
16501539|NCT01558752|40310157|FG001|Overall Study|Physician Decision|0|||
16501540|NCT02039674|40310158|FG000|Overall Study|Adverse Event|0|||
16501541|NCT02039674|40310159|FG001|Overall Study|Adverse Event|0|||
16501542|NCT02039674|40310160|FG002|Overall Study|Adverse Event|0|||
16501543|NCT02039674|40310161|FG003|Overall Study|Adverse Event|1|||
16501544|NCT02039674|40310162|FG004|Overall Study|Adverse Event|0|||
16501545|NCT02039674|40310163|FG005|Overall Study|Adverse Event|0|||
16501546|NCT02039674|40310164|FG006|Overall Study|Adverse Event|0|||
16501547|NCT02039674|40310165|FG007|Overall Study|Adverse Event|0|||
16501548|NCT02039674|40310166|FG008|Overall Study|Adverse Event|2|||
16501549|NCT02039674|40310167|FG009|Overall Study|Adverse Event|1|||
16501550|NCT02039674|40310168|FG010|Overall Study|Adverse Event|0|||
16501551|NCT02039674|40310169|FG011|Overall Study|Adverse Event|2|||
16501552|NCT02039674|40310170|FG012|Overall Study|Adverse Event|3|||
16088786|NCT00622700|38816724|FG001|Extension Treatment Period|Missing|0|||
16088787|NCT00622700|38816725|FG002|Extension Treatment Period|Missing|0|||
16088788|NCT00622700|38816726|FG003|Extension Treatment Period|Missing|2|||
16088789|NCT00622700|38816727|FG004|Extension Treatment Period|Missing|3|||
16088790|NCT00622700|38816728|FG005|Extension Treatment Period|Missing|1|||
16088791|NCT00622700|38816729|FG006|Extension Treatment Period|Missing|0|||
16088792|NCT00622700|38816723|FG000|Extension Treatment Period|Other than specified above|0|||
16088793|NCT00622700|38816724|FG001|Extension Treatment Period|Other than specified above|0|||
16088794|NCT00622700|38816725|FG002|Extension Treatment Period|Other than specified above|0|||
16195561|NCT02175771|39193370|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16195562|NCT02175771|39193371|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16501553|NCT02039674|40310171|FG013|Overall Study|Adverse Event|1|||
16501554|NCT02039674|40310158|FG000|Overall Study|Death|2|||
16501555|NCT02039674|40310159|FG001|Overall Study|Death|0|||
16501556|NCT02039674|40310160|FG002|Overall Study|Death|2|||
16501557|NCT02039674|40310161|FG003|Overall Study|Death|3|||
16501558|NCT02039674|40310162|FG004|Overall Study|Death|0|||
16501559|NCT02039674|40310163|FG005|Overall Study|Death|0|||
16501560|NCT02039674|40310164|FG006|Overall Study|Death|1|||
16501561|NCT02039674|40310165|FG007|Overall Study|Death|0|||
16501562|NCT02039674|40310166|FG008|Overall Study|Death|2|||
16501563|NCT02039674|40310167|FG009|Overall Study|Death|0|||
16501564|NCT02039674|40310168|FG010|Overall Study|Death|1|||
16501565|NCT02039674|40310169|FG011|Overall Study|Death|3|||
16501566|NCT02039674|40310170|FG012|Overall Study|Death|2|||
16501567|NCT02039674|40310171|FG013|Overall Study|Death|8|||
16501568|NCT02039674|40310158|FG000|Overall Study|Excluded Medication|1|||
16088795|NCT00622700|38816726|FG003|Extension Treatment Period|Other than specified above|0|||
16088796|NCT00622700|38816727|FG004|Extension Treatment Period|Other than specified above|0|||
16088797|NCT00622700|38816728|FG005|Extension Treatment Period|Other than specified above|1|||
16088798|NCT00622700|38816729|FG006|Extension Treatment Period|Other than specified above|1|||
16088799|NCT01856569|38816730|FG000|Overall Study|Other|1|||
16088800|NCT01856569|38816730|FG000|Overall Study|Changed Site/Structure|1|||
16088801|NCT01856569|38816730|FG000|Overall Study|Lost to Follow-up|3|||
16088802|NCT01856569|38816730|FG000|Overall Study|Did not met inclusion criteria|8|||
16088803|NCT01307800|38816731|FG000|Overall Study|Adverse Event|9|||
16088804|NCT01307800|38816732|FG001|Overall Study|Adverse Event|8|||
16088805|NCT01307800|38816733|FG002|Overall Study|Adverse Event|10|||
16088806|NCT01307800|38816734|FG003|Overall Study|Adverse Event|14|||
16088807|NCT01307800|38816731|FG000|Overall Study|Entry Criteria Not Met|0|||
16088808|NCT01307800|38816732|FG001|Overall Study|Entry Criteria Not Met|0|||
16088809|NCT01307800|38816733|FG002|Overall Study|Entry Criteria Not Met|0|||
16088810|NCT01307800|38816734|FG003|Overall Study|Entry Criteria Not Met|2|||
16088811|NCT01307800|38816731|FG000|Overall Study|Lost to Follow-up|5|||
16088812|NCT01307800|38816732|FG001|Overall Study|Lost to Follow-up|6|||
16088813|NCT01307800|38816733|FG002|Overall Study|Lost to Follow-up|2|||
16088814|NCT01307800|38816734|FG003|Overall Study|Lost to Follow-up|8|||
16088815|NCT01307800|38816731|FG000|Overall Study|Perceived Lack of Efficacy|24|||
16088816|NCT01307800|38816732|FG001|Overall Study|Perceived Lack of Efficacy|23|||
16088817|NCT01307800|38816733|FG002|Overall Study|Perceived Lack of Efficacy|20|||
16088818|NCT01307800|38816734|FG003|Overall Study|Perceived Lack of Efficacy|33|||
16501569|NCT02039674|40310159|FG001|Overall Study|Excluded Medication|1|||
16501570|NCT02039674|40310160|FG002|Overall Study|Excluded Medication|0|||
16501571|NCT02039674|40310161|FG003|Overall Study|Excluded Medication|1|||
16501572|NCT02039674|40310162|FG004|Overall Study|Excluded Medication|0|||
16501573|NCT02039674|40310163|FG005|Overall Study|Excluded Medication|1|||
16501574|NCT02039674|40310164|FG006|Overall Study|Excluded Medication|0|||
16501575|NCT02039674|40310165|FG007|Overall Study|Excluded Medication|0|||
16501576|NCT02039674|40310166|FG008|Overall Study|Excluded Medication|2|||
16501577|NCT02039674|40310167|FG009|Overall Study|Excluded Medication|3|||
16501578|NCT02039674|40310168|FG010|Overall Study|Excluded Medication|5|||
16501579|NCT02039674|40310169|FG011|Overall Study|Excluded Medication|6|||
16501580|NCT02039674|40310170|FG012|Overall Study|Excluded Medication|8|||
16501581|NCT02039674|40310171|FG013|Overall Study|Excluded Medication|3|||
16501582|NCT02039674|40310158|FG000|Overall Study|Lost to Follow-up|0|||
16088819|NCT01307800|38816731|FG000|Overall Study|Protocol Violation|0|||
16088820|NCT01307800|38816732|FG001|Overall Study|Protocol Violation|3|||
16195563|NCT02175771|39193372|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16195564|NCT02175771|39193373|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16195565|NCT02175771|39193374|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16195566|NCT02175771|39193375|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16195567|NCT02175771|39193376|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16195568|NCT02175771|39193368|FG000|Run-In Period (Pre-assignment)|Other|8|||
16195569|NCT02175771|39193369|FG001|Run-In Period (Pre-assignment)|Other|0|||
16195570|NCT02175771|39193370|FG002|Run-In Period (Pre-assignment)|Other|0|||
16195571|NCT02175771|39193371|FG003|Run-In Period (Pre-assignment)|Other|0|||
16195572|NCT02175771|39193372|FG004|Run-In Period (Pre-assignment)|Other|0|||
16195573|NCT02175771|39193373|FG005|Run-In Period (Pre-assignment)|Other|0|||
16195574|NCT02175771|39193374|FG006|Run-In Period (Pre-assignment)|Other|0|||
16195575|NCT02175771|39193375|FG007|Run-In Period (Pre-assignment)|Other|0|||
16195576|NCT02175771|39193376|FG008|Run-In Period (Pre-assignment)|Other|0|||
16195577|NCT02175771|39193368|FG000|Treatment Period|Adverse Event|0|||
16195578|NCT02175771|39193369|FG001|Treatment Period|Adverse Event|2|||
16195579|NCT02175771|39193370|FG002|Treatment Period|Adverse Event|1|||
16195580|NCT02175771|39193371|FG003|Treatment Period|Adverse Event|1|||
16195581|NCT02175771|39193372|FG004|Treatment Period|Adverse Event|1|||
16195582|NCT02175771|39193373|FG005|Treatment Period|Adverse Event|3|||
16195583|NCT02175771|39193374|FG006|Treatment Period|Adverse Event|2|||
16195584|NCT02175771|39193375|FG007|Treatment Period|Adverse Event|0|||
16088821|NCT01307800|38816733|FG002|Overall Study|Protocol Violation|4|||
16088822|NCT01307800|38816734|FG003|Overall Study|Protocol Violation|5|||
16088823|NCT01307800|38816731|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
16088824|NCT01307800|38816732|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
16195585|NCT02175771|39193376|FG008|Treatment Period|Adverse Event|1|||
16195586|NCT02175771|39193368|FG000|Treatment Period|Withdrawal by Subject|0|||
16195587|NCT02175771|39193369|FG001|Treatment Period|Withdrawal by Subject|9|||
16088825|NCT01307800|38816733|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
16088826|NCT01307800|38816734|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
16088827|NCT01307800|38816731|FG000|Overall Study|Sponsor Decision|6|||
16195588|NCT02175771|39193370|FG002|Treatment Period|Withdrawal by Subject|3|||
16501583|NCT02039674|40310159|FG001|Overall Study|Lost to Follow-up|0|||
16501584|NCT02039674|40310160|FG002|Overall Study|Lost to Follow-up|0|||
16501585|NCT02039674|40310161|FG003|Overall Study|Lost to Follow-up|0|||
16501586|NCT02039674|40310162|FG004|Overall Study|Lost to Follow-up|1|||
16501587|NCT02039674|40310163|FG005|Overall Study|Lost to Follow-up|1|||
16501588|NCT02039674|40310164|FG006|Overall Study|Lost to Follow-up|0|||
16501589|NCT02039674|40310165|FG007|Overall Study|Lost to Follow-up|0|||
16501590|NCT02039674|40310166|FG008|Overall Study|Lost to Follow-up|0|||
16501591|NCT02039674|40310167|FG009|Overall Study|Lost to Follow-up|0|||
16501592|NCT02039674|40310168|FG010|Overall Study|Lost to Follow-up|0|||
16501593|NCT02039674|40310169|FG011|Overall Study|Lost to Follow-up|2|||
16501594|NCT02039674|40310170|FG012|Overall Study|Lost to Follow-up|2|||
16501595|NCT02039674|40310171|FG013|Overall Study|Lost to Follow-up|1|||
16501596|NCT02039674|40310158|FG000|Overall Study|Physician Decision|0|||
16501597|NCT02039674|40310159|FG001|Overall Study|Physician Decision|0|||
16501598|NCT02039674|40310160|FG002|Overall Study|Physician Decision|0|||
16501599|NCT02039674|40310161|FG003|Overall Study|Physician Decision|0|||
16501600|NCT02039674|40310162|FG004|Overall Study|Physician Decision|0|||
16501601|NCT02039674|40310163|FG005|Overall Study|Physician Decision|0|||
16501602|NCT02039674|40310164|FG006|Overall Study|Physician Decision|0|||
16501603|NCT02039674|40310165|FG007|Overall Study|Physician Decision|0|||
16501604|NCT02039674|40310166|FG008|Overall Study|Physician Decision|0|||
16501605|NCT02039674|40310167|FG009|Overall Study|Physician Decision|0|||
16501606|NCT02039674|40310168|FG010|Overall Study|Physician Decision|0|||
16501607|NCT02039674|40310169|FG011|Overall Study|Physician Decision|1|||
16501608|NCT02039674|40310170|FG012|Overall Study|Physician Decision|1|||
16501609|NCT02039674|40310171|FG013|Overall Study|Physician Decision|0|||
16501610|NCT02039674|40310158|FG000|Overall Study|Progressive Disease|8|||
16501611|NCT02039674|40310159|FG001|Overall Study|Progressive Disease|8|||
16501612|NCT02039674|40310160|FG002|Overall Study|Progressive Disease|6|||
16501613|NCT02039674|40310161|FG003|Overall Study|Progressive Disease|7|||
16501614|NCT02039674|40310162|FG004|Overall Study|Progressive Disease|9|||
16501615|NCT02039674|40310163|FG005|Overall Study|Progressive Disease|10|||
16501616|NCT02039674|40310164|FG006|Overall Study|Progressive Disease|1|||
16501617|NCT02039674|40310165|FG007|Overall Study|Progressive Disease|3|||
16501618|NCT02039674|40310166|FG008|Overall Study|Progressive Disease|6|||
16501619|NCT02039674|40310167|FG009|Overall Study|Progressive Disease|4|||
16501620|NCT02039674|40310168|FG010|Overall Study|Progressive Disease|0|||
16501621|NCT02039674|40310169|FG011|Overall Study|Progressive Disease|34|||
16501622|NCT02039674|40310170|FG012|Overall Study|Progressive Disease|34|||
16501623|NCT02039674|40310171|FG013|Overall Study|Progressive Disease|18|||
16501624|NCT02039674|40310158|FG000|Overall Study|Withdrawal by Subject|1|||
16501625|NCT02039674|40310159|FG001|Overall Study|Withdrawal by Subject|2|||
16501626|NCT02039674|40310160|FG002|Overall Study|Withdrawal by Subject|3|||
16501627|NCT02039674|40310161|FG003|Overall Study|Withdrawal by Subject|0|||
16501628|NCT02039674|40310162|FG004|Overall Study|Withdrawal by Subject|1|||
16501629|NCT02039674|40310163|FG005|Overall Study|Withdrawal by Subject|0|||
16501630|NCT02039674|40310164|FG006|Overall Study|Withdrawal by Subject|0|||
16501631|NCT02039674|40310165|FG007|Overall Study|Withdrawal by Subject|0|||
16501632|NCT02039674|40310166|FG008|Overall Study|Withdrawal by Subject|0|||
16501633|NCT02039674|40310167|FG009|Overall Study|Withdrawal by Subject|1|||
16501634|NCT02039674|40310168|FG010|Overall Study|Withdrawal by Subject|1|||
16501635|NCT02039674|40310169|FG011|Overall Study|Withdrawal by Subject|4|||
16501636|NCT02039674|40310170|FG012|Overall Study|Withdrawal by Subject|6|||
16501637|NCT02039674|40310171|FG013|Overall Study|Withdrawal by Subject|2|||
16501638|NCT02039674|40310158|FG000|Overall Study|Clinical Progression|0|||
16501639|NCT02039674|40310159|FG001|Overall Study|Clinical Progression|0|||
16501640|NCT02039674|40310160|FG002|Overall Study|Clinical Progression|0|||
16501641|NCT02039674|40310161|FG003|Overall Study|Clinical Progression|0|||
16501642|NCT02039674|40310162|FG004|Overall Study|Clinical Progression|0|||
16501643|NCT02039674|40310163|FG005|Overall Study|Clinical Progression|0|||
16501644|NCT02039674|40310164|FG006|Overall Study|Clinical Progression|1|||
16501645|NCT02039674|40310165|FG007|Overall Study|Clinical Progression|0|||
16501646|NCT02039674|40310166|FG008|Overall Study|Clinical Progression|0|||
16501647|NCT02039674|40310167|FG009|Overall Study|Clinical Progression|0|||
16501648|NCT02039674|40310168|FG010|Overall Study|Clinical Progression|0|||
16501649|NCT02039674|40310169|FG011|Overall Study|Clinical Progression|0|||
16501650|NCT02039674|40310170|FG012|Overall Study|Clinical Progression|1|||
16501651|NCT02039674|40310171|FG013|Overall Study|Clinical Progression|0|||
16501652|NCT02039674|40310158|FG000|Overall Study|Sponsor Decision|1|||
16501653|NCT02039674|40310159|FG001|Overall Study|Sponsor Decision|1|||
16501654|NCT02039674|40310160|FG002|Overall Study|Sponsor Decision|1|||
16501655|NCT02039674|40310161|FG003|Overall Study|Sponsor Decision|1|||
16501656|NCT02039674|40310162|FG004|Overall Study|Sponsor Decision|1|||
16389919|NCT02820844|39911853|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
16088828|NCT01307800|38816732|FG001|Overall Study|Sponsor Decision|9|||
16088829|NCT01307800|38816733|FG002|Overall Study|Sponsor Decision|12|||
16088830|NCT01307800|38816734|FG003|Overall Study|Sponsor Decision|28|||
16088831|NCT01307800|38816731|FG000|Overall Study|Withdrawal by Subject|10|||
16088832|NCT01307800|38816732|FG001|Overall Study|Withdrawal by Subject|11|||
16088833|NCT01307800|38816733|FG002|Overall Study|Withdrawal by Subject|8|||
16088834|NCT01307800|38816734|FG003|Overall Study|Withdrawal by Subject|15|||
16088835|NCT01307800|38816731|FG000|Overall Study|Participant Moved|0|||
16088836|NCT01307800|38816732|FG001|Overall Study|Participant Moved|2|||
16088837|NCT01307800|38816733|FG002|Overall Study|Participant Moved|1|||
16088838|NCT01307800|38816734|FG003|Overall Study|Participant Moved|3|||
16389920|NCT02820844|39911854|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
16389921|NCT02820844|39911855|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
16389922|NCT02820844|39911856|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
16088839|NCT01989104|38816735|FG000|Overall Study|Withdrawal by Subject|3|||
16088840|NCT01989104|38816736|FG001|Overall Study|Withdrawal by Subject|0|||
16088841|NCT01989104|38816737|FG002|Overall Study|Withdrawal by Subject|0|||
16088842|NCT01989104|38816738|FG003|Overall Study|Withdrawal by Subject|0|||
16389923|NCT02820844|39911851|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
16389924|NCT02820844|39911852|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
16389925|NCT02820844|39911853|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
16501657|NCT02039674|40310163|FG005|Overall Study|Sponsor Decision|0|||
16501658|NCT02039674|40310164|FG006|Overall Study|Sponsor Decision|0|||
16501659|NCT02039674|40310165|FG007|Overall Study|Sponsor Decision|0|||
16501660|NCT02039674|40310166|FG008|Overall Study|Sponsor Decision|0|||
16501661|NCT02039674|40310167|FG009|Overall Study|Sponsor Decision|3|||
16501662|NCT02039674|40310168|FG010|Overall Study|Sponsor Decision|0|||
16501663|NCT02039674|40310169|FG011|Overall Study|Sponsor Decision|8|||
16501664|NCT02039674|40310170|FG012|Overall Study|Sponsor Decision|5|||
16501665|NCT02039674|40310171|FG013|Overall Study|Sponsor Decision|0|||
16501666|NCT02039674|40310158|FG000|Overall Study|Other|0|||
16501667|NCT02039674|40310159|FG001|Overall Study|Other|0|||
16501668|NCT02039674|40310160|FG002|Overall Study|Other|0|||
16389926|NCT02820844|39911854|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
16389927|NCT02820844|39911855|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
16501669|NCT02039674|40310161|FG003|Overall Study|Other|0|||
16501670|NCT02039674|40310162|FG004|Overall Study|Other|0|||
16501671|NCT02039674|40310163|FG005|Overall Study|Other|0|||
16501672|NCT02039674|40310164|FG006|Overall Study|Other|0|||
16501673|NCT02039674|40310165|FG007|Overall Study|Other|0|||
16501674|NCT02039674|40310166|FG008|Overall Study|Other|0|||
16501675|NCT02039674|40310167|FG009|Overall Study|Other|0|||
16501676|NCT02039674|40310168|FG010|Overall Study|Other|0|||
16501677|NCT02039674|40310169|FG011|Overall Study|Other|0|||
16501678|NCT02039674|40310170|FG012|Overall Study|Other|1|||
16501679|NCT02039674|40310171|FG013|Overall Study|Other|0|||
16501680|NCT00811577|40310174|FG000|Overall Study|Lost to Follow-up|7|||
16389928|NCT02820844|39911856|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
16389929|NCT02820844|39911851|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
16501681|NCT00811577|40310175|FG001|Overall Study|Lost to Follow-up|1|||
16501682|NCT00811577|40310174|FG000|Overall Study|Withdrawal by Subject|3|||
16501683|NCT00811577|40310175|FG001|Overall Study|Withdrawal by Subject|0|||
16501684|NCT02432846|40310176|FG000|Overall Study (4 Arms/Strata)|Death|3|||
16501685|NCT02432846|40310177|FG001|Overall Study (4 Arms/Strata)|Death|2|||
16501686|NCT02432846|40310178|FG002|Overall Study (4 Arms/Strata)|Death|4|||
16501687|NCT02432846|40310179|FG003|Overall Study (4 Arms/Strata)|Death|3|||
16501688|NCT02432846|40310180|FG004|Overall Study (4 Arms/Strata)|Death|0|||
16501689|NCT02432846|40310181|FG005|Overall Study (4 Arms/Strata)|Death|0|||
16501690|NCT02432846|40310176|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
16501691|NCT02432846|40310177|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
16501692|NCT02432846|40310178|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
16501693|NCT02432846|40310179|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
16389930|NCT02820844|39911852|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
16389931|NCT02820844|39911853|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
16389932|NCT02820844|39911854|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
16389933|NCT02820844|39911855|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
16389934|NCT02820844|39911856|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
16389935|NCT02820844|39911851|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
16389936|NCT02820844|39911852|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
16389937|NCT02820844|39911853|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
16088843|NCT01989104|38816739|FG004|Overall Study|Withdrawal by Subject|0|||
16088844|NCT00512252|38816740|FG000|Overall Study|Lost to Follow-up|0|||
16389938|NCT02820844|39911854|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
16389939|NCT02820844|39911855|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
16389940|NCT02820844|39911856|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
16389941|NCT02820844|39911851|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
16389942|NCT02820844|39911852|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
16389943|NCT02820844|39911853|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
16389944|NCT02820844|39911854|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
16389945|NCT02820844|39911855|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
16389946|NCT02820844|39911856|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
16389947|NCT02820844|39911851|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
16389948|NCT02820844|39911852|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
16389949|NCT02820844|39911853|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
16389950|NCT02820844|39911854|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
16389951|NCT02820844|39911855|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
16389952|NCT02820844|39911856|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
16389953|NCT02820844|39911851|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
16389954|NCT02820844|39911852|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
16389955|NCT02820844|39911853|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
16389956|NCT02820844|39911854|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
16501694|NCT02432846|40310180|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
16501695|NCT02432846|40310181|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
16501696|NCT02432846|40310176|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
16501697|NCT02432846|40310177|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
16501698|NCT02432846|40310178|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
16501699|NCT02432846|40310179|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
16501700|NCT02432846|40310180|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
16501701|NCT02432846|40310181|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
16389957|NCT02820844|39911855|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
16389958|NCT02820844|39911856|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
16389959|NCT02820844|39911851|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
16501702|NCT02432846|40310176|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
16501703|NCT02432846|40310177|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
16501704|NCT02432846|40310178|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
16501705|NCT02432846|40310179|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
16501706|NCT02432846|40310180|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
16501707|NCT02432846|40310181|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
16501708|NCT02432846|40310176|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
16501709|NCT02432846|40310177|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
16501710|NCT02432846|40310178|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
16501711|NCT02432846|40310179|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
16389960|NCT02820844|39911852|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
16389961|NCT02820844|39911853|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
16389962|NCT02820844|39911854|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
16389963|NCT02820844|39911855|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
16195589|NCT02175771|39193371|FG003|Treatment Period|Withdrawal by Subject|6|||
16195590|NCT02175771|39193372|FG004|Treatment Period|Withdrawal by Subject|2|||
16195591|NCT02175771|39193373|FG005|Treatment Period|Withdrawal by Subject|4|||
16195592|NCT02175771|39193374|FG006|Treatment Period|Withdrawal by Subject|2|||
16195593|NCT02175771|39193375|FG007|Treatment Period|Withdrawal by Subject|9|||
16195594|NCT02175771|39193376|FG008|Treatment Period|Withdrawal by Subject|2|||
16195595|NCT02175771|39193368|FG000|Treatment Period|Noncompliance|0|||
16195596|NCT02175771|39193369|FG001|Treatment Period|Noncompliance|1|||
16195597|NCT02175771|39193370|FG002|Treatment Period|Noncompliance|2|||
16195598|NCT02175771|39193371|FG003|Treatment Period|Noncompliance|0|||
16195599|NCT02175771|39193372|FG004|Treatment Period|Noncompliance|0|||
16195600|NCT02175771|39193373|FG005|Treatment Period|Noncompliance|0|||
16195601|NCT02175771|39193374|FG006|Treatment Period|Noncompliance|0|||
16195602|NCT02175771|39193375|FG007|Treatment Period|Noncompliance|0|||
16195603|NCT02175771|39193376|FG008|Treatment Period|Noncompliance|1|||
16501712|NCT02432846|40310180|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
16501713|NCT02432846|40310181|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
16501714|NCT02432846|40310176|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
16501715|NCT02432846|40310177|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
16501716|NCT02432846|40310178|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
16501717|NCT02432846|40310179|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
16501718|NCT02432846|40310180|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
16501719|NCT02432846|40310181|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
16501720|NCT02432846|40310176|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
16501721|NCT02432846|40310177|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
16501722|NCT02432846|40310178|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
16501723|NCT02432846|40310179|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
16501724|NCT02432846|40310180|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
16501725|NCT02432846|40310181|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
16501726|NCT02432846|40310176|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
16501727|NCT02432846|40310177|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
16195604|NCT02175771|39193368|FG000|Treatment Period|Protocol Violation|0|||
16195605|NCT02175771|39193369|FG001|Treatment Period|Protocol Violation|0|||
16389964|NCT02820844|39911856|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
16389965|NCT02820844|39911851|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
16389966|NCT02820844|39911852|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
16389967|NCT02820844|39911853|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
16389968|NCT02820844|39911854|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
16195606|NCT02175771|39193370|FG002|Treatment Period|Protocol Violation|0|||
16195607|NCT02175771|39193371|FG003|Treatment Period|Protocol Violation|0|||
16389969|NCT02820844|39911855|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
16389970|NCT02820844|39911856|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
16501728|NCT02432846|40310178|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
16501729|NCT02432846|40310179|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
16389971|NCT01466491|39911857|FG000|Overall Study|Protocol Violation|0|||
16389972|NCT01466491|39911858|FG001|Overall Study|Protocol Violation|3|||
16389973|NCT01466491|39911859|FG002|Overall Study|Protocol Violation|2|||
16501730|NCT02432846|40310180|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
16501731|NCT02432846|40310181|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
16501732|NCT02432846|40310176|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
16195608|NCT02175771|39193372|FG004|Treatment Period|Protocol Violation|0|||
16389974|NCT01466491|39911860|FG003|Overall Study|Protocol Violation|0|||
16088845|NCT00512252|38816741|FG001|Overall Study|Lost to Follow-up|0|||
16501733|NCT02432846|40310177|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
16501734|NCT02432846|40310178|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
16501735|NCT02432846|40310179|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
16501736|NCT02432846|40310180|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
16501737|NCT02432846|40310181|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
16501738|NCT02432846|40310176|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
16501739|NCT02432846|40310177|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
16501740|NCT02432846|40310178|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
16501741|NCT02432846|40310179|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
16501742|NCT02432846|40310180|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
16501743|NCT02432846|40310181|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
16501744|NCT02432846|40310176|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
16501745|NCT02432846|40310177|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
16501746|NCT02432846|40310178|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
16501747|NCT02432846|40310179|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
16501748|NCT02432846|40310180|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
16501749|NCT02432846|40310181|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
16501750|NCT02432846|40310176|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
16501751|NCT02432846|40310177|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
16501752|NCT02432846|40310178|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
16501753|NCT02432846|40310179|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
16389975|NCT01466491|39911857|FG000|Overall Study|Missing Data|0|||
16389976|NCT01466491|39911858|FG001|Overall Study|Missing Data|0|||
16195609|NCT02175771|39193373|FG005|Treatment Period|Protocol Violation|0|||
16195610|NCT02175771|39193374|FG006|Treatment Period|Protocol Violation|0|||
16195611|NCT02175771|39193375|FG007|Treatment Period|Protocol Violation|1|||
16195612|NCT02175771|39193376|FG008|Treatment Period|Protocol Violation|0|||
16389977|NCT01466491|39911859|FG002|Overall Study|Missing Data|1|||
16195613|NCT02175771|39193368|FG000|Treatment Period|Disease progression|0|||
16195614|NCT02175771|39193369|FG001|Treatment Period|Disease progression|0|||
16195615|NCT02175771|39193370|FG002|Treatment Period|Disease progression|0|||
16195616|NCT02175771|39193371|FG003|Treatment Period|Disease progression|0|||
16195617|NCT02175771|39193372|FG004|Treatment Period|Disease progression|0|||
16195618|NCT02175771|39193373|FG005|Treatment Period|Disease progression|0|||
16195619|NCT02175771|39193374|FG006|Treatment Period|Disease progression|0|||
16195620|NCT02175771|39193375|FG007|Treatment Period|Disease progression|2|||
16195621|NCT02175771|39193376|FG008|Treatment Period|Disease progression|0|||
16195622|NCT02175771|39193368|FG000|Treatment Period|Lost to Follow-up|0|||
16310306|NCT02847260|39619306|FG000|Overall Study|Withdrawal by Subject|2|||
16310307|NCT02847260|39619306|FG000|Overall Study|Clinical Deterioration|1|||
16310308|NCT02847260|39619306|FG000|Overall Study|Physician Decision|1|||
16310309|NCT00991887|39619307|FG000|Overall Study|Lost to Follow-up|2|||
16310310|NCT00991887|39619308|FG001|Overall Study|Lost to Follow-up|1|||
16310311|NCT01147068|39619309|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
16310312|NCT01147068|39619310|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
16310313|NCT01147068|39619311|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
16310314|NCT01147068|39619312|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
16310315|NCT01147068|39619313|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
16310316|NCT01147068|39619314|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
16310317|NCT01147068|39619315|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
16310318|NCT01147068|39619309|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
16310319|NCT01147068|39619310|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
16310320|NCT01147068|39619311|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
16310321|NCT01147068|39619312|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
16310322|NCT01147068|39619313|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
16310323|NCT01147068|39619314|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
16310324|NCT01147068|39619315|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
16310325|NCT01147068|39619309|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
16310326|NCT01147068|39619310|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
16310327|NCT01147068|39619311|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
16310328|NCT01147068|39619312|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
16310329|NCT01147068|39619313|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
16310330|NCT01147068|39619314|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
16310331|NCT01147068|39619315|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
16389978|NCT01466491|39911860|FG003|Overall Study|Missing Data|0|||
16310332|NCT01147068|39619309|FG000|Subjects That Received 2nd Dose|Other|0|||
16310333|NCT01147068|39619310|FG001|Subjects That Received 2nd Dose|Other|3|||
16389979|NCT02240121|39911863|FG000|Overall Study|Protocol Violation|1|||
16195623|NCT02175771|39193369|FG001|Treatment Period|Lost to Follow-up|3|||
16195624|NCT02175771|39193370|FG002|Treatment Period|Lost to Follow-up|1|||
16195625|NCT02175771|39193371|FG003|Treatment Period|Lost to Follow-up|3|||
16195626|NCT02175771|39193372|FG004|Treatment Period|Lost to Follow-up|1|||
16195627|NCT02175771|39193373|FG005|Treatment Period|Lost to Follow-up|2|||
16195628|NCT02175771|39193374|FG006|Treatment Period|Lost to Follow-up|1|||
16195629|NCT02175771|39193375|FG007|Treatment Period|Lost to Follow-up|2|||
16195630|NCT02175771|39193376|FG008|Treatment Period|Lost to Follow-up|2|||
16195631|NCT02175771|39193368|FG000|Treatment Period|Lack of Efficacy|0|||
16195632|NCT02175771|39193369|FG001|Treatment Period|Lack of Efficacy|0|||
16195633|NCT02175771|39193370|FG002|Treatment Period|Lack of Efficacy|0|||
16195634|NCT02175771|39193371|FG003|Treatment Period|Lack of Efficacy|0|||
16195635|NCT02175771|39193372|FG004|Treatment Period|Lack of Efficacy|0|||
16195636|NCT02175771|39193373|FG005|Treatment Period|Lack of Efficacy|1|||
16310334|NCT01147068|39619311|FG002|Subjects That Received 2nd Dose|Other|3|||
16310335|NCT01147068|39619312|FG003|Subjects That Received 2nd Dose|Other|0|||
16310336|NCT01147068|39619313|FG004|Subjects That Received 2nd Dose|Other|1|||
16310337|NCT01147068|39619314|FG005|Subjects That Received 2nd Dose|Other|0|||
16310338|NCT01147068|39619315|FG006|Subjects That Received 2nd Dose|Other|0|||
16310339|NCT01147068|39619309|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
16310340|NCT01147068|39619310|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
16310341|NCT01147068|39619311|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
16310342|NCT01147068|39619312|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
16310343|NCT01147068|39619313|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
16310344|NCT01147068|39619314|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
16310345|NCT01147068|39619315|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
16501754|NCT02432846|40310180|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
16501755|NCT02432846|40310181|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
16501756|NCT02432846|40310176|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
16501757|NCT02432846|40310177|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
16310346|NCT01147068|39619309|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16310347|NCT01147068|39619310|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16310348|NCT01147068|39619311|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16310349|NCT01147068|39619312|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
16310350|NCT01147068|39619313|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16310351|NCT01147068|39619314|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16310352|NCT01147068|39619315|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
16310353|NCT01147068|39619309|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
16310354|NCT01147068|39619310|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
16310355|NCT01147068|39619311|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
16310356|NCT01147068|39619312|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
16310357|NCT01147068|39619313|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
16389980|NCT02240121|39911864|FG001|Overall Study|Protocol Violation|2|||
16389981|NCT02240121|39911863|FG000|Overall Study|Physician Decision|0|||
16389982|NCT02240121|39911864|FG001|Overall Study|Physician Decision|1|||
16389983|NCT02240121|39911863|FG000|Overall Study|Change in protocol interpretation|1|||
16389984|NCT02240121|39911864|FG001|Overall Study|Change in protocol interpretation|0|||
16389985|NCT02240121|39911863|FG000|Overall Study|Lack of Efficacy|2|||
16389986|NCT02240121|39911864|FG001|Overall Study|Lack of Efficacy|3|||
16389987|NCT02240121|39911863|FG000|Overall Study|Site closed|1|||
16389988|NCT02240121|39911864|FG001|Overall Study|Site closed|1|||
16389989|NCT02240121|39911863|FG000|Overall Study|Pregnancy|1|||
16501758|NCT02432846|40310178|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
16501759|NCT02432846|40310179|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
16501760|NCT02432846|40310180|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
16501761|NCT02432846|40310181|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
16501762|NCT02432846|40310176|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
16501763|NCT02432846|40310177|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
16501764|NCT02432846|40310178|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
16501765|NCT02432846|40310179|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
16501766|NCT02432846|40310180|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
16501767|NCT02432846|40310181|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
16501768|NCT00411645|40310182|FG000|Overall Study|Consent Withdrawn|13|||
16501769|NCT00411645|40310183|FG001|Overall Study|Consent Withdrawn|22|||
16501770|NCT00411645|40310182|FG000|Overall Study|Death|56|||
16501771|NCT00411645|40310183|FG001|Overall Study|Death|135|||
16501772|NCT00411645|40310182|FG000|Overall Study|Investigator/Sponsor Decision|10|||
16195637|NCT02175771|39193374|FG006|Treatment Period|Lack of Efficacy|0|||
16195638|NCT02175771|39193375|FG007|Treatment Period|Lack of Efficacy|1|||
16195639|NCT02175771|39193376|FG008|Treatment Period|Lack of Efficacy|0|||
16195640|NCT02175771|39193368|FG000|Treatment Period|Other|0|||
16195641|NCT02175771|39193369|FG001|Treatment Period|Other|1|||
16195642|NCT02175771|39193370|FG002|Treatment Period|Other|0|||
16195643|NCT02175771|39193371|FG003|Treatment Period|Other|3|||
16195644|NCT02175771|39193372|FG004|Treatment Period|Other|1|||
16195645|NCT02175771|39193373|FG005|Treatment Period|Other|0|||
16195646|NCT02175771|39193374|FG006|Treatment Period|Other|0|||
16195647|NCT02175771|39193375|FG007|Treatment Period|Other|2|||
16195648|NCT02175771|39193376|FG008|Treatment Period|Other|0|||
16195649|NCT01658579|39193377|FG000|Treatment Period A|Other|0|||
16195650|NCT01658579|39193378|FG001|Treatment Period A|Other|0|||
16195651|NCT01658579|39193379|FG002|Treatment Period A|Other|1|||
16195652|NCT01658579|39193380|FG003|Treatment Period A|Other|1|||
16195653|NCT01658579|39193377|FG000|Treatment Period A|Adverse Event|1|||
16195654|NCT01658579|39193378|FG001|Treatment Period A|Adverse Event|0|||
16195655|NCT01658579|39193379|FG002|Treatment Period A|Adverse Event|0|||
16195656|NCT01658579|39193380|FG003|Treatment Period A|Adverse Event|0|||
16195657|NCT01658579|39193377|FG000|Treatment Period B|Other|0|||
16195658|NCT01658579|39193378|FG001|Treatment Period B|Other|0|||
16195659|NCT01658579|39193379|FG002|Treatment Period B|Other|0|||
16195660|NCT01658579|39193380|FG003|Treatment Period B|Other|1|||
16195661|NCT03288493|39193385|FG000|Overall Study|Withdrawal by Subject|4|||
16195662|NCT03288493|39193386|FG001|Overall Study|Withdrawal by Subject|0|||
16195663|NCT03288493|39193387|FG002|Overall Study|Withdrawal by Subject|0|||
16195664|NCT03288493|39193388|FG003|Overall Study|Withdrawal by Subject|0|||
16195665|NCT03288493|39193389|FG004|Overall Study|Withdrawal by Subject|0|||
16195666|NCT03288493|39193390|FG005|Overall Study|Withdrawal by Subject|2|||
16501773|NCT00411645|40310183|FG001|Overall Study|Investigator/Sponsor Decision|7|||
16195667|NCT03288493|39193391|FG006|Overall Study|Withdrawal by Subject|0|||
16195668|NCT03288493|39193385|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
16195669|NCT03288493|39193386|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
16195670|NCT03288493|39193387|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
16195671|NCT03288493|39193388|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
16195672|NCT03288493|39193389|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
16195673|NCT03288493|39193390|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
16195674|NCT03288493|39193391|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
16195675|NCT03288493|39193385|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
16195676|NCT03288493|39193386|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
16195677|NCT03288493|39193387|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
16195678|NCT03288493|39193388|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
16195679|NCT03288493|39193389|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
16195680|NCT03288493|39193390|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
16310358|NCT01147068|39619314|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
16310359|NCT01147068|39619315|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
16310360|NCT02553772|39619329|FG000|Overall Study|Adverse Event|2|||
16310361|NCT02553772|39619330|FG001|Overall Study|Adverse Event|3|||
16310362|NCT02553772|39619329|FG000|Overall Study|Lost to Follow-up|2|||
16310363|NCT02553772|39619330|FG001|Overall Study|Lost to Follow-up|1|||
16310364|NCT02553772|39619329|FG000|Overall Study|Withdrawal of Consent|1|||
16310365|NCT02553772|39619330|FG001|Overall Study|Withdrawal of Consent|1|||
16310366|NCT02553772|39619329|FG000|Overall Study|Lack of Efficacy|1|||
16310367|NCT02553772|39619330|FG001|Overall Study|Lack of Efficacy|0|||
16310368|NCT02553772|39619329|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16310369|NCT02553772|39619330|FG001|Overall Study|Other Miscellaneous Reasons|1|||
16310370|NCT00916383|39619334|FG000|Overall Study|Adverse Event|1|||
16310371|NCT00916383|39619334|FG000|Overall Study|Death|1|||
16310372|NCT00916383|39619334|FG000|Overall Study|Protocol Violation|1|||
16310373|NCT02152137|39619335|FG000|Overall Study|Withdrawal by Subject|1|||
16501774|NCT00411645|40310182|FG000|Overall Study|Lost to Follow-up|2|||
16501775|NCT00411645|40310183|FG001|Overall Study|Lost to Follow-up|0|||
16501776|NCT02276872|40310185|FG000|Overall Study|Adverse Event|1|||
16501777|NCT02276872|40310186|FG001|Overall Study|Adverse Event|0|||
16501778|NCT02276872|40310187|FG002|Overall Study|Adverse Event|0|||
16501779|NCT00022633|40310188|FG000|Overall Study|Adverse Event|11|||
16088846|NCT00512252|38816742|FG002|Overall Study|Lost to Follow-up|1|||
16310374|NCT02152137|39619335|FG000|Overall Study|Originally assigned to Arm B|3|||
16310375|NCT02501928|39619336|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
16389990|NCT02240121|39911864|FG001|Overall Study|Pregnancy|0|||
16501780|NCT00022633|40310189|FG001|Overall Study|Adverse Event|1|||
16501781|NCT00022633|40310188|FG000|Overall Study|Refusal unrelated to adverse event|1|||
16389991|NCT02240121|39911863|FG000|Overall Study|Adverse Event|2|||
16389992|NCT02240121|39911864|FG001|Overall Study|Adverse Event|4|||
16389993|NCT02240121|39911863|FG000|Overall Study|Withdrawal by Subject|6|||
16501782|NCT00022633|40310189|FG001|Overall Study|Refusal unrelated to adverse event|0|||
16501783|NCT00022633|40310188|FG000|Overall Study|Progression/relapse|9|||
16501784|NCT00022633|40310189|FG001|Overall Study|Progression/relapse|2|||
16501785|NCT00022633|40310188|FG000|Overall Study|Death|4|||
16501786|NCT00022633|40310189|FG001|Overall Study|Death|0|||
16501787|NCT00022633|40310188|FG000|Overall Study|Other - not protocol specified|3|||
16501788|NCT00022633|40310189|FG001|Overall Study|Other - not protocol specified|2|||
16501789|NCT00022633|40310188|FG000|Overall Study|Ineligible|4|||
16501790|NCT00022633|40310189|FG001|Overall Study|Ineligible|0|||
16501791|NCT02424383|40310190|FG000|Overall Study|Withdrawal by Subject|32|||
16501792|NCT02424383|40310190|FG000|Overall Study|Death|170|||
16501793|NCT02424383|40310190|FG000|Overall Study|Sponsor's decision|3|||
16501794|NCT02424383|40310190|FG000|Overall Study|Investigator's decision|44|||
16501795|NCT02424383|40310190|FG000|Overall Study|Lost to Follow-up|81|||
16501796|NCT02424383|40310190|FG000|Overall Study|Other|7|||
16501797|NCT02424383|40310190|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
16501798|NCT01710033|40310191|FG000|Stage 2|Adverse Event|0|||
16501799|NCT01710033|40310192|FG001|Stage 2|Adverse Event|0|||
16501800|NCT01710033|40310193|FG002|Stage 2|Adverse Event|0|||
16501801|NCT01710033|40310194|FG003|Stage 2|Adverse Event|0|||
16501802|NCT01710033|40310195|FG004|Stage 2|Adverse Event|1|||
16501803|NCT02005250|40310196|FG000|Overall Study|Lost to Follow-up|15|||
16501804|NCT02005250|40310197|FG001|Overall Study|Lost to Follow-up|5|||
16501805|NCT01275833|40310200|FG000|Overall Study|Study terminated|1|||
16501806|NCT01275833|40310201|FG001|Overall Study|Study terminated|1|||
16501807|NCT01541969|40310202|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
16501808|NCT01541969|40310203|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
16501809|NCT01541969|40310202|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
16088847|NCT00512252|38816740|FG000|Overall Study|Protocol Violation|0|||
16389994|NCT02240121|39911864|FG001|Overall Study|Withdrawal by Subject|2|||
16389995|NCT02240121|39911863|FG000|Overall Study|Lost to Follow-up|3|||
16389996|NCT02240121|39911864|FG001|Overall Study|Lost to Follow-up|4|||
16389997|NCT02240121|39911863|FG000|Overall Study|Other than specified|1|||
16389998|NCT02240121|39911864|FG001|Overall Study|Other than specified|3|||
16389999|NCT01446874|39911865|FG000|Overall Study|Not eligible|1|||
16390000|NCT01446874|39911866|FG001|Overall Study|Not eligible|0|||
16390001|NCT01446874|39911867|FG002|Overall Study|Not eligible|0|||
16390002|NCT01446874|39911865|FG000|Overall Study|No surgery/No qualifying surgery|1|||
16390003|NCT01446874|39911866|FG001|Overall Study|No surgery/No qualifying surgery|0|||
16390004|NCT01446874|39911867|FG002|Overall Study|No surgery/No qualifying surgery|12|||
16390005|NCT01446874|39911865|FG000|Overall Study|Non-compliance|0|||
16390006|NCT01446874|39911866|FG001|Overall Study|Non-compliance|4|||
16390007|NCT01446874|39911867|FG002|Overall Study|Non-compliance|0|||
16390008|NCT01446874|39911865|FG000|Overall Study|Antibiotics for pre-op infection|0|||
16390009|NCT01446874|39911866|FG001|Overall Study|Antibiotics for pre-op infection|0|||
16390010|NCT01446874|39911867|FG002|Overall Study|Antibiotics for pre-op infection|2|||
16390011|NCT01446874|39911865|FG000|Overall Study|Withdrawal by Subject|0|||
16390012|NCT01446874|39911866|FG001|Overall Study|Withdrawal by Subject|0|||
16390013|NCT01446874|39911867|FG002|Overall Study|Withdrawal by Subject|4|||
16390014|NCT04872569|39911874|FG000|Overall Study|Withdrawal by Subject|2|||
16390015|NCT00355368|39911875|FG000|Overall Study|Protocol Violation|8|||
16390016|NCT00355368|39911876|FG001|Overall Study|Protocol Violation|7|||
16390017|NCT00355368|39911875|FG000|Overall Study|cardiac arrest prior to intubation|2|||
16390018|NCT00355368|39911876|FG001|Overall Study|cardiac arrest prior to intubation|2|||
16390019|NCT02850978|39911878|FG000|Overall Study|Uncollectable CRF|27|||
16390020|NCT02850978|39911878|FG000|Overall Study|No visit since the first visit|35|||
16390021|NCT02850978|39911878|FG000|Overall Study|Adverse Event|81|||
16390022|NCT02850978|39911878|FG000|Overall Study|Lack of Efficacy|40|||
16390023|NCT02850978|39911878|FG000|Overall Study|Improvement in condition|34|||
16390024|NCT02850978|39911878|FG000|Overall Study|Lost to Follow-up|121|||
16390025|NCT02850978|39911878|FG000|Overall Study|Reason not listed|88|||
16390026|NCT00506779|39911879|FG000|Overall Study|Withdrawal by Subject|1|||
16501810|NCT01541969|40310203|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
16501811|NCT01541969|40310202|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
16501812|NCT01541969|40310203|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
16501813|NCT01541969|40310202|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
16501814|NCT01541969|40310203|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
16088848|NCT00512252|38816741|FG001|Overall Study|Protocol Violation|0|||
16390027|NCT00506779|39911880|FG001|Overall Study|Withdrawal by Subject|0|||
16501815|NCT01541969|40310202|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
16501816|NCT01541969|40310203|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
16390028|NCT00506779|39911881|FG002|Overall Study|Withdrawal by Subject|1|||
16390029|NCT00506779|39911882|FG003|Overall Study|Withdrawal by Subject|0|||
16390030|NCT00506779|39911879|FG000|Overall Study|Adverse Event|0|||
16390031|NCT00506779|39911880|FG001|Overall Study|Adverse Event|1|||
16390032|NCT00506779|39911881|FG002|Overall Study|Adverse Event|1|||
16390033|NCT00506779|39911882|FG003|Overall Study|Adverse Event|1|||
16390034|NCT03533660|39911883|FG000|Overall Study|Withdrawal by Subject|2|||
16390035|NCT03533660|39911884|FG001|Overall Study|Withdrawal by Subject|2|||
16390036|NCT03533660|39911883|FG000|Overall Study|Death|2|||
16390037|NCT03533660|39911884|FG001|Overall Study|Death|4|||
16390038|NCT03533660|39911883|FG000|Overall Study|Adverse Event|0|||
16390039|NCT03533660|39911884|FG001|Overall Study|Adverse Event|2|||
16390040|NCT03886493|39911887|FG000|Overall Study|Adverse Event|1|||
16390041|NCT01191697|39911891|FG000|Overall Study|Death|1|||
16390042|NCT01191697|39911891|FG000|Overall Study|Physician Decision|2|||
16390043|NCT01191697|39911891|FG000|Overall Study|Pursue chemoradiation|2|||
16390044|NCT01191697|39911891|FG000|Overall Study|Break from chemotherapy|2|||
16390045|NCT01191697|39911891|FG000|Overall Study|Withdrawal by Subject|1|||
16390046|NCT01191697|39911891|FG000|Overall Study|Surveillance|1|||
16390047|NCT01191697|39911891|FG000|Overall Study|Adverse Event|2|||
16390048|NCT01191697|39911891|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
16390049|NCT01191697|39911891|FG000|Overall Study|Not completed but analyzed|25|||
16390050|NCT00790582|39911894|FG000|Overall Study|Death|14|||
16390051|NCT00790582|39911895|FG001|Overall Study|Death|32|||
16390052|NCT00790582|39911894|FG000|Overall Study|Physician Decision|7|||
16390053|NCT00790582|39911895|FG001|Overall Study|Physician Decision|1|||
16390054|NCT00790582|39911894|FG000|Overall Study|Lost to Follow-up|3|||
16390055|NCT00790582|39911895|FG001|Overall Study|Lost to Follow-up|3|||
16501817|NCT01541969|40310202|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
16501818|NCT01541969|40310203|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
16501819|NCT01541969|40310202|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
16501820|NCT01541969|40310203|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
16501821|NCT01541969|40310202|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
16501822|NCT01541969|40310203|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
16501823|NCT01541969|40310202|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
16501824|NCT01541969|40310203|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
16501825|NCT01541969|40310202|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
16501826|NCT01541969|40310203|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
16501827|NCT02320149|40310204|FG000|Overall Study|Adverse Event|3|||
16501828|NCT02320149|40310205|FG001|Overall Study|Adverse Event|7|||
16501829|NCT02320149|40310204|FG000|Overall Study|Withdrawal of Consent|28|||
16501830|NCT02320149|40310205|FG001|Overall Study|Withdrawal of Consent|32|||
16501831|NCT02320149|40310204|FG000|Overall Study|Lost to Follow-up|21|||
16501832|NCT02320149|40310205|FG001|Overall Study|Lost to Follow-up|34|||
16501833|NCT02320149|40310204|FG000|Overall Study|Protocol Violation|2|||
16501834|NCT02320149|40310205|FG001|Overall Study|Protocol Violation|1|||
16501835|NCT02320149|40310204|FG000|Overall Study|Noncompliance with Study Treatment|7|||
16501836|NCT02320149|40310205|FG001|Overall Study|Noncompliance with Study Treatment|2|||
16501837|NCT02320149|40310204|FG000|Overall Study|Lack of Efficacy|0|||
16501838|NCT02320149|40310205|FG001|Overall Study|Lack of Efficacy|1|||
16501839|NCT02320149|40310204|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16501840|NCT02320149|40310205|FG001|Overall Study|Other Miscellaneous Reasons|3|||
16501841|NCT02564042|40310206|FG000|Overall Study|Adverse Event|4|||
16501842|NCT02564042|40310207|FG001|Overall Study|Adverse Event|4|||
16501843|NCT02564042|40310208|FG002|Overall Study|Adverse Event|3|||
16501844|NCT02564042|40310209|FG003|Overall Study|Adverse Event|0|||
16501845|NCT02564042|40310210|FG004|Overall Study|Adverse Event|0|||
16501846|NCT02564042|40310211|FG005|Overall Study|Adverse Event|1|||
16088849|NCT00512252|38816742|FG002|Overall Study|Protocol Violation|1|||
16501847|NCT02564042|40310206|FG000|Overall Study|Lost to Follow-up|1|||
16501848|NCT02564042|40310207|FG001|Overall Study|Lost to Follow-up|1|||
16501849|NCT02564042|40310208|FG002|Overall Study|Lost to Follow-up|1|||
16501850|NCT02564042|40310209|FG003|Overall Study|Lost to Follow-up|0|||
16501851|NCT02564042|40310210|FG004|Overall Study|Lost to Follow-up|1|||
16501852|NCT02564042|40310211|FG005|Overall Study|Lost to Follow-up|1|||
16501853|NCT02564042|40310206|FG000|Overall Study|Physician Decision|1|||
16501854|NCT02564042|40310207|FG001|Overall Study|Physician Decision|0|||
16501855|NCT02564042|40310208|FG002|Overall Study|Physician Decision|0|||
16501856|NCT02564042|40310209|FG003|Overall Study|Physician Decision|1|||
16501857|NCT02564042|40310210|FG004|Overall Study|Physician Decision|0|||
16088850|NCT00512252|38816740|FG000|Overall Study|Death|0|||
16390056|NCT00790582|39911894|FG000|Overall Study|Withdrawal by Subject|7|||
16390057|NCT00790582|39911895|FG001|Overall Study|Withdrawal by Subject|51|||
16501858|NCT02564042|40310211|FG005|Overall Study|Physician Decision|0|||
16501859|NCT02564042|40310206|FG000|Overall Study|Withdrawal by Subject|5|||
16088851|NCT00512252|38816741|FG001|Overall Study|Death|0|||
16390058|NCT02777086|39911897|FG000|Overall Study|Lost to Follow-up|96|||
16390059|NCT02777086|39911898|FG001|Overall Study|Lost to Follow-up|99|||
16501860|NCT02564042|40310207|FG001|Overall Study|Withdrawal by Subject|3|||
16088852|NCT00512252|38816742|FG002|Overall Study|Death|1|||
16088853|NCT04809623|38816743|FG000|Overall Study|Study Terminated by Sponsor|1|||
16088854|NCT04809623|38816744|FG001|Overall Study|Study Terminated by Sponsor|0|||
16088855|NCT01970007|38816745|FG000|Overall Study|Death|5|||
16088856|NCT01970007|38816745|FG000|Overall Study|Withdrawal by Subject|23|||
16088857|NCT01970007|38816745|FG000|Overall Study|Lost to Follow-up|24|||
16088858|NCT01970007|38816745|FG000|Overall Study|"Other endpoint"|3|||
16088859|NCT00786864|38816746|FG000|Overall Study|Lost to Follow-up|0|||
16088860|NCT00786864|38816747|FG001|Overall Study|Lost to Follow-up|1|||
16088861|NCT00786864|38816746|FG000|Overall Study|Sustained serious back injury|1|||
16088862|NCT00786864|38816747|FG001|Overall Study|Sustained serious back injury|0|||
16088863|NCT03345095|38816750|FG000|Overall Study|Lack of Efficacy|184|||
16088864|NCT03345095|38816751|FG001|Overall Study|Lack of Efficacy|156|||
16088865|NCT03345095|38816750|FG000|Overall Study|Adverse Event|36|||
16088866|NCT03345095|38816751|FG001|Overall Study|Adverse Event|118|||
16088867|NCT03345095|38816750|FG000|Overall Study|Withdrawal by Subject|22|||
16088868|NCT03345095|38816751|FG001|Overall Study|Withdrawal by Subject|59|||
16088869|NCT03345095|38816750|FG000|Overall Study|Physician Decision|3|||
16088870|NCT03345095|38816751|FG001|Overall Study|Physician Decision|18|||
16088871|NCT03345095|38816750|FG000|Overall Study|Death|2|||
16088872|NCT03345095|38816751|FG001|Overall Study|Death|4|||
16088873|NCT03345095|38816750|FG000|Overall Study|Other reasons|2|||
16088874|NCT03345095|38816751|FG001|Overall Study|Other reasons|11|||
16088875|NCT03345095|38816750|FG000|Overall Study|Protocol Violation|0|||
16088876|NCT03345095|38816751|FG001|Overall Study|Protocol Violation|1|||
16088877|NCT01662505|38816758|FG000|Overall Study|Progressive disease|6|||
16088878|NCT01662505|38816759|FG001|Overall Study|Progressive disease|1|||
16088879|NCT01662505|38816760|FG002|Overall Study|Progressive disease|5|||
16088880|NCT01662505|38816758|FG000|Overall Study|Refused cont. medication|0|||
16088881|NCT01662505|38816759|FG001|Overall Study|Refused cont. medication|0|||
16088882|NCT01662505|38816760|FG002|Overall Study|Refused cont. medication|1|||
16088883|NCT01662505|38816758|FG000|Overall Study|Not specified above|1|||
16088884|NCT01662505|38816759|FG001|Overall Study|Not specified above|3|||
16088885|NCT01662505|38816760|FG002|Overall Study|Not specified above|2|||
16088886|NCT03340961|38816761|FG000|Overall Study|Adverse Event|1|||
16088887|NCT03340961|38816762|FG001|Overall Study|Adverse Event|3|||
16088888|NCT03340961|38816763|FG002|Overall Study|Adverse Event|2|||
16088889|NCT03340961|38816764|FG003|Overall Study|Adverse Event|4|||
16088890|NCT03340961|38816761|FG000|Overall Study|Lost to Follow-up|0|||
16088891|NCT03340961|38816762|FG001|Overall Study|Lost to Follow-up|1|||
16088892|NCT03340961|38816763|FG002|Overall Study|Lost to Follow-up|0|||
16088893|NCT03340961|38816764|FG003|Overall Study|Lost to Follow-up|1|||
16088894|NCT03340961|38816761|FG000|Overall Study|Withdrawal by Subject|3|||
16088895|NCT03340961|38816762|FG001|Overall Study|Withdrawal by Subject|2|||
16088896|NCT03340961|38816763|FG002|Overall Study|Withdrawal by Subject|4|||
16088897|NCT03340961|38816764|FG003|Overall Study|Withdrawal by Subject|7|||
16088898|NCT03340961|38816761|FG000|Overall Study|Use of prohibited treatment|0|||
16088899|NCT03340961|38816762|FG001|Overall Study|Use of prohibited treatment|3|||
16088900|NCT03340961|38816763|FG002|Overall Study|Use of prohibited treatment|2|||
16088901|NCT03340961|38816764|FG003|Overall Study|Use of prohibited treatment|4|||
16088902|NCT03340961|38816761|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
16088903|NCT03340961|38816762|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
16088904|NCT03340961|38816763|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
16088905|NCT03340961|38816764|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
16088906|NCT03340961|38816761|FG000|Overall Study|Subject developed an exclusion criterion|0|||
16088907|NCT03340961|38816762|FG001|Overall Study|Subject developed an exclusion criterion|1|||
16088908|NCT03340961|38816763|FG002|Overall Study|Subject developed an exclusion criterion|0|||
16088909|NCT03340961|38816764|FG003|Overall Study|Subject developed an exclusion criterion|0|||
16088910|NCT03340961|38816761|FG000|Overall Study|Protocol Violation|1|||
16088911|NCT03340961|38816762|FG001|Overall Study|Protocol Violation|0|||
16088912|NCT03340961|38816763|FG002|Overall Study|Protocol Violation|1|||
16088913|NCT03340961|38816764|FG003|Overall Study|Protocol Violation|0|||
16088914|NCT03340961|38816761|FG000|Overall Study|Adverse Event|1|||
16088915|NCT03340961|38816762|FG001|Overall Study|Adverse Event|1|||
16088916|NCT03340961|38816763|FG002|Overall Study|Adverse Event|0|||
16088917|NCT03340961|38816764|FG003|Overall Study|Adverse Event|0|||
16088918|NCT03340961|38816761|FG000|Overall Study|Lack of Efficacy|0|||
16088919|NCT03340961|38816762|FG001|Overall Study|Lack of Efficacy|0|||
16088920|NCT03340961|38816763|FG002|Overall Study|Lack of Efficacy|0|||
16088921|NCT03340961|38816764|FG003|Overall Study|Lack of Efficacy|1|||
16088922|NCT04183491|38816765|FG000|Overall Study|Withdrawal by Subject|0|||
16088923|NCT04183491|38816766|FG001|Overall Study|Withdrawal by Subject|0|||
16088924|NCT04183491|38816767|FG002|Overall Study|Withdrawal by Subject|1|||
16088925|NCT04183491|38816768|FG003|Overall Study|Withdrawal by Subject|0|||
16088926|NCT04183491|38816769|FG004|Overall Study|Withdrawal by Subject|0|||
16088927|NCT04183491|38816770|FG005|Overall Study|Withdrawal by Subject|1|||
16088928|NCT04183491|38816771|FG006|Overall Study|Withdrawal by Subject|0|||
16088929|NCT00641537|38816772|FG000|96-week Period|Adverse Event|0|||
16088930|NCT00641537|38816773|FG001|96-week Period|Adverse Event|1|||
16088931|NCT00641537|38816774|FG002|96-week Period|Adverse Event|3|||
16088932|NCT00641537|38816775|FG003|96-week Period|Adverse Event|0|||
16088933|NCT00641537|38816776|FG004|96-week Period|Adverse Event|2|||
16088934|NCT00641537|38816777|FG005|96-week Period|Adverse Event|0|||
16088935|NCT00641537|38816778|FG006|96-week Period|Adverse Event|0|||
16088936|NCT00641537|38816779|FG007|96-week Period|Adverse Event|0|||
16088937|NCT00641537|38816772|FG000|96-week Period|Lost to Follow-up|3|||
16088938|NCT00641537|38816773|FG001|96-week Period|Lost to Follow-up|1|||
16088939|NCT00641537|38816774|FG002|96-week Period|Lost to Follow-up|2|||
16088940|NCT00641537|38816775|FG003|96-week Period|Lost to Follow-up|2|||
16088941|NCT00641537|38816776|FG004|96-week Period|Lost to Follow-up|4|||
16088942|NCT00641537|38816777|FG005|96-week Period|Lost to Follow-up|0|||
16088943|NCT00641537|38816778|FG006|96-week Period|Lost to Follow-up|1|||
16501861|NCT02564042|40310208|FG002|Overall Study|Withdrawal by Subject|2|||
16088944|NCT00641537|38816779|FG007|96-week Period|Lost to Follow-up|0|||
16088945|NCT00641537|38816772|FG000|96-week Period|Protocol Violation|0|||
16088946|NCT00641537|38816773|FG001|96-week Period|Protocol Violation|1|||
16088947|NCT00641537|38816774|FG002|96-week Period|Protocol Violation|0|||
16088948|NCT00641537|38816775|FG003|96-week Period|Protocol Violation|1|||
16088949|NCT00641537|38816776|FG004|96-week Period|Protocol Violation|0|||
16088950|NCT00641537|38816777|FG005|96-week Period|Protocol Violation|1|||
16088951|NCT00641537|38816778|FG006|96-week Period|Protocol Violation|0|||
16088952|NCT00641537|38816779|FG007|96-week Period|Protocol Violation|0|||
16088953|NCT00641537|38816772|FG000|96-week Period|Death|2|||
16088954|NCT00641537|38816773|FG001|96-week Period|Death|0|||
16088955|NCT00641537|38816774|FG002|96-week Period|Death|1|||
16088956|NCT00641537|38816775|FG003|96-week Period|Death|0|||
16088957|NCT00641537|38816776|FG004|96-week Period|Death|0|||
16088958|NCT00641537|38816777|FG005|96-week Period|Death|0|||
16088959|NCT00641537|38816778|FG006|96-week Period|Death|0|||
16088960|NCT00641537|38816779|FG007|96-week Period|Death|0|||
16088961|NCT00641537|38816772|FG000|96-week Period|Other|4|||
16088962|NCT00641537|38816773|FG001|96-week Period|Other|7|||
16088963|NCT00641537|38816774|FG002|96-week Period|Other|14|||
16088964|NCT00641537|38816775|FG003|96-week Period|Other|9|||
16088965|NCT00641537|38816776|FG004|96-week Period|Other|11|||
16088966|NCT00641537|38816777|FG005|96-week Period|Other|6|||
16088967|NCT00641537|38816778|FG006|96-week Period|Other|4|||
16088968|NCT00641537|38816779|FG007|96-week Period|Other|6|||
16088969|NCT00641537|38816772|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
16088970|NCT00641537|38816773|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
16088971|NCT00641537|38816774|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
16088972|NCT00641537|38816775|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
16088973|NCT00641537|38816776|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
16088974|NCT00641537|38816777|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
16088975|NCT00641537|38816778|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
16088976|NCT00641537|38816779|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
16088977|NCT00641537|38816772|FG000|24-Week Supplemental Follow-up Period|Other|0|||
16088978|NCT00641537|38816773|FG001|24-Week Supplemental Follow-up Period|Other|2|||
16088979|NCT00641537|38816774|FG002|24-Week Supplemental Follow-up Period|Other|2|||
16088980|NCT00641537|38816775|FG003|24-Week Supplemental Follow-up Period|Other|1|||
16088981|NCT00641537|38816776|FG004|24-Week Supplemental Follow-up Period|Other|3|||
16088982|NCT00641537|38816777|FG005|24-Week Supplemental Follow-up Period|Other|0|||
16088983|NCT00641537|38816778|FG006|24-Week Supplemental Follow-up Period|Other|1|||
16088984|NCT00641537|38816779|FG007|24-Week Supplemental Follow-up Period|Other|1|||
16088985|NCT03851094|38816782|FG000|Overall Study|Withdrawal by Subject|0|||
16088986|NCT03851094|38816783|FG001|Overall Study|Withdrawal by Subject|1|||
16088987|NCT03851094|38816782|FG000|Overall Study|Participant lost device|0|||
16088988|NCT03851094|38816783|FG001|Overall Study|Participant lost device|1|||
16310376|NCT02501928|39619337|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
16501862|NCT02564042|40310209|FG003|Overall Study|Withdrawal by Subject|2|||
16088989|NCT03851094|38816782|FG000|Overall Study|Participant returned device|0|||
16088990|NCT03851094|38816783|FG001|Overall Study|Participant returned device|2|||
16088991|NCT03560206|38816784|FG000|Overall Study|Lost to Follow-up|19|||
16088992|NCT03560206|38816785|FG001|Overall Study|Lost to Follow-up|11|||
16088993|NCT03560206|38816784|FG000|Overall Study|Withdrawal by Subject|2|||
16088994|NCT03560206|38816785|FG001|Overall Study|Withdrawal by Subject|4|||
16088995|NCT03560206|38816784|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
16088996|NCT03560206|38816785|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
16088997|NCT03560206|38816784|FG000|Overall Study|Busy schedule|14|||
16088998|NCT03560206|38816785|FG001|Overall Study|Busy schedule|2|||
16088999|NCT03560206|38816784|FG000|Overall Study|patients' new health condition such as cancer|10|||
16089000|NCT03560206|38816785|FG001|Overall Study|patients' new health condition such as cancer|1|||
16089001|NCT02384382|38816786|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
16089002|NCT02384382|38816786|FG000|Overall Study|Death|1|||
16501863|NCT02564042|40310210|FG004|Overall Study|Withdrawal by Subject|10|||
16089003|NCT02384382|38816786|FG000|Overall Study|Adverse Event|1|||
16089004|NCT02384382|38816786|FG000|Overall Study|Disease progression|16|||
16089005|NCT01286311|38816787|FG000|Overall Study|Physician did not want outreach sent|14|||
16089006|NCT01286311|38816788|FG001|Overall Study|Physician did not want outreach sent|0|||
16089007|NCT03100370|38816789|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16089008|NCT03100370|38816790|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16089009|NCT03100370|38816791|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16089010|NCT03100370|38816792|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
16089011|NCT03100370|38816793|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16089012|NCT03100370|38816794|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16089013|NCT02347332|38816795|FG000|Overall Study|Not treated|5|||
16089014|NCT02347332|38816796|FG001|Overall Study|Not treated|2|||
16089015|NCT02347332|38816795|FG000|Overall Study|Progressive disease|141|||
16089016|NCT02347332|38816796|FG001|Overall Study|Progressive disease|159|||
16089017|NCT02347332|38816795|FG000|Overall Study|Adverse Event|50|||
16089018|NCT02347332|38816796|FG001|Overall Study|Adverse Event|41|||
16089019|NCT02347332|38816795|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
16089020|NCT02347332|38816796|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
16089021|NCT02347332|38816795|FG000|Overall Study|Protocol Violation|1|||
16089022|NCT02347332|38816796|FG001|Overall Study|Protocol Violation|1|||
16089023|NCT02347332|38816795|FG000|Overall Study|Lost to Follow-up|2|||
16089024|NCT02347332|38816796|FG001|Overall Study|Lost to Follow-up|1|||
16089025|NCT02347332|38816795|FG000|Overall Study|Physician Decision|4|||
16089026|NCT02347332|38816796|FG001|Overall Study|Physician Decision|3|||
16089027|NCT02347332|38816795|FG000|Overall Study|Withdrawal by Subject|20|||
16089028|NCT02347332|38816796|FG001|Overall Study|Withdrawal by Subject|14|||
16089029|NCT02347332|38816795|FG000|Overall Study|Protocol requirement|1|||
16089030|NCT02347332|38816796|FG001|Overall Study|Protocol requirement|1|||
16089031|NCT02347332|38816795|FG000|Overall Study|Switch Post-Trial program|0|||
16089032|NCT02347332|38816796|FG001|Overall Study|Switch Post-Trial program|1|||
16089033|NCT00308308|38816797|FG000|Overall Study|Adverse Event|17|||
16089034|NCT00308308|38816798|FG001|Overall Study|Adverse Event|2|||
16089035|NCT00308308|38816797|FG000|Overall Study|Lost to Follow-up|5|||
16089036|NCT00308308|38816798|FG001|Overall Study|Lost to Follow-up|5|||
16089037|NCT00308308|38816797|FG000|Overall Study|Physician Decision|15|||
16089038|NCT00308308|38816798|FG001|Overall Study|Physician Decision|7|||
16089039|NCT00308308|38816797|FG000|Overall Study|Protocol Violation|3|||
16089040|NCT00308308|38816798|FG001|Overall Study|Protocol Violation|14|||
16089041|NCT00308308|38816797|FG000|Overall Study|Withdrawal by Subject|47|||
16089042|NCT00308308|38816798|FG001|Overall Study|Withdrawal by Subject|19|||
16089043|NCT00308308|38816797|FG000|Overall Study|Various|7|||
16089044|NCT00308308|38816798|FG001|Overall Study|Various|5|||
16089045|NCT00308308|38816797|FG000|Overall Study|Randomized but not dosed|8|||
16089046|NCT00308308|38816798|FG001|Overall Study|Randomized but not dosed|16|||
16089047|NCT00308308|38816797|FG000|Overall Study|Other|1|||
16089048|NCT00308308|38816798|FG001|Overall Study|Other|0|||
16089049|NCT00089791|38816799|FG000|Overall Study|Physician Decision|6|||
16089050|NCT00089791|38816800|FG001|Overall Study|Physician Decision|3|||
16089051|NCT00089791|38816799|FG000|Overall Study|Adverse Event|81|||
16089052|NCT00089791|38816800|FG001|Overall Study|Adverse Event|93|||
16089053|NCT00089791|38816799|FG000|Overall Study|Withdrawal by Subject|403|||
16089054|NCT00089791|38816800|FG001|Overall Study|Withdrawal by Subject|344|||
16089055|NCT00089791|38816799|FG000|Overall Study|Death|78|||
16089056|NCT00089791|38816800|FG001|Overall Study|Death|62|||
16089057|NCT00089791|38816799|FG000|Overall Study|Disease progression|7|||
16089058|NCT00089791|38816800|FG001|Overall Study|Disease progression|3|||
16089059|NCT00089791|38816799|FG000|Overall Study|Ineligibility determined|12|||
16089060|NCT00089791|38816800|FG001|Overall Study|Ineligibility determined|9|||
16089061|NCT00089791|38816799|FG000|Overall Study|Lost to Follow-up|57|||
16089062|NCT00089791|38816800|FG001|Overall Study|Lost to Follow-up|57|||
16089063|NCT00089791|38816799|FG000|Overall Study|Noncompliance|17|||
16089064|NCT00089791|38816800|FG001|Overall Study|Noncompliance|13|||
16089065|NCT00089791|38816799|FG000|Overall Study|Other|20|||
16089066|NCT00089791|38816800|FG001|Overall Study|Other|32|||
16089067|NCT00089791|38816799|FG000|Overall Study|Protocol deviation|12|||
16089068|NCT00089791|38816800|FG001|Overall Study|Protocol deviation|10|||
16089069|NCT00089791|38816799|FG000|Overall Study|Requirement for alternative therapy|7|||
16089070|NCT00089791|38816800|FG001|Overall Study|Requirement for alternative therapy|4|||
16089071|NCT03953079|38816801|FG000|Core Study|Withdrawal by Subject|1|||
16089072|NCT03953079|38816802|FG001|Core Study|Withdrawal by Subject|2|||
16089073|NCT03953079|38816803|FG002|Core Study|Withdrawal by Subject|1|||
16089074|NCT03953079|38816801|FG000|Core Study|COVID-19|0|||
16089075|NCT03953079|38816802|FG001|Core Study|COVID-19|1|||
16089076|NCT03953079|38816803|FG002|Core Study|COVID-19|0|||
16089077|NCT03953079|38816801|FG000|Core Study|Difficulties leaving the house|0|||
16089078|NCT03953079|38816802|FG001|Core Study|Difficulties leaving the house|1|||
16089079|NCT03953079|38816803|FG002|Core Study|Difficulties leaving the house|0|||
16089080|NCT03953079|38816801|FG000|Extension Study|Withdrawal by Subject|1|||
16089081|NCT03953079|38816802|FG001|Extension Study|Withdrawal by Subject|0|||
16089082|NCT03953079|38816803|FG002|Extension Study|Withdrawal by Subject|0|||
16089083|NCT03953079|38816801|FG000|Extension Study|Received Rescue Treatment|5|||
16089084|NCT03953079|38816802|FG001|Extension Study|Received Rescue Treatment|6|||
16089085|NCT03953079|38816803|FG002|Extension Study|Received Rescue Treatment|5|||
16089086|NCT03352713|38816806|FG000|Overall Study|Lost to Follow-up|8|||
16089087|NCT03352713|38816806|FG000|Overall Study|Withdrawn by investigator|5|||
16089088|NCT03352713|38816806|FG000|Overall Study|Completed 0 EMAs|8|||
16089089|NCT03352713|38816806|FG000|Overall Study|Device incompatible/stolen|5|||
16089090|NCT01593020|38816807|FG000|Overall Study|Adverse Event|1|||
16089091|NCT01593020|38816808|FG001|Overall Study|Adverse Event|1|||
16089092|NCT01593020|38816807|FG000|Overall Study|Death|0|||
16089093|NCT01593020|38816808|FG001|Overall Study|Death|1|||
16089094|NCT01593020|38816807|FG000|Overall Study|Ineligible|1|||
16089095|NCT01593020|38816808|FG001|Overall Study|Ineligible|0|||
16089096|NCT00687297|38816809|FG000|Randomization|Withdrawal by Subject|2|||
16089097|NCT00687297|38816810|FG001|Randomization|Withdrawal by Subject|0|||
16089098|NCT00687297|38816809|FG000|Randomization|Withdrew before treatment, ineligible|1|||
16089099|NCT00687297|38816810|FG001|Randomization|Withdrew before treatment, ineligible|1|||
16089100|NCT00687297|38816809|FG000|Induction|Withdrawal by Subject|4|||
16089101|NCT00687297|38816810|FG001|Induction|Withdrawal by Subject|4|||
16089102|NCT00687297|38816809|FG000|Induction|Adverse Event|16|||
16089103|NCT00687297|38816810|FG001|Induction|Adverse Event|15|||
16089104|NCT00687297|38816809|FG000|Induction|Death|7|||
16089105|NCT00687297|38816810|FG001|Induction|Death|11|||
16089106|NCT00687297|38816809|FG000|Induction|Lack of Efficacy|17|||
16089107|NCT00687297|38816810|FG001|Induction|Lack of Efficacy|21|||
16089108|NCT00687297|38816809|FG000|Induction|Ineligible|0|||
16089109|NCT00687297|38816810|FG001|Induction|Ineligible|1|||
16089110|NCT00687297|38816809|FG000|Induction|Patient Noncompliance|1|||
16089111|NCT00687297|38816810|FG001|Induction|Patient Noncompliance|0|||
16089112|NCT00687297|38816809|FG000|Induction|Physician Decision|0|||
16089113|NCT00687297|38816810|FG001|Induction|Physician Decision|2|||
16089114|NCT00687297|38816809|FG000|Induction|Other|0|||
16089115|NCT00687297|38816810|FG001|Induction|Other|1|||
16089116|NCT03775213|38816811|FG000|Overall Study|Withdrawal by Subject|51|||
16089117|NCT03775213|38816812|FG001|Overall Study|Withdrawal by Subject|53|||
16089118|NCT03775213|38816811|FG000|Overall Study|Incomplete Survey|7|||
16089119|NCT03775213|38816812|FG001|Overall Study|Incomplete Survey|7|||
16089120|NCT04660799|38816813|FG000|Overall Study|Progressive Disease|1|||
16089121|NCT04660799|38816814|FG001|Overall Study|Progressive Disease|1|||
16089122|NCT04660799|38816813|FG000|Overall Study|Death|2|||
16089123|NCT04660799|38816814|FG001|Overall Study|Death|1|||
16089124|NCT04660799|38816813|FG000|Overall Study|Adverse Event|2|||
16089125|NCT04660799|38816814|FG001|Overall Study|Adverse Event|1|||
16089126|NCT04660799|38816813|FG000|Overall Study|Withdrawal by Subject|2|||
16089127|NCT04660799|38816814|FG001|Overall Study|Withdrawal by Subject|5|||
16089128|NCT00273052|38816817|FG000|Overall Study|Withdrawal by Subject|16|||
16089129|NCT00273052|38816818|FG001|Overall Study|Withdrawal by Subject|19|||
16089130|NCT00273052|38816817|FG000|Overall Study|Adverse Event|21|||
16089131|NCT00273052|38816818|FG001|Overall Study|Adverse Event|19|||
16089132|NCT00273052|38816817|FG000|Overall Study|Protocol Violation|14|||
16089133|NCT00273052|38816818|FG001|Overall Study|Protocol Violation|18|||
16089134|NCT00273052|38816817|FG000|Overall Study|Lost to Follow-up|7|||
16089135|NCT00273052|38816818|FG001|Overall Study|Lost to Follow-up|25|||
16089136|NCT00273052|38816817|FG000|Overall Study|Lack of Efficacy|6|||
16089137|NCT00273052|38816818|FG001|Overall Study|Lack of Efficacy|4|||
16089138|NCT00273052|38816817|FG000|Overall Study|Non-Compliance|3|||
16089139|NCT00273052|38816818|FG001|Overall Study|Non-Compliance|1|||
16089140|NCT00273052|38816817|FG000|Overall Study|Other|2|||
16089141|NCT00273052|38816818|FG001|Overall Study|Other|0|||
16089142|NCT00273052|38816817|FG000|Overall Study|Worsening serum lipid levels|0|||
16089143|NCT00273052|38816818|FG001|Overall Study|Worsening serum lipid levels|2|||
16089144|NCT02991118|38816823|FG000|Overall Study|Death|3|||
16089145|NCT02991118|38816824|FG001|Overall Study|Death|8|||
16089146|NCT02991118|38816823|FG000|Overall Study|Protocol Violation|0|||
16089147|NCT02991118|38816824|FG001|Overall Study|Protocol Violation|3|||
16089148|NCT02991118|38816823|FG000|Overall Study|Physician Decision|0|||
16089149|NCT02991118|38816824|FG001|Overall Study|Physician Decision|1|||
16089150|NCT02991118|38816823|FG000|Overall Study|Moved out of the country|0|||
16501864|NCT02564042|40310211|FG005|Overall Study|Withdrawal by Subject|12|||
16089151|NCT02991118|38816824|FG001|Overall Study|Moved out of the country|1|||
16089152|NCT02991118|38816823|FG000|Overall Study|Adverse Event|2|||
16089153|NCT02991118|38816824|FG001|Overall Study|Adverse Event|2|||
16089154|NCT02991118|38816823|FG000|Overall Study|Withdrawal by Subject|1|||
16089155|NCT02991118|38816824|FG001|Overall Study|Withdrawal by Subject|7|||
16089156|NCT02991118|38816823|FG000|Overall Study|Could not attend study visits|0|||
16089157|NCT02991118|38816824|FG001|Overall Study|Could not attend study visits|1|||
16089158|NCT02991118|38816823|FG000|Overall Study|Lost to Follow-up|1|||
16089159|NCT02991118|38816824|FG001|Overall Study|Lost to Follow-up|9|||
16089160|NCT01409837|38816828|FG000|Overall Study|Withdrawal by Subject|2|||
16089161|NCT01409837|38816829|FG001|Overall Study|Withdrawal by Subject|1|||
16089162|NCT01409837|38816828|FG000|Overall Study|Lost to Follow-up|1|||
16089163|NCT01409837|38816829|FG001|Overall Study|Lost to Follow-up|0|||
16089164|NCT01409837|38816828|FG000|Overall Study|Physician Decision|0|||
16089165|NCT01409837|38816829|FG001|Overall Study|Physician Decision|1|||
16089166|NCT03259568|38816830|FG000|Overall Study|Participant performance was low|3|||
16089167|NCT02326220|38816831|FG000|Double-blind Treatment Period|Adverse Event|1|||
16089168|NCT02326220|38816832|FG001|Double-blind Treatment Period|Adverse Event|2|||
16089169|NCT02326220|38816833|FG002|Double-blind Treatment Period|Adverse Event|0|||
16089170|NCT02326220|38816831|FG000|Double-blind Treatment Period|Protocol Violation|0|||
16089171|NCT02326220|38816832|FG001|Double-blind Treatment Period|Protocol Violation|1|||
16089172|NCT02326220|38816833|FG002|Double-blind Treatment Period|Protocol Violation|0|||
16089173|NCT02326220|38816831|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
16089174|NCT02326220|38816832|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
16089175|NCT02326220|38816833|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16089176|NCT02326220|38816831|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
16089177|NCT02326220|38816832|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
16089178|NCT02326220|38816833|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
16089179|NCT02326220|38816831|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
16089180|NCT02326220|38816832|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
16089181|NCT02326220|38816833|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
16089182|NCT02114515|38816835|FG000|Overall Study|Lost to Follow-up|52|||
16089183|NCT02114515|38816836|FG001|Overall Study|Lost to Follow-up|55|||
16089184|NCT02114515|38816835|FG000|Overall Study|Death|12|||
16089185|NCT02114515|38816836|FG001|Overall Study|Death|12|||
16089186|NCT02114515|38816835|FG000|Overall Study|Withdrawal by Subject|4|||
16089187|NCT02114515|38816836|FG001|Overall Study|Withdrawal by Subject|22|||
16089188|NCT02114515|38816835|FG000|Overall Study|Other|65|||
16089189|NCT02114515|38816836|FG001|Overall Study|Other|61|||
16089190|NCT03137784|38816837|FG000|Overall Study|Adverse Event|1|||
16089191|NCT03137784|38816838|FG001|Overall Study|Adverse Event|1|||
16089192|NCT03137784|38816839|FG002|Overall Study|Adverse Event|0|||
16089193|NCT03137784|38816840|FG003|Overall Study|Adverse Event|0|||
16089194|NCT03137784|38816841|FG004|Overall Study|Adverse Event|0|||
16089195|NCT03137784|38816842|FG005|Overall Study|Adverse Event|0|||
16089196|NCT03137784|38816837|FG000|Overall Study|Subject/guardian decision|1|||
16089197|NCT03137784|38816838|FG001|Overall Study|Subject/guardian decision|0|||
16089198|NCT03137784|38816839|FG002|Overall Study|Subject/guardian decision|0|||
16089199|NCT03137784|38816840|FG003|Overall Study|Subject/guardian decision|0|||
16089200|NCT03137784|38816841|FG004|Overall Study|Subject/guardian decision|0|||
16089201|NCT03137784|38816842|FG005|Overall Study|Subject/guardian decision|0|||
16089202|NCT03137784|38816837|FG000|Overall Study|Non-compliance with study treatment|0|||
16089203|NCT03137784|38816838|FG001|Overall Study|Non-compliance with study treatment|0|||
16089204|NCT03137784|38816839|FG002|Overall Study|Non-compliance with study treatment|0|||
16089205|NCT03137784|38816840|FG003|Overall Study|Non-compliance with study treatment|0|||
16089206|NCT03137784|38816841|FG004|Overall Study|Non-compliance with study treatment|1|||
16089207|NCT03137784|38816842|FG005|Overall Study|Non-compliance with study treatment|0|||
16089208|NCT03451422|38816843|FG000|Overall Study|Lost to Follow-up|0|||
16195681|NCT03288493|39193391|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
16195682|NCT03288493|39193385|FG000|Overall Study|Death|2|||
16195683|NCT03288493|39193386|FG001|Overall Study|Death|0|||
16195684|NCT03288493|39193387|FG002|Overall Study|Death|0|||
16195685|NCT03288493|39193388|FG003|Overall Study|Death|0|||
16195686|NCT03288493|39193389|FG004|Overall Study|Death|0|||
16195687|NCT03288493|39193390|FG005|Overall Study|Death|0|||
16195688|NCT03288493|39193391|FG006|Overall Study|Death|0|||
16195689|NCT03288493|39193385|FG000|Overall Study|other reason not listed above|2|||
16195690|NCT03288493|39193386|FG001|Overall Study|other reason not listed above|0|||
16195691|NCT03288493|39193387|FG002|Overall Study|other reason not listed above|0|||
16195692|NCT03288493|39193388|FG003|Overall Study|other reason not listed above|0|||
16089209|NCT03451422|38816844|FG001|Overall Study|Lost to Follow-up|0|||
16089210|NCT03451422|38816845|FG002|Overall Study|Lost to Follow-up|0|||
16089211|NCT03451422|38816846|FG003|Overall Study|Lost to Follow-up|0|||
16089212|NCT03451422|38816847|FG004|Overall Study|Lost to Follow-up|0|||
16089213|NCT03451422|38816848|FG005|Overall Study|Lost to Follow-up|1|||
16089214|NCT03451422|38816843|FG000|Overall Study|Decision by sponsor|1|||
16089215|NCT03451422|38816844|FG001|Overall Study|Decision by sponsor|0|||
16089216|NCT03451422|38816845|FG002|Overall Study|Decision by sponsor|1|||
16089217|NCT03451422|38816846|FG003|Overall Study|Decision by sponsor|0|||
16089218|NCT03451422|38816847|FG004|Overall Study|Decision by sponsor|0|||
16089219|NCT03451422|38816848|FG005|Overall Study|Decision by sponsor|0|||
16089220|NCT03451422|38816843|FG000|Overall Study|Withdrawal by Subject|0|||
16195693|NCT03288493|39193389|FG004|Overall Study|other reason not listed above|0|||
16195694|NCT03288493|39193390|FG005|Overall Study|other reason not listed above|0|||
16195695|NCT03288493|39193391|FG006|Overall Study|other reason not listed above|0|||
16195696|NCT02056834|39193396|FG000|Overall Study|Lost to Follow-up|7|||
16195697|NCT01669811|39193397|FG000|Overall Study|Investigator decision|0|||
16501865|NCT00322842|40310215|FG000|Overall Study|Withdrawal by Subject|0|||
16501866|NCT00322842|40310216|FG001|Overall Study|Withdrawal by Subject|1|||
16501867|NCT00322842|40310215|FG000|Overall Study|Lost to Follow-up|0|||
16501868|NCT00322842|40310216|FG001|Overall Study|Lost to Follow-up|1|||
16501869|NCT00322842|40310215|FG000|Overall Study|Refused transplant|1|||
16501870|NCT00322842|40310216|FG001|Overall Study|Refused transplant|0|||
16501871|NCT00322842|40310215|FG000|Overall Study|Death|1|||
16501872|NCT00322842|40310216|FG001|Overall Study|Death|0|||
16501873|NCT01528254|40310217|FG000|Overall Study|Administrative problems|96|||
16501874|NCT01528254|40310218|FG001|Overall Study|Administrative problems|94|||
16501875|NCT01528254|40310217|FG000|Overall Study|Adverse Event|28|||
16501876|NCT01528254|40310218|FG001|Overall Study|Adverse Event|44|||
16390060|NCT00775268|39911899|FG000|Baseline|Drug not synthesize dose|1|||
16390061|NCT00775268|39911900|FG001|Baseline|Drug not synthesize dose|0|||
16390062|NCT00775268|39911899|FG000|Baseline|Not treated-ineligible per CT|0|||
16390063|NCT00775268|39911900|FG001|Baseline|Not treated-ineligible per CT|1|||
16390064|NCT00775268|39911899|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
16390065|NCT00775268|39911900|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
16390066|NCT00775268|39911899|FG000|After Completion|Participant missed scan appointment|1|||
16390067|NCT00775268|39911900|FG001|After Completion|Participant missed scan appointment|0|||
16390068|NCT01265992|39911903|FG000|Overall Study|Lost to Follow-up|1|||
16390069|NCT01265992|39911903|FG000|Overall Study|Withdrawal by Subject|1|||
16390070|NCT01265992|39911903|FG000|Overall Study|Adverse Event|1|||
16195698|NCT01669811|39193398|FG001|Overall Study|Investigator decision|1|||
16310377|NCT02501928|39619338|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
16310378|NCT02501928|39619339|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
16501877|NCT01528254|40310217|FG000|Overall Study|Lost to Follow-up|17|||
16501878|NCT01528254|40310218|FG001|Overall Study|Lost to Follow-up|24|||
16501879|NCT01528254|40310217|FG000|Overall Study|Death|13|||
16501880|NCT01528254|40310218|FG001|Overall Study|Death|9|||
16501881|NCT01528254|40310217|FG000|Overall Study|Protocol deviation|9|||
16501882|NCT01528254|40310218|FG001|Overall Study|Protocol deviation|19|||
16501883|NCT01528254|40310217|FG000|Overall Study|New therapy for study indication|8|||
16501884|NCT01528254|40310218|FG001|Overall Study|New therapy for study indication|6|||
16501885|NCT01528254|40310217|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
16501886|NCT01528254|40310218|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
16501887|NCT01528254|40310217|FG000|Overall Study|Withdrawal by Subject|5|||
16310379|NCT02501928|39619340|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
16310380|NCT02501928|39619341|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
16310381|NCT03203473|39619344|FG000|Induction Phase|Never started primary treatment|2|||
16310382|NCT03203473|39619345|FG001|Induction Phase|Never started primary treatment|0|||
16310383|NCT03203473|39619346|FG002|Induction Phase|Never started primary treatment|0|||
16310384|NCT03203473|39619344|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
16310385|NCT03203473|39619345|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
16501888|NCT01528254|40310218|FG001|Overall Study|Withdrawal by Subject|4|||
16501889|NCT01528254|40310217|FG000|Overall Study|Abnormal laboratory value(s)|3|||
16501890|NCT01528254|40310218|FG001|Overall Study|Abnormal laboratory value(s)|7|||
16501891|NCT01528254|40310217|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16501892|NCT01528254|40310218|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16501893|NCT01528254|40310217|FG000|Overall Study|No longer requires study drug|1|||
16501894|NCT01528254|40310218|FG001|Overall Study|No longer requires study drug|1|||
16501895|NCT01046682|40310219|FG000|Overall Study|Adverse Event|2|||
16501896|NCT01046682|40310220|FG001|Overall Study|Adverse Event|0|||
16501897|NCT03108027|40310221|FG000|Period 1|Subject/Guardian Decision|0|||
16501898|NCT03108027|40310222|FG001|Period 1|Subject/Guardian Decision|0|||
16501899|NCT03108027|40310223|FG002|Period 1|Subject/Guardian Decision|0|||
16501900|NCT03108027|40310224|FG003|Period 1|Subject/Guardian Decision|2|||
16501901|NCT03108027|40310225|FG004|Period 1|Subject/Guardian Decision|0|||
16501902|NCT03108027|40310226|FG005|Period 1|Subject/Guardian Decision|0|||
16501903|NCT03108027|40310221|FG000|Period 3|Adverse Event|0|||
16501904|NCT03108027|40310222|FG001|Period 3|Adverse Event|1|||
16310386|NCT03203473|39619346|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
16310387|NCT03203473|39619344|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
16501905|NCT03108027|40310223|FG002|Period 3|Adverse Event|0|||
16501906|NCT03108027|40310224|FG003|Period 3|Adverse Event|0|||
16390071|NCT01265992|39911903|FG000|Overall Study|Administrative reasons|2|||
16195699|NCT01669811|39193397|FG000|Overall Study|Withdrawal by Subject|1|||
16310388|NCT03203473|39619345|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
16390072|NCT01265992|39911903|FG000|Overall Study|Stopped treatment|3|||
16501907|NCT03108027|40310225|FG004|Period 3|Adverse Event|0|||
16501908|NCT03108027|40310226|FG005|Period 3|Adverse Event|0|||
16501909|NCT01581307|40310227|FG000|Overall Study|Withdrawal by Subject|1|||
16501910|NCT01909479|40310228|FG000|From Baseline to Week 26|Adverse Event|3|||
16310389|NCT03203473|39619346|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
16310390|NCT03203473|39619344|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
16310391|NCT03203473|39619345|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
16310392|NCT03203473|39619346|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
16310393|NCT03203473|39619344|FG000|Arm Allocation Phase|started salvage therapy|0|||
16310394|NCT03203473|39619345|FG001|Arm Allocation Phase|started salvage therapy|5|||
16310395|NCT03203473|39619346|FG002|Arm Allocation Phase|started salvage therapy|0|||
16310396|NCT03203473|39619344|FG000|Arm Allocation Phase|Disease progression|0|||
16310397|NCT03203473|39619345|FG001|Arm Allocation Phase|Disease progression|0|||
16310398|NCT03203473|39619346|FG002|Arm Allocation Phase|Disease progression|37|||
16390073|NCT01265992|39911903|FG000|Overall Study|Did not receive treatment|1|||
16390074|NCT00181844|39911904|FG000|Signed Consent|Withdrawal by Subject|5|||
16390075|NCT00181844|39911904|FG000|Signed Consent|Did not meet entrance criteria|7|||
16390076|NCT00181844|39911904|FG000|Exposed to Study Medication|Adverse Event|10|||
16390077|NCT00181844|39911904|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
16390078|NCT00181844|39911904|FG000|Exposed to Study Medication|Non-compliance|2|||
16390079|NCT00181844|39911904|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
16310399|NCT03203473|39619344|FG000|Arm Allocation Phase|Adverse Event|0|||
16310400|NCT03203473|39619345|FG001|Arm Allocation Phase|Adverse Event|0|||
16310401|NCT03203473|39619346|FG002|Arm Allocation Phase|Adverse Event|11|||
16310402|NCT03203473|39619344|FG000|Arm Allocation Phase|Physician Decision|0|||
16310403|NCT03203473|39619345|FG001|Arm Allocation Phase|Physician Decision|0|||
16310404|NCT03203473|39619346|FG002|Arm Allocation Phase|Physician Decision|3|||
16310405|NCT03203473|39619344|FG000|Arm Allocation Phase|Death|0|||
16310406|NCT03203473|39619345|FG001|Arm Allocation Phase|Death|0|||
16310407|NCT03203473|39619346|FG002|Arm Allocation Phase|Death|1|||
16310408|NCT03203473|39619344|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
16310409|NCT03203473|39619345|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
16310410|NCT03203473|39619346|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
16310411|NCT03203473|39619344|FG000|Arm Allocation Phase|Intercurrent illness|0|||
16310412|NCT03203473|39619345|FG001|Arm Allocation Phase|Intercurrent illness|0|||
16310413|NCT03203473|39619346|FG002|Arm Allocation Phase|Intercurrent illness|1|||
16310414|NCT03203473|39619344|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
16310415|NCT03203473|39619345|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
16310416|NCT03203473|39619346|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
16310417|NCT01707290|39619347|FG000|Overall Study|Adverse event (AE)|1|||
16501911|NCT01909479|40310229|FG001|From Baseline to Week 26|Adverse Event|2|||
16501912|NCT01909479|40310228|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
16501913|NCT01909479|40310229|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
16501914|NCT01909479|40310228|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
16501915|NCT01909479|40310229|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
16501916|NCT01909479|40310228|FG000|26 - 52 Weeks|Adverse Event|0|||
16501917|NCT01909479|40310229|FG001|26 - 52 Weeks|Adverse Event|1|||
16501918|NCT01909479|40310228|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
16501919|NCT01909479|40310229|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
16501920|NCT01909479|40310228|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
16501921|NCT01909479|40310229|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
16501922|NCT01909479|40310228|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
16501923|NCT01909479|40310229|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
16501924|NCT01909479|40310228|FG000|52 Weeks to End of Study|Adverse Event|2|||
16501925|NCT01909479|40310229|FG001|52 Weeks to End of Study|Adverse Event|1|||
16501926|NCT01909479|40310228|FG000|52 Weeks to End of Study|Death|0|||
16501927|NCT01909479|40310229|FG001|52 Weeks to End of Study|Death|1|||
16501928|NCT01909479|40310228|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
16501929|NCT01909479|40310229|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
16501930|NCT01909479|40310228|FG000|52 Weeks to End of Study|Protocol Violation|1|||
16501931|NCT01909479|40310229|FG001|52 Weeks to End of Study|Protocol Violation|0|||
16501932|NCT01909479|40310228|FG000|52 Weeks to End of Study|Progressive disease|1|||
16501933|NCT01909479|40310229|FG001|52 Weeks to End of Study|Progressive disease|1|||
16501934|NCT01909479|40310228|FG000|52 Weeks to End of Study|Personal reasons|2|||
16501935|NCT01909479|40310229|FG001|52 Weeks to End of Study|Personal reasons|1|||
16501936|NCT01909479|40310228|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
16501937|NCT01909479|40310229|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
16501938|NCT01909479|40310228|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
16501939|NCT01909479|40310229|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
16501940|NCT01909479|40310228|FG000|52 Weeks to End of Study|Lack of contact|1|||
16501941|NCT01909479|40310229|FG001|52 Weeks to End of Study|Lack of contact|0|||
16501942|NCT01909479|40310228|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
16501943|NCT01909479|40310229|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
16501944|NCT01909479|40310228|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
16501945|NCT01909479|40310229|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
16501946|NCT04568590|40310231|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
16310418|NCT01707290|39619348|FG001|Overall Study|Adverse event (AE)|0|||
16310419|NCT01707290|39619347|FG000|Overall Study|Physician Decision|1|||
16310420|NCT01707290|39619348|FG001|Overall Study|Physician Decision|0|||
16310421|NCT01707290|39619347|FG000|Overall Study|Lost to Follow-up|3|||
16310422|NCT01707290|39619348|FG001|Overall Study|Lost to Follow-up|0|||
16310423|NCT01707290|39619347|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
16310424|NCT01707290|39619348|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
16310425|NCT01707290|39619347|FG000|Overall Study|Commercial drug available|60|||
16310426|NCT01707290|39619348|FG001|Overall Study|Commercial drug available|1|||
16310427|NCT01707290|39619347|FG000|Overall Study|Other unspecified|17|||
16310428|NCT01707290|39619348|FG001|Overall Study|Other unspecified|0|||
16310429|NCT02556801|39623399|FG000|Overall Study|Lost to Follow-up|1|||
16310430|NCT02556801|39623400|FG001|Overall Study|Lost to Follow-up|0|||
16310431|NCT02556801|39623401|FG002|Overall Study|Lost to Follow-up|2|||
16310432|NCT02556801|39623402|FG003|Overall Study|Lost to Follow-up|0|||
16310433|NCT02556801|39623399|FG000|Overall Study|Withdrawal by Subject|1|||
16310434|NCT02556801|39623400|FG001|Overall Study|Withdrawal by Subject|1|||
16310435|NCT02556801|39623401|FG002|Overall Study|Withdrawal by Subject|1|||
16310436|NCT02556801|39623402|FG003|Overall Study|Withdrawal by Subject|0|||
16310437|NCT02556801|39623399|FG000|Overall Study|Protocol Violation|0|||
16310438|NCT02556801|39623400|FG001|Overall Study|Protocol Violation|3|||
16310439|NCT02556801|39623401|FG002|Overall Study|Protocol Violation|1|||
16310440|NCT02556801|39623402|FG003|Overall Study|Protocol Violation|1|||
16310441|NCT02556801|39623399|FG000|Overall Study|Adverse Event|0|||
16310442|NCT02556801|39623400|FG001|Overall Study|Adverse Event|2|||
16310443|NCT02556801|39623401|FG002|Overall Study|Adverse Event|0|||
16310444|NCT02556801|39623402|FG003|Overall Study|Adverse Event|3|||
16310445|NCT02556801|39623399|FG000|Overall Study|Pregnancy|0|||
16310446|NCT02556801|39623400|FG001|Overall Study|Pregnancy|1|||
16310447|NCT02556801|39623401|FG002|Overall Study|Pregnancy|0|||
16310448|NCT02556801|39623402|FG003|Overall Study|Pregnancy|0|||
16310449|NCT02556801|39623399|FG000|Overall Study|Personal reasons patient|0|||
16310450|NCT02556801|39623400|FG001|Overall Study|Personal reasons patient|0|||
16310451|NCT02556801|39623401|FG002|Overall Study|Personal reasons patient|0|||
16310452|NCT02556801|39623402|FG003|Overall Study|Personal reasons patient|1|||
16310453|NCT03347110|39623403|FG000|Overall Study|Other (Participant is incarcerated)|1|||
16310454|NCT03347110|39623403|FG000|Overall Study|Withdrawal by Subject|9|||
16310455|NCT03347110|39623403|FG000|Overall Study|Lost to Follow-up|1|||
16310456|NCT03347110|39623403|FG000|Overall Study|Lack of Efficacy|2|||
16310457|NCT03347110|39623403|FG000|Overall Study|Adverse Event, non-fatal|9|||
16310458|NCT01779440|39623404|FG000|Overall Study|Withdrawal by Subject|3|||
16310459|NCT01779440|39623405|FG001|Overall Study|Withdrawal by Subject|5|||
16310460|NCT00564850|39623406|FG000|Overall Study|Protocol Violation|2|||
16310461|NCT00513240|39623407|FG000|Overall Study|Did not have intended surgery|3|||
16310462|NCT00513240|39623408|FG001|Overall Study|Did not have intended surgery|0|||
16310463|NCT00513240|39623407|FG000|Overall Study|Death|3|||
16310464|NCT00513240|39623408|FG001|Overall Study|Death|3|||
16310465|NCT00513240|39623407|FG000|Overall Study|Withdrawal by Subject|7|||
16310466|NCT00513240|39623408|FG001|Overall Study|Withdrawal by Subject|4|||
16310467|NCT01777282|39623409|FG000|Overall Study|Persistent Hyperglycemia|0|||
16310468|NCT01777282|39623410|FG001|Overall Study|Persistent Hyperglycemia|0|||
16310469|NCT01777282|39623411|FG002|Overall Study|Persistent Hyperglycemia|1|||
16310470|NCT01777282|39623412|FG003|Overall Study|Persistent Hyperglycemia|0|||
16310471|NCT01777282|39623413|FG004|Overall Study|Persistent Hyperglycemia|0|||
16310472|NCT01777282|39623409|FG000|Overall Study|New Antidiabetic Medication|0|||
16310473|NCT01777282|39623410|FG001|Overall Study|New Antidiabetic Medication|0|||
16310474|NCT01777282|39623411|FG002|Overall Study|New Antidiabetic Medication|1|||
16310475|NCT01777282|39623412|FG003|Overall Study|New Antidiabetic Medication|0|||
16310476|NCT01777282|39623413|FG004|Overall Study|New Antidiabetic Medication|0|||
16310477|NCT01777282|39623409|FG000|Overall Study|Adverse Event|4|||
16310478|NCT01777282|39623410|FG001|Overall Study|Adverse Event|4|||
16310479|NCT01777282|39623411|FG002|Overall Study|Adverse Event|2|||
16310480|NCT01777282|39623412|FG003|Overall Study|Adverse Event|1|||
16310481|NCT01777282|39623413|FG004|Overall Study|Adverse Event|3|||
16310482|NCT01777282|39623409|FG000|Overall Study|Withdrawal by Subject|4|||
16310483|NCT01777282|39623410|FG001|Overall Study|Withdrawal by Subject|0|||
16310484|NCT01777282|39623411|FG002|Overall Study|Withdrawal by Subject|0|||
16310485|NCT01777282|39623412|FG003|Overall Study|Withdrawal by Subject|1|||
16310486|NCT01777282|39623413|FG004|Overall Study|Withdrawal by Subject|2|||
16310487|NCT01777282|39623409|FG000|Overall Study|Protocol Violation|2|||
16310488|NCT01777282|39623410|FG001|Overall Study|Protocol Violation|0|||
16310489|NCT01777282|39623411|FG002|Overall Study|Protocol Violation|1|||
16310490|NCT01777282|39623412|FG003|Overall Study|Protocol Violation|0|||
16310491|NCT01777282|39623413|FG004|Overall Study|Protocol Violation|2|||
16310492|NCT01777282|39623409|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
16310493|NCT01777282|39623410|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
16310494|NCT01777282|39623411|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
16310495|NCT01777282|39623412|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
16310496|NCT01777282|39623413|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
16310497|NCT00879086|39623416|FG000|Overall Study|Adverse Event|3|||
16310498|NCT00879086|39623417|FG001|Overall Study|Adverse Event|15|||
16310499|NCT00879086|39623416|FG000|Overall Study|Participant choice|2|||
16310500|NCT00879086|39623417|FG001|Overall Study|Participant choice|2|||
16310501|NCT00879086|39623416|FG000|Overall Study|Progression of disease|40|||
16310502|NCT00879086|39623417|FG001|Overall Study|Progression of disease|26|||
16310503|NCT00879086|39623416|FG000|Overall Study|Withdrawal of consent|2|||
16310504|NCT00879086|39623417|FG001|Overall Study|Withdrawal of consent|1|||
16310505|NCT00879086|39623416|FG000|Overall Study|Other|4|||
16310506|NCT00879086|39623417|FG001|Overall Study|Other|6|||
16310507|NCT00879086|39623416|FG000|Overall Study|Death|1|||
16310508|NCT00879086|39623417|FG001|Overall Study|Death|2|||
16310509|NCT03125798|39623418|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
16310510|NCT03125798|39623419|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
16310511|NCT03125798|39623418|FG000|Overall Study|Conversion to thoracotomy|7|||
16310512|NCT03125798|39623419|FG001|Overall Study|Conversion to thoracotomy|7|||
16310513|NCT02763046|39623420|FG000|Overall Study|Adverse Event|5|||
16310514|NCT02763046|39623421|FG001|Overall Study|Adverse Event|4|||
16310515|NCT02763046|39623422|FG002|Overall Study|Adverse Event|0|||
16310516|NCT02763046|39623420|FG000|Overall Study|Lack of Efficacy|1|||
16310517|NCT02763046|39623421|FG001|Overall Study|Lack of Efficacy|1|||
16310518|NCT02763046|39623422|FG002|Overall Study|Lack of Efficacy|3|||
16310519|NCT02763046|39623420|FG000|Overall Study|Physician Decision|1|||
16310520|NCT02763046|39623421|FG001|Overall Study|Physician Decision|0|||
16310521|NCT02763046|39623422|FG002|Overall Study|Physician Decision|1|||
16501947|NCT00930579|40310241|FG000|Overall Study|Withdrawal by Subject|1|||
16501948|NCT00930579|40310241|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
16501949|NCT04339296|40310242|FG000|Overall Study|Refuse to participate after allocation|1|||
16501950|NCT04339296|40310243|FG001|Overall Study|Refuse to participate after allocation|1|||
16501951|NCT04339296|40310242|FG000|Overall Study|Withdrew after completion of baseline|2|||
16501952|NCT04339296|40310243|FG001|Overall Study|Withdrew after completion of baseline|1|||
16501953|NCT04339296|40310242|FG000|Overall Study|Lost to Follow-up|0|||
16501954|NCT04339296|40310243|FG001|Overall Study|Lost to Follow-up|4|||
16501955|NCT04339296|40310242|FG000|Overall Study|Discontinued intervention|5|||
16501956|NCT04339296|40310243|FG001|Overall Study|Discontinued intervention|3|||
16501957|NCT03045887|40310244|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
16501958|NCT03045887|40310245|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
16501959|NCT03045887|40310246|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
16501960|NCT03045887|40310247|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
16501961|NCT03045887|40310248|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
16501962|NCT03045887|40310249|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
16501963|NCT03045887|40310250|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
16501964|NCT03045887|40310251|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
16501965|NCT03045887|40310252|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
16501966|NCT03045887|40310253|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
16501967|NCT03045887|40310244|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
16501968|NCT03045887|40310245|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
16501969|NCT03045887|40310246|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
16501970|NCT03045887|40310247|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
16501971|NCT03045887|40310248|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
16501972|NCT03045887|40310249|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
16501973|NCT03045887|40310250|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
16310522|NCT02763046|39623420|FG000|Overall Study|Subject/guardian decision|2|||
16310523|NCT02763046|39623421|FG001|Overall Study|Subject/guardian decision|0|||
16310524|NCT02763046|39623422|FG002|Overall Study|Subject/guardian decision|4|||
16310525|NCT00811733|39623429|FG000|Overall Study|Investigator Discretion|10|||
16310526|NCT00811733|39623430|FG001|Overall Study|Investigator Discretion|8|||
16501974|NCT03045887|40310251|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
16501975|NCT03045887|40310252|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
16501976|NCT03045887|40310253|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
16501977|NCT03045887|40310244|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
16501978|NCT03045887|40310245|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
16501979|NCT03045887|40310246|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
16501980|NCT03045887|40310247|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
16501981|NCT03045887|40310248|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
16501982|NCT03045887|40310249|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
16501983|NCT03045887|40310250|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
16501984|NCT03045887|40310251|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
16501985|NCT03045887|40310252|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
16501986|NCT03045887|40310253|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
16501987|NCT03045887|40310244|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
16501988|NCT03045887|40310245|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
16501989|NCT03045887|40310246|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
16501990|NCT03045887|40310247|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
16501991|NCT03045887|40310248|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
16501992|NCT03045887|40310249|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
16501993|NCT03045887|40310250|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
16501994|NCT03045887|40310251|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
16501995|NCT03045887|40310252|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
16501996|NCT03045887|40310253|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
16501997|NCT03045887|40310244|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16501998|NCT03045887|40310245|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16501999|NCT03045887|40310246|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16502000|NCT03045887|40310247|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
16502001|NCT03045887|40310248|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16502002|NCT03045887|40310249|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16502003|NCT03045887|40310250|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16502004|NCT03045887|40310251|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16502005|NCT03045887|40310252|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16502006|NCT03045887|40310253|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16502007|NCT02522286|40310254|FG000|Overall Study|Withdrawal by Subject|3|||
16502008|NCT02522286|40310255|FG001|Overall Study|Withdrawal by Subject|0|||
16502009|NCT02522286|40310256|FG002|Overall Study|Withdrawal by Subject|0|||
16502010|NCT02522286|40310257|FG003|Overall Study|Withdrawal by Subject|3|||
16502011|NCT01042236|40310261|FG000|Treatment Period 1|Adverse Event|0|||
16502012|NCT01042236|40310262|FG001|Treatment Period 1|Adverse Event|1|||
16502013|NCT01042236|40310263|FG002|Treatment Period 1|Adverse Event|0|||
16502014|NCT01042236|40310264|FG003|Treatment Period 1|Adverse Event|0|||
16502015|NCT01042236|40310265|FG004|Treatment Period 1|Adverse Event|1|||
16502016|NCT01042236|40310266|FG005|Treatment Period 1|Adverse Event|0|||
16502017|NCT01042236|40310261|FG000|Treatment Period 3|Adverse Event|0|||
16390080|NCT00181844|39911904|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
16390081|NCT00928187|39911905|FG000|Overall Study|Death|1|||
16390082|NCT00928187|39911906|FG001|Overall Study|Death|2|||
16390083|NCT00928187|39911907|FG002|Overall Study|Death|3|||
16390084|NCT00928187|39911905|FG000|Overall Study|Lost to Follow-up|1|||
16390085|NCT00928187|39911906|FG001|Overall Study|Lost to Follow-up|2|||
16390086|NCT00928187|39911907|FG002|Overall Study|Lost to Follow-up|1|||
16390087|NCT00928187|39911905|FG000|Overall Study|Withdrawal by Subject|0|||
16390088|NCT00928187|39911906|FG001|Overall Study|Withdrawal by Subject|1|||
16390089|NCT00928187|39911907|FG002|Overall Study|Withdrawal by Subject|1|||
16390090|NCT00928187|39911905|FG000|Overall Study|Protocol Violation|0|||
16390091|NCT00928187|39911906|FG001|Overall Study|Protocol Violation|1|||
16390092|NCT00928187|39911907|FG002|Overall Study|Protocol Violation|0|||
16390093|NCT03943290|39911908|FG000|Overall Study|Sponsor Terminated Study|6|||
16390094|NCT03943290|39911909|FG001|Overall Study|Sponsor Terminated Study|1|||
16390095|NCT03943290|39911910|FG002|Overall Study|Sponsor Terminated Study|11|||
16390096|NCT03943290|39911911|FG003|Overall Study|Sponsor Terminated Study|6|||
16390097|NCT03943290|39911912|FG004|Overall Study|Sponsor Terminated Study|7|||
16390098|NCT03943290|39911913|FG005|Overall Study|Sponsor Terminated Study|6|||
16390099|NCT03943290|39911914|FG006|Overall Study|Sponsor Terminated Study|6|||
16390100|NCT03943290|39911915|FG007|Overall Study|Sponsor Terminated Study|7|||
16390101|NCT03943290|39911916|FG008|Overall Study|Sponsor Terminated Study|8|||
16502018|NCT01042236|40310262|FG001|Treatment Period 3|Adverse Event|0|||
16390102|NCT03943290|39911908|FG000|Overall Study|Lost to Follow-up|1|||
16502019|NCT01042236|40310263|FG002|Treatment Period 3|Adverse Event|0|||
16502020|NCT01042236|40310264|FG003|Treatment Period 3|Adverse Event|1|||
16502021|NCT01042236|40310265|FG004|Treatment Period 3|Adverse Event|0|||
16502022|NCT01042236|40310266|FG005|Treatment Period 3|Adverse Event|0|||
16502023|NCT01042236|40310261|FG000|Treatment Period 3|Protocol Violation|0|||
16502024|NCT01042236|40310262|FG001|Treatment Period 3|Protocol Violation|0|||
16502025|NCT01042236|40310263|FG002|Treatment Period 3|Protocol Violation|0|||
16502026|NCT01042236|40310264|FG003|Treatment Period 3|Protocol Violation|1|||
16502027|NCT01042236|40310265|FG004|Treatment Period 3|Protocol Violation|0|||
16502028|NCT01042236|40310266|FG005|Treatment Period 3|Protocol Violation|0|||
16502029|NCT02617511|40310268|FG000|Overall Study|Withdrawal by Subject|1|||
16502030|NCT02617511|40310269|FG001|Overall Study|Withdrawal by Subject|0|||
16502031|NCT01103284|40310270|FG000|Overall Study|Death|2|||
16502032|NCT01103284|40310271|FG001|Overall Study|Death|0|||
16502033|NCT01103284|40310270|FG000|Overall Study|Lost to Follow-up|9|||
16502034|NCT01103284|40310271|FG001|Overall Study|Lost to Follow-up|10|||
16502035|NCT01103284|40310270|FG000|Overall Study|Pregnancy|3|||
16502036|NCT01103284|40310271|FG001|Overall Study|Pregnancy|1|||
16502037|NCT01103284|40310270|FG000|Overall Study|Protocol Violation|12|||
16502038|NCT01103284|40310271|FG001|Overall Study|Protocol Violation|5|||
16502039|NCT01103284|40310270|FG000|Overall Study|Adverse Event|0|||
16502040|NCT01103284|40310271|FG001|Overall Study|Adverse Event|5|||
16390103|NCT03943290|39911909|FG001|Overall Study|Lost to Follow-up|0|||
16502041|NCT01103284|40310270|FG000|Overall Study|Withdrawal by Subject|14|||
16390104|NCT03943290|39911910|FG002|Overall Study|Lost to Follow-up|1|||
16390105|NCT03943290|39911911|FG003|Overall Study|Lost to Follow-up|0|||
16390106|NCT03943290|39911912|FG004|Overall Study|Lost to Follow-up|0|||
16390107|NCT03943290|39911913|FG005|Overall Study|Lost to Follow-up|0|||
16390108|NCT03943290|39911914|FG006|Overall Study|Lost to Follow-up|0|||
16390109|NCT03943290|39911915|FG007|Overall Study|Lost to Follow-up|1|||
16390110|NCT03943290|39911916|FG008|Overall Study|Lost to Follow-up|0|||
16390111|NCT03943290|39911908|FG000|Overall Study|Withdrawal by Subject|0|||
16390112|NCT03943290|39911909|FG001|Overall Study|Withdrawal by Subject|0|||
16390113|NCT03943290|39911910|FG002|Overall Study|Withdrawal by Subject|1|||
16390114|NCT03943290|39911911|FG003|Overall Study|Withdrawal by Subject|0|||
16390115|NCT03943290|39911912|FG004|Overall Study|Withdrawal by Subject|0|||
16390116|NCT03943290|39911913|FG005|Overall Study|Withdrawal by Subject|0|||
16390117|NCT03943290|39911914|FG006|Overall Study|Withdrawal by Subject|0|||
16390118|NCT03943290|39911915|FG007|Overall Study|Withdrawal by Subject|0|||
16390119|NCT03943290|39911916|FG008|Overall Study|Withdrawal by Subject|0|||
16390120|NCT00107276|39911923|FG000|Overall Study|Progression|46|||
16390121|NCT00107276|39911923|FG000|Overall Study|Adverse Event|6|||
16390122|NCT00107276|39911923|FG000|Overall Study|M.D. decision|2|||
16390123|NCT00107276|39911923|FG000|Overall Study|Patient refusal|1|||
16390124|NCT00107276|39911923|FG000|Overall Study|Death|1|||
16390125|NCT00107276|39911923|FG000|Overall Study|Ineligible|16|||
16502042|NCT01103284|40310271|FG001|Overall Study|Withdrawal by Subject|18|||
16502043|NCT01103284|40310270|FG000|Overall Study|Dermal Hypersensitivity|0|||
16502044|NCT01103284|40310271|FG001|Overall Study|Dermal Hypersensitivity|1|||
16502045|NCT01103284|40310270|FG000|Overall Study|Termination by the Sponsor|0|||
16310527|NCT00811733|39623429|FG000|Overall Study|Withdrawal by Subject|1|||
16310528|NCT00811733|39623430|FG001|Overall Study|Withdrawal by Subject|2|||
16310529|NCT02585778|39623434|FG000|Overall Study|Adverse Event|17|||
16310530|NCT02585778|39623435|FG001|Overall Study|Adverse Event|4|||
16310531|NCT02585778|39623434|FG000|Overall Study|Participant did not wish to continue|9|||
16502046|NCT01103284|40310271|FG001|Overall Study|Termination by the Sponsor|1|||
16310532|NCT02585778|39623435|FG001|Overall Study|Participant did not wish to continue|4|||
16310533|NCT02585778|39623434|FG000|Overall Study|Poor compliance to study protocol|0|||
16310534|NCT02585778|39623435|FG001|Overall Study|Poor compliance to study protocol|2|||
16310535|NCT02585778|39623434|FG000|Overall Study|Death|0|||
16310536|NCT02585778|39623435|FG001|Overall Study|Death|1|||
16502047|NCT01103284|40310270|FG000|Overall Study|Not described|2|||
16502048|NCT01103284|40310271|FG001|Overall Study|Not described|1|||
16310537|NCT02585778|39623434|FG000|Overall Study|Randomized but not treated|1|||
16310538|NCT02585778|39623435|FG001|Overall Study|Randomized but not treated|2|||
16310539|NCT02585778|39623434|FG000|Overall Study|Other than specified above|6|||
16310540|NCT02585778|39623435|FG001|Overall Study|Other than specified above|2|||
16310541|NCT02152605|39623440|FG000|Overall Study|Adverse Event|6|||
16310542|NCT02152605|39623441|FG001|Overall Study|Adverse Event|8|||
16310543|NCT02152605|39623440|FG000|Overall Study|Lack of Efficacy|7|||
16310544|NCT02152605|39623441|FG001|Overall Study|Lack of Efficacy|4|||
16390126|NCT00517699|39911928|FG000|Overall Study|Withdrawal by Subject|1|||
16390127|NCT00517699|39911928|FG000|Overall Study|Lack of Efficacy|1|||
16502049|NCT01103284|40310270|FG000|Overall Study|Missing CRF entries for study completion|0|||
16502050|NCT01103284|40310271|FG001|Overall Study|Missing CRF entries for study completion|2|||
16502051|NCT00849381|40310272|FG000|Overall Study|Adverse Event|1|||
16502052|NCT00849381|40310272|FG000|Overall Study|Lost to Follow-up|129|||
16502053|NCT00849381|40310272|FG000|Overall Study|Protocol Violation|5|||
16502054|NCT00849381|40310272|FG000|Overall Study|Withdrawal by Subject|6|||
16502055|NCT00849381|40310272|FG000|Overall Study|Other|4|||
16502056|NCT03717480|40310274|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
16502057|NCT02092662|40310277|FG000|Overall Study|Lost to Follow-up|13|||
16502058|NCT02092662|40310278|FG001|Overall Study|Lost to Follow-up|0|||
16502059|NCT03721276|40310284|FG000|Overall Study|Lost to Follow-up|5|||
16502060|NCT03721276|40310285|FG001|Overall Study|Lost to Follow-up|3|||
16502061|NCT03721276|40310284|FG000|Overall Study|Adverse Event|0|||
16502062|NCT03721276|40310285|FG001|Overall Study|Adverse Event|1|||
16502063|NCT02514447|40310288|FG000|Overall Study|Withdrawal by Subject|3|||
16502064|NCT02514447|40310289|FG001|Overall Study|Withdrawal by Subject|1|||
16502065|NCT02514447|40310290|FG002|Overall Study|Withdrawal by Subject|1|||
16502066|NCT02514447|40310291|FG003|Overall Study|Withdrawal by Subject|0|||
16502067|NCT02514447|40310292|FG004|Overall Study|Withdrawal by Subject|0|||
16502068|NCT02514447|40310293|FG005|Overall Study|Withdrawal by Subject|0|||
16390128|NCT00517699|39911928|FG000|Overall Study|Administrative error|1|||
16390129|NCT00517699|39911928|FG000|Overall Study|Study terminated by Sponsor|2|||
16390130|NCT05384834|39911938|FG000|Overall Study|Lost to Follow-up|43|||
16310545|NCT02152605|39623440|FG000|Overall Study|Protocol deviation|1|||
16390131|NCT05384834|39911938|FG000|Overall Study|Withdrawal by Subject|5|||
16390132|NCT02707965|39911939|FG000|Overall Study|Withdrawal by Subject|0|||
16310546|NCT02152605|39623441|FG001|Overall Study|Protocol deviation|4|||
16310547|NCT02152605|39623440|FG000|Overall Study|Lost to Follow-up|1|||
16390133|NCT02707965|39911940|FG001|Overall Study|Withdrawal by Subject|0|||
16390134|NCT02707965|39911941|FG002|Overall Study|Withdrawal by Subject|1|||
16390135|NCT02707965|39911942|FG003|Overall Study|Withdrawal by Subject|0|||
16390136|NCT02707965|39911943|FG004|Overall Study|Withdrawal by Subject|0|||
16390137|NCT02707965|39911944|FG005|Overall Study|Withdrawal by Subject|0|||
16390138|NCT02707965|39911945|FG006|Overall Study|Withdrawal by Subject|0|||
16390139|NCT02707965|39911946|FG007|Overall Study|Withdrawal by Subject|2|||
16390140|NCT02707965|39911947|FG008|Overall Study|Withdrawal by Subject|0|||
16390141|NCT02707965|39911948|FG009|Overall Study|Withdrawal by Subject|0|||
16390142|NCT02707965|39911949|FG010|Overall Study|Withdrawal by Subject|0|||
16390143|NCT02707965|39911950|FG011|Overall Study|Withdrawal by Subject|0|||
16390144|NCT02707965|39911951|FG012|Overall Study|Withdrawal by Subject|0|||
16390145|NCT02707965|39911952|FG013|Overall Study|Withdrawal by Subject|0|||
16390146|NCT02707965|39911953|FG014|Overall Study|Withdrawal by Subject|0|||
16390147|NCT02707965|39911954|FG015|Overall Study|Withdrawal by Subject|0|||
16390148|NCT02707965|39911939|FG000|Overall Study|PI decisions|0|||
16390149|NCT02707965|39911940|FG001|Overall Study|PI decisions|0|||
16390150|NCT02707965|39911941|FG002|Overall Study|PI decisions|0|||
16390151|NCT02707965|39911942|FG003|Overall Study|PI decisions|0|||
16089221|NCT03451422|38816844|FG001|Overall Study|Withdrawal by Subject|0|||
16089222|NCT03451422|38816845|FG002|Overall Study|Withdrawal by Subject|2|||
16089223|NCT03451422|38816846|FG003|Overall Study|Withdrawal by Subject|3|||
16089224|NCT03451422|38816847|FG004|Overall Study|Withdrawal by Subject|2|||
16310548|NCT02152605|39623441|FG001|Overall Study|Lost to Follow-up|0|||
16310549|NCT02152605|39623440|FG000|Overall Study|Withdrew consent|4|||
16310550|NCT02152605|39623441|FG001|Overall Study|Withdrew consent|2|||
16310551|NCT01651117|39623451|FG000|Overall Study|Death|2|||
16310552|NCT01651117|39623452|FG001|Overall Study|Death|3|||
16310553|NCT01651117|39623453|FG002|Overall Study|Death|2|||
16310554|NCT01651117|39623454|FG003|Overall Study|Death|2|||
16310555|NCT01486446|39623455|FG000|Overall Study|Adverse Event|1|||
16310556|NCT01486446|39623456|FG001|Overall Study|Adverse Event|0|||
16310557|NCT04123405|39623461|FG000|Overall Study|Adverse Event|1|||
16310558|NCT04123405|39623462|FG001|Overall Study|Adverse Event|2|||
16310559|NCT04123405|39623463|FG002|Overall Study|Adverse Event|3|||
16310560|NCT04123405|39623464|FG003|Overall Study|Adverse Event|3|||
16310561|NCT04123405|39623461|FG000|Overall Study|Exclusion criteria met|1|||
16310562|NCT04123405|39623462|FG001|Overall Study|Exclusion criteria met|2|||
16310563|NCT04123405|39623463|FG002|Overall Study|Exclusion criteria met|0|||
16310564|NCT04123405|39623464|FG003|Overall Study|Exclusion criteria met|2|||
16310565|NCT04123405|39623461|FG000|Overall Study|Withdrawal by Subject|1|||
16310566|NCT04123405|39623462|FG001|Overall Study|Withdrawal by Subject|3|||
16310567|NCT04123405|39623463|FG002|Overall Study|Withdrawal by Subject|0|||
16310568|NCT04123405|39623464|FG003|Overall Study|Withdrawal by Subject|2|||
16310569|NCT04123405|39623461|FG000|Overall Study|Contact to subject lost|0|||
16310570|NCT04123405|39623462|FG001|Overall Study|Contact to subject lost|0|||
16310571|NCT04123405|39623463|FG002|Overall Study|Contact to subject lost|0|||
16310572|NCT04123405|39623464|FG003|Overall Study|Contact to subject lost|1|||
16310573|NCT04123405|39623461|FG000|Overall Study|screening failure|1|||
16310574|NCT04123405|39623462|FG001|Overall Study|screening failure|0|||
16310575|NCT04123405|39623463|FG002|Overall Study|screening failure|0|||
16310576|NCT04123405|39623464|FG003|Overall Study|screening failure|0|||
16310577|NCT01515423|39623471|FG000|Open Label Phase|Adverse Event|57|||
16310578|NCT01515423|39623472|FG001|Open Label Phase|Adverse Event|0|||
16310579|NCT01515423|39623473|FG002|Open Label Phase|Adverse Event|0|||
16310580|NCT01515423|39623471|FG000|Open Label Phase|Death|2|||
16310581|NCT01515423|39623472|FG001|Open Label Phase|Death|0|||
16310582|NCT01515423|39623473|FG002|Open Label Phase|Death|0|||
16310583|NCT01515423|39623471|FG000|Open Label Phase|Lack of Efficacy|117|||
16310584|NCT01515423|39623472|FG001|Open Label Phase|Lack of Efficacy|0|||
16310585|NCT01515423|39623473|FG002|Open Label Phase|Lack of Efficacy|0|||
16310586|NCT01515423|39623471|FG000|Open Label Phase|Lost to Follow-up|21|||
16310587|NCT01515423|39623472|FG001|Open Label Phase|Lost to Follow-up|0|||
16310588|NCT01515423|39623473|FG002|Open Label Phase|Lost to Follow-up|0|||
16310589|NCT01515423|39623471|FG000|Open Label Phase|Withdrawal by Subject|118|||
16310590|NCT01515423|39623472|FG001|Open Label Phase|Withdrawal by Subject|0|||
16310591|NCT01515423|39623473|FG002|Open Label Phase|Withdrawal by Subject|0|||
16310592|NCT01515423|39623471|FG000|Open Label Phase|excluded from DB Phase|70|||
16310593|NCT01515423|39623472|FG001|Open Label Phase|excluded from DB Phase|0|||
16310594|NCT01515423|39623473|FG002|Open Label Phase|excluded from DB Phase|0|||
16310595|NCT01515423|39623471|FG000|Open Label Phase|Other|28|||
16310596|NCT01515423|39623472|FG001|Open Label Phase|Other|0|||
16310597|NCT01515423|39623473|FG002|Open Label Phase|Other|0|||
16310598|NCT01515423|39623471|FG000|DOUBLE BLIND|Adverse Event|0|||
16310599|NCT01515423|39623472|FG001|DOUBLE BLIND|Adverse Event|15|||
16310600|NCT01515423|39623473|FG002|DOUBLE BLIND|Adverse Event|13|||
16390152|NCT02707965|39911943|FG004|Overall Study|PI decisions|0|||
16390153|NCT02707965|39911944|FG005|Overall Study|PI decisions|0|||
16390154|NCT02707965|39911945|FG006|Overall Study|PI decisions|0|||
16390155|NCT02707965|39911946|FG007|Overall Study|PI decisions|0|||
16089225|NCT03451422|38816848|FG005|Overall Study|Withdrawal by Subject|1|||
16089226|NCT03288506|38816854|FG000|Overall Study|Withdrawal by Subject|52|||
16089227|NCT01334606|38816856|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
16089228|NCT03615404|38816859|FG000|Overall Study|Death|1|||
16089229|NCT03615404|38816859|FG000|Overall Study|vaccine did not pass quality assurance|1|||
16089230|NCT02958553|38816860|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
16089231|NCT02958553|38816860|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
16089232|NCT00800176|38816861|FG000|Overall Study|Adverse Event|2|||
16089233|NCT00800176|38816862|FG001|Overall Study|Adverse Event|1|||
16089234|NCT00800176|38816863|FG002|Overall Study|Adverse Event|0|||
16089235|NCT00800176|38816864|FG003|Overall Study|Adverse Event|2|||
16089236|NCT00800176|38816865|FG004|Overall Study|Adverse Event|1|||
16502069|NCT02514447|40310294|FG006|Overall Study|Withdrawal by Subject|0|||
16502070|NCT02514447|40310295|FG007|Overall Study|Withdrawal by Subject|1|||
16502071|NCT02514447|40310296|FG008|Overall Study|Withdrawal by Subject|1|||
16502072|NCT02514447|40310288|FG000|Overall Study|Death|24|||
16089237|NCT00800176|38816866|FG005|Overall Study|Adverse Event|1|||
16089238|NCT00800176|38816861|FG000|Overall Study|Refused treatment|3|||
16502073|NCT02514447|40310289|FG001|Overall Study|Death|28|||
16502074|NCT02514447|40310290|FG002|Overall Study|Death|29|||
16502075|NCT02514447|40310291|FG003|Overall Study|Death|0|||
16502076|NCT02514447|40310292|FG004|Overall Study|Death|3|||
16502077|NCT02514447|40310293|FG005|Overall Study|Death|4|||
16502078|NCT02514447|40310294|FG006|Overall Study|Death|8|||
16502079|NCT02514447|40310295|FG007|Overall Study|Death|6|||
16502080|NCT02514447|40310296|FG008|Overall Study|Death|5|||
16502081|NCT02514447|40310288|FG000|Overall Study|Lost to Follow-up|1|||
16502082|NCT02514447|40310289|FG001|Overall Study|Lost to Follow-up|0|||
16502083|NCT02514447|40310290|FG002|Overall Study|Lost to Follow-up|0|||
16502084|NCT02514447|40310291|FG003|Overall Study|Lost to Follow-up|0|||
16502085|NCT02514447|40310292|FG004|Overall Study|Lost to Follow-up|0|||
16502086|NCT02514447|40310293|FG005|Overall Study|Lost to Follow-up|0|||
16502087|NCT02514447|40310294|FG006|Overall Study|Lost to Follow-up|0|||
16502088|NCT02514447|40310295|FG007|Overall Study|Lost to Follow-up|0|||
16502089|NCT02514447|40310296|FG008|Overall Study|Lost to Follow-up|1|||
16502090|NCT02514447|40310288|FG000|Overall Study|Sponsor Termination of Study|0|||
16502091|NCT02514447|40310289|FG001|Overall Study|Sponsor Termination of Study|1|||
16502092|NCT02514447|40310290|FG002|Overall Study|Sponsor Termination of Study|1|||
16502093|NCT02514447|40310291|FG003|Overall Study|Sponsor Termination of Study|0|||
16502094|NCT02514447|40310292|FG004|Overall Study|Sponsor Termination of Study|0|||
16502095|NCT02514447|40310293|FG005|Overall Study|Sponsor Termination of Study|0|||
16502096|NCT02514447|40310294|FG006|Overall Study|Sponsor Termination of Study|0|||
16502097|NCT02514447|40310295|FG007|Overall Study|Sponsor Termination of Study|0|||
16502098|NCT02514447|40310296|FG008|Overall Study|Sponsor Termination of Study|0|||
16502099|NCT02514447|40310288|FG000|Overall Study|Study completion per Investigator|1|||
16502100|NCT02514447|40310289|FG001|Overall Study|Study completion per Investigator|0|||
16502101|NCT02514447|40310290|FG002|Overall Study|Study completion per Investigator|1|||
16502102|NCT02514447|40310291|FG003|Overall Study|Study completion per Investigator|2|||
16502103|NCT02514447|40310292|FG004|Overall Study|Study completion per Investigator|0|||
16502104|NCT02514447|40310293|FG005|Overall Study|Study completion per Investigator|0|||
16502105|NCT02514447|40310294|FG006|Overall Study|Study completion per Investigator|0|||
16502106|NCT02514447|40310295|FG007|Overall Study|Study completion per Investigator|0|||
16502107|NCT02514447|40310296|FG008|Overall Study|Study completion per Investigator|1|||
16502108|NCT00939809|40310299|FG000|Overall Study|Adverse Event|2|||
16502109|NCT00939809|40310299|FG000|Overall Study|Death|1|||
16502110|NCT02864251|40310306|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
16502111|NCT02864251|40310307|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
16502112|NCT02864251|40310308|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
16502113|NCT02864251|40310306|FG000|Pre-Treatment|Withdrawal by Participant|0|||
16502114|NCT02864251|40310307|FG001|Pre-Treatment|Withdrawal by Participant|0|||
16502115|NCT02864251|40310308|FG002|Pre-Treatment|Withdrawal by Participant|4|||
16502116|NCT02864251|40310306|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
16502117|NCT02864251|40310307|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
16502118|NCT02864251|40310308|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
16502119|NCT02864251|40310306|FG000|Pre-Treatment|Other Reasons|0|||
16089239|NCT00800176|38816862|FG001|Overall Study|Refused treatment|2|||
16089240|NCT00800176|38816863|FG002|Overall Study|Refused treatment|0|||
16390156|NCT02707965|39911947|FG008|Overall Study|PI decisions|0|||
16502120|NCT02864251|40310307|FG001|Pre-Treatment|Other Reasons|1|||
16502121|NCT02864251|40310308|FG002|Pre-Treatment|Other Reasons|1|||
16502122|NCT02864251|40310306|FG000|Treatment|Disease Progression|109|||
16089241|NCT00800176|38816864|FG003|Overall Study|Refused treatment|0|||
16089242|NCT00800176|38816865|FG004|Overall Study|Refused treatment|1|||
16089243|NCT00800176|38816866|FG005|Overall Study|Refused treatment|4|||
16502123|NCT02864251|40310307|FG001|Treatment|Disease Progression|52|||
16502124|NCT02864251|40310308|FG002|Treatment|Disease Progression|101|||
16502125|NCT02864251|40310306|FG000|Treatment|Study Drug Toxicity|9|||
16502126|NCT02864251|40310307|FG001|Treatment|Study Drug Toxicity|4|||
16502127|NCT02864251|40310308|FG002|Treatment|Study Drug Toxicity|10|||
16502128|NCT02864251|40310306|FG000|Treatment|Death|0|||
16502129|NCT02864251|40310307|FG001|Treatment|Death|2|||
16502130|NCT02864251|40310308|FG002|Treatment|Death|3|||
16502131|NCT02864251|40310306|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
16502132|NCT02864251|40310307|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
16502133|NCT02864251|40310308|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
16502134|NCT02864251|40310306|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
16502135|NCT02864251|40310307|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
16502136|NCT02864251|40310308|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
16502137|NCT02864251|40310306|FG000|Treatment|Withdrawal by Participant|8|||
16502138|NCT02864251|40310307|FG001|Treatment|Withdrawal by Participant|5|||
16502139|NCT02864251|40310308|FG002|Treatment|Withdrawal by Participant|13|||
16502140|NCT02864251|40310306|FG000|Treatment|Maximum Clinical Benefit|1|||
16502141|NCT02864251|40310307|FG001|Treatment|Maximum Clinical Benefit|0|||
16502142|NCT02864251|40310308|FG002|Treatment|Maximum Clinical Benefit|1|||
16502143|NCT02864251|40310306|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
16502144|NCT02864251|40310307|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
16502145|NCT02864251|40310308|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
16502146|NCT02864251|40310306|FG000|Treatment|Other Reasons|1|||
16502147|NCT02864251|40310307|FG001|Treatment|Other Reasons|1|||
16502148|NCT02864251|40310308|FG002|Treatment|Other Reasons|4|||
16502149|NCT02864251|40310306|FG000|Treatment|Administrative Reason by Sponsor|1|||
16502150|NCT02864251|40310307|FG001|Treatment|Administrative Reason by Sponsor|0|||
16502151|NCT02864251|40310308|FG002|Treatment|Administrative Reason by Sponsor|0|||
16502152|NCT04210310|40310309|FG000|Overall Study|Lost to Follow-up|32|||
16502153|NCT04210310|40310310|FG001|Overall Study|Lost to Follow-up|1|||
16502154|NCT01826487|40310311|FG000|Overall Study|Adverse Event|1|||
16502155|NCT01826487|40310312|FG001|Overall Study|Adverse Event|1|||
16502156|NCT01826487|40310311|FG000|Overall Study|Lost to Follow-up|1|||
16502157|NCT01826487|40310312|FG001|Overall Study|Lost to Follow-up|0|||
16502158|NCT01826487|40310311|FG000|Overall Study|Withdrawal by Subject|1|||
16502159|NCT01826487|40310312|FG001|Overall Study|Withdrawal by Subject|3|||
16502160|NCT01826487|40310311|FG000|Overall Study|Protocol Violation|1|||
16502161|NCT01826487|40310312|FG001|Overall Study|Protocol Violation|1|||
16502162|NCT00006903|40310313|FG000|Overall Study|Still receiving treatment|0|||
16502163|NCT00006903|40310314|FG001|Overall Study|Still receiving treatment|0|||
16502164|NCT00006903|40310315|FG002|Overall Study|Still receiving treatment|1|||
16502165|NCT00006903|40310313|FG000|Overall Study|Refused further treatment|0|||
16502166|NCT00006903|40310314|FG001|Overall Study|Refused further treatment|2|||
16502167|NCT00006903|40310315|FG002|Overall Study|Refused further treatment|1|||
16502168|NCT00006903|40310313|FG000|Overall Study|Adverse Event|0|||
16502169|NCT00006903|40310314|FG001|Overall Study|Adverse Event|0|||
16502170|NCT00006903|40310315|FG002|Overall Study|Adverse Event|1|||
16502171|NCT00006903|40310313|FG000|Overall Study|Death|0|||
16502172|NCT00006903|40310314|FG001|Overall Study|Death|1|||
16502173|NCT00006903|40310315|FG002|Overall Study|Death|0|||
16502174|NCT00006903|40310313|FG000|Overall Study|Patient never treated|0|||
16502175|NCT00006903|40310314|FG001|Overall Study|Patient never treated|0|||
16502176|NCT00006903|40310315|FG002|Overall Study|Patient never treated|1|||
16502177|NCT00006903|40310313|FG000|Overall Study|Ineligible|10|||
16502178|NCT00006903|40310314|FG001|Overall Study|Ineligible|1|||
16502179|NCT00006903|40310315|FG002|Overall Study|Ineligible|2|||
16502180|NCT02587065|40310316|FG000|Overall Study|Adverse Event|14|||
16502181|NCT02587065|40310316|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
16502182|NCT02587065|40310316|FG000|Overall Study|Non-adherence to the Protocol|3|||
16502183|NCT02587065|40310316|FG000|Overall Study|Discontinuation of Study Medication|2|||
16502184|NCT02587065|40310316|FG000|Overall Study|Reason not Specified|3|||
16502185|NCT03683758|40310317|FG000|Overall Study|Non-study commitment conflict|1|||
16502186|NCT03683758|40310318|FG001|Overall Study|Non-study commitment conflict|3|||
16502187|NCT03683758|40310317|FG000|Overall Study|Illness preventing participation|1|||
16502188|NCT03683758|40310318|FG001|Overall Study|Illness preventing participation|0|||
16502189|NCT03683758|40310317|FG000|Overall Study|Adverse Event|1|||
16502190|NCT03683758|40310318|FG001|Overall Study|Adverse Event|0|||
16502191|NCT05517382|40310326|FG000|Overall Study|Lost to Follow-up|0|||
16502192|NCT05517382|40310327|FG001|Overall Study|Lost to Follow-up|1|||
16502193|NCT01405963|40310328|FG000|Overall Study|Moved Away|2|||
16502194|NCT01405963|40310329|FG001|Overall Study|Moved Away|0|||
16502195|NCT01405963|40310328|FG000|Overall Study|Adverse Event|0|||
16502196|NCT01405963|40310329|FG001|Overall Study|Adverse Event|1|||
16502197|NCT01405963|40310328|FG000|Overall Study|Lost to Follow-up|0|||
16502198|NCT01405963|40310329|FG001|Overall Study|Lost to Follow-up|1|||
16502199|NCT03774433|40310330|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
16502200|NCT02024867|40310333|FG000|Overall Study|Protocol Violation|3|||
16502201|NCT02024867|40310334|FG001|Overall Study|Protocol Violation|3|||
16502202|NCT02024867|40310333|FG000|Overall Study|Lost to Follow-up|6|||
16502203|NCT02024867|40310334|FG001|Overall Study|Lost to Follow-up|4|||
16502204|NCT04267133|40310335|FG000|Overall Study|Withdrawal by Subject|1|||
16502205|NCT04267133|40310335|FG000|Overall Study|Adverse Event|4|||
16502206|NCT02420691|40310337|FG000|Overall Study|Adverse Event|3|||
16502207|NCT02420691|40310337|FG000|Overall Study|Withdrawal by Subject|3|||
16502208|NCT01741701|40310341|FG000|Overall Study|Adverse Event|5|||
16502209|NCT01741701|40310342|FG001|Overall Study|Adverse Event|1|||
16502210|NCT01741701|40310341|FG000|Overall Study|Withdrawal by Subject|0|||
16502211|NCT01741701|40310342|FG001|Overall Study|Withdrawal by Subject|1|||
16502212|NCT00405587|40310343|FG000|Overall Study|Death|0|||
16502213|NCT00405587|40310344|FG001|Overall Study|Death|0|||
16502214|NCT00405587|40310345|FG002|Overall Study|Death|0|||
16502215|NCT00405587|40310346|FG003|Overall Study|Death|1|||
16502216|NCT00405587|40310343|FG000|Overall Study|Disease Progression|22|||
16502217|NCT00405587|40310344|FG001|Overall Study|Disease Progression|23|||
16502218|NCT00405587|40310345|FG002|Overall Study|Disease Progression|21|||
16502219|NCT00405587|40310346|FG003|Overall Study|Disease Progression|17|||
16502220|NCT00405587|40310343|FG000|Overall Study|Physician Decision|3|||
16502221|NCT00405587|40310344|FG001|Overall Study|Physician Decision|2|||
16502222|NCT00405587|40310345|FG002|Overall Study|Physician Decision|0|||
16502223|NCT00405587|40310346|FG003|Overall Study|Physician Decision|0|||
16502224|NCT00405587|40310343|FG000|Overall Study|Adverse Event|1|||
16502225|NCT00405587|40310344|FG001|Overall Study|Adverse Event|0|||
16502226|NCT00405587|40310345|FG002|Overall Study|Adverse Event|0|||
16502227|NCT00405587|40310346|FG003|Overall Study|Adverse Event|0|||
16502228|NCT00405587|40310343|FG000|Overall Study|Lost to Follow-up|0|||
16502229|NCT00405587|40310344|FG001|Overall Study|Lost to Follow-up|1|||
16502230|NCT00405587|40310345|FG002|Overall Study|Lost to Follow-up|1|||
16502231|NCT00405587|40310346|FG003|Overall Study|Lost to Follow-up|0|||
16502232|NCT00405587|40310343|FG000|Overall Study|Radiation induced necrosis|0|||
16502233|NCT00405587|40310344|FG001|Overall Study|Radiation induced necrosis|1|||
16502234|NCT00405587|40310345|FG002|Overall Study|Radiation induced necrosis|0|||
16502235|NCT00405587|40310346|FG003|Overall Study|Radiation induced necrosis|0|||
16502236|NCT00405587|40310343|FG000|Overall Study|Withdrawal by Subject|0|||
16502237|NCT00405587|40310344|FG001|Overall Study|Withdrawal by Subject|0|||
16502238|NCT00405587|40310345|FG002|Overall Study|Withdrawal by Subject|0|||
16502239|NCT00405587|40310346|FG003|Overall Study|Withdrawal by Subject|2|||
16089244|NCT00800176|38816861|FG000|Overall Study|Failure to return|3|||
16089245|NCT00800176|38816862|FG001|Overall Study|Failure to return|3|||
16089246|NCT00800176|38816863|FG002|Overall Study|Failure to return|0|||
16089247|NCT00800176|38816864|FG003|Overall Study|Failure to return|2|||
16089248|NCT00800176|38816865|FG004|Overall Study|Failure to return|0|||
16089249|NCT00800176|38816866|FG005|Overall Study|Failure to return|0|||
16089250|NCT00800176|38816861|FG000|Overall Study|Other|1|||
16089251|NCT00800176|38816862|FG001|Overall Study|Other|0|||
16089252|NCT00800176|38816863|FG002|Overall Study|Other|0|||
16089253|NCT00800176|38816864|FG003|Overall Study|Other|0|||
16089254|NCT00800176|38816865|FG004|Overall Study|Other|2|||
16390157|NCT02707965|39911948|FG009|Overall Study|PI decisions|0|||
16390158|NCT02707965|39911949|FG010|Overall Study|PI decisions|0|||
16390159|NCT02707965|39911950|FG011|Overall Study|PI decisions|0|||
16390160|NCT02707965|39911951|FG012|Overall Study|PI decisions|0|||
16390161|NCT02707965|39911952|FG013|Overall Study|PI decisions|0|||
16390162|NCT02707965|39911953|FG014|Overall Study|PI decisions|2|||
16390163|NCT02707965|39911954|FG015|Overall Study|PI decisions|0|||
16390164|NCT02707965|39911939|FG000|Overall Study|Protocol deviation|1|||
16390165|NCT02707965|39911940|FG001|Overall Study|Protocol deviation|1|||
16390166|NCT02707965|39911941|FG002|Overall Study|Protocol deviation|0|||
16390167|NCT02707965|39911942|FG003|Overall Study|Protocol deviation|0|||
16502240|NCT00405587|40310343|FG000|Overall Study|Participant not dosed|0|||
16390168|NCT02707965|39911943|FG004|Overall Study|Protocol deviation|0|||
16089255|NCT00800176|38816866|FG005|Overall Study|Other|0|||
16089256|NCT02091752|38816867|FG000|Overall Study|Study terminated by Sponsor|2|||
16089257|NCT02091752|38816867|FG000|Overall Study|Adverse Event|1|||
16089258|NCT03200574|38816868|FG000|Overall Study|Death|4|||
16390169|NCT02707965|39911944|FG005|Overall Study|Protocol deviation|0|||
16390170|NCT02707965|39911945|FG006|Overall Study|Protocol deviation|0|||
16390171|NCT02707965|39911946|FG007|Overall Study|Protocol deviation|1|||
16502241|NCT00405587|40310344|FG001|Overall Study|Participant not dosed|1|||
16502242|NCT00405587|40310345|FG002|Overall Study|Participant not dosed|0|||
16502243|NCT00405587|40310346|FG003|Overall Study|Participant not dosed|0|||
16502244|NCT04964128|40310347|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
16502245|NCT04964128|40310347|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
16502246|NCT03340025|40310348|FG000|Overall Study|Lost to Follow-up|2|||
16502247|NCT03340025|40310349|FG001|Overall Study|Lost to Follow-up|2|||
16502248|NCT00507442|40310350|FG000|Overall Study|Adverse Event|8|||
16502249|NCT00507442|40310351|FG001|Overall Study|Adverse Event|11|||
16502250|NCT00507442|40310352|FG002|Overall Study|Adverse Event|4|||
16502251|NCT00507442|40310353|FG003|Overall Study|Adverse Event|1|||
16502252|NCT00507442|40310350|FG000|Overall Study|Protocol Violation|0|||
16502253|NCT00507442|40310351|FG001|Overall Study|Protocol Violation|1|||
16502254|NCT00507442|40310352|FG002|Overall Study|Protocol Violation|0|||
16502255|NCT00507442|40310353|FG003|Overall Study|Protocol Violation|0|||
16502256|NCT00507442|40310350|FG000|Overall Study|Lost to Follow-up|0|||
16502257|NCT00507442|40310351|FG001|Overall Study|Lost to Follow-up|0|||
16502258|NCT00507442|40310352|FG002|Overall Study|Lost to Follow-up|1|||
16502259|NCT00507442|40310353|FG003|Overall Study|Lost to Follow-up|0|||
16502260|NCT00507442|40310350|FG000|Overall Study|Physician Decision|0|||
16502261|NCT00507442|40310351|FG001|Overall Study|Physician Decision|2|||
16502262|NCT00507442|40310352|FG002|Overall Study|Physician Decision|4|||
16502263|NCT00507442|40310353|FG003|Overall Study|Physician Decision|1|||
16502264|NCT00507442|40310350|FG000|Overall Study|Progressive Disease|2|||
16502265|NCT00507442|40310351|FG001|Overall Study|Progressive Disease|4|||
16502266|NCT00507442|40310352|FG002|Overall Study|Progressive Disease|2|||
16502267|NCT00507442|40310353|FG003|Overall Study|Progressive Disease|0|||
16502268|NCT00507442|40310350|FG000|Overall Study|Withdrawal by Subject|4|||
16502269|NCT00507442|40310351|FG001|Overall Study|Withdrawal by Subject|4|||
16502270|NCT00507442|40310352|FG002|Overall Study|Withdrawal by Subject|2|||
16502271|NCT00507442|40310353|FG003|Overall Study|Withdrawal by Subject|1|||
16502272|NCT00507442|40310350|FG000|Overall Study|Other|2|||
16502273|NCT00507442|40310351|FG001|Overall Study|Other|5|||
16502274|NCT00507442|40310352|FG002|Overall Study|Other|2|||
16502275|NCT00507442|40310353|FG003|Overall Study|Other|2|||
16502276|NCT02189473|40310354|FG000|Overall Study|Death|22|||
16502277|NCT02189473|40310355|FG001|Overall Study|Death|23|||
16502278|NCT02189473|40310354|FG000|Overall Study|Lost to Follow-up|1|||
16502279|NCT02189473|40310355|FG001|Overall Study|Lost to Follow-up|2|||
16502280|NCT02968563|40310356|FG000|Overall Study|Adverse Event|0|||
16502281|NCT02968563|40310357|FG001|Overall Study|Adverse Event|6|||
16502282|NCT02968563|40310356|FG000|Overall Study|Death|1|||
16502283|NCT02968563|40310357|FG001|Overall Study|Death|1|||
16502284|NCT02968563|40310356|FG000|Overall Study|Lost to Follow-up|0|||
16502285|NCT02968563|40310357|FG001|Overall Study|Lost to Follow-up|1|||
16502286|NCT02905331|40310358|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
16502287|NCT02905331|40310359|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
16502288|NCT02905331|40310360|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
16502289|NCT02905331|40310358|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
16502290|NCT02905331|40310359|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
16502291|NCT02905331|40310360|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
16502292|NCT02905331|40310358|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
16502293|NCT02905331|40310359|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
16502294|NCT02905331|40310360|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
16502295|NCT02905331|40310358|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
16502296|NCT02905331|40310359|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
16502297|NCT02905331|40310360|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
16502298|NCT02905331|40310358|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
16502299|NCT02905331|40310359|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
16502300|NCT02905331|40310360|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
16502301|NCT02426892|40310361|FG000|Overall Study|Adverse Event|2|||
16502302|NCT02426892|40310361|FG000|Overall Study|Lack of Efficacy|17|||
16502303|NCT02426892|40310361|FG000|Overall Study|Withdrawal by Subject|1|||
16502304|NCT03312933|40310362|FG000|Overall Study|Protocol Violation|15|||
16502305|NCT03312933|40310362|FG000|Overall Study|Lost to Follow-up|36|||
16502306|NCT03312933|40310362|FG000|Overall Study|Withdrawal by Subject|3|||
16502307|NCT00483379|40310373|FG000|Treatment Period|Adverse Event|1|||
16502308|NCT00483379|40310374|FG001|Treatment Period|Adverse Event|0|||
16502309|NCT00483379|40310373|FG000|Treatment Period|Withdrawal by Subject|1|||
16195700|NCT01669811|39193398|FG001|Overall Study|Withdrawal by Subject|2|||
16502310|NCT00483379|40310374|FG001|Treatment Period|Withdrawal by Subject|0|||
16502311|NCT02626520|40310375|FG000|Overall Study|Physician Decision|1|||
16502312|NCT02626520|40310376|FG001|Overall Study|Physician Decision|1|||
16195701|NCT01669811|39193397|FG000|Overall Study|Adverse Event|2|||
16502313|NCT02626520|40310375|FG000|Overall Study|Adverse Event|0|||
16502314|NCT02626520|40310376|FG001|Overall Study|Adverse Event|4|||
16502315|NCT02626520|40310375|FG000|Overall Study|Lack of Efficacy|0|||
16502316|NCT02626520|40310376|FG001|Overall Study|Lack of Efficacy|2|||
16195702|NCT01669811|39193398|FG001|Overall Study|Adverse Event|6|||
16502317|NCT02626520|40310375|FG000|Overall Study|Did not start protocol therapy|0|||
16502318|NCT02626520|40310376|FG001|Overall Study|Did not start protocol therapy|2|||
16089259|NCT03200574|38816868|FG000|Overall Study|Withdrawal by Subject|8|||
16089260|NCT03200574|38816868|FG000|Overall Study|Long-Term need for anticoagulation|1|||
16089261|NCT03200574|38816868|FG000|Overall Study|Relocation|2|||
16089262|NCT03200574|38816868|FG000|Overall Study|Lost to Follow-up|2|||
16089263|NCT02203032|38816869|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
16089264|NCT02203032|38816870|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
16089265|NCT02203032|38816871|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
16089266|NCT02203032|38816872|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
16089267|NCT02203032|38816869|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
16089268|NCT02203032|38816870|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
16089269|NCT02203032|38816871|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
16089270|NCT02203032|38816872|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
16089271|NCT02203032|38816869|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
16089272|NCT02203032|38816870|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
16089273|NCT02203032|38816871|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
16089274|NCT02203032|38816872|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
16089275|NCT02203032|38816869|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
16089276|NCT02203032|38816870|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
16089277|NCT02203032|38816871|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
16089278|NCT02203032|38816872|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
16089279|NCT02203032|38816869|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
16502319|NCT02626520|40310375|FG000|Overall Study|Study terminated|0|||
16502320|NCT02626520|40310376|FG001|Overall Study|Study terminated|1|||
16502321|NCT02154581|40310377|FG000|Overall Study|Lost to Follow-up|7|||
16502322|NCT02154581|40310378|FG001|Overall Study|Lost to Follow-up|8|||
16502323|NCT04446377|40310381|FG000|Overall Study|Withdrawal by Subject|6|||
16502324|NCT04446377|40310382|FG001|Overall Study|Withdrawal by Subject|1|||
16502325|NCT04446377|40310381|FG000|Overall Study|Physician Decision|1|||
16502326|NCT04446377|40310382|FG001|Overall Study|Physician Decision|1|||
16502327|NCT04446377|40310381|FG000|Overall Study|Lost to Follow-up|0|||
16502328|NCT04446377|40310382|FG001|Overall Study|Lost to Follow-up|2|||
16502329|NCT04446377|40310381|FG000|Overall Study|Not eligible|0|||
16502330|NCT04446377|40310382|FG001|Overall Study|Not eligible|1|||
16502331|NCT03255382|40310389|FG000|Overall Study|Adverse Event|3|||
16089280|NCT02203032|38816870|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
16390172|NCT02707965|39911947|FG008|Overall Study|Protocol deviation|0|||
16390173|NCT02707965|39911948|FG009|Overall Study|Protocol deviation|0|||
16390174|NCT02707965|39911949|FG010|Overall Study|Protocol deviation|0|||
16390175|NCT02707965|39911950|FG011|Overall Study|Protocol deviation|0|||
16390176|NCT02707965|39911951|FG012|Overall Study|Protocol deviation|0|||
16390177|NCT02707965|39911952|FG013|Overall Study|Protocol deviation|0|||
16390178|NCT02707965|39911953|FG014|Overall Study|Protocol deviation|0|||
16390179|NCT02707965|39911954|FG015|Overall Study|Protocol deviation|0|||
16390180|NCT00972023|39911958|FG000|Overall Study|Withdrawal by Subject|1|||
16390181|NCT01119443|39911959|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
16089281|NCT02203032|38816871|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
16089282|NCT02203032|38816872|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
16089283|NCT02203032|38816869|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
16089284|NCT02203032|38816870|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
16089285|NCT02203032|38816871|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
16089286|NCT02203032|38816872|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
16089287|NCT02203032|38816869|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
16089288|NCT02203032|38816870|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
16089289|NCT02203032|38816871|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
16089290|NCT02203032|38816872|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
16089291|NCT02203032|38816869|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
16089292|NCT02203032|38816870|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
16089293|NCT02203032|38816871|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
16089294|NCT02203032|38816872|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
16089295|NCT02203032|38816869|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
16089296|NCT02203032|38816870|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
16089297|NCT02203032|38816871|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
16089298|NCT02203032|38816872|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
16089299|NCT02203032|38816869|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
16089300|NCT02203032|38816870|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
16089301|NCT02203032|38816871|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
16089302|NCT02203032|38816872|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
16089303|NCT02203032|38816869|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
16089304|NCT02203032|38816870|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
16089305|NCT02203032|38816871|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
16089306|NCT02203032|38816872|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
16089307|NCT02203032|38816869|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
16089308|NCT02203032|38816870|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
16089309|NCT02203032|38816871|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
16089310|NCT02203032|38816872|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
16089311|NCT03265132|38816873|FG000|Overall Study|Adverse Event|0|||
16089312|NCT03265132|38816874|FG001|Overall Study|Adverse Event|1|||
16089313|NCT03265132|38816873|FG000|Overall Study|Lack of Efficacy|0|||
16089314|NCT03265132|38816874|FG001|Overall Study|Lack of Efficacy|2|||
16089315|NCT03265132|38816873|FG000|Overall Study|Progressive disease|0|||
16089316|NCT03265132|38816874|FG001|Overall Study|Progressive disease|2|||
16089317|NCT03265132|38816873|FG000|Overall Study|Withdrawal by Subject|0|||
16195703|NCT01669811|39193397|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16195704|NCT01669811|39193398|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
16195705|NCT00960934|39193399|FG000|Overall Study|Adverse Event|2|||
16195706|NCT00960934|39193400|FG001|Overall Study|Adverse Event|3|||
16195707|NCT00960934|39193401|FG002|Overall Study|Adverse Event|3|||
16390182|NCT01119443|39911960|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
16390183|NCT01170273|39911961|FG000|Overall Study|Lost to Follow-up|6|||
16390184|NCT01170273|39911962|FG001|Overall Study|Lost to Follow-up|8|||
16502332|NCT03255382|40310390|FG001|Overall Study|Adverse Event|0|||
16502333|NCT03255382|40310389|FG000|Overall Study|Lost to Follow-up|2|||
16502334|NCT03255382|40310390|FG001|Overall Study|Lost to Follow-up|0|||
16502335|NCT03255382|40310389|FG000|Overall Study|Withdrawal by Subject|2|||
16502336|NCT03255382|40310390|FG001|Overall Study|Withdrawal by Subject|0|||
16502337|NCT03255382|40310389|FG000|Overall Study|Other|6|||
16502338|NCT03255382|40310390|FG001|Overall Study|Other|0|||
16502339|NCT03265249|40310391|FG000|Overall Study|Withdrawal by Subject|0|||
16502340|NCT03265249|40310392|FG001|Overall Study|Withdrawal by Subject|1|||
16502341|NCT02393547|40310396|FG000|Overall Study|Adverse Event|2|||
16390185|NCT01170273|39911961|FG000|Overall Study|Protocol Violation|1|||
16089318|NCT03265132|38816874|FG001|Overall Study|Withdrawal by Subject|1|||
16502342|NCT02393547|40310396|FG000|Overall Study|Withdrawal by Subject|3|||
16502343|NCT02393547|40310396|FG000|Overall Study|Lost to Follow-up|1|||
16502344|NCT02736409|40310398|FG000|Overall Study|Withdrawal by Subject|4|||
16502345|NCT02736409|40310399|FG001|Overall Study|Withdrawal by Subject|2|||
16195708|NCT00960934|39193402|FG003|Overall Study|Adverse Event|2|||
16195709|NCT00960934|39193403|FG004|Overall Study|Adverse Event|4|||
16195710|NCT00960934|39193404|FG005|Overall Study|Adverse Event|3|||
16195711|NCT00960934|39193399|FG000|Overall Study|Lack of Efficacy|1|||
16195712|NCT00960934|39193400|FG001|Overall Study|Lack of Efficacy|0|||
16195713|NCT00960934|39193401|FG002|Overall Study|Lack of Efficacy|0|||
16195714|NCT00960934|39193402|FG003|Overall Study|Lack of Efficacy|0|||
16195715|NCT00960934|39193403|FG004|Overall Study|Lack of Efficacy|0|||
16195716|NCT00960934|39193404|FG005|Overall Study|Lack of Efficacy|0|||
16502346|NCT02736409|40310400|FG002|Overall Study|Withdrawal by Subject|17|||
16502347|NCT02736409|40310401|FG003|Overall Study|Withdrawal by Subject|3|||
16502348|NCT02736409|40310398|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16502349|NCT02736409|40310399|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16502350|NCT02736409|40310400|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16502351|NCT02736409|40310401|FG003|Overall Study|Non-Compliance with Study Drug|1|||
16502352|NCT02736409|40310398|FG000|Overall Study|Adverse Event|0|||
16502353|NCT02736409|40310399|FG001|Overall Study|Adverse Event|1|||
16502354|NCT02736409|40310400|FG002|Overall Study|Adverse Event|5|||
16502355|NCT02736409|40310401|FG003|Overall Study|Adverse Event|4|||
16502356|NCT02736409|40310398|FG000|Overall Study|Other|0|||
16195717|NCT00960934|39193399|FG000|Overall Study|Lost to Follow-up|0|||
16502357|NCT02736409|40310399|FG001|Overall Study|Other|0|||
16502358|NCT02736409|40310400|FG002|Overall Study|Other|1|||
16502359|NCT02736409|40310401|FG003|Overall Study|Other|1|||
16502360|NCT02736409|40310398|FG000|Overall Study|Pregnancy|0|||
16502361|NCT02736409|40310399|FG001|Overall Study|Pregnancy|0|||
16502362|NCT02736409|40310400|FG002|Overall Study|Pregnancy|1|||
16502363|NCT02736409|40310401|FG003|Overall Study|Pregnancy|0|||
16502364|NCT02736409|40310398|FG000|Overall Study|Lost to Follow-up|0|||
16502365|NCT02736409|40310399|FG001|Overall Study|Lost to Follow-up|0|||
16195718|NCT00960934|39193400|FG001|Overall Study|Lost to Follow-up|1|||
16195719|NCT00960934|39193401|FG002|Overall Study|Lost to Follow-up|0|||
16195720|NCT00960934|39193402|FG003|Overall Study|Lost to Follow-up|0|||
16195721|NCT00960934|39193403|FG004|Overall Study|Lost to Follow-up|0|||
16195722|NCT00960934|39193404|FG005|Overall Study|Lost to Follow-up|0|||
16195723|NCT00960934|39193399|FG000|Overall Study|Other|2|||
16195724|NCT00960934|39193400|FG001|Overall Study|Other|1|||
16310601|NCT01515423|39623471|FG000|DOUBLE BLIND|Death|0|||
16310602|NCT01515423|39623472|FG001|DOUBLE BLIND|Death|1|||
16502366|NCT02736409|40310400|FG002|Overall Study|Lost to Follow-up|2|||
16502367|NCT02736409|40310401|FG003|Overall Study|Lost to Follow-up|1|||
16502368|NCT02736409|40310398|FG000|Overall Study|Physician Decision|0|||
16502369|NCT02736409|40310399|FG001|Overall Study|Physician Decision|0|||
16502370|NCT02736409|40310400|FG002|Overall Study|Physician Decision|0|||
16502371|NCT02736409|40310401|FG003|Overall Study|Physician Decision|2|||
16502372|NCT00372112|40310402|FG000|Overall Study|Adverse Event|0|||
16502373|NCT00372112|40310403|FG001|Overall Study|Adverse Event|1|||
16502374|NCT00372112|40310404|FG002|Overall Study|Adverse Event|1|||
16502375|NCT00372112|40310405|FG003|Overall Study|Adverse Event|1|||
16502376|NCT00372112|40310402|FG000|Overall Study|Withdrawal by Subject|0|||
16502377|NCT00372112|40310403|FG001|Overall Study|Withdrawal by Subject|0|||
16502378|NCT00372112|40310404|FG002|Overall Study|Withdrawal by Subject|2|||
16502379|NCT00372112|40310405|FG003|Overall Study|Withdrawal by Subject|1|||
16502380|NCT00372112|40310402|FG000|Overall Study|Exacerbation|0|||
16502381|NCT00372112|40310403|FG001|Overall Study|Exacerbation|0|||
16502382|NCT00372112|40310404|FG002|Overall Study|Exacerbation|0|||
16502383|NCT00372112|40310405|FG003|Overall Study|Exacerbation|1|||
16502384|NCT00372112|40310402|FG000|Overall Study|PR >240 at Visit 3|0|||
16502385|NCT00372112|40310403|FG001|Overall Study|PR >240 at Visit 3|0|||
16502386|NCT00372112|40310404|FG002|Overall Study|PR >240 at Visit 3|0|||
16502387|NCT00372112|40310405|FG003|Overall Study|PR >240 at Visit 3|1|||
16502388|NCT00372112|40310402|FG000|Overall Study|Hepatitis B|1|||
16502389|NCT00372112|40310403|FG001|Overall Study|Hepatitis B|0|||
16195725|NCT00960934|39193401|FG002|Overall Study|Other|5|||
16195726|NCT00960934|39193402|FG003|Overall Study|Other|4|||
16195727|NCT00960934|39193403|FG004|Overall Study|Other|2|||
16195728|NCT00960934|39193404|FG005|Overall Study|Other|2|||
16195729|NCT00960934|39193399|FG000|Overall Study|Physician Decision|0|||
16502390|NCT00372112|40310404|FG002|Overall Study|Hepatitis B|0|||
16502391|NCT00372112|40310405|FG003|Overall Study|Hepatitis B|0|||
16502392|NCT00372112|40310402|FG000|Overall Study|Other-protocol violation|0|||
16502393|NCT00372112|40310403|FG001|Overall Study|Other-protocol violation|0|||
16502394|NCT00372112|40310404|FG002|Overall Study|Other-protocol violation|1|||
16502395|NCT00372112|40310405|FG003|Overall Study|Other-protocol violation|0|||
16502396|NCT01359449|40310421|FG000|Overall Study|Lost to Follow-up|1|||
16502397|NCT01359449|40310422|FG001|Overall Study|Lost to Follow-up|0|||
16502398|NCT01359449|40310421|FG000|Overall Study|Protocol Violation|0|||
16502399|NCT01359449|40310422|FG001|Overall Study|Protocol Violation|2|||
16502400|NCT01359449|40310421|FG000|Overall Study|Withdrawal by Subject|3|||
16502401|NCT01359449|40310422|FG001|Overall Study|Withdrawal by Subject|2|||
16502402|NCT01996826|40310423|FG000|Overall Study|Lost to Follow-up|6|||
16390186|NCT01170273|39911962|FG001|Overall Study|Protocol Violation|0|||
16390187|NCT01170273|39911961|FG000|Overall Study|Death|1|||
16390188|NCT01170273|39911962|FG001|Overall Study|Death|0|||
16390189|NCT01170273|39911961|FG000|Overall Study|Adverse Event|0|||
16390190|NCT01170273|39911962|FG001|Overall Study|Adverse Event|1|||
16390191|NCT00251693|39911967|FG000|Overall Study|Adverse Event|17|||
16502403|NCT01996826|40310424|FG001|Overall Study|Lost to Follow-up|2|||
16502404|NCT01996826|40310423|FG000|Overall Study|Physician Decision|1|||
16502405|NCT01996826|40310424|FG001|Overall Study|Physician Decision|1|||
16502406|NCT00350636|40310425|FG000|Overall Study|Adverse Event|19|||
16502407|NCT00350636|40310426|FG001|Overall Study|Adverse Event|13|||
16502408|NCT00350636|40310425|FG000|Overall Study|Protocol Violation|1|||
16502409|NCT00350636|40310426|FG001|Overall Study|Protocol Violation|3|||
16502410|NCT00350636|40310425|FG000|Overall Study|Withdrawal by Subject|13|||
16502411|NCT00350636|40310426|FG001|Overall Study|Withdrawal by Subject|17|||
16502412|NCT00350636|40310425|FG000|Overall Study|Lost to Follow-up|9|||
16502413|NCT00350636|40310426|FG001|Overall Study|Lost to Follow-up|8|||
16502414|NCT00350636|40310425|FG000|Overall Study|Physician Decision|0|||
16502415|NCT00350636|40310426|FG001|Overall Study|Physician Decision|2|||
16502416|NCT00350636|40310425|FG000|Overall Study|Other|1|||
16310603|NCT01515423|39623473|FG002|DOUBLE BLIND|Death|2|||
16310604|NCT01515423|39623471|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
16310605|NCT01515423|39623472|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
16310606|NCT01515423|39623473|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
16310607|NCT01515423|39623471|FG000|DOUBLE BLIND|Pregnancy|0|||
16310608|NCT01515423|39623472|FG001|DOUBLE BLIND|Pregnancy|2|||
16310609|NCT01515423|39623473|FG002|DOUBLE BLIND|Pregnancy|0|||
16310610|NCT01515423|39623471|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
16310611|NCT01515423|39623472|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
16310612|NCT01515423|39623473|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
16310613|NCT01515423|39623471|FG000|DOUBLE BLIND|Other|0|||
16390192|NCT00251693|39911968|FG001|Overall Study|Adverse Event|9|||
16390193|NCT00251693|39911969|FG002|Overall Study|Adverse Event|9|||
16390194|NCT00251693|39911967|FG000|Overall Study|Protocol Violation|2|||
16502417|NCT00350636|40310426|FG001|Overall Study|Other|2|||
16502418|NCT02118012|40310431|FG000|Overall Study|Adverse Event|0|||
16502419|NCT02118012|40310432|FG001|Overall Study|Adverse Event|1|||
16502420|NCT02118012|40310431|FG000|Overall Study|Physician Decision|0|||
16502421|NCT02118012|40310432|FG001|Overall Study|Physician Decision|1|||
16502422|NCT02921776|40310433|FG000|Overall Study|patient deterioration, fatigue|2|||
16502423|NCT02921776|40310434|FG001|Overall Study|patient deterioration, fatigue|6|||
16502424|NCT02921776|40310435|FG002|Overall Study|patient deterioration, fatigue|0|||
16502425|NCT02921776|40310436|FG003|Overall Study|patient deterioration, fatigue|0|||
16502426|NCT02921776|40310437|FG004|Overall Study|patient deterioration, fatigue|0|||
16502427|NCT02921776|40310438|FG005|Overall Study|patient deterioration, fatigue|0|||
16502428|NCT02921776|40310439|FG006|Overall Study|patient deterioration, fatigue|0|||
16502429|NCT02921776|40310440|FG007|Overall Study|patient deterioration, fatigue|0|||
16502430|NCT02921776|40310433|FG000|Overall Study|Withdrawal by Subject|0|||
16502431|NCT02921776|40310434|FG001|Overall Study|Withdrawal by Subject|2|||
16502432|NCT02921776|40310435|FG002|Overall Study|Withdrawal by Subject|0|||
16502433|NCT02921776|40310436|FG003|Overall Study|Withdrawal by Subject|1|||
16502434|NCT02921776|40310437|FG004|Overall Study|Withdrawal by Subject|1|||
16502435|NCT02921776|40310438|FG005|Overall Study|Withdrawal by Subject|0|||
16502436|NCT02921776|40310439|FG006|Overall Study|Withdrawal by Subject|8|||
16502437|NCT02921776|40310440|FG007|Overall Study|Withdrawal by Subject|1|||
16502438|NCT02921776|40310433|FG000|Overall Study|Death|0|||
16502439|NCT02921776|40310434|FG001|Overall Study|Death|0|||
16502440|NCT02921776|40310435|FG002|Overall Study|Death|0|||
16502441|NCT02921776|40310436|FG003|Overall Study|Death|2|||
16502442|NCT02921776|40310437|FG004|Overall Study|Death|0|||
16502443|NCT02921776|40310438|FG005|Overall Study|Death|0|||
16502444|NCT02921776|40310439|FG006|Overall Study|Death|0|||
16502445|NCT02921776|40310440|FG007|Overall Study|Death|0|||
16502446|NCT02921776|40310433|FG000|Overall Study|extubation or early discharge|0|||
16502447|NCT02921776|40310434|FG001|Overall Study|extubation or early discharge|0|||
16502448|NCT02921776|40310435|FG002|Overall Study|extubation or early discharge|0|||
16502449|NCT02921776|40310436|FG003|Overall Study|extubation or early discharge|5|||
16195730|NCT00960934|39193400|FG001|Overall Study|Physician Decision|1|||
16310614|NCT01515423|39623472|FG001|DOUBLE BLIND|Other|6|||
16390195|NCT00251693|39911968|FG001|Overall Study|Protocol Violation|0|||
16390196|NCT00251693|39911969|FG002|Overall Study|Protocol Violation|2|||
16310615|NCT01515423|39623473|FG002|DOUBLE BLIND|Other|12|||
16390197|NCT00251693|39911967|FG000|Overall Study|Lost to Follow-up|12|||
16390198|NCT00251693|39911968|FG001|Overall Study|Lost to Follow-up|7|||
16502450|NCT02921776|40310437|FG004|Overall Study|extubation or early discharge|5|||
16502451|NCT02921776|40310438|FG005|Overall Study|extubation or early discharge|0|||
16390199|NCT00251693|39911969|FG002|Overall Study|Lost to Follow-up|8|||
16390200|NCT00251693|39911967|FG000|Overall Study|Withdrawal by Subject|11|||
16390201|NCT00251693|39911968|FG001|Overall Study|Withdrawal by Subject|17|||
16390202|NCT00251693|39911969|FG002|Overall Study|Withdrawal by Subject|14|||
16390203|NCT00251693|39911967|FG000|Overall Study|Lack of Efficacy|0|||
16502452|NCT02921776|40310439|FG006|Overall Study|extubation or early discharge|0|||
16502453|NCT02921776|40310440|FG007|Overall Study|extubation or early discharge|0|||
16502454|NCT02921776|40310433|FG000|Overall Study|Lost to Follow-up|0|||
16502455|NCT02921776|40310434|FG001|Overall Study|Lost to Follow-up|0|||
16502456|NCT02921776|40310435|FG002|Overall Study|Lost to Follow-up|0|||
16502457|NCT02921776|40310436|FG003|Overall Study|Lost to Follow-up|0|||
16502458|NCT02921776|40310437|FG004|Overall Study|Lost to Follow-up|0|||
16502459|NCT02921776|40310438|FG005|Overall Study|Lost to Follow-up|2|||
16502460|NCT02921776|40310439|FG006|Overall Study|Lost to Follow-up|3|||
16502461|NCT02921776|40310440|FG007|Overall Study|Lost to Follow-up|6|||
16502462|NCT02221284|40313878|FG000|Overall Study|Case Report Forms Uncollected|56|||
16502463|NCT02221284|40313878|FG000|Overall Study|Protocol Deviation|5|||
16390204|NCT00251693|39911968|FG001|Overall Study|Lack of Efficacy|1|||
16390205|NCT00251693|39911969|FG002|Overall Study|Lack of Efficacy|0|||
16390206|NCT00251693|39911967|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
16390207|NCT00251693|39911968|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
16390208|NCT00251693|39911969|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
16390209|NCT00251693|39911967|FG000|Overall Study|Noncompliant|0|||
16390210|NCT00251693|39911968|FG001|Overall Study|Noncompliant|0|||
16390211|NCT00251693|39911969|FG002|Overall Study|Noncompliant|2|||
16390212|NCT00251693|39911967|FG000|Overall Study|Possible Barrett's esophagus|3|||
16390213|NCT00251693|39911968|FG001|Overall Study|Possible Barrett's esophagus|5|||
16502464|NCT00326950|40313880|FG000|Overall Study|Progressive Disease|1|||
16502465|NCT03315208|40313881|FG000|Overall Study|Lost to Follow-up|11|||
16502466|NCT03315208|40313882|FG001|Overall Study|Lost to Follow-up|6|||
16502467|NCT03315208|40313881|FG000|Overall Study|Withdrawal by Subject|2|||
16502468|NCT03315208|40313882|FG001|Overall Study|Withdrawal by Subject|0|||
16502469|NCT00741039|40313883|FG000|Overall Study|Patient non-compliance|2|||
16390214|NCT00251693|39911969|FG002|Overall Study|Possible Barrett's esophagus|2|||
16390215|NCT00251693|39911967|FG000|Overall Study|Subject request/subject unavailable|1|||
16390216|NCT00251693|39911968|FG001|Overall Study|Subject request/subject unavailable|2|||
16390217|NCT00251693|39911969|FG002|Overall Study|Subject request/subject unavailable|0|||
16390218|NCT00251693|39911967|FG000|Overall Study|Abnormal laboratory findings|0|||
16390219|NCT00251693|39911968|FG001|Overall Study|Abnormal laboratory findings|0|||
16390220|NCT00251693|39911969|FG002|Overall Study|Abnormal laboratory findings|1|||
16390221|NCT02639247|39911978|FG000|Overall Study|Lost to Follow-up|2|||
16390222|NCT02639247|39911979|FG001|Overall Study|Lost to Follow-up|1|||
16390223|NCT02639247|39911978|FG000|Overall Study|Death|2|||
16390224|NCT02639247|39911979|FG001|Overall Study|Death|0|||
16390225|NCT02639247|39911978|FG000|Overall Study|Withdrew Consent|0|||
16390226|NCT02639247|39911979|FG001|Overall Study|Withdrew Consent|1|||
16390227|NCT02639247|39911978|FG000|Overall Study|Protocol Violation|1|||
16390228|NCT02639247|39911979|FG001|Overall Study|Protocol Violation|0|||
16390229|NCT04846231|39911980|FG000|Overall Study|Lost to Follow-up|1|||
16390230|NCT04846231|39911981|FG001|Overall Study|Lost to Follow-up|0|||
16390231|NCT04846231|39911982|FG002|Overall Study|Lost to Follow-up|0|||
16390232|NCT04846231|39911983|FG003|Overall Study|Lost to Follow-up|0|||
16390233|NCT04846231|39911984|FG004|Overall Study|Lost to Follow-up|0|||
16390234|NCT04846231|39911985|FG005|Overall Study|Lost to Follow-up|0|||
16390235|NCT04846231|39911986|FG006|Overall Study|Lost to Follow-up|0|||
16390236|NCT04846231|39911987|FG007|Overall Study|Lost to Follow-up|1|||
16390237|NCT04846231|39911980|FG000|Overall Study|Withdrawal by Subject|0|||
16390238|NCT04846231|39911981|FG001|Overall Study|Withdrawal by Subject|1|||
16390239|NCT04846231|39911982|FG002|Overall Study|Withdrawal by Subject|2|||
16502470|NCT00741039|40313884|FG001|Overall Study|Patient non-compliance|0|||
16502471|NCT02069366|40313885|FG000|Overall Study|Lost to Follow-up|0|||
16502472|NCT02069366|40313886|FG001|Overall Study|Lost to Follow-up|0|||
16502473|NCT02069366|40313887|FG002|Overall Study|Lost to Follow-up|1|||
16502474|NCT02069366|40313888|FG003|Overall Study|Lost to Follow-up|0|||
16502475|NCT02069366|40313889|FG004|Overall Study|Lost to Follow-up|0|||
16390240|NCT04846231|39911983|FG003|Overall Study|Withdrawal by Subject|1|||
16390241|NCT04846231|39911984|FG004|Overall Study|Withdrawal by Subject|0|||
16502476|NCT02069366|40313890|FG005|Overall Study|Lost to Follow-up|2|||
16390242|NCT04846231|39911985|FG005|Overall Study|Withdrawal by Subject|0|||
16390243|NCT04846231|39911986|FG006|Overall Study|Withdrawal by Subject|0|||
16390244|NCT04846231|39911987|FG007|Overall Study|Withdrawal by Subject|0|||
16390245|NCT04846231|39911980|FG000|Overall Study|Protocol Violation|0|||
16390246|NCT04846231|39911981|FG001|Overall Study|Protocol Violation|1|||
16390247|NCT04846231|39911982|FG002|Overall Study|Protocol Violation|0|||
16390248|NCT04846231|39911983|FG003|Overall Study|Protocol Violation|0|||
16390249|NCT04846231|39911984|FG004|Overall Study|Protocol Violation|0|||
16502477|NCT02069366|40313885|FG000|Overall Study|Protocol Violation|0|||
16502478|NCT02069366|40313886|FG001|Overall Study|Protocol Violation|0|||
16390250|NCT04846231|39911985|FG005|Overall Study|Protocol Violation|0|||
16390251|NCT04846231|39911986|FG006|Overall Study|Protocol Violation|0|||
16390252|NCT04846231|39911987|FG007|Overall Study|Protocol Violation|0|||
16390253|NCT04846231|39911980|FG000|Overall Study|Adverse Event|0|||
16390254|NCT04846231|39911981|FG001|Overall Study|Adverse Event|0|||
16390255|NCT04846231|39911982|FG002|Overall Study|Adverse Event|0|||
16390256|NCT04846231|39911983|FG003|Overall Study|Adverse Event|0|||
16390257|NCT04846231|39911984|FG004|Overall Study|Adverse Event|0|||
16390258|NCT04846231|39911985|FG005|Overall Study|Adverse Event|0|||
16390259|NCT04846231|39911986|FG006|Overall Study|Adverse Event|1|||
16390260|NCT04846231|39911987|FG007|Overall Study|Adverse Event|1|||
16390261|NCT00038948|39911988|FG000|Overall Study|Adverse Event|131|||
16390262|NCT00038948|39911989|FG001|Overall Study|Adverse Event|43|||
16390263|NCT00038948|39911988|FG000|Overall Study|Lost to Follow-up|4|||
16390264|NCT00038948|39911989|FG001|Overall Study|Lost to Follow-up|4|||
16502479|NCT02069366|40313887|FG002|Overall Study|Protocol Violation|1|||
16502480|NCT02069366|40313888|FG003|Overall Study|Protocol Violation|0|||
16502481|NCT02069366|40313889|FG004|Overall Study|Protocol Violation|0|||
16502482|NCT02069366|40313890|FG005|Overall Study|Protocol Violation|0|||
16502483|NCT02069366|40313885|FG000|Overall Study|Withdrawal by Subject|1|||
16502484|NCT02069366|40313886|FG001|Overall Study|Withdrawal by Subject|0|||
16502485|NCT02069366|40313887|FG002|Overall Study|Withdrawal by Subject|1|||
16502486|NCT02069366|40313888|FG003|Overall Study|Withdrawal by Subject|2|||
16502487|NCT02069366|40313889|FG004|Overall Study|Withdrawal by Subject|0|||
16502488|NCT02069366|40313890|FG005|Overall Study|Withdrawal by Subject|0|||
16502489|NCT02951156|40313896|FG000|Overall Study|Death|3|||
16502490|NCT02951156|40313897|FG001|Overall Study|Death|8|||
16502491|NCT02951156|40313898|FG002|Overall Study|Death|5|||
16502492|NCT02951156|40313896|FG000|Overall Study|Progressive disease|1|||
16502493|NCT02951156|40313897|FG001|Overall Study|Progressive disease|0|||
16502494|NCT02951156|40313898|FG002|Overall Study|Progressive disease|1|||
16502495|NCT02951156|40313896|FG000|Overall Study|Withdrawal by Subject|0|||
16502496|NCT02951156|40313897|FG001|Overall Study|Withdrawal by Subject|0|||
16502497|NCT02951156|40313898|FG002|Overall Study|Withdrawal by Subject|1|||
16502498|NCT02951156|40313896|FG000|Overall Study|Study terminated by sponsor|0|||
16502499|NCT02951156|40313897|FG001|Overall Study|Study terminated by sponsor|0|||
16502500|NCT02951156|40313898|FG002|Overall Study|Study terminated by sponsor|1|||
16502501|NCT02951156|40313896|FG000|Overall Study|Other|5|||
16502502|NCT02951156|40313897|FG001|Overall Study|Other|1|||
16502503|NCT02951156|40313898|FG002|Overall Study|Other|2|||
16502504|NCT00537381|40313901|FG000|Overall Study|Adverse Event|13|||
16502505|NCT00537381|40313902|FG001|Overall Study|Adverse Event|9|||
16502506|NCT00537381|40313901|FG000|Overall Study|Death|3|||
16502507|NCT00537381|40313902|FG001|Overall Study|Death|3|||
16502508|NCT00537381|40313901|FG000|Overall Study|Withdrawal by Subject|5|||
16502509|NCT00537381|40313902|FG001|Overall Study|Withdrawal by Subject|14|||
16502510|NCT00537381|40313901|FG000|Overall Study|Physician Decision|7|||
16502511|NCT00537381|40313902|FG001|Overall Study|Physician Decision|6|||
16502512|NCT00537381|40313901|FG000|Overall Study|Disease Progression|9|||
16502513|NCT00537381|40313902|FG001|Overall Study|Disease Progression|18|||
16502514|NCT00537381|40313901|FG000|Overall Study|Sponsor decision|14|||
16502515|NCT00537381|40313902|FG001|Overall Study|Sponsor decision|9|||
16502516|NCT00537381|40313901|FG000|Overall Study|Other|5|||
16502517|NCT00537381|40313902|FG001|Overall Study|Other|3|||
16502518|NCT00840294|40313904|FG000|Overall Study|Withdrawal by Subject|2|||
16502519|NCT00840294|40313905|FG001|Overall Study|Withdrawal by Subject|1|||
16502520|NCT00840294|40313904|FG000|Overall Study|Protocol Violation|1|||
16502521|NCT00840294|40313905|FG001|Overall Study|Protocol Violation|3|||
16502522|NCT00840294|40313904|FG000|Overall Study|Illness|0|||
16502523|NCT00840294|40313905|FG001|Overall Study|Illness|1|||
16502524|NCT02094261|40313906|FG000|Overall Study|Death|24|||
16502525|NCT02094261|40313906|FG000|Overall Study|Lost to Follow-up|1|||
16502526|NCT02094261|40313906|FG000|Overall Study|Withdrawal by Subject|4|||
16502527|NCT02094261|40313906|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
16502528|NCT01086540|40313907|FG000|Overall Study|Death|3|||
16502529|NCT01086540|40313908|FG001|Overall Study|Death|1|||
16502530|NCT01086540|40313907|FG000|Overall Study|Physician Decision|2|||
16502531|NCT01086540|40313908|FG001|Overall Study|Physician Decision|1|||
16502532|NCT01086540|40313907|FG000|Overall Study|Addition of new therapy for PAH|1|||
16502533|NCT01086540|40313908|FG001|Overall Study|Addition of new therapy for PAH|0|||
16502534|NCT00664742|40313909|FG000|Overall Study|Withdrawn due to adverse events|3|||
16502535|NCT00664742|40313909|FG000|Overall Study|Withdrawal by Subject|31|||
16502536|NCT00664742|40313909|FG000|Overall Study|Lost to Follow-up|92|||
16502537|NCT02710045|40313910|FG000|Overall Study|Death|1|||
16502538|NCT02710045|40313911|FG001|Overall Study|Death|2|||
16502539|NCT02710045|40313912|FG002|Overall Study|Death|0|||
16502540|NCT02710045|40313910|FG000|Overall Study|Withdrawal by Subject|6|||
16502541|NCT02710045|40313911|FG001|Overall Study|Withdrawal by Subject|6|||
16390265|NCT00038948|39911988|FG000|Overall Study|Nonmedical event|5|||
16502542|NCT02710045|40313912|FG002|Overall Study|Withdrawal by Subject|2|||
16502543|NCT02710045|40313910|FG000|Overall Study|Protocol Violation|1|||
16502544|NCT02710045|40313911|FG001|Overall Study|Protocol Violation|2|||
16502545|NCT02710045|40313912|FG002|Overall Study|Protocol Violation|3|||
16502546|NCT02710045|40313910|FG000|Overall Study|Lost to Follow-up|3|||
16502547|NCT02710045|40313911|FG001|Overall Study|Lost to Follow-up|6|||
16502548|NCT02710045|40313912|FG002|Overall Study|Lost to Follow-up|7|||
16502549|NCT02710045|40313910|FG000|Overall Study|Physician Decision|0|||
16502550|NCT02710045|40313911|FG001|Overall Study|Physician Decision|0|||
16089319|NCT00983294|38816875|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
16502551|NCT02710045|40313912|FG002|Overall Study|Physician Decision|1|||
16502552|NCT02710045|40313910|FG000|Overall Study|Poor Attendance|0|||
16502553|NCT02710045|40313911|FG001|Overall Study|Poor Attendance|1|||
16502554|NCT02710045|40313912|FG002|Overall Study|Poor Attendance|0|||
16502555|NCT02574247|40313913|FG000|Overall Study|Withdrawal by Subject|1|||
16502556|NCT02574247|40313914|FG001|Overall Study|Withdrawal by Subject|0|||
16502557|NCT02574247|40313915|FG002|Overall Study|Withdrawal by Subject|0|||
16502558|NCT02574247|40313913|FG000|Overall Study|Did not meet inclusion criteria|4|||
16502559|NCT02574247|40313914|FG001|Overall Study|Did not meet inclusion criteria|3|||
16502560|NCT02574247|40313915|FG002|Overall Study|Did not meet inclusion criteria|5|||
16502561|NCT00108160|40313916|FG000|Overall Study|Lost to Follow-up|25|||
16502562|NCT00108160|40313917|FG001|Overall Study|Lost to Follow-up|12|||
16502563|NCT00108160|40313916|FG000|Overall Study|Death|1|||
16502564|NCT00108160|40313917|FG001|Overall Study|Death|2|||
16502565|NCT00108160|40313916|FG000|Overall Study|Withdrawal by Subject|4|||
16502566|NCT00108160|40313917|FG001|Overall Study|Withdrawal by Subject|2|||
16502567|NCT00108160|40313916|FG000|Overall Study|Protocol Violation|9|||
16502568|NCT00108160|40313917|FG001|Overall Study|Protocol Violation|5|||
16502569|NCT04351087|40313922|FG000|Overall Study|Lost to Follow-up|7|||
16502570|NCT04351087|40313923|FG001|Overall Study|Lost to Follow-up|3|||
16502571|NCT04351087|40313922|FG000|Overall Study|Withdrawal by Subject|3|||
16502572|NCT04351087|40313923|FG001|Overall Study|Withdrawal by Subject|4|||
16502573|NCT04351087|40313922|FG000|Overall Study|Lack of Efficacy|3|||
16502574|NCT04351087|40313923|FG001|Overall Study|Lack of Efficacy|2|||
16502575|NCT01614990|40313924|FG000|Overall Study|Protocol Violation|1|||
16502576|NCT01614990|40313925|FG001|Overall Study|Protocol Violation|1|||
16502577|NCT02268786|40313926|FG000|Overall Study|No Euploid Embryos available|42|||
16502578|NCT02268786|40313927|FG001|Overall Study|No Euploid Embryos available|0|||
16502579|NCT02268786|40313926|FG000|Overall Study|Withdrawal by Subject|7|||
16502580|NCT02268786|40313927|FG001|Overall Study|Withdrawal by Subject|14|||
16502581|NCT02268786|40313926|FG000|Overall Study|Thaw Failure|6|||
16502582|NCT02268786|40313927|FG001|Overall Study|Thaw Failure|4|||
16502583|NCT02268786|40313926|FG000|Overall Study|Protocol Violation|1|||
16502584|NCT02268786|40313927|FG001|Overall Study|Protocol Violation|0|||
16502585|NCT00378209|40313934|FG000|Overall Study|Progressive disease|11|||
16502586|NCT00378209|40313934|FG000|Overall Study|Adverse Event|3|||
16502587|NCT00378209|40313934|FG000|Overall Study|Initiation of non-protocol therapy|3|||
16310616|NCT01515423|39623471|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
16502588|NCT00378209|40313934|FG000|Overall Study|Physician Decision|3|||
16502589|NCT00378209|40313934|FG000|Overall Study|Death|1|||
16502590|NCT00378209|40313934|FG000|Overall Study|Treatment delay|1|||
16546323|NCT02237508|40464777|FG004|Overall Study|Protocol Violation|0|||
16502591|NCT02068443|40313939|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16502592|NCT02068443|40313940|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
16502593|NCT02068443|40313941|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
16502594|NCT02068443|40313939|FG000|Overall Study|Voluntary Withdrawal|4|||
16502595|NCT02068443|40313940|FG001|Overall Study|Voluntary Withdrawal|0|||
16502596|NCT02068443|40313941|FG002|Overall Study|Voluntary Withdrawal|1|||
16502597|NCT02068443|40313939|FG000|Overall Study|Lack of Efficacy|2|||
16502598|NCT02068443|40313940|FG001|Overall Study|Lack of Efficacy|1|||
16502599|NCT02068443|40313941|FG002|Overall Study|Lack of Efficacy|0|||
16502600|NCT02068443|40313939|FG000|Overall Study|Other Reason Not Specified|1|||
16502601|NCT02068443|40313940|FG001|Overall Study|Other Reason Not Specified|0|||
16502602|NCT02068443|40313941|FG002|Overall Study|Other Reason Not Specified|0|||
16502603|NCT01428453|40313942|FG000|Overall Study|Adverse Event|2|||
16502604|NCT01428453|40313943|FG001|Overall Study|Adverse Event|7|||
16502605|NCT01428453|40313942|FG000|Overall Study|Protocol Violation|1|||
16502606|NCT01428453|40313943|FG001|Overall Study|Protocol Violation|0|||
16502607|NCT01428453|40313942|FG000|Overall Study|Lost to Follow-up|0|||
16502608|NCT01428453|40313943|FG001|Overall Study|Lost to Follow-up|1|||
16502609|NCT01428453|40313942|FG000|Overall Study|Withdrawal by Subject|3|||
16502610|NCT01428453|40313943|FG001|Overall Study|Withdrawal by Subject|1|||
16502611|NCT01132547|40313952|FG000|Overall Study|Withdrawal by Subject|3|||
16502612|NCT01132547|40313953|FG001|Overall Study|Withdrawal by Subject|1|||
16502613|NCT01132547|40313952|FG000|Overall Study|Death|1|||
16502614|NCT01132547|40313953|FG001|Overall Study|Death|0|||
16502615|NCT01172847|40313954|FG000|Overall Study|Withdrawal by Subject|3|||
16502616|NCT00399360|40313956|FG000|Overall Study|Lost to Follow-up|2|||
16502617|NCT00399360|40313957|FG001|Overall Study|Lost to Follow-up|1|||
16502618|NCT00399360|40313958|FG002|Overall Study|Lost to Follow-up|2|||
16502619|NCT00399360|40313959|FG003|Overall Study|Lost to Follow-up|4|||
16502620|NCT00399360|40313956|FG000|Overall Study|Adverse Event|0|||
16502621|NCT00399360|40313957|FG001|Overall Study|Adverse Event|0|||
16502622|NCT00399360|40313958|FG002|Overall Study|Adverse Event|1|||
16502623|NCT00399360|40313959|FG003|Overall Study|Adverse Event|0|||
16502624|NCT00399360|40313956|FG000|Overall Study|Withdrawal by Subject|0|||
16502625|NCT00399360|40313957|FG001|Overall Study|Withdrawal by Subject|2|||
16502626|NCT00399360|40313958|FG002|Overall Study|Withdrawal by Subject|0|||
16502627|NCT00399360|40313959|FG003|Overall Study|Withdrawal by Subject|2|||
16502628|NCT01951157|40313960|FG000|Overall Study|Progressive Disease|12|||
16502629|NCT01951157|40313961|FG001|Overall Study|Progressive Disease|13|||
16502630|NCT01951157|40313962|FG002|Overall Study|Progressive Disease|10|||
16502631|NCT01951157|40313960|FG000|Overall Study|Treatment-unrelated AE|1|||
16502632|NCT01951157|40313961|FG001|Overall Study|Treatment-unrelated AE|0|||
16502633|NCT01951157|40313962|FG002|Overall Study|Treatment-unrelated AE|3|||
16502634|NCT01951157|40313960|FG000|Overall Study|Study Termination|0|||
16502635|NCT01951157|40313961|FG001|Overall Study|Study Termination|0|||
16502636|NCT01951157|40313962|FG002|Overall Study|Study Termination|1|||
16502637|NCT01951157|40313960|FG000|Overall Study|Physician Decision|5|||
16502638|NCT01951157|40313961|FG001|Overall Study|Physician Decision|3|||
16502639|NCT01951157|40313962|FG002|Overall Study|Physician Decision|2|||
16502640|NCT01951157|40313960|FG000|Overall Study|Non-treatmentrelated death|2|||
16502641|NCT01951157|40313961|FG001|Overall Study|Non-treatmentrelated death|2|||
16502642|NCT01951157|40313962|FG002|Overall Study|Non-treatmentrelated death|2|||
16502643|NCT01951157|40313960|FG000|Overall Study|No treated|0|||
16502644|NCT01951157|40313961|FG001|Overall Study|No treated|1|||
16502645|NCT01951157|40313962|FG002|Overall Study|No treated|0|||
16502646|NCT01951157|40313960|FG000|Overall Study|Treatment-related AE|2|||
16502647|NCT01951157|40313961|FG001|Overall Study|Treatment-related AE|0|||
16502648|NCT01951157|40313962|FG002|Overall Study|Treatment-related AE|4|||
16502649|NCT01951157|40313960|FG000|Overall Study|Consent withdrawn by subject|0|||
16502650|NCT01951157|40313961|FG001|Overall Study|Consent withdrawn by subject|1|||
16502651|NCT01951157|40313962|FG002|Overall Study|Consent withdrawn by subject|3|||
16502652|NCT01951157|40313960|FG000|Overall Study|Treatment-related death|0|||
16502653|NCT01951157|40313961|FG001|Overall Study|Treatment-related death|2|||
16502654|NCT01951157|40313962|FG002|Overall Study|Treatment-related death|0|||
16502655|NCT01068509|40313964|FG000|Overall Study|Death|0|||
16502656|NCT01068509|40313965|FG001|Overall Study|Death|0|||
16502657|NCT01068509|40313966|FG002|Overall Study|Death|1|||
16502658|NCT01068509|40313964|FG000|Overall Study|Disease Progression|5|||
16502659|NCT01068509|40313965|FG001|Overall Study|Disease Progression|20|||
16502660|NCT01068509|40313966|FG002|Overall Study|Disease Progression|18|||
16502661|NCT01068509|40313964|FG000|Overall Study|Lost to Follow-up|1|||
16502662|NCT01068509|40313965|FG001|Overall Study|Lost to Follow-up|0|||
16502663|NCT01068509|40313966|FG002|Overall Study|Lost to Follow-up|0|||
16502664|NCT01068509|40313964|FG000|Overall Study|Withdrew Consent|0|||
16502665|NCT01068509|40313965|FG001|Overall Study|Withdrew Consent|1|||
16502666|NCT01068509|40313966|FG002|Overall Study|Withdrew Consent|2|||
16502667|NCT01068509|40313964|FG000|Overall Study|Reason Not Specified|0|||
16502668|NCT01068509|40313965|FG001|Overall Study|Reason Not Specified|1|||
16546324|NCT02237508|40464778|FG005|Overall Study|Protocol Violation|0|||
16195731|NCT00960934|39193401|FG002|Overall Study|Physician Decision|0|||
16310617|NCT01515423|39623472|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
16310618|NCT01515423|39623473|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
16310619|NCT02906670|39623474|FG000|Cohort 1, QW|Radiological Progression|1|||
16310620|NCT02906670|39623475|FG001|Cohort 1, QW|Radiological Progression|0|||
16502669|NCT01068509|40313966|FG002|Overall Study|Reason Not Specified|0|||
16502670|NCT01288287|40313967|FG000|Overall Study|Lost to Follow-up|8|||
16502671|NCT01288287|40313967|FG000|Overall Study|Withdrawal by Subject|4|||
16502672|NCT01288287|40313967|FG000|Overall Study|Lack of Efficacy|13|||
16502673|NCT01288287|40313967|FG000|Overall Study|Other Reason|13|||
16502674|NCT01288287|40313967|FG000|Overall Study|Unknown Reason|1|||
16502675|NCT01288287|40313967|FG000|Overall Study|Unknown Status|7|||
16502676|NCT02677922|40313968|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
16502677|NCT02677922|40313969|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
16502678|NCT02677922|40313970|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
16502679|NCT02677922|40313971|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
16502680|NCT02677922|40313972|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
16502681|NCT02677922|40313973|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
16502682|NCT02677922|40313968|FG000|Treatment Period|Adverse Event|0|||
16502683|NCT02677922|40313969|FG001|Treatment Period|Adverse Event|0|||
16502684|NCT02677922|40313970|FG002|Treatment Period|Adverse Event|1|||
16502685|NCT02677922|40313971|FG003|Treatment Period|Adverse Event|3|||
16502686|NCT02677922|40313972|FG004|Treatment Period|Adverse Event|5|||
16502687|NCT02677922|40313973|FG005|Treatment Period|Adverse Event|2|||
16502688|NCT02677922|40313968|FG000|Treatment Period|Progressive Disease|1|||
16502689|NCT02677922|40313969|FG001|Treatment Period|Progressive Disease|1|||
16502690|NCT02677922|40313970|FG002|Treatment Period|Progressive Disease|0|||
16502691|NCT02677922|40313971|FG003|Treatment Period|Progressive Disease|0|||
16502692|NCT02677922|40313972|FG004|Treatment Period|Progressive Disease|8|||
16502693|NCT02677922|40313973|FG005|Treatment Period|Progressive Disease|7|||
16502694|NCT02677922|40313968|FG000|Treatment Period|Lack of Efficacy|0|||
16502695|NCT02677922|40313969|FG001|Treatment Period|Lack of Efficacy|0|||
16502696|NCT02677922|40313970|FG002|Treatment Period|Lack of Efficacy|0|||
16502697|NCT02677922|40313971|FG003|Treatment Period|Lack of Efficacy|1|||
16502698|NCT02677922|40313972|FG004|Treatment Period|Lack of Efficacy|1|||
16502699|NCT02677922|40313973|FG005|Treatment Period|Lack of Efficacy|6|||
16502700|NCT02677922|40313968|FG000|Treatment Period|Withdrawal by Subject|0|||
16502701|NCT02677922|40313969|FG001|Treatment Period|Withdrawal by Subject|0|||
16502702|NCT02677922|40313970|FG002|Treatment Period|Withdrawal by Subject|1|||
16502703|NCT02677922|40313971|FG003|Treatment Period|Withdrawal by Subject|3|||
16502704|NCT02677922|40313972|FG004|Treatment Period|Withdrawal by Subject|5|||
16502705|NCT02677922|40313973|FG005|Treatment Period|Withdrawal by Subject|5|||
16502706|NCT02677922|40313968|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
16502707|NCT02677922|40313969|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
16502708|NCT02677922|40313970|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
16502709|NCT02677922|40313971|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
16502710|NCT02677922|40313972|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
16502711|NCT02677922|40313973|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
16502712|NCT02677922|40313968|FG000|Treatment Period|Disease Relapse|0|||
16502713|NCT02677922|40313969|FG001|Treatment Period|Disease Relapse|0|||
16502714|NCT02677922|40313970|FG002|Treatment Period|Disease Relapse|0|||
16502715|NCT02677922|40313971|FG003|Treatment Period|Disease Relapse|3|||
16502716|NCT02677922|40313972|FG004|Treatment Period|Disease Relapse|6|||
16195732|NCT00960934|39193402|FG003|Overall Study|Physician Decision|0|||
16310621|NCT02906670|39623476|FG002|Cohort 1, QW|Radiological Progression|0|||
16502717|NCT02677922|40313973|FG005|Treatment Period|Disease Relapse|1|||
16502718|NCT02677922|40313968|FG000|Treatment Period|Allogeneic HSCT|1|||
16502719|NCT02677922|40313969|FG001|Treatment Period|Allogeneic HSCT|0|||
16502720|NCT02677922|40313970|FG002|Treatment Period|Allogeneic HSCT|0|||
16502721|NCT02677922|40313971|FG003|Treatment Period|Allogeneic HSCT|1|||
16502722|NCT02677922|40313972|FG004|Treatment Period|Allogeneic HSCT|4|||
16502723|NCT02677922|40313973|FG005|Treatment Period|Allogeneic HSCT|1|||
16502724|NCT02677922|40313968|FG000|Treatment Period|Other Reasons|0|||
16502725|NCT02677922|40313969|FG001|Treatment Period|Other Reasons|0|||
16502726|NCT02677922|40313970|FG002|Treatment Period|Other Reasons|0|||
16502727|NCT02677922|40313971|FG003|Treatment Period|Other Reasons|1|||
16502728|NCT02677922|40313972|FG004|Treatment Period|Other Reasons|3|||
16502729|NCT02677922|40313973|FG005|Treatment Period|Other Reasons|5|||
16502730|NCT02677922|40313968|FG000|Treatment Period|Death|0|||
16502731|NCT02677922|40313969|FG001|Treatment Period|Death|0|||
16502732|NCT02677922|40313970|FG002|Treatment Period|Death|0|||
16502733|NCT02677922|40313971|FG003|Treatment Period|Death|0|||
16502734|NCT02677922|40313972|FG004|Treatment Period|Death|12|||
16502735|NCT02677922|40313973|FG005|Treatment Period|Death|1|||
16502736|NCT02677922|40313968|FG000|Treatment Period|Non-compliance with Study Drug|0|||
16502737|NCT02677922|40313969|FG001|Treatment Period|Non-compliance with Study Drug|0|||
16502738|NCT02677922|40313970|FG002|Treatment Period|Non-compliance with Study Drug|0|||
16502739|NCT02677922|40313971|FG003|Treatment Period|Non-compliance with Study Drug|0|||
16502740|NCT02677922|40313972|FG004|Treatment Period|Non-compliance with Study Drug|1|||
16502741|NCT02677922|40313973|FG005|Treatment Period|Non-compliance with Study Drug|0|||
16502742|NCT02677922|40313968|FG000|Treatment Period|Physician Decision|0|||
16502743|NCT02677922|40313969|FG001|Treatment Period|Physician Decision|0|||
16502744|NCT02677922|40313970|FG002|Treatment Period|Physician Decision|0|||
16502745|NCT02677922|40313971|FG003|Treatment Period|Physician Decision|0|||
16502746|NCT02677922|40313972|FG004|Treatment Period|Physician Decision|0|||
16502747|NCT02677922|40313973|FG005|Treatment Period|Physician Decision|1|||
16502748|NCT02677922|40313968|FG000|Treatment Period|Symptomatic Deterioration|0|||
16502749|NCT02677922|40313969|FG001|Treatment Period|Symptomatic Deterioration|0|||
16502750|NCT02677922|40313970|FG002|Treatment Period|Symptomatic Deterioration|0|||
16502751|NCT02677922|40313971|FG003|Treatment Period|Symptomatic Deterioration|0|||
16502752|NCT02677922|40313972|FG004|Treatment Period|Symptomatic Deterioration|1|||
16502753|NCT02677922|40313973|FG005|Treatment Period|Symptomatic Deterioration|0|||
16502754|NCT00518323|40313974|FG000|Overall Study|Lack of Efficacy|14|||
16502755|NCT00518323|40313975|FG001|Overall Study|Lack of Efficacy|2|||
16502756|NCT00518323|40313976|FG002|Overall Study|Lack of Efficacy|4|||
16502757|NCT00518323|40313977|FG003|Overall Study|Lack of Efficacy|20|||
16502758|NCT00518323|40313974|FG000|Overall Study|Withdrawal by Subject|1|||
16502759|NCT00518323|40313975|FG001|Overall Study|Withdrawal by Subject|2|||
16502760|NCT00518323|40313976|FG002|Overall Study|Withdrawal by Subject|4|||
16502761|NCT00518323|40313977|FG003|Overall Study|Withdrawal by Subject|2|||
16502762|NCT00518323|40313974|FG000|Overall Study|Lost to Follow-up|0|||
16502763|NCT00518323|40313975|FG001|Overall Study|Lost to Follow-up|2|||
16502764|NCT00518323|40313976|FG002|Overall Study|Lost to Follow-up|1|||
16502765|NCT00518323|40313977|FG003|Overall Study|Lost to Follow-up|3|||
16502766|NCT00518323|40313974|FG000|Overall Study|Adverse Event|1|||
16502767|NCT00518323|40313975|FG001|Overall Study|Adverse Event|1|||
16502768|NCT00518323|40313976|FG002|Overall Study|Adverse Event|1|||
16502769|NCT00518323|40313977|FG003|Overall Study|Adverse Event|0|||
16502770|NCT00518323|40313974|FG000|Overall Study|Prohibited medication and others|3|||
16502771|NCT00518323|40313975|FG001|Overall Study|Prohibited medication and others|1|||
16502772|NCT00518323|40313976|FG002|Overall Study|Prohibited medication and others|1|||
16502773|NCT00518323|40313977|FG003|Overall Study|Prohibited medication and others|0|||
16502774|NCT00810407|40313978|FG000|Overall Study|Protocol Violation|3|||
16502775|NCT00810407|40313978|FG000|Overall Study|No Visit After First Day of Treatment|3|||
16502776|NCT02335099|40313979|FG000|Treatment|Withdrawal by Subject|1|||
16502777|NCT02335099|40313980|FG001|Treatment|Withdrawal by Subject|3|||
16502778|NCT02335099|40313979|FG000|Treatment|Lost to Follow-up|2|||
16502779|NCT02335099|40313980|FG001|Treatment|Lost to Follow-up|0|||
16502780|NCT02335099|40313979|FG000|Treatment|Death|1|||
16502781|NCT02335099|40313980|FG001|Treatment|Death|0|||
16502782|NCT02335099|40313979|FG000|Treatment|Adverse Event|1|||
16502783|NCT02335099|40313980|FG001|Treatment|Adverse Event|2|||
16502784|NCT02335099|40313979|FG000|Follow-up|Death|0|||
16502785|NCT02335099|40313980|FG001|Follow-up|Death|1|||
16502786|NCT03745937|40313981|FG000|Overall Study|Withdrawal by Subject|0|||
16502787|NCT03745937|40313982|FG001|Overall Study|Withdrawal by Subject|0|||
16502788|NCT03745937|40313983|FG002|Overall Study|Withdrawal by Subject|0|||
16502789|NCT03745937|40313984|FG003|Overall Study|Withdrawal by Subject|1|||
16502790|NCT03745937|40313981|FG000|Overall Study|Not-specifed|0|||
16502791|NCT03745937|40313982|FG001|Overall Study|Not-specifed|1|||
16502792|NCT03745937|40313983|FG002|Overall Study|Not-specifed|0|||
16502793|NCT03745937|40313984|FG003|Overall Study|Not-specifed|1|||
16502794|NCT00520975|40313985|FG000|Overall Study|Disease progression|31|||
16502795|NCT00520975|40313986|FG001|Overall Study|Disease progression|23|||
16502796|NCT00520975|40313985|FG000|Overall Study|Adverse Event|7|||
16502797|NCT00520975|40313986|FG001|Overall Study|Adverse Event|10|||
16502798|NCT00520975|40313985|FG000|Overall Study|Death|0|||
16502799|NCT00520975|40313986|FG001|Overall Study|Death|2|||
16502800|NCT00520975|40313985|FG000|Overall Study|Withdrawal by Subject|3|||
16502801|NCT00520975|40313986|FG001|Overall Study|Withdrawal by Subject|5|||
16502802|NCT00520975|40313985|FG000|Overall Study|Other therapy|2|||
16502803|NCT00520975|40313986|FG001|Overall Study|Other therapy|4|||
16502804|NCT00520975|40313985|FG000|Overall Study|Other reasons|4|||
16502805|NCT00520975|40313986|FG001|Overall Study|Other reasons|2|||
16502806|NCT00520975|40313985|FG000|Overall Study|Not start protocol therapy|1|||
16502807|NCT00520975|40313986|FG001|Overall Study|Not start protocol therapy|2|||
16502808|NCT02225743|40313987|FG000|Overall Study|Withdrawal by Subject|18|||
16502809|NCT00311623|40313988|FG000|Overall Study|Physician Decision|0|||
16502810|NCT00311623|40313989|FG001|Overall Study|Physician Decision|0|||
16502811|NCT00311623|40313990|FG002|Overall Study|Physician Decision|2|||
16502812|NCT01675128|40313991|FG000|Overall Study|Disease progression on study|1|||
16502813|NCT01675128|40313992|FG001|Overall Study|Disease progression on study|1|||
16502814|NCT01675128|40313993|FG002|Overall Study|Disease progression on study|1|||
16502815|NCT01675128|40313991|FG000|Overall Study|Refused further treatment|1|||
16089320|NCT00983294|38816875|FG000|Colchicine With Azithromycin|Adverse Event|1|||
16089321|NCT01228734|38816876|FG000|Overall Study|Randomized, but not treated|0|||
16089322|NCT01228734|38816877|FG001|Overall Study|Randomized, but not treated|4|||
16089323|NCT00620854|38816889|FG000|Washout 1|Withdrawal by Subject|0|||
16089324|NCT00620854|38816890|FG001|Washout 1|Withdrawal by Subject|0|||
16089325|NCT00620854|38816891|FG002|Washout 1|Withdrawal by Subject|1|||
16089326|NCT00620854|38816892|FG003|Washout 1|Withdrawal by Subject|1|||
16089327|NCT00620854|38816893|FG004|Washout 1|Withdrawal by Subject|0|||
16089328|NCT00620854|38816894|FG005|Washout 1|Withdrawal by Subject|0|||
16089329|NCT02630966|38816897|FG000|Overall Study|Adverse Event|1|||
16089330|NCT02630966|38816898|FG001|Overall Study|Adverse Event|3|||
16089331|NCT02630966|38816897|FG000|Overall Study|Significant Protocol Deviation|0|||
16089332|NCT02630966|38816898|FG001|Overall Study|Significant Protocol Deviation|2|||
16089333|NCT02630966|38816897|FG000|Overall Study|Voluntary Withdrawal|1|||
16089334|NCT02630966|38816898|FG001|Overall Study|Voluntary Withdrawal|1|||
16089335|NCT02630966|38816897|FG000|Overall Study|Lack of Efficacy|0|||
16089336|NCT02630966|38816898|FG001|Overall Study|Lack of Efficacy|2|||
16089337|NCT02502526|38816899|FG000|Overall Study|Lost to Follow-up|2|||
16089338|NCT02502526|38816900|FG001|Overall Study|Lost to Follow-up|2|||
16502816|NCT01675128|40313992|FG001|Overall Study|Refused further treatment|0|||
16502817|NCT01675128|40313993|FG002|Overall Study|Refused further treatment|0|||
16089339|NCT02502526|38816901|FG002|Overall Study|Lost to Follow-up|3|||
16502818|NCT01675128|40313991|FG000|Overall Study|Pulmonary complication; off study|0|||
16502819|NCT01675128|40313992|FG001|Overall Study|Pulmonary complication; off study|1|||
16502820|NCT01675128|40313993|FG002|Overall Study|Pulmonary complication; off study|0|||
16502821|NCT02197806|40313994|FG000|Overall Study|Adverse Event|0|||
16502822|NCT02197806|40313995|FG001|Overall Study|Adverse Event|1|||
16502823|NCT02197806|40313996|FG002|Overall Study|Adverse Event|0|||
16502824|NCT02197806|40313997|FG003|Overall Study|Adverse Event|1|||
16502825|NCT01092182|40314000|FG000|Overall Study|Death|0|||
16502826|NCT01092182|40314001|FG001|Overall Study|Death|5|||
16502827|NCT01092182|40314002|FG002|Overall Study|Death|3|||
16502828|NCT01092182|40314000|FG000|Overall Study|participant safety|1|||
16502829|NCT01092182|40314001|FG001|Overall Study|participant safety|2|||
16502830|NCT01092182|40314002|FG002|Overall Study|participant safety|0|||
16089340|NCT02502526|38816899|FG000|Overall Study|Withdrawal by Subject|0|||
16502831|NCT01092182|40314000|FG000|Overall Study|Physician Decision|0|||
16502832|NCT01092182|40314001|FG001|Overall Study|Physician Decision|6|||
16502833|NCT01092182|40314002|FG002|Overall Study|Physician Decision|0|||
16502834|NCT01092182|40314000|FG000|Overall Study|Did not meet criteria|0|||
16502835|NCT01092182|40314001|FG001|Overall Study|Did not meet criteria|0|||
16502836|NCT01092182|40314002|FG002|Overall Study|Did not meet criteria|25|||
16089341|NCT02502526|38816900|FG001|Overall Study|Withdrawal by Subject|1|||
16089342|NCT02502526|38816901|FG002|Overall Study|Withdrawal by Subject|1|||
16089343|NCT02502526|38816899|FG000|Overall Study|Disqualified due to cataract grading|0|||
16502837|NCT01092182|40314000|FG000|Overall Study|Non-compliance|0|||
16502838|NCT01092182|40314001|FG001|Overall Study|Non-compliance|3|||
16502839|NCT01092182|40314002|FG002|Overall Study|Non-compliance|0|||
16502840|NCT01092182|40314000|FG000|Overall Study|Participant refused follow-up|0|||
16502841|NCT01092182|40314001|FG001|Overall Study|Participant refused follow-up|2|||
16502842|NCT01092182|40314002|FG002|Overall Study|Participant refused follow-up|0|||
16502843|NCT02875860|40314003|FG000|Overall Study|Withdrawal by Subject|0|||
16502844|NCT02875860|40314004|FG001|Overall Study|Withdrawal by Subject|1|||
16502845|NCT02268812|40314007|FG000|Overall Study|Adverse Event|8|||
16502846|NCT02268812|40314008|FG001|Overall Study|Adverse Event|26|||
16502847|NCT02268812|40314009|FG002|Overall Study|Adverse Event|7|||
16502848|NCT02268812|40314010|FG003|Overall Study|Adverse Event|10|||
16502849|NCT02268812|40314007|FG000|Overall Study|Protocol deviation|0|||
16502850|NCT02268812|40314008|FG001|Overall Study|Protocol deviation|0|||
16502851|NCT02268812|40314009|FG002|Overall Study|Protocol deviation|1|||
16502852|NCT02268812|40314010|FG003|Overall Study|Protocol deviation|0|||
16502853|NCT02268812|40314007|FG000|Overall Study|Withdrawal by Subject|0|||
16502854|NCT02268812|40314008|FG001|Overall Study|Withdrawal by Subject|1|||
16502855|NCT02268812|40314009|FG002|Overall Study|Withdrawal by Subject|0|||
16502856|NCT02268812|40314010|FG003|Overall Study|Withdrawal by Subject|0|||
16502857|NCT02268812|40314007|FG000|Overall Study|Physician Decision|3|||
16502858|NCT02268812|40314008|FG001|Overall Study|Physician Decision|1|||
16502859|NCT02268812|40314009|FG002|Overall Study|Physician Decision|0|||
16502860|NCT02268812|40314010|FG003|Overall Study|Physician Decision|1|||
16502861|NCT02268812|40314007|FG000|Overall Study|Other|5|||
16502862|NCT02268812|40314008|FG001|Overall Study|Other|4|||
16502863|NCT02268812|40314009|FG002|Overall Study|Other|1|||
16502864|NCT02268812|40314010|FG003|Overall Study|Other|3|||
16502865|NCT03316885|40314012|FG000|Overall Study|Adverse Event|1|||
16502866|NCT03316885|40314012|FG000|Overall Study|Death|10|||
16502867|NCT03316885|40314012|FG000|Overall Study|Lost to Follow-up|4|||
16502868|NCT03316885|40314012|FG000|Overall Study|Withdrawal by Subject|9|||
16502869|NCT03316885|40314012|FG000|Overall Study|COVID related|8|||
16502870|NCT01062555|40314014|FG000|Phase 1|Death|10|||
16502871|NCT01062555|40314015|FG001|Phase 1|Death|17|||
16502872|NCT01062555|40314016|FG002|Phase 1|Death|0|||
16502873|NCT01062555|40314017|FG003|Phase 1|Death|0|||
16502874|NCT01062555|40314014|FG000|Phase 1|Graft Failure|12|||
16502875|NCT01062555|40314015|FG001|Phase 1|Graft Failure|8|||
16502876|NCT01062555|40314016|FG002|Phase 1|Graft Failure|0|||
16502877|NCT01062555|40314017|FG003|Phase 1|Graft Failure|0|||
16502878|NCT01062555|40314014|FG000|Phase 1|Withdrawal by Subject|1|||
16502879|NCT01062555|40314015|FG001|Phase 1|Withdrawal by Subject|1|||
16502880|NCT01062555|40314016|FG002|Phase 1|Withdrawal by Subject|0|||
16502881|NCT01062555|40314017|FG003|Phase 1|Withdrawal by Subject|0|||
16502882|NCT01062555|40314014|FG000|Phase 2|Death|0|||
16502883|NCT01062555|40314015|FG001|Phase 2|Death|0|||
16502884|NCT01062555|40314016|FG002|Phase 2|Death|8|||
16502885|NCT01062555|40314017|FG003|Phase 2|Death|3|||
16502886|NCT01062555|40314014|FG000|Phase 2|Graft failure|0|||
16502887|NCT01062555|40314015|FG001|Phase 2|Graft failure|0|||
16502888|NCT01062555|40314016|FG002|Phase 2|Graft failure|7|||
16502889|NCT01062555|40314017|FG003|Phase 2|Graft failure|4|||
16502890|NCT01062555|40314014|FG000|Phase 2|Withdrawal by Subject|0|||
16502891|NCT01062555|40314015|FG001|Phase 2|Withdrawal by Subject|0|||
16502892|NCT01062555|40314016|FG002|Phase 2|Withdrawal by Subject|0|||
16502893|NCT01062555|40314017|FG003|Phase 2|Withdrawal by Subject|7|||
16502894|NCT01062555|40314014|FG000|Phase 2|Protocol Violation|0|||
16502895|NCT01062555|40314015|FG001|Phase 2|Protocol Violation|0|||
16502896|NCT01062555|40314016|FG002|Phase 2|Protocol Violation|0|||
16502897|NCT01062555|40314017|FG003|Phase 2|Protocol Violation|3|||
16502898|NCT01062555|40314014|FG000|Phase 2|Physician Decision|0|||
16502899|NCT01062555|40314015|FG001|Phase 2|Physician Decision|0|||
16502900|NCT01062555|40314016|FG002|Phase 2|Physician Decision|0|||
16502901|NCT01062555|40314017|FG003|Phase 2|Physician Decision|17|||
16502902|NCT00454987|40314020|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
16502903|NCT00454987|40314021|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
16502904|NCT00454987|40314022|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
16502905|NCT00454987|40314020|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
16502906|NCT00454987|40314021|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
16089344|NCT02502526|38816900|FG001|Overall Study|Disqualified due to cataract grading|0|||
16195733|NCT00960934|39193403|FG004|Overall Study|Physician Decision|0|||
16502907|NCT00454987|40314022|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
16502908|NCT00454987|40314020|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
16502909|NCT00454987|40314021|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
16502910|NCT00454987|40314022|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
16502911|NCT00680745|40314023|FG000|Overall Study|Withdrawal by Subject|8|||
16502912|NCT00680745|40314024|FG001|Overall Study|Withdrawal by Subject|3|||
16502913|NCT00680745|40314025|FG002|Overall Study|Withdrawal by Subject|2|||
16502914|NCT00680745|40314026|FG003|Overall Study|Withdrawal by Subject|8|||
16502915|NCT00680745|40314023|FG000|Overall Study|Lost to Follow-up|0|||
16502916|NCT00680745|40314024|FG001|Overall Study|Lost to Follow-up|1|||
16502917|NCT00680745|40314025|FG002|Overall Study|Lost to Follow-up|1|||
16502918|NCT00680745|40314026|FG003|Overall Study|Lost to Follow-up|0|||
16502919|NCT00680745|40314023|FG000|Overall Study|Death|1|||
16502920|NCT00680745|40314024|FG001|Overall Study|Death|0|||
16502921|NCT00680745|40314025|FG002|Overall Study|Death|1|||
16502922|NCT00680745|40314026|FG003|Overall Study|Death|0|||
16502923|NCT00680745|40314023|FG000|Overall Study|Adverse Event|5|||
16502924|NCT00680745|40314024|FG001|Overall Study|Adverse Event|3|||
16502925|NCT00680745|40314025|FG002|Overall Study|Adverse Event|3|||
16502926|NCT00680745|40314026|FG003|Overall Study|Adverse Event|3|||
16502927|NCT00680745|40314023|FG000|Overall Study|Poor/Non-compliance|0|||
16502928|NCT00680745|40314024|FG001|Overall Study|Poor/Non-compliance|3|||
16502929|NCT00680745|40314025|FG002|Overall Study|Poor/Non-compliance|0|||
16502930|NCT00680745|40314026|FG003|Overall Study|Poor/Non-compliance|0|||
16310622|NCT02906670|39623477|FG003|Cohort 1, QW|Radiological Progression|0|||
16310623|NCT02906670|39623478|FG004|Cohort 1, QW|Radiological Progression|0|||
16502931|NCT00680745|40314023|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
16502932|NCT00680745|40314024|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
16502933|NCT00680745|40314025|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
16502934|NCT00680745|40314026|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
16502935|NCT00680745|40314023|FG000|Overall Study|False Treatment|0|||
16502936|NCT00680745|40314024|FG001|Overall Study|False Treatment|1|||
16502937|NCT00680745|40314025|FG002|Overall Study|False Treatment|3|||
16502938|NCT00680745|40314026|FG003|Overall Study|False Treatment|0|||
16502939|NCT00723892|40314027|FG000|Overall Study|Participant not tracked|33|||
16502940|NCT00723892|40314028|FG001|Overall Study|Participant not tracked|35|||
16502941|NCT00723892|40314027|FG000|Overall Study|Virological criterion|24|||
16502942|NCT00723892|40314028|FG001|Overall Study|Virological criterion|9|||
16502943|NCT00723892|40314027|FG000|Overall Study|Withdrawal by Subject|6|||
16502944|NCT00723892|40314028|FG001|Overall Study|Withdrawal by Subject|9|||
16502945|NCT00723892|40314027|FG000|Overall Study|End planned|11|||
16502946|NCT00723892|40314028|FG001|Overall Study|End planned|7|||
16502947|NCT00723892|40314027|FG000|Overall Study|Bad tolerance|5|||
16502948|NCT00723892|40314028|FG001|Overall Study|Bad tolerance|5|||
16502949|NCT00723892|40314027|FG000|Overall Study|Multiple reasons|17|||
16502950|NCT00723892|40314028|FG001|Overall Study|Multiple reasons|12|||
16502951|NCT00723892|40314027|FG000|Overall Study|Other|6|||
16502952|NCT00723892|40314028|FG001|Overall Study|Other|3|||
16502953|NCT00723892|40314027|FG000|Overall Study|Study end|1|||
16502954|NCT00723892|40314028|FG001|Overall Study|Study end|3|||
16502955|NCT00723892|40314027|FG000|Overall Study|Weight loss|1|||
16502956|NCT00723892|40314028|FG001|Overall Study|Weight loss|3|||
16502957|NCT00723892|40314027|FG000|Overall Study|Alcohol abuse|0|||
16502958|NCT00723892|40314028|FG001|Overall Study|Alcohol abuse|1|||
16502959|NCT00723892|40314027|FG000|Overall Study|Intercurrent infection|2|||
16502960|NCT00723892|40314028|FG001|Overall Study|Intercurrent infection|0|||
16502961|NCT00723892|40314027|FG000|Overall Study|Drug addiction|1|||
16502962|NCT00723892|40314028|FG001|Overall Study|Drug addiction|0|||
16502963|NCT00624052|40314029|FG000|Overall Study|Adverse Event|7|||
16502964|NCT00624052|40314030|FG001|Overall Study|Adverse Event|6|||
16502965|NCT00624052|40314031|FG002|Overall Study|Adverse Event|0|||
16502966|NCT00624052|40314032|FG003|Overall Study|Adverse Event|3|||
16502967|NCT00624052|40314029|FG000|Overall Study|Lack of Efficacy|1|||
16502968|NCT00624052|40314030|FG001|Overall Study|Lack of Efficacy|1|||
16502969|NCT00624052|40314031|FG002|Overall Study|Lack of Efficacy|0|||
16195734|NCT00960934|39193404|FG005|Overall Study|Physician Decision|0|||
16502970|NCT00624052|40314032|FG003|Overall Study|Lack of Efficacy|0|||
16502971|NCT00624052|40314029|FG000|Overall Study|Lost to Follow-up|2|||
16502972|NCT00624052|40314030|FG001|Overall Study|Lost to Follow-up|3|||
16502973|NCT00624052|40314031|FG002|Overall Study|Lost to Follow-up|1|||
16502974|NCT00624052|40314032|FG003|Overall Study|Lost to Follow-up|0|||
16502975|NCT00624052|40314029|FG000|Overall Study|Non compliant with the protocol|2|||
16502976|NCT00624052|40314030|FG001|Overall Study|Non compliant with the protocol|1|||
16502977|NCT00624052|40314031|FG002|Overall Study|Non compliant with the protocol|1|||
16195735|NCT00960934|39193399|FG000|Overall Study|Progressive Disease|1|||
16502978|NCT00624052|40314032|FG003|Overall Study|Non compliant with the protocol|1|||
16502979|NCT00624052|40314029|FG000|Overall Study|Consent withdrawn|3|||
16502980|NCT00624052|40314030|FG001|Overall Study|Consent withdrawn|1|||
16502981|NCT00624052|40314031|FG002|Overall Study|Consent withdrawn|1|||
16502982|NCT00624052|40314032|FG003|Overall Study|Consent withdrawn|0|||
16502983|NCT00624052|40314029|FG000|Overall Study|Changed job/ran out if meds|0|||
16502984|NCT00624052|40314030|FG001|Overall Study|Changed job/ran out if meds|2|||
16502985|NCT00624052|40314031|FG002|Overall Study|Changed job/ran out if meds|0|||
16502986|NCT00624052|40314032|FG003|Overall Study|Changed job/ran out if meds|0|||
16502987|NCT01475331|40314033|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
16502988|NCT01475331|40314034|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
16502989|NCT01475331|40314033|FG000|Overall Study|excessive main duct communication|1|||
16502990|NCT01475331|40314034|FG001|Overall Study|excessive main duct communication|1|||
16502991|NCT01475331|40314033|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
16502992|NCT01475331|40314034|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
16502993|NCT01475331|40314033|FG000|Overall Study|Sign of malignancy during the procedure|2|||
16502994|NCT01475331|40314034|FG001|Overall Study|Sign of malignancy during the procedure|0|||
16502995|NCT01475331|40314033|FG000|Overall Study|cyst found to be prohibitively small|0|||
16502996|NCT01475331|40314034|FG001|Overall Study|cyst found to be prohibitively small|1|||
16502997|NCT03178773|40314043|FG000|Overall Study|Death|0|||
16502998|NCT03178773|40314044|FG001|Overall Study|Death|1|||
16502999|NCT03178773|40314043|FG000|Overall Study|Lost to Follow-up|29|||
16503000|NCT03178773|40314044|FG001|Overall Study|Lost to Follow-up|25|||
16503001|NCT03178773|40314043|FG000|Overall Study|Withdrawal by Subject|10|||
16503002|NCT03178773|40314044|FG001|Overall Study|Withdrawal by Subject|14|||
16503003|NCT02120950|40314045|FG000|Overall Study|Adverse Event|5|||
16503004|NCT02120950|40314046|FG001|Overall Study|Adverse Event|4|||
16503005|NCT02120950|40314047|FG002|Overall Study|Adverse Event|3|||
16503006|NCT02120950|40314045|FG000|Overall Study|Death|3|||
16503007|NCT02120950|40314046|FG001|Overall Study|Death|0|||
16503008|NCT02120950|40314047|FG002|Overall Study|Death|1|||
16503009|NCT02120950|40314045|FG000|Overall Study|Withdrawal by Subject|6|||
16503010|NCT02120950|40314046|FG001|Overall Study|Withdrawal by Subject|3|||
16503011|NCT02120950|40314047|FG002|Overall Study|Withdrawal by Subject|2|||
16503012|NCT02120950|40314045|FG000|Overall Study|Protocol Violation|1|||
16503013|NCT02120950|40314046|FG001|Overall Study|Protocol Violation|1|||
16503014|NCT02120950|40314047|FG002|Overall Study|Protocol Violation|7|||
16503015|NCT02120950|40314045|FG000|Overall Study|Other reasons|5|||
16503016|NCT02120950|40314046|FG001|Overall Study|Other reasons|4|||
16503017|NCT02120950|40314047|FG002|Overall Study|Other reasons|1|||
16503018|NCT02120950|40314045|FG000|Overall Study|Lost to Follow-up|0|||
16503019|NCT02120950|40314046|FG001|Overall Study|Lost to Follow-up|2|||
16503020|NCT02120950|40314047|FG002|Overall Study|Lost to Follow-up|1|||
16503021|NCT02794103|40314048|FG000|Overall Study|Loss to follow up due to high sedation|3|||
16503022|NCT00413192|40314049|FG000|Overall Study|Disease progression|26|||
16503023|NCT00413192|40314050|FG001|Overall Study|Disease progression|31|||
16503024|NCT00413192|40314051|FG002|Overall Study|Disease progression|16|||
16503025|NCT00413192|40314052|FG003|Overall Study|Disease progression|25|||
16503026|NCT00413192|40314049|FG000|Overall Study|Toxicity|3|||
16503027|NCT00413192|40314050|FG001|Overall Study|Toxicity|2|||
16503028|NCT00413192|40314051|FG002|Overall Study|Toxicity|2|||
16503029|NCT00413192|40314052|FG003|Overall Study|Toxicity|2|||
16503030|NCT00413192|40314049|FG000|Overall Study|Withdrawal by Subject|3|||
16503031|NCT00413192|40314050|FG001|Overall Study|Withdrawal by Subject|5|||
16503032|NCT00413192|40314051|FG002|Overall Study|Withdrawal by Subject|0|||
16503033|NCT00413192|40314052|FG003|Overall Study|Withdrawal by Subject|1|||
16503034|NCT00413192|40314049|FG000|Overall Study|Intercurrent illness|0|||
16503035|NCT00413192|40314050|FG001|Overall Study|Intercurrent illness|0|||
16503036|NCT00413192|40314051|FG002|Overall Study|Intercurrent illness|0|||
16503037|NCT00413192|40314052|FG003|Overall Study|Intercurrent illness|1|||
16503038|NCT00413192|40314049|FG000|Overall Study|Intercurrent death|0|||
16503039|NCT00413192|40314050|FG001|Overall Study|Intercurrent death|1|||
16503040|NCT00413192|40314051|FG002|Overall Study|Intercurrent death|0|||
16503041|NCT00413192|40314052|FG003|Overall Study|Intercurrent death|0|||
16503042|NCT00413192|40314049|FG000|Overall Study|Other|5|||
16503043|NCT00413192|40314050|FG001|Overall Study|Other|1|||
16503044|NCT00413192|40314051|FG002|Overall Study|Other|1|||
16503045|NCT00413192|40314052|FG003|Overall Study|Other|2|||
16503046|NCT00413192|40314049|FG000|Overall Study|Not treated|0|||
16503047|NCT00413192|40314050|FG001|Overall Study|Not treated|0|||
16503048|NCT00413192|40314051|FG002|Overall Study|Not treated|0|||
16503049|NCT00413192|40314052|FG003|Overall Study|Not treated|1|||
16503050|NCT00878709|40314053|FG000|Overall Study|Withdrawal by Subject|197|||
16503051|NCT00878709|40314054|FG001|Overall Study|Withdrawal by Subject|120|||
16503052|NCT00878709|40314053|FG000|Overall Study|Lost to Follow-up|35|||
16503053|NCT00878709|40314054|FG001|Overall Study|Lost to Follow-up|33|||
16503054|NCT00878709|40314053|FG000|Overall Study|Other Reasons|93|||
16503055|NCT00878709|40314054|FG001|Overall Study|Other Reasons|84|||
16546325|NCT02237508|40464779|FG006|Overall Study|Protocol Violation|0|||
16310624|NCT02906670|39623479|FG005|Cohort 1, QW|Radiological Progression|0|||
16310625|NCT02906670|39623480|FG006|Cohort 1, QW|Radiological Progression|0|||
16503056|NCT02411292|40314062|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
16503057|NCT02411292|40314062|FG000|Overall Study|Death|2|||
16503058|NCT02411292|40314062|FG000|Overall Study|Lost to Follow-up|3|||
16310626|NCT02906670|39623481|FG007|Cohort 1, QW|Radiological Progression|0|||
16310627|NCT02906670|39623482|FG008|Cohort 1, QW|Radiological Progression|0|||
16503059|NCT00238121|40314063|FG000|Overall Study|Withdrawal by Subject|1|||
16503060|NCT00238121|40314064|FG001|Overall Study|Withdrawal by Subject|1|||
16503061|NCT00238121|40314063|FG000|Overall Study|Adverse Event|2|||
16503062|NCT00238121|40314064|FG001|Overall Study|Adverse Event|1|||
16503063|NCT03605303|40314065|FG000|Period 1|Study Terminated|2|||
16503064|NCT03605303|40314066|FG001|Period 1|Study Terminated|1|||
16503065|NCT02045797|40314067|FG000|Overall Study|Adverse Event|3|||
16503066|NCT02045797|40314068|FG001|Overall Study|Adverse Event|1|||
16503067|NCT02045797|40314069|FG002|Overall Study|Adverse Event|0|||
16503068|NCT02045797|40314067|FG000|Overall Study|Lack of Efficacy|1|||
16503069|NCT02045797|40314068|FG001|Overall Study|Lack of Efficacy|0|||
16503070|NCT02045797|40314069|FG002|Overall Study|Lack of Efficacy|0|||
16503071|NCT02045797|40314067|FG000|Overall Study|Lost to Follow-up|2|||
16503072|NCT02045797|40314068|FG001|Overall Study|Lost to Follow-up|3|||
16503073|NCT02045797|40314069|FG002|Overall Study|Lost to Follow-up|1|||
16503074|NCT02045797|40314067|FG000|Overall Study|Physician Decision|0|||
16503075|NCT02045797|40314068|FG001|Overall Study|Physician Decision|1|||
16503076|NCT02045797|40314069|FG002|Overall Study|Physician Decision|0|||
16503077|NCT02045797|40314067|FG000|Overall Study|Withdrawal by Subject|1|||
16503078|NCT02045797|40314068|FG001|Overall Study|Withdrawal by Subject|2|||
16503079|NCT02045797|40314069|FG002|Overall Study|Withdrawal by Subject|0|||
16503080|NCT01132482|40314077|FG000|Overall Study|Adverse Event|1|||
16503081|NCT01132482|40314078|FG001|Overall Study|Adverse Event|0|||
16503082|NCT00491387|40314079|FG000|Overall Study|study terminated|20|||
16310628|NCT02906670|39623483|FG009|Cohort 1, QW|Radiological Progression|0|||
16310629|NCT02906670|39623474|FG000|Cohort 2, QW|Radiological Progression|0|||
16310630|NCT02906670|39623475|FG001|Cohort 2, QW|Radiological Progression|1|||
16310631|NCT02906670|39623476|FG002|Cohort 2, QW|Radiological Progression|0|||
16310632|NCT02906670|39623477|FG003|Cohort 2, QW|Radiological Progression|0|||
16310633|NCT02906670|39623478|FG004|Cohort 2, QW|Radiological Progression|0|||
16310634|NCT02906670|39623479|FG005|Cohort 2, QW|Radiological Progression|0|||
16310635|NCT02906670|39623480|FG006|Cohort 2, QW|Radiological Progression|0|||
16503083|NCT00744627|40314081|FG000|Overall Study|Adverse Event|6|||
16503084|NCT00744627|40314082|FG001|Overall Study|Adverse Event|9|||
16310636|NCT02906670|39623481|FG007|Cohort 2, QW|Radiological Progression|0|||
16310637|NCT02906670|39623482|FG008|Cohort 2, QW|Radiological Progression|0|||
16310638|NCT02906670|39623483|FG009|Cohort 2, QW|Radiological Progression|0|||
16503085|NCT00744627|40314081|FG000|Overall Study|Lack of Efficacy|7|||
16503086|NCT00744627|40314082|FG001|Overall Study|Lack of Efficacy|3|||
16503087|NCT00744627|40314081|FG000|Overall Study|Noncompliance|0|||
16390266|NCT00038948|39911989|FG001|Overall Study|Nonmedical event|7|||
16390267|NCT00038948|39911988|FG000|Overall Study|Withdrawal by Subject|23|||
16390268|NCT00038948|39911989|FG001|Overall Study|Withdrawal by Subject|10|||
16390269|NCT00038948|39911988|FG000|Overall Study|Protocol Violation|3|||
16390270|NCT00038948|39911989|FG001|Overall Study|Protocol Violation|7|||
16390271|NCT00038948|39911988|FG000|Overall Study|Lack of Efficacy|3|||
16390272|NCT00038948|39911989|FG001|Overall Study|Lack of Efficacy|6|||
16390273|NCT01016067|39911990|FG000|Overall Study|Lost to Follow-up|1|||
16390274|NCT01016067|39911991|FG001|Overall Study|Lost to Follow-up|2|||
16390275|NCT01016067|39911990|FG000|Overall Study|Physician Decision|1|||
16390276|NCT01016067|39911991|FG001|Overall Study|Physician Decision|1|||
16390277|NCT01016067|39911990|FG000|Overall Study|Withdrew due to Relocation|0|||
16390278|NCT01016067|39911991|FG001|Overall Study|Withdrew due to Relocation|1|||
16390279|NCT00892008|39911993|FG000|Overall Study|Death|5|||
16390280|NCT00892008|39911993|FG000|Overall Study|Lack of Efficacy|3|||
16390281|NCT00892008|39911993|FG000|Overall Study|Lost to Follow-up|142|||
16390282|NCT00892008|39911993|FG000|Overall Study|Other|378|||
16390283|NCT00892008|39911993|FG000|Overall Study|Adverse Event|37|||
16390284|NCT01042158|39911994|FG000|Overall Study|Physician Decision|1|||
16390285|NCT01770743|39911995|FG000|Overall Study|Adverse Event|1|||
16390286|NCT01770743|39911996|FG001|Overall Study|Adverse Event|0|||
16390287|NCT01770743|39911997|FG002|Overall Study|Adverse Event|0|||
16390288|NCT01770743|39911998|FG003|Overall Study|Adverse Event|0|||
16503088|NCT00744627|40314082|FG001|Overall Study|Noncompliance|1|||
16503089|NCT00744627|40314081|FG000|Overall Study|Protocol Deviations|0|||
16503090|NCT00744627|40314082|FG001|Overall Study|Protocol Deviations|2|||
16503091|NCT00744627|40314081|FG000|Overall Study|Voluntary Withdrawal|9|||
16503092|NCT00744627|40314082|FG001|Overall Study|Voluntary Withdrawal|6|||
16503093|NCT00744627|40314081|FG000|Overall Study|Lost to Follow-up|2|||
16503094|NCT00744627|40314082|FG001|Overall Study|Lost to Follow-up|1|||
16503095|NCT00744627|40314081|FG000|Overall Study|Other|1|||
16503096|NCT00744627|40314082|FG001|Overall Study|Other|0|||
16503097|NCT00276159|40314083|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
16503098|NCT01454570|40314084|FG000|Overall Study|Withdrawal by Subject|2|||
16503099|NCT01454570|40314084|FG000|Overall Study|Screen Failure|7|||
16503100|NCT00075582|40314090|FG000|Overall Study|Adverse Event|3|||
16503101|NCT00075582|40314091|FG001|Overall Study|Adverse Event|1|||
16503102|NCT00075582|40314090|FG000|Overall Study|Lack of Efficacy|4|||
16503103|NCT00075582|40314091|FG001|Overall Study|Lack of Efficacy|8|||
16503104|NCT00075582|40314090|FG000|Overall Study|Physician Decision|5|||
16503105|NCT00075582|40314091|FG001|Overall Study|Physician Decision|8|||
16503106|NCT00075582|40314090|FG000|Overall Study|Withdrawal by Subject|2|||
16503107|NCT00075582|40314091|FG001|Overall Study|Withdrawal by Subject|2|||
16503108|NCT00075582|40314090|FG000|Overall Study|Ineligible for study|36|||
16390289|NCT01770743|39911999|FG004|Overall Study|Adverse Event|0|||
16390290|NCT01770743|39911995|FG000|Overall Study|Withdrawal by Subject|0|||
16390291|NCT01770743|39911996|FG001|Overall Study|Withdrawal by Subject|0|||
16503109|NCT00075582|40314091|FG001|Overall Study|Ineligible for study|16|||
16503110|NCT00536107|40314092|FG000|Overall Study|Death|5|||
16503111|NCT00536107|40314093|FG001|Overall Study|Death|1|||
16503112|NCT00536107|40314092|FG000|Overall Study|Incorrect enrolment|1|||
16503113|NCT00536107|40314093|FG001|Overall Study|Incorrect enrolment|0|||
16390292|NCT01770743|39911997|FG002|Overall Study|Withdrawal by Subject|1|||
16503114|NCT00536107|40314092|FG000|Overall Study|Withdrawal by Subject|0|||
16546326|NCT02237508|40464780|FG007|Overall Study|Protocol Violation|0|||
16503115|NCT00536107|40314093|FG001|Overall Study|Withdrawal by Subject|1|||
16503116|NCT00536107|40314092|FG000|Overall Study|Study Termination|2|||
16503117|NCT00536107|40314093|FG001|Overall Study|Study Termination|4|||
16503118|NCT01641692|40314094|FG000|Treatment Period 1|Adverse Event|1|||
16503119|NCT01641692|40314095|FG001|Treatment Period 1|Adverse Event|0|||
16503120|NCT01641692|40314096|FG002|Treatment Period 1|Adverse Event|0|||
16503121|NCT01641692|40314097|FG003|Treatment Period 1|Adverse Event|0|||
16503122|NCT01641692|40314098|FG004|Treatment Period 1|Adverse Event|0|||
16503123|NCT01641692|40314099|FG005|Treatment Period 1|Adverse Event|0|||
16503124|NCT01641692|40314100|FG006|Treatment Period 1|Adverse Event|0|||
16503125|NCT01641692|40314101|FG007|Treatment Period 1|Adverse Event|0|||
16503126|NCT01641692|40314094|FG000|Treatment Period 1|Lack of Efficacy|0|||
16503127|NCT01641692|40314095|FG001|Treatment Period 1|Lack of Efficacy|0|||
16503128|NCT01641692|40314096|FG002|Treatment Period 1|Lack of Efficacy|0|||
16503129|NCT01641692|40314097|FG003|Treatment Period 1|Lack of Efficacy|0|||
16503130|NCT01641692|40314098|FG004|Treatment Period 1|Lack of Efficacy|0|||
16503131|NCT01641692|40314099|FG005|Treatment Period 1|Lack of Efficacy|0|||
16503132|NCT01641692|40314100|FG006|Treatment Period 1|Lack of Efficacy|0|||
16503133|NCT01641692|40314101|FG007|Treatment Period 1|Lack of Efficacy|1|||
16503134|NCT01641692|40314094|FG000|Treatment Period 1|Protocol Violation|1|||
16503135|NCT01641692|40314095|FG001|Treatment Period 1|Protocol Violation|0|||
16503136|NCT01641692|40314096|FG002|Treatment Period 1|Protocol Violation|0|||
16503137|NCT01641692|40314097|FG003|Treatment Period 1|Protocol Violation|0|||
16503138|NCT01641692|40314098|FG004|Treatment Period 1|Protocol Violation|2|||
16503139|NCT01641692|40314099|FG005|Treatment Period 1|Protocol Violation|0|||
16503140|NCT01641692|40314100|FG006|Treatment Period 1|Protocol Violation|0|||
16503141|NCT01641692|40314101|FG007|Treatment Period 1|Protocol Violation|0|||
16503142|NCT01641692|40314094|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16503143|NCT01641692|40314095|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16503144|NCT01641692|40314096|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16503145|NCT01641692|40314097|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16503146|NCT01641692|40314098|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
16503147|NCT01641692|40314099|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16503148|NCT01641692|40314100|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
16503149|NCT01641692|40314101|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
16503150|NCT01641692|40314094|FG000|Treatment Period 1|Lost to Follow-up|0|||
16503151|NCT01641692|40314095|FG001|Treatment Period 1|Lost to Follow-up|0|||
16503152|NCT01641692|40314096|FG002|Treatment Period 1|Lost to Follow-up|1|||
16503153|NCT01641692|40314097|FG003|Treatment Period 1|Lost to Follow-up|0|||
16503154|NCT01641692|40314098|FG004|Treatment Period 1|Lost to Follow-up|0|||
16503155|NCT01641692|40314099|FG005|Treatment Period 1|Lost to Follow-up|0|||
16503156|NCT01641692|40314100|FG006|Treatment Period 1|Lost to Follow-up|0|||
16503157|NCT01641692|40314101|FG007|Treatment Period 1|Lost to Follow-up|0|||
16503158|NCT01641692|40314094|FG000|Treatment Period 1|Physician Decision|0|||
16503159|NCT01641692|40314095|FG001|Treatment Period 1|Physician Decision|0|||
16503160|NCT01641692|40314096|FG002|Treatment Period 1|Physician Decision|0|||
16503161|NCT01641692|40314097|FG003|Treatment Period 1|Physician Decision|0|||
16503162|NCT01641692|40314098|FG004|Treatment Period 1|Physician Decision|1|||
16503163|NCT01641692|40314099|FG005|Treatment Period 1|Physician Decision|0|||
16503164|NCT01641692|40314100|FG006|Treatment Period 1|Physician Decision|0|||
16503165|NCT01641692|40314101|FG007|Treatment Period 1|Physician Decision|0|||
16503166|NCT01641692|40314094|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16503167|NCT01641692|40314095|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16503168|NCT01641692|40314096|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16503169|NCT01641692|40314097|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16503170|NCT01641692|40314098|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16503171|NCT01641692|40314099|FG005|Treatment Period 1|Withdrawal by Subject|2|||
16503172|NCT01641692|40314100|FG006|Treatment Period 1|Withdrawal by Subject|0|||
16503173|NCT01641692|40314101|FG007|Treatment Period 1|Withdrawal by Subject|1|||
16503174|NCT01641692|40314094|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
16503175|NCT01641692|40314095|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16503176|NCT01641692|40314096|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16503177|NCT01641692|40314097|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16503178|NCT01641692|40314098|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16503179|NCT01641692|40314099|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16503180|NCT01641692|40314100|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16503181|NCT01641692|40314101|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
16503182|NCT01641692|40314094|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16503183|NCT01641692|40314095|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16503184|NCT01641692|40314096|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16503185|NCT01641692|40314097|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16503186|NCT01641692|40314098|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16503187|NCT01641692|40314099|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16503188|NCT01641692|40314100|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
16503189|NCT01641692|40314101|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16503190|NCT01641692|40314094|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
16503191|NCT01641692|40314095|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16503192|NCT01641692|40314096|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
16503193|NCT01641692|40314097|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
16503194|NCT01641692|40314098|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
16503195|NCT01641692|40314099|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16503196|NCT01641692|40314100|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16503197|NCT01641692|40314101|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
16503198|NCT01641692|40314094|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16503199|NCT01641692|40314095|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16503200|NCT01641692|40314096|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16503201|NCT01641692|40314097|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16503202|NCT01641692|40314098|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16503203|NCT01641692|40314099|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16503204|NCT01641692|40314100|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16503205|NCT01641692|40314101|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16503206|NCT01641692|40314094|FG000|Treatment Period 2|Lack of Efficacy|1|||
16503207|NCT01641692|40314095|FG001|Treatment Period 2|Lack of Efficacy|0|||
16503208|NCT01641692|40314096|FG002|Treatment Period 2|Lack of Efficacy|0|||
16503209|NCT01641692|40314097|FG003|Treatment Period 2|Lack of Efficacy|0|||
16503210|NCT01641692|40314098|FG004|Treatment Period 2|Lack of Efficacy|0|||
16503211|NCT01641692|40314099|FG005|Treatment Period 2|Lack of Efficacy|0|||
16503212|NCT01641692|40314100|FG006|Treatment Period 2|Lack of Efficacy|0|||
16503213|NCT01641692|40314101|FG007|Treatment Period 2|Lack of Efficacy|0|||
16503214|NCT01641692|40314094|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
16503215|NCT01641692|40314095|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16503216|NCT01641692|40314096|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16503217|NCT01641692|40314097|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16503218|NCT01641692|40314098|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16503219|NCT01641692|40314099|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16503220|NCT01641692|40314100|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16089345|NCT02502526|38816901|FG002|Overall Study|Disqualified due to cataract grading|1|||
16089346|NCT02502526|38816899|FG000|Overall Study|Enrollment suspension|4|||
16089347|NCT02502526|38816900|FG001|Overall Study|Enrollment suspension|1|||
16089348|NCT02502526|38816901|FG002|Overall Study|Enrollment suspension|1|||
16089349|NCT04108858|38816902|FG000|Overall Study|Adverse Event|1|||
16089350|NCT01779700|38816903|FG000|Overall Study|Adverse Event|4|||
16089351|NCT01779700|38816904|FG001|Overall Study|Adverse Event|3|||
16089352|NCT01779700|38816903|FG000|Overall Study|Withdrawal by Subject|0|||
16089353|NCT01779700|38816904|FG001|Overall Study|Withdrawal by Subject|2|||
16089354|NCT03418922|38816905|FG000|Overall Study|Withdrawal by Subject|0|||
16390293|NCT01770743|39911998|FG003|Overall Study|Withdrawal by Subject|1|||
16390294|NCT01770743|39911999|FG004|Overall Study|Withdrawal by Subject|1|||
16390295|NCT01770743|39911995|FG000|Overall Study|Lost to Follow-up|0|||
16390296|NCT01770743|39911996|FG001|Overall Study|Lost to Follow-up|2|||
16390297|NCT01770743|39911997|FG002|Overall Study|Lost to Follow-up|0|||
16390298|NCT01770743|39911998|FG003|Overall Study|Lost to Follow-up|0|||
16390299|NCT01770743|39911999|FG004|Overall Study|Lost to Follow-up|1|||
16390300|NCT01770743|39911995|FG000|Overall Study|Sponsor Terminated Subject|1|||
16390301|NCT01770743|39911996|FG001|Overall Study|Sponsor Terminated Subject|0|||
16390302|NCT01770743|39911997|FG002|Overall Study|Sponsor Terminated Subject|0|||
16390303|NCT01770743|39911998|FG003|Overall Study|Sponsor Terminated Subject|1|||
16503221|NCT01641692|40314101|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16503222|NCT01641692|40314094|FG000|Treatment Period 2|Lost to Follow-up|0|||
16503223|NCT01641692|40314095|FG001|Treatment Period 2|Lost to Follow-up|0|||
16503224|NCT01641692|40314096|FG002|Treatment Period 2|Lost to Follow-up|0|||
16503225|NCT01641692|40314097|FG003|Treatment Period 2|Lost to Follow-up|0|||
16503226|NCT01641692|40314098|FG004|Treatment Period 2|Lost to Follow-up|0|||
16503227|NCT01641692|40314099|FG005|Treatment Period 2|Lost to Follow-up|1|||
16503228|NCT01641692|40314100|FG006|Treatment Period 2|Lost to Follow-up|0|||
16503229|NCT01641692|40314101|FG007|Treatment Period 2|Lost to Follow-up|0|||
16503230|NCT01641692|40314094|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16503231|NCT01641692|40314095|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16503232|NCT01641692|40314096|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16503233|NCT01641692|40314097|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16503234|NCT01641692|40314098|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16503235|NCT01641692|40314099|FG005|Treatment Period 2|Withdrawal by Subject|1|||
16503236|NCT01641692|40314100|FG006|Treatment Period 2|Withdrawal by Subject|0|||
16089355|NCT03418922|38816906|FG001|Overall Study|Withdrawal by Subject|2|||
16390304|NCT01770743|39911999|FG004|Overall Study|Sponsor Terminated Subject|0|||
16089356|NCT03418922|38816905|FG000|Overall Study|Adverse Event|2|||
16089357|NCT03418922|38816906|FG001|Overall Study|Adverse Event|2|||
16089358|NCT03418922|38816905|FG000|Overall Study|Death|0|||
16089359|NCT03418922|38816906|FG001|Overall Study|Death|1|||
16089360|NCT03418922|38816905|FG000|Overall Study|Physician Decision|0|||
16089361|NCT03418922|38816906|FG001|Overall Study|Physician Decision|1|||
16089362|NCT02454959|38816908|FG000|Overall Study|Protocol-Specified Criteria|3|||
16089363|NCT02454959|38816908|FG000|Overall Study|Physician Decision|1|||
16089364|NCT02454959|38816908|FG000|Overall Study|Withdrawal by Subject|3|||
16089365|NCT02454959|38816908|FG000|Overall Study|Adverse Event|2|||
16089366|NCT00518206|38816911|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
16089367|NCT00518206|38816912|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
16089368|NCT00518206|38816911|FG000|Overall Study|Withdrawal by Subject|2|||
16089369|NCT00518206|38816912|FG001|Overall Study|Withdrawal by Subject|0|||
16089370|NCT00518206|38816911|FG000|Overall Study|Drug Supply Issue|1|||
16089371|NCT00518206|38816912|FG001|Overall Study|Drug Supply Issue|0|||
16089372|NCT00518206|38816911|FG000|Overall Study|Reason Unknown|1|||
16089373|NCT00518206|38816912|FG001|Overall Study|Reason Unknown|0|||
16089374|NCT00518206|38816911|FG000|Overall Study|Completion Status Unknown|1|||
16089375|NCT00518206|38816912|FG001|Overall Study|Completion Status Unknown|0|||
16089376|NCT04009291|38816913|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
16089377|NCT04009291|38816914|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
16089378|NCT04009291|38816915|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
16089379|NCT04009291|38816916|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
16089380|NCT04009291|38816917|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
16089381|NCT04009291|38816913|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
16089382|NCT04009291|38816914|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
16089383|NCT04009291|38816915|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
16089384|NCT04009291|38816916|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
16089385|NCT04009291|38816917|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
16089386|NCT01686152|38816918|FG000|Overall Study|Withdrawal by Subject|11|||
16089387|NCT01686152|38816919|FG001|Overall Study|Withdrawal by Subject|11|||
16089388|NCT01686152|38816920|FG002|Overall Study|Withdrawal by Subject|3|||
16089389|NCT01686152|38816918|FG000|Overall Study|Drug Code Unblinded|0|||
16089390|NCT01686152|38816919|FG001|Overall Study|Drug Code Unblinded|1|||
16089391|NCT01686152|38816920|FG002|Overall Study|Drug Code Unblinded|0|||
16089392|NCT01686152|38816918|FG000|Overall Study|Protocol Violation|6|||
16089393|NCT01686152|38816919|FG001|Overall Study|Protocol Violation|1|||
16089394|NCT01686152|38816920|FG002|Overall Study|Protocol Violation|0|||
16089395|NCT01686152|38816918|FG000|Overall Study|Adverse Event|12|||
16089396|NCT01686152|38816919|FG001|Overall Study|Adverse Event|11|||
16089397|NCT01686152|38816920|FG002|Overall Study|Adverse Event|0|||
16089398|NCT01686152|38816918|FG000|Overall Study|Lack of Efficacy|0|||
16089399|NCT01686152|38816919|FG001|Overall Study|Lack of Efficacy|0|||
16089400|NCT01686152|38816920|FG002|Overall Study|Lack of Efficacy|1|||
16089401|NCT01686152|38816918|FG000|Overall Study|IP Non-compliance|5|||
16089402|NCT01686152|38816919|FG001|Overall Study|IP Non-compliance|5|||
16089403|NCT01686152|38816920|FG002|Overall Study|IP Non-compliance|0|||
16089404|NCT01686152|38816918|FG000|Overall Study|Lost to Follow-up|7|||
16089405|NCT01686152|38816919|FG001|Overall Study|Lost to Follow-up|6|||
16089406|NCT01686152|38816920|FG002|Overall Study|Lost to Follow-up|5|||
16089407|NCT01566890|38816921|FG000|Overall Study|Adverse Event|1|||
16089408|NCT01566890|38816922|FG001|Overall Study|Adverse Event|0|||
16089409|NCT01566890|38816923|FG002|Overall Study|Adverse Event|0|||
16089410|NCT01566890|38816924|FG003|Overall Study|Adverse Event|0|||
16089411|NCT01566890|38816925|FG004|Overall Study|Adverse Event|0|||
16089412|NCT01566890|38816921|FG000|Overall Study|Withdrawal by Subject|3|||
16089413|NCT01566890|38816922|FG001|Overall Study|Withdrawal by Subject|1|||
16503237|NCT01641692|40314101|FG007|Treatment Period 2|Withdrawal by Subject|1|||
16503238|NCT01641692|40314094|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16089414|NCT01566890|38816923|FG002|Overall Study|Withdrawal by Subject|1|||
16089415|NCT01566890|38816924|FG003|Overall Study|Withdrawal by Subject|1|||
16089416|NCT01566890|38816925|FG004|Overall Study|Withdrawal by Subject|0|||
16089417|NCT01566890|38816921|FG000|Overall Study|Screen failure|6|||
16089418|NCT01566890|38816922|FG001|Overall Study|Screen failure|0|||
16089419|NCT01566890|38816923|FG002|Overall Study|Screen failure|1|||
16503239|NCT01641692|40314095|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16503240|NCT01641692|40314096|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16089420|NCT01566890|38816924|FG003|Overall Study|Screen failure|1|||
16089421|NCT01566890|38816925|FG004|Overall Study|Screen failure|0|||
16089422|NCT01566890|38816921|FG000|Overall Study|Incomplete CEU data|1|||
16089423|NCT01566890|38816922|FG001|Overall Study|Incomplete CEU data|3|||
16089424|NCT01566890|38816923|FG002|Overall Study|Incomplete CEU data|5|||
16089425|NCT01566890|38816924|FG003|Overall Study|Incomplete CEU data|8|||
16089426|NCT01566890|38816925|FG004|Overall Study|Incomplete CEU data|0|||
16089427|NCT01566890|38816921|FG000|Overall Study|Lost to Follow-up|0|||
16089428|NCT01566890|38816922|FG001|Overall Study|Lost to Follow-up|0|||
16089429|NCT01566890|38816923|FG002|Overall Study|Lost to Follow-up|4|||
16089430|NCT01566890|38816924|FG003|Overall Study|Lost to Follow-up|4|||
16089431|NCT01566890|38816925|FG004|Overall Study|Lost to Follow-up|0|||
16089432|NCT01566890|38816921|FG000|Overall Study|Other|0|||
16089433|NCT01566890|38816922|FG001|Overall Study|Other|0|||
16089434|NCT01566890|38816923|FG002|Overall Study|Other|0|||
16089435|NCT01566890|38816924|FG003|Overall Study|Other|0|||
16089436|NCT01566890|38816925|FG004|Overall Study|Other|7|||
16089437|NCT03128099|38816926|FG000|Overall Study|High dose task was too long|0|||
16089438|NCT03128099|38816927|FG001|Overall Study|High dose task was too long|4|||
16089439|NCT03128099|38816928|FG002|Overall Study|High dose task was too long|0|||
16089440|NCT03128099|38816926|FG000|Overall Study|Participant got a full time job.|1|||
16089441|NCT03128099|38816927|FG001|Overall Study|Participant got a full time job.|0|||
16089442|NCT03128099|38816928|FG002|Overall Study|Participant got a full time job.|0|||
16089443|NCT03128099|38816926|FG000|Overall Study|Became homeless and lost contact|1|||
16089444|NCT03128099|38816927|FG001|Overall Study|Became homeless and lost contact|0|||
16089445|NCT03128099|38816928|FG002|Overall Study|Became homeless and lost contact|0|||
16089446|NCT03128099|38816926|FG000|Overall Study|Did not complete all the assessments|0|||
16089447|NCT03128099|38816927|FG001|Overall Study|Did not complete all the assessments|0|||
16089448|NCT03128099|38816928|FG002|Overall Study|Did not complete all the assessments|1|||
16089449|NCT00068107|38816929|FG000|Overall Study|end-stage renal disease|6|||
16089450|NCT00068107|38816929|FG000|Overall Study|Death|2|||
16089451|NCT00068107|38816929|FG000|Overall Study|Withdrawal by Subject|1|||
16089452|NCT02707952|38816930|FG000|Overall Study|Adverse Event|1|||
16089453|NCT02707952|38816931|FG001|Overall Study|Adverse Event|0|||
16089454|NCT02707952|38816932|FG002|Overall Study|Adverse Event|0|||
16089455|NCT02707952|38816933|FG003|Overall Study|Adverse Event|0|||
16089456|NCT02707952|38816930|FG000|Overall Study|Lost to Follow-up|1|||
16089457|NCT02707952|38816931|FG001|Overall Study|Lost to Follow-up|0|||
16089458|NCT02707952|38816932|FG002|Overall Study|Lost to Follow-up|0|||
16089459|NCT02707952|38816933|FG003|Overall Study|Lost to Follow-up|0|||
16089460|NCT02707952|38816930|FG000|Overall Study|Withdrawal by Subject|0|||
16089461|NCT02707952|38816931|FG001|Overall Study|Withdrawal by Subject|1|||
16089462|NCT02707952|38816932|FG002|Overall Study|Withdrawal by Subject|2|||
16089463|NCT02707952|38816933|FG003|Overall Study|Withdrawal by Subject|0|||
16089464|NCT02224755|38816934|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
16089465|NCT02224755|38816935|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
16089466|NCT02224755|38816934|FG000|Two Year Follow up Post-implant|Death|103|||
16089467|NCT02224755|38816935|FG001|Two Year Follow up Post-implant|Death|98|||
16089468|NCT02224755|38816934|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
16089469|NCT02224755|38816935|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
16089470|NCT02224755|38816934|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
16089471|NCT02224755|38816935|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
16089472|NCT02224755|38816934|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
16089473|NCT02224755|38816935|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
16089474|NCT00756574|38816936|FG000|Overall Study|Withdrawal by Subject|9|||
16089475|NCT00756574|38816937|FG001|Overall Study|Withdrawal by Subject|7|||
16089476|NCT00756574|38816936|FG000|Overall Study|Lost to Follow-up|4|||
16089477|NCT00756574|38816937|FG001|Overall Study|Lost to Follow-up|4|||
16089478|NCT03345979|38816938|FG000|Overall Study|Withdrawal by Subject|20|||
16089479|NCT03345979|38816939|FG001|Overall Study|Withdrawal by Subject|31|||
16089480|NCT03345979|38816938|FG000|Overall Study|Adverse Event|10|||
16089481|NCT03345979|38816939|FG001|Overall Study|Adverse Event|11|||
16089482|NCT03345979|38816938|FG000|Overall Study|Lost to Follow-up|8|||
16089483|NCT03345979|38816939|FG001|Overall Study|Lost to Follow-up|9|||
16089484|NCT03345979|38816938|FG000|Overall Study|Lack of Efficacy|4|||
16089485|NCT03345979|38816939|FG001|Overall Study|Lack of Efficacy|2|||
16089486|NCT03345979|38816938|FG000|Overall Study|Protocol Violation|1|||
16089487|NCT03345979|38816939|FG001|Overall Study|Protocol Violation|3|||
16310639|NCT02906670|39623474|FG000|Cohort 3, QW|Radiological Progression|0|||
16089488|NCT03345979|38816938|FG000|Overall Study|Physician Decision|0|||
16089489|NCT03345979|38816939|FG001|Overall Study|Physician Decision|2|||
16089490|NCT03032198|38816946|FG000|Overall Study|Screen Fail|1|||
16089491|NCT03737110|38816950|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
16089492|NCT03737110|38816951|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
16089493|NCT03737110|38816952|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
16089494|NCT03737110|38816953|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
16089495|NCT03737110|38816954|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
16089496|NCT03737110|38816955|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
16089497|NCT03737110|38816950|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
16089498|NCT03737110|38816951|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
16089499|NCT03737110|38816952|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
16310640|NCT02906670|39623475|FG001|Cohort 3, QW|Radiological Progression|0|||
16089500|NCT03737110|38816953|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
16089501|NCT03737110|38816954|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
16089502|NCT03737110|38816955|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
16089503|NCT03737110|38816950|FG000|Run-in (RI) Period|Adverse Event|4|||
16089504|NCT03737110|38816951|FG001|Run-in (RI) Period|Adverse Event|0|||
16089505|NCT03737110|38816952|FG002|Run-in (RI) Period|Adverse Event|0|||
16089506|NCT03737110|38816953|FG003|Run-in (RI) Period|Adverse Event|0|||
16089507|NCT03737110|38816954|FG004|Run-in (RI) Period|Adverse Event|0|||
16089508|NCT03737110|38816955|FG005|Run-in (RI) Period|Adverse Event|0|||
16089509|NCT03737110|38816950|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
16089510|NCT03737110|38816951|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
16089511|NCT03737110|38816952|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
16089512|NCT03737110|38816953|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
16089513|NCT03737110|38816954|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
16089514|NCT03737110|38816955|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
16089515|NCT03737110|38816950|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
16089516|NCT03737110|38816951|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
16089517|NCT03737110|38816952|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
16089518|NCT03737110|38816953|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
16089519|NCT03737110|38816954|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
16089520|NCT03737110|38816955|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
16089521|NCT03737110|38816950|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
16089522|NCT03737110|38816951|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
16503241|NCT01641692|40314097|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16503242|NCT01641692|40314098|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
16503243|NCT01641692|40314099|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16503244|NCT01641692|40314100|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
16503245|NCT01641692|40314101|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
16503246|NCT01641692|40314094|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16089523|NCT03737110|38816952|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
16089524|NCT03737110|38816953|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
16089525|NCT03737110|38816954|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
16089526|NCT03737110|38816955|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
16089527|NCT03737110|38816950|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
16089528|NCT03737110|38816951|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
16089529|NCT03737110|38816952|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
16089530|NCT03737110|38816953|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
16089531|NCT03737110|38816954|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
16089532|NCT03737110|38816955|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
16089533|NCT03737110|38816950|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
16089534|NCT03737110|38816951|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
16089535|NCT03737110|38816952|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
16089536|NCT03737110|38816953|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
16089537|NCT03737110|38816954|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
16089538|NCT03737110|38816955|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
16089539|NCT02915783|38816960|FG000|Overall Study|Death|21|||
16503247|NCT01641692|40314095|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16503248|NCT01641692|40314096|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
16195736|NCT00960934|39193400|FG001|Overall Study|Progressive Disease|1|||
16195737|NCT00960934|39193401|FG002|Overall Study|Progressive Disease|0|||
16503249|NCT01641692|40314097|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16503250|NCT01641692|40314098|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16503251|NCT01641692|40314099|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
16503252|NCT01641692|40314100|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16503253|NCT01641692|40314101|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
16503254|NCT01641692|40314094|FG000|Treatment Period 3|Adverse Event|0|||
16089540|NCT02915783|38816960|FG000|Overall Study|Lost to Follow-up|1|||
16089541|NCT02915783|38816960|FG000|Overall Study|Withdrawal by Subject|2|||
16089542|NCT00999596|38816961|FG000|Overall Study|Statistical population not required|101|||
16089543|NCT01159600|38816962|FG000|Overall Study|Not treated|0|||
16089544|NCT01159600|38816963|FG001|Overall Study|Not treated|0|||
16089545|NCT01159600|38816964|FG002|Overall Study|Not treated|1|||
16089546|NCT01159600|38816965|FG003|Overall Study|Not treated|0|||
16089547|NCT01159600|38816966|FG004|Overall Study|Not treated|0|||
16089548|NCT01159600|38816967|FG005|Overall Study|Not treated|1|||
16089549|NCT01159600|38816968|FG006|Overall Study|Not treated|2|||
16089550|NCT01159600|38816969|FG007|Overall Study|Not treated|2|||
16089551|NCT01159600|38816962|FG000|Overall Study|Adverse Event|7|||
16089552|NCT01159600|38816963|FG001|Overall Study|Adverse Event|2|||
16089553|NCT01159600|38816964|FG002|Overall Study|Adverse Event|5|||
16089554|NCT01159600|38816965|FG003|Overall Study|Adverse Event|1|||
16089555|NCT01159600|38816966|FG004|Overall Study|Adverse Event|8|||
16089556|NCT01159600|38816967|FG005|Overall Study|Adverse Event|6|||
16089557|NCT01159600|38816968|FG006|Overall Study|Adverse Event|7|||
16503255|NCT01641692|40314095|FG001|Treatment Period 3|Adverse Event|0|||
16503256|NCT01641692|40314096|FG002|Treatment Period 3|Adverse Event|0|||
16089558|NCT01159600|38816969|FG007|Overall Study|Adverse Event|5|||
16503257|NCT01641692|40314097|FG003|Treatment Period 3|Adverse Event|0|||
16503258|NCT01641692|40314098|FG004|Treatment Period 3|Adverse Event|0|||
16503259|NCT01641692|40314099|FG005|Treatment Period 3|Adverse Event|0|||
16503260|NCT01641692|40314100|FG006|Treatment Period 3|Adverse Event|1|||
16503261|NCT01641692|40314101|FG007|Treatment Period 3|Adverse Event|0|||
16503262|NCT01641692|40314094|FG000|Treatment Period 3|Protocol Violation|0|||
16503263|NCT01641692|40314095|FG001|Treatment Period 3|Protocol Violation|0|||
16503264|NCT01641692|40314096|FG002|Treatment Period 3|Protocol Violation|1|||
16503265|NCT01641692|40314097|FG003|Treatment Period 3|Protocol Violation|0|||
16503266|NCT01641692|40314098|FG004|Treatment Period 3|Protocol Violation|0|||
16503267|NCT01641692|40314099|FG005|Treatment Period 3|Protocol Violation|0|||
16503268|NCT01641692|40314100|FG006|Treatment Period 3|Protocol Violation|0|||
16195738|NCT00960934|39193402|FG003|Overall Study|Progressive Disease|0|||
16390305|NCT01770743|39911995|FG000|Overall Study|Moving Out of State|0|||
16390306|NCT01770743|39911996|FG001|Overall Study|Moving Out of State|1|||
16089559|NCT01159600|38816962|FG000|Overall Study|Lack of Efficacy|0|||
16089560|NCT01159600|38816963|FG001|Overall Study|Lack of Efficacy|0|||
16195739|NCT00960934|39193403|FG004|Overall Study|Progressive Disease|1|||
16195740|NCT00960934|39193404|FG005|Overall Study|Progressive Disease|1|||
16503269|NCT01641692|40314101|FG007|Treatment Period 3|Protocol Violation|0|||
16503270|NCT01641692|40314094|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16503271|NCT01641692|40314095|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16195741|NCT00960934|39193399|FG000|Overall Study|Protocol Violation|3|||
16390307|NCT01770743|39911997|FG002|Overall Study|Moving Out of State|0|||
16503272|NCT01641692|40314096|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16089561|NCT01159600|38816964|FG002|Overall Study|Lack of Efficacy|0|||
16089562|NCT01159600|38816965|FG003|Overall Study|Lack of Efficacy|0|||
16089563|NCT01159600|38816966|FG004|Overall Study|Lack of Efficacy|2|||
16089564|NCT01159600|38816967|FG005|Overall Study|Lack of Efficacy|0|||
16089565|NCT01159600|38816968|FG006|Overall Study|Lack of Efficacy|0|||
16089566|NCT01159600|38816969|FG007|Overall Study|Lack of Efficacy|1|||
16089567|NCT01159600|38816962|FG000|Overall Study|Non compliant with protocol|2|||
16089568|NCT01159600|38816963|FG001|Overall Study|Non compliant with protocol|1|||
16089569|NCT01159600|38816964|FG002|Overall Study|Non compliant with protocol|0|||
16089570|NCT01159600|38816965|FG003|Overall Study|Non compliant with protocol|0|||
16089571|NCT01159600|38816966|FG004|Overall Study|Non compliant with protocol|2|||
16089572|NCT01159600|38816967|FG005|Overall Study|Non compliant with protocol|0|||
16089573|NCT01159600|38816968|FG006|Overall Study|Non compliant with protocol|2|||
16089574|NCT01159600|38816969|FG007|Overall Study|Non compliant with protocol|0|||
16089575|NCT01159600|38816962|FG000|Overall Study|Lost to Follow-up|2|||
16089576|NCT01159600|38816963|FG001|Overall Study|Lost to Follow-up|3|||
16089577|NCT01159600|38816964|FG002|Overall Study|Lost to Follow-up|4|||
16089578|NCT01159600|38816965|FG003|Overall Study|Lost to Follow-up|3|||
16089579|NCT01159600|38816966|FG004|Overall Study|Lost to Follow-up|3|||
16089580|NCT01159600|38816967|FG005|Overall Study|Lost to Follow-up|0|||
16195742|NCT00960934|39193400|FG001|Overall Study|Protocol Violation|4|||
16195743|NCT00960934|39193401|FG002|Overall Study|Protocol Violation|0|||
16195744|NCT00960934|39193402|FG003|Overall Study|Protocol Violation|3|||
16503273|NCT01641692|40314097|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16503274|NCT01641692|40314098|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16503275|NCT01641692|40314099|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16503276|NCT01641692|40314100|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
16503277|NCT01641692|40314101|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16089581|NCT01159600|38816968|FG006|Overall Study|Lost to Follow-up|3|||
16503278|NCT01641692|40314094|FG000|Treatment Period 3|Lost to Follow-up|0|||
16503279|NCT01641692|40314095|FG001|Treatment Period 3|Lost to Follow-up|1|||
16503280|NCT01641692|40314096|FG002|Treatment Period 3|Lost to Follow-up|0|||
16503281|NCT01641692|40314097|FG003|Treatment Period 3|Lost to Follow-up|0|||
16503282|NCT01641692|40314098|FG004|Treatment Period 3|Lost to Follow-up|0|||
16503283|NCT01641692|40314099|FG005|Treatment Period 3|Lost to Follow-up|0|||
16503284|NCT01641692|40314100|FG006|Treatment Period 3|Lost to Follow-up|0|||
16503285|NCT01641692|40314101|FG007|Treatment Period 3|Lost to Follow-up|0|||
16503286|NCT01641692|40314094|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
16503287|NCT01641692|40314095|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
16195745|NCT00960934|39193403|FG004|Overall Study|Protocol Violation|3|||
16195746|NCT00960934|39193404|FG005|Overall Study|Protocol Violation|2|||
16195747|NCT00960934|39193399|FG000|Overall Study|Withdrawal by Subject|5|||
16195748|NCT00960934|39193400|FG001|Overall Study|Withdrawal by Subject|6|||
16195749|NCT00960934|39193401|FG002|Overall Study|Withdrawal by Subject|4|||
16310641|NCT02906670|39623476|FG002|Cohort 3, QW|Radiological Progression|2|||
16310642|NCT02906670|39623477|FG003|Cohort 3, QW|Radiological Progression|0|||
16503288|NCT01641692|40314096|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
16089582|NCT01159600|38816969|FG007|Overall Study|Lost to Follow-up|2|||
16089583|NCT01159600|38816962|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
16089584|NCT01159600|38816963|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
16195750|NCT00960934|39193402|FG003|Overall Study|Withdrawal by Subject|5|||
16195751|NCT00960934|39193403|FG004|Overall Study|Withdrawal by Subject|5|||
16195752|NCT00960934|39193404|FG005|Overall Study|Withdrawal by Subject|7|||
16195753|NCT00960934|39193399|FG000|Overall Study|Study Terminated by Sponsor|50|||
16503289|NCT01641692|40314097|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
16503290|NCT01641692|40314098|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
16503291|NCT01641692|40314099|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
16503292|NCT01641692|40314100|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
16503293|NCT01641692|40314101|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
16503294|NCT01641692|40314094|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
16503295|NCT01641692|40314095|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
16503296|NCT01641692|40314096|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
16546327|NCT02237508|40464781|FG008|Overall Study|Protocol Violation|0|||
16195754|NCT00960934|39193400|FG001|Overall Study|Study Terminated by Sponsor|46|||
16310643|NCT02906670|39623478|FG004|Cohort 3, QW|Radiological Progression|0|||
16310644|NCT02906670|39623479|FG005|Cohort 3, QW|Radiological Progression|0|||
16310645|NCT02906670|39623480|FG006|Cohort 3, QW|Radiological Progression|0|||
16310646|NCT02906670|39623481|FG007|Cohort 3, QW|Radiological Progression|0|||
16310647|NCT02906670|39623482|FG008|Cohort 3, QW|Radiological Progression|0|||
16310648|NCT02906670|39623483|FG009|Cohort 3, QW|Radiological Progression|0|||
16390308|NCT01770743|39911998|FG003|Overall Study|Moving Out of State|0|||
16390309|NCT01770743|39911999|FG004|Overall Study|Moving Out of State|0|||
16390310|NCT02967679|39912030|FG000|Overall Study|Adverse Event|1|||
16390311|NCT01277822|39912033|FG000|Overall Study|Adverse Event|2|||
16390312|NCT01277822|39912034|FG001|Overall Study|Adverse Event|1|||
16390313|NCT01277822|39912033|FG000|Overall Study|Withdrawal by Subject|6|||
16390314|NCT01277822|39912034|FG001|Overall Study|Withdrawal by Subject|7|||
16310649|NCT02906670|39623474|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
16310650|NCT02906670|39623475|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
16310651|NCT02906670|39623476|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
16310652|NCT02906670|39623477|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
16310653|NCT02906670|39623478|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
16310654|NCT02906670|39623479|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
16310655|NCT02906670|39623480|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
16310656|NCT02906670|39623481|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
16310657|NCT02906670|39623482|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
16310658|NCT02906670|39623483|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
16390315|NCT01277822|39912033|FG000|Overall Study|Physician Decision|1|||
16390316|NCT01277822|39912034|FG001|Overall Study|Physician Decision|1|||
16390317|NCT01277822|39912033|FG000|Overall Study|Protocol Violation|1|||
16390318|NCT01277822|39912034|FG001|Overall Study|Protocol Violation|0|||
16390319|NCT01277822|39912033|FG000|Overall Study|Lost to Follow-up|2|||
16390320|NCT01277822|39912034|FG001|Overall Study|Lost to Follow-up|1|||
16390321|NCT01277822|39912033|FG000|Overall Study|Contraindicated medication used|2|||
16390322|NCT01277822|39912034|FG001|Overall Study|Contraindicated medication used|1|||
16390323|NCT01277822|39912033|FG000|Overall Study|Participant moved|1|||
16390324|NCT01277822|39912034|FG001|Overall Study|Participant moved|0|||
16390325|NCT01055613|39912035|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
16310659|NCT02906670|39623474|FG000|Cohort 4, Q2W|Radiological Progression|0|||
16310660|NCT02906670|39623475|FG001|Cohort 4, Q2W|Radiological Progression|0|||
16310661|NCT02906670|39623476|FG002|Cohort 4, Q2W|Radiological Progression|0|||
16310662|NCT02906670|39623477|FG003|Cohort 4, Q2W|Radiological Progression|0|||
16310663|NCT02906670|39623478|FG004|Cohort 4, Q2W|Radiological Progression|0|||
16310664|NCT02906670|39623479|FG005|Cohort 4, Q2W|Radiological Progression|1|||
16310665|NCT02906670|39623480|FG006|Cohort 4, Q2W|Radiological Progression|0|||
16310666|NCT02906670|39623481|FG007|Cohort 4, Q2W|Radiological Progression|0|||
16310667|NCT02906670|39623482|FG008|Cohort 4, Q2W|Radiological Progression|0|||
16310668|NCT02906670|39623483|FG009|Cohort 4, Q2W|Radiological Progression|0|||
16310669|NCT02906670|39623474|FG000|Cohort 4, Q2W|Clinical Progression|0|||
16310670|NCT02906670|39623475|FG001|Cohort 4, Q2W|Clinical Progression|0|||
16310671|NCT02906670|39623476|FG002|Cohort 4, Q2W|Clinical Progression|0|||
16310672|NCT02906670|39623477|FG003|Cohort 4, Q2W|Clinical Progression|0|||
16310673|NCT02906670|39623478|FG004|Cohort 4, Q2W|Clinical Progression|0|||
16310674|NCT02906670|39623479|FG005|Cohort 4, Q2W|Clinical Progression|2|||
16310675|NCT02906670|39623480|FG006|Cohort 4, Q2W|Clinical Progression|0|||
16310676|NCT02906670|39623481|FG007|Cohort 4, Q2W|Clinical Progression|0|||
16310677|NCT02906670|39623482|FG008|Cohort 4, Q2W|Clinical Progression|0|||
16390326|NCT01055613|39912036|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16390327|NCT01055613|39912035|FG000|Overall Study|Unacceptable lens fit|1|||
16195755|NCT00960934|39193401|FG002|Overall Study|Study Terminated by Sponsor|52|||
16390328|NCT01055613|39912036|FG001|Overall Study|Unacceptable lens fit|0|||
16390329|NCT01055613|39912035|FG000|Overall Study|Discomfort|2|||
16390330|NCT01055613|39912036|FG001|Overall Study|Discomfort|1|||
16310678|NCT02906670|39623483|FG009|Cohort 4, Q2W|Clinical Progression|0|||
16310679|NCT02906670|39623474|FG000|Cohort 5, Q2W|Radiological Progression|0|||
16195756|NCT00960934|39193402|FG003|Overall Study|Study Terminated by Sponsor|50|||
16503297|NCT01641692|40314097|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
16503298|NCT01641692|40314098|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
16503299|NCT01641692|40314099|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
16503300|NCT01641692|40314100|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
16503301|NCT01641692|40314101|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
16503302|NCT00409617|40314102|FG000|Overall Study|Adverse Event|57|||
16503303|NCT00409617|40314102|FG000|Overall Study|Lack of Efficacy|54|||
16503304|NCT00409617|40314102|FG000|Overall Study|Lost to Follow-up|2|||
16503305|NCT00409617|40314102|FG000|Overall Study|Protocol Violation|24|||
16503306|NCT00409617|40314102|FG000|Overall Study|Withdrawal by Subject|8|||
16503307|NCT00409617|40314102|FG000|Overall Study|Administrative reasons|1|||
16503308|NCT00409617|40314102|FG000|Overall Study|Not described|14|||
16503309|NCT03082599|40314106|FG000|Overall Study|Lost to Follow-up|1|||
16503310|NCT03082599|40314107|FG001|Overall Study|Lost to Follow-up|0|||
16503311|NCT00323492|40314108|FG000|Study Phase 1|Adverse Event|2|||
16390331|NCT01055613|39912035|FG000|Overall Study|Lost to Follow-up|1|||
16390332|NCT01055613|39912036|FG001|Overall Study|Lost to Follow-up|1|||
16390333|NCT01055613|39912035|FG000|Overall Study|Protocol Violation|1|||
16390334|NCT01055613|39912036|FG001|Overall Study|Protocol Violation|1|||
16390335|NCT01055613|39912035|FG000|Overall Study|Subject Disinterest|1|||
16390336|NCT01055613|39912036|FG001|Overall Study|Subject Disinterest|1|||
16390337|NCT03089047|39912039|FG000|Overall Study|Lost to Follow-up|1|||
16503312|NCT00323492|40314109|FG001|Study Phase 1|Adverse Event|0|||
16503313|NCT00323492|40314110|FG002|Study Phase 1|Adverse Event|0|||
16503314|NCT00323492|40314108|FG000|Study Phase 2|Adverse Event|1|||
16503315|NCT00323492|40314109|FG001|Study Phase 2|Adverse Event|0|||
16503316|NCT00323492|40314110|FG002|Study Phase 2|Adverse Event|0|||
16503317|NCT00323492|40314108|FG000|Study Phase 2|Physician Decision|1|||
16503318|NCT00323492|40314109|FG001|Study Phase 2|Physician Decision|0|||
16503319|NCT00323492|40314110|FG002|Study Phase 2|Physician Decision|0|||
16503320|NCT00323492|40314108|FG000|Study Phase 2|Lost to Follow-up|1|||
16503321|NCT00323492|40314109|FG001|Study Phase 2|Lost to Follow-up|0|||
16503322|NCT00323492|40314110|FG002|Study Phase 2|Lost to Follow-up|0|||
16503323|NCT00323492|40314108|FG000|Study Phase 2|Withdrawal by Subject|0|||
16503324|NCT00323492|40314109|FG001|Study Phase 2|Withdrawal by Subject|1|||
16503325|NCT00323492|40314110|FG002|Study Phase 2|Withdrawal by Subject|0|||
16503326|NCT00323492|40314108|FG000|Study Phase 2|Noncompliance with study schedule|0|||
16503327|NCT00323492|40314109|FG001|Study Phase 2|Noncompliance with study schedule|0|||
16503328|NCT00323492|40314110|FG002|Study Phase 2|Noncompliance with study schedule|1|||
16503329|NCT00323492|40314108|FG000|Study Phase 2|Protocol Violation|1|||
16503330|NCT00323492|40314109|FG001|Study Phase 2|Protocol Violation|0|||
16503331|NCT00323492|40314110|FG002|Study Phase 2|Protocol Violation|0|||
16503332|NCT01852942|40314111|FG000|Overall Study|Physician Decision|1|||
16503333|NCT01852942|40314112|FG001|Overall Study|Physician Decision|0|||
16503334|NCT01852942|40314111|FG000|Overall Study|Death|1|||
16503335|NCT01852942|40314112|FG001|Overall Study|Death|1|||
16503336|NCT01852942|40314111|FG000|Overall Study|Withdrawal by Subject|2|||
16503337|NCT01852942|40314112|FG001|Overall Study|Withdrawal by Subject|3|||
16390338|NCT03089047|39912040|FG001|Overall Study|Lost to Follow-up|0|||
16503338|NCT01852942|40314111|FG000|Overall Study|Lost to Follow-up|1|||
16503339|NCT01852942|40314112|FG001|Overall Study|Lost to Follow-up|2|||
16503340|NCT00500292|40314113|FG000|Overall Study|Adverse Event|3|||
16503341|NCT00500292|40314114|FG001|Overall Study|Adverse Event|6|||
16503342|NCT00500292|40314115|FG002|Overall Study|Adverse Event|4|||
16503343|NCT00500292|40314113|FG000|Overall Study|Condition under investigation worsened|21|||
16503344|NCT00500292|40314114|FG001|Overall Study|Condition under investigation worsened|23|||
16503345|NCT00500292|40314115|FG002|Overall Study|Condition under investigation worsened|19|||
16310680|NCT02906670|39623475|FG001|Cohort 5, Q2W|Radiological Progression|0|||
16310681|NCT02906670|39623476|FG002|Cohort 5, Q2W|Radiological Progression|0|||
16310682|NCT02906670|39623477|FG003|Cohort 5, Q2W|Radiological Progression|0|||
16310683|NCT02906670|39623478|FG004|Cohort 5, Q2W|Radiological Progression|0|||
16310684|NCT02906670|39623479|FG005|Cohort 5, Q2W|Radiological Progression|0|||
16310685|NCT02906670|39623480|FG006|Cohort 5, Q2W|Radiological Progression|4|||
16310686|NCT02906670|39623481|FG007|Cohort 5, Q2W|Radiological Progression|0|||
16310687|NCT02906670|39623482|FG008|Cohort 5, Q2W|Radiological Progression|0|||
16310688|NCT02906670|39623483|FG009|Cohort 5, Q2W|Radiological Progression|0|||
16310689|NCT02906670|39623474|FG000|Cohort 5, Q2W|Clinical Progression|0|||
16310690|NCT02906670|39623475|FG001|Cohort 5, Q2W|Clinical Progression|0|||
16310691|NCT02906670|39623476|FG002|Cohort 5, Q2W|Clinical Progression|0|||
16310692|NCT02906670|39623477|FG003|Cohort 5, Q2W|Clinical Progression|0|||
16310693|NCT02906670|39623478|FG004|Cohort 5, Q2W|Clinical Progression|0|||
16310694|NCT02906670|39623479|FG005|Cohort 5, Q2W|Clinical Progression|0|||
16310695|NCT02906670|39623480|FG006|Cohort 5, Q2W|Clinical Progression|1|||
16310696|NCT02906670|39623481|FG007|Cohort 5, Q2W|Clinical Progression|0|||
16310697|NCT02906670|39623482|FG008|Cohort 5, Q2W|Clinical Progression|0|||
16310698|NCT02906670|39623483|FG009|Cohort 5, Q2W|Clinical Progression|0|||
16310699|NCT02906670|39623474|FG000|Cohort 5, Q2W|Adverse Event|0|||
16503346|NCT00500292|40314113|FG000|Overall Study|Withdrawal by Subject|0|||
16503347|NCT00500292|40314114|FG001|Overall Study|Withdrawal by Subject|1|||
16503348|NCT00500292|40314115|FG002|Overall Study|Withdrawal by Subject|0|||
16503349|NCT00500292|40314113|FG000|Overall Study|Other|1|||
16503350|NCT00500292|40314114|FG001|Overall Study|Other|1|||
16503351|NCT00500292|40314115|FG002|Overall Study|Other|4|||
16503352|NCT01277523|40314116|FG000|Overall Study|Adverse Event|1|||
16503353|NCT01277523|40314117|FG001|Overall Study|Adverse Event|0|||
16503354|NCT01277523|40314118|FG002|Overall Study|Adverse Event|0|||
16503355|NCT01277523|40314116|FG000|Overall Study|Protocol Violation|2|||
16503356|NCT01277523|40314117|FG001|Overall Study|Protocol Violation|0|||
16503357|NCT01277523|40314118|FG002|Overall Study|Protocol Violation|0|||
16503358|NCT01277523|40314116|FG000|Overall Study|Other Reason not Defined|0|||
16503359|NCT01277523|40314117|FG001|Overall Study|Other Reason not Defined|1|||
16503360|NCT01277523|40314118|FG002|Overall Study|Other Reason not Defined|0|||
16503361|NCT00560950|40314120|FG000|Overall Study|Lost to Follow-up|1|||
16503362|NCT00560950|40314121|FG001|Overall Study|Lost to Follow-up|0|||
16503363|NCT03103919|40314122|FG000|Overall Study|Adverse Event|2|||
16503364|NCT03103919|40314123|FG001|Overall Study|Adverse Event|2|||
16503365|NCT00487747|40314124|FG000|Overall Study|Adverse Event|1|||
16503366|NCT00487747|40314124|FG000|Overall Study|Lost to Follow-up|9|||
16503367|NCT00487747|40314124|FG000|Overall Study|Lack of Efficacy|1|||
16503368|NCT01382446|40314129|FG000|Overall Study|Withdrawal by Subject|0|||
16503369|NCT01382446|40314130|FG001|Overall Study|Withdrawal by Subject|1|||
16503370|NCT01382446|40314129|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
16503371|NCT01382446|40314130|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
16503372|NCT00605813|40314132|FG000|Overall Study|Protocol Violation|25|||
16503373|NCT00071760|40314134|FG000|Overall Study|Adverse Event|2|||
16503374|NCT00071760|40314135|FG001|Overall Study|Adverse Event|1|||
16503375|NCT00071760|40314134|FG000|Overall Study|Lost to Follow-up|0|||
16503376|NCT00071760|40314135|FG001|Overall Study|Lost to Follow-up|3|||
16503377|NCT00071760|40314134|FG000|Overall Study|Protocol Violation|1|||
16503378|NCT00071760|40314135|FG001|Overall Study|Protocol Violation|0|||
16503379|NCT00071760|40314134|FG000|Overall Study|Withdrawal by Subject|0|||
16310700|NCT02906670|39623475|FG001|Cohort 5, Q2W|Adverse Event|0|||
16310701|NCT02906670|39623476|FG002|Cohort 5, Q2W|Adverse Event|0|||
16310702|NCT02906670|39623477|FG003|Cohort 5, Q2W|Adverse Event|0|||
16310703|NCT02906670|39623478|FG004|Cohort 5, Q2W|Adverse Event|0|||
16310704|NCT02906670|39623479|FG005|Cohort 5, Q2W|Adverse Event|0|||
16310705|NCT02906670|39623480|FG006|Cohort 5, Q2W|Adverse Event|1|||
16310706|NCT02906670|39623481|FG007|Cohort 5, Q2W|Adverse Event|0|||
16310707|NCT02906670|39623482|FG008|Cohort 5, Q2W|Adverse Event|0|||
16310708|NCT02906670|39623483|FG009|Cohort 5, Q2W|Adverse Event|0|||
16310709|NCT02906670|39623474|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
16310710|NCT02906670|39623475|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
16390339|NCT01925768|39912045|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
16390340|NCT01925768|39912046|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16310711|NCT02906670|39623476|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
16503380|NCT00071760|40314135|FG001|Overall Study|Withdrawal by Subject|1|||
16503381|NCT00071760|40314134|FG000|Overall Study|Insufficient Viral Load Response|1|||
16503382|NCT00071760|40314135|FG001|Overall Study|Insufficient Viral Load Response|1|||
16503383|NCT00071760|40314134|FG000|Overall Study|Lack of availability of RTV|1|||
16503384|NCT00071760|40314135|FG001|Overall Study|Lack of availability of RTV|0|||
16503385|NCT00071760|40314134|FG000|Overall Study|Physician Decision|2|||
16310712|NCT02906670|39623477|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
16310713|NCT02906670|39623478|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
16310714|NCT02906670|39623479|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
16310715|NCT02906670|39623480|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
16310716|NCT02906670|39623481|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
16310717|NCT02906670|39623482|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
16310718|NCT02906670|39623483|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
16310719|NCT02906670|39623474|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
16503386|NCT00071760|40314135|FG001|Overall Study|Physician Decision|1|||
16503387|NCT00071760|40314134|FG000|Overall Study|Relocation|0|||
16503388|NCT00071760|40314135|FG001|Overall Study|Relocation|1|||
16503389|NCT00303498|40314138|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
16503390|NCT00303498|40314139|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
16503391|NCT00303498|40314138|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
16310720|NCT02906670|39623475|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
16310721|NCT02906670|39623476|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
16310722|NCT02906670|39623477|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
16310723|NCT02906670|39623478|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
16310724|NCT02906670|39623479|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
16310725|NCT02906670|39623480|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
16310726|NCT02906670|39623481|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
16310727|NCT02906670|39623482|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
16503392|NCT00303498|40314139|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
16503393|NCT00303498|40314138|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
16503394|NCT00303498|40314139|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
16503395|NCT00303498|40314138|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
16503396|NCT00303498|40314139|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
16503397|NCT00303498|40314138|FG000|Run-In-Phase (10 Weeks)|Other|4|||
16503398|NCT00303498|40314139|FG001|Run-In-Phase (10 Weeks)|Other|1|||
16503399|NCT00303498|40314138|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
16503400|NCT00303498|40314139|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
16503401|NCT00303498|40314138|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
16503402|NCT00303498|40314139|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
16503403|NCT00303498|40314138|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
16503404|NCT00303498|40314139|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
16503405|NCT00303498|40314138|FG000|Maintenance Phase (24 Weeks)|Death|1|||
16503406|NCT00303498|40314139|FG001|Maintenance Phase (24 Weeks)|Death|0|||
16503407|NCT00303498|40314138|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
16503408|NCT00303498|40314139|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
16503409|NCT00303498|40314138|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
16503410|NCT00303498|40314139|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
16503411|NCT00303498|40314138|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
16503412|NCT00303498|40314139|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
16503413|NCT00303498|40314138|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
16503414|NCT00303498|40314139|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
16310728|NCT02906670|39623483|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
16503415|NCT00303498|40314138|FG000|Maintenance Phase (24 Weeks)|Other|1|||
16503416|NCT00303498|40314139|FG001|Maintenance Phase (24 Weeks)|Other|0|||
16503417|NCT00303498|40314138|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
16503418|NCT00303498|40314139|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
16503419|NCT00303498|40314138|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
16503420|NCT00303498|40314139|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
16503421|NCT03897179|40314145|FG000|Overall Study|Withdrawal by Subject|1|||
16503422|NCT01881230|40314146|FG000|Overall Study|Death|2|||
16503423|NCT01881230|40314147|FG001|Overall Study|Death|0|||
16503424|NCT01881230|40314148|FG002|Overall Study|Death|1|||
16503425|NCT01881230|40314146|FG000|Overall Study|Adverse Event|9|||
16503426|NCT01881230|40314147|FG001|Overall Study|Adverse Event|13|||
16503427|NCT01881230|40314148|FG002|Overall Study|Adverse Event|12|||
16503428|NCT01881230|40314146|FG000|Overall Study|Progressive Disease|31|||
16503429|NCT01881230|40314147|FG001|Overall Study|Progressive Disease|35|||
16503430|NCT01881230|40314148|FG002|Overall Study|Progressive Disease|36|||
16310729|NCT02906670|39623474|FG000|Cohort 5P, Q2W|Adverse Event|0|||
16503431|NCT01881230|40314146|FG000|Overall Study|Symptomatic Deterioration|3|||
16503432|NCT01881230|40314147|FG001|Overall Study|Symptomatic Deterioration|3|||
16503433|NCT01881230|40314148|FG002|Overall Study|Symptomatic Deterioration|1|||
16503434|NCT01881230|40314146|FG000|Overall Study|Withdrawal by Subject|6|||
16503435|NCT01881230|40314147|FG001|Overall Study|Withdrawal by Subject|4|||
16503436|NCT01881230|40314148|FG002|Overall Study|Withdrawal by Subject|6|||
16503437|NCT01881230|40314146|FG000|Overall Study|Physician Decision|4|||
16503438|NCT01881230|40314147|FG001|Overall Study|Physician Decision|3|||
16503439|NCT01881230|40314148|FG002|Overall Study|Physician Decision|6|||
16503440|NCT01881230|40314146|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16503441|NCT01881230|40314147|FG001|Overall Study|Non-Compliance with Study Drug|2|||
16503442|NCT01881230|40314148|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16503443|NCT01881230|40314146|FG000|Overall Study|Given Commercially Available Drug|0|||
16503444|NCT01881230|40314147|FG001|Overall Study|Given Commercially Available Drug|0|||
16503445|NCT01881230|40314148|FG002|Overall Study|Given Commercially Available Drug|2|||
16503446|NCT01881230|40314146|FG000|Overall Study|Protocol Violation|1|||
16503447|NCT01881230|40314147|FG001|Overall Study|Protocol Violation|1|||
16503448|NCT01881230|40314148|FG002|Overall Study|Protocol Violation|0|||
16503449|NCT01881230|40314146|FG000|Overall Study|Miscellaneous|3|||
16503450|NCT01881230|40314147|FG001|Overall Study|Miscellaneous|3|||
16503451|NCT01881230|40314148|FG002|Overall Study|Miscellaneous|0|||
16503452|NCT01881230|40314146|FG000|Overall Study|Untreated: Other|0|||
16503453|NCT01881230|40314147|FG001|Overall Study|Untreated: Other|0|||
16503454|NCT01881230|40314148|FG002|Overall Study|Untreated: Other|1|||
16503455|NCT01881230|40314146|FG000|Overall Study|Untreated: Death|0|||
16503456|NCT01881230|40314147|FG001|Overall Study|Untreated: Death|0|||
16503457|NCT01881230|40314148|FG002|Overall Study|Untreated: Death|1|||
16503458|NCT01881230|40314146|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
16503459|NCT01881230|40314147|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
16503460|NCT01881230|40314148|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
16503461|NCT00003901|40314157|FG000|Overall Study|Adverse Event|1|||
16503462|NCT00003901|40314157|FG000|Overall Study|Withdrawal by Subject|1|||
16503463|NCT00003901|40314157|FG000|Overall Study|Ineligible|6|||
16503464|NCT00003901|40314157|FG000|Overall Study|CT Scan not within protocol requirement|2|||
16503465|NCT00003901|40314157|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
16503466|NCT00003901|40314157|FG000|Overall Study|Medical problems|6|||
16503467|NCT01154218|40314163|FG000|Third Intervention Period|Adverse Event|0|||
16503468|NCT01154218|40314164|FG001|Third Intervention Period|Adverse Event|1|||
16503469|NCT01154218|40314165|FG002|Third Intervention Period|Adverse Event|0|||
16503470|NCT01154218|40314166|FG003|Third Intervention Period|Adverse Event|0|||
16503471|NCT01154218|40314163|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
16503472|NCT01154218|40314164|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
16503473|NCT01154218|40314165|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
16503474|NCT01154218|40314166|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
16503475|NCT01154218|40314163|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
16503476|NCT01154218|40314164|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
16503477|NCT01154218|40314165|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
16503478|NCT01154218|40314166|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
16503479|NCT01782859|40314167|FG000|Overall Study|Protocol Violation|6|||
16503480|NCT01782859|40314168|FG001|Overall Study|Protocol Violation|6|||
16503481|NCT01782859|40314167|FG000|Overall Study|Withdrawal by Subject|0|||
16503482|NCT01782859|40314168|FG001|Overall Study|Withdrawal by Subject|1|||
16503483|NCT02636868|40314169|FG000|Overall Study|Death|0|||
16503484|NCT02636868|40314170|FG001|Overall Study|Death|1|||
16503485|NCT02636868|40314171|FG002|Overall Study|Death|2|||
16503486|NCT00281684|40314174|FG000|Overall Study|Lost to Follow-up|0|||
16503487|NCT00281684|40314175|FG001|Overall Study|Lost to Follow-up|0|||
16503488|NCT00281684|40314176|FG002|Overall Study|Lost to Follow-up|1|||
16503489|NCT00281684|40314177|FG003|Overall Study|Lost to Follow-up|0|||
16503490|NCT00281684|40314174|FG000|Overall Study|Withdrawal by Subject|1|||
16503491|NCT00281684|40314175|FG001|Overall Study|Withdrawal by Subject|0|||
16503492|NCT00281684|40314176|FG002|Overall Study|Withdrawal by Subject|0|||
16503493|NCT00281684|40314177|FG003|Overall Study|Withdrawal by Subject|0|||
16503494|NCT01990495|40314178|FG000|Overall Study|Physician Decision|5|||
16503495|NCT01990495|40314179|FG001|Overall Study|Physician Decision|4|||
16503496|NCT02590939|40318554|FG000|Overall Study|Withdrawal by Subject|3|||
16503497|NCT02590939|40318555|FG001|Overall Study|Withdrawal by Subject|1|||
16310730|NCT02906670|39623475|FG001|Cohort 5P, Q2W|Adverse Event|0|||
16503498|NCT02590939|40318554|FG000|Overall Study|Failed the nociceptive test|2|||
16503499|NCT02590939|40318555|FG001|Overall Study|Failed the nociceptive test|1|||
16503500|NCT03311659|40318556|FG000|Overall Study|Protocol Violation|1|||
16503501|NCT01986855|40318559|FG000|Overall Study|Adverse Event|1|||
16503502|NCT01986855|40318560|FG001|Overall Study|Adverse Event|0|||
16503503|NCT01986855|40318561|FG002|Overall Study|Adverse Event|0|||
16503504|NCT01986855|40318559|FG000|Overall Study|Death|3|||
16503505|NCT01986855|40318560|FG001|Overall Study|Death|4|||
16503506|NCT01986855|40318561|FG002|Overall Study|Death|4|||
16503507|NCT01986855|40318559|FG000|Overall Study|Lost to Follow-up|2|||
16503508|NCT01986855|40318560|FG001|Overall Study|Lost to Follow-up|1|||
16503509|NCT01986855|40318561|FG002|Overall Study|Lost to Follow-up|0|||
16390341|NCT01925768|39912045|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
16390342|NCT01925768|39912046|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
16390343|NCT01925768|39912045|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
16390344|NCT01925768|39912046|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
16390345|NCT01925768|39912045|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
16390346|NCT01925768|39912046|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
16390347|NCT01925768|39912045|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
16390348|NCT01925768|39912046|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
16390349|NCT01925768|39912045|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
16390350|NCT01925768|39912046|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
16390351|NCT01925768|39912045|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
16390352|NCT01925768|39912046|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
16390353|NCT01925768|39912045|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
16390354|NCT01925768|39912046|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
16390355|NCT01925768|39912045|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
16390356|NCT01925768|39912046|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
16390357|NCT01925768|39912045|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
16390358|NCT01925768|39912046|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
16390359|NCT01925768|39912045|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
16503510|NCT01986855|40318559|FG000|Overall Study|Screen Failure|0|||
16503511|NCT01986855|40318560|FG001|Overall Study|Screen Failure|1|||
16503512|NCT01986855|40318561|FG002|Overall Study|Screen Failure|0|||
16503513|NCT01986855|40318559|FG000|Overall Study|Participant Moved|0|||
16503514|NCT01986855|40318560|FG001|Overall Study|Participant Moved|0|||
16503515|NCT01986855|40318561|FG002|Overall Study|Participant Moved|2|||
16310731|NCT02906670|39623476|FG002|Cohort 5P, Q2W|Adverse Event|0|||
16310732|NCT02906670|39623477|FG003|Cohort 5P, Q2W|Adverse Event|0|||
16310733|NCT02906670|39623478|FG004|Cohort 5P, Q2W|Adverse Event|0|||
16310734|NCT02906670|39623479|FG005|Cohort 5P, Q2W|Adverse Event|0|||
16310735|NCT02906670|39623480|FG006|Cohort 5P, Q2W|Adverse Event|0|||
16310736|NCT02906670|39623481|FG007|Cohort 5P, Q2W|Adverse Event|1|||
16310737|NCT02906670|39623482|FG008|Cohort 5P, Q2W|Adverse Event|0|||
16310738|NCT02906670|39623483|FG009|Cohort 5P, Q2W|Adverse Event|0|||
16310739|NCT02906670|39623474|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
16310740|NCT02906670|39623475|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
16310741|NCT02906670|39623476|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
16310742|NCT02906670|39623477|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
16310743|NCT02906670|39623478|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
16310744|NCT02906670|39623479|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
16310745|NCT02906670|39623480|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
16503516|NCT01986855|40318559|FG000|Overall Study|Withdrawal by Subject|7|||
16089585|NCT01159600|38816964|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
16503517|NCT01986855|40318560|FG001|Overall Study|Withdrawal by Subject|8|||
16503518|NCT01986855|40318561|FG002|Overall Study|Withdrawal by Subject|5|||
16503519|NCT02741700|40318562|FG000|Overall Study|Lost to Follow-up|17|||
16503520|NCT02741700|40318563|FG001|Overall Study|Lost to Follow-up|8|||
16503521|NCT02741700|40318562|FG000|Overall Study|Withdrawal by Subject|2|||
16503522|NCT02741700|40318563|FG001|Overall Study|Withdrawal by Subject|5|||
16503523|NCT02741700|40318562|FG000|Overall Study|Physician Decision|3|||
16503524|NCT02741700|40318563|FG001|Overall Study|Physician Decision|0|||
16503525|NCT02741700|40318562|FG000|Overall Study|Moved out of State|0|||
16503526|NCT02741700|40318563|FG001|Overall Study|Moved out of State|1|||
16503527|NCT02741700|40318562|FG000|Overall Study|Death|4|||
16503528|NCT02741700|40318563|FG001|Overall Study|Death|5|||
16503529|NCT00495170|40318564|FG000|Overall Study|Lost to Follow-up|9|||
16503530|NCT00495170|40318564|FG000|Overall Study|Withdrawal by Subject|3|||
16503531|NCT00495170|40318564|FG000|Overall Study|Inappropriate staging|8|||
16503532|NCT02206828|40318568|FG000|Overall Study|Lost to Follow-up|7|||
16503533|NCT00832585|40318569|FG000|Overall Study|Withdrawal by Subject|1|||
16503534|NCT00832585|40318569|FG000|Overall Study|Lost to Follow-up|1|||
16503535|NCT02515045|40318570|FG000|Overall Study|Adverse Event|0|||
16503536|NCT02515045|40318571|FG001|Overall Study|Adverse Event|3|||
16503537|NCT02515045|40318572|FG002|Overall Study|Adverse Event|3|||
16503538|NCT02515045|40318570|FG000|Overall Study|Lost to Follow-up|0|||
16503539|NCT02515045|40318571|FG001|Overall Study|Lost to Follow-up|1|||
16503540|NCT02515045|40318572|FG002|Overall Study|Lost to Follow-up|1|||
16503541|NCT00453921|40318573|FG000|Overall Study|Withdrawal by Subject|1|||
16503542|NCT00453921|40318574|FG001|Overall Study|Withdrawal by Subject|1|||
16503543|NCT00453921|40318575|FG002|Overall Study|Withdrawal by Subject|1|||
16503544|NCT00453921|40318576|FG003|Overall Study|Withdrawal by Subject|1|||
16503545|NCT00453921|40318573|FG000|Overall Study|Lost to Follow-up|0|||
16503546|NCT00453921|40318574|FG001|Overall Study|Lost to Follow-up|0|||
16503547|NCT00453921|40318575|FG002|Overall Study|Lost to Follow-up|1|||
16503548|NCT00453921|40318576|FG003|Overall Study|Lost to Follow-up|0|||
16503549|NCT02419742|40318584|FG000|Overall Study|Adverse Event|2|||
16503550|NCT02419742|40318585|FG001|Overall Study|Adverse Event|0|||
16503551|NCT02419742|40318584|FG000|Overall Study|Disease Progression|0|||
16503552|NCT02419742|40318585|FG001|Overall Study|Disease Progression|1|||
16503553|NCT02419742|40318584|FG000|Overall Study|Withdrew Consent|2|||
16503554|NCT02419742|40318585|FG001|Overall Study|Withdrew Consent|1|||
16503555|NCT02419742|40318584|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
16503556|NCT02419742|40318585|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
16503557|NCT02939560|40318587|FG000|Overall Study|Withdrawal by Subject|2|||
16503558|NCT02939560|40318587|FG000|Overall Study|Protocol Violation|1|||
16503559|NCT00492115|40318588|FG000|Overall Study|Withdrawal by Subject|3|||
16503560|NCT00492115|40318589|FG001|Overall Study|Withdrawal by Subject|4|||
16503561|NCT02389998|40318590|FG000|Overall Study|car accident|1|||
16503562|NCT02389998|40318591|FG001|Overall Study|car accident|0|||
16503563|NCT03564145|40318596|FG000|Overall Study|Adverse Event|4|||
16503564|NCT03564145|40318596|FG000|Overall Study|Lost to Follow-up|21|||
16503565|NCT03564145|40318596|FG000|Overall Study|Protocol Violation|2|||
16503566|NCT03564145|40318596|FG000|Overall Study|Withdrawal by Subject|48|||
16503567|NCT03564145|40318596|FG000|Overall Study|Study Terminated by Sponsor|146|||
16503568|NCT03564145|40318596|FG000|Overall Study|Physician Decision|1|||
16503569|NCT03564145|40318596|FG000|Overall Study|Other Than Specified|1|||
16503570|NCT03564145|40318596|FG000|Overall Study|Pregnancy|1|||
16503571|NCT03318315|40318597|FG000|Overall Study|Lost to Follow-up|3|||
16503572|NCT03318315|40318598|FG001|Overall Study|Lost to Follow-up|2|||
16503573|NCT03318315|40318599|FG002|Overall Study|Lost to Follow-up|1|||
16503574|NCT03318315|40318597|FG000|Overall Study|Protocol Violation|1|||
16503575|NCT03318315|40318598|FG001|Overall Study|Protocol Violation|1|||
16503576|NCT03318315|40318599|FG002|Overall Study|Protocol Violation|1|||
16503577|NCT03318315|40318597|FG000|Overall Study|Withdrawal by Subject|0|||
16503578|NCT03318315|40318598|FG001|Overall Study|Withdrawal by Subject|0|||
16503579|NCT03318315|40318599|FG002|Overall Study|Withdrawal by Subject|2|||
16503580|NCT01166178|40318602|FG000|Overall Study|Withdrawal by Subject|1|||
16503581|NCT01166178|40318603|FG001|Overall Study|Withdrawal by Subject|0|||
16503582|NCT01166178|40318602|FG000|Overall Study|Study was terminated|20|||
16503583|NCT01166178|40318603|FG001|Overall Study|Study was terminated|8|||
16503584|NCT04273217|40318604|FG000|Overall Study|Lost to Follow-up|0|||
16503585|NCT04273217|40318605|FG001|Overall Study|Lost to Follow-up|0|||
16503586|NCT04273217|40318606|FG002|Overall Study|Lost to Follow-up|0|||
16503587|NCT04273217|40318607|FG003|Overall Study|Lost to Follow-up|0|||
16503588|NCT04273217|40318608|FG004|Overall Study|Lost to Follow-up|0|||
16503589|NCT04273217|40318609|FG005|Overall Study|Lost to Follow-up|1|||
16503590|NCT04273217|40318604|FG000|Overall Study|Participant non-compliance|0|||
16503591|NCT04273217|40318605|FG001|Overall Study|Participant non-compliance|0|||
16503592|NCT04273217|40318606|FG002|Overall Study|Participant non-compliance|0|||
16503593|NCT04273217|40318607|FG003|Overall Study|Participant non-compliance|0|||
16503594|NCT04273217|40318608|FG004|Overall Study|Participant non-compliance|1|||
16503595|NCT04273217|40318609|FG005|Overall Study|Participant non-compliance|0|||
16503596|NCT04273217|40318604|FG000|Overall Study|Positive urine drug screen|1|||
16503597|NCT04273217|40318605|FG001|Overall Study|Positive urine drug screen|0|||
16503598|NCT04273217|40318606|FG002|Overall Study|Positive urine drug screen|1|||
16503599|NCT04273217|40318607|FG003|Overall Study|Positive urine drug screen|0|||
16503600|NCT04273217|40318608|FG004|Overall Study|Positive urine drug screen|0|||
16503601|NCT04273217|40318609|FG005|Overall Study|Positive urine drug screen|1|||
16503602|NCT00304356|40318614|FG000|Nitazoxanide|Physician Decision|5|||
16503603|NCT00304356|40318614|FG000|Nitazoxanide|Physician Decision|1|||
16503604|NCT00304356|40318614|FG000|Nitazoxanide|number is 0|1|||
16503605|NCT00304356|40318614|FG000|Nitazoxanide|Physician Decision|1|||
16503606|NCT00304356|40318614|FG000|Nitazoxanide|Physician Decision|1|||
16503607|NCT00304356|40318614|FG000|Nitazoxanide|Physician Decision|1|||
16503608|NCT00768300|40318617|FG000|Overall Study|Randomized but not treated|1|||
16503609|NCT00768300|40318618|FG001|Overall Study|Randomized but not treated|1|||
16310746|NCT02906670|39623481|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
16310747|NCT02906670|39623482|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
16310748|NCT02906670|39623483|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
16310749|NCT02906670|39623474|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
16310750|NCT02906670|39623475|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
16310751|NCT02906670|39623476|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
16310752|NCT02906670|39623477|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
16310753|NCT02906670|39623478|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
16310754|NCT02906670|39623479|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
16310755|NCT02906670|39623480|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
16310756|NCT02906670|39623481|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
16310757|NCT02906670|39623482|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
16310758|NCT02906670|39623483|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
16310759|NCT02906670|39623474|FG000|Cohort 4P, QW|Radiological Progression|0|||
16310760|NCT02906670|39623475|FG001|Cohort 4P, QW|Radiological Progression|0|||
16310761|NCT02906670|39623476|FG002|Cohort 4P, QW|Radiological Progression|0|||
16503610|NCT00768300|40318617|FG000|Overall Study|Adverse Event|10|||
16503611|NCT00768300|40318618|FG001|Overall Study|Adverse Event|2|||
16503612|NCT00768300|40318617|FG000|Overall Study|Protocol Violation|6|||
16503613|NCT00768300|40318618|FG001|Overall Study|Protocol Violation|1|||
16503614|NCT00768300|40318617|FG000|Overall Study|Withdrawal by Subject|13|||
16503615|NCT00768300|40318618|FG001|Overall Study|Withdrawal by Subject|7|||
16503616|NCT00768300|40318617|FG000|Overall Study|Physician Decision|2|||
16503617|NCT00768300|40318618|FG001|Overall Study|Physician Decision|3|||
16503618|NCT00768300|40318617|FG000|Overall Study|Study discontinued by Sponsor|271|||
16503619|NCT00768300|40318618|FG001|Overall Study|Study discontinued by Sponsor|140|||
16503620|NCT00768300|40318617|FG000|Overall Study|Death|21|||
16503621|NCT00768300|40318618|FG001|Overall Study|Death|5|||
16503622|NCT00768300|40318617|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
16503623|NCT00768300|40318618|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
16503624|NCT00768300|40318617|FG000|Overall Study|Screen failure following randomization|1|||
16503625|NCT00768300|40318618|FG001|Overall Study|Screen failure following randomization|0|||
16503626|NCT00768300|40318617|FG000|Overall Study|Received lung transplant|1|||
16503627|NCT00768300|40318618|FG001|Overall Study|Received lung transplant|1|||
16503628|NCT00768300|40318617|FG000|Overall Study|Lost to Follow-up|0|||
16503629|NCT00768300|40318618|FG001|Overall Study|Lost to Follow-up|1|||
16503630|NCT00768300|40318617|FG000|Overall Study|Began prohibited concomitant medication|0|||
16503631|NCT00768300|40318618|FG001|Overall Study|Began prohibited concomitant medication|1|||
16503632|NCT00768300|40318617|FG000|Overall Study|Treated but never dosed with Study drug|1|||
16503633|NCT00768300|40318618|FG001|Overall Study|Treated but never dosed with Study drug|0|||
16503634|NCT00768300|40318617|FG000|Overall Study|Missing data|1|||
16503635|NCT00768300|40318618|FG001|Overall Study|Missing data|0|||
16503636|NCT01348347|40318623|FG000|Overall Study|Withdrawal by Subject|1|||
16503637|NCT01348347|40318624|FG001|Overall Study|Withdrawal by Subject|1|||
16503638|NCT01348347|40318625|FG002|Overall Study|Withdrawal by Subject|1|||
16503639|NCT01348347|40318623|FG000|Overall Study|Progressive disease|2|||
16503640|NCT01348347|40318624|FG001|Overall Study|Progressive disease|5|||
16503641|NCT01348347|40318625|FG002|Overall Study|Progressive disease|5|||
16503642|NCT00567892|40318629|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
16503643|NCT00567892|40318630|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
16503644|NCT00567892|40318631|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
16503645|NCT00567892|40318632|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
16503646|NCT00567892|40318629|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
16503647|NCT00567892|40318630|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
16503648|NCT00567892|40318631|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
16546328|NCT02237508|40464782|FG009|Overall Study|Protocol Violation|0|||
16310762|NCT02906670|39623477|FG003|Cohort 4P, QW|Radiological Progression|3|||
16310763|NCT02906670|39623478|FG004|Cohort 4P, QW|Radiological Progression|0|||
16310764|NCT02906670|39623479|FG005|Cohort 4P, QW|Radiological Progression|0|||
16310765|NCT02906670|39623480|FG006|Cohort 4P, QW|Radiological Progression|0|||
16310766|NCT02906670|39623481|FG007|Cohort 4P, QW|Radiological Progression|0|||
16310767|NCT02906670|39623482|FG008|Cohort 4P, QW|Radiological Progression|0|||
16310768|NCT02906670|39623483|FG009|Cohort 4P, QW|Radiological Progression|0|||
16503649|NCT00567892|40318632|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
16503650|NCT02723084|40318633|FG000|Overall Study|Withdrawal by Subject|1|||
16503651|NCT02723084|40318634|FG001|Overall Study|Withdrawal by Subject|1|||
16503652|NCT02723084|40318633|FG000|Overall Study|Lost to Follow-up|3|||
16503653|NCT02723084|40318634|FG001|Overall Study|Lost to Follow-up|0|||
16503654|NCT02489344|40318635|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
16503655|NCT02489344|40318635|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
16503656|NCT02489344|40318635|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
16503657|NCT02489344|40318635|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
16503658|NCT05045144|40318636|FG000|Overall Study|Lost to Follow-up|3|||
16503659|NCT05045144|40318637|FG001|Overall Study|Lost to Follow-up|2|||
16503660|NCT05045144|40318638|FG002|Overall Study|Lost to Follow-up|3|||
16503661|NCT05045144|40318639|FG003|Overall Study|Lost to Follow-up|5|||
16503662|NCT05045144|40318640|FG004|Overall Study|Lost to Follow-up|13|||
16503663|NCT05045144|40318636|FG000|Overall Study|Withdrawal by Subject|0|||
16503664|NCT05045144|40318637|FG001|Overall Study|Withdrawal by Subject|1|||
16503665|NCT05045144|40318638|FG002|Overall Study|Withdrawal by Subject|0|||
16503666|NCT05045144|40318639|FG003|Overall Study|Withdrawal by Subject|0|||
16503667|NCT05045144|40318640|FG004|Overall Study|Withdrawal by Subject|0|||
16503668|NCT05045144|40318636|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16503669|NCT05045144|40318637|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16503670|NCT05045144|40318638|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16503671|NCT05045144|40318639|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16503672|NCT05045144|40318640|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16503673|NCT01374087|40318647|FG000|Overall Study|Adverse Event|1|||
16503674|NCT01374087|40318648|FG001|Overall Study|Adverse Event|0|||
16503675|NCT01374087|40318647|FG000|Overall Study|Disease progression|2|||
16503676|NCT01374087|40318648|FG001|Overall Study|Disease progression|2|||
16503677|NCT01374087|40318647|FG000|Overall Study|Study discontinued|13|||
16503678|NCT01374087|40318648|FG001|Overall Study|Study discontinued|13|||
16503679|NCT02677987|40318650|FG000|Overall Study|Withdrawal by Subject|3|||
16503680|NCT02677987|40318651|FG001|Overall Study|Withdrawal by Subject|0|||
16503681|NCT02677987|40318650|FG000|Overall Study|Lost to Follow-up|1|||
16503682|NCT02677987|40318651|FG001|Overall Study|Lost to Follow-up|0|||
16503683|NCT04824131|40318654|FG000|CAB LA Oral Phase|Adverse Event|1|||
16310769|NCT02906670|39623474|FG000|Cohort 7P, Q2W|Adverse Event|0|||
16310770|NCT02906670|39623475|FG001|Cohort 7P, Q2W|Adverse Event|0|||
16310771|NCT02906670|39623476|FG002|Cohort 7P, Q2W|Adverse Event|0|||
16310772|NCT02906670|39623477|FG003|Cohort 7P, Q2W|Adverse Event|0|||
16310773|NCT02906670|39623478|FG004|Cohort 7P, Q2W|Adverse Event|0|||
16310774|NCT02906670|39623479|FG005|Cohort 7P, Q2W|Adverse Event|0|||
16310775|NCT02906670|39623480|FG006|Cohort 7P, Q2W|Adverse Event|0|||
16310776|NCT02906670|39623481|FG007|Cohort 7P, Q2W|Adverse Event|0|||
16310777|NCT02906670|39623482|FG008|Cohort 7P, Q2W|Adverse Event|0|||
16310778|NCT02906670|39623483|FG009|Cohort 7P, Q2W|Adverse Event|1|||
16310779|NCT02906670|39623474|FG000|Cohort 7P, Q2W|Physician Decision|0|||
16310780|NCT02906670|39623475|FG001|Cohort 7P, Q2W|Physician Decision|0|||
16310781|NCT02906670|39623476|FG002|Cohort 7P, Q2W|Physician Decision|0|||
16310782|NCT02906670|39623477|FG003|Cohort 7P, Q2W|Physician Decision|0|||
16310783|NCT02906670|39623478|FG004|Cohort 7P, Q2W|Physician Decision|0|||
16310784|NCT02906670|39623479|FG005|Cohort 7P, Q2W|Physician Decision|0|||
16503684|NCT04824131|40318654|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
16503685|NCT04824131|40318654|FG000|Step 3|Withdrawal by Subject|2|||
16503686|NCT01996709|40318656|FG000|Overall Study|Withdrawal by Subject|1|||
16503687|NCT01996709|40318657|FG001|Overall Study|Withdrawal by Subject|0|||
16503688|NCT01996709|40318656|FG000|Overall Study|Lost to Follow-up|3|||
16503689|NCT01996709|40318657|FG001|Overall Study|Lost to Follow-up|0|||
16503690|NCT01996709|40318656|FG000|Overall Study|Subject Non-Compliant|1|||
16503691|NCT01996709|40318657|FG001|Overall Study|Subject Non-Compliant|0|||
16503692|NCT01996709|40318656|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
16503693|NCT01996709|40318657|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
16503694|NCT01412021|40318658|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
16503695|NCT01412021|40318658|FG000|Overall Study|Treatment Prior to Approval|3|||
16503696|NCT01412021|40318658|FG000|Overall Study|Transferred to Other Hospital|9|||
16503697|NCT03720470|40318661|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
16503698|NCT03720470|40318662|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
16310785|NCT02906670|39623480|FG006|Cohort 7P, Q2W|Physician Decision|0|||
16310786|NCT02906670|39623481|FG007|Cohort 7P, Q2W|Physician Decision|0|||
16310787|NCT02906670|39623482|FG008|Cohort 7P, Q2W|Physician Decision|0|||
16310788|NCT02906670|39623483|FG009|Cohort 7P, Q2W|Physician Decision|1|||
16310789|NCT02906670|39623474|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
16310790|NCT02906670|39623475|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
16310791|NCT02906670|39623476|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
16310792|NCT02906670|39623477|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
16089586|NCT01159600|38816965|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
16089587|NCT01159600|38816966|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
16089588|NCT01159600|38816967|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
16089589|NCT01159600|38816968|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
16195757|NCT00960934|39193403|FG004|Overall Study|Study Terminated by Sponsor|49|||
16195758|NCT00960934|39193404|FG005|Overall Study|Study Terminated by Sponsor|49|||
16195759|NCT01905150|39193407|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
16195760|NCT01905150|39193408|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
16195761|NCT02045212|39193411|FG000|Overall Study|Adverse Event|0|||
16195762|NCT02045212|39193412|FG001|Overall Study|Adverse Event|1|||
16195763|NCT02045212|39193411|FG000|Overall Study|Withdrawal by Subject|1|||
16195764|NCT02045212|39193412|FG001|Overall Study|Withdrawal by Subject|0|||
16195765|NCT02045212|39193411|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
16195766|NCT02045212|39193412|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
16195767|NCT01842308|39193413|FG000|Overall Study|Withdrawal by Subject|0|||
16195768|NCT01842308|39193414|FG001|Overall Study|Withdrawal by Subject|0|||
16195769|NCT01842308|39193415|FG002|Overall Study|Withdrawal by Subject|0|||
16195770|NCT01842308|39193416|FG003|Overall Study|Withdrawal by Subject|0|||
16195771|NCT01842308|39193417|FG004|Overall Study|Withdrawal by Subject|1|||
16195772|NCT00377611|39193418|FG000|Overall Study|Adverse Event|2|||
16195773|NCT00377611|39193419|FG001|Overall Study|Adverse Event|9|||
16195774|NCT00377611|39193418|FG000|Overall Study|Protocol Violation|2|||
16195775|NCT00377611|39193419|FG001|Overall Study|Protocol Violation|0|||
16310793|NCT02906670|39623478|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
16310794|NCT02906670|39623479|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
16195776|NCT00377611|39193418|FG000|Overall Study|Withdrawal by Subject|0|||
16195777|NCT00377611|39193419|FG001|Overall Study|Withdrawal by Subject|5|||
16195778|NCT00377611|39193418|FG000|Overall Study|Lost to Follow-up|18|||
16195779|NCT00377611|39193419|FG001|Overall Study|Lost to Follow-up|16|||
16195780|NCT00377611|39193418|FG000|Overall Study|Other|0|||
16195781|NCT00377611|39193419|FG001|Overall Study|Other|3|||
16195782|NCT02078713|39193422|FG000|Overall Study|Lost to Follow-up|49|||
16195783|NCT02078713|39193423|FG001|Overall Study|Lost to Follow-up|55|||
16195784|NCT02078713|39193424|FG002|Overall Study|Lost to Follow-up|0|||
16195785|NCT02078713|39193425|FG003|Overall Study|Lost to Follow-up|0|||
16195786|NCT02078713|39193422|FG000|Overall Study|Pregnant at baseline|3|||
16195787|NCT02078713|39193423|FG001|Overall Study|Pregnant at baseline|5|||
16195788|NCT02078713|39193424|FG002|Overall Study|Pregnant at baseline|0|||
16195789|NCT02078713|39193425|FG003|Overall Study|Pregnant at baseline|0|||
16310795|NCT02906670|39623480|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
16310796|NCT02906670|39623481|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
16310797|NCT02906670|39623482|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
16310798|NCT02906670|39623483|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
16310799|NCT02906670|39623474|FG000|Cohort 5P, QW|Radiological Progression|0|||
16310800|NCT02906670|39623475|FG001|Cohort 5P, QW|Radiological Progression|0|||
16310801|NCT02906670|39623476|FG002|Cohort 5P, QW|Radiological Progression|0|||
16503699|NCT03720470|40318663|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
16503700|NCT03720470|40318664|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
16503701|NCT03720470|40318665|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
16503702|NCT03720470|40318666|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
16503703|NCT03720470|40318661|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
16503704|NCT03720470|40318662|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
16503705|NCT03720470|40318663|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
16503706|NCT03720470|40318664|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
16503707|NCT03720470|40318665|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
16503708|NCT03720470|40318666|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
16503709|NCT03720470|40318661|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
16503710|NCT03720470|40318662|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
16503711|NCT03720470|40318663|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
16503712|NCT03720470|40318664|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
16503713|NCT03720470|40318665|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
16503714|NCT03720470|40318666|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
16503715|NCT03720470|40318661|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
16503716|NCT03720470|40318662|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
16546329|NCT01986881|40464783|FG000|Overall Study|Death|228|||
16195790|NCT02078713|39193422|FG000|Overall Study|Enrolled twice|0|||
16195791|NCT02078713|39193423|FG001|Overall Study|Enrolled twice|1|||
16310802|NCT02906670|39623477|FG003|Cohort 5P, QW|Radiological Progression|0|||
16310803|NCT02906670|39623478|FG004|Cohort 5P, QW|Radiological Progression|3|||
16195792|NCT02078713|39193424|FG002|Overall Study|Enrolled twice|0|||
16195793|NCT02078713|39193425|FG003|Overall Study|Enrolled twice|0|||
16195794|NCT00064350|39193428|FG000|Induction Treatment|Disease Progression|5|||
16195795|NCT00064350|39193429|FG001|Induction Treatment|Disease Progression|1|||
16195796|NCT00064350|39193430|FG002|Induction Treatment|Disease Progression|110|||
16195797|NCT00064350|39193428|FG000|Induction Treatment|Adverse Event|0|||
16195798|NCT00064350|39193429|FG001|Induction Treatment|Adverse Event|2|||
16195799|NCT00064350|39193430|FG002|Induction Treatment|Adverse Event|49|||
16195800|NCT00064350|39193428|FG000|Induction Treatment|Death|0|||
16195801|NCT00064350|39193429|FG001|Induction Treatment|Death|0|||
16195802|NCT00064350|39193430|FG002|Induction Treatment|Death|9|||
16089590|NCT01159600|38816969|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
16089591|NCT01159600|38816962|FG000|Overall Study|Other reason not defined above|3|||
16089592|NCT01159600|38816963|FG001|Overall Study|Other reason not defined above|0|||
16089593|NCT01159600|38816964|FG002|Overall Study|Other reason not defined above|4|||
16089594|NCT01159600|38816965|FG003|Overall Study|Other reason not defined above|2|||
16089595|NCT01159600|38816966|FG004|Overall Study|Other reason not defined above|5|||
16089596|NCT01159600|38816967|FG005|Overall Study|Other reason not defined above|7|||
16089597|NCT01159600|38816968|FG006|Overall Study|Other reason not defined above|3|||
16089598|NCT01159600|38816969|FG007|Overall Study|Other reason not defined above|3|||
16089599|NCT02321514|38816970|FG000|Overall Study|Death|15|||
16089600|NCT02321514|38816970|FG000|Overall Study|Missed Visit|7|||
16089601|NCT02321514|38816970|FG000|Overall Study|Study Exit|3|||
16089602|NCT02410278|38816971|FG000|Run-in Period|Adverse Event|5|||
16089603|NCT02410278|38816972|FG001|Run-in Period|Adverse Event|0|||
16089604|NCT02410278|38816973|FG002|Run-in Period|Adverse Event|0|||
16089605|NCT02410278|38816971|FG000|Run-in Period|GSRS Threshold Not Met|30|||
16089606|NCT02410278|38816972|FG001|Run-in Period|GSRS Threshold Not Met|0|||
16089607|NCT02410278|38816973|FG002|Run-in Period|GSRS Threshold Not Met|0|||
16089608|NCT02410278|38816971|FG000|Run-in Period|Lost to Follow-up|1|||
16089609|NCT02410278|38816972|FG001|Run-in Period|Lost to Follow-up|0|||
16089610|NCT02410278|38816973|FG002|Run-in Period|Lost to Follow-up|0|||
16089611|NCT02410278|38816971|FG000|Run-in Period|Withdrawal by Subject|1|||
16089612|NCT02410278|38816972|FG001|Run-in Period|Withdrawal by Subject|0|||
16089613|NCT02410278|38816973|FG002|Run-in Period|Withdrawal by Subject|0|||
16089614|NCT02410278|38816971|FG000|Run-in Period|Pregnancy|1|||
16089615|NCT02410278|38816972|FG001|Run-in Period|Pregnancy|0|||
16089616|NCT02410278|38816973|FG002|Run-in Period|Pregnancy|0|||
16089617|NCT02410278|38816971|FG000|Study Treatment Period|Adverse Event|0|||
16089618|NCT02410278|38816972|FG001|Study Treatment Period|Adverse Event|6|||
16089619|NCT02410278|38816973|FG002|Study Treatment Period|Adverse Event|3|||
16089620|NCT02410278|38816971|FG000|Study Treatment Period|Physician Decision|0|||
16089621|NCT02410278|38816972|FG001|Study Treatment Period|Physician Decision|0|||
16503717|NCT03720470|40318663|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
16503718|NCT03720470|40318664|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
16503719|NCT03720470|40318665|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
16503720|NCT03720470|40318666|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
16503721|NCT03720470|40318661|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
16503722|NCT03720470|40318662|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
16089622|NCT02410278|38816973|FG002|Study Treatment Period|Physician Decision|1|||
16089623|NCT02410278|38816971|FG000|Study Treatment Period|Withdrawal by Subject|0|||
16089624|NCT02410278|38816972|FG001|Study Treatment Period|Withdrawal by Subject|1|||
16310804|NCT02906670|39623479|FG005|Cohort 5P, QW|Radiological Progression|0|||
16089625|NCT02410278|38816973|FG002|Study Treatment Period|Withdrawal by Subject|0|||
16089626|NCT02410278|38816971|FG000|Study Treatment Period|Other|0|||
16089627|NCT02410278|38816972|FG001|Study Treatment Period|Other|3|||
16089628|NCT02410278|38816973|FG002|Study Treatment Period|Other|0|||
16089629|NCT02410278|38816971|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
16089630|NCT02410278|38816972|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
16089631|NCT02410278|38816973|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
16089632|NCT01976507|38816977|FG000|Overall Study|Adverse Event|6|||
16089633|NCT01976507|38816977|FG000|Overall Study|ablation not done, drug not given|1|||
16089634|NCT02736188|38816978|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
16089635|NCT02736188|38816978|FG000|Overall Study|Adverse Event|1|||
16089636|NCT02736188|38816978|FG000|Overall Study|Withdrawal by Subject|1|||
16089637|NCT02736188|38816978|FG000|Overall Study|Other|6|||
16089638|NCT01005914|38816979|FG000|Overall Study|Adverse Event|4|||
16089639|NCT01005914|38816979|FG000|Overall Study|Death|4|||
16089640|NCT01005914|38816979|FG000|Overall Study|Lack of Efficacy|1|||
16089641|NCT01005914|38816979|FG000|Overall Study|Withdrawal by Subject|1|||
16089642|NCT00047385|38819941|FG000|Overall Study|Death before any screening|2|||
16089643|NCT00047385|38819942|FG001|Overall Study|Death before any screening|5|||
16195803|NCT00064350|39193428|FG000|Induction Treatment|Withdrawal by Subject|0|||
16310805|NCT02906670|39623480|FG006|Cohort 5P, QW|Radiological Progression|0|||
16195804|NCT00064350|39193429|FG001|Induction Treatment|Withdrawal by Subject|0|||
16195805|NCT00064350|39193430|FG002|Induction Treatment|Withdrawal by Subject|21|||
16503723|NCT03720470|40318663|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
16503724|NCT03720470|40318664|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
16503725|NCT03720470|40318665|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
16503726|NCT03720470|40318666|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
16503727|NCT03720470|40318661|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
16503728|NCT03720470|40318662|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
16503729|NCT03720470|40318663|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
16503730|NCT03720470|40318664|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
16503731|NCT03720470|40318665|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
16503732|NCT03720470|40318666|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
16503733|NCT03720470|40318661|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
16503734|NCT03720470|40318662|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
16503735|NCT03720470|40318663|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
16503736|NCT03720470|40318664|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
16503737|NCT03720470|40318665|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
16503738|NCT03720470|40318666|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
16503739|NCT03720470|40318661|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
16503740|NCT03720470|40318662|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
16503741|NCT03720470|40318663|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
16503742|NCT03720470|40318664|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
16503743|NCT03720470|40318665|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
16503744|NCT03720470|40318666|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
16503745|NCT03720470|40318661|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
16503746|NCT03720470|40318662|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
16503747|NCT03720470|40318663|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
16503748|NCT03720470|40318664|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
16503749|NCT03720470|40318665|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
16503750|NCT03720470|40318666|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
16503751|NCT03720470|40318661|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
16503752|NCT03720470|40318662|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
16503753|NCT03720470|40318663|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
16503754|NCT03720470|40318664|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
16503755|NCT03720470|40318665|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
16503756|NCT03720470|40318666|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
16503757|NCT03720470|40318661|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
16503758|NCT03720470|40318662|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
16503759|NCT03720470|40318663|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
16503760|NCT03720470|40318664|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
16503761|NCT03720470|40318665|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
16503762|NCT03720470|40318666|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
16503763|NCT03720470|40318661|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
16503764|NCT03720470|40318662|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
16503765|NCT03720470|40318663|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
16503766|NCT03720470|40318664|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
16503767|NCT03720470|40318665|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
16503768|NCT03720470|40318666|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
16503769|NCT03720470|40318661|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
16503770|NCT03720470|40318662|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
16503771|NCT03720470|40318663|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
16503772|NCT03720470|40318664|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
16503773|NCT03720470|40318665|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
16503774|NCT03720470|40318666|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
16503775|NCT03720470|40318661|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
16503776|NCT03720470|40318662|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
16503777|NCT03720470|40318663|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
16503778|NCT03720470|40318664|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
16503779|NCT03720470|40318665|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
16503780|NCT03720470|40318666|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
16503781|NCT03720470|40318661|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
16503782|NCT03720470|40318662|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
16503783|NCT03720470|40318663|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
16503784|NCT03720470|40318664|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
16503785|NCT03720470|40318665|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
16503786|NCT03720470|40318666|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
16546330|NCT01986881|40464784|FG001|Overall Study|Death|233|||
16195806|NCT00064350|39193428|FG000|Induction Treatment|Ineligible or never started treatment|3|||
16089644|NCT00047385|38819941|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
16089645|NCT00047385|38819942|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
16089646|NCT00047385|38819941|FG000|Overall Study|Eligible for screening but had no screen|260|||
16089647|NCT00047385|38819942|FG001|Overall Study|Eligible for screening but had no screen|492|||
16089648|NCT03392194|38819943|FG000|Overall Study|Withdrawal by Subject|1|||
16089649|NCT03392194|38819944|FG001|Overall Study|Withdrawal by Subject|2|||
16089650|NCT03392194|38819943|FG000|Overall Study|Conflicts with personal schedule|1|||
16089651|NCT03392194|38819944|FG001|Overall Study|Conflicts with personal schedule|0|||
16089652|NCT01240785|38819951|FG000|Overall Study|Lost to Follow-up|1|||
16089653|NCT01240785|38819952|FG001|Overall Study|Lost to Follow-up|0|||
16089654|NCT01240785|38819951|FG000|Overall Study|Protocol Violation|0|||
16089655|NCT01240785|38819952|FG001|Overall Study|Protocol Violation|3|||
16089656|NCT03006393|38819953|FG000|Overall Study|Withdrawal by Subject|1|||
16089657|NCT03006393|38819954|FG001|Overall Study|Withdrawal by Subject|1|||
16089658|NCT03006393|38819953|FG000|Overall Study|Pregnancy|0|||
16089659|NCT03006393|38819954|FG001|Overall Study|Pregnancy|1|||
16089660|NCT03006393|38819953|FG000|Overall Study|Lost to Follow-up|0|||
16089661|NCT03006393|38819954|FG001|Overall Study|Lost to Follow-up|1|||
16089662|NCT02538094|38819955|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
16089663|NCT02538094|38819956|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
16089664|NCT02538094|38819955|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
16310806|NCT02906670|39623481|FG007|Cohort 5P, QW|Radiological Progression|0|||
16310807|NCT02906670|39623482|FG008|Cohort 5P, QW|Radiological Progression|0|||
16503787|NCT03720470|40318661|FG000|Treatment Period: Final 4 Weeks|Other|0|||
16503788|NCT03720470|40318662|FG001|Treatment Period: Final 4 Weeks|Other|1|||
16310808|NCT02906670|39623483|FG009|Cohort 5P, QW|Radiological Progression|0|||
16310809|NCT02892331|39623484|FG000|Overall Study|Withdrawal by Subject|0|||
16390360|NCT01925768|39912046|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
16390361|NCT01030822|39912049|FG000|Overall Study|Moved/migrated from study area|6|||
16390362|NCT01030822|39912050|FG001|Overall Study|Moved/migrated from study area|7|||
16390363|NCT01030822|39912051|FG002|Overall Study|Moved/migrated from study area|3|||
16390364|NCT01030822|39912049|FG000|Overall Study|Withdrawal by Subject|16|||
16390365|NCT01030822|39912050|FG001|Overall Study|Withdrawal by Subject|13|||
16390366|NCT01030822|39912051|FG002|Overall Study|Withdrawal by Subject|16|||
16390367|NCT01030822|39912049|FG000|Overall Study|Lost to Follow-up|9|||
16390368|NCT01030822|39912050|FG001|Overall Study|Lost to Follow-up|4|||
16390369|NCT01030822|39912051|FG002|Overall Study|Lost to Follow-up|7|||
16503789|NCT03720470|40318663|FG002|Treatment Period: Final 4 Weeks|Other|0|||
16310810|NCT02892331|39623485|FG001|Overall Study|Withdrawal by Subject|1|||
16310811|NCT02892331|39623486|FG002|Overall Study|Withdrawal by Subject|1|||
16310812|NCT02892331|39623484|FG000|Overall Study|Sick family member|0|||
16310813|NCT02892331|39623485|FG001|Overall Study|Sick family member|0|||
16310814|NCT02892331|39623486|FG002|Overall Study|Sick family member|1|||
16310815|NCT02892331|39623484|FG000|Overall Study|Corona virus pandemic|1|||
16310816|NCT02892331|39623485|FG001|Overall Study|Corona virus pandemic|0|||
16310817|NCT02892331|39623486|FG002|Overall Study|Corona virus pandemic|1|||
16310818|NCT02892331|39623484|FG000|Overall Study|Lost to Follow-up|1|||
16310819|NCT02892331|39623485|FG001|Overall Study|Lost to Follow-up|0|||
16310820|NCT02892331|39623486|FG002|Overall Study|Lost to Follow-up|1|||
16310821|NCT02892331|39623484|FG000|Overall Study|Blood pressure was too elevated|0|||
16310822|NCT02892331|39623485|FG001|Overall Study|Blood pressure was too elevated|1|||
16310823|NCT02892331|39623486|FG002|Overall Study|Blood pressure was too elevated|0|||
16310824|NCT02892331|39623484|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
16310825|NCT02892331|39623485|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
16503790|NCT03720470|40318664|FG003|Treatment Period: Final 4 Weeks|Other|2|||
16503791|NCT03720470|40318665|FG004|Treatment Period: Final 4 Weeks|Other|1|||
16503792|NCT03720470|40318666|FG005|Treatment Period: Final 4 Weeks|Other|0|||
16503793|NCT01603459|40318678|FG000|Overall Study|Adverse Event|5|||
16503794|NCT01603459|40318678|FG000|Overall Study|Withdrawal by Subject|5|||
16503795|NCT01603459|40318678|FG000|Overall Study|Lost to Follow-up|3|||
16503796|NCT01603459|40318678|FG000|Overall Study|Predefined discontinuation criteria|3|||
16503797|NCT01603459|40318678|FG000|Overall Study|Non-compliance|1|||
16503798|NCT01603459|40318678|FG000|Overall Study|Administrative reason|1|||
16503799|NCT01536379|40318681|FG000|Overall Study|Adverse Event|1|||
16089665|NCT02538094|38819956|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
16089666|NCT01313884|38819958|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
16089667|NCT02203799|38819961|FG000|Overall Study|Withdrawal by Subject|3|||
16089668|NCT01009645|38819964|FG000|Overall Study|Lost to Follow-up|2|||
16089669|NCT01009645|38819965|FG001|Overall Study|Lost to Follow-up|8|||
16390370|NCT01135992|39912057|FG000|Overall Study|Adverse Event|1|||
16390371|NCT01135992|39912057|FG000|Overall Study|Lack of Efficacy|1|||
16390372|NCT01135992|39912057|FG000|Overall Study|Protocol Violation|2|||
16503800|NCT01536379|40318682|FG001|Overall Study|Adverse Event|2|||
16503801|NCT01536379|40318681|FG000|Overall Study|Withdrawal by Subject|1|||
16310826|NCT02892331|39623486|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
16310827|NCT02126826|39623487|FG000|Overall Study|Withdrawal by Subject|0|||
16310828|NCT02126826|39623488|FG001|Overall Study|Withdrawal by Subject|0|||
16310829|NCT02126826|39623489|FG002|Overall Study|Withdrawal by Subject|0|||
16310830|NCT02126826|39623490|FG003|Overall Study|Withdrawal by Subject|1|||
16310831|NCT02126826|39623491|FG004|Overall Study|Withdrawal by Subject|0|||
16310832|NCT02126826|39623492|FG005|Overall Study|Withdrawal by Subject|0|||
16310833|NCT02126826|39623493|FG006|Overall Study|Withdrawal by Subject|0|||
16310834|NCT01991743|39623494|FG000|Overall Study|external cephalic version not performed|0|||
16310835|NCT01991743|39623495|FG001|Overall Study|external cephalic version not performed|0|||
16310836|NCT01991743|39623496|FG002|Overall Study|external cephalic version not performed|1|||
16310837|NCT01991743|39623497|FG003|Overall Study|external cephalic version not performed|0|||
16310838|NCT02203357|39623498|FG000|Overall Study|Lost to Follow-up|58|||
16310839|NCT02203357|39623499|FG001|Overall Study|Lost to Follow-up|66|||
16310840|NCT02203357|39623500|FG002|Overall Study|Lost to Follow-up|70|||
16310841|NCT03832686|39623502|FG000|Overall Study|Lost to Follow-up|6|||
16310842|NCT03832686|39623503|FG001|Overall Study|Lost to Follow-up|9|||
16310843|NCT03832686|39623502|FG000|Overall Study|Discontinued Intervention|5|||
16310844|NCT03832686|39623503|FG001|Overall Study|Discontinued Intervention|4|||
16310845|NCT01125189|39623504|FG000|Treatment Period|Lack of Efficacy|15|||
16310846|NCT01125189|39623505|FG001|Treatment Period|Lack of Efficacy|18|||
16310847|NCT01125189|39623506|FG002|Treatment Period|Lack of Efficacy|25|||
16310848|NCT01125189|39623504|FG000|Treatment Period|Adverse Event|7|||
16310849|NCT01125189|39623505|FG001|Treatment Period|Adverse Event|8|||
16310850|NCT01125189|39623506|FG002|Treatment Period|Adverse Event|8|||
16310851|NCT01125189|39623504|FG000|Treatment Period|Withdrawal by Subject|3|||
16310852|NCT01125189|39623505|FG001|Treatment Period|Withdrawal by Subject|1|||
16310853|NCT01125189|39623506|FG002|Treatment Period|Withdrawal by Subject|1|||
16310854|NCT01125189|39623504|FG000|Treatment Period|Death|1|||
16310855|NCT01125189|39623505|FG001|Treatment Period|Death|0|||
16310856|NCT01125189|39623506|FG002|Treatment Period|Death|0|||
16310857|NCT01125189|39623504|FG000|Treatment Period|Lost to Follow-up|1|||
16310858|NCT01125189|39623505|FG001|Treatment Period|Lost to Follow-up|2|||
16310859|NCT01125189|39623506|FG002|Treatment Period|Lost to Follow-up|1|||
16310860|NCT01125189|39623504|FG000|Treatment Period|Poor compliance/noncompliance|0|||
16310861|NCT01125189|39623505|FG001|Treatment Period|Poor compliance/noncompliance|1|||
16310862|NCT01125189|39623506|FG002|Treatment Period|Poor compliance/noncompliance|0|||
16310863|NCT01125189|39623504|FG000|Treatment Period|Participants requested to discontinue|1|||
16310864|NCT01125189|39623505|FG001|Treatment Period|Participants requested to discontinue|3|||
16310865|NCT01125189|39623506|FG002|Treatment Period|Participants requested to discontinue|4|||
16310866|NCT01125189|39623504|FG000|Treatment Period|Other reasons|1|||
16310867|NCT01125189|39623505|FG001|Treatment Period|Other reasons|1|||
16310868|NCT01125189|39623506|FG002|Treatment Period|Other reasons|0|||
16310869|NCT01125189|39623504|FG000|Treatment Period|Completed 24 week treatment period only|2|||
16310870|NCT01125189|39623505|FG001|Treatment Period|Completed 24 week treatment period only|1|||
16310871|NCT01125189|39623506|FG002|Treatment Period|Completed 24 week treatment period only|2|||
16310872|NCT01125189|39623504|FG000|Follow up Period|Withdrawal by Subject|3|||
16310873|NCT01125189|39623505|FG001|Follow up Period|Withdrawal by Subject|2|||
16310874|NCT01125189|39623506|FG002|Follow up Period|Withdrawal by Subject|5|||
16310875|NCT01125189|39623504|FG000|Follow up Period|Death|1|||
16310876|NCT01125189|39623505|FG001|Follow up Period|Death|0|||
16503802|NCT01536379|40318682|FG001|Overall Study|Withdrawal by Subject|1|||
16503803|NCT01148511|40318685|FG000|Exposed to Study Drug|Protocol Violation|2|||
16503804|NCT01148511|40318686|FG001|Exposed to Study Drug|Protocol Violation|0|||
16503805|NCT01148511|40318687|FG002|Exposed to Study Drug|Protocol Violation|0|||
16503806|NCT01148511|40318685|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
16503807|NCT01148511|40318686|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
16310877|NCT01125189|39623506|FG002|Follow up Period|Death|0|||
16310878|NCT01125189|39623504|FG000|Follow up Period|Lost to Follow-up|12|||
16310879|NCT01125189|39623505|FG001|Follow up Period|Lost to Follow-up|9|||
16503808|NCT01148511|40318687|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
16310880|NCT01125189|39623506|FG002|Follow up Period|Lost to Follow-up|6|||
16310881|NCT01125189|39623504|FG000|Follow up Period|Other reasons|4|||
16310882|NCT01125189|39623505|FG001|Follow up Period|Other reasons|4|||
16310883|NCT01125189|39623506|FG002|Follow up Period|Other reasons|5|||
16310884|NCT00979654|39623507|FG000|Overall Study|Lost to Follow-up|1|||
16310885|NCT00979654|39623507|FG000|Overall Study|Withdrawal by Subject|22|||
16310886|NCT00979654|39623507|FG000|Overall Study|Death|1|||
16310887|NCT00979654|39623507|FG000|Overall Study|Lack of Efficacy|6|||
16310888|NCT00979654|39623507|FG000|Overall Study|Adverse Event|1|||
16310889|NCT00979654|39623507|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
16310890|NCT00979654|39623507|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
16503809|NCT01148511|40318685|FG000|Randomized|Adverse Event|0|||
16503810|NCT01148511|40318686|FG001|Randomized|Adverse Event|1|||
16310891|NCT00979654|39623507|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
16503811|NCT01148511|40318687|FG002|Randomized|Adverse Event|0|||
16503812|NCT01148511|40318685|FG000|Randomized|Protocol Violation|0|||
16503813|NCT01148511|40318686|FG001|Randomized|Protocol Violation|2|||
16503814|NCT01148511|40318687|FG002|Randomized|Protocol Violation|1|||
16503815|NCT01148511|40318685|FG000|Randomized|Lost to Follow-up|0|||
16503816|NCT01148511|40318686|FG001|Randomized|Lost to Follow-up|1|||
16503817|NCT01148511|40318687|FG002|Randomized|Lost to Follow-up|1|||
16503818|NCT01148511|40318685|FG000|Randomized|Consent withdrawal|0|||
16503819|NCT01148511|40318686|FG001|Randomized|Consent withdrawal|5|||
16503820|NCT01148511|40318687|FG002|Randomized|Consent withdrawal|3|||
16310892|NCT00979654|39623507|FG000|Overall Study|Serious Adverse Event|1|||
16310893|NCT00979654|39623507|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
16310894|NCT01202175|39623508|FG000|Overall Study|Lost to Follow-up|2|||
16310895|NCT01202175|39623508|FG000|Overall Study|Withdrawal by Subject|1|||
16310896|NCT01202175|39623508|FG000|Overall Study|Adverse Event|2|||
16310897|NCT02505217|39623509|FG000|Overall Study|Withdrawal by Subject|1|||
16310898|NCT02505217|39623510|FG001|Overall Study|Withdrawal by Subject|2|||
16310899|NCT03896022|39623511|FG000|Overall Study|Withdrawal by Subject|1|||
16310900|NCT03896022|39623512|FG001|Overall Study|Withdrawal by Subject|0|||
16310901|NCT03896022|39623513|FG002|Overall Study|Withdrawal by Subject|0|||
16310902|NCT03896022|39623511|FG000|Overall Study|Did not have procedure|3|||
16310903|NCT03896022|39623512|FG001|Overall Study|Did not have procedure|0|||
16310904|NCT03896022|39623513|FG002|Overall Study|Did not have procedure|0|||
16310905|NCT04720105|39623514|FG000|Overall Study|Lack of Efficacy|1|||
16310906|NCT04720105|39623514|FG000|Overall Study|Lost to Follow-up|1|||
16310907|NCT04720105|39623514|FG000|Overall Study|Withdrawal by Subject|3|||
16310908|NCT02604407|39623515|FG000|Overall Study|Adverse Event|0|||
16310909|NCT02604407|39623516|FG001|Overall Study|Adverse Event|7|||
16310910|NCT02604407|39623517|FG002|Overall Study|Adverse Event|5|||
16310911|NCT02604407|39623515|FG000|Overall Study|Protocol Violation|2|||
16310912|NCT02604407|39623516|FG001|Overall Study|Protocol Violation|0|||
16310913|NCT02604407|39623517|FG002|Overall Study|Protocol Violation|0|||
16310914|NCT02604407|39623515|FG000|Overall Study|Withdrawal by Subject|3|||
16310915|NCT02604407|39623516|FG001|Overall Study|Withdrawal by Subject|3|||
16310916|NCT02604407|39623517|FG002|Overall Study|Withdrawal by Subject|5|||
16310917|NCT02604407|39623515|FG000|Overall Study|Lost to Follow-up|2|||
16195807|NCT00064350|39193429|FG001|Induction Treatment|Ineligible or never started treatment|6|||
16195808|NCT00064350|39193430|FG002|Induction Treatment|Ineligible or never started treatment|34|||
16310918|NCT02604407|39623516|FG001|Overall Study|Lost to Follow-up|1|||
16310919|NCT02604407|39623517|FG002|Overall Study|Lost to Follow-up|2|||
16310920|NCT02604407|39623515|FG000|Overall Study|Lack of Efficacy|1|||
16310921|NCT02604407|39623516|FG001|Overall Study|Lack of Efficacy|0|||
16503821|NCT01148511|40318685|FG000|Randomized|Other|0|||
16310922|NCT02604407|39623517|FG002|Overall Study|Lack of Efficacy|0|||
16310923|NCT02604407|39623515|FG000|Overall Study|Other|3|||
16310924|NCT02604407|39623516|FG001|Overall Study|Other|1|||
16310925|NCT02604407|39623517|FG002|Overall Study|Other|4|||
16310926|NCT00987337|39623518|FG000|Overall Study|Adverse Event|10|||
16310927|NCT00987337|39623519|FG001|Overall Study|Adverse Event|9|||
16310928|NCT00987337|39623520|FG002|Overall Study|Adverse Event|8|||
16310929|NCT00987337|39623518|FG000|Overall Study|Insufficient Virologic Response|10|||
16310930|NCT00987337|39623519|FG001|Overall Study|Insufficient Virologic Response|7|||
16310931|NCT00987337|39623520|FG002|Overall Study|Insufficient Virologic Response|12|||
16310932|NCT00987337|39623518|FG000|Overall Study|Virologic Breakthrough|2|||
16310933|NCT00987337|39623519|FG001|Overall Study|Virologic Breakthrough|2|||
16310934|NCT00987337|39623520|FG002|Overall Study|Virologic Breakthrough|8|||
16310935|NCT00987337|39623518|FG000|Overall Study|Lost to Follow-up|10|||
16310936|NCT00987337|39623519|FG001|Overall Study|Lost to Follow-up|6|||
16310937|NCT00987337|39623520|FG002|Overall Study|Lost to Follow-up|2|||
16310938|NCT00987337|39623518|FG000|Overall Study|Withdrawal by Subject|6|||
16310939|NCT00987337|39623519|FG001|Overall Study|Withdrawal by Subject|9|||
16310940|NCT00987337|39623520|FG002|Overall Study|Withdrawal by Subject|9|||
16310941|NCT00987337|39623518|FG000|Overall Study|Other|0|||
16310942|NCT00987337|39623519|FG001|Overall Study|Other|2|||
16310943|NCT00987337|39623520|FG002|Overall Study|Other|5|||
16310944|NCT00987337|39623518|FG000|Overall Study|Protocol Violation|1|||
16310945|NCT00987337|39623519|FG001|Overall Study|Protocol Violation|0|||
16310946|NCT00987337|39623520|FG002|Overall Study|Protocol Violation|2|||
16310947|NCT00987337|39623518|FG000|Overall Study|Participant Relapsed|18|||
16195809|NCT00064350|39193428|FG000|Induction Treatment|Other|0|||
16310948|NCT00987337|39623519|FG001|Overall Study|Participant Relapsed|20|||
16310949|NCT00987337|39623520|FG002|Overall Study|Participant Relapsed|5|||
16503822|NCT01148511|40318686|FG001|Randomized|Other|1|||
16503823|NCT01148511|40318687|FG002|Randomized|Other|1|||
16310950|NCT00942357|39623521|FG000|Overall Study|Ineligible|37|||
16503824|NCT01894581|40318698|FG000|Overall Study|Withdrawal by Subject|2|||
16503825|NCT01894581|40318699|FG001|Overall Study|Withdrawal by Subject|3|||
16503826|NCT01894581|40318698|FG000|Overall Study|Screen Failure|3|||
16503827|NCT01894581|40318699|FG001|Overall Study|Screen Failure|4|||
16503828|NCT00464568|40318702|FG000|Overall Study|Adverse Event|2|||
16503829|NCT02762266|40318703|FG000|Overall Study|Physician Decision|2|||
16503830|NCT02762266|40318704|FG001|Overall Study|Physician Decision|0|||
16503831|NCT00982488|40318705|FG000|Overall Study|Administrative reason by sponsor|81|||
16503832|NCT00982488|40318706|FG001|Overall Study|Administrative reason by sponsor|3|||
16503833|NCT00982488|40318707|FG002|Overall Study|Administrative reason by sponsor|11|||
16503834|NCT00982488|40318708|FG003|Overall Study|Administrative reason by sponsor|0|||
16503835|NCT00982488|40318709|FG004|Overall Study|Administrative reason by sponsor|0|||
16503836|NCT00982488|40318705|FG000|Overall Study|Adverse event unrelated to study drug|5|||
16503837|NCT00982488|40318706|FG001|Overall Study|Adverse event unrelated to study drug|1|||
16503838|NCT00982488|40318707|FG002|Overall Study|Adverse event unrelated to study drug|0|||
16089670|NCT01009645|38819966|FG002|Overall Study|Lost to Follow-up|4|||
16310951|NCT00942357|39623522|FG001|Overall Study|Ineligible|40|||
16310952|NCT00517881|39623523|FG000|Overall Study|Protocol Violation|2|||
16310953|NCT00517881|39623523|FG000|Overall Study|Adverse Event|1|||
16310954|NCT00517881|39623523|FG000|Overall Study|Renal transplantation|2|||
16310955|NCT01482312|39623526|FG000|Period 1, 90 Minutes of Wear|Other|1|||
16310956|NCT01482312|39623527|FG001|Period 1, 90 Minutes of Wear|Other|0|||
16310957|NCT01482312|39623528|FG002|Period 1, 90 Minutes of Wear|Other|0|||
16310958|NCT01482312|39623526|FG000|Period 2, 90 Minutes of Wear|Other|1|||
16310959|NCT01482312|39623527|FG001|Period 2, 90 Minutes of Wear|Other|0|||
16310960|NCT01482312|39623528|FG002|Period 2, 90 Minutes of Wear|Other|0|||
16310961|NCT02790437|39623529|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
16310962|NCT02790437|39623530|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
16310963|NCT02790437|39623529|FG000|Overall Study|Adverse Event|1|||
16310964|NCT02790437|39623530|FG001|Overall Study|Adverse Event|0|||
16310965|NCT02790437|39623529|FG000|Overall Study|Withdrawal by Subject|1|||
16310966|NCT02790437|39623530|FG001|Overall Study|Withdrawal by Subject|0|||
16310967|NCT02676882|39623531|FG000|Overall Study|Adverse Event|1|||
16310968|NCT02676882|39623532|FG001|Overall Study|Adverse Event|0|||
16310969|NCT02676882|39623531|FG000|Overall Study|Lost to Follow-up|1|||
16310970|NCT02676882|39623532|FG001|Overall Study|Lost to Follow-up|0|||
16310971|NCT02676882|39623531|FG000|Overall Study|Withdrawal by Subject|1|||
16310972|NCT02676882|39623532|FG001|Overall Study|Withdrawal by Subject|2|||
16310973|NCT03642262|39623536|FG000|Period 1|Withdrawal by Subject|1|||
16310974|NCT03642262|39623537|FG001|Period 1|Withdrawal by Subject|1|||
16310975|NCT03642262|39623536|FG000|Period 1|Adverse Event|0|||
16310976|NCT03642262|39623537|FG001|Period 1|Adverse Event|1|||
16310977|NCT05377749|39623540|FG000|3 Weeks|Lost to Follow-up|2|||
16310978|NCT05377749|39623541|FG001|3 Weeks|Lost to Follow-up|4|||
16310979|NCT05377749|39623540|FG000|3 Weeks|Withdrawal by Subject|1|||
16310980|NCT05377749|39623541|FG001|3 Weeks|Withdrawal by Subject|1|||
16310981|NCT04515147|39623542|FG000|Overall Study|Withdrawal by Subject|1|||
16310982|NCT04515147|39623543|FG001|Overall Study|Withdrawal by Subject|0|||
16310983|NCT04515147|39623544|FG002|Overall Study|Withdrawal by Subject|10|||
16310984|NCT04515147|39623545|FG003|Overall Study|Withdrawal by Subject|18|||
16310985|NCT04515147|39623546|FG004|Overall Study|Withdrawal by Subject|1|||
16310986|NCT04515147|39623547|FG005|Overall Study|Withdrawal by Subject|8|||
16310987|NCT04515147|39623542|FG000|Overall Study|Lost to Follow-up|0|||
16310988|NCT04515147|39623543|FG001|Overall Study|Lost to Follow-up|1|||
16310989|NCT04515147|39623544|FG002|Overall Study|Lost to Follow-up|5|||
16310990|NCT04515147|39623545|FG003|Overall Study|Lost to Follow-up|6|||
16310991|NCT04515147|39623546|FG004|Overall Study|Lost to Follow-up|2|||
16310992|NCT04515147|39623547|FG005|Overall Study|Lost to Follow-up|1|||
16310993|NCT04515147|39623542|FG000|Overall Study|Adverse Event|0|||
16310994|NCT04515147|39623543|FG001|Overall Study|Adverse Event|0|||
16310995|NCT04515147|39623544|FG002|Overall Study|Adverse Event|0|||
16310996|NCT04515147|39623545|FG003|Overall Study|Adverse Event|2|||
16310997|NCT04515147|39623546|FG004|Overall Study|Adverse Event|0|||
16310998|NCT04515147|39623547|FG005|Overall Study|Adverse Event|0|||
16310999|NCT04515147|39623542|FG000|Overall Study|Miscellaneous|0|||
16311000|NCT04515147|39623543|FG001|Overall Study|Miscellaneous|0|||
16311001|NCT04515147|39623544|FG002|Overall Study|Miscellaneous|0|||
16311002|NCT04515147|39623545|FG003|Overall Study|Miscellaneous|1|||
16311003|NCT04515147|39623546|FG004|Overall Study|Miscellaneous|0|||
16311004|NCT04515147|39623547|FG005|Overall Study|Miscellaneous|1|||
16311005|NCT01103180|39623548|FG000|Overall Study|Withdrawal by Subject|8|||
16311006|NCT01103180|39623549|FG001|Overall Study|Withdrawal by Subject|13|||
16311007|NCT01103180|39623548|FG000|Overall Study|Lost to Follow-up|13|||
16311008|NCT01103180|39623549|FG001|Overall Study|Lost to Follow-up|7|||
16311009|NCT01103180|39623548|FG000|Overall Study|Physician Decision|1|||
16311010|NCT01103180|39623549|FG001|Overall Study|Physician Decision|0|||
16311011|NCT01103180|39623548|FG000|Overall Study|Protocol Violation|0|||
16311012|NCT01103180|39623549|FG001|Overall Study|Protocol Violation|1|||
16503839|NCT00982488|40318708|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16503840|NCT00982488|40318709|FG004|Overall Study|Adverse event unrelated to study drug|0|||
16089671|NCT01009645|38819967|FG003|Overall Study|Lost to Follow-up|5|||
16089672|NCT00263757|38819970|FG000|Overall Study|Withdrawal by Subject|5|||
16089673|NCT00263757|38819971|FG001|Overall Study|Withdrawal by Subject|4|||
16089674|NCT00263757|38819970|FG000|Overall Study|Screen failure|0|||
16089675|NCT00263757|38819971|FG001|Overall Study|Screen failure|1|||
16089676|NCT00263757|38819970|FG000|Overall Study|Adverse Event|3|||
16089677|NCT00263757|38819971|FG001|Overall Study|Adverse Event|3|||
16089678|NCT00807599|38819972|FG000|Overall Study|Not treated on protocol study|0|||
16195810|NCT00064350|39193429|FG001|Induction Treatment|Other|0|||
16195811|NCT00064350|39193430|FG002|Induction Treatment|Other|13|||
16195812|NCT00064350|39193428|FG000|Randomization|Adverse Event|8|||
16195813|NCT00064350|39193429|FG001|Randomization|Adverse Event|3|||
16195814|NCT00064350|39193430|FG002|Randomization|Adverse Event|0|||
16195815|NCT00064350|39193428|FG000|Randomization|Death|3|||
16195816|NCT00064350|39193429|FG001|Randomization|Death|0|||
16195817|NCT00064350|39193430|FG002|Randomization|Death|0|||
16195818|NCT00064350|39193428|FG000|Randomization|Withdrawal by Subject|1|||
16195819|NCT00064350|39193429|FG001|Randomization|Withdrawal by Subject|0|||
16195820|NCT00064350|39193430|FG002|Randomization|Withdrawal by Subject|0|||
16195821|NCT00064350|39193428|FG000|Randomization|Ineligible or never started treatment|9|||
16195822|NCT00064350|39193429|FG001|Randomization|Ineligible or never started treatment|15|||
16195823|NCT00064350|39193430|FG002|Randomization|Ineligible or never started treatment|0|||
16195824|NCT00064350|39193428|FG000|Randomization|Other|5|||
16195825|NCT00064350|39193429|FG001|Randomization|Other|0|||
16195826|NCT00064350|39193430|FG002|Randomization|Other|0|||
16195827|NCT00064350|39193428|FG000|Cross-Over|Adverse Event|0|||
16195828|NCT00064350|39193429|FG001|Cross-Over|Adverse Event|1|||
16195829|NCT00064350|39193430|FG002|Cross-Over|Adverse Event|0|||
16195830|NCT00064350|39193428|FG000|Cross-Over|Death|1|||
16195831|NCT00064350|39193429|FG001|Cross-Over|Death|3|||
16195832|NCT00064350|39193430|FG002|Cross-Over|Death|0|||
16195833|NCT00064350|39193428|FG000|Cross-Over|Withdrawal by Subject|2|||
16195834|NCT00064350|39193429|FG001|Cross-Over|Withdrawal by Subject|2|||
16195835|NCT00064350|39193430|FG002|Cross-Over|Withdrawal by Subject|0|||
16195836|NCT00064350|39193428|FG000|Cross-Over|Ineligible or never started treatment|3|||
16195837|NCT00064350|39193429|FG001|Cross-Over|Ineligible or never started treatment|6|||
16195838|NCT00064350|39193430|FG002|Cross-Over|Ineligible or never started treatment|0|||
16195839|NCT00064350|39193428|FG000|Cross-Over|Other|0|||
16195840|NCT00064350|39193429|FG001|Cross-Over|Other|2|||
16311013|NCT01330303|39623550|FG000|Period 1|Adverse Event|1|||
16089679|NCT00807599|38819973|FG001|Overall Study|Not treated on protocol study|0|||
16195841|NCT00064350|39193430|FG002|Cross-Over|Other|0|||
16195842|NCT02678741|39193433|FG000|Overall Study|Death|4|||
16195843|NCT02678741|39193433|FG000|Overall Study|Withdrawal by Subject|1|||
16195844|NCT02678741|39193433|FG000|Overall Study|ineligible|3|||
16195845|NCT02678741|39193433|FG000|Overall Study|Not RECIST Measurable|2|||
16195846|NCT02678741|39193433|FG000|Overall Study|Lack of Efficacy|10|||
16195847|NCT00980343|39193439|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
16089680|NCT00807599|38819974|FG002|Overall Study|Not treated on protocol study|2|||
16089681|NCT00807599|38819972|FG000|Overall Study|Adverse Event|0|||
16089682|NCT00807599|38819973|FG001|Overall Study|Adverse Event|0|||
16089683|NCT00807599|38819974|FG002|Overall Study|Adverse Event|5|||
16089684|NCT00807599|38819972|FG000|Overall Study|Inadequate response to induction|0|||
16089685|NCT00807599|38819973|FG001|Overall Study|Inadequate response to induction|0|||
16311014|NCT01330303|39623551|FG001|Period 1|Adverse Event|0|||
16311015|NCT01330303|39623550|FG000|Period 1|Protocol Violation|0|||
16311016|NCT01330303|39623551|FG001|Period 1|Protocol Violation|1|||
16311017|NCT01330303|39623550|FG000|Period 1|Withdrawal by Subject|0|||
16311018|NCT01330303|39623551|FG001|Period 1|Withdrawal by Subject|1|||
16311019|NCT00450437|39623555|FG000|Overall Study|Withdrawal by Subject|10|||
16311020|NCT00450437|39623556|FG001|Overall Study|Withdrawal by Subject|2|||
16311021|NCT00450437|39623557|FG002|Overall Study|Withdrawal by Subject|0|||
16311022|NCT00450437|39623558|FG003|Overall Study|Withdrawal by Subject|1|||
16311023|NCT00450437|39623555|FG000|Overall Study|Lost to Follow-up|31|||
16311024|NCT00450437|39623556|FG001|Overall Study|Lost to Follow-up|12|||
16311025|NCT00450437|39623557|FG002|Overall Study|Lost to Follow-up|19|||
16311026|NCT00450437|39623558|FG003|Overall Study|Lost to Follow-up|9|||
16311027|NCT00450437|39623555|FG000|Overall Study|Protocol Violation|0|||
16311028|NCT00450437|39623556|FG001|Overall Study|Protocol Violation|1|||
16311029|NCT00450437|39623557|FG002|Overall Study|Protocol Violation|0|||
16089686|NCT00807599|38819974|FG002|Overall Study|Inadequate response to induction|9|||
16089687|NCT00807599|38819972|FG000|Overall Study|Withdrawal by Subject|0|||
16089688|NCT00807599|38819973|FG001|Overall Study|Withdrawal by Subject|0|||
16089689|NCT00807599|38819974|FG002|Overall Study|Withdrawal by Subject|1|||
16089690|NCT00824408|38819975|FG000|Run-in Phase|Progressive disease|4|||
16089691|NCT00824408|38819976|FG001|Run-in Phase|Progressive disease|4|||
16089692|NCT00824408|38819977|FG002|Run-in Phase|Progressive disease|0|||
16089693|NCT00824408|38819978|FG003|Run-in Phase|Progressive disease|0|||
16089694|NCT00824408|38819979|FG004|Run-in Phase|Progressive disease|0|||
16089695|NCT00824408|38819975|FG000|Run-in Phase|Adverse Event|1|||
16089696|NCT00824408|38819976|FG001|Run-in Phase|Adverse Event|1|||
16089697|NCT00824408|38819977|FG002|Run-in Phase|Adverse Event|0|||
16089698|NCT00824408|38819978|FG003|Run-in Phase|Adverse Event|0|||
16089699|NCT00824408|38819979|FG004|Run-in Phase|Adverse Event|0|||
16089700|NCT00824408|38819975|FG000|Run-in Phase|Refused to continue medication|1|||
16089701|NCT00824408|38819976|FG001|Run-in Phase|Refused to continue medication|0|||
16089702|NCT00824408|38819977|FG002|Run-in Phase|Refused to continue medication|0|||
16089703|NCT00824408|38819978|FG003|Run-in Phase|Refused to continue medication|0|||
16089704|NCT00824408|38819979|FG004|Run-in Phase|Refused to continue medication|0|||
16089705|NCT00824408|38819975|FG000|Run-in Phase|Other reason not defined above|0|||
16089706|NCT00824408|38819976|FG001|Run-in Phase|Other reason not defined above|1|||
16089707|NCT00824408|38819977|FG002|Run-in Phase|Other reason not defined above|0|||
16089708|NCT00824408|38819978|FG003|Run-in Phase|Other reason not defined above|0|||
16089709|NCT00824408|38819979|FG004|Run-in Phase|Other reason not defined above|0|||
16089710|NCT00824408|38819975|FG000|Randomized Phase|Not treated|0|||
16311030|NCT00450437|39623558|FG003|Overall Study|Protocol Violation|1|||
16311031|NCT00450437|39623555|FG000|Overall Study|Inappropriate enrollment|4|||
16311032|NCT00450437|39623556|FG001|Overall Study|Inappropriate enrollment|1|||
16503841|NCT00982488|40318705|FG000|Overall Study|Death|11|||
16503842|NCT00982488|40318706|FG001|Overall Study|Death|0|||
16503843|NCT00982488|40318707|FG002|Overall Study|Death|2|||
16503844|NCT00982488|40318708|FG003|Overall Study|Death|0|||
16503845|NCT00982488|40318709|FG004|Overall Study|Death|0|||
16503846|NCT00982488|40318705|FG000|Overall Study|Disease progression|30|||
16503847|NCT00982488|40318706|FG001|Overall Study|Disease progression|5|||
16503848|NCT00982488|40318707|FG002|Overall Study|Disease progression|10|||
16503849|NCT00982488|40318708|FG003|Overall Study|Disease progression|1|||
16503850|NCT00982488|40318709|FG004|Overall Study|Disease progression|1|||
16503851|NCT00982488|40318705|FG000|Overall Study|Lost to Follow-up|1|||
16503852|NCT00982488|40318706|FG001|Overall Study|Lost to Follow-up|0|||
16503853|NCT00982488|40318707|FG002|Overall Study|Lost to Follow-up|0|||
16503854|NCT00982488|40318708|FG003|Overall Study|Lost to Follow-up|0|||
16503855|NCT00982488|40318709|FG004|Overall Study|Lost to Follow-up|0|||
16503856|NCT00982488|40318705|FG000|Overall Study|Maximum clinical benefit|1|||
16503857|NCT00982488|40318706|FG001|Overall Study|Maximum clinical benefit|1|||
16503858|NCT00982488|40318707|FG002|Overall Study|Maximum clinical benefit|1|||
16503859|NCT00982488|40318708|FG003|Overall Study|Maximum clinical benefit|0|||
16503860|NCT00982488|40318709|FG004|Overall Study|Maximum clinical benefit|0|||
16503861|NCT00982488|40318705|FG000|Overall Study|Other|15|||
16503862|NCT00982488|40318706|FG001|Overall Study|Other|1|||
16503863|NCT00982488|40318707|FG002|Overall Study|Other|3|||
16503864|NCT00982488|40318708|FG003|Overall Study|Other|1|||
16503865|NCT00982488|40318709|FG004|Overall Study|Other|0|||
16503866|NCT00982488|40318705|FG000|Overall Study|Poor compliance/noncompliance|0|||
16503867|NCT00982488|40318706|FG001|Overall Study|Poor compliance/noncompliance|1|||
16503868|NCT00982488|40318707|FG002|Overall Study|Poor compliance/noncompliance|0|||
16503869|NCT00982488|40318708|FG003|Overall Study|Poor compliance/noncompliance|0|||
16503870|NCT00982488|40318709|FG004|Overall Study|Poor compliance/noncompliance|0|||
16503871|NCT00982488|40318705|FG000|Overall Study|Stem cell transplant|2|||
16503872|NCT00982488|40318706|FG001|Overall Study|Stem cell transplant|0|||
16503873|NCT00982488|40318707|FG002|Overall Study|Stem cell transplant|0|||
16503874|NCT00982488|40318708|FG003|Overall Study|Stem cell transplant|1|||
16503875|NCT00982488|40318709|FG004|Overall Study|Stem cell transplant|0|||
16503876|NCT00982488|40318705|FG000|Overall Study|Study drug toxicity|34|||
16503877|NCT00982488|40318706|FG001|Overall Study|Study drug toxicity|1|||
16503878|NCT00982488|40318707|FG002|Overall Study|Study drug toxicity|6|||
16503879|NCT00982488|40318708|FG003|Overall Study|Study drug toxicity|0|||
16503880|NCT00982488|40318709|FG004|Overall Study|Study drug toxicity|0|||
16503881|NCT00982488|40318705|FG000|Overall Study|Withdrawal by Subject|5|||
16503882|NCT00982488|40318706|FG001|Overall Study|Withdrawal by Subject|1|||
16503883|NCT00982488|40318707|FG002|Overall Study|Withdrawal by Subject|1|||
16503884|NCT00982488|40318708|FG003|Overall Study|Withdrawal by Subject|0|||
16503885|NCT00982488|40318709|FG004|Overall Study|Withdrawal by Subject|0|||
16503886|NCT00651755|40318713|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
16503887|NCT00651755|40318714|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
16503888|NCT00651755|40318713|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
16503889|NCT00651755|40318714|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
16089711|NCT00824408|38819976|FG001|Randomized Phase|Not treated|0|||
16089712|NCT00824408|38819977|FG002|Randomized Phase|Not treated|1|||
16089713|NCT00824408|38819978|FG003|Randomized Phase|Not treated|1|||
16089714|NCT00824408|38819979|FG004|Randomized Phase|Not treated|1|||
16089715|NCT00824408|38819975|FG000|Randomized Phase|Progressive disease|0|||
16089716|NCT00824408|38819976|FG001|Randomized Phase|Progressive disease|0|||
16089717|NCT00824408|38819977|FG002|Randomized Phase|Progressive disease|25|||
16089718|NCT00824408|38819978|FG003|Randomized Phase|Progressive disease|36|||
16089719|NCT00824408|38819979|FG004|Randomized Phase|Progressive disease|34|||
16089720|NCT00824408|38819975|FG000|Randomized Phase|Adverse Event|0|||
16089721|NCT00824408|38819976|FG001|Randomized Phase|Adverse Event|0|||
16089722|NCT00824408|38819977|FG002|Randomized Phase|Adverse Event|4|||
16089723|NCT00824408|38819978|FG003|Randomized Phase|Adverse Event|5|||
16089724|NCT00824408|38819979|FG004|Randomized Phase|Adverse Event|5|||
16089725|NCT00824408|38819975|FG000|Randomized Phase|Refused to continue medication|0|||
16089726|NCT00824408|38819976|FG001|Randomized Phase|Refused to continue medication|0|||
16089727|NCT00824408|38819977|FG002|Randomized Phase|Refused to continue medication|2|||
16089728|NCT00824408|38819978|FG003|Randomized Phase|Refused to continue medication|2|||
16195848|NCT00980343|39193440|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
16195849|NCT01623531|39193444|FG000|Overall Study|Death|1|||
16195850|NCT01623531|39193445|FG001|Overall Study|Death|0|||
16195851|NCT01623531|39193444|FG000|Overall Study|Protocol Violation|2|||
16503890|NCT02016482|40318715|FG000|Period A|Adverse Event|3|||
16503891|NCT02016482|40318716|FG001|Period A|Adverse Event|5|||
16089729|NCT00824408|38819979|FG004|Randomized Phase|Refused to continue medication|2|||
16089730|NCT00824408|38819975|FG000|Randomized Phase|Other reason not defined above|0|||
16195852|NCT01623531|39193445|FG001|Overall Study|Protocol Violation|1|||
16195853|NCT01623531|39193444|FG000|Overall Study|Missing data at primary outcome time poi|1|||
16195854|NCT01623531|39193445|FG001|Overall Study|Missing data at primary outcome time poi|1|||
16195855|NCT01885078|39193446|FG000|Treatment Period|Adverse Event|52|||
16195856|NCT01885078|39193447|FG001|Treatment Period|Adverse Event|136|||
16195857|NCT01885078|39193448|FG002|Treatment Period|Adverse Event|30|||
16195858|NCT01885078|39193449|FG003|Treatment Period|Adverse Event|73|||
16089731|NCT00824408|38819976|FG001|Randomized Phase|Other reason not defined above|0|||
16089732|NCT00824408|38819977|FG002|Randomized Phase|Other reason not defined above|4|||
16195859|NCT01885078|39193450|FG004|Treatment Period|Adverse Event|17|||
16195860|NCT01885078|39193451|FG005|Treatment Period|Adverse Event|72|||
16195861|NCT01885078|39193452|FG006|Treatment Period|Adverse Event|24|||
16195862|NCT01885078|39193453|FG007|Treatment Period|Adverse Event|5|||
16195863|NCT01885078|39193454|FG008|Treatment Period|Adverse Event|0|||
16195864|NCT01885078|39193455|FG009|Treatment Period|Adverse Event|0|||
16195865|NCT01885078|39193446|FG000|Treatment Period|Death|13|||
16195866|NCT01885078|39193447|FG001|Treatment Period|Death|33|||
16311033|NCT00450437|39623557|FG002|Overall Study|Inappropriate enrollment|3|||
16311034|NCT00450437|39623558|FG003|Overall Study|Inappropriate enrollment|0|||
16311035|NCT00450437|39623555|FG000|Overall Study|Administrative reason|0|||
16311036|NCT00450437|39623556|FG001|Overall Study|Administrative reason|0|||
16311037|NCT00450437|39623557|FG002|Overall Study|Administrative reason|1|||
16311038|NCT00450437|39623558|FG003|Overall Study|Administrative reason|0|||
16311039|NCT00450437|39623555|FG000|Overall Study|Unable to Classify|1|||
16311040|NCT00450437|39623556|FG001|Overall Study|Unable to Classify|0|||
16311041|NCT00450437|39623557|FG002|Overall Study|Unable to Classify|1|||
16311042|NCT00450437|39623558|FG003|Overall Study|Unable to Classify|0|||
16311043|NCT04982575|39623559|FG000|Overall Study|Withdrawal by Subject|2|||
16311044|NCT04982575|39623560|FG001|Overall Study|Withdrawal by Subject|0|||
16311045|NCT04982575|39623561|FG002|Overall Study|Withdrawal by Subject|2|||
16311046|NCT03170544|39623566|FG000|Part 1|Lost to Follow-up|1|||
16311047|NCT03170544|39623567|FG001|Part 1|Lost to Follow-up|0|||
16311048|NCT03170544|39623568|FG002|Part 1|Lost to Follow-up|0|||
16311049|NCT03170544|39623569|FG003|Part 1|Lost to Follow-up|0|||
16311050|NCT03170544|39623570|FG004|Part 1|Lost to Follow-up|0|||
16311051|NCT03170544|39623571|FG005|Part 1|Lost to Follow-up|0|||
16311052|NCT03170544|39623572|FG006|Part 1|Lost to Follow-up|0|||
16311053|NCT03170544|39623573|FG007|Part 1|Lost to Follow-up|0|||
16311054|NCT03170544|39623574|FG008|Part 1|Lost to Follow-up|0|||
16311055|NCT03170544|39623575|FG009|Part 1|Lost to Follow-up|0|||
16311056|NCT03170544|39623576|FG010|Part 1|Lost to Follow-up|0|||
16311057|NCT03170544|39623577|FG011|Part 1|Lost to Follow-up|0|||
16311058|NCT03170544|39623566|FG000|Part 1|Not treated|0|||
16503892|NCT02016482|40318715|FG000|Period A|Withdrawal by Subject|3|||
16089733|NCT00824408|38819978|FG003|Randomized Phase|Other reason not defined above|2|||
16089734|NCT00824408|38819979|FG004|Randomized Phase|Other reason not defined above|4|||
16089735|NCT00670488|38819980|FG000|Overall Study|Adverse Event|0|||
16503893|NCT02016482|40318716|FG001|Period A|Withdrawal by Subject|4|||
16089736|NCT00670488|38819981|FG001|Overall Study|Adverse Event|7|||
16195867|NCT01885078|39193448|FG002|Treatment Period|Death|5|||
16195868|NCT01885078|39193449|FG003|Treatment Period|Death|9|||
16311059|NCT03170544|39623567|FG001|Part 1|Not treated|0|||
16311060|NCT03170544|39623568|FG002|Part 1|Not treated|0|||
16503894|NCT02016482|40318715|FG000|Period A|Lost to Follow-up|3|||
16503895|NCT02016482|40318716|FG001|Period A|Lost to Follow-up|3|||
16503896|NCT02016482|40318715|FG000|Period A|Lack of Efficacy|2|||
16503897|NCT02016482|40318716|FG001|Period A|Lack of Efficacy|1|||
16503898|NCT02016482|40318715|FG000|Period A|Other|3|||
16503899|NCT02016482|40318716|FG001|Period A|Other|0|||
16503900|NCT02016482|40318715|FG000|Period A|Protocol Violation|0|||
16503901|NCT02016482|40318716|FG001|Period A|Protocol Violation|1|||
16503902|NCT02016482|40318715|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
16503903|NCT02016482|40318716|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
16503904|NCT02016482|40318715|FG000|Period B|Withdrawal by Subject|1|||
16503905|NCT02016482|40318716|FG001|Period B|Withdrawal by Subject|1|||
16503906|NCT02016482|40318715|FG000|Period B|Lost to Follow-up|2|||
16503907|NCT02016482|40318716|FG001|Period B|Lost to Follow-up|0|||
16503908|NCT02016482|40318715|FG000|Period B|Lack of Efficacy|6|||
16503909|NCT02016482|40318716|FG001|Period B|Lack of Efficacy|4|||
16503910|NCT02016482|40318715|FG000|Period B|Other|4|||
16503911|NCT02016482|40318716|FG001|Period B|Other|0|||
16503912|NCT02016482|40318715|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
16503913|NCT02016482|40318716|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
16503914|NCT03989440|40318722|FG000|Overall Study|COVID-19 travel restrictions|0|||
16503915|NCT03989440|40318723|FG001|Overall Study|COVID-19 travel restrictions|0|||
16503916|NCT03989440|40318724|FG002|Overall Study|COVID-19 travel restrictions|1|||
16503917|NCT03989440|40318725|FG003|Overall Study|COVID-19 travel restrictions|0|||
16503918|NCT03989440|40318726|FG004|Overall Study|COVID-19 travel restrictions|0|||
16503919|NCT03989440|40318727|FG005|Overall Study|COVID-19 travel restrictions|0|||
16503920|NCT03989440|40318722|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
16503921|NCT03989440|40318723|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
16503922|NCT03989440|40318724|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
16503923|NCT03989440|40318725|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
16503924|NCT03989440|40318726|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
16503925|NCT03989440|40318727|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
16503926|NCT02788981|40318728|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
16503927|NCT02788981|40318729|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
16503928|NCT00227305|40318730|FG000|Overall Study|Adverse Event|40|||
16503929|NCT00227305|40318730|FG000|Overall Study|Withdrawal by Subject|42|||
16503930|NCT00227305|40318730|FG000|Overall Study|Lost to Follow-up|33|||
16503931|NCT00227305|40318730|FG000|Overall Study|Study specific discontinuation|13|||
16503932|NCT00227305|40318730|FG000|Overall Study|MOVED OUT OF AREA|3|||
16503933|NCT00227305|40318730|FG000|Overall Study|Lack of Efficacy|7|||
16503934|NCT00227305|40318730|FG000|Overall Study|Physician Decision|3|||
16503935|NCT00227305|40318730|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
16503936|NCT00227305|40318730|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
16503937|NCT00227305|40318730|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
16503938|NCT03131440|40318733|FG000|Overall Study|Withdrawal by Subject|1|||
16503939|NCT03131440|40318734|FG001|Overall Study|Withdrawal by Subject|3|||
16503940|NCT03131440|40318735|FG002|Overall Study|Withdrawal by Subject|0|||
16503941|NCT03131440|40318736|FG003|Overall Study|Withdrawal by Subject|0|||
16503942|NCT03131440|40318737|FG004|Overall Study|Withdrawal by Subject|1|||
16503943|NCT03131440|40318738|FG005|Overall Study|Withdrawal by Subject|0|||
16503944|NCT03131440|40318739|FG006|Overall Study|Withdrawal by Subject|0|||
16503945|NCT03131440|40318740|FG007|Overall Study|Withdrawal by Subject|1|||
16503946|NCT03131440|40318741|FG008|Overall Study|Withdrawal by Subject|1|||
16503947|NCT03131440|40318742|FG009|Overall Study|Withdrawal by Subject|1|||
16503948|NCT03131440|40318743|FG010|Overall Study|Withdrawal by Subject|0|||
16503949|NCT03131440|40318744|FG011|Overall Study|Withdrawal by Subject|1|||
16503950|NCT03131440|40318745|FG012|Overall Study|Withdrawal by Subject|1|||
16503951|NCT03131440|40318746|FG013|Overall Study|Withdrawal by Subject|0|||
16503952|NCT03131440|40318747|FG014|Overall Study|Withdrawal by Subject|1|||
16503953|NCT03131440|40318748|FG015|Overall Study|Withdrawal by Subject|0|||
16503954|NCT03131440|40318749|FG016|Overall Study|Withdrawal by Subject|0|||
16503955|NCT03131440|40318750|FG017|Overall Study|Withdrawal by Subject|0|||
16503956|NCT03131440|40318751|FG018|Overall Study|Withdrawal by Subject|1|||
16503957|NCT03131440|40318752|FG019|Overall Study|Withdrawal by Subject|0|||
16503958|NCT03131440|40318753|FG020|Overall Study|Withdrawal by Subject|1|||
16503959|NCT03131440|40318754|FG021|Overall Study|Withdrawal by Subject|1|||
16503960|NCT03131440|40318755|FG022|Overall Study|Withdrawal by Subject|1|||
16390373|NCT01135992|39912057|FG000|Overall Study|Withdrawal criteria|10|||
16390374|NCT01135992|39912057|FG000|Overall Study|Unclassified|7|||
16390375|NCT00955474|39912058|FG000|Overall Study|Physician Decision|7|||
16390376|NCT00955474|39912059|FG001|Overall Study|Physician Decision|5|||
16390377|NCT04749745|39912060|FG000|Overall Study|Withdrawal by Subject|1|||
16390378|NCT04749745|39912061|FG001|Overall Study|Withdrawal by Subject|0|||
16503961|NCT03131440|40318756|FG023|Overall Study|Withdrawal by Subject|0|||
16503962|NCT03131440|40318757|FG024|Overall Study|Withdrawal by Subject|0|||
16503963|NCT03131440|40318758|FG025|Overall Study|Withdrawal by Subject|0|||
16503964|NCT03131440|40318759|FG026|Overall Study|Withdrawal by Subject|0|||
16503965|NCT03131440|40318760|FG027|Overall Study|Withdrawal by Subject|0|||
16503966|NCT03131440|40318761|FG028|Overall Study|Withdrawal by Subject|0|||
16503967|NCT03131440|40318762|FG029|Overall Study|Withdrawal by Subject|0|||
16503968|NCT03131440|40318763|FG030|Overall Study|Withdrawal by Subject|1|||
16503969|NCT03131440|40318764|FG031|Overall Study|Withdrawal by Subject|0|||
16503970|NCT03131440|40318733|FG000|Overall Study|Lost to Follow-up|0|||
16503971|NCT03131440|40318734|FG001|Overall Study|Lost to Follow-up|0|||
16503972|NCT03131440|40318735|FG002|Overall Study|Lost to Follow-up|0|||
16503973|NCT03131440|40318736|FG003|Overall Study|Lost to Follow-up|0|||
16503974|NCT03131440|40318737|FG004|Overall Study|Lost to Follow-up|0|||
16503975|NCT03131440|40318738|FG005|Overall Study|Lost to Follow-up|1|||
16503976|NCT03131440|40318739|FG006|Overall Study|Lost to Follow-up|0|||
16503977|NCT03131440|40318740|FG007|Overall Study|Lost to Follow-up|0|||
16503978|NCT03131440|40318741|FG008|Overall Study|Lost to Follow-up|0|||
16503979|NCT03131440|40318742|FG009|Overall Study|Lost to Follow-up|0|||
16503980|NCT03131440|40318743|FG010|Overall Study|Lost to Follow-up|0|||
16503981|NCT03131440|40318744|FG011|Overall Study|Lost to Follow-up|0|||
16503982|NCT03131440|40318745|FG012|Overall Study|Lost to Follow-up|0|||
16503983|NCT03131440|40318746|FG013|Overall Study|Lost to Follow-up|0|||
16503984|NCT03131440|40318747|FG014|Overall Study|Lost to Follow-up|0|||
16503985|NCT03131440|40318748|FG015|Overall Study|Lost to Follow-up|0|||
16503986|NCT03131440|40318749|FG016|Overall Study|Lost to Follow-up|0|||
16503987|NCT03131440|40318750|FG017|Overall Study|Lost to Follow-up|0|||
16503988|NCT03131440|40318751|FG018|Overall Study|Lost to Follow-up|0|||
16503989|NCT03131440|40318752|FG019|Overall Study|Lost to Follow-up|2|||
16503990|NCT03131440|40318753|FG020|Overall Study|Lost to Follow-up|1|||
16503991|NCT03131440|40318754|FG021|Overall Study|Lost to Follow-up|0|||
16503992|NCT03131440|40318755|FG022|Overall Study|Lost to Follow-up|1|||
16503993|NCT03131440|40318756|FG023|Overall Study|Lost to Follow-up|0|||
16503994|NCT03131440|40318757|FG024|Overall Study|Lost to Follow-up|1|||
16311061|NCT03170544|39623569|FG003|Part 1|Not treated|1|||
16311062|NCT03170544|39623570|FG004|Part 1|Not treated|0|||
16311063|NCT03170544|39623571|FG005|Part 1|Not treated|0|||
16311064|NCT03170544|39623572|FG006|Part 1|Not treated|0|||
16311065|NCT03170544|39623573|FG007|Part 1|Not treated|0|||
16311066|NCT03170544|39623574|FG008|Part 1|Not treated|0|||
16311067|NCT03170544|39623575|FG009|Part 1|Not treated|0|||
16311068|NCT03170544|39623576|FG010|Part 1|Not treated|0|||
16311069|NCT03170544|39623577|FG011|Part 1|Not treated|0|||
16311070|NCT02207634|39623582|FG000|Overall Study|Withdrawal by Subject|21|||
16311071|NCT02207634|39623583|FG001|Overall Study|Withdrawal by Subject|31|||
16311072|NCT02207634|39623582|FG000|Overall Study|Lost to Follow-up|1|||
16311073|NCT02207634|39623583|FG001|Overall Study|Lost to Follow-up|0|||
16311074|NCT02069015|39623584|FG000|Overall Study|Lost to Follow-up|39|||
16311075|NCT02069015|39623585|FG001|Overall Study|Lost to Follow-up|32|||
16311076|NCT02069015|39623584|FG000|Overall Study|Withdrawal by Subject|1|||
16311077|NCT02069015|39623585|FG001|Overall Study|Withdrawal by Subject|1|||
16311078|NCT01622673|39623586|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16311079|NCT01622673|39623587|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16311080|NCT01622673|39623588|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16311081|NCT01622673|39623589|FG003|Treatment Period 1|Withdrawal by Subject|1|||
16311082|NCT01622673|39623590|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16311083|NCT01622673|39623591|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16311084|NCT01622673|39623586|FG000|Treatment Period 1|Protocol Violation|0|||
16311085|NCT01622673|39623587|FG001|Treatment Period 1|Protocol Violation|1|||
16311086|NCT01622673|39623588|FG002|Treatment Period 1|Protocol Violation|0|||
16311087|NCT01622673|39623589|FG003|Treatment Period 1|Protocol Violation|0|||
16311088|NCT01622673|39623590|FG004|Treatment Period 1|Protocol Violation|0|||
16311089|NCT01622673|39623591|FG005|Treatment Period 1|Protocol Violation|0|||
16311090|NCT01622673|39623586|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16311091|NCT01622673|39623587|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16311092|NCT01622673|39623588|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16311093|NCT01622673|39623589|FG003|Treatment Period 2|Withdrawal by Subject|1|||
16311094|NCT01622673|39623590|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16311095|NCT01622673|39623591|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16311096|NCT01622673|39623586|FG000|Treatment Period 3|Protocol Violation|0|||
16503995|NCT03131440|40318758|FG025|Overall Study|Lost to Follow-up|0|||
16089737|NCT00670488|38819982|FG002|Overall Study|Adverse Event|0|||
16311097|NCT01622673|39623587|FG001|Treatment Period 3|Protocol Violation|1|||
16311098|NCT01622673|39623588|FG002|Treatment Period 3|Protocol Violation|0|||
16311099|NCT01622673|39623589|FG003|Treatment Period 3|Protocol Violation|0|||
16311100|NCT01622673|39623590|FG004|Treatment Period 3|Protocol Violation|0|||
16311101|NCT01622673|39623591|FG005|Treatment Period 3|Protocol Violation|0|||
16503996|NCT03131440|40318759|FG026|Overall Study|Lost to Follow-up|0|||
16503997|NCT03131440|40318760|FG027|Overall Study|Lost to Follow-up|2|||
16503998|NCT03131440|40318761|FG028|Overall Study|Lost to Follow-up|0|||
16503999|NCT03131440|40318762|FG029|Overall Study|Lost to Follow-up|2|||
16504000|NCT03131440|40318763|FG030|Overall Study|Lost to Follow-up|0|||
16504001|NCT03131440|40318764|FG031|Overall Study|Lost to Follow-up|0|||
16504002|NCT03131440|40318733|FG000|Overall Study|Death|0|||
16504003|NCT03131440|40318734|FG001|Overall Study|Death|0|||
16504004|NCT03131440|40318735|FG002|Overall Study|Death|0|||
16504005|NCT03131440|40318736|FG003|Overall Study|Death|0|||
16504006|NCT03131440|40318737|FG004|Overall Study|Death|0|||
16504007|NCT03131440|40318738|FG005|Overall Study|Death|0|||
16504008|NCT03131440|40318739|FG006|Overall Study|Death|0|||
16504009|NCT03131440|40318740|FG007|Overall Study|Death|0|||
16504010|NCT03131440|40318741|FG008|Overall Study|Death|0|||
16504011|NCT03131440|40318742|FG009|Overall Study|Death|0|||
16504012|NCT03131440|40318743|FG010|Overall Study|Death|0|||
16504013|NCT03131440|40318744|FG011|Overall Study|Death|0|||
16504014|NCT03131440|40318745|FG012|Overall Study|Death|0|||
16504015|NCT03131440|40318746|FG013|Overall Study|Death|0|||
16504016|NCT03131440|40318747|FG014|Overall Study|Death|0|||
16504017|NCT03131440|40318748|FG015|Overall Study|Death|0|||
16504018|NCT03131440|40318749|FG016|Overall Study|Death|0|||
16504019|NCT03131440|40318750|FG017|Overall Study|Death|0|||
16504020|NCT03131440|40318751|FG018|Overall Study|Death|0|||
16504021|NCT03131440|40318752|FG019|Overall Study|Death|0|||
16504022|NCT03131440|40318753|FG020|Overall Study|Death|0|||
16504023|NCT03131440|40318754|FG021|Overall Study|Death|0|||
16504024|NCT03131440|40318755|FG022|Overall Study|Death|0|||
16504025|NCT03131440|40318756|FG023|Overall Study|Death|0|||
16504026|NCT03131440|40318757|FG024|Overall Study|Death|0|||
16504027|NCT03131440|40318758|FG025|Overall Study|Death|1|||
16504028|NCT03131440|40318759|FG026|Overall Study|Death|0|||
16504029|NCT03131440|40318760|FG027|Overall Study|Death|0|||
16504030|NCT03131440|40318761|FG028|Overall Study|Death|0|||
16504031|NCT03131440|40318762|FG029|Overall Study|Death|0|||
16504032|NCT03131440|40318763|FG030|Overall Study|Death|0|||
16504033|NCT03131440|40318764|FG031|Overall Study|Death|0|||
16504034|NCT00415909|40318765|FG000|Overall Study|Withdrawal by Subject|2|||
16504035|NCT00415909|40318765|FG000|Overall Study|Death|1|||
16504036|NCT03406858|40318770|FG000|Overall Study|Failure to receive treatment drug.|1|||
16504037|NCT03406858|40318770|FG000|Overall Study|ineligible|1|||
16504038|NCT00736723|40318773|FG000|Overall Study|Withdrawal by Subject|4|||
16504039|NCT00736723|40318774|FG001|Overall Study|Withdrawal by Subject|3|||
16504040|NCT01266460|40318775|FG000|Overall Study|Adverse Event|3|||
16504041|NCT01266460|40318775|FG000|Overall Study|Withdrawal by Subject|5|||
16504042|NCT01266460|40318775|FG000|Overall Study|Disease Progression|18|||
16504043|NCT01266460|40318775|FG000|Overall Study|Not otherwise specified|8|||
16504044|NCT03571581|40318776|FG000|Overall Study|Death|2|||
16504045|NCT03571581|40318776|FG000|Overall Study|Withdrawal by Subject|2|||
16504046|NCT01854775|40318778|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
16504047|NCT01854775|40318779|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
16504048|NCT01854775|40318780|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
16504049|NCT01854775|40318778|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
16504050|NCT01854775|40318779|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
16504051|NCT01854775|40318780|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
16504052|NCT01854775|40318778|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
16504053|NCT01854775|40318779|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
16504054|NCT01854775|40318780|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
16504055|NCT01854775|40318778|FG000|Extension Phase|Pregnancy|3|||
16504056|NCT01854775|40318779|FG001|Extension Phase|Pregnancy|0|||
16504057|NCT01854775|40318780|FG002|Extension Phase|Pregnancy|0|||
16504058|NCT01854775|40318778|FG000|Extension Phase|Investigator's Discretion|1|||
16504059|NCT01854775|40318779|FG001|Extension Phase|Investigator's Discretion|0|||
16504060|NCT01854775|40318780|FG002|Extension Phase|Investigator's Discretion|0|||
16504061|NCT01854775|40318778|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
16504062|NCT01854775|40318779|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
16504063|NCT01854775|40318780|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
16504064|NCT01854775|40318778|FG000|Extension Phase|Lost to Follow-up|2|||
16504065|NCT01854775|40318779|FG001|Extension Phase|Lost to Follow-up|0|||
16504066|NCT01854775|40318780|FG002|Extension Phase|Lost to Follow-up|0|||
16311102|NCT04447040|39623599|FG000|Overall Study|Lost to Follow-up|2|||
16311103|NCT04447040|39623600|FG001|Overall Study|Lost to Follow-up|1|||
16311104|NCT04447040|39623601|FG002|Overall Study|Lost to Follow-up|3|||
16311105|NCT04447040|39623602|FG003|Overall Study|Lost to Follow-up|3|||
16504067|NCT01854775|40318778|FG000|Extension Phase|Still on Study|32|||
16504068|NCT01854775|40318779|FG001|Extension Phase|Still on Study|47|||
16311106|NCT04447040|39623603|FG004|Overall Study|Lost to Follow-up|1|||
16311107|NCT04447040|39623604|FG005|Overall Study|Lost to Follow-up|3|||
16390379|NCT00603941|39912063|FG000|Overall Study|Disease progression|6|||
16504069|NCT01854775|40318780|FG002|Extension Phase|Still on Study|18|||
16504070|NCT01163279|40318783|FG000|Overall Study|Withdrawal by Subject|2|||
16504071|NCT01163279|40318784|FG001|Overall Study|Withdrawal by Subject|0|||
16504072|NCT02604212|40318785|FG000|Overall Study|Study Terminated by Sponsor|2|||
16504073|NCT02604212|40318786|FG001|Overall Study|Study Terminated by Sponsor|1|||
16504074|NCT02604212|40318787|FG002|Overall Study|Study Terminated by Sponsor|3|||
16546331|NCT01986881|40464785|FG002|Overall Study|Death|247|||
16504075|NCT02604212|40318788|FG003|Overall Study|Study Terminated by Sponsor|3|||
16504076|NCT02604212|40318785|FG000|Overall Study|Withdrawal by Subject|0|||
16504077|NCT02604212|40318786|FG001|Overall Study|Withdrawal by Subject|0|||
16504078|NCT02604212|40318787|FG002|Overall Study|Withdrawal by Subject|1|||
16504079|NCT02604212|40318788|FG003|Overall Study|Withdrawal by Subject|0|||
16504080|NCT02632552|40318789|FG000|Overall Study|Lost to Follow-up|14|||
16504081|NCT02632552|40318790|FG001|Overall Study|Lost to Follow-up|8|||
16504082|NCT02632552|40318789|FG000|Overall Study|Withdrawal by Subject|2|||
16504083|NCT02632552|40318790|FG001|Overall Study|Withdrawal by Subject|0|||
16504084|NCT02632552|40318789|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
16504085|NCT02632552|40318790|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
16504086|NCT02532647|40318791|FG000|Overall Study|Did not receive trial medication|1|||
16504087|NCT02532647|40318792|FG001|Overall Study|Did not receive trial medication|0|||
16504088|NCT02532647|40318793|FG002|Overall Study|Did not receive trial medication|1|||
16504089|NCT01085097|40318794|FG000|Overall Study|Adverse Event|0|||
16504090|NCT01085097|40318795|FG001|Overall Study|Adverse Event|0|||
16504091|NCT01085097|40318796|FG002|Overall Study|Adverse Event|2|||
16504092|NCT01085097|40318794|FG000|Overall Study|Treatment failure|2|||
16504093|NCT01085097|40318795|FG001|Overall Study|Treatment failure|0|||
16504094|NCT01085097|40318796|FG002|Overall Study|Treatment failure|0|||
16504095|NCT03204981|40318798|FG000|Overall Study|Physician Decision|2|||
16504096|NCT03204981|40318798|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
16504097|NCT03970733|40318799|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
16504098|NCT03970733|40318800|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
16504099|NCT03970733|40318801|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
16504100|NCT03970733|40318802|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
16504101|NCT03970733|40318803|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
16504102|NCT03970733|40318799|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
16504103|NCT03970733|40318800|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
16504104|NCT03970733|40318801|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
16504105|NCT03970733|40318802|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
16504106|NCT03970733|40318803|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
16504107|NCT03970733|40318799|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
16504108|NCT03970733|40318800|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
16504109|NCT03970733|40318801|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
16504110|NCT03970733|40318802|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
16504111|NCT03970733|40318803|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
16504112|NCT03970733|40318799|FG000|Main Study Phase (18 Months)|Other|1|||
16504113|NCT03970733|40318800|FG001|Main Study Phase (18 Months)|Other|1|||
16504114|NCT03970733|40318801|FG002|Main Study Phase (18 Months)|Other|0|||
16504115|NCT03970733|40318802|FG003|Main Study Phase (18 Months)|Other|0|||
16504116|NCT03970733|40318803|FG004|Main Study Phase (18 Months)|Other|0|||
16504117|NCT03970733|40318799|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
16504118|NCT03970733|40318800|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
16504119|NCT03970733|40318801|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
16504120|NCT03970733|40318802|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
16504121|NCT03970733|40318803|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
16504122|NCT03320564|40318804|FG000|Overall Study|Protocol Violation|1|||
16504123|NCT03011307|40318805|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
16504124|NCT03011307|40318806|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
16504125|NCT03011307|40318805|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
16504126|NCT03011307|40318806|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
16504127|NCT03011307|40318805|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
16504128|NCT03011307|40318806|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
16504129|NCT02132767|40318807|FG000|Overall Study|Death|3|||
16504130|NCT02132767|40318808|FG001|Overall Study|Death|2|||
16504131|NCT02132767|40318807|FG000|Overall Study|Withdrawal by Subject|10|||
16504132|NCT02132767|40318808|FG001|Overall Study|Withdrawal by Subject|9|||
16504133|NCT02132767|40318807|FG000|Overall Study|Lost to Follow-up|4|||
16504134|NCT02132767|40318808|FG001|Overall Study|Lost to Follow-up|4|||
16504135|NCT00720057|40318809|FG000|Overall Study|Lost to Follow-up|0|||
16504136|NCT00720057|40318810|FG001|Overall Study|Lost to Follow-up|2|||
16504137|NCT00720057|40318809|FG000|Overall Study|Protocol Violation|1|||
16504138|NCT00720057|40318810|FG001|Overall Study|Protocol Violation|0|||
16311108|NCT04447040|39623599|FG000|Overall Study|Withdrawal by Subject|0|||
16311109|NCT04447040|39623600|FG001|Overall Study|Withdrawal by Subject|1|||
16504139|NCT00720057|40318809|FG000|Overall Study|Withdrawal by Subject|0|||
16504140|NCT00720057|40318810|FG001|Overall Study|Withdrawal by Subject|1|||
16504141|NCT04251221|40318811|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
16504142|NCT04251221|40318812|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
16504143|NCT00501293|40318817|FG000|Optimization Period|Enrolled in error|1|||
16504144|NCT00501293|40318818|FG001|Optimization Period|Enrolled in error|0|||
16504145|NCT00501293|40318817|FG000|Maintenance Period|Withdrawal by Subject|14|||
16504146|NCT00501293|40318818|FG001|Maintenance Period|Withdrawal by Subject|13|||
16504147|NCT00501293|40318817|FG000|Maintenance Period|Lost to Follow-up|12|||
16504148|NCT00501293|40318818|FG001|Maintenance Period|Lost to Follow-up|7|||
16504149|NCT00501293|40318817|FG000|Maintenance Period|Adverse Event|6|||
16504150|NCT00501293|40318818|FG001|Maintenance Period|Adverse Event|6|||
16504151|NCT00501293|40318817|FG000|Maintenance Period|Protocol Violation|2|||
16504152|NCT00501293|40318818|FG001|Maintenance Period|Protocol Violation|1|||
16504153|NCT00501293|40318817|FG000|Maintenance Period|Lack of Efficacy|4|||
16504154|NCT00501293|40318818|FG001|Maintenance Period|Lack of Efficacy|1|||
16504155|NCT00501293|40318817|FG000|Maintenance Period|Noncompliant with study medication|5|||
16504156|NCT00501293|40318818|FG001|Maintenance Period|Noncompliant with study medication|0|||
16504157|NCT00501293|40318817|FG000|Maintenance Period|Went into rehabilitation|1|||
16504158|NCT00501293|40318818|FG001|Maintenance Period|Went into rehabilitation|0|||
16504159|NCT00501293|40318817|FG000|Maintenance Period|Would not wear patch|1|||
16504160|NCT00501293|40318818|FG001|Maintenance Period|Would not wear patch|0|||
16504161|NCT00501293|40318817|FG000|Maintenance Period|Application site reaction|1|||
16504162|NCT00501293|40318818|FG001|Maintenance Period|Application site reaction|0|||
16504163|NCT02009046|40318819|FG000|Overall Study|Lost to Follow-up|256|||
16504164|NCT02009046|40318820|FG001|Overall Study|Lost to Follow-up|206|||
16504165|NCT02784821|40318821|FG000|Overall Study|Death|0|||
16504166|NCT02784821|40318822|FG001|Overall Study|Death|5|||
16504167|NCT02784821|40318823|FG002|Overall Study|Death|4|||
16504168|NCT02784821|40318824|FG003|Overall Study|Death|5|||
16504169|NCT01696994|40318825|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
16504170|NCT01696994|40318826|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
16504171|NCT01696994|40318825|FG000|Overall Study|Died Before Randomization|1|||
16504172|NCT01696994|40318826|FG001|Overall Study|Died Before Randomization|2|||
16504173|NCT01696994|40318825|FG000|Overall Study|Died Before ASU (Control)|73|||
16504174|NCT01696994|40318826|FG001|Overall Study|Died Before ASU (Control)|0|||
16504175|NCT01696994|40318825|FG000|Overall Study|No Ovaries at Baseline|4807|||
16504176|NCT01696994|40318826|FG001|Overall Study|No Ovaries at Baseline|4851|||
16504177|NCT01696994|40318825|FG000|Overall Study|Refused ASU (Control)|311|||
16504178|NCT01696994|40318826|FG001|Overall Study|Refused ASU (Control)|0|||
16504179|NCT01696994|40318825|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
16504180|NCT01696994|40318826|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
16504181|NCT04120974|40318827|FG000|Overall Study|Death|1|||
16504182|NCT04120974|40318827|FG000|Overall Study|Physician Decision|1|||
16504183|NCT04120974|40318827|FG000|Overall Study|Lost to Follow-up|6|||
16504184|NCT02141282|40318830|FG000|Overall Study|Adverse event, not related to progression|8|||
16504185|NCT02141282|40318831|FG001|Overall Study|Adverse event, not related to progression|1|||
16504186|NCT02141282|40318832|FG002|Overall Study|Adverse event, not related to progression|3|||
16504187|NCT02141282|40318833|FG003|Overall Study|Adverse event, not related to progression|1|||
16504188|NCT02141282|40318830|FG000|Overall Study|Adverse event, related to progression|1|||
16504189|NCT02141282|40318831|FG001|Overall Study|Adverse event, related to progression|0|||
16504190|NCT02141282|40318832|FG002|Overall Study|Adverse event, related to progression|2|||
16504191|NCT02141282|40318833|FG003|Overall Study|Adverse event, related to progression|0|||
16504192|NCT02141282|40318830|FG000|Overall Study|COVID-19 infection|1|||
16504193|NCT02141282|40318831|FG001|Overall Study|COVID-19 infection|0|||
16504194|NCT02141282|40318832|FG002|Overall Study|COVID-19 infection|0|||
16504195|NCT02141282|40318833|FG003|Overall Study|COVID-19 infection|0|||
16504196|NCT02141282|40318830|FG000|Overall Study|Lost to Follow-up|0|||
16504197|NCT02141282|40318831|FG001|Overall Study|Lost to Follow-up|0|||
16504198|NCT02141282|40318832|FG002|Overall Study|Lost to Follow-up|4|||
16504199|NCT02141282|40318833|FG003|Overall Study|Lost to Follow-up|2|||
16504200|NCT02141282|40318830|FG000|Overall Study|Other, not specified|14|||
16504201|NCT02141282|40318831|FG001|Overall Study|Other, not specified|11|||
16504202|NCT02141282|40318832|FG002|Overall Study|Other, not specified|23|||
16504203|NCT02141282|40318833|FG003|Overall Study|Other, not specified|9|||
16504204|NCT02141282|40318830|FG000|Overall Study|Progressive disease, Richter's|4|||
16504205|NCT02141282|40318831|FG001|Overall Study|Progressive disease, Richter's|1|||
16504206|NCT02141282|40318832|FG002|Overall Study|Progressive disease, Richter's|1|||
16504207|NCT02141282|40318833|FG003|Overall Study|Progressive disease, Richter's|1|||
16504208|NCT02141282|40318830|FG000|Overall Study|Progressive disease per protocol|12|||
16504209|NCT02141282|40318831|FG001|Overall Study|Progressive disease per protocol|7|||
16504210|NCT02141282|40318832|FG002|Overall Study|Progressive disease per protocol|9|||
16504211|NCT02141282|40318833|FG003|Overall Study|Progressive disease per protocol|2|||
16504212|NCT02141282|40318830|FG000|Overall Study|Stem cell transplant|1|||
16504213|NCT02141282|40318831|FG001|Overall Study|Stem cell transplant|0|||
16195869|NCT01885078|39193450|FG004|Treatment Period|Death|2|||
16195870|NCT01885078|39193451|FG005|Treatment Period|Death|10|||
16195871|NCT01885078|39193452|FG006|Treatment Period|Death|3|||
16195872|NCT01885078|39193453|FG007|Treatment Period|Death|2|||
16195873|NCT01885078|39193454|FG008|Treatment Period|Death|0|||
16195874|NCT01885078|39193455|FG009|Treatment Period|Death|0|||
16195875|NCT01885078|39193446|FG000|Treatment Period|Lack of Efficacy|12|||
16195876|NCT01885078|39193447|FG001|Treatment Period|Lack of Efficacy|33|||
16195877|NCT01885078|39193448|FG002|Treatment Period|Lack of Efficacy|10|||
16195878|NCT01885078|39193449|FG003|Treatment Period|Lack of Efficacy|23|||
16195879|NCT01885078|39193450|FG004|Treatment Period|Lack of Efficacy|24|||
16195880|NCT01885078|39193451|FG005|Treatment Period|Lack of Efficacy|58|||
16195881|NCT01885078|39193452|FG006|Treatment Period|Lack of Efficacy|9|||
16195882|NCT01885078|39193453|FG007|Treatment Period|Lack of Efficacy|5|||
16195883|NCT01885078|39193454|FG008|Treatment Period|Lack of Efficacy|0|||
16195884|NCT01885078|39193455|FG009|Treatment Period|Lack of Efficacy|0|||
16195885|NCT01885078|39193446|FG000|Treatment Period|Lost to Follow-up|16|||
16195886|NCT01885078|39193447|FG001|Treatment Period|Lost to Follow-up|19|||
16195887|NCT01885078|39193448|FG002|Treatment Period|Lost to Follow-up|7|||
16195888|NCT01885078|39193449|FG003|Treatment Period|Lost to Follow-up|9|||
16195889|NCT01885078|39193450|FG004|Treatment Period|Lost to Follow-up|2|||
16195890|NCT01885078|39193451|FG005|Treatment Period|Lost to Follow-up|8|||
16195891|NCT01885078|39193452|FG006|Treatment Period|Lost to Follow-up|2|||
16195892|NCT01885078|39193453|FG007|Treatment Period|Lost to Follow-up|0|||
16195893|NCT01885078|39193454|FG008|Treatment Period|Lost to Follow-up|0|||
16195894|NCT01885078|39193455|FG009|Treatment Period|Lost to Follow-up|0|||
16195895|NCT01885078|39193446|FG000|Treatment Period|Physician Decision|19|||
16195896|NCT01885078|39193447|FG001|Treatment Period|Physician Decision|21|||
16195897|NCT01885078|39193448|FG002|Treatment Period|Physician Decision|5|||
16195898|NCT01885078|39193449|FG003|Treatment Period|Physician Decision|12|||
16195899|NCT01885078|39193450|FG004|Treatment Period|Physician Decision|9|||
16195900|NCT01885078|39193451|FG005|Treatment Period|Physician Decision|24|||
16195901|NCT01885078|39193452|FG006|Treatment Period|Physician Decision|4|||
16195902|NCT01885078|39193453|FG007|Treatment Period|Physician Decision|3|||
16195903|NCT01885078|39193454|FG008|Treatment Period|Physician Decision|0|||
16195904|NCT01885078|39193455|FG009|Treatment Period|Physician Decision|0|||
16195905|NCT01885078|39193446|FG000|Treatment Period|Protocol Violation|3|||
16195906|NCT01885078|39193447|FG001|Treatment Period|Protocol Violation|5|||
16195907|NCT01885078|39193448|FG002|Treatment Period|Protocol Violation|0|||
16195908|NCT01885078|39193449|FG003|Treatment Period|Protocol Violation|3|||
16195909|NCT01885078|39193450|FG004|Treatment Period|Protocol Violation|1|||
16195910|NCT01885078|39193451|FG005|Treatment Period|Protocol Violation|6|||
16195911|NCT01885078|39193452|FG006|Treatment Period|Protocol Violation|0|||
16504214|NCT02141282|40318832|FG002|Overall Study|Stem cell transplant|1|||
16504215|NCT02141282|40318833|FG003|Overall Study|Stem cell transplant|0|||
16504216|NCT02141282|40318830|FG000|Overall Study|Study terminated by Sponsor|0|||
16504217|NCT02141282|40318831|FG001|Overall Study|Study terminated by Sponsor|1|||
16504218|NCT02141282|40318832|FG002|Overall Study|Study terminated by Sponsor|0|||
16504219|NCT02141282|40318833|FG003|Overall Study|Study terminated by Sponsor|0|||
16504220|NCT02141282|40318830|FG000|Overall Study|Subject non-compliance|0|||
16504221|NCT02141282|40318831|FG001|Overall Study|Subject non-compliance|0|||
16504222|NCT02141282|40318832|FG002|Overall Study|Subject non-compliance|1|||
16504223|NCT02141282|40318833|FG003|Overall Study|Subject non-compliance|0|||
16504224|NCT02141282|40318830|FG000|Overall Study|Withdrew consent|2|||
16504225|NCT02141282|40318831|FG001|Overall Study|Withdrew consent|0|||
16504226|NCT02141282|40318832|FG002|Overall Study|Withdrew consent|4|||
16504227|NCT02141282|40318833|FG003|Overall Study|Withdrew consent|0|||
16504228|NCT01480076|40318838|FG000|Overall Study|Run-in Failure|52|||
16504229|NCT01480076|40318838|FG000|Overall Study|Adverse Event|39|||
16504230|NCT01480076|40318838|FG000|Overall Study|Death|2|||
16504231|NCT01480076|40318838|FG000|Overall Study|Disease Progression|5|||
16504232|NCT01480076|40318838|FG000|Overall Study|Non-compliance With Study Protocol|15|||
16504233|NCT01480076|40318838|FG000|Overall Study|Withdrawal by Subject|105|||
16504234|NCT01480076|40318838|FG000|Overall Study|Lost to Follow-up|7|||
16504235|NCT01480076|40318838|FG000|Overall Study|Investigator Decision|13|||
16504236|NCT01480076|40318838|FG000|Overall Study|Other|52|||
16504237|NCT03025542|40318845|FG000|Overall Study|Adverse Event|0|||
16504238|NCT03025542|40318846|FG001|Overall Study|Adverse Event|2|||
16504239|NCT03025542|40318845|FG000|Overall Study|Lost to Follow-up|1|||
16195912|NCT01885078|39193453|FG007|Treatment Period|Protocol Violation|0|||
16195913|NCT01885078|39193454|FG008|Treatment Period|Protocol Violation|0|||
16195914|NCT01885078|39193455|FG009|Treatment Period|Protocol Violation|0|||
16195915|NCT01885078|39193446|FG000|Treatment Period|Sponsor Decision|245|||
16195916|NCT01885078|39193447|FG001|Treatment Period|Sponsor Decision|648|||
16195917|NCT01885078|39193448|FG002|Treatment Period|Sponsor Decision|49|||
16504240|NCT03025542|40318846|FG001|Overall Study|Lost to Follow-up|0|||
16504241|NCT03025542|40318845|FG000|Overall Study|Withdrawal by Subject|1|||
16195918|NCT01885078|39193449|FG003|Treatment Period|Sponsor Decision|90|||
16195919|NCT01885078|39193450|FG004|Treatment Period|Sponsor Decision|20|||
16195920|NCT01885078|39193451|FG005|Treatment Period|Sponsor Decision|38|||
16195921|NCT01885078|39193452|FG006|Treatment Period|Sponsor Decision|162|||
16195922|NCT01885078|39193453|FG007|Treatment Period|Sponsor Decision|3|||
16195923|NCT01885078|39193454|FG008|Treatment Period|Sponsor Decision|0|||
16195924|NCT01885078|39193455|FG009|Treatment Period|Sponsor Decision|0|||
16195925|NCT01885078|39193446|FG000|Treatment Period|Withdrawal by Subject|72|||
16195926|NCT01885078|39193447|FG001|Treatment Period|Withdrawal by Subject|132|||
16195927|NCT01885078|39193448|FG002|Treatment Period|Withdrawal by Subject|25|||
16195928|NCT01885078|39193449|FG003|Treatment Period|Withdrawal by Subject|63|||
16195929|NCT01885078|39193450|FG004|Treatment Period|Withdrawal by Subject|15|||
16311110|NCT04447040|39623601|FG002|Overall Study|Withdrawal by Subject|1|||
16311111|NCT04447040|39623602|FG003|Overall Study|Withdrawal by Subject|1|||
16311112|NCT04447040|39623603|FG004|Overall Study|Withdrawal by Subject|0|||
16311113|NCT04447040|39623604|FG005|Overall Study|Withdrawal by Subject|0|||
16311114|NCT02548156|39623605|FG000|Washout Period 1|Lost to Follow-up|0|||
16311115|NCT02548156|39623606|FG001|Washout Period 1|Lost to Follow-up|0|||
16195930|NCT01885078|39193451|FG005|Treatment Period|Withdrawal by Subject|34|||
16195931|NCT01885078|39193452|FG006|Treatment Period|Withdrawal by Subject|17|||
16311116|NCT02548156|39623607|FG002|Washout Period 1|Lost to Follow-up|0|||
16311117|NCT02548156|39623608|FG003|Washout Period 1|Lost to Follow-up|0|||
16311118|NCT02548156|39623609|FG004|Washout Period 1|Lost to Follow-up|1|||
16504242|NCT03025542|40318846|FG001|Overall Study|Withdrawal by Subject|0|||
16504243|NCT00613015|40318852|FG000|Overall Study|Lost to Follow-up|0|||
16504244|NCT00613015|40318853|FG001|Overall Study|Lost to Follow-up|1|||
16504245|NCT00613015|40318854|FG002|Overall Study|Lost to Follow-up|3|||
16504246|NCT00613015|40318855|FG003|Overall Study|Lost to Follow-up|3|||
16504247|NCT00613015|40318856|FG004|Overall Study|Lost to Follow-up|2|||
16504248|NCT00613015|40318857|FG005|Overall Study|Lost to Follow-up|3|||
16504249|NCT01471379|40318858|FG000|Overall Study|Adverse Event|1|||
16504250|NCT01471379|40318859|FG001|Overall Study|Adverse Event|0|||
16504251|NCT01471379|40318860|FG002|Overall Study|Adverse Event|0|||
16504252|NCT01471379|40318858|FG000|Overall Study|Study terminated|0|||
16504253|NCT01471379|40318859|FG001|Overall Study|Study terminated|1|||
16504254|NCT01471379|40318860|FG002|Overall Study|Study terminated|0|||
16504255|NCT01857934|40318861|FG000|Overall Study|Relapse or progression|2|||
16504256|NCT01857934|40318861|FG000|Overall Study|Unacceptable toxicity|3|||
16504257|NCT01857934|40318861|FG000|Overall Study|Unwillingness or inability to comply|2|||
16504258|NCT01857934|40318861|FG000|Overall Study|Physician Decision|3|||
16504259|NCT00909779|40318862|FG000|Overall Study|Adverse Event|53|||
16504260|NCT00909779|40318863|FG001|Overall Study|Adverse Event|55|||
16504261|NCT00909779|40318862|FG000|Overall Study|Lack of Efficacy|7|||
16504262|NCT00909779|40318863|FG001|Overall Study|Lack of Efficacy|4|||
16504263|NCT00909779|40318862|FG000|Overall Study|Lost to Follow-up|19|||
16504264|NCT00909779|40318863|FG001|Overall Study|Lost to Follow-up|15|||
16504265|NCT00909779|40318862|FG000|Overall Study|Physician Decision|8|||
16504266|NCT00909779|40318863|FG001|Overall Study|Physician Decision|2|||
16504267|NCT00909779|40318862|FG000|Overall Study|Protocol Violation|2|||
16504268|NCT00909779|40318863|FG001|Overall Study|Protocol Violation|5|||
16504269|NCT00909779|40318862|FG000|Overall Study|Withdrawal by Subject|116|||
16504270|NCT00909779|40318863|FG001|Overall Study|Withdrawal by Subject|80|||
16504271|NCT00909779|40318862|FG000|Overall Study|Site Ceasing Operation|2|||
16504272|NCT00909779|40318863|FG001|Overall Study|Site Ceasing Operation|2|||
16504273|NCT00909779|40318862|FG000|Overall Study|Medical Monitor Decision|1|||
16504274|NCT00909779|40318863|FG001|Overall Study|Medical Monitor Decision|0|||
16504275|NCT00909779|40318862|FG000|Overall Study|Noncompliance|1|||
16504276|NCT00909779|40318863|FG001|Overall Study|Noncompliance|1|||
16504277|NCT00909779|40318862|FG000|Overall Study|Randomized in error|1|||
16504278|NCT00909779|40318863|FG001|Overall Study|Randomized in error|1|||
16504279|NCT01166763|40318864|FG000|Overall Study|Withdrawal by Subject|3|||
16504280|NCT00768144|40318868|FG000|Overall Study|Adverse Event|13|||
16504281|NCT00768144|40318868|FG000|Overall Study|Progressive Disease|21|||
16504282|NCT00768144|40318868|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
16504283|NCT00768144|40318868|FG000|Overall Study|Pt Withdrew Consent|1|||
16504284|NCT03054870|40318869|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
16504285|NCT03054870|40318869|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
16504286|NCT00945009|40318870|FG000|Overall Study|Lack of Efficacy|10|||
16504287|NCT00945009|40318871|FG001|Overall Study|Lack of Efficacy|0|||
16504288|NCT00945009|40318872|FG002|Overall Study|Lack of Efficacy|0|||
16504289|NCT00945009|40318870|FG000|Overall Study|Physician Decision|21|||
16504290|NCT00945009|40318871|FG001|Overall Study|Physician Decision|4|||
16504291|NCT00945009|40318872|FG002|Overall Study|Physician Decision|3|||
16504292|NCT00945009|40318870|FG000|Overall Study|Protocol Violation|6|||
16504293|NCT00945009|40318871|FG001|Overall Study|Protocol Violation|1|||
16504294|NCT00945009|40318872|FG002|Overall Study|Protocol Violation|0|||
16504295|NCT00945009|40318870|FG000|Overall Study|Withdrawal by Subject|1|||
16504296|NCT00945009|40318871|FG001|Overall Study|Withdrawal by Subject|0|||
16504297|NCT00945009|40318872|FG002|Overall Study|Withdrawal by Subject|0|||
16504298|NCT00945009|40318870|FG000|Overall Study|Ineligible|6|||
16504299|NCT00945009|40318871|FG001|Overall Study|Ineligible|1|||
16504300|NCT00945009|40318872|FG002|Overall Study|Ineligible|0|||
16504301|NCT00945009|40318870|FG000|Overall Study|Inevaluable|0|||
16504302|NCT00945009|40318871|FG001|Overall Study|Inevaluable|1|||
16504303|NCT00945009|40318872|FG002|Overall Study|Inevaluable|0|||
16504304|NCT00945009|40318870|FG000|Overall Study|Refusal of further protocol|1|||
16504305|NCT00945009|40318871|FG001|Overall Study|Refusal of further protocol|0|||
16504306|NCT00945009|40318872|FG002|Overall Study|Refusal of further protocol|0|||
16504307|NCT02608268|40318874|FG000|Overall Study|Adverse Event|0|||
16504308|NCT02608268|40318875|FG001|Overall Study|Adverse Event|0|||
16311119|NCT02548156|39623610|FG005|Washout Period 1|Lost to Follow-up|0|||
16504309|NCT02608268|40318876|FG002|Overall Study|Adverse Event|1|||
16504310|NCT02608268|40318877|FG003|Overall Study|Adverse Event|0|||
16504311|NCT02608268|40318878|FG004|Overall Study|Adverse Event|0|||
16504312|NCT02608268|40318879|FG005|Overall Study|Adverse Event|0|||
16195932|NCT01885078|39193453|FG007|Treatment Period|Withdrawal by Subject|10|||
16195933|NCT01885078|39193454|FG008|Treatment Period|Withdrawal by Subject|0|||
16195934|NCT01885078|39193455|FG009|Treatment Period|Withdrawal by Subject|0|||
16390380|NCT00603941|39912064|FG001|Overall Study|Disease progression|7|||
16504313|NCT02608268|40318880|FG006|Overall Study|Adverse Event|0|||
16504314|NCT02608268|40318881|FG007|Overall Study|Adverse Event|0|||
16504315|NCT02608268|40318882|FG008|Overall Study|Adverse Event|0|||
16504316|NCT02608268|40318883|FG009|Overall Study|Adverse Event|0|||
16504317|NCT02608268|40318884|FG010|Overall Study|Adverse Event|0|||
16504318|NCT02608268|40318885|FG011|Overall Study|Adverse Event|0|||
16504319|NCT02608268|40318886|FG012|Overall Study|Adverse Event|2|||
16504320|NCT02608268|40318887|FG013|Overall Study|Adverse Event|0|||
16504321|NCT02608268|40318888|FG014|Overall Study|Adverse Event|0|||
16504322|NCT02608268|40318889|FG015|Overall Study|Adverse Event|0|||
16504323|NCT02608268|40318890|FG016|Overall Study|Adverse Event|0|||
16504324|NCT02608268|40318891|FG017|Overall Study|Adverse Event|0|||
16504325|NCT02608268|40318892|FG018|Overall Study|Adverse Event|0|||
16504326|NCT02608268|40318893|FG019|Overall Study|Adverse Event|0|||
16504327|NCT02608268|40318894|FG020|Overall Study|Adverse Event|1|||
16504328|NCT02608268|40318895|FG021|Overall Study|Adverse Event|1|||
16504329|NCT02608268|40318896|FG022|Overall Study|Adverse Event|0|||
16504330|NCT02608268|40318897|FG023|Overall Study|Adverse Event|0|||
16504331|NCT02608268|40318898|FG024|Overall Study|Adverse Event|1|||
16504332|NCT02608268|40318899|FG025|Overall Study|Adverse Event|0|||
16504333|NCT02608268|40318900|FG026|Overall Study|Adverse Event|0|||
16504334|NCT02608268|40318901|FG027|Overall Study|Adverse Event|0|||
16504335|NCT02608268|40318902|FG028|Overall Study|Adverse Event|1|||
16504336|NCT02608268|40318903|FG029|Overall Study|Adverse Event|0|||
16504337|NCT02608268|40318874|FG000|Overall Study|Death|1|||
16504338|NCT02608268|40318875|FG001|Overall Study|Death|0|||
16504339|NCT02608268|40318876|FG002|Overall Study|Death|0|||
16504340|NCT02608268|40318877|FG003|Overall Study|Death|0|||
16504341|NCT02608268|40318878|FG004|Overall Study|Death|0|||
16504342|NCT02608268|40318879|FG005|Overall Study|Death|0|||
16504343|NCT02608268|40318880|FG006|Overall Study|Death|0|||
16504344|NCT02608268|40318881|FG007|Overall Study|Death|0|||
16504345|NCT02608268|40318882|FG008|Overall Study|Death|1|||
16504346|NCT02608268|40318883|FG009|Overall Study|Death|1|||
16504347|NCT02608268|40318884|FG010|Overall Study|Death|0|||
16504348|NCT02608268|40318885|FG011|Overall Study|Death|0|||
16504349|NCT02608268|40318886|FG012|Overall Study|Death|0|||
16504350|NCT02608268|40318887|FG013|Overall Study|Death|0|||
16504351|NCT02608268|40318888|FG014|Overall Study|Death|0|||
16504352|NCT02608268|40318889|FG015|Overall Study|Death|1|||
16504353|NCT02608268|40318890|FG016|Overall Study|Death|0|||
16504354|NCT02608268|40318891|FG017|Overall Study|Death|1|||
16504355|NCT02608268|40318892|FG018|Overall Study|Death|0|||
16504356|NCT02608268|40318893|FG019|Overall Study|Death|1|||
16504357|NCT02608268|40318894|FG020|Overall Study|Death|1|||
16504358|NCT02608268|40318895|FG021|Overall Study|Death|0|||
16504359|NCT02608268|40318896|FG022|Overall Study|Death|0|||
16504360|NCT02608268|40318897|FG023|Overall Study|Death|0|||
16504361|NCT02608268|40318898|FG024|Overall Study|Death|1|||
16504362|NCT02608268|40318899|FG025|Overall Study|Death|2|||
16504363|NCT02608268|40318900|FG026|Overall Study|Death|0|||
16504364|NCT02608268|40318901|FG027|Overall Study|Death|1|||
16504365|NCT02608268|40318902|FG028|Overall Study|Death|4|||
16390381|NCT00603941|39912065|FG002|Overall Study|Disease progression|1|||
16195935|NCT01885078|39193446|FG000|Treatment Period|Other|0|||
16504366|NCT02608268|40318903|FG029|Overall Study|Death|0|||
16504367|NCT02608268|40318874|FG000|Overall Study|Physician Decision|0|||
16504368|NCT02608268|40318875|FG001|Overall Study|Physician Decision|0|||
16504369|NCT02608268|40318876|FG002|Overall Study|Physician Decision|0|||
16504370|NCT02608268|40318877|FG003|Overall Study|Physician Decision|0|||
16504371|NCT02608268|40318878|FG004|Overall Study|Physician Decision|0|||
16504372|NCT02608268|40318879|FG005|Overall Study|Physician Decision|0|||
16504373|NCT02608268|40318880|FG006|Overall Study|Physician Decision|0|||
16504374|NCT02608268|40318881|FG007|Overall Study|Physician Decision|0|||
16504375|NCT02608268|40318882|FG008|Overall Study|Physician Decision|0|||
16504376|NCT02608268|40318883|FG009|Overall Study|Physician Decision|0|||
16504377|NCT02608268|40318884|FG010|Overall Study|Physician Decision|1|||
16504378|NCT02608268|40318885|FG011|Overall Study|Physician Decision|0|||
16504379|NCT02608268|40318886|FG012|Overall Study|Physician Decision|0|||
16504380|NCT02608268|40318887|FG013|Overall Study|Physician Decision|1|||
16504381|NCT02608268|40318888|FG014|Overall Study|Physician Decision|0|||
16504382|NCT02608268|40318889|FG015|Overall Study|Physician Decision|0|||
16504383|NCT02608268|40318890|FG016|Overall Study|Physician Decision|0|||
16504384|NCT02608268|40318891|FG017|Overall Study|Physician Decision|0|||
16504385|NCT02608268|40318892|FG018|Overall Study|Physician Decision|0|||
16504386|NCT02608268|40318893|FG019|Overall Study|Physician Decision|0|||
16504387|NCT02608268|40318894|FG020|Overall Study|Physician Decision|0|||
16504388|NCT02608268|40318895|FG021|Overall Study|Physician Decision|0|||
16504389|NCT02608268|40318896|FG022|Overall Study|Physician Decision|1|||
16504390|NCT02608268|40318897|FG023|Overall Study|Physician Decision|1|||
16504391|NCT02608268|40318898|FG024|Overall Study|Physician Decision|1|||
16504392|NCT02608268|40318899|FG025|Overall Study|Physician Decision|0|||
16504393|NCT02608268|40318900|FG026|Overall Study|Physician Decision|0|||
16504394|NCT02608268|40318901|FG027|Overall Study|Physician Decision|2|||
16504395|NCT02608268|40318902|FG028|Overall Study|Physician Decision|1|||
16504396|NCT02608268|40318903|FG029|Overall Study|Physician Decision|1|||
16504397|NCT02608268|40318874|FG000|Overall Study|Progressive disease|12|||
16504398|NCT02608268|40318875|FG001|Overall Study|Progressive disease|8|||
16504399|NCT02608268|40318876|FG002|Overall Study|Progressive disease|13|||
16504400|NCT02608268|40318877|FG003|Overall Study|Progressive disease|5|||
16504401|NCT02608268|40318878|FG004|Overall Study|Progressive disease|2|||
16504402|NCT02608268|40318879|FG005|Overall Study|Progressive disease|4|||
16504403|NCT02608268|40318880|FG006|Overall Study|Progressive disease|6|||
16504404|NCT02608268|40318881|FG007|Overall Study|Progressive disease|2|||
16504405|NCT02608268|40318882|FG008|Overall Study|Progressive disease|5|||
16504406|NCT02608268|40318883|FG009|Overall Study|Progressive disease|6|||
16504407|NCT02608268|40318884|FG010|Overall Study|Progressive disease|5|||
16504408|NCT02608268|40318885|FG011|Overall Study|Progressive disease|5|||
16504409|NCT02608268|40318886|FG012|Overall Study|Progressive disease|4|||
16504410|NCT02608268|40318887|FG013|Overall Study|Progressive disease|11|||
16504411|NCT02608268|40318888|FG014|Overall Study|Progressive disease|6|||
16504412|NCT02608268|40318889|FG015|Overall Study|Progressive disease|3|||
16504413|NCT02608268|40318890|FG016|Overall Study|Progressive disease|5|||
16504414|NCT02608268|40318891|FG017|Overall Study|Progressive disease|5|||
16504415|NCT02608268|40318892|FG018|Overall Study|Progressive disease|5|||
16504416|NCT02608268|40318893|FG019|Overall Study|Progressive disease|2|||
16504417|NCT02608268|40318894|FG020|Overall Study|Progressive disease|10|||
16504418|NCT02608268|40318895|FG021|Overall Study|Progressive disease|4|||
16504419|NCT02608268|40318896|FG022|Overall Study|Progressive disease|5|||
16504420|NCT02608268|40318897|FG023|Overall Study|Progressive disease|5|||
16504421|NCT02608268|40318898|FG024|Overall Study|Progressive disease|3|||
16504422|NCT02608268|40318899|FG025|Overall Study|Progressive disease|11|||
16504423|NCT02608268|40318900|FG026|Overall Study|Progressive disease|16|||
16504424|NCT02608268|40318901|FG027|Overall Study|Progressive disease|11|||
16089738|NCT00670488|38819983|FG003|Overall Study|Adverse Event|3|||
16311120|NCT01129557|39623611|FG000|Overall Study|Adverse Event|1|||
16311121|NCT01129557|39623612|FG001|Overall Study|Adverse Event|2|||
16311122|NCT01129557|39623613|FG002|Overall Study|Adverse Event|2|||
16311123|NCT01129557|39623611|FG000|Overall Study|Novartis terminated study early|3|||
16311124|NCT01129557|39623612|FG001|Overall Study|Novartis terminated study early|3|||
16311125|NCT01129557|39623613|FG002|Overall Study|Novartis terminated study early|2|||
16311126|NCT02515331|39623614|FG000|Overall Study|Withdrawal by Subject|0|||
16311127|NCT02515331|39623615|FG001|Overall Study|Withdrawal by Subject|0|||
16311128|NCT02515331|39623616|FG002|Overall Study|Withdrawal by Subject|1|||
16311129|NCT02515331|39623614|FG000|Overall Study|Protocol deviation|0|||
16311130|NCT02515331|39623615|FG001|Overall Study|Protocol deviation|0|||
16311131|NCT02515331|39623616|FG002|Overall Study|Protocol deviation|3|||
16311132|NCT02515331|39623614|FG000|Overall Study|Adverse Event|2|||
16311133|NCT02515331|39623615|FG001|Overall Study|Adverse Event|0|||
16311134|NCT02515331|39623616|FG002|Overall Study|Adverse Event|0|||
16504425|NCT02608268|40318902|FG028|Overall Study|Progressive disease|10|||
16089739|NCT00670488|38819984|FG004|Overall Study|Adverse Event|1|||
16311135|NCT00942084|39623620|FG000|Overall Study|Death|2|||
16311136|NCT02832687|39623621|FG000|Overall Study|Adverse Event|0|||
16311137|NCT02832687|39623622|FG001|Overall Study|Adverse Event|2|||
16311138|NCT00708461|39623623|FG000|Overall Study|Lost to Follow-up|18|||
16311139|NCT00708461|39623624|FG001|Overall Study|Lost to Follow-up|11|||
16311140|NCT00708461|39623623|FG000|Overall Study|Withdrawal by Subject|8|||
16311141|NCT00708461|39623624|FG001|Overall Study|Withdrawal by Subject|9|||
16311142|NCT00708461|39623623|FG000|Overall Study|left workforce|115|||
16311143|NCT00708461|39623624|FG001|Overall Study|left workforce|180|||
16311144|NCT00974922|39623625|FG000|Overall Study|study terminated|24|||
16311145|NCT03103087|39623626|FG000|Overall Study|Did not receive any study drug|1|||
16311146|NCT03103087|39623627|FG001|Overall Study|Did not receive any study drug|0|||
16311147|NCT03103087|39623628|FG002|Overall Study|Did not receive any study drug|0|||
16311148|NCT03103087|39623626|FG000|Overall Study|Protocol Violation|1|||
16311149|NCT03103087|39623627|FG001|Overall Study|Protocol Violation|2|||
16311150|NCT03103087|39623628|FG002|Overall Study|Protocol Violation|1|||
16311151|NCT03103087|39623626|FG000|Overall Study|Lack of Efficacy|2|||
16311152|NCT03103087|39623627|FG001|Overall Study|Lack of Efficacy|1|||
16311153|NCT03103087|39623628|FG002|Overall Study|Lack of Efficacy|1|||
16311154|NCT03103087|39623626|FG000|Overall Study|Pregnancy|0|||
16311155|NCT03103087|39623627|FG001|Overall Study|Pregnancy|0|||
16311156|NCT03103087|39623628|FG002|Overall Study|Pregnancy|1|||
16311157|NCT03103087|39623626|FG000|Overall Study|Adverse Event|2|||
16311158|NCT03103087|39623627|FG001|Overall Study|Adverse Event|15|||
16311159|NCT03103087|39623628|FG002|Overall Study|Adverse Event|6|||
16311160|NCT03103087|39623626|FG000|Overall Study|Withdrawal by Subject|13|||
16311161|NCT03103087|39623627|FG001|Overall Study|Withdrawal by Subject|6|||
16311162|NCT03103087|39623628|FG002|Overall Study|Withdrawal by Subject|6|||
16311163|NCT03103087|39623626|FG000|Overall Study|Lost to Follow-up|4|||
16311164|NCT03103087|39623627|FG001|Overall Study|Lost to Follow-up|2|||
16311165|NCT03103087|39623628|FG002|Overall Study|Lost to Follow-up|7|||
16311166|NCT03103087|39623626|FG000|Overall Study|Other reason not reported|1|||
16311167|NCT03103087|39623627|FG001|Overall Study|Other reason not reported|3|||
16311168|NCT03103087|39623628|FG002|Overall Study|Other reason not reported|5|||
16311169|NCT03181633|39623629|FG000|Overall Study|Withdrawal by Subject|1|||
16311170|NCT03181633|39623629|FG000|Overall Study|Missing follow-up visit|1|||
16311171|NCT01153815|39623630|FG000|Overall Study|Adverse Event|3|||
16311172|NCT01153815|39623631|FG001|Overall Study|Adverse Event|1|||
16311173|NCT01153815|39623630|FG000|Overall Study|Withdrawal by Subject|6|||
16311174|NCT01153815|39623631|FG001|Overall Study|Withdrawal by Subject|4|||
16311175|NCT05048329|39623632|FG000|Overall Study|Withdrawal by Subject|1|||
16311176|NCT05048329|39623632|FG000|Overall Study|Screenfail|1|||
16311177|NCT03333941|39623633|FG000|Overall Study|Lost to Follow-up|10|||
16311178|NCT03333941|39623633|FG000|Overall Study|Death|2|||
16311179|NCT03333941|39623633|FG000|Overall Study|Adverse Event|1|||
16311180|NCT03517540|39623635|FG000|Overall Study|Protocol Violation|2|||
16311181|NCT03517540|39623636|FG001|Overall Study|Protocol Violation|0|||
16311182|NCT03517540|39623637|FG002|Overall Study|Protocol Violation|0|||
16311183|NCT03517540|39623638|FG003|Overall Study|Protocol Violation|1|||
16504426|NCT02608268|40318903|FG029|Overall Study|Progressive disease|15|||
16504427|NCT02608268|40318874|FG000|Overall Study|Subject/guardian decision|1|||
16504428|NCT02608268|40318875|FG001|Overall Study|Subject/guardian decision|1|||
16504429|NCT02608268|40318876|FG002|Overall Study|Subject/guardian decision|2|||
16504430|NCT02608268|40318877|FG003|Overall Study|Subject/guardian decision|0|||
16504431|NCT02608268|40318878|FG004|Overall Study|Subject/guardian decision|0|||
16504432|NCT02608268|40318879|FG005|Overall Study|Subject/guardian decision|0|||
16504433|NCT02608268|40318880|FG006|Overall Study|Subject/guardian decision|0|||
16504434|NCT02608268|40318881|FG007|Overall Study|Subject/guardian decision|0|||
16504435|NCT02608268|40318882|FG008|Overall Study|Subject/guardian decision|2|||
16504436|NCT02608268|40318883|FG009|Overall Study|Subject/guardian decision|2|||
16504437|NCT02608268|40318884|FG010|Overall Study|Subject/guardian decision|0|||
16504438|NCT02608268|40318885|FG011|Overall Study|Subject/guardian decision|1|||
16504439|NCT02608268|40318886|FG012|Overall Study|Subject/guardian decision|0|||
16504440|NCT02608268|40318887|FG013|Overall Study|Subject/guardian decision|1|||
16504441|NCT02608268|40318888|FG014|Overall Study|Subject/guardian decision|0|||
16504442|NCT02608268|40318889|FG015|Overall Study|Subject/guardian decision|1|||
16504443|NCT02608268|40318890|FG016|Overall Study|Subject/guardian decision|0|||
16504444|NCT02608268|40318891|FG017|Overall Study|Subject/guardian decision|0|||
16504445|NCT02608268|40318892|FG018|Overall Study|Subject/guardian decision|1|||
16504446|NCT02608268|40318893|FG019|Overall Study|Subject/guardian decision|0|||
16504447|NCT02608268|40318894|FG020|Overall Study|Subject/guardian decision|0|||
16504448|NCT02608268|40318895|FG021|Overall Study|Subject/guardian decision|0|||
16504449|NCT02608268|40318896|FG022|Overall Study|Subject/guardian decision|1|||
16504450|NCT02608268|40318897|FG023|Overall Study|Subject/guardian decision|0|||
16504451|NCT02608268|40318898|FG024|Overall Study|Subject/guardian decision|0|||
16504452|NCT02608268|40318899|FG025|Overall Study|Subject/guardian decision|1|||
16504453|NCT02608268|40318900|FG026|Overall Study|Subject/guardian decision|1|||
16504454|NCT02608268|40318901|FG027|Overall Study|Subject/guardian decision|1|||
16504455|NCT02608268|40318902|FG028|Overall Study|Subject/guardian decision|1|||
16504456|NCT02608268|40318903|FG029|Overall Study|Subject/guardian decision|0|||
16504457|NCT01139450|40318914|FG000|Overall Study|Withdrawal by Subject|7|||
16504458|NCT01139450|40318915|FG001|Overall Study|Withdrawal by Subject|10|||
16504459|NCT01139450|40318916|FG002|Overall Study|Withdrawal by Subject|13|||
16504460|NCT01139450|40318914|FG000|Overall Study|Lack of Efficacy|3|||
16504461|NCT01139450|40318915|FG001|Overall Study|Lack of Efficacy|1|||
16504462|NCT01139450|40318916|FG002|Overall Study|Lack of Efficacy|8|||
16504463|NCT01139450|40318914|FG000|Overall Study|Protocol Violation|6|||
16504464|NCT01139450|40318915|FG001|Overall Study|Protocol Violation|5|||
16504465|NCT01139450|40318916|FG002|Overall Study|Protocol Violation|2|||
16504466|NCT01139450|40318914|FG000|Overall Study|Lost to Follow-up|9|||
16504467|NCT01139450|40318915|FG001|Overall Study|Lost to Follow-up|7|||
16311184|NCT03517540|39623635|FG000|Overall Study|Adverse Event|9|||
16311185|NCT03517540|39623636|FG001|Overall Study|Adverse Event|3|||
16311186|NCT03517540|39623637|FG002|Overall Study|Adverse Event|8|||
16311187|NCT03517540|39623638|FG003|Overall Study|Adverse Event|1|||
16311188|NCT03517540|39623635|FG000|Overall Study|Withdrawal by Subject|3|||
16311189|NCT03517540|39623636|FG001|Overall Study|Withdrawal by Subject|4|||
16504468|NCT01139450|40318916|FG002|Overall Study|Lost to Follow-up|11|||
16504469|NCT01139450|40318914|FG000|Overall Study|Administrative|0|||
16504470|NCT01139450|40318915|FG001|Overall Study|Administrative|0|||
16504471|NCT01139450|40318916|FG002|Overall Study|Administrative|1|||
16504472|NCT01139450|40318914|FG000|Overall Study|Adverse Event|2|||
16504473|NCT01139450|40318915|FG001|Overall Study|Adverse Event|2|||
16504474|NCT01139450|40318916|FG002|Overall Study|Adverse Event|3|||
16504475|NCT01708174|40318919|FG000|Treatment Period|Withdrawal by Subject|1|||
16311190|NCT03517540|39623637|FG002|Overall Study|Withdrawal by Subject|1|||
16311191|NCT03517540|39623638|FG003|Overall Study|Withdrawal by Subject|3|||
16504476|NCT01708174|40318920|FG001|Treatment Period|Withdrawal by Subject|0|||
16504477|NCT01708174|40318921|FG002|Treatment Period|Withdrawal by Subject|0|||
16504478|NCT01708174|40318919|FG000|Treatment Period|Progressive disease|0|||
16504479|NCT01708174|40318920|FG001|Treatment Period|Progressive disease|1|||
16504480|NCT01708174|40318921|FG002|Treatment Period|Progressive disease|0|||
16504481|NCT01708174|40318919|FG000|Treatment Period|Death|0|||
16504482|NCT01708174|40318920|FG001|Treatment Period|Death|0|||
16504483|NCT01708174|40318921|FG002|Treatment Period|Death|1|||
16504484|NCT01708174|40318919|FG000|Treatment Period|Adverse Event|0|||
16504485|NCT01708174|40318920|FG001|Treatment Period|Adverse Event|1|||
16504486|NCT01708174|40318921|FG002|Treatment Period|Adverse Event|0|||
16504487|NCT01912287|40318922|FG000|Overall Study|Ineligible|1|||
16089740|NCT00670488|38819985|FG005|Overall Study|Adverse Event|1|||
16089741|NCT00670488|38819986|FG006|Overall Study|Adverse Event|5|||
16504488|NCT01912287|40318923|FG001|Overall Study|Ineligible|0|||
16504489|NCT01912287|40318924|FG002|Overall Study|Ineligible|1|||
16089742|NCT00670488|38819987|FG007|Overall Study|Adverse Event|1|||
16311192|NCT03022370|39623639|FG000|Overall Study|Death|6|||
16311193|NCT03022370|39623640|FG001|Overall Study|Death|12|||
16504490|NCT01912287|40318922|FG000|Overall Study|No-show|0|||
16089743|NCT00670488|38819988|FG008|Overall Study|Adverse Event|0|||
16504491|NCT01912287|40318923|FG001|Overall Study|No-show|0|||
16504492|NCT01912287|40318924|FG002|Overall Study|No-show|1|||
16504493|NCT01912287|40318922|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
16504494|NCT01912287|40318923|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
16504495|NCT01912287|40318924|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
16504496|NCT01912287|40318922|FG000|Overall Study|Felt treatment no longer needed|0|||
16504497|NCT01912287|40318923|FG001|Overall Study|Felt treatment no longer needed|1|||
16504498|NCT01912287|40318924|FG002|Overall Study|Felt treatment no longer needed|0|||
16504499|NCT01912287|40318922|FG000|Overall Study|Life circumstances|4|||
16504500|NCT01912287|40318923|FG001|Overall Study|Life circumstances|2|||
16504501|NCT01912287|40318924|FG002|Overall Study|Life circumstances|0|||
16504502|NCT01912287|40318922|FG000|Overall Study|Lost Interest|1|||
16504503|NCT01912287|40318923|FG001|Overall Study|Lost Interest|0|||
16504504|NCT01912287|40318924|FG002|Overall Study|Lost Interest|0|||
16504505|NCT01912287|40318922|FG000|Overall Study|Uknown reason - subject drop out|5|||
16504506|NCT01912287|40318923|FG001|Overall Study|Uknown reason - subject drop out|7|||
16504507|NCT01912287|40318924|FG002|Overall Study|Uknown reason - subject drop out|3|||
16504508|NCT01912287|40318922|FG000|Overall Study|Missed Assesment|1|||
16504509|NCT01912287|40318923|FG001|Overall Study|Missed Assesment|1|||
16504510|NCT01912287|40318924|FG002|Overall Study|Missed Assesment|1|||
16504511|NCT01912287|40318922|FG000|Overall Study|Scheduling/change in availability|17|||
16504512|NCT01912287|40318923|FG001|Overall Study|Scheduling/change in availability|10|||
16504513|NCT01912287|40318924|FG002|Overall Study|Scheduling/change in availability|8|||
16504514|NCT03220217|40318925|FG000|Overall Study|Withdrawal by Subject|0|||
16504515|NCT03220217|40318926|FG001|Overall Study|Withdrawal by Subject|1|||
16504516|NCT03220217|40318927|FG002|Overall Study|Withdrawal by Subject|0|||
16504517|NCT03220217|40318925|FG000|Overall Study|Subject Missed Procedure|0|||
16504518|NCT03220217|40318926|FG001|Overall Study|Subject Missed Procedure|0|||
16504519|NCT03220217|40318927|FG002|Overall Study|Subject Missed Procedure|1|||
16504520|NCT00271947|40318928|FG000|Overall Study|Lost to Follow-up|1|||
16504521|NCT02345811|40318929|FG000|First Intervention|Withdrawal by Subject|1|||
16504522|NCT02345811|40318930|FG001|First Intervention|Withdrawal by Subject|1|||
16504523|NCT01466387|40318931|FG000|Overall Study|Adverse Event|0|||
16504524|NCT01466387|40318932|FG001|Overall Study|Adverse Event|0|||
16504525|NCT01466387|40318933|FG002|Overall Study|Adverse Event|1|||
16504526|NCT01466387|40318934|FG003|Overall Study|Adverse Event|1|||
16504527|NCT01466387|40318935|FG004|Overall Study|Adverse Event|0|||
16504528|NCT01466387|40318936|FG005|Overall Study|Adverse Event|0|||
16504529|NCT01466387|40318931|FG000|Overall Study|Lost to Follow-up|0|||
16504530|NCT01466387|40318932|FG001|Overall Study|Lost to Follow-up|0|||
16504531|NCT01466387|40318933|FG002|Overall Study|Lost to Follow-up|0|||
16504532|NCT01466387|40318934|FG003|Overall Study|Lost to Follow-up|0|||
16504533|NCT01466387|40318935|FG004|Overall Study|Lost to Follow-up|0|||
16504534|NCT01466387|40318936|FG005|Overall Study|Lost to Follow-up|1|||
16504535|NCT01466387|40318931|FG000|Overall Study|Protocol Violation|1|||
16504536|NCT01466387|40318932|FG001|Overall Study|Protocol Violation|0|||
16504537|NCT01466387|40318933|FG002|Overall Study|Protocol Violation|0|||
16504538|NCT01466387|40318934|FG003|Overall Study|Protocol Violation|1|||
16504539|NCT01466387|40318935|FG004|Overall Study|Protocol Violation|0|||
16504540|NCT01466387|40318936|FG005|Overall Study|Protocol Violation|0|||
16504541|NCT02347189|40318939|FG000|Overall Study|No implant attempted of study device|9|||
16504542|NCT02347189|40318939|FG000|Overall Study|No primary outcome data available|2|||
16504543|NCT00811473|40318940|FG000|Overall Study|Adverse Event|3|||
16504544|NCT00811473|40318941|FG001|Overall Study|Adverse Event|12|||
16504545|NCT00811473|40318940|FG000|Overall Study|Lost to Follow-up|5|||
16504546|NCT00811473|40318941|FG001|Overall Study|Lost to Follow-up|1|||
16504547|NCT00811473|40318940|FG000|Overall Study|Withdrawal by Subject|2|||
16504548|NCT00811473|40318941|FG001|Overall Study|Withdrawal by Subject|4|||
16504549|NCT00811473|40318940|FG000|Overall Study|Severe non-compliance to protocol|2|||
16504550|NCT00811473|40318941|FG001|Overall Study|Severe non-compliance to protocol|4|||
16504551|NCT00811473|40318940|FG000|Overall Study|Lack of therapeutic response|4|||
16504552|NCT00811473|40318941|FG001|Overall Study|Lack of therapeutic response|1|||
16504553|NCT00811473|40318940|FG000|Overall Study|Condition under investigation worsened|1|||
16504554|NCT00811473|40318941|FG001|Overall Study|Condition under investigation worsened|3|||
16504555|NCT00811473|40318940|FG000|Overall Study|Other 2|4|||
16504556|NCT00811473|40318941|FG001|Overall Study|Other 2|1|||
16504557|NCT00811473|40318940|FG000|Overall Study|Incorrect Enrollment|1|||
16504558|NCT00811473|40318941|FG001|Overall Study|Incorrect Enrollment|0|||
16504559|NCT00811473|40318940|FG000|Overall Study|Safety Reasons|1|||
16504560|NCT00811473|40318941|FG001|Overall Study|Safety Reasons|0|||
16504561|NCT02369341|40322058|FG000|Overall Study|Migrated/moved from study area|1|||
16504562|NCT02369341|40322059|FG001|Overall Study|Migrated/moved from study area|0|||
16504563|NCT00735878|40322066|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
16504564|NCT00735878|40322067|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
16504565|NCT00735878|40322068|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
16504566|NCT03711162|40322069|FG000|Overall Study|Adverse Event|5|||
16504567|NCT03711162|40322070|FG001|Overall Study|Adverse Event|2|||
16504568|NCT03711162|40322071|FG002|Overall Study|Adverse Event|4|||
16504569|NCT03711162|40322069|FG000|Overall Study|Death|11|||
16504570|NCT03711162|40322070|FG001|Overall Study|Death|7|||
16504571|NCT03711162|40322071|FG002|Overall Study|Death|8|||
16504572|NCT03711162|40322069|FG000|Overall Study|Lost to Follow-up|1|||
16504573|NCT03711162|40322070|FG001|Overall Study|Lost to Follow-up|0|||
16504574|NCT03711162|40322071|FG002|Overall Study|Lost to Follow-up|1|||
16504575|NCT03711162|40322069|FG000|Overall Study|Study Terminated by Sponsor|139|||
16504576|NCT03711162|40322070|FG001|Overall Study|Study Terminated by Sponsor|152|||
16504577|NCT03711162|40322071|FG002|Overall Study|Study Terminated by Sponsor|146|||
16504578|NCT03711162|40322069|FG000|Overall Study|Withdrawal by Subject|17|||
16504579|NCT03711162|40322070|FG001|Overall Study|Withdrawal by Subject|10|||
16504580|NCT03711162|40322071|FG002|Overall Study|Withdrawal by Subject|10|||
16504581|NCT03711162|40322069|FG000|Overall Study|Miscellaneous|1|||
16504582|NCT03711162|40322070|FG001|Overall Study|Miscellaneous|2|||
16504583|NCT03711162|40322071|FG002|Overall Study|Miscellaneous|2|||
16504584|NCT03711162|40322069|FG000|Overall Study|Not Treated|1|||
16504585|NCT03711162|40322070|FG001|Overall Study|Not Treated|0|||
16504586|NCT03711162|40322071|FG002|Overall Study|Not Treated|1|||
16504587|NCT03711162|40322069|FG000|Overall Study|Physician Decision|0|||
16504588|NCT03711162|40322070|FG001|Overall Study|Physician Decision|2|||
16504589|NCT03711162|40322071|FG002|Overall Study|Physician Decision|0|||
16504590|NCT03711162|40322069|FG000|Overall Study|Lack of Efficacy|0|||
16504591|NCT03711162|40322070|FG001|Overall Study|Lack of Efficacy|0|||
16504592|NCT03711162|40322071|FG002|Overall Study|Lack of Efficacy|2|||
16504593|NCT03711162|40322069|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
16504594|NCT03711162|40322070|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
16504595|NCT03711162|40322071|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
16504596|NCT02486042|40322072|FG000|Overall Study|Physician Decision|1|||
16504597|NCT02486042|40322073|FG001|Overall Study|Physician Decision|7|||
16504598|NCT02486042|40322072|FG000|Overall Study|Hospital transfer|2|||
16504599|NCT02486042|40322073|FG001|Overall Study|Hospital transfer|2|||
16504600|NCT02486042|40322072|FG000|Overall Study|Withdrawal by Subject|0|||
16504601|NCT02486042|40322073|FG001|Overall Study|Withdrawal by Subject|2|||
16504602|NCT02385084|40322074|FG000|Period 2|Protocol Violation|0|||
16504603|NCT02385084|40322075|FG001|Period 2|Protocol Violation|0|||
16504604|NCT02385084|40322076|FG002|Period 2|Protocol Violation|1|||
16504605|NCT02385084|40322077|FG003|Period 2|Protocol Violation|0|||
16504606|NCT02385084|40322078|FG004|Period 2|Protocol Violation|0|||
16504607|NCT02385084|40322079|FG005|Period 2|Protocol Violation|0|||
16504608|NCT00329407|40322080|FG000|Overall Study|Withdrawal by Subject|1|||
16311194|NCT03022370|39623639|FG000|Overall Study|Lost to Follow-up|174|||
16311195|NCT03022370|39623640|FG001|Overall Study|Lost to Follow-up|109|||
16311196|NCT01730053|39623641|FG000|Overall Study|Participant moved|0|||
16311197|NCT01730053|39623642|FG001|Overall Study|Participant moved|0|||
16311198|NCT01730053|39623643|FG002|Overall Study|Participant moved|1|||
16311199|NCT01730053|39623644|FG003|Overall Study|Participant moved|0|||
16311200|NCT01730053|39623645|FG004|Overall Study|Participant moved|0|||
16311201|NCT01730053|39623646|FG005|Overall Study|Participant moved|0|||
16311202|NCT01730053|39623641|FG000|Overall Study|Physician Decision|0|||
16311203|NCT01730053|39623642|FG001|Overall Study|Physician Decision|0|||
16311204|NCT01730053|39623643|FG002|Overall Study|Physician Decision|0|||
16311205|NCT01730053|39623644|FG003|Overall Study|Physician Decision|1|||
16311206|NCT01730053|39623645|FG004|Overall Study|Physician Decision|0|||
16311207|NCT01730053|39623646|FG005|Overall Study|Physician Decision|0|||
16311208|NCT01730053|39623641|FG000|Overall Study|Adverse Event|2|||
16311209|NCT01730053|39623642|FG001|Overall Study|Adverse Event|6|||
16311210|NCT01730053|39623643|FG002|Overall Study|Adverse Event|3|||
16311211|NCT01730053|39623644|FG003|Overall Study|Adverse Event|3|||
16311212|NCT01730053|39623645|FG004|Overall Study|Adverse Event|2|||
16311213|NCT01730053|39623646|FG005|Overall Study|Adverse Event|2|||
16311214|NCT01730053|39623641|FG000|Overall Study|Poor compliance to protocol|1|||
16311215|NCT01730053|39623642|FG001|Overall Study|Poor compliance to protocol|2|||
16311216|NCT01730053|39623643|FG002|Overall Study|Poor compliance to protocol|2|||
16311217|NCT01730053|39623644|FG003|Overall Study|Poor compliance to protocol|0|||
16311218|NCT01730053|39623645|FG004|Overall Study|Poor compliance to protocol|0|||
16390382|NCT00603941|39912063|FG000|Overall Study|Adverse Event|1|||
16504609|NCT01316276|40322081|FG000|Overall Study|Death|1|||
16504610|NCT01316276|40322081|FG000|Overall Study|Adverse Event|19|||
16311219|NCT01730053|39623646|FG005|Overall Study|Poor compliance to protocol|2|||
16311220|NCT01730053|39623641|FG000|Overall Study|Other than specified|2|||
16311221|NCT01730053|39623642|FG001|Overall Study|Other than specified|6|||
16311222|NCT01730053|39623643|FG002|Overall Study|Other than specified|5|||
16311223|NCT01730053|39623644|FG003|Overall Study|Other than specified|4|||
16311224|NCT01730053|39623645|FG004|Overall Study|Other than specified|7|||
16504611|NCT01316276|40322081|FG000|Overall Study|Withdrawal of consent|24|||
16504612|NCT01316276|40322081|FG000|Overall Study|Lost to Follow-up|1|||
16504613|NCT01316276|40322081|FG000|Overall Study|Other|22|||
16311225|NCT01730053|39623646|FG005|Overall Study|Other than specified|9|||
16311226|NCT01199939|39623653|FG000|Overall Study|Adverse Event|4|||
16311227|NCT01199939|39623653|FG000|Overall Study|Protocol Violation|3|||
16311228|NCT01199939|39623653|FG000|Overall Study|Lost to Follow-up|2|||
16311229|NCT01199939|39623653|FG000|Overall Study|Reached a virologic endpoint|4|||
16311230|NCT02456740|39623654|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
16311231|NCT02456740|39623655|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
16311232|NCT02456740|39623656|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
16311233|NCT02456740|39623657|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
16311234|NCT02456740|39623658|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
16504614|NCT00885755|40322084|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
16504615|NCT00885755|40322085|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
16311235|NCT02456740|39623659|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
16311236|NCT02456740|39623660|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
16311237|NCT02456740|39623661|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
16311238|NCT02456740|39623662|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
16504616|NCT00885755|40322086|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
16504617|NCT00885755|40322084|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
16504618|NCT00885755|40322085|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
16504619|NCT00885755|40322086|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
16504620|NCT00885755|40322084|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
16504621|NCT00885755|40322085|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
16504622|NCT00885755|40322086|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
16504623|NCT00885755|40322084|FG000|Part I: Trastuzumab+Taxane|Death|0|||
16504624|NCT00885755|40322085|FG001|Part I: Trastuzumab+Taxane|Death|0|||
16504625|NCT00885755|40322086|FG002|Part I: Trastuzumab+Taxane|Death|1|||
16504626|NCT00885755|40322084|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
16504627|NCT00885755|40322085|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
16504628|NCT00885755|40322086|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
16504629|NCT00923559|40322087|FG000|Overall Study|Lost to Follow-up|2|||
16504630|NCT00923559|40322088|FG001|Overall Study|Lost to Follow-up|3|||
16504631|NCT00772707|40322089|FG000|Overall Study|Withdrawn|3|||
16504632|NCT02357940|40322092|FG000|Overall Study|Adverse Event|0|||
16504633|NCT02357940|40322093|FG001|Overall Study|Adverse Event|1|||
16504634|NCT02357940|40322092|FG000|Overall Study|Investigator's judgement|0|||
16504635|NCT02357940|40322093|FG001|Overall Study|Investigator's judgement|1|||
16504636|NCT02068222|40322094|FG000|Overall Study|Lost to Follow-up|1|||
16311239|NCT02456740|39623654|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
16504637|NCT00335972|40322100|FG000|Overall Study|not given treatments|0|||
16504638|NCT00335972|40322101|FG001|Overall Study|not given treatments|3|||
16504639|NCT00278954|40322108|FG000|Overall Study|Adverse Event|3|||
16504640|NCT00278954|40322108|FG000|Overall Study|Lost to Follow-up|1|||
16504641|NCT00278954|40322108|FG000|Overall Study|Withdrawal by Subject|1|||
16504642|NCT00729183|40322109|FG000|Overall Study|Adverse Event|11|||
16504643|NCT00729183|40322110|FG001|Overall Study|Adverse Event|5|||
16504644|NCT00729183|40322109|FG000|Overall Study|Lack of Efficacy|0|||
16504645|NCT00729183|40322110|FG001|Overall Study|Lack of Efficacy|1|||
16504646|NCT00729183|40322109|FG000|Overall Study|Lost to Follow-up|3|||
16504647|NCT00729183|40322110|FG001|Overall Study|Lost to Follow-up|1|||
16504648|NCT00729183|40322109|FG000|Overall Study|Physician Decision|1|||
16504649|NCT00729183|40322110|FG001|Overall Study|Physician Decision|1|||
16504650|NCT00729183|40322109|FG000|Overall Study|Protocol Violation|1|||
16504651|NCT00729183|40322110|FG001|Overall Study|Protocol Violation|0|||
16504652|NCT00729183|40322109|FG000|Overall Study|Withdrawal by Subject|9|||
16504653|NCT00729183|40322110|FG001|Overall Study|Withdrawal by Subject|7|||
16504654|NCT02738333|40322112|FG000|Overall Study|Death|1|||
16504655|NCT02738333|40322113|FG001|Overall Study|Death|0|||
16311240|NCT02456740|39623655|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
16311241|NCT02456740|39623656|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
16311242|NCT02456740|39623657|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
16311243|NCT02456740|39623658|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
16311244|NCT02456740|39623659|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
16504656|NCT02738333|40322114|FG002|Overall Study|Death|0|||
16504657|NCT02738333|40322112|FG000|Overall Study|Lost to Follow-up|1|||
16504658|NCT02738333|40322113|FG001|Overall Study|Lost to Follow-up|0|||
16089744|NCT00670488|38819989|FG009|Overall Study|Adverse Event|1|||
16504659|NCT02738333|40322114|FG002|Overall Study|Lost to Follow-up|0|||
16504660|NCT01955161|40322116|FG000|Overall Study|Withdrawal before treatment|2|||
16504661|NCT01955161|40322117|FG001|Overall Study|Withdrawal before treatment|0|||
16504662|NCT01955161|40322118|FG002|Overall Study|Withdrawal before treatment|1|||
16504663|NCT01955161|40322116|FG000|Overall Study|Adverse Event|10|||
16504664|NCT01955161|40322117|FG001|Overall Study|Adverse Event|14|||
16504665|NCT01955161|40322118|FG002|Overall Study|Adverse Event|15|||
16311245|NCT02456740|39623660|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
16311246|NCT02456740|39623661|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
16311247|NCT02456740|39623662|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
16311248|NCT02456740|39623654|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
16311249|NCT02456740|39623655|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
16311250|NCT02456740|39623656|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
16311251|NCT02456740|39623657|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
16311252|NCT02456740|39623658|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
16311253|NCT02456740|39623659|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
16311254|NCT02456740|39623660|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
16311255|NCT02456740|39623661|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
16311256|NCT02456740|39623662|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
16311257|NCT02456740|39623654|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
16311258|NCT02456740|39623655|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
16311259|NCT02456740|39623656|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
16311260|NCT02456740|39623657|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
16311261|NCT02456740|39623658|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
16311262|NCT02456740|39623659|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
16311263|NCT02456740|39623660|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
16311264|NCT02456740|39623661|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
16311265|NCT02456740|39623662|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
16311266|NCT02456740|39623654|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16311267|NCT02456740|39623655|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16311268|NCT02456740|39623656|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16311269|NCT02456740|39623657|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
16311270|NCT02456740|39623658|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
16311271|NCT02456740|39623659|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
16390383|NCT00603941|39912064|FG001|Overall Study|Adverse Event|0|||
16390384|NCT00603941|39912065|FG002|Overall Study|Adverse Event|1|||
16390385|NCT00603941|39912063|FG000|Overall Study|Physician Decision|0|||
16089745|NCT00670488|38819980|FG000|Overall Study|Physician Decision|1|||
16390386|NCT00603941|39912064|FG001|Overall Study|Physician Decision|1|||
16311272|NCT02456740|39623660|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
16311273|NCT02456740|39623661|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
16311274|NCT02456740|39623662|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
16311275|NCT02456740|39623654|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
16311276|NCT02456740|39623655|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
16311277|NCT02456740|39623656|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
16311278|NCT02456740|39623657|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
16311279|NCT02456740|39623658|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
16311280|NCT02456740|39623659|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
16311281|NCT02456740|39623660|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
16311282|NCT02456740|39623661|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
16311283|NCT02456740|39623662|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
16311284|NCT02456740|39623654|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16311285|NCT02456740|39623655|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16311286|NCT02456740|39623656|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16311287|NCT02456740|39623657|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
16504666|NCT01955161|40322116|FG000|Overall Study|Death|1|||
16504667|NCT01955161|40322117|FG001|Overall Study|Death|1|||
16504668|NCT01955161|40322118|FG002|Overall Study|Death|3|||
16504669|NCT01955161|40322116|FG000|Overall Study|Withdrawal by Subject|9|||
16504670|NCT01955161|40322117|FG001|Overall Study|Withdrawal by Subject|8|||
16504671|NCT01955161|40322118|FG002|Overall Study|Withdrawal by Subject|12|||
16504672|NCT01955161|40322116|FG000|Overall Study|Protocol Violation|2|||
16504673|NCT01955161|40322117|FG001|Overall Study|Protocol Violation|0|||
16504674|NCT01955161|40322118|FG002|Overall Study|Protocol Violation|0|||
16504675|NCT01955161|40322116|FG000|Overall Study|Other reason: physician decision|0|||
16504676|NCT01955161|40322117|FG001|Overall Study|Other reason: physician decision|1|||
16504677|NCT01955161|40322118|FG002|Overall Study|Other reason: physician decision|1|||
16504678|NCT01955161|40322116|FG000|Overall Study|Other reason: disallowed medication|1|||
16504679|NCT01955161|40322117|FG001|Overall Study|Other reason: disallowed medication|0|||
16504680|NCT01955161|40322118|FG002|Overall Study|Other reason: disallowed medication|1|||
16504681|NCT01955161|40322116|FG000|Overall Study|Other reason: caregiver unavailable|1|||
16504682|NCT01955161|40322117|FG001|Overall Study|Other reason: caregiver unavailable|0|||
16504683|NCT01955161|40322118|FG002|Overall Study|Other reason: caregiver unavailable|0|||
16504684|NCT01955161|40322116|FG000|Overall Study|Other reason: moved to nursing home|0|||
16504685|NCT01955161|40322117|FG001|Overall Study|Other reason: moved to nursing home|1|||
16504686|NCT01955161|40322118|FG002|Overall Study|Other reason: moved to nursing home|0|||
16504687|NCT01955161|40322116|FG000|Overall Study|Other reason: insufficient compliance|0|||
16504688|NCT01955161|40322117|FG001|Overall Study|Other reason: insufficient compliance|0|||
16504689|NCT01955161|40322118|FG002|Overall Study|Other reason: insufficient compliance|1|||
16504690|NCT01955161|40322116|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
16504691|NCT01955161|40322117|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
16504692|NCT01955161|40322118|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
16504693|NCT01955161|40322116|FG000|Overall Study|Other reason: patient's will|0|||
16504694|NCT01955161|40322117|FG001|Overall Study|Other reason: patient's will|0|||
16504695|NCT01955161|40322118|FG002|Overall Study|Other reason: patient's will|1|||
16504696|NCT01522365|40322119|FG000|Overall Study|Withdrawal by Subject|1|||
16504697|NCT01522365|40322120|FG001|Overall Study|Withdrawal by Subject|1|||
16504698|NCT01522365|40322119|FG000|Overall Study|Lost to Follow-up|1|||
16311288|NCT02456740|39623658|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
16311289|NCT02456740|39623659|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
16311290|NCT02456740|39623660|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
16311291|NCT02456740|39623661|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
16311292|NCT02456740|39623662|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
16311293|NCT03866577|39623663|FG000|Overall Study|Protocol Violation|0|||
16311294|NCT03866577|39623664|FG001|Overall Study|Protocol Violation|0|||
16311295|NCT03866577|39623665|FG002|Overall Study|Protocol Violation|0|||
16311296|NCT03866577|39623666|FG003|Overall Study|Protocol Violation|0|||
16311297|NCT03866577|39623667|FG004|Overall Study|Protocol Violation|0|||
16311298|NCT03866577|39623668|FG005|Overall Study|Protocol Violation|0|||
16311299|NCT03866577|39623669|FG006|Overall Study|Protocol Violation|0|||
16311300|NCT03866577|39623670|FG007|Overall Study|Protocol Violation|0|||
16311301|NCT03866577|39623671|FG008|Overall Study|Protocol Violation|0|||
16311302|NCT03866577|39623672|FG009|Overall Study|Protocol Violation|0|||
16311303|NCT03866577|39623673|FG010|Overall Study|Protocol Violation|0|||
16311304|NCT03866577|39623674|FG011|Overall Study|Protocol Violation|1|||
16504699|NCT01522365|40322120|FG001|Overall Study|Lost to Follow-up|1|||
16504700|NCT00665353|40322121|FG000|Study Step 1|Adverse Event|1|||
16504701|NCT00665353|40322121|FG000|Study Step 1|Withdrawal by Subject|2|||
16504702|NCT00665353|40322121|FG000|Study Step 2|Lost to Follow-up|2|||
16504703|NCT00665353|40322121|FG000|Study Step 2|Lack of Efficacy|12|||
16311305|NCT03866577|39623675|FG012|Overall Study|Protocol Violation|0|||
16504704|NCT00352846|40322128|FG000|Overall Study|Disease progression|0|||
16311306|NCT03866577|39623663|FG000|Overall Study|Withdrawal by Subject|0|||
16311307|NCT03866577|39623664|FG001|Overall Study|Withdrawal by Subject|0|||
16311308|NCT03866577|39623665|FG002|Overall Study|Withdrawal by Subject|0|||
16311309|NCT03866577|39623666|FG003|Overall Study|Withdrawal by Subject|0|||
16311310|NCT03866577|39623667|FG004|Overall Study|Withdrawal by Subject|0|||
16311311|NCT03866577|39623668|FG005|Overall Study|Withdrawal by Subject|0|||
16311312|NCT03866577|39623669|FG006|Overall Study|Withdrawal by Subject|0|||
16311313|NCT03866577|39623670|FG007|Overall Study|Withdrawal by Subject|0|||
16311314|NCT03866577|39623671|FG008|Overall Study|Withdrawal by Subject|1|||
16311315|NCT03866577|39623672|FG009|Overall Study|Withdrawal by Subject|1|||
16311316|NCT03866577|39623673|FG010|Overall Study|Withdrawal by Subject|0|||
16504705|NCT00352846|40322129|FG001|Overall Study|Disease progression|2|||
16504706|NCT00352846|40322128|FG000|Overall Study|Withdrawal by Subject|3|||
16504707|NCT00352846|40322129|FG001|Overall Study|Withdrawal by Subject|8|||
16504708|NCT00352846|40322128|FG000|Overall Study|Ineligible|3|||
16504709|NCT00352846|40322129|FG001|Overall Study|Ineligible|2|||
16504710|NCT00352846|40322128|FG000|Overall Study|Non-compliance|2|||
16504711|NCT00352846|40322129|FG001|Overall Study|Non-compliance|0|||
16504712|NCT00352846|40322128|FG000|Overall Study|Death|0|||
16504713|NCT00352846|40322129|FG001|Overall Study|Death|1|||
16504714|NCT01082965|40322130|FG000|Overall Study|Protocol Violation|0|||
16504715|NCT01082965|40322131|FG001|Overall Study|Protocol Violation|1|||
16504716|NCT01082965|40322130|FG000|Overall Study|Other|1|||
16504717|NCT01082965|40322131|FG001|Overall Study|Other|1|||
16504718|NCT00853723|40322132|FG000|Overall Study|Adverse Event|3|||
16311317|NCT03866577|39623674|FG011|Overall Study|Withdrawal by Subject|0|||
16311318|NCT03866577|39623675|FG012|Overall Study|Withdrawal by Subject|0|||
16311319|NCT03866577|39623663|FG000|Overall Study|Not qualified for IVIg infusion|0|||
16311320|NCT03866577|39623664|FG001|Overall Study|Not qualified for IVIg infusion|0|||
16311321|NCT03866577|39623665|FG002|Overall Study|Not qualified for IVIg infusion|0|||
16311322|NCT03866577|39623666|FG003|Overall Study|Not qualified for IVIg infusion|0|||
16311323|NCT03866577|39623667|FG004|Overall Study|Not qualified for IVIg infusion|0|||
16390387|NCT00603941|39912065|FG002|Overall Study|Physician Decision|0|||
16390388|NCT00603941|39912063|FG000|Overall Study|Withdrawal by Subject|0|||
16390389|NCT00603941|39912064|FG001|Overall Study|Withdrawal by Subject|2|||
16390390|NCT00603941|39912065|FG002|Overall Study|Withdrawal by Subject|0|||
16390391|NCT00976716|39912066|FG000|Overall Study|Adverse Event|1|||
16390392|NCT02441101|39912067|FG000|Overall Study|Withdrawal by Subject|1|||
16390393|NCT02441101|39912068|FG001|Overall Study|Withdrawal by Subject|0|||
16390394|NCT02441101|39912067|FG000|Overall Study|Lost to Follow-up|1|||
16390395|NCT02441101|39912068|FG001|Overall Study|Lost to Follow-up|0|||
16390396|NCT02441101|39912067|FG000|Overall Study|PI relocated and study terminated|1|||
16390397|NCT02441101|39912068|FG001|Overall Study|PI relocated and study terminated|0|||
16504719|NCT00853723|40322133|FG001|Overall Study|Adverse Event|4|||
16504720|NCT00853723|40322134|FG002|Overall Study|Adverse Event|1|||
16311324|NCT03866577|39623668|FG005|Overall Study|Not qualified for IVIg infusion|0|||
16390398|NCT03497039|39912071|FG000|Overall Study|Withdrawal by Subject|1|||
16504721|NCT00853723|40322132|FG000|Overall Study|Withdrawal by Subject|2|||
16390399|NCT03497039|39912072|FG001|Overall Study|Withdrawal by Subject|0|||
16390400|NCT03497039|39912071|FG000|Overall Study|Protocol Violation|0|||
16390401|NCT03497039|39912072|FG001|Overall Study|Protocol Violation|1|||
16390402|NCT02503085|39912074|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
16390403|NCT02503085|39912075|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
16390404|NCT02503085|39912076|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
16390405|NCT02503085|39912077|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
16390406|NCT00619918|39915855|FG000|Overall Study|Withdrawal by Subject|4|||
16390407|NCT00619918|39915856|FG001|Overall Study|Withdrawal by Subject|3|||
16390408|NCT00619918|39915855|FG000|Overall Study|Physician Decision|8|||
16390409|NCT00619918|39915856|FG001|Overall Study|Physician Decision|8|||
16390410|NCT00619918|39915855|FG000|Overall Study|Transfer to outside facility|3|||
16390411|NCT00619918|39915856|FG001|Overall Study|Transfer to outside facility|3|||
16390412|NCT00619918|39915855|FG000|Overall Study|Left before receiving first dose|5|||
16390413|NCT00619918|39915856|FG001|Overall Study|Left before receiving first dose|8|||
16390414|NCT04703192|39915858|FG000|Overall Study|Withdrawal by Subject|2|||
16390415|NCT04703192|39915859|FG001|Overall Study|Withdrawal by Subject|0|||
16390416|NCT04703192|39915858|FG000|Overall Study|Death|3|||
16390417|NCT04703192|39915859|FG001|Overall Study|Death|1|||
16390418|NCT04703192|39915858|FG000|Overall Study|Adverse Event|13|||
16390419|NCT04703192|39915859|FG001|Overall Study|Adverse Event|2|||
16390420|NCT04703192|39915858|FG000|Overall Study|Progressive or Relapsed Disease|46|||
16390421|NCT04703192|39915859|FG001|Overall Study|Progressive or Relapsed Disease|7|||
16390422|NCT04703192|39915858|FG000|Overall Study|Clinical Progression|19|||
16390423|NCT04703192|39915859|FG001|Overall Study|Clinical Progression|8|||
16390424|NCT04703192|39915858|FG000|Overall Study|Lost to Follow-up|1|||
16390425|NCT04703192|39915859|FG001|Overall Study|Lost to Follow-up|0|||
16390426|NCT04703192|39915858|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
16390427|NCT04703192|39915859|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
16390428|NCT04703192|39915858|FG000|Overall Study|Other|5|||
16390429|NCT04703192|39915859|FG001|Overall Study|Other|1|||
16390430|NCT01244035|39915874|FG000|Part 1: Period 1|Adverse Event|0|||
16390431|NCT01244035|39915875|FG001|Part 1: Period 1|Adverse Event|0|||
16311325|NCT03866577|39623669|FG006|Overall Study|Not qualified for IVIg infusion|0|||
16311326|NCT03866577|39623670|FG007|Overall Study|Not qualified for IVIg infusion|0|||
16311327|NCT03866577|39623671|FG008|Overall Study|Not qualified for IVIg infusion|0|||
16311328|NCT03866577|39623672|FG009|Overall Study|Not qualified for IVIg infusion|1|||
16311329|NCT03866577|39623673|FG010|Overall Study|Not qualified for IVIg infusion|0|||
16311330|NCT03866577|39623674|FG011|Overall Study|Not qualified for IVIg infusion|0|||
16311331|NCT03866577|39623675|FG012|Overall Study|Not qualified for IVIg infusion|0|||
16390432|NCT01244035|39915876|FG002|Part 1: Period 1|Adverse Event|0|||
16390433|NCT01244035|39915877|FG003|Part 1: Period 1|Adverse Event|0|||
16390434|NCT01244035|39915878|FG004|Part 1: Period 1|Adverse Event|0|||
16390435|NCT01244035|39915879|FG005|Part 1: Period 1|Adverse Event|1|||
16390436|NCT01244035|39915874|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
16390437|NCT01244035|39915875|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
16390438|NCT01244035|39915876|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
16390439|NCT01244035|39915877|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
16390440|NCT01244035|39915878|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
16390441|NCT01244035|39915879|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
16390442|NCT01244035|39915874|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
16390443|NCT01244035|39915875|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
16390444|NCT01244035|39915876|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
16390445|NCT01244035|39915877|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
16390446|NCT01244035|39915878|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
16390447|NCT01244035|39915879|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
16390448|NCT01244035|39915874|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
16390449|NCT01244035|39915875|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
16311332|NCT03305848|39623676|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
16311333|NCT03305848|39623676|FG000|Overall Study|Physician Decision|2|||
16311334|NCT01403051|39623677|FG000|Overall Study|Protocol Violation|2|||
16311335|NCT01403051|39623678|FG001|Overall Study|Protocol Violation|0|||
16311336|NCT01403051|39623677|FG000|Overall Study|Death|1|||
16311337|NCT01403051|39623678|FG001|Overall Study|Death|0|||
16311338|NCT01403051|39623677|FG000|Overall Study|Withdrawal by Subject|2|||
16504722|NCT00853723|40322133|FG001|Overall Study|Withdrawal by Subject|1|||
16504723|NCT00853723|40322134|FG002|Overall Study|Withdrawal by Subject|0|||
16504724|NCT00853723|40322132|FG000|Overall Study|Protocol Violation|1|||
16504725|NCT00853723|40322133|FG001|Overall Study|Protocol Violation|2|||
16504726|NCT00853723|40322134|FG002|Overall Study|Protocol Violation|1|||
16504727|NCT03329690|40322135|FG000|Overall Study|Progressive disease per RECIST|85|||
16504728|NCT03329690|40322136|FG001|Overall Study|Progressive disease per RECIST|44|||
16311339|NCT01403051|39623678|FG001|Overall Study|Withdrawal by Subject|1|||
16311340|NCT01403051|39623677|FG000|Overall Study|Lost to Follow-up|5|||
16311341|NCT01403051|39623678|FG001|Overall Study|Lost to Follow-up|5|||
16311342|NCT01383174|39623679|FG000|3 Month Assessment|Death|0|||
16504729|NCT03329690|40322137|FG002|Overall Study|Progressive disease per RECIST|6|||
16504730|NCT03329690|40322138|FG003|Overall Study|Progressive disease per RECIST|16|||
16504731|NCT03329690|40322139|FG004|Overall Study|Progressive disease per RECIST|20|||
16504732|NCT03329690|40322135|FG000|Overall Study|Clinical progression|7|||
16504733|NCT03329690|40322136|FG001|Overall Study|Clinical progression|4|||
16504734|NCT03329690|40322137|FG002|Overall Study|Clinical progression|1|||
16504735|NCT03329690|40322138|FG003|Overall Study|Clinical progression|1|||
16311343|NCT01383174|39623680|FG001|3 Month Assessment|Death|1|||
16311344|NCT01383174|39623679|FG000|3 Month Assessment|Lost to Follow-up|2|||
16311345|NCT01383174|39623680|FG001|3 Month Assessment|Lost to Follow-up|0|||
16390450|NCT01244035|39915876|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
16390451|NCT01244035|39915877|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
16390452|NCT01244035|39915878|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
16390453|NCT01244035|39915879|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
16390454|NCT01244035|39915874|FG000|Part 1: Period 3|Adverse Event|0|||
16390455|NCT01244035|39915875|FG001|Part 1: Period 3|Adverse Event|0|||
16390456|NCT01244035|39915876|FG002|Part 1: Period 3|Adverse Event|0|||
16390457|NCT01244035|39915877|FG003|Part 1: Period 3|Adverse Event|0|||
16390458|NCT01244035|39915878|FG004|Part 1: Period 3|Adverse Event|0|||
16390459|NCT01244035|39915879|FG005|Part 1: Period 3|Adverse Event|1|||
16390460|NCT01244035|39915874|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
16390461|NCT01244035|39915875|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
16390462|NCT01244035|39915876|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
16504736|NCT03329690|40322139|FG004|Overall Study|Clinical progression|1|||
16504737|NCT03329690|40322135|FG000|Overall Study|Adverse Event|22|||
16504738|NCT03329690|40322136|FG001|Overall Study|Adverse Event|4|||
16311346|NCT01383174|39623679|FG000|3 Month Assessment|Refused to complete|4|||
16311347|NCT01383174|39623680|FG001|3 Month Assessment|Refused to complete|0|||
16311348|NCT01383174|39623679|FG000|6 Month Assessment|Lost to Follow-up|1|||
16390463|NCT01244035|39915877|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
16390464|NCT01244035|39915878|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
16311349|NCT01383174|39623680|FG001|6 Month Assessment|Lost to Follow-up|1|||
16390465|NCT01244035|39915879|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
16390466|NCT01244035|39915874|FG000|Part 1: Period 3|Protocol Deviation|0|||
16390467|NCT01244035|39915875|FG001|Part 1: Period 3|Protocol Deviation|1|||
16390468|NCT01244035|39915876|FG002|Part 1: Period 3|Protocol Deviation|0|||
16390469|NCT01244035|39915877|FG003|Part 1: Period 3|Protocol Deviation|0|||
16390470|NCT01244035|39915878|FG004|Part 1: Period 3|Protocol Deviation|0|||
16390471|NCT01244035|39915879|FG005|Part 1: Period 3|Protocol Deviation|0|||
16390472|NCT00570323|39915880|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
16390473|NCT00570323|39915881|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
16390474|NCT00570323|39915880|FG000|Started Treatment After Randomization|Protocol Violation|1|||
16390475|NCT00570323|39915881|FG001|Started Treatment After Randomization|Protocol Violation|0|||
16390476|NCT00570323|39915880|FG000|Started Treatment After Randomization|Physician Decision|1|||
16390477|NCT00570323|39915881|FG001|Started Treatment After Randomization|Physician Decision|0|||
16390478|NCT00570323|39915880|FG000|Complete Study After Start|Lost to Follow-up|0|||
16390479|NCT00570323|39915881|FG001|Complete Study After Start|Lost to Follow-up|1|||
16311350|NCT01383174|39623679|FG000|6 Month Assessment|Refused to complete|4|||
16311351|NCT01383174|39623680|FG001|6 Month Assessment|Refused to complete|0|||
16311352|NCT00560391|39623681|FG000|Overall Study|Still on treatment|0|||
16311353|NCT00560391|39623682|FG001|Overall Study|Still on treatment|0|||
16311354|NCT00560391|39623683|FG002|Overall Study|Still on treatment|0|||
16311355|NCT00560391|39623684|FG003|Overall Study|Still on treatment|1|||
16311356|NCT00560391|39623685|FG004|Overall Study|Still on treatment|2|||
16311357|NCT03871543|39623686|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
16311358|NCT03871543|39623686|FG000|Period 1|Investigator Error|1|||
16311359|NCT03871543|39623686|FG000|Period 1|Protocol Violation|2|||
16311360|NCT03871543|39623686|FG000|Period 1|COVID-19 Related|1|||
16311361|NCT03871543|39623686|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
16311362|NCT03871543|39623686|FG000|Period 1|Withdrawal by Subject|10|||
16311363|NCT03871543|39623686|FG000|Period 2|Adverse Event|1|||
16311364|NCT03871543|39623686|FG000|Period 2|Withdrawal by Subject|1|||
16311365|NCT00594165|39623691|FG000|Overall Study|Major protocol violation|1|||
16311366|NCT00594165|39623691|FG000|Overall Study|Lack of Efficacy|12|||
16311367|NCT00594165|39623691|FG000|Overall Study|Adverse Event|52|||
16311368|NCT00594165|39623691|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
16311369|NCT00594165|39623691|FG000|Overall Study|Subject withdrew consent|27|||
16311370|NCT00594165|39623691|FG000|Overall Study|Study ended per sponsor|102|||
16311371|NCT00594165|39623691|FG000|Overall Study|Lost to Follow-up|4|||
16311372|NCT00594165|39623691|FG000|Overall Study|Other: PI discretion|5|||
16311373|NCT00594165|39623691|FG000|Overall Study|Other: Subject moving|3|||
16311374|NCT00594165|39623691|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
16311375|NCT00594165|39623691|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
16311376|NCT00594165|39623691|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
16311377|NCT00594165|39623691|FG000|Overall Study|Other: Site terminated participation|2|||
16311378|NCT02792517|39623692|FG000|Overall Study|Withdrawal by Subject|10|||
16311379|NCT02792517|39623692|FG000|Overall Study|Decision by Sponsor|7|||
16311380|NCT02792517|39623692|FG000|Overall Study|Lost to Follow-up|3|||
16311381|NCT01070953|39623693|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
16311382|NCT01070953|39623693|FG000|Participants for Safety Evaluation|Off-label use|283|||
16311383|NCT01070953|39623693|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
16311384|NCT01070953|39623693|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
16311385|NCT01070953|39623693|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
16390480|NCT00570323|39915880|FG000|Complete Study After Start|Withdrawal by Subject|2|||
16504739|NCT03329690|40322137|FG002|Overall Study|Adverse Event|0|||
16311386|NCT01070953|39623693|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
16311387|NCT01070953|39623693|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
16311388|NCT01070953|39623693|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
16311389|NCT01070953|39623693|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
16311390|NCT01070953|39623693|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
16504740|NCT03329690|40322138|FG003|Overall Study|Adverse Event|1|||
16311391|NCT01977417|39623695|FG000|Overall Study|Adverse Event|1|||
16311392|NCT01977417|39623696|FG001|Overall Study|Adverse Event|0|||
16311393|NCT01977417|39623695|FG000|Overall Study|Withdrawal by Subject|2|||
16311394|NCT01977417|39623696|FG001|Overall Study|Withdrawal by Subject|4|||
16311395|NCT01977417|39623695|FG000|Overall Study|Female enrollment goal met|0|||
16311396|NCT01977417|39623696|FG001|Overall Study|Female enrollment goal met|2|||
16311397|NCT05005507|39623697|FG000|Overall Study|Premature termination of study|1|||
16311398|NCT03850483|39623700|FG000|Treatment for Stage 1|Adverse Event|1|||
16311399|NCT03850483|39623701|FG001|Treatment for Stage 1|Adverse Event|1|||
16311400|NCT03850483|39623702|FG002|Treatment for Stage 1|Adverse Event|3|||
16311401|NCT03850483|39623703|FG003|Treatment for Stage 1|Adverse Event|0|||
16311402|NCT03850483|39623704|FG004|Treatment for Stage 1|Adverse Event|2|||
16311403|NCT03850483|39623705|FG005|Treatment for Stage 1|Adverse Event|0|||
16311404|NCT03850483|39623706|FG006|Treatment for Stage 1|Adverse Event|2|||
16311405|NCT03850483|39623707|FG007|Treatment for Stage 1|Adverse Event|2|||
16311406|NCT03850483|39623708|FG008|Treatment for Stage 1|Adverse Event|0|||
16311407|NCT03850483|39623709|FG009|Treatment for Stage 1|Adverse Event|0|||
16311408|NCT03850483|39623700|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
16311409|NCT03850483|39623701|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
16311410|NCT03850483|39623702|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
16311411|NCT03850483|39623703|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
16311412|NCT03850483|39623704|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
16311413|NCT03850483|39623705|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
16311414|NCT03850483|39623706|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
16311415|NCT03850483|39623707|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
16311416|NCT03850483|39623708|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
16390481|NCT00570323|39915881|FG001|Complete Study After Start|Withdrawal by Subject|0|||
16390482|NCT00570323|39915880|FG000|Complete Study After Start|Physician Decision|1|||
16390483|NCT00570323|39915881|FG001|Complete Study After Start|Physician Decision|0|||
16390484|NCT01898286|39915882|FG000|Overall Study|Withdrawal by Subject|1|||
16390485|NCT01898286|39915882|FG000|Overall Study|Protocol Violation|1|||
16390486|NCT01898286|39915882|FG000|Overall Study|Lost to Follow-up|1|||
16390487|NCT03688919|39915883|FG000|Overall Study|Lost to Follow-up|2|||
16390488|NCT03688919|39915884|FG001|Overall Study|Lost to Follow-up|1|||
16390489|NCT03688919|39915883|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
16390490|NCT03688919|39915884|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
16390491|NCT02311881|39915887|FG000|Overall Study|Did not meet the study criteria|2|||
16390492|NCT02311881|39915888|FG001|Overall Study|Did not meet the study criteria|2|||
16390493|NCT02311881|39915889|FG002|Overall Study|Did not meet the study criteria|0|||
16390494|NCT02311881|39915887|FG000|Overall Study|Adverse Event|7|||
16390495|NCT02311881|39915888|FG001|Overall Study|Adverse Event|15|||
16390496|NCT02311881|39915889|FG002|Overall Study|Adverse Event|8|||
16390497|NCT02311881|39915887|FG000|Overall Study|Lost to Follow-up|3|||
16390498|NCT02311881|39915888|FG001|Overall Study|Lost to Follow-up|3|||
16390499|NCT02311881|39915889|FG002|Overall Study|Lost to Follow-up|2|||
16390500|NCT02311881|39915887|FG000|Overall Study|Protocol Violation|1|||
16390501|NCT02311881|39915888|FG001|Overall Study|Protocol Violation|2|||
16390502|NCT02311881|39915889|FG002|Overall Study|Protocol Violation|3|||
16390503|NCT02311881|39915887|FG000|Overall Study|Withdrawal of consent|14|||
16390504|NCT02311881|39915888|FG001|Overall Study|Withdrawal of consent|16|||
16390505|NCT02311881|39915889|FG002|Overall Study|Withdrawal of consent|17|||
16390506|NCT02311881|39915887|FG000|Overall Study|Other|0|||
16390507|NCT02311881|39915888|FG001|Overall Study|Other|0|||
16390508|NCT02311881|39915889|FG002|Overall Study|Other|1|||
16390509|NCT02311881|39915887|FG000|Overall Study|Lack of Efficacy|1|||
16311417|NCT03850483|39623709|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
16311418|NCT03850483|39623700|FG000|Treatment for Stage 1|Protocol Violation|1|||
16311419|NCT03850483|39623701|FG001|Treatment for Stage 1|Protocol Violation|0|||
16311420|NCT03850483|39623702|FG002|Treatment for Stage 1|Protocol Violation|0|||
16311421|NCT03850483|39623703|FG003|Treatment for Stage 1|Protocol Violation|0|||
16311422|NCT03850483|39623704|FG004|Treatment for Stage 1|Protocol Violation|0|||
16311423|NCT03850483|39623705|FG005|Treatment for Stage 1|Protocol Violation|0|||
16311424|NCT03850483|39623706|FG006|Treatment for Stage 1|Protocol Violation|1|||
16390510|NCT02311881|39915888|FG001|Overall Study|Lack of Efficacy|2|||
16311425|NCT03850483|39623707|FG007|Treatment for Stage 1|Protocol Violation|0|||
16311426|NCT03850483|39623708|FG008|Treatment for Stage 1|Protocol Violation|0|||
16311427|NCT03850483|39623709|FG009|Treatment for Stage 1|Protocol Violation|0|||
16311428|NCT03850483|39623700|FG000|Treatment for Stage 1|Physician Decision|0|||
16390511|NCT02311881|39915889|FG002|Overall Study|Lack of Efficacy|0|||
16390512|NCT02311881|39915887|FG000|Overall Study|Subject has border line pregnancy test|1|||
16390513|NCT02311881|39915888|FG001|Overall Study|Subject has border line pregnancy test|0|||
16390514|NCT02311881|39915889|FG002|Overall Study|Subject has border line pregnancy test|0|||
16390515|NCT02311881|39915887|FG000|Overall Study|Withdrawal by Subject|3|||
16390516|NCT02311881|39915888|FG001|Overall Study|Withdrawal by Subject|1|||
16311429|NCT03850483|39623701|FG001|Treatment for Stage 1|Physician Decision|0|||
16311430|NCT03850483|39623702|FG002|Treatment for Stage 1|Physician Decision|0|||
16311431|NCT03850483|39623703|FG003|Treatment for Stage 1|Physician Decision|0|||
16504741|NCT03329690|40322139|FG004|Overall Study|Adverse Event|2|||
16504742|NCT03329690|40322135|FG000|Overall Study|Death|2|||
16504743|NCT03329690|40322136|FG001|Overall Study|Death|0|||
16504744|NCT03329690|40322137|FG002|Overall Study|Death|0|||
16504745|NCT03329690|40322138|FG003|Overall Study|Death|1|||
16504746|NCT03329690|40322139|FG004|Overall Study|Death|0|||
16504747|NCT03329690|40322135|FG000|Overall Study|Withdrawal by Subject|2|||
16504748|NCT03329690|40322136|FG001|Overall Study|Withdrawal by Subject|3|||
16504749|NCT03329690|40322137|FG002|Overall Study|Withdrawal by Subject|0|||
16504750|NCT03329690|40322138|FG003|Overall Study|Withdrawal by Subject|1|||
16504751|NCT03329690|40322139|FG004|Overall Study|Withdrawal by Subject|0|||
16504752|NCT03329690|40322135|FG000|Overall Study|Physician Decision|1|||
16504753|NCT03329690|40322136|FG001|Overall Study|Physician Decision|0|||
16504754|NCT03329690|40322137|FG002|Overall Study|Physician Decision|0|||
16504755|NCT03329690|40322138|FG003|Overall Study|Physician Decision|0|||
16504756|NCT03329690|40322139|FG004|Overall Study|Physician Decision|1|||
16504757|NCT03329690|40322135|FG000|Overall Study|Miscellaneous|6|||
16504758|NCT03329690|40322136|FG001|Overall Study|Miscellaneous|0|||
16504759|NCT03329690|40322137|FG002|Overall Study|Miscellaneous|0|||
16504760|NCT03329690|40322138|FG003|Overall Study|Miscellaneous|0|||
16504761|NCT03329690|40322139|FG004|Overall Study|Miscellaneous|0|||
16311432|NCT03850483|39623704|FG004|Treatment for Stage 1|Physician Decision|0|||
16311433|NCT03850483|39623705|FG005|Treatment for Stage 1|Physician Decision|1|||
16311434|NCT03850483|39623706|FG006|Treatment for Stage 1|Physician Decision|0|||
16311435|NCT03850483|39623707|FG007|Treatment for Stage 1|Physician Decision|0|||
16311436|NCT03850483|39623708|FG008|Treatment for Stage 1|Physician Decision|0|||
16311437|NCT03850483|39623709|FG009|Treatment for Stage 1|Physician Decision|0|||
16311438|NCT03850483|39623700|FG000|Treatment for Stage 1|Other|0|||
16311439|NCT03850483|39623701|FG001|Treatment for Stage 1|Other|0|||
16311440|NCT03850483|39623702|FG002|Treatment for Stage 1|Other|0|||
16311441|NCT03850483|39623703|FG003|Treatment for Stage 1|Other|0|||
16311442|NCT03850483|39623704|FG004|Treatment for Stage 1|Other|2|||
16311443|NCT03850483|39623705|FG005|Treatment for Stage 1|Other|1|||
16311444|NCT03850483|39623706|FG006|Treatment for Stage 1|Other|0|||
16311445|NCT03850483|39623707|FG007|Treatment for Stage 1|Other|0|||
16311446|NCT03850483|39623708|FG008|Treatment for Stage 1|Other|0|||
16311447|NCT03850483|39623709|FG009|Treatment for Stage 1|Other|0|||
16311448|NCT03850483|39623700|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16311449|NCT03850483|39623701|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16311450|NCT03850483|39623702|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
16311451|NCT03850483|39623703|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16311452|NCT03850483|39623704|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16311453|NCT03850483|39623705|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16311454|NCT03850483|39623706|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16311455|NCT03850483|39623707|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16311456|NCT03850483|39623708|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16311457|NCT03850483|39623709|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
16311458|NCT03850483|39623700|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16311459|NCT03850483|39623701|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16311460|NCT03850483|39623702|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16311461|NCT03850483|39623703|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16504762|NCT03329690|40322135|FG000|Overall Study|Did not receive treatment|1|||
16504763|NCT03329690|40322136|FG001|Overall Study|Did not receive treatment|0|||
16504764|NCT03329690|40322137|FG002|Overall Study|Did not receive treatment|0|||
16504765|NCT03329690|40322138|FG003|Overall Study|Did not receive treatment|1|||
16504766|NCT03329690|40322139|FG004|Overall Study|Did not receive treatment|0|||
16504767|NCT03060447|40322142|FG000|Overall Study|Withdrawal by Subject|2|||
16504768|NCT03060447|40322143|FG001|Overall Study|Withdrawal by Subject|0|||
16311462|NCT03850483|39623704|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16311463|NCT03850483|39623705|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
16311464|NCT03850483|39623706|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16311465|NCT03850483|39623707|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16311466|NCT03850483|39623708|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16311467|NCT03850483|39623709|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
16311468|NCT03850483|39623700|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
16311469|NCT03850483|39623701|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
16311470|NCT03850483|39623702|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
16311471|NCT03850483|39623703|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
16390517|NCT02311881|39915889|FG002|Overall Study|Withdrawal by Subject|4|||
16390518|NCT02311881|39915887|FG000|Overall Study|Sponsor Decision|1|||
16390519|NCT02311881|39915888|FG001|Overall Study|Sponsor Decision|1|||
16390520|NCT02311881|39915889|FG002|Overall Study|Sponsor Decision|1|||
16390521|NCT02311881|39915887|FG000|Overall Study|Protocol Deviation|1|||
16390522|NCT02311881|39915888|FG001|Overall Study|Protocol Deviation|0|||
16390523|NCT02311881|39915889|FG002|Overall Study|Protocol Deviation|0|||
16390524|NCT02311881|39915887|FG000|Overall Study|Non-Compliance|1|||
16390525|NCT02311881|39915888|FG001|Overall Study|Non-Compliance|0|||
16390526|NCT02311881|39915889|FG002|Overall Study|Non-Compliance|2|||
16089746|NCT00670488|38819981|FG001|Overall Study|Physician Decision|9|||
16390527|NCT02311881|39915887|FG000|Overall Study|Physician Decision|0|||
16390528|NCT02311881|39915888|FG001|Overall Study|Physician Decision|0|||
16390529|NCT02311881|39915889|FG002|Overall Study|Physician Decision|1|||
16390530|NCT02311881|39915887|FG000|Overall Study|Medical Monitor Discretion|0|||
16390531|NCT02311881|39915888|FG001|Overall Study|Medical Monitor Discretion|0|||
16390532|NCT02311881|39915889|FG002|Overall Study|Medical Monitor Discretion|1|||
16390533|NCT02311881|39915887|FG000|Overall Study|Participant taking another medication|0|||
16390534|NCT02311881|39915888|FG001|Overall Study|Participant taking another medication|0|||
16390535|NCT02311881|39915889|FG002|Overall Study|Participant taking another medication|1|||
16390536|NCT02311881|39915887|FG000|Overall Study|Serious Adverse Event|0|||
16390537|NCT02311881|39915888|FG001|Overall Study|Serious Adverse Event|1|||
16390538|NCT02311881|39915889|FG002|Overall Study|Serious Adverse Event|0|||
16390539|NCT00444925|39915894|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
16390540|NCT00444925|39915895|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
16390541|NCT00444925|39915896|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
16390542|NCT00444925|39915894|FG000|Double-blind Treatment Period|Death|2|||
16390543|NCT00444925|39915895|FG001|Double-blind Treatment Period|Death|0|||
16390544|NCT00444925|39915896|FG002|Double-blind Treatment Period|Death|0|||
16390545|NCT00444925|39915894|FG000|Double-blind Treatment Period|Adverse Event|6|||
16390546|NCT00444925|39915895|FG001|Double-blind Treatment Period|Adverse Event|28|||
16390547|NCT00444925|39915896|FG002|Double-blind Treatment Period|Adverse Event|44|||
16390548|NCT00444925|39915894|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
16390549|NCT00444925|39915895|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
16390550|NCT00444925|39915896|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
16390551|NCT00444925|39915894|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
16390552|NCT00444925|39915895|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
16390553|NCT00444925|39915896|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
16390554|NCT00444925|39915894|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
16390555|NCT00444925|39915895|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
16390556|NCT00444925|39915896|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
16390557|NCT00444925|39915894|FG000|Double-blind Treatment Period|Other|7|||
16390558|NCT00444925|39915895|FG001|Double-blind Treatment Period|Other|7|||
16390559|NCT00444925|39915896|FG002|Double-blind Treatment Period|Other|12|||
16390560|NCT04194944|39915899|FG000|Overall Study|Lost to Follow-up|3|||
16390561|NCT04194944|39915900|FG001|Overall Study|Lost to Follow-up|0|||
16390562|NCT04194944|39915899|FG000|Overall Study|Withdrawal by Subject|2|||
16390563|NCT04194944|39915900|FG001|Overall Study|Withdrawal by Subject|2|||
16390564|NCT04194944|39915899|FG000|Overall Study|On Treatment|93|||
16390565|NCT04194944|39915900|FG001|Overall Study|On Treatment|30|||
16390566|NCT04263766|39915901|FG000|Overall Study|Withdrawal by Subject|6|||
16390567|NCT04263766|39915902|FG001|Overall Study|Withdrawal by Subject|4|||
16504769|NCT02357147|40322144|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
16504770|NCT02357147|40322145|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
16504771|NCT02357147|40322144|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
16504772|NCT02357147|40322145|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
16504773|NCT02357147|40322144|FG000|Combination Treatment Phase|Investigator Discretion|1|||
16504774|NCT02357147|40322145|FG001|Combination Treatment Phase|Investigator Discretion|1|||
16504775|NCT02357147|40322144|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
16504776|NCT02357147|40322145|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
16504777|NCT02357147|40322144|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
16504778|NCT02357147|40322145|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
16504779|NCT02357147|40322144|FG000|Combination Treatment Phase|Adverse Event|12|||
16504780|NCT02357147|40322145|FG001|Combination Treatment Phase|Adverse Event|4|||
16504781|NCT02357147|40322144|FG000|Combination Treatment Phase|Death|1|||
16504782|NCT02357147|40322145|FG001|Combination Treatment Phase|Death|1|||
16504783|NCT02357147|40322144|FG000|Combination Treatment Phase|Sponsor Decision|0|||
16504784|NCT02357147|40322145|FG001|Combination Treatment Phase|Sponsor Decision|12|||
16504785|NCT02357147|40322144|FG000|Combination Treatment Phase|Other|1|||
16504786|NCT02357147|40322145|FG001|Combination Treatment Phase|Other|0|||
16504787|NCT02357147|40322144|FG000|Combination Treatment Phase|Not treated|0|||
16504788|NCT02357147|40322145|FG001|Combination Treatment Phase|Not treated|2|||
16504789|NCT02357147|40322144|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
16504790|NCT02357147|40322145|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
16504791|NCT02357147|40322144|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16504792|NCT02357147|40322145|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
16504793|NCT02357147|40322144|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
16504794|NCT02357147|40322145|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
16504795|NCT02357147|40322144|FG000|Maintenance Treatment Phase|Adverse Event|0|||
16504796|NCT02357147|40322145|FG001|Maintenance Treatment Phase|Adverse Event|3|||
16504797|NCT02357147|40322144|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
16504798|NCT02357147|40322145|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
16089747|NCT00670488|38819982|FG002|Overall Study|Physician Decision|0|||
16089748|NCT00670488|38819983|FG003|Overall Study|Physician Decision|1|||
16089749|NCT00670488|38819984|FG004|Overall Study|Physician Decision|0|||
16089750|NCT00670488|38819985|FG005|Overall Study|Physician Decision|0|||
16089751|NCT00670488|38819986|FG006|Overall Study|Physician Decision|0|||
16089752|NCT00670488|38819987|FG007|Overall Study|Physician Decision|0|||
16089753|NCT00670488|38819988|FG008|Overall Study|Physician Decision|0|||
16089754|NCT00670488|38819989|FG009|Overall Study|Physician Decision|0|||
16504799|NCT02357147|40322144|FG000|Maintenance Treatment Phase|Not Treated|1|||
16504800|NCT02357147|40322145|FG001|Maintenance Treatment Phase|Not Treated|0|||
16504801|NCT02275481|40322147|FG000|Overall Study|Death|2|||
16504802|NCT02275481|40322148|FG001|Overall Study|Death|1|||
16504803|NCT02275481|40322147|FG000|Overall Study|Lost to Follow-up|2|||
16504804|NCT02275481|40322148|FG001|Overall Study|Lost to Follow-up|0|||
16504805|NCT02275481|40322147|FG000|Overall Study|Withdrawal by Subject|3|||
16504806|NCT02275481|40322148|FG001|Overall Study|Withdrawal by Subject|0|||
16504807|NCT02275481|40322147|FG000|Overall Study|all other reasons combined|2|||
16504808|NCT02275481|40322148|FG001|Overall Study|all other reasons combined|1|||
16504809|NCT02275481|40322147|FG000|Overall Study|Physician Decision|0|||
16089755|NCT00670488|38819980|FG000|Overall Study|Progressive Disease|2|||
16089756|NCT00670488|38819981|FG001|Overall Study|Progressive Disease|41|||
16390568|NCT04263766|39915901|FG000|Overall Study|Lack of Efficacy|1|||
16504810|NCT02275481|40322148|FG001|Overall Study|Physician Decision|1|||
16504811|NCT02073279|40322149|FG000|Double-blind Period|Adverse Event|1|||
16504812|NCT02073279|40322150|FG001|Double-blind Period|Adverse Event|1|||
16504813|NCT02073279|40322149|FG000|Double-blind Period|Switched to another treatment|1|||
16504814|NCT02073279|40322150|FG001|Double-blind Period|Switched to another treatment|2|||
16504815|NCT02073279|40322149|FG000|Double-blind Period|Protocol Violation|0|||
16089757|NCT00670488|38819982|FG002|Overall Study|Progressive Disease|3|||
16504816|NCT02073279|40322150|FG001|Double-blind Period|Protocol Violation|1|||
16390569|NCT04263766|39915902|FG001|Overall Study|Lack of Efficacy|3|||
16390570|NCT01484496|39915903|FG000|Period 1|Protocol Violation|3|||
16390571|NCT01484496|39915904|FG001|Period 1|Protocol Violation|4|||
16390572|NCT01484496|39915905|FG002|Period 1|Protocol Violation|0|||
16390573|NCT01484496|39915906|FG003|Period 1|Protocol Violation|0|||
16390574|NCT01484496|39915903|FG000|Period 1|Physician Decision|5|||
16390575|NCT01484496|39915904|FG001|Period 1|Physician Decision|1|||
16390576|NCT01484496|39915905|FG002|Period 1|Physician Decision|0|||
16390577|NCT01484496|39915906|FG003|Period 1|Physician Decision|0|||
16390578|NCT01484496|39915903|FG000|Period 1|Lack of Efficacy|10|||
16390579|NCT01484496|39915904|FG001|Period 1|Lack of Efficacy|15|||
16504817|NCT02073279|40322149|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
16504818|NCT02073279|40322150|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
16504819|NCT02073279|40322149|FG000|Double-blind Period|Withdrawal by Subject|2|||
16504820|NCT02073279|40322150|FG001|Double-blind Period|Withdrawal by Subject|2|||
16504821|NCT02073279|40322149|FG000|Open-label Extension Period|Adverse Event|1|||
16504822|NCT02073279|40322150|FG001|Open-label Extension Period|Adverse Event|0|||
16390580|NCT01484496|39915905|FG002|Period 1|Lack of Efficacy|0|||
16390581|NCT01484496|39915906|FG003|Period 1|Lack of Efficacy|0|||
16504823|NCT02073279|40322149|FG000|Open-label Extension Period|Lack of Efficacy|1|||
16504824|NCT02073279|40322150|FG001|Open-label Extension Period|Lack of Efficacy|0|||
16504825|NCT02073279|40322149|FG000|Open-label Extension Period|Lost to Follow-up|0|||
16504826|NCT02073279|40322150|FG001|Open-label Extension Period|Lost to Follow-up|4|||
16504827|NCT02073279|40322149|FG000|Open-label Extension Period|Switched to another treatment|1|||
16504828|NCT02073279|40322150|FG001|Open-label Extension Period|Switched to another treatment|4|||
16504829|NCT02073279|40322149|FG000|Open-label Extension Period|Protocol Violation|0|||
16504830|NCT02073279|40322150|FG001|Open-label Extension Period|Protocol Violation|1|||
16504831|NCT02073279|40322149|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
16504832|NCT02073279|40322150|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
16390582|NCT01484496|39915903|FG000|Period 1|Adverse Event|25|||
16390583|NCT01484496|39915904|FG001|Period 1|Adverse Event|40|||
16390584|NCT01484496|39915905|FG002|Period 1|Adverse Event|0|||
16390585|NCT01484496|39915906|FG003|Period 1|Adverse Event|0|||
16390586|NCT01484496|39915903|FG000|Period 1|Withdrawal by Subject|15|||
16504833|NCT02073279|40322149|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
16546332|NCT01986881|40464783|FG000|Overall Study|Lost to Follow-up|51|||
16504834|NCT02073279|40322150|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
16504835|NCT00192504|40322151|FG000|Overall Study|Lost to Follow-up|1|||
16504836|NCT00192504|40322152|FG001|Overall Study|Lost to Follow-up|0|||
16504837|NCT00192504|40322153|FG002|Overall Study|Lost to Follow-up|0|||
16504838|NCT00192504|40322154|FG003|Overall Study|Lost to Follow-up|0|||
16504839|NCT00192504|40322151|FG000|Overall Study|Dosing window missed|0|||
16504840|NCT00192504|40322152|FG001|Overall Study|Dosing window missed|0|||
16504841|NCT00192504|40322153|FG002|Overall Study|Dosing window missed|1|||
16504842|NCT00192504|40322154|FG003|Overall Study|Dosing window missed|0|||
16504843|NCT00858442|40322160|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
16504844|NCT00858442|40322161|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
16504845|NCT04404855|40322164|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
16504846|NCT04404855|40322165|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
16504847|NCT03839212|40322166|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
16504848|NCT01077804|40322167|FG000|Overall Study|Unreachable|102|||
16504849|NCT01077804|40322167|FG000|Overall Study|Refused to continue|79|||
16504850|NCT01077804|40322167|FG000|Overall Study|Other|18|||
16504851|NCT02255500|40322170|FG000|Overall Study|Withdrawal by Subject|1|||
16504852|NCT02255500|40322171|FG001|Overall Study|Withdrawal by Subject|0|||
16504853|NCT02641379|40322178|FG000|Overall Study|Exclusion criterion during screening|1|||
16089758|NCT00670488|38819983|FG003|Overall Study|Progressive Disease|2|||
16311472|NCT03850483|39623704|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
16311473|NCT03850483|39623705|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
16311474|NCT03850483|39623706|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
16311475|NCT03850483|39623707|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
16311476|NCT03850483|39623708|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
16311477|NCT03850483|39623709|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
16311478|NCT03850483|39623700|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
16311479|NCT03850483|39623701|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
16311480|NCT03850483|39623702|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
16311481|NCT03850483|39623703|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
16311482|NCT03850483|39623704|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
16504854|NCT02641379|40322179|FG001|Overall Study|Exclusion criterion during screening|0|||
16504855|NCT02641379|40322180|FG002|Overall Study|Exclusion criterion during screening|0|||
16504856|NCT02641379|40322181|FG003|Overall Study|Exclusion criterion during screening|1|||
16504857|NCT02641379|40322182|FG004|Overall Study|Exclusion criterion during screening|2|||
16504858|NCT02641379|40322183|FG005|Overall Study|Exclusion criterion during screening|0|||
16504859|NCT02641379|40322184|FG006|Overall Study|Exclusion criterion during screening|0|||
16504860|NCT02641379|40322185|FG007|Overall Study|Exclusion criterion during screening|0|||
16504861|NCT02641379|40322186|FG008|Overall Study|Exclusion criterion during screening|0|||
16504862|NCT02641379|40322187|FG009|Overall Study|Exclusion criterion during screening|0|||
16504863|NCT02641379|40322188|FG010|Overall Study|Exclusion criterion during screening|0|||
16504864|NCT02641379|40322178|FG000|Overall Study|Withdrawal of informed consent|0|||
16504865|NCT02641379|40322179|FG001|Overall Study|Withdrawal of informed consent|1|||
16504866|NCT02641379|40322180|FG002|Overall Study|Withdrawal of informed consent|0|||
16504867|NCT02641379|40322181|FG003|Overall Study|Withdrawal of informed consent|0|||
16504868|NCT02641379|40322182|FG004|Overall Study|Withdrawal of informed consent|0|||
16504869|NCT02641379|40322183|FG005|Overall Study|Withdrawal of informed consent|0|||
16504870|NCT02641379|40322184|FG006|Overall Study|Withdrawal of informed consent|0|||
16504871|NCT02641379|40322185|FG007|Overall Study|Withdrawal of informed consent|1|||
16504872|NCT02641379|40322186|FG008|Overall Study|Withdrawal of informed consent|0|||
16504873|NCT02641379|40322187|FG009|Overall Study|Withdrawal of informed consent|0|||
16311483|NCT03850483|39623705|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
16311484|NCT03850483|39623706|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
16311485|NCT03850483|39623707|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
16311486|NCT03850483|39623708|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
16311487|NCT03850483|39623709|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
16311488|NCT03850483|39623700|FG000|Treatment for Stage 1|Death|0|||
16311489|NCT03850483|39623701|FG001|Treatment for Stage 1|Death|0|||
16311490|NCT03850483|39623702|FG002|Treatment for Stage 1|Death|0|||
16311491|NCT03850483|39623703|FG003|Treatment for Stage 1|Death|0|||
16311492|NCT03850483|39623704|FG004|Treatment for Stage 1|Death|0|||
16311493|NCT03850483|39623705|FG005|Treatment for Stage 1|Death|1|||
16311494|NCT03850483|39623706|FG006|Treatment for Stage 1|Death|0|||
16311495|NCT03850483|39623707|FG007|Treatment for Stage 1|Death|0|||
16311496|NCT03850483|39623708|FG008|Treatment for Stage 1|Death|0|||
16311497|NCT03850483|39623709|FG009|Treatment for Stage 1|Death|0|||
16311498|NCT03850483|39623700|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
16311499|NCT03850483|39623701|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
16311500|NCT03850483|39623702|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
16311501|NCT03850483|39623703|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
16311502|NCT03850483|39623704|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
16311503|NCT03850483|39623705|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
16311504|NCT03850483|39623706|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
16311505|NCT03850483|39623707|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
16504874|NCT02641379|40322188|FG010|Overall Study|Withdrawal of informed consent|0|||
16311506|NCT03850483|39623708|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
16311507|NCT03850483|39623709|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
16311508|NCT03850483|39623700|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
16504875|NCT02641379|40322178|FG000|Overall Study|Adverse Event|7|||
16504876|NCT02641379|40322179|FG001|Overall Study|Adverse Event|8|||
16504877|NCT02641379|40322180|FG002|Overall Study|Adverse Event|2|||
16504878|NCT02641379|40322181|FG003|Overall Study|Adverse Event|2|||
16504879|NCT02641379|40322182|FG004|Overall Study|Adverse Event|5|||
16504880|NCT02641379|40322183|FG005|Overall Study|Adverse Event|1|||
16504881|NCT02641379|40322184|FG006|Overall Study|Adverse Event|5|||
16504882|NCT02641379|40322185|FG007|Overall Study|Adverse Event|0|||
16504883|NCT02641379|40322186|FG008|Overall Study|Adverse Event|1|||
16504884|NCT02641379|40322187|FG009|Overall Study|Adverse Event|1|||
16504885|NCT02641379|40322188|FG010|Overall Study|Adverse Event|5|||
16504886|NCT02641379|40322178|FG000|Overall Study|Lack of Efficacy|0|||
16504887|NCT02641379|40322179|FG001|Overall Study|Lack of Efficacy|0|||
16504888|NCT02641379|40322180|FG002|Overall Study|Lack of Efficacy|2|||
16504889|NCT02641379|40322181|FG003|Overall Study|Lack of Efficacy|0|||
16504890|NCT02641379|40322182|FG004|Overall Study|Lack of Efficacy|0|||
16504891|NCT02641379|40322183|FG005|Overall Study|Lack of Efficacy|2|||
16504892|NCT02641379|40322184|FG006|Overall Study|Lack of Efficacy|0|||
16504893|NCT02641379|40322185|FG007|Overall Study|Lack of Efficacy|5|||
16504894|NCT02641379|40322186|FG008|Overall Study|Lack of Efficacy|0|||
16504895|NCT02641379|40322187|FG009|Overall Study|Lack of Efficacy|0|||
16504896|NCT02641379|40322188|FG010|Overall Study|Lack of Efficacy|0|||
16504897|NCT02641379|40322178|FG000|Overall Study|Participant unable to attend study visit|4|||
16504898|NCT02641379|40322179|FG001|Overall Study|Participant unable to attend study visit|10|||
16504899|NCT02641379|40322180|FG002|Overall Study|Participant unable to attend study visit|1|||
16504900|NCT02641379|40322181|FG003|Overall Study|Participant unable to attend study visit|2|||
16504901|NCT02641379|40322182|FG004|Overall Study|Participant unable to attend study visit|5|||
16504902|NCT02641379|40322183|FG005|Overall Study|Participant unable to attend study visit|1|||
16504903|NCT02641379|40322184|FG006|Overall Study|Participant unable to attend study visit|1|||
16504904|NCT02641379|40322185|FG007|Overall Study|Participant unable to attend study visit|1|||
16390587|NCT01484496|39915904|FG001|Period 1|Withdrawal by Subject|12|||
16390588|NCT01484496|39915905|FG002|Period 1|Withdrawal by Subject|0|||
16390589|NCT01484496|39915906|FG003|Period 1|Withdrawal by Subject|0|||
16504905|NCT02641379|40322186|FG008|Overall Study|Participant unable to attend study visit|0|||
16504906|NCT02641379|40322187|FG009|Overall Study|Participant unable to attend study visit|2|||
16504907|NCT02641379|40322188|FG010|Overall Study|Participant unable to attend study visit|0|||
16504908|NCT02641379|40322178|FG000|Overall Study|Participant's compliance|0|||
16504909|NCT02641379|40322179|FG001|Overall Study|Participant's compliance|1|||
16504910|NCT02641379|40322180|FG002|Overall Study|Participant's compliance|0|||
16504911|NCT02641379|40322181|FG003|Overall Study|Participant's compliance|1|||
16504912|NCT02641379|40322182|FG004|Overall Study|Participant's compliance|0|||
16504913|NCT02641379|40322183|FG005|Overall Study|Participant's compliance|2|||
16504914|NCT02641379|40322184|FG006|Overall Study|Participant's compliance|0|||
16504915|NCT02641379|40322185|FG007|Overall Study|Participant's compliance|0|||
16504916|NCT02641379|40322186|FG008|Overall Study|Participant's compliance|1|||
16504917|NCT02641379|40322187|FG009|Overall Study|Participant's compliance|1|||
16504918|NCT02641379|40322188|FG010|Overall Study|Participant's compliance|1|||
16504919|NCT02641379|40322178|FG000|Overall Study|Participant cannot be reached|4|||
16504920|NCT02641379|40322179|FG001|Overall Study|Participant cannot be reached|4|||
16504921|NCT02641379|40322180|FG002|Overall Study|Participant cannot be reached|0|||
16504922|NCT02641379|40322181|FG003|Overall Study|Participant cannot be reached|8|||
16504923|NCT02641379|40322182|FG004|Overall Study|Participant cannot be reached|2|||
16504924|NCT02641379|40322183|FG005|Overall Study|Participant cannot be reached|1|||
16504925|NCT02641379|40322184|FG006|Overall Study|Participant cannot be reached|0|||
16504926|NCT02641379|40322185|FG007|Overall Study|Participant cannot be reached|1|||
16504927|NCT02641379|40322186|FG008|Overall Study|Participant cannot be reached|0|||
16504928|NCT02641379|40322187|FG009|Overall Study|Participant cannot be reached|2|||
16504929|NCT02641379|40322188|FG010|Overall Study|Participant cannot be reached|1|||
16504930|NCT02641379|40322178|FG000|Overall Study|PCR positive at Week 24|15|||
16504931|NCT02641379|40322179|FG001|Overall Study|PCR positive at Week 24|21|||
16504932|NCT02641379|40322180|FG002|Overall Study|PCR positive at Week 24|62|||
16504933|NCT02641379|40322181|FG003|Overall Study|PCR positive at Week 24|0|||
16504934|NCT02641379|40322182|FG004|Overall Study|PCR positive at Week 24|0|||
16504935|NCT02641379|40322183|FG005|Overall Study|PCR positive at Week 24|6|||
16504936|NCT02641379|40322184|FG006|Overall Study|PCR positive at Week 24|3|||
16504937|NCT02641379|40322185|FG007|Overall Study|PCR positive at Week 24|8|||
16504938|NCT02641379|40322186|FG008|Overall Study|PCR positive at Week 24|0|||
16504939|NCT02641379|40322187|FG009|Overall Study|PCR positive at Week 24|1|||
16504940|NCT02641379|40322188|FG010|Overall Study|PCR positive at Week 24|0|||
16504941|NCT02641379|40322178|FG000|Overall Study|PCR positive at follow up 2|1|||
16504942|NCT02641379|40322179|FG001|Overall Study|PCR positive at follow up 2|0|||
16504943|NCT02641379|40322180|FG002|Overall Study|PCR positive at follow up 2|0|||
16504944|NCT02641379|40322181|FG003|Overall Study|PCR positive at follow up 2|0|||
16504945|NCT02641379|40322182|FG004|Overall Study|PCR positive at follow up 2|0|||
16504946|NCT02641379|40322183|FG005|Overall Study|PCR positive at follow up 2|0|||
16390590|NCT01484496|39915903|FG000|Period 1|Lost to Follow-up|2|||
16390591|NCT01484496|39915904|FG001|Period 1|Lost to Follow-up|6|||
16390592|NCT01484496|39915905|FG002|Period 1|Lost to Follow-up|0|||
16390593|NCT01484496|39915906|FG003|Period 1|Lost to Follow-up|0|||
16390594|NCT01484496|39915903|FG000|Period 1|Positive Pregnancy|1|||
16390595|NCT01484496|39915904|FG001|Period 1|Positive Pregnancy|6|||
16390596|NCT01484496|39915905|FG002|Period 1|Positive Pregnancy|0|||
16390597|NCT01484496|39915906|FG003|Period 1|Positive Pregnancy|0|||
16390598|NCT01484496|39915903|FG000|Period 1|Treatment Failure|3|||
16390599|NCT01484496|39915904|FG001|Period 1|Treatment Failure|6|||
16390600|NCT01484496|39915905|FG002|Period 1|Treatment Failure|0|||
16390601|NCT01484496|39915906|FG003|Period 1|Treatment Failure|0|||
16390602|NCT01484496|39915903|FG000|Period 1|Lack of Compliance|2|||
16390603|NCT01484496|39915904|FG001|Period 1|Lack of Compliance|1|||
16390604|NCT01484496|39915905|FG002|Period 1|Lack of Compliance|0|||
16390605|NCT01484496|39915906|FG003|Period 1|Lack of Compliance|0|||
16390606|NCT01484496|39915903|FG000|Period 1|Unable to Visit Site|0|||
16390607|NCT01484496|39915904|FG001|Period 1|Unable to Visit Site|2|||
16504947|NCT02641379|40322184|FG006|Overall Study|PCR positive at follow up 2|0|||
16504948|NCT02641379|40322185|FG007|Overall Study|PCR positive at follow up 2|0|||
16504949|NCT02641379|40322186|FG008|Overall Study|PCR positive at follow up 2|0|||
16504950|NCT02641379|40322187|FG009|Overall Study|PCR positive at follow up 2|0|||
16504951|NCT02641379|40322188|FG010|Overall Study|PCR positive at follow up 2|0|||
16504952|NCT02641379|40322178|FG000|Overall Study|Participant showed relapse|1|||
16504953|NCT02641379|40322179|FG001|Overall Study|Participant showed relapse|0|||
16504954|NCT02641379|40322180|FG002|Overall Study|Participant showed relapse|0|||
16504955|NCT02641379|40322181|FG003|Overall Study|Participant showed relapse|0|||
16504956|NCT02641379|40322182|FG004|Overall Study|Participant showed relapse|0|||
16504957|NCT02641379|40322183|FG005|Overall Study|Participant showed relapse|0|||
16504958|NCT02641379|40322184|FG006|Overall Study|Participant showed relapse|1|||
16504959|NCT02641379|40322185|FG007|Overall Study|Participant showed relapse|0|||
16504960|NCT02641379|40322186|FG008|Overall Study|Participant showed relapse|0|||
16504961|NCT02641379|40322187|FG009|Overall Study|Participant showed relapse|0|||
16504962|NCT02641379|40322188|FG010|Overall Study|Participant showed relapse|0|||
16504963|NCT02641379|40322178|FG000|Overall Study|Participant stopped study/treatment|1|||
16504964|NCT02641379|40322179|FG001|Overall Study|Participant stopped study/treatment|3|||
16504965|NCT02641379|40322180|FG002|Overall Study|Participant stopped study/treatment|1|||
16504966|NCT02641379|40322181|FG003|Overall Study|Participant stopped study/treatment|0|||
16504967|NCT02641379|40322182|FG004|Overall Study|Participant stopped study/treatment|0|||
16504968|NCT02641379|40322183|FG005|Overall Study|Participant stopped study/treatment|1|||
16504969|NCT02641379|40322184|FG006|Overall Study|Participant stopped study/treatment|2|||
16504970|NCT02641379|40322185|FG007|Overall Study|Participant stopped study/treatment|0|||
16504971|NCT02641379|40322186|FG008|Overall Study|Participant stopped study/treatment|1|||
16504972|NCT02641379|40322187|FG009|Overall Study|Participant stopped study/treatment|0|||
16504973|NCT02641379|40322188|FG010|Overall Study|Participant stopped study/treatment|0|||
16504974|NCT02641379|40322178|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
16504975|NCT02641379|40322179|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
16504976|NCT02641379|40322180|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
16504977|NCT02641379|40322181|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
16504978|NCT02641379|40322182|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
16504979|NCT02641379|40322183|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
16504980|NCT02641379|40322184|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
16504981|NCT02641379|40322185|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
16504982|NCT02641379|40322186|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
16504983|NCT02641379|40322187|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
16504984|NCT02641379|40322188|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
16504985|NCT02641379|40322178|FG000|Overall Study|Financial problems|0|||
16504986|NCT02641379|40322179|FG001|Overall Study|Financial problems|1|||
16504987|NCT02641379|40322180|FG002|Overall Study|Financial problems|0|||
16504988|NCT02641379|40322181|FG003|Overall Study|Financial problems|0|||
16504989|NCT02641379|40322182|FG004|Overall Study|Financial problems|0|||
16504990|NCT02641379|40322183|FG005|Overall Study|Financial problems|0|||
16504991|NCT02641379|40322184|FG006|Overall Study|Financial problems|0|||
16504992|NCT02641379|40322185|FG007|Overall Study|Financial problems|0|||
16504993|NCT02641379|40322186|FG008|Overall Study|Financial problems|0|||
16504994|NCT02641379|40322187|FG009|Overall Study|Financial problems|0|||
16504995|NCT02641379|40322188|FG010|Overall Study|Financial problems|0|||
16504996|NCT02641379|40322178|FG000|Overall Study|PCR positive at Week 68|0|||
16504997|NCT02641379|40322179|FG001|Overall Study|PCR positive at Week 68|1|||
16504998|NCT02641379|40322180|FG002|Overall Study|PCR positive at Week 68|0|||
16504999|NCT02641379|40322181|FG003|Overall Study|PCR positive at Week 68|0|||
16505000|NCT02641379|40322182|FG004|Overall Study|PCR positive at Week 68|0|||
16505001|NCT02641379|40322183|FG005|Overall Study|PCR positive at Week 68|0|||
16505002|NCT02641379|40322184|FG006|Overall Study|PCR positive at Week 68|0|||
16505003|NCT02641379|40322185|FG007|Overall Study|PCR positive at Week 68|0|||
16505004|NCT02641379|40322186|FG008|Overall Study|PCR positive at Week 68|0|||
16505005|NCT02641379|40322187|FG009|Overall Study|PCR positive at Week 68|0|||
16505006|NCT02641379|40322188|FG010|Overall Study|PCR positive at Week 68|0|||
16505007|NCT02641379|40322178|FG000|Overall Study|PCR positive at Week 48|0|||
16505008|NCT02641379|40322179|FG001|Overall Study|PCR positive at Week 48|1|||
16505009|NCT02641379|40322180|FG002|Overall Study|PCR positive at Week 48|0|||
16505010|NCT02641379|40322181|FG003|Overall Study|PCR positive at Week 48|0|||
16505011|NCT02641379|40322182|FG004|Overall Study|PCR positive at Week 48|0|||
16505012|NCT02641379|40322183|FG005|Overall Study|PCR positive at Week 48|0|||
16505013|NCT02641379|40322184|FG006|Overall Study|PCR positive at Week 48|0|||
16505014|NCT02641379|40322185|FG007|Overall Study|PCR positive at Week 48|0|||
16505015|NCT02641379|40322186|FG008|Overall Study|PCR positive at Week 48|0|||
16311509|NCT03850483|39623701|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
16311510|NCT03850483|39623702|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
16311511|NCT03850483|39623703|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
16311512|NCT03850483|39623704|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
16311513|NCT03850483|39623705|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
16311514|NCT03850483|39623706|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
16311515|NCT03850483|39623707|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
16311516|NCT03850483|39623708|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
16311517|NCT03850483|39623709|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
16390608|NCT01484496|39915905|FG002|Period 1|Unable to Visit Site|0|||
16505016|NCT02641379|40322187|FG009|Overall Study|PCR positive at Week 48|0|||
16505017|NCT02641379|40322188|FG010|Overall Study|PCR positive at Week 48|0|||
16505018|NCT02641379|40322178|FG000|Overall Study|PCR not performed at Week 12|0|||
16505019|NCT02641379|40322179|FG001|Overall Study|PCR not performed at Week 12|0|||
16505020|NCT02641379|40322180|FG002|Overall Study|PCR not performed at Week 12|1|||
16505021|NCT02641379|40322181|FG003|Overall Study|PCR not performed at Week 12|0|||
16311518|NCT03850483|39623700|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
16311519|NCT03850483|39623701|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
16311520|NCT03850483|39623702|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
16311521|NCT03850483|39623703|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
16311522|NCT03850483|39623704|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
16311523|NCT03850483|39623705|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
16311524|NCT03850483|39623706|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
16311525|NCT03850483|39623707|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
16311526|NCT03850483|39623708|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
16311527|NCT03850483|39623709|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
16311528|NCT03850483|39623700|FG000|Follow-up for Stage 1|Physician Decision|0|||
16311529|NCT03850483|39623701|FG001|Follow-up for Stage 1|Physician Decision|0|||
16311530|NCT03850483|39623702|FG002|Follow-up for Stage 1|Physician Decision|0|||
16311531|NCT03850483|39623703|FG003|Follow-up for Stage 1|Physician Decision|0|||
16311532|NCT03850483|39623704|FG004|Follow-up for Stage 1|Physician Decision|1|||
16311533|NCT03850483|39623705|FG005|Follow-up for Stage 1|Physician Decision|0|||
16311534|NCT03850483|39623706|FG006|Follow-up for Stage 1|Physician Decision|1|||
16311535|NCT03850483|39623707|FG007|Follow-up for Stage 1|Physician Decision|0|||
16311536|NCT03850483|39623708|FG008|Follow-up for Stage 1|Physician Decision|0|||
16390609|NCT01484496|39915906|FG003|Period 1|Unable to Visit Site|0|||
16390610|NCT01484496|39915903|FG000|Period 2|Lack of Efficacy|0|||
16390611|NCT01484496|39915904|FG001|Period 2|Lack of Efficacy|0|||
16390612|NCT01484496|39915905|FG002|Period 2|Lack of Efficacy|1|||
16390613|NCT01484496|39915906|FG003|Period 2|Lack of Efficacy|3|||
16390614|NCT01484496|39915903|FG000|Period 2|Adverse Event|0|||
16390615|NCT01484496|39915904|FG001|Period 2|Adverse Event|0|||
16390616|NCT01484496|39915905|FG002|Period 2|Adverse Event|5|||
16390617|NCT01484496|39915906|FG003|Period 2|Adverse Event|13|||
16390618|NCT01484496|39915903|FG000|Period 2|Other|0|||
16390619|NCT01484496|39915904|FG001|Period 2|Other|0|||
16390620|NCT01484496|39915905|FG002|Period 2|Other|9|||
16505022|NCT02641379|40322182|FG004|Overall Study|PCR not performed at Week 12|0|||
16505023|NCT02641379|40322183|FG005|Overall Study|PCR not performed at Week 12|0|||
16505024|NCT02641379|40322184|FG006|Overall Study|PCR not performed at Week 12|0|||
16505025|NCT02641379|40322185|FG007|Overall Study|PCR not performed at Week 12|0|||
16505026|NCT02641379|40322186|FG008|Overall Study|PCR not performed at Week 12|0|||
16505027|NCT02641379|40322187|FG009|Overall Study|PCR not performed at Week 12|0|||
16505028|NCT02641379|40322188|FG010|Overall Study|PCR not performed at Week 12|0|||
16505029|NCT02641379|40322178|FG000|Overall Study|No PCR at baseline|0|||
16505030|NCT02641379|40322179|FG001|Overall Study|No PCR at baseline|0|||
16505031|NCT02641379|40322180|FG002|Overall Study|No PCR at baseline|1|||
16505032|NCT02641379|40322181|FG003|Overall Study|No PCR at baseline|0|||
16505033|NCT02641379|40322182|FG004|Overall Study|No PCR at baseline|0|||
16505034|NCT02641379|40322183|FG005|Overall Study|No PCR at baseline|0|||
16505035|NCT02641379|40322184|FG006|Overall Study|No PCR at baseline|0|||
16505036|NCT02641379|40322185|FG007|Overall Study|No PCR at baseline|0|||
16505037|NCT02641379|40322186|FG008|Overall Study|No PCR at baseline|0|||
16505038|NCT02641379|40322187|FG009|Overall Study|No PCR at baseline|0|||
16505039|NCT02641379|40322188|FG010|Overall Study|No PCR at baseline|0|||
16390621|NCT01484496|39915906|FG003|Period 2|Other|6|||
16390622|NCT00996658|39915907|FG000|Overall Study|Adverse Event|2|||
16390623|NCT00996658|39915908|FG001|Overall Study|Adverse Event|5|||
16390624|NCT00996658|39915907|FG000|Overall Study|Protocol Violation|0|||
16390625|NCT00996658|39915908|FG001|Overall Study|Protocol Violation|1|||
16390626|NCT00996658|39915907|FG000|Overall Study|Lost to Follow-up|2|||
16390627|NCT00996658|39915908|FG001|Overall Study|Lost to Follow-up|5|||
16390628|NCT00996658|39915907|FG000|Overall Study|Non-compliance issues|3|||
16390629|NCT00996658|39915908|FG001|Overall Study|Non-compliance issues|3|||
16390630|NCT00996658|39915907|FG000|Overall Study|Other|9|||
16390631|NCT00996658|39915908|FG001|Overall Study|Other|7|||
16390632|NCT00339040|39915909|FG000|Stage I|Not able to attend clinic|1|||
16505040|NCT02641379|40322178|FG000|Overall Study|PCR positive at Week 28|0|||
16505041|NCT02641379|40322179|FG001|Overall Study|PCR positive at Week 28|0|||
16505042|NCT02641379|40322180|FG002|Overall Study|PCR positive at Week 28|1|||
16505043|NCT02641379|40322181|FG003|Overall Study|PCR positive at Week 28|0|||
16505044|NCT02641379|40322182|FG004|Overall Study|PCR positive at Week 28|0|||
16311537|NCT03850483|39623709|FG009|Follow-up for Stage 1|Physician Decision|0|||
16311538|NCT03850483|39623700|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
16311539|NCT03850483|39623701|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
16311540|NCT03850483|39623702|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
16311541|NCT03850483|39623703|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
16311542|NCT03850483|39623704|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
16311543|NCT03850483|39623705|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
16311544|NCT03850483|39623706|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
16390633|NCT00339040|39915910|FG001|Stage I|Not able to attend clinic|0|||
16390634|NCT00339040|39915909|FG000|Stage I|Protocol Violation|1|||
16390635|NCT00339040|39915910|FG001|Stage I|Protocol Violation|1|||
16195936|NCT01885078|39193447|FG001|Treatment Period|Other|0|||
16195937|NCT01885078|39193448|FG002|Treatment Period|Other|0|||
16195938|NCT01885078|39193449|FG003|Treatment Period|Other|1|||
16195939|NCT01885078|39193450|FG004|Treatment Period|Other|0|||
16195940|NCT01885078|39193451|FG005|Treatment Period|Other|0|||
16195941|NCT01885078|39193452|FG006|Treatment Period|Other|0|||
16195942|NCT01885078|39193453|FG007|Treatment Period|Other|0|||
16195943|NCT01885078|39193454|FG008|Treatment Period|Other|0|||
16195944|NCT01885078|39193455|FG009|Treatment Period|Other|0|||
16195945|NCT01885078|39193446|FG000|Step-down Period|Sponsor Decision|0|||
16195946|NCT01885078|39193447|FG001|Step-down Period|Sponsor Decision|0|||
16195947|NCT01885078|39193448|FG002|Step-down Period|Sponsor Decision|0|||
16195948|NCT01885078|39193449|FG003|Step-down Period|Sponsor Decision|0|||
16195949|NCT01885078|39193450|FG004|Step-down Period|Sponsor Decision|0|||
16195950|NCT01885078|39193451|FG005|Step-down Period|Sponsor Decision|0|||
16195951|NCT01885078|39193452|FG006|Step-down Period|Sponsor Decision|0|||
16195952|NCT01885078|39193453|FG007|Step-down Period|Sponsor Decision|0|||
16195953|NCT01885078|39193454|FG008|Step-down Period|Sponsor Decision|1|||
16390636|NCT00339040|39915909|FG000|Stage II|Lost to Follow-up|3|||
16089759|NCT00670488|38819984|FG004|Overall Study|Progressive Disease|2|||
16195954|NCT01885078|39193455|FG009|Step-down Period|Sponsor Decision|1|||
16195955|NCT01885078|39193446|FG000|Step-down Period|Adverse Event|0|||
16195956|NCT01885078|39193447|FG001|Step-down Period|Adverse Event|0|||
16195957|NCT01885078|39193448|FG002|Step-down Period|Adverse Event|0|||
16195958|NCT01885078|39193449|FG003|Step-down Period|Adverse Event|0|||
16195959|NCT01885078|39193450|FG004|Step-down Period|Adverse Event|0|||
16195960|NCT01885078|39193451|FG005|Step-down Period|Adverse Event|0|||
16195961|NCT01885078|39193452|FG006|Step-down Period|Adverse Event|0|||
16195962|NCT01885078|39193453|FG007|Step-down Period|Adverse Event|0|||
16195963|NCT01885078|39193454|FG008|Step-down Period|Adverse Event|29|||
16195964|NCT01885078|39193455|FG009|Step-down Period|Adverse Event|38|||
16195965|NCT01885078|39193446|FG000|Step-down Period|Withdrawal by Subject|0|||
16195966|NCT01885078|39193447|FG001|Step-down Period|Withdrawal by Subject|0|||
16195967|NCT01885078|39193448|FG002|Step-down Period|Withdrawal by Subject|0|||
16195968|NCT01885078|39193449|FG003|Step-down Period|Withdrawal by Subject|0|||
16195969|NCT01885078|39193450|FG004|Step-down Period|Withdrawal by Subject|0|||
16195970|NCT01885078|39193451|FG005|Step-down Period|Withdrawal by Subject|0|||
16195971|NCT01885078|39193452|FG006|Step-down Period|Withdrawal by Subject|0|||
16195972|NCT01885078|39193453|FG007|Step-down Period|Withdrawal by Subject|0|||
16195973|NCT01885078|39193454|FG008|Step-down Period|Withdrawal by Subject|25|||
16195974|NCT01885078|39193455|FG009|Step-down Period|Withdrawal by Subject|15|||
16195975|NCT01885078|39193446|FG000|Step-down Period|Physician Decision|0|||
16195976|NCT01885078|39193447|FG001|Step-down Period|Physician Decision|0|||
16195977|NCT01885078|39193448|FG002|Step-down Period|Physician Decision|0|||
16195978|NCT01885078|39193449|FG003|Step-down Period|Physician Decision|0|||
16195979|NCT01885078|39193450|FG004|Step-down Period|Physician Decision|0|||
16195980|NCT01885078|39193451|FG005|Step-down Period|Physician Decision|0|||
16195981|NCT01885078|39193452|FG006|Step-down Period|Physician Decision|0|||
16195982|NCT01885078|39193453|FG007|Step-down Period|Physician Decision|0|||
16195983|NCT01885078|39193454|FG008|Step-down Period|Physician Decision|7|||
16195984|NCT01885078|39193455|FG009|Step-down Period|Physician Decision|2|||
16195985|NCT01885078|39193446|FG000|Step-down Period|Death|0|||
16195986|NCT01885078|39193447|FG001|Step-down Period|Death|0|||
16195987|NCT01885078|39193448|FG002|Step-down Period|Death|0|||
16195988|NCT01885078|39193449|FG003|Step-down Period|Death|0|||
16195989|NCT01885078|39193450|FG004|Step-down Period|Death|0|||
16195990|NCT01885078|39193451|FG005|Step-down Period|Death|0|||
16195991|NCT01885078|39193452|FG006|Step-down Period|Death|0|||
16195992|NCT01885078|39193453|FG007|Step-down Period|Death|0|||
16195993|NCT01885078|39193454|FG008|Step-down Period|Death|4|||
16195994|NCT01885078|39193455|FG009|Step-down Period|Death|3|||
16195995|NCT01885078|39193446|FG000|Step-down Period|Lost to Follow-up|0|||
16195996|NCT01885078|39193447|FG001|Step-down Period|Lost to Follow-up|0|||
16195997|NCT01885078|39193448|FG002|Step-down Period|Lost to Follow-up|0|||
16195998|NCT01885078|39193449|FG003|Step-down Period|Lost to Follow-up|0|||
16195999|NCT01885078|39193450|FG004|Step-down Period|Lost to Follow-up|0|||
16196000|NCT01885078|39193451|FG005|Step-down Period|Lost to Follow-up|0|||
16196001|NCT01885078|39193452|FG006|Step-down Period|Lost to Follow-up|0|||
16196002|NCT01885078|39193453|FG007|Step-down Period|Lost to Follow-up|0|||
16196003|NCT01885078|39193454|FG008|Step-down Period|Lost to Follow-up|1|||
16196004|NCT01885078|39193455|FG009|Step-down Period|Lost to Follow-up|1|||
16196005|NCT01885078|39193446|FG000|Step-down Period|Lack of Efficacy|0|||
16196006|NCT01885078|39193447|FG001|Step-down Period|Lack of Efficacy|0|||
16196007|NCT01885078|39193448|FG002|Step-down Period|Lack of Efficacy|0|||
16196008|NCT01885078|39193449|FG003|Step-down Period|Lack of Efficacy|0|||
16196009|NCT01885078|39193450|FG004|Step-down Period|Lack of Efficacy|0|||
16196010|NCT01885078|39193451|FG005|Step-down Period|Lack of Efficacy|0|||
16196011|NCT01885078|39193452|FG006|Step-down Period|Lack of Efficacy|0|||
16196012|NCT01885078|39193453|FG007|Step-down Period|Lack of Efficacy|0|||
16196013|NCT01885078|39193454|FG008|Step-down Period|Lack of Efficacy|1|||
16196014|NCT01885078|39193455|FG009|Step-down Period|Lack of Efficacy|0|||
16196015|NCT01885078|39193446|FG000|Step-down Period|Protocol Violation|0|||
16196016|NCT01885078|39193447|FG001|Step-down Period|Protocol Violation|0|||
16196017|NCT01885078|39193448|FG002|Step-down Period|Protocol Violation|0|||
16196018|NCT01885078|39193449|FG003|Step-down Period|Protocol Violation|0|||
16196019|NCT01885078|39193450|FG004|Step-down Period|Protocol Violation|0|||
16196020|NCT01885078|39193451|FG005|Step-down Period|Protocol Violation|0|||
16196021|NCT01885078|39193452|FG006|Step-down Period|Protocol Violation|0|||
16196022|NCT01885078|39193453|FG007|Step-down Period|Protocol Violation|0|||
16196023|NCT01885078|39193454|FG008|Step-down Period|Protocol Violation|1|||
16196024|NCT01885078|39193455|FG009|Step-down Period|Protocol Violation|1|||
16196025|NCT04105244|39193456|FG000|Overall Study|Withdrawal by Subject|10|||
16196026|NCT04105244|39193457|FG001|Overall Study|Withdrawal by Subject|12|||
16196027|NCT04105244|39193456|FG000|Overall Study|Lost to Follow-up|20|||
16196028|NCT04105244|39193457|FG001|Overall Study|Lost to Follow-up|15|||
16196029|NCT04105244|39193456|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
16196030|NCT04105244|39193457|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
16196031|NCT04105244|39193456|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
16196032|NCT04105244|39193457|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
16196033|NCT00383721|39193458|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
16196034|NCT00383721|39193459|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
16196035|NCT00383721|39193460|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
16196036|NCT00383721|39193461|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
16196037|NCT00383721|39193462|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
16196038|NCT00383721|39193458|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
16196039|NCT00383721|39193459|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
16196040|NCT00383721|39193460|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
16196041|NCT00383721|39193461|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
16196042|NCT00383721|39193462|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
16196043|NCT00383721|39193458|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
16196044|NCT00383721|39193459|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
16196045|NCT00383721|39193460|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
16196046|NCT00383721|39193461|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
16196047|NCT00383721|39193462|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
16196048|NCT00383721|39193458|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
16196049|NCT00383721|39193459|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
16196050|NCT00383721|39193460|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
16196051|NCT00383721|39193461|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
16196052|NCT00383721|39193462|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
16196053|NCT00383721|39193458|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
16196054|NCT00383721|39193459|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
16196055|NCT00383721|39193460|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
16196056|NCT00383721|39193461|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
16196057|NCT00383721|39193462|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
16196058|NCT00383721|39193458|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
16196059|NCT00383721|39193459|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
16196060|NCT00383721|39193460|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
16196061|NCT00383721|39193461|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
16196062|NCT00383721|39193462|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
16196063|NCT00383721|39193458|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
16196064|NCT00383721|39193459|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
16311545|NCT03850483|39623707|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
16311546|NCT03850483|39623708|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
16311547|NCT03850483|39623709|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
16311548|NCT03850483|39623700|FG000|Follow-up for Stage 1|Adverse Event|0|||
16311549|NCT03850483|39623701|FG001|Follow-up for Stage 1|Adverse Event|0|||
16311550|NCT03850483|39623702|FG002|Follow-up for Stage 1|Adverse Event|1|||
16311551|NCT03850483|39623703|FG003|Follow-up for Stage 1|Adverse Event|0|||
16311552|NCT03850483|39623704|FG004|Follow-up for Stage 1|Adverse Event|0|||
16311553|NCT03850483|39623705|FG005|Follow-up for Stage 1|Adverse Event|1|||
16311554|NCT03850483|39623706|FG006|Follow-up for Stage 1|Adverse Event|0|||
16311555|NCT03850483|39623707|FG007|Follow-up for Stage 1|Adverse Event|0|||
16311556|NCT03850483|39623708|FG008|Follow-up for Stage 1|Adverse Event|0|||
16311557|NCT03850483|39623709|FG009|Follow-up for Stage 1|Adverse Event|0|||
16311558|NCT03850483|39623700|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16311559|NCT03850483|39623701|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
16311560|NCT03850483|39623702|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16311561|NCT03850483|39623703|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16311562|NCT03850483|39623704|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
16311563|NCT03850483|39623705|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
16311564|NCT03850483|39623706|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16311565|NCT03850483|39623707|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16311566|NCT03850483|39623708|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16505045|NCT02641379|40322183|FG005|Overall Study|PCR positive at Week 28|0|||
16505046|NCT02641379|40322184|FG006|Overall Study|PCR positive at Week 28|0|||
16505047|NCT02641379|40322185|FG007|Overall Study|PCR positive at Week 28|0|||
16311567|NCT03850483|39623709|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
16311568|NCT03850483|39623700|FG000|Follow-up for Stage 1|Other|0|||
16311569|NCT03850483|39623701|FG001|Follow-up for Stage 1|Other|2|||
16311570|NCT03850483|39623702|FG002|Follow-up for Stage 1|Other|0|||
16311571|NCT03850483|39623703|FG003|Follow-up for Stage 1|Other|2|||
16311572|NCT03850483|39623704|FG004|Follow-up for Stage 1|Other|0|||
16311573|NCT03850483|39623705|FG005|Follow-up for Stage 1|Other|1|||
16311574|NCT03850483|39623706|FG006|Follow-up for Stage 1|Other|0|||
16311575|NCT03850483|39623707|FG007|Follow-up for Stage 1|Other|0|||
16311576|NCT03850483|39623708|FG008|Follow-up for Stage 1|Other|0|||
16311577|NCT03850483|39623709|FG009|Follow-up for Stage 1|Other|0|||
16390637|NCT00339040|39915910|FG001|Stage II|Lost to Follow-up|0|||
16390638|NCT00339040|39915909|FG000|Stage II|Withdrawal by Subject|1|||
16390639|NCT00339040|39915910|FG001|Stage II|Withdrawal by Subject|2|||
16390640|NCT00339040|39915909|FG000|Stage II|Protocol Violation|3|||
16390641|NCT00339040|39915910|FG001|Stage II|Protocol Violation|0|||
16390642|NCT00339040|39915909|FG000|Stage II|Not able to attend clinic|1|||
16390643|NCT00339040|39915910|FG001|Stage II|Not able to attend clinic|0|||
16390644|NCT00339040|39915909|FG000|Stage II|Site closing|2|||
16390645|NCT00339040|39915910|FG001|Stage II|Site closing|0|||
16390646|NCT00600067|39915918|FG000|Overall Study|Adverse Event|0|||
16390647|NCT00600067|39915919|FG001|Overall Study|Adverse Event|1|||
16390648|NCT00600067|39915918|FG000|Overall Study|Lost to Follow-up|2|||
16311578|NCT03850483|39623700|FG000|Treatment for Stage 2|Adverse Event|0|||
16311579|NCT03850483|39623701|FG001|Treatment for Stage 2|Adverse Event|0|||
16311580|NCT03850483|39623702|FG002|Treatment for Stage 2|Adverse Event|0|||
16311581|NCT03850483|39623703|FG003|Treatment for Stage 2|Adverse Event|0|||
16311582|NCT03850483|39623704|FG004|Treatment for Stage 2|Adverse Event|0|||
16311583|NCT03850483|39623705|FG005|Treatment for Stage 2|Adverse Event|0|||
16311584|NCT03850483|39623706|FG006|Treatment for Stage 2|Adverse Event|0|||
16311585|NCT03850483|39623707|FG007|Treatment for Stage 2|Adverse Event|0|||
16311586|NCT03850483|39623708|FG008|Treatment for Stage 2|Adverse Event|0|||
16390649|NCT00600067|39915919|FG001|Overall Study|Lost to Follow-up|3|||
16390650|NCT00600067|39915918|FG000|Overall Study|protocol non-compliance|0|||
16390651|NCT00600067|39915919|FG001|Overall Study|protocol non-compliance|3|||
16390652|NCT00600067|39915918|FG000|Overall Study|Lack of Efficacy|1|||
16390653|NCT00600067|39915919|FG001|Overall Study|Lack of Efficacy|0|||
16390654|NCT01721486|39915923|FG000|Overall Study|Protocol Violation|1|||
16390655|NCT01721486|39915924|FG001|Overall Study|Protocol Violation|0|||
16390656|NCT01721486|39915923|FG000|Overall Study|Physician Decision|0|||
16390657|NCT01721486|39915924|FG001|Overall Study|Physician Decision|1|||
16390658|NCT01837680|39915925|FG000|Overall Study|Lost to Follow-up|2|||
16390659|NCT01837680|39915926|FG001|Overall Study|Lost to Follow-up|2|||
16390660|NCT01837680|39915925|FG000|Overall Study|lack of insurance|0|||
16390661|NCT01837680|39915926|FG001|Overall Study|lack of insurance|2|||
16390662|NCT01837680|39915925|FG000|Overall Study|allergic reaction|6|||
16390663|NCT01837680|39915926|FG001|Overall Study|allergic reaction|0|||
16390664|NCT01837680|39915925|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
16390665|NCT01837680|39915926|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
16390666|NCT02528942|39915927|FG000|Overall Study|Did not meet imaging criteria|9|||
16390667|NCT02528942|39915927|FG000|Overall Study|Lost to Follow-up|25|||
16390668|NCT00763256|39915931|FG000|Overall Study|Didn't return for appointments|7|||
16390669|NCT00763256|39915932|FG001|Overall Study|Didn't return for appointments|10|||
16390670|NCT03456700|39915933|FG000|Overall Study|Withdrawal by Subject|1|||
16390671|NCT00131352|39915934|FG000|Initial Treatment Period|Adverse Event|1|||
16390672|NCT00131352|39915935|FG001|Initial Treatment Period|Adverse Event|3|||
16505048|NCT02641379|40322186|FG008|Overall Study|PCR positive at Week 28|0|||
16505049|NCT02641379|40322187|FG009|Overall Study|PCR positive at Week 28|0|||
16505050|NCT02641379|40322188|FG010|Overall Study|PCR positive at Week 28|0|||
16505051|NCT02641379|40322178|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
16505052|NCT02641379|40322179|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
16505053|NCT02641379|40322180|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
16311587|NCT03850483|39623709|FG009|Treatment for Stage 2|Adverse Event|1|||
16311588|NCT03850483|39623700|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
16311589|NCT03850483|39623701|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
16311590|NCT03850483|39623702|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
16311591|NCT03850483|39623703|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
16311592|NCT03850483|39623704|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
16505054|NCT02641379|40322181|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
16505055|NCT02641379|40322182|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
16505056|NCT02641379|40322183|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
16505057|NCT02641379|40322184|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
16546333|NCT01986881|40464784|FG001|Overall Study|Lost to Follow-up|44|||
16311593|NCT03850483|39623705|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
16311594|NCT03850483|39623706|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
16390673|NCT00131352|39915934|FG000|Initial Treatment Period|Non-compliant|1|||
16390674|NCT00131352|39915935|FG001|Initial Treatment Period|Non-compliant|2|||
16196065|NCT00383721|39193460|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
16196066|NCT00383721|39193461|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
16311595|NCT03850483|39623707|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
16311596|NCT03850483|39623708|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
16311597|NCT03850483|39623709|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
16311598|NCT03850483|39623700|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
16311599|NCT03850483|39623701|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
16311600|NCT03850483|39623702|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
16311601|NCT03850483|39623703|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
16311602|NCT03850483|39623704|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
16311603|NCT03850483|39623705|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
16311604|NCT03850483|39623706|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
16311605|NCT03850483|39623707|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
16311606|NCT03850483|39623708|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
16311607|NCT03850483|39623709|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
16311608|NCT03850483|39623700|FG000|Treatment for Stage 2|Physician Decision|0|||
16311609|NCT03850483|39623701|FG001|Treatment for Stage 2|Physician Decision|0|||
16311610|NCT03850483|39623702|FG002|Treatment for Stage 2|Physician Decision|0|||
16311611|NCT03850483|39623703|FG003|Treatment for Stage 2|Physician Decision|0|||
16311612|NCT03850483|39623704|FG004|Treatment for Stage 2|Physician Decision|0|||
16311613|NCT03850483|39623705|FG005|Treatment for Stage 2|Physician Decision|0|||
16311614|NCT03850483|39623706|FG006|Treatment for Stage 2|Physician Decision|0|||
16311615|NCT03850483|39623707|FG007|Treatment for Stage 2|Physician Decision|0|||
16311616|NCT03850483|39623708|FG008|Treatment for Stage 2|Physician Decision|0|||
16311617|NCT03850483|39623709|FG009|Treatment for Stage 2|Physician Decision|1|||
16311618|NCT03850483|39623700|FG000|Treatment for Stage 2|Protocol Violation|0|||
16311619|NCT03850483|39623701|FG001|Treatment for Stage 2|Protocol Violation|0|||
16196067|NCT00383721|39193462|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
16196068|NCT00383721|39193458|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
16196069|NCT00383721|39193459|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
16196070|NCT00383721|39193460|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
16196071|NCT00383721|39193461|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
16196072|NCT00383721|39193462|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
16196073|NCT00383721|39193458|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
16311620|NCT03850483|39623702|FG002|Treatment for Stage 2|Protocol Violation|0|||
16311621|NCT03850483|39623703|FG003|Treatment for Stage 2|Protocol Violation|0|||
16311622|NCT03850483|39623704|FG004|Treatment for Stage 2|Protocol Violation|0|||
16311623|NCT03850483|39623705|FG005|Treatment for Stage 2|Protocol Violation|0|||
16311624|NCT03850483|39623706|FG006|Treatment for Stage 2|Protocol Violation|0|||
16311625|NCT03850483|39623707|FG007|Treatment for Stage 2|Protocol Violation|0|||
16311626|NCT03850483|39623708|FG008|Treatment for Stage 2|Protocol Violation|1|||
16311627|NCT03850483|39623709|FG009|Treatment for Stage 2|Protocol Violation|0|||
16311628|NCT03850483|39623700|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
16505058|NCT02641379|40322185|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
16505059|NCT02641379|40322186|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
16505060|NCT02641379|40322187|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
16505061|NCT02641379|40322188|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
16311629|NCT03850483|39623701|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
16311630|NCT03850483|39623702|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
16311631|NCT03850483|39623703|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
16311632|NCT03850483|39623704|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
16311633|NCT03850483|39623705|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
16311634|NCT03850483|39623706|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
16505062|NCT02641379|40322178|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
16505063|NCT02641379|40322179|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
16505064|NCT02641379|40322180|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
16505065|NCT02641379|40322181|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
16505066|NCT02641379|40322182|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
16505067|NCT02641379|40322183|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
16311635|NCT03850483|39623707|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
16311636|NCT03850483|39623708|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
16311637|NCT03850483|39623709|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
16311638|NCT03850483|39623700|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16311639|NCT03850483|39623701|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16311640|NCT03850483|39623702|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16311641|NCT03850483|39623703|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16505068|NCT02641379|40322184|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
16505069|NCT02641379|40322185|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
16505070|NCT02641379|40322186|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
16546334|NCT01986881|40464785|FG002|Overall Study|Lost to Follow-up|55|||
16311642|NCT03850483|39623704|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16311643|NCT03850483|39623705|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16311644|NCT03850483|39623706|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16311645|NCT03850483|39623707|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16311646|NCT03850483|39623708|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
16311647|NCT03850483|39623709|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
16311648|NCT03850483|39623700|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
16311649|NCT03850483|39623701|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
16311650|NCT03850483|39623702|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
16311651|NCT03850483|39623703|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
16311652|NCT03850483|39623704|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
16311653|NCT03850483|39623705|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
16311654|NCT03850483|39623706|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
16311655|NCT03850483|39623707|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
16311656|NCT03850483|39623708|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
16311657|NCT03850483|39623709|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
16311658|NCT03850483|39623700|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
16311659|NCT03850483|39623701|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
16311660|NCT03850483|39623702|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
16311661|NCT03850483|39623703|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
16311662|NCT03850483|39623704|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
16311663|NCT03850483|39623705|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
16311664|NCT03850483|39623706|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
16311665|NCT03850483|39623707|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
16311666|NCT03850483|39623708|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
16311667|NCT03850483|39623709|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
16311668|NCT03850483|39623700|FG000|Follow-up For Stage 2|Other|0|||
16311669|NCT03850483|39623701|FG001|Follow-up For Stage 2|Other|0|||
16311670|NCT03850483|39623702|FG002|Follow-up For Stage 2|Other|0|||
16311671|NCT03850483|39623703|FG003|Follow-up For Stage 2|Other|0|||
16311672|NCT03850483|39623704|FG004|Follow-up For Stage 2|Other|0|||
16505071|NCT02641379|40322187|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
16505072|NCT02641379|40322188|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
16505073|NCT02641379|40322178|FG000|Overall Study|Baseline viral load unavailable|0|||
16505074|NCT02641379|40322179|FG001|Overall Study|Baseline viral load unavailable|0|||
16505075|NCT02641379|40322180|FG002|Overall Study|Baseline viral load unavailable|0|||
16505076|NCT02641379|40322181|FG003|Overall Study|Baseline viral load unavailable|1|||
16505077|NCT02641379|40322182|FG004|Overall Study|Baseline viral load unavailable|0|||
16505078|NCT02641379|40322183|FG005|Overall Study|Baseline viral load unavailable|0|||
16505079|NCT02641379|40322184|FG006|Overall Study|Baseline viral load unavailable|0|||
16505080|NCT02641379|40322185|FG007|Overall Study|Baseline viral load unavailable|0|||
16505081|NCT02641379|40322186|FG008|Overall Study|Baseline viral load unavailable|0|||
16505082|NCT02641379|40322187|FG009|Overall Study|Baseline viral load unavailable|0|||
16311673|NCT03850483|39623705|FG005|Follow-up For Stage 2|Other|0|||
16311674|NCT03850483|39623706|FG006|Follow-up For Stage 2|Other|0|||
16311675|NCT03850483|39623707|FG007|Follow-up For Stage 2|Other|0|||
16311676|NCT03850483|39623708|FG008|Follow-up For Stage 2|Other|0|||
16311677|NCT03850483|39623709|FG009|Follow-up For Stage 2|Other|1|||
16311678|NCT00124917|39623710|FG000|Overall Study|Physician Decision|3|||
16311679|NCT01042093|39623711|FG000|Overall Study|Protocol Violation|2|||
16311680|NCT01042093|39623712|FG001|Overall Study|Protocol Violation|2|||
16311681|NCT01042093|39623713|FG002|Overall Study|Protocol Violation|2|||
16311682|NCT01042093|39623714|FG003|Overall Study|Protocol Violation|3|||
16311683|NCT01042093|39623711|FG000|Overall Study|Withdrawal by Subject|0|||
16311684|NCT01042093|39623712|FG001|Overall Study|Withdrawal by Subject|0|||
16311685|NCT01042093|39623713|FG002|Overall Study|Withdrawal by Subject|0|||
16311686|NCT01042093|39623714|FG003|Overall Study|Withdrawal by Subject|1|||
16311687|NCT05064397|39623715|FG000|Overall Study|Adverse Event|4|||
16311688|NCT05064397|39623715|FG000|Overall Study|Lack of Efficacy|12|||
16311689|NCT05064397|39623715|FG000|Overall Study|Withdrawal by Subject|3|||
16505083|NCT02641379|40322188|FG010|Overall Study|Baseline viral load unavailable|0|||
16311690|NCT05064397|39623715|FG000|Overall Study|Lost to Follow-up|1|||
16311691|NCT05064397|39623715|FG000|Overall Study|Other reasons|3|||
16311692|NCT00886015|39623718|FG000|Overall Study|Death|0|||
16311693|NCT00886015|39623719|FG001|Overall Study|Death|2|||
16311694|NCT01526655|39623729|FG000|Overall Study|Withdrawal by Subject|0|||
16311695|NCT01526655|39623730|FG001|Overall Study|Withdrawal by Subject|1|||
16311696|NCT01276756|39623731|FG000|Overall Study|Lost to Follow-up|2|||
16311697|NCT01276756|39623732|FG001|Overall Study|Lost to Follow-up|0|||
16311698|NCT01276756|39623731|FG000|Overall Study|Adverse Event|3|||
16311699|NCT01276756|39623732|FG001|Overall Study|Adverse Event|2|||
16505084|NCT02641379|40322178|FG000|Overall Study|Blood could not be drawn|0|||
16196074|NCT00383721|39193459|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
16196075|NCT00383721|39193460|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
16505085|NCT02641379|40322179|FG001|Overall Study|Blood could not be drawn|0|||
16505086|NCT02641379|40322180|FG002|Overall Study|Blood could not be drawn|0|||
16505087|NCT02641379|40322181|FG003|Overall Study|Blood could not be drawn|0|||
16505088|NCT02641379|40322182|FG004|Overall Study|Blood could not be drawn|1|||
16505089|NCT02641379|40322183|FG005|Overall Study|Blood could not be drawn|0|||
16505090|NCT02641379|40322184|FG006|Overall Study|Blood could not be drawn|0|||
16196076|NCT00383721|39193461|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
16196077|NCT00383721|39193462|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
16196078|NCT00383721|39193458|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
16196079|NCT00383721|39193459|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
16196080|NCT00383721|39193460|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
16196081|NCT00383721|39193461|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
16196082|NCT00383721|39193462|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
16505091|NCT02641379|40322185|FG007|Overall Study|Blood could not be drawn|0|||
16505092|NCT02641379|40322186|FG008|Overall Study|Blood could not be drawn|0|||
16505093|NCT02641379|40322187|FG009|Overall Study|Blood could not be drawn|0|||
16505094|NCT02641379|40322188|FG010|Overall Study|Blood could not be drawn|0|||
16505095|NCT02641379|40322178|FG000|Overall Study|Protocol Violation|0|||
16505096|NCT02641379|40322179|FG001|Overall Study|Protocol Violation|0|||
16505097|NCT02641379|40322180|FG002|Overall Study|Protocol Violation|0|||
16505098|NCT02641379|40322181|FG003|Overall Study|Protocol Violation|0|||
16505099|NCT02641379|40322182|FG004|Overall Study|Protocol Violation|2|||
16505100|NCT02641379|40322183|FG005|Overall Study|Protocol Violation|0|||
16505101|NCT02641379|40322184|FG006|Overall Study|Protocol Violation|0|||
16505102|NCT02641379|40322185|FG007|Overall Study|Protocol Violation|0|||
16505103|NCT02641379|40322186|FG008|Overall Study|Protocol Violation|1|||
16505104|NCT02641379|40322187|FG009|Overall Study|Protocol Violation|0|||
16505105|NCT02641379|40322188|FG010|Overall Study|Protocol Violation|0|||
16505106|NCT02641379|40322178|FG000|Overall Study|Participation in sili rescue study|0|||
16505107|NCT02641379|40322179|FG001|Overall Study|Participation in sili rescue study|0|||
16196083|NCT00383721|39193458|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
16196084|NCT00383721|39193459|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
16196085|NCT00383721|39193460|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
16196086|NCT00383721|39193461|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
16196087|NCT00383721|39193462|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
16196088|NCT00383721|39193458|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
16196089|NCT00383721|39193459|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
16196090|NCT00383721|39193460|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
16196091|NCT00383721|39193461|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
16196092|NCT00383721|39193462|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
16196093|NCT00383721|39193458|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
16196094|NCT00383721|39193459|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
16196095|NCT00383721|39193460|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
16196096|NCT00383721|39193461|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
16196097|NCT00383721|39193462|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
16196098|NCT00383721|39193458|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
16196099|NCT00383721|39193459|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
16196100|NCT00383721|39193460|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
16196101|NCT00383721|39193461|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
16196102|NCT00383721|39193462|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
16311700|NCT01942993|39623738|FG000|Overall Study|Lost to Follow-up|1|||
16311701|NCT01942993|39623738|FG000|Overall Study|Physician Decision|1|||
16311702|NCT02554682|39623739|FG000|Overall Study|Lost to Follow-up|11|||
16311703|NCT02554682|39623740|FG001|Overall Study|Lost to Follow-up|9|||
16390675|NCT00131352|39915934|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
16505108|NCT02641379|40322180|FG002|Overall Study|Participation in sili rescue study|0|||
16505109|NCT02641379|40322181|FG003|Overall Study|Participation in sili rescue study|0|||
16505110|NCT02641379|40322182|FG004|Overall Study|Participation in sili rescue study|0|||
16505111|NCT02641379|40322183|FG005|Overall Study|Participation in sili rescue study|1|||
16505112|NCT02641379|40322184|FG006|Overall Study|Participation in sili rescue study|0|||
16505113|NCT02641379|40322185|FG007|Overall Study|Participation in sili rescue study|0|||
16505114|NCT02641379|40322186|FG008|Overall Study|Participation in sili rescue study|0|||
16505115|NCT02641379|40322187|FG009|Overall Study|Participation in sili rescue study|0|||
16505116|NCT02641379|40322188|FG010|Overall Study|Participation in sili rescue study|0|||
16311704|NCT02554682|39623741|FG002|Overall Study|Lost to Follow-up|4|||
16311705|NCT02554682|39623742|FG003|Overall Study|Lost to Follow-up|3|||
16311706|NCT02554682|39623743|FG004|Overall Study|Lost to Follow-up|2|||
16311707|NCT02554682|39623744|FG005|Overall Study|Lost to Follow-up|1|||
16311708|NCT02554682|39623745|FG006|Overall Study|Lost to Follow-up|6|||
16311709|NCT02554682|39623746|FG007|Overall Study|Lost to Follow-up|6|||
16311710|NCT02554682|39623747|FG008|Overall Study|Lost to Follow-up|2|||
16311711|NCT02554682|39623748|FG009|Overall Study|Lost to Follow-up|2|||
16311712|NCT02554682|39623739|FG000|Overall Study|Withdrawal by Subject|2|||
16390676|NCT00131352|39915935|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
16390677|NCT00131352|39915934|FG000|Initial Treatment Period|Lack of Efficacy|6|||
16311713|NCT02554682|39623740|FG001|Overall Study|Withdrawal by Subject|1|||
16311714|NCT02554682|39623741|FG002|Overall Study|Withdrawal by Subject|0|||
16311715|NCT02554682|39623742|FG003|Overall Study|Withdrawal by Subject|0|||
16311716|NCT02554682|39623743|FG004|Overall Study|Withdrawal by Subject|0|||
16311717|NCT02554682|39623744|FG005|Overall Study|Withdrawal by Subject|0|||
16311718|NCT02554682|39623745|FG006|Overall Study|Withdrawal by Subject|0|||
16311719|NCT02554682|39623746|FG007|Overall Study|Withdrawal by Subject|0|||
16311720|NCT02554682|39623747|FG008|Overall Study|Withdrawal by Subject|0|||
16311721|NCT02554682|39623748|FG009|Overall Study|Withdrawal by Subject|0|||
16311722|NCT02554682|39623739|FG000|Overall Study|Physician Decision|2|||
16311723|NCT02554682|39623740|FG001|Overall Study|Physician Decision|2|||
16311724|NCT02554682|39623741|FG002|Overall Study|Physician Decision|0|||
16311725|NCT02554682|39623742|FG003|Overall Study|Physician Decision|0|||
16390678|NCT00131352|39915935|FG001|Initial Treatment Period|Lack of Efficacy|4|||
16390679|NCT00131352|39915934|FG000|Initial Treatment Period|Other|0|||
16390680|NCT00131352|39915935|FG001|Initial Treatment Period|Other|2|||
16390681|NCT00131352|39915934|FG000|Repeat Treatment Period|Adverse Event|1|||
16390682|NCT00131352|39915935|FG001|Repeat Treatment Period|Adverse Event|0|||
16390683|NCT00131352|39915934|FG000|Repeat Treatment Period|Other|1|||
16390684|NCT00131352|39915935|FG001|Repeat Treatment Period|Other|0|||
16390685|NCT00673231|39915936|FG000|Overall Study|Withdrawal by Subject|14|||
16390686|NCT00673231|39915937|FG001|Overall Study|Withdrawal by Subject|10|||
16390687|NCT00673231|39915938|FG002|Overall Study|Withdrawal by Subject|8|||
16390688|NCT00673231|39915939|FG003|Overall Study|Withdrawal by Subject|6|||
16390689|NCT00673231|39915936|FG000|Overall Study|Adverse Event|6|||
16390690|NCT00673231|39915937|FG001|Overall Study|Adverse Event|5|||
16390691|NCT00673231|39915938|FG002|Overall Study|Adverse Event|9|||
16390692|NCT00673231|39915939|FG003|Overall Study|Adverse Event|6|||
16390693|NCT00673231|39915936|FG000|Overall Study|Lost to Follow-up|1|||
16390694|NCT00673231|39915937|FG001|Overall Study|Lost to Follow-up|2|||
16390695|NCT00673231|39915938|FG002|Overall Study|Lost to Follow-up|1|||
16390696|NCT00673231|39915939|FG003|Overall Study|Lost to Follow-up|2|||
16390697|NCT00673231|39915936|FG000|Overall Study|Death|0|||
16390698|NCT00673231|39915937|FG001|Overall Study|Death|0|||
16390699|NCT00673231|39915938|FG002|Overall Study|Death|1|||
16311726|NCT02554682|39623743|FG004|Overall Study|Physician Decision|0|||
16311727|NCT02554682|39623744|FG005|Overall Study|Physician Decision|0|||
16311728|NCT02554682|39623745|FG006|Overall Study|Physician Decision|0|||
16311729|NCT02554682|39623746|FG007|Overall Study|Physician Decision|0|||
16311730|NCT02554682|39623747|FG008|Overall Study|Physician Decision|0|||
16311731|NCT02554682|39623748|FG009|Overall Study|Physician Decision|0|||
16311732|NCT00246324|39623749|FG000|Overall Study|Withdrawal by Subject|1|||
16311733|NCT03627546|39623750|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
16311734|NCT03627546|39623751|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
16311735|NCT03627546|39623752|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
16311736|NCT03627546|39623750|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
16390700|NCT00673231|39915939|FG003|Overall Study|Death|0|||
16390701|NCT00673231|39915936|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
16390702|NCT00673231|39915937|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
16390703|NCT00673231|39915938|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
16311737|NCT03627546|39623751|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
16311738|NCT03627546|39623752|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
16311739|NCT01431079|39623757|FG000|Overall Study|Lost to Follow-up|35|||
16311740|NCT01431079|39623758|FG001|Overall Study|Lost to Follow-up|39|||
16311741|NCT01306305|39623759|FG000|Overall Study|Lost to Follow-up|1|||
16311742|NCT01306305|39623760|FG001|Overall Study|Lost to Follow-up|0|||
16390704|NCT00673231|39915939|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
16390705|NCT01945996|39915940|FG000|Overall Study|Lost to Follow-up|3|||
16311743|NCT01306305|39623759|FG000|Overall Study|Withdrew consent|1|||
16311744|NCT01306305|39623760|FG001|Overall Study|Withdrew consent|0|||
16311745|NCT01350271|39627225|FG000|Overall Study|Lost to Follow-up|21|||
16311746|NCT01350271|39627226|FG001|Overall Study|Lost to Follow-up|17|||
16311747|NCT01350271|39627227|FG002|Overall Study|Lost to Follow-up|26|||
16311748|NCT02347813|39627230|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
16311749|NCT02347813|39627231|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
16311750|NCT02347813|39627230|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
16311751|NCT02347813|39627231|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
16311752|NCT01215136|39627232|FG000|Overall Study|Adverse Event|2|||
16311753|NCT01215136|39627233|FG001|Overall Study|Adverse Event|9|||
16311754|NCT01215136|39627232|FG000|Overall Study|Disease Progression|3|||
16311755|NCT01215136|39627233|FG001|Overall Study|Disease Progression|14|||
16311756|NCT01215136|39627232|FG000|Overall Study|Symptomatic Deterioration|1|||
16311757|NCT01215136|39627233|FG001|Overall Study|Symptomatic Deterioration|1|||
16311758|NCT01215136|39627232|FG000|Overall Study|Death|0|||
16311759|NCT01215136|39627233|FG001|Overall Study|Death|2|||
16311760|NCT01215136|39627232|FG000|Overall Study|Withdrawal by Subject|0|||
16311761|NCT01215136|39627233|FG001|Overall Study|Withdrawal by Subject|1|||
16311762|NCT02064816|39627236|FG000|Overall Study|Adverse Event|3|||
16311763|NCT02064816|39627237|FG001|Overall Study|Adverse Event|2|||
16311764|NCT02064816|39627236|FG000|Overall Study|Withdrawal by Subject|2|||
16311765|NCT02064816|39627237|FG001|Overall Study|Withdrawal by Subject|1|||
16311766|NCT02064816|39627236|FG000|Overall Study|Lost to Follow-up|2|||
16311767|NCT02064816|39627237|FG001|Overall Study|Lost to Follow-up|1|||
16311768|NCT02064816|39627236|FG000|Overall Study|Therapeutic failure|0|||
16311769|NCT02064816|39627237|FG001|Overall Study|Therapeutic failure|1|||
16311770|NCT02064816|39627236|FG000|Overall Study|Other|1|||
16311771|NCT02064816|39627237|FG001|Overall Study|Other|3|||
16311772|NCT01217112|39627238|FG000|Overall Study|Adverse Event|0|||
16311773|NCT01217112|39627239|FG001|Overall Study|Adverse Event|2|||
16311774|NCT01217112|39627240|FG002|Overall Study|Adverse Event|0|||
16311775|NCT01217112|39627241|FG003|Overall Study|Adverse Event|2|||
16311776|NCT01217112|39627242|FG004|Overall Study|Adverse Event|0|||
16311777|NCT01217112|39627238|FG000|Overall Study|Withdrawal by Subject|0|||
16311778|NCT01217112|39627239|FG001|Overall Study|Withdrawal by Subject|0|||
16311779|NCT01217112|39627240|FG002|Overall Study|Withdrawal by Subject|1|||
16311780|NCT01217112|39627241|FG003|Overall Study|Withdrawal by Subject|0|||
16311781|NCT01217112|39627242|FG004|Overall Study|Withdrawal by Subject|0|||
16311782|NCT01217112|39627238|FG000|Overall Study|Physician Decision|0|||
16311783|NCT01217112|39627239|FG001|Overall Study|Physician Decision|0|||
16311784|NCT01217112|39627240|FG002|Overall Study|Physician Decision|0|||
16390706|NCT01945996|39915941|FG001|Overall Study|Lost to Follow-up|5|||
16390707|NCT00540592|39915942|FG000|Overall Study|Adverse Event|0|||
16390708|NCT00540592|39915943|FG001|Overall Study|Adverse Event|1|||
16390709|NCT00540592|39915944|FG002|Overall Study|Adverse Event|0|||
16390710|NCT00540592|39915945|FG003|Overall Study|Adverse Event|0|||
16505117|NCT02641379|40322178|FG000|Overall Study|Lost to Follow-up|0|||
16505118|NCT02641379|40322179|FG001|Overall Study|Lost to Follow-up|0|||
16505119|NCT02641379|40322180|FG002|Overall Study|Lost to Follow-up|0|||
16505120|NCT02641379|40322181|FG003|Overall Study|Lost to Follow-up|0|||
16505121|NCT02641379|40322182|FG004|Overall Study|Lost to Follow-up|0|||
16505122|NCT02641379|40322183|FG005|Overall Study|Lost to Follow-up|0|||
16505123|NCT02641379|40322184|FG006|Overall Study|Lost to Follow-up|0|||
16505124|NCT02641379|40322185|FG007|Overall Study|Lost to Follow-up|0|||
16505125|NCT02641379|40322186|FG008|Overall Study|Lost to Follow-up|1|||
16505126|NCT02641379|40322187|FG009|Overall Study|Lost to Follow-up|0|||
16505127|NCT02641379|40322188|FG010|Overall Study|Lost to Follow-up|0|||
16505128|NCT02641379|40322178|FG000|Overall Study|Source data not found|0|||
16505129|NCT02641379|40322179|FG001|Overall Study|Source data not found|0|||
16505130|NCT02641379|40322180|FG002|Overall Study|Source data not found|0|||
16505131|NCT02641379|40322181|FG003|Overall Study|Source data not found|0|||
16505132|NCT02641379|40322182|FG004|Overall Study|Source data not found|0|||
16505133|NCT02641379|40322183|FG005|Overall Study|Source data not found|1|||
16311785|NCT01217112|39627241|FG003|Overall Study|Physician Decision|0|||
16311786|NCT01217112|39627242|FG004|Overall Study|Physician Decision|1|||
16311787|NCT00595621|39627245|FG000|Open Label Run in|Adverse Event|1|||
16311788|NCT00595621|39627246|FG001|Open Label Run in|Adverse Event|0|||
16311789|NCT00595621|39627245|FG000|Open Label Run in|Physician Decision|1|||
16311790|NCT00595621|39627246|FG001|Open Label Run in|Physician Decision|0|||
16311791|NCT00595621|39627245|FG000|Open Label Run in|Withdrawal by Subject|1|||
16311792|NCT00595621|39627246|FG001|Open Label Run in|Withdrawal by Subject|0|||
16311793|NCT00595621|39627245|FG000|Randomization and Study|Adverse Event|2|||
16311794|NCT00595621|39627246|FG001|Randomization and Study|Adverse Event|0|||
16311795|NCT00595621|39627245|FG000|Randomization and Study|Withdrawal by Subject|0|||
16311796|NCT00595621|39627246|FG001|Randomization and Study|Withdrawal by Subject|1|||
16311797|NCT02383017|39627247|FG000|Overall Study|Injury Sustained Outside Study|1|||
16311798|NCT02383017|39627248|FG001|Overall Study|Injury Sustained Outside Study|0|||
16311799|NCT02383017|39627247|FG000|Overall Study|Compliance|3|||
16311800|NCT02383017|39627248|FG001|Overall Study|Compliance|2|||
16505134|NCT02641379|40322184|FG006|Overall Study|Source data not found|0|||
16390711|NCT00540592|39915946|FG004|Overall Study|Adverse Event|1|||
16390712|NCT00540592|39915947|FG005|Overall Study|Adverse Event|0|||
16505135|NCT02641379|40322185|FG007|Overall Study|Source data not found|0|||
16196103|NCT00383721|39193458|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
16196104|NCT00383721|39193459|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
16196105|NCT00383721|39193460|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
16505136|NCT02641379|40322186|FG008|Overall Study|Source data not found|0|||
16505137|NCT02641379|40322187|FG009|Overall Study|Source data not found|0|||
16505138|NCT02641379|40322188|FG010|Overall Study|Source data not found|0|||
16505139|NCT02641379|40322178|FG000|Overall Study|Participant showed weight reduction|0|||
16505140|NCT02641379|40322179|FG001|Overall Study|Participant showed weight reduction|0|||
16505141|NCT02641379|40322180|FG002|Overall Study|Participant showed weight reduction|0|||
16505142|NCT02641379|40322181|FG003|Overall Study|Participant showed weight reduction|0|||
16505143|NCT02641379|40322182|FG004|Overall Study|Participant showed weight reduction|0|||
16505144|NCT02641379|40322183|FG005|Overall Study|Participant showed weight reduction|0|||
16505145|NCT02641379|40322184|FG006|Overall Study|Participant showed weight reduction|0|||
16505146|NCT02641379|40322185|FG007|Overall Study|Participant showed weight reduction|1|||
16505147|NCT02641379|40322186|FG008|Overall Study|Participant showed weight reduction|0|||
16505148|NCT02641379|40322187|FG009|Overall Study|Participant showed weight reduction|0|||
16505149|NCT02641379|40322188|FG010|Overall Study|Participant showed weight reduction|0|||
16505150|NCT02641379|40322178|FG000|Overall Study|Non-response Week 12|0|||
16505151|NCT02641379|40322179|FG001|Overall Study|Non-response Week 12|0|||
16505152|NCT02641379|40322180|FG002|Overall Study|Non-response Week 12|0|||
16505153|NCT02641379|40322181|FG003|Overall Study|Non-response Week 12|0|||
16505154|NCT02641379|40322182|FG004|Overall Study|Non-response Week 12|0|||
16505155|NCT02641379|40322183|FG005|Overall Study|Non-response Week 12|0|||
16505156|NCT02641379|40322184|FG006|Overall Study|Non-response Week 12|0|||
16505157|NCT02641379|40322185|FG007|Overall Study|Non-response Week 12|1|||
16505158|NCT02641379|40322186|FG008|Overall Study|Non-response Week 12|0|||
16505159|NCT02641379|40322187|FG009|Overall Study|Non-response Week 12|0|||
16505160|NCT02641379|40322188|FG010|Overall Study|Non-response Week 12|0|||
16505161|NCT02641379|40322178|FG000|Overall Study|No 2 Log drop at Week 12|0|||
16505162|NCT02641379|40322179|FG001|Overall Study|No 2 Log drop at Week 12|0|||
16505163|NCT02641379|40322180|FG002|Overall Study|No 2 Log drop at Week 12|0|||
16505164|NCT02641379|40322181|FG003|Overall Study|No 2 Log drop at Week 12|0|||
16505165|NCT02641379|40322182|FG004|Overall Study|No 2 Log drop at Week 12|0|||
16505166|NCT02641379|40322183|FG005|Overall Study|No 2 Log drop at Week 12|0|||
16505167|NCT02641379|40322184|FG006|Overall Study|No 2 Log drop at Week 12|0|||
16505168|NCT02641379|40322185|FG007|Overall Study|No 2 Log drop at Week 12|0|||
16505169|NCT02641379|40322186|FG008|Overall Study|No 2 Log drop at Week 12|0|||
16505170|NCT02641379|40322187|FG009|Overall Study|No 2 Log drop at Week 12|0|||
16505171|NCT02641379|40322188|FG010|Overall Study|No 2 Log drop at Week 12|1|||
16505172|NCT02641379|40322178|FG000|Overall Study|Negative PCR result|0|||
16505173|NCT02641379|40322179|FG001|Overall Study|Negative PCR result|0|||
16505174|NCT02641379|40322180|FG002|Overall Study|Negative PCR result|0|||
16505175|NCT02641379|40322181|FG003|Overall Study|Negative PCR result|0|||
16505176|NCT02641379|40322182|FG004|Overall Study|Negative PCR result|0|||
16196106|NCT00383721|39193461|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
16196107|NCT00383721|39193462|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
16196108|NCT00383721|39193458|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
16196109|NCT00383721|39193459|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
16196110|NCT00383721|39193460|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
16196111|NCT00383721|39193461|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
16196112|NCT00383721|39193462|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
16196113|NCT00383721|39193458|FG000|26-Week Treatment Safety Extension|Administrative|1|||
16196114|NCT00383721|39193459|FG001|26-Week Treatment Safety Extension|Administrative|2|||
16196115|NCT00383721|39193460|FG002|26-Week Treatment Safety Extension|Administrative|3|||
16196116|NCT00383721|39193461|FG003|26-Week Treatment Safety Extension|Administrative|1|||
16196117|NCT00383721|39193462|FG004|26-Week Treatment Safety Extension|Administrative|0|||
16505177|NCT02641379|40322183|FG005|Overall Study|Negative PCR result|0|||
16505178|NCT02641379|40322184|FG006|Overall Study|Negative PCR result|0|||
16505179|NCT02641379|40322185|FG007|Overall Study|Negative PCR result|0|||
16505180|NCT02641379|40322186|FG008|Overall Study|Negative PCR result|0|||
16505181|NCT02641379|40322187|FG009|Overall Study|Negative PCR result|1|||
16505182|NCT02641379|40322188|FG010|Overall Study|Negative PCR result|0|||
16505183|NCT02641379|40322178|FG000|Overall Study|Participant's PCR high|0|||
16505184|NCT02641379|40322179|FG001|Overall Study|Participant's PCR high|0|||
16311801|NCT02383017|39627247|FG000|Overall Study|Found to be Hypogonadal|1|||
16505185|NCT02641379|40322180|FG002|Overall Study|Participant's PCR high|0|||
16505186|NCT02641379|40322181|FG003|Overall Study|Participant's PCR high|0|||
16505187|NCT02641379|40322182|FG004|Overall Study|Participant's PCR high|0|||
16505188|NCT02641379|40322183|FG005|Overall Study|Participant's PCR high|0|||
16505189|NCT02641379|40322184|FG006|Overall Study|Participant's PCR high|0|||
16505190|NCT02641379|40322185|FG007|Overall Study|Participant's PCR high|1|||
16505191|NCT02641379|40322186|FG008|Overall Study|Participant's PCR high|0|||
16505192|NCT02641379|40322187|FG009|Overall Study|Participant's PCR high|0|||
16505193|NCT02641379|40322188|FG010|Overall Study|Participant's PCR high|0|||
16505194|NCT02641379|40322178|FG000|Overall Study|Participant treated after Week 24|0|||
16505195|NCT02641379|40322179|FG001|Overall Study|Participant treated after Week 24|0|||
16505196|NCT02641379|40322180|FG002|Overall Study|Participant treated after Week 24|0|||
16505197|NCT02641379|40322181|FG003|Overall Study|Participant treated after Week 24|0|||
16505198|NCT02641379|40322182|FG004|Overall Study|Participant treated after Week 24|0|||
16505199|NCT02641379|40322183|FG005|Overall Study|Participant treated after Week 24|0|||
16505200|NCT02641379|40322184|FG006|Overall Study|Participant treated after Week 24|0|||
16505201|NCT02641379|40322185|FG007|Overall Study|Participant treated after Week 24|0|||
16505202|NCT02641379|40322186|FG008|Overall Study|Participant treated after Week 24|1|||
16505203|NCT02641379|40322187|FG009|Overall Study|Participant treated after Week 24|0|||
16505204|NCT02641379|40322188|FG010|Overall Study|Participant treated after Week 24|0|||
16505205|NCT02641379|40322178|FG000|Overall Study|Missing PCR result at Week 8|0|||
16505206|NCT02641379|40322179|FG001|Overall Study|Missing PCR result at Week 8|0|||
16505207|NCT02641379|40322180|FG002|Overall Study|Missing PCR result at Week 8|0|||
16505208|NCT02641379|40322181|FG003|Overall Study|Missing PCR result at Week 8|0|||
16505209|NCT02641379|40322182|FG004|Overall Study|Missing PCR result at Week 8|0|||
16505210|NCT02641379|40322183|FG005|Overall Study|Missing PCR result at Week 8|0|||
16505211|NCT02641379|40322184|FG006|Overall Study|Missing PCR result at Week 8|0|||
16505212|NCT02641379|40322185|FG007|Overall Study|Missing PCR result at Week 8|0|||
16505213|NCT02641379|40322186|FG008|Overall Study|Missing PCR result at Week 8|0|||
16505214|NCT02641379|40322187|FG009|Overall Study|Missing PCR result at Week 8|1|||
16505215|NCT02641379|40322188|FG010|Overall Study|Missing PCR result at Week 8|0|||
16505216|NCT02641379|40322178|FG000|Overall Study|PCR positive|0|||
16505217|NCT02641379|40322179|FG001|Overall Study|PCR positive|0|||
16505218|NCT02641379|40322180|FG002|Overall Study|PCR positive|0|||
16505219|NCT02641379|40322181|FG003|Overall Study|PCR positive|0|||
16505220|NCT02641379|40322182|FG004|Overall Study|PCR positive|0|||
16505221|NCT02641379|40322183|FG005|Overall Study|PCR positive|0|||
16505222|NCT02641379|40322184|FG006|Overall Study|PCR positive|1|||
16505223|NCT02641379|40322185|FG007|Overall Study|PCR positive|0|||
16505224|NCT02641379|40322186|FG008|Overall Study|PCR positive|0|||
16505225|NCT02641379|40322187|FG009|Overall Study|PCR positive|0|||
16505226|NCT02641379|40322188|FG010|Overall Study|PCR positive|0|||
16505227|NCT01527682|40322189|FG000|Overall Study|Protocol Violation|8|||
16505228|NCT00605475|40322193|FG000|Overall Study|Abnormal Laboratory Values|0|||
16505229|NCT00605475|40322194|FG001|Overall Study|Abnormal Laboratory Values|0|||
16505230|NCT00605475|40322195|FG002|Overall Study|Abnormal Laboratory Values|0|||
16505231|NCT00605475|40322196|FG003|Overall Study|Abnormal Laboratory Values|0|||
16505232|NCT00605475|40322197|FG004|Overall Study|Abnormal Laboratory Values|0|||
16505233|NCT00605475|40322198|FG005|Overall Study|Abnormal Laboratory Values|0|||
16505234|NCT00605475|40322199|FG006|Overall Study|Abnormal Laboratory Values|0|||
16505235|NCT00605475|40322200|FG007|Overall Study|Abnormal Laboratory Values|0|||
16505236|NCT00605475|40322201|FG008|Overall Study|Abnormal Laboratory Values|1|||
16505237|NCT00605475|40322202|FG009|Overall Study|Abnormal Laboratory Values|0|||
16505238|NCT00605475|40322193|FG000|Overall Study|Administrative problems|0|||
16505239|NCT00605475|40322194|FG001|Overall Study|Administrative problems|0|||
16505240|NCT00605475|40322195|FG002|Overall Study|Administrative problems|0|||
16505241|NCT00605475|40322196|FG003|Overall Study|Administrative problems|0|||
16505242|NCT00605475|40322197|FG004|Overall Study|Administrative problems|0|||
16505243|NCT00605475|40322198|FG005|Overall Study|Administrative problems|0|||
16505244|NCT00605475|40322199|FG006|Overall Study|Administrative problems|1|||
16505245|NCT00605475|40322200|FG007|Overall Study|Administrative problems|0|||
16505246|NCT00605475|40322201|FG008|Overall Study|Administrative problems|0|||
16505247|NCT00605475|40322202|FG009|Overall Study|Administrative problems|0|||
16505248|NCT00605475|40322193|FG000|Overall Study|Lost to Follow-up|0|||
16505249|NCT00605475|40322194|FG001|Overall Study|Lost to Follow-up|0|||
16505250|NCT00605475|40322195|FG002|Overall Study|Lost to Follow-up|0|||
16505251|NCT00605475|40322196|FG003|Overall Study|Lost to Follow-up|0|||
16505252|NCT00605475|40322197|FG004|Overall Study|Lost to Follow-up|0|||
16505253|NCT00605475|40322198|FG005|Overall Study|Lost to Follow-up|0|||
16505254|NCT00605475|40322199|FG006|Overall Study|Lost to Follow-up|0|||
16505255|NCT00605475|40322200|FG007|Overall Study|Lost to Follow-up|0|||
16505256|NCT00605475|40322201|FG008|Overall Study|Lost to Follow-up|1|||
16505257|NCT00605475|40322202|FG009|Overall Study|Lost to Follow-up|1|||
16505258|NCT00605475|40322193|FG000|Overall Study|Protocol Violation|0|||
16505259|NCT00605475|40322194|FG001|Overall Study|Protocol Violation|0|||
16505260|NCT00605475|40322195|FG002|Overall Study|Protocol Violation|0|||
16505261|NCT00605475|40322196|FG003|Overall Study|Protocol Violation|0|||
16505262|NCT00605475|40322197|FG004|Overall Study|Protocol Violation|1|||
16505263|NCT00605475|40322198|FG005|Overall Study|Protocol Violation|0|||
16089760|NCT00670488|38819985|FG005|Overall Study|Progressive Disease|4|||
16505264|NCT00605475|40322199|FG006|Overall Study|Protocol Violation|0|||
16505265|NCT00605475|40322200|FG007|Overall Study|Protocol Violation|0|||
16505266|NCT00605475|40322201|FG008|Overall Study|Protocol Violation|0|||
16196118|NCT03103906|39193463|FG000|Overall Study|Adverse Event|2|||
16196119|NCT03103906|39193464|FG001|Overall Study|Adverse Event|3|||
16196120|NCT03103906|39193463|FG000|Overall Study|Other|2|||
16196121|NCT03103906|39193464|FG001|Overall Study|Other|0|||
16505267|NCT00605475|40322202|FG009|Overall Study|Protocol Violation|0|||
16505268|NCT00605475|40322193|FG000|Overall Study|Withdrawal by Subject|0|||
16196122|NCT00438399|39193468|FG000|Overall Study|Lost to Follow-up|2|||
16196123|NCT00438399|39193469|FG001|Overall Study|Lost to Follow-up|2|||
16196124|NCT00438399|39193470|FG002|Overall Study|Lost to Follow-up|1|||
16196125|NCT00438399|39193471|FG003|Overall Study|Lost to Follow-up|1|||
16196126|NCT00438399|39193472|FG004|Overall Study|Lost to Follow-up|1|||
16196127|NCT00438399|39193473|FG005|Overall Study|Lost to Follow-up|1|||
16196128|NCT00438399|39193468|FG000|Overall Study|Adverse Event|0|||
16196129|NCT00438399|39193469|FG001|Overall Study|Adverse Event|0|||
16196130|NCT00438399|39193470|FG002|Overall Study|Adverse Event|1|||
16196131|NCT00438399|39193471|FG003|Overall Study|Adverse Event|1|||
16196132|NCT00438399|39193472|FG004|Overall Study|Adverse Event|0|||
16196133|NCT00438399|39193473|FG005|Overall Study|Adverse Event|1|||
16196134|NCT00438399|39193468|FG000|Overall Study|Withdrawal by Subject|5|||
16196135|NCT00438399|39193469|FG001|Overall Study|Withdrawal by Subject|6|||
16196136|NCT00438399|39193470|FG002|Overall Study|Withdrawal by Subject|3|||
16196137|NCT00438399|39193471|FG003|Overall Study|Withdrawal by Subject|2|||
16196138|NCT00438399|39193472|FG004|Overall Study|Withdrawal by Subject|2|||
16196139|NCT00438399|39193473|FG005|Overall Study|Withdrawal by Subject|2|||
16196140|NCT00438399|39193468|FG000|Overall Study|Protocol Violation|0|||
16196141|NCT00438399|39193469|FG001|Overall Study|Protocol Violation|0|||
16196142|NCT00438399|39193470|FG002|Overall Study|Protocol Violation|1|||
16196143|NCT00438399|39193471|FG003|Overall Study|Protocol Violation|0|||
16196144|NCT00438399|39193472|FG004|Overall Study|Protocol Violation|0|||
16196145|NCT00438399|39193473|FG005|Overall Study|Protocol Violation|1|||
16196146|NCT00438399|39193468|FG000|Overall Study|Subje stopped study|0|||
16196147|NCT00438399|39193469|FG001|Overall Study|Subje stopped study|0|||
16196148|NCT00438399|39193470|FG002|Overall Study|Subje stopped study|1|||
16196149|NCT00438399|39193471|FG003|Overall Study|Subje stopped study|0|||
16196150|NCT00438399|39193472|FG004|Overall Study|Subje stopped study|0|||
16196151|NCT00438399|39193473|FG005|Overall Study|Subje stopped study|0|||
16196152|NCT00438399|39193468|FG000|Overall Study|Pregnancy|0|||
16196153|NCT00438399|39193469|FG001|Overall Study|Pregnancy|0|||
16196154|NCT00438399|39193470|FG002|Overall Study|Pregnancy|0|||
16196155|NCT00438399|39193471|FG003|Overall Study|Pregnancy|0|||
16196156|NCT00438399|39193472|FG004|Overall Study|Pregnancy|0|||
16196157|NCT00438399|39193473|FG005|Overall Study|Pregnancy|1|||
16196158|NCT00438399|39193468|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
16196159|NCT00438399|39193469|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
16196160|NCT00438399|39193470|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
16196161|NCT00438399|39193471|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
16196162|NCT00438399|39193472|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
16196163|NCT00438399|39193473|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
16505269|NCT00605475|40322194|FG001|Overall Study|Withdrawal by Subject|0|||
16505270|NCT00605475|40322195|FG002|Overall Study|Withdrawal by Subject|0|||
16505271|NCT00605475|40322196|FG003|Overall Study|Withdrawal by Subject|0|||
16505272|NCT00605475|40322197|FG004|Overall Study|Withdrawal by Subject|0|||
16505273|NCT00605475|40322198|FG005|Overall Study|Withdrawal by Subject|2|||
16505274|NCT00605475|40322199|FG006|Overall Study|Withdrawal by Subject|0|||
16505275|NCT00605475|40322200|FG007|Overall Study|Withdrawal by Subject|0|||
16505276|NCT00605475|40322201|FG008|Overall Study|Withdrawal by Subject|0|||
16505277|NCT00605475|40322202|FG009|Overall Study|Withdrawal by Subject|1|||
16505278|NCT01559012|40322203|FG000|Overall Study|Withdrawal by Subject|0|||
16505279|NCT01559012|40322204|FG001|Overall Study|Withdrawal by Subject|1|||
16505280|NCT01215227|40322205|FG000|Overall Study|Adverse Event|11|||
16505281|NCT01215227|40322206|FG001|Overall Study|Adverse Event|11|||
16505282|NCT01215227|40322207|FG002|Overall Study|Adverse Event|4|||
16505283|NCT01215227|40322208|FG003|Overall Study|Adverse Event|8|||
16505284|NCT01215227|40322209|FG004|Overall Study|Adverse Event|7|||
16505285|NCT01215227|40322210|FG005|Overall Study|Adverse Event|6|||
16505286|NCT01215227|40322205|FG000|Overall Study|Treatment Failure|8|||
16505287|NCT01215227|40322206|FG001|Overall Study|Treatment Failure|4|||
16196164|NCT01753076|39193474|FG000|Overall Study|Adverse Event|17|||
16196165|NCT01753076|39193475|FG001|Overall Study|Adverse Event|18|||
16196166|NCT01753076|39193474|FG000|Overall Study|Lack of Efficacy|3|||
16196167|NCT01753076|39193475|FG001|Overall Study|Lack of Efficacy|1|||
16196168|NCT01753076|39193474|FG000|Overall Study|Lost to Follow-up|2|||
16196169|NCT01753076|39193475|FG001|Overall Study|Lost to Follow-up|1|||
16505288|NCT01215227|40322207|FG002|Overall Study|Treatment Failure|1|||
16505289|NCT01215227|40322208|FG003|Overall Study|Treatment Failure|5|||
16196170|NCT01753076|39193474|FG000|Overall Study|Physician Decision|4|||
16196171|NCT01753076|39193475|FG001|Overall Study|Physician Decision|2|||
16505290|NCT01215227|40322209|FG004|Overall Study|Treatment Failure|1|||
16505291|NCT01215227|40322210|FG005|Overall Study|Treatment Failure|1|||
16505292|NCT01215227|40322205|FG000|Overall Study|Lost to Follow-up|1|||
16505293|NCT01215227|40322206|FG001|Overall Study|Lost to Follow-up|4|||
16505294|NCT01215227|40322207|FG002|Overall Study|Lost to Follow-up|1|||
16505295|NCT01215227|40322208|FG003|Overall Study|Lost to Follow-up|1|||
16505296|NCT01215227|40322209|FG004|Overall Study|Lost to Follow-up|1|||
16505297|NCT01215227|40322210|FG005|Overall Study|Lost to Follow-up|2|||
16505298|NCT01215227|40322205|FG000|Overall Study|Subject Withdrew Consent|16|||
16505299|NCT01215227|40322206|FG001|Overall Study|Subject Withdrew Consent|20|||
16505300|NCT01215227|40322207|FG002|Overall Study|Subject Withdrew Consent|7|||
16505301|NCT01215227|40322208|FG003|Overall Study|Subject Withdrew Consent|10|||
16505302|NCT01215227|40322209|FG004|Overall Study|Subject Withdrew Consent|11|||
16505303|NCT01215227|40322210|FG005|Overall Study|Subject Withdrew Consent|8|||
16505304|NCT01215227|40322205|FG000|Overall Study|Non-Compliance With Protocol|2|||
16505305|NCT01215227|40322206|FG001|Overall Study|Non-Compliance With Protocol|6|||
16505306|NCT01215227|40322207|FG002|Overall Study|Non-Compliance With Protocol|1|||
16505307|NCT01215227|40322208|FG003|Overall Study|Non-Compliance With Protocol|0|||
16505308|NCT01215227|40322209|FG004|Overall Study|Non-Compliance With Protocol|0|||
16505309|NCT01215227|40322210|FG005|Overall Study|Non-Compliance With Protocol|0|||
16505310|NCT01215227|40322205|FG000|Overall Study|Administrative|83|||
16505311|NCT01215227|40322206|FG001|Overall Study|Administrative|73|||
16505312|NCT01215227|40322207|FG002|Overall Study|Administrative|42|||
16505313|NCT01215227|40322208|FG003|Overall Study|Administrative|24|||
16505314|NCT01215227|40322209|FG004|Overall Study|Administrative|28|||
16505315|NCT01215227|40322210|FG005|Overall Study|Administrative|40|||
16505316|NCT01215227|40322205|FG000|Overall Study|Missing Status|0|||
16505317|NCT01215227|40322206|FG001|Overall Study|Missing Status|1|||
16505318|NCT01215227|40322207|FG002|Overall Study|Missing Status|0|||
16505319|NCT01215227|40322208|FG003|Overall Study|Missing Status|0|||
16505320|NCT01215227|40322209|FG004|Overall Study|Missing Status|0|||
16505321|NCT01215227|40322210|FG005|Overall Study|Missing Status|0|||
16505322|NCT01215227|40322205|FG000|Overall Study|Randomized but not treated|0|||
16505323|NCT01215227|40322206|FG001|Overall Study|Randomized but not treated|0|||
16505324|NCT01215227|40322207|FG002|Overall Study|Randomized but not treated|1|||
16505325|NCT01215227|40322208|FG003|Overall Study|Randomized but not treated|1|||
16505326|NCT01215227|40322209|FG004|Overall Study|Randomized but not treated|0|||
16505327|NCT01215227|40322210|FG005|Overall Study|Randomized but not treated|1|||
16505328|NCT05333900|40322211|FG000|Overall Study|Protocol Violation|0|||
16505329|NCT05333900|40322212|FG001|Overall Study|Protocol Violation|1|||
16505330|NCT05333900|40322211|FG000|Overall Study|Withdrawal by Subject|0|||
16505331|NCT05333900|40322212|FG001|Overall Study|Withdrawal by Subject|1|||
16505332|NCT05333900|40322211|FG000|Overall Study|COVID-19 Pandemic|1|||
16505333|NCT05333900|40322212|FG001|Overall Study|COVID-19 Pandemic|1|||
16505334|NCT00460031|40322213|FG000|Overall Study|Adverse Event|5|||
16505335|NCT00460031|40322213|FG000|Overall Study|Withdrawal by Subject|5|||
16505336|NCT00460031|40322213|FG000|Overall Study|Death|1|||
16505337|NCT00704535|40322216|FG000|Overall Study|Adverse Event|2|||
16505338|NCT00704535|40322216|FG000|Overall Study|Death|2|||
16505339|NCT00704535|40322216|FG000|Overall Study|Lost to Follow-up|8|||
16505340|NCT00704535|40322216|FG000|Overall Study|Protocol Violation|10|||
16505341|NCT00704535|40322216|FG000|Overall Study|Completed status not on Case Report Form|124|||
16505342|NCT01150123|40322217|FG000|Overall Study|Withdrawal by Subject|1|||
16505343|NCT01150123|40322218|FG001|Overall Study|Withdrawal by Subject|1|||
16505344|NCT01150123|40322219|FG002|Overall Study|Withdrawal by Subject|2|||
16505345|NCT01150123|40322220|FG003|Overall Study|Withdrawal by Subject|1|||
16505346|NCT01150123|40322221|FG004|Overall Study|Withdrawal by Subject|1|||
16505347|NCT01150123|40322222|FG005|Overall Study|Withdrawal by Subject|1|||
16505348|NCT01150123|40322223|FG006|Overall Study|Withdrawal by Subject|0|||
16505349|NCT01150123|40322224|FG007|Overall Study|Withdrawal by Subject|3|||
16505350|NCT01150123|40322225|FG008|Overall Study|Withdrawal by Subject|2|||
16505351|NCT01150123|40322226|FG009|Overall Study|Withdrawal by Subject|0|||
16505352|NCT01150123|40322227|FG010|Overall Study|Withdrawal by Subject|1|||
16505353|NCT01150123|40322228|FG011|Overall Study|Withdrawal by Subject|0|||
16505354|NCT01150123|40322229|FG012|Overall Study|Withdrawal by Subject|1|||
16196172|NCT01753076|39193474|FG000|Overall Study|Withdrawal by Subject|14|||
16505355|NCT01150123|40322230|FG013|Overall Study|Withdrawal by Subject|0|||
16505356|NCT01150123|40322231|FG014|Overall Study|Withdrawal by Subject|0|||
16505357|NCT01150123|40322232|FG015|Overall Study|Withdrawal by Subject|1|||
16505358|NCT01150123|40322233|FG016|Overall Study|Withdrawal by Subject|0|||
16505359|NCT01150123|40322234|FG017|Overall Study|Withdrawal by Subject|1|||
16505360|NCT01150123|40322217|FG000|Overall Study|Lost to Follow-up|2|||
16505361|NCT01150123|40322218|FG001|Overall Study|Lost to Follow-up|1|||
16505362|NCT01150123|40322219|FG002|Overall Study|Lost to Follow-up|2|||
16505363|NCT01150123|40322220|FG003|Overall Study|Lost to Follow-up|2|||
16505364|NCT01150123|40322221|FG004|Overall Study|Lost to Follow-up|2|||
16505365|NCT01150123|40322222|FG005|Overall Study|Lost to Follow-up|5|||
16505366|NCT01150123|40322223|FG006|Overall Study|Lost to Follow-up|0|||
16505367|NCT01150123|40322224|FG007|Overall Study|Lost to Follow-up|0|||
16505368|NCT01150123|40322225|FG008|Overall Study|Lost to Follow-up|3|||
16505369|NCT01150123|40322226|FG009|Overall Study|Lost to Follow-up|1|||
16505370|NCT01150123|40322227|FG010|Overall Study|Lost to Follow-up|1|||
16505371|NCT01150123|40322228|FG011|Overall Study|Lost to Follow-up|1|||
16505372|NCT01150123|40322229|FG012|Overall Study|Lost to Follow-up|2|||
16505373|NCT01150123|40322230|FG013|Overall Study|Lost to Follow-up|0|||
16505374|NCT01150123|40322231|FG014|Overall Study|Lost to Follow-up|0|||
16505375|NCT01150123|40322232|FG015|Overall Study|Lost to Follow-up|0|||
16505376|NCT01150123|40322233|FG016|Overall Study|Lost to Follow-up|0|||
16505377|NCT01150123|40322234|FG017|Overall Study|Lost to Follow-up|0|||
16505378|NCT00484939|40322235|FG000|Overall Study|Death|9|||
16505379|NCT00484939|40322236|FG001|Overall Study|Death|13|||
16505380|NCT00484939|40322235|FG000|Overall Study|Adverse Event|22|||
16505381|NCT00484939|40322236|FG001|Overall Study|Adverse Event|12|||
16505382|NCT00484939|40322235|FG000|Overall Study|Patient Withdrew Consent|19|||
16505383|NCT00484939|40322236|FG001|Overall Study|Patient Withdrew Consent|10|||
16505384|NCT00484939|40322235|FG000|Overall Study|Protocol Violation|3|||
16505385|NCT00484939|40322236|FG001|Overall Study|Protocol Violation|3|||
16505386|NCT00484939|40322235|FG000|Overall Study|Lost to Follow-up|0|||
16505387|NCT00484939|40322236|FG001|Overall Study|Lost to Follow-up|3|||
16505388|NCT00484939|40322235|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
16505389|NCT00484939|40322236|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
16505390|NCT00484939|40322235|FG000|Overall Study|Disease progression|67|||
16505391|NCT00484939|40322236|FG001|Overall Study|Disease progression|88|||
16505392|NCT00484939|40322235|FG000|Overall Study|Screen Failure|2|||
16505393|NCT00484939|40322236|FG001|Overall Study|Screen Failure|2|||
16505394|NCT00484939|40322235|FG000|Overall Study|Reason Not Specified|11|||
16505395|NCT00484939|40322236|FG001|Overall Study|Reason Not Specified|6|||
16505396|NCT01288911|40322237|FG000|Double-blind Period|Death|11|||
16505397|NCT01288911|40322238|FG001|Double-blind Period|Death|7|||
16505398|NCT01288911|40322237|FG000|Double-blind Period|Lost to Follow-up|0|||
16505399|NCT01288911|40322238|FG001|Double-blind Period|Lost to Follow-up|2|||
16505400|NCT01288911|40322237|FG000|Double-blind Period|Progressive Disease|75|||
16505401|NCT01288911|40322238|FG001|Double-blind Period|Progressive Disease|103|||
16505402|NCT01288911|40322237|FG000|Double-blind Period|Protocol Violation|1|||
16505403|NCT01288911|40322238|FG001|Double-blind Period|Protocol Violation|0|||
16505404|NCT01288911|40322237|FG000|Double-blind Period|Withdrawal by Subject|25|||
16505405|NCT01288911|40322238|FG001|Double-blind Period|Withdrawal by Subject|26|||
16505406|NCT01288911|40322237|FG000|Double-blind Period|Miscellaneous Reason|29|||
16505407|NCT01288911|40322238|FG001|Double-blind Period|Miscellaneous Reason|42|||
16505408|NCT01288911|40322237|FG000|Double-blind Period|Randomized but never received study drug|1|||
16505409|NCT01288911|40322238|FG001|Double-blind Period|Randomized but never received study drug|2|||
16505410|NCT01288911|40322237|FG000|Open-label Period (All Enzalutamide)|Death|0|||
16196173|NCT01753076|39193475|FG001|Overall Study|Withdrawal by Subject|24|||
16196174|NCT01753076|39193474|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
16196175|NCT01753076|39193475|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
16196176|NCT02680587|39193476|FG000|Overall Study|Withdrawal by Subject|1|||
16196177|NCT02680587|39193477|FG001|Overall Study|Withdrawal by Subject|0|||
16196178|NCT03544268|39193478|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
16196179|NCT03544268|39193479|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
16196180|NCT02279524|39193480|FG000|Overall Study|Withdrawal by Subject|3|||
16196181|NCT02279524|39193481|FG001|Overall Study|Withdrawal by Subject|6|||
16196182|NCT02279524|39193482|FG002|Overall Study|Withdrawal by Subject|3|||
16196183|NCT02279524|39193480|FG000|Overall Study|Adverse Event|4|||
16196184|NCT02279524|39193481|FG001|Overall Study|Adverse Event|3|||
16196185|NCT02279524|39193482|FG002|Overall Study|Adverse Event|2|||
16311802|NCT02383017|39627248|FG001|Overall Study|Found to be Hypogonadal|0|||
16505411|NCT01288911|40322238|FG001|Open-label Period (All Enzalutamide)|Death|1|||
16505412|NCT01288911|40322237|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
16505413|NCT01288911|40322238|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
16505414|NCT01288911|40322237|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
16505415|NCT01288911|40322238|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
16505416|NCT01288911|40322237|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
16505417|NCT01288911|40322238|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
16505418|NCT01288911|40322237|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
16505419|NCT01288911|40322238|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
16505420|NCT01288911|40322237|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
16505421|NCT01288911|40322238|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
16505422|NCT01413360|40322244|FG000|Overall Study|Lost to Follow-up|2|||
16505423|NCT01413360|40322244|FG000|Overall Study|Adverse Event|1|||
16505424|NCT02232425|40322245|FG000|Overall Study|Lost to Follow-up|6|||
16505425|NCT02232425|40322246|FG001|Overall Study|Lost to Follow-up|2|||
16505426|NCT02232425|40322245|FG000|Overall Study|Adverse Event|2|||
16505427|NCT02232425|40322246|FG001|Overall Study|Adverse Event|0|||
16505428|NCT02232425|40322245|FG000|Overall Study|Withdrawal by Subject|5|||
16505429|NCT02232425|40322246|FG001|Overall Study|Withdrawal by Subject|6|||
16505430|NCT02232425|40322245|FG000|Overall Study|Lack of Efficacy|1|||
16505431|NCT02232425|40322246|FG001|Overall Study|Lack of Efficacy|0|||
16505432|NCT02171260|40322247|FG000|Overall Study|Death|0|||
16505433|NCT02171260|40322248|FG001|Overall Study|Death|0|||
16505434|NCT02171260|40322249|FG002|Overall Study|Death|0|||
16505435|NCT02171260|40322250|FG003|Overall Study|Death|1|||
16505436|NCT02171260|40322247|FG000|Overall Study|Physician Decision|1|||
16505437|NCT02171260|40322248|FG001|Overall Study|Physician Decision|0|||
16505438|NCT02171260|40322249|FG002|Overall Study|Physician Decision|1|||
16505439|NCT02171260|40322250|FG003|Overall Study|Physician Decision|0|||
16505440|NCT02171260|40322247|FG000|Overall Study|Withdrawal by Subject|1|||
16505441|NCT02171260|40322248|FG001|Overall Study|Withdrawal by Subject|0|||
16505442|NCT02171260|40322249|FG002|Overall Study|Withdrawal by Subject|0|||
16505443|NCT02171260|40322250|FG003|Overall Study|Withdrawal by Subject|0|||
16505444|NCT02171260|40322247|FG000|Overall Study|Evidence of progressive disease|4|||
16505445|NCT02171260|40322248|FG001|Overall Study|Evidence of progressive disease|6|||
16505446|NCT02171260|40322249|FG002|Overall Study|Evidence of progressive disease|4|||
16505447|NCT02171260|40322250|FG003|Overall Study|Evidence of progressive disease|4|||
16505448|NCT01523886|40322257|FG000|Overall Study|surgery cancelled|0|||
16505449|NCT01523886|40322258|FG001|Overall Study|surgery cancelled|1|||
16505450|NCT01455012|40322260|FG000|Overall Study|Adverse Event|0|||
16505451|NCT01455012|40322261|FG001|Overall Study|Adverse Event|2|||
16505452|NCT01455012|40322260|FG000|Overall Study|Lack of Efficacy|6|||
16505453|NCT01455012|40322261|FG001|Overall Study|Lack of Efficacy|1|||
16505454|NCT01455012|40322260|FG000|Overall Study|Withdrawal by Subject|3|||
16505455|NCT01455012|40322261|FG001|Overall Study|Withdrawal by Subject|1|||
16505456|NCT01455012|40322260|FG000|Overall Study|Unknown reason|2|||
16505457|NCT01455012|40322261|FG001|Overall Study|Unknown reason|0|||
16505458|NCT00265343|40322265|FG000|Overall Study|Adverse Event|10|||
16505459|NCT00265343|40322266|FG001|Overall Study|Adverse Event|7|||
16505460|NCT00265343|40322265|FG000|Overall Study|Withdrawal by Subject|3|||
16505461|NCT00265343|40322266|FG001|Overall Study|Withdrawal by Subject|9|||
16505462|NCT00265343|40322265|FG000|Overall Study|Other|8|||
16311803|NCT01890122|39627249|FG000|Overall Study|Adverse Event|1|||
16311804|NCT01890122|39627250|FG001|Overall Study|Adverse Event|1|||
16311805|NCT01890122|39627251|FG002|Overall Study|Adverse Event|1|||
16311806|NCT01890122|39627252|FG003|Overall Study|Adverse Event|2|||
16311807|NCT01890122|39627249|FG000|Overall Study|Major Protocol Deviation|3|||
16311808|NCT01890122|39627250|FG001|Overall Study|Major Protocol Deviation|1|||
16311809|NCT01890122|39627251|FG002|Overall Study|Major Protocol Deviation|0|||
16311810|NCT01890122|39627252|FG003|Overall Study|Major Protocol Deviation|1|||
16311811|NCT01890122|39627249|FG000|Overall Study|Lost to Follow-up|0|||
16311812|NCT01890122|39627250|FG001|Overall Study|Lost to Follow-up|1|||
16311813|NCT01890122|39627251|FG002|Overall Study|Lost to Follow-up|2|||
16311814|NCT01890122|39627252|FG003|Overall Study|Lost to Follow-up|2|||
16311815|NCT01890122|39627249|FG000|Overall Study|Voluntary Withdrawal|8|||
16311816|NCT01890122|39627250|FG001|Overall Study|Voluntary Withdrawal|8|||
16505463|NCT00265343|40322266|FG001|Overall Study|Other|3|||
16505464|NCT03608774|40322271|FG000|Overall Study|Lost to Follow-up|5|||
16505465|NCT03608774|40322272|FG001|Overall Study|Lost to Follow-up|5|||
16505466|NCT03608774|40322271|FG000|Overall Study|Withdrawal by Subject|1|||
16505467|NCT03608774|40322272|FG001|Overall Study|Withdrawal by Subject|0|||
16505468|NCT03608774|40322271|FG000|Overall Study|Protocol Violation|1|||
16505469|NCT03608774|40322272|FG001|Overall Study|Protocol Violation|0|||
16505470|NCT03608774|40322271|FG000|Overall Study|Not eligible at enrollment|0|||
16311817|NCT01890122|39627251|FG002|Overall Study|Voluntary Withdrawal|2|||
16311818|NCT01890122|39627252|FG003|Overall Study|Voluntary Withdrawal|11|||
16311819|NCT01890122|39627249|FG000|Overall Study|Lack of Efficacy|14|||
16311820|NCT01890122|39627250|FG001|Overall Study|Lack of Efficacy|24|||
16311821|NCT01890122|39627251|FG002|Overall Study|Lack of Efficacy|7|||
16311822|NCT01890122|39627252|FG003|Overall Study|Lack of Efficacy|41|||
16311823|NCT01890122|39627249|FG000|Overall Study|Reason not Specified|0|||
16505471|NCT03608774|40322272|FG001|Overall Study|Not eligible at enrollment|1|||
16505472|NCT03608774|40322271|FG000|Overall Study|Health related event|0|||
16505473|NCT03608774|40322272|FG001|Overall Study|Health related event|1|||
16505474|NCT04117347|40322273|FG000|Overall Study|Adverse Event|0|||
16311824|NCT01890122|39627250|FG001|Overall Study|Reason not Specified|1|||
16311825|NCT01890122|39627251|FG002|Overall Study|Reason not Specified|1|||
16311826|NCT01890122|39627252|FG003|Overall Study|Reason not Specified|2|||
16311827|NCT01890122|39627249|FG000|Overall Study|Randomized but not Treated|1|||
16311828|NCT01890122|39627250|FG001|Overall Study|Randomized but not Treated|1|||
16311829|NCT01890122|39627251|FG002|Overall Study|Randomized but not Treated|0|||
16311830|NCT01890122|39627252|FG003|Overall Study|Randomized but not Treated|0|||
16311831|NCT02630251|39627260|FG000|Overall Study|Physician Decision|0|||
16311832|NCT02630251|39627261|FG001|Overall Study|Physician Decision|0|||
16311833|NCT02630251|39627262|FG002|Overall Study|Physician Decision|1|||
16311834|NCT02630251|39627263|FG003|Overall Study|Physician Decision|0|||
16311835|NCT02969044|39627264|FG000|Overall Study|Withdrawal by Subject|2|||
16390713|NCT00540592|39915948|FG006|Overall Study|Adverse Event|0|||
16505475|NCT04117347|40322274|FG001|Overall Study|Adverse Event|0|||
16505476|NCT04117347|40322275|FG002|Overall Study|Adverse Event|1|||
16505477|NCT04117347|40322273|FG000|Overall Study|No time for study|0|||
16505478|NCT04117347|40322274|FG001|Overall Study|No time for study|2|||
16196186|NCT02279524|39193480|FG000|Overall Study|Lost to Follow-up|1|||
16196187|NCT02279524|39193481|FG001|Overall Study|Lost to Follow-up|1|||
16196188|NCT02279524|39193482|FG002|Overall Study|Lost to Follow-up|0|||
16196189|NCT02279524|39193480|FG000|Overall Study|Disallowed medication|1|||
16196190|NCT02279524|39193481|FG001|Overall Study|Disallowed medication|1|||
16196191|NCT02279524|39193482|FG002|Overall Study|Disallowed medication|2|||
16196192|NCT02279524|39193480|FG000|Overall Study|Bariatric surgery|1|||
16196193|NCT02279524|39193481|FG001|Overall Study|Bariatric surgery|0|||
16196194|NCT02279524|39193482|FG002|Overall Study|Bariatric surgery|0|||
16196195|NCT02389816|39193483|FG000|Overall Study|Randomized but Not Treated|1|||
16196196|NCT02389816|39193484|FG001|Overall Study|Randomized but Not Treated|0|||
16196197|NCT02389816|39193485|FG002|Overall Study|Randomized but Not Treated|0|||
16196198|NCT02389816|39193483|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
16196199|NCT02389816|39193484|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
16196200|NCT02389816|39193485|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
16196201|NCT02389816|39193483|FG000|Overall Study|Major Protocol Deviation|1|||
16196202|NCT02389816|39193484|FG001|Overall Study|Major Protocol Deviation|0|||
16196203|NCT02389816|39193485|FG002|Overall Study|Major Protocol Deviation|0|||
16196204|NCT02389816|39193483|FG000|Overall Study|Lost to Follow-up|1|||
16196205|NCT02389816|39193484|FG001|Overall Study|Lost to Follow-up|0|||
16196206|NCT02389816|39193485|FG002|Overall Study|Lost to Follow-up|0|||
16196207|NCT02389816|39193483|FG000|Overall Study|Withdrawal of Consent|6|||
16196208|NCT02389816|39193484|FG001|Overall Study|Withdrawal of Consent|4|||
16196209|NCT02389816|39193485|FG002|Overall Study|Withdrawal of Consent|4|||
16196210|NCT02389816|39193483|FG000|Overall Study|Lack of Efficacy|1|||
16196211|NCT02389816|39193484|FG001|Overall Study|Lack of Efficacy|0|||
16196212|NCT02389816|39193485|FG002|Overall Study|Lack of Efficacy|0|||
16196213|NCT02389816|39193483|FG000|Overall Study|Non Compliance with Study Drug|1|||
16196214|NCT02389816|39193484|FG001|Overall Study|Non Compliance with Study Drug|1|||
16196215|NCT02389816|39193485|FG002|Overall Study|Non Compliance with Study Drug|1|||
16196216|NCT02389816|39193483|FG000|Overall Study|Reason not Specified|0|||
16196217|NCT02389816|39193484|FG001|Overall Study|Reason not Specified|2|||
16196218|NCT02389816|39193485|FG002|Overall Study|Reason not Specified|0|||
16196219|NCT01996748|39193488|FG000|Overall Study|Personal reason|1|||
16196220|NCT01996748|39193489|FG001|Overall Study|Personal reason|0|||
16196221|NCT01996748|39193488|FG000|Overall Study|Physician Decision|2|||
16196222|NCT01996748|39193489|FG001|Overall Study|Physician Decision|0|||
16196223|NCT01996748|39193488|FG000|Overall Study|Adverse Event|1|||
16196224|NCT01996748|39193489|FG001|Overall Study|Adverse Event|4|||
16196225|NCT01996748|39193488|FG000|Overall Study|Withdrawal by Subject|0|||
16196226|NCT01996748|39193489|FG001|Overall Study|Withdrawal by Subject|1|||
16196227|NCT01996748|39193488|FG000|Overall Study|Lost to Follow-up|4|||
16196228|NCT01996748|39193489|FG001|Overall Study|Lost to Follow-up|1|||
16196229|NCT03136367|39193491|FG000|T1 Consultation|discontinued mistakenly included|2|||
16196230|NCT03136367|39193492|FG001|T1 Consultation|discontinued mistakenly included|6|||
16196231|NCT03136367|39193493|FG002|T1 Consultation|discontinued mistakenly included|1|||
16196232|NCT03136367|39193491|FG000|T1 Consultation|Discontinued other|0|||
16311836|NCT02969044|39627265|FG001|Overall Study|Withdrawal by Subject|6|||
16311837|NCT02969044|39627264|FG000|Overall Study|Adverse Event|3|||
16311838|NCT02969044|39627265|FG001|Overall Study|Adverse Event|0|||
16505479|NCT04117347|40322275|FG002|Overall Study|No time for study|0|||
16196233|NCT03136367|39193492|FG001|T1 Consultation|Discontinued other|1|||
16196234|NCT03136367|39193493|FG002|T1 Consultation|Discontinued other|0|||
16196235|NCT03136367|39193491|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
16311839|NCT02946463|39627266|FG000|Primary Evaluation Period|Physician Decision|0|||
16311840|NCT02946463|39627267|FG001|Primary Evaluation Period|Physician Decision|1|||
16311841|NCT02946463|39627268|FG002|Primary Evaluation Period|Physician Decision|0|||
16311842|NCT02946463|39627269|FG003|Primary Evaluation Period|Physician Decision|0|||
16311843|NCT02946463|39627266|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
16196236|NCT03136367|39193492|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
16196237|NCT03136367|39193493|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
16196238|NCT03136367|39193491|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
16196239|NCT03136367|39193492|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
16196240|NCT03136367|39193493|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
16196241|NCT03136367|39193491|FG000|T2 Post-consultation|Discontinued other|0|||
16196242|NCT03136367|39193492|FG001|T2 Post-consultation|Discontinued other|2|||
16196243|NCT03136367|39193493|FG002|T2 Post-consultation|Discontinued other|6|||
16196244|NCT03136367|39193491|FG000|T2 Post-consultation|Discontinued transferred care|0|||
16196245|NCT03136367|39193492|FG001|T2 Post-consultation|Discontinued transferred care|0|||
16196246|NCT03136367|39193493|FG002|T2 Post-consultation|Discontinued transferred care|3|||
16196247|NCT03136367|39193491|FG000|T2 Post-consultation|Discontinued lost contact|0|||
16196248|NCT03136367|39193492|FG001|T2 Post-consultation|Discontinued lost contact|1|||
16196249|NCT03136367|39193493|FG002|T2 Post-consultation|Discontinued lost contact|0|||
16196250|NCT03136367|39193491|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
16196251|NCT03136367|39193492|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
16196252|NCT03136367|39193493|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
16196253|NCT03136367|39193491|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
16196254|NCT03136367|39193492|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
16196255|NCT03136367|39193493|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
16196256|NCT03136367|39193491|FG000|T3 1 Week After Surgery|other discontinued|2|||
16196257|NCT03136367|39193492|FG001|T3 1 Week After Surgery|other discontinued|4|||
16196258|NCT03136367|39193493|FG002|T3 1 Week After Surgery|other discontinued|3|||
16196259|NCT03136367|39193491|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
16505480|NCT04117347|40322273|FG000|Overall Study|Family emergency|1|||
16505481|NCT04117347|40322274|FG001|Overall Study|Family emergency|0|||
16505482|NCT04117347|40322275|FG002|Overall Study|Family emergency|0|||
16505483|NCT03034954|40322276|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
16505484|NCT03034954|40322277|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
16505485|NCT01176266|40322278|FG000|Overall Study|Death|6|||
16505486|NCT01176266|40322278|FG000|Overall Study|Withdrawal by Subject|3|||
16505487|NCT00978068|40322288|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
16505488|NCT00978068|40322289|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
16505489|NCT00978068|40322288|FG000|Overall Study|Death|1|||
16196260|NCT03136367|39193492|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
16196261|NCT03136367|39193493|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
16196262|NCT03136367|39193491|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
16196263|NCT03136367|39193492|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
16196264|NCT03136367|39193493|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
16196265|NCT03136367|39193491|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
16196266|NCT03136367|39193492|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
16196267|NCT03136367|39193493|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
16196268|NCT03136367|39193491|FG000|T4 12 Weeks After Surgery|Death|0|||
16196269|NCT03136367|39193492|FG001|T4 12 Weeks After Surgery|Death|1|||
16196270|NCT03136367|39193493|FG002|T4 12 Weeks After Surgery|Death|3|||
16196271|NCT03136367|39193491|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
16196272|NCT03136367|39193492|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
16196273|NCT03136367|39193493|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
16196274|NCT03136367|39193491|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
16196275|NCT03136367|39193492|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
16196276|NCT03136367|39193493|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
16196277|NCT03136367|39193491|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
16196278|NCT03136367|39193492|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
16196279|NCT03136367|39193493|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
16196280|NCT03136367|39193491|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
16196281|NCT03136367|39193492|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
16196282|NCT03136367|39193493|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
16196283|NCT03136367|39193491|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
16196284|NCT03136367|39193492|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
16196285|NCT03136367|39193493|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
16196286|NCT03136367|39193491|FG000|T5 1 Year After Surgery|Death|0|||
16196287|NCT03136367|39193492|FG001|T5 1 Year After Surgery|Death|0|||
16196288|NCT03136367|39193493|FG002|T5 1 Year After Surgery|Death|1|||
16196289|NCT03136367|39193491|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
16196290|NCT03136367|39193492|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
16505490|NCT00978068|40322289|FG001|Overall Study|Death|2|||
16505491|NCT00978068|40322288|FG000|Overall Study|Lost to Follow-up|1|||
16196291|NCT03136367|39193493|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
16196292|NCT03136367|39193491|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
16196293|NCT03136367|39193492|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
16196294|NCT03136367|39193493|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
16196295|NCT03136367|39193491|FG000|T5 1 Year After Surgery|study ended before due|31|||
16196296|NCT03136367|39193492|FG001|T5 1 Year After Surgery|study ended before due|103|||
16196297|NCT03136367|39193493|FG002|T5 1 Year After Surgery|study ended before due|110|||
16196298|NCT03136367|39193491|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
16196299|NCT03136367|39193492|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
16196300|NCT03136367|39193493|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
16196301|NCT05294211|39193494|FG000|Overall Study|Withdrawal by Subject|3|||
16196302|NCT05294211|39193494|FG000|Overall Study|Physician Decision|2|||
16196303|NCT05294211|39193494|FG000|Overall Study|Progressed to active labor|1|||
16196304|NCT05294211|39193494|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
16196305|NCT05294211|39193494|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
16196306|NCT01309841|39193495|FG000|Overall Study|Other|0|||
16196307|NCT01309841|39193496|FG001|Overall Study|Other|1|||
16196308|NCT01309841|39193497|FG002|Overall Study|Other|1|||
16196309|NCT01309841|39193495|FG000|Overall Study|Lost to Follow-up|7|||
16196310|NCT01309841|39193496|FG001|Overall Study|Lost to Follow-up|6|||
16196311|NCT01309841|39193497|FG002|Overall Study|Lost to Follow-up|4|||
16196312|NCT01309841|39193495|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
16196313|NCT01309841|39193496|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
16196314|NCT01309841|39193497|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
16196315|NCT01309841|39193495|FG000|Overall Study|Lack of Efficacy|0|||
16196316|NCT01309841|39193496|FG001|Overall Study|Lack of Efficacy|0|||
16196317|NCT01309841|39193497|FG002|Overall Study|Lack of Efficacy|2|||
16196318|NCT01309841|39193495|FG000|Overall Study|Adverse Event|9|||
16196319|NCT01309841|39193496|FG001|Overall Study|Adverse Event|22|||
16196320|NCT01309841|39193497|FG002|Overall Study|Adverse Event|11|||
16196321|NCT01309841|39193495|FG000|Overall Study|Death|1|||
16196322|NCT01309841|39193496|FG001|Overall Study|Death|0|||
16196323|NCT01309841|39193497|FG002|Overall Study|Death|0|||
16196324|NCT01309841|39193495|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16196325|NCT01309841|39193496|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16196326|NCT01309841|39193497|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
16196327|NCT01309841|39193495|FG000|Overall Study|Withdrawal by Subject|17|||
16196328|NCT01309841|39193496|FG001|Overall Study|Withdrawal by Subject|6|||
16196329|NCT01309841|39193497|FG002|Overall Study|Withdrawal by Subject|13|||
16196330|NCT01309841|39193495|FG000|Overall Study|Did Not Receive Treatment|2|||
16196331|NCT01309841|39193496|FG001|Overall Study|Did Not Receive Treatment|0|||
16196332|NCT01309841|39193497|FG002|Overall Study|Did Not Receive Treatment|1|||
16196333|NCT01309841|39193495|FG000|Overall Study|Severe non-compliance with protocol|0|||
16196334|NCT01309841|39193496|FG001|Overall Study|Severe non-compliance with protocol|5|||
16196335|NCT01309841|39193497|FG002|Overall Study|Severe non-compliance with protocol|2|||
16196336|NCT02128763|39193498|FG000|Overall Study|Death|1|||
16196337|NCT02128763|39193499|FG001|Overall Study|Death|0|||
16196338|NCT02128763|39193498|FG000|Overall Study|Lost to Follow-up|19|||
16196339|NCT02128763|39193499|FG001|Overall Study|Lost to Follow-up|16|||
16196340|NCT00623467|39193507|FG000|Overall Study|Lost to Follow-up|1|||
16196341|NCT00623467|39193507|FG000|Overall Study|Protocol Violation|4|||
16196342|NCT00623467|39193507|FG000|Overall Study|Withdrawal by Subject|2|||
16196343|NCT00393913|39193512|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
16196344|NCT00393913|39193512|FG000|Initial Assessment|Withdrawal by Subject|16|||
16196345|NCT00393913|39193512|FG000|CPAP|Withdrawal by Subject|3|||
16196346|NCT00393913|39193512|FG000|CPAP|Physician Decision|1|||
16196347|NCT00393913|39193512|FG000|CPAP|TEchnical problem with CPAP|3|||
16196348|NCT00446446|39193513|FG000|Overall Study|Death|10|||
16196349|NCT00446446|39193513|FG000|Overall Study|Withdrawal by Subject|6|||
16196350|NCT00446446|39193513|FG000|Overall Study|Other|4|||
16196351|NCT00446446|39193513|FG000|Overall Study|Disease Progession|2|||
16196352|NCT00446446|39193513|FG000|Overall Study|Adverse Event|1|||
16196353|NCT00446446|39193513|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
16196354|NCT05554471|39193514|FG000|Overall Study|Physician Decision|2|||
16196355|NCT05554471|39193515|FG001|Overall Study|Physician Decision|1|||
16196356|NCT05554471|39193514|FG000|Overall Study|Lost to Follow-up|2|||
16196357|NCT05554471|39193515|FG001|Overall Study|Lost to Follow-up|1|||
16196358|NCT05554471|39193514|FG000|Overall Study|Death|0|||
16196359|NCT05554471|39193515|FG001|Overall Study|Death|1|||
16196360|NCT00696657|39193518|FG000|Overall Study|Protocol Violation|0|||
16196361|NCT00696657|39193519|FG001|Overall Study|Protocol Violation|0|||
16196362|NCT00696657|39193520|FG002|Overall Study|Protocol Violation|0|||
16196363|NCT00696657|39193521|FG003|Overall Study|Protocol Violation|0|||
16196364|NCT00696657|39193522|FG004|Overall Study|Protocol Violation|0|||
16196365|NCT00696657|39193523|FG005|Overall Study|Protocol Violation|1|||
16196366|NCT00696657|39193524|FG006|Overall Study|Protocol Violation|0|||
16196367|NCT00696657|39193525|FG007|Overall Study|Protocol Violation|0|||
16311844|NCT02946463|39627267|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
16311845|NCT02946463|39627268|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
16311846|NCT02946463|39627269|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
16311847|NCT02946463|39627266|FG000|Extension Period|Death|4|||
16311848|NCT02946463|39627267|FG001|Extension Period|Death|4|||
16311849|NCT02946463|39627268|FG002|Extension Period|Death|0|||
16311850|NCT02946463|39627269|FG003|Extension Period|Death|0|||
16311851|NCT02946463|39627266|FG000|Extension Period|Withdrawal by Subject|4|||
16311852|NCT02946463|39627267|FG001|Extension Period|Withdrawal by Subject|3|||
16311853|NCT02946463|39627268|FG002|Extension Period|Withdrawal by Subject|0|||
16311854|NCT02946463|39627269|FG003|Extension Period|Withdrawal by Subject|0|||
16311855|NCT02946463|39627266|FG000|Extension Period|Other than specified|2|||
16311856|NCT02946463|39627267|FG001|Extension Period|Other than specified|3|||
16311857|NCT02946463|39627268|FG002|Extension Period|Other than specified|2|||
16311858|NCT02946463|39627269|FG003|Extension Period|Other than specified|0|||
16311859|NCT02946463|39627266|FG000|Extension Period|Physician Decision|1|||
16311860|NCT02946463|39627267|FG001|Extension Period|Physician Decision|4|||
16311861|NCT02946463|39627268|FG002|Extension Period|Physician Decision|0|||
16311862|NCT02946463|39627269|FG003|Extension Period|Physician Decision|0|||
16311863|NCT02946463|39627266|FG000|Extension Period|Pregnancy|3|||
16311864|NCT02946463|39627267|FG001|Extension Period|Pregnancy|1|||
16311865|NCT02946463|39627268|FG002|Extension Period|Pregnancy|0|||
16311866|NCT02946463|39627269|FG003|Extension Period|Pregnancy|0|||
16311867|NCT02946463|39627266|FG000|Extension Period|Adverse Event|1|||
16311868|NCT02946463|39627267|FG001|Extension Period|Adverse Event|2|||
16311869|NCT02946463|39627268|FG002|Extension Period|Adverse Event|0|||
16311870|NCT02946463|39627269|FG003|Extension Period|Adverse Event|0|||
16311871|NCT02946463|39627266|FG000|Extension Period|Lost to Follow-up|1|||
16311872|NCT02946463|39627267|FG001|Extension Period|Lost to Follow-up|0|||
16311873|NCT02946463|39627268|FG002|Extension Period|Lost to Follow-up|0|||
16311874|NCT02946463|39627269|FG003|Extension Period|Lost to Follow-up|0|||
16311875|NCT02503540|39627275|FG000|Overall Study|Death|2|||
16311876|NCT02503540|39627275|FG000|Overall Study|Withdrawal by Subject|1|||
16311877|NCT02115269|39627282|FG000|Overall Study|Lost to Follow-up|43|||
16311878|NCT02115269|39627282|FG000|Overall Study|Did not complete patient diary|3|||
16311879|NCT02115269|39627282|FG000|Overall Study|Moved to another city|7|||
16311880|NCT02115269|39627282|FG000|Overall Study|Withdrawal by Subject|2|||
16311881|NCT02115269|39627282|FG000|Overall Study|Didn't take study drug|2|||
16311882|NCT02058069|39627317|FG000|Overall Study|Exclusion due to implant size|5|||
16311883|NCT02058069|39627317|FG000|Overall Study|Withdrawal by Subject|6|||
16311884|NCT04650204|39627321|FG000|Overall Study|Study was Terminated|2|||
16311885|NCT04650204|39627322|FG001|Overall Study|Study was Terminated|1|||
16311886|NCT00699816|39627323|FG000|Overall Study|Protocol Violation|1|||
16311887|NCT00699816|39627324|FG001|Overall Study|Protocol Violation|3|||
16311888|NCT03164551|39627327|FG000|Overall Study|Imaging discontinued prior completion|8|||
16311889|NCT03164551|39627328|FG001|Overall Study|Imaging discontinued prior completion|0|||
16311890|NCT03164551|39627327|FG000|Overall Study|Participant was non-compliant|1|||
16311891|NCT03164551|39627328|FG001|Overall Study|Participant was non-compliant|0|||
16311892|NCT03164551|39627327|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
16311893|NCT03164551|39627328|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
16311894|NCT03164551|39627327|FG000|Overall Study|Other|8|||
16311895|NCT03164551|39627328|FG001|Overall Study|Other|2|||
16311896|NCT01609790|39627332|FG000|Overall Study|Protocol Violation|1|||
16311897|NCT01609790|39627333|FG001|Overall Study|Protocol Violation|7|||
16311898|NCT01609790|39627334|FG002|Overall Study|Protocol Violation|8|||
16311899|NCT00360282|39627339|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
16311900|NCT00360282|39627340|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
16311901|NCT00360282|39627341|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
16311902|NCT00360282|39627342|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
16311903|NCT00360282|39627339|FG000|Second Intervention|Adverse Event|0|||
16311904|NCT00360282|39627340|FG001|Second Intervention|Adverse Event|1|||
16311905|NCT00360282|39627341|FG002|Second Intervention|Adverse Event|0|||
16311906|NCT00360282|39627342|FG003|Second Intervention|Adverse Event|0|||
16311907|NCT00122382|39627346|FG000|Double-Blind Study|Adverse Event|9|||
16311908|NCT00122382|39627347|FG001|Double-Blind Study|Adverse Event|11|||
16311909|NCT00122382|39627348|FG002|Double-Blind Study|Adverse Event|0|||
16311910|NCT00122382|39627346|FG000|Double-Blind Study|Death|2|||
16311911|NCT00122382|39627347|FG001|Double-Blind Study|Death|2|||
16311912|NCT00122382|39627348|FG002|Double-Blind Study|Death|0|||
16311913|NCT00122382|39627346|FG000|Double-Blind Study|Lack of Efficacy|0|||
16311914|NCT00122382|39627347|FG001|Double-Blind Study|Lack of Efficacy|8|||
16311915|NCT00122382|39627348|FG002|Double-Blind Study|Lack of Efficacy|0|||
16311916|NCT00122382|39627346|FG000|Double-Blind Study|Lost to Follow-up|2|||
16311917|NCT00122382|39627347|FG001|Double-Blind Study|Lost to Follow-up|1|||
16311918|NCT00122382|39627348|FG002|Double-Blind Study|Lost to Follow-up|0|||
16311919|NCT00122382|39627346|FG000|Double-Blind Study|Pregnancy|2|||
16311920|NCT00122382|39627347|FG001|Double-Blind Study|Pregnancy|0|||
16311921|NCT00122382|39627348|FG002|Double-Blind Study|Pregnancy|0|||
16311922|NCT00122382|39627346|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
16311923|NCT00122382|39627347|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
16311924|NCT00122382|39627348|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
16311925|NCT00122382|39627346|FG000|Double-Blind Study|Withdrawal of Consent|7|||
16311926|NCT00122382|39627347|FG001|Double-Blind Study|Withdrawal of Consent|3|||
16311927|NCT00122382|39627348|FG002|Double-Blind Study|Withdrawal of Consent|0|||
16311928|NCT00122382|39627346|FG000|Double-Blind Study|Protocol Violation|1|||
16311929|NCT00122382|39627347|FG001|Double-Blind Study|Protocol Violation|0|||
16311930|NCT00122382|39627348|FG002|Double-Blind Study|Protocol Violation|0|||
16311931|NCT00122382|39627346|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
16311932|NCT00122382|39627347|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
16311933|NCT00122382|39627348|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
16311934|NCT00122382|39627346|FG000|Double-Blind Study|Randomized but not treated|0|||
16311935|NCT00122382|39627347|FG001|Double-Blind Study|Randomized but not treated|2|||
16311936|NCT00122382|39627348|FG002|Double-Blind Study|Randomized but not treated|0|||
16311937|NCT00122382|39627346|FG000|Open-Label Study|Adverse Event|0|||
16311938|NCT00122382|39627347|FG001|Open-Label Study|Adverse Event|0|||
16311939|NCT00122382|39627348|FG002|Open-Label Study|Adverse Event|11|||
16311940|NCT00122382|39627346|FG000|Open-Label Study|Death|0|||
16311941|NCT00122382|39627347|FG001|Open-Label Study|Death|0|||
16311942|NCT00122382|39627348|FG002|Open-Label Study|Death|2|||
16311943|NCT00122382|39627346|FG000|Open-Label Study|Lack of Efficacy|0|||
16311944|NCT00122382|39627347|FG001|Open-Label Study|Lack of Efficacy|0|||
16311945|NCT00122382|39627348|FG002|Open-Label Study|Lack of Efficacy|3|||
16311946|NCT00122382|39627346|FG000|Open-Label Study|Lost to Follow-up|0|||
16311947|NCT00122382|39627347|FG001|Open-Label Study|Lost to Follow-up|0|||
16311948|NCT00122382|39627348|FG002|Open-Label Study|Lost to Follow-up|3|||
16311949|NCT00122382|39627346|FG000|Open-Label Study|Pregnancy|0|||
16311950|NCT00122382|39627347|FG001|Open-Label Study|Pregnancy|0|||
16311951|NCT00122382|39627348|FG002|Open-Label Study|Pregnancy|2|||
16311952|NCT00122382|39627346|FG000|Open-Label Study|Poor/Non-Compliance|0|||
16311953|NCT00122382|39627347|FG001|Open-Label Study|Poor/Non-Compliance|0|||
16311954|NCT00122382|39627348|FG002|Open-Label Study|Poor/Non-Compliance|1|||
16311955|NCT00122382|39627346|FG000|Open-Label Study|Withdrawal of Consent|0|||
16390714|NCT00540592|39915949|FG007|Overall Study|Adverse Event|1|||
16390715|NCT00540592|39915950|FG008|Overall Study|Adverse Event|1|||
16505492|NCT00978068|40322289|FG001|Overall Study|Lost to Follow-up|2|||
16505493|NCT00978068|40322288|FG000|Overall Study|Physician Decision|0|||
16505494|NCT00978068|40322289|FG001|Overall Study|Physician Decision|1|||
16311956|NCT00122382|39627347|FG001|Open-Label Study|Withdrawal of Consent|0|||
16311957|NCT00122382|39627348|FG002|Open-Label Study|Withdrawal of Consent|4|||
16311958|NCT00470470|39627349|FG000|Overall Study|Adverse Event|2|||
16311959|NCT00470470|39627349|FG000|Overall Study|Death|2|||
16311960|NCT00470470|39627349|FG000|Overall Study|Not treated|1|||
16311961|NCT01787292|39627354|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
16311962|NCT01787292|39627355|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
16311963|NCT01787292|39627354|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
16311964|NCT01787292|39627355|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
16311965|NCT04526288|39627358|FG000|Overall Study|Disease Progression|1|||
16311966|NCT04526288|39627359|FG001|Overall Study|Disease Progression|0|||
16311967|NCT02077140|39627360|FG000|Overall Study|Lost to Follow-up|4|||
16311968|NCT02077140|39627361|FG001|Overall Study|Lost to Follow-up|1|||
16311969|NCT02077140|39627362|FG002|Overall Study|Lost to Follow-up|2|||
16311970|NCT02077140|39627363|FG003|Overall Study|Lost to Follow-up|2|||
16311971|NCT02077140|39627364|FG004|Overall Study|Lost to Follow-up|3|||
16311972|NCT02077140|39627360|FG000|Overall Study|Withdrawal by Subject|0|||
16311973|NCT02077140|39627361|FG001|Overall Study|Withdrawal by Subject|1|||
16311974|NCT02077140|39627362|FG002|Overall Study|Withdrawal by Subject|0|||
16311975|NCT02077140|39627363|FG003|Overall Study|Withdrawal by Subject|2|||
16311976|NCT02077140|39627364|FG004|Overall Study|Withdrawal by Subject|2|||
16311977|NCT05317312|39627365|FG000|Overall Study|Withdrawal by Subject|0|||
16311978|NCT05317312|39627366|FG001|Overall Study|Withdrawal by Subject|1|||
16311979|NCT05317312|39627367|FG002|Overall Study|Withdrawal by Subject|0|||
16311980|NCT05317312|39627368|FG003|Overall Study|Withdrawal by Subject|0|||
16311981|NCT05317312|39627365|FG000|Overall Study|Lost to Follow-up|0|||
16311982|NCT05317312|39627366|FG001|Overall Study|Lost to Follow-up|0|||
16311983|NCT05317312|39627367|FG002|Overall Study|Lost to Follow-up|0|||
16311984|NCT05317312|39627368|FG003|Overall Study|Lost to Follow-up|1|||
16311985|NCT05317312|39627365|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
16505495|NCT00978068|40322288|FG000|Overall Study|Unable to Comply with Study|0|||
16311986|NCT05317312|39627366|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
16311987|NCT05317312|39627367|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
16311988|NCT05317312|39627368|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
16311989|NCT02137252|39627370|FG000|Overall Study|trial terminated early|2|||
16390716|NCT00540592|39915951|FG009|Overall Study|Adverse Event|2|||
16311990|NCT02137252|39627371|FG001|Overall Study|trial terminated early|1|||
16311991|NCT03534687|39627373|FG000|Overall Study|Lost to Follow-up|7|||
16311992|NCT03534687|39627374|FG001|Overall Study|Lost to Follow-up|2|||
16311993|NCT00413699|39627376|FG000|Initial Period|Death|25|||
16311994|NCT00413699|39627377|FG001|Initial Period|Death|30|||
16311995|NCT00413699|39627378|FG002|Initial Period|Death|0|||
16311996|NCT00413699|39627376|FG000|Initial Period|Lack of Efficacy|59|||
16311997|NCT00413699|39627377|FG001|Initial Period|Lack of Efficacy|115|||
16311998|NCT00413699|39627378|FG002|Initial Period|Lack of Efficacy|0|||
16311999|NCT00413699|39627376|FG000|Initial Period|Lost to Follow-up|31|||
16312000|NCT00413699|39627377|FG001|Initial Period|Lost to Follow-up|101|||
16312001|NCT00413699|39627378|FG002|Initial Period|Lost to Follow-up|0|||
16312002|NCT00413699|39627376|FG000|Initial Period|Protocol Violation|38|||
16312003|NCT00413699|39627377|FG001|Initial Period|Protocol Violation|89|||
16312004|NCT00413699|39627378|FG002|Initial Period|Protocol Violation|0|||
16312005|NCT00413699|39627376|FG000|Initial Period|Pregnancy|10|||
16312006|NCT00413699|39627377|FG001|Initial Period|Pregnancy|8|||
16312007|NCT00413699|39627378|FG002|Initial Period|Pregnancy|0|||
16312008|NCT00413699|39627376|FG000|Initial Period|Did not meet entrance criteria|2|||
16312009|NCT00413699|39627377|FG001|Initial Period|Did not meet entrance criteria|2|||
16312010|NCT00413699|39627378|FG002|Initial Period|Did not meet entrance criteria|0|||
16312011|NCT00413699|39627376|FG000|Initial Period|Medication error without adverse event|0|||
16312012|NCT00413699|39627377|FG001|Initial Period|Medication error without adverse event|1|||
16312013|NCT00413699|39627378|FG002|Initial Period|Medication error without adverse event|0|||
16312014|NCT00413699|39627376|FG000|Initial Period|Study terminated by Sponsor|0|||
16312015|NCT00413699|39627377|FG001|Initial Period|Study terminated by Sponsor|1|||
16312016|NCT00413699|39627378|FG002|Initial Period|Study terminated by Sponsor|0|||
16312017|NCT00413699|39627376|FG000|Initial Period|Other|67|||
16312018|NCT00413699|39627377|FG001|Initial Period|Other|211|||
16312019|NCT00413699|39627378|FG002|Initial Period|Other|0|||
16312020|NCT00413699|39627376|FG000|Initial Period|Adverse event related to study drug|178|||
16312021|NCT00413699|39627377|FG001|Initial Period|Adverse event related to study drug|527|||
16312022|NCT00413699|39627378|FG002|Initial Period|Adverse event related to study drug|0|||
16312023|NCT00413699|39627376|FG000|Initial Period|Adverse event not related to study drug|113|||
16312024|NCT00413699|39627377|FG001|Initial Period|Adverse event not related to study drug|248|||
16312025|NCT00413699|39627378|FG002|Initial Period|Adverse event not related to study drug|0|||
16312026|NCT00413699|39627376|FG000|Initial Period|Missing end of study page|0|||
16312027|NCT00413699|39627377|FG001|Initial Period|Missing end of study page|4|||
16312028|NCT00413699|39627378|FG002|Initial Period|Missing end of study page|0|||
16312029|NCT00413699|39627376|FG000|Initial Period|No longer willing to participate|116|||
16312030|NCT00413699|39627377|FG001|Initial Period|No longer willing to participate|368|||
16312031|NCT00413699|39627378|FG002|Initial Period|No longer willing to participate|0|||
16312032|NCT00413699|39627376|FG000|Extension Period|No Longer Willing to Participate|0|||
16089761|NCT00670488|38819986|FG006|Overall Study|Progressive Disease|11|||
16089762|NCT00670488|38819987|FG007|Overall Study|Progressive Disease|2|||
16089763|NCT00670488|38819988|FG008|Overall Study|Progressive Disease|2|||
16089764|NCT00670488|38819989|FG009|Overall Study|Progressive Disease|1|||
16089765|NCT00670488|38819980|FG000|Overall Study|Withdrawal by Subject|0|||
16089766|NCT00670488|38819981|FG001|Overall Study|Withdrawal by Subject|1|||
16089767|NCT00670488|38819982|FG002|Overall Study|Withdrawal by Subject|0|||
16089768|NCT00670488|38819983|FG003|Overall Study|Withdrawal by Subject|1|||
16312033|NCT00413699|39627377|FG001|Extension Period|No Longer Willing to Participate|0|||
16312034|NCT00413699|39627378|FG002|Extension Period|No Longer Willing to Participate|2|||
16312035|NCT00413699|39627376|FG000|Extension Period|Protocol Violation|0|||
16312036|NCT00413699|39627377|FG001|Extension Period|Protocol Violation|0|||
16312037|NCT00413699|39627378|FG002|Extension Period|Protocol Violation|1|||
16312038|NCT00413699|39627376|FG000|Extension Period|Adverse Event|0|||
16312039|NCT00413699|39627377|FG001|Extension Period|Adverse Event|0|||
16089769|NCT00670488|38819984|FG004|Overall Study|Withdrawal by Subject|0|||
16089770|NCT00670488|38819985|FG005|Overall Study|Withdrawal by Subject|0|||
16089771|NCT00670488|38819986|FG006|Overall Study|Withdrawal by Subject|1|||
16196368|NCT00696657|39193526|FG008|Overall Study|Protocol Violation|1|||
16312040|NCT00413699|39627378|FG002|Extension Period|Adverse Event|2|||
16312041|NCT03259425|39627379|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
16312042|NCT03918629|39627380|FG000|Overall Study|Adverse Event|19|||
16312043|NCT03918629|39627381|FG001|Overall Study|Adverse Event|20|||
16312044|NCT03918629|39627380|FG000|Overall Study|Death|14|||
16312045|NCT03918629|39627381|FG001|Overall Study|Death|7|||
16312046|NCT03918629|39627380|FG000|Overall Study|Lost to Follow-up|36|||
16312047|NCT03918629|39627381|FG001|Overall Study|Lost to Follow-up|28|||
16312048|NCT03918629|39627380|FG000|Overall Study|Physician Decision|1|||
16312049|NCT03918629|39627381|FG001|Overall Study|Physician Decision|0|||
16312050|NCT03918629|39627380|FG000|Overall Study|Protocol Violation|7|||
16312051|NCT03918629|39627381|FG001|Overall Study|Protocol Violation|4|||
16312052|NCT03918629|39627380|FG000|Overall Study|Withdrawal by Subject|47|||
16312053|NCT03918629|39627381|FG001|Overall Study|Withdrawal by Subject|47|||
16312054|NCT03918629|39627380|FG000|Overall Study|Other|7|||
16312055|NCT03918629|39627381|FG001|Overall Study|Other|11|||
16312056|NCT03918629|39627380|FG000|Overall Study|Randomized but not vaccinated|2|||
16312057|NCT03918629|39627381|FG001|Overall Study|Randomized but not vaccinated|1|||
16312058|NCT00661193|39627382|FG000|Overall Study|Adverse Event|2|||
16312059|NCT00661193|39627383|FG001|Overall Study|Adverse Event|1|||
16312060|NCT00661193|39627382|FG000|Overall Study|Withdrawal by Subject|3|||
16312061|NCT00661193|39627383|FG001|Overall Study|Withdrawal by Subject|1|||
16312062|NCT00661193|39627382|FG000|Overall Study|Progression|27|||
16312063|NCT00661193|39627383|FG001|Overall Study|Progression|24|||
16312064|NCT00661193|39627382|FG000|Overall Study|Not protocol specified|1|||
16312065|NCT00661193|39627383|FG001|Overall Study|Not protocol specified|0|||
16312066|NCT00114140|39627384|FG000|Overall Study|Protocol Violation|7|||
16312067|NCT04495829|39627385|FG000|Overall Study|Lost to Follow-up|2|||
16312068|NCT04495829|39627385|FG000|Overall Study|Inclusion criterion not met|3|||
16312069|NCT02968576|39627386|FG000|Overall Study|Pregnancy|0|||
16312070|NCT02968576|39627387|FG001|Overall Study|Pregnancy|1|||
16312071|NCT00118157|39627388|FG000|Overall Study|Adverse Event|2|||
16312072|NCT00118157|39627388|FG000|Overall Study|Death|8|||
16312073|NCT00118157|39627388|FG000|Overall Study|Withdrawal by Subject|2|||
16312074|NCT00485264|39627389|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
16312075|NCT00485264|39627390|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
16312076|NCT00485264|39627391|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
16312077|NCT00485264|39627392|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
16312078|NCT00485264|39627393|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
16390717|NCT00540592|39915942|FG000|Overall Study|Lost to Follow-up|2|||
16089772|NCT00670488|38819987|FG007|Overall Study|Withdrawal by Subject|0|||
16089773|NCT00670488|38819988|FG008|Overall Study|Withdrawal by Subject|1|||
16089774|NCT00670488|38819989|FG009|Overall Study|Withdrawal by Subject|0|||
16089775|NCT02241785|38819990|FG000|Overall Study|Sponsor Termination|43|||
16089776|NCT02241785|38819990|FG000|Overall Study|Withdrawal by Subject|1|||
16089777|NCT02241785|38819990|FG000|Overall Study|Lost to Follow-up|2|||
16089778|NCT02241785|38819990|FG000|Overall Study|Adverse Event|1|||
16089779|NCT01670877|38819991|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
16089780|NCT01670877|38819992|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
16089781|NCT01670877|38819993|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
16089782|NCT01670877|38819994|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
16089783|NCT01670877|38819995|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
16089784|NCT01670877|38819996|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
16089785|NCT01670877|38819991|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
16089786|NCT01670877|38819992|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
16089787|NCT01670877|38819993|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
16089788|NCT01670877|38819994|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
16089789|NCT01670877|38819995|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
16089790|NCT01670877|38819996|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
16089791|NCT01670877|38819991|FG000|Part I and Part 2|Grade 2 vomiting|0|||
16312079|NCT00485264|39627394|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
16312080|NCT00485264|39627389|FG000|Overall Study|Death|1|||
16312081|NCT00485264|39627390|FG001|Overall Study|Death|0|||
16312082|NCT00485264|39627391|FG002|Overall Study|Death|0|||
16312083|NCT00485264|39627392|FG003|Overall Study|Death|0|||
16312084|NCT00485264|39627393|FG004|Overall Study|Death|1|||
16312085|NCT00485264|39627394|FG005|Overall Study|Death|0|||
16505496|NCT00978068|40322289|FG001|Overall Study|Unable to Comply with Study|2|||
16505497|NCT02747420|40322296|FG000|Overall Study|Lost to Follow-up|4|||
16505498|NCT02747420|40322297|FG001|Overall Study|Lost to Follow-up|2|||
16505499|NCT02747420|40322296|FG000|Overall Study|Withdrawal by Subject|3|||
16505500|NCT02747420|40322297|FG001|Overall Study|Withdrawal by Subject|2|||
16505501|NCT01774786|40322300|FG000|Overall Study|Death|300|||
16505502|NCT01774786|40322301|FG001|Overall Study|Death|319|||
16505503|NCT01774786|40322300|FG000|Overall Study|Lost to Follow-up|6|||
16505504|NCT01774786|40322301|FG001|Overall Study|Lost to Follow-up|7|||
16505505|NCT01774786|40322300|FG000|Overall Study|Withdrawal by Subject|18|||
16505506|NCT01774786|40322301|FG001|Overall Study|Withdrawal by Subject|14|||
16505507|NCT01774786|40322300|FG000|Overall Study|Physician Decision|2|||
16505508|NCT01774786|40322301|FG001|Overall Study|Physician Decision|0|||
16505509|NCT01774786|40322300|FG000|Overall Study|Non-compliance|0|||
16505510|NCT01774786|40322301|FG001|Overall Study|Non-compliance|1|||
16505511|NCT01774786|40322300|FG000|Overall Study|Reason Not Specified|2|||
16196369|NCT00696657|39193518|FG000|Overall Study|Lack of Efficacy|0|||
16196370|NCT00696657|39193519|FG001|Overall Study|Lack of Efficacy|1|||
16196371|NCT00696657|39193520|FG002|Overall Study|Lack of Efficacy|0|||
16196372|NCT00696657|39193521|FG003|Overall Study|Lack of Efficacy|0|||
16196373|NCT00696657|39193522|FG004|Overall Study|Lack of Efficacy|0|||
16390718|NCT00540592|39915943|FG001|Overall Study|Lost to Follow-up|0|||
16390719|NCT00540592|39915944|FG002|Overall Study|Lost to Follow-up|0|||
16196374|NCT00696657|39193523|FG005|Overall Study|Lack of Efficacy|0|||
16196375|NCT00696657|39193524|FG006|Overall Study|Lack of Efficacy|0|||
16196376|NCT00696657|39193525|FG007|Overall Study|Lack of Efficacy|0|||
16390720|NCT00540592|39915945|FG003|Overall Study|Lost to Follow-up|0|||
16390721|NCT00540592|39915946|FG004|Overall Study|Lost to Follow-up|0|||
16390722|NCT00540592|39915947|FG005|Overall Study|Lost to Follow-up|0|||
16390723|NCT00540592|39915948|FG006|Overall Study|Lost to Follow-up|0|||
16390724|NCT00540592|39915949|FG007|Overall Study|Lost to Follow-up|0|||
16390725|NCT00540592|39915950|FG008|Overall Study|Lost to Follow-up|0|||
16390726|NCT00540592|39915951|FG009|Overall Study|Lost to Follow-up|0|||
16390727|NCT00540592|39915942|FG000|Overall Study|Withdrawal by Subject|0|||
16390728|NCT00540592|39915943|FG001|Overall Study|Withdrawal by Subject|0|||
16390729|NCT00540592|39915944|FG002|Overall Study|Withdrawal by Subject|1|||
16390730|NCT00540592|39915945|FG003|Overall Study|Withdrawal by Subject|1|||
16390731|NCT00540592|39915946|FG004|Overall Study|Withdrawal by Subject|0|||
16390732|NCT00540592|39915947|FG005|Overall Study|Withdrawal by Subject|0|||
16390733|NCT00540592|39915948|FG006|Overall Study|Withdrawal by Subject|0|||
16390734|NCT00540592|39915949|FG007|Overall Study|Withdrawal by Subject|0|||
16390735|NCT00540592|39915950|FG008|Overall Study|Withdrawal by Subject|0|||
16390736|NCT00540592|39915951|FG009|Overall Study|Withdrawal by Subject|0|||
16390737|NCT03768089|39915956|FG000|Part A|Lost to Follow-up|0|||
16390738|NCT03768089|39915957|FG001|Part A|Lost to Follow-up|0|||
16390739|NCT03768089|39915958|FG002|Part A|Lost to Follow-up|0|||
16390740|NCT03768089|39915959|FG003|Part A|Lost to Follow-up|0|||
16390741|NCT03768089|39915960|FG004|Part A|Lost to Follow-up|1|||
16390742|NCT03768089|39915961|FG005|Part A|Lost to Follow-up|0|||
16390743|NCT03768089|39915962|FG006|Part A|Lost to Follow-up|0|||
16390744|NCT03768089|39915963|FG007|Part A|Lost to Follow-up|0|||
16390745|NCT03768089|39915964|FG008|Part A|Lost to Follow-up|0|||
16390746|NCT03768089|39915965|FG009|Part A|Lost to Follow-up|0|||
16390747|NCT03768089|39915966|FG010|Part A|Lost to Follow-up|0|||
16505512|NCT01774786|40322301|FG001|Overall Study|Reason Not Specified|5|||
16390748|NCT03768089|39915967|FG011|Part A|Lost to Follow-up|0|||
16390749|NCT03768089|39915968|FG012|Part A|Lost to Follow-up|0|||
16390750|NCT03768089|39915969|FG013|Part A|Lost to Follow-up|0|||
16390751|NCT03768089|39915970|FG014|Part A|Lost to Follow-up|0|||
16390752|NCT03768089|39915971|FG015|Part A|Lost to Follow-up|0|||
16390753|NCT03768089|39915972|FG016|Part A|Lost to Follow-up|0|||
16390754|NCT03768089|39915973|FG017|Part A|Lost to Follow-up|0|||
16390755|NCT03768089|39915956|FG000|Part C|Randomized, Never Dosed|0|||
16505513|NCT04898673|40322308|FG000|Overall Study|Screenfail|1|||
16390756|NCT03768089|39915957|FG001|Part C|Randomized, Never Dosed|0|||
16390757|NCT03768089|39915958|FG002|Part C|Randomized, Never Dosed|0|||
16505514|NCT04898673|40322309|FG001|Overall Study|Screenfail|0|||
16505515|NCT04552587|40322310|FG000|Overall Study|Lost to Follow-up|4|||
16505516|NCT02018458|40322311|FG000|Overall Study|Death|4|||
16505517|NCT01476696|40322312|FG000|Overall Study|Sponsor decision|2|||
16505518|NCT01476696|40322313|FG001|Overall Study|Sponsor decision|1|||
16505519|NCT01476696|40322314|FG002|Overall Study|Sponsor decision|0|||
16505520|NCT01476696|40322312|FG000|Overall Study|Withdrawal by Subject|1|||
16505521|NCT01476696|40322313|FG001|Overall Study|Withdrawal by Subject|0|||
16505522|NCT01476696|40322314|FG002|Overall Study|Withdrawal by Subject|0|||
16505523|NCT01030523|40322317|FG000|Initial Study (5 Years)|Death|1|||
16505524|NCT01030523|40322318|FG001|Initial Study (5 Years)|Death|0|||
16196377|NCT00696657|39193526|FG008|Overall Study|Lack of Efficacy|0|||
16196378|NCT00696657|39193518|FG000|Overall Study|Withdrawal criteria|1|||
16196379|NCT00696657|39193519|FG001|Overall Study|Withdrawal criteria|3|||
16196380|NCT00696657|39193520|FG002|Overall Study|Withdrawal criteria|2|||
16196381|NCT00696657|39193521|FG003|Overall Study|Withdrawal criteria|2|||
16196382|NCT00696657|39193522|FG004|Overall Study|Withdrawal criteria|0|||
16390758|NCT03768089|39915959|FG003|Part C|Randomized, Never Dosed|0|||
16390759|NCT03768089|39915960|FG004|Part C|Randomized, Never Dosed|0|||
16390760|NCT03768089|39915961|FG005|Part C|Randomized, Never Dosed|0|||
16505525|NCT01030523|40322317|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
16505526|NCT01030523|40322318|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
16505527|NCT01030523|40322317|FG000|Initial Study (5 Years)|Implant failure|1|||
16505528|NCT01030523|40322318|FG001|Initial Study (5 Years)|Implant failure|0|||
16505529|NCT01030523|40322317|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
16505530|NCT01030523|40322318|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
16505531|NCT01030523|40322317|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
16505532|NCT01030523|40322318|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
16505533|NCT01030523|40322317|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
16505534|NCT01030523|40322318|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
16505535|NCT04668950|40322321|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
16505536|NCT04668950|40322322|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
16505537|NCT04668950|40322321|FG000|Overall Study|Could not confirm started study medication|15|||
16505538|NCT04668950|40322322|FG001|Overall Study|Could not confirm started study medication|15|||
16505539|NCT04668950|40322321|FG000|Overall Study|Could not confirm baseline status|6|||
16505540|NCT04668950|40322322|FG001|Overall Study|Could not confirm baseline status|2|||
16505541|NCT04668950|40322321|FG000|Overall Study|Drop out and did not start medication|15|||
16505542|NCT04668950|40322322|FG001|Overall Study|Drop out and did not start medication|17|||
16505543|NCT04668950|40322321|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
16505544|NCT04668950|40322322|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
16505545|NCT04668950|40322321|FG000|Overall Study|Other|2|||
16505546|NCT04668950|40322322|FG001|Overall Study|Other|4|||
16505547|NCT01173718|40322323|FG000|Overall Study|Death|17|||
16505548|NCT01173718|40322323|FG000|Overall Study|Abandonment of study graft|27|||
16505549|NCT00673179|40322325|FG000|Overall Study|Toxicity/Complications|3|||
16505550|NCT00673179|40322326|FG001|Overall Study|Toxicity/Complications|0|||
16505551|NCT03343483|40322327|FG000|Overall Study|Death|0|||
16505552|NCT03343483|40322328|FG001|Overall Study|Death|3|||
16505553|NCT03343483|40322327|FG000|Overall Study|Lost to Follow-up|9|||
16505554|NCT03343483|40322328|FG001|Overall Study|Lost to Follow-up|13|||
16505555|NCT03343483|40322327|FG000|Overall Study|Withdrawal by Subject|8|||
16505556|NCT03343483|40322328|FG001|Overall Study|Withdrawal by Subject|17|||
16505557|NCT02385266|40322329|FG000|Overall Study|Withdrawal by Subject|1|||
16505558|NCT02385266|40322330|FG001|Overall Study|Withdrawal by Subject|3|||
16505559|NCT04127786|40322331|FG000|Primary Series|Adverse Event|1|||
16505560|NCT04127786|40322332|FG001|Primary Series|Adverse Event|0|||
16505561|NCT04127786|40322333|FG002|Primary Series|Adverse Event|0|||
16196383|NCT00696657|39193523|FG005|Overall Study|Withdrawal criteria|0|||
16196384|NCT00696657|39193524|FG006|Overall Study|Withdrawal criteria|1|||
16505562|NCT04127786|40322334|FG003|Primary Series|Adverse Event|1|||
16505563|NCT04127786|40322335|FG004|Primary Series|Adverse Event|0|||
16505564|NCT04127786|40322336|FG005|Primary Series|Adverse Event|1|||
16505565|NCT04127786|40322331|FG000|Primary Series|Protocol Violation|5|||
16505566|NCT04127786|40322332|FG001|Primary Series|Protocol Violation|3|||
16390761|NCT03768089|39915962|FG006|Part C|Randomized, Never Dosed|0|||
16390762|NCT03768089|39915963|FG007|Part C|Randomized, Never Dosed|0|||
16390763|NCT03768089|39915964|FG008|Part C|Randomized, Never Dosed|0|||
16505567|NCT04127786|40322333|FG002|Primary Series|Protocol Violation|4|||
16505568|NCT04127786|40322334|FG003|Primary Series|Protocol Violation|3|||
16505569|NCT04127786|40322335|FG004|Primary Series|Protocol Violation|2|||
16505570|NCT04127786|40322336|FG005|Primary Series|Protocol Violation|0|||
16505571|NCT04127786|40322331|FG000|Primary Series|Withdrawal by Subject|0|||
16505572|NCT04127786|40322332|FG001|Primary Series|Withdrawal by Subject|0|||
16505573|NCT04127786|40322333|FG002|Primary Series|Withdrawal by Subject|0|||
16505574|NCT04127786|40322334|FG003|Primary Series|Withdrawal by Subject|1|||
16505575|NCT04127786|40322335|FG004|Primary Series|Withdrawal by Subject|0|||
16505576|NCT04127786|40322336|FG005|Primary Series|Withdrawal by Subject|0|||
16505577|NCT04127786|40322331|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
16505578|NCT04127786|40322332|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
16505579|NCT04127786|40322333|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
16505580|NCT04127786|40322334|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
16505581|NCT04127786|40322335|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
16505582|NCT04127786|40322336|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
16505583|NCT04127786|40322331|FG000|Booster Phase|Withdrawal by Subject|2|||
16505584|NCT04127786|40322332|FG001|Booster Phase|Withdrawal by Subject|0|||
16505585|NCT04127786|40322333|FG002|Booster Phase|Withdrawal by Subject|0|||
16505586|NCT04127786|40322334|FG003|Booster Phase|Withdrawal by Subject|0|||
16505587|NCT04127786|40322335|FG004|Booster Phase|Withdrawal by Subject|0|||
16505588|NCT04127786|40322336|FG005|Booster Phase|Withdrawal by Subject|0|||
16505589|NCT01465022|40322337|FG000|Overall Study|Lost to Follow-up|15|||
16505590|NCT01465022|40322338|FG001|Overall Study|Lost to Follow-up|14|||
16505591|NCT01465022|40322339|FG002|Overall Study|Lost to Follow-up|0|||
16505592|NCT01465022|40322337|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
16505593|NCT01465022|40322338|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
16505594|NCT01465022|40322339|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
16505595|NCT01465022|40322337|FG000|Overall Study|Not Randomized|0|||
16505596|NCT01465022|40322338|FG001|Overall Study|Not Randomized|0|||
16089792|NCT01670877|38819992|FG001|Part I and Part 2|Grade 2 vomiting|0|||
16312086|NCT00485264|39627389|FG000|Overall Study|Adverse Event|1|||
16312087|NCT00485264|39627390|FG001|Overall Study|Adverse Event|0|||
16312088|NCT00485264|39627391|FG002|Overall Study|Adverse Event|2|||
16312089|NCT00485264|39627392|FG003|Overall Study|Adverse Event|3|||
16312090|NCT00485264|39627393|FG004|Overall Study|Adverse Event|1|||
16312091|NCT00485264|39627394|FG005|Overall Study|Adverse Event|3|||
16312092|NCT00485264|39627389|FG000|Overall Study|Pregnancy|4|||
16312093|NCT00485264|39627390|FG001|Overall Study|Pregnancy|0|||
16312094|NCT00485264|39627391|FG002|Overall Study|Pregnancy|0|||
16312095|NCT00485264|39627392|FG003|Overall Study|Pregnancy|0|||
16312096|NCT00485264|39627393|FG004|Overall Study|Pregnancy|0|||
16312097|NCT00485264|39627394|FG005|Overall Study|Pregnancy|0|||
16312098|NCT00485264|39627389|FG000|Overall Study|Disallowed Medication|0|||
16312099|NCT00485264|39627390|FG001|Overall Study|Disallowed Medication|0|||
16312100|NCT00485264|39627391|FG002|Overall Study|Disallowed Medication|0|||
16312101|NCT00485264|39627392|FG003|Overall Study|Disallowed Medication|0|||
16312102|NCT00485264|39627393|FG004|Overall Study|Disallowed Medication|0|||
16312103|NCT00485264|39627394|FG005|Overall Study|Disallowed Medication|1|||
16312104|NCT00485264|39627389|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
16312105|NCT00485264|39627390|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
16312106|NCT00485264|39627391|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
16312107|NCT00485264|39627392|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
16312108|NCT00485264|39627393|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
16312109|NCT00485264|39627394|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
16312110|NCT00485264|39627389|FG000|Overall Study|Lack of Efficacy|0|||
16505597|NCT01465022|40322339|FG002|Overall Study|Not Randomized|70|||
16505598|NCT02291055|40322340|FG000|Overall Study|Death|2|||
16312111|NCT00485264|39627390|FG001|Overall Study|Lack of Efficacy|1|||
16312112|NCT00485264|39627391|FG002|Overall Study|Lack of Efficacy|0|||
16505599|NCT02291055|40322341|FG001|Overall Study|Death|2|||
16505600|NCT02291055|40322342|FG002|Overall Study|Death|5|||
16505601|NCT02291055|40322343|FG003|Overall Study|Death|8|||
16505602|NCT02291055|40322344|FG004|Overall Study|Death|12|||
16505603|NCT02291055|40322340|FG000|Overall Study|Lost to Follow-up|0|||
16312113|NCT00485264|39627392|FG003|Overall Study|Lack of Efficacy|0|||
16505604|NCT02291055|40322341|FG001|Overall Study|Lost to Follow-up|0|||
16505605|NCT02291055|40322342|FG002|Overall Study|Lost to Follow-up|0|||
16312114|NCT00485264|39627393|FG004|Overall Study|Lack of Efficacy|0|||
16312115|NCT00485264|39627394|FG005|Overall Study|Lack of Efficacy|0|||
16312116|NCT00485264|39627389|FG000|Overall Study|Guardian Consent Withdrawn|1|||
16312117|NCT00485264|39627390|FG001|Overall Study|Guardian Consent Withdrawn|0|||
16312118|NCT00485264|39627391|FG002|Overall Study|Guardian Consent Withdrawn|0|||
16312119|NCT00485264|39627392|FG003|Overall Study|Guardian Consent Withdrawn|0|||
16312120|NCT00485264|39627393|FG004|Overall Study|Guardian Consent Withdrawn|1|||
16312121|NCT00485264|39627394|FG005|Overall Study|Guardian Consent Withdrawn|0|||
16312122|NCT00485264|39627389|FG000|Overall Study|Physician Decision|0|||
16312123|NCT00485264|39627390|FG001|Overall Study|Physician Decision|2|||
16312124|NCT00485264|39627391|FG002|Overall Study|Physician Decision|0|||
16312125|NCT00485264|39627392|FG003|Overall Study|Physician Decision|0|||
16312126|NCT00485264|39627393|FG004|Overall Study|Physician Decision|0|||
16312127|NCT00485264|39627394|FG005|Overall Study|Physician Decision|0|||
16312128|NCT00485264|39627389|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
16312129|NCT00485264|39627390|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
16505606|NCT02291055|40322343|FG003|Overall Study|Lost to Follow-up|1|||
16089793|NCT01670877|38819993|FG002|Part I and Part 2|Grade 2 vomiting|0|||
16089794|NCT01670877|38819994|FG003|Part I and Part 2|Grade 2 vomiting|1|||
16390764|NCT03768089|39915965|FG009|Part C|Randomized, Never Dosed|0|||
16390765|NCT03768089|39915966|FG010|Part C|Randomized, Never Dosed|0|||
16390766|NCT03768089|39915967|FG011|Part C|Randomized, Never Dosed|0|||
16390767|NCT03768089|39915968|FG012|Part C|Randomized, Never Dosed|0|||
16312130|NCT00485264|39627391|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
16312131|NCT00485264|39627392|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
16312132|NCT00485264|39627393|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
16312133|NCT00485264|39627394|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
16312134|NCT00485264|39627389|FG000|Overall Study|Not Able to Attend Clinic|5|||
16312135|NCT00485264|39627390|FG001|Overall Study|Not Able to Attend Clinic|0|||
16312136|NCT00485264|39627391|FG002|Overall Study|Not Able to Attend Clinic|0|||
16312137|NCT00485264|39627392|FG003|Overall Study|Not Able to Attend Clinic|1|||
16312138|NCT00485264|39627393|FG004|Overall Study|Not Able to Attend Clinic|1|||
16312139|NCT00485264|39627394|FG005|Overall Study|Not Able to Attend Clinic|2|||
16312140|NCT00485264|39627389|FG000|Overall Study|Non-Compliant|17|||
16312141|NCT00485264|39627390|FG001|Overall Study|Non-Compliant|2|||
16312142|NCT00485264|39627391|FG002|Overall Study|Non-Compliant|1|||
16312143|NCT00485264|39627392|FG003|Overall Study|Non-Compliant|0|||
16312144|NCT00485264|39627393|FG004|Overall Study|Non-Compliant|1|||
16312145|NCT00485264|39627394|FG005|Overall Study|Non-Compliant|0|||
16312146|NCT00485264|39627389|FG000|Overall Study|Lost to Follow-up|2|||
16312147|NCT00485264|39627390|FG001|Overall Study|Lost to Follow-up|1|||
16312148|NCT00485264|39627391|FG002|Overall Study|Lost to Follow-up|1|||
16312149|NCT00485264|39627392|FG003|Overall Study|Lost to Follow-up|0|||
16312150|NCT00485264|39627393|FG004|Overall Study|Lost to Follow-up|0|||
16390768|NCT03768089|39915969|FG013|Part C|Randomized, Never Dosed|0|||
16390769|NCT03768089|39915970|FG014|Part C|Randomized, Never Dosed|1|||
16390770|NCT03768089|39915971|FG015|Part C|Randomized, Never Dosed|0|||
16390771|NCT03768089|39915972|FG016|Part C|Randomized, Never Dosed|0|||
16390772|NCT03768089|39915973|FG017|Part C|Randomized, Never Dosed|0|||
16390773|NCT03276728|39915974|FG000|Overall Study|Lost to Follow-up|0|||
16390774|NCT03276728|39915975|FG001|Overall Study|Lost to Follow-up|0|||
16390775|NCT03276728|39915976|FG002|Overall Study|Lost to Follow-up|2|||
16505607|NCT02291055|40322344|FG004|Overall Study|Lost to Follow-up|2|||
16505608|NCT02291055|40322340|FG000|Overall Study|Withdrawal by Subject|3|||
16505609|NCT02291055|40322341|FG001|Overall Study|Withdrawal by Subject|1|||
16505610|NCT02291055|40322342|FG002|Overall Study|Withdrawal by Subject|1|||
16505611|NCT02291055|40322343|FG003|Overall Study|Withdrawal by Subject|5|||
16089795|NCT01670877|38819995|FG004|Part I and Part 2|Grade 2 vomiting|0|||
16089796|NCT01670877|38819996|FG005|Part I and Part 2|Grade 2 vomiting|0|||
16089797|NCT01670877|38819991|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
16312151|NCT00485264|39627394|FG005|Overall Study|Lost to Follow-up|1|||
16390776|NCT03276728|39915977|FG003|Overall Study|Lost to Follow-up|2|||
16505612|NCT02291055|40322344|FG004|Overall Study|Withdrawal by Subject|10|||
16089798|NCT01670877|38819992|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
16312152|NCT00485264|39627389|FG000|Overall Study|Other Reason|3|||
16312153|NCT00485264|39627390|FG001|Overall Study|Other Reason|0|||
16312154|NCT00485264|39627391|FG002|Overall Study|Other Reason|0|||
16312155|NCT00485264|39627392|FG003|Overall Study|Other Reason|0|||
16312156|NCT00485264|39627393|FG004|Overall Study|Other Reason|0|||
16312157|NCT00485264|39627394|FG005|Overall Study|Other Reason|0|||
16312158|NCT01796392|39627400|FG000|Overall Study|Withdrawal by Subject|2|||
16390777|NCT03276728|39915978|FG004|Overall Study|Lost to Follow-up|0|||
16390778|NCT03276728|39915979|FG005|Overall Study|Lost to Follow-up|0|||
16390779|NCT03276728|39915980|FG006|Overall Study|Lost to Follow-up|0|||
16390780|NCT03276728|39915981|FG007|Overall Study|Lost to Follow-up|0|||
16390781|NCT03276728|39915974|FG000|Overall Study|Withdrawal by Subject|0|||
16089799|NCT01670877|38819993|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
16089800|NCT01670877|38819994|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
16089801|NCT01670877|38819995|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
16089802|NCT01670877|38819996|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
16089803|NCT01670877|38819991|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
16312159|NCT01796392|39627401|FG001|Overall Study|Withdrawal by Subject|0|||
16312160|NCT01796392|39627400|FG000|Overall Study|Death|5|||
16089804|NCT01670877|38819992|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
16089805|NCT01670877|38819993|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
16089806|NCT01670877|38819994|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
16089807|NCT01670877|38819995|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
16312161|NCT01796392|39627401|FG001|Overall Study|Death|1|||
16312162|NCT01796392|39627400|FG000|Overall Study|Excluded for medical reasons|1|||
16312163|NCT01796392|39627401|FG001|Overall Study|Excluded for medical reasons|2|||
16312164|NCT01796392|39627400|FG000|Overall Study|Lost to Follow-up|1|||
16312165|NCT01796392|39627401|FG001|Overall Study|Lost to Follow-up|0|||
16312166|NCT00129389|39627407|FG000|Overall Study|Adverse Event|19|||
16312167|NCT00129389|39627408|FG001|Overall Study|Adverse Event|87|||
16312168|NCT00129389|39627407|FG000|Overall Study|Death|0|||
16312169|NCT00129389|39627408|FG001|Overall Study|Death|1|||
16312170|NCT00129389|39627407|FG000|Overall Study|Lost to Follow-up|2|||
16312171|NCT00129389|39627408|FG001|Overall Study|Lost to Follow-up|1|||
16312172|NCT00129389|39627407|FG000|Overall Study|Physician Decision|0|||
16312173|NCT00129389|39627408|FG001|Overall Study|Physician Decision|4|||
16312174|NCT00129389|39627407|FG000|Overall Study|Protocol Violation|0|||
16312175|NCT00129389|39627408|FG001|Overall Study|Protocol Violation|6|||
16312176|NCT00129389|39627407|FG000|Overall Study|Withdrawal by Subject|9|||
16312177|NCT00129389|39627408|FG001|Overall Study|Withdrawal by Subject|23|||
16312178|NCT00129389|39627407|FG000|Overall Study|Relapse|1|||
16312179|NCT00129389|39627408|FG001|Overall Study|Relapse|0|||
16312180|NCT00129389|39627407|FG000|Overall Study|Not eligible|1|||
16312181|NCT00129389|39627408|FG001|Overall Study|Not eligible|2|||
16312182|NCT00129389|39627407|FG000|Overall Study|Crossed to the other arm|1|||
16312183|NCT00129389|39627408|FG001|Overall Study|Crossed to the other arm|16|||
16312184|NCT01134939|39627409|FG000|Overall Study|Adverse Event|9|||
16312185|NCT01134939|39627410|FG001|Overall Study|Adverse Event|3|||
16312186|NCT01134939|39627411|FG002|Overall Study|Adverse Event|4|||
16312187|NCT01134939|39627412|FG003|Overall Study|Adverse Event|5|||
16312188|NCT01134939|39627413|FG004|Overall Study|Adverse Event|5|||
16312189|NCT01134939|39627414|FG005|Overall Study|Adverse Event|5|||
16505613|NCT02291055|40322340|FG000|Overall Study|Progressive Disease|0|||
16505614|NCT02291055|40322341|FG001|Overall Study|Progressive Disease|0|||
16505615|NCT02291055|40322342|FG002|Overall Study|Progressive Disease|1|||
16505616|NCT02291055|40322343|FG003|Overall Study|Progressive Disease|4|||
16505617|NCT02291055|40322344|FG004|Overall Study|Progressive Disease|2|||
16505618|NCT02291055|40322340|FG000|Overall Study|Study Terminated by Sponsor|0|||
16505619|NCT02291055|40322341|FG001|Overall Study|Study Terminated by Sponsor|0|||
16505620|NCT02291055|40322342|FG002|Overall Study|Study Terminated by Sponsor|0|||
16505621|NCT02291055|40322343|FG003|Overall Study|Study Terminated by Sponsor|5|||
16505622|NCT02291055|40322344|FG004|Overall Study|Study Terminated by Sponsor|1|||
16505623|NCT02291055|40322340|FG000|Overall Study|Other|0|||
16505624|NCT02291055|40322341|FG001|Overall Study|Other|2|||
16505625|NCT02291055|40322342|FG002|Overall Study|Other|1|||
16505626|NCT02291055|40322343|FG003|Overall Study|Other|4|||
16505627|NCT02291055|40322344|FG004|Overall Study|Other|0|||
16505628|NCT01921179|40322356|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
16505629|NCT01921179|40322357|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
16505630|NCT01921179|40322356|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
16505631|NCT01921179|40322357|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
16505632|NCT00600938|40322358|FG000|Core Study|Abnormal test procedure result(s)|3|||
16505633|NCT00600938|40322359|FG001|Core Study|Abnormal test procedure result(s)|2|||
16505634|NCT00600938|40322360|FG002|Core Study|Abnormal test procedure result(s)|0|||
16505635|NCT00600938|40322361|FG003|Core Study|Abnormal test procedure result(s)|0|||
16505636|NCT00600938|40322358|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
16505637|NCT00600938|40322359|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
16196385|NCT00696657|39193525|FG007|Overall Study|Withdrawal criteria|1|||
16312190|NCT01134939|39627415|FG006|Overall Study|Adverse Event|1|||
16312191|NCT01134939|39627416|FG007|Overall Study|Adverse Event|0|||
16312192|NCT01134939|39627409|FG000|Overall Study|Lack of Efficacy|2|||
16312193|NCT01134939|39627410|FG001|Overall Study|Lack of Efficacy|5|||
16312194|NCT01134939|39627411|FG002|Overall Study|Lack of Efficacy|1|||
16505638|NCT00600938|40322360|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
16505639|NCT00600938|40322361|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
16505640|NCT00600938|40322358|FG000|Core Study|Patient withdrew consent|7|||
16505641|NCT00600938|40322359|FG001|Core Study|Patient withdrew consent|12|||
16505642|NCT00600938|40322360|FG002|Core Study|Patient withdrew consent|0|||
16089808|NCT01670877|38819996|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
16089809|NCT02924051|38819997|FG000|Overall Study|Withdrawal by Subject|1|||
16089810|NCT02924051|38819998|FG001|Overall Study|Withdrawal by Subject|9|||
16089811|NCT01262456|38819999|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
16089812|NCT01262456|38820000|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
16089813|NCT01262456|38820001|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
16089814|NCT01262456|38819999|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
16089815|NCT01262456|38820000|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
16089816|NCT01262456|38820001|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
16089817|NCT01262456|38819999|FG000|3-Month Double-Blind Period|Adverse Event|6|||
16089818|NCT01262456|38820000|FG001|3-Month Double-Blind Period|Adverse Event|4|||
16089819|NCT01262456|38820001|FG002|3-Month Double-Blind Period|Adverse Event|8|||
16089820|NCT01262456|38819999|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
16089821|NCT01262456|38820000|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
16196386|NCT00696657|39193526|FG008|Overall Study|Withdrawal criteria|2|||
16196387|NCT00696657|39193518|FG000|Overall Study|Unclassified|0|||
16196388|NCT00696657|39193519|FG001|Overall Study|Unclassified|1|||
16196389|NCT00696657|39193520|FG002|Overall Study|Unclassified|3|||
16196390|NCT00696657|39193521|FG003|Overall Study|Unclassified|2|||
16196391|NCT00696657|39193522|FG004|Overall Study|Unclassified|4|||
16196392|NCT00696657|39193523|FG005|Overall Study|Unclassified|2|||
16196393|NCT00696657|39193524|FG006|Overall Study|Unclassified|0|||
16196394|NCT00696657|39193525|FG007|Overall Study|Unclassified|0|||
16196395|NCT00696657|39193526|FG008|Overall Study|Unclassified|1|||
16196396|NCT00696657|39193518|FG000|Overall Study|Adverse Event|0|||
16089822|NCT01262456|38820001|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
16089823|NCT01262456|38819999|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
16089824|NCT01262456|38820000|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
16089825|NCT01262456|38820001|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
16089826|NCT01262456|38819999|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
16089827|NCT01262456|38820000|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
16089828|NCT01262456|38820001|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
16089829|NCT01262456|38819999|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
16089830|NCT01262456|38820000|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
16089831|NCT01262456|38820001|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
16089832|NCT01262456|38819999|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
16089833|NCT01262456|38820000|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
16089834|NCT01262456|38820001|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
16089835|NCT01262456|38819999|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
16089836|NCT01262456|38820000|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
16089837|NCT01262456|38820001|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
16089838|NCT02542696|38820002|FG000|Overall Study|Adverse Event|167|||
16089839|NCT02542696|38820002|FG000|Overall Study|Lack of Efficacy|26|||
16089840|NCT02542696|38820002|FG000|Overall Study|Lost to Follow-up|6|||
16089841|NCT02542696|38820002|FG000|Overall Study|Withdrawal by Subject|104|||
16089842|NCT02542696|38820002|FG000|Overall Study|Protocol Violation|5|||
16089843|NCT02542696|38820002|FG000|Overall Study|Death|8|||
16089844|NCT02542696|38820002|FG000|Overall Study|DECREASED OFF TIME|1|||
16089845|NCT02542696|38820002|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
16089846|NCT02542696|38820002|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
16089847|NCT02542696|38820002|FG000|Overall Study|MEDICAL HISTORY|1|||
16196397|NCT00696657|39193519|FG001|Overall Study|Adverse Event|0|||
16089848|NCT02542696|38820002|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
16196398|NCT00696657|39193520|FG002|Overall Study|Adverse Event|3|||
16505643|NCT00600938|40322361|FG003|Core Study|Patient withdrew consent|0|||
16505644|NCT00600938|40322358|FG000|Core Study|Lost to Follow-up|3|||
16505645|NCT00600938|40322359|FG001|Core Study|Lost to Follow-up|2|||
16505646|NCT00600938|40322360|FG002|Core Study|Lost to Follow-up|0|||
16505647|NCT00600938|40322361|FG003|Core Study|Lost to Follow-up|0|||
16505648|NCT00600938|40322358|FG000|Core Study|Death|1|||
16505649|NCT00600938|40322359|FG001|Core Study|Death|1|||
16505650|NCT00600938|40322360|FG002|Core Study|Death|0|||
16505651|NCT00600938|40322361|FG003|Core Study|Death|0|||
16505652|NCT00600938|40322358|FG000|Core Study|Protocol Violation|1|||
16505653|NCT00600938|40322359|FG001|Core Study|Protocol Violation|2|||
16505654|NCT00600938|40322360|FG002|Core Study|Protocol Violation|0|||
16505655|NCT00600938|40322361|FG003|Core Study|Protocol Violation|0|||
16505656|NCT00600938|40322358|FG000|Extension Study|Adverse Event|1|||
16505657|NCT00600938|40322359|FG001|Extension Study|Adverse Event|0|||
16505658|NCT00600938|40322360|FG002|Extension Study|Adverse Event|2|||
16505659|NCT00600938|40322361|FG003|Extension Study|Adverse Event|0|||
16505660|NCT00600938|40322358|FG000|Extension Study|Abnormal test procedure results|0|||
16505661|NCT00600938|40322359|FG001|Extension Study|Abnormal test procedure results|1|||
16505662|NCT00600938|40322360|FG002|Extension Study|Abnormal test procedure results|1|||
16505663|NCT00600938|40322361|FG003|Extension Study|Abnormal test procedure results|1|||
16505664|NCT00600938|40322358|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
16505665|NCT00600938|40322359|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
16505666|NCT00600938|40322360|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
16505667|NCT00600938|40322361|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
16505668|NCT00600938|40322358|FG000|Extension Study|Withdrawal by Subject|2|||
16505669|NCT00600938|40322359|FG001|Extension Study|Withdrawal by Subject|2|||
16505670|NCT00600938|40322360|FG002|Extension Study|Withdrawal by Subject|3|||
16505671|NCT00600938|40322361|FG003|Extension Study|Withdrawal by Subject|0|||
16505672|NCT00600938|40322358|FG000|Extension Study|Lost to Follow-up|1|||
16505673|NCT00600938|40322359|FG001|Extension Study|Lost to Follow-up|1|||
16505674|NCT00600938|40322360|FG002|Extension Study|Lost to Follow-up|2|||
16505675|NCT00600938|40322361|FG003|Extension Study|Lost to Follow-up|0|||
16505676|NCT00600938|40322358|FG000|Extension Study|Death|1|||
16312195|NCT01134939|39627412|FG003|Overall Study|Lack of Efficacy|0|||
16312196|NCT01134939|39627413|FG004|Overall Study|Lack of Efficacy|3|||
16312197|NCT01134939|39627414|FG005|Overall Study|Lack of Efficacy|0|||
16312198|NCT01134939|39627415|FG006|Overall Study|Lack of Efficacy|1|||
16312199|NCT01134939|39627416|FG007|Overall Study|Lack of Efficacy|0|||
16312200|NCT01134939|39627409|FG000|Overall Study|Lost to Follow-up|2|||
16312201|NCT01134939|39627410|FG001|Overall Study|Lost to Follow-up|3|||
16312202|NCT01134939|39627411|FG002|Overall Study|Lost to Follow-up|0|||
16312203|NCT01134939|39627412|FG003|Overall Study|Lost to Follow-up|1|||
16312204|NCT01134939|39627413|FG004|Overall Study|Lost to Follow-up|2|||
16505677|NCT00600938|40322359|FG001|Extension Study|Death|0|||
16505678|NCT00600938|40322360|FG002|Extension Study|Death|0|||
16505679|NCT00600938|40322361|FG003|Extension Study|Death|0|||
16505680|NCT02775344|40322362|FG000|Overall Study|No ovarian cyst identified|3|||
16505681|NCT02775344|40322363|FG001|Overall Study|No ovarian cyst identified|2|||
16505682|NCT02503332|40322364|FG000|Overall Study|Adverse Event|17|||
16505683|NCT02503332|40322365|FG001|Overall Study|Adverse Event|5|||
16505684|NCT02503332|40322366|FG002|Overall Study|Adverse Event|3|||
16505685|NCT02503332|40322367|FG003|Overall Study|Adverse Event|1|||
16505686|NCT02503332|40322364|FG000|Overall Study|Investigator's Decision|5|||
16505687|NCT02503332|40322365|FG001|Overall Study|Investigator's Decision|1|||
16505688|NCT02503332|40322366|FG002|Overall Study|Investigator's Decision|0|||
16505689|NCT02503332|40322367|FG003|Overall Study|Investigator's Decision|0|||
16505690|NCT02503332|40322364|FG000|Overall Study|Sponsor's Decision|1|||
16505691|NCT02503332|40322365|FG001|Overall Study|Sponsor's Decision|0|||
16505692|NCT02503332|40322366|FG002|Overall Study|Sponsor's Decision|0|||
16505693|NCT02503332|40322367|FG003|Overall Study|Sponsor's Decision|1|||
16505694|NCT02503332|40322364|FG000|Overall Study|Subject Request|6|||
16505695|NCT02503332|40322365|FG001|Overall Study|Subject Request|5|||
16505696|NCT02503332|40322366|FG002|Overall Study|Subject Request|2|||
16505697|NCT02503332|40322367|FG003|Overall Study|Subject Request|1|||
16505698|NCT02503332|40322364|FG000|Overall Study|Death|0|||
16505699|NCT02503332|40322365|FG001|Overall Study|Death|2|||
16505700|NCT02503332|40322366|FG002|Overall Study|Death|2|||
16505701|NCT02503332|40322367|FG003|Overall Study|Death|0|||
16505702|NCT02503332|40322364|FG000|Overall Study|Other|5|||
16505703|NCT02503332|40322365|FG001|Overall Study|Other|6|||
16312205|NCT01134939|39627414|FG005|Overall Study|Lost to Follow-up|1|||
16312206|NCT01134939|39627415|FG006|Overall Study|Lost to Follow-up|0|||
16505704|NCT02503332|40322366|FG002|Overall Study|Other|1|||
16505705|NCT02503332|40322367|FG003|Overall Study|Other|1|||
16505706|NCT04865354|40322370|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
16505707|NCT04865354|40322371|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
16505708|NCT04865354|40322370|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
16312207|NCT01134939|39627416|FG007|Overall Study|Lost to Follow-up|0|||
16505709|NCT04865354|40322371|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
16505710|NCT04865354|40322370|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
16505711|NCT04865354|40322371|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
16505712|NCT03020823|40322372|FG000|Overall Study|Physician Decision|4|||
16505713|NCT03020823|40322372|FG000|Overall Study|Lack of Efficacy|4|||
16505714|NCT03020823|40322372|FG000|Overall Study|Adverse Event|2|||
16505715|NCT04105998|40322373|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
16505716|NCT04105998|40322374|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
16505717|NCT00542919|40325522|FG000|Overall Study|Adverse Event|1|||
16505718|NCT00542919|40325523|FG001|Overall Study|Adverse Event|5|||
16505719|NCT00542919|40325524|FG002|Overall Study|Adverse Event|1|||
16505720|NCT00542919|40325522|FG000|Overall Study|Withdrawal by Subject|1|||
16505721|NCT00542919|40325523|FG001|Overall Study|Withdrawal by Subject|0|||
16505722|NCT00542919|40325524|FG002|Overall Study|Withdrawal by Subject|3|||
16505723|NCT00542919|40325522|FG000|Overall Study|Physician Decision|2|||
16505724|NCT00542919|40325523|FG001|Overall Study|Physician Decision|2|||
16505725|NCT00542919|40325524|FG002|Overall Study|Physician Decision|1|||
16505726|NCT00542919|40325522|FG000|Overall Study|Sponsor Decision|1|||
16505727|NCT00542919|40325523|FG001|Overall Study|Sponsor Decision|0|||
16505728|NCT00542919|40325524|FG002|Overall Study|Sponsor Decision|0|||
16505729|NCT00542919|40325522|FG000|Overall Study|Lost to Follow-up|2|||
16505730|NCT00542919|40325523|FG001|Overall Study|Lost to Follow-up|0|||
16505731|NCT00542919|40325524|FG002|Overall Study|Lost to Follow-up|1|||
16505732|NCT02319031|40325525|FG000|Treatment Period|Death|1|||
16505733|NCT02319031|40325526|FG001|Treatment Period|Death|0|||
16505734|NCT00371254|40325527|FG000|Overall Study|Disease progression|13|||
16505735|NCT00371254|40325528|FG001|Overall Study|Disease progression|13|||
16505736|NCT00371254|40325527|FG000|Overall Study|Study drug toxicity|3|||
16505737|NCT00371254|40325528|FG001|Overall Study|Study drug toxicity|5|||
16505738|NCT00371254|40325527|FG000|Overall Study|Subject request|5|||
16505739|NCT00371254|40325528|FG001|Overall Study|Subject request|0|||
16505740|NCT00371254|40325527|FG000|Overall Study|Investigator Decision|2|||
16505741|NCT00371254|40325528|FG001|Overall Study|Investigator Decision|0|||
16505742|NCT00371254|40325527|FG000|Overall Study|Adverse event unrelated to study drug|0|||
16505743|NCT00371254|40325528|FG001|Overall Study|Adverse event unrelated to study drug|1|||
16505744|NCT00371254|40325527|FG000|Overall Study|Lost to Follow-up|0|||
16505745|NCT00371254|40325528|FG001|Overall Study|Lost to Follow-up|1|||
16505746|NCT00371254|40325527|FG000|Overall Study|Withdrawal by Subject|0|||
16505747|NCT00371254|40325528|FG001|Overall Study|Withdrawal by Subject|1|||
16505748|NCT02205333|40325529|FG000|Overall Study|Death|5|||
16505749|NCT02205333|40325530|FG001|Overall Study|Death|6|||
16505750|NCT02205333|40325531|FG002|Overall Study|Death|2|||
16505751|NCT02205333|40325532|FG003|Overall Study|Death|6|||
16505752|NCT02205333|40325533|FG004|Overall Study|Death|5|||
16505753|NCT02205333|40325534|FG005|Overall Study|Death|3|||
16505754|NCT02205333|40325535|FG006|Overall Study|Death|3|||
16505755|NCT02205333|40325536|FG007|Overall Study|Death|2|||
16505756|NCT02205333|40325537|FG008|Overall Study|Death|0|||
16505757|NCT02205333|40325529|FG000|Overall Study|Withdrawal by Subject|1|||
16505758|NCT02205333|40325530|FG001|Overall Study|Withdrawal by Subject|0|||
16505759|NCT02205333|40325531|FG002|Overall Study|Withdrawal by Subject|0|||
16505760|NCT02205333|40325532|FG003|Overall Study|Withdrawal by Subject|1|||
16505761|NCT02205333|40325533|FG004|Overall Study|Withdrawal by Subject|0|||
16505762|NCT02205333|40325534|FG005|Overall Study|Withdrawal by Subject|0|||
16505763|NCT02205333|40325535|FG006|Overall Study|Withdrawal by Subject|2|||
16505764|NCT02205333|40325536|FG007|Overall Study|Withdrawal by Subject|0|||
16505765|NCT02205333|40325537|FG008|Overall Study|Withdrawal by Subject|0|||
16505766|NCT01319877|40325540|FG000|Overall Study|Lost to Follow-up|100|||
16505767|NCT01319877|40325541|FG001|Overall Study|Lost to Follow-up|37|||
16505768|NCT01319877|40325540|FG000|Overall Study|Physician Decision|2|||
16505769|NCT01319877|40325541|FG001|Overall Study|Physician Decision|0|||
16505770|NCT01319877|40325540|FG000|Overall Study|Disease Progression|2|||
16505771|NCT01319877|40325541|FG001|Overall Study|Disease Progression|2|||
16505772|NCT01319877|40325540|FG000|Overall Study|Withdrawal by Subject|0|||
16505773|NCT01319877|40325541|FG001|Overall Study|Withdrawal by Subject|1|||
16505774|NCT01319877|40325540|FG000|Overall Study|Reason Not Specified|4|||
16505775|NCT01319877|40325541|FG001|Overall Study|Reason Not Specified|5|||
16505776|NCT02968979|40325542|FG000|Overall Study|Protocol Violation|7|||
16505777|NCT02968979|40325542|FG000|Overall Study|Withdrawal by Subject|1|||
16505778|NCT01782664|40325544|FG000|Overall Study|Adverse Event|2|||
16505779|NCT01782664|40325545|FG001|Overall Study|Adverse Event|2|||
16505780|NCT01782664|40325546|FG002|Overall Study|Adverse Event|2|||
16505781|NCT01782664|40325547|FG003|Overall Study|Adverse Event|2|||
16505782|NCT01782664|40325548|FG004|Overall Study|Adverse Event|0|||
16505783|NCT01782664|40325549|FG005|Overall Study|Adverse Event|0|||
16505784|NCT01782664|40325544|FG000|Overall Study|Lack of Efficacy|2|||
16505785|NCT01782664|40325545|FG001|Overall Study|Lack of Efficacy|0|||
16505786|NCT01782664|40325546|FG002|Overall Study|Lack of Efficacy|2|||
16505787|NCT01782664|40325547|FG003|Overall Study|Lack of Efficacy|2|||
16505788|NCT01782664|40325548|FG004|Overall Study|Lack of Efficacy|0|||
16505789|NCT01782664|40325549|FG005|Overall Study|Lack of Efficacy|0|||
16505790|NCT01782664|40325544|FG000|Overall Study|Protocol Violation|0|||
16505791|NCT01782664|40325545|FG001|Overall Study|Protocol Violation|1|||
16505792|NCT01782664|40325546|FG002|Overall Study|Protocol Violation|0|||
16505793|NCT01782664|40325547|FG003|Overall Study|Protocol Violation|1|||
16505794|NCT01782664|40325548|FG004|Overall Study|Protocol Violation|0|||
16505795|NCT01782664|40325549|FG005|Overall Study|Protocol Violation|0|||
16505796|NCT01782664|40325544|FG000|Overall Study|Withdrawal by Subject|2|||
16505797|NCT01782664|40325545|FG001|Overall Study|Withdrawal by Subject|2|||
16505798|NCT01782664|40325546|FG002|Overall Study|Withdrawal by Subject|0|||
16312208|NCT01134939|39627409|FG000|Overall Study|Death|0|||
16312209|NCT01134939|39627410|FG001|Overall Study|Death|1|||
16312210|NCT01134939|39627411|FG002|Overall Study|Death|0|||
16505799|NCT01782664|40325547|FG003|Overall Study|Withdrawal by Subject|0|||
16505800|NCT01782664|40325548|FG004|Overall Study|Withdrawal by Subject|0|||
16505801|NCT01782664|40325549|FG005|Overall Study|Withdrawal by Subject|0|||
16505802|NCT03642717|40325552|FG000|Overall Study|Lost to Follow-up|2|||
16505803|NCT03642717|40325552|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
16505804|NCT03642717|40325552|FG000|Overall Study|Taken study drug prior to contract date|3|||
16505805|NCT03526458|40325553|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
16312211|NCT01134939|39627412|FG003|Overall Study|Death|0|||
16312212|NCT01134939|39627413|FG004|Overall Study|Death|0|||
16505806|NCT03526458|40325554|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
16505807|NCT03526458|40325553|FG000|Overall Study|Stone passed, surgery cancelled|2|||
16505808|NCT03526458|40325554|FG001|Overall Study|Stone passed, surgery cancelled|1|||
16505809|NCT03526458|40325553|FG000|Overall Study|Withdrawal by Subject|1|||
16505810|NCT03526458|40325554|FG001|Overall Study|Withdrawal by Subject|0|||
16505811|NCT03526458|40325553|FG000|Overall Study|Physician Decision|2|||
16312213|NCT01134939|39627414|FG005|Overall Study|Death|0|||
16505812|NCT03526458|40325554|FG001|Overall Study|Physician Decision|1|||
16505813|NCT03526458|40325553|FG000|Overall Study|Lack of equipment|1|||
16505814|NCT03526458|40325554|FG001|Overall Study|Lack of equipment|1|||
16505815|NCT03424265|40325555|FG000|Overall Study|screening failure|1|||
16505816|NCT03424265|40325556|FG001|Overall Study|screening failure|0|||
16505817|NCT03424265|40325555|FG000|Overall Study|Withdrawal by Subject|0|||
16505818|NCT03424265|40325556|FG001|Overall Study|Withdrawal by Subject|2|||
16505819|NCT04532099|40325559|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
16505820|NCT04532099|40325560|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
16505821|NCT04532099|40325561|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
16505822|NCT03042468|40325562|FG000|Overall Study|Death|0|||
16505823|NCT03042468|40325563|FG001|Overall Study|Death|1|||
16505824|NCT03042468|40325564|FG002|Overall Study|Death|1|||
16505825|NCT03042468|40325565|FG003|Overall Study|Death|0|||
16505826|NCT03042468|40325566|FG004|Overall Study|Death|0|||
16505827|NCT03042468|40325567|FG005|Overall Study|Death|0|||
16505828|NCT03042468|40325562|FG000|Overall Study|Withdrawal by Subject|0|||
16505829|NCT03042468|40325563|FG001|Overall Study|Withdrawal by Subject|0|||
16505830|NCT03042468|40325564|FG002|Overall Study|Withdrawal by Subject|0|||
16505831|NCT03042468|40325565|FG003|Overall Study|Withdrawal by Subject|0|||
16505832|NCT03042468|40325566|FG004|Overall Study|Withdrawal by Subject|0|||
16505833|NCT03042468|40325567|FG005|Overall Study|Withdrawal by Subject|1|||
16505834|NCT03042468|40325562|FG000|Overall Study|Lost to Follow-up|0|||
16505835|NCT03042468|40325563|FG001|Overall Study|Lost to Follow-up|0|||
16505836|NCT03042468|40325564|FG002|Overall Study|Lost to Follow-up|0|||
16505837|NCT03042468|40325565|FG003|Overall Study|Lost to Follow-up|0|||
16505838|NCT03042468|40325566|FG004|Overall Study|Lost to Follow-up|1|||
16505839|NCT03042468|40325567|FG005|Overall Study|Lost to Follow-up|1|||
16505840|NCT00325754|40325568|FG000|Overall Study|Adverse Event|4|||
16505841|NCT00325754|40325569|FG001|Overall Study|Adverse Event|1|||
16505842|NCT01290666|40325589|FG000|Overall Study|Lost to Follow-up|11|||
16505843|NCT01290666|40325589|FG000|Overall Study|Withdrawal by Subject|23|||
16505844|NCT01290666|40325589|FG000|Overall Study|Early Termination of Study|4|||
16505845|NCT01848756|40325601|FG000|Overall Study|Adverse Event|1|||
16505846|NCT01848756|40325601|FG000|Overall Study|Withdrawal by Subject|1|||
16312214|NCT01134939|39627415|FG006|Overall Study|Death|0|||
16312215|NCT01134939|39627416|FG007|Overall Study|Death|0|||
16505847|NCT01848756|40325601|FG000|Overall Study|Enrolled in Error|1|||
16505848|NCT04475588|40325602|FG000|Overall Study|Adverse Event|2|||
16505849|NCT04475588|40325603|FG001|Overall Study|Adverse Event|0|||
16505850|NCT01528072|40325604|FG000|Overall Study|Withdrawal by Subject|5|||
16312216|NCT01134939|39627409|FG000|Overall Study|Termination page not available|4|||
16505851|NCT01528072|40325604|FG000|Overall Study|Physician Decision|1|||
16546335|NCT01986881|40464783|FG000|Overall Study|Physician Decision|7|||
16390782|NCT03276728|39915975|FG001|Overall Study|Withdrawal by Subject|0|||
16390783|NCT03276728|39915976|FG002|Overall Study|Withdrawal by Subject|0|||
16390784|NCT03276728|39915977|FG003|Overall Study|Withdrawal by Subject|3|||
16390785|NCT03276728|39915978|FG004|Overall Study|Withdrawal by Subject|0|||
16390786|NCT03276728|39915979|FG005|Overall Study|Withdrawal by Subject|0|||
16390787|NCT03276728|39915980|FG006|Overall Study|Withdrawal by Subject|0|||
16390788|NCT03276728|39915981|FG007|Overall Study|Withdrawal by Subject|0|||
16505852|NCT01528072|40325604|FG000|Overall Study|Determined not eligible by AEAC|1|||
16505853|NCT01528072|40325604|FG000|Overall Study|Missed Visit|2|||
16505854|NCT01528072|40325604|FG000|Overall Study|Lost to Follow-up|5|||
16505855|NCT01528072|40325604|FG000|Overall Study|Explanted|2|||
16505856|NCT01528072|40325604|FG000|Overall Study|Site Closure|4|||
16505857|NCT01528072|40325604|FG000|Overall Study|Death|2|||
16505858|NCT01528072|40325604|FG000|Overall Study|Early Termination of Study|52|||
16505859|NCT00791518|40325609|FG000|Overall Study|Protocol Violation|93|||
16505860|NCT03299192|40325610|FG000|Overall Study|Fell before classes started|1|||
16505861|NCT03299192|40325611|FG001|Overall Study|Fell before classes started|0|||
16505862|NCT03299192|40325612|FG002|Overall Study|Fell before classes started|0|||
16505863|NCT03299192|40325610|FG000|Overall Study|Other|0|||
16505864|NCT03299192|40325611|FG001|Overall Study|Other|2|||
16505865|NCT03299192|40325612|FG002|Overall Study|Other|1|||
16505866|NCT01531387|40325613|FG000|Overall Study|Early termination of study|11|||
16505867|NCT01531387|40325614|FG001|Overall Study|Early termination of study|11|||
16505868|NCT01838642|40325615|FG000|Overall Study|Died on study|1|||
16505869|NCT01817725|40325621|FG000|Overall Study|Withdrawal by Subject|1|||
16505870|NCT01265849|40325622|FG000|Overall Study|Randomized//Treatment not initiated|1|||
16505871|NCT01265849|40325623|FG001|Overall Study|Randomized//Treatment not initiated|4|||
16505872|NCT01265849|40325624|FG002|Overall Study|Randomized//Treatment not initiated|0|||
16505873|NCT01265849|40325622|FG000|Overall Study|Physician Decision|1|||
16505874|NCT01265849|40325623|FG001|Overall Study|Physician Decision|2|||
16505875|NCT01265849|40325624|FG002|Overall Study|Physician Decision|0|||
16505876|NCT01265849|40325622|FG000|Overall Study|Lost to Follow-up|18|||
16505877|NCT01265849|40325623|FG001|Overall Study|Lost to Follow-up|15|||
16505878|NCT01265849|40325624|FG002|Overall Study|Lost to Follow-up|5|||
16505879|NCT01265849|40325622|FG000|Overall Study|Not otherwise specified|1|||
16505880|NCT01265849|40325623|FG001|Overall Study|Not otherwise specified|6|||
16505881|NCT01265849|40325624|FG002|Overall Study|Not otherwise specified|1|||
16505882|NCT01265849|40325622|FG000|Overall Study|Withdrawal by Subject|25|||
16505883|NCT01265849|40325623|FG001|Overall Study|Withdrawal by Subject|34|||
16505884|NCT01265849|40325624|FG002|Overall Study|Withdrawal by Subject|13|||
16505885|NCT00291668|40325625|FG000|Overall Study|Lack of Efficacy|1|||
16505886|NCT00291668|40325626|FG001|Overall Study|Lack of Efficacy|0|||
16505887|NCT00291668|40325627|FG002|Overall Study|Lack of Efficacy|0|||
16505888|NCT00291668|40325625|FG000|Overall Study|SAE, non-fatal|1|||
16505889|NCT00291668|40325626|FG001|Overall Study|SAE, non-fatal|1|||
16505890|NCT00291668|40325627|FG002|Overall Study|SAE, non-fatal|1|||
16505891|NCT00291668|40325625|FG000|Overall Study|AE, non-serious non-fatal|1|||
16505892|NCT00291668|40325626|FG001|Overall Study|AE, non-serious non-fatal|0|||
16505893|NCT00291668|40325627|FG002|Overall Study|AE, non-serious non-fatal|0|||
16505894|NCT00291668|40325625|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16196399|NCT00696657|39193521|FG003|Overall Study|Adverse Event|7|||
16312217|NCT01134939|39627410|FG001|Overall Study|Termination page not available|6|||
16312218|NCT01134939|39627411|FG002|Overall Study|Termination page not available|5|||
16312219|NCT01134939|39627412|FG003|Overall Study|Termination page not available|8|||
16312220|NCT01134939|39627413|FG004|Overall Study|Termination page not available|0|||
16312221|NCT01134939|39627414|FG005|Overall Study|Termination page not available|3|||
16312222|NCT01134939|39627415|FG006|Overall Study|Termination page not available|7|||
16312223|NCT01134939|39627416|FG007|Overall Study|Termination page not available|0|||
16312224|NCT02157935|39627417|FG000|Overall Study|Withdrawal by Subject|25|||
16312225|NCT02157935|39627418|FG001|Overall Study|Withdrawal by Subject|39|||
16312226|NCT02157935|39627417|FG000|Overall Study|Screen failure|1|||
16312227|NCT02157935|39627418|FG001|Overall Study|Screen failure|2|||
16312228|NCT02157935|39627417|FG000|Overall Study|Protocol Violation|1|||
16312229|NCT02157935|39627418|FG001|Overall Study|Protocol Violation|0|||
16312230|NCT02157935|39627417|FG000|Overall Study|Progressive disease|0|||
16312231|NCT02157935|39627418|FG001|Overall Study|Progressive disease|2|||
16312232|NCT02157935|39627417|FG000|Overall Study|Other|5|||
16312233|NCT02157935|39627418|FG001|Overall Study|Other|12|||
16312234|NCT02157935|39627417|FG000|Overall Study|Lack of Efficacy|0|||
16312235|NCT02157935|39627418|FG001|Overall Study|Lack of Efficacy|1|||
16312236|NCT02157935|39627417|FG000|Overall Study|Death|4|||
16546336|NCT01986881|40464784|FG001|Overall Study|Physician Decision|4|||
16312237|NCT02157935|39627418|FG001|Overall Study|Death|4|||
16312238|NCT02157935|39627417|FG000|Overall Study|Adverse Event|3|||
16312239|NCT02157935|39627418|FG001|Overall Study|Adverse Event|5|||
16312240|NCT03518008|39627419|FG000|Period 2, Second Week of Wear|Family emergency|0|||
16390789|NCT03276728|39915974|FG000|Overall Study|Decision by sponsor|0|||
16505895|NCT00291668|40325626|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
16505896|NCT00291668|40325627|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
16505897|NCT01464346|40325628|FG000|Overall Study|Withdrawal by Subject|0|||
16196400|NCT00696657|39193522|FG004|Overall Study|Adverse Event|6|||
16196401|NCT00696657|39193523|FG005|Overall Study|Adverse Event|9|||
16196402|NCT00696657|39193524|FG006|Overall Study|Adverse Event|14|||
16196403|NCT00696657|39193525|FG007|Overall Study|Adverse Event|2|||
16196404|NCT00696657|39193526|FG008|Overall Study|Adverse Event|5|||
16196405|NCT04737031|39193527|FG000|Overall Study|Patients who did not have a treatment visit|0|||
16196406|NCT04737031|39193528|FG001|Overall Study|Patients who did not have a treatment visit|31|||
16196407|NCT04737031|39193529|FG002|Overall Study|Patients who did not have a treatment visit|93|||
16196408|NCT04737031|39193530|FG003|Overall Study|Patients who did not have a treatment visit|227|||
16196409|NCT02044159|39193531|FG000|Overall Study|Consent declined (deferred consent)|2|||
16196410|NCT02044159|39193532|FG001|Overall Study|Consent declined (deferred consent)|4|||
16312241|NCT03518008|39627420|FG001|Period 2, Second Week of Wear|Family emergency|1|||
16312242|NCT03922321|39627421|FG000|Overall Study|Participant Moved|1|||
16312243|NCT03922321|39627421|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
16312244|NCT03351608|39627422|FG000|Overall Study|Lost to Follow-up|0|||
16312245|NCT03351608|39627423|FG001|Overall Study|Lost to Follow-up|1|||
16312246|NCT03351608|39627424|FG002|Overall Study|Lost to Follow-up|1|||
16312247|NCT03351608|39627425|FG003|Overall Study|Lost to Follow-up|1|||
16312248|NCT03351608|39627426|FG004|Overall Study|Lost to Follow-up|1|||
16312249|NCT03351608|39627422|FG000|Overall Study|Physician Decision|1|||
16312250|NCT03351608|39627423|FG001|Overall Study|Physician Decision|0|||
16312251|NCT03351608|39627424|FG002|Overall Study|Physician Decision|0|||
16312252|NCT03351608|39627425|FG003|Overall Study|Physician Decision|2|||
16312253|NCT03351608|39627426|FG004|Overall Study|Physician Decision|1|||
16312254|NCT03351608|39627422|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
16312255|NCT03351608|39627423|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
16312256|NCT03351608|39627424|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
16312257|NCT03351608|39627425|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
16312258|NCT03351608|39627426|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
16312259|NCT03351608|39627422|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16312260|NCT03351608|39627423|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16312261|NCT03351608|39627424|FG002|Overall Study|Withdrawal by parent/guardian|1|||
16312262|NCT03351608|39627425|FG003|Overall Study|Withdrawal by parent/guardian|1|||
16312263|NCT03351608|39627426|FG004|Overall Study|Withdrawal by parent/guardian|0|||
16312264|NCT03351608|39627422|FG000|Overall Study|Other|0|||
16312265|NCT03351608|39627423|FG001|Overall Study|Other|1|||
16312266|NCT03351608|39627424|FG002|Overall Study|Other|1|||
16312267|NCT03351608|39627425|FG003|Overall Study|Other|3|||
16312268|NCT03351608|39627426|FG004|Overall Study|Other|0|||
16312269|NCT01895777|39627427|FG000|Overall Study|Adverse Event|1|||
16312270|NCT01895777|39627428|FG001|Overall Study|Adverse Event|2|||
16312271|NCT01895777|39627427|FG000|Overall Study|Lost to Follow-up|2|||
16312272|NCT01895777|39627428|FG001|Overall Study|Lost to Follow-up|0|||
16505898|NCT01464346|40325629|FG001|Overall Study|Withdrawal by Subject|0|||
16505899|NCT01464346|40325630|FG002|Overall Study|Withdrawal by Subject|1|||
16505900|NCT00698581|40325633|FG000|Overall Study|Lack of Efficacy|23|||
16505901|NCT00698581|40325634|FG001|Overall Study|Lack of Efficacy|11|||
16505902|NCT00698581|40325633|FG000|Overall Study|Withdrawal by Subject|6|||
16505903|NCT00698581|40325634|FG001|Overall Study|Withdrawal by Subject|0|||
16196411|NCT02044159|39193531|FG000|Overall Study|No longer eligible, drug not given|1|||
16196412|NCT02044159|39193532|FG001|Overall Study|No longer eligible, drug not given|0|||
16505904|NCT00698581|40325633|FG000|Overall Study|Other reason|9|||
16505905|NCT00698581|40325634|FG001|Overall Study|Other reason|1|||
16505906|NCT00698581|40325633|FG000|Overall Study|SAE, non-fatal|1|||
16505907|NCT00698581|40325634|FG001|Overall Study|SAE, non-fatal|0|||
16505908|NCT00698581|40325633|FG000|Overall Study|AE, non-serious non-fatal|4|||
16312273|NCT01895777|39627427|FG000|Overall Study|Not treated|1|||
16312274|NCT01895777|39627428|FG001|Overall Study|Not treated|0|||
16312275|NCT01895777|39627427|FG000|Overall Study|Other reasons|3|||
16312276|NCT01895777|39627428|FG001|Overall Study|Other reasons|2|||
16312277|NCT01895777|39627427|FG000|Overall Study|Non-compliance with the CTP|2|||
16312278|NCT01895777|39627428|FG001|Overall Study|Non-compliance with the CTP|1|||
16312279|NCT03597295|39627441|FG000|Overall Study|Death|70|||
16312280|NCT03597295|39627441|FG000|Overall Study|Lost to Follow-up|7|||
16312281|NCT03335475|39627442|FG000|Overall Study|Did not wear accelerometer|4|||
16390790|NCT03276728|39915975|FG001|Overall Study|Decision by sponsor|0|||
16505909|NCT00698581|40325634|FG001|Overall Study|AE, non-serious non-fatal|0|||
16312282|NCT03335475|39627443|FG001|Overall Study|Did not wear accelerometer|0|||
16312283|NCT03335475|39627442|FG000|Overall Study|Withdrawal by Subject|0|||
16312284|NCT03335475|39627443|FG001|Overall Study|Withdrawal by Subject|1|||
16312285|NCT00745901|39627444|FG000|Overall Study|Adverse Event|3|||
16312286|NCT00745901|39627445|FG001|Overall Study|Adverse Event|4|||
16312287|NCT00745901|39627444|FG000|Overall Study|Protocol Violation|0|||
16312288|NCT00745901|39627445|FG001|Overall Study|Protocol Violation|1|||
16312289|NCT00745901|39627444|FG000|Overall Study|Withdrawal by Subject|1|||
16312290|NCT00745901|39627445|FG001|Overall Study|Withdrawal by Subject|0|||
16312291|NCT00745901|39627444|FG000|Overall Study|Lost to Follow-up|7|||
16312292|NCT00745901|39627445|FG001|Overall Study|Lost to Follow-up|4|||
16089849|NCT02542696|38820002|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
16196413|NCT02044159|39193531|FG000|Overall Study|Nurse declined to give study drug|1|||
16312293|NCT00745901|39627444|FG000|Overall Study|Pregnancy|2|||
16312294|NCT00745901|39627445|FG001|Overall Study|Pregnancy|4|||
16312295|NCT00745901|39627444|FG000|Overall Study|Lack of compliance|2|||
16312296|NCT00745901|39627445|FG001|Overall Study|Lack of compliance|2|||
16505910|NCT00698581|40325633|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16505911|NCT00698581|40325634|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
16505912|NCT00698581|40325633|FG000|Overall Study|AE of unknown type|1|||
16505913|NCT00698581|40325634|FG001|Overall Study|AE of unknown type|0|||
16505914|NCT00218296|40325636|FG000|Overall Study|Lost to Follow-up|9|||
16505915|NCT00218296|40325637|FG001|Overall Study|Lost to Follow-up|7|||
16505916|NCT00218296|40325636|FG000|Overall Study|Withdrawal by Subject|36|||
16505917|NCT00218296|40325637|FG001|Overall Study|Withdrawal by Subject|47|||
16505918|NCT00218296|40325636|FG000|Overall Study|Randomized but did not enter treatment|66|||
16505919|NCT00218296|40325637|FG001|Overall Study|Randomized but did not enter treatment|67|||
16505920|NCT04248933|40325638|FG000|Overall Study|Lost to Follow-up|9|||
16505921|NCT04248933|40325638|FG000|Overall Study|Withdrawal by Subject|2|||
16505922|NCT04756154|40325639|FG000|Overall Study|Did not meet treatment day baseline|30|||
16505923|NCT04756154|40325640|FG001|Overall Study|Did not meet treatment day baseline|28|||
16505924|NCT04756154|40325641|FG002|Overall Study|Did not meet treatment day baseline|7|||
16505925|NCT04756154|40325639|FG000|Overall Study|Did not return for final sample collection|1|||
16505926|NCT04756154|40325640|FG001|Overall Study|Did not return for final sample collection|1|||
16505927|NCT04756154|40325641|FG002|Overall Study|Did not return for final sample collection|0|||
16505928|NCT02442778|40325642|FG000|Overall Study|Adverse Event|2|||
16505929|NCT02442778|40325643|FG001|Overall Study|Adverse Event|6|||
16505930|NCT02442778|40325644|FG002|Overall Study|Adverse Event|6|||
16505931|NCT02442778|40325642|FG000|Overall Study|Death|0|||
16505932|NCT02442778|40325643|FG001|Overall Study|Death|2|||
16505933|NCT02442778|40325644|FG002|Overall Study|Death|0|||
16505934|NCT02442778|40325642|FG000|Overall Study|Lack of Efficacy|1|||
16505935|NCT02442778|40325643|FG001|Overall Study|Lack of Efficacy|0|||
16505936|NCT02442778|40325644|FG002|Overall Study|Lack of Efficacy|0|||
16505937|NCT02442778|40325642|FG000|Overall Study|Lost to Follow-up|1|||
16505938|NCT02442778|40325643|FG001|Overall Study|Lost to Follow-up|1|||
16505939|NCT02442778|40325644|FG002|Overall Study|Lost to Follow-up|1|||
16505940|NCT02442778|40325642|FG000|Overall Study|Non-compliance with study drug|2|||
16505941|NCT02442778|40325643|FG001|Overall Study|Non-compliance with study drug|0|||
16505942|NCT02442778|40325644|FG002|Overall Study|Non-compliance with study drug|1|||
16505943|NCT02442778|40325642|FG000|Overall Study|Physician Decision|1|||
16505944|NCT02442778|40325643|FG001|Overall Study|Physician Decision|1|||
16505945|NCT02442778|40325644|FG002|Overall Study|Physician Decision|1|||
16505946|NCT02442778|40325642|FG000|Overall Study|Protocol Deviation|3|||
16505947|NCT02442778|40325643|FG001|Overall Study|Protocol Deviation|0|||
16505948|NCT02442778|40325644|FG002|Overall Study|Protocol Deviation|1|||
16505949|NCT02442778|40325642|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
16505950|NCT02442778|40325643|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
16505951|NCT02442778|40325644|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
16505952|NCT02442778|40325642|FG000|Overall Study|Withdrawal by Subject|4|||
16505953|NCT02442778|40325643|FG001|Overall Study|Withdrawal by Subject|4|||
16505954|NCT02442778|40325644|FG002|Overall Study|Withdrawal by Subject|3|||
16505955|NCT02442778|40325642|FG000|Overall Study|Reason not specified|1|||
16312297|NCT00745901|39627444|FG000|Overall Study|Patient's next menses did not start with|1|||
16505956|NCT02442778|40325643|FG001|Overall Study|Reason not specified|4|||
16505957|NCT02442778|40325644|FG002|Overall Study|Reason not specified|0|||
16505958|NCT02410954|40325646|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
16505959|NCT02410954|40325647|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
16505960|NCT02410954|40325646|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
16505961|NCT02410954|40325647|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
16505962|NCT03144674|40325649|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
16505963|NCT03144674|40325650|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
16505964|NCT03144674|40325651|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
16312298|NCT00745901|39627445|FG001|Overall Study|Patient's next menses did not start with|0|||
16196414|NCT02044159|39193532|FG001|Overall Study|Nurse declined to give study drug|0|||
16196415|NCT02815293|39193533|FG000|Overall Study|Study termination by sponsor|10|||
16196416|NCT02815293|39193534|FG001|Overall Study|Study termination by sponsor|7|||
16196417|NCT02815293|39193535|FG002|Overall Study|Study termination by sponsor|0|||
16196418|NCT02815293|39193533|FG000|Overall Study|Participants not randomized|0|||
16196419|NCT02815293|39193534|FG001|Overall Study|Participants not randomized|0|||
16196420|NCT02815293|39193535|FG002|Overall Study|Participants not randomized|18|||
16196421|NCT02815293|39193533|FG000|Overall Study|Adverse Event|0|||
16196422|NCT02815293|39193534|FG001|Overall Study|Adverse Event|1|||
16196423|NCT02815293|39193535|FG002|Overall Study|Adverse Event|0|||
16196424|NCT00948818|39193538|FG000|Overall Study|Adverse Event|10|||
16196425|NCT00948818|39193539|FG001|Overall Study|Adverse Event|32|||
16196426|NCT00948818|39193538|FG000|Overall Study|Protocol Violation|9|||
16196427|NCT00948818|39193539|FG001|Overall Study|Protocol Violation|10|||
16196428|NCT00948818|39193538|FG000|Overall Study|Withdrawal by Subject|25|||
16196429|NCT00948818|39193539|FG001|Overall Study|Withdrawal by Subject|25|||
16196430|NCT00948818|39193538|FG000|Overall Study|Lost to Follow-up|10|||
16196431|NCT00948818|39193539|FG001|Overall Study|Lost to Follow-up|17|||
16196432|NCT00948818|39193538|FG000|Overall Study|Lack of Efficacy|4|||
16196433|NCT00948818|39193539|FG001|Overall Study|Lack of Efficacy|5|||
16196434|NCT00948818|39193538|FG000|Overall Study|Other Reason|4|||
16196435|NCT00948818|39193539|FG001|Overall Study|Other Reason|5|||
16196436|NCT01163253|39193540|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
16196437|NCT01163253|39193541|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
16196438|NCT01163253|39193540|FG000|Overall Study|Study Terminated by Sponsor|978|||
16196439|NCT01163253|39193541|FG001|Overall Study|Study Terminated by Sponsor|349|||
16196440|NCT01163253|39193540|FG000|Overall Study|Protocol Violation|43|||
16196441|NCT01163253|39193541|FG001|Overall Study|Protocol Violation|12|||
16196442|NCT01163253|39193540|FG000|Overall Study|Withdrawal by Subject|199|||
16196443|NCT01163253|39193541|FG001|Overall Study|Withdrawal by Subject|50|||
16312299|NCT00745901|39627444|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
16312300|NCT00745901|39627445|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
16312301|NCT00745901|39627444|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
16312302|NCT00745901|39627445|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
16312303|NCT00745901|39627444|FG000|Overall Study|Patient didn't take any study medication|7|||
16312304|NCT00745901|39627445|FG001|Overall Study|Patient didn't take any study medication|3|||
16312305|NCT03288714|39627446|FG000|Overall Study|Lost to Follow-up|2|||
16312306|NCT03288714|39627447|FG001|Overall Study|Lost to Follow-up|1|||
16312307|NCT03288714|39627446|FG000|Overall Study|Non-compliance with study schedule|2|||
16312308|NCT03288714|39627447|FG001|Overall Study|Non-compliance with study schedule|0|||
16312309|NCT03288714|39627446|FG000|Overall Study|Withdrawal by Subject|3|||
16312310|NCT03288714|39627447|FG001|Overall Study|Withdrawal by Subject|1|||
16312311|NCT03288714|39627446|FG000|Overall Study|Clinical Worsening|2|||
16312312|NCT03288714|39627447|FG001|Overall Study|Clinical Worsening|1|||
16312313|NCT03288714|39627446|FG000|Overall Study|Adverse Event|1|||
16312314|NCT03288714|39627447|FG001|Overall Study|Adverse Event|0|||
16312315|NCT00287586|39627448|FG000|Overall Study|Withdrew Consent|19|||
16312316|NCT00287586|39627449|FG001|Overall Study|Withdrew Consent|30|||
16312317|NCT00287586|39627448|FG000|Overall Study|Lost to Follow-up|5|||
16312318|NCT00287586|39627449|FG001|Overall Study|Lost to Follow-up|4|||
16312319|NCT00287586|39627448|FG000|Overall Study|Death|2|||
16312320|NCT00287586|39627449|FG001|Overall Study|Death|3|||
16312321|NCT00287586|39627448|FG000|Overall Study|Elevated Hematocrit|3|||
16312322|NCT00287586|39627449|FG001|Overall Study|Elevated Hematocrit|0|||
16312323|NCT00287586|39627448|FG000|Overall Study|Rash|3|||
16312324|NCT00287586|39627449|FG001|Overall Study|Rash|0|||
16312325|NCT00287586|39627448|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
16312326|NCT00287586|39627449|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
16312327|NCT00287586|39627448|FG000|Overall Study|Stroke|2|||
16312328|NCT00287586|39627449|FG001|Overall Study|Stroke|0|||
16312329|NCT00287586|39627448|FG000|Overall Study|Myocardial Infarction|1|||
16390791|NCT03276728|39915976|FG002|Overall Study|Decision by sponsor|0|||
16312330|NCT00287586|39627449|FG001|Overall Study|Myocardial Infarction|0|||
16312331|NCT00287586|39627448|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
16390792|NCT03276728|39915977|FG003|Overall Study|Decision by sponsor|0|||
16390793|NCT03276728|39915978|FG004|Overall Study|Decision by sponsor|1|||
16390794|NCT03276728|39915979|FG005|Overall Study|Decision by sponsor|0|||
16196444|NCT01163253|39193540|FG000|Overall Study|Medication Error|1|||
16196445|NCT01163253|39193541|FG001|Overall Study|Medication Error|0|||
16196446|NCT01163253|39193540|FG000|Overall Study|Lost to Follow-up|125|||
16196447|NCT01163253|39193541|FG001|Overall Study|Lost to Follow-up|23|||
16196448|NCT01163253|39193540|FG000|Overall Study|Insufficient Clinical Response|423|||
16196449|NCT01163253|39193541|FG001|Overall Study|Insufficient Clinical Response|29|||
16089850|NCT02542696|38820002|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
16089851|NCT02542696|38820002|FG000|Overall Study|SPONSOR DECISION|3|||
16089852|NCT02542696|38820002|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
16089853|NCT02542696|38820002|FG000|Overall Study|SUBJECT DECISION|2|||
16089854|NCT03002194|38820009|FG000|Overall Study|Lost to Follow-up|6|||
16089855|NCT03002194|38820009|FG000|Overall Study|Adverse Event|1|||
16089856|NCT03002194|38820009|FG000|Overall Study|Lack of Efficacy|1|||
16089857|NCT03002194|38820009|FG000|Overall Study|Withdrawal by Subject|2|||
16089858|NCT01947491|38820010|FG000|Overall Study|Lost to Follow-up|5|||
16089859|NCT01947491|38820011|FG001|Overall Study|Lost to Follow-up|3|||
16312332|NCT00287586|39627449|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
16312333|NCT00287586|39627448|FG000|Overall Study|Cognitive Impairment|1|||
16312334|NCT00287586|39627449|FG001|Overall Study|Cognitive Impairment|0|||
16312335|NCT00287586|39627448|FG000|Overall Study|Pancreatic Cancer|1|||
16312336|NCT00287586|39627449|FG001|Overall Study|Pancreatic Cancer|3|||
16312337|NCT00287586|39627448|FG000|Overall Study|Sleep Apnea|1|||
16312338|NCT00287586|39627449|FG001|Overall Study|Sleep Apnea|0|||
16312339|NCT00287586|39627448|FG000|Overall Study|Shoulder Pain|1|||
16312340|NCT00287586|39627449|FG001|Overall Study|Shoulder Pain|0|||
16312341|NCT00287586|39627448|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
16312342|NCT00287586|39627449|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
16312343|NCT00287586|39627448|FG000|Overall Study|Nonadherence|1|||
16312344|NCT00287586|39627449|FG001|Overall Study|Nonadherence|1|||
16312345|NCT00287586|39627448|FG000|Overall Study|Enrolled in Another Study|1|||
16312346|NCT00287586|39627449|FG001|Overall Study|Enrolled in Another Study|0|||
16505965|NCT03144674|40325652|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
16505966|NCT03144674|40325649|FG000|Overall Study|Death|3|||
16505967|NCT03144674|40325650|FG001|Overall Study|Death|1|||
16089860|NCT01947491|38820012|FG002|Overall Study|Lost to Follow-up|1|||
16089861|NCT01947491|38820013|FG003|Overall Study|Lost to Follow-up|2|||
16089862|NCT01947491|38820010|FG000|Overall Study|Lack of Efficacy|1|||
16089863|NCT01947491|38820011|FG001|Overall Study|Lack of Efficacy|0|||
16089864|NCT01947491|38820012|FG002|Overall Study|Lack of Efficacy|0|||
16089865|NCT01947491|38820013|FG003|Overall Study|Lack of Efficacy|1|||
16089866|NCT01947491|38820010|FG000|Overall Study|Protocol Violation|1|||
16089867|NCT01947491|38820011|FG001|Overall Study|Protocol Violation|0|||
16089868|NCT01947491|38820012|FG002|Overall Study|Protocol Violation|0|||
16089869|NCT01947491|38820013|FG003|Overall Study|Protocol Violation|0|||
16089870|NCT01947491|38820010|FG000|Overall Study|Withdrawal by Subject|1|||
16089871|NCT01947491|38820011|FG001|Overall Study|Withdrawal by Subject|1|||
16089872|NCT01947491|38820012|FG002|Overall Study|Withdrawal by Subject|1|||
16089873|NCT01947491|38820013|FG003|Overall Study|Withdrawal by Subject|0|||
16089874|NCT01947491|38820010|FG000|Overall Study|Worsening of condition|0|||
16089875|NCT01947491|38820011|FG001|Overall Study|Worsening of condition|1|||
16089876|NCT01947491|38820012|FG002|Overall Study|Worsening of condition|0|||
16089877|NCT01947491|38820013|FG003|Overall Study|Worsening of condition|0|||
16089878|NCT01947491|38820010|FG000|Overall Study|Adverse Event|0|||
16089879|NCT01947491|38820011|FG001|Overall Study|Adverse Event|1|||
16089880|NCT01947491|38820012|FG002|Overall Study|Adverse Event|0|||
16505968|NCT03144674|40325651|FG002|Overall Study|Death|1|||
16505969|NCT03144674|40325652|FG003|Overall Study|Death|10|||
16505970|NCT03144674|40325649|FG000|Overall Study|Lost to Follow-up|0|||
16089881|NCT01947491|38820013|FG003|Overall Study|Adverse Event|2|||
16089882|NCT01777932|38820016|FG000|Overall Study|Disease progression|136|||
16089883|NCT01777932|38820016|FG000|Overall Study|Death|3|||
16089884|NCT01777932|38820016|FG000|Overall Study|Adverse Event|34|||
16089885|NCT01777932|38820016|FG000|Overall Study|Lost to Follow-up|3|||
16089886|NCT01777932|38820016|FG000|Overall Study|Investigator decision|10|||
16089887|NCT01777932|38820016|FG000|Overall Study|Reimbursement limit|9|||
16089888|NCT01777932|38820016|FG000|Overall Study|Patient refused further treatment|10|||
16089889|NCT01852045|38820017|FG000|Overall Study|Adverse Event|1|||
16089890|NCT01852045|38820018|FG001|Overall Study|Adverse Event|0|||
16089891|NCT01852045|38820019|FG002|Overall Study|Adverse Event|0|||
16089892|NCT01852045|38820017|FG000|Overall Study|Lack of Efficacy|3|||
16089893|NCT01852045|38820018|FG001|Overall Study|Lack of Efficacy|0|||
16089894|NCT01852045|38820019|FG002|Overall Study|Lack of Efficacy|0|||
16312347|NCT00287586|39627448|FG000|Overall Study|Major Depression|0|||
16390795|NCT03276728|39915980|FG006|Overall Study|Decision by sponsor|2|||
16089895|NCT01852045|38820017|FG000|Overall Study|Lost to Follow-up|0|||
16089896|NCT01852045|38820018|FG001|Overall Study|Lost to Follow-up|1|||
16089897|NCT01852045|38820019|FG002|Overall Study|Lost to Follow-up|1|||
16089898|NCT01852045|38820017|FG000|Overall Study|Withdrawal by Subject|1|||
16312348|NCT00287586|39627449|FG001|Overall Study|Major Depression|2|||
16312349|NCT00287586|39627448|FG000|Overall Study|Lung Cancer|0|||
16505971|NCT03144674|40325650|FG001|Overall Study|Lost to Follow-up|1|||
16505972|NCT03144674|40325651|FG002|Overall Study|Lost to Follow-up|1|||
16505973|NCT03144674|40325652|FG003|Overall Study|Lost to Follow-up|1|||
16505974|NCT03144674|40325649|FG000|Overall Study|Withdrawal by Participant|0|||
16089899|NCT01852045|38820018|FG001|Overall Study|Withdrawal by Subject|0|||
16089900|NCT01852045|38820019|FG002|Overall Study|Withdrawal by Subject|1|||
16089901|NCT01852045|38820017|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16089902|NCT01852045|38820018|FG001|Overall Study|Other Miscellaneous Reasons|3|||
16089903|NCT01852045|38820019|FG002|Overall Study|Other Miscellaneous Reasons|2|||
16089904|NCT02102724|38820020|FG000|Overall Study|Lost to Follow-up|1|||
16089905|NCT02102724|38820021|FG001|Overall Study|Lost to Follow-up|0|||
16089906|NCT02102724|38820020|FG000|Overall Study|surgery for brain aneurysm|1|||
16089907|NCT02102724|38820021|FG001|Overall Study|surgery for brain aneurysm|1|||
16089908|NCT00088166|38820022|FG000|Overall Study|Adverse Event|11|||
16089909|NCT00088166|38820023|FG001|Overall Study|Adverse Event|9|||
16089910|NCT00088166|38820022|FG000|Overall Study|Death|3|||
16089911|NCT00088166|38820023|FG001|Overall Study|Death|1|||
16089912|NCT00088166|38820022|FG000|Overall Study|Lost to Follow-up|0|||
16089913|NCT00088166|38820023|FG001|Overall Study|Lost to Follow-up|1|||
16089914|NCT00088166|38820022|FG000|Overall Study|Physician Decision|4|||
16089915|NCT00088166|38820023|FG001|Overall Study|Physician Decision|1|||
16089916|NCT00088166|38820022|FG000|Overall Study|Protocol Violation|1|||
16089917|NCT00088166|38820023|FG001|Overall Study|Protocol Violation|5|||
16089918|NCT00088166|38820022|FG000|Overall Study|Patient deterioration|29|||
16089919|NCT00088166|38820023|FG001|Overall Study|Patient deterioration|39|||
16089920|NCT00088166|38820022|FG000|Overall Study|Withdrawal by Subject|5|||
16089921|NCT00088166|38820023|FG001|Overall Study|Withdrawal by Subject|5|||
16089922|NCT00614614|38820026|FG000|Primary Vaccination Phase|Adverse Event|6|||
16089923|NCT00614614|38820027|FG001|Primary Vaccination Phase|Adverse Event|0|||
16089924|NCT00614614|38820028|FG002|Primary Vaccination Phase|Adverse Event|0|||
16089925|NCT00614614|38820029|FG003|Primary Vaccination Phase|Adverse Event|0|||
16089926|NCT00614614|38820030|FG004|Primary Vaccination Phase|Adverse Event|0|||
16390796|NCT03276728|39915981|FG007|Overall Study|Decision by sponsor|1|||
16390797|NCT04677543|39915982|FG000|Overall Study|Withdrawal by Subject|4|||
16390798|NCT04677543|39915983|FG001|Overall Study|Withdrawal by Subject|1|||
16390799|NCT04677543|39915982|FG000|Overall Study|Physician Decision|0|||
16390800|NCT04677543|39915983|FG001|Overall Study|Physician Decision|1|||
16390801|NCT04677543|39915982|FG000|Overall Study|Adverse Event|0|||
16390802|NCT04677543|39915983|FG001|Overall Study|Adverse Event|1|||
16390803|NCT00413660|39915988|FG000|Up To Week 12|Adverse Event|1|||
16390804|NCT00413660|39915989|FG001|Up To Week 12|Adverse Event|3|||
16390805|NCT00413660|39915990|FG002|Up To Week 12|Adverse Event|1|||
16390806|NCT00413660|39915991|FG003|Up To Week 12|Adverse Event|4|||
16390807|NCT00413660|39915992|FG004|Up To Week 12|Adverse Event|6|||
16390808|NCT00413660|39915993|FG005|Up To Week 12|Adverse Event|4|||
16390809|NCT00413660|39915994|FG006|Up To Week 12|Adverse Event|1|||
16390810|NCT00413660|39915995|FG007|Up To Week 12|Adverse Event|0|||
16390811|NCT00413660|39915996|FG008|Up To Week 12|Adverse Event|0|||
16390812|NCT00413660|39915997|FG009|Up To Week 12|Adverse Event|0|||
16390813|NCT00413660|39915998|FG010|Up To Week 12|Adverse Event|0|||
16390814|NCT00413660|39915988|FG000|Up To Week 12|Lack of Efficacy|2|||
16390815|NCT00413660|39915989|FG001|Up To Week 12|Lack of Efficacy|0|||
16390816|NCT00413660|39915990|FG002|Up To Week 12|Lack of Efficacy|0|||
16089927|NCT00614614|38820026|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
16089928|NCT00614614|38820027|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
16089929|NCT00614614|38820028|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
16390817|NCT00413660|39915991|FG003|Up To Week 12|Lack of Efficacy|0|||
16390818|NCT00413660|39915992|FG004|Up To Week 12|Lack of Efficacy|0|||
16390819|NCT00413660|39915993|FG005|Up To Week 12|Lack of Efficacy|0|||
16390820|NCT00413660|39915994|FG006|Up To Week 12|Lack of Efficacy|5|||
16390821|NCT00413660|39915995|FG007|Up To Week 12|Lack of Efficacy|0|||
16390822|NCT00413660|39915996|FG008|Up To Week 12|Lack of Efficacy|0|||
16390823|NCT00413660|39915997|FG009|Up To Week 12|Lack of Efficacy|0|||
16390824|NCT00413660|39915998|FG010|Up To Week 12|Lack of Efficacy|0|||
16390825|NCT00413660|39915988|FG000|Up To Week 12|Lost to Follow-up|0|||
16390826|NCT00413660|39915989|FG001|Up To Week 12|Lost to Follow-up|1|||
16390827|NCT00413660|39915990|FG002|Up To Week 12|Lost to Follow-up|0|||
16390828|NCT00413660|39915991|FG003|Up To Week 12|Lost to Follow-up|0|||
16390829|NCT00413660|39915992|FG004|Up To Week 12|Lost to Follow-up|1|||
16390830|NCT00413660|39915993|FG005|Up To Week 12|Lost to Follow-up|0|||
16390831|NCT00413660|39915994|FG006|Up To Week 12|Lost to Follow-up|0|||
16390832|NCT00413660|39915995|FG007|Up To Week 12|Lost to Follow-up|0|||
16390833|NCT00413660|39915996|FG008|Up To Week 12|Lost to Follow-up|0|||
16390834|NCT00413660|39915997|FG009|Up To Week 12|Lost to Follow-up|0|||
16390835|NCT00413660|39915998|FG010|Up To Week 12|Lost to Follow-up|0|||
16505975|NCT03144674|40325650|FG001|Overall Study|Withdrawal by Participant|0|||
16505976|NCT03144674|40325651|FG002|Overall Study|Withdrawal by Participant|0|||
16505977|NCT03144674|40325652|FG003|Overall Study|Withdrawal by Participant|3|||
16505978|NCT03144674|40325649|FG000|Overall Study|Reason not Specified|0|||
16505979|NCT03144674|40325650|FG001|Overall Study|Reason not Specified|0|||
16505980|NCT03144674|40325651|FG002|Overall Study|Reason not Specified|2|||
16390836|NCT00413660|39915988|FG000|Up To Week 12|Withdrawal by Subject|0|||
16390837|NCT00413660|39915989|FG001|Up To Week 12|Withdrawal by Subject|2|||
16390838|NCT00413660|39915990|FG002|Up To Week 12|Withdrawal by Subject|0|||
16390839|NCT00413660|39915991|FG003|Up To Week 12|Withdrawal by Subject|2|||
16390840|NCT00413660|39915992|FG004|Up To Week 12|Withdrawal by Subject|0|||
16312350|NCT00287586|39627449|FG001|Overall Study|Lung Cancer|2|||
16312351|NCT00287586|39627448|FG000|Overall Study|Elevated IPSS Score|0|||
16312352|NCT00287586|39627449|FG001|Overall Study|Elevated IPSS Score|1|||
16312353|NCT00287586|39627448|FG000|Overall Study|Retroperitoneal Cancer|0|||
16312354|NCT00287586|39627449|FG001|Overall Study|Retroperitoneal Cancer|1|||
16312355|NCT00287586|39627448|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
16312356|NCT00287586|39627449|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
16312357|NCT00287586|39627448|FG000|Overall Study|Mood Swings and Irritability|0|||
16312358|NCT00287586|39627449|FG001|Overall Study|Mood Swings and Irritability|1|||
16312359|NCT00287586|39627448|FG000|Overall Study|Bradycardia|0|||
16312360|NCT00287586|39627449|FG001|Overall Study|Bradycardia|1|||
16312361|NCT00287586|39627448|FG000|Overall Study|Itchy Swollen Eyes|0|||
16312362|NCT00287586|39627449|FG001|Overall Study|Itchy Swollen Eyes|1|||
16505981|NCT03144674|40325652|FG003|Overall Study|Reason not Specified|4|||
16505982|NCT00798369|40325655|FG000|Overall Study|Subject withdrew consent|0|||
16505983|NCT00798369|40325656|FG001|Overall Study|Subject withdrew consent|0|||
16390841|NCT00413660|39915993|FG005|Up To Week 12|Withdrawal by Subject|2|||
16390842|NCT00413660|39915994|FG006|Up To Week 12|Withdrawal by Subject|2|||
16312363|NCT00287586|39627448|FG000|Overall Study|Recurrent Melanoma|0|||
16312364|NCT00287586|39627449|FG001|Overall Study|Recurrent Melanoma|1|||
16390843|NCT00413660|39915995|FG007|Up To Week 12|Withdrawal by Subject|0|||
16390844|NCT00413660|39915996|FG008|Up To Week 12|Withdrawal by Subject|0|||
16390845|NCT00413660|39915997|FG009|Up To Week 12|Withdrawal by Subject|0|||
16390846|NCT00413660|39915998|FG010|Up To Week 12|Withdrawal by Subject|0|||
16390847|NCT00413660|39915988|FG000|Up To Week 12|Randomized, Not Treated|1|||
16390848|NCT00413660|39915989|FG001|Up To Week 12|Randomized, Not Treated|0|||
16390849|NCT00413660|39915990|FG002|Up To Week 12|Randomized, Not Treated|0|||
16390850|NCT00413660|39915991|FG003|Up To Week 12|Randomized, Not Treated|1|||
16390851|NCT00413660|39915992|FG004|Up To Week 12|Randomized, Not Treated|0|||
16390852|NCT00413660|39915993|FG005|Up To Week 12|Randomized, Not Treated|0|||
16390853|NCT00413660|39915994|FG006|Up To Week 12|Randomized, Not Treated|0|||
16390854|NCT00413660|39915995|FG007|Up To Week 12|Randomized, Not Treated|0|||
16390855|NCT00413660|39915996|FG008|Up To Week 12|Randomized, Not Treated|0|||
16390856|NCT00413660|39915997|FG009|Up To Week 12|Randomized, Not Treated|0|||
16312365|NCT03591874|39627456|FG000|Overall Study|Adverse Event|4|||
16312366|NCT03591874|39627457|FG001|Overall Study|Adverse Event|0|||
16312367|NCT03591874|39627456|FG000|Overall Study|Withdrawal by Subject|2|||
16312368|NCT03591874|39627457|FG001|Overall Study|Withdrawal by Subject|1|||
16312369|NCT03591874|39627456|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
16312370|NCT03591874|39627457|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
16312371|NCT03591874|39627456|FG000|Overall Study|On Study at Time of Study Termination|12|||
16312372|NCT03591874|39627457|FG001|Overall Study|On Study at Time of Study Termination|6|||
16312373|NCT00468819|39627458|FG000|Overall Study|Withdrawal by Subject|4|||
16312374|NCT00468819|39627459|FG001|Overall Study|Withdrawal by Subject|0|||
16312375|NCT00468819|39627460|FG002|Overall Study|Withdrawal by Subject|1|||
16312376|NCT00468819|39627458|FG000|Overall Study|Lost to Follow-up|0|||
16312377|NCT00468819|39627459|FG001|Overall Study|Lost to Follow-up|0|||
16312378|NCT00468819|39627460|FG002|Overall Study|Lost to Follow-up|1|||
16312379|NCT00468819|39627458|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
16312380|NCT00468819|39627459|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
16312381|NCT00468819|39627460|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
16312382|NCT00071110|39627461|FG000|Overall Study|Protocol Violation|0|||
16312383|NCT00071110|39627462|FG001|Overall Study|Protocol Violation|4|||
16312384|NCT02404805|39627463|FG000|Overall Study|Withdrawal by Subject|1|||
16312385|NCT02404805|39627464|FG001|Overall Study|Withdrawal by Subject|0|||
16312386|NCT02404805|39627465|FG002|Overall Study|Withdrawal by Subject|0|||
16312387|NCT02404805|39627466|FG003|Overall Study|Withdrawal by Subject|0|||
16312388|NCT02404805|39627467|FG004|Overall Study|Withdrawal by Subject|0|||
16312389|NCT02404805|39627468|FG005|Overall Study|Withdrawal by Subject|0|||
16312390|NCT00369941|39627469|FG000|Overall Study|Never Treated|1|||
16312391|NCT00369941|39627470|FG001|Overall Study|Never Treated|2|||
16312392|NCT00369941|39627469|FG000|Overall Study|Adverse Event|14|||
16312393|NCT00369941|39627470|FG001|Overall Study|Adverse Event|28|||
16312394|NCT00369941|39627469|FG000|Overall Study|Lack of Efficacy|6|||
16312395|NCT00369941|39627470|FG001|Overall Study|Lack of Efficacy|10|||
16312396|NCT00369941|39627469|FG000|Overall Study|Lost to Follow-up|12|||
16312397|NCT00369941|39627470|FG001|Overall Study|Lost to Follow-up|22|||
16312398|NCT00369941|39627469|FG000|Overall Study|Protocol Violation|5|||
16312399|NCT00369941|39627470|FG001|Overall Study|Protocol Violation|3|||
16312400|NCT00369941|39627469|FG000|Overall Study|Withdrawal by Subject|5|||
16312401|NCT00369941|39627470|FG001|Overall Study|Withdrawal by Subject|18|||
16312402|NCT00369941|39627469|FG000|Overall Study|Pregnancy|4|||
16312403|NCT00369941|39627470|FG001|Overall Study|Pregnancy|2|||
16312404|NCT00369941|39627469|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
16312405|NCT00369941|39627470|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
16312406|NCT00369941|39627469|FG000|Overall Study|Moved|11|||
16312407|NCT00369941|39627470|FG001|Overall Study|Moved|5|||
16390857|NCT00413660|39915998|FG010|Up To Week 12|Randomized, Not Treated|0|||
16390858|NCT00413660|39915988|FG000|Up To Week 12|Other|3|||
16312408|NCT00369941|39627469|FG000|Overall Study|Treatment with Prohibited Medication|3|||
16390859|NCT00413660|39915989|FG001|Up To Week 12|Other|1|||
16196450|NCT01163253|39193540|FG000|Overall Study|Adverse Event|300|||
16312409|NCT00369941|39627470|FG001|Overall Study|Treatment with Prohibited Medication|1|||
16312410|NCT00369941|39627469|FG000|Overall Study|Employment Interfered with Study Visits|1|||
16312411|NCT00369941|39627470|FG001|Overall Study|Employment Interfered with Study Visits|0|||
16312412|NCT00369941|39627469|FG000|Overall Study|Study Site Terminated|2|||
16312413|NCT00369941|39627470|FG001|Overall Study|Study Site Terminated|0|||
16312414|NCT00369941|39627469|FG000|Overall Study|Miscellaneous|3|||
16312415|NCT00369941|39627470|FG001|Overall Study|Miscellaneous|3|||
16390860|NCT00413660|39915990|FG002|Up To Week 12|Other|6|||
16390861|NCT00413660|39915991|FG003|Up To Week 12|Other|1|||
16390862|NCT00413660|39915992|FG004|Up To Week 12|Other|2|||
16390863|NCT00413660|39915993|FG005|Up To Week 12|Other|4|||
16390864|NCT00413660|39915994|FG006|Up To Week 12|Other|3|||
16390865|NCT00413660|39915995|FG007|Up To Week 12|Other|0|||
16390866|NCT00413660|39915996|FG008|Up To Week 12|Other|0|||
16390867|NCT00413660|39915997|FG009|Up To Week 12|Other|0|||
16390868|NCT00413660|39915998|FG010|Up To Week 12|Other|0|||
16390869|NCT00413660|39915988|FG000|Post Week 12|Adverse Event|2|||
16390870|NCT00413660|39915989|FG001|Post Week 12|Adverse Event|0|||
16390871|NCT00413660|39915990|FG002|Post Week 12|Adverse Event|2|||
16390872|NCT00413660|39915991|FG003|Post Week 12|Adverse Event|1|||
16390873|NCT00413660|39915992|FG004|Post Week 12|Adverse Event|4|||
16390874|NCT00413660|39915993|FG005|Post Week 12|Adverse Event|2|||
16390875|NCT00413660|39915994|FG006|Post Week 12|Adverse Event|2|||
16390876|NCT00413660|39915995|FG007|Post Week 12|Adverse Event|0|||
16390877|NCT00413660|39915996|FG008|Post Week 12|Adverse Event|0|||
16390878|NCT00413660|39915997|FG009|Post Week 12|Adverse Event|0|||
16390879|NCT00413660|39915998|FG010|Post Week 12|Adverse Event|0|||
16390880|NCT00413660|39915988|FG000|Post Week 12|Lack of Efficacy|0|||
16390881|NCT00413660|39915989|FG001|Post Week 12|Lack of Efficacy|0|||
16390882|NCT00413660|39915990|FG002|Post Week 12|Lack of Efficacy|1|||
16390883|NCT00413660|39915991|FG003|Post Week 12|Lack of Efficacy|0|||
16390884|NCT00413660|39915992|FG004|Post Week 12|Lack of Efficacy|0|||
16390885|NCT00413660|39915993|FG005|Post Week 12|Lack of Efficacy|0|||
16390886|NCT00413660|39915994|FG006|Post Week 12|Lack of Efficacy|0|||
16390887|NCT00413660|39915995|FG007|Post Week 12|Lack of Efficacy|0|||
16390888|NCT00413660|39915996|FG008|Post Week 12|Lack of Efficacy|0|||
16390889|NCT00413660|39915997|FG009|Post Week 12|Lack of Efficacy|1|||
16390890|NCT00413660|39915998|FG010|Post Week 12|Lack of Efficacy|0|||
16390891|NCT00413660|39915988|FG000|Post Week 12|Lost to Follow-up|0|||
16390892|NCT00413660|39915989|FG001|Post Week 12|Lost to Follow-up|1|||
16390893|NCT00413660|39915990|FG002|Post Week 12|Lost to Follow-up|1|||
16390894|NCT00413660|39915991|FG003|Post Week 12|Lost to Follow-up|0|||
16390895|NCT00413660|39915992|FG004|Post Week 12|Lost to Follow-up|0|||
16390896|NCT00413660|39915993|FG005|Post Week 12|Lost to Follow-up|0|||
16390897|NCT00413660|39915994|FG006|Post Week 12|Lost to Follow-up|0|||
16390898|NCT00413660|39915995|FG007|Post Week 12|Lost to Follow-up|0|||
16390899|NCT00413660|39915996|FG008|Post Week 12|Lost to Follow-up|0|||
16390900|NCT00413660|39915997|FG009|Post Week 12|Lost to Follow-up|0|||
16390901|NCT00413660|39915998|FG010|Post Week 12|Lost to Follow-up|0|||
16390902|NCT00413660|39915988|FG000|Post Week 12|Withdrawal by Subject|0|||
16390903|NCT00413660|39915989|FG001|Post Week 12|Withdrawal by Subject|1|||
16390904|NCT00413660|39915990|FG002|Post Week 12|Withdrawal by Subject|1|||
16390905|NCT00413660|39915991|FG003|Post Week 12|Withdrawal by Subject|0|||
16390906|NCT00413660|39915992|FG004|Post Week 12|Withdrawal by Subject|1|||
16390907|NCT00413660|39915993|FG005|Post Week 12|Withdrawal by Subject|0|||
16390908|NCT00413660|39915994|FG006|Post Week 12|Withdrawal by Subject|0|||
16390909|NCT00413660|39915995|FG007|Post Week 12|Withdrawal by Subject|0|||
16390910|NCT00413660|39915996|FG008|Post Week 12|Withdrawal by Subject|0|||
16390911|NCT00413660|39915997|FG009|Post Week 12|Withdrawal by Subject|0|||
16390912|NCT00413660|39915998|FG010|Post Week 12|Withdrawal by Subject|1|||
16390913|NCT00413660|39915988|FG000|Post Week 12|Other|1|||
16390914|NCT00413660|39915989|FG001|Post Week 12|Other|2|||
16390915|NCT00413660|39915990|FG002|Post Week 12|Other|3|||
16390916|NCT00413660|39915991|FG003|Post Week 12|Other|0|||
16390917|NCT00413660|39915992|FG004|Post Week 12|Other|1|||
16390918|NCT00413660|39915993|FG005|Post Week 12|Other|1|||
16390919|NCT00413660|39915994|FG006|Post Week 12|Other|1|||
16390920|NCT00413660|39915995|FG007|Post Week 12|Other|0|||
16390921|NCT00413660|39915996|FG008|Post Week 12|Other|0|||
16390922|NCT00413660|39915997|FG009|Post Week 12|Other|0|||
16390923|NCT00413660|39915998|FG010|Post Week 12|Other|0|||
16390924|NCT05525910|39915999|FG000|Period 4|Per sponsor due to study timelines|0|||
16390925|NCT05525910|39916000|FG001|Period 4|Per sponsor due to study timelines|0|||
16390926|NCT05525910|39916001|FG002|Period 4|Per sponsor due to study timelines|1|||
16196451|NCT01163253|39193541|FG001|Overall Study|Adverse Event|78|||
16390927|NCT05525910|39916002|FG003|Period 4|Per sponsor due to study timelines|1|||
16390928|NCT05525910|39916003|FG004|Period 4|Per sponsor due to study timelines|1|||
16390929|NCT00984594|39916004|FG000|Overall Study|Lost to Follow-up|1|||
16390930|NCT00984594|39916005|FG001|Overall Study|Lost to Follow-up|0|||
16390931|NCT00984594|39916004|FG000|Overall Study|Withdrawal by Subject|0|||
16390932|NCT00984594|39916005|FG001|Overall Study|Withdrawal by Subject|1|||
16390933|NCT00003645|39916006|FG000|Overall Study|Death|4|||
16390934|NCT00003645|39916007|FG001|Overall Study|Death|1|||
16390935|NCT00003645|39916006|FG000|Overall Study|Lost to Follow-up|7|||
16390936|NCT00003645|39916007|FG001|Overall Study|Lost to Follow-up|8|||
16390937|NCT00003645|39916006|FG000|Overall Study|Withdrawal by Subject|1|||
16390938|NCT00003645|39916007|FG001|Overall Study|Withdrawal by Subject|3|||
16390939|NCT03599518|39916016|FG000|Overall Study|Clinical progression|0|||
16546337|NCT01986881|40464785|FG002|Overall Study|Physician Decision|6|||
16312416|NCT02633293|39627471|FG000|Overall Study|Death|56|||
16312417|NCT02633293|39627471|FG000|Overall Study|Progressive Disease|12|||
16312418|NCT02633293|39627471|FG000|Overall Study|Adverse Event|29|||
16312419|NCT02633293|39627471|FG000|Overall Study|Withdrawal by Subject|41|||
16312420|NCT02633293|39627471|FG000|Overall Study|Protocol Violation|1|||
16312421|NCT02633293|39627471|FG000|Overall Study|Lost to Follow-up|1|||
16312422|NCT02633293|39627471|FG000|Overall Study|Study Terminated by Sponsor|24|||
16312423|NCT02633293|39627471|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
16312424|NCT02633293|39627471|FG000|Overall Study|Lung Transplant|5|||
16312425|NCT02633293|39627471|FG000|Overall Study|Lack of Efficacy|2|||
16312426|NCT02633293|39627471|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
16312427|NCT02105987|39627473|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
16505984|NCT00798369|40325657|FG002|Overall Study|Subject withdrew consent|1|||
16312428|NCT02105987|39627474|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
16312429|NCT02105987|39627475|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
16312430|NCT02105987|39627476|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
16312431|NCT02105987|39627477|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
16312432|NCT02105987|39627478|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
16312433|NCT02105987|39627473|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
16312434|NCT02105987|39627474|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
16312435|NCT02105987|39627475|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
16312436|NCT02105987|39627476|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
16312437|NCT02105987|39627477|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
16312438|NCT02105987|39627478|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
16312439|NCT02105987|39627473|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
16312440|NCT02105987|39627474|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
16312441|NCT02105987|39627475|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16312442|NCT02105987|39627476|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16312443|NCT02105987|39627477|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16312444|NCT02105987|39627478|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16312445|NCT02105987|39627473|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
16312446|NCT02105987|39627474|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
16312447|NCT02105987|39627475|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16312448|NCT02105987|39627476|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16312449|NCT02105987|39627477|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16312450|NCT02105987|39627478|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16312451|NCT02105987|39627473|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
16312452|NCT02105987|39627474|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
16312453|NCT02105987|39627475|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
16312454|NCT02105987|39627476|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
16312455|NCT02105987|39627477|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
16312456|NCT02105987|39627478|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
16312457|NCT02105987|39627473|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
16312458|NCT02105987|39627474|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
16312459|NCT02105987|39627475|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
16312460|NCT02105987|39627476|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
16312461|NCT02105987|39627477|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
16312462|NCT02105987|39627478|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
16312463|NCT02105987|39627473|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
16312464|NCT02105987|39627474|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
16312465|NCT02105987|39627475|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
16312466|NCT02105987|39627476|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
16312467|NCT02105987|39627477|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
16312468|NCT02105987|39627478|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
16312469|NCT02105987|39627473|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
16312470|NCT02105987|39627474|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
16312471|NCT02105987|39627475|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
16312472|NCT02105987|39627476|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
16312473|NCT02105987|39627477|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
16312474|NCT02105987|39627478|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
16312475|NCT02105987|39627473|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16312476|NCT02105987|39627474|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16312477|NCT02105987|39627475|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
16312478|NCT02105987|39627476|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
16312479|NCT02105987|39627477|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16312480|NCT02105987|39627478|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
16312481|NCT02105987|39627473|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16312482|NCT02105987|39627474|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16505985|NCT00798369|40325658|FG003|Overall Study|Subject withdrew consent|1|||
16196452|NCT01163253|39193540|FG000|Overall Study|Death|17|||
16312483|NCT02105987|39627475|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
16312484|NCT02105987|39627476|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
16312485|NCT02105987|39627477|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16312486|NCT02105987|39627478|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
16312487|NCT02105987|39627473|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
16312488|NCT02105987|39627474|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
16312489|NCT02105987|39627475|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
16312490|NCT02105987|39627476|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
16312491|NCT02105987|39627477|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
16312492|NCT02105987|39627478|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
16312493|NCT02105987|39627473|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
16390940|NCT03599518|39916017|FG001|Overall Study|Clinical progression|0|||
16390941|NCT03599518|39916018|FG002|Overall Study|Clinical progression|0|||
16390942|NCT03599518|39916019|FG003|Overall Study|Clinical progression|0|||
16390943|NCT03599518|39916020|FG004|Overall Study|Clinical progression|1|||
16390944|NCT03599518|39916016|FG000|Overall Study|Adverse Event|0|||
16390945|NCT03599518|39916017|FG001|Overall Study|Adverse Event|0|||
16390946|NCT03599518|39916018|FG002|Overall Study|Adverse Event|0|||
16390947|NCT03599518|39916019|FG003|Overall Study|Adverse Event|0|||
16390948|NCT03599518|39916020|FG004|Overall Study|Adverse Event|1|||
16390949|NCT03599518|39916016|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
16390950|NCT03599518|39916017|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
16390951|NCT03599518|39916018|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
16390952|NCT03599518|39916019|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
16390953|NCT03599518|39916020|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
16390954|NCT03599518|39916016|FG000|Overall Study|Participant withdrawal from study treatment|0|||
16390955|NCT03599518|39916017|FG001|Overall Study|Participant withdrawal from study treatment|0|||
16390956|NCT03599518|39916018|FG002|Overall Study|Participant withdrawal from study treatment|1|||
16390957|NCT03599518|39916019|FG003|Overall Study|Participant withdrawal from study treatment|0|||
16390958|NCT03599518|39916020|FG004|Overall Study|Participant withdrawal from study treatment|0|||
16390959|NCT04011735|39916021|FG000|Overall Study|Withdrawal by Subject|1|||
16390960|NCT04011735|39916022|FG001|Overall Study|Withdrawal by Subject|0|||
16390961|NCT04011735|39916023|FG002|Overall Study|Withdrawal by Subject|1|||
16390962|NCT04011735|39916021|FG000|Overall Study|Met exclusion criteria after study entry|0|||
16390963|NCT04011735|39916022|FG001|Overall Study|Met exclusion criteria after study entry|1|||
16390964|NCT04011735|39916023|FG002|Overall Study|Met exclusion criteria after study entry|0|||
16390965|NCT01964378|39916025|FG000|Overall Study|Disc. due to death before first dosing|0|||
16390966|NCT01964378|39916026|FG001|Overall Study|Disc. due to death before first dosing|1|||
16390967|NCT01964378|39916025|FG000|Overall Study|Disc. due to AE before first dosing|1|||
16390968|NCT01964378|39916026|FG001|Overall Study|Disc. due to AE before first dosing|0|||
16390969|NCT01964378|39916025|FG000|Overall Study|Death|3|||
16390970|NCT01964378|39916026|FG001|Overall Study|Death|2|||
16390971|NCT01964378|39916025|FG000|Overall Study|Adverse Event|12|||
16390972|NCT01964378|39916026|FG001|Overall Study|Adverse Event|5|||
16390973|NCT01964378|39916025|FG000|Overall Study|Lack of Efficacy|0|||
16390974|NCT01964378|39916026|FG001|Overall Study|Lack of Efficacy|1|||
16390975|NCT01964378|39916025|FG000|Overall Study|Protocol Violation|0|||
16390976|NCT01964378|39916026|FG001|Overall Study|Protocol Violation|1|||
16390977|NCT01964378|39916025|FG000|Overall Study|Lost to Follow-up|0|||
16390978|NCT01964378|39916026|FG001|Overall Study|Lost to Follow-up|1|||
16390979|NCT01964378|39916025|FG000|Overall Study|Withdrawal by Subject|7|||
16390980|NCT01964378|39916026|FG001|Overall Study|Withdrawal by Subject|5|||
16390981|NCT01964378|39916025|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
16390982|NCT01964378|39916026|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
16390983|NCT01964378|39916025|FG000|Overall Study|Other|1|||
16390984|NCT01964378|39916026|FG001|Overall Study|Other|2|||
16390985|NCT02146131|39916030|FG000|Overall Study|Physician Decision|61|||
16505986|NCT00798369|40325659|FG004|Overall Study|Subject withdrew consent|0|||
16505987|NCT00798369|40325660|FG005|Overall Study|Subject withdrew consent|2|||
16505988|NCT00798369|40325655|FG000|Overall Study|Lost to Follow-up|1|||
16505989|NCT00798369|40325656|FG001|Overall Study|Lost to Follow-up|1|||
16505990|NCT00798369|40325657|FG002|Overall Study|Lost to Follow-up|1|||
16505991|NCT00798369|40325658|FG003|Overall Study|Lost to Follow-up|0|||
16089930|NCT00614614|38820029|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
16312494|NCT02105987|39627474|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
16312495|NCT02105987|39627475|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
16312496|NCT02105987|39627476|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
16312497|NCT02105987|39627477|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
16505992|NCT00798369|40325659|FG004|Overall Study|Lost to Follow-up|1|||
16505993|NCT00798369|40325660|FG005|Overall Study|Lost to Follow-up|0|||
16505994|NCT00798369|40325655|FG000|Overall Study|Adminstrative problems|0|||
16505995|NCT00798369|40325656|FG001|Overall Study|Adminstrative problems|0|||
16505996|NCT00798369|40325657|FG002|Overall Study|Adminstrative problems|0|||
16505997|NCT00798369|40325658|FG003|Overall Study|Adminstrative problems|0|||
16505998|NCT00798369|40325659|FG004|Overall Study|Adminstrative problems|0|||
16505999|NCT00798369|40325660|FG005|Overall Study|Adminstrative problems|1|||
16506000|NCT02406651|40325661|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
16506001|NCT00949325|40325662|FG000|Overall Study|Adverse Event|0|||
16506002|NCT00949325|40325663|FG001|Overall Study|Adverse Event|2|||
16506003|NCT00949325|40325664|FG002|Overall Study|Adverse Event|0|||
16506004|NCT03739112|40325665|FG000|Overall Study|Adverse Event|2|||
16506005|NCT03739112|40325666|FG001|Overall Study|Adverse Event|2|||
16506006|NCT03739112|40325665|FG000|Overall Study|Withdrawal by Subject|38|||
16506007|NCT03739112|40325666|FG001|Overall Study|Withdrawal by Subject|19|||
16506008|NCT03739112|40325665|FG000|Overall Study|Lost to Follow-up|31|||
16506009|NCT03739112|40325666|FG001|Overall Study|Lost to Follow-up|33|||
16506010|NCT03739112|40325665|FG000|Overall Study|Protocol Deviation|12|||
16506011|NCT03739112|40325666|FG001|Overall Study|Protocol Deviation|9|||
16506012|NCT03739112|40325665|FG000|Overall Study|Physician Decision|1|||
16312498|NCT02105987|39627478|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
16312499|NCT02105987|39627473|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
16312500|NCT02105987|39627474|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
16312501|NCT02105987|39627475|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
16312502|NCT02105987|39627476|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
16312503|NCT02105987|39627477|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
16312504|NCT02105987|39627478|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
16312505|NCT02105987|39627473|FG000|Continuation Phase|Protocol Violation|0|||
16312506|NCT02105987|39627474|FG001|Continuation Phase|Protocol Violation|0|||
16312507|NCT02105987|39627475|FG002|Continuation Phase|Protocol Violation|0|||
16312508|NCT02105987|39627476|FG003|Continuation Phase|Protocol Violation|0|||
16312509|NCT02105987|39627477|FG004|Continuation Phase|Protocol Violation|1|||
16312510|NCT02105987|39627478|FG005|Continuation Phase|Protocol Violation|0|||
16312511|NCT01894919|39627480|FG000|Overall Study|Withdrawal by Subject|1|||
16506013|NCT03739112|40325666|FG001|Overall Study|Physician Decision|0|||
16506014|NCT03739112|40325665|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
16506015|NCT03739112|40325666|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
16506016|NCT03739112|40325665|FG000|Overall Study|Site went on hold|65|||
16506017|NCT03739112|40325666|FG001|Overall Study|Site went on hold|67|||
16506018|NCT03739112|40325665|FG000|Overall Study|Other than specified|8|||
16506019|NCT03739112|40325666|FG001|Overall Study|Other than specified|5|||
16506020|NCT03739112|40325665|FG000|Overall Study|Randomized but not vaccinated|31|||
16506021|NCT03739112|40325666|FG001|Overall Study|Randomized but not vaccinated|25|||
16506022|NCT01359254|40325678|FG000|Overall Study|Death|1|||
16506023|NCT01359254|40325679|FG001|Overall Study|Death|0|||
16506024|NCT01574612|40325680|FG000|Overall Study|Adverse Event|3|||
16506025|NCT01574612|40325680|FG000|Overall Study|non compliant with drug|2|||
16506026|NCT01574612|40325680|FG000|Overall Study|Withdrawal by Subject|1|||
16506027|NCT01574612|40325680|FG000|Overall Study|Lost to Follow-up|2|||
16506028|NCT04254978|40325681|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
16506029|NCT04254978|40325681|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
16506030|NCT04254978|40325681|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
16506031|NCT04254978|40325681|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
16506032|NCT04254978|40325681|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
16506033|NCT04254978|40325681|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
16506034|NCT01050257|40325682|FG000|Overall Study|Adverse Event|4|||
16506035|NCT01050257|40325683|FG001|Overall Study|Adverse Event|4|||
16506036|NCT01050257|40325684|FG002|Overall Study|Adverse Event|2|||
16506037|NCT01050257|40325682|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
16506038|NCT01050257|40325683|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
16506039|NCT01050257|40325684|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
16506040|NCT01050257|40325682|FG000|Overall Study|Withdrawal by Subject|0|||
16506041|NCT01050257|40325683|FG001|Overall Study|Withdrawal by Subject|3|||
16506042|NCT01050257|40325684|FG002|Overall Study|Withdrawal by Subject|0|||
16506043|NCT01050257|40325682|FG000|Overall Study|No reason specified|0|||
16506044|NCT01050257|40325683|FG001|Overall Study|No reason specified|0|||
16312512|NCT01894919|39627481|FG001|Overall Study|Withdrawal by Subject|0|||
16312513|NCT01894919|39627482|FG002|Overall Study|Withdrawal by Subject|0|||
16312514|NCT01894919|39627483|FG003|Overall Study|Withdrawal by Subject|0|||
16312515|NCT01894919|39627484|FG004|Overall Study|Withdrawal by Subject|1|||
16312516|NCT01894919|39627485|FG005|Overall Study|Withdrawal by Subject|0|||
16312517|NCT01894919|39627486|FG006|Overall Study|Withdrawal by Subject|0|||
16312518|NCT01894919|39627487|FG007|Overall Study|Withdrawal by Subject|0|||
16312519|NCT01894919|39627488|FG008|Overall Study|Withdrawal by Subject|0|||
16312520|NCT01894919|39627489|FG009|Overall Study|Withdrawal by Subject|1|||
16312521|NCT01894919|39627490|FG010|Overall Study|Withdrawal by Subject|1|||
16312522|NCT01894919|39627491|FG011|Overall Study|Withdrawal by Subject|0|||
16312523|NCT01894919|39627492|FG012|Overall Study|Withdrawal by Subject|0|||
16312524|NCT01894919|39627480|FG000|Overall Study|Adverse Event|0|||
16312525|NCT01894919|39627481|FG001|Overall Study|Adverse Event|0|||
16312526|NCT01894919|39627482|FG002|Overall Study|Adverse Event|0|||
16312527|NCT01894919|39627483|FG003|Overall Study|Adverse Event|0|||
16312528|NCT01894919|39627484|FG004|Overall Study|Adverse Event|0|||
16312529|NCT01894919|39627485|FG005|Overall Study|Adverse Event|0|||
16312530|NCT01894919|39627486|FG006|Overall Study|Adverse Event|0|||
16312531|NCT01894919|39627487|FG007|Overall Study|Adverse Event|0|||
16312532|NCT01894919|39627488|FG008|Overall Study|Adverse Event|0|||
16312533|NCT01894919|39627489|FG009|Overall Study|Adverse Event|0|||
16312534|NCT01894919|39627490|FG010|Overall Study|Adverse Event|1|||
16312535|NCT01894919|39627491|FG011|Overall Study|Adverse Event|0|||
16312536|NCT01894919|39627492|FG012|Overall Study|Adverse Event|0|||
16312537|NCT01894919|39627480|FG000|Overall Study|Other-Unspecified|1|||
16312538|NCT01894919|39627481|FG001|Overall Study|Other-Unspecified|0|||
16312539|NCT01894919|39627482|FG002|Overall Study|Other-Unspecified|0|||
16312540|NCT01894919|39627483|FG003|Overall Study|Other-Unspecified|0|||
16312541|NCT01894919|39627484|FG004|Overall Study|Other-Unspecified|0|||
16312542|NCT01894919|39627485|FG005|Overall Study|Other-Unspecified|0|||
16312543|NCT01894919|39627486|FG006|Overall Study|Other-Unspecified|0|||
16312544|NCT01894919|39627487|FG007|Overall Study|Other-Unspecified|0|||
16312545|NCT01894919|39627488|FG008|Overall Study|Other-Unspecified|0|||
16312546|NCT01894919|39627489|FG009|Overall Study|Other-Unspecified|0|||
16312547|NCT01894919|39627490|FG010|Overall Study|Other-Unspecified|0|||
16312548|NCT01894919|39627491|FG011|Overall Study|Other-Unspecified|0|||
16312549|NCT01894919|39627492|FG012|Overall Study|Other-Unspecified|0|||
16312550|NCT01894919|39627480|FG000|Overall Study|Lost to Follow-up|0|||
16312551|NCT01894919|39627481|FG001|Overall Study|Lost to Follow-up|0|||
16312552|NCT01894919|39627482|FG002|Overall Study|Lost to Follow-up|0|||
16312553|NCT01894919|39627483|FG003|Overall Study|Lost to Follow-up|0|||
16312554|NCT01894919|39627484|FG004|Overall Study|Lost to Follow-up|2|||
16312555|NCT01894919|39627485|FG005|Overall Study|Lost to Follow-up|0|||
16312556|NCT01894919|39627486|FG006|Overall Study|Lost to Follow-up|0|||
16312557|NCT01894919|39627487|FG007|Overall Study|Lost to Follow-up|0|||
16312558|NCT01894919|39627488|FG008|Overall Study|Lost to Follow-up|0|||
16312559|NCT01894919|39627489|FG009|Overall Study|Lost to Follow-up|0|||
16506045|NCT01050257|40325684|FG002|Overall Study|No reason specified|2|||
16506046|NCT01050257|40325682|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
16506047|NCT01050257|40325683|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
16506048|NCT01050257|40325684|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
16506049|NCT01050257|40325682|FG000|Overall Study|Violation criteria|0|||
16506050|NCT01050257|40325683|FG001|Overall Study|Violation criteria|1|||
16506051|NCT01050257|40325684|FG002|Overall Study|Violation criteria|0|||
16506052|NCT01050257|40325682|FG000|Overall Study|Failure to return|0|||
16506053|NCT01050257|40325683|FG001|Overall Study|Failure to return|2|||
16506054|NCT01050257|40325684|FG002|Overall Study|Failure to return|0|||
16506055|NCT01050257|40325682|FG000|Overall Study|Death|0|||
16506056|NCT01050257|40325683|FG001|Overall Study|Death|0|||
16506057|NCT01050257|40325684|FG002|Overall Study|Death|1|||
16506058|NCT01289847|40325685|FG000|Overall Study|Patient could not comply with visits|1|||
16506059|NCT05024058|40325686|FG000|Treatment|Study terminated by sponsor|5|||
16506060|NCT05024058|40325687|FG001|Treatment|Study terminated by sponsor|6|||
16506061|NCT05024058|40325688|FG002|Treatment|Study terminated by sponsor|4|||
16506062|NCT05024058|40325689|FG003|Treatment|Study terminated by sponsor|2|||
16506063|NCT05024058|40325690|FG004|Treatment|Study terminated by sponsor|3|||
16506064|NCT05024058|40325691|FG005|Treatment|Study terminated by sponsor|3|||
16506065|NCT05024058|40325692|FG006|Treatment|Study terminated by sponsor|1|||
16506066|NCT05024058|40325693|FG007|Treatment|Study terminated by sponsor|3|||
16506067|NCT05024058|40325694|FG008|Treatment|Study terminated by sponsor|6|||
16506068|NCT05024058|40325695|FG009|Treatment|Study terminated by sponsor|6|||
16506069|NCT05024058|40325686|FG000|Follow-up|Withdrawal by Subject|1|||
16506070|NCT05024058|40325687|FG001|Follow-up|Withdrawal by Subject|0|||
16089931|NCT00614614|38820030|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
16089932|NCT00614614|38820026|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
16506071|NCT05024058|40325688|FG002|Follow-up|Withdrawal by Subject|1|||
16506072|NCT05024058|40325689|FG003|Follow-up|Withdrawal by Subject|0|||
16506073|NCT05024058|40325690|FG004|Follow-up|Withdrawal by Subject|0|||
16506074|NCT05024058|40325691|FG005|Follow-up|Withdrawal by Subject|0|||
16506075|NCT05024058|40325692|FG006|Follow-up|Withdrawal by Subject|0|||
16506076|NCT05024058|40325693|FG007|Follow-up|Withdrawal by Subject|1|||
16506077|NCT05024058|40325694|FG008|Follow-up|Withdrawal by Subject|0|||
16506078|NCT05024058|40325695|FG009|Follow-up|Withdrawal by Subject|1|||
16506079|NCT01293240|40325696|FG000|Overall Study|Noncompliance|2|||
16506080|NCT03724812|40325697|FG000|Overall Study|Missed Visit|1|||
16506081|NCT03724812|40325697|FG000|Overall Study|Death|2|||
16506082|NCT03724812|40325697|FG000|Overall Study|Withdrawal by Subject|1|||
16506083|NCT01644175|40325702|FG000|Overall Study|Randomized But Not Treated|0|||
16506084|NCT01644175|40325703|FG001|Overall Study|Randomized But Not Treated|2|||
16506085|NCT01644175|40325702|FG000|Overall Study|Adverse Event|8|||
16506086|NCT01644175|40325703|FG001|Overall Study|Adverse Event|13|||
16506087|NCT01644175|40325702|FG000|Overall Study|Death|1|||
16506088|NCT01644175|40325703|FG001|Overall Study|Death|2|||
16506089|NCT01644175|40325702|FG000|Overall Study|Poor compliance to protocol|9|||
16506090|NCT01644175|40325703|FG001|Overall Study|Poor compliance to protocol|10|||
16506091|NCT01644175|40325702|FG000|Overall Study|Physician Decision|1|||
16506092|NCT01644175|40325703|FG001|Overall Study|Physician Decision|2|||
16506093|NCT01644175|40325702|FG000|Overall Study|Participant Moved|1|||
16506094|NCT01644175|40325703|FG001|Overall Study|Participant Moved|2|||
16506095|NCT01644175|40325702|FG000|Overall Study|Consent withdrawn by participant|3|||
16506096|NCT01644175|40325703|FG001|Overall Study|Consent withdrawn by participant|4|||
16506097|NCT01644175|40325702|FG000|Overall Study|Related to Autoinjector Administration|2|||
16506098|NCT01644175|40325703|FG001|Overall Study|Related to Autoinjector Administration|1|||
16506099|NCT01644175|40325702|FG000|Overall Study|Last visit outside protocol visit window|4|||
16506100|NCT01644175|40325703|FG001|Overall Study|Last visit outside protocol visit window|11|||
16506101|NCT01644175|40325702|FG000|Overall Study|Selection criteria finally not met|0|||
16506102|NCT01644175|40325703|FG001|Overall Study|Selection criteria finally not met|1|||
16506103|NCT01644175|40325702|FG000|Overall Study|Site closure|2|||
16506104|NCT01644175|40325703|FG001|Overall Study|Site closure|2|||
16506105|NCT01644175|40325702|FG000|Overall Study|Lost to Follow-up|1|||
16506106|NCT01644175|40325703|FG001|Overall Study|Lost to Follow-up|0|||
16506107|NCT01644175|40325702|FG000|Overall Study|Other than specified above|0|||
16506108|NCT01644175|40325703|FG001|Overall Study|Other than specified above|3|||
16506109|NCT01165138|40325704|FG000|Overall Study|Adverse Event|0|||
16312560|NCT01894919|39627490|FG010|Overall Study|Lost to Follow-up|0|||
16506110|NCT01165138|40325705|FG001|Overall Study|Adverse Event|1|||
16506111|NCT01165138|40325706|FG002|Overall Study|Adverse Event|0|||
16506112|NCT01165138|40325707|FG003|Overall Study|Adverse Event|2|||
16506113|NCT01165138|40325704|FG000|Overall Study|Lack of Efficacy|0|||
16506114|NCT01165138|40325705|FG001|Overall Study|Lack of Efficacy|32|||
16506115|NCT01165138|40325706|FG002|Overall Study|Lack of Efficacy|6|||
16506116|NCT01165138|40325707|FG003|Overall Study|Lack of Efficacy|7|||
16506117|NCT01165138|40325704|FG000|Overall Study|Protocol Violation|0|||
16506118|NCT01165138|40325705|FG001|Overall Study|Protocol Violation|7|||
16506119|NCT01165138|40325706|FG002|Overall Study|Protocol Violation|0|||
16506120|NCT01165138|40325707|FG003|Overall Study|Protocol Violation|2|||
16506121|NCT01165138|40325704|FG000|Overall Study|Lost to Follow-up|0|||
16506122|NCT01165138|40325705|FG001|Overall Study|Lost to Follow-up|0|||
16506123|NCT01165138|40325706|FG002|Overall Study|Lost to Follow-up|1|||
16506124|NCT01165138|40325707|FG003|Overall Study|Lost to Follow-up|2|||
16506125|NCT01165138|40325704|FG000|Overall Study|Physician Decision|0|||
16506126|NCT01165138|40325705|FG001|Overall Study|Physician Decision|6|||
16506127|NCT01165138|40325706|FG002|Overall Study|Physician Decision|7|||
16506128|NCT01165138|40325707|FG003|Overall Study|Physician Decision|6|||
16506129|NCT01165138|40325704|FG000|Overall Study|Withdrawal by Subject|0|||
16506130|NCT01165138|40325705|FG001|Overall Study|Withdrawal by Subject|6|||
16506131|NCT01165138|40325706|FG002|Overall Study|Withdrawal by Subject|6|||
16506132|NCT01165138|40325707|FG003|Overall Study|Withdrawal by Subject|3|||
16312561|NCT01894919|39627491|FG011|Overall Study|Lost to Follow-up|0|||
16506133|NCT02642432|40325708|FG000|Overall Study|Adverse Event|2|||
16506134|NCT02642432|40325708|FG000|Overall Study|Withdrew Consent|1|||
16506135|NCT02642432|40325708|FG000|Overall Study|Lost to Follow-up|2|||
16506136|NCT02642432|40325708|FG000|Overall Study|Other|3|||
16506137|NCT02867709|40325719|FG000|Treatment Period|Adverse Event|1|||
16506138|NCT02867709|40325720|FG001|Treatment Period|Adverse Event|1|||
16506139|NCT02867709|40325721|FG002|Treatment Period|Adverse Event|2|||
16506140|NCT02867709|40325719|FG000|Treatment Period|Withdrawal of Consent|7|||
16506141|NCT02867709|40325720|FG001|Treatment Period|Withdrawal of Consent|9|||
16506142|NCT02867709|40325721|FG002|Treatment Period|Withdrawal of Consent|8|||
16506143|NCT02867709|40325719|FG000|Treatment Period|Lost to Follow-up|17|||
16506144|NCT02867709|40325720|FG001|Treatment Period|Lost to Follow-up|20|||
16506145|NCT02867709|40325721|FG002|Treatment Period|Lost to Follow-up|20|||
16506146|NCT02867709|40325719|FG000|Treatment Period|Lack of Qualifying Event|42|||
16506147|NCT02867709|40325720|FG001|Treatment Period|Lack of Qualifying Event|55|||
16506148|NCT02867709|40325721|FG002|Treatment Period|Lack of Qualifying Event|42|||
16506149|NCT02867709|40325719|FG000|Treatment Period|Protocol Violation|3|||
16506150|NCT02867709|40325720|FG001|Treatment Period|Protocol Violation|2|||
16506151|NCT02867709|40325721|FG002|Treatment Period|Protocol Violation|3|||
16506152|NCT02867709|40325719|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
16506153|NCT02867709|40325720|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
16506154|NCT02867709|40325721|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
16506155|NCT02867709|40325719|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
16506156|NCT02867709|40325720|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
16506157|NCT02867709|40325721|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
16506158|NCT02867709|40325719|FG000|Safety Follow-up Period|Pregnancy|0|||
16506159|NCT02867709|40325720|FG001|Safety Follow-up Period|Pregnancy|1|||
16506160|NCT02867709|40325721|FG002|Safety Follow-up Period|Pregnancy|0|||
16506161|NCT02867709|40325719|FG000|Safety Follow-up Period|Protocol Violation|0|||
16506162|NCT02867709|40325720|FG001|Safety Follow-up Period|Protocol Violation|1|||
16506163|NCT02867709|40325721|FG002|Safety Follow-up Period|Protocol Violation|1|||
16506164|NCT00706641|40325722|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
16506165|NCT00706641|40325722|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
16506166|NCT00706641|40325722|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
16506167|NCT01623596|40325723|FG000|Overall Study|Abnormal laboratory values|2|||
16506168|NCT01623596|40325724|FG001|Overall Study|Abnormal laboratory values|0|||
16506169|NCT01623596|40325723|FG000|Overall Study|Administrative problems|9|||
16506170|NCT01623596|40325724|FG001|Overall Study|Administrative problems|13|||
16506171|NCT01623596|40325723|FG000|Overall Study|Adverse Event|20|||
16506172|NCT01623596|40325724|FG001|Overall Study|Adverse Event|29|||
16506173|NCT01623596|40325723|FG000|Overall Study|Death|0|||
16506174|NCT01623596|40325724|FG001|Overall Study|Death|2|||
16506175|NCT01623596|40325723|FG000|Overall Study|Lost to Follow-up|12|||
16506176|NCT01623596|40325724|FG001|Overall Study|Lost to Follow-up|16|||
16506177|NCT01623596|40325723|FG000|Overall Study|Withdrawal by Subject|13|||
16506178|NCT01623596|40325724|FG001|Overall Study|Withdrawal by Subject|31|||
16196453|NCT01163253|39193541|FG001|Overall Study|Death|5|||
16312562|NCT01894919|39627492|FG012|Overall Study|Lost to Follow-up|0|||
16506179|NCT01623596|40325723|FG000|Overall Study|Patient no longer requires study drug|1|||
16506180|NCT01623596|40325724|FG001|Overall Study|Patient no longer requires study drug|0|||
16506181|NCT01623596|40325723|FG000|Overall Study|Protocol Violation|0|||
16506182|NCT01623596|40325724|FG001|Overall Study|Protocol Violation|6|||
16506183|NCT01623596|40325723|FG000|Overall Study|Lack of Efficacy|5|||
16506184|NCT01623596|40325724|FG001|Overall Study|Lack of Efficacy|3|||
16506185|NCT02246673|40325725|FG000|Overall Study|Sponsor Decision|1|||
16506186|NCT02246673|40325726|FG001|Overall Study|Sponsor Decision|0|||
16506187|NCT02246673|40325727|FG002|Overall Study|Sponsor Decision|0|||
16506188|NCT02246673|40325728|FG003|Overall Study|Sponsor Decision|0|||
16506189|NCT02246673|40325729|FG004|Overall Study|Sponsor Decision|0|||
16506190|NCT02246673|40325725|FG000|Overall Study|Withdrawal by Subject|0|||
16506191|NCT02246673|40325726|FG001|Overall Study|Withdrawal by Subject|0|||
16506192|NCT02246673|40325727|FG002|Overall Study|Withdrawal by Subject|0|||
16506193|NCT02246673|40325728|FG003|Overall Study|Withdrawal by Subject|0|||
16506194|NCT02246673|40325729|FG004|Overall Study|Withdrawal by Subject|1|||
16506195|NCT02246673|40325725|FG000|Overall Study|Lost to Follow-up|0|||
16506196|NCT02246673|40325726|FG001|Overall Study|Lost to Follow-up|0|||
16506197|NCT02246673|40325727|FG002|Overall Study|Lost to Follow-up|0|||
16506198|NCT02246673|40325728|FG003|Overall Study|Lost to Follow-up|1|||
16506199|NCT02246673|40325729|FG004|Overall Study|Lost to Follow-up|0|||
16506200|NCT02246673|40325725|FG000|Overall Study|Protocol Violation|0|||
16390986|NCT02146131|39916031|FG001|Overall Study|Physician Decision|56|||
16312563|NCT03408639|39627493|FG000|Overall Study|Death|5|||
16312564|NCT03408639|39627494|FG001|Overall Study|Death|5|||
16312565|NCT03408639|39627493|FG000|Overall Study|Lost to Follow-up|1|||
16312566|NCT03408639|39627494|FG001|Overall Study|Lost to Follow-up|4|||
16312567|NCT03408639|39627493|FG000|Overall Study|Withdrawal by Subject|2|||
16312568|NCT03408639|39627494|FG001|Overall Study|Withdrawal by Subject|7|||
16312569|NCT03408639|39627493|FG000|Overall Study|Physician Decision|3|||
16312570|NCT03408639|39627494|FG001|Overall Study|Physician Decision|6|||
16312571|NCT00536939|39627497|FG000|Overall Study|Withdrawal by Subject|1|||
16312572|NCT00536939|39627498|FG001|Overall Study|Withdrawal by Subject|0|||
16312573|NCT00536939|39627497|FG000|Overall Study|Other Complicating Disease|1|||
16312574|NCT00536939|39627498|FG001|Overall Study|Other Complicating Disease|0|||
16312575|NCT00882518|39627499|FG000|Overall Study|Adverse Event|9|||
16312576|NCT00882518|39627500|FG001|Overall Study|Adverse Event|18|||
16390987|NCT00400517|39916032|FG000|Overall Study|Withdrawal by Subject|1|||
16390988|NCT00400517|39916032|FG000|Overall Study|Physician Decision|1|||
16390989|NCT02257242|39916033|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
16390990|NCT02257242|39916034|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16390991|NCT02257242|39916035|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16390992|NCT02257242|39916036|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16390993|NCT02257242|39916037|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16390994|NCT02257242|39916038|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16390995|NCT02257242|39916039|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16390996|NCT02257242|39916040|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16390997|NCT02257242|39916041|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
16390998|NCT00809926|39916042|FG000|Overall Study|Adverse Event|18|||
16390999|NCT00809926|39916043|FG001|Overall Study|Adverse Event|10|||
16391000|NCT00809926|39916042|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
16391001|NCT00809926|39916043|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16391002|NCT00809926|39916042|FG000|Overall Study|Patient withdrew consent|8|||
16391003|NCT00809926|39916043|FG001|Overall Study|Patient withdrew consent|6|||
16391004|NCT00809926|39916042|FG000|Overall Study|Lost to Follow-up|2|||
16391005|NCT00809926|39916043|FG001|Overall Study|Lost to Follow-up|1|||
16391006|NCT00809926|39916042|FG000|Overall Study|Administrative Problems|0|||
16391007|NCT00809926|39916043|FG001|Overall Study|Administrative Problems|1|||
16391008|NCT00809926|39916042|FG000|Overall Study|Protocol deviation|0|||
16391009|NCT00809926|39916043|FG001|Overall Study|Protocol deviation|2|||
16506201|NCT02246673|40325726|FG001|Overall Study|Protocol Violation|0|||
16506202|NCT02246673|40325727|FG002|Overall Study|Protocol Violation|0|||
16506203|NCT02246673|40325728|FG003|Overall Study|Protocol Violation|1|||
16506204|NCT02246673|40325729|FG004|Overall Study|Protocol Violation|0|||
16506205|NCT02063737|40325730|FG000|Overall Study|Lost to Follow-up|11|||
16506206|NCT02063737|40325731|FG001|Overall Study|Lost to Follow-up|4|||
16506207|NCT00679263|40325732|FG000|Visit 2/Dose 1|Adverse Event|1|||
16506208|NCT00679263|40325733|FG001|Visit 2/Dose 1|Adverse Event|0|||
16506209|NCT00679263|40325734|FG002|Visit 2/Dose 1|Adverse Event|0|||
16506210|NCT00679263|40325732|FG000|Visit 2/Dose 1|subject not compliance|1|||
16506211|NCT00679263|40325733|FG001|Visit 2/Dose 1|subject not compliance|1|||
16312577|NCT00882518|39627499|FG000|Overall Study|Withdrawal by Subject|9|||
16312578|NCT00882518|39627500|FG001|Overall Study|Withdrawal by Subject|13|||
16312579|NCT00882518|39627499|FG000|Overall Study|Lack of Efficacy|12|||
16506212|NCT00679263|40325734|FG002|Visit 2/Dose 1|subject not compliance|0|||
16506213|NCT01217060|40325735|FG000|Overall Study|Withdrawal by Subject|1|||
16506214|NCT01012622|40325736|FG000|Overall Study|Withdrawal by Subject|6|||
16312580|NCT00882518|39627500|FG001|Overall Study|Lack of Efficacy|9|||
16506215|NCT01012622|40325736|FG000|Overall Study|Lost to Follow-up|5|||
16506216|NCT01012622|40325736|FG000|Overall Study|Adverse Event|7|||
16506217|NCT01012622|40325736|FG000|Overall Study|non-compliance with the drug|9|||
16506218|NCT01012622|40325736|FG000|Overall Study|Other|1|||
16506219|NCT01012622|40325736|FG000|Overall Study|screening failure|1|||
16506220|NCT01012622|40325736|FG000|Overall Study|withdrawal of consent by a parent|2|||
16506221|NCT02064166|40325742|FG000|Overall Study|Adverse Event|1|||
16506222|NCT02064166|40325743|FG001|Overall Study|Adverse Event|0|||
16506223|NCT01586819|40325744|FG000|Overall Study|Withdrawal by Subject|1|||
16506224|NCT01586819|40325745|FG001|Overall Study|Withdrawal by Subject|0|||
16506225|NCT00946712|40325746|FG000|Overall Study|Adverse Event|118|||
16506226|NCT00946712|40325747|FG001|Overall Study|Adverse Event|124|||
16506227|NCT00946712|40325746|FG000|Overall Study|Disease progression|308|||
16506228|NCT00946712|40325747|FG001|Overall Study|Disease progression|404|||
16506229|NCT00946712|40325746|FG000|Overall Study|Death|21|||
16506230|NCT00946712|40325747|FG001|Overall Study|Death|22|||
16506231|NCT00946712|40325746|FG000|Overall Study|No treatment given|25|||
16506232|NCT00946712|40325747|FG001|Overall Study|No treatment given|29|||
16506233|NCT00946712|40325746|FG000|Overall Study|Other reasons|61|||
16506234|NCT00946712|40325747|FG001|Overall Study|Other reasons|73|||
16506235|NCT00946712|40325746|FG000|Overall Study|On Treatment|0|||
16506236|NCT00946712|40325747|FG001|Overall Study|On Treatment|4|||
16506237|NCT00946712|40325746|FG000|Overall Study|Ineligible|14|||
16312581|NCT00882518|39627499|FG000|Overall Study|Severe non-compliance to protocol|3|||
16312582|NCT00882518|39627500|FG001|Overall Study|Severe non-compliance to protocol|1|||
16312583|NCT00882518|39627499|FG000|Overall Study|Incorrect enrolment|4|||
16312584|NCT00882518|39627500|FG001|Overall Study|Incorrect enrolment|2|||
16312585|NCT00882518|39627499|FG000|Overall Study|Central lab closure for National day|1|||
16312586|NCT00882518|39627500|FG001|Overall Study|Central lab closure for National day|0|||
16506238|NCT00946712|40325747|FG001|Overall Study|Ineligible|6|||
16506239|NCT00644969|40325753|FG000|Treatment Phase|Randomized, not treated|1|||
16506240|NCT00644969|40325754|FG001|Treatment Phase|Randomized, not treated|0|||
16506241|NCT00644969|40325753|FG000|Treatment Phase|Adverse Event|3|||
16506242|NCT00644969|40325754|FG001|Treatment Phase|Adverse Event|0|||
16506243|NCT00644969|40325753|FG000|Treatment Phase|Withdrawal by Subject|4|||
16506244|NCT00644969|40325754|FG001|Treatment Phase|Withdrawal by Subject|0|||
16506245|NCT00644969|40325753|FG000|Treatment Phase|Lost to Follow-up|2|||
16506246|NCT00644969|40325754|FG001|Treatment Phase|Lost to Follow-up|2|||
16506247|NCT00644969|40325753|FG000|Treatment Phase|Other|4|||
16506248|NCT00644969|40325754|FG001|Treatment Phase|Other|1|||
16506249|NCT00644969|40325753|FG000|Post Treatment Phase|Death|1|||
16506250|NCT00644969|40325754|FG001|Post Treatment Phase|Death|0|||
16506251|NCT00644969|40325753|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
16506252|NCT00644969|40325754|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
16506253|NCT00644969|40325753|FG000|Post Treatment Phase|Lost to Follow-up|4|||
16506254|NCT00644969|40325754|FG001|Post Treatment Phase|Lost to Follow-up|1|||
16506255|NCT00644969|40325753|FG000|Post Treatment Phase|Other|1|||
16506256|NCT00644969|40325754|FG001|Post Treatment Phase|Other|0|||
16506257|NCT01324349|40325759|FG000|Overall Study|Death|1|||
16506258|NCT01324349|40325760|FG001|Overall Study|Death|1|||
16506259|NCT01324349|40325759|FG000|Overall Study|Withdrawal by Subject|0|||
16506260|NCT01324349|40325760|FG001|Overall Study|Withdrawal by Subject|1|||
16506261|NCT02917031|40325761|FG000|Overall Study|Reason not specified|7|||
16506262|NCT02917031|40325762|FG001|Overall Study|Reason not specified|5|||
16312587|NCT00882518|39627499|FG000|Overall Study|Allocating random number by mistake|0|||
16312588|NCT00882518|39627500|FG001|Overall Study|Allocating random number by mistake|1|||
16312589|NCT02837731|39627501|FG000|Allocation|Admitted to General Floor|3|||
16312590|NCT02837731|39627502|FG001|Allocation|Admitted to General Floor|4|||
16312591|NCT02837731|39627501|FG000|Allocation|Immediate surgery/withdrew|2|||
16391010|NCT00690430|39916044|FG000|Core Phase|Abnormal Laboratory value|0|||
16391011|NCT00690430|39916045|FG001|Core Phase|Abnormal Laboratory value|1|||
16506263|NCT02917031|40325763|FG002|Overall Study|Reason not specified|6|||
16506264|NCT02917031|40325761|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
16506265|NCT02917031|40325762|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
16506266|NCT02917031|40325763|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
16506267|NCT02917031|40325761|FG000|Overall Study|Withdrawal by Subject|3|||
16506268|NCT02917031|40325762|FG001|Overall Study|Withdrawal by Subject|3|||
16506269|NCT02917031|40325763|FG002|Overall Study|Withdrawal by Subject|0|||
16506270|NCT02917031|40325761|FG000|Overall Study|Physician Decision|1|||
16506271|NCT02917031|40325762|FG001|Overall Study|Physician Decision|0|||
16506272|NCT02917031|40325763|FG002|Overall Study|Physician Decision|0|||
16506273|NCT02917031|40325761|FG000|Overall Study|Adverse Event|4|||
16506274|NCT02917031|40325762|FG001|Overall Study|Adverse Event|1|||
16506275|NCT02917031|40325763|FG002|Overall Study|Adverse Event|5|||
16506276|NCT02917031|40325761|FG000|Overall Study|Death|2|||
16506277|NCT02917031|40325762|FG001|Overall Study|Death|3|||
16506278|NCT02917031|40325763|FG002|Overall Study|Death|4|||
16506279|NCT00733746|40325764|FG000|Overall Study|Ineligible|5|||
16506280|NCT00171223|40325767|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
16506281|NCT00171223|40325768|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
16506282|NCT00171223|40325769|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
16506283|NCT00171223|40325767|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
16506284|NCT00171223|40325768|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
16506285|NCT00171223|40325769|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
16506286|NCT00171223|40325767|FG000|Overall Study|Abnormal Procedure|1|||
16506287|NCT00171223|40325768|FG001|Overall Study|Abnormal Procedure|0|||
16506288|NCT00171223|40325769|FG002|Overall Study|Abnormal Procedure|0|||
16506289|NCT00171223|40325767|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
16506290|NCT00171223|40325768|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
16506291|NCT00171223|40325769|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
16506292|NCT00171223|40325767|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
16506293|NCT00171223|40325768|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
16506294|NCT00171223|40325769|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
16506295|NCT00171223|40325767|FG000|Overall Study|Protocol Violation|2|||
16506296|NCT00171223|40325768|FG001|Overall Study|Protocol Violation|2|||
16506297|NCT00171223|40325769|FG002|Overall Study|Protocol Violation|3|||
16506298|NCT00171223|40325767|FG000|Overall Study|Participant Withdrew Consent|12|||
16506299|NCT00171223|40325768|FG001|Overall Study|Participant Withdrew Consent|21|||
16506300|NCT00171223|40325769|FG002|Overall Study|Participant Withdrew Consent|15|||
16506301|NCT00171223|40325767|FG000|Overall Study|Lost to Follow-up|5|||
16506302|NCT00171223|40325768|FG001|Overall Study|Lost to Follow-up|2|||
16506303|NCT00171223|40325769|FG002|Overall Study|Lost to Follow-up|3|||
16506304|NCT00171223|40325767|FG000|Overall Study|Administrative Problems|4|||
16506305|NCT00171223|40325768|FG001|Overall Study|Administrative Problems|7|||
16506306|NCT00171223|40325769|FG002|Overall Study|Administrative Problems|6|||
16506307|NCT00171223|40325767|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
16506308|NCT00171223|40325768|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
16506309|NCT00171223|40325769|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
16506310|NCT00171223|40325767|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
16506311|NCT00171223|40325768|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
16506312|NCT00171223|40325769|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
16506313|NCT03245008|40325770|FG000|Overall Study|Adverse Event|15|||
16506314|NCT03245008|40325771|FG001|Overall Study|Adverse Event|18|||
16506315|NCT03245008|40325772|FG002|Overall Study|Adverse Event|15|||
16506316|NCT03245008|40325773|FG003|Overall Study|Adverse Event|0|||
16506317|NCT03245008|40325774|FG004|Overall Study|Adverse Event|1|||
16506318|NCT03245008|40325770|FG000|Overall Study|Lack of Efficacy|0|||
16506319|NCT03245008|40325771|FG001|Overall Study|Lack of Efficacy|1|||
16506320|NCT03245008|40325772|FG002|Overall Study|Lack of Efficacy|0|||
16506321|NCT03245008|40325773|FG003|Overall Study|Lack of Efficacy|0|||
16506322|NCT03245008|40325774|FG004|Overall Study|Lack of Efficacy|0|||
16506323|NCT03245008|40325770|FG000|Overall Study|Lost to Follow-up|4|||
16506324|NCT03245008|40325771|FG001|Overall Study|Lost to Follow-up|1|||
16506325|NCT03245008|40325772|FG002|Overall Study|Lost to Follow-up|0|||
16506326|NCT03245008|40325773|FG003|Overall Study|Lost to Follow-up|0|||
16506327|NCT03245008|40325774|FG004|Overall Study|Lost to Follow-up|1|||
16506328|NCT03245008|40325770|FG000|Overall Study|Physician Decision|1|||
16506329|NCT03245008|40325771|FG001|Overall Study|Physician Decision|3|||
16506330|NCT03245008|40325772|FG002|Overall Study|Physician Decision|4|||
16506331|NCT03245008|40325773|FG003|Overall Study|Physician Decision|0|||
16506332|NCT03245008|40325774|FG004|Overall Study|Physician Decision|0|||
16506333|NCT03245008|40325770|FG000|Overall Study|Protocol Violation|0|||
16506334|NCT03245008|40325771|FG001|Overall Study|Protocol Violation|1|||
16506335|NCT03245008|40325772|FG002|Overall Study|Protocol Violation|0|||
16506336|NCT03245008|40325773|FG003|Overall Study|Protocol Violation|0|||
16506337|NCT03245008|40325774|FG004|Overall Study|Protocol Violation|0|||
16506338|NCT03245008|40325770|FG000|Overall Study|Withdrawal by Subject|20|||
16506339|NCT03245008|40325771|FG001|Overall Study|Withdrawal by Subject|19|||
16506340|NCT03245008|40325772|FG002|Overall Study|Withdrawal by Subject|11|||
16506341|NCT03245008|40325773|FG003|Overall Study|Withdrawal by Subject|0|||
16506342|NCT03245008|40325774|FG004|Overall Study|Withdrawal by Subject|0|||
16506343|NCT03245008|40325770|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
16506344|NCT03245008|40325771|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
16506345|NCT03245008|40325772|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
16506346|NCT03245008|40325773|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
16506347|NCT03245008|40325774|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
16506348|NCT03245008|40325770|FG000|Overall Study|Failure to meet randomization criteria|0|||
16506349|NCT03245008|40325771|FG001|Overall Study|Failure to meet randomization criteria|1|||
16506350|NCT03245008|40325772|FG002|Overall Study|Failure to meet randomization criteria|0|||
16506351|NCT03245008|40325773|FG003|Overall Study|Failure to meet randomization criteria|1|||
16506352|NCT03245008|40325774|FG004|Overall Study|Failure to meet randomization criteria|0|||
16506353|NCT00788827|40325775|FG000|Overall Study|Lack of Efficacy|2|||
16506354|NCT00149747|40325776|FG000|Overall Study|Death|1|||
16506355|NCT00149747|40325777|FG001|Overall Study|Death|0|||
16506356|NCT00149747|40325776|FG000|Overall Study|Withdrawal by Subject|3|||
16506357|NCT00149747|40325777|FG001|Overall Study|Withdrawal by Subject|3|||
16312592|NCT02837731|39627502|FG001|Allocation|Immediate surgery/withdrew|0|||
16312593|NCT02837731|39627501|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
16506358|NCT02211131|40325778|FG000|Overall Study|Death|26|||
16312594|NCT02837731|39627502|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
16312595|NCT02837731|39627501|FG000|Allocation|Withdrawal by Subject|2|||
16312596|NCT02837731|39627502|FG001|Allocation|Withdrawal by Subject|0|||
16312597|NCT02837731|39627501|FG000|Allocation|Device not available|1|||
16312598|NCT02837731|39627502|FG001|Allocation|Device not available|0|||
16312599|NCT02837731|39627501|FG000|Allocation|Protocol not implemented|7|||
16312600|NCT02837731|39627502|FG001|Allocation|Protocol not implemented|0|||
16312601|NCT02837731|39627501|FG000|Allocation|Moribund/Do not resuscitate|2|||
16312602|NCT02837731|39627502|FG001|Allocation|Moribund/Do not resuscitate|0|||
16312603|NCT02837731|39627501|FG000|Allocation|Did not meet sepsis criteria|1|||
16312604|NCT02837731|39627502|FG001|Allocation|Did not meet sepsis criteria|2|||
16312605|NCT02837731|39627501|FG000|Allocation|Known aortic abnormalities|0|||
16312606|NCT02837731|39627502|FG001|Allocation|Known aortic abnormalities|1|||
16312607|NCT01578239|39627505|FG000|Treatment Period|Progressive Disease|19|||
16312608|NCT01578239|39627506|FG001|Treatment Period|Progressive Disease|64|||
16312609|NCT01578239|39627505|FG000|Treatment Period|Physician Decision|17|||
16312610|NCT01578239|39627506|FG001|Treatment Period|Physician Decision|17|||
16312611|NCT01578239|39627505|FG000|Treatment Period|Adverse Event|13|||
16312612|NCT01578239|39627506|FG001|Treatment Period|Adverse Event|10|||
16312613|NCT01578239|39627505|FG000|Treatment Period|Non-compliance|2|||
16312614|NCT01578239|39627506|FG001|Treatment Period|Non-compliance|0|||
16312615|NCT01578239|39627505|FG000|Treatment Period|Withdrawal by Subject|10|||
16312616|NCT01578239|39627506|FG001|Treatment Period|Withdrawal by Subject|9|||
16312617|NCT01578239|39627505|FG000|Treatment Period|Other|6|||
16312618|NCT01578239|39627506|FG001|Treatment Period|Other|1|||
16312619|NCT01578239|39627505|FG000|Long-term Follow-Up Period|Death|69|||
16312620|NCT01578239|39627506|FG001|Long-term Follow-Up Period|Death|64|||
16312621|NCT01578239|39627505|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
16312622|NCT01578239|39627506|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
16312623|NCT01578239|39627505|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
16312624|NCT01578239|39627506|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
16312625|NCT01578239|39627505|FG000|Long-term Follow-Up Period|Other|2|||
16312626|NCT01578239|39627506|FG001|Long-term Follow-Up Period|Other|2|||
16312627|NCT02208089|39627513|FG000|Overall Study|Withdrawal by Subject|1|||
16506359|NCT02211131|40325779|FG001|Overall Study|Death|16|||
16506360|NCT02211131|40325778|FG000|Overall Study|Lost to Follow-up|4|||
16506361|NCT02211131|40325779|FG001|Overall Study|Lost to Follow-up|3|||
16506362|NCT02211131|40325778|FG000|Overall Study|Decision by Sponsor|1|||
16506363|NCT02211131|40325779|FG001|Overall Study|Decision by Sponsor|1|||
16506364|NCT02211131|40325778|FG000|Overall Study|Withdrawal by Subject|3|||
16506365|NCT02211131|40325779|FG001|Overall Study|Withdrawal by Subject|8|||
16506366|NCT02120794|40325780|FG000|Overall Study|Withdrawal by Subject|43|||
16506367|NCT02120794|40325780|FG000|Overall Study|Adverse Event|10|||
16506368|NCT02120794|40325780|FG000|Overall Study|Physician Decision|4|||
16506369|NCT02120794|40325780|FG000|Overall Study|Due to insurance coverage|1|||
16506370|NCT02085785|40325781|FG000|Overall Study|Withdrawal by Subject|2|||
16506371|NCT02085785|40325782|FG001|Overall Study|Withdrawal by Subject|1|||
16506372|NCT02085785|40325781|FG000|Overall Study|Lost to Follow-up|0|||
16506373|NCT02085785|40325782|FG001|Overall Study|Lost to Follow-up|1|||
16506374|NCT03886220|40325783|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
16506375|NCT03886220|40325784|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
16506376|NCT03886220|40325783|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
16506377|NCT03886220|40325784|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16506378|NCT03886220|40325783|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
16506379|NCT03886220|40325784|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
16506380|NCT02579265|40325785|FG000|Overall Study|Weaned off earlier than 28 days|44|||
16506381|NCT02579265|40325786|FG001|Overall Study|Weaned off earlier than 28 days|43|||
16506382|NCT02579265|40325785|FG000|Overall Study|Adverse Event|2|||
16506383|NCT02579265|40325786|FG001|Overall Study|Adverse Event|0|||
16506384|NCT02579265|40325785|FG000|Overall Study|Any other reason not specified|0|||
16506385|NCT02579265|40325786|FG001|Overall Study|Any other reason not specified|2|||
16506386|NCT02579265|40325785|FG000|Overall Study|Withdrawal by Subject|2|||
16312628|NCT02208089|39627514|FG001|Overall Study|Withdrawal by Subject|0|||
16312629|NCT02208089|39627513|FG000|Overall Study|Lost to Follow-up|6|||
16506387|NCT02579265|40325786|FG001|Overall Study|Withdrawal by Subject|0|||
16506388|NCT02579265|40325785|FG000|Overall Study|Physician Decision|1|||
16312630|NCT02208089|39627514|FG001|Overall Study|Lost to Follow-up|0|||
16312631|NCT02301169|39627515|FG000|Overall Study|Adverse Event|1|||
16312632|NCT02301169|39627516|FG001|Overall Study|Adverse Event|0|||
16312633|NCT02747108|39627517|FG000|Overall Study|Death|2|||
16506389|NCT02579265|40325786|FG001|Overall Study|Physician Decision|0|||
16506390|NCT02579265|40325785|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
16506391|NCT02579265|40325786|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
16506392|NCT02250443|40325787|FG000|Overall Study|Administrative problems|7|||
16506393|NCT02250443|40325787|FG000|Overall Study|Adverse Event|3|||
16506394|NCT03560531|40325788|FG000|Overall Study|Death|4|||
16506395|NCT03560531|40325789|FG001|Overall Study|Death|1|||
16506396|NCT03560531|40325790|FG002|Overall Study|Death|1|||
16506397|NCT03560531|40325791|FG003|Overall Study|Death|2|||
16506398|NCT03560531|40325792|FG004|Overall Study|Death|6|||
16506399|NCT03560531|40325793|FG005|Overall Study|Death|1|||
16506400|NCT03560531|40325794|FG006|Overall Study|Death|4|||
16506401|NCT03560531|40325795|FG007|Overall Study|Death|8|||
16506402|NCT03560531|40325796|FG008|Overall Study|Death|1|||
16506403|NCT03560531|40325797|FG009|Overall Study|Death|3|||
16506404|NCT03560531|40325798|FG010|Overall Study|Death|2|||
16506405|NCT03560531|40325799|FG011|Overall Study|Death|0|||
16506406|NCT03560531|40325800|FG012|Overall Study|Death|4|||
16506407|NCT03560531|40325801|FG013|Overall Study|Death|1|||
16506408|NCT03560531|40325788|FG000|Overall Study|Lost to Follow-up|1|||
16506409|NCT03560531|40325789|FG001|Overall Study|Lost to Follow-up|1|||
16506410|NCT03560531|40325790|FG002|Overall Study|Lost to Follow-up|0|||
16506411|NCT03560531|40325791|FG003|Overall Study|Lost to Follow-up|0|||
16506412|NCT03560531|40325792|FG004|Overall Study|Lost to Follow-up|0|||
16506413|NCT03560531|40325793|FG005|Overall Study|Lost to Follow-up|0|||
16506414|NCT03560531|40325794|FG006|Overall Study|Lost to Follow-up|1|||
16506415|NCT03560531|40325795|FG007|Overall Study|Lost to Follow-up|0|||
16506416|NCT03560531|40325796|FG008|Overall Study|Lost to Follow-up|0|||
16506417|NCT03560531|40325797|FG009|Overall Study|Lost to Follow-up|0|||
16506418|NCT03560531|40325798|FG010|Overall Study|Lost to Follow-up|0|||
16506419|NCT03560531|40325799|FG011|Overall Study|Lost to Follow-up|0|||
16506420|NCT03560531|40325800|FG012|Overall Study|Lost to Follow-up|0|||
16506421|NCT03560531|40325801|FG013|Overall Study|Lost to Follow-up|0|||
16506422|NCT03560531|40325788|FG000|Overall Study|Withdrawal by Subject|1|||
16506423|NCT03560531|40325789|FG001|Overall Study|Withdrawal by Subject|0|||
16506424|NCT03560531|40325790|FG002|Overall Study|Withdrawal by Subject|0|||
16506425|NCT03560531|40325791|FG003|Overall Study|Withdrawal by Subject|0|||
16506426|NCT03560531|40325792|FG004|Overall Study|Withdrawal by Subject|0|||
16506427|NCT03560531|40325793|FG005|Overall Study|Withdrawal by Subject|0|||
16506428|NCT03560531|40325794|FG006|Overall Study|Withdrawal by Subject|0|||
16506429|NCT03560531|40325795|FG007|Overall Study|Withdrawal by Subject|3|||
16506430|NCT03560531|40325796|FG008|Overall Study|Withdrawal by Subject|2|||
16506431|NCT03560531|40325797|FG009|Overall Study|Withdrawal by Subject|0|||
16506432|NCT03560531|40325798|FG010|Overall Study|Withdrawal by Subject|0|||
16506433|NCT03560531|40325799|FG011|Overall Study|Withdrawal by Subject|0|||
16506434|NCT03560531|40325800|FG012|Overall Study|Withdrawal by Subject|2|||
16506435|NCT03560531|40325801|FG013|Overall Study|Withdrawal by Subject|0|||
16506436|NCT03560531|40325788|FG000|Overall Study|Study end per-protocol|1|||
16506437|NCT03560531|40325789|FG001|Overall Study|Study end per-protocol|1|||
16506438|NCT03560531|40325790|FG002|Overall Study|Study end per-protocol|2|||
16506439|NCT03560531|40325791|FG003|Overall Study|Study end per-protocol|0|||
16506440|NCT03560531|40325792|FG004|Overall Study|Study end per-protocol|1|||
16506441|NCT03560531|40325793|FG005|Overall Study|Study end per-protocol|0|||
16506442|NCT03560531|40325794|FG006|Overall Study|Study end per-protocol|0|||
16506443|NCT03560531|40325795|FG007|Overall Study|Study end per-protocol|0|||
16506444|NCT03560531|40325796|FG008|Overall Study|Study end per-protocol|0|||
16506445|NCT03560531|40325797|FG009|Overall Study|Study end per-protocol|0|||
16506446|NCT03560531|40325798|FG010|Overall Study|Study end per-protocol|0|||
16506447|NCT03560531|40325799|FG011|Overall Study|Study end per-protocol|0|||
16506448|NCT03560531|40325800|FG012|Overall Study|Study end per-protocol|0|||
16506449|NCT03560531|40325801|FG013|Overall Study|Study end per-protocol|0|||
16506450|NCT03560531|40325788|FG000|Overall Study|Early study termination by sponsor|9|||
16506451|NCT03560531|40325789|FG001|Overall Study|Early study termination by sponsor|0|||
16506452|NCT03560531|40325790|FG002|Overall Study|Early study termination by sponsor|0|||
16506453|NCT03560531|40325791|FG003|Overall Study|Early study termination by sponsor|4|||
16506454|NCT03560531|40325792|FG004|Overall Study|Early study termination by sponsor|8|||
16506455|NCT03560531|40325793|FG005|Overall Study|Early study termination by sponsor|2|||
16506456|NCT03560531|40325794|FG006|Overall Study|Early study termination by sponsor|5|||
16196454|NCT01163253|39193540|FG000|Overall Study|Ongoing|13|||
16196455|NCT01163253|39193541|FG001|Overall Study|Ongoing|4|||
16506457|NCT03560531|40325795|FG007|Overall Study|Early study termination by sponsor|64|||
16506458|NCT03560531|40325796|FG008|Overall Study|Early study termination by sponsor|7|||
16506459|NCT03560531|40325797|FG009|Overall Study|Early study termination by sponsor|2|||
16506460|NCT03560531|40325798|FG010|Overall Study|Early study termination by sponsor|16|||
16506461|NCT03560531|40325799|FG011|Overall Study|Early study termination by sponsor|2|||
16506462|NCT03560531|40325800|FG012|Overall Study|Early study termination by sponsor|6|||
16506463|NCT03560531|40325801|FG013|Overall Study|Early study termination by sponsor|2|||
16506464|NCT05129488|40325803|FG000|Overall Study|Protocol Violation|3|||
16196456|NCT01163253|39193540|FG000|Overall Study|Other Unspecified|170|||
16196457|NCT01163253|39193541|FG001|Overall Study|Other Unspecified|34|||
16196458|NCT02796391|39193543|FG000|Overall Study|Lost to Follow-up|2|||
16196459|NCT02796391|39193544|FG001|Overall Study|Lost to Follow-up|2|||
16196460|NCT02796391|39193545|FG002|Overall Study|Lost to Follow-up|13|||
16196461|NCT02796391|39193546|FG003|Overall Study|Lost to Follow-up|8|||
16196462|NCT02796391|39193547|FG004|Overall Study|Lost to Follow-up|14|||
16196463|NCT02796391|39193548|FG005|Overall Study|Lost to Follow-up|13|||
16196464|NCT02796391|39193543|FG000|Overall Study|COVID|0|||
16196465|NCT02796391|39193544|FG001|Overall Study|COVID|0|||
16196466|NCT02796391|39193545|FG002|Overall Study|COVID|5|||
16196467|NCT02796391|39193546|FG003|Overall Study|COVID|5|||
16312634|NCT02747108|39627518|FG001|Overall Study|Death|2|||
16312635|NCT02747108|39627517|FG000|Overall Study|Withdrawal by Subject|1|||
16506465|NCT03873987|40325804|FG000|Overall Study|Adverse Event|1|||
16506466|NCT03873987|40325805|FG001|Overall Study|Adverse Event|0|||
16506467|NCT03873987|40325804|FG000|Overall Study|staff was unable to start a new IV line|1|||
16312636|NCT02747108|39627518|FG001|Overall Study|Withdrawal by Subject|0|||
16506468|NCT03873987|40325805|FG001|Overall Study|staff was unable to start a new IV line|0|||
16506469|NCT03873987|40325804|FG000|Overall Study|Lost to Follow-up|0|||
16506470|NCT03873987|40325805|FG001|Overall Study|Lost to Follow-up|1|||
16506471|NCT04608500|40325812|FG000|Overall Study|Adverse Event|2|||
16506472|NCT04608500|40325813|FG001|Overall Study|Adverse Event|0|||
16506473|NCT04608500|40325812|FG000|Overall Study|Lost to Follow-up|15|||
16506474|NCT04608500|40325813|FG001|Overall Study|Lost to Follow-up|9|||
16506475|NCT04608500|40325812|FG000|Overall Study|Participant request|11|||
16506476|NCT04608500|40325813|FG001|Overall Study|Participant request|7|||
16506477|NCT04608500|40325812|FG000|Overall Study|Protocol Violation|1|||
16196468|NCT02796391|39193547|FG004|Overall Study|COVID|2|||
16196469|NCT02796391|39193548|FG005|Overall Study|COVID|4|||
16196470|NCT02796391|39193543|FG000|Overall Study|Participant did not like study cigarettes|0|||
16312637|NCT02747108|39627517|FG000|Overall Study|Protocol Violation|2|||
16312638|NCT02747108|39627518|FG001|Overall Study|Protocol Violation|0|||
16312639|NCT02462603|39627519|FG000|Overall Study|Investigator Decision|1|||
16312640|NCT02462603|39627519|FG000|Overall Study|Non-Compliance|1|||
16312641|NCT02462603|39627519|FG000|Overall Study|Withdrawal by Subject|2|||
16312642|NCT02001987|39627520|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
16312643|NCT02001987|39627520|FG000|Core Study Period (24 Weeks)|Death|1|||
16312644|NCT02001987|39627520|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
16312645|NCT02001987|39627520|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
16312646|NCT02001987|39627520|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
16312647|NCT02001987|39627520|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
16312648|NCT02001987|39627520|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
16312649|NCT02001987|39627520|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
16312650|NCT02001987|39627520|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
16312651|NCT02001987|39627520|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
16312652|NCT02001987|39627520|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
16312653|NCT02001987|39627520|FG000|LTE Period (52 Weeks)|Other|3|||
16312654|NCT01958437|39627521|FG000|Overall Study|Incidental MRI findings|0|||
16312655|NCT01958437|39627522|FG001|Overall Study|Incidental MRI findings|0|||
16312656|NCT01958437|39627523|FG002|Overall Study|Incidental MRI findings|1|||
16312657|NCT01958437|39627524|FG003|Overall Study|Incidental MRI findings|1|||
16312658|NCT03759392|39627525|FG000|Overall Study|Adverse Event|12|||
16312659|NCT03759392|39627526|FG001|Overall Study|Adverse Event|4|||
16312660|NCT03759392|39627525|FG000|Overall Study|Death|2|||
16312661|NCT03759392|39627526|FG001|Overall Study|Death|1|||
16312662|NCT03759392|39627525|FG000|Overall Study|Withdrawal by Subject|2|||
16312663|NCT03759392|39627526|FG001|Overall Study|Withdrawal by Subject|0|||
16312664|NCT03759392|39627525|FG000|Overall Study|Protocol Violation|2|||
16312665|NCT03759392|39627526|FG001|Overall Study|Protocol Violation|0|||
16312666|NCT03759392|39627525|FG000|Overall Study|Physician Decision|0|||
16312667|NCT03759392|39627526|FG001|Overall Study|Physician Decision|1|||
16312668|NCT03759392|39627525|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
16312669|NCT03759392|39627526|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
16312670|NCT03759392|39627525|FG000|Overall Study|No longer able to take medicines|1|||
16312671|NCT03759392|39627526|FG001|Overall Study|No longer able to take medicines|0|||
16312672|NCT03759392|39627525|FG000|Overall Study|Stopped taking study drug|1|||
16506478|NCT04608500|40325813|FG001|Overall Study|Protocol Violation|0|||
16312673|NCT03759392|39627526|FG001|Overall Study|Stopped taking study drug|0|||
16312674|NCT02949973|39627527|FG000|Overall Study|Physician Decision|1|||
16312675|NCT02540083|39627532|FG000|Overall Study|Withdrawal by Subject|16|||
16312676|NCT03500198|39627534|FG000|Overall Study|Lost to Follow-up|0|||
16196471|NCT02796391|39193544|FG001|Overall Study|Participant did not like study cigarettes|0|||
16506479|NCT04608500|40325812|FG000|Overall Study|Other|6|||
16506480|NCT04608500|40325813|FG001|Overall Study|Other|2|||
16196472|NCT02796391|39193545|FG002|Overall Study|Participant did not like study cigarettes|3|||
16312677|NCT03500198|39627535|FG001|Overall Study|Lost to Follow-up|1|||
16312678|NCT03022084|39627545|FG000|Overall Study|Lost to Follow-up|2|||
16312679|NCT03022084|39627546|FG001|Overall Study|Lost to Follow-up|3|||
16312680|NCT01487525|39627547|FG000|Overall Study|Withdrawal by Subject|0|||
16312681|NCT01487525|39627548|FG001|Overall Study|Withdrawal by Subject|1|||
16312682|NCT00725491|39627550|FG000|Overall Study|Adverse Event|3|||
16312683|NCT00725491|39627551|FG001|Overall Study|Adverse Event|2|||
16312684|NCT00725491|39627550|FG000|Overall Study|Pregnancy|0|||
16312685|NCT00725491|39627551|FG001|Overall Study|Pregnancy|3|||
16312686|NCT00725491|39627550|FG000|Overall Study|Risk for hyperstimulation|2|||
16312687|NCT00725491|39627551|FG001|Overall Study|Risk for hyperstimulation|9|||
16312688|NCT00725491|39627550|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
16312689|NCT00725491|39627551|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
16312690|NCT00725491|39627550|FG000|Overall Study|Fertilization failure|0|||
16312691|NCT00725491|39627551|FG001|Overall Study|Fertilization failure|1|||
16312692|NCT00725491|39627550|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
16312693|NCT00725491|39627551|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
16391012|NCT00690430|39916046|FG002|Core Phase|Abnormal Laboratory value|0|||
16391013|NCT00690430|39916044|FG000|Core Phase|Adverse Event|5|||
16391014|NCT00690430|39916045|FG001|Core Phase|Adverse Event|1|||
16391015|NCT00690430|39916046|FG002|Core Phase|Adverse Event|0|||
16391016|NCT00690430|39916044|FG000|Core Phase|Death|0|||
16391017|NCT00690430|39916045|FG001|Core Phase|Death|2|||
16391018|NCT00690430|39916046|FG002|Core Phase|Death|0|||
16391019|NCT00690430|39916044|FG000|Core Phase|Protocol Violation|1|||
16312694|NCT02626026|39627554|FG000|Overall Study|Randomized but Never Treated|0|||
16312695|NCT02626026|39627555|FG001|Overall Study|Randomized but Never Treated|0|||
16312696|NCT02626026|39627556|FG002|Overall Study|Randomized but Never Treated|0|||
16312697|NCT02626026|39627557|FG003|Overall Study|Randomized but Never Treated|0|||
16312698|NCT02626026|39627558|FG004|Overall Study|Randomized but Never Treated|1|||
16312699|NCT02626026|39627559|FG005|Overall Study|Randomized but Never Treated|0|||
16312700|NCT00586703|39627560|FG000|Overall Study|Death|12|||
16312701|NCT00707239|39630680|FG000|Overall Study|Adverse Event|5|||
16312702|NCT00707239|39630681|FG001|Overall Study|Adverse Event|3|||
16312703|NCT00707239|39630682|FG002|Overall Study|Adverse Event|2|||
16312704|NCT00707239|39630680|FG000|Overall Study|Death|3|||
16312705|NCT00707239|39630681|FG001|Overall Study|Death|1|||
16312706|NCT00707239|39630682|FG002|Overall Study|Death|3|||
16312707|NCT00707239|39630680|FG000|Overall Study|Physician Decision|1|||
16312708|NCT00707239|39630681|FG001|Overall Study|Physician Decision|1|||
16312709|NCT00707239|39630682|FG002|Overall Study|Physician Decision|2|||
16312710|NCT00707239|39630680|FG000|Overall Study|Protocol Violation|0|||
16312711|NCT00707239|39630681|FG001|Overall Study|Protocol Violation|0|||
16312712|NCT00707239|39630682|FG002|Overall Study|Protocol Violation|1|||
16312713|NCT00707239|39630680|FG000|Overall Study|Lack of Efficacy|1|||
16312714|NCT00707239|39630681|FG001|Overall Study|Lack of Efficacy|2|||
16312715|NCT00707239|39630682|FG002|Overall Study|Lack of Efficacy|0|||
16312716|NCT00707239|39630680|FG000|Overall Study|Randomized, but not treated|1|||
16312717|NCT00707239|39630681|FG001|Overall Study|Randomized, but not treated|1|||
16312718|NCT00707239|39630682|FG002|Overall Study|Randomized, but not treated|1|||
16312719|NCT00707239|39630680|FG000|Overall Study|Other|8|||
16312720|NCT00707239|39630681|FG001|Overall Study|Other|3|||
16312721|NCT00707239|39630682|FG002|Overall Study|Other|5|||
16312722|NCT01562782|39630683|FG000|Overall Study|Withdrawal by Subject|3|||
16312723|NCT01562782|39630684|FG001|Overall Study|Withdrawal by Subject|3|||
16312724|NCT01562782|39630683|FG000|Overall Study|screen failure|1|||
16312725|NCT01562782|39630684|FG001|Overall Study|screen failure|2|||
16312726|NCT02877004|39630685|FG000|Overall Study|Pregnancy|0|||
16312727|NCT02877004|39630686|FG001|Overall Study|Pregnancy|0|||
16312728|NCT02877004|39630687|FG002|Overall Study|Pregnancy|1|||
16312729|NCT00495391|39630688|FG000|Overall Study|Lack of Efficacy|34|||
16312730|NCT00495391|39630689|FG001|Overall Study|Lack of Efficacy|18|||
16312731|NCT00495391|39630688|FG000|Overall Study|Withdrawal by Subject|2|||
16312732|NCT00495391|39630689|FG001|Overall Study|Withdrawal by Subject|3|||
16391020|NCT00690430|39916045|FG001|Core Phase|Protocol Violation|0|||
16312733|NCT01686373|39630690|FG000|Overall Study|Lost to Follow-up|3|||
16312734|NCT01686373|39630691|FG001|Overall Study|Lost to Follow-up|0|||
16312735|NCT01686373|39630690|FG000|Overall Study|Withdrawal by Subject|0|||
16312736|NCT01686373|39630691|FG001|Overall Study|Withdrawal by Subject|1|||
16391021|NCT00690430|39916046|FG002|Core Phase|Protocol Violation|0|||
16391022|NCT00690430|39916044|FG000|Core Phase|Withdrawal by Subject|3|||
16312737|NCT01686373|39630690|FG000|Overall Study|Adverse Event|0|||
16312738|NCT01686373|39630691|FG001|Overall Study|Adverse Event|1|||
16312739|NCT02653625|39630692|FG000|Overall Study|Adverse Event|1|||
16312740|NCT02653625|39630692|FG000|Overall Study|Non-compliance with Study Drug|1|||
16312741|NCT02653625|39630692|FG000|Overall Study|Protocol Violation|1|||
16312742|NCT02653625|39630692|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
16391023|NCT00690430|39916045|FG001|Core Phase|Withdrawal by Subject|3|||
16312743|NCT04479787|39630695|FG000|Overall Study|Withdrawal by Subject|19|||
16312744|NCT04479787|39630696|FG001|Overall Study|Withdrawal by Subject|27|||
16312745|NCT04479787|39630695|FG000|Overall Study|Unsuccessful Trial|17|||
16312746|NCT04479787|39630696|FG001|Overall Study|Unsuccessful Trial|7|||
16312747|NCT04479787|39630695|FG000|Overall Study|Subject Participation Terminated By Investigator|14|||
16312748|NCT04479787|39630696|FG001|Overall Study|Subject Participation Terminated By Investigator|5|||
16312749|NCT04479787|39630695|FG000|Overall Study|IPG/Lead(s) Explanted But Not Replaced|4|||
16312750|NCT04479787|39630696|FG001|Overall Study|IPG/Lead(s) Explanted But Not Replaced|4|||
16312751|NCT04479787|39630695|FG000|Overall Study|Lost to Follow-up|3|||
16312752|NCT04479787|39630696|FG001|Overall Study|Lost to Follow-up|3|||
16312753|NCT04479787|39630695|FG000|Overall Study|Death|4|||
16312754|NCT04479787|39630696|FG001|Overall Study|Death|0|||
16312755|NCT04479787|39630695|FG000|Overall Study|Inclusion/Exclusion|2|||
16312756|NCT04479787|39630696|FG001|Overall Study|Inclusion/Exclusion|1|||
16312757|NCT04479787|39630695|FG000|Overall Study|Subject Became Pregnant|1|||
16312758|NCT04479787|39630696|FG001|Overall Study|Subject Became Pregnant|1|||
16312759|NCT04479787|39630695|FG000|Overall Study|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
16312760|NCT04479787|39630696|FG001|Overall Study|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
16312761|NCT04479787|39630695|FG000|Overall Study|Patient's Health Significantly Declined|0|||
16312762|NCT04479787|39630696|FG001|Overall Study|Patient's Health Significantly Declined|1|||
16312763|NCT04479787|39630695|FG000|Overall Study|Subject Had Back Surgery On March 1st|0|||
16312764|NCT04479787|39630696|FG001|Overall Study|Subject Had Back Surgery On March 1st|1|||
16312765|NCT04479787|39630695|FG000|Overall Study|Withdrawn At Sponsor's Request|1|||
16506481|NCT02281552|40325814|FG000|Overall Study|Medication error|1|||
16312766|NCT04479787|39630696|FG001|Overall Study|Withdrawn At Sponsor's Request|0|||
16312767|NCT04479787|39630695|FG000|Overall Study|Subject Failed To Comply With The Protocol Requirements|1|||
16312768|NCT04479787|39630696|FG001|Overall Study|Subject Failed To Comply With The Protocol Requirements|0|||
16312769|NCT00380874|39630698|FG000|Overall Study|Adverse Event|7|||
16312770|NCT00380874|39630699|FG001|Overall Study|Adverse Event|7|||
16312771|NCT00380874|39630698|FG000|Overall Study|Death|1|||
16312772|NCT00380874|39630699|FG001|Overall Study|Death|0|||
16506482|NCT02281552|40325815|FG001|Overall Study|Medication error|0|||
16312773|NCT00380874|39630698|FG000|Overall Study|Withdrawal by Subject|2|||
16312774|NCT00380874|39630699|FG001|Overall Study|Withdrawal by Subject|1|||
16312775|NCT00380874|39630698|FG000|Overall Study|Not related to study drug|3|||
16312776|NCT00380874|39630699|FG001|Overall Study|Not related to study drug|2|||
16312777|NCT01346696|39630700|FG000|Overall Study|Death|1|||
16312778|NCT02268916|39630701|FG000|Overall Study|Lost to Follow-up|1|||
16312779|NCT02268916|39630702|FG001|Overall Study|Lost to Follow-up|1|||
16312780|NCT02268916|39630701|FG000|Overall Study|Withdrawal by Subject|6|||
16312781|NCT02268916|39630702|FG001|Overall Study|Withdrawal by Subject|5|||
16312782|NCT02268916|39630701|FG000|Overall Study|Participant did not have diabetes|1|||
16312783|NCT02268916|39630702|FG001|Overall Study|Participant did not have diabetes|0|||
16312784|NCT02268916|39630701|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
16312785|NCT02268916|39630702|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
16312786|NCT03751098|39630703|FG000|Overall Study|Withdrawal by Subject|0|||
16312787|NCT03751098|39630704|FG001|Overall Study|Withdrawal by Subject|1|||
16312788|NCT02166333|39630706|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
16312789|NCT02166333|39630707|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
16312790|NCT02166333|39630708|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
16312791|NCT02166333|39630709|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
16312792|NCT02166333|39630710|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
16312793|NCT02166333|39630711|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
16312794|NCT02166333|39630706|FG000|Stage 1|Death|4|||
16312795|NCT02166333|39630707|FG001|Stage 1|Death|0|||
16312796|NCT02166333|39630708|FG002|Stage 1|Death|2|||
16312797|NCT02166333|39630709|FG003|Stage 1|Death|0|||
16312798|NCT02166333|39630710|FG004|Stage 1|Death|3|||
16312799|NCT02166333|39630711|FG005|Stage 1|Death|2|||
16506483|NCT02281552|40325814|FG000|Overall Study|Insufficient clinical response|0|||
16506484|NCT02281552|40325815|FG001|Overall Study|Insufficient clinical response|1|||
16506485|NCT02281552|40325814|FG000|Overall Study|Adverse Event|3|||
16506486|NCT02281552|40325815|FG001|Overall Study|Adverse Event|9|||
16506487|NCT02447081|40325816|FG000|Overall Study|Death|161|||
16506488|NCT02447081|40325816|FG000|Overall Study|Lost to Follow-up|36|||
16506489|NCT02447081|40325816|FG000|Overall Study|Visit not completed|17|||
16506490|NCT02447081|40325816|FG000|Overall Study|unsuccessful implant procedure|10|||
16506491|NCT01124643|40329217|FG000|Overall Study|Death|1|||
16506492|NCT02046148|40329218|FG000|Overall Study|Lost to Follow-up|1|||
16506493|NCT02046148|40329219|FG001|Overall Study|Lost to Follow-up|1|||
16506494|NCT02046148|40329218|FG000|Overall Study|Withdrawal by Subject|0|||
16506495|NCT02046148|40329219|FG001|Overall Study|Withdrawal by Subject|2|||
16506496|NCT04211337|40329224|FG000|Overall Study|On Treatment|175|||
16506497|NCT04211337|40329225|FG001|Overall Study|On Treatment|40|||
16391024|NCT00690430|39916046|FG002|Core Phase|Withdrawal by Subject|0|||
16391025|NCT00690430|39916044|FG000|Core Phase|Subject no longer requires study drug|1|||
16391026|NCT00690430|39916045|FG001|Core Phase|Subject no longer requires study drug|0|||
16391027|NCT00690430|39916046|FG002|Core Phase|Subject no longer requires study drug|0|||
16391028|NCT00690430|39916044|FG000|Core Phase|Lack of Efficacy|8|||
16391029|NCT00690430|39916045|FG001|Core Phase|Lack of Efficacy|10|||
16391030|NCT00690430|39916046|FG002|Core Phase|Lack of Efficacy|0|||
16391031|NCT00690430|39916044|FG000|Core Phase|Administrative Problems|0|||
16391032|NCT00690430|39916045|FG001|Core Phase|Administrative Problems|1|||
16391033|NCT00690430|39916046|FG002|Core Phase|Administrative Problems|0|||
16391034|NCT00690430|39916044|FG000|Core Phase|Early Termination|0|||
16391035|NCT00690430|39916045|FG001|Core Phase|Early Termination|5|||
16391036|NCT00690430|39916046|FG002|Core Phase|Early Termination|0|||
16391037|NCT00690430|39916044|FG000|Extension Phase|Lack of Efficacy|3|||
16391038|NCT00690430|39916045|FG001|Extension Phase|Lack of Efficacy|1|||
16391039|NCT00690430|39916046|FG002|Extension Phase|Lack of Efficacy|4|||
16391040|NCT00690430|39916044|FG000|Extension Phase|Abnormal Lab Values|1|||
16391041|NCT00690430|39916045|FG001|Extension Phase|Abnormal Lab Values|0|||
16391042|NCT00690430|39916046|FG002|Extension Phase|Abnormal Lab Values|0|||
16391043|NCT00690430|39916044|FG000|Extension Phase|Abnormal test procedure results|1|||
16391044|NCT00690430|39916045|FG001|Extension Phase|Abnormal test procedure results|0|||
16391045|NCT00690430|39916046|FG002|Extension Phase|Abnormal test procedure results|0|||
16391046|NCT00690430|39916044|FG000|Extension Phase|Administrative Problems|0|||
16391047|NCT00690430|39916045|FG001|Extension Phase|Administrative Problems|1|||
16391048|NCT00690430|39916046|FG002|Extension Phase|Administrative Problems|1|||
16391049|NCT00690430|39916044|FG000|Extension Phase|Adverse Event|2|||
16391050|NCT00690430|39916045|FG001|Extension Phase|Adverse Event|1|||
16391051|NCT00690430|39916046|FG002|Extension Phase|Adverse Event|2|||
16391052|NCT00690430|39916044|FG000|Extension Phase|Death|1|||
16391053|NCT00690430|39916045|FG001|Extension Phase|Death|1|||
16391054|NCT00690430|39916046|FG002|Extension Phase|Death|1|||
16391055|NCT00690430|39916044|FG000|Extension Phase|Withdrawal by Subject|0|||
16391056|NCT00690430|39916045|FG001|Extension Phase|Withdrawal by Subject|0|||
16391057|NCT00690430|39916046|FG002|Extension Phase|Withdrawal by Subject|2|||
16391058|NCT00690430|39916044|FG000|Extension Phase|Early Termination|10|||
16391059|NCT00690430|39916045|FG001|Extension Phase|Early Termination|1|||
16391060|NCT00690430|39916046|FG002|Extension Phase|Early Termination|3|||
16391061|NCT00003631|39916047|FG000|Overall Study|Patient not treated|1|||
16391062|NCT00003631|39916048|FG001|Overall Study|Patient not treated|0|||
16391063|NCT00003631|39916049|FG002|Overall Study|Patient not treated|1|||
16391064|NCT00003631|39916047|FG000|Overall Study|Protocol Violation|1|||
16391065|NCT00003631|39916048|FG001|Overall Study|Protocol Violation|0|||
16391066|NCT00003631|39916049|FG002|Overall Study|Protocol Violation|0|||
16391067|NCT00003631|39916047|FG000|Overall Study|Adverse Event|1|||
16391068|NCT00003631|39916048|FG001|Overall Study|Adverse Event|1|||
16391069|NCT00003631|39916049|FG002|Overall Study|Adverse Event|5|||
16391070|NCT00003631|39916047|FG000|Overall Study|Death|0|||
16391071|NCT00003631|39916048|FG001|Overall Study|Death|0|||
16391072|NCT00003631|39916049|FG002|Overall Study|Death|1|||
16391073|NCT00003631|39916047|FG000|Overall Study|Evaluable for toxicity only|0|||
16391074|NCT00003631|39916048|FG001|Overall Study|Evaluable for toxicity only|0|||
16391075|NCT00003631|39916049|FG002|Overall Study|Evaluable for toxicity only|2|||
16391076|NCT02819297|39916057|FG000|Overall Study|Withdrawal by Subject|25|||
16391077|NCT02819297|39916058|FG001|Overall Study|Withdrawal by Subject|13|||
16391078|NCT02819297|39916057|FG000|Overall Study|Lost to Follow-up|12|||
16391079|NCT02819297|39916058|FG001|Overall Study|Lost to Follow-up|14|||
16391080|NCT02819297|39916057|FG000|Overall Study|Adverse Event|12|||
16391081|NCT02819297|39916058|FG001|Overall Study|Adverse Event|10|||
16391082|NCT02819297|39916057|FG000|Overall Study|Physician Decision|5|||
16391083|NCT02819297|39916058|FG001|Overall Study|Physician Decision|5|||
16391084|NCT02819297|39916057|FG000|Overall Study|Lack of Efficacy|5|||
16391085|NCT02819297|39916058|FG001|Overall Study|Lack of Efficacy|8|||
16391086|NCT02819297|39916057|FG000|Overall Study|Protocol Violation|1|||
16506498|NCT04211337|40329224|FG000|Overall Study|Withdrawal by Subject|0|||
16506499|NCT04211337|40329225|FG001|Overall Study|Withdrawal by Subject|2|||
16391087|NCT02819297|39916058|FG001|Overall Study|Protocol Violation|2|||
16391088|NCT00625586|39916060|FG000|Overall Study|Adverse Event|1|||
16391089|NCT00625586|39916060|FG000|Overall Study|Progressive disease|1|||
16391090|NCT02628444|39916061|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
16391091|NCT02628444|39916062|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16391092|NCT02628444|39916063|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16391093|NCT02628444|39916064|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16391094|NCT02628444|39916065|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16409944|NCT00343915|39981841|FG000|Primary Study|Withdrawal by Subject|1|||
16391095|NCT02628444|39916066|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16391096|NCT02628444|39916067|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16391097|NCT02628444|39916068|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16391098|NCT02628444|39916069|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
16506500|NCT04307446|40329229|FG000|Overall Study|Lost to Follow-up|2|||
16506501|NCT04307446|40329230|FG001|Overall Study|Lost to Follow-up|0|||
16506502|NCT01350128|40329231|FG000|Overall Study|Withdrawal by Subject|3|||
16506503|NCT01350128|40329231|FG000|Overall Study|Protocol discontinuation criteria|8|||
16391099|NCT02628444|39916061|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16391100|NCT02628444|39916062|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
16391101|NCT02628444|39916063|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
16312800|NCT02166333|39630706|FG000|Stage 1|Lost to Follow-up|12|||
16391102|NCT02628444|39916064|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16391103|NCT02628444|39916065|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16391104|NCT02628444|39916066|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16391105|NCT02628444|39916067|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16391106|NCT02628444|39916068|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16391107|NCT02628444|39916069|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
16391108|NCT02628444|39916061|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
16391109|NCT02628444|39916062|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
16391110|NCT02628444|39916063|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
16391111|NCT02628444|39916064|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16391112|NCT02628444|39916065|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16391113|NCT02628444|39916066|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16391114|NCT02628444|39916067|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16391115|NCT02628444|39916068|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16391116|NCT02628444|39916069|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
16391117|NCT02628444|39916061|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
16506504|NCT01350128|40329231|FG000|Overall Study|Physician Decision|1|||
16506505|NCT01350128|40329231|FG000|Overall Study|Lost to Follow-up|2|||
16506506|NCT04809220|40329232|FG000|Overall Study|Adverse Event|4|||
16506507|NCT04809220|40329233|FG001|Overall Study|Adverse Event|0|||
16506508|NCT04809220|40329232|FG000|Overall Study|Death|1|||
16312801|NCT02166333|39630707|FG001|Stage 1|Lost to Follow-up|0|||
16312802|NCT02166333|39630708|FG002|Stage 1|Lost to Follow-up|6|||
16312803|NCT02166333|39630709|FG003|Stage 1|Lost to Follow-up|0|||
16312804|NCT02166333|39630710|FG004|Stage 1|Lost to Follow-up|3|||
16312805|NCT02166333|39630711|FG005|Stage 1|Lost to Follow-up|3|||
16312806|NCT02166333|39630706|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
16312807|NCT02166333|39630707|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
16312808|NCT02166333|39630708|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
16312809|NCT02166333|39630709|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
16312810|NCT02166333|39630710|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
16312811|NCT02166333|39630711|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
16312812|NCT02166333|39630706|FG000|Stage 2|Death|4|||
16312813|NCT02166333|39630707|FG001|Stage 2|Death|2|||
16312814|NCT02166333|39630708|FG002|Stage 2|Death|1|||
16312815|NCT02166333|39630709|FG003|Stage 2|Death|0|||
16312816|NCT02166333|39630710|FG004|Stage 2|Death|0|||
16312817|NCT02166333|39630711|FG005|Stage 2|Death|1|||
16312818|NCT02166333|39630706|FG000|Stage 2|Lost to Follow-up|23|||
16312819|NCT02166333|39630707|FG001|Stage 2|Lost to Follow-up|4|||
16312820|NCT02166333|39630708|FG002|Stage 2|Lost to Follow-up|11|||
16312821|NCT02166333|39630709|FG003|Stage 2|Lost to Follow-up|9|||
16312822|NCT02166333|39630710|FG004|Stage 2|Lost to Follow-up|3|||
16312823|NCT02166333|39630711|FG005|Stage 2|Lost to Follow-up|6|||
16312824|NCT03564119|39630712|FG000|Overall Study|Adverse Event|4|||
16312825|NCT03564119|39630713|FG001|Overall Study|Adverse Event|0|||
16312826|NCT03564119|39630712|FG000|Overall Study|Lost to Follow-up|1|||
16312827|NCT03564119|39630713|FG001|Overall Study|Lost to Follow-up|4|||
16312828|NCT03564119|39630712|FG000|Overall Study|Protocol Violation|1|||
16312829|NCT03564119|39630713|FG001|Overall Study|Protocol Violation|0|||
16312830|NCT03564119|39630712|FG000|Overall Study|Withdrawal by Subject|9|||
16312831|NCT03564119|39630713|FG001|Overall Study|Withdrawal by Subject|4|||
16312832|NCT03564119|39630712|FG000|Overall Study|Other Than Specified|0|||
16312833|NCT03564119|39630713|FG001|Overall Study|Other Than Specified|1|||
16312834|NCT01082328|39630719|FG000|Overall Study|Adverse Event|1|||
16312835|NCT05393037|39630720|FG000|Overall Study|Death|1|||
16312836|NCT05393037|39630721|FG001|Overall Study|Death|0|||
16312837|NCT05393037|39630720|FG000|Overall Study|Lost to Follow-up|1|||
16312838|NCT05393037|39630721|FG001|Overall Study|Lost to Follow-up|1|||
16312839|NCT05393037|39630720|FG000|Overall Study|Withdrawal by Subject|2|||
16312840|NCT05393037|39630721|FG001|Overall Study|Withdrawal by Subject|4|||
16312841|NCT05393037|39630720|FG000|Overall Study|Ongoing|152|||
16312842|NCT05393037|39630721|FG001|Overall Study|Ongoing|0|||
16312843|NCT02090725|39630722|FG000|Overall Study|Withdrawal by Subject|1|||
16391118|NCT02628444|39916062|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
16391119|NCT02628444|39916063|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
16391120|NCT02628444|39916064|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16391121|NCT02628444|39916065|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16391122|NCT02628444|39916066|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16391123|NCT02628444|39916067|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16391124|NCT02628444|39916068|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16391125|NCT02628444|39916069|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
16391126|NCT02628444|39916061|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
16391127|NCT02628444|39916062|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
16391128|NCT02628444|39916063|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
16391129|NCT02628444|39916064|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16391130|NCT02628444|39916065|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16391131|NCT02628444|39916066|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16506509|NCT04809220|40329233|FG001|Overall Study|Death|0|||
16312844|NCT02090725|39630722|FG000|Overall Study|participants moved from area|3|||
16312845|NCT03192488|39630727|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
16312846|NCT03192488|39630728|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
16312847|NCT03192488|39630729|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
16312848|NCT03192488|39630730|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
16312849|NCT03192488|39630731|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
16312850|NCT03192488|39630732|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
16312851|NCT03192488|39630727|FG000|Third Intervention (d1)|Adverse Event|0|||
16312852|NCT03192488|39630728|FG001|Third Intervention (d1)|Adverse Event|0|||
16312853|NCT03192488|39630729|FG002|Third Intervention (d1)|Adverse Event|0|||
16312854|NCT03192488|39630730|FG003|Third Intervention (d1)|Adverse Event|0|||
16312855|NCT03192488|39630731|FG004|Third Intervention (d1)|Adverse Event|1|||
16312856|NCT03192488|39630732|FG005|Third Intervention (d1)|Adverse Event|0|||
16312857|NCT00634036|39630738|FG000|Overall Study|Lost to Follow-up|1|||
16312858|NCT00634036|39630739|FG001|Overall Study|Lost to Follow-up|1|||
16312859|NCT00634036|39630738|FG000|Overall Study|Withdrawal by Subject|1|||
16312860|NCT00634036|39630739|FG001|Overall Study|Withdrawal by Subject|1|||
16312861|NCT01671007|39630742|FG000|Overall Study|Other reasons than listed|166|||
16312862|NCT01671007|39630743|FG001|Overall Study|Other reasons than listed|373|||
16312863|NCT01671007|39630744|FG002|Overall Study|Other reasons than listed|197|||
16312864|NCT01671007|39630745|FG003|Overall Study|Other reasons than listed|228|||
16312865|NCT01671007|39630746|FG004|Overall Study|Other reasons than listed|14|||
16312866|NCT01671007|39630747|FG005|Overall Study|Other reasons than listed|71|||
16312867|NCT01671007|39630748|FG006|Overall Study|Other reasons than listed|17|||
16506510|NCT04809220|40329232|FG000|Overall Study|Lost to Follow-up|3|||
16506511|NCT04809220|40329233|FG001|Overall Study|Lost to Follow-up|0|||
16196473|NCT02796391|39193546|FG003|Overall Study|Participant did not like study cigarettes|0|||
16196474|NCT02796391|39193547|FG004|Overall Study|Participant did not like study cigarettes|0|||
16196475|NCT02796391|39193548|FG005|Overall Study|Participant did not like study cigarettes|0|||
16196476|NCT02796391|39193543|FG000|Overall Study|Withdrawal by Subject|1|||
16196477|NCT02796391|39193544|FG001|Overall Study|Withdrawal by Subject|1|||
16196478|NCT02796391|39193545|FG002|Overall Study|Withdrawal by Subject|4|||
16196479|NCT02796391|39193546|FG003|Overall Study|Withdrawal by Subject|3|||
16196480|NCT02796391|39193547|FG004|Overall Study|Withdrawal by Subject|4|||
16196481|NCT02796391|39193548|FG005|Overall Study|Withdrawal by Subject|3|||
16196482|NCT02796391|39193543|FG000|Overall Study|Adverse Event|0|||
16196483|NCT02796391|39193544|FG001|Overall Study|Adverse Event|0|||
16196484|NCT02796391|39193545|FG002|Overall Study|Adverse Event|0|||
16196485|NCT02796391|39193546|FG003|Overall Study|Adverse Event|1|||
16506512|NCT04809220|40329232|FG000|Overall Study|Physician Decision|0|||
16506513|NCT04809220|40329233|FG001|Overall Study|Physician Decision|1|||
16506514|NCT04809220|40329232|FG000|Overall Study|Withdrawal by Subject|9|||
16506515|NCT04809220|40329233|FG001|Overall Study|Withdrawal by Subject|5|||
16506516|NCT04809220|40329232|FG000|Overall Study|Due to long-term overseas business trips|1|||
16506517|NCT04809220|40329233|FG001|Overall Study|Due to long-term overseas business trips|0|||
16506518|NCT02013167|40329236|FG000|Overall Study|Withdrawal by Subject|15|||
16506519|NCT02013167|40329237|FG001|Overall Study|Withdrawal by Subject|14|||
16506520|NCT02013167|40329236|FG000|Overall Study|Sponsor Decision|1|||
16506521|NCT02013167|40329237|FG001|Overall Study|Sponsor Decision|3|||
16506522|NCT02013167|40329236|FG000|Overall Study|Lost to Follow-up|0|||
16506523|NCT02013167|40329237|FG001|Overall Study|Lost to Follow-up|1|||
16506524|NCT02013167|40329236|FG000|Overall Study|Death|85|||
16089933|NCT00614614|38820027|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
16196486|NCT02796391|39193547|FG004|Overall Study|Adverse Event|0|||
16506525|NCT02013167|40329237|FG001|Overall Study|Death|160|||
16506526|NCT00778700|40329238|FG000|Overall Study|Adverse Event|6|||
16506527|NCT00778700|40329239|FG001|Overall Study|Adverse Event|1|||
16506528|NCT00778700|40329240|FG002|Overall Study|Adverse Event|3|||
16506529|NCT00778700|40329241|FG003|Overall Study|Adverse Event|5|||
16506530|NCT00778700|40329238|FG000|Overall Study|Protocol Violation|1|||
16506531|NCT00778700|40329239|FG001|Overall Study|Protocol Violation|1|||
16506532|NCT00778700|40329240|FG002|Overall Study|Protocol Violation|0|||
16506533|NCT00778700|40329241|FG003|Overall Study|Protocol Violation|0|||
16506534|NCT00778700|40329238|FG000|Overall Study|Subject Withdrew Consent|6|||
16506535|NCT00778700|40329239|FG001|Overall Study|Subject Withdrew Consent|4|||
16506536|NCT00778700|40329240|FG002|Overall Study|Subject Withdrew Consent|1|||
16506537|NCT00778700|40329241|FG003|Overall Study|Subject Withdrew Consent|4|||
16506538|NCT00778700|40329238|FG000|Overall Study|Lost to Follow-up|3|||
16506539|NCT00778700|40329239|FG001|Overall Study|Lost to Follow-up|1|||
16506540|NCT00778700|40329240|FG002|Overall Study|Lost to Follow-up|0|||
16506541|NCT00778700|40329241|FG003|Overall Study|Lost to Follow-up|1|||
16506542|NCT00778700|40329238|FG000|Overall Study|Reason not Specified|2|||
16506543|NCT00778700|40329239|FG001|Overall Study|Reason not Specified|0|||
16506544|NCT00778700|40329240|FG002|Overall Study|Reason not Specified|1|||
16506545|NCT00778700|40329241|FG003|Overall Study|Reason not Specified|3|||
16506546|NCT00778700|40329238|FG000|Overall Study|Other|0|||
16506547|NCT00778700|40329239|FG001|Overall Study|Other|0|||
16506548|NCT00778700|40329240|FG002|Overall Study|Other|1|||
16506549|NCT00778700|40329241|FG003|Overall Study|Other|0|||
16506550|NCT00004888|40329244|FG000|Overall Study|Adverse Event|5|||
16506551|NCT00004888|40329245|FG001|Overall Study|Adverse Event|10|||
16506552|NCT00004888|40329244|FG000|Overall Study|Withdrawal by Subject|0|||
16506553|NCT00004888|40329245|FG001|Overall Study|Withdrawal by Subject|3|||
16506554|NCT00004888|40329244|FG000|Overall Study|Physician Decision|1|||
16506555|NCT00004888|40329245|FG001|Overall Study|Physician Decision|1|||
16506556|NCT00004888|40329244|FG000|Overall Study|Progressive Disease|4|||
16506557|NCT00004888|40329245|FG001|Overall Study|Progressive Disease|9|||
16506558|NCT00004888|40329244|FG000|Overall Study|Death without progressive disease|0|||
16506559|NCT00004888|40329245|FG001|Overall Study|Death without progressive disease|1|||
16506560|NCT00004888|40329244|FG000|Overall Study|Toxic death|1|||
16506561|NCT00004888|40329245|FG001|Overall Study|Toxic death|0|||
16506562|NCT00573755|40329246|FG000|Overall Study|Still receiving treatment|1|||
16506563|NCT00573755|40329247|FG001|Overall Study|Still receiving treatment|0|||
16506564|NCT02874742|40329248|FG000|Overall Study|Death|0|||
16506565|NCT02874742|40329249|FG001|Overall Study|Death|1|||
16506566|NCT02874742|40329250|FG002|Overall Study|Death|0|||
16506567|NCT02874742|40329248|FG000|Overall Study|Lost to Follow-up|5|||
16506568|NCT02874742|40329249|FG001|Overall Study|Lost to Follow-up|4|||
16506569|NCT02874742|40329250|FG002|Overall Study|Lost to Follow-up|1|||
16506570|NCT02874742|40329248|FG000|Overall Study|Withdrawal by Subject|17|||
16506571|NCT02874742|40329249|FG001|Overall Study|Withdrawal by Subject|8|||
16506572|NCT02874742|40329250|FG002|Overall Study|Withdrawal by Subject|0|||
16506573|NCT02874742|40329248|FG000|Overall Study|Other|4|||
16506574|NCT02874742|40329249|FG001|Overall Study|Other|1|||
16506575|NCT02874742|40329250|FG002|Overall Study|Other|0|||
16506576|NCT02874742|40329248|FG000|Overall Study|Progressive Disease|1|||
16506577|NCT02874742|40329249|FG001|Overall Study|Progressive Disease|0|||
16506578|NCT02874742|40329250|FG002|Overall Study|Progressive Disease|0|||
16506579|NCT02874742|40329248|FG000|Overall Study|Screen Failure|0|||
16506580|NCT02874742|40329249|FG001|Overall Study|Screen Failure|2|||
16506581|NCT02874742|40329250|FG002|Overall Study|Screen Failure|0|||
16506582|NCT01474876|40329251|FG000|Overall Study|Adverse Event|11|||
16506583|NCT01474876|40329252|FG001|Overall Study|Adverse Event|5|||
16506584|NCT01474876|40329253|FG002|Overall Study|Adverse Event|0|||
16506585|NCT01474876|40329251|FG000|Overall Study|Serious Adverse Event|2|||
16506586|NCT01474876|40329252|FG001|Overall Study|Serious Adverse Event|3|||
16506587|NCT01474876|40329253|FG002|Overall Study|Serious Adverse Event|0|||
16506588|NCT01474876|40329251|FG000|Overall Study|Lost to Follow-up|5|||
16506589|NCT01474876|40329252|FG001|Overall Study|Lost to Follow-up|4|||
16506590|NCT01474876|40329253|FG002|Overall Study|Lost to Follow-up|0|||
16506591|NCT01474876|40329251|FG000|Overall Study|Investigator's decision|28|||
16506592|NCT01474876|40329252|FG001|Overall Study|Investigator's decision|6|||
16506593|NCT01474876|40329253|FG002|Overall Study|Investigator's decision|0|||
16506594|NCT01474876|40329251|FG000|Overall Study|Patient's request|19|||
16506595|NCT01474876|40329252|FG001|Overall Study|Patient's request|5|||
16506596|NCT01474876|40329253|FG002|Overall Study|Patient's request|0|||
16506597|NCT01474876|40329251|FG000|Overall Study|Investigator's decision and pt request|1|||
16506598|NCT01474876|40329252|FG001|Overall Study|Investigator's decision and pt request|0|||
16506599|NCT01474876|40329253|FG002|Overall Study|Investigator's decision and pt request|0|||
16506600|NCT02689258|40329254|FG000|Overall Study|Subject Non-Compliance|0|||
16506601|NCT02689258|40329255|FG001|Overall Study|Subject Non-Compliance|1|||
16506602|NCT02689258|40329256|FG002|Overall Study|Subject Non-Compliance|0|||
16506603|NCT02689258|40329257|FG003|Overall Study|Subject Non-Compliance|0|||
16506604|NCT02689258|40329258|FG004|Overall Study|Subject Non-Compliance|0|||
16506605|NCT02689258|40329259|FG005|Overall Study|Subject Non-Compliance|0|||
16312868|NCT01671007|39630749|FG007|Overall Study|Other reasons than listed|66|||
16312869|NCT01671007|39630750|FG008|Overall Study|Other reasons than listed|0|||
16312870|NCT01671007|39630742|FG000|Overall Study|Withdrawal by Subject|36|||
16312871|NCT01671007|39630743|FG001|Overall Study|Withdrawal by Subject|59|||
16312872|NCT01671007|39630744|FG002|Overall Study|Withdrawal by Subject|53|||
16312873|NCT01671007|39630745|FG003|Overall Study|Withdrawal by Subject|58|||
16312874|NCT01671007|39630746|FG004|Overall Study|Withdrawal by Subject|4|||
16312875|NCT01671007|39630747|FG005|Overall Study|Withdrawal by Subject|15|||
16506606|NCT02689258|40329260|FG006|Overall Study|Subject Non-Compliance|0|||
16506607|NCT02689258|40329261|FG007|Overall Study|Subject Non-Compliance|0|||
16506608|NCT02689258|40329262|FG008|Overall Study|Subject Non-Compliance|0|||
16506609|NCT02689258|40329263|FG009|Overall Study|Subject Non-Compliance|0|||
16506610|NCT02689258|40329264|FG010|Overall Study|Subject Non-Compliance|0|||
16506611|NCT02689258|40329265|FG011|Overall Study|Subject Non-Compliance|0|||
16506612|NCT02689258|40329254|FG000|Overall Study|Subject Refusal to Continue|0|||
16506613|NCT02689258|40329255|FG001|Overall Study|Subject Refusal to Continue|1|||
16506614|NCT02689258|40329256|FG002|Overall Study|Subject Refusal to Continue|0|||
16506615|NCT02689258|40329257|FG003|Overall Study|Subject Refusal to Continue|0|||
16506616|NCT02689258|40329258|FG004|Overall Study|Subject Refusal to Continue|0|||
16506617|NCT02689258|40329259|FG005|Overall Study|Subject Refusal to Continue|0|||
16506618|NCT02689258|40329260|FG006|Overall Study|Subject Refusal to Continue|0|||
16506619|NCT02689258|40329261|FG007|Overall Study|Subject Refusal to Continue|0|||
16506620|NCT02689258|40329262|FG008|Overall Study|Subject Refusal to Continue|1|||
16506621|NCT02689258|40329263|FG009|Overall Study|Subject Refusal to Continue|0|||
16506622|NCT02689258|40329264|FG010|Overall Study|Subject Refusal to Continue|0|||
16506623|NCT02689258|40329265|FG011|Overall Study|Subject Refusal to Continue|1|||
16506624|NCT02689258|40329254|FG000|Overall Study|Other|0|||
16506625|NCT02689258|40329255|FG001|Overall Study|Other|2|||
16506626|NCT02689258|40329256|FG002|Overall Study|Other|0|||
16506627|NCT02689258|40329257|FG003|Overall Study|Other|0|||
16506628|NCT02689258|40329258|FG004|Overall Study|Other|1|||
16506629|NCT02689258|40329259|FG005|Overall Study|Other|0|||
16506630|NCT02689258|40329260|FG006|Overall Study|Other|0|||
16506631|NCT02689258|40329261|FG007|Overall Study|Other|0|||
16506632|NCT02689258|40329262|FG008|Overall Study|Other|1|||
16506633|NCT02689258|40329263|FG009|Overall Study|Other|0|||
16506634|NCT02689258|40329264|FG010|Overall Study|Other|0|||
16506635|NCT02689258|40329265|FG011|Overall Study|Other|0|||
16506636|NCT02535741|40329274|FG000|Overall Study|Adverse Event|3|||
16506637|NCT02535741|40329274|FG000|Overall Study|Withdrawal by Subject|9|||
16506638|NCT02535741|40329274|FG000|Overall Study|Lost to Follow-up|10|||
16506639|NCT02535741|40329274|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
16506640|NCT02535741|40329274|FG000|Overall Study|Missing data|6|||
16506641|NCT02520011|40329275|FG000|Overall Study|Adverse Event|0|||
16506642|NCT02520011|40329276|FG001|Overall Study|Adverse Event|1|||
16506643|NCT02520011|40329277|FG002|Overall Study|Adverse Event|2|||
16506644|NCT02520011|40329275|FG000|Overall Study|Death|0|||
16506645|NCT02520011|40329276|FG001|Overall Study|Death|8|||
16506646|NCT02520011|40329277|FG002|Overall Study|Death|1|||
16506647|NCT02520011|40329275|FG000|Overall Study|Lack of Efficacy|4|||
16506648|NCT02520011|40329276|FG001|Overall Study|Lack of Efficacy|26|||
16506649|NCT02520011|40329277|FG002|Overall Study|Lack of Efficacy|4|||
16506650|NCT02520011|40329275|FG000|Overall Study|Physician Decision|0|||
16506651|NCT02520011|40329276|FG001|Overall Study|Physician Decision|2|||
16506652|NCT02520011|40329277|FG002|Overall Study|Physician Decision|0|||
16506653|NCT02520011|40329275|FG000|Overall Study|Withdrawal by Subject|1|||
16506654|NCT02520011|40329276|FG001|Overall Study|Withdrawal by Subject|3|||
16506655|NCT02520011|40329277|FG002|Overall Study|Withdrawal by Subject|0|||
16506656|NCT02520011|40329275|FG000|Overall Study|Protocol Deviation|0|||
16506657|NCT02520011|40329276|FG001|Overall Study|Protocol Deviation|1|||
16506658|NCT02520011|40329277|FG002|Overall Study|Protocol Deviation|0|||
16506659|NCT02520011|40329275|FG000|Overall Study|Patient went to hospice|0|||
16506660|NCT02520011|40329276|FG001|Overall Study|Patient went to hospice|1|||
16506661|NCT02520011|40329277|FG002|Overall Study|Patient went to hospice|0|||
16506662|NCT02520011|40329275|FG000|Overall Study|Progressive disease following response|0|||
16506663|NCT02520011|40329276|FG001|Overall Study|Progressive disease following response|4|||
16506664|NCT02520011|40329277|FG002|Overall Study|Progressive disease following response|2|||
16506665|NCT02337907|40329288|FG000|Overall Study|Other than listed|1|||
16506666|NCT02337907|40329289|FG001|Overall Study|Other than listed|0|||
16312876|NCT01671007|39630748|FG006|Overall Study|Withdrawal by Subject|1|||
16506667|NCT02337907|40329290|FG002|Overall Study|Other than listed|0|||
16506668|NCT02337907|40329291|FG003|Overall Study|Other than listed|1|||
16506669|NCT02337907|40329292|FG004|Overall Study|Other than listed|1|||
16506670|NCT02337907|40329293|FG005|Overall Study|Other than listed|0|||
16506671|NCT02337907|40329288|FG000|Overall Study|Withdrawal by Subject|2|||
16506672|NCT02337907|40329289|FG001|Overall Study|Withdrawal by Subject|3|||
16506673|NCT02337907|40329290|FG002|Overall Study|Withdrawal by Subject|0|||
16506674|NCT02337907|40329291|FG003|Overall Study|Withdrawal by Subject|2|||
16506675|NCT02337907|40329292|FG004|Overall Study|Withdrawal by Subject|5|||
16506676|NCT02337907|40329293|FG005|Overall Study|Withdrawal by Subject|0|||
16506677|NCT02337907|40329288|FG000|Overall Study|Lost to Follow-up|0|||
16506678|NCT02337907|40329289|FG001|Overall Study|Lost to Follow-up|0|||
16506679|NCT02337907|40329290|FG002|Overall Study|Lost to Follow-up|0|||
16506680|NCT02337907|40329291|FG003|Overall Study|Lost to Follow-up|0|||
16506681|NCT02337907|40329292|FG004|Overall Study|Lost to Follow-up|0|||
16506682|NCT02337907|40329293|FG005|Overall Study|Lost to Follow-up|1|||
16506683|NCT02337907|40329288|FG000|Overall Study|Adverse Event|1|||
16506684|NCT02337907|40329289|FG001|Overall Study|Adverse Event|1|||
16506685|NCT02337907|40329290|FG002|Overall Study|Adverse Event|1|||
16506686|NCT02337907|40329291|FG003|Overall Study|Adverse Event|1|||
16506687|NCT02337907|40329292|FG004|Overall Study|Adverse Event|4|||
16506688|NCT02337907|40329293|FG005|Overall Study|Adverse Event|0|||
16506689|NCT00112502|40329294|FG000|Overall Study|Withdrawal by Subject|0|||
16506690|NCT00112502|40329295|FG001|Overall Study|Withdrawal by Subject|1|||
16506691|NCT00112502|40329296|FG002|Overall Study|Withdrawal by Subject|1|||
16506692|NCT00112502|40329297|FG003|Overall Study|Withdrawal by Subject|4|||
16506693|NCT00112502|40329298|FG004|Overall Study|Withdrawal by Subject|2|||
16506694|NCT00112502|40329299|FG005|Overall Study|Withdrawal by Subject|5|||
16506695|NCT00112502|40329300|FG006|Overall Study|Withdrawal by Subject|3|||
16506696|NCT00112502|40329301|FG007|Overall Study|Withdrawal by Subject|7|||
16506697|NCT04059146|40329309|FG000|Overall Study|Withdrawal by Subject|0|||
16506698|NCT04059146|40329310|FG001|Overall Study|Withdrawal by Subject|1|||
16506699|NCT00914810|40329312|FG000|Overall Study|Withdrawal by Subject|1|||
16506700|NCT00914810|40329313|FG001|Overall Study|Withdrawal by Subject|0|||
16506701|NCT00914810|40329312|FG000|Overall Study|Relocated out of state|1|||
16506702|NCT00914810|40329313|FG001|Overall Study|Relocated out of state|0|||
16506703|NCT00914810|40329312|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
16506704|NCT00914810|40329313|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
16506705|NCT01120756|40329314|FG000|Overall Study|Withdrawal by Subject|1|||
16506706|NCT01120756|40329315|FG001|Overall Study|Withdrawal by Subject|1|||
16506707|NCT00174915|40329317|FG000|Overall Study|Lost to Follow-up|19|||
16506708|NCT00174915|40329318|FG001|Overall Study|Lost to Follow-up|17|||
16506709|NCT00174915|40329319|FG002|Overall Study|Lost to Follow-up|9|||
16506710|NCT00174915|40329320|FG003|Overall Study|Lost to Follow-up|17|||
16506711|NCT00174915|40329321|FG004|Overall Study|Lost to Follow-up|10|||
16506712|NCT00174915|40329317|FG000|Overall Study|Adverse Event|18|||
16506713|NCT00174915|40329318|FG001|Overall Study|Adverse Event|16|||
16506714|NCT00174915|40329319|FG002|Overall Study|Adverse Event|11|||
16506715|NCT00174915|40329320|FG003|Overall Study|Adverse Event|18|||
16506716|NCT00174915|40329321|FG004|Overall Study|Adverse Event|5|||
16506717|NCT00174915|40329317|FG000|Overall Study|Personal Reason(s)|16|||
16506718|NCT00174915|40329318|FG001|Overall Study|Personal Reason(s)|16|||
16506719|NCT00174915|40329319|FG002|Overall Study|Personal Reason(s)|9|||
16506720|NCT00174915|40329320|FG003|Overall Study|Personal Reason(s)|9|||
16506721|NCT00174915|40329321|FG004|Overall Study|Personal Reason(s)|9|||
16506722|NCT00174915|40329317|FG000|Overall Study|Other|15|||
16506723|NCT00174915|40329318|FG001|Overall Study|Other|8|||
16506724|NCT00174915|40329319|FG002|Overall Study|Other|6|||
16506725|NCT00174915|40329320|FG003|Overall Study|Other|5|||
16506726|NCT00174915|40329321|FG004|Overall Study|Other|3|||
16506727|NCT00174915|40329317|FG000|Overall Study|Gout Flare|13|||
16506728|NCT00174915|40329318|FG001|Overall Study|Gout Flare|6|||
16506729|NCT00174915|40329319|FG002|Overall Study|Gout Flare|8|||
16506730|NCT00174915|40329320|FG003|Overall Study|Gout Flare|1|||
16506731|NCT00174915|40329321|FG004|Overall Study|Gout Flare|0|||
16506732|NCT00174915|40329317|FG000|Overall Study|Protocol Violation|6|||
16506733|NCT00174915|40329318|FG001|Overall Study|Protocol Violation|3|||
16506734|NCT00174915|40329319|FG002|Overall Study|Protocol Violation|3|||
16506735|NCT00174915|40329320|FG003|Overall Study|Protocol Violation|6|||
16506736|NCT00174915|40329321|FG004|Overall Study|Protocol Violation|3|||
16506737|NCT00174915|40329317|FG000|Overall Study|Therapeutic Failure|6|||
16506738|NCT00174915|40329318|FG001|Overall Study|Therapeutic Failure|3|||
16196487|NCT02796391|39193548|FG005|Overall Study|Adverse Event|0|||
16196488|NCT02796391|39193543|FG000|Overall Study|Protocol Violation|0|||
16196489|NCT02796391|39193544|FG001|Overall Study|Protocol Violation|0|||
16196490|NCT02796391|39193545|FG002|Overall Study|Protocol Violation|0|||
16196491|NCT02796391|39193546|FG003|Overall Study|Protocol Violation|1|||
16196492|NCT02796391|39193547|FG004|Overall Study|Protocol Violation|0|||
16196493|NCT02796391|39193548|FG005|Overall Study|Protocol Violation|0|||
16196494|NCT01911845|39197206|FG000|Overall Study|Adverse Event|2|||
16196495|NCT01911845|39197206|FG000|Overall Study|Lost to Follow-up|1|||
16196496|NCT01911845|39197206|FG000|Overall Study|Other (not specified)|3|||
16196497|NCT01651052|39197207|FG000|Overall Study|Death|21|||
16196498|NCT01651052|39197207|FG000|Overall Study|Explant|1|||
16196499|NCT01651052|39197207|FG000|Overall Study|Withdrawal by Subject|1|||
16196500|NCT01651052|39197207|FG000|Overall Study|Lost to Follow-up|3|||
16196501|NCT02509494|39197208|FG000|Overall Study|Lost to Follow-up|8|||
16196502|NCT02509494|39197209|FG001|Overall Study|Lost to Follow-up|47|||
16196503|NCT02509494|39197210|FG002|Overall Study|Lost to Follow-up|19|||
16196504|NCT02509494|39197211|FG003|Overall Study|Lost to Follow-up|6|||
16196505|NCT02509494|39197212|FG004|Overall Study|Lost to Follow-up|3|||
16196506|NCT02509494|39197213|FG005|Overall Study|Lost to Follow-up|3|||
16196507|NCT02509494|39197214|FG006|Overall Study|Lost to Follow-up|1|||
16196508|NCT02509494|39197215|FG007|Overall Study|Lost to Follow-up|3|||
16196509|NCT02509494|39197216|FG008|Overall Study|Lost to Follow-up|1|||
16196510|NCT02509494|39197208|FG000|Overall Study|Physician Decision|2|||
16196511|NCT02509494|39197209|FG001|Overall Study|Physician Decision|1|||
16196512|NCT02509494|39197210|FG002|Overall Study|Physician Decision|0|||
16196513|NCT02509494|39197211|FG003|Overall Study|Physician Decision|0|||
16196514|NCT02509494|39197212|FG004|Overall Study|Physician Decision|0|||
16196515|NCT02509494|39197213|FG005|Overall Study|Physician Decision|0|||
16196516|NCT02509494|39197214|FG006|Overall Study|Physician Decision|0|||
16196517|NCT02509494|39197215|FG007|Overall Study|Physician Decision|0|||
16196518|NCT02509494|39197216|FG008|Overall Study|Physician Decision|0|||
16196519|NCT02509494|39197208|FG000|Overall Study|Withdrawal by Subject|4|||
16196520|NCT02509494|39197209|FG001|Overall Study|Withdrawal by Subject|17|||
16196521|NCT02509494|39197210|FG002|Overall Study|Withdrawal by Subject|7|||
16196522|NCT02509494|39197211|FG003|Overall Study|Withdrawal by Subject|5|||
16196523|NCT02509494|39197212|FG004|Overall Study|Withdrawal by Subject|0|||
16196524|NCT02509494|39197213|FG005|Overall Study|Withdrawal by Subject|6|||
16196525|NCT02509494|39197214|FG006|Overall Study|Withdrawal by Subject|1|||
16196526|NCT02509494|39197215|FG007|Overall Study|Withdrawal by Subject|2|||
16196527|NCT02509494|39197216|FG008|Overall Study|Withdrawal by Subject|1|||
16196528|NCT02509494|39197208|FG000|Overall Study|Death|0|||
16196529|NCT02509494|39197209|FG001|Overall Study|Death|1|||
16196530|NCT02509494|39197210|FG002|Overall Study|Death|0|||
16196531|NCT02509494|39197211|FG003|Overall Study|Death|0|||
16196532|NCT02509494|39197212|FG004|Overall Study|Death|1|||
16196533|NCT02509494|39197213|FG005|Overall Study|Death|0|||
16196534|NCT02509494|39197214|FG006|Overall Study|Death|0|||
16196535|NCT02509494|39197215|FG007|Overall Study|Death|1|||
16196536|NCT02509494|39197216|FG008|Overall Study|Death|0|||
16196537|NCT02509494|39197208|FG000|Overall Study|Other|0|||
16196538|NCT02509494|39197209|FG001|Overall Study|Other|4|||
16196539|NCT02509494|39197210|FG002|Overall Study|Other|5|||
16196540|NCT02509494|39197211|FG003|Overall Study|Other|0|||
16196541|NCT02509494|39197212|FG004|Overall Study|Other|0|||
16196542|NCT02509494|39197213|FG005|Overall Study|Other|0|||
16196543|NCT02509494|39197214|FG006|Overall Study|Other|0|||
16196544|NCT02509494|39197215|FG007|Overall Study|Other|0|||
16196545|NCT02509494|39197216|FG008|Overall Study|Other|0|||
16196546|NCT02509494|39197208|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16196547|NCT02509494|39197209|FG001|Overall Study|Non-Compliance With Study Drug|11|||
16196548|NCT02509494|39197210|FG002|Overall Study|Non-Compliance With Study Drug|7|||
16196549|NCT02509494|39197211|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16196550|NCT02509494|39197212|FG004|Overall Study|Non-Compliance With Study Drug|1|||
16196551|NCT02509494|39197213|FG005|Overall Study|Non-Compliance With Study Drug|2|||
16196552|NCT02509494|39197214|FG006|Overall Study|Non-Compliance With Study Drug|1|||
16196553|NCT02509494|39197215|FG007|Overall Study|Non-Compliance With Study Drug|1|||
16196554|NCT02509494|39197216|FG008|Overall Study|Non-Compliance With Study Drug|0|||
16196555|NCT01740388|39197225|FG000|Overall Study|Withdrawal by Subject|1|||
16196556|NCT01740388|39197226|FG001|Overall Study|Withdrawal by Subject|2|||
16196557|NCT01740388|39197225|FG000|Overall Study|Lost to Follow-up|2|||
16196558|NCT01740388|39197226|FG001|Overall Study|Lost to Follow-up|0|||
16196559|NCT01740388|39197225|FG000|Overall Study|Physician Decision|2|||
16196560|NCT01740388|39197226|FG001|Overall Study|Physician Decision|6|||
16196561|NCT01740388|39197225|FG000|Overall Study|Subjects missing data, completed|41|||
16196562|NCT01740388|39197226|FG001|Overall Study|Subjects missing data, completed|36|||
16312877|NCT01671007|39630749|FG007|Overall Study|Withdrawal by Subject|19|||
16312878|NCT01671007|39630750|FG008|Overall Study|Withdrawal by Subject|0|||
16312879|NCT01671007|39630742|FG000|Overall Study|Lost to Follow-up|93|||
16312880|NCT01671007|39630743|FG001|Overall Study|Lost to Follow-up|142|||
16312881|NCT01671007|39630744|FG002|Overall Study|Lost to Follow-up|91|||
16312882|NCT01671007|39630745|FG003|Overall Study|Lost to Follow-up|63|||
16312883|NCT01671007|39630746|FG004|Overall Study|Lost to Follow-up|7|||
16312884|NCT01671007|39630747|FG005|Overall Study|Lost to Follow-up|20|||
16312885|NCT01671007|39630748|FG006|Overall Study|Lost to Follow-up|2|||
16312886|NCT01671007|39630749|FG007|Overall Study|Lost to Follow-up|28|||
16312887|NCT01671007|39630750|FG008|Overall Study|Lost to Follow-up|0|||
16312888|NCT01671007|39630742|FG000|Overall Study|No end of study case report form|3|||
16312889|NCT01671007|39630743|FG001|Overall Study|No end of study case report form|1|||
16312890|NCT01671007|39630744|FG002|Overall Study|No end of study case report form|0|||
16312891|NCT01671007|39630745|FG003|Overall Study|No end of study case report form|2|||
16312892|NCT01671007|39630746|FG004|Overall Study|No end of study case report form|0|||
16312893|NCT01671007|39630747|FG005|Overall Study|No end of study case report form|0|||
16312894|NCT01671007|39630748|FG006|Overall Study|No end of study case report form|0|||
16312895|NCT01671007|39630749|FG007|Overall Study|No end of study case report form|0|||
16312896|NCT01671007|39630750|FG008|Overall Study|No end of study case report form|0|||
16312897|NCT01671007|39630742|FG000|Overall Study|Not eligible|23|||
16312898|NCT01671007|39630743|FG001|Overall Study|Not eligible|76|||
16312899|NCT01671007|39630744|FG002|Overall Study|Not eligible|25|||
16312900|NCT01671007|39630745|FG003|Overall Study|Not eligible|17|||
16312901|NCT01671007|39630746|FG004|Overall Study|Not eligible|0|||
16312902|NCT01671007|39630747|FG005|Overall Study|Not eligible|6|||
16312903|NCT01671007|39630748|FG006|Overall Study|Not eligible|1|||
16312904|NCT01671007|39630749|FG007|Overall Study|Not eligible|19|||
16312905|NCT01671007|39630750|FG008|Overall Study|Not eligible|0|||
16312906|NCT01402570|39630765|FG000|Overall Study|Adverse Event|1|||
16312907|NCT02071225|39630781|FG000|Overall Study|Withdrawal of Consent|2|||
16312908|NCT02071225|39630781|FG000|Overall Study|Protocol Deviation|1|||
16312909|NCT02071225|39630781|FG000|Overall Study|Lost to Follow-up|2|||
16312910|NCT02071225|39630781|FG000|Overall Study|Death|25|||
16312911|NCT02286713|39630782|FG000|One Week Follow-Up|Death|1|||
16312912|NCT02286713|39630783|FG001|One Week Follow-Up|Death|0|||
16312913|NCT02286713|39630782|FG000|One Week Follow-Up|Lost to Follow-up|17|||
16312914|NCT02286713|39630783|FG001|One Week Follow-Up|Lost to Follow-up|21|||
16312915|NCT02286713|39630782|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
16312916|NCT02286713|39630783|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
16312917|NCT02286713|39630782|FG000|Three Month Follow-Up|Death|1|||
16312918|NCT02286713|39630783|FG001|Three Month Follow-Up|Death|1|||
16312919|NCT02286713|39630782|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
16312920|NCT02286713|39630783|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
16312921|NCT02286713|39630782|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
16312922|NCT02286713|39630783|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
16312923|NCT02286713|39630782|FG000|Six Month Follow-Up|Death|2|||
16312924|NCT02286713|39630783|FG001|Six Month Follow-Up|Death|0|||
16312925|NCT02286713|39630782|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
16312926|NCT02286713|39630783|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
16312927|NCT00725920|39630784|FG000|Overall Study|Lack of Efficacy|3|||
16312928|NCT00725920|39630785|FG001|Overall Study|Lack of Efficacy|6|||
16312929|NCT04537078|39630788|FG000|Overall Study|Protocol Violation|3|||
16312930|NCT04537078|39630789|FG001|Overall Study|Protocol Violation|2|||
16312931|NCT04537078|39630788|FG000|Overall Study|Lost to Follow-up|1|||
16312932|NCT04537078|39630789|FG001|Overall Study|Lost to Follow-up|0|||
16312933|NCT04537078|39630788|FG000|Overall Study|Withdrawal by Subject|0|||
16312934|NCT04537078|39630789|FG001|Overall Study|Withdrawal by Subject|1|||
16312935|NCT00570063|39630790|FG000|Overall Study|Adverse Event|4|||
16312936|NCT00570063|39630791|FG001|Overall Study|Adverse Event|1|||
16312937|NCT00570063|39630790|FG000|Overall Study|Lack of Efficacy|0|||
16312938|NCT00570063|39630791|FG001|Overall Study|Lack of Efficacy|1|||
16312939|NCT00570063|39630790|FG000|Overall Study|Withdrawal by Subject|4|||
16312940|NCT00570063|39630791|FG001|Overall Study|Withdrawal by Subject|3|||
16312941|NCT00570063|39630790|FG000|Overall Study|Sponsor's Decision|7|||
16312942|NCT00570063|39630791|FG001|Overall Study|Sponsor's Decision|3|||
16312943|NCT00837148|39630792|FG000|Overall Study|Adverse Event|1|||
16312944|NCT00837148|39630792|FG000|Overall Study|Death|1|||
16312945|NCT02741076|39630793|FG000|Overall Study|Adverse Event|0|||
16196563|NCT02457182|39197229|FG000|Overall Study|Lost to Follow-up|1|||
16312946|NCT02741076|39630794|FG001|Overall Study|Adverse Event|1|||
16312947|NCT02741076|39630795|FG002|Overall Study|Adverse Event|1|||
16312948|NCT02741076|39630796|FG003|Overall Study|Adverse Event|0|||
16312949|NCT02741076|39630793|FG000|Overall Study|Lack of Efficacy|1|||
16089934|NCT00614614|38820028|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
16089935|NCT00614614|38820029|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
16196564|NCT02457182|39197230|FG001|Overall Study|Lost to Follow-up|0|||
16196565|NCT00511342|39197231|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
16196566|NCT00511342|39197232|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
16196567|NCT00511342|39197231|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
16196568|NCT00511342|39197232|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
16196569|NCT00511342|39197231|FG000|Overall Study|Pregnancy|0|||
16196570|NCT00511342|39197232|FG001|Overall Study|Pregnancy|1|||
16196571|NCT00511342|39197231|FG000|Overall Study|Pregnancy wish|0|||
16196572|NCT00511342|39197232|FG001|Overall Study|Pregnancy wish|1|||
16196573|NCT00511342|39197231|FG000|Overall Study|Lost to Follow-up|1|||
16196574|NCT00511342|39197232|FG001|Overall Study|Lost to Follow-up|5|||
16196575|NCT00511342|39197231|FG000|Overall Study|Other Reason|2|||
16196576|NCT00511342|39197232|FG001|Overall Study|Other Reason|2|||
16196577|NCT02546674|39197234|FG000|Overall Study|Adverse Event|19|||
16196578|NCT02546674|39197234|FG000|Overall Study|Death|1|||
16196579|NCT02546674|39197234|FG000|Overall Study|Lost to Follow-up|1|||
16196580|NCT02546674|39197234|FG000|Overall Study|Physician Decision|13|||
16196581|NCT02546674|39197234|FG000|Overall Study|Pregnancy|1|||
16196582|NCT02546674|39197234|FG000|Overall Study|Progressive Disease|2|||
16196583|NCT02546674|39197234|FG000|Overall Study|Protocol Deviation|2|||
16196584|NCT02546674|39197234|FG000|Overall Study|Subject/Guardian Decision|6|||
16196585|NCT02546674|39197234|FG000|Overall Study|Withdrawal of Informed Consent|3|||
16196586|NCT00192036|39197235|FG000|Overall Study|Protocol Violation|3|||
16196587|NCT00192036|39197235|FG000|Overall Study|Adverse Event|6|||
16196588|NCT00192036|39197235|FG000|Overall Study|Patient/Physician Perception|1|||
16196589|NCT00192036|39197235|FG000|Overall Study|Objective Tumor Progression|4|||
16196590|NCT00192036|39197235|FG000|Overall Study|Clinical Disease Progression|1|||
16196591|NCT00192036|39197235|FG000|Overall Study|Death|1|||
16196592|NCT00192036|39197235|FG000|Overall Study|Unknown or Not Specified|5|||
16196593|NCT01324622|39197236|FG000|Overall Study|Lost to Follow-up|7|||
16196594|NCT01324622|39197237|FG001|Overall Study|Lost to Follow-up|7|||
16196595|NCT01324622|39197236|FG000|Overall Study|Death|1|||
16196596|NCT01324622|39197237|FG001|Overall Study|Death|0|||
16196597|NCT01324622|39197236|FG000|Overall Study|Lack of Efficacy|1|||
16196598|NCT01324622|39197237|FG001|Overall Study|Lack of Efficacy|0|||
16196599|NCT01019486|39197240|FG000|Overall Study|Withdrawal by Subject|1|||
16196600|NCT01019486|39197241|FG001|Overall Study|Withdrawal by Subject|1|||
16196601|NCT01019486|39197242|FG002|Overall Study|Withdrawal by Subject|1|||
16196602|NCT01253044|39197248|FG000|Overall Study|Lost to Follow-up|38|||
16196603|NCT01253044|39197249|FG001|Overall Study|Lost to Follow-up|29|||
16196604|NCT05674344|39197250|FG000|Overall Study|Screen Fail|21|||
16196605|NCT05674344|39197250|FG000|Overall Study|Incomplete study procedures|3|||
16312950|NCT02741076|39630794|FG001|Overall Study|Lack of Efficacy|0|||
16312951|NCT02741076|39630795|FG002|Overall Study|Lack of Efficacy|0|||
16312952|NCT02741076|39630796|FG003|Overall Study|Lack of Efficacy|0|||
16312953|NCT02741076|39630793|FG000|Overall Study|Withdrawal by Subject|0|||
16312954|NCT02741076|39630794|FG001|Overall Study|Withdrawal by Subject|1|||
16312955|NCT02741076|39630795|FG002|Overall Study|Withdrawal by Subject|0|||
16312956|NCT02741076|39630796|FG003|Overall Study|Withdrawal by Subject|0|||
16312957|NCT02741076|39630793|FG000|Overall Study|Sponsor Request|2|||
16196606|NCT02807363|39197251|FG000|Dosing Period|Adverse Event|0|||
16196607|NCT02807363|39197252|FG001|Dosing Period|Adverse Event|1|||
16196608|NCT02807363|39197253|FG002|Dosing Period|Adverse Event|0|||
16196609|NCT02807363|39197254|FG003|Dosing Period|Adverse Event|0|||
16196610|NCT01348425|39197255|FG000|Overall Study|Imaging was not taken.|1|||
16196611|NCT01348425|39197256|FG001|Overall Study|Imaging was not taken.|1|||
16196612|NCT01797965|39197257|FG000|Overall Study|Adverse Event|104|||
16196613|NCT01797965|39197258|FG001|Overall Study|Adverse Event|129|||
16196614|NCT01797965|39197259|FG002|Overall Study|Adverse Event|4|||
16196615|NCT01797965|39197260|FG003|Overall Study|Adverse Event|21|||
16196616|NCT01797965|39197257|FG000|Overall Study|Lost to Follow-up|9|||
16196617|NCT01797965|39197258|FG001|Overall Study|Lost to Follow-up|8|||
16196618|NCT01797965|39197259|FG002|Overall Study|Lost to Follow-up|1|||
16196619|NCT01797965|39197260|FG003|Overall Study|Lost to Follow-up|2|||
16196620|NCT01797965|39197257|FG000|Overall Study|Consent withdrawn|130|||
16196621|NCT01797965|39197258|FG001|Overall Study|Consent withdrawn|117|||
16196622|NCT01797965|39197259|FG002|Overall Study|Consent withdrawn|3|||
16196623|NCT01797965|39197260|FG003|Overall Study|Consent withdrawn|35|||
16196624|NCT01797965|39197257|FG000|Overall Study|Investigator decision|21|||
16196625|NCT01797965|39197258|FG001|Overall Study|Investigator decision|15|||
16196626|NCT01797965|39197259|FG002|Overall Study|Investigator decision|0|||
16312958|NCT02741076|39630794|FG001|Overall Study|Sponsor Request|3|||
16196627|NCT01797965|39197260|FG003|Overall Study|Investigator decision|0|||
16196628|NCT01797965|39197257|FG000|Overall Study|Death|2|||
16196629|NCT01797965|39197258|FG001|Overall Study|Death|4|||
16196630|NCT01797965|39197259|FG002|Overall Study|Death|0|||
16196631|NCT01797965|39197260|FG003|Overall Study|Death|0|||
16196632|NCT01797965|39197257|FG000|Overall Study|Disease progression, defined by protocol|3|||
16196633|NCT01797965|39197258|FG001|Overall Study|Disease progression, defined by protocol|1|||
16196634|NCT01797965|39197259|FG002|Overall Study|Disease progression, defined by protocol|0|||
16312959|NCT02741076|39630795|FG002|Overall Study|Sponsor Request|0|||
16312960|NCT02741076|39630796|FG003|Overall Study|Sponsor Request|1|||
16312961|NCT02741076|39630793|FG000|Overall Study|No additional information available|0|||
16312962|NCT02741076|39630794|FG001|Overall Study|No additional information available|0|||
16312963|NCT02741076|39630795|FG002|Overall Study|No additional information available|1|||
16312964|NCT02741076|39630796|FG003|Overall Study|No additional information available|1|||
16312965|NCT01207687|39630803|FG000|Overall Study|Adverse Event|1|||
16312966|NCT01207687|39630803|FG000|Overall Study|Withdrawal by Subject|1|||
16312967|NCT02288325|39630804|FG000|Run-in Period|Adverse Event|48|||
16312968|NCT02288325|39630805|FG001|Run-in Period|Adverse Event|0|||
16312969|NCT02288325|39630806|FG002|Run-in Period|Adverse Event|0|||
16312970|NCT02288325|39630804|FG000|Run-in Period|Lack of Efficacy|16|||
16312971|NCT02288325|39630805|FG001|Run-in Period|Lack of Efficacy|0|||
16312972|NCT02288325|39630806|FG002|Run-in Period|Lack of Efficacy|0|||
16312973|NCT02288325|39630804|FG000|Run-in Period|Withdrawal of Consent|28|||
16312974|NCT02288325|39630805|FG001|Run-in Period|Withdrawal of Consent|0|||
16312975|NCT02288325|39630806|FG002|Run-in Period|Withdrawal of Consent|0|||
16506739|NCT00174915|40329319|FG002|Overall Study|Therapeutic Failure|2|||
16506740|NCT00174915|40329320|FG003|Overall Study|Therapeutic Failure|1|||
16506741|NCT00174915|40329321|FG004|Overall Study|Therapeutic Failure|3|||
16506742|NCT01339390|40329322|FG000|Overall Study|Death|32|||
16506743|NCT01339390|40329323|FG001|Overall Study|Death|29|||
16506744|NCT01339390|40329322|FG000|Overall Study|Lost to Follow-up|125|||
16506745|NCT01339390|40329323|FG001|Overall Study|Lost to Follow-up|127|||
16506746|NCT01557400|40329324|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
16506747|NCT01557400|40329324|FG000|Overall Study|Adverse Event|3|||
16506748|NCT01557400|40329324|FG000|Overall Study|Lost to Follow-up|5|||
16506749|NCT01557400|40329324|FG000|Overall Study|Withdrawal by Subject|9|||
16312976|NCT02288325|39630804|FG000|Run-in Period|Lost to Follow-up|25|||
16312977|NCT02288325|39630805|FG001|Run-in Period|Lost to Follow-up|0|||
16312978|NCT02288325|39630806|FG002|Run-in Period|Lost to Follow-up|0|||
16312979|NCT02288325|39630804|FG000|Run-in Period|Protocol Violation|17|||
16312980|NCT02288325|39630805|FG001|Run-in Period|Protocol Violation|0|||
16312981|NCT02288325|39630806|FG002|Run-in Period|Protocol Violation|0|||
16312982|NCT02288325|39630804|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
16312983|NCT02288325|39630805|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
16312984|NCT02288325|39630806|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
16312985|NCT02288325|39630804|FG000|Run-in Period|Reason not Specified|8|||
16312986|NCT02288325|39630805|FG001|Run-in Period|Reason not Specified|0|||
16312987|NCT02288325|39630806|FG002|Run-in Period|Reason not Specified|0|||
16312988|NCT02288325|39630804|FG000|Stabilization Period|Adverse Event|13|||
16312989|NCT02288325|39630805|FG001|Stabilization Period|Adverse Event|0|||
16506750|NCT02053753|40329338|FG000|Overall Study|Withdrawal by Subject|2|||
16089936|NCT00614614|38820030|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
16312990|NCT02288325|39630806|FG002|Stabilization Period|Adverse Event|0|||
16506751|NCT02053753|40329339|FG001|Overall Study|Withdrawal by Subject|4|||
16089937|NCT00614614|38820026|FG000|Primary Vaccination Phase|Protocol Violation|9|||
16312991|NCT02288325|39630804|FG000|Stabilization Period|Lack of Efficacy|22|||
16312992|NCT02288325|39630805|FG001|Stabilization Period|Lack of Efficacy|0|||
16312993|NCT02288325|39630806|FG002|Stabilization Period|Lack of Efficacy|0|||
16506752|NCT02053753|40329338|FG000|Overall Study|Decision by Sponsor|1|||
16312994|NCT02288325|39630804|FG000|Stabilization Period|Withdrawal of Consent|23|||
16312995|NCT02288325|39630805|FG001|Stabilization Period|Withdrawal of Consent|0|||
16312996|NCT02288325|39630806|FG002|Stabilization Period|Withdrawal of Consent|0|||
16312997|NCT02288325|39630804|FG000|Stabilization Period|Lost to Follow-up|12|||
16506753|NCT02053753|40329339|FG001|Overall Study|Decision by Sponsor|1|||
16506754|NCT02053753|40329338|FG000|Overall Study|Lost to Follow-up|4|||
16506755|NCT02053753|40329339|FG001|Overall Study|Lost to Follow-up|3|||
16506756|NCT00445965|40329344|FG000|Overall Study|Adverse Event|2|||
16506757|NCT00445965|40329344|FG000|Overall Study|Physician Decision|1|||
16506758|NCT00445965|40329344|FG000|Overall Study|Enrolled but not treated|1|||
16506759|NCT00445965|40329344|FG000|Overall Study|Removed due to progressive disease|29|||
16506760|NCT00994240|40329352|FG000|Overall Study|Lost to Follow-up|3|||
16506761|NCT00994240|40329353|FG001|Overall Study|Lost to Follow-up|2|||
16506762|NCT00994240|40329352|FG000|Overall Study|Withdrawal by Subject|1|||
16506763|NCT00994240|40329353|FG001|Overall Study|Withdrawal by Subject|0|||
16506764|NCT00994240|40329352|FG000|Overall Study|study termination|2|||
16506765|NCT00994240|40329353|FG001|Overall Study|study termination|3|||
16506766|NCT02818777|40329359|FG000|Overall Study|Adverse Event|3|||
16506767|NCT00097721|40329360|FG000|Overall Study|Adverse Event|8|||
16506768|NCT00097721|40329361|FG001|Overall Study|Adverse Event|1|||
16312998|NCT02288325|39630805|FG001|Stabilization Period|Lost to Follow-up|0|||
16312999|NCT02288325|39630806|FG002|Stabilization Period|Lost to Follow-up|0|||
16313000|NCT02288325|39630804|FG000|Stabilization Period|Protocol Violation|8|||
16313001|NCT02288325|39630805|FG001|Stabilization Period|Protocol Violation|0|||
16313002|NCT02288325|39630806|FG002|Stabilization Period|Protocol Violation|0|||
16313003|NCT02288325|39630804|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
16313004|NCT02288325|39630805|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
16313005|NCT02288325|39630806|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
16506769|NCT00097721|40329360|FG000|Overall Study|Withdrawal by Subject|6|||
16506770|NCT00097721|40329361|FG001|Overall Study|Withdrawal by Subject|1|||
16506771|NCT00097721|40329360|FG000|Overall Study|Progressive Disease|55|||
16506772|NCT00097721|40329361|FG001|Overall Study|Progressive Disease|27|||
16506773|NCT00097721|40329360|FG000|Overall Study|Physician Decision|1|||
16313006|NCT02288325|39630804|FG000|Stabilization Period|Reason not Specified|15|||
16313007|NCT02288325|39630805|FG001|Stabilization Period|Reason not Specified|0|||
16313008|NCT02288325|39630806|FG002|Stabilization Period|Reason not Specified|0|||
16506774|NCT00097721|40329361|FG001|Overall Study|Physician Decision|3|||
16506775|NCT00097721|40329360|FG000|Overall Study|Reason not given|1|||
16506776|NCT00097721|40329361|FG001|Overall Study|Reason not given|1|||
16506777|NCT01870583|40329364|FG000|Overall Study|Protocol Violation|0|||
16506778|NCT01870583|40329365|FG001|Overall Study|Protocol Violation|5|||
16506779|NCT01870583|40329366|FG002|Overall Study|Protocol Violation|3|||
16506780|NCT01870583|40329364|FG000|Overall Study|Lost to Follow-up|11|||
16506781|NCT01870583|40329365|FG001|Overall Study|Lost to Follow-up|13|||
16506782|NCT01870583|40329366|FG002|Overall Study|Lost to Follow-up|5|||
16506783|NCT02075658|40329368|FG000|Overall Study|Physician Decision|2|||
16506784|NCT02075658|40329369|FG001|Overall Study|Physician Decision|2|||
16506785|NCT05071183|40329374|FG000|Overall Study|Death|1|||
16506786|NCT05071183|40329375|FG001|Overall Study|Death|2|||
16506787|NCT05071183|40329376|FG002|Overall Study|Death|0|||
16506788|NCT05071183|40329374|FG000|Overall Study|Other Reasons|1|||
16506789|NCT05071183|40329375|FG001|Overall Study|Other Reasons|3|||
16506790|NCT05071183|40329376|FG002|Overall Study|Other Reasons|2|||
16506791|NCT01365273|40329379|FG000|Overall Study|Lost to Follow-up|1|||
16506792|NCT01365273|40329380|FG001|Overall Study|Lost to Follow-up|0|||
16506793|NCT01365273|40329379|FG000|Overall Study|Protocol Violation|0|||
16506794|NCT01365273|40329380|FG001|Overall Study|Protocol Violation|1|||
16506795|NCT01365273|40329379|FG000|Overall Study|Physician Decision|1|||
16506796|NCT01365273|40329380|FG001|Overall Study|Physician Decision|0|||
16506797|NCT01452412|40329384|FG000|Overall Study|Withdrawal by Subject|15|||
16506798|NCT01452412|40329385|FG001|Overall Study|Withdrawal by Subject|11|||
16506799|NCT01452412|40329384|FG000|Overall Study|Adverse Event|4|||
16506800|NCT01452412|40329385|FG001|Overall Study|Adverse Event|3|||
16506801|NCT01452412|40329384|FG000|Overall Study|Lost to Follow-up|5|||
16506802|NCT01452412|40329385|FG001|Overall Study|Lost to Follow-up|3|||
16506803|NCT01452412|40329384|FG000|Overall Study|Death|1|||
16506804|NCT01452412|40329385|FG001|Overall Study|Death|0|||
16506805|NCT01452412|40329384|FG000|Overall Study|Initiated dialysis|1|||
16506806|NCT01452412|40329385|FG001|Overall Study|Initiated dialysis|0|||
16506807|NCT01452412|40329384|FG000|Overall Study|Other|2|||
16506808|NCT01452412|40329385|FG001|Overall Study|Other|0|||
16506809|NCT02678676|40329386|FG000|Overall Study|Death|619|||
16506810|NCT02678676|40329387|FG001|Overall Study|Death|649|||
16506811|NCT02678676|40329386|FG000|Overall Study|Withdrawal by Subject|13|||
16506812|NCT02678676|40329387|FG001|Overall Study|Withdrawal by Subject|5|||
16506813|NCT02678676|40329386|FG000|Overall Study|Lost to Follow-up|171|||
16313009|NCT02288325|39630804|FG000|Double-blind Treatment Period|Adverse Event|0|||
16313010|NCT02288325|39630805|FG001|Double-blind Treatment Period|Adverse Event|2|||
16313011|NCT02288325|39630806|FG002|Double-blind Treatment Period|Adverse Event|5|||
16313012|NCT02288325|39630804|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
16313013|NCT02288325|39630805|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
16313014|NCT02288325|39630806|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
16313015|NCT02288325|39630804|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16313016|NCT02288325|39630805|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
16313017|NCT02288325|39630806|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
16313018|NCT02288325|39630804|FG000|Double-blind Treatment Period|Protocol Violation|0|||
16313019|NCT02288325|39630805|FG001|Double-blind Treatment Period|Protocol Violation|1|||
16506814|NCT02678676|40329387|FG001|Overall Study|Lost to Follow-up|151|||
16196635|NCT01797965|39197260|FG003|Overall Study|Disease progression, defined by protocol|0|||
16196636|NCT01797965|39197257|FG000|Overall Study|Reason Not Specified|280|||
16313020|NCT02288325|39630806|FG002|Double-blind Treatment Period|Protocol Violation|2|||
16313021|NCT02288325|39630804|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
16506815|NCT02678676|40329386|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
16506816|NCT02678676|40329387|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
16506817|NCT04782856|40329392|FG000|Overall Study|Withdrawal by Subject|0|||
16506818|NCT04782856|40329393|FG001|Overall Study|Withdrawal by Subject|1|||
16506819|NCT01851720|40329396|FG000|Overall Study|Lost to Follow-up|0|||
16506820|NCT01851720|40329397|FG001|Overall Study|Lost to Follow-up|1|||
16506821|NCT00451321|40329400|FG000|Overall Study|Lost to Follow-up|3|||
16506822|NCT00451321|40329401|FG001|Overall Study|Lost to Follow-up|3|||
16506823|NCT00451321|40329402|FG002|Overall Study|Lost to Follow-up|1|||
16313022|NCT02288325|39630805|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
16313023|NCT02288325|39630806|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
16196637|NCT01797965|39197258|FG001|Overall Study|Reason Not Specified|295|||
16196638|NCT01797965|39197259|FG002|Overall Study|Reason Not Specified|0|||
16506824|NCT00451321|40329403|FG003|Overall Study|Lost to Follow-up|3|||
16506825|NCT00451321|40329404|FG004|Overall Study|Lost to Follow-up|0|||
16506826|NCT00451321|40329405|FG005|Overall Study|Lost to Follow-up|1|||
16506827|NCT00451321|40329406|FG006|Overall Study|Lost to Follow-up|0|||
16506828|NCT00451321|40329407|FG007|Overall Study|Lost to Follow-up|0|||
16506829|NCT00451321|40329400|FG000|Overall Study|Withdrawal by Subject|3|||
16506830|NCT00451321|40329401|FG001|Overall Study|Withdrawal by Subject|1|||
16506831|NCT00451321|40329402|FG002|Overall Study|Withdrawal by Subject|0|||
16506832|NCT00451321|40329403|FG003|Overall Study|Withdrawal by Subject|4|||
16506833|NCT00451321|40329404|FG004|Overall Study|Withdrawal by Subject|0|||
16506834|NCT00451321|40329405|FG005|Overall Study|Withdrawal by Subject|0|||
16506835|NCT00451321|40329406|FG006|Overall Study|Withdrawal by Subject|0|||
16506836|NCT00451321|40329407|FG007|Overall Study|Withdrawal by Subject|0|||
16506837|NCT00451321|40329400|FG000|Overall Study|Study closed/terminated|1|||
16506838|NCT00451321|40329401|FG001|Overall Study|Study closed/terminated|1|||
16506839|NCT00451321|40329402|FG002|Overall Study|Study closed/terminated|17|||
16506840|NCT00451321|40329403|FG003|Overall Study|Study closed/terminated|5|||
16506841|NCT00451321|40329404|FG004|Overall Study|Study closed/terminated|7|||
16506842|NCT00451321|40329405|FG005|Overall Study|Study closed/terminated|7|||
16506843|NCT00451321|40329406|FG006|Overall Study|Study closed/terminated|5|||
16506844|NCT00451321|40329407|FG007|Overall Study|Study closed/terminated|3|||
16196639|NCT01797965|39197260|FG003|Overall Study|Reason Not Specified|15|||
16196640|NCT00238303|39197261|FG000|Overall Study|Withdrawal by Subject|11|||
16196641|NCT00238303|39197262|FG001|Overall Study|Withdrawal by Subject|1|||
16506845|NCT00451321|40329400|FG000|Overall Study|Sponsor decision to amend protocol|0|||
16506846|NCT00451321|40329401|FG001|Overall Study|Sponsor decision to amend protocol|0|||
16506847|NCT00451321|40329402|FG002|Overall Study|Sponsor decision to amend protocol|0|||
16506848|NCT00451321|40329403|FG003|Overall Study|Sponsor decision to amend protocol|0|||
16506849|NCT00451321|40329404|FG004|Overall Study|Sponsor decision to amend protocol|0|||
16506850|NCT00451321|40329405|FG005|Overall Study|Sponsor decision to amend protocol|1|||
16506851|NCT00451321|40329406|FG006|Overall Study|Sponsor decision to amend protocol|1|||
16506852|NCT00451321|40329407|FG007|Overall Study|Sponsor decision to amend protocol|3|||
16506853|NCT02910167|40329412|FG000|Overall Study|Adverse Event|1|||
16506854|NCT02910167|40329412|FG000|Overall Study|Lost to Follow-up|18|||
16506855|NCT01904604|40329413|FG000|Overall Study|Withdrew before receiving dosing|0|||
16506856|NCT01904604|40329414|FG001|Overall Study|Withdrew before receiving dosing|1|||
16506857|NCT01904604|40329415|FG002|Overall Study|Withdrew before receiving dosing|0|||
16506858|NCT01904604|40329413|FG000|Overall Study|Non-compliance|1|||
16196642|NCT00238303|39197263|FG002|Overall Study|Withdrawal by Subject|2|||
16196643|NCT00238303|39197261|FG000|Overall Study|Death|1|||
16196644|NCT00238303|39197262|FG001|Overall Study|Death|0|||
16196645|NCT00238303|39197263|FG002|Overall Study|Death|1|||
16196646|NCT00238303|39197261|FG000|Overall Study|Other Medical Problems|2|||
16196647|NCT00238303|39197262|FG001|Overall Study|Other Medical Problems|0|||
16196648|NCT00238303|39197263|FG002|Overall Study|Other Medical Problems|2|||
16196649|NCT00238303|39197261|FG000|Overall Study|Poor tolerance of study treatment|1|||
16196650|NCT00238303|39197262|FG001|Overall Study|Poor tolerance of study treatment|0|||
16196651|NCT00238303|39197263|FG002|Overall Study|Poor tolerance of study treatment|1|||
16196652|NCT00238303|39197261|FG000|Overall Study|Adverse Event|0|||
16313024|NCT02288325|39630804|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
16313025|NCT02288325|39630805|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
16313026|NCT02288325|39630806|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
16313027|NCT01982682|39630807|FG000|Overall Study|Physician Decision|1|||
16313028|NCT00273182|39630809|FG000|Overall Study|Death|450|||
16313029|NCT00273182|39630809|FG000|Overall Study|Lost to Follow-up|88|||
16506859|NCT01904604|40329414|FG001|Overall Study|Non-compliance|0|||
16196653|NCT00238303|39197262|FG001|Overall Study|Adverse Event|1|||
16313030|NCT00273182|39630809|FG000|Overall Study|Withdrawal by Subject|257|||
16506860|NCT01904604|40329415|FG002|Overall Study|Non-compliance|0|||
16506861|NCT01904604|40329413|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
16506862|NCT01904604|40329414|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
16506863|NCT01904604|40329415|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
16506864|NCT01904604|40329413|FG000|Overall Study|Patch site reactions|1|||
16506865|NCT01904604|40329414|FG001|Overall Study|Patch site reactions|1|||
16506866|NCT01904604|40329415|FG002|Overall Study|Patch site reactions|0|||
16506867|NCT01904604|40329413|FG000|Overall Study|Increased syncope|0|||
16506868|NCT01904604|40329414|FG001|Overall Study|Increased syncope|1|||
16506869|NCT01904604|40329415|FG002|Overall Study|Increased syncope|0|||
16506870|NCT01904604|40329413|FG000|Overall Study|Unrelated illness|0|||
16506871|NCT01904604|40329414|FG001|Overall Study|Unrelated illness|1|||
16506872|NCT01904604|40329415|FG002|Overall Study|Unrelated illness|0|||
16506873|NCT01904604|40329413|FG000|Overall Study|Passed Week 52 OFC|1|||
16506874|NCT01904604|40329414|FG001|Overall Study|Passed Week 52 OFC|0|||
16506875|NCT01904604|40329415|FG002|Overall Study|Passed Week 52 OFC|0|||
16506876|NCT01904604|40329413|FG000|Overall Study|Withdrawal by Subject|1|||
16506877|NCT01904604|40329414|FG001|Overall Study|Withdrawal by Subject|2|||
16506878|NCT01904604|40329415|FG002|Overall Study|Withdrawal by Subject|0|||
16506879|NCT01904604|40329413|FG000|Overall Study|Participant Relocated|1|||
16506880|NCT01904604|40329414|FG001|Overall Study|Participant Relocated|1|||
16506881|NCT01904604|40329415|FG002|Overall Study|Participant Relocated|1|||
16506882|NCT01904604|40329413|FG000|Overall Study|Lost to Follow-up|0|||
16506883|NCT01904604|40329414|FG001|Overall Study|Lost to Follow-up|0|||
16196654|NCT00238303|39197263|FG002|Overall Study|Adverse Event|3|||
16196655|NCT01397552|39197264|FG000|Overall Study|Adverse Event|1|||
16196656|NCT01397552|39197265|FG001|Overall Study|Adverse Event|0|||
16196657|NCT01397552|39197264|FG000|Overall Study|Withdrawal by Subject|2|||
16196658|NCT01397552|39197265|FG001|Overall Study|Withdrawal by Subject|1|||
16196659|NCT03649321|39197266|FG000|Overall Study|Withdrawal by Subject|1|||
16196660|NCT03649321|39197267|FG001|Overall Study|Withdrawal by Subject|0|||
16313031|NCT00273182|39630809|FG000|Overall Study|Device/System Explant|154|||
16313032|NCT00273182|39630809|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
16506884|NCT01904604|40329415|FG002|Overall Study|Lost to Follow-up|1|||
16506885|NCT01988103|40329416|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
16196661|NCT03649321|39197266|FG000|Overall Study|Death|1|||
16196662|NCT03649321|39197267|FG001|Overall Study|Death|0|||
16196663|NCT00992784|39197268|FG000|Overall Study|Adverse Event|2|||
16196664|NCT00992784|39197269|FG001|Overall Study|Adverse Event|1|||
16196665|NCT00992784|39197270|FG002|Overall Study|Adverse Event|0|||
16196666|NCT00992784|39197268|FG000|Overall Study|Withdrawal by Subject|1|||
16196667|NCT00992784|39197269|FG001|Overall Study|Withdrawal by Subject|1|||
16196668|NCT00992784|39197270|FG002|Overall Study|Withdrawal by Subject|1|||
16196669|NCT00973921|39197271|FG000|Overall Study|IVUS results were not available|9|||
16196670|NCT03580382|39197274|FG000|Overall Study|Early Termination of Study|0|||
16196671|NCT03580382|39197275|FG001|Overall Study|Early Termination of Study|3|||
16196672|NCT00718666|39197279|FG000|Booster Phase Year 5|No active participation request|0|||
16196673|NCT00718666|39197280|FG001|Booster Phase Year 5|No active participation request|0|||
16196674|NCT00718666|39197281|FG002|Booster Phase Year 5|No active participation request|1|||
16196675|NCT00718666|39197279|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
16196676|NCT00718666|39197280|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
16196677|NCT00718666|39197281|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
16196678|NCT00718666|39197279|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
16196679|NCT00718666|39197280|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
16196680|NCT00718666|39197281|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
16196681|NCT00718666|39197279|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
16196682|NCT00718666|39197280|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
16196683|NCT00718666|39197281|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
16196684|NCT03722784|39197282|FG000|Overall Study|Withdrawal by Subject|1|||
16196685|NCT03722784|39197283|FG001|Overall Study|Withdrawal by Subject|0|||
16196686|NCT03722784|39197282|FG000|Overall Study|Physician Decision|1|||
16196687|NCT03722784|39197283|FG001|Overall Study|Physician Decision|1|||
16196688|NCT03722784|39197282|FG000|Overall Study|Protocol Violation|0|||
16196689|NCT03722784|39197283|FG001|Overall Study|Protocol Violation|1|||
16196690|NCT01511107|39197289|FG000|Overall Study|Ineligible|3|||
16196691|NCT01511107|39197290|FG001|Overall Study|Ineligible|2|||
16196692|NCT01511107|39197289|FG000|Overall Study|Lost to Follow-up|10|||
16196693|NCT01511107|39197290|FG001|Overall Study|Lost to Follow-up|19|||
16196694|NCT01511107|39197289|FG000|Overall Study|Withdrawal by Subject|9|||
16196695|NCT01511107|39197290|FG001|Overall Study|Withdrawal by Subject|20|||
16196696|NCT00082758|39197293|FG000|Overall Study|Adverse Event|0|||
16196697|NCT00082758|39197294|FG001|Overall Study|Adverse Event|2|||
16196698|NCT00082758|39197295|FG002|Overall Study|Adverse Event|0|||
16196699|NCT00082758|39197293|FG000|Overall Study|Lack of Efficacy|12|||
16196700|NCT00082758|39197294|FG001|Overall Study|Lack of Efficacy|13|||
16196701|NCT00082758|39197295|FG002|Overall Study|Lack of Efficacy|0|||
16196702|NCT00082758|39197293|FG000|Overall Study|Physician Decision|0|||
16196703|NCT00082758|39197294|FG001|Overall Study|Physician Decision|1|||
16196704|NCT00082758|39197295|FG002|Overall Study|Physician Decision|0|||
16196705|NCT00082758|39197293|FG000|Overall Study|Withdrawal by Subject|3|||
16196706|NCT00082758|39197294|FG001|Overall Study|Withdrawal by Subject|0|||
16196707|NCT00082758|39197295|FG002|Overall Study|Withdrawal by Subject|0|||
16196708|NCT00082758|39197293|FG000|Overall Study|Protocol Violation|0|||
16196709|NCT00082758|39197294|FG001|Overall Study|Protocol Violation|1|||
16196710|NCT00082758|39197295|FG002|Overall Study|Protocol Violation|0|||
16196711|NCT02855450|39197296|FG000|Overall Study|Adverse Event|1|||
16196712|NCT02855450|39197297|FG001|Overall Study|Adverse Event|0|||
16196713|NCT02855450|39197296|FG000|Overall Study|Lost to Follow-up|4|||
16196714|NCT02855450|39197297|FG001|Overall Study|Lost to Follow-up|0|||
16196715|NCT00333619|39197300|FG000|Overall Study|Death|12|||
16196716|NCT00333619|39197301|FG001|Overall Study|Death|6|||
16196717|NCT00333619|39197300|FG000|Overall Study|Withdrawal by Subject|6|||
16196718|NCT00333619|39197301|FG001|Overall Study|Withdrawal by Subject|1|||
16196719|NCT00333619|39197300|FG000|Overall Study|Lost to Follow-up|3|||
16196720|NCT00333619|39197301|FG001|Overall Study|Lost to Follow-up|3|||
16196721|NCT02237157|39197302|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
16196722|NCT02237157|39197303|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
16196723|NCT02237157|39197304|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
16196724|NCT02237157|39197305|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
16196725|NCT02237157|39197302|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
16196726|NCT02237157|39197303|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
16196727|NCT02237157|39197304|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
16196728|NCT02237157|39197305|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
16196729|NCT02985450|39197306|FG000|Overall Study|Lost to Follow-up|7|||
16196730|NCT00772382|39197307|FG000|Overall Study|Adverse Event|19|||
16196731|NCT00772382|39197307|FG000|Overall Study|Death|6|||
16196732|NCT00772382|39197307|FG000|Overall Study|Lack of Efficacy|4|||
16196733|NCT00772382|39197307|FG000|Overall Study|Physician Decision|5|||
16196734|NCT00772382|39197307|FG000|Overall Study|Protocol Violation|1|||
16196735|NCT00772382|39197307|FG000|Overall Study|Withdrawal by Subject|10|||
16196736|NCT00772382|39197307|FG000|Overall Study|Other Reasons|10|||
16196737|NCT00710034|39197308|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
16196738|NCT00710034|39197309|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
16196739|NCT00710034|39197308|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
16196740|NCT00710034|39197309|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
16196741|NCT00710034|39197308|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
16196742|NCT00710034|39197309|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
16196743|NCT00710034|39197308|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
16196744|NCT00710034|39197309|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
16196745|NCT00710034|39197308|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
16196746|NCT00710034|39197309|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
16196747|NCT00710034|39197308|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
16196748|NCT00710034|39197309|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
16196749|NCT00710034|39197308|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
16196750|NCT00710034|39197309|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
16196751|NCT00710034|39197308|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
16196752|NCT00710034|39197309|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
16196753|NCT00710034|39197308|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
16196754|NCT00710034|39197309|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
16196755|NCT00710034|39197308|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
16196756|NCT00710034|39197309|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
16196757|NCT00710034|39197308|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
16196758|NCT00710034|39197309|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
16196759|NCT03888391|39197310|FG000|Overall Study|Lost to Follow-up|15|||
16196760|NCT02559206|39197312|FG000|Overall Study|Adverse Event|0|||
16196761|NCT02559206|39197313|FG001|Overall Study|Adverse Event|4|||
16196762|NCT02559206|39197314|FG002|Overall Study|Adverse Event|1|||
16196763|NCT02559206|39197315|FG003|Overall Study|Adverse Event|5|||
16196764|NCT02559206|39197316|FG004|Overall Study|Adverse Event|3|||
16196765|NCT02559206|39197317|FG005|Overall Study|Adverse Event|0|||
16196766|NCT02559206|39197318|FG006|Overall Study|Adverse Event|1|||
16196767|NCT02559206|39197319|FG007|Overall Study|Adverse Event|0|||
16196768|NCT02559206|39197312|FG000|Overall Study|Protocol Violation|1|||
16196769|NCT02559206|39197313|FG001|Overall Study|Protocol Violation|0|||
16196770|NCT02559206|39197314|FG002|Overall Study|Protocol Violation|1|||
16196771|NCT02559206|39197315|FG003|Overall Study|Protocol Violation|0|||
16196772|NCT02559206|39197316|FG004|Overall Study|Protocol Violation|0|||
16196773|NCT02559206|39197317|FG005|Overall Study|Protocol Violation|2|||
16196774|NCT02559206|39197318|FG006|Overall Study|Protocol Violation|0|||
16196775|NCT02559206|39197319|FG007|Overall Study|Protocol Violation|0|||
16196776|NCT02559206|39197312|FG000|Overall Study|Withdrawal by Subject|3|||
16196777|NCT02559206|39197313|FG001|Overall Study|Withdrawal by Subject|3|||
16196778|NCT02559206|39197314|FG002|Overall Study|Withdrawal by Subject|1|||
16196779|NCT02559206|39197315|FG003|Overall Study|Withdrawal by Subject|3|||
16196780|NCT02559206|39197316|FG004|Overall Study|Withdrawal by Subject|5|||
16196781|NCT02559206|39197317|FG005|Overall Study|Withdrawal by Subject|4|||
16196782|NCT02559206|39197318|FG006|Overall Study|Withdrawal by Subject|1|||
16196783|NCT02559206|39197319|FG007|Overall Study|Withdrawal by Subject|2|||
16196784|NCT02559206|39197312|FG000|Overall Study|Lost to Follow-up|3|||
16196785|NCT02559206|39197313|FG001|Overall Study|Lost to Follow-up|5|||
16196786|NCT02559206|39197314|FG002|Overall Study|Lost to Follow-up|3|||
16196787|NCT02559206|39197315|FG003|Overall Study|Lost to Follow-up|3|||
16196788|NCT02559206|39197316|FG004|Overall Study|Lost to Follow-up|2|||
16196789|NCT02559206|39197317|FG005|Overall Study|Lost to Follow-up|5|||
16196790|NCT02559206|39197318|FG006|Overall Study|Lost to Follow-up|1|||
16196791|NCT02559206|39197319|FG007|Overall Study|Lost to Follow-up|4|||
16196792|NCT02559206|39197312|FG000|Overall Study|Lack of Efficacy|1|||
16196793|NCT02559206|39197313|FG001|Overall Study|Lack of Efficacy|0|||
16196794|NCT02559206|39197314|FG002|Overall Study|Lack of Efficacy|3|||
16196795|NCT02559206|39197315|FG003|Overall Study|Lack of Efficacy|2|||
16196796|NCT02559206|39197316|FG004|Overall Study|Lack of Efficacy|2|||
16196797|NCT02559206|39197317|FG005|Overall Study|Lack of Efficacy|3|||
16196798|NCT02559206|39197318|FG006|Overall Study|Lack of Efficacy|3|||
16196799|NCT02559206|39197319|FG007|Overall Study|Lack of Efficacy|3|||
16196800|NCT02559206|39197312|FG000|Overall Study|Other Not Specified|0|||
16196801|NCT02559206|39197313|FG001|Overall Study|Other Not Specified|0|||
16196802|NCT02559206|39197314|FG002|Overall Study|Other Not Specified|0|||
16196803|NCT02559206|39197315|FG003|Overall Study|Other Not Specified|1|||
16196804|NCT02559206|39197316|FG004|Overall Study|Other Not Specified|0|||
16196805|NCT02559206|39197317|FG005|Overall Study|Other Not Specified|0|||
16196806|NCT02559206|39197318|FG006|Overall Study|Other Not Specified|0|||
16196807|NCT02559206|39197319|FG007|Overall Study|Other Not Specified|0|||
16196808|NCT00077376|39197320|FG000|Overall Study|Adverse Event|8|||
16196809|NCT00077376|39197320|FG000|Overall Study|Withdrawal by Subject|2|||
16196810|NCT00077376|39197320|FG000|Overall Study|Death|1|||
16196811|NCT00077376|39197320|FG000|Overall Study|Physician Decision|1|||
16196812|NCT00077376|39197320|FG000|Overall Study|Alternative therapy|5|||
16196813|NCT00077376|39197320|FG000|Overall Study|Complicating disease|1|||
16196814|NCT00077376|39197320|FG000|Overall Study|Still on treatment|1|||
16196815|NCT00077376|39197320|FG000|Overall Study|Symptomatic deterioration|1|||
16196816|NCT00077376|39197320|FG000|Overall Study|Surgery|1|||
16196817|NCT00077376|39197320|FG000|Overall Study|Insurance ran out|1|||
16196818|NCT00916370|39197327|FG000|Overall Study|Death|3|||
16196819|NCT00916370|39197328|FG001|Overall Study|Death|1|||
16196820|NCT00916370|39197327|FG000|Overall Study|Withdrawal by Subject|2|||
16196821|NCT00916370|39197328|FG001|Overall Study|Withdrawal by Subject|0|||
16196822|NCT00916370|39197327|FG000|Overall Study|Physician Decision|0|||
16196823|NCT00916370|39197328|FG001|Overall Study|Physician Decision|1|||
16196824|NCT02756650|39197333|FG000|Overall Study|Physician Decision|1|||
16196825|NCT02756650|39197333|FG000|Overall Study|Adverse Event|1|||
16196826|NCT05216406|39197338|FG000|Overall Study|Lost to Follow-up|8|||
16196827|NCT05216406|39197339|FG001|Overall Study|Lost to Follow-up|9|||
16196828|NCT00305253|39197341|FG000|Overall Study|Withdrawal by Subject|0|||
16196829|NCT00305253|39197342|FG001|Overall Study|Withdrawal by Subject|1|||
16196830|NCT00315705|39197343|FG000|Phase 1|Refused further treatment|1|||
16196831|NCT00315705|39197343|FG000|Phase 1|Failure to achieve response|8|||
16196832|NCT00315705|39197343|FG000|Phase 1|Disease relapse|4|||
16196833|NCT00315705|39197343|FG000|Phase 1|Scheduled for transplant|9|||
16196834|NCT00315705|39197343|FG000|Phase 1|Death|3|||
16196835|NCT00315705|39197343|FG000|Phase 2|Physician Decision|4|||
16196836|NCT00315705|39197343|FG000|Phase 2|Adverse Event|1|||
16196837|NCT00315705|39197343|FG000|Phase 2|Failure to achieve response|3|||
16196838|NCT00315705|39197343|FG000|Phase 2|Disease relapse|1|||
16196839|NCT00315705|39197343|FG000|Phase 2|Scheduled for transplant|8|||
16196840|NCT00315705|39197343|FG000|Phase 2|Other|1|||
16196841|NCT00315705|39197343|FG000|Phase 2|Death|7|||
16196842|NCT02326467|39197348|FG000|Overall Study|Withdrawal by Subject|1|||
16196843|NCT04092816|39197354|FG000|Overall Study|Lost to Follow-up|1|||
16196844|NCT04092816|39197355|FG001|Overall Study|Lost to Follow-up|2|||
16196845|NCT00808249|39197360|FG000|Overall Study|Adverse Event|4|||
16196846|NCT00808249|39197361|FG001|Overall Study|Adverse Event|7|||
16196847|NCT00808249|39197362|FG002|Overall Study|Adverse Event|10|||
16196848|NCT00808249|39197363|FG003|Overall Study|Adverse Event|6|||
16196849|NCT00808249|39197360|FG000|Overall Study|Lost to Follow-up|2|||
16196850|NCT00808249|39197361|FG001|Overall Study|Lost to Follow-up|3|||
16196851|NCT00808249|39197362|FG002|Overall Study|Lost to Follow-up|3|||
16313067|NCT02568072|39630812|FG000|Overall Study|Unavailable for appointment|23|||
16313068|NCT02568072|39630812|FG000|Overall Study|Unable to contact|3|||
16313069|NCT02568072|39630812|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
16313070|NCT02568072|39630812|FG000|Overall Study|Withdrawal by Subject|1|||
16196852|NCT00808249|39197363|FG003|Overall Study|Lost to Follow-up|5|||
16196853|NCT00808249|39197360|FG000|Overall Study|Withdrawal by Subject|4|||
16196854|NCT00808249|39197361|FG001|Overall Study|Withdrawal by Subject|0|||
16196855|NCT00808249|39197362|FG002|Overall Study|Withdrawal by Subject|2|||
16196856|NCT00808249|39197363|FG003|Overall Study|Withdrawal by Subject|4|||
16196857|NCT00808249|39197360|FG000|Overall Study|Protocol Violation|3|||
16196858|NCT00808249|39197361|FG001|Overall Study|Protocol Violation|3|||
16196859|NCT00808249|39197362|FG002|Overall Study|Protocol Violation|3|||
16196860|NCT00808249|39197363|FG003|Overall Study|Protocol Violation|0|||
16313071|NCT02568072|39630812|FG000|Overall Study|Sustained injury, marathon not run|24|||
16313072|NCT03655405|39630817|FG000|Overall Study|Death after initial data collection|4|||
16196861|NCT00808249|39197360|FG000|Overall Study|Lack of Efficacy|1|||
16196862|NCT00808249|39197361|FG001|Overall Study|Lack of Efficacy|1|||
16196863|NCT00808249|39197362|FG002|Overall Study|Lack of Efficacy|0|||
16196864|NCT00808249|39197363|FG003|Overall Study|Lack of Efficacy|0|||
16196865|NCT00808249|39197360|FG000|Overall Study|study specific discontinuation criteria|1|||
16196866|NCT00808249|39197361|FG001|Overall Study|study specific discontinuation criteria|0|||
16196867|NCT00808249|39197362|FG002|Overall Study|study specific discontinuation criteria|1|||
16196868|NCT00808249|39197363|FG003|Overall Study|study specific discontinuation criteria|0|||
16196869|NCT00808249|39197360|FG000|Overall Study|All other reasons|2|||
16196870|NCT00808249|39197361|FG001|Overall Study|All other reasons|1|||
16196871|NCT00808249|39197362|FG002|Overall Study|All other reasons|3|||
16196872|NCT00808249|39197363|FG003|Overall Study|All other reasons|1|||
16196873|NCT00847730|39197364|FG000|Overall Study|Multiple interruptions in therapy|8|||
16196874|NCT00910429|39197365|FG000|Overall Study|Death|18|||
16196875|NCT00910429|39197366|FG001|Overall Study|Death|12|||
16196876|NCT00910429|39197365|FG000|Overall Study|Withdrawal by Subject|3|||
16506886|NCT01988103|40329417|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
16506887|NCT01988103|40329418|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
16506888|NCT01988103|40329419|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
16506889|NCT01988103|40329420|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
16506890|NCT01988103|40329416|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
16506891|NCT01988103|40329417|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
16506892|NCT01988103|40329418|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
16506893|NCT01988103|40329419|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
16506894|NCT01988103|40329420|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
16506895|NCT01988103|40329416|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
16506896|NCT01988103|40329417|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
16506897|NCT01988103|40329418|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
16506898|NCT01988103|40329419|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
16506899|NCT01988103|40329420|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
16506900|NCT01988103|40329416|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
16506901|NCT01988103|40329417|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
16506902|NCT01988103|40329418|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
16506903|NCT01988103|40329419|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
16506904|NCT01988103|40329420|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
16506905|NCT01988103|40329416|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
16196877|NCT00910429|39197366|FG001|Overall Study|Withdrawal by Subject|2|||
16196878|NCT00910429|39197365|FG000|Overall Study|Protocol Violation|1|||
16196879|NCT00910429|39197366|FG001|Overall Study|Protocol Violation|0|||
16196880|NCT00910429|39197365|FG000|Overall Study|Lost to Follow-up|2|||
16196881|NCT00910429|39197366|FG001|Overall Study|Lost to Follow-up|1|||
16196882|NCT00910429|39197365|FG000|Overall Study|Adverse Event|10|||
16196883|NCT00910429|39197366|FG001|Overall Study|Adverse Event|5|||
16196884|NCT00910429|39197365|FG000|Overall Study|Drug non-compliance|1|||
16196885|NCT00910429|39197366|FG001|Overall Study|Drug non-compliance|0|||
16196886|NCT00910429|39197365|FG000|Overall Study|Lack of Efficacy|4|||
16196887|NCT00910429|39197366|FG001|Overall Study|Lack of Efficacy|1|||
16196888|NCT02397694|39197367|FG000|Double-Blinded Phase|Adverse Event|1|||
16506906|NCT01988103|40329417|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
16506907|NCT01988103|40329418|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
16506908|NCT01988103|40329419|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
16196889|NCT02397694|39197368|FG001|Double-Blinded Phase|Adverse Event|0|||
16196890|NCT02397694|39197367|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
16196891|NCT02397694|39197368|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
16196892|NCT02397694|39197367|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
16196893|NCT02397694|39197368|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
16196894|NCT02397694|39197367|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
16196895|NCT02397694|39197368|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
16196896|NCT02397694|39197367|FG000|Open Label Extension Phase|Protocol Violation|1|||
16196897|NCT02397694|39197368|FG001|Open Label Extension Phase|Protocol Violation|0|||
16313073|NCT03655405|39630818|FG001|Overall Study|Death after initial data collection|2|||
16313074|NCT03655405|39630817|FG000|Overall Study|Died before initial data collection|1|||
16196898|NCT02397694|39197367|FG000|Open Label Extension Phase|Withdrew Consent|3|||
16196899|NCT02397694|39197368|FG001|Open Label Extension Phase|Withdrew Consent|1|||
16196900|NCT02397694|39197367|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
16313075|NCT03655405|39630818|FG001|Overall Study|Died before initial data collection|2|||
16313076|NCT03655405|39630817|FG000|Overall Study|Protocol Violation|0|||
16313077|NCT03655405|39630818|FG001|Overall Study|Protocol Violation|1|||
16313078|NCT02750618|39630823|FG000|Overall Study|Withdrawal by Subject|1|||
16313079|NCT01252095|39630828|FG000|Overall Study|Disease progression|1|||
16313080|NCT01252095|39630829|FG001|Overall Study|Disease progression|0|||
16196901|NCT02397694|39197368|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
16313081|NCT00840749|39630830|FG000|Overall Study|Death|1|||
16313082|NCT00840749|39630831|FG001|Overall Study|Death|2|||
16196902|NCT00349752|39197369|FG000|Overall Study|Adverse Event|8|||
16196903|NCT00349752|39197370|FG001|Overall Study|Adverse Event|12|||
16196904|NCT00349752|39197369|FG000|Overall Study|Lack of Efficacy|37|||
16196905|NCT00349752|39197370|FG001|Overall Study|Lack of Efficacy|42|||
16196906|NCT00349752|39197369|FG000|Overall Study|Lost to Follow-up|4|||
16196907|NCT00349752|39197370|FG001|Overall Study|Lost to Follow-up|2|||
16196908|NCT00349752|39197369|FG000|Overall Study|Personal reasons|6|||
16196909|NCT00349752|39197370|FG001|Overall Study|Personal reasons|5|||
16196910|NCT00349752|39197369|FG000|Overall Study|Other: Required exclusionary medication|0|||
16196911|NCT00349752|39197370|FG001|Overall Study|Other: Required exclusionary medication|1|||
16196912|NCT00349752|39197369|FG000|Overall Study|Other: Non compliance|0|||
16196913|NCT00349752|39197370|FG001|Overall Study|Other: Non compliance|1|||
16196914|NCT00349752|39197369|FG000|Overall Study|Other: Patient stopped steroids|0|||
16196915|NCT00349752|39197370|FG001|Overall Study|Other: Patient stopped steroids|1|||
16196916|NCT00349752|39197369|FG000|Overall Study|Other: Patient's steroid use|1|||
16196917|NCT00349752|39197370|FG001|Overall Study|Other: Patient's steroid use|0|||
16196918|NCT00349752|39197369|FG000|Overall Study|Other: Ineligible|1|||
16313083|NCT00840749|39630830|FG000|Overall Study|not treated on study arm|11|||
16313084|NCT00840749|39630831|FG001|Overall Study|not treated on study arm|11|||
16313085|NCT00840749|39630830|FG000|Overall Study|study closed|19|||
16313086|NCT00840749|39630831|FG001|Overall Study|study closed|14|||
16313087|NCT01037218|39630832|FG000|Overall Study|Adverse Event|4|||
16313088|NCT01037218|39630833|FG001|Overall Study|Adverse Event|2|||
16506909|NCT01988103|40329420|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
16506910|NCT01988103|40329416|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
16506911|NCT01988103|40329417|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
16506912|NCT01988103|40329418|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
16506913|NCT01988103|40329419|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
16196919|NCT00349752|39197370|FG001|Overall Study|Other: Ineligible|0|||
16506914|NCT01988103|40329420|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
16506915|NCT01988103|40329416|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
16506916|NCT01988103|40329417|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
16506917|NCT01988103|40329418|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
16506918|NCT01988103|40329419|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
16506919|NCT01988103|40329420|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
16506920|NCT01859494|40329422|FG000|Overall Study|Adverse Event|1|||
16506921|NCT03200899|40329425|FG000|Overall Study|Lost to Follow-up|10|||
16506922|NCT03200899|40329426|FG001|Overall Study|Lost to Follow-up|23|||
16506923|NCT03412084|40329427|FG000|Overall Study|Withdrawal by Subject|2|||
16506924|NCT03412084|40329428|FG001|Overall Study|Withdrawal by Subject|0|||
16506925|NCT03412084|40329427|FG000|Overall Study|Participant moved|1|||
16506926|NCT03412084|40329428|FG001|Overall Study|Participant moved|0|||
16506927|NCT03412084|40329427|FG000|Overall Study|Lost to Follow-up|1|||
16506928|NCT03412084|40329428|FG001|Overall Study|Lost to Follow-up|1|||
16506929|NCT00006489|40329429|FG000|Overall Study|Adverse Event|3|||
16506930|NCT00006489|40329430|FG001|Overall Study|Adverse Event|2|||
16506931|NCT00006489|40329431|FG002|Overall Study|Adverse Event|4|||
16506932|NCT00006489|40329432|FG003|Overall Study|Adverse Event|3|||
16506933|NCT00006489|40329429|FG000|Overall Study|Withdrawal by Subject|10|||
16506934|NCT00006489|40329430|FG001|Overall Study|Withdrawal by Subject|9|||
16506935|NCT00006489|40329431|FG002|Overall Study|Withdrawal by Subject|9|||
16506936|NCT00006489|40329432|FG003|Overall Study|Withdrawal by Subject|6|||
16506937|NCT00006489|40329429|FG000|Overall Study|Scheduling Conflict|0|||
16506938|NCT00006489|40329430|FG001|Overall Study|Scheduling Conflict|3|||
16506939|NCT00006489|40329431|FG002|Overall Study|Scheduling Conflict|2|||
16506940|NCT00006489|40329432|FG003|Overall Study|Scheduling Conflict|1|||
16506941|NCT00006489|40329429|FG000|Overall Study|Death|0|||
16196920|NCT00349752|39197369|FG000|Overall Study|Other: Inadvertently unblinded|1|||
16313089|NCT01037218|39630834|FG002|Overall Study|Adverse Event|2|||
16313090|NCT01037218|39630835|FG003|Overall Study|Adverse Event|1|||
16313091|NCT01037218|39630832|FG000|Overall Study|Lack of Efficacy|0|||
16313092|NCT01037218|39630833|FG001|Overall Study|Lack of Efficacy|2|||
16313093|NCT01037218|39630834|FG002|Overall Study|Lack of Efficacy|1|||
16506942|NCT00006489|40329430|FG001|Overall Study|Death|0|||
16506943|NCT00006489|40329431|FG002|Overall Study|Death|0|||
16506944|NCT00006489|40329432|FG003|Overall Study|Death|1|||
16506945|NCT01712256|40329433|FG000|Overall Study|Lost to Follow-up|1|||
16506946|NCT04327999|40329434|FG000|Overall Study|Protocol Violation|1|||
16196921|NCT00349752|39197370|FG001|Overall Study|Other: Inadvertently unblinded|0|||
16196922|NCT00349752|39197369|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
16313094|NCT01037218|39630835|FG003|Overall Study|Lack of Efficacy|5|||
16196923|NCT00349752|39197370|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
16196924|NCT00751114|39197376|FG000|Overall Study|Adverse Event|2|||
16196925|NCT00751114|39197377|FG001|Overall Study|Adverse Event|4|||
16196926|NCT00751114|39197376|FG000|Overall Study|Protocol Violation|8|||
16196927|NCT00751114|39197377|FG001|Overall Study|Protocol Violation|9|||
16196928|NCT00751114|39197376|FG000|Overall Study|Withdrawal by Subject|9|||
16196929|NCT00751114|39197377|FG001|Overall Study|Withdrawal by Subject|4|||
16196930|NCT00751114|39197376|FG000|Overall Study|Lost to Follow-up|4|||
16196931|NCT00751114|39197377|FG001|Overall Study|Lost to Follow-up|7|||
16196932|NCT00751114|39197376|FG000|Overall Study|Lack of Efficacy|0|||
16196933|NCT00751114|39197377|FG001|Overall Study|Lack of Efficacy|7|||
16196934|NCT00751114|39197376|FG000|Overall Study|Not Treated|13|||
16196935|NCT00751114|39197377|FG001|Overall Study|Not Treated|1|||
16196936|NCT00751114|39197376|FG000|Overall Study|Out of country for 2 months|1|||
16196937|NCT00751114|39197377|FG001|Overall Study|Out of country for 2 months|0|||
16196938|NCT00751114|39197376|FG000|Overall Study|Move to another city|1|||
16196939|NCT00751114|39197377|FG001|Overall Study|Move to another city|0|||
16196940|NCT00870818|39197378|FG000|Overall Study|Lost to Follow-up|3|||
16196941|NCT00870818|39197379|FG001|Overall Study|Lost to Follow-up|2|||
16196942|NCT00870818|39197380|FG002|Overall Study|Lost to Follow-up|1|||
16196943|NCT00870818|39197381|FG003|Overall Study|Lost to Follow-up|0|||
16196944|NCT00870818|39197382|FG004|Overall Study|Lost to Follow-up|0|||
16196945|NCT00870818|39197378|FG000|Overall Study|Withdrawal by Subject|0|||
16196946|NCT00870818|39197379|FG001|Overall Study|Withdrawal by Subject|0|||
16196947|NCT00870818|39197380|FG002|Overall Study|Withdrawal by Subject|1|||
16196948|NCT00870818|39197381|FG003|Overall Study|Withdrawal by Subject|2|||
16196949|NCT00870818|39197382|FG004|Overall Study|Withdrawal by Subject|0|||
16196950|NCT00870818|39197378|FG000|Overall Study|Terminated by sponsor|29|||
16196951|NCT00870818|39197379|FG001|Overall Study|Terminated by sponsor|70|||
16196952|NCT00870818|39197380|FG002|Overall Study|Terminated by sponsor|36|||
16196953|NCT00870818|39197381|FG003|Overall Study|Terminated by sponsor|36|||
16196954|NCT00870818|39197382|FG004|Overall Study|Terminated by sponsor|38|||
16196955|NCT00870818|39197378|FG000|Overall Study|Other|0|||
16196956|NCT00870818|39197379|FG001|Overall Study|Other|1|||
16196957|NCT00870818|39197380|FG002|Overall Study|Other|0|||
16196958|NCT00870818|39197381|FG003|Overall Study|Other|0|||
16196959|NCT00870818|39197382|FG004|Overall Study|Other|0|||
16196960|NCT00789958|39197383|FG000|Overall Study|Adverse Event|3|||
16196961|NCT00789958|39197383|FG000|Overall Study|Withdrawal by Subject|4|||
16196962|NCT00789958|39197383|FG000|Overall Study|Progression|3|||
16196963|NCT00789958|39197383|FG000|Overall Study|not protocol specified|1|||
16196964|NCT00789958|39197383|FG000|Overall Study|Not eligible/not analyzable|26|||
16196965|NCT00434122|39197384|FG000|Overall Study|Non-compliance with protocol|0|||
16196966|NCT00434122|39197385|FG001|Overall Study|Non-compliance with protocol|1|||
16196967|NCT00434122|39197384|FG000|Overall Study|loss of subject contact|1|||
16196968|NCT00434122|39197385|FG001|Overall Study|loss of subject contact|1|||
16196969|NCT00434122|39197384|FG000|Overall Study|Personal reasons|1|||
16196970|NCT00434122|39197385|FG001|Overall Study|Personal reasons|1|||
16196971|NCT00434122|39197384|FG000|Overall Study|Large follicle size|2|||
16196972|NCT00434122|39197385|FG001|Overall Study|Large follicle size|2|||
16196973|NCT00434122|39197384|FG000|Overall Study|Low follicular response.|1|||
16196974|NCT00434122|39197385|FG001|Overall Study|Low follicular response.|2|||
16196975|NCT00434122|39197384|FG000|Overall Study|Travelling of subject.|1|||
16196976|NCT00434122|39197385|FG001|Overall Study|Travelling of subject.|0|||
16196977|NCT01702363|39197386|FG000|Overall Study|Adverse Event|14|||
16196978|NCT01702363|39197386|FG000|Overall Study|Lack of Efficacy|4|||
16196979|NCT01702363|39197386|FG000|Overall Study|Withdrawal by Subject|2|||
16313095|NCT01037218|39630832|FG000|Overall Study|Lost to Follow-up|3|||
16313096|NCT01037218|39630833|FG001|Overall Study|Lost to Follow-up|5|||
16313097|NCT01037218|39630834|FG002|Overall Study|Lost to Follow-up|4|||
16313098|NCT01037218|39630835|FG003|Overall Study|Lost to Follow-up|2|||
16313099|NCT01037218|39630832|FG000|Overall Study|Withdrawal by Subject|6|||
16506947|NCT00480779|40329435|FG000|Overall Study|Other|2|||
16506948|NCT00480779|40329436|FG001|Overall Study|Other|0|||
16506949|NCT00480779|40329435|FG000|Overall Study|Job and Health-related|0|||
16506950|NCT00480779|40329436|FG001|Overall Study|Job and Health-related|3|||
16506951|NCT03979638|40329437|FG000|Period 1|Physician Decision|1|||
16506952|NCT03979638|40329438|FG001|Period 1|Physician Decision|1|||
16506953|NCT03979638|40329437|FG000|Period 1|Withdrawal by Subject|4|||
16506954|NCT03979638|40329438|FG001|Period 1|Withdrawal by Subject|3|||
16506955|NCT03979638|40329437|FG000|Period 1|Study terminated by Sponsor|1|||
16196980|NCT02669862|39197389|FG000|Overall Study|Lost to Follow-up|0|||
16196981|NCT02669862|39197390|FG001|Overall Study|Lost to Follow-up|2|||
16313100|NCT01037218|39630833|FG001|Overall Study|Withdrawal by Subject|7|||
16506956|NCT03979638|40329438|FG001|Period 1|Study terminated by Sponsor|3|||
16506957|NCT03979638|40329437|FG000|Period 1|Protocol Violation|1|||
16196982|NCT02669862|39197391|FG002|Overall Study|Lost to Follow-up|1|||
16196983|NCT02669862|39197389|FG000|Overall Study|Withdrawal by Subject|2|||
16196984|NCT02669862|39197390|FG001|Overall Study|Withdrawal by Subject|2|||
16196985|NCT02669862|39197391|FG002|Overall Study|Withdrawal by Subject|3|||
16506958|NCT03979638|40329438|FG001|Period 1|Protocol Violation|0|||
16506959|NCT03979638|40329437|FG000|Period 2|Study terminated by Sponsor|1|||
16506960|NCT03979638|40329438|FG001|Period 2|Study terminated by Sponsor|1|||
16506961|NCT00453999|40329439|FG000|Overall Study|Adverse Event|1|||
16506962|NCT00453999|40329440|FG001|Overall Study|Adverse Event|2|||
16506963|NCT00453999|40329441|FG002|Overall Study|Adverse Event|1|||
16506964|NCT00453999|40329439|FG000|Overall Study|Lost to Follow-up|0|||
16506965|NCT00453999|40329440|FG001|Overall Study|Lost to Follow-up|1|||
16506966|NCT00453999|40329441|FG002|Overall Study|Lost to Follow-up|1|||
16313101|NCT01037218|39630834|FG002|Overall Study|Withdrawal by Subject|7|||
16313102|NCT01037218|39630835|FG003|Overall Study|Withdrawal by Subject|4|||
16313103|NCT01037218|39630832|FG000|Overall Study|Partner Withdrew Consent|0|||
16313104|NCT01037218|39630833|FG001|Overall Study|Partner Withdrew Consent|3|||
16313105|NCT01037218|39630834|FG002|Overall Study|Partner Withdrew Consent|2|||
16313106|NCT01037218|39630835|FG003|Overall Study|Partner Withdrew Consent|1|||
16313107|NCT01037218|39630832|FG000|Overall Study|Protocol Violation|0|||
16313108|NCT01037218|39630833|FG001|Overall Study|Protocol Violation|0|||
16313109|NCT01037218|39630834|FG002|Overall Study|Protocol Violation|2|||
16313110|NCT01037218|39630835|FG003|Overall Study|Protocol Violation|2|||
16313111|NCT01037218|39630832|FG000|Overall Study|Various|3|||
16313112|NCT01037218|39630833|FG001|Overall Study|Various|2|||
16313113|NCT01037218|39630834|FG002|Overall Study|Various|3|||
16313114|NCT01037218|39630835|FG003|Overall Study|Various|1|||
16313115|NCT02182843|39630836|FG000|Overall Study|Withdrawal by Subject|7|||
16313116|NCT02182843|39630836|FG000|Overall Study|Lost to Follow-up|2|||
16313117|NCT02182843|39630836|FG000|Overall Study|Adverse Event|1|||
16313118|NCT01692626|39630837|FG000|Overall Study|Death|0|||
16313119|NCT01692626|39630838|FG001|Overall Study|Death|1|||
16313120|NCT01692626|39630837|FG000|Overall Study|Adverse Event|2|||
16313121|NCT01692626|39630838|FG001|Overall Study|Adverse Event|3|||
16313122|NCT01692626|39630837|FG000|Overall Study|Protocol Violation|1|||
16313123|NCT01692626|39630838|FG001|Overall Study|Protocol Violation|2|||
16313124|NCT01692626|39630837|FG000|Overall Study|Withdrawal by Subject|1|||
16313125|NCT01692626|39630838|FG001|Overall Study|Withdrawal by Subject|0|||
16313126|NCT04021914|39630841|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
16313127|NCT02088177|39630842|FG000|Overall Study|Lost to Follow-up|3|||
16313128|NCT02342678|39630843|FG000|Overall Study|Lost to Follow-up|0|||
16313129|NCT02342678|39630844|FG001|Overall Study|Lost to Follow-up|1|||
16313130|NCT02342678|39630843|FG000|Overall Study|Too busy to complete study|0|||
16313131|NCT02342678|39630844|FG001|Overall Study|Too busy to complete study|2|||
16313132|NCT02342678|39630843|FG000|Overall Study|Family illness/emergency|0|||
16313133|NCT02342678|39630844|FG001|Overall Study|Family illness/emergency|1|||
16313134|NCT02342678|39630843|FG000|Overall Study|Illness/medical reason|1|||
16313135|NCT02342678|39630844|FG001|Overall Study|Illness/medical reason|1|||
16506967|NCT00453999|40329439|FG000|Overall Study|Withdrawal by Subject|2|||
16506968|NCT00453999|40329440|FG001|Overall Study|Withdrawal by Subject|1|||
16506969|NCT00453999|40329441|FG002|Overall Study|Withdrawal by Subject|1|||
16506970|NCT00453999|40329439|FG000|Overall Study|Subject Request|2|||
16506971|NCT00453999|40329440|FG001|Overall Study|Subject Request|1|||
16506972|NCT00453999|40329441|FG002|Overall Study|Subject Request|0|||
16506973|NCT00588822|40329442|FG000|Overall Study|progression of disease|8|||
16506974|NCT03662542|40329449|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
16506975|NCT03662542|40329450|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
16506976|NCT03662542|40329451|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
16506977|NCT03662542|40329452|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
16506978|NCT03662542|40329453|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
16506979|NCT03662542|40329454|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
16506980|NCT03662542|40329455|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
16506981|NCT03662542|40329456|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
16506982|NCT03662542|40329457|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
16506983|NCT03662542|40329449|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
16506984|NCT03662542|40329450|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
16506985|NCT03662542|40329451|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
16506986|NCT03662542|40329452|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
16506987|NCT03662542|40329453|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
16506988|NCT03662542|40329454|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
16506989|NCT03662542|40329455|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
16506990|NCT03662542|40329456|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
16506991|NCT03662542|40329457|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
16506992|NCT03662542|40329449|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
16506993|NCT03662542|40329450|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
16506994|NCT03662542|40329451|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
16506995|NCT03662542|40329452|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
16506996|NCT03662542|40329453|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
16506997|NCT03662542|40329454|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
16506998|NCT03662542|40329455|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
16506999|NCT03662542|40329456|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
16507000|NCT03662542|40329457|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
16507001|NCT03662542|40329449|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
16507002|NCT03662542|40329450|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
16507003|NCT03662542|40329451|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
16507004|NCT03662542|40329452|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
16507005|NCT03662542|40329453|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
16507006|NCT03662542|40329454|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
16507007|NCT03662542|40329455|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
16507008|NCT03662542|40329456|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
16507009|NCT03662542|40329457|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
16507010|NCT03662542|40329449|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
16507011|NCT03662542|40329450|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
16507012|NCT03662542|40329451|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
16507013|NCT03662542|40329452|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
16507014|NCT03662542|40329453|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
16507015|NCT03662542|40329454|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
16507016|NCT03662542|40329455|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
16507017|NCT03662542|40329456|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
16507018|NCT03662542|40329457|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
16507019|NCT03662542|40329449|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
16507020|NCT03662542|40329450|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
16507021|NCT03662542|40329451|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
16507022|NCT03662542|40329452|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
16507023|NCT03662542|40329453|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
16507024|NCT03662542|40329454|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
16196986|NCT02669862|39197389|FG000|Overall Study|moved|0|||
16391132|NCT02628444|39916067|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16507025|NCT03662542|40329455|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
16507026|NCT03662542|40329456|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
16507027|NCT03662542|40329457|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
16507028|NCT03662542|40329449|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
16507029|NCT03662542|40329450|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
16507030|NCT03662542|40329451|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
16507031|NCT03662542|40329452|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
16507032|NCT03662542|40329453|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
16507033|NCT03662542|40329454|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
16507034|NCT03662542|40329455|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
16507035|NCT03662542|40329456|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
16507036|NCT03662542|40329457|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
16391133|NCT02628444|39916068|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16391134|NCT02628444|39916069|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
16391135|NCT02628444|39916061|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16391136|NCT02628444|39916062|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16391137|NCT02628444|39916063|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16391138|NCT02628444|39916064|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
16391139|NCT02628444|39916065|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16391140|NCT02628444|39916066|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16391141|NCT02628444|39916067|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16391142|NCT02628444|39916068|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16391143|NCT02628444|39916069|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
16391144|NCT02628444|39916061|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
16391145|NCT02628444|39916062|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
16391146|NCT02628444|39916063|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
16391147|NCT02628444|39916064|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
16391148|NCT02628444|39916065|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
16391149|NCT02628444|39916066|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
16391150|NCT02628444|39916067|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
16391151|NCT02628444|39916068|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
16391152|NCT02628444|39916069|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
16391153|NCT02628444|39916061|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
16391154|NCT02628444|39916062|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
16391155|NCT02628444|39916063|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
16391156|NCT02628444|39916064|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
16391157|NCT02628444|39916065|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
16391158|NCT02628444|39916066|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
16391159|NCT02628444|39916067|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
16391160|NCT02628444|39916068|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
16391161|NCT02628444|39916069|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
16391162|NCT02628444|39916061|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16507037|NCT03662542|40329449|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
16507038|NCT03662542|40329450|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
16507039|NCT03662542|40329451|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
16507040|NCT03662542|40329452|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
16507041|NCT03662542|40329453|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
16507042|NCT03662542|40329454|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
16507043|NCT03662542|40329455|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
16507044|NCT03662542|40329456|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
16507045|NCT03662542|40329457|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
16507046|NCT03662542|40329449|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
16507047|NCT03662542|40329450|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
16507048|NCT03662542|40329451|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
16507049|NCT03662542|40329452|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
16507050|NCT03662542|40329453|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
16507051|NCT03662542|40329454|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
16507052|NCT03662542|40329455|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
16507053|NCT03662542|40329456|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
16507054|NCT03662542|40329457|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
16391163|NCT02628444|39916062|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16391164|NCT02628444|39916063|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16196987|NCT02669862|39197390|FG001|Overall Study|moved|1|||
16196988|NCT02669862|39197391|FG002|Overall Study|moved|0|||
16196989|NCT02669862|39197389|FG000|Overall Study|Protocol Violation|0|||
16196990|NCT02669862|39197390|FG001|Overall Study|Protocol Violation|0|||
16196991|NCT02669862|39197391|FG002|Overall Study|Protocol Violation|1|||
16196992|NCT01953328|39197393|FG000|Overall Study|Withdrawal by Subject|0|||
16196993|NCT01953328|39197394|FG001|Overall Study|Withdrawal by Subject|0|||
16196994|NCT01953328|39197395|FG002|Overall Study|Withdrawal by Subject|0|||
16391165|NCT02628444|39916064|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16391166|NCT02628444|39916065|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
16391167|NCT02628444|39916066|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16391168|NCT02628444|39916067|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
16196995|NCT01953328|39197396|FG003|Overall Study|Withdrawal by Subject|0|||
16196996|NCT01953328|39197397|FG004|Overall Study|Withdrawal by Subject|1|||
16196997|NCT01953328|39197398|FG005|Overall Study|Withdrawal by Subject|0|||
16196998|NCT01953328|39197399|FG006|Overall Study|Withdrawal by Subject|0|||
16196999|NCT01953328|39197400|FG007|Overall Study|Withdrawal by Subject|0|||
16197000|NCT01953328|39197393|FG000|Overall Study|Lost to Follow-up|0|||
16197001|NCT01953328|39197394|FG001|Overall Study|Lost to Follow-up|0|||
16197002|NCT01953328|39197395|FG002|Overall Study|Lost to Follow-up|0|||
16197003|NCT01953328|39197396|FG003|Overall Study|Lost to Follow-up|0|||
16197004|NCT01953328|39197397|FG004|Overall Study|Lost to Follow-up|1|||
16197005|NCT01953328|39197398|FG005|Overall Study|Lost to Follow-up|0|||
16197006|NCT01953328|39197399|FG006|Overall Study|Lost to Follow-up|0|||
16197007|NCT01953328|39197400|FG007|Overall Study|Lost to Follow-up|0|||
16197008|NCT01778127|39197401|FG000|Overall Study|Lost to Follow-up|5|||
16197009|NCT01778127|39197402|FG001|Overall Study|Lost to Follow-up|1|||
16197010|NCT01778127|39197403|FG002|Overall Study|Lost to Follow-up|2|||
16197011|NCT01778127|39197401|FG000|Overall Study|Withdrawal by Subject|3|||
16197012|NCT01778127|39197402|FG001|Overall Study|Withdrawal by Subject|1|||
16197013|NCT01778127|39197403|FG002|Overall Study|Withdrawal by Subject|4|||
16197014|NCT00171314|39197408|FG000|Overall Study|Adverse Event|44|||
16197015|NCT00171314|39197409|FG001|Overall Study|Adverse Event|41|||
16197016|NCT00171314|39197408|FG000|Overall Study|Lack of Efficacy|19|||
16197017|NCT00171314|39197409|FG001|Overall Study|Lack of Efficacy|14|||
16197018|NCT00171314|39197408|FG000|Overall Study|Withdrawal by Subject|9|||
16197019|NCT00171314|39197409|FG001|Overall Study|Withdrawal by Subject|6|||
16197020|NCT00171314|39197408|FG000|Overall Study|Abnormal Test Procedure Results|9|||
16197021|NCT00171314|39197409|FG001|Overall Study|Abnormal Test Procedure Results|3|||
16197022|NCT00171314|39197408|FG000|Overall Study|Protocol Violation|3|||
16197023|NCT00171314|39197409|FG001|Overall Study|Protocol Violation|7|||
16197024|NCT00171314|39197408|FG000|Overall Study|Administrative Problems|4|||
16197025|NCT00171314|39197409|FG001|Overall Study|Administrative Problems|3|||
16197026|NCT00171314|39197408|FG000|Overall Study|Lost to Follow-up|1|||
16197027|NCT00171314|39197409|FG001|Overall Study|Lost to Follow-up|3|||
16197028|NCT00171314|39197408|FG000|Overall Study|Death|2|||
16197029|NCT00171314|39197409|FG001|Overall Study|Death|1|||
16197030|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
16197031|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
16197032|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
16197033|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
16197034|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Death|8|||
16197035|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Death|3|||
16197036|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
16197037|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
16197038|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
16197039|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
16197040|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
16197041|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
16197042|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
16197043|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
16197044|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
16197045|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
16197046|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
16197047|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
16197048|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
16197049|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
16197050|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
16197051|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
16197052|NCT00494871|39197415|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
16197053|NCT00494871|39197416|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
16197054|NCT00494871|39197415|FG000|Follow-up (FU) Period|Adverse Event|1|||
16197055|NCT00494871|39197416|FG001|Follow-up (FU) Period|Adverse Event|1|||
16197056|NCT00494871|39197415|FG000|Follow-up (FU) Period|Death|13|||
16197057|NCT00494871|39197416|FG001|Follow-up (FU) Period|Death|12|||
16197058|NCT00494871|39197415|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
16197059|NCT00494871|39197416|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
16197060|NCT00494871|39197415|FG000|Follow-up (FU) Period|Physician Decision|0|||
16197061|NCT00494871|39197416|FG001|Follow-up (FU) Period|Physician Decision|1|||
16197062|NCT00494871|39197415|FG000|Follow-up (FU) Period|Protocol Violation|1|||
16197063|NCT00494871|39197416|FG001|Follow-up (FU) Period|Protocol Violation|0|||
16197064|NCT00494871|39197415|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
16197065|NCT00494871|39197416|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
16197066|NCT00494871|39197415|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
16197067|NCT00494871|39197416|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
16197068|NCT02695524|39197420|FG000|Overall Study|Lost to Follow-up|3|||
16197069|NCT02695524|39197421|FG001|Overall Study|Lost to Follow-up|2|||
16197070|NCT02695524|39197420|FG000|Overall Study|Death|0|||
16197071|NCT02695524|39197421|FG001|Overall Study|Death|1|||
16197072|NCT02681055|39197422|FG000|Weeks 5-12|Adverse Event|1|||
16197073|NCT00495495|39197423|FG000|Overall Study|Protocol Violation|99|||
16197074|NCT02855411|39197424|FG000|Overall Study|Study terminated by sponsor|21|||
16197075|NCT02855411|39197424|FG000|Overall Study|Does not meet entrance criteria|14|||
16197076|NCT03303092|39197425|FG000|Overall Study|Adverse Event|1|||
16197077|NCT03303092|39197426|FG001|Overall Study|Adverse Event|0|||
16197078|NCT03303092|39197427|FG002|Overall Study|Adverse Event|1|||
16197079|NCT03303092|39197425|FG000|Overall Study|Protocol Violation|1|||
16197080|NCT03303092|39197426|FG001|Overall Study|Protocol Violation|5|||
16197081|NCT03303092|39197427|FG002|Overall Study|Protocol Violation|1|||
16197082|NCT03303092|39197425|FG000|Overall Study|Withdrawal by Subject|1|||
16197083|NCT03303092|39197426|FG001|Overall Study|Withdrawal by Subject|1|||
16197084|NCT03303092|39197427|FG002|Overall Study|Withdrawal by Subject|3|||
16197085|NCT01694420|39197428|FG000|Overall Study|Lost to Follow-up|3|||
16197086|NCT00831441|39197429|FG000|Randomized|Death|82|||
16197087|NCT00831441|39197430|FG001|Randomized|Death|81|||
16197088|NCT00831441|39197429|FG000|Randomized|Adverse Event|248|||
16197089|NCT00831441|39197430|FG001|Randomized|Adverse Event|321|||
16197090|NCT00831441|39197429|FG000|Randomized|Emergency procedure|2|||
16197091|NCT00831441|39197430|FG001|Randomized|Emergency procedure|2|||
16197092|NCT00831441|39197429|FG000|Randomized|Elective procedure|26|||
16197093|NCT00831441|39197430|FG001|Randomized|Elective procedure|25|||
16197094|NCT00831441|39197429|FG000|Randomized|Physician Decision|26|||
16197095|NCT00831441|39197430|FG001|Randomized|Physician Decision|35|||
16197096|NCT00831441|39197429|FG000|Randomized|No longer met criteria|13|||
16197097|NCT00831441|39197430|FG001|Randomized|No longer met criteria|19|||
16197098|NCT00831441|39197429|FG000|Randomized|Withdrawal by Subject|178|||
16197099|NCT00831441|39197430|FG001|Randomized|Withdrawal by Subject|212|||
16197100|NCT00831441|39197429|FG000|Randomized|Lost to Follow-up|26|||
16197101|NCT00831441|39197430|FG001|Randomized|Lost to Follow-up|35|||
16197102|NCT00831441|39197429|FG000|Randomized|Administrative reason by sponsor|2780|||
16197103|NCT00831441|39197430|FG001|Randomized|Administrative reason by sponsor|2671|||
16197104|NCT00831441|39197429|FG000|Randomized|poor/non-compliance|30|||
16313136|NCT00669669|39630845|FG000|Overall Study|To late to start treatment|1|||
16313137|NCT00733421|39630848|FG000|Overall Study|Withdrawal by Subject|1|||
16313138|NCT00733421|39630849|FG001|Overall Study|Withdrawal by Subject|1|||
16313139|NCT00662649|39630850|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
16313140|NCT00662649|39630851|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
16313141|NCT00662649|39630852|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
16313142|NCT00662649|39630853|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
16313143|NCT00662649|39630854|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
16391169|NCT02628444|39916068|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
16197105|NCT00831441|39197430|FG001|Randomized|poor/non-compliance|38|||
16197106|NCT00831441|39197429|FG000|Randomized|non-specified|276|||
16197107|NCT00831441|39197430|FG001|Randomized|non-specified|266|||
16197108|NCT00831441|39197429|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
16197109|NCT00831441|39197430|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
16197110|NCT00831441|39197429|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
16197111|NCT00831441|39197430|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
16197112|NCT00831441|39197429|FG000|Follow Up (30 Days)|Death|63|||
16197113|NCT00831441|39197430|FG001|Follow Up (30 Days)|Death|86|||
16197114|NCT00831441|39197429|FG000|Follow Up (30 Days)|non-specified|16|||
16197115|NCT00831441|39197430|FG001|Follow Up (30 Days)|non-specified|26|||
16197116|NCT00831441|39197429|FG000|Follow Up (30 Days)|missing end of study status|0|||
16197117|NCT00831441|39197430|FG001|Follow Up (30 Days)|missing end of study status|1|||
16391170|NCT02628444|39916069|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
16391171|NCT02628444|39916061|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
16507055|NCT03662542|40329449|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
16507056|NCT03662542|40329450|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
16507057|NCT03662542|40329451|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
16507058|NCT03662542|40329452|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
16507059|NCT03662542|40329453|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
16507060|NCT03662542|40329454|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
16507061|NCT03662542|40329455|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
16507062|NCT03662542|40329456|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
16507063|NCT03662542|40329457|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
16507064|NCT03662542|40329449|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
16507065|NCT03662542|40329450|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
16507066|NCT03662542|40329451|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
16507067|NCT03662542|40329452|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
16507068|NCT03662542|40329453|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
16507069|NCT03662542|40329454|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
16197118|NCT00755846|39197431|FG000|Overall Study|Adverse Event|0|||
16197119|NCT00755846|39197432|FG001|Overall Study|Adverse Event|0|||
16197120|NCT00755846|39197433|FG002|Overall Study|Adverse Event|0|||
16391172|NCT02628444|39916062|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
16391173|NCT02628444|39916063|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
16391174|NCT02628444|39916064|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
16391175|NCT02628444|39916065|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
16391176|NCT02628444|39916066|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
16391177|NCT02628444|39916067|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
16391178|NCT02628444|39916068|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
16391179|NCT02628444|39916069|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
16391180|NCT03462758|39916070|FG000|Overall Study|Chose no or other method of contraception|20|||
16391181|NCT03462758|39916071|FG001|Overall Study|Chose no or other method of contraception|23|||
16391182|NCT03462758|39916070|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
16391183|NCT03462758|39916071|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
16197121|NCT00755846|39197434|FG003|Overall Study|Adverse Event|1|||
16197122|NCT00755846|39197435|FG004|Overall Study|Adverse Event|3|||
16197123|NCT00755846|39197436|FG005|Overall Study|Adverse Event|2|||
16197124|NCT00755846|39197431|FG000|Overall Study|Protocol Violation|1|||
16197125|NCT00755846|39197432|FG001|Overall Study|Protocol Violation|1|||
16197126|NCT00755846|39197433|FG002|Overall Study|Protocol Violation|1|||
16197127|NCT00755846|39197434|FG003|Overall Study|Protocol Violation|1|||
16197128|NCT00755846|39197435|FG004|Overall Study|Protocol Violation|1|||
16197129|NCT00755846|39197436|FG005|Overall Study|Protocol Violation|1|||
16197130|NCT00755846|39197431|FG000|Overall Study|Lost to Follow-up|0|||
16197131|NCT00755846|39197432|FG001|Overall Study|Lost to Follow-up|2|||
16197132|NCT00755846|39197433|FG002|Overall Study|Lost to Follow-up|1|||
16197133|NCT00755846|39197434|FG003|Overall Study|Lost to Follow-up|0|||
16197134|NCT00755846|39197435|FG004|Overall Study|Lost to Follow-up|4|||
16197135|NCT00755846|39197436|FG005|Overall Study|Lost to Follow-up|2|||
16197136|NCT00755846|39197431|FG000|Overall Study|Withdrawal by Subject|2|||
16197137|NCT00755846|39197432|FG001|Overall Study|Withdrawal by Subject|3|||
16197138|NCT00755846|39197433|FG002|Overall Study|Withdrawal by Subject|5|||
16197139|NCT00755846|39197434|FG003|Overall Study|Withdrawal by Subject|2|||
16197140|NCT00755846|39197435|FG004|Overall Study|Withdrawal by Subject|0|||
16197141|NCT00755846|39197436|FG005|Overall Study|Withdrawal by Subject|1|||
16197142|NCT00755846|39197431|FG000|Overall Study|Hyperglycemic Rescue|21|||
16197143|NCT00755846|39197432|FG001|Overall Study|Hyperglycemic Rescue|7|||
16197144|NCT00755846|39197433|FG002|Overall Study|Hyperglycemic Rescue|5|||
16197145|NCT00755846|39197434|FG003|Overall Study|Hyperglycemic Rescue|8|||
16197146|NCT00755846|39197435|FG004|Overall Study|Hyperglycemic Rescue|8|||
16197147|NCT00755846|39197436|FG005|Overall Study|Hyperglycemic Rescue|7|||
16197148|NCT00755846|39197431|FG000|Overall Study|Physician Decision|1|||
16197149|NCT00755846|39197432|FG001|Overall Study|Physician Decision|3|||
16197150|NCT00755846|39197433|FG002|Overall Study|Physician Decision|0|||
16197151|NCT00755846|39197434|FG003|Overall Study|Physician Decision|1|||
16197152|NCT00755846|39197435|FG004|Overall Study|Physician Decision|0|||
16197153|NCT00755846|39197436|FG005|Overall Study|Physician Decision|1|||
16197154|NCT00755846|39197431|FG000|Overall Study|Administrative Error|0|||
16197155|NCT00755846|39197432|FG001|Overall Study|Administrative Error|1|||
16197156|NCT00755846|39197433|FG002|Overall Study|Administrative Error|0|||
16391184|NCT03462758|39916070|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
16391185|NCT03462758|39916071|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
16391186|NCT03462758|39916070|FG000|Overall Study|Medical contraindication|2|||
16391187|NCT03462758|39916071|FG001|Overall Study|Medical contraindication|2|||
16391188|NCT03462758|39916070|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
16391189|NCT03462758|39916071|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
16391190|NCT00442416|39916072|FG000|Overall Study|Adverse Event|4|||
16391191|NCT00442416|39916073|FG001|Overall Study|Adverse Event|1|||
16391192|NCT00442416|39916072|FG000|Overall Study|Death|1|||
16391193|NCT00442416|39916073|FG001|Overall Study|Death|0|||
16391194|NCT00442416|39916072|FG000|Overall Study|Lack of Efficacy|2|||
16391195|NCT00442416|39916073|FG001|Overall Study|Lack of Efficacy|0|||
16391196|NCT00442416|39916072|FG000|Overall Study|Protocol Violation|2|||
16391197|NCT00442416|39916073|FG001|Overall Study|Protocol Violation|3|||
16391198|NCT00442416|39916072|FG000|Overall Study|Withdrew consent|1|||
16391199|NCT00442416|39916073|FG001|Overall Study|Withdrew consent|2|||
16391200|NCT00442416|39916072|FG000|Overall Study|Administrative/Other|27|||
16197157|NCT00755846|39197434|FG003|Overall Study|Administrative Error|0|||
16197158|NCT00755846|39197435|FG004|Overall Study|Administrative Error|0|||
16197159|NCT00755846|39197436|FG005|Overall Study|Administrative Error|0|||
16197160|NCT00755846|39197431|FG000|Overall Study|Participant Non-compliance|0|||
16313144|NCT00662649|39630850|FG000|Core Study (24 Months)|Adverse Event|22|||
16391201|NCT00442416|39916073|FG001|Overall Study|Administrative/Other|33|||
16391202|NCT03432494|39916076|FG000|Overall Study|Death|1|||
16391203|NCT03432494|39916076|FG000|Overall Study|Noncompliance|1|||
16391204|NCT02457247|39916077|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
16313145|NCT00662649|39630851|FG001|Core Study (24 Months)|Adverse Event|13|||
16313146|NCT00662649|39630852|FG002|Core Study (24 Months)|Adverse Event|18|||
16391205|NCT02457247|39916078|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
16391206|NCT02457247|39916079|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
16391207|NCT02457247|39916080|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
16507070|NCT03662542|40329455|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
16507071|NCT03662542|40329456|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
16507072|NCT03662542|40329457|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
16507073|NCT03662542|40329449|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
16507074|NCT03662542|40329450|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
16507075|NCT03662542|40329451|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
16507076|NCT03662542|40329452|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
16507077|NCT03662542|40329453|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
16507078|NCT03662542|40329454|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
16507079|NCT03662542|40329455|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
16507080|NCT03662542|40329456|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
16197161|NCT00755846|39197432|FG001|Overall Study|Participant Non-compliance|0|||
16313147|NCT00662649|39630853|FG003|Core Study (24 Months)|Adverse Event|0|||
16313148|NCT00662649|39630854|FG004|Core Study (24 Months)|Adverse Event|0|||
16313149|NCT00662649|39630850|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
16313150|NCT00662649|39630851|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
16313151|NCT00662649|39630852|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
16313152|NCT00662649|39630853|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
16313153|NCT00662649|39630854|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
16313154|NCT00662649|39630850|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
16313155|NCT00662649|39630851|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
16313156|NCT00662649|39630852|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
16313157|NCT00662649|39630853|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
16313158|NCT00662649|39630854|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
16313159|NCT00662649|39630850|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
16313160|NCT00662649|39630851|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
16313161|NCT00662649|39630852|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
16313162|NCT00662649|39630853|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
16313163|NCT00662649|39630854|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
16313164|NCT00662649|39630850|FG000|Core Study (24 Months)|Protocol Violation|5|||
16313165|NCT00662649|39630851|FG001|Core Study (24 Months)|Protocol Violation|5|||
16313166|NCT00662649|39630852|FG002|Core Study (24 Months)|Protocol Violation|4|||
16391208|NCT02457247|39916077|FG000|Period 1|Significant Protocol Deviation|1|||
16391209|NCT02457247|39916078|FG001|Period 1|Significant Protocol Deviation|1|||
16391210|NCT02457247|39916079|FG002|Period 1|Significant Protocol Deviation|0|||
16391211|NCT02457247|39916080|FG003|Period 1|Significant Protocol Deviation|0|||
16313167|NCT00662649|39630853|FG003|Core Study (24 Months)|Protocol Violation|0|||
16313168|NCT00662649|39630854|FG004|Core Study (24 Months)|Protocol Violation|0|||
16313169|NCT00662649|39630850|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
16391212|NCT02457247|39916077|FG000|Period 1|Voluntary Withdrawal|1|||
16313170|NCT00662649|39630851|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
16507081|NCT03662542|40329457|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
16507082|NCT03662542|40329449|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
16507083|NCT03662542|40329450|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
16507084|NCT03662542|40329451|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
16507085|NCT03662542|40329452|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
16507086|NCT03662542|40329453|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
16507087|NCT03662542|40329454|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
16507088|NCT03662542|40329455|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
16507089|NCT03662542|40329456|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
16507090|NCT03662542|40329457|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
16507091|NCT02515942|40329461|FG000|Overall Study|Adverse Event|5|||
16507092|NCT02515942|40329462|FG001|Overall Study|Adverse Event|0|||
16507093|NCT02515942|40329463|FG002|Overall Study|Adverse Event|0|||
16507094|NCT02515942|40329461|FG000|Overall Study|Death|0|||
16507095|NCT02515942|40329462|FG001|Overall Study|Death|0|||
16507096|NCT02515942|40329463|FG002|Overall Study|Death|1|||
16507097|NCT02515942|40329461|FG000|Overall Study|Lack of Efficacy|0|||
16507098|NCT02515942|40329462|FG001|Overall Study|Lack of Efficacy|0|||
16507099|NCT02515942|40329463|FG002|Overall Study|Lack of Efficacy|1|||
16507100|NCT02515942|40329461|FG000|Overall Study|Lost to Follow-up|2|||
16507101|NCT02515942|40329462|FG001|Overall Study|Lost to Follow-up|0|||
16507102|NCT02515942|40329463|FG002|Overall Study|Lost to Follow-up|0|||
16507103|NCT02515942|40329461|FG000|Overall Study|Withdrawal by Subject|0|||
16507104|NCT02515942|40329462|FG001|Overall Study|Withdrawal by Subject|3|||
16507105|NCT02515942|40329463|FG002|Overall Study|Withdrawal by Subject|2|||
16507106|NCT02563028|40329464|FG000|Overall Study|Lack of equipment|1|||
16507107|NCT02563028|40329464|FG000|Overall Study|Unable to elicit VEP post induction|1|||
16507108|NCT05778786|40329474|FG000|Period 1|COVID-19 Related|3|||
16507109|NCT05778786|40329475|FG001|Period 1|COVID-19 Related|3|||
16507110|NCT05778786|40329474|FG000|Period 1|Withdrew Consent during Study|1|||
16507111|NCT05778786|40329475|FG001|Period 1|Withdrew Consent during Study|0|||
16507112|NCT05778786|40329474|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
16507113|NCT05778786|40329475|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
16507114|NCT05778786|40329474|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
16507115|NCT05778786|40329475|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
16507116|NCT03745144|40329476|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
16507117|NCT03745144|40329477|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
16507118|NCT03745144|40329478|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
16507119|NCT03745144|40329476|FG000|Period 1|Other|0|||
16507120|NCT03745144|40329477|FG001|Period 1|Other|0|||
16507121|NCT03745144|40329478|FG002|Period 1|Other|1|||
16507122|NCT03373383|40329481|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
16507123|NCT03373383|40329482|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
16507124|NCT03373383|40329483|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
16507125|NCT03373383|40329484|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
16507126|NCT03373383|40329485|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
16507127|NCT03373383|40329481|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
16507128|NCT03373383|40329482|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
16507129|NCT03373383|40329483|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
16507130|NCT03373383|40329484|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
16507131|NCT03373383|40329485|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
16507132|NCT03373383|40329481|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
16507133|NCT03373383|40329482|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
16313171|NCT00662649|39630852|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
16313172|NCT00662649|39630853|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
16313173|NCT00662649|39630854|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
16313174|NCT00662649|39630850|FG000|Core Study (24 Months)|Death|1|||
16313175|NCT00662649|39630851|FG001|Core Study (24 Months)|Death|0|||
16313176|NCT00662649|39630852|FG002|Core Study (24 Months)|Death|2|||
16313177|NCT00662649|39630853|FG003|Core Study (24 Months)|Death|0|||
16313178|NCT00662649|39630854|FG004|Core Study (24 Months)|Death|0|||
16313179|NCT00662649|39630850|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
16313180|NCT00662649|39630851|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
16313181|NCT00662649|39630852|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
16313182|NCT00662649|39630853|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
16507134|NCT03373383|40329483|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
16313183|NCT00662649|39630854|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
16313184|NCT00662649|39630850|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
16507135|NCT03373383|40329484|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
16507136|NCT03373383|40329485|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
16507137|NCT03373383|40329481|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
16507138|NCT03373383|40329482|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
16507139|NCT03373383|40329483|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
16507140|NCT03373383|40329484|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
16507141|NCT03373383|40329485|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
16507142|NCT03373383|40329481|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
16507143|NCT03373383|40329482|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
16507144|NCT03373383|40329483|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
16313185|NCT00662649|39630851|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
16313186|NCT00662649|39630852|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
16313187|NCT00662649|39630853|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
16313188|NCT00662649|39630854|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
16313189|NCT00662649|39630850|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
16313190|NCT00662649|39630851|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
16313191|NCT00662649|39630852|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
16313192|NCT00662649|39630853|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
16313193|NCT00662649|39630854|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
16313194|NCT00662649|39630850|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
16313195|NCT00662649|39630851|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
16313196|NCT00662649|39630852|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
16313197|NCT00662649|39630853|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
16313198|NCT00662649|39630854|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
16313199|NCT00662649|39630850|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
16313200|NCT00662649|39630851|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
16313201|NCT00662649|39630852|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
16313202|NCT00662649|39630853|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
16313203|NCT00662649|39630854|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
16313204|NCT00662649|39630850|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
16507145|NCT03373383|40329484|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
16507146|NCT03373383|40329485|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
16507147|NCT03373383|40329481|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
16507148|NCT03373383|40329482|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
16507149|NCT03373383|40329483|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
16507150|NCT03373383|40329484|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
16507151|NCT03373383|40329485|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
16507152|NCT03373383|40329481|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
16507153|NCT03373383|40329482|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
16507154|NCT03373383|40329483|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
16313205|NCT00662649|39630851|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
16313206|NCT00662649|39630852|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
16313207|NCT00662649|39630853|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
16313208|NCT00662649|39630854|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
16313209|NCT00662649|39630850|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
16313210|NCT00662649|39630851|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
16313211|NCT00662649|39630852|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
16313212|NCT00662649|39630853|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
16313213|NCT00662649|39630854|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
16313214|NCT00662649|39630850|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
16313215|NCT00662649|39630851|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
16313216|NCT00662649|39630852|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
16391213|NCT02457247|39916078|FG001|Period 1|Voluntary Withdrawal|0|||
16391214|NCT02457247|39916079|FG002|Period 1|Voluntary Withdrawal|0|||
16391215|NCT02457247|39916080|FG003|Period 1|Voluntary Withdrawal|0|||
16391216|NCT02457247|39916077|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
16391217|NCT02457247|39916078|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
16391218|NCT02457247|39916079|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
16391219|NCT02457247|39916080|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
16391220|NCT02457247|39916077|FG000|Period 2|Significant Protocol Deviation|1|||
16391221|NCT02457247|39916078|FG001|Period 2|Significant Protocol Deviation|0|||
16391222|NCT02457247|39916079|FG002|Period 2|Significant Protocol Deviation|0|||
16391223|NCT02457247|39916080|FG003|Period 2|Significant Protocol Deviation|0|||
16507155|NCT03373383|40329484|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
16507156|NCT03373383|40329485|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
16507157|NCT03373383|40329481|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
16507158|NCT03373383|40329482|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
16507159|NCT03373383|40329483|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
16507160|NCT03373383|40329484|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
16507161|NCT03373383|40329485|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
16507162|NCT03373383|40329481|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
16507163|NCT03373383|40329482|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
16313217|NCT00662649|39630853|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
16507164|NCT03373383|40329483|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
16507165|NCT03373383|40329484|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
16507166|NCT03373383|40329485|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
16507167|NCT01327300|40329488|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
16507168|NCT01327300|40329489|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
16507169|NCT02098109|40329493|FG000|Overall Study|Protocol Violation|3|||
16507170|NCT02098109|40329494|FG001|Overall Study|Protocol Violation|0|||
16507171|NCT01852812|40329496|FG000|Overall Study|Adverse Event|0|||
16507172|NCT01852812|40329497|FG001|Overall Study|Adverse Event|0|||
16507173|NCT01852812|40329498|FG002|Overall Study|Adverse Event|1|||
16507174|NCT01852812|40329496|FG000|Overall Study|Non-compliance With Study Drug|0|||
16507175|NCT01852812|40329497|FG001|Overall Study|Non-compliance With Study Drug|1|||
16507176|NCT01852812|40329498|FG002|Overall Study|Non-compliance With Study Drug|0|||
16507177|NCT03165110|40329499|FG000|Overall Study|Anroid phone software incompatibility|1|||
16507178|NCT00746941|40329523|FG000|Overall Study|Death|2|||
16507179|NCT00746941|40329524|FG001|Overall Study|Death|0|||
16507180|NCT00746941|40329525|FG002|Overall Study|Death|0|||
16507181|NCT00746941|40329526|FG003|Overall Study|Death|6|||
16507182|NCT00746941|40329523|FG000|Overall Study|Physician Decision|0|||
16507183|NCT00746941|40329524|FG001|Overall Study|Physician Decision|0|||
16507184|NCT00746941|40329525|FG002|Overall Study|Physician Decision|2|||
16507185|NCT00746941|40329526|FG003|Overall Study|Physician Decision|0|||
16507186|NCT00746941|40329523|FG000|Overall Study|Withdrawal by Subject|3|||
16507187|NCT00746941|40329524|FG001|Overall Study|Withdrawal by Subject|0|||
16197162|NCT00755846|39197433|FG002|Overall Study|Participant Non-compliance|0|||
16197163|NCT00755846|39197434|FG003|Overall Study|Participant Non-compliance|0|||
16197164|NCT00755846|39197435|FG004|Overall Study|Participant Non-compliance|1|||
16197165|NCT00755846|39197436|FG005|Overall Study|Participant Non-compliance|0|||
16197166|NCT04550221|39197437|FG000|Overall Study|Lost to Follow-up|0|||
16197167|NCT04550221|39197438|FG001|Overall Study|Lost to Follow-up|4|||
16197168|NCT04550221|39197437|FG000|Overall Study|Withdrawn|3|||
16197169|NCT04550221|39197438|FG001|Overall Study|Withdrawn|0|||
16197170|NCT04550221|39197437|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
16197171|NCT04550221|39197438|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
16197172|NCT00363246|39197448|FG000|Overall Study|Death|40|||
16197173|NCT00363246|39197448|FG000|Overall Study|Withdrawal by Subject|19|||
16197174|NCT00363246|39197448|FG000|Overall Study|Lost to Follow-up|14|||
16197175|NCT00363246|39197448|FG000|Overall Study|Bad health|6|||
16197176|NCT00363246|39197448|FG000|Overall Study|Stopped using wheelchair|11|||
16197177|NCT00363246|39197448|FG000|Overall Study|Subject expressed security concerns|2|||
16197178|NCT00363246|39197448|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
16313218|NCT00662649|39630854|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
16313219|NCT00662649|39630850|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
16313220|NCT00662649|39630851|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
16313221|NCT00662649|39630852|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
16313222|NCT00662649|39630853|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
16313223|NCT00662649|39630854|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
16313224|NCT04011722|39630855|FG000|30 Days|Death|5|||
16313225|NCT04011722|39630856|FG001|30 Days|Death|1|||
16313226|NCT04011722|39630855|FG000|1 Year|Death|13|||
16313227|NCT04011722|39630856|FG001|1 Year|Death|5|||
16313228|NCT04011722|39630855|FG000|1 Year|Withdrawal by Subject|8|||
16313229|NCT04011722|39630856|FG001|1 Year|Withdrawal by Subject|2|||
16313230|NCT04011722|39630855|FG000|1 Year|Missed Visit|6|||
16313231|NCT04011722|39630856|FG001|1 Year|Missed Visit|1|||
16391224|NCT02457247|39916077|FG000|Period 2|Lost to Follow-up|0|||
16391225|NCT02457247|39916078|FG001|Period 2|Lost to Follow-up|1|||
16507188|NCT00746941|40329525|FG002|Overall Study|Withdrawal by Subject|0|||
16391226|NCT02457247|39916079|FG002|Period 2|Lost to Follow-up|0|||
16391227|NCT02457247|39916080|FG003|Period 2|Lost to Follow-up|0|||
16391228|NCT02457247|39916077|FG000|Period 2|Voluntary Withdrawal|1|||
16391229|NCT02457247|39916078|FG001|Period 2|Voluntary Withdrawal|1|||
16391230|NCT02457247|39916079|FG002|Period 2|Voluntary Withdrawal|0|||
16391231|NCT02457247|39916080|FG003|Period 2|Voluntary Withdrawal|0|||
16391232|NCT01492426|39916081|FG000|Treatment|Death|0|||
16391233|NCT01492426|39916082|FG001|Treatment|Death|1|||
16507189|NCT00746941|40329526|FG003|Overall Study|Withdrawal by Subject|2|||
16197179|NCT04382586|39197449|FG000|Overall Study|Death|3|||
16197180|NCT04382586|39197450|FG001|Overall Study|Death|4|||
16507190|NCT00746941|40329523|FG000|Overall Study|Other, reason not provided|2|||
16507191|NCT00746941|40329524|FG001|Overall Study|Other, reason not provided|4|||
16507192|NCT00746941|40329525|FG002|Overall Study|Other, reason not provided|0|||
16197181|NCT04382586|39197449|FG000|Overall Study|Lost to Follow-up|11|||
16313232|NCT04011722|39630855|FG000|1 Year|Pending Visit|0|||
16313233|NCT04011722|39630856|FG001|1 Year|Pending Visit|11|||
16391234|NCT01492426|39916081|FG000|Treatment|Other|1|||
16507193|NCT00746941|40329526|FG003|Overall Study|Other, reason not provided|4|||
16197182|NCT04382586|39197450|FG001|Overall Study|Lost to Follow-up|8|||
16391235|NCT01492426|39916082|FG001|Treatment|Other|0|||
16391236|NCT01492426|39916081|FG000|Treatment|Adverse Event|25|||
16313234|NCT04011722|39630855|FG000|1 Year|Not Yet Due|0|||
16313235|NCT04011722|39630856|FG001|1 Year|Not Yet Due|9|||
16313236|NCT04011722|39630855|FG000|2 Year|Death|16|||
16313237|NCT04011722|39630856|FG001|2 Year|Death|1|||
16391237|NCT01492426|39916082|FG001|Treatment|Adverse Event|25|||
16391238|NCT01492426|39916081|FG000|Treatment|Lack of Efficacy|38|||
16391239|NCT01492426|39916082|FG001|Treatment|Lack of Efficacy|5|||
16391240|NCT01492426|39916081|FG000|Treatment|Participant withdrew consent|1|||
16391241|NCT01492426|39916082|FG001|Treatment|Participant withdrew consent|2|||
16391242|NCT01492426|39916081|FG000|Treatment|Poor compliance/noncompliance|1|||
16391243|NCT01492426|39916082|FG001|Treatment|Poor compliance/noncompliance|0|||
16391244|NCT01492426|39916081|FG000|Treatment|Subject requested discontinue study drug|7|||
16391245|NCT01492426|39916082|FG001|Treatment|Subject requested discontinue study drug|3|||
16391246|NCT01492426|39916081|FG000|Treatment|Lost to Follow-up|9|||
16391247|NCT01492426|39916082|FG001|Treatment|Lost to Follow-up|4|||
16391248|NCT01492426|39916081|FG000|Treatment|Participant does not meet study criteria|1|||
16391249|NCT01492426|39916082|FG001|Treatment|Participant does not meet study criteria|0|||
16391250|NCT01492426|39916081|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
16391251|NCT01492426|39916082|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
16197183|NCT04382586|39197449|FG000|Overall Study|Withdrawal by Subject|3|||
16313238|NCT04011722|39630855|FG000|2 Year|Withdrawal by Subject|10|||
16313239|NCT04011722|39630856|FG001|2 Year|Withdrawal by Subject|1|||
16313240|NCT04011722|39630855|FG000|2 Year|Missed Visit|9|||
16313241|NCT04011722|39630856|FG001|2 Year|Missed Visit|0|||
16313242|NCT04011722|39630855|FG000|2 Year|Visit Pending|1|||
16313243|NCT04011722|39630856|FG001|2 Year|Visit Pending|3|||
16313244|NCT04011722|39630855|FG000|2 Year|Not Yet Due|43|||
16313245|NCT04011722|39630856|FG001|2 Year|Not Yet Due|54|||
16313246|NCT04011722|39630855|FG000|3 Year|Death|10|||
16313247|NCT04011722|39630856|FG001|3 Year|Death|0|||
16313248|NCT04011722|39630855|FG000|3 Year|Withdrawal by Subject|2|||
16313249|NCT04011722|39630856|FG001|3 Year|Withdrawal by Subject|0|||
16313250|NCT04011722|39630855|FG000|3 Year|Missed Visit|2|||
16313251|NCT04011722|39630856|FG001|3 Year|Missed Visit|0|||
16313252|NCT04011722|39630855|FG000|3 Year|Pending Visit|34|||
16313253|NCT04011722|39630856|FG001|3 Year|Pending Visit|0|||
16313254|NCT04011722|39630855|FG000|3 Year|Not Yet Due|99|||
16313255|NCT04011722|39630856|FG001|3 Year|Not Yet Due|0|||
16313256|NCT02714218|39630857|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16313257|NCT02714218|39630858|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16313258|NCT02714218|39630859|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16313259|NCT02714218|39630857|FG000|Pre-Treatment Period|Other reasons|0|||
16313260|NCT02714218|39630858|FG001|Pre-Treatment Period|Other reasons|1|||
16313261|NCT02714218|39630859|FG002|Pre-Treatment Period|Other reasons|0|||
16313262|NCT02714218|39630857|FG000|Treatment Period|Disease Progression|55|||
16313263|NCT02714218|39630858|FG001|Treatment Period|Disease Progression|52|||
16313264|NCT02714218|39630859|FG002|Treatment Period|Disease Progression|14|||
16313265|NCT02714218|39630857|FG000|Treatment Period|Study drug toxicity|46|||
16313266|NCT02714218|39630858|FG001|Treatment Period|Study drug toxicity|70|||
16313267|NCT02714218|39630859|FG002|Treatment Period|Study drug toxicity|6|||
16313268|NCT02714218|39630857|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
16313269|NCT02714218|39630858|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
16313270|NCT02714218|39630859|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
16313271|NCT02714218|39630857|FG000|Treatment Period|Request to discontinue treatment|1|||
16313272|NCT02714218|39630858|FG001|Treatment Period|Request to discontinue treatment|4|||
16313273|NCT02714218|39630859|FG002|Treatment Period|Request to discontinue treatment|1|||
16313274|NCT02714218|39630857|FG000|Treatment Period|Participant withdrew consent|2|||
16313275|NCT02714218|39630858|FG001|Treatment Period|Participant withdrew consent|2|||
16313276|NCT02714218|39630859|FG002|Treatment Period|Participant withdrew consent|0|||
16313277|NCT02714218|39630857|FG000|Treatment Period|Maximum clinical benefit|4|||
16391252|NCT01492426|39916081|FG000|Follow-Up|Death|1|||
16391253|NCT01492426|39916082|FG001|Follow-Up|Death|0|||
16391254|NCT01492426|39916081|FG000|Follow-Up|Other|4|||
16391255|NCT01492426|39916082|FG001|Follow-Up|Other|2|||
16391256|NCT01492426|39916081|FG000|Follow-Up|Participant Withdrew Consent|6|||
16313278|NCT02714218|39630858|FG001|Treatment Period|Maximum clinical benefit|2|||
16313279|NCT02714218|39630859|FG002|Treatment Period|Maximum clinical benefit|0|||
16313280|NCT02714218|39630857|FG000|Treatment Period|Administrative reason by sponsor|2|||
16313281|NCT02714218|39630858|FG001|Treatment Period|Administrative reason by sponsor|1|||
16313282|NCT02714218|39630859|FG002|Treatment Period|Administrative reason by sponsor|0|||
16313283|NCT02714218|39630857|FG000|Treatment Period|Other reasons|6|||
16313284|NCT02714218|39630858|FG001|Treatment Period|Other reasons|6|||
16313285|NCT02714218|39630859|FG002|Treatment Period|Other reasons|0|||
16313286|NCT02714218|39630857|FG000|Treatment Period|Completed treatment as per protocol|36|||
16391257|NCT01492426|39916082|FG001|Follow-Up|Participant Withdrew Consent|1|||
16313287|NCT02714218|39630858|FG001|Treatment Period|Completed treatment as per protocol|27|||
16391258|NCT01492426|39916081|FG000|Follow-Up|Lost to Follow-up|12|||
16391259|NCT01492426|39916082|FG001|Follow-Up|Lost to Follow-up|6|||
16391260|NCT01408277|39916087|FG000|Overall Study|Adverse Event|3|||
16391261|NCT01408277|39916088|FG001|Overall Study|Adverse Event|4|||
16391262|NCT01408277|39916087|FG000|Overall Study|Lost to Follow-up|1|||
16391263|NCT01408277|39916088|FG001|Overall Study|Lost to Follow-up|0|||
16391264|NCT01408277|39916087|FG000|Overall Study|Withdrawal by Subject|2|||
16391265|NCT01408277|39916088|FG001|Overall Study|Withdrawal by Subject|0|||
16197184|NCT04382586|39197450|FG001|Overall Study|Withdrawal by Subject|1|||
16197185|NCT04382586|39197449|FG000|Overall Study|Physician Decision|0|||
16313288|NCT02714218|39630859|FG002|Treatment Period|Completed treatment as per protocol|3|||
16313289|NCT02714218|39630857|FG000|Treatment Period|Not reported|9|||
16313290|NCT02714218|39630858|FG001|Treatment Period|Not reported|6|||
16313291|NCT02714218|39630859|FG002|Treatment Period|Not reported|0|||
16313292|NCT04565145|39630860|FG000|Overall Study|Withdrawal by Subject|1|||
16313293|NCT04565145|39630861|FG001|Overall Study|Withdrawal by Subject|1|||
16313294|NCT00884117|39630862|FG000|Overall Study|Adverse Event|2|||
16391266|NCT01408277|39916087|FG000|Overall Study|Protocol Violation|2|||
16313295|NCT00884117|39630862|FG000|Overall Study|Withdrawal by Subject|89|||
16391267|NCT01408277|39916088|FG001|Overall Study|Protocol Violation|0|||
16391268|NCT00819156|39916089|FG000|Overall Study|Adverse Event|1|||
16391269|NCT00819156|39916090|FG001|Overall Study|Adverse Event|4|||
16391270|NCT00819156|39916091|FG002|Overall Study|Adverse Event|2|||
16391271|NCT00819156|39916092|FG003|Overall Study|Adverse Event|1|||
16507194|NCT00746941|40329523|FG000|Overall Study|Adverse Event|0|||
16507195|NCT00746941|40329524|FG001|Overall Study|Adverse Event|0|||
16391272|NCT00819156|39916093|FG004|Overall Study|Adverse Event|2|||
16391273|NCT00819156|39916094|FG005|Overall Study|Adverse Event|3|||
16507196|NCT00746941|40329525|FG002|Overall Study|Adverse Event|0|||
16391274|NCT00819156|39916089|FG000|Overall Study|Withdrawal by Subject|0|||
16391275|NCT00819156|39916090|FG001|Overall Study|Withdrawal by Subject|3|||
16391276|NCT00819156|39916091|FG002|Overall Study|Withdrawal by Subject|2|||
16391277|NCT00819156|39916092|FG003|Overall Study|Withdrawal by Subject|0|||
16391278|NCT00819156|39916093|FG004|Overall Study|Withdrawal by Subject|1|||
16391279|NCT00819156|39916094|FG005|Overall Study|Withdrawal by Subject|0|||
16391280|NCT00819156|39916089|FG000|Overall Study|Protocol Violation|1|||
16391281|NCT00819156|39916090|FG001|Overall Study|Protocol Violation|0|||
16391282|NCT00819156|39916091|FG002|Overall Study|Protocol Violation|1|||
16391283|NCT00819156|39916092|FG003|Overall Study|Protocol Violation|0|||
16391284|NCT00819156|39916093|FG004|Overall Study|Protocol Violation|0|||
16391285|NCT00819156|39916094|FG005|Overall Study|Protocol Violation|1|||
16391286|NCT00819156|39916089|FG000|Overall Study|Lost to Follow-up|0|||
16391287|NCT00819156|39916090|FG001|Overall Study|Lost to Follow-up|1|||
16391288|NCT00819156|39916091|FG002|Overall Study|Lost to Follow-up|0|||
16507197|NCT00746941|40329526|FG003|Overall Study|Adverse Event|1|||
16391289|NCT00819156|39916092|FG003|Overall Study|Lost to Follow-up|0|||
16391290|NCT00819156|39916093|FG004|Overall Study|Lost to Follow-up|0|||
16391291|NCT00819156|39916094|FG005|Overall Study|Lost to Follow-up|2|||
16391292|NCT00819156|39916089|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
16391293|NCT00819156|39916090|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
16391294|NCT00819156|39916091|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
16391295|NCT00819156|39916092|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
16391296|NCT00819156|39916093|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
16391297|NCT00819156|39916094|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
16391298|NCT00819156|39916089|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
16391299|NCT00819156|39916090|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
16391300|NCT00819156|39916091|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
16391301|NCT00819156|39916092|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
16391302|NCT00819156|39916093|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
16391303|NCT00819156|39916094|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
16391304|NCT00819156|39916089|FG000|Overall Study|Prostate-specific antigen progression|0|||
16391305|NCT00819156|39916090|FG001|Overall Study|Prostate-specific antigen progression|0|||
16391306|NCT00819156|39916091|FG002|Overall Study|Prostate-specific antigen progression|0|||
16391307|NCT00819156|39916092|FG003|Overall Study|Prostate-specific antigen progression|0|||
16391308|NCT00819156|39916093|FG004|Overall Study|Prostate-specific antigen progression|1|||
16507198|NCT00048542|40329527|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
16507199|NCT00048542|40329528|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
16507200|NCT00048542|40329529|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
16197186|NCT04382586|39197450|FG001|Overall Study|Physician Decision|3|||
16197187|NCT00592553|39197451|FG000|Overall Study|Protocol Noncompliance|1|||
16313296|NCT00884117|39630862|FG000|Overall Study|Death|3|||
16391309|NCT00819156|39916094|FG005|Overall Study|Prostate-specific antigen progression|0|||
16391310|NCT01023217|39916095|FG000|Overall Study|Withdrawal by Subject|1|||
16391311|NCT01023217|39916096|FG001|Overall Study|Withdrawal by Subject|0|||
16507201|NCT00048542|40329530|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
16507202|NCT00048542|40329531|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
16507203|NCT00048542|40329532|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
16507204|NCT00048542|40329533|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
16507205|NCT00048542|40329534|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
16507206|NCT00048542|40329527|FG000|Double-Blind Phase|Protocol Violation|0|||
16507207|NCT00048542|40329528|FG001|Double-Blind Phase|Protocol Violation|0|||
16507208|NCT00048542|40329529|FG002|Double-Blind Phase|Protocol Violation|1|||
16507209|NCT00048542|40329530|FG003|Double-Blind Phase|Protocol Violation|0|||
16507210|NCT00048542|40329531|FG004|Double-Blind Phase|Protocol Violation|0|||
16507211|NCT00048542|40329532|FG005|Double-Blind Phase|Protocol Violation|0|||
16507212|NCT00048542|40329533|FG006|Double-Blind Phase|Protocol Violation|0|||
16391312|NCT02504372|39916097|FG000|Overall Study|Death|136|||
16391313|NCT02504372|39916098|FG001|Overall Study|Death|154|||
16507213|NCT00048542|40329534|FG007|Double-Blind Phase|Protocol Violation|0|||
16507214|NCT00048542|40329527|FG000|Double-Blind Phase|Sponsor request or decision|2|||
16507215|NCT00048542|40329528|FG001|Double-Blind Phase|Sponsor request or decision|0|||
16507216|NCT00048542|40329529|FG002|Double-Blind Phase|Sponsor request or decision|0|||
16507217|NCT00048542|40329530|FG003|Double-Blind Phase|Sponsor request or decision|0|||
16507218|NCT00048542|40329531|FG004|Double-Blind Phase|Sponsor request or decision|0|||
16507219|NCT00048542|40329532|FG005|Double-Blind Phase|Sponsor request or decision|0|||
16507220|NCT00048542|40329533|FG006|Double-Blind Phase|Sponsor request or decision|0|||
16507221|NCT00048542|40329534|FG007|Double-Blind Phase|Sponsor request or decision|0|||
16507222|NCT00048542|40329527|FG000|Double-Blind Phase|Randomized in error|1|||
16507223|NCT00048542|40329528|FG001|Double-Blind Phase|Randomized in error|0|||
16507224|NCT00048542|40329529|FG002|Double-Blind Phase|Randomized in error|0|||
16507225|NCT00048542|40329530|FG003|Double-Blind Phase|Randomized in error|0|||
16507226|NCT00048542|40329531|FG004|Double-Blind Phase|Randomized in error|0|||
16507227|NCT00048542|40329532|FG005|Double-Blind Phase|Randomized in error|0|||
16507228|NCT00048542|40329533|FG006|Double-Blind Phase|Randomized in error|0|||
16507229|NCT00048542|40329534|FG007|Double-Blind Phase|Randomized in error|0|||
16507230|NCT00048542|40329527|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
16507231|NCT00048542|40329528|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
16507232|NCT00048542|40329529|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
16507233|NCT00048542|40329530|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
16507234|NCT00048542|40329531|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
16507235|NCT00048542|40329532|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
16507236|NCT00048542|40329533|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
16507237|NCT00048542|40329534|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
16507238|NCT00048542|40329527|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
16507239|NCT00048542|40329528|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
16507240|NCT00048542|40329529|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
16507241|NCT00048542|40329530|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
16507242|NCT00048542|40329531|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
16507243|NCT00048542|40329532|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
16507244|NCT00048542|40329533|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
16507245|NCT00048542|40329534|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
16507246|NCT00048542|40329527|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
16507247|NCT00048542|40329528|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
16507248|NCT00048542|40329529|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
16507249|NCT00048542|40329530|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
16507250|NCT00048542|40329531|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
16507251|NCT00048542|40329532|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
16313297|NCT00884117|39630862|FG000|Overall Study|Lost to Follow-up|143|||
16313298|NCT00884117|39630862|FG000|Overall Study|Other|12|||
16313299|NCT00350207|39630863|FG000|Overall Study|Adverse Event|5|||
16313300|NCT00350207|39630864|FG001|Overall Study|Adverse Event|2|||
16313301|NCT00350207|39630865|FG002|Overall Study|Adverse Event|2|||
16313302|NCT00350207|39630863|FG000|Overall Study|Lack of Efficacy|1|||
16313303|NCT00350207|39630864|FG001|Overall Study|Lack of Efficacy|0|||
16313304|NCT00350207|39630865|FG002|Overall Study|Lack of Efficacy|2|||
16313305|NCT00350207|39630863|FG000|Overall Study|Lost to Follow-up|1|||
16507252|NCT00048542|40329533|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
16507253|NCT00048542|40329534|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
16507254|NCT00048542|40329527|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
16507255|NCT00048542|40329528|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
16507256|NCT00048542|40329529|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
16507257|NCT00048542|40329530|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
16507258|NCT00048542|40329531|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
16507259|NCT00048542|40329532|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
16507260|NCT00048542|40329533|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
16507261|NCT00048542|40329534|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
16507262|NCT00048542|40329527|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
16507263|NCT00048542|40329528|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
16507264|NCT00048542|40329529|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
16507265|NCT00048542|40329530|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
16507266|NCT00048542|40329531|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
16507267|NCT00048542|40329532|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
16507268|NCT00048542|40329533|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
16507269|NCT00048542|40329534|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
16507270|NCT00048542|40329527|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
16507271|NCT00048542|40329528|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
16507272|NCT00048542|40329529|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
16507273|NCT00048542|40329530|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
16507274|NCT00048542|40329531|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
16507275|NCT00048542|40329532|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
16507276|NCT00048542|40329533|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
16507277|NCT00048542|40329534|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
16507278|NCT00048542|40329527|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
16507279|NCT00048542|40329528|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
16507280|NCT00048542|40329529|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
16507281|NCT00048542|40329530|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
16507282|NCT00048542|40329531|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
16507283|NCT00048542|40329532|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
16507284|NCT00048542|40329533|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
16507285|NCT00048542|40329534|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
16507286|NCT00048542|40329527|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
16507287|NCT00048542|40329528|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
16507288|NCT00048542|40329529|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
16507289|NCT00048542|40329530|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
16507290|NCT00048542|40329531|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
16507291|NCT00048542|40329532|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
16507292|NCT00048542|40329533|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
16507293|NCT00048542|40329534|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
16507294|NCT00048542|40329527|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
16507295|NCT00048542|40329528|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
16507296|NCT00048542|40329529|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
16507297|NCT00048542|40329530|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
16507298|NCT00048542|40329531|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
16507299|NCT00048542|40329532|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
16507300|NCT00048542|40329533|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
16507301|NCT00048542|40329534|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
16507302|NCT00048542|40329527|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
16507303|NCT00048542|40329528|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
16507304|NCT00048542|40329529|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
16507305|NCT00048542|40329530|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
16507306|NCT00048542|40329531|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
16507307|NCT00048542|40329532|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
16507308|NCT00048542|40329533|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
16507309|NCT00048542|40329534|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
16507310|NCT00048542|40329527|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
16507311|NCT00048542|40329528|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
16507312|NCT00048542|40329529|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
16507313|NCT00048542|40329530|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
16507314|NCT00048542|40329531|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
16507315|NCT00048542|40329532|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
16313306|NCT00350207|39630864|FG001|Overall Study|Lost to Follow-up|0|||
16313307|NCT00350207|39630865|FG002|Overall Study|Lost to Follow-up|1|||
16313308|NCT00350207|39630863|FG000|Overall Study|Withdrawal by Subject|0|||
16313309|NCT00350207|39630864|FG001|Overall Study|Withdrawal by Subject|1|||
16313310|NCT00350207|39630865|FG002|Overall Study|Withdrawal by Subject|1|||
16313311|NCT00350207|39630863|FG000|Overall Study|Other|1|||
16313312|NCT00350207|39630864|FG001|Overall Study|Other|3|||
16313313|NCT00350207|39630865|FG002|Overall Study|Other|1|||
16313314|NCT00359424|39630866|FG000|Overall Study|Death|99|||
16313315|NCT00359424|39630867|FG001|Overall Study|Death|58|||
16313316|NCT00359424|39630866|FG000|Overall Study|Lost to Follow-up|19|||
16313317|NCT00359424|39630867|FG001|Overall Study|Lost to Follow-up|7|||
16313318|NCT00359424|39630866|FG000|Overall Study|Withdrawal by Subject|10|||
16197188|NCT00592553|39197452|FG001|Overall Study|Protocol Noncompliance|0|||
16313319|NCT00359424|39630867|FG001|Overall Study|Withdrawal by Subject|2|||
16507316|NCT00048542|40329533|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
16507317|NCT00048542|40329534|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
16507318|NCT04098458|40329535|FG000|Overall Study|Death|1|||
16313320|NCT00359424|39630866|FG000|Overall Study|follow up not conducted|2|||
16313321|NCT00359424|39630867|FG001|Overall Study|follow up not conducted|0|||
16313322|NCT01068860|39630869|FG000|Overall Study|Withdrawal by Subject|0|||
16313323|NCT01068860|39630870|FG001|Overall Study|Withdrawal by Subject|0|||
16313324|NCT01068860|39630871|FG002|Overall Study|Withdrawal by Subject|0|||
16313325|NCT01068860|39630872|FG003|Overall Study|Withdrawal by Subject|0|||
16313326|NCT01068860|39630873|FG004|Overall Study|Withdrawal by Subject|0|||
16313327|NCT01068860|39630874|FG005|Overall Study|Withdrawal by Subject|2|||
16313328|NCT01068860|39630875|FG006|Overall Study|Withdrawal by Subject|0|||
16313329|NCT01068860|39630876|FG007|Overall Study|Withdrawal by Subject|0|||
16313330|NCT01068860|39630877|FG008|Overall Study|Withdrawal by Subject|0|||
16313331|NCT01068860|39630878|FG009|Overall Study|Withdrawal by Subject|3|||
16313332|NCT01068860|39630869|FG000|Overall Study|Administrative problems; misrandomized|0|||
16313333|NCT01068860|39630870|FG001|Overall Study|Administrative problems; misrandomized|0|||
16313334|NCT01068860|39630871|FG002|Overall Study|Administrative problems; misrandomized|0|||
16313335|NCT01068860|39630872|FG003|Overall Study|Administrative problems; misrandomized|1|||
16313336|NCT01068860|39630873|FG004|Overall Study|Administrative problems; misrandomized|0|||
16313337|NCT01068860|39630874|FG005|Overall Study|Administrative problems; misrandomized|0|||
16313338|NCT01068860|39630875|FG006|Overall Study|Administrative problems; misrandomized|0|||
16313339|NCT01068860|39630876|FG007|Overall Study|Administrative problems; misrandomized|0|||
16313340|NCT01068860|39630877|FG008|Overall Study|Administrative problems; misrandomized|0|||
16313341|NCT01068860|39630878|FG009|Overall Study|Administrative problems; misrandomized|1|||
16313342|NCT01068860|39630869|FG000|Overall Study|Lost to Follow-up|0|||
16313343|NCT01068860|39630870|FG001|Overall Study|Lost to Follow-up|1|||
16313344|NCT01068860|39630871|FG002|Overall Study|Lost to Follow-up|0|||
16313345|NCT01068860|39630872|FG003|Overall Study|Lost to Follow-up|0|||
16313346|NCT01068860|39630873|FG004|Overall Study|Lost to Follow-up|0|||
16313347|NCT01068860|39630874|FG005|Overall Study|Lost to Follow-up|0|||
16313348|NCT01068860|39630875|FG006|Overall Study|Lost to Follow-up|0|||
16507319|NCT04098458|40329535|FG000|Overall Study|did not meet study inclusion criteria|3|||
16507320|NCT03025828|40329539|FG000|Overall Study|Lost to Follow-up|1|||
16507321|NCT02466555|40329540|FG000|Overall Study|Lost to Follow-up|2|||
16507322|NCT00256698|40329541|FG000|Overall Study|Withdrawal by Subject|7|||
16507323|NCT00256698|40329542|FG001|Overall Study|Withdrawal by Subject|7|||
16507324|NCT00256698|40329541|FG000|Overall Study|Adverse Event|13|||
16507325|NCT00256698|40329542|FG001|Overall Study|Adverse Event|6|||
16507326|NCT00256698|40329541|FG000|Overall Study|Protocol Violation|6|||
16507327|NCT00256698|40329542|FG001|Overall Study|Protocol Violation|5|||
16507328|NCT00256698|40329541|FG000|Overall Study|Lost to Follow-up|1|||
16507329|NCT00256698|40329542|FG001|Overall Study|Lost to Follow-up|3|||
16507330|NCT00256698|40329541|FG000|Overall Study|disease progression|97|||
16507331|NCT00256698|40329542|FG001|Overall Study|disease progression|105|||
16507332|NCT00256698|40329541|FG000|Overall Study|still ongoing at data cut-off|41|||
16507333|NCT00256698|40329542|FG001|Overall Study|still ongoing at data cut-off|46|||
16507334|NCT00256698|40329541|FG000|Overall Study|withdrawn due to osteoporosis|1|||
16507335|NCT00256698|40329542|FG001|Overall Study|withdrawn due to osteoporosis|0|||
16507336|NCT00256698|40329541|FG000|Overall Study|Prematurely Discontinued|1|||
16507337|NCT00256698|40329542|FG001|Overall Study|Prematurely Discontinued|0|||
16507338|NCT04033159|40329543|FG000|Washout Period|Physician Decision|0|||
16507339|NCT04033159|40329544|FG001|Washout Period|Physician Decision|1|||
16507340|NCT04033159|40329545|FG002|Washout Period|Physician Decision|0|||
16507341|NCT04033159|40329543|FG000|Washout Period|Study terminated by Sponsor|0|||
16313349|NCT01068860|39630876|FG007|Overall Study|Lost to Follow-up|0|||
16313350|NCT01068860|39630877|FG008|Overall Study|Lost to Follow-up|0|||
16507342|NCT04033159|40329544|FG001|Washout Period|Study terminated by Sponsor|7|||
16313351|NCT01068860|39630878|FG009|Overall Study|Lost to Follow-up|0|||
16313352|NCT04358081|39630884|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
16313353|NCT04358081|39630885|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
16313354|NCT04358081|39630886|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
16313355|NCT04358081|39630884|FG000|Treatment Phase of Study|Adverse Event|1|||
16313356|NCT04358081|39630885|FG001|Treatment Phase of Study|Adverse Event|0|||
16313357|NCT04358081|39630886|FG002|Treatment Phase of Study|Adverse Event|1|||
16313358|NCT04358081|39630884|FG000|Treatment Phase of Study|Physician Decision|2|||
16313359|NCT04358081|39630885|FG001|Treatment Phase of Study|Physician Decision|0|||
16313360|NCT04358081|39630886|FG002|Treatment Phase of Study|Physician Decision|1|||
16313361|NCT04358081|39630884|FG000|Treatment Phase of Study|Protocol Violation|1|||
16507343|NCT04033159|40329545|FG002|Washout Period|Study terminated by Sponsor|0|||
16507344|NCT04033159|40329543|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
16507345|NCT04033159|40329544|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
16507346|NCT04033159|40329545|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
16507347|NCT02618434|40329548|FG000|Overall Study|Withdrawal by Subject|0|||
16507348|NCT02618434|40329549|FG001|Overall Study|Withdrawal by Subject|2|||
16507349|NCT02618434|40329550|FG002|Overall Study|Withdrawal by Subject|3|||
16507350|NCT02618434|40329548|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
16507351|NCT02618434|40329549|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
16507352|NCT02618434|40329550|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
16507353|NCT02618434|40329548|FG000|Overall Study|Lost to Follow-up|3|||
16507354|NCT02618434|40329549|FG001|Overall Study|Lost to Follow-up|1|||
16507355|NCT02618434|40329550|FG002|Overall Study|Lost to Follow-up|3|||
16507356|NCT02618434|40329548|FG000|Overall Study|Adverse Event|1|||
16507357|NCT02618434|40329549|FG001|Overall Study|Adverse Event|0|||
16507358|NCT02618434|40329550|FG002|Overall Study|Adverse Event|12|||
16507359|NCT02618434|40329548|FG000|Overall Study|Physician Decision|0|||
16507360|NCT02618434|40329549|FG001|Overall Study|Physician Decision|1|||
16507361|NCT02618434|40329550|FG002|Overall Study|Physician Decision|0|||
16507362|NCT02618434|40329548|FG000|Overall Study|Protocol Violation|0|||
16507363|NCT02618434|40329549|FG001|Overall Study|Protocol Violation|0|||
16507364|NCT02618434|40329550|FG002|Overall Study|Protocol Violation|1|||
16507365|NCT02618434|40329548|FG000|Overall Study|Other, Multiple categories|1|||
16507366|NCT02618434|40329549|FG001|Overall Study|Other, Multiple categories|1|||
16507367|NCT02618434|40329550|FG002|Overall Study|Other, Multiple categories|1|||
16507368|NCT01816893|40329556|FG000|Washout Period|Withdrawal by Subject|2|||
16507369|NCT01816893|40329557|FG001|Washout Period|Withdrawal by Subject|0|||
16507370|NCT04356963|40329558|FG000|First Session|Withdrawal by Subject|1|||
16507371|NCT04356963|40329558|FG000|Second Session|Withdrawal by Subject|3|||
16507372|NCT04356963|40329558|FG000|Second Session|Lost to Follow-up|1|||
16507373|NCT04356963|40329558|FG000|Third Session|Lost to Follow-up|6|||
16507374|NCT04356963|40329558|FG000|Third Session|Withdrawal by Subject|1|||
16507375|NCT03760146|40329566|FG000|Overall Study|Adverse Event|11|||
16507376|NCT03760146|40329567|FG001|Overall Study|Adverse Event|8|||
16507377|NCT03760146|40329568|FG002|Overall Study|Adverse Event|0|||
16507378|NCT03760146|40329569|FG003|Overall Study|Adverse Event|0|||
16507379|NCT03760146|40329570|FG004|Overall Study|Adverse Event|0|||
16507380|NCT03760146|40329571|FG005|Overall Study|Adverse Event|0|||
16507381|NCT03760146|40329566|FG000|Overall Study|Death|1|||
16507382|NCT03760146|40329567|FG001|Overall Study|Death|0|||
16507383|NCT03760146|40329568|FG002|Overall Study|Death|0|||
16507384|NCT03760146|40329569|FG003|Overall Study|Death|0|||
16507385|NCT03760146|40329570|FG004|Overall Study|Death|0|||
16507386|NCT03760146|40329571|FG005|Overall Study|Death|0|||
16507387|NCT03760146|40329566|FG000|Overall Study|Lost to Follow-up|41|||
16507388|NCT03760146|40329567|FG001|Overall Study|Lost to Follow-up|28|||
16507389|NCT03760146|40329568|FG002|Overall Study|Lost to Follow-up|9|||
16507390|NCT03760146|40329569|FG003|Overall Study|Lost to Follow-up|2|||
16507391|NCT03760146|40329570|FG004|Overall Study|Lost to Follow-up|14|||
16507392|NCT03760146|40329571|FG005|Overall Study|Lost to Follow-up|8|||
16507393|NCT03760146|40329566|FG000|Overall Study|No longer met eligibility criteria|3|||
16507394|NCT03760146|40329567|FG001|Overall Study|No longer met eligibility criteria|9|||
16507395|NCT03760146|40329568|FG002|Overall Study|No longer met eligibility criteria|0|||
16507396|NCT03760146|40329569|FG003|Overall Study|No longer met eligibility criteria|0|||
16507397|NCT03760146|40329570|FG004|Overall Study|No longer met eligibility criteria|1|||
16507398|NCT03760146|40329571|FG005|Overall Study|No longer met eligibility criteria|0|||
16507399|NCT03760146|40329566|FG000|Overall Study|Protocol Violation|21|||
16507400|NCT03760146|40329567|FG001|Overall Study|Protocol Violation|13|||
16313362|NCT04358081|39630885|FG001|Treatment Phase of Study|Protocol Violation|0|||
16507401|NCT03760146|40329568|FG002|Overall Study|Protocol Violation|1|||
16507402|NCT03760146|40329569|FG003|Overall Study|Protocol Violation|0|||
16507403|NCT03760146|40329570|FG004|Overall Study|Protocol Violation|1|||
16507404|NCT03760146|40329571|FG005|Overall Study|Protocol Violation|0|||
16507405|NCT03760146|40329566|FG000|Overall Study|Withdrawal by Subject|19|||
16507406|NCT03760146|40329567|FG001|Overall Study|Withdrawal by Subject|20|||
16313363|NCT04358081|39630886|FG002|Treatment Phase of Study|Protocol Violation|0|||
16313364|NCT04358081|39630884|FG000|Study Completion Phase|Death|0|||
16313365|NCT04358081|39630885|FG001|Study Completion Phase|Death|0|||
16313366|NCT04358081|39630886|FG002|Study Completion Phase|Death|1|||
16313367|NCT04358081|39630884|FG000|Study Completion Phase|Lost to Follow-up|1|||
16313368|NCT04358081|39630885|FG001|Study Completion Phase|Lost to Follow-up|0|||
16313369|NCT04358081|39630886|FG002|Study Completion Phase|Lost to Follow-up|1|||
16313370|NCT01778855|39630888|FG000|Overall Study|Death|0|||
16313371|NCT01778855|39630889|FG001|Overall Study|Death|1|||
16313372|NCT00764881|39630892|FG000|Overall Study|Adverse Event|5|||
16313373|NCT00764881|39630893|FG001|Overall Study|Adverse Event|1|||
16313374|NCT00764881|39630892|FG000|Overall Study|Withdrawal by Subject|1|||
16313375|NCT00764881|39630893|FG001|Overall Study|Withdrawal by Subject|3|||
16313376|NCT00764881|39630892|FG000|Overall Study|Protocol Violation|2|||
16313377|NCT00764881|39630893|FG001|Overall Study|Protocol Violation|2|||
16313378|NCT00764881|39630892|FG000|Overall Study|Lost to Follow-up|2|||
16313379|NCT00764881|39630893|FG001|Overall Study|Lost to Follow-up|0|||
16197189|NCT00592553|39197453|FG002|Overall Study|Protocol Noncompliance|0|||
16197190|NCT03137121|39197454|FG000|Overall Study|Withdrawal by Subject|0|||
16507407|NCT03760146|40329568|FG002|Overall Study|Withdrawal by Subject|1|||
16507408|NCT03760146|40329569|FG003|Overall Study|Withdrawal by Subject|0|||
16507409|NCT03760146|40329570|FG004|Overall Study|Withdrawal by Subject|1|||
16507410|NCT03760146|40329571|FG005|Overall Study|Withdrawal by Subject|0|||
16507411|NCT01200797|40329580|FG000|Overall Study|symptomatic deterioration|2|||
16197191|NCT03137121|39197455|FG001|Overall Study|Withdrawal by Subject|1|||
16197192|NCT00433446|39197458|FG000|Overall Study|Adverse Event|4|||
16197193|NCT00433446|39197458|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
16197194|NCT00433446|39197458|FG000|Overall Study|Progression|44|||
16197195|NCT00433446|39197458|FG000|Overall Study|Other - Not Protocol specified|3|||
16197196|NCT00433446|39197458|FG000|Overall Study|Ineligible|9|||
16197197|NCT03583372|39197460|FG000|Overall Study|Withdrawal by Subject|6|||
16197198|NCT03583372|39197461|FG001|Overall Study|Withdrawal by Subject|11|||
16197199|NCT03583372|39197462|FG002|Overall Study|Withdrawal by Subject|7|||
16197200|NCT03583372|39197463|FG003|Overall Study|Withdrawal by Subject|8|||
16197201|NCT03583372|39197460|FG000|Overall Study|Lost to Follow-up|4|||
16197202|NCT03583372|39197461|FG001|Overall Study|Lost to Follow-up|6|||
16197203|NCT03583372|39197462|FG002|Overall Study|Lost to Follow-up|3|||
16197204|NCT03583372|39197463|FG003|Overall Study|Lost to Follow-up|2|||
16197205|NCT03583372|39197460|FG000|Overall Study|Adverse Event|1|||
16197206|NCT03583372|39197461|FG001|Overall Study|Adverse Event|3|||
16197207|NCT03583372|39197462|FG002|Overall Study|Adverse Event|4|||
16197208|NCT03583372|39197463|FG003|Overall Study|Adverse Event|4|||
16197209|NCT03583372|39197460|FG000|Overall Study|Physician Decision|0|||
16197210|NCT03583372|39197461|FG001|Overall Study|Physician Decision|1|||
16197211|NCT03583372|39197462|FG002|Overall Study|Physician Decision|1|||
16197212|NCT03583372|39197463|FG003|Overall Study|Physician Decision|1|||
16197213|NCT03583372|39197460|FG000|Overall Study|Lack of Efficacy|0|||
16197214|NCT03583372|39197461|FG001|Overall Study|Lack of Efficacy|1|||
16197215|NCT03583372|39197462|FG002|Overall Study|Lack of Efficacy|0|||
16197216|NCT03583372|39197463|FG003|Overall Study|Lack of Efficacy|1|||
16197217|NCT03583372|39197460|FG000|Overall Study|Death|1|||
16197218|NCT03583372|39197461|FG001|Overall Study|Death|0|||
16197219|NCT03583372|39197462|FG002|Overall Study|Death|0|||
16197220|NCT03583372|39197463|FG003|Overall Study|Death|0|||
16197221|NCT03583372|39197460|FG000|Overall Study|Protocol Violation|0|||
16197222|NCT03583372|39197461|FG001|Overall Study|Protocol Violation|1|||
16507412|NCT01200797|40329580|FG000|Overall Study|Adverse Event|4|||
16507413|NCT01200797|40329580|FG000|Overall Study|Disease Progression|13|||
16507414|NCT01822132|40329581|FG000|Overall Study|Lost to Follow-up|4|||
16197223|NCT03583372|39197462|FG002|Overall Study|Protocol Violation|0|||
16313380|NCT00764881|39630892|FG000|Overall Study|Noncompliant|1|||
16197224|NCT03583372|39197463|FG003|Overall Study|Protocol Violation|0|||
16197225|NCT03583372|39197460|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
16197226|NCT03583372|39197461|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
16197227|NCT03583372|39197462|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
16313381|NCT00764881|39630893|FG001|Overall Study|Noncompliant|0|||
16197228|NCT03583372|39197463|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
16507415|NCT01822132|40329582|FG001|Overall Study|Lost to Follow-up|2|||
16507416|NCT02488681|40329599|FG000|Overall Study|Implant unsuccessful|7|||
16507417|NCT01398956|40329600|FG000|Overall Study|Withdrawal by Subject|4|||
16507418|NCT01398956|40329600|FG000|Overall Study|AE, non-serious non-fatal|4|||
16507419|NCT01398956|40329600|FG000|Overall Study|Withdrawal Criteria No.3|1|||
16507420|NCT01398956|40329600|FG000|Overall Study|Subject moved a long distance|1|||
16507421|NCT00642668|40329601|FG000|Overall Study|Lost to Follow-up|1|||
16507422|NCT00642668|40329601|FG000|Overall Study|Adverse Event|2|||
16507423|NCT00642668|40329601|FG000|Overall Study|Death|2|||
16507424|NCT00642668|40329601|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16507425|NCT00642668|40329601|FG000|Overall Study|Failure to Return|1|||
16507426|NCT00642668|40329601|FG000|Overall Study|Dialysis Initiation|5|||
16507427|NCT00642668|40329601|FG000|Overall Study|Blood Transfusion|2|||
16507428|NCT02226003|40333093|FG000|Overall Study|Lost to Follow-up|2|||
16507429|NCT02226003|40333094|FG001|Overall Study|Lost to Follow-up|1|||
16507430|NCT02226003|40333095|FG002|Overall Study|Lost to Follow-up|3|||
16507431|NCT02226003|40333093|FG000|Overall Study|Withdrawal by Subject|0|||
16507432|NCT02226003|40333094|FG001|Overall Study|Withdrawal by Subject|0|||
16507433|NCT02226003|40333095|FG002|Overall Study|Withdrawal by Subject|3|||
16507434|NCT02580357|40333100|FG000|Overall Study|Lost to Follow-up|2|||
16507435|NCT02580357|40333101|FG001|Overall Study|Lost to Follow-up|0|||
16507436|NCT02580357|40333102|FG002|Overall Study|Lost to Follow-up|0|||
16507437|NCT02580357|40333100|FG000|Overall Study|Protocol Violation|1|||
16507438|NCT02580357|40333101|FG001|Overall Study|Protocol Violation|0|||
16507439|NCT02580357|40333102|FG002|Overall Study|Protocol Violation|0|||
16507440|NCT00896337|40333103|FG000|Overall Study|Death|7|||
16507441|NCT00896337|40333103|FG000|Overall Study|Withdrawal by Subject|7|||
16507442|NCT00896337|40333103|FG000|Overall Study|Lost to Follow-up|11|||
16391314|NCT02504372|39916097|FG000|Overall Study|Lost to Follow-up|0|||
16391315|NCT02504372|39916098|FG001|Overall Study|Lost to Follow-up|2|||
16391316|NCT02504372|39916097|FG000|Overall Study|Withdrawal of consent|25|||
16391317|NCT02504372|39916098|FG001|Overall Study|Withdrawal of consent|16|||
16391318|NCT02504372|39916097|FG000|Overall Study|Participants ongoing|429|||
16391319|NCT02504372|39916098|FG001|Overall Study|Participants ongoing|415|||
16391320|NCT01284959|39916099|FG000|Overall Study|Withdrawal by Subject|1|||
16391321|NCT01284959|39916100|FG001|Overall Study|Withdrawal by Subject|0|||
16391322|NCT01284959|39916101|FG002|Overall Study|Withdrawal by Subject|0|||
16391323|NCT01284959|39916099|FG000|Overall Study|Adverse Event|0|||
16391324|NCT01284959|39916100|FG001|Overall Study|Adverse Event|0|||
16391325|NCT01284959|39916101|FG002|Overall Study|Adverse Event|1|||
16391326|NCT00833027|39916102|FG000|Overall Study|Adverse Event|33|||
16391327|NCT00833027|39916102|FG000|Overall Study|Death|1|||
16391328|NCT00833027|39916102|FG000|Overall Study|Lack of Efficacy|12|||
16391329|NCT00833027|39916102|FG000|Overall Study|Lost to Follow-up|24|||
16391330|NCT00833027|39916102|FG000|Overall Study|Protocol Violation|115|||
16391331|NCT00833027|39916102|FG000|Overall Study|Withdrawal by Subject|16|||
16391332|NCT00833027|39916102|FG000|Overall Study|Missing|10|||
16391333|NCT02625220|39916103|FG000|Overall Study|Adverse Event|2|||
16391334|NCT02625220|39916103|FG000|Overall Study|Lost to Follow-up|2|||
16391335|NCT02625220|39916103|FG000|Overall Study|Protocol Violation|1|||
16391336|NCT02625220|39916103|FG000|Overall Study|Study discontinued at site|2|||
16391337|NCT04240886|39916104|FG000|Treatment Phase|Death|4|||
16391338|NCT04240886|39916104|FG000|Treatment Phase|Discontinuation by Subject|1|||
16391339|NCT04240886|39916104|FG000|Treatment Phase|Adverse Event|5|||
16391340|NCT04240886|39916104|FG000|Follow-up Phase|Withdrawal by Subject|1|||
16391341|NCT04240886|39916104|FG000|Follow-up Phase|Discontinuation by Subject|1|||
16507443|NCT00613509|40333104|FG000|Cycle 1|Adverse Event|2|||
16507444|NCT00613509|40333105|FG001|Cycle 1|Adverse Event|1|||
16507445|NCT00613509|40333104|FG000|Cycle 1|Disease Progression|2|||
16507446|NCT00613509|40333105|FG001|Cycle 1|Disease Progression|6|||
16507447|NCT00613509|40333104|FG000|Cycle 1|Unacceptable Toxicity|1|||
16507448|NCT00613509|40333105|FG001|Cycle 1|Unacceptable Toxicity|0|||
16507449|NCT00613509|40333104|FG000|Cycle 1|Other administrative reason|0|||
16507450|NCT00613509|40333105|FG001|Cycle 1|Other administrative reason|1|||
16507451|NCT00908960|40333111|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
16507452|NCT00908960|40333112|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
16507453|NCT00908960|40333113|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
16507454|NCT01187043|40333114|FG000|Overall Study|Adverse Event|0|||
16507455|NCT01187043|40333115|FG001|Overall Study|Adverse Event|0|||
16507456|NCT01187043|40333116|FG002|Overall Study|Adverse Event|0|||
16507457|NCT01187043|40333117|FG003|Overall Study|Adverse Event|0|||
16507458|NCT01187043|40333118|FG004|Overall Study|Adverse Event|1|||
16507459|NCT01187043|40333114|FG000|Overall Study|Unable to make scheduled visits|1|||
16313382|NCT00764881|39630892|FG000|Overall Study|Accidentally discontinued study drug|1|||
16313383|NCT00764881|39630893|FG001|Overall Study|Accidentally discontinued study drug|0|||
16313384|NCT00764881|39630892|FG000|Overall Study|Wished to become pregnant|1|||
16507460|NCT01187043|40333115|FG001|Overall Study|Unable to make scheduled visits|0|||
16507461|NCT01187043|40333116|FG002|Overall Study|Unable to make scheduled visits|4|||
16507462|NCT01187043|40333117|FG003|Overall Study|Unable to make scheduled visits|0|||
16507463|NCT01187043|40333118|FG004|Overall Study|Unable to make scheduled visits|1|||
16507464|NCT00702403|40333119|FG000|From Consent to Engraftment|Progressive leukemia|6|||
16507465|NCT00702403|40333119|FG000|From Consent to Engraftment|Critically ill|2|||
16507466|NCT00702403|40333119|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
16391342|NCT04240886|39916104|FG000|Follow-up Phase|Death|2|||
16391343|NCT00573391|39916105|FG000|Overall Study|study stopped|2|||
16391344|NCT00573391|39916106|FG001|Overall Study|study stopped|2|||
16391345|NCT00573391|39916105|FG000|Overall Study|Death|1|||
16391346|NCT00573391|39916106|FG001|Overall Study|Death|0|||
16391347|NCT01369199|39916109|FG000|Overall Study|Withdrawal by Subject|1|||
16391348|NCT01369199|39916109|FG000|Overall Study|Lost to Follow-up|2|||
16391349|NCT03230318|39916113|FG000|Overall Study|Radiographic disease progression|72|||
16391350|NCT03230318|39916114|FG001|Overall Study|Radiographic disease progression|19|||
16391351|NCT03230318|39916113|FG000|Overall Study|Clinical progression|17|||
16391352|NCT03230318|39916114|FG001|Overall Study|Clinical progression|7|||
16391353|NCT03230318|39916113|FG000|Overall Study|Adverse Event|5|||
16507467|NCT00702403|40333119|FG000|From Consent to Engraftment|Myocardial infarction|1|||
16507468|NCT00702403|40333119|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
16507469|NCT00702403|40333119|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
16507470|NCT00702403|40333119|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
16507471|NCT00702403|40333119|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
16507472|NCT00702403|40333119|FG000|From Engraftment to Study Completion|Non-compliance|2|||
16313385|NCT00764881|39630893|FG001|Overall Study|Wished to become pregnant|0|||
16313386|NCT00764881|39630892|FG000|Overall Study|Carcinoma detected|1|||
16313387|NCT00764881|39630893|FG001|Overall Study|Carcinoma detected|0|||
16313388|NCT00764881|39630892|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
16313389|NCT00764881|39630893|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
16313390|NCT00764881|39630892|FG000|Overall Study|no treatment or no observation|2|||
16313391|NCT00764881|39630893|FG001|Overall Study|no treatment or no observation|2|||
16313392|NCT02942017|39630894|FG000|Overall Study|Adverse Event|0|||
16313393|NCT02942017|39630895|FG001|Overall Study|Adverse Event|1|||
16313394|NCT02942017|39630894|FG000|Overall Study|Withdrawal by Subject|0|||
16313395|NCT02942017|39630895|FG001|Overall Study|Withdrawal by Subject|1|||
16507473|NCT00702403|40333119|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
16313396|NCT02942017|39630894|FG000|Overall Study|Lost to Follow-up|1|||
16507474|NCT00702403|40333119|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
16507475|NCT00702403|40333119|FG000|From Engraftment to Study Completion|Suicide|1|||
16507476|NCT00702403|40333119|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
16507477|NCT00702403|40333119|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
16507478|NCT00702403|40333119|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
16507479|NCT02174848|40333120|FG000|Overall Study|Adverse Event|2|||
16507480|NCT02174848|40333121|FG001|Overall Study|Adverse Event|1|||
16507481|NCT02174848|40333120|FG000|Overall Study|Withdrawal by Subject|3|||
16507482|NCT02174848|40333121|FG001|Overall Study|Withdrawal by Subject|3|||
16507483|NCT02174848|40333120|FG000|Overall Study|Lost to Follow-up|0|||
16507484|NCT02174848|40333121|FG001|Overall Study|Lost to Follow-up|1|||
16507485|NCT02174848|40333120|FG000|Overall Study|Worsening of disease|1|||
16507486|NCT02174848|40333121|FG001|Overall Study|Worsening of disease|1|||
16507487|NCT02174848|40333120|FG000|Overall Study|Unable to comply with study requirements|1|||
16507488|NCT02174848|40333121|FG001|Overall Study|Unable to comply with study requirements|0|||
16507489|NCT03388138|40333122|FG000|Overall Study|Protocol Violation|1|||
16313397|NCT02942017|39630895|FG001|Overall Study|Lost to Follow-up|1|||
16391354|NCT03230318|39916114|FG001|Overall Study|Adverse Event|3|||
16507490|NCT03388138|40333123|FG001|Overall Study|Protocol Violation|0|||
16391355|NCT03230318|39916113|FG000|Overall Study|Physician Decision|2|||
16391356|NCT03230318|39916114|FG001|Overall Study|Physician Decision|3|||
16391357|NCT03230318|39916113|FG000|Overall Study|Death|3|||
16391358|NCT03230318|39916114|FG001|Overall Study|Death|2|||
16507491|NCT01727141|40333133|FG000|Overall Study|Physician Decision|0|||
16507492|NCT01727141|40333134|FG001|Overall Study|Physician Decision|1|||
16507493|NCT01727141|40333135|FG002|Overall Study|Physician Decision|0|||
16507494|NCT01727141|40333136|FG003|Overall Study|Physician Decision|2|||
16507495|NCT01727141|40333133|FG000|Overall Study|Lost to Follow-up|0|||
16507496|NCT01727141|40333134|FG001|Overall Study|Lost to Follow-up|2|||
16507497|NCT01727141|40333135|FG002|Overall Study|Lost to Follow-up|0|||
16507498|NCT01727141|40333136|FG003|Overall Study|Lost to Follow-up|0|||
16507499|NCT01727141|40333133|FG000|Overall Study|Death|0|||
16507500|NCT01727141|40333134|FG001|Overall Study|Death|1|||
16507501|NCT01727141|40333135|FG002|Overall Study|Death|1|||
16507502|NCT01727141|40333136|FG003|Overall Study|Death|1|||
16507503|NCT01727141|40333133|FG000|Overall Study|Protocol deviation|1|||
16507504|NCT01727141|40333134|FG001|Overall Study|Protocol deviation|1|||
16507505|NCT01727141|40333135|FG002|Overall Study|Protocol deviation|0|||
16507506|NCT01727141|40333136|FG003|Overall Study|Protocol deviation|1|||
16507507|NCT01727141|40333133|FG000|Overall Study|Withdrawal by Subject|4|||
16507508|NCT01727141|40333134|FG001|Overall Study|Withdrawal by Subject|4|||
16507509|NCT01727141|40333135|FG002|Overall Study|Withdrawal by Subject|2|||
16507510|NCT01727141|40333136|FG003|Overall Study|Withdrawal by Subject|11|||
16507511|NCT02082210|40333139|FG000|Overall Study|Death|0|||
16507512|NCT02082210|40333140|FG001|Overall Study|Death|0|||
16507513|NCT02082210|40333141|FG002|Overall Study|Death|1|||
16507514|NCT02082210|40333142|FG003|Overall Study|Death|1|||
16507515|NCT02082210|40333143|FG004|Overall Study|Death|1|||
16507516|NCT02082210|40333144|FG005|Overall Study|Death|0|||
16507517|NCT02082210|40333139|FG000|Overall Study|Withdrawal by Subject|0|||
16507518|NCT02082210|40333140|FG001|Overall Study|Withdrawal by Subject|0|||
16507519|NCT02082210|40333141|FG002|Overall Study|Withdrawal by Subject|0|||
16507520|NCT02082210|40333142|FG003|Overall Study|Withdrawal by Subject|1|||
16313398|NCT02942017|39630894|FG000|Overall Study|Randomized but not dosed|1|||
16313399|NCT02942017|39630895|FG001|Overall Study|Randomized but not dosed|3|||
16313400|NCT00725283|39630898|FG000|Overall Study|Missing Code|3|||
16313401|NCT00725283|39630898|FG000|Overall Study|Death|5|||
16391359|NCT03230318|39916113|FG000|Overall Study|Lost to Follow-up|1|||
16391360|NCT03230318|39916114|FG001|Overall Study|Lost to Follow-up|0|||
16391361|NCT03230318|39916113|FG000|Overall Study|Withdrawal by Subject|1|||
16391362|NCT03230318|39916114|FG001|Overall Study|Withdrawal by Subject|3|||
16391363|NCT03230318|39916113|FG000|Overall Study|Other|3|||
16391364|NCT03230318|39916114|FG001|Overall Study|Other|7|||
16391365|NCT03606486|39916115|FG000|Overall Study|Unable to collect sample|5|||
16313402|NCT00725283|39630898|FG000|Overall Study|Other|6|||
16313403|NCT00725283|39630898|FG000|Overall Study|Withdrawal by Subject|10|||
16313404|NCT03877068|39630899|FG000|Overall Study|Physician Decision|9|||
16313405|NCT03877068|39630900|FG001|Overall Study|Physician Decision|3|||
16313406|NCT00395629|39630901|FG000|Core Study|Adverse Event|0|||
16313407|NCT00395629|39630902|FG001|Core Study|Adverse Event|3|||
16313408|NCT00395629|39630903|FG002|Core Study|Adverse Event|4|||
16313409|NCT00395629|39630901|FG000|Core Study|Abnormal laboratory value(s)|0|||
16313410|NCT00395629|39630902|FG001|Core Study|Abnormal laboratory value(s)|0|||
16313411|NCT00395629|39630903|FG002|Core Study|Abnormal laboratory value(s)|1|||
16313412|NCT00395629|39630901|FG000|Core Study|Protocol Violation|1|||
16313413|NCT00395629|39630902|FG001|Core Study|Protocol Violation|0|||
16391366|NCT00803595|39916117|FG000|Overall Study|Adverse Event|3|||
16507521|NCT02082210|40333143|FG004|Overall Study|Withdrawal by Subject|2|||
16507522|NCT02082210|40333144|FG005|Overall Study|Withdrawal by Subject|2|||
16313414|NCT00395629|39630903|FG002|Core Study|Protocol Violation|0|||
16313415|NCT00395629|39630901|FG000|Core Study|Withdrawal by Subject|0|||
16391367|NCT00803595|39916118|FG001|Overall Study|Adverse Event|4|||
16507523|NCT02082210|40333139|FG000|Overall Study|Clinical Progression|0|||
16507524|NCT02082210|40333140|FG001|Overall Study|Clinical Progression|0|||
16391368|NCT00803595|39916119|FG002|Overall Study|Adverse Event|1|||
16507525|NCT02082210|40333141|FG002|Overall Study|Clinical Progression|0|||
16507526|NCT02082210|40333142|FG003|Overall Study|Clinical Progression|1|||
16313416|NCT00395629|39630902|FG001|Core Study|Withdrawal by Subject|1|||
16313417|NCT00395629|39630903|FG002|Core Study|Withdrawal by Subject|1|||
16313418|NCT00395629|39630901|FG000|Core Study|Lost to Follow-up|0|||
16313419|NCT00395629|39630902|FG001|Core Study|Lost to Follow-up|0|||
16313420|NCT00395629|39630903|FG002|Core Study|Lost to Follow-up|1|||
16313421|NCT00395629|39630901|FG000|Extension Study|Adverse Event|0|||
16507527|NCT02082210|40333143|FG004|Overall Study|Clinical Progression|0|||
16507528|NCT02082210|40333144|FG005|Overall Study|Clinical Progression|0|||
16507529|NCT02082210|40333139|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
16507530|NCT02082210|40333140|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
16507531|NCT02082210|40333141|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
16507532|NCT02082210|40333142|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
16507533|NCT02082210|40333143|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
16507534|NCT02082210|40333144|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
16507535|NCT02082210|40333139|FG000|Overall Study|Physician Decision|0|||
16197229|NCT03583372|39197460|FG000|Overall Study|Did Not Receive Study Drug|0|||
16197230|NCT03583372|39197461|FG001|Overall Study|Did Not Receive Study Drug|1|||
16197231|NCT03583372|39197462|FG002|Overall Study|Did Not Receive Study Drug|0|||
16197232|NCT03583372|39197463|FG003|Overall Study|Did Not Receive Study Drug|0|||
16197233|NCT03583372|39197460|FG000|Overall Study|Captured as Other in the Database|1|||
16197234|NCT03583372|39197461|FG001|Overall Study|Captured as Other in the Database|2|||
16197235|NCT03583372|39197462|FG002|Overall Study|Captured as Other in the Database|4|||
16197236|NCT03583372|39197463|FG003|Overall Study|Captured as Other in the Database|1|||
16197237|NCT01860534|39197466|FG000|ROP #1|Needed treatment for ROP|0|||
16197238|NCT01860534|39197467|FG001|ROP #1|Needed treatment for ROP|1|||
16197239|NCT01860534|39197466|FG000|ROP #2|discharged prior to ROP #2|1|||
16507536|NCT02082210|40333140|FG001|Overall Study|Physician Decision|0|||
16507537|NCT02082210|40333141|FG002|Overall Study|Physician Decision|1|||
16507538|NCT02082210|40333142|FG003|Overall Study|Physician Decision|1|||
16507539|NCT02082210|40333143|FG004|Overall Study|Physician Decision|0|||
16507540|NCT02082210|40333144|FG005|Overall Study|Physician Decision|0|||
16507541|NCT03690388|40333145|FG000|Overall Study|Adverse Event|8|||
16507542|NCT03690388|40333146|FG001|Overall Study|Adverse Event|1|||
16507543|NCT03690388|40333145|FG000|Overall Study|Radiographic Progression|14|||
16507544|NCT03690388|40333146|FG001|Overall Study|Radiographic Progression|29|||
16507545|NCT03690388|40333145|FG000|Overall Study|Clinical deterioration|10|||
16507546|NCT03690388|40333146|FG001|Overall Study|Clinical deterioration|6|||
16507547|NCT03690388|40333145|FG000|Overall Study|Withdrawal by Subject|2|||
16507548|NCT03690388|40333146|FG001|Overall Study|Withdrawal by Subject|0|||
16507549|NCT03690388|40333145|FG000|Overall Study|Lack of Efficacy|1|||
16507550|NCT03690388|40333146|FG001|Overall Study|Lack of Efficacy|0|||
16507551|NCT03690388|40333145|FG000|Overall Study|Lost to Follow-up|1|||
16507552|NCT03690388|40333146|FG001|Overall Study|Lost to Follow-up|0|||
16507553|NCT00697515|40333154|FG000|Dose Optimization Period|Adverse Event|4|||
16507554|NCT00697515|40333155|FG001|Dose Optimization Period|Adverse Event|0|||
16507555|NCT00697515|40333154|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
16507556|NCT00697515|40333155|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
16507557|NCT00697515|40333154|FG000|Dose Optimization Period|Lost to Follow-up|2|||
16507558|NCT00697515|40333155|FG001|Dose Optimization Period|Lost to Follow-up|0|||
16507559|NCT00697515|40333154|FG000|Dose Optimization Period|sponsor request|2|||
16507560|NCT00697515|40333155|FG001|Dose Optimization Period|sponsor request|0|||
16507561|NCT00697515|40333154|FG000|Dose Optimization Period|called to active duty|1|||
16507562|NCT00697515|40333155|FG001|Dose Optimization Period|called to active duty|0|||
16507563|NCT00697515|40333154|FG000|Dose Optimization Period|elevated QTc|1|||
16507564|NCT00697515|40333155|FG001|Dose Optimization Period|elevated QTc|0|||
16507565|NCT00697515|40333154|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
16507566|NCT00697515|40333155|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
16507567|NCT00697515|40333154|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
16507568|NCT00697515|40333155|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
16507569|NCT00697515|40333154|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
16507570|NCT00697515|40333155|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
16507571|NCT00697515|40333154|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
16197240|NCT01860534|39197467|FG001|ROP #2|discharged prior to ROP #2|0|||
16313422|NCT00395629|39630902|FG001|Extension Study|Adverse Event|0|||
16313423|NCT00395629|39630903|FG002|Extension Study|Adverse Event|2|||
16313424|NCT00395629|39630901|FG000|Extension Study|Administrative problems|0|||
16313425|NCT00395629|39630902|FG001|Extension Study|Administrative problems|0|||
16313426|NCT00395629|39630903|FG002|Extension Study|Administrative problems|1|||
16507572|NCT00697515|40333155|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
16507573|NCT00549562|40333156|FG000|Overall Study|Adverse Event|1|||
16507574|NCT00549562|40333156|FG000|Overall Study|Lack of Efficacy|1|||
16507575|NCT00666757|40333157|FG000|Overall Study|Lost to Follow-up|39|||
16507576|NCT00666757|40333158|FG001|Overall Study|Lost to Follow-up|35|||
16507577|NCT00666757|40333157|FG000|Overall Study|Protocol Violation|23|||
16507578|NCT00666757|40333158|FG001|Overall Study|Protocol Violation|24|||
16197241|NCT01757405|39197468|FG000|Overall Study|Lost to Follow-up|1|||
16313427|NCT02291237|39630904|FG000|Overall Study|Study Terminated by Sponsor|72|||
16313428|NCT02291237|39630905|FG001|Overall Study|Study Terminated by Sponsor|67|||
16313429|NCT02291237|39630904|FG000|Overall Study|Adverse Event|1|||
16313430|NCT02291237|39630905|FG001|Overall Study|Adverse Event|3|||
16313431|NCT02291237|39630904|FG000|Overall Study|Investigator's Discretion|0|||
16313432|NCT02291237|39630905|FG001|Overall Study|Investigator's Discretion|3|||
16313433|NCT02291237|39630904|FG000|Overall Study|Withdrew Consent|11|||
16313434|NCT02291237|39630905|FG001|Overall Study|Withdrew Consent|11|||
16197242|NCT01757405|39197469|FG001|Overall Study|Lost to Follow-up|1|||
16197243|NCT01757405|39197468|FG000|Overall Study|Withdrawal by Subject|0|||
16197244|NCT01757405|39197469|FG001|Overall Study|Withdrawal by Subject|1|||
16197245|NCT03004469|39197470|FG000|Overall Study|Adverse Event|6|||
16197246|NCT03004469|39197471|FG001|Overall Study|Adverse Event|4|||
16197247|NCT03004469|39197472|FG002|Overall Study|Adverse Event|6|||
16197248|NCT03004469|39197470|FG000|Overall Study|Lack of Efficacy|1|||
16197249|NCT03004469|39197471|FG001|Overall Study|Lack of Efficacy|0|||
16197250|NCT03004469|39197472|FG002|Overall Study|Lack of Efficacy|1|||
16197251|NCT03004469|39197470|FG000|Overall Study|Lost to Follow-up|23|||
16197252|NCT03004469|39197471|FG001|Overall Study|Lost to Follow-up|14|||
16197253|NCT03004469|39197472|FG002|Overall Study|Lost to Follow-up|6|||
16507579|NCT00666757|40333157|FG000|Overall Study|Adverse Event|22|||
16507580|NCT00666757|40333158|FG001|Overall Study|Adverse Event|12|||
16507581|NCT00666757|40333157|FG000|Overall Study|Withdrawal by Subject|13|||
16507582|NCT00666757|40333158|FG001|Overall Study|Withdrawal by Subject|17|||
16507583|NCT00666757|40333157|FG000|Overall Study|Lack of Efficacy|3|||
16507584|NCT00666757|40333158|FG001|Overall Study|Lack of Efficacy|6|||
16507585|NCT00666757|40333157|FG000|Overall Study|Physician Decision|0|||
16507586|NCT00666757|40333158|FG001|Overall Study|Physician Decision|2|||
16507587|NCT00666757|40333157|FG000|Overall Study|Sponsor decision|0|||
16507588|NCT00666757|40333158|FG001|Overall Study|Sponsor decision|1|||
16313435|NCT02291237|39630904|FG000|Overall Study|Lost to Follow-up|0|||
16313436|NCT02291237|39630905|FG001|Overall Study|Lost to Follow-up|2|||
16313437|NCT02291237|39630904|FG000|Overall Study|Subject Required Prohibited Medication|2|||
16313438|NCT02291237|39630905|FG001|Overall Study|Subject Required Prohibited Medication|0|||
16313439|NCT00529373|39630906|FG000|Base Study|Adverse Event|525|||
16313440|NCT00529373|39630907|FG001|Base Study|Adverse Event|470|||
16313441|NCT00529373|39630906|FG000|Base Study|Lack of Efficacy|16|||
16507589|NCT01224639|40333159|FG000|Overall Study|Withdrawal by Subject|0|||
16507590|NCT01224639|40333160|FG001|Overall Study|Withdrawal by Subject|0|||
16507591|NCT01224639|40333161|FG002|Overall Study|Withdrawal by Subject|0|||
16313442|NCT00529373|39630907|FG001|Base Study|Lack of Efficacy|75|||
16313443|NCT00529373|39630906|FG000|Base Study|Lost to Follow-up|221|||
16313444|NCT00529373|39630907|FG001|Base Study|Lost to Follow-up|208|||
16313445|NCT00529373|39630906|FG000|Base Study|Other Protocol Specified Criteria|19|||
16313446|NCT00529373|39630907|FG001|Base Study|Other Protocol Specified Criteria|20|||
16313447|NCT00529373|39630906|FG000|Base Study|Physician Decision|60|||
16313448|NCT00529373|39630907|FG001|Base Study|Physician Decision|52|||
16313449|NCT00529373|39630906|FG000|Base Study|Protocol Violation|48|||
16313450|NCT00529373|39630907|FG001|Base Study|Protocol Violation|38|||
16313451|NCT00529373|39630906|FG000|Base Study|Withdrawal by Subject|1062|||
16313452|NCT00529373|39630907|FG001|Base Study|Withdrawal by Subject|967|||
16313453|NCT00529373|39630906|FG000|Base Study|Did not continue into Extension|1795|||
16313454|NCT00529373|39630907|FG001|Base Study|Did not continue into Extension|2238|||
16313455|NCT00529373|39630906|FG000|First Extension Study|Adverse Event|162|||
16313456|NCT00529373|39630907|FG001|First Extension Study|Adverse Event|142|||
16313457|NCT00529373|39630906|FG000|First Extension Study|Lack of Efficacy|65|||
16313458|NCT00529373|39630907|FG001|First Extension Study|Lack of Efficacy|427|||
16313459|NCT00529373|39630906|FG000|First Extension Study|Lost to Follow-up|41|||
16313460|NCT00529373|39630907|FG001|First Extension Study|Lost to Follow-up|37|||
16313461|NCT00529373|39630906|FG000|First Extension Study|Other|27|||
16313462|NCT00529373|39630907|FG001|First Extension Study|Other|47|||
16313463|NCT00529373|39630906|FG000|First Extension Study|Physician Decision|50|||
16313464|NCT00529373|39630907|FG001|First Extension Study|Physician Decision|45|||
16507592|NCT01224639|40333162|FG003|Overall Study|Withdrawal by Subject|0|||
16197254|NCT03004469|39197470|FG000|Overall Study|Non-Compliance with Study Drug|2|||
16197255|NCT03004469|39197471|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16313465|NCT00529373|39630906|FG000|First Extension Study|Protocol Violation|16|||
16507593|NCT01224639|40333163|FG004|Overall Study|Withdrawal by Subject|2|||
16507594|NCT01224639|40333164|FG005|Overall Study|Withdrawal by Subject|0|||
16507595|NCT01224639|40333165|FG006|Overall Study|Withdrawal by Subject|1|||
16313466|NCT00529373|39630907|FG001|First Extension Study|Protocol Violation|13|||
16313467|NCT00529373|39630906|FG000|First Extension Study|Withdrawal by Subject|296|||
16313468|NCT00529373|39630907|FG001|First Extension Study|Withdrawal by Subject|287|||
16313469|NCT00529373|39630906|FG000|First Extension Study|Disposition record non-existing|0|||
16313470|NCT00529373|39630907|FG001|First Extension Study|Disposition record non-existing|1|||
16391369|NCT00803595|39916117|FG000|Overall Study|Protocol Violation|7|||
16507596|NCT01224639|40333166|FG007|Overall Study|Withdrawal by Subject|1|||
16507597|NCT01224639|40333159|FG000|Overall Study|Adverse Event|0|||
16507598|NCT01224639|40333160|FG001|Overall Study|Adverse Event|0|||
16507599|NCT01224639|40333161|FG002|Overall Study|Adverse Event|0|||
16507600|NCT01224639|40333162|FG003|Overall Study|Adverse Event|0|||
16507601|NCT01224639|40333163|FG004|Overall Study|Adverse Event|0|||
16507602|NCT01224639|40333164|FG005|Overall Study|Adverse Event|0|||
16507603|NCT01224639|40333165|FG006|Overall Study|Adverse Event|0|||
16507604|NCT01224639|40333166|FG007|Overall Study|Adverse Event|1|||
16507605|NCT00449644|40333170|FG000|Overall Study|Adverse Event|0|||
16507606|NCT00449644|40333171|FG001|Overall Study|Adverse Event|0|||
16507607|NCT00449644|40333172|FG002|Overall Study|Adverse Event|3|||
16507608|NCT00449644|40333173|FG003|Overall Study|Adverse Event|5|||
16507609|NCT00449644|40333170|FG000|Overall Study|Death|1|||
16507610|NCT00449644|40333171|FG001|Overall Study|Death|0|||
16507611|NCT00449644|40333172|FG002|Overall Study|Death|6|||
16507612|NCT00449644|40333173|FG003|Overall Study|Death|1|||
16507613|NCT00449644|40333170|FG000|Overall Study|Lost to Follow-up|1|||
16507614|NCT00449644|40333171|FG001|Overall Study|Lost to Follow-up|1|||
16507615|NCT00449644|40333172|FG002|Overall Study|Lost to Follow-up|5|||
16507616|NCT00449644|40333173|FG003|Overall Study|Lost to Follow-up|3|||
16507617|NCT00449644|40333170|FG000|Overall Study|Pregnancy|0|||
16507618|NCT00449644|40333171|FG001|Overall Study|Pregnancy|0|||
16507619|NCT00449644|40333172|FG002|Overall Study|Pregnancy|3|||
16507620|NCT00449644|40333173|FG003|Overall Study|Pregnancy|2|||
16507621|NCT00449644|40333170|FG000|Overall Study|Protocol Violation|4|||
16507622|NCT00449644|40333171|FG001|Overall Study|Protocol Violation|4|||
16507623|NCT00449644|40333172|FG002|Overall Study|Protocol Violation|3|||
16507624|NCT00449644|40333173|FG003|Overall Study|Protocol Violation|7|||
16507625|NCT00449644|40333170|FG000|Overall Study|Withdrawal by Subject|3|||
16507626|NCT00449644|40333171|FG001|Overall Study|Withdrawal by Subject|4|||
16507627|NCT00449644|40333172|FG002|Overall Study|Withdrawal by Subject|6|||
16507628|NCT00449644|40333173|FG003|Overall Study|Withdrawal by Subject|7|||
16507629|NCT00449644|40333170|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
16507630|NCT00449644|40333171|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
16197256|NCT03004469|39197472|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16197257|NCT03004469|39197470|FG000|Overall Study|Protocol Violation|0|||
16197258|NCT03004469|39197471|FG001|Overall Study|Protocol Violation|0|||
16313471|NCT00529373|39630906|FG000|First Extension Study|Discontinued after 5 years completion|208|||
16507631|NCT00449644|40333172|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
16507632|NCT00449644|40333173|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
16507633|NCT00449644|40333170|FG000|Overall Study|Other|1|||
16507634|NCT00449644|40333171|FG001|Overall Study|Other|4|||
16507635|NCT00449644|40333172|FG002|Overall Study|Other|1|||
16507636|NCT00449644|40333173|FG003|Overall Study|Other|0|||
16507637|NCT00449644|40333170|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
16507638|NCT00449644|40333171|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
16507639|NCT00449644|40333172|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
16507640|NCT00449644|40333173|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
16507641|NCT01478321|40333185|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
16197259|NCT03004469|39197472|FG002|Overall Study|Protocol Violation|1|||
16313472|NCT00529373|39630907|FG001|First Extension Study|Discontinued after 5 years completion|346|||
16313473|NCT00529373|39630906|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
16313474|NCT00529373|39630907|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
16313475|NCT00529373|39630906|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
16313476|NCT00529373|39630907|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
16313477|NCT00529373|39630906|FG000|Second Extension Study|Adverse Event|101|||
16313478|NCT00529373|39630907|FG001|Second Extension Study|Adverse Event|51|||
16313479|NCT00529373|39630906|FG000|Second Extension Study|Lack of Efficacy|7|||
16313480|NCT00529373|39630907|FG001|Second Extension Study|Lack of Efficacy|15|||
16313481|NCT00529373|39630906|FG000|Second Extension Study|Lost to Follow-up|18|||
16313482|NCT00529373|39630907|FG001|Second Extension Study|Lost to Follow-up|12|||
16313483|NCT00529373|39630906|FG000|Second Extension Study|Other|7|||
16313484|NCT00529373|39630907|FG001|Second Extension Study|Other|12|||
16313485|NCT00529373|39630906|FG000|Second Extension Study|Physician Decision|63|||
16313486|NCT00529373|39630907|FG001|Second Extension Study|Physician Decision|26|||
16313487|NCT00529373|39630906|FG000|Second Extension Study|Protocol Violation|2|||
16313488|NCT00529373|39630907|FG001|Second Extension Study|Protocol Violation|1|||
16507642|NCT01478321|40333185|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
16507643|NCT01478321|40333185|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
16507644|NCT01478321|40333185|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
16507645|NCT01478321|40333185|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
16507646|NCT01478321|40333185|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
16507647|NCT01478321|40333185|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
16313489|NCT00529373|39630906|FG000|Second Extension Study|Withdrawal by Subject|97|||
16313490|NCT00529373|39630907|FG001|Second Extension Study|Withdrawal by Subject|75|||
16313491|NCT00529373|39630906|FG000|Second Extension Study|Status Missing|5|||
16313492|NCT00529373|39630907|FG001|Second Extension Study|Status Missing|5|||
16313493|NCT02392481|39630908|FG000|Overall Study|Adverse Event|0|||
16313494|NCT02392481|39630909|FG001|Overall Study|Adverse Event|0|||
16313495|NCT02392481|39630910|FG002|Overall Study|Adverse Event|1|||
16313496|NCT02392481|39630911|FG003|Overall Study|Adverse Event|2|||
16313497|NCT02392481|39630908|FG000|Overall Study|Withdrawal by Subject|0|||
16313498|NCT02392481|39630909|FG001|Overall Study|Withdrawal by Subject|0|||
16313499|NCT02392481|39630910|FG002|Overall Study|Withdrawal by Subject|1|||
16313500|NCT02392481|39630911|FG003|Overall Study|Withdrawal by Subject|0|||
16313501|NCT04030299|39630912|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
16313502|NCT04030299|39630912|FG000|Overall Study|Withdrawal by Subject|3|||
16313503|NCT01960413|39630915|FG000|Overall Study|Withdrawal by Subject|1|||
16313504|NCT01960413|39630916|FG001|Overall Study|Withdrawal by Subject|1|||
16313505|NCT01960413|39630915|FG000|Overall Study|Physician Decision|1|||
16313506|NCT01960413|39630916|FG001|Overall Study|Physician Decision|0|||
16313507|NCT01960413|39630915|FG000|Overall Study|Lost to Follow-up|2|||
16313508|NCT01960413|39630916|FG001|Overall Study|Lost to Follow-up|0|||
16313509|NCT02969382|39630917|FG000|Overall Study|Adverse Event|8|||
16313510|NCT02969382|39630918|FG001|Overall Study|Adverse Event|10|||
16313511|NCT02969382|39630917|FG000|Overall Study|Lack of Efficacy|4|||
16313512|NCT02969382|39630918|FG001|Overall Study|Lack of Efficacy|5|||
16313513|NCT02969382|39630917|FG000|Overall Study|Death|0|||
16313514|NCT02969382|39630918|FG001|Overall Study|Death|1|||
16313515|NCT02969382|39630917|FG000|Overall Study|PROTOCOL DEVIATION|0|||
16313516|NCT02969382|39630918|FG001|Overall Study|PROTOCOL DEVIATION|1|||
16313517|NCT02969382|39630917|FG000|Overall Study|Withdrawal by Subject|14|||
16313518|NCT02969382|39630918|FG001|Overall Study|Withdrawal by Subject|9|||
16313519|NCT00712712|39630919|FG000|Overall Study|Protocol Violation|11|||
16313520|NCT00712712|39630919|FG000|Overall Study|Radiofrequency not done|3|||
16313521|NCT00712712|39630919|FG000|Overall Study|Death|8|||
16313522|NCT00712712|39630919|FG000|Overall Study|Withdrawal by Subject|1|||
16313523|NCT00666328|39630921|FG000|Overall Study|Death|2|||
16313524|NCT00666328|39630921|FG000|Overall Study|Lost to Follow-up|2|||
16313525|NCT00666328|39630921|FG000|Overall Study|No longer met eligibility criteria|1|||
16313526|NCT04421131|39630933|FG000|Overall Study|Lost to Follow-up|1|||
16313527|NCT04421131|39630933|FG000|Overall Study|Protocol Violation|2|||
16313528|NCT04421131|39630933|FG000|Overall Study|App crashed|5|||
16313529|NCT04846569|39630935|FG000|Overall Study|Withdrawal by Subject|3|||
16313530|NCT04846569|39630936|FG001|Overall Study|Withdrawal by Subject|1|||
16313531|NCT00733005|39630937|FG000|Overall Study|Adverse Event|0|||
16313532|NCT00733005|39630938|FG001|Overall Study|Adverse Event|1|||
16313533|NCT00733005|39630937|FG000|Overall Study|Treatment Failure|0|||
16313534|NCT00733005|39630938|FG001|Overall Study|Treatment Failure|1|||
16313535|NCT00733005|39630937|FG000|Overall Study|Withdrawal by Subject|0|||
16313536|NCT00733005|39630938|FG001|Overall Study|Withdrawal by Subject|1|||
16313537|NCT00733005|39630937|FG000|Overall Study|Protocol Violation|2|||
16313538|NCT00733005|39630938|FG001|Overall Study|Protocol Violation|0|||
16313539|NCT02513160|39630939|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
16313540|NCT02513160|39630940|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
16391370|NCT00803595|39916118|FG001|Overall Study|Protocol Violation|2|||
16391371|NCT00803595|39916119|FG002|Overall Study|Protocol Violation|12|||
16391372|NCT00803595|39916117|FG000|Overall Study|Withdrawal by Subject|5|||
16391373|NCT00803595|39916118|FG001|Overall Study|Withdrawal by Subject|2|||
16391374|NCT00803595|39916119|FG002|Overall Study|Withdrawal by Subject|3|||
16391375|NCT01456130|39916120|FG000|Overall Study|Adverse Event|4|||
16391376|NCT01456130|39916120|FG000|Overall Study|Voluntary Withdrawal|1|||
16391377|NCT01456130|39916120|FG000|Overall Study|Lack of Efficacy|4|||
16391378|NCT01456130|39916120|FG000|Overall Study|Other|1|||
16391379|NCT00700622|39916121|FG000|Overall Study|Adverse Event|4|||
16391380|NCT00700622|39916122|FG001|Overall Study|Adverse Event|0|||
16507648|NCT01478321|40333185|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
16313541|NCT02513160|39630941|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
16391381|NCT00700622|39916121|FG000|Overall Study|Lost to Follow-up|0|||
16391382|NCT00700622|39916122|FG001|Overall Study|Lost to Follow-up|1|||
16391383|NCT00700622|39916121|FG000|Overall Study|Physician Decision|2|||
16391384|NCT00700622|39916122|FG001|Overall Study|Physician Decision|1|||
16391385|NCT00700622|39916121|FG000|Overall Study|Protocol Violation|0|||
16313542|NCT02513160|39630942|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
16313543|NCT02513160|39630939|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
16313544|NCT02513160|39630940|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
16313545|NCT02513160|39630941|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
16313546|NCT02513160|39630942|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
16313547|NCT02513160|39630939|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
16391386|NCT00700622|39916122|FG001|Overall Study|Protocol Violation|1|||
16391387|NCT00700622|39916121|FG000|Overall Study|Withdrawal by Subject|4|||
16313548|NCT02513160|39630940|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
16313549|NCT02513160|39630941|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
16313550|NCT02513160|39630942|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
16313551|NCT02513160|39630939|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
16313552|NCT02513160|39630940|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
16313553|NCT02513160|39630941|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
16313554|NCT02513160|39630942|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
16313555|NCT02513160|39630939|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
16313556|NCT02513160|39630940|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
16313557|NCT02513160|39630941|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
16313558|NCT02513160|39630942|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
16313559|NCT02513160|39630939|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
16313560|NCT02513160|39630940|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
16507649|NCT01526889|40333188|FG000|Treatment Period|Adverse Event|2|||
16507650|NCT01526889|40333189|FG001|Treatment Period|Adverse Event|0|||
16507651|NCT01526889|40333188|FG000|Treatment Extension Period|Administrative problems|1|||
16507652|NCT01526889|40333189|FG001|Treatment Extension Period|Administrative problems|0|||
16507653|NCT01063595|40333190|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
16507654|NCT01063595|40333191|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
16507655|NCT01063595|40333190|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
16507656|NCT01063595|40333191|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
16507657|NCT01063595|40333190|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
16507658|NCT01063595|40333191|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
16507659|NCT01063595|40333190|FG000|First Intervention|Adverse Event|1|||
16507660|NCT01063595|40333191|FG001|First Intervention|Adverse Event|4|||
16507661|NCT01063595|40333190|FG000|First Intervention|Withdrawal by Subject|1|||
16507662|NCT01063595|40333191|FG001|First Intervention|Withdrawal by Subject|0|||
16507663|NCT01063595|40333190|FG000|First Intervention|Reason not Specified|0|||
16391388|NCT00700622|39916122|FG001|Overall Study|Withdrawal by Subject|1|||
16391389|NCT00700622|39916121|FG000|Overall Study|Other|3|||
16391390|NCT00700622|39916122|FG001|Overall Study|Other|1|||
16391391|NCT04339413|39916123|FG000|Overall Study|Reason Not Specified|2|||
16313561|NCT02513160|39630941|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
16391392|NCT04339413|39916124|FG001|Overall Study|Reason Not Specified|7|||
16507664|NCT01063595|40333191|FG001|First Intervention|Reason not Specified|1|||
16507665|NCT02449239|40333195|FG000|Induction Phase|Lack of Efficacy|64|||
16507666|NCT02449239|40333195|FG000|Induction Phase|Adverse Event|1|||
16507667|NCT02449239|40333195|FG000|Induction Phase|Lost to Follow-up|1|||
16313562|NCT02513160|39630942|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
16507668|NCT02449239|40333195|FG000|Induction Phase|Protocol Violation|1|||
16507669|NCT02449239|40333195|FG000|Induction Phase|Physician Decision|1|||
16507670|NCT02449239|40333195|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
16507671|NCT02449239|40333195|FG000|Induction Phase|Withdrawal by Subject|1|||
16507672|NCT02449239|40333195|FG000|Maintenance Month 3|Lack of Efficacy|14|||
16507673|NCT02449239|40333195|FG000|Maintenance Month 6|Lack of Efficacy|10|||
16507674|NCT02449239|40333195|FG000|Maintenance Month 6|Adverse Event|2|||
16507675|NCT02449239|40333195|FG000|Maintenance Month 6|Physician Decision|1|||
16507676|NCT02449239|40333195|FG000|Maintenance Month 9|Lack of Efficacy|2|||
16507677|NCT02449239|40333195|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
16507678|NCT02449239|40333195|FG000|Maintenance Month 12|Lack of Efficacy|5|||
16507679|NCT02449239|40333195|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
16507680|NCT02449239|40333195|FG000|Maintenance Month 12|Subject moved from area|1|||
16507681|NCT02449239|40333195|FG000|Maintenance Month 15|Lack of Efficacy|1|||
16507682|NCT02449239|40333195|FG000|Maintenance Month 21|Lack of Efficacy|1|||
16507683|NCT02449239|40333195|FG000|Maintenance Month 21|Sponsor decision|1|||
16507684|NCT02159521|40333196|FG000|Overall Study|Enrolled but not treated|3|||
16507685|NCT02159521|40333196|FG000|Overall Study|Withdrawal by Subject|7|||
16313563|NCT02513160|39630939|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
16391393|NCT04339413|39916123|FG000|Overall Study|Study Terminated by Sponsor|30|||
16391394|NCT04339413|39916124|FG001|Overall Study|Study Terminated by Sponsor|33|||
16391395|NCT04339413|39916123|FG000|Overall Study|Progressive Disease|9|||
16313564|NCT02513160|39630940|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
16313565|NCT02513160|39630941|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
16313566|NCT02513160|39630942|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
16313567|NCT02513160|39630939|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
16313568|NCT02513160|39630940|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
16313569|NCT02513160|39630941|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
16313570|NCT02513160|39630942|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
16313571|NCT02513160|39630939|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
16313572|NCT02513160|39630940|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
16313573|NCT02513160|39630941|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
16313574|NCT02513160|39630942|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
16313575|NCT02513160|39630939|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
16313576|NCT02513160|39630940|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
16313577|NCT02513160|39630941|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
16313578|NCT02513160|39630942|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
16313579|NCT02513160|39630939|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
16313580|NCT02513160|39630940|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
16313581|NCT02513160|39630941|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
16313582|NCT02513160|39630942|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
16313583|NCT02513160|39630939|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
16313584|NCT02513160|39630940|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
16507686|NCT02159521|40333196|FG000|Overall Study|Lost to Follow-up|6|||
16507687|NCT02159521|40333196|FG000|Overall Study|Death|1|||
16507688|NCT02159521|40333196|FG000|Overall Study|Other than specified|1|||
16507689|NCT03465878|40333198|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
16507690|NCT03465878|40333199|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
16507691|NCT03465878|40333200|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
16391396|NCT04339413|39916124|FG001|Overall Study|Progressive Disease|6|||
16391397|NCT04339413|39916123|FG000|Overall Study|Withdrawal by Subject|9|||
16391398|NCT04339413|39916124|FG001|Overall Study|Withdrawal by Subject|10|||
16391399|NCT04339413|39916123|FG000|Overall Study|Physician Decision|3|||
16391400|NCT04339413|39916124|FG001|Overall Study|Physician Decision|1|||
16391401|NCT04339413|39916123|FG000|Overall Study|Death|2|||
16313585|NCT02513160|39630941|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
16313586|NCT02513160|39630942|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
16313587|NCT01922037|39630944|FG000|Overall Study|Withdrawal by Subject|2|||
16313588|NCT01922037|39630945|FG001|Overall Study|Withdrawal by Subject|44|||
16313589|NCT01922037|39630944|FG000|Overall Study|Adverse Event|1|||
16313590|NCT01922037|39630945|FG001|Overall Study|Adverse Event|7|||
16313591|NCT01922037|39630944|FG000|Overall Study|Death|0|||
16313592|NCT01922037|39630945|FG001|Overall Study|Death|5|||
16313593|NCT01922037|39630944|FG000|Overall Study|Pregnancy|0|||
16313594|NCT01922037|39630945|FG001|Overall Study|Pregnancy|2|||
16507692|NCT03465878|40333201|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
16507693|NCT03465878|40333198|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
16313595|NCT01922037|39630944|FG000|Overall Study|Participant non-compliance|4|||
16313596|NCT01922037|39630945|FG001|Overall Study|Participant non-compliance|46|||
16313597|NCT01922037|39630944|FG000|Overall Study|Investigator/Sponsor decision|1|||
16313598|NCT01922037|39630945|FG001|Overall Study|Investigator/Sponsor decision|4|||
16313599|NCT01922037|39630944|FG000|Overall Study|Other unspecified|2|||
16313600|NCT01922037|39630945|FG001|Overall Study|Other unspecified|66|||
16313601|NCT00315458|39630946|FG000|Overall Study|Administrative|0|||
16313602|NCT00315458|39630947|FG001|Overall Study|Administrative|3|||
16313603|NCT00315458|39630948|FG002|Overall Study|Administrative|8|||
16313604|NCT00315458|39630949|FG003|Overall Study|Administrative|21|||
16313605|NCT00315458|39630946|FG000|Overall Study|Adverse Event|2|||
16313606|NCT00315458|39630947|FG001|Overall Study|Adverse Event|4|||
16313607|NCT00315458|39630948|FG002|Overall Study|Adverse Event|23|||
16313608|NCT00315458|39630949|FG003|Overall Study|Adverse Event|3|||
16313609|NCT00315458|39630946|FG000|Overall Study|Lost to Follow-up|1|||
16313610|NCT00315458|39630947|FG001|Overall Study|Lost to Follow-up|2|||
16313611|NCT00315458|39630948|FG002|Overall Study|Lost to Follow-up|0|||
16313612|NCT00315458|39630949|FG003|Overall Study|Lost to Follow-up|2|||
16313613|NCT00315458|39630946|FG000|Overall Study|Withdrawal by Subject|0|||
16313614|NCT00315458|39630947|FG001|Overall Study|Withdrawal by Subject|3|||
16313615|NCT00315458|39630948|FG002|Overall Study|Withdrawal by Subject|0|||
16391402|NCT04339413|39916124|FG001|Overall Study|Death|0|||
16391403|NCT04339413|39916123|FG000|Overall Study|Adverse Event|3|||
16507694|NCT03465878|40333199|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
16313616|NCT00315458|39630949|FG003|Overall Study|Withdrawal by Subject|2|||
16313617|NCT00315458|39630946|FG000|Overall Study|Lack of Efficacy|0|||
16313618|NCT00315458|39630947|FG001|Overall Study|Lack of Efficacy|0|||
16313619|NCT00315458|39630948|FG002|Overall Study|Lack of Efficacy|20|||
16313620|NCT00315458|39630949|FG003|Overall Study|Lack of Efficacy|1|||
16313621|NCT00315458|39630946|FG000|Overall Study|Did not qualify|0|||
16313622|NCT00315458|39630947|FG001|Overall Study|Did not qualify|0|||
16313623|NCT00315458|39630948|FG002|Overall Study|Did not qualify|1|||
16313624|NCT00315458|39630949|FG003|Overall Study|Did not qualify|0|||
16313625|NCT04231825|39633789|FG000|Overall Study|Protocol Violation|3|||
16313626|NCT04231825|39633790|FG001|Overall Study|Protocol Violation|3|||
16313627|NCT04231825|39633789|FG000|Overall Study|Lost to Follow-up|0|||
16313628|NCT04231825|39633790|FG001|Overall Study|Lost to Follow-up|1|||
16313629|NCT01290068|39633796|FG000|Overall Study|Adverse Event|1|||
16313630|NCT01290068|39633797|FG001|Overall Study|Adverse Event|3|||
16313631|NCT01290068|39633796|FG000|Overall Study|Lost to Follow-up|3|||
16313632|NCT01290068|39633797|FG001|Overall Study|Lost to Follow-up|0|||
16313633|NCT01290068|39633796|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
16313634|NCT01290068|39633797|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
16313635|NCT01290068|39633796|FG000|Overall Study|Other|3|||
16313636|NCT01290068|39633797|FG001|Overall Study|Other|1|||
16313637|NCT00739882|39633802|FG000|Double-blind Period|Adverse Event|1|||
16313638|NCT00739882|39633803|FG001|Double-blind Period|Adverse Event|2|||
16313639|NCT00739882|39633802|FG000|Double-blind Period|Protocol Violation|1|||
16313640|NCT00739882|39633803|FG001|Double-blind Period|Protocol Violation|0|||
16313641|NCT00739882|39633802|FG000|Double-blind Period|Lack of Efficacy|1|||
16313642|NCT00739882|39633803|FG001|Double-blind Period|Lack of Efficacy|1|||
16313643|NCT00739882|39633802|FG000|Double-blind Period|Other|16|||
16391404|NCT04339413|39916124|FG001|Overall Study|Adverse Event|0|||
16391405|NCT03364231|39916125|FG000|Overall Study|Adverse Event|1|||
16391406|NCT03364231|39916126|FG001|Overall Study|Adverse Event|4|||
16391407|NCT03364231|39916125|FG000|Overall Study|Death|1|||
16391408|NCT03364231|39916126|FG001|Overall Study|Death|0|||
16391409|NCT03364231|39916125|FG000|Overall Study|Investigator Decision|2|||
16391410|NCT03364231|39916126|FG001|Overall Study|Investigator Decision|2|||
16391411|NCT03364231|39916125|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
16507695|NCT03465878|40333200|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
16507696|NCT03465878|40333201|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
16197260|NCT03004469|39197470|FG000|Overall Study|Withdrawal by Subject|29|||
16197261|NCT03004469|39197471|FG001|Overall Study|Withdrawal by Subject|27|||
16507697|NCT03465878|40333198|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
16507698|NCT03465878|40333199|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
16507699|NCT03465878|40333200|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
16507700|NCT03465878|40333201|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
16507701|NCT01104636|40333202|FG000|Overall Study|Lack of Efficacy|43|||
16507702|NCT01104636|40333202|FG000|Overall Study|Lost to Follow-up|24|||
16507703|NCT01104636|40333202|FG000|Overall Study|Withdrawal by Subject|4|||
16507704|NCT01104636|40333202|FG000|Overall Study|Other|43|||
16507705|NCT01104636|40333202|FG000|Overall Study|Study terminated by sponsor|1|||
16507706|NCT01104636|40333202|FG000|Overall Study|Pregnancy|2|||
16507707|NCT01104636|40333202|FG000|Overall Study|Adverse Event|40|||
16507708|NCT01104636|40333202|FG000|Overall Study|Ongoing|21|||
16507709|NCT04649164|40333206|FG000|Overall Study|Withdrawal by Subject|1|||
16507710|NCT04649164|40333207|FG001|Overall Study|Withdrawal by Subject|1|||
16507711|NCT04649164|40333208|FG002|Overall Study|Withdrawal by Subject|2|||
16507712|NCT04649164|40333206|FG000|Overall Study|Participant's care recipient expired|0|||
16507713|NCT04649164|40333207|FG001|Overall Study|Participant's care recipient expired|0|||
16507714|NCT04649164|40333208|FG002|Overall Study|Participant's care recipient expired|2|||
16507715|NCT04151290|40333209|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
16507716|NCT02734810|40333210|FG000|Overall Study|Adverse Event|1|||
16507717|NCT02734810|40333211|FG001|Overall Study|Adverse Event|0|||
16507718|NCT02734810|40333210|FG000|Overall Study|Lack of Efficacy|1|||
16507719|NCT02734810|40333211|FG001|Overall Study|Lack of Efficacy|0|||
16507720|NCT01675882|40333212|FG000|Overall Study|Adverse Event|0|||
16507721|NCT01675882|40333213|FG001|Overall Study|Adverse Event|2|||
16507722|NCT01675882|40333214|FG002|Overall Study|Adverse Event|1|||
16507723|NCT01675882|40333215|FG003|Overall Study|Adverse Event|0|||
16507724|NCT01675882|40333212|FG000|Overall Study|Participant unwilling to continue|2|||
16507725|NCT01675882|40333213|FG001|Overall Study|Participant unwilling to continue|4|||
16313644|NCT00739882|39633803|FG001|Double-blind Period|Other|8|||
16313645|NCT00739882|39633802|FG000|Open-label Period|Adverse Event|1|||
16313646|NCT00739882|39633803|FG001|Open-label Period|Adverse Event|0|||
16313647|NCT00739882|39633802|FG000|Open-label Period|Other|9|||
16313648|NCT00739882|39633803|FG001|Open-label Period|Other|5|||
16313649|NCT02550561|39633804|FG000|Overall Study|Lost to Follow-up|5|||
16313650|NCT02550561|39633804|FG000|Overall Study|Withdrawal by Subject|1|||
16507726|NCT01675882|40333214|FG002|Overall Study|Participant unwilling to continue|2|||
16507727|NCT01675882|40333215|FG003|Overall Study|Participant unwilling to continue|1|||
16507728|NCT01675882|40333212|FG000|Overall Study|Lost to Follow-up|0|||
16507729|NCT01675882|40333213|FG001|Overall Study|Lost to Follow-up|1|||
16313651|NCT03640312|39633808|FG000|Overall Study|Lost to Follow-up|3|||
16313652|NCT03640312|39633809|FG001|Overall Study|Lost to Follow-up|6|||
16313653|NCT01532934|39633812|FG000|Overall Study|Lost to Follow-up|11|||
16313654|NCT01532934|39633813|FG001|Overall Study|Lost to Follow-up|11|||
16313655|NCT01532934|39633812|FG000|Overall Study|In controlled environment|3|||
16507730|NCT01675882|40333214|FG002|Overall Study|Lost to Follow-up|0|||
16313656|NCT01532934|39633813|FG001|Overall Study|In controlled environment|2|||
16313657|NCT02091089|39633819|FG000|Overall Study|Lost to Follow-up|2|||
16313658|NCT01568892|39633822|FG000|Open-label Phase|Adverse Event|2|||
16313659|NCT01568892|39633823|FG001|Open-label Phase|Adverse Event|0|||
16313660|NCT01568892|39633822|FG000|Open-label Phase|Lack of Efficacy|4|||
16313661|NCT01568892|39633823|FG001|Open-label Phase|Lack of Efficacy|2|||
16313662|NCT01568892|39633822|FG000|Open-label Phase|Lost to Follow-up|0|||
16313663|NCT01568892|39633823|FG001|Open-label Phase|Lost to Follow-up|1|||
16313664|NCT02259010|39633825|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
16313665|NCT00982657|39633826|FG000|Overall Study|Death|1|||
16313666|NCT00982657|39633827|FG001|Overall Study|Death|0|||
16313667|NCT00982657|39633828|FG002|Overall Study|Death|1|||
16313668|NCT00982657|39633829|FG003|Overall Study|Death|1|||
16313669|NCT00982657|39633826|FG000|Overall Study|Withdrawal by Subject|0|||
16313670|NCT00982657|39633827|FG001|Overall Study|Withdrawal by Subject|0|||
16507731|NCT01675882|40333215|FG003|Overall Study|Lost to Follow-up|0|||
16507732|NCT01675882|40333212|FG000|Overall Study|Non-compliance|0|||
16507733|NCT01675882|40333213|FG001|Overall Study|Non-compliance|0|||
16507734|NCT01675882|40333214|FG002|Overall Study|Non-compliance|0|||
16507735|NCT01675882|40333215|FG003|Overall Study|Non-compliance|1|||
16507736|NCT03917654|40333217|FG000|Year 1|Withdrawal by Subject|1|||
16507737|NCT03917654|40333218|FG001|Year 1|Withdrawal by Subject|0|||
16507738|NCT03917654|40333219|FG002|Year 1|Withdrawal by Subject|0|||
16507739|NCT03917654|40333220|FG003|Year 1|Withdrawal by Subject|0|||
16507740|NCT03917654|40333221|FG004|Year 1|Withdrawal by Subject|0|||
16507741|NCT03917654|40333222|FG005|Year 1|Withdrawal by Subject|1|||
16507742|NCT03917654|40333223|FG006|Year 1|Withdrawal by Subject|6|||
16507743|NCT03917654|40333224|FG007|Year 1|Withdrawal by Subject|2|||
16507744|NCT03917654|40333225|FG008|Year 1|Withdrawal by Subject|5|||
16507745|NCT03917654|40333226|FG009|Year 1|Withdrawal by Subject|3|||
16507746|NCT03917654|40333227|FG010|Year 1|Withdrawal by Subject|1|||
16507747|NCT03917654|40333228|FG011|Year 1|Withdrawal by Subject|0|||
16507748|NCT03917654|40333217|FG000|Year 1|Travel|0|||
16313671|NCT00982657|39633828|FG002|Overall Study|Withdrawal by Subject|1|||
16313672|NCT00982657|39633829|FG003|Overall Study|Withdrawal by Subject|3|||
16313673|NCT00982657|39633826|FG000|Overall Study|Other|0|||
16313674|NCT00982657|39633827|FG001|Overall Study|Other|0|||
16313675|NCT00982657|39633828|FG002|Overall Study|Other|0|||
16507749|NCT03917654|40333218|FG001|Year 1|Travel|1|||
16313676|NCT00982657|39633829|FG003|Overall Study|Other|4|||
16313677|NCT00982657|39633826|FG000|Overall Study|On going at date of cut-off|0|||
16313678|NCT00982657|39633827|FG001|Overall Study|On going at date of cut-off|0|||
16507750|NCT03917654|40333219|FG002|Year 1|Travel|1|||
16507751|NCT03917654|40333220|FG003|Year 1|Travel|0|||
16507752|NCT03917654|40333221|FG004|Year 1|Travel|4|||
16507753|NCT03917654|40333222|FG005|Year 1|Travel|4|||
16507754|NCT03917654|40333223|FG006|Year 1|Travel|10|||
16507755|NCT03917654|40333224|FG007|Year 1|Travel|8|||
16507756|NCT03917654|40333225|FG008|Year 1|Travel|2|||
16507757|NCT03917654|40333226|FG009|Year 1|Travel|5|||
16507758|NCT03917654|40333227|FG010|Year 1|Travel|3|||
16507759|NCT03917654|40333228|FG011|Year 1|Travel|3|||
16507760|NCT03917654|40333217|FG000|Year 1|Subject moved away from site|0|||
16507761|NCT03917654|40333218|FG001|Year 1|Subject moved away from site|1|||
16507762|NCT03917654|40333219|FG002|Year 1|Subject moved away from site|0|||
16507763|NCT03917654|40333220|FG003|Year 1|Subject moved away from site|0|||
16507764|NCT03917654|40333221|FG004|Year 1|Subject moved away from site|0|||
16507765|NCT03917654|40333222|FG005|Year 1|Subject moved away from site|0|||
16507766|NCT03917654|40333223|FG006|Year 1|Subject moved away from site|1|||
16507767|NCT03917654|40333224|FG007|Year 1|Subject moved away from site|2|||
16507768|NCT03917654|40333225|FG008|Year 1|Subject moved away from site|1|||
16507769|NCT03917654|40333226|FG009|Year 1|Subject moved away from site|0|||
16507770|NCT03917654|40333227|FG010|Year 1|Subject moved away from site|0|||
16507771|NCT03917654|40333228|FG011|Year 1|Subject moved away from site|3|||
16507772|NCT03917654|40333217|FG000|Year 1|Spouse/Family member request|0|||
16507773|NCT03917654|40333218|FG001|Year 1|Spouse/Family member request|0|||
16507774|NCT03917654|40333219|FG002|Year 1|Spouse/Family member request|1|||
16507775|NCT03917654|40333220|FG003|Year 1|Spouse/Family member request|0|||
16507776|NCT03917654|40333221|FG004|Year 1|Spouse/Family member request|1|||
16507777|NCT03917654|40333222|FG005|Year 1|Spouse/Family member request|0|||
16507778|NCT03917654|40333223|FG006|Year 1|Spouse/Family member request|0|||
16507779|NCT03917654|40333224|FG007|Year 1|Spouse/Family member request|2|||
16507780|NCT03917654|40333225|FG008|Year 1|Spouse/Family member request|0|||
16507781|NCT03917654|40333226|FG009|Year 1|Spouse/Family member request|0|||
16507782|NCT03917654|40333227|FG010|Year 1|Spouse/Family member request|0|||
16507783|NCT03917654|40333228|FG011|Year 1|Spouse/Family member request|1|||
16507784|NCT03917654|40333217|FG000|Year 1|Death|0|||
16507785|NCT03917654|40333218|FG001|Year 1|Death|0|||
16507786|NCT03917654|40333219|FG002|Year 1|Death|0|||
16507787|NCT03917654|40333220|FG003|Year 1|Death|0|||
16507788|NCT03917654|40333221|FG004|Year 1|Death|0|||
16507789|NCT03917654|40333222|FG005|Year 1|Death|0|||
16507790|NCT03917654|40333223|FG006|Year 1|Death|0|||
16507791|NCT03917654|40333224|FG007|Year 1|Death|0|||
16507792|NCT03917654|40333225|FG008|Year 1|Death|1|||
16507793|NCT03917654|40333226|FG009|Year 1|Death|1|||
16507794|NCT03917654|40333227|FG010|Year 1|Death|0|||
16507795|NCT03917654|40333228|FG011|Year 1|Death|0|||
16507796|NCT03917654|40333217|FG000|Year 1|Lost to Follow-up|0|||
16507797|NCT03917654|40333218|FG001|Year 1|Lost to Follow-up|0|||
16507798|NCT03917654|40333219|FG002|Year 1|Lost to Follow-up|0|||
16507799|NCT03917654|40333220|FG003|Year 1|Lost to Follow-up|0|||
16507800|NCT03917654|40333221|FG004|Year 1|Lost to Follow-up|0|||
16507801|NCT03917654|40333222|FG005|Year 1|Lost to Follow-up|0|||
16507802|NCT03917654|40333223|FG006|Year 1|Lost to Follow-up|2|||
16507803|NCT03917654|40333224|FG007|Year 1|Lost to Follow-up|0|||
16507804|NCT03917654|40333225|FG008|Year 1|Lost to Follow-up|0|||
16507805|NCT03917654|40333226|FG009|Year 1|Lost to Follow-up|0|||
16507806|NCT03917654|40333227|FG010|Year 1|Lost to Follow-up|0|||
16507807|NCT03917654|40333228|FG011|Year 1|Lost to Follow-up|0|||
16507808|NCT03917654|40333217|FG000|Year 1|Missed visits|0|||
16507809|NCT03917654|40333218|FG001|Year 1|Missed visits|0|||
16507810|NCT03917654|40333219|FG002|Year 1|Missed visits|0|||
16507811|NCT03917654|40333220|FG003|Year 1|Missed visits|0|||
16507812|NCT03917654|40333221|FG004|Year 1|Missed visits|0|||
16507813|NCT03917654|40333222|FG005|Year 1|Missed visits|0|||
16507814|NCT03917654|40333223|FG006|Year 1|Missed visits|0|||
16507815|NCT03917654|40333224|FG007|Year 1|Missed visits|0|||
16507816|NCT03917654|40333225|FG008|Year 1|Missed visits|0|||
16507817|NCT03917654|40333226|FG009|Year 1|Missed visits|0|||
16507818|NCT03917654|40333227|FG010|Year 1|Missed visits|1|||
16507819|NCT03917654|40333228|FG011|Year 1|Missed visits|1|||
16507820|NCT03917654|40333217|FG000|Year 1|Pregnancy|0|||
16507821|NCT03917654|40333218|FG001|Year 1|Pregnancy|0|||
16507822|NCT03917654|40333219|FG002|Year 1|Pregnancy|0|||
16507823|NCT03917654|40333220|FG003|Year 1|Pregnancy|0|||
16507824|NCT03917654|40333221|FG004|Year 1|Pregnancy|0|||
16507825|NCT03917654|40333222|FG005|Year 1|Pregnancy|0|||
16507826|NCT03917654|40333223|FG006|Year 1|Pregnancy|0|||
16391412|NCT03364231|39916126|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
16507827|NCT03917654|40333224|FG007|Year 1|Pregnancy|1|||
16507828|NCT03917654|40333225|FG008|Year 1|Pregnancy|0|||
16507829|NCT03917654|40333226|FG009|Year 1|Pregnancy|1|||
16507830|NCT03917654|40333227|FG010|Year 1|Pregnancy|0|||
16507831|NCT03917654|40333228|FG011|Year 1|Pregnancy|0|||
16507832|NCT03917654|40333217|FG000|Year 2|Travel|1|||
16391413|NCT03364231|39916125|FG000|Overall Study|Withdrawal of Subject Consent|1|||
16391414|NCT03364231|39916126|FG001|Overall Study|Withdrawal of Subject Consent|0|||
16391415|NCT03364231|39916125|FG000|Overall Study|Reason Not Specified|1|||
16391416|NCT03364231|39916126|FG001|Overall Study|Reason Not Specified|0|||
16391417|NCT03364231|39916125|FG000|Overall Study|Disease Progression|0|||
16391418|NCT03364231|39916126|FG001|Overall Study|Disease Progression|6|||
16197262|NCT03004469|39197472|FG002|Overall Study|Withdrawal by Subject|10|||
16197263|NCT03004469|39197470|FG000|Overall Study|Other unspecified reason|0|||
16313679|NCT00982657|39633828|FG002|Overall Study|On going at date of cut-off|0|||
16313680|NCT00982657|39633829|FG003|Overall Study|On going at date of cut-off|1|||
16313681|NCT00488644|39633830|FG000|Overall Study|Not Eligible|1|||
16313682|NCT00488644|39633830|FG000|Overall Study|Not Evaluable|1|||
16313683|NCT00679211|39633836|FG000|Overall Study|Progressive disease|82|||
16507833|NCT03917654|40333218|FG001|Year 2|Travel|0|||
16507834|NCT03917654|40333219|FG002|Year 2|Travel|0|||
16197264|NCT03004469|39197471|FG001|Overall Study|Other unspecified reason|4|||
16313684|NCT00679211|39633836|FG000|Overall Study|Adverse Event|7|||
16313685|NCT00679211|39633836|FG000|Overall Study|Withdrawal by Subject|2|||
16507835|NCT03917654|40333220|FG003|Year 2|Travel|0|||
16313686|NCT00679211|39633836|FG000|Overall Study|Physician Decision|5|||
16313687|NCT00679211|39633836|FG000|Overall Study|Refused to undergo protocol procedures|1|||
16313688|NCT00679211|39633836|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
16313689|NCT00679211|39633836|FG000|Overall Study|Other|1|||
16313690|NCT01641640|39633837|FG000|Overall Study|Enrolled but not treated|1|||
16391419|NCT01558115|39916127|FG000|Overall Study|Withdrawal by Subject|3|||
16391420|NCT01558115|39916127|FG000|Overall Study|Study closed due to poor enrollment|4|||
16391421|NCT00616642|39916129|FG000|Overall Study|Withdrawal by Subject|0|||
16507836|NCT03917654|40333221|FG004|Year 2|Travel|1|||
16507837|NCT03917654|40333222|FG005|Year 2|Travel|1|||
16197265|NCT03004469|39197472|FG002|Overall Study|Other unspecified reason|1|||
16507838|NCT03917654|40333223|FG006|Year 2|Travel|2|||
16507839|NCT03917654|40333224|FG007|Year 2|Travel|1|||
16507840|NCT03917654|40333225|FG008|Year 2|Travel|0|||
16507841|NCT03917654|40333226|FG009|Year 2|Travel|1|||
16507842|NCT03917654|40333227|FG010|Year 2|Travel|0|||
16507843|NCT03917654|40333228|FG011|Year 2|Travel|1|||
16507844|NCT03917654|40333217|FG000|Year 2|Married|1|||
16507845|NCT03917654|40333218|FG001|Year 2|Married|0|||
16507846|NCT03917654|40333219|FG002|Year 2|Married|0|||
16507847|NCT03917654|40333220|FG003|Year 2|Married|0|||
16507848|NCT03917654|40333221|FG004|Year 2|Married|0|||
16507849|NCT03917654|40333222|FG005|Year 2|Married|0|||
16507850|NCT03917654|40333223|FG006|Year 2|Married|1|||
16507851|NCT03917654|40333224|FG007|Year 2|Married|1|||
16507852|NCT03917654|40333225|FG008|Year 2|Married|0|||
16507853|NCT03917654|40333226|FG009|Year 2|Married|0|||
16507854|NCT03917654|40333227|FG010|Year 2|Married|0|||
16507855|NCT03917654|40333228|FG011|Year 2|Married|0|||
16507856|NCT03917654|40333217|FG000|Year 2|Subject moved away from site|1|||
16507857|NCT03917654|40333218|FG001|Year 2|Subject moved away from site|0|||
16507858|NCT03917654|40333219|FG002|Year 2|Subject moved away from site|0|||
16507859|NCT03917654|40333220|FG003|Year 2|Subject moved away from site|0|||
16507860|NCT03917654|40333221|FG004|Year 2|Subject moved away from site|1|||
16507861|NCT03917654|40333222|FG005|Year 2|Subject moved away from site|0|||
16507862|NCT03917654|40333223|FG006|Year 2|Subject moved away from site|2|||
16507863|NCT03917654|40333224|FG007|Year 2|Subject moved away from site|3|||
16507864|NCT03917654|40333225|FG008|Year 2|Subject moved away from site|0|||
16507865|NCT03917654|40333226|FG009|Year 2|Subject moved away from site|2|||
16507866|NCT03917654|40333227|FG010|Year 2|Subject moved away from site|0|||
16507867|NCT03917654|40333228|FG011|Year 2|Subject moved away from site|1|||
16507868|NCT03917654|40333217|FG000|Year 2|Year 2 Screening failure|0|||
16507869|NCT03917654|40333218|FG001|Year 2|Year 2 Screening failure|1|||
16507870|NCT03917654|40333219|FG002|Year 2|Year 2 Screening failure|0|||
16507871|NCT03917654|40333220|FG003|Year 2|Year 2 Screening failure|0|||
16507872|NCT03917654|40333221|FG004|Year 2|Year 2 Screening failure|2|||
16507873|NCT03917654|40333222|FG005|Year 2|Year 2 Screening failure|0|||
16507874|NCT03917654|40333223|FG006|Year 2|Year 2 Screening failure|4|||
16507875|NCT03917654|40333224|FG007|Year 2|Year 2 Screening failure|3|||
16507876|NCT03917654|40333225|FG008|Year 2|Year 2 Screening failure|10|||
16507877|NCT03917654|40333226|FG009|Year 2|Year 2 Screening failure|2|||
16507878|NCT03917654|40333227|FG010|Year 2|Year 2 Screening failure|1|||
16197266|NCT01429077|39197473|FG000|Overall Study|Lost to Follow-up|0|||
16391422|NCT00616642|39916130|FG001|Overall Study|Withdrawal by Subject|1|||
16391423|NCT02524145|39916131|FG000|Overall Study|Withdrawal by Subject|2|||
16391424|NCT02524145|39916132|FG001|Overall Study|Withdrawal by Subject|2|||
16391425|NCT02524145|39916133|FG002|Overall Study|Withdrawal by Subject|3|||
16391426|NCT03542266|39916134|FG000|Treatment Phase|Withdrawal by Subject|1|||
16391427|NCT03542266|39916134|FG000|Treatment Phase|Adverse Event|1|||
16391428|NCT03542266|39916134|FG000|Treatment Phase|PD|1|||
16391429|NCT00881530|39916142|FG000|Overall Study|Adverse Event|5|||
16391430|NCT00881530|39916143|FG001|Overall Study|Adverse Event|1|||
16391431|NCT00881530|39916144|FG002|Overall Study|Adverse Event|1|||
16391432|NCT00881530|39916145|FG003|Overall Study|Adverse Event|4|||
16391433|NCT00881530|39916146|FG004|Overall Study|Adverse Event|10|||
16391434|NCT00881530|39916147|FG005|Overall Study|Adverse Event|2|||
16391435|NCT00881530|39916142|FG000|Overall Study|Lack of Efficacy|1|||
16391436|NCT00881530|39916143|FG001|Overall Study|Lack of Efficacy|0|||
16391437|NCT00881530|39916144|FG002|Overall Study|Lack of Efficacy|0|||
16391438|NCT00881530|39916145|FG003|Overall Study|Lack of Efficacy|0|||
16391439|NCT00881530|39916146|FG004|Overall Study|Lack of Efficacy|1|||
16391440|NCT00881530|39916147|FG005|Overall Study|Lack of Efficacy|1|||
16391441|NCT00881530|39916142|FG000|Overall Study|Not compliant with the protocol|0|||
16391442|NCT00881530|39916143|FG001|Overall Study|Not compliant with the protocol|0|||
16391443|NCT00881530|39916144|FG002|Overall Study|Not compliant with the protocol|0|||
16391444|NCT00881530|39916145|FG003|Overall Study|Not compliant with the protocol|0|||
16391445|NCT00881530|39916146|FG004|Overall Study|Not compliant with the protocol|2|||
16391446|NCT00881530|39916147|FG005|Overall Study|Not compliant with the protocol|0|||
16391447|NCT00881530|39916142|FG000|Overall Study|Lost to Follow-up|0|||
16391448|NCT00881530|39916143|FG001|Overall Study|Lost to Follow-up|1|||
16391449|NCT00881530|39916144|FG002|Overall Study|Lost to Follow-up|1|||
16391450|NCT00881530|39916145|FG003|Overall Study|Lost to Follow-up|3|||
16391451|NCT00881530|39916146|FG004|Overall Study|Lost to Follow-up|1|||
16507879|NCT03917654|40333228|FG011|Year 2|Year 2 Screening failure|1|||
16391452|NCT00881530|39916147|FG005|Overall Study|Lost to Follow-up|0|||
16391453|NCT00881530|39916142|FG000|Overall Study|Refused to continue medication|7|||
16391454|NCT00881530|39916143|FG001|Overall Study|Refused to continue medication|2|||
16507880|NCT03917654|40333217|FG000|Year 2|Death|0|||
16507881|NCT03917654|40333218|FG001|Year 2|Death|0|||
16391455|NCT00881530|39916144|FG002|Overall Study|Refused to continue medication|1|||
16507882|NCT03917654|40333219|FG002|Year 2|Death|0|||
16507883|NCT03917654|40333220|FG003|Year 2|Death|0|||
16507884|NCT03917654|40333221|FG004|Year 2|Death|0|||
16507885|NCT03917654|40333222|FG005|Year 2|Death|1|||
16507886|NCT03917654|40333223|FG006|Year 2|Death|0|||
16391456|NCT00881530|39916145|FG003|Overall Study|Refused to continue medication|2|||
16391457|NCT00881530|39916146|FG004|Overall Study|Refused to continue medication|0|||
16391458|NCT00881530|39916147|FG005|Overall Study|Refused to continue medication|0|||
16391459|NCT00881530|39916142|FG000|Overall Study|Other reason not defined above|1|||
16507887|NCT03917654|40333224|FG007|Year 2|Death|0|||
16507888|NCT03917654|40333225|FG008|Year 2|Death|1|||
16313691|NCT01641640|39633837|FG000|Overall Study|Efficacy failure|29|||
16313692|NCT01641640|39633837|FG000|Overall Study|Lost to Follow-up|3|||
16313693|NCT01641640|39633837|FG000|Overall Study|Withdrawal by Subject|2|||
16313694|NCT01641640|39633837|FG000|Overall Study|Adverse Event|1|||
16313695|NCT04031846|39633842|FG000|Overall Study|Lost to Follow-up|4|||
16507889|NCT03917654|40333226|FG009|Year 2|Death|1|||
16507890|NCT03917654|40333227|FG010|Year 2|Death|0|||
16507891|NCT03917654|40333228|FG011|Year 2|Death|0|||
16507892|NCT03917654|40333217|FG000|Year 2|Withdrawal by Subject|0|||
16507893|NCT03917654|40333218|FG001|Year 2|Withdrawal by Subject|0|||
16507894|NCT03917654|40333219|FG002|Year 2|Withdrawal by Subject|0|||
16507895|NCT03917654|40333220|FG003|Year 2|Withdrawal by Subject|0|||
16507896|NCT03917654|40333221|FG004|Year 2|Withdrawal by Subject|0|||
16507897|NCT03917654|40333222|FG005|Year 2|Withdrawal by Subject|0|||
16507898|NCT03917654|40333223|FG006|Year 2|Withdrawal by Subject|3|||
16507899|NCT03917654|40333224|FG007|Year 2|Withdrawal by Subject|0|||
16507900|NCT03917654|40333225|FG008|Year 2|Withdrawal by Subject|2|||
16313696|NCT04031846|39633843|FG001|Overall Study|Lost to Follow-up|4|||
16313697|NCT04031846|39633842|FG000|Overall Study|Physician Decision|0|||
16313698|NCT04031846|39633843|FG001|Overall Study|Physician Decision|1|||
16313699|NCT04031846|39633842|FG000|Overall Study|Protocol Violation|1|||
16313700|NCT04031846|39633843|FG001|Overall Study|Protocol Violation|1|||
16313701|NCT04031846|39633842|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
16313702|NCT04031846|39633843|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
16313703|NCT01198470|39633844|FG000|Overall Study|Adverse Event|2|||
16313704|NCT00722137|39633845|FG000|Overall Study|Overt Disease Progression|5|||
16313705|NCT00722137|39633846|FG001|Overall Study|Overt Disease Progression|4|||
16313706|NCT00722137|39633845|FG000|Overall Study|Adverse Event|17|||
16313707|NCT00722137|39633846|FG001|Overall Study|Adverse Event|21|||
16313708|NCT00722137|39633845|FG000|Overall Study|Death|12|||
16313709|NCT00722137|39633846|FG001|Overall Study|Death|7|||
16313710|NCT00722137|39633845|FG000|Overall Study|Withdrawal by Subject|6|||
16313711|NCT00722137|39633846|FG001|Overall Study|Withdrawal by Subject|9|||
16313712|NCT00722137|39633845|FG000|Overall Study|Other Reason Unknown|3|||
16313713|NCT00722137|39633846|FG001|Overall Study|Other Reason Unknown|4|||
16313714|NCT00722137|39633845|FG000|Overall Study|Randomized But Not Treated|2|||
16313715|NCT00722137|39633846|FG001|Overall Study|Randomized But Not Treated|3|||
16313716|NCT00351468|39633847|FG000|Overall Study|Adverse Event|42|||
16313717|NCT00351468|39633847|FG000|Overall Study|Withdrawal by Subject|39|||
16313718|NCT00351468|39633847|FG000|Overall Study|Various -follow up w clinical team|39|||
16313719|NCT00351468|39633847|FG000|Overall Study|Lack of Efficacy|32|||
16313720|NCT00351468|39633847|FG000|Overall Study|Non-compliance|8|||
16313721|NCT00351468|39633847|FG000|Overall Study|Lost to Follow-up|4|||
16313722|NCT00351468|39633847|FG000|Overall Study|Protocol Violation|3|||
16507901|NCT03917654|40333226|FG009|Year 2|Withdrawal by Subject|5|||
16507902|NCT03917654|40333227|FG010|Year 2|Withdrawal by Subject|0|||
16507903|NCT03917654|40333228|FG011|Year 2|Withdrawal by Subject|0|||
16507904|NCT03917654|40333217|FG000|Year 2|Spouse/family member request|0|||
16507905|NCT03917654|40333218|FG001|Year 2|Spouse/family member request|0|||
16507906|NCT03917654|40333219|FG002|Year 2|Spouse/family member request|0|||
16507907|NCT03917654|40333220|FG003|Year 2|Spouse/family member request|0|||
16507908|NCT03917654|40333221|FG004|Year 2|Spouse/family member request|0|||
16507909|NCT03917654|40333222|FG005|Year 2|Spouse/family member request|0|||
16313723|NCT02157376|39633848|FG000|Overall Study|Death|10|||
16313724|NCT02157376|39633849|FG001|Overall Study|Death|4|||
16313725|NCT02157376|39633848|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16313726|NCT02157376|39633849|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16313727|NCT02157376|39633848|FG000|Overall Study|Withdrawal by Subject|3|||
16313728|NCT02157376|39633849|FG001|Overall Study|Withdrawal by Subject|8|||
16313729|NCT02157376|39633848|FG000|Overall Study|Not treated|8|||
16313730|NCT02157376|39633849|FG001|Overall Study|Not treated|3|||
16313731|NCT02157376|39633848|FG000|Overall Study|Investigator's misjudgement|1|||
16507910|NCT03917654|40333223|FG006|Year 2|Spouse/family member request|1|||
16313732|NCT02157376|39633849|FG001|Overall Study|Investigator's misjudgement|2|||
16313733|NCT01791894|39633852|FG000|Overall Study|Adverse Event|1|||
16313734|NCT01841593|39633854|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
16313735|NCT01841593|39633855|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
16313736|NCT01841593|39633854|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
16313737|NCT01841593|39633855|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
16313738|NCT04871776|39633856|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
16507911|NCT03917654|40333224|FG007|Year 2|Spouse/family member request|0|||
16507912|NCT03917654|40333225|FG008|Year 2|Spouse/family member request|0|||
16507913|NCT03917654|40333226|FG009|Year 2|Spouse/family member request|0|||
16507914|NCT03917654|40333227|FG010|Year 2|Spouse/family member request|0|||
16507915|NCT03917654|40333228|FG011|Year 2|Spouse/family member request|0|||
16507916|NCT03917654|40333217|FG000|Year 2|Lost to Follow-up|0|||
16507917|NCT03917654|40333218|FG001|Year 2|Lost to Follow-up|0|||
16507918|NCT03917654|40333219|FG002|Year 2|Lost to Follow-up|0|||
16507919|NCT03917654|40333220|FG003|Year 2|Lost to Follow-up|0|||
16507920|NCT03917654|40333221|FG004|Year 2|Lost to Follow-up|0|||
16507921|NCT03917654|40333222|FG005|Year 2|Lost to Follow-up|0|||
16507922|NCT03917654|40333223|FG006|Year 2|Lost to Follow-up|1|||
16507923|NCT03917654|40333224|FG007|Year 2|Lost to Follow-up|0|||
16507924|NCT03917654|40333225|FG008|Year 2|Lost to Follow-up|1|||
16507925|NCT03917654|40333226|FG009|Year 2|Lost to Follow-up|0|||
16507926|NCT03917654|40333227|FG010|Year 2|Lost to Follow-up|0|||
16507927|NCT03917654|40333228|FG011|Year 2|Lost to Follow-up|1|||
16507928|NCT03917654|40333217|FG000|Year 2|Adverse Event|0|||
16507929|NCT03917654|40333218|FG001|Year 2|Adverse Event|0|||
16507930|NCT03917654|40333219|FG002|Year 2|Adverse Event|0|||
16507931|NCT03917654|40333220|FG003|Year 2|Adverse Event|0|||
16507932|NCT03917654|40333221|FG004|Year 2|Adverse Event|0|||
16507933|NCT03917654|40333222|FG005|Year 2|Adverse Event|0|||
16507934|NCT03917654|40333223|FG006|Year 2|Adverse Event|0|||
16507935|NCT03917654|40333224|FG007|Year 2|Adverse Event|0|||
16507936|NCT03917654|40333225|FG008|Year 2|Adverse Event|0|||
16507937|NCT03917654|40333226|FG009|Year 2|Adverse Event|1|||
16507938|NCT03917654|40333227|FG010|Year 2|Adverse Event|0|||
16507939|NCT03917654|40333228|FG011|Year 2|Adverse Event|0|||
16507940|NCT01498458|40333229|FG000|Overall Study|Adverse Event|4|||
16507941|NCT01498458|40333229|FG000|Overall Study|Physician Decision|3|||
16507942|NCT00278109|40333233|FG000|Overall Study|Adverse Event|3|||
16507943|NCT00278109|40333233|FG000|Overall Study|social circumstances|1|||
16507944|NCT01549964|40333235|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
16507945|NCT01549964|40333236|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
16507946|NCT01549964|40333237|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
16507947|NCT01549964|40333238|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
16507948|NCT01549964|40333235|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
16507949|NCT01549964|40333236|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
16507950|NCT01549964|40333237|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
16507951|NCT01549964|40333238|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
16507952|NCT01549964|40333235|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
16507953|NCT01549964|40333236|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
16507954|NCT01549964|40333237|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
16507955|NCT01549964|40333238|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
16507956|NCT01549964|40333235|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
16507957|NCT01549964|40333236|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
16507958|NCT01549964|40333237|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
16507959|NCT01549964|40333238|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
16507960|NCT01549964|40333235|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
16313739|NCT04871776|39633857|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
16507961|NCT01549964|40333236|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
16507962|NCT01549964|40333237|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
16313740|NCT04871776|39633858|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
16507963|NCT01549964|40333238|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
16507964|NCT01549964|40333235|FG000|24-Week Treatment Period|Other|1|||
16507965|NCT01549964|40333236|FG001|24-Week Treatment Period|Other|0|||
16507966|NCT01549964|40333237|FG002|24-Week Treatment Period|Other|1|||
16507967|NCT01549964|40333238|FG003|24-Week Treatment Period|Other|0|||
16507968|NCT01549964|40333235|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
16507969|NCT01549964|40333236|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
16507970|NCT01549964|40333237|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
16507971|NCT01549964|40333238|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
16507972|NCT01549964|40333235|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
16507973|NCT01549964|40333236|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
16507974|NCT01549964|40333237|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
16507975|NCT01549964|40333238|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
16507976|NCT01549964|40333235|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
16507977|NCT01549964|40333236|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
16507978|NCT01549964|40333237|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
16507979|NCT01549964|40333238|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
16507980|NCT01549964|40333235|FG000|80-Week Extension Period|Pregnancy|0|||
16507981|NCT01549964|40333236|FG001|80-Week Extension Period|Pregnancy|0|||
16507982|NCT01549964|40333237|FG002|80-Week Extension Period|Pregnancy|1|||
16507983|NCT01549964|40333238|FG003|80-Week Extension Period|Pregnancy|0|||
16507984|NCT01549964|40333235|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
16507985|NCT01549964|40333236|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
16507986|NCT01549964|40333237|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
16507987|NCT01549964|40333238|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
16507988|NCT01549964|40333235|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
16507989|NCT01549964|40333236|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
16507990|NCT01549964|40333237|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
16507991|NCT01549964|40333238|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
16507992|NCT01549964|40333235|FG000|80-Week Extension Period|Lost to Follow-up|1|||
16507993|NCT01549964|40333236|FG001|80-Week Extension Period|Lost to Follow-up|0|||
16507994|NCT01549964|40333237|FG002|80-Week Extension Period|Lost to Follow-up|2|||
16507995|NCT01549964|40333238|FG003|80-Week Extension Period|Lost to Follow-up|1|||
16507996|NCT01549964|40333235|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
16507997|NCT01549964|40333236|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
16507998|NCT01549964|40333237|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
16507999|NCT01549964|40333238|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
16508000|NCT01752855|40333239|FG000|Overall Study|Adverse Event|1|||
16508001|NCT01752855|40333240|FG001|Overall Study|Adverse Event|0|||
16508002|NCT01752855|40333239|FG000|Overall Study|Withdrew Consent|0|||
16508003|NCT01752855|40333240|FG001|Overall Study|Withdrew Consent|2|||
16508004|NCT01752855|40333239|FG000|Overall Study|Lack of Efficacy|0|||
16508005|NCT01752855|40333240|FG001|Overall Study|Lack of Efficacy|2|||
16508006|NCT04656132|40333241|FG000|Overall Study|Lost to Follow-up|4|||
16508007|NCT04656132|40333241|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
16508008|NCT00312494|40333243|FG000|Overall Study|Randomized; not treated with study drug|9|||
16508009|NCT00312494|40333244|FG001|Overall Study|Randomized; not treated with study drug|10|||
16508010|NCT00312494|40333245|FG002|Overall Study|Randomized; not treated with study drug|5|||
16508011|NCT00312494|40333243|FG000|Overall Study|Adverse Event|33|||
16508012|NCT00312494|40333244|FG001|Overall Study|Adverse Event|15|||
16508013|NCT00312494|40333245|FG002|Overall Study|Adverse Event|11|||
16508014|NCT00312494|40333243|FG000|Overall Study|Lack of Efficacy|4|||
16508015|NCT00312494|40333244|FG001|Overall Study|Lack of Efficacy|6|||
16508016|NCT00312494|40333245|FG002|Overall Study|Lack of Efficacy|8|||
16508017|NCT00312494|40333243|FG000|Overall Study|Laboratory abnormality|1|||
16508018|NCT00312494|40333244|FG001|Overall Study|Laboratory abnormality|0|||
16508019|NCT00312494|40333245|FG002|Overall Study|Laboratory abnormality|0|||
16508020|NCT00312494|40333243|FG000|Overall Study|Lost to Follow-up|8|||
16508021|NCT00312494|40333244|FG001|Overall Study|Lost to Follow-up|8|||
16508022|NCT00312494|40333245|FG002|Overall Study|Lost to Follow-up|8|||
16508023|NCT00312494|40333243|FG000|Overall Study|Withdrawal by Subject|6|||
16508024|NCT00312494|40333244|FG001|Overall Study|Withdrawal by Subject|9|||
16508025|NCT00312494|40333245|FG002|Overall Study|Withdrawal by Subject|10|||
16508026|NCT00312494|40333243|FG000|Overall Study|Other|10|||
16508027|NCT00312494|40333244|FG001|Overall Study|Other|10|||
16508028|NCT00312494|40333245|FG002|Overall Study|Other|1|||
16508029|NCT01418937|40333246|FG000|Overall Study|Lost to Follow-up|5|||
16508030|NCT01418937|40333246|FG000|Overall Study|Protocol Violation|1|||
16508031|NCT01418937|40333246|FG000|Overall Study|Pregnancy|1|||
16508032|NCT01418937|40333246|FG000|Overall Study|Withdrawal by Subject|1|||
16508033|NCT01928862|40333250|FG000|Overall Study|Lost to Follow-up|1|||
16508034|NCT01928862|40333251|FG001|Overall Study|Lost to Follow-up|0|||
16508035|NCT01928862|40333252|FG002|Overall Study|Lost to Follow-up|0|||
16508036|NCT01928862|40333253|FG003|Overall Study|Lost to Follow-up|0|||
16508037|NCT01928862|40333254|FG004|Overall Study|Lost to Follow-up|1|||
16508038|NCT03323658|40333255|FG000|Overall Study|Adverse Event|0|||
16508039|NCT03323658|40333256|FG001|Overall Study|Adverse Event|1|||
16508040|NCT03323658|40333257|FG002|Overall Study|Adverse Event|0|||
16508041|NCT00856908|40333258|FG000|Overall Study|Lost to Follow-up|1|||
16508042|NCT00856908|40333259|FG001|Overall Study|Lost to Follow-up|0|||
16508043|NCT00136084|40333260|FG000|Overall Study|Death|12|||
16197267|NCT01429077|39197474|FG001|Overall Study|Lost to Follow-up|3|||
16508044|NCT00136084|40333261|FG001|Overall Study|Death|5|||
16508045|NCT00136084|40333260|FG000|Overall Study|Unacceptable toxicity|8|||
16508046|NCT00136084|40333261|FG001|Overall Study|Unacceptable toxicity|11|||
16313741|NCT04871776|39633856|FG000|Overall Study|Did not meet eligibility criteria|1|||
16313742|NCT04871776|39633857|FG001|Overall Study|Did not meet eligibility criteria|1|||
16313743|NCT04871776|39633858|FG002|Overall Study|Did not meet eligibility criteria|1|||
16313744|NCT00985504|39633861|FG000|Acute Treatment Period|Adverse Event|3|||
16313745|NCT00985504|39633862|FG001|Acute Treatment Period|Adverse Event|4|||
16313746|NCT00985504|39633861|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
16508047|NCT00136084|40333260|FG000|Overall Study|Relapse|20|||
16508048|NCT00136084|40333261|FG001|Overall Study|Relapse|23|||
16508049|NCT00136084|40333260|FG000|Overall Study|Lost to Follow-up|2|||
16508050|NCT00136084|40333261|FG001|Overall Study|Lost to Follow-up|0|||
16508051|NCT00136084|40333260|FG000|Overall Study|No Response|1|||
16508052|NCT00136084|40333261|FG001|Overall Study|No Response|2|||
16508053|NCT00136084|40333260|FG000|Overall Study|Withdrawal by Subject|5|||
16508054|NCT00136084|40333261|FG001|Overall Study|Withdrawal by Subject|1|||
16508055|NCT02680639|40333268|FG000|Screening Period|Screen Failure|7|||
16508056|NCT02680639|40333269|FG001|Screening Period|Screen Failure|0|||
16508057|NCT02680639|40333270|FG002|Screening Period|Screen Failure|0|||
16508058|NCT00962104|40333273|FG000|Overall Study|Adverse Event|10|||
16508059|NCT00962104|40333274|FG001|Overall Study|Adverse Event|3|||
16508060|NCT00962104|40333273|FG000|Overall Study|Entry Criteria Not Met|1|||
16508061|NCT00962104|40333274|FG001|Overall Study|Entry Criteria Not Met|2|||
16508062|NCT00962104|40333273|FG000|Overall Study|Lack of Efficacy|0|||
16508063|NCT00962104|40333274|FG001|Overall Study|Lack of Efficacy|1|||
16508064|NCT00962104|40333273|FG000|Overall Study|Lost to Follow-up|10|||
16508065|NCT00962104|40333274|FG001|Overall Study|Lost to Follow-up|4|||
16508066|NCT00962104|40333273|FG000|Overall Study|Physician Decision|1|||
16508067|NCT00962104|40333274|FG001|Overall Study|Physician Decision|0|||
16508068|NCT00962104|40333273|FG000|Overall Study|Protocol Violation|6|||
16508069|NCT00962104|40333274|FG001|Overall Study|Protocol Violation|8|||
16508070|NCT00962104|40333273|FG000|Overall Study|Sponsor Decision|0|||
16508071|NCT00962104|40333274|FG001|Overall Study|Sponsor Decision|1|||
16508072|NCT00962104|40333273|FG000|Overall Study|Withdrawal by Subject|10|||
16508073|NCT00962104|40333274|FG001|Overall Study|Withdrawal by Subject|6|||
16508074|NCT00962104|40333273|FG000|Overall Study|Other|2|||
16508075|NCT00962104|40333274|FG001|Overall Study|Other|0|||
16508076|NCT00313612|40333276|FG000|Overall Study|Patient never received treatment|0|||
16508077|NCT00313612|40333277|FG001|Overall Study|Patient never received treatment|1|||
16508078|NCT00407563|40333285|FG000|Overall Study|Patient continues on treatment|1|||
16508079|NCT01113879|40333287|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
16508080|NCT01113879|40333288|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
16508081|NCT00857220|40333289|FG000|Overall Study|Adverse Event|35|||
16508082|NCT00857220|40333289|FG000|Overall Study|Death|1|||
16508083|NCT00857220|40333289|FG000|Overall Study|Lack of Efficacy|11|||
16508084|NCT00857220|40333289|FG000|Overall Study|Lost to Follow-up|30|||
16508085|NCT00857220|40333289|FG000|Overall Study|Physician Decision|4|||
16508086|NCT00857220|40333289|FG000|Overall Study|Protocol Violation|16|||
16508087|NCT00857220|40333289|FG000|Overall Study|Withdrawal by Subject|67|||
16197268|NCT01397448|39197475|FG000|Overall Study|Adverse Event|4|||
16197269|NCT01397448|39197476|FG001|Overall Study|Adverse Event|4|||
16197270|NCT01397448|39197477|FG002|Overall Study|Adverse Event|6|||
16197271|NCT01397448|39197475|FG000|Overall Study|Withdrawal by Subject|4|||
16197272|NCT01397448|39197476|FG001|Overall Study|Withdrawal by Subject|4|||
16197273|NCT01397448|39197477|FG002|Overall Study|Withdrawal by Subject|3|||
16508088|NCT00857220|40333289|FG000|Overall Study|Clinical Hold|6|||
16508089|NCT00857220|40333289|FG000|Overall Study|Site Closed|5|||
16197274|NCT01397448|39197475|FG000|Overall Study|Lack of Efficacy|2|||
16197275|NCT01397448|39197476|FG001|Overall Study|Lack of Efficacy|0|||
16197276|NCT01397448|39197477|FG002|Overall Study|Lack of Efficacy|5|||
16197277|NCT01397448|39197475|FG000|Overall Study|Other|8|||
16197278|NCT01397448|39197476|FG001|Overall Study|Other|7|||
16197279|NCT01397448|39197477|FG002|Overall Study|Other|4|||
16508090|NCT00857220|40333289|FG000|Overall Study|Miscellaneous|8|||
16508091|NCT01652664|40333291|FG000|Overall Study|Treatment Failure|5|||
16508092|NCT01652664|40333292|FG001|Overall Study|Treatment Failure|1|||
16508093|NCT01652664|40333291|FG000|Overall Study|Inadequate IOP control|1|||
16508094|NCT01652664|40333292|FG001|Overall Study|Inadequate IOP control|0|||
16508095|NCT02625090|40333298|FG000|Overall Study|Participant wants to be pregnant|2|||
16508096|NCT02625090|40333298|FG000|Overall Study|For the Promoter|1|||
16508097|NCT02625090|40333298|FG000|Overall Study|Sponsor's Decision|9|||
16508098|NCT02625090|40333298|FG000|Overall Study|Somnolence|1|||
16508099|NCT02625090|40333298|FG000|Overall Study|Study terminated by Sponsor|7|||
16197280|NCT04093258|39197478|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
16508100|NCT02625090|40333298|FG000|Overall Study|Negative Benefit/Risk|1|||
16508101|NCT02625090|40333298|FG000|Overall Study|Protocol Deviation|2|||
16508102|NCT02625090|40333298|FG000|Overall Study|Lack of Efficacy|16|||
16508103|NCT02625090|40333298|FG000|Overall Study|Adverse Event|3|||
16508104|NCT02436759|40333299|FG000|Overall Study|Adverse Event|3|||
16508105|NCT02436759|40333300|FG001|Overall Study|Adverse Event|0|||
16508106|NCT02436759|40333299|FG000|Overall Study|Protocol Violation|1|||
16508107|NCT02436759|40333300|FG001|Overall Study|Protocol Violation|0|||
16508108|NCT02436759|40333299|FG000|Overall Study|Withdrawal by Subject|0|||
16508109|NCT02436759|40333300|FG001|Overall Study|Withdrawal by Subject|1|||
16508110|NCT02519712|40333301|FG000|Overall Study|Disease Relapse|1|||
16508111|NCT02519712|40333301|FG000|Overall Study|Disease Progression|1|||
16508112|NCT02519712|40333301|FG000|Overall Study|Accruals are donors|2|||
16508113|NCT04144166|40333305|FG000|Overall Study|Discharged before study start|1|||
16508114|NCT04144166|40333305|FG000|Overall Study|Pregnancy|1|||
16508115|NCT04144166|40333305|FG000|Overall Study|Nail polish could not be removed from finger|1|||
16508116|NCT03257631|40333306|FG000|Overall Study|Death|1|||
16508117|NCT03257631|40333307|FG001|Overall Study|Death|0|||
16508118|NCT03257631|40333308|FG002|Overall Study|Death|1|||
16508119|NCT03257631|40333309|FG003|Overall Study|Death|1|||
16508120|NCT03257631|40333306|FG000|Overall Study|Progressive Disease|10|||
16508121|NCT03257631|40333307|FG001|Overall Study|Progressive Disease|9|||
16508122|NCT03257631|40333308|FG002|Overall Study|Progressive Disease|17|||
16508123|NCT03257631|40333309|FG003|Overall Study|Progressive Disease|8|||
16508124|NCT03257631|40333306|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16508125|NCT03257631|40333307|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16508126|NCT03257631|40333308|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
16508127|NCT03257631|40333309|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
16508128|NCT03257631|40333306|FG000|Overall Study|Adverse Event|0|||
16508129|NCT03257631|40333307|FG001|Overall Study|Adverse Event|0|||
16508130|NCT03257631|40333308|FG002|Overall Study|Adverse Event|2|||
16508131|NCT03257631|40333309|FG003|Overall Study|Adverse Event|0|||
16508132|NCT01498952|40333310|FG000|Overall Study|Death|2|||
16508133|NCT01498952|40333311|FG001|Overall Study|Death|2|||
16508134|NCT01498952|40333312|FG002|Overall Study|Death|0|||
16508135|NCT01498952|40333313|FG003|Overall Study|Death|0|||
16508136|NCT01498952|40333314|FG004|Overall Study|Death|0|||
16508137|NCT00677807|40333315|FG000|Overall Study|Adverse Event|4|||
16508138|NCT00677807|40333316|FG001|Overall Study|Adverse Event|1|||
16508139|NCT00677807|40333317|FG002|Overall Study|Adverse Event|6|||
16508140|NCT00677807|40333315|FG000|Overall Study|Lack of Efficacy|0|||
16508141|NCT00677807|40333316|FG001|Overall Study|Lack of Efficacy|0|||
16508142|NCT00677807|40333317|FG002|Overall Study|Lack of Efficacy|2|||
16197281|NCT04093258|39197479|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
16197282|NCT01195363|39197480|FG000|Overall Study|Lost to Follow-up|7|||
16197283|NCT01195363|39197481|FG001|Overall Study|Lost to Follow-up|4|||
16197284|NCT01195363|39197480|FG000|Overall Study|Adverse Event|3|||
16197285|NCT01195363|39197481|FG001|Overall Study|Adverse Event|1|||
16197286|NCT01195363|39197480|FG000|Overall Study|Lack of Efficacy|0|||
16197287|NCT01195363|39197481|FG001|Overall Study|Lack of Efficacy|4|||
16197288|NCT01195363|39197480|FG000|Overall Study|incarceration|1|||
16197289|NCT01195363|39197481|FG001|Overall Study|incarceration|0|||
16197290|NCT01486784|39197482|FG000|Overall Study|Withdrawal by Subject|0|||
16197291|NCT01486784|39197483|FG001|Overall Study|Withdrawal by Subject|0|||
16197292|NCT01486784|39197484|FG002|Overall Study|Withdrawal by Subject|1|||
16197293|NCT01486784|39197485|FG003|Overall Study|Withdrawal by Subject|0|||
16197294|NCT01486784|39197486|FG004|Overall Study|Withdrawal by Subject|1|||
16197295|NCT01486784|39197487|FG005|Overall Study|Withdrawal by Subject|2|||
16197296|NCT01486784|39197482|FG000|Overall Study|Subject did not meet entry criteria|0|||
16197297|NCT01486784|39197483|FG001|Overall Study|Subject did not meet entry criteria|0|||
16197298|NCT01486784|39197484|FG002|Overall Study|Subject did not meet entry criteria|0|||
16197299|NCT01486784|39197485|FG003|Overall Study|Subject did not meet entry criteria|0|||
16508143|NCT00677807|40333315|FG000|Overall Study|Participant no longer needs study drug|0|||
16508144|NCT00677807|40333316|FG001|Overall Study|Participant no longer needs study drug|0|||
16508145|NCT00677807|40333317|FG002|Overall Study|Participant no longer needs study drug|1|||
16508146|NCT00677807|40333315|FG000|Overall Study|Withdrawal by Subject|10|||
16197300|NCT01486784|39197486|FG004|Overall Study|Subject did not meet entry criteria|1|||
16197301|NCT01486784|39197487|FG005|Overall Study|Subject did not meet entry criteria|0|||
16197302|NCT01486784|39197482|FG000|Overall Study|Death|0|||
16508147|NCT00677807|40333316|FG001|Overall Study|Withdrawal by Subject|3|||
16508148|NCT00677807|40333317|FG002|Overall Study|Withdrawal by Subject|6|||
16508149|NCT00677807|40333315|FG000|Overall Study|Lost to Follow-up|2|||
16197303|NCT01486784|39197483|FG001|Overall Study|Death|0|||
16197304|NCT01486784|39197484|FG002|Overall Study|Death|0|||
16197305|NCT01486784|39197485|FG003|Overall Study|Death|0|||
16197306|NCT01486784|39197486|FG004|Overall Study|Death|0|||
16197307|NCT01486784|39197487|FG005|Overall Study|Death|1|||
16197308|NCT02841787|39197489|FG000|Overall Study|Lost to Follow-up|1|||
16313747|NCT00985504|39633862|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
16313748|NCT00985504|39633861|FG000|Acute Treatment Period|Protocol Violation|2|||
16313749|NCT00985504|39633862|FG001|Acute Treatment Period|Protocol Violation|0|||
16313750|NCT00985504|39633861|FG000|Acute Treatment Period|Sponsor Decision|0|||
16313751|NCT00985504|39633862|FG001|Acute Treatment Period|Sponsor Decision|1|||
16313752|NCT00985504|39633861|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
16313753|NCT00985504|39633862|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
16313754|NCT00985504|39633861|FG000|Optimization Period|Adverse Event|7|||
16313755|NCT00985504|39633862|FG001|Optimization Period|Adverse Event|9|||
16313756|NCT00985504|39633861|FG000|Optimization Period|Death|0|||
16313757|NCT00985504|39633862|FG001|Optimization Period|Death|1|||
16313758|NCT00985504|39633861|FG000|Optimization Period|Lack of Efficacy|5|||
16313759|NCT00985504|39633862|FG001|Optimization Period|Lack of Efficacy|3|||
16313760|NCT00985504|39633861|FG000|Optimization Period|Lost to Follow-up|0|||
16313761|NCT00985504|39633862|FG001|Optimization Period|Lost to Follow-up|1|||
16313762|NCT00985504|39633861|FG000|Optimization Period|Physician Decision|1|||
16313763|NCT00985504|39633862|FG001|Optimization Period|Physician Decision|0|||
16391460|NCT00881530|39916143|FG001|Overall Study|Other reason not defined above|1|||
16391461|NCT00881530|39916144|FG002|Overall Study|Other reason not defined above|2|||
16391462|NCT00881530|39916145|FG003|Overall Study|Other reason not defined above|0|||
16391463|NCT00881530|39916146|FG004|Overall Study|Other reason not defined above|0|||
16391464|NCT00881530|39916147|FG005|Overall Study|Other reason not defined above|2|||
16391465|NCT04179305|39916148|FG000|Overall Study|Death|1|||
16391466|NCT04179305|39916149|FG001|Overall Study|Death|1|||
16197309|NCT02841787|39197490|FG001|Overall Study|Lost to Follow-up|0|||
16197310|NCT02841787|39197491|FG002|Overall Study|Lost to Follow-up|0|||
16313764|NCT00985504|39633861|FG000|Optimization Period|Protocol Violation|3|||
16313765|NCT00985504|39633862|FG001|Optimization Period|Protocol Violation|1|||
16313766|NCT00985504|39633861|FG000|Optimization Period|Withdrawal by Subject|10|||
16313767|NCT00985504|39633862|FG001|Optimization Period|Withdrawal by Subject|8|||
16391467|NCT04179305|39916150|FG002|Overall Study|Death|0|||
16197311|NCT02841787|39197489|FG000|Overall Study|Symptoms dropped below threshold|1|||
16313768|NCT04570670|39633863|FG000|Overall Study|Withdrawal by Subject|1|||
16197312|NCT02841787|39197490|FG001|Overall Study|Symptoms dropped below threshold|0|||
16197313|NCT02841787|39197491|FG002|Overall Study|Symptoms dropped below threshold|0|||
16197314|NCT02841787|39197489|FG000|Overall Study|Withdrawal by Subject|1|||
16197315|NCT02841787|39197490|FG001|Overall Study|Withdrawal by Subject|4|||
16197316|NCT02841787|39197491|FG002|Overall Study|Withdrawal by Subject|0|||
16197317|NCT00764478|39197494|FG000|Overall Study|Adverse Event|1|||
16197318|NCT00764478|39197495|FG001|Overall Study|Adverse Event|1|||
16197319|NCT00764478|39197496|FG002|Overall Study|Adverse Event|1|||
16197320|NCT00764478|39197494|FG000|Overall Study|Withdrawal by Subject|7|||
16197321|NCT00764478|39197495|FG001|Overall Study|Withdrawal by Subject|12|||
16197322|NCT00764478|39197496|FG002|Overall Study|Withdrawal by Subject|1|||
16197323|NCT00764478|39197494|FG000|Overall Study|Lost to Follow-up|7|||
16197324|NCT00764478|39197495|FG001|Overall Study|Lost to Follow-up|8|||
16197325|NCT00764478|39197496|FG002|Overall Study|Lost to Follow-up|5|||
16197326|NCT00764478|39197494|FG000|Overall Study|Protocol Violation|0|||
16197327|NCT00764478|39197495|FG001|Overall Study|Protocol Violation|1|||
16197328|NCT00764478|39197496|FG002|Overall Study|Protocol Violation|1|||
16313769|NCT04570670|39633864|FG001|Overall Study|Withdrawal by Subject|0|||
16313770|NCT04830969|39633873|FG000|Overall Study|Withdrawal by Subject|6|||
16313771|NCT04830969|39633874|FG001|Overall Study|Withdrawal by Subject|2|||
16313772|NCT04830969|39633873|FG000|Overall Study|Protocol Violation|3|||
16313773|NCT04830969|39633874|FG001|Overall Study|Protocol Violation|9|||
16313774|NCT04830969|39633873|FG000|Overall Study|Lost to Follow-up|4|||
16313775|NCT04830969|39633874|FG001|Overall Study|Lost to Follow-up|4|||
16313776|NCT03859427|39633875|FG000|Overall Study|Withdrawal by Subject|4|||
16313777|NCT03859427|39633876|FG001|Overall Study|Withdrawal by Subject|7|||
16313778|NCT03859427|39633875|FG000|Overall Study|Decision by sponsor|0|||
16313779|NCT03859427|39633876|FG001|Overall Study|Decision by sponsor|3|||
16313780|NCT03859427|39633875|FG000|Overall Study|Lost to Follow-up|3|||
16313781|NCT03859427|39633876|FG001|Overall Study|Lost to Follow-up|2|||
16313782|NCT03859427|39633875|FG000|Overall Study|Death|22|||
16313783|NCT03859427|39633876|FG001|Overall Study|Death|25|||
16313784|NCT00866281|39633877|FG000|Overall Study|Adverse Event|1|||
16313785|NCT00866281|39633878|FG001|Overall Study|Adverse Event|0|||
16313786|NCT00866281|39633877|FG000|Overall Study|Withdrawal by participants|3|||
16313787|NCT00866281|39633878|FG001|Overall Study|Withdrawal by participants|0|||
16313788|NCT00866281|39633877|FG000|Overall Study|Disease progression|3|||
16313789|NCT00866281|39633878|FG001|Overall Study|Disease progression|11|||
16313790|NCT00866281|39633877|FG000|Overall Study|New cancer therapy|0|||
16313791|NCT00866281|39633878|FG001|Overall Study|New cancer therapy|4|||
16313792|NCT00921557|39633879|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
16313793|NCT00921557|39633880|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
16313794|NCT00921557|39633881|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
16313795|NCT00921557|39633879|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
16313796|NCT00921557|39633880|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
16313797|NCT00921557|39633881|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
16313798|NCT00921557|39633879|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
16313799|NCT00921557|39633880|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
16313800|NCT00921557|39633881|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
16313801|NCT00921557|39633879|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
16313802|NCT00921557|39633880|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
16313803|NCT00921557|39633881|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
16313804|NCT00921557|39633879|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
16313805|NCT00921557|39633880|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
16313806|NCT00921557|39633881|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
16313807|NCT02755103|39633882|FG000|Overall Study|Lost to Follow-up|17|||
16313808|NCT02755103|39633883|FG001|Overall Study|Lost to Follow-up|15|||
16313809|NCT02755103|39633882|FG000|Overall Study|Death|0|||
16313810|NCT02755103|39633883|FG001|Overall Study|Death|1|||
16313811|NCT02755103|39633882|FG000|Overall Study|Physician Decision|0|||
16313812|NCT02755103|39633883|FG001|Overall Study|Physician Decision|1|||
16313813|NCT02755103|39633882|FG000|Overall Study|Pregnancy|0|||
16313814|NCT02755103|39633883|FG001|Overall Study|Pregnancy|1|||
16313815|NCT02755103|39633882|FG000|Overall Study|Withdrawal by Subject|3|||
16313816|NCT02755103|39633883|FG001|Overall Study|Withdrawal by Subject|0|||
16313817|NCT00915018|39633884|FG000|Overall Study|Death|75|||
16313818|NCT00915018|39633885|FG001|Overall Study|Death|70|||
16391468|NCT04179305|39916151|FG003|Overall Study|Death|0|||
16508150|NCT00677807|40333316|FG001|Overall Study|Lost to Follow-up|2|||
16197329|NCT01536119|39197497|FG000|Overall Study|Lost to Follow-up|17|||
16197330|NCT01536119|39197498|FG001|Overall Study|Lost to Follow-up|14|||
16197331|NCT02702011|39197499|FG000|Overall Study|Withdrawal by Subject|0|||
16197332|NCT02702011|39197500|FG001|Overall Study|Withdrawal by Subject|1|||
16313819|NCT00915018|39633884|FG000|Overall Study|Lost to Follow-up|10|||
16313820|NCT00915018|39633885|FG001|Overall Study|Lost to Follow-up|5|||
16197333|NCT02702011|39197501|FG002|Overall Study|Withdrawal by Subject|0|||
16313821|NCT00915018|39633884|FG000|Overall Study|Withdrawal by Subject|38|||
16313822|NCT00915018|39633885|FG001|Overall Study|Withdrawal by Subject|27|||
16313823|NCT00915018|39633884|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
16313824|NCT00915018|39633885|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
16313825|NCT02810457|39633889|FG000|Overall Study|Randomised but no treatment received|2|||
16313826|NCT02810457|39633890|FG001|Overall Study|Randomised but no treatment received|1|||
16313827|NCT02810457|39633889|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
16313828|NCT02810457|39633890|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
16313829|NCT02810457|39633889|FG000|Overall Study|Adverse Event|37|||
16313830|NCT02810457|39633890|FG001|Overall Study|Adverse Event|43|||
16313831|NCT02810457|39633889|FG000|Overall Study|Patient decision|31|||
16313832|NCT02810457|39633890|FG001|Overall Study|Patient decision|35|||
16313833|NCT02810457|39633889|FG000|Overall Study|Patient lost to follow-up|2|||
16313834|NCT02810457|39633890|FG001|Overall Study|Patient lost to follow-up|2|||
16313835|NCT02810457|39633889|FG000|Overall Study|Death|39|||
16313836|NCT02810457|39633890|FG001|Overall Study|Death|28|||
16313837|NCT02810457|39633889|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
16313838|NCT02810457|39633890|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
16313839|NCT02810457|39633889|FG000|Overall Study|Clinical progression|15|||
16313840|NCT02810457|39633890|FG001|Overall Study|Clinical progression|16|||
16313841|NCT02810457|39633889|FG000|Overall Study|Investigator decision|3|||
16313842|NCT02810457|39633890|FG001|Overall Study|Investigator decision|2|||
16313843|NCT02810457|39633889|FG000|Overall Study|Patient ineligibility|3|||
16313844|NCT02810457|39633890|FG001|Overall Study|Patient ineligibility|0|||
16313845|NCT02810457|39633889|FG000|Overall Study|Miscalculated PD|1|||
16313846|NCT02810457|39633890|FG001|Overall Study|Miscalculated PD|0|||
16313847|NCT02810457|39633889|FG000|Overall Study|Physician Decision|0|||
16313848|NCT02810457|39633890|FG001|Overall Study|Physician Decision|1|||
16313849|NCT01139125|39633891|FG000|Overall Study|Withdrawal by Subject|1|||
16313850|NCT00288626|39633892|FG000|Overall Study|Death|3|||
16313851|NCT00288626|39633892|FG000|Overall Study|Withdrawal by Subject|4|||
16313852|NCT03214224|39633893|FG000|Overall Study|Protocol Violation|1|||
16313853|NCT03214224|39633893|FG000|Overall Study|Withdrawal by Subject|2|||
16313854|NCT03214224|39633893|FG000|Overall Study|Practice controls or therapists|6|||
16313855|NCT01823328|39633894|FG000|Overall Study|Withdrawal by Subject|8|||
16313856|NCT01823328|39633895|FG001|Overall Study|Withdrawal by Subject|6|||
16313857|NCT00460603|39633916|FG000|Phase 1|Death|1|||
16313858|NCT00460603|39633917|FG001|Phase 1|Death|0|||
16313859|NCT00460603|39633918|FG002|Phase 1|Death|0|||
16313860|NCT00460603|39633919|FG003|Phase 1|Death|2|||
16313861|NCT00460603|39633920|FG004|Phase 1|Death|0|||
16313862|NCT00460603|39633921|FG005|Phase 1|Death|0|||
16313863|NCT00460603|39633922|FG006|Phase 1|Death|0|||
16313864|NCT00460603|39633923|FG007|Phase 1|Death|0|||
16313865|NCT00460603|39633924|FG008|Phase 1|Death|1|||
16313866|NCT00460603|39633925|FG009|Phase 1|Death|0|||
16313867|NCT00460603|39633926|FG010|Phase 1|Death|0|||
16313868|NCT00460603|39633927|FG011|Phase 1|Death|0|||
16313869|NCT00460603|39633916|FG000|Phase 1|Adverse Event|3|||
16313870|NCT00460603|39633917|FG001|Phase 1|Adverse Event|1|||
16313871|NCT00460603|39633918|FG002|Phase 1|Adverse Event|1|||
16313872|NCT00460603|39633919|FG003|Phase 1|Adverse Event|2|||
16313873|NCT00460603|39633920|FG004|Phase 1|Adverse Event|0|||
16313874|NCT00460603|39633921|FG005|Phase 1|Adverse Event|0|||
16313875|NCT00460603|39633922|FG006|Phase 1|Adverse Event|3|||
16313876|NCT00460603|39633923|FG007|Phase 1|Adverse Event|0|||
16313877|NCT00460603|39633924|FG008|Phase 1|Adverse Event|4|||
16313878|NCT00460603|39633925|FG009|Phase 1|Adverse Event|0|||
16313879|NCT00460603|39633926|FG010|Phase 1|Adverse Event|0|||
16313880|NCT00460603|39633927|FG011|Phase 1|Adverse Event|0|||
16313881|NCT00460603|39633916|FG000|Phase 1|Lack of Efficacy|1|||
16313882|NCT00460603|39633917|FG001|Phase 1|Lack of Efficacy|0|||
16508151|NCT00677807|40333317|FG002|Overall Study|Lost to Follow-up|2|||
16508152|NCT00677807|40333315|FG000|Overall Study|Administrative problems|1|||
16508153|NCT00677807|40333316|FG001|Overall Study|Administrative problems|1|||
16508154|NCT00677807|40333317|FG002|Overall Study|Administrative problems|2|||
16508155|NCT00677807|40333315|FG000|Overall Study|Death|0|||
16508156|NCT00677807|40333316|FG001|Overall Study|Death|1|||
16508157|NCT00677807|40333317|FG002|Overall Study|Death|1|||
16508158|NCT00677807|40333315|FG000|Overall Study|Protocol Deviation|1|||
16313883|NCT00460603|39633918|FG002|Phase 1|Lack of Efficacy|1|||
16313884|NCT00460603|39633919|FG003|Phase 1|Lack of Efficacy|2|||
16508159|NCT00677807|40333316|FG001|Overall Study|Protocol Deviation|3|||
16313885|NCT00460603|39633920|FG004|Phase 1|Lack of Efficacy|2|||
16313886|NCT00460603|39633921|FG005|Phase 1|Lack of Efficacy|2|||
16313887|NCT00460603|39633922|FG006|Phase 1|Lack of Efficacy|2|||
16313888|NCT00460603|39633923|FG007|Phase 1|Lack of Efficacy|2|||
16313889|NCT00460603|39633924|FG008|Phase 1|Lack of Efficacy|11|||
16313890|NCT00460603|39633925|FG009|Phase 1|Lack of Efficacy|0|||
16313891|NCT00460603|39633926|FG010|Phase 1|Lack of Efficacy|0|||
16313892|NCT00460603|39633927|FG011|Phase 1|Lack of Efficacy|0|||
16508160|NCT00677807|40333317|FG002|Overall Study|Protocol Deviation|0|||
16508161|NCT01520363|40333318|FG000|Overall Study|Withdrawal by Subject|2|||
16508162|NCT01520363|40333319|FG001|Overall Study|Withdrawal by Subject|0|||
16313893|NCT00460603|39633916|FG000|Phase 1|Withdrawal by Subject|1|||
16313894|NCT00460603|39633917|FG001|Phase 1|Withdrawal by Subject|2|||
16313895|NCT00460603|39633918|FG002|Phase 1|Withdrawal by Subject|1|||
16313896|NCT00460603|39633919|FG003|Phase 1|Withdrawal by Subject|1|||
16313897|NCT00460603|39633920|FG004|Phase 1|Withdrawal by Subject|3|||
16313898|NCT00460603|39633921|FG005|Phase 1|Withdrawal by Subject|0|||
16313899|NCT00460603|39633922|FG006|Phase 1|Withdrawal by Subject|1|||
16313900|NCT00460603|39633923|FG007|Phase 1|Withdrawal by Subject|0|||
16313901|NCT00460603|39633924|FG008|Phase 1|Withdrawal by Subject|2|||
16508163|NCT01179477|40333324|FG000|Overall Study|Death|542|||
16508164|NCT01179477|40333324|FG000|Overall Study|Unsuccessful implant|80|||
16508165|NCT01179477|40333324|FG000|Overall Study|Non-death withdrawal|438|||
16508166|NCT01179477|40333324|FG000|Overall Study|Did not complete final visit|27|||
16508167|NCT02346136|40333326|FG000|Overall Study|Withdrawal by Subject|7|||
16508168|NCT02346136|40333327|FG001|Overall Study|Withdrawal by Subject|5|||
16508169|NCT02346136|40333326|FG000|Overall Study|Death|1|||
16508170|NCT02346136|40333327|FG001|Overall Study|Death|0|||
16508171|NCT02346136|40333326|FG000|Overall Study|Study termination|14|||
16508172|NCT02346136|40333327|FG001|Overall Study|Study termination|18|||
16508173|NCT02446236|40333328|FG000|Overall Study|Screen Failure|1|||
16508174|NCT02446236|40333329|FG001|Overall Study|Screen Failure|0|||
16508175|NCT02446236|40333330|FG002|Overall Study|Screen Failure|1|||
16508176|NCT02446236|40333328|FG000|Overall Study|Actively Receiving Therapy|0|||
16508177|NCT02446236|40333329|FG001|Overall Study|Actively Receiving Therapy|0|||
16508178|NCT02446236|40333330|FG002|Overall Study|Actively Receiving Therapy|1|||
16508179|NCT01251380|40333331|FG000|Overall Study|Other (Not otherwise specified)|12|||
16508180|NCT01251380|40333331|FG000|Overall Study|Withdrawal by Subject|6|||
16508181|NCT01251380|40333331|FG000|Overall Study|Lack of Efficacy|1|||
16508182|NCT01251380|40333331|FG000|Overall Study|Adverse Event|1|||
16508183|NCT01251380|40333331|FG000|Overall Study|Lost to Follow-up|2|||
16508184|NCT01434290|40333336|FG000|Overall Study|Protocol Violation|6|||
16313902|NCT00460603|39633925|FG009|Phase 1|Withdrawal by Subject|0|||
16508185|NCT01434290|40333337|FG001|Overall Study|Protocol Violation|3|||
16508186|NCT01434290|40333336|FG000|Overall Study|No protocol treatment|2|||
16508187|NCT01434290|40333337|FG001|Overall Study|No protocol treatment|4|||
16508188|NCT00101907|40333338|FG000|Overall Study|Adverse Event|1|||
16508189|NCT00101907|40333339|FG001|Overall Study|Adverse Event|0|||
16508190|NCT00101907|40333340|FG002|Overall Study|Adverse Event|0|||
16508191|NCT00101907|40333341|FG003|Overall Study|Adverse Event|0|||
16313903|NCT00460603|39633926|FG010|Phase 1|Withdrawal by Subject|0|||
16391469|NCT04179305|39916148|FG000|Overall Study|Lost to Follow-up|1|||
16508192|NCT00101907|40333342|FG004|Overall Study|Adverse Event|0|||
16508193|NCT00101907|40333343|FG005|Overall Study|Adverse Event|0|||
16508194|NCT00101907|40333338|FG000|Overall Study|Death|0|||
16508195|NCT00101907|40333339|FG001|Overall Study|Death|1|||
16313904|NCT00460603|39633927|FG011|Phase 1|Withdrawal by Subject|0|||
16313905|NCT00460603|39633916|FG000|Phase 1|Other|0|||
16313906|NCT00460603|39633917|FG001|Phase 1|Other|3|||
16508196|NCT00101907|40333340|FG002|Overall Study|Death|0|||
16508197|NCT00101907|40333341|FG003|Overall Study|Death|0|||
16508198|NCT00101907|40333342|FG004|Overall Study|Death|3|||
16508199|NCT00101907|40333343|FG005|Overall Study|Death|0|||
16508200|NCT00101907|40333338|FG000|Overall Study|Physician Decision|0|||
16508201|NCT00101907|40333339|FG001|Overall Study|Physician Decision|0|||
16508202|NCT00101907|40333340|FG002|Overall Study|Physician Decision|0|||
16508203|NCT00101907|40333341|FG003|Overall Study|Physician Decision|1|||
16508204|NCT00101907|40333342|FG004|Overall Study|Physician Decision|1|||
16508205|NCT00101907|40333343|FG005|Overall Study|Physician Decision|0|||
16508206|NCT00101907|40333338|FG000|Overall Study|Withdrawal by Subject|1|||
16508207|NCT00101907|40333339|FG001|Overall Study|Withdrawal by Subject|0|||
16508208|NCT00101907|40333340|FG002|Overall Study|Withdrawal by Subject|1|||
16508209|NCT00101907|40333341|FG003|Overall Study|Withdrawal by Subject|0|||
16508210|NCT00101907|40333342|FG004|Overall Study|Withdrawal by Subject|1|||
16508211|NCT00101907|40333343|FG005|Overall Study|Withdrawal by Subject|0|||
16508212|NCT02586493|40333344|FG000|Overall Study|Adverse Event|4|||
16508213|NCT02586493|40333344|FG000|Overall Study|Protocol Violation|6|||
16508214|NCT02586493|40333344|FG000|Overall Study|Lost to Follow-up|1|||
16508215|NCT02586493|40333344|FG000|Overall Study|Withdrawal by Subject|1|||
16508216|NCT01592344|40333346|FG000|Overall Study|Adverse Event|1|||
16508217|NCT01592344|40333347|FG001|Overall Study|Adverse Event|1|||
16508218|NCT01592344|40333346|FG000|Overall Study|Lack of Efficacy|1|||
16508219|NCT01592344|40333347|FG001|Overall Study|Lack of Efficacy|0|||
16508220|NCT01592344|40333346|FG000|Overall Study|not available at primary outcome visit|2|||
16508221|NCT01592344|40333347|FG001|Overall Study|not available at primary outcome visit|4|||
16508222|NCT04907032|40333348|FG000|Overall Study|Withdrawal by Subject|7|||
16508223|NCT04907032|40333349|FG001|Overall Study|Withdrawal by Subject|1|||
16508224|NCT01070316|40333352|FG000|Extension Phase|Lack of Efficacy|3|||
16508225|NCT01070316|40333352|FG000|Extension Phase|Withdrawal by Subject|1|||
16508226|NCT00851799|40333353|FG000|Overall Study|Death|1|||
16508227|NCT00851799|40333354|FG001|Overall Study|Death|0|||
16508228|NCT00851799|40333355|FG002|Overall Study|Death|1|||
16508229|NCT00851799|40333353|FG000|Overall Study|Lost to Follow-up|5|||
16508230|NCT00851799|40333354|FG001|Overall Study|Lost to Follow-up|3|||
16508231|NCT00851799|40333355|FG002|Overall Study|Lost to Follow-up|10|||
16508232|NCT00851799|40333353|FG000|Overall Study|Not able to get to clinic|8|||
16508233|NCT00851799|40333354|FG001|Overall Study|Not able to get to clinic|5|||
16508234|NCT00851799|40333355|FG002|Overall Study|Not able to get to clinic|9|||
16508235|NCT00851799|40333353|FG000|Overall Study|Not willing to adhere to requirements|1|||
16508236|NCT00851799|40333354|FG001|Overall Study|Not willing to adhere to requirements|2|||
16508237|NCT00851799|40333355|FG002|Overall Study|Not willing to adhere to requirements|2|||
16508238|NCT00851799|40333353|FG000|Overall Study|Withdrew consent prior study completion|1|||
16508239|NCT00851799|40333354|FG001|Overall Study|Withdrew consent prior study completion|2|||
16508240|NCT00851799|40333355|FG002|Overall Study|Withdrew consent prior study completion|1|||
16508241|NCT00851799|40333353|FG000|Overall Study|Severe Debilitation|0|||
16508242|NCT00851799|40333354|FG001|Overall Study|Severe Debilitation|1|||
16508243|NCT00851799|40333355|FG002|Overall Study|Severe Debilitation|0|||
16508244|NCT00851799|40333353|FG000|Overall Study|Completed protocol due to pregnancy|0|||
16508245|NCT00851799|40333354|FG001|Overall Study|Completed protocol due to pregnancy|0|||
16508246|NCT00851799|40333355|FG002|Overall Study|Completed protocol due to pregnancy|1|||
16391470|NCT04179305|39916149|FG001|Overall Study|Lost to Follow-up|1|||
16391471|NCT04179305|39916150|FG002|Overall Study|Lost to Follow-up|0|||
16391472|NCT04179305|39916151|FG003|Overall Study|Lost to Follow-up|0|||
16391473|NCT04179305|39916148|FG000|Overall Study|Withdrawal by Subject|0|||
16391474|NCT04179305|39916149|FG001|Overall Study|Withdrawal by Subject|1|||
16391475|NCT04179305|39916150|FG002|Overall Study|Withdrawal by Subject|0|||
16391476|NCT04179305|39916151|FG003|Overall Study|Withdrawal by Subject|0|||
16391477|NCT04179305|39916148|FG000|Overall Study|Did not have scan|1|||
16391478|NCT04179305|39916149|FG001|Overall Study|Did not have scan|0|||
16391479|NCT04179305|39916150|FG002|Overall Study|Did not have scan|0|||
16391480|NCT04179305|39916151|FG003|Overall Study|Did not have scan|0|||
16508247|NCT02308735|40333358|FG000|Overall Study|Physician Decision|2|||
16508248|NCT02308735|40333359|FG001|Overall Study|Physician Decision|0|||
16313907|NCT00460603|39633918|FG002|Phase 1|Other|1|||
16508249|NCT02308735|40333360|FG002|Overall Study|Physician Decision|0|||
16508250|NCT02308735|40333361|FG003|Overall Study|Physician Decision|2|||
16508251|NCT04847674|40333362|FG000|Overall Study|Withdrawal by Subject|0|||
16508252|NCT04847674|40333363|FG001|Overall Study|Withdrawal by Subject|1|||
16391481|NCT04179305|39916148|FG000|Overall Study|In hospice care|3|||
16197334|NCT02702011|39197502|FG003|Overall Study|Withdrawal by Subject|0|||
16197335|NCT00165841|39197503|FG000|Overall Study|Adverse Event|2|||
16197336|NCT00165841|39197504|FG001|Overall Study|Adverse Event|3|||
16197337|NCT00165841|39197503|FG000|Overall Study|Lack of Efficacy|6|||
16197338|NCT00165841|39197504|FG001|Overall Study|Lack of Efficacy|33|||
16197339|NCT00165841|39197503|FG000|Overall Study|Lost to Follow-up|4|||
16197340|NCT00165841|39197504|FG001|Overall Study|Lost to Follow-up|4|||
16197341|NCT00165841|39197503|FG000|Overall Study|Withdrawal by Subject|7|||
16197342|NCT00165841|39197504|FG001|Overall Study|Withdrawal by Subject|8|||
16197343|NCT00165841|39197503|FG000|Overall Study|Physician Decision|1|||
16197344|NCT00165841|39197504|FG001|Overall Study|Physician Decision|0|||
16197345|NCT00165841|39197503|FG000|Overall Study|Protocol Violation|6|||
16197346|NCT00165841|39197504|FG001|Overall Study|Protocol Violation|8|||
16197347|NCT00165841|39197503|FG000|Overall Study|Other|3|||
16197348|NCT00165841|39197504|FG001|Overall Study|Other|5|||
16197349|NCT00165841|39197503|FG000|Overall Study|Medication Noncompliance|1|||
16197350|NCT00165841|39197504|FG001|Overall Study|Medication Noncompliance|1|||
16197351|NCT02605447|39197505|FG000|Overall Study|Death|66|||
16197352|NCT02605447|39197505|FG000|Overall Study|Physician Decision|1|||
16197353|NCT02605447|39197505|FG000|Overall Study|Lost to Follow-up|24|||
16197354|NCT02605447|39197505|FG000|Overall Study|Withdrawal by Subject|10|||
16197355|NCT02605447|39197505|FG000|Overall Study|Not disclosed|1|||
16197356|NCT00434512|39197509|FG000|Overall Study|Migrated/moved from study area|0|||
16197357|NCT00434512|39197510|FG001|Overall Study|Migrated/moved from study area|0|||
16197358|NCT00434512|39197511|FG002|Overall Study|Migrated/moved from study area|0|||
16197359|NCT00434512|39197512|FG003|Overall Study|Migrated/moved from study area|1|||
16197360|NCT00434512|39197513|FG004|Overall Study|Migrated/moved from study area|1|||
16197361|NCT00434512|39197514|FG005|Overall Study|Migrated/moved from study area|1|||
16197362|NCT00434512|39197509|FG000|Overall Study|Other|0|||
16197363|NCT00434512|39197510|FG001|Overall Study|Other|1|||
16197364|NCT00434512|39197511|FG002|Overall Study|Other|0|||
16197365|NCT00434512|39197512|FG003|Overall Study|Other|0|||
16197366|NCT00434512|39197513|FG004|Overall Study|Other|0|||
16197367|NCT00434512|39197514|FG005|Overall Study|Other|0|||
16197368|NCT01094730|39197515|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
16197369|NCT01094730|39197516|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
16197370|NCT01094730|39197515|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
16197371|NCT01094730|39197516|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
16197372|NCT01094730|39197515|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
16197373|NCT01094730|39197516|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
16197374|NCT01094730|39197515|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
16197375|NCT01094730|39197516|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
16197376|NCT01094730|39197515|FG000|Period 2 (14 Days)|Protocol Violation|2|||
16197377|NCT01094730|39197516|FG001|Period 2 (14 Days)|Protocol Violation|0|||
16197378|NCT01094730|39197515|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
16197379|NCT01094730|39197516|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
16197380|NCT01094730|39197515|FG000|Period 2 (14 Days)|Adverse Event|0|||
16197381|NCT01094730|39197516|FG001|Period 2 (14 Days)|Adverse Event|1|||
16197382|NCT01094730|39197515|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
16197383|NCT01094730|39197516|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
16197384|NCT00747617|39197517|FG000|Overall Study|Lost to Follow-up|3|||
16197385|NCT00747617|39197518|FG001|Overall Study|Lost to Follow-up|1|||
16197386|NCT01315847|39197519|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
16197387|NCT01315847|39197520|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
16197388|NCT01315847|39197519|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
16197389|NCT01315847|39197520|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
16197390|NCT04831515|39197521|FG000|First Intervention|Adverse Event|0|||
16197391|NCT04831515|39197522|FG001|First Intervention|Adverse Event|1|||
16197392|NCT00111917|39197523|FG000|Overall Study|Withdrawal by Subject|1|||
16197393|NCT00111917|39197524|FG001|Overall Study|Withdrawal by Subject|1|||
16197394|NCT02232087|39197526|FG000|Overall Study|Withdrawal by Subject|2|||
16313908|NCT00460603|39633919|FG003|Phase 1|Other|1|||
16508253|NCT04847674|40333364|FG002|Overall Study|Withdrawal by Subject|0|||
16508254|NCT04847674|40333362|FG000|Overall Study|Lost to Follow-up|0|||
16508255|NCT04847674|40333363|FG001|Overall Study|Lost to Follow-up|0|||
16508256|NCT04847674|40333364|FG002|Overall Study|Lost to Follow-up|2|||
16508257|NCT04847674|40333362|FG000|Overall Study|Other than specified|21|||
16508258|NCT04847674|40333363|FG001|Overall Study|Other than specified|20|||
16197395|NCT02232087|39197527|FG001|Overall Study|Withdrawal by Subject|0|||
16197396|NCT02232087|39197528|FG002|Overall Study|Withdrawal by Subject|0|||
16508259|NCT04847674|40333364|FG002|Overall Study|Other than specified|20|||
16197397|NCT02232087|39197529|FG003|Overall Study|Withdrawal by Subject|0|||
16197398|NCT02232087|39197530|FG004|Overall Study|Withdrawal by Subject|0|||
16197399|NCT02232087|39197531|FG005|Overall Study|Withdrawal by Subject|1|||
16197400|NCT02232087|39197526|FG000|Overall Study|poor inhalation technique|0|||
16197401|NCT02232087|39197527|FG001|Overall Study|poor inhalation technique|1|||
16508260|NCT04753164|40333370|FG000|Overall Study|Adverse Event|0|||
16313909|NCT00460603|39633920|FG004|Phase 1|Other|1|||
16313910|NCT00460603|39633921|FG005|Phase 1|Other|2|||
16313911|NCT00460603|39633922|FG006|Phase 1|Other|0|||
16313912|NCT00460603|39633923|FG007|Phase 1|Other|1|||
16313913|NCT00460603|39633924|FG008|Phase 1|Other|0|||
16313914|NCT00460603|39633925|FG009|Phase 1|Other|0|||
16313915|NCT00460603|39633926|FG010|Phase 1|Other|0|||
16313916|NCT00460603|39633927|FG011|Phase 1|Other|0|||
16313917|NCT00460603|39633916|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313918|NCT00460603|39633917|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313919|NCT00460603|39633918|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313920|NCT00460603|39633919|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313921|NCT00460603|39633920|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313922|NCT00460603|39633921|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313923|NCT00460603|39633922|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313924|NCT00460603|39633923|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313925|NCT00460603|39633924|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313926|NCT00460603|39633925|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
16313927|NCT00460603|39633926|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313928|NCT00460603|39633927|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
16313929|NCT00460603|39633916|FG000|Phase 2|Adverse Event|0|||
16313930|NCT00460603|39633917|FG001|Phase 2|Adverse Event|0|||
16313931|NCT00460603|39633918|FG002|Phase 2|Adverse Event|0|||
16313932|NCT00460603|39633919|FG003|Phase 2|Adverse Event|0|||
16313933|NCT00460603|39633920|FG004|Phase 2|Adverse Event|0|||
16313934|NCT00460603|39633921|FG005|Phase 2|Adverse Event|0|||
16313935|NCT00460603|39633922|FG006|Phase 2|Adverse Event|0|||
16313936|NCT00460603|39633923|FG007|Phase 2|Adverse Event|0|||
16313937|NCT00460603|39633924|FG008|Phase 2|Adverse Event|0|||
16313938|NCT00460603|39633925|FG009|Phase 2|Adverse Event|12|||
16313939|NCT00460603|39633926|FG010|Phase 2|Adverse Event|9|||
16313940|NCT00460603|39633927|FG011|Phase 2|Adverse Event|10|||
16313941|NCT00460603|39633916|FG000|Phase 2|Death|0|||
16313942|NCT00460603|39633917|FG001|Phase 2|Death|0|||
16313943|NCT00460603|39633918|FG002|Phase 2|Death|0|||
16313944|NCT00460603|39633919|FG003|Phase 2|Death|0|||
16313945|NCT00460603|39633920|FG004|Phase 2|Death|0|||
16508261|NCT04753164|40333371|FG001|Overall Study|Adverse Event|2|||
16508262|NCT04753164|40333370|FG000|Overall Study|Withdrawal by Subject|9|||
16508263|NCT04753164|40333371|FG001|Overall Study|Withdrawal by Subject|7|||
16508264|NCT04753164|40333370|FG000|Overall Study|Lost to Follow-up|6|||
16508265|NCT04753164|40333371|FG001|Overall Study|Lost to Follow-up|6|||
16508266|NCT04753164|40333370|FG000|Overall Study|Other|12|||
16508267|NCT04753164|40333371|FG001|Overall Study|Other|5|||
16508268|NCT03168464|40333375|FG000|Overall Study|Death|9|||
16508269|NCT03168464|40333375|FG000|Overall Study|Progression of disease|6|||
16508270|NCT03999892|40333376|FG000|Overall Study|Lost to Follow-up|1|||
16508271|NCT00277212|40333387|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
16508272|NCT00277212|40333388|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
16508273|NCT00277212|40333389|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
16508274|NCT00277212|40333387|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
16508275|NCT00277212|40333388|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
16508276|NCT00277212|40333389|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
16508277|NCT00277212|40333387|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
16508278|NCT00277212|40333388|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
16508279|NCT00277212|40333389|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
16508280|NCT00277212|40333387|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
16508281|NCT00277212|40333388|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
16508282|NCT00277212|40333389|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
16508283|NCT00277212|40333387|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
16508284|NCT00277212|40333388|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
16508285|NCT00277212|40333389|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
16508286|NCT00277212|40333387|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
16508287|NCT00277212|40333388|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
16508288|NCT00277212|40333389|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
16508289|NCT00277212|40333387|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
16508290|NCT00277212|40333388|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
16313946|NCT00460603|39633921|FG005|Phase 2|Death|0|||
16313947|NCT00460603|39633922|FG006|Phase 2|Death|0|||
16313948|NCT00460603|39633923|FG007|Phase 2|Death|0|||
16313949|NCT00460603|39633924|FG008|Phase 2|Death|0|||
16313950|NCT00460603|39633925|FG009|Phase 2|Death|4|||
16313951|NCT00460603|39633926|FG010|Phase 2|Death|2|||
16313952|NCT00460603|39633927|FG011|Phase 2|Death|2|||
16313953|NCT00460603|39633916|FG000|Phase 2|Protocol Violation|0|||
16313954|NCT00460603|39633917|FG001|Phase 2|Protocol Violation|0|||
16313955|NCT00460603|39633918|FG002|Phase 2|Protocol Violation|0|||
16313956|NCT00460603|39633919|FG003|Phase 2|Protocol Violation|0|||
16313957|NCT00460603|39633920|FG004|Phase 2|Protocol Violation|0|||
16313958|NCT00460603|39633921|FG005|Phase 2|Protocol Violation|0|||
16313959|NCT00460603|39633922|FG006|Phase 2|Protocol Violation|0|||
16313960|NCT00460603|39633923|FG007|Phase 2|Protocol Violation|0|||
16313961|NCT00460603|39633924|FG008|Phase 2|Protocol Violation|0|||
16313962|NCT00460603|39633925|FG009|Phase 2|Protocol Violation|1|||
16313963|NCT00460603|39633926|FG010|Phase 2|Protocol Violation|1|||
16313964|NCT00460603|39633927|FG011|Phase 2|Protocol Violation|0|||
16391482|NCT04179305|39916149|FG001|Overall Study|In hospice care|0|||
16391483|NCT04179305|39916150|FG002|Overall Study|In hospice care|0|||
16391484|NCT04179305|39916151|FG003|Overall Study|In hospice care|0|||
16391485|NCT00589797|39916154|FG000|Overall Study|Death|1|||
16391486|NCT00589797|39916155|FG001|Overall Study|Death|0|||
16391487|NCT00589797|39916154|FG000|Overall Study|Lost to Follow-up|12|||
16391488|NCT00589797|39916155|FG001|Overall Study|Lost to Follow-up|9|||
16391489|NCT00589797|39916154|FG000|Overall Study|Physician Decision|8|||
16391490|NCT00589797|39916155|FG001|Overall Study|Physician Decision|3|||
16391491|NCT00589797|39916154|FG000|Overall Study|Withdrawal by Subject|6|||
16391492|NCT00589797|39916155|FG001|Overall Study|Withdrawal by Subject|5|||
16313965|NCT00460603|39633916|FG000|Phase 2|Lost to Follow-up|0|||
16313966|NCT00460603|39633917|FG001|Phase 2|Lost to Follow-up|0|||
16313967|NCT00460603|39633918|FG002|Phase 2|Lost to Follow-up|0|||
16313968|NCT00460603|39633919|FG003|Phase 2|Lost to Follow-up|0|||
16313969|NCT00460603|39633920|FG004|Phase 2|Lost to Follow-up|0|||
16313970|NCT00460603|39633921|FG005|Phase 2|Lost to Follow-up|0|||
16313971|NCT00460603|39633922|FG006|Phase 2|Lost to Follow-up|0|||
16313972|NCT00460603|39633923|FG007|Phase 2|Lost to Follow-up|0|||
16313973|NCT00460603|39633924|FG008|Phase 2|Lost to Follow-up|0|||
16313974|NCT00460603|39633925|FG009|Phase 2|Lost to Follow-up|1|||
16313975|NCT00460603|39633926|FG010|Phase 2|Lost to Follow-up|0|||
16313976|NCT00460603|39633927|FG011|Phase 2|Lost to Follow-up|0|||
16313977|NCT00460603|39633916|FG000|Phase 2|Other|0|||
16313978|NCT00460603|39633917|FG001|Phase 2|Other|0|||
16313979|NCT00460603|39633918|FG002|Phase 2|Other|0|||
16313980|NCT00460603|39633919|FG003|Phase 2|Other|0|||
16313981|NCT00460603|39633920|FG004|Phase 2|Other|0|||
16313982|NCT00460603|39633921|FG005|Phase 2|Other|0|||
16313983|NCT00460603|39633922|FG006|Phase 2|Other|0|||
16313984|NCT00460603|39633923|FG007|Phase 2|Other|0|||
16313985|NCT00460603|39633924|FG008|Phase 2|Other|0|||
16313986|NCT00460603|39633925|FG009|Phase 2|Other|6|||
16313987|NCT00460603|39633926|FG010|Phase 2|Other|16|||
16313988|NCT00460603|39633927|FG011|Phase 2|Other|7|||
16313989|NCT00460603|39633916|FG000|Phase 2|Objective Progression or Relapse|0|||
16313990|NCT00460603|39633917|FG001|Phase 2|Objective Progression or Relapse|0|||
16313991|NCT00460603|39633918|FG002|Phase 2|Objective Progression or Relapse|0|||
16391493|NCT00589797|39916154|FG000|Overall Study|Non-Randomized Training Subjects|46|||
16313992|NCT00460603|39633919|FG003|Phase 2|Objective Progression or Relapse|0|||
16313993|NCT00460603|39633920|FG004|Phase 2|Objective Progression or Relapse|0|||
16313994|NCT00460603|39633921|FG005|Phase 2|Objective Progression or Relapse|0|||
16313995|NCT00460603|39633922|FG006|Phase 2|Objective Progression or Relapse|0|||
16313996|NCT00460603|39633923|FG007|Phase 2|Objective Progression or Relapse|0|||
16313997|NCT00460603|39633924|FG008|Phase 2|Objective Progression or Relapse|0|||
16313998|NCT00460603|39633925|FG009|Phase 2|Objective Progression or Relapse|9|||
16391494|NCT00589797|39916155|FG001|Overall Study|Non-Randomized Training Subjects|6|||
16391495|NCT02382991|39916161|FG000|Overall Study|Adverse Event|1|||
16508291|NCT00277212|40333389|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
16508292|NCT00277212|40333387|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
16508293|NCT00277212|40333388|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
16508294|NCT00277212|40333389|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
16508295|NCT00277212|40333387|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
16508296|NCT00277212|40333388|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
16508297|NCT00277212|40333389|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
16508298|NCT00277212|40333387|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
16197402|NCT02232087|39197528|FG002|Overall Study|poor inhalation technique|0|||
16197403|NCT02232087|39197529|FG003|Overall Study|poor inhalation technique|0|||
16197404|NCT02232087|39197530|FG004|Overall Study|poor inhalation technique|0|||
16197405|NCT02232087|39197531|FG005|Overall Study|poor inhalation technique|2|||
16197406|NCT02232087|39197526|FG000|Overall Study|protocol stop criteria|0|||
16197407|NCT02232087|39197527|FG001|Overall Study|protocol stop criteria|1|||
16197408|NCT02232087|39197528|FG002|Overall Study|protocol stop criteria|0|||
16197409|NCT02232087|39197529|FG003|Overall Study|protocol stop criteria|1|||
16197410|NCT02232087|39197530|FG004|Overall Study|protocol stop criteria|0|||
16197411|NCT02232087|39197531|FG005|Overall Study|protocol stop criteria|0|||
16197412|NCT02232087|39197526|FG000|Overall Study|Adverse Event|0|||
16197413|NCT02232087|39197527|FG001|Overall Study|Adverse Event|0|||
16197414|NCT02232087|39197528|FG002|Overall Study|Adverse Event|0|||
16197415|NCT02232087|39197529|FG003|Overall Study|Adverse Event|0|||
16197416|NCT02232087|39197530|FG004|Overall Study|Adverse Event|1|||
16197417|NCT02232087|39197531|FG005|Overall Study|Adverse Event|0|||
16197418|NCT03095521|39197532|FG000|Overall Study|Withdrawal by Subject|0|||
16197419|NCT03095521|39197533|FG001|Overall Study|Withdrawal by Subject|1|||
16197420|NCT03095521|39197532|FG000|Overall Study|Lost to Follow-up|0|||
16197421|NCT03095521|39197533|FG001|Overall Study|Lost to Follow-up|1|||
16197422|NCT01954251|39197536|FG000|Overall Study|Adverse Event|5|||
16197423|NCT01954251|39197537|FG001|Overall Study|Adverse Event|7|||
16197424|NCT01954251|39197536|FG000|Overall Study|Lost to Follow-up|6|||
16197425|NCT01954251|39197537|FG001|Overall Study|Lost to Follow-up|6|||
16197426|NCT01954251|39197536|FG000|Overall Study|Withdrawal by Subject|2|||
16197427|NCT01954251|39197537|FG001|Overall Study|Withdrawal by Subject|6|||
16197428|NCT01009983|39197542|FG000|Overall Study|necessary scans not completed|1|||
16197429|NCT00748553|39197543|FG000|Overall Study|Adverse Event|0|||
16197430|NCT00748553|39197544|FG001|Overall Study|Adverse Event|1|||
16197431|NCT00748553|39197543|FG000|Overall Study|disease progression|2|||
16197432|NCT00748553|39197544|FG001|Overall Study|disease progression|0|||
16197433|NCT00748553|39197543|FG000|Overall Study|noncompliance|1|||
16197434|NCT00748553|39197544|FG001|Overall Study|noncompliance|0|||
16197435|NCT01114373|39197545|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
16197436|NCT01114373|39197546|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
16197437|NCT01114373|39197545|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
16197438|NCT01114373|39197546|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
16197439|NCT01114373|39197545|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
16197440|NCT01114373|39197546|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
16197441|NCT01114373|39197545|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
16197442|NCT01114373|39197546|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
16197443|NCT03446651|39201102|FG000|Overall Study|Lost to Follow-up|4|||
16197444|NCT03446651|39201103|FG001|Overall Study|Lost to Follow-up|0|||
16391496|NCT02382991|39916162|FG001|Overall Study|Adverse Event|2|||
16391497|NCT02382991|39916161|FG000|Overall Study|Lost to Follow-up|1|||
16391498|NCT02382991|39916162|FG001|Overall Study|Lost to Follow-up|0|||
16508299|NCT00277212|40333388|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
16391499|NCT02382991|39916161|FG000|Overall Study|Withdrawal by Subject|0|||
16391500|NCT02382991|39916162|FG001|Overall Study|Withdrawal by Subject|1|||
16508300|NCT00277212|40333389|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
16508301|NCT00277212|40333387|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
16508302|NCT00277212|40333388|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
16508303|NCT00277212|40333389|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
16508304|NCT00277212|40333387|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
16508305|NCT00277212|40333388|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
16508306|NCT00277212|40333389|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
16508307|NCT00277212|40333387|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
16391501|NCT03386435|39916163|FG000|Overall Study|Protocol Violation|5|||
16391502|NCT03386435|39916164|FG001|Overall Study|Protocol Violation|7|||
16197445|NCT03446651|39201102|FG000|Overall Study|Open Label Participants|5|||
16391503|NCT00582712|39916165|FG000|Overall Study|Adverse Event|1|||
16391504|NCT00582712|39916165|FG000|Overall Study|Lack of Efficacy|1|||
16197446|NCT03446651|39201103|FG001|Overall Study|Open Label Participants|0|||
16197447|NCT02387372|39201106|FG000|Overall Study|Not Treated|1|||
16391505|NCT00582712|39916165|FG000|Overall Study|Withdrawal by Subject|1|||
16391506|NCT00582712|39916165|FG000|Overall Study|Complicating disease requiring treatment|1|||
16508308|NCT00277212|40333388|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
16508309|NCT00277212|40333389|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
16508310|NCT00277212|40333387|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
16391507|NCT03896477|39916166|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
16391508|NCT03896477|39916167|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
16391509|NCT03896477|39916168|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
16391510|NCT03896477|39916166|FG000|Overall Study|Parent Requested Withdrawal|8|||
16391511|NCT03896477|39916167|FG001|Overall Study|Parent Requested Withdrawal|12|||
16391512|NCT03896477|39916168|FG002|Overall Study|Parent Requested Withdrawal|9|||
16391513|NCT03896477|39916166|FG000|Overall Study|Adverse Event|0|||
16391514|NCT03896477|39916167|FG001|Overall Study|Adverse Event|0|||
16391515|NCT03896477|39916168|FG002|Overall Study|Adverse Event|1|||
16391516|NCT03896477|39916166|FG000|Overall Study|Death|1|||
16391517|NCT03896477|39916167|FG001|Overall Study|Death|0|||
16391518|NCT03896477|39916168|FG002|Overall Study|Death|0|||
16391519|NCT03896477|39916166|FG000|Overall Study|Other|5|||
16391520|NCT03896477|39916167|FG001|Overall Study|Other|6|||
16391521|NCT03896477|39916168|FG002|Overall Study|Other|7|||
16391522|NCT03896477|39916166|FG000|Overall Study|Lost to Follow-up|2|||
16391523|NCT03896477|39916167|FG001|Overall Study|Lost to Follow-up|1|||
16391524|NCT03896477|39916168|FG002|Overall Study|Lost to Follow-up|1|||
16391525|NCT00120627|39916172|FG000|Overall Study|Withdrawal by Subject|5|||
16391526|NCT00120627|39916173|FG001|Overall Study|Withdrawal by Subject|5|||
16391527|NCT01182298|39916179|FG000|Overall Study|Lack of Efficacy|4|||
16391528|NCT01182298|39916179|FG000|Overall Study|Withdrawal by Subject|2|||
16391529|NCT02446769|39916183|FG000|Screening Period|Screen Failure|11|||
16391530|NCT02446769|39916184|FG001|Screening Period|Screen Failure|0|||
16391531|NCT02446769|39916185|FG002|Screening Period|Screen Failure|0|||
16391532|NCT02446769|39916183|FG000|Study Period|Randomized in Error|0|||
16391533|NCT02446769|39916184|FG001|Study Period|Randomized in Error|2|||
16391534|NCT02446769|39916185|FG002|Study Period|Randomized in Error|0|||
16391535|NCT00470262|39916186|FG000|Overall Study|Withdrawal by Subject|2|||
16391536|NCT00470262|39916187|FG001|Overall Study|Withdrawal by Subject|0|||
16391537|NCT03314935|39916188|FG000|Phase 1|Death|4|||
16391538|NCT03314935|39916189|FG001|Phase 1|Death|2|||
16391539|NCT03314935|39916190|FG002|Phase 1|Death|5|||
16391540|NCT03314935|39916191|FG003|Phase 1|Death|4|||
16391541|NCT03314935|39916192|FG004|Phase 1|Death|3|||
16391542|NCT03314935|39916193|FG005|Phase 1|Death|4|||
16391543|NCT03314935|39916194|FG006|Phase 1|Death|5|||
16391544|NCT03314935|39916195|FG007|Phase 1|Death|4|||
16391545|NCT03314935|39916196|FG008|Phase 1|Death|3|||
16391546|NCT03314935|39916197|FG009|Phase 1|Death|0|||
16391547|NCT03314935|39916198|FG010|Phase 1|Death|0|||
16391548|NCT03314935|39916199|FG011|Phase 1|Death|0|||
16391549|NCT03314935|39916200|FG012|Phase 1|Death|0|||
16391550|NCT03314935|39916201|FG013|Phase 1|Death|0|||
16391551|NCT03314935|39916202|FG014|Phase 1|Death|0|||
16391552|NCT03314935|39916188|FG000|Phase 1|Withdrawal by Subject|2|||
16391553|NCT03314935|39916189|FG001|Phase 1|Withdrawal by Subject|1|||
16391554|NCT03314935|39916190|FG002|Phase 1|Withdrawal by Subject|1|||
16391555|NCT03314935|39916191|FG003|Phase 1|Withdrawal by Subject|2|||
16391556|NCT03314935|39916192|FG004|Phase 1|Withdrawal by Subject|1|||
16391557|NCT03314935|39916193|FG005|Phase 1|Withdrawal by Subject|0|||
16391558|NCT03314935|39916194|FG006|Phase 1|Withdrawal by Subject|1|||
16391559|NCT03314935|39916195|FG007|Phase 1|Withdrawal by Subject|0|||
16391560|NCT03314935|39916196|FG008|Phase 1|Withdrawal by Subject|1|||
16391561|NCT03314935|39916197|FG009|Phase 1|Withdrawal by Subject|0|||
16391562|NCT03314935|39916198|FG010|Phase 1|Withdrawal by Subject|0|||
16391563|NCT03314935|39916199|FG011|Phase 1|Withdrawal by Subject|0|||
16391564|NCT03314935|39916200|FG012|Phase 1|Withdrawal by Subject|0|||
16391565|NCT03314935|39916201|FG013|Phase 1|Withdrawal by Subject|0|||
16391566|NCT03314935|39916202|FG014|Phase 1|Withdrawal by Subject|0|||
16391567|NCT03314935|39916188|FG000|Phase 1|Progressive Disease|2|||
16391568|NCT03314935|39916189|FG001|Phase 1|Progressive Disease|0|||
16391569|NCT03314935|39916190|FG002|Phase 1|Progressive Disease|0|||
16391570|NCT03314935|39916191|FG003|Phase 1|Progressive Disease|1|||
16391571|NCT03314935|39916192|FG004|Phase 1|Progressive Disease|0|||
16391572|NCT03314935|39916193|FG005|Phase 1|Progressive Disease|0|||
16391573|NCT03314935|39916194|FG006|Phase 1|Progressive Disease|0|||
16391574|NCT03314935|39916195|FG007|Phase 1|Progressive Disease|0|||
16391575|NCT03314935|39916196|FG008|Phase 1|Progressive Disease|0|||
16391576|NCT03314935|39916197|FG009|Phase 1|Progressive Disease|0|||
16391577|NCT03314935|39916198|FG010|Phase 1|Progressive Disease|0|||
16391578|NCT03314935|39916199|FG011|Phase 1|Progressive Disease|0|||
16391579|NCT03314935|39916200|FG012|Phase 1|Progressive Disease|0|||
16391580|NCT03314935|39916201|FG013|Phase 1|Progressive Disease|0|||
16391581|NCT03314935|39916202|FG014|Phase 1|Progressive Disease|0|||
16391582|NCT03314935|39916188|FG000|Phase 1|Study Terminated by Sponsor|0|||
16391583|NCT03314935|39916189|FG001|Phase 1|Study Terminated by Sponsor|1|||
16391584|NCT03314935|39916190|FG002|Phase 1|Study Terminated by Sponsor|0|||
16391585|NCT03314935|39916191|FG003|Phase 1|Study Terminated by Sponsor|0|||
16391586|NCT03314935|39916192|FG004|Phase 1|Study Terminated by Sponsor|0|||
16391587|NCT03314935|39916193|FG005|Phase 1|Study Terminated by Sponsor|0|||
16391588|NCT03314935|39916194|FG006|Phase 1|Study Terminated by Sponsor|0|||
16391589|NCT03314935|39916195|FG007|Phase 1|Study Terminated by Sponsor|0|||
16391590|NCT03314935|39916196|FG008|Phase 1|Study Terminated by Sponsor|1|||
16391591|NCT03314935|39916197|FG009|Phase 1|Study Terminated by Sponsor|0|||
16391592|NCT03314935|39916198|FG010|Phase 1|Study Terminated by Sponsor|0|||
16391593|NCT03314935|39916199|FG011|Phase 1|Study Terminated by Sponsor|0|||
16391594|NCT03314935|39916200|FG012|Phase 1|Study Terminated by Sponsor|0|||
16391595|NCT03314935|39916201|FG013|Phase 1|Study Terminated by Sponsor|0|||
16508311|NCT00277212|40333388|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
16508312|NCT00277212|40333389|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
16508313|NCT00277212|40333387|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
16508314|NCT00277212|40333388|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
16508315|NCT00277212|40333389|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
16508316|NCT00277212|40333387|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
16508317|NCT00277212|40333388|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
16508318|NCT00277212|40333389|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
16508319|NCT00277212|40333387|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
16508320|NCT00277212|40333388|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
16508321|NCT00277212|40333389|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
16508322|NCT00277212|40333387|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
16508323|NCT00277212|40333388|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
16508324|NCT00277212|40333389|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
16508325|NCT03551210|40333395|FG000|Overall Study|Adverse Event|5|||
16508326|NCT03551210|40333396|FG001|Overall Study|Adverse Event|6|||
16508327|NCT03551210|40333395|FG000|Overall Study|Withdrawal by Subject|1|||
16508328|NCT03551210|40333396|FG001|Overall Study|Withdrawal by Subject|7|||
16508329|NCT03551210|40333395|FG000|Overall Study|Needed in other antibiotic treatment|2|||
16508330|NCT03551210|40333396|FG001|Overall Study|Needed in other antibiotic treatment|5|||
16508331|NCT03551210|40333395|FG000|Overall Study|Lost to Follow-up|1|||
16508332|NCT03551210|40333396|FG001|Overall Study|Lost to Follow-up|1|||
16508333|NCT03551210|40333395|FG000|Overall Study|Absence of visit 4 and 5|1|||
16508334|NCT03551210|40333396|FG001|Overall Study|Absence of visit 4 and 5|0|||
16508335|NCT03551210|40333395|FG000|Overall Study|No drug for dispensing|0|||
16508336|NCT03551210|40333396|FG001|Overall Study|No drug for dispensing|1|||
16508337|NCT03792672|40333411|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
16508338|NCT03792672|40333412|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
16508339|NCT03792672|40333413|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
16508340|NCT03792672|40333414|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
16508341|NCT03792672|40333415|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
16508342|NCT03792672|40333416|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
16508343|NCT03792672|40333411|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
16508344|NCT03792672|40333412|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
16508345|NCT03792672|40333413|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
16508346|NCT03792672|40333414|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
16508347|NCT03792672|40333415|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
16508348|NCT03792672|40333416|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
16508349|NCT03792672|40333411|FG000|Treatment Period 4 (2 Days)|Other|1|||
16508350|NCT03792672|40333412|FG001|Treatment Period 4 (2 Days)|Other|0|||
16508351|NCT03792672|40333413|FG002|Treatment Period 4 (2 Days)|Other|0|||
16508352|NCT03792672|40333414|FG003|Treatment Period 4 (2 Days)|Other|0|||
16391596|NCT03314935|39916202|FG014|Phase 1|Study Terminated by Sponsor|0|||
16391597|NCT03314935|39916188|FG000|Phase 1|"Captured as Other in Database"|0|||
16508353|NCT03792672|40333415|FG004|Treatment Period 4 (2 Days)|Other|0|||
16508354|NCT03792672|40333416|FG005|Treatment Period 4 (2 Days)|Other|0|||
16508355|NCT05402995|40333419|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
16508356|NCT05402995|40333420|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
16508357|NCT05402995|40333421|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
16508358|NCT05402995|40333422|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
16508359|NCT00486265|40333431|FG000|Overall Study|Adverse Event|1|||
16508360|NCT00486265|40333431|FG000|Overall Study|Lack of Efficacy|8|||
16508361|NCT01367158|40333432|FG000|Overall Study|Withdrew consent|0|||
16508362|NCT01367158|40333433|FG001|Overall Study|Withdrew consent|2|||
16508363|NCT01367158|40333434|FG002|Overall Study|Withdrew consent|1|||
16508364|NCT01367158|40333435|FG003|Overall Study|Withdrew consent|0|||
16508365|NCT01367158|40333436|FG004|Overall Study|Withdrew consent|2|||
16508366|NCT01367158|40333437|FG005|Overall Study|Withdrew consent|0|||
16508367|NCT01367158|40333438|FG006|Overall Study|Withdrew consent|0|||
16508368|NCT01367158|40333439|FG007|Overall Study|Withdrew consent|1|||
16508369|NCT01367158|40333440|FG008|Overall Study|Withdrew consent|0|||
16197448|NCT02387372|39201107|FG001|Overall Study|Not Treated|0|||
16197449|NCT00373490|39201108|FG000|Overall Study|Adverse Event|0|||
16197450|NCT00373490|39201109|FG001|Overall Study|Adverse Event|1|||
16197451|NCT00373490|39201108|FG000|Overall Study|Lack of Efficacy|9|||
16197452|NCT00373490|39201109|FG001|Overall Study|Lack of Efficacy|4|||
16197453|NCT00373490|39201108|FG000|Overall Study|Withdrawal by Subject|0|||
16197454|NCT00373490|39201109|FG001|Overall Study|Withdrawal by Subject|1|||
16197455|NCT02492997|39201110|FG000|Overall Study|Withdrawal by Subject|1|||
16197456|NCT02492997|39201111|FG001|Overall Study|Withdrawal by Subject|0|||
16197457|NCT02492997|39201110|FG000|Overall Study|Gained Weight|1|||
16197458|NCT02492997|39201111|FG001|Overall Study|Gained Weight|0|||
16197459|NCT02492997|39201110|FG000|Overall Study|Lost to Follow-up|0|||
16197460|NCT02492997|39201111|FG001|Overall Study|Lost to Follow-up|1|||
16391598|NCT03314935|39916189|FG001|Phase 1|"Captured as Other in Database"|2|||
16391599|NCT03314935|39916190|FG002|Phase 1|"Captured as Other in Database"|0|||
16391600|NCT03314935|39916191|FG003|Phase 1|"Captured as Other in Database"|0|||
16391601|NCT03314935|39916192|FG004|Phase 1|"Captured as Other in Database"|0|||
16391602|NCT03314935|39916193|FG005|Phase 1|"Captured as Other in Database"|0|||
16391603|NCT03314935|39916194|FG006|Phase 1|"Captured as Other in Database"|1|||
16391604|NCT03314935|39916195|FG007|Phase 1|"Captured as Other in Database"|1|||
16391605|NCT03314935|39916196|FG008|Phase 1|"Captured as Other in Database"|1|||
16391606|NCT03314935|39916197|FG009|Phase 1|"Captured as Other in Database"|0|||
16197461|NCT01980706|39201112|FG000|Overall Study|Withdrawal by Subject|9|||
16197462|NCT01980706|39201113|FG001|Overall Study|Withdrawal by Subject|6|||
16197463|NCT01980706|39201114|FG002|Overall Study|Withdrawal by Subject|2|||
16197464|NCT01980706|39201112|FG000|Overall Study|Adverse Event|1|||
16197465|NCT01980706|39201113|FG001|Overall Study|Adverse Event|2|||
16197466|NCT01980706|39201114|FG002|Overall Study|Adverse Event|5|||
16197467|NCT01980706|39201112|FG000|Overall Study|Lost to Follow-up|3|||
16197468|NCT01980706|39201113|FG001|Overall Study|Lost to Follow-up|4|||
16197469|NCT01980706|39201114|FG002|Overall Study|Lost to Follow-up|3|||
16197470|NCT01980706|39201112|FG000|Overall Study|miscellaneous|4|||
16197471|NCT01980706|39201113|FG001|Overall Study|miscellaneous|5|||
16197472|NCT01980706|39201114|FG002|Overall Study|miscellaneous|3|||
16197473|NCT02180217|39201115|FG000|Overall Study|Adverse Event|3|||
16197474|NCT02180217|39201116|FG001|Overall Study|Adverse Event|2|||
16197475|NCT02180217|39201117|FG002|Overall Study|Adverse Event|22|||
16197476|NCT02180217|39201115|FG000|Overall Study|Death|1|||
16197477|NCT02180217|39201116|FG001|Overall Study|Death|1|||
16391607|NCT03314935|39916198|FG010|Phase 1|"Captured as Other in Database"|0|||
16391608|NCT03314935|39916199|FG011|Phase 1|"Captured as Other in Database"|0|||
16391609|NCT03314935|39916200|FG012|Phase 1|"Captured as Other in Database"|0|||
16391610|NCT03314935|39916201|FG013|Phase 1|"Captured as Other in Database"|0|||
16391611|NCT03314935|39916202|FG014|Phase 1|"Captured as Other in Database"|0|||
16508370|NCT01367158|40333441|FG009|Overall Study|Withdrew consent|0|||
16508371|NCT01367158|40333442|FG010|Overall Study|Withdrew consent|0|||
16508372|NCT01367158|40333432|FG000|Overall Study|Lost to Follow-up|0|||
16508373|NCT01367158|40333433|FG001|Overall Study|Lost to Follow-up|0|||
16508374|NCT01367158|40333434|FG002|Overall Study|Lost to Follow-up|0|||
16508375|NCT01367158|40333435|FG003|Overall Study|Lost to Follow-up|1|||
16508376|NCT01367158|40333436|FG004|Overall Study|Lost to Follow-up|0|||
16508377|NCT01367158|40333437|FG005|Overall Study|Lost to Follow-up|2|||
16508378|NCT01367158|40333438|FG006|Overall Study|Lost to Follow-up|0|||
16508379|NCT01367158|40333439|FG007|Overall Study|Lost to Follow-up|1|||
16197478|NCT02180217|39201117|FG002|Overall Study|Death|0|||
16197479|NCT02180217|39201115|FG000|Overall Study|Withdrawal by Subject|1|||
16197480|NCT02180217|39201116|FG001|Overall Study|Withdrawal by Subject|1|||
16197481|NCT02180217|39201117|FG002|Overall Study|Withdrawal by Subject|4|||
16391612|NCT03314935|39916188|FG000|Phase 1|Lost to Follow-up|0|||
16391613|NCT03314935|39916189|FG001|Phase 1|Lost to Follow-up|0|||
16391614|NCT03314935|39916190|FG002|Phase 1|Lost to Follow-up|0|||
16391615|NCT03314935|39916191|FG003|Phase 1|Lost to Follow-up|0|||
16391616|NCT03314935|39916192|FG004|Phase 1|Lost to Follow-up|0|||
16197482|NCT02180217|39201115|FG000|Overall Study|Subject/Guardian decision|5|||
16391617|NCT03314935|39916193|FG005|Phase 1|Lost to Follow-up|0|||
16391618|NCT03314935|39916194|FG006|Phase 1|Lost to Follow-up|0|||
16391619|NCT03314935|39916195|FG007|Phase 1|Lost to Follow-up|0|||
16391620|NCT03314935|39916196|FG008|Phase 1|Lost to Follow-up|1|||
16391621|NCT03314935|39916197|FG009|Phase 1|Lost to Follow-up|0|||
16391622|NCT03314935|39916198|FG010|Phase 1|Lost to Follow-up|0|||
16197483|NCT02180217|39201116|FG001|Overall Study|Subject/Guardian decision|3|||
16197484|NCT02180217|39201117|FG002|Overall Study|Subject/Guardian decision|6|||
16197485|NCT02180217|39201115|FG000|Overall Study|Physician Decision|1|||
16197486|NCT02180217|39201116|FG001|Overall Study|Physician Decision|1|||
16197487|NCT02180217|39201117|FG002|Overall Study|Physician Decision|6|||
16197488|NCT02180217|39201115|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16391623|NCT03314935|39916199|FG011|Phase 1|Lost to Follow-up|0|||
16391624|NCT03314935|39916200|FG012|Phase 1|Lost to Follow-up|0|||
16391625|NCT03314935|39916201|FG013|Phase 1|Lost to Follow-up|0|||
16391626|NCT03314935|39916202|FG014|Phase 1|Lost to Follow-up|0|||
16391627|NCT03314935|39916188|FG000|Phase 2|Death|0|||
16391628|NCT03314935|39916189|FG001|Phase 2|Death|0|||
16391629|NCT03314935|39916190|FG002|Phase 2|Death|0|||
16391630|NCT03314935|39916191|FG003|Phase 2|Death|0|||
16391631|NCT03314935|39916192|FG004|Phase 2|Death|0|||
16391632|NCT03314935|39916193|FG005|Phase 2|Death|0|||
16391633|NCT03314935|39916194|FG006|Phase 2|Death|0|||
16391634|NCT03314935|39916195|FG007|Phase 2|Death|0|||
16391635|NCT03314935|39916196|FG008|Phase 2|Death|0|||
16391636|NCT03314935|39916197|FG009|Phase 2|Death|5|||
16391637|NCT03314935|39916198|FG010|Phase 2|Death|20|||
16391638|NCT03314935|39916199|FG011|Phase 2|Death|6|||
16391639|NCT03314935|39916200|FG012|Phase 2|Death|7|||
16391640|NCT03314935|39916201|FG013|Phase 2|Death|6|||
16391641|NCT03314935|39916202|FG014|Phase 2|Death|17|||
16391642|NCT03314935|39916188|FG000|Phase 2|Withdrawal by Subject|0|||
16391643|NCT03314935|39916189|FG001|Phase 2|Withdrawal by Subject|0|||
16391644|NCT03314935|39916190|FG002|Phase 2|Withdrawal by Subject|0|||
16391645|NCT03314935|39916191|FG003|Phase 2|Withdrawal by Subject|0|||
16391646|NCT03314935|39916192|FG004|Phase 2|Withdrawal by Subject|0|||
16391647|NCT03314935|39916193|FG005|Phase 2|Withdrawal by Subject|0|||
16391648|NCT03314935|39916194|FG006|Phase 2|Withdrawal by Subject|0|||
16391649|NCT03314935|39916195|FG007|Phase 2|Withdrawal by Subject|0|||
16391650|NCT03314935|39916196|FG008|Phase 2|Withdrawal by Subject|0|||
16391651|NCT03314935|39916197|FG009|Phase 2|Withdrawal by Subject|1|||
16391652|NCT03314935|39916198|FG010|Phase 2|Withdrawal by Subject|4|||
16391653|NCT03314935|39916199|FG011|Phase 2|Withdrawal by Subject|0|||
16391654|NCT03314935|39916200|FG012|Phase 2|Withdrawal by Subject|1|||
16391655|NCT03314935|39916201|FG013|Phase 2|Withdrawal by Subject|0|||
16391656|NCT03314935|39916202|FG014|Phase 2|Withdrawal by Subject|1|||
16391657|NCT03314935|39916188|FG000|Phase 2|Progressive Disease|0|||
16391658|NCT03314935|39916189|FG001|Phase 2|Progressive Disease|0|||
16508380|NCT01367158|40333440|FG008|Overall Study|Lost to Follow-up|0|||
16508381|NCT01367158|40333441|FG009|Overall Study|Lost to Follow-up|0|||
16508382|NCT01367158|40333442|FG010|Overall Study|Lost to Follow-up|1|||
16508383|NCT01367158|40333432|FG000|Overall Study|Protocol Violation|0|||
16508384|NCT01367158|40333433|FG001|Overall Study|Protocol Violation|1|||
16508385|NCT01367158|40333434|FG002|Overall Study|Protocol Violation|0|||
16508386|NCT01367158|40333435|FG003|Overall Study|Protocol Violation|0|||
16508387|NCT01367158|40333436|FG004|Overall Study|Protocol Violation|0|||
16508388|NCT01367158|40333437|FG005|Overall Study|Protocol Violation|0|||
16508389|NCT01367158|40333438|FG006|Overall Study|Protocol Violation|0|||
16508390|NCT01367158|40333439|FG007|Overall Study|Protocol Violation|0|||
16508391|NCT01367158|40333440|FG008|Overall Study|Protocol Violation|0|||
16508392|NCT01367158|40333441|FG009|Overall Study|Protocol Violation|0|||
16508393|NCT01367158|40333442|FG010|Overall Study|Protocol Violation|0|||
16508394|NCT02113956|40333443|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
16508395|NCT02113956|40333444|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
16508396|NCT02113956|40333443|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
16391659|NCT03314935|39916190|FG002|Phase 2|Progressive Disease|0|||
16197489|NCT02180217|39201116|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16391660|NCT03314935|39916191|FG003|Phase 2|Progressive Disease|0|||
16391661|NCT03314935|39916192|FG004|Phase 2|Progressive Disease|0|||
16391662|NCT03314935|39916193|FG005|Phase 2|Progressive Disease|0|||
16391663|NCT03314935|39916194|FG006|Phase 2|Progressive Disease|0|||
16391664|NCT03314935|39916195|FG007|Phase 2|Progressive Disease|0|||
16391665|NCT03314935|39916196|FG008|Phase 2|Progressive Disease|0|||
16391666|NCT03314935|39916197|FG009|Phase 2|Progressive Disease|1|||
16391667|NCT03314935|39916198|FG010|Phase 2|Progressive Disease|1|||
16391668|NCT03314935|39916199|FG011|Phase 2|Progressive Disease|1|||
16391669|NCT03314935|39916200|FG012|Phase 2|Progressive Disease|2|||
16391670|NCT03314935|39916201|FG013|Phase 2|Progressive Disease|0|||
16508397|NCT02113956|40333444|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
16508398|NCT02113956|40333443|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
16197490|NCT02180217|39201117|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16197491|NCT04169061|39201125|FG000|Overall Study|Adverse Event|2|||
16197492|NCT04169061|39201125|FG000|Overall Study|Death|1|||
16197493|NCT04169061|39201125|FG000|Overall Study|Withdrawal by Subject|1|||
16197494|NCT04169061|39201125|FG000|Overall Study|Protocol Violation|1|||
16197495|NCT04876599|39201127|FG000|Overall Study|Missed|2|||
16508399|NCT02113956|40333444|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
16508400|NCT04056195|40336149|FG000|Overall Study|Adverse Event|1|||
16508401|NCT04056195|40336150|FG001|Overall Study|Adverse Event|0|||
16197496|NCT04876599|39201128|FG001|Overall Study|Missed|0|||
16197497|NCT04876599|39201127|FG000|Overall Study|Declined|2|||
16197498|NCT04876599|39201128|FG001|Overall Study|Declined|3|||
16508402|NCT04056195|40336151|FG002|Overall Study|Adverse Event|0|||
16508403|NCT04056195|40336149|FG000|Overall Study|Withdrawal by Subject|0|||
16508404|NCT04056195|40336150|FG001|Overall Study|Withdrawal by Subject|1|||
16508405|NCT04056195|40336151|FG002|Overall Study|Withdrawal by Subject|1|||
16508406|NCT04056195|40336149|FG000|Overall Study|Physician Decision|1|||
16508407|NCT04056195|40336150|FG001|Overall Study|Physician Decision|1|||
16508408|NCT04056195|40336151|FG002|Overall Study|Physician Decision|1|||
16197499|NCT03337139|39201132|FG000|Phase I|Withdrawal by Subject|10|||
16197500|NCT03337139|39201133|FG001|Phase I|Withdrawal by Subject|0|||
16197501|NCT04682353|39201134|FG000|Overall Study|Lost to Follow-up|0|||
16197502|NCT04682353|39201135|FG001|Overall Study|Lost to Follow-up|1|||
16197503|NCT04682353|39201136|FG002|Overall Study|Lost to Follow-up|0|||
16508409|NCT01177540|40336153|FG000|Overall Study|Adverse Event|1|||
16508410|NCT01177540|40336154|FG001|Overall Study|Adverse Event|0|||
16197504|NCT04682353|39201137|FG003|Overall Study|Lost to Follow-up|1|||
16197505|NCT04682353|39201134|FG000|Overall Study|Personal reasons|0|||
16197506|NCT04682353|39201135|FG001|Overall Study|Personal reasons|1|||
16197507|NCT04682353|39201136|FG002|Overall Study|Personal reasons|0|||
16197508|NCT04682353|39201137|FG003|Overall Study|Personal reasons|0|||
16197509|NCT02157506|39201138|FG000|Overall Study|Adverse Event|0|||
16197510|NCT02157506|39201139|FG001|Overall Study|Adverse Event|1|||
16197511|NCT02157506|39201140|FG002|Overall Study|Adverse Event|0|||
16197512|NCT02157506|39201141|FG003|Overall Study|Adverse Event|0|||
16197513|NCT02157506|39201142|FG004|Overall Study|Adverse Event|0|||
16197514|NCT02157506|39201138|FG000|Overall Study|Lost to Follow-up|0|||
16197515|NCT02157506|39201139|FG001|Overall Study|Lost to Follow-up|0|||
16197516|NCT02157506|39201140|FG002|Overall Study|Lost to Follow-up|1|||
16197517|NCT02157506|39201141|FG003|Overall Study|Lost to Follow-up|0|||
16508411|NCT00842348|40336155|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
16508412|NCT00842348|40336156|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
16508413|NCT00842348|40336155|FG000|Study 729|Disease progression/death|19|||
16508414|NCT00842348|40336156|FG001|Study 729|Disease progression/death|30|||
16197518|NCT02157506|39201142|FG004|Overall Study|Lost to Follow-up|0|||
16197519|NCT01996904|39201143|FG000|Overall Study|Lost to Follow-up|38|||
16197520|NCT01996904|39201144|FG001|Overall Study|Lost to Follow-up|27|||
16197521|NCT00059215|39201145|FG000|Overall Study|Adverse Event|5|||
16197522|NCT00059215|39201146|FG001|Overall Study|Adverse Event|5|||
16197523|NCT00059215|39201147|FG002|Overall Study|Adverse Event|9|||
16197524|NCT00059215|39201148|FG003|Overall Study|Adverse Event|9|||
16197525|NCT00059215|39201145|FG000|Overall Study|Death|0|||
16313999|NCT00460603|39633926|FG010|Phase 2|Objective Progression or Relapse|10|||
16314000|NCT00460603|39633927|FG011|Phase 2|Objective Progression or Relapse|17|||
16508415|NCT00842348|40336155|FG000|Study 729|Adverse Event|1|||
16197526|NCT00059215|39201146|FG001|Overall Study|Death|0|||
16197527|NCT00059215|39201147|FG002|Overall Study|Death|3|||
16197528|NCT00059215|39201148|FG003|Overall Study|Death|0|||
16197529|NCT00059215|39201145|FG000|Overall Study|Lost to Follow-up|1|||
16197530|NCT00059215|39201146|FG001|Overall Study|Lost to Follow-up|2|||
16197531|NCT00059215|39201147|FG002|Overall Study|Lost to Follow-up|0|||
16197532|NCT00059215|39201148|FG003|Overall Study|Lost to Follow-up|0|||
16197533|NCT00059215|39201145|FG000|Overall Study|Withdrawal by Subject|4|||
16197534|NCT00059215|39201146|FG001|Overall Study|Withdrawal by Subject|4|||
16197535|NCT00059215|39201147|FG002|Overall Study|Withdrawal by Subject|1|||
16197536|NCT00059215|39201148|FG003|Overall Study|Withdrawal by Subject|3|||
16197537|NCT00059215|39201145|FG000|Overall Study|Protocol Violation|1|||
16197538|NCT00059215|39201146|FG001|Overall Study|Protocol Violation|0|||
16197539|NCT00059215|39201147|FG002|Overall Study|Protocol Violation|1|||
16197540|NCT00059215|39201148|FG003|Overall Study|Protocol Violation|0|||
16197541|NCT00059215|39201145|FG000|Overall Study|Protocol entry criteria not met|1|||
16197542|NCT00059215|39201146|FG001|Overall Study|Protocol entry criteria not met|1|||
16197543|NCT00059215|39201147|FG002|Overall Study|Protocol entry criteria not met|0|||
16197544|NCT00059215|39201148|FG003|Overall Study|Protocol entry criteria not met|2|||
16197545|NCT00059215|39201145|FG000|Overall Study|Physician Decision|1|||
16197546|NCT00059215|39201146|FG001|Overall Study|Physician Decision|2|||
16314001|NCT00460603|39633916|FG000|Phase 2|Global Deterioration of Health Status|0|||
16314002|NCT00460603|39633917|FG001|Phase 2|Global Deterioration of Health Status|0|||
16314003|NCT00460603|39633918|FG002|Phase 2|Global Deterioration of Health Status|0|||
16508416|NCT00842348|40336156|FG001|Study 729|Adverse Event|1|||
16508417|NCT00842348|40336155|FG000|Study 729|Protocol Violation|1|||
16508418|NCT00842348|40336156|FG001|Study 729|Protocol Violation|1|||
16508419|NCT00842348|40336155|FG000|Study 729|Withdrawal by Subject|2|||
16508420|NCT00842348|40336156|FG001|Study 729|Withdrawal by Subject|4|||
16508421|NCT00842348|40336155|FG000|Study 729|Due to Sponsor stopping the study|1|||
16508422|NCT00842348|40336156|FG001|Study 729|Due to Sponsor stopping the study|1|||
16508423|NCT00842348|40336155|FG000|Study 729|Due to non-availability of IP|0|||
16508424|NCT00842348|40336156|FG001|Study 729|Due to non-availability of IP|1|||
16508425|NCT00842348|40336155|FG000|Study 729|Sponsor's decision|1|||
16508426|NCT00842348|40336156|FG001|Study 729|Sponsor's decision|0|||
16508427|NCT00842348|40336155|FG000|Study 729|Surgical resection|1|||
16508428|NCT00842348|40336156|FG001|Study 729|Surgical resection|0|||
16508429|NCT00451035|40336161|FG000|Overall Study|Disease progression|11|||
16508430|NCT00451035|40336161|FG000|Overall Study|Death|3|||
16508431|NCT00451035|40336161|FG000|Overall Study|New anti-neoplastic therapy|3|||
16314004|NCT00460603|39633919|FG003|Phase 2|Global Deterioration of Health Status|0|||
16314005|NCT00460603|39633920|FG004|Phase 2|Global Deterioration of Health Status|0|||
16314006|NCT00460603|39633921|FG005|Phase 2|Global Deterioration of Health Status|0|||
16508432|NCT00302458|40336162|FG000|Overall Study|Lost to Follow-up|1|||
16508433|NCT00302458|40336162|FG000|Overall Study|Ineligible after screening|1|||
16508434|NCT00302458|40336162|FG000|Overall Study|Withdrawal by Subject|1|||
16508435|NCT02295995|40336165|FG000|Overall Study|Lost to Follow-up|5|||
16508436|NCT02295995|40336166|FG001|Overall Study|Lost to Follow-up|1|||
16508437|NCT02596854|40336171|FG000|Overall Study|Withdrawn|8|||
16508438|NCT02290821|40336172|FG000|Overall Study|Withdrawal by Subject|1|||
16508439|NCT02290821|40336173|FG001|Overall Study|Withdrawal by Subject|1|||
16508440|NCT02290821|40336172|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
16508441|NCT02290821|40336173|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
16508442|NCT02290821|40336172|FG000|Overall Study|Lost to Follow-up|3|||
16508443|NCT02290821|40336173|FG001|Overall Study|Lost to Follow-up|2|||
16508444|NCT00749463|40336174|FG000|Overall Study|Adverse Event|0|||
16508445|NCT00749463|40336175|FG001|Overall Study|Adverse Event|4|||
16508446|NCT00749463|40336176|FG002|Overall Study|Adverse Event|1|||
16508447|NCT00749463|40336174|FG000|Overall Study|Withdrawal by Subject|1|||
16508448|NCT00749463|40336175|FG001|Overall Study|Withdrawal by Subject|0|||
16508449|NCT00749463|40336176|FG002|Overall Study|Withdrawal by Subject|0|||
16508450|NCT03509675|40336177|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
16508451|NCT03509675|40336178|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
16508452|NCT03509675|40336177|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
16508453|NCT03509675|40336178|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
16508454|NCT03509675|40336177|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
16508455|NCT03509675|40336178|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
16508456|NCT03509675|40336177|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
16508457|NCT03509675|40336178|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
16508458|NCT02086110|40336184|FG000|Overall Study|Withdrawal by Subject|1|||
16508459|NCT02086110|40336185|FG001|Overall Study|Withdrawal by Subject|1|||
16508460|NCT00663052|40336189|FG000|Overall Study|Adverse Event|6|||
16508461|NCT00663052|40336190|FG001|Overall Study|Adverse Event|3|||
16508462|NCT00663052|40336189|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
16508463|NCT00663052|40336190|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
16508464|NCT00663052|40336189|FG000|Overall Study|Protocol Violation|1|||
16508465|NCT00663052|40336190|FG001|Overall Study|Protocol Violation|0|||
16508466|NCT00663052|40336189|FG000|Overall Study|Withdrawal by Subject|2|||
16508467|NCT00663052|40336190|FG001|Overall Study|Withdrawal by Subject|5|||
16508468|NCT00663052|40336189|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
16508469|NCT00663052|40336190|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
16508470|NCT00663052|40336189|FG000|Overall Study|Other|0|||
16197547|NCT00059215|39201147|FG002|Overall Study|Physician Decision|1|||
16391671|NCT03314935|39916202|FG014|Phase 2|Progressive Disease|1|||
16391672|NCT03314935|39916188|FG000|Phase 2|Study Terminated by Sponsor|0|||
16391673|NCT03314935|39916189|FG001|Phase 2|Study Terminated by Sponsor|0|||
16391674|NCT03314935|39916190|FG002|Phase 2|Study Terminated by Sponsor|0|||
16391675|NCT03314935|39916191|FG003|Phase 2|Study Terminated by Sponsor|0|||
16391676|NCT03314935|39916192|FG004|Phase 2|Study Terminated by Sponsor|0|||
16391677|NCT03314935|39916193|FG005|Phase 2|Study Terminated by Sponsor|0|||
16391678|NCT03314935|39916194|FG006|Phase 2|Study Terminated by Sponsor|0|||
16391679|NCT03314935|39916195|FG007|Phase 2|Study Terminated by Sponsor|0|||
16391680|NCT03314935|39916196|FG008|Phase 2|Study Terminated by Sponsor|0|||
16391681|NCT03314935|39916197|FG009|Phase 2|Study Terminated by Sponsor|0|||
16391682|NCT03314935|39916198|FG010|Phase 2|Study Terminated by Sponsor|7|||
16391683|NCT03314935|39916199|FG011|Phase 2|Study Terminated by Sponsor|2|||
16391684|NCT03314935|39916200|FG012|Phase 2|Study Terminated by Sponsor|1|||
16391685|NCT03314935|39916201|FG013|Phase 2|Study Terminated by Sponsor|4|||
16391686|NCT03314935|39916202|FG014|Phase 2|Study Terminated by Sponsor|4|||
16391687|NCT03314935|39916188|FG000|Phase 2|Lost to Follow-up|0|||
16391688|NCT03314935|39916189|FG001|Phase 2|Lost to Follow-up|0|||
16391689|NCT03314935|39916190|FG002|Phase 2|Lost to Follow-up|0|||
16508471|NCT00663052|40336190|FG001|Overall Study|Other|1|||
16508472|NCT03254134|40336191|FG000|Overall Study|Not eligible patients|599|||
16508473|NCT03254134|40336192|FG001|Overall Study|Not eligible patients|3630|||
16508474|NCT01640366|40336193|FG000|Overall Study|Withdrawal by Subject|1|||
16508475|NCT01640366|40336193|FG000|Overall Study|Protocol Violation|16|||
16508476|NCT01640366|40336193|FG000|Overall Study|Lost to Follow-up|5|||
16508477|NCT01063764|40336194|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
16508478|NCT01063764|40336194|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
16508479|NCT01063764|40336194|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
16508480|NCT01063764|40336194|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
16508481|NCT01063764|40336194|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
16508482|NCT01063764|40336194|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
16508483|NCT01063764|40336194|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
16508484|NCT03925727|40336195|FG000|Overall Study|Adverse Event|4|||
16197548|NCT00059215|39201148|FG003|Overall Study|Physician Decision|1|||
16197549|NCT03074149|39201149|FG000|Overall Study|Reason unknown|22|||
16197550|NCT03074149|39201150|FG001|Overall Study|Reason unknown|35|||
16197551|NCT03074149|39201149|FG000|Overall Study|Death|10|||
16197552|NCT03074149|39201150|FG001|Overall Study|Death|45|||
16197553|NCT02864940|39201151|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
16197554|NCT02864940|39201152|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
16197555|NCT02677220|39201153|FG000|Overall Study|Adverse Event|1|||
16197556|NCT02947022|39201155|FG000|Overall Study|Study Stopped|1|||
16197557|NCT03712345|39201156|FG000|Overall Study|Failure to meet randomization criteria|0|||
16508485|NCT03925727|40336196|FG001|Overall Study|Adverse Event|0|||
16508486|NCT03925727|40336197|FG002|Overall Study|Adverse Event|3|||
16508487|NCT03925727|40336195|FG000|Overall Study|Protocol Violation|1|||
16508488|NCT03925727|40336196|FG001|Overall Study|Protocol Violation|2|||
16508489|NCT03925727|40336197|FG002|Overall Study|Protocol Violation|2|||
16508490|NCT03925727|40336195|FG000|Overall Study|Withdrawal by Subject|3|||
16508491|NCT03925727|40336196|FG001|Overall Study|Withdrawal by Subject|2|||
16508492|NCT03925727|40336197|FG002|Overall Study|Withdrawal by Subject|4|||
16508493|NCT03925727|40336195|FG000|Overall Study|Administrative Reasons|3|||
16508494|NCT03925727|40336196|FG001|Overall Study|Administrative Reasons|1|||
16197558|NCT03712345|39201157|FG001|Overall Study|Failure to meet randomization criteria|0|||
16314007|NCT00460603|39633922|FG006|Phase 2|Global Deterioration of Health Status|0|||
16314008|NCT00460603|39633923|FG007|Phase 2|Global Deterioration of Health Status|0|||
16314009|NCT00460603|39633924|FG008|Phase 2|Global Deterioration of Health Status|0|||
16314010|NCT00460603|39633925|FG009|Phase 2|Global Deterioration of Health Status|0|||
16314011|NCT00460603|39633926|FG010|Phase 2|Global Deterioration of Health Status|1|||
16314012|NCT00460603|39633927|FG011|Phase 2|Global Deterioration of Health Status|0|||
16314013|NCT00460603|39633916|FG000|Phase 2|Withdrawal by Subject|0|||
16314014|NCT00460603|39633917|FG001|Phase 2|Withdrawal by Subject|0|||
16314015|NCT00460603|39633918|FG002|Phase 2|Withdrawal by Subject|0|||
16314016|NCT00460603|39633919|FG003|Phase 2|Withdrawal by Subject|0|||
16314017|NCT00460603|39633920|FG004|Phase 2|Withdrawal by Subject|0|||
16314018|NCT00460603|39633921|FG005|Phase 2|Withdrawal by Subject|0|||
16314019|NCT00460603|39633922|FG006|Phase 2|Withdrawal by Subject|0|||
16508495|NCT03925727|40336197|FG002|Overall Study|Administrative Reasons|2|||
16508496|NCT03925727|40336195|FG000|Overall Study|Randomized in error or Disqualified|8|||
16508497|NCT03925727|40336196|FG001|Overall Study|Randomized in error or Disqualified|1|||
16314020|NCT00460603|39633923|FG007|Phase 2|Withdrawal by Subject|0|||
16391690|NCT03314935|39916191|FG003|Phase 2|Lost to Follow-up|0|||
16391691|NCT03314935|39916192|FG004|Phase 2|Lost to Follow-up|0|||
16391692|NCT03314935|39916193|FG005|Phase 2|Lost to Follow-up|0|||
16391693|NCT03314935|39916194|FG006|Phase 2|Lost to Follow-up|0|||
16508498|NCT03925727|40336197|FG002|Overall Study|Randomized in error or Disqualified|7|||
16508499|NCT02350309|40336198|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
16508500|NCT02350309|40336199|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
16508501|NCT02350309|40336200|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
16508502|NCT02350309|40336201|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
16508503|NCT02350309|40336202|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
16508504|NCT02350309|40336203|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
16508505|NCT02350309|40336198|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
16508506|NCT02350309|40336199|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
16508507|NCT02350309|40336200|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
16508508|NCT02350309|40336201|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
16508509|NCT02350309|40336202|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
16508510|NCT02350309|40336203|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
16508511|NCT02016625|40336206|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
16508512|NCT02016625|40336207|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
16508513|NCT02016625|40336206|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
16508514|NCT02016625|40336207|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
16508515|NCT02016625|40336206|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
16508516|NCT02016625|40336207|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
16508517|NCT00718328|40336208|FG000|Overall Study|Lost to Follow-up|1|||
16508518|NCT00718328|40336209|FG001|Overall Study|Lost to Follow-up|0|||
16508519|NCT01524627|40336211|FG000|Overall Study|Physician Decision|0|||
16508520|NCT01524627|40336212|FG001|Overall Study|Physician Decision|1|||
16508521|NCT01524627|40336211|FG000|Overall Study|Lost to Follow-up|1|||
16508522|NCT01524627|40336212|FG001|Overall Study|Lost to Follow-up|1|||
16508523|NCT00006478|40336218|FG000|Overall Study|Vaccine could not be produced|1|||
16508524|NCT00006478|40336218|FG000|Overall Study|Physician Decision|6|||
16508525|NCT04220411|40336220|FG000|Overall Study|Adverse Event|0|||
16508526|NCT04220411|40336221|FG001|Overall Study|Adverse Event|0|||
16508527|NCT04220411|40336222|FG002|Overall Study|Adverse Event|0|||
16508528|NCT04220411|40336223|FG003|Overall Study|Adverse Event|1|||
16508529|NCT00588445|40336226|FG000|Overall Study|Protocol Violation|1|||
16508530|NCT00588445|40336226|FG000|Overall Study|Withdrawal by Subject|3|||
16508531|NCT00588445|40336226|FG000|Overall Study|Disease Progression|1|||
16508532|NCT00588445|40336226|FG000|Overall Study|Not Treated|10|||
16508533|NCT01371656|40336227|FG000|Overall Study|Death|7|||
16508534|NCT01371656|40336228|FG001|Overall Study|Death|4|||
16508535|NCT01371656|40336227|FG000|Overall Study|Physician Decision|46|||
16508536|NCT01371656|40336228|FG001|Overall Study|Physician Decision|7|||
16508537|NCT01371656|40336227|FG000|Overall Study|Withdrawal by Subject|7|||
16508538|NCT01371656|40336228|FG001|Overall Study|Withdrawal by Subject|0|||
16508539|NCT01371656|40336227|FG000|Overall Study|Ineligible|4|||
16508540|NCT01371656|40336228|FG001|Overall Study|Ineligible|3|||
16508541|NCT00694369|40336229|FG000|Overall Study|Adverse Event|0|||
16508542|NCT00694369|40336230|FG001|Overall Study|Adverse Event|1|||
16508543|NCT00694369|40336231|FG002|Overall Study|Adverse Event|0|||
16508544|NCT00694369|40336232|FG003|Overall Study|Adverse Event|1|||
16508545|NCT00694369|40336233|FG004|Overall Study|Adverse Event|3|||
16508546|NCT00694369|40336229|FG000|Overall Study|Lost to Follow-up|0|||
16508547|NCT00694369|40336230|FG001|Overall Study|Lost to Follow-up|0|||
16508548|NCT00694369|40336231|FG002|Overall Study|Lost to Follow-up|1|||
16508549|NCT00694369|40336232|FG003|Overall Study|Lost to Follow-up|1|||
16314021|NCT00460603|39633924|FG008|Phase 2|Withdrawal by Subject|0|||
16314022|NCT00460603|39633925|FG009|Phase 2|Withdrawal by Subject|5|||
16314023|NCT00460603|39633926|FG010|Phase 2|Withdrawal by Subject|4|||
16314024|NCT00460603|39633927|FG011|Phase 2|Withdrawal by Subject|5|||
16314025|NCT00460603|39633916|FG000|Phase 2|Randomized, but not treated|0|||
16314026|NCT00460603|39633917|FG001|Phase 2|Randomized, but not treated|0|||
16314027|NCT00460603|39633918|FG002|Phase 2|Randomized, but not treated|0|||
16508550|NCT00694369|40336233|FG004|Overall Study|Lost to Follow-up|0|||
16508551|NCT00694369|40336229|FG000|Overall Study|Physician Decision|0|||
16508552|NCT00694369|40336230|FG001|Overall Study|Physician Decision|0|||
16508553|NCT00694369|40336231|FG002|Overall Study|Physician Decision|0|||
16508554|NCT00694369|40336232|FG003|Overall Study|Physician Decision|0|||
16508555|NCT00694369|40336233|FG004|Overall Study|Physician Decision|1|||
16314028|NCT00460603|39633919|FG003|Phase 2|Randomized, but not treated|0|||
16508556|NCT00694369|40336229|FG000|Overall Study|Protocol Violation|0|||
16508557|NCT00694369|40336230|FG001|Overall Study|Protocol Violation|1|||
16508558|NCT00694369|40336231|FG002|Overall Study|Protocol Violation|0|||
16508559|NCT00694369|40336232|FG003|Overall Study|Protocol Violation|0|||
16314029|NCT00460603|39633920|FG004|Phase 2|Randomized, but not treated|0|||
16314030|NCT00460603|39633921|FG005|Phase 2|Randomized, but not treated|0|||
16314031|NCT00460603|39633922|FG006|Phase 2|Randomized, but not treated|0|||
16508560|NCT00694369|40336233|FG004|Overall Study|Protocol Violation|0|||
16508561|NCT00694369|40336229|FG000|Overall Study|Withdrawal by Subject|1|||
16508562|NCT00694369|40336230|FG001|Overall Study|Withdrawal by Subject|1|||
16508563|NCT00694369|40336231|FG002|Overall Study|Withdrawal by Subject|1|||
16197559|NCT03712345|39201158|FG002|Overall Study|Failure to meet randomization criteria|1|||
16197560|NCT03297216|39201164|FG000|Overall Study|Death|0|||
16197561|NCT03297216|39201165|FG001|Overall Study|Death|1|||
16197562|NCT03297216|39201164|FG000|Overall Study|Miscarriage|0|||
16197563|NCT03297216|39201165|FG001|Overall Study|Miscarriage|2|||
16197564|NCT03297216|39201164|FG000|Overall Study|Lost to Follow-up|3|||
16197565|NCT03297216|39201165|FG001|Overall Study|Lost to Follow-up|2|||
16197566|NCT00293423|39201166|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
16197567|NCT00293423|39201167|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
16197568|NCT00293423|39201166|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
16197569|NCT00293423|39201167|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
16197570|NCT00293423|39201166|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
16197571|NCT00293423|39201167|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
16197572|NCT00293423|39201166|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
16197573|NCT00293423|39201167|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
16197574|NCT00293423|39201166|FG000|Surgical Resection|processing error during surgical resection|1|||
16197575|NCT00293423|39201167|FG001|Surgical Resection|processing error during surgical resection|0|||
16197576|NCT00293423|39201166|FG000|Surgical Resection|Withdrawal by Subject|4|||
16197577|NCT00293423|39201167|FG001|Surgical Resection|Withdrawal by Subject|0|||
16197578|NCT00293423|39201166|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
16197579|NCT00293423|39201167|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
16197580|NCT03726333|39201168|FG000|Overall Study|Progressive Disease|0|||
16197581|NCT03726333|39201169|FG001|Overall Study|Progressive Disease|0|||
16197582|NCT03726333|39201170|FG002|Overall Study|Progressive Disease|1|||
16197583|NCT03726333|39201171|FG003|Overall Study|Progressive Disease|0|||
16197584|NCT03726333|39201172|FG004|Overall Study|Progressive Disease|0|||
16314032|NCT00460603|39633923|FG007|Phase 2|Randomized, but not treated|0|||
16314033|NCT00460603|39633924|FG008|Phase 2|Randomized, but not treated|0|||
16314034|NCT00460603|39633925|FG009|Phase 2|Randomized, but not treated|3|||
16314035|NCT00460603|39633926|FG010|Phase 2|Randomized, but not treated|0|||
16197585|NCT01124448|39201173|FG000|Overall Study|Lost to Follow-up|0|||
16197586|NCT01124448|39201174|FG001|Overall Study|Lost to Follow-up|3|||
16197587|NCT01124448|39201173|FG000|Overall Study|Protocol Violation|2|||
16314036|NCT00460603|39633927|FG011|Phase 2|Randomized, but not treated|0|||
16314037|NCT01870973|39633928|FG000|Overall Study|Lost to Follow-up|10|||
16314038|NCT01870973|39633929|FG001|Overall Study|Lost to Follow-up|3|||
16314039|NCT01532518|39633930|FG000|Overall Study|Withdrawal by Subject|0|||
16314040|NCT01532518|39633931|FG001|Overall Study|Withdrawal by Subject|0|||
16314041|NCT01532518|39633932|FG002|Overall Study|Withdrawal by Subject|1|||
16314042|NCT03367819|39633933|FG000|Overall Study|Adverse Event|4|||
16508564|NCT00694369|40336232|FG003|Overall Study|Withdrawal by Subject|1|||
16508565|NCT00694369|40336233|FG004|Overall Study|Withdrawal by Subject|2|||
16508566|NCT01706003|40336234|FG000|Overall Study|Withdrawal by Subject|2|||
16508567|NCT01706003|40336235|FG001|Overall Study|Withdrawal by Subject|0|||
16508568|NCT01706003|40336234|FG000|Overall Study|Not scheduled|3|||
16508569|NCT01706003|40336235|FG001|Overall Study|Not scheduled|0|||
16508570|NCT01706003|40336234|FG000|Overall Study|Lost to Follow-up|6|||
16508571|NCT01706003|40336235|FG001|Overall Study|Lost to Follow-up|4|||
16508572|NCT01537783|40336245|FG000|Overall Study|Lost to Follow-up|11|||
16508573|NCT01537783|40336246|FG001|Overall Study|Lost to Follow-up|2|||
16508574|NCT02439320|40336248|FG000|Overall Study|Adverse Event|0|||
16508575|NCT02439320|40336249|FG001|Overall Study|Adverse Event|2|||
16508576|NCT02439320|40336250|FG002|Overall Study|Adverse Event|0|||
16508577|NCT02439320|40336248|FG000|Overall Study|Lost to Follow-up|37|||
16508578|NCT02439320|40336249|FG001|Overall Study|Lost to Follow-up|34|||
16508579|NCT02439320|40336250|FG002|Overall Study|Lost to Follow-up|42|||
16508580|NCT02439320|40336248|FG000|Overall Study|Death|0|||
16508581|NCT02439320|40336249|FG001|Overall Study|Death|1|||
16508582|NCT02439320|40336250|FG002|Overall Study|Death|0|||
16508583|NCT02439320|40336248|FG000|Overall Study|Noncompliance with Protocol|10|||
16508584|NCT02439320|40336249|FG001|Overall Study|Noncompliance with Protocol|11|||
16508585|NCT02439320|40336250|FG002|Overall Study|Noncompliance with Protocol|7|||
16508586|NCT02439320|40336248|FG000|Overall Study|Pregnancy|0|||
16508587|NCT02439320|40336249|FG001|Overall Study|Pregnancy|1|||
16508588|NCT02439320|40336250|FG002|Overall Study|Pregnancy|1|||
16508589|NCT02439320|40336248|FG000|Overall Study|Withdrawal by Subject|12|||
16508590|NCT02439320|40336249|FG001|Overall Study|Withdrawal by Subject|16|||
16508591|NCT02439320|40336250|FG002|Overall Study|Withdrawal by Subject|14|||
16508592|NCT02439320|40336248|FG000|Overall Study|Physician Decision|2|||
16508593|NCT02439320|40336249|FG001|Overall Study|Physician Decision|1|||
16508594|NCT02439320|40336250|FG002|Overall Study|Physician Decision|0|||
16508595|NCT02439320|40336248|FG000|Overall Study|Sponsor Request|0|||
16508596|NCT02439320|40336249|FG001|Overall Study|Sponsor Request|2|||
16508597|NCT02439320|40336250|FG002|Overall Study|Sponsor Request|1|||
16508598|NCT02439320|40336248|FG000|Overall Study|Randomization Failure|35|||
16508599|NCT02439320|40336249|FG001|Overall Study|Randomization Failure|46|||
16508600|NCT02439320|40336250|FG002|Overall Study|Randomization Failure|34|||
16508601|NCT03274986|40336256|FG000|Overall Study|Withdrawal by Subject|0|||
16508602|NCT03274986|40336257|FG001|Overall Study|Withdrawal by Subject|1|||
16508603|NCT03274986|40336256|FG000|Overall Study|Lost to Follow-up|0|||
16508604|NCT03274986|40336257|FG001|Overall Study|Lost to Follow-up|1|||
16508605|NCT03616912|40336262|FG000|Overall Study|Adverse Event|17|||
16508606|NCT03616912|40336263|FG001|Overall Study|Adverse Event|21|||
16314043|NCT03367819|39633934|FG001|Overall Study|Adverse Event|4|||
16314044|NCT03367819|39633933|FG000|Overall Study|Progressive Disease|15|||
16314045|NCT03367819|39633934|FG001|Overall Study|Progressive Disease|13|||
16314046|NCT03367819|39633933|FG000|Overall Study|Withdrawal by Subject|1|||
16314047|NCT03367819|39633934|FG001|Overall Study|Withdrawal by Subject|0|||
16314048|NCT03367819|39633933|FG000|Overall Study|Other|4|||
16314049|NCT03367819|39633934|FG001|Overall Study|Other|2|||
16314050|NCT02588612|39633935|FG000|Overall Study|Physician Decision|1|||
16508607|NCT03616912|40336264|FG002|Overall Study|Adverse Event|9|||
16508608|NCT03616912|40336265|FG003|Overall Study|Adverse Event|0|||
16508609|NCT03616912|40336266|FG004|Overall Study|Adverse Event|0|||
16508610|NCT03616912|40336267|FG005|Overall Study|Adverse Event|0|||
16508611|NCT03616912|40336262|FG000|Overall Study|Death|1|||
16508612|NCT03616912|40336263|FG001|Overall Study|Death|1|||
16508613|NCT03616912|40336264|FG002|Overall Study|Death|0|||
16508614|NCT03616912|40336265|FG003|Overall Study|Death|0|||
16508615|NCT03616912|40336266|FG004|Overall Study|Death|0|||
16508616|NCT03616912|40336267|FG005|Overall Study|Death|0|||
16508617|NCT03616912|40336262|FG000|Overall Study|Lack of Efficacy|13|||
16508618|NCT03616912|40336263|FG001|Overall Study|Lack of Efficacy|6|||
16508619|NCT03616912|40336264|FG002|Overall Study|Lack of Efficacy|8|||
16508620|NCT03616912|40336265|FG003|Overall Study|Lack of Efficacy|4|||
16508621|NCT03616912|40336266|FG004|Overall Study|Lack of Efficacy|5|||
16508622|NCT03616912|40336267|FG005|Overall Study|Lack of Efficacy|1|||
16508623|NCT03616912|40336262|FG000|Overall Study|Lost to Follow-up|1|||
16508624|NCT03616912|40336263|FG001|Overall Study|Lost to Follow-up|2|||
16508625|NCT03616912|40336264|FG002|Overall Study|Lost to Follow-up|3|||
16508626|NCT03616912|40336265|FG003|Overall Study|Lost to Follow-up|0|||
16508627|NCT03616912|40336266|FG004|Overall Study|Lost to Follow-up|0|||
16508628|NCT03616912|40336267|FG005|Overall Study|Lost to Follow-up|0|||
16508629|NCT03616912|40336262|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
16508630|NCT03616912|40336263|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
16508631|NCT03616912|40336264|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
16508632|NCT03616912|40336265|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
16508633|NCT03616912|40336266|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
16197588|NCT01124448|39201174|FG001|Overall Study|Protocol Violation|0|||
16197589|NCT01763866|39201180|FG000|Overall Study|Withdrawal by Subject|2|||
16197590|NCT01763866|39201181|FG001|Overall Study|Withdrawal by Subject|1|||
16197591|NCT01763866|39201182|FG002|Overall Study|Withdrawal by Subject|4|||
16197592|NCT01763866|39201183|FG003|Overall Study|Withdrawal by Subject|0|||
16197593|NCT01763866|39201184|FG004|Overall Study|Withdrawal by Subject|0|||
16197594|NCT01763866|39201185|FG005|Overall Study|Withdrawal by Subject|3|||
16197595|NCT01763866|39201186|FG006|Overall Study|Withdrawal by Subject|4|||
16508634|NCT03616912|40336267|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
16508635|NCT03616912|40336262|FG000|Overall Study|Withdrawal by Subject|12|||
16508636|NCT03616912|40336263|FG001|Overall Study|Withdrawal by Subject|12|||
16508637|NCT03616912|40336264|FG002|Overall Study|Withdrawal by Subject|15|||
16508638|NCT03616912|40336265|FG003|Overall Study|Withdrawal by Subject|2|||
16508639|NCT03616912|40336266|FG004|Overall Study|Withdrawal by Subject|0|||
16314051|NCT02588612|39633935|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
16314052|NCT02588612|39633935|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
16314053|NCT02588612|39633935|FG000|Overall Study|Death prior to T-cell infusion|1|||
16314054|NCT02764762|39633940|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
16314055|NCT02764762|39633940|FG000|Overall Study|Lost to Follow-up|4|||
16314056|NCT02764762|39633940|FG000|Overall Study|Voluntary Withdrawal|8|||
16314057|NCT02764762|39633940|FG000|Overall Study|Site Termination|1|||
16314058|NCT02764762|39633940|FG000|Overall Study|Lack of Efficacy|16|||
16314059|NCT02764762|39633940|FG000|Overall Study|Reason not Specified|1|||
16314060|NCT00611923|39633945|FG000|Overall Study|Withdrawal by Subject|2|||
16508640|NCT03616912|40336267|FG005|Overall Study|Withdrawal by Subject|2|||
16508641|NCT03616912|40336262|FG000|Overall Study|Study Terminated by Sponsor|0|||
16508642|NCT03616912|40336263|FG001|Overall Study|Study Terminated by Sponsor|0|||
16508643|NCT03616912|40336264|FG002|Overall Study|Study Terminated by Sponsor|0|||
16314061|NCT00611923|39633946|FG001|Overall Study|Withdrawal by Subject|2|||
16314062|NCT00364923|39633947|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
16508644|NCT03616912|40336265|FG003|Overall Study|Study Terminated by Sponsor|10|||
16508645|NCT03616912|40336266|FG004|Overall Study|Study Terminated by Sponsor|9|||
16508646|NCT03616912|40336267|FG005|Overall Study|Study Terminated by Sponsor|11|||
16508647|NCT03616912|40336262|FG000|Overall Study|Protocol Deviation|1|||
16508648|NCT03616912|40336263|FG001|Overall Study|Protocol Deviation|1|||
16508649|NCT03616912|40336264|FG002|Overall Study|Protocol Deviation|0|||
16508650|NCT03616912|40336265|FG003|Overall Study|Protocol Deviation|0|||
16508651|NCT03616912|40336266|FG004|Overall Study|Protocol Deviation|0|||
16508652|NCT03616912|40336267|FG005|Overall Study|Protocol Deviation|0|||
16508653|NCT03616912|40336262|FG000|Overall Study|Pregnancy|1|||
16508654|NCT03616912|40336263|FG001|Overall Study|Pregnancy|0|||
16508655|NCT03616912|40336264|FG002|Overall Study|Pregnancy|4|||
16508656|NCT03616912|40336265|FG003|Overall Study|Pregnancy|0|||
16508657|NCT03616912|40336266|FG004|Overall Study|Pregnancy|0|||
16508658|NCT03616912|40336267|FG005|Overall Study|Pregnancy|0|||
16508659|NCT03616912|40336262|FG000|Overall Study|Protocol Violation|1|||
16508660|NCT03616912|40336263|FG001|Overall Study|Protocol Violation|0|||
16508661|NCT03616912|40336264|FG002|Overall Study|Protocol Violation|2|||
16508662|NCT03616912|40336265|FG003|Overall Study|Protocol Violation|0|||
16314063|NCT00364923|39633947|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
16314064|NCT02454608|39633948|FG000|Double-Blind Period|Lack of Efficacy|0|||
16314065|NCT02454608|39633949|FG001|Double-Blind Period|Lack of Efficacy|2|||
16314066|NCT02454608|39633950|FG002|Double-Blind Period|Lack of Efficacy|0|||
16314067|NCT02454608|39633948|FG000|Open Label Period|Lost to Follow-up|0|||
16314068|NCT02454608|39633949|FG001|Open Label Period|Lost to Follow-up|0|||
16314069|NCT02454608|39633950|FG002|Open Label Period|Lost to Follow-up|11|||
16508663|NCT03616912|40336266|FG004|Overall Study|Protocol Violation|0|||
16508664|NCT03616912|40336267|FG005|Overall Study|Protocol Violation|0|||
16508665|NCT03616912|40336262|FG000|Overall Study|Physician Decision|2|||
16197596|NCT01763866|39201187|FG007|Overall Study|Withdrawal by Subject|0|||
16197597|NCT01763866|39201188|FG008|Overall Study|Withdrawal by Subject|1|||
16314070|NCT02454608|39633948|FG000|Open Label Period|Withdrawal by Subject|0|||
16314071|NCT02454608|39633949|FG001|Open Label Period|Withdrawal by Subject|0|||
16508666|NCT03616912|40336263|FG001|Overall Study|Physician Decision|0|||
16508667|NCT03616912|40336264|FG002|Overall Study|Physician Decision|0|||
16508668|NCT03616912|40336265|FG003|Overall Study|Physician Decision|0|||
16508669|NCT03616912|40336266|FG004|Overall Study|Physician Decision|1|||
16508670|NCT03616912|40336267|FG005|Overall Study|Physician Decision|0|||
16508671|NCT03616912|40336262|FG000|Overall Study|Randomized But Never Treated|0|||
16508672|NCT03616912|40336263|FG001|Overall Study|Randomized But Never Treated|2|||
16508673|NCT03616912|40336264|FG002|Overall Study|Randomized But Never Treated|0|||
16508674|NCT03616912|40336265|FG003|Overall Study|Randomized But Never Treated|0|||
16508675|NCT03616912|40336266|FG004|Overall Study|Randomized But Never Treated|0|||
16508676|NCT03616912|40336267|FG005|Overall Study|Randomized But Never Treated|0|||
16508677|NCT00974571|40336269|FG000|Overall Study|Adverse Event|31|||
16508678|NCT00974571|40336270|FG001|Overall Study|Adverse Event|4|||
16508679|NCT00974571|40336271|FG002|Overall Study|Adverse Event|27|||
16508680|NCT00974571|40336269|FG000|Overall Study|Lack of Efficacy|3|||
16508681|NCT00974571|40336270|FG001|Overall Study|Lack of Efficacy|2|||
16508682|NCT00974571|40336271|FG002|Overall Study|Lack of Efficacy|9|||
16508683|NCT00974571|40336269|FG000|Overall Study|Lost to Follow-up|2|||
16508684|NCT00974571|40336270|FG001|Overall Study|Lost to Follow-up|1|||
16508685|NCT00974571|40336271|FG002|Overall Study|Lost to Follow-up|2|||
16508686|NCT00974571|40336269|FG000|Overall Study|Protocol Violation|13|||
16508687|NCT00974571|40336270|FG001|Overall Study|Protocol Violation|4|||
16508688|NCT00974571|40336271|FG002|Overall Study|Protocol Violation|18|||
16508689|NCT00974571|40336269|FG000|Overall Study|Withdrawal by Subject|14|||
16508690|NCT00974571|40336270|FG001|Overall Study|Withdrawal by Subject|5|||
16508691|NCT00974571|40336271|FG002|Overall Study|Withdrawal by Subject|16|||
16508692|NCT00974571|40336269|FG000|Overall Study|Patient Moved|1|||
16508693|NCT00974571|40336270|FG001|Overall Study|Patient Moved|0|||
16508694|NCT00974571|40336271|FG002|Overall Study|Patient Moved|1|||
16508695|NCT00974571|40336269|FG000|Overall Study|Other|4|||
16508696|NCT00974571|40336270|FG001|Overall Study|Other|0|||
16508697|NCT00974571|40336271|FG002|Overall Study|Other|10|||
16508698|NCT02865915|40336274|FG000|Overall Study|Pregnancy|1|||
16508699|NCT02865915|40336275|FG001|Overall Study|Pregnancy|0|||
16508700|NCT02865915|40336274|FG000|Overall Study|Withdrawal by Subject|1|||
16508701|NCT02865915|40336275|FG001|Overall Study|Withdrawal by Subject|1|||
16508702|NCT02865915|40336274|FG000|Overall Study|Adverse Event|0|||
16508703|NCT02865915|40336275|FG001|Overall Study|Adverse Event|4|||
16508704|NCT02865915|40336274|FG000|Overall Study|Lost to Follow-up|0|||
16508705|NCT02865915|40336275|FG001|Overall Study|Lost to Follow-up|1|||
16508706|NCT02865915|40336274|FG000|Overall Study|Protocol Violation|0|||
16508707|NCT02865915|40336275|FG001|Overall Study|Protocol Violation|1|||
16508708|NCT02865915|40336274|FG000|Overall Study|Study terminated by sponsor|23|||
16508709|NCT02865915|40336275|FG001|Overall Study|Study terminated by sponsor|18|||
16508710|NCT02865915|40336274|FG000|Overall Study|Dosing group discontinued|0|||
16508711|NCT02865915|40336275|FG001|Overall Study|Dosing group discontinued|5|||
16508712|NCT00751348|40336278|FG000|Overall Study|Withdrawal by Subject|5|||
16508713|NCT00751348|40336279|FG001|Overall Study|Withdrawal by Subject|2|||
16508714|NCT00751348|40336278|FG000|Overall Study|Migration from study area|1|||
16508715|NCT00751348|40336279|FG001|Overall Study|Migration from study area|0|||
16508716|NCT01023581|40336285|FG000|Overall Study|Adverse Event|4|||
16508717|NCT01023581|40336286|FG001|Overall Study|Adverse Event|4|||
16508718|NCT01023581|40336287|FG002|Overall Study|Adverse Event|7|||
16508719|NCT01023581|40336288|FG003|Overall Study|Adverse Event|3|||
16508720|NCT01023581|40336289|FG004|Overall Study|Adverse Event|2|||
16508721|NCT01023581|40336290|FG005|Overall Study|Adverse Event|5|||
16508722|NCT01023581|40336291|FG006|Overall Study|Adverse Event|11|||
16508723|NCT01023581|40336285|FG000|Overall Study|Major protocol deviation|2|||
16508724|NCT01023581|40336286|FG001|Overall Study|Major protocol deviation|0|||
16508725|NCT01023581|40336287|FG002|Overall Study|Major protocol deviation|3|||
16508726|NCT01023581|40336288|FG003|Overall Study|Major protocol deviation|0|||
16508727|NCT01023581|40336289|FG004|Overall Study|Major protocol deviation|0|||
16508728|NCT01023581|40336290|FG005|Overall Study|Major protocol deviation|0|||
16508729|NCT01023581|40336291|FG006|Overall Study|Major protocol deviation|0|||
16508730|NCT01023581|40336285|FG000|Overall Study|Lost to Follow-up|4|||
16508731|NCT01023581|40336286|FG001|Overall Study|Lost to Follow-up|8|||
16508732|NCT01023581|40336287|FG002|Overall Study|Lost to Follow-up|7|||
16508733|NCT01023581|40336288|FG003|Overall Study|Lost to Follow-up|2|||
16197598|NCT01763866|39201189|FG009|Overall Study|Withdrawal by Subject|1|||
16508734|NCT01023581|40336289|FG004|Overall Study|Lost to Follow-up|5|||
16508735|NCT01023581|40336290|FG005|Overall Study|Lost to Follow-up|2|||
16508736|NCT01023581|40336291|FG006|Overall Study|Lost to Follow-up|2|||
16508737|NCT01023581|40336285|FG000|Overall Study|Withdrawal by Subject|13|||
16508738|NCT01023581|40336286|FG001|Overall Study|Withdrawal by Subject|8|||
16508739|NCT01023581|40336287|FG002|Overall Study|Withdrawal by Subject|16|||
16508740|NCT01023581|40336288|FG003|Overall Study|Withdrawal by Subject|10|||
16508741|NCT01023581|40336289|FG004|Overall Study|Withdrawal by Subject|6|||
16508742|NCT01023581|40336290|FG005|Overall Study|Withdrawal by Subject|8|||
16508743|NCT01023581|40336291|FG006|Overall Study|Withdrawal by Subject|5|||
16391694|NCT03314935|39916195|FG007|Phase 2|Lost to Follow-up|0|||
16391695|NCT03314935|39916196|FG008|Phase 2|Lost to Follow-up|0|||
16391696|NCT03314935|39916197|FG009|Phase 2|Lost to Follow-up|1|||
16391697|NCT03314935|39916198|FG010|Phase 2|Lost to Follow-up|0|||
16391698|NCT03314935|39916199|FG011|Phase 2|Lost to Follow-up|0|||
16391699|NCT03314935|39916200|FG012|Phase 2|Lost to Follow-up|0|||
16391700|NCT03314935|39916201|FG013|Phase 2|Lost to Follow-up|0|||
16391701|NCT03314935|39916202|FG014|Phase 2|Lost to Follow-up|1|||
16391702|NCT03314935|39916188|FG000|Phase 2|Physician Decision|0|||
16391703|NCT03314935|39916189|FG001|Phase 2|Physician Decision|0|||
16391704|NCT03314935|39916190|FG002|Phase 2|Physician Decision|0|||
16391705|NCT03314935|39916191|FG003|Phase 2|Physician Decision|0|||
16391706|NCT03314935|39916192|FG004|Phase 2|Physician Decision|0|||
16314072|NCT02454608|39633950|FG002|Open Label Period|Withdrawal by Subject|8|||
16314073|NCT02564900|39633951|FG000|Dose Escalation|Progressive disease per RECIST|2|||
16314074|NCT02564900|39633952|FG001|Dose Escalation|Progressive disease per RECIST|3|||
16314075|NCT02564900|39633953|FG002|Dose Escalation|Progressive disease per RECIST|3|||
16314076|NCT02564900|39633954|FG003|Dose Escalation|Progressive disease per RECIST|3|||
16314077|NCT02564900|39633955|FG004|Dose Escalation|Progressive disease per RECIST|3|||
16314078|NCT02564900|39633956|FG005|Dose Escalation|Progressive disease per RECIST|1|||
16314079|NCT02564900|39633957|FG006|Dose Escalation|Progressive disease per RECIST|0|||
16314080|NCT02564900|39633958|FG007|Dose Escalation|Progressive disease per RECIST|0|||
16314081|NCT02564900|39633959|FG008|Dose Escalation|Progressive disease per RECIST|0|||
16314082|NCT02564900|39633960|FG009|Dose Escalation|Progressive disease per RECIST|0|||
16314083|NCT02564900|39633961|FG010|Dose Escalation|Progressive disease per RECIST|0|||
16314084|NCT02564900|39633962|FG011|Dose Escalation|Progressive disease per RECIST|0|||
16314085|NCT02564900|39633963|FG012|Dose Escalation|Progressive disease per RECIST|0|||
16314086|NCT02564900|39633964|FG013|Dose Escalation|Progressive disease per RECIST|0|||
16314087|NCT02564900|39633965|FG014|Dose Escalation|Progressive disease per RECIST|0|||
16314088|NCT02564900|39633951|FG000|Dose Escalation|Ongoing|1|||
16314089|NCT02564900|39633952|FG001|Dose Escalation|Ongoing|0|||
16314090|NCT02564900|39633953|FG002|Dose Escalation|Ongoing|0|||
16314091|NCT02564900|39633954|FG003|Dose Escalation|Ongoing|2|||
16314092|NCT02564900|39633955|FG004|Dose Escalation|Ongoing|2|||
16314093|NCT02564900|39633956|FG005|Dose Escalation|Ongoing|2|||
16314094|NCT02564900|39633957|FG006|Dose Escalation|Ongoing|0|||
16314095|NCT02564900|39633958|FG007|Dose Escalation|Ongoing|0|||
16314096|NCT02564900|39633959|FG008|Dose Escalation|Ongoing|0|||
16314097|NCT02564900|39633960|FG009|Dose Escalation|Ongoing|0|||
16314098|NCT02564900|39633961|FG010|Dose Escalation|Ongoing|0|||
16314099|NCT02564900|39633962|FG011|Dose Escalation|Ongoing|0|||
16314100|NCT02564900|39633963|FG012|Dose Escalation|Ongoing|0|||
16314101|NCT02564900|39633964|FG013|Dose Escalation|Ongoing|0|||
16314102|NCT02564900|39633965|FG014|Dose Escalation|Ongoing|0|||
16314103|NCT02564900|39633951|FG000|Dose Escalation|Adverse Event|0|||
16314104|NCT02564900|39633952|FG001|Dose Escalation|Adverse Event|0|||
16314105|NCT02564900|39633953|FG002|Dose Escalation|Adverse Event|0|||
16314106|NCT02564900|39633954|FG003|Dose Escalation|Adverse Event|1|||
16314107|NCT02564900|39633955|FG004|Dose Escalation|Adverse Event|1|||
16314108|NCT02564900|39633956|FG005|Dose Escalation|Adverse Event|3|||
16314109|NCT02564900|39633957|FG006|Dose Escalation|Adverse Event|0|||
16314110|NCT02564900|39633958|FG007|Dose Escalation|Adverse Event|0|||
16314111|NCT02564900|39633959|FG008|Dose Escalation|Adverse Event|0|||
16314112|NCT02564900|39633960|FG009|Dose Escalation|Adverse Event|0|||
16314113|NCT02564900|39633961|FG010|Dose Escalation|Adverse Event|0|||
16314114|NCT02564900|39633962|FG011|Dose Escalation|Adverse Event|0|||
16314115|NCT02564900|39633963|FG012|Dose Escalation|Adverse Event|0|||
16314116|NCT02564900|39633964|FG013|Dose Escalation|Adverse Event|0|||
16314117|NCT02564900|39633965|FG014|Dose Escalation|Adverse Event|0|||
16314118|NCT02564900|39633951|FG000|Dose Expansion|Progressive disease per RECIST|0|||
16314119|NCT02564900|39633952|FG001|Dose Expansion|Progressive disease per RECIST|0|||
16314120|NCT02564900|39633953|FG002|Dose Expansion|Progressive disease per RECIST|0|||
16314121|NCT02564900|39633954|FG003|Dose Expansion|Progressive disease per RECIST|0|||
16314122|NCT02564900|39633955|FG004|Dose Expansion|Progressive disease per RECIST|0|||
16391707|NCT03314935|39916193|FG005|Phase 2|Physician Decision|0|||
16391708|NCT03314935|39916194|FG006|Phase 2|Physician Decision|0|||
16314123|NCT02564900|39633956|FG005|Dose Expansion|Progressive disease per RECIST|0|||
16314124|NCT02564900|39633957|FG006|Dose Expansion|Progressive disease per RECIST|19|||
16391709|NCT03314935|39916195|FG007|Phase 2|Physician Decision|0|||
16314125|NCT02564900|39633958|FG007|Dose Expansion|Progressive disease per RECIST|17|||
16314126|NCT02564900|39633959|FG008|Dose Expansion|Progressive disease per RECIST|8|||
16314127|NCT02564900|39633960|FG009|Dose Expansion|Progressive disease per RECIST|16|||
16314128|NCT02564900|39633961|FG010|Dose Expansion|Progressive disease per RECIST|13|||
16314129|NCT02564900|39633962|FG011|Dose Expansion|Progressive disease per RECIST|19|||
16314130|NCT02564900|39633963|FG012|Dose Expansion|Progressive disease per RECIST|10|||
16314131|NCT02564900|39633964|FG013|Dose Expansion|Progressive disease per RECIST|13|||
16314132|NCT02564900|39633965|FG014|Dose Expansion|Progressive disease per RECIST|11|||
16314133|NCT02564900|39633951|FG000|Dose Expansion|Clinical progression|0|||
16314134|NCT02564900|39633952|FG001|Dose Expansion|Clinical progression|0|||
16314135|NCT02564900|39633953|FG002|Dose Expansion|Clinical progression|0|||
16314136|NCT02564900|39633954|FG003|Dose Expansion|Clinical progression|0|||
16314137|NCT02564900|39633955|FG004|Dose Expansion|Clinical progression|0|||
16314138|NCT02564900|39633956|FG005|Dose Expansion|Clinical progression|0|||
16314139|NCT02564900|39633957|FG006|Dose Expansion|Clinical progression|5|||
16314140|NCT02564900|39633958|FG007|Dose Expansion|Clinical progression|12|||
16314141|NCT02564900|39633959|FG008|Dose Expansion|Clinical progression|0|||
16314142|NCT02564900|39633960|FG009|Dose Expansion|Clinical progression|3|||
16314143|NCT02564900|39633961|FG010|Dose Expansion|Clinical progression|2|||
16314144|NCT02564900|39633962|FG011|Dose Expansion|Clinical progression|0|||
16314145|NCT02564900|39633963|FG012|Dose Expansion|Clinical progression|1|||
16314146|NCT02564900|39633964|FG013|Dose Expansion|Clinical progression|3|||
16314147|NCT02564900|39633965|FG014|Dose Expansion|Clinical progression|1|||
16314148|NCT02564900|39633951|FG000|Dose Expansion|Adverse Event|0|||
16314149|NCT02564900|39633952|FG001|Dose Expansion|Adverse Event|0|||
16314150|NCT02564900|39633953|FG002|Dose Expansion|Adverse Event|0|||
16314151|NCT02564900|39633954|FG003|Dose Expansion|Adverse Event|0|||
16314152|NCT02564900|39633955|FG004|Dose Expansion|Adverse Event|0|||
16314153|NCT02564900|39633956|FG005|Dose Expansion|Adverse Event|0|||
16314154|NCT02564900|39633957|FG006|Dose Expansion|Adverse Event|9|||
16314155|NCT02564900|39633958|FG007|Dose Expansion|Adverse Event|22|||
16314156|NCT02564900|39633959|FG008|Dose Expansion|Adverse Event|0|||
16314157|NCT02564900|39633960|FG009|Dose Expansion|Adverse Event|11|||
16314158|NCT02564900|39633961|FG010|Dose Expansion|Adverse Event|0|||
16314159|NCT02564900|39633962|FG011|Dose Expansion|Adverse Event|5|||
16314160|NCT02564900|39633963|FG012|Dose Expansion|Adverse Event|2|||
16314161|NCT02564900|39633964|FG013|Dose Expansion|Adverse Event|2|||
16314162|NCT02564900|39633965|FG014|Dose Expansion|Adverse Event|1|||
16314163|NCT02564900|39633951|FG000|Dose Expansion|Ongoing|0|||
16314164|NCT02564900|39633952|FG001|Dose Expansion|Ongoing|0|||
16314165|NCT02564900|39633953|FG002|Dose Expansion|Ongoing|0|||
16314166|NCT02564900|39633954|FG003|Dose Expansion|Ongoing|0|||
16314167|NCT02564900|39633955|FG004|Dose Expansion|Ongoing|0|||
16314168|NCT02564900|39633956|FG005|Dose Expansion|Ongoing|0|||
16314169|NCT02564900|39633957|FG006|Dose Expansion|Ongoing|9|||
16314170|NCT02564900|39633958|FG007|Dose Expansion|Ongoing|10|||
16314171|NCT02564900|39633959|FG008|Dose Expansion|Ongoing|11|||
16314172|NCT02564900|39633960|FG009|Dose Expansion|Ongoing|3|||
16314173|NCT02564900|39633961|FG010|Dose Expansion|Ongoing|0|||
16314174|NCT02564900|39633962|FG011|Dose Expansion|Ongoing|0|||
16314175|NCT02564900|39633963|FG012|Dose Expansion|Ongoing|4|||
16314176|NCT02564900|39633964|FG013|Dose Expansion|Ongoing|0|||
16314177|NCT02564900|39633965|FG014|Dose Expansion|Ongoing|6|||
16314178|NCT02564900|39633951|FG000|Dose Expansion|Death|0|||
16314179|NCT02564900|39633952|FG001|Dose Expansion|Death|0|||
16314180|NCT02564900|39633953|FG002|Dose Expansion|Death|0|||
16197599|NCT01763866|39201190|FG010|Overall Study|Withdrawal by Subject|2|||
16314181|NCT02564900|39633954|FG003|Dose Expansion|Death|0|||
16314182|NCT02564900|39633955|FG004|Dose Expansion|Death|0|||
16391710|NCT03314935|39916196|FG008|Phase 2|Physician Decision|0|||
16391711|NCT03314935|39916197|FG009|Phase 2|Physician Decision|0|||
16391712|NCT03314935|39916198|FG010|Phase 2|Physician Decision|1|||
16314183|NCT02564900|39633956|FG005|Dose Expansion|Death|0|||
16314184|NCT02564900|39633957|FG006|Dose Expansion|Death|1|||
16314185|NCT02564900|39633958|FG007|Dose Expansion|Death|0|||
16391713|NCT03314935|39916199|FG011|Phase 2|Physician Decision|0|||
16391714|NCT03314935|39916200|FG012|Phase 2|Physician Decision|0|||
16391715|NCT03314935|39916201|FG013|Phase 2|Physician Decision|0|||
16314186|NCT02564900|39633959|FG008|Dose Expansion|Death|0|||
16314187|NCT02564900|39633960|FG009|Dose Expansion|Death|0|||
16314188|NCT02564900|39633961|FG010|Dose Expansion|Death|1|||
16314189|NCT02564900|39633962|FG011|Dose Expansion|Death|0|||
16314190|NCT02564900|39633963|FG012|Dose Expansion|Death|1|||
16314191|NCT02564900|39633964|FG013|Dose Expansion|Death|1|||
16314192|NCT02564900|39633965|FG014|Dose Expansion|Death|0|||
16314193|NCT02564900|39633951|FG000|Dose Expansion|Withdrawal by Subject|0|||
16391716|NCT03314935|39916202|FG014|Phase 2|Physician Decision|0|||
16391717|NCT02727322|39916205|FG000|Overall Study|Withdrawal by Subject|1|||
16391718|NCT02727322|39916206|FG001|Overall Study|Withdrawal by Subject|1|||
16508744|NCT01023581|40336285|FG000|Overall Study|Pregnancy|0|||
16508745|NCT01023581|40336286|FG001|Overall Study|Pregnancy|0|||
16508746|NCT01023581|40336287|FG002|Overall Study|Pregnancy|0|||
16508747|NCT01023581|40336288|FG003|Overall Study|Pregnancy|2|||
16508748|NCT01023581|40336289|FG004|Overall Study|Pregnancy|0|||
16508749|NCT01023581|40336290|FG005|Overall Study|Pregnancy|1|||
16391719|NCT02727322|39916205|FG000|Overall Study|Protocol Violation|1|||
16391720|NCT02727322|39916206|FG001|Overall Study|Protocol Violation|0|||
16508750|NCT01023581|40336291|FG006|Overall Study|Pregnancy|0|||
16314194|NCT02564900|39633952|FG001|Dose Expansion|Withdrawal by Subject|0|||
16314195|NCT02564900|39633953|FG002|Dose Expansion|Withdrawal by Subject|0|||
16314196|NCT02564900|39633954|FG003|Dose Expansion|Withdrawal by Subject|0|||
16314197|NCT02564900|39633955|FG004|Dose Expansion|Withdrawal by Subject|0|||
16314198|NCT02564900|39633956|FG005|Dose Expansion|Withdrawal by Subject|0|||
16314199|NCT02564900|39633957|FG006|Dose Expansion|Withdrawal by Subject|4|||
16314200|NCT02564900|39633958|FG007|Dose Expansion|Withdrawal by Subject|0|||
16314201|NCT02564900|39633959|FG008|Dose Expansion|Withdrawal by Subject|0|||
16314202|NCT02564900|39633960|FG009|Dose Expansion|Withdrawal by Subject|0|||
16314203|NCT02564900|39633961|FG010|Dose Expansion|Withdrawal by Subject|1|||
16508751|NCT01023581|40336285|FG000|Overall Study|Lack of Efficacy|9|||
16508752|NCT01023581|40336286|FG001|Overall Study|Lack of Efficacy|3|||
16508753|NCT01023581|40336287|FG002|Overall Study|Lack of Efficacy|6|||
16508754|NCT01023581|40336288|FG003|Overall Study|Lack of Efficacy|2|||
16508755|NCT01023581|40336289|FG004|Overall Study|Lack of Efficacy|1|||
16508756|NCT01023581|40336290|FG005|Overall Study|Lack of Efficacy|2|||
16508757|NCT01023581|40336291|FG006|Overall Study|Lack of Efficacy|1|||
16508758|NCT01023581|40336285|FG000|Overall Study|Physician Decision|2|||
16508759|NCT01023581|40336286|FG001|Overall Study|Physician Decision|0|||
16508760|NCT01023581|40336287|FG002|Overall Study|Physician Decision|2|||
16508761|NCT01023581|40336288|FG003|Overall Study|Physician Decision|1|||
16391721|NCT02980107|39916209|FG000|Overall Study|Withdrawal by Subject|51|||
16391722|NCT02980107|39916210|FG001|Overall Study|Withdrawal by Subject|62|||
16391723|NCT01603043|39916211|FG000|Overall Study|Study Futility|7|||
16391724|NCT01603043|39916212|FG001|Overall Study|Study Futility|3|||
16391725|NCT01198574|39916213|FG000|Overall Study|Resigned from schools|4|||
16391726|NCT01198574|39916214|FG001|Overall Study|Resigned from schools|1|||
16391727|NCT01198574|39916215|FG002|Overall Study|Resigned from schools|1|||
16391728|NCT01198574|39916216|FG003|Overall Study|Resigned from schools|4|||
16391729|NCT00049322|39916221|FG000|Overall Study|disease burden|0|||
16391730|NCT00049322|39916222|FG001|Overall Study|disease burden|3|||
16391731|NCT00049322|39916221|FG000|Overall Study|Adverse Event|1|||
16391732|NCT00049322|39916222|FG001|Overall Study|Adverse Event|0|||
16391733|NCT00049322|39916221|FG000|Overall Study|refused angio|0|||
16391734|NCT00049322|39916222|FG001|Overall Study|refused angio|3|||
16391735|NCT00326599|39916224|FG000|Overall Study|Withdrawal by Subject|1|||
16391736|NCT00326599|39916225|FG001|Overall Study|Withdrawal by Subject|0|||
16391737|NCT00326599|39916226|FG002|Overall Study|Withdrawal by Subject|5|||
16508762|NCT01023581|40336289|FG004|Overall Study|Physician Decision|1|||
16508763|NCT01023581|40336290|FG005|Overall Study|Physician Decision|1|||
16391738|NCT00326599|39916227|FG003|Overall Study|Withdrawal by Subject|2|||
16314204|NCT02564900|39633962|FG011|Dose Expansion|Withdrawal by Subject|0|||
16314205|NCT02564900|39633963|FG012|Dose Expansion|Withdrawal by Subject|0|||
16391739|NCT00326599|39916224|FG000|Overall Study|Adverse Event|1|||
16391740|NCT00326599|39916225|FG001|Overall Study|Adverse Event|0|||
16391741|NCT00326599|39916226|FG002|Overall Study|Adverse Event|32|||
16508764|NCT01023581|40336291|FG006|Overall Study|Physician Decision|1|||
16508765|NCT01023581|40336285|FG000|Overall Study|Other|1|||
16508766|NCT01023581|40336286|FG001|Overall Study|Other|0|||
16508767|NCT01023581|40336287|FG002|Overall Study|Other|1|||
16508768|NCT01023581|40336288|FG003|Overall Study|Other|0|||
16508769|NCT01023581|40336289|FG004|Overall Study|Other|1|||
16508770|NCT01023581|40336290|FG005|Overall Study|Other|0|||
16508771|NCT01023581|40336291|FG006|Overall Study|Other|0|||
16508772|NCT02612428|40336293|FG000|VTL-308|Death|14|||
16508773|NCT02612428|40336294|FG001|VTL-308|Death|16|||
16314206|NCT02564900|39633964|FG013|Dose Expansion|Withdrawal by Subject|1|||
16314207|NCT02564900|39633965|FG014|Dose Expansion|Withdrawal by Subject|1|||
16314208|NCT02564900|39633951|FG000|Dose Expansion|Other|0|||
16314209|NCT02564900|39633952|FG001|Dose Expansion|Other|0|||
16314210|NCT02564900|39633953|FG002|Dose Expansion|Other|0|||
16314211|NCT02564900|39633954|FG003|Dose Expansion|Other|0|||
16314212|NCT02564900|39633955|FG004|Dose Expansion|Other|0|||
16314213|NCT02564900|39633956|FG005|Dose Expansion|Other|0|||
16314214|NCT02564900|39633957|FG006|Dose Expansion|Other|1|||
16314215|NCT02564900|39633958|FG007|Dose Expansion|Other|0|||
16314216|NCT02564900|39633959|FG008|Dose Expansion|Other|1|||
16391742|NCT00326599|39916227|FG003|Overall Study|Adverse Event|3|||
16391743|NCT00326599|39916224|FG000|Overall Study|Disease Progression|3|||
16391744|NCT00326599|39916225|FG001|Overall Study|Disease Progression|1|||
16391745|NCT00326599|39916226|FG002|Overall Study|Disease Progression|13|||
16391746|NCT00326599|39916227|FG003|Overall Study|Disease Progression|11|||
16391747|NCT00326599|39916224|FG000|Overall Study|Alternate Treatment|1|||
16391748|NCT00326599|39916225|FG001|Overall Study|Alternate Treatment|0|||
16391749|NCT00326599|39916226|FG002|Overall Study|Alternate Treatment|0|||
16391750|NCT00326599|39916227|FG003|Overall Study|Alternate Treatment|0|||
16391751|NCT00326599|39916224|FG000|Overall Study|Death|0|||
16391752|NCT00326599|39916225|FG001|Overall Study|Death|0|||
16391753|NCT00326599|39916226|FG002|Overall Study|Death|1|||
16508774|NCT02612428|40336293|FG000|VTL-308|Withdrawal by Subject|0|||
16508775|NCT02612428|40336294|FG001|VTL-308|Withdrawal by Subject|1|||
16391754|NCT00326599|39916227|FG003|Overall Study|Death|2|||
16391755|NCT00326599|39916224|FG000|Overall Study|Other Unspecified Reason|0|||
16314217|NCT02564900|39633960|FG009|Dose Expansion|Other|0|||
16314218|NCT02564900|39633961|FG010|Dose Expansion|Other|0|||
16314219|NCT02564900|39633962|FG011|Dose Expansion|Other|0|||
16314220|NCT02564900|39633963|FG012|Dose Expansion|Other|0|||
16314221|NCT02564900|39633964|FG013|Dose Expansion|Other|0|||
16314222|NCT02564900|39633965|FG014|Dose Expansion|Other|1|||
16314223|NCT02564900|39633951|FG000|Dose Expansion|Did not receive treatment|0|||
16314224|NCT02564900|39633952|FG001|Dose Expansion|Did not receive treatment|0|||
16314225|NCT02564900|39633953|FG002|Dose Expansion|Did not receive treatment|0|||
16314226|NCT02564900|39633954|FG003|Dose Expansion|Did not receive treatment|0|||
16391756|NCT00326599|39916225|FG001|Overall Study|Other Unspecified Reason|0|||
16391757|NCT00326599|39916226|FG002|Overall Study|Other Unspecified Reason|2|||
16391758|NCT00326599|39916227|FG003|Overall Study|Other Unspecified Reason|1|||
16314227|NCT02564900|39633955|FG004|Dose Expansion|Did not receive treatment|0|||
16314228|NCT02564900|39633956|FG005|Dose Expansion|Did not receive treatment|0|||
16314229|NCT02564900|39633957|FG006|Dose Expansion|Did not receive treatment|1|||
16314230|NCT02564900|39633958|FG007|Dose Expansion|Did not receive treatment|1|||
16314231|NCT02564900|39633959|FG008|Dose Expansion|Did not receive treatment|0|||
16508776|NCT02612428|40336293|FG000|VTL-308E|Death|9|||
16508777|NCT02612428|40336294|FG001|VTL-308E|Death|7|||
16508778|NCT02612428|40336293|FG000|VTL-308E|Lost to Follow-up|2|||
16508779|NCT02612428|40336294|FG001|VTL-308E|Lost to Follow-up|0|||
16508780|NCT01393405|40336295|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
16508781|NCT01393405|40336296|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
16508782|NCT01393405|40336297|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
16391759|NCT00825994|39916228|FG000|Overall Study|Withdrawal by Subject|2|||
16508783|NCT01393405|40336295|FG000|Induction Period (week1-16)|Adverse Event|16|||
16508784|NCT01393405|40336296|FG001|Induction Period (week1-16)|Adverse Event|0|||
16508785|NCT01393405|40336297|FG002|Induction Period (week1-16)|Adverse Event|0|||
16508786|NCT01393405|40336295|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
16508787|NCT01393405|40336296|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
16314232|NCT02564900|39633960|FG009|Dose Expansion|Did not receive treatment|0|||
16314233|NCT02564900|39633961|FG010|Dose Expansion|Did not receive treatment|0|||
16314234|NCT02564900|39633962|FG011|Dose Expansion|Did not receive treatment|0|||
16314235|NCT02564900|39633963|FG012|Dose Expansion|Did not receive treatment|0|||
16391760|NCT00825994|39916228|FG000|Overall Study|Lost to Follow-up|1|||
16391761|NCT00825994|39916228|FG000|Overall Study|Protocol Violation|1|||
16508788|NCT01393405|40336297|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
16314236|NCT02564900|39633964|FG013|Dose Expansion|Did not receive treatment|0|||
16314237|NCT02564900|39633965|FG014|Dose Expansion|Did not receive treatment|1|||
16314238|NCT01431716|39633968|FG000|Overall Study|Withdrawal of consent|1|||
16508789|NCT01393405|40336295|FG000|Maintenance Period Week|Lack of Efficacy|0|||
16508790|NCT01393405|40336296|FG001|Maintenance Period Week|Lack of Efficacy|22|||
16508791|NCT01393405|40336297|FG002|Maintenance Period Week|Lack of Efficacy|22|||
16508792|NCT01393405|40336295|FG000|Maintenance Period Week|Adverse Event|0|||
16508793|NCT01393405|40336296|FG001|Maintenance Period Week|Adverse Event|5|||
16508794|NCT01393405|40336297|FG002|Maintenance Period Week|Adverse Event|2|||
16508795|NCT01393405|40336295|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
16508796|NCT01393405|40336296|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
16508797|NCT01393405|40336297|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
16508798|NCT01393405|40336295|FG000|Maintenance Period Week|Lost to Follow-up|0|||
16508799|NCT01393405|40336296|FG001|Maintenance Period Week|Lost to Follow-up|1|||
16508800|NCT01393405|40336297|FG002|Maintenance Period Week|Lost to Follow-up|0|||
16508801|NCT00066066|40336300|FG000|Overall Study|Lost to Follow-up|6|||
16508802|NCT00066066|40336301|FG001|Overall Study|Lost to Follow-up|4|||
16508803|NCT00066066|40336302|FG002|Overall Study|Lost to Follow-up|7|||
16314239|NCT03711188|39633969|FG000|Overall Study|Disease progression|11|||
16314240|NCT03711188|39633969|FG000|Overall Study|Adverse Event|1|||
16314241|NCT03926117|39633970|FG000|Overall Study|Unclassified|1|||
16314242|NCT03926117|39633971|FG001|Overall Study|Unclassified|4|||
16314243|NCT03926117|39633972|FG002|Overall Study|Unclassified|1|||
16314244|NCT03926117|39633973|FG003|Overall Study|Unclassified|4|||
16314245|NCT03926117|39633970|FG000|Overall Study|Withdrawal by Subject|3|||
16314246|NCT03926117|39633971|FG001|Overall Study|Withdrawal by Subject|0|||
16314247|NCT03926117|39633972|FG002|Overall Study|Withdrawal by Subject|1|||
16314248|NCT03926117|39633973|FG003|Overall Study|Withdrawal by Subject|1|||
16314249|NCT03926117|39633970|FG000|Overall Study|Lost to Follow-up|0|||
16314250|NCT03926117|39633971|FG001|Overall Study|Lost to Follow-up|2|||
16314251|NCT03926117|39633972|FG002|Overall Study|Lost to Follow-up|1|||
16314252|NCT03926117|39633973|FG003|Overall Study|Lost to Follow-up|0|||
16314253|NCT03926117|39633970|FG000|Overall Study|Adverse Event|1|||
16314254|NCT03926117|39633971|FG001|Overall Study|Adverse Event|2|||
16314255|NCT03926117|39633972|FG002|Overall Study|Adverse Event|3|||
16314256|NCT03926117|39633973|FG003|Overall Study|Adverse Event|1|||
16314257|NCT03926117|39633970|FG000|Overall Study|Randomized but not treated|1|||
16314258|NCT03926117|39633971|FG001|Overall Study|Randomized but not treated|1|||
16314259|NCT03926117|39633972|FG002|Overall Study|Randomized but not treated|0|||
16314260|NCT03926117|39633973|FG003|Overall Study|Randomized but not treated|1|||
16314261|NCT03428152|39633979|FG000|Overall Study|Physician Decision|4|||
16314262|NCT03428152|39633980|FG001|Overall Study|Physician Decision|2|||
16314263|NCT03428152|39633979|FG000|Overall Study|Protocol Violation|3|||
16314264|NCT03428152|39633980|FG001|Overall Study|Protocol Violation|5|||
16314265|NCT03428152|39633979|FG000|Overall Study|Lack of Efficacy|0|||
16314266|NCT03428152|39633980|FG001|Overall Study|Lack of Efficacy|4|||
16314267|NCT00473590|39633985|FG000|Overall Study|Adverse Event|3|||
16314268|NCT00473590|39633986|FG001|Overall Study|Adverse Event|3|||
16314269|NCT00473590|39633985|FG000|Overall Study|Death|4|||
16314270|NCT00473590|39633986|FG001|Overall Study|Death|2|||
16314271|NCT00473590|39633985|FG000|Overall Study|Progression not resulting in death|24|||
16314272|NCT00473590|39633986|FG001|Overall Study|Progression not resulting in death|20|||
16314273|NCT00473590|39633985|FG000|Overall Study|Non-protocol-specified therapy|7|||
16314274|NCT00473590|39633986|FG001|Overall Study|Non-protocol-specified therapy|5|||
16314275|NCT00473590|39633985|FG000|Overall Study|Physician Decision|2|||
16314276|NCT00473590|39633986|FG001|Overall Study|Physician Decision|4|||
16314277|NCT00473590|39633985|FG000|Overall Study|Withdrawal by Subject|5|||
16314278|NCT00473590|39633986|FG001|Overall Study|Withdrawal by Subject|3|||
16314279|NCT00473590|39633985|FG000|Overall Study|Other|0|||
16314280|NCT00473590|39633986|FG001|Overall Study|Other|1|||
16314281|NCT03307252|39633989|FG000|Part 2, Period 1|Treatment not received|0|||
16314282|NCT03307252|39633990|FG001|Part 2, Period 1|Treatment not received|0|||
16314283|NCT03307252|39633991|FG002|Part 2, Period 1|Treatment not received|0|||
16314284|NCT03307252|39633992|FG003|Part 2, Period 1|Treatment not received|0|||
16314285|NCT03307252|39633993|FG004|Part 2, Period 1|Treatment not received|0|||
16314286|NCT03307252|39633994|FG005|Part 2, Period 1|Treatment not received|1|||
16314287|NCT03307252|39633995|FG006|Part 2, Period 1|Treatment not received|0|||
16314288|NCT03307252|39633996|FG007|Part 2, Period 1|Treatment not received|0|||
16314289|NCT03307252|39633997|FG008|Part 2, Period 1|Treatment not received|0|||
16314290|NCT03307252|39633998|FG009|Part 2, Period 1|Treatment not received|0|||
16314291|NCT03307252|39633999|FG010|Part 2, Period 1|Treatment not received|0|||
16314292|NCT03307252|39633989|FG000|Part 2, Period 3|Other than listed|0|||
16314293|NCT03307252|39633990|FG001|Part 2, Period 3|Other than listed|0|||
16508804|NCT00066066|40336303|FG003|Overall Study|Lost to Follow-up|4|||
16508805|NCT00066066|40336304|FG004|Overall Study|Lost to Follow-up|3|||
16508806|NCT00066066|40336305|FG005|Overall Study|Lost to Follow-up|5|||
16508807|NCT02780804|40336310|FG000|Overall Study|Death|1|||
16508808|NCT02780804|40336311|FG001|Overall Study|Death|0|||
16508809|NCT02780804|40336312|FG002|Overall Study|Death|0|||
16508810|NCT02780804|40336310|FG000|Overall Study|Lack of Efficacy|5|||
16508811|NCT02780804|40336311|FG001|Overall Study|Lack of Efficacy|8|||
16508812|NCT02780804|40336312|FG002|Overall Study|Lack of Efficacy|4|||
16314294|NCT03307252|39633991|FG002|Part 2, Period 3|Other than listed|0|||
16314295|NCT03307252|39633992|FG003|Part 2, Period 3|Other than listed|0|||
16314296|NCT03307252|39633993|FG004|Part 2, Period 3|Other than listed|1|||
16314297|NCT03307252|39633994|FG005|Part 2, Period 3|Other than listed|0|||
16314298|NCT03307252|39633995|FG006|Part 2, Period 3|Other than listed|0|||
16314299|NCT03307252|39633996|FG007|Part 2, Period 3|Other than listed|0|||
16314300|NCT03307252|39633997|FG008|Part 2, Period 3|Other than listed|0|||
16314301|NCT03307252|39633998|FG009|Part 2, Period 3|Other than listed|0|||
16314302|NCT03307252|39633999|FG010|Part 2, Period 3|Other than listed|0|||
16314303|NCT03307252|39633989|FG000|Part 2, Period 4|Other than listed|0|||
16314304|NCT03307252|39633990|FG001|Part 2, Period 4|Other than listed|0|||
16314305|NCT03307252|39633991|FG002|Part 2, Period 4|Other than listed|0|||
16314306|NCT03307252|39633992|FG003|Part 2, Period 4|Other than listed|0|||
16314307|NCT03307252|39633993|FG004|Part 2, Period 4|Other than listed|0|||
16314308|NCT03307252|39633994|FG005|Part 2, Period 4|Other than listed|0|||
16314309|NCT03307252|39633995|FG006|Part 2, Period 4|Other than listed|1|||
16314310|NCT03307252|39633996|FG007|Part 2, Period 4|Other than listed|0|||
16197600|NCT01763866|39201191|FG011|Overall Study|Withdrawal by Subject|2|||
16197601|NCT01763866|39201192|FG012|Overall Study|Withdrawal by Subject|2|||
16197602|NCT01763866|39201193|FG013|Overall Study|Withdrawal by Subject|0|||
16314311|NCT03307252|39633997|FG008|Part 2, Period 4|Other than listed|0|||
16314312|NCT03307252|39633998|FG009|Part 2, Period 4|Other than listed|0|||
16314313|NCT03307252|39633999|FG010|Part 2, Period 4|Other than listed|0|||
16314314|NCT03307252|39633989|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
16314315|NCT03307252|39633990|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
16314316|NCT03307252|39633991|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
16314317|NCT03307252|39633992|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
16314318|NCT03307252|39633993|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
16314319|NCT03307252|39633994|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
16314320|NCT03307252|39633995|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
16314321|NCT03307252|39633996|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
16314322|NCT03307252|39633997|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
16314323|NCT03307252|39633998|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
16314324|NCT03307252|39633999|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
16314325|NCT03762850|39634007|FG000|Overall Study|Death|0|||
16314326|NCT03762850|39634008|FG001|Overall Study|Death|1|||
16314327|NCT03762850|39634007|FG000|Overall Study|Lost to Follow-up|0|||
16314328|NCT03762850|39634008|FG001|Overall Study|Lost to Follow-up|1|||
16314329|NCT03762850|39634007|FG000|Overall Study|Physician Decision|0|||
16314330|NCT03762850|39634008|FG001|Overall Study|Physician Decision|1|||
16314331|NCT03762850|39634007|FG000|Overall Study|Withdrawal by Subject|4|||
16314332|NCT03762850|39634008|FG001|Overall Study|Withdrawal by Subject|9|||
16314333|NCT02640482|39634009|FG000|Overall Study|Lost to Follow-up|3|||
16314334|NCT02640482|39634010|FG001|Overall Study|Lost to Follow-up|0|||
16314335|NCT04341363|39634011|FG000|Overall Study|Adverse Event|1|||
16314336|NCT04341363|39634011|FG000|Overall Study|Withdrawal by Subject|1|||
16314337|NCT02025725|39634012|FG000|Overall Study|Adverse Event|5|||
16508813|NCT02780804|40336310|FG000|Overall Study|Physician Decision|0|||
16508814|NCT02780804|40336311|FG001|Overall Study|Physician Decision|0|||
16508815|NCT02780804|40336312|FG002|Overall Study|Physician Decision|2|||
16508816|NCT02780804|40336310|FG000|Overall Study|Withdrawal by Subject|0|||
16391762|NCT00825994|39916228|FG000|Overall Study|Placebo Responder at V2|1|||
16391763|NCT00532129|39916232|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
16391764|NCT00532129|39916232|FG000|Treatment Period|Physician Decision|15|||
16391765|NCT00532129|39916232|FG000|Treatment Period|Disease progression|3|||
16391766|NCT00532129|39916232|FG000|Treatment Period|Protocol Violation|1|||
16391767|NCT00532129|39916232|FG000|Treatment Period|Other|5|||
16391768|NCT00532129|39916232|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
16391769|NCT00532129|39916232|FG000|Follow-up Period|Disease progression|57|||
16391770|NCT00532129|39916232|FG000|Follow-up Period|Lost to Follow-up|1|||
16391771|NCT00532129|39916232|FG000|Follow-up Period|Other|6|||
16391772|NCT01664247|39916235|FG000|Overall Study|Adverse Event|5|||
16391773|NCT01664247|39916236|FG001|Overall Study|Adverse Event|3|||
16391774|NCT01664247|39916235|FG000|Overall Study|Protocol Violation|3|||
16391775|NCT01664247|39916236|FG001|Overall Study|Protocol Violation|5|||
16391776|NCT01664247|39916235|FG000|Overall Study|Withdrawal Criteria|1|||
16314338|NCT02025725|39634013|FG001|Overall Study|Adverse Event|0|||
16391777|NCT01664247|39916236|FG001|Overall Study|Withdrawal Criteria|4|||
16391778|NCT01664247|39916235|FG000|Overall Study|Unclassified|5|||
16089938|NCT00614614|38820027|FG001|Primary Vaccination Phase|Protocol Violation|3|||
16089939|NCT00614614|38820028|FG002|Primary Vaccination Phase|Protocol Violation|0|||
16089940|NCT00614614|38820029|FG003|Primary Vaccination Phase|Protocol Violation|0|||
16089941|NCT00614614|38820030|FG004|Primary Vaccination Phase|Protocol Violation|0|||
16089942|NCT00614614|38820026|FG000|Primary Vaccination Phase|Other|4|||
16089943|NCT00614614|38820027|FG001|Primary Vaccination Phase|Other|0|||
16314339|NCT02025725|39634012|FG000|Overall Study|Lost to Follow-up|2|||
16314340|NCT02025725|39634013|FG001|Overall Study|Lost to Follow-up|0|||
16314341|NCT02025725|39634012|FG000|Overall Study|Protocol Violation|1|||
16314342|NCT02025725|39634013|FG001|Overall Study|Protocol Violation|1|||
16314343|NCT02025725|39634012|FG000|Overall Study|Withdrawal by Subject|3|||
16314344|NCT02025725|39634013|FG001|Overall Study|Withdrawal by Subject|2|||
16314345|NCT02025725|39634012|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
16314346|NCT02025725|39634013|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
16314347|NCT02547428|39634014|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
16314348|NCT02547428|39634015|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
16314349|NCT02547428|39634014|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
16314350|NCT02547428|39634015|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
16314351|NCT02547428|39634014|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
16508817|NCT02780804|40336311|FG001|Overall Study|Withdrawal by Subject|1|||
16508818|NCT02780804|40336312|FG002|Overall Study|Withdrawal by Subject|0|||
16314352|NCT02547428|39634015|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
16314353|NCT02547428|39634014|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
16314354|NCT02547428|39634015|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
16314355|NCT02547428|39634014|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
16314356|NCT02547428|39634015|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
16508819|NCT00634088|40336313|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
16508820|NCT00634088|40336314|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
16508821|NCT00634088|40336315|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
16508822|NCT00634088|40336316|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
16508823|NCT00634088|40336313|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
16508824|NCT00634088|40336314|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
16508825|NCT00634088|40336315|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
16508826|NCT00634088|40336316|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
16508827|NCT00634088|40336313|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
16508828|NCT00634088|40336314|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
16508829|NCT00634088|40336315|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
16508830|NCT00634088|40336316|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
16508831|NCT00634088|40336313|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
16508832|NCT00634088|40336314|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
16508833|NCT00634088|40336315|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
16508834|NCT00634088|40336316|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
16508835|NCT00634088|40336313|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
16508836|NCT00634088|40336314|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
16508837|NCT00634088|40336315|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
16508838|NCT00634088|40336316|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
16508839|NCT00634088|40336313|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
16314357|NCT02547428|39634014|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
16508840|NCT00634088|40336314|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
16089944|NCT00614614|38820028|FG002|Primary Vaccination Phase|Other|0|||
16391779|NCT01664247|39916236|FG001|Overall Study|Unclassified|29|||
16508841|NCT00634088|40336315|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
16508842|NCT00634088|40336316|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
16391780|NCT01847092|39916237|FG000|Overall Study|Adverse Event|12|||
16391781|NCT01847092|39916238|FG001|Overall Study|Adverse Event|3|||
16391782|NCT01847092|39916237|FG000|Overall Study|Withdrawal by Subject|5|||
16391783|NCT01847092|39916238|FG001|Overall Study|Withdrawal by Subject|5|||
16391784|NCT01847092|39916237|FG000|Overall Study|Protocol Specified|8|||
16391785|NCT01847092|39916238|FG001|Overall Study|Protocol Specified|0|||
16391786|NCT01847092|39916237|FG000|Overall Study|Physician Decision|1|||
16391787|NCT01847092|39916238|FG001|Overall Study|Physician Decision|1|||
16391788|NCT01847092|39916237|FG000|Overall Study|Protocol Violation|0|||
16391789|NCT01847092|39916238|FG001|Overall Study|Protocol Violation|2|||
16508843|NCT01116232|40336317|FG000|Overall Study|Progressive diease|4|||
16508844|NCT00615056|40336325|FG000|Overall Study|Death|31|||
16508845|NCT00615056|40336326|FG001|Overall Study|Death|31|||
16508846|NCT00615056|40336327|FG002|Overall Study|Death|21|||
16508847|NCT00615056|40336328|FG003|Overall Study|Death|23|||
16508848|NCT00615056|40336325|FG000|Overall Study|Lost to Follow-up|1|||
16508849|NCT00615056|40336326|FG001|Overall Study|Lost to Follow-up|2|||
16508850|NCT00615056|40336327|FG002|Overall Study|Lost to Follow-up|4|||
16508851|NCT00615056|40336328|FG003|Overall Study|Lost to Follow-up|5|||
16508852|NCT00615056|40336325|FG000|Overall Study|Other|13|||
16508853|NCT00615056|40336326|FG001|Overall Study|Other|15|||
16508854|NCT00615056|40336327|FG002|Overall Study|Other|10|||
16508855|NCT00615056|40336328|FG003|Overall Study|Other|7|||
16508856|NCT00615056|40336325|FG000|Overall Study|Objective progression or relapse|0|||
16508857|NCT00615056|40336326|FG001|Overall Study|Objective progression or relapse|2|||
16508858|NCT00615056|40336327|FG002|Overall Study|Objective progression or relapse|0|||
16508859|NCT00615056|40336328|FG003|Overall Study|Objective progression or relapse|0|||
16508860|NCT00615056|40336325|FG000|Overall Study|Withdrawal by Subject|0|||
16508861|NCT00615056|40336326|FG001|Overall Study|Withdrawal by Subject|1|||
16508862|NCT00615056|40336327|FG002|Overall Study|Withdrawal by Subject|1|||
16508863|NCT00615056|40336328|FG003|Overall Study|Withdrawal by Subject|0|||
16508864|NCT00615056|40336325|FG000|Overall Study|Discontinued by Sponsor|1|||
16508865|NCT00615056|40336326|FG001|Overall Study|Discontinued by Sponsor|0|||
16508866|NCT00615056|40336327|FG002|Overall Study|Discontinued by Sponsor|0|||
16508867|NCT00615056|40336328|FG003|Overall Study|Discontinued by Sponsor|0|||
16508868|NCT00615056|40336325|FG000|Overall Study|Randomized but not treated|3|||
16508869|NCT00615056|40336326|FG001|Overall Study|Randomized but not treated|0|||
16508870|NCT00615056|40336327|FG002|Overall Study|Randomized but not treated|0|||
16508871|NCT00615056|40336328|FG003|Overall Study|Randomized but not treated|0|||
16508872|NCT00854581|40336329|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
16508873|NCT00854581|40336329|FG000|Induction (Up to Day 21)|Death|1|||
16508874|NCT00854581|40336329|FG000|Induction (Up to Day 21)|Physician Decision|1|||
16508875|NCT00854581|40336329|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
16508876|NCT01380184|40336337|FG000|Part 1 (19 Days)|Adverse Event|1|||
16508877|NCT01380184|40336337|FG000|Part 2|Adverse Event|5|||
16508878|NCT01380184|40336337|FG000|Part 2|Disease Progression|8|||
16508879|NCT01380184|40336337|FG000|Part 2|Lost to Follow-up|1|||
16391790|NCT03159468|39916239|FG000|Overall Study|Withdrawal by Subject|0|||
16391791|NCT03159468|39916240|FG001|Overall Study|Withdrawal by Subject|0|||
16391792|NCT03159468|39916241|FG002|Overall Study|Withdrawal by Subject|3|||
16391793|NCT03159468|39916242|FG003|Overall Study|Withdrawal by Subject|0|||
16391794|NCT03159468|39916243|FG004|Overall Study|Withdrawal by Subject|0|||
16391795|NCT03159468|39916244|FG005|Overall Study|Withdrawal by Subject|0|||
16391796|NCT00443703|39916245|FG000|Overall Study|Never Treated|3|||
16391797|NCT00443703|39916246|FG001|Overall Study|Never Treated|1|||
16391798|NCT00443703|39916245|FG000|Overall Study|Adverse Event|7|||
16391799|NCT00443703|39916246|FG001|Overall Study|Adverse Event|3|||
16391800|NCT00443703|39916245|FG000|Overall Study|Lack of Efficacy|3|||
16391801|NCT00443703|39916246|FG001|Overall Study|Lack of Efficacy|1|||
16391802|NCT00443703|39916245|FG000|Overall Study|Lost to Follow-up|0|||
16391803|NCT00443703|39916246|FG001|Overall Study|Lost to Follow-up|4|||
16391804|NCT00443703|39916245|FG000|Overall Study|Physician Decision|4|||
16391805|NCT00443703|39916246|FG001|Overall Study|Physician Decision|2|||
16391806|NCT00443703|39916245|FG000|Overall Study|Protocol Violation|1|||
16391807|NCT00443703|39916246|FG001|Overall Study|Protocol Violation|1|||
16508880|NCT00316199|40336338|FG000|Overall Study|Adverse Event|2|||
16391808|NCT00443703|39916245|FG000|Overall Study|Withdrawal by Subject|9|||
16391809|NCT00443703|39916246|FG001|Overall Study|Withdrawal by Subject|6|||
16391810|NCT00443703|39916245|FG000|Overall Study|Progressive Disease|1|||
16391811|NCT00443703|39916246|FG001|Overall Study|Progressive Disease|0|||
16391812|NCT00465972|39916247|FG000|Overall Study|Withdrawal by Subject|2|||
16391813|NCT00465972|39916248|FG001|Overall Study|Withdrawal by Subject|1|||
16391814|NCT03135431|39919452|FG000|Overall Study|Study Surgeon not available|2|||
16508881|NCT00316199|40336338|FG000|Overall Study|Death|8|||
16508882|NCT00316199|40336338|FG000|Overall Study|Lost to Follow-up|2|||
16508883|NCT00531232|40336339|FG000|Overall Study|Investigator decision|0|||
16508884|NCT00531232|40336340|FG001|Overall Study|Investigator decision|0|||
16508885|NCT00531232|40336341|FG002|Overall Study|Investigator decision|4|||
16197603|NCT01763866|39201194|FG014|Overall Study|Withdrawal by Subject|6|||
16197604|NCT01763866|39201195|FG015|Overall Study|Withdrawal by Subject|3|||
16197605|NCT01763866|39201196|FG016|Overall Study|Withdrawal by Subject|0|||
16197606|NCT01763866|39201197|FG017|Overall Study|Withdrawal by Subject|1|||
16197607|NCT01763866|39201198|FG018|Overall Study|Withdrawal by Subject|1|||
16197608|NCT01763866|39201199|FG019|Overall Study|Withdrawal by Subject|1|||
16197609|NCT01763866|39201200|FG020|Overall Study|Withdrawal by Subject|2|||
16197610|NCT01763866|39201201|FG021|Overall Study|Withdrawal by Subject|1|||
16197611|NCT01763866|39201202|FG022|Overall Study|Withdrawal by Subject|2|||
16197612|NCT01763866|39201203|FG023|Overall Study|Withdrawal by Subject|1|||
16197613|NCT01763866|39201180|FG000|Overall Study|Decision by sponsor|0|||
16197614|NCT01763866|39201181|FG001|Overall Study|Decision by sponsor|0|||
16197615|NCT01763866|39201182|FG002|Overall Study|Decision by sponsor|1|||
16197616|NCT01763866|39201183|FG003|Overall Study|Decision by sponsor|0|||
16197617|NCT01763866|39201184|FG004|Overall Study|Decision by sponsor|2|||
16197618|NCT01763866|39201185|FG005|Overall Study|Decision by sponsor|0|||
16197619|NCT01763866|39201186|FG006|Overall Study|Decision by sponsor|2|||
16197620|NCT01763866|39201187|FG007|Overall Study|Decision by sponsor|0|||
16197621|NCT01763866|39201188|FG008|Overall Study|Decision by sponsor|2|||
16197622|NCT01763866|39201189|FG009|Overall Study|Decision by sponsor|0|||
16197623|NCT01763866|39201190|FG010|Overall Study|Decision by sponsor|6|||
16197624|NCT01763866|39201191|FG011|Overall Study|Decision by sponsor|0|||
16197625|NCT01763866|39201192|FG012|Overall Study|Decision by sponsor|1|||
16314358|NCT02547428|39634015|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
16314359|NCT02547428|39634014|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
16314360|NCT02547428|39634015|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
16314361|NCT02547428|39634014|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
16314362|NCT02547428|39634015|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
16391815|NCT03135431|39919453|FG001|Overall Study|Study Surgeon not available|0|||
16391816|NCT04971967|39919454|FG000|Overall Study|Lost to Follow-up|6|||
16391817|NCT04971967|39919455|FG001|Overall Study|Lost to Follow-up|7|||
16391818|NCT00938912|39919457|FG000|Overall Study|Withdrawal by Subject|28|||
16391819|NCT00938912|39919457|FG000|Overall Study|Lost to Follow-up|4|||
16391820|NCT00938912|39919457|FG000|Overall Study|Lack of Efficacy|43|||
16391821|NCT00938912|39919457|FG000|Overall Study|Adverse event, non-fatal|24|||
16391822|NCT00938912|39919457|FG000|Overall Study|Adverse event, fatal|1|||
16391823|NCT00938912|39919457|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
16391824|NCT00938912|39919457|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
16391825|NCT00938912|39919457|FG000|Overall Study|Participant needed prohibit medication|1|||
16391826|NCT00938912|39919457|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
16391827|NCT00938912|39919457|FG000|Overall Study|Did not meet Eligibility criteria|1|||
16391828|NCT00938912|39919457|FG000|Overall Study|Participant relocated not related to AE|1|||
16391829|NCT00938912|39919457|FG000|Overall Study|Participant moved to another city|1|||
16391830|NCT00938912|39919457|FG000|Overall Study|Participant experienced break through seizures|1|||
16391831|NCT00938912|39919457|FG000|Overall Study|No longer wished to participate in the study|1|||
16391832|NCT00938912|39919457|FG000|Overall Study|Protocol Deviation|2|||
16391833|NCT02140970|39919458|FG000|Overall Study|Lost to Follow-up|1|||
16391834|NCT02140970|39919459|FG001|Overall Study|Lost to Follow-up|2|||
16391835|NCT02140970|39919458|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
16391836|NCT02140970|39919459|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
16508886|NCT00531232|40336339|FG000|Overall Study|Participants refused further treatment|0|||
16197626|NCT01763866|39201193|FG013|Overall Study|Decision by sponsor|0|||
16314363|NCT01169350|39634016|FG000|Overall Study|Physician Decision|3|||
16314364|NCT01169350|39634016|FG000|Overall Study|Lost to Follow-up|2|||
16314365|NCT01790984|39634017|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
16314366|NCT01790984|39634018|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
16314367|NCT01790984|39634019|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
16314368|NCT01790984|39634020|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
16391837|NCT02140970|39919458|FG000|Overall Study|Did not meet inclusion criteria|0|||
16391838|NCT02140970|39919459|FG001|Overall Study|Did not meet inclusion criteria|1|||
16508887|NCT00531232|40336340|FG001|Overall Study|Participants refused further treatment|1|||
16508888|NCT00531232|40336341|FG002|Overall Study|Participants refused further treatment|2|||
16508889|NCT00531232|40336339|FG000|Overall Study|Adverse events (AEs)|1|||
16508890|NCT00531232|40336340|FG001|Overall Study|Adverse events (AEs)|2|||
16197627|NCT01763866|39201194|FG014|Overall Study|Decision by sponsor|5|||
16197628|NCT01763866|39201195|FG015|Overall Study|Decision by sponsor|0|||
16197629|NCT01763866|39201196|FG016|Overall Study|Decision by sponsor|0|||
16197630|NCT01763866|39201197|FG017|Overall Study|Decision by sponsor|0|||
16197631|NCT01763866|39201198|FG018|Overall Study|Decision by sponsor|4|||
16197632|NCT01763866|39201199|FG019|Overall Study|Decision by sponsor|0|||
16197633|NCT01763866|39201200|FG020|Overall Study|Decision by sponsor|2|||
16391839|NCT00427011|39919462|FG000|Overall Study|Adverse Event|10|||
16391840|NCT00427011|39919462|FG000|Overall Study|Withdrawal by Subject|1|||
16197634|NCT01763866|39201201|FG021|Overall Study|Decision by sponsor|0|||
16197635|NCT01763866|39201202|FG022|Overall Study|Decision by sponsor|1|||
16197636|NCT01763866|39201203|FG023|Overall Study|Decision by sponsor|0|||
16197637|NCT01763866|39201180|FG000|Overall Study|Lost to Follow-up|0|||
16197638|NCT01763866|39201181|FG001|Overall Study|Lost to Follow-up|0|||
16197639|NCT01763866|39201182|FG002|Overall Study|Lost to Follow-up|0|||
16197640|NCT01763866|39201183|FG003|Overall Study|Lost to Follow-up|0|||
16197641|NCT01763866|39201184|FG004|Overall Study|Lost to Follow-up|0|||
16197642|NCT01763866|39201185|FG005|Overall Study|Lost to Follow-up|0|||
16197643|NCT01763866|39201186|FG006|Overall Study|Lost to Follow-up|1|||
16197644|NCT01763866|39201187|FG007|Overall Study|Lost to Follow-up|0|||
16197645|NCT01763866|39201188|FG008|Overall Study|Lost to Follow-up|0|||
16197646|NCT01763866|39201189|FG009|Overall Study|Lost to Follow-up|0|||
16197647|NCT01763866|39201190|FG010|Overall Study|Lost to Follow-up|0|||
16314369|NCT00078767|39634021|FG000|Overall Study|Withdrawal by Subject|1|||
16314370|NCT00078767|39634022|FG001|Overall Study|Withdrawal by Subject|1|||
16314371|NCT00658723|39634023|FG000|Overall Study|Lost to Follow-up|0|||
16314372|NCT00658723|39634024|FG001|Overall Study|Lost to Follow-up|2|||
16314373|NCT00658723|39634025|FG002|Overall Study|Lost to Follow-up|2|||
16314374|NCT00658723|39634023|FG000|Overall Study|Death|2|||
16314375|NCT00658723|39634024|FG001|Overall Study|Death|1|||
16314376|NCT00658723|39634025|FG002|Overall Study|Death|4|||
16314377|NCT00658723|39634023|FG000|Overall Study|Scheduling Issue|1|||
16314378|NCT00658723|39634024|FG001|Overall Study|Scheduling Issue|1|||
16314379|NCT00658723|39634025|FG002|Overall Study|Scheduling Issue|0|||
16314380|NCT00658723|39634023|FG000|Overall Study|Withdrawal by Subject|1|||
16314381|NCT00658723|39634024|FG001|Overall Study|Withdrawal by Subject|0|||
16314382|NCT00658723|39634025|FG002|Overall Study|Withdrawal by Subject|1|||
16314383|NCT01611883|39634026|FG000|Overall Study|Adverse Event|1|||
16314384|NCT01611883|39634027|FG001|Overall Study|Adverse Event|1|||
16314385|NCT03187301|39634028|FG000|Titration Period|Adverse Event|0|||
16314386|NCT03187301|39634029|FG001|Titration Period|Adverse Event|0|||
16314387|NCT03187301|39634030|FG002|Titration Period|Adverse Event|0|||
16508891|NCT00531232|40336341|FG002|Overall Study|Adverse events (AEs)|2|||
16508892|NCT00531232|40336339|FG000|Overall Study|Treatment failure|1|||
16508893|NCT00531232|40336340|FG001|Overall Study|Treatment failure|3|||
16508894|NCT00531232|40336341|FG002|Overall Study|Treatment failure|7|||
16508895|NCT00531232|40336339|FG000|Overall Study|Disease recurrence|0|||
16508896|NCT00531232|40336340|FG001|Overall Study|Disease recurrence|0|||
16508897|NCT00531232|40336341|FG002|Overall Study|Disease recurrence|1|||
16508898|NCT00531232|40336339|FG000|Overall Study|Deceased|2|||
16508899|NCT00531232|40336340|FG001|Overall Study|Deceased|2|||
16508900|NCT00531232|40336341|FG002|Overall Study|Deceased|2|||
16508901|NCT00531232|40336339|FG000|Overall Study|Withdrawal by Subject|0|||
16197648|NCT01763866|39201191|FG011|Overall Study|Lost to Follow-up|0|||
16197649|NCT01763866|39201192|FG012|Overall Study|Lost to Follow-up|1|||
16197650|NCT01763866|39201193|FG013|Overall Study|Lost to Follow-up|0|||
16197651|NCT01763866|39201194|FG014|Overall Study|Lost to Follow-up|1|||
16197652|NCT01763866|39201195|FG015|Overall Study|Lost to Follow-up|0|||
16197653|NCT01763866|39201196|FG016|Overall Study|Lost to Follow-up|0|||
16197654|NCT01763866|39201197|FG017|Overall Study|Lost to Follow-up|0|||
16197655|NCT01763866|39201198|FG018|Overall Study|Lost to Follow-up|1|||
16197656|NCT01763866|39201199|FG019|Overall Study|Lost to Follow-up|1|||
16197657|NCT01763866|39201200|FG020|Overall Study|Lost to Follow-up|0|||
16197658|NCT01763866|39201201|FG021|Overall Study|Lost to Follow-up|0|||
16197659|NCT01763866|39201202|FG022|Overall Study|Lost to Follow-up|0|||
16197660|NCT01763866|39201203|FG023|Overall Study|Lost to Follow-up|1|||
16197661|NCT01763866|39201180|FG000|Overall Study|Death|0|||
16197662|NCT01763866|39201181|FG001|Overall Study|Death|0|||
16197663|NCT01763866|39201182|FG002|Overall Study|Death|0|||
16197664|NCT01763866|39201183|FG003|Overall Study|Death|0|||
16197665|NCT01763866|39201184|FG004|Overall Study|Death|0|||
16197666|NCT01763866|39201185|FG005|Overall Study|Death|0|||
16197667|NCT01763866|39201186|FG006|Overall Study|Death|0|||
16508902|NCT00531232|40336340|FG001|Overall Study|Withdrawal by Subject|1|||
16197668|NCT01763866|39201187|FG007|Overall Study|Death|0|||
16197669|NCT01763866|39201188|FG008|Overall Study|Death|0|||
16197670|NCT01763866|39201189|FG009|Overall Study|Death|0|||
16197671|NCT01763866|39201190|FG010|Overall Study|Death|0|||
16314388|NCT03187301|39634031|FG003|Titration Period|Adverse Event|0|||
16314389|NCT03187301|39634032|FG004|Titration Period|Adverse Event|0|||
16197672|NCT01763866|39201191|FG011|Overall Study|Death|0|||
16197673|NCT01763866|39201192|FG012|Overall Study|Death|0|||
16197674|NCT01763866|39201193|FG013|Overall Study|Death|0|||
16197675|NCT01763866|39201194|FG014|Overall Study|Death|0|||
16197676|NCT01763866|39201195|FG015|Overall Study|Death|0|||
16197677|NCT01763866|39201196|FG016|Overall Study|Death|1|||
16197678|NCT01763866|39201197|FG017|Overall Study|Death|0|||
16197679|NCT01763866|39201198|FG018|Overall Study|Death|0|||
16314390|NCT03187301|39634033|FG005|Titration Period|Adverse Event|0|||
16314391|NCT03187301|39634034|FG006|Titration Period|Adverse Event|5|||
16391841|NCT00427011|39919462|FG000|Overall Study|Lack of Efficacy|2|||
16197680|NCT01763866|39201199|FG019|Overall Study|Death|0|||
16197681|NCT01763866|39201200|FG020|Overall Study|Death|0|||
16197682|NCT01763866|39201201|FG021|Overall Study|Death|0|||
16197683|NCT01763866|39201202|FG022|Overall Study|Death|0|||
16197684|NCT01763866|39201203|FG023|Overall Study|Death|0|||
16197685|NCT00819585|39201206|FG000|Core Study|Adverse Event|2|||
16197686|NCT00819585|39201207|FG001|Core Study|Adverse Event|1|||
16197687|NCT00819585|39201208|FG002|Core Study|Adverse Event|1|||
16314392|NCT03187301|39634028|FG000|Titration Period|Withdrawal by Subject|0|||
16314393|NCT03187301|39634029|FG001|Titration Period|Withdrawal by Subject|0|||
16314394|NCT03187301|39634030|FG002|Titration Period|Withdrawal by Subject|0|||
16391842|NCT00427011|39919462|FG000|Overall Study|Other|12|||
16391843|NCT00642707|39919470|FG000|Overall Study|Adverse Event|0|||
16391844|NCT00642707|39919471|FG001|Overall Study|Adverse Event|0|||
16391845|NCT00642707|39919472|FG002|Overall Study|Adverse Event|0|||
16391846|NCT00642707|39919473|FG003|Overall Study|Adverse Event|2|||
16391847|NCT00642707|39919470|FG000|Overall Study|Withdrawal by Subject|1|||
16391848|NCT00642707|39919471|FG001|Overall Study|Withdrawal by Subject|0|||
16391849|NCT00642707|39919472|FG002|Overall Study|Withdrawal by Subject|0|||
16391850|NCT00642707|39919473|FG003|Overall Study|Withdrawal by Subject|0|||
16391851|NCT01485796|39919474|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
16391852|NCT01485796|39919474|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
16391853|NCT01485796|39919474|FG000|Period 2: Epoch 2|Adverse Event|3|||
16391854|NCT01485796|39919474|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
16391855|NCT01485796|39919474|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
16391856|NCT01485796|39919474|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
16391857|NCT01485796|39919474|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
16314395|NCT03187301|39634031|FG003|Titration Period|Withdrawal by Subject|0|||
16314396|NCT03187301|39634032|FG004|Titration Period|Withdrawal by Subject|0|||
16391858|NCT01485796|39919474|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
16391859|NCT02735421|39919475|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
16391860|NCT02735421|39919475|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
16391861|NCT02735421|39919475|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
16391862|NCT02735421|39919475|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
16391863|NCT02735421|39919475|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
16391864|NCT02735421|39919475|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
16391865|NCT02735421|39919475|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
16391866|NCT00755807|39919476|FG000|Acute Phase|Adverse Event|16|||
16391867|NCT00755807|39919477|FG001|Acute Phase|Adverse Event|5|||
16391868|NCT00755807|39919476|FG000|Acute Phase|Protocol Violation|1|||
16391869|NCT00755807|39919477|FG001|Acute Phase|Protocol Violation|3|||
16391870|NCT00755807|39919476|FG000|Acute Phase|Withdrawal by Subject|1|||
16391871|NCT00755807|39919477|FG001|Acute Phase|Withdrawal by Subject|2|||
16508903|NCT00531232|40336341|FG002|Overall Study|Withdrawal by Subject|2|||
16508904|NCT00531232|40336339|FG000|Overall Study|Other|0|||
16508905|NCT00531232|40336340|FG001|Overall Study|Other|0|||
16508906|NCT00531232|40336341|FG002|Overall Study|Other|5|||
16391872|NCT00755807|39919476|FG000|Acute Phase|Lack of Efficacy|0|||
16391873|NCT00755807|39919477|FG001|Acute Phase|Lack of Efficacy|1|||
16508907|NCT02253810|40336342|FG000|Overall Study|Withdrawal by Subject|2|||
16508908|NCT02253810|40336343|FG001|Overall Study|Withdrawal by Subject|1|||
16508909|NCT02253810|40336342|FG000|Overall Study|Unknown concomitant procedure|3|||
16508910|NCT02253810|40336343|FG001|Overall Study|Unknown concomitant procedure|2|||
16314397|NCT03187301|39634033|FG005|Titration Period|Withdrawal by Subject|0|||
16314398|NCT03187301|39634034|FG006|Titration Period|Withdrawal by Subject|1|||
16314399|NCT03187301|39634028|FG000|Titration Period|Exclusion Criteria Met|0|||
16314400|NCT03187301|39634029|FG001|Titration Period|Exclusion Criteria Met|0|||
16314401|NCT03187301|39634030|FG002|Titration Period|Exclusion Criteria Met|0|||
16314402|NCT03187301|39634031|FG003|Titration Period|Exclusion Criteria Met|0|||
16314403|NCT03187301|39634032|FG004|Titration Period|Exclusion Criteria Met|0|||
16314404|NCT03187301|39634033|FG005|Titration Period|Exclusion Criteria Met|0|||
16314405|NCT03187301|39634034|FG006|Titration Period|Exclusion Criteria Met|1|||
16314406|NCT03187301|39634028|FG000|Pre-Intervention|Withdrawal by Subject|1|||
16314407|NCT03187301|39634029|FG001|Pre-Intervention|Withdrawal by Subject|0|||
16314408|NCT03187301|39634030|FG002|Pre-Intervention|Withdrawal by Subject|0|||
16314409|NCT03187301|39634031|FG003|Pre-Intervention|Withdrawal by Subject|0|||
16314410|NCT03187301|39634032|FG004|Pre-Intervention|Withdrawal by Subject|0|||
16314411|NCT03187301|39634033|FG005|Pre-Intervention|Withdrawal by Subject|0|||
16314412|NCT03187301|39634034|FG006|Pre-Intervention|Withdrawal by Subject|0|||
16314413|NCT01173523|39634038|FG000|Overall Study|Clinical Progression|1|||
16197688|NCT00819585|39201209|FG003|Core Study|Adverse Event|4|||
16197689|NCT00819585|39201210|FG004|Core Study|Adverse Event|1|||
16197690|NCT00819585|39201211|FG005|Core Study|Adverse Event|0|||
16314414|NCT01173523|39634039|FG001|Overall Study|Clinical Progression|1|||
16314415|NCT01173523|39634038|FG000|Overall Study|Progressive Disease|10|||
16391874|NCT00755807|39919476|FG000|Acute Phase|Physician Decision|0|||
16197691|NCT00819585|39201212|FG006|Core Study|Adverse Event|2|||
16197692|NCT00819585|39201213|FG007|Core Study|Adverse Event|0|||
16197693|NCT00819585|39201214|FG008|Core Study|Adverse Event|0|||
16197694|NCT00819585|39201215|FG009|Core Study|Adverse Event|0|||
16197695|NCT00819585|39201216|FG010|Core Study|Adverse Event|0|||
16197696|NCT00819585|39201206|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
16197697|NCT00819585|39201207|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
16197698|NCT00819585|39201208|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
16197699|NCT00819585|39201209|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
16197700|NCT00819585|39201210|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
16197701|NCT00819585|39201211|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
16197702|NCT00819585|39201212|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
16197703|NCT00819585|39201213|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
16197704|NCT00819585|39201214|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
16197705|NCT00819585|39201215|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
16197706|NCT00819585|39201216|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
16197707|NCT00819585|39201206|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
16197708|NCT00819585|39201207|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
16197709|NCT00819585|39201208|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
16197710|NCT00819585|39201209|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
16197711|NCT00819585|39201210|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
16197712|NCT00819585|39201211|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
16197713|NCT00819585|39201212|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
16197714|NCT00819585|39201213|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
16197715|NCT00819585|39201214|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
16197716|NCT00819585|39201215|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
16197717|NCT00819585|39201216|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
16197718|NCT00819585|39201206|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
16197719|NCT00819585|39201207|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
16197720|NCT00819585|39201208|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
16197721|NCT00819585|39201209|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
16197722|NCT00819585|39201210|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
16197723|NCT00819585|39201211|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
16197724|NCT00819585|39201212|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
16197725|NCT00819585|39201213|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
16197726|NCT00819585|39201214|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
16197727|NCT00819585|39201215|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
16197728|NCT00819585|39201216|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
16197729|NCT00819585|39201206|FG000|Core Study|Subject Withdrew Consent|0|||
16197730|NCT00819585|39201207|FG001|Core Study|Subject Withdrew Consent|3|||
16197731|NCT00819585|39201208|FG002|Core Study|Subject Withdrew Consent|2|||
16197732|NCT00819585|39201209|FG003|Core Study|Subject Withdrew Consent|1|||
16197733|NCT00819585|39201210|FG004|Core Study|Subject Withdrew Consent|0|||
16197734|NCT00819585|39201211|FG005|Core Study|Subject Withdrew Consent|0|||
16197735|NCT00819585|39201212|FG006|Core Study|Subject Withdrew Consent|3|||
16197736|NCT00819585|39201213|FG007|Core Study|Subject Withdrew Consent|0|||
16197737|NCT00819585|39201214|FG008|Core Study|Subject Withdrew Consent|0|||
16197738|NCT00819585|39201215|FG009|Core Study|Subject Withdrew Consent|0|||
16197739|NCT00819585|39201216|FG010|Core Study|Subject Withdrew Consent|0|||
16197740|NCT00819585|39201206|FG000|Core Study|Lost to Follow-up|2|||
16197741|NCT00819585|39201207|FG001|Core Study|Lost to Follow-up|1|||
16197742|NCT00819585|39201208|FG002|Core Study|Lost to Follow-up|2|||
16197743|NCT00819585|39201209|FG003|Core Study|Lost to Follow-up|0|||
16197744|NCT00819585|39201210|FG004|Core Study|Lost to Follow-up|1|||
16197745|NCT00819585|39201211|FG005|Core Study|Lost to Follow-up|1|||
16197746|NCT00819585|39201212|FG006|Core Study|Lost to Follow-up|1|||
16197747|NCT00819585|39201213|FG007|Core Study|Lost to Follow-up|0|||
16197748|NCT00819585|39201214|FG008|Core Study|Lost to Follow-up|0|||
16197749|NCT00819585|39201215|FG009|Core Study|Lost to Follow-up|0|||
16197750|NCT00819585|39201216|FG010|Core Study|Lost to Follow-up|0|||
16197751|NCT00819585|39201206|FG000|Core Study|Administrative Problems|0|||
16197752|NCT00819585|39201207|FG001|Core Study|Administrative Problems|0|||
16197753|NCT00819585|39201208|FG002|Core Study|Administrative Problems|0|||
16508911|NCT02028988|40336344|FG000|Overall Study|Withdrawal by Subject|2|||
16197754|NCT00819585|39201209|FG003|Core Study|Administrative Problems|0|||
16197755|NCT00819585|39201210|FG004|Core Study|Administrative Problems|0|||
16197756|NCT00819585|39201211|FG005|Core Study|Administrative Problems|0|||
16197757|NCT00819585|39201212|FG006|Core Study|Administrative Problems|2|||
16197758|NCT00819585|39201213|FG007|Core Study|Administrative Problems|0|||
16197759|NCT00819585|39201214|FG008|Core Study|Administrative Problems|0|||
16197760|NCT00819585|39201215|FG009|Core Study|Administrative Problems|0|||
16197761|NCT00819585|39201216|FG010|Core Study|Administrative Problems|0|||
16197762|NCT00819585|39201206|FG000|Core Study|Death|0|||
16197763|NCT00819585|39201207|FG001|Core Study|Death|0|||
16197764|NCT00819585|39201208|FG002|Core Study|Death|0|||
16197765|NCT00819585|39201209|FG003|Core Study|Death|0|||
16197766|NCT00819585|39201210|FG004|Core Study|Death|0|||
16197767|NCT00819585|39201211|FG005|Core Study|Death|0|||
16197768|NCT00819585|39201212|FG006|Core Study|Death|1|||
16197769|NCT00819585|39201213|FG007|Core Study|Death|0|||
16197770|NCT00819585|39201214|FG008|Core Study|Death|0|||
16197771|NCT00819585|39201215|FG009|Core Study|Death|0|||
16197772|NCT00819585|39201216|FG010|Core Study|Death|0|||
16197773|NCT00819585|39201206|FG000|Core Study|Protocol Violation|0|||
16197774|NCT00819585|39201207|FG001|Core Study|Protocol Violation|0|||
16197775|NCT00819585|39201208|FG002|Core Study|Protocol Violation|1|||
16197776|NCT00819585|39201209|FG003|Core Study|Protocol Violation|0|||
16197777|NCT00819585|39201210|FG004|Core Study|Protocol Violation|0|||
16197778|NCT00819585|39201211|FG005|Core Study|Protocol Violation|1|||
16197779|NCT00819585|39201212|FG006|Core Study|Protocol Violation|3|||
16197780|NCT00819585|39201213|FG007|Core Study|Protocol Violation|0|||
16197781|NCT00819585|39201214|FG008|Core Study|Protocol Violation|0|||
16197782|NCT00819585|39201215|FG009|Core Study|Protocol Violation|0|||
16197783|NCT00819585|39201216|FG010|Core Study|Protocol Violation|0|||
16197784|NCT00819585|39201206|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
16197785|NCT00819585|39201207|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
16197786|NCT00819585|39201208|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
16197787|NCT00819585|39201209|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
16197788|NCT00819585|39201210|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
16197789|NCT00819585|39201211|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
16197790|NCT00819585|39201212|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
16197791|NCT00819585|39201213|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
16508912|NCT01334866|40336345|FG000|Overall Study|Withdrawal by Subject|10|||
16508913|NCT01334866|40336345|FG000|Overall Study|Lost to Follow-up|3|||
16508914|NCT01334866|40336345|FG000|Overall Study|Physician Decision|3|||
16508915|NCT01334866|40336345|FG000|Overall Study|medically necessary prior to procedure|2|||
16508916|NCT01334866|40336345|FG000|Overall Study|medically necessary post-procedure|1|||
16508917|NCT01527292|40336348|FG000|Overall Study|Physician Decision|0|||
16508918|NCT01527292|40336349|FG001|Overall Study|Physician Decision|3|||
16508919|NCT01940120|40336350|FG000|Overall Study|Death|40|||
16508920|NCT01940120|40336350|FG000|Overall Study|Withdrawal by Subject|8|||
16508921|NCT04248816|40336353|FG000|Overall Study|Ineligible post-randomization|7|||
16508922|NCT04248816|40336354|FG001|Overall Study|Ineligible post-randomization|21|||
16508923|NCT04248816|40336355|FG002|Overall Study|Ineligible post-randomization|25|||
16508924|NCT00696137|40336356|FG000|Overall Study|Withdrawal by Subject|2|||
16508925|NCT02321462|40336361|FG000|Overall Study|Withdrawal by Subject|5|||
16508926|NCT02321462|40336362|FG001|Overall Study|Withdrawal by Subject|2|||
16508927|NCT02321462|40336361|FG000|Overall Study|Subject withdrawn before any treatment|1|||
16508928|NCT02321462|40336362|FG001|Overall Study|Subject withdrawn before any treatment|1|||
16508929|NCT04014075|40336363|FG000|Overall Study|Progressive Disease|48|||
16508930|NCT04014075|40336363|FG000|Overall Study|Adverse Event|11|||
16197792|NCT00819585|39201214|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
16197793|NCT00819585|39201215|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
16197794|NCT00819585|39201216|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
16508931|NCT04014075|40336363|FG000|Overall Study|Clinical Progression|4|||
16508932|NCT04014075|40336363|FG000|Overall Study|Death|2|||
16508933|NCT04014075|40336363|FG000|Overall Study|Withdrawal by Subject|2|||
16197795|NCT00819585|39201206|FG000|Extension Study|Subject Withdrew Consent|0|||
16197796|NCT00819585|39201207|FG001|Extension Study|Subject Withdrew Consent|0|||
16197797|NCT00819585|39201208|FG002|Extension Study|Subject Withdrew Consent|0|||
16197798|NCT00819585|39201209|FG003|Extension Study|Subject Withdrew Consent|0|||
16197799|NCT00819585|39201210|FG004|Extension Study|Subject Withdrew Consent|0|||
16197800|NCT00819585|39201211|FG005|Extension Study|Subject Withdrew Consent|0|||
16197801|NCT00819585|39201212|FG006|Extension Study|Subject Withdrew Consent|0|||
16197802|NCT00819585|39201213|FG007|Extension Study|Subject Withdrew Consent|0|||
16314416|NCT01173523|39634039|FG001|Overall Study|Progressive Disease|8|||
16314417|NCT01173523|39634038|FG000|Overall Study|Other|2|||
16314418|NCT01173523|39634039|FG001|Overall Study|Other|3|||
16314419|NCT00697463|39634040|FG000|Overall Study|Withdrawal by Subject|1|||
16314420|NCT03660930|39634041|FG000|Overall Study|Adverse Event|0|||
16314421|NCT03660930|39634042|FG001|Overall Study|Adverse Event|0|||
16314422|NCT03660930|39634043|FG002|Overall Study|Adverse Event|0|||
16314423|NCT03660930|39634044|FG003|Overall Study|Adverse Event|2|||
16314424|NCT03660930|39634045|FG004|Overall Study|Adverse Event|0|||
16314425|NCT03660930|39634046|FG005|Overall Study|Adverse Event|1|||
16314426|NCT03660930|39634047|FG006|Overall Study|Adverse Event|0|||
16314427|NCT03660930|39634048|FG007|Overall Study|Adverse Event|0|||
16314428|NCT03660930|39634041|FG000|Overall Study|Withdrawal by Subject|0|||
16314429|NCT03660930|39634042|FG001|Overall Study|Withdrawal by Subject|0|||
16314430|NCT03660930|39634043|FG002|Overall Study|Withdrawal by Subject|0|||
16314431|NCT03660930|39634044|FG003|Overall Study|Withdrawal by Subject|0|||
16314432|NCT03660930|39634045|FG004|Overall Study|Withdrawal by Subject|0|||
16314433|NCT03660930|39634046|FG005|Overall Study|Withdrawal by Subject|1|||
16314434|NCT03660930|39634047|FG006|Overall Study|Withdrawal by Subject|0|||
16391875|NCT00755807|39919477|FG001|Acute Phase|Physician Decision|1|||
16391876|NCT00755807|39919476|FG000|Open-label Extension Phase|Adverse Event|7|||
16391877|NCT00755807|39919477|FG001|Open-label Extension Phase|Adverse Event|7|||
16391878|NCT00755807|39919476|FG000|Open-label Extension Phase|Protocol Violation|5|||
16391879|NCT00755807|39919477|FG001|Open-label Extension Phase|Protocol Violation|2|||
16391880|NCT00755807|39919476|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
16391881|NCT00755807|39919477|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
16391882|NCT00755807|39919476|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
16391883|NCT00755807|39919477|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
16391884|NCT00755807|39919476|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
16391885|NCT00755807|39919477|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
16391886|NCT00755807|39919476|FG000|Open-label Extension Phase|Sponsor Decision|0|||
16391887|NCT00755807|39919477|FG001|Open-label Extension Phase|Sponsor Decision|1|||
16391888|NCT00945659|39919480|FG000|Overall Study|Lost to Follow-up|7|||
16391889|NCT00945659|39919481|FG001|Overall Study|Lost to Follow-up|20|||
16391890|NCT00945659|39919482|FG002|Overall Study|Lost to Follow-up|17|||
16391891|NCT03666988|39919484|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
16391892|NCT03666988|39919485|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
16391893|NCT03666988|39919486|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
16391894|NCT03666988|39919487|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
16391895|NCT03666988|39919488|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
16391896|NCT03666988|39919489|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
16391897|NCT03666988|39919484|FG000|Part 1 (Up to 28 Months)|Other|0|||
16391898|NCT03666988|39919485|FG001|Part 1 (Up to 28 Months)|Other|1|||
16391899|NCT03666988|39919486|FG002|Part 1 (Up to 28 Months)|Other|1|||
16391900|NCT03666988|39919487|FG003|Part 1 (Up to 28 Months)|Other|0|||
16391901|NCT03666988|39919488|FG004|Part 1 (Up to 28 Months)|Other|0|||
16391902|NCT03666988|39919489|FG005|Part 1 (Up to 28 Months)|Other|0|||
16391903|NCT03666988|39919484|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
16391904|NCT03666988|39919485|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
16391905|NCT03666988|39919486|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
16391906|NCT03666988|39919487|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
16391907|NCT03666988|39919488|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
16391908|NCT03666988|39919489|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
16508934|NCT04014075|40336363|FG000|Overall Study|Miscellaneous|1|||
16508935|NCT04014075|40336363|FG000|Overall Study|Physician Decision|1|||
16508936|NCT03913091|40336364|FG000|Overall Study|Lost to Follow-up|18|||
16508937|NCT03913091|40336365|FG001|Overall Study|Lost to Follow-up|11|||
16508938|NCT03913091|40336364|FG000|Overall Study|Required additional meds/surgery|1|||
16508939|NCT03913091|40336365|FG001|Overall Study|Required additional meds/surgery|2|||
16508940|NCT03913091|40336364|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
16508941|NCT03913091|40336365|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
16508942|NCT00378703|40336367|FG000|Overall Study|Disease progression|59|||
16508943|NCT00378703|40336368|FG001|Overall Study|Disease progression|43|||
16508944|NCT00378703|40336369|FG002|Overall Study|Disease progression|48|||
16508945|NCT00378703|40336370|FG003|Overall Study|Disease progression|49|||
16508946|NCT00378703|40336367|FG000|Overall Study|Adverse Event|11|||
16508947|NCT00378703|40336368|FG001|Overall Study|Adverse Event|17|||
16508948|NCT00378703|40336369|FG002|Overall Study|Adverse Event|20|||
16508949|NCT00378703|40336370|FG003|Overall Study|Adverse Event|18|||
16508950|NCT00378703|40336367|FG000|Overall Study|Death|2|||
16508951|NCT00378703|40336368|FG001|Overall Study|Death|2|||
16508952|NCT00378703|40336369|FG002|Overall Study|Death|4|||
16508953|NCT00378703|40336370|FG003|Overall Study|Death|3|||
16508954|NCT00378703|40336367|FG000|Overall Study|Withdrawal by Subject|4|||
16508955|NCT00378703|40336368|FG001|Overall Study|Withdrawal by Subject|8|||
16508956|NCT00378703|40336369|FG002|Overall Study|Withdrawal by Subject|5|||
16508957|NCT00378703|40336370|FG003|Overall Study|Withdrawal by Subject|7|||
16508958|NCT00378703|40336367|FG000|Overall Study|Physician Decision|1|||
16508959|NCT00378703|40336368|FG001|Overall Study|Physician Decision|4|||
16508960|NCT00378703|40336369|FG002|Overall Study|Physician Decision|1|||
16508961|NCT00378703|40336370|FG003|Overall Study|Physician Decision|0|||
16508962|NCT00378703|40336367|FG000|Overall Study|Alternative therapy|4|||
16508963|NCT00378703|40336368|FG001|Overall Study|Alternative therapy|2|||
16508964|NCT00378703|40336369|FG002|Overall Study|Alternative therapy|0|||
16508965|NCT00378703|40336370|FG003|Overall Study|Alternative therapy|0|||
16508966|NCT00378703|40336367|FG000|Overall Study|Other complicated disease|0|||
16508967|NCT00378703|40336368|FG001|Overall Study|Other complicated disease|2|||
16391909|NCT03666988|39919484|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
16508968|NCT00378703|40336369|FG002|Overall Study|Other complicated disease|2|||
16508969|NCT00378703|40336370|FG003|Overall Study|Other complicated disease|0|||
16508970|NCT00378703|40336367|FG000|Overall Study|Symptomatic deterioration|0|||
16508971|NCT00378703|40336368|FG001|Overall Study|Symptomatic deterioration|1|||
16391910|NCT03666988|39919485|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
16508972|NCT00378703|40336369|FG002|Overall Study|Symptomatic deterioration|0|||
16197803|NCT00819585|39201214|FG008|Extension Study|Subject Withdrew Consent|3|||
16197804|NCT00819585|39201215|FG009|Extension Study|Subject Withdrew Consent|0|||
16197805|NCT00819585|39201216|FG010|Extension Study|Subject Withdrew Consent|1|||
16197806|NCT00819585|39201206|FG000|Extension Study|Lost to Follow-up|0|||
16197807|NCT00819585|39201207|FG001|Extension Study|Lost to Follow-up|0|||
16197808|NCT00819585|39201208|FG002|Extension Study|Lost to Follow-up|0|||
16197809|NCT00819585|39201209|FG003|Extension Study|Lost to Follow-up|0|||
16197810|NCT00819585|39201210|FG004|Extension Study|Lost to Follow-up|0|||
16197811|NCT00819585|39201211|FG005|Extension Study|Lost to Follow-up|0|||
16197812|NCT00819585|39201212|FG006|Extension Study|Lost to Follow-up|0|||
16197813|NCT00819585|39201213|FG007|Extension Study|Lost to Follow-up|0|||
16197814|NCT00819585|39201214|FG008|Extension Study|Lost to Follow-up|2|||
16197815|NCT00819585|39201215|FG009|Extension Study|Lost to Follow-up|1|||
16197816|NCT00819585|39201216|FG010|Extension Study|Lost to Follow-up|1|||
16197817|NCT00819585|39201206|FG000|Extension Study|Death|0|||
16197818|NCT00819585|39201207|FG001|Extension Study|Death|0|||
16197819|NCT00819585|39201208|FG002|Extension Study|Death|0|||
16197820|NCT00819585|39201209|FG003|Extension Study|Death|0|||
16197821|NCT00819585|39201210|FG004|Extension Study|Death|0|||
16197822|NCT00819585|39201211|FG005|Extension Study|Death|0|||
16197823|NCT00819585|39201212|FG006|Extension Study|Death|0|||
16197824|NCT00819585|39201213|FG007|Extension Study|Death|0|||
16197825|NCT00819585|39201214|FG008|Extension Study|Death|2|||
16197826|NCT00819585|39201215|FG009|Extension Study|Death|0|||
16197827|NCT00819585|39201216|FG010|Extension Study|Death|0|||
16197828|NCT00507416|39201217|FG000|Overall Study|Adverse Event|58|||
16197829|NCT00507416|39201218|FG001|Overall Study|Adverse Event|67|||
16197830|NCT00507416|39201219|FG002|Overall Study|Adverse Event|65|||
16197831|NCT00507416|39201217|FG000|Overall Study|Protocol Violation|1|||
16197832|NCT00507416|39201218|FG001|Overall Study|Protocol Violation|2|||
16197833|NCT00507416|39201219|FG002|Overall Study|Protocol Violation|0|||
16197834|NCT00507416|39201217|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
16197835|NCT00507416|39201218|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
16197836|NCT00507416|39201219|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
16197837|NCT00507416|39201217|FG000|Overall Study|Progressive Disease|20|||
16197838|NCT00507416|39201218|FG001|Overall Study|Progressive Disease|10|||
16197839|NCT00507416|39201219|FG002|Overall Study|Progressive Disease|13|||
16197840|NCT00507416|39201217|FG000|Overall Study|Patient declined further treatment|18|||
16197841|NCT00507416|39201218|FG001|Overall Study|Patient declined further treatment|14|||
16314435|NCT03660930|39634048|FG007|Overall Study|Withdrawal by Subject|0|||
16314436|NCT03660930|39634041|FG000|Overall Study|On Treatment|0|||
16314437|NCT03660930|39634042|FG001|Overall Study|On Treatment|0|||
16314438|NCT03660930|39634043|FG002|Overall Study|On Treatment|0|||
16314439|NCT03660930|39634044|FG003|Overall Study|On Treatment|0|||
16314440|NCT03660930|39634045|FG004|Overall Study|On Treatment|0|||
16197842|NCT00507416|39201219|FG002|Overall Study|Patient declined further treatment|11|||
16197843|NCT00507416|39201217|FG000|Overall Study|Other|11|||
16314441|NCT03660930|39634046|FG005|Overall Study|On Treatment|0|||
16314442|NCT03660930|39634047|FG006|Overall Study|On Treatment|0|||
16314443|NCT03660930|39634048|FG007|Overall Study|On Treatment|1|||
16314444|NCT03660930|39634041|FG000|Overall Study|In Follow-up|0|||
16314445|NCT03660930|39634042|FG001|Overall Study|In Follow-up|0|||
16314446|NCT03660930|39634043|FG002|Overall Study|In Follow-up|0|||
16314447|NCT03660930|39634044|FG003|Overall Study|In Follow-up|0|||
16314448|NCT03660930|39634045|FG004|Overall Study|In Follow-up|0|||
16314449|NCT03660930|39634046|FG005|Overall Study|In Follow-up|0|||
16197844|NCT00507416|39201218|FG001|Overall Study|Other|16|||
16197845|NCT00507416|39201219|FG002|Overall Study|Other|13|||
16197846|NCT00507416|39201217|FG000|Overall Study|Did not Receive Study Treatment|3|||
16197847|NCT00507416|39201218|FG001|Overall Study|Did not Receive Study Treatment|9|||
16197848|NCT00507416|39201219|FG002|Overall Study|Did not Receive Study Treatment|4|||
16197849|NCT01968954|39201220|FG000|Overall Study|Adverse Event|6|||
16314450|NCT03660930|39634047|FG006|Overall Study|In Follow-up|1|||
16314451|NCT03660930|39634048|FG007|Overall Study|In Follow-up|2|||
16314452|NCT00489918|39634049|FG000|Overall Study|Withdrawal by Subject|2|||
16197850|NCT01968954|39201221|FG001|Overall Study|Adverse Event|3|||
16197851|NCT01968954|39201220|FG000|Overall Study|Death|1|||
16197852|NCT01968954|39201221|FG001|Overall Study|Death|2|||
16197853|NCT01968954|39201220|FG000|Overall Study|Lost to Follow-up|6|||
16197854|NCT01968954|39201221|FG001|Overall Study|Lost to Follow-up|4|||
16197855|NCT01968954|39201220|FG000|Overall Study|Withdrawal by Subject|20|||
16197856|NCT01968954|39201221|FG001|Overall Study|Withdrawal by Subject|23|||
16197857|NCT01968954|39201220|FG000|Overall Study|Other|7|||
16197858|NCT01968954|39201221|FG001|Overall Study|Other|8|||
16197859|NCT01968954|39201220|FG000|Overall Study|Protocol Violation|0|||
16197860|NCT01968954|39201221|FG001|Overall Study|Protocol Violation|1|||
16197861|NCT01968954|39201220|FG000|Overall Study|Did not met inclusion criteria|0|||
16197862|NCT01968954|39201221|FG001|Overall Study|Did not met inclusion criteria|2|||
16197863|NCT00280150|39201222|FG000|Overall Study|Adverse Event|0|||
16197864|NCT00280150|39201223|FG001|Overall Study|Adverse Event|1|||
16197865|NCT00280150|39201224|FG002|Overall Study|Adverse Event|2|||
16197866|NCT00280150|39201225|FG003|Overall Study|Adverse Event|3|||
16197867|NCT00280150|39201222|FG000|Overall Study|Lack of Efficacy|0|||
16197868|NCT00280150|39201223|FG001|Overall Study|Lack of Efficacy|0|||
16197869|NCT00280150|39201224|FG002|Overall Study|Lack of Efficacy|0|||
16197870|NCT00280150|39201225|FG003|Overall Study|Lack of Efficacy|3|||
16197871|NCT00280150|39201222|FG000|Overall Study|Physician Decision|0|||
16314453|NCT00489918|39634050|FG001|Overall Study|Withdrawal by Subject|1|||
16314454|NCT00489918|39634051|FG002|Overall Study|Withdrawal by Subject|1|||
16314455|NCT00489918|39634052|FG003|Overall Study|Withdrawal by Subject|0|||
16314456|NCT00489918|39634053|FG004|Overall Study|Withdrawal by Subject|1|||
16314457|NCT00489918|39634049|FG000|Overall Study|Adverse Event|0|||
16197872|NCT00280150|39201223|FG001|Overall Study|Physician Decision|0|||
16197873|NCT00280150|39201224|FG002|Overall Study|Physician Decision|0|||
16197874|NCT00280150|39201225|FG003|Overall Study|Physician Decision|1|||
16197875|NCT00280150|39201222|FG000|Overall Study|Protocol Violation|0|||
16197876|NCT00280150|39201223|FG001|Overall Study|Protocol Violation|0|||
16197877|NCT00280150|39201224|FG002|Overall Study|Protocol Violation|0|||
16197878|NCT00280150|39201225|FG003|Overall Study|Protocol Violation|1|||
16197879|NCT00280150|39201222|FG000|Overall Study|Withdrawal by Subject|0|||
16197880|NCT00280150|39201223|FG001|Overall Study|Withdrawal by Subject|0|||
16197881|NCT00280150|39201224|FG002|Overall Study|Withdrawal by Subject|0|||
16197882|NCT00280150|39201225|FG003|Overall Study|Withdrawal by Subject|1|||
16197883|NCT00280150|39201222|FG000|Overall Study|Did not get consolidation therapy|3|||
16197884|NCT00280150|39201223|FG001|Overall Study|Did not get consolidation therapy|0|||
16197885|NCT00280150|39201224|FG002|Overall Study|Did not get consolidation therapy|3|||
16197886|NCT00280150|39201225|FG003|Overall Study|Did not get consolidation therapy|0|||
16197887|NCT00280150|39201222|FG000|Overall Study|Declining Performance Status|0|||
16197888|NCT00280150|39201223|FG001|Overall Study|Declining Performance Status|0|||
16197889|NCT00280150|39201224|FG002|Overall Study|Declining Performance Status|0|||
16197890|NCT00280150|39201225|FG003|Overall Study|Declining Performance Status|1|||
16197891|NCT01714817|39201228|FG000|Year 1 Period|Lack of Efficacy|11|||
16197892|NCT01714817|39201229|FG001|Year 1 Period|Lack of Efficacy|9|||
16197893|NCT01714817|39201228|FG000|Year 1 Period|Adverse Event|20|||
16197894|NCT01714817|39201229|FG001|Year 1 Period|Adverse Event|17|||
16197895|NCT01714817|39201228|FG000|Year 1 Period|Withdrawal by Subject|6|||
16197896|NCT01714817|39201229|FG001|Year 1 Period|Withdrawal by Subject|7|||
16197897|NCT01714817|39201228|FG000|Year 1 Period|Death|1|||
16197898|NCT01714817|39201229|FG001|Year 1 Period|Death|1|||
16197899|NCT01714817|39201228|FG000|Year 1 Period|Lost to Follow-up|0|||
16197900|NCT01714817|39201229|FG001|Year 1 Period|Lost to Follow-up|2|||
16197901|NCT01714817|39201228|FG000|Year 1 Period|Poor / non-compliance|0|||
16197902|NCT01714817|39201229|FG001|Year 1 Period|Poor / non-compliance|1|||
16197903|NCT01714817|39201228|FG000|Year 1 Period|Pregnancy|2|||
16197904|NCT01714817|39201229|FG001|Year 1 Period|Pregnancy|0|||
16197905|NCT01714817|39201228|FG000|Year 1 Period|Participant no longer meets criteria|6|||
16197906|NCT01714817|39201229|FG001|Year 1 Period|Participant no longer meets criteria|2|||
16197907|NCT01714817|39201228|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
16197908|NCT01714817|39201229|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
16197909|NCT01714817|39201228|FG000|Year 1 Period|Change in Concomitant Medication|0|||
16197910|NCT01714817|39201229|FG001|Year 1 Period|Change in Concomitant Medication|1|||
16314458|NCT00489918|39634050|FG001|Overall Study|Adverse Event|1|||
16314459|NCT00489918|39634051|FG002|Overall Study|Adverse Event|1|||
16197911|NCT01714817|39201228|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
16197912|NCT01714817|39201229|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
16197913|NCT01714817|39201228|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
16197914|NCT01714817|39201229|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
16197915|NCT01714817|39201228|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
16197916|NCT01714817|39201229|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
16197917|NCT01714817|39201228|FG000|Year 2 Period|Lack of Efficacy|4|||
16197918|NCT01714817|39201229|FG001|Year 2 Period|Lack of Efficacy|12|||
16314460|NCT00489918|39634052|FG003|Overall Study|Adverse Event|0|||
16197919|NCT01714817|39201228|FG000|Year 2 Period|Adverse Event|7|||
16197920|NCT01714817|39201229|FG001|Year 2 Period|Adverse Event|6|||
16197921|NCT01714817|39201228|FG000|Year 2 Period|Participant request to stop treatment|4|||
16197922|NCT01714817|39201229|FG001|Year 2 Period|Participant request to stop treatment|4|||
16197923|NCT01714817|39201228|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
16197924|NCT01714817|39201229|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
16197925|NCT01714817|39201228|FG000|Year 2 Period|Participant withdrew consent|1|||
16197926|NCT01714817|39201229|FG001|Year 2 Period|Participant withdrew consent|5|||
16197927|NCT01714817|39201228|FG000|Year 2 Period|Participant no longer meets criteria|1|||
16197928|NCT01714817|39201229|FG001|Year 2 Period|Participant no longer meets criteria|4|||
16197929|NCT01714817|39201228|FG000|Year 2 Period|Lost to Follow-up|2|||
16197930|NCT01714817|39201229|FG001|Year 2 Period|Lost to Follow-up|0|||
16197931|NCT01714817|39201228|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
16197932|NCT01714817|39201229|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
16197933|NCT01714817|39201228|FG000|Year 2 Period|Pregnancy|1|||
16197934|NCT01714817|39201229|FG001|Year 2 Period|Pregnancy|1|||
16197935|NCT01714817|39201228|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
16197936|NCT01714817|39201229|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
16197937|NCT01714817|39201228|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
16197938|NCT01714817|39201229|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
16197939|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
16197940|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
16197941|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
16197942|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
16197943|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
16197944|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
16197945|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
16197946|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
16197947|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
16197948|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
16197949|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
16197950|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
16197951|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
16197952|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
16197953|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
16197954|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
16197955|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
16197956|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
16197957|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
16197958|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
16197959|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
16197960|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
16197961|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
16197962|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
16197963|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
16197964|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
16197965|NCT01714817|39201228|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
16197966|NCT01714817|39201229|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
16197967|NCT03334396|39201232|FG000|Overall Study|Adverse Event|1|||
16197968|NCT03334396|39201233|FG001|Overall Study|Adverse Event|0|||
16197969|NCT03334396|39201234|FG002|Overall Study|Adverse Event|1|||
16197970|NCT03334396|39201235|FG003|Overall Study|Adverse Event|0|||
16197971|NCT03334396|39201236|FG004|Overall Study|Adverse Event|0|||
16197972|NCT03334396|39201237|FG005|Overall Study|Adverse Event|0|||
16197973|NCT03334396|39201238|FG006|Overall Study|Adverse Event|0|||
16197974|NCT03334396|39201239|FG007|Overall Study|Adverse Event|0|||
16197975|NCT03334396|39201232|FG000|Overall Study|Lack of Efficacy|10|||
16197976|NCT03334396|39201233|FG001|Overall Study|Lack of Efficacy|4|||
16391911|NCT03666988|39919486|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
16391912|NCT03666988|39919487|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
16391913|NCT03666988|39919488|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
16197977|NCT03334396|39201234|FG002|Overall Study|Lack of Efficacy|1|||
16197978|NCT03334396|39201235|FG003|Overall Study|Lack of Efficacy|3|||
16197979|NCT03334396|39201236|FG004|Overall Study|Lack of Efficacy|1|||
16197980|NCT03334396|39201237|FG005|Overall Study|Lack of Efficacy|0|||
16197981|NCT03334396|39201238|FG006|Overall Study|Lack of Efficacy|0|||
16391914|NCT03666988|39919489|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
16391915|NCT03666988|39919484|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
16391916|NCT03666988|39919485|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
16391917|NCT03666988|39919486|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
16391918|NCT03666988|39919487|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
16391919|NCT03666988|39919488|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
16391920|NCT03666988|39919489|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
16197982|NCT03334396|39201239|FG007|Overall Study|Lack of Efficacy|1|||
16197983|NCT03334396|39201232|FG000|Overall Study|Lost to Follow-up|0|||
16197984|NCT03334396|39201233|FG001|Overall Study|Lost to Follow-up|0|||
16197985|NCT03334396|39201234|FG002|Overall Study|Lost to Follow-up|1|||
16391921|NCT02122146|39919492|FG000|Part 1: Dose Escalation|Death|0|||
16391922|NCT02122146|39919493|FG001|Part 1: Dose Escalation|Death|1|||
16391923|NCT02122146|39919494|FG002|Part 1: Dose Escalation|Death|1|||
16391924|NCT02122146|39919495|FG003|Part 1: Dose Escalation|Death|0|||
16391925|NCT02122146|39919496|FG004|Part 1: Dose Escalation|Death|0|||
16391926|NCT02122146|39919497|FG005|Part 1: Dose Escalation|Death|0|||
16391927|NCT02122146|39919498|FG006|Part 1: Dose Escalation|Death|0|||
16391928|NCT02122146|39919499|FG007|Part 1: Dose Escalation|Death|0|||
16391929|NCT02122146|39919492|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
16391930|NCT02122146|39919493|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
16391931|NCT02122146|39919494|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
16197986|NCT03334396|39201235|FG003|Overall Study|Lost to Follow-up|0|||
16197987|NCT03334396|39201236|FG004|Overall Study|Lost to Follow-up|0|||
16197988|NCT03334396|39201237|FG005|Overall Study|Lost to Follow-up|0|||
16197989|NCT03334396|39201238|FG006|Overall Study|Lost to Follow-up|1|||
16197990|NCT03334396|39201239|FG007|Overall Study|Lost to Follow-up|0|||
16197991|NCT03334396|39201232|FG000|Overall Study|Physician Decision|1|||
16197992|NCT03334396|39201233|FG001|Overall Study|Physician Decision|0|||
16197993|NCT03334396|39201234|FG002|Overall Study|Physician Decision|0|||
16197994|NCT03334396|39201235|FG003|Overall Study|Physician Decision|0|||
16197995|NCT03334396|39201236|FG004|Overall Study|Physician Decision|0|||
16197996|NCT03334396|39201237|FG005|Overall Study|Physician Decision|0|||
16197997|NCT03334396|39201238|FG006|Overall Study|Physician Decision|0|||
16197998|NCT03334396|39201239|FG007|Overall Study|Physician Decision|0|||
16197999|NCT03334396|39201232|FG000|Overall Study|Withdrawal by Subject|10|||
16089945|NCT00614614|38820029|FG003|Primary Vaccination Phase|Other|0|||
16198000|NCT03334396|39201233|FG001|Overall Study|Withdrawal by Subject|5|||
16198001|NCT03334396|39201234|FG002|Overall Study|Withdrawal by Subject|7|||
16198002|NCT03334396|39201235|FG003|Overall Study|Withdrawal by Subject|2|||
16198003|NCT03334396|39201236|FG004|Overall Study|Withdrawal by Subject|2|||
16198004|NCT03334396|39201237|FG005|Overall Study|Withdrawal by Subject|1|||
16198005|NCT03334396|39201238|FG006|Overall Study|Withdrawal by Subject|2|||
16198006|NCT03334396|39201239|FG007|Overall Study|Withdrawal by Subject|0|||
16198007|NCT03334396|39201232|FG000|Overall Study|Pregnancy|0|||
16198008|NCT03334396|39201233|FG001|Overall Study|Pregnancy|1|||
16198009|NCT03334396|39201234|FG002|Overall Study|Pregnancy|0|||
16198010|NCT03334396|39201235|FG003|Overall Study|Pregnancy|0|||
16198011|NCT03334396|39201236|FG004|Overall Study|Pregnancy|0|||
16198012|NCT03334396|39201237|FG005|Overall Study|Pregnancy|0|||
16198013|NCT03334396|39201238|FG006|Overall Study|Pregnancy|0|||
16198014|NCT03334396|39201239|FG007|Overall Study|Pregnancy|0|||
16198015|NCT03334396|39201232|FG000|Overall Study|Ineligible|0|||
16198016|NCT03334396|39201233|FG001|Overall Study|Ineligible|1|||
16198017|NCT03334396|39201234|FG002|Overall Study|Ineligible|0|||
16198018|NCT03334396|39201235|FG003|Overall Study|Ineligible|0|||
16198019|NCT03334396|39201236|FG004|Overall Study|Ineligible|0|||
16198020|NCT03334396|39201237|FG005|Overall Study|Ineligible|0|||
16198021|NCT03334396|39201238|FG006|Overall Study|Ineligible|0|||
16198022|NCT03334396|39201239|FG007|Overall Study|Ineligible|0|||
16198023|NCT03334396|39201232|FG000|Overall Study|Started New Job|1|||
16198024|NCT03334396|39201233|FG001|Overall Study|Started New Job|0|||
16198025|NCT03334396|39201234|FG002|Overall Study|Started New Job|0|||
16391932|NCT02122146|39919495|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
16391933|NCT02122146|39919496|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
16391934|NCT02122146|39919497|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
16391935|NCT02122146|39919498|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
16198026|NCT03334396|39201235|FG003|Overall Study|Started New Job|0|||
16198027|NCT03334396|39201236|FG004|Overall Study|Started New Job|0|||
16198028|NCT03334396|39201237|FG005|Overall Study|Started New Job|0|||
16198029|NCT03334396|39201238|FG006|Overall Study|Started New Job|0|||
16198030|NCT03334396|39201239|FG007|Overall Study|Started New Job|0|||
16198031|NCT01401465|39201242|FG000|Treatment Period 1|Adverse Event|4|||
16198032|NCT01401465|39201243|FG001|Treatment Period 1|Adverse Event|1|||
16198033|NCT01401465|39201242|FG000|Treatment Period 1|Pregnancy|0|||
16198034|NCT01401465|39201243|FG001|Treatment Period 1|Pregnancy|1|||
16198035|NCT01401465|39201242|FG000|Treatment Period 1|Protocol Violation|5|||
16198036|NCT01401465|39201243|FG001|Treatment Period 1|Protocol Violation|0|||
16198037|NCT01401465|39201242|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16198038|NCT01401465|39201243|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16198039|NCT01401465|39201242|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
16198040|NCT01401465|39201243|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
16198041|NCT01401465|39201242|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
16198042|NCT01401465|39201243|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
16198043|NCT01401465|39201242|FG000|Treatment Period 1|Scheduling Difficulties|1|||
16198044|NCT01401465|39201243|FG001|Treatment Period 1|Scheduling Difficulties|1|||
16198045|NCT01401465|39201242|FG000|Treatment Period 2|Lost to Follow-up|0|||
16198046|NCT01401465|39201243|FG001|Treatment Period 2|Lost to Follow-up|1|||
16198047|NCT01401465|39201242|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16198048|NCT01401465|39201243|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16198049|NCT02432040|39201244|FG000|Overall Study|Lack of Efficacy|3|||
16198050|NCT02432040|39201245|FG001|Overall Study|Lack of Efficacy|0|||
16198051|NCT02432040|39201244|FG000|Overall Study|Lost to Follow-up|4|||
16198052|NCT02432040|39201245|FG001|Overall Study|Lost to Follow-up|5|||
16198053|NCT02432040|39201244|FG000|Overall Study|Physician Decision|1|||
16198054|NCT02432040|39201245|FG001|Overall Study|Physician Decision|1|||
16198055|NCT00405821|39201247|FG000|Overall Study|Death|5|||
16198056|NCT00405821|39201248|FG001|Overall Study|Death|7|||
16198057|NCT00405821|39201247|FG000|Overall Study|Lost to Follow-up|7|||
16508973|NCT00378703|40336370|FG003|Overall Study|Symptomatic deterioration|2|||
16198058|NCT00405821|39201248|FG001|Overall Study|Lost to Follow-up|7|||
16198059|NCT00405821|39201247|FG000|Overall Study|Protocol Violation|1|||
16198060|NCT00405821|39201248|FG001|Overall Study|Protocol Violation|0|||
16198061|NCT00405821|39201247|FG000|Overall Study|initiated ART|9|||
16198062|NCT00405821|39201248|FG001|Overall Study|initiated ART|8|||
16198063|NCT02723591|39201251|FG000|Overall Study|Adverse Event|48|||
16198064|NCT02723591|39201252|FG001|Overall Study|Adverse Event|40|||
16198065|NCT02723591|39201251|FG000|Overall Study|Death|2|||
16198066|NCT02723591|39201252|FG001|Overall Study|Death|2|||
16198067|NCT02723591|39201251|FG000|Overall Study|Lack of Efficacy|4|||
16198068|NCT02723591|39201252|FG001|Overall Study|Lack of Efficacy|3|||
16198069|NCT02723591|39201251|FG000|Overall Study|Lost to Follow-up|1|||
16198070|NCT02723591|39201252|FG001|Overall Study|Lost to Follow-up|7|||
16198071|NCT02723591|39201251|FG000|Overall Study|Protocol Violation|20|||
16198072|NCT02723591|39201252|FG001|Overall Study|Protocol Violation|23|||
16198073|NCT02723591|39201251|FG000|Overall Study|Withdrawal by Subject|4|||
16198074|NCT02723591|39201252|FG001|Overall Study|Withdrawal by Subject|8|||
16198075|NCT02723591|39201251|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
16198076|NCT02723591|39201252|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
16198077|NCT02723591|39201251|FG000|Overall Study|Miscellaneous|5|||
16198078|NCT02723591|39201252|FG001|Overall Study|Miscellaneous|6|||
16198079|NCT03550131|39201255|FG000|Overall Study|Lost to Follow-up|16|||
16198080|NCT03550131|39201256|FG001|Overall Study|Lost to Follow-up|24|||
16198081|NCT03550131|39201255|FG000|Overall Study|Withdrawal by Subject|36|||
16198082|NCT03550131|39201256|FG001|Overall Study|Withdrawal by Subject|28|||
16198083|NCT03550131|39201255|FG000|Overall Study|Illness of dyad member|10|||
16391936|NCT02122146|39919499|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
16391937|NCT02122146|39919492|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16391938|NCT02122146|39919493|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16391939|NCT02122146|39919494|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16391940|NCT02122146|39919495|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
16391941|NCT02122146|39919496|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16391942|NCT02122146|39919497|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16391943|NCT02122146|39919498|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16391944|NCT02122146|39919499|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
16508974|NCT00378703|40336367|FG000|Overall Study|Surgery|1|||
16508975|NCT00378703|40336368|FG001|Overall Study|Surgery|0|||
16508976|NCT00378703|40336369|FG002|Overall Study|Surgery|0|||
16391945|NCT02122146|39919492|FG000|Part 1: Dose Escalation|Other|1|||
16391946|NCT02122146|39919493|FG001|Part 1: Dose Escalation|Other|0|||
16391947|NCT02122146|39919494|FG002|Part 1: Dose Escalation|Other|0|||
16391948|NCT02122146|39919495|FG003|Part 1: Dose Escalation|Other|0|||
16391949|NCT02122146|39919496|FG004|Part 1: Dose Escalation|Other|0|||
16391950|NCT02122146|39919497|FG005|Part 1: Dose Escalation|Other|1|||
16198084|NCT03550131|39201256|FG001|Overall Study|Illness of dyad member|2|||
16198085|NCT03550131|39201255|FG000|Overall Study|Death of person with dementia|4|||
16198086|NCT03550131|39201256|FG001|Overall Study|Death of person with dementia|8|||
16198087|NCT01033487|39201257|FG000|Fourth Intervention Period|Adverse Event|0|||
16198088|NCT01033487|39201258|FG001|Fourth Intervention Period|Adverse Event|0|||
16089946|NCT00614614|38820030|FG004|Primary Vaccination Phase|Other|0|||
16508977|NCT00378703|40336370|FG003|Overall Study|Surgery|1|||
16508978|NCT00378703|40336367|FG000|Overall Study|Joint decision of physician and patient|1|||
16508979|NCT00378703|40336368|FG001|Overall Study|Joint decision of physician and patient|0|||
16508980|NCT00378703|40336369|FG002|Overall Study|Joint decision of physician and patient|0|||
16508981|NCT00378703|40336370|FG003|Overall Study|Joint decision of physician and patient|0|||
16508982|NCT00378703|40336367|FG000|Overall Study|Adverse events and progressive disease|0|||
16391951|NCT02122146|39919498|FG006|Part 1: Dose Escalation|Other|1|||
16508983|NCT00378703|40336368|FG001|Overall Study|Adverse events and progressive disease|0|||
16508984|NCT00378703|40336369|FG002|Overall Study|Adverse events and progressive disease|0|||
16508985|NCT00378703|40336370|FG003|Overall Study|Adverse events and progressive disease|1|||
16508986|NCT00378703|40336367|FG000|Overall Study|Relocation|0|||
16508987|NCT00378703|40336368|FG001|Overall Study|Relocation|0|||
16508988|NCT00378703|40336369|FG002|Overall Study|Relocation|1|||
16508989|NCT00378703|40336370|FG003|Overall Study|Relocation|0|||
16508990|NCT00378703|40336367|FG000|Overall Study|Ineligible|4|||
16508991|NCT00378703|40336368|FG001|Overall Study|Ineligible|7|||
16508992|NCT00378703|40336369|FG002|Overall Study|Ineligible|7|||
16508993|NCT00378703|40336370|FG003|Overall Study|Ineligible|7|||
16508994|NCT00378703|40336367|FG000|Overall Study|Never started treatment|1|||
16508995|NCT00378703|40336368|FG001|Overall Study|Never started treatment|4|||
16508996|NCT00378703|40336369|FG002|Overall Study|Never started treatment|0|||
16508997|NCT00378703|40336370|FG003|Overall Study|Never started treatment|0|||
16508998|NCT00378703|40336367|FG000|Overall Study|Other|1|||
16508999|NCT00378703|40336368|FG001|Overall Study|Other|1|||
16509000|NCT00378703|40336369|FG002|Overall Study|Other|2|||
16509001|NCT00378703|40336370|FG003|Overall Study|Other|3|||
16509002|NCT00449956|40336371|FG000|Overall Study|Adverse Event|7|||
16509003|NCT00449956|40336372|FG001|Overall Study|Adverse Event|1|||
16509004|NCT00449956|40336373|FG002|Overall Study|Adverse Event|6|||
16509005|NCT00449956|40336371|FG000|Overall Study|Lack of Efficacy|0|||
16509006|NCT00449956|40336372|FG001|Overall Study|Lack of Efficacy|0|||
16509007|NCT00449956|40336373|FG002|Overall Study|Lack of Efficacy|1|||
16509008|NCT00449956|40336371|FG000|Overall Study|Protocol Violation|1|||
16509009|NCT00449956|40336372|FG001|Overall Study|Protocol Violation|1|||
16509010|NCT00449956|40336373|FG002|Overall Study|Protocol Violation|1|||
16509011|NCT00449956|40336371|FG000|Overall Study|Withdrawal by Subject|0|||
16509012|NCT00449956|40336372|FG001|Overall Study|Withdrawal by Subject|1|||
16509013|NCT00449956|40336373|FG002|Overall Study|Withdrawal by Subject|0|||
16509014|NCT00449956|40336371|FG000|Overall Study|Physician Decision|2|||
16509015|NCT00449956|40336372|FG001|Overall Study|Physician Decision|1|||
16509016|NCT00449956|40336373|FG002|Overall Study|Physician Decision|1|||
16509017|NCT02871739|40336380|FG000|Overall Study|Lost to Follow-up|3|||
16509018|NCT02871739|40336381|FG001|Overall Study|Lost to Follow-up|2|||
16509019|NCT02871739|40336382|FG002|Overall Study|Lost to Follow-up|0|||
16509020|NCT02871739|40336383|FG003|Overall Study|Lost to Follow-up|2|||
16509021|NCT00314366|40336384|FG000|Overall Study|not treated due to patient medical condi|1|||
16509022|NCT00314366|40336385|FG001|Overall Study|not treated due to patient medical condi|0|||
16509023|NCT00973479|40336386|FG000|Overall Study|Lost to Follow-up|0|||
16509024|NCT00973479|40336387|FG001|Overall Study|Lost to Follow-up|3|||
16391952|NCT02122146|39919499|FG007|Part 1: Dose Escalation|Other|2|||
16509025|NCT00973479|40336386|FG000|Overall Study|Death|2|||
16509026|NCT00973479|40336387|FG001|Overall Study|Death|2|||
16509027|NCT00973479|40336386|FG000|Overall Study|Withdrawal by Subject|15|||
16509028|NCT00973479|40336387|FG001|Overall Study|Withdrawal by Subject|16|||
16509029|NCT00973479|40336386|FG000|Overall Study|Lack of Efficacy|5|||
16509030|NCT00973479|40336387|FG001|Overall Study|Lack of Efficacy|7|||
16509031|NCT00973479|40336386|FG000|Overall Study|Adverse Event|12|||
16509032|NCT00973479|40336387|FG001|Overall Study|Adverse Event|32|||
16509033|NCT00973479|40336386|FG000|Overall Study|Protocol Violation|2|||
16509034|NCT00973479|40336387|FG001|Overall Study|Protocol Violation|2|||
16509035|NCT00973479|40336386|FG000|Overall Study|Other|1|||
16509036|NCT00973479|40336387|FG001|Overall Study|Other|7|||
16509037|NCT03818516|40336394|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
16509038|NCT01428193|40336397|FG000|Overall Study|Physician Decision|1|||
16509039|NCT01428193|40336397|FG000|Overall Study|Elevated screening liver enzymes|1|||
16509040|NCT01554618|40336398|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
16509041|NCT01554618|40336399|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
16509042|NCT01554618|40336398|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
16509043|NCT01554618|40336399|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
16391953|NCT02100423|39919500|FG000|Overall Study|Death|1|||
16509044|NCT01554618|40336398|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
16509045|NCT01554618|40336399|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
16509046|NCT01554618|40336398|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
16509047|NCT01554618|40336399|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
16509048|NCT01554618|40336398|FG000|Open-Label Extension Period|Physician Decision|0|||
16509049|NCT01554618|40336399|FG001|Open-Label Extension Period|Physician Decision|1|||
16509050|NCT01554618|40336398|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
16509051|NCT01554618|40336399|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
16509052|NCT00314574|40336400|FG000|Overall Study|Death|3|||
16509053|NCT00314574|40336401|FG001|Overall Study|Death|0|||
16391954|NCT02100423|39919500|FG000|Overall Study|Withdrawal by Subject|3|||
16509054|NCT00314574|40336400|FG000|Overall Study|Adverse Event|11|||
16391955|NCT02100423|39919500|FG000|Overall Study|Adverse Event|1|||
16509055|NCT00314574|40336401|FG001|Overall Study|Adverse Event|16|||
16509056|NCT00314574|40336400|FG000|Overall Study|Lost to Follow-up|19|||
16509057|NCT00314574|40336401|FG001|Overall Study|Lost to Follow-up|25|||
16509058|NCT00314574|40336400|FG000|Overall Study|Withdrawal by Subject|33|||
16509059|NCT00314574|40336401|FG001|Overall Study|Withdrawal by Subject|22|||
16509060|NCT00314574|40336400|FG000|Overall Study|Physician Decision|22|||
16509061|NCT00314574|40336401|FG001|Overall Study|Physician Decision|15|||
16509062|NCT00314574|40336400|FG000|Overall Study|Pregnancy|6|||
16509063|NCT00314574|40336401|FG001|Overall Study|Pregnancy|4|||
16509064|NCT00314574|40336400|FG000|Overall Study|Data unknown at database lock|0|||
16509065|NCT00314574|40336401|FG001|Overall Study|Data unknown at database lock|1|||
16509066|NCT02603432|40336402|FG000|Overall Study|Adverse Event|1|||
16509067|NCT02603432|40336403|FG001|Overall Study|Adverse Event|0|||
16509068|NCT02603432|40336402|FG000|Overall Study|Death|221|||
16509069|NCT02603432|40336403|FG001|Overall Study|Death|242|||
16509070|NCT02603432|40336402|FG000|Overall Study|Lost to Follow-up|3|||
16509071|NCT02603432|40336403|FG001|Overall Study|Lost to Follow-up|9|||
16509072|NCT02603432|40336402|FG000|Overall Study|Progressive Disease|7|||
16509073|NCT02603432|40336403|FG001|Overall Study|Progressive Disease|5|||
16509074|NCT02603432|40336402|FG000|Overall Study|Withdrawal by Subject|12|||
16509075|NCT02603432|40336403|FG001|Overall Study|Withdrawal by Subject|18|||
16509076|NCT02603432|40336402|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
16509077|NCT02603432|40336403|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16509078|NCT02603432|40336402|FG000|Overall Study|Study terminated by sponsor|74|||
16509079|NCT02603432|40336403|FG001|Overall Study|Study terminated by sponsor|75|||
16509080|NCT02603432|40336402|FG000|Overall Study|Other|13|||
16509081|NCT02603432|40336403|FG001|Overall Study|Other|0|||
16509082|NCT01257204|40336406|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
16509083|NCT01257204|40336407|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
16509084|NCT01257204|40336408|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
16509085|NCT01257204|40336406|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
16509086|NCT01257204|40336407|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
16509087|NCT01257204|40336408|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
16509088|NCT01257204|40336406|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
16509089|NCT01257204|40336407|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
16509090|NCT01257204|40336408|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
16509091|NCT01257204|40336406|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
16509092|NCT01257204|40336407|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
16509093|NCT01257204|40336408|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
16509094|NCT01257204|40336406|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
16509095|NCT01257204|40336407|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
16509096|NCT01257204|40336408|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
16509097|NCT01257204|40336406|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
16509098|NCT01257204|40336407|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
16509099|NCT01257204|40336408|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
16509100|NCT01257204|40336406|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
16509101|NCT01257204|40336407|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
16509102|NCT01257204|40336408|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
16509103|NCT01257204|40336406|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
16314461|NCT00489918|39634053|FG004|Overall Study|Adverse Event|0|||
16314462|NCT00489918|39634049|FG000|Overall Study|Lost to Follow-up|0|||
16314463|NCT00489918|39634050|FG001|Overall Study|Lost to Follow-up|0|||
16314464|NCT00489918|39634051|FG002|Overall Study|Lost to Follow-up|1|||
16314465|NCT00489918|39634052|FG003|Overall Study|Lost to Follow-up|1|||
16314466|NCT00489918|39634053|FG004|Overall Study|Lost to Follow-up|0|||
16314467|NCT00489918|39634049|FG000|Overall Study|Physician Decision|0|||
16314468|NCT00489918|39634050|FG001|Overall Study|Physician Decision|0|||
16314469|NCT00489918|39634051|FG002|Overall Study|Physician Decision|1|||
16314470|NCT00489918|39634052|FG003|Overall Study|Physician Decision|0|||
16314471|NCT00489918|39634053|FG004|Overall Study|Physician Decision|0|||
16391956|NCT02100423|39919500|FG000|Overall Study|Physician Decision|1|||
16391957|NCT00735553|39919503|FG000|Overall Study|Study prematurely terminated|77|||
16391958|NCT00003869|39919504|FG000|Overall Study|Adverse Event|14|||
16391959|NCT00003869|39919505|FG001|Overall Study|Adverse Event|3|||
16391960|NCT00003869|39919504|FG000|Overall Study|Withdrawal by Subject|21|||
16391961|NCT00003869|39919505|FG001|Overall Study|Withdrawal by Subject|3|||
16391962|NCT00003869|39919504|FG000|Overall Study|Death|1|||
16314472|NCT02570308|39634054|FG000|Overall Study|Death|1|||
16391963|NCT00003869|39919505|FG001|Overall Study|Death|2|||
16391964|NCT00003869|39919504|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
16314473|NCT02570308|39634055|FG001|Overall Study|Death|5|||
16314474|NCT02570308|39634056|FG002|Overall Study|Death|4|||
16314475|NCT02570308|39634057|FG003|Overall Study|Death|4|||
16314476|NCT02570308|39634058|FG004|Overall Study|Death|69|||
16391965|NCT00003869|39919505|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
16391966|NCT00556439|39919506|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
16391967|NCT00556439|39919507|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
16391968|NCT00556439|39919508|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
16391969|NCT00556439|39919509|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
16509104|NCT01257204|40336407|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
16509105|NCT01257204|40336408|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
16314477|NCT02570308|39634054|FG000|Overall Study|Lost to Follow-up|0|||
16198089|NCT01033487|39201259|FG002|Fourth Intervention Period|Adverse Event|0|||
16198090|NCT01033487|39201260|FG003|Fourth Intervention Period|Adverse Event|0|||
16198091|NCT01033487|39201261|FG004|Fourth Intervention Period|Adverse Event|0|||
16198092|NCT01033487|39201262|FG005|Fourth Intervention Period|Adverse Event|0|||
16198093|NCT01033487|39201263|FG006|Fourth Intervention Period|Adverse Event|0|||
16198094|NCT01033487|39201264|FG007|Fourth Intervention Period|Adverse Event|0|||
16314478|NCT02570308|39634055|FG001|Overall Study|Lost to Follow-up|0|||
16314479|NCT02570308|39634056|FG002|Overall Study|Lost to Follow-up|0|||
16198095|NCT01033487|39201265|FG008|Fourth Intervention Period|Adverse Event|1|||
16198096|NCT01033487|39201266|FG009|Fourth Intervention Period|Adverse Event|0|||
16198097|NCT02999100|39201269|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
16198098|NCT02999100|39201270|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
16314480|NCT02570308|39634057|FG003|Overall Study|Lost to Follow-up|0|||
16314481|NCT02570308|39634058|FG004|Overall Study|Lost to Follow-up|2|||
16509106|NCT01257204|40336406|FG000|Follow-up Period (up to Week 48)|Other|0|||
16509107|NCT01257204|40336407|FG001|Follow-up Period (up to Week 48)|Other|0|||
16509108|NCT01257204|40336408|FG002|Follow-up Period (up to Week 48)|Other|5|||
16509109|NCT01498640|40336409|FG000|Overall Study|Lost to Follow-up|1|||
16509110|NCT01498640|40336409|FG000|Overall Study|Death|1|||
16509111|NCT01498640|40336409|FG000|Overall Study|Other|3|||
16509112|NCT03336216|40336410|FG000|Randomization|Not reported|2|||
16509113|NCT03336216|40336411|FG001|Randomization|Not reported|0|||
16509114|NCT03336216|40336412|FG002|Randomization|Not reported|1|||
16509115|NCT03336216|40336413|FG003|Randomization|Not reported|0|||
16509116|NCT03336216|40336410|FG000|Randomization|Other reasons|1|||
16509117|NCT03336216|40336411|FG001|Randomization|Other reasons|1|||
16509118|NCT03336216|40336412|FG002|Randomization|Other reasons|1|||
16509119|NCT03336216|40336413|FG003|Randomization|Other reasons|0|||
16314482|NCT02570308|39634054|FG000|Overall Study|Withdrawal by Subject|0|||
16314483|NCT02570308|39634055|FG001|Overall Study|Withdrawal by Subject|0|||
16314484|NCT02570308|39634056|FG002|Overall Study|Withdrawal by Subject|0|||
16314485|NCT02570308|39634057|FG003|Overall Study|Withdrawal by Subject|0|||
16314486|NCT02570308|39634058|FG004|Overall Study|Withdrawal by Subject|1|||
16314487|NCT02570308|39634054|FG000|Overall Study|Other|0|||
16314488|NCT02570308|39634055|FG001|Overall Study|Other|0|||
16314489|NCT02570308|39634056|FG002|Overall Study|Other|0|||
16314490|NCT02570308|39634057|FG003|Overall Study|Other|0|||
16314491|NCT02570308|39634058|FG004|Overall Study|Other|2|||
16314492|NCT01372618|39634059|FG000|Overall Study|PI Died. Study Terminated|9|||
16314493|NCT03391960|39634060|FG000|Overall Study|Protocol Violation|0|||
16314494|NCT03391960|39634061|FG001|Overall Study|Protocol Violation|0|||
16314495|NCT00014495|39634062|FG000|Overall Study|Death|0|||
16509120|NCT03336216|40336410|FG000|Randomization|Participant no longer meets study criteria|0|||
16509121|NCT03336216|40336411|FG001|Randomization|Participant no longer meets study criteria|2|||
16509122|NCT03336216|40336412|FG002|Randomization|Participant no longer meets study criteria|4|||
16509123|NCT03336216|40336413|FG003|Randomization|Participant no longer meets study criteria|1|||
16509124|NCT03336216|40336410|FG000|Randomization|Lost to Follow-up|1|||
16509125|NCT03336216|40336411|FG001|Randomization|Lost to Follow-up|0|||
16509126|NCT03336216|40336412|FG002|Randomization|Lost to Follow-up|0|||
16509127|NCT03336216|40336413|FG003|Randomization|Lost to Follow-up|0|||
16509128|NCT03336216|40336410|FG000|Randomization|Participant withdrew consent|9|||
16509129|NCT03336216|40336411|FG001|Randomization|Participant withdrew consent|1|||
16509130|NCT03336216|40336412|FG002|Randomization|Participant withdrew consent|0|||
16509131|NCT03336216|40336413|FG003|Randomization|Participant withdrew consent|0|||
16509132|NCT03336216|40336410|FG000|Randomization|Adverse Event|1|||
16198099|NCT02999100|39201271|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
16314496|NCT00014495|39634063|FG001|Overall Study|Death|0|||
16314497|NCT00014495|39634064|FG002|Overall Study|Death|1|||
16314498|NCT00014495|39634065|FG003|Overall Study|Death|0|||
16314499|NCT00014495|39634062|FG000|Overall Study|Clinical deterioration|0|||
16314500|NCT00014495|39634063|FG001|Overall Study|Clinical deterioration|0|||
16314501|NCT00014495|39634064|FG002|Overall Study|Clinical deterioration|0|||
16314502|NCT00014495|39634065|FG003|Overall Study|Clinical deterioration|1|||
16314503|NCT01801865|39634066|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
16391970|NCT00556439|39919506|FG000|Study Entry to Week 12|Physician Decision|1|||
16314504|NCT01801865|39634066|FG000|Overall Study|Physician Decision|7|||
16198100|NCT02999100|39201272|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
16198101|NCT02999100|39201273|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
16314505|NCT02291510|39634071|FG000|Overall Study|Adverse Event|0|||
16198102|NCT02999100|39201274|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
16198103|NCT02999100|39201269|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
16198104|NCT02999100|39201270|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
16198105|NCT02999100|39201271|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
16198106|NCT02999100|39201272|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
16198107|NCT02999100|39201273|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
16198108|NCT02999100|39201274|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
16198109|NCT02999100|39201269|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
16198110|NCT02999100|39201270|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
16198111|NCT02999100|39201271|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
16198112|NCT02999100|39201272|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
16198113|NCT02999100|39201273|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
16198114|NCT02999100|39201274|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
16198115|NCT02721251|39201278|FG000|Overall Study|Withdrawal by Subject|8|||
16198116|NCT02721251|39201279|FG001|Overall Study|Withdrawal by Subject|7|||
16198117|NCT02721251|39201280|FG002|Overall Study|Withdrawal by Subject|9|||
16198118|NCT02721251|39201278|FG000|Overall Study|poor adherence|2|||
16198119|NCT02721251|39201279|FG001|Overall Study|poor adherence|2|||
16198120|NCT02721251|39201280|FG002|Overall Study|poor adherence|2|||
16198121|NCT01479374|39201281|FG000|Overall Study|Adverse Event|2|||
16198122|NCT01479374|39201282|FG001|Overall Study|Adverse Event|1|||
16198123|NCT01479374|39201283|FG002|Overall Study|Adverse Event|0|||
16198124|NCT01479374|39201281|FG000|Overall Study|Lost to Follow-up|1|||
16198125|NCT01479374|39201282|FG001|Overall Study|Lost to Follow-up|2|||
16198126|NCT01479374|39201283|FG002|Overall Study|Lost to Follow-up|0|||
16198127|NCT01479374|39201281|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
16198128|NCT01479374|39201282|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
16198129|NCT01479374|39201283|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
16198130|NCT01479374|39201281|FG000|Overall Study|Other|0|||
16198131|NCT01479374|39201282|FG001|Overall Study|Other|4|||
16198132|NCT01479374|39201283|FG002|Overall Study|Other|5|||
16198133|NCT00738374|39201286|FG000|Induction Treatment Phase|Adverse Event|14|||
16198134|NCT00738374|39201287|FG001|Induction Treatment Phase|Adverse Event|0|||
16198135|NCT00738374|39201288|FG002|Induction Treatment Phase|Adverse Event|0|||
16198136|NCT00738374|39201289|FG003|Induction Treatment Phase|Adverse Event|0|||
16198137|NCT00738374|39201286|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
16198138|NCT00738374|39201287|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
16198139|NCT00738374|39201288|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
16198140|NCT00738374|39201289|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
16198141|NCT00738374|39201286|FG000|Induction Treatment Phase|Physician Decision|2|||
16198142|NCT00738374|39201287|FG001|Induction Treatment Phase|Physician Decision|0|||
16198143|NCT00738374|39201288|FG002|Induction Treatment Phase|Physician Decision|0|||
16198144|NCT00738374|39201289|FG003|Induction Treatment Phase|Physician Decision|0|||
16198145|NCT00738374|39201286|FG000|Induction Treatment Phase|Protocol Violation|2|||
16198146|NCT00738374|39201287|FG001|Induction Treatment Phase|Protocol Violation|0|||
16198147|NCT00738374|39201288|FG002|Induction Treatment Phase|Protocol Violation|0|||
16198148|NCT00738374|39201289|FG003|Induction Treatment Phase|Protocol Violation|0|||
16198149|NCT00738374|39201286|FG000|Induction Treatment Phase|Non-compliance|1|||
16198150|NCT00738374|39201287|FG001|Induction Treatment Phase|Non-compliance|0|||
16198151|NCT00738374|39201288|FG002|Induction Treatment Phase|Non-compliance|0|||
16198152|NCT00738374|39201289|FG003|Induction Treatment Phase|Non-compliance|0|||
16198153|NCT00738374|39201286|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
16198154|NCT00738374|39201287|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
16198155|NCT00738374|39201288|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
16198156|NCT00738374|39201289|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
16509133|NCT03336216|40336411|FG001|Randomization|Adverse Event|1|||
16509134|NCT03336216|40336412|FG002|Randomization|Adverse Event|0|||
16509135|NCT03336216|40336413|FG003|Randomization|Adverse Event|0|||
16509136|NCT03336216|40336410|FG000|Treatment|Adverse Event|2|||
16509137|NCT03336216|40336411|FG001|Treatment|Adverse Event|3|||
16509138|NCT03336216|40336412|FG002|Treatment|Adverse Event|4|||
16509139|NCT03336216|40336413|FG003|Treatment|Adverse Event|4|||
16509140|NCT03336216|40336410|FG000|Treatment|Participant request to discontinue treatment|2|||
16509141|NCT03336216|40336411|FG001|Treatment|Participant request to discontinue treatment|1|||
16509142|NCT03336216|40336412|FG002|Treatment|Participant request to discontinue treatment|2|||
16509143|NCT03336216|40336413|FG003|Treatment|Participant request to discontinue treatment|2|||
16089947|NCT00614614|38820026|FG000|Booster Vaccination Phase|Adverse Event|0|||
16089948|NCT00614614|38820027|FG001|Booster Vaccination Phase|Adverse Event|0|||
16198157|NCT00738374|39201286|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
16198158|NCT00738374|39201287|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
16198159|NCT00738374|39201288|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
16198160|NCT00738374|39201289|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
16198161|NCT00738374|39201286|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
16198162|NCT00738374|39201287|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
16198163|NCT00738374|39201288|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
16198164|NCT00738374|39201289|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
16198165|NCT00738374|39201286|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
16198166|NCT00738374|39201287|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
16198167|NCT00738374|39201288|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
16198168|NCT00738374|39201289|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
16198169|NCT00738374|39201286|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
16198170|NCT00738374|39201287|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
16198171|NCT00738374|39201288|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
16198172|NCT00738374|39201289|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
16198173|NCT00738374|39201286|FG000|Maintenance Treatment/Observation Phase|Other|0|||
16198174|NCT00738374|39201287|FG001|Maintenance Treatment/Observation Phase|Other|1|||
16198175|NCT00738374|39201288|FG002|Maintenance Treatment/Observation Phase|Other|0|||
16198176|NCT00738374|39201289|FG003|Maintenance Treatment/Observation Phase|Other|0|||
16198177|NCT01354353|39201290|FG000|Overall Study|Adverse Event|1|||
16198178|NCT01354353|39201291|FG001|Overall Study|Adverse Event|0|||
16198179|NCT01354353|39201292|FG002|Overall Study|Adverse Event|0|||
16198180|NCT01354353|39201293|FG003|Overall Study|Adverse Event|4|||
16198181|NCT01354353|39201294|FG004|Overall Study|Adverse Event|0|||
16198182|NCT01354353|39201295|FG005|Overall Study|Adverse Event|5|||
16198183|NCT01354353|39201290|FG000|Overall Study|Entry Criteria Not Met|0|||
16198184|NCT01354353|39201291|FG001|Overall Study|Entry Criteria Not Met|0|||
16198185|NCT01354353|39201292|FG002|Overall Study|Entry Criteria Not Met|0|||
16198186|NCT01354353|39201293|FG003|Overall Study|Entry Criteria Not Met|1|||
16198187|NCT01354353|39201294|FG004|Overall Study|Entry Criteria Not Met|1|||
16198188|NCT01354353|39201295|FG005|Overall Study|Entry Criteria Not Met|0|||
16198189|NCT01354353|39201290|FG000|Overall Study|Physician Decision|0|||
16198190|NCT01354353|39201291|FG001|Overall Study|Physician Decision|1|||
16198191|NCT01354353|39201292|FG002|Overall Study|Physician Decision|1|||
16198192|NCT01354353|39201293|FG003|Overall Study|Physician Decision|0|||
16198193|NCT01354353|39201294|FG004|Overall Study|Physician Decision|0|||
16198194|NCT01354353|39201295|FG005|Overall Study|Physician Decision|0|||
16198195|NCT01354353|39201290|FG000|Overall Study|Withdrawal by Subject|2|||
16198196|NCT01354353|39201291|FG001|Overall Study|Withdrawal by Subject|0|||
16198197|NCT01354353|39201292|FG002|Overall Study|Withdrawal by Subject|1|||
16198198|NCT01354353|39201293|FG003|Overall Study|Withdrawal by Subject|0|||
16198199|NCT01354353|39201294|FG004|Overall Study|Withdrawal by Subject|0|||
16198200|NCT01354353|39201295|FG005|Overall Study|Withdrawal by Subject|1|||
16198201|NCT00622869|39201296|FG000|Overall Study|Subject Withdrew Consent|13|||
16198202|NCT00622869|39201297|FG001|Overall Study|Subject Withdrew Consent|17|||
16198203|NCT00622869|39201298|FG002|Overall Study|Subject Withdrew Consent|11|||
16198204|NCT00622869|39201296|FG000|Overall Study|Administrative Problems|11|||
16198205|NCT00622869|39201297|FG001|Overall Study|Administrative Problems|17|||
16198206|NCT00622869|39201298|FG002|Overall Study|Administrative Problems|13|||
16198207|NCT00622869|39201296|FG000|Overall Study|Death|12|||
16198208|NCT00622869|39201297|FG001|Overall Study|Death|15|||
16198209|NCT00622869|39201298|FG002|Overall Study|Death|10|||
16198210|NCT00622869|39201296|FG000|Overall Study|Lost to Follow-up|2|||
16198211|NCT00622869|39201297|FG001|Overall Study|Lost to Follow-up|4|||
16198212|NCT00622869|39201298|FG002|Overall Study|Lost to Follow-up|2|||
16198213|NCT00622869|39201296|FG000|Overall Study|Graft Loss|5|||
16198214|NCT00622869|39201297|FG001|Overall Study|Graft Loss|3|||
16198215|NCT00622869|39201298|FG002|Overall Study|Graft Loss|2|||
16198216|NCT00622869|39201296|FG000|Overall Study|Missing|0|||
16198217|NCT00622869|39201297|FG001|Overall Study|Missing|1|||
16198218|NCT00622869|39201298|FG002|Overall Study|Missing|1|||
16198219|NCT01429792|39201299|FG000|Overall Study|Other Reasons|67|||
16198220|NCT01429792|39201299|FG000|Overall Study|Unknown Disposition|94|||
16198221|NCT01429792|39201299|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
16198222|NCT01429792|39201299|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
16198223|NCT01429792|39201299|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
16198224|NCT01429792|39201299|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
16198225|NCT01429792|39201299|FG000|Overall Study|Withdrawal by Subject|70|||
16198226|NCT01429792|39201299|FG000|Overall Study|Lost to Follow-up|88|||
16198227|NCT03488251|39201300|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
16198228|NCT03488251|39201301|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
16198229|NCT03488251|39201302|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
16198230|NCT03488251|39201303|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
16198231|NCT03488251|39201300|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
16198232|NCT03488251|39201301|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
16198233|NCT03488251|39201302|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
16198234|NCT03488251|39201303|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
16198235|NCT03488251|39201300|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
16198236|NCT03488251|39201301|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
16198237|NCT03488251|39201302|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
16198238|NCT03488251|39201303|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
16198239|NCT03488251|39201300|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
16198240|NCT03488251|39201301|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
16198241|NCT03488251|39201302|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
16198242|NCT03488251|39201303|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
16198243|NCT03488251|39201300|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
16198244|NCT03488251|39201301|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
16198245|NCT03488251|39201302|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
16198246|NCT03488251|39201303|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
16198247|NCT02294318|39201304|FG000|Overall Study|Worsening of drinking|3|||
16198248|NCT02294318|39201305|FG001|Overall Study|Worsening of drinking|0|||
16198249|NCT02294318|39201304|FG000|Overall Study|Not exposed to intervention|0|||
16198250|NCT02294318|39201305|FG001|Overall Study|Not exposed to intervention|2|||
16198251|NCT03162055|39201306|FG000|Overall Study|Adverse Event|6|||
16198252|NCT03162055|39201307|FG001|Overall Study|Adverse Event|5|||
16198253|NCT03162055|39201306|FG000|Overall Study|Death|3|||
16314506|NCT02291510|39634072|FG001|Overall Study|Adverse Event|0|||
16314507|NCT02291510|39634073|FG002|Overall Study|Adverse Event|0|||
16314508|NCT02291510|39634074|FG003|Overall Study|Adverse Event|1|||
16314509|NCT02656303|39634075|FG000|Overall Study|Adverse Event|3|||
16314510|NCT02656303|39634076|FG001|Overall Study|Adverse Event|2|||
16314511|NCT02656303|39634077|FG002|Overall Study|Adverse Event|0|||
16314512|NCT02656303|39634075|FG000|Overall Study|Death|12|||
16314513|NCT02656303|39634076|FG001|Overall Study|Death|4|||
16314514|NCT02656303|39634077|FG002|Overall Study|Death|1|||
16314515|NCT02656303|39634075|FG000|Overall Study|Lack of Efficacy|1|||
16314516|NCT02656303|39634076|FG001|Overall Study|Lack of Efficacy|0|||
16314517|NCT02656303|39634077|FG002|Overall Study|Lack of Efficacy|0|||
16314518|NCT02656303|39634075|FG000|Overall Study|Non-Compliance with Study|1|||
16314519|NCT02656303|39634076|FG001|Overall Study|Non-Compliance with Study|1|||
16314520|NCT02656303|39634077|FG002|Overall Study|Non-Compliance with Study|0|||
16314521|NCT02656303|39634075|FG000|Overall Study|Investigator Decision|2|||
16314522|NCT02656303|39634076|FG001|Overall Study|Investigator Decision|1|||
16314523|NCT02656303|39634077|FG002|Overall Study|Investigator Decision|0|||
16314524|NCT02656303|39634075|FG000|Overall Study|Progressive Disease|25|||
16314525|NCT02656303|39634076|FG001|Overall Study|Progressive Disease|14|||
16314526|NCT02656303|39634077|FG002|Overall Study|Progressive Disease|10|||
16314527|NCT02656303|39634075|FG000|Overall Study|Study Terminated by Sponsor|20|||
16314528|NCT02656303|39634076|FG001|Overall Study|Study Terminated by Sponsor|7|||
16314529|NCT02656303|39634077|FG002|Overall Study|Study Terminated by Sponsor|5|||
16314530|NCT02656303|39634075|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
16314531|NCT02656303|39634076|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
16314532|NCT02656303|39634077|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
16314533|NCT02656303|39634075|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
16198254|NCT03162055|39201307|FG001|Overall Study|Death|3|||
16198255|NCT03162055|39201306|FG000|Overall Study|Lost to Follow-up|0|||
16198256|NCT03162055|39201307|FG001|Overall Study|Lost to Follow-up|1|||
16198257|NCT03162055|39201306|FG000|Overall Study|Study-specific withdrawal criteria|22|||
16198258|NCT03162055|39201307|FG001|Overall Study|Study-specific withdrawal criteria|14|||
16198259|NCT03162055|39201306|FG000|Overall Study|Withdrawal by Subject|17|||
16198260|NCT03162055|39201307|FG001|Overall Study|Withdrawal by Subject|2|||
16198261|NCT03162055|39201306|FG000|Overall Study|Did not receive treatment|2|||
16198262|NCT03162055|39201307|FG001|Overall Study|Did not receive treatment|0|||
16198263|NCT03162055|39201306|FG000|Overall Study|Incorrect randomization|4|||
16198264|NCT03162055|39201307|FG001|Overall Study|Incorrect randomization|3|||
16198265|NCT03162055|39201306|FG000|Overall Study|Other|8|||
16198266|NCT03162055|39201307|FG001|Overall Study|Other|15|||
16198267|NCT01051986|39201309|FG000|Overall Study|Death|1|||
16198268|NCT01051986|39201310|FG001|Overall Study|Death|0|||
16314534|NCT02656303|39634076|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
16314535|NCT02656303|39634077|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
16314536|NCT02656303|39634075|FG000|Overall Study|Reason not Specified|1|||
16314537|NCT02656303|39634076|FG001|Overall Study|Reason not Specified|1|||
16198269|NCT01051986|39201309|FG000|Overall Study|Withdrawal by Subject|2|||
16198270|NCT01051986|39201310|FG001|Overall Study|Withdrawal by Subject|1|||
16198271|NCT01051986|39201309|FG000|Overall Study|Protocol Violation|2|||
16198272|NCT01051986|39201310|FG001|Overall Study|Protocol Violation|3|||
16198273|NCT01999946|39201311|FG000|Overall Study|Participant not released from jail|2|||
16198274|NCT01999946|39201312|FG001|Overall Study|Participant not released from jail|2|||
16198275|NCT01999946|39201313|FG002|Overall Study|Participant not released from jail|0|||
16198276|NCT01999946|39201311|FG000|Overall Study|Not included in primary outcome analysis|0|||
16198277|NCT01999946|39201312|FG001|Overall Study|Not included in primary outcome analysis|0|||
16198278|NCT01999946|39201313|FG002|Overall Study|Not included in primary outcome analysis|79|||
16198279|NCT02808312|39201316|FG000|Overall Study|Enrolled but Never Treated|0|||
16198280|NCT02808312|39201317|FG001|Overall Study|Enrolled but Never Treated|0|||
16198281|NCT02808312|39201318|FG002|Overall Study|Enrolled but Never Treated|1|||
16198282|NCT02808312|39201319|FG003|Overall Study|Enrolled but Never Treated|0|||
16198283|NCT02808312|39201320|FG004|Overall Study|Enrolled but Never Treated|0|||
16198284|NCT00423735|39201324|FG000|Overall Study|Ineligible / No protocol treatment|8|||
16198285|NCT00423735|39201325|FG001|Overall Study|Ineligible / No protocol treatment|6|||
16198286|NCT00423735|39201326|FG002|Overall Study|Ineligible / No protocol treatment|0|||
16198287|NCT00752609|39201329|FG000|Overall Study|Adverse Event|2|||
16198288|NCT00752609|39201330|FG001|Overall Study|Adverse Event|2|||
16198289|NCT00752609|39201329|FG000|Overall Study|Withdrawal by Subject|3|||
16198290|NCT00752609|39201330|FG001|Overall Study|Withdrawal by Subject|0|||
16198291|NCT00752609|39201329|FG000|Overall Study|Physician Decision|1|||
16198292|NCT00752609|39201330|FG001|Overall Study|Physician Decision|0|||
16198293|NCT00752609|39201329|FG000|Overall Study|Death|1|||
16198294|NCT00752609|39201330|FG001|Overall Study|Death|0|||
16198295|NCT00752609|39201329|FG000|Overall Study|Met exclusion criteria|1|||
16198296|NCT00752609|39201330|FG001|Overall Study|Met exclusion criteria|0|||
16198297|NCT00752609|39201329|FG000|Overall Study|Received Aranesp in error|1|||
16198298|NCT00752609|39201330|FG001|Overall Study|Received Aranesp in error|0|||
16198299|NCT01894477|39201331|FG000|Overall Study|Protocol Violation|0|||
16198300|NCT01894477|39201332|FG001|Overall Study|Protocol Violation|1|||
16198301|NCT01894477|39201331|FG000|Overall Study|protocol changed due SC changed to cord|0|||
16198302|NCT01894477|39201332|FG001|Overall Study|protocol changed due SC changed to cord|1|||
16198303|NCT02115113|39201333|FG000|Participants in Run-in Period|Death|0|||
16198304|NCT02115113|39201334|FG001|Participants in Run-in Period|Death|0|||
16198305|NCT02115113|39201335|FG002|Participants in Run-in Period|Death|1|||
16198306|NCT02115113|39201333|FG000|Participants in Run-in Period|Administrative problems|0|||
16198307|NCT02115113|39201334|FG001|Participants in Run-in Period|Administrative problems|0|||
16198308|NCT02115113|39201335|FG002|Participants in Run-in Period|Administrative problems|1|||
16198309|NCT02115113|39201333|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
16198310|NCT02115113|39201334|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
16198311|NCT02115113|39201335|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
16198312|NCT02115113|39201333|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
16198313|NCT02115113|39201334|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
16198314|NCT02115113|39201335|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
16198315|NCT02115113|39201333|FG000|Participants Randomized|Lost to Follow-up|1|||
16198316|NCT02115113|39201334|FG001|Participants Randomized|Lost to Follow-up|0|||
16198317|NCT02115113|39201335|FG002|Participants Randomized|Lost to Follow-up|0|||
16198318|NCT02115113|39201333|FG000|Participants Randomized|Death|1|||
16198319|NCT02115113|39201334|FG001|Participants Randomized|Death|0|||
16198320|NCT02115113|39201335|FG002|Participants Randomized|Death|0|||
16198321|NCT00471445|39201342|FG000|Overall Study|Withdrawal by Subject|1|||
16198322|NCT00471445|39201343|FG001|Overall Study|Withdrawal by Subject|1|||
16198323|NCT00471445|39201342|FG000|Overall Study|Ineligible|1|||
16198324|NCT00471445|39201343|FG001|Overall Study|Ineligible|0|||
16198325|NCT00471445|39201342|FG000|Overall Study|Protocol Violation|0|||
16198326|NCT00471445|39201343|FG001|Overall Study|Protocol Violation|1|||
16198327|NCT00413062|39201352|FG000|Overall Study|Adverse event/serious adverse event|289|||
16198328|NCT00413062|39201353|FG001|Overall Study|Adverse event/serious adverse event|56|||
16198329|NCT00413062|39201352|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
16198330|NCT00413062|39201353|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
16198331|NCT00413062|39201352|FG000|Overall Study|Withdrawal of informed consent|111|||
16198332|NCT00413062|39201353|FG001|Overall Study|Withdrawal of informed consent|36|||
16198333|NCT00413062|39201352|FG000|Overall Study|Pregnancy|15|||
16198334|NCT00413062|39201353|FG001|Overall Study|Pregnancy|5|||
16198335|NCT00413062|39201352|FG000|Overall Study|Pregnancy wish|17|||
16198336|NCT00413062|39201353|FG001|Overall Study|Pregnancy wish|6|||
16198337|NCT00413062|39201352|FG000|Overall Study|Lost to Follow-up|175|||
16198338|NCT00413062|39201353|FG001|Overall Study|Lost to Follow-up|73|||
16198339|NCT00413062|39201352|FG000|Overall Study|Other reason|70|||
16198340|NCT00413062|39201353|FG001|Overall Study|Other reason|34|||
16198341|NCT01582971|39201354|FG000|Overall Study|Death|2|||
16198342|NCT01582971|39201355|FG001|Overall Study|Death|1|||
16198343|NCT01582971|39201354|FG000|Overall Study|Lost to Follow-up|18|||
16198344|NCT01582971|39201355|FG001|Overall Study|Lost to Follow-up|21|||
16198345|NCT01582971|39201354|FG000|Overall Study|Withdrawal by Subject|4|||
16198346|NCT01582971|39201355|FG001|Overall Study|Withdrawal by Subject|2|||
16198347|NCT01582971|39201354|FG000|Overall Study|Other|15|||
16198348|NCT01582971|39201355|FG001|Overall Study|Other|13|||
16198349|NCT01518244|39201356|FG000|Overall Study|Adverse Event|3|||
16198350|NCT01025817|39201361|FG000|Completed Study Medication|Adverse Event|66|||
16198351|NCT01025817|39201362|FG001|Completed Study Medication|Adverse Event|39|||
16198352|NCT01025817|39201361|FG000|Completed Study Medication|Protocol Deviation|9|||
16198353|NCT01025817|39201362|FG001|Completed Study Medication|Protocol Deviation|8|||
16198354|NCT01025817|39201361|FG000|Completed Study Medication|Withdrawal by Subject|8|||
16198355|NCT01025817|39201362|FG001|Completed Study Medication|Withdrawal by Subject|9|||
16198356|NCT01025817|39201361|FG000|Completed Study Medication|Administrative problems|7|||
16198357|NCT01025817|39201362|FG001|Completed Study Medication|Administrative problems|5|||
16198358|NCT01025817|39201361|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
16198359|NCT01025817|39201362|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
16198360|NCT01025817|39201361|FG000|Completed Study Medication|Abnormal test procedure|4|||
16198361|NCT01025817|39201362|FG001|Completed Study Medication|Abnormal test procedure|0|||
16198362|NCT01025817|39201361|FG000|Completed Study Medication|Graft loss|2|||
16198363|NCT01025817|39201362|FG001|Completed Study Medication|Graft loss|5|||
16198364|NCT01025817|39201361|FG000|Completed Study Medication|Death|2|||
16198365|NCT01025817|39201362|FG001|Completed Study Medication|Death|2|||
16198366|NCT01025817|39201361|FG000|Completed Study Medication|Abnormal lab values|0|||
16198367|NCT01025817|39201362|FG001|Completed Study Medication|Abnormal lab values|2|||
16198368|NCT01025817|39201361|FG000|Completed Study Medication|Subject no longer required study drug|0|||
16198369|NCT01025817|39201362|FG001|Completed Study Medication|Subject no longer required study drug|1|||
16198370|NCT01025817|39201361|FG000|Completed Study Medication|Lost to Follow-up|0|||
16198371|NCT01025817|39201362|FG001|Completed Study Medication|Lost to Follow-up|1|||
16198372|NCT01025817|39201361|FG000|Completed Study|Withdrawal by Subject|8|||
16198373|NCT01025817|39201362|FG001|Completed Study|Withdrawal by Subject|16|||
16198374|NCT01025817|39201361|FG000|Completed Study|Death|6|||
16198375|NCT01025817|39201362|FG001|Completed Study|Death|5|||
16198376|NCT01025817|39201361|FG000|Completed Study|Missing|2|||
16198377|NCT01025817|39201362|FG001|Completed Study|Missing|0|||
16198378|NCT01025817|39201361|FG000|Completed Study|Lost to Follow-up|0|||
16314538|NCT02656303|39634077|FG002|Overall Study|Reason not Specified|2|||
16314539|NCT00320710|39634078|FG000|Overall Study|Disease progression|24|||
16314540|NCT00320710|39634079|FG001|Overall Study|Disease progression|19|||
16314541|NCT00320710|39634080|FG002|Overall Study|Disease progression|2|||
16314542|NCT00320710|39634078|FG000|Overall Study|Death|10|||
16314543|NCT00320710|39634079|FG001|Overall Study|Death|7|||
16314544|NCT00320710|39634080|FG002|Overall Study|Death|1|||
16314545|NCT00320710|39634078|FG000|Overall Study|Administrative problems|1|||
16314546|NCT00320710|39634079|FG001|Overall Study|Administrative problems|2|||
16314547|NCT00320710|39634080|FG002|Overall Study|Administrative problems|0|||
16314548|NCT00320710|39634078|FG000|Overall Study|Withdrawal by Subject|20|||
16314549|NCT00320710|39634079|FG001|Overall Study|Withdrawal by Subject|26|||
16314550|NCT00320710|39634080|FG002|Overall Study|Withdrawal by Subject|1|||
16314551|NCT00320710|39634078|FG000|Overall Study|Protocol Violation|6|||
16314552|NCT00320710|39634079|FG001|Overall Study|Protocol Violation|5|||
16314553|NCT00320710|39634080|FG002|Overall Study|Protocol Violation|0|||
16314554|NCT00320710|39634078|FG000|Overall Study|Abnormal test procedure result(s)|2|||
16314555|NCT00320710|39634079|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16314556|NCT00320710|39634080|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16314557|NCT00320710|39634078|FG000|Overall Study|Abnormal laboratory value(s)|12|||
16314558|NCT00320710|39634079|FG001|Overall Study|Abnormal laboratory value(s)|3|||
16314559|NCT00320710|39634080|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16391971|NCT00556439|39919507|FG001|Study Entry to Week 12|Physician Decision|0|||
16391972|NCT00556439|39919508|FG002|Study Entry to Week 12|Physician Decision|0|||
16391973|NCT00556439|39919509|FG003|Study Entry to Week 12|Physician Decision|0|||
16391974|NCT00556439|39919506|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
16391975|NCT00556439|39919507|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
16391976|NCT00556439|39919508|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
16391977|NCT00556439|39919509|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
16198379|NCT01025817|39201362|FG001|Completed Study|Lost to Follow-up|1|||
16198380|NCT01795898|39201363|FG000|Overall Study|Adverse Event|27|||
16198381|NCT01795898|39201363|FG000|Overall Study|Lost to Follow-up|20|||
16314560|NCT00320710|39634078|FG000|Overall Study|Adverse Event|18|||
16314561|NCT00320710|39634079|FG001|Overall Study|Adverse Event|14|||
16314562|NCT00320710|39634080|FG002|Overall Study|Adverse Event|1|||
16391978|NCT00556439|39919506|FG000|Study Entry to Week 12|Recurrent infection|1|||
16391979|NCT00556439|39919507|FG001|Study Entry to Week 12|Recurrent infection|0|||
16391980|NCT00556439|39919508|FG002|Study Entry to Week 12|Recurrent infection|0|||
16198382|NCT01795898|39201363|FG000|Overall Study|Withdrawal of consent|6|||
16314563|NCT00320710|39634078|FG000|Overall Study|Lost to Follow-up|1|||
16314564|NCT00320710|39634079|FG001|Overall Study|Lost to Follow-up|0|||
16314565|NCT00320710|39634080|FG002|Overall Study|Lost to Follow-up|0|||
16314566|NCT00678210|39634081|FG000|Overall Study|Adverse Event|1|||
16314567|NCT00678210|39634082|FG001|Overall Study|Adverse Event|2|||
16314568|NCT00678210|39634083|FG002|Overall Study|Adverse Event|3|||
16314569|NCT00678210|39634084|FG003|Overall Study|Adverse Event|3|||
16314570|NCT00678210|39634081|FG000|Overall Study|Lack of Efficacy|2|||
16314571|NCT00678210|39634082|FG001|Overall Study|Lack of Efficacy|3|||
16314572|NCT00678210|39634083|FG002|Overall Study|Lack of Efficacy|1|||
16314573|NCT00678210|39634084|FG003|Overall Study|Lack of Efficacy|9|||
16314574|NCT00678210|39634081|FG000|Overall Study|Lost to Follow-up|4|||
16314575|NCT00678210|39634082|FG001|Overall Study|Lost to Follow-up|2|||
16314576|NCT00678210|39634083|FG002|Overall Study|Lost to Follow-up|0|||
16314577|NCT00678210|39634084|FG003|Overall Study|Lost to Follow-up|1|||
16314578|NCT00678210|39634081|FG000|Overall Study|Withdrawal by Subject|3|||
16314579|NCT00678210|39634082|FG001|Overall Study|Withdrawal by Subject|4|||
16314580|NCT00678210|39634083|FG002|Overall Study|Withdrawal by Subject|1|||
16314581|NCT00678210|39634084|FG003|Overall Study|Withdrawal by Subject|7|||
16314582|NCT00678210|39634081|FG000|Overall Study|Other|1|||
16314583|NCT00678210|39634082|FG001|Overall Study|Other|0|||
16314584|NCT00678210|39634083|FG002|Overall Study|Other|1|||
16314585|NCT00678210|39634084|FG003|Overall Study|Other|0|||
16314586|NCT01836471|39634085|FG000|Overall Study|Pregnancy|1|||
16314587|NCT01836471|39634086|FG001|Overall Study|Pregnancy|0|||
16314588|NCT01836471|39634087|FG002|Overall Study|Pregnancy|0|||
16314589|NCT01836471|39634088|FG003|Overall Study|Pregnancy|0|||
16314590|NCT01836471|39634089|FG004|Overall Study|Pregnancy|0|||
16314591|NCT01836471|39634085|FG000|Overall Study|Withdrawal by Subject|3|||
16314592|NCT01836471|39634086|FG001|Overall Study|Withdrawal by Subject|4|||
16314593|NCT01836471|39634087|FG002|Overall Study|Withdrawal by Subject|1|||
16314594|NCT01836471|39634088|FG003|Overall Study|Withdrawal by Subject|0|||
16314595|NCT01836471|39634089|FG004|Overall Study|Withdrawal by Subject|2|||
16314596|NCT01836471|39634085|FG000|Overall Study|Physician Decision|0|||
16314597|NCT01836471|39634086|FG001|Overall Study|Physician Decision|1|||
16314598|NCT01836471|39634087|FG002|Overall Study|Physician Decision|0|||
16314599|NCT01836471|39634088|FG003|Overall Study|Physician Decision|0|||
16314600|NCT01836471|39634089|FG004|Overall Study|Physician Decision|0|||
16314601|NCT01836471|39634085|FG000|Overall Study|Lost to Follow-up|0|||
16314602|NCT01836471|39634086|FG001|Overall Study|Lost to Follow-up|0|||
16314603|NCT01836471|39634087|FG002|Overall Study|Lost to Follow-up|0|||
16314604|NCT01836471|39634088|FG003|Overall Study|Lost to Follow-up|1|||
16314605|NCT01836471|39634089|FG004|Overall Study|Lost to Follow-up|1|||
16314606|NCT01836471|39634085|FG000|Overall Study|Adverse Event|6|||
16314607|NCT01836471|39634086|FG001|Overall Study|Adverse Event|3|||
16314608|NCT01836471|39634087|FG002|Overall Study|Adverse Event|1|||
16314609|NCT01836471|39634088|FG003|Overall Study|Adverse Event|1|||
16314610|NCT01836471|39634089|FG004|Overall Study|Adverse Event|2|||
16314611|NCT01836471|39634085|FG000|Overall Study|Non compliance with tx|1|||
16314612|NCT01836471|39634086|FG001|Overall Study|Non compliance with tx|1|||
16314613|NCT01836471|39634087|FG002|Overall Study|Non compliance with tx|0|||
16314614|NCT01836471|39634088|FG003|Overall Study|Non compliance with tx|0|||
16314615|NCT01836471|39634089|FG004|Overall Study|Non compliance with tx|0|||
16314616|NCT02440464|39634090|FG000|Overall Study|Withdrawal by Subject|3|||
16314617|NCT02440464|39634091|FG001|Overall Study|Withdrawal by Subject|2|||
16314618|NCT01808066|39634092|FG000|Overall Study|Withdrawal by Subject|15|||
16314619|NCT02727478|39634093|FG000|Overall Study|Withdrawal by Subject|8|||
16314620|NCT02727478|39634094|FG001|Overall Study|Withdrawal by Subject|10|||
16314621|NCT01415518|39634095|FG000|Overall Study|Withdrawal by Subject|2|||
16314622|NCT01415518|39634096|FG001|Overall Study|Withdrawal by Subject|12|||
16314623|NCT01415518|39634095|FG000|Overall Study|Protocol Violation|6|||
16314624|NCT01415518|39634096|FG001|Overall Study|Protocol Violation|8|||
16314625|NCT01415518|39634095|FG000|Overall Study|Lost to Follow-up|3|||
16314626|NCT01415518|39634096|FG001|Overall Study|Lost to Follow-up|5|||
16314627|NCT01415518|39634095|FG000|Overall Study|Adverse Event|3|||
16198383|NCT01795898|39201363|FG000|Overall Study|Diagnosed with metastasis|1|||
16198384|NCT01795898|39201363|FG000|Overall Study|No pain|1|||
16198385|NCT01795898|39201363|FG000|Overall Study|Death|1|||
16198386|NCT01795898|39201363|FG000|Overall Study|Withdrew consent & had adverse events|3|||
16198387|NCT01795898|39201363|FG000|Overall Study|Physician Decision|1|||
16198388|NCT01895452|39201366|FG000|Overall Study|Adverse Event|1|||
16198389|NCT01895452|39201367|FG001|Overall Study|Adverse Event|4|||
16198390|NCT01895452|39201366|FG000|Overall Study|Lost to Follow-up|1|||
16198391|NCT01895452|39201367|FG001|Overall Study|Lost to Follow-up|5|||
16198392|NCT01895452|39201366|FG000|Overall Study|Pregnancy|0|||
16198393|NCT01895452|39201367|FG001|Overall Study|Pregnancy|1|||
16198394|NCT01895452|39201366|FG000|Overall Study|Withdrawal by Subject|2|||
16198395|NCT01895452|39201367|FG001|Overall Study|Withdrawal by Subject|14|||
16198396|NCT01895452|39201366|FG000|Overall Study|Underlying disease|0|||
16198397|NCT01895452|39201367|FG001|Overall Study|Underlying disease|3|||
16198398|NCT01895452|39201366|FG000|Overall Study|Noncompliance with study drug|0|||
16198399|NCT01895452|39201367|FG001|Overall Study|Noncompliance with study drug|1|||
16198400|NCT04017442|39201368|FG000|Overall Study|Withdrawal by Subject|0|||
16198401|NCT04017442|39201369|FG001|Overall Study|Withdrawal by Subject|3|||
16198402|NCT04017442|39201368|FG000|Overall Study|Lost to Follow-up|21|||
16198403|NCT04017442|39201369|FG001|Overall Study|Lost to Follow-up|19|||
16198404|NCT00254293|39201370|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
16198405|NCT00254293|39201371|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
16198406|NCT00254293|39201372|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
16198407|NCT00254293|39201373|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
16198408|NCT00254293|39201374|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
16198409|NCT00254293|39201375|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
16198410|NCT00254293|39201376|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
16198411|NCT00254293|39201370|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
16198412|NCT00254293|39201371|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
16198413|NCT00254293|39201372|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
16198414|NCT00254293|39201373|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
16198415|NCT00254293|39201374|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
16198416|NCT00254293|39201375|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
16198417|NCT00254293|39201376|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
16198418|NCT00254293|39201370|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
16198419|NCT00254293|39201371|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
16198420|NCT00254293|39201372|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
16198421|NCT00254293|39201373|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
16314628|NCT01415518|39634096|FG001|Overall Study|Adverse Event|4|||
16198422|NCT00254293|39201374|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
16198423|NCT00254293|39201375|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
16314629|NCT01415518|39634095|FG000|Overall Study|Death|1|||
16314630|NCT01415518|39634096|FG001|Overall Study|Death|1|||
16314631|NCT01415518|39634095|FG000|Overall Study|Condition under Investigation Worsened|1|||
16314632|NCT01415518|39634096|FG001|Overall Study|Condition under Investigation Worsened|1|||
16314633|NCT03096314|39634097|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
16314634|NCT03096314|39634098|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
16314635|NCT03361306|39634101|FG000|Overall Study|Death|5|||
16314636|NCT03361306|39634101|FG000|Overall Study|Still On Study (on study treatment)|3|||
16314637|NCT03361306|39634101|FG000|Overall Study|Still On Study (in follow up)|7|||
16314638|NCT01051960|39637148|FG000|Overall Study|Adverse Event|1|||
16509144|NCT03336216|40336410|FG000|Treatment|Participant withdrew consent|7|||
16509145|NCT03336216|40336411|FG001|Treatment|Participant withdrew consent|2|||
16509146|NCT03336216|40336412|FG002|Treatment|Participant withdrew consent|3|||
16509147|NCT03336216|40336413|FG003|Treatment|Participant withdrew consent|2|||
16509148|NCT03336216|40336410|FG000|Treatment|Death|2|||
16509149|NCT03336216|40336411|FG001|Treatment|Death|3|||
16509150|NCT03336216|40336412|FG002|Treatment|Death|3|||
16509151|NCT03336216|40336413|FG003|Treatment|Death|4|||
16509152|NCT03336216|40336410|FG000|Treatment|Participant no longer meets study criteria|0|||
16509153|NCT03336216|40336411|FG001|Treatment|Participant no longer meets study criteria|1|||
16509154|NCT03336216|40336412|FG002|Treatment|Participant no longer meets study criteria|0|||
16509155|NCT03336216|40336413|FG003|Treatment|Participant no longer meets study criteria|0|||
16509156|NCT03336216|40336410|FG000|Treatment|Other reasons|2|||
16509157|NCT03336216|40336411|FG001|Treatment|Other reasons|0|||
16509158|NCT03336216|40336412|FG002|Treatment|Other reasons|0|||
16509159|NCT03336216|40336413|FG003|Treatment|Other reasons|3|||
16509160|NCT03336216|40336410|FG000|Treatment|Disease progression|23|||
16509161|NCT03336216|40336411|FG001|Treatment|Disease progression|34|||
16509162|NCT03336216|40336412|FG002|Treatment|Disease progression|33|||
16509163|NCT03336216|40336413|FG003|Treatment|Disease progression|26|||
16509164|NCT03336216|40336410|FG000|Treatment|Study drug toxicity|0|||
16509165|NCT03336216|40336411|FG001|Treatment|Study drug toxicity|3|||
16198424|NCT00254293|39201376|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
16198425|NCT00254293|39201370|FG000|LTE Open Label Variable SC Dosing|Death|0|||
16198426|NCT00254293|39201371|FG001|LTE Open Label Variable SC Dosing|Death|0|||
16198427|NCT00254293|39201372|FG002|LTE Open Label Variable SC Dosing|Death|1|||
16198428|NCT00254293|39201373|FG003|LTE Open Label Variable SC Dosing|Death|0|||
16198429|NCT00254293|39201374|FG004|LTE Open Label Variable SC Dosing|Death|0|||
16198430|NCT00254293|39201375|FG005|LTE Open Label Variable SC Dosing|Death|0|||
16198431|NCT00254293|39201376|FG006|LTE Open Label Variable SC Dosing|Death|0|||
16198432|NCT00254293|39201370|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
16198433|NCT00254293|39201371|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
16198434|NCT00254293|39201372|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
16198435|NCT00254293|39201373|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
16198436|NCT00254293|39201374|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
16198437|NCT00254293|39201375|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
16198438|NCT00254293|39201376|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
16198439|NCT00254293|39201370|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
16198440|NCT00254293|39201371|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
16198441|NCT00254293|39201372|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
16198442|NCT00254293|39201373|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
16198443|NCT00254293|39201374|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
16198444|NCT00254293|39201375|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
16198445|NCT00254293|39201376|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
16198446|NCT00254293|39201370|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
16198447|NCT00254293|39201371|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
16198448|NCT00254293|39201372|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
16198449|NCT00254293|39201373|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
16198450|NCT00254293|39201374|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
16198451|NCT00254293|39201375|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
16198452|NCT00254293|39201376|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
16198453|NCT00254293|39201370|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
16198454|NCT00254293|39201371|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
16198455|NCT00254293|39201372|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
16198456|NCT00254293|39201373|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
16198457|NCT00254293|39201374|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
16198458|NCT00254293|39201375|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
16198459|NCT00254293|39201376|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
16198460|NCT00254293|39201370|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
16198461|NCT00254293|39201371|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
16198462|NCT00254293|39201372|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
16198463|NCT00254293|39201373|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
16198464|NCT00254293|39201374|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
16198465|NCT00254293|39201375|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
16198466|NCT00254293|39201376|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
16198467|NCT00254293|39201370|FG000|LTE Open Label Variable SC Dosing|Other|0|||
16198468|NCT00254293|39201371|FG001|LTE Open Label Variable SC Dosing|Other|0|||
16198469|NCT00254293|39201372|FG002|LTE Open Label Variable SC Dosing|Other|2|||
16198470|NCT00254293|39201373|FG003|LTE Open Label Variable SC Dosing|Other|0|||
16314639|NCT00703157|39637149|FG000|Overall Study|Lost to Follow-up|0|||
16314640|NCT00703157|39637150|FG001|Overall Study|Lost to Follow-up|1|||
16314641|NCT00703157|39637149|FG000|Overall Study|source data permanently lost/ other|4|||
16314642|NCT00703157|39637150|FG001|Overall Study|source data permanently lost/ other|1|||
16314643|NCT01139775|39637151|FG000|Overall Study|Adverse Event|0|||
16509166|NCT03336216|40336412|FG002|Treatment|Study drug toxicity|2|||
16509167|NCT03336216|40336413|FG003|Treatment|Study drug toxicity|0|||
16198471|NCT00254293|39201374|FG004|LTE Open Label Variable SC Dosing|Other|0|||
16198472|NCT00254293|39201375|FG005|LTE Open Label Variable SC Dosing|Other|0|||
16198473|NCT00254293|39201376|FG006|LTE Open Label Variable SC Dosing|Other|0|||
16198474|NCT00254293|39201370|FG000|LTE Open Label Fixed Dosing|Death|0|||
16198475|NCT00254293|39201371|FG001|LTE Open Label Fixed Dosing|Death|0|||
16198476|NCT00254293|39201372|FG002|LTE Open Label Fixed Dosing|Death|0|||
16198477|NCT00254293|39201373|FG003|LTE Open Label Fixed Dosing|Death|0|||
16198478|NCT00254293|39201374|FG004|LTE Open Label Fixed Dosing|Death|0|||
16198479|NCT00254293|39201375|FG005|LTE Open Label Fixed Dosing|Death|0|||
16198480|NCT00254293|39201376|FG006|LTE Open Label Fixed Dosing|Death|3|||
16198481|NCT00254293|39201370|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
16198482|NCT00254293|39201371|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
16509168|NCT03336216|40336410|FG000|Treatment|Adverse Event unrelated to study drug|1|||
16509169|NCT03336216|40336411|FG001|Treatment|Adverse Event unrelated to study drug|1|||
16314644|NCT01139775|39637152|FG001|Overall Study|Adverse Event|6|||
16314645|NCT01139775|39637153|FG002|Overall Study|Adverse Event|2|||
16509170|NCT03336216|40336412|FG002|Treatment|Adverse Event unrelated to study drug|1|||
16198483|NCT00254293|39201372|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
16198484|NCT00254293|39201373|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
16198485|NCT00254293|39201374|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
16198486|NCT00254293|39201375|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
16198487|NCT00254293|39201376|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
16198488|NCT00254293|39201370|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
16198489|NCT00254293|39201371|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
16198490|NCT00254293|39201372|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
16314646|NCT01139775|39637151|FG000|Overall Study|Protocol Violation|0|||
16314647|NCT01139775|39637152|FG001|Overall Study|Protocol Violation|5|||
16198491|NCT00254293|39201373|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
16314648|NCT01139775|39637153|FG002|Overall Study|Protocol Violation|0|||
16314649|NCT01139775|39637151|FG000|Overall Study|Withdrawal by Subject|1|||
16314650|NCT01139775|39637152|FG001|Overall Study|Withdrawal by Subject|0|||
16314651|NCT01139775|39637153|FG002|Overall Study|Withdrawal by Subject|2|||
16314652|NCT01139775|39637151|FG000|Overall Study|Physician Decision|0|||
16314653|NCT01139775|39637152|FG001|Overall Study|Physician Decision|2|||
16314654|NCT01139775|39637153|FG002|Overall Study|Physician Decision|2|||
16314655|NCT01422889|39637156|FG000|Overall Study|No Data Entered for Study Stent|9|||
16314656|NCT03922308|39637157|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
16314657|NCT03922308|39637158|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
16314658|NCT03922308|39637159|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
16314659|NCT03922308|39637157|FG000|Overall Study|Lost to Follow-up|1|||
16314660|NCT03922308|39637158|FG001|Overall Study|Lost to Follow-up|0|||
16314661|NCT03922308|39637159|FG002|Overall Study|Lost to Follow-up|0|||
16314662|NCT03922308|39637157|FG000|Overall Study|Reason not Specified|0|||
16314663|NCT03922308|39637158|FG001|Overall Study|Reason not Specified|2|||
16314664|NCT03922308|39637159|FG002|Overall Study|Reason not Specified|1|||
16314665|NCT01441765|39637160|FG000|Overall Study|Death|1|||
16314666|NCT01441765|39637161|FG001|Overall Study|Death|0|||
16314667|NCT01753310|39637162|FG000|Overall Study|Entered into open label extension study|25|||
16314668|NCT01753310|39637163|FG001|Overall Study|Entered into open label extension study|22|||
16314669|NCT01753310|39637162|FG000|Overall Study|Adverse Event|1|||
16314670|NCT01753310|39637163|FG001|Overall Study|Adverse Event|0|||
16314671|NCT01753310|39637162|FG000|Overall Study|Lost to Follow-up|2|||
16314672|NCT01753310|39637163|FG001|Overall Study|Lost to Follow-up|0|||
16314673|NCT01753310|39637162|FG000|Overall Study|Subject decision|2|||
16314674|NCT01753310|39637163|FG001|Overall Study|Subject decision|2|||
16314675|NCT01753310|39637162|FG000|Overall Study|Sponsor decision|1|||
16314676|NCT01753310|39637163|FG001|Overall Study|Sponsor decision|0|||
16314677|NCT01753310|39637162|FG000|Overall Study|Withdrawal by Subject|1|||
16314678|NCT01753310|39637163|FG001|Overall Study|Withdrawal by Subject|0|||
16314679|NCT01998919|39637170|FG000|Overall Study|Death|2|||
16314680|NCT01998919|39637171|FG001|Overall Study|Death|2|||
16314681|NCT01998919|39637170|FG000|Overall Study|Adverse Event|0|||
16314682|NCT01998919|39637171|FG001|Overall Study|Adverse Event|5|||
16314683|NCT01998919|39637170|FG000|Overall Study|Disease progression|31|||
16314684|NCT01998919|39637171|FG001|Overall Study|Disease progression|22|||
16314685|NCT01998919|39637170|FG000|Overall Study|Withdrawal by Subject|2|||
16314686|NCT01998919|39637171|FG001|Overall Study|Withdrawal by Subject|4|||
16314687|NCT01998919|39637170|FG000|Overall Study|Lost to Follow-up|2|||
16314688|NCT01998919|39637171|FG001|Overall Study|Lost to Follow-up|0|||
16314689|NCT01998919|39637170|FG000|Overall Study|Other|5|||
16314690|NCT01998919|39637171|FG001|Overall Study|Other|2|||
16314691|NCT03190915|39637172|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
16314692|NCT03190915|39637172|FG000|Overall Study|Progressive Disease|3|||
16314693|NCT01960257|39637176|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
16314694|NCT01960257|39637177|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
16314695|NCT01960257|39637178|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
16314696|NCT01960257|39637176|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
16314697|NCT01960257|39637177|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
16314698|NCT01960257|39637178|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
16314699|NCT01960257|39637176|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
16314700|NCT01960257|39637177|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
16314701|NCT01960257|39637178|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
16314702|NCT03207815|39637179|FG000|Overall Study|Protocol Violation|3|||
16314703|NCT03207815|39637180|FG001|Overall Study|Protocol Violation|1|||
16314704|NCT03207815|39637179|FG000|Overall Study|Adverse Event|1|||
16314705|NCT03207815|39637180|FG001|Overall Study|Adverse Event|2|||
16314706|NCT03207815|39637179|FG000|Overall Study|Lost to Follow-up|1|||
16314707|NCT03207815|39637180|FG001|Overall Study|Lost to Follow-up|2|||
16314708|NCT03207815|39637179|FG000|Overall Study|Investigator's Discretion|1|||
16314709|NCT03207815|39637180|FG001|Overall Study|Investigator's Discretion|1|||
16314710|NCT03207815|39637179|FG000|Overall Study|Lack of Efficacy|0|||
16314711|NCT03207815|39637180|FG001|Overall Study|Lack of Efficacy|1|||
16314712|NCT03207815|39637179|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
16314713|NCT03207815|39637180|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
16314714|NCT03207815|39637179|FG000|Overall Study|Withdrew Consent|1|||
16314715|NCT03207815|39637180|FG001|Overall Study|Withdrew Consent|0|||
16314716|NCT02220764|39637182|FG000|Overall Study|Lost to Follow-up|3|||
16314717|NCT02220764|39637183|FG001|Overall Study|Lost to Follow-up|1|||
16314718|NCT02220764|39637182|FG000|Overall Study|Death|1|||
16314719|NCT02220764|39637183|FG001|Overall Study|Death|0|||
16198492|NCT00254293|39201374|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
16198493|NCT00254293|39201375|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
16198494|NCT00254293|39201376|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
16198495|NCT00254293|39201370|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
16198496|NCT00254293|39201371|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
16198497|NCT00254293|39201372|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
16198498|NCT00254293|39201373|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
16198499|NCT00254293|39201374|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
16198500|NCT00254293|39201375|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
16198501|NCT00254293|39201376|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
16198502|NCT00254293|39201370|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
16314720|NCT00862823|39637184|FG000|First Intervention|Withdrawal by Subject|1|||
16314721|NCT00862823|39637185|FG001|First Intervention|Withdrawal by Subject|1|||
16314722|NCT05000164|39637186|FG000|Overall Study|Adverse Event|1|||
16314723|NCT05000164|39637186|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
16314724|NCT05000164|39637186|FG000|Overall Study|Lens Discomfort|3|||
16314725|NCT05000164|39637186|FG000|Overall Study|Withdrew Consent during Study|2|||
16314726|NCT05000164|39637186|FG000|Overall Study|Subject Withdrawn by PI|2|||
16314727|NCT05000164|39637186|FG000|Overall Study|Other Fractured Test Article|1|||
16314728|NCT01483027|39637187|FG000|Overall Study|Administrative Reasons|2|||
16314729|NCT01483027|39637188|FG001|Overall Study|Administrative Reasons|1|||
16314730|NCT01483027|39637187|FG000|Overall Study|Withdrawal by Subject|21|||
16314731|NCT01483027|39637188|FG001|Overall Study|Withdrawal by Subject|32|||
16314732|NCT01483027|39637187|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
16314733|NCT01483027|39637188|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
16314734|NCT01483027|39637187|FG000|Overall Study|Lost to Follow-up|1|||
16314735|NCT01483027|39637188|FG001|Overall Study|Lost to Follow-up|1|||
16314736|NCT01483027|39637187|FG000|Overall Study|Adverse Event|0|||
16314737|NCT01483027|39637188|FG001|Overall Study|Adverse Event|1|||
16314738|NCT01483027|39637187|FG000|Overall Study|Withdrawal by Subject|0|||
16314739|NCT01483027|39637188|FG001|Overall Study|Withdrawal by Subject|1|||
16314740|NCT00683618|39637189|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
16314741|NCT00683618|39637190|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
16314742|NCT00683618|39637191|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
16314743|NCT00683618|39637189|FG000|Randomised Treatment Period|Protocol Violation|0|||
16314744|NCT00683618|39637190|FG001|Randomised Treatment Period|Protocol Violation|1|||
16314745|NCT00683618|39637191|FG002|Randomised Treatment Period|Protocol Violation|0|||
16314746|NCT00683618|39637189|FG000|Randomised Treatment Period|Adverse Event|2|||
16314747|NCT00683618|39637190|FG001|Randomised Treatment Period|Adverse Event|0|||
16314748|NCT00683618|39637191|FG002|Randomised Treatment Period|Adverse Event|2|||
16314749|NCT00683618|39637189|FG000|Randomised Treatment Period|Reason not provided|0|||
16314750|NCT00683618|39637190|FG001|Randomised Treatment Period|Reason not provided|0|||
16314751|NCT00683618|39637191|FG002|Randomised Treatment Period|Reason not provided|2|||
16314752|NCT00683618|39637189|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
16509171|NCT03336216|40336413|FG003|Treatment|Adverse Event unrelated to study drug|0|||
16509172|NCT03336216|40336410|FG000|Treatment|Disease Recurrence|1|||
16509173|NCT03336216|40336411|FG001|Treatment|Disease Recurrence|0|||
16509174|NCT03336216|40336412|FG002|Treatment|Disease Recurrence|0|||
16509175|NCT03336216|40336413|FG003|Treatment|Disease Recurrence|0|||
16509176|NCT02529137|40336414|FG000|Overall Study|Discontinuation for different reasons|8|||
16509177|NCT05620576|40336416|FG000|Overall Study|Adverse Event|1|||
16509178|NCT05620576|40336417|FG001|Overall Study|Adverse Event|1|||
16509179|NCT05620576|40336416|FG000|Overall Study|Lost to Follow-up|3|||
16509180|NCT05620576|40336417|FG001|Overall Study|Lost to Follow-up|1|||
16509181|NCT05620576|40336416|FG000|Overall Study|Physician Decision|0|||
16509182|NCT05620576|40336417|FG001|Overall Study|Physician Decision|1|||
16509183|NCT05620576|40336416|FG000|Overall Study|Protocol Deviation|1|||
16509184|NCT05620576|40336417|FG001|Overall Study|Protocol Deviation|1|||
16198503|NCT00254293|39201371|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
16314753|NCT00683618|39637190|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
16314754|NCT00683618|39637191|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
16314755|NCT00683618|39637189|FG000|Extension Treatment Period|Adverse Event|1|||
16314756|NCT00683618|39637190|FG001|Extension Treatment Period|Adverse Event|0|||
16314757|NCT00683618|39637191|FG002|Extension Treatment Period|Adverse Event|0|||
16314758|NCT00683618|39637189|FG000|Extension Treatment Period|Protocol Violation|1|||
16509185|NCT05620576|40336416|FG000|Overall Study|Withdrawal by Subject|2|||
16509186|NCT05620576|40336417|FG001|Overall Study|Withdrawal by Subject|3|||
16314759|NCT00683618|39637190|FG001|Extension Treatment Period|Protocol Violation|0|||
16314760|NCT00683618|39637191|FG002|Extension Treatment Period|Protocol Violation|0|||
16314761|NCT00105079|39637192|FG000|Overall Study|Adverse Event|5|||
16314762|NCT00105079|39637193|FG001|Overall Study|Adverse Event|12|||
16314763|NCT00105079|39637192|FG000|Overall Study|Death|3|||
16314764|NCT00105079|39637193|FG001|Overall Study|Death|1|||
16314765|NCT00105079|39637192|FG000|Overall Study|Lost to Follow-up|12|||
16314766|NCT00105079|39637193|FG001|Overall Study|Lost to Follow-up|12|||
16314767|NCT00105079|39637192|FG000|Overall Study|Lack of Efficacy|9|||
16314768|NCT00105079|39637193|FG001|Overall Study|Lack of Efficacy|3|||
16314769|NCT00105079|39637192|FG000|Overall Study|Refused treatment|6|||
16314770|NCT00105079|39637193|FG001|Overall Study|Refused treatment|4|||
16314771|NCT00105079|39637192|FG000|Overall Study|Violation of selection criteria at entry|0|||
16314772|NCT00105079|39637193|FG001|Overall Study|Violation of selection criteria at entry|2|||
16314773|NCT00105079|39637192|FG000|Overall Study|Protocol Violation|1|||
16314774|NCT00105079|39637193|FG001|Overall Study|Protocol Violation|0|||
16509187|NCT01660412|40336418|FG000|Overall Study|Protocol Violation|0|||
16509188|NCT01660412|40336419|FG001|Overall Study|Protocol Violation|3|||
16314775|NCT00105079|39637192|FG000|Overall Study|Other|3|||
16314776|NCT00105079|39637193|FG001|Overall Study|Other|1|||
16314777|NCT00778817|39637194|FG000|Overall Study|Adverse Event|2|||
16314778|NCT00778817|39637194|FG000|Overall Study|Withdrawal by Subject|2|||
16314779|NCT01051791|39637195|FG000|Overall Study|Failed screening|3|||
16314780|NCT01051791|39637195|FG000|Overall Study|Withdrawal by Subject|1|||
16314781|NCT02418182|39637197|FG000|Overall Study|Unable to re-consent|18|||
16314782|NCT02418182|39637198|FG001|Overall Study|Unable to re-consent|15|||
16314783|NCT02418182|39637197|FG000|Overall Study|Lost to Follow-up|0|||
16314784|NCT02418182|39637198|FG001|Overall Study|Lost to Follow-up|2|||
16314785|NCT00767455|39637199|FG000|Overall Study|Investigator error|19|||
16314786|NCT02548143|39637200|FG000|Overall Study|Adverse Event|1|||
16314787|NCT02548143|39637201|FG001|Overall Study|Adverse Event|0|||
16314788|NCT02548143|39637200|FG000|Overall Study|Withdrawal by Subject|0|||
16314789|NCT02548143|39637201|FG001|Overall Study|Withdrawal by Subject|1|||
16314790|NCT01113892|39637207|FG000|Overall Study|Lost to Follow-up|2|||
16314791|NCT01113892|39637208|FG001|Overall Study|Lost to Follow-up|2|||
16314792|NCT01113892|39637207|FG000|Overall Study|Withdrawal by Subject|1|||
16314793|NCT01113892|39637208|FG001|Overall Study|Withdrawal by Subject|1|||
16314794|NCT01113892|39637207|FG000|Overall Study|Death|2|||
16314795|NCT01113892|39637208|FG001|Overall Study|Death|4|||
16314796|NCT01113892|39637207|FG000|Overall Study|Graft no longer evaluable|9|||
16314797|NCT01113892|39637208|FG001|Overall Study|Graft no longer evaluable|9|||
16314798|NCT00764660|39637209|FG000|Overall Study|Adverse Event|6|||
16314799|NCT00764660|39637210|FG001|Overall Study|Adverse Event|3|||
16314800|NCT00764660|39637209|FG000|Overall Study|Lost to Follow-up|3|||
16314801|NCT00764660|39637210|FG001|Overall Study|Lost to Follow-up|4|||
16314802|NCT00764660|39637209|FG000|Overall Study|Withdrawal by Subject|7|||
16314803|NCT00764660|39637210|FG001|Overall Study|Withdrawal by Subject|3|||
16314804|NCT00764660|39637209|FG000|Overall Study|Noncompliance With Protocol|5|||
16314805|NCT00764660|39637210|FG001|Overall Study|Noncompliance With Protocol|1|||
16314806|NCT00764660|39637209|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
16314807|NCT00764660|39637210|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
16314808|NCT02841995|39637213|FG000|Overall Study|Disease progression|5|||
16314809|NCT02841995|39637214|FG001|Overall Study|Disease progression|11|||
16314810|NCT02841995|39637215|FG002|Overall Study|Disease progression|8|||
16509189|NCT00606892|40336420|FG000|First Intervention|Protocol Violation|1|||
16509190|NCT00606892|40336421|FG001|First Intervention|Protocol Violation|4|||
16509191|NCT03385239|40336422|FG000|Overall Study|Voluntary Withdrawal|2|||
16509192|NCT03385239|40336423|FG001|Overall Study|Voluntary Withdrawal|3|||
16314811|NCT02841995|39637213|FG000|Overall Study|Withdrawal by Subject|2|||
16314812|NCT02841995|39637214|FG001|Overall Study|Withdrawal by Subject|4|||
16314813|NCT02841995|39637215|FG002|Overall Study|Withdrawal by Subject|4|||
16314814|NCT02841995|39637213|FG000|Overall Study|Adverse Event|2|||
16314815|NCT02841995|39637214|FG001|Overall Study|Adverse Event|0|||
16314816|NCT02841995|39637215|FG002|Overall Study|Adverse Event|1|||
16314817|NCT02841995|39637213|FG000|Overall Study|Investigator decision|2|||
16314818|NCT02841995|39637214|FG001|Overall Study|Investigator decision|0|||
16314819|NCT02841995|39637215|FG002|Overall Study|Investigator decision|1|||
16314820|NCT02841995|39637213|FG000|Overall Study|Death|0|||
16314821|NCT02841995|39637214|FG001|Overall Study|Death|0|||
16314822|NCT02841995|39637215|FG002|Overall Study|Death|2|||
16314823|NCT02841995|39637213|FG000|Overall Study|Noncompliance to protocol|1|||
16314824|NCT02841995|39637214|FG001|Overall Study|Noncompliance to protocol|0|||
16314825|NCT02841995|39637215|FG002|Overall Study|Noncompliance to protocol|0|||
16314826|NCT02841995|39637213|FG000|Overall Study|Sponsor decision|1|||
16314827|NCT02841995|39637214|FG001|Overall Study|Sponsor decision|0|||
16314828|NCT02841995|39637215|FG002|Overall Study|Sponsor decision|0|||
16314829|NCT02841995|39637213|FG000|Overall Study|Other|4|||
16314830|NCT02841995|39637214|FG001|Overall Study|Other|1|||
16509193|NCT03385239|40336424|FG002|Overall Study|Voluntary Withdrawal|2|||
16314831|NCT02841995|39637215|FG002|Overall Study|Other|5|||
16314832|NCT01954056|39637216|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
16314833|NCT01954056|39637217|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
16314834|NCT03472014|39637218|FG000|Overall Study|Lost to Follow-up|4|||
16314835|NCT01930162|39637219|FG000|Overall Study|Abnormal test procedure result(s)|4|||
16314836|NCT01930162|39637219|FG000|Overall Study|Death|1|||
16314837|NCT03150719|39637220|FG000|Overall Study|Adverse Event|0|||
16391981|NCT00556439|39919509|FG003|Study Entry to Week 12|Recurrent infection|0|||
16391982|NCT00556439|39919506|FG000|Study Entry to Week 12|Malignancy|0|||
16391983|NCT00556439|39919507|FG001|Study Entry to Week 12|Malignancy|0|||
16391984|NCT00556439|39919508|FG002|Study Entry to Week 12|Malignancy|1|||
16391985|NCT00556439|39919509|FG003|Study Entry to Week 12|Malignancy|0|||
16391986|NCT00556439|39919506|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
16391987|NCT00556439|39919507|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
16391988|NCT00556439|39919508|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
16391989|NCT00556439|39919509|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
16391990|NCT00556439|39919506|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
16391991|NCT00556439|39919507|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
16391992|NCT00556439|39919508|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
16391993|NCT00556439|39919509|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
16391994|NCT00556439|39919506|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
16391995|NCT00556439|39919507|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
16391996|NCT00556439|39919508|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
16391997|NCT00556439|39919509|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
16391998|NCT00556439|39919506|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
16391999|NCT00556439|39919507|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
16392000|NCT00556439|39919508|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
16392001|NCT00556439|39919509|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
16392002|NCT03592771|39919512|FG000|Overall Study|Adverse Event|2|||
16392003|NCT03592771|39919513|FG001|Overall Study|Adverse Event|0|||
16392004|NCT03592771|39919514|FG002|Overall Study|Adverse Event|1|||
16392005|NCT03592771|39919512|FG000|Overall Study|Death|0|||
16392006|NCT03592771|39919513|FG001|Overall Study|Death|1|||
16392007|NCT03592771|39919514|FG002|Overall Study|Death|1|||
16392008|NCT03592771|39919512|FG000|Overall Study|Lost to Follow-up|5|||
16392009|NCT03592771|39919513|FG001|Overall Study|Lost to Follow-up|11|||
16392010|NCT03592771|39919514|FG002|Overall Study|Lost to Follow-up|15|||
16392011|NCT03592771|39919512|FG000|Overall Study|Withdrawal by Subject|0|||
16392012|NCT03592771|39919513|FG001|Overall Study|Withdrawal by Subject|2|||
16392013|NCT03592771|39919514|FG002|Overall Study|Withdrawal by Subject|0|||
16392014|NCT01206140|39919521|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
16392015|NCT01206140|39919522|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
16314838|NCT03150719|39637221|FG001|Overall Study|Adverse Event|1|||
16314839|NCT03150719|39637220|FG000|Overall Study|Death|0|||
16314840|NCT03150719|39637221|FG001|Overall Study|Death|1|||
16314841|NCT03150719|39637220|FG000|Overall Study|Other|1|||
16314842|NCT03150719|39637221|FG001|Overall Study|Other|0|||
16314843|NCT01420068|39637222|FG000|Overall Study|Administrative problems|1|||
16314844|NCT01420068|39637223|FG001|Overall Study|Administrative problems|3|||
16392016|NCT03902392|39919526|FG000|Overall Study|Lost to Follow-up|7|||
16392017|NCT03902392|39919527|FG001|Overall Study|Lost to Follow-up|7|||
16392018|NCT03484429|39919528|FG000|Overall Study|Withdrawal by Subject|1|||
16392019|NCT03484429|39919529|FG001|Overall Study|Withdrawal by Subject|0|||
16314845|NCT01420068|39637222|FG000|Overall Study|Withdrawal by Subject|1|||
16392020|NCT03484429|39919528|FG000|Overall Study|Adverse Event|2|||
16392021|NCT03484429|39919529|FG001|Overall Study|Adverse Event|0|||
16392022|NCT00784368|39919530|FG000|Overall Study|Physician Decision|0|||
16392023|NCT00784368|39919531|FG001|Overall Study|Physician Decision|0|||
16392024|NCT00784368|39919532|FG002|Overall Study|Physician Decision|6|||
16314846|NCT01420068|39637223|FG001|Overall Study|Withdrawal by Subject|2|||
16314847|NCT01422213|39637227|FG000|Overall Study|Adverse Event|8|||
16392025|NCT00784368|39919530|FG000|Overall Study|Lack of Efficacy|2|||
16314848|NCT01422213|39637228|FG001|Overall Study|Adverse Event|7|||
16314849|NCT01422213|39637229|FG002|Overall Study|Adverse Event|11|||
16314850|NCT01422213|39637227|FG000|Overall Study|Lack of Efficacy|10|||
16314851|NCT01422213|39637228|FG001|Overall Study|Lack of Efficacy|2|||
16314852|NCT01422213|39637229|FG002|Overall Study|Lack of Efficacy|2|||
16314853|NCT01422213|39637227|FG000|Overall Study|Non-compliance with study drug|0|||
16314854|NCT01422213|39637228|FG001|Overall Study|Non-compliance with study drug|1|||
16314855|NCT01422213|39637229|FG002|Overall Study|Non-compliance with study drug|0|||
16314856|NCT01422213|39637227|FG000|Overall Study|Protocol Violation|0|||
16314857|NCT01422213|39637228|FG001|Overall Study|Protocol Violation|2|||
16314858|NCT01422213|39637229|FG002|Overall Study|Protocol Violation|4|||
16314859|NCT01422213|39637227|FG000|Overall Study|Withdrawal of Consent|7|||
16314860|NCT01422213|39637228|FG001|Overall Study|Withdrawal of Consent|3|||
16314861|NCT01422213|39637229|FG002|Overall Study|Withdrawal of Consent|5|||
16314862|NCT01422213|39637227|FG000|Overall Study|Lost to Follow-up|3|||
16314863|NCT01422213|39637228|FG001|Overall Study|Lost to Follow-up|3|||
16314864|NCT01422213|39637229|FG002|Overall Study|Lost to Follow-up|5|||
16314865|NCT01422213|39637227|FG000|Overall Study|Administrative or Other Reason(s)|5|||
16314866|NCT01422213|39637228|FG001|Overall Study|Administrative or Other Reason(s)|4|||
16314867|NCT01422213|39637229|FG002|Overall Study|Administrative or Other Reason(s)|2|||
16314868|NCT02801617|39637232|FG000|Overall Study|Protocol Violation|2|||
16314869|NCT02801617|39637233|FG001|Overall Study|Protocol Violation|6|||
16314870|NCT00897715|39637234|FG000|Overall Study|Lost to Follow-up|0|||
16314871|NCT00897715|39637235|FG001|Overall Study|Lost to Follow-up|1|||
16314872|NCT00897715|39637234|FG000|Overall Study|Physician Decision|1|||
16314873|NCT00897715|39637235|FG001|Overall Study|Physician Decision|0|||
16314874|NCT00897715|39637234|FG000|Overall Study|increased risk of infection|1|||
16314875|NCT00897715|39637235|FG001|Overall Study|increased risk of infection|0|||
16314876|NCT03382834|39637236|FG000|Step 1|Lost to Follow-up|0|||
16314877|NCT03382834|39637237|FG001|Step 1|Lost to Follow-up|1|||
16314878|NCT03382834|39637236|FG000|Step 2|Death|1|||
16314879|NCT03382834|39637237|FG001|Step 2|Death|0|||
16314880|NCT03382834|39637236|FG000|Step 2|Lost to Follow-up|2|||
16314881|NCT03382834|39637237|FG001|Step 2|Lost to Follow-up|2|||
16314882|NCT03382834|39637236|FG000|Step 2|Site Terminated by Sponsor|1|||
16314883|NCT03382834|39637237|FG001|Step 2|Site Terminated by Sponsor|0|||
16314884|NCT03652051|39637240|FG000|Stage 1|Adverse Event|0|||
16314885|NCT03652051|39637241|FG001|Stage 1|Adverse Event|5|||
16314886|NCT03652051|39637242|FG002|Stage 1|Adverse Event|7|||
16314887|NCT03652051|39637243|FG003|Stage 1|Adverse Event|1|||
16314888|NCT03652051|39637240|FG000|Stage 1|Withdrawal by Subject|0|||
16314889|NCT03652051|39637241|FG001|Stage 1|Withdrawal by Subject|0|||
16314890|NCT03652051|39637242|FG002|Stage 1|Withdrawal by Subject|1|||
16509194|NCT03385239|40336425|FG003|Overall Study|Voluntary Withdrawal|3|||
16509195|NCT03385239|40336426|FG004|Overall Study|Voluntary Withdrawal|0|||
16509196|NCT03385239|40336422|FG000|Overall Study|Adverse Event|0|||
16509197|NCT03385239|40336423|FG001|Overall Study|Adverse Event|0|||
16509198|NCT03385239|40336424|FG002|Overall Study|Adverse Event|1|||
16509199|NCT03385239|40336425|FG003|Overall Study|Adverse Event|0|||
16509200|NCT03385239|40336426|FG004|Overall Study|Adverse Event|0|||
16509201|NCT03385239|40336422|FG000|Overall Study|Other|0|||
16314891|NCT03652051|39637243|FG003|Stage 1|Withdrawal by Subject|0|||
16314892|NCT03652051|39637240|FG000|Stage 2|Adverse Event|0|||
16314893|NCT03652051|39637241|FG001|Stage 2|Adverse Event|2|||
16314894|NCT03652051|39637242|FG002|Stage 2|Adverse Event|1|||
16314895|NCT03652051|39637243|FG003|Stage 2|Adverse Event|0|||
16314896|NCT03652051|39637240|FG000|Stage 2|Protocol Violation|0|||
16314897|NCT03652051|39637241|FG001|Stage 2|Protocol Violation|1|||
16314898|NCT03652051|39637242|FG002|Stage 2|Protocol Violation|6|||
16314899|NCT03652051|39637243|FG003|Stage 2|Protocol Violation|0|||
16509202|NCT03385239|40336423|FG001|Overall Study|Other|0|||
16509203|NCT03385239|40336424|FG002|Overall Study|Other|0|||
16509204|NCT03385239|40336425|FG003|Overall Study|Other|1|||
16509205|NCT03385239|40336426|FG004|Overall Study|Other|0|||
16509206|NCT00747435|40336430|FG000|Overall Study|Lost to Follow-up|2|||
16509207|NCT00747435|40336430|FG000|Overall Study|Withdrawal by Subject|3|||
16509208|NCT00747435|40336430|FG000|Overall Study|Still undergoing follow up|1|||
16509209|NCT01275066|40336431|FG000|Overall Study|Withdrawal by Subject|0|||
16509210|NCT01275066|40336432|FG001|Overall Study|Withdrawal by Subject|0|||
16509211|NCT01275066|40336433|FG002|Overall Study|Withdrawal by Subject|1|||
16509212|NCT01275066|40336431|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
16509213|NCT01275066|40336432|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
16509214|NCT01275066|40336433|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
16509215|NCT02268409|40336434|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
16509216|NCT02268409|40336434|FG000|Overall Study|Death|1|||
16509217|NCT02268409|40336434|FG000|Overall Study|Lost to Follow-up|1|||
16509218|NCT02268409|40336434|FG000|Overall Study|Protocol Violation|3|||
16509219|NCT02268409|40336434|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
16509220|NCT02268409|40336434|FG000|Overall Study|Withdrawal by Subject|5|||
16509221|NCT00477672|40336435|FG000|Overall Study|Adverse Event|3|||
16509222|NCT00477672|40336436|FG001|Overall Study|Adverse Event|5|||
16509223|NCT00477672|40336437|FG002|Overall Study|Adverse Event|6|||
16509224|NCT00477672|40336435|FG000|Overall Study|Death|0|||
16509225|NCT00477672|40336436|FG001|Overall Study|Death|1|||
16509226|NCT00477672|40336437|FG002|Overall Study|Death|0|||
16509227|NCT00477672|40336435|FG000|Overall Study|Disease progression|0|||
16509228|NCT00477672|40336436|FG001|Overall Study|Disease progression|1|||
16509229|NCT00477672|40336437|FG002|Overall Study|Disease progression|0|||
16509230|NCT00477672|40336435|FG000|Overall Study|Physician Decision|1|||
16509231|NCT00477672|40336436|FG001|Overall Study|Physician Decision|0|||
16509232|NCT00477672|40336437|FG002|Overall Study|Physician Decision|0|||
16509233|NCT00477672|40336435|FG000|Overall Study|Protocol noncompliance|0|||
16509234|NCT00477672|40336436|FG001|Overall Study|Protocol noncompliance|2|||
16314900|NCT03652051|39637240|FG000|Stage 2|Lost to Follow-up|0|||
16314901|NCT03652051|39637241|FG001|Stage 2|Lost to Follow-up|2|||
16314902|NCT03652051|39637242|FG002|Stage 2|Lost to Follow-up|0|||
16314903|NCT03652051|39637243|FG003|Stage 2|Lost to Follow-up|3|||
16314904|NCT03652051|39637240|FG000|Stage 2|Withdrawal by Subject|0|||
16314905|NCT03652051|39637241|FG001|Stage 2|Withdrawal by Subject|11|||
16314906|NCT03652051|39637242|FG002|Stage 2|Withdrawal by Subject|9|||
16314907|NCT03652051|39637243|FG003|Stage 2|Withdrawal by Subject|3|||
16314908|NCT04762160|39637244|FG000|Overall Study|Study terminated early due to business reasons|5|||
16392026|NCT00784368|39919531|FG001|Overall Study|Lack of Efficacy|0|||
16509235|NCT00477672|40336437|FG002|Overall Study|Protocol noncompliance|0|||
16509236|NCT00477672|40336435|FG000|Overall Study|Consent withdrawn|2|||
16509237|NCT00477672|40336436|FG001|Overall Study|Consent withdrawn|5|||
16314909|NCT01343043|39637245|FG000|Overall Study|Disease progression before treatment|1|||
16314910|NCT01343043|39637246|FG001|Overall Study|Disease progression before treatment|0|||
16314911|NCT01343043|39637247|FG002|Overall Study|Disease progression before treatment|0|||
16314912|NCT01343043|39637248|FG003|Overall Study|Disease progression before treatment|0|||
16314913|NCT01343043|39637245|FG000|Overall Study|Withdrawal by Subject|1|||
16314914|NCT01343043|39637246|FG001|Overall Study|Withdrawal by Subject|0|||
16314915|NCT01343043|39637247|FG002|Overall Study|Withdrawal by Subject|0|||
16314916|NCT01343043|39637248|FG003|Overall Study|Withdrawal by Subject|0|||
16314917|NCT01343043|39637245|FG000|Overall Study|Death|1|||
16314918|NCT01343043|39637246|FG001|Overall Study|Death|1|||
16314919|NCT01343043|39637247|FG002|Overall Study|Death|0|||
16314920|NCT01343043|39637248|FG003|Overall Study|Death|1|||
16314921|NCT00752128|39637249|FG000|Overall Study|Withdrawal by Subject|4|||
16314922|NCT03620708|39637250|FG000|Overall Study|Lost to Follow-up|1|||
16314923|NCT03620708|39637251|FG001|Overall Study|Lost to Follow-up|1|||
16314924|NCT03620708|39637252|FG002|Overall Study|Lost to Follow-up|2|||
16314925|NCT03620708|39637250|FG000|Overall Study|Withdrawal by Subject|0|||
16314926|NCT03620708|39637251|FG001|Overall Study|Withdrawal by Subject|0|||
16314927|NCT03620708|39637252|FG002|Overall Study|Withdrawal by Subject|1|||
16314928|NCT00461630|39637253|FG000|Overall Study|Death|798|||
16314929|NCT00461630|39637254|FG001|Overall Study|Death|732|||
16314930|NCT00461630|39637253|FG000|Overall Study|Lost to Follow-up|108|||
16314931|NCT00461630|39637254|FG001|Overall Study|Lost to Follow-up|95|||
16314932|NCT00460811|39637255|FG000|Overall Study|Adverse Event|4|||
16314933|NCT00460811|39637256|FG001|Overall Study|Adverse Event|6|||
16314934|NCT00460811|39637257|FG002|Overall Study|Adverse Event|3|||
16314935|NCT00460811|39637258|FG003|Overall Study|Adverse Event|10|||
16314936|NCT00460811|39637259|FG004|Overall Study|Adverse Event|2|||
16314937|NCT00460811|39637255|FG000|Overall Study|Noncompliance|1|||
16314938|NCT00460811|39637256|FG001|Overall Study|Noncompliance|0|||
16314939|NCT00460811|39637257|FG002|Overall Study|Noncompliance|0|||
16314940|NCT00460811|39637258|FG003|Overall Study|Noncompliance|2|||
16314941|NCT00460811|39637259|FG004|Overall Study|Noncompliance|1|||
16314942|NCT00460811|39637255|FG000|Overall Study|Withdrawal by Subject|7|||
16314943|NCT00460811|39637256|FG001|Overall Study|Withdrawal by Subject|7|||
16314944|NCT00460811|39637257|FG002|Overall Study|Withdrawal by Subject|6|||
16314945|NCT00460811|39637258|FG003|Overall Study|Withdrawal by Subject|3|||
16314946|NCT00460811|39637259|FG004|Overall Study|Withdrawal by Subject|11|||
16314947|NCT00460811|39637255|FG000|Overall Study|Physician Decision|1|||
16314948|NCT00460811|39637256|FG001|Overall Study|Physician Decision|0|||
16314949|NCT00460811|39637257|FG002|Overall Study|Physician Decision|0|||
16314950|NCT00460811|39637258|FG003|Overall Study|Physician Decision|0|||
16314951|NCT00460811|39637259|FG004|Overall Study|Physician Decision|0|||
16314952|NCT00460811|39637255|FG000|Overall Study|Lost to Follow-up|3|||
16314953|NCT00460811|39637256|FG001|Overall Study|Lost to Follow-up|2|||
16314954|NCT00460811|39637257|FG002|Overall Study|Lost to Follow-up|5|||
16314955|NCT00460811|39637258|FG003|Overall Study|Lost to Follow-up|3|||
16314956|NCT00460811|39637259|FG004|Overall Study|Lost to Follow-up|6|||
16314957|NCT03511105|39637260|FG000|Overall Study|Adverse Event|1|||
16314958|NCT03511105|39637261|FG001|Overall Study|Adverse Event|0|||
16314959|NCT03511105|39637260|FG000|Overall Study|Withdrew consent|1|||
16314960|NCT03511105|39637261|FG001|Overall Study|Withdrew consent|0|||
16314961|NCT01167140|39637262|FG000|Overall Study|Withdrawal by Subject|1|||
16314962|NCT00615550|39637263|FG000|Overall Study|Lost to Follow-up|6|||
16314963|NCT00615550|39637264|FG001|Overall Study|Lost to Follow-up|1|||
16314964|NCT01567462|39637265|FG000|Overall Study|Withdrawal by Subject|4|||
16314965|NCT01567462|39637266|FG001|Overall Study|Withdrawal by Subject|7|||
16314966|NCT02042014|39637267|FG000|Overall Study|Adverse Event|1|||
16314967|NCT02042014|39637267|FG000|Overall Study|Physician Decision|7|||
16314968|NCT00858273|39637268|FG000|Overall Study|Protocol Violation|3|||
16314969|NCT00858273|39637269|FG001|Overall Study|Protocol Violation|5|||
16314970|NCT01100086|39637273|FG000|Period 1|Withdrawal by Subject|1|||
16314971|NCT01100086|39637274|FG001|Period 1|Withdrawal by Subject|0|||
16314972|NCT01234350|39637275|FG000|Overall Study|Adverse Event|277|||
16314973|NCT01234350|39637276|FG001|Overall Study|Adverse Event|92|||
16314974|NCT01234350|39637275|FG000|Overall Study|Withdrawal by Subject|61|||
16314975|NCT01234350|39637276|FG001|Overall Study|Withdrawal by Subject|36|||
16314976|NCT01234350|39637275|FG000|Overall Study|Lost to Follow-up|115|||
16314977|NCT01234350|39637276|FG001|Overall Study|Lost to Follow-up|47|||
16314978|NCT01234350|39637275|FG000|Overall Study|Covers a diverse set of reasons|234|||
16392027|NCT00784368|39919532|FG002|Overall Study|Lack of Efficacy|1|||
16314979|NCT01234350|39637276|FG001|Overall Study|Covers a diverse set of reasons|92|||
16314980|NCT03762265|39637277|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
16314981|NCT03762265|39637278|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
16314982|NCT03762265|39637277|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
16314983|NCT03762265|39637278|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
16314984|NCT03762265|39637277|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
16314985|NCT03762265|39637278|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
16314986|NCT03762265|39637277|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
16314987|NCT03762265|39637278|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
16314988|NCT03762265|39637277|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
16314989|NCT03762265|39637278|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
16314990|NCT03762265|39637277|FG000|BT Period: Weeks 1 to 37|Other|0|||
16314991|NCT03762265|39637278|FG001|BT Period: Weeks 1 to 37|Other|1|||
16314992|NCT03762265|39637277|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
16314993|NCT03762265|39637278|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
16314994|NCT03762265|39637277|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
16314995|NCT03762265|39637278|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
16314996|NCT03762265|39637277|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
16314997|NCT03762265|39637278|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
16314998|NCT03762265|39637277|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
16314999|NCT03762265|39637278|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
16315000|NCT03762265|39637277|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
16315001|NCT03762265|39637278|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
16315002|NCT03762265|39637277|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
16315003|NCT03762265|39637278|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
16315004|NCT03762265|39637277|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
16315005|NCT03762265|39637278|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
16315006|NCT03762265|39637277|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
16315007|NCT03762265|39637278|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
16315008|NCT03762265|39637277|FG000|LTE Period: Weeks 61 to 109|Other|1|||
16315009|NCT03762265|39637278|FG001|LTE Period: Weeks 61 to 109|Other|0|||
16315010|NCT00696423|39637279|FG000|Overall Study|Lost to Follow-up|0|||
16315011|NCT00696423|39637280|FG001|Overall Study|Lost to Follow-up|5|||
16315012|NCT01697748|39637281|FG000|Overall Study|ineligible skin incision|1|||
16315013|NCT01697748|39637282|FG001|Overall Study|ineligible skin incision|2|||
16315014|NCT01697748|39637281|FG000|Overall Study|ineligible uterine incision|4|||
16315015|NCT01697748|39637282|FG001|Overall Study|ineligible uterine incision|1|||
16315016|NCT01697748|39637281|FG000|Overall Study|Lost to Follow-up|53|||
16315017|NCT01697748|39637282|FG001|Overall Study|Lost to Follow-up|65|||
16315018|NCT02314026|39637285|FG000|Overall Study|Protocol Violation|28|||
16315019|NCT01956773|39637286|FG000|Overall Study|Lost to Follow-up|628|||
16315020|NCT01956773|39637287|FG001|Overall Study|Lost to Follow-up|1|||
16315021|NCT02623725|39637288|FG000|Overall Study|Non compliance with protocol|9|||
16315022|NCT02623725|39637289|FG001|Overall Study|Non compliance with protocol|3|||
16315023|NCT02623725|39637288|FG000|Overall Study|Serious adverse event|0|||
16315024|NCT02623725|39637289|FG001|Overall Study|Serious adverse event|2|||
16315025|NCT02623725|39637288|FG000|Overall Study|Withdrawal by Subject|7|||
16315026|NCT02623725|39637289|FG001|Overall Study|Withdrawal by Subject|1|||
16315027|NCT01965860|39637290|FG000|Overall Study|Pregnancy|1|||
16315028|NCT01965860|39637291|FG001|Overall Study|Pregnancy|0|||
16315029|NCT01965860|39637292|FG002|Overall Study|Pregnancy|1|||
16315030|NCT01965860|39637290|FG000|Overall Study|Logistics|1|||
16315031|NCT01965860|39637291|FG001|Overall Study|Logistics|0|||
16315032|NCT01965860|39637292|FG002|Overall Study|Logistics|0|||
16315033|NCT02484456|39637299|FG000|Washout Period|Withdrawal by Subject|0|||
16315034|NCT02484456|39637300|FG001|Washout Period|Withdrawal by Subject|1|||
16315035|NCT02484456|39637299|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
16392028|NCT00784368|39919530|FG000|Overall Study|Adverse Event|6|||
16315036|NCT02484456|39637300|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
16315037|NCT02484456|39637299|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
16315038|NCT02484456|39637300|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
16315039|NCT02484456|39637299|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
16315040|NCT02484456|39637300|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
16315041|NCT01205776|39637302|FG000|Overall Study|Lost to Follow-up|53|||
16315042|NCT01205776|39637303|FG001|Overall Study|Lost to Follow-up|61|||
16315043|NCT01205776|39637302|FG000|Overall Study|Withdrawal by Subject|11|||
16315044|NCT01205776|39637303|FG001|Overall Study|Withdrawal by Subject|34|||
16315045|NCT02502149|39637304|FG000|Intermediate|Discontinued prematurely|1|||
16315046|NCT02502149|39637305|FG001|Intermediate|Discontinued prematurely|0|||
16315047|NCT02502149|39637306|FG002|Intermediate|Discontinued prematurely|0|||
16315048|NCT02502149|39637307|FG003|Intermediate|Discontinued prematurely|0|||
16315049|NCT02502149|39637308|FG004|Intermediate|Discontinued prematurely|0|||
16315050|NCT01269918|39637311|FG000|Overall Study|Did not receive study drug|0|||
16315051|NCT01269918|39637312|FG001|Overall Study|Did not receive study drug|3|||
16315052|NCT01164579|39637313|FG000|Overall Study|Lack of Efficacy|0|||
16315053|NCT01164579|39637314|FG001|Overall Study|Lack of Efficacy|0|||
16315054|NCT01164579|39637315|FG002|Overall Study|Lack of Efficacy|6|||
16315055|NCT01164579|39637313|FG000|Overall Study|Lost to Follow-up|1|||
16315056|NCT01164579|39637314|FG001|Overall Study|Lost to Follow-up|1|||
16315057|NCT01164579|39637315|FG002|Overall Study|Lost to Follow-up|0|||
16315058|NCT01164579|39637313|FG000|Overall Study|Withdrawal by Subject|2|||
16315059|NCT01164579|39637314|FG001|Overall Study|Withdrawal by Subject|5|||
16315060|NCT01164579|39637315|FG002|Overall Study|Withdrawal by Subject|3|||
16315061|NCT01164579|39637313|FG000|Overall Study|Protocol Violation|0|||
16315062|NCT01164579|39637314|FG001|Overall Study|Protocol Violation|1|||
16315063|NCT01164579|39637315|FG002|Overall Study|Protocol Violation|2|||
16315064|NCT01164579|39637313|FG000|Overall Study|Adverse Event|4|||
16315065|NCT01164579|39637314|FG001|Overall Study|Adverse Event|2|||
16315066|NCT01164579|39637315|FG002|Overall Study|Adverse Event|5|||
16315067|NCT01164579|39637313|FG000|Overall Study|Reason not specified|1|||
16315068|NCT01164579|39637314|FG001|Overall Study|Reason not specified|0|||
16392029|NCT00784368|39919531|FG001|Overall Study|Adverse Event|9|||
16509238|NCT00477672|40336437|FG002|Overall Study|Consent withdrawn|10|||
16509239|NCT00477672|40336435|FG000|Overall Study|Discretion of Sponsor|1|||
16509240|NCT00477672|40336436|FG001|Overall Study|Discretion of Sponsor|2|||
16509241|NCT00477672|40336437|FG002|Overall Study|Discretion of Sponsor|0|||
16509242|NCT00997503|40339658|FG000|Overall Study|Death|53|||
16509243|NCT00997503|40339658|FG000|Overall Study|Withdrawal by Subject|76|||
16509244|NCT00997503|40339658|FG000|Overall Study|Lost to Follow-up|33|||
16509245|NCT00997503|40339658|FG000|Overall Study|Adverse Event|3|||
16509246|NCT00997503|40339658|FG000|Overall Study|Physician Decision|10|||
16509247|NCT00997503|40339658|FG000|Overall Study|Missed 12-month follow-up|85|||
16509248|NCT00997503|40339658|FG000|Overall Study|Other reason|13|||
16509249|NCT01723163|40339659|FG000|Treatment Phase|Withdrawal by Subject|14|||
16509250|NCT01723163|40339660|FG001|Treatment Phase|Withdrawal by Subject|6|||
16509251|NCT01723163|40339659|FG000|Treatment Phase|Withdrawal by PI|5|||
16509252|NCT01723163|40339660|FG001|Treatment Phase|Withdrawal by PI|1|||
16509253|NCT01723163|40339659|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
16509254|NCT01723163|40339660|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
16509255|NCT01723163|40339659|FG000|3-Month Follow-up|Unable to Contact|12|||
16509256|NCT01723163|40339660|FG001|3-Month Follow-up|Unable to Contact|19|||
16509257|NCT01723163|40339659|FG000|6-Month Follow-up|Death|1|||
16509258|NCT01723163|40339660|FG001|6-Month Follow-up|Death|0|||
16509259|NCT01723163|40339659|FG000|6-Month Follow-up|Unable to Contact|17|||
16509260|NCT01723163|40339660|FG001|6-Month Follow-up|Unable to Contact|15|||
16509261|NCT01723163|40339659|FG000|12-Month Follow-up|Death|1|||
16509262|NCT01723163|40339660|FG001|12-Month Follow-up|Death|0|||
16509263|NCT01723163|40339659|FG000|12-Month Follow-up|Unable to Contact|23|||
16509264|NCT01723163|40339660|FG001|12-Month Follow-up|Unable to Contact|28|||
16509265|NCT02702401|40339661|FG000|Overall Study|Death|242|||
16509266|NCT02702401|40339662|FG001|Overall Study|Death|125|||
16509267|NCT02702401|40339661|FG000|Overall Study|Withdrawal by Subject|15|||
16509268|NCT02702401|40339662|FG001|Overall Study|Withdrawal by Subject|5|||
16509269|NCT02702401|40339661|FG000|Overall Study|Sponsor Decision|19|||
16509270|NCT02702401|40339662|FG001|Overall Study|Sponsor Decision|3|||
16509271|NCT02702401|40339661|FG000|Overall Study|Physician Decision|1|||
16509272|NCT02702401|40339662|FG001|Overall Study|Physician Decision|2|||
16509273|NCT02702401|40339661|FG000|Overall Study|Lost to Follow-up|1|||
16509274|NCT02702401|40339662|FG001|Overall Study|Lost to Follow-up|0|||
16509275|NCT01158222|40339663|FG000|Overall Study|Not eligible for intermediate phase|17|||
16509276|NCT00907374|40339664|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
16509277|NCT00907374|40339665|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
16509278|NCT00805935|40339670|FG000|Overall Study|Stimulation Failure|1|||
16509279|NCT00805935|40339671|FG001|Overall Study|Stimulation Failure|5|||
16509280|NCT00805935|40339672|FG002|Overall Study|Stimulation Failure|2|||
16509281|NCT00805935|40339673|FG003|Overall Study|Stimulation Failure|2|||
16509282|NCT00805935|40339670|FG000|Overall Study|Cycle cancelled|0|||
16509283|NCT00805935|40339671|FG001|Overall Study|Cycle cancelled|0|||
16509284|NCT00805935|40339672|FG002|Overall Study|Cycle cancelled|2|||
16509285|NCT00805935|40339673|FG003|Overall Study|Cycle cancelled|0|||
16509286|NCT00805935|40339670|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
16509287|NCT00805935|40339671|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
16509288|NCT00805935|40339672|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
16315069|NCT01164579|39637315|FG002|Overall Study|Reason not specified|0|||
16315070|NCT03749330|39637318|FG000|Overall Study|Clinicians left work in the CICU|0|||
16315071|NCT03749330|39637319|FG001|Overall Study|Clinicians left work in the CICU|2|||
16315072|NCT03749330|39637320|FG002|Overall Study|Clinicians left work in the CICU|0|||
16509289|NCT00805935|40339673|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
16509290|NCT00805935|40339670|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
16509291|NCT00805935|40339671|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
16315073|NCT03749330|39637321|FG003|Overall Study|Clinicians left work in the CICU|0|||
16315074|NCT03749330|39637322|FG004|Overall Study|Clinicians left work in the CICU|0|||
16315075|NCT03749330|39637323|FG005|Overall Study|Clinicians left work in the CICU|0|||
16315076|NCT01293695|39637326|FG000|Overall Study|Withdrawal by Subject|7|||
16315077|NCT01293695|39637327|FG001|Overall Study|Withdrawal by Subject|1|||
16315078|NCT01293695|39637326|FG000|Overall Study|Lost to Follow-up|8|||
16315079|NCT01293695|39637327|FG001|Overall Study|Lost to Follow-up|6|||
16315080|NCT01218087|39637328|FG000|Overall Study|Death|2|||
16315081|NCT01218087|39637329|FG001|Overall Study|Death|1|||
16315082|NCT01218087|39637328|FG000|Overall Study|Withdrawal by Subject|5|||
16315083|NCT01218087|39637329|FG001|Overall Study|Withdrawal by Subject|0|||
16315084|NCT01218087|39637328|FG000|Overall Study|Transferred|8|||
16315085|NCT01218087|39637329|FG001|Overall Study|Transferred|5|||
16315086|NCT04152837|39637332|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
16315087|NCT04152837|39637332|FG000|Maintenance Period|Adverse Event|1|||
16315088|NCT04152837|39637332|FG000|Maintenance Period|Withdrawal by Subject|1|||
16315089|NCT04152837|39637332|FG000|Maintenance Period|Sponsor Termination of Study|2|||
16315090|NCT02105467|39637335|FG000|Period 1|Lost to Follow-up|1|||
16315091|NCT02105467|39637336|FG001|Period 1|Lost to Follow-up|0|||
16315092|NCT02105467|39637335|FG000|Period 1|Death|1|||
16315093|NCT02105467|39637336|FG001|Period 1|Death|0|||
16315094|NCT02105467|39637335|FG000|Period 2|Lost to Follow-up|1|||
16315095|NCT02105467|39637336|FG001|Period 2|Lost to Follow-up|0|||
16315096|NCT02105467|39637335|FG000|Period 2|Death|1|||
16315097|NCT02105467|39637336|FG001|Period 2|Death|0|||
16315098|NCT02105467|39637335|FG000|Period 2|Withdrawal by Subject|0|||
16315099|NCT02105467|39637336|FG001|Period 2|Withdrawal by Subject|2|||
16315100|NCT02105467|39637335|FG000|Period 3|Lost to Follow-up|0|||
16315101|NCT02105467|39637336|FG001|Period 3|Lost to Follow-up|1|||
16315102|NCT00848718|39637337|FG000|Overall Study|Adverse Event|2|||
16315103|NCT00848718|39637338|FG001|Overall Study|Adverse Event|2|||
16315104|NCT00848718|39637339|FG002|Overall Study|Adverse Event|1|||
16315105|NCT00848718|39637340|FG003|Overall Study|Adverse Event|1|||
16315106|NCT00848718|39637341|FG004|Overall Study|Adverse Event|1|||
16315107|NCT00848718|39637342|FG005|Overall Study|Adverse Event|0|||
16315108|NCT00848718|39637343|FG006|Overall Study|Adverse Event|0|||
16315109|NCT00848718|39637344|FG007|Overall Study|Adverse Event|1|||
16315110|NCT00848718|39637345|FG008|Overall Study|Adverse Event|1|||
16392030|NCT00784368|39919532|FG002|Overall Study|Adverse Event|2|||
16392031|NCT00784368|39919530|FG000|Overall Study|Diagnosis of fever|0|||
16392032|NCT00784368|39919531|FG001|Overall Study|Diagnosis of fever|0|||
16392033|NCT00784368|39919532|FG002|Overall Study|Diagnosis of fever|1|||
16392034|NCT00784368|39919530|FG000|Overall Study|Worsening of complications|0|||
16392035|NCT00784368|39919531|FG001|Overall Study|Worsening of complications|0|||
16392036|NCT00784368|39919532|FG002|Overall Study|Worsening of complications|1|||
16392037|NCT00784368|39919530|FG000|Overall Study|Worsening of symptoms|0|||
16392038|NCT00784368|39919531|FG001|Overall Study|Worsening of symptoms|1|||
16392039|NCT00784368|39919532|FG002|Overall Study|Worsening of symptoms|0|||
16392040|NCT00784368|39919530|FG000|Overall Study|Withdrawal of informed consent|0|||
16392041|NCT00784368|39919531|FG001|Overall Study|Withdrawal of informed consent|1|||
16392042|NCT00784368|39919532|FG002|Overall Study|Withdrawal of informed consent|0|||
16315111|NCT00848718|39637346|FG009|Overall Study|Adverse Event|0|||
16315112|NCT00848718|39637347|FG010|Overall Study|Adverse Event|0|||
16315113|NCT00848718|39637348|FG011|Overall Study|Adverse Event|0|||
16315114|NCT00848718|39637349|FG012|Overall Study|Adverse Event|2|||
16315115|NCT00848718|39637337|FG000|Overall Study|Lack of Efficacy|0|||
16315116|NCT00848718|39637338|FG001|Overall Study|Lack of Efficacy|0|||
16315117|NCT00848718|39637339|FG002|Overall Study|Lack of Efficacy|1|||
16315118|NCT00848718|39637340|FG003|Overall Study|Lack of Efficacy|0|||
16315119|NCT00848718|39637341|FG004|Overall Study|Lack of Efficacy|0|||
16315120|NCT00848718|39637342|FG005|Overall Study|Lack of Efficacy|0|||
16392043|NCT00952705|39919533|FG000|Overall Study|Lost to Follow-up|24|||
16392044|NCT00952705|39919534|FG001|Overall Study|Lost to Follow-up|8|||
16392045|NCT00952705|39919535|FG002|Overall Study|Lost to Follow-up|9|||
16392046|NCT00952705|39919533|FG000|Overall Study|Withdrawal by Subject|2|||
16392047|NCT00952705|39919534|FG001|Overall Study|Withdrawal by Subject|1|||
16392048|NCT00952705|39919535|FG002|Overall Study|Withdrawal by Subject|1|||
16392049|NCT00952705|39919533|FG000|Overall Study|Death|2|||
16392050|NCT00952705|39919534|FG001|Overall Study|Death|0|||
16392051|NCT00952705|39919535|FG002|Overall Study|Death|0|||
16392052|NCT00952705|39919533|FG000|Overall Study|Incarcerated post dose|5|||
16392053|NCT00952705|39919534|FG001|Overall Study|Incarcerated post dose|0|||
16392054|NCT00952705|39919535|FG002|Overall Study|Incarcerated post dose|0|||
16392055|NCT00952705|39919533|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
16392056|NCT00952705|39919534|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
16392057|NCT00952705|39919535|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
16392058|NCT01694433|39919541|FG000|Overall Study|Adverse Event|7|||
16392059|NCT01694433|39919542|FG001|Overall Study|Adverse Event|0|||
16392060|NCT01694433|39919541|FG000|Overall Study|Physician Decision|1|||
16392061|NCT01694433|39919542|FG001|Overall Study|Physician Decision|0|||
16392062|NCT01694433|39919541|FG000|Overall Study|Withdrawal by Subject|3|||
16392063|NCT01694433|39919542|FG001|Overall Study|Withdrawal by Subject|4|||
16392064|NCT02148263|39919547|FG000|Overall Study|Withdrawal by Subject|3|||
16392065|NCT02148263|39919548|FG001|Overall Study|Withdrawal by Subject|2|||
16392066|NCT02316353|39919552|FG000|Overall Study|Pregnancy|1|||
16392067|NCT02316353|39919553|FG001|Overall Study|Pregnancy|3|||
16392068|NCT02316353|39919552|FG000|Overall Study|Adverse Event|1|||
16392069|NCT02316353|39919553|FG001|Overall Study|Adverse Event|3|||
16392070|NCT02316353|39919552|FG000|Overall Study|Withdrawal by Subject|6|||
16392071|NCT02316353|39919553|FG001|Overall Study|Withdrawal by Subject|2|||
16315121|NCT00848718|39637343|FG006|Overall Study|Lack of Efficacy|1|||
16315122|NCT00848718|39637344|FG007|Overall Study|Lack of Efficacy|0|||
16315123|NCT00848718|39637345|FG008|Overall Study|Lack of Efficacy|0|||
16315124|NCT00848718|39637346|FG009|Overall Study|Lack of Efficacy|0|||
16315125|NCT00848718|39637347|FG010|Overall Study|Lack of Efficacy|0|||
16315126|NCT00848718|39637348|FG011|Overall Study|Lack of Efficacy|0|||
16315127|NCT00848718|39637349|FG012|Overall Study|Lack of Efficacy|0|||
16315128|NCT00848718|39637337|FG000|Overall Study|Physician Decision|0|||
16315129|NCT00848718|39637338|FG001|Overall Study|Physician Decision|1|||
16315130|NCT00848718|39637339|FG002|Overall Study|Physician Decision|0|||
16315131|NCT00848718|39637340|FG003|Overall Study|Physician Decision|0|||
16315132|NCT00848718|39637341|FG004|Overall Study|Physician Decision|1|||
16315133|NCT00848718|39637342|FG005|Overall Study|Physician Decision|1|||
16315134|NCT00848718|39637343|FG006|Overall Study|Physician Decision|0|||
16315135|NCT00848718|39637344|FG007|Overall Study|Physician Decision|0|||
16315136|NCT00848718|39637345|FG008|Overall Study|Physician Decision|1|||
16315137|NCT00848718|39637346|FG009|Overall Study|Physician Decision|2|||
16315138|NCT00848718|39637347|FG010|Overall Study|Physician Decision|0|||
16315139|NCT00848718|39637348|FG011|Overall Study|Physician Decision|0|||
16315140|NCT00848718|39637349|FG012|Overall Study|Physician Decision|1|||
16315141|NCT00848718|39637337|FG000|Overall Study|Progressive disease before treatment|1|||
16315142|NCT00848718|39637338|FG001|Overall Study|Progressive disease before treatment|5|||
16315143|NCT00848718|39637339|FG002|Overall Study|Progressive disease before treatment|1|||
16315144|NCT00848718|39637340|FG003|Overall Study|Progressive disease before treatment|3|||
16315145|NCT00848718|39637341|FG004|Overall Study|Progressive disease before treatment|4|||
16315146|NCT00848718|39637342|FG005|Overall Study|Progressive disease before treatment|4|||
16315147|NCT00848718|39637343|FG006|Overall Study|Progressive disease before treatment|2|||
16315148|NCT00848718|39637344|FG007|Overall Study|Progressive disease before treatment|1|||
16315149|NCT00848718|39637345|FG008|Overall Study|Progressive disease before treatment|2|||
16392088|NCT01582009|39919562|FG000|Overall Study|Withdrawal by Subject|1|||
16392089|NCT01582009|39919562|FG000|Overall Study|Physician Decision|1|||
16392090|NCT00130039|39919568|FG000|Overall Study|Withdrawal by Subject|15|||
16392091|NCT00130039|39919569|FG001|Overall Study|Withdrawal by Subject|11|||
16315150|NCT00848718|39637346|FG009|Overall Study|Progressive disease before treatment|7|||
16315151|NCT00848718|39637347|FG010|Overall Study|Progressive disease before treatment|3|||
16315152|NCT00848718|39637348|FG011|Overall Study|Progressive disease before treatment|6|||
16315153|NCT00848718|39637349|FG012|Overall Study|Progressive disease before treatment|2|||
16315154|NCT00848718|39637337|FG000|Overall Study|Protocol Violation|0|||
16315155|NCT00848718|39637338|FG001|Overall Study|Protocol Violation|1|||
16315156|NCT00848718|39637339|FG002|Overall Study|Protocol Violation|0|||
16315157|NCT00848718|39637340|FG003|Overall Study|Protocol Violation|0|||
16315158|NCT00848718|39637341|FG004|Overall Study|Protocol Violation|0|||
16315159|NCT00848718|39637342|FG005|Overall Study|Protocol Violation|0|||
16315160|NCT00848718|39637343|FG006|Overall Study|Protocol Violation|0|||
16315161|NCT00848718|39637344|FG007|Overall Study|Protocol Violation|1|||
16509292|NCT00805935|40339672|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
16315162|NCT00848718|39637345|FG008|Overall Study|Protocol Violation|0|||
16315163|NCT00848718|39637346|FG009|Overall Study|Protocol Violation|0|||
16315164|NCT00848718|39637347|FG010|Overall Study|Protocol Violation|0|||
16509293|NCT00805935|40339673|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
16509294|NCT00805935|40339670|FG000|Overall Study|Lost to Follow-up|1|||
16509295|NCT00805935|40339671|FG001|Overall Study|Lost to Follow-up|0|||
16509296|NCT00805935|40339672|FG002|Overall Study|Lost to Follow-up|0|||
16509297|NCT00805935|40339673|FG003|Overall Study|Lost to Follow-up|0|||
16509298|NCT00805935|40339670|FG000|Overall Study|No positive serum pregnancy|8|||
16509299|NCT00805935|40339671|FG001|Overall Study|No positive serum pregnancy|7|||
16509300|NCT00805935|40339672|FG002|Overall Study|No positive serum pregnancy|6|||
16509301|NCT00805935|40339673|FG003|Overall Study|No positive serum pregnancy|5|||
16509302|NCT00805935|40339670|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
16509303|NCT00805935|40339671|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
16509304|NCT00805935|40339672|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
16509305|NCT00805935|40339673|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
16509306|NCT00805935|40339670|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
16509307|NCT00805935|40339671|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
16509308|NCT00805935|40339672|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
16509309|NCT00805935|40339673|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
16509310|NCT00805935|40339670|FG000|Overall Study|Biochemical pregnancy|0|||
16509311|NCT00805935|40339671|FG001|Overall Study|Biochemical pregnancy|1|||
16509312|NCT00805935|40339672|FG002|Overall Study|Biochemical pregnancy|0|||
16509313|NCT00805935|40339673|FG003|Overall Study|Biochemical pregnancy|0|||
16509314|NCT00805935|40339670|FG000|Overall Study|Chemical pregnancy|0|||
16509315|NCT00805935|40339671|FG001|Overall Study|Chemical pregnancy|5|||
16509316|NCT00805935|40339672|FG002|Overall Study|Chemical pregnancy|3|||
16509317|NCT00805935|40339673|FG003|Overall Study|Chemical pregnancy|2|||
16509318|NCT00805935|40339670|FG000|Overall Study|Ectopic pregnancy|0|||
16509319|NCT00805935|40339671|FG001|Overall Study|Ectopic pregnancy|0|||
16509320|NCT00805935|40339672|FG002|Overall Study|Ectopic pregnancy|1|||
16509321|NCT00805935|40339673|FG003|Overall Study|Ectopic pregnancy|0|||
16509322|NCT00805935|40339670|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
16509323|NCT00805935|40339671|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
16509324|NCT00805935|40339672|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
16509325|NCT00805935|40339673|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
16509326|NCT00026793|40339674|FG000|Overall Study|Death on study due to underlying disease|4|||
16509327|NCT00026793|40339674|FG000|Overall Study|Physician Decision|2|||
16509328|NCT00026793|40339674|FG000|Overall Study|Off study|2|||
16509329|NCT05179421|40339676|FG000|First Infusion Day|Adverse Event|1|||
16509330|NCT05179421|40339677|FG001|First Infusion Day|Adverse Event|0|||
16509331|NCT01482767|40339679|FG000|Overall Study|Death|1|||
16509332|NCT01482767|40339680|FG001|Overall Study|Death|1|||
16509333|NCT01482767|40339679|FG000|Overall Study|Withdrawal by Subject|7|||
16509334|NCT01482767|40339680|FG001|Overall Study|Withdrawal by Subject|5|||
16509335|NCT01482767|40339679|FG000|Overall Study|Lost to Follow-up|12|||
16509336|NCT01482767|40339680|FG001|Overall Study|Lost to Follow-up|6|||
16509337|NCT01482767|40339679|FG000|Overall Study|Adverse Event|0|||
16509338|NCT01482767|40339680|FG001|Overall Study|Adverse Event|3|||
16509339|NCT01482767|40339679|FG000|Overall Study|Site closure|22|||
16509340|NCT01482767|40339680|FG001|Overall Study|Site closure|14|||
16509341|NCT01482767|40339679|FG000|Overall Study|Non-adherence to study requirements|4|||
16509342|NCT01482767|40339680|FG001|Overall Study|Non-adherence to study requirements|7|||
16509343|NCT01482767|40339679|FG000|Overall Study|Alternate HCV treatment|7|||
16509344|NCT01482767|40339680|FG001|Overall Study|Alternate HCV treatment|8|||
16509345|NCT01482767|40339679|FG000|Overall Study|Ineligible|0|||
16509346|NCT01482767|40339680|FG001|Overall Study|Ineligible|5|||
16509347|NCT01482767|40339679|FG000|Overall Study|Nurse error|1|||
16509348|NCT01482767|40339680|FG001|Overall Study|Nurse error|0|||
16509349|NCT00145509|40339681|FG000|Overall Study|Adverse Event|10|||
16392092|NCT00130039|39919568|FG000|Overall Study|Lost to Follow-up|3|||
16392093|NCT00130039|39919569|FG001|Overall Study|Lost to Follow-up|1|||
16392094|NCT00130039|39919568|FG000|Overall Study|Adverse Event|4|||
16392095|NCT00130039|39919569|FG001|Overall Study|Adverse Event|2|||
16392096|NCT00130039|39919568|FG000|Overall Study|Physician Decision|3|||
16392097|NCT00130039|39919569|FG001|Overall Study|Physician Decision|0|||
16392098|NCT00130039|39919568|FG000|Overall Study|clinical events without follow up MRI|5|||
16392099|NCT00130039|39919569|FG001|Overall Study|clinical events without follow up MRI|4|||
16392100|NCT01509846|39919571|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
16392101|NCT01509846|39919572|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
16392102|NCT01509846|39919573|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
16392103|NCT01509846|39919574|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
16392104|NCT01509846|39919575|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
16392105|NCT01509846|39919571|FG000|Received Vaccination 2|Illness|0|||
16392106|NCT01509846|39919572|FG001|Received Vaccination 2|Illness|0|||
16392107|NCT01509846|39919573|FG002|Received Vaccination 2|Illness|0|||
16392108|NCT01509846|39919574|FG003|Received Vaccination 2|Illness|0|||
16392109|NCT01509846|39919575|FG004|Received Vaccination 2|Illness|1|||
16509350|NCT00145509|40339682|FG001|Overall Study|Adverse Event|3|||
16509351|NCT00145509|40339681|FG000|Overall Study|Lack of Efficacy|3|||
16509352|NCT00145509|40339682|FG001|Overall Study|Lack of Efficacy|1|||
16509353|NCT00145509|40339681|FG000|Overall Study|Lost to Follow-up|5|||
16509354|NCT00145509|40339682|FG001|Overall Study|Lost to Follow-up|9|||
16509355|NCT00145509|40339681|FG000|Overall Study|Withdrew Consent|2|||
16509356|NCT00145509|40339682|FG001|Overall Study|Withdrew Consent|7|||
16315165|NCT00848718|39637348|FG011|Overall Study|Protocol Violation|0|||
16315166|NCT00848718|39637349|FG012|Overall Study|Protocol Violation|1|||
16315167|NCT00848718|39637337|FG000|Overall Study|Withdrawal by Subject|1|||
16315168|NCT00848718|39637338|FG001|Overall Study|Withdrawal by Subject|0|||
16315169|NCT00848718|39637339|FG002|Overall Study|Withdrawal by Subject|0|||
16315170|NCT00848718|39637340|FG003|Overall Study|Withdrawal by Subject|1|||
16315171|NCT00848718|39637341|FG004|Overall Study|Withdrawal by Subject|0|||
16315172|NCT00848718|39637342|FG005|Overall Study|Withdrawal by Subject|0|||
16315173|NCT00848718|39637343|FG006|Overall Study|Withdrawal by Subject|0|||
16315174|NCT00848718|39637344|FG007|Overall Study|Withdrawal by Subject|0|||
16315175|NCT00848718|39637345|FG008|Overall Study|Withdrawal by Subject|0|||
16315176|NCT00848718|39637346|FG009|Overall Study|Withdrawal by Subject|0|||
16315177|NCT00848718|39637347|FG010|Overall Study|Withdrawal by Subject|1|||
16392110|NCT01509846|39919571|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
16392111|NCT01509846|39919572|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
16509357|NCT00145509|40339681|FG000|Overall Study|Reason not provided|2|||
16509358|NCT00145509|40339682|FG001|Overall Study|Reason not provided|1|||
16509359|NCT00205712|40339695|FG000|Overall Study|Lost to Follow-up|0|||
16509360|NCT00205712|40339696|FG001|Overall Study|Lost to Follow-up|1|||
16509361|NCT04292730|40339702|FG000|Overall Study|Lost to Follow-up|8|||
16509362|NCT04292730|40339703|FG001|Overall Study|Lost to Follow-up|12|||
16509363|NCT04292730|40339704|FG002|Overall Study|Lost to Follow-up|12|||
16509364|NCT04292730|40339705|FG003|Overall Study|Lost to Follow-up|48|||
16509365|NCT04292730|40339702|FG000|Overall Study|Death|2|||
16509366|NCT04292730|40339703|FG001|Overall Study|Death|2|||
16509367|NCT04292730|40339704|FG002|Overall Study|Death|4|||
16509368|NCT04292730|40339705|FG003|Overall Study|Death|12|||
16509369|NCT04292730|40339702|FG000|Overall Study|Withdrew Consent|2|||
16509370|NCT04292730|40339703|FG001|Overall Study|Withdrew Consent|2|||
16509371|NCT04292730|40339704|FG002|Overall Study|Withdrew Consent|5|||
16509372|NCT04292730|40339705|FG003|Overall Study|Withdrew Consent|6|||
16509373|NCT04292730|40339702|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16509374|NCT04292730|40339703|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16509375|NCT04292730|40339704|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16509376|NCT04292730|40339705|FG003|Overall Study|Non-Compliance with Study Drug|0|||
16509377|NCT04292730|40339702|FG000|Overall Study|Protocol Violation|0|||
16509378|NCT04292730|40339703|FG001|Overall Study|Protocol Violation|0|||
16509379|NCT04292730|40339704|FG002|Overall Study|Protocol Violation|1|||
16509380|NCT04292730|40339705|FG003|Overall Study|Protocol Violation|0|||
16509381|NCT04292730|40339702|FG000|Overall Study|Randomized but not Treated|8|||
16509382|NCT04292730|40339703|FG001|Overall Study|Randomized but not Treated|4|||
16509383|NCT04292730|40339704|FG002|Overall Study|Randomized but not Treated|0|||
16315178|NCT00848718|39637348|FG011|Overall Study|Withdrawal by Subject|0|||
16509384|NCT04292730|40339705|FG003|Overall Study|Randomized but not Treated|14|||
16392112|NCT01509846|39919573|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
16392113|NCT01509846|39919574|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
16392114|NCT01509846|39919575|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
16509385|NCT02552316|40339706|FG000|Overall Study|Withdrawal by Subject|1|||
16509386|NCT02552316|40339706|FG000|Overall Study|Withdrawal due to non-compliance|1|||
16509387|NCT00903617|40339707|FG000|Overall Study|Adverse Event|0|||
16509388|NCT00903617|40339708|FG001|Overall Study|Adverse Event|1|||
16509389|NCT00903617|40339709|FG002|Overall Study|Adverse Event|1|||
16315179|NCT00848718|39637349|FG012|Overall Study|Withdrawal by Subject|0|||
16315180|NCT00848718|39637337|FG000|Overall Study|Progressive disease during treatment|3|||
16315181|NCT00848718|39637338|FG001|Overall Study|Progressive disease during treatment|0|||
16315182|NCT00848718|39637339|FG002|Overall Study|Progressive disease during treatment|3|||
16315183|NCT00848718|39637340|FG003|Overall Study|Progressive disease during treatment|0|||
16315184|NCT00848718|39637341|FG004|Overall Study|Progressive disease during treatment|0|||
16509390|NCT00903617|40339710|FG003|Overall Study|Adverse Event|0|||
16509391|NCT00903617|40339707|FG000|Overall Study|Protocol-defined stopping criteria|0|||
16509392|NCT00903617|40339708|FG001|Overall Study|Protocol-defined stopping criteria|2|||
16509393|NCT00903617|40339709|FG002|Overall Study|Protocol-defined stopping criteria|0|||
16509394|NCT00903617|40339710|FG003|Overall Study|Protocol-defined stopping criteria|0|||
16509395|NCT00903617|40339707|FG000|Overall Study|Lost to Follow-up|2|||
16509396|NCT00903617|40339708|FG001|Overall Study|Lost to Follow-up|0|||
16509397|NCT00903617|40339709|FG002|Overall Study|Lost to Follow-up|1|||
16509398|NCT00903617|40339710|FG003|Overall Study|Lost to Follow-up|1|||
16509399|NCT00903617|40339707|FG000|Overall Study|Withdrawal by Subject|1|||
16509400|NCT00903617|40339708|FG001|Overall Study|Withdrawal by Subject|2|||
16509401|NCT00903617|40339709|FG002|Overall Study|Withdrawal by Subject|3|||
16509402|NCT00903617|40339710|FG003|Overall Study|Withdrawal by Subject|0|||
16509403|NCT01446965|40339713|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
16509404|NCT01446965|40339714|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
16509405|NCT01446965|40339713|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
16509406|NCT01446965|40339714|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
16509407|NCT00922766|40339718|FG000|Overall Study|Death|3|||
16509408|NCT00922766|40339718|FG000|Overall Study|Withdrawal by Subject|2|||
16509409|NCT00922766|40339718|FG000|Overall Study|Other|1|||
16509410|NCT00922766|40339718|FG000|Overall Study|Adverse Event|1|||
16509411|NCT00394212|40339719|FG000|Overall Study|Lost to Follow-up|3|||
16509412|NCT00394212|40339720|FG001|Overall Study|Lost to Follow-up|0|||
16509413|NCT00394212|40339719|FG000|Overall Study|Withdrawal by Subject|4|||
16509414|NCT00394212|40339720|FG001|Overall Study|Withdrawal by Subject|1|||
16509415|NCT00116831|40339724|FG000|Overall Study|Adverse Event|14|||
16509416|NCT00116831|40339725|FG001|Overall Study|Adverse Event|16|||
16509417|NCT00116831|40339724|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
16509418|NCT00116831|40339725|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
16509419|NCT00116831|40339724|FG000|Overall Study|Lost to Follow-up|8|||
16509420|NCT00116831|40339725|FG001|Overall Study|Lost to Follow-up|6|||
16509421|NCT00116831|40339724|FG000|Overall Study|Protocol Violation|3|||
16509422|NCT00116831|40339725|FG001|Overall Study|Protocol Violation|6|||
16509423|NCT00116831|40339724|FG000|Overall Study|Hypoglycaemic events|1|||
16509424|NCT00116831|40339725|FG001|Overall Study|Hypoglycaemic events|0|||
16509425|NCT00116831|40339724|FG000|Overall Study|Low haemoglobin on screening|1|||
16509426|NCT00116831|40339725|FG001|Overall Study|Low haemoglobin on screening|0|||
16509427|NCT00116831|40339724|FG000|Overall Study|Withdrawn investigational product|1|||
16509428|NCT00116831|40339725|FG001|Overall Study|Withdrawn investigational product|0|||
16509429|NCT00116831|40339724|FG000|Overall Study|Withdrawal by Subject|32|||
16509430|NCT00116831|40339725|FG001|Overall Study|Withdrawal by Subject|32|||
16509431|NCT00116831|40339724|FG000|Overall Study|Insufficient therapeutic effect|0|||
16509432|NCT00116831|40339725|FG001|Overall Study|Insufficient therapeutic effect|1|||
16509433|NCT00116831|40339724|FG000|Overall Study|Missing data for participant|1|||
16509434|NCT00116831|40339725|FG001|Overall Study|Missing data for participant|0|||
16509435|NCT02276612|40339726|FG000|Overall Study|Death|1|||
16509436|NCT02276612|40339727|FG001|Overall Study|Death|0|||
16509437|NCT02276612|40339726|FG000|Overall Study|Pregnancy|1|||
16509438|NCT02276612|40339727|FG001|Overall Study|Pregnancy|0|||
16509439|NCT02276612|40339726|FG000|Overall Study|Withdrew Consent|1|||
16509440|NCT02276612|40339727|FG001|Overall Study|Withdrew Consent|0|||
16509441|NCT02276612|40339726|FG000|Overall Study|Lost to Follow-up|1|||
16509442|NCT02276612|40339727|FG001|Overall Study|Lost to Follow-up|0|||
16509443|NCT00902564|40339728|FG000|Overall Study|Withdrawal by Subject|2|||
16509444|NCT03093428|40339729|FG000|Overall Study|Not eligible for treatment|2|||
16509445|NCT03093428|40339730|FG001|Overall Study|Not eligible for treatment|1|||
16509446|NCT03093428|40339729|FG000|Overall Study|Progression|14|||
16509447|NCT03093428|40339730|FG001|Overall Study|Progression|4|||
16509448|NCT03093428|40339729|FG000|Overall Study|Death|1|||
16509449|NCT03093428|40339730|FG001|Overall Study|Death|0|||
16509450|NCT03093428|40339729|FG000|Overall Study|Adverse Event|1|||
16509451|NCT03093428|40339730|FG001|Overall Study|Adverse Event|0|||
16315185|NCT00848718|39637342|FG005|Overall Study|Progressive disease during treatment|0|||
16509452|NCT03093428|40339729|FG000|Overall Study|Withdrawal by Subject|1|||
16509453|NCT03093428|40339730|FG001|Overall Study|Withdrawal by Subject|1|||
16509454|NCT01342510|40339731|FG000|Overall Study|Protocol Violation|12|||
16509455|NCT01342510|40339732|FG001|Overall Study|Protocol Violation|6|||
16509456|NCT01342510|40339733|FG002|Overall Study|Protocol Violation|13|||
16315186|NCT00848718|39637343|FG006|Overall Study|Progressive disease during treatment|0|||
16315187|NCT00848718|39637344|FG007|Overall Study|Progressive disease during treatment|2|||
16315188|NCT00848718|39637345|FG008|Overall Study|Progressive disease during treatment|0|||
16315189|NCT00848718|39637346|FG009|Overall Study|Progressive disease during treatment|0|||
16315190|NCT00848718|39637347|FG010|Overall Study|Progressive disease during treatment|0|||
16315191|NCT00848718|39637348|FG011|Overall Study|Progressive disease during treatment|0|||
16315192|NCT00848718|39637349|FG012|Overall Study|Progressive disease during treatment|2|||
16315193|NCT03283566|39637353|FG000|Overall Study|Lost to Follow-up|1|||
16315194|NCT03283566|39637354|FG001|Overall Study|Lost to Follow-up|2|||
16315195|NCT01209949|39637355|FG000|Overall Study|Lost to Follow-up|3|||
16315196|NCT01408303|39637360|FG000|Overall Study|Adverse Event|3|||
16315197|NCT01408303|39637361|FG001|Overall Study|Adverse Event|7|||
16315198|NCT01408303|39637362|FG002|Overall Study|Adverse Event|2|||
16315199|NCT01408303|39637360|FG000|Overall Study|Lost to Follow-up|0|||
16315200|NCT01408303|39637361|FG001|Overall Study|Lost to Follow-up|1|||
16315201|NCT01408303|39637362|FG002|Overall Study|Lost to Follow-up|2|||
16315202|NCT01408303|39637360|FG000|Overall Study|Withdrawal by Subject|2|||
16315203|NCT01408303|39637361|FG001|Overall Study|Withdrawal by Subject|3|||
16315204|NCT01408303|39637362|FG002|Overall Study|Withdrawal by Subject|1|||
16315205|NCT01408303|39637360|FG000|Overall Study|Protocol Violation|0|||
16315206|NCT01408303|39637361|FG001|Overall Study|Protocol Violation|1|||
16315207|NCT01408303|39637362|FG002|Overall Study|Protocol Violation|0|||
16315208|NCT01408303|39637360|FG000|Overall Study|Noncompliance|1|||
16315209|NCT01408303|39637361|FG001|Overall Study|Noncompliance|0|||
16315210|NCT01408303|39637362|FG002|Overall Study|Noncompliance|1|||
16315211|NCT03817853|39637364|FG000|Induction Phase|Adverse Event|5|||
16315212|NCT03817853|39637365|FG001|Induction Phase|Adverse Event|0|||
16315213|NCT03817853|39637366|FG002|Induction Phase|Adverse Event|0|||
16315214|NCT03817853|39637364|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
16315215|NCT03817853|39637365|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
16315216|NCT03817853|39637366|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
16315217|NCT03817853|39637364|FG000|Induction Phase|Physician Decision|2|||
16315218|NCT03817853|39637365|FG001|Induction Phase|Physician Decision|0|||
16315219|NCT03817853|39637366|FG002|Induction Phase|Physician Decision|0|||
16315220|NCT03817853|39637364|FG000|Induction Phase|Progressive Disease|6|||
16315221|NCT03817853|39637365|FG001|Induction Phase|Progressive Disease|0|||
16315222|NCT03817853|39637366|FG002|Induction Phase|Progressive Disease|0|||
16315223|NCT03817853|39637364|FG000|Induction Phase|Withdrawal by Subject|4|||
16315224|NCT03817853|39637365|FG001|Induction Phase|Withdrawal by Subject|0|||
16315225|NCT03817853|39637366|FG002|Induction Phase|Withdrawal by Subject|0|||
16315226|NCT03817853|39637364|FG000|Maintenance Phase|Adverse Event|0|||
16315227|NCT03817853|39637365|FG001|Maintenance Phase|Adverse Event|8|||
16315228|NCT03817853|39637366|FG002|Maintenance Phase|Adverse Event|0|||
16315229|NCT03817853|39637364|FG000|Maintenance Phase|Death|0|||
16509457|NCT01342510|40339734|FG003|Overall Study|Protocol Violation|11|||
16509458|NCT00006916|40339735|FG000|Overall Study|Device not inserted|4|||
16509459|NCT00006916|40339735|FG000|Overall Study|Complication of device insertion|1|||
16509460|NCT00082433|40339736|FG000|Overall Study|Adverse Event|12|||
16509461|NCT00082433|40339737|FG001|Overall Study|Adverse Event|17|||
16509462|NCT00082433|40339736|FG000|Overall Study|Death|8|||
16509463|NCT00082433|40339737|FG001|Overall Study|Death|18|||
16509464|NCT00082433|40339736|FG000|Overall Study|Disease Progression/Relapse|270|||
16509465|NCT00082433|40339737|FG001|Overall Study|Disease Progression/Relapse|388|||
16509466|NCT00082433|40339736|FG000|Overall Study|Physician Decision|50|||
16509467|NCT00082433|40339737|FG001|Overall Study|Physician Decision|61|||
16509468|NCT00082433|40339736|FG000|Overall Study|Lost to Follow-up|1|||
16315230|NCT03817853|39637365|FG001|Maintenance Phase|Death|5|||
16315231|NCT03817853|39637366|FG002|Maintenance Phase|Death|0|||
16315232|NCT03817853|39637364|FG000|Maintenance Phase|Progressive Disease|0|||
16509469|NCT00082433|40339737|FG001|Overall Study|Lost to Follow-up|2|||
16509470|NCT00082433|40339736|FG000|Overall Study|Study Drug Toxicity|179|||
16509471|NCT00082433|40339737|FG001|Overall Study|Study Drug Toxicity|66|||
16315233|NCT03817853|39637365|FG001|Maintenance Phase|Progressive Disease|7|||
16315234|NCT03817853|39637366|FG002|Maintenance Phase|Progressive Disease|0|||
16315235|NCT03817853|39637364|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16315236|NCT03817853|39637365|FG001|Maintenance Phase|Withdrawal by Subject|2|||
16315237|NCT03817853|39637366|FG002|Maintenance Phase|Withdrawal by Subject|0|||
16315238|NCT03817853|39637364|FG000|Maintenance Phase|Physician Decision|0|||
16315239|NCT03817853|39637365|FG001|Maintenance Phase|Physician Decision|1|||
16315240|NCT03817853|39637366|FG002|Maintenance Phase|Physician Decision|0|||
16315241|NCT03817853|39637364|FG000|Maintenance Phase|Various reasons|0|||
16315242|NCT03817853|39637365|FG001|Maintenance Phase|Various reasons|4|||
16509472|NCT00082433|40339736|FG000|Overall Study|Withdrawal by Subject|55|||
16509473|NCT00082433|40339737|FG001|Overall Study|Withdrawal by Subject|30|||
16509474|NCT00082433|40339736|FG000|Overall Study|Still On Treatment|2|||
16509475|NCT00082433|40339737|FG001|Overall Study|Still On Treatment|1|||
16509476|NCT00082433|40339736|FG000|Overall Study|Not Treated|12|||
16509477|NCT00082433|40339737|FG001|Overall Study|Not Treated|11|||
16315243|NCT03817853|39637366|FG002|Maintenance Phase|Various reasons|0|||
16315244|NCT03817853|39637364|FG000|Maintenance Phase|Protocol Deviation|0|||
16315245|NCT03817853|39637365|FG001|Maintenance Phase|Protocol Deviation|1|||
16315246|NCT03817853|39637366|FG002|Maintenance Phase|Protocol Deviation|0|||
16315247|NCT03817853|39637364|FG000|Follow-up Phase|Adverse Event|0|||
16315248|NCT03817853|39637365|FG001|Follow-up Phase|Adverse Event|0|||
16315249|NCT03817853|39637366|FG002|Follow-up Phase|Adverse Event|2|||
16315250|NCT03817853|39637364|FG000|Follow-up Phase|Death|0|||
16315251|NCT03817853|39637365|FG001|Follow-up Phase|Death|0|||
16198504|NCT00254293|39201372|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
16509478|NCT00082433|40339736|FG000|Overall Study|Ineligible|2|||
16509479|NCT00082433|40339737|FG001|Overall Study|Ineligible|1|||
16509480|NCT00082433|40339736|FG000|Overall Study|Noncompliance|2|||
16509481|NCT00082433|40339737|FG001|Overall Study|Noncompliance|1|||
16509482|NCT00082433|40339736|FG000|Overall Study|New primary cancer|1|||
16509483|NCT00082433|40339737|FG001|Overall Study|New primary cancer|0|||
16315252|NCT03817853|39637366|FG002|Follow-up Phase|Death|1|||
16509484|NCT00082433|40339736|FG000|Overall Study|Impending surgery|0|||
16509485|NCT00082433|40339737|FG001|Overall Study|Impending surgery|1|||
16315253|NCT03817853|39637364|FG000|Follow-up Phase|Progressive Disease|0|||
16509486|NCT03400033|40339740|FG000|Overall Study|Withdrawal by Subject|1|||
16509487|NCT03400033|40339741|FG001|Overall Study|Withdrawal by Subject|2|||
16315254|NCT03817853|39637365|FG001|Follow-up Phase|Progressive Disease|0|||
16315255|NCT03817853|39637366|FG002|Follow-up Phase|Progressive Disease|3|||
16315256|NCT03817853|39637364|FG000|Follow-up Phase|Withdrawal by Subject|0|||
16315257|NCT03817853|39637365|FG001|Follow-up Phase|Withdrawal by Subject|0|||
16509488|NCT00439556|40339742|FG000|Overall Study|Patient was taken off study for non-comp|0|||
16509489|NCT00439556|40339743|FG001|Overall Study|Patient was taken off study for non-comp|1|||
16509490|NCT00439556|40339744|FG002|Overall Study|Patient was taken off study for non-comp|0|||
16509491|NCT03161483|40339750|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
16509492|NCT03161483|40339751|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
16509493|NCT03161483|40339752|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
16509494|NCT03161483|40339753|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
16509495|NCT03161483|40339750|FG000|Treatment Period|Death|1|||
16509496|NCT03161483|40339751|FG001|Treatment Period|Death|0|||
16509497|NCT03161483|40339752|FG002|Treatment Period|Death|0|||
16509498|NCT03161483|40339753|FG003|Treatment Period|Death|0|||
16198505|NCT00254293|39201373|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
16198506|NCT00254293|39201374|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
16198507|NCT00254293|39201375|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
16198508|NCT00254293|39201376|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
16198509|NCT00254293|39201370|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
16315258|NCT03817853|39637366|FG002|Follow-up Phase|Withdrawal by Subject|1|||
16315259|NCT01995513|39637367|FG000|Period 1: First Open Label Treatment|Other|34|||
16315260|NCT01995513|39637368|FG001|Period 1: First Open Label Treatment|Other|0|||
16315261|NCT01995513|39637369|FG002|Period 1: First Open Label Treatment|Other|0|||
16315262|NCT01995513|39637370|FG003|Period 1: First Open Label Treatment|Other|0|||
16315263|NCT01995513|39637367|FG000|Period 1: First Open Label Treatment|Death|14|||
16315264|NCT01995513|39637368|FG001|Period 1: First Open Label Treatment|Death|0|||
16315265|NCT01995513|39637369|FG002|Period 1: First Open Label Treatment|Death|0|||
16315266|NCT01995513|39637370|FG003|Period 1: First Open Label Treatment|Death|0|||
16315267|NCT01995513|39637367|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
16315268|NCT01995513|39637368|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
16315269|NCT01995513|39637369|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
16315270|NCT01995513|39637370|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
16315271|NCT01995513|39637367|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
16315272|NCT01995513|39637368|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
16315273|NCT01995513|39637369|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
16315274|NCT01995513|39637370|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
16315275|NCT01995513|39637367|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
16315276|NCT01995513|39637368|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
16315277|NCT01995513|39637369|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
16315278|NCT01995513|39637370|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
16315279|NCT01995513|39637367|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
16315280|NCT01995513|39637368|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
16315281|NCT01995513|39637369|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
16315282|NCT01995513|39637370|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
16315283|NCT01995513|39637367|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
16315284|NCT01995513|39637368|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
16315285|NCT01995513|39637369|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
16315286|NCT01995513|39637370|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
16315287|NCT01995513|39637367|FG000|Period 1: Second Open Label Treatment|Other|0|||
16315288|NCT01995513|39637368|FG001|Period 1: Second Open Label Treatment|Other|2|||
16315289|NCT01995513|39637369|FG002|Period 1: Second Open Label Treatment|Other|0|||
16315290|NCT01995513|39637370|FG003|Period 1: Second Open Label Treatment|Other|0|||
16315291|NCT01995513|39637367|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
16315292|NCT01995513|39637368|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
16315293|NCT01995513|39637369|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
16315294|NCT01995513|39637370|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
16315295|NCT01995513|39637367|FG000|Period 2: Double Blind Treatment|Death|0|||
16315296|NCT01995513|39637368|FG001|Period 2: Double Blind Treatment|Death|0|||
16315297|NCT01995513|39637369|FG002|Period 2: Double Blind Treatment|Death|0|||
16315298|NCT01995513|39637370|FG003|Period 2: Double Blind Treatment|Death|1|||
16315299|NCT01995513|39637367|FG000|Period 2: Double Blind Treatment|Other|0|||
16315300|NCT01995513|39637368|FG001|Period 2: Double Blind Treatment|Other|0|||
16315301|NCT01995513|39637369|FG002|Period 2: Double Blind Treatment|Other|3|||
16509499|NCT03161483|40339750|FG000|Treatment Period|Adverse Event|5|||
16509500|NCT03161483|40339751|FG001|Treatment Period|Adverse Event|2|||
16315302|NCT01995513|39637370|FG003|Period 2: Double Blind Treatment|Other|3|||
16315303|NCT01995513|39637367|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
16198510|NCT00254293|39201371|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
16198511|NCT00254293|39201372|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
16198512|NCT00254293|39201373|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
16198513|NCT00254293|39201374|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
16315304|NCT01995513|39637368|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
16315305|NCT01995513|39637369|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
16315306|NCT01995513|39637370|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
16315307|NCT01995513|39637367|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
16315308|NCT01995513|39637368|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
16315309|NCT01995513|39637369|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
16315310|NCT01995513|39637370|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
16315311|NCT01995513|39637367|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
16315312|NCT01995513|39637368|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
16315313|NCT01995513|39637369|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
16315314|NCT01995513|39637370|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
16315315|NCT01995513|39637367|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
16315316|NCT01995513|39637368|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
16315317|NCT01995513|39637369|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
16315318|NCT01995513|39637370|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
16315319|NCT03885661|39637372|FG000|Overall Study|Withdrawal by Subject|0|||
16315320|NCT03885661|39637373|FG001|Overall Study|Withdrawal by Subject|1|||
16315321|NCT03885661|39637372|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
16315322|NCT03885661|39637373|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
16315323|NCT00568451|39637378|FG000|Overall Study|Disease Progression|0|||
16509501|NCT03161483|40339752|FG002|Treatment Period|Adverse Event|1|||
16509502|NCT03161483|40339753|FG003|Treatment Period|Adverse Event|11|||
16509503|NCT03161483|40339750|FG000|Treatment Period|Pregnancy|1|||
16509504|NCT03161483|40339751|FG001|Treatment Period|Pregnancy|0|||
16509505|NCT03161483|40339752|FG002|Treatment Period|Pregnancy|0|||
16509506|NCT03161483|40339753|FG003|Treatment Period|Pregnancy|0|||
16509507|NCT03161483|40339750|FG000|Treatment Period|Lack of Efficacy|0|||
16509508|NCT03161483|40339751|FG001|Treatment Period|Lack of Efficacy|0|||
16509509|NCT03161483|40339752|FG002|Treatment Period|Lack of Efficacy|0|||
16509510|NCT03161483|40339753|FG003|Treatment Period|Lack of Efficacy|1|||
16509511|NCT03161483|40339750|FG000|Treatment Period|Withdrawal by Subject|2|||
16509512|NCT03161483|40339751|FG001|Treatment Period|Withdrawal by Subject|5|||
16509513|NCT03161483|40339752|FG002|Treatment Period|Withdrawal by Subject|2|||
16509514|NCT03161483|40339753|FG003|Treatment Period|Withdrawal by Subject|6|||
16509515|NCT03161483|40339750|FG000|Treatment Period|Lost to Follow-up|0|||
16509516|NCT03161483|40339751|FG001|Treatment Period|Lost to Follow-up|0|||
16509517|NCT03161483|40339752|FG002|Treatment Period|Lost to Follow-up|0|||
16509518|NCT03161483|40339753|FG003|Treatment Period|Lost to Follow-up|1|||
16509519|NCT03161483|40339750|FG000|Treatment Period|Protocol Violation|0|||
16509520|NCT03161483|40339751|FG001|Treatment Period|Protocol Violation|0|||
16509521|NCT03161483|40339752|FG002|Treatment Period|Protocol Violation|0|||
16509522|NCT03161483|40339753|FG003|Treatment Period|Protocol Violation|1|||
16509523|NCT03161483|40339750|FG000|Treatment Period|Other reasons|1|||
16509524|NCT03161483|40339751|FG001|Treatment Period|Other reasons|1|||
16509525|NCT03161483|40339752|FG002|Treatment Period|Other reasons|0|||
16509526|NCT03161483|40339753|FG003|Treatment Period|Other reasons|0|||
16509527|NCT01393743|40339758|FG000|Core Study|Adverse Event|5|||
16509528|NCT01393743|40339759|FG001|Core Study|Adverse Event|9|||
16509529|NCT01393743|40339760|FG002|Core Study|Adverse Event|0|||
16509530|NCT01393743|40339758|FG000|Core Study|Lost to Follow-up|1|||
16509531|NCT01393743|40339759|FG001|Core Study|Lost to Follow-up|1|||
16509532|NCT01393743|40339760|FG002|Core Study|Lost to Follow-up|0|||
16509533|NCT01393743|40339758|FG000|Core Study|Participant's Choice|2|||
16509534|NCT01393743|40339759|FG001|Core Study|Participant's Choice|3|||
16509535|NCT01393743|40339760|FG002|Core Study|Participant's Choice|0|||
16509536|NCT01393743|40339758|FG000|Core Study|Inadequate therapeutic effect|2|||
16509537|NCT01393743|40339759|FG001|Core Study|Inadequate therapeutic effect|0|||
16509538|NCT01393743|40339760|FG002|Core Study|Inadequate therapeutic effect|0|||
16509539|NCT01393743|40339758|FG000|Extension Phase|Adverse Event|0|||
16509540|NCT01393743|40339759|FG001|Extension Phase|Adverse Event|0|||
16509541|NCT01393743|40339760|FG002|Extension Phase|Adverse Event|12|||
16509542|NCT01393743|40339758|FG000|Extension Phase|Lost to Follow-up|0|||
16509543|NCT01393743|40339759|FG001|Extension Phase|Lost to Follow-up|0|||
16509544|NCT01393743|40339760|FG002|Extension Phase|Lost to Follow-up|2|||
16509545|NCT01393743|40339758|FG000|Extension Phase|Participant choice|0|||
16509546|NCT01393743|40339759|FG001|Extension Phase|Participant choice|0|||
16509547|NCT01393743|40339760|FG002|Extension Phase|Participant choice|16|||
16509548|NCT01393743|40339758|FG000|Extension Phase|Inadequate therapeutic effect|0|||
16509549|NCT01393743|40339759|FG001|Extension Phase|Inadequate therapeutic effect|0|||
16509550|NCT01393743|40339760|FG002|Extension Phase|Inadequate therapeutic effect|7|||
16509551|NCT01393743|40339758|FG000|Extension Phase|Withdrawal by Subject|0|||
16509552|NCT01393743|40339759|FG001|Extension Phase|Withdrawal by Subject|0|||
16509553|NCT01393743|40339760|FG002|Extension Phase|Withdrawal by Subject|8|||
16509554|NCT01393743|40339758|FG000|Extension Phase|Pregnancy|0|||
16509555|NCT01393743|40339759|FG001|Extension Phase|Pregnancy|0|||
16509556|NCT01393743|40339760|FG002|Extension Phase|Pregnancy|1|||
16509557|NCT01393743|40339758|FG000|Extension Phase|Other|0|||
16392115|NCT01509846|39919571|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
16315324|NCT00568451|39637379|FG001|Overall Study|Disease Progression|0|||
16315325|NCT00568451|39637380|FG002|Overall Study|Disease Progression|2|||
16315326|NCT00568451|39637381|FG003|Overall Study|Disease Progression|7|||
16315327|NCT00191477|39637382|FG000|Overall Study|Tumor Recurrence|49|||
16315328|NCT00191477|39637383|FG001|Overall Study|Tumor Recurrence|48|||
16315329|NCT00191477|39637382|FG000|Overall Study|Death, Study Disease|1|||
16315330|NCT00191477|39637383|FG001|Overall Study|Death, Study Disease|1|||
16315331|NCT00191477|39637382|FG000|Overall Study|Death, Other Cause|3|||
16315332|NCT00191477|39637383|FG001|Overall Study|Death, Other Cause|6|||
16315333|NCT00191477|39637382|FG000|Overall Study|Lost to Follow-up|23|||
16315334|NCT00191477|39637383|FG001|Overall Study|Lost to Follow-up|21|||
16315335|NCT00191477|39637382|FG000|Overall Study|Protocol Violation|1|||
16315336|NCT00191477|39637383|FG001|Overall Study|Protocol Violation|1|||
16315337|NCT00191477|39637382|FG000|Overall Study|Treatment Change|2|||
16315338|NCT00191477|39637383|FG001|Overall Study|Treatment Change|0|||
16315339|NCT00191477|39637382|FG000|Overall Study|Withdrawal by Subject|2|||
16315340|NCT00191477|39637383|FG001|Overall Study|Withdrawal by Subject|0|||
16315341|NCT00191477|39637382|FG000|Overall Study|Other|2|||
16315342|NCT00191477|39637383|FG001|Overall Study|Other|0|||
16315343|NCT00191477|39637382|FG000|Overall Study|Not Eligible|41|||
16315344|NCT00191477|39637383|FG001|Overall Study|Not Eligible|38|||
16315345|NCT00191477|39637382|FG000|Overall Study|Pathological Specimen Lost|1|||
16315346|NCT00191477|39637383|FG001|Overall Study|Pathological Specimen Lost|0|||
16315347|NCT00191477|39637382|FG000|Overall Study|Discontinued Prior to Instillation|13|||
16315348|NCT00191477|39637383|FG001|Overall Study|Discontinued Prior to Instillation|14|||
16315349|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
16315350|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
16315351|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
16315352|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
16315353|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
16392116|NCT01509846|39919572|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
16392117|NCT01509846|39919573|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
16392118|NCT01509846|39919574|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
16392119|NCT01509846|39919575|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
16392120|NCT01509846|39919571|FG000|Received Vaccination 3|Pregnancy|0|||
16392121|NCT01509846|39919572|FG001|Received Vaccination 3|Pregnancy|0|||
16315354|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
16392122|NCT01509846|39919573|FG002|Received Vaccination 3|Pregnancy|0|||
16392123|NCT01509846|39919574|FG003|Received Vaccination 3|Pregnancy|1|||
16392124|NCT01509846|39919575|FG004|Received Vaccination 3|Pregnancy|0|||
16392125|NCT01509846|39919571|FG000|Received Vaccination 3|Lost to Follow-up|0|||
16392126|NCT01509846|39919572|FG001|Received Vaccination 3|Lost to Follow-up|0|||
16392127|NCT01509846|39919573|FG002|Received Vaccination 3|Lost to Follow-up|1|||
16392128|NCT01509846|39919574|FG003|Received Vaccination 3|Lost to Follow-up|0|||
16392129|NCT01509846|39919575|FG004|Received Vaccination 3|Lost to Follow-up|0|||
16392130|NCT01995526|39919578|FG000|Overall Study|Physician Decision|1|||
16392131|NCT01106157|39919581|FG000|Overall Study|Withdrawal by Subject|1|||
16392132|NCT01106157|39919582|FG001|Overall Study|Withdrawal by Subject|0|||
16315355|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
16315356|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
16315357|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
16315358|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
16315359|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
16315360|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
16392133|NCT04482439|39919583|FG000|Overall Study|Lost to Follow-up|1|||
16392134|NCT04482439|39919583|FG000|Overall Study|Unrelated illness|1|||
16392135|NCT00466947|39919584|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
16392136|NCT00466947|39919585|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
16392137|NCT00466947|39919584|FG000|Study End Analysis Period|Adverse Event|35|||
16509558|NCT01393743|40339759|FG001|Extension Phase|Other|0|||
16315361|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
16315362|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
16315363|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
16315364|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
16315365|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
16315366|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
16315367|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
16315368|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
16315369|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
16315370|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
16315371|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
16315372|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
16315373|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
16315374|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
16315375|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
16315376|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
16315377|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
16315378|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
16315379|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
16315380|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
16315381|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
16315382|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
16315383|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
16315384|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
16315385|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
16315386|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
16315387|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
16315388|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
16315389|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
16315390|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
16315391|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
16315392|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
16315393|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
16315394|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
16315395|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
16315396|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
16315397|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
16315398|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
16315399|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
16315400|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
16315401|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Site closed|0|||
16315402|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Site closed|0|||
16315403|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Site closed|1|||
16315404|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Site closed|0|||
16315405|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
16315406|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
16315407|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
16315408|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
16315409|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
16315410|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
16315411|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
16315412|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
16315413|NCT00838903|39637384|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
16315414|NCT00838903|39637385|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
16315415|NCT00838903|39637386|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
16315416|NCT00838903|39637387|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
16315417|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
16315418|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
16315419|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
16315420|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
16315421|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
16315422|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
16315423|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
16315424|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
16509559|NCT01393743|40339760|FG002|Extension Phase|Other|14|||
16198514|NCT00254293|39201375|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
16509560|NCT00748215|40339761|FG000|Overall Study|Withdrawal by Subject|7|||
16509561|NCT00748215|40339762|FG001|Overall Study|Withdrawal by Subject|7|||
16509562|NCT00748215|40339761|FG000|Overall Study|Treatment change|2|||
16509563|NCT00748215|40339762|FG001|Overall Study|Treatment change|1|||
16509564|NCT00748215|40339761|FG000|Overall Study|Change in patient condition|0|||
16509565|NCT00748215|40339762|FG001|Overall Study|Change in patient condition|3|||
16509566|NCT00748215|40339761|FG000|Overall Study|Non-compliant|0|||
16509567|NCT00748215|40339762|FG001|Overall Study|Non-compliant|2|||
16509568|NCT00748215|40339761|FG000|Overall Study|Adverse Event|0|||
16509569|NCT00748215|40339762|FG001|Overall Study|Adverse Event|5|||
16509570|NCT00983580|40339763|FG000|Overall Study|Cancel Prior to treatment|1|||
16509571|NCT00983580|40339764|FG001|Overall Study|Cancel Prior to treatment|3|||
16509572|NCT00983580|40339763|FG000|Overall Study|Protocol Violation|1|||
16509573|NCT00983580|40339764|FG001|Overall Study|Protocol Violation|1|||
16509574|NCT00983580|40339763|FG000|Overall Study|Ineligible|3|||
16509575|NCT00983580|40339764|FG001|Overall Study|Ineligible|0|||
16509576|NCT01933048|40339765|FG000|Overall Study|Lost to Follow-up|15|||
16509577|NCT01933048|40339766|FG001|Overall Study|Lost to Follow-up|18|||
16509578|NCT01933048|40339765|FG000|Overall Study|personal reasons|1|||
16509579|NCT01933048|40339766|FG001|Overall Study|personal reasons|1|||
16509580|NCT01933048|40339765|FG000|Overall Study|Protocol Violation|7|||
16509581|NCT01933048|40339766|FG001|Overall Study|Protocol Violation|8|||
16509582|NCT01933048|40339765|FG000|Overall Study|Physician Decision|1|||
16509583|NCT01933048|40339766|FG001|Overall Study|Physician Decision|0|||
16509584|NCT01933048|40339765|FG000|Overall Study|unknown reasons|1|||
16509585|NCT01933048|40339766|FG001|Overall Study|unknown reasons|1|||
16509586|NCT01132495|40339773|FG000|Overall Study|Various reasons|40|||
16509587|NCT01132495|40339774|FG001|Overall Study|Various reasons|38|||
16509588|NCT01132495|40339775|FG002|Overall Study|Various reasons|20|||
16509589|NCT01132495|40339776|FG003|Overall Study|Various reasons|12|||
16509590|NCT01400516|40339780|FG000|Primary Trial|Withdrawal by Subject|0|||
16509591|NCT01400516|40339781|FG001|Primary Trial|Withdrawal by Subject|2|||
16509592|NCT03338062|40339782|FG000|Overall Study|Alternative Therapy|1|||
16509593|NCT03338062|40339783|FG001|Overall Study|Alternative Therapy|0|||
16509594|NCT01231581|40339785|FG000|Overall Study|Lost to Follow-up|2|||
16509595|NCT01231581|40339786|FG001|Overall Study|Lost to Follow-up|2|||
16198515|NCT00254293|39201376|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
16198516|NCT00254293|39201370|FG000|LTE Open Label Fixed Dosing|Other|0|||
16198517|NCT00254293|39201371|FG001|LTE Open Label Fixed Dosing|Other|0|||
16509596|NCT01231581|40339785|FG000|Overall Study|Withdrawal by Subject|6|||
16509597|NCT01231581|40339786|FG001|Overall Study|Withdrawal by Subject|9|||
16198518|NCT00254293|39201372|FG002|LTE Open Label Fixed Dosing|Other|0|||
16509598|NCT01231581|40339785|FG000|Overall Study|Study Closed/Terminated|6|||
16509599|NCT01231581|40339786|FG001|Overall Study|Study Closed/Terminated|5|||
16509600|NCT01231581|40339785|FG000|Overall Study|Death|65|||
16198519|NCT00254293|39201373|FG003|LTE Open Label Fixed Dosing|Other|0|||
16198520|NCT00254293|39201374|FG004|LTE Open Label Fixed Dosing|Other|0|||
16198521|NCT00254293|39201375|FG005|LTE Open Label Fixed Dosing|Other|0|||
16198522|NCT00254293|39201376|FG006|LTE Open Label Fixed Dosing|Other|1|||
16509601|NCT01231581|40339786|FG001|Overall Study|Death|64|||
16509602|NCT01231581|40339785|FG000|Overall Study|Ongoing|1|||
16509603|NCT01231581|40339786|FG001|Overall Study|Ongoing|0|||
16509604|NCT01009099|40339787|FG000|Overall Study|Lost to Follow-up|1|||
16509605|NCT01009099|40339788|FG001|Overall Study|Lost to Follow-up|0|||
16198523|NCT01640925|39201382|FG000|Overall Study|Withdrawal by Subject|1|||
16509606|NCT01009099|40339787|FG000|Overall Study|Physician Decision|3|||
16198524|NCT01640925|39201383|FG001|Overall Study|Withdrawal by Subject|0|||
16198525|NCT01640925|39201382|FG000|Overall Study|Previously enrolled in this trial|13|||
16198526|NCT01640925|39201383|FG001|Overall Study|Previously enrolled in this trial|11|||
16198527|NCT02670330|39201384|FG000|Overall Study|Protocol Deviation|1|||
16198528|NCT02670330|39201385|FG001|Overall Study|Protocol Deviation|0|||
16198529|NCT02670330|39201384|FG000|Overall Study|Study Terminated By Sponsor|36|||
16198530|NCT02670330|39201385|FG001|Overall Study|Study Terminated By Sponsor|43|||
16198531|NCT02670330|39201384|FG000|Overall Study|Adverse Event|1|||
16198532|NCT02670330|39201385|FG001|Overall Study|Adverse Event|3|||
16198533|NCT02670330|39201384|FG000|Overall Study|Withdrawal by Subject|34|||
16198534|NCT02670330|39201385|FG001|Overall Study|Withdrawal by Subject|29|||
16198535|NCT02670330|39201384|FG000|Overall Study|Lost to Follow-up|3|||
16198536|NCT02670330|39201385|FG001|Overall Study|Lost to Follow-up|2|||
16198537|NCT02062463|39201386|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
16198538|NCT02062463|39201387|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
16198539|NCT02062463|39201388|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
16198540|NCT02062463|39201389|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
16198541|NCT02062463|39201386|FG000|Stage 2|Adverse Event|0|||
16198542|NCT02062463|39201387|FG001|Stage 2|Adverse Event|0|||
16198543|NCT02062463|39201388|FG002|Stage 2|Adverse Event|12|||
16198544|NCT02062463|39201389|FG003|Stage 2|Adverse Event|20|||
16198545|NCT02062463|39201386|FG000|Stage 2|Lack of Efficacy|0|||
16198546|NCT02062463|39201387|FG001|Stage 2|Lack of Efficacy|0|||
16198547|NCT02062463|39201388|FG002|Stage 2|Lack of Efficacy|3|||
16198548|NCT02062463|39201389|FG003|Stage 2|Lack of Efficacy|4|||
16198549|NCT02062463|39201386|FG000|Stage 2|Lost to Follow-up|0|||
16198550|NCT02062463|39201387|FG001|Stage 2|Lost to Follow-up|0|||
16198551|NCT02062463|39201388|FG002|Stage 2|Lost to Follow-up|20|||
16198552|NCT02062463|39201389|FG003|Stage 2|Lost to Follow-up|20|||
16198553|NCT02062463|39201386|FG000|Stage 2|Non-Compliance|0|||
16198554|NCT02062463|39201387|FG001|Stage 2|Non-Compliance|0|||
16198555|NCT02062463|39201388|FG002|Stage 2|Non-Compliance|0|||
16198556|NCT02062463|39201389|FG003|Stage 2|Non-Compliance|1|||
16198557|NCT02062463|39201386|FG000|Stage 2|Other than specified|0|||
16198558|NCT02062463|39201387|FG001|Stage 2|Other than specified|0|||
16198559|NCT02062463|39201388|FG002|Stage 2|Other than specified|3|||
16198560|NCT02062463|39201389|FG003|Stage 2|Other than specified|1|||
16198561|NCT02062463|39201386|FG000|Stage 2|Withdrawal by Subject|0|||
16198562|NCT02062463|39201387|FG001|Stage 2|Withdrawal by Subject|0|||
16198563|NCT02062463|39201388|FG002|Stage 2|Withdrawal by Subject|15|||
16198564|NCT02062463|39201389|FG003|Stage 2|Withdrawal by Subject|10|||
16198565|NCT02559713|39201390|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
16198566|NCT02862548|39201391|FG000|Randomized Phase (Up to Week 48)|Death|0|||
16198567|NCT02862548|39201392|FG001|Randomized Phase (Up to Week 48)|Death|1|||
16198568|NCT02862548|39201391|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
16198569|NCT02862548|39201392|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
16198570|NCT02862548|39201391|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
16198571|NCT02862548|39201392|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
16198572|NCT02862548|39201391|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
16198573|NCT02862548|39201392|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
16198574|NCT00579501|39201395|FG000|Overall Study|Death|1|||
16198575|NCT00579501|39201395|FG000|Overall Study|End of neoadjuvant therapy|25|||
16198576|NCT00579501|39201395|FG000|Overall Study|toxicity|1|||
16198577|NCT00579501|39201395|FG000|Overall Study|Secondary lesion|1|||
16198578|NCT00579501|39201395|FG000|Overall Study|Radiation therapy before surgery|1|||
16198579|NCT00012012|39201396|FG000|Overall Study|Protocol Violation|1|||
16198580|NCT00012012|39201397|FG001|Overall Study|Protocol Violation|1|||
16198581|NCT00012012|39201396|FG000|Overall Study|Withdrawal by Subject|0|||
16198582|NCT00012012|39201397|FG001|Overall Study|Withdrawal by Subject|2|||
16198583|NCT01767519|39201400|FG000|Overall Study|Other Reasons|4|||
16198584|NCT01767519|39201401|FG001|Overall Study|Other Reasons|4|||
16509607|NCT01009099|40339788|FG001|Overall Study|Physician Decision|2|||
16509608|NCT01009099|40339787|FG000|Overall Study|Withdrawal by Subject|1|||
16198585|NCT01767519|39201402|FG002|Overall Study|Other Reasons|2|||
16198586|NCT01767519|39201400|FG000|Overall Study|Protocol Violation|0|||
16198587|NCT01767519|39201401|FG001|Overall Study|Protocol Violation|3|||
16198588|NCT01767519|39201402|FG002|Overall Study|Protocol Violation|0|||
16198589|NCT01767519|39201400|FG000|Overall Study|Personal Reasons|1|||
16198590|NCT01767519|39201401|FG001|Overall Study|Personal Reasons|0|||
16198591|NCT01767519|39201402|FG002|Overall Study|Personal Reasons|0|||
16198592|NCT01767519|39201400|FG000|Overall Study|Lost to Follow-up|3|||
16198593|NCT01767519|39201401|FG001|Overall Study|Lost to Follow-up|1|||
16509609|NCT01009099|40339788|FG001|Overall Study|Withdrawal by Subject|1|||
16198594|NCT01767519|39201402|FG002|Overall Study|Lost to Follow-up|2|||
16198595|NCT01767519|39201400|FG000|Overall Study|Lack of Efficacy|1|||
16198596|NCT01767519|39201401|FG001|Overall Study|Lack of Efficacy|0|||
16198597|NCT01767519|39201402|FG002|Overall Study|Lack of Efficacy|0|||
16198598|NCT01767519|39201400|FG000|Overall Study|Adverse Event|5|||
16198599|NCT01767519|39201401|FG001|Overall Study|Adverse Event|5|||
16509610|NCT01009099|40339787|FG000|Overall Study|Death|0|||
16509611|NCT01009099|40339788|FG001|Overall Study|Death|1|||
16509612|NCT02129803|40339789|FG000|Overall Study|Protocol Violation|4|||
16509613|NCT02129803|40339790|FG001|Overall Study|Protocol Violation|0|||
16509614|NCT02129803|40339789|FG000|Overall Study|Physician Decision|0|||
16509615|NCT02129803|40339790|FG001|Overall Study|Physician Decision|1|||
16509616|NCT02129803|40339789|FG000|Overall Study|Difficulty sleeping|1|||
16509617|NCT02129803|40339790|FG001|Overall Study|Difficulty sleeping|0|||
16509618|NCT02129803|40339789|FG000|Overall Study|Morning headache|0|||
16509619|NCT02129803|40339790|FG001|Overall Study|Morning headache|1|||
16509620|NCT02129803|40339789|FG000|Overall Study|Withdrawal by Subject|1|||
16509621|NCT02129803|40339790|FG001|Overall Study|Withdrawal by Subject|1|||
16509622|NCT01859507|40339791|FG000|Overall Study|left the country|4|||
16509623|NCT02622828|40339801|FG000|Overall Study|participant withdrew|3|||
16509624|NCT01765153|40339802|FG000|Training Phase 1|Format of intervention differed|1|||
16509625|NCT01765153|40339803|FG001|Training Phase 1|Format of intervention differed|0|||
16509626|NCT01765153|40339802|FG000|Training Phase 1|Poor participation in intervention|0|||
16509627|NCT01765153|40339803|FG001|Training Phase 1|Poor participation in intervention|1|||
16509628|NCT01765153|40339802|FG000|Rest Phase 1|Withdrawal by Subject|0|||
16509629|NCT01765153|40339803|FG001|Rest Phase 1|Withdrawal by Subject|1|||
16509630|NCT01765153|40339802|FG000|Training Phase 2|Withdrawal by Subject|0|||
16509631|NCT01765153|40339803|FG001|Training Phase 2|Withdrawal by Subject|1|||
16509632|NCT01765153|40339802|FG000|Rest Phase 2|Lost to Follow-up|2|||
16509633|NCT01765153|40339803|FG001|Rest Phase 2|Lost to Follow-up|1|||
16509634|NCT02457325|40339804|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
16509635|NCT02457325|40339805|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
16509636|NCT03044197|40339806|FG000|Overall Study|Withdrawal by Subject|3|||
16509637|NCT03044197|40339807|FG001|Overall Study|Withdrawal by Subject|1|||
16509638|NCT02196324|40339808|FG000|Overall Study|Withdrawal by Subject|8|||
16509639|NCT02196324|40339809|FG001|Overall Study|Withdrawal by Subject|4|||
16509640|NCT02196324|40339808|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
16509641|NCT02196324|40339809|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
16509642|NCT02196324|40339808|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
16509643|NCT02196324|40339809|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
16509644|NCT02196324|40339808|FG000|Overall Study|Other|1|||
16509645|NCT02196324|40339809|FG001|Overall Study|Other|0|||
16509646|NCT04365699|40339813|FG000|Overall Study|Death|2|||
16509647|NCT04365699|40339814|FG001|Overall Study|Death|5|||
16509648|NCT04365699|40339815|FG002|Overall Study|Death|15|||
16509649|NCT01945489|40339816|FG000|Cycle 1|Adverse Event|2|||
16509650|NCT01945489|40339817|FG001|Cycle 1|Adverse Event|0|||
16509651|NCT01945489|40339816|FG000|Cycle 1|Lost to Follow-up|4|||
16509652|NCT01945489|40339817|FG001|Cycle 1|Lost to Follow-up|0|||
16509653|NCT01945489|40339816|FG000|Cycle 1|Personal Reasons|4|||
16509654|NCT01945489|40339817|FG001|Cycle 1|Personal Reasons|2|||
16509655|NCT01945489|40339816|FG000|Cycle 1|Protocol Violation|0|||
16509656|NCT01945489|40339817|FG001|Cycle 1|Protocol Violation|1|||
16509657|NCT01945489|40339816|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
16509658|NCT01945489|40339817|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
16509659|NCT01945489|40339816|FG000|Cycle 2|Adverse Event|1|||
16509660|NCT01945489|40339817|FG001|Cycle 2|Adverse Event|0|||
16509661|NCT01945489|40339816|FG000|Cycle 2|Lost to Follow-up|0|||
16509662|NCT01945489|40339817|FG001|Cycle 2|Lost to Follow-up|1|||
16509663|NCT00235872|40339818|FG000|Overall Study|Adverse Event|34|||
16509664|NCT00235872|40339818|FG000|Overall Study|Death|1|||
16509665|NCT00235872|40339818|FG000|Overall Study|Lost to Follow-up|1|||
16509666|NCT00235872|40339818|FG000|Overall Study|Withdrawal by Subject|50|||
16509667|NCT00235872|40339818|FG000|Overall Study|Administrative reason|61|||
16509668|NCT01418209|40339820|FG000|Overall Study|Withdrawal by Subject|1|||
16509669|NCT01418209|40339821|FG001|Overall Study|Withdrawal by Subject|0|||
16509670|NCT01418209|40339822|FG002|Overall Study|Withdrawal by Subject|1|||
16509671|NCT01418209|40339820|FG000|Overall Study|Did not provide hot flash diary data|1|||
16509672|NCT01418209|40339821|FG001|Overall Study|Did not provide hot flash diary data|3|||
16509673|NCT01418209|40339822|FG002|Overall Study|Did not provide hot flash diary data|3|||
16509674|NCT00405548|40339831|FG000|Overall Study|Cognitive Memory problems on study day|1|||
16509675|NCT00405548|40339832|FG001|Overall Study|Cognitive Memory problems on study day|0|||
16509676|NCT00405548|40339831|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
16509677|NCT00405548|40339832|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
16509678|NCT00405548|40339831|FG000|Overall Study|Unable to self-administer shots|1|||
16509679|NCT00405548|40339832|FG001|Overall Study|Unable to self-administer shots|0|||
16509680|NCT00405548|40339831|FG000|Overall Study|Venous access failed during study day|1|||
16509681|NCT00405548|40339832|FG001|Overall Study|Venous access failed during study day|0|||
16509682|NCT00405548|40339831|FG000|Overall Study|Withdrawal by Subject|1|||
16509683|NCT00405548|40339832|FG001|Overall Study|Withdrawal by Subject|0|||
16509684|NCT00380393|40339835|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
16509685|NCT00380393|40339836|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
16509686|NCT00380393|40339835|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
16509687|NCT00380393|40339836|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
16509688|NCT00380393|40339835|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
16509689|NCT00380393|40339836|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
16509690|NCT00380393|40339835|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
16509691|NCT00380393|40339836|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
16509692|NCT00380393|40339835|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
16509693|NCT00380393|40339836|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
16509694|NCT00380393|40339835|FG000|Month 14|Withdrawal by Subject|9|||
16509695|NCT00380393|40339836|FG001|Month 14|Withdrawal by Subject|7|||
16509696|NCT00380393|40339835|FG000|Month 14|Death|1|||
16509697|NCT00380393|40339836|FG001|Month 14|Death|0|||
16509698|NCT00380393|40339835|FG000|Month 14|Lost to Follow-up|0|||
16198600|NCT01767519|39201402|FG002|Overall Study|Adverse Event|1|||
16198601|NCT00805545|39201403|FG000|Overall Study|Protocol Violation|3|||
16198602|NCT00805545|39201404|FG001|Overall Study|Protocol Violation|2|||
16198603|NCT00805545|39201403|FG000|Overall Study|Protocol Violation|3|||
16198604|NCT00805545|39201404|FG001|Overall Study|Protocol Violation|1|||
16198605|NCT01086150|39201405|FG000|Overall Study|Withdrawal by Subject|0|||
16198606|NCT01086150|39201406|FG001|Overall Study|Withdrawal by Subject|4|||
16198607|NCT01086150|39201407|FG002|Overall Study|Withdrawal by Subject|1|||
16198608|NCT01086150|39201405|FG000|Overall Study|Lost to Follow-up|0|||
16198609|NCT01086150|39201406|FG001|Overall Study|Lost to Follow-up|1|||
16198610|NCT01086150|39201407|FG002|Overall Study|Lost to Follow-up|0|||
16198611|NCT01086150|39201405|FG000|Overall Study|Screen Failure|0|||
16198612|NCT01086150|39201406|FG001|Overall Study|Screen Failure|1|||
16198613|NCT01086150|39201407|FG002|Overall Study|Screen Failure|0|||
16198614|NCT02657551|39201408|FG000|Overall Study|Adverse Event|2|||
16198615|NCT02657551|39201408|FG000|Overall Study|Withdrawal by Subject|1|||
16198616|NCT02657551|39201408|FG000|Overall Study|Non-Compliance|1|||
16198617|NCT02657551|39201408|FG000|Overall Study|Progression / Relapse|4|||
16198618|NCT00946530|39201409|FG000|Overall Study|Withdrawal by Subject|0|||
16198619|NCT00946530|39201410|FG001|Overall Study|Withdrawal by Subject|3|||
16198620|NCT00946530|39201411|FG002|Overall Study|Withdrawal by Subject|0|||
16198621|NCT00946530|39201412|FG003|Overall Study|Withdrawal by Subject|3|||
16198622|NCT00946530|39201409|FG000|Overall Study|Physician Decision|1|||
16198623|NCT00946530|39201410|FG001|Overall Study|Physician Decision|1|||
16198624|NCT00946530|39201411|FG002|Overall Study|Physician Decision|1|||
16198625|NCT00946530|39201412|FG003|Overall Study|Physician Decision|1|||
16198626|NCT00111475|39204349|FG000|Overall Study|Lost to Follow-up|0|||
16198627|NCT00111475|39204350|FG001|Overall Study|Lost to Follow-up|0|||
16198628|NCT00111475|39204351|FG002|Overall Study|Lost to Follow-up|0|||
16198629|NCT00111475|39204352|FG003|Overall Study|Lost to Follow-up|0|||
16198630|NCT00111475|39204353|FG004|Overall Study|Lost to Follow-up|0|||
16198631|NCT00111475|39204354|FG005|Overall Study|Lost to Follow-up|1|||
16198632|NCT00111475|39204355|FG006|Overall Study|Lost to Follow-up|0|||
16198633|NCT00111475|39204356|FG007|Overall Study|Lost to Follow-up|0|||
16198634|NCT00111475|39204357|FG008|Overall Study|Lost to Follow-up|0|||
16198635|NCT00111475|39204358|FG009|Overall Study|Lost to Follow-up|0|||
16198636|NCT01208038|39204362|FG000|Overall Study|Withdrawal by Subject|1|||
16198637|NCT02124707|39204363|FG000|Overall Study|Adverse Event|5|||
16198638|NCT02124707|39204363|FG000|Overall Study|Physician Decision|1|||
16198639|NCT02124707|39204363|FG000|Overall Study|Death|1|||
16198640|NCT00817206|39204365|FG000|Overall Study|Adverse Event|10|||
16198641|NCT00817206|39204366|FG001|Overall Study|Adverse Event|3|||
16198642|NCT00817206|39204365|FG000|Overall Study|Protocol Violation|0|||
16198643|NCT00817206|39204366|FG001|Overall Study|Protocol Violation|2|||
16198644|NCT00817206|39204365|FG000|Overall Study|Lost to Follow-up|0|||
16198645|NCT00817206|39204366|FG001|Overall Study|Lost to Follow-up|1|||
16198646|NCT00817206|39204365|FG000|Overall Study|Death|2|||
16198647|NCT00817206|39204366|FG001|Overall Study|Death|0|||
16198648|NCT00817206|39204365|FG000|Overall Study|Withdrawal by Subject|7|||
16198649|NCT00817206|39204366|FG001|Overall Study|Withdrawal by Subject|3|||
16198650|NCT00817206|39204365|FG000|Overall Study|Physician Decision|2|||
16198651|NCT00817206|39204366|FG001|Overall Study|Physician Decision|0|||
16198652|NCT00264849|39204367|FG000|Overall Study|Adverse Event|7|||
16198653|NCT00264849|39204368|FG001|Overall Study|Adverse Event|2|||
16198654|NCT00264849|39204367|FG000|Overall Study|Withdrawal by Subject|7|||
16198655|NCT00264849|39204368|FG001|Overall Study|Withdrawal by Subject|11|||
16198656|NCT00264849|39204367|FG000|Overall Study|Protocol Violation|5|||
16198657|NCT00264849|39204368|FG001|Overall Study|Protocol Violation|3|||
16198658|NCT00264849|39204367|FG000|Overall Study|Lack of Efficacy|1|||
16198659|NCT00264849|39204368|FG001|Overall Study|Lack of Efficacy|6|||
16198660|NCT00264849|39204367|FG000|Overall Study|Lost to Follow-up|0|||
16198661|NCT00264849|39204368|FG001|Overall Study|Lost to Follow-up|2|||
16198662|NCT00264849|39204367|FG000|Overall Study|Death|0|||
16198663|NCT00264849|39204368|FG001|Overall Study|Death|1|||
16198664|NCT00264849|39204367|FG000|Overall Study|Administrative Problems|2|||
16198665|NCT00264849|39204368|FG001|Overall Study|Administrative Problems|0|||
16198666|NCT00643487|39204369|FG000|Overall Study|Technical difficulty|3|||
16198667|NCT00964158|39204374|FG000|Overall Study|Lost to Follow-up|0|||
16198668|NCT00964158|39204375|FG001|Overall Study|Lost to Follow-up|1|||
16198669|NCT00964158|39204376|FG002|Overall Study|Lost to Follow-up|2|||
16198670|NCT00964158|39204374|FG000|Overall Study|Withdrawal by Subject|0|||
16198671|NCT00964158|39204375|FG001|Overall Study|Withdrawal by Subject|0|||
16198672|NCT00964158|39204376|FG002|Overall Study|Withdrawal by Subject|6|||
16198673|NCT00567541|39204377|FG000|Overall Study|Adverse Event|0|||
16198674|NCT00567541|39204378|FG001|Overall Study|Adverse Event|1|||
16198675|NCT02310906|39204379|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
16198676|NCT02310906|39204380|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
16198677|NCT02310906|39204381|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
16198678|NCT02310906|39204382|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
16198679|NCT02310906|39204379|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
16198680|NCT02310906|39204380|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
16198681|NCT02310906|39204381|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
16198682|NCT02310906|39204382|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
16198683|NCT02310906|39204379|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
16198684|NCT02310906|39204380|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
16198685|NCT02310906|39204381|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
16198686|NCT02310906|39204382|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
16198687|NCT02310906|39204379|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
16198688|NCT02310906|39204380|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
16198689|NCT02310906|39204381|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
16198690|NCT02310906|39204382|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
16198691|NCT02701192|39204383|FG000|Overall Study|Protocol Violation|2|||
16509699|NCT00380393|40339836|FG001|Month 14|Lost to Follow-up|1|||
16509700|NCT00380393|40339835|FG000|Month 14|Migrated/moved from study area|39|||
16509701|NCT00380393|40339836|FG001|Month 14|Migrated/moved from study area|42|||
16509702|NCT00380393|40339835|FG000|Month 14|Protocol Violation|2|||
16509703|NCT00380393|40339836|FG001|Month 14|Protocol Violation|0|||
16509704|NCT00380393|40339835|FG000|Month 14|Others|6|||
16509705|NCT00380393|40339836|FG001|Month 14|Others|6|||
16509706|NCT01247090|40339837|FG000|Overall Study|Physician Decision|1|||
16392138|NCT00466947|39919585|FG001|Study End Analysis Period|Adverse Event|43|||
16392139|NCT00466947|39919584|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
16392140|NCT00466947|39919585|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
16509707|NCT01247090|40339838|FG001|Overall Study|Physician Decision|0|||
16509708|NCT01247090|40339839|FG002|Overall Study|Physician Decision|0|||
16198692|NCT02701192|39204383|FG000|Overall Study|Lost to Follow-up|4|||
16198693|NCT03954444|39204390|FG000|Overall Study|Withdrawal by Subject|5|||
16509709|NCT01247090|40339837|FG000|Overall Study|Withdrawal by Subject|0|||
16509710|NCT01247090|40339838|FG001|Overall Study|Withdrawal by Subject|1|||
16198694|NCT03954444|39204391|FG001|Overall Study|Withdrawal by Subject|5|||
16198695|NCT03954444|39204392|FG002|Overall Study|Withdrawal by Subject|5|||
16198696|NCT03954444|39204390|FG000|Overall Study|Adverse Event|1|||
16198697|NCT03954444|39204391|FG001|Overall Study|Adverse Event|3|||
16198698|NCT03954444|39204392|FG002|Overall Study|Adverse Event|2|||
16198699|NCT03954444|39204390|FG000|Overall Study|Protocol Violation|0|||
16198700|NCT03954444|39204391|FG001|Overall Study|Protocol Violation|3|||
16198701|NCT03954444|39204392|FG002|Overall Study|Protocol Violation|5|||
16198702|NCT03954444|39204390|FG000|Overall Study|Use of prohibited therapy|1|||
16198703|NCT03954444|39204391|FG001|Overall Study|Use of prohibited therapy|1|||
16198704|NCT03954444|39204392|FG002|Overall Study|Use of prohibited therapy|2|||
16198705|NCT03954444|39204390|FG000|Overall Study|Lost to Follow-up|1|||
16198706|NCT03954444|39204391|FG001|Overall Study|Lost to Follow-up|0|||
16198707|NCT03954444|39204392|FG002|Overall Study|Lost to Follow-up|1|||
16198708|NCT03954444|39204390|FG000|Overall Study|Non-compliant with study drug application|2|||
16198709|NCT03954444|39204391|FG001|Overall Study|Non-compliant with study drug application|2|||
16198710|NCT03954444|39204392|FG002|Overall Study|Non-compliant with study drug application|0|||
16198711|NCT03954444|39204390|FG000|Overall Study|Administrative reasons|0|||
16198712|NCT03954444|39204391|FG001|Overall Study|Administrative reasons|0|||
16198713|NCT03954444|39204392|FG002|Overall Study|Administrative reasons|1|||
16198714|NCT03954444|39204390|FG000|Overall Study|Miscellaneous|3|||
16198715|NCT03954444|39204391|FG001|Overall Study|Miscellaneous|2|||
16198716|NCT03954444|39204392|FG002|Overall Study|Miscellaneous|1|||
16198717|NCT03589885|39204393|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
16198718|NCT03589885|39204394|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
16198719|NCT03589885|39204395|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
16198720|NCT03589885|39204396|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
16198721|NCT03589885|39204397|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
16198722|NCT03589885|39204393|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
16198723|NCT03589885|39204394|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
16198724|NCT03589885|39204395|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
16198725|NCT03589885|39204396|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
16198726|NCT03589885|39204397|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
16198727|NCT03589885|39204393|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
16198728|NCT03589885|39204394|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
16198729|NCT03589885|39204395|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
16198730|NCT03589885|39204396|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
16198731|NCT03589885|39204397|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
16198732|NCT03589885|39204393|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
16198733|NCT03589885|39204394|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
16198734|NCT03589885|39204395|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
16198735|NCT03589885|39204396|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
16198736|NCT03589885|39204397|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
16198737|NCT03589885|39204393|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
16198738|NCT03589885|39204394|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
16198739|NCT03589885|39204395|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
16198740|NCT03589885|39204396|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
16198741|NCT03589885|39204397|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
16198742|NCT03589885|39204393|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
16198743|NCT03589885|39204394|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
16198744|NCT03589885|39204395|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
16198745|NCT03589885|39204396|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
16198746|NCT03589885|39204397|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
16198747|NCT03589885|39204393|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
16198748|NCT03589885|39204394|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
16198749|NCT03589885|39204395|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
16198750|NCT03589885|39204396|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
16198751|NCT03589885|39204397|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
16198752|NCT03589885|39204393|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
16198753|NCT03589885|39204394|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
16198754|NCT03589885|39204395|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
16198755|NCT03589885|39204396|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
16198756|NCT03589885|39204397|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
16198757|NCT01195831|39204398|FG000|Overall Study|Lost to Follow-up|2|||
16509711|NCT01247090|40339839|FG002|Overall Study|Withdrawal by Subject|0|||
16198758|NCT01195831|39204399|FG001|Overall Study|Lost to Follow-up|4|||
16198759|NCT01195831|39204398|FG000|Overall Study|Withdrawal by Subject|2|||
16198760|NCT01195831|39204399|FG001|Overall Study|Withdrawal by Subject|2|||
16198761|NCT01195831|39204398|FG000|Overall Study|Adverse Event|4|||
16198762|NCT01195831|39204399|FG001|Overall Study|Adverse Event|2|||
16315425|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
16315426|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
16315427|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
16315428|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
16315429|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
16315430|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
16315431|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
16315432|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
16315433|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
16198763|NCT01195831|39204398|FG000|Overall Study|Protocol Violation|0|||
16198764|NCT01195831|39204399|FG001|Overall Study|Protocol Violation|2|||
16198765|NCT03655717|39204401|FG000|Overall Study|Withdrawal by Subject|4|||
16198766|NCT03655717|39204402|FG001|Overall Study|Withdrawal by Subject|8|||
16315434|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
16315435|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
16315436|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
16315437|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
16315438|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
16315439|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
16315440|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
16315441|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
16392141|NCT00466947|39919584|FG000|Study End Analysis Period|Physician Decision|29|||
16392142|NCT00466947|39919585|FG001|Study End Analysis Period|Physician Decision|29|||
16392143|NCT00466947|39919584|FG000|Study End Analysis Period|Protocol Violation|9|||
16315442|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
16315443|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
16315444|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
16315445|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
16315446|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
16392144|NCT00466947|39919585|FG001|Study End Analysis Period|Protocol Violation|17|||
16392145|NCT00466947|39919584|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
16315447|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
16315448|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
16315449|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
16315450|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
16315451|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
16315452|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
16315453|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
16315454|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
16315455|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
16315456|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
16315457|NCT00838903|39637384|FG000|Follow-up Period (8 Weeks)|Missing|1|||
16315458|NCT00838903|39637385|FG001|Follow-up Period (8 Weeks)|Missing|2|||
16315459|NCT00838903|39637386|FG002|Follow-up Period (8 Weeks)|Missing|1|||
16315460|NCT00838903|39637387|FG003|Follow-up Period (8 Weeks)|Missing|1|||
16315461|NCT00740636|39637394|FG000|Overall Study|Adverse Event|0|||
16315462|NCT00740636|39637395|FG001|Overall Study|Adverse Event|2|||
16315463|NCT00740636|39637394|FG000|Overall Study|Patient Ineligible|0|||
16315464|NCT00740636|39637395|FG001|Overall Study|Patient Ineligible|1|||
16315465|NCT00740636|39637394|FG000|Overall Study|Patient Not Treated|0|||
16315466|NCT00740636|39637395|FG001|Overall Study|Patient Not Treated|1|||
16392146|NCT00466947|39919585|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
16392147|NCT00466947|39919584|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
16392148|NCT00466947|39919585|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
16392149|NCT00466947|39919584|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
16392150|NCT00466947|39919585|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
16392151|NCT00466947|39919584|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
16409945|NCT00343915|39981842|FG001|Primary Study|Withdrawal by Subject|0|||
16315467|NCT00740636|39637394|FG000|Overall Study|Progressive Disease|1|||
16315468|NCT00740636|39637395|FG001|Overall Study|Progressive Disease|0|||
16315469|NCT00740636|39637394|FG000|Overall Study|Death|1|||
16315470|NCT00740636|39637395|FG001|Overall Study|Death|0|||
16509712|NCT00127712|40339840|FG000|Overall Study|Adverse Event|3|||
16509713|NCT00127712|40339841|FG001|Overall Study|Adverse Event|0|||
16509714|NCT00127712|40339840|FG000|Overall Study|Lack of GI access to continue|2|||
16509715|NCT00127712|40339841|FG001|Overall Study|Lack of GI access to continue|0|||
16509716|NCT01488097|40339842|FG000|Overall Study|Lost to Follow-up|1|||
16509717|NCT02188485|40339843|FG000|Overall Study|Withdrawal by Subject|2|||
16509718|NCT02188485|40339844|FG001|Overall Study|Withdrawal by Subject|1|||
16509719|NCT02188485|40339843|FG000|Overall Study|PI withdrew, lack of capacity|0|||
16509720|NCT02188485|40339844|FG001|Overall Study|PI withdrew, lack of capacity|2|||
16509721|NCT00207142|40339848|FG000|Induction Phase|Adverse Event|9|||
16509722|NCT00207142|40339849|FG001|Induction Phase|Adverse Event|0|||
16509723|NCT00207142|40339850|FG002|Induction Phase|Adverse Event|0|||
16509724|NCT00207142|40339851|FG003|Induction Phase|Adverse Event|0|||
16509725|NCT00207142|40339848|FG000|Induction Phase|Death|1|||
16509726|NCT00207142|40339849|FG001|Induction Phase|Death|0|||
16509727|NCT00207142|40339850|FG002|Induction Phase|Death|0|||
16509728|NCT00207142|40339851|FG003|Induction Phase|Death|0|||
16509729|NCT00207142|40339848|FG000|Induction Phase|Lack of Efficacy|1|||
16509730|NCT00207142|40339849|FG001|Induction Phase|Lack of Efficacy|0|||
16509731|NCT00207142|40339850|FG002|Induction Phase|Lack of Efficacy|0|||
16509732|NCT00207142|40339851|FG003|Induction Phase|Lack of Efficacy|0|||
16509733|NCT00207142|40339848|FG000|Induction Phase|Lost to Follow-up|5|||
16509734|NCT00207142|40339849|FG001|Induction Phase|Lost to Follow-up|0|||
16509735|NCT00207142|40339850|FG002|Induction Phase|Lost to Follow-up|0|||
16509736|NCT00207142|40339851|FG003|Induction Phase|Lost to Follow-up|0|||
16315471|NCT03539302|39637396|FG000|Overall Study|Spontaneous cardio version|0|||
16315472|NCT03539302|39637397|FG001|Overall Study|Spontaneous cardio version|0|||
16315473|NCT03539302|39637398|FG002|Overall Study|Spontaneous cardio version|0|||
16315474|NCT03539302|39637399|FG003|Overall Study|Spontaneous cardio version|0|||
16315475|NCT03539302|39637400|FG004|Overall Study|Spontaneous cardio version|0|||
16315476|NCT03539302|39637401|FG005|Overall Study|Spontaneous cardio version|1|||
16315477|NCT03539302|39637402|FG006|Overall Study|Spontaneous cardio version|1|||
16315478|NCT02512302|39637405|FG000|Period 1|Adverse Event|0|||
16315479|NCT02512302|39637406|FG001|Period 1|Adverse Event|1|||
16315480|NCT02512302|39637407|FG002|Period 1|Adverse Event|0|||
16315481|NCT02512302|39637408|FG003|Period 1|Adverse Event|0|||
16315482|NCT02512302|39637409|FG004|Period 1|Adverse Event|0|||
16315483|NCT02512302|39637410|FG005|Period 1|Adverse Event|0|||
16315484|NCT02512302|39637411|FG006|Period 1|Adverse Event|0|||
16315485|NCT02512302|39637412|FG007|Period 1|Adverse Event|0|||
16315486|NCT02512302|39637413|FG008|Period 1|Adverse Event|0|||
16315487|NCT02512302|39637414|FG009|Period 1|Adverse Event|0|||
16315488|NCT02512302|39637405|FG000|Period 2|Adverse Event|0|||
16315489|NCT02512302|39637406|FG001|Period 2|Adverse Event|0|||
16315490|NCT02512302|39637407|FG002|Period 2|Adverse Event|0|||
16315491|NCT02512302|39637408|FG003|Period 2|Adverse Event|0|||
16315492|NCT02512302|39637409|FG004|Period 2|Adverse Event|0|||
16315493|NCT02512302|39637410|FG005|Period 2|Adverse Event|0|||
16315494|NCT02512302|39637411|FG006|Period 2|Adverse Event|0|||
16315495|NCT02512302|39637412|FG007|Period 2|Adverse Event|0|||
16315496|NCT02512302|39637413|FG008|Period 2|Adverse Event|0|||
16315497|NCT02512302|39637414|FG009|Period 2|Adverse Event|1|||
16315498|NCT02512302|39637405|FG000|Period 3|Lost to Follow-up|0|||
16315499|NCT02512302|39637406|FG001|Period 3|Lost to Follow-up|0|||
16315500|NCT02512302|39637407|FG002|Period 3|Lost to Follow-up|1|||
16315501|NCT02512302|39637408|FG003|Period 3|Lost to Follow-up|0|||
16315502|NCT02512302|39637409|FG004|Period 3|Lost to Follow-up|0|||
16315503|NCT02512302|39637410|FG005|Period 3|Lost to Follow-up|0|||
16315504|NCT02512302|39637411|FG006|Period 3|Lost to Follow-up|0|||
16315505|NCT02512302|39637412|FG007|Period 3|Lost to Follow-up|0|||
16315506|NCT02512302|39637413|FG008|Period 3|Lost to Follow-up|0|||
16315507|NCT02512302|39637414|FG009|Period 3|Lost to Follow-up|0|||
16315508|NCT02512302|39637405|FG000|Period 4|Adverse Event|0|||
16509737|NCT00207142|40339848|FG000|Induction Phase|Physician Decision|2|||
16509738|NCT00207142|40339849|FG001|Induction Phase|Physician Decision|0|||
16509739|NCT00207142|40339850|FG002|Induction Phase|Physician Decision|0|||
16315509|NCT02512302|39637406|FG001|Period 4|Adverse Event|0|||
16315510|NCT02512302|39637407|FG002|Period 4|Adverse Event|0|||
16315511|NCT02512302|39637408|FG003|Period 4|Adverse Event|0|||
16509740|NCT00207142|40339851|FG003|Induction Phase|Physician Decision|0|||
16315512|NCT02512302|39637409|FG004|Period 4|Adverse Event|0|||
16315513|NCT02512302|39637410|FG005|Period 4|Adverse Event|0|||
16315514|NCT02512302|39637411|FG006|Period 4|Adverse Event|1|||
16315515|NCT02512302|39637412|FG007|Period 4|Adverse Event|0|||
16315516|NCT02512302|39637413|FG008|Period 4|Adverse Event|0|||
16315517|NCT02512302|39637414|FG009|Period 4|Adverse Event|0|||
16315518|NCT01896128|39637417|FG000|Overall Study|Withdrawal by Subject|3|||
16315519|NCT01896128|39637418|FG001|Overall Study|Withdrawal by Subject|3|||
16392152|NCT00466947|39919585|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
16392153|NCT02840253|39919586|FG000|Overall Study|Unsuccessful block|4|||
16392154|NCT03783962|39919594|FG000|Overall Study|Lost to Follow-up|3|||
16392155|NCT03783962|39919595|FG001|Overall Study|Lost to Follow-up|6|||
16392156|NCT03783962|39919594|FG000|Overall Study|Protocol Violation|0|||
16392157|NCT03783962|39919595|FG001|Overall Study|Protocol Violation|1|||
16509741|NCT00207142|40339848|FG000|Induction Phase|Poor/noncompliance|2|||
16509742|NCT00207142|40339849|FG001|Induction Phase|Poor/noncompliance|0|||
16509743|NCT00207142|40339850|FG002|Induction Phase|Poor/noncompliance|0|||
16509744|NCT00207142|40339851|FG003|Induction Phase|Poor/noncompliance|0|||
16509745|NCT00207142|40339848|FG000|Induction Phase|Pregnancy|1|||
16509746|NCT00207142|40339849|FG001|Induction Phase|Pregnancy|0|||
16509747|NCT00207142|40339850|FG002|Induction Phase|Pregnancy|0|||
16509748|NCT00207142|40339851|FG003|Induction Phase|Pregnancy|0|||
16509749|NCT00207142|40339848|FG000|Induction Phase|Subject no longer meets study criteria|3|||
16509750|NCT00207142|40339849|FG001|Induction Phase|Subject no longer meets study criteria|0|||
16509751|NCT00207142|40339850|FG002|Induction Phase|Subject no longer meets study criteria|0|||
16509752|NCT00207142|40339851|FG003|Induction Phase|Subject no longer meets study criteria|0|||
16509753|NCT00207142|40339848|FG000|Induction Phase|Withdrawal by Subject|4|||
16509754|NCT00207142|40339849|FG001|Induction Phase|Withdrawal by Subject|0|||
16509755|NCT00207142|40339850|FG002|Induction Phase|Withdrawal by Subject|0|||
16509756|NCT00207142|40339851|FG003|Induction Phase|Withdrawal by Subject|0|||
16509757|NCT00207142|40339848|FG000|Induction Phase|Incarceration|1|||
16509758|NCT00207142|40339849|FG001|Induction Phase|Incarceration|0|||
16509759|NCT00207142|40339850|FG002|Induction Phase|Incarceration|0|||
16198767|NCT03655717|39204403|FG002|Overall Study|Withdrawal by Subject|1|||
16198768|NCT03655717|39204404|FG003|Overall Study|Withdrawal by Subject|0|||
16198769|NCT03655717|39204405|FG004|Overall Study|Withdrawal by Subject|0|||
16198770|NCT03655717|39204406|FG005|Overall Study|Withdrawal by Subject|1|||
16198771|NCT03655717|39204407|FG006|Overall Study|Withdrawal by Subject|3|||
16198772|NCT03655717|39204408|FG007|Overall Study|Withdrawal by Subject|1|||
16198773|NCT03655717|39204409|FG008|Overall Study|Withdrawal by Subject|2|||
16198774|NCT03655717|39204410|FG009|Overall Study|Withdrawal by Subject|0|||
16198775|NCT03655717|39204411|FG010|Overall Study|Withdrawal by Subject|0|||
16198776|NCT03655717|39204412|FG011|Overall Study|Withdrawal by Subject|1|||
16198777|NCT03655717|39204413|FG012|Overall Study|Withdrawal by Subject|0|||
16198778|NCT03655717|39204414|FG013|Overall Study|Withdrawal by Subject|3|||
16198779|NCT03655717|39204415|FG014|Overall Study|Withdrawal by Subject|0|||
16198780|NCT03655717|39204416|FG015|Overall Study|Withdrawal by Subject|1|||
16198781|NCT03655717|39204417|FG016|Overall Study|Withdrawal by Subject|0|||
16198782|NCT03655717|39204418|FG017|Overall Study|Withdrawal by Subject|0|||
16198783|NCT03655717|39204419|FG018|Overall Study|Withdrawal by Subject|1|||
16198784|NCT03655717|39204420|FG019|Overall Study|Withdrawal by Subject|0|||
16198785|NCT03655717|39204421|FG020|Overall Study|Withdrawal by Subject|0|||
16198786|NCT03655717|39204422|FG021|Overall Study|Withdrawal by Subject|1|||
16198787|NCT03655717|39204423|FG022|Overall Study|Withdrawal by Subject|2|||
16198788|NCT03655717|39204424|FG023|Overall Study|Withdrawal by Subject|1|||
16198789|NCT03655717|39204425|FG024|Overall Study|Withdrawal by Subject|1|||
16198790|NCT03655717|39204426|FG025|Overall Study|Withdrawal by Subject|0|||
16198791|NCT03655717|39204401|FG000|Overall Study|Physician Decision|3|||
16198792|NCT03655717|39204402|FG001|Overall Study|Physician Decision|3|||
16198793|NCT03655717|39204403|FG002|Overall Study|Physician Decision|0|||
16198794|NCT03655717|39204404|FG003|Overall Study|Physician Decision|0|||
16198795|NCT03655717|39204405|FG004|Overall Study|Physician Decision|0|||
16198796|NCT03655717|39204406|FG005|Overall Study|Physician Decision|0|||
16198797|NCT03655717|39204407|FG006|Overall Study|Physician Decision|0|||
16198798|NCT03655717|39204408|FG007|Overall Study|Physician Decision|0|||
16198799|NCT03655717|39204409|FG008|Overall Study|Physician Decision|0|||
16198800|NCT03655717|39204410|FG009|Overall Study|Physician Decision|1|||
16198801|NCT03655717|39204411|FG010|Overall Study|Physician Decision|0|||
16198802|NCT03655717|39204412|FG011|Overall Study|Physician Decision|0|||
16198803|NCT03655717|39204413|FG012|Overall Study|Physician Decision|0|||
16198804|NCT03655717|39204414|FG013|Overall Study|Physician Decision|0|||
16198805|NCT03655717|39204415|FG014|Overall Study|Physician Decision|0|||
16198806|NCT03655717|39204416|FG015|Overall Study|Physician Decision|0|||
16198807|NCT03655717|39204417|FG016|Overall Study|Physician Decision|0|||
16198808|NCT03655717|39204418|FG017|Overall Study|Physician Decision|0|||
16198809|NCT03655717|39204419|FG018|Overall Study|Physician Decision|0|||
16198810|NCT03655717|39204420|FG019|Overall Study|Physician Decision|1|||
16198811|NCT03655717|39204421|FG020|Overall Study|Physician Decision|0|||
16198812|NCT03655717|39204422|FG021|Overall Study|Physician Decision|0|||
16198813|NCT03655717|39204423|FG022|Overall Study|Physician Decision|0|||
16198814|NCT03655717|39204424|FG023|Overall Study|Physician Decision|1|||
16509760|NCT00207142|40339851|FG003|Induction Phase|Incarceration|0|||
16509761|NCT00207142|40339848|FG000|Induction Phase|Missing lab data|1|||
16392158|NCT02553928|39919596|FG000|Overall Study|Adverse Event|2|||
16392159|NCT02553928|39919597|FG001|Overall Study|Adverse Event|1|||
16509762|NCT00207142|40339849|FG001|Induction Phase|Missing lab data|0|||
16315520|NCT03631706|39637421|FG000|Overall Study|Randomized, not treated|1|||
16315521|NCT03631706|39637422|FG001|Overall Study|Randomized, not treated|0|||
16392160|NCT02553928|39919596|FG000|Overall Study|Lost to Follow-up|0|||
16392161|NCT02553928|39919597|FG001|Overall Study|Lost to Follow-up|1|||
16392162|NCT02553928|39919596|FG000|Overall Study|Administrative reason(s)|0|||
16315522|NCT03631706|39637421|FG000|Overall Study|Treatment ongoing|26|||
16315523|NCT03631706|39637422|FG001|Overall Study|Treatment ongoing|57|||
16315524|NCT03631706|39637421|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
16315525|NCT03631706|39637422|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
16315526|NCT02044302|39637423|FG000|Overall Study|study terminated|2|||
16315527|NCT02044302|39637424|FG001|Overall Study|study terminated|0|||
16315528|NCT02898597|39637425|FG000|Overall Study|Protocol Violation|4|||
16315529|NCT02898597|39637426|FG001|Overall Study|Protocol Violation|2|||
16315530|NCT02898597|39637425|FG000|Overall Study|Lost to Follow-up|0|||
16315531|NCT02898597|39637426|FG001|Overall Study|Lost to Follow-up|9|||
16315532|NCT02898597|39637425|FG000|Overall Study|Death|0|||
16315533|NCT02898597|39637426|FG001|Overall Study|Death|1|||
16315534|NCT04335123|39637427|FG000|Overall Study|Withdrawal by Subject|2|||
16315535|NCT04335123|39637428|FG001|Overall Study|Withdrawal by Subject|0|||
16315536|NCT04335123|39637427|FG000|Overall Study|Physician Decision|2|||
16315537|NCT04335123|39637428|FG001|Overall Study|Physician Decision|0|||
16315538|NCT00314340|39637429|FG000|Overall Study|lost interest|1|||
16315539|NCT01074268|39637430|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
16315540|NCT01074268|39637431|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
16315541|NCT01074268|39637430|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
16315542|NCT01074268|39637431|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
16315543|NCT01074268|39637430|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
16315544|NCT01074268|39637431|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
16315545|NCT01074268|39637430|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
16315546|NCT01074268|39637431|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
16315547|NCT01074268|39637430|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
16315548|NCT01074268|39637431|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
16315549|NCT01074268|39637430|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
16315550|NCT01074268|39637431|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
16509763|NCT00207142|40339850|FG002|Induction Phase|Missing lab data|0|||
16509764|NCT00207142|40339851|FG003|Induction Phase|Missing lab data|0|||
16509765|NCT00207142|40339848|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
16509766|NCT00207142|40339849|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
16509767|NCT00207142|40339850|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
16509768|NCT00207142|40339851|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
16509769|NCT00207142|40339848|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
16509770|NCT00207142|40339849|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
16509771|NCT00207142|40339850|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
16392163|NCT02553928|39919597|FG001|Overall Study|Administrative reason(s)|1|||
16392164|NCT00114127|39919600|FG000|Overall Study|Adverse Event|2|||
16392165|NCT00114127|39919601|FG001|Overall Study|Adverse Event|1|||
16392166|NCT00114127|39919600|FG000|Overall Study|Lost to Follow-up|1|||
16392167|NCT00114127|39919601|FG001|Overall Study|Lost to Follow-up|0|||
16392168|NCT00114127|39919600|FG000|Overall Study|Withdrawal by Subject|1|||
16315551|NCT01074268|39637430|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
16509772|NCT00207142|40339851|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
16509773|NCT00207142|40339848|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
16509774|NCT00207142|40339849|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
16509775|NCT00207142|40339850|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
16509776|NCT00207142|40339851|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
16509777|NCT00207142|40339848|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
16509778|NCT00207142|40339849|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
16509779|NCT00207142|40339850|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
16509780|NCT00207142|40339851|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
16315552|NCT01074268|39637431|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
16315553|NCT01074268|39637430|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
16315554|NCT01074268|39637431|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
16315555|NCT01074268|39637430|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
16315556|NCT01074268|39637431|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
16315557|NCT02929589|39637442|FG000|Overall Study|Withdrawal by Subject|1|||
16315558|NCT02929589|39637443|FG001|Overall Study|Withdrawal by Subject|0|||
16315559|NCT02929589|39637444|FG002|Overall Study|Withdrawal by Subject|0|||
16315560|NCT02929589|39637445|FG003|Overall Study|Withdrawal by Subject|0|||
16315561|NCT02929589|39637442|FG000|Overall Study|Physician Decision|2|||
16392169|NCT00114127|39919601|FG001|Overall Study|Withdrawal by Subject|3|||
16392170|NCT00851890|39919602|FG000|Overall Study|Lost to Follow-up|0|||
16509781|NCT00207142|40339848|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
16509782|NCT00207142|40339849|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
16509783|NCT00207142|40339850|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
16509784|NCT00207142|40339851|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
16509785|NCT00207142|40339848|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
16509786|NCT00207142|40339849|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
16509787|NCT00207142|40339850|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
16509788|NCT00207142|40339851|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
16509789|NCT00207142|40339848|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
16509790|NCT00207142|40339849|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
16509791|NCT00207142|40339850|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
16509792|NCT00207142|40339851|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
16509793|NCT00207142|40339848|FG000|Maintenance Phase/Rescue Phase|Death|0|||
16509794|NCT00207142|40339849|FG001|Maintenance Phase/Rescue Phase|Death|0|||
16509795|NCT00207142|40339850|FG002|Maintenance Phase/Rescue Phase|Death|0|||
16509796|NCT00207142|40339851|FG003|Maintenance Phase/Rescue Phase|Death|1|||
16509797|NCT00207142|40339848|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
16509798|NCT00207142|40339849|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
16509799|NCT00207142|40339850|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
16509800|NCT00207142|40339851|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
16509801|NCT01736696|40339858|FG000|Overall Study|Withdrawal by Subject|0|||
16509802|NCT01736696|40339859|FG001|Overall Study|Withdrawal by Subject|0|||
16509803|NCT01736696|40339860|FG002|Overall Study|Withdrawal by Subject|1|||
16509804|NCT01736696|40339861|FG003|Overall Study|Withdrawal by Subject|0|||
16509805|NCT01736696|40339862|FG004|Overall Study|Withdrawal by Subject|0|||
16509806|NCT01736696|40339863|FG005|Overall Study|Withdrawal by Subject|0|||
16509807|NCT01736696|40339864|FG006|Overall Study|Withdrawal by Subject|0|||
16509808|NCT01785602|40339865|FG000|Overall Study|Withdrawal by Subject|2|||
16509809|NCT01785602|40339866|FG001|Overall Study|Withdrawal by Subject|0|||
16509810|NCT01785602|40339865|FG000|Overall Study|Lost to Follow-up|1|||
16509811|NCT01785602|40339866|FG001|Overall Study|Lost to Follow-up|1|||
16509812|NCT01785602|40339865|FG000|Overall Study|Adverse Event|3|||
16509813|NCT01785602|40339866|FG001|Overall Study|Adverse Event|5|||
16509814|NCT01785602|40339865|FG000|Overall Study|Administrative problems|7|||
16509815|NCT01785602|40339866|FG001|Overall Study|Administrative problems|3|||
16509816|NCT02726074|40339880|FG000|Overall Study|Withdrawal by Subject|4|||
16509817|NCT02726074|40339880|FG000|Overall Study|Adverse Event|14|||
16509818|NCT02726074|40339880|FG000|Overall Study|Protocol Violation|3|||
16509819|NCT02726074|40339880|FG000|Overall Study|Lost to Follow-up|2|||
16509820|NCT02726074|40339880|FG000|Overall Study|Others|3|||
16509821|NCT01449526|40339884|FG000|Overall Study|Lost to Follow-up|1|||
16509822|NCT01449526|40339885|FG001|Overall Study|Lost to Follow-up|2|||
16509823|NCT01449526|40339884|FG000|Overall Study|Withdrawal by Subject|1|||
16509824|NCT01449526|40339885|FG001|Overall Study|Withdrawal by Subject|1|||
16509825|NCT01449526|40339884|FG000|Overall Study|Symptoms/complaints|0|||
16509826|NCT01449526|40339885|FG001|Overall Study|Symptoms/complaints|1|||
16509827|NCT01449526|40339884|FG000|Overall Study|Lack of Motivation|0|||
16509828|NCT01449526|40339885|FG001|Overall Study|Lack of Motivation|1|||
16509829|NCT01449526|40339884|FG000|Overall Study|Cannot maintain visits|0|||
16509830|NCT01449526|40339885|FG001|Overall Study|Cannot maintain visits|1|||
16509831|NCT00813358|40339890|FG000|Overall Study|Death|32|||
16509832|NCT00813358|40339890|FG000|Overall Study|Lost to Follow-up|12|||
16509833|NCT00813358|40339890|FG000|Overall Study|other endpoints|5|||
16509834|NCT00813358|40339890|FG000|Overall Study|Withdrawal by Subject|20|||
16509835|NCT02945410|40339891|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
16509836|NCT02945410|40339892|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
16509837|NCT02945410|40339893|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
16509838|NCT02945410|40339894|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
16509839|NCT02945410|40339895|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
16509840|NCT02945410|40339896|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
16509841|NCT02945410|40339891|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
16509842|NCT02945410|40339892|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
16509843|NCT02945410|40339893|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
16509844|NCT02945410|40339894|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
16509845|NCT02945410|40339895|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
16509846|NCT02945410|40339896|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
16509847|NCT02945410|40339891|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
16509848|NCT02945410|40339892|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
16509849|NCT02945410|40339893|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
16509850|NCT02945410|40339894|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
16509851|NCT02945410|40339895|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
16198815|NCT03655717|39204425|FG024|Overall Study|Physician Decision|0|||
16509852|NCT02945410|40339896|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
16509853|NCT00603746|40339899|FG000|Overall Study|Adverse Event|2|||
16509854|NCT00603746|40339900|FG001|Overall Study|Adverse Event|3|||
16509855|NCT00603746|40339901|FG002|Overall Study|Adverse Event|0|||
16509856|NCT00603746|40339902|FG003|Overall Study|Adverse Event|1|||
16509857|NCT00603746|40339903|FG004|Overall Study|Adverse Event|0|||
16509858|NCT00603746|40339904|FG005|Overall Study|Adverse Event|4|||
16509859|NCT00603746|40339899|FG000|Overall Study|Lack of Efficacy|34|||
16509860|NCT00603746|40339900|FG001|Overall Study|Lack of Efficacy|11|||
16509861|NCT00603746|40339901|FG002|Overall Study|Lack of Efficacy|6|||
16509862|NCT00603746|40339902|FG003|Overall Study|Lack of Efficacy|11|||
16509863|NCT00603746|40339903|FG004|Overall Study|Lack of Efficacy|12|||
16509864|NCT00603746|40339904|FG005|Overall Study|Lack of Efficacy|8|||
16509865|NCT00603746|40339899|FG000|Overall Study|Protocol Violation|0|||
16509866|NCT00603746|40339900|FG001|Overall Study|Protocol Violation|3|||
16509867|NCT00603746|40339901|FG002|Overall Study|Protocol Violation|1|||
16509868|NCT00603746|40339902|FG003|Overall Study|Protocol Violation|0|||
16509869|NCT00603746|40339903|FG004|Overall Study|Protocol Violation|1|||
16509870|NCT00603746|40339904|FG005|Overall Study|Protocol Violation|0|||
16509871|NCT00603746|40339899|FG000|Overall Study|Lost to Follow-up|0|||
16315562|NCT02929589|39637443|FG001|Overall Study|Physician Decision|0|||
16315563|NCT02929589|39637444|FG002|Overall Study|Physician Decision|0|||
16315564|NCT02929589|39637445|FG003|Overall Study|Physician Decision|0|||
16315565|NCT02095691|39640671|FG000|Overall Study|Physician Decision|1|||
16315566|NCT00298272|39640672|FG000|Double-blind Phase|Adverse Event|2|||
16315567|NCT00298272|39640673|FG001|Double-blind Phase|Adverse Event|0|||
16315568|NCT00298272|39640672|FG000|Double-blind Phase|Failure to Return|2|||
16315569|NCT00298272|39640673|FG001|Double-blind Phase|Failure to Return|0|||
16315570|NCT00298272|39640672|FG000|Double-blind Phase|Protocol Violation|2|||
16315571|NCT00298272|39640673|FG001|Double-blind Phase|Protocol Violation|0|||
16315572|NCT00298272|39640672|FG000|Double-blind Phase|Withdrawal by Subject|2|||
16315573|NCT00298272|39640673|FG001|Double-blind Phase|Withdrawal by Subject|0|||
16315574|NCT00298272|39640672|FG000|Open Label Retreatment Phase|Adverse Event|1|||
16315575|NCT00298272|39640673|FG001|Open Label Retreatment Phase|Adverse Event|2|||
16315576|NCT00298272|39640672|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
16315577|NCT00298272|39640673|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
16315578|NCT00298272|39640672|FG000|Open Label Retreatment Phase|Failure to Return|1|||
16315579|NCT00298272|39640673|FG001|Open Label Retreatment Phase|Failure to Return|0|||
16315580|NCT00298272|39640672|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
16315581|NCT00298272|39640673|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
16315582|NCT00298272|39640672|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
16315583|NCT00298272|39640673|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
16315584|NCT00298272|39640672|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
16315585|NCT00298272|39640673|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
16315586|NCT00298272|39640672|FG000|Safety Follow-up Phase|Failure to Return|1|||
16315587|NCT00298272|39640673|FG001|Safety Follow-up Phase|Failure to Return|1|||
16315588|NCT00298272|39640672|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
16315589|NCT00298272|39640673|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
16315590|NCT00298272|39640672|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
16315591|NCT00298272|39640673|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
16315592|NCT04615403|39640674|FG000|Overall Study|Death|1|||
16315593|NCT02859337|39640677|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
16315594|NCT02859337|39640678|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
16315595|NCT02859337|39640679|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
16315596|NCT02859337|39640677|FG000|Overall Study|Withdrawal by Subject|3|||
16315597|NCT02859337|39640678|FG001|Overall Study|Withdrawal by Subject|1|||
16315598|NCT02859337|39640679|FG002|Overall Study|Withdrawal by Subject|0|||
16315599|NCT02859337|39640677|FG000|Overall Study|Lost to Follow-up|1|||
16315600|NCT02859337|39640678|FG001|Overall Study|Lost to Follow-up|0|||
16315601|NCT02859337|39640679|FG002|Overall Study|Lost to Follow-up|0|||
16315602|NCT01205269|39640680|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
16315603|NCT01205269|39640681|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
16315604|NCT01205269|39640682|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
16315605|NCT01205269|39640683|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
16315606|NCT01205269|39640684|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
16315607|NCT01205269|39640685|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
16315608|NCT01286467|39640686|FG000|Overall Study|Death|1|||
16315609|NCT01286467|39640687|FG001|Overall Study|Death|1|||
16315610|NCT01286467|39640688|FG002|Overall Study|Death|1|||
16315611|NCT01286467|39640689|FG003|Overall Study|Death|0|||
16315612|NCT01286467|39640686|FG000|Overall Study|Lost to Follow-up|0|||
16315613|NCT01286467|39640687|FG001|Overall Study|Lost to Follow-up|0|||
16509872|NCT00603746|40339900|FG001|Overall Study|Lost to Follow-up|1|||
16509873|NCT00603746|40339901|FG002|Overall Study|Lost to Follow-up|1|||
16315614|NCT01286467|39640688|FG002|Overall Study|Lost to Follow-up|0|||
16315615|NCT01286467|39640689|FG003|Overall Study|Lost to Follow-up|1|||
16315616|NCT01286467|39640686|FG000|Overall Study|Withdrawal by Subject|0|||
16315617|NCT01286467|39640687|FG001|Overall Study|Withdrawal by Subject|0|||
16315618|NCT01286467|39640688|FG002|Overall Study|Withdrawal by Subject|1|||
16315619|NCT01286467|39640689|FG003|Overall Study|Withdrawal by Subject|0|||
16315620|NCT01286467|39640686|FG000|Overall Study|Physician Decision|0|||
16315621|NCT01286467|39640687|FG001|Overall Study|Physician Decision|0|||
16315622|NCT01286467|39640688|FG002|Overall Study|Physician Decision|0|||
16315623|NCT01286467|39640689|FG003|Overall Study|Physician Decision|1|||
16315624|NCT01286467|39640686|FG000|Overall Study|Disease progression|3|||
16315625|NCT01286467|39640687|FG001|Overall Study|Disease progression|2|||
16315626|NCT01286467|39640688|FG002|Overall Study|Disease progression|2|||
16315627|NCT01286467|39640689|FG003|Overall Study|Disease progression|3|||
16315628|NCT01286467|39640686|FG000|Overall Study|Adverse Event|0|||
16315629|NCT01286467|39640687|FG001|Overall Study|Adverse Event|1|||
16315630|NCT01286467|39640688|FG002|Overall Study|Adverse Event|2|||
16315631|NCT01286467|39640689|FG003|Overall Study|Adverse Event|3|||
16315632|NCT01286467|39640686|FG000|Overall Study|Study drug stop longer than 14 days|0|||
16315633|NCT01286467|39640687|FG001|Overall Study|Study drug stop longer than 14 days|0|||
16315634|NCT01286467|39640688|FG002|Overall Study|Study drug stop longer than 14 days|1|||
16315635|NCT01286467|39640689|FG003|Overall Study|Study drug stop longer than 14 days|0|||
16315636|NCT01283464|39640690|FG000|Overall Study|Lost to Follow-up|0|||
16315637|NCT01283464|39640691|FG001|Overall Study|Lost to Follow-up|1|||
16315638|NCT01283464|39640690|FG000|Overall Study|Withdrawal by Subject|1|||
16315639|NCT01283464|39640691|FG001|Overall Study|Withdrawal by Subject|0|||
16392171|NCT00851890|39919603|FG001|Overall Study|Lost to Follow-up|1|||
16392172|NCT00851890|39919604|FG002|Overall Study|Lost to Follow-up|0|||
16392173|NCT00851890|39919605|FG003|Overall Study|Lost to Follow-up|1|||
16392174|NCT01747915|39919607|FG000|Overall Study|Other|1|||
16315640|NCT01283464|39640690|FG000|Overall Study|Physician Decision|1|||
16315641|NCT01283464|39640691|FG001|Overall Study|Physician Decision|0|||
16315642|NCT00391768|39640692|FG000|Overall Study|Withdrawal by Subject|0|||
16315643|NCT00391768|39640693|FG001|Overall Study|Withdrawal by Subject|0|||
16392175|NCT01747915|39919608|FG001|Overall Study|Other|1|||
16392176|NCT01747915|39919609|FG002|Overall Study|Other|1|||
16315644|NCT00391768|39640694|FG002|Overall Study|Withdrawal by Subject|1|||
16315645|NCT00391768|39640695|FG003|Overall Study|Withdrawal by Subject|0|||
16315646|NCT00391768|39640696|FG004|Overall Study|Withdrawal by Subject|0|||
16315647|NCT00391768|39640697|FG005|Overall Study|Withdrawal by Subject|1|||
16315648|NCT00391768|39640698|FG006|Overall Study|Withdrawal by Subject|1|||
16315649|NCT00391768|39640692|FG000|Overall Study|Lost to Follow-up|0|||
16315650|NCT00391768|39640693|FG001|Overall Study|Lost to Follow-up|0|||
16315651|NCT00391768|39640694|FG002|Overall Study|Lost to Follow-up|0|||
16315652|NCT00391768|39640695|FG003|Overall Study|Lost to Follow-up|1|||
16315653|NCT00391768|39640696|FG004|Overall Study|Lost to Follow-up|2|||
16315654|NCT00391768|39640697|FG005|Overall Study|Lost to Follow-up|2|||
16315655|NCT00391768|39640698|FG006|Overall Study|Lost to Follow-up|3|||
16315656|NCT00386360|39640699|FG000|Overall Study|Adverse Event|4|||
16315657|NCT00386360|39640700|FG001|Overall Study|Adverse Event|2|||
16315658|NCT00386360|39640699|FG000|Overall Study|Physician Decision|2|||
16315659|NCT00386360|39640700|FG001|Overall Study|Physician Decision|2|||
16315660|NCT00386360|39640699|FG000|Overall Study|Lost to Follow-up|0|||
16315661|NCT00386360|39640700|FG001|Overall Study|Lost to Follow-up|2|||
16315662|NCT00386360|39640699|FG000|Overall Study|Protocol Violation|0|||
16315663|NCT00386360|39640700|FG001|Overall Study|Protocol Violation|3|||
16315664|NCT00386360|39640699|FG000|Overall Study|Withdrawal by Subject|3|||
16509874|NCT00603746|40339902|FG003|Overall Study|Lost to Follow-up|0|||
16315665|NCT00386360|39640700|FG001|Overall Study|Withdrawal by Subject|6|||
16315666|NCT00386360|39640699|FG000|Overall Study|Did not take any study medication|0|||
16315667|NCT00386360|39640700|FG001|Overall Study|Did not take any study medication|2|||
16315668|NCT01067105|39640701|FG000|Overall Study|Adverse Event|14|||
16315669|NCT01067105|39640701|FG000|Overall Study|Protocol Violation|48|||
16315670|NCT01067105|39640701|FG000|Overall Study|Withdrawal by Subject|36|||
16315671|NCT01067105|39640701|FG000|Overall Study|Lost to Follow-up|6|||
16315672|NCT01067105|39640701|FG000|Overall Study|Physician Decision|6|||
16315673|NCT01067105|39640701|FG000|Overall Study|Other|31|||
16315674|NCT01052480|39640702|FG000|Overall Study|Lost to Follow-up|3|||
16392177|NCT01747915|39919607|FG000|Overall Study|Adverse Event|8|||
16509875|NCT00603746|40339903|FG004|Overall Study|Lost to Follow-up|0|||
16509876|NCT00603746|40339904|FG005|Overall Study|Lost to Follow-up|0|||
16509877|NCT00603746|40339899|FG000|Overall Study|Physician Decision|1|||
16509878|NCT00603746|40339900|FG001|Overall Study|Physician Decision|0|||
16315675|NCT01052480|39640703|FG001|Overall Study|Lost to Follow-up|3|||
16315676|NCT01052480|39640702|FG000|Overall Study|Protocol Violation|1|||
16315677|NCT01052480|39640703|FG001|Overall Study|Protocol Violation|0|||
16315678|NCT01052480|39640702|FG000|Overall Study|Withdrawal by Subject|3|||
16392178|NCT01747915|39919608|FG001|Overall Study|Adverse Event|5|||
16509879|NCT00603746|40339901|FG002|Overall Study|Physician Decision|0|||
16509880|NCT00603746|40339902|FG003|Overall Study|Physician Decision|0|||
16509881|NCT00603746|40339903|FG004|Overall Study|Physician Decision|1|||
16509882|NCT00603746|40339904|FG005|Overall Study|Physician Decision|0|||
16509883|NCT00603746|40339899|FG000|Overall Study|Withdrawal by Subject|1|||
16509884|NCT00603746|40339900|FG001|Overall Study|Withdrawal by Subject|0|||
16509885|NCT00603746|40339901|FG002|Overall Study|Withdrawal by Subject|0|||
16509886|NCT00603746|40339902|FG003|Overall Study|Withdrawal by Subject|1|||
16509887|NCT00603746|40339903|FG004|Overall Study|Withdrawal by Subject|3|||
16509888|NCT00603746|40339904|FG005|Overall Study|Withdrawal by Subject|1|||
16509889|NCT03240133|40339914|FG000|Overall Study|Withdrawal by Subject|0|||
16509890|NCT03240133|40339915|FG001|Overall Study|Withdrawal by Subject|1|||
16509891|NCT03240133|40339916|FG002|Overall Study|Withdrawal by Subject|0|||
16509892|NCT03240133|40339914|FG000|Overall Study|Adverse Event|1|||
16509893|NCT03240133|40339915|FG001|Overall Study|Adverse Event|1|||
16509894|NCT03240133|40339916|FG002|Overall Study|Adverse Event|0|||
16509895|NCT03240133|40339914|FG000|Overall Study|Rash|1|||
16509896|NCT03240133|40339915|FG001|Overall Study|Rash|0|||
16509897|NCT03240133|40339916|FG002|Overall Study|Rash|0|||
16509898|NCT03240133|40339914|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
16509899|NCT03240133|40339915|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
16509900|NCT03240133|40339916|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
16509901|NCT03240133|40339914|FG000|Overall Study|Intercurrent illness.|0|||
16509902|NCT03240133|40339915|FG001|Overall Study|Intercurrent illness.|1|||
16509903|NCT03240133|40339916|FG002|Overall Study|Intercurrent illness.|0|||
16509904|NCT03240133|40339914|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
16509905|NCT03240133|40339915|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
16509906|NCT03240133|40339916|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
16509907|NCT03734016|40339921|FG000|Overall Study|Participants Remaining in the Study|260|||
16509908|NCT03734016|40339922|FG001|Overall Study|Participants Remaining in the Study|240|||
16509909|NCT03734016|40339921|FG000|Overall Study|Death|48|||
16509910|NCT03734016|40339922|FG001|Overall Study|Death|60|||
16509911|NCT03734016|40339921|FG000|Overall Study|Withdrawal by Subject|14|||
16509912|NCT03734016|40339922|FG001|Overall Study|Withdrawal by Subject|16|||
16509913|NCT03734016|40339921|FG000|Overall Study|Physician Decision|0|||
16509914|NCT03734016|40339922|FG001|Overall Study|Physician Decision|7|||
16509915|NCT03734016|40339921|FG000|Overall Study|Lost to Follow-up|3|||
16509916|NCT03734016|40339922|FG001|Overall Study|Lost to Follow-up|1|||
16509917|NCT03734016|40339921|FG000|Overall Study|Adverse Event|2|||
16315679|NCT01052480|39640703|FG001|Overall Study|Withdrawal by Subject|7|||
16315680|NCT01052480|39640702|FG000|Overall Study|Physician Decision|0|||
16315681|NCT01052480|39640703|FG001|Overall Study|Physician Decision|2|||
16315682|NCT01052480|39640702|FG000|Overall Study|Death|1|||
16315683|NCT01052480|39640703|FG001|Overall Study|Death|5|||
16315684|NCT02362360|39640704|FG000|Period 1|Lack of Efficacy|1|||
16315685|NCT02362360|39640705|FG001|Period 1|Lack of Efficacy|0|||
16315686|NCT02362360|39640704|FG000|Period 1|Withdrawal by Subject|2|||
16315687|NCT02362360|39640705|FG001|Period 1|Withdrawal by Subject|1|||
16315688|NCT00470704|39640710|FG000|Overall Study|Withdrawal by Subject|4|||
16315689|NCT00470704|39640711|FG001|Overall Study|Withdrawal by Subject|3|||
16315690|NCT00470704|39640710|FG000|Overall Study|Relapse/Progression|37|||
16315691|NCT00470704|39640711|FG001|Overall Study|Relapse/Progression|42|||
16315692|NCT00470704|39640710|FG000|Overall Study|toxicity|0|||
16392179|NCT01747915|39919609|FG002|Overall Study|Adverse Event|2|||
16392180|NCT01747915|39919607|FG000|Overall Study|Death|0|||
16392181|NCT01747915|39919608|FG001|Overall Study|Death|0|||
16392182|NCT01747915|39919609|FG002|Overall Study|Death|1|||
16392183|NCT01747915|39919607|FG000|Overall Study|Lack of Efficacy|0|||
16392184|NCT01747915|39919608|FG001|Overall Study|Lack of Efficacy|1|||
16392185|NCT01747915|39919609|FG002|Overall Study|Lack of Efficacy|0|||
16392186|NCT01747915|39919607|FG000|Overall Study|Lost to Follow-up|1|||
16392187|NCT01747915|39919608|FG001|Overall Study|Lost to Follow-up|0|||
16392188|NCT01747915|39919609|FG002|Overall Study|Lost to Follow-up|0|||
16392189|NCT01747915|39919607|FG000|Overall Study|Withdrawal by Subject|4|||
16392190|NCT01747915|39919608|FG001|Overall Study|Withdrawal by Subject|4|||
16392191|NCT01747915|39919609|FG002|Overall Study|Withdrawal by Subject|1|||
16392192|NCT01747915|39919607|FG000|Overall Study|Protocol Violation|1|||
16392193|NCT01747915|39919608|FG001|Overall Study|Protocol Violation|0|||
16392194|NCT01747915|39919609|FG002|Overall Study|Protocol Violation|0|||
16392195|NCT01747915|39919607|FG000|Overall Study|Pregnancy|0|||
16392196|NCT01747915|39919608|FG001|Overall Study|Pregnancy|0|||
16392197|NCT01747915|39919609|FG002|Overall Study|Pregnancy|1|||
16392198|NCT03335150|39919612|FG000|Overall Study|Withdrawal by Subject|10|||
16509918|NCT03734016|40339922|FG001|Overall Study|Adverse Event|1|||
16509919|NCT01462357|40339932|FG000|Overall Study|Death|0|||
16509920|NCT01462357|40339933|FG001|Overall Study|Death|0|||
16509921|NCT01462357|40339934|FG002|Overall Study|Death|1|||
16509922|NCT01462357|40339932|FG000|Overall Study|Withdrawal by Subject|3|||
16509923|NCT01462357|40339933|FG001|Overall Study|Withdrawal by Subject|11|||
16315693|NCT00470704|39640711|FG001|Overall Study|toxicity|1|||
16315694|NCT02962648|39640712|FG000|Overall Study|Withdrawal by Subject|3|||
16315695|NCT02962648|39640712|FG000|Overall Study|Lost to Follow-up|3|||
16315696|NCT02962648|39640712|FG000|Overall Study|Physician Decision|1|||
16315697|NCT02962648|39640712|FG000|Overall Study|Subject had problems with transportation|2|||
16315698|NCT02914613|39640713|FG000|Overall Study|Withdrawal by Subject|1|||
16315699|NCT02914613|39640714|FG001|Overall Study|Withdrawal by Subject|2|||
16315700|NCT02914613|39640713|FG000|Overall Study|Adverse Event|1|||
16315701|NCT02914613|39640714|FG001|Overall Study|Adverse Event|0|||
16315702|NCT01966120|39640715|FG000|Overall Study|Withdrawal by Subject|0|||
16315703|NCT01966120|39640716|FG001|Overall Study|Withdrawal by Subject|5|||
16315704|NCT01966120|39640715|FG000|Overall Study|Lost to Follow-up|1|||
16315705|NCT01966120|39640716|FG001|Overall Study|Lost to Follow-up|1|||
16315706|NCT02729025|39640717|FG000|Overall Study|Sponsor Decision|0|||
16315707|NCT02729025|39640718|FG001|Overall Study|Sponsor Decision|1|||
16315708|NCT00478777|39640719|FG000|Overall Study|Adverse Event|29|||
16315709|NCT00478777|39640719|FG000|Overall Study|Lack of Efficacy|23|||
16315710|NCT00478777|39640719|FG000|Overall Study|Withdrawal by Subject|4|||
16315711|NCT00478777|39640719|FG000|Overall Study|Death|3|||
16315712|NCT00478777|39640719|FG000|Overall Study|Protocol Violation|3|||
16315713|NCT00478777|39640719|FG000|Overall Study|Lost to Follow-up|3|||
16315714|NCT00478777|39640719|FG000|Overall Study|Physician Decision|1|||
16315715|NCT00478777|39640719|FG000|Overall Study|Intolerance of therapy|1|||
16315716|NCT00478777|39640719|FG000|Overall Study|Lack of compliance|1|||
16509924|NCT01462357|40339934|FG002|Overall Study|Withdrawal by Subject|3|||
16509925|NCT01462357|40339932|FG000|Overall Study|Migrated/moved from study area|2|||
16509926|NCT01462357|40339933|FG001|Overall Study|Migrated/moved from study area|3|||
16509927|NCT01462357|40339934|FG002|Overall Study|Migrated/moved from study area|1|||
16509928|NCT01462357|40339932|FG000|Overall Study|Lost to Follow-up|3|||
16509929|NCT01462357|40339933|FG001|Overall Study|Lost to Follow-up|5|||
16509930|NCT01462357|40339934|FG002|Overall Study|Lost to Follow-up|7|||
16509931|NCT04145895|40339935|FG000|Overall Study|Physician Decision|2|||
16509932|NCT04145895|40339936|FG001|Overall Study|Physician Decision|0|||
16509933|NCT04145895|40339935|FG000|Overall Study|Withdrawal by Subject|0|||
16509934|NCT04145895|40339936|FG001|Overall Study|Withdrawal by Subject|2|||
16509935|NCT00558103|40339937|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
16509936|NCT00558103|40339938|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
16509937|NCT00558103|40339939|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
16509938|NCT00558103|40339940|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
16509939|NCT00558103|40339941|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
16509940|NCT00558103|40339942|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
16509941|NCT00558103|40339937|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
16509942|NCT00558103|40339938|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
16509943|NCT00558103|40339939|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
16509944|NCT00558103|40339940|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
16509945|NCT00558103|40339941|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
16509946|NCT00558103|40339942|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
16509947|NCT00558103|40339937|FG000|Randomized Treatment Phase|Disease Progression|1|||
16509948|NCT00558103|40339938|FG001|Randomized Treatment Phase|Disease Progression|0|||
16509949|NCT00558103|40339939|FG002|Randomized Treatment Phase|Disease Progression|1|||
16509950|NCT00558103|40339940|FG003|Randomized Treatment Phase|Disease Progression|0|||
16509951|NCT00558103|40339941|FG004|Randomized Treatment Phase|Disease Progression|0|||
16509952|NCT00558103|40339942|FG005|Randomized Treatment Phase|Disease Progression|0|||
16509953|NCT00558103|40339937|FG000|Randomized Treatment Phase|Adverse Event|0|||
16509954|NCT00558103|40339938|FG001|Randomized Treatment Phase|Adverse Event|0|||
16509955|NCT00558103|40339939|FG002|Randomized Treatment Phase|Adverse Event|0|||
16509956|NCT00558103|40339940|FG003|Randomized Treatment Phase|Adverse Event|1|||
16509957|NCT00558103|40339941|FG004|Randomized Treatment Phase|Adverse Event|1|||
16509958|NCT00558103|40339942|FG005|Randomized Treatment Phase|Adverse Event|0|||
16509959|NCT00558103|40339937|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
16509960|NCT00558103|40339938|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
16509961|NCT00558103|40339939|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
16315717|NCT00478777|39640719|FG000|Overall Study|Lymphocytes infusion|1|||
16315718|NCT00478777|39640719|FG000|Overall Study|End of therapy|2|||
16315719|NCT00478777|39640719|FG000|Overall Study|Not treated with lenalidomide|6|||
16315720|NCT02476578|39640720|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
16315721|NCT02476578|39640721|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
16315722|NCT02476578|39640720|FG000|Overall Study|Lost to Follow-up|6|||
16315723|NCT02476578|39640721|FG001|Overall Study|Lost to Follow-up|13|||
16315724|NCT02070965|39640722|FG000|Overall Study|Lost to Follow-up|0|||
16315725|NCT02070965|39640723|FG001|Overall Study|Lost to Follow-up|1|||
16509962|NCT00558103|40339940|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
16509963|NCT00558103|40339941|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
16509964|NCT00558103|40339942|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
16509965|NCT00558103|40339937|FG000|Monotherapy Extension Phase|Disease Progression|0|||
16509966|NCT00558103|40339938|FG001|Monotherapy Extension Phase|Disease Progression|0|||
16509967|NCT00558103|40339939|FG002|Monotherapy Extension Phase|Disease Progression|0|||
16509968|NCT00558103|40339940|FG003|Monotherapy Extension Phase|Disease Progression|0|||
16509969|NCT00558103|40339941|FG004|Monotherapy Extension Phase|Disease Progression|0|||
16509970|NCT00558103|40339942|FG005|Monotherapy Extension Phase|Disease Progression|8|||
16509971|NCT01505608|40339947|FG000|Phase I|Lack of Efficacy|0|||
16509972|NCT01505608|40339948|FG001|Phase I|Lack of Efficacy|4|||
16509973|NCT01505608|40339947|FG000|Phase I|Adverse Event|0|||
16509974|NCT01505608|40339948|FG001|Phase I|Adverse Event|1|||
16509975|NCT01505608|40339947|FG000|Phase I|Withdrawal by Subject|0|||
16509976|NCT01505608|40339948|FG001|Phase I|Withdrawal by Subject|1|||
16509977|NCT01505608|40339947|FG000|Phase II|Lack of Efficacy|2|||
16509978|NCT01505608|40339948|FG001|Phase II|Lack of Efficacy|1|||
16509979|NCT01505608|40339947|FG000|Phase II|Protocol Violation|0|||
16509980|NCT01505608|40339948|FG001|Phase II|Protocol Violation|1|||
16509981|NCT01859715|40339952|FG000|Overall Study|No 2nd VAS|16|||
16509982|NCT01859715|40339953|FG001|Overall Study|No 2nd VAS|8|||
16509983|NCT01859715|40339954|FG002|Overall Study|No 2nd VAS|23|||
16509984|NCT02659020|40339958|FG000|Overall Study|Adverse Event|0|||
16509985|NCT02659020|40339959|FG001|Overall Study|Adverse Event|0|||
16509986|NCT02659020|40339960|FG002|Overall Study|Adverse Event|0|||
16509987|NCT02659020|40339961|FG003|Overall Study|Adverse Event|2|||
16509988|NCT02659020|40339962|FG004|Overall Study|Adverse Event|0|||
16509989|NCT02659020|40339963|FG005|Overall Study|Adverse Event|0|||
16509990|NCT02659020|40339964|FG006|Overall Study|Adverse Event|2|||
16509991|NCT02659020|40339958|FG000|Overall Study|Lost to Follow-up|1|||
16509992|NCT02659020|40339959|FG001|Overall Study|Lost to Follow-up|2|||
16509993|NCT02659020|40339960|FG002|Overall Study|Lost to Follow-up|1|||
16509994|NCT02659020|40339961|FG003|Overall Study|Lost to Follow-up|6|||
16509995|NCT02659020|40339962|FG004|Overall Study|Lost to Follow-up|1|||
16509996|NCT02659020|40339963|FG005|Overall Study|Lost to Follow-up|5|||
16509997|NCT02659020|40339964|FG006|Overall Study|Lost to Follow-up|0|||
16509998|NCT02659020|40339958|FG000|Overall Study|Physician Decision|0|||
16509999|NCT02659020|40339959|FG001|Overall Study|Physician Decision|0|||
16510000|NCT02659020|40339960|FG002|Overall Study|Physician Decision|0|||
16510001|NCT02659020|40339961|FG003|Overall Study|Physician Decision|1|||
16510002|NCT02659020|40339962|FG004|Overall Study|Physician Decision|1|||
16510003|NCT02659020|40339963|FG005|Overall Study|Physician Decision|0|||
16510004|NCT02659020|40339964|FG006|Overall Study|Physician Decision|1|||
16510005|NCT02659020|40339958|FG000|Overall Study|Withdrawal by Subject|2|||
16510006|NCT02659020|40339959|FG001|Overall Study|Withdrawal by Subject|1|||
16510007|NCT02659020|40339960|FG002|Overall Study|Withdrawal by Subject|0|||
16510008|NCT02659020|40339961|FG003|Overall Study|Withdrawal by Subject|3|||
16510009|NCT02659020|40339962|FG004|Overall Study|Withdrawal by Subject|3|||
16510010|NCT02659020|40339963|FG005|Overall Study|Withdrawal by Subject|6|||
16510011|NCT02659020|40339964|FG006|Overall Study|Withdrawal by Subject|3|||
16510012|NCT02659020|40339958|FG000|Overall Study|Progressive Disease|0|||
16510013|NCT02659020|40339959|FG001|Overall Study|Progressive Disease|0|||
16510014|NCT02659020|40339960|FG002|Overall Study|Progressive Disease|0|||
16510015|NCT02659020|40339961|FG003|Overall Study|Progressive Disease|4|||
16510016|NCT02659020|40339962|FG004|Overall Study|Progressive Disease|1|||
16510017|NCT02659020|40339963|FG005|Overall Study|Progressive Disease|0|||
16510018|NCT02659020|40339964|FG006|Overall Study|Progressive Disease|2|||
16510019|NCT02244580|40339965|FG000|Overall Study|No cancer tissues available|241|||
16510020|NCT01869192|40339968|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
16510021|NCT01869192|40339969|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
16510022|NCT01869192|40339968|FG000|Postoperative Chemotherapy|Physician Decision|0|||
16510023|NCT01869192|40339969|FG001|Postoperative Chemotherapy|Physician Decision|2|||
16510024|NCT01856543|40339974|FG000|Overall Study|Treatment discontinued|6|||
16510025|NCT01856543|40339975|FG001|Overall Study|Treatment discontinued|3|||
16510026|NCT01856543|40339974|FG000|Overall Study|Withdrawn before start|7|||
16510027|NCT01856543|40339975|FG001|Overall Study|Withdrawn before start|3|||
16510028|NCT00357370|40343713|FG000|Cohort 2|Lack of Efficacy|0|||
16510029|NCT00357370|40343714|FG001|Cohort 2|Lack of Efficacy|2|||
16510030|NCT00357370|40343715|FG002|Cohort 2|Lack of Efficacy|1|||
16510031|NCT00357370|40343713|FG000|Cohort 2|Adverse Event|1|||
16510032|NCT00357370|40343714|FG001|Cohort 2|Adverse Event|1|||
16510033|NCT00357370|40343715|FG002|Cohort 2|Adverse Event|1|||
16510034|NCT00357370|40343713|FG000|Cohort 2|Lost to Follow-up|0|||
16510035|NCT00357370|40343714|FG001|Cohort 2|Lost to Follow-up|1|||
16510036|NCT00357370|40343715|FG002|Cohort 2|Lost to Follow-up|0|||
16510037|NCT00357370|40343713|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
16510038|NCT00357370|40343714|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
16510039|NCT00357370|40343715|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
16510040|NCT00357370|40343713|FG000|Cohort 2|Withdrawal by Subject|0|||
16510041|NCT00357370|40343714|FG001|Cohort 2|Withdrawal by Subject|2|||
16510042|NCT00357370|40343715|FG002|Cohort 2|Withdrawal by Subject|0|||
16510043|NCT03102918|40343725|FG000|Overall Study|Protocol Violation|1|||
16510044|NCT03102918|40343726|FG001|Overall Study|Protocol Violation|0|||
16510045|NCT00419562|40343728|FG000|Overall Study|Lost to Follow-up|12|||
16510046|NCT00419562|40343729|FG001|Overall Study|Lost to Follow-up|13|||
16510047|NCT00419562|40343728|FG000|Overall Study|Withdrawal by Subject|20|||
16510048|NCT00419562|40343729|FG001|Overall Study|Withdrawal by Subject|18|||
16510049|NCT00419562|40343728|FG000|Overall Study|Participant Institutionalized|1|||
16315726|NCT02070965|39640724|FG002|Overall Study|Lost to Follow-up|0|||
16315727|NCT02070965|39640722|FG000|Overall Study|Withdrawal by Subject|1|||
16315728|NCT02070965|39640723|FG001|Overall Study|Withdrawal by Subject|1|||
16315729|NCT02070965|39640724|FG002|Overall Study|Withdrawal by Subject|1|||
16315730|NCT02070965|39640722|FG000|Overall Study|Subject moved|1|||
16315731|NCT02070965|39640723|FG001|Overall Study|Subject moved|0|||
16315732|NCT02070965|39640724|FG002|Overall Study|Subject moved|0|||
16315733|NCT01367886|39640728|FG000|Overall Study|Lost to Follow-up|4|||
16315734|NCT01367886|39640728|FG000|Overall Study|Lack of Efficacy|2|||
16315735|NCT01367886|39640728|FG000|Overall Study|Death|1|||
16315736|NCT03711786|39640729|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
16315737|NCT03711786|39640730|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
16315738|NCT03711786|39640729|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
16315739|NCT03711786|39640730|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
16315740|NCT03711786|39640729|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
16315741|NCT03711786|39640730|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
16315742|NCT03711786|39640729|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
16315743|NCT03711786|39640730|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
16315744|NCT03711786|39640729|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
16315745|NCT03711786|39640730|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
16315746|NCT03711786|39640729|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
16315747|NCT03711786|39640730|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
16315748|NCT02028767|39640733|FG000|Treatment Period 2|Non compliant with protocol|1|||
16315749|NCT02028767|39640734|FG001|Treatment Period 2|Non compliant with protocol|0|||
16315750|NCT02028767|39640733|FG000|Treatment Period 2|Reason other than those specified above|1|||
16315751|NCT02028767|39640734|FG001|Treatment Period 2|Reason other than those specified above|0|||
16315752|NCT03875092|39640736|FG000|Overall Study|Adverse Event|2|||
16315753|NCT03875092|39640737|FG001|Overall Study|Adverse Event|5|||
16315754|NCT03875092|39640736|FG000|Overall Study|Death|28|||
16315755|NCT03875092|39640737|FG001|Overall Study|Death|41|||
16315756|NCT03875092|39640736|FG000|Overall Study|Ongoing in Study|35|||
16315757|NCT03875092|39640737|FG001|Overall Study|Ongoing in Study|14|||
16315758|NCT00634803|39640740|FG000|Overall Study|Lost to Follow-up|6|||
16315759|NCT00634803|39640741|FG001|Overall Study|Lost to Follow-up|7|||
16315760|NCT00634803|39640742|FG002|Overall Study|Lost to Follow-up|7|||
16315761|NCT01000155|39640743|FG000|Overall Study|Withdrawal by Subject|1|||
16315762|NCT01000155|39640743|FG000|Overall Study|Adverse Event|1|||
16315763|NCT00813150|39640744|FG000|Treatment Period|Adverse Event|16|||
16315764|NCT00813150|39640745|FG001|Treatment Period|Adverse Event|15|||
16315765|NCT00813150|39640744|FG000|Treatment Period|Death|2|||
16315766|NCT00813150|39640745|FG001|Treatment Period|Death|0|||
16315767|NCT00813150|39640744|FG000|Treatment Period|Progressive disease|1|||
16315768|NCT00813150|39640745|FG001|Treatment Period|Progressive disease|0|||
16315769|NCT00813150|39640744|FG000|Treatment Period|Complete response|0|||
16315770|NCT00813150|39640745|FG001|Treatment Period|Complete response|1|||
16315771|NCT00813150|39640744|FG000|Treatment Period|Stable disease|1|||
16315772|NCT00813150|39640745|FG001|Treatment Period|Stable disease|2|||
16315773|NCT00813150|39640744|FG000|Treatment Period|Protocol Violation|3|||
16315774|NCT00813150|39640745|FG001|Treatment Period|Protocol Violation|4|||
16315775|NCT00813150|39640744|FG000|Treatment Period|Withdrawal by Subject|5|||
16315776|NCT00813150|39640745|FG001|Treatment Period|Withdrawal by Subject|3|||
16315777|NCT00813150|39640744|FG000|Treatment Period|Non compliance|0|||
16315778|NCT00813150|39640745|FG001|Treatment Period|Non compliance|1|||
16315779|NCT00813150|39640744|FG000|Treatment Period|Reason not specified|3|||
16315780|NCT00813150|39640745|FG001|Treatment Period|Reason not specified|4|||
16315781|NCT00813150|39640744|FG000|Treatment Period|Data not available|1|||
16315782|NCT00813150|39640745|FG001|Treatment Period|Data not available|2|||
16510050|NCT00419562|40343729|FG001|Overall Study|Participant Institutionalized|0|||
16510051|NCT01176292|40343732|FG000|Overall Study|Lost to Follow-up|2|||
16510052|NCT01176292|40343733|FG001|Overall Study|Lost to Follow-up|4|||
16315783|NCT00813150|39640744|FG000|Long Term Follow-up|Death|0|||
16315784|NCT00813150|39640745|FG001|Long Term Follow-up|Death|4|||
16315785|NCT00813150|39640744|FG000|Long Term Follow-up|Other|0|||
16315786|NCT00813150|39640745|FG001|Long Term Follow-up|Other|3|||
16510053|NCT01176292|40343732|FG000|Overall Study|Adverse Event|1|||
16510054|NCT01176292|40343733|FG001|Overall Study|Adverse Event|1|||
16510055|NCT01176292|40343732|FG000|Overall Study|Physician Decision|0|||
16510056|NCT01176292|40343733|FG001|Overall Study|Physician Decision|2|||
16510057|NCT01176292|40343732|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
16510058|NCT01176292|40343733|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
16510059|NCT03568942|40343738|FG000|Overall Study|Family emergency|1|||
16510060|NCT03568942|40343738|FG000|Overall Study|Lost to Follow-up|1|||
16510061|NCT05074433|40343743|FG000|Overall Study|Adverse Event|0|||
16510062|NCT05074433|40343744|FG001|Overall Study|Adverse Event|2|||
16510063|NCT05074433|40343745|FG002|Overall Study|Adverse Event|0|||
16510064|NCT05074433|40343746|FG003|Overall Study|Adverse Event|1|||
16510065|NCT05074433|40343743|FG000|Overall Study|Sponsor Request|0|||
16510066|NCT05074433|40343744|FG001|Overall Study|Sponsor Request|1|||
16510067|NCT05074433|40343745|FG002|Overall Study|Sponsor Request|1|||
16510068|NCT05074433|40343746|FG003|Overall Study|Sponsor Request|0|||
16510069|NCT05074433|40343743|FG000|Overall Study|Death|1|||
16510070|NCT05074433|40343744|FG001|Overall Study|Death|0|||
16510071|NCT05074433|40343745|FG002|Overall Study|Death|0|||
16510072|NCT05074433|40343746|FG003|Overall Study|Death|0|||
16510073|NCT05074433|40343743|FG000|Overall Study|Lost to Follow-up|0|||
16510074|NCT05074433|40343744|FG001|Overall Study|Lost to Follow-up|0|||
16510075|NCT05074433|40343745|FG002|Overall Study|Lost to Follow-up|2|||
16510076|NCT05074433|40343746|FG003|Overall Study|Lost to Follow-up|0|||
16198816|NCT03655717|39204426|FG025|Overall Study|Physician Decision|0|||
16198817|NCT03655717|39204401|FG000|Overall Study|Lost to Follow-up|3|||
16198818|NCT03655717|39204402|FG001|Overall Study|Lost to Follow-up|1|||
16198819|NCT03655717|39204403|FG002|Overall Study|Lost to Follow-up|0|||
16198820|NCT03655717|39204404|FG003|Overall Study|Lost to Follow-up|1|||
16198821|NCT03655717|39204405|FG004|Overall Study|Lost to Follow-up|0|||
16198822|NCT03655717|39204406|FG005|Overall Study|Lost to Follow-up|1|||
16198823|NCT03655717|39204407|FG006|Overall Study|Lost to Follow-up|0|||
16198824|NCT03655717|39204408|FG007|Overall Study|Lost to Follow-up|0|||
16089949|NCT00614614|38820028|FG002|Booster Vaccination Phase|Adverse Event|1|||
16089950|NCT00614614|38820029|FG003|Booster Vaccination Phase|Adverse Event|1|||
16089951|NCT00614614|38820030|FG004|Booster Vaccination Phase|Adverse Event|0|||
16089952|NCT00614614|38820026|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
16089953|NCT00614614|38820027|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
16089954|NCT00614614|38820028|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
16089955|NCT00614614|38820029|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
16089956|NCT00614614|38820030|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
16089957|NCT00614614|38820026|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
16089958|NCT00614614|38820027|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
16198825|NCT03655717|39204409|FG008|Overall Study|Lost to Follow-up|0|||
16198826|NCT03655717|39204410|FG009|Overall Study|Lost to Follow-up|0|||
16198827|NCT03655717|39204411|FG010|Overall Study|Lost to Follow-up|0|||
16198828|NCT03655717|39204412|FG011|Overall Study|Lost to Follow-up|1|||
16510077|NCT05074433|40343743|FG000|Overall Study|Subject Decision|8|||
16510078|NCT05074433|40343744|FG001|Overall Study|Subject Decision|6|||
16510079|NCT05074433|40343745|FG002|Overall Study|Subject Decision|4|||
16510080|NCT05074433|40343746|FG003|Overall Study|Subject Decision|5|||
16510081|NCT00806546|40343749|FG000|Overall Study|Enrolled, not treated|35|||
16510082|NCT00806546|40343749|FG000|Overall Study|Lost to Follow-up|32|||
16510083|NCT00806546|40343749|FG000|Overall Study|Adverse Event|74|||
16510084|NCT00806546|40343749|FG000|Overall Study|Withdrawal by Subject|75|||
16510085|NCT00806546|40343749|FG000|Overall Study|Protocol Violation|49|||
16510086|NCT00806546|40343749|FG000|Overall Study|Various|42|||
16510087|NCT02155738|40343750|FG000|Overall Study|Missing critical information|1|||
16510088|NCT02155738|40343751|FG001|Overall Study|Missing critical information|0|||
16510089|NCT02155738|40343752|FG002|Overall Study|Missing critical information|0|||
16510090|NCT02155738|40343753|FG003|Overall Study|Missing critical information|1|||
16510091|NCT03013543|40343760|FG000|Overall Study|Withdrawal by Subject|0|||
16510092|NCT03013543|40343761|FG001|Overall Study|Withdrawal by Subject|2|||
16510093|NCT03013543|40343762|FG002|Overall Study|Withdrawal by Subject|0|||
16198829|NCT03655717|39204413|FG012|Overall Study|Lost to Follow-up|0|||
16198830|NCT03655717|39204414|FG013|Overall Study|Lost to Follow-up|0|||
16198831|NCT03655717|39204415|FG014|Overall Study|Lost to Follow-up|0|||
16198832|NCT03655717|39204416|FG015|Overall Study|Lost to Follow-up|0|||
16198833|NCT03655717|39204417|FG016|Overall Study|Lost to Follow-up|0|||
16198834|NCT03655717|39204418|FG017|Overall Study|Lost to Follow-up|0|||
16198835|NCT03655717|39204419|FG018|Overall Study|Lost to Follow-up|0|||
16510094|NCT03013543|40343763|FG003|Overall Study|Withdrawal by Subject|5|||
16510095|NCT03013543|40343764|FG004|Overall Study|Withdrawal by Subject|6|||
16510096|NCT03013543|40343765|FG005|Overall Study|Withdrawal by Subject|2|||
16510097|NCT03013543|40343766|FG006|Overall Study|Withdrawal by Subject|3|||
16510098|NCT03013543|40343767|FG007|Overall Study|Withdrawal by Subject|1|||
16510099|NCT03013543|40343768|FG008|Overall Study|Withdrawal by Subject|0|||
16510100|NCT03013543|40343769|FG009|Overall Study|Withdrawal by Subject|4|||
16510101|NCT03013543|40343760|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
16510102|NCT03013543|40343761|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
16198836|NCT03655717|39204420|FG019|Overall Study|Lost to Follow-up|0|||
16198837|NCT03655717|39204421|FG020|Overall Study|Lost to Follow-up|0|||
16198838|NCT03655717|39204422|FG021|Overall Study|Lost to Follow-up|0|||
16198839|NCT03655717|39204423|FG022|Overall Study|Lost to Follow-up|0|||
16198840|NCT03655717|39204424|FG023|Overall Study|Lost to Follow-up|0|||
16198841|NCT03655717|39204425|FG024|Overall Study|Lost to Follow-up|0|||
16198842|NCT03655717|39204426|FG025|Overall Study|Lost to Follow-up|0|||
16198843|NCT01295580|39204427|FG000|Overall Study|Protocol Violation|4|||
16198844|NCT01295580|39204428|FG001|Overall Study|Protocol Violation|2|||
16198845|NCT01295580|39204427|FG000|Overall Study|Withdrawal by Subject|1|||
16198846|NCT01295580|39204428|FG001|Overall Study|Withdrawal by Subject|4|||
16198847|NCT01295580|39204427|FG000|Overall Study|Adverse Event|2|||
16198848|NCT01295580|39204428|FG001|Overall Study|Adverse Event|1|||
16198849|NCT01295580|39204427|FG000|Overall Study|Lost to Follow-up|1|||
16198850|NCT01295580|39204428|FG001|Overall Study|Lost to Follow-up|0|||
16198851|NCT01295580|39204427|FG000|Overall Study|Lack of Efficacy|1|||
16198852|NCT01295580|39204428|FG001|Overall Study|Lack of Efficacy|0|||
16198853|NCT01295580|39204427|FG000|Overall Study|Other: inconvenience|1|||
16198854|NCT01295580|39204428|FG001|Overall Study|Other: inconvenience|0|||
16198855|NCT01295580|39204427|FG000|Overall Study|Other: family objection|0|||
16198856|NCT01295580|39204428|FG001|Overall Study|Other: family objection|1|||
16198857|NCT00488592|39204429|FG000|Overall Study|Withdrawal by Subject|1|||
16198858|NCT00488592|39204429|FG000|Overall Study|Disease progression|1|||
16198859|NCT00488592|39204429|FG000|Overall Study|Enrolled but not treated|1|||
16198860|NCT03089216|39204439|FG000|Overall Study|Adverse Event|0|||
16198861|NCT03089216|39204440|FG001|Overall Study|Adverse Event|0|||
16198862|NCT03089216|39204441|FG002|Overall Study|Adverse Event|0|||
16198863|NCT03089216|39204442|FG003|Overall Study|Adverse Event|1|||
16198864|NCT03364335|39204443|FG000|Overall Study|Adverse Event|3|||
16198865|NCT03364335|39204444|FG001|Overall Study|Adverse Event|4|||
16198866|NCT03364335|39204445|FG002|Overall Study|Adverse Event|1|||
16198867|NCT03364335|39204446|FG003|Overall Study|Adverse Event|2|||
16198868|NCT03364335|39204447|FG004|Overall Study|Adverse Event|0|||
16198869|NCT03364335|39204443|FG000|Overall Study|Lost to Follow-up|7|||
16198870|NCT03364335|39204444|FG001|Overall Study|Lost to Follow-up|7|||
16198871|NCT03364335|39204445|FG002|Overall Study|Lost to Follow-up|10|||
16198872|NCT03364335|39204446|FG003|Overall Study|Lost to Follow-up|11|||
16198873|NCT03364335|39204447|FG004|Overall Study|Lost to Follow-up|11|||
16198874|NCT01755195|39204448|FG000|Overall Study|Participant noncompliance|2|||
16198875|NCT01755195|39204448|FG000|Overall Study|Switched to alternative treatment|4|||
16198876|NCT01755195|39204448|FG000|Overall Study|Withdrawal by Subject|1|||
16198877|NCT01755195|39204448|FG000|Overall Study|Participant refused to start treatment|1|||
16198878|NCT01755195|39204448|FG000|Overall Study|Participant has been consented for another trial|1|||
16198879|NCT01755195|39204448|FG000|Overall Study|Refused further treatment|3|||
16198880|NCT01755195|39204448|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
16198881|NCT00676208|39204449|FG000|Overall Study|Lost to Follow-up|0|||
16198882|NCT00676208|39204450|FG001|Overall Study|Lost to Follow-up|2|||
16198883|NCT00676208|39204449|FG000|Overall Study|Incomplete data|2|||
16198884|NCT00676208|39204450|FG001|Overall Study|Incomplete data|4|||
16198885|NCT01844830|39204451|FG000|Overall Study|Withdrawal by Subject|1|||
16198886|NCT01844830|39204452|FG001|Overall Study|Withdrawal by Subject|0|||
16198887|NCT00868166|39204457|FG000|Overall Study|Death|58|||
16198888|NCT00868166|39204458|FG001|Overall Study|Death|65|||
16198889|NCT00868166|39204457|FG000|Overall Study|Withdrawal by Subject|33|||
16198890|NCT00868166|39204458|FG001|Overall Study|Withdrawal by Subject|25|||
16198891|NCT00868166|39204457|FG000|Overall Study|Protocol Violation|1|||
16198892|NCT00868166|39204458|FG001|Overall Study|Protocol Violation|0|||
16198893|NCT00868166|39204457|FG000|Overall Study|Lost to Follow-up|1|||
16198894|NCT00868166|39204458|FG001|Overall Study|Lost to Follow-up|3|||
16198895|NCT00868166|39204457|FG000|Overall Study|Adverse Event|9|||
16198896|NCT00868166|39204458|FG001|Overall Study|Adverse Event|10|||
16198897|NCT00868166|39204457|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
16198898|NCT00868166|39204458|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
16315787|NCT00813150|39640744|FG000|Long Term Follow-up|Lost to Follow-up|2|||
16409946|NCT00343915|39981841|FG000|Primary Study|Lost to Follow-up|2|||
16198899|NCT00868166|39204457|FG000|Overall Study|Non-compliance with IMP|1|||
16198900|NCT00868166|39204458|FG001|Overall Study|Non-compliance with IMP|1|||
16198901|NCT00798655|39204459|FG000|Overall Study|Did not receive at least one dose of pan|2|||
16198902|NCT00343291|39204460|FG000|Overall Study|Adverse Event|13|||
16198903|NCT00343291|39204461|FG001|Overall Study|Adverse Event|13|||
16198904|NCT00343291|39204460|FG000|Overall Study|Death|3|||
16198905|NCT00343291|39204461|FG001|Overall Study|Death|2|||
16198906|NCT00343291|39204460|FG000|Overall Study|Progressive disease|33|||
16198907|NCT00343291|39204461|FG001|Overall Study|Progressive disease|34|||
16198908|NCT00343291|39204460|FG000|Overall Study|Withdrawal by Subject|0|||
16198909|NCT00343291|39204461|FG001|Overall Study|Withdrawal by Subject|2|||
16198910|NCT00343291|39204460|FG000|Overall Study|Other|8|||
16198911|NCT00343291|39204461|FG001|Overall Study|Other|5|||
16198912|NCT04543955|39204462|FG000|Overall Study|Company cancelled study|1|||
16198913|NCT04543955|39204463|FG001|Overall Study|Company cancelled study|0|||
16198914|NCT01244191|39204469|FG000|Overall Study|Progressive disease|295|||
16198915|NCT01244191|39204470|FG001|Overall Study|Progressive disease|350|||
16198916|NCT01244191|39204469|FG000|Overall Study|Clinical disease progression|54|||
16198917|NCT01244191|39204470|FG001|Overall Study|Clinical disease progression|36|||
16198918|NCT01244191|39204469|FG000|Overall Study|Adverse Event|65|||
16198919|NCT01244191|39204470|FG001|Overall Study|Adverse Event|48|||
16198920|NCT01244191|39204469|FG000|Overall Study|Death|22|||
16198921|NCT01244191|39204470|FG001|Overall Study|Death|29|||
16198922|NCT01244191|39204469|FG000|Overall Study|Lost to Follow-up|0|||
16198923|NCT01244191|39204470|FG001|Overall Study|Lost to Follow-up|2|||
16198924|NCT01244191|39204469|FG000|Overall Study|Protocol Violation|1|||
16198925|NCT01244191|39204470|FG001|Overall Study|Protocol Violation|2|||
16198926|NCT01244191|39204469|FG000|Overall Study|Withdrawal by Subject|31|||
16198927|NCT01244191|39204470|FG001|Overall Study|Withdrawal by Subject|23|||
16198928|NCT01244191|39204469|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
16198929|NCT01244191|39204470|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
16198930|NCT00424528|39204471|FG000|Overall Study|Adverse Event|2|||
16198931|NCT00424528|39204472|FG001|Overall Study|Adverse Event|1|||
16198932|NCT00424528|39204473|FG002|Overall Study|Adverse Event|2|||
16198933|NCT00424528|39204471|FG000|Overall Study|Protocol Violation|1|||
16198934|NCT00424528|39204472|FG001|Overall Study|Protocol Violation|1|||
16198935|NCT00424528|39204473|FG002|Overall Study|Protocol Violation|0|||
16198936|NCT00424528|39204471|FG000|Overall Study|Lost to Follow-up|0|||
16198937|NCT00424528|39204472|FG001|Overall Study|Lost to Follow-up|1|||
16198938|NCT00424528|39204473|FG002|Overall Study|Lost to Follow-up|0|||
16198939|NCT00424528|39204471|FG000|Overall Study|noncompliance with study requirements|2|||
16198940|NCT00424528|39204472|FG001|Overall Study|noncompliance with study requirements|1|||
16198941|NCT00424528|39204473|FG002|Overall Study|noncompliance with study requirements|2|||
16198942|NCT01098461|39204474|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
16198943|NCT01098461|39204475|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
16198944|NCT01098461|39204476|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
16198945|NCT01098461|39204477|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
16198946|NCT01098461|39204474|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
16198947|NCT01098461|39204475|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
16198948|NCT01098461|39204476|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
16198949|NCT01098461|39204477|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
16198950|NCT01098461|39204474|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
16198951|NCT01098461|39204475|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
16198952|NCT01098461|39204476|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
16198953|NCT01098461|39204477|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
16198954|NCT01098461|39204474|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
16198955|NCT01098461|39204475|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
16198956|NCT01098461|39204476|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
16198957|NCT01098461|39204477|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
16198958|NCT01098461|39204474|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
16198959|NCT01098461|39204475|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
16198960|NCT01098461|39204476|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
16198961|NCT01098461|39204477|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
16198962|NCT01098461|39204474|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
16198963|NCT01098461|39204475|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
16198964|NCT01098461|39204476|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
16198965|NCT01098461|39204477|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
16198966|NCT01098461|39204474|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
16198967|NCT01098461|39204475|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
16198968|NCT01098461|39204476|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
16198969|NCT01098461|39204477|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
16198970|NCT00631540|39204479|FG000|Overall Study|Withdrawal by Subject|5|||
16198971|NCT00631540|39204479|FG000|Overall Study|Death|4|||
16198972|NCT00631540|39204479|FG000|Overall Study|Lost to Follow-up|2|||
16198973|NCT00631540|39204479|FG000|Overall Study|Core Lab Data Unavailable|3|||
16198974|NCT03017846|39204483|FG000|Overall Study|Lost to Follow-up|3|||
16198975|NCT03017846|39204483|FG000|Overall Study|Adverse Event|2|||
16198976|NCT01374217|39204484|FG000|Overall Study|Lack of Efficacy|13|||
16198977|NCT00599027|39204485|FG000|Overall Study|Withdrawal by Subject|1|||
16198978|NCT00599027|39204486|FG001|Overall Study|Withdrawal by Subject|1|||
16198979|NCT00599027|39204485|FG000|Overall Study|Adverse Event|0|||
16198980|NCT00599027|39204486|FG001|Overall Study|Adverse Event|1|||
16198981|NCT00599027|39204485|FG000|Overall Study|Treatment Failure|0|||
16198982|NCT00599027|39204486|FG001|Overall Study|Treatment Failure|1|||
16198983|NCT01654523|39204489|FG000|Overall Study|Withdrawal by Subject|1|||
16198984|NCT02648724|39204492|FG000|Overall Study|Withdrawal by Subject|0|||
16198985|NCT02648724|39204493|FG001|Overall Study|Withdrawal by Subject|1|||
16198986|NCT02648724|39204494|FG002|Overall Study|Withdrawal by Subject|1|||
16198987|NCT02648724|39204495|FG003|Overall Study|Withdrawal by Subject|0|||
16198988|NCT02648724|39204496|FG004|Overall Study|Withdrawal by Subject|1|||
16198989|NCT02648724|39204497|FG005|Overall Study|Withdrawal by Subject|0|||
16198990|NCT02648724|39204498|FG006|Overall Study|Withdrawal by Subject|0|||
16198991|NCT02648724|39204492|FG000|Overall Study|Progressive disease|2|||
16198992|NCT02648724|39204493|FG001|Overall Study|Progressive disease|2|||
16198993|NCT02648724|39204494|FG002|Overall Study|Progressive disease|2|||
16198994|NCT02648724|39204495|FG003|Overall Study|Progressive disease|3|||
16198995|NCT02648724|39204496|FG004|Overall Study|Progressive disease|22|||
16198996|NCT02648724|39204497|FG005|Overall Study|Progressive disease|7|||
16198997|NCT02648724|39204498|FG006|Overall Study|Progressive disease|8|||
16198998|NCT02648724|39204492|FG000|Overall Study|Other reason (unknown)|1|||
16198999|NCT02648724|39204493|FG001|Overall Study|Other reason (unknown)|0|||
16199000|NCT02648724|39204494|FG002|Overall Study|Other reason (unknown)|0|||
16199001|NCT02648724|39204495|FG003|Overall Study|Other reason (unknown)|0|||
16199002|NCT02648724|39204496|FG004|Overall Study|Other reason (unknown)|0|||
16199003|NCT02648724|39204497|FG005|Overall Study|Other reason (unknown)|0|||
16199004|NCT02648724|39204498|FG006|Overall Study|Other reason (unknown)|0|||
16199005|NCT02648724|39204492|FG000|Overall Study|Protocol Violation|0|||
16199006|NCT02648724|39204493|FG001|Overall Study|Protocol Violation|0|||
16199007|NCT02648724|39204494|FG002|Overall Study|Protocol Violation|0|||
16199008|NCT02648724|39204495|FG003|Overall Study|Protocol Violation|0|||
16199009|NCT02648724|39204496|FG004|Overall Study|Protocol Violation|1|||
16199010|NCT02648724|39204497|FG005|Overall Study|Protocol Violation|0|||
16199011|NCT02648724|39204498|FG006|Overall Study|Protocol Violation|0|||
16315788|NCT00813150|39640745|FG001|Long Term Follow-up|Lost to Follow-up|0|||
16199012|NCT02648724|39204492|FG000|Overall Study|Death|0|||
16199013|NCT02648724|39204493|FG001|Overall Study|Death|0|||
16199014|NCT02648724|39204494|FG002|Overall Study|Death|0|||
16199015|NCT02648724|39204495|FG003|Overall Study|Death|0|||
16199016|NCT02648724|39204496|FG004|Overall Study|Death|0|||
16199017|NCT02648724|39204497|FG005|Overall Study|Death|0|||
16199018|NCT02648724|39204498|FG006|Overall Study|Death|3|||
16199019|NCT02648724|39204492|FG000|Overall Study|Physician Decision|0|||
16199020|NCT02648724|39204493|FG001|Overall Study|Physician Decision|0|||
16199021|NCT02648724|39204494|FG002|Overall Study|Physician Decision|0|||
16199022|NCT02648724|39204495|FG003|Overall Study|Physician Decision|0|||
16199023|NCT02648724|39204496|FG004|Overall Study|Physician Decision|1|||
16199024|NCT02648724|39204497|FG005|Overall Study|Physician Decision|0|||
16199025|NCT02648724|39204498|FG006|Overall Study|Physician Decision|1|||
16199026|NCT02648724|39204492|FG000|Overall Study|Transferred to named patient program|0|||
16199027|NCT02648724|39204493|FG001|Overall Study|Transferred to named patient program|0|||
16199028|NCT02648724|39204494|FG002|Overall Study|Transferred to named patient program|0|||
16199029|NCT02648724|39204495|FG003|Overall Study|Transferred to named patient program|0|||
16199030|NCT02648724|39204496|FG004|Overall Study|Transferred to named patient program|0|||
16199031|NCT02648724|39204497|FG005|Overall Study|Transferred to named patient program|1|||
16199032|NCT02648724|39204498|FG006|Overall Study|Transferred to named patient program|0|||
16199033|NCT05086289|39204499|FG000|Overall Study|Adverse Event|4|||
16199034|NCT05086289|39204500|FG001|Overall Study|Adverse Event|2|||
16199035|NCT05086289|39204499|FG000|Overall Study|Lost to Follow-up|2|||
16199036|NCT05086289|39204500|FG001|Overall Study|Lost to Follow-up|0|||
16199037|NCT05086289|39204499|FG000|Overall Study|Non-compliance with study drug|2|||
16315789|NCT00813150|39640744|FG000|Long Term Follow-up|Progression/Relapse|22|||
16315790|NCT00813150|39640745|FG001|Long Term Follow-up|Progression/Relapse|24|||
16315791|NCT02222922|39640747|FG000|Overall Study|Death|0|||
16392199|NCT03335150|39919613|FG001|Overall Study|Withdrawal by Subject|4|||
16199038|NCT05086289|39204500|FG001|Overall Study|Non-compliance with study drug|1|||
16199039|NCT05086289|39204499|FG000|Overall Study|Physician Decision|2|||
16199040|NCT05086289|39204500|FG001|Overall Study|Physician Decision|0|||
16199041|NCT05086289|39204499|FG000|Overall Study|Withdrawal by Subject|5|||
16199042|NCT05086289|39204500|FG001|Overall Study|Withdrawal by Subject|2|||
16199043|NCT01175213|39204503|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
16199044|NCT01175213|39204504|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
16199045|NCT01175213|39204503|FG000|IGSC, 10%/rHuPH20|Death|1|||
16199046|NCT01175213|39204504|FG001|IGSC, 10%/rHuPH20|Death|0|||
16199047|NCT01175213|39204503|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
16199048|NCT01175213|39204504|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
16199049|NCT01175213|39204503|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
16199050|NCT01175213|39204504|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
16199051|NCT01175213|39204503|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
16199052|NCT01175213|39204504|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
16199053|NCT01175213|39204503|FG000|Safety Follow-up|Adverse Event|1|||
16199054|NCT01175213|39204504|FG001|Safety Follow-up|Adverse Event|0|||
16199055|NCT00667251|39204505|FG000|Overall Study|Adverse Event|13|||
16199056|NCT00667251|39204506|FG001|Overall Study|Adverse Event|4|||
16199057|NCT00667251|39204505|FG000|Overall Study|Withdrawal by Subject|6|||
16199058|NCT00667251|39204506|FG001|Overall Study|Withdrawal by Subject|2|||
16199059|NCT00667251|39204505|FG000|Overall Study|Other/missing|46|||
16199060|NCT00667251|39204506|FG001|Overall Study|Other/missing|84|||
16199061|NCT00667251|39204505|FG000|Overall Study|Intercurrent Illness|4|||
16199062|NCT00667251|39204506|FG001|Overall Study|Intercurrent Illness|3|||
16199063|NCT00667251|39204505|FG000|Overall Study|Symptomatic progression|1|||
16199064|NCT00667251|39204506|FG001|Overall Study|Symptomatic progression|2|||
16199065|NCT01391819|39204507|FG000|Overall Study|Withdrawal by Subject|56|||
16199066|NCT01391819|39204507|FG000|Overall Study|Migrated/moved from study area|82|||
16199067|NCT01391819|39204507|FG000|Overall Study|Lost to Follow-up|252|||
16199068|NCT01391819|39204507|FG000|Overall Study|Death|3|||
16199069|NCT01391819|39204507|FG000|Overall Study|Other|9|||
16199070|NCT02561299|39204510|FG000|Overall Study|Death|2|||
16199071|NCT02561299|39204511|FG001|Overall Study|Death|4|||
16199072|NCT02561299|39204510|FG000|Overall Study|Lost to Follow-up|1|||
16199073|NCT02561299|39204511|FG001|Overall Study|Lost to Follow-up|0|||
16199074|NCT02561299|39204510|FG000|Overall Study|Withdrawal by Subject|2|||
16199075|NCT02561299|39204511|FG001|Overall Study|Withdrawal by Subject|2|||
16199076|NCT01879319|39204514|FG000|Overall Study|Withdrawal by Subject|1|||
16199077|NCT01879319|39204515|FG001|Overall Study|Withdrawal by Subject|0|||
16199078|NCT01879319|39204514|FG000|Overall Study|Lost to Follow-up|1|||
16199079|NCT01879319|39204515|FG001|Overall Study|Lost to Follow-up|5|||
16199080|NCT00400712|39204516|FG000|Overall Study|Death|1|||
16199081|NCT00400712|39204517|FG001|Overall Study|Death|0|||
16199082|NCT00400712|39204516|FG000|Overall Study|Withdrawal by Subject|11|||
16199083|NCT00400712|39204517|FG001|Overall Study|Withdrawal by Subject|12|||
16199084|NCT00400712|39204516|FG000|Overall Study|Physician Decision|5|||
16199085|NCT00400712|39204517|FG001|Overall Study|Physician Decision|4|||
16199086|NCT00003476|39204524|FG000|Overall Study|Not evaluable|1|||
16199087|NCT00889681|39204525|FG000|Overall Study|Not meeting qualification Criteria|2|||
16199088|NCT00889681|39204525|FG000|Overall Study|Insurance disapproval|1|||
16199089|NCT02887859|39204526|FG000|Overall Study|Ongoing|6|||
16199090|NCT02887859|39204526|FG000|Overall Study|Adverse Event|7|||
16199091|NCT02887859|39204526|FG000|Overall Study|Death|1|||
16199092|NCT02887859|39204526|FG000|Overall Study|Physician Decision|1|||
16199093|NCT01054976|39204532|FG000|Overall Study|Adverse Event|16|||
16199094|NCT01054976|39204532|FG000|Overall Study|Uncooperative participations to study|7|||
16199095|NCT01054976|39204532|FG000|Overall Study|Withdrawal by Subject|4|||
16199096|NCT01054976|39204532|FG000|Overall Study|Other|8|||
16199097|NCT01089582|39204533|FG000|Overall Study|Death|2|||
16199098|NCT01089582|39204533|FG000|Overall Study|Adverse Event|15|||
16199099|NCT01089582|39204533|FG000|Overall Study|Lost to Follow-up|8|||
16199100|NCT01089582|39204533|FG000|Overall Study|Other|4|||
16199101|NCT01089582|39204533|FG000|Overall Study|Withdrawal by Subject|1|||
16199102|NCT02975700|39204535|FG000|Overall Study|Adverse Event|1|||
16199103|NCT02975700|39204535|FG000|Overall Study|Progressive disease|3|||
16199104|NCT02975700|39204535|FG000|Overall Study|Failed screening criteria|2|||
16199105|NCT01116687|39204536|FG000|Overall Study|Withdrawal by Subject|4|||
16199106|NCT02530671|39204537|FG000|Overall Study|Lost to Follow-up|2|||
16199107|NCT02530671|39204538|FG001|Overall Study|Lost to Follow-up|0|||
16199108|NCT02530671|39204537|FG000|Overall Study|Withdrawal by Subject|1|||
16315792|NCT02222922|39640748|FG001|Overall Study|Death|0|||
16315793|NCT02222922|39640749|FG002|Overall Study|Death|0|||
16315794|NCT02222922|39640750|FG003|Overall Study|Death|0|||
16315795|NCT02222922|39640751|FG004|Overall Study|Death|13|||
16315796|NCT02222922|39640752|FG005|Overall Study|Death|0|||
16315797|NCT02222922|39640753|FG006|Overall Study|Death|0|||
16315798|NCT02222922|39640754|FG007|Overall Study|Death|0|||
16315799|NCT02222922|39640755|FG008|Overall Study|Death|2|||
16315800|NCT02222922|39640747|FG000|Overall Study|Lost to Follow-up|0|||
16315801|NCT02222922|39640748|FG001|Overall Study|Lost to Follow-up|0|||
16315802|NCT02222922|39640749|FG002|Overall Study|Lost to Follow-up|1|||
16315803|NCT02222922|39640750|FG003|Overall Study|Lost to Follow-up|0|||
16315804|NCT02222922|39640751|FG004|Overall Study|Lost to Follow-up|9|||
16315805|NCT02222922|39640752|FG005|Overall Study|Lost to Follow-up|1|||
16199109|NCT02530671|39204538|FG001|Overall Study|Withdrawal by Subject|0|||
16199110|NCT03094832|39204539|FG000|Overall Study|Lost to Follow-up|0|||
16199111|NCT03094832|39204540|FG001|Overall Study|Lost to Follow-up|0|||
16199112|NCT03094832|39204541|FG002|Overall Study|Lost to Follow-up|0|||
16199113|NCT03094832|39204542|FG003|Overall Study|Lost to Follow-up|1|||
16199114|NCT03094832|39204543|FG004|Overall Study|Lost to Follow-up|1|||
16199115|NCT03094832|39204539|FG000|Overall Study|Death|1|||
16199116|NCT03094832|39204540|FG001|Overall Study|Death|0|||
16199117|NCT03094832|39204541|FG002|Overall Study|Death|0|||
16199118|NCT03094832|39204542|FG003|Overall Study|Death|0|||
16199119|NCT03094832|39204543|FG004|Overall Study|Death|0|||
16199120|NCT03094832|39204539|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
16315806|NCT02222922|39640753|FG006|Overall Study|Lost to Follow-up|0|||
16315807|NCT02222922|39640754|FG007|Overall Study|Lost to Follow-up|0|||
16315808|NCT02222922|39640755|FG008|Overall Study|Lost to Follow-up|0|||
16315809|NCT02222922|39640747|FG000|Overall Study|Other|0|||
16315810|NCT02222922|39640748|FG001|Overall Study|Other|0|||
16315811|NCT02222922|39640749|FG002|Overall Study|Other|0|||
16315812|NCT02222922|39640750|FG003|Overall Study|Other|2|||
16315813|NCT02222922|39640751|FG004|Overall Study|Other|10|||
16315814|NCT02222922|39640752|FG005|Overall Study|Other|2|||
16315815|NCT02222922|39640753|FG006|Overall Study|Other|2|||
16315816|NCT02222922|39640754|FG007|Overall Study|Other|4|||
16315817|NCT02222922|39640755|FG008|Overall Study|Other|1|||
16315818|NCT02222922|39640747|FG000|Overall Study|Participant refused further follow-up|1|||
16315819|NCT02222922|39640748|FG001|Overall Study|Participant refused further follow-up|0|||
16315820|NCT02222922|39640749|FG002|Overall Study|Participant refused further follow-up|0|||
16315821|NCT02222922|39640750|FG003|Overall Study|Participant refused further follow-up|1|||
16315822|NCT02222922|39640751|FG004|Overall Study|Participant refused further follow-up|6|||
16315823|NCT02222922|39640752|FG005|Overall Study|Participant refused further follow-up|0|||
16315824|NCT02222922|39640753|FG006|Overall Study|Participant refused further follow-up|0|||
16315825|NCT02222922|39640754|FG007|Overall Study|Participant refused further follow-up|0|||
16315826|NCT02222922|39640755|FG008|Overall Study|Participant refused further follow-up|3|||
16315827|NCT04620746|39640759|FG000|Overall Study|Adverse Event|2|||
16392200|NCT03335150|39919612|FG000|Overall Study|Adverse Event|0|||
16392201|NCT03335150|39919613|FG001|Overall Study|Adverse Event|1|||
16392202|NCT00703963|39919614|FG000|Overall Study|Withdrawal by Subject|7|||
16392203|NCT00703963|39919615|FG001|Overall Study|Withdrawal by Subject|13|||
16392204|NCT00703963|39919614|FG000|Overall Study|Physician Decision|0|||
16315828|NCT04620746|39640760|FG001|Overall Study|Adverse Event|0|||
16315829|NCT04620746|39640759|FG000|Overall Study|Uniterpretable skin test|1|||
16315830|NCT04620746|39640760|FG001|Overall Study|Uniterpretable skin test|0|||
16315831|NCT04620746|39640759|FG000|Overall Study|Withdrawal by Subject|0|||
16315832|NCT04620746|39640760|FG001|Overall Study|Withdrawal by Subject|1|||
16315833|NCT02273388|39640761|FG000|Overall Study|Adverse Event|0|||
16315834|NCT02273388|39640762|FG001|Overall Study|Adverse Event|0|||
16315835|NCT02273388|39640763|FG002|Overall Study|Adverse Event|0|||
16315836|NCT02273388|39640764|FG003|Overall Study|Adverse Event|0|||
16315837|NCT02273388|39640765|FG004|Overall Study|Adverse Event|0|||
16315838|NCT02273388|39640766|FG005|Overall Study|Adverse Event|0|||
16315839|NCT02273388|39640767|FG006|Overall Study|Adverse Event|1|||
16315840|NCT02273388|39640768|FG007|Overall Study|Adverse Event|2|||
16315841|NCT02273388|39640769|FG008|Overall Study|Adverse Event|0|||
16315842|NCT02273388|39640770|FG009|Overall Study|Adverse Event|0|||
16392205|NCT00703963|39919615|FG001|Overall Study|Physician Decision|1|||
16392206|NCT00811954|39919616|FG000|Overall Study|Death|10|||
16392207|NCT00811954|39919617|FG001|Overall Study|Death|6|||
16392208|NCT00811954|39919618|FG002|Overall Study|Death|13|||
16392209|NCT00811954|39919616|FG000|Overall Study|Lost to Follow-up|29|||
16392210|NCT00811954|39919617|FG001|Overall Study|Lost to Follow-up|23|||
16392211|NCT00811954|39919618|FG002|Overall Study|Lost to Follow-up|34|||
16392212|NCT00811954|39919616|FG000|Overall Study|Not able to get to clinic|28|||
16392213|NCT00811954|39919617|FG001|Overall Study|Not able to get to clinic|35|||
16392214|NCT00811954|39919618|FG002|Overall Study|Not able to get to clinic|30|||
16392215|NCT00811954|39919616|FG000|Overall Study|Not willing to adhere to requirements|12|||
16392216|NCT00811954|39919617|FG001|Overall Study|Not willing to adhere to requirements|2|||
16392217|NCT00811954|39919618|FG002|Overall Study|Not willing to adhere to requirements|16|||
16392218|NCT00811954|39919616|FG000|Overall Study|Withdraw consent prior study completion|4|||
16392219|NCT00811954|39919617|FG001|Overall Study|Withdraw consent prior study completion|6|||
16392220|NCT00811954|39919618|FG002|Overall Study|Withdraw consent prior study completion|5|||
16392221|NCT00811954|39919616|FG000|Overall Study|Site Closure|4|||
16392222|NCT00811954|39919617|FG001|Overall Study|Site Closure|0|||
16392223|NCT00811954|39919618|FG002|Overall Study|Site Closure|1|||
16392224|NCT00811954|39919616|FG000|Overall Study|Severe Debilitation|2|||
16392225|NCT00811954|39919617|FG001|Overall Study|Severe Debilitation|0|||
16392226|NCT00811954|39919618|FG002|Overall Study|Severe Debilitation|1|||
16392227|NCT00811954|39919616|FG000|Overall Study|Complete Protocol: No follow-up|0|||
16392228|NCT00811954|39919617|FG001|Overall Study|Complete Protocol: No follow-up|0|||
16392229|NCT00811954|39919618|FG002|Overall Study|Complete Protocol: No follow-up|1|||
16392230|NCT02484443|39919622|FG000|Overall Study|Lack of Efficacy|28|||
16392231|NCT02484443|39919622|FG000|Overall Study|Physician Decision|2|||
16392232|NCT02484443|39919622|FG000|Overall Study|Ineligible|2|||
16392233|NCT01462929|39919623|FG000|Overall Study|Adverse Event|3|||
16315843|NCT02273388|39640771|FG010|Overall Study|Adverse Event|0|||
16315844|NCT02273388|39640772|FG011|Overall Study|Adverse Event|0|||
16315845|NCT02273388|39640761|FG000|Overall Study|Adverse Event study disease worse|4|||
16315846|NCT02273388|39640762|FG001|Overall Study|Adverse Event study disease worse|3|||
16315847|NCT02273388|39640763|FG002|Overall Study|Adverse Event study disease worse|3|||
16315848|NCT02273388|39640764|FG003|Overall Study|Adverse Event study disease worse|2|||
16392234|NCT01462929|39919624|FG001|Overall Study|Adverse Event|3|||
16392235|NCT01462929|39919625|FG002|Overall Study|Adverse Event|4|||
16392236|NCT01462929|39919623|FG000|Overall Study|Withdrawal by Subject|2|||
16392237|NCT01462929|39919624|FG001|Overall Study|Withdrawal by Subject|1|||
16392238|NCT01462929|39919625|FG002|Overall Study|Withdrawal by Subject|0|||
16392239|NCT01462929|39919623|FG000|Overall Study|Lack of Efficacy|0|||
16392240|NCT01462929|39919624|FG001|Overall Study|Lack of Efficacy|0|||
16392241|NCT01462929|39919625|FG002|Overall Study|Lack of Efficacy|1|||
16392242|NCT01194245|39919626|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
16392243|NCT01194245|39919627|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
16392244|NCT01194245|39919628|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
16392245|NCT01194245|39919629|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
16392246|NCT01194245|39919630|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
16392247|NCT01194245|39919626|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
16392248|NCT01194245|39919627|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
16392249|NCT01194245|39919628|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
16392250|NCT01194245|39919629|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
16392251|NCT01194245|39919630|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
16392252|NCT01194245|39919626|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
16392253|NCT01194245|39919627|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
16392254|NCT01194245|39919628|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
16392255|NCT01194245|39919629|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
16315849|NCT02273388|39640765|FG004|Overall Study|Adverse Event study disease worse|4|||
16315850|NCT02273388|39640766|FG005|Overall Study|Adverse Event study disease worse|3|||
16315851|NCT02273388|39640767|FG006|Overall Study|Adverse Event study disease worse|14|||
16315852|NCT02273388|39640768|FG007|Overall Study|Adverse Event study disease worse|6|||
16392256|NCT01194245|39919630|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
16392257|NCT01194245|39919626|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
16392258|NCT01194245|39919627|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
16392259|NCT01194245|39919628|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
16392260|NCT01194245|39919629|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
16392261|NCT01194245|39919630|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
16315853|NCT02273388|39640769|FG008|Overall Study|Adverse Event study disease worse|6|||
16315854|NCT02273388|39640770|FG009|Overall Study|Adverse Event study disease worse|5|||
16315855|NCT02273388|39640771|FG010|Overall Study|Adverse Event study disease worse|10|||
16315856|NCT02273388|39640772|FG011|Overall Study|Adverse Event study disease worse|1|||
16315857|NCT02273388|39640761|FG000|Overall Study|Sponsor decision|0|||
16315858|NCT02273388|39640762|FG001|Overall Study|Sponsor decision|0|||
16392262|NCT01194245|39919626|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16392263|NCT01194245|39919627|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16392264|NCT01194245|39919628|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16392265|NCT01194245|39919629|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
16392266|NCT01194245|39919630|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
16392267|NCT01194245|39919626|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16392268|NCT01194245|39919627|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
16392269|NCT01194245|39919628|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
16392270|NCT01194245|39919629|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
16392271|NCT01194245|39919630|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
16392272|NCT00787839|39919642|FG000|Overall Study|Failure to have the OGTT was most common|404|||
16392273|NCT02685826|39919643|FG000|Overall Study|Adverse Event|2|||
16392274|NCT02685826|39919644|FG001|Overall Study|Adverse Event|0|||
16392275|NCT02685826|39919645|FG002|Overall Study|Adverse Event|1|||
16392276|NCT02685826|39919643|FG000|Overall Study|Progressive Disease|2|||
16392277|NCT02685826|39919644|FG001|Overall Study|Progressive Disease|1|||
16392278|NCT02685826|39919645|FG002|Overall Study|Progressive Disease|0|||
16392279|NCT02685826|39919643|FG000|Overall Study|Withdrawal by Subject|2|||
16392280|NCT02685826|39919644|FG001|Overall Study|Withdrawal by Subject|0|||
16392281|NCT02685826|39919645|FG002|Overall Study|Withdrawal by Subject|0|||
16392282|NCT02685826|39919643|FG000|Overall Study|Full Clinical Hold by FDA|19|||
16392283|NCT02685826|39919644|FG001|Overall Study|Full Clinical Hold by FDA|9|||
16392284|NCT02685826|39919645|FG002|Overall Study|Full Clinical Hold by FDA|20|||
16392285|NCT01333722|39919646|FG000|Overall Study|Lack of Efficacy|0|||
16392286|NCT01333722|39919647|FG001|Overall Study|Lack of Efficacy|2|||
16392287|NCT01333722|39919646|FG000|Overall Study|Withdrawal by Subject|0|||
16392288|NCT01333722|39919647|FG001|Overall Study|Withdrawal by Subject|1|||
16392289|NCT01595529|39919648|FG000|Overall Study|Adverse Event|2|||
16392290|NCT01595529|39919649|FG001|Overall Study|Adverse Event|0|||
16392291|NCT01595529|39919648|FG000|Overall Study|Subject Non-Compliant|2|||
16392292|NCT01595529|39919649|FG001|Overall Study|Subject Non-Compliant|0|||
16392293|NCT01595529|39919648|FG000|Overall Study|Lost to Follow-up|8|||
16392294|NCT01595529|39919649|FG001|Overall Study|Lost to Follow-up|14|||
16315859|NCT02273388|39640763|FG002|Overall Study|Sponsor decision|0|||
16199121|NCT03094832|39204540|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16199122|NCT03094832|39204541|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16199123|NCT03094832|39204542|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
16199124|NCT03094832|39204543|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
16199125|NCT03094832|39204539|FG000|Overall Study|Other|13|||
16199126|NCT03094832|39204540|FG001|Overall Study|Other|20|||
16199127|NCT03094832|39204541|FG002|Overall Study|Other|1|||
16199128|NCT03094832|39204542|FG003|Overall Study|Other|7|||
16199129|NCT03094832|39204543|FG004|Overall Study|Other|1|||
16199130|NCT00789191|39204546|FG000|Overall Study|Adverse Event|2|||
16199131|NCT00789191|39204547|FG001|Overall Study|Adverse Event|4|||
16199132|NCT00789191|39204546|FG000|Overall Study|Lack of Efficacy|0|||
16199133|NCT00789191|39204547|FG001|Overall Study|Lack of Efficacy|5|||
16199134|NCT00789191|39204546|FG000|Overall Study|Protocol Violation|5|||
16199135|NCT00789191|39204547|FG001|Overall Study|Protocol Violation|3|||
16199136|NCT00789191|39204546|FG000|Overall Study|Withdrawal Criteria|2|||
16199137|NCT00789191|39204547|FG001|Overall Study|Withdrawal Criteria|4|||
16199138|NCT00789191|39204546|FG000|Overall Study|Unclassified|5|||
16199139|NCT00789191|39204547|FG001|Overall Study|Unclassified|3|||
16199140|NCT02156492|39204548|FG000|Period 1|No Reason Given|0|||
16199141|NCT02156492|39204549|FG001|Period 1|No Reason Given|1|||
16199142|NCT02156492|39204550|FG002|Period 1|No Reason Given|0|||
16199143|NCT02156492|39204548|FG000|Period 3|Adverse Event|0|||
16199144|NCT02156492|39204549|FG001|Period 3|Adverse Event|1|||
16199145|NCT02156492|39204550|FG002|Period 3|Adverse Event|0|||
16199146|NCT00848250|39204551|FG000|Overall Study|surgery was completed without cardiopulm|0|||
16199147|NCT00848250|39204552|FG001|Overall Study|surgery was completed without cardiopulm|1|||
16199148|NCT02932332|39204553|FG000|Overall Study|Withdrawal by Subject|1|||
16199149|NCT02932332|39204554|FG001|Overall Study|Withdrawal by Subject|1|||
16199150|NCT02932332|39204555|FG002|Overall Study|Withdrawal by Subject|0|||
16199151|NCT02932332|39204556|FG003|Overall Study|Withdrawal by Subject|1|||
16199152|NCT02932332|39204553|FG000|Overall Study|Chest pain|0|||
16199153|NCT02932332|39204554|FG001|Overall Study|Chest pain|0|||
16199154|NCT02932332|39204555|FG002|Overall Study|Chest pain|0|||
16199155|NCT02932332|39204556|FG003|Overall Study|Chest pain|1|||
16199156|NCT02932332|39204553|FG000|Overall Study|Not Dyspneic cough|1|||
16199157|NCT02932332|39204554|FG001|Overall Study|Not Dyspneic cough|2|||
16199158|NCT02932332|39204555|FG002|Overall Study|Not Dyspneic cough|1|||
16199159|NCT02932332|39204556|FG003|Overall Study|Not Dyspneic cough|0|||
16199160|NCT00987623|39204558|FG000|Overall Study|Lost to Follow-up|2|||
16199161|NCT00987623|39204559|FG001|Overall Study|Lost to Follow-up|1|||
16199162|NCT00987623|39204558|FG000|Overall Study|Time/job conflict|2|||
16199163|NCT00987623|39204559|FG001|Overall Study|Time/job conflict|0|||
16199164|NCT00987623|39204558|FG000|Overall Study|Discomfort|1|||
16199165|NCT00987623|39204559|FG001|Overall Study|Discomfort|0|||
16199166|NCT00987623|39204558|FG000|Overall Study|Biomicroscopy|0|||
16199167|NCT00987623|39204559|FG001|Overall Study|Biomicroscopy|1|||
16199168|NCT00987623|39204558|FG000|Overall Study|Influenza|0|||
16199169|NCT00987623|39204559|FG001|Overall Study|Influenza|1|||
16199170|NCT01764256|39204560|FG000|Received All Vaccinations|Adverse Event|1|||
16315860|NCT02273388|39640764|FG003|Overall Study|Sponsor decision|0|||
16315861|NCT02273388|39640765|FG004|Overall Study|Sponsor decision|0|||
16315862|NCT02273388|39640766|FG005|Overall Study|Sponsor decision|0|||
16315863|NCT02273388|39640767|FG006|Overall Study|Sponsor decision|0|||
16392295|NCT01595529|39919648|FG000|Overall Study|Protocol Violation|1|||
16392296|NCT01595529|39919649|FG001|Overall Study|Protocol Violation|2|||
16315864|NCT02273388|39640768|FG007|Overall Study|Sponsor decision|0|||
16315865|NCT02273388|39640769|FG008|Overall Study|Sponsor decision|0|||
16315866|NCT02273388|39640770|FG009|Overall Study|Sponsor decision|0|||
16315867|NCT02273388|39640771|FG010|Overall Study|Sponsor decision|0|||
16315868|NCT02273388|39640772|FG011|Overall Study|Sponsor decision|1|||
16315869|NCT00063934|39640773|FG000|Overall Study|Ineligible|1|||
16315870|NCT00628212|39640774|FG000|Overall Study|Adverse Event|2|||
16315871|NCT00628212|39640775|FG001|Overall Study|Adverse Event|0|||
16315872|NCT00628212|39640776|FG002|Overall Study|Adverse Event|1|||
16392297|NCT01595529|39919648|FG000|Overall Study|Physician Decision|1|||
16392298|NCT01595529|39919649|FG001|Overall Study|Physician Decision|0|||
16199171|NCT01764256|39204561|FG001|Received All Vaccinations|Adverse Event|1|||
16199172|NCT01764256|39204562|FG002|Received All Vaccinations|Adverse Event|0|||
16199173|NCT01764256|39204563|FG003|Received All Vaccinations|Adverse Event|0|||
16199174|NCT01764256|39204560|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
16409947|NCT00343915|39981842|FG001|Primary Study|Lost to Follow-up|3|||
16199175|NCT01764256|39204561|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
16199176|NCT01764256|39204562|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
16199177|NCT01764256|39204563|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
16199178|NCT01764256|39204560|FG000|Received All Vaccinations|Lost to Follow-up|1|||
16199179|NCT01764256|39204561|FG001|Received All Vaccinations|Lost to Follow-up|0|||
16315873|NCT00628212|39640777|FG003|Overall Study|Adverse Event|2|||
16315874|NCT00628212|39640774|FG000|Overall Study|Physician Decision|1|||
16315875|NCT00628212|39640775|FG001|Overall Study|Physician Decision|1|||
16392299|NCT01595529|39919648|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
16315876|NCT00628212|39640776|FG002|Overall Study|Physician Decision|2|||
16315877|NCT00628212|39640777|FG003|Overall Study|Physician Decision|3|||
16315878|NCT00891020|39640778|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
16315879|NCT00891020|39640779|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
16315880|NCT00891020|39640780|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
16315881|NCT00891020|39640778|FG000|24 Week Treatment Period|Death|0|||
16392300|NCT01595529|39919649|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
16392301|NCT01595529|39919648|FG000|Overall Study|Administrative Decision|1|||
16392302|NCT01595529|39919649|FG001|Overall Study|Administrative Decision|0|||
16392303|NCT01595529|39919648|FG000|Overall Study|Entry Failure/Screening Failure|6|||
16392304|NCT01595529|39919649|FG001|Overall Study|Entry Failure/Screening Failure|1|||
16392305|NCT01722994|39919650|FG000|Overall Study|Missing data|25|||
16392306|NCT01722994|39919651|FG001|Overall Study|Missing data|17|||
16392307|NCT02567799|39919652|FG000|Concurrent Chemoradiotherapy|Death|1|||
16315882|NCT00891020|39640779|FG001|24 Week Treatment Period|Death|2|||
16315883|NCT00891020|39640780|FG002|24 Week Treatment Period|Death|0|||
16315884|NCT00891020|39640778|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
16315885|NCT00891020|39640779|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
16315886|NCT00891020|39640780|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
16315887|NCT00891020|39640778|FG000|24 Week Treatment Period|Failure to return|4|||
16315888|NCT00891020|39640779|FG001|24 Week Treatment Period|Failure to return|5|||
16315889|NCT00891020|39640780|FG002|24 Week Treatment Period|Failure to return|5|||
16315890|NCT00891020|39640778|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
16315891|NCT00891020|39640779|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
16315892|NCT00891020|39640780|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
16315893|NCT00891020|39640778|FG000|24 Week Treatment Period|Other protocol violation|1|||
16315894|NCT00891020|39640779|FG001|24 Week Treatment Period|Other protocol violation|1|||
16392308|NCT02567799|39919653|FG001|Concurrent Chemoradiotherapy|Death|0|||
16392309|NCT02567799|39919654|FG002|Concurrent Chemoradiotherapy|Death|0|||
16392310|NCT02567799|39919652|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
16392311|NCT02567799|39919653|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
16392312|NCT02567799|39919654|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
16392313|NCT02567799|39919652|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
16315895|NCT00891020|39640780|FG002|24 Week Treatment Period|Other protocol violation|2|||
16392314|NCT02567799|39919653|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
16392315|NCT02567799|39919654|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
16392316|NCT02567799|39919652|FG000|Follow-up|Death|1|||
16392317|NCT02567799|39919653|FG001|Follow-up|Death|0|||
16392318|NCT02567799|39919654|FG002|Follow-up|Death|1|||
16392319|NCT02567799|39919652|FG000|Follow-up|Progressive Disease|1|||
16392320|NCT02567799|39919653|FG001|Follow-up|Progressive Disease|1|||
16392321|NCT02567799|39919654|FG002|Follow-up|Progressive Disease|3|||
16392322|NCT00355030|39919655|FG000|Study Period 1 Treatment|Adverse Event|1|||
16392323|NCT00355030|39919656|FG001|Study Period 1 Treatment|Adverse Event|1|||
16392324|NCT00355030|39919655|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
16392325|NCT00355030|39919656|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
16392326|NCT00355030|39919655|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
16392327|NCT00355030|39919656|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
16392328|NCT00355030|39919655|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
16392329|NCT00355030|39919656|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
16392330|NCT00355030|39919655|FG000|Study Period 1 Treatment|Physician Decision|0|||
16392331|NCT00355030|39919656|FG001|Study Period 1 Treatment|Physician Decision|1|||
16392332|NCT00355030|39919655|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
16392333|NCT00355030|39919656|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
16392334|NCT00355030|39919655|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
16392335|NCT00355030|39919656|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
16392336|NCT00355030|39919655|FG000|Study Period 1 Treatment|Other|2|||
16392337|NCT00355030|39919656|FG001|Study Period 1 Treatment|Other|6|||
16392338|NCT00355030|39919655|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
16392339|NCT00355030|39919656|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
16392340|NCT00355030|39919655|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
16392341|NCT00355030|39919656|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
16392342|NCT01637584|39919659|FG000|Overall Study|Withdrawal by Subject|1|||
16392343|NCT01637584|39919660|FG001|Overall Study|Withdrawal by Subject|3|||
16392344|NCT00662831|39919661|FG000|Overall Study|Death|4|||
16392345|NCT00662831|39919662|FG001|Overall Study|Death|1|||
16392346|NCT00662831|39919661|FG000|Overall Study|Lack of Efficacy|6|||
16392347|NCT00662831|39919662|FG001|Overall Study|Lack of Efficacy|6|||
16392348|NCT00662831|39919661|FG000|Overall Study|Lost to Follow-up|1|||
16392349|NCT00662831|39919662|FG001|Overall Study|Lost to Follow-up|0|||
16315896|NCT00891020|39640778|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
16392350|NCT00662831|39919661|FG000|Overall Study|Withdrawal by Subject|2|||
16392351|NCT00662831|39919662|FG001|Overall Study|Withdrawal by Subject|1|||
16392352|NCT00662831|39919661|FG000|Overall Study|Other|62|||
16392353|NCT00662831|39919662|FG001|Overall Study|Other|31|||
16392354|NCT00662831|39919661|FG000|Overall Study|Protocol Violation|8|||
16392355|NCT00662831|39919662|FG001|Overall Study|Protocol Violation|4|||
16392356|NCT00662831|39919661|FG000|Overall Study|Adverse Event|23|||
16392357|NCT00662831|39919662|FG001|Overall Study|Adverse Event|16|||
16392358|NCT04571060|39919678|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
16392359|NCT04571060|39919679|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
16392360|NCT04571060|39919678|FG000|Overall Study|Never treated migraine|47|||
16392361|NCT04571060|39919679|FG001|Overall Study|Never treated migraine|36|||
16392362|NCT04571060|39919678|FG000|Overall Study|Protocol Violation|4|||
16392363|NCT04571060|39919679|FG001|Overall Study|Protocol Violation|2|||
16392364|NCT04571060|39919678|FG000|Overall Study|Withdrawal by Subject|6|||
16392365|NCT04571060|39919679|FG001|Overall Study|Withdrawal by Subject|2|||
16392366|NCT04571060|39919678|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
16392367|NCT04571060|39919679|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
16392368|NCT02131662|39919680|FG000|Overall Study|Protocol Violation|1|||
16392369|NCT02131662|39919681|FG001|Overall Study|Protocol Violation|0|||
16392370|NCT02131662|39919682|FG002|Overall Study|Protocol Violation|0|||
16392371|NCT02131662|39919683|FG003|Overall Study|Protocol Violation|0|||
16392372|NCT02131662|39919684|FG004|Overall Study|Protocol Violation|0|||
16392373|NCT02131662|39919680|FG000|Overall Study|Other|2|||
16392374|NCT02131662|39919681|FG001|Overall Study|Other|4|||
16392375|NCT02131662|39919682|FG002|Overall Study|Other|3|||
16392376|NCT02131662|39919683|FG003|Overall Study|Other|3|||
16392377|NCT02131662|39919684|FG004|Overall Study|Other|4|||
16392378|NCT02131662|39919680|FG000|Overall Study|Adverse Event|0|||
16392379|NCT02131662|39919681|FG001|Overall Study|Adverse Event|1|||
16392380|NCT02131662|39919682|FG002|Overall Study|Adverse Event|1|||
16392381|NCT02131662|39919683|FG003|Overall Study|Adverse Event|1|||
16392382|NCT02131662|39919684|FG004|Overall Study|Adverse Event|3|||
16392383|NCT02131662|39919680|FG000|Overall Study|Pregnancy|0|||
16392384|NCT02131662|39919681|FG001|Overall Study|Pregnancy|1|||
16392385|NCT02131662|39919682|FG002|Overall Study|Pregnancy|0|||
16392386|NCT02131662|39919683|FG003|Overall Study|Pregnancy|1|||
16392387|NCT02131662|39919684|FG004|Overall Study|Pregnancy|0|||
16392388|NCT02131662|39919680|FG000|Overall Study|Wish for pregnancy|0|||
16392389|NCT02131662|39919681|FG001|Overall Study|Wish for pregnancy|0|||
16392390|NCT02131662|39919682|FG002|Overall Study|Wish for pregnancy|0|||
16392391|NCT02131662|39919683|FG003|Overall Study|Wish for pregnancy|0|||
16392392|NCT02131662|39919684|FG004|Overall Study|Wish for pregnancy|1|||
16392393|NCT02131662|39919680|FG000|Overall Study|Lack of Efficacy|1|||
16392394|NCT02131662|39919681|FG001|Overall Study|Lack of Efficacy|0|||
16392395|NCT02131662|39919682|FG002|Overall Study|Lack of Efficacy|0|||
16392396|NCT02131662|39919683|FG003|Overall Study|Lack of Efficacy|0|||
16392397|NCT02131662|39919684|FG004|Overall Study|Lack of Efficacy|1|||
16392398|NCT02131662|39919680|FG000|Overall Study|Withdrawal by Subject|1|||
16315897|NCT00891020|39640779|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
16315898|NCT00891020|39640780|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
16315899|NCT00891020|39640778|FG000|24 Week Treatment Period|Withdrew consent|6|||
16315900|NCT00891020|39640779|FG001|24 Week Treatment Period|Withdrew consent|3|||
16315901|NCT00891020|39640780|FG002|24 Week Treatment Period|Withdrew consent|15|||
16392399|NCT02131662|39919681|FG001|Overall Study|Withdrawal by Subject|5|||
16392400|NCT02131662|39919682|FG002|Overall Study|Withdrawal by Subject|1|||
16392401|NCT02131662|39919683|FG003|Overall Study|Withdrawal by Subject|5|||
16392402|NCT02131662|39919684|FG004|Overall Study|Withdrawal by Subject|6|||
16392403|NCT02131662|39919680|FG000|Overall Study|Lost to Follow-up|1|||
16315902|NCT00891020|39640778|FG000|24 Week Treatment Period|Administrative/Other|5|||
16315903|NCT00891020|39640779|FG001|24 Week Treatment Period|Administrative/Other|6|||
16315904|NCT00891020|39640780|FG002|24 Week Treatment Period|Administrative/Other|1|||
16315905|NCT00891020|39640778|FG000|Long-term Extension Period|Adverse Event|1|||
16315906|NCT00891020|39640779|FG001|Long-term Extension Period|Adverse Event|11|||
16315907|NCT00891020|39640780|FG002|Long-term Extension Period|Adverse Event|10|||
16315908|NCT00891020|39640778|FG000|Long-term Extension Period|Death|0|||
16315909|NCT00891020|39640779|FG001|Long-term Extension Period|Death|0|||
16392404|NCT02131662|39919681|FG001|Overall Study|Lost to Follow-up|3|||
16392405|NCT02131662|39919682|FG002|Overall Study|Lost to Follow-up|0|||
16392406|NCT02131662|39919683|FG003|Overall Study|Lost to Follow-up|9|||
16392407|NCT02131662|39919684|FG004|Overall Study|Lost to Follow-up|0|||
16392408|NCT02131662|39919680|FG000|Overall Study|Not treated|2|||
16392409|NCT02131662|39919681|FG001|Overall Study|Not treated|0|||
16392410|NCT02131662|39919682|FG002|Overall Study|Not treated|2|||
16392411|NCT02131662|39919683|FG003|Overall Study|Not treated|2|||
16315910|NCT00891020|39640780|FG002|Long-term Extension Period|Death|1|||
16392412|NCT02131662|39919684|FG004|Overall Study|Not treated|3|||
16392413|NCT00910910|39919685|FG000|Overall Study|Adverse Event|63|||
16315911|NCT00891020|39640778|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
16315912|NCT00891020|39640779|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
16315913|NCT00891020|39640780|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
16315914|NCT00891020|39640778|FG000|Long-term Extension Period|Protocol Violation|0|||
16315915|NCT00891020|39640779|FG001|Long-term Extension Period|Protocol Violation|1|||
16315916|NCT00891020|39640780|FG002|Long-term Extension Period|Protocol Violation|1|||
16315917|NCT00891020|39640778|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
16315918|NCT00891020|39640779|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
16315919|NCT00891020|39640780|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
16315920|NCT00891020|39640778|FG000|Long-term Extension Period|Failure to return|0|||
16315921|NCT00891020|39640779|FG001|Long-term Extension Period|Failure to return|2|||
16392414|NCT00910910|39919686|FG001|Overall Study|Adverse Event|35|||
16392415|NCT00910910|39919685|FG000|Overall Study|PD without histologic change|27|||
16392416|NCT00910910|39919686|FG001|Overall Study|PD without histologic change|23|||
16392417|NCT00910910|39919685|FG000|Overall Study|PD with histologic change|0|||
16392418|NCT00910910|39919686|FG001|Overall Study|PD with histologic change|2|||
16392419|NCT00910910|39919685|FG000|Overall Study|Withdrawal by Subject|7|||
16392420|NCT00910910|39919686|FG001|Overall Study|Withdrawal by Subject|5|||
16392421|NCT00910910|39919685|FG000|Overall Study|Lost to Follow-up|2|||
16392422|NCT00910910|39919686|FG001|Overall Study|Lost to Follow-up|2|||
16392423|NCT00910910|39919685|FG000|Overall Study|Death|9|||
16392424|NCT00910910|39919686|FG001|Overall Study|Death|3|||
16392425|NCT00910910|39919685|FG000|Overall Study|Protocol Violation|2|||
16392426|NCT00910910|39919686|FG001|Overall Study|Protocol Violation|2|||
16392427|NCT00910910|39919685|FG000|Overall Study|Completed 13 cycles of treatment|0|||
16392428|NCT00910910|39919686|FG001|Overall Study|Completed 13 cycles of treatment|118|||
16392429|NCT00910910|39919685|FG000|Overall Study|Other|114|||
16392430|NCT00910910|39919686|FG001|Overall Study|Other|32|||
16392431|NCT00910910|39919685|FG000|Overall Study|Untreated before cycle 1|1|||
16392432|NCT00910910|39919686|FG001|Overall Study|Untreated before cycle 1|2|||
16392433|NCT02383862|39919687|FG000|3 Month Follow up|Lost to Follow-up|23|||
16392434|NCT02383862|39919688|FG001|3 Month Follow up|Lost to Follow-up|21|||
16392435|NCT01135459|39919689|FG000|Overall Study|Adverse Event|8|||
16392436|NCT01135459|39919690|FG001|Overall Study|Adverse Event|10|||
16392437|NCT01135459|39919689|FG000|Overall Study|Lack of Efficacy|3|||
16392438|NCT01135459|39919690|FG001|Overall Study|Lack of Efficacy|1|||
16392439|NCT01135459|39919689|FG000|Overall Study|Withdrawal by Subject|2|||
16392440|NCT01135459|39919690|FG001|Overall Study|Withdrawal by Subject|3|||
16392441|NCT01135459|39919689|FG000|Overall Study|Protocol Violation|5|||
16392442|NCT01135459|39919690|FG001|Overall Study|Protocol Violation|3|||
16392443|NCT01135459|39919689|FG000|Overall Study|Lost to Follow-up|2|||
16392444|NCT01135459|39919690|FG001|Overall Study|Lost to Follow-up|1|||
16392445|NCT01135459|39919689|FG000|Overall Study|Non-compliance to study procedures|0|||
16392446|NCT01135459|39919690|FG001|Overall Study|Non-compliance to study procedures|1|||
16392447|NCT01135459|39919689|FG000|Overall Study|Other than specified|1|||
16392448|NCT01135459|39919690|FG001|Overall Study|Other than specified|1|||
16392449|NCT01791517|39919691|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
16392450|NCT01791517|39919692|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
16392451|NCT01791517|39919693|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
16392452|NCT01791517|39919694|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
16392453|NCT01791517|39919695|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
16315922|NCT00891020|39640780|FG002|Long-term Extension Period|Failure to return|3|||
16392454|NCT01791517|39919696|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
16510103|NCT03013543|40343762|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
16510104|NCT03013543|40343763|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
16510105|NCT03013543|40343764|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
16510106|NCT03013543|40343765|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
16510107|NCT03013543|40343766|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
16510108|NCT03013543|40343767|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
16510109|NCT03013543|40343768|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
16392455|NCT01791517|39919697|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
16392456|NCT01791517|39919698|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
16510110|NCT03013543|40343769|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
16510111|NCT03013543|40343760|FG000|Overall Study|Other|0|||
16510112|NCT03013543|40343761|FG001|Overall Study|Other|0|||
16510113|NCT03013543|40343762|FG002|Overall Study|Other|2|||
16510114|NCT03013543|40343763|FG003|Overall Study|Other|0|||
16510115|NCT03013543|40343764|FG004|Overall Study|Other|2|||
16510116|NCT03013543|40343765|FG005|Overall Study|Other|0|||
16510117|NCT03013543|40343766|FG006|Overall Study|Other|0|||
16392457|NCT01791517|39919699|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
16510118|NCT03013543|40343767|FG007|Overall Study|Other|0|||
16510119|NCT03013543|40343768|FG008|Overall Study|Other|1|||
16510120|NCT03013543|40343769|FG009|Overall Study|Other|0|||
16510121|NCT03013543|40343760|FG000|Overall Study|Adverse Event|0|||
16510122|NCT03013543|40343761|FG001|Overall Study|Adverse Event|0|||
16510123|NCT03013543|40343762|FG002|Overall Study|Adverse Event|0|||
16510124|NCT03013543|40343763|FG003|Overall Study|Adverse Event|3|||
16510125|NCT03013543|40343764|FG004|Overall Study|Adverse Event|2|||
16510126|NCT03013543|40343765|FG005|Overall Study|Adverse Event|1|||
16510127|NCT03013543|40343766|FG006|Overall Study|Adverse Event|3|||
16510128|NCT03013543|40343767|FG007|Overall Study|Adverse Event|8|||
16510129|NCT03013543|40343768|FG008|Overall Study|Adverse Event|0|||
16510130|NCT03013543|40343769|FG009|Overall Study|Adverse Event|2|||
16510131|NCT03013543|40343760|FG000|Overall Study|Death|0|||
16510132|NCT03013543|40343761|FG001|Overall Study|Death|0|||
16510133|NCT03013543|40343762|FG002|Overall Study|Death|0|||
16510134|NCT03013543|40343763|FG003|Overall Study|Death|1|||
16510135|NCT03013543|40343764|FG004|Overall Study|Death|0|||
16510136|NCT03013543|40343765|FG005|Overall Study|Death|0|||
16510137|NCT03013543|40343766|FG006|Overall Study|Death|0|||
16510138|NCT03013543|40343767|FG007|Overall Study|Death|0|||
16510139|NCT03013543|40343768|FG008|Overall Study|Death|0|||
16510140|NCT03013543|40343769|FG009|Overall Study|Death|0|||
16510141|NCT03013543|40343760|FG000|Overall Study|Lack of Efficacy|0|||
16510142|NCT03013543|40343761|FG001|Overall Study|Lack of Efficacy|0|||
16510143|NCT03013543|40343762|FG002|Overall Study|Lack of Efficacy|0|||
16510144|NCT03013543|40343763|FG003|Overall Study|Lack of Efficacy|1|||
16510145|NCT03013543|40343764|FG004|Overall Study|Lack of Efficacy|0|||
16510146|NCT03013543|40343765|FG005|Overall Study|Lack of Efficacy|0|||
16510147|NCT03013543|40343766|FG006|Overall Study|Lack of Efficacy|0|||
16315923|NCT00891020|39640778|FG000|Long-term Extension Period|Administrative|1|||
16315924|NCT00891020|39640779|FG001|Long-term Extension Period|Administrative|2|||
16315925|NCT00891020|39640780|FG002|Long-term Extension Period|Administrative|2|||
16315926|NCT02954601|39640785|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
16315927|NCT02954601|39640786|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
16315928|NCT02954601|39640787|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
16315929|NCT02954601|39640788|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
16315930|NCT00961571|39640789|FG000|Overall Study|Physician Decision|39|||
16315931|NCT01297517|39640790|FG000|Overall Study|Adverse Event|21|||
16315932|NCT01297517|39640791|FG001|Overall Study|Adverse Event|7|||
16315933|NCT01297517|39640792|FG002|Overall Study|Adverse Event|16|||
16315934|NCT01297517|39640790|FG000|Overall Study|Lost to Follow-up|1|||
16315935|NCT01297517|39640791|FG001|Overall Study|Lost to Follow-up|0|||
16315936|NCT01297517|39640792|FG002|Overall Study|Lost to Follow-up|1|||
16315937|NCT01297517|39640790|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
16315938|NCT01297517|39640791|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
16315939|NCT01297517|39640792|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
16315940|NCT01297517|39640790|FG000|Overall Study|Noncompliance|1|||
16315941|NCT01297517|39640791|FG001|Overall Study|Noncompliance|0|||
16315942|NCT01297517|39640792|FG002|Overall Study|Noncompliance|0|||
16315943|NCT01297517|39640790|FG000|Overall Study|Protocol Violation|1|||
16315944|NCT01297517|39640791|FG001|Overall Study|Protocol Violation|1|||
16315945|NCT01297517|39640792|FG002|Overall Study|Protocol Violation|1|||
16315946|NCT01297517|39640790|FG000|Overall Study|Inadequate Control of IOP|1|||
16315947|NCT01297517|39640791|FG001|Overall Study|Inadequate Control of IOP|1|||
16315948|NCT01297517|39640792|FG002|Overall Study|Inadequate Control of IOP|2|||
16315949|NCT01073605|39640799|FG000|Overall Study|Ongoing at Cutoff Date|1|||
16315950|NCT01073605|39640800|FG001|Overall Study|Ongoing at Cutoff Date|1|||
16315951|NCT01073605|39640801|FG002|Overall Study|Ongoing at Cutoff Date|0|||
16315952|NCT01073605|39640799|FG000|Overall Study|Adverse Event|2|||
16315953|NCT01073605|39640800|FG001|Overall Study|Adverse Event|1|||
16315954|NCT01073605|39640801|FG002|Overall Study|Adverse Event|0|||
16315955|NCT01073605|39640799|FG000|Overall Study|Lost to Follow-up|3|||
16315956|NCT01073605|39640800|FG001|Overall Study|Lost to Follow-up|4|||
16315957|NCT01073605|39640801|FG002|Overall Study|Lost to Follow-up|9|||
16315958|NCT01073605|39640799|FG000|Overall Study|Other|25|||
16315959|NCT01073605|39640800|FG001|Overall Study|Other|21|||
16315960|NCT01073605|39640801|FG002|Overall Study|Other|29|||
16315961|NCT01073605|39640799|FG000|Overall Study|Withdrawal by Subject|31|||
16315962|NCT01073605|39640800|FG001|Overall Study|Withdrawal by Subject|39|||
16315963|NCT01073605|39640801|FG002|Overall Study|Withdrawal by Subject|22|||
16315964|NCT01073605|39640799|FG000|Overall Study|Randomized But Not Treated|0|||
16510148|NCT03013543|40343767|FG007|Overall Study|Lack of Efficacy|0|||
16510149|NCT03013543|40343768|FG008|Overall Study|Lack of Efficacy|0|||
16510150|NCT03013543|40343769|FG009|Overall Study|Lack of Efficacy|0|||
16510151|NCT03013543|40343760|FG000|Overall Study|Lost to Follow-up|0|||
16510152|NCT03013543|40343761|FG001|Overall Study|Lost to Follow-up|0|||
16510153|NCT03013543|40343762|FG002|Overall Study|Lost to Follow-up|0|||
16315965|NCT01073605|39640800|FG001|Overall Study|Randomized But Not Treated|1|||
16510154|NCT03013543|40343763|FG003|Overall Study|Lost to Follow-up|1|||
16510155|NCT03013543|40343764|FG004|Overall Study|Lost to Follow-up|0|||
16510156|NCT03013543|40343765|FG005|Overall Study|Lost to Follow-up|0|||
16510157|NCT03013543|40343766|FG006|Overall Study|Lost to Follow-up|1|||
16510158|NCT03013543|40343767|FG007|Overall Study|Lost to Follow-up|0|||
16510159|NCT03013543|40343768|FG008|Overall Study|Lost to Follow-up|0|||
16510160|NCT03013543|40343769|FG009|Overall Study|Lost to Follow-up|2|||
16510161|NCT03013543|40343760|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16199180|NCT01764256|39204562|FG002|Received All Vaccinations|Lost to Follow-up|0|||
16199181|NCT01764256|39204563|FG003|Received All Vaccinations|Lost to Follow-up|0|||
16392458|NCT01791517|39919700|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
16392459|NCT01791517|39919701|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
16392460|NCT01791517|39919702|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
16392461|NCT01791517|39919691|FG000|Phase I: Period 1|Adverse Event|0|||
16392462|NCT01791517|39919692|FG001|Phase I: Period 1|Adverse Event|0|||
16392463|NCT01791517|39919693|FG002|Phase I: Period 1|Adverse Event|1|||
16392464|NCT01791517|39919694|FG003|Phase I: Period 1|Adverse Event|1|||
16392465|NCT01791517|39919695|FG004|Phase I: Period 1|Adverse Event|0|||
16392466|NCT01791517|39919696|FG005|Phase I: Period 1|Adverse Event|0|||
16392467|NCT01791517|39919697|FG006|Phase I: Period 1|Adverse Event|0|||
16392468|NCT01791517|39919698|FG007|Phase I: Period 1|Adverse Event|0|||
16392469|NCT01791517|39919699|FG008|Phase I: Period 1|Adverse Event|0|||
16392470|NCT01791517|39919700|FG009|Phase I: Period 1|Adverse Event|0|||
16392471|NCT01791517|39919701|FG010|Phase I: Period 1|Adverse Event|0|||
16392472|NCT01791517|39919702|FG011|Phase I: Period 1|Adverse Event|0|||
16392473|NCT01791517|39919691|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
16392474|NCT01791517|39919692|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392475|NCT01791517|39919693|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392476|NCT01791517|39919694|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392477|NCT01791517|39919695|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392478|NCT01791517|39919696|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392479|NCT01791517|39919697|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392480|NCT01791517|39919698|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392481|NCT01791517|39919699|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392482|NCT01791517|39919700|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392483|NCT01791517|39919701|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392484|NCT01791517|39919702|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
16392485|NCT01791517|39919691|FG000|Phase I: Period 1|Protocol Violation|0|||
16392486|NCT01791517|39919692|FG001|Phase I: Period 1|Protocol Violation|1|||
16392487|NCT01791517|39919693|FG002|Phase I: Period 1|Protocol Violation|0|||
16392488|NCT01791517|39919694|FG003|Phase I: Period 1|Protocol Violation|0|||
16392489|NCT01791517|39919695|FG004|Phase I: Period 1|Protocol Violation|0|||
16392490|NCT01791517|39919696|FG005|Phase I: Period 1|Protocol Violation|0|||
16392491|NCT01791517|39919697|FG006|Phase I: Period 1|Protocol Violation|0|||
16392492|NCT01791517|39919698|FG007|Phase I: Period 1|Protocol Violation|0|||
16392493|NCT01791517|39919699|FG008|Phase I: Period 1|Protocol Violation|0|||
16392494|NCT01791517|39919700|FG009|Phase I: Period 1|Protocol Violation|0|||
16392495|NCT01791517|39919701|FG010|Phase I: Period 1|Protocol Violation|0|||
16392496|NCT01791517|39919702|FG011|Phase I: Period 1|Protocol Violation|0|||
16392497|NCT01791517|39919691|FG000|Phase I: Period 1|Lost to Follow-up|0|||
16392498|NCT01791517|39919692|FG001|Phase I: Period 1|Lost to Follow-up|0|||
16392499|NCT01791517|39919693|FG002|Phase I: Period 1|Lost to Follow-up|0|||
16392500|NCT01791517|39919694|FG003|Phase I: Period 1|Lost to Follow-up|1|||
16510162|NCT03013543|40343761|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16510163|NCT03013543|40343762|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16510164|NCT03013543|40343763|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16510165|NCT03013543|40343764|FG004|Overall Study|Non-Compliance With Study Drug|0|||
16510166|NCT03013543|40343765|FG005|Overall Study|Non-Compliance With Study Drug|0|||
16510167|NCT03013543|40343766|FG006|Overall Study|Non-Compliance With Study Drug|0|||
16510168|NCT03013543|40343767|FG007|Overall Study|Non-Compliance With Study Drug|0|||
16510169|NCT03013543|40343768|FG008|Overall Study|Non-Compliance With Study Drug|1|||
16510170|NCT03013543|40343769|FG009|Overall Study|Non-Compliance With Study Drug|0|||
16510171|NCT03013543|40343760|FG000|Overall Study|Physician Decision|0|||
16510172|NCT03013543|40343761|FG001|Overall Study|Physician Decision|0|||
16510173|NCT03013543|40343762|FG002|Overall Study|Physician Decision|0|||
16510174|NCT03013543|40343763|FG003|Overall Study|Physician Decision|0|||
16510175|NCT03013543|40343764|FG004|Overall Study|Physician Decision|1|||
16510176|NCT03013543|40343765|FG005|Overall Study|Physician Decision|0|||
16510177|NCT03013543|40343766|FG006|Overall Study|Physician Decision|0|||
16510178|NCT03013543|40343767|FG007|Overall Study|Physician Decision|0|||
16199182|NCT01764256|39204560|FG000|Completed Study|Lost to Follow-up|0|||
16392501|NCT01791517|39919695|FG004|Phase I: Period 1|Lost to Follow-up|0|||
16392502|NCT01791517|39919696|FG005|Phase I: Period 1|Lost to Follow-up|0|||
16510179|NCT03013543|40343768|FG008|Overall Study|Physician Decision|0|||
16510180|NCT03013543|40343769|FG009|Overall Study|Physician Decision|0|||
16510181|NCT03013543|40343760|FG000|Overall Study|Protocol Violation|0|||
16510182|NCT03013543|40343761|FG001|Overall Study|Protocol Violation|0|||
16392503|NCT01791517|39919697|FG006|Phase I: Period 1|Lost to Follow-up|1|||
16199183|NCT01764256|39204561|FG001|Completed Study|Lost to Follow-up|0|||
16392504|NCT01791517|39919698|FG007|Phase I: Period 1|Lost to Follow-up|0|||
16392505|NCT01791517|39919699|FG008|Phase I: Period 1|Lost to Follow-up|1|||
16392506|NCT01791517|39919700|FG009|Phase I: Period 1|Lost to Follow-up|1|||
16392507|NCT01791517|39919701|FG010|Phase I: Period 1|Lost to Follow-up|0|||
16392508|NCT01791517|39919702|FG011|Phase I: Period 1|Lost to Follow-up|0|||
16510183|NCT03013543|40343762|FG002|Overall Study|Protocol Violation|0|||
16315966|NCT01073605|39640801|FG002|Overall Study|Randomized But Not Treated|1|||
16315967|NCT01804946|39640802|FG000|Overall Study|Protocol Violation|1|||
16315968|NCT01804946|39640803|FG001|Overall Study|Protocol Violation|0|||
16315969|NCT01804946|39640802|FG000|Overall Study|Adverse Event|0|||
16315970|NCT01804946|39640803|FG001|Overall Study|Adverse Event|1|||
16315971|NCT01804946|39640802|FG000|Overall Study|Insufficient data available|0|||
16315972|NCT01804946|39640803|FG001|Overall Study|Insufficient data available|1|||
16510184|NCT03013543|40343763|FG003|Overall Study|Protocol Violation|0|||
16315973|NCT01804946|39640802|FG000|Overall Study|Do not meet inclusion criteria|1|||
16315974|NCT01804946|39640803|FG001|Overall Study|Do not meet inclusion criteria|2|||
16315975|NCT01433471|39640804|FG000|Overall Study|Withdrawal by Subject|0|||
16315976|NCT01433471|39640805|FG001|Overall Study|Withdrawal by Subject|1|||
16315977|NCT03776357|39640806|FG000|Overall Study|Lost to Follow-up|3|||
16315978|NCT02283268|39640807|FG000|Overall Study|Withdrawal by Subject|1|||
16315979|NCT00347958|39640808|FG000|Overall Study|Adverse Event|1|||
16315980|NCT00347958|39640808|FG000|Overall Study|Protocol Violation|2|||
16315981|NCT00347958|39640808|FG000|Overall Study|Withdrawal by Subject|1|||
16510185|NCT03013543|40343764|FG004|Overall Study|Protocol Violation|0|||
16510186|NCT03013543|40343765|FG005|Overall Study|Protocol Violation|0|||
16510187|NCT03013543|40343766|FG006|Overall Study|Protocol Violation|0|||
16510188|NCT03013543|40343767|FG007|Overall Study|Protocol Violation|0|||
16510189|NCT03013543|40343768|FG008|Overall Study|Protocol Violation|0|||
16510190|NCT03013543|40343769|FG009|Overall Study|Protocol Violation|1|||
16510191|NCT00578942|40343774|FG000|Overall Study|Lost to Follow-up|1|||
16315982|NCT03817125|39640809|FG000|Overall Study|Adverse Event|1|||
16315983|NCT03817125|39640810|FG001|Overall Study|Adverse Event|0|||
16315984|NCT03817125|39640809|FG000|Overall Study|Physician Decision|0|||
16315985|NCT03817125|39640810|FG001|Overall Study|Physician Decision|1|||
16315986|NCT03817125|39640809|FG000|Overall Study|Lack of Efficacy|1|||
16510192|NCT02469610|40343783|FG000|Overall Study|Death|1|||
16510193|NCT02469610|40343784|FG001|Overall Study|Death|0|||
16510194|NCT02469610|40343783|FG000|Overall Study|Lost to Follow-up|1|||
16510195|NCT02469610|40343784|FG001|Overall Study|Lost to Follow-up|0|||
16510196|NCT02469610|40343783|FG000|Overall Study|exclusion criteria|2|||
16510197|NCT02469610|40343784|FG001|Overall Study|exclusion criteria|1|||
16510198|NCT04889625|40343785|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
16510199|NCT04889625|40343786|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
16510200|NCT04889625|40343785|FG000|Period 1|Subject out of window|0|||
16510201|NCT04889625|40343786|FG001|Period 1|Subject out of window|1|||
16315987|NCT03817125|39640810|FG001|Overall Study|Lack of Efficacy|5|||
16315988|NCT01058642|39640811|FG000|Treatment Period 1|Adverse Event|0|||
16315989|NCT01058642|39640812|FG001|Treatment Period 1|Adverse Event|1|||
16315990|NCT01058642|39640813|FG002|Treatment Period 1|Adverse Event|1|||
16315991|NCT01058642|39640814|FG003|Treatment Period 1|Adverse Event|0|||
16315992|NCT01058642|39640811|FG000|Treatment Period 1|Physician Decision|0|||
16315993|NCT01058642|39640812|FG001|Treatment Period 1|Physician Decision|0|||
16315994|NCT01058642|39640813|FG002|Treatment Period 1|Physician Decision|1|||
16510202|NCT04889625|40343785|FG000|Period 1|Wrong add power dispensed|0|||
16510203|NCT04889625|40343786|FG001|Period 1|Wrong add power dispensed|1|||
16510204|NCT04889625|40343785|FG000|Period 1|Discontinued due to fitting guide error|1|||
16510205|NCT04889625|40343786|FG001|Period 1|Discontinued due to fitting guide error|1|||
16315995|NCT01058642|39640814|FG003|Treatment Period 1|Physician Decision|0|||
16315996|NCT01058642|39640811|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16315997|NCT01058642|39640812|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16315998|NCT01058642|39640813|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16315999|NCT01058642|39640814|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16316000|NCT01058642|39640811|FG000|Treatment Period 1|Lack of Efficacy|0|||
16316001|NCT01058642|39640812|FG001|Treatment Period 1|Lack of Efficacy|0|||
16316002|NCT01058642|39640813|FG002|Treatment Period 1|Lack of Efficacy|0|||
16316003|NCT01058642|39640814|FG003|Treatment Period 1|Lack of Efficacy|1|||
16316004|NCT01058642|39640811|FG000|Treatment Period 1|Protocol Violation|0|||
16316005|NCT01058642|39640812|FG001|Treatment Period 1|Protocol Violation|0|||
16316006|NCT01058642|39640813|FG002|Treatment Period 1|Protocol Violation|0|||
16316007|NCT01058642|39640814|FG003|Treatment Period 1|Protocol Violation|1|||
16316008|NCT01058642|39640811|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
16316009|NCT01058642|39640812|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
16316010|NCT01058642|39640813|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
16316011|NCT01058642|39640814|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
16316012|NCT00739661|39640815|FG000|Overall Study|Adverse Event|2|||
16316013|NCT00739661|39640816|FG001|Overall Study|Adverse Event|0|||
16316014|NCT00739661|39640815|FG000|Overall Study|Physician decision to withdraw patient|1|||
16316015|NCT00739661|39640816|FG001|Overall Study|Physician decision to withdraw patient|0|||
16316016|NCT00739661|39640815|FG000|Overall Study|Patient decision to withdraw|9|||
16316017|NCT00739661|39640816|FG001|Overall Study|Patient decision to withdraw|4|||
16316018|NCT00739661|39640815|FG000|Overall Study|Disease progression, radiographic|33|||
16316019|NCT00739661|39640816|FG001|Overall Study|Disease progression, radiographic|37|||
16316020|NCT00739661|39640815|FG000|Overall Study|Reason for discontinuation not available|1|||
16316021|NCT00739661|39640816|FG001|Overall Study|Reason for discontinuation not available|1|||
16316022|NCT03194542|39640817|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
16316023|NCT03194542|39640818|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
16316024|NCT03194542|39640819|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
16316025|NCT03194542|39640820|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
16316026|NCT03194542|39640817|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
16316027|NCT03194542|39640818|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
16316028|NCT03194542|39640819|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
16316029|NCT03194542|39640820|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
16316030|NCT03194542|39640817|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
16316031|NCT03194542|39640818|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
16316032|NCT03194542|39640819|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
16316033|NCT03194542|39640820|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
16316034|NCT03194542|39640817|FG000|Overall Study|Loss of Response|4|||
16316035|NCT03194542|39640818|FG001|Overall Study|Loss of Response|2|||
16316036|NCT03194542|39640819|FG002|Overall Study|Loss of Response|3|||
16316037|NCT03194542|39640820|FG003|Overall Study|Loss of Response|4|||
16316038|NCT03194542|39640817|FG000|Overall Study|Physician Decision|0|||
16316039|NCT03194542|39640818|FG001|Overall Study|Physician Decision|1|||
16316040|NCT03194542|39640819|FG002|Overall Study|Physician Decision|0|||
16316041|NCT03194542|39640820|FG003|Overall Study|Physician Decision|0|||
16316042|NCT03194542|39640817|FG000|Overall Study|Lack of Efficacy|2|||
16316043|NCT03194542|39640818|FG001|Overall Study|Lack of Efficacy|2|||
16316044|NCT03194542|39640819|FG002|Overall Study|Lack of Efficacy|2|||
16316045|NCT03194542|39640820|FG003|Overall Study|Lack of Efficacy|6|||
16316046|NCT03194542|39640817|FG000|Overall Study|Withdrawal by Subject|2|||
16316047|NCT03194542|39640818|FG001|Overall Study|Withdrawal by Subject|1|||
16316048|NCT03194542|39640819|FG002|Overall Study|Withdrawal by Subject|5|||
16316049|NCT03194542|39640820|FG003|Overall Study|Withdrawal by Subject|4|||
16316050|NCT03194542|39640817|FG000|Overall Study|Progressive Disease|1|||
16510206|NCT04889625|40343785|FG000|Period 2|Test article no longer available|1|||
16510207|NCT04889625|40343786|FG001|Period 2|Test article no longer available|0|||
16510208|NCT04889625|40343785|FG000|Period 2|Incorrect lens dispensed|1|||
16510209|NCT04889625|40343786|FG001|Period 2|Incorrect lens dispensed|0|||
16510210|NCT04889625|40343785|FG000|Period 2|Wrong add power dispensed|0|||
16510211|NCT04889625|40343786|FG001|Period 2|Wrong add power dispensed|1|||
16510212|NCT03090100|40343789|FG000|Overall Study|Adverse Event|9|||
16510213|NCT03090100|40343790|FG001|Overall Study|Adverse Event|11|||
16510214|NCT03090100|40343789|FG000|Overall Study|Pregnancy|1|||
16510215|NCT03090100|40343790|FG001|Overall Study|Pregnancy|1|||
16510216|NCT03090100|40343789|FG000|Overall Study|Lack of Efficacy|2|||
16510217|NCT03090100|40343790|FG001|Overall Study|Lack of Efficacy|7|||
16316051|NCT03194542|39640818|FG001|Overall Study|Progressive Disease|0|||
16316052|NCT03194542|39640819|FG002|Overall Study|Progressive Disease|1|||
16316053|NCT03194542|39640820|FG003|Overall Study|Progressive Disease|1|||
16316054|NCT03194542|39640817|FG000|Overall Study|Adverse Event|1|||
16316055|NCT03194542|39640818|FG001|Overall Study|Adverse Event|2|||
16510218|NCT03090100|40343789|FG000|Overall Study|Lost to Follow-up|2|||
16510219|NCT03090100|40343790|FG001|Overall Study|Lost to Follow-up|2|||
16510220|NCT03090100|40343789|FG000|Overall Study|Withdrawal by Subject|7|||
16510221|NCT03090100|40343790|FG001|Overall Study|Withdrawal by Subject|19|||
16510222|NCT03090100|40343789|FG000|Overall Study|Protocol Violation|2|||
16510223|NCT03090100|40343790|FG001|Overall Study|Protocol Violation|6|||
16510224|NCT03090100|40343789|FG000|Overall Study|Non-compliance|2|||
16510225|NCT03090100|40343790|FG001|Overall Study|Non-compliance|0|||
16510226|NCT03090100|40343789|FG000|Overall Study|Other|2|||
16510227|NCT03090100|40343790|FG001|Overall Study|Other|2|||
16510228|NCT01147653|40343791|FG000|Year 2|Withdrawal by Subject|2|||
16510229|NCT01147653|40343792|FG001|Year 2|Withdrawal by Subject|3|||
16510230|NCT02404350|40343793|FG000|Overall Study|Adverse Event|2|||
16510231|NCT02404350|40343794|FG001|Overall Study|Adverse Event|2|||
16510232|NCT02404350|40343795|FG002|Overall Study|Adverse Event|3|||
16510233|NCT02404350|40343796|FG003|Overall Study|Adverse Event|9|||
16510234|NCT02404350|40343793|FG000|Overall Study|Lack of Efficacy|3|||
16510235|NCT02404350|40343794|FG001|Overall Study|Lack of Efficacy|1|||
16510236|NCT02404350|40343795|FG002|Overall Study|Lack of Efficacy|0|||
16510237|NCT02404350|40343796|FG003|Overall Study|Lack of Efficacy|3|||
16510238|NCT02404350|40343793|FG000|Overall Study|Lost to Follow-up|2|||
16510239|NCT02404350|40343794|FG001|Overall Study|Lost to Follow-up|0|||
16510240|NCT02404350|40343795|FG002|Overall Study|Lost to Follow-up|0|||
16510241|NCT02404350|40343796|FG003|Overall Study|Lost to Follow-up|1|||
16510242|NCT02404350|40343793|FG000|Overall Study|Physician Decision|1|||
16510243|NCT02404350|40343794|FG001|Overall Study|Physician Decision|0|||
16510244|NCT02404350|40343795|FG002|Overall Study|Physician Decision|0|||
16510245|NCT02404350|40343796|FG003|Overall Study|Physician Decision|2|||
16510246|NCT02404350|40343793|FG000|Overall Study|Pregnancy|0|||
16510247|NCT02404350|40343794|FG001|Overall Study|Pregnancy|0|||
16510248|NCT02404350|40343795|FG002|Overall Study|Pregnancy|0|||
16510249|NCT02404350|40343796|FG003|Overall Study|Pregnancy|1|||
16510250|NCT02404350|40343793|FG000|Overall Study|Withdrawal by Subject|7|||
16510251|NCT02404350|40343794|FG001|Overall Study|Withdrawal by Subject|3|||
16316056|NCT03194542|39640819|FG002|Overall Study|Adverse Event|0|||
16316057|NCT03194542|39640820|FG003|Overall Study|Adverse Event|5|||
16316058|NCT03194542|39640817|FG000|Overall Study|Death|1|||
16316059|NCT03194542|39640818|FG001|Overall Study|Death|2|||
16316060|NCT03194542|39640819|FG002|Overall Study|Death|0|||
16316061|NCT03194542|39640820|FG003|Overall Study|Death|5|||
16316062|NCT03194542|39640817|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
16316063|NCT03194542|39640818|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
16316064|NCT03194542|39640819|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
16316065|NCT03194542|39640820|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
16316066|NCT02285361|39640829|FG000|Overall Study|Protocol Violation|43|||
16316067|NCT02285361|39640829|FG000|Overall Study|Lost to Follow-up|5|||
16316068|NCT02285361|39640829|FG000|Overall Study|Not taken GIOTRIF|2|||
16316069|NCT02285361|39640829|FG000|Overall Study|Consented prior to the contract date|1|||
16316070|NCT00828568|39640830|FG000|Randomized|Withdrawal by Subject|1|||
16316071|NCT00828568|39640831|FG001|Randomized|Withdrawal by Subject|0|||
16316072|NCT00828568|39640832|FG002|Randomized|Withdrawal by Subject|2|||
16316073|NCT00828568|39640830|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
16316074|NCT00828568|39640831|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
16510252|NCT02404350|40343795|FG002|Overall Study|Withdrawal by Subject|3|||
16510253|NCT02404350|40343796|FG003|Overall Study|Withdrawal by Subject|19|||
16510254|NCT02404350|40343793|FG000|Overall Study|Due to Non-compliance with treatment|0|||
16510255|NCT02404350|40343794|FG001|Overall Study|Due to Non-compliance with treatment|0|||
16510256|NCT02404350|40343795|FG002|Overall Study|Due to Non-compliance with treatment|0|||
16510257|NCT02404350|40343796|FG003|Overall Study|Due to Non-compliance with treatment|1|||
16510258|NCT02404350|40343793|FG000|Overall Study|Due to Technical problems|0|||
16316075|NCT00828568|39640832|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
16316076|NCT00828568|39640830|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
16316077|NCT00828568|39640831|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
16409948|NCT00343915|39981841|FG000|Primary Study|Other|1|||
16409949|NCT00343915|39981842|FG001|Primary Study|Other|0|||
16409950|NCT03757130|39981843|FG000|Overall Study|Lost to Follow-up|0|||
16409951|NCT03757130|39981844|FG001|Overall Study|Lost to Follow-up|0|||
16409952|NCT03757130|39981845|FG002|Overall Study|Lost to Follow-up|0|||
16409953|NCT03757130|39981846|FG003|Overall Study|Lost to Follow-up|1|||
16409954|NCT03757130|39981847|FG004|Overall Study|Lost to Follow-up|0|||
16409955|NCT03757130|39981848|FG005|Overall Study|Lost to Follow-up|0|||
16409956|NCT03757130|39981849|FG006|Overall Study|Lost to Follow-up|0|||
16409957|NCT03757130|39981850|FG007|Overall Study|Lost to Follow-up|1|||
16409958|NCT03757130|39981843|FG000|Overall Study|Withdrawal by Subject|0|||
16409959|NCT03757130|39981844|FG001|Overall Study|Withdrawal by Subject|0|||
16409960|NCT03757130|39981845|FG002|Overall Study|Withdrawal by Subject|0|||
16409961|NCT03757130|39981846|FG003|Overall Study|Withdrawal by Subject|0|||
16316078|NCT00828568|39640832|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
16316079|NCT00828568|39640830|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
16316080|NCT00828568|39640831|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
16316081|NCT00828568|39640832|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
16316082|NCT00828568|39640830|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
16510259|NCT02404350|40343794|FG001|Overall Study|Due to Technical problems|0|||
16510260|NCT02404350|40343795|FG002|Overall Study|Due to Technical problems|0|||
16510261|NCT02404350|40343796|FG003|Overall Study|Due to Technical problems|1|||
16510262|NCT00358527|40343797|FG000|Overall Study|Adverse Event|4|||
16510263|NCT00358527|40343798|FG001|Overall Study|Adverse Event|0|||
16510264|NCT00358527|40343797|FG000|Overall Study|Withdrawal by Subject|1|||
16510265|NCT00358527|40343798|FG001|Overall Study|Withdrawal by Subject|1|||
16510266|NCT00358527|40343797|FG000|Overall Study|Non-compliance with protocol|6|||
16510267|NCT00358527|40343798|FG001|Overall Study|Non-compliance with protocol|1|||
16510268|NCT00358527|40343797|FG000|Overall Study|Administrative|2|||
16510269|NCT00358527|40343798|FG001|Overall Study|Administrative|1|||
16510270|NCT00427635|40343799|FG000|Treatment Phase|Withdrawal by Subject|1|||
16510271|NCT00427635|40343800|FG001|Treatment Phase|Withdrawal by Subject|0|||
16510272|NCT00427635|40343799|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
16510273|NCT00427635|40343800|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
16510274|NCT02972632|40343801|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
16316083|NCT00828568|39640831|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
16316084|NCT00828568|39640832|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
16316085|NCT01891864|39640835|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
16316086|NCT01891864|39640836|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
16316087|NCT01891864|39640837|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
16316088|NCT01891864|39640838|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
16316089|NCT01891864|39640839|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
16316090|NCT01891864|39640840|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
16316091|NCT01891864|39640835|FG000|Treatment Period 1|Physician Decision|0|||
16316092|NCT01891864|39640836|FG001|Treatment Period 1|Physician Decision|1|||
16316093|NCT01891864|39640837|FG002|Treatment Period 1|Physician Decision|0|||
16316094|NCT01891864|39640838|FG003|Treatment Period 1|Physician Decision|0|||
16316095|NCT01891864|39640839|FG004|Treatment Period 1|Physician Decision|0|||
16316096|NCT01891864|39640840|FG005|Treatment Period 1|Physician Decision|0|||
16316097|NCT01891864|39640835|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
16316098|NCT01891864|39640836|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
16316099|NCT01891864|39640837|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
16316100|NCT01891864|39640838|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
16316101|NCT01891864|39640839|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
16316102|NCT01891864|39640840|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
16316103|NCT01891864|39640835|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
16316104|NCT01891864|39640836|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
16316105|NCT01891864|39640837|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
16316106|NCT01891864|39640838|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
16316107|NCT01891864|39640839|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
16316108|NCT01891864|39640840|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
16316109|NCT01891864|39640835|FG000|Treatment Period 1|Withdrawal by Subject|2|||
16316110|NCT01891864|39640836|FG001|Treatment Period 1|Withdrawal by Subject|5|||
16316111|NCT01891864|39640837|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16510275|NCT02972632|40343801|FG000|Overall Study|Lost to Follow-up|4|||
16510276|NCT02972632|40343801|FG000|Overall Study|Voluntary Withdrawal|10|||
16510277|NCT03181542|40343802|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
16510278|NCT03181542|40343803|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
16510279|NCT00913744|40343804|FG000|Overall Study|Adverse Event|2|||
16510280|NCT00913744|40343805|FG001|Overall Study|Adverse Event|0|||
16510281|NCT00913744|40343804|FG000|Overall Study|Withdrawal by Subject|2|||
16510282|NCT00913744|40343805|FG001|Overall Study|Withdrawal by Subject|1|||
16510283|NCT00913744|40343804|FG000|Overall Study|Death|1|||
16510284|NCT00913744|40343805|FG001|Overall Study|Death|0|||
16316112|NCT01891864|39640838|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16316113|NCT01891864|39640839|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16316114|NCT01891864|39640840|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16316115|NCT01891864|39640835|FG000|Treatment Period 1|Lost to Follow-up|1|||
16316116|NCT01891864|39640836|FG001|Treatment Period 1|Lost to Follow-up|0|||
16199184|NCT01764256|39204562|FG002|Completed Study|Lost to Follow-up|0|||
16316117|NCT01891864|39640837|FG002|Treatment Period 1|Lost to Follow-up|0|||
16316118|NCT01891864|39640838|FG003|Treatment Period 1|Lost to Follow-up|0|||
16316119|NCT01891864|39640839|FG004|Treatment Period 1|Lost to Follow-up|0|||
16510285|NCT00058825|40343811|FG000|Overall Study|Relapse|9|||
16510286|NCT00058825|40343811|FG000|Overall Study|Progressive Disease|5|||
16510287|NCT00058825|40343811|FG000|Overall Study|Graft Failure|5|||
16510288|NCT00058825|40343811|FG000|Overall Study|Death|3|||
16510289|NCT01465464|40343812|FG000|Overall Study|Adverse Event|96|||
16510290|NCT01465464|40343813|FG001|Overall Study|Adverse Event|49|||
16510291|NCT01465464|40343812|FG000|Overall Study|Lack of Efficacy|139|||
16510292|NCT01465464|40343813|FG001|Overall Study|Lack of Efficacy|190|||
16316120|NCT01891864|39640840|FG005|Treatment Period 1|Lost to Follow-up|0|||
16316121|NCT01891864|39640835|FG000|Treatment Period 2|Protocol Violation|0|||
16316122|NCT01891864|39640836|FG001|Treatment Period 2|Protocol Violation|0|||
16316123|NCT01891864|39640837|FG002|Treatment Period 2|Protocol Violation|0|||
16316124|NCT01891864|39640838|FG003|Treatment Period 2|Protocol Violation|1|||
16316125|NCT01891864|39640839|FG004|Treatment Period 2|Protocol Violation|0|||
16316126|NCT01891864|39640840|FG005|Treatment Period 2|Protocol Violation|0|||
16316127|NCT01891864|39640835|FG000|Treatment Period 2|Physician Decision|0|||
16316128|NCT01891864|39640836|FG001|Treatment Period 2|Physician Decision|0|||
16316129|NCT01891864|39640837|FG002|Treatment Period 2|Physician Decision|1|||
16316130|NCT01891864|39640838|FG003|Treatment Period 2|Physician Decision|0|||
16510293|NCT01465464|40343812|FG000|Overall Study|Physician Decision|13|||
16510294|NCT01465464|40343813|FG001|Overall Study|Physician Decision|5|||
16510295|NCT01465464|40343812|FG000|Overall Study|Protocol Violation|1|||
16510296|NCT01465464|40343813|FG001|Overall Study|Protocol Violation|1|||
16510297|NCT01465464|40343812|FG000|Overall Study|Withdrawal by Subject|46|||
16510298|NCT01465464|40343813|FG001|Overall Study|Withdrawal by Subject|30|||
16510299|NCT01465464|40343812|FG000|Overall Study|Other|9|||
16510300|NCT01465464|40343813|FG001|Overall Study|Other|3|||
16316131|NCT01891864|39640839|FG004|Treatment Period 2|Physician Decision|0|||
16316132|NCT01891864|39640840|FG005|Treatment Period 2|Physician Decision|0|||
16316133|NCT01891864|39640835|FG000|Treatment Period 2|Site Termination|0|||
16316134|NCT01891864|39640836|FG001|Treatment Period 2|Site Termination|0|||
16316135|NCT01891864|39640837|FG002|Treatment Period 2|Site Termination|1|||
16316136|NCT01891864|39640838|FG003|Treatment Period 2|Site Termination|2|||
16316137|NCT01891864|39640839|FG004|Treatment Period 2|Site Termination|0|||
16316138|NCT01891864|39640840|FG005|Treatment Period 2|Site Termination|0|||
16316139|NCT01891864|39640835|FG000|Treatment Period 2|Lack of Efficacy|0|||
16316140|NCT01891864|39640836|FG001|Treatment Period 2|Lack of Efficacy|0|||
16316141|NCT01891864|39640837|FG002|Treatment Period 2|Lack of Efficacy|1|||
16316142|NCT01891864|39640838|FG003|Treatment Period 2|Lack of Efficacy|0|||
16316143|NCT01891864|39640839|FG004|Treatment Period 2|Lack of Efficacy|1|||
16316144|NCT01891864|39640840|FG005|Treatment Period 2|Lack of Efficacy|0|||
16316145|NCT01891864|39640835|FG000|Treatment Period 2|Adverse Event|0|||
16316146|NCT01891864|39640836|FG001|Treatment Period 2|Adverse Event|0|||
16316147|NCT01891864|39640837|FG002|Treatment Period 2|Adverse Event|1|||
16316148|NCT01891864|39640838|FG003|Treatment Period 2|Adverse Event|2|||
16316149|NCT01891864|39640839|FG004|Treatment Period 2|Adverse Event|0|||
16316150|NCT01891864|39640840|FG005|Treatment Period 2|Adverse Event|4|||
16316151|NCT01891864|39640835|FG000|Treatment Period 2|Termination of Site|0|||
16316152|NCT01891864|39640836|FG001|Treatment Period 2|Termination of Site|0|||
16316153|NCT01891864|39640837|FG002|Treatment Period 2|Termination of Site|0|||
16316154|NCT01891864|39640838|FG003|Treatment Period 2|Termination of Site|0|||
16316155|NCT01891864|39640839|FG004|Treatment Period 2|Termination of Site|2|||
16316156|NCT01891864|39640840|FG005|Treatment Period 2|Termination of Site|0|||
16316157|NCT01891864|39640835|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16316158|NCT01891864|39640836|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16316159|NCT01891864|39640837|FG002|Treatment Period 2|Withdrawal by Subject|3|||
16316160|NCT01891864|39640838|FG003|Treatment Period 2|Withdrawal by Subject|4|||
16316161|NCT01891864|39640839|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16316162|NCT01891864|39640840|FG005|Treatment Period 2|Withdrawal by Subject|1|||
16316163|NCT01891864|39640835|FG000|Extension Period|Lack of Efficacy|0|||
16316164|NCT01891864|39640836|FG001|Extension Period|Lack of Efficacy|0|||
16316165|NCT01891864|39640837|FG002|Extension Period|Lack of Efficacy|0|||
16316166|NCT01891864|39640838|FG003|Extension Period|Lack of Efficacy|1|||
16510301|NCT01465464|40343812|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
16510302|NCT01465464|40343813|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
16316167|NCT01891864|39640839|FG004|Extension Period|Lack of Efficacy|1|||
16392509|NCT01791517|39919691|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
16316168|NCT01891864|39640840|FG005|Extension Period|Lack of Efficacy|0|||
16316169|NCT01891864|39640835|FG000|Extension Period|Pregnancy|0|||
16316170|NCT01891864|39640836|FG001|Extension Period|Pregnancy|0|||
16316171|NCT01891864|39640837|FG002|Extension Period|Pregnancy|1|||
16316172|NCT01891864|39640838|FG003|Extension Period|Pregnancy|0|||
16316173|NCT01891864|39640839|FG004|Extension Period|Pregnancy|0|||
16316174|NCT01891864|39640840|FG005|Extension Period|Pregnancy|0|||
16316175|NCT01891864|39640835|FG000|Extension Period|Adverse Event|0|||
16316176|NCT01891864|39640836|FG001|Extension Period|Adverse Event|0|||
16316177|NCT01891864|39640837|FG002|Extension Period|Adverse Event|4|||
16316178|NCT01891864|39640838|FG003|Extension Period|Adverse Event|2|||
16316179|NCT01891864|39640839|FG004|Extension Period|Adverse Event|2|||
16510303|NCT03829046|40343814|FG000|Overall Study|Withdrawal by Subject|1|||
16510304|NCT03829046|40343815|FG001|Overall Study|Withdrawal by Subject|0|||
16510305|NCT04536727|40343816|FG000|Overall Study|Lost to Follow-up|1|||
16510306|NCT04536727|40343817|FG001|Overall Study|Lost to Follow-up|1|||
16510307|NCT04536727|40343816|FG000|Overall Study|Death|0|||
16510308|NCT04536727|40343817|FG001|Overall Study|Death|1|||
16510309|NCT00129129|40343818|FG000|Primary Phase|Adverse Event|2|||
16510310|NCT00129129|40343819|FG001|Primary Phase|Adverse Event|1|||
16510311|NCT00129129|40343820|FG002|Primary Phase|Adverse Event|0|||
16316180|NCT01891864|39640840|FG005|Extension Period|Adverse Event|0|||
16316181|NCT01891864|39640835|FG000|Extension Period|Withdrawal by Subject|0|||
16316182|NCT01891864|39640836|FG001|Extension Period|Withdrawal by Subject|0|||
16316183|NCT01891864|39640837|FG002|Extension Period|Withdrawal by Subject|1|||
16316184|NCT01891864|39640838|FG003|Extension Period|Withdrawal by Subject|2|||
16316185|NCT01891864|39640839|FG004|Extension Period|Withdrawal by Subject|4|||
16316186|NCT01891864|39640840|FG005|Extension Period|Withdrawal by Subject|0|||
16316187|NCT01891864|39640835|FG000|Extension Period|Lost to Follow-up|0|||
16316188|NCT01891864|39640836|FG001|Extension Period|Lost to Follow-up|0|||
16316189|NCT01891864|39640837|FG002|Extension Period|Lost to Follow-up|2|||
16316190|NCT01891864|39640838|FG003|Extension Period|Lost to Follow-up|0|||
16316191|NCT01891864|39640839|FG004|Extension Period|Lost to Follow-up|0|||
16316192|NCT01891864|39640840|FG005|Extension Period|Lost to Follow-up|0|||
16316193|NCT02075203|39640841|FG000|Overall Study|Withdrawal by Subject|1|||
16316194|NCT02075203|39640842|FG001|Overall Study|Withdrawal by Subject|0|||
16316195|NCT02075203|39640843|FG002|Overall Study|Withdrawal by Subject|1|||
16316196|NCT02075203|39640841|FG000|Overall Study|Adverse Event|1|||
16316197|NCT02075203|39640842|FG001|Overall Study|Adverse Event|0|||
16316198|NCT02075203|39640843|FG002|Overall Study|Adverse Event|0|||
16316199|NCT02075203|39640841|FG000|Overall Study|participant refused to use contraception|1|||
16316200|NCT02075203|39640842|FG001|Overall Study|participant refused to use contraception|0|||
16316201|NCT02075203|39640843|FG002|Overall Study|participant refused to use contraception|0|||
16316202|NCT04938180|39640844|FG000|Overall Study|Adverse Event|1|||
16316203|NCT00396656|39640845|FG000|First Treatment Period|Withdrawal by Subject|0|||
16316204|NCT00396656|39640846|FG001|First Treatment Period|Withdrawal by Subject|2|||
16316205|NCT00396656|39640845|FG000|Second Treatment Period|Adverse Event|0|||
16316206|NCT00396656|39640846|FG001|Second Treatment Period|Adverse Event|1|||
16316207|NCT00529087|39640847|FG000|Overall Study|Adverse Event|10|||
16316208|NCT00529087|39640848|FG001|Overall Study|Adverse Event|13|||
16316209|NCT00529087|39640849|FG002|Overall Study|Adverse Event|4|||
16316210|NCT00529087|39640847|FG000|Overall Study|Lost to Follow-up|6|||
16316211|NCT00529087|39640848|FG001|Overall Study|Lost to Follow-up|4|||
16316212|NCT00529087|39640849|FG002|Overall Study|Lost to Follow-up|1|||
16316213|NCT00529087|39640847|FG000|Overall Study|Protocol Violation|8|||
16316214|NCT00529087|39640848|FG001|Overall Study|Protocol Violation|7|||
16316215|NCT00529087|39640849|FG002|Overall Study|Protocol Violation|6|||
16316216|NCT00529087|39640847|FG000|Overall Study|Withdrawal by Subject|3|||
16316217|NCT00529087|39640848|FG001|Overall Study|Withdrawal by Subject|3|||
16316218|NCT00529087|39640849|FG002|Overall Study|Withdrawal by Subject|3|||
16316219|NCT00529087|39640847|FG000|Overall Study|Protocol deviation|1|||
16316220|NCT00529087|39640848|FG001|Overall Study|Protocol deviation|1|||
16316221|NCT00529087|39640849|FG002|Overall Study|Protocol deviation|2|||
16316222|NCT00571727|39640850|FG000|Overall Study|Did not enter in this study|1|||
16316223|NCT00571727|39640850|FG000|Overall Study|Non-compliance|4|||
16510312|NCT00129129|40343821|FG003|Primary Phase|Adverse Event|0|||
16510313|NCT00129129|40343822|FG004|Primary Phase|Adverse Event|0|||
16510314|NCT00129129|40343818|FG000|Primary Phase|Withdrawal by Subject|12|||
16510315|NCT00129129|40343819|FG001|Primary Phase|Withdrawal by Subject|10|||
16510316|NCT00129129|40343820|FG002|Primary Phase|Withdrawal by Subject|0|||
16510317|NCT00129129|40343821|FG003|Primary Phase|Withdrawal by Subject|0|||
16510318|NCT00129129|40343822|FG004|Primary Phase|Withdrawal by Subject|0|||
16510319|NCT00129129|40343818|FG000|Primary Phase|Migration from study area|1|||
16510320|NCT00129129|40343819|FG001|Primary Phase|Migration from study area|3|||
16510321|NCT00129129|40343820|FG002|Primary Phase|Migration from study area|0|||
16510322|NCT00129129|40343821|FG003|Primary Phase|Migration from study area|0|||
16510323|NCT00129129|40343822|FG004|Primary Phase|Migration from study area|0|||
16510324|NCT00129129|40343818|FG000|Primary Phase|Lost to Follow-up|8|||
16510325|NCT00129129|40343819|FG001|Primary Phase|Lost to Follow-up|6|||
16510326|NCT00129129|40343820|FG002|Primary Phase|Lost to Follow-up|0|||
16316224|NCT00571727|39640850|FG000|Overall Study|Lost to Follow-up|30|||
16510327|NCT00129129|40343821|FG003|Primary Phase|Lost to Follow-up|0|||
16510328|NCT00129129|40343822|FG004|Primary Phase|Lost to Follow-up|0|||
16316225|NCT00571727|39640850|FG000|Overall Study|Poor growth|1|||
16316226|NCT00571727|39640850|FG000|Overall Study|Parent/patient decision|2|||
16316227|NCT00571727|39640850|FG000|Overall Study|Participant transferred to commercial drug|14|||
16316228|NCT00571727|39640850|FG000|Overall Study|Unable to provide study drug|6|||
16316229|NCT00571727|39640850|FG000|Overall Study|On-treatment at end of study|8|||
16510329|NCT00129129|40343818|FG000|Primary Phase|Other|2|||
16510330|NCT00129129|40343819|FG001|Primary Phase|Other|5|||
16510331|NCT00129129|40343820|FG002|Primary Phase|Other|0|||
16510332|NCT00129129|40343821|FG003|Primary Phase|Other|0|||
16510333|NCT00129129|40343822|FG004|Primary Phase|Other|0|||
16510334|NCT00129129|40343818|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
16510335|NCT00129129|40343819|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
16510336|NCT00129129|40343820|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
16510337|NCT00129129|40343821|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
16510338|NCT00129129|40343822|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
16510339|NCT00129129|40343818|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
16510340|NCT00129129|40343819|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
16510341|NCT00129129|40343820|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
16510342|NCT00129129|40343821|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
16510343|NCT00129129|40343822|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
16510344|NCT00129129|40343818|FG000|Fourth Dose Phase|Migration from study area|0|||
16510345|NCT00129129|40343819|FG001|Fourth Dose Phase|Migration from study area|0|||
16510346|NCT00129129|40343820|FG002|Fourth Dose Phase|Migration from study area|0|||
16510347|NCT00129129|40343821|FG003|Fourth Dose Phase|Migration from study area|0|||
16510348|NCT00129129|40343822|FG004|Fourth Dose Phase|Migration from study area|2|||
16510349|NCT00129129|40343818|FG000|Fourth Dose Phase|Other|0|||
16510350|NCT00129129|40343819|FG001|Fourth Dose Phase|Other|0|||
16510351|NCT00129129|40343820|FG002|Fourth Dose Phase|Other|0|||
16510352|NCT00129129|40343821|FG003|Fourth Dose Phase|Other|1|||
16510353|NCT00129129|40343822|FG004|Fourth Dose Phase|Other|1|||
16510354|NCT00129129|40343818|FG000|Fourth Dose Phase|Protocol Violation|0|||
16510355|NCT00129129|40343819|FG001|Fourth Dose Phase|Protocol Violation|0|||
16510356|NCT00129129|40343820|FG002|Fourth Dose Phase|Protocol Violation|0|||
16510357|NCT00129129|40343821|FG003|Fourth Dose Phase|Protocol Violation|1|||
16510358|NCT00129129|40343822|FG004|Fourth Dose Phase|Protocol Violation|0|||
16510359|NCT03907683|40343823|FG000|Overall Study|Pregnancy|1|||
16510360|NCT03907683|40343823|FG000|Overall Study|Withdrawal by Subject|1|||
16510361|NCT00794196|40343824|FG000|Overall Study|Lost to Follow-up|5|||
16510362|NCT00794196|40343825|FG001|Overall Study|Lost to Follow-up|23|||
16510363|NCT03277261|40343826|FG000|Overall Study|Adverse Event|17|||
16510364|NCT03277261|40343827|FG001|Overall Study|Adverse Event|1|||
16510365|NCT03277261|40343826|FG000|Overall Study|Participant Withdrawal of Consent|6|||
16510366|NCT03277261|40343827|FG001|Overall Study|Participant Withdrawal of Consent|15|||
16510367|NCT03277261|40343826|FG000|Overall Study|Investigator / Sponsor Decision|4|||
16510368|NCT03277261|40343827|FG001|Overall Study|Investigator / Sponsor Decision|2|||
16510369|NCT03277261|40343826|FG000|Overall Study|Pregnancy|2|||
16510370|NCT03277261|40343827|FG001|Overall Study|Pregnancy|0|||
16510371|NCT03277261|40343826|FG000|Overall Study|Lost to Follow-up|2|||
16510372|NCT03277261|40343827|FG001|Overall Study|Lost to Follow-up|2|||
16510373|NCT03277261|40343826|FG000|Overall Study|Lack of Efficacy|2|||
16510374|NCT03277261|40343827|FG001|Overall Study|Lack of Efficacy|2|||
16510375|NCT03277261|40343826|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
16510376|NCT03277261|40343827|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
16510377|NCT01190254|40343828|FG000|Overall Study|Adverse Event|3|||
16510378|NCT01190254|40343829|FG001|Overall Study|Adverse Event|6|||
16510379|NCT01190254|40343830|FG002|Overall Study|Adverse Event|8|||
16199185|NCT01764256|39204563|FG003|Completed Study|Lost to Follow-up|1|||
16199186|NCT01989754|39204564|FG000|Overall Study|Withdrawal by Subject|10|||
16199187|NCT01989754|39204565|FG001|Overall Study|Withdrawal by Subject|14|||
16199188|NCT01989754|39204564|FG000|Overall Study|Lost to Follow-up|28|||
16199189|NCT01989754|39204565|FG001|Overall Study|Lost to Follow-up|20|||
16199190|NCT01989754|39204564|FG000|Overall Study|Closed Site|1|||
16199191|NCT01989754|39204565|FG001|Overall Study|Closed Site|1|||
16199192|NCT02785952|39204568|FG000|Overall Study|Adverse Event|31|||
16199193|NCT02785952|39204569|FG001|Overall Study|Adverse Event|19|||
16199194|NCT02785952|39204568|FG000|Overall Study|Refusal unrelated to adverse events|10|||
16199195|NCT02785952|39204569|FG001|Overall Study|Refusal unrelated to adverse events|5|||
16199196|NCT02785952|39204568|FG000|Overall Study|Disease progression/relapse|61|||
16199197|NCT02785952|39204569|FG001|Overall Study|Disease progression/relapse|89|||
16199198|NCT02785952|39204568|FG000|Overall Study|Death|11|||
16199199|NCT02785952|39204569|FG001|Overall Study|Death|7|||
16199200|NCT02785952|39204568|FG000|Overall Study|Other- not protocol specified|6|||
16199201|NCT02785952|39204569|FG001|Overall Study|Other- not protocol specified|4|||
16510380|NCT01190254|40343828|FG000|Overall Study|Lack of Efficacy|7|||
16510381|NCT01190254|40343829|FG001|Overall Study|Lack of Efficacy|4|||
16510382|NCT01190254|40343830|FG002|Overall Study|Lack of Efficacy|5|||
16510383|NCT01190254|40343828|FG000|Overall Study|Lost to Follow-up|4|||
16510384|NCT01190254|40343829|FG001|Overall Study|Lost to Follow-up|2|||
16510385|NCT01190254|40343830|FG002|Overall Study|Lost to Follow-up|0|||
16510386|NCT01190254|40343828|FG000|Overall Study|Withdrawal by Subject|4|||
16199202|NCT02785952|39204568|FG000|Overall Study|On protocol treatment|6|||
16199203|NCT02785952|39204569|FG001|Overall Study|On protocol treatment|3|||
16510387|NCT01190254|40343829|FG001|Overall Study|Withdrawal by Subject|5|||
16199204|NCT04656418|39204570|FG000|Overall Study|Withdrawal by Subject|1|||
16199205|NCT04656418|39204571|FG001|Overall Study|Withdrawal by Subject|3|||
16199206|NCT00830960|39204572|FG000|Overall Study|Death|5|||
16199207|NCT00830960|39204573|FG001|Overall Study|Death|4|||
16199208|NCT00830960|39204574|FG002|Overall Study|Death|3|||
16199209|NCT00830960|39204575|FG003|Overall Study|Death|2|||
16199210|NCT00830960|39204576|FG004|Overall Study|Death|6|||
16199211|NCT00830960|39204577|FG005|Overall Study|Death|1|||
16199212|NCT00830960|39204572|FG000|Overall Study|Lost to Follow-up|1|||
16199213|NCT00830960|39204573|FG001|Overall Study|Lost to Follow-up|1|||
16199214|NCT00830960|39204574|FG002|Overall Study|Lost to Follow-up|1|||
16199215|NCT00830960|39204575|FG003|Overall Study|Lost to Follow-up|0|||
16199216|NCT00830960|39204576|FG004|Overall Study|Lost to Follow-up|0|||
16199217|NCT00830960|39204577|FG005|Overall Study|Lost to Follow-up|1|||
16199218|NCT00830960|39204572|FG000|Overall Study|Withdrawal by Subject|19|||
16199219|NCT00830960|39204573|FG001|Overall Study|Withdrawal by Subject|19|||
16199220|NCT00830960|39204574|FG002|Overall Study|Withdrawal by Subject|18|||
16199221|NCT00830960|39204575|FG003|Overall Study|Withdrawal by Subject|23|||
16199222|NCT00830960|39204576|FG004|Overall Study|Withdrawal by Subject|16|||
16199223|NCT00830960|39204577|FG005|Overall Study|Withdrawal by Subject|21|||
16199224|NCT00830960|39204572|FG000|Overall Study|Sponsor Decision|1|||
16199225|NCT00830960|39204573|FG001|Overall Study|Sponsor Decision|2|||
16199226|NCT00830960|39204574|FG002|Overall Study|Sponsor Decision|3|||
16199227|NCT00830960|39204575|FG003|Overall Study|Sponsor Decision|4|||
16199228|NCT00830960|39204576|FG004|Overall Study|Sponsor Decision|5|||
16199229|NCT00830960|39204577|FG005|Overall Study|Sponsor Decision|7|||
16199230|NCT00830960|39204572|FG000|Overall Study|No study drug received|7|||
16199231|NCT00830960|39204573|FG001|Overall Study|No study drug received|2|||
16199232|NCT00830960|39204574|FG002|Overall Study|No study drug received|4|||
16510388|NCT01190254|40343830|FG002|Overall Study|Withdrawal by Subject|7|||
16510389|NCT01190254|40343828|FG000|Overall Study|Protocol Violation|2|||
16510390|NCT01190254|40343829|FG001|Overall Study|Protocol Violation|0|||
16510391|NCT01190254|40343830|FG002|Overall Study|Protocol Violation|2|||
16510392|NCT01190254|40343828|FG000|Overall Study|Did not meet protocol eligibility|1|||
16510393|NCT01190254|40343829|FG001|Overall Study|Did not meet protocol eligibility|0|||
16510394|NCT01190254|40343830|FG002|Overall Study|Did not meet protocol eligibility|0|||
16510395|NCT04200248|40343831|FG000|Overall Study|Personal reasons|0|||
16510396|NCT04200248|40343832|FG001|Overall Study|Personal reasons|0|||
16510397|NCT04200248|40343833|FG002|Overall Study|Personal reasons|1|||
16510398|NCT04200248|40343831|FG000|Overall Study|Discontinued prior to treatment|3|||
16510399|NCT04200248|40343832|FG001|Overall Study|Discontinued prior to treatment|3|||
16510400|NCT04200248|40343833|FG002|Overall Study|Discontinued prior to treatment|2|||
16510401|NCT02141997|40343834|FG000|Overall Study|Adverse Event|0|||
16510402|NCT02141997|40343835|FG001|Overall Study|Adverse Event|2|||
16510403|NCT02141997|40343836|FG002|Overall Study|Adverse Event|0|||
16510404|NCT02141997|40343837|FG003|Overall Study|Adverse Event|1|||
16510405|NCT02141997|40343834|FG000|Overall Study|Participant noncompliance|1|||
16510406|NCT02141997|40343835|FG001|Overall Study|Participant noncompliance|0|||
16510407|NCT02141997|40343836|FG002|Overall Study|Participant noncompliance|0|||
16199233|NCT00830960|39204575|FG003|Overall Study|No study drug received|3|||
16316230|NCT00086684|39640851|FG000|Overall Study|Adverse Event|12|||
16316231|NCT00086684|39640852|FG001|Overall Study|Adverse Event|17|||
16316232|NCT00086684|39640853|FG002|Overall Study|Adverse Event|14|||
16316233|NCT00086684|39640851|FG000|Overall Study|Lack of Efficacy|6|||
16316234|NCT00086684|39640852|FG001|Overall Study|Lack of Efficacy|6|||
16316235|NCT00086684|39640853|FG002|Overall Study|Lack of Efficacy|5|||
16510408|NCT02141997|40343837|FG003|Overall Study|Participant noncompliance|0|||
16510409|NCT02141997|40343834|FG000|Overall Study|Withdrew consent|1|||
16510410|NCT02141997|40343835|FG001|Overall Study|Withdrew consent|0|||
16510411|NCT02141997|40343836|FG002|Overall Study|Withdrew consent|3|||
16316236|NCT00086684|39640851|FG000|Overall Study|Lost to Follow-up|15|||
16316237|NCT00086684|39640852|FG001|Overall Study|Lost to Follow-up|8|||
16316238|NCT00086684|39640853|FG002|Overall Study|Lost to Follow-up|10|||
16316239|NCT00086684|39640851|FG000|Overall Study|Protocol Violation|8|||
16316240|NCT00086684|39640852|FG001|Overall Study|Protocol Violation|3|||
16316241|NCT00086684|39640853|FG002|Overall Study|Protocol Violation|0|||
16510412|NCT02141997|40343837|FG003|Overall Study|Withdrew consent|0|||
16510413|NCT02141997|40343834|FG000|Overall Study|Other|1|||
16510414|NCT02141997|40343835|FG001|Overall Study|Other|4|||
16199234|NCT00830960|39204576|FG004|Overall Study|No study drug received|5|||
16199235|NCT00830960|39204577|FG005|Overall Study|No study drug received|7|||
16199236|NCT00259740|39204578|FG000|Overall Study|Physician Decision|1|||
16199237|NCT00259740|39204579|FG001|Overall Study|Physician Decision|1|||
16199238|NCT00259740|39204578|FG000|Overall Study|Adverse Event|0|||
16316242|NCT00086684|39640851|FG000|Overall Study|Withdrawal by Subject|0|||
16316243|NCT00086684|39640852|FG001|Overall Study|Withdrawal by Subject|4|||
16510415|NCT02141997|40343836|FG002|Overall Study|Other|0|||
16510416|NCT02141997|40343837|FG003|Overall Study|Other|0|||
16510417|NCT00323414|40343838|FG000|Overall Study|Withdrawal by Subject|0|||
16316244|NCT00086684|39640853|FG002|Overall Study|Withdrawal by Subject|10|||
16316245|NCT00086684|39640851|FG000|Overall Study|NONCOMPLIANCE|5|||
16316246|NCT00086684|39640852|FG001|Overall Study|NONCOMPLIANCE|7|||
16316247|NCT00086684|39640853|FG002|Overall Study|NONCOMPLIANCE|6|||
16316248|NCT00086684|39640851|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
16316249|NCT00086684|39640852|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
16392510|NCT01791517|39919692|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
16392511|NCT01791517|39919693|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
16392512|NCT01791517|39919694|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
16392513|NCT01791517|39919695|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
16510418|NCT00323414|40343839|FG001|Overall Study|Withdrawal by Subject|1|||
16392514|NCT01791517|39919696|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
16392515|NCT01791517|39919697|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
16392516|NCT01791517|39919698|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
16392517|NCT01791517|39919699|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
16392518|NCT01791517|39919700|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
16392519|NCT01791517|39919701|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
16392520|NCT01791517|39919702|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
16392521|NCT01791517|39919691|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
16392522|NCT01791517|39919692|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392523|NCT01791517|39919693|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392524|NCT01791517|39919694|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392525|NCT01791517|39919695|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392526|NCT01791517|39919696|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392527|NCT01791517|39919697|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392528|NCT01791517|39919698|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392529|NCT01791517|39919699|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392530|NCT01791517|39919700|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392531|NCT01791517|39919701|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392532|NCT01791517|39919702|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
16392533|NCT01791517|39919691|FG000|Phase I: Period 2|Protocol Violation|0|||
16392534|NCT01791517|39919692|FG001|Phase I: Period 2|Protocol Violation|0|||
16392535|NCT01791517|39919693|FG002|Phase I: Period 2|Protocol Violation|0|||
16392536|NCT01791517|39919694|FG003|Phase I: Period 2|Protocol Violation|1|||
16392537|NCT01791517|39919695|FG004|Phase I: Period 2|Protocol Violation|0|||
16392538|NCT01791517|39919696|FG005|Phase I: Period 2|Protocol Violation|0|||
16392539|NCT01791517|39919697|FG006|Phase I: Period 2|Protocol Violation|0|||
16392540|NCT01791517|39919698|FG007|Phase I: Period 2|Protocol Violation|0|||
16392541|NCT01791517|39919699|FG008|Phase I: Period 2|Protocol Violation|0|||
16392542|NCT01791517|39919700|FG009|Phase I: Period 2|Protocol Violation|0|||
16392543|NCT01791517|39919701|FG010|Phase I: Period 2|Protocol Violation|0|||
16392544|NCT01791517|39919702|FG011|Phase I: Period 2|Protocol Violation|0|||
16392545|NCT01791517|39919691|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
16392546|NCT01791517|39919692|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
16392547|NCT01791517|39919693|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
16392548|NCT01791517|39919694|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
16392549|NCT01791517|39919695|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
16392550|NCT01791517|39919696|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
16392551|NCT01791517|39919697|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
16392552|NCT01791517|39919698|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
16392553|NCT01791517|39919699|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
16392554|NCT01791517|39919700|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
16392555|NCT01791517|39919701|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
16392556|NCT01791517|39919702|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
16392557|NCT01791517|39919691|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16392558|NCT01791517|39919692|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16392559|NCT01791517|39919693|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16392560|NCT01791517|39919694|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16392561|NCT01791517|39919695|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16392562|NCT01791517|39919696|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16392563|NCT01791517|39919697|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16510419|NCT04327986|40343840|FG000|Overall Study|Physician Decision|2|||
16510420|NCT04327986|40343841|FG001|Overall Study|Physician Decision|0|||
16510421|NCT04327986|40343842|FG002|Overall Study|Physician Decision|0|||
16510422|NCT04327986|40343840|FG000|Overall Study|Death|1|||
16510423|NCT04327986|40343841|FG001|Overall Study|Death|0|||
16510424|NCT04327986|40343842|FG002|Overall Study|Death|0|||
16392564|NCT01791517|39919698|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16199239|NCT00259740|39204579|FG001|Overall Study|Adverse Event|2|||
16316250|NCT00086684|39640853|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
16392565|NCT01791517|39919699|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16392566|NCT01791517|39919700|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16199240|NCT00259740|39204578|FG000|Overall Study|Withdrawal by Subject|2|||
16316251|NCT00086684|39640851|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
16316252|NCT00086684|39640852|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
16316253|NCT00086684|39640853|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
16316254|NCT00086684|39640851|FG000|Overall Study|Other|4|||
16316255|NCT00086684|39640852|FG001|Overall Study|Other|2|||
16316256|NCT00086684|39640853|FG002|Overall Study|Other|3|||
16316257|NCT01537042|39640854|FG000|Overall Study|Adverse Event|0|||
16316258|NCT01537042|39640855|FG001|Overall Study|Adverse Event|2|||
16316259|NCT01537042|39640854|FG000|Overall Study|Lack of Efficacy|0|||
16316260|NCT01537042|39640855|FG001|Overall Study|Lack of Efficacy|1|||
16510425|NCT03029624|40343849|FG000|Overall Study|Adverse Event|1|||
16510426|NCT03029624|40343849|FG000|Overall Study|Withdrawal by Subject|1|||
16510427|NCT03029624|40343849|FG000|Overall Study|Lack of Efficacy|1|||
16510428|NCT03029624|40343849|FG000|Overall Study|MRI need|2|||
16510429|NCT02658890|40343856|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510430|NCT02658890|40343857|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510431|NCT02658890|40343858|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510432|NCT02658890|40343859|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510433|NCT02658890|40343860|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510434|NCT02658890|40343861|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510435|NCT02658890|40343862|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510436|NCT02658890|40343863|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510437|NCT02658890|40343864|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
16510438|NCT02658890|40343865|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510439|NCT02658890|40343866|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510440|NCT02658890|40343867|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510441|NCT02658890|40343868|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510442|NCT02658890|40343869|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16316261|NCT01537042|39640854|FG000|Overall Study|Protocol Violation|0|||
16316262|NCT01537042|39640855|FG001|Overall Study|Protocol Violation|1|||
16316263|NCT01537042|39640854|FG000|Overall Study|Other|0|||
16316264|NCT01537042|39640855|FG001|Overall Study|Other|1|||
16316265|NCT00734994|39640866|FG000|Overall Study|Withdrawal by Subject|1|||
16316266|NCT03379727|39640874|FG000|Overall Study|Lack of Efficacy|73|||
16316267|NCT03379727|39640874|FG000|Overall Study|Adverse Event|32|||
16316268|NCT03379727|39640874|FG000|Overall Study|Death|18|||
16316269|NCT03379727|39640874|FG000|Overall Study|Patient/guardian decision|17|||
16316270|NCT03379727|39640874|FG000|Overall Study|Physician Decision|104|||
16316271|NCT03379727|39640874|FG000|Overall Study|Protocol Violation|4|||
16316272|NCT03379727|39640874|FG000|Overall Study|Lost to Follow-up|1|||
16316273|NCT02068508|39640875|FG000|Overall Study|Case report forms uncollected|27|||
16316274|NCT02068508|39640875|FG000|Overall Study|Patient did not visit the study site|1|||
16316275|NCT02068508|39640875|FG000|Overall Study|Protocol Violation|4|||
16316276|NCT00314327|39640876|FG000|Overall Study|Withdrawal by Subject|1|||
16316277|NCT00444535|39640880|FG000|Overall Study|Withdrawal by Subject|5|||
16510443|NCT02658890|40343870|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510444|NCT02658890|40343871|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16316278|NCT00444535|39640880|FG000|Overall Study|Physician Decision|5|||
16316279|NCT00444535|39640880|FG000|Overall Study|progressive disease|1|||
16510445|NCT02658890|40343872|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510446|NCT02658890|40343873|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16199241|NCT00259740|39204579|FG001|Overall Study|Withdrawal by Subject|6|||
16199242|NCT00259740|39204578|FG000|Overall Study|Death|1|||
16316280|NCT00444535|39640880|FG000|Overall Study|Adverse Event|2|||
16316281|NCT02375971|39640881|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
16316282|NCT02375971|39640882|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
16316283|NCT02375971|39640883|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
16316284|NCT02375971|39640881|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
16316285|NCT02375971|39640882|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
16316286|NCT02375971|39640883|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
16316287|NCT02375971|39640881|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
16316288|NCT02375971|39640882|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
16316289|NCT02375971|39640883|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
16316290|NCT02375971|39640881|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
16316291|NCT02375971|39640882|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
16316292|NCT02375971|39640883|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
16316293|NCT02375971|39640881|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
16316294|NCT02375971|39640882|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
16316295|NCT02375971|39640883|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
16316296|NCT02375971|39640881|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
16316297|NCT02375971|39640882|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
16316298|NCT02375971|39640883|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
16510447|NCT02658890|40343874|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510448|NCT02658890|40343875|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16392567|NCT01791517|39919701|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
16392568|NCT01791517|39919702|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
16392569|NCT01791517|39919691|FG000|Phase I: Period 2|Lens Discomfort|0|||
16510449|NCT02658890|40343876|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510450|NCT02658890|40343877|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510451|NCT02658890|40343878|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510452|NCT02658890|40343879|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510453|NCT02658890|40343880|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510454|NCT02658890|40343881|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510455|NCT02658890|40343882|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510456|NCT02658890|40343856|FG000|Treatment Phase|Adverse Event|0|||
16510457|NCT02658890|40343857|FG001|Treatment Phase|Adverse Event|1|||
16510458|NCT02658890|40343858|FG002|Treatment Phase|Adverse Event|2|||
16510459|NCT02658890|40343859|FG003|Treatment Phase|Adverse Event|2|||
16510460|NCT02658890|40343860|FG004|Treatment Phase|Adverse Event|1|||
16510461|NCT02658890|40343861|FG005|Treatment Phase|Adverse Event|0|||
16510462|NCT02658890|40343862|FG006|Treatment Phase|Adverse Event|0|||
16510463|NCT02658890|40343863|FG007|Treatment Phase|Adverse Event|2|||
16510464|NCT02658890|40343864|FG008|Treatment Phase|Adverse Event|1|||
16510465|NCT02658890|40343865|FG009|Treatment Phase|Adverse Event|2|||
16510466|NCT02658890|40343866|FG010|Treatment Phase|Adverse Event|3|||
16510467|NCT02658890|40343867|FG011|Treatment Phase|Adverse Event|0|||
16510468|NCT02658890|40343868|FG012|Treatment Phase|Adverse Event|1|||
16510469|NCT02658890|40343869|FG013|Treatment Phase|Adverse Event|4|||
16510470|NCT02658890|40343870|FG014|Treatment Phase|Adverse Event|0|||
16510471|NCT02658890|40343871|FG015|Treatment Phase|Adverse Event|0|||
16510472|NCT02658890|40343872|FG016|Treatment Phase|Adverse Event|0|||
16510473|NCT02658890|40343873|FG017|Treatment Phase|Adverse Event|0|||
16510474|NCT02658890|40343874|FG018|Treatment Phase|Adverse Event|5|||
16510475|NCT02658890|40343875|FG019|Treatment Phase|Adverse Event|1|||
16510476|NCT02658890|40343876|FG020|Treatment Phase|Adverse Event|3|||
16510477|NCT02658890|40343877|FG021|Treatment Phase|Adverse Event|0|||
16510478|NCT02658890|40343878|FG022|Treatment Phase|Adverse Event|5|||
16510479|NCT02658890|40343879|FG023|Treatment Phase|Adverse Event|0|||
16510480|NCT02658890|40343880|FG024|Treatment Phase|Adverse Event|0|||
16510481|NCT02658890|40343881|FG025|Treatment Phase|Adverse Event|2|||
16510482|NCT02658890|40343882|FG026|Treatment Phase|Adverse Event|1|||
16510483|NCT02658890|40343856|FG000|Treatment Phase|Death|0|||
16510484|NCT02658890|40343857|FG001|Treatment Phase|Death|0|||
16510485|NCT02658890|40343858|FG002|Treatment Phase|Death|0|||
16510486|NCT02658890|40343859|FG003|Treatment Phase|Death|0|||
16510487|NCT02658890|40343860|FG004|Treatment Phase|Death|0|||
16510488|NCT02658890|40343861|FG005|Treatment Phase|Death|0|||
16510489|NCT02658890|40343862|FG006|Treatment Phase|Death|0|||
16510490|NCT02658890|40343863|FG007|Treatment Phase|Death|0|||
16510491|NCT02658890|40343864|FG008|Treatment Phase|Death|0|||
16510492|NCT02658890|40343865|FG009|Treatment Phase|Death|0|||
16510493|NCT02658890|40343866|FG010|Treatment Phase|Death|0|||
16510494|NCT02658890|40343867|FG011|Treatment Phase|Death|0|||
16510495|NCT02658890|40343868|FG012|Treatment Phase|Death|0|||
16510496|NCT02658890|40343869|FG013|Treatment Phase|Death|0|||
16510497|NCT02658890|40343870|FG014|Treatment Phase|Death|0|||
16510498|NCT02658890|40343871|FG015|Treatment Phase|Death|0|||
16510499|NCT02658890|40343872|FG016|Treatment Phase|Death|0|||
16510500|NCT02658890|40343873|FG017|Treatment Phase|Death|0|||
16510501|NCT02658890|40343874|FG018|Treatment Phase|Death|1|||
16510502|NCT02658890|40343875|FG019|Treatment Phase|Death|0|||
16510503|NCT02658890|40343876|FG020|Treatment Phase|Death|0|||
16510504|NCT02658890|40343877|FG021|Treatment Phase|Death|0|||
16510505|NCT02658890|40343878|FG022|Treatment Phase|Death|0|||
16510506|NCT02658890|40343879|FG023|Treatment Phase|Death|0|||
16510507|NCT02658890|40343880|FG024|Treatment Phase|Death|0|||
16392570|NCT01791517|39919692|FG001|Phase I: Period 2|Lens Discomfort|0|||
16392571|NCT01791517|39919693|FG002|Phase I: Period 2|Lens Discomfort|0|||
16510508|NCT02658890|40343881|FG025|Treatment Phase|Death|0|||
16510509|NCT02658890|40343882|FG026|Treatment Phase|Death|0|||
16510510|NCT02658890|40343856|FG000|Treatment Phase|Lost to Follow-up|0|||
16510511|NCT02658890|40343857|FG001|Treatment Phase|Lost to Follow-up|0|||
16510512|NCT02658890|40343858|FG002|Treatment Phase|Lost to Follow-up|0|||
16510513|NCT02658890|40343859|FG003|Treatment Phase|Lost to Follow-up|0|||
16510514|NCT02658890|40343860|FG004|Treatment Phase|Lost to Follow-up|0|||
16510515|NCT02658890|40343861|FG005|Treatment Phase|Lost to Follow-up|0|||
16510516|NCT02658890|40343862|FG006|Treatment Phase|Lost to Follow-up|1|||
16510517|NCT02658890|40343863|FG007|Treatment Phase|Lost to Follow-up|0|||
16510518|NCT02658890|40343864|FG008|Treatment Phase|Lost to Follow-up|0|||
16510519|NCT02658890|40343865|FG009|Treatment Phase|Lost to Follow-up|0|||
16510520|NCT02658890|40343866|FG010|Treatment Phase|Lost to Follow-up|0|||
16510521|NCT02658890|40343867|FG011|Treatment Phase|Lost to Follow-up|0|||
16510522|NCT02658890|40343868|FG012|Treatment Phase|Lost to Follow-up|0|||
16510523|NCT02658890|40343869|FG013|Treatment Phase|Lost to Follow-up|0|||
16510524|NCT02658890|40343870|FG014|Treatment Phase|Lost to Follow-up|0|||
16510525|NCT02658890|40343871|FG015|Treatment Phase|Lost to Follow-up|0|||
16510526|NCT02658890|40343872|FG016|Treatment Phase|Lost to Follow-up|0|||
16510527|NCT02658890|40343873|FG017|Treatment Phase|Lost to Follow-up|0|||
16510528|NCT02658890|40343874|FG018|Treatment Phase|Lost to Follow-up|0|||
16510529|NCT02658890|40343875|FG019|Treatment Phase|Lost to Follow-up|0|||
16510530|NCT02658890|40343876|FG020|Treatment Phase|Lost to Follow-up|0|||
16510531|NCT02658890|40343877|FG021|Treatment Phase|Lost to Follow-up|0|||
16510532|NCT02658890|40343878|FG022|Treatment Phase|Lost to Follow-up|0|||
16510533|NCT02658890|40343879|FG023|Treatment Phase|Lost to Follow-up|0|||
16510534|NCT02658890|40343880|FG024|Treatment Phase|Lost to Follow-up|0|||
16510535|NCT02658890|40343881|FG025|Treatment Phase|Lost to Follow-up|0|||
16510536|NCT02658890|40343882|FG026|Treatment Phase|Lost to Follow-up|0|||
16510537|NCT02658890|40343856|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
16510538|NCT02658890|40343857|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
16510539|NCT02658890|40343858|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
16510540|NCT02658890|40343859|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
16510541|NCT02658890|40343860|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
16392572|NCT01791517|39919694|FG003|Phase I: Period 2|Lens Discomfort|0|||
16392573|NCT01791517|39919695|FG004|Phase I: Period 2|Lens Discomfort|0|||
16392574|NCT01791517|39919696|FG005|Phase I: Period 2|Lens Discomfort|1|||
16392575|NCT01791517|39919697|FG006|Phase I: Period 2|Lens Discomfort|0|||
16392576|NCT01791517|39919698|FG007|Phase I: Period 2|Lens Discomfort|0|||
16392577|NCT01791517|39919699|FG008|Phase I: Period 2|Lens Discomfort|0|||
16392578|NCT01791517|39919700|FG009|Phase I: Period 2|Lens Discomfort|0|||
16392579|NCT01791517|39919701|FG010|Phase I: Period 2|Lens Discomfort|0|||
16510542|NCT02658890|40343861|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
16510543|NCT02658890|40343862|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
16510544|NCT02658890|40343863|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
16510545|NCT02658890|40343864|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
16510546|NCT02658890|40343865|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
16510547|NCT02658890|40343866|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
16510548|NCT02658890|40343867|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
16510549|NCT02658890|40343868|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
16510550|NCT02658890|40343869|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
16510551|NCT02658890|40343870|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
16510552|NCT02658890|40343871|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
16510553|NCT02658890|40343872|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
16510554|NCT02658890|40343873|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
16510555|NCT02658890|40343874|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
16510556|NCT02658890|40343875|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
16510557|NCT02658890|40343876|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
16510558|NCT02658890|40343877|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
16510559|NCT02658890|40343878|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
16510560|NCT02658890|40343879|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
16510561|NCT02658890|40343880|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
16510562|NCT02658890|40343881|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
16510563|NCT02658890|40343882|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
16510564|NCT02658890|40343856|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
16510565|NCT02658890|40343857|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
16510566|NCT02658890|40343858|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
16510567|NCT02658890|40343859|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
16510568|NCT02658890|40343860|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
16510569|NCT02658890|40343861|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
16510570|NCT02658890|40343862|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
16510571|NCT02658890|40343863|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
16510572|NCT02658890|40343864|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
16510573|NCT02658890|40343865|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
16510574|NCT02658890|40343866|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
16510575|NCT02658890|40343867|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
16510576|NCT02658890|40343868|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
16510577|NCT02658890|40343869|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
16510578|NCT02658890|40343870|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
16510579|NCT02658890|40343871|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
16510580|NCT02658890|40343872|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
16510581|NCT02658890|40343873|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
16510582|NCT02658890|40343874|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
16510583|NCT02658890|40343875|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
16510584|NCT02658890|40343876|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
16510585|NCT02658890|40343877|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
16392580|NCT01791517|39919702|FG011|Phase I: Period 2|Lens Discomfort|0|||
16510586|NCT02658890|40343878|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
16510587|NCT02658890|40343879|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
16510588|NCT02658890|40343880|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
16510589|NCT02658890|40343881|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
16510590|NCT02658890|40343882|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
16510591|NCT02658890|40343856|FG000|Treatment Phase|Other Reasons|0|||
16510592|NCT02658890|40343857|FG001|Treatment Phase|Other Reasons|0|||
16510593|NCT02658890|40343858|FG002|Treatment Phase|Other Reasons|0|||
16316299|NCT02375971|39640881|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
16316300|NCT02375971|39640882|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
16316301|NCT02375971|39640883|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
16316302|NCT02375971|39640881|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
16316303|NCT02375971|39640882|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
16316304|NCT02375971|39640883|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
16316305|NCT00720213|39640884|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
16316306|NCT00720213|39640885|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
16316307|NCT00720213|39640886|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
16316308|NCT00954941|39640887|FG000|Overall Study|Received treatment at home|1|||
16392581|NCT01791517|39919691|FG000|Phase I: Period 2|Lost to Follow-up|0|||
16392582|NCT01791517|39919692|FG001|Phase I: Period 2|Lost to Follow-up|3|||
16392583|NCT01791517|39919693|FG002|Phase I: Period 2|Lost to Follow-up|2|||
16392584|NCT01791517|39919694|FG003|Phase I: Period 2|Lost to Follow-up|0|||
16392585|NCT01791517|39919695|FG004|Phase I: Period 2|Lost to Follow-up|0|||
16392586|NCT01791517|39919696|FG005|Phase I: Period 2|Lost to Follow-up|0|||
16392587|NCT01791517|39919697|FG006|Phase I: Period 2|Lost to Follow-up|0|||
16392588|NCT01791517|39919698|FG007|Phase I: Period 2|Lost to Follow-up|0|||
16392589|NCT01791517|39919699|FG008|Phase I: Period 2|Lost to Follow-up|0|||
16392590|NCT01791517|39919700|FG009|Phase I: Period 2|Lost to Follow-up|0|||
16392591|NCT01791517|39919701|FG010|Phase I: Period 2|Lost to Follow-up|0|||
16392592|NCT01791517|39919702|FG011|Phase I: Period 2|Lost to Follow-up|0|||
16316309|NCT00954941|39640888|FG001|Overall Study|Received treatment at home|0|||
16510594|NCT02658890|40343859|FG003|Treatment Phase|Other Reasons|0|||
16510595|NCT02658890|40343860|FG004|Treatment Phase|Other Reasons|0|||
16510596|NCT02658890|40343861|FG005|Treatment Phase|Other Reasons|0|||
16510597|NCT02658890|40343862|FG006|Treatment Phase|Other Reasons|1|||
16510598|NCT02658890|40343863|FG007|Treatment Phase|Other Reasons|0|||
16510599|NCT02658890|40343864|FG008|Treatment Phase|Other Reasons|1|||
16510600|NCT02658890|40343865|FG009|Treatment Phase|Other Reasons|0|||
16510601|NCT02658890|40343866|FG010|Treatment Phase|Other Reasons|0|||
16510602|NCT02658890|40343867|FG011|Treatment Phase|Other Reasons|0|||
16510603|NCT02658890|40343868|FG012|Treatment Phase|Other Reasons|0|||
16199243|NCT00259740|39204579|FG001|Overall Study|Death|1|||
16316310|NCT00954941|39640887|FG000|Overall Study|Withdrawal by Subject|1|||
16316311|NCT00954941|39640888|FG001|Overall Study|Withdrawal by Subject|0|||
16316312|NCT00954941|39640887|FG000|Overall Study|Insurance Denial|2|||
16316313|NCT00954941|39640888|FG001|Overall Study|Insurance Denial|2|||
16316314|NCT00954941|39640887|FG000|Overall Study|Physician Decision|2|||
16316315|NCT00954941|39640888|FG001|Overall Study|Physician Decision|2|||
16316316|NCT00954941|39640887|FG000|Overall Study|Ineligible|2|||
16316317|NCT00954941|39640888|FG001|Overall Study|Ineligible|2|||
16316318|NCT00954941|39640887|FG000|Overall Study|Adverse Event|0|||
16316319|NCT00954941|39640888|FG001|Overall Study|Adverse Event|1|||
16316320|NCT04200651|39640889|FG000|Overall Study|Moved to another country during follow-up|2|||
16316321|NCT04200651|39640890|FG001|Overall Study|Moved to another country during follow-up|2|||
16316322|NCT04200651|39640889|FG000|Overall Study|Lost to Follow-up|1|||
16392593|NCT01791517|39919691|FG000|Phase I: Period 3|Lens Discomfort|0|||
16392594|NCT01791517|39919692|FG001|Phase I: Period 3|Lens Discomfort|0|||
16392595|NCT01791517|39919693|FG002|Phase I: Period 3|Lens Discomfort|0|||
16392596|NCT01791517|39919694|FG003|Phase I: Period 3|Lens Discomfort|0|||
16392597|NCT01791517|39919695|FG004|Phase I: Period 3|Lens Discomfort|0|||
16392598|NCT01791517|39919696|FG005|Phase I: Period 3|Lens Discomfort|0|||
16392599|NCT01791517|39919697|FG006|Phase I: Period 3|Lens Discomfort|0|||
16392600|NCT01791517|39919698|FG007|Phase I: Period 3|Lens Discomfort|0|||
16392601|NCT01791517|39919699|FG008|Phase I: Period 3|Lens Discomfort|0|||
16392602|NCT01791517|39919700|FG009|Phase I: Period 3|Lens Discomfort|0|||
16392603|NCT01791517|39919701|FG010|Phase I: Period 3|Lens Discomfort|0|||
16392604|NCT01791517|39919702|FG011|Phase I: Period 3|Lens Discomfort|1|||
16316323|NCT04200651|39640890|FG001|Overall Study|Lost to Follow-up|3|||
16316324|NCT03313180|39640891|FG000|Overall Study|Adverse Event|120|||
16316325|NCT03313180|39640891|FG000|Overall Study|Lost to Follow-up|3|||
16316326|NCT03313180|39640891|FG000|Overall Study|Withdrawal by Subject|39|||
16392605|NCT01791517|39919691|FG000|Phase I: Period 3|Lost to Follow-up|0|||
16510604|NCT02658890|40343869|FG013|Treatment Phase|Other Reasons|2|||
16510605|NCT02658890|40343870|FG014|Treatment Phase|Other Reasons|0|||
16510606|NCT02658890|40343871|FG015|Treatment Phase|Other Reasons|0|||
16316327|NCT03313180|39640891|FG000|Overall Study|Other than listed above|15|||
16392606|NCT01791517|39919692|FG001|Phase I: Period 3|Lost to Follow-up|1|||
16392607|NCT01791517|39919693|FG002|Phase I: Period 3|Lost to Follow-up|0|||
16392608|NCT01791517|39919694|FG003|Phase I: Period 3|Lost to Follow-up|0|||
16392609|NCT01791517|39919695|FG004|Phase I: Period 3|Lost to Follow-up|1|||
16392610|NCT01791517|39919696|FG005|Phase I: Period 3|Lost to Follow-up|0|||
16392611|NCT01791517|39919697|FG006|Phase I: Period 3|Lost to Follow-up|0|||
16392612|NCT01791517|39919698|FG007|Phase I: Period 3|Lost to Follow-up|0|||
16392613|NCT01791517|39919699|FG008|Phase I: Period 3|Lost to Follow-up|0|||
16392614|NCT01791517|39919700|FG009|Phase I: Period 3|Lost to Follow-up|0|||
16392615|NCT01791517|39919701|FG010|Phase I: Period 3|Lost to Follow-up|0|||
16392616|NCT01791517|39919702|FG011|Phase I: Period 3|Lost to Follow-up|0|||
16510607|NCT02658890|40343872|FG016|Treatment Phase|Other Reasons|0|||
16510608|NCT02658890|40343873|FG017|Treatment Phase|Other Reasons|0|||
16510609|NCT02658890|40343874|FG018|Treatment Phase|Other Reasons|1|||
16510610|NCT02658890|40343875|FG019|Treatment Phase|Other Reasons|0|||
16392617|NCT01791517|39919691|FG000|Phase I: Period 3|Adverse Event|0|||
16392618|NCT01791517|39919692|FG001|Phase I: Period 3|Adverse Event|0|||
16392619|NCT01791517|39919693|FG002|Phase I: Period 3|Adverse Event|0|||
16392620|NCT01791517|39919694|FG003|Phase I: Period 3|Adverse Event|1|||
16392621|NCT01791517|39919695|FG004|Phase I: Period 3|Adverse Event|0|||
16392622|NCT01791517|39919696|FG005|Phase I: Period 3|Adverse Event|0|||
16392623|NCT01791517|39919697|FG006|Phase I: Period 3|Adverse Event|0|||
16510611|NCT02658890|40343876|FG020|Treatment Phase|Other Reasons|0|||
16510612|NCT02658890|40343877|FG021|Treatment Phase|Other Reasons|0|||
16510613|NCT02658890|40343878|FG022|Treatment Phase|Other Reasons|0|||
16510614|NCT02658890|40343879|FG023|Treatment Phase|Other Reasons|0|||
16510615|NCT02658890|40343880|FG024|Treatment Phase|Other Reasons|1|||
16510616|NCT02658890|40343881|FG025|Treatment Phase|Other Reasons|0|||
16510617|NCT02658890|40343882|FG026|Treatment Phase|Other Reasons|1|||
16392624|NCT01791517|39919698|FG007|Phase I: Period 3|Adverse Event|0|||
16392625|NCT01791517|39919699|FG008|Phase I: Period 3|Adverse Event|0|||
16392626|NCT01791517|39919700|FG009|Phase I: Period 3|Adverse Event|0|||
16392627|NCT01791517|39919701|FG010|Phase I: Period 3|Adverse Event|0|||
16392628|NCT01791517|39919702|FG011|Phase I: Period 3|Adverse Event|0|||
16392629|NCT01791517|39919691|FG000|Phase II|Lost to Follow-up|1|||
16392630|NCT01791517|39919692|FG001|Phase II|Lost to Follow-up|0|||
16392631|NCT01791517|39919693|FG002|Phase II|Lost to Follow-up|1|||
16392632|NCT01791517|39919694|FG003|Phase II|Lost to Follow-up|0|||
16510618|NCT02658890|40343856|FG000|Treatment Phase|Progressive Disease|6|||
16510619|NCT02658890|40343857|FG001|Treatment Phase|Progressive Disease|7|||
16510620|NCT02658890|40343858|FG002|Treatment Phase|Progressive Disease|6|||
16510621|NCT02658890|40343859|FG003|Treatment Phase|Progressive Disease|12|||
16510622|NCT02658890|40343860|FG004|Treatment Phase|Progressive Disease|6|||
16510623|NCT02658890|40343861|FG005|Treatment Phase|Progressive Disease|18|||
16510624|NCT02658890|40343862|FG006|Treatment Phase|Progressive Disease|12|||
16510625|NCT02658890|40343863|FG007|Treatment Phase|Progressive Disease|19|||
16510626|NCT02658890|40343864|FG008|Treatment Phase|Progressive Disease|26|||
16510627|NCT02658890|40343865|FG009|Treatment Phase|Progressive Disease|8|||
16510628|NCT02658890|40343866|FG010|Treatment Phase|Progressive Disease|7|||
16510629|NCT02658890|40343867|FG011|Treatment Phase|Progressive Disease|9|||
16510630|NCT02658890|40343868|FG012|Treatment Phase|Progressive Disease|8|||
16510631|NCT02658890|40343869|FG013|Treatment Phase|Progressive Disease|29|||
16510632|NCT02658890|40343870|FG014|Treatment Phase|Progressive Disease|6|||
16510633|NCT02658890|40343871|FG015|Treatment Phase|Progressive Disease|2|||
16510634|NCT02658890|40343872|FG016|Treatment Phase|Progressive Disease|32|||
16510635|NCT02658890|40343873|FG017|Treatment Phase|Progressive Disease|14|||
16510636|NCT02658890|40343874|FG018|Treatment Phase|Progressive Disease|40|||
16510637|NCT02658890|40343875|FG019|Treatment Phase|Progressive Disease|32|||
16510638|NCT02658890|40343876|FG020|Treatment Phase|Progressive Disease|19|||
16510639|NCT02658890|40343877|FG021|Treatment Phase|Progressive Disease|30|||
16510640|NCT02658890|40343878|FG022|Treatment Phase|Progressive Disease|15|||
16392633|NCT01791517|39919695|FG004|Phase II|Lost to Follow-up|1|||
16392634|NCT01791517|39919696|FG005|Phase II|Lost to Follow-up|2|||
16392635|NCT01791517|39919697|FG006|Phase II|Lost to Follow-up|0|||
16510641|NCT02658890|40343879|FG023|Treatment Phase|Progressive Disease|0|||
16510642|NCT02658890|40343880|FG024|Treatment Phase|Progressive Disease|0|||
16510643|NCT02658890|40343881|FG025|Treatment Phase|Progressive Disease|14|||
16510644|NCT02658890|40343882|FG026|Treatment Phase|Progressive Disease|11|||
16392636|NCT01791517|39919698|FG007|Phase II|Lost to Follow-up|1|||
16392637|NCT01791517|39919699|FG008|Phase II|Lost to Follow-up|1|||
16510645|NCT02658890|40343856|FG000|Treatment Phase|Study Drug Toxicity|0|||
16510646|NCT02658890|40343857|FG001|Treatment Phase|Study Drug Toxicity|0|||
16392638|NCT01791517|39919700|FG009|Phase II|Lost to Follow-up|1|||
16392639|NCT01791517|39919701|FG010|Phase II|Lost to Follow-up|0|||
16392640|NCT01791517|39919702|FG011|Phase II|Lost to Follow-up|0|||
16316328|NCT03313180|39640891|FG000|Overall Study|Covid-19 related|2|||
16510647|NCT02658890|40343858|FG002|Treatment Phase|Study Drug Toxicity|2|||
16510648|NCT02658890|40343859|FG003|Treatment Phase|Study Drug Toxicity|0|||
16510649|NCT02658890|40343860|FG004|Treatment Phase|Study Drug Toxicity|0|||
16510650|NCT02658890|40343861|FG005|Treatment Phase|Study Drug Toxicity|0|||
16510651|NCT02658890|40343862|FG006|Treatment Phase|Study Drug Toxicity|0|||
16510652|NCT02658890|40343863|FG007|Treatment Phase|Study Drug Toxicity|0|||
16510653|NCT02658890|40343864|FG008|Treatment Phase|Study Drug Toxicity|3|||
16510654|NCT02658890|40343865|FG009|Treatment Phase|Study Drug Toxicity|0|||
16510655|NCT02658890|40343866|FG010|Treatment Phase|Study Drug Toxicity|1|||
16510656|NCT02658890|40343867|FG011|Treatment Phase|Study Drug Toxicity|1|||
16510657|NCT02658890|40343868|FG012|Treatment Phase|Study Drug Toxicity|2|||
16199244|NCT00259740|39204578|FG000|Overall Study|Disease progression|19|||
16199245|NCT00259740|39204579|FG001|Overall Study|Disease progression|36|||
16199246|NCT00259740|39204578|FG000|Overall Study|Ongoing|17|||
16199247|NCT00259740|39204579|FG001|Overall Study|Ongoing|3|||
16199248|NCT00259740|39204578|FG000|Overall Study|Other|3|||
16199249|NCT00259740|39204579|FG001|Overall Study|Other|0|||
16199250|NCT00259740|39204578|FG000|Overall Study|Requirement for alternative therapy|0|||
16199251|NCT00259740|39204579|FG001|Overall Study|Requirement for alternative therapy|4|||
16199252|NCT04176445|39204581|FG000|Overall Study|Adverse Event|0|||
16199253|NCT04176445|39204582|FG001|Overall Study|Adverse Event|1|||
16199254|NCT04176445|39204581|FG000|Overall Study|change plans weaning after first intervention|0|||
16199255|NCT04176445|39204582|FG001|Overall Study|change plans weaning after first intervention|1|||
16199256|NCT01995136|39204585|FG000|Overall Study|Change in residence|1|||
16199257|NCT03730194|39204591|FG000|First Stage Treatment|Withdrawal by Subject|1|||
16316329|NCT02964208|39640894|FG000|Overall Study|Death|103|||
16199258|NCT03730194|39204592|FG001|First Stage Treatment|Withdrawal by Subject|1|||
16316330|NCT02964208|39640894|FG000|Overall Study|Withdrawal by Subject|6|||
16316331|NCT02964208|39640894|FG000|Overall Study|Lost to Follow-up|6|||
16316332|NCT02964208|39640894|FG000|Overall Study|Unsuccessful Procedure|5|||
16316333|NCT02964208|39640894|FG000|Overall Study|Device Explant|1|||
16316334|NCT02964208|39640894|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
16316335|NCT02099110|39640895|FG000|Overall Study|Protocol Violation|2|||
16316336|NCT02099110|39640896|FG001|Overall Study|Protocol Violation|1|||
16316337|NCT02099110|39640897|FG002|Overall Study|Protocol Violation|0|||
16316338|NCT02099110|39640898|FG003|Overall Study|Protocol Violation|3|||
16316339|NCT02099110|39640899|FG004|Overall Study|Protocol Violation|1|||
16316340|NCT02099110|39640895|FG000|Overall Study|Participant moved|1|||
16316341|NCT02099110|39640896|FG001|Overall Study|Participant moved|1|||
16316342|NCT02099110|39640897|FG002|Overall Study|Participant moved|1|||
16316343|NCT02099110|39640898|FG003|Overall Study|Participant moved|0|||
16316344|NCT02099110|39640899|FG004|Overall Study|Participant moved|2|||
16316345|NCT02099110|39640895|FG000|Overall Study|Withdrawal by Subject|7|||
16316346|NCT02099110|39640896|FG001|Overall Study|Withdrawal by Subject|11|||
16316347|NCT02099110|39640897|FG002|Overall Study|Withdrawal by Subject|13|||
16316348|NCT02099110|39640898|FG003|Overall Study|Withdrawal by Subject|9|||
16316349|NCT02099110|39640899|FG004|Overall Study|Withdrawal by Subject|13|||
16316350|NCT02099110|39640895|FG000|Overall Study|Adverse Event|3|||
16316351|NCT02099110|39640896|FG001|Overall Study|Adverse Event|5|||
16316352|NCT02099110|39640897|FG002|Overall Study|Adverse Event|2|||
16316353|NCT02099110|39640898|FG003|Overall Study|Adverse Event|3|||
16316354|NCT02099110|39640899|FG004|Overall Study|Adverse Event|2|||
16316355|NCT02099110|39640895|FG000|Overall Study|Lost to Follow-up|6|||
16316356|NCT02099110|39640896|FG001|Overall Study|Lost to Follow-up|12|||
16316357|NCT02099110|39640897|FG002|Overall Study|Lost to Follow-up|11|||
16316358|NCT02099110|39640898|FG003|Overall Study|Lost to Follow-up|5|||
16316359|NCT02099110|39640899|FG004|Overall Study|Lost to Follow-up|6|||
16316360|NCT02099110|39640895|FG000|Overall Study|Death|0|||
16316361|NCT02099110|39640896|FG001|Overall Study|Death|1|||
16316362|NCT02099110|39640897|FG002|Overall Study|Death|0|||
16316363|NCT02099110|39640898|FG003|Overall Study|Death|0|||
16316364|NCT02099110|39640899|FG004|Overall Study|Death|0|||
16316365|NCT02099110|39640895|FG000|Overall Study|Screen failure|0|||
16316366|NCT02099110|39640896|FG001|Overall Study|Screen failure|0|||
16316367|NCT02099110|39640897|FG002|Overall Study|Screen failure|0|||
16316368|NCT02099110|39640898|FG003|Overall Study|Screen failure|0|||
16316369|NCT02099110|39640899|FG004|Overall Study|Screen failure|1|||
16316370|NCT02099110|39640895|FG000|Overall Study|Non-compliance with study drug|2|||
16316371|NCT02099110|39640896|FG001|Overall Study|Non-compliance with study drug|0|||
16510658|NCT02658890|40343869|FG013|Treatment Phase|Study Drug Toxicity|9|||
16510659|NCT02658890|40343870|FG014|Treatment Phase|Study Drug Toxicity|0|||
16316372|NCT02099110|39640897|FG002|Overall Study|Non-compliance with study drug|0|||
16316373|NCT02099110|39640898|FG003|Overall Study|Non-compliance with study drug|0|||
16316374|NCT02099110|39640899|FG004|Overall Study|Non-compliance with study drug|1|||
16316375|NCT02099110|39640895|FG000|Overall Study|Physician Decision|3|||
16316376|NCT02099110|39640896|FG001|Overall Study|Physician Decision|0|||
16510660|NCT02658890|40343871|FG015|Treatment Phase|Study Drug Toxicity|1|||
16510661|NCT02658890|40343872|FG016|Treatment Phase|Study Drug Toxicity|1|||
16510662|NCT02658890|40343873|FG017|Treatment Phase|Study Drug Toxicity|0|||
16510663|NCT02658890|40343874|FG018|Treatment Phase|Study Drug Toxicity|8|||
16510664|NCT02658890|40343875|FG019|Treatment Phase|Study Drug Toxicity|3|||
16510665|NCT02658890|40343876|FG020|Treatment Phase|Study Drug Toxicity|2|||
16510666|NCT02658890|40343877|FG021|Treatment Phase|Study Drug Toxicity|0|||
16510667|NCT02658890|40343878|FG022|Treatment Phase|Study Drug Toxicity|8|||
16510668|NCT02658890|40343879|FG023|Treatment Phase|Study Drug Toxicity|0|||
16510669|NCT02658890|40343880|FG024|Treatment Phase|Study Drug Toxicity|0|||
16392641|NCT01791517|39919691|FG000|Phase II|Withdrawal by Subject|1|||
16392642|NCT01791517|39919692|FG001|Phase II|Withdrawal by Subject|0|||
16392643|NCT01791517|39919693|FG002|Phase II|Withdrawal by Subject|0|||
16392644|NCT01791517|39919694|FG003|Phase II|Withdrawal by Subject|0|||
16392645|NCT01791517|39919695|FG004|Phase II|Withdrawal by Subject|0|||
16392646|NCT01791517|39919696|FG005|Phase II|Withdrawal by Subject|2|||
16392647|NCT01791517|39919697|FG006|Phase II|Withdrawal by Subject|0|||
16392648|NCT01791517|39919698|FG007|Phase II|Withdrawal by Subject|1|||
16392649|NCT01791517|39919699|FG008|Phase II|Withdrawal by Subject|0|||
16392650|NCT01791517|39919700|FG009|Phase II|Withdrawal by Subject|0|||
16392651|NCT01791517|39919701|FG010|Phase II|Withdrawal by Subject|1|||
16392652|NCT01791517|39919702|FG011|Phase II|Withdrawal by Subject|0|||
16392653|NCT01791517|39919691|FG000|Phase II|Lack of Efficacy|0|||
16392654|NCT01791517|39919692|FG001|Phase II|Lack of Efficacy|0|||
16392655|NCT01791517|39919693|FG002|Phase II|Lack of Efficacy|0|||
16392656|NCT01791517|39919694|FG003|Phase II|Lack of Efficacy|0|||
16392657|NCT01791517|39919695|FG004|Phase II|Lack of Efficacy|1|||
16392658|NCT01791517|39919696|FG005|Phase II|Lack of Efficacy|0|||
16392659|NCT01791517|39919697|FG006|Phase II|Lack of Efficacy|0|||
16392660|NCT01791517|39919698|FG007|Phase II|Lack of Efficacy|0|||
16392661|NCT01791517|39919699|FG008|Phase II|Lack of Efficacy|0|||
16392662|NCT01791517|39919700|FG009|Phase II|Lack of Efficacy|0|||
16392663|NCT01791517|39919701|FG010|Phase II|Lack of Efficacy|0|||
16392664|NCT01791517|39919702|FG011|Phase II|Lack of Efficacy|0|||
16392665|NCT01791517|39919691|FG000|Phase II|Adverse Event|0|||
16392666|NCT01791517|39919692|FG001|Phase II|Adverse Event|0|||
16392667|NCT01791517|39919693|FG002|Phase II|Adverse Event|0|||
16392668|NCT01791517|39919694|FG003|Phase II|Adverse Event|0|||
16392669|NCT01791517|39919695|FG004|Phase II|Adverse Event|0|||
16392670|NCT01791517|39919696|FG005|Phase II|Adverse Event|0|||
16392671|NCT01791517|39919697|FG006|Phase II|Adverse Event|2|||
16392672|NCT01791517|39919698|FG007|Phase II|Adverse Event|1|||
16392673|NCT01791517|39919699|FG008|Phase II|Adverse Event|0|||
16392674|NCT01791517|39919700|FG009|Phase II|Adverse Event|1|||
16392675|NCT01791517|39919701|FG010|Phase II|Adverse Event|0|||
16392676|NCT01791517|39919702|FG011|Phase II|Adverse Event|0|||
16392677|NCT01791517|39919691|FG000|Phase II|Lens Handling Difficulties|0|||
16392678|NCT01791517|39919692|FG001|Phase II|Lens Handling Difficulties|0|||
16392679|NCT01791517|39919693|FG002|Phase II|Lens Handling Difficulties|0|||
16392680|NCT01791517|39919694|FG003|Phase II|Lens Handling Difficulties|0|||
16392681|NCT01791517|39919695|FG004|Phase II|Lens Handling Difficulties|0|||
16392682|NCT01791517|39919696|FG005|Phase II|Lens Handling Difficulties|0|||
16392683|NCT01791517|39919697|FG006|Phase II|Lens Handling Difficulties|0|||
16392684|NCT01791517|39919698|FG007|Phase II|Lens Handling Difficulties|0|||
16392685|NCT01791517|39919699|FG008|Phase II|Lens Handling Difficulties|1|||
16392686|NCT01791517|39919700|FG009|Phase II|Lens Handling Difficulties|0|||
16392687|NCT01791517|39919701|FG010|Phase II|Lens Handling Difficulties|0|||
16392688|NCT01791517|39919702|FG011|Phase II|Lens Handling Difficulties|0|||
16392689|NCT01791517|39919691|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
16392690|NCT01791517|39919692|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
16392691|NCT01791517|39919693|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
16392692|NCT01791517|39919694|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
16392693|NCT01791517|39919695|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
16392694|NCT01791517|39919696|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
16392695|NCT01791517|39919697|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
16199259|NCT03730194|39204593|FG002|First Stage Treatment|Withdrawal by Subject|0|||
16392696|NCT01791517|39919698|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
16392697|NCT01791517|39919699|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
16392698|NCT01791517|39919700|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
16392699|NCT01791517|39919701|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
16392700|NCT01791517|39919702|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
16392701|NCT01791517|39919691|FG000|Phase II|Pre-Existing Ocular Issue|0|||
16392702|NCT01791517|39919692|FG001|Phase II|Pre-Existing Ocular Issue|0|||
16510670|NCT02658890|40343881|FG025|Treatment Phase|Study Drug Toxicity|2|||
16392703|NCT01791517|39919693|FG002|Phase II|Pre-Existing Ocular Issue|0|||
16392704|NCT01791517|39919694|FG003|Phase II|Pre-Existing Ocular Issue|0|||
16392705|NCT01791517|39919695|FG004|Phase II|Pre-Existing Ocular Issue|0|||
16392706|NCT01791517|39919696|FG005|Phase II|Pre-Existing Ocular Issue|0|||
16392707|NCT01791517|39919697|FG006|Phase II|Pre-Existing Ocular Issue|0|||
16510671|NCT02658890|40343882|FG026|Treatment Phase|Study Drug Toxicity|0|||
16392708|NCT01791517|39919698|FG007|Phase II|Pre-Existing Ocular Issue|0|||
16392709|NCT01791517|39919699|FG008|Phase II|Pre-Existing Ocular Issue|0|||
16392710|NCT01791517|39919700|FG009|Phase II|Pre-Existing Ocular Issue|0|||
16392711|NCT01791517|39919701|FG010|Phase II|Pre-Existing Ocular Issue|0|||
16392712|NCT01791517|39919702|FG011|Phase II|Pre-Existing Ocular Issue|1|||
16392713|NCT00244725|39919703|FG000|Overall Study|Lost to Follow-up|3|||
16392714|NCT00244725|39919704|FG001|Overall Study|Lost to Follow-up|4|||
16392715|NCT00244725|39919705|FG002|Overall Study|Lost to Follow-up|9|||
16392716|NCT00244725|39919706|FG003|Overall Study|Lost to Follow-up|2|||
16392717|NCT00244725|39919703|FG000|Overall Study|Withdrawal by Subject|9|||
16392718|NCT00244725|39919704|FG001|Overall Study|Withdrawal by Subject|7|||
16392719|NCT00244725|39919705|FG002|Overall Study|Withdrawal by Subject|7|||
16392720|NCT00244725|39919706|FG003|Overall Study|Withdrawal by Subject|8|||
16392721|NCT00244725|39919703|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
16392722|NCT00244725|39919704|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
16392723|NCT00244725|39919705|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
16392724|NCT00244725|39919706|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
16392725|NCT00244725|39919703|FG000|Overall Study|Physician Decision|3|||
16392726|NCT00244725|39919704|FG001|Overall Study|Physician Decision|0|||
16392727|NCT00244725|39919705|FG002|Overall Study|Physician Decision|1|||
16392728|NCT00244725|39919706|FG003|Overall Study|Physician Decision|2|||
16392729|NCT00244725|39919703|FG000|Overall Study|Adverse Events|3|||
16392730|NCT00244725|39919704|FG001|Overall Study|Adverse Events|1|||
16392731|NCT00244725|39919705|FG002|Overall Study|Adverse Events|4|||
16392732|NCT00244725|39919706|FG003|Overall Study|Adverse Events|4|||
16392733|NCT00244725|39919703|FG000|Overall Study|Withdrwal by participant|1|||
16392734|NCT00244725|39919704|FG001|Overall Study|Withdrwal by participant|0|||
16392735|NCT00244725|39919705|FG002|Overall Study|Withdrwal by participant|0|||
16392736|NCT00244725|39919706|FG003|Overall Study|Withdrwal by participant|1|||
16392737|NCT00244725|39919703|FG000|Overall Study|Liver function test abnormality|2|||
16392738|NCT00244725|39919704|FG001|Overall Study|Liver function test abnormality|0|||
16392739|NCT00244725|39919705|FG002|Overall Study|Liver function test abnormality|0|||
16392740|NCT00244725|39919706|FG003|Overall Study|Liver function test abnormality|1|||
16392741|NCT00244725|39919703|FG000|Overall Study|Sponsor withdrew the participant|1|||
16392742|NCT00244725|39919704|FG001|Overall Study|Sponsor withdrew the participant|0|||
16392743|NCT00244725|39919705|FG002|Overall Study|Sponsor withdrew the participant|0|||
16392744|NCT00244725|39919706|FG003|Overall Study|Sponsor withdrew the participant|1|||
16392745|NCT00244725|39919703|FG000|Overall Study|Mediciation Error|0|||
16392746|NCT00244725|39919704|FG001|Overall Study|Mediciation Error|1|||
16392747|NCT00244725|39919705|FG002|Overall Study|Mediciation Error|0|||
16392748|NCT00244725|39919706|FG003|Overall Study|Mediciation Error|0|||
16392749|NCT00244725|39919703|FG000|Overall Study|Rehab Refused to allow participantion|0|||
16392750|NCT00244725|39919704|FG001|Overall Study|Rehab Refused to allow participantion|1|||
16392751|NCT00244725|39919705|FG002|Overall Study|Rehab Refused to allow participantion|0|||
16392752|NCT00244725|39919706|FG003|Overall Study|Rehab Refused to allow participantion|0|||
16392753|NCT00244725|39919703|FG000|Overall Study|Headache|0|||
16392754|NCT00244725|39919704|FG001|Overall Study|Headache|1|||
16392755|NCT00244725|39919705|FG002|Overall Study|Headache|0|||
16392756|NCT00244725|39919706|FG003|Overall Study|Headache|0|||
16392757|NCT00244725|39919703|FG000|Overall Study|Received prohibited medication|0|||
16392758|NCT00244725|39919704|FG001|Overall Study|Received prohibited medication|1|||
16392759|NCT00244725|39919705|FG002|Overall Study|Received prohibited medication|0|||
16392760|NCT00244725|39919706|FG003|Overall Study|Received prohibited medication|1|||
16392761|NCT00244725|39919703|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
16392762|NCT00244725|39919704|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
16392763|NCT00244725|39919705|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
16392764|NCT00244725|39919706|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
16392765|NCT00244725|39919703|FG000|Overall Study|Administrative reason|0|||
16392766|NCT00244725|39919704|FG001|Overall Study|Administrative reason|0|||
16392767|NCT00244725|39919705|FG002|Overall Study|Administrative reason|1|||
16392768|NCT00244725|39919706|FG003|Overall Study|Administrative reason|0|||
16392769|NCT00244725|39919703|FG000|Overall Study|Vomit|0|||
16392770|NCT00244725|39919704|FG001|Overall Study|Vomit|0|||
16392771|NCT00244725|39919705|FG002|Overall Study|Vomit|1|||
16392772|NCT00244725|39919706|FG003|Overall Study|Vomit|0|||
16392773|NCT00244725|39919703|FG000|Overall Study|Failed to follow-up|0|||
16392774|NCT00244725|39919704|FG001|Overall Study|Failed to follow-up|0|||
16392775|NCT00244725|39919705|FG002|Overall Study|Failed to follow-up|1|||
16392776|NCT00244725|39919706|FG003|Overall Study|Failed to follow-up|1|||
16392777|NCT00682929|39919711|FG000|Overall Study|Adverse Event|4|||
16392778|NCT00682929|39919712|FG001|Overall Study|Adverse Event|1|||
16392779|NCT00682929|39919713|FG002|Overall Study|Adverse Event|1|||
16392780|NCT00682929|39919711|FG000|Overall Study|Withdrawal by Subject|1|||
16392781|NCT00682929|39919712|FG001|Overall Study|Withdrawal by Subject|2|||
16316377|NCT02099110|39640897|FG002|Overall Study|Physician Decision|1|||
16392782|NCT00682929|39919713|FG002|Overall Study|Withdrawal by Subject|1|||
16392783|NCT00682929|39919711|FG000|Overall Study|dosing compliance < 80%|0|||
16392784|NCT00682929|39919712|FG001|Overall Study|dosing compliance < 80%|2|||
16510672|NCT02658890|40343856|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510673|NCT02658890|40343857|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510674|NCT02658890|40343858|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510675|NCT02658890|40343859|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
16510676|NCT02658890|40343860|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510677|NCT02658890|40343861|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510678|NCT02658890|40343862|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510679|NCT02658890|40343863|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510680|NCT02658890|40343864|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510681|NCT02658890|40343865|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
16510682|NCT02658890|40343866|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16392785|NCT00682929|39919713|FG002|Overall Study|dosing compliance < 80%|0|||
16392786|NCT00682929|39919711|FG000|Overall Study|lag in DEA renewal|1|||
16392787|NCT00682929|39919712|FG001|Overall Study|lag in DEA renewal|0|||
16392788|NCT00682929|39919713|FG002|Overall Study|lag in DEA renewal|0|||
16392789|NCT00401843|39919714|FG000|Overall Study|Achieved Complete Response|1|||
16392790|NCT00401843|39919715|FG001|Overall Study|Achieved Complete Response|5|||
16392791|NCT00401843|39919716|FG002|Overall Study|Achieved Complete Response|11|||
16392792|NCT00401843|39919714|FG000|Overall Study|Adverse Event|7|||
16392793|NCT00401843|39919715|FG001|Overall Study|Adverse Event|26|||
16392794|NCT00401843|39919716|FG002|Overall Study|Adverse Event|27|||
16392795|NCT00401843|39919714|FG000|Overall Study|Death|0|||
16392796|NCT00401843|39919715|FG001|Overall Study|Death|8|||
16392797|NCT00401843|39919716|FG002|Overall Study|Death|10|||
16392798|NCT00401843|39919714|FG000|Overall Study|Disease progression|10|||
16392799|NCT00401843|39919715|FG001|Overall Study|Disease progression|60|||
16392800|NCT00401843|39919716|FG002|Overall Study|Disease progression|49|||
16392801|NCT00401843|39919714|FG000|Overall Study|End of Study|1|||
16392802|NCT00401843|39919715|FG001|Overall Study|End of Study|1|||
16392803|NCT00401843|39919716|FG002|Overall Study|End of Study|2|||
16392804|NCT00401843|39919714|FG000|Overall Study|Lost to Follow-up|0|||
16392805|NCT00401843|39919715|FG001|Overall Study|Lost to Follow-up|0|||
16392806|NCT00401843|39919716|FG002|Overall Study|Lost to Follow-up|2|||
16392807|NCT00401843|39919714|FG000|Overall Study|Other Unspecified|0|||
16392808|NCT00401843|39919715|FG001|Overall Study|Other Unspecified|3|||
16392809|NCT00401843|39919716|FG002|Overall Study|Other Unspecified|5|||
16392810|NCT00401843|39919714|FG000|Overall Study|Physician Decision|0|||
16392811|NCT00401843|39919715|FG001|Overall Study|Physician Decision|16|||
16392812|NCT00401843|39919716|FG002|Overall Study|Physician Decision|10|||
16392813|NCT00401843|39919714|FG000|Overall Study|Protocol Violation|0|||
16392814|NCT00401843|39919715|FG001|Overall Study|Protocol Violation|0|||
16392815|NCT00401843|39919716|FG002|Overall Study|Protocol Violation|1|||
16392816|NCT00401843|39919714|FG000|Overall Study|Withdrawal by Subject|1|||
16392817|NCT00401843|39919715|FG001|Overall Study|Withdrawal by Subject|5|||
16392818|NCT00401843|39919716|FG002|Overall Study|Withdrawal by Subject|5|||
16392819|NCT00401843|39919714|FG000|Overall Study|Withdrawal of consent to study agent|1|||
16392820|NCT00401843|39919715|FG001|Overall Study|Withdrawal of consent to study agent|15|||
16392821|NCT00401843|39919716|FG002|Overall Study|Withdrawal of consent to study agent|17|||
16392822|NCT00401843|39919714|FG000|Overall Study|Randomized but not Treated|0|||
16392823|NCT00401843|39919715|FG001|Overall Study|Randomized but not Treated|2|||
16392824|NCT00401843|39919716|FG002|Overall Study|Randomized but not Treated|3|||
16392825|NCT00401843|39919714|FG000|Overall Study|Received incorrect treatment|0|||
16392826|NCT00401843|39919715|FG001|Overall Study|Received incorrect treatment|3|||
16392827|NCT00401843|39919716|FG002|Overall Study|Received incorrect treatment|0|||
16392828|NCT01279044|39919717|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
16392829|NCT01279044|39919718|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
16392830|NCT01279044|39919719|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
16510683|NCT02658890|40343867|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510684|NCT02658890|40343868|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510685|NCT02658890|40343869|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16392831|NCT01279044|39919717|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
16392832|NCT01279044|39919718|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
16392833|NCT01279044|39919719|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
16392834|NCT01279044|39919717|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
16392835|NCT01279044|39919718|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
16392836|NCT01279044|39919719|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
16392837|NCT01444430|39919726|FG000|Overall Study|Withdrawal by Subject|53|||
16392838|NCT01444430|39919727|FG001|Overall Study|Withdrawal by Subject|72|||
16510686|NCT02658890|40343870|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510687|NCT02658890|40343871|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510688|NCT02658890|40343872|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510689|NCT02658890|40343873|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510690|NCT02658890|40343874|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
16510691|NCT02658890|40343875|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510692|NCT02658890|40343876|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510693|NCT02658890|40343877|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510694|NCT02658890|40343878|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
16510695|NCT02658890|40343879|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510696|NCT02658890|40343880|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510697|NCT02658890|40343881|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510698|NCT02658890|40343882|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
16510699|NCT02658890|40343856|FG000|Treatment Phase|Withdrawal by Subject|0|||
16510700|NCT02658890|40343857|FG001|Treatment Phase|Withdrawal by Subject|1|||
16510701|NCT02658890|40343858|FG002|Treatment Phase|Withdrawal by Subject|0|||
16510702|NCT02658890|40343859|FG003|Treatment Phase|Withdrawal by Subject|0|||
16510703|NCT02658890|40343860|FG004|Treatment Phase|Withdrawal by Subject|0|||
16510704|NCT02658890|40343861|FG005|Treatment Phase|Withdrawal by Subject|0|||
16510705|NCT02658890|40343862|FG006|Treatment Phase|Withdrawal by Subject|1|||
16510706|NCT02658890|40343863|FG007|Treatment Phase|Withdrawal by Subject|0|||
16510707|NCT02658890|40343864|FG008|Treatment Phase|Withdrawal by Subject|0|||
16510708|NCT02658890|40343865|FG009|Treatment Phase|Withdrawal by Subject|1|||
16510709|NCT02658890|40343866|FG010|Treatment Phase|Withdrawal by Subject|0|||
16510710|NCT02658890|40343867|FG011|Treatment Phase|Withdrawal by Subject|0|||
16510711|NCT02658890|40343868|FG012|Treatment Phase|Withdrawal by Subject|1|||
16510712|NCT02658890|40343869|FG013|Treatment Phase|Withdrawal by Subject|3|||
16510713|NCT02658890|40343870|FG014|Treatment Phase|Withdrawal by Subject|0|||
16510714|NCT02658890|40343871|FG015|Treatment Phase|Withdrawal by Subject|0|||
16510715|NCT02658890|40343872|FG016|Treatment Phase|Withdrawal by Subject|1|||
16510716|NCT02658890|40343873|FG017|Treatment Phase|Withdrawal by Subject|0|||
16510717|NCT02658890|40343874|FG018|Treatment Phase|Withdrawal by Subject|4|||
16510718|NCT02658890|40343875|FG019|Treatment Phase|Withdrawal by Subject|3|||
16510719|NCT02658890|40343876|FG020|Treatment Phase|Withdrawal by Subject|0|||
16510720|NCT02658890|40343877|FG021|Treatment Phase|Withdrawal by Subject|4|||
16510721|NCT02658890|40343878|FG022|Treatment Phase|Withdrawal by Subject|1|||
16510722|NCT02658890|40343879|FG023|Treatment Phase|Withdrawal by Subject|1|||
16510723|NCT02658890|40343880|FG024|Treatment Phase|Withdrawal by Subject|0|||
16510724|NCT02658890|40343881|FG025|Treatment Phase|Withdrawal by Subject|0|||
16510725|NCT02658890|40343882|FG026|Treatment Phase|Withdrawal by Subject|0|||
16510726|NCT01921829|40343886|FG000|Overall Study|Withdrawal by Subject|0|||
16510727|NCT01921829|40343887|FG001|Overall Study|Withdrawal by Subject|1|||
16510728|NCT00244712|40343890|FG000|Overall Study|Adverse Event|20|||
16510729|NCT00244712|40343891|FG001|Overall Study|Adverse Event|21|||
16510730|NCT00244712|40343890|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
16510731|NCT00244712|40343891|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
16510732|NCT00244712|40343890|FG000|Overall Study|Lack of Compliance|10|||
16510733|NCT00244712|40343891|FG001|Overall Study|Lack of Compliance|11|||
16510734|NCT00244712|40343890|FG000|Overall Study|Lost to Follow-up|45|||
16510735|NCT00244712|40343891|FG001|Overall Study|Lost to Follow-up|52|||
16510736|NCT00244712|40343890|FG000|Overall Study|Withdrawal by Subject|13|||
16510737|NCT00244712|40343891|FG001|Overall Study|Withdrawal by Subject|23|||
16510738|NCT00244712|40343890|FG000|Overall Study|Protocol Violation, disease progression|13|||
16510739|NCT00244712|40343891|FG001|Overall Study|Protocol Violation, disease progression|11|||
16510740|NCT01649375|40343892|FG000|Up to Week 16|Adverse Event|2|||
16510741|NCT01649375|40343893|FG001|Up to Week 16|Adverse Event|5|||
16510742|NCT01649375|40343894|FG002|Up to Week 16|Adverse Event|4|||
16510743|NCT01649375|40343895|FG003|Up to Week 16|Adverse Event|0|||
16510744|NCT01649375|40343896|FG004|Up to Week 16|Adverse Event|0|||
16510745|NCT01649375|40343892|FG000|Up to Week 16|Lack of Efficacy|0|||
16510746|NCT01649375|40343893|FG001|Up to Week 16|Lack of Efficacy|0|||
16510747|NCT01649375|40343894|FG002|Up to Week 16|Lack of Efficacy|1|||
16510748|NCT01649375|40343895|FG003|Up to Week 16|Lack of Efficacy|0|||
16510749|NCT01649375|40343896|FG004|Up to Week 16|Lack of Efficacy|0|||
16510750|NCT01649375|40343892|FG000|Up to Week 16|Physician Decision|0|||
16510751|NCT01649375|40343893|FG001|Up to Week 16|Physician Decision|0|||
16510752|NCT01649375|40343894|FG002|Up to Week 16|Physician Decision|1|||
16510753|NCT01649375|40343895|FG003|Up to Week 16|Physician Decision|0|||
16510754|NCT01649375|40343896|FG004|Up to Week 16|Physician Decision|0|||
16510755|NCT01649375|40343892|FG000|Up to Week 16|Withdrawal by Subject|2|||
16510756|NCT01649375|40343893|FG001|Up to Week 16|Withdrawal by Subject|1|||
16510757|NCT01649375|40343894|FG002|Up to Week 16|Withdrawal by Subject|2|||
16510758|NCT01649375|40343895|FG003|Up to Week 16|Withdrawal by Subject|0|||
16510759|NCT01649375|40343896|FG004|Up to Week 16|Withdrawal by Subject|0|||
16510760|NCT01649375|40343892|FG000|Up to Week 16|Death|1|||
16510761|NCT01649375|40343893|FG001|Up to Week 16|Death|0|||
16510762|NCT01649375|40343894|FG002|Up to Week 16|Death|0|||
16510763|NCT01649375|40343895|FG003|Up to Week 16|Death|0|||
16510764|NCT01649375|40343896|FG004|Up to Week 16|Death|0|||
16510765|NCT01649375|40343892|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
16510766|NCT01649375|40343893|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
16510767|NCT01649375|40343894|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
16510768|NCT01649375|40343895|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
16510769|NCT01649375|40343896|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
16510770|NCT01649375|40343892|FG000|Week 16 up to Week 260|Non-compliance|0|||
16510771|NCT01649375|40343893|FG001|Week 16 up to Week 260|Non-compliance|1|||
16510772|NCT01649375|40343894|FG002|Week 16 up to Week 260|Non-compliance|0|||
16510773|NCT01649375|40343895|FG003|Week 16 up to Week 260|Non-compliance|1|||
16510774|NCT01649375|40343896|FG004|Week 16 up to Week 260|Non-compliance|0|||
16510775|NCT01649375|40343892|FG000|Week 16 up to Week 260|Physician Decision|0|||
16510776|NCT01649375|40343893|FG001|Week 16 up to Week 260|Physician Decision|2|||
16510777|NCT01649375|40343894|FG002|Week 16 up to Week 260|Physician Decision|0|||
16510778|NCT01649375|40343895|FG003|Week 16 up to Week 260|Physician Decision|0|||
16510779|NCT01649375|40343896|FG004|Week 16 up to Week 260|Physician Decision|0|||
16510780|NCT01649375|40343892|FG000|Week 16 up to Week 260|Technical issues|0|||
16510781|NCT01649375|40343893|FG001|Week 16 up to Week 260|Technical issues|1|||
16510782|NCT01649375|40343894|FG002|Week 16 up to Week 260|Technical issues|0|||
16510783|NCT01649375|40343895|FG003|Week 16 up to Week 260|Technical issues|1|||
16510784|NCT01649375|40343896|FG004|Week 16 up to Week 260|Technical issues|0|||
16510785|NCT01649375|40343892|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
16510786|NCT01649375|40343893|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
16510787|NCT01649375|40343894|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
16510788|NCT01649375|40343895|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
16392839|NCT01444430|39919726|FG000|Overall Study|Death|6|||
16510789|NCT01649375|40343896|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
16510790|NCT01649375|40343892|FG000|Week 16 up to Week 260|Death|1|||
16510791|NCT01649375|40343893|FG001|Week 16 up to Week 260|Death|1|||
16510792|NCT01649375|40343894|FG002|Week 16 up to Week 260|Death|0|||
16510793|NCT01649375|40343895|FG003|Week 16 up to Week 260|Death|0|||
16510794|NCT01649375|40343896|FG004|Week 16 up to Week 260|Death|0|||
16510795|NCT01649375|40343892|FG000|Week 16 up to Week 260|Adverse Event|5|||
16510796|NCT01649375|40343893|FG001|Week 16 up to Week 260|Adverse Event|2|||
16510797|NCT01649375|40343894|FG002|Week 16 up to Week 260|Adverse Event|0|||
16510798|NCT01649375|40343895|FG003|Week 16 up to Week 260|Adverse Event|3|||
16510799|NCT01649375|40343896|FG004|Week 16 up to Week 260|Adverse Event|2|||
16510800|NCT01604343|40343899|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
16510801|NCT01604343|40343900|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
16316378|NCT02099110|39640898|FG003|Overall Study|Physician Decision|2|||
16316379|NCT02099110|39640899|FG004|Overall Study|Physician Decision|1|||
16316380|NCT00449865|39640904|FG000|Overall Study|Withdrawal by Subject|110|||
16316381|NCT00449865|39640905|FG001|Overall Study|Withdrawal by Subject|110|||
16316382|NCT00449865|39640904|FG000|Overall Study|Lost to Follow-up|36|||
16316383|NCT00449865|39640905|FG001|Overall Study|Lost to Follow-up|37|||
16316384|NCT00449865|39640904|FG000|Overall Study|Physician Decision|13|||
16316385|NCT00449865|39640905|FG001|Overall Study|Physician Decision|12|||
16316386|NCT00449865|39640904|FG000|Overall Study|Death|31|||
16316387|NCT00449865|39640905|FG001|Overall Study|Death|40|||
16316388|NCT00449865|39640904|FG000|Overall Study|Protocol Violation|8|||
16316389|NCT00449865|39640905|FG001|Overall Study|Protocol Violation|7|||
16316390|NCT00449865|39640904|FG000|Overall Study|Study was stopped|324|||
16316391|NCT00449865|39640905|FG001|Overall Study|Study was stopped|328|||
16316392|NCT01254643|39640906|FG000|Overall Study|Withdrawal by Subject|1|||
16316393|NCT05244122|39640908|FG000|Overall Study|Withdrawal by Subject|318|||
16316394|NCT03743051|39640909|FG000|Overall Study|Adverse Event|5|||
16316395|NCT03743051|39640910|FG001|Overall Study|Adverse Event|9|||
16316396|NCT03743051|39640909|FG000|Overall Study|Death|27|||
16316397|NCT03743051|39640910|FG001|Overall Study|Death|26|||
16316398|NCT03743051|39640909|FG000|Overall Study|Lost to Follow-up|4|||
16316399|NCT03743051|39640910|FG001|Overall Study|Lost to Follow-up|8|||
16392840|NCT01444430|39919727|FG001|Overall Study|Death|8|||
16392841|NCT01444430|39919726|FG000|Overall Study|Lost to Follow-up|2|||
16392842|NCT01444430|39919727|FG001|Overall Study|Lost to Follow-up|0|||
16510802|NCT01604343|40343901|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
16392843|NCT01444430|39919726|FG000|Overall Study|CRF termination module not completed.|0|||
16510803|NCT01604343|40343902|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
16510804|NCT01604343|40343903|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
16316400|NCT03743051|39640909|FG000|Overall Study|Withdrawal by Subject|32|||
16316401|NCT03743051|39640910|FG001|Overall Study|Withdrawal by Subject|19|||
16316402|NCT03743051|39640909|FG000|Overall Study|Physician Decision|10|||
16510805|NCT01604343|40343899|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
16510806|NCT01604343|40343900|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
16510807|NCT01604343|40343901|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
16510808|NCT01604343|40343902|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
16510809|NCT01604343|40343903|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
16510810|NCT01604343|40343899|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
16510811|NCT01604343|40343900|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
16510812|NCT01604343|40343901|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
16510813|NCT01604343|40343902|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
16510814|NCT01604343|40343903|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
16510815|NCT01604343|40343899|FG000|Prior to W52 Administration(Through W52)|Death|5|||
16510816|NCT01604343|40343900|FG001|Prior to W52 Administration(Through W52)|Death|0|||
16510817|NCT01604343|40343901|FG002|Prior to W52 Administration(Through W52)|Death|2|||
16510818|NCT01604343|40343902|FG003|Prior to W52 Administration(Through W52)|Death|0|||
16510819|NCT01604343|40343903|FG004|Prior to W52 Administration(Through W52)|Death|4|||
16510820|NCT01604343|40343899|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
16510821|NCT01604343|40343900|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
16510822|NCT01604343|40343901|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
16510823|NCT01604343|40343902|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
16510824|NCT01604343|40343903|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
16510825|NCT01604343|40343899|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
16510826|NCT01604343|40343900|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
16510827|NCT01604343|40343901|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
16510828|NCT01604343|40343902|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
16510829|NCT01604343|40343903|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
16510830|NCT01604343|40343899|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
16510831|NCT01604343|40343900|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
16510832|NCT01604343|40343901|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
16510833|NCT01604343|40343902|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
16510834|NCT01604343|40343903|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
16510835|NCT01604343|40343899|FG000|Prior to W52 Administration(Through W52)|Other|15|||
16510836|NCT01604343|40343900|FG001|Prior to W52 Administration(Through W52)|Other|0|||
16510837|NCT01604343|40343901|FG002|Prior to W52 Administration(Through W52)|Other|10|||
16510838|NCT01604343|40343902|FG003|Prior to W52 Administration(Through W52)|Other|0|||
16510839|NCT01604343|40343903|FG004|Prior to W52 Administration(Through W52)|Other|6|||
16510840|NCT01604343|40343899|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
16510841|NCT01604343|40343900|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
16510842|NCT01604343|40343901|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
16510843|NCT01604343|40343902|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
16510844|NCT01604343|40343903|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
16510845|NCT01604343|40343899|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
16510846|NCT01604343|40343900|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
16510847|NCT01604343|40343901|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
16510848|NCT01604343|40343902|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
16510849|NCT01604343|40343903|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
16510850|NCT01604343|40343899|FG000|Week 52 to Week 104|Adverse Event|0|||
16199260|NCT03730194|39204594|FG003|First Stage Treatment|Withdrawal by Subject|0|||
16199261|NCT03730194|39204595|FG004|First Stage Treatment|Withdrawal by Subject|0|||
16199262|NCT03730194|39204596|FG005|First Stage Treatment|Withdrawal by Subject|0|||
16510851|NCT01604343|40343900|FG001|Week 52 to Week 104|Adverse Event|12|||
16510852|NCT01604343|40343901|FG002|Week 52 to Week 104|Adverse Event|26|||
16510853|NCT01604343|40343902|FG003|Week 52 to Week 104|Adverse Event|21|||
16510854|NCT01604343|40343903|FG004|Week 52 to Week 104|Adverse Event|27|||
16510855|NCT01604343|40343899|FG000|Week 52 to Week 104|Death|0|||
16510856|NCT01604343|40343900|FG001|Week 52 to Week 104|Death|4|||
16510857|NCT01604343|40343901|FG002|Week 52 to Week 104|Death|2|||
16510858|NCT01604343|40343902|FG003|Week 52 to Week 104|Death|5|||
16510859|NCT01604343|40343903|FG004|Week 52 to Week 104|Death|0|||
16510860|NCT01604343|40343899|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
16510861|NCT01604343|40343900|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
16510862|NCT01604343|40343901|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
16510863|NCT01604343|40343902|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
16510864|NCT01604343|40343903|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
16510865|NCT01604343|40343899|FG000|Week 52 to Week 104|Physician Decision|0|||
16510866|NCT01604343|40343900|FG001|Week 52 to Week 104|Physician Decision|1|||
16510867|NCT01604343|40343901|FG002|Week 52 to Week 104|Physician Decision|0|||
16510868|NCT01604343|40343902|FG003|Week 52 to Week 104|Physician Decision|0|||
16510869|NCT01604343|40343903|FG004|Week 52 to Week 104|Physician Decision|2|||
16510870|NCT01604343|40343899|FG000|Week 52 to Week 104|Pregnancy|0|||
16510871|NCT01604343|40343900|FG001|Week 52 to Week 104|Pregnancy|0|||
16510872|NCT01604343|40343901|FG002|Week 52 to Week 104|Pregnancy|1|||
16510873|NCT01604343|40343902|FG003|Week 52 to Week 104|Pregnancy|2|||
16510874|NCT01604343|40343903|FG004|Week 52 to Week 104|Pregnancy|1|||
16510875|NCT01604343|40343899|FG000|Week 52 to Week 104|Other|0|||
16510876|NCT01604343|40343900|FG001|Week 52 to Week 104|Other|11|||
16510877|NCT01604343|40343901|FG002|Week 52 to Week 104|Other|11|||
16510878|NCT01604343|40343902|FG003|Week 52 to Week 104|Other|6|||
16510879|NCT01604343|40343903|FG004|Week 52 to Week 104|Other|3|||
16510880|NCT01604343|40343899|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
16510881|NCT01604343|40343900|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
16510882|NCT01604343|40343901|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
16510883|NCT01604343|40343902|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
16510884|NCT01604343|40343903|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
16510885|NCT01604343|40343899|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
16510886|NCT01604343|40343900|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
16510887|NCT01604343|40343901|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
16510888|NCT01604343|40343902|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
16510889|NCT01604343|40343903|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
16510890|NCT01604343|40343899|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
16510891|NCT01604343|40343900|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
16510892|NCT01604343|40343901|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
16510893|NCT01604343|40343902|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
16510894|NCT01604343|40343903|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
16510895|NCT03026257|40343905|FG000|Overall Study|Adverse Event|3|||
16510896|NCT03026257|40343906|FG001|Overall Study|Adverse Event|0|||
16510897|NCT03026257|40343907|FG002|Overall Study|Adverse Event|0|||
16510898|NCT03026257|40343908|FG003|Overall Study|Adverse Event|0|||
16510899|NCT03026257|40343909|FG004|Overall Study|Adverse Event|0|||
16510900|NCT03026257|40343910|FG005|Overall Study|Adverse Event|0|||
16510901|NCT03026257|40343905|FG000|Overall Study|Lost to Follow-up|1|||
16510902|NCT03026257|40343906|FG001|Overall Study|Lost to Follow-up|0|||
16510903|NCT03026257|40343907|FG002|Overall Study|Lost to Follow-up|0|||
16510904|NCT03026257|40343908|FG003|Overall Study|Lost to Follow-up|0|||
16510905|NCT03026257|40343909|FG004|Overall Study|Lost to Follow-up|0|||
16510906|NCT03026257|40343910|FG005|Overall Study|Lost to Follow-up|0|||
16510907|NCT03026257|40343905|FG000|Overall Study|Protocol Violation|1|||
16510908|NCT03026257|40343906|FG001|Overall Study|Protocol Violation|0|||
16510909|NCT03026257|40343907|FG002|Overall Study|Protocol Violation|0|||
16510910|NCT03026257|40343908|FG003|Overall Study|Protocol Violation|1|||
16510911|NCT03026257|40343909|FG004|Overall Study|Protocol Violation|1|||
16510912|NCT03026257|40343910|FG005|Overall Study|Protocol Violation|0|||
16510913|NCT03026257|40343905|FG000|Overall Study|Withdrawal by Subject|1|||
16510914|NCT03026257|40343906|FG001|Overall Study|Withdrawal by Subject|1|||
16510915|NCT03026257|40343907|FG002|Overall Study|Withdrawal by Subject|0|||
16510916|NCT03026257|40343908|FG003|Overall Study|Withdrawal by Subject|0|||
16510917|NCT03026257|40343909|FG004|Overall Study|Withdrawal by Subject|0|||
16510918|NCT03026257|40343910|FG005|Overall Study|Withdrawal by Subject|0|||
16510919|NCT00850395|40343918|FG000|Overall Study|Death|1|||
16510920|NCT00850395|40343918|FG000|Overall Study|Adverse Event|1|||
16199263|NCT03730194|39204591|FG000|First Stage Treatment|Protocol Violation|3|||
16199264|NCT03730194|39204592|FG001|First Stage Treatment|Protocol Violation|3|||
16199265|NCT03730194|39204593|FG002|First Stage Treatment|Protocol Violation|0|||
16199266|NCT03730194|39204594|FG003|First Stage Treatment|Protocol Violation|0|||
16199267|NCT03730194|39204595|FG004|First Stage Treatment|Protocol Violation|0|||
16199268|NCT03730194|39204596|FG005|First Stage Treatment|Protocol Violation|0|||
16199269|NCT04577183|39204597|FG000|Overall Study|Death|1|||
16199270|NCT04577183|39204597|FG000|Overall Study|Withdrawal by Subject|3|||
16199271|NCT04577183|39204597|FG000|Overall Study|Early termination|2|||
16199272|NCT01653158|39204598|FG000|Overall Study|Death|0|||
16199273|NCT01653158|39204599|FG001|Overall Study|Death|0|||
16199274|NCT01653158|39204600|FG002|Overall Study|Death|0|||
16199275|NCT01653158|39204601|FG003|Overall Study|Death|1|||
16199276|NCT01653158|39204602|FG004|Overall Study|Death|0|||
16199277|NCT01653158|39204603|FG005|Overall Study|Death|0|||
16199278|NCT01653158|39204604|FG006|Overall Study|Death|0|||
16199279|NCT01653158|39204605|FG007|Overall Study|Death|2|||
16199280|NCT01653158|39204598|FG000|Overall Study|Adverse Event|0|||
16316403|NCT03743051|39640910|FG001|Overall Study|Physician Decision|15|||
16392844|NCT01444430|39919727|FG001|Overall Study|CRF termination module not completed.|1|||
16510921|NCT00850395|40343918|FG000|Overall Study|Insufficient clinical response|3|||
16510922|NCT00850395|40343918|FG000|Overall Study|Other|5|||
16510923|NCT00590954|40343919|FG000|Overall Study|Inevaluable|2|||
16510924|NCT02027844|40343922|FG000|Overall Study|Withdrawal by Subject|3|||
16510925|NCT02027844|40343923|FG001|Overall Study|Withdrawal by Subject|2|||
16510926|NCT02027844|40343924|FG002|Overall Study|Withdrawal by Subject|1|||
16510927|NCT02027844|40343922|FG000|Overall Study|Lost to Follow-up|0|||
16199281|NCT01653158|39204599|FG001|Overall Study|Adverse Event|0|||
16199282|NCT01653158|39204600|FG002|Overall Study|Adverse Event|0|||
16316404|NCT03743051|39640909|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
16510928|NCT02027844|40343923|FG001|Overall Study|Lost to Follow-up|2|||
16510929|NCT02027844|40343924|FG002|Overall Study|Lost to Follow-up|1|||
16510930|NCT02027844|40343922|FG000|Overall Study|Protocol Violation|0|||
16089959|NCT00614614|38820028|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
16510931|NCT02027844|40343923|FG001|Overall Study|Protocol Violation|2|||
16510932|NCT02027844|40343924|FG002|Overall Study|Protocol Violation|0|||
16510933|NCT02027844|40343922|FG000|Overall Study|Incomlete data|2|||
16510934|NCT02027844|40343923|FG001|Overall Study|Incomlete data|0|||
16510935|NCT02027844|40343924|FG002|Overall Study|Incomlete data|0|||
16510936|NCT03216850|40343929|FG000|Overall Study|Pre-analytical error|6|||
16510937|NCT04382911|40343930|FG000|Overall Study|unable to be imaged prior to surgery|2|||
16510938|NCT02540954|40343933|FG000|Overall Study|Physician Decision|3|||
16510939|NCT02540954|40343934|FG001|Overall Study|Physician Decision|1|||
16510940|NCT02540954|40343933|FG000|Overall Study|Withdrawal by Subject|6|||
16510941|NCT02540954|40343934|FG001|Overall Study|Withdrawal by Subject|5|||
16510942|NCT02540954|40343933|FG000|Overall Study|Lost to Follow-up|1|||
16510943|NCT02540954|40343934|FG001|Overall Study|Lost to Follow-up|1|||
16510944|NCT02540954|40343933|FG000|Overall Study|Adverse Event|4|||
16510945|NCT02540954|40343934|FG001|Overall Study|Adverse Event|2|||
16510946|NCT02540954|40343933|FG000|Overall Study|Death|0|||
16510947|NCT02540954|40343934|FG001|Overall Study|Death|3|||
16510948|NCT02540954|40343933|FG000|Overall Study|Treatment failure|1|||
16510949|NCT02540954|40343934|FG001|Overall Study|Treatment failure|0|||
16510950|NCT02540954|40343933|FG000|Overall Study|Other reason|4|||
16510951|NCT02540954|40343934|FG001|Overall Study|Other reason|2|||
16510952|NCT01236755|40343935|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
16510953|NCT01236755|40343935|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
16510954|NCT01236755|40343935|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
16510955|NCT01236755|40343935|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
16510956|NCT00994448|40343936|FG000|Overall Study|Adverse Event|1|||
16510957|NCT00994448|40343937|FG001|Overall Study|Adverse Event|0|||
16510958|NCT00994448|40343936|FG000|Overall Study|Lost to Follow-up|5|||
16510959|NCT00994448|40343937|FG001|Overall Study|Lost to Follow-up|1|||
16510960|NCT00994448|40343936|FG000|Overall Study|Withdrawal by Subject|1|||
16510961|NCT00994448|40343937|FG001|Overall Study|Withdrawal by Subject|1|||
16510962|NCT00994448|40343936|FG000|Overall Study|Physician Decision|1|||
16510963|NCT00994448|40343937|FG001|Overall Study|Physician Decision|0|||
16510964|NCT02789176|40343938|FG000|Overall Study|Death|0|||
16199283|NCT01653158|39204601|FG003|Overall Study|Adverse Event|1|||
16199284|NCT01653158|39204602|FG004|Overall Study|Adverse Event|0|||
16199285|NCT01653158|39204603|FG005|Overall Study|Adverse Event|0|||
16199286|NCT01653158|39204604|FG006|Overall Study|Adverse Event|0|||
16199287|NCT01653158|39204605|FG007|Overall Study|Adverse Event|3|||
16199288|NCT01653158|39204598|FG000|Overall Study|Other|0|||
16199289|NCT01653158|39204599|FG001|Overall Study|Other|0|||
16510965|NCT02789176|40343939|FG001|Overall Study|Death|0|||
16510966|NCT02789176|40343940|FG002|Overall Study|Death|3|||
16510967|NCT02789176|40343941|FG003|Overall Study|Death|0|||
16510968|NCT02789176|40343938|FG000|Overall Study|Withdrawal by Subject|0|||
16510969|NCT02789176|40343939|FG001|Overall Study|Withdrawal by Subject|0|||
16510970|NCT02789176|40343940|FG002|Overall Study|Withdrawal by Subject|1|||
16510971|NCT02789176|40343941|FG003|Overall Study|Withdrawal by Subject|0|||
16510972|NCT02789176|40343938|FG000|Overall Study|Lost to Follow-up|8|||
16510973|NCT02789176|40343939|FG001|Overall Study|Lost to Follow-up|2|||
16089960|NCT00614614|38820029|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
16089961|NCT00614614|38820030|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
16089962|NCT00614614|38820026|FG000|Booster Vaccination Phase|Protocol Violation|0|||
16089963|NCT00614614|38820027|FG001|Booster Vaccination Phase|Protocol Violation|0|||
16089964|NCT00614614|38820028|FG002|Booster Vaccination Phase|Protocol Violation|2|||
16089965|NCT00614614|38820029|FG003|Booster Vaccination Phase|Protocol Violation|3|||
16199290|NCT01653158|39204600|FG002|Overall Study|Other|0|||
16510974|NCT02789176|40343940|FG002|Overall Study|Lost to Follow-up|6|||
16510975|NCT02789176|40343941|FG003|Overall Study|Lost to Follow-up|1|||
16199291|NCT01653158|39204601|FG003|Overall Study|Other|0|||
16199292|NCT01653158|39204602|FG004|Overall Study|Other|0|||
16510976|NCT03569371|40343942|FG000|Overall Study|Lack of Efficacy|1|||
16510977|NCT03569371|40343942|FG000|Overall Study|Lost to Follow-up|1|||
16510978|NCT03569371|40343942|FG000|Overall Study|Adverse Event|1|||
16510979|NCT00445328|40343943|FG000|Overall Study|Death|0|||
16510980|NCT00445328|40343944|FG001|Overall Study|Death|1|||
16510981|NCT00445328|40343943|FG000|Overall Study|Adverse Event|0|||
16510982|NCT00445328|40343944|FG001|Overall Study|Adverse Event|3|||
16510983|NCT00445328|40343943|FG000|Overall Study|Other|0|||
16510984|NCT00445328|40343944|FG001|Overall Study|Other|2|||
16510985|NCT00445328|40343943|FG000|Overall Study|Withdrawal by Subject|2|||
16510986|NCT00445328|40343944|FG001|Overall Study|Withdrawal by Subject|0|||
16510987|NCT00445328|40343943|FG000|Overall Study|Protocol Violation|1|||
16510988|NCT00445328|40343944|FG001|Overall Study|Protocol Violation|0|||
16510989|NCT02932904|40343945|FG000|Overall Study|Reason not Specified|1|||
16510990|NCT02932904|40343946|FG001|Overall Study|Reason not Specified|0|||
16510991|NCT02932904|40343947|FG002|Overall Study|Reason not Specified|2|||
16510992|NCT02932904|40343948|FG003|Overall Study|Reason not Specified|2|||
16510993|NCT02932904|40343945|FG000|Overall Study|Noncompliance with Study Drug|2|||
16510994|NCT02932904|40343946|FG001|Overall Study|Noncompliance with Study Drug|3|||
16510995|NCT02932904|40343947|FG002|Overall Study|Noncompliance with Study Drug|3|||
16510996|NCT02932904|40343948|FG003|Overall Study|Noncompliance with Study Drug|4|||
16510997|NCT02932904|40343945|FG000|Overall Study|Pregnancy|0|||
16510998|NCT02932904|40343946|FG001|Overall Study|Pregnancy|1|||
16510999|NCT02932904|40343947|FG002|Overall Study|Pregnancy|1|||
16511000|NCT02932904|40343948|FG003|Overall Study|Pregnancy|0|||
16511001|NCT02932904|40343945|FG000|Overall Study|Study Termination|0|||
16511002|NCT02932904|40343946|FG001|Overall Study|Study Termination|1|||
16511003|NCT02932904|40343947|FG002|Overall Study|Study Termination|0|||
16511004|NCT02932904|40343948|FG003|Overall Study|Study Termination|0|||
16511005|NCT02932904|40343945|FG000|Overall Study|Voluntary Withdrawal|2|||
16511006|NCT02932904|40343946|FG001|Overall Study|Voluntary Withdrawal|1|||
16511007|NCT02932904|40343947|FG002|Overall Study|Voluntary Withdrawal|4|||
16511008|NCT02932904|40343948|FG003|Overall Study|Voluntary Withdrawal|2|||
16511009|NCT02932904|40343945|FG000|Overall Study|Lost to Follow-up|5|||
16511010|NCT02932904|40343946|FG001|Overall Study|Lost to Follow-up|3|||
16511011|NCT02932904|40343947|FG002|Overall Study|Lost to Follow-up|6|||
16511012|NCT02932904|40343948|FG003|Overall Study|Lost to Follow-up|0|||
16511013|NCT02932904|40343945|FG000|Overall Study|Significant Protocol Deviation|2|||
16511014|NCT02932904|40343946|FG001|Overall Study|Significant Protocol Deviation|3|||
16511015|NCT02932904|40343947|FG002|Overall Study|Significant Protocol Deviation|6|||
16511016|NCT02932904|40343948|FG003|Overall Study|Significant Protocol Deviation|1|||
16511017|NCT02932904|40343945|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
16511018|NCT02932904|40343946|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
16511019|NCT02932904|40343947|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
16511020|NCT02932904|40343948|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
16511021|NCT02932904|40343945|FG000|Overall Study|Randomized But Not Treated|1|||
16511022|NCT02932904|40343946|FG001|Overall Study|Randomized But Not Treated|1|||
16511023|NCT02932904|40343947|FG002|Overall Study|Randomized But Not Treated|0|||
16511024|NCT02932904|40343948|FG003|Overall Study|Randomized But Not Treated|2|||
16511025|NCT01124604|40343949|FG000|Overall Study|Adverse Event|10|||
16511026|NCT01124604|40343950|FG001|Overall Study|Adverse Event|1|||
16511027|NCT01124604|40343949|FG000|Overall Study|Lack of Efficacy|1|||
16511028|NCT01124604|40343950|FG001|Overall Study|Lack of Efficacy|0|||
16511029|NCT01124604|40343949|FG000|Overall Study|Withdrawal by Subject|4|||
16511030|NCT01124604|40343950|FG001|Overall Study|Withdrawal by Subject|0|||
16511031|NCT01124604|40343949|FG000|Overall Study|Disease Progression|0|||
16511032|NCT01124604|40343950|FG001|Overall Study|Disease Progression|1|||
16511033|NCT03238911|40343957|FG000|Overall Study|Withdrawal by Subject|1|||
16511034|NCT03238911|40343958|FG001|Overall Study|Withdrawal by Subject|2|||
16511035|NCT03238911|40343957|FG000|Overall Study|Lost to Follow-up|2|||
16511036|NCT03238911|40343958|FG001|Overall Study|Lost to Follow-up|1|||
16511037|NCT02584504|40343959|FG000|Double-blind Treatment|Participant withdrew consent|0|||
16511038|NCT02584504|40343960|FG001|Double-blind Treatment|Participant withdrew consent|0|||
16511039|NCT02584504|40343961|FG002|Double-blind Treatment|Participant withdrew consent|1|||
16511040|NCT02584504|40343959|FG000|Double-blind Treatment|Adverse Event|0|||
16511041|NCT02584504|40343960|FG001|Double-blind Treatment|Adverse Event|1|||
16511042|NCT02584504|40343961|FG002|Double-blind Treatment|Adverse Event|0|||
16511043|NCT02584504|40343959|FG000|Double-blind Treatment|Family Matter|0|||
16511044|NCT02584504|40343960|FG001|Double-blind Treatment|Family Matter|1|||
16511045|NCT02584504|40343961|FG002|Double-blind Treatment|Family Matter|0|||
16511046|NCT02584504|40343959|FG000|Open-label Treatment|Participant withdrew consent|0|||
16511047|NCT02584504|40343960|FG001|Open-label Treatment|Participant withdrew consent|0|||
16511048|NCT02584504|40343961|FG002|Open-label Treatment|Participant withdrew consent|4|||
16511049|NCT02584504|40343959|FG000|Open-label Treatment|Adverse Event|2|||
16511050|NCT02584504|40343960|FG001|Open-label Treatment|Adverse Event|2|||
16511051|NCT02584504|40343961|FG002|Open-label Treatment|Adverse Event|3|||
16511052|NCT02584504|40343959|FG000|Open-label Treatment|Physician Decision|0|||
16511053|NCT02584504|40343960|FG001|Open-label Treatment|Physician Decision|1|||
16511054|NCT02584504|40343961|FG002|Open-label Treatment|Physician Decision|0|||
16511055|NCT02584504|40343959|FG000|Open-label Treatment|Entered but not treated|0|||
16511056|NCT02584504|40343960|FG001|Open-label Treatment|Entered but not treated|1|||
16511057|NCT02584504|40343961|FG002|Open-label Treatment|Entered but not treated|1|||
16511058|NCT00579826|40343963|FG000|Overall Study|Withdrawal by Subject|5|||
16511059|NCT00579826|40343964|FG001|Overall Study|Withdrawal by Subject|3|||
16511060|NCT01652716|40343965|FG000|Overall Study|Loss of glucose control|1|||
16511061|NCT01652716|40343966|FG001|Overall Study|Loss of glucose control|0|||
16511062|NCT01652716|40343965|FG000|Overall Study|Administrative|0|||
16511063|NCT01652716|40343966|FG001|Overall Study|Administrative|2|||
16511064|NCT01652716|40343965|FG000|Overall Study|Investigator decision|1|||
16511065|NCT01652716|40343966|FG001|Overall Study|Investigator decision|4|||
16511066|NCT01652716|40343965|FG000|Overall Study|Lost to Follow-up|12|||
16511067|NCT01652716|40343966|FG001|Overall Study|Lost to Follow-up|11|||
16511068|NCT01652716|40343965|FG000|Overall Study|Protocol Violation|2|||
16511069|NCT01652716|40343966|FG001|Overall Study|Protocol Violation|1|||
16511070|NCT01652716|40343965|FG000|Overall Study|Adverse Event|7|||
16511071|NCT01652716|40343966|FG001|Overall Study|Adverse Event|10|||
16511072|NCT01652716|40343965|FG000|Overall Study|Withdrawal by Subject|33|||
16511073|NCT01652716|40343966|FG001|Overall Study|Withdrawal by Subject|18|||
16511074|NCT00743652|40343967|FG000|Overall Study|Parent/Legal Guardian Request|3|||
16511075|NCT00743652|40343968|FG001|Overall Study|Parent/Legal Guardian Request|2|||
16511076|NCT00743652|40343969|FG002|Overall Study|Parent/Legal Guardian Request|2|||
16511077|NCT00743652|40343970|FG003|Overall Study|Parent/Legal Guardian Request|2|||
16511078|NCT00743652|40343971|FG004|Overall Study|Parent/Legal Guardian Request|0|||
16511079|NCT00743652|40343967|FG000|Overall Study|Adverse Event|3|||
16511080|NCT00743652|40343968|FG001|Overall Study|Adverse Event|0|||
16511081|NCT00743652|40343969|FG002|Overall Study|Adverse Event|0|||
16511082|NCT00743652|40343970|FG003|Overall Study|Adverse Event|0|||
16511083|NCT00743652|40343971|FG004|Overall Study|Adverse Event|0|||
16511084|NCT00743652|40343967|FG000|Overall Study|Death|2|||
16511085|NCT00743652|40343968|FG001|Overall Study|Death|0|||
16511086|NCT00743652|40343969|FG002|Overall Study|Death|0|||
16511087|NCT00743652|40343970|FG003|Overall Study|Death|0|||
16511088|NCT00743652|40343971|FG004|Overall Study|Death|0|||
16511089|NCT00743652|40343967|FG000|Overall Study|Investigator Request|0|||
16511090|NCT00743652|40343968|FG001|Overall Study|Investigator Request|0|||
16511091|NCT00743652|40343969|FG002|Overall Study|Investigator Request|0|||
16511092|NCT00743652|40343970|FG003|Overall Study|Investigator Request|2|||
16511093|NCT00743652|40343971|FG004|Overall Study|Investigator Request|0|||
16511094|NCT00743652|40343967|FG000|Overall Study|Other|1|||
16511095|NCT00743652|40343968|FG001|Overall Study|Other|1|||
16511096|NCT00743652|40343969|FG002|Overall Study|Other|0|||
16511097|NCT00743652|40343970|FG003|Overall Study|Other|0|||
16511098|NCT00743652|40343971|FG004|Overall Study|Other|0|||
16511099|NCT00743652|40343967|FG000|Overall Study|Lost to Follow-up|1|||
16511100|NCT00743652|40343968|FG001|Overall Study|Lost to Follow-up|0|||
16511101|NCT00743652|40343969|FG002|Overall Study|Lost to Follow-up|0|||
16511102|NCT00743652|40343970|FG003|Overall Study|Lost to Follow-up|0|||
16511103|NCT00743652|40343971|FG004|Overall Study|Lost to Follow-up|0|||
16511104|NCT01364428|40343972|FG000|Overall Study|Adverse Event|1|||
16511105|NCT01364428|40343973|FG001|Overall Study|Adverse Event|2|||
16511106|NCT01364428|40343972|FG000|Overall Study|Protocol Violation|2|||
16511107|NCT01364428|40343973|FG001|Overall Study|Protocol Violation|0|||
16511108|NCT01364428|40343972|FG000|Overall Study|Withdrawal Criteria|14|||
16511109|NCT01364428|40343973|FG001|Overall Study|Withdrawal Criteria|10|||
16511110|NCT01364428|40343972|FG000|Overall Study|Other|3|||
16511111|NCT01364428|40343973|FG001|Overall Study|Other|3|||
16511112|NCT02476968|40343974|FG000|Overall Study|Other|0|||
16511113|NCT02476968|40343975|FG001|Overall Study|Other|2|||
16511114|NCT02476968|40343976|FG002|Overall Study|Other|0|||
16511115|NCT02476968|40343974|FG000|Overall Study|Lost to Follow-up|10|||
16511116|NCT02476968|40343975|FG001|Overall Study|Lost to Follow-up|0|||
16511117|NCT02476968|40343976|FG002|Overall Study|Lost to Follow-up|1|||
16511118|NCT02476968|40343974|FG000|Overall Study|Death|48|||
16511119|NCT02476968|40343975|FG001|Overall Study|Death|8|||
16511120|NCT02476968|40343976|FG002|Overall Study|Death|1|||
16511121|NCT02476968|40343974|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16511122|NCT02476968|40343975|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16511123|NCT02476968|40343976|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
16511124|NCT02476968|40343974|FG000|Overall Study|Patient decision|37|||
16511125|NCT02476968|40343975|FG001|Overall Study|Patient decision|8|||
16511126|NCT02476968|40343976|FG002|Overall Study|Patient decision|0|||
16511127|NCT02703636|40343977|FG000|Overall Study|Adverse Event|14|||
16511128|NCT02703636|40343977|FG000|Overall Study|Study stopped by sponsor|1|||
16511129|NCT02703636|40343977|FG000|Overall Study|Withdrawal by Subject|1|||
16511130|NCT03239470|40343978|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
16511131|NCT03239470|40343979|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
16511132|NCT02075320|40343987|FG000|Overall Study|Withdrawal by Subject|2|||
16511133|NCT01574703|40343988|FG000|Overall Study|Adverse Event|0|||
16511134|NCT01574703|40343989|FG001|Overall Study|Adverse Event|2|||
16511135|NCT01574703|40343990|FG002|Overall Study|Adverse Event|1|||
16089966|NCT00614614|38820030|FG004|Booster Vaccination Phase|Protocol Violation|0|||
16199293|NCT01653158|39204603|FG005|Overall Study|Other|0|||
16199294|NCT01653158|39204604|FG006|Overall Study|Other|0|||
16199295|NCT01653158|39204605|FG007|Overall Study|Other|1|||
16199296|NCT01653158|39204598|FG000|Overall Study|Progressive disease|0|||
16199297|NCT01653158|39204599|FG001|Overall Study|Progressive disease|0|||
16511136|NCT01574703|40343991|FG003|Overall Study|Adverse Event|1|||
16511137|NCT01574703|40343988|FG000|Overall Study|Protocol Violation|0|||
16511138|NCT01574703|40343989|FG001|Overall Study|Protocol Violation|0|||
16511139|NCT01574703|40343990|FG002|Overall Study|Protocol Violation|0|||
16511140|NCT01574703|40343991|FG003|Overall Study|Protocol Violation|1|||
16511141|NCT01574703|40343988|FG000|Overall Study|Unspecified Reason|27|||
16511142|NCT01574703|40343989|FG001|Overall Study|Unspecified Reason|15|||
16199298|NCT01653158|39204600|FG002|Overall Study|Progressive disease|0|||
16199299|NCT01653158|39204601|FG003|Overall Study|Progressive disease|0|||
16199300|NCT01653158|39204602|FG004|Overall Study|Progressive disease|1|||
16199301|NCT01653158|39204603|FG005|Overall Study|Progressive disease|1|||
16199302|NCT01653158|39204604|FG006|Overall Study|Progressive disease|2|||
16199303|NCT01653158|39204605|FG007|Overall Study|Progressive disease|9|||
16199304|NCT01653158|39204598|FG000|Overall Study|Withdrawal by Subject|1|||
16199305|NCT01653158|39204599|FG001|Overall Study|Withdrawal by Subject|0|||
16199306|NCT01653158|39204600|FG002|Overall Study|Withdrawal by Subject|0|||
16199307|NCT01653158|39204601|FG003|Overall Study|Withdrawal by Subject|0|||
16199308|NCT01653158|39204602|FG004|Overall Study|Withdrawal by Subject|0|||
16199309|NCT01653158|39204603|FG005|Overall Study|Withdrawal by Subject|0|||
16199310|NCT01653158|39204604|FG006|Overall Study|Withdrawal by Subject|0|||
16199311|NCT01653158|39204605|FG007|Overall Study|Withdrawal by Subject|0|||
16199312|NCT03543358|39204608|FG000|Overall Study|Death|1|||
16199313|NCT03543358|39204609|FG001|Overall Study|Death|0|||
16199314|NCT03543358|39204608|FG000|Overall Study|Disease Progression|1|||
16199315|NCT03543358|39204609|FG001|Overall Study|Disease Progression|0|||
16199316|NCT03543358|39204608|FG000|Overall Study|Parent Study Closure|1|||
16199317|NCT03543358|39204609|FG001|Overall Study|Parent Study Closure|0|||
16199318|NCT01120379|39204610|FG000|One Year Timepoint|Withdrawal by Subject|41|||
16199319|NCT01120379|39204610|FG000|One Year Timepoint|Lost to Follow-up|115|||
16199320|NCT01120379|39204610|FG000|One Year Timepoint|Death|108|||
16199321|NCT01120379|39204610|FG000|One Year Timepoint|Physician Decision|9|||
16511143|NCT01574703|40343990|FG002|Overall Study|Unspecified Reason|20|||
16199322|NCT01120379|39204610|FG000|One Year Timepoint|Any other reason for early termination|5|||
16199323|NCT01120379|39204610|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
16199324|NCT01120379|39204610|FG000|Two Year Timepoint|Lost to Follow-up|87|||
16392845|NCT01737762|39919728|FG000|Overall Study|Adverse Event|2|||
16511144|NCT01574703|40343991|FG003|Overall Study|Unspecified Reason|16|||
16511145|NCT01574703|40343988|FG000|Overall Study|Withdrawal by Subject|53|||
16511146|NCT01574703|40343989|FG001|Overall Study|Withdrawal by Subject|52|||
16199325|NCT01120379|39204610|FG000|Two Year Timepoint|Death|123|||
16199326|NCT01120379|39204610|FG000|Two Year Timepoint|Physician Decision|12|||
16199327|NCT01120379|39204610|FG000|Two Year Timepoint|Any other reason for early termination|4|||
16199328|NCT01120379|39204610|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
16199329|NCT01120379|39204610|FG000|Three Year Timepoint|Lost to Follow-up|43|||
16199330|NCT01120379|39204610|FG000|Three Year Timepoint|Death|120|||
16199331|NCT01120379|39204610|FG000|Three Year Timepoint|Physician Decision|9|||
16199332|NCT01120379|39204610|FG000|Three Year Timepoint|Any other reason for early termination|17|||
16199333|NCT01120379|39204610|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
16199334|NCT01120379|39204610|FG000|Four Year Timepoint|Lost to Follow-up|10|||
16199335|NCT01120379|39204610|FG000|Four Year Timepoint|Death|131|||
16199336|NCT01120379|39204610|FG000|Four Year Timepoint|Physician Decision|5|||
16199337|NCT01120379|39204610|FG000|Four Year Timepoint|Any other reason for early termination|217|||
16199338|NCT02248857|39204611|FG000|3 Month|Withdrawal by Subject|9|||
16199339|NCT02248857|39204612|FG001|3 Month|Withdrawal by Subject|3|||
16199340|NCT02248857|39204613|FG002|3 Month|Withdrawal by Subject|4|||
16199341|NCT02248857|39204611|FG000|3 Month|Unable to reach for 3 month|35|||
16199342|NCT02248857|39204612|FG001|3 Month|Unable to reach for 3 month|29|||
16199343|NCT02248857|39204613|FG002|3 Month|Unable to reach for 3 month|26|||
16199344|NCT02248857|39204611|FG000|3 Month|Partially completed, unable to finish|2|||
16199345|NCT02248857|39204612|FG001|3 Month|Partially completed, unable to finish|2|||
16199346|NCT02248857|39204613|FG002|3 Month|Partially completed, unable to finish|1|||
16199347|NCT02248857|39204611|FG000|6 Month|Lost to Follow-up|27|||
16199348|NCT02248857|39204612|FG001|6 Month|Lost to Follow-up|26|||
16199349|NCT02248857|39204613|FG002|6 Month|Lost to Follow-up|15|||
16199350|NCT02248857|39204611|FG000|6 Month|Partially completed, unable to finish|0|||
16199351|NCT02248857|39204612|FG001|6 Month|Partially completed, unable to finish|1|||
16199352|NCT02248857|39204613|FG002|6 Month|Partially completed, unable to finish|0|||
16199353|NCT02248857|39204611|FG000|6 Month|Withdrawal by Subject|0|||
16199354|NCT02248857|39204612|FG001|6 Month|Withdrawal by Subject|2|||
16199355|NCT02248857|39204613|FG002|6 Month|Withdrawal by Subject|2|||
16199356|NCT02248857|39204611|FG000|6 Month|Death|1|||
16199357|NCT02248857|39204612|FG001|6 Month|Death|0|||
16199358|NCT02248857|39204613|FG002|6 Month|Death|0|||
16199359|NCT01188564|39204618|FG000|Double-blind Phase|randomized not treated|1|||
16316405|NCT03743051|39640910|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
16316406|NCT01499095|39640912|FG000|Overall Study|Randomized But Not Treated|1|||
16316407|NCT01499095|39640913|FG001|Overall Study|Randomized But Not Treated|1|||
16316408|NCT01499095|39640912|FG000|Overall Study|Adverse Event|12|||
16316409|NCT01499095|39640913|FG001|Overall Study|Adverse Event|7|||
16316410|NCT01499095|39640912|FG000|Overall Study|Lack of Efficacy|2|||
16316411|NCT01499095|39640913|FG001|Overall Study|Lack of Efficacy|1|||
16316412|NCT01499095|39640912|FG000|Overall Study|Protocol Violation|6|||
16316413|NCT01499095|39640913|FG001|Overall Study|Protocol Violation|7|||
16316414|NCT01499095|39640912|FG000|Overall Study|Received Rescue Therapy|32|||
16316415|NCT01499095|39640913|FG001|Overall Study|Received Rescue Therapy|40|||
16316416|NCT01499095|39640912|FG000|Overall Study|Diverse Reasons|22|||
16316417|NCT01499095|39640913|FG001|Overall Study|Diverse Reasons|25|||
16316418|NCT01499095|39640912|FG000|Overall Study|Lost to Follow-up|6|||
16316419|NCT01499095|39640913|FG001|Overall Study|Lost to Follow-up|4|||
16316420|NCT01499095|39640912|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
16316421|NCT01499095|39640913|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
16316422|NCT01499095|39640912|FG000|Overall Study|Hypoglycemia|3|||
16316423|NCT01499095|39640913|FG001|Overall Study|Hypoglycemia|1|||
16316424|NCT01499095|39640912|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
16316425|NCT01499095|39640913|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
16316426|NCT01499095|39640912|FG000|Overall Study|Change in Injection Schedule|2|||
16316427|NCT01499095|39640913|FG001|Overall Study|Change in Injection Schedule|0|||
16316428|NCT01499095|39640912|FG000|Overall Study|Perceived Lack of Efficacy|1|||
16316429|NCT01499095|39640913|FG001|Overall Study|Perceived Lack of Efficacy|1|||
16316430|NCT03743415|39640915|FG000|Overall Study|Death|5|||
16199360|NCT01188564|39204619|FG001|Double-blind Phase|randomized not treated|0|||
16199361|NCT03364673|39204620|FG000|Overall Study|Withdrawal by Subject|2|||
16199362|NCT03364673|39204620|FG000|Overall Study|Injury unrelated to study|3|||
16199363|NCT01736254|39204624|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
16199364|NCT01736254|39204624|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
16199365|NCT03956225|39204627|FG000|Overall Study|Lack of Efficacy|1|||
16199366|NCT03956225|39204628|FG001|Overall Study|Lack of Efficacy|1|||
16199367|NCT03956225|39204627|FG000|Overall Study|Lost to Follow-up|0|||
16199368|NCT03956225|39204628|FG001|Overall Study|Lost to Follow-up|1|||
16316431|NCT03743415|39640916|FG001|Overall Study|Death|3|||
16316432|NCT03743415|39640917|FG002|Overall Study|Death|1|||
16316433|NCT03743415|39640918|FG003|Overall Study|Death|4|||
16316434|NCT03743415|39640919|FG004|Overall Study|Death|0|||
16316435|NCT03743415|39640920|FG005|Overall Study|Death|0|||
16316436|NCT03743415|39640921|FG006|Overall Study|Death|0|||
16316437|NCT03743415|39640922|FG007|Overall Study|Death|0|||
16316438|NCT03743415|39640923|FG008|Overall Study|Death|1|||
16199369|NCT03956225|39204627|FG000|Overall Study|Withdrawal by Subject|2|||
16199370|NCT03956225|39204628|FG001|Overall Study|Withdrawal by Subject|1|||
16199371|NCT03956225|39204627|FG000|Overall Study|Other Reasons|2|||
16392846|NCT01737762|39919729|FG001|Overall Study|Adverse Event|2|||
16392847|NCT01737762|39919728|FG000|Overall Study|Lost to Follow-up|1|||
16392848|NCT01737762|39919729|FG001|Overall Study|Lost to Follow-up|0|||
16392849|NCT01737762|39919728|FG000|Overall Study|Withdrawal by Subject|2|||
16392850|NCT01737762|39919729|FG001|Overall Study|Withdrawal by Subject|2|||
16392851|NCT01737762|39919728|FG000|Overall Study|Progressive disease|1|||
16392852|NCT01737762|39919729|FG001|Overall Study|Progressive disease|2|||
16392853|NCT01737762|39919728|FG000|Overall Study|Physician Decision|1|||
16392854|NCT01737762|39919729|FG001|Overall Study|Physician Decision|1|||
16392855|NCT01737762|39919728|FG000|Overall Study|Moved from area|2|||
16392856|NCT01737762|39919729|FG001|Overall Study|Moved from area|1|||
16392857|NCT01737762|39919728|FG000|Overall Study|Trial termination|11|||
16392858|NCT01737762|39919729|FG001|Overall Study|Trial termination|9|||
16392859|NCT03782259|39919730|FG000|Overall Study|Lost to Follow-up|1|||
16392860|NCT03782259|39919731|FG001|Overall Study|Lost to Follow-up|1|||
16392861|NCT03782259|39919730|FG000|Overall Study|Moved out of state|0|||
16392862|NCT03782259|39919731|FG001|Overall Study|Moved out of state|2|||
16392863|NCT03782259|39919730|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
16392864|NCT03782259|39919731|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
16392865|NCT03782259|39919730|FG000|Overall Study|Subject discontinued intervention|1|||
16392866|NCT03782259|39919731|FG001|Overall Study|Subject discontinued intervention|0|||
16392867|NCT01030952|39922202|FG000|Overall Study|Protocol Violation|0|||
16392868|NCT01030952|39922203|FG001|Overall Study|Protocol Violation|1|||
16392869|NCT01030952|39922202|FG000|Overall Study|Informed consent withdrawal|1|||
16392870|NCT01030952|39922203|FG001|Overall Study|Informed consent withdrawal|0|||
16392871|NCT01030952|39922202|FG000|Overall Study|Lost to Follow-up|0|||
16392872|NCT01030952|39922203|FG001|Overall Study|Lost to Follow-up|1|||
16392873|NCT01030952|39922202|FG000|Overall Study|Unexplained|1|||
16392874|NCT01030952|39922203|FG001|Overall Study|Unexplained|1|||
16392875|NCT01295944|39922204|FG000|Overall Study|Switched to alternative treatment|1|||
16392876|NCT01295944|39922204|FG000|Overall Study|Ineligible|9|||
16392877|NCT01295944|39922204|FG000|Overall Study|Withdrawal by Subject|4|||
16392878|NCT01295944|39922204|FG000|Overall Study|Participant chose to be treated in Peru|1|||
16392879|NCT01295944|39922204|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
16392880|NCT01295944|39922204|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
16392881|NCT01295944|39922204|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
16392882|NCT02278341|39922205|FG000|Overall Study|Randomized but never received study drug|1|||
16392883|NCT02278341|39922206|FG001|Overall Study|Randomized but never received study drug|1|||
16392884|NCT02278341|39922205|FG000|Overall Study|Adverse Event|3|||
16392885|NCT02278341|39922206|FG001|Overall Study|Adverse Event|0|||
16392886|NCT02278341|39922205|FG000|Overall Study|Death|68|||
16392887|NCT02278341|39922206|FG001|Overall Study|Death|56|||
16392888|NCT02278341|39922205|FG000|Overall Study|Withdrawal by Subject|30|||
16392889|NCT02278341|39922206|FG001|Overall Study|Withdrawal by Subject|19|||
16392890|NCT02278341|39922205|FG000|Overall Study|Lost to Follow-up|0|||
16392891|NCT02278341|39922206|FG001|Overall Study|Lost to Follow-up|1|||
16392892|NCT02278341|39922205|FG000|Overall Study|Physician Decision|1|||
16392893|NCT02278341|39922206|FG001|Overall Study|Physician Decision|1|||
16392894|NCT02278341|39922205|FG000|Overall Study|Miscellaneous|15|||
16392895|NCT02278341|39922206|FG001|Overall Study|Miscellaneous|14|||
16392896|NCT02168101|39922209|FG000|Overall Study|Death|2|||
16392897|NCT02168101|39922210|FG001|Overall Study|Death|2|||
16511147|NCT01574703|40343990|FG002|Overall Study|Withdrawal by Subject|36|||
16511148|NCT01574703|40343991|FG003|Overall Study|Withdrawal by Subject|61|||
16511149|NCT01574703|40343988|FG000|Overall Study|Met Withdrawal Criteria|0|||
16511150|NCT01574703|40343989|FG001|Overall Study|Met Withdrawal Criteria|1|||
16511151|NCT01574703|40343990|FG002|Overall Study|Met Withdrawal Criteria|1|||
16511152|NCT01574703|40343991|FG003|Overall Study|Met Withdrawal Criteria|0|||
16511153|NCT01574703|40343988|FG000|Overall Study|Lost to Follow-up|43|||
16199372|NCT03956225|39204628|FG001|Overall Study|Other Reasons|1|||
16392898|NCT02168101|39922211|FG002|Overall Study|Death|1|||
16392899|NCT02522429|39922212|FG000|Overall Study|Lost to Follow-up|8|||
16392900|NCT02522429|39922212|FG000|Overall Study|Adverse Event|2|||
16392901|NCT02522429|39922212|FG000|Overall Study|Death|1|||
16392902|NCT02522429|39922212|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
16392903|NCT02923531|39922213|FG000|Overall Study|Adverse Event|4|||
16392904|NCT02923531|39922213|FG000|Overall Study|Clinical Deterioration|1|||
16392905|NCT02923531|39922213|FG000|Overall Study|Disease Progression|3|||
16392906|NCT02923531|39922213|FG000|Overall Study|Study Termination|1|||
16392907|NCT02817776|39922216|FG000|Overall Study|Excluded|33|||
16392908|NCT02817776|39922216|FG000|Overall Study|Lost to Follow-up|20|||
16511154|NCT01574703|40343989|FG001|Overall Study|Lost to Follow-up|41|||
16511155|NCT01574703|40343990|FG002|Overall Study|Lost to Follow-up|46|||
16316439|NCT03743415|39640924|FG009|Overall Study|Death|0|||
16316440|NCT03743415|39640915|FG000|Overall Study|Withdrawal by Subject|1|||
16511156|NCT01574703|40343991|FG003|Overall Study|Lost to Follow-up|35|||
16511157|NCT01574703|40343988|FG000|Overall Study|Death|2|||
16316441|NCT03743415|39640916|FG001|Overall Study|Withdrawal by Subject|0|||
16316442|NCT03743415|39640917|FG002|Overall Study|Withdrawal by Subject|4|||
16316443|NCT03743415|39640918|FG003|Overall Study|Withdrawal by Subject|5|||
16316444|NCT03743415|39640919|FG004|Overall Study|Withdrawal by Subject|5|||
16316445|NCT03743415|39640920|FG005|Overall Study|Withdrawal by Subject|2|||
16316446|NCT03743415|39640921|FG006|Overall Study|Withdrawal by Subject|2|||
16316447|NCT03743415|39640922|FG007|Overall Study|Withdrawal by Subject|5|||
16316448|NCT03743415|39640923|FG008|Overall Study|Withdrawal by Subject|9|||
16316449|NCT03743415|39640924|FG009|Overall Study|Withdrawal by Subject|10|||
16316450|NCT03743415|39640915|FG000|Overall Study|Lost to Follow-up|2|||
16316451|NCT03743415|39640916|FG001|Overall Study|Lost to Follow-up|0|||
16316452|NCT03743415|39640917|FG002|Overall Study|Lost to Follow-up|2|||
16316453|NCT03743415|39640918|FG003|Overall Study|Lost to Follow-up|1|||
16316454|NCT03743415|39640919|FG004|Overall Study|Lost to Follow-up|1|||
16316455|NCT03743415|39640920|FG005|Overall Study|Lost to Follow-up|0|||
16316456|NCT03743415|39640921|FG006|Overall Study|Lost to Follow-up|1|||
16316457|NCT03743415|39640922|FG007|Overall Study|Lost to Follow-up|4|||
16316458|NCT03743415|39640923|FG008|Overall Study|Lost to Follow-up|13|||
16316459|NCT03743415|39640924|FG009|Overall Study|Lost to Follow-up|13|||
16316460|NCT01209520|39640927|FG000|Overall Study|Withdrawal by Subject|3|||
16316461|NCT04909853|39640928|FG000|Part 1|Assigned but not treated|0|||
16316462|NCT04909853|39640929|FG001|Part 1|Assigned but not treated|0|||
16316463|NCT04909853|39640930|FG002|Part 1|Assigned but not treated|1|||
16316464|NCT04909853|39640931|FG003|Part 1|Assigned but not treated|0|||
16316465|NCT04909853|39640928|FG000|Part 2|Adverse Event|0|||
16316466|NCT04909853|39640929|FG001|Part 2|Adverse Event|0|||
16316467|NCT04909853|39640930|FG002|Part 2|Adverse Event|0|||
16316468|NCT04909853|39640931|FG003|Part 2|Adverse Event|1|||
16316469|NCT02712320|39640932|FG000|Overall Study|Lost to Follow-up|1|||
16316470|NCT02712320|39640932|FG000|Overall Study|Withdrawal by Subject|1|||
16316471|NCT02712320|39640932|FG000|Overall Study|Transferred to another facility|1|||
16316472|NCT02712320|39640932|FG000|Overall Study|Treating with the prohibited medications|2|||
16316473|NCT01028014|39640933|FG000|Overall Study|Lost to Follow-up|1|||
16316474|NCT01028014|39640934|FG001|Overall Study|Lost to Follow-up|2|||
16316475|NCT01028014|39640935|FG002|Overall Study|Lost to Follow-up|0|||
16316476|NCT01028014|39640936|FG003|Overall Study|Lost to Follow-up|1|||
16316477|NCT01028014|39640937|FG004|Overall Study|Lost to Follow-up|1|||
16316478|NCT01028014|39640938|FG005|Overall Study|Lost to Follow-up|2|||
16316479|NCT05271175|39640941|FG000|One Week Follow up|Lost to Follow-up|10|||
16316480|NCT05271175|39640942|FG001|One Week Follow up|Lost to Follow-up|7|||
16316481|NCT05271175|39640943|FG002|One Week Follow up|Lost to Follow-up|5|||
16511158|NCT01574703|40343989|FG001|Overall Study|Death|1|||
16511159|NCT01574703|40343990|FG002|Overall Study|Death|1|||
16511160|NCT01574703|40343991|FG003|Overall Study|Death|0|||
16511161|NCT01324388|40343993|FG000|Part 1 of Study|Adverse Event|2|||
16511162|NCT01324388|40343994|FG001|Part 1 of Study|Adverse Event|0|||
16511163|NCT01324388|40343995|FG002|Part 1 of Study|Adverse Event|0|||
16511164|NCT01324388|40343996|FG003|Part 1 of Study|Adverse Event|0|||
16511165|NCT01324388|40343993|FG000|Part 1 of Study|Protocol Violation|1|||
16511166|NCT01324388|40343994|FG001|Part 1 of Study|Protocol Violation|2|||
16511167|NCT01324388|40343995|FG002|Part 1 of Study|Protocol Violation|0|||
16511168|NCT01324388|40343996|FG003|Part 1 of Study|Protocol Violation|0|||
16511169|NCT01324388|40343993|FG000|Part 1 of Study|Physician Decision|1|||
16511170|NCT01324388|40343994|FG001|Part 1 of Study|Physician Decision|0|||
16511171|NCT01324388|40343995|FG002|Part 1 of Study|Physician Decision|0|||
16511172|NCT01324388|40343996|FG003|Part 1 of Study|Physician Decision|0|||
16511173|NCT01324388|40343993|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
16511174|NCT01324388|40343994|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
16511175|NCT01324388|40343995|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
16511176|NCT01324388|40343996|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
16511177|NCT01324388|40343993|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
16511178|NCT01324388|40343994|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
16511179|NCT01324388|40343995|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
16316482|NCT05271175|39640941|FG000|One Month Follow up|Lost to Follow-up|12|||
16316483|NCT05271175|39640942|FG001|One Month Follow up|Lost to Follow-up|7|||
16316484|NCT05271175|39640943|FG002|One Month Follow up|Lost to Follow-up|9|||
16316485|NCT05271175|39640941|FG000|Six Months Follow up|Lost to Follow-up|8|||
16316486|NCT05271175|39640942|FG001|Six Months Follow up|Lost to Follow-up|2|||
16316487|NCT05271175|39640943|FG002|Six Months Follow up|Lost to Follow-up|2|||
16316488|NCT01882985|39640944|FG000|Overall Study|Lost to Follow-up|1|||
16316489|NCT01882985|39640944|FG000|Overall Study|Withdrawal by Subject|1|||
16316490|NCT01842438|39640945|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
16392909|NCT02817776|39922216|FG000|Overall Study|Withdrawal by Subject|33|||
16392910|NCT02817776|39922216|FG000|Overall Study|Death|2|||
16392911|NCT00375427|39922217|FG000|Overall Study|Adverse Event|21|||
16392912|NCT00375427|39922218|FG001|Overall Study|Adverse Event|27|||
16392913|NCT00375427|39922217|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16392914|NCT00375427|39922218|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16392915|NCT00375427|39922217|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16392916|NCT00375427|39922218|FG001|Overall Study|Abnormal laboratory value(s)|2|||
16392917|NCT00375427|39922217|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16392918|NCT00375427|39922218|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
16392919|NCT00375427|39922217|FG000|Overall Study|Patient no longer requires study drug|3|||
16392920|NCT00375427|39922218|FG001|Overall Study|Patient no longer requires study drug|7|||
16392921|NCT00375427|39922217|FG000|Overall Study|Protocol Violation|10|||
16392922|NCT00375427|39922218|FG001|Overall Study|Protocol Violation|8|||
16392923|NCT00375427|39922217|FG000|Overall Study|Withdrawal by Subject|9|||
16392924|NCT00375427|39922218|FG001|Overall Study|Withdrawal by Subject|13|||
16392925|NCT00375427|39922217|FG000|Overall Study|Lost to Follow-up|1|||
16392926|NCT00375427|39922218|FG001|Overall Study|Lost to Follow-up|1|||
16392927|NCT00375427|39922217|FG000|Overall Study|Administrative reasons|0|||
16392928|NCT00375427|39922218|FG001|Overall Study|Administrative reasons|1|||
16392929|NCT00375427|39922217|FG000|Overall Study|Death|11|||
16392930|NCT00375427|39922218|FG001|Overall Study|Death|10|||
16392931|NCT05010070|39922219|FG000|Overall Study|Lost to Follow-up|1|||
16392932|NCT05010070|39922219|FG000|Overall Study|Withdrawal by Subject|1|||
16392933|NCT03554018|39922220|FG000|Overall Study|Lost to Follow-up|3|||
16392934|NCT03554018|39922221|FG001|Overall Study|Lost to Follow-up|7|||
16392935|NCT03188263|39922222|FG000|Overall Study|Withdrawal by Subject|3|||
16316491|NCT01842438|39640946|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
16316492|NCT01842438|39640945|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
16316493|NCT01842438|39640946|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
16316494|NCT01842438|39640945|FG000|T2: 6month Follow-up|Death|0|||
16316495|NCT01842438|39640946|FG001|T2: 6month Follow-up|Death|1|||
16316496|NCT01703260|39640947|FG000|Overall Study|Adverse Event|1|||
16316497|NCT01703260|39640948|FG001|Overall Study|Adverse Event|2|||
16316498|NCT01703260|39640949|FG002|Overall Study|Adverse Event|2|||
16316499|NCT01703260|39640947|FG000|Overall Study|Lost to Follow-up|1|||
16316500|NCT01703260|39640948|FG001|Overall Study|Lost to Follow-up|0|||
16316501|NCT01703260|39640949|FG002|Overall Study|Lost to Follow-up|0|||
16316502|NCT01703260|39640947|FG000|Overall Study|Withdrawal by Subject|0|||
16316503|NCT01703260|39640948|FG001|Overall Study|Withdrawal by Subject|0|||
16316504|NCT01703260|39640949|FG002|Overall Study|Withdrawal by Subject|1|||
16392936|NCT03188263|39922223|FG001|Overall Study|Withdrawal by Subject|0|||
16392937|NCT03188263|39922222|FG000|Overall Study|Physician Decision|1|||
16392938|NCT03188263|39922223|FG001|Overall Study|Physician Decision|0|||
16392939|NCT00194077|39922224|FG000|Overall Study|Lack of Efficacy|22|||
16392940|NCT00194077|39922225|FG001|Overall Study|Lack of Efficacy|29|||
16392941|NCT00194077|39922224|FG000|Overall Study|Study nonadherence|1|||
16392942|NCT00194077|39922225|FG001|Overall Study|Study nonadherence|0|||
16392943|NCT00194077|39922224|FG000|Overall Study|Withdrawal by Subject|1|||
16392944|NCT00194077|39922225|FG001|Overall Study|Withdrawal by Subject|1|||
16392945|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
16392946|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
16392947|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
16392948|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
16392949|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Death|58|||
16392950|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Death|65|||
16392951|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Adverse Event|28|||
16392952|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Adverse Event|40|||
16392953|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Disease Progression|22|||
16392954|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Disease Progression|35|||
16392955|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Other|25|||
16392956|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Other|33|||
16392957|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
16392958|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
16392959|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Noncompliance|8|||
16392960|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Noncompliance|8|||
16392961|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
16392962|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
16392963|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
16392964|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
16316505|NCT01703260|39640947|FG000|Overall Study|Study Termination|1|||
16316506|NCT01703260|39640948|FG001|Overall Study|Study Termination|2|||
16316507|NCT01703260|39640949|FG002|Overall Study|Study Termination|0|||
16316508|NCT02568189|39640954|FG000|Overall Study|Protocol Violation|0|||
16316509|NCT02568189|39640955|FG001|Overall Study|Protocol Violation|0|||
16316510|NCT02568189|39640956|FG002|Overall Study|Protocol Violation|19|||
16316511|NCT02568189|39640957|FG003|Overall Study|Protocol Violation|18|||
16316512|NCT03442751|39640958|FG000|Overall Study|Withdrawal by Subject|3|||
16316513|NCT03442751|39640959|FG001|Overall Study|Withdrawal by Subject|1|||
16316514|NCT03442751|39640958|FG000|Overall Study|Lost to Follow-up|3|||
16316515|NCT03442751|39640959|FG001|Overall Study|Lost to Follow-up|0|||
16316516|NCT01464593|39640960|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
16316517|NCT01530464|39640961|FG000|Washout (24h)|Withdrawal by Subject|1|||
16316518|NCT01530464|39640962|FG001|Washout (24h)|Withdrawal by Subject|0|||
16316519|NCT01530464|39640961|FG000|Washout (24h)|Withdrawal by Subject|0|||
16316520|NCT01530464|39640962|FG001|Washout (24h)|Withdrawal by Subject|1|||
16316521|NCT04090060|39640968|FG000|Overall Study|Lost to Follow-up|76|||
16316522|NCT04090060|39640969|FG001|Overall Study|Lost to Follow-up|77|||
16316523|NCT03168711|39644465|FG000|Overall Study|Adverse Event|2|||
16316524|NCT03168711|39644466|FG001|Overall Study|Adverse Event|0|||
16316525|NCT03168711|39644465|FG000|Overall Study|Withdrawal by Subject|0|||
16316526|NCT03168711|39644466|FG001|Overall Study|Withdrawal by Subject|1|||
16316527|NCT03168711|39644465|FG000|Overall Study|Death|0|||
16316528|NCT03168711|39644466|FG001|Overall Study|Death|1|||
16316529|NCT01662635|39644467|FG000|Overall Study|scarce samples for evaluation|30|||
16316530|NCT03319732|39644468|FG000|Overall Study|Adverse Event|40|||
16316531|NCT03319732|39644468|FG000|Overall Study|Withdrawal by Subject|50|||
16316532|NCT03319732|39644468|FG000|Overall Study|MS relapse|10|||
16316533|NCT03319732|39644468|FG000|Overall Study|reason not specified|5|||
16316534|NCT03478644|39644469|FG000|Phase 2|Withdrawal by Subject|2|||
16316535|NCT03478644|39644470|FG001|Phase 2|Withdrawal by Subject|1|||
16392965|NCT00286091|39922226|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
16316536|NCT03478644|39644469|FG000|Phase 2|Lost to Follow-up|1|||
16316537|NCT03478644|39644470|FG001|Phase 2|Lost to Follow-up|0|||
16316538|NCT03989102|39644471|FG000|Year 1|Withdrawal by Subject|6|||
16316539|NCT03989102|39644472|FG001|Year 1|Withdrawal by Subject|2|||
16392966|NCT00286091|39922227|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
16392967|NCT00286091|39922226|FG000|Open-label Treatment Phase|Physician Decision|24|||
16392968|NCT00286091|39922227|FG001|Open-label Treatment Phase|Physician Decision|21|||
16392969|NCT00286091|39922226|FG000|Open-label Treatment Phase|Adverse Event|5|||
16392970|NCT00286091|39922227|FG001|Open-label Treatment Phase|Adverse Event|16|||
16392971|NCT00286091|39922226|FG000|Open-label Treatment Phase|Other|11|||
16392972|NCT00286091|39922227|FG001|Open-label Treatment Phase|Other|11|||
16392973|NCT00286091|39922226|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
16392974|NCT00286091|39922227|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
16392975|NCT00286091|39922226|FG000|Open-label Treatment Phase|Death|10|||
16392976|NCT00286091|39922227|FG001|Open-label Treatment Phase|Death|7|||
16392977|NCT00286091|39922226|FG000|Open-label Treatment Phase|Disease Progression|9|||
16316540|NCT03989102|39644473|FG002|Year 1|Withdrawal by Subject|7|||
16316541|NCT03989102|39644471|FG000|Year 1|Lost to Follow-up|5|||
16316542|NCT03989102|39644472|FG001|Year 1|Lost to Follow-up|2|||
16316543|NCT03989102|39644473|FG002|Year 1|Lost to Follow-up|5|||
16392978|NCT00286091|39922227|FG001|Open-label Treatment Phase|Disease Progression|3|||
16316544|NCT03989102|39644471|FG000|Year 1|Subject met withdrawal criteria|1|||
16316545|NCT03989102|39644472|FG001|Year 1|Subject met withdrawal criteria|0|||
16316546|NCT03989102|39644473|FG002|Year 1|Subject met withdrawal criteria|1|||
16316547|NCT03989102|39644471|FG000|Year 2|Lost to Follow-up|7|||
16316548|NCT03989102|39644472|FG001|Year 2|Lost to Follow-up|3|||
16316549|NCT03989102|39644473|FG002|Year 2|Lost to Follow-up|4|||
16316550|NCT03989102|39644471|FG000|Year 2|Withdrawal by Subject|3|||
16316551|NCT03989102|39644472|FG001|Year 2|Withdrawal by Subject|1|||
16316552|NCT03989102|39644473|FG002|Year 2|Withdrawal by Subject|2|||
16392979|NCT00286091|39922226|FG000|Open-label Treatment Phase|Noncompliance|3|||
16392980|NCT00286091|39922227|FG001|Open-label Treatment Phase|Noncompliance|1|||
16392981|NCT00286091|39922226|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
16089967|NCT00614614|38820026|FG000|Booster Vaccination Phase|Other|0|||
16392982|NCT00286091|39922227|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
16392983|NCT00286091|39922226|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
16392984|NCT00286091|39922227|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
16316553|NCT03989102|39644471|FG000|Year 2|Subject non-compliant|3|||
16316554|NCT03989102|39644472|FG001|Year 2|Subject non-compliant|2|||
16316555|NCT03989102|39644473|FG002|Year 2|Subject non-compliant|0|||
16316556|NCT03989102|39644471|FG000|Year 2|Travel|1|||
16316557|NCT03989102|39644472|FG001|Year 2|Travel|0|||
16316558|NCT03989102|39644473|FG002|Year 2|Travel|1|||
16316559|NCT03989102|39644471|FG000|Year 2|P16 missing|4|||
16316560|NCT03989102|39644472|FG001|Year 2|P16 missing|2|||
16316561|NCT03989102|39644473|FG002|Year 2|P16 missing|1|||
16316562|NCT03989102|39644471|FG000|Year 2|P11 missing|1|||
16316563|NCT03989102|39644472|FG001|Year 2|P11 missing|3|||
16316564|NCT03989102|39644473|FG002|Year 2|P11 missing|7|||
16316565|NCT03989102|39644471|FG000|Year 2|Definitive displacement outside the study site|0|||
16316566|NCT03989102|39644472|FG001|Year 2|Definitive displacement outside the study site|1|||
16316567|NCT03989102|39644473|FG002|Year 2|Definitive displacement outside the study site|0|||
16316568|NCT03989102|39644471|FG000|Year 2|Subject missed last study visit|0|||
16316569|NCT03989102|39644472|FG001|Year 2|Subject missed last study visit|1|||
16316570|NCT03989102|39644473|FG002|Year 2|Subject missed last study visit|0|||
16316571|NCT03989102|39644471|FG000|Year 2|Death|0|||
16316572|NCT03989102|39644472|FG001|Year 2|Death|1|||
16316573|NCT03989102|39644473|FG002|Year 2|Death|0|||
16316574|NCT03989102|39644471|FG000|Year 2|Subject not reachable|0|||
16316575|NCT03989102|39644472|FG001|Year 2|Subject not reachable|0|||
16316576|NCT03989102|39644473|FG002|Year 2|Subject not reachable|1|||
16316577|NCT03989102|39644471|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
16316578|NCT03989102|39644472|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
16316579|NCT03989102|39644473|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
16316580|NCT03989102|39644471|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
16316581|NCT03989102|39644472|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
16316582|NCT03989102|39644473|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
16316583|NCT03989102|39644471|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
16316584|NCT03989102|39644472|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
16316585|NCT03989102|39644473|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
16316586|NCT03989102|39644471|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
16316587|NCT03989102|39644472|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
16316588|NCT03989102|39644473|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
16316589|NCT03989102|39644471|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
16316590|NCT03989102|39644472|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
16316591|NCT03989102|39644473|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
16316592|NCT03989102|39644471|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
16316593|NCT03989102|39644472|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
16316594|NCT03989102|39644473|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
16316595|NCT02748213|39644474|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
16316596|NCT02748213|39644475|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
16316597|NCT02748213|39644474|FG000|Overall Study|Abnormal Laboratory Test|1|||
16316598|NCT02748213|39644475|FG001|Overall Study|Abnormal Laboratory Test|0|||
16316599|NCT02748213|39644474|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
16316600|NCT02748213|39644475|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
16316601|NCT02748213|39644474|FG000|Overall Study|Death|5|||
16392985|NCT00286091|39922226|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
16392986|NCT00286091|39922227|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
16392987|NCT02998671|39922228|FG000|Period 1|Study Terminated By Sponsor|2|||
16392988|NCT02998671|39922229|FG001|Period 1|Study Terminated By Sponsor|1|||
16392989|NCT02998671|39922230|FG002|Period 1|Study Terminated By Sponsor|0|||
16392990|NCT02998671|39922231|FG003|Period 1|Study Terminated By Sponsor|0|||
16392991|NCT02998671|39922232|FG004|Period 1|Study Terminated By Sponsor|1|||
16392992|NCT02998671|39922228|FG000|Period 1|Withdrawal by Subject|1|||
16392993|NCT02998671|39922229|FG001|Period 1|Withdrawal by Subject|2|||
16392994|NCT02998671|39922230|FG002|Period 1|Withdrawal by Subject|0|||
16392995|NCT02998671|39922231|FG003|Period 1|Withdrawal by Subject|0|||
16392996|NCT02998671|39922232|FG004|Period 1|Withdrawal by Subject|2|||
16392997|NCT02998671|39922228|FG000|Period 1|Pregnancy|1|||
16392998|NCT02998671|39922229|FG001|Period 1|Pregnancy|0|||
16392999|NCT02998671|39922230|FG002|Period 1|Pregnancy|0|||
16393000|NCT02998671|39922231|FG003|Period 1|Pregnancy|0|||
16393001|NCT02998671|39922232|FG004|Period 1|Pregnancy|0|||
16393002|NCT02998671|39922228|FG000|Period 1|Adverse Event|0|||
16393003|NCT02998671|39922229|FG001|Period 1|Adverse Event|0|||
16393004|NCT02998671|39922230|FG002|Period 1|Adverse Event|0|||
16393005|NCT02998671|39922231|FG003|Period 1|Adverse Event|0|||
16393006|NCT02998671|39922232|FG004|Period 1|Adverse Event|1|||
16393007|NCT02998671|39922228|FG000|Period 2|Adverse Event|0|||
16393008|NCT02998671|39922229|FG001|Period 2|Adverse Event|1|||
16393009|NCT02998671|39922230|FG002|Period 2|Adverse Event|0|||
16393010|NCT02998671|39922231|FG003|Period 2|Adverse Event|0|||
16393011|NCT02998671|39922232|FG004|Period 2|Adverse Event|0|||
16393012|NCT02998671|39922228|FG000|Period 2|Study Terminated By Sponsor|3|||
16393013|NCT02998671|39922229|FG001|Period 2|Study Terminated By Sponsor|5|||
16393014|NCT02998671|39922230|FG002|Period 2|Study Terminated By Sponsor|1|||
16089968|NCT00614614|38820027|FG001|Booster Vaccination Phase|Other|1|||
16316602|NCT02748213|39644475|FG001|Overall Study|Death|3|||
16316603|NCT02748213|39644474|FG000|Overall Study|Insufficient Therapeutic Response|56|||
16316604|NCT02748213|39644475|FG001|Overall Study|Insufficient Therapeutic Response|57|||
16316605|NCT02748213|39644474|FG000|Overall Study|Violation of Selection Criteria|2|||
16316606|NCT02748213|39644475|FG001|Overall Study|Violation of Selection Criteria|0|||
16316607|NCT02748213|39644474|FG000|Overall Study|Protocol Violation|6|||
16393015|NCT02998671|39922231|FG003|Period 2|Study Terminated By Sponsor|3|||
16316608|NCT02748213|39644475|FG001|Overall Study|Protocol Violation|4|||
16316609|NCT02748213|39644474|FG000|Overall Study|Refused Treatment*|6|||
16316610|NCT02748213|39644475|FG001|Overall Study|Refused Treatment*|6|||
16316611|NCT02748213|39644474|FG000|Overall Study|Failure to Return|1|||
16316612|NCT02748213|39644475|FG001|Overall Study|Failure to Return|0|||
16316613|NCT02748213|39644474|FG000|Overall Study|Other|30|||
16316614|NCT02748213|39644475|FG001|Overall Study|Other|29|||
16316615|NCT00502242|39644479|FG000|Overall Study|Lack of Efficacy|1|||
16316616|NCT00502242|39644480|FG001|Overall Study|Lack of Efficacy|11|||
16316617|NCT00502242|39644479|FG000|Overall Study|Adverse Event|31|||
16316618|NCT00502242|39644480|FG001|Overall Study|Adverse Event|20|||
16316619|NCT00502242|39644479|FG000|Overall Study|Physician Decision|2|||
16316620|NCT00502242|39644480|FG001|Overall Study|Physician Decision|3|||
16316621|NCT00502242|39644479|FG000|Overall Study|Other - Unspecified|8|||
16316622|NCT00502242|39644480|FG001|Overall Study|Other - Unspecified|14|||
16316623|NCT00502242|39644479|FG000|Overall Study|Protocol Violation|3|||
16316624|NCT00502242|39644480|FG001|Overall Study|Protocol Violation|1|||
16316625|NCT00502242|39644479|FG000|Overall Study|Withdrawal by Subject|6|||
16316626|NCT00502242|39644480|FG001|Overall Study|Withdrawal by Subject|7|||
16316627|NCT02151851|39644481|FG000|Overall Study|Lack of Efficacy|67|||
16316628|NCT02151851|39644482|FG001|Overall Study|Lack of Efficacy|94|||
16393016|NCT02998671|39922232|FG004|Period 2|Study Terminated By Sponsor|0|||
16316629|NCT02151851|39644481|FG000|Overall Study|Protocol Violation|0|||
16393017|NCT02998671|39922228|FG000|Period 2|Withdrawal by Subject|0|||
16393018|NCT02998671|39922229|FG001|Period 2|Withdrawal by Subject|1|||
16393019|NCT02998671|39922230|FG002|Period 2|Withdrawal by Subject|0|||
16393020|NCT02998671|39922231|FG003|Period 2|Withdrawal by Subject|0|||
16393021|NCT02998671|39922232|FG004|Period 2|Withdrawal by Subject|0|||
16393022|NCT02998671|39922228|FG000|Period 2|Lost to Follow-up|0|||
16393023|NCT02998671|39922229|FG001|Period 2|Lost to Follow-up|0|||
16393024|NCT02998671|39922230|FG002|Period 2|Lost to Follow-up|0|||
16393025|NCT02998671|39922231|FG003|Period 2|Lost to Follow-up|1|||
16393026|NCT02998671|39922232|FG004|Period 2|Lost to Follow-up|0|||
16393027|NCT01107392|39922233|FG000|Overall Study|Adverse Event|2|||
16393028|NCT01107392|39922234|FG001|Overall Study|Adverse Event|0|||
16393029|NCT01107392|39922233|FG000|Overall Study|Personal Reasons|2|||
16393030|NCT01107392|39922234|FG001|Overall Study|Personal Reasons|3|||
16393031|NCT01107392|39922233|FG000|Overall Study|Administrative decision|1|||
16393032|NCT01107392|39922234|FG001|Overall Study|Administrative decision|0|||
16393033|NCT00437268|39922235|FG000|Overall Study|Adverse Event|1|||
16393034|NCT00437268|39922236|FG001|Overall Study|Adverse Event|1|||
16393035|NCT00437268|39922235|FG000|Overall Study|Withdrawal by Subject|2|||
16393036|NCT00437268|39922236|FG001|Overall Study|Withdrawal by Subject|2|||
16393037|NCT00437268|39922235|FG000|Overall Study|Progressive disease|9|||
16393038|NCT00437268|39922236|FG001|Overall Study|Progressive disease|9|||
16393039|NCT00437268|39922235|FG000|Overall Study|Physician Decision|1|||
16393040|NCT00437268|39922236|FG001|Overall Study|Physician Decision|0|||
16393041|NCT00437268|39922235|FG000|Overall Study|Death|0|||
16393042|NCT00437268|39922236|FG001|Overall Study|Death|1|||
16393043|NCT01833494|39922237|FG000|Overall Study|Adverse Event|24|||
16393044|NCT01833494|39922237|FG000|Overall Study|Physician Decision|6|||
16393045|NCT01833494|39922237|FG000|Overall Study|Withdrawal by Subject|6|||
16393046|NCT01833494|39922237|FG000|Overall Study|Decrease in serum phosphorus|4|||
16393047|NCT01833494|39922237|FG000|Overall Study|Decrease in serum calcium|4|||
16393048|NCT01833494|39922237|FG000|Overall Study|Increase in serum ferritin|1|||
16393049|NCT00699413|39922238|FG000|Overall Study|Withdrawal by Subject|0|||
16393050|NCT00699413|39922239|FG001|Overall Study|Withdrawal by Subject|2|||
16393051|NCT00699413|39922238|FG000|Overall Study|Study terminated by sponsor|4|||
16393052|NCT00699413|39922239|FG001|Overall Study|Study terminated by sponsor|2|||
16393053|NCT01194219|39922240|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
16511180|NCT01324388|40343996|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
16511181|NCT03299842|40343997|FG000|Overall Study|Caregiver withdrew consent|2|||
16511182|NCT03299842|40343997|FG000|Overall Study|Child would not keep the watch on|3|||
16511183|NCT02558790|40343999|FG000|Overall Study|Lost to Follow-up|2|||
16511184|NCT02558790|40343999|FG000|Overall Study|Physician Decision|1|||
16511185|NCT02558790|40343999|FG000|Overall Study|Withdrawal by Subject|1|||
16511186|NCT02558790|40343999|FG000|Overall Study|Screen Fail|3|||
16511187|NCT01494610|40344000|FG000|Period 1|Withdrawal by Subject|1|||
16393054|NCT01194219|39922241|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
16393055|NCT01194219|39922242|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16316630|NCT02151851|39644482|FG001|Overall Study|Protocol Violation|1|||
16316631|NCT02151851|39644481|FG000|Overall Study|Withdrawal by Subject|2|||
16316632|NCT02151851|39644482|FG001|Overall Study|Withdrawal by Subject|5|||
16316633|NCT02151851|39644481|FG000|Overall Study|Medical impairment|1|||
16316634|NCT02151851|39644482|FG001|Overall Study|Medical impairment|0|||
16316635|NCT02151851|39644481|FG000|Overall Study|Low compliance to study visits|0|||
16393056|NCT01194219|39922243|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16393057|NCT01194219|39922244|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16511188|NCT01494610|40344001|FG001|Period 1|Withdrawal by Subject|1|||
16199373|NCT00946881|39204629|FG000|First Treatment|Withdrawal by Subject|1|||
16199374|NCT00946881|39204629|FG000|First Treatment|Patient relocated to another state|1|||
16199375|NCT00946881|39204629|FG000|Retreatment|Withdrawal by Subject|1|||
16199376|NCT03497429|39204630|FG000|Overall Study|Progressive disease|3|||
16199377|NCT03497429|39204631|FG001|Overall Study|Progressive disease|4|||
16316636|NCT02151851|39644482|FG001|Overall Study|Low compliance to study visits|1|||
16316637|NCT02151851|39644481|FG000|Overall Study|Subject entered into study in error|0|||
16316638|NCT02151851|39644482|FG001|Overall Study|Subject entered into study in error|1|||
16316639|NCT02151851|39644481|FG000|Overall Study|Adverse Event|6|||
16316640|NCT02151851|39644482|FG001|Overall Study|Adverse Event|28|||
16316641|NCT03802825|39644487|FG000|Overall Study|Lost to follow-up for intervention|12|||
16199378|NCT03497429|39204630|FG000|Overall Study|Adverse Event|0|||
16199379|NCT03497429|39204631|FG001|Overall Study|Adverse Event|2|||
16316642|NCT03802825|39644488|FG001|Overall Study|Lost to follow-up for intervention|3|||
16316643|NCT03802825|39644487|FG000|Overall Study|Received only 1 component of intervention|0|||
16316644|NCT03802825|39644488|FG001|Overall Study|Received only 1 component of intervention|13|||
16316645|NCT04185220|39644489|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
16199380|NCT00650091|39204632|FG000|Amended Study Design|Withdrawal by Subject|12|||
16199381|NCT00650091|39204633|FG001|Amended Study Design|Withdrawal by Subject|11|||
16199382|NCT00650091|39204634|FG002|Amended Study Design|Withdrawal by Subject|0|||
16199383|NCT00650091|39204632|FG000|Amended Study Design|Physician Decision|5|||
16199384|NCT00650091|39204633|FG001|Amended Study Design|Physician Decision|0|||
16199385|NCT00650091|39204634|FG002|Amended Study Design|Physician Decision|0|||
16199386|NCT00650091|39204632|FG000|Amended Study Design|Adverse Event|1|||
16199387|NCT00650091|39204633|FG001|Amended Study Design|Adverse Event|4|||
16199388|NCT00650091|39204634|FG002|Amended Study Design|Adverse Event|0|||
16199389|NCT00650091|39204632|FG000|Amended Study Design|Lung transplantation|4|||
16199390|NCT00650091|39204633|FG001|Amended Study Design|Lung transplantation|2|||
16199391|NCT00650091|39204634|FG002|Amended Study Design|Lung transplantation|0|||
16199392|NCT00650091|39204632|FG000|Amended Study Design|Other|1|||
16199393|NCT00650091|39204633|FG001|Amended Study Design|Other|3|||
16199394|NCT00650091|39204634|FG002|Amended Study Design|Other|0|||
16199395|NCT00634114|39204635|FG000|Overall Study|Adverse Event|6|||
16199396|NCT00634114|39204636|FG001|Overall Study|Adverse Event|8|||
16199397|NCT00634114|39204637|FG002|Overall Study|Adverse Event|3|||
16199398|NCT00634114|39204635|FG000|Overall Study|Withdrawal by Subject|9|||
16199399|NCT00634114|39204636|FG001|Overall Study|Withdrawal by Subject|6|||
16199400|NCT00634114|39204637|FG002|Overall Study|Withdrawal by Subject|11|||
16199401|NCT00634114|39204635|FG000|Overall Study|Lost to Follow-up|0|||
16199402|NCT00634114|39204636|FG001|Overall Study|Lost to Follow-up|0|||
16199403|NCT00634114|39204637|FG002|Overall Study|Lost to Follow-up|1|||
16199404|NCT00634114|39204635|FG000|Overall Study|Protocol Violation|3|||
16199405|NCT00634114|39204636|FG001|Overall Study|Protocol Violation|3|||
16199406|NCT00634114|39204637|FG002|Overall Study|Protocol Violation|1|||
16199407|NCT00634114|39204635|FG000|Overall Study|Pregnancy|1|||
16199408|NCT00634114|39204636|FG001|Overall Study|Pregnancy|0|||
16199409|NCT00634114|39204637|FG002|Overall Study|Pregnancy|0|||
16199410|NCT00634114|39204635|FG000|Overall Study|Incorrect enrolment|0|||
16199411|NCT00634114|39204636|FG001|Overall Study|Incorrect enrolment|1|||
16316646|NCT04185220|39644490|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
16316647|NCT04185220|39644489|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
16316648|NCT04185220|39644490|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
16199412|NCT00634114|39204637|FG002|Overall Study|Incorrect enrolment|0|||
16199413|NCT00634114|39204635|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
16199414|NCT00634114|39204636|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
16199415|NCT00634114|39204637|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
16199416|NCT00634114|39204635|FG000|Overall Study|Difficult to continue|3|||
16199417|NCT00634114|39204636|FG001|Overall Study|Difficult to continue|1|||
16199418|NCT00634114|39204637|FG002|Overall Study|Difficult to continue|1|||
16199419|NCT00634114|39204635|FG000|Overall Study|Other reason|1|||
16199420|NCT00634114|39204636|FG001|Overall Study|Other reason|1|||
16199421|NCT00634114|39204637|FG002|Overall Study|Other reason|1|||
16199422|NCT04111107|39204638|FG000|Overall Study|Withdrawal by Subject|6|||
16199423|NCT04111107|39204638|FG000|Overall Study|Declining Health|5|||
16316649|NCT03225105|39644491|FG000|Overall Study|Withdrawal by Subject|1|||
16316650|NCT03225105|39644492|FG001|Overall Study|Withdrawal by Subject|0|||
16316651|NCT03225105|39644493|FG002|Overall Study|Withdrawal by Subject|0|||
16316652|NCT03225105|39644494|FG003|Overall Study|Withdrawal by Subject|0|||
16316653|NCT03225105|39644491|FG000|Overall Study|Death|0|||
16316654|NCT03225105|39644492|FG001|Overall Study|Death|4|||
16316655|NCT03225105|39644493|FG002|Overall Study|Death|2|||
16316656|NCT03225105|39644494|FG003|Overall Study|Death|0|||
16316657|NCT03225105|39644491|FG000|Overall Study|Study termination per Sponsor Decision|2|||
16316658|NCT03225105|39644492|FG001|Overall Study|Study termination per Sponsor Decision|0|||
16316659|NCT03225105|39644493|FG002|Overall Study|Study termination per Sponsor Decision|3|||
16316660|NCT03225105|39644494|FG003|Overall Study|Study termination per Sponsor Decision|3|||
16316661|NCT00462709|39644500|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
16316662|NCT00462709|39644500|FG000|Overall Study|Lost to Follow-up|10|||
16316663|NCT00462709|39644500|FG000|Overall Study|Withdrawal by Subject|8|||
16316664|NCT00462709|39644500|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
16316665|NCT00462709|39644500|FG000|Overall Study|Death|2|||
16316666|NCT00462709|39644500|FG000|Overall Study|Logistical reasons|2|||
16316667|NCT00462709|39644500|FG000|Overall Study|Physician Decision|1|||
16316668|NCT00462709|39644500|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
16316669|NCT00154284|39644501|FG000|Overall Study|Adverse Event|6|||
16316670|NCT00154284|39644502|FG001|Overall Study|Adverse Event|9|||
16316671|NCT00154284|39644501|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16316672|NCT00154284|39644502|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16316673|NCT00154284|39644501|FG000|Overall Study|Lack of Efficacy|1|||
16316674|NCT00154284|39644502|FG001|Overall Study|Lack of Efficacy|2|||
16316675|NCT00154284|39644501|FG000|Overall Study|Protocol Violation|0|||
16316676|NCT00154284|39644502|FG001|Overall Study|Protocol Violation|1|||
16316677|NCT04855760|39644518|FG000|Overall Study|Adverse Event|21|||
16316678|NCT04855760|39644518|FG000|Overall Study|Withdrawal by Subject|116|||
16316679|NCT04855760|39644518|FG000|Overall Study|Lack of Efficacy|21|||
16316680|NCT04855760|39644518|FG000|Overall Study|Lost to Follow-up|49|||
16316681|NCT04855760|39644518|FG000|Overall Study|Protocol Violation|2|||
16316682|NCT04855760|39644518|FG000|Overall Study|Physician Decision|5|||
16316683|NCT04855760|39644518|FG000|Overall Study|Pregnancy|1|||
16316684|NCT04855760|39644518|FG000|Overall Study|Non-Compliance with Study Drug|11|||
16316685|NCT04855760|39644518|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
16316686|NCT04855760|39644518|FG000|Overall Study|Study Completed by Sponsor|202|||
16316687|NCT04855760|39644518|FG000|Overall Study|Other|13|||
16316688|NCT01314872|39644520|FG000|Treatment Period 1|Protocol Violation|2|||
16316689|NCT01314872|39644521|FG001|Treatment Period 1|Protocol Violation|1|||
16316690|NCT01314872|39644522|FG002|Treatment Period 1|Protocol Violation|1|||
16316691|NCT01314872|39644523|FG003|Treatment Period 1|Protocol Violation|0|||
16316692|NCT01314872|39644524|FG004|Treatment Period 1|Protocol Violation|1|||
16316693|NCT01314872|39644525|FG005|Treatment Period 1|Protocol Violation|0|||
16316694|NCT01314872|39644526|FG006|Treatment Period 1|Protocol Violation|0|||
16316695|NCT01314872|39644527|FG007|Treatment Period 1|Protocol Violation|0|||
16316696|NCT01314872|39644528|FG008|Treatment Period 1|Protocol Violation|0|||
16316697|NCT01314872|39644529|FG009|Treatment Period 1|Protocol Violation|1|||
16316698|NCT01314872|39644530|FG010|Treatment Period 1|Protocol Violation|1|||
16316699|NCT01314872|39644531|FG011|Treatment Period 1|Protocol Violation|0|||
16316700|NCT01314872|39644532|FG012|Treatment Period 1|Protocol Violation|0|||
16316701|NCT01314872|39644533|FG013|Treatment Period 1|Protocol Violation|0|||
16316702|NCT01314872|39644534|FG014|Treatment Period 1|Protocol Violation|0|||
16316703|NCT01314872|39644520|FG000|Treatment Period 1|Physician Decision|0|||
16316704|NCT01314872|39644521|FG001|Treatment Period 1|Physician Decision|1|||
16316705|NCT01314872|39644522|FG002|Treatment Period 1|Physician Decision|0|||
16316706|NCT01314872|39644523|FG003|Treatment Period 1|Physician Decision|1|||
16316707|NCT01314872|39644524|FG004|Treatment Period 1|Physician Decision|0|||
16316708|NCT01314872|39644525|FG005|Treatment Period 1|Physician Decision|0|||
16316709|NCT01314872|39644526|FG006|Treatment Period 1|Physician Decision|0|||
16316710|NCT01314872|39644527|FG007|Treatment Period 1|Physician Decision|0|||
16316711|NCT01314872|39644528|FG008|Treatment Period 1|Physician Decision|0|||
16316712|NCT01314872|39644529|FG009|Treatment Period 1|Physician Decision|1|||
16316713|NCT01314872|39644530|FG010|Treatment Period 1|Physician Decision|0|||
16316714|NCT01314872|39644531|FG011|Treatment Period 1|Physician Decision|0|||
16316715|NCT01314872|39644532|FG012|Treatment Period 1|Physician Decision|0|||
16316716|NCT01314872|39644533|FG013|Treatment Period 1|Physician Decision|0|||
16316717|NCT01314872|39644534|FG014|Treatment Period 1|Physician Decision|0|||
16316718|NCT01314872|39644520|FG000|Treatment Period 1|Lack of Efficacy|1|||
16316719|NCT01314872|39644521|FG001|Treatment Period 1|Lack of Efficacy|0|||
16316720|NCT01314872|39644522|FG002|Treatment Period 1|Lack of Efficacy|0|||
16316721|NCT01314872|39644523|FG003|Treatment Period 1|Lack of Efficacy|0|||
16316722|NCT01314872|39644524|FG004|Treatment Period 1|Lack of Efficacy|0|||
16316723|NCT01314872|39644525|FG005|Treatment Period 1|Lack of Efficacy|1|||
16316724|NCT01314872|39644526|FG006|Treatment Period 1|Lack of Efficacy|0|||
16316725|NCT01314872|39644527|FG007|Treatment Period 1|Lack of Efficacy|2|||
16316726|NCT01314872|39644528|FG008|Treatment Period 1|Lack of Efficacy|0|||
16316727|NCT01314872|39644529|FG009|Treatment Period 1|Lack of Efficacy|0|||
16316728|NCT01314872|39644530|FG010|Treatment Period 1|Lack of Efficacy|0|||
16316729|NCT01314872|39644531|FG011|Treatment Period 1|Lack of Efficacy|0|||
16316730|NCT01314872|39644532|FG012|Treatment Period 1|Lack of Efficacy|0|||
16316731|NCT01314872|39644533|FG013|Treatment Period 1|Lack of Efficacy|0|||
16316732|NCT01314872|39644534|FG014|Treatment Period 1|Lack of Efficacy|0|||
16316733|NCT01314872|39644520|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
16316734|NCT01314872|39644521|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
16199424|NCT01441115|39204639|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
16316735|NCT01314872|39644522|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
16316736|NCT01314872|39644523|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
16316737|NCT01314872|39644524|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
16316738|NCT01314872|39644525|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
16316739|NCT01314872|39644526|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
16316740|NCT01314872|39644527|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
16316741|NCT01314872|39644528|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
16316742|NCT01314872|39644529|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
16316743|NCT01314872|39644530|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
16316744|NCT01314872|39644531|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
16316745|NCT01314872|39644532|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
16316746|NCT01314872|39644533|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
16316747|NCT01314872|39644534|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
16316748|NCT01314872|39644520|FG000|Treatment Period 1|Withdrawal by Subject|3|||
16316749|NCT01314872|39644521|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16316750|NCT01314872|39644522|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16316751|NCT01314872|39644523|FG003|Treatment Period 1|Withdrawal by Subject|2|||
16316752|NCT01314872|39644524|FG004|Treatment Period 1|Withdrawal by Subject|3|||
16316753|NCT01314872|39644525|FG005|Treatment Period 1|Withdrawal by Subject|1|||
16316754|NCT01314872|39644526|FG006|Treatment Period 1|Withdrawal by Subject|3|||
16316755|NCT01314872|39644527|FG007|Treatment Period 1|Withdrawal by Subject|2|||
16316756|NCT01314872|39644528|FG008|Treatment Period 1|Withdrawal by Subject|2|||
16316757|NCT01314872|39644529|FG009|Treatment Period 1|Withdrawal by Subject|2|||
16316758|NCT01314872|39644530|FG010|Treatment Period 1|Withdrawal by Subject|1|||
16316759|NCT01314872|39644531|FG011|Treatment Period 1|Withdrawal by Subject|0|||
16316760|NCT01314872|39644532|FG012|Treatment Period 1|Withdrawal by Subject|0|||
16316761|NCT01314872|39644533|FG013|Treatment Period 1|Withdrawal by Subject|0|||
16316762|NCT01314872|39644534|FG014|Treatment Period 1|Withdrawal by Subject|0|||
16316763|NCT01314872|39644520|FG000|Treatment Period 1|Lost to Follow-up|0|||
16316764|NCT01314872|39644521|FG001|Treatment Period 1|Lost to Follow-up|1|||
16316765|NCT01314872|39644522|FG002|Treatment Period 1|Lost to Follow-up|2|||
16316766|NCT01314872|39644523|FG003|Treatment Period 1|Lost to Follow-up|2|||
16316767|NCT01314872|39644524|FG004|Treatment Period 1|Lost to Follow-up|1|||
16316768|NCT01314872|39644525|FG005|Treatment Period 1|Lost to Follow-up|1|||
16316769|NCT01314872|39644526|FG006|Treatment Period 1|Lost to Follow-up|1|||
16316770|NCT01314872|39644527|FG007|Treatment Period 1|Lost to Follow-up|1|||
16316771|NCT01314872|39644528|FG008|Treatment Period 1|Lost to Follow-up|1|||
16316772|NCT01314872|39644529|FG009|Treatment Period 1|Lost to Follow-up|0|||
16316773|NCT01314872|39644530|FG010|Treatment Period 1|Lost to Follow-up|0|||
16316774|NCT01314872|39644531|FG011|Treatment Period 1|Lost to Follow-up|0|||
16316775|NCT01314872|39644532|FG012|Treatment Period 1|Lost to Follow-up|0|||
16316776|NCT01314872|39644533|FG013|Treatment Period 1|Lost to Follow-up|0|||
16316777|NCT01314872|39644534|FG014|Treatment Period 1|Lost to Follow-up|0|||
16316778|NCT01314872|39644520|FG000|Period 2|Protocol Violation|0|||
16316779|NCT01314872|39644521|FG001|Period 2|Protocol Violation|0|||
16316780|NCT01314872|39644522|FG002|Period 2|Protocol Violation|0|||
16316781|NCT01314872|39644523|FG003|Period 2|Protocol Violation|0|||
16316782|NCT01314872|39644524|FG004|Period 2|Protocol Violation|0|||
16316783|NCT01314872|39644525|FG005|Period 2|Protocol Violation|0|||
16316784|NCT01314872|39644526|FG006|Period 2|Protocol Violation|0|||
16316785|NCT01314872|39644527|FG007|Period 2|Protocol Violation|0|||
16316786|NCT01314872|39644528|FG008|Period 2|Protocol Violation|0|||
16316787|NCT01314872|39644529|FG009|Period 2|Protocol Violation|0|||
16393058|NCT01194219|39922245|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16393059|NCT01194219|39922246|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16393060|NCT01194219|39922247|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16393061|NCT01194219|39922248|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16393062|NCT01194219|39922249|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
16316788|NCT01314872|39644530|FG010|Period 2|Protocol Violation|0|||
16316789|NCT01314872|39644531|FG011|Period 2|Protocol Violation|3|||
16316790|NCT01314872|39644532|FG012|Period 2|Protocol Violation|3|||
16316791|NCT01314872|39644533|FG013|Period 2|Protocol Violation|2|||
16316792|NCT01314872|39644534|FG014|Period 2|Protocol Violation|0|||
16511189|NCT01494610|40344000|FG000|Period 3|Adverse Event|1|||
16511190|NCT01494610|40344001|FG001|Period 3|Adverse Event|0|||
16511191|NCT01494610|40344000|FG000|Period 3|Withdrawal by Subject|1|||
16511192|NCT01494610|40344001|FG001|Period 3|Withdrawal by Subject|0|||
16511193|NCT01494610|40344000|FG000|Period 4|Protocol Violation|1|||
16511194|NCT01494610|40344001|FG001|Period 4|Protocol Violation|0|||
16316793|NCT01314872|39644520|FG000|Period 2|Non-compliance with study drug|0|||
16316794|NCT01314872|39644521|FG001|Period 2|Non-compliance with study drug|0|||
16316795|NCT01314872|39644522|FG002|Period 2|Non-compliance with study drug|0|||
16316796|NCT01314872|39644523|FG003|Period 2|Non-compliance with study drug|0|||
16316797|NCT01314872|39644524|FG004|Period 2|Non-compliance with study drug|0|||
16316798|NCT01314872|39644525|FG005|Period 2|Non-compliance with study drug|0|||
16316799|NCT01314872|39644526|FG006|Period 2|Non-compliance with study drug|0|||
16316800|NCT01314872|39644527|FG007|Period 2|Non-compliance with study drug|0|||
16316801|NCT01314872|39644528|FG008|Period 2|Non-compliance with study drug|0|||
16316802|NCT01314872|39644529|FG009|Period 2|Non-compliance with study drug|0|||
16316803|NCT01314872|39644530|FG010|Period 2|Non-compliance with study drug|0|||
16316804|NCT01314872|39644531|FG011|Period 2|Non-compliance with study drug|3|||
16316805|NCT01314872|39644532|FG012|Period 2|Non-compliance with study drug|3|||
16316806|NCT01314872|39644533|FG013|Period 2|Non-compliance with study drug|1|||
16316807|NCT01314872|39644534|FG014|Period 2|Non-compliance with study drug|2|||
16316808|NCT01314872|39644520|FG000|Period 2|Lack of Efficacy|0|||
16316809|NCT01314872|39644521|FG001|Period 2|Lack of Efficacy|0|||
16316810|NCT01314872|39644522|FG002|Period 2|Lack of Efficacy|0|||
16316811|NCT01314872|39644523|FG003|Period 2|Lack of Efficacy|0|||
16316812|NCT01314872|39644524|FG004|Period 2|Lack of Efficacy|0|||
16316813|NCT01314872|39644525|FG005|Period 2|Lack of Efficacy|0|||
16316814|NCT01314872|39644526|FG006|Period 2|Lack of Efficacy|0|||
16316815|NCT01314872|39644527|FG007|Period 2|Lack of Efficacy|0|||
16316816|NCT01314872|39644528|FG008|Period 2|Lack of Efficacy|0|||
16316817|NCT01314872|39644529|FG009|Period 2|Lack of Efficacy|0|||
16316818|NCT01314872|39644530|FG010|Period 2|Lack of Efficacy|0|||
16316819|NCT01314872|39644531|FG011|Period 2|Lack of Efficacy|7|||
16316820|NCT01314872|39644532|FG012|Period 2|Lack of Efficacy|12|||
16316821|NCT01314872|39644533|FG013|Period 2|Lack of Efficacy|9|||
16316822|NCT01314872|39644534|FG014|Period 2|Lack of Efficacy|2|||
16316823|NCT01314872|39644520|FG000|Period 2|Pregnancy|0|||
16316824|NCT01314872|39644521|FG001|Period 2|Pregnancy|0|||
16316825|NCT01314872|39644522|FG002|Period 2|Pregnancy|0|||
16316826|NCT01314872|39644523|FG003|Period 2|Pregnancy|0|||
16316827|NCT01314872|39644524|FG004|Period 2|Pregnancy|0|||
16316828|NCT01314872|39644525|FG005|Period 2|Pregnancy|0|||
16316829|NCT01314872|39644526|FG006|Period 2|Pregnancy|0|||
16316830|NCT01314872|39644527|FG007|Period 2|Pregnancy|0|||
16316831|NCT01314872|39644528|FG008|Period 2|Pregnancy|0|||
16316832|NCT01314872|39644529|FG009|Period 2|Pregnancy|0|||
16316833|NCT01314872|39644530|FG010|Period 2|Pregnancy|0|||
16316834|NCT01314872|39644531|FG011|Period 2|Pregnancy|0|||
16511195|NCT00655564|40344002|FG000|Overall Study|Adverse Event|1|||
16199425|NCT02475850|39204642|FG000|Overall Study|Death|155|||
16199426|NCT02475850|39204643|FG001|Overall Study|Death|141|||
16199427|NCT02475850|39204642|FG000|Overall Study|Lost to Follow-up|217|||
16199428|NCT02475850|39204643|FG001|Overall Study|Lost to Follow-up|188|||
16199429|NCT02475850|39204642|FG000|Overall Study|Withdrawal by Subject|221|||
16199430|NCT02475850|39204643|FG001|Overall Study|Withdrawal by Subject|155|||
16199431|NCT02709083|39204644|FG000|Overall Study|Original PI left institution|7|||
16199432|NCT03325556|39204645|FG000|Open-label Period|Lack of Response in OL period|70|||
16199433|NCT03325556|39204646|FG001|Open-label Period|Lack of Response in OL period|0|||
16199434|NCT03325556|39204647|FG002|Open-label Period|Lack of Response in OL period|0|||
16199435|NCT03325556|39204645|FG000|Open-label Period|Adverse Event|27|||
16199436|NCT03325556|39204646|FG001|Open-label Period|Adverse Event|0|||
16199437|NCT03325556|39204647|FG002|Open-label Period|Adverse Event|0|||
16199438|NCT03325556|39204645|FG000|Open-label Period|Death|1|||
16199439|NCT03325556|39204646|FG001|Open-label Period|Death|0|||
16316835|NCT01314872|39644532|FG012|Period 2|Pregnancy|0|||
16511196|NCT00655564|40344002|FG000|Overall Study|Lost to Follow-up|1|||
16511197|NCT00655564|40344002|FG000|Overall Study|Desired Alternate Therapy|1|||
16199440|NCT03325556|39204647|FG002|Open-label Period|Death|0|||
16316836|NCT01314872|39644533|FG013|Period 2|Pregnancy|0|||
16199441|NCT03325556|39204645|FG000|Open-label Period|Lost to Follow-up|1|||
16199442|NCT03325556|39204646|FG001|Open-label Period|Lost to Follow-up|0|||
16316837|NCT01314872|39644534|FG014|Period 2|Pregnancy|1|||
16316838|NCT01314872|39644520|FG000|Period 2|Study terminated by Sponsor|0|||
16316839|NCT01314872|39644521|FG001|Period 2|Study terminated by Sponsor|0|||
16316840|NCT01314872|39644522|FG002|Period 2|Study terminated by Sponsor|0|||
16316841|NCT01314872|39644523|FG003|Period 2|Study terminated by Sponsor|0|||
16511198|NCT02126969|40344003|FG000|Overall Study|Withdrawal by Subject|1|||
16511199|NCT02126969|40344004|FG001|Overall Study|Withdrawal by Subject|2|||
16089969|NCT00614614|38820028|FG002|Booster Vaccination Phase|Other|3|||
16316842|NCT01314872|39644524|FG004|Period 2|Study terminated by Sponsor|0|||
16316843|NCT01314872|39644525|FG005|Period 2|Study terminated by Sponsor|0|||
16316844|NCT01314872|39644526|FG006|Period 2|Study terminated by Sponsor|0|||
16316845|NCT01314872|39644527|FG007|Period 2|Study terminated by Sponsor|0|||
16316846|NCT01314872|39644528|FG008|Period 2|Study terminated by Sponsor|0|||
16316847|NCT01314872|39644529|FG009|Period 2|Study terminated by Sponsor|0|||
16316848|NCT01314872|39644530|FG010|Period 2|Study terminated by Sponsor|0|||
16316849|NCT01314872|39644531|FG011|Period 2|Study terminated by Sponsor|2|||
16316850|NCT01314872|39644532|FG012|Period 2|Study terminated by Sponsor|2|||
16316851|NCT01314872|39644533|FG013|Period 2|Study terminated by Sponsor|3|||
16316852|NCT01314872|39644534|FG014|Period 2|Study terminated by Sponsor|0|||
16316853|NCT01314872|39644520|FG000|Period 2|Adverse event, non-fatal|0|||
16316854|NCT01314872|39644521|FG001|Period 2|Adverse event, non-fatal|0|||
16316855|NCT01314872|39644522|FG002|Period 2|Adverse event, non-fatal|0|||
16316856|NCT01314872|39644523|FG003|Period 2|Adverse event, non-fatal|0|||
16316857|NCT01314872|39644524|FG004|Period 2|Adverse event, non-fatal|0|||
16316858|NCT01314872|39644525|FG005|Period 2|Adverse event, non-fatal|0|||
16316859|NCT01314872|39644526|FG006|Period 2|Adverse event, non-fatal|0|||
16316860|NCT01314872|39644527|FG007|Period 2|Adverse event, non-fatal|0|||
16316861|NCT01314872|39644528|FG008|Period 2|Adverse event, non-fatal|0|||
16316862|NCT01314872|39644529|FG009|Period 2|Adverse event, non-fatal|0|||
16316863|NCT01314872|39644530|FG010|Period 2|Adverse event, non-fatal|0|||
16316864|NCT01314872|39644531|FG011|Period 2|Adverse event, non-fatal|13|||
16316865|NCT01314872|39644532|FG012|Period 2|Adverse event, non-fatal|16|||
16316866|NCT01314872|39644533|FG013|Period 2|Adverse event, non-fatal|24|||
16316867|NCT01314872|39644534|FG014|Period 2|Adverse event, non-fatal|9|||
16316868|NCT01314872|39644520|FG000|Period 2|Withdrawal by Subject|0|||
16511200|NCT00838201|40344005|FG000|Overall Study|Investigator decision, or other reasons|2|||
16511201|NCT00838201|40344006|FG001|Overall Study|Investigator decision, or other reasons|3|||
16511202|NCT00838201|40344005|FG000|Overall Study|Noncompliance|0|||
16511203|NCT00838201|40344006|FG001|Overall Study|Noncompliance|1|||
16511204|NCT00838201|40344005|FG000|Overall Study|Administrative decision|1|||
16511205|NCT00838201|40344006|FG001|Overall Study|Administrative decision|2|||
16511206|NCT00838201|40344005|FG000|Overall Study|Disease progression|3|||
16511207|NCT00838201|40344006|FG001|Overall Study|Disease progression|3|||
16511208|NCT00838201|40344005|FG000|Overall Study|Consent withdrawn|16|||
16511209|NCT00838201|40344006|FG001|Overall Study|Consent withdrawn|19|||
16511210|NCT00838201|40344005|FG000|Overall Study|Lost to Follow-up|4|||
16511211|NCT00838201|40344006|FG001|Overall Study|Lost to Follow-up|3|||
16511212|NCT00838201|40344005|FG000|Overall Study|Adverse Event|5|||
16511213|NCT00838201|40344006|FG001|Overall Study|Adverse Event|9|||
16511214|NCT00838201|40344005|FG000|Overall Study|Death|11|||
16511215|NCT00838201|40344006|FG001|Overall Study|Death|13|||
16511216|NCT01354496|40344007|FG000|Period 1|Adverse Event|0|||
16511217|NCT01354496|40344008|FG001|Period 1|Adverse Event|0|||
16511218|NCT01354496|40344009|FG002|Period 1|Adverse Event|1|||
16511219|NCT01354496|40344010|FG003|Period 1|Adverse Event|0|||
16511220|NCT01354496|40344011|FG004|Period 1|Adverse Event|0|||
16511221|NCT01354496|40344012|FG005|Period 1|Adverse Event|0|||
16511222|NCT01354496|40344007|FG000|Period 1|Physician Decision|0|||
16511223|NCT01354496|40344008|FG001|Period 1|Physician Decision|0|||
16089970|NCT00614614|38820029|FG003|Booster Vaccination Phase|Other|2|||
16089971|NCT00614614|38820030|FG004|Booster Vaccination Phase|Other|1|||
16089972|NCT02077374|38820039|FG000|Overall Study|Withdrawal by Subject|0|||
16089973|NCT02077374|38820040|FG001|Overall Study|Withdrawal by Subject|1|||
16511224|NCT01354496|40344009|FG002|Period 1|Physician Decision|1|||
16511225|NCT01354496|40344010|FG003|Period 1|Physician Decision|0|||
16089974|NCT02077374|38820039|FG000|Overall Study|Protocol Violation|0|||
16089975|NCT02077374|38820040|FG001|Overall Study|Protocol Violation|1|||
16089976|NCT03140670|38820041|FG000|Overall Study|Withdrawal by Subject|2|||
16089977|NCT03140670|38820041|FG000|Overall Study|Lost to Follow-up|1|||
16089978|NCT03140670|38820041|FG000|Overall Study|Physician Decision|1|||
16089979|NCT02542943|38820042|FG000|Overall Study|Lost to Follow-up|1|||
16089980|NCT02542943|38820043|FG001|Overall Study|Lost to Follow-up|0|||
16089981|NCT02542943|38820044|FG002|Overall Study|Lost to Follow-up|0|||
16089982|NCT02542943|38820042|FG000|Overall Study|Withdrawal by Subject|0|||
16089983|NCT02542943|38820043|FG001|Overall Study|Withdrawal by Subject|1|||
16316869|NCT01314872|39644521|FG001|Period 2|Withdrawal by Subject|0|||
16089984|NCT02542943|38820044|FG002|Overall Study|Withdrawal by Subject|0|||
16089985|NCT02506192|38820045|FG000|Overall Study|Withdrawal by Subject|1|||
16316870|NCT01314872|39644522|FG002|Period 2|Withdrawal by Subject|0|||
16316871|NCT01314872|39644523|FG003|Period 2|Withdrawal by Subject|0|||
16316872|NCT01314872|39644524|FG004|Period 2|Withdrawal by Subject|0|||
16511226|NCT01354496|40344011|FG004|Period 1|Physician Decision|0|||
16511227|NCT01354496|40344012|FG005|Period 1|Physician Decision|0|||
16511228|NCT01354496|40344007|FG000|Period 2|Adverse Event|0|||
16511229|NCT01354496|40344008|FG001|Period 2|Adverse Event|0|||
16511230|NCT01354496|40344009|FG002|Period 2|Adverse Event|0|||
16511231|NCT01354496|40344010|FG003|Period 2|Adverse Event|1|||
16511232|NCT01354496|40344011|FG004|Period 2|Adverse Event|0|||
16511233|NCT01354496|40344012|FG005|Period 2|Adverse Event|0|||
16511234|NCT01354496|40344007|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
16511235|NCT01354496|40344008|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
16511236|NCT01354496|40344009|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
16511237|NCT01354496|40344010|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
16511238|NCT01354496|40344011|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
16511239|NCT01354496|40344012|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
16511240|NCT04193176|40344013|FG000|Overall Study|Withdrawal by Subject|6|||
16511241|NCT04193176|40344014|FG001|Overall Study|Withdrawal by Subject|10|||
16511242|NCT00692770|40344015|FG000|Overall Study|Protocol Violation|2|||
16511243|NCT00692770|40344016|FG001|Overall Study|Protocol Violation|7|||
16511244|NCT00692770|40344015|FG000|Overall Study|Withdrawal by Subject|97|||
16511245|NCT00692770|40344016|FG001|Overall Study|Withdrawal by Subject|36|||
16511246|NCT00692770|40344015|FG000|Overall Study|Adverse Event|136|||
16511247|NCT00692770|40344016|FG001|Overall Study|Adverse Event|41|||
16511248|NCT00692770|40344015|FG000|Overall Study|Death|10|||
16199443|NCT03325556|39204647|FG002|Open-label Period|Lost to Follow-up|0|||
16199444|NCT03325556|39204645|FG000|Open-label Period|Non-compliance with study drug|5|||
16199445|NCT03325556|39204646|FG001|Open-label Period|Non-compliance with study drug|0|||
16199446|NCT03325556|39204647|FG002|Open-label Period|Non-compliance with study drug|0|||
16199447|NCT03325556|39204645|FG000|Open-label Period|Use of prohibited medication|1|||
16199448|NCT03325556|39204646|FG001|Open-label Period|Use of prohibited medication|0|||
16199449|NCT03325556|39204647|FG002|Open-label Period|Use of prohibited medication|0|||
16199450|NCT03325556|39204645|FG000|Open-label Period|Protocol Violation|4|||
16199451|NCT03325556|39204646|FG001|Open-label Period|Protocol Violation|0|||
16199452|NCT03325556|39204647|FG002|Open-label Period|Protocol Violation|0|||
16199453|NCT03325556|39204645|FG000|Open-label Period|Withdrawal by Subject|17|||
16199454|NCT03325556|39204646|FG001|Open-label Period|Withdrawal by Subject|0|||
16199455|NCT03325556|39204647|FG002|Open-label Period|Withdrawal by Subject|0|||
16199456|NCT03325556|39204645|FG000|Open-label Period|Not otherwise specified|8|||
16199457|NCT03325556|39204646|FG001|Open-label Period|Not otherwise specified|0|||
16199458|NCT03325556|39204647|FG002|Open-label Period|Not otherwise specified|0|||
16199459|NCT03325556|39204645|FG000|Open-label Period|Administrative discont. at study termination|41|||
16199460|NCT03325556|39204646|FG001|Open-label Period|Administrative discont. at study termination|0|||
16199461|NCT03325556|39204647|FG002|Open-label Period|Administrative discont. at study termination|0|||
16199462|NCT03325556|39204645|FG000|Double-blind Period|Relapse|0|||
16199463|NCT03325556|39204646|FG001|Double-blind Period|Relapse|15|||
16199464|NCT03325556|39204647|FG002|Double-blind Period|Relapse|34|||
16199465|NCT03325556|39204645|FG000|Double-blind Period|Adverse Event|0|||
16199466|NCT03325556|39204646|FG001|Double-blind Period|Adverse Event|3|||
16199467|NCT03325556|39204647|FG002|Double-blind Period|Adverse Event|1|||
16199468|NCT03325556|39204645|FG000|Double-blind Period|Noncompliance with study drug|0|||
16199469|NCT03325556|39204646|FG001|Double-blind Period|Noncompliance with study drug|0|||
16199470|NCT03325556|39204647|FG002|Double-blind Period|Noncompliance with study drug|1|||
16199471|NCT03325556|39204645|FG000|Double-blind Period|Use of prohibited medication|0|||
16199472|NCT03325556|39204646|FG001|Double-blind Period|Use of prohibited medication|1|||
16199473|NCT03325556|39204647|FG002|Double-blind Period|Use of prohibited medication|0|||
16199474|NCT03325556|39204645|FG000|Double-blind Period|Physician Decision|0|||
16199475|NCT03325556|39204646|FG001|Double-blind Period|Physician Decision|0|||
16199476|NCT03325556|39204647|FG002|Double-blind Period|Physician Decision|1|||
16199477|NCT03325556|39204645|FG000|Double-blind Period|Withdrawal by Subject|0|||
16199478|NCT03325556|39204646|FG001|Double-blind Period|Withdrawal by Subject|6|||
16199479|NCT03325556|39204647|FG002|Double-blind Period|Withdrawal by Subject|4|||
16199480|NCT03325556|39204645|FG000|Double-blind Period|Not otherwise specified|0|||
16199481|NCT03325556|39204646|FG001|Double-blind Period|Not otherwise specified|1|||
16199482|NCT03325556|39204647|FG002|Double-blind Period|Not otherwise specified|5|||
16199483|NCT03325556|39204645|FG000|Double-blind Period|Administrative discont. at study termination|0|||
16199484|NCT03325556|39204646|FG001|Double-blind Period|Administrative discont. at study termination|35|||
16199485|NCT03325556|39204647|FG002|Double-blind Period|Administrative discont. at study termination|31|||
16199486|NCT01681576|39204649|FG000|Period 1|Adverse Event|1|||
16199487|NCT01681576|39204650|FG001|Period 1|Adverse Event|0|||
16199488|NCT01681576|39204649|FG000|Period 1|Protocol Deviation|1|||
16199489|NCT01681576|39204650|FG001|Period 1|Protocol Deviation|0|||
16199490|NCT01681576|39204649|FG000|Period 2|subject/guardian decision|3|||
16511249|NCT00692770|40344016|FG001|Overall Study|Death|5|||
16199491|NCT01681576|39204650|FG001|Period 2|subject/guardian decision|1|||
16199492|NCT01681576|39204649|FG000|Period 2|Non-compliance with study treatment|1|||
16199493|NCT01681576|39204650|FG001|Period 2|Non-compliance with study treatment|0|||
16199494|NCT01021813|39204651|FG000|DB Treatment Phase|Adverse Event|60|||
16199495|NCT01021813|39204652|FG001|DB Treatment Phase|Adverse Event|22|||
16199496|NCT01021813|39204653|FG002|DB Treatment Phase|Adverse Event|0|||
16199497|NCT01021813|39204654|FG003|DB Treatment Phase|Adverse Event|0|||
16511250|NCT00692770|40344015|FG000|Overall Study|Lost to Follow-up|7|||
16199498|NCT01021813|39204655|FG004|DB Treatment Phase|Adverse Event|0|||
16199499|NCT01021813|39204651|FG000|DB Treatment Phase|Lack of Efficacy|44|||
16199500|NCT01021813|39204652|FG001|DB Treatment Phase|Lack of Efficacy|28|||
16199501|NCT01021813|39204653|FG002|DB Treatment Phase|Lack of Efficacy|0|||
16199502|NCT01021813|39204654|FG003|DB Treatment Phase|Lack of Efficacy|0|||
16199503|NCT01021813|39204655|FG004|DB Treatment Phase|Lack of Efficacy|0|||
16199504|NCT01021813|39204651|FG000|DB Treatment Phase|Lost to Follow-up|14|||
16199505|NCT01021813|39204652|FG001|DB Treatment Phase|Lost to Follow-up|12|||
16199506|NCT01021813|39204653|FG002|DB Treatment Phase|Lost to Follow-up|0|||
16199507|NCT01021813|39204654|FG003|DB Treatment Phase|Lost to Follow-up|0|||
16199508|NCT01021813|39204655|FG004|DB Treatment Phase|Lost to Follow-up|0|||
16199509|NCT01021813|39204651|FG000|DB Treatment Phase|Physician Decision|17|||
16199510|NCT01021813|39204652|FG001|DB Treatment Phase|Physician Decision|8|||
16199511|NCT01021813|39204653|FG002|DB Treatment Phase|Physician Decision|0|||
16199512|NCT01021813|39204654|FG003|DB Treatment Phase|Physician Decision|0|||
16199513|NCT01021813|39204655|FG004|DB Treatment Phase|Physician Decision|0|||
16199514|NCT01021813|39204651|FG000|DB Treatment Phase|Pregnancy|1|||
16199515|NCT01021813|39204652|FG001|DB Treatment Phase|Pregnancy|0|||
16199516|NCT01021813|39204653|FG002|DB Treatment Phase|Pregnancy|0|||
16199517|NCT01021813|39204654|FG003|DB Treatment Phase|Pregnancy|0|||
16199518|NCT01021813|39204655|FG004|DB Treatment Phase|Pregnancy|0|||
16199519|NCT01021813|39204651|FG000|DB Treatment Phase|Protocol Violation|4|||
16199520|NCT01021813|39204652|FG001|DB Treatment Phase|Protocol Violation|3|||
16199521|NCT01021813|39204653|FG002|DB Treatment Phase|Protocol Violation|0|||
16199522|NCT01021813|39204654|FG003|DB Treatment Phase|Protocol Violation|0|||
16199523|NCT01021813|39204655|FG004|DB Treatment Phase|Protocol Violation|0|||
16199524|NCT01021813|39204651|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
16199525|NCT01021813|39204652|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
16199526|NCT01021813|39204653|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
16199527|NCT01021813|39204654|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
16199528|NCT01021813|39204655|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
16199529|NCT01021813|39204651|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
16199530|NCT01021813|39204652|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
16089986|NCT02506192|38820046|FG001|Overall Study|Withdrawal by Subject|1|||
16089987|NCT04497415|38820047|FG000|Overall Study|Lost to Follow-up|43|||
16089988|NCT04497415|38820048|FG001|Overall Study|Lost to Follow-up|27|||
16089989|NCT01706159|38820049|FG000|Overall Study|Withdrawal Criteria|2|||
16089990|NCT01706159|38820050|FG001|Overall Study|Withdrawal Criteria|1|||
16089991|NCT01706159|38820049|FG000|Overall Study|Unclassified|6|||
16089992|NCT01706159|38820050|FG001|Overall Study|Unclassified|1|||
16511251|NCT00692770|40344016|FG001|Overall Study|Lost to Follow-up|3|||
16511252|NCT00692770|40344015|FG000|Overall Study|Non-compliant with study medication|11|||
16511253|NCT00692770|40344016|FG001|Overall Study|Non-compliant with study medication|5|||
16511254|NCT00692770|40344015|FG000|Overall Study|Progression by clinical judgment|2|||
16511255|NCT00692770|40344016|FG001|Overall Study|Progression by clinical judgment|3|||
16511256|NCT00692770|40344015|FG000|Overall Study|Physician decision not protocol driven|10|||
16511257|NCT00692770|40344016|FG001|Overall Study|Physician decision not protocol driven|14|||
16089993|NCT03865732|38820051|FG000|Overall Study|Adverse Event|0|||
16089994|NCT03865732|38820052|FG001|Overall Study|Adverse Event|1|||
16089995|NCT00871715|38820053|FG000|Overall Study|Withdrawal by Subject|6|||
16089996|NCT00871715|38820054|FG001|Overall Study|Withdrawal by Subject|10|||
16089997|NCT00871715|38820055|FG002|Overall Study|Withdrawal by Subject|15|||
16511258|NCT00692770|40344015|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
16511259|NCT00692770|40344016|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
16511260|NCT00692770|40344015|FG000|Overall Study|Protocol driven decision point|3|||
16511261|NCT00692770|40344016|FG001|Overall Study|Protocol driven decision point|7|||
16511262|NCT00692770|40344015|FG000|Overall Study|Completed all planned assessments|79|||
16511263|NCT00692770|40344016|FG001|Overall Study|Completed all planned assessments|101|||
16089998|NCT00871715|38820053|FG000|Overall Study|Physician Decision|6|||
16089999|NCT00871715|38820054|FG001|Overall Study|Physician Decision|0|||
16090000|NCT00871715|38820055|FG002|Overall Study|Physician Decision|2|||
16090001|NCT00871715|38820053|FG000|Overall Study|Lost to Follow-up|3|||
16090002|NCT00871715|38820054|FG001|Overall Study|Lost to Follow-up|6|||
16090003|NCT00871715|38820055|FG002|Overall Study|Lost to Follow-up|9|||
16090004|NCT02674399|38820058|FG000|Overall Study|Lost to Follow-up|2|||
16090005|NCT02674399|38820059|FG001|Overall Study|Lost to Follow-up|0|||
16199531|NCT01021813|39204653|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
16316873|NCT01314872|39644525|FG005|Period 2|Withdrawal by Subject|0|||
16316874|NCT01314872|39644526|FG006|Period 2|Withdrawal by Subject|0|||
16316875|NCT01314872|39644527|FG007|Period 2|Withdrawal by Subject|0|||
16316876|NCT01314872|39644528|FG008|Period 2|Withdrawal by Subject|0|||
16316877|NCT01314872|39644529|FG009|Period 2|Withdrawal by Subject|0|||
16316878|NCT01314872|39644530|FG010|Period 2|Withdrawal by Subject|0|||
16316879|NCT01314872|39644531|FG011|Period 2|Withdrawal by Subject|14|||
16316880|NCT01314872|39644532|FG012|Period 2|Withdrawal by Subject|17|||
16316881|NCT01314872|39644533|FG013|Period 2|Withdrawal by Subject|12|||
16090006|NCT00357994|38820060|FG000|Overall Study|Adverse Event|1|||
16090007|NCT00357994|38820061|FG001|Overall Study|Adverse Event|2|||
16090008|NCT00357994|38820060|FG000|Overall Study|Lack of Efficacy|0|||
16090009|NCT00357994|38820061|FG001|Overall Study|Lack of Efficacy|1|||
16090010|NCT00357994|38820060|FG000|Overall Study|Protocol Violation|1|||
16090011|NCT00357994|38820061|FG001|Overall Study|Protocol Violation|0|||
16090012|NCT01683409|38820062|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
16090013|NCT01683409|38820063|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
16090014|NCT01683409|38820064|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
16090015|NCT01683409|38820065|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
16090016|NCT01683409|38820066|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
16090017|NCT01683409|38820062|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
16090018|NCT01683409|38820063|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
16393063|NCT01194219|39922240|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
16393064|NCT01194219|39922241|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
16393065|NCT01194219|39922242|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16393066|NCT01194219|39922243|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16393067|NCT01194219|39922244|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16393068|NCT01194219|39922245|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16393069|NCT01194219|39922246|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16393070|NCT01194219|39922247|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16393071|NCT01194219|39922248|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16393072|NCT01194219|39922249|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
16393073|NCT01194219|39922240|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
16393074|NCT01194219|39922241|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16393075|NCT01194219|39922242|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16393076|NCT01194219|39922243|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16393077|NCT01194219|39922244|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16393078|NCT01194219|39922245|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16393079|NCT01194219|39922246|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16393080|NCT01194219|39922247|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16393081|NCT01194219|39922248|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16393082|NCT01194219|39922249|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
16393083|NCT01194219|39922240|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
16393084|NCT01194219|39922241|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
16393085|NCT01194219|39922242|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16393086|NCT01194219|39922243|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16393087|NCT01194219|39922244|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16393088|NCT01194219|39922245|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16393089|NCT01194219|39922246|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16393090|NCT01194219|39922247|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16393091|NCT01194219|39922248|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16393092|NCT01194219|39922249|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
16393093|NCT01194219|39922240|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16393094|NCT01194219|39922241|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
16393095|NCT01194219|39922242|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16393096|NCT01194219|39922243|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16393097|NCT01194219|39922244|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16393098|NCT01194219|39922245|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16393099|NCT01194219|39922246|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16393100|NCT01194219|39922247|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16393101|NCT01194219|39922248|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16393102|NCT01194219|39922249|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
16393103|NCT01194219|39922240|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
16393104|NCT01194219|39922241|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
16393105|NCT01194219|39922242|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16393106|NCT01194219|39922243|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16511264|NCT00692770|40344015|FG000|Overall Study|Radiological and clinical progression|8|||
16511265|NCT00692770|40344016|FG001|Overall Study|Radiological and clinical progression|8|||
16511266|NCT00692770|40344015|FG000|Overall Study|Clinical endpoint reached|16|||
16511267|NCT00692770|40344016|FG001|Overall Study|Clinical endpoint reached|43|||
16511268|NCT00692770|40344015|FG000|Overall Study|Study terminated by sponsor|2|||
16511269|NCT00692770|40344016|FG001|Overall Study|Study terminated by sponsor|2|||
16511270|NCT00692770|40344015|FG000|Overall Study|Randomized but not treated|3|||
16511271|NCT00692770|40344016|FG001|Overall Study|Randomized but not treated|4|||
16090019|NCT01683409|38820064|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
16199532|NCT01021813|39204654|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
16199533|NCT01021813|39204655|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
16511272|NCT02286193|40344023|FG000|Overall Study|Referred: CRS unable to make contact|62|||
16511273|NCT02286193|40344023|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
16511274|NCT02286193|40344023|FG000|Overall Study|Referred: Declined service|38|||
16511275|NCT00969553|40344025|FG000|Overall Study|Progressive disease (PD)|2|||
16393107|NCT01194219|39922244|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16393108|NCT01194219|39922245|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16393109|NCT01194219|39922246|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16393110|NCT01194219|39922247|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16393111|NCT01194219|39922248|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16393112|NCT01194219|39922249|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
16393113|NCT01194219|39922240|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
16393114|NCT01194219|39922241|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
16393115|NCT01194219|39922242|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16393116|NCT01194219|39922243|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16393117|NCT01194219|39922244|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16393118|NCT01194219|39922245|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16393119|NCT01194219|39922246|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16393120|NCT01194219|39922247|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16393121|NCT01194219|39922248|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16393122|NCT01194219|39922249|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
16393123|NCT01194219|39922240|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
16393124|NCT01194219|39922241|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
16393125|NCT01194219|39922242|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16393126|NCT01194219|39922243|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16393127|NCT01194219|39922244|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16393128|NCT01194219|39922245|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16393129|NCT01194219|39922246|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16393130|NCT01194219|39922247|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16393131|NCT01194219|39922248|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16393132|NCT01194219|39922249|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
16393133|NCT01194219|39922240|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
16393134|NCT01194219|39922241|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
16393135|NCT01194219|39922242|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
16393136|NCT01194219|39922243|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
16393137|NCT01194219|39922244|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
16393138|NCT01194219|39922245|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
16393139|NCT01194219|39922246|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
16393140|NCT01194219|39922247|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
16393141|NCT01194219|39922248|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
16393142|NCT01194219|39922249|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
16393143|NCT01194219|39922240|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16393144|NCT01194219|39922241|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16393145|NCT01194219|39922242|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
16393146|NCT01194219|39922243|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
16393147|NCT01194219|39922244|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16511276|NCT00969553|40344026|FG001|Overall Study|Progressive disease (PD)|2|||
16511277|NCT00969553|40344027|FG002|Overall Study|Progressive disease (PD)|6|||
16393148|NCT01194219|39922245|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16393149|NCT01194219|39922246|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16511278|NCT00969553|40344028|FG003|Overall Study|Progressive disease (PD)|9|||
16511279|NCT00969553|40344029|FG004|Overall Study|Progressive disease (PD)|2|||
16511280|NCT00969553|40344030|FG005|Overall Study|Progressive disease (PD)|4|||
16393150|NCT01194219|39922247|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16393151|NCT01194219|39922248|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16393152|NCT01194219|39922249|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
16393153|NCT01194219|39922240|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16393154|NCT01194219|39922241|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16393155|NCT01194219|39922242|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
16393156|NCT01194219|39922243|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
16393157|NCT01194219|39922244|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16393158|NCT01194219|39922245|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16511281|NCT00969553|40344031|FG006|Overall Study|Progressive disease (PD)|2|||
16511282|NCT00969553|40344032|FG007|Overall Study|Progressive disease (PD)|12|||
16511283|NCT00969553|40344033|FG008|Overall Study|Progressive disease (PD)|3|||
16511284|NCT00969553|40344025|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
16511285|NCT00969553|40344026|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
16511286|NCT00969553|40344027|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
16511287|NCT00969553|40344028|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
16511288|NCT00969553|40344029|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
16393159|NCT01194219|39922246|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16393160|NCT01194219|39922247|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16393161|NCT01194219|39922248|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16393162|NCT01194219|39922249|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
16393163|NCT01194219|39922240|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16393164|NCT01194219|39922241|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16393165|NCT01194219|39922242|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
16393166|NCT01194219|39922243|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
16393167|NCT01194219|39922244|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16393168|NCT01194219|39922245|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16393169|NCT01194219|39922246|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16393170|NCT01194219|39922247|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16393171|NCT01194219|39922248|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16393172|NCT01194219|39922249|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
16393173|NCT01194219|39922240|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16393174|NCT01194219|39922241|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16393175|NCT01194219|39922242|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
16393176|NCT01194219|39922243|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16393177|NCT01194219|39922244|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16393178|NCT01194219|39922245|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16393179|NCT01194219|39922246|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16393180|NCT01194219|39922247|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16393181|NCT01194219|39922248|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16393182|NCT01194219|39922249|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
16393183|NCT01194219|39922240|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16393184|NCT01194219|39922241|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16393185|NCT01194219|39922242|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16393186|NCT01194219|39922243|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
16393187|NCT01194219|39922244|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16393188|NCT01194219|39922245|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16393189|NCT01194219|39922246|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16393190|NCT01194219|39922247|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16393191|NCT01194219|39922248|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16393192|NCT01194219|39922249|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
16393193|NCT01194219|39922240|FG000|Maintenance Phase Weeks16-32|Other|0|||
16393194|NCT01194219|39922241|FG001|Maintenance Phase Weeks16-32|Other|0|||
16393195|NCT01194219|39922242|FG002|Maintenance Phase Weeks16-32|Other|2|||
16393196|NCT01194219|39922243|FG003|Maintenance Phase Weeks16-32|Other|1|||
16393197|NCT01194219|39922244|FG004|Maintenance Phase Weeks16-32|Other|0|||
16393198|NCT01194219|39922245|FG005|Maintenance Phase Weeks16-32|Other|0|||
16393199|NCT01194219|39922246|FG006|Maintenance Phase Weeks16-32|Other|0|||
16393200|NCT01194219|39922247|FG007|Maintenance Phase Weeks16-32|Other|0|||
16393201|NCT01194219|39922248|FG008|Maintenance Phase Weeks16-32|Other|0|||
16393202|NCT01194219|39922249|FG009|Maintenance Phase Weeks16-32|Other|0|||
16393203|NCT01194219|39922240|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16393204|NCT01194219|39922241|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16393205|NCT01194219|39922242|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16393206|NCT01194219|39922243|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16393207|NCT01194219|39922244|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16393208|NCT01194219|39922245|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
16393209|NCT01194219|39922246|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
16393210|NCT01194219|39922247|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
16393211|NCT01194219|39922248|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16393212|NCT01194219|39922249|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
16393213|NCT01194219|39922240|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16511289|NCT00969553|40344030|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
16511290|NCT00969553|40344031|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
16511291|NCT00969553|40344032|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
16511292|NCT00969553|40344033|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
16511293|NCT00969553|40344025|FG000|Overall Study|Other Adverse Event|0|||
16511294|NCT00969553|40344026|FG001|Overall Study|Other Adverse Event|0|||
16511295|NCT00969553|40344027|FG002|Overall Study|Other Adverse Event|0|||
16090020|NCT01683409|38820065|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
16090021|NCT01683409|38820066|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
16199534|NCT01021813|39204651|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
16511296|NCT00969553|40344028|FG003|Overall Study|Other Adverse Event|1|||
16511297|NCT00969553|40344029|FG004|Overall Study|Other Adverse Event|0|||
16511298|NCT00969553|40344030|FG005|Overall Study|Other Adverse Event|0|||
16511299|NCT00969553|40344031|FG006|Overall Study|Other Adverse Event|1|||
16511300|NCT00969553|40344032|FG007|Overall Study|Other Adverse Event|0|||
16316882|NCT01314872|39644534|FG014|Period 2|Withdrawal by Subject|4|||
16316883|NCT01314872|39644520|FG000|Period 2|Lost to Follow-up|0|||
16316884|NCT01314872|39644521|FG001|Period 2|Lost to Follow-up|0|||
16316885|NCT01314872|39644522|FG002|Period 2|Lost to Follow-up|0|||
16316886|NCT01314872|39644523|FG003|Period 2|Lost to Follow-up|0|||
16316887|NCT01314872|39644524|FG004|Period 2|Lost to Follow-up|0|||
16316888|NCT01314872|39644525|FG005|Period 2|Lost to Follow-up|0|||
16316889|NCT01314872|39644526|FG006|Period 2|Lost to Follow-up|0|||
16316890|NCT01314872|39644527|FG007|Period 2|Lost to Follow-up|0|||
16316891|NCT01314872|39644528|FG008|Period 2|Lost to Follow-up|0|||
16316892|NCT01314872|39644529|FG009|Period 2|Lost to Follow-up|0|||
16316893|NCT01314872|39644530|FG010|Period 2|Lost to Follow-up|0|||
16316894|NCT01314872|39644531|FG011|Period 2|Lost to Follow-up|6|||
16316895|NCT01314872|39644532|FG012|Period 2|Lost to Follow-up|7|||
16316896|NCT01314872|39644533|FG013|Period 2|Lost to Follow-up|2|||
16316897|NCT01314872|39644534|FG014|Period 2|Lost to Follow-up|6|||
16316898|NCT01057810|39644537|FG000|Overall Study|Disease progression|156|||
16316899|NCT01057810|39644538|FG001|Overall Study|Disease progression|197|||
16316900|NCT01057810|39644537|FG000|Overall Study|Study drug toxicity|5|||
16316901|NCT01057810|39644538|FG001|Overall Study|Study drug toxicity|114|||
16316902|NCT01057810|39644537|FG000|Overall Study|Adverse event unrelated to study drug|13|||
16316903|NCT01057810|39644538|FG001|Overall Study|Adverse event unrelated to study drug|29|||
16316904|NCT01057810|39644537|FG000|Overall Study|Withdrawal by Subject|10|||
16316905|NCT01057810|39644538|FG001|Overall Study|Withdrawal by Subject|25|||
16316906|NCT01057810|39644537|FG000|Overall Study|Death|2|||
16316907|NCT01057810|39644538|FG001|Overall Study|Death|12|||
16316908|NCT01057810|39644537|FG000|Overall Study|Maximum clinical benefit|5|||
16316909|NCT01057810|39644538|FG001|Overall Study|Maximum clinical benefit|5|||
16316910|NCT01057810|39644537|FG000|Overall Study|Poor/non-compliance|0|||
16316911|NCT01057810|39644538|FG001|Overall Study|Poor/non-compliance|1|||
16511301|NCT00969553|40344033|FG008|Overall Study|Other Adverse Event|0|||
16511302|NCT00969553|40344025|FG000|Overall Study|Refused cont. medication|1|||
16511303|NCT00969553|40344026|FG001|Overall Study|Refused cont. medication|1|||
16511304|NCT00969553|40344027|FG002|Overall Study|Refused cont. medication|0|||
16511305|NCT00969553|40344028|FG003|Overall Study|Refused cont. medication|2|||
16511306|NCT00969553|40344029|FG004|Overall Study|Refused cont. medication|0|||
16511307|NCT00969553|40344030|FG005|Overall Study|Refused cont. medication|0|||
16511308|NCT00969553|40344031|FG006|Overall Study|Refused cont. medication|0|||
16511309|NCT00969553|40344032|FG007|Overall Study|Refused cont. medication|1|||
16511310|NCT00969553|40344033|FG008|Overall Study|Refused cont. medication|0|||
16511311|NCT00969553|40344025|FG000|Overall Study|Not specified above|0|||
16511312|NCT00969553|40344026|FG001|Overall Study|Not specified above|0|||
16511313|NCT00969553|40344027|FG002|Overall Study|Not specified above|0|||
16511314|NCT00969553|40344028|FG003|Overall Study|Not specified above|4|||
16511315|NCT00969553|40344029|FG004|Overall Study|Not specified above|0|||
16511316|NCT00969553|40344030|FG005|Overall Study|Not specified above|0|||
16511317|NCT00969553|40344031|FG006|Overall Study|Not specified above|1|||
16511318|NCT00969553|40344032|FG007|Overall Study|Not specified above|1|||
16511319|NCT00969553|40344033|FG008|Overall Study|Not specified above|0|||
16511320|NCT01502644|40344036|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
16511321|NCT01502644|40344037|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
16511322|NCT01502644|40344038|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
16511323|NCT01502644|40344039|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
16511324|NCT01502644|40344036|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
16316912|NCT01057810|39644537|FG000|Overall Study|No longer met study criteria|0|||
16316913|NCT01057810|39644538|FG001|Overall Study|No longer met study criteria|1|||
16316914|NCT01057810|39644537|FG000|Overall Study|Other|7|||
16511325|NCT01502644|40344037|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
16511326|NCT01502644|40344038|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
16511327|NCT01502644|40344039|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
16511328|NCT01502644|40344036|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
16511329|NCT01502644|40344037|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
16511330|NCT01502644|40344038|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
16511331|NCT01502644|40344039|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
16511332|NCT01502644|40344036|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
16511333|NCT01502644|40344037|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
16511334|NCT01502644|40344038|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
16511335|NCT01502644|40344039|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
16393214|NCT01194219|39922241|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16393215|NCT01194219|39922242|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16393216|NCT01194219|39922243|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16393217|NCT01194219|39922244|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
16393218|NCT01194219|39922245|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
16393219|NCT01194219|39922246|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
16393220|NCT01194219|39922247|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
16393221|NCT01194219|39922248|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16511336|NCT01502644|40344036|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
16511337|NCT01502644|40344037|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
16511338|NCT01502644|40344038|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
16511339|NCT01502644|40344039|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
16511340|NCT04372602|40344040|FG000|Overall Study|Withdrawal by Subject|1|||
16511341|NCT04372602|40344041|FG001|Overall Study|Withdrawal by Subject|1|||
16511342|NCT04372602|40344040|FG000|Overall Study|Adverse Event|0|||
16511343|NCT04372602|40344041|FG001|Overall Study|Adverse Event|1|||
16511344|NCT04372602|40344040|FG000|Overall Study|Transitioned to comfort care|0|||
16511345|NCT04372602|40344041|FG001|Overall Study|Transitioned to comfort care|1|||
16511346|NCT00297037|40344042|FG000|Overall Study|Withdrawal by Subject|2|||
16511347|NCT00297037|40344043|FG001|Overall Study|Withdrawal by Subject|0|||
16393222|NCT01194219|39922249|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
16393223|NCT01194219|39922240|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16511348|NCT02167256|40344044|FG000|Overall Study|Adverse Event|13|||
16511349|NCT02167256|40344045|FG001|Overall Study|Adverse Event|6|||
16511350|NCT02167256|40344044|FG000|Overall Study|Withdrawal by Subject|4|||
16511351|NCT02167256|40344045|FG001|Overall Study|Withdrawal by Subject|4|||
16511352|NCT02167256|40344044|FG000|Overall Study|non-compliance|3|||
16511353|NCT02167256|40344045|FG001|Overall Study|non-compliance|0|||
16511354|NCT02167256|40344044|FG000|Overall Study|Study partner unable to participate|1|||
16511355|NCT02167256|40344045|FG001|Overall Study|Study partner unable to participate|0|||
16511356|NCT02239536|40344046|FG000|Overall Study|Non-neoplastic polyp|23|||
16511357|NCT02239536|40344047|FG001|Overall Study|Non-neoplastic polyp|17|||
16511358|NCT00397982|40344048|FG000|Overall Study|Withdrawal by Subject|1|||
16511359|NCT00397982|40344048|FG000|Overall Study|Adverse Event|1|||
16511360|NCT00397982|40344048|FG000|Overall Study|noncompliance|1|||
16511361|NCT00397982|40344048|FG000|Overall Study|Unrelated health issues|1|||
16511362|NCT00697346|40344052|FG000|Overall Study|Adverse Event|4|||
16511363|NCT00697346|40344053|FG001|Overall Study|Adverse Event|5|||
16199535|NCT01021813|39204652|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
16511364|NCT00697346|40344054|FG002|Overall Study|Adverse Event|0|||
16511365|NCT00697346|40344052|FG000|Overall Study|Progressive Disease|19|||
16316915|NCT01057810|39644538|FG001|Overall Study|Other|14|||
16393224|NCT01194219|39922241|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16393225|NCT01194219|39922242|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16393226|NCT01194219|39922243|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16393227|NCT01194219|39922244|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
16393228|NCT01194219|39922245|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16393229|NCT01194219|39922246|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
16393230|NCT01194219|39922247|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16393231|NCT01194219|39922248|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16511366|NCT00697346|40344053|FG001|Overall Study|Progressive Disease|18|||
16511367|NCT00697346|40344054|FG002|Overall Study|Progressive Disease|0|||
16511368|NCT00697346|40344052|FG000|Overall Study|Symptomatic Deterioration|0|||
16511369|NCT00697346|40344053|FG001|Overall Study|Symptomatic Deterioration|1|||
16316916|NCT01303172|39644539|FG000|Overall Study|Physician Decision|9|||
16316917|NCT01303172|39644540|FG001|Overall Study|Physician Decision|6|||
16316918|NCT01303172|39644539|FG000|Overall Study|Adverse Event|5|||
16316919|NCT01303172|39644540|FG001|Overall Study|Adverse Event|2|||
16316920|NCT01303172|39644539|FG000|Overall Study|Withdrawal by Subject|4|||
16316921|NCT01303172|39644540|FG001|Overall Study|Withdrawal by Subject|2|||
16316922|NCT01303172|39644539|FG000|Overall Study|Death|20|||
16316923|NCT01303172|39644540|FG001|Overall Study|Death|7|||
16316924|NCT01303172|39644539|FG000|Overall Study|Lack of Efficacy|25|||
16316925|NCT01303172|39644540|FG001|Overall Study|Lack of Efficacy|17|||
16316926|NCT02019472|39644544|FG000|Overall Study|Adverse Event|14|||
16316927|NCT02019472|39644545|FG001|Overall Study|Adverse Event|23|||
16316928|NCT02019472|39644546|FG002|Overall Study|Adverse Event|17|||
16316929|NCT02019472|39644544|FG000|Overall Study|Death|0|||
16511370|NCT00697346|40344054|FG002|Overall Study|Symptomatic Deterioration|0|||
16511371|NCT00697346|40344052|FG000|Overall Study|Withdrawal by Subject|2|||
16511372|NCT00697346|40344053|FG001|Overall Study|Withdrawal by Subject|2|||
16511373|NCT00697346|40344054|FG002|Overall Study|Withdrawal by Subject|0|||
16511374|NCT00697346|40344052|FG000|Overall Study|Reason not Specified|3|||
16511375|NCT00697346|40344053|FG001|Overall Study|Reason not Specified|0|||
16511376|NCT00697346|40344054|FG002|Overall Study|Reason not Specified|1|||
16511377|NCT00076011|40344058|FG000|Overall Study|Death|1|||
16511378|NCT00076011|40344058|FG000|Overall Study|Adverse Event|10|||
16511379|NCT00076011|40344058|FG000|Overall Study|Lack of Efficacy|25|||
16511380|NCT00076011|40344058|FG000|Overall Study|Withdrawal by Subject|1|||
16511381|NCT00076011|40344058|FG000|Overall Study|Study terminated by sponsor|3|||
16511382|NCT00076011|40344058|FG000|Overall Study|Other|11|||
16511383|NCT00076011|40344058|FG000|Overall Study|Ongoing|1|||
16511384|NCT04019041|40344059|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
16511385|NCT04019041|40344060|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
16511386|NCT04019041|40344061|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
16511387|NCT04019041|40344062|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
16511388|NCT04019041|40344063|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
16511389|NCT04019041|40344064|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
16511390|NCT04019041|40344059|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
16511391|NCT04019041|40344060|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
16511392|NCT04019041|40344061|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
16511393|NCT04019041|40344062|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
16511394|NCT04019041|40344063|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
16511395|NCT04019041|40344064|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
16511396|NCT04019041|40344059|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
16511397|NCT04019041|40344060|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
16511398|NCT04019041|40344061|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
16511399|NCT04019041|40344062|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
16511400|NCT04019041|40344063|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
16511401|NCT04019041|40344064|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
16090022|NCT01683409|38820062|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
16090023|NCT01683409|38820063|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
16090024|NCT01683409|38820064|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
16316930|NCT02019472|39644545|FG001|Overall Study|Death|1|||
16316931|NCT02019472|39644546|FG002|Overall Study|Death|1|||
16393232|NCT01194219|39922249|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
16393233|NCT01194219|39922240|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16393234|NCT01194219|39922241|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16393235|NCT01194219|39922242|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16393236|NCT01194219|39922243|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16393237|NCT01194219|39922244|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
16393238|NCT01194219|39922245|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16393239|NCT01194219|39922246|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
16393240|NCT01194219|39922247|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
16393241|NCT01194219|39922248|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16393242|NCT01194219|39922249|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
16393243|NCT01194219|39922240|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16393244|NCT01194219|39922241|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16393245|NCT01194219|39922242|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16393246|NCT01194219|39922243|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16393247|NCT01194219|39922244|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
16393248|NCT01194219|39922245|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
16393249|NCT01194219|39922246|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
16393250|NCT01194219|39922247|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16393251|NCT01194219|39922248|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16393252|NCT01194219|39922249|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
16393253|NCT01194219|39922240|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16393254|NCT01194219|39922241|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16393255|NCT01194219|39922242|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16393256|NCT01194219|39922243|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16393257|NCT01194219|39922244|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16393258|NCT01194219|39922245|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16393259|NCT01194219|39922246|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16393260|NCT01194219|39922247|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
16393261|NCT01194219|39922248|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16393262|NCT01194219|39922249|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
16393263|NCT01194219|39922240|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16393264|NCT01194219|39922241|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16393265|NCT01194219|39922242|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16393266|NCT01194219|39922243|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16393267|NCT01194219|39922244|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16393268|NCT01194219|39922245|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16393269|NCT01194219|39922246|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
16393270|NCT01194219|39922247|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16393271|NCT01194219|39922248|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16393272|NCT01194219|39922249|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
16393273|NCT01194219|39922240|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16393274|NCT01194219|39922241|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16393275|NCT01194219|39922242|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16393276|NCT01194219|39922243|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16393277|NCT01194219|39922244|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16393278|NCT01194219|39922245|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16393279|NCT01194219|39922246|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16393280|NCT01194219|39922247|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
16393281|NCT01194219|39922248|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
16393282|NCT01194219|39922249|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
16393283|NCT01194219|39922240|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16393284|NCT01194219|39922241|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16393285|NCT01194219|39922242|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16511402|NCT04019041|40344059|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
16511403|NCT04019041|40344060|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
16511404|NCT04019041|40344061|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
16511405|NCT04019041|40344062|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
16316932|NCT02019472|39644544|FG000|Overall Study|Lack of Efficacy|7|||
16393286|NCT01194219|39922243|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16393287|NCT01194219|39922244|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16393288|NCT01194219|39922245|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16393289|NCT01194219|39922246|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16393290|NCT01194219|39922247|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
16511406|NCT04019041|40344063|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
16393291|NCT01194219|39922248|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
16393292|NCT01194219|39922249|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
16393293|NCT01194219|39922240|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16393294|NCT01194219|39922241|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16393295|NCT01194219|39922242|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16393296|NCT01194219|39922243|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16393297|NCT01194219|39922244|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16393298|NCT01194219|39922245|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16393299|NCT01194219|39922246|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16393300|NCT01194219|39922247|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
16393301|NCT01194219|39922248|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
16393302|NCT01194219|39922249|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
16393303|NCT01194219|39922240|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16393304|NCT01194219|39922241|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16393305|NCT01194219|39922242|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16393306|NCT01194219|39922243|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16393307|NCT01194219|39922244|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16393308|NCT01194219|39922245|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16393309|NCT01194219|39922246|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16393310|NCT01194219|39922247|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
16393311|NCT01194219|39922248|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
16511407|NCT04019041|40344064|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
16511408|NCT04019041|40344059|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
16511409|NCT04019041|40344060|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
16511410|NCT04019041|40344061|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
16511411|NCT04019041|40344062|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
16511412|NCT04019041|40344063|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
16511413|NCT04019041|40344064|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
16511414|NCT04019041|40344059|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
16511415|NCT04019041|40344060|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
16511416|NCT04019041|40344061|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
16511417|NCT04019041|40344062|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
16511418|NCT04019041|40344063|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
16511419|NCT04019041|40344064|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
16511420|NCT04019041|40344059|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
16511421|NCT04019041|40344060|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
16511422|NCT04019041|40344061|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
16511423|NCT04019041|40344062|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
16511424|NCT04019041|40344063|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
16511425|NCT04019041|40344064|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
16511426|NCT04019041|40344059|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
16199536|NCT01021813|39204653|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
16199537|NCT01021813|39204654|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
16316933|NCT02019472|39644545|FG001|Overall Study|Lack of Efficacy|4|||
16316934|NCT02019472|39644546|FG002|Overall Study|Lack of Efficacy|4|||
16316935|NCT02019472|39644544|FG000|Overall Study|Lost to Follow-up|0|||
16316936|NCT02019472|39644545|FG001|Overall Study|Lost to Follow-up|2|||
16316937|NCT02019472|39644546|FG002|Overall Study|Lost to Follow-up|1|||
16316938|NCT02019472|39644544|FG000|Overall Study|Physician Decision|1|||
16316939|NCT02019472|39644545|FG001|Overall Study|Physician Decision|2|||
16316940|NCT02019472|39644546|FG002|Overall Study|Physician Decision|0|||
16316941|NCT02019472|39644544|FG000|Overall Study|Pregnancy|1|||
16316942|NCT02019472|39644545|FG001|Overall Study|Pregnancy|2|||
16316943|NCT02019472|39644546|FG002|Overall Study|Pregnancy|2|||
16316944|NCT02019472|39644544|FG000|Overall Study|Withdrawal by Subject|11|||
16316945|NCT02019472|39644545|FG001|Overall Study|Withdrawal by Subject|10|||
16316946|NCT02019472|39644546|FG002|Overall Study|Withdrawal by Subject|11|||
16316947|NCT02019472|39644544|FG000|Overall Study|Other|3|||
16316948|NCT02019472|39644545|FG001|Overall Study|Other|8|||
16316949|NCT02019472|39644546|FG002|Overall Study|Other|6|||
16316950|NCT01256450|39644547|FG000|Open-label Titration|Adverse Event|39|||
16316951|NCT01256450|39644548|FG001|Open-label Titration|Adverse Event|0|||
16316952|NCT01256450|39644549|FG002|Open-label Titration|Adverse Event|0|||
16316953|NCT01256450|39644547|FG000|Open-label Titration|Lost to Follow-up|7|||
16316954|NCT01256450|39644548|FG001|Open-label Titration|Lost to Follow-up|0|||
16316955|NCT01256450|39644549|FG002|Open-label Titration|Lost to Follow-up|0|||
16316956|NCT01256450|39644547|FG000|Open-label Titration|Lack of analgesic effect|30|||
16316957|NCT01256450|39644548|FG001|Open-label Titration|Lack of analgesic effect|0|||
16316958|NCT01256450|39644549|FG002|Open-label Titration|Lack of analgesic effect|0|||
16316959|NCT01256450|39644547|FG000|Open-label Titration|Non-compliance|9|||
16511427|NCT04019041|40344060|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
16511428|NCT04019041|40344061|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
16511429|NCT04019041|40344062|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
16511430|NCT04019041|40344063|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
16511431|NCT04019041|40344064|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
16511432|NCT04019041|40344059|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
16511433|NCT04019041|40344060|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
16511434|NCT04019041|40344061|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
16511435|NCT04019041|40344062|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
16511436|NCT04019041|40344063|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
16316960|NCT01256450|39644548|FG001|Open-label Titration|Non-compliance|0|||
16316961|NCT01256450|39644549|FG002|Open-label Titration|Non-compliance|0|||
16316962|NCT01256450|39644547|FG000|Open-label Titration|Screen failure|1|||
16316963|NCT01256450|39644548|FG001|Open-label Titration|Screen failure|0|||
16316964|NCT01256450|39644549|FG002|Open-label Titration|Screen failure|0|||
16316965|NCT01256450|39644547|FG000|Open-label Titration|Other|13|||
16316966|NCT01256450|39644548|FG001|Open-label Titration|Other|0|||
16316967|NCT01256450|39644549|FG002|Open-label Titration|Other|0|||
16316968|NCT01256450|39644547|FG000|Double-blind Treatment|Adverse Event|0|||
16316969|NCT01256450|39644548|FG001|Double-blind Treatment|Adverse Event|8|||
16316970|NCT01256450|39644549|FG002|Double-blind Treatment|Adverse Event|6|||
16316971|NCT01256450|39644547|FG000|Double-blind Treatment|Lost to Follow-up|0|||
16511437|NCT04019041|40344064|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
16511438|NCT01720069|40344066|FG000|Overall Study|Could not use e-diary correctly|0|||
16511439|NCT01720069|40344067|FG001|Overall Study|Could not use e-diary correctly|1|||
16511440|NCT01720069|40344068|FG002|Overall Study|Could not use e-diary correctly|1|||
16511441|NCT01720069|40344066|FG000|Overall Study|Randomised without baseline values|0|||
16511442|NCT01720069|40344067|FG001|Overall Study|Randomised without baseline values|0|||
16511443|NCT01720069|40344068|FG002|Overall Study|Randomised without baseline values|1|||
16511444|NCT01720069|40344066|FG000|Overall Study|Adverse Event|0|||
16511445|NCT01720069|40344067|FG001|Overall Study|Adverse Event|0|||
16511446|NCT01720069|40344068|FG002|Overall Study|Adverse Event|1|||
16511447|NCT01720069|40344066|FG000|Overall Study|Lack of Efficacy|0|||
16511448|NCT01720069|40344067|FG001|Overall Study|Lack of Efficacy|4|||
16511449|NCT01720069|40344068|FG002|Overall Study|Lack of Efficacy|0|||
16511450|NCT01720069|40344066|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
16511451|NCT01720069|40344067|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
16511452|NCT01720069|40344068|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
16511453|NCT01720069|40344066|FG000|Overall Study|Withdrawal by Subject|0|||
16511454|NCT01720069|40344067|FG001|Overall Study|Withdrawal by Subject|2|||
16511455|NCT01720069|40344068|FG002|Overall Study|Withdrawal by Subject|1|||
16511456|NCT01720069|40344066|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
16511457|NCT01720069|40344067|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
16511458|NCT01720069|40344068|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
16511459|NCT01720069|40344066|FG000|Overall Study|Non-compliance on using e-diary|0|||
16511460|NCT01720069|40344067|FG001|Overall Study|Non-compliance on using e-diary|0|||
16511461|NCT01720069|40344068|FG002|Overall Study|Non-compliance on using e-diary|1|||
16511462|NCT01720069|40344066|FG000|Overall Study|Lost to Follow-up|0|||
16511463|NCT01720069|40344067|FG001|Overall Study|Lost to Follow-up|0|||
16511464|NCT01720069|40344068|FG002|Overall Study|Lost to Follow-up|1|||
16511465|NCT04091646|40344069|FG000|Overall Study|Adverse Event|2|||
16511466|NCT04091646|40344070|FG001|Overall Study|Adverse Event|1|||
16511467|NCT04091646|40344069|FG000|Overall Study|Lost to Follow-up|6|||
16511468|NCT04091646|40344070|FG001|Overall Study|Lost to Follow-up|2|||
16511469|NCT04091646|40344069|FG000|Overall Study|Protocol Violation|0|||
16511470|NCT04091646|40344070|FG001|Overall Study|Protocol Violation|1|||
16511471|NCT04091646|40344069|FG000|Overall Study|Withdrawal by Subject|4|||
16511472|NCT04091646|40344070|FG001|Overall Study|Withdrawal by Subject|1|||
16511473|NCT04091646|40344069|FG000|Overall Study|Participant Incarcerated|1|||
16511474|NCT04091646|40344070|FG001|Overall Study|Participant Incarcerated|0|||
16511475|NCT03434041|40344071|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
16511476|NCT03434041|40344072|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
16511477|NCT03434041|40344071|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
16316972|NCT01256450|39644548|FG001|Double-blind Treatment|Lost to Follow-up|1|||
16316973|NCT01256450|39644549|FG002|Double-blind Treatment|Lost to Follow-up|7|||
16511478|NCT03434041|40344072|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
16316974|NCT01256450|39644547|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
16511479|NCT03434041|40344071|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
16511480|NCT03434041|40344072|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
16511481|NCT03434041|40344071|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
16511482|NCT03434041|40344072|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
16511483|NCT03434041|40344071|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
16199538|NCT01021813|39204655|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
16199539|NCT01021813|39204651|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
16199540|NCT01021813|39204652|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
16199541|NCT01021813|39204653|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
16199542|NCT01021813|39204654|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
16199543|NCT01021813|39204655|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
16199544|NCT01021813|39204651|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
16199545|NCT01021813|39204652|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
16199546|NCT01021813|39204653|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
16199547|NCT01021813|39204654|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
16199548|NCT01021813|39204655|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
16199549|NCT01021813|39204651|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
16316975|NCT01256450|39644548|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
16316976|NCT01256450|39644549|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
16316977|NCT01256450|39644547|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
16316978|NCT01256450|39644548|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
16316979|NCT01256450|39644549|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
16316980|NCT01256450|39644547|FG000|Double-blind Treatment|Non-compliance|0|||
16316981|NCT01256450|39644548|FG001|Double-blind Treatment|Non-compliance|5|||
16316982|NCT01256450|39644549|FG002|Double-blind Treatment|Non-compliance|4|||
16316983|NCT01256450|39644547|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
16316984|NCT01256450|39644548|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
16316985|NCT01256450|39644549|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
16316986|NCT01256450|39644547|FG000|Double-blind Treatment|Other|0|||
16316987|NCT01256450|39644548|FG001|Double-blind Treatment|Other|9|||
16316988|NCT01256450|39644549|FG002|Double-blind Treatment|Other|12|||
16316989|NCT03570619|39644551|FG000|Overall Study|Adverse Event|2|||
16316990|NCT03570619|39644552|FG001|Overall Study|Adverse Event|0|||
16316991|NCT03570619|39644553|FG002|Overall Study|Adverse Event|1|||
16316992|NCT03570619|39644551|FG000|Overall Study|new diagnosis of new malignancy|1|||
16316993|NCT03570619|39644552|FG001|Overall Study|new diagnosis of new malignancy|0|||
16316994|NCT03570619|39644553|FG002|Overall Study|new diagnosis of new malignancy|0|||
16316995|NCT03570619|39644551|FG000|Overall Study|Physician Decision|1|||
16316996|NCT03570619|39644552|FG001|Overall Study|Physician Decision|1|||
16316997|NCT03570619|39644553|FG002|Overall Study|Physician Decision|0|||
16316998|NCT03570619|39644551|FG000|Overall Study|Withdrawal by Subject|0|||
16316999|NCT03570619|39644552|FG001|Overall Study|Withdrawal by Subject|2|||
16317000|NCT03570619|39644553|FG002|Overall Study|Withdrawal by Subject|0|||
16317001|NCT02198664|39644554|FG000|Overall Study|Adverse Event|2|||
16317002|NCT02198664|39644555|FG001|Overall Study|Adverse Event|0|||
16317003|NCT02198664|39644554|FG000|Overall Study|Withdrawal by Subject|11|||
16317004|NCT02198664|39644555|FG001|Overall Study|Withdrawal by Subject|8|||
16317005|NCT02198664|39644554|FG000|Overall Study|Failure to tolerate|2|||
16317006|NCT02198664|39644555|FG001|Overall Study|Failure to tolerate|0|||
16317007|NCT02198664|39644554|FG000|Overall Study|Not stated|1|||
16317008|NCT02198664|39644555|FG001|Overall Study|Not stated|0|||
16317009|NCT01778530|39644556|FG000|Overall Study|Progression on study|1|||
16317010|NCT01778530|39644556|FG000|Overall Study|Adverse event/side effect|1|||
16317011|NCT01757184|39644557|FG000|Double-blind Period|Adverse Event|1|||
16317012|NCT01757184|39644558|FG001|Double-blind Period|Adverse Event|0|||
16317013|NCT01757184|39644559|FG002|Double-blind Period|Adverse Event|0|||
16317014|NCT01757184|39644560|FG003|Double-blind Period|Adverse Event|0|||
16317015|NCT01757184|39644557|FG000|Open-label Period|Lost to Follow-up|0|||
16317016|NCT01757184|39644558|FG001|Open-label Period|Lost to Follow-up|0|||
16317017|NCT01757184|39644559|FG002|Open-label Period|Lost to Follow-up|2|||
16317018|NCT01757184|39644560|FG003|Open-label Period|Lost to Follow-up|0|||
16317019|NCT01757184|39644557|FG000|Open-label Period|Withdrawal by Subject|0|||
16317020|NCT01757184|39644558|FG001|Open-label Period|Withdrawal by Subject|0|||
16317021|NCT01757184|39644559|FG002|Open-label Period|Withdrawal by Subject|1|||
16317022|NCT01757184|39644560|FG003|Open-label Period|Withdrawal by Subject|1|||
16317023|NCT01757184|39644557|FG000|Open-label Period|Discontinued by Sponsor|0|||
16317024|NCT01757184|39644558|FG001|Open-label Period|Discontinued by Sponsor|0|||
16317025|NCT01757184|39644559|FG002|Open-label Period|Discontinued by Sponsor|1|||
16511484|NCT03434041|40344072|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
16511485|NCT03434041|40344071|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
16317026|NCT01757184|39644560|FG003|Open-label Period|Discontinued by Sponsor|2|||
16317027|NCT01031680|39644562|FG000|Overall Study|Adverse Event|8|||
16317028|NCT01031680|39644563|FG001|Overall Study|Adverse Event|3|||
16317029|NCT01031680|39644562|FG000|Overall Study|Lost to Follow-up|2|||
16317030|NCT01031680|39644563|FG001|Overall Study|Lost to Follow-up|10|||
16393312|NCT01194219|39922249|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
16317031|NCT01031680|39644562|FG000|Overall Study|Withdrawal by Subject|12|||
16317032|NCT01031680|39644563|FG001|Overall Study|Withdrawal by Subject|16|||
16317033|NCT01031680|39644562|FG000|Overall Study|Death|2|||
16511486|NCT03434041|40344072|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
16511487|NCT03434041|40344071|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
16511488|NCT03434041|40344072|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
16511489|NCT03434041|40344071|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
16511490|NCT03434041|40344072|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
16511491|NCT03434041|40344071|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
16511492|NCT03434041|40344072|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
16511493|NCT03434041|40344071|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
16511494|NCT03434041|40344072|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
16511495|NCT03434041|40344071|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
16511496|NCT03434041|40344072|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
16511497|NCT01481116|40344076|FG000|Overall Study|Adverse Event|26|||
16511498|NCT01481116|40344077|FG001|Overall Study|Adverse Event|26|||
16511499|NCT01481116|40344078|FG002|Overall Study|Adverse Event|42|||
16511500|NCT01481116|40344076|FG000|Overall Study|Major Protocol Deviation|3|||
16511501|NCT01481116|40344077|FG001|Overall Study|Major Protocol Deviation|7|||
16511502|NCT01481116|40344078|FG002|Overall Study|Major Protocol Deviation|1|||
16511503|NCT01481116|40344076|FG000|Overall Study|Lost to Follow-up|8|||
16511504|NCT01481116|40344077|FG001|Overall Study|Lost to Follow-up|12|||
16511505|NCT01481116|40344078|FG002|Overall Study|Lost to Follow-up|11|||
16511506|NCT01481116|40344076|FG000|Overall Study|Withdrawal by Subject|37|||
16511507|NCT01481116|40344077|FG001|Overall Study|Withdrawal by Subject|33|||
16511508|NCT01481116|40344078|FG002|Overall Study|Withdrawal by Subject|37|||
16511509|NCT01481116|40344076|FG000|Overall Study|Study Termination|730|||
16511510|NCT01481116|40344077|FG001|Overall Study|Study Termination|729|||
16511511|NCT01481116|40344078|FG002|Overall Study|Study Termination|713|||
16511512|NCT01481116|40344076|FG000|Overall Study|Pregnancy|0|||
16511513|NCT01481116|40344077|FG001|Overall Study|Pregnancy|0|||
16511514|NCT01481116|40344078|FG002|Overall Study|Pregnancy|1|||
16511515|NCT01481116|40344076|FG000|Overall Study|Lack of Efficacy|3|||
16511516|NCT01481116|40344077|FG001|Overall Study|Lack of Efficacy|3|||
16511517|NCT01481116|40344078|FG002|Overall Study|Lack of Efficacy|1|||
16511518|NCT01481116|40344076|FG000|Overall Study|Contraindications|1|||
16511519|NCT01481116|40344077|FG001|Overall Study|Contraindications|1|||
16511520|NCT01481116|40344078|FG002|Overall Study|Contraindications|0|||
16511521|NCT01481116|40344076|FG000|Overall Study|Other|1|||
16511522|NCT01481116|40344077|FG001|Overall Study|Other|1|||
16511523|NCT01481116|40344078|FG002|Overall Study|Other|0|||
16511524|NCT01481116|40344076|FG000|Overall Study|Participant Started Taking Glipizide|1|||
16511525|NCT01481116|40344077|FG001|Overall Study|Participant Started Taking Glipizide|0|||
16511526|NCT01481116|40344078|FG002|Overall Study|Participant Started Taking Glipizide|0|||
16511527|NCT01481116|40344076|FG000|Overall Study|Participant Moved Out of Area|2|||
16511528|NCT01481116|40344077|FG001|Overall Study|Participant Moved Out of Area|0|||
16511529|NCT01481116|40344078|FG002|Overall Study|Participant Moved Out of Area|1|||
16511530|NCT01481116|40344076|FG000|Overall Study|Participant Moved Out of Country|1|||
16511531|NCT01481116|40344077|FG001|Overall Study|Participant Moved Out of Country|0|||
16511532|NCT01481116|40344078|FG002|Overall Study|Participant Moved Out of Country|1|||
16511533|NCT01481116|40344076|FG000|Overall Study|Investigator Decision|3|||
16511534|NCT01481116|40344077|FG001|Overall Study|Investigator Decision|2|||
16511535|NCT01481116|40344078|FG002|Overall Study|Investigator Decision|1|||
16511536|NCT01481116|40344076|FG000|Overall Study|Sponsor Decision|0|||
16511537|NCT01481116|40344077|FG001|Overall Study|Sponsor Decision|1|||
16511538|NCT01481116|40344078|FG002|Overall Study|Sponsor Decision|3|||
16511539|NCT01481116|40344076|FG000|Overall Study|Non-Compliant With Study Drug|0|||
16511540|NCT01481116|40344077|FG001|Overall Study|Non-Compliant With Study Drug|1|||
16511541|NCT01481116|40344078|FG002|Overall Study|Non-Compliant With Study Drug|1|||
16511542|NCT01481116|40344076|FG000|Overall Study|Investigator's Discretion|2|||
16511543|NCT01481116|40344077|FG001|Overall Study|Investigator's Discretion|0|||
16090025|NCT01683409|38820065|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
16511544|NCT01481116|40344078|FG002|Overall Study|Investigator's Discretion|0|||
16511545|NCT01481116|40344076|FG000|Overall Study|Death|2|||
16511546|NCT01481116|40344077|FG001|Overall Study|Death|1|||
16317034|NCT01031680|39644563|FG001|Overall Study|Death|1|||
16511547|NCT01481116|40344078|FG002|Overall Study|Death|0|||
16511548|NCT01481116|40344076|FG000|Overall Study|Hypoglycemic Event|4|||
16511549|NCT01481116|40344077|FG001|Overall Study|Hypoglycemic Event|0|||
16511550|NCT01481116|40344078|FG002|Overall Study|Hypoglycemic Event|0|||
16511551|NCT00235989|40344079|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
16511552|NCT00235989|40344080|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
16511553|NCT00235989|40344081|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
16511554|NCT00235989|40344082|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
16511555|NCT00235989|40344083|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
16511556|NCT00235989|40344084|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
16511557|NCT00235989|40344079|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
16511558|NCT00235989|40344080|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
16511559|NCT00235989|40344081|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
16511560|NCT00235989|40344082|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
16511561|NCT00235989|40344083|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
16511562|NCT00235989|40344084|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
16511563|NCT00235989|40344079|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
16511564|NCT00235989|40344080|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
16511565|NCT00235989|40344081|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
16511566|NCT00235989|40344082|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
16511567|NCT00235989|40344083|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
16511568|NCT00235989|40344084|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
16511569|NCT00235989|40344079|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
16511570|NCT00235989|40344080|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
16511571|NCT00235989|40344081|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
16511572|NCT00235989|40344082|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
16511573|NCT00235989|40344083|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
16511574|NCT00235989|40344084|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
16511575|NCT00235989|40344079|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
16511576|NCT00235989|40344080|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
16511577|NCT00235989|40344081|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
16511578|NCT00235989|40344082|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
16511579|NCT00235989|40344083|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
16511580|NCT00235989|40344084|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
16511581|NCT00360334|40347342|FG000|Overall Study|Adverse Event|7|||
16511582|NCT00360334|40347343|FG001|Overall Study|Adverse Event|4|||
16511583|NCT00360334|40347342|FG000|Overall Study|Protocol Violation|1|||
16511584|NCT00360334|40347343|FG001|Overall Study|Protocol Violation|1|||
16511585|NCT00360334|40347342|FG000|Overall Study|Physician Decision|2|||
16511586|NCT00360334|40347343|FG001|Overall Study|Physician Decision|3|||
16511587|NCT00360334|40347342|FG000|Overall Study|Lack of Efficacy|0|||
16511588|NCT00360334|40347343|FG001|Overall Study|Lack of Efficacy|1|||
16511589|NCT00360334|40347342|FG000|Overall Study|Entry criterion not met|1|||
16511590|NCT00360334|40347343|FG001|Overall Study|Entry criterion not met|2|||
16511591|NCT00360334|40347342|FG000|Overall Study|Subject decision|8|||
16511592|NCT00360334|40347343|FG001|Overall Study|Subject decision|2|||
16511593|NCT02739269|40347344|FG000|Overall Study|Protocol Violation|5|||
16511594|NCT02739269|40347345|FG001|Overall Study|Protocol Violation|0|||
16090026|NCT01683409|38820066|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
16317035|NCT01031680|39644562|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
16317036|NCT01031680|39644563|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
16317037|NCT01031680|39644562|FG000|Overall Study|Poor/Non-compliance|5|||
16317038|NCT01031680|39644563|FG001|Overall Study|Poor/Non-compliance|6|||
16317039|NCT01031680|39644562|FG000|Overall Study|Safety|1|||
16317040|NCT01031680|39644563|FG001|Overall Study|Safety|0|||
16317041|NCT01031680|39644562|FG000|Overall Study|Incorrect Enrolment|1|||
16317042|NCT01031680|39644563|FG001|Overall Study|Incorrect Enrolment|2|||
16317043|NCT01031680|39644562|FG000|Overall Study|Administrative Reason by Sponsor|0|||
16317044|NCT01031680|39644563|FG001|Overall Study|Administrative Reason by Sponsor|1|||
16317045|NCT01031680|39644562|FG000|Overall Study|Various|0|||
16317046|NCT01031680|39644563|FG001|Overall Study|Various|2|||
16317047|NCT05506046|39644564|FG000|Overall Study|Lost to Follow-up|89|||
16317048|NCT05506046|39644565|FG001|Overall Study|Lost to Follow-up|101|||
16317049|NCT05506046|39644566|FG002|Overall Study|Lost to Follow-up|102|||
16317050|NCT05506046|39644567|FG003|Overall Study|Lost to Follow-up|99|||
16317051|NCT04707469|39644568|FG000|Overall Study|Site closure|0|||
16317052|NCT04707469|39644569|FG001|Overall Study|Site closure|2|||
16317053|NCT04707469|39644570|FG002|Overall Study|Site closure|0|||
16511595|NCT02739269|40347344|FG000|Overall Study|Cycle cancellation|2|||
16511596|NCT02739269|40347345|FG001|Overall Study|Cycle cancellation|2|||
16511597|NCT02739269|40347344|FG000|Overall Study|Withdrawal by Subject|0|||
16511598|NCT02739269|40347345|FG001|Overall Study|Withdrawal by Subject|2|||
16511599|NCT01723228|40347346|FG000|Overall Study|Adverse Event|2|||
16511600|NCT01723228|40347347|FG001|Overall Study|Adverse Event|6|||
16511601|NCT01723228|40347346|FG000|Overall Study|Withdrawal by Subject|2|||
16511602|NCT01723228|40347347|FG001|Overall Study|Withdrawal by Subject|1|||
16511603|NCT01723228|40347346|FG000|Overall Study|Protocol Violation|0|||
16511604|NCT01723228|40347347|FG001|Overall Study|Protocol Violation|2|||
16511605|NCT01723228|40347346|FG000|Overall Study|Lost to Follow-up|2|||
16511606|NCT01723228|40347347|FG001|Overall Study|Lost to Follow-up|1|||
16317054|NCT04707469|39644568|FG000|Overall Study|Physician Decision|2|||
16317055|NCT04707469|39644569|FG001|Overall Study|Physician Decision|2|||
16317056|NCT04707469|39644570|FG002|Overall Study|Physician Decision|2|||
16317057|NCT04707469|39644568|FG000|Overall Study|Death|1|||
16511607|NCT01723228|40347346|FG000|Overall Study|Other|2|||
16511608|NCT01723228|40347347|FG001|Overall Study|Other|1|||
16511609|NCT01399593|40347348|FG000|Overall Study|Physician Decision|1|||
16511610|NCT01399593|40347349|FG001|Overall Study|Physician Decision|0|||
16511611|NCT01399593|40347348|FG000|Overall Study|Adverse Event|1|||
16511612|NCT01399593|40347349|FG001|Overall Study|Adverse Event|0|||
16511613|NCT01399593|40347348|FG000|Overall Study|Death|1|||
16511614|NCT01399593|40347349|FG001|Overall Study|Death|1|||
16511615|NCT01399593|40347348|FG000|Overall Study|Transplantectomy|0|||
16511616|NCT01399593|40347349|FG001|Overall Study|Transplantectomy|1|||
16511617|NCT01856790|40347350|FG000|Closed Loop Control|Withdrawal by Subject|2|||
16511618|NCT01856790|40347350|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
16511619|NCT02114879|40347351|FG000|Overall Study|Withdrawal by Subject|9|||
16511620|NCT02114879|40347352|FG001|Overall Study|Withdrawal by Subject|5|||
16511621|NCT02114879|40347351|FG000|Overall Study|Death|6|||
16511622|NCT02114879|40347352|FG001|Overall Study|Death|11|||
16511623|NCT02114879|40347351|FG000|Overall Study|Lost to Follow-up|4|||
16511624|NCT02114879|40347352|FG001|Overall Study|Lost to Follow-up|6|||
16511625|NCT02114879|40347351|FG000|Overall Study|Physician Decision|0|||
16511626|NCT02114879|40347352|FG001|Overall Study|Physician Decision|2|||
16511627|NCT01806896|40347353|FG000|Overall Study|Adverse Event|2|||
16511628|NCT01806896|40347354|FG001|Overall Study|Adverse Event|0|||
16511629|NCT01806896|40347353|FG000|Overall Study|Other|1|||
16511630|NCT01806896|40347354|FG001|Overall Study|Other|0|||
16511631|NCT01971346|40347356|FG000|Overall Study|Protocol Violation|3|||
16511632|NCT01971346|40347356|FG000|Overall Study|Lost to Follow-up|2|||
16511633|NCT01971346|40347356|FG000|Overall Study|Withdrawal by Subject|2|||
16511634|NCT01971346|40347356|FG000|Overall Study|Physician Decision|1|||
16511635|NCT01982253|40347357|FG000|Overall Study|Withdrawal by Subject|1|||
16511636|NCT01982253|40347358|FG001|Overall Study|Withdrawal by Subject|0|||
16511637|NCT01982253|40347359|FG002|Overall Study|Withdrawal by Subject|0|||
16511638|NCT01982253|40347357|FG000|Overall Study|Study terminated by sponsor|1|||
16317058|NCT04707469|39644569|FG001|Overall Study|Death|6|||
16317059|NCT04707469|39644570|FG002|Overall Study|Death|2|||
16317060|NCT04707469|39644568|FG000|Overall Study|Lost to Follow-up|9|||
16317061|NCT04707469|39644569|FG001|Overall Study|Lost to Follow-up|19|||
16317062|NCT04707469|39644570|FG002|Overall Study|Lost to Follow-up|14|||
16317063|NCT04707469|39644568|FG000|Overall Study|Withdrawal by Subject|17|||
16317064|NCT04707469|39644569|FG001|Overall Study|Withdrawal by Subject|16|||
16317065|NCT04707469|39644570|FG002|Overall Study|Withdrawal by Subject|12|||
16317066|NCT00984542|39644578|FG000|Overall Study|disease progression|19|||
16317067|NCT00984542|39644578|FG000|Overall Study|toxicity|7|||
16317068|NCT00984542|39644578|FG000|Overall Study|Death|7|||
16317069|NCT00984542|39644578|FG000|Overall Study|complicating disease|3|||
16317070|NCT00984542|39644578|FG000|Overall Study|Withdrawal by Subject|3|||
16317071|NCT00984542|39644578|FG000|Overall Study|clinical deterioration|2|||
16317072|NCT02356588|39644579|FG000|Overall Study|Lack of Efficacy|4|||
16317073|NCT02356588|39644580|FG001|Overall Study|Lack of Efficacy|10|||
16317074|NCT02356588|39644579|FG000|Overall Study|Adverse Event|0|||
16317075|NCT02356588|39644580|FG001|Overall Study|Adverse Event|2|||
16317076|NCT02356588|39644579|FG000|Overall Study|Withdrawal by Subject|1|||
16317077|NCT02356588|39644580|FG001|Overall Study|Withdrawal by Subject|0|||
16317078|NCT02356588|39644579|FG000|Overall Study|Protocol Violation|0|||
16317079|NCT02356588|39644580|FG001|Overall Study|Protocol Violation|1|||
16317080|NCT02366689|39644585|FG000|Overall Study|Withdrawal by Subject|1|||
16317081|NCT02366689|39644586|FG001|Overall Study|Withdrawal by Subject|0|||
16317082|NCT02366689|39644587|FG002|Overall Study|Withdrawal by Subject|1|||
16393313|NCT01194219|39922240|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
16511639|NCT01982253|40347358|FG001|Overall Study|Study terminated by sponsor|4|||
16511640|NCT01982253|40347359|FG002|Overall Study|Study terminated by sponsor|4|||
16511641|NCT01344369|40347360|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
16511642|NCT01344369|40347361|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
16511643|NCT01344369|40347360|FG000|Washout of 28 Days|Physician Decision|0|||
16511644|NCT01344369|40347361|FG001|Washout of 28 Days|Physician Decision|1|||
16511645|NCT01344369|40347360|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
16317083|NCT02366689|39644585|FG000|Overall Study|Lost to Follow-up|3|||
16317084|NCT02366689|39644586|FG001|Overall Study|Lost to Follow-up|2|||
16317085|NCT02366689|39644587|FG002|Overall Study|Lost to Follow-up|0|||
16317086|NCT02366689|39644585|FG000|Overall Study|Pregnancy|0|||
16317087|NCT02366689|39644586|FG001|Overall Study|Pregnancy|1|||
16317088|NCT02366689|39644587|FG002|Overall Study|Pregnancy|1|||
16317089|NCT00832455|39644593|FG000|Overall Study|Adverse Event|13|||
16511646|NCT01344369|40347361|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
16511647|NCT01957462|40347362|FG000|Test Period 1|Withdrawal by Subject|1|||
16511648|NCT01957462|40347363|FG001|Test Period 1|Withdrawal by Subject|0|||
16511649|NCT01957462|40347362|FG000|Test Period 1|Adverse Event|1|||
16511650|NCT01957462|40347363|FG001|Test Period 1|Adverse Event|0|||
16511651|NCT00213148|40347366|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
16511652|NCT00213148|40347367|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
16511653|NCT00213148|40347368|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
16511654|NCT00213148|40347369|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
16317090|NCT00832455|39644593|FG000|Overall Study|Lost to Follow-up|26|||
16317091|NCT00832455|39644593|FG000|Overall Study|Protocol Violation|4|||
16317092|NCT00832455|39644593|FG000|Overall Study|Withdrawal by Subject|17|||
16511655|NCT00213148|40347370|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
16511656|NCT00213148|40347366|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
16511657|NCT00213148|40347367|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
16511658|NCT00213148|40347368|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
16511659|NCT00213148|40347369|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
16511660|NCT00213148|40347370|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
16511661|NCT00213148|40347366|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
16511662|NCT00213148|40347367|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
16511663|NCT00213148|40347368|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
16511664|NCT00213148|40347369|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
16511665|NCT00213148|40347370|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
16511666|NCT00213148|40347366|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
16199550|NCT01021813|39204652|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
16199551|NCT01021813|39204653|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
16317093|NCT00832455|39644593|FG000|Overall Study|Screening Failure|2|||
16317094|NCT00832455|39644593|FG000|Overall Study|Stopped Medication|4|||
16317095|NCT00832455|39644593|FG000|Overall Study|Parent misunderstood study|1|||
16317096|NCT00832455|39644593|FG000|Overall Study|Parent dissatisfied|1|||
16317097|NCT00832455|39644593|FG000|Overall Study|No improvement|3|||
16317098|NCT00832455|39644593|FG000|Overall Study|Patient moved|1|||
16317099|NCT02860130|39644594|FG000|Overall Study|Adverse Event|2|||
16317100|NCT02860130|39644595|FG001|Overall Study|Adverse Event|3|||
16317101|NCT02860130|39644594|FG000|Overall Study|Protocol Violation|1|||
16317102|NCT02860130|39644595|FG001|Overall Study|Protocol Violation|1|||
16317103|NCT02860130|39644594|FG000|Overall Study|Withdrawal by Subject|0|||
16317104|NCT02860130|39644595|FG001|Overall Study|Withdrawal by Subject|2|||
16317105|NCT02860130|39644594|FG000|Overall Study|Physician Decision|2|||
16317106|NCT02860130|39644595|FG001|Overall Study|Physician Decision|2|||
16317107|NCT02860130|39644594|FG000|Overall Study|Other|2|||
16317108|NCT02860130|39644595|FG001|Overall Study|Other|1|||
16199552|NCT01021813|39204654|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
16199553|NCT01021813|39204655|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
16317109|NCT02418949|39644600|FG000|Overall Study|Withdrawal by Subject|1|||
16317110|NCT02418949|39644601|FG001|Overall Study|Withdrawal by Subject|0|||
16317111|NCT02418949|39644602|FG002|Overall Study|Withdrawal by Subject|1|||
16317112|NCT02418949|39644603|FG003|Overall Study|Withdrawal by Subject|1|||
16317113|NCT02418949|39644600|FG000|Overall Study|Lost to Follow-up|1|||
16317114|NCT02418949|39644601|FG001|Overall Study|Lost to Follow-up|0|||
16317115|NCT02418949|39644602|FG002|Overall Study|Lost to Follow-up|1|||
16317116|NCT02418949|39644603|FG003|Overall Study|Lost to Follow-up|0|||
16317117|NCT02418949|39644600|FG000|Overall Study|Physician Decision|1|||
16317118|NCT02418949|39644601|FG001|Overall Study|Physician Decision|1|||
16317119|NCT02418949|39644602|FG002|Overall Study|Physician Decision|1|||
16317120|NCT02418949|39644603|FG003|Overall Study|Physician Decision|0|||
16511667|NCT00213148|40347367|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
16511668|NCT00213148|40347368|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
16511669|NCT00213148|40347369|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
16199554|NCT01601470|39204659|FG000|Period 2 - LCZ696|Physician Decision|1|||
16199555|NCT02188719|39204660|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
16199556|NCT02188719|39204661|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
16199557|NCT02188719|39204662|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
16199558|NCT02188719|39204663|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
16199559|NCT00995670|39204673|FG000|Overall Study|Failed arterial cannulation|1|||
16199560|NCT00995670|39204674|FG001|Overall Study|Failed arterial cannulation|0|||
16199561|NCT00995670|39204675|FG002|Overall Study|Failed arterial cannulation|3|||
16199562|NCT01592409|39207374|FG000|Overall Study|Withdrawal by Subject|0|||
16199563|NCT01592409|39207375|FG001|Overall Study|Withdrawal by Subject|1|||
16090027|NCT01683409|38820062|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
16317121|NCT01516008|39644604|FG000|Overall Study|Adverse Event|0|||
16317122|NCT01516008|39644605|FG001|Overall Study|Adverse Event|2|||
16317123|NCT01516008|39644606|FG002|Overall Study|Adverse Event|7|||
16317124|NCT01516008|39644604|FG000|Overall Study|Lack of Efficacy|44|||
16317125|NCT01516008|39644605|FG001|Overall Study|Lack of Efficacy|14|||
16317126|NCT01516008|39644606|FG002|Overall Study|Lack of Efficacy|10|||
16317127|NCT01516008|39644604|FG000|Overall Study|Protocol Violation|1|||
16511670|NCT00213148|40347370|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
16511671|NCT00213148|40347366|FG000|Cycle 1 (1 Month)|Other|3|||
16511672|NCT00213148|40347367|FG001|Cycle 1 (1 Month)|Other|0|||
16317128|NCT01516008|39644605|FG001|Overall Study|Protocol Violation|0|||
16511673|NCT00213148|40347368|FG002|Cycle 1 (1 Month)|Other|2|||
16511674|NCT00213148|40347369|FG003|Cycle 1 (1 Month)|Other|2|||
16511675|NCT00213148|40347370|FG004|Cycle 1 (1 Month)|Other|7|||
16199564|NCT04124692|39207378|FG000|Overall Study|Medical reason|0|||
16511676|NCT00213148|40347366|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16511677|NCT00213148|40347367|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16511678|NCT00213148|40347368|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16511679|NCT00213148|40347369|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
16511680|NCT00213148|40347370|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16511681|NCT00213148|40347366|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
16511682|NCT00213148|40347367|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
16511683|NCT00213148|40347368|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
16511684|NCT00213148|40347369|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
16199565|NCT04124692|39207379|FG001|Overall Study|Medical reason|1|||
16199566|NCT04124692|39207378|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
16199567|NCT04124692|39207379|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
16199568|NCT04124692|39207378|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
16199569|NCT04124692|39207379|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
16199570|NCT04124692|39207378|FG000|Overall Study|Lost to Follow-up|2|||
16199571|NCT04124692|39207379|FG001|Overall Study|Lost to Follow-up|4|||
16199572|NCT04124692|39207378|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
16199573|NCT04124692|39207379|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
16199574|NCT00642018|39207382|FG000|Overall Study|Adverse Event|11|||
16199575|NCT00642018|39207383|FG001|Overall Study|Adverse Event|36|||
16317129|NCT01516008|39644606|FG002|Overall Study|Protocol Violation|0|||
16199576|NCT00642018|39207382|FG000|Overall Study|Withdrawal by Subject|4|||
16199577|NCT00642018|39207383|FG001|Overall Study|Withdrawal by Subject|10|||
16199578|NCT00642018|39207382|FG000|Overall Study|Progressive Disease|13|||
16199579|NCT00642018|39207383|FG001|Overall Study|Progressive Disease|18|||
16199580|NCT00642018|39207382|FG000|Overall Study|Physician Decision|0|||
16199581|NCT00642018|39207383|FG001|Overall Study|Physician Decision|10|||
16199582|NCT00642018|39207382|FG000|Overall Study|Protocol Violation|0|||
16199583|NCT00642018|39207383|FG001|Overall Study|Protocol Violation|1|||
16199584|NCT00642018|39207382|FG000|Overall Study|Death|0|||
16199585|NCT00642018|39207383|FG001|Overall Study|Death|3|||
16199586|NCT00642018|39207382|FG000|Overall Study|Entry Criteria Not Met|0|||
16199587|NCT00642018|39207383|FG001|Overall Study|Entry Criteria Not Met|1|||
16199588|NCT04404010|39207384|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
16199589|NCT04404010|39207385|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
16199590|NCT02322411|39207387|FG000|Overall Study|Lost to Follow-up|4|||
16199591|NCT02322411|39207388|FG001|Overall Study|Lost to Follow-up|7|||
16199592|NCT02322411|39207387|FG000|Overall Study|Withdrawal by Subject|1|||
16199593|NCT02322411|39207388|FG001|Overall Study|Withdrawal by Subject|0|||
16199594|NCT00980980|39207389|FG000|Overall Study|Withdrawal by Hospital|0|||
16199595|NCT00980980|39207390|FG001|Overall Study|Withdrawal by Hospital|1|||
16199596|NCT00980980|39207391|FG002|Overall Study|Withdrawal by Hospital|0|||
16199597|NCT05590767|39207396|FG000|Overall Study|Protocol Violation|1|||
16199598|NCT05590767|39207396|FG000|Overall Study|surgery canceled|1|||
16199599|NCT05590767|39207396|FG000|Overall Study|interscalene brachial block not performed|1|||
16199600|NCT00618449|39207397|FG000|Overall Study|Lost to Follow-up|98|||
16199601|NCT00618449|39207398|FG001|Overall Study|Lost to Follow-up|110|||
16199602|NCT03247413|39207400|FG000|Overall Study|Lost to Follow-up|28|||
16199603|NCT03600714|39207401|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
16199604|NCT00853489|39207402|FG000|Overall Study|Lost to Follow-up|5|||
16199605|NCT00853489|39207403|FG001|Overall Study|Lost to Follow-up|2|||
16199606|NCT01697267|39207404|FG000|Overall Study|Death|3|||
16199607|NCT01697267|39207405|FG001|Overall Study|Death|1|||
16199608|NCT01697267|39207404|FG000|Overall Study|Withdrawal by Subject|5|||
16199609|NCT01697267|39207405|FG001|Overall Study|Withdrawal by Subject|5|||
16199610|NCT01697267|39207404|FG000|Overall Study|Adverse Event|2|||
16199611|NCT01697267|39207405|FG001|Overall Study|Adverse Event|1|||
16199612|NCT01697267|39207404|FG000|Overall Study|Lost to Follow-up|2|||
16317130|NCT01516008|39644604|FG000|Overall Study|Reason not specified|0|||
16199613|NCT01697267|39207405|FG001|Overall Study|Lost to Follow-up|4|||
16199614|NCT01697267|39207404|FG000|Overall Study|Physician Decision|2|||
16199615|NCT01697267|39207405|FG001|Overall Study|Physician Decision|4|||
16199616|NCT01283997|39207406|FG000|Overall Study|Physician Decision|8|||
16199617|NCT01283997|39207407|FG001|Overall Study|Physician Decision|10|||
16199618|NCT01283997|39207406|FG000|Overall Study|Withdrawal by Subject|3|||
16199619|NCT01283997|39207407|FG001|Overall Study|Withdrawal by Subject|2|||
16199620|NCT01283997|39207406|FG000|Overall Study|Physically unable to continue|0|||
16199621|NCT01283997|39207407|FG001|Overall Study|Physically unable to continue|1|||
16199622|NCT01283997|39207406|FG000|Overall Study|Progressive disease|1|||
16199623|NCT01283997|39207407|FG001|Overall Study|Progressive disease|0|||
16199624|NCT01283997|39207406|FG000|Overall Study|Other|4|||
16199625|NCT01283997|39207407|FG001|Overall Study|Other|4|||
16199626|NCT01956240|39207415|FG000|Overall Study|Lost to Follow-up|6|||
16199627|NCT01956240|39207416|FG001|Overall Study|Lost to Follow-up|20|||
16199628|NCT01956240|39207415|FG000|Overall Study|Adverse Event|17|||
16199629|NCT01956240|39207416|FG001|Overall Study|Adverse Event|4|||
16199630|NCT00311181|39207428|FG000|Overall Study|Final DFTs were not obtained|96|||
16199631|NCT04199793|39207429|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
16199632|NCT04199793|39207430|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
16199633|NCT04199793|39207429|FG000|Overall Study|Withdrawal by Subject|1|||
16199634|NCT04199793|39207430|FG001|Overall Study|Withdrawal by Subject|1|||
16199635|NCT01265420|39207435|FG000|Overall Study|Lost to Follow-up|1|||
16199636|NCT00593840|39207436|FG000|Overall Study|Withdrawal by Subject|1|||
16199637|NCT01313208|39207438|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
16199638|NCT01313208|39207439|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
16199639|NCT01313208|39207438|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
16199640|NCT01313208|39207439|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
16199641|NCT01313208|39207438|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
16199642|NCT01313208|39207439|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
16199643|NCT01313208|39207438|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
16199644|NCT01313208|39207439|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
16199645|NCT01313208|39207438|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
16199646|NCT01313208|39207439|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
16199647|NCT01313208|39207438|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
16199648|NCT01313208|39207439|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
16199649|NCT01313208|39207438|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
16199650|NCT01313208|39207439|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
16199651|NCT01313208|39207438|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
16199652|NCT01313208|39207439|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
16199653|NCT01313208|39207438|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
16199654|NCT01313208|39207439|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
16199655|NCT01392378|39207442|FG000|Infant Series|Adverse Event|0|||
16199656|NCT01392378|39207443|FG001|Infant Series|Adverse Event|0|||
16199657|NCT01392378|39207444|FG002|Infant Series|Adverse Event|0|||
16199658|NCT01392378|39207445|FG003|Infant Series|Adverse Event|1|||
16199659|NCT01392378|39207446|FG004|Infant Series|Adverse Event|0|||
16199660|NCT01392378|39207442|FG000|Infant Series|Lost to Follow-up|0|||
16199661|NCT01392378|39207443|FG001|Infant Series|Lost to Follow-up|0|||
16199662|NCT01392378|39207444|FG002|Infant Series|Lost to Follow-up|0|||
16199663|NCT01392378|39207445|FG003|Infant Series|Lost to Follow-up|1|||
16199664|NCT01392378|39207446|FG004|Infant Series|Lost to Follow-up|0|||
16199665|NCT01392378|39207442|FG000|Infant Series|Protocol Violation|0|||
16199666|NCT01392378|39207443|FG001|Infant Series|Protocol Violation|1|||
16199667|NCT01392378|39207444|FG002|Infant Series|Protocol Violation|0|||
16199668|NCT01392378|39207445|FG003|Infant Series|Protocol Violation|0|||
16199669|NCT01392378|39207446|FG004|Infant Series|Protocol Violation|0|||
16199670|NCT01392378|39207442|FG000|Infant Series|Withdrawal by Parent|4|||
16199671|NCT01392378|39207443|FG001|Infant Series|Withdrawal by Parent|1|||
16199672|NCT01392378|39207444|FG002|Infant Series|Withdrawal by Parent|0|||
16199673|NCT01392378|39207445|FG003|Infant Series|Withdrawal by Parent|0|||
16199674|NCT01392378|39207446|FG004|Infant Series|Withdrawal by Parent|0|||
16199675|NCT01392378|39207442|FG000|After Infant Series|Lost to Follow-up|0|||
16199676|NCT01392378|39207443|FG001|After Infant Series|Lost to Follow-up|0|||
16199677|NCT01392378|39207444|FG002|After Infant Series|Lost to Follow-up|1|||
16199678|NCT01392378|39207445|FG003|After Infant Series|Lost to Follow-up|0|||
16199679|NCT01392378|39207446|FG004|After Infant Series|Lost to Follow-up|0|||
16199680|NCT01392378|39207442|FG000|After Infant Series|Withdrawal by Parent|0|||
16199681|NCT01392378|39207443|FG001|After Infant Series|Withdrawal by Parent|1|||
16199682|NCT01392378|39207444|FG002|After Infant Series|Withdrawal by Parent|1|||
16199683|NCT01392378|39207445|FG003|After Infant Series|Withdrawal by Parent|0|||
16199684|NCT01392378|39207446|FG004|After Infant Series|Withdrawal by Parent|1|||
16199685|NCT01392378|39207442|FG000|Toddler Dose|Lost to Follow-up|0|||
16090028|NCT01683409|38820063|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
16199686|NCT01392378|39207443|FG001|Toddler Dose|Lost to Follow-up|0|||
16199687|NCT01392378|39207444|FG002|Toddler Dose|Lost to Follow-up|0|||
16199688|NCT01392378|39207445|FG003|Toddler Dose|Lost to Follow-up|1|||
16199689|NCT01392378|39207446|FG004|Toddler Dose|Lost to Follow-up|0|||
16199690|NCT01392378|39207442|FG000|Toddler Dose|Withdrawal by Parent|0|||
16199691|NCT01392378|39207443|FG001|Toddler Dose|Withdrawal by Parent|1|||
16199692|NCT01392378|39207444|FG002|Toddler Dose|Withdrawal by Parent|0|||
16199693|NCT01392378|39207445|FG003|Toddler Dose|Withdrawal by Parent|1|||
16199694|NCT01392378|39207446|FG004|Toddler Dose|Withdrawal by Parent|1|||
16199695|NCT02022033|39207449|FG000|Overall Study|Physician Decision|1|||
16199696|NCT01934894|39207450|FG000|Overall Study|Adverse Event|1|||
16199697|NCT01934894|39207451|FG001|Overall Study|Adverse Event|2|||
16199698|NCT01934894|39207450|FG000|Overall Study|Death|2|||
16199699|NCT01934894|39207451|FG001|Overall Study|Death|0|||
16199700|NCT01934894|39207450|FG000|Overall Study|Withdrawal by Subject|0|||
16199701|NCT01934894|39207451|FG001|Overall Study|Withdrawal by Subject|1|||
16199702|NCT01934894|39207450|FG000|Overall Study|Progressive Disease|3|||
16199703|NCT01934894|39207451|FG001|Overall Study|Progressive Disease|2|||
16199704|NCT00675103|39207452|FG000|Overall Study|Lack of Efficacy|2|||
16199705|NCT00675103|39207452|FG000|Overall Study|Adverse Event|1|||
16199706|NCT01413542|39207455|FG000|Overall Study|Physician Decision|1|||
16199707|NCT01413542|39207456|FG001|Overall Study|Physician Decision|0|||
16199708|NCT01413542|39207457|FG002|Overall Study|Physician Decision|3|||
16199709|NCT01413542|39207458|FG003|Overall Study|Physician Decision|0|||
16199710|NCT01413542|39207455|FG000|Overall Study|Adverse Event|0|||
16199711|NCT01413542|39207456|FG001|Overall Study|Adverse Event|0|||
16199712|NCT01413542|39207457|FG002|Overall Study|Adverse Event|0|||
16199713|NCT01413542|39207458|FG003|Overall Study|Adverse Event|1|||
16199714|NCT03495817|39207459|FG000|26 Week Open Label|Adverse Event|3|||
16199715|NCT03495817|39207459|FG000|26 Week Open Label|Withdrawal by Subject|4|||
16199716|NCT03495817|39207459|FG000|26 Week Open Label|Lost to Follow-up|1|||
16199717|NCT03495817|39207459|FG000|26 Week Extension|Lost to Follow-up|2|||
16199718|NCT03115112|39207460|FG000|Overall Study|Adverse Event|5|||
16199719|NCT03115112|39207461|FG001|Overall Study|Adverse Event|1|||
16199720|NCT03115112|39207460|FG000|Overall Study|Withdrawal by Subject|4|||
16199721|NCT03115112|39207461|FG001|Overall Study|Withdrawal by Subject|2|||
16199722|NCT03115112|39207460|FG000|Overall Study|Lost to Follow-up|0|||
16199723|NCT03115112|39207461|FG001|Overall Study|Lost to Follow-up|1|||
16199724|NCT03115112|39207460|FG000|Overall Study|Death|1|||
16199725|NCT03115112|39207461|FG001|Overall Study|Death|0|||
16199726|NCT03115112|39207460|FG000|Overall Study|Pregnancy|1|||
16199727|NCT03115112|39207461|FG001|Overall Study|Pregnancy|0|||
16199728|NCT03115112|39207460|FG000|Overall Study|Site closure|1|||
16199729|NCT03115112|39207461|FG001|Overall Study|Site closure|1|||
16199730|NCT02713789|39207462|FG000|Overall Study|Lost to Follow-up|0|||
16199731|NCT02713789|39207463|FG001|Overall Study|Lost to Follow-up|1|||
16199732|NCT02713789|39207464|FG002|Overall Study|Lost to Follow-up|1|||
16199733|NCT00165646|39207475|FG000|Overall Study|Adverse Event|1|||
16199734|NCT00165646|39207476|FG001|Overall Study|Adverse Event|1|||
16199735|NCT00165646|39207477|FG002|Overall Study|Adverse Event|1|||
16199736|NCT00165646|39207475|FG000|Overall Study|Lack of Efficacy|1|||
16199737|NCT00165646|39207476|FG001|Overall Study|Lack of Efficacy|2|||
16199738|NCT00165646|39207477|FG002|Overall Study|Lack of Efficacy|0|||
16199739|NCT00165646|39207475|FG000|Overall Study|Withdrawal by Subject|0|||
16199740|NCT00165646|39207476|FG001|Overall Study|Withdrawal by Subject|2|||
16199741|NCT00165646|39207477|FG002|Overall Study|Withdrawal by Subject|1|||
16199742|NCT00165646|39207475|FG000|Overall Study|Physician Decision|2|||
16199743|NCT00165646|39207476|FG001|Overall Study|Physician Decision|0|||
16199744|NCT00165646|39207477|FG002|Overall Study|Physician Decision|2|||
16199745|NCT00165646|39207475|FG000|Overall Study|Protocol Violation|1|||
16199746|NCT00165646|39207476|FG001|Overall Study|Protocol Violation|0|||
16199747|NCT00165646|39207477|FG002|Overall Study|Protocol Violation|0|||
16199748|NCT00229203|39207478|FG000|Overall Study|Progressive disease|18|||
16199749|NCT00229203|39207479|FG001|Overall Study|Progressive disease|9|||
16199750|NCT00229203|39207478|FG000|Overall Study|Toxicity|6|||
16199751|NCT00229203|39207479|FG001|Overall Study|Toxicity|1|||
16199752|NCT00229203|39207478|FG000|Overall Study|Death|4|||
16199753|NCT00229203|39207479|FG001|Overall Study|Death|2|||
16199754|NCT00229203|39207478|FG000|Overall Study|Other|3|||
16199755|NCT00229203|39207479|FG001|Overall Study|Other|3|||
16199756|NCT00229203|39207478|FG000|Overall Study|Withdrawal by Subject|1|||
16199757|NCT00229203|39207479|FG001|Overall Study|Withdrawal by Subject|4|||
16199758|NCT01529385|39207480|FG000|Overall Study|Lost to Follow-up|2|||
16199759|NCT01529385|39207481|FG001|Overall Study|Lost to Follow-up|1|||
16199760|NCT00126581|39207485|FG000|Overall Study|Adverse Event|3|||
16199761|NCT00126581|39207486|FG001|Overall Study|Adverse Event|7|||
16199762|NCT00126581|39207485|FG000|Overall Study|Death|3|||
16317131|NCT01516008|39644605|FG001|Overall Study|Reason not specified|0|||
16317132|NCT01516008|39644606|FG002|Overall Study|Reason not specified|1|||
16317133|NCT02059135|39644607|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
16199763|NCT00126581|39207486|FG001|Overall Study|Death|2|||
16199764|NCT00126581|39207485|FG000|Overall Study|Withdrawal by Subject|1|||
16199765|NCT00126581|39207486|FG001|Overall Study|Withdrawal by Subject|4|||
16199766|NCT00126581|39207485|FG000|Overall Study|Alternative therapy|3|||
16199767|NCT00126581|39207486|FG001|Overall Study|Alternative therapy|3|||
16199768|NCT00126581|39207485|FG000|Overall Study|Other illness/MD discretion|3|||
16317134|NCT02059135|39644608|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
16317135|NCT02059135|39644607|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
16199769|NCT00126581|39207486|FG001|Overall Study|Other illness/MD discretion|4|||
16199770|NCT03519516|39207490|FG000|Overall Study|Adverse Event|0|||
16199771|NCT03519516|39207491|FG001|Overall Study|Adverse Event|1|||
16199772|NCT00255086|39207500|FG000|Overall Study|Adverse Event|1|||
16199773|NCT00255086|39207501|FG001|Overall Study|Adverse Event|1|||
16199774|NCT00255086|39207500|FG000|Overall Study|Protocol Violation|1|||
16199775|NCT00255086|39207501|FG001|Overall Study|Protocol Violation|1|||
16199776|NCT03695393|39207502|FG000|Overall Study|Death|3|||
16199777|NCT03695393|39207503|FG001|Overall Study|Death|1|||
16199778|NCT03695393|39207502|FG000|Overall Study|Lost to Follow-up|0|||
16199779|NCT03695393|39207503|FG001|Overall Study|Lost to Follow-up|1|||
16199780|NCT03404518|39207505|FG000|Overall Study|Lost to Follow-up|28|||
16199781|NCT03404518|39207506|FG001|Overall Study|Lost to Follow-up|30|||
16199782|NCT03404518|39207505|FG000|Overall Study|Protocol Violation|13|||
16199783|NCT03404518|39207506|FG001|Overall Study|Protocol Violation|6|||
16199784|NCT00836277|39207507|FG000|Overall Study|Not evaluable for response|6|||
16199785|NCT00109772|39207509|FG000|Double-blind Treatment|Adverse Event|14|||
16199786|NCT00109772|39207510|FG001|Double-blind Treatment|Adverse Event|5|||
16199787|NCT00109772|39207509|FG000|Double-blind Treatment|Lack of Efficacy|1|||
16199788|NCT00109772|39207510|FG001|Double-blind Treatment|Lack of Efficacy|0|||
16199789|NCT00109772|39207509|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
16199790|NCT00109772|39207510|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
16199791|NCT00109772|39207509|FG000|Double-blind Treatment|Lost to Follow-up|2|||
16199792|NCT00109772|39207510|FG001|Double-blind Treatment|Lost to Follow-up|3|||
16199793|NCT00109772|39207509|FG000|Double-blind Treatment|Protocol Violation|0|||
16199794|NCT00109772|39207510|FG001|Double-blind Treatment|Protocol Violation|1|||
16199795|NCT00109772|39207509|FG000|Double-blind Treatment|Other|0|||
16199796|NCT00109772|39207510|FG001|Double-blind Treatment|Other|4|||
16199797|NCT00109772|39207509|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
16199798|NCT00109772|39207510|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
16199799|NCT00109772|39207509|FG000|Open-label Extension|Adverse Event|10|||
16199800|NCT00109772|39207510|FG001|Open-label Extension|Adverse Event|19|||
16199801|NCT00109772|39207509|FG000|Open-label Extension|Lack of Efficacy|19|||
16199802|NCT00109772|39207510|FG001|Open-label Extension|Lack of Efficacy|11|||
16199803|NCT00109772|39207509|FG000|Open-label Extension|Withdrawal by Subject|9|||
16199804|NCT00109772|39207510|FG001|Open-label Extension|Withdrawal by Subject|6|||
16199805|NCT00109772|39207509|FG000|Open-label Extension|Lost to Follow-up|1|||
16199806|NCT00109772|39207510|FG001|Open-label Extension|Lost to Follow-up|0|||
16199807|NCT00109772|39207509|FG000|Open-label Extension|Death|0|||
16199808|NCT00109772|39207510|FG001|Open-label Extension|Death|1|||
16199809|NCT00109772|39207509|FG000|Open-label Extension|Protocol Violation|2|||
16199810|NCT00109772|39207510|FG001|Open-label Extension|Protocol Violation|2|||
16199811|NCT00109772|39207509|FG000|Open-label Extension|Other|4|||
16199812|NCT00109772|39207510|FG001|Open-label Extension|Other|10|||
16199813|NCT01700985|39207514|FG000|Overall Study|Incarcerated|0|||
16199814|NCT01700985|39207515|FG001|Overall Study|Incarcerated|1|||
16199815|NCT00115765|39207519|FG000|Overall Study|Withdrawal by Subject|22|||
16199816|NCT00115765|39207520|FG001|Overall Study|Withdrawal by Subject|53|||
16199817|NCT00115765|39207521|FG002|Overall Study|Withdrawal by Subject|76|||
16199818|NCT00115765|39207522|FG003|Overall Study|Withdrawal by Subject|15|||
16199819|NCT00115765|39207519|FG000|Overall Study|Physician Decision|4|||
16199820|NCT00115765|39207520|FG001|Overall Study|Physician Decision|15|||
16199821|NCT00115765|39207521|FG002|Overall Study|Physician Decision|18|||
16199822|NCT00115765|39207522|FG003|Overall Study|Physician Decision|13|||
16317136|NCT02059135|39644608|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
16317137|NCT02059135|39644607|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
16317138|NCT02059135|39644608|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
16317139|NCT02059135|39644607|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
16317140|NCT02059135|39644608|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
16317141|NCT02059135|39644607|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
16317142|NCT02059135|39644608|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
16317143|NCT02059135|39644607|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
16317144|NCT02059135|39644608|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
16317145|NCT02059135|39644607|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
16317146|NCT02059135|39644608|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
16317147|NCT02059135|39644607|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
16317148|NCT02059135|39644608|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
16393314|NCT01194219|39922241|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
16393315|NCT01194219|39922242|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
16199823|NCT00115765|39207519|FG000|Overall Study|Lost to Follow-up|3|||
16199824|NCT00115765|39207520|FG001|Overall Study|Lost to Follow-up|20|||
16199825|NCT00115765|39207521|FG002|Overall Study|Lost to Follow-up|18|||
16199826|NCT00115765|39207522|FG003|Overall Study|Lost to Follow-up|1|||
16199827|NCT00115765|39207519|FG000|Overall Study|Other|6|||
16199828|NCT00115765|39207520|FG001|Overall Study|Other|12|||
16199829|NCT00115765|39207521|FG002|Overall Study|Other|9|||
16199830|NCT00115765|39207522|FG003|Overall Study|Other|2|||
16199831|NCT02208024|39207523|FG000|Overall Study|Withdrawal by Subject|1|||
16199832|NCT01317615|39207524|FG000|Overall Study|Disease progression|25|||
16511685|NCT00213148|40347370|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
16511686|NCT00213148|40347366|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
16511687|NCT00213148|40347367|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
16511688|NCT00213148|40347368|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
16511689|NCT00213148|40347369|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
16511690|NCT00213148|40347370|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
16511691|NCT00213148|40347366|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
16511692|NCT00213148|40347367|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
16511693|NCT00213148|40347368|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
16511694|NCT00213148|40347369|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
16511695|NCT00213148|40347370|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
16511696|NCT00213148|40347366|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
16511697|NCT00213148|40347367|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
16511698|NCT00213148|40347368|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
16511699|NCT00213148|40347369|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
16511700|NCT00213148|40347370|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
16511701|NCT00213148|40347366|FG000|Cycle 2 (1 Month)|Other|2|||
16511702|NCT00213148|40347367|FG001|Cycle 2 (1 Month)|Other|1|||
16511703|NCT00213148|40347368|FG002|Cycle 2 (1 Month)|Other|2|||
16511704|NCT00213148|40347369|FG003|Cycle 2 (1 Month)|Other|8|||
16511705|NCT00213148|40347370|FG004|Cycle 2 (1 Month)|Other|7|||
16511706|NCT00213148|40347366|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16511707|NCT00213148|40347367|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
16511708|NCT00213148|40347368|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16511709|NCT00213148|40347369|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16511710|NCT00213148|40347370|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
16511711|NCT00213148|40347366|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
16511712|NCT00213148|40347367|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
16511713|NCT00213148|40347368|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
16511714|NCT00213148|40347369|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
16511715|NCT00213148|40347370|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
16511716|NCT00213148|40347366|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
16511717|NCT00213148|40347367|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
16511718|NCT00213148|40347368|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
16511719|NCT00213148|40347369|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
16511720|NCT00213148|40347370|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
16511721|NCT00213148|40347366|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
16511722|NCT00213148|40347367|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
16511723|NCT00213148|40347368|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
16511724|NCT00213148|40347369|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
16511725|NCT00213148|40347370|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
16511726|NCT00213148|40347366|FG000|Cycle 3 (1 Month)|Other|0|||
16511727|NCT00213148|40347367|FG001|Cycle 3 (1 Month)|Other|0|||
16511728|NCT00213148|40347368|FG002|Cycle 3 (1 Month)|Other|1|||
16511729|NCT00213148|40347369|FG003|Cycle 3 (1 Month)|Other|1|||
16511730|NCT00213148|40347370|FG004|Cycle 3 (1 Month)|Other|0|||
16511731|NCT00735371|40347374|FG000|Overall Study|Adverse Event|3|||
16511732|NCT00735371|40347375|FG001|Overall Study|Adverse Event|3|||
16511733|NCT00735371|40347376|FG002|Overall Study|Adverse Event|4|||
16511734|NCT00735371|40347377|FG003|Overall Study|Adverse Event|1|||
16511735|NCT00735371|40347374|FG000|Overall Study|Protocol Violation|2|||
16511736|NCT00735371|40347375|FG001|Overall Study|Protocol Violation|2|||
16511737|NCT00735371|40347376|FG002|Overall Study|Protocol Violation|0|||
16511738|NCT00735371|40347377|FG003|Overall Study|Protocol Violation|3|||
16511739|NCT00735371|40347374|FG000|Overall Study|Withdrawal by Subject|0|||
16511740|NCT00735371|40347375|FG001|Overall Study|Withdrawal by Subject|2|||
16511741|NCT00735371|40347376|FG002|Overall Study|Withdrawal by Subject|2|||
16511742|NCT00735371|40347377|FG003|Overall Study|Withdrawal by Subject|0|||
16511743|NCT00735371|40347374|FG000|Overall Study|Lost to Follow-up|1|||
16199833|NCT01317615|39207524|FG000|Overall Study|New cancer therapy|5|||
16511744|NCT00735371|40347375|FG001|Overall Study|Lost to Follow-up|1|||
16511745|NCT00735371|40347376|FG002|Overall Study|Lost to Follow-up|3|||
16511746|NCT00735371|40347377|FG003|Overall Study|Lost to Follow-up|1|||
16511747|NCT00735371|40347374|FG000|Overall Study|Lack of Efficacy|4|||
16511748|NCT00735371|40347375|FG001|Overall Study|Lack of Efficacy|2|||
16511749|NCT00735371|40347376|FG002|Overall Study|Lack of Efficacy|0|||
16511750|NCT00735371|40347377|FG003|Overall Study|Lack of Efficacy|4|||
16511751|NCT00735371|40347374|FG000|Overall Study|Sponsor Decision|3|||
16511752|NCT00735371|40347375|FG001|Overall Study|Sponsor Decision|1|||
16511753|NCT00735371|40347376|FG002|Overall Study|Sponsor Decision|0|||
16511754|NCT00735371|40347377|FG003|Overall Study|Sponsor Decision|1|||
16511755|NCT00735371|40347374|FG000|Overall Study|Protocol Violation|0|||
16511756|NCT00735371|40347375|FG001|Overall Study|Protocol Violation|1|||
16511757|NCT00735371|40347376|FG002|Overall Study|Protocol Violation|2|||
16511758|NCT00735371|40347377|FG003|Overall Study|Protocol Violation|0|||
16511759|NCT00735371|40347374|FG000|Overall Study|Prior Vyvanse Exposure|1|||
16317149|NCT02406027|39644609|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
16317150|NCT02406027|39644610|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
16317151|NCT02406027|39644611|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
16317152|NCT02406027|39644612|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
16317153|NCT02406027|39644613|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
16317154|NCT02406027|39644614|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
16317155|NCT02406027|39644615|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
16317156|NCT02406027|39644609|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
16317157|NCT02406027|39644610|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
16317158|NCT02406027|39644611|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
16511760|NCT00735371|40347375|FG001|Overall Study|Prior Vyvanse Exposure|1|||
16511761|NCT00735371|40347376|FG002|Overall Study|Prior Vyvanse Exposure|0|||
16511762|NCT00735371|40347377|FG003|Overall Study|Prior Vyvanse Exposure|0|||
16511763|NCT00735371|40347374|FG000|Overall Study|Exclusion criteria|1|||
16317159|NCT02406027|39644612|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
16317160|NCT02406027|39644613|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
16317161|NCT02406027|39644614|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
16317162|NCT02406027|39644615|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
16317163|NCT02406027|39644609|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
16317164|NCT02406027|39644610|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
16317165|NCT02406027|39644611|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
16317166|NCT02406027|39644612|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
16317167|NCT02406027|39644613|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
16317168|NCT02406027|39644614|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
16317169|NCT02406027|39644615|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
16317170|NCT02406027|39644609|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
16317171|NCT02406027|39644610|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
16317172|NCT02406027|39644611|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
16317173|NCT02406027|39644612|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
16317174|NCT02406027|39644613|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
16317175|NCT02406027|39644614|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
16317176|NCT02406027|39644615|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
16317177|NCT02406027|39644609|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
16317178|NCT02406027|39644610|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
16317179|NCT02406027|39644611|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
16317180|NCT02406027|39644612|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
16317181|NCT02406027|39644613|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
16317182|NCT02406027|39644614|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
16317183|NCT02406027|39644615|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
16317184|NCT02406027|39644609|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
16317185|NCT02406027|39644610|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
16317186|NCT02406027|39644611|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
16317187|NCT02406027|39644612|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
16317188|NCT02406027|39644613|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
16317189|NCT02406027|39644614|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
16317190|NCT02406027|39644615|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
16317191|NCT02406027|39644609|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
16317192|NCT02406027|39644610|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
16317193|NCT02406027|39644611|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
16511764|NCT00735371|40347375|FG001|Overall Study|Exclusion criteria|0|||
16511765|NCT00735371|40347376|FG002|Overall Study|Exclusion criteria|0|||
16511766|NCT00735371|40347377|FG003|Overall Study|Exclusion criteria|0|||
16511767|NCT01755416|40347378|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
16511768|NCT01755416|40347379|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
16511769|NCT02375672|40347386|FG000|Overall Study|remain on follow up|20|||
16511770|NCT04238728|40347387|FG000|Overall Study|Withdrawal by Subject|1|||
16511771|NCT04238728|40347387|FG000|Overall Study|Lost to Follow-up|2|||
16511772|NCT00262067|40347388|FG000|Overall Study|Death|190|||
16317194|NCT02406027|39644612|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
16511773|NCT00262067|40347389|FG001|Overall Study|Death|89|||
16511774|NCT00262067|40347390|FG002|Overall Study|Death|186|||
16511775|NCT00262067|40347391|FG003|Overall Study|Death|99|||
16511776|NCT00262067|40347388|FG000|Overall Study|Lost to Follow-up|5|||
16511777|NCT00262067|40347389|FG001|Overall Study|Lost to Follow-up|4|||
16511778|NCT00262067|40347390|FG002|Overall Study|Lost to Follow-up|7|||
16511779|NCT00262067|40347391|FG003|Overall Study|Lost to Follow-up|5|||
16511780|NCT00262067|40347388|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
16511781|NCT00262067|40347389|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
16511782|NCT00262067|40347390|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
16511783|NCT00262067|40347391|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
16511784|NCT00262067|40347388|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
16511785|NCT00262067|40347389|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
16511786|NCT00262067|40347390|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
16511787|NCT00262067|40347391|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
16511788|NCT04244786|40347392|FG000|Overall Study|Adverse Event|0|||
16511789|NCT04244786|40347393|FG001|Overall Study|Adverse Event|0|||
16511790|NCT04244786|40347394|FG002|Overall Study|Adverse Event|2|||
16511791|NCT04244786|40347392|FG000|Overall Study|Withdrawal by Subject|0|||
16511792|NCT04244786|40347393|FG001|Overall Study|Withdrawal by Subject|0|||
16511793|NCT04244786|40347394|FG002|Overall Study|Withdrawal by Subject|5|||
16511794|NCT00110812|40347395|FG000|Main Study|Death|0|||
16511795|NCT00110812|40347396|FG001|Main Study|Death|0|||
16511796|NCT00110812|40347397|FG002|Main Study|Death|2|||
16511797|NCT00110812|40347395|FG000|Main Study|Withdrawal by Subject|0|||
16511798|NCT00110812|40347396|FG001|Main Study|Withdrawal by Subject|0|||
16511799|NCT00110812|40347397|FG002|Main Study|Withdrawal by Subject|1|||
16511800|NCT00110812|40347395|FG000|Main Study|Lost to Follow-up|8|||
16511801|NCT00110812|40347396|FG001|Main Study|Lost to Follow-up|11|||
16511802|NCT00110812|40347397|FG002|Main Study|Lost to Follow-up|10|||
16511803|NCT00110812|40347395|FG000|Extended Follow-up|Death|1|||
16511804|NCT00110812|40347396|FG001|Extended Follow-up|Death|0|||
16511805|NCT00110812|40347397|FG002|Extended Follow-up|Death|3|||
16511806|NCT00110812|40347395|FG000|Extended Follow-up|Withdrawal by Subject|0|||
16511807|NCT00110812|40347396|FG001|Extended Follow-up|Withdrawal by Subject|1|||
16511808|NCT00110812|40347397|FG002|Extended Follow-up|Withdrawal by Subject|0|||
16511809|NCT00110812|40347395|FG000|Extended Follow-up|Lost to Follow-up|1|||
16511810|NCT00110812|40347396|FG001|Extended Follow-up|Lost to Follow-up|3|||
16511811|NCT00110812|40347397|FG002|Extended Follow-up|Lost to Follow-up|1|||
16511812|NCT00581776|40347401|FG000|Overall Study|Disease progression or no response|3|||
16511813|NCT00717769|40347406|FG000|Overall Study|Adverse Event|9|||
16511814|NCT00717769|40347407|FG001|Overall Study|Adverse Event|6|||
16511815|NCT00717769|40347408|FG002|Overall Study|Adverse Event|1|||
16317195|NCT02406027|39644613|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
16317196|NCT02406027|39644614|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
16317197|NCT02406027|39644615|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
16317198|NCT02406027|39644609|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
16317199|NCT02406027|39644610|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
16317200|NCT02406027|39644611|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
16317201|NCT02406027|39644612|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
16317202|NCT02406027|39644613|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
16317203|NCT02406027|39644614|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
16317204|NCT02406027|39644615|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
16511816|NCT00717769|40347406|FG000|Overall Study|Lack of compliance|0|||
16511817|NCT00717769|40347407|FG001|Overall Study|Lack of compliance|2|||
16511818|NCT00717769|40347408|FG002|Overall Study|Lack of compliance|0|||
16511819|NCT00717769|40347406|FG000|Overall Study|Lost to Follow-up|3|||
16511820|NCT00717769|40347407|FG001|Overall Study|Lost to Follow-up|4|||
16511821|NCT00717769|40347408|FG002|Overall Study|Lost to Follow-up|0|||
16511822|NCT00717769|40347406|FG000|Overall Study|Lack of Efficacy|1|||
16511823|NCT00717769|40347407|FG001|Overall Study|Lack of Efficacy|2|||
16511824|NCT00717769|40347408|FG002|Overall Study|Lack of Efficacy|0|||
16511825|NCT00717769|40347406|FG000|Overall Study|Protocol Violation|0|||
16511826|NCT00717769|40347407|FG001|Overall Study|Protocol Violation|2|||
16317205|NCT02406027|39644609|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16317206|NCT02406027|39644610|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16511827|NCT00717769|40347408|FG002|Overall Study|Protocol Violation|0|||
16511828|NCT00717769|40347406|FG000|Overall Study|Sponsor decision|1|||
16511829|NCT00717769|40347407|FG001|Overall Study|Sponsor decision|0|||
16511830|NCT00717769|40347408|FG002|Overall Study|Sponsor decision|10|||
16511831|NCT00717769|40347406|FG000|Overall Study|Withdrew consent|2|||
16511832|NCT00717769|40347407|FG001|Overall Study|Withdrew consent|2|||
16511833|NCT00717769|40347408|FG002|Overall Study|Withdrew consent|0|||
16511834|NCT03467425|40347409|FG000|Overall Study|Adverse Event|9|||
16511835|NCT03467425|40347410|FG001|Overall Study|Adverse Event|9|||
16511836|NCT03467425|40347409|FG000|Overall Study|Lack of Efficacy|3|||
16511837|NCT03467425|40347410|FG001|Overall Study|Lack of Efficacy|1|||
16511838|NCT03467425|40347409|FG000|Overall Study|Protocol Violation|0|||
16511839|NCT03467425|40347410|FG001|Overall Study|Protocol Violation|1|||
16511840|NCT03467425|40347409|FG000|Overall Study|Lost to Follow-up|18|||
16511841|NCT03467425|40347410|FG001|Overall Study|Lost to Follow-up|25|||
16511842|NCT03467425|40347409|FG000|Overall Study|Physician Decision|2|||
16511843|NCT03467425|40347410|FG001|Overall Study|Physician Decision|1|||
16511844|NCT03467425|40347409|FG000|Overall Study|Withdrawal by Subject|15|||
16511845|NCT03467425|40347410|FG001|Overall Study|Withdrawal by Subject|17|||
16511846|NCT02433834|40347411|FG000|Overall Study|Protocol-specified criteria|7|||
16511847|NCT02433834|40347411|FG000|Overall Study|Protocol Violation|3|||
16511848|NCT02433834|40347411|FG000|Overall Study|Lost to Follow-up|6|||
16511849|NCT02433834|40347411|FG000|Overall Study|Withdrawal by Subject|14|||
16511850|NCT02433834|40347411|FG000|Overall Study|Adverse Event|6|||
16317207|NCT02406027|39644611|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16317208|NCT02406027|39644612|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16317209|NCT02406027|39644613|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16317210|NCT02406027|39644614|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
16317211|NCT02406027|39644615|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
16317212|NCT02406027|39644609|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16317213|NCT02406027|39644610|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16317214|NCT02406027|39644611|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16317215|NCT02406027|39644612|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16317216|NCT02406027|39644613|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
16317217|NCT02406027|39644614|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16317218|NCT02406027|39644615|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
16317219|NCT01749826|39644623|FG000|Overall Study|Study Terminated|20|||
16317220|NCT01749826|39644624|FG001|Overall Study|Study Terminated|0|||
16317221|NCT02275819|39644625|FG000|Overall Study|Adverse Event|0|||
16317222|NCT02275819|39644626|FG001|Overall Study|Adverse Event|1|||
16317223|NCT00558467|39644627|FG000|Overall Study|Adverse Event|1|||
16317224|NCT00558467|39644628|FG001|Overall Study|Adverse Event|2|||
16317225|NCT00558467|39644627|FG000|Overall Study|Lack of Efficacy|0|||
16317226|NCT00558467|39644628|FG001|Overall Study|Lack of Efficacy|1|||
16317227|NCT00558467|39644627|FG000|Overall Study|Patient moving out of state|0|||
16317228|NCT00558467|39644628|FG001|Overall Study|Patient moving out of state|1|||
16317229|NCT02872714|39644630|FG000|Overall Study|Progressive Disease|1|||
16317230|NCT02872714|39644631|FG001|Overall Study|Progressive Disease|2|||
16317231|NCT02872714|39644632|FG002|Overall Study|Progressive Disease|0|||
16317232|NCT02872714|39644633|FG003|Overall Study|Progressive Disease|0|||
16317233|NCT02872714|39644634|FG004|Overall Study|Progressive Disease|0|||
16317234|NCT02872714|39644630|FG000|Overall Study|Death|87|||
16317235|NCT02872714|39644631|FG001|Overall Study|Death|36|||
16317236|NCT02872714|39644632|FG002|Overall Study|Death|8|||
16317237|NCT02872714|39644633|FG003|Overall Study|Death|81|||
16317238|NCT02872714|39644634|FG004|Overall Study|Death|2|||
16317239|NCT02872714|39644630|FG000|Overall Study|Lost to Follow-up|2|||
16317240|NCT02872714|39644631|FG001|Overall Study|Lost to Follow-up|1|||
16317241|NCT02872714|39644632|FG002|Overall Study|Lost to Follow-up|0|||
16317242|NCT02872714|39644633|FG003|Overall Study|Lost to Follow-up|3|||
16317243|NCT02872714|39644634|FG004|Overall Study|Lost to Follow-up|0|||
16317244|NCT02872714|39644630|FG000|Overall Study|Physician Decision|0|||
16317245|NCT02872714|39644631|FG001|Overall Study|Physician Decision|0|||
16317246|NCT02872714|39644632|FG002|Overall Study|Physician Decision|0|||
16317247|NCT02872714|39644633|FG003|Overall Study|Physician Decision|1|||
16317248|NCT02872714|39644634|FG004|Overall Study|Physician Decision|0|||
16317249|NCT02872714|39644630|FG000|Overall Study|Withdrawal by Subject|1|||
16317250|NCT02872714|39644631|FG001|Overall Study|Withdrawal by Subject|3|||
16317251|NCT02872714|39644632|FG002|Overall Study|Withdrawal by Subject|0|||
16317252|NCT02872714|39644633|FG003|Overall Study|Withdrawal by Subject|2|||
16317253|NCT02872714|39644634|FG004|Overall Study|Withdrawal by Subject|0|||
16317254|NCT02872714|39644630|FG000|Overall Study|Captured as Other|2|||
16317255|NCT02872714|39644631|FG001|Overall Study|Captured as Other|0|||
16317256|NCT02872714|39644632|FG002|Overall Study|Captured as Other|0|||
16317257|NCT02872714|39644633|FG003|Overall Study|Captured as Other|1|||
16317258|NCT02872714|39644634|FG004|Overall Study|Captured as Other|0|||
16511851|NCT02433834|40347411|FG000|Overall Study|Physician Decision|1|||
16511852|NCT01071512|40347414|FG000|Overall Study|Adverse Event|1|||
16511853|NCT01071512|40347414|FG000|Overall Study|Development of antibodies to drug|2|||
16511854|NCT01071512|40347414|FG000|Overall Study|positive anti-JC virus antibody test|2|||
16511855|NCT04371380|40347420|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
16511856|NCT04371380|40347421|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
16511857|NCT04371380|40347422|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
16317259|NCT00856193|39644635|FG000|Period 2|Abnormal test procedure results|0|||
16317260|NCT00856193|39644636|FG001|Period 2|Abnormal test procedure results|1|||
16317261|NCT00856193|39644635|FG000|Period 2|Lost to Follow-up|0|||
16317262|NCT00856193|39644636|FG001|Period 2|Lost to Follow-up|1|||
16317263|NCT02013817|39644637|FG000|Overall Study|Adverse Event|12|||
16317264|NCT02013817|39644637|FG000|Overall Study|Withdrawal by Subject|4|||
16317265|NCT02013817|39644637|FG000|Overall Study|Death|2|||
16317266|NCT02013817|39644637|FG000|Overall Study|Other|9|||
16317267|NCT00806403|39644638|FG000|Overall Study|Death|4|||
16317268|NCT00806403|39644639|FG001|Overall Study|Death|3|||
16511858|NCT01072201|40347424|FG000|Overall Study|Lost to Follow-up|0|||
16511859|NCT01072201|40347425|FG001|Overall Study|Lost to Follow-up|1|||
16511860|NCT02365636|40347426|FG000|Overall Study|Adverse Event|3|||
16317269|NCT03048747|39644640|FG000|Overall Study|Adverse Event|2|||
16317270|NCT03048747|39644640|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
16317271|NCT03048747|39644640|FG000|Overall Study|Physician Decision|1|||
16317272|NCT02088905|39644641|FG000|Overall Study|Withdrawal by Subject|5|||
16317273|NCT02088905|39644642|FG001|Overall Study|Withdrawal by Subject|1|||
16317274|NCT01611935|39644643|FG000|Overall Study|Family Declined Participation|1|||
16317275|NCT01611935|39644644|FG001|Overall Study|Family Declined Participation|0|||
16317276|NCT00940823|39644651|FG000|Overall Study|Death|8|||
16317277|NCT00940823|39644652|FG001|Overall Study|Death|12|||
16317278|NCT00940823|39644651|FG000|Overall Study|Lost to Follow-up|27|||
16317279|NCT00940823|39644652|FG001|Overall Study|Lost to Follow-up|20|||
16317280|NCT02445248|39644655|FG000|Overall Study|Death|45|||
16317281|NCT02445248|39644656|FG001|Overall Study|Death|12|||
16317282|NCT02445248|39644655|FG000|Overall Study|Progressive disease|13|||
16317283|NCT02445248|39644656|FG001|Overall Study|Progressive disease|1|||
16317284|NCT02445248|39644655|FG000|Overall Study|Subject decision|8|||
16317285|NCT02445248|39644656|FG001|Overall Study|Subject decision|0|||
16317286|NCT02445248|39644655|FG000|Overall Study|Physician Decision|5|||
16317287|NCT02445248|39644656|FG001|Overall Study|Physician Decision|0|||
16317288|NCT02445248|39644655|FG000|Overall Study|Adverse Event|1|||
16317289|NCT02445248|39644656|FG001|Overall Study|Adverse Event|0|||
16317290|NCT02445248|39644655|FG000|Overall Study|Lost to Follow-up|1|||
16317291|NCT02445248|39644656|FG001|Overall Study|Lost to Follow-up|0|||
16317292|NCT00958828|39644660|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
16317293|NCT00958828|39644661|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
16317294|NCT00958828|39644660|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
16317295|NCT00958828|39644661|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
16317296|NCT02907177|39644662|FG000|Overall Study|Death|0|||
16317297|NCT02907177|39644663|FG001|Overall Study|Death|1|||
16317298|NCT02907177|39644662|FG000|Overall Study|Physician Decision|3|||
16317299|NCT02907177|39644663|FG001|Overall Study|Physician Decision|3|||
16317300|NCT02907177|39644662|FG000|Overall Study|Withdrawal by Subject|15|||
16317301|NCT02907177|39644663|FG001|Overall Study|Withdrawal by Subject|7|||
16317302|NCT02907177|39644662|FG000|Overall Study|Sponsor's Decision|50|||
16317303|NCT02907177|39644663|FG001|Overall Study|Sponsor's Decision|57|||
16317304|NCT02176655|39644664|FG000|Overall Study|Subjects did not treat|6|||
16317305|NCT05370040|39644665|FG000|Overall Study|Lost to Follow-up|0|||
16317306|NCT05370040|39644666|FG001|Overall Study|Lost to Follow-up|0|||
16317307|NCT05370040|39644667|FG002|Overall Study|Lost to Follow-up|1|||
16317308|NCT05370040|39644668|FG003|Overall Study|Lost to Follow-up|0|||
16317309|NCT05370040|39644669|FG004|Overall Study|Lost to Follow-up|1|||
16317310|NCT05370040|39644670|FG005|Overall Study|Lost to Follow-up|0|||
16317311|NCT05344560|39644671|FG000|Period 1|Subject out of visit window|1|||
16317312|NCT05344560|39644672|FG001|Period 1|Subject out of visit window|1|||
16317313|NCT05344560|39644671|FG000|Period 2|Covid-19 Related|1|||
16317314|NCT05344560|39644672|FG001|Period 2|Covid-19 Related|0|||
16317315|NCT05344560|39644671|FG000|Period 2|Adverse Event|1|||
16317316|NCT05344560|39644672|FG001|Period 2|Adverse Event|0|||
16317317|NCT05344560|39644671|FG000|Period 2|Subject out of visit window|1|||
16317318|NCT05344560|39644672|FG001|Period 2|Subject out of visit window|1|||
16317319|NCT05344560|39644671|FG000|Period 3|Subject out of visit window|1|||
16511861|NCT02365636|40347427|FG001|Overall Study|Adverse Event|3|||
16511862|NCT02365636|40347428|FG002|Overall Study|Adverse Event|2|||
16511863|NCT02365636|40347426|FG000|Overall Study|Protocol Violation|1|||
16511864|NCT02365636|40347427|FG001|Overall Study|Protocol Violation|4|||
16511865|NCT02365636|40347428|FG002|Overall Study|Protocol Violation|0|||
16511866|NCT02365636|40347426|FG000|Overall Study|Lost to Follow-up|0|||
16511867|NCT02365636|40347427|FG001|Overall Study|Lost to Follow-up|0|||
16511868|NCT02365636|40347428|FG002|Overall Study|Lost to Follow-up|1|||
16317320|NCT05344560|39644672|FG001|Period 3|Subject out of visit window|0|||
16317321|NCT01928472|39644677|FG000|Overall Study|Death|0|||
16317322|NCT01928472|39644678|FG001|Overall Study|Death|0|||
16317323|NCT01928472|39644679|FG002|Overall Study|Death|1|||
16317324|NCT01928472|39644680|FG003|Overall Study|Death|0|||
16317325|NCT01928472|39644677|FG000|Overall Study|Withdrawal by Subject|4|||
16317326|NCT01928472|39644678|FG001|Overall Study|Withdrawal by Subject|4|||
16317327|NCT01928472|39644679|FG002|Overall Study|Withdrawal by Subject|1|||
16317328|NCT01928472|39644680|FG003|Overall Study|Withdrawal by Subject|2|||
16317329|NCT01928472|39644677|FG000|Overall Study|Lost to Follow-up|2|||
16317330|NCT01928472|39644678|FG001|Overall Study|Lost to Follow-up|3|||
16317331|NCT01928472|39644679|FG002|Overall Study|Lost to Follow-up|4|||
16317332|NCT01928472|39644680|FG003|Overall Study|Lost to Follow-up|0|||
16317333|NCT01928472|39644677|FG000|Overall Study|Administrative Reason|2|||
16317334|NCT01928472|39644678|FG001|Overall Study|Administrative Reason|1|||
16317335|NCT01928472|39644679|FG002|Overall Study|Administrative Reason|0|||
16511869|NCT02365636|40347426|FG000|Overall Study|Other|2|||
16511870|NCT02365636|40347427|FG001|Overall Study|Other|0|||
16317336|NCT01928472|39644680|FG003|Overall Study|Administrative Reason|0|||
16317337|NCT01928472|39644677|FG000|Overall Study|Unclassified|0|||
16511871|NCT02365636|40347428|FG002|Overall Study|Other|0|||
16090029|NCT01683409|38820064|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
16090030|NCT01683409|38820065|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
16090031|NCT01683409|38820066|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
16090032|NCT01683409|38820062|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
16090033|NCT01683409|38820063|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
16090034|NCT01683409|38820064|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
16090035|NCT01683409|38820065|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
16090036|NCT01683409|38820066|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
16090037|NCT01683409|38820062|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
16090038|NCT01683409|38820063|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
16090039|NCT01683409|38820064|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
16090040|NCT01683409|38820065|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
16090041|NCT01683409|38820066|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
16090042|NCT01683409|38820062|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
16090043|NCT01683409|38820063|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
16090044|NCT01683409|38820064|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
16317338|NCT01928472|39644678|FG001|Overall Study|Unclassified|0|||
16511872|NCT01203072|40347429|FG000|Overall Study|Adverse Event|5|||
16199834|NCT01317615|39207524|FG000|Overall Study|Death|6|||
16199835|NCT01317615|39207524|FG000|Overall Study|Withdrawal by Subject|5|||
16199836|NCT01317615|39207524|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16199837|NCT01317615|39207524|FG000|Overall Study|Adverse Event|7|||
16199838|NCT00781599|39207532|FG000|Overall Study|Lost to Follow-up|7|||
16199839|NCT00781599|39207533|FG001|Overall Study|Lost to Follow-up|4|||
16090045|NCT01683409|38820065|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
16511873|NCT01203072|40347430|FG001|Overall Study|Adverse Event|3|||
16199840|NCT02429258|39207534|FG000|Overall Study|Withdrawal by Subject|2|||
16199841|NCT02429258|39207535|FG001|Overall Study|Withdrawal by Subject|0|||
16199842|NCT02429258|39207534|FG000|Overall Study|Protocol Violation|0|||
16511874|NCT01203072|40347431|FG002|Overall Study|Adverse Event|2|||
16511875|NCT01203072|40347432|FG003|Overall Study|Adverse Event|4|||
16511876|NCT01203072|40347433|FG004|Overall Study|Adverse Event|2|||
16511877|NCT01203072|40347429|FG000|Overall Study|Lack of Efficacy|1|||
16511878|NCT01203072|40347430|FG001|Overall Study|Lack of Efficacy|0|||
16090046|NCT01683409|38820066|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
16199843|NCT02429258|39207535|FG001|Overall Study|Protocol Violation|1|||
16199844|NCT01293032|39207536|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
16199845|NCT01293032|39207537|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
16199846|NCT01293032|39207538|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
16199847|NCT01293032|39207539|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
16199848|NCT01293032|39207536|FG000|Treatment|Adverse Event|0|||
16199849|NCT01293032|39207537|FG001|Treatment|Adverse Event|0|||
16199850|NCT01293032|39207538|FG002|Treatment|Adverse Event|1|||
16199851|NCT01293032|39207539|FG003|Treatment|Adverse Event|1|||
16199852|NCT01293032|39207536|FG000|Treatment|Withdrawal by Subject|2|||
16199853|NCT01293032|39207537|FG001|Treatment|Withdrawal by Subject|4|||
16199854|NCT01293032|39207538|FG002|Treatment|Withdrawal by Subject|0|||
16199855|NCT01293032|39207539|FG003|Treatment|Withdrawal by Subject|0|||
16199856|NCT01293032|39207536|FG000|Treatment|Disease Progression, relapse|0|||
16199857|NCT01293032|39207537|FG001|Treatment|Disease Progression, relapse|1|||
16199858|NCT01293032|39207538|FG002|Treatment|Disease Progression, relapse|0|||
16199859|NCT01293032|39207539|FG003|Treatment|Disease Progression, relapse|0|||
16199860|NCT00492856|39207540|FG000|Induction|Adverse Event|2|||
16199861|NCT00492856|39207541|FG001|Induction|Adverse Event|0|||
16199862|NCT00492856|39207542|FG002|Induction|Adverse Event|0|||
16199863|NCT00492856|39207543|FG003|Induction|Adverse Event|0|||
16199864|NCT00492856|39207540|FG000|Induction|Withdrawal by Subject|1|||
16199865|NCT00492856|39207541|FG001|Induction|Withdrawal by Subject|0|||
16199866|NCT00492856|39207542|FG002|Induction|Withdrawal by Subject|0|||
16199867|NCT00492856|39207543|FG003|Induction|Withdrawal by Subject|0|||
16199868|NCT00492856|39207540|FG000|Induction|Death|3|||
16199869|NCT00492856|39207541|FG001|Induction|Death|0|||
16199870|NCT00492856|39207542|FG002|Induction|Death|0|||
16199871|NCT00492856|39207543|FG003|Induction|Death|0|||
16199872|NCT00492856|39207540|FG000|Consolidation|Adverse Event|6|||
16199873|NCT00492856|39207541|FG001|Consolidation|Adverse Event|0|||
16199874|NCT00492856|39207542|FG002|Consolidation|Adverse Event|0|||
16199875|NCT00492856|39207543|FG003|Consolidation|Adverse Event|0|||
16199876|NCT00492856|39207540|FG000|Consolidation|Not protocol specified|2|||
16199877|NCT00492856|39207541|FG001|Consolidation|Not protocol specified|0|||
16199878|NCT00492856|39207542|FG002|Consolidation|Not protocol specified|0|||
16199879|NCT00492856|39207543|FG003|Consolidation|Not protocol specified|0|||
16199880|NCT00492856|39207540|FG000|Consolidation|Lost to Follow-up|1|||
16199881|NCT00492856|39207541|FG001|Consolidation|Lost to Follow-up|0|||
16199882|NCT00492856|39207542|FG002|Consolidation|Lost to Follow-up|0|||
16511879|NCT01203072|40347431|FG002|Overall Study|Lack of Efficacy|0|||
16511880|NCT01203072|40347432|FG003|Overall Study|Lack of Efficacy|0|||
16090047|NCT01683409|38820062|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
16090048|NCT01683409|38820063|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
16317339|NCT01928472|39644679|FG002|Overall Study|Unclassified|1|||
16199883|NCT00492856|39207543|FG003|Consolidation|Lost to Follow-up|0|||
16199884|NCT00492856|39207540|FG000|Post-consolidation|Adverse Event|0|||
16199885|NCT00492856|39207541|FG001|Post-consolidation|Adverse Event|4|||
16199886|NCT00492856|39207542|FG002|Post-consolidation|Adverse Event|0|||
16199887|NCT00492856|39207543|FG003|Post-consolidation|Adverse Event|1|||
16199888|NCT00492856|39207540|FG000|Post-consolidation|Withdrawal by Subject|0|||
16199889|NCT00492856|39207541|FG001|Post-consolidation|Withdrawal by Subject|4|||
16199890|NCT00492856|39207542|FG002|Post-consolidation|Withdrawal by Subject|0|||
16199891|NCT00492856|39207543|FG003|Post-consolidation|Withdrawal by Subject|0|||
16199892|NCT00492856|39207540|FG000|Post-consolidation|Death|0|||
16199893|NCT00492856|39207541|FG001|Post-consolidation|Death|1|||
16199894|NCT00492856|39207542|FG002|Post-consolidation|Death|0|||
16199895|NCT00492856|39207543|FG003|Post-consolidation|Death|0|||
16199896|NCT00492856|39207540|FG000|Post-consolidation|Not protocol specified|0|||
16199897|NCT00492856|39207541|FG001|Post-consolidation|Not protocol specified|1|||
16199898|NCT00492856|39207542|FG002|Post-consolidation|Not protocol specified|0|||
16199899|NCT00492856|39207543|FG003|Post-consolidation|Not protocol specified|0|||
16199900|NCT00492856|39207540|FG000|Post-consolidation|Lost to Follow-up|0|||
16199901|NCT00492856|39207541|FG001|Post-consolidation|Lost to Follow-up|2|||
16199902|NCT00492856|39207542|FG002|Post-consolidation|Lost to Follow-up|0|||
16199903|NCT00492856|39207543|FG003|Post-consolidation|Lost to Follow-up|0|||
16199904|NCT00492856|39207540|FG000|Post-consolidation|Observation Arm|0|||
16199905|NCT00492856|39207541|FG001|Post-consolidation|Observation Arm|0|||
16199906|NCT00492856|39207542|FG002|Post-consolidation|Observation Arm|27|||
16199907|NCT00492856|39207543|FG003|Post-consolidation|Observation Arm|0|||
16199908|NCT03517436|39207544|FG000|Overall Study|Death|3|||
16199909|NCT03517436|39207544|FG000|Overall Study|Withdrawal by Subject|4|||
16199910|NCT03517436|39207544|FG000|Overall Study|Did not receive study valve.|1|||
16199911|NCT02193828|39207545|FG000|Overall Study|Withdrawal by Subject|0|||
16199912|NCT02193828|39207546|FG001|Overall Study|Withdrawal by Subject|0|||
16199913|NCT02193828|39207547|FG002|Overall Study|Withdrawal by Subject|1|||
16199914|NCT02193828|39207548|FG003|Overall Study|Withdrawal by Subject|1|||
16199915|NCT00762372|39207554|FG000|Overall Study|Adverse Event|1|||
16199916|NCT00762372|39207555|FG001|Overall Study|Adverse Event|0|||
16199917|NCT00762372|39207556|FG002|Overall Study|Adverse Event|0|||
16199918|NCT01935336|39207557|FG000|Overall Study|Adverse Event|1|||
16199919|NCT01935336|39207558|FG001|Overall Study|Adverse Event|0|||
16199920|NCT01935336|39207559|FG002|Overall Study|Adverse Event|0|||
16199921|NCT01935336|39207560|FG003|Overall Study|Adverse Event|0|||
16199922|NCT01935336|39207557|FG000|Overall Study|Progressive disease|5|||
16199923|NCT01935336|39207558|FG001|Overall Study|Progressive disease|3|||
16199924|NCT01935336|39207559|FG002|Overall Study|Progressive disease|47|||
16199925|NCT01935336|39207560|FG003|Overall Study|Progressive disease|66|||
16199926|NCT00493974|39207562|FG000|Overall Study|Death|1|||
16199927|NCT00493974|39207563|FG001|Overall Study|Death|2|||
16199928|NCT00493974|39207562|FG000|Overall Study|Withdrawal by Subject|8|||
16199929|NCT00493974|39207563|FG001|Overall Study|Withdrawal by Subject|6|||
16199930|NCT00493974|39207562|FG000|Overall Study|Lost to Follow-up|4|||
16199931|NCT00493974|39207563|FG001|Overall Study|Lost to Follow-up|6|||
16199932|NCT01194804|39207568|FG000|Overall Study|Withdrawal by Subject|1|||
16199933|NCT00555906|39207569|FG000|Phase 1|Objective Progression or Relapse|3|||
16199934|NCT00555906|39207570|FG001|Phase 1|Objective Progression or Relapse|5|||
16090049|NCT01683409|38820064|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
16199935|NCT00555906|39207571|FG002|Phase 1|Objective Progression or Relapse|3|||
16199936|NCT00555906|39207572|FG003|Phase 1|Objective Progression or Relapse|1|||
16199937|NCT00555906|39207573|FG004|Phase 1|Objective Progression or Relapse|0|||
16199938|NCT00555906|39207569|FG000|Phase 1|Global Deterioration of Health Status|0|||
16199939|NCT00555906|39207570|FG001|Phase 1|Global Deterioration of Health Status|1|||
16199940|NCT00555906|39207571|FG002|Phase 1|Global Deterioration of Health Status|1|||
16199941|NCT00555906|39207572|FG003|Phase 1|Global Deterioration of Health Status|1|||
16199942|NCT00555906|39207573|FG004|Phase 1|Global Deterioration of Health Status|0|||
16199943|NCT00555906|39207569|FG000|Phase 1|Adverse Event|0|||
16090050|NCT01683409|38820065|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
16199944|NCT00555906|39207570|FG001|Phase 1|Adverse Event|0|||
16199945|NCT00555906|39207571|FG002|Phase 1|Adverse Event|3|||
16199946|NCT00555906|39207572|FG003|Phase 1|Adverse Event|2|||
16199947|NCT00555906|39207573|FG004|Phase 1|Adverse Event|0|||
16199948|NCT00555906|39207569|FG000|Phase 1|Withdrawal by Subject|0|||
16199949|NCT00555906|39207570|FG001|Phase 1|Withdrawal by Subject|0|||
16199950|NCT00555906|39207571|FG002|Phase 1|Withdrawal by Subject|0|||
16199951|NCT00555906|39207572|FG003|Phase 1|Withdrawal by Subject|1|||
16199952|NCT00555906|39207573|FG004|Phase 1|Withdrawal by Subject|0|||
16199953|NCT00555906|39207569|FG000|Phase 2|Adverse Event|0|||
16199954|NCT00555906|39207570|FG001|Phase 2|Adverse Event|0|||
16199955|NCT00555906|39207571|FG002|Phase 2|Adverse Event|0|||
16199956|NCT00555906|39207572|FG003|Phase 2|Adverse Event|0|||
16199957|NCT00555906|39207573|FG004|Phase 2|Adverse Event|4|||
16199958|NCT00555906|39207569|FG000|Phase 2|Global Deterioration of Health Status|0|||
16199959|NCT00555906|39207570|FG001|Phase 2|Global Deterioration of Health Status|0|||
16199960|NCT00555906|39207571|FG002|Phase 2|Global Deterioration of Health Status|0|||
16199961|NCT00555906|39207572|FG003|Phase 2|Global Deterioration of Health Status|0|||
16199962|NCT00555906|39207573|FG004|Phase 2|Global Deterioration of Health Status|2|||
16199963|NCT00555906|39207569|FG000|Phase 2|Objective Progression or Relapse|0|||
16199964|NCT00555906|39207570|FG001|Phase 2|Objective Progression or Relapse|0|||
16199965|NCT00555906|39207571|FG002|Phase 2|Objective Progression or Relapse|0|||
16199966|NCT00555906|39207572|FG003|Phase 2|Objective Progression or Relapse|0|||
16199967|NCT00555906|39207573|FG004|Phase 2|Objective Progression or Relapse|16|||
16199968|NCT00555906|39207569|FG000|Phase 2|Withdrawal by Subject|0|||
16199969|NCT00555906|39207570|FG001|Phase 2|Withdrawal by Subject|0|||
16199970|NCT00555906|39207571|FG002|Phase 2|Withdrawal by Subject|0|||
16199971|NCT00555906|39207572|FG003|Phase 2|Withdrawal by Subject|0|||
16199972|NCT00555906|39207573|FG004|Phase 2|Withdrawal by Subject|2|||
16199973|NCT00555906|39207569|FG000|Phase 2|Other|0|||
16317340|NCT01928472|39644680|FG003|Overall Study|Unclassified|0|||
16317341|NCT03123393|39644681|FG000|Overall Study|Study Terminated by Sponsor|6|||
16317342|NCT03123393|39644682|FG001|Overall Study|Study Terminated by Sponsor|9|||
16317343|NCT03123393|39644681|FG000|Overall Study|Withdrawal by Subject|2|||
16317344|NCT03123393|39644682|FG001|Overall Study|Withdrawal by Subject|1|||
16317345|NCT03123393|39644681|FG000|Overall Study|Reason not Specified|13|||
16317346|NCT03123393|39644682|FG001|Overall Study|Reason not Specified|13|||
16317347|NCT02712554|39644687|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
16317348|NCT02712554|39644688|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
16199974|NCT00555906|39207570|FG001|Phase 2|Other|0|||
16199975|NCT00555906|39207571|FG002|Phase 2|Other|0|||
16199976|NCT00555906|39207572|FG003|Phase 2|Other|0|||
16199977|NCT00555906|39207573|FG004|Phase 2|Other|6|||
16199978|NCT00555906|39207569|FG000|Phase 2|Randomized but not Treated|0|||
16199979|NCT00555906|39207570|FG001|Phase 2|Randomized but not Treated|0|||
16199980|NCT00555906|39207571|FG002|Phase 2|Randomized but not Treated|0|||
16199981|NCT00555906|39207572|FG003|Phase 2|Randomized but not Treated|0|||
16199982|NCT00555906|39207573|FG004|Phase 2|Randomized but not Treated|2|||
16199983|NCT00862121|39207576|FG000|Overall Study|Adverse Event|1|||
16199984|NCT00862121|39207577|FG001|Overall Study|Adverse Event|2|||
16199985|NCT00862121|39207576|FG000|Overall Study|Lack of Efficacy|0|||
16199986|NCT00862121|39207577|FG001|Overall Study|Lack of Efficacy|3|||
16199987|NCT00862121|39207576|FG000|Overall Study|Protocol Violation|0|||
16199988|NCT00862121|39207577|FG001|Overall Study|Protocol Violation|1|||
16199989|NCT00862121|39207576|FG000|Overall Study|Exclusion criterion violation|0|||
16199990|NCT00862121|39207577|FG001|Overall Study|Exclusion criterion violation|1|||
16199991|NCT00862121|39207576|FG000|Overall Study|Incorrect randomisation|0|||
16199992|NCT00862121|39207577|FG001|Overall Study|Incorrect randomisation|1|||
16199993|NCT04126031|39207580|FG000|Part A|Withdrawal by Subject|0|||
16199994|NCT04126031|39207581|FG001|Part A|Withdrawal by Subject|0|||
16199995|NCT04126031|39207582|FG002|Part A|Withdrawal by Subject|1|||
16199996|NCT04126031|39207583|FG003|Part A|Withdrawal by Subject|0|||
16199997|NCT04126031|39207584|FG004|Part A|Withdrawal by Subject|0|||
16199998|NCT04126031|39207585|FG005|Part A|Withdrawal by Subject|0|||
16199999|NCT04126031|39207580|FG000|Part A|Other|1|||
16200000|NCT04126031|39207581|FG001|Part A|Other|0|||
16200001|NCT04126031|39207582|FG002|Part A|Other|0|||
16200002|NCT04126031|39207583|FG003|Part A|Other|0|||
16200003|NCT04126031|39207584|FG004|Part A|Other|0|||
16200004|NCT04126031|39207585|FG005|Part A|Other|0|||
16200005|NCT04126031|39207580|FG000|Part B|Adverse Event|0|||
16317349|NCT02712554|39644687|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
16200006|NCT04126031|39207581|FG001|Part B|Adverse Event|0|||
16317350|NCT02712554|39644688|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
16317351|NCT02712554|39644687|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
16200007|NCT04126031|39207582|FG002|Part B|Adverse Event|0|||
16200008|NCT04126031|39207583|FG003|Part B|Adverse Event|0|||
16200009|NCT04126031|39207584|FG004|Part B|Adverse Event|0|||
16200010|NCT04126031|39207585|FG005|Part B|Adverse Event|2|||
16200011|NCT04126031|39207580|FG000|Part B|Pre-existing hypertransaminasemia|0|||
16200012|NCT04126031|39207581|FG001|Part B|Pre-existing hypertransaminasemia|0|||
16200013|NCT04126031|39207582|FG002|Part B|Pre-existing hypertransaminasemia|0|||
16200014|NCT04126031|39207583|FG003|Part B|Pre-existing hypertransaminasemia|0|||
16200015|NCT04126031|39207584|FG004|Part B|Pre-existing hypertransaminasemia|1|||
16200016|NCT04126031|39207585|FG005|Part B|Pre-existing hypertransaminasemia|0|||
16200017|NCT00779324|39207593|FG000|Overall Study|Lost to Follow-up|2|||
16200018|NCT00779324|39207594|FG001|Overall Study|Lost to Follow-up|1|||
16200019|NCT00779324|39207593|FG000|Overall Study|Withdrawal by Subject|4|||
16200020|NCT00779324|39207594|FG001|Overall Study|Withdrawal by Subject|2|||
16200021|NCT00779324|39207593|FG000|Overall Study|Missed visit|1|||
16200022|NCT00779324|39207594|FG001|Overall Study|Missed visit|1|||
16200023|NCT02921763|39207595|FG000|Overall Study|Adverse Event|4|||
16200024|NCT02921763|39207595|FG000|Overall Study|Lost to Follow-up|4|||
16200025|NCT02921763|39207595|FG000|Overall Study|Lack of Efficacy|3|||
16200026|NCT02921763|39207595|FG000|Overall Study|Protocol Violation|2|||
16200027|NCT02921763|39207595|FG000|Overall Study|Withdrawal by Subject|2|||
16200028|NCT02921763|39207595|FG000|Overall Study|Physician Decision|1|||
16200029|NCT02921763|39207595|FG000|Overall Study|No data obtained|2|||
16200030|NCT02853032|39207596|FG000|Overall Study|Adverse Event|4|||
16200031|NCT02853032|39207597|FG001|Overall Study|Adverse Event|0|||
16200032|NCT02853032|39207596|FG000|Overall Study|Withdrawal by Subject|3|||
16200033|NCT02853032|39207597|FG001|Overall Study|Withdrawal by Subject|1|||
16200034|NCT02853032|39207596|FG000|Overall Study|Requested to withdraw from all treatment|2|||
16200035|NCT02853032|39207597|FG001|Overall Study|Requested to withdraw from all treatment|2|||
16200036|NCT01151540|39207598|FG000|Overall Study|Other|2|||
16200037|NCT01151540|39207598|FG000|Overall Study|Adverse event, non-fatal|4|||
16200038|NCT01151540|39207598|FG000|Overall Study|Withdrawal by Subject|7|||
16200039|NCT01230749|39207599|FG000|Overall Study|Adverse Event|0|||
16200040|NCT01230749|39207600|FG001|Overall Study|Adverse Event|0|||
16200041|NCT01230749|39207601|FG002|Overall Study|Adverse Event|0|||
16200042|NCT01230749|39207602|FG003|Overall Study|Adverse Event|1|||
16200043|NCT01230749|39207599|FG000|Overall Study|Physician Decision|0|||
16200044|NCT01230749|39207600|FG001|Overall Study|Physician Decision|0|||
16200045|NCT01230749|39207601|FG002|Overall Study|Physician Decision|1|||
16200046|NCT01230749|39207602|FG003|Overall Study|Physician Decision|0|||
16200047|NCT01230749|39207599|FG000|Overall Study|Withdrawal by Subject|0|||
16200048|NCT01230749|39207600|FG001|Overall Study|Withdrawal by Subject|1|||
16200049|NCT01230749|39207601|FG002|Overall Study|Withdrawal by Subject|0|||
16200050|NCT01230749|39207602|FG003|Overall Study|Withdrawal by Subject|0|||
16200051|NCT01230749|39207599|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
16200052|NCT01230749|39207600|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
16200053|NCT01230749|39207601|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
16200054|NCT01230749|39207602|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
16200055|NCT03428997|39207603|FG000|Overall Study|Sponsor decision.|1|||
16200056|NCT03428997|39207603|FG000|Overall Study|Withdrawal by Subject|3|||
16200057|NCT03428997|39207603|FG000|Overall Study|Lost to Follow-up|4|||
16200058|NCT00475540|39207604|FG000|36 Months|Lost to Follow-up|4|||
16200059|NCT00475540|39207605|FG001|36 Months|Lost to Follow-up|4|||
16200060|NCT00475540|39207604|FG000|36 Months|Death|1|||
16200061|NCT00475540|39207605|FG001|36 Months|Death|2|||
16200062|NCT00475540|39207604|FG000|36 Months|Censored due to reoperation|3|||
16200063|NCT00475540|39207605|FG001|36 Months|Censored due to reoperation|0|||
16200064|NCT01107405|39207616|FG000|Overall Study|Adverse Event|1|||
16200065|NCT01107405|39207617|FG001|Overall Study|Adverse Event|1|||
16200066|NCT01107405|39207618|FG002|Overall Study|Adverse Event|0|||
16200067|NCT01107405|39207619|FG003|Overall Study|Adverse Event|0|||
16200068|NCT01107405|39207620|FG004|Overall Study|Adverse Event|2|||
16200069|NCT01107405|39207616|FG000|Overall Study|Withdrawal by Subject|1|||
16200070|NCT01107405|39207617|FG001|Overall Study|Withdrawal by Subject|0|||
16200071|NCT01107405|39207618|FG002|Overall Study|Withdrawal by Subject|1|||
16200072|NCT01107405|39207619|FG003|Overall Study|Withdrawal by Subject|2|||
16317352|NCT02712554|39644688|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
16317353|NCT02712554|39644687|FG000|Part B: Qualification Phase|Adverse Event|0|||
16317354|NCT02712554|39644688|FG001|Part B: Qualification Phase|Adverse Event|1|||
16317355|NCT02712554|39644687|FG000|Part B: Treatment Phase|Adverse Event|0|||
16317356|NCT02712554|39644688|FG001|Part B: Treatment Phase|Adverse Event|1|||
16090051|NCT01683409|38820066|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
16200073|NCT01107405|39207620|FG004|Overall Study|Withdrawal by Subject|1|||
16317357|NCT02712554|39644687|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
16317358|NCT02712554|39644688|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
16317359|NCT02712554|39644687|FG000|Part B: Treatment Phase|Other|0|||
16200074|NCT01107405|39207616|FG000|Overall Study|Protocol Violation|0|||
16200075|NCT01107405|39207617|FG001|Overall Study|Protocol Violation|0|||
16200076|NCT01107405|39207618|FG002|Overall Study|Protocol Violation|1|||
16200077|NCT01107405|39207619|FG003|Overall Study|Protocol Violation|1|||
16200078|NCT01107405|39207620|FG004|Overall Study|Protocol Violation|0|||
16200079|NCT03628417|39207621|FG000|Overall Study|Death|1|||
16200080|NCT03628417|39207622|FG001|Overall Study|Death|1|||
16200081|NCT03457103|39207623|FG000|Overall Study|illness/hospitalization|4|||
16200082|NCT03457103|39207624|FG001|Overall Study|illness/hospitalization|2|||
16200083|NCT03457103|39207623|FG000|Overall Study|Lost to Follow-up|2|||
16200084|NCT03457103|39207624|FG001|Overall Study|Lost to Follow-up|1|||
16200085|NCT03457103|39207623|FG000|Overall Study|Withdrawal by Subject|1|||
16317360|NCT02712554|39644688|FG001|Part B: Treatment Phase|Other|1|||
16317361|NCT02549859|39644689|FG000|Long-term 60 Hz DBS|Study Closed|1|||
16317362|NCT01445730|39644690|FG000|Overall Study|Adverse Event|1|||
16317363|NCT01445730|39644690|FG000|Overall Study|For the advice of a dentist|1|||
16317364|NCT01445730|39644690|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
16317365|NCT02510664|39644694|FG000|Overall Study|Transferred Care|9|||
16317366|NCT02510664|39644695|FG001|Overall Study|Transferred Care|9|||
16317367|NCT02510664|39644696|FG002|Overall Study|Transferred Care|0|||
16511881|NCT01203072|40347433|FG004|Overall Study|Lack of Efficacy|0|||
16511882|NCT01203072|40347429|FG000|Overall Study|Lost to Follow-up|0|||
16511883|NCT01203072|40347430|FG001|Overall Study|Lost to Follow-up|1|||
16511884|NCT01203072|40347431|FG002|Overall Study|Lost to Follow-up|0|||
16511885|NCT01203072|40347432|FG003|Overall Study|Lost to Follow-up|0|||
16511886|NCT01203072|40347433|FG004|Overall Study|Lost to Follow-up|0|||
16511887|NCT01203072|40347429|FG000|Overall Study|Protocol Violation|2|||
16511888|NCT01203072|40347430|FG001|Overall Study|Protocol Violation|0|||
16511889|NCT01203072|40347431|FG002|Overall Study|Protocol Violation|0|||
16511890|NCT01203072|40347432|FG003|Overall Study|Protocol Violation|0|||
16511891|NCT01203072|40347433|FG004|Overall Study|Protocol Violation|1|||
16090052|NCT01683409|38820062|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
16090053|NCT01683409|38820063|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
16090054|NCT01683409|38820064|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
16090055|NCT01683409|38820065|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
16090056|NCT01683409|38820066|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
16090057|NCT01683409|38820062|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
16090058|NCT01683409|38820063|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
16090059|NCT01683409|38820064|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
16090060|NCT01683409|38820065|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
16090061|NCT01683409|38820066|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
16090062|NCT01683409|38820062|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
16317368|NCT02510664|39644694|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
16090063|NCT01683409|38820063|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
16090064|NCT01683409|38820064|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
16317369|NCT02510664|39644695|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
16317370|NCT02510664|39644696|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
16511892|NCT01203072|40347429|FG000|Overall Study|Withdrawal by Subject|2|||
16511893|NCT01203072|40347430|FG001|Overall Study|Withdrawal by Subject|2|||
16511894|NCT01203072|40347431|FG002|Overall Study|Withdrawal by Subject|1|||
16511895|NCT01203072|40347432|FG003|Overall Study|Withdrawal by Subject|2|||
16317371|NCT02510664|39644694|FG000|Overall Study|Time Constraints|1|||
16317372|NCT02510664|39644695|FG001|Overall Study|Time Constraints|1|||
16317373|NCT02510664|39644696|FG002|Overall Study|Time Constraints|0|||
16317374|NCT04463251|39644699|FG000|Overall Study|Death|1|||
16317375|NCT04463251|39644700|FG001|Overall Study|Death|0|||
16317376|NCT04463251|39644701|FG002|Overall Study|Death|1|||
16317377|NCT04463251|39644699|FG000|Overall Study|Adverse Event|0|||
16317378|NCT04463251|39644700|FG001|Overall Study|Adverse Event|1|||
16317379|NCT04463251|39644701|FG002|Overall Study|Adverse Event|0|||
16511896|NCT01203072|40347433|FG004|Overall Study|Withdrawal by Subject|3|||
16511897|NCT00547703|40347436|FG000|Overall Study|Lost to Follow-up|1|||
16511898|NCT00547703|40347437|FG001|Overall Study|Lost to Follow-up|0|||
16511899|NCT00539838|40347438|FG000|Overall Study|Fail to return|2|||
16511900|NCT00539838|40347439|FG001|Overall Study|Fail to return|0|||
16511901|NCT00539838|40347440|FG002|Overall Study|Fail to return|0|||
16511902|NCT00539838|40347438|FG000|Overall Study|Withdrawal by Subject|0|||
16317380|NCT04463251|39644699|FG000|Overall Study|Lost to Follow-up|0|||
16317381|NCT04463251|39644700|FG001|Overall Study|Lost to Follow-up|1|||
16317382|NCT04463251|39644701|FG002|Overall Study|Lost to Follow-up|0|||
16317383|NCT04463251|39644699|FG000|Overall Study|Withdrawal by Subject|0|||
16317384|NCT04463251|39644700|FG001|Overall Study|Withdrawal by Subject|2|||
16317385|NCT04463251|39644701|FG002|Overall Study|Withdrawal by Subject|2|||
16317386|NCT01894841|39644703|FG000|Overall Study|Withdrawal by Subject|9|||
16317387|NCT01894841|39644704|FG001|Overall Study|Withdrawal by Subject|4|||
16317388|NCT01894841|39644703|FG000|Overall Study|Withdrawn by investigator|2|||
16511903|NCT00539838|40347439|FG001|Overall Study|Withdrawal by Subject|4|||
16511904|NCT00539838|40347440|FG002|Overall Study|Withdrawal by Subject|0|||
16511905|NCT00539838|40347438|FG000|Overall Study|Death|0|||
16511906|NCT00539838|40347439|FG001|Overall Study|Death|2|||
16511907|NCT00539838|40347440|FG002|Overall Study|Death|0|||
16511908|NCT00539838|40347438|FG000|Overall Study|Did not cooperate|1|||
16511909|NCT00539838|40347439|FG001|Overall Study|Did not cooperate|0|||
16511910|NCT00539838|40347440|FG002|Overall Study|Did not cooperate|1|||
16511911|NCT00539838|40347438|FG000|Overall Study|Administrative|4|||
16511912|NCT00539838|40347439|FG001|Overall Study|Administrative|0|||
16317389|NCT01894841|39644704|FG001|Overall Study|Withdrawn by investigator|2|||
16317390|NCT01894841|39644703|FG000|Overall Study|Lost to Follow-up|7|||
16317391|NCT01894841|39644704|FG001|Overall Study|Lost to Follow-up|3|||
16511913|NCT00539838|40347440|FG002|Overall Study|Administrative|8|||
16511914|NCT00414388|40347441|FG000|Overall Study|Adverse Event|1|||
16511915|NCT02214121|40347444|FG000|Part A|Patient decision|2|||
16511916|NCT02214121|40347445|FG001|Part A|Patient decision|0|||
16511917|NCT02214121|40347446|FG002|Part A|Patient decision|0|||
16511918|NCT02214121|40347444|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
16511919|NCT02214121|40347445|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
16511920|NCT02214121|40347446|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
16511921|NCT02214121|40347444|FG000|Part A|Other|1|||
16511922|NCT02214121|40347445|FG001|Part A|Other|0|||
16511923|NCT02214121|40347446|FG002|Part A|Other|0|||
16511924|NCT02214121|40347444|FG000|Part B|Patient decision|0|||
16511925|NCT02214121|40347445|FG001|Part B|Patient decision|1|||
16511926|NCT02214121|40347446|FG002|Part B|Patient decision|0|||
16511927|NCT02214121|40347444|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
16511928|NCT02214121|40347445|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
16511929|NCT02214121|40347446|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
16511930|NCT02214121|40347444|FG000|Part B|Lost to Follow-up|0|||
16511931|NCT02214121|40347445|FG001|Part B|Lost to Follow-up|0|||
16511932|NCT02214121|40347446|FG002|Part B|Lost to Follow-up|1|||
16511933|NCT00025883|40347450|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
16511934|NCT00025883|40347450|FG000|Overall Study|no baseline data|1|||
16511935|NCT00025883|40347450|FG000|Overall Study|Death|1|||
16511936|NCT00025883|40347450|FG000|Overall Study|Adverse Event|1|||
16511937|NCT00025883|40347450|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
16511938|NCT01709695|40347452|FG000|Overall Study|Withdrawal by Subject|1|||
16511939|NCT01709695|40347453|FG001|Overall Study|Withdrawal by Subject|1|||
16511940|NCT00855309|40347454|FG000|Overall Study|patient never recieved drug|1|||
16511941|NCT00855309|40347455|FG001|Overall Study|patient never recieved drug|0|||
16511942|NCT02347527|40347456|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
16511943|NCT02347527|40347457|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
16511944|NCT02347527|40347458|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
16511945|NCT02347527|40347459|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
16511946|NCT02347527|40347456|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
16511947|NCT02347527|40347457|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
16511948|NCT02347527|40347458|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
16511949|NCT02347527|40347459|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
16511950|NCT02347527|40347456|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
16511951|NCT02347527|40347457|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
16511952|NCT02347527|40347458|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
16511953|NCT02347527|40347459|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
16317392|NCT01962103|39644705|FG000|Phase 1|Adverse Event|4|||
16317393|NCT01962103|39644706|FG001|Phase 1|Adverse Event|0|||
16317394|NCT01962103|39644707|FG002|Phase 1|Adverse Event|2|||
16317395|NCT01962103|39644708|FG003|Phase 1|Adverse Event|1|||
16317396|NCT01962103|39644709|FG004|Phase 1|Adverse Event|2|||
16511954|NCT02347527|40347456|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
16511955|NCT02347527|40347457|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
16511956|NCT02347527|40347458|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
16511957|NCT02347527|40347459|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
16511958|NCT02347527|40347456|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
16200086|NCT03457103|39207624|FG001|Overall Study|Withdrawal by Subject|2|||
16200087|NCT03457103|39207623|FG000|Overall Study|financial/ insurance issues|1|||
16200088|NCT03457103|39207624|FG001|Overall Study|financial/ insurance issues|1|||
16200089|NCT01594333|39207625|FG000|Overall Study|Death|96|||
16200090|NCT01594333|39207626|FG001|Overall Study|Death|83|||
16200091|NCT01594333|39207625|FG000|Overall Study|Lost to Follow-up|5|||
16200092|NCT01594333|39207626|FG001|Overall Study|Lost to Follow-up|5|||
16200093|NCT01594333|39207625|FG000|Overall Study|Withdrawal by Subject|60|||
16200094|NCT01594333|39207626|FG001|Overall Study|Withdrawal by Subject|63|||
16200095|NCT00574496|39207627|FG000|Overall Study|Withdrawal by Subject|1|||
16200096|NCT02338492|39207632|FG000|Overall Study|Death|32|||
16200097|NCT02338492|39207632|FG000|Overall Study|Adverse Event|3|||
16200098|NCT02338492|39207632|FG000|Overall Study|Lost to Follow-up|4|||
16200099|NCT02338492|39207632|FG000|Overall Study|Reason not captured above|6|||
16200100|NCT00390416|39207636|FG000|Overall Study|Withdrawal by Subject|1|||
16200101|NCT00390416|39207636|FG000|Overall Study|Not treated|3|||
16200102|NCT01164865|39207638|FG000|Overall Study|Lost to Follow-up|2|||
16200103|NCT01164865|39207639|FG001|Overall Study|Lost to Follow-up|1|||
16511959|NCT02347527|40347457|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
16511960|NCT02347527|40347458|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
16511961|NCT02347527|40347459|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
16511962|NCT00637195|40347460|FG000|Overall Study|Lost to Follow-up|1|||
16511963|NCT00637195|40347461|FG001|Overall Study|Lost to Follow-up|0|||
16511964|NCT00637195|40347460|FG000|Overall Study|Other|2|||
16511965|NCT00637195|40347461|FG001|Overall Study|Other|0|||
16511966|NCT00637195|40347460|FG000|Overall Study|Withdrawal by Subject|0|||
16511967|NCT00637195|40347461|FG001|Overall Study|Withdrawal by Subject|1|||
16200104|NCT00643604|39207640|FG000|Overall Study|Death|1|||
16200105|NCT02447458|39211634|FG000|Overall Study|Other|0|||
16200106|NCT02447458|39211635|FG001|Overall Study|Other|0|||
16200107|NCT02447458|39211636|FG002|Overall Study|Other|1|||
16200108|NCT02447458|39211637|FG003|Overall Study|Other|0|||
16200109|NCT02447458|39211638|FG004|Overall Study|Other|0|||
16200110|NCT02447458|39211639|FG005|Overall Study|Other|0|||
16200111|NCT00617656|39211641|FG000|Overall Study|Inclusion error|4|||
16200112|NCT00617656|39211642|FG001|Overall Study|Inclusion error|4|||
16200113|NCT00617656|39211643|FG002|Overall Study|Inclusion error|0|||
16200114|NCT00617656|39211644|FG003|Overall Study|Inclusion error|0|||
16200115|NCT00617656|39211641|FG000|Overall Study|Missing data|44|||
16200116|NCT00617656|39211642|FG001|Overall Study|Missing data|30|||
16200117|NCT00617656|39211643|FG002|Overall Study|Missing data|13|||
16200118|NCT00617656|39211644|FG003|Overall Study|Missing data|6|||
16200119|NCT00617656|39211641|FG000|Overall Study|Withdrawal by Subject|0|||
16200120|NCT00617656|39211642|FG001|Overall Study|Withdrawal by Subject|2|||
16200121|NCT00617656|39211643|FG002|Overall Study|Withdrawal by Subject|0|||
16200122|NCT00617656|39211644|FG003|Overall Study|Withdrawal by Subject|0|||
16200123|NCT00594204|39211645|FG000|Overall Study|Adverse Event|15|||
16200124|NCT00594204|39211646|FG001|Overall Study|Adverse Event|3|||
16200125|NCT00594204|39211645|FG000|Overall Study|Lost to Follow-up|9|||
16200126|NCT00594204|39211646|FG001|Overall Study|Lost to Follow-up|5|||
16200127|NCT00594204|39211645|FG000|Overall Study|Withdrawal by Subject|23|||
16200128|NCT00594204|39211646|FG001|Overall Study|Withdrawal by Subject|29|||
16200129|NCT00594204|39211645|FG000|Overall Study|Other|4|||
16200130|NCT00594204|39211646|FG001|Overall Study|Other|3|||
16200131|NCT00594204|39211645|FG000|Overall Study|Lack of Efficacy|3|||
16200132|NCT00594204|39211646|FG001|Overall Study|Lack of Efficacy|4|||
16200133|NCT00594204|39211645|FG000|Overall Study|Randomized but not treated|4|||
16200134|NCT00594204|39211646|FG001|Overall Study|Randomized but not treated|1|||
16200135|NCT00039741|39211647|FG000|Overall Study|Death|0|||
16200136|NCT00039741|39211648|FG001|Overall Study|Death|1|||
16511968|NCT00192075|40347464|FG000|Overall Study|Disease Progression|23|||
16511969|NCT00192075|40347465|FG001|Overall Study|Disease Progression|6|||
16511970|NCT00192075|40347464|FG000|Overall Study|Adverse Event|1|||
16200137|NCT00039741|39211649|FG002|Overall Study|Death|0|||
16200138|NCT00039741|39211650|FG003|Overall Study|Death|0|||
16200139|NCT00039741|39211647|FG000|Overall Study|Lost to Follow-up|3|||
16200140|NCT00039741|39211648|FG001|Overall Study|Lost to Follow-up|1|||
16200141|NCT00039741|39211649|FG002|Overall Study|Lost to Follow-up|5|||
16200142|NCT00039741|39211650|FG003|Overall Study|Lost to Follow-up|2|||
16200143|NCT00039741|39211647|FG000|Overall Study|Confounding medical condition|1|||
16200144|NCT00039741|39211648|FG001|Overall Study|Confounding medical condition|0|||
16200145|NCT00039741|39211649|FG002|Overall Study|Confounding medical condition|0|||
16200146|NCT00039741|39211650|FG003|Overall Study|Confounding medical condition|0|||
16200147|NCT00039741|39211647|FG000|Overall Study|Not able to get to clinic|5|||
16200148|NCT00039741|39211648|FG001|Overall Study|Not able to get to clinic|2|||
16200149|NCT00039741|39211649|FG002|Overall Study|Not able to get to clinic|0|||
16200150|NCT00039741|39211650|FG003|Overall Study|Not able to get to clinic|3|||
16200151|NCT00039741|39211647|FG000|Overall Study|Moved|3|||
16511971|NCT00192075|40347465|FG001|Overall Study|Adverse Event|3|||
16511972|NCT00192075|40347464|FG000|Overall Study|Death|0|||
16511973|NCT00192075|40347465|FG001|Overall Study|Death|1|||
16511974|NCT00192075|40347464|FG000|Overall Study|Lack of Efficacy|0|||
16511975|NCT00192075|40347465|FG001|Overall Study|Lack of Efficacy|0|||
16511976|NCT00192075|40347464|FG000|Overall Study|Physician Decision|3|||
16511977|NCT00192075|40347465|FG001|Overall Study|Physician Decision|0|||
16511978|NCT00192075|40347464|FG000|Overall Study|Withdrawal by Subject|5|||
16511979|NCT00192075|40347465|FG001|Overall Study|Withdrawal by Subject|5|||
16511980|NCT00192075|40347464|FG000|Overall Study|Patient Non-Compliance|0|||
16511981|NCT00192075|40347465|FG001|Overall Study|Patient Non-Compliance|1|||
16511982|NCT00192075|40347464|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
16511983|NCT00192075|40347465|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
16511984|NCT00192075|40347464|FG000|Overall Study|Other|5|||
16511985|NCT00192075|40347465|FG001|Overall Study|Other|2|||
16511986|NCT02382016|40347466|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
16511987|NCT02382016|40347467|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
16511988|NCT02382016|40347466|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
16511989|NCT02382016|40347467|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
16511990|NCT02382016|40347466|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
16511991|NCT02382016|40347467|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
16511992|NCT02382016|40347466|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
16511993|NCT02382016|40347467|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
16511994|NCT02382016|40347466|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
16511995|NCT02382016|40347467|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
16511996|NCT02382016|40347466|FG000|Open-label (OL) Treatment Period|Death|4|||
16511997|NCT02382016|40347467|FG001|Open-label (OL) Treatment Period|Death|0|||
16511998|NCT02382016|40347466|FG000|OL Extension Period|Physician Decision|3|||
16511999|NCT02382016|40347467|FG001|OL Extension Period|Physician Decision|0|||
16512000|NCT02382016|40347466|FG000|OL Extension Period|Death|2|||
16512001|NCT02382016|40347467|FG001|OL Extension Period|Death|0|||
16512002|NCT02382016|40347466|FG000|OL Extension Period|Withdrawal by Subject|1|||
16200152|NCT00039741|39211648|FG001|Overall Study|Moved|2|||
16200153|NCT00039741|39211649|FG002|Overall Study|Moved|3|||
16200154|NCT00039741|39211650|FG003|Overall Study|Moved|6|||
16200155|NCT00039741|39211647|FG000|Overall Study|Non-compliance with protocol|1|||
16200156|NCT00039741|39211648|FG001|Overall Study|Non-compliance with protocol|0|||
16200157|NCT00039741|39211649|FG002|Overall Study|Non-compliance with protocol|1|||
16200158|NCT00039741|39211650|FG003|Overall Study|Non-compliance with protocol|0|||
16200159|NCT00039741|39211647|FG000|Overall Study|Withdrew consent|0|||
16200160|NCT00039741|39211648|FG001|Overall Study|Withdrew consent|5|||
16200161|NCT00039741|39211649|FG002|Overall Study|Withdrew consent|0|||
16200162|NCT00039741|39211650|FG003|Overall Study|Withdrew consent|1|||
16200163|NCT00039741|39211647|FG000|Overall Study|Missed final visit|2|||
16200164|NCT00039741|39211648|FG001|Overall Study|Missed final visit|1|||
16200165|NCT00039741|39211649|FG002|Overall Study|Missed final visit|2|||
16200166|NCT00039741|39211650|FG003|Overall Study|Missed final visit|2|||
16200167|NCT03943953|39211651|FG000|Trial of ITG 1|Lost to Follow-up|19|||
16200168|NCT03943953|39211652|FG001|Trial of ITG 1|Lost to Follow-up|1|||
16200169|NCT03943953|39211651|FG000|Trial of ITG 2|Lost to Follow-up|8|||
16200170|NCT03943953|39211652|FG001|Trial of ITG 2|Lost to Follow-up|0|||
16200171|NCT03943953|39211651|FG000|Trial of ITG 3|Lost to Follow-up|2|||
16200172|NCT03943953|39211652|FG001|Trial of ITG 3|Lost to Follow-up|0|||
16200173|NCT03943953|39211651|FG000|Trial of ITG 4|Lost to Follow-up|2|||
16200174|NCT03943953|39211652|FG001|Trial of ITG 4|Lost to Follow-up|0|||
16200175|NCT01927419|39211653|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
16200176|NCT01927419|39211654|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
16200177|NCT01927419|39211653|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
16200178|NCT01927419|39211654|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
16200179|NCT01927419|39211653|FG000|Treatment Period|Disease progression|17|||
16200180|NCT01927419|39211654|FG001|Treatment Period|Disease progression|20|||
16200181|NCT01927419|39211653|FG000|Treatment Period|Study drug toxicity|48|||
16200182|NCT01927419|39211654|FG001|Treatment Period|Study drug toxicity|10|||
16200183|NCT01927419|39211653|FG000|Treatment Period|Death|0|||
16512003|NCT02382016|40347467|FG001|OL Extension Period|Withdrawal by Subject|0|||
16200184|NCT01927419|39211654|FG001|Treatment Period|Death|1|||
16200185|NCT01927419|39211653|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
16512004|NCT03848845|40347468|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
16200186|NCT01927419|39211654|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
16200187|NCT01927419|39211653|FG000|Treatment Period|Participant request to discontinue|12|||
16200188|NCT01927419|39211654|FG001|Treatment Period|Participant request to discontinue|4|||
16200189|NCT01927419|39211653|FG000|Treatment Period|Withdrawal by Subject|1|||
16200190|NCT01927419|39211654|FG001|Treatment Period|Withdrawal by Subject|1|||
16200191|NCT01927419|39211653|FG000|Treatment Period|Maximum Clinical Benefit|6|||
16200192|NCT01927419|39211654|FG001|Treatment Period|Maximum Clinical Benefit|2|||
16200193|NCT01927419|39211653|FG000|Treatment Period|Other reasons|3|||
16200194|NCT01927419|39211654|FG001|Treatment Period|Other reasons|4|||
16200195|NCT01927419|39211653|FG000|Treatment Period|Not Reported|1|||
16200196|NCT01927419|39211654|FG001|Treatment Period|Not Reported|1|||
16200197|NCT00729326|39211657|FG000|Overall Study|Lost to Follow-up|2|||
16200198|NCT00729326|39211658|FG001|Overall Study|Lost to Follow-up|0|||
16200199|NCT00729326|39211657|FG000|Overall Study|Physician Decision|0|||
16200200|NCT00729326|39211658|FG001|Overall Study|Physician Decision|1|||
16200201|NCT00729326|39211657|FG000|Overall Study|Protocol Violation|3|||
16200202|NCT00729326|39211658|FG001|Overall Study|Protocol Violation|2|||
16200203|NCT00729326|39211657|FG000|Overall Study|Subject Decision|4|||
16200204|NCT00729326|39211658|FG001|Overall Study|Subject Decision|4|||
16200205|NCT00729326|39211657|FG000|Overall Study|Sponsor Decision|1|||
16200206|NCT00729326|39211658|FG001|Overall Study|Sponsor Decision|2|||
16200207|NCT01184846|39211659|FG000|Overall Study|Adverse Event|2|||
16200208|NCT01184846|39211659|FG000|Overall Study|Insufficient response|1|||
16200209|NCT04209530|39211660|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
16200210|NCT04209530|39211661|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
16200211|NCT04209530|39211660|FG000|Overall Study|Withdrawal by Subject|0|||
16200212|NCT04209530|39211661|FG001|Overall Study|Withdrawal by Subject|1|||
16200213|NCT01412060|39211666|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
16200214|NCT01412060|39211667|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
16200215|NCT01412060|39211668|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
16200216|NCT01412060|39211666|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
16200217|NCT01412060|39211667|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
16200218|NCT01412060|39211668|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
16200219|NCT01412060|39211666|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
16200220|NCT01412060|39211667|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
16200221|NCT01412060|39211668|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
16200222|NCT01412060|39211666|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
16200223|NCT01412060|39211667|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
16200224|NCT01412060|39211668|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
16200225|NCT01412060|39211666|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
16200226|NCT01412060|39211667|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
16200227|NCT01412060|39211668|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
16200228|NCT01412060|39211666|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
16200229|NCT01412060|39211667|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
16200230|NCT01412060|39211668|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
16200231|NCT01412060|39211666|FG000|Period Between RIP and SP|Adverse Event|4|||
16200232|NCT01412060|39211667|FG001|Period Between RIP and SP|Adverse Event|0|||
16200233|NCT01412060|39211668|FG002|Period Between RIP and SP|Adverse Event|0|||
16200234|NCT01412060|39211666|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
16200235|NCT01412060|39211667|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
16200236|NCT01412060|39211668|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
16200237|NCT01412060|39211666|FG000|Period Between RIP and SP|Protocol Violation|2|||
16200238|NCT01412060|39211667|FG001|Period Between RIP and SP|Protocol Violation|0|||
16200239|NCT01412060|39211668|FG002|Period Between RIP and SP|Protocol Violation|0|||
16200240|NCT01412060|39211666|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
16200241|NCT01412060|39211667|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
16200242|NCT01412060|39211668|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
16200243|NCT01412060|39211666|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
16200244|NCT01412060|39211667|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
16200245|NCT01412060|39211668|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
16200246|NCT01412060|39211666|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
16200247|NCT01412060|39211667|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
16200248|NCT01412060|39211668|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
16200249|NCT01412060|39211666|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
16200250|NCT01412060|39211667|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
16200251|NCT01412060|39211668|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
16200252|NCT01412060|39211666|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
16200253|NCT01412060|39211667|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
16200254|NCT01412060|39211668|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
16200255|NCT01412060|39211666|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
16200256|NCT01412060|39211667|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
16200257|NCT01412060|39211668|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
16200258|NCT01412060|39211666|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
16200259|NCT01412060|39211667|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
16200260|NCT01412060|39211668|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
16200261|NCT01412060|39211666|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
16200262|NCT01412060|39211667|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
16200263|NCT01412060|39211668|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
16200264|NCT01412060|39211666|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
16200265|NCT01412060|39211667|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
16200266|NCT01412060|39211668|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
16200267|NCT01412060|39211666|FG000|Period Between SP and DBP|Protocol Violation|2|||
16200268|NCT01412060|39211667|FG001|Period Between SP and DBP|Protocol Violation|0|||
16200269|NCT01412060|39211668|FG002|Period Between SP and DBP|Protocol Violation|0|||
16200270|NCT01412060|39211666|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
16200271|NCT01412060|39211667|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
16200272|NCT01412060|39211668|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
16200273|NCT01412060|39211666|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
16200274|NCT01412060|39211667|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
16200275|NCT01412060|39211668|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
16200276|NCT01412060|39211666|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
16200277|NCT01412060|39211667|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
16200278|NCT01412060|39211668|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
16200279|NCT01412060|39211666|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
16200280|NCT01412060|39211667|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
16200281|NCT01412060|39211668|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
16200282|NCT01412060|39211666|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
16200283|NCT01412060|39211667|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
16200284|NCT01412060|39211668|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
16200285|NCT01412060|39211666|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
16200286|NCT01412060|39211667|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
16200287|NCT01412060|39211668|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
16200288|NCT01412060|39211666|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
16200289|NCT01412060|39211667|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
16200290|NCT01412060|39211668|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
16200291|NCT01412060|39211666|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
16200292|NCT01412060|39211667|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
16200293|NCT01412060|39211668|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
16200294|NCT01412060|39211666|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
16200295|NCT01412060|39211667|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
16200296|NCT01412060|39211668|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
16200297|NCT01412060|39211666|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
16200298|NCT01412060|39211667|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
16200299|NCT01412060|39211668|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
16200300|NCT03814590|39211669|FG000|Overall Study|Adverse Event|0|||
16200301|NCT03814590|39211670|FG001|Overall Study|Adverse Event|0|||
16200302|NCT03814590|39211671|FG002|Overall Study|Adverse Event|0|||
16200303|NCT03814590|39211672|FG003|Overall Study|Adverse Event|0|||
16200304|NCT03814590|39211673|FG004|Overall Study|Adverse Event|0|||
16200305|NCT03814590|39211674|FG005|Overall Study|Adverse Event|1|||
16200306|NCT03814590|39211675|FG006|Overall Study|Adverse Event|1|||
16200307|NCT03814590|39211676|FG007|Overall Study|Adverse Event|1|||
16200308|NCT03814590|39211677|FG008|Overall Study|Adverse Event|0|||
16200309|NCT03814590|39211678|FG009|Overall Study|Adverse Event|0|||
16200310|NCT03814590|39211679|FG010|Overall Study|Adverse Event|1|||
16200311|NCT03814590|39211680|FG011|Overall Study|Adverse Event|0|||
16200312|NCT03814590|39211681|FG012|Overall Study|Adverse Event|3|||
16200313|NCT03814590|39211682|FG013|Overall Study|Adverse Event|0|||
16200314|NCT03814590|39211669|FG000|Overall Study|Lost to Follow-up|0|||
16200315|NCT03814590|39211670|FG001|Overall Study|Lost to Follow-up|2|||
16200316|NCT03814590|39211671|FG002|Overall Study|Lost to Follow-up|1|||
16200317|NCT03814590|39211672|FG003|Overall Study|Lost to Follow-up|0|||
16200318|NCT03814590|39211673|FG004|Overall Study|Lost to Follow-up|1|||
16200319|NCT03814590|39211674|FG005|Overall Study|Lost to Follow-up|1|||
16200320|NCT03814590|39211675|FG006|Overall Study|Lost to Follow-up|1|||
16200321|NCT03814590|39211676|FG007|Overall Study|Lost to Follow-up|1|||
16200322|NCT03814590|39211677|FG008|Overall Study|Lost to Follow-up|0|||
16200323|NCT03814590|39211678|FG009|Overall Study|Lost to Follow-up|0|||
16200324|NCT03814590|39211679|FG010|Overall Study|Lost to Follow-up|1|||
16200325|NCT03814590|39211680|FG011|Overall Study|Lost to Follow-up|0|||
16200326|NCT03814590|39211681|FG012|Overall Study|Lost to Follow-up|0|||
16200327|NCT03814590|39211682|FG013|Overall Study|Lost to Follow-up|1|||
16200328|NCT03814590|39211669|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200329|NCT03814590|39211670|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200330|NCT03814590|39211671|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200331|NCT03814590|39211672|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200332|NCT03814590|39211673|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200333|NCT03814590|39211674|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200334|NCT03814590|39211675|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200335|NCT03814590|39211676|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200336|NCT03814590|39211677|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200337|NCT03814590|39211678|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
16200338|NCT03814590|39211679|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200339|NCT03814590|39211680|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200340|NCT03814590|39211681|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200341|NCT03814590|39211682|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
16200342|NCT03814590|39211669|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
16200343|NCT03814590|39211670|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
16200344|NCT03814590|39211671|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
16200345|NCT03814590|39211672|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
16200346|NCT03814590|39211673|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
16200347|NCT03814590|39211674|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
16200348|NCT03814590|39211675|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
16200349|NCT03814590|39211676|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
16200350|NCT03814590|39211677|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
16200351|NCT03814590|39211678|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
16200352|NCT03814590|39211679|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
16200353|NCT03814590|39211680|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
16200354|NCT03814590|39211681|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
16200355|NCT03814590|39211682|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
16200356|NCT03814590|39211669|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200357|NCT03814590|39211670|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200358|NCT03814590|39211671|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200359|NCT03814590|39211672|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200360|NCT03814590|39211673|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200361|NCT03814590|39211674|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200362|NCT03814590|39211675|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200363|NCT03814590|39211676|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16200364|NCT03814590|39211677|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200365|NCT03814590|39211678|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16200366|NCT03814590|39211679|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200367|NCT03814590|39211680|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200368|NCT03814590|39211681|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200369|NCT03814590|39211682|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16200370|NCT03814590|39211669|FG000|Overall Study|UNKNOWN REASON|0|||
16200371|NCT03814590|39211670|FG001|Overall Study|UNKNOWN REASON|0|||
16200372|NCT03814590|39211671|FG002|Overall Study|UNKNOWN REASON|0|||
16200373|NCT03814590|39211672|FG003|Overall Study|UNKNOWN REASON|0|||
16317397|NCT01962103|39644710|FG005|Phase 1|Adverse Event|2|||
16317398|NCT01962103|39644711|FG006|Phase 1|Adverse Event|0|||
16317399|NCT01962103|39644712|FG007|Phase 1|Adverse Event|0|||
16317400|NCT01962103|39644713|FG008|Phase 1|Adverse Event|0|||
16200374|NCT03814590|39211673|FG004|Overall Study|UNKNOWN REASON|0|||
16200375|NCT03814590|39211674|FG005|Overall Study|UNKNOWN REASON|0|||
16200376|NCT03814590|39211675|FG006|Overall Study|UNKNOWN REASON|0|||
16317401|NCT01962103|39644705|FG000|Phase 1|Progressive Disease|8|||
16317402|NCT01962103|39644706|FG001|Phase 1|Progressive Disease|6|||
16200377|NCT03814590|39211676|FG007|Overall Study|UNKNOWN REASON|1|||
16317403|NCT01962103|39644707|FG002|Phase 1|Progressive Disease|8|||
16317404|NCT01962103|39644708|FG003|Phase 1|Progressive Disease|4|||
16317405|NCT01962103|39644709|FG004|Phase 1|Progressive Disease|5|||
16317406|NCT01962103|39644710|FG005|Phase 1|Progressive Disease|4|||
16200378|NCT03814590|39211677|FG008|Overall Study|UNKNOWN REASON|0|||
16200379|NCT03814590|39211678|FG009|Overall Study|UNKNOWN REASON|0|||
16200380|NCT03814590|39211679|FG010|Overall Study|UNKNOWN REASON|0|||
16200381|NCT03814590|39211680|FG011|Overall Study|UNKNOWN REASON|0|||
16200382|NCT03814590|39211681|FG012|Overall Study|UNKNOWN REASON|0|||
16200383|NCT03814590|39211682|FG013|Overall Study|UNKNOWN REASON|0|||
16200384|NCT04154943|39211689|FG000|Overall Study|Study Ongoing|68|||
16200385|NCT04154943|39211689|FG000|Overall Study|Lost to Follow-up|1|||
16200386|NCT04154943|39211689|FG000|Overall Study|Decision by the Investigator|1|||
16200387|NCT04154943|39211689|FG000|Overall Study|Death|5|||
16200388|NCT04154943|39211689|FG000|Overall Study|Withdrawal by Subject|4|||
16200389|NCT00843843|39211693|FG000|Overall Study|Physician Decision|1|||
16200390|NCT00843843|39211694|FG001|Overall Study|Physician Decision|1|||
16200391|NCT00843843|39211693|FG000|Overall Study|Protocol Violation|1|||
16200392|NCT00843843|39211694|FG001|Overall Study|Protocol Violation|1|||
16200393|NCT05319080|39211696|FG000|Overall Study|Withdrawal by Subject|2|||
16200394|NCT05319080|39211696|FG000|Overall Study|Physician Decision|4|||
16200395|NCT02420223|39211697|FG000|Overall Study|Adverse Event|1|||
16200396|NCT02420223|39211698|FG001|Overall Study|Adverse Event|0|||
16200397|NCT02420223|39211697|FG000|Overall Study|Physician Decision|0|||
16200398|NCT02420223|39211698|FG001|Overall Study|Physician Decision|2|||
16200399|NCT02726113|39211704|FG000|Total Enrollment|Physician Decision|0|||
16200400|NCT02726113|39211705|FG001|Total Enrollment|Physician Decision|1|||
16200401|NCT02726113|39211704|FG000|Total Enrollment|Protocol Violation|1|||
16200402|NCT02726113|39211705|FG001|Total Enrollment|Protocol Violation|0|||
16200403|NCT02726113|39211704|FG000|Total Enrollment|Withdrawal by Subject|2|||
16200404|NCT02726113|39211705|FG001|Total Enrollment|Withdrawal by Subject|1|||
16200405|NCT02726113|39211704|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
16200406|NCT02726113|39211705|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
16200407|NCT02726113|39211704|FG000|Genomic Analysis|Protocol Violation|1|||
16200408|NCT02726113|39211705|FG001|Genomic Analysis|Protocol Violation|0|||
16200409|NCT02726113|39211704|FG000|Genomic Analysis|Withdrawal by Subject|2|||
16200410|NCT02726113|39211705|FG001|Genomic Analysis|Withdrawal by Subject|1|||
16200411|NCT02726113|39211704|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
16200412|NCT02726113|39211705|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
16200413|NCT01586806|39211706|FG000|Overall Study|Protocol Violation|0|||
16200414|NCT01586806|39211707|FG001|Overall Study|Protocol Violation|1|||
16200415|NCT01586806|39211708|FG002|Overall Study|Protocol Violation|0|||
16200416|NCT01586806|39211706|FG000|Overall Study|Withdrawal by Subject|1|||
16200417|NCT01586806|39211707|FG001|Overall Study|Withdrawal by Subject|0|||
16200418|NCT01586806|39211708|FG002|Overall Study|Withdrawal by Subject|0|||
16200419|NCT01586806|39211706|FG000|Overall Study|Lost to Follow-up|2|||
16200420|NCT01586806|39211707|FG001|Overall Study|Lost to Follow-up|3|||
16200421|NCT01586806|39211708|FG002|Overall Study|Lost to Follow-up|2|||
16200422|NCT03558555|39211709|FG000|Overall Study|Lost to Follow-up|2|||
16200423|NCT03558555|39211710|FG001|Overall Study|Lost to Follow-up|1|||
16200424|NCT01890512|39211711|FG000|Overall Study|Physician Decision|1|||
16200425|NCT01890512|39211711|FG000|Overall Study|Withdrawal by Subject|1|||
16200426|NCT01890512|39211711|FG000|Overall Study|Protocol Violation|1|||
16200427|NCT02158091|39211712|FG000|Overall Study|DLT|2|||
16200428|NCT02158091|39211713|FG001|Overall Study|DLT|1|||
16200429|NCT02158091|39211714|FG002|Overall Study|DLT|0|||
16200430|NCT01686958|39211715|FG000|Overall Study|Withdrawal by Subject|1|||
16200431|NCT02219087|39211721|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
16200432|NCT02219087|39211722|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
16200433|NCT03198754|39211723|FG000|Overall Study|Withdrawal by Subject|5|||
16200434|NCT03198754|39211724|FG001|Overall Study|Withdrawal by Subject|4|||
16200435|NCT03198754|39211723|FG000|Overall Study|Lost to Follow-up|4|||
16090065|NCT01683409|38820065|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
16090066|NCT01683409|38820066|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
16090067|NCT02392507|38820067|FG000|Induction Regimen|Death|3|||
16090068|NCT02392507|38820067|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
16090069|NCT02392507|38820067|FG000|Induction Regimen|Physician Decision|1|||
16200436|NCT03198754|39211724|FG001|Overall Study|Lost to Follow-up|3|||
16200437|NCT03198754|39211723|FG000|Overall Study|Ineligible|2|||
16200438|NCT03198754|39211724|FG001|Overall Study|Ineligible|1|||
16200439|NCT02690207|39211728|FG000|Overall Study|Lost to Follow-up|48|||
16200440|NCT02690207|39211728|FG000|Overall Study|Withdrawal by Subject|46|||
16200441|NCT02690207|39211728|FG000|Overall Study|Protocol Violation|2|||
16200442|NCT02690207|39211728|FG000|Overall Study|Serious adverse event|110|||
16200443|NCT02690207|39211728|FG000|Overall Study|Non-serious Adverse Event|18|||
16200444|NCT02690207|39211728|FG000|Overall Study|Migrated/moved from study area|5|||
16200445|NCT02690207|39211728|FG000|Overall Study|Suspected HZ Episode|1|||
16200446|NCT02690207|39211728|FG000|Overall Study|Other reasons for withdrawal|23|||
16200447|NCT00506948|39211729|FG000|Overall Study|Death|4|||
16200448|NCT00506948|39211729|FG000|Overall Study|Adverse Event|5|||
16200449|NCT00506948|39211729|FG000|Overall Study|Physician Decision|1|||
16200450|NCT03700736|39211733|FG000|Overall Study|Pregnancy|1|||
16200451|NCT03700736|39211734|FG001|Overall Study|Pregnancy|1|||
16200452|NCT03700736|39211733|FG000|Overall Study|Withdrawal by Subject|2|||
16200453|NCT03700736|39211734|FG001|Overall Study|Withdrawal by Subject|6|||
16200454|NCT01182337|39211735|FG000|Overall Study|Withdrawal by Subject|3|||
16200455|NCT01182337|39211736|FG001|Overall Study|Withdrawal by Subject|1|||
16200456|NCT01182337|39211735|FG000|Overall Study|Lost to Follow-up|0|||
16512005|NCT03848845|40347469|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
16512006|NCT03848845|40347470|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
16512007|NCT03848845|40347471|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
16200457|NCT01182337|39211736|FG001|Overall Study|Lost to Follow-up|1|||
16200458|NCT00084929|39211737|FG000|Overall Study|ineligible - medical contraindication|1|||
16200459|NCT00084929|39211737|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
16200460|NCT00084929|39211737|FG000|Overall Study|Ineligible - Medical history|6|||
16200461|NCT00084929|39211737|FG000|Overall Study|Withdrawal by Subject|10|||
16200462|NCT00084929|39211737|FG000|Overall Study|Missing/incomplete CTC exam|9|||
16200463|NCT00084929|39211737|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
16200464|NCT00997321|39211738|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
16200465|NCT00997321|39211739|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
16200466|NCT04046341|39211740|FG000|Overall Study|Lost to Follow-up|2|||
16200467|NCT04046341|39211740|FG000|Overall Study|Withdrawal by Subject|1|||
16200468|NCT05425719|39211741|FG000|Overall Study|Lost to Follow-up|4|||
16200469|NCT05425719|39211742|FG001|Overall Study|Lost to Follow-up|0|||
16200470|NCT05425719|39211741|FG000|Overall Study|Withdrew consent|1|||
16200471|NCT05425719|39211742|FG001|Overall Study|Withdrew consent|1|||
16200472|NCT02671461|39211754|FG000|Treatment|Adverse Event|0|||
16200473|NCT02671461|39211755|FG001|Treatment|Adverse Event|0|||
16200474|NCT02671461|39211756|FG002|Treatment|Adverse Event|1|||
16200475|NCT02671461|39211754|FG000|Treatment|Administrative Reason by Sponsor|1|||
16200476|NCT02671461|39211755|FG001|Treatment|Administrative Reason by Sponsor|3|||
16200477|NCT02671461|39211756|FG002|Treatment|Administrative Reason by Sponsor|4|||
16200478|NCT02671461|39211754|FG000|Treatment|Randomized, not treated|1|||
16200479|NCT02671461|39211755|FG001|Treatment|Randomized, not treated|0|||
16200480|NCT02671461|39211756|FG002|Treatment|Randomized, not treated|0|||
16200481|NCT02671461|39211754|FG000|Follow-up|Withdrawal by Subject|1|||
16200482|NCT02671461|39211755|FG001|Follow-up|Withdrawal by Subject|0|||
16200483|NCT02671461|39211756|FG002|Follow-up|Withdrawal by Subject|0|||
16200484|NCT02671461|39211754|FG000|Follow-up|Lost to Follow-up|0|||
16200485|NCT02671461|39211755|FG001|Follow-up|Lost to Follow-up|0|||
16200486|NCT02671461|39211756|FG002|Follow-up|Lost to Follow-up|1|||
16200487|NCT02671461|39211754|FG000|Follow-up|Administrative Reason by Sponsor|0|||
16200488|NCT02671461|39211755|FG001|Follow-up|Administrative Reason by Sponsor|1|||
16200489|NCT02671461|39211756|FG002|Follow-up|Administrative Reason by Sponsor|0|||
16200490|NCT01106625|39211757|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
16200491|NCT01106625|39211758|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
16200492|NCT01106625|39211759|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
16200493|NCT01106625|39211757|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
16200494|NCT01106625|39211758|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
16200495|NCT01106625|39211759|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
16200496|NCT01106625|39211757|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
16200497|NCT01106625|39211758|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
16200498|NCT01106625|39211759|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
16200499|NCT01106625|39211757|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
16200500|NCT01106625|39211758|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
16200501|NCT01106625|39211759|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
16200502|NCT01106625|39211757|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
16200503|NCT01106625|39211758|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
16200504|NCT01106625|39211759|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
16200505|NCT01106625|39211757|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
16200506|NCT01106625|39211758|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
16200507|NCT01106625|39211759|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16200508|NCT01106625|39211757|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
16200509|NCT01106625|39211758|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
16200510|NCT01106625|39211759|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
16200511|NCT01106625|39211757|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
16200512|NCT01106625|39211758|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
16317407|NCT01962103|39644711|FG006|Phase 1|Progressive Disease|0|||
16512008|NCT03848845|40347468|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
16200513|NCT01106625|39211759|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16200514|NCT01106625|39211757|FG000|Core Period: Baseline to Week 26|Other|8|||
16317408|NCT01962103|39644712|FG007|Phase 1|Progressive Disease|0|||
16317409|NCT01962103|39644713|FG008|Phase 1|Progressive Disease|0|||
16200515|NCT01106625|39211758|FG001|Core Period: Baseline to Week 26|Other|7|||
16200516|NCT01106625|39211759|FG002|Core Period: Baseline to Week 26|Other|4|||
16200517|NCT01106625|39211757|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
16200518|NCT01106625|39211758|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
16200519|NCT01106625|39211759|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
16200520|NCT01106625|39211757|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
16200521|NCT01106625|39211758|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
16200522|NCT01106625|39211759|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
16200523|NCT01106625|39211757|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
16200524|NCT01106625|39211758|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16200525|NCT01106625|39211759|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
16200526|NCT01106625|39211757|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16200527|NCT01106625|39211758|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
16200528|NCT01106625|39211759|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16200529|NCT01106625|39211757|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
16200530|NCT01106625|39211758|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16200531|NCT01106625|39211759|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16200532|NCT01106625|39211757|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
16200533|NCT01106625|39211758|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
16200534|NCT01106625|39211759|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
16317410|NCT01962103|39644705|FG000|Phase 1|Withdrawal by Subject|0|||
16317411|NCT01962103|39644706|FG001|Phase 1|Withdrawal by Subject|0|||
16317412|NCT01962103|39644707|FG002|Phase 1|Withdrawal by Subject|0|||
16317413|NCT01962103|39644708|FG003|Phase 1|Withdrawal by Subject|2|||
16317414|NCT01962103|39644709|FG004|Phase 1|Withdrawal by Subject|0|||
16317415|NCT01962103|39644710|FG005|Phase 1|Withdrawal by Subject|0|||
16317416|NCT01962103|39644711|FG006|Phase 1|Withdrawal by Subject|0|||
16317417|NCT01962103|39644712|FG007|Phase 1|Withdrawal by Subject|0|||
16317418|NCT01962103|39644713|FG008|Phase 1|Withdrawal by Subject|0|||
16317419|NCT01962103|39644705|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
16317420|NCT01962103|39644706|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
16317421|NCT01962103|39644707|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
16317422|NCT01962103|39644708|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
16317423|NCT01962103|39644709|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
16317424|NCT01962103|39644710|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
16317425|NCT01962103|39644711|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
16317426|NCT01962103|39644712|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
16317427|NCT01962103|39644713|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
16317428|NCT01962103|39644705|FG000|Phase 1|Physician Decision|0|||
16317429|NCT01962103|39644706|FG001|Phase 1|Physician Decision|0|||
16317430|NCT01962103|39644707|FG002|Phase 1|Physician Decision|0|||
16317431|NCT01962103|39644708|FG003|Phase 1|Physician Decision|1|||
16317432|NCT01962103|39644709|FG004|Phase 1|Physician Decision|0|||
16317433|NCT01962103|39644710|FG005|Phase 1|Physician Decision|0|||
16317434|NCT01962103|39644711|FG006|Phase 1|Physician Decision|0|||
16317435|NCT01962103|39644712|FG007|Phase 1|Physician Decision|0|||
16317436|NCT01962103|39644713|FG008|Phase 1|Physician Decision|0|||
16317437|NCT01962103|39644705|FG000|Phase 1|Symptomatic Deterioration|3|||
16317438|NCT01962103|39644706|FG001|Phase 1|Symptomatic Deterioration|2|||
16317439|NCT01962103|39644707|FG002|Phase 1|Symptomatic Deterioration|2|||
16317440|NCT01962103|39644708|FG003|Phase 1|Symptomatic Deterioration|2|||
16317441|NCT01962103|39644709|FG004|Phase 1|Symptomatic Deterioration|1|||
16200535|NCT01106625|39211757|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
16200536|NCT01106625|39211758|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
16200537|NCT01106625|39211759|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
16200538|NCT01106625|39211757|FG000|Extension Period: Week 26 to Week 52|Other|5|||
16200539|NCT01106625|39211758|FG001|Extension Period: Week 26 to Week 52|Other|5|||
16317442|NCT01962103|39644710|FG005|Phase 1|Symptomatic Deterioration|1|||
16317443|NCT01962103|39644711|FG006|Phase 1|Symptomatic Deterioration|0|||
16317444|NCT01962103|39644712|FG007|Phase 1|Symptomatic Deterioration|0|||
16317445|NCT01962103|39644713|FG008|Phase 1|Symptomatic Deterioration|0|||
16317446|NCT01962103|39644705|FG000|Phase 1|Miscellaneous|1|||
16317447|NCT01962103|39644706|FG001|Phase 1|Miscellaneous|0|||
16317448|NCT01962103|39644707|FG002|Phase 1|Miscellaneous|0|||
16317449|NCT01962103|39644708|FG003|Phase 1|Miscellaneous|0|||
16317450|NCT01962103|39644709|FG004|Phase 1|Miscellaneous|0|||
16317451|NCT01962103|39644710|FG005|Phase 1|Miscellaneous|0|||
16317452|NCT01962103|39644711|FG006|Phase 1|Miscellaneous|0|||
16317453|NCT01962103|39644712|FG007|Phase 1|Miscellaneous|0|||
16317454|NCT01962103|39644713|FG008|Phase 1|Miscellaneous|0|||
16317455|NCT01962103|39644705|FG000|Phase 2|Adverse Event|0|||
16317456|NCT01962103|39644706|FG001|Phase 2|Adverse Event|0|||
16200540|NCT01106625|39211759|FG002|Extension Period: Week 26 to Week 52|Other|4|||
16200541|NCT03627494|39211760|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
16200542|NCT03627494|39211761|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
16200543|NCT03627494|39211762|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
16200544|NCT03627494|39211763|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
16200545|NCT03627494|39211764|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
16200546|NCT03627494|39211765|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
16200547|NCT03627494|39211766|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
16200548|NCT03627494|39211767|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
16200549|NCT03627494|39211768|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
16200550|NCT03627494|39211769|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
16200551|NCT03627494|39211770|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
16200552|NCT03627494|39211771|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
16200553|NCT03627494|39211760|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
16200554|NCT03627494|39211761|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
16200555|NCT03627494|39211762|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
16200556|NCT03627494|39211763|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
16200557|NCT03627494|39211764|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
16200558|NCT03627494|39211765|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
16200559|NCT03627494|39211766|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
16200560|NCT03627494|39211767|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
16512009|NCT03848845|40347469|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
16512010|NCT03848845|40347470|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
16512011|NCT03848845|40347471|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
16512012|NCT03848845|40347468|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
16512013|NCT03848845|40347469|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
16512014|NCT03848845|40347470|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
16512015|NCT03848845|40347471|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
16512016|NCT03848845|40347468|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
16512017|NCT03848845|40347469|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
16512018|NCT03848845|40347470|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
16512019|NCT03848845|40347471|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
16512020|NCT02418468|40347473|FG000|Overall Study|Adverse Event|1|||
16512021|NCT02418468|40347474|FG001|Overall Study|Adverse Event|0|||
16512022|NCT02418468|40347473|FG000|Overall Study|Withdrawal of informed consent|1|||
16512023|NCT02418468|40347474|FG001|Overall Study|Withdrawal of informed consent|1|||
16512024|NCT00086580|40347475|FG000|Treatment Period|Disease progression|9|||
16512025|NCT00086580|40347476|FG001|Treatment Period|Disease progression|8|||
16512026|NCT00086580|40347475|FG000|Treatment Period|Unable to comply with protocol|3|||
16512027|NCT00086580|40347476|FG001|Treatment Period|Unable to comply with protocol|1|||
16512028|NCT00086580|40347475|FG000|Treatment Period|Withdrawal by Subject|7|||
16512029|NCT00086580|40347476|FG001|Treatment Period|Withdrawal by Subject|8|||
16200561|NCT03627494|39211768|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
16200562|NCT03627494|39211769|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
16200563|NCT03627494|39211770|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
16200564|NCT03627494|39211771|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
16200565|NCT03627494|39211760|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
16200566|NCT03627494|39211761|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
16200567|NCT03627494|39211762|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
16200568|NCT03627494|39211763|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
16200569|NCT03627494|39211764|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
16200570|NCT03627494|39211765|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
16317457|NCT01962103|39644707|FG002|Phase 2|Adverse Event|0|||
16317458|NCT01962103|39644708|FG003|Phase 2|Adverse Event|0|||
16317459|NCT01962103|39644709|FG004|Phase 2|Adverse Event|0|||
16317460|NCT01962103|39644710|FG005|Phase 2|Adverse Event|0|||
16317461|NCT01962103|39644711|FG006|Phase 2|Adverse Event|1|||
16317462|NCT01962103|39644712|FG007|Phase 2|Adverse Event|0|||
16317463|NCT01962103|39644713|FG008|Phase 2|Adverse Event|3|||
16317464|NCT01962103|39644705|FG000|Phase 2|Progressive Disease|0|||
16317465|NCT01962103|39644706|FG001|Phase 2|Progressive Disease|0|||
16317466|NCT01962103|39644707|FG002|Phase 2|Progressive Disease|0|||
16317467|NCT01962103|39644708|FG003|Phase 2|Progressive Disease|0|||
16317468|NCT01962103|39644709|FG004|Phase 2|Progressive Disease|0|||
16317469|NCT01962103|39644710|FG005|Phase 2|Progressive Disease|0|||
16317470|NCT01962103|39644711|FG006|Phase 2|Progressive Disease|11|||
16317471|NCT01962103|39644712|FG007|Phase 2|Progressive Disease|12|||
16317472|NCT01962103|39644713|FG008|Phase 2|Progressive Disease|11|||
16317473|NCT01962103|39644705|FG000|Phase 2|Symptomatic Deterioration|0|||
16317474|NCT01962103|39644706|FG001|Phase 2|Symptomatic Deterioration|0|||
16317475|NCT01962103|39644707|FG002|Phase 2|Symptomatic Deterioration|0|||
16317476|NCT01962103|39644708|FG003|Phase 2|Symptomatic Deterioration|0|||
16317477|NCT01962103|39644709|FG004|Phase 2|Symptomatic Deterioration|0|||
16317478|NCT01962103|39644710|FG005|Phase 2|Symptomatic Deterioration|0|||
16317479|NCT01962103|39644711|FG006|Phase 2|Symptomatic Deterioration|2|||
16317480|NCT01962103|39644712|FG007|Phase 2|Symptomatic Deterioration|2|||
16317481|NCT01962103|39644713|FG008|Phase 2|Symptomatic Deterioration|0|||
16317482|NCT00793871|39644729|FG000|Overall Study|Death|50|||
16317483|NCT00793871|39644729|FG000|Overall Study|Lost to Follow-up|3|||
16317484|NCT00793871|39644729|FG000|Overall Study|Study terminated by the Sponsor|7|||
16317485|NCT00595920|39644730|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
16317486|NCT03493854|39644731|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
16317487|NCT03493854|39644732|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
16317488|NCT03493854|39644731|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
16317489|NCT03493854|39644732|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
16317490|NCT03493854|39644731|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
16317491|NCT03493854|39644732|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
16317492|NCT03493854|39644731|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
16317493|NCT03493854|39644732|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
16317494|NCT03493854|39644731|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
16317495|NCT03493854|39644732|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
16317496|NCT03493854|39644731|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
16317497|NCT03493854|39644732|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
16317498|NCT03493854|39644731|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
16317499|NCT03493854|39644732|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
16317500|NCT03493854|39644731|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
16317501|NCT03493854|39644732|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
16317502|NCT03493854|39644731|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
16317503|NCT03493854|39644732|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
16317504|NCT03493854|39644731|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
16317505|NCT03493854|39644732|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
16317506|NCT03493854|39644731|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
16317507|NCT03493854|39644732|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
16317508|NCT03493854|39644731|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
16317509|NCT03493854|39644732|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
16393316|NCT01194219|39922243|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
16512030|NCT00086580|40347475|FG000|Treatment Period|Physician Decision|13|||
16512031|NCT00086580|40347476|FG001|Treatment Period|Physician Decision|7|||
16512032|NCT00086580|40347475|FG000|Treatment Period|AE - not treatment related|7|||
16512033|NCT00086580|40347476|FG001|Treatment Period|AE - not treatment related|7|||
16512034|NCT00086580|40347475|FG000|Treatment Period|Toxicity - treatment related|15|||
16512035|NCT00086580|40347476|FG001|Treatment Period|Toxicity - treatment related|15|||
16317510|NCT03493854|39644731|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
16317511|NCT03493854|39644732|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
16317512|NCT03493854|39644731|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
16317513|NCT03493854|39644732|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
16317514|NCT03493854|39644731|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
16317515|NCT03493854|39644732|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
16317516|NCT03493854|39644731|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
16317517|NCT03493854|39644732|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
16317518|NCT03493854|39644731|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
16317519|NCT03493854|39644732|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
16317520|NCT03493854|39644731|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
16317521|NCT03493854|39644732|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
16317522|NCT02097745|39644733|FG000|Overall Study|Adverse Event|25|||
16317523|NCT02097745|39644733|FG000|Overall Study|Death|16|||
16317524|NCT02097745|39644733|FG000|Overall Study|Failure to Return|14|||
16317525|NCT02097745|39644733|FG000|Overall Study|Administrative/Other|27|||
16317526|NCT02097745|39644733|FG000|Overall Study|Reason Not Specified|96|||
16317527|NCT00420420|39644736|FG000|Overall Study|Adverse Event|5|||
16317528|NCT00420420|39644737|FG001|Overall Study|Adverse Event|3|||
16317529|NCT00420420|39644736|FG000|Overall Study|Protocol Violation|1|||
16317530|NCT00420420|39644737|FG001|Overall Study|Protocol Violation|1|||
16317531|NCT00420420|39644736|FG000|Overall Study|Withdrawal by Subject|1|||
16317532|NCT00420420|39644737|FG001|Overall Study|Withdrawal by Subject|0|||
16317533|NCT00420420|39644736|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
16317534|NCT00420420|39644737|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
16317535|NCT03735498|39644738|FG000|Overall Study|Withdrawal by Subject|5|||
16317536|NCT03735498|39644738|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
16317537|NCT02861807|39644739|FG000|Overall Study|Lost to Follow-up|7|||
16317538|NCT02861807|39644740|FG001|Overall Study|Lost to Follow-up|6|||
16317539|NCT02861807|39644739|FG000|Overall Study|Withdrawal by Subject|5|||
16317540|NCT02861807|39644740|FG001|Overall Study|Withdrawal by Subject|8|||
16317541|NCT00077207|39644741|FG000|Overall Study|Adverse Event|5|||
16317542|NCT00077207|39644741|FG000|Overall Study|Lack of Efficacy|12|||
16317543|NCT00077207|39644741|FG000|Overall Study|Physician Decision|6|||
16317544|NCT00077207|39644741|FG000|Overall Study|Withdrawal by Subject|6|||
16317545|NCT00077207|39644741|FG000|Overall Study|Ineligible|1|||
16317546|NCT02522884|39644742|FG000|Overall Study|Withdrawal by Subject|6|||
16317547|NCT02522884|39644742|FG000|Overall Study|Death|3|||
16317548|NCT02522884|39644742|FG000|Overall Study|Missed 12-month Follow-up|9|||
16317549|NCT00961350|39644745|FG000|Overall Study|Adverse Event|18|||
16317550|NCT00961350|39644746|FG001|Overall Study|Adverse Event|33|||
16317551|NCT00961350|39644745|FG000|Overall Study|Withdrawal by Subject|10|||
16317552|NCT00961350|39644746|FG001|Overall Study|Withdrawal by Subject|10|||
16317553|NCT00961350|39644745|FG000|Overall Study|Lost to Follow-up|3|||
16317554|NCT00961350|39644746|FG001|Overall Study|Lost to Follow-up|3|||
16317555|NCT00961350|39644745|FG000|Overall Study|Misc|16|||
16317556|NCT00961350|39644746|FG001|Overall Study|Misc|21|||
16317557|NCT03376789|39644747|FG000|Overall Study|Withdrawal by Subject|3|||
16317558|NCT03376789|39644748|FG001|Overall Study|Withdrawal by Subject|5|||
16317559|NCT03376789|39644747|FG000|Overall Study|Protocol Violation|0|||
16317560|NCT03376789|39644748|FG001|Overall Study|Protocol Violation|1|||
16317561|NCT03376789|39644747|FG000|Overall Study|Adverse Event|0|||
16317562|NCT03376789|39644748|FG001|Overall Study|Adverse Event|1|||
16317563|NCT03376789|39644747|FG000|Overall Study|Lost to Follow-up|1|||
16317564|NCT03376789|39644748|FG001|Overall Study|Lost to Follow-up|1|||
16317565|NCT03376789|39644747|FG000|Overall Study|Per sponsor due to noncompliance|1|||
16317566|NCT03376789|39644748|FG001|Overall Study|Per sponsor due to noncompliance|0|||
16317567|NCT03376789|39644747|FG000|Overall Study|Subject off study medication|0|||
16317568|NCT03376789|39644748|FG001|Overall Study|Subject off study medication|1|||
16317569|NCT03103152|39644749|FG000|Overall Study|Physician Decision|5|||
16317570|NCT03103152|39644750|FG001|Overall Study|Physician Decision|2|||
16317571|NCT03103152|39644751|FG002|Overall Study|Physician Decision|6|||
16317572|NCT03103152|39644752|FG003|Overall Study|Physician Decision|3|||
16317573|NCT03103152|39644753|FG004|Overall Study|Physician Decision|3|||
16317574|NCT03103152|39644754|FG005|Overall Study|Physician Decision|1|||
16317575|NCT03103152|39644749|FG000|Overall Study|Protocol Violation|2|||
16317576|NCT03103152|39644750|FG001|Overall Study|Protocol Violation|2|||
16317577|NCT03103152|39644751|FG002|Overall Study|Protocol Violation|1|||
16317578|NCT03103152|39644752|FG003|Overall Study|Protocol Violation|2|||
16317579|NCT03103152|39644753|FG004|Overall Study|Protocol Violation|1|||
16393317|NCT01194219|39922244|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
16393318|NCT01194219|39922245|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
16393319|NCT01194219|39922246|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
16393320|NCT01194219|39922247|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
16393321|NCT01194219|39922248|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
16393322|NCT01194219|39922249|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
16393323|NCT01194219|39922240|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16393324|NCT01194219|39922241|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16317580|NCT03103152|39644754|FG005|Overall Study|Protocol Violation|1|||
16317581|NCT03103152|39644749|FG000|Overall Study|Inter-current illness|0|||
16317582|NCT03103152|39644750|FG001|Overall Study|Inter-current illness|0|||
16317583|NCT03103152|39644751|FG002|Overall Study|Inter-current illness|1|||
16317584|NCT03103152|39644752|FG003|Overall Study|Inter-current illness|0|||
16317585|NCT03103152|39644753|FG004|Overall Study|Inter-current illness|0|||
16317586|NCT03103152|39644754|FG005|Overall Study|Inter-current illness|0|||
16317587|NCT03103152|39644749|FG000|Overall Study|Death|0|||
16317588|NCT03103152|39644750|FG001|Overall Study|Death|1|||
16317589|NCT03103152|39644751|FG002|Overall Study|Death|0|||
16317590|NCT03103152|39644752|FG003|Overall Study|Death|0|||
16317591|NCT03103152|39644753|FG004|Overall Study|Death|0|||
16200571|NCT03627494|39211766|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
16200572|NCT03627494|39211767|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
16200573|NCT03627494|39211768|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
16200574|NCT03627494|39211769|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
16200575|NCT03627494|39211770|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
16200576|NCT03627494|39211771|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
16200577|NCT02505542|39211772|FG000|Part A: Open-Label Period|Adverse Event|31|||
16200578|NCT02505542|39211773|FG001|Part A: Open-Label Period|Adverse Event|0|||
16200579|NCT02505542|39211774|FG002|Part A: Open-Label Period|Adverse Event|0|||
16200580|NCT02505542|39211775|FG003|Part A: Open-Label Period|Adverse Event|0|||
16200581|NCT02505542|39211772|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
16200582|NCT02505542|39211773|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
16200583|NCT02505542|39211774|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
16317592|NCT03103152|39644754|FG005|Overall Study|Death|0|||
16317593|NCT03103152|39644749|FG000|Overall Study|Adverse Event|0|||
16317594|NCT03103152|39644750|FG001|Overall Study|Adverse Event|0|||
16317595|NCT03103152|39644751|FG002|Overall Study|Adverse Event|1|||
16317596|NCT03103152|39644752|FG003|Overall Study|Adverse Event|0|||
16317597|NCT03103152|39644753|FG004|Overall Study|Adverse Event|0|||
16317598|NCT03103152|39644754|FG005|Overall Study|Adverse Event|1|||
16317599|NCT03103152|39644749|FG000|Overall Study|Withdrawal by Subject|1|||
16317600|NCT03103152|39644750|FG001|Overall Study|Withdrawal by Subject|0|||
16317601|NCT03103152|39644751|FG002|Overall Study|Withdrawal by Subject|1|||
16317602|NCT03103152|39644752|FG003|Overall Study|Withdrawal by Subject|1|||
16317603|NCT03103152|39644753|FG004|Overall Study|Withdrawal by Subject|1|||
16317604|NCT03103152|39644754|FG005|Overall Study|Withdrawal by Subject|1|||
16317605|NCT03103152|39644749|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
16317606|NCT03103152|39644750|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
16317607|NCT03103152|39644751|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
16317608|NCT03103152|39644752|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
16317609|NCT03103152|39644753|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
16512036|NCT00086580|40347475|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
16512037|NCT00086580|40347476|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
16200584|NCT02505542|39211775|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
16200585|NCT02505542|39211772|FG000|Part A: Open-Label Period|Protocol Violation|1|||
16317610|NCT03103152|39644754|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
16317611|NCT03103152|39644749|FG000|Overall Study|Unacceptable side effects|0|||
16512038|NCT00086580|40347475|FG000|Treatment Period|Death|5|||
16512039|NCT00086580|40347476|FG001|Treatment Period|Death|7|||
16512040|NCT00086580|40347475|FG000|Treatment Period|Other|5|||
16512041|NCT00086580|40347476|FG001|Treatment Period|Other|3|||
16512042|NCT00086580|40347475|FG000|Follow-up Period|Disease progression|72|||
16512043|NCT00086580|40347476|FG001|Follow-up Period|Disease progression|99|||
16512044|NCT00086580|40347475|FG000|Follow-up Period|Unable to comply with protocol|5|||
16512045|NCT00086580|40347476|FG001|Follow-up Period|Unable to comply with protocol|0|||
16512046|NCT00086580|40347475|FG000|Follow-up Period|Withdrawal by Subject|6|||
16512047|NCT00086580|40347476|FG001|Follow-up Period|Withdrawal by Subject|6|||
16512048|NCT00086580|40347475|FG000|Follow-up Period|Physician Decision|0|||
16512049|NCT00086580|40347476|FG001|Follow-up Period|Physician Decision|1|||
16512050|NCT00086580|40347475|FG000|Follow-up Period|AE - not related|1|||
16512051|NCT00086580|40347476|FG001|Follow-up Period|AE - not related|0|||
16512052|NCT00086580|40347475|FG000|Follow-up Period|Death|13|||
16512053|NCT00086580|40347476|FG001|Follow-up Period|Death|7|||
16512054|NCT00086580|40347475|FG000|Follow-up Period|Other|7|||
16512055|NCT00086580|40347476|FG001|Follow-up Period|Other|6|||
16512056|NCT00086580|40347475|FG000|Observation Period|Unable to comply with protocol|1|||
16512057|NCT00086580|40347476|FG001|Observation Period|Unable to comply with protocol|1|||
16512058|NCT00086580|40347475|FG000|Observation Period|Withdrawal by Subject|4|||
16512059|NCT00086580|40347476|FG001|Observation Period|Withdrawal by Subject|2|||
16512060|NCT00086580|40347475|FG000|Observation Period|Death|33|||
16512061|NCT00086580|40347476|FG001|Observation Period|Death|55|||
16512062|NCT00086580|40347475|FG000|Observation Period|Other|8|||
16512063|NCT00086580|40347476|FG001|Observation Period|Other|7|||
16512064|NCT00834912|40347477|FG000|Treatment Period 1|Adverse Event|0|||
16512065|NCT00834912|40347478|FG001|Treatment Period 1|Adverse Event|1|||
16512066|NCT00834912|40347479|FG002|Treatment Period 1|Adverse Event|0|||
16512067|NCT00834912|40347480|FG003|Treatment Period 1|Adverse Event|1|||
16512068|NCT00834912|40347481|FG004|Treatment Period 1|Adverse Event|0|||
16512069|NCT00834912|40347482|FG005|Treatment Period 1|Adverse Event|0|||
16512070|NCT00834912|40347477|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16200586|NCT02505542|39211773|FG001|Part A: Open-Label Period|Protocol Violation|0|||
16317612|NCT03103152|39644750|FG001|Overall Study|Unacceptable side effects|0|||
16512071|NCT00834912|40347478|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16512072|NCT00834912|40347479|FG002|Treatment Period 2|Withdrawal by Subject|1|||
16512073|NCT00834912|40347480|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16512074|NCT00834912|40347481|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16317613|NCT03103152|39644751|FG002|Overall Study|Unacceptable side effects|0|||
16317614|NCT03103152|39644752|FG003|Overall Study|Unacceptable side effects|0|||
16317615|NCT03103152|39644753|FG004|Overall Study|Unacceptable side effects|0|||
16317616|NCT03103152|39644754|FG005|Overall Study|Unacceptable side effects|1|||
16317617|NCT03103152|39644749|FG000|Overall Study|Lost to Follow-up|0|||
16317618|NCT03103152|39644750|FG001|Overall Study|Lost to Follow-up|1|||
16317619|NCT03103152|39644751|FG002|Overall Study|Lost to Follow-up|0|||
16317620|NCT03103152|39644752|FG003|Overall Study|Lost to Follow-up|1|||
16317621|NCT03103152|39644753|FG004|Overall Study|Lost to Follow-up|0|||
16200587|NCT02505542|39211774|FG002|Part A: Open-Label Period|Protocol Violation|0|||
16200588|NCT02505542|39211775|FG003|Part A: Open-Label Period|Protocol Violation|0|||
16200589|NCT02505542|39211772|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
16200590|NCT02505542|39211773|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
16200591|NCT02505542|39211774|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
16200592|NCT02505542|39211775|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
16200593|NCT02505542|39211772|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
16200594|NCT02505542|39211773|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
16200595|NCT02505542|39211774|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
16200596|NCT02505542|39211775|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
16200597|NCT02505542|39211772|FG000|Part A: Open-Label Period|New medical history available|1|||
16200598|NCT02505542|39211773|FG001|Part A: Open-Label Period|New medical history available|0|||
16200599|NCT02505542|39211774|FG002|Part A: Open-Label Period|New medical history available|0|||
16200600|NCT02505542|39211775|FG003|Part A: Open-Label Period|New medical history available|0|||
16200601|NCT02505542|39211772|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
16200602|NCT02505542|39211773|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
16200603|NCT02505542|39211774|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
16200604|NCT02505542|39211775|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
16200605|NCT02505542|39211772|FG000|Part A: Open-Label Period|Pregnancy|2|||
16200606|NCT02505542|39211773|FG001|Part A: Open-Label Period|Pregnancy|0|||
16200607|NCT02505542|39211774|FG002|Part A: Open-Label Period|Pregnancy|0|||
16200608|NCT02505542|39211775|FG003|Part A: Open-Label Period|Pregnancy|0|||
16200609|NCT02505542|39211772|FG000|Part A: Open-Label Period|Sponsor directive|1|||
16200610|NCT02505542|39211773|FG001|Part A: Open-Label Period|Sponsor directive|0|||
16200611|NCT02505542|39211774|FG002|Part A: Open-Label Period|Sponsor directive|0|||
16200612|NCT02505542|39211775|FG003|Part A: Open-Label Period|Sponsor directive|0|||
16200613|NCT02505542|39211772|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
16200614|NCT02505542|39211773|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
16200615|NCT02505542|39211774|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
16200616|NCT02505542|39211775|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
16200617|NCT02505542|39211772|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
16200618|NCT02505542|39211773|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
16200619|NCT02505542|39211774|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
16200620|NCT02505542|39211775|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
16200621|NCT02505542|39211772|FG000|Part A: Open-Label Period|Non-compliance|1|||
16200622|NCT02505542|39211773|FG001|Part A: Open-Label Period|Non-compliance|0|||
16317622|NCT03103152|39644754|FG005|Overall Study|Lost to Follow-up|1|||
16317623|NCT03103152|39644749|FG000|Overall Study|Testicular pain|0|||
16317624|NCT03103152|39644750|FG001|Overall Study|Testicular pain|0|||
16200623|NCT02505542|39211774|FG002|Part A: Open-Label Period|Non-compliance|0|||
16200624|NCT02505542|39211775|FG003|Part A: Open-Label Period|Non-compliance|0|||
16200625|NCT02505542|39211772|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
16200626|NCT02505542|39211773|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
16200627|NCT02505542|39211774|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
16200628|NCT02505542|39211775|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
16200629|NCT02505542|39211772|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
16200630|NCT02505542|39211773|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
16200631|NCT02505542|39211774|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
16200632|NCT02505542|39211775|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
16200633|NCT02505542|39211772|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
16200634|NCT02505542|39211773|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
16200635|NCT02505542|39211774|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
16200636|NCT02505542|39211775|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
16200637|NCT02505542|39211772|FG000|Part B: Double-Blind Period|Adverse Event|0|||
16200638|NCT02505542|39211773|FG001|Part B: Double-Blind Period|Adverse Event|0|||
16200639|NCT02505542|39211774|FG002|Part B: Double-Blind Period|Adverse Event|1|||
16200640|NCT02505542|39211775|FG003|Part B: Double-Blind Period|Adverse Event|3|||
16200641|NCT02505542|39211772|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
16200642|NCT02505542|39211773|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
16200643|NCT02505542|39211774|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
16200644|NCT02505542|39211775|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
16200645|NCT02505542|39211772|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
16200646|NCT02505542|39211773|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
16200647|NCT02505542|39211774|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
16317625|NCT03103152|39644751|FG002|Overall Study|Testicular pain|0|||
16317626|NCT03103152|39644752|FG003|Overall Study|Testicular pain|1|||
16090070|NCT02392507|38820067|FG000|Induction Regimen|Withdrawal by Subject|2|||
16393325|NCT01194219|39922242|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16393326|NCT01194219|39922243|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16393327|NCT01194219|39922244|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16393328|NCT01194219|39922245|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16393329|NCT01194219|39922246|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16393330|NCT01194219|39922247|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
16393331|NCT01194219|39922248|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
16317627|NCT03103152|39644753|FG004|Overall Study|Testicular pain|0|||
16317628|NCT03103152|39644754|FG005|Overall Study|Testicular pain|0|||
16317629|NCT00824772|39644755|FG000|Overall Study|Withdrawal by Subject|8|||
16317630|NCT00455403|39644756|FG000|Overall Study|Lost to Follow-up|2|||
16317631|NCT00455403|39644757|FG001|Overall Study|Lost to Follow-up|1|||
16317632|NCT00455403|39644756|FG000|Overall Study|Withdrawal by Subject|1|||
16393332|NCT01194219|39922249|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
16393333|NCT01194219|39922240|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16393334|NCT01194219|39922241|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16393335|NCT01194219|39922242|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16393336|NCT01194219|39922243|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16393337|NCT01194219|39922244|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16393338|NCT01194219|39922245|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16393339|NCT01194219|39922246|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16393340|NCT01194219|39922247|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16393341|NCT01194219|39922248|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
16393342|NCT01194219|39922249|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
16200648|NCT02505542|39211775|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
16200649|NCT02505542|39211772|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
16317633|NCT00455403|39644757|FG001|Overall Study|Withdrawal by Subject|3|||
16317634|NCT00455403|39644756|FG000|Overall Study|Protocol Violation|0|||
16317635|NCT00455403|39644757|FG001|Overall Study|Protocol Violation|2|||
16317636|NCT03448419|39644758|FG000|Overall Study|Adverse Event|10|||
16317637|NCT03448419|39644759|FG001|Overall Study|Adverse Event|9|||
16317638|NCT03448419|39644758|FG000|Overall Study|Lost to Follow-up|0|||
16317639|NCT03448419|39644759|FG001|Overall Study|Lost to Follow-up|2|||
16317640|NCT03448419|39644758|FG000|Overall Study|Withdrawal by Subject|3|||
16317641|NCT03448419|39644759|FG001|Overall Study|Withdrawal by Subject|1|||
16317642|NCT03448419|39644758|FG000|Overall Study|Not treated|0|||
16317643|NCT03448419|39644759|FG001|Overall Study|Not treated|1|||
16317644|NCT03448419|39644758|FG000|Overall Study|Patient did not attend all visits|0|||
16317645|NCT03448419|39644759|FG001|Overall Study|Patient did not attend all visits|2|||
16317646|NCT03448419|39644758|FG000|Overall Study|Withdrawn by Sponsor|0|||
16317647|NCT03448419|39644759|FG001|Overall Study|Withdrawn by Sponsor|1|||
16317648|NCT04314037|39644763|FG000|Treatment Period 2|Adverse Event|1|||
16317649|NCT04314037|39644764|FG001|Treatment Period 2|Adverse Event|0|||
16317650|NCT04314037|39644763|FG000|Treatment Period 3|Protocol Violation|1|||
16317651|NCT04314037|39644764|FG001|Treatment Period 3|Protocol Violation|0|||
16317652|NCT04314037|39644763|FG000|Treatment Period 3|Adverse Event|0|||
16317653|NCT04314037|39644764|FG001|Treatment Period 3|Adverse Event|1|||
16317654|NCT03349060|39644765|FG000|Overall Study|Adverse Event|9|||
16317655|NCT03349060|39644766|FG001|Overall Study|Adverse Event|9|||
16317656|NCT03349060|39644767|FG002|Overall Study|Adverse Event|7|||
16317657|NCT03349060|39644765|FG000|Overall Study|Lack of Efficacy|1|||
16317658|NCT03349060|39644766|FG001|Overall Study|Lack of Efficacy|0|||
16317659|NCT03349060|39644767|FG002|Overall Study|Lack of Efficacy|2|||
16317660|NCT03349060|39644765|FG000|Overall Study|Lost to Follow-up|2|||
16317661|NCT03349060|39644766|FG001|Overall Study|Lost to Follow-up|1|||
16317662|NCT03349060|39644767|FG002|Overall Study|Lost to Follow-up|1|||
16317663|NCT03349060|39644765|FG000|Overall Study|Protocol Violation|2|||
16317664|NCT03349060|39644766|FG001|Overall Study|Protocol Violation|2|||
16393343|NCT01194219|39922240|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16512075|NCT00834912|40347482|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16512076|NCT01454726|40347484|FG000|Overall Study|Withdrawal by Subject|0|||
16512077|NCT01454726|40347485|FG001|Overall Study|Withdrawal by Subject|1|||
16512078|NCT02510794|40347486|FG000|Overall Study|Adverse Event|0|||
16512079|NCT02510794|40347487|FG001|Overall Study|Adverse Event|1|||
16512080|NCT02510794|40347488|FG002|Overall Study|Adverse Event|0|||
16512081|NCT02510794|40347489|FG003|Overall Study|Adverse Event|0|||
16512082|NCT02510794|40347486|FG000|Overall Study|Death|1|||
16512083|NCT02510794|40347487|FG001|Overall Study|Death|2|||
16512084|NCT02510794|40347488|FG002|Overall Study|Death|1|||
16317665|NCT03349060|39644767|FG002|Overall Study|Protocol Violation|1|||
16317666|NCT03349060|39644765|FG000|Overall Study|Withdrawal by Subject|5|||
16317667|NCT03349060|39644766|FG001|Overall Study|Withdrawal by Subject|3|||
16317668|NCT03349060|39644767|FG002|Overall Study|Withdrawal by Subject|4|||
16317669|NCT03349060|39644765|FG000|Overall Study|Medication error,no linked adverse event|0|||
16317670|NCT03349060|39644766|FG001|Overall Study|Medication error,no linked adverse event|0|||
16317671|NCT03349060|39644767|FG002|Overall Study|Medication error,no linked adverse event|1|||
16317672|NCT03349060|39644765|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
16317673|NCT03349060|39644766|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
16317674|NCT03349060|39644767|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
16317675|NCT03349060|39644765|FG000|Overall Study|Other|2|||
16317676|NCT03349060|39644766|FG001|Overall Study|Other|1|||
16317677|NCT03349060|39644767|FG002|Overall Study|Other|0|||
16317678|NCT00282113|39644768|FG000|Overall Study|Removed at parents request|1|||
16317679|NCT00282113|39644769|FG001|Overall Study|Removed at parents request|0|||
16317680|NCT00282113|39644770|FG002|Overall Study|Removed at parents request|0|||
16317681|NCT04227197|39644776|FG000|Randomization|Protocol Violation|1|||
16317682|NCT04227197|39644777|FG001|Randomization|Protocol Violation|0|||
16317683|NCT04227197|39644776|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
16317684|NCT04227197|39644777|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
16317685|NCT04227197|39644776|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
16317686|NCT04227197|39644777|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
16317687|NCT04227197|39644776|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
16317688|NCT04227197|39644777|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
16317689|NCT04227197|39644776|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
16317690|NCT04227197|39644777|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
16317691|NCT04227197|39644776|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
16317692|NCT04227197|39644777|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
16317693|NCT04227197|39644776|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
16317694|NCT04227197|39644777|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
16317695|NCT02569801|39644778|FG000|Overall Study|Withdrawal by Subject|9|||
16317696|NCT02569801|39644779|FG001|Overall Study|Withdrawal by Subject|9|||
16317697|NCT02569801|39644778|FG000|Overall Study|Sponsor Decision|13|||
16317698|NCT02569801|39644779|FG001|Overall Study|Sponsor Decision|14|||
16317699|NCT02569801|39644778|FG000|Overall Study|Progressive Disease|2|||
16317700|NCT02569801|39644779|FG001|Overall Study|Progressive Disease|7|||
16317701|NCT02569801|39644778|FG000|Overall Study|Lost to Follow-up|0|||
16317702|NCT02569801|39644779|FG001|Overall Study|Lost to Follow-up|1|||
16317703|NCT02569801|39644778|FG000|Overall Study|Death|12|||
16317704|NCT02569801|39644779|FG001|Overall Study|Death|4|||
16317705|NCT01973439|39644782|FG000|Overall Study|Lost samples from one PK Day|2|||
16317706|NCT01973439|39644782|FG000|Overall Study|Vomiting after commencing once daily|1|||
16317707|NCT01973439|39644782|FG000|Overall Study|PK curve incomplete|2|||
16317708|NCT00558701|39644783|FG000|Overall Study|Protocol Deviations|1|||
16317709|NCT00558701|39644784|FG001|Overall Study|Protocol Deviations|4|||
16317710|NCT01134107|39644788|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
16317711|NCT01134107|39644789|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
16317712|NCT01134107|39644788|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
16317713|NCT01134107|39644789|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
16317714|NCT01134107|39644788|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
16317715|NCT01134107|39644789|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
16317716|NCT01134107|39644788|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
16317717|NCT01134107|39644789|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
16317718|NCT01134107|39644788|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
16317719|NCT01134107|39644789|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
16317720|NCT01134107|39644788|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
16317721|NCT01134107|39644789|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
16317722|NCT01134107|39644788|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
16317723|NCT01134107|39644789|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
16317724|NCT00789373|39644792|FG000|Induction|Adverse Event|64|||
16317725|NCT00789373|39644793|FG001|Induction|Adverse Event|0|||
16317726|NCT00789373|39644794|FG002|Induction|Adverse Event|0|||
16317727|NCT00789373|39644792|FG000|Induction|Death Due to study disease|24|||
16317728|NCT00789373|39644793|FG001|Induction|Death Due to study disease|0|||
16317729|NCT00789373|39644794|FG002|Induction|Death Due to study disease|0|||
16317730|NCT00789373|39644792|FG000|Induction|Death due to adverse event|19|||
16512085|NCT02510794|40347489|FG003|Overall Study|Death|1|||
16317731|NCT00789373|39644793|FG001|Induction|Death due to adverse event|0|||
16317732|NCT00789373|39644794|FG002|Induction|Death due to adverse event|0|||
16317733|NCT00789373|39644792|FG000|Induction|Death due to toxicity|11|||
16317734|NCT00789373|39644793|FG001|Induction|Death due to toxicity|0|||
16317735|NCT00789373|39644794|FG002|Induction|Death due to toxicity|0|||
16317736|NCT00789373|39644792|FG000|Induction|Death due to procedure|1|||
16317737|NCT00789373|39644793|FG001|Induction|Death due to procedure|0|||
16317738|NCT00789373|39644794|FG002|Induction|Death due to procedure|0|||
16317739|NCT00789373|39644792|FG000|Induction|Investigator decision|7|||
16317740|NCT00789373|39644793|FG001|Induction|Investigator decision|0|||
16317741|NCT00789373|39644794|FG002|Induction|Investigator decision|0|||
16512086|NCT02510794|40347486|FG000|Overall Study|Lack of Efficacy|3|||
16317742|NCT00789373|39644792|FG000|Induction|Protocol entry criteria not met|9|||
16317743|NCT00789373|39644793|FG001|Induction|Protocol entry criteria not met|0|||
16317744|NCT00789373|39644794|FG002|Induction|Protocol entry criteria not met|0|||
16317745|NCT00789373|39644792|FG000|Induction|Lost to Follow-up|6|||
16317746|NCT00789373|39644793|FG001|Induction|Lost to Follow-up|0|||
16317747|NCT00789373|39644794|FG002|Induction|Lost to Follow-up|0|||
16317748|NCT00789373|39644792|FG000|Induction|Protocol Violation|1|||
16317749|NCT00789373|39644793|FG001|Induction|Protocol Violation|0|||
16317750|NCT00789373|39644794|FG002|Induction|Protocol Violation|0|||
16317751|NCT00789373|39644792|FG000|Induction|Progressive Disease|220|||
16317752|NCT00789373|39644793|FG001|Induction|Progressive Disease|0|||
16317753|NCT00789373|39644794|FG002|Induction|Progressive Disease|0|||
16317754|NCT00789373|39644792|FG000|Induction|Withdrawal by Subject|37|||
16317755|NCT00789373|39644793|FG001|Induction|Withdrawal by Subject|0|||
16317756|NCT00789373|39644794|FG002|Induction|Withdrawal by Subject|0|||
16317757|NCT00789373|39644792|FG000|Maintenance|Adverse Event|0|||
16317758|NCT00789373|39644793|FG001|Maintenance|Adverse Event|65|||
16317759|NCT00789373|39644794|FG002|Maintenance|Adverse Event|12|||
16317760|NCT00789373|39644792|FG000|Maintenance|Death due to study disease|0|||
16317761|NCT00789373|39644793|FG001|Maintenance|Death due to study disease|3|||
16317762|NCT00789373|39644794|FG002|Maintenance|Death due to study disease|1|||
16090071|NCT02392507|38820067|FG000|Maintenance Regimen|Death|1|||
16393344|NCT01194219|39922241|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16393345|NCT01194219|39922242|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16393346|NCT01194219|39922243|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16200650|NCT02505542|39211773|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
16200651|NCT02505542|39211774|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
16200652|NCT02505542|39211775|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
16200653|NCT02505542|39211772|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
16200654|NCT02505542|39211773|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
16200655|NCT02505542|39211774|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
16200656|NCT02505542|39211775|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
16200657|NCT02505542|39211772|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
16200658|NCT02505542|39211773|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
16200659|NCT02505542|39211774|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
16200660|NCT02505542|39211775|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
16393347|NCT01194219|39922244|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16393348|NCT01194219|39922245|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16393349|NCT01194219|39922246|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16393350|NCT01194219|39922247|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
16393351|NCT01194219|39922248|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
16393352|NCT01194219|39922249|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
16393353|NCT00658541|39922250|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
16393354|NCT00658541|39922251|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16393355|NCT00658541|39922250|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
16393356|NCT00658541|39922251|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16393357|NCT01393899|39922252|FG000|Overall Study|Study terminated by sponsor|1|||
16393358|NCT01393899|39922253|FG001|Overall Study|Study terminated by sponsor|0|||
16393359|NCT01393899|39922254|FG002|Overall Study|Study terminated by sponsor|1|||
16393360|NCT01393899|39922252|FG000|Overall Study|Other|1|||
16393361|NCT01393899|39922253|FG001|Overall Study|Other|0|||
16393362|NCT01393899|39922254|FG002|Overall Study|Other|0|||
16393363|NCT01393899|39922252|FG000|Overall Study|Withdrawal by Subject|2|||
16393364|NCT01393899|39922253|FG001|Overall Study|Withdrawal by Subject|2|||
16393365|NCT01393899|39922254|FG002|Overall Study|Withdrawal by Subject|1|||
16317763|NCT00789373|39644792|FG000|Maintenance|Death due to adverse event|0|||
16317764|NCT00789373|39644793|FG001|Maintenance|Death due to adverse event|4|||
16317765|NCT00789373|39644794|FG002|Maintenance|Death due to adverse event|1|||
16317766|NCT00789373|39644792|FG000|Maintenance|Death due to toxicity|0|||
16317767|NCT00789373|39644793|FG001|Maintenance|Death due to toxicity|1|||
16317768|NCT00789373|39644794|FG002|Maintenance|Death due to toxicity|2|||
16317769|NCT00789373|39644792|FG000|Maintenance|Investigator Decision|0|||
16317770|NCT00789373|39644793|FG001|Maintenance|Investigator Decision|4|||
16317771|NCT00789373|39644794|FG002|Maintenance|Investigator Decision|2|||
16317772|NCT00789373|39644792|FG000|Maintenance|Protocol entry criteria not met|0|||
16317773|NCT00789373|39644793|FG001|Maintenance|Protocol entry criteria not met|2|||
16317774|NCT00789373|39644794|FG002|Maintenance|Protocol entry criteria not met|0|||
16317775|NCT00789373|39644792|FG000|Maintenance|Lost to Follow-up|0|||
16317776|NCT00789373|39644793|FG001|Maintenance|Lost to Follow-up|2|||
16317777|NCT00789373|39644794|FG002|Maintenance|Lost to Follow-up|0|||
16200661|NCT02505542|39211772|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
16317778|NCT00789373|39644792|FG000|Maintenance|Progressive Disease|0|||
16317779|NCT00789373|39644793|FG001|Maintenance|Progressive Disease|253|||
16317780|NCT00789373|39644794|FG002|Maintenance|Progressive Disease|152|||
16393366|NCT01393899|39922252|FG000|Overall Study|Lost to Follow-up|0|||
16200662|NCT02505542|39211773|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
16200663|NCT02505542|39211774|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
16200664|NCT02505542|39211775|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
16200665|NCT02505542|39211772|FG000|Part B: Double-Blind Period|Miscalculation|0|||
16090072|NCT02392507|38820067|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
16090073|NCT01951703|38820068|FG000|First Intervention|Withdrawal by Subject|1|||
16090074|NCT01951703|38820069|FG001|First Intervention|Withdrawal by Subject|0|||
16090075|NCT01951703|38820068|FG000|First Intervention|Subject was not compliant|1|||
16090076|NCT01951703|38820069|FG001|First Intervention|Subject was not compliant|1|||
16090077|NCT01951703|38820068|FG000|First Intervention|Physician Decision|1|||
16090078|NCT01951703|38820069|FG001|First Intervention|Physician Decision|0|||
16090079|NCT01951703|38820068|FG000|Second Intervention|Protocol Violation|0|||
16090080|NCT01951703|38820069|FG001|Second Intervention|Protocol Violation|1|||
16090081|NCT01951703|38820068|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
16090082|NCT01951703|38820069|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
16090083|NCT03820024|38820079|FG000|Overall Study|Physician Decision|1|||
16090084|NCT03820024|38820080|FG001|Overall Study|Physician Decision|2|||
16200666|NCT02505542|39211773|FG001|Part B: Double-Blind Period|Miscalculation|1|||
16200667|NCT02505542|39211774|FG002|Part B: Double-Blind Period|Miscalculation|0|||
16200668|NCT02505542|39211775|FG003|Part B: Double-Blind Period|Miscalculation|0|||
16200669|NCT02505542|39211772|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
16200670|NCT02505542|39211773|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
16200671|NCT02505542|39211774|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
16200672|NCT02505542|39211775|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
16200673|NCT02849626|39211780|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
16200674|NCT02849626|39211781|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
16200675|NCT02849626|39211782|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
16200676|NCT02849626|39211783|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
16200677|NCT02849626|39211780|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
16200678|NCT02849626|39211781|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
16200679|NCT02849626|39211782|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
16200680|NCT02849626|39211783|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
16200681|NCT02849626|39211780|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
16200682|NCT02849626|39211781|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
16200683|NCT02849626|39211782|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
16200684|NCT02849626|39211783|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
16200685|NCT02849626|39211780|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
16200686|NCT02849626|39211781|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
16200687|NCT02849626|39211782|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
16200688|NCT02849626|39211783|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
16200689|NCT02849626|39211780|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
16200690|NCT02849626|39211781|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
16200691|NCT02849626|39211782|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
16200692|NCT02849626|39211783|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
16200693|NCT02849626|39211780|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
16200694|NCT02849626|39211781|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
16200695|NCT02849626|39211782|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
16200696|NCT02849626|39211783|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
16200697|NCT02849626|39211780|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
16200698|NCT02849626|39211781|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
16200699|NCT02849626|39211782|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
16200700|NCT02849626|39211783|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
16200701|NCT02849626|39211780|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
16317781|NCT00789373|39644792|FG000|Maintenance|Withdrawal by Subject|0|||
16317782|NCT00789373|39644793|FG001|Maintenance|Withdrawal by Subject|21|||
16317783|NCT00789373|39644794|FG002|Maintenance|Withdrawal by Subject|8|||
16317784|NCT00789373|39644792|FG000|Maintenance|Sponsor Decision|0|||
16512087|NCT02510794|40347487|FG001|Overall Study|Lack of Efficacy|1|||
16512088|NCT02510794|40347488|FG002|Overall Study|Lack of Efficacy|1|||
16512089|NCT02510794|40347489|FG003|Overall Study|Lack of Efficacy|0|||
16512090|NCT02510794|40347486|FG000|Overall Study|Participant moved out of the area|0|||
16317785|NCT00789373|39644793|FG001|Maintenance|Sponsor Decision|0|||
16317786|NCT00789373|39644794|FG002|Maintenance|Sponsor Decision|2|||
16317787|NCT00789373|39644792|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
16317788|NCT00789373|39644793|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
16512091|NCT02510794|40347487|FG001|Overall Study|Participant moved out of the area|0|||
16090085|NCT02706483|38820081|FG000|Overall Study|Adverse Event|97|||
16200702|NCT02849626|39211781|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
16200703|NCT02849626|39211782|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
16200704|NCT02849626|39211783|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
16512092|NCT02510794|40347488|FG002|Overall Study|Participant moved out of the area|0|||
16317789|NCT00789373|39644794|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
16317790|NCT01277601|39644797|FG000|Overall Study|Adverse Event|5|||
16317791|NCT01277601|39644798|FG001|Overall Study|Adverse Event|3|||
16317792|NCT01277601|39644799|FG002|Overall Study|Adverse Event|0|||
16317793|NCT01277601|39644800|FG003|Overall Study|Adverse Event|7|||
16317794|NCT01277601|39644797|FG000|Overall Study|Withdrawal by Subject|18|||
16317795|NCT01277601|39644798|FG001|Overall Study|Withdrawal by Subject|21|||
16317796|NCT01277601|39644799|FG002|Overall Study|Withdrawal by Subject|8|||
16317797|NCT01277601|39644800|FG003|Overall Study|Withdrawal by Subject|17|||
16317798|NCT01277601|39644797|FG000|Overall Study|Lost to Follow-up|7|||
16317799|NCT01277601|39644798|FG001|Overall Study|Lost to Follow-up|9|||
16317800|NCT01277601|39644799|FG002|Overall Study|Lost to Follow-up|4|||
16317801|NCT01277601|39644800|FG003|Overall Study|Lost to Follow-up|2|||
16317802|NCT01277601|39644797|FG000|Overall Study|Physician Decision|3|||
16317803|NCT01277601|39644798|FG001|Overall Study|Physician Decision|5|||
16317804|NCT01277601|39644799|FG002|Overall Study|Physician Decision|1|||
16317805|NCT01277601|39644800|FG003|Overall Study|Physician Decision|6|||
16317806|NCT01277601|39644797|FG000|Overall Study|Pregnancy|2|||
16317807|NCT01277601|39644798|FG001|Overall Study|Pregnancy|2|||
16317808|NCT01277601|39644799|FG002|Overall Study|Pregnancy|4|||
16317809|NCT01277601|39644800|FG003|Overall Study|Pregnancy|1|||
16317810|NCT01277601|39644797|FG000|Overall Study|Noncompliance with Study Drug|1|||
16317811|NCT01277601|39644798|FG001|Overall Study|Noncompliance with Study Drug|3|||
16317812|NCT01277601|39644799|FG002|Overall Study|Noncompliance with Study Drug|2|||
16317813|NCT01277601|39644800|FG003|Overall Study|Noncompliance with Study Drug|0|||
16317814|NCT01277601|39644797|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
16317815|NCT01277601|39644798|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
16317816|NCT01277601|39644799|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
16317817|NCT01277601|39644800|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
16317818|NCT01277601|39644797|FG000|Overall Study|Protocol Violation|0|||
16317819|NCT01277601|39644798|FG001|Overall Study|Protocol Violation|2|||
16512093|NCT02510794|40347489|FG003|Overall Study|Participant moved out of the area|1|||
16512094|NCT02510794|40347486|FG000|Overall Study|Physician Decision|3|||
16512095|NCT02510794|40347487|FG001|Overall Study|Physician Decision|0|||
16512096|NCT02510794|40347488|FG002|Overall Study|Physician Decision|0|||
16512097|NCT02510794|40347489|FG003|Overall Study|Physician Decision|0|||
16512098|NCT02510794|40347486|FG000|Overall Study|Protocol Violation|0|||
16512099|NCT02510794|40347487|FG001|Overall Study|Protocol Violation|0|||
16512100|NCT02510794|40347488|FG002|Overall Study|Protocol Violation|1|||
16512101|NCT02510794|40347489|FG003|Overall Study|Protocol Violation|0|||
16090086|NCT02706483|38820081|FG000|Overall Study|Death|1|||
16090087|NCT02706483|38820081|FG000|Overall Study|Lack of Efficacy|39|||
16090088|NCT02706483|38820081|FG000|Overall Study|Lost to Follow-up|101|||
16317820|NCT01277601|39644799|FG002|Overall Study|Protocol Violation|5|||
16317821|NCT01277601|39644800|FG003|Overall Study|Protocol Violation|0|||
16317822|NCT01277601|39644797|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
16317823|NCT01277601|39644798|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
16317824|NCT01277601|39644799|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
16317825|NCT01277601|39644800|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
16317826|NCT01591096|39648096|FG000|Overall Study|Adverse Event|1|||
16317827|NCT00171210|39648099|FG000|Overall Study|Adverse Event|16|||
16317828|NCT00171210|39648100|FG001|Overall Study|Adverse Event|27|||
16317829|NCT00171210|39648099|FG000|Overall Study|Abnormal laboratory value(s)|6|||
16317830|NCT00171210|39648100|FG001|Overall Study|Abnormal laboratory value(s)|3|||
16317831|NCT00171210|39648099|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16317832|NCT00171210|39648100|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16317833|NCT00171210|39648099|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
16317834|NCT00171210|39648100|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
16317835|NCT00171210|39648099|FG000|Overall Study|Protocol Violation|0|||
16317836|NCT00171210|39648100|FG001|Overall Study|Protocol Violation|2|||
16317837|NCT00171210|39648099|FG000|Overall Study|Withdrawal by Subject|32|||
16317838|NCT00171210|39648100|FG001|Overall Study|Withdrawal by Subject|30|||
16317839|NCT00171210|39648099|FG000|Overall Study|Lost to Follow-up|1|||
16317840|NCT00171210|39648100|FG001|Overall Study|Lost to Follow-up|0|||
16317841|NCT00171210|39648099|FG000|Overall Study|Administrative problems|1|||
16317842|NCT00171210|39648100|FG001|Overall Study|Administrative problems|1|||
16317843|NCT00171210|39648099|FG000|Overall Study|Death|2|||
16317844|NCT00171210|39648100|FG001|Overall Study|Death|3|||
16317845|NCT00171210|39648099|FG000|Overall Study|Stopped at end of core|0|||
16317846|NCT00171210|39648100|FG001|Overall Study|Stopped at end of core|32|||
16317847|NCT00171210|39648099|FG000|Overall Study|Stopped at end of extension 1|0|||
16393367|NCT01393899|39922253|FG001|Overall Study|Lost to Follow-up|0|||
16512102|NCT02510794|40347486|FG000|Overall Study|Withdrawal by Subject|1|||
16512103|NCT02510794|40347487|FG001|Overall Study|Withdrawal by Subject|2|||
16512104|NCT02510794|40347488|FG002|Overall Study|Withdrawal by Subject|4|||
16200705|NCT02849626|39211780|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
16200706|NCT02849626|39211781|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
16090089|NCT02706483|38820081|FG000|Overall Study|Non-compliance with study drug|15|||
16090090|NCT02706483|38820081|FG000|Overall Study|Physician Decision|6|||
16512105|NCT02510794|40347489|FG003|Overall Study|Withdrawal by Subject|3|||
16512106|NCT01302392|40347490|FG000|Overall Study|Lost to Follow-up|1|||
16512107|NCT01302392|40347491|FG001|Overall Study|Lost to Follow-up|0|||
16512108|NCT01302392|40347490|FG000|Overall Study|Withdrawal by Subject|6|||
16512109|NCT01302392|40347491|FG001|Overall Study|Withdrawal by Subject|1|||
16512110|NCT01572038|40347492|FG000|Overall Study|Death|648|||
16512111|NCT01572038|40347492|FG000|Overall Study|Withdrawal by Subject|204|||
16512112|NCT01572038|40347492|FG000|Overall Study|Lost to Follow-up|81|||
16512113|NCT01572038|40347492|FG000|Overall Study|Physician Decision|20|||
16090091|NCT02706483|38820081|FG000|Overall Study|Pregnancy|6|||
16090092|NCT02706483|38820081|FG000|Overall Study|Protocol Violation|18|||
16200707|NCT02849626|39211782|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
16200708|NCT02849626|39211783|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
16200709|NCT02849626|39211780|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
16200710|NCT02849626|39211781|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
16200711|NCT02849626|39211782|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
16200712|NCT02849626|39211783|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
16200713|NCT02849626|39211780|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
16200714|NCT02849626|39211781|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
16200715|NCT02849626|39211782|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
16200716|NCT02849626|39211783|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
16200717|NCT01973452|39211785|FG000|Overall Study|Lack of Efficacy|0|||
16200718|NCT01973452|39211786|FG001|Overall Study|Lack of Efficacy|1|||
16200719|NCT01973452|39211785|FG000|Overall Study|Lost to Follow-up|1|||
16200720|NCT01973452|39211786|FG001|Overall Study|Lost to Follow-up|0|||
16393368|NCT01393899|39922254|FG002|Overall Study|Lost to Follow-up|1|||
16393369|NCT01393899|39922252|FG000|Overall Study|Does not meet entrance criteria|1|||
16393370|NCT01393899|39922253|FG001|Overall Study|Does not meet entrance criteria|0|||
16393371|NCT01393899|39922254|FG002|Overall Study|Does not meet entrance criteria|1|||
16512114|NCT01572038|40347492|FG000|Overall Study|Patient Decision|14|||
16512115|NCT01572038|40347492|FG000|Overall Study|Progressive Disease|8|||
16512116|NCT01572038|40347492|FG000|Overall Study|Site Closed Before Completing Form|6|||
16512117|NCT01572038|40347492|FG000|Overall Study|Enrolled into Another Trial|3|||
16512118|NCT01572038|40347492|FG000|Overall Study|Participated in Another Trial|3|||
16512119|NCT01572038|40347492|FG000|Overall Study|Termination by Sponsor|2|||
16512120|NCT01572038|40347492|FG000|Overall Study|Patient Deterioration|1|||
16512121|NCT01572038|40347492|FG000|Overall Study|Sponsor Decision|1|||
16512122|NCT04187196|40347493|FG000|Overall Study|Screen Failure|2|||
16512123|NCT04187196|40347494|FG001|Overall Study|Screen Failure|0|||
16512124|NCT00684424|40347495|FG000|Overall Study|Adverse Event|1|||
16512125|NCT00684424|40347495|FG000|Overall Study|Lost to Follow-up|2|||
16090093|NCT02706483|38820081|FG000|Overall Study|Withdrawal by Subject|136|||
16200721|NCT01973452|39211785|FG000|Overall Study|Withdrawal by Subject|10|||
16200722|NCT01973452|39211786|FG001|Overall Study|Withdrawal by Subject|9|||
16512126|NCT00684424|40347495|FG000|Overall Study|Other|2|||
16512127|NCT04568122|40347498|FG000|Overall Study|Lost to Follow-up|48|||
16512128|NCT04568122|40347499|FG001|Overall Study|Lost to Follow-up|44|||
16200723|NCT01973452|39211785|FG000|Overall Study|Ineligible|1|||
16393372|NCT01393899|39922252|FG000|Overall Study|Lack of Efficacy|26|||
16393373|NCT01393899|39922253|FG001|Overall Study|Lack of Efficacy|21|||
16393374|NCT01393899|39922254|FG002|Overall Study|Lack of Efficacy|16|||
16393375|NCT01393899|39922252|FG000|Overall Study|Adverse Event|1|||
16393376|NCT01393899|39922253|FG001|Overall Study|Adverse Event|5|||
16393377|NCT01393899|39922254|FG002|Overall Study|Adverse Event|3|||
16512129|NCT04568122|40347500|FG002|Overall Study|Lost to Follow-up|4|||
16200724|NCT01973452|39211786|FG001|Overall Study|Ineligible|1|||
16200725|NCT01973452|39211785|FG000|Overall Study|Surgery canceled by participant|5|||
16200726|NCT01973452|39211786|FG001|Overall Study|Surgery canceled by participant|3|||
16200727|NCT00485589|39211788|FG000|Overall Study|Death|2|||
16200728|NCT00485589|39211789|FG001|Overall Study|Death|2|||
16393378|NCT02010593|39922255|FG000|Overall Study|Lost to Follow-up|1|||
16512130|NCT04568122|40347501|FG003|Overall Study|Lost to Follow-up|0|||
16512131|NCT04568122|40347502|FG004|Overall Study|Lost to Follow-up|0|||
16512132|NCT00989833|40347515|FG000|Overall Study|Lost to Follow-up|0|||
16512133|NCT00989833|40347516|FG001|Overall Study|Lost to Follow-up|1|||
16512134|NCT00989833|40347517|FG002|Overall Study|Lost to Follow-up|0|||
16512135|NCT00989833|40347515|FG000|Overall Study|Protocol Violation|1|||
16512136|NCT00989833|40347516|FG001|Overall Study|Protocol Violation|2|||
16512137|NCT00989833|40347517|FG002|Overall Study|Protocol Violation|1|||
16512138|NCT00989833|40347515|FG000|Overall Study|Withdrawal by Subject|0|||
16512139|NCT00989833|40347516|FG001|Overall Study|Withdrawal by Subject|0|||
16512140|NCT00989833|40347517|FG002|Overall Study|Withdrawal by Subject|1|||
16512141|NCT00989833|40347515|FG000|Overall Study|Incorrectly randomized|1|||
16512142|NCT00989833|40347516|FG001|Overall Study|Incorrectly randomized|0|||
16200729|NCT00485589|39211790|FG002|Overall Study|Death|0|||
16512143|NCT00989833|40347517|FG002|Overall Study|Incorrectly randomized|0|||
16512144|NCT01848990|40347518|FG000|Overall Study|Adverse Event|6|||
16512145|NCT01848990|40347519|FG001|Overall Study|Adverse Event|2|||
16200730|NCT00485589|39211788|FG000|Overall Study|Failure to return|6|||
16200731|NCT00485589|39211789|FG001|Overall Study|Failure to return|5|||
16200732|NCT00485589|39211790|FG002|Overall Study|Failure to return|1|||
16200733|NCT00485589|39211788|FG000|Overall Study|Protocol Violation|1|||
16512146|NCT01848990|40347520|FG002|Overall Study|Adverse Event|0|||
16512147|NCT01848990|40347518|FG000|Overall Study|Lost to Follow-up|6|||
16512148|NCT01848990|40347519|FG001|Overall Study|Lost to Follow-up|2|||
16200734|NCT00485589|39211789|FG001|Overall Study|Protocol Violation|0|||
16200735|NCT00485589|39211790|FG002|Overall Study|Protocol Violation|0|||
16200736|NCT00485589|39211788|FG000|Overall Study|Violation of selection criteria at entry|0|||
16200737|NCT00485589|39211789|FG001|Overall Study|Violation of selection criteria at entry|3|||
16200738|NCT00485589|39211790|FG002|Overall Study|Violation of selection criteria at entry|1|||
16200739|NCT00485589|39211788|FG000|Overall Study|Administrative/Other|1|||
16200740|NCT00485589|39211789|FG001|Overall Study|Administrative/Other|2|||
16200741|NCT00485589|39211790|FG002|Overall Study|Administrative/Other|1|||
16200742|NCT00485589|39211788|FG000|Overall Study|Insufficient therapeutic response|10|||
16200743|NCT00485589|39211789|FG001|Overall Study|Insufficient therapeutic response|3|||
16200744|NCT00485589|39211790|FG002|Overall Study|Insufficient therapeutic response|1|||
16200745|NCT00485589|39211788|FG000|Overall Study|Refused treatment/did not cooperate|1|||
16200746|NCT00485589|39211789|FG001|Overall Study|Refused treatment/did not cooperate|0|||
16200747|NCT00485589|39211790|FG002|Overall Study|Refused treatment/did not cooperate|2|||
16200748|NCT00485589|39211788|FG000|Overall Study|Withdrawal by Subject|3|||
16200749|NCT00485589|39211789|FG001|Overall Study|Withdrawal by Subject|2|||
16200750|NCT00485589|39211790|FG002|Overall Study|Withdrawal by Subject|2|||
16200751|NCT00485589|39211788|FG000|Overall Study|Adverse Event|3|||
16200752|NCT00485589|39211789|FG001|Overall Study|Adverse Event|3|||
16200753|NCT00485589|39211790|FG002|Overall Study|Adverse Event|10|||
16200754|NCT00225147|39211791|FG000|Open-label Phase|Lost to Follow-up|0|||
16200755|NCT00225147|39211792|FG001|Open-label Phase|Lost to Follow-up|0|||
16200756|NCT00225147|39211793|FG002|Open-label Phase|Lost to Follow-up|0|||
16200757|NCT00225147|39211794|FG003|Open-label Phase|Lost to Follow-up|4|||
16200758|NCT00225147|39211791|FG000|Open-label Phase|Withdrawal by Subject|0|||
16200759|NCT00225147|39211792|FG001|Open-label Phase|Withdrawal by Subject|0|||
16200760|NCT00225147|39211793|FG002|Open-label Phase|Withdrawal by Subject|0|||
16200761|NCT00225147|39211794|FG003|Open-label Phase|Withdrawal by Subject|6|||
16200762|NCT01030458|39211795|FG000|Overall Study|Lost to Follow-up|9|||
16200763|NCT01030458|39211796|FG001|Overall Study|Lost to Follow-up|10|||
16200764|NCT01030458|39211795|FG000|Overall Study|Withdrawal by Subject|2|||
16393379|NCT02010593|39922256|FG001|Overall Study|Lost to Follow-up|0|||
16512149|NCT01848990|40347520|FG002|Overall Study|Lost to Follow-up|2|||
16512150|NCT01848990|40347518|FG000|Overall Study|Protocol Violation|1|||
16512151|NCT01848990|40347519|FG001|Overall Study|Protocol Violation|1|||
16512152|NCT01848990|40347520|FG002|Overall Study|Protocol Violation|0|||
16512153|NCT01848990|40347518|FG000|Overall Study|Withdrawal by Subject|29|||
16512154|NCT01848990|40347519|FG001|Overall Study|Withdrawal by Subject|10|||
16512155|NCT01848990|40347520|FG002|Overall Study|Withdrawal by Subject|11|||
16200765|NCT01030458|39211796|FG001|Overall Study|Withdrawal by Subject|3|||
16200766|NCT01030458|39211795|FG000|Overall Study|Logistical reasons|9|||
16200767|NCT01030458|39211796|FG001|Overall Study|Logistical reasons|5|||
16200768|NCT01030458|39211795|FG000|Overall Study|Moved or changed job|6|||
16200769|NCT01030458|39211796|FG001|Overall Study|Moved or changed job|13|||
16512156|NCT01848990|40347518|FG000|Overall Study|Physician Decision|1|||
16512157|NCT01848990|40347519|FG001|Overall Study|Physician Decision|1|||
16512158|NCT01848990|40347520|FG002|Overall Study|Physician Decision|0|||
16512159|NCT01848990|40347518|FG000|Overall Study|Non Compliance|1|||
16512160|NCT01848990|40347519|FG001|Overall Study|Non Compliance|0|||
16090094|NCT02706483|38820081|FG000|Overall Study|Non-compliance with visits|6|||
16090095|NCT02706483|38820081|FG000|Overall Study|Site closure|4|||
16090096|NCT02706483|38820081|FG000|Overall Study|Subject moved|1|||
16090097|NCT03652610|38820087|FG000|Overall Study|Lost to Follow-up|1|||
16512161|NCT01848990|40347520|FG002|Overall Study|Non Compliance|0|||
16512162|NCT01848990|40347518|FG000|Overall Study|Death|1|||
16512163|NCT01848990|40347519|FG001|Overall Study|Death|0|||
16512164|NCT01848990|40347520|FG002|Overall Study|Death|1|||
16512165|NCT01848990|40347518|FG000|Overall Study|Other|1|||
16512166|NCT01848990|40347519|FG001|Overall Study|Other|4|||
16512167|NCT01848990|40347520|FG002|Overall Study|Other|2|||
16512168|NCT00101101|40347521|FG000|Overall Study|never received vaccine|20|||
16512169|NCT01192152|40347523|FG000|Period 1|left prematurely (while on treatment B)|0|||
16090098|NCT03652610|38820088|FG001|Overall Study|Lost to Follow-up|0|||
16090099|NCT03652610|38820087|FG000|Overall Study|Withdrawal by Subject|3|||
16090100|NCT03652610|38820088|FG001|Overall Study|Withdrawal by Subject|5|||
16317848|NCT00171210|39648100|FG001|Overall Study|Stopped at end of extension 1|1|||
16317849|NCT02684097|39648104|FG000|Overall Study|Lack of Efficacy|13|||
16317850|NCT02684097|39648105|FG001|Overall Study|Lack of Efficacy|6|||
16317851|NCT04478695|39648116|FG000|Overall Study|Death|1|||
16090101|NCT01536704|38820089|FG000|Washout Period 1|Withdrawal by Subject|1|||
16090102|NCT01536704|38820090|FG001|Washout Period 1|Withdrawal by Subject|2|||
16090103|NCT01536704|38820091|FG002|Washout Period 1|Withdrawal by Subject|0|||
16200770|NCT01030458|39211795|FG000|Overall Study|Side effect of medication|1|||
16317852|NCT04478695|39648117|FG001|Overall Study|Death|0|||
16317853|NCT02968173|39648120|FG000|Overall Study|Withdrawal by Subject|1|||
16317854|NCT02572570|39648121|FG000|Overall Study|Study Terminated|27|||
16317855|NCT02887183|39648130|FG000|Overall Study|Adverse Event|44|||
16317856|NCT02887183|39648130|FG000|Overall Study|Death|30|||
16317857|NCT02887183|39648130|FG000|Overall Study|Pregnancy|1|||
16317858|NCT02887183|39648130|FG000|Overall Study|Protocol Violation|6|||
16317859|NCT02887183|39648130|FG000|Overall Study|Technical Problems|2|||
16317860|NCT02887183|39648130|FG000|Overall Study|Lost to Follow-up|13|||
16317861|NCT02887183|39648130|FG000|Overall Study|Physician Decision|10|||
16317862|NCT02887183|39648130|FG000|Overall Study|Withdrawal by Subject|35|||
16317863|NCT02195869|39648131|FG000|Overall Study|cGVHD Progression|5|||
16317864|NCT02195869|39648131|FG000|Overall Study|Malignancy Progression/relapse|2|||
16317865|NCT02195869|39648131|FG000|Overall Study|Adverse Event|15|||
16317866|NCT02195869|39648131|FG000|Overall Study|Withdrawal by Subject|7|||
16317867|NCT02195869|39648131|FG000|Overall Study|Physician Decision|4|||
16317868|NCT02195869|39648131|FG000|Overall Study|Study Terminated by Sponsor|7|||
16317869|NCT02195869|39648131|FG000|Overall Study|Noncompliance with study drug|2|||
16317870|NCT03866512|39648132|FG000|Overall Study|Lost to Follow-up|1|||
16317871|NCT03866512|39648133|FG001|Overall Study|Lost to Follow-up|2|||
16317872|NCT03866512|39648134|FG002|Overall Study|Lost to Follow-up|1|||
16317873|NCT03866512|39648132|FG000|Overall Study|Cannulation issues|0|||
16317874|NCT03866512|39648133|FG001|Overall Study|Cannulation issues|1|||
16317875|NCT03866512|39648134|FG002|Overall Study|Cannulation issues|2|||
16317876|NCT01464424|39648135|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
16317877|NCT01464424|39648136|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
16317878|NCT00030901|39648139|FG000|Initial Registration|Ineligible|167|||
16090104|NCT01536704|38820092|FG003|Washout Period 1|Withdrawal by Subject|0|||
16090105|NCT01536704|38820089|FG000|Washout Period 2|Adverse Event|1|||
16317879|NCT00030901|39648140|FG001|Initial Registration|Ineligible|0|||
16317880|NCT00030901|39648141|FG002|Initial Registration|Ineligible|0|||
16317881|NCT00030901|39648139|FG000|Randomization|Adverse Event|0|||
16317882|NCT00030901|39648140|FG001|Randomization|Adverse Event|11|||
16317883|NCT00030901|39648141|FG002|Randomization|Adverse Event|7|||
16317884|NCT00030901|39648139|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
16317885|NCT00030901|39648140|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
16512170|NCT01192152|40347524|FG001|Period 1|left prematurely (while on treatment B)|1|||
16512171|NCT01192152|40347523|FG000|Period 3|family emergency|1|||
16512172|NCT01192152|40347524|FG001|Period 3|family emergency|0|||
16512173|NCT01886833|40347525|FG000|Overall Study|IgA not available from both periods|204|||
16512174|NCT02751983|40347526|FG000|Treatment|Stopped ACT, but Remained in study|2|||
16393380|NCT02010593|39922255|FG000|Overall Study|Physician Decision|1|||
16393381|NCT02010593|39922256|FG001|Overall Study|Physician Decision|0|||
16393382|NCT02010593|39922255|FG000|Overall Study|Unable to adhere to visit schedule|0|||
16393383|NCT02010593|39922256|FG001|Overall Study|Unable to adhere to visit schedule|2|||
16393384|NCT02831855|39922257|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
16393385|NCT02831855|39922258|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
16393386|NCT02831855|39922259|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
16393387|NCT02831855|39922257|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
16512175|NCT02751983|40347527|FG001|Treatment|Stopped ACT, but Remained in study|0|||
16512176|NCT02751983|40347526|FG000|Treatment|Discharged prior to beginning ACT|2|||
16512177|NCT02751983|40347527|FG001|Treatment|Discharged prior to beginning ACT|0|||
16512178|NCT02751983|40347526|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
16512179|NCT02751983|40347527|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
16512180|NCT02751983|40347526|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
16512181|NCT02751983|40347527|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
16512182|NCT02751983|40347526|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
16512183|NCT02751983|40347527|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
16512184|NCT00393939|40347528|FG000|Overall Study|Protocol Violation|1|||
16512185|NCT00393939|40347529|FG001|Overall Study|Protocol Violation|1|||
16512186|NCT00393939|40347528|FG000|Overall Study|Lost to Follow-up|2|||
16512187|NCT00393939|40347529|FG001|Overall Study|Lost to Follow-up|4|||
16512188|NCT00393939|40347528|FG000|Overall Study|Death|10|||
16512189|NCT00393939|40347529|FG001|Overall Study|Death|4|||
16512190|NCT00393939|40347528|FG000|Overall Study|Sponsor|5|||
16512191|NCT00393939|40347529|FG001|Overall Study|Sponsor|13|||
16512192|NCT00393939|40347528|FG000|Overall Study|Objective progression or relapse|239|||
16512193|NCT00393939|40347529|FG001|Overall Study|Objective progression or relapse|223|||
16512194|NCT00393939|40347528|FG000|Overall Study|Withdrawal by Subject|2|||
16512195|NCT00393939|40347529|FG001|Overall Study|Withdrawal by Subject|7|||
16512196|NCT00393939|40347528|FG000|Overall Study|Other|37|||
16512197|NCT00393939|40347529|FG001|Overall Study|Other|45|||
16512198|NCT02223767|40347530|FG000|Overall Study|Withdrawal by Subject|4|||
16512199|NCT02223767|40347531|FG001|Overall Study|Withdrawal by Subject|4|||
16512200|NCT01916304|40347532|FG000|Overall Study|Screening failure|17|||
16512201|NCT00298831|40347535|FG000|Overall Study|Adverse Event|1|||
16512202|NCT00298831|40347535|FG000|Overall Study|Lost to Follow-up|3|||
16512203|NCT00298831|40347535|FG000|Overall Study|Withdrawal by Subject|1|||
16512204|NCT00298831|40347535|FG000|Overall Study|Participants did not receive treatment|27|||
16512205|NCT01541826|40347538|FG000|Overall Study|Lost to Follow-up|2|||
16512206|NCT01541826|40347539|FG001|Overall Study|Lost to Follow-up|3|||
16512207|NCT01541826|40347540|FG002|Overall Study|Lost to Follow-up|0|||
16512208|NCT01541826|40347538|FG000|Overall Study|Withdrawal by Subject|2|||
16512209|NCT01541826|40347539|FG001|Overall Study|Withdrawal by Subject|0|||
16512210|NCT01541826|40347540|FG002|Overall Study|Withdrawal by Subject|0|||
16512211|NCT03144180|40347541|FG000|Overall Study|STAT Delivery|1|||
16512212|NCT03144180|40347542|FG001|Overall Study|STAT Delivery|1|||
16512213|NCT03144180|40347541|FG000|Overall Study|Provider forgot to fill out forms|1|||
16512214|NCT03144180|40347542|FG001|Overall Study|Provider forgot to fill out forms|3|||
16512215|NCT03144180|40347541|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
16512216|NCT03144180|40347542|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
16512217|NCT03144180|40347541|FG000|Overall Study|Scrub tech removed tube cap|0|||
16512218|NCT03144180|40347542|FG001|Overall Study|Scrub tech removed tube cap|1|||
16512219|NCT01800903|40347543|FG000|Second Test Period|unable to catheterise|1|||
16512220|NCT01800903|40347544|FG001|Second Test Period|unable to catheterise|0|||
16512221|NCT01800903|40347545|FG002|Second Test Period|unable to catheterise|0|||
16512222|NCT01800903|40347546|FG003|Second Test Period|unable to catheterise|0|||
16512223|NCT01800903|40347547|FG004|Second Test Period|unable to catheterise|0|||
16512224|NCT01800903|40347548|FG005|Second Test Period|unable to catheterise|0|||
16512225|NCT02722928|40347549|FG000|Overall Study|Standard CT was not as required per prot|5|||
16512226|NCT02722928|40347550|FG001|Overall Study|Standard CT was not as required per prot|13|||
16512227|NCT02722928|40347549|FG000|Overall Study|Required Intraoperative MRI|5|||
16512228|NCT02722928|40347550|FG001|Overall Study|Required Intraoperative MRI|7|||
16512229|NCT00116558|40347555|FG000|Overall Study|Death|11|||
16512230|NCT00116558|40347556|FG001|Overall Study|Death|5|||
16512231|NCT00116558|40347557|FG002|Overall Study|Death|3|||
16393388|NCT02831855|39922258|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
16393389|NCT02831855|39922259|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
16393390|NCT02831855|39922257|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
16393391|NCT02831855|39922258|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
16393392|NCT02831855|39922259|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
16393393|NCT02831855|39922257|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
16393394|NCT02831855|39922258|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
16393395|NCT02831855|39922259|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
16393396|NCT02831855|39922257|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
16393397|NCT02831855|39922258|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
16393398|NCT02831855|39922259|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
16393399|NCT02831855|39922257|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
16393400|NCT02831855|39922258|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
16393401|NCT02831855|39922259|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
16393402|NCT02831855|39922257|FG000|Open Label Phase (24 Weeks)|Other|4|||
16393403|NCT02831855|39922258|FG001|Open Label Phase (24 Weeks)|Other|0|||
16393404|NCT02831855|39922259|FG002|Open Label Phase (24 Weeks)|Other|0|||
16393405|NCT02831855|39922257|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
16393406|NCT02831855|39922258|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
16393407|NCT02831855|39922259|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
16393408|NCT02831855|39922257|FG000|Double Blind Phase (24 Weeks)|Death|0|||
16393409|NCT02831855|39922258|FG001|Double Blind Phase (24 Weeks)|Death|0|||
16393410|NCT02831855|39922259|FG002|Double Blind Phase (24 Weeks)|Death|2|||
16393411|NCT02831855|39922257|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
16393412|NCT02831855|39922258|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
16393413|NCT02831855|39922259|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
16393414|NCT02831855|39922257|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
16393415|NCT02831855|39922258|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
16393416|NCT02831855|39922259|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
16393417|NCT02831855|39922257|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
16393418|NCT02831855|39922258|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
16393419|NCT02831855|39922259|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
16393420|NCT02831855|39922257|FG000|Double Blind Phase (24 Weeks)|Other|0|||
16200771|NCT01030458|39211796|FG001|Overall Study|Side effect of medication|1|||
16200772|NCT01217190|39211797|FG000|Second Dosing|Withdrawal by Subject|0|||
16200773|NCT01217190|39211798|FG001|Second Dosing|Withdrawal by Subject|2|||
16393421|NCT02831855|39922258|FG001|Double Blind Phase (24 Weeks)|Other|2|||
16393422|NCT02831855|39922259|FG002|Double Blind Phase (24 Weeks)|Other|5|||
16393423|NCT02831855|39922257|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
16393424|NCT02831855|39922258|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
16393425|NCT02831855|39922259|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
16393426|NCT02831855|39922257|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
16393427|NCT02831855|39922258|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
16393428|NCT02831855|39922259|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
16393429|NCT02831855|39922257|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
16512232|NCT00116558|40347555|FG000|Overall Study|Withdrawal by Subject|17|||
16512233|NCT00116558|40347556|FG001|Overall Study|Withdrawal by Subject|3|||
16512234|NCT00116558|40347557|FG002|Overall Study|Withdrawal by Subject|12|||
16512235|NCT00116558|40347555|FG000|Overall Study|disease progression|3|||
16512236|NCT00116558|40347556|FG001|Overall Study|disease progression|7|||
16512237|NCT00116558|40347557|FG002|Overall Study|disease progression|18|||
16512238|NCT00094653|40347558|FG000|Overall Study|Death|306|||
16512239|NCT00094653|40347559|FG001|Overall Study|Death|100|||
16512240|NCT00094653|40347560|FG002|Overall Study|Death|119|||
16512241|NCT00094653|40347558|FG000|Overall Study|Subject Withdrew Consent|10|||
16512242|NCT00094653|40347559|FG001|Overall Study|Subject Withdrew Consent|2|||
16512243|NCT00094653|40347560|FG002|Overall Study|Subject Withdrew Consent|3|||
16512244|NCT00094653|40347558|FG000|Overall Study|Other|2|||
16512245|NCT00094653|40347559|FG001|Overall Study|Other|2|||
16512246|NCT00094653|40347560|FG002|Overall Study|Other|2|||
16512247|NCT00094653|40347558|FG000|Overall Study|Lost to Follow-up|3|||
16512248|NCT00094653|40347559|FG001|Overall Study|Lost to Follow-up|2|||
16512249|NCT00094653|40347560|FG002|Overall Study|Lost to Follow-up|1|||
16512250|NCT00094653|40347558|FG000|Overall Study|Protocol Violation|0|||
16512251|NCT00094653|40347559|FG001|Overall Study|Protocol Violation|0|||
16512252|NCT00094653|40347560|FG002|Overall Study|Protocol Violation|1|||
16512253|NCT04476030|40347561|FG000|Overall Study|Withdrawal by Subject|20|||
16512254|NCT04476030|40347562|FG001|Overall Study|Withdrawal by Subject|16|||
16512255|NCT04476030|40347561|FG000|Overall Study|Adverse Event|10|||
16512256|NCT04476030|40347562|FG001|Overall Study|Adverse Event|11|||
16512257|NCT04476030|40347561|FG000|Overall Study|Lost to Follow-up|7|||
16512258|NCT04476030|40347562|FG001|Overall Study|Lost to Follow-up|4|||
16512259|NCT04476030|40347561|FG000|Overall Study|Physician Decision|1|||
16090106|NCT01536704|38820090|FG001|Washout Period 2|Adverse Event|0|||
16090107|NCT01536704|38820091|FG002|Washout Period 2|Adverse Event|0|||
16393430|NCT02831855|39922258|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
16393431|NCT02831855|39922259|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
16393432|NCT00925002|39922260|FG000|Overall Study|Other|1|||
16393433|NCT00925002|39922261|FG001|Overall Study|Other|4|||
16393434|NCT00925002|39922262|FG002|Overall Study|Other|0|||
16393435|NCT00925002|39922260|FG000|Overall Study|Death|1|||
16393436|NCT00925002|39922261|FG001|Overall Study|Death|1|||
16393437|NCT00925002|39922262|FG002|Overall Study|Death|5|||
16393438|NCT00925002|39922260|FG000|Overall Study|Adverse Event|3|||
16393439|NCT00925002|39922261|FG001|Overall Study|Adverse Event|1|||
16393440|NCT00925002|39922262|FG002|Overall Study|Adverse Event|2|||
16393441|NCT00925002|39922260|FG000|Overall Study|Participant withdrew consent|1|||
16393442|NCT00925002|39922261|FG001|Overall Study|Participant withdrew consent|3|||
16512260|NCT04476030|40347562|FG001|Overall Study|Physician Decision|1|||
16512261|NCT04476030|40347561|FG000|Overall Study|Protocol Deviation|2|||
16512262|NCT04476030|40347562|FG001|Overall Study|Protocol Deviation|0|||
16512263|NCT04476030|40347561|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
16512264|NCT04476030|40347562|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
16512265|NCT04476030|40347561|FG000|Overall Study|Randomized but not Dosed|2|||
16512266|NCT04476030|40347562|FG001|Overall Study|Randomized but not Dosed|8|||
16512267|NCT00596011|40347563|FG000|Overall Study|Withdrawal by Subject|2|||
16512268|NCT00596011|40347564|FG001|Overall Study|Withdrawal by Subject|3|||
16512269|NCT00596011|40347563|FG000|Overall Study|Adverse Event|11|||
16512270|NCT00596011|40347564|FG001|Overall Study|Adverse Event|7|||
16512271|NCT00489853|40347566|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
16512272|NCT00489853|40347567|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
16512273|NCT00489853|40347568|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
16512274|NCT00489853|40347566|FG000|Wash-out Period 1|Adverse Event|0|||
16512275|NCT00489853|40347567|FG001|Wash-out Period 1|Adverse Event|1|||
16512276|NCT00489853|40347568|FG002|Wash-out Period 1|Adverse Event|1|||
16512277|NCT00489853|40347566|FG000|Wash-out Period 1|Protocol Violation|0|||
16512278|NCT00489853|40347567|FG001|Wash-out Period 1|Protocol Violation|1|||
16512279|NCT00489853|40347568|FG002|Wash-out Period 1|Protocol Violation|1|||
16512280|NCT00489853|40347566|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
16512281|NCT00489853|40347567|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
16512282|NCT00489853|40347568|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
16512283|NCT00489853|40347566|FG000|Wash-out Period 2|Adverse Event|1|||
16512284|NCT00489853|40347567|FG001|Wash-out Period 2|Adverse Event|1|||
16512285|NCT00489853|40347568|FG002|Wash-out Period 2|Adverse Event|0|||
16512286|NCT00489853|40347566|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
16512287|NCT00489853|40347567|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
16512288|NCT00489853|40347568|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
16512289|NCT00489853|40347566|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
16512290|NCT00489853|40347567|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
16512291|NCT00489853|40347568|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
16512292|NCT01907828|40347570|FG000|Overall Study|Exclusion criteria not met|0|||
16512293|NCT01907828|40347571|FG001|Overall Study|Exclusion criteria not met|1|||
16512294|NCT01907828|40347570|FG000|Overall Study|Withdrawal by Subject|3|||
16512295|NCT01907828|40347571|FG001|Overall Study|Withdrawal by Subject|4|||
16512296|NCT01907828|40347570|FG000|Overall Study|Lost to Follow-up|3|||
16512297|NCT01907828|40347571|FG001|Overall Study|Lost to Follow-up|0|||
16512298|NCT01907828|40347570|FG000|Overall Study|Participant refused 24-month follow-up|1|||
16512299|NCT01907828|40347571|FG001|Overall Study|Participant refused 24-month follow-up|0|||
16393443|NCT00925002|39922262|FG002|Overall Study|Participant withdrew consent|3|||
16393444|NCT04644276|39922263|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
16393445|NCT04644276|39922264|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
16512300|NCT01907828|40347570|FG000|Overall Study|Participant met exclusion criteria|0|||
16409962|NCT03757130|39981847|FG004|Overall Study|Withdrawal by Subject|0|||
16200774|NCT00844649|39211801|FG000|Overall Study|Progressive Disease|196|||
16200775|NCT00844649|39211802|FG001|Overall Study|Progressive Disease|245|||
16317886|NCT00030901|39648141|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
16317887|NCT00030901|39648139|FG000|Randomization|Progression/Relapse|0|||
16317888|NCT00030901|39648140|FG001|Randomization|Progression/Relapse|22|||
16317889|NCT00030901|39648141|FG002|Randomization|Progression/Relapse|21|||
16317890|NCT00030901|39648139|FG000|Randomization|Death|0|||
16317891|NCT00030901|39648140|FG001|Randomization|Death|1|||
16317892|NCT00030901|39648141|FG002|Randomization|Death|3|||
16512301|NCT01907828|40347571|FG001|Overall Study|Participant met exclusion criteria|1|||
16512302|NCT02385799|40347572|FG000|Overall Study|Lost to Follow-up|1|||
16512303|NCT02385799|40347573|FG001|Overall Study|Lost to Follow-up|2|||
16512304|NCT02385799|40347572|FG000|Overall Study|Adverse Event|4|||
16512305|NCT02385799|40347573|FG001|Overall Study|Adverse Event|2|||
16512306|NCT02385799|40347572|FG000|Overall Study|Withdrawal by Subject|0|||
16512307|NCT02385799|40347573|FG001|Overall Study|Withdrawal by Subject|4|||
16512308|NCT00004031|40347580|FG000|Overall Study|Adverse Event|5|||
16512309|NCT00004031|40347581|FG001|Overall Study|Adverse Event|0|||
16512310|NCT00004031|40347580|FG000|Overall Study|Refusal unrelated to adverse events|2|||
16512311|NCT00004031|40347581|FG001|Overall Study|Refusal unrelated to adverse events|11|||
16512312|NCT00004031|40347580|FG000|Overall Study|Progression/relapse|9|||
16512313|NCT00004031|40347581|FG001|Overall Study|Progression/relapse|4|||
16512314|NCT00004031|40347580|FG000|Overall Study|Death|3|||
16512315|NCT00004031|40347581|FG001|Overall Study|Death|1|||
16512316|NCT00004031|40347580|FG000|Overall Study|Other- not protocol specified|3|||
16512317|NCT00004031|40347581|FG001|Overall Study|Other- not protocol specified|3|||
16512318|NCT00004031|40347580|FG000|Overall Study|Reason under review|3|||
16512319|NCT00004031|40347581|FG001|Overall Study|Reason under review|2|||
16317893|NCT00030901|39648139|FG000|Randomization|Other|0|||
16317894|NCT00030901|39648140|FG001|Randomization|Other|36|||
16512320|NCT02296112|40347582|FG000|Overall Study|Disease progression|7|||
16512321|NCT02296112|40347582|FG000|Overall Study|Toxicity|1|||
16512322|NCT02296112|40347582|FG000|Overall Study|Began an alternate therapy|1|||
16512323|NCT03925324|40347583|FG000|Overall Study|Death|1|||
16512324|NCT03925324|40347584|FG001|Overall Study|Death|1|||
16512325|NCT02318693|40347585|FG000|Overall Study|Protocol Violation|0|||
16512326|NCT02318693|40347586|FG001|Overall Study|Protocol Violation|1|||
16317895|NCT00030901|39648141|FG002|Randomization|Other|33|||
16317896|NCT00030901|39648139|FG000|Randomization|Ineligible|0|||
16317897|NCT00030901|39648140|FG001|Randomization|Ineligible|15|||
16317898|NCT00030901|39648141|FG002|Randomization|Ineligible|14|||
16317899|NCT00955955|39648144|FG000|Overall Study|Lost to Follow-up|2|||
16317900|NCT00955955|39648145|FG001|Overall Study|Lost to Follow-up|0|||
16317901|NCT00955955|39648146|FG002|Overall Study|Lost to Follow-up|0|||
16317902|NCT01620138|39648149|FG000|Overall Study|Withdrawal by Subject|3|||
16317903|NCT01620138|39648150|FG001|Overall Study|Withdrawal by Subject|0|||
16317904|NCT01620138|39648149|FG000|Overall Study|Lack of Efficacy|1|||
16317905|NCT01620138|39648150|FG001|Overall Study|Lack of Efficacy|0|||
16317906|NCT01620138|39648149|FG000|Overall Study|Adverse Event|2|||
16317907|NCT01620138|39648150|FG001|Overall Study|Adverse Event|0|||
16317908|NCT01383707|39648156|FG000|Overall Study|Consent withdrawal|6|||
16317909|NCT01383707|39648156|FG000|Overall Study|Death|19|||
16317910|NCT01383707|39648156|FG000|Overall Study|Other|8|||
16317911|NCT01383707|39648156|FG000|Overall Study|Sponsor's decision|2|||
16317912|NCT01383707|39648156|FG000|Overall Study|Adverse Event|14|||
16317913|NCT01383707|39648156|FG000|Overall Study|Progressive disease|23|||
16317914|NCT00586820|39648157|FG000|Overall Study|Unsuccessful PCI|1|||
16317915|NCT00586820|39648158|FG001|Overall Study|Unsuccessful PCI|0|||
16512327|NCT00423891|40347589|FG000|Enrolled|Withdrawal by Subject|0|||
16512328|NCT00423891|40347590|FG001|Enrolled|Withdrawal by Subject|0|||
16512329|NCT00423891|40347591|FG002|Enrolled|Withdrawal by Subject|1|||
16512330|NCT00423891|40347589|FG000|Enrolled|Lost to Follow-up|0|||
16512331|NCT00423891|40347590|FG001|Enrolled|Lost to Follow-up|0|||
16512332|NCT00423891|40347591|FG002|Enrolled|Lost to Follow-up|1|||
16512333|NCT00423891|40347589|FG000|Enrolled|No longer met criteria|11|||
16512334|NCT00423891|40347590|FG001|Enrolled|No longer met criteria|2|||
16512335|NCT00423891|40347591|FG002|Enrolled|No longer met criteria|1|||
16512336|NCT00423891|40347589|FG000|Treatment|Withdrawal by Subject|1|||
16512337|NCT00423891|40347590|FG001|Treatment|Withdrawal by Subject|0|||
16512338|NCT00423891|40347591|FG002|Treatment|Withdrawal by Subject|0|||
16512339|NCT00423891|40347589|FG000|Treatment|Lost to Follow-up|1|||
16512340|NCT00423891|40347590|FG001|Treatment|Lost to Follow-up|0|||
16512341|NCT00423891|40347591|FG002|Treatment|Lost to Follow-up|0|||
16512342|NCT00423891|40347589|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
16512343|NCT00423891|40347590|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
16512344|NCT00423891|40347591|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
16512345|NCT00423891|40347589|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
16317916|NCT00855894|39648164|FG000|Overall Study|Death|31|||
16317917|NCT00855894|39648164|FG000|Overall Study|Patient's decision|1|||
16317918|NCT00855894|39648164|FG000|Overall Study|Disease progression|1|||
16317919|NCT01467713|39648165|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
16317920|NCT01467713|39648166|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
16317921|NCT01467713|39648167|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
16317922|NCT01467713|39648168|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
16512346|NCT00423891|40347590|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
16512347|NCT00423891|40347591|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
16317923|NCT01467713|39648165|FG000|Overall Study|Major Protocol Deviation|2|||
16317924|NCT01467713|39648166|FG001|Overall Study|Major Protocol Deviation|4|||
16317925|NCT01467713|39648167|FG002|Overall Study|Major Protocol Deviation|4|||
16317926|NCT01467713|39648168|FG003|Overall Study|Major Protocol Deviation|1|||
16317927|NCT01467713|39648165|FG000|Overall Study|Lost to Follow-up|9|||
16393446|NCT04644276|39922265|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
16317928|NCT01467713|39648166|FG001|Overall Study|Lost to Follow-up|12|||
16317929|NCT01467713|39648167|FG002|Overall Study|Lost to Follow-up|6|||
16317930|NCT01467713|39648168|FG003|Overall Study|Lost to Follow-up|9|||
16317931|NCT01467713|39648165|FG000|Overall Study|Voluntary Withdrawal|18|||
16317932|NCT01467713|39648166|FG001|Overall Study|Voluntary Withdrawal|14|||
16317933|NCT01467713|39648167|FG002|Overall Study|Voluntary Withdrawal|21|||
16317934|NCT01467713|39648168|FG003|Overall Study|Voluntary Withdrawal|20|||
16317935|NCT01467713|39648165|FG000|Overall Study|Study Termination|23|||
16317936|NCT01467713|39648166|FG001|Overall Study|Study Termination|33|||
16317937|NCT01467713|39648167|FG002|Overall Study|Study Termination|28|||
16317938|NCT01467713|39648168|FG003|Overall Study|Study Termination|29|||
16317939|NCT01467713|39648165|FG000|Overall Study|Pregnancy|0|||
16317940|NCT01467713|39648166|FG001|Overall Study|Pregnancy|1|||
16393447|NCT00407602|39922271|FG000|Overall Study|Death - unrelated to device|1|||
16393448|NCT00407602|39922271|FG000|Overall Study|Device explanted|5|||
16393449|NCT00407602|39922271|FG000|Overall Study|Withdrawal by Subject|1|||
16393450|NCT01000506|39922272|FG000|Overall Study|Adverse Event|6|||
16393451|NCT01000506|39922273|FG001|Overall Study|Adverse Event|5|||
16393452|NCT01000506|39922274|FG002|Overall Study|Adverse Event|8|||
16393453|NCT01000506|39922275|FG003|Overall Study|Adverse Event|9|||
16393454|NCT01000506|39922272|FG000|Overall Study|Lack of Efficacy|8|||
16393455|NCT01000506|39922273|FG001|Overall Study|Lack of Efficacy|6|||
16393456|NCT01000506|39922274|FG002|Overall Study|Lack of Efficacy|4|||
16393457|NCT01000506|39922275|FG003|Overall Study|Lack of Efficacy|4|||
16393458|NCT01000506|39922272|FG000|Overall Study|Protocol Violation|1|||
16393459|NCT01000506|39922273|FG001|Overall Study|Protocol Violation|1|||
16393460|NCT01000506|39922274|FG002|Overall Study|Protocol Violation|0|||
16393461|NCT01000506|39922275|FG003|Overall Study|Protocol Violation|0|||
16393462|NCT01000506|39922272|FG000|Overall Study|Lost to Follow-up|1|||
16393463|NCT01000506|39922273|FG001|Overall Study|Lost to Follow-up|1|||
16512348|NCT00245765|40347593|FG000|Overall Study|Adverse Event|1|||
16512349|NCT00245765|40347594|FG001|Overall Study|Adverse Event|1|||
16512350|NCT00245765|40347595|FG002|Overall Study|Adverse Event|0|||
16317941|NCT01467713|39648167|FG002|Overall Study|Pregnancy|1|||
16317942|NCT01467713|39648168|FG003|Overall Study|Pregnancy|3|||
16317943|NCT01467713|39648165|FG000|Overall Study|Relapse|35|||
16317944|NCT01467713|39648166|FG001|Overall Study|Relapse|25|||
16317945|NCT01467713|39648167|FG002|Overall Study|Relapse|28|||
16317946|NCT01467713|39648168|FG003|Overall Study|Relapse|35|||
16317947|NCT01467713|39648165|FG000|Overall Study|Reason not Specified|6|||
16317948|NCT01467713|39648166|FG001|Overall Study|Reason not Specified|11|||
16317949|NCT01467713|39648167|FG002|Overall Study|Reason not Specified|8|||
16317950|NCT01467713|39648168|FG003|Overall Study|Reason not Specified|7|||
16317951|NCT00428246|39648171|FG000|Overall Study|Withdrawal by Subject|0|||
16317952|NCT00428246|39648172|FG001|Overall Study|Withdrawal by Subject|0|||
16317953|NCT00428246|39648173|FG002|Overall Study|Withdrawal by Subject|1|||
16317954|NCT00428246|39648171|FG000|Overall Study|Adverse Event|1|||
16317955|NCT00428246|39648172|FG001|Overall Study|Adverse Event|0|||
16317956|NCT00428246|39648173|FG002|Overall Study|Adverse Event|0|||
16512351|NCT00245765|40347593|FG000|Overall Study|Lack of Efficacy|14|||
16512352|NCT00245765|40347594|FG001|Overall Study|Lack of Efficacy|7|||
16512353|NCT00245765|40347595|FG002|Overall Study|Lack of Efficacy|0|||
16512354|NCT00245765|40347593|FG000|Overall Study|Lost to Follow-up|1|||
16512355|NCT00245765|40347594|FG001|Overall Study|Lost to Follow-up|2|||
16512356|NCT00245765|40347595|FG002|Overall Study|Lost to Follow-up|0|||
16512357|NCT00245765|40347593|FG000|Overall Study|Withdrawal by Subject|1|||
16512358|NCT00245765|40347594|FG001|Overall Study|Withdrawal by Subject|0|||
16512359|NCT00245765|40347595|FG002|Overall Study|Withdrawal by Subject|3|||
16512360|NCT00245765|40347593|FG000|Overall Study|Other reason|2|||
16512361|NCT00245765|40347594|FG001|Overall Study|Other reason|0|||
16317957|NCT01557504|39648174|FG000|Overall Study|Physician Decision|1|||
16317958|NCT01557504|39648175|FG001|Overall Study|Physician Decision|0|||
16317959|NCT04509076|39648181|FG000|Overall Study|Withdrawal by Subject|1|||
16317960|NCT04509076|39648182|FG001|Overall Study|Withdrawal by Subject|2|||
16317961|NCT04509076|39648181|FG000|Overall Study|Lost to Follow-up|1|||
16317962|NCT04509076|39648182|FG001|Overall Study|Lost to Follow-up|2|||
16317963|NCT01346059|39648183|FG000|Overall Study|Withdrawal by Subject|1|||
16317964|NCT01346059|39648184|FG001|Overall Study|Withdrawal by Subject|0|||
16317965|NCT01321749|39648185|FG000|Overall Study|Lost to Follow-up|4|||
16393464|NCT01000506|39922274|FG002|Overall Study|Lost to Follow-up|4|||
16393465|NCT01000506|39922275|FG003|Overall Study|Lost to Follow-up|0|||
16393466|NCT01000506|39922272|FG000|Overall Study|Physician Decision|1|||
16512362|NCT00245765|40347595|FG002|Overall Study|Other reason|1|||
16393467|NCT01000506|39922273|FG001|Overall Study|Physician Decision|3|||
16393468|NCT01000506|39922274|FG002|Overall Study|Physician Decision|3|||
16393469|NCT01000506|39922275|FG003|Overall Study|Physician Decision|3|||
16393470|NCT01000506|39922272|FG000|Overall Study|Withdrawal by Subject|11|||
16393471|NCT01000506|39922273|FG001|Overall Study|Withdrawal by Subject|8|||
16393472|NCT01000506|39922274|FG002|Overall Study|Withdrawal by Subject|2|||
16393473|NCT01000506|39922275|FG003|Overall Study|Withdrawal by Subject|7|||
16393474|NCT01498692|39922278|FG000|Overall Study|Death|4|||
16393475|NCT01498692|39922278|FG000|Overall Study|Withdrawal by Subject|1|||
16512363|NCT00245765|40347593|FG000|Overall Study|Other|13|||
16512364|NCT00245765|40347594|FG001|Overall Study|Other|4|||
16317966|NCT01321749|39648186|FG001|Overall Study|Lost to Follow-up|11|||
16317967|NCT01321749|39648185|FG000|Overall Study|Protocol Violation|4|||
16317968|NCT01321749|39648186|FG001|Overall Study|Protocol Violation|7|||
16317969|NCT01321749|39648185|FG000|Overall Study|Withdrawal by Subject|5|||
16317970|NCT01321749|39648186|FG001|Overall Study|Withdrawal by Subject|4|||
16317971|NCT04548193|39648187|FG000|Overall Study|Lost to Follow-up|0|||
16317972|NCT04548193|39648188|FG001|Overall Study|Lost to Follow-up|1|||
16317973|NCT04548193|39648187|FG000|Overall Study|Death|0|||
16317974|NCT04548193|39648188|FG001|Overall Study|Death|1|||
16317975|NCT04548193|39648187|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
16317976|NCT04548193|39648188|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
16317977|NCT04548193|39648187|FG000|Overall Study|Withdrawal by Subject|2|||
16317978|NCT04548193|39648188|FG001|Overall Study|Withdrawal by Subject|2|||
16393476|NCT01498692|39922278|FG000|Overall Study|Missed 12-month visit|3|||
16393477|NCT00383331|39922279|FG000|Overall Study|Protocol Violation|0|||
16512365|NCT00245765|40347595|FG002|Overall Study|Other|4|||
16512366|NCT00280566|40347596|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
16512367|NCT00280566|40347597|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
16512368|NCT00280566|40347598|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
16512369|NCT00280566|40347596|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
16512370|NCT00280566|40347597|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
16512371|NCT00280566|40347598|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
16512372|NCT00280566|40347596|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
16512373|NCT00280566|40347597|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
16512374|NCT00280566|40347598|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
16512375|NCT00280566|40347596|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
16512376|NCT00280566|40347597|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
16512377|NCT00280566|40347598|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
16512378|NCT00280566|40347596|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
16512379|NCT00280566|40347597|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
16512380|NCT00280566|40347598|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
16512381|NCT00280566|40347596|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
16512382|NCT00280566|40347597|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
16512383|NCT00280566|40347598|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
16512384|NCT00280566|40347596|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
16512385|NCT00280566|40347597|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
16512386|NCT00280566|40347598|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
16512387|NCT00280566|40347596|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
16512388|NCT00280566|40347597|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
16512389|NCT00280566|40347598|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
16512390|NCT00280566|40347596|FG000|Period 2 Double Blind|Adverse Event|0|||
16512391|NCT00280566|40347597|FG001|Period 2 Double Blind|Adverse Event|11|||
16512392|NCT00280566|40347598|FG002|Period 2 Double Blind|Adverse Event|15|||
16512393|NCT00280566|40347596|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
16512394|NCT00280566|40347597|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
16512395|NCT00280566|40347598|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
16512396|NCT00280566|40347596|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
16512397|NCT00280566|40347597|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
16512398|NCT00280566|40347598|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
16512399|NCT00280566|40347596|FG000|Period 2 Double Blind|miscellaneous|0|||
16512400|NCT00280566|40347597|FG001|Period 2 Double Blind|miscellaneous|10|||
16512401|NCT00280566|40347598|FG002|Period 2 Double Blind|miscellaneous|5|||
16512402|NCT03595878|40347599|FG000|Overall Study|Death|2|||
16512403|NCT03595878|40347600|FG001|Overall Study|Death|1|||
16512404|NCT03595878|40347601|FG002|Overall Study|Death|0|||
16512405|NCT03595878|40347599|FG000|Overall Study|Disease progression|2|||
16393478|NCT00383331|39922280|FG001|Overall Study|Protocol Violation|1|||
16512406|NCT03595878|40347600|FG001|Overall Study|Disease progression|1|||
16512407|NCT03595878|40347601|FG002|Overall Study|Disease progression|2|||
16512408|NCT03670810|40347602|FG000|Main Study|Adverse Event|37|||
16090108|NCT01536704|38820092|FG003|Washout Period 2|Adverse Event|0|||
16317979|NCT00135512|39648189|FG000|Overall Study|Adverse Event|56|||
16317980|NCT00135512|39648189|FG000|Overall Study|Lack of Efficacy|25|||
16512409|NCT03670810|40347603|FG001|Main Study|Adverse Event|38|||
16317981|NCT00135512|39648189|FG000|Overall Study|Other|42|||
16317982|NCT03777436|39648191|FG000|Placebo-controlled Phase|Adverse Event|8|||
16317983|NCT03777436|39648192|FG001|Placebo-controlled Phase|Adverse Event|10|||
16317984|NCT03777436|39648193|FG002|Placebo-controlled Phase|Adverse Event|0|||
16317985|NCT03777436|39648191|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
16317986|NCT03777436|39648192|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
16317987|NCT03777436|39648193|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
16200776|NCT00844649|39211801|FG000|Overall Study|Adverse Event|128|||
16200777|NCT00844649|39211802|FG001|Overall Study|Adverse Event|73|||
16200778|NCT00844649|39211801|FG000|Overall Study|Physician Decision|25|||
16200779|NCT00844649|39211802|FG001|Overall Study|Physician Decision|18|||
16317988|NCT03777436|39648191|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
16317989|NCT03777436|39648192|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
16317990|NCT03777436|39648193|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
16200780|NCT00844649|39211801|FG000|Overall Study|Protocol Violation|10|||
16200781|NCT00844649|39211802|FG001|Overall Study|Protocol Violation|6|||
16317991|NCT03777436|39648191|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
16317992|NCT03777436|39648192|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
16317993|NCT03777436|39648193|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
16317994|NCT03777436|39648191|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
16317995|NCT03777436|39648192|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
16317996|NCT03777436|39648193|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
16317997|NCT03777436|39648191|FG000|Placebo-controlled Phase|Physician Decision|0|||
16317998|NCT03777436|39648192|FG001|Placebo-controlled Phase|Physician Decision|1|||
16317999|NCT03777436|39648193|FG002|Placebo-controlled Phase|Physician Decision|0|||
16318000|NCT03777436|39648191|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
16318001|NCT03777436|39648192|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
16318002|NCT03777436|39648193|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
16318003|NCT03777436|39648191|FG000|Apremilast Extension Phase|Adverse Event|0|||
16318004|NCT03777436|39648192|FG001|Apremilast Extension Phase|Adverse Event|0|||
16318005|NCT03777436|39648193|FG002|Apremilast Extension Phase|Adverse Event|6|||
16318006|NCT03777436|39648191|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
16318007|NCT03777436|39648192|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
16318008|NCT03777436|39648193|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
16318009|NCT03777436|39648191|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
16318010|NCT03777436|39648192|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
16318011|NCT03777436|39648193|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
16318012|NCT03777436|39648191|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
16318013|NCT03777436|39648192|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
16318014|NCT03777436|39648193|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
16318015|NCT03777436|39648191|FG000|Apremilast Extension Phase|Miscellaneous|0|||
16318016|NCT03777436|39648192|FG001|Apremilast Extension Phase|Miscellaneous|0|||
16318017|NCT03777436|39648193|FG002|Apremilast Extension Phase|Miscellaneous|1|||
16318018|NCT04411810|39648194|FG000|Overall Study|Screen failure|1|||
16318019|NCT04411810|39648194|FG000|Overall Study|Withdrawal by Subject|1|||
16200782|NCT00844649|39211801|FG000|Overall Study|Withdrawal by Subject|28|||
16200783|NCT00844649|39211802|FG001|Overall Study|Withdrawal by Subject|39|||
16200784|NCT00844649|39211801|FG000|Overall Study|Other|7|||
16200785|NCT00844649|39211802|FG001|Overall Study|Other|10|||
16200786|NCT00844649|39211801|FG000|Overall Study|Withdrew prior to starting treatment|11|||
16318020|NCT01609296|39648195|FG000|Overall Study|Death|253|||
16318021|NCT01609296|39648195|FG000|Overall Study|Withdrawal by Subject|151|||
16318022|NCT01609296|39648195|FG000|Overall Study|Lost to Follow-up|21|||
16318023|NCT01609296|39648195|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
16318024|NCT01609296|39648195|FG000|Overall Study|missed visit but known to be alive|28|||
16318025|NCT04305327|39648196|FG000|Overall Study|Study early termination|2|||
16318026|NCT04305327|39648197|FG001|Overall Study|Study early termination|5|||
16318027|NCT04305327|39648198|FG002|Overall Study|Study early termination|2|||
16318028|NCT04305327|39648199|FG003|Overall Study|Study early termination|2|||
16318029|NCT04305327|39648196|FG000|Overall Study|Withdrawal by Subject|0|||
16318030|NCT04305327|39648197|FG001|Overall Study|Withdrawal by Subject|1|||
16318031|NCT04305327|39648198|FG002|Overall Study|Withdrawal by Subject|0|||
16318032|NCT04305327|39648199|FG003|Overall Study|Withdrawal by Subject|0|||
16318033|NCT00765336|39648200|FG000|Overall Study|Protocol Violation|4|||
16318034|NCT00765336|39648201|FG001|Overall Study|Protocol Violation|2|||
16318035|NCT00765336|39648200|FG000|Overall Study|Withdrawal by Subject|6|||
16393479|NCT02015481|39922281|FG000|Overall Study|Death|1|||
16090109|NCT01536704|38820089|FG000|Washout Period 2|Withdrawal by Subject|0|||
16090110|NCT01536704|38820090|FG001|Washout Period 2|Withdrawal by Subject|0|||
16393480|NCT03663569|39922282|FG000|Overall Study|Discontinuation of study|11|||
16393481|NCT03663569|39922282|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
16090111|NCT01536704|38820091|FG002|Washout Period 2|Withdrawal by Subject|0|||
16090112|NCT01536704|38820092|FG003|Washout Period 2|Withdrawal by Subject|1|||
16090113|NCT01536704|38820089|FG000|Period 3|Adverse Event|0|||
16090114|NCT01536704|38820090|FG001|Period 3|Adverse Event|0|||
16090115|NCT01536704|38820091|FG002|Period 3|Adverse Event|0|||
16090116|NCT01536704|38820092|FG003|Period 3|Adverse Event|1|||
16090117|NCT01536704|38820089|FG000|Washout Period 3|Adverse Event|0|||
16090118|NCT01536704|38820090|FG001|Washout Period 3|Adverse Event|0|||
16090119|NCT01536704|38820091|FG002|Washout Period 3|Adverse Event|1|||
16090120|NCT01536704|38820092|FG003|Washout Period 3|Adverse Event|0|||
16090121|NCT03075878|38820094|FG000|Overall Study|Physician Decision|1|||
16090122|NCT01229176|38820095|FG000|Overall Study|Withdrawal by Subject|0|||
16090123|NCT01229176|38820096|FG001|Overall Study|Withdrawal by Subject|0|||
16090124|NCT01229176|38820097|FG002|Overall Study|Withdrawal by Subject|0|||
16090125|NCT01229176|38820098|FG003|Overall Study|Withdrawal by Subject|1|||
16090126|NCT01229176|38820099|FG004|Overall Study|Withdrawal by Subject|1|||
16090127|NCT01229176|38820100|FG005|Overall Study|Withdrawal by Subject|1|||
16090128|NCT01229176|38820101|FG006|Overall Study|Withdrawal by Subject|0|||
16090129|NCT01229176|38820102|FG007|Overall Study|Withdrawal by Subject|1|||
16090130|NCT01229176|38820095|FG000|Overall Study|Lost to Follow-up|0|||
16090131|NCT01229176|38820096|FG001|Overall Study|Lost to Follow-up|3|||
16090132|NCT01229176|38820097|FG002|Overall Study|Lost to Follow-up|0|||
16090133|NCT01229176|38820098|FG003|Overall Study|Lost to Follow-up|0|||
16090134|NCT01229176|38820099|FG004|Overall Study|Lost to Follow-up|1|||
16090135|NCT01229176|38820100|FG005|Overall Study|Lost to Follow-up|1|||
16090136|NCT01229176|38820101|FG006|Overall Study|Lost to Follow-up|0|||
16090137|NCT01229176|38820102|FG007|Overall Study|Lost to Follow-up|2|||
16090138|NCT03009344|38820103|FG000|Overall Study|Lack of Efficacy|5|||
16090139|NCT03009344|38820103|FG000|Overall Study|Withdrawal by Subject|1|||
16090140|NCT03009344|38820103|FG000|Overall Study|Adverse Event|1|||
16090141|NCT00508144|38820106|FG000|Overall Study|Not eligible|6|||
16090142|NCT00508144|38820106|FG000|Overall Study|Death|5|||
16090143|NCT04213807|38820107|FG000|Overall Study|Physician Decision|0|||
16090144|NCT04213807|38820108|FG001|Overall Study|Physician Decision|0|||
16090145|NCT04213807|38820109|FG002|Overall Study|Physician Decision|1|||
16090146|NCT00487240|38820110|FG000|Overall Study|Withdrawal by Subject|12|||
16090147|NCT00487240|38820111|FG001|Overall Study|Withdrawal by Subject|6|||
16090148|NCT00487240|38820110|FG000|Overall Study|Lost to Follow-up|7|||
16090149|NCT00487240|38820111|FG001|Overall Study|Lost to Follow-up|6|||
16090150|NCT00487240|38820110|FG000|Overall Study|Adverse Event|0|||
16090151|NCT00487240|38820111|FG001|Overall Study|Adverse Event|4|||
16090152|NCT00487240|38820110|FG000|Overall Study|Protocol Violation|5|||
16090153|NCT00487240|38820111|FG001|Overall Study|Protocol Violation|5|||
16090154|NCT00487240|38820110|FG000|Overall Study|Entry Criteria Not Met|3|||
16090155|NCT00487240|38820111|FG001|Overall Study|Entry Criteria Not Met|4|||
16090156|NCT00487240|38820110|FG000|Overall Study|Sponsor Decision|2|||
16090157|NCT00487240|38820111|FG001|Overall Study|Sponsor Decision|1|||
16200787|NCT00844649|39211802|FG001|Overall Study|Withdrew prior to starting treatment|27|||
16393482|NCT03663569|39922282|FG000|Overall Study|Deceased patient|6|||
16090158|NCT00487240|38820110|FG000|Overall Study|Physician Decision|2|||
16090159|NCT00487240|38820111|FG001|Overall Study|Physician Decision|0|||
16090160|NCT04658784|38820115|FG000|6-month Follow-up|Lost to Follow-up|2|||
16090161|NCT04658784|38820116|FG001|6-month Follow-up|Lost to Follow-up|5|||
16090162|NCT01787032|38820117|FG000|Overall Study|Protocol Violation|0|||
16090163|NCT01787032|38820118|FG001|Overall Study|Protocol Violation|0|||
16090164|NCT01787032|38820119|FG002|Overall Study|Protocol Violation|0|||
16090165|NCT01787032|38820120|FG003|Overall Study|Protocol Violation|0|||
16090166|NCT01787032|38820121|FG004|Overall Study|Protocol Violation|1|||
16090167|NCT01787032|38820122|FG005|Overall Study|Protocol Violation|1|||
16090168|NCT01109979|38820124|FG000|Overall Study|Physician Decision|2|||
16090169|NCT01109979|38820125|FG001|Overall Study|Physician Decision|0|||
16090170|NCT01109979|38820124|FG000|Overall Study|Withdrawal by Subject|0|||
16090171|NCT01109979|38820125|FG001|Overall Study|Withdrawal by Subject|1|||
16090172|NCT00701415|38820126|FG000|Overall Study|Adverse Event|0|||
16090173|NCT00701415|38820127|FG001|Overall Study|Adverse Event|1|||
16090174|NCT00701415|38820126|FG000|Overall Study|Social/family issues and needle phobia|1|||
16090175|NCT00701415|38820127|FG001|Overall Study|Social/family issues and needle phobia|0|||
16090176|NCT01860079|38820128|FG000|Overall Study|Physician Decision|14|||
16090177|NCT01860079|38820129|FG001|Overall Study|Physician Decision|22|||
16090178|NCT03875729|38820132|FG000|Overall Study|Adverse Event|0|||
16090179|NCT03875729|38820133|FG001|Overall Study|Adverse Event|5|||
16090180|NCT03875729|38820132|FG000|Overall Study|Withdrawal by Subject|8|||
16090181|NCT03875729|38820133|FG001|Overall Study|Withdrawal by Subject|11|||
16090182|NCT03875729|38820132|FG000|Overall Study|Pregnancy|0|||
16090183|NCT03875729|38820133|FG001|Overall Study|Pregnancy|1|||
16090184|NCT03875729|38820132|FG000|Overall Study|Lost to Follow-up|0|||
16090185|NCT03875729|38820133|FG001|Overall Study|Lost to Follow-up|5|||
16090186|NCT03875729|38820132|FG000|Overall Study|Personal reasons|2|||
16090187|NCT03875729|38820133|FG001|Overall Study|Personal reasons|0|||
16090188|NCT03622580|38820137|FG000|Overall Study|Death|16|||
16090189|NCT03622580|38820138|FG001|Overall Study|Death|21|||
16090190|NCT03622580|38820139|FG002|Overall Study|Death|13|||
16090191|NCT03622580|38820137|FG000|Overall Study|Adverse Event|6|||
16090192|NCT03622580|38820138|FG001|Overall Study|Adverse Event|6|||
16090193|NCT03622580|38820139|FG002|Overall Study|Adverse Event|5|||
16090194|NCT03622580|38820137|FG000|Overall Study|Withdrawal by Subject|12|||
16090195|NCT03622580|38820138|FG001|Overall Study|Withdrawal by Subject|7|||
16090196|NCT03622580|38820139|FG002|Overall Study|Withdrawal by Subject|19|||
16090197|NCT03622580|38820137|FG000|Overall Study|Lost to Follow-up|12|||
16090198|NCT03622580|38820138|FG001|Overall Study|Lost to Follow-up|9|||
16090199|NCT03622580|38820139|FG002|Overall Study|Lost to Follow-up|9|||
16090200|NCT03622580|38820137|FG000|Overall Study|Protocol Violation|1|||
16512410|NCT03670810|40347604|FG002|Main Study|Adverse Event|3|||
16512411|NCT03670810|40347605|FG003|Main Study|Adverse Event|4|||
16512412|NCT03670810|40347606|FG004|Main Study|Adverse Event|4|||
16512413|NCT03670810|40347607|FG005|Main Study|Adverse Event|5|||
16512414|NCT03670810|40347608|FG006|Main Study|Adverse Event|0|||
16512415|NCT03670810|40347609|FG007|Main Study|Adverse Event|0|||
16512416|NCT03670810|40347610|FG008|Main Study|Adverse Event|0|||
16512417|NCT03670810|40347602|FG000|Main Study|Lack of Efficacy|8|||
16512418|NCT03670810|40347603|FG001|Main Study|Lack of Efficacy|9|||
16512419|NCT03670810|40347604|FG002|Main Study|Lack of Efficacy|3|||
16512420|NCT03670810|40347605|FG003|Main Study|Lack of Efficacy|4|||
16512421|NCT03670810|40347606|FG004|Main Study|Lack of Efficacy|0|||
16512422|NCT03670810|40347607|FG005|Main Study|Lack of Efficacy|0|||
16512423|NCT03670810|40347608|FG006|Main Study|Lack of Efficacy|0|||
16512424|NCT03670810|40347609|FG007|Main Study|Lack of Efficacy|0|||
16512425|NCT03670810|40347610|FG008|Main Study|Lack of Efficacy|0|||
16512426|NCT03670810|40347602|FG000|Main Study|Lost to Follow-up|9|||
16512427|NCT03670810|40347603|FG001|Main Study|Lost to Follow-up|7|||
16512428|NCT03670810|40347604|FG002|Main Study|Lost to Follow-up|4|||
16512429|NCT03670810|40347605|FG003|Main Study|Lost to Follow-up|6|||
16512430|NCT03670810|40347606|FG004|Main Study|Lost to Follow-up|1|||
16512431|NCT03670810|40347607|FG005|Main Study|Lost to Follow-up|0|||
16090201|NCT03622580|38820138|FG001|Overall Study|Protocol Violation|0|||
16090202|NCT03622580|38820139|FG002|Overall Study|Protocol Violation|1|||
16090203|NCT03622580|38820137|FG000|Overall Study|Physician Decision|3|||
16090204|NCT03622580|38820138|FG001|Overall Study|Physician Decision|0|||
16090205|NCT03622580|38820139|FG002|Overall Study|Physician Decision|1|||
16090206|NCT03622580|38820137|FG000|Overall Study|Pregnancy|0|||
16090207|NCT03622580|38820138|FG001|Overall Study|Pregnancy|1|||
16090208|NCT03622580|38820139|FG002|Overall Study|Pregnancy|0|||
16090209|NCT03622580|38820137|FG000|Overall Study|Lack of Efficacy|0|||
16090210|NCT03622580|38820138|FG001|Overall Study|Lack of Efficacy|0|||
16512432|NCT03670810|40347608|FG006|Main Study|Lost to Follow-up|0|||
16090211|NCT03622580|38820139|FG002|Overall Study|Lack of Efficacy|1|||
16090212|NCT03622580|38820137|FG000|Overall Study|Other|2|||
16090213|NCT03622580|38820138|FG001|Overall Study|Other|0|||
16512433|NCT03670810|40347609|FG007|Main Study|Lost to Follow-up|0|||
16512434|NCT03670810|40347610|FG008|Main Study|Lost to Follow-up|0|||
16318036|NCT00765336|39648201|FG001|Overall Study|Withdrawal by Subject|4|||
16318037|NCT00765336|39648200|FG000|Overall Study|Lost to Follow-up|7|||
16318038|NCT00765336|39648201|FG001|Overall Study|Lost to Follow-up|9|||
16512435|NCT03670810|40347602|FG000|Main Study|Non-compliance with Study Drug|0|||
16512436|NCT03670810|40347603|FG001|Main Study|Non-compliance with Study Drug|2|||
16512437|NCT03670810|40347604|FG002|Main Study|Non-compliance with Study Drug|3|||
16512438|NCT03670810|40347605|FG003|Main Study|Non-compliance with Study Drug|0|||
16512439|NCT03670810|40347606|FG004|Main Study|Non-compliance with Study Drug|0|||
16512440|NCT03670810|40347607|FG005|Main Study|Non-compliance with Study Drug|0|||
16512441|NCT03670810|40347608|FG006|Main Study|Non-compliance with Study Drug|0|||
16512442|NCT03670810|40347609|FG007|Main Study|Non-compliance with Study Drug|1|||
16512443|NCT03670810|40347610|FG008|Main Study|Non-compliance with Study Drug|0|||
16512444|NCT03670810|40347602|FG000|Main Study|Physician Decision|3|||
16512445|NCT03670810|40347603|FG001|Main Study|Physician Decision|0|||
16512446|NCT03670810|40347604|FG002|Main Study|Physician Decision|1|||
16512447|NCT03670810|40347605|FG003|Main Study|Physician Decision|0|||
16512448|NCT03670810|40347606|FG004|Main Study|Physician Decision|0|||
16512449|NCT03670810|40347607|FG005|Main Study|Physician Decision|0|||
16512450|NCT03670810|40347608|FG006|Main Study|Physician Decision|1|||
16512451|NCT03670810|40347609|FG007|Main Study|Physician Decision|1|||
16512452|NCT03670810|40347610|FG008|Main Study|Physician Decision|0|||
16512453|NCT03670810|40347602|FG000|Main Study|Pregnancy|1|||
16512454|NCT03670810|40347603|FG001|Main Study|Pregnancy|2|||
16512455|NCT03670810|40347604|FG002|Main Study|Pregnancy|0|||
16512456|NCT03670810|40347605|FG003|Main Study|Pregnancy|0|||
16512457|NCT03670810|40347606|FG004|Main Study|Pregnancy|0|||
16512458|NCT03670810|40347607|FG005|Main Study|Pregnancy|0|||
16512459|NCT03670810|40347608|FG006|Main Study|Pregnancy|0|||
16512460|NCT03670810|40347609|FG007|Main Study|Pregnancy|0|||
16512461|NCT03670810|40347610|FG008|Main Study|Pregnancy|0|||
16318039|NCT00765336|39648200|FG000|Overall Study|Adverse Event|2|||
16318040|NCT00765336|39648201|FG001|Overall Study|Adverse Event|1|||
16512462|NCT03670810|40347602|FG000|Main Study|Protocol Deviation|2|||
16512463|NCT03670810|40347603|FG001|Main Study|Protocol Deviation|12|||
16512464|NCT03670810|40347604|FG002|Main Study|Protocol Deviation|8|||
16512465|NCT03670810|40347605|FG003|Main Study|Protocol Deviation|4|||
16512466|NCT03670810|40347606|FG004|Main Study|Protocol Deviation|0|||
16090214|NCT03622580|38820139|FG002|Overall Study|Other|3|||
16512467|NCT03670810|40347607|FG005|Main Study|Protocol Deviation|0|||
16512468|NCT03670810|40347608|FG006|Main Study|Protocol Deviation|0|||
16512469|NCT03670810|40347609|FG007|Main Study|Protocol Deviation|0|||
16512470|NCT03670810|40347610|FG008|Main Study|Protocol Deviation|0|||
16512471|NCT03670810|40347602|FG000|Main Study|Withdrawal by Subject|21|||
16318041|NCT01743560|39648207|FG000|Overall Study|Disease progression|26|||
16512472|NCT03670810|40347603|FG001|Main Study|Withdrawal by Subject|21|||
16512473|NCT03670810|40347604|FG002|Main Study|Withdrawal by Subject|8|||
16318042|NCT01743560|39648207|FG000|Overall Study|Adverse Event|8|||
16318043|NCT01743560|39648207|FG000|Overall Study|Death|3|||
16318044|NCT01743560|39648207|FG000|Overall Study|Withdrawal by Subject|2|||
16318045|NCT01743560|39648207|FG000|Overall Study|Protocol Violation|1|||
16318046|NCT01743560|39648207|FG000|Overall Study|>1 dose of study drug|3|||
16318047|NCT02395848|39648208|FG000|Overall Study|Lost to Follow-up|2|||
16318048|NCT00086619|39648209|FG000|Overall Study|Withdrawal by Subject|6|||
16318049|NCT00086619|39648210|FG001|Overall Study|Withdrawal by Subject|6|||
16318050|NCT00086619|39648209|FG000|Overall Study|Adverse Event|8|||
16318051|NCT00086619|39648210|FG001|Overall Study|Adverse Event|10|||
16318052|NCT00086619|39648209|FG000|Overall Study|Protocol Violation|1|||
16318053|NCT00086619|39648210|FG001|Overall Study|Protocol Violation|1|||
16318054|NCT02097238|39648211|FG000|Overall Study|Death|1|||
16318055|NCT02097238|39648211|FG000|Overall Study|Physician Decision|1|||
16318056|NCT02097238|39648211|FG000|Overall Study|Progressive Disease|17|||
16512474|NCT03670810|40347605|FG003|Main Study|Withdrawal by Subject|9|||
16318057|NCT00955409|39648212|FG000|Overall Study|Lack of Efficacy|1|||
16318058|NCT00955409|39648213|FG001|Overall Study|Lack of Efficacy|0|||
16512475|NCT03670810|40347606|FG004|Main Study|Withdrawal by Subject|5|||
16318059|NCT00955409|39648214|FG002|Overall Study|Lack of Efficacy|0|||
16318060|NCT00955409|39648215|FG003|Overall Study|Lack of Efficacy|0|||
16512476|NCT03670810|40347607|FG005|Main Study|Withdrawal by Subject|2|||
16512477|NCT03670810|40347608|FG006|Main Study|Withdrawal by Subject|1|||
16512478|NCT03670810|40347609|FG007|Main Study|Withdrawal by Subject|1|||
16512479|NCT03670810|40347610|FG008|Main Study|Withdrawal by Subject|0|||
16512480|NCT03670810|40347602|FG000|Main Study|Participant did not want to take the three other treatments|1|||
16512481|NCT03670810|40347603|FG001|Main Study|Participant did not want to take the three other treatments|0|||
16512482|NCT03670810|40347604|FG002|Main Study|Participant did not want to take the three other treatments|0|||
16512483|NCT03670810|40347605|FG003|Main Study|Participant did not want to take the three other treatments|0|||
16512484|NCT03670810|40347606|FG004|Main Study|Participant did not want to take the three other treatments|0|||
16512485|NCT03670810|40347607|FG005|Main Study|Participant did not want to take the three other treatments|0|||
16318061|NCT00955409|39648216|FG004|Overall Study|Lack of Efficacy|0|||
16512486|NCT03670810|40347608|FG006|Main Study|Participant did not want to take the three other treatments|0|||
16512487|NCT03670810|40347609|FG007|Main Study|Participant did not want to take the three other treatments|0|||
16512488|NCT03670810|40347610|FG008|Main Study|Participant did not want to take the three other treatments|0|||
16512489|NCT03670810|40347602|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
16512490|NCT03670810|40347603|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
16512491|NCT03670810|40347604|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
16512492|NCT03670810|40347605|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
16512493|NCT03670810|40347606|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
16512494|NCT03670810|40347607|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
16512495|NCT03670810|40347608|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
16512496|NCT03670810|40347609|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
16512497|NCT03670810|40347610|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
16512498|NCT03670810|40347602|FG000|Main Study|Travel and Coronavirus issues|0|||
16512499|NCT03670810|40347603|FG001|Main Study|Travel and Coronavirus issues|0|||
16512500|NCT03670810|40347604|FG002|Main Study|Travel and Coronavirus issues|0|||
16512501|NCT03670810|40347605|FG003|Main Study|Travel and Coronavirus issues|1|||
16512502|NCT03670810|40347606|FG004|Main Study|Travel and Coronavirus issues|0|||
16512503|NCT03670810|40347607|FG005|Main Study|Travel and Coronavirus issues|0|||
16512504|NCT03670810|40347608|FG006|Main Study|Travel and Coronavirus issues|0|||
16512505|NCT03670810|40347609|FG007|Main Study|Travel and Coronavirus issues|0|||
16512506|NCT03670810|40347610|FG008|Main Study|Travel and Coronavirus issues|0|||
16512507|NCT03670810|40347602|FG000|Open Label Extension|Protocol Deviation|0|||
16512508|NCT03670810|40347603|FG001|Open Label Extension|Protocol Deviation|0|||
16512509|NCT03670810|40347604|FG002|Open Label Extension|Protocol Deviation|0|||
16318062|NCT00955409|39648217|FG005|Overall Study|Lack of Efficacy|0|||
16393483|NCT03663569|39922282|FG000|Overall Study|Lost to Follow-up|18|||
16090215|NCT03890484|38820140|FG000|Overall Study|Lost to Follow-up|1|||
16512510|NCT03670810|40347605|FG003|Open Label Extension|Protocol Deviation|0|||
16318063|NCT00955409|39648218|FG006|Overall Study|Lack of Efficacy|0|||
16318064|NCT00955409|39648219|FG007|Overall Study|Lack of Efficacy|0|||
16318065|NCT00955409|39648220|FG008|Overall Study|Lack of Efficacy|0|||
16318066|NCT00955409|39648221|FG009|Overall Study|Lack of Efficacy|0|||
16318067|NCT00955409|39648212|FG000|Overall Study|Withdrawal by Subject|1|||
16318068|NCT00955409|39648213|FG001|Overall Study|Withdrawal by Subject|0|||
16318069|NCT00955409|39648214|FG002|Overall Study|Withdrawal by Subject|5|||
16318070|NCT00955409|39648215|FG003|Overall Study|Withdrawal by Subject|2|||
16318071|NCT00955409|39648216|FG004|Overall Study|Withdrawal by Subject|0|||
16318072|NCT00955409|39648217|FG005|Overall Study|Withdrawal by Subject|0|||
16318073|NCT00955409|39648218|FG006|Overall Study|Withdrawal by Subject|2|||
16318074|NCT00955409|39648219|FG007|Overall Study|Withdrawal by Subject|0|||
16318075|NCT00955409|39648220|FG008|Overall Study|Withdrawal by Subject|1|||
16318076|NCT00955409|39648221|FG009|Overall Study|Withdrawal by Subject|0|||
16318077|NCT00955409|39648212|FG000|Overall Study|Caregiver Request|2|||
16318078|NCT00955409|39648213|FG001|Overall Study|Caregiver Request|0|||
16318079|NCT00955409|39648214|FG002|Overall Study|Caregiver Request|6|||
16318080|NCT00955409|39648215|FG003|Overall Study|Caregiver Request|5|||
16318081|NCT00955409|39648216|FG004|Overall Study|Caregiver Request|0|||
16512511|NCT03670810|40347606|FG004|Open Label Extension|Protocol Deviation|0|||
16512512|NCT03670810|40347607|FG005|Open Label Extension|Protocol Deviation|0|||
16512513|NCT03670810|40347608|FG006|Open Label Extension|Protocol Deviation|0|||
16512514|NCT03670810|40347609|FG007|Open Label Extension|Protocol Deviation|0|||
16512515|NCT03670810|40347610|FG008|Open Label Extension|Protocol Deviation|5|||
16512516|NCT03670810|40347602|FG000|Open Label Extension|Death|0|||
16512517|NCT03670810|40347603|FG001|Open Label Extension|Death|0|||
16512518|NCT03670810|40347604|FG002|Open Label Extension|Death|0|||
16512519|NCT03670810|40347605|FG003|Open Label Extension|Death|0|||
16512520|NCT03670810|40347606|FG004|Open Label Extension|Death|0|||
16512521|NCT03670810|40347607|FG005|Open Label Extension|Death|0|||
16512522|NCT03670810|40347608|FG006|Open Label Extension|Death|0|||
16512523|NCT03670810|40347609|FG007|Open Label Extension|Death|0|||
16512524|NCT03670810|40347610|FG008|Open Label Extension|Death|1|||
16512525|NCT03670810|40347602|FG000|Open Label Extension|COVID-19|0|||
16512526|NCT03670810|40347603|FG001|Open Label Extension|COVID-19|0|||
16318082|NCT00955409|39648217|FG005|Overall Study|Caregiver Request|2|||
16318083|NCT00955409|39648218|FG006|Overall Study|Caregiver Request|3|||
16318084|NCT00955409|39648219|FG007|Overall Study|Caregiver Request|1|||
16318085|NCT00955409|39648220|FG008|Overall Study|Caregiver Request|3|||
16318086|NCT00955409|39648221|FG009|Overall Study|Caregiver Request|0|||
16318087|NCT00955409|39648212|FG000|Overall Study|Investigator Request|0|||
16512527|NCT03670810|40347604|FG002|Open Label Extension|COVID-19|0|||
16512528|NCT03670810|40347605|FG003|Open Label Extension|COVID-19|0|||
16512529|NCT03670810|40347606|FG004|Open Label Extension|COVID-19|0|||
16318088|NCT00955409|39648213|FG001|Overall Study|Investigator Request|0|||
16318089|NCT00955409|39648214|FG002|Overall Study|Investigator Request|1|||
16318090|NCT00955409|39648215|FG003|Overall Study|Investigator Request|0|||
16318091|NCT00955409|39648216|FG004|Overall Study|Investigator Request|0|||
16318092|NCT00955409|39648217|FG005|Overall Study|Investigator Request|0|||
16512530|NCT03670810|40347607|FG005|Open Label Extension|COVID-19|0|||
16512531|NCT03670810|40347608|FG006|Open Label Extension|COVID-19|0|||
16512532|NCT03670810|40347609|FG007|Open Label Extension|COVID-19|0|||
16512533|NCT03670810|40347610|FG008|Open Label Extension|COVID-19|1|||
16200788|NCT02207556|39211806|FG000|Overall Study|Physician Decision|1|||
16200789|NCT02207556|39211807|FG001|Overall Study|Physician Decision|0|||
16200790|NCT02207556|39211806|FG000|Overall Study|Withdrawal by Subject|1|||
16200791|NCT02207556|39211807|FG001|Overall Study|Withdrawal by Subject|0|||
16200792|NCT02207556|39211806|FG000|Overall Study|Death|0|||
16200793|NCT02207556|39211807|FG001|Overall Study|Death|5|||
16200794|NCT02919683|39211808|FG000|Post-Surgery Follow-Up|Death|2|||
16200795|NCT02919683|39211809|FG001|Post-Surgery Follow-Up|Death|2|||
16200796|NCT02919683|39211808|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
16200797|NCT02919683|39211809|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
16200798|NCT01088438|39211813|FG000|Overall Study|Withdrawal by Subject|11|||
16200799|NCT01088438|39211814|FG001|Overall Study|Withdrawal by Subject|6|||
16200800|NCT01088438|39211813|FG000|Overall Study|Lost to Follow-up|18|||
16200801|NCT01088438|39211814|FG001|Overall Study|Lost to Follow-up|30|||
16200802|NCT00424294|39211815|FG000|Overall Study|Adverse Event|4|||
16200803|NCT00424294|39211816|FG001|Overall Study|Adverse Event|10|||
16200804|NCT00424294|39211815|FG000|Overall Study|Lack of Efficacy|2|||
16200805|NCT00424294|39211816|FG001|Overall Study|Lack of Efficacy|1|||
16512534|NCT03670810|40347602|FG000|Open Label Extension|Lack of Efficacy|0|||
16512535|NCT03670810|40347603|FG001|Open Label Extension|Lack of Efficacy|0|||
16090216|NCT03890484|38820141|FG001|Overall Study|Lost to Follow-up|1|||
16200806|NCT00424294|39211815|FG000|Overall Study|Withdrawal by Subject|1|||
16200807|NCT00424294|39211816|FG001|Overall Study|Withdrawal by Subject|2|||
16318093|NCT00955409|39648218|FG006|Overall Study|Investigator Request|0|||
16318094|NCT00955409|39648219|FG007|Overall Study|Investigator Request|0|||
16318095|NCT00955409|39648220|FG008|Overall Study|Investigator Request|0|||
16318096|NCT00955409|39648221|FG009|Overall Study|Investigator Request|0|||
16318097|NCT00955409|39648212|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
16200808|NCT00424294|39211815|FG000|Overall Study|Other|0|||
16318098|NCT00955409|39648213|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
16318099|NCT00955409|39648214|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
16318100|NCT00955409|39648215|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
16318101|NCT00955409|39648216|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
16318102|NCT00955409|39648217|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
16318103|NCT00955409|39648218|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
16318104|NCT00955409|39648219|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
16318105|NCT00955409|39648220|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
16318106|NCT00955409|39648221|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
16318107|NCT00955409|39648212|FG000|Overall Study|Lost to Follow-up|0|||
16318108|NCT00955409|39648213|FG001|Overall Study|Lost to Follow-up|0|||
16318109|NCT00955409|39648214|FG002|Overall Study|Lost to Follow-up|1|||
16318110|NCT00955409|39648215|FG003|Overall Study|Lost to Follow-up|0|||
16318111|NCT00955409|39648216|FG004|Overall Study|Lost to Follow-up|0|||
16318112|NCT00955409|39648217|FG005|Overall Study|Lost to Follow-up|0|||
16318113|NCT00955409|39648218|FG006|Overall Study|Lost to Follow-up|1|||
16318114|NCT00955409|39648219|FG007|Overall Study|Lost to Follow-up|0|||
16318115|NCT00955409|39648220|FG008|Overall Study|Lost to Follow-up|0|||
16318116|NCT00955409|39648221|FG009|Overall Study|Lost to Follow-up|0|||
16318117|NCT00955409|39648212|FG000|Overall Study|Failed to Return|2|||
16318118|NCT00955409|39648213|FG001|Overall Study|Failed to Return|0|||
16318119|NCT00955409|39648214|FG002|Overall Study|Failed to Return|0|||
16318120|NCT00955409|39648215|FG003|Overall Study|Failed to Return|0|||
16318121|NCT00955409|39648216|FG004|Overall Study|Failed to Return|0|||
16318122|NCT00955409|39648217|FG005|Overall Study|Failed to Return|0|||
16318123|NCT00955409|39648218|FG006|Overall Study|Failed to Return|0|||
16318124|NCT00955409|39648219|FG007|Overall Study|Failed to Return|2|||
16318125|NCT00955409|39648220|FG008|Overall Study|Failed to Return|0|||
16318126|NCT00955409|39648221|FG009|Overall Study|Failed to Return|0|||
16318127|NCT00955409|39648212|FG000|Overall Study|Adverse Event (AE)|2|||
16318128|NCT00955409|39648213|FG001|Overall Study|Adverse Event (AE)|0|||
16318129|NCT00955409|39648214|FG002|Overall Study|Adverse Event (AE)|0|||
16318130|NCT00955409|39648215|FG003|Overall Study|Adverse Event (AE)|0|||
16318131|NCT00955409|39648216|FG004|Overall Study|Adverse Event (AE)|0|||
16318132|NCT00955409|39648217|FG005|Overall Study|Adverse Event (AE)|1|||
16200809|NCT00424294|39211816|FG001|Overall Study|Other|2|||
16200810|NCT00424294|39211815|FG000|Overall Study|Randomized but not Treated|1|||
16200811|NCT00424294|39211816|FG001|Overall Study|Randomized but not Treated|0|||
16200812|NCT02591238|39211820|FG000|Overall Study|Pregnancy|1|||
16200813|NCT02591238|39211821|FG001|Overall Study|Pregnancy|0|||
16200814|NCT02591238|39211822|FG002|Overall Study|Pregnancy|0|||
16200815|NCT02591238|39211823|FG003|Overall Study|Pregnancy|0|||
16200816|NCT02591238|39211820|FG000|Overall Study|Withdrawal by Subject|0|||
16200817|NCT02591238|39211821|FG001|Overall Study|Withdrawal by Subject|0|||
16200818|NCT02591238|39211822|FG002|Overall Study|Withdrawal by Subject|0|||
16200819|NCT02591238|39211823|FG003|Overall Study|Withdrawal by Subject|1|||
16200820|NCT02591238|39211820|FG000|Overall Study|influenza|0|||
16200821|NCT02591238|39211821|FG001|Overall Study|influenza|0|||
16200822|NCT02591238|39211822|FG002|Overall Study|influenza|0|||
16200823|NCT02591238|39211823|FG003|Overall Study|influenza|1|||
16200824|NCT02591238|39211820|FG000|Overall Study|personal circumstances|0|||
16200825|NCT02591238|39211821|FG001|Overall Study|personal circumstances|0|||
16200826|NCT02591238|39211822|FG002|Overall Study|personal circumstances|0|||
16200827|NCT02591238|39211823|FG003|Overall Study|personal circumstances|1|||
16200828|NCT02591238|39211820|FG000|Overall Study|personal circumstances|0|||
16200829|NCT02591238|39211821|FG001|Overall Study|personal circumstances|1|||
16200830|NCT02591238|39211822|FG002|Overall Study|personal circumstances|0|||
16200831|NCT02591238|39211823|FG003|Overall Study|personal circumstances|0|||
16200832|NCT01670656|39211827|FG000|Overall Study|Non-compliance with study drug|0|||
16200833|NCT01670656|39211828|FG001|Overall Study|Non-compliance with study drug|0|||
16200834|NCT01670656|39211829|FG002|Overall Study|Non-compliance with study drug|3|||
16200835|NCT01670656|39211830|FG003|Overall Study|Non-compliance with study drug|0|||
16200836|NCT01670656|39211831|FG004|Overall Study|Non-compliance with study drug|1|||
16200837|NCT01670656|39211827|FG000|Overall Study|Pregnancy|0|||
16200838|NCT01670656|39211828|FG001|Overall Study|Pregnancy|0|||
16200839|NCT01670656|39211829|FG002|Overall Study|Pregnancy|0|||
16200840|NCT01670656|39211830|FG003|Overall Study|Pregnancy|0|||
16200841|NCT01670656|39211831|FG004|Overall Study|Pregnancy|1|||
16200842|NCT01670656|39211827|FG000|Overall Study|Withdrawal by Subject|1|||
16200843|NCT01670656|39211828|FG001|Overall Study|Withdrawal by Subject|1|||
16200844|NCT01670656|39211829|FG002|Overall Study|Withdrawal by Subject|0|||
16200845|NCT01670656|39211830|FG003|Overall Study|Withdrawal by Subject|0|||
16200846|NCT01670656|39211831|FG004|Overall Study|Withdrawal by Subject|0|||
16200847|NCT01670656|39211827|FG000|Overall Study|Non-compliance with protocol|0|||
16200848|NCT01670656|39211828|FG001|Overall Study|Non-compliance with protocol|3|||
16200849|NCT01670656|39211829|FG002|Overall Study|Non-compliance with protocol|1|||
16200850|NCT01670656|39211830|FG003|Overall Study|Non-compliance with protocol|1|||
16200851|NCT01670656|39211831|FG004|Overall Study|Non-compliance with protocol|2|||
16200852|NCT01670656|39211827|FG000|Overall Study|Adverse Event|2|||
16200853|NCT01670656|39211828|FG001|Overall Study|Adverse Event|2|||
16200854|NCT01670656|39211829|FG002|Overall Study|Adverse Event|2|||
16200855|NCT01670656|39211830|FG003|Overall Study|Adverse Event|3|||
16200856|NCT01670656|39211831|FG004|Overall Study|Adverse Event|3|||
16200857|NCT01670656|39211827|FG000|Overall Study|Subject withdrew consent|0|||
16200858|NCT01670656|39211828|FG001|Overall Study|Subject withdrew consent|1|||
16200859|NCT01670656|39211829|FG002|Overall Study|Subject withdrew consent|2|||
16200860|NCT01670656|39211830|FG003|Overall Study|Subject withdrew consent|1|||
16200861|NCT01670656|39211831|FG004|Overall Study|Subject withdrew consent|1|||
16200862|NCT01670656|39211827|FG000|Overall Study|Lost to Follow-up|0|||
16200863|NCT01670656|39211828|FG001|Overall Study|Lost to Follow-up|0|||
16200864|NCT01670656|39211829|FG002|Overall Study|Lost to Follow-up|0|||
16200865|NCT01670656|39211830|FG003|Overall Study|Lost to Follow-up|0|||
16200866|NCT01670656|39211831|FG004|Overall Study|Lost to Follow-up|3|||
16200867|NCT01670656|39211827|FG000|Overall Study|Subject moved|0|||
16200868|NCT01670656|39211828|FG001|Overall Study|Subject moved|0|||
16200869|NCT01670656|39211829|FG002|Overall Study|Subject moved|0|||
16512536|NCT03670810|40347604|FG002|Open Label Extension|Lack of Efficacy|0|||
16318133|NCT00955409|39648218|FG006|Overall Study|Adverse Event (AE)|2|||
16318134|NCT00955409|39648219|FG007|Overall Study|Adverse Event (AE)|0|||
16318135|NCT00955409|39648220|FG008|Overall Study|Adverse Event (AE)|2|||
16318136|NCT00955409|39648221|FG009|Overall Study|Adverse Event (AE)|0|||
16318137|NCT00955409|39648212|FG000|Overall Study|Reason not Specified|2|||
16318138|NCT00955409|39648213|FG001|Overall Study|Reason not Specified|1|||
16318139|NCT00955409|39648214|FG002|Overall Study|Reason not Specified|13|||
16318140|NCT00955409|39648215|FG003|Overall Study|Reason not Specified|1|||
16318141|NCT00955409|39648216|FG004|Overall Study|Reason not Specified|2|||
16318142|NCT00955409|39648217|FG005|Overall Study|Reason not Specified|0|||
16318143|NCT00955409|39648218|FG006|Overall Study|Reason not Specified|16|||
16318144|NCT00955409|39648219|FG007|Overall Study|Reason not Specified|0|||
16318145|NCT00955409|39648220|FG008|Overall Study|Reason not Specified|8|||
16318146|NCT00955409|39648221|FG009|Overall Study|Reason not Specified|1|||
16318147|NCT01294696|39648224|FG000|Overall Study|Screening failures|7|||
16318148|NCT01294696|39648224|FG000|Overall Study|Protocol Violation|8|||
16318149|NCT01294696|39648224|FG000|Overall Study|Missing BPI Response|7|||
16318150|NCT01294696|39648224|FG000|Overall Study|Site closure|52|||
16318151|NCT00561392|39648225|FG000|Overall Study|Adverse Event|38|||
16318152|NCT00561392|39648225|FG000|Overall Study|Lack of Efficacy|2|||
16318153|NCT00561392|39648225|FG000|Overall Study|Protocol Violation|1|||
16318154|NCT00561392|39648225|FG000|Overall Study|Withdrawal by Subject|8|||
16318155|NCT00561392|39648225|FG000|Overall Study|Administrative problems|4|||
16318156|NCT02547220|39648226|FG000|Overall Study|Withdrawal by Subject|1|||
16318157|NCT02547220|39648227|FG001|Overall Study|Withdrawal by Subject|0|||
16318158|NCT02547220|39648226|FG000|Overall Study|Study terminated by sponsor|18|||
16318159|NCT02547220|39648227|FG001|Overall Study|Study terminated by sponsor|20|||
16318160|NCT00083759|39648228|FG000|Overall Study|Adverse Event|5|||
16318161|NCT00083759|39648229|FG001|Overall Study|Adverse Event|3|||
16318162|NCT00083759|39648228|FG000|Overall Study|Lost to Follow-up|1|||
16318163|NCT00083759|39648229|FG001|Overall Study|Lost to Follow-up|0|||
16318164|NCT00083759|39648228|FG000|Overall Study|Death|1|||
16318165|NCT00083759|39648229|FG001|Overall Study|Death|1|||
16318166|NCT00083759|39648228|FG000|Overall Study|Inadequate Therapeutic Response|32|||
16318167|NCT00083759|39648229|FG001|Overall Study|Inadequate Therapeutic Response|35|||
16318168|NCT00083759|39648228|FG000|Overall Study|Subject Withdrew Consent|2|||
16318169|NCT00083759|39648229|FG001|Overall Study|Subject Withdrew Consent|2|||
16318170|NCT00083759|39648228|FG000|Overall Study|Non-Compliance|1|||
16318171|NCT00083759|39648229|FG001|Overall Study|Non-Compliance|0|||
16318172|NCT00083759|39648228|FG000|Overall Study|Sponsor's Discretion|28|||
16318173|NCT00083759|39648229|FG001|Overall Study|Sponsor's Discretion|29|||
16318174|NCT00083759|39648228|FG000|Overall Study|Other|14|||
16318175|NCT00083759|39648229|FG001|Overall Study|Other|13|||
16318176|NCT05253573|39648230|FG000|Overall Study|Death|1|||
16318177|NCT05253573|39648231|FG001|Overall Study|Death|0|||
16318178|NCT02211209|39648234|FG000|Overall Study|Investigator judgment|0|||
16318179|NCT02211209|39648235|FG001|Overall Study|Investigator judgment|1|||
16318180|NCT02211209|39648234|FG000|Overall Study|Voluntary withdrawal|1|||
16318181|NCT02211209|39648235|FG001|Overall Study|Voluntary withdrawal|4|||
16318182|NCT02211209|39648234|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
16318183|NCT02211209|39648235|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
16318184|NCT02211209|39648234|FG000|Overall Study|Reason Not Specified|1|||
16318185|NCT02211209|39648235|FG001|Overall Study|Reason Not Specified|0|||
16318186|NCT01776840|39648236|FG000|Overall Study|Lost to Follow-up|4|||
16318187|NCT01776840|39648237|FG001|Overall Study|Lost to Follow-up|4|||
16318188|NCT01776840|39648236|FG000|Overall Study|Withdrawal by Subject|42|||
16318189|NCT01776840|39648237|FG001|Overall Study|Withdrawal by Subject|22|||
16318190|NCT01776840|39648236|FG000|Overall Study|Ongoing|112|||
16318191|NCT01776840|39648237|FG001|Overall Study|Ongoing|129|||
16318192|NCT01208974|39648240|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
16318193|NCT01208974|39648241|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
16318194|NCT01208974|39648242|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
16318195|NCT01208974|39648243|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
16318196|NCT01208974|39648240|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
16318197|NCT01208974|39648241|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
16318198|NCT01208974|39648242|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
16318199|NCT01208974|39648243|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
16318200|NCT01208974|39648240|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
16318201|NCT01208974|39648241|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
16318202|NCT01208974|39648242|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
16318203|NCT01208974|39648243|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
16318204|NCT05107492|39648245|FG000|Overall Study|Lost to Follow-up|1|||
16318205|NCT05107492|39648246|FG001|Overall Study|Lost to Follow-up|0|||
16318206|NCT00507455|39648247|FG000|Overall Study|Adverse Event|3|||
16393484|NCT03663569|39922282|FG000|Overall Study|Withdrawal of consent|5|||
16393485|NCT03663569|39922282|FG000|Overall Study|Patient's request|11|||
16393486|NCT03663569|39922282|FG000|Overall Study|Adverse Event|4|||
16393487|NCT03663569|39922282|FG000|Overall Study|Not come to second visit|3|||
16393488|NCT03663569|39922282|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
16393489|NCT03663569|39922282|FG000|Overall Study|Serious adverse event|1|||
16393490|NCT01881009|39922283|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
16393491|NCT01881009|39922284|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
16393492|NCT03900728|39922285|FG000|Overall Study|No text responses|0|||
16393493|NCT03900728|39922286|FG001|Overall Study|No text responses|0|||
16393494|NCT03900728|39922287|FG002|Overall Study|No text responses|4|||
16393495|NCT03458325|39922288|FG000|Overall Study|Withdrawal by Subject|1|||
16393496|NCT01453036|39922289|FG000|Overall Study|Lost to Follow-up|26|||
16393497|NCT01453036|39922290|FG001|Overall Study|Lost to Follow-up|115|||
16393498|NCT01453036|39922291|FG002|Overall Study|Lost to Follow-up|31|||
16393499|NCT02151903|39922292|FG000|Overall Study|Withdrawal by Subject|1|||
16393500|NCT02151903|39922293|FG001|Overall Study|Withdrawal by Subject|0|||
16393501|NCT02151903|39922292|FG000|Overall Study|Progressive disease|2|||
16393502|NCT02151903|39922293|FG001|Overall Study|Progressive disease|1|||
16393503|NCT01063062|39922294|FG000|Overall Study|Patient withdrew consent|0|||
16393504|NCT01063062|39922295|FG001|Overall Study|Patient withdrew consent|1|||
16393505|NCT01063062|39922294|FG000|Overall Study|Adverse Event|2|||
16393506|NCT01063062|39922295|FG001|Overall Study|Adverse Event|4|||
16393507|NCT01063062|39922294|FG000|Overall Study|Protocol Violation|5|||
16393508|NCT01063062|39922295|FG001|Overall Study|Protocol Violation|4|||
16393509|NCT01063062|39922294|FG000|Overall Study|Investigator's request|1|||
16393510|NCT01063062|39922295|FG001|Overall Study|Investigator's request|0|||
16393511|NCT01063062|39922294|FG000|Overall Study|Lost to Follow-up|0|||
16393512|NCT01063062|39922295|FG001|Overall Study|Lost to Follow-up|2|||
16393513|NCT01063062|39922294|FG000|Overall Study|Miscellaneous reason|0|||
16393514|NCT01063062|39922295|FG001|Overall Study|Miscellaneous reason|1|||
16393515|NCT03012828|39922296|FG000|Overall Study|Lost to Follow-up|1|||
16393516|NCT03012828|39922297|FG001|Overall Study|Lost to Follow-up|0|||
16393517|NCT03012828|39922298|FG002|Overall Study|Lost to Follow-up|1|||
16393518|NCT03012828|39922299|FG003|Overall Study|Lost to Follow-up|0|||
16393519|NCT03012828|39922300|FG004|Overall Study|Lost to Follow-up|1|||
16393520|NCT03012828|39922301|FG005|Overall Study|Lost to Follow-up|0|||
16393521|NCT03012828|39922296|FG000|Overall Study|Withdrawal by Subject|0|||
16393522|NCT03012828|39922297|FG001|Overall Study|Withdrawal by Subject|0|||
16090217|NCT04017611|38820142|FG000|Overall Study|Withdrawn prior to completion|1|||
16090218|NCT00310037|38820145|FG000|Overall Study|Adverse Event|7|||
16393523|NCT03012828|39922298|FG002|Overall Study|Withdrawal by Subject|1|||
16393524|NCT03012828|39922299|FG003|Overall Study|Withdrawal by Subject|0|||
16393525|NCT03012828|39922300|FG004|Overall Study|Withdrawal by Subject|0|||
16393526|NCT03012828|39922301|FG005|Overall Study|Withdrawal by Subject|1|||
16393527|NCT03012828|39922296|FG000|Overall Study|Non-compliance with protocol|0|||
16393528|NCT03012828|39922297|FG001|Overall Study|Non-compliance with protocol|0|||
16090219|NCT00310037|38820146|FG001|Overall Study|Adverse Event|14|||
16090220|NCT00310037|38820145|FG000|Overall Study|Withdrawal by Subject|4|||
16090221|NCT00310037|38820146|FG001|Overall Study|Withdrawal by Subject|3|||
16090222|NCT00310037|38820145|FG000|Overall Study|Progression|6|||
16090223|NCT00310037|38820146|FG001|Overall Study|Progression|0|||
16090224|NCT00310037|38820145|FG000|Overall Study|Non-protocol treatment|1|||
16090225|NCT00310037|38820146|FG001|Overall Study|Non-protocol treatment|0|||
16200870|NCT01670656|39211830|FG003|Overall Study|Subject moved|1|||
16200871|NCT01670656|39211831|FG004|Overall Study|Subject moved|0|||
16200872|NCT02565615|39211832|FG000|Overall Study|Death|0|||
16200873|NCT02565615|39211833|FG001|Overall Study|Death|1|||
16512537|NCT03670810|40347605|FG003|Open Label Extension|Lack of Efficacy|0|||
16393529|NCT03012828|39922298|FG002|Overall Study|Non-compliance with protocol|0|||
16393530|NCT03012828|39922299|FG003|Overall Study|Non-compliance with protocol|0|||
16393531|NCT03012828|39922300|FG004|Overall Study|Non-compliance with protocol|1|||
16393532|NCT03012828|39922301|FG005|Overall Study|Non-compliance with protocol|0|||
16393533|NCT03012828|39922296|FG000|Overall Study|Delay to last visit would delay DBL|0|||
16512538|NCT03670810|40347606|FG004|Open Label Extension|Lack of Efficacy|0|||
16512539|NCT03670810|40347607|FG005|Open Label Extension|Lack of Efficacy|0|||
16512540|NCT03670810|40347608|FG006|Open Label Extension|Lack of Efficacy|0|||
16512541|NCT03670810|40347609|FG007|Open Label Extension|Lack of Efficacy|0|||
16512542|NCT03670810|40347610|FG008|Open Label Extension|Lack of Efficacy|39|||
16512543|NCT03670810|40347602|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
16512544|NCT03670810|40347603|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
16512545|NCT03670810|40347604|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
16512546|NCT03670810|40347605|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
16512547|NCT03670810|40347606|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
16512548|NCT03670810|40347607|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
16512549|NCT03670810|40347608|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
16200874|NCT02565615|39211834|FG002|Overall Study|Death|0|||
16200875|NCT02565615|39211835|FG003|Overall Study|Death|0|||
16200876|NCT02565615|39211836|FG004|Overall Study|Death|4|||
16200877|NCT02565615|39211832|FG000|Overall Study|Not willing to participate in study|2|||
16200878|NCT02565615|39211833|FG001|Overall Study|Not willing to participate in study|21|||
16200879|NCT02565615|39211834|FG002|Overall Study|Not willing to participate in study|0|||
16200880|NCT02565615|39211835|FG003|Overall Study|Not willing to participate in study|1|||
16200881|NCT02565615|39211836|FG004|Overall Study|Not willing to participate in study|169|||
16200882|NCT02565615|39211832|FG000|Overall Study|Lost to Follow-up|0|||
16200883|NCT02565615|39211833|FG001|Overall Study|Lost to Follow-up|4|||
16200884|NCT02565615|39211834|FG002|Overall Study|Lost to Follow-up|0|||
16090226|NCT03005106|38820147|FG000|Overall Study|Lost to Follow-up|16|||
16200885|NCT02565615|39211835|FG003|Overall Study|Lost to Follow-up|1|||
16200886|NCT02565615|39211836|FG004|Overall Study|Lost to Follow-up|765|||
16200887|NCT02565615|39211832|FG000|Overall Study|Not meeting eligibility criteria|0|||
16393534|NCT03012828|39922297|FG001|Overall Study|Delay to last visit would delay DBL|0|||
16393535|NCT03012828|39922298|FG002|Overall Study|Delay to last visit would delay DBL|0|||
16393536|NCT03012828|39922299|FG003|Overall Study|Delay to last visit would delay DBL|0|||
16393537|NCT03012828|39922300|FG004|Overall Study|Delay to last visit would delay DBL|0|||
16393538|NCT03012828|39922301|FG005|Overall Study|Delay to last visit would delay DBL|1|||
16393539|NCT02466425|39922302|FG000|Overall Study|Adverse Event|3|||
16393540|NCT02466425|39922303|FG001|Overall Study|Adverse Event|11|||
16393541|NCT02466425|39922302|FG000|Overall Study|Lack of Efficacy|4|||
16393542|NCT02466425|39922303|FG001|Overall Study|Lack of Efficacy|1|||
16393543|NCT02466425|39922302|FG000|Overall Study|Lost to Follow-up|3|||
16393544|NCT02466425|39922303|FG001|Overall Study|Lost to Follow-up|0|||
16393545|NCT02466425|39922302|FG000|Overall Study|Protocol Violation|1|||
16393546|NCT02466425|39922303|FG001|Overall Study|Protocol Violation|0|||
16393547|NCT02466425|39922302|FG000|Overall Study|Withdrawal by Subject|0|||
16393548|NCT02466425|39922303|FG001|Overall Study|Withdrawal by Subject|1|||
16393549|NCT02466425|39922302|FG000|Overall Study|Other|1|||
16393550|NCT02466425|39922303|FG001|Overall Study|Other|3|||
16393551|NCT02466425|39922302|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
16393552|NCT02466425|39922303|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16393553|NCT01575808|39922306|FG000|Overall Study|Death|2|||
16393554|NCT01575808|39922307|FG001|Overall Study|Death|0|||
16393555|NCT01575808|39922306|FG000|Overall Study|Withdrawal by Subject|1|||
16393556|NCT01575808|39922307|FG001|Overall Study|Withdrawal by Subject|0|||
16393557|NCT03583359|39922315|FG000|Overall Study|Withdrawal by Subject|15|||
16393558|NCT03583359|39922316|FG001|Overall Study|Withdrawal by Subject|6|||
16393559|NCT03583359|39922315|FG000|Overall Study|Lost to Follow-up|12|||
16393560|NCT03583359|39922316|FG001|Overall Study|Lost to Follow-up|3|||
16393561|NCT03583359|39922315|FG000|Overall Study|Adverse Event|0|||
16393562|NCT03583359|39922316|FG001|Overall Study|Adverse Event|1|||
16393563|NCT03583359|39922315|FG000|Overall Study|Protocol Violation|0|||
16393564|NCT03583359|39922316|FG001|Overall Study|Protocol Violation|1|||
16393565|NCT03583359|39922315|FG000|Overall Study|Other|2|||
16393566|NCT03583359|39922316|FG001|Overall Study|Other|1|||
16393567|NCT03981744|39922317|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
16393568|NCT03981744|39922318|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
16393569|NCT03981744|39922319|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
16393570|NCT03981744|39922320|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
16393571|NCT03981744|39922317|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
16393572|NCT03981744|39922318|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
16393573|NCT03981744|39922319|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
16393574|NCT03981744|39922320|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
16393575|NCT03981744|39922317|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
16393576|NCT03981744|39922318|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
16393577|NCT03981744|39922319|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
16512550|NCT03670810|40347609|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
16512551|NCT03670810|40347610|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
16512552|NCT03670810|40347602|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
16512553|NCT03670810|40347603|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
16512554|NCT03670810|40347604|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
16512555|NCT03670810|40347605|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
16512556|NCT03670810|40347606|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
16512557|NCT03670810|40347607|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
16512558|NCT03670810|40347608|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
16512559|NCT03670810|40347609|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
16512560|NCT03670810|40347610|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
16512561|NCT03670810|40347602|FG000|Open Label Extension|Withdrawal by Subject|0|||
16512562|NCT03670810|40347603|FG001|Open Label Extension|Withdrawal by Subject|0|||
16512563|NCT03670810|40347604|FG002|Open Label Extension|Withdrawal by Subject|0|||
16512564|NCT03670810|40347605|FG003|Open Label Extension|Withdrawal by Subject|0|||
16512565|NCT03670810|40347606|FG004|Open Label Extension|Withdrawal by Subject|0|||
16512566|NCT03670810|40347607|FG005|Open Label Extension|Withdrawal by Subject|0|||
16512567|NCT03670810|40347608|FG006|Open Label Extension|Withdrawal by Subject|0|||
16512568|NCT03670810|40347609|FG007|Open Label Extension|Withdrawal by Subject|0|||
16512569|NCT03670810|40347610|FG008|Open Label Extension|Withdrawal by Subject|46|||
16512570|NCT03670810|40347602|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
16512571|NCT03670810|40347603|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
16512572|NCT03670810|40347604|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
16512573|NCT03670810|40347605|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
16090227|NCT03005106|38820147|FG000|Overall Study|Adverse Event|1|||
16200888|NCT02565615|39211833|FG001|Overall Study|Not meeting eligibility criteria|7|||
16393578|NCT03981744|39922320|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
16393579|NCT02366923|39922321|FG000|Overall Study|Withdrawal by Subject|1|||
16393580|NCT02366923|39922321|FG000|Overall Study|Positive Slit Lamp Findings|2|||
16393581|NCT02366923|39922321|FG000|Overall Study|High Astigmatism|3|||
16393582|NCT01467466|39922322|FG000|Overall Study|Withdrawal by Subject|15|||
16393583|NCT01467466|39922323|FG001|Overall Study|Withdrawal by Subject|18|||
16393584|NCT01467466|39922324|FG002|Overall Study|Withdrawal by Subject|13|||
16393585|NCT01467466|39922325|FG003|Overall Study|Withdrawal by Subject|11|||
16393586|NCT01467466|39922322|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
16393587|NCT01467466|39922323|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
16393588|NCT01467466|39922324|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
16393589|NCT01467466|39922325|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
16393590|NCT01467466|39922322|FG000|Overall Study|Procedure Cancelled|46|||
16393591|NCT01467466|39922323|FG001|Overall Study|Procedure Cancelled|45|||
16393592|NCT01467466|39922324|FG002|Overall Study|Procedure Cancelled|25|||
16393593|NCT01467466|39922325|FG003|Overall Study|Procedure Cancelled|29|||
16393594|NCT01467466|39922322|FG000|Overall Study|No Endpoint Blood Draw|38|||
16393595|NCT01467466|39922323|FG001|Overall Study|No Endpoint Blood Draw|32|||
16393596|NCT01467466|39922324|FG002|Overall Study|No Endpoint Blood Draw|51|||
16393597|NCT01467466|39922325|FG003|Overall Study|No Endpoint Blood Draw|43|||
16393598|NCT00803738|39922326|FG000|Overall Study|Adverse Event|3|||
16393599|NCT00803738|39922327|FG001|Overall Study|Adverse Event|5|||
16393600|NCT00803738|39922326|FG000|Overall Study|Lost to Follow-up|4|||
16393601|NCT00803738|39922327|FG001|Overall Study|Lost to Follow-up|4|||
16200889|NCT02565615|39211834|FG002|Overall Study|Not meeting eligibility criteria|0|||
16200890|NCT02565615|39211835|FG003|Overall Study|Not meeting eligibility criteria|0|||
16200891|NCT02565615|39211836|FG004|Overall Study|Not meeting eligibility criteria|25|||
16200892|NCT02565615|39211832|FG000|Overall Study|Reason not defined|0|||
16200893|NCT02565615|39211833|FG001|Overall Study|Reason not defined|2|||
16200894|NCT02565615|39211834|FG002|Overall Study|Reason not defined|0|||
16200895|NCT02565615|39211835|FG003|Overall Study|Reason not defined|1|||
16200896|NCT02565615|39211836|FG004|Overall Study|Reason not defined|62|||
16200897|NCT02565615|39211832|FG000|Overall Study|Adverse Event|1|||
16200898|NCT02565615|39211833|FG001|Overall Study|Adverse Event|1|||
16200899|NCT02565615|39211834|FG002|Overall Study|Adverse Event|0|||
16200900|NCT02565615|39211835|FG003|Overall Study|Adverse Event|0|||
16200901|NCT02565615|39211836|FG004|Overall Study|Adverse Event|9|||
16200902|NCT02565615|39211832|FG000|Overall Study|Untreated|0|||
16200903|NCT02565615|39211833|FG001|Overall Study|Untreated|0|||
16200904|NCT02565615|39211834|FG002|Overall Study|Untreated|0|||
16200905|NCT02565615|39211835|FG003|Overall Study|Untreated|0|||
16200906|NCT02565615|39211836|FG004|Overall Study|Untreated|567|||
16200907|NCT01205451|39211838|FG000|Overall Study|Lost to Follow-up|1|||
16200908|NCT01205451|39211839|FG001|Overall Study|Lost to Follow-up|1|||
16200909|NCT01205451|39211838|FG000|Overall Study|Withdrawal by Subject|5|||
16393602|NCT00803738|39922326|FG000|Overall Study|Protocol Violation|18|||
16393603|NCT00803738|39922327|FG001|Overall Study|Protocol Violation|10|||
16393604|NCT00803738|39922326|FG000|Overall Study|Withdrawal by Subject|1|||
16393605|NCT00803738|39922327|FG001|Overall Study|Withdrawal by Subject|4|||
16393606|NCT00803738|39922326|FG000|Overall Study|Lack of Efficacy|10|||
16393607|NCT00803738|39922327|FG001|Overall Study|Lack of Efficacy|16|||
16393608|NCT00803738|39922326|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
16393609|NCT00803738|39922327|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
16393610|NCT00803738|39922326|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
16393611|NCT00803738|39922327|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
16393612|NCT00414076|39922329|FG000|Overall Study|Progression|1|||
16393613|NCT00414076|39922330|FG001|Overall Study|Progression|2|||
16200910|NCT01205451|39211839|FG001|Overall Study|Withdrawal by Subject|9|||
16393614|NCT00414076|39922329|FG000|Overall Study|Withdrawal by Subject|1|||
16200911|NCT02555657|39211840|FG000|Overall Study|Death|274|||
16200912|NCT02555657|39211841|FG001|Overall Study|Death|262|||
16200913|NCT02555657|39211840|FG000|Overall Study|Physician Decision|0|||
16393615|NCT00414076|39922330|FG001|Overall Study|Withdrawal by Subject|3|||
16393616|NCT00414076|39922329|FG000|Overall Study|Adverse Event|1|||
16200914|NCT02555657|39211841|FG001|Overall Study|Physician Decision|1|||
16200915|NCT02555657|39211840|FG000|Overall Study|Sponsor Decision|27|||
16200916|NCT02555657|39211841|FG001|Overall Study|Sponsor Decision|15|||
16393617|NCT00414076|39922330|FG001|Overall Study|Adverse Event|0|||
16393618|NCT02544750|39922333|FG000|Overall Study|Physician Decision|3|||
16393619|NCT02544750|39922334|FG001|Overall Study|Physician Decision|1|||
16393620|NCT02544750|39922333|FG000|Overall Study|Other reasons|69|||
16393621|NCT02544750|39922334|FG001|Overall Study|Other reasons|39|||
16393622|NCT02544750|39922333|FG000|Overall Study|Met withdrawal criteria|2|||
16393623|NCT02544750|39922334|FG001|Overall Study|Met withdrawal criteria|2|||
16512574|NCT03670810|40347606|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
16512575|NCT03670810|40347607|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
16512576|NCT03670810|40347608|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
16318207|NCT00507455|39648248|FG001|Overall Study|Adverse Event|3|||
16318208|NCT00507455|39648249|FG002|Overall Study|Adverse Event|6|||
16318209|NCT00507455|39648247|FG000|Overall Study|Withdrawal by Subject|2|||
16318210|NCT00507455|39648248|FG001|Overall Study|Withdrawal by Subject|1|||
16318211|NCT00507455|39648249|FG002|Overall Study|Withdrawal by Subject|2|||
16318212|NCT00507455|39648247|FG000|Overall Study|Protocol Violation|4|||
16318213|NCT00507455|39648248|FG001|Overall Study|Protocol Violation|1|||
16318214|NCT00507455|39648249|FG002|Overall Study|Protocol Violation|1|||
16318215|NCT00507455|39648247|FG000|Overall Study|Lost to Follow-up|2|||
16318216|NCT00507455|39648248|FG001|Overall Study|Lost to Follow-up|0|||
16318217|NCT00507455|39648249|FG002|Overall Study|Lost to Follow-up|2|||
16318218|NCT00507455|39648247|FG000|Overall Study|Lack of Efficacy|0|||
16318219|NCT00507455|39648248|FG001|Overall Study|Lack of Efficacy|1|||
16512577|NCT03670810|40347609|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
16512578|NCT03670810|40347610|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
16512579|NCT03670810|40347602|FG000|Open Label Extension|Physician Decision|0|||
16512580|NCT03670810|40347603|FG001|Open Label Extension|Physician Decision|0|||
16512581|NCT03670810|40347604|FG002|Open Label Extension|Physician Decision|0|||
16512582|NCT03670810|40347605|FG003|Open Label Extension|Physician Decision|0|||
16512583|NCT03670810|40347606|FG004|Open Label Extension|Physician Decision|0|||
16512584|NCT03670810|40347607|FG005|Open Label Extension|Physician Decision|0|||
16318220|NCT00507455|39648249|FG002|Overall Study|Lack of Efficacy|0|||
16318221|NCT00507455|39648247|FG000|Overall Study|Other - miscellaneous reason|1|||
16318222|NCT00507455|39648248|FG001|Overall Study|Other - miscellaneous reason|0|||
16318223|NCT00507455|39648249|FG002|Overall Study|Other - miscellaneous reason|1|||
16318224|NCT02792062|39648250|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
16318225|NCT02792062|39648251|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
16318226|NCT02792062|39648252|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
16318227|NCT02792062|39648253|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
16318228|NCT02792062|39648254|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
16318229|NCT02792062|39648255|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
16318230|NCT03682848|39648256|FG000|Overall Study|Withdrawal by Subject|2|||
16318231|NCT03682848|39648256|FG000|Overall Study|Site closed|5|||
16318232|NCT03682848|39648256|FG000|Overall Study|Protocol Deviation|1|||
16318233|NCT03682848|39648256|FG000|Overall Study|Adverse Event|1|||
16318234|NCT01379768|39648257|FG000|Overall Study|Adverse Event|1|||
16318235|NCT01379768|39648258|FG001|Overall Study|Adverse Event|1|||
16318236|NCT01379768|39648259|FG002|Overall Study|Adverse Event|0|||
16318237|NCT01379768|39648257|FG000|Overall Study|Lost to Follow-up|2|||
16318238|NCT01379768|39648258|FG001|Overall Study|Lost to Follow-up|0|||
16318239|NCT01379768|39648259|FG002|Overall Study|Lost to Follow-up|0|||
16318240|NCT01464333|39648262|FG000|Overall Study|Adverse Event|34|||
16318241|NCT01464333|39648262|FG000|Overall Study|Lack of Efficacy|72|||
16318242|NCT01464333|39648262|FG000|Overall Study|Withdrawal by Subject|11|||
16318243|NCT01464333|39648262|FG000|Overall Study|Other|4|||
16318244|NCT01464333|39648262|FG000|Overall Study|No Hospital Visit|42|||
16318245|NCT00777296|39648263|FG000|Overall Study|Adverse Event|0|||
16318246|NCT00777296|39648264|FG001|Overall Study|Adverse Event|1|||
16318247|NCT00777296|39648265|FG002|Overall Study|Adverse Event|0|||
16318248|NCT00777296|39648266|FG003|Overall Study|Adverse Event|1|||
16318249|NCT00777296|39648263|FG000|Overall Study|Withdrawal by Subject|1|||
16318250|NCT00777296|39648264|FG001|Overall Study|Withdrawal by Subject|0|||
16318251|NCT00777296|39648265|FG002|Overall Study|Withdrawal by Subject|0|||
16318252|NCT00777296|39648266|FG003|Overall Study|Withdrawal by Subject|0|||
16318253|NCT00777296|39648263|FG000|Overall Study|CRF form not completed|0|||
16318254|NCT00777296|39648264|FG001|Overall Study|CRF form not completed|0|||
16318255|NCT00777296|39648265|FG002|Overall Study|CRF form not completed|2|||
16318256|NCT00777296|39648266|FG003|Overall Study|CRF form not completed|0|||
16318257|NCT03270657|39648267|FG000|Overall Study|Withdrawal by Subject|1|||
16318258|NCT00997373|39648272|FG000|Overall Study|Withdrawal by Subject|5|||
16393624|NCT02544750|39922333|FG000|Overall Study|Transition To Commercial Product|1|||
16318259|NCT00997373|39648273|FG001|Overall Study|Withdrawal by Subject|0|||
16318260|NCT00997373|39648272|FG000|Overall Study|wrong tumor type|4|||
16318261|NCT00997373|39648273|FG001|Overall Study|wrong tumor type|0|||
16318262|NCT00997373|39648272|FG000|Overall Study|could not have hysterectomy|6|||
16318263|NCT00997373|39648273|FG001|Overall Study|could not have hysterectomy|0|||
16318264|NCT03473925|39648274|FG000|Overall Study|Death|48|||
16318265|NCT03473925|39648275|FG001|Overall Study|Death|44|||
16318266|NCT03473925|39648274|FG000|Overall Study|Sponsor Decision|2|||
16318267|NCT03473925|39648275|FG001|Overall Study|Sponsor Decision|7|||
16318268|NCT03473925|39648274|FG000|Overall Study|Withdrawal by Subject|1|||
16318269|NCT03473925|39648275|FG001|Overall Study|Withdrawal by Subject|3|||
16318270|NCT03473925|39648274|FG000|Overall Study|Not Treated|1|||
16318271|NCT03473925|39648275|FG001|Overall Study|Not Treated|1|||
16318272|NCT02965573|39648282|FG000|Overall Study|Lack of Efficacy|1|||
16318273|NCT02965573|39648283|FG001|Overall Study|Lack of Efficacy|0|||
16318274|NCT02142803|39648288|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
16318275|NCT02142803|39648289|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
16318276|NCT02142803|39648290|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
16318277|NCT02142803|39648291|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
16318278|NCT05047211|39648292|FG000|Overall Study|Lost to Follow-up|8|||
16318279|NCT05047211|39648293|FG001|Overall Study|Lost to Follow-up|5|||
16318280|NCT00403481|39648297|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
16318281|NCT00403481|39648297|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
16318282|NCT00403481|39648297|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
16318283|NCT00403481|39648297|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
16318284|NCT00403481|39648297|FG000|Olm 40 mg|Adverse Event|2|||
16318285|NCT00403481|39648297|FG000|Olm 40 mg|Protocol Violation|1|||
16318286|NCT00403481|39648297|FG000|Olm 40 mg|Withdrawal by Subject|1|||
16318287|NCT00403481|39648297|FG000|Olm 40 mg|Other|1|||
16318288|NCT00403481|39648297|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
16318289|NCT00403481|39648297|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
16318290|NCT00403481|39648297|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
16318291|NCT00403481|39648297|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
16318292|NCT00403481|39648297|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
16318293|NCT00403481|39648297|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
16318294|NCT03193853|39648298|FG000|Overall Study|Death|6|||
16318295|NCT00728468|39648299|FG000|Overall Study|Enrolled but not treated|1|||
16318296|NCT00728468|39648299|FG000|Overall Study|Death|1|||
16318297|NCT00728468|39648299|FG000|Overall Study|Protocol Violation|4|||
16318298|NCT00728468|39648299|FG000|Overall Study|Objective progression or relapse|9|||
16318299|NCT00728468|39648299|FG000|Overall Study|Study terminated by sponsor|1|||
16318300|NCT02589639|39648300|FG000|Overall Study|Lost to Follow-up|1|||
16318301|NCT02589639|39648301|FG001|Overall Study|Lost to Follow-up|0|||
16318302|NCT02589639|39648302|FG002|Overall Study|Lost to Follow-up|0|||
16318303|NCT02589639|39648300|FG000|Overall Study|Protocol Violation|1|||
16318304|NCT02589639|39648301|FG001|Overall Study|Protocol Violation|0|||
16318305|NCT02589639|39648302|FG002|Overall Study|Protocol Violation|0|||
16318306|NCT02589639|39648300|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
16318307|NCT02589639|39648301|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
16318308|NCT02589639|39648302|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
16318309|NCT02589639|39648300|FG000|Overall Study|Adverse Event|4|||
16318310|NCT02589639|39648301|FG001|Overall Study|Adverse Event|5|||
16318311|NCT02589639|39648302|FG002|Overall Study|Adverse Event|3|||
16318312|NCT02589639|39648300|FG000|Overall Study|Other reason than specified above|1|||
16318313|NCT02589639|39648301|FG001|Overall Study|Other reason than specified above|2|||
16318314|NCT02589639|39648302|FG002|Overall Study|Other reason than specified above|1|||
16318315|NCT02589639|39648300|FG000|Overall Study|Not Treated|0|||
16318316|NCT02589639|39648301|FG001|Overall Study|Not Treated|3|||
16318317|NCT02589639|39648302|FG002|Overall Study|Not Treated|0|||
16318318|NCT00552396|39648305|FG000|Overall Study|protocol withdrawal criteria|3|||
16318319|NCT00552396|39648306|FG001|Overall Study|protocol withdrawal criteria|3|||
16318320|NCT00552396|39648307|FG002|Overall Study|protocol withdrawal criteria|3|||
16318321|NCT00552396|39648308|FG003|Overall Study|protocol withdrawal criteria|6|||
16318322|NCT00552396|39648309|FG004|Overall Study|protocol withdrawal criteria|3|||
16318323|NCT00552396|39648310|FG005|Overall Study|protocol withdrawal criteria|3|||
16318324|NCT00552396|39648311|FG006|Overall Study|protocol withdrawal criteria|9|||
16318325|NCT01323387|39648313|FG000|Overall Study|Withdrawal by Subject|41|||
16318326|NCT01323387|39648313|FG000|Overall Study|Radiographic Data Unavailable|1|||
16318327|NCT01323387|39648313|FG000|Overall Study|Revision|14|||
16512585|NCT03670810|40347608|FG006|Open Label Extension|Physician Decision|0|||
16512586|NCT03670810|40347609|FG007|Open Label Extension|Physician Decision|0|||
16512587|NCT03670810|40347610|FG008|Open Label Extension|Physician Decision|2|||
16318328|NCT01323387|39648313|FG000|Overall Study|Protocol Violation|12|||
16318329|NCT01323387|39648313|FG000|Overall Study|Randomized but Never Treated|16|||
16318330|NCT00757042|39648314|FG000|Overall Study|Lost to Follow-up|0|||
16318331|NCT00757042|39648315|FG001|Overall Study|Lost to Follow-up|0|||
16318332|NCT00757042|39648316|FG002|Overall Study|Lost to Follow-up|0|||
16318333|NCT00757042|39648317|FG003|Overall Study|Lost to Follow-up|0|||
16318334|NCT00757042|39648318|FG004|Overall Study|Lost to Follow-up|0|||
16200917|NCT02555657|39211840|FG000|Overall Study|Withdrawal by Subject|11|||
16200918|NCT02555657|39211841|FG001|Overall Study|Withdrawal by Subject|32|||
16200919|NCT01626989|39211843|FG000|Screening Period|Screen Failure|15|||
16200920|NCT01626989|39211844|FG001|Screening Period|Screen Failure|0|||
16200921|NCT01626989|39211845|FG002|Screening Period|Screen Failure|0|||
16200922|NCT01626989|39211843|FG000|Screening Period|Withdrawal by Subject|2|||
16200923|NCT01626989|39211844|FG001|Screening Period|Withdrawal by Subject|0|||
16200924|NCT01626989|39211845|FG002|Screening Period|Withdrawal by Subject|0|||
16200925|NCT01769469|39211846|FG000|Overall Study|Consent Withdrawn|5|||
16200926|NCT01769469|39211846|FG000|Overall Study|Moved Out Of Area|3|||
16200927|NCT01769469|39211846|FG000|Overall Study|Lost to Follow-up|17|||
16200928|NCT01769469|39211846|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
16200929|NCT01769469|39211846|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
16200930|NCT00476996|39211847|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
16200931|NCT00476996|39211848|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
16200932|NCT00476996|39211849|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
16200933|NCT00476996|39211850|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
16200934|NCT00476996|39211847|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
16200935|NCT00476996|39211848|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
16200936|NCT00476996|39211849|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
16200937|NCT00476996|39211850|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
16200938|NCT00476996|39211847|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
16200939|NCT00476996|39211848|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
16200940|NCT00476996|39211849|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
16200941|NCT00476996|39211850|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
16200942|NCT00476996|39211847|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
16200943|NCT00476996|39211848|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
16200944|NCT00476996|39211849|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
16200945|NCT00476996|39211850|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
16200946|NCT00476996|39211847|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
16200947|NCT00476996|39211848|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
16200948|NCT00476996|39211849|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
16200949|NCT00476996|39211850|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
16200950|NCT00476996|39211847|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
16200951|NCT00476996|39211848|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
16200952|NCT00476996|39211849|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
16200953|NCT00476996|39211850|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
16200954|NCT00476996|39211847|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
16200955|NCT00476996|39211848|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
16200956|NCT00476996|39211849|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
16200957|NCT00476996|39211850|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
16200958|NCT00476996|39211847|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
16200959|NCT00476996|39211848|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
16200960|NCT00476996|39211849|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
16512588|NCT03670810|40347602|FG000|Open Label Extension|Non-compliance with study drug|0|||
16512589|NCT03670810|40347603|FG001|Open Label Extension|Non-compliance with study drug|0|||
16512590|NCT03670810|40347604|FG002|Open Label Extension|Non-compliance with study drug|0|||
16200961|NCT00476996|39211850|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
16200962|NCT00476996|39211847|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
16200963|NCT00476996|39211848|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
16200964|NCT00476996|39211849|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
16200965|NCT00476996|39211850|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
16200966|NCT00476996|39211847|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
16200967|NCT00476996|39211848|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
16200968|NCT00476996|39211849|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
16200969|NCT00476996|39211850|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
16200970|NCT00476996|39211847|FG000|OLE Phase (From Week 48)|Death|0|||
16200971|NCT00476996|39211848|FG001|OLE Phase (From Week 48)|Death|0|||
16200972|NCT00476996|39211849|FG002|OLE Phase (From Week 48)|Death|0|||
16200973|NCT00476996|39211850|FG003|OLE Phase (From Week 48)|Death|7|||
16512591|NCT03670810|40347605|FG003|Open Label Extension|Non-compliance with study drug|0|||
16512592|NCT03670810|40347606|FG004|Open Label Extension|Non-compliance with study drug|0|||
16512593|NCT03670810|40347607|FG005|Open Label Extension|Non-compliance with study drug|0|||
16512594|NCT03670810|40347608|FG006|Open Label Extension|Non-compliance with study drug|0|||
16512595|NCT03670810|40347609|FG007|Open Label Extension|Non-compliance with study drug|0|||
16512596|NCT03670810|40347610|FG008|Open Label Extension|Non-compliance with study drug|5|||
16512597|NCT03670810|40347602|FG000|Open Label Extension|Pregnancy|0|||
16512598|NCT03670810|40347603|FG001|Open Label Extension|Pregnancy|0|||
16318335|NCT00757042|39648319|FG005|Overall Study|Lost to Follow-up|0|||
16318336|NCT00757042|39648320|FG006|Overall Study|Lost to Follow-up|0|||
16318337|NCT00757042|39648321|FG007|Overall Study|Lost to Follow-up|0|||
16200974|NCT00476996|39211847|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
16393625|NCT02544750|39922334|FG001|Overall Study|Transition To Commercial Product|0|||
16393626|NCT02544750|39922333|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
16393627|NCT02544750|39922334|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
16393628|NCT02544750|39922333|FG000|Overall Study|Adverse Event|8|||
16393629|NCT02544750|39922334|FG001|Overall Study|Adverse Event|10|||
16393630|NCT02544750|39922333|FG000|Overall Study|Withdrawal by Subject|10|||
16393631|NCT02544750|39922334|FG001|Overall Study|Withdrawal by Subject|4|||
16393632|NCT02544750|39922333|FG000|Overall Study|Lost to Follow-up|1|||
16393633|NCT02544750|39922334|FG001|Overall Study|Lost to Follow-up|0|||
16393634|NCT03951766|39922335|FG000|Treatment Phase|Lost to Follow-up|1|||
16393635|NCT03951766|39922335|FG000|Follow-up Phase|Lost to Follow-up|10|||
16393636|NCT03035864|39922341|FG000|Treatment Period|Adverse Event|1|||
16393637|NCT03035864|39922342|FG001|Treatment Period|Adverse Event|0|||
16393638|NCT03035864|39922341|FG000|Treatment Period|Other|3|||
16512599|NCT03670810|40347604|FG002|Open Label Extension|Pregnancy|0|||
16512600|NCT03670810|40347605|FG003|Open Label Extension|Pregnancy|0|||
16200975|NCT00476996|39211848|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
16200976|NCT00476996|39211849|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
16200977|NCT00476996|39211850|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
16200978|NCT00476996|39211847|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
16200979|NCT00476996|39211848|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
16200980|NCT00476996|39211849|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
16200981|NCT00476996|39211850|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
16200982|NCT00476996|39211847|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
16318338|NCT00757042|39648322|FG008|Overall Study|Lost to Follow-up|1|||
16318339|NCT00757042|39648323|FG009|Overall Study|Lost to Follow-up|0|||
16318340|NCT00757042|39648324|FG010|Overall Study|Lost to Follow-up|0|||
16318341|NCT00757042|39648314|FG000|Overall Study|Ineligibility Determined|0|||
16512601|NCT03670810|40347606|FG004|Open Label Extension|Pregnancy|0|||
16512602|NCT03670810|40347607|FG005|Open Label Extension|Pregnancy|0|||
16318342|NCT00757042|39648315|FG001|Overall Study|Ineligibility Determined|0|||
16318343|NCT00757042|39648316|FG002|Overall Study|Ineligibility Determined|0|||
16318344|NCT00757042|39648317|FG003|Overall Study|Ineligibility Determined|0|||
16318345|NCT00757042|39648318|FG004|Overall Study|Ineligibility Determined|0|||
16318346|NCT00757042|39648319|FG005|Overall Study|Ineligibility Determined|0|||
16318347|NCT00757042|39648320|FG006|Overall Study|Ineligibility Determined|0|||
16318348|NCT00757042|39648321|FG007|Overall Study|Ineligibility Determined|0|||
16393639|NCT03035864|39922342|FG001|Treatment Period|Other|1|||
16393640|NCT03035864|39922341|FG000|Follow-up Period|Adverse Event|1|||
16393641|NCT03035864|39922342|FG001|Follow-up Period|Adverse Event|0|||
16512603|NCT03670810|40347608|FG006|Open Label Extension|Pregnancy|0|||
16512604|NCT03670810|40347609|FG007|Open Label Extension|Pregnancy|0|||
16512605|NCT03670810|40347610|FG008|Open Label Extension|Pregnancy|3|||
16090228|NCT03005106|38820147|FG000|Overall Study|Physician Decision|1|||
16393642|NCT03035864|39922341|FG000|Follow-up Period|Lost to Follow-up|6|||
16512606|NCT03670810|40347602|FG000|Open Label Extension|Adverse Event|0|||
16090229|NCT03005106|38820147|FG000|Overall Study|Death|2|||
16318349|NCT00757042|39648322|FG008|Overall Study|Ineligibility Determined|0|||
16393643|NCT03035864|39922342|FG001|Follow-up Period|Lost to Follow-up|2|||
16318350|NCT00757042|39648323|FG009|Overall Study|Ineligibility Determined|0|||
16318351|NCT00757042|39648324|FG010|Overall Study|Ineligibility Determined|1|||
16318352|NCT00757042|39648314|FG000|Overall Study|Withdrawal by Subject|0|||
16512607|NCT03670810|40347603|FG001|Open Label Extension|Adverse Event|0|||
16512608|NCT03670810|40347604|FG002|Open Label Extension|Adverse Event|0|||
16512609|NCT03670810|40347605|FG003|Open Label Extension|Adverse Event|0|||
16512610|NCT03670810|40347606|FG004|Open Label Extension|Adverse Event|0|||
16512611|NCT03670810|40347607|FG005|Open Label Extension|Adverse Event|0|||
16512612|NCT03670810|40347608|FG006|Open Label Extension|Adverse Event|0|||
16512613|NCT03670810|40347609|FG007|Open Label Extension|Adverse Event|0|||
16512614|NCT03670810|40347610|FG008|Open Label Extension|Adverse Event|24|||
16512615|NCT03670810|40347602|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
16512616|NCT03670810|40347603|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
16512617|NCT03670810|40347604|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
16512618|NCT03670810|40347605|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
16512619|NCT03670810|40347606|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
16512620|NCT03670810|40347607|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
16512621|NCT03670810|40347608|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
16393644|NCT03035864|39922341|FG000|Follow-up Period|Physician Decision|1|||
16393645|NCT03035864|39922342|FG001|Follow-up Period|Physician Decision|0|||
16393646|NCT03035864|39922341|FG000|Follow-up Period|Other|3|||
16512622|NCT03670810|40347609|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
16512623|NCT03670810|40347610|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
16512624|NCT03670810|40347602|FG000|Open Label Extension|Lost to Follow-up|0|||
16512625|NCT03670810|40347603|FG001|Open Label Extension|Lost to Follow-up|0|||
16512626|NCT03670810|40347604|FG002|Open Label Extension|Lost to Follow-up|0|||
16512627|NCT03670810|40347605|FG003|Open Label Extension|Lost to Follow-up|0|||
16200983|NCT00476996|39211848|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
16200984|NCT00476996|39211849|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
16200985|NCT00476996|39211850|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
16200986|NCT00476996|39211847|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
16200987|NCT00476996|39211848|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
16200988|NCT00476996|39211849|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
16200989|NCT00476996|39211850|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
16200990|NCT00282568|39211854|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
16200991|NCT00282568|39211854|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
16200992|NCT00282568|39211854|FG000|Extended Treatment Period|Adverse Event|17|||
16200993|NCT00282568|39211854|FG000|Extended Treatment Period|Non-compliance|4|||
16200994|NCT00282568|39211854|FG000|Extended Treatment Period|Physician Decision|1|||
16200995|NCT00282568|39211854|FG000|Extended Treatment Period|Lost to Follow-up|2|||
16200996|NCT00563368|39211855|FG000|Overall Study|Lost to Follow-up|14|||
16200997|NCT00563368|39211856|FG001|Overall Study|Lost to Follow-up|14|||
16200998|NCT00563368|39211857|FG002|Overall Study|Lost to Follow-up|12|||
16200999|NCT00563368|39211858|FG003|Overall Study|Lost to Follow-up|6|||
16201000|NCT00563368|39211859|FG004|Overall Study|Lost to Follow-up|9|||
16201001|NCT00563368|39211860|FG005|Overall Study|Lost to Follow-up|8|||
16201002|NCT00563368|39211861|FG006|Overall Study|Lost to Follow-up|9|||
16201003|NCT00563368|39211855|FG000|Overall Study|Adverse Event|3|||
16201004|NCT00563368|39211856|FG001|Overall Study|Adverse Event|4|||
16201005|NCT00563368|39211857|FG002|Overall Study|Adverse Event|5|||
16201006|NCT00563368|39211858|FG003|Overall Study|Adverse Event|9|||
16201007|NCT00563368|39211859|FG004|Overall Study|Adverse Event|6|||
16512628|NCT03670810|40347606|FG004|Open Label Extension|Lost to Follow-up|0|||
16512629|NCT03670810|40347607|FG005|Open Label Extension|Lost to Follow-up|0|||
16512630|NCT03670810|40347608|FG006|Open Label Extension|Lost to Follow-up|0|||
16512631|NCT03670810|40347609|FG007|Open Label Extension|Lost to Follow-up|0|||
16512632|NCT03670810|40347610|FG008|Open Label Extension|Lost to Follow-up|23|||
16512633|NCT00354172|40347611|FG000|Overall Study|Did not receive transplant|1|||
16512634|NCT02203591|40347612|FG000|Overall Study|Did not meet treatment day baseline|147|||
16512635|NCT02203591|40347613|FG001|Overall Study|Did not meet treatment day baseline|141|||
16512636|NCT02203591|40347614|FG002|Overall Study|Did not meet treatment day baseline|150|||
16512637|NCT02203591|40347615|FG003|Overall Study|Did not meet treatment day baseline|45|||
16512638|NCT02203591|40347616|FG004|Overall Study|Did not meet treatment day baseline|33|||
16512639|NCT02203591|40347617|FG005|Overall Study|Did not meet treatment day baseline|35|||
16512640|NCT02203591|40347618|FG006|Overall Study|Did not meet treatment day baseline|29|||
16512641|NCT02203591|40347619|FG007|Overall Study|Did not meet treatment day baseline|12|||
16512642|NCT02203591|40347612|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
16512643|NCT02203591|40347613|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
16512644|NCT02203591|40347614|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
16512645|NCT02203591|40347615|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
16512646|NCT02203591|40347616|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
16201008|NCT00563368|39211860|FG005|Overall Study|Adverse Event|10|||
16201009|NCT00563368|39211861|FG006|Overall Study|Adverse Event|17|||
16201010|NCT00563368|39211855|FG000|Overall Study|Withdrawal by Subject|11|||
16512647|NCT02203591|40347617|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
16512648|NCT02203591|40347618|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
16512649|NCT02203591|40347619|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
16512650|NCT01073865|40347620|FG000|Overall Study|Reasons other than below|19|||
16512651|NCT01073865|40347621|FG001|Overall Study|Reasons other than below|31|||
16512652|NCT01073865|40347620|FG000|Overall Study|Lost to Follow-up|1|||
16512653|NCT01073865|40347621|FG001|Overall Study|Lost to Follow-up|1|||
16512654|NCT01073865|40347620|FG000|Overall Study|Death|3|||
16512655|NCT01073865|40347621|FG001|Overall Study|Death|2|||
16512656|NCT01073865|40347620|FG000|Overall Study|Withdrawal by Subject|5|||
16512657|NCT01073865|40347621|FG001|Overall Study|Withdrawal by Subject|5|||
16512658|NCT01417481|40347627|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
16512659|NCT01417481|40347628|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
16512660|NCT01120210|40347629|FG000|MAIN INFUSION|Adverse Event|1|||
16512661|NCT01120210|40347630|FG001|MAIN INFUSION|Adverse Event|0|||
16512662|NCT01120210|40347629|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
16318353|NCT00757042|39648315|FG001|Overall Study|Withdrawal by Subject|0|||
16318354|NCT00757042|39648316|FG002|Overall Study|Withdrawal by Subject|0|||
16318355|NCT00757042|39648317|FG003|Overall Study|Withdrawal by Subject|0|||
16318356|NCT00757042|39648318|FG004|Overall Study|Withdrawal by Subject|0|||
16318357|NCT00757042|39648319|FG005|Overall Study|Withdrawal by Subject|0|||
16318358|NCT00757042|39648320|FG006|Overall Study|Withdrawal by Subject|0|||
16318359|NCT00757042|39648321|FG007|Overall Study|Withdrawal by Subject|0|||
16318360|NCT00757042|39648322|FG008|Overall Study|Withdrawal by Subject|0|||
16318361|NCT00757042|39648323|FG009|Overall Study|Withdrawal by Subject|1|||
16318362|NCT00757042|39648324|FG010|Overall Study|Withdrawal by Subject|0|||
16318363|NCT00687271|39648329|FG000|Overall Study|Adverse Event|1|||
16318364|NCT00687271|39648330|FG001|Overall Study|Adverse Event|3|||
16318365|NCT00687271|39648331|FG002|Overall Study|Adverse Event|1|||
16318366|NCT00687271|39648332|FG003|Overall Study|Adverse Event|0|||
16318367|NCT00687271|39648329|FG000|Overall Study|Lost to Follow-up|0|||
16318368|NCT00687271|39648330|FG001|Overall Study|Lost to Follow-up|1|||
16318369|NCT00687271|39648331|FG002|Overall Study|Lost to Follow-up|0|||
16512663|NCT01120210|40347630|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
16512664|NCT00111228|40347631|FG000|Overall Study|Withdrawal by Subject|5|||
16512665|NCT00111228|40347632|FG001|Overall Study|Withdrawal by Subject|1|||
16512666|NCT00111228|40347633|FG002|Overall Study|Withdrawal by Subject|0|||
16512667|NCT00240071|40350994|FG000|Overall Study|Withdrawal by Subject|3|||
16512668|NCT01541930|40350997|FG000|Overall Study|Withdrawal by Subject|1|||
16512669|NCT04334460|40350998|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
16512670|NCT04334460|40350999|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
16512671|NCT04334460|40350998|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
16512672|NCT04334460|40350999|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
16512673|NCT04399161|40351000|FG000|Overall Study|Withdrawal by Subject|1|||
16512674|NCT04399161|40351001|FG001|Overall Study|Withdrawal by Subject|0|||
16512675|NCT04399161|40351002|FG002|Overall Study|Withdrawal by Subject|2|||
16512676|NCT04399161|40351000|FG000|Overall Study|Protocol Violation|1|||
16512677|NCT04399161|40351001|FG001|Overall Study|Protocol Violation|2|||
16512678|NCT04399161|40351002|FG002|Overall Study|Protocol Violation|0|||
16512679|NCT01533246|40351003|FG000|Overall Study|Adverse Event|1|||
16512680|NCT01533246|40351003|FG000|Overall Study|Withdrawal by Subject|1|||
16512681|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
16512682|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
16512683|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
16512684|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
16512685|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
16512686|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
16512687|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
16512688|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
16512689|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
16512690|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
16512691|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
16512692|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
16512693|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
16512694|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
16318370|NCT00687271|39648332|FG003|Overall Study|Lost to Follow-up|0|||
16318371|NCT00687271|39648329|FG000|Overall Study|Protocol Violation|2|||
16318372|NCT00687271|39648330|FG001|Overall Study|Protocol Violation|1|||
16318373|NCT00687271|39648331|FG002|Overall Study|Protocol Violation|1|||
16318374|NCT00687271|39648332|FG003|Overall Study|Protocol Violation|0|||
16201011|NCT00563368|39211856|FG001|Overall Study|Withdrawal by Subject|6|||
16512695|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
16512696|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
16201012|NCT00563368|39211857|FG002|Overall Study|Withdrawal by Subject|5|||
16201013|NCT00563368|39211858|FG003|Overall Study|Withdrawal by Subject|7|||
16201014|NCT00563368|39211859|FG004|Overall Study|Withdrawal by Subject|8|||
16201015|NCT00563368|39211860|FG005|Overall Study|Withdrawal by Subject|5|||
16201016|NCT00563368|39211861|FG006|Overall Study|Withdrawal by Subject|4|||
16201017|NCT00563368|39211855|FG000|Overall Study|protocol non-compliance|1|||
16201018|NCT00563368|39211856|FG001|Overall Study|protocol non-compliance|1|||
16201019|NCT00563368|39211857|FG002|Overall Study|protocol non-compliance|2|||
16201020|NCT00563368|39211858|FG003|Overall Study|protocol non-compliance|1|||
16201021|NCT00563368|39211859|FG004|Overall Study|protocol non-compliance|0|||
16201022|NCT00563368|39211860|FG005|Overall Study|protocol non-compliance|1|||
16201023|NCT00563368|39211861|FG006|Overall Study|protocol non-compliance|3|||
16201024|NCT00563368|39211855|FG000|Overall Study|Pregnancy|1|||
16201025|NCT00563368|39211856|FG001|Overall Study|Pregnancy|0|||
16201026|NCT00563368|39211857|FG002|Overall Study|Pregnancy|1|||
16201027|NCT00563368|39211858|FG003|Overall Study|Pregnancy|2|||
16201028|NCT00563368|39211859|FG004|Overall Study|Pregnancy|1|||
16201029|NCT00563368|39211860|FG005|Overall Study|Pregnancy|2|||
16201030|NCT00563368|39211861|FG006|Overall Study|Pregnancy|0|||
16201031|NCT00563368|39211855|FG000|Overall Study|requirement for restricted medication|0|||
16201032|NCT00563368|39211856|FG001|Overall Study|requirement for restricted medication|0|||
16201033|NCT00563368|39211857|FG002|Overall Study|requirement for restricted medication|2|||
16201034|NCT00563368|39211858|FG003|Overall Study|requirement for restricted medication|0|||
16201035|NCT00563368|39211859|FG004|Overall Study|requirement for restricted medication|0|||
16201036|NCT00563368|39211860|FG005|Overall Study|requirement for restricted medication|0|||
16201037|NCT00563368|39211861|FG006|Overall Study|requirement for restricted medication|0|||
16201038|NCT00563368|39211855|FG000|Overall Study|Other|5|||
16201039|NCT00563368|39211856|FG001|Overall Study|Other|5|||
16201040|NCT00563368|39211857|FG002|Overall Study|Other|3|||
16201041|NCT00563368|39211858|FG003|Overall Study|Other|4|||
16201042|NCT00563368|39211859|FG004|Overall Study|Other|4|||
16201043|NCT00563368|39211860|FG005|Overall Study|Other|4|||
16201044|NCT00563368|39211861|FG006|Overall Study|Other|0|||
16201045|NCT01204697|39211862|FG000|Overall Study|Death|26|||
16201046|NCT01204697|39211863|FG001|Overall Study|Death|27|||
16201047|NCT01204697|39211862|FG000|Overall Study|Lost to Follow-up|3|||
16201048|NCT01204697|39211863|FG001|Overall Study|Lost to Follow-up|4|||
16201049|NCT01204697|39211862|FG000|Overall Study|Withdrawal by Subject|2|||
16201050|NCT01204697|39211863|FG001|Overall Study|Withdrawal by Subject|4|||
16201051|NCT01204697|39211862|FG000|Overall Study|Randomized, but not treated|0|||
16201052|NCT01204697|39211863|FG001|Overall Study|Randomized, but not treated|1|||
16201053|NCT05254613|39211867|FG000|Overall Study|Lost to Follow-up|0|||
16201054|NCT05254613|39211868|FG001|Overall Study|Lost to Follow-up|0|||
16201055|NCT05254613|39211869|FG002|Overall Study|Lost to Follow-up|1|||
16201056|NCT01167582|39211871|FG000|Overall Study|Lost to Follow-up|0|||
16201057|NCT01167582|39211872|FG001|Overall Study|Lost to Follow-up|1|||
16201058|NCT01318512|39211874|FG000|Maintenance Period (6 Months)|Death|2|||
16201059|NCT01318512|39211874|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
16201060|NCT00881361|39211875|FG000|Overall Study|Terminated prior to surgery|27|||
16201061|NCT00881361|39211876|FG001|Overall Study|Terminated prior to surgery|7|||
16201062|NCT00881361|39211877|FG002|Overall Study|Terminated prior to surgery|0|||
16201063|NCT00881361|39211875|FG000|Overall Study|Ineligible|17|||
16201064|NCT00881361|39211876|FG001|Overall Study|Ineligible|2|||
16201065|NCT00881361|39211877|FG002|Overall Study|Ineligible|2|||
16201066|NCT02802878|39211878|FG000|Overall Study|Withdrawal by Subject|3|||
16201067|NCT02802878|39211879|FG001|Overall Study|Withdrawal by Subject|3|||
16201068|NCT02802878|39211878|FG000|Overall Study|Protocol Violation|1|||
16201069|NCT02802878|39211879|FG001|Overall Study|Protocol Violation|0|||
16201070|NCT01840228|39211880|FG000|Overall Study|Lost to Follow-up|1|||
16201071|NCT01840228|39211881|FG001|Overall Study|Lost to Follow-up|1|||
16201072|NCT00699842|39211882|FG000|Overall Study|Death|0|||
16201073|NCT00699842|39211883|FG001|Overall Study|Death|1|||
16201074|NCT00699842|39211884|FG002|Overall Study|Death|0|||
16201075|NCT03067129|39211885|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
16512697|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
16512698|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
16512699|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
16512700|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
16201076|NCT03067129|39211886|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
16201077|NCT03067129|39211887|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
16201078|NCT03067129|39211888|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
16201079|NCT03067129|39211885|FG000|Overall Study|Withdrawal by Subject|0|||
16201080|NCT03067129|39211886|FG001|Overall Study|Withdrawal by Subject|0|||
16201081|NCT03067129|39211887|FG002|Overall Study|Withdrawal by Subject|1|||
16201082|NCT03067129|39211888|FG003|Overall Study|Withdrawal by Subject|2|||
16201083|NCT03067129|39211885|FG000|Overall Study|Lost to Follow-up|5|||
16201084|NCT03067129|39211886|FG001|Overall Study|Lost to Follow-up|5|||
16201085|NCT03067129|39211887|FG002|Overall Study|Lost to Follow-up|4|||
16201086|NCT03067129|39211888|FG003|Overall Study|Lost to Follow-up|3|||
16201087|NCT00892957|39211889|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
16201088|NCT00892957|39211890|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
16201089|NCT00892957|39211889|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
16201090|NCT00892957|39211890|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
16201091|NCT04603391|39211891|FG000|First Intervention (4 Days)|Adverse Event|1|||
16201092|NCT04603391|39211892|FG001|First Intervention (4 Days)|Adverse Event|0|||
16201093|NCT04603391|39211891|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
16201094|NCT04603391|39211892|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
16201095|NCT00067470|39211895|FG000|Overall Study|Withdrawal by Subject|0|||
16201096|NCT00067470|39211896|FG001|Overall Study|Withdrawal by Subject|1|||
16201097|NCT00565058|39211901|FG000|Overall Study|Adverse Event|1|||
16201098|NCT00565058|39211902|FG001|Overall Study|Adverse Event|0|||
16201099|NCT01928485|39211903|FG000|Overall Study|Physician Decision|0|||
16201100|NCT01928485|39211904|FG001|Overall Study|Physician Decision|1|||
16201101|NCT00795509|39211905|FG000|Overall Study|Protocol Violation|31|||
16201102|NCT03521193|39211906|FG000|Overall Study|Withdrawal by Subject|8|||
16201103|NCT03521193|39211907|FG001|Overall Study|Withdrawal by Subject|0|||
16201104|NCT03521193|39211906|FG000|Overall Study|non compliant to ASA treatment|8|||
16201105|NCT03521193|39211907|FG001|Overall Study|non compliant to ASA treatment|0|||
16201106|NCT04096326|39211911|FG000|Overall Study|Withdrawal by Subject|0|||
16201107|NCT04096326|39211912|FG001|Overall Study|Withdrawal by Subject|0|||
16201108|NCT04096326|39211913|FG002|Overall Study|Withdrawal by Subject|0|||
16201109|NCT04096326|39211914|FG003|Overall Study|Withdrawal by Subject|0|||
16201110|NCT04096326|39211915|FG004|Overall Study|Withdrawal by Subject|0|||
16201111|NCT04096326|39211916|FG005|Overall Study|Withdrawal by Subject|0|||
16201112|NCT04096326|39211917|FG006|Overall Study|Withdrawal by Subject|1|||
16201113|NCT04096326|39211918|FG007|Overall Study|Withdrawal by Subject|0|||
16512701|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
16512702|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
16512703|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
16512704|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
16512705|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
16512706|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
16512707|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
16512708|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
16512709|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
16512710|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
16512711|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
16512712|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
16512713|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
16201114|NCT04096326|39211919|FG008|Overall Study|Withdrawal by Subject|0|||
16201115|NCT04096326|39211920|FG009|Overall Study|Withdrawal by Subject|0|||
16201116|NCT04096326|39211911|FG000|Overall Study|Lost to Follow-up|0|||
16201117|NCT04096326|39211912|FG001|Overall Study|Lost to Follow-up|1|||
16201118|NCT04096326|39211913|FG002|Overall Study|Lost to Follow-up|0|||
16201119|NCT04096326|39211914|FG003|Overall Study|Lost to Follow-up|0|||
16201120|NCT04096326|39211915|FG004|Overall Study|Lost to Follow-up|0|||
16201121|NCT04096326|39211916|FG005|Overall Study|Lost to Follow-up|0|||
16201122|NCT04096326|39211917|FG006|Overall Study|Lost to Follow-up|0|||
16201123|NCT04096326|39211918|FG007|Overall Study|Lost to Follow-up|0|||
16318375|NCT00687271|39648329|FG000|Overall Study|Withdrawal by Subject|0|||
16318376|NCT00687271|39648330|FG001|Overall Study|Withdrawal by Subject|1|||
16318377|NCT00687271|39648331|FG002|Overall Study|Withdrawal by Subject|3|||
16318378|NCT00687271|39648332|FG003|Overall Study|Withdrawal by Subject|0|||
16318379|NCT00556933|39648333|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
16318380|NCT00556933|39648334|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
16318381|NCT00556933|39648335|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
16318382|NCT00556933|39648336|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
16318383|NCT00556933|39648333|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
16318384|NCT00556933|39648334|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
16393647|NCT03035864|39922342|FG001|Follow-up Period|Other|2|||
16201124|NCT04096326|39211919|FG008|Overall Study|Lost to Follow-up|0|||
16201125|NCT04096326|39211920|FG009|Overall Study|Lost to Follow-up|0|||
16201126|NCT04096326|39211911|FG000|Overall Study|COVID-19-related reasons|0|||
16201127|NCT04096326|39211912|FG001|Overall Study|COVID-19-related reasons|0|||
16201128|NCT04096326|39211913|FG002|Overall Study|COVID-19-related reasons|0|||
16201129|NCT04096326|39211914|FG003|Overall Study|COVID-19-related reasons|0|||
16201130|NCT04096326|39211915|FG004|Overall Study|COVID-19-related reasons|1|||
16201131|NCT04096326|39211916|FG005|Overall Study|COVID-19-related reasons|5|||
16201132|NCT04096326|39211917|FG006|Overall Study|COVID-19-related reasons|0|||
16201133|NCT04096326|39211918|FG007|Overall Study|COVID-19-related reasons|0|||
16201134|NCT04096326|39211919|FG008|Overall Study|COVID-19-related reasons|0|||
16201135|NCT04096326|39211920|FG009|Overall Study|COVID-19-related reasons|0|||
16201136|NCT02504268|39211921|FG000|Overall Study|Adverse Event|18|||
16201137|NCT02504268|39211922|FG001|Overall Study|Adverse Event|8|||
16201138|NCT02504268|39211923|FG002|Overall Study|Adverse Event|14|||
16201139|NCT02504268|39211924|FG003|Overall Study|Adverse Event|0|||
16201140|NCT02504268|39211925|FG004|Overall Study|Adverse Event|0|||
16201141|NCT02504268|39211926|FG005|Overall Study|Adverse Event|0|||
16201142|NCT02504268|39211927|FG006|Overall Study|Adverse Event|0|||
16201143|NCT02504268|39211928|FG007|Overall Study|Adverse Event|0|||
16201144|NCT02504268|39211929|FG008|Overall Study|Adverse Event|0|||
16201145|NCT02504268|39211921|FG000|Overall Study|Withdrawal of Consent|11|||
16201146|NCT02504268|39211922|FG001|Overall Study|Withdrawal of Consent|10|||
16201147|NCT02504268|39211923|FG002|Overall Study|Withdrawal of Consent|3|||
16201148|NCT02504268|39211924|FG003|Overall Study|Withdrawal of Consent|0|||
16201149|NCT02504268|39211925|FG004|Overall Study|Withdrawal of Consent|0|||
16201150|NCT02504268|39211926|FG005|Overall Study|Withdrawal of Consent|0|||
16201151|NCT02504268|39211927|FG006|Overall Study|Withdrawal of Consent|0|||
16201152|NCT02504268|39211928|FG007|Overall Study|Withdrawal of Consent|0|||
16201153|NCT02504268|39211929|FG008|Overall Study|Withdrawal of Consent|0|||
16201154|NCT02504268|39211921|FG000|Overall Study|Pregnancy|2|||
16201155|NCT02504268|39211922|FG001|Overall Study|Pregnancy|0|||
16201156|NCT02504268|39211923|FG002|Overall Study|Pregnancy|0|||
16201157|NCT02504268|39211924|FG003|Overall Study|Pregnancy|0|||
16512714|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
16512715|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
16512716|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
16512717|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
16512718|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
16512719|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
16512720|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
16512721|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
16512722|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
16512723|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
16512724|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
16512725|NCT01218516|40351004|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
16512726|NCT01218516|40351005|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
16512727|NCT01218516|40351006|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
16512728|NCT01218516|40351007|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
16512729|NCT01077960|40351008|FG000|Overall Study|Adverse Event|6|||
16512730|NCT01077960|40351008|FG000|Overall Study|Protocol Violation|3|||
16512731|NCT01077960|40351008|FG000|Overall Study|Lost to Follow-up|5|||
16512732|NCT01077960|40351008|FG000|Overall Study|Subject decision|1|||
16512733|NCT01077960|40351008|FG000|Overall Study|Reason unspecified|1|||
16512734|NCT03080961|40351009|FG000|Overall Study|Withdrawal by Subject|3|||
16512735|NCT04542070|40351010|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
16512736|NCT04542070|40351011|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
16512737|NCT04542070|40351012|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
16512738|NCT04542070|40351013|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
16512739|NCT04542070|40351010|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
16512740|NCT04542070|40351011|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
16512741|NCT04542070|40351012|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
16512742|NCT04542070|40351013|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
16512743|NCT04542070|40351010|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
16512744|NCT04542070|40351011|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
16512745|NCT04542070|40351012|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
16512746|NCT04542070|40351013|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
16512747|NCT04542070|40351010|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
16512748|NCT04542070|40351011|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
16201158|NCT02504268|39211925|FG004|Overall Study|Pregnancy|0|||
16201159|NCT02504268|39211926|FG005|Overall Study|Pregnancy|0|||
16201160|NCT02504268|39211927|FG006|Overall Study|Pregnancy|0|||
16393648|NCT03341637|39922343|FG000|Overall Study|Lost to Follow-up|1|||
16201161|NCT02504268|39211928|FG007|Overall Study|Pregnancy|0|||
16201162|NCT02504268|39211929|FG008|Overall Study|Pregnancy|0|||
16201163|NCT02504268|39211921|FG000|Overall Study|Lost to Follow-up|3|||
16201164|NCT02504268|39211922|FG001|Overall Study|Lost to Follow-up|6|||
16201165|NCT02504268|39211923|FG002|Overall Study|Lost to Follow-up|4|||
16201166|NCT02504268|39211924|FG003|Overall Study|Lost to Follow-up|0|||
16201167|NCT02504268|39211925|FG004|Overall Study|Lost to Follow-up|0|||
16201168|NCT02504268|39211926|FG005|Overall Study|Lost to Follow-up|0|||
16201169|NCT02504268|39211927|FG006|Overall Study|Lost to Follow-up|0|||
16201170|NCT02504268|39211928|FG007|Overall Study|Lost to Follow-up|0|||
16201171|NCT02504268|39211929|FG008|Overall Study|Lost to Follow-up|0|||
16201172|NCT02504268|39211921|FG000|Overall Study|Death|1|||
16201173|NCT02504268|39211922|FG001|Overall Study|Death|1|||
16201174|NCT02504268|39211923|FG002|Overall Study|Death|0|||
16201175|NCT02504268|39211924|FG003|Overall Study|Death|0|||
16201176|NCT02504268|39211925|FG004|Overall Study|Death|0|||
16201177|NCT02504268|39211926|FG005|Overall Study|Death|0|||
16201178|NCT02504268|39211927|FG006|Overall Study|Death|0|||
16201179|NCT02504268|39211928|FG007|Overall Study|Death|0|||
16201180|NCT02504268|39211929|FG008|Overall Study|Death|0|||
16201181|NCT02504268|39211921|FG000|Overall Study|Subject Request to Discontinue|11|||
16201182|NCT02504268|39211922|FG001|Overall Study|Subject Request to Discontinue|3|||
16201183|NCT02504268|39211923|FG002|Overall Study|Subject Request to Discontinue|6|||
16201184|NCT02504268|39211924|FG003|Overall Study|Subject Request to Discontinue|0|||
16201185|NCT02504268|39211925|FG004|Overall Study|Subject Request to Discontinue|0|||
16201186|NCT02504268|39211926|FG005|Overall Study|Subject Request to Discontinue|0|||
16201187|NCT02504268|39211927|FG006|Overall Study|Subject Request to Discontinue|0|||
16201188|NCT02504268|39211928|FG007|Overall Study|Subject Request to Discontinue|0|||
16201189|NCT02504268|39211929|FG008|Overall Study|Subject Request to Discontinue|0|||
16201190|NCT02504268|39211921|FG000|Overall Study|No Longer Meets Study Criteria|2|||
16201191|NCT02504268|39211922|FG001|Overall Study|No Longer Meets Study Criteria|3|||
16201192|NCT02504268|39211923|FG002|Overall Study|No Longer Meets Study Criteria|0|||
16201193|NCT02504268|39211924|FG003|Overall Study|No Longer Meets Study Criteria|0|||
16201194|NCT02504268|39211925|FG004|Overall Study|No Longer Meets Study Criteria|0|||
16201195|NCT02504268|39211926|FG005|Overall Study|No Longer Meets Study Criteria|0|||
16201196|NCT02504268|39211927|FG006|Overall Study|No Longer Meets Study Criteria|0|||
16201197|NCT02504268|39211928|FG007|Overall Study|No Longer Meets Study Criteria|0|||
16201198|NCT02504268|39211929|FG008|Overall Study|No Longer Meets Study Criteria|0|||
16201199|NCT02504268|39211921|FG000|Overall Study|Lack of Efficacy|11|||
16201200|NCT02504268|39211922|FG001|Overall Study|Lack of Efficacy|35|||
16201201|NCT02504268|39211923|FG002|Overall Study|Lack of Efficacy|9|||
16201202|NCT02504268|39211924|FG003|Overall Study|Lack of Efficacy|0|||
16201203|NCT02504268|39211925|FG004|Overall Study|Lack of Efficacy|0|||
16201204|NCT02504268|39211926|FG005|Overall Study|Lack of Efficacy|0|||
16318385|NCT00556933|39648335|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
16318386|NCT00556933|39648336|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
16318387|NCT00556933|39648333|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
16318388|NCT00556933|39648334|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
16318389|NCT00556933|39648335|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
16318390|NCT00556933|39648336|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
16318391|NCT00556933|39648333|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
16318392|NCT00556933|39648334|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
16512749|NCT04542070|40351012|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
16512750|NCT04542070|40351013|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
16512751|NCT04542070|40351010|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
16512752|NCT04542070|40351011|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
16318393|NCT00556933|39648335|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
16318394|NCT00556933|39648336|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
16318395|NCT00556933|39648333|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
16318396|NCT00556933|39648334|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
16318397|NCT00556933|39648335|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
16318398|NCT00556933|39648336|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
16318399|NCT00556933|39648333|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
16393649|NCT03341637|39922344|FG001|Overall Study|Lost to Follow-up|0|||
16393650|NCT03341637|39922343|FG000|Overall Study|Withdrawal by Subject|3|||
16393651|NCT03341637|39922344|FG001|Overall Study|Withdrawal by Subject|3|||
16512753|NCT04542070|40351012|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
16512754|NCT04542070|40351013|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
16512755|NCT04542070|40351010|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
16090230|NCT00713596|38820148|FG000|Overall Study|Study was terminated|2|||
16201205|NCT02504268|39211927|FG006|Overall Study|Lack of Efficacy|0|||
16201206|NCT02504268|39211928|FG007|Overall Study|Lack of Efficacy|0|||
16201207|NCT02504268|39211929|FG008|Overall Study|Lack of Efficacy|0|||
16201208|NCT02504268|39211921|FG000|Overall Study|Poor/Non-Compliance|3|||
16318400|NCT00556933|39648334|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
16318401|NCT00556933|39648335|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
16318402|NCT00556933|39648336|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
16318403|NCT00556933|39648333|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
16318404|NCT00556933|39648334|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
16318405|NCT00556933|39648335|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
16318406|NCT00556933|39648336|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
16318407|NCT00556933|39648333|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
16318408|NCT00556933|39648334|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
16318409|NCT00556933|39648335|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
16318410|NCT00556933|39648336|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
16318411|NCT00556933|39648333|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
16318412|NCT00556933|39648334|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
16318413|NCT00556933|39648335|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
16318414|NCT00556933|39648336|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
16318415|NCT00556933|39648333|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
16318416|NCT00556933|39648334|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
16318417|NCT00556933|39648335|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
16318418|NCT00556933|39648336|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
16318419|NCT00556933|39648333|FG000|CNI Withdrawal vs. Minimization|Death|0|||
16318420|NCT00556933|39648334|FG001|CNI Withdrawal vs. Minimization|Death|0|||
16318421|NCT00556933|39648335|FG002|CNI Withdrawal vs. Minimization|Death|0|||
16318422|NCT00556933|39648336|FG003|CNI Withdrawal vs. Minimization|Death|1|||
16318423|NCT03526861|39648337|FG000|Initial Treatment Period|Not dosed|1|||
16318424|NCT03526861|39648338|FG001|Initial Treatment Period|Not dosed|1|||
16318425|NCT03526861|39648339|FG002|Initial Treatment Period|Not dosed|1|||
16318426|NCT03526861|39648340|FG003|Initial Treatment Period|Not dosed|0|||
16318427|NCT03526861|39648341|FG004|Initial Treatment Period|Not dosed|0|||
16318428|NCT03526861|39648342|FG005|Initial Treatment Period|Not dosed|0|||
16318429|NCT03526861|39648343|FG006|Initial Treatment Period|Not dosed|0|||
16318430|NCT03526861|39648344|FG007|Initial Treatment Period|Not dosed|0|||
16318431|NCT03526861|39648345|FG008|Initial Treatment Period|Not dosed|0|||
16318432|NCT03526861|39648337|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
16318433|NCT03526861|39648338|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
16318434|NCT03526861|39648339|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
16318435|NCT03526861|39648340|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16512756|NCT04542070|40351011|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
16512757|NCT04542070|40351012|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
16512758|NCT04542070|40351013|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
16512759|NCT04542070|40351010|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
16512760|NCT04542070|40351011|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
16512761|NCT04542070|40351012|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
16512762|NCT04542070|40351013|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
16512763|NCT04542070|40351010|FG000|Maintenance + Extension Period|Adverse Event|10|||
16512764|NCT04542070|40351011|FG001|Maintenance + Extension Period|Adverse Event|2|||
16512765|NCT04542070|40351012|FG002|Maintenance + Extension Period|Adverse Event|0|||
16512766|NCT04542070|40351013|FG003|Maintenance + Extension Period|Adverse Event|0|||
16512767|NCT04542070|40351010|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
16512768|NCT04542070|40351011|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
16512769|NCT04542070|40351012|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
16512770|NCT04542070|40351013|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
16512771|NCT04542070|40351010|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
16512772|NCT04542070|40351011|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
16512773|NCT04542070|40351012|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
16512774|NCT04542070|40351013|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
16512775|NCT04542070|40351010|FG000|Maintenance + Extension Period|Physician Decision|1|||
16512776|NCT04542070|40351011|FG001|Maintenance + Extension Period|Physician Decision|1|||
16512777|NCT04542070|40351012|FG002|Maintenance + Extension Period|Physician Decision|0|||
16512778|NCT04542070|40351013|FG003|Maintenance + Extension Period|Physician Decision|0|||
16512779|NCT04542070|40351010|FG000|Maintenance + Extension Period|Protocol Violation|2|||
16512780|NCT04542070|40351011|FG001|Maintenance + Extension Period|Protocol Violation|5|||
16512781|NCT04542070|40351012|FG002|Maintenance + Extension Period|Protocol Violation|0|||
16512782|NCT04542070|40351013|FG003|Maintenance + Extension Period|Protocol Violation|0|||
16318436|NCT03526861|39648341|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16090231|NCT00713596|38820149|FG001|Overall Study|Study was terminated|3|||
16512783|NCT04542070|40351010|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
16512784|NCT04542070|40351011|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
16512785|NCT04542070|40351012|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
16512786|NCT04542070|40351013|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
16512787|NCT04542070|40351010|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
16512788|NCT04542070|40351011|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
16512789|NCT04542070|40351012|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
16512790|NCT04542070|40351013|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
16512791|NCT04542070|40351010|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
16512792|NCT04542070|40351011|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
16512793|NCT04542070|40351012|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
16512794|NCT04542070|40351013|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
16512795|NCT04542070|40351010|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
16512796|NCT04542070|40351011|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
16512797|NCT04542070|40351012|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
16512798|NCT04542070|40351013|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
16512799|NCT04542070|40351010|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
16512800|NCT04542070|40351011|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
16512801|NCT04542070|40351012|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
16512802|NCT04542070|40351013|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
16512803|NCT04542070|40351010|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
16512804|NCT04542070|40351011|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
16512805|NCT04542070|40351012|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
16512806|NCT04542070|40351013|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
16512807|NCT04542070|40351010|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
16090232|NCT00713596|38820150|FG002|Overall Study|Study was terminated|2|||
16090233|NCT00553332|38820155|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
16090234|NCT00570505|38820156|FG000|Overall Study|Adverse Event|7|||
16090235|NCT00570505|38820156|FG000|Overall Study|Withdrawal by Subject|7|||
16090236|NCT00570505|38820156|FG000|Overall Study|Lost to Follow-up|23|||
16090237|NCT00570505|38820156|FG000|Overall Study|Other loss to follow-up|4|||
16318437|NCT03526861|39648342|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318438|NCT03526861|39648343|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16090238|NCT02514824|38820157|FG000|Overall Study|Withdrawal by Subject|1|||
16090239|NCT02514824|38820158|FG001|Overall Study|Withdrawal by Subject|0|||
16318439|NCT03526861|39648344|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318440|NCT03526861|39648345|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318441|NCT03526861|39648337|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
16318442|NCT03526861|39648338|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
16318443|NCT03526861|39648339|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
16318444|NCT03526861|39648340|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
16318445|NCT03526861|39648341|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
16318446|NCT03526861|39648342|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
16318447|NCT03526861|39648343|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
16318448|NCT03526861|39648344|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
16318449|NCT03526861|39648345|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
16318450|NCT03526861|39648337|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318451|NCT03526861|39648338|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318452|NCT03526861|39648339|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318453|NCT03526861|39648340|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
16318454|NCT03526861|39648341|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
16318455|NCT03526861|39648342|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318456|NCT03526861|39648343|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
16318457|NCT03526861|39648344|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318458|NCT03526861|39648345|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318459|NCT03526861|39648337|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
16318460|NCT03526861|39648338|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
16318461|NCT03526861|39648339|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
16318462|NCT03526861|39648340|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
16318463|NCT03526861|39648341|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
16318464|NCT03526861|39648342|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
16318465|NCT03526861|39648343|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
16318466|NCT03526861|39648344|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
16318467|NCT03526861|39648345|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
16318468|NCT03526861|39648337|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318469|NCT03526861|39648338|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318470|NCT03526861|39648339|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318471|NCT03526861|39648340|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
16318472|NCT03526861|39648341|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318473|NCT03526861|39648342|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318474|NCT03526861|39648343|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318475|NCT03526861|39648344|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318476|NCT03526861|39648345|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318477|NCT03526861|39648337|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318478|NCT03526861|39648338|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318479|NCT03526861|39648339|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318480|NCT03526861|39648340|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318481|NCT03526861|39648341|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318482|NCT03526861|39648342|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318483|NCT03526861|39648343|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318484|NCT03526861|39648344|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
16318485|NCT03526861|39648345|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
16318486|NCT03526861|39648337|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
16318487|NCT03526861|39648338|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
16318488|NCT03526861|39648339|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
16318489|NCT03526861|39648340|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
16318490|NCT03526861|39648341|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
16318491|NCT03526861|39648342|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
16318492|NCT03526861|39648343|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
16318493|NCT03526861|39648344|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
16318494|NCT03526861|39648345|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
16318495|NCT03526861|39648337|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318496|NCT03526861|39648338|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318497|NCT03526861|39648339|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318498|NCT03526861|39648340|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16393652|NCT03341637|39922343|FG000|Overall Study|Reason not Specified|1|||
16393653|NCT03341637|39922344|FG001|Overall Study|Reason not Specified|1|||
16393654|NCT00224120|39922345|FG000|Overall Study|Adverse Event|10|||
16393655|NCT00224120|39922346|FG001|Overall Study|Adverse Event|4|||
16393656|NCT00224120|39922345|FG000|Overall Study|Protocol Violation|1|||
16393657|NCT00224120|39922346|FG001|Overall Study|Protocol Violation|0|||
16393658|NCT00224120|39922345|FG000|Overall Study|Withdrawal by Subject|5|||
16393659|NCT00224120|39922346|FG001|Overall Study|Withdrawal by Subject|10|||
16393660|NCT00224120|39922345|FG000|Overall Study|Lack of Efficacy|0|||
16393661|NCT00224120|39922346|FG001|Overall Study|Lack of Efficacy|2|||
16393662|NCT00224120|39922345|FG000|Overall Study|Lost to Follow-up|2|||
16393663|NCT00224120|39922346|FG001|Overall Study|Lost to Follow-up|3|||
16393664|NCT00224120|39922345|FG000|Overall Study|Other|4|||
16393665|NCT00224120|39922346|FG001|Overall Study|Other|5|||
16393666|NCT01890265|39922347|FG000|Overall Study|Other (Unspecified reason)|0|||
16393667|NCT01890265|39922348|FG001|Overall Study|Other (Unspecified reason)|1|||
16393668|NCT01890265|39922349|FG002|Overall Study|Other (Unspecified reason)|0|||
16393669|NCT01890265|39922350|FG003|Overall Study|Other (Unspecified reason)|0|||
16393670|NCT01890265|39922351|FG004|Overall Study|Other (Unspecified reason)|0|||
16393671|NCT01890265|39922352|FG005|Overall Study|Other (Unspecified reason)|0|||
16318499|NCT03526861|39648341|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318500|NCT03526861|39648342|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318501|NCT03526861|39648343|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318502|NCT03526861|39648344|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
16318503|NCT03526861|39648345|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
16318504|NCT02996968|39648348|FG000|Overall Study|Withdrawal by Subject|1|||
16090240|NCT02514824|38820159|FG002|Overall Study|Withdrawal by Subject|0|||
16090241|NCT02514824|38820160|FG003|Overall Study|Withdrawal by Subject|0|||
16090242|NCT02514824|38820157|FG000|Overall Study|Dose-Limiting Toxicity|0|||
16090243|NCT02514824|38820158|FG001|Overall Study|Dose-Limiting Toxicity|1|||
16393672|NCT01890265|39922347|FG000|Overall Study|Progressive disease|6|||
16393673|NCT01890265|39922348|FG001|Overall Study|Progressive disease|6|||
16393674|NCT01890265|39922349|FG002|Overall Study|Progressive disease|0|||
16393675|NCT01890265|39922350|FG003|Overall Study|Progressive disease|0|||
16393676|NCT01890265|39922351|FG004|Overall Study|Progressive disease|0|||
16393677|NCT01890265|39922352|FG005|Overall Study|Progressive disease|0|||
16393678|NCT01890265|39922347|FG000|Overall Study|Adverse Event|2|||
16393679|NCT01890265|39922348|FG001|Overall Study|Adverse Event|1|||
16393680|NCT01890265|39922349|FG002|Overall Study|Adverse Event|0|||
16393681|NCT01890265|39922350|FG003|Overall Study|Adverse Event|0|||
16393682|NCT01890265|39922351|FG004|Overall Study|Adverse Event|0|||
16393683|NCT01890265|39922352|FG005|Overall Study|Adverse Event|0|||
16393684|NCT01890265|39922347|FG000|Overall Study|Death|2|||
16393685|NCT01890265|39922348|FG001|Overall Study|Death|3|||
16393686|NCT01890265|39922349|FG002|Overall Study|Death|1|||
16393687|NCT01890265|39922350|FG003|Overall Study|Death|0|||
16393688|NCT01890265|39922351|FG004|Overall Study|Death|0|||
16393689|NCT01890265|39922352|FG005|Overall Study|Death|0|||
16393690|NCT01890265|39922347|FG000|Overall Study|Withdrawal by Subject|0|||
16393691|NCT01890265|39922348|FG001|Overall Study|Withdrawal by Subject|2|||
16393692|NCT01890265|39922349|FG002|Overall Study|Withdrawal by Subject|3|||
16393693|NCT01890265|39922350|FG003|Overall Study|Withdrawal by Subject|0|||
16393694|NCT01890265|39922351|FG004|Overall Study|Withdrawal by Subject|2|||
16393695|NCT01890265|39922352|FG005|Overall Study|Withdrawal by Subject|0|||
16393696|NCT01977729|39922355|FG000|Overall Study|Study terminated|1|||
16393697|NCT01146613|39922356|FG000|Overall Study|Lost to Follow-up|3|||
16393698|NCT01146613|39922357|FG001|Overall Study|Lost to Follow-up|8|||
16512808|NCT04542070|40351011|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
16512809|NCT04542070|40351012|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
16512810|NCT04542070|40351013|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
16512811|NCT01469065|40351014|FG000|Overall Study|Lack of Efficacy|0|||
16512812|NCT01469065|40351015|FG001|Overall Study|Lack of Efficacy|0|||
16512813|NCT01469065|40351016|FG002|Overall Study|Lack of Efficacy|0|||
16512814|NCT01469065|40351017|FG003|Overall Study|Lack of Efficacy|0|||
16512815|NCT01469065|40351018|FG004|Overall Study|Lack of Efficacy|1|||
16512816|NCT01469065|40351014|FG000|Overall Study|Other|0|||
16512817|NCT01469065|40351015|FG001|Overall Study|Other|1|||
16512818|NCT01469065|40351016|FG002|Overall Study|Other|0|||
16512819|NCT01469065|40351017|FG003|Overall Study|Other|0|||
16512820|NCT01469065|40351018|FG004|Overall Study|Other|0|||
16512821|NCT00836875|40351019|FG000|Overall Study|Death|3|||
16512822|NCT00836875|40351020|FG001|Overall Study|Death|2|||
16512823|NCT00836875|40351019|FG000|Overall Study|Withdrawal by Subject|0|||
16512824|NCT00836875|40351020|FG001|Overall Study|Withdrawal by Subject|1|||
16512825|NCT04960228|40351021|FG000|Overall Study|Withdrawal by Subject|216|||
16512826|NCT04960228|40351022|FG001|Overall Study|Withdrawal by Subject|35|||
16512827|NCT04960228|40351021|FG000|Overall Study|Failed attention check|69|||
16512828|NCT04960228|40351022|FG001|Overall Study|Failed attention check|148|||
16512829|NCT04960228|40351021|FG000|Overall Study|Flagged for response quality by Dynata|3|||
16512830|NCT04960228|40351022|FG001|Overall Study|Flagged for response quality by Dynata|3|||
16512831|NCT04428333|40351023|FG000|Overall Study|Physician Decision|2|||
16512832|NCT04428333|40351024|FG001|Overall Study|Physician Decision|0|||
16512833|NCT04428333|40351023|FG000|Overall Study|Withdrawal by Subject|0|||
16512834|NCT04428333|40351024|FG001|Overall Study|Withdrawal by Subject|1|||
16512835|NCT04428333|40351023|FG000|Overall Study|In Follow-Up|5|||
16512836|NCT04428333|40351024|FG001|Overall Study|In Follow-Up|10|||
16512837|NCT04428333|40351023|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
16512838|NCT04428333|40351024|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
16512839|NCT01712984|40351028|FG000|Overall Study|Adverse Event|0|||
16512840|NCT01712984|40351029|FG001|Overall Study|Adverse Event|0|||
16512841|NCT01712984|40351030|FG002|Overall Study|Adverse Event|1|||
16512842|NCT01712984|40351028|FG000|Overall Study|Protocol Violation|2|||
16512843|NCT01712984|40351029|FG001|Overall Study|Protocol Violation|0|||
16512844|NCT01712984|40351030|FG002|Overall Study|Protocol Violation|1|||
16512845|NCT01712984|40351028|FG000|Overall Study|Lost to Follow-up|8|||
16512846|NCT01712984|40351029|FG001|Overall Study|Lost to Follow-up|10|||
16512847|NCT01712984|40351030|FG002|Overall Study|Lost to Follow-up|1|||
16512848|NCT01712984|40351028|FG000|Overall Study|Withdrawal by Subject|6|||
16512849|NCT01712984|40351029|FG001|Overall Study|Withdrawal by Subject|6|||
16090244|NCT02514824|38820159|FG002|Overall Study|Dose-Limiting Toxicity|0|||
16393699|NCT01146613|39922356|FG000|Overall Study|Lack of Efficacy|0|||
16393700|NCT01146613|39922357|FG001|Overall Study|Lack of Efficacy|1|||
16393701|NCT01146613|39922356|FG000|Overall Study|Death|1|||
16393702|NCT01146613|39922357|FG001|Overall Study|Death|0|||
16393703|NCT01146613|39922356|FG000|Overall Study|Physician Decision|1|||
16393704|NCT01146613|39922357|FG001|Overall Study|Physician Decision|0|||
16318505|NCT02996968|39648349|FG001|Overall Study|Withdrawal by Subject|0|||
16318506|NCT01120184|39648350|FG000|Overall Study|Adverse Event|0|||
16318507|NCT01120184|39648351|FG001|Overall Study|Adverse Event|1|||
16393705|NCT01146613|39922356|FG000|Overall Study|Withdrawal by Subject|0|||
16393706|NCT01146613|39922357|FG001|Overall Study|Withdrawal by Subject|3|||
16393707|NCT01146613|39922356|FG000|Overall Study|schedule conflict|1|||
16393708|NCT01146613|39922357|FG001|Overall Study|schedule conflict|0|||
16393709|NCT01146613|39922356|FG000|Overall Study|Outpatient detox|1|||
16393710|NCT01146613|39922357|FG001|Overall Study|Outpatient detox|0|||
16393711|NCT01970241|39922361|FG000|Overall Study|Withdrawal by Subject|2|||
16393712|NCT01970241|39922362|FG001|Overall Study|Withdrawal by Subject|0|||
16393713|NCT01970241|39922361|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
16393714|NCT01970241|39922362|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
16393715|NCT00402324|39922363|FG000|Overall Study|Lost to Follow-up|11|||
16393716|NCT00402324|39922364|FG001|Overall Study|Lost to Follow-up|11|||
16393717|NCT00402324|39922363|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
16393718|NCT00402324|39922364|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
16393719|NCT00402324|39922363|FG000|Overall Study|Protocol Violation|8|||
16393720|NCT00402324|39922364|FG001|Overall Study|Protocol Violation|7|||
16393721|NCT00402324|39922363|FG000|Overall Study|Withdrawal by Subject|5|||
16318508|NCT01120184|39648352|FG002|Overall Study|Adverse Event|0|||
16318509|NCT01120184|39648350|FG000|Overall Study|Lost to Follow-up|13|||
16318510|NCT01120184|39648351|FG001|Overall Study|Lost to Follow-up|13|||
16318511|NCT01120184|39648352|FG002|Overall Study|Lost to Follow-up|11|||
16318512|NCT01120184|39648350|FG000|Overall Study|Physician Decision|9|||
16318513|NCT01120184|39648351|FG001|Overall Study|Physician Decision|1|||
16318514|NCT01120184|39648352|FG002|Overall Study|Physician Decision|3|||
16318515|NCT01120184|39648350|FG000|Overall Study|Reason not Specified|8|||
16318516|NCT01120184|39648351|FG001|Overall Study|Reason not Specified|3|||
16318517|NCT01120184|39648352|FG002|Overall Study|Reason not Specified|12|||
16318518|NCT01120184|39648350|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
16318519|NCT01120184|39648351|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
16318520|NCT01120184|39648352|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
16318521|NCT01120184|39648350|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
16318522|NCT01120184|39648351|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
16318523|NCT01120184|39648352|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
16318524|NCT01120184|39648350|FG000|Overall Study|Death|170|||
16318525|NCT01120184|39648351|FG001|Overall Study|Death|176|||
16318526|NCT01120184|39648352|FG002|Overall Study|Death|169|||
16318527|NCT00523848|39648364|FG000|Overall Study|Adverse Event|11|||
16318528|NCT00523848|39648364|FG000|Overall Study|Withdrawal by Subject|2|||
16318529|NCT00523848|39648364|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
16318530|NCT00523848|39648364|FG000|Overall Study|Disease Progression|5|||
16393722|NCT00402324|39922364|FG001|Overall Study|Withdrawal by Subject|2|||
16318531|NCT00523848|39648364|FG000|Overall Study|Other, unspecified|4|||
16318532|NCT00927862|39648365|FG000|Overall Study|Missing data needed for endpt analyses|27|||
16393723|NCT00402324|39922363|FG000|Overall Study|Physician Decision|2|||
16393724|NCT00402324|39922364|FG001|Overall Study|Physician Decision|4|||
16393725|NCT00402324|39922363|FG000|Overall Study|Sponsor Decision|4|||
16318533|NCT00927862|39648366|FG001|Overall Study|Missing data needed for endpt analyses|45|||
16318534|NCT00957801|39648367|FG000|Overall Study|Withdrawal by Subject|0|||
16318535|NCT00957801|39648368|FG001|Overall Study|Withdrawal by Subject|0|||
16318536|NCT00957801|39648369|FG002|Overall Study|Withdrawal by Subject|0|||
16318537|NCT00957801|39648370|FG003|Overall Study|Withdrawal by Subject|1|||
16318538|NCT00162981|39648371|FG000|Overall Study|Adverse Event|2|||
16318539|NCT00162981|39648372|FG001|Overall Study|Adverse Event|5|||
16318540|NCT00162981|39648371|FG000|Overall Study|Withdrawal by Subject|1|||
16318541|NCT00162981|39648372|FG001|Overall Study|Withdrawal by Subject|1|||
16318542|NCT00162981|39648371|FG000|Overall Study|Physician Decision|1|||
16318543|NCT00162981|39648372|FG001|Overall Study|Physician Decision|0|||
16318544|NCT04390113|39648374|FG000|Overall Study|Not Treated|0|||
16318545|NCT04390113|39648375|FG001|Overall Study|Not Treated|1|||
16318546|NCT04390113|39648374|FG000|Overall Study|Adverse Event|1|||
16318547|NCT04390113|39648375|FG001|Overall Study|Adverse Event|0|||
16318548|NCT04390113|39648374|FG000|Overall Study|Death|2|||
16318549|NCT04390113|39648375|FG001|Overall Study|Death|1|||
16512850|NCT01712984|40351030|FG002|Overall Study|Withdrawal by Subject|7|||
16512851|NCT03350503|40351031|FG000|Overall Study|Adverse Event|5|||
16512852|NCT03350503|40351031|FG000|Overall Study|Withdrawal by Subject|5|||
16512853|NCT03350503|40351031|FG000|Overall Study|Continuation impossible due to move|4|||
16512854|NCT03350503|40351031|FG000|Overall Study|Physician Decision|3|||
16512855|NCT03277846|40351034|FG000|Overall Study|Inpatient stay too brief|12|||
16512856|NCT03277846|40351035|FG001|Overall Study|Inpatient stay too brief|11|||
16512857|NCT00678691|40351036|FG000|Overall Study|Adverse Event|6|||
16512858|NCT00678691|40351037|FG001|Overall Study|Adverse Event|4|||
16512859|NCT00799617|40351040|FG000|Main Testosterone Trial|Randomized in error|1|||
16512860|NCT00799617|40351041|FG001|Main Testosterone Trial|Randomized in error|1|||
16512861|NCT00799617|40351040|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
16512862|NCT00799617|40351041|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
16512863|NCT00799617|40351040|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
16512864|NCT00799617|40351041|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
16512865|NCT00799617|40351040|FG000|Sexual Funtion Trial|No Baseline Data|4|||
16512866|NCT00799617|40351041|FG001|Sexual Funtion Trial|No Baseline Data|7|||
16512867|NCT00799617|40351040|FG000|Physical Function Trial|Lost to Follow-up|6|||
16512868|NCT00799617|40351041|FG001|Physical Function Trial|Lost to Follow-up|11|||
16512869|NCT00799617|40351040|FG000|Vitality Trial|Lost to Follow-up|7|||
16512870|NCT00799617|40351041|FG001|Vitality Trial|Lost to Follow-up|22|||
16512871|NCT00799617|40351040|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
16512872|NCT00799617|40351041|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
16512873|NCT00799617|40351040|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
16512874|NCT00799617|40351041|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
16512875|NCT00799617|40351040|FG000|Bone Trial|Month 12 scan not available|6|||
16512876|NCT00799617|40351041|FG001|Bone Trial|Month 12 scan not available|16|||
16512877|NCT00799617|40351040|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
16512878|NCT00799617|40351041|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
16512879|NCT00799617|40351040|FG000|Anemia Trial|Withdrawal by Subject|3|||
16512880|NCT00799617|40351041|FG001|Anemia Trial|Withdrawal by Subject|3|||
16512881|NCT01143090|40351042|FG000|Overall Study|Lack of Efficacy|2|||
16512882|NCT01143090|40351042|FG000|Overall Study|Adverse Event|17|||
16512883|NCT01143090|40351042|FG000|Overall Study|Lost to Follow-up|9|||
16512884|NCT01143090|40351042|FG000|Overall Study|Protocol Violation|2|||
16512885|NCT01143090|40351042|FG000|Overall Study|Withdrawal by Subject|18|||
16512886|NCT01143090|40351042|FG000|Overall Study|Non-compliance with study drug|1|||
16512887|NCT01143090|40351042|FG000|Overall Study|Failure to meet eligibility criteria|1|||
16512888|NCT01143090|40351042|FG000|Overall Study|Administrative|1|||
16512889|NCT01539226|40351048|FG000|Overall Study|Withdrawal by Subject|24|||
16512890|NCT01539226|40351049|FG001|Overall Study|Withdrawal by Subject|54|||
16512891|NCT01539226|40351048|FG000|Overall Study|Lost to Follow-up|20|||
16512892|NCT01539226|40351049|FG001|Overall Study|Lost to Follow-up|54|||
16512893|NCT01539226|40351048|FG000|Overall Study|Death|1|||
16512894|NCT01539226|40351049|FG001|Overall Study|Death|2|||
16512895|NCT01539226|40351048|FG000|Overall Study|Adverse Event|2|||
16512896|NCT01539226|40351049|FG001|Overall Study|Adverse Event|0|||
16512897|NCT01539226|40351048|FG000|Overall Study|Pregnancy|13|||
16512898|NCT01539226|40351049|FG001|Overall Study|Pregnancy|29|||
16512899|NCT01539226|40351048|FG000|Overall Study|inappropriate enrollment|0|||
16512900|NCT01539226|40351049|FG001|Overall Study|inappropriate enrollment|1|||
16512901|NCT01539226|40351048|FG000|Overall Study|Multiple Reasons|3|||
16512902|NCT01539226|40351049|FG001|Overall Study|Multiple Reasons|1|||
16512903|NCT01539226|40351048|FG000|Overall Study|not HIV seroconversion-related|93|||
16512904|NCT01539226|40351049|FG001|Overall Study|not HIV seroconversion-related|176|||
16318550|NCT04390113|39648374|FG000|Overall Study|Physician Decision|1|||
16318551|NCT04390113|39648375|FG001|Overall Study|Physician Decision|3|||
16318552|NCT04390113|39648374|FG000|Overall Study|Study Terminated by Sponsor|5|||
16318553|NCT04390113|39648375|FG001|Overall Study|Study Terminated by Sponsor|3|||
16318554|NCT04390113|39648374|FG000|Overall Study|Withdrawal by Subject|10|||
16090245|NCT02514824|38820160|FG003|Overall Study|Dose-Limiting Toxicity|0|||
16512905|NCT01539226|40351048|FG000|Overall Study|HIV seroconversion-related|55|||
16512906|NCT01539226|40351049|FG001|Overall Study|HIV seroconversion-related|80|||
16512907|NCT01539226|40351048|FG000|Overall Study|Non-compliance|6|||
16512908|NCT01539226|40351049|FG001|Overall Study|Non-compliance|8|||
16512909|NCT02404311|40351050|FG000|Part A: Month 0-18|Death|2|||
16512910|NCT02404311|40351051|FG001|Part A: Month 0-18|Death|0|||
16512911|NCT02404311|40351052|FG002|Part A: Month 0-18|Death|0|||
16512912|NCT02404311|40351053|FG003|Part A: Month 0-18|Death|0|||
16512913|NCT02404311|40351054|FG004|Part A: Month 0-18|Death|0|||
16512914|NCT02404311|40351050|FG000|Part A: Month 0-18|Physician Decision|1|||
16512915|NCT02404311|40351051|FG001|Part A: Month 0-18|Physician Decision|0|||
16512916|NCT02404311|40351052|FG002|Part A: Month 0-18|Physician Decision|0|||
16512917|NCT02404311|40351053|FG003|Part A: Month 0-18|Physician Decision|0|||
16512918|NCT02404311|40351054|FG004|Part A: Month 0-18|Physician Decision|0|||
16512919|NCT02404311|40351050|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
16512920|NCT02404311|40351051|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
16318555|NCT04390113|39648375|FG001|Overall Study|Withdrawal by Subject|5|||
16318556|NCT04390113|39648374|FG000|Overall Study|Other|1|||
16318557|NCT04390113|39648375|FG001|Overall Study|Other|0|||
16318558|NCT04390113|39648374|FG000|Overall Study|Missing|0|||
16318559|NCT04390113|39648375|FG001|Overall Study|Missing|1|||
16512921|NCT02404311|40351052|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
16512922|NCT02404311|40351053|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
16512923|NCT02404311|40351054|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
16512924|NCT02404311|40351050|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
16512925|NCT02404311|40351051|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
16512926|NCT02404311|40351052|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
16512927|NCT02404311|40351053|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
16512928|NCT02404311|40351054|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
16512929|NCT02404311|40351050|FG000|Part A: Month 0-18|HIV Infection|6|||
16512930|NCT02404311|40351051|FG001|Part A: Month 0-18|HIV Infection|2|||
16512931|NCT02404311|40351052|FG002|Part A: Month 0-18|HIV Infection|0|||
16512932|NCT02404311|40351053|FG003|Part A: Month 0-18|HIV Infection|0|||
16512933|NCT02404311|40351054|FG004|Part A: Month 0-18|HIV Infection|0|||
16512934|NCT02404311|40351050|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
16512935|NCT02404311|40351051|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
16512936|NCT02404311|40351052|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
16512937|NCT02404311|40351053|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
16512938|NCT02404311|40351054|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
16512939|NCT03491150|40351057|FG000|Overall Study|Adverse Event|1|||
16512940|NCT03491150|40351058|FG001|Overall Study|Adverse Event|0|||
16512941|NCT03491150|40351057|FG000|Overall Study|Study Terminated by Sponsor|74|||
16512942|NCT03491150|40351058|FG001|Overall Study|Study Terminated by Sponsor|70|||
16090246|NCT00484198|38820161|FG000|Overall Study|Participant Withdrew Consent|12|||
16512943|NCT03491150|40351057|FG000|Overall Study|Other|0|||
16512944|NCT03491150|40351058|FG001|Overall Study|Other|1|||
16512945|NCT03491150|40351057|FG000|Overall Study|Withdrawal by Subject|1|||
16512946|NCT03491150|40351058|FG001|Overall Study|Withdrawal by Subject|2|||
16512947|NCT02346240|40351059|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512948|NCT02346240|40351060|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
16512949|NCT02346240|40351061|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
16512950|NCT02346240|40351062|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
16512951|NCT02346240|40351063|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512952|NCT02346240|40351064|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512953|NCT02346240|40351065|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512954|NCT02346240|40351066|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512955|NCT02346240|40351067|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512956|NCT02346240|40351068|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512957|NCT02346240|40351069|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16090247|NCT00484198|38820162|FG001|Overall Study|Participant Withdrew Consent|21|||
16090248|NCT00484198|38820163|FG002|Overall Study|Participant Withdrew Consent|47|||
16090249|NCT00484198|38820164|FG003|Overall Study|Participant Withdrew Consent|59|||
16318560|NCT04390503|39648377|FG000|Overall Study|Physician Decision|2|||
16318561|NCT04390503|39648378|FG001|Overall Study|Physician Decision|1|||
16318562|NCT04390503|39648377|FG000|Overall Study|Adverse Event|1|||
16318563|NCT04390503|39648378|FG001|Overall Study|Adverse Event|0|||
16318564|NCT00917852|39648379|FG000|Overall Study|Death|6|||
16318565|NCT04179838|39648385|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
16318566|NCT04179838|39648386|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
16318567|NCT04179838|39648385|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
16318568|NCT04179838|39648386|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
16512958|NCT02346240|40351070|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512959|NCT02346240|40351071|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16318569|NCT02062450|39648387|FG000|Overall Study|No follow-up visit|124|||
16393726|NCT00402324|39922364|FG001|Overall Study|Sponsor Decision|5|||
16393727|NCT00402324|39922363|FG000|Overall Study|Lack of Efficacy|1|||
16393728|NCT00402324|39922364|FG001|Overall Study|Lack of Efficacy|4|||
16393729|NCT00402324|39922363|FG000|Overall Study|Adverse Event|6|||
16393730|NCT00402324|39922364|FG001|Overall Study|Adverse Event|4|||
16393731|NCT00402324|39922363|FG000|Overall Study|Death|1|||
16393732|NCT00402324|39922364|FG001|Overall Study|Death|0|||
16393733|NCT01508910|39922367|FG000|Treatment|Death|2|||
16393734|NCT01508910|39922368|FG001|Treatment|Death|3|||
16393735|NCT01508910|39922369|FG002|Treatment|Death|2|||
16393736|NCT01508910|39922370|FG003|Treatment|Death|0|||
16393737|NCT01508910|39922367|FG000|Treatment|Lost to Follow-up|0|||
16318570|NCT02172664|39648388|FG000|Overall Study|Lost to Follow-up|4|||
16090250|NCT00484198|38820161|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
16090251|NCT00484198|38820162|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
16090252|NCT00484198|38820163|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
16318571|NCT02172664|39648389|FG001|Overall Study|Lost to Follow-up|4|||
16318572|NCT02172664|39648388|FG000|Overall Study|Death|1|||
16318573|NCT02172664|39648389|FG001|Overall Study|Death|1|||
16318574|NCT02172664|39648388|FG000|Overall Study|Moved out of area|1|||
16318575|NCT02172664|39648389|FG001|Overall Study|Moved out of area|1|||
16318576|NCT04176250|39648390|FG000|Overall Study|Adverse Event|0|||
16318577|NCT04176250|39648391|FG001|Overall Study|Adverse Event|1|||
16318578|NCT04176250|39648392|FG002|Overall Study|Adverse Event|0|||
16318579|NCT04176250|39648393|FG003|Overall Study|Adverse Event|1|||
16318580|NCT04176250|39648394|FG004|Overall Study|Adverse Event|0|||
16318581|NCT04176250|39648395|FG005|Overall Study|Adverse Event|1|||
16318582|NCT04176250|39648390|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
16318583|NCT04176250|39648391|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
16318584|NCT04176250|39648392|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
16318585|NCT04176250|39648393|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
16318586|NCT04176250|39648394|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
16318587|NCT04176250|39648395|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
16318588|NCT04176250|39648390|FG000|Overall Study|Withdrawal by Subject|0|||
16318589|NCT04176250|39648391|FG001|Overall Study|Withdrawal by Subject|0|||
16318590|NCT04176250|39648392|FG002|Overall Study|Withdrawal by Subject|0|||
16318591|NCT04176250|39648393|FG003|Overall Study|Withdrawal by Subject|0|||
16318592|NCT04176250|39648394|FG004|Overall Study|Withdrawal by Subject|0|||
16318593|NCT04176250|39648395|FG005|Overall Study|Withdrawal by Subject|1|||
16318594|NCT04176250|39648390|FG000|Overall Study|Randomized in error|0|||
16318595|NCT04176250|39648391|FG001|Overall Study|Randomized in error|0|||
16318596|NCT04176250|39648392|FG002|Overall Study|Randomized in error|0|||
16318597|NCT04176250|39648393|FG003|Overall Study|Randomized in error|0|||
16318598|NCT04176250|39648394|FG004|Overall Study|Randomized in error|1|||
16318599|NCT04176250|39648395|FG005|Overall Study|Randomized in error|0|||
16318600|NCT01131455|39648398|FG000|Overall Study|Death of PI|6|||
16318601|NCT01131455|39648399|FG001|Overall Study|Death of PI|4|||
16318602|NCT01131455|39648400|FG002|Overall Study|Death of PI|0|||
16318603|NCT03852472|39648401|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
16318604|NCT03852472|39648402|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
16318605|NCT03852472|39648403|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
16318606|NCT03852472|39648404|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
16318607|NCT03852472|39648405|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
16318608|NCT03852472|39648401|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
16318609|NCT03852472|39648402|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
16318610|NCT03852472|39648403|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
16318611|NCT03852472|39648404|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
16090253|NCT00484198|38820164|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
16090254|NCT00484198|38820161|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
16090255|NCT00484198|38820162|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
16090256|NCT00484198|38820163|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
16090257|NCT00484198|38820164|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
16090258|NCT00484198|38820161|FG000|Overall Study|Adverse Event|3|||
16090259|NCT00484198|38820162|FG001|Overall Study|Adverse Event|11|||
16318612|NCT03852472|39648405|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
16318613|NCT03852472|39648401|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
16393738|NCT01508910|39922368|FG001|Treatment|Lost to Follow-up|0|||
16318614|NCT03852472|39648402|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
16393739|NCT01508910|39922369|FG002|Treatment|Lost to Follow-up|2|||
16393740|NCT01508910|39922370|FG003|Treatment|Lost to Follow-up|1|||
16512960|NCT02346240|40351072|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16393741|NCT01508910|39922367|FG000|Treatment|Withdrawal by Subject|0|||
16393742|NCT01508910|39922368|FG001|Treatment|Withdrawal by Subject|1|||
16393743|NCT01508910|39922369|FG002|Treatment|Withdrawal by Subject|6|||
16393744|NCT01508910|39922370|FG003|Treatment|Withdrawal by Subject|1|||
16393745|NCT01508910|39922367|FG000|Treatment|Sponsor Decision|0|||
16393746|NCT01508910|39922368|FG001|Treatment|Sponsor Decision|0|||
16393747|NCT01508910|39922369|FG002|Treatment|Sponsor Decision|0|||
16393748|NCT01508910|39922370|FG003|Treatment|Sponsor Decision|1|||
16393749|NCT01127633|39922371|FG000|Overall Study|Adverse Event|74|||
16393750|NCT01127633|39922372|FG001|Overall Study|Adverse Event|73|||
16393751|NCT01127633|39922371|FG000|Overall Study|Death|40|||
16393752|NCT01127633|39922372|FG001|Overall Study|Death|43|||
16393753|NCT01127633|39922371|FG000|Overall Study|Lost to Follow-up|4|||
16393754|NCT01127633|39922372|FG001|Overall Study|Lost to Follow-up|0|||
16393755|NCT01127633|39922371|FG000|Overall Study|Parent/Caregiver Decision|246|||
16393756|NCT01127633|39922372|FG001|Overall Study|Parent/Caregiver Decision|228|||
16201209|NCT02504268|39211922|FG001|Overall Study|Poor/Non-Compliance|2|||
16201210|NCT02504268|39211923|FG002|Overall Study|Poor/Non-Compliance|3|||
16201211|NCT02504268|39211924|FG003|Overall Study|Poor/Non-Compliance|0|||
16201212|NCT02504268|39211925|FG004|Overall Study|Poor/Non-Compliance|0|||
16201213|NCT02504268|39211926|FG005|Overall Study|Poor/Non-Compliance|0|||
16201214|NCT02504268|39211927|FG006|Overall Study|Poor/Non-Compliance|0|||
16201215|NCT02504268|39211928|FG007|Overall Study|Poor/Non-Compliance|0|||
16201216|NCT02504268|39211929|FG008|Overall Study|Poor/Non-Compliance|0|||
16201217|NCT02504268|39211921|FG000|Overall Study|Not Disclosed|1|||
16201218|NCT02504268|39211922|FG001|Overall Study|Not Disclosed|0|||
16201219|NCT02504268|39211923|FG002|Overall Study|Not Disclosed|2|||
16318615|NCT03852472|39648403|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
16318616|NCT03852472|39648404|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
16318617|NCT03852472|39648405|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
16318618|NCT03852472|39648401|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
16318619|NCT03852472|39648402|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
16318620|NCT03852472|39648403|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
16318621|NCT03852472|39648404|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
16318622|NCT03852472|39648405|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
16318623|NCT03852472|39648401|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
16318624|NCT03852472|39648402|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
16318625|NCT03852472|39648403|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
16318626|NCT03852472|39648404|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
16318627|NCT03852472|39648405|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
16318628|NCT03852472|39648401|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
16318629|NCT03852472|39648402|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
16318630|NCT03852472|39648403|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
16318631|NCT03852472|39648404|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
16318632|NCT03852472|39648405|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
16318633|NCT03852472|39648401|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
16318634|NCT03852472|39648402|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
16318635|NCT03852472|39648403|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
16318636|NCT03852472|39648404|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
16318637|NCT03852472|39648405|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
16318638|NCT03852472|39648401|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
16318639|NCT03852472|39648402|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
16318640|NCT03852472|39648403|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
16318641|NCT03852472|39648404|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
16318642|NCT03852472|39648405|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
16318643|NCT03852472|39648401|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
16393757|NCT01127633|39922371|FG000|Overall Study|Physician Decision|60|||
16201220|NCT02504268|39211924|FG003|Overall Study|Not Disclosed|0|||
16201221|NCT02504268|39211925|FG004|Overall Study|Not Disclosed|0|||
16201222|NCT02504268|39211926|FG005|Overall Study|Not Disclosed|0|||
16201223|NCT02504268|39211927|FG006|Overall Study|Not Disclosed|0|||
16318644|NCT03852472|39648402|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
16393758|NCT01127633|39922372|FG001|Overall Study|Physician Decision|45|||
16393759|NCT01127633|39922371|FG000|Overall Study|Withdrawal by Subject|57|||
16393760|NCT01127633|39922372|FG001|Overall Study|Withdrawal by Subject|72|||
16318645|NCT03852472|39648403|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
16318646|NCT03852472|39648404|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
16318647|NCT03852472|39648405|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
16318648|NCT03852472|39648401|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
16318649|NCT03852472|39648402|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
16318650|NCT03852472|39648403|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
16318651|NCT03852472|39648404|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
16318652|NCT03852472|39648405|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
16318653|NCT03852472|39648401|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
16318654|NCT03852472|39648402|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
16318655|NCT03852472|39648403|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
16318656|NCT03852472|39648404|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
16318657|NCT03852472|39648405|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
16318658|NCT03852472|39648401|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
16318659|NCT03852472|39648402|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
16318660|NCT03852472|39648403|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
16318661|NCT03852472|39648404|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
16318662|NCT03852472|39648405|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
16318663|NCT03852472|39648401|FG000|Period 2 - Week 44|Adverse Event|0|||
16318664|NCT03852472|39648402|FG001|Period 2 - Week 44|Adverse Event|3|||
16318665|NCT03852472|39648403|FG002|Period 2 - Week 44|Adverse Event|1|||
16318666|NCT03852472|39648404|FG003|Period 2 - Week 44|Adverse Event|2|||
16318667|NCT03852472|39648405|FG004|Period 2 - Week 44|Adverse Event|2|||
16318668|NCT03852472|39648401|FG000|Period 2 - Week 44|COVID-19 Related|0|||
16318669|NCT03852472|39648402|FG001|Period 2 - Week 44|COVID-19 Related|0|||
16318670|NCT03852472|39648403|FG002|Period 2 - Week 44|COVID-19 Related|0|||
16318671|NCT03852472|39648404|FG003|Period 2 - Week 44|COVID-19 Related|1|||
16318672|NCT03852472|39648405|FG004|Period 2 - Week 44|COVID-19 Related|0|||
16318673|NCT03852472|39648401|FG000|Period 2 - Week 44|Reason not stated|0|||
16318674|NCT03852472|39648402|FG001|Period 2 - Week 44|Reason not stated|0|||
16318675|NCT03852472|39648403|FG002|Period 2 - Week 44|Reason not stated|0|||
16318676|NCT03852472|39648404|FG003|Period 2 - Week 44|Reason not stated|0|||
16318677|NCT03852472|39648405|FG004|Period 2 - Week 44|Reason not stated|1|||
16318678|NCT01996241|39648406|FG000|Overall Study|Lost to Follow-up|252|||
16318679|NCT01996241|39648407|FG001|Overall Study|Lost to Follow-up|235|||
16318680|NCT00782626|39650993|FG000|Overall Study|Adverse Event|1|||
16318681|NCT00782626|39650993|FG000|Overall Study|Progressive Disease|5|||
16318682|NCT00782626|39650993|FG000|Overall Study|Other Complicating Disease|1|||
16318683|NCT03693612|39650995|FG000|Overall Study|Lost to Follow-up|0|||
16318684|NCT03693612|39650996|FG001|Overall Study|Lost to Follow-up|0|||
16318685|NCT03693612|39650997|FG002|Overall Study|Lost to Follow-up|0|||
16318686|NCT03693612|39650998|FG003|Overall Study|Lost to Follow-up|0|||
16318687|NCT03693612|39650999|FG004|Overall Study|Lost to Follow-up|1|||
16512961|NCT02346240|40351073|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512962|NCT02346240|40351074|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512963|NCT02346240|40351075|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512964|NCT02346240|40351076|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512965|NCT02346240|40351077|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512966|NCT02346240|40351078|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512967|NCT02346240|40351079|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512968|NCT02346240|40351080|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512969|NCT02346240|40351081|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16512970|NCT02346240|40351082|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
16090260|NCT00484198|38820163|FG002|Overall Study|Adverse Event|32|||
16090261|NCT00484198|38820164|FG003|Overall Study|Adverse Event|31|||
16090262|NCT00484198|38820161|FG000|Overall Study|Protocol Violation|0|||
16090263|NCT00484198|38820162|FG001|Overall Study|Protocol Violation|5|||
16090264|NCT00484198|38820163|FG002|Overall Study|Protocol Violation|6|||
16090265|NCT00484198|38820164|FG003|Overall Study|Protocol Violation|8|||
16090266|NCT00484198|38820161|FG000|Overall Study|Other|7|||
16090267|NCT00484198|38820162|FG001|Overall Study|Other|10|||
16090268|NCT00484198|38820163|FG002|Overall Study|Other|31|||
16090269|NCT00484198|38820164|FG003|Overall Study|Other|28|||
16090270|NCT04748341|38820165|FG000|Overall Study|Lost to Follow-up|1|||
16090271|NCT04748341|38820166|FG001|Overall Study|Lost to Follow-up|1|||
16090272|NCT02208843|38820167|FG000|Overall Study|Clinical symptoms of progression|2|||
16090273|NCT02208843|38820167|FG000|Overall Study|Progression disease according to RECIST|24|||
16090274|NCT02208843|38820167|FG000|Overall Study|Adverse Event|12|||
16512971|NCT02346240|40351059|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512972|NCT02346240|40351060|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
16512973|NCT02346240|40351061|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512974|NCT02346240|40351062|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512975|NCT02346240|40351063|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512976|NCT02346240|40351064|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512977|NCT02346240|40351065|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512978|NCT02346240|40351066|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512979|NCT02346240|40351067|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512980|NCT02346240|40351068|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16090275|NCT02208843|38820167|FG000|Overall Study|Protocol Violation|1|||
16201224|NCT02504268|39211928|FG007|Overall Study|Not Disclosed|0|||
16090276|NCT02208843|38820167|FG000|Overall Study|Withdrawal by Subject|1|||
16090277|NCT02208843|38820167|FG000|Overall Study|Switched to commercial afatinib|20|||
16090278|NCT02827201|38820168|FG000|Overall Study|Death|1|||
16090279|NCT02827201|38820169|FG001|Overall Study|Death|2|||
16318688|NCT03693612|39651000|FG005|Overall Study|Lost to Follow-up|0|||
16318689|NCT03693612|39651001|FG006|Overall Study|Lost to Follow-up|0|||
16318690|NCT03693612|39650995|FG000|Overall Study|Withdrawal by Subject|0|||
16318691|NCT03693612|39650996|FG001|Overall Study|Withdrawal by Subject|0|||
16318692|NCT03693612|39650997|FG002|Overall Study|Withdrawal by Subject|1|||
16318693|NCT03693612|39650998|FG003|Overall Study|Withdrawal by Subject|0|||
16318694|NCT03693612|39650999|FG004|Overall Study|Withdrawal by Subject|2|||
16318695|NCT03693612|39651000|FG005|Overall Study|Withdrawal by Subject|0|||
16318696|NCT03693612|39651001|FG006|Overall Study|Withdrawal by Subject|0|||
16318697|NCT03693612|39650995|FG000|Overall Study|Study Terminated by Sponsor|0|||
16318698|NCT03693612|39650996|FG001|Overall Study|Study Terminated by Sponsor|1|||
16318699|NCT03693612|39650997|FG002|Overall Study|Study Terminated by Sponsor|0|||
16318700|NCT03693612|39650998|FG003|Overall Study|Study Terminated by Sponsor|0|||
16318701|NCT03693612|39650999|FG004|Overall Study|Study Terminated by Sponsor|3|||
16318702|NCT03693612|39651000|FG005|Overall Study|Study Terminated by Sponsor|0|||
16318703|NCT03693612|39651001|FG006|Overall Study|Study Terminated by Sponsor|0|||
16318704|NCT02520154|39651004|FG000|Overall Study|Death|1|||
16318705|NCT02520154|39651004|FG000|Overall Study|Withdrawal by Subject|2|||
16318706|NCT02520154|39651004|FG000|Overall Study|Physician Decision|2|||
16318707|NCT02844933|39651012|FG000|Overall Study|Discontinued due to premature termination of study|3|||
16318708|NCT02844933|39651013|FG001|Overall Study|Discontinued due to premature termination of study|2|||
16318709|NCT00318474|39651016|FG000|Overall Study|Adverse Event|1|||
16318710|NCT00318474|39651017|FG001|Overall Study|Adverse Event|1|||
16318711|NCT00318474|39651016|FG000|Overall Study|Lost to Follow-up|0|||
16318712|NCT00318474|39651017|FG001|Overall Study|Lost to Follow-up|1|||
16318713|NCT00318474|39651016|FG000|Overall Study|Pregnancy|0|||
16318714|NCT00318474|39651017|FG001|Overall Study|Pregnancy|2|||
16318715|NCT00318474|39651016|FG000|Overall Study|Protocol Violation|1|||
16318716|NCT00318474|39651017|FG001|Overall Study|Protocol Violation|0|||
16318717|NCT00318474|39651016|FG000|Overall Study|Withdrawal by Subject|3|||
16318718|NCT00318474|39651017|FG001|Overall Study|Withdrawal by Subject|2|||
16318719|NCT00318474|39651016|FG000|Overall Study|Fall in GFR|3|||
16318720|NCT00318474|39651017|FG001|Overall Study|Fall in GFR|3|||
16318721|NCT00318474|39651016|FG000|Overall Study|Post-therapy hyperflycemia|0|||
16318722|NCT00318474|39651017|FG001|Overall Study|Post-therapy hyperflycemia|1|||
16318723|NCT00318474|39651016|FG000|Overall Study|Trial terminated|10|||
16318724|NCT00318474|39651017|FG001|Overall Study|Trial terminated|7|||
16318725|NCT01806051|39651022|FG000|Overall Study|Withdrawal by Subject|6|||
16318726|NCT00072280|39651023|FG000|Treatment|Found ineligible|1|||
16318727|NCT00072280|39651024|FG001|Treatment|Found ineligible|2|||
16318728|NCT00072280|39651023|FG000|Follow-up|Early termination of study|2|||
16318729|NCT00072280|39651024|FG001|Follow-up|Early termination of study|2|||
16318730|NCT00245466|39651031|FG000|Overall Study|Adverse Event|2|||
16318731|NCT00245466|39651032|FG001|Overall Study|Adverse Event|8|||
16318732|NCT00245466|39651033|FG002|Overall Study|Adverse Event|4|||
16318733|NCT00245466|39651031|FG000|Overall Study|Low prostate specific antigen suppr|16|||
16318734|NCT00245466|39651032|FG001|Overall Study|Low prostate specific antigen suppr|14|||
16318735|NCT00245466|39651033|FG002|Overall Study|Low prostate specific antigen suppr|5|||
16318736|NCT00245466|39651031|FG000|Overall Study|Insufficient testosterone suppr|12|||
16318737|NCT00245466|39651032|FG001|Overall Study|Insufficient testosterone suppr|12|||
16318738|NCT00245466|39651033|FG002|Overall Study|Insufficient testosterone suppr|21|||
16318739|NCT00245466|39651031|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
16318740|NCT00245466|39651032|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
16318741|NCT00245466|39651033|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
16318742|NCT00245466|39651031|FG000|Overall Study|Withdrawal by Subject|2|||
16318743|NCT00245466|39651032|FG001|Overall Study|Withdrawal by Subject|2|||
16318744|NCT00245466|39651033|FG002|Overall Study|Withdrawal by Subject|1|||
16393761|NCT01127633|39922371|FG000|Overall Study|Sponsor Decision|163|||
16318745|NCT00245466|39651031|FG000|Overall Study|Lost to Follow-up|3|||
16318746|NCT00245466|39651032|FG001|Overall Study|Lost to Follow-up|0|||
16318747|NCT00245466|39651033|FG002|Overall Study|Lost to Follow-up|0|||
16318748|NCT00245466|39651031|FG000|Overall Study|Disease progression|0|||
16318749|NCT00245466|39651032|FG001|Overall Study|Disease progression|3|||
16318750|NCT00245466|39651033|FG002|Overall Study|Disease progression|1|||
16318751|NCT00245466|39651031|FG000|Overall Study|Protocol Violation|1|||
16318752|NCT00245466|39651032|FG001|Overall Study|Protocol Violation|2|||
16318753|NCT00245466|39651033|FG002|Overall Study|Protocol Violation|2|||
16318754|NCT00245466|39651031|FG000|Overall Study|Death|0|||
16318755|NCT00245466|39651032|FG001|Overall Study|Death|2|||
16318756|NCT00245466|39651033|FG002|Overall Study|Death|0|||
16318757|NCT00245466|39651031|FG000|Overall Study|Administrative reasons|0|||
16318758|NCT00245466|39651032|FG001|Overall Study|Administrative reasons|1|||
16318759|NCT00245466|39651033|FG002|Overall Study|Administrative reasons|0|||
16318760|NCT02159053|39651034|FG000|Overall Study|Death|2|||
16318761|NCT02159053|39651035|FG001|Overall Study|Death|0|||
16318762|NCT02159053|39651036|FG002|Overall Study|Death|1|||
16318763|NCT02159053|39651034|FG000|Overall Study|Physician Decision|0|||
16318764|NCT02159053|39651035|FG001|Overall Study|Physician Decision|1|||
16318765|NCT02159053|39651036|FG002|Overall Study|Physician Decision|1|||
16318766|NCT02159053|39651034|FG000|Overall Study|Lack of Efficacy|3|||
16318767|NCT02159053|39651035|FG001|Overall Study|Lack of Efficacy|4|||
16318768|NCT02159053|39651036|FG002|Overall Study|Lack of Efficacy|7|||
16318769|NCT02159053|39651034|FG000|Overall Study|Adverse Event|7|||
16318770|NCT02159053|39651035|FG001|Overall Study|Adverse Event|6|||
16318771|NCT02159053|39651036|FG002|Overall Study|Adverse Event|5|||
16318772|NCT02159053|39651034|FG000|Overall Study|Participants/guardian decision|8|||
16318773|NCT02159053|39651035|FG001|Overall Study|Participants/guardian decision|10|||
16318774|NCT02159053|39651036|FG002|Overall Study|Participants/guardian decision|6|||
16318775|NCT00302328|39651041|FG000|Overall Study|Physician Decision|0|||
16318776|NCT00302328|39651042|FG001|Overall Study|Physician Decision|1|||
16318777|NCT00302328|39651043|FG002|Overall Study|Physician Decision|0|||
16318778|NCT03850496|39651044|FG000|Overall Study|Withdrawal by Subject|1|||
16318779|NCT03850496|39651045|FG001|Overall Study|Withdrawal by Subject|0|||
16318780|NCT03850496|39651046|FG002|Overall Study|Withdrawal by Subject|0|||
16318781|NCT03850496|39651044|FG000|Overall Study|Lost to Follow-up|0|||
16318782|NCT03850496|39651045|FG001|Overall Study|Lost to Follow-up|1|||
16318783|NCT03850496|39651046|FG002|Overall Study|Lost to Follow-up|4|||
16318784|NCT01794793|39651050|FG000|Treatment Period|Withdrawal by Subject|24|||
16318785|NCT01794793|39651050|FG000|Treatment Period|Lack of Efficacy|22|||
16318786|NCT01794793|39651050|FG000|Treatment Period|Adverse Event|17|||
16318787|NCT01794793|39651050|FG000|Treatment Period|Physician Decision|14|||
16318788|NCT01794793|39651050|FG000|Treatment Period|Lost to Follow-up|7|||
16393762|NCT01127633|39922372|FG001|Overall Study|Sponsor Decision|195|||
16393763|NCT01127633|39922371|FG000|Overall Study|Protocol Violation|8|||
16393764|NCT01127633|39922372|FG001|Overall Study|Protocol Violation|16|||
16393765|NCT01127633|39922371|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
16318789|NCT01794793|39651050|FG000|Treatment Period|Death|6|||
16318790|NCT01794793|39651050|FG000|Treatment Period|Protocol Violation|5|||
16318791|NCT01794793|39651050|FG000|Treatment Period|administrative problem|3|||
16318792|NCT01794793|39651050|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
16318793|NCT01794793|39651050|FG000|Post-treatment Follow-up|Adverse Event|8|||
16318794|NCT01794793|39651050|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
16318795|NCT01794793|39651050|FG000|Post-treatment Follow-up|administrative problem|5|||
16318796|NCT01794793|39651050|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
16201225|NCT02504268|39211929|FG008|Overall Study|Not Disclosed|0|||
16393766|NCT01127633|39922372|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
16318797|NCT01794793|39651050|FG000|Post-treatment Follow-up|Protocol Violation|3|||
16318798|NCT04553471|39651051|FG000|Overall Study|Did not start treatment on protocol|3|||
16318799|NCT04553471|39651051|FG000|Overall Study|Death|1|||
16318800|NCT00554515|39651059|FG000|Overall Study|Withdrawal by Subject|3|||
16318801|NCT00554515|39651059|FG000|Overall Study|Disease progression|52|||
16318802|NCT00554515|39651059|FG000|Overall Study|Physician Decision|18|||
16318803|NCT00554515|39651059|FG000|Overall Study|Withdrawal by Subject|11|||
16318804|NCT00554515|39651059|FG000|Overall Study|Adverse Event|9|||
16318805|NCT00554515|39651059|FG000|Overall Study|Death|2|||
16318806|NCT00554515|39651059|FG000|Overall Study|Achieved Stable Disease|7|||
16318807|NCT00554515|39651059|FG000|Overall Study|Other|1|||
16318808|NCT00554515|39651059|FG000|Overall Study|Misc|15|||
16318809|NCT00513695|39651060|FG000|Overall Study|Discontinued therapy|2|||
16318810|NCT00513695|39651060|FG000|Overall Study|Progression prior to surgery|3|||
16318811|NCT05061693|39651062|FG000|Overall Study|Adverse Event|1|||
16318812|NCT05061693|39651063|FG001|Overall Study|Adverse Event|1|||
16318813|NCT05061693|39651064|FG002|Overall Study|Adverse Event|1|||
16318814|NCT05061693|39651065|FG003|Overall Study|Adverse Event|0|||
16318815|NCT05061693|39651062|FG000|Overall Study|Death|0|||
16318816|NCT05061693|39651063|FG001|Overall Study|Death|1|||
16318817|NCT05061693|39651064|FG002|Overall Study|Death|0|||
16318818|NCT05061693|39651065|FG003|Overall Study|Death|0|||
16318819|NCT05061693|39651062|FG000|Overall Study|Lack of Efficacy|1|||
16318820|NCT05061693|39651063|FG001|Overall Study|Lack of Efficacy|0|||
16318821|NCT05061693|39651064|FG002|Overall Study|Lack of Efficacy|0|||
16318822|NCT05061693|39651065|FG003|Overall Study|Lack of Efficacy|0|||
16318823|NCT05061693|39651062|FG000|Overall Study|Lost to Follow-up|0|||
16318824|NCT05061693|39651063|FG001|Overall Study|Lost to Follow-up|0|||
16318825|NCT05061693|39651064|FG002|Overall Study|Lost to Follow-up|1|||
16318826|NCT05061693|39651065|FG003|Overall Study|Lost to Follow-up|0|||
16318827|NCT05061693|39651062|FG000|Overall Study|Protocol Violation|1|||
16318828|NCT05061693|39651063|FG001|Overall Study|Protocol Violation|1|||
16318829|NCT05061693|39651064|FG002|Overall Study|Protocol Violation|1|||
16318830|NCT05061693|39651065|FG003|Overall Study|Protocol Violation|2|||
16318831|NCT05061693|39651062|FG000|Overall Study|Withdrawal by Subject|2|||
16318832|NCT05061693|39651063|FG001|Overall Study|Withdrawal by Subject|4|||
16318833|NCT05061693|39651064|FG002|Overall Study|Withdrawal by Subject|2|||
16318834|NCT05061693|39651065|FG003|Overall Study|Withdrawal by Subject|2|||
16318835|NCT01435460|39651066|FG000|Overall Study|Adverse Event|2|||
16318836|NCT01435460|39651067|FG001|Overall Study|Adverse Event|1|||
16318837|NCT01435460|39651066|FG000|Overall Study|Lost to Follow-up|6|||
16318838|NCT01435460|39651067|FG001|Overall Study|Lost to Follow-up|1|||
16318839|NCT01435460|39651066|FG000|Overall Study|Withdrawal by Subject|1|||
16318840|NCT01435460|39651067|FG001|Overall Study|Withdrawal by Subject|3|||
16318841|NCT01435460|39651066|FG000|Overall Study|Protocol Violation|0|||
16318842|NCT01435460|39651067|FG001|Overall Study|Protocol Violation|1|||
16318843|NCT01435460|39651066|FG000|Overall Study|Did not meet eligibility criteria|2|||
16318844|NCT01435460|39651067|FG001|Overall Study|Did not meet eligibility criteria|0|||
16393767|NCT01127633|39922371|FG000|Overall Study|Not treated|1|||
16393768|NCT01127633|39922372|FG001|Overall Study|Not treated|0|||
16393769|NCT01063348|39922373|FG000|Overall Study|Lost to Follow-up|3|||
16393770|NCT01063348|39922374|FG001|Overall Study|Lost to Follow-up|10|||
16318845|NCT01706939|39651068|FG000|Pre Randomization|Screen Failure|1|||
16318846|NCT01706939|39651069|FG001|Pre Randomization|Screen Failure|0|||
16318847|NCT01706939|39651070|FG002|Pre Randomization|Screen Failure|0|||
16318848|NCT01706939|39651068|FG000|Pre Randomization|Ineligible for Randomization|1|||
16318849|NCT01706939|39651069|FG001|Pre Randomization|Ineligible for Randomization|0|||
16318850|NCT01706939|39651070|FG002|Pre Randomization|Ineligible for Randomization|0|||
16318851|NCT01706939|39651068|FG000|Pre Randomization|Withdrawal by Subject|1|||
16318852|NCT01706939|39651069|FG001|Pre Randomization|Withdrawal by Subject|0|||
16393771|NCT01766037|39922376|FG000|Overall Study|Adverse Event|1|||
16393772|NCT01766037|39922377|FG001|Overall Study|Adverse Event|0|||
16393773|NCT01766037|39922376|FG000|Overall Study|Lack of Efficacy|1|||
16393774|NCT01766037|39922377|FG001|Overall Study|Lack of Efficacy|0|||
16393775|NCT01766037|39922376|FG000|Overall Study|Lost to Follow-up|0|||
16393776|NCT01766037|39922377|FG001|Overall Study|Lost to Follow-up|10|||
16393777|NCT01766037|39922376|FG000|Overall Study|Physician Decision|0|||
16393778|NCT01766037|39922377|FG001|Overall Study|Physician Decision|1|||
16318853|NCT01706939|39651070|FG002|Pre Randomization|Withdrawal by Subject|0|||
16318854|NCT01706939|39651068|FG000|Randomization|Insufficient QoL survey compliance|0|||
16318855|NCT01706939|39651069|FG001|Randomization|Insufficient QoL survey compliance|1|||
16318856|NCT01706939|39651070|FG002|Randomization|Insufficient QoL survey compliance|1|||
16318857|NCT01706939|39651068|FG000|Randomization|Progression of disease|0|||
16393779|NCT01766037|39922376|FG000|Overall Study|Withdrawal by Subject|18|||
16393780|NCT01766037|39922377|FG001|Overall Study|Withdrawal by Subject|16|||
16318858|NCT01706939|39651069|FG001|Randomization|Progression of disease|2|||
16318859|NCT01706939|39651070|FG002|Randomization|Progression of disease|1|||
16318860|NCT01284348|39651075|FG000|Overall Study|Death|1|||
16318861|NCT01284348|39651076|FG001|Overall Study|Death|1|||
16393781|NCT01766037|39922376|FG000|Overall Study|Moved from area|5|||
16393782|NCT01766037|39922377|FG001|Overall Study|Moved from area|0|||
16318862|NCT01284348|39651075|FG000|Overall Study|Withdrew consent|0|||
16393783|NCT01766037|39922376|FG000|Overall Study|medical - unrelated|1|||
16393784|NCT01766037|39922377|FG001|Overall Study|medical - unrelated|2|||
16393785|NCT01766037|39922376|FG000|Overall Study|nausea / discomfort|3|||
16393786|NCT01766037|39922377|FG001|Overall Study|nausea / discomfort|0|||
16393787|NCT03154476|39922381|FG000|Overall Study|Lost to Follow-up|4|||
16393788|NCT03154476|39922382|FG001|Overall Study|Lost to Follow-up|4|||
16393789|NCT00503425|39922384|FG000|Overall Study|Participant files lost|6|||
16393790|NCT00503425|39922384|FG000|Overall Study|Adverse Event|5|||
16393791|NCT00503425|39922384|FG000|Overall Study|Lack of Efficacy|25|||
16393792|NCT00503425|39922384|FG000|Overall Study|Withdrawal by Subject|8|||
16393793|NCT00503425|39922384|FG000|Overall Study|Lost to Follow-up|3|||
16393794|NCT00503425|39922384|FG000|Overall Study|Death|3|||
16318863|NCT01284348|39651076|FG001|Overall Study|Withdrew consent|1|||
16318864|NCT01284348|39651075|FG000|Overall Study|Status not recorded|9|||
16318865|NCT01284348|39651076|FG001|Overall Study|Status not recorded|10|||
16318866|NCT04577404|39651085|FG000|Overall Study|Adverse Event|31|||
16318867|NCT04577404|39651085|FG000|Overall Study|Death|1|||
16318868|NCT04577404|39651085|FG000|Overall Study|Lack of Efficacy|3|||
16318869|NCT04577404|39651085|FG000|Overall Study|Physician Decision|7|||
16318870|NCT04577404|39651085|FG000|Overall Study|Withdrawal by Subject|21|||
16318871|NCT04577404|39651085|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
16318872|NCT04075682|39651086|FG000|Overall Study|Lost to Follow-up|5|||
16318873|NCT04075682|39651087|FG001|Overall Study|Lost to Follow-up|5|||
16318874|NCT04075682|39651088|FG002|Overall Study|Lost to Follow-up|2|||
16318875|NCT04075682|39651089|FG003|Overall Study|Lost to Follow-up|2|||
16318876|NCT04075682|39651086|FG000|Overall Study|Withdrawal by Subject|1|||
16318877|NCT04075682|39651087|FG001|Overall Study|Withdrawal by Subject|0|||
16318878|NCT04075682|39651088|FG002|Overall Study|Withdrawal by Subject|1|||
16318879|NCT04075682|39651089|FG003|Overall Study|Withdrawal by Subject|0|||
16318880|NCT04075682|39651086|FG000|Overall Study|Protocol Violation|0|||
16318881|NCT04075682|39651087|FG001|Overall Study|Protocol Violation|1|||
16318882|NCT04075682|39651088|FG002|Overall Study|Protocol Violation|1|||
16318883|NCT04075682|39651089|FG003|Overall Study|Protocol Violation|0|||
16318884|NCT04075682|39651086|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
16318885|NCT04075682|39651087|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
16318886|NCT04075682|39651088|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
16318887|NCT04075682|39651089|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
16318888|NCT04075682|39651086|FG000|Overall Study|Lost study phone the first day of study participation|0|||
16318889|NCT04075682|39651087|FG001|Overall Study|Lost study phone the first day of study participation|1|||
16318890|NCT04075682|39651088|FG002|Overall Study|Lost study phone the first day of study participation|0|||
16318891|NCT04075682|39651089|FG003|Overall Study|Lost study phone the first day of study participation|0|||
16318892|NCT04013672|39651090|FG000|Overall Study|Withdrawal by Subject|3|||
16318893|NCT04013672|39651091|FG001|Overall Study|Withdrawal by Subject|0|||
16318894|NCT04013672|39651090|FG000|Overall Study|Death|1|||
16318895|NCT04013672|39651091|FG001|Overall Study|Death|0|||
16318896|NCT04013672|39651090|FG000|Overall Study|Physician Decision|5|||
16393795|NCT00503425|39922384|FG000|Overall Study|Missing Data/Unknown|4|||
16393796|NCT00792740|39922385|FG000|Overall Study|Disease Worsening|3|||
16318897|NCT04013672|39651091|FG001|Overall Study|Physician Decision|0|||
16318898|NCT00463047|39651092|FG000|Titration Period 1|Adverse Event|10|||
16318899|NCT00463047|39651093|FG001|Titration Period 1|Adverse Event|8|||
16318900|NCT00463047|39651092|FG000|Titration Period 1|Lack of Efficacy|10|||
16318901|NCT00463047|39651093|FG001|Titration Period 1|Lack of Efficacy|4|||
16318902|NCT00463047|39651092|FG000|Titration Period 1|Lost to Follow-up|2|||
16318903|NCT00463047|39651093|FG001|Titration Period 1|Lost to Follow-up|0|||
16318904|NCT00463047|39651092|FG000|Titration Period 1|Non-compliance with study medication|3|||
16318905|NCT00463047|39651093|FG001|Titration Period 1|Non-compliance with study medication|5|||
16318906|NCT00463047|39651092|FG000|Titration Period 1|Protocol Violation|5|||
16318907|NCT00463047|39651093|FG001|Titration Period 1|Protocol Violation|5|||
16393797|NCT00792740|39922386|FG001|Overall Study|Disease Worsening|2|||
16393798|NCT00792740|39922385|FG000|Overall Study|Personal Reason|1|||
16393799|NCT00792740|39922386|FG001|Overall Study|Personal Reason|0|||
16393800|NCT00792740|39922385|FG000|Overall Study|Adverse Event|1|||
16393801|NCT00792740|39922386|FG001|Overall Study|Adverse Event|3|||
16318908|NCT00463047|39651092|FG000|Titration Period 1|Withdrawal by Subject|3|||
16318909|NCT00463047|39651093|FG001|Titration Period 1|Withdrawal by Subject|5|||
16318910|NCT00463047|39651092|FG000|Titration Period 1|Non-compliance procedures|4|||
16318911|NCT00463047|39651093|FG001|Titration Period 1|Non-compliance procedures|10|||
16318912|NCT00463047|39651092|FG000|Titration Period 1|Other|0|||
16318913|NCT00463047|39651093|FG001|Titration Period 1|Other|2|||
16318914|NCT00463047|39651092|FG000|Titration Period 2|Adverse Event|9|||
16318915|NCT00463047|39651093|FG001|Titration Period 2|Adverse Event|9|||
16318916|NCT00463047|39651092|FG000|Titration Period 2|Lack of Efficacy|6|||
16318917|NCT00463047|39651093|FG001|Titration Period 2|Lack of Efficacy|4|||
16318918|NCT00463047|39651092|FG000|Titration Period 2|Withdrawal by Subject|1|||
16318919|NCT00463047|39651093|FG001|Titration Period 2|Withdrawal by Subject|0|||
16318920|NCT00463047|39651092|FG000|Titration Period 2|Protocol Violation|2|||
16318921|NCT00463047|39651093|FG001|Titration Period 2|Protocol Violation|3|||
16318922|NCT00463047|39651092|FG000|Titration Period 2|Lost to Follow-up|1|||
16318923|NCT00463047|39651093|FG001|Titration Period 2|Lost to Follow-up|2|||
16318924|NCT00463047|39651092|FG000|Titration Period 2|Non-compliance study medication|4|||
16318925|NCT00463047|39651093|FG001|Titration Period 2|Non-compliance study medication|2|||
16318926|NCT00463047|39651092|FG000|Titration Period 2|Non-compliance procedures|4|||
16318927|NCT00463047|39651093|FG001|Titration Period 2|Non-compliance procedures|1|||
16318928|NCT00463047|39651092|FG000|Titration Period 2|Other|3|||
16318929|NCT00463047|39651093|FG001|Titration Period 2|Other|2|||
16318930|NCT00463047|39651092|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
16318931|NCT00463047|39651093|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
16318932|NCT00463047|39651092|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
16393802|NCT00792740|39922385|FG000|Overall Study|Patient's withdrawal of consent|0|||
16393803|NCT00792740|39922386|FG001|Overall Study|Patient's withdrawal of consent|1|||
16318933|NCT00463047|39651093|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
16318934|NCT00463047|39651092|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
16318935|NCT00463047|39651093|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
16393804|NCT00792740|39922385|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
16393805|NCT00792740|39922386|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
16393806|NCT00792740|39922385|FG000|Overall Study|Other reasons|0|||
16393807|NCT00792740|39922386|FG001|Overall Study|Other reasons|1|||
16393808|NCT00887159|39922389|FG000|Overall Study|Disease progression|6|||
16090280|NCT02827201|38820168|FG000|Overall Study|Patients not treated|1|||
16318936|NCT00463047|39651092|FG000|Double-Blind Treatment Period 1|Other|1|||
16318937|NCT00463047|39651093|FG001|Double-Blind Treatment Period 1|Other|0|||
16393809|NCT00887159|39922390|FG001|Overall Study|Disease progression|39|||
16393810|NCT00887159|39922391|FG002|Overall Study|Disease progression|33|||
16393811|NCT00887159|39922389|FG000|Overall Study|Adverse Event|3|||
16318938|NCT00463047|39651092|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
16318939|NCT00463047|39651093|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
16318940|NCT00463047|39651092|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
16318941|NCT00463047|39651093|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
16318942|NCT00463047|39651092|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
16318943|NCT00463047|39651093|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
16318944|NCT00092118|39651094|FG000|Overall Study|Adverse Event|35|||
16318945|NCT00092118|39651095|FG001|Overall Study|Adverse Event|32|||
16318946|NCT00092118|39651094|FG000|Overall Study|Lack of Efficacy|12|||
16318947|NCT00092118|39651095|FG001|Overall Study|Lack of Efficacy|14|||
16318948|NCT00092118|39651094|FG000|Overall Study|Lost to Follow-up|4|||
16318949|NCT00092118|39651095|FG001|Overall Study|Lost to Follow-up|3|||
16318950|NCT00092118|39651094|FG000|Overall Study|Protocol Violation|23|||
16318951|NCT00092118|39651095|FG001|Overall Study|Protocol Violation|25|||
16318952|NCT00092118|39651094|FG000|Overall Study|Withdrawal by Subject|4|||
16318953|NCT00092118|39651095|FG001|Overall Study|Withdrawal by Subject|10|||
16318954|NCT00092118|39651094|FG000|Overall Study|Other|6|||
16318955|NCT00092118|39651095|FG001|Overall Study|Other|5|||
16318956|NCT00125242|39651102|FG000|Overall Study|did not qualify|7|||
16318957|NCT00125242|39651103|FG001|Overall Study|did not qualify|2|||
16318958|NCT00179660|39651104|FG000|Overall Study|Adverse Event|7|||
16318959|NCT00179660|39651104|FG000|Overall Study|Lack of therapeutic effect|28|||
16318960|NCT00179660|39651104|FG000|Overall Study|Withdrawal by Subject|2|||
16318961|NCT00179660|39651104|FG000|Overall Study|Lost to Follow-up|1|||
16318962|NCT00179660|39651104|FG000|Overall Study|Death|3|||
16318963|NCT00179660|39651104|FG000|Overall Study|Other - Unspecified|9|||
16318964|NCT00603473|39651105|FG000|Overall Study|Adverse Event|4|||
16318965|NCT00603473|39651105|FG000|Overall Study|Lack of Efficacy|4|||
16318966|NCT00603473|39651105|FG000|Overall Study|Protocol Violation|1|||
16318967|NCT00506415|39651108|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
16318968|NCT00506415|39651109|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
16318969|NCT00506415|39651110|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
16318970|NCT00506415|39651111|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
16318971|NCT00506415|39651108|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
16512981|NCT02346240|40351069|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512982|NCT02346240|40351070|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512983|NCT02346240|40351071|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512984|NCT02346240|40351072|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512985|NCT02346240|40351073|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512986|NCT02346240|40351074|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512987|NCT02346240|40351075|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512988|NCT02346240|40351076|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512989|NCT02346240|40351077|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512990|NCT02346240|40351078|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512991|NCT02346240|40351079|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512992|NCT02346240|40351080|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512993|NCT02346240|40351081|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512994|NCT02346240|40351082|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
16512995|NCT02346240|40351059|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16512996|NCT02346240|40351060|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
16512997|NCT02346240|40351061|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16512998|NCT02346240|40351062|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16512999|NCT02346240|40351063|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513000|NCT02346240|40351064|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513001|NCT02346240|40351065|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513002|NCT02346240|40351066|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513003|NCT02346240|40351067|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513004|NCT02346240|40351068|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513005|NCT02346240|40351069|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513006|NCT02346240|40351070|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513007|NCT02346240|40351071|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513008|NCT02346240|40351072|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513009|NCT02346240|40351073|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513010|NCT02346240|40351074|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513011|NCT02346240|40351075|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513012|NCT02346240|40351076|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16318972|NCT00506415|39651109|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
16318973|NCT00506415|39651110|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
16318974|NCT00506415|39651111|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
16090281|NCT02827201|38820169|FG001|Overall Study|Patients not treated|1|||
16090282|NCT03055988|38820170|FG000|Period 1|Adverse Event|0|||
16090283|NCT03055988|38820171|FG001|Period 1|Adverse Event|1|||
16090284|NCT03055988|38820170|FG000|Period 1|Lost to Follow-up|1|||
16090285|NCT03055988|38820171|FG001|Period 1|Lost to Follow-up|0|||
16090286|NCT03055988|38820170|FG000|Period 1|Withdrawal by Subject|0|||
16090287|NCT03055988|38820171|FG001|Period 1|Withdrawal by Subject|4|||
16090288|NCT03055988|38820170|FG000|Period 2|Adverse Event|0|||
16393812|NCT00887159|39922390|FG001|Overall Study|Adverse Event|4|||
16393813|NCT00887159|39922391|FG002|Overall Study|Adverse Event|17|||
16393814|NCT00887159|39922389|FG000|Overall Study|Death|2|||
16393815|NCT00887159|39922390|FG001|Overall Study|Death|2|||
16393816|NCT00887159|39922391|FG002|Overall Study|Death|0|||
16393817|NCT00887159|39922389|FG000|Overall Study|Withdrawal by Subject|4|||
16393818|NCT00887159|39922390|FG001|Overall Study|Withdrawal by Subject|4|||
16393819|NCT00887159|39922391|FG002|Overall Study|Withdrawal by Subject|2|||
16393820|NCT00887159|39922389|FG000|Overall Study|Alternative therapy|2|||
16393821|NCT00887159|39922390|FG001|Overall Study|Alternative therapy|0|||
16393822|NCT00887159|39922391|FG002|Overall Study|Alternative therapy|0|||
16393823|NCT00887159|39922389|FG000|Overall Study|Physician Decision|1|||
16393824|NCT00887159|39922390|FG001|Overall Study|Physician Decision|1|||
16393825|NCT00887159|39922391|FG002|Overall Study|Physician Decision|0|||
16393826|NCT00887159|39922389|FG000|Overall Study|Sympomatic deterioration|1|||
16393827|NCT00887159|39922390|FG001|Overall Study|Sympomatic deterioration|0|||
16393828|NCT00887159|39922391|FG002|Overall Study|Sympomatic deterioration|0|||
16393829|NCT00887159|39922389|FG000|Overall Study|Treatment delayed|1|||
16393830|NCT00887159|39922390|FG001|Overall Study|Treatment delayed|1|||
16393831|NCT00887159|39922391|FG002|Overall Study|Treatment delayed|0|||
16393832|NCT00887159|39922389|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
16393833|NCT00887159|39922390|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
16393834|NCT00887159|39922391|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
16393835|NCT00887159|39922389|FG000|Overall Study|Received more tx instead of observation|1|||
16393836|NCT00887159|39922390|FG001|Overall Study|Received more tx instead of observation|0|||
16393837|NCT00887159|39922391|FG002|Overall Study|Received more tx instead of observation|0|||
16513013|NCT02346240|40351077|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513014|NCT02346240|40351078|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513015|NCT02346240|40351079|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513016|NCT02346240|40351080|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513017|NCT02346240|40351081|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513018|NCT02346240|40351082|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
16513019|NCT02346240|40351059|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
16513020|NCT02346240|40351060|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
16513021|NCT02346240|40351061|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
16513022|NCT02346240|40351062|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
16513023|NCT02346240|40351063|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513024|NCT02346240|40351064|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513025|NCT02346240|40351065|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513026|NCT02346240|40351066|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513027|NCT02346240|40351067|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513028|NCT02346240|40351068|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513029|NCT02346240|40351069|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513030|NCT02346240|40351070|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513031|NCT02346240|40351071|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513032|NCT02346240|40351072|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513033|NCT02346240|40351073|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513034|NCT02346240|40351074|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513035|NCT02346240|40351075|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513036|NCT02346240|40351076|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513037|NCT02346240|40351077|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513038|NCT02346240|40351078|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513039|NCT02346240|40351079|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513040|NCT02346240|40351080|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513041|NCT02346240|40351081|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513042|NCT02346240|40351082|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
16513043|NCT02346240|40351059|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
16090289|NCT03055988|38820171|FG001|Period 2|Adverse Event|1|||
16090290|NCT03055988|38820170|FG000|Period 2|Other than listed|1|||
16090291|NCT03055988|38820171|FG001|Period 2|Other than listed|1|||
16393838|NCT00887159|39922389|FG000|Overall Study|Ineligible|5|||
16513044|NCT02346240|40351060|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
16090292|NCT01855399|38820172|FG000|6 Month|Lost to Follow-up|12|||
16393839|NCT00887159|39922390|FG001|Overall Study|Ineligible|1|||
16318975|NCT00506415|39651108|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
16318976|NCT00506415|39651109|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
16318977|NCT00506415|39651110|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
16318978|NCT00506415|39651111|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
16318979|NCT00506415|39651108|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
16318980|NCT00506415|39651109|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
16318981|NCT00506415|39651110|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
16318982|NCT00506415|39651111|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
16318983|NCT00506415|39651108|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
16318984|NCT00506415|39651109|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
16318985|NCT00506415|39651110|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
16393840|NCT00887159|39922391|FG002|Overall Study|Ineligible|0|||
16513045|NCT02346240|40351061|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
16513046|NCT02346240|40351062|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
16513047|NCT02346240|40351063|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513048|NCT02346240|40351064|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513049|NCT02346240|40351065|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513050|NCT02346240|40351066|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513051|NCT02346240|40351067|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16090293|NCT01855399|38820173|FG001|6 Month|Lost to Follow-up|9|||
16090294|NCT01855399|38820172|FG000|6 Month|Withdrawal by Subject|8|||
16513052|NCT02346240|40351068|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513053|NCT02346240|40351069|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513054|NCT02346240|40351070|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513055|NCT02346240|40351071|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513056|NCT02346240|40351072|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513057|NCT02346240|40351073|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513058|NCT02346240|40351074|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513059|NCT02346240|40351075|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16090295|NCT01855399|38820173|FG001|6 Month|Withdrawal by Subject|6|||
16090296|NCT01855399|38820172|FG000|12 Month|Lost to Follow-up|7|||
16513060|NCT02346240|40351076|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513061|NCT02346240|40351077|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513062|NCT02346240|40351078|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513063|NCT02346240|40351079|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513064|NCT02346240|40351080|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513065|NCT02346240|40351081|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513066|NCT02346240|40351082|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
16513067|NCT02346240|40351059|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513068|NCT02346240|40351060|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
16513069|NCT02346240|40351061|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513070|NCT02346240|40351062|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
16513071|NCT02346240|40351063|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513072|NCT02346240|40351064|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513073|NCT02346240|40351065|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513074|NCT02346240|40351066|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513075|NCT02346240|40351067|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513076|NCT02346240|40351068|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513077|NCT02346240|40351069|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16201226|NCT00502320|39211930|FG000|Overall Study|Lost to Follow-up|1|||
16201227|NCT00502320|39211931|FG001|Overall Study|Lost to Follow-up|1|||
16201228|NCT00502320|39211930|FG000|Overall Study|Withdrew Consent|1|||
16201229|NCT00502320|39211931|FG001|Overall Study|Withdrew Consent|0|||
16201230|NCT00502320|39211930|FG000|Overall Study|No longer met criteria|1|||
16201231|NCT00502320|39211931|FG001|Overall Study|No longer met criteria|0|||
16201232|NCT00502320|39211930|FG000|Overall Study|Screen Failure|0|||
16201233|NCT00502320|39211931|FG001|Overall Study|Screen Failure|1|||
16201234|NCT00502320|39211930|FG000|Overall Study|Adverse Event|3|||
16201235|NCT00502320|39211931|FG001|Overall Study|Adverse Event|5|||
16201236|NCT00642746|39211940|FG000|Overall Study|Patient unevaluable|1|||
16201237|NCT00642746|39211941|FG001|Overall Study|Patient unevaluable|0|||
16201238|NCT05631548|39211950|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
16201239|NCT05631548|39211951|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
16201240|NCT00523341|39211955|FG000|Overall Study|Withdrawal by Subject|399|||
16090297|NCT01855399|38820173|FG001|12 Month|Lost to Follow-up|11|||
16090298|NCT01428583|38820174|FG000|Overall Study|Adverse Event|75|||
16090299|NCT01428583|38820174|FG000|Overall Study|Withdrawal by Subject|51|||
16090300|NCT01428583|38820174|FG000|Overall Study|Lack of Efficacy|37|||
16090301|NCT01428583|38820174|FG000|Overall Study|Lost to Follow-up|17|||
16090302|NCT01428583|38820174|FG000|Overall Study|Death|1|||
16090303|NCT01428583|38820174|FG000|Overall Study|Pregnancy|1|||
16090304|NCT01428583|38820174|FG000|Overall Study|Protocol Violation|1|||
16090305|NCT01428583|38820174|FG000|Overall Study|Physician Decision|12|||
16090306|NCT01428583|38820174|FG000|Overall Study|Non-compliant|25|||
16090307|NCT01428583|38820174|FG000|Overall Study|Confirmed positive urine drug test|8|||
16090308|NCT01428583|38820174|FG000|Overall Study|Sponsor's request|3|||
16393841|NCT00887159|39922389|FG000|Overall Study|Never started assigned therapy|3|||
16393842|NCT00887159|39922390|FG001|Overall Study|Never started assigned therapy|3|||
16393843|NCT00887159|39922391|FG002|Overall Study|Never started assigned therapy|4|||
16393844|NCT02141672|39922396|FG000|Overall Study|Adverse Event|0|||
16393845|NCT02141672|39922397|FG001|Overall Study|Adverse Event|1|||
16393846|NCT02141672|39922398|FG002|Overall Study|Adverse Event|0|||
16393847|NCT02141672|39922396|FG000|Overall Study|Death|10|||
16393848|NCT02141672|39922397|FG001|Overall Study|Death|2|||
16393849|NCT02141672|39922398|FG002|Overall Study|Death|1|||
16393850|NCT02141672|39922396|FG000|Overall Study|Lack of Efficacy|0|||
16393851|NCT02141672|39922397|FG001|Overall Study|Lack of Efficacy|0|||
16393852|NCT02141672|39922398|FG002|Overall Study|Lack of Efficacy|2|||
16393853|NCT02141672|39922396|FG000|Overall Study|Lost to Follow-up|1|||
16393854|NCT02141672|39922397|FG001|Overall Study|Lost to Follow-up|1|||
16393855|NCT02141672|39922398|FG002|Overall Study|Lost to Follow-up|3|||
16393856|NCT02141672|39922396|FG000|Overall Study|Physician Decision|1|||
16393857|NCT02141672|39922397|FG001|Overall Study|Physician Decision|2|||
16393858|NCT02141672|39922398|FG002|Overall Study|Physician Decision|5|||
16393859|NCT02141672|39922396|FG000|Overall Study|Protocol Violation|0|||
16393860|NCT02141672|39922397|FG001|Overall Study|Protocol Violation|0|||
16393861|NCT02141672|39922398|FG002|Overall Study|Protocol Violation|1|||
16393862|NCT02141672|39922396|FG000|Overall Study|Withdrawal by Subject|3|||
16393863|NCT02141672|39922397|FG001|Overall Study|Withdrawal by Subject|2|||
16393864|NCT02141672|39922398|FG002|Overall Study|Withdrawal by Subject|5|||
16393865|NCT02141672|39922396|FG000|Overall Study|refused to follow-up|1|||
16393866|NCT02141672|39922397|FG001|Overall Study|refused to follow-up|0|||
16393867|NCT02141672|39922398|FG002|Overall Study|refused to follow-up|1|||
16393868|NCT01901289|39922399|FG000|Overall Study|Death|32|||
16393869|NCT01901289|39922399|FG000|Overall Study|Lost to Follow-up|16|||
16393870|NCT01901289|39922399|FG000|Overall Study|Withdrawal by Subject|35|||
16393871|NCT01901289|39922399|FG000|Overall Study|Other type of endpoint met|2|||
16393872|NCT00430989|39922400|FG000|Overall Study|Lost to Follow-up|2|||
16090309|NCT01428583|38820174|FG000|Overall Study|Other|6|||
16090310|NCT01915914|38820178|FG000|Acute Phase|Withdrawal by Subject|4|||
16393873|NCT00430989|39922401|FG001|Overall Study|Lost to Follow-up|3|||
16393874|NCT00430989|39922400|FG000|Overall Study|Withdrawal by Subject|15|||
16318986|NCT00506415|39651111|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
16318987|NCT00506415|39651108|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
16318988|NCT00506415|39651109|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
16318989|NCT00506415|39651110|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
16318990|NCT00506415|39651111|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
16318991|NCT00506415|39651108|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
16318992|NCT00506415|39651109|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
16318993|NCT00506415|39651110|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
16318994|NCT00506415|39651111|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
16318995|NCT00506415|39651108|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
16318996|NCT00506415|39651109|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
16318997|NCT00506415|39651110|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
16318998|NCT00506415|39651111|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
16318999|NCT00506415|39651108|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
16319000|NCT00506415|39651109|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
16319001|NCT00506415|39651110|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
16319002|NCT00506415|39651111|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
16319003|NCT00506415|39651108|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
16319004|NCT00506415|39651109|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
16319005|NCT00506415|39651110|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
16319006|NCT00506415|39651111|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
16319007|NCT00506415|39651108|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
16319008|NCT00506415|39651109|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
16319009|NCT00506415|39651110|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
16319010|NCT00506415|39651111|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
16319011|NCT00506415|39651108|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
16319012|NCT00506415|39651109|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
16319013|NCT00506415|39651110|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
16319014|NCT00506415|39651111|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
16319015|NCT00506415|39651108|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
16319016|NCT00506415|39651109|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
16319017|NCT00506415|39651110|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
16319018|NCT00506415|39651111|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
16319019|NCT00506415|39651108|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
16319020|NCT00506415|39651109|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
16319021|NCT00506415|39651110|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
16319022|NCT00506415|39651111|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
16319023|NCT00506415|39651108|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
16319024|NCT00506415|39651109|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
16319025|NCT00506415|39651110|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
16319026|NCT00506415|39651111|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
16319027|NCT00506415|39651108|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
16319028|NCT00506415|39651109|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
16319029|NCT00506415|39651110|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
16319030|NCT00506415|39651111|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
16319031|NCT00506415|39651108|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
16319032|NCT00506415|39651109|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
16319033|NCT00506415|39651110|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
16393875|NCT00430989|39922401|FG001|Overall Study|Withdrawal by Subject|14|||
16513078|NCT02346240|40351070|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513079|NCT02346240|40351071|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513080|NCT02346240|40351072|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513081|NCT02346240|40351073|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513082|NCT02346240|40351074|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513083|NCT02346240|40351075|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513084|NCT02346240|40351076|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513085|NCT02346240|40351077|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513086|NCT02346240|40351078|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513087|NCT02346240|40351079|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513088|NCT02346240|40351080|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513089|NCT02346240|40351081|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513090|NCT02346240|40351082|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
16513091|NCT02346240|40351059|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513092|NCT02346240|40351060|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513093|NCT02346240|40351061|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
16513094|NCT02346240|40351062|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513095|NCT02346240|40351063|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513096|NCT02346240|40351064|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513097|NCT02346240|40351065|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513098|NCT02346240|40351066|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513099|NCT02346240|40351067|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513100|NCT02346240|40351068|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513101|NCT02346240|40351069|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513102|NCT02346240|40351070|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513103|NCT02346240|40351071|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513104|NCT02346240|40351072|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513105|NCT02346240|40351073|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513106|NCT02346240|40351074|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513107|NCT02346240|40351075|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513108|NCT02346240|40351076|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513109|NCT02346240|40351077|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513110|NCT02346240|40351078|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16319034|NCT00506415|39651111|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
16319035|NCT00506415|39651108|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
16319036|NCT00506415|39651109|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
16319037|NCT00506415|39651110|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
16319038|NCT00506415|39651111|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
16319039|NCT00506415|39651108|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
16319040|NCT00506415|39651109|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
16319041|NCT00506415|39651110|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
16319042|NCT00506415|39651111|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
16319043|NCT00506415|39651108|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
16319044|NCT00506415|39651109|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
16319045|NCT00506415|39651110|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
16319046|NCT00506415|39651111|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
16319047|NCT00506415|39651108|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
16319048|NCT00506415|39651109|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
16319049|NCT00506415|39651110|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
16319050|NCT00506415|39651111|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
16319051|NCT00506415|39651108|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
16319052|NCT00506415|39651109|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
16319053|NCT00506415|39651110|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
16319054|NCT00506415|39651111|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
16319055|NCT00506415|39651108|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
16319056|NCT00506415|39651109|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
16393876|NCT00430989|39922400|FG000|Overall Study|Protocol Violation|30|||
16319057|NCT00506415|39651110|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
16319058|NCT00506415|39651111|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
16319059|NCT00506415|39651108|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
16319060|NCT00506415|39651109|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
16319061|NCT00506415|39651110|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
16319062|NCT00506415|39651111|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
16319063|NCT03474731|39651114|FG000|Overall Study|Withdrawal by Subject|36|||
16319064|NCT03474731|39651115|FG001|Overall Study|Withdrawal by Subject|29|||
16319065|NCT03474731|39651116|FG002|Overall Study|Withdrawal by Subject|11|||
16393877|NCT00430989|39922401|FG001|Overall Study|Protocol Violation|37|||
16393878|NCT00430989|39922400|FG000|Overall Study|Not eligible|13|||
16393879|NCT00430989|39922401|FG001|Overall Study|Not eligible|6|||
16393880|NCT02517398|39922404|FG000|Overall Study|Death|2|||
16393881|NCT02517398|39922405|FG001|Overall Study|Death|3|||
16393882|NCT02517398|39922406|FG002|Overall Study|Death|4|||
16393883|NCT02517398|39922407|FG003|Overall Study|Death|2|||
16393884|NCT02517398|39922408|FG004|Overall Study|Death|3|||
16393885|NCT02517398|39922409|FG005|Overall Study|Death|8|||
16393886|NCT02517398|39922410|FG006|Overall Study|Death|3|||
16393887|NCT02517398|39922411|FG007|Overall Study|Death|2|||
16393888|NCT02517398|39922412|FG008|Overall Study|Death|6|||
16393889|NCT02517398|39922413|FG009|Overall Study|Death|24|||
16393890|NCT02517398|39922414|FG010|Overall Study|Death|53|||
16393891|NCT02517398|39922415|FG011|Overall Study|Death|25|||
16393892|NCT02517398|39922416|FG012|Overall Study|Death|73|||
16393893|NCT02517398|39922417|FG013|Overall Study|Death|29|||
16393894|NCT02517398|39922418|FG014|Overall Study|Death|26|||
16393895|NCT02517398|39922419|FG015|Overall Study|Death|23|||
16393896|NCT02517398|39922420|FG016|Overall Study|Death|26|||
16393897|NCT02517398|39922421|FG017|Overall Study|Death|25|||
16393898|NCT02517398|39922422|FG018|Overall Study|Death|22|||
16393899|NCT02517398|39922423|FG019|Overall Study|Death|7|||
16393900|NCT02517398|39922424|FG020|Overall Study|Death|26|||
16393901|NCT02517398|39922425|FG021|Overall Study|Death|30|||
16393902|NCT02517398|39922426|FG022|Overall Study|Death|20|||
16393903|NCT02517398|39922404|FG000|Overall Study|Other|0|||
16393904|NCT02517398|39922405|FG001|Overall Study|Other|0|||
16393905|NCT02517398|39922406|FG002|Overall Study|Other|0|||
16393906|NCT02517398|39922407|FG003|Overall Study|Other|1|||
16393907|NCT02517398|39922408|FG004|Overall Study|Other|0|||
16393908|NCT02517398|39922409|FG005|Overall Study|Other|0|||
16393909|NCT02517398|39922410|FG006|Overall Study|Other|0|||
16393910|NCT02517398|39922411|FG007|Overall Study|Other|0|||
16393911|NCT02517398|39922412|FG008|Overall Study|Other|0|||
16393912|NCT02517398|39922413|FG009|Overall Study|Other|1|||
16393913|NCT02517398|39922414|FG010|Overall Study|Other|0|||
16393914|NCT02517398|39922415|FG011|Overall Study|Other|0|||
16393915|NCT02517398|39922416|FG012|Overall Study|Other|0|||
16393916|NCT02517398|39922417|FG013|Overall Study|Other|1|||
16393917|NCT02517398|39922418|FG014|Overall Study|Other|0|||
16393918|NCT02517398|39922419|FG015|Overall Study|Other|1|||
16393919|NCT02517398|39922420|FG016|Overall Study|Other|1|||
16393920|NCT02517398|39922421|FG017|Overall Study|Other|0|||
16393921|NCT02517398|39922422|FG018|Overall Study|Other|0|||
16393922|NCT02517398|39922423|FG019|Overall Study|Other|1|||
16393923|NCT02517398|39922424|FG020|Overall Study|Other|0|||
16393924|NCT02517398|39922425|FG021|Overall Study|Other|0|||
16393925|NCT02517398|39922426|FG022|Overall Study|Other|0|||
16393926|NCT02517398|39922404|FG000|Overall Study|Lost to Follow-up|0|||
16393927|NCT02517398|39922405|FG001|Overall Study|Lost to Follow-up|0|||
16393928|NCT02517398|39922406|FG002|Overall Study|Lost to Follow-up|0|||
16393929|NCT02517398|39922407|FG003|Overall Study|Lost to Follow-up|0|||
16393930|NCT02517398|39922408|FG004|Overall Study|Lost to Follow-up|0|||
16393931|NCT02517398|39922409|FG005|Overall Study|Lost to Follow-up|0|||
16393932|NCT02517398|39922410|FG006|Overall Study|Lost to Follow-up|0|||
16393933|NCT02517398|39922411|FG007|Overall Study|Lost to Follow-up|0|||
16393934|NCT02517398|39922412|FG008|Overall Study|Lost to Follow-up|0|||
16393935|NCT02517398|39922413|FG009|Overall Study|Lost to Follow-up|1|||
16393936|NCT02517398|39922414|FG010|Overall Study|Lost to Follow-up|0|||
16319066|NCT03474731|39651117|FG003|Overall Study|Withdrawal by Subject|27|||
16393937|NCT02517398|39922415|FG011|Overall Study|Lost to Follow-up|2|||
16393938|NCT02517398|39922416|FG012|Overall Study|Lost to Follow-up|2|||
16393939|NCT02517398|39922417|FG013|Overall Study|Lost to Follow-up|0|||
16393940|NCT02517398|39922418|FG014|Overall Study|Lost to Follow-up|1|||
16393941|NCT02517398|39922419|FG015|Overall Study|Lost to Follow-up|1|||
16393942|NCT02517398|39922420|FG016|Overall Study|Lost to Follow-up|0|||
16319067|NCT03474731|39651114|FG000|Overall Study|COVID|0|||
16393943|NCT02517398|39922421|FG017|Overall Study|Lost to Follow-up|3|||
16393944|NCT02517398|39922422|FG018|Overall Study|Lost to Follow-up|1|||
16393945|NCT02517398|39922423|FG019|Overall Study|Lost to Follow-up|0|||
16393946|NCT02517398|39922424|FG020|Overall Study|Lost to Follow-up|1|||
16393947|NCT02517398|39922425|FG021|Overall Study|Lost to Follow-up|0|||
16393948|NCT02517398|39922426|FG022|Overall Study|Lost to Follow-up|2|||
16513111|NCT02346240|40351079|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513112|NCT02346240|40351080|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513113|NCT02346240|40351081|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513114|NCT02346240|40351082|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
16513115|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513116|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513117|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513118|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513119|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513120|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513121|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513122|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
16513123|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
16513124|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16201241|NCT00523341|39211956|FG001|Overall Study|Withdrawal by Subject|427|||
16201242|NCT00523341|39211955|FG000|Overall Study|Other|181|||
16201243|NCT00523341|39211956|FG001|Overall Study|Other|198|||
16201244|NCT00523341|39211955|FG000|Overall Study|Adverse Event|122|||
16319068|NCT03474731|39651115|FG001|Overall Study|COVID|23|||
16319069|NCT03474731|39651116|FG002|Overall Study|COVID|0|||
16319070|NCT03474731|39651117|FG003|Overall Study|COVID|0|||
16393949|NCT02517398|39922404|FG000|Overall Study|Withdrew Consent|0|||
16393950|NCT02517398|39922405|FG001|Overall Study|Withdrew Consent|0|||
16393951|NCT02517398|39922406|FG002|Overall Study|Withdrew Consent|0|||
16393952|NCT02517398|39922407|FG003|Overall Study|Withdrew Consent|0|||
16393953|NCT02517398|39922408|FG004|Overall Study|Withdrew Consent|0|||
16393954|NCT02517398|39922409|FG005|Overall Study|Withdrew Consent|0|||
16393955|NCT02517398|39922410|FG006|Overall Study|Withdrew Consent|1|||
16393956|NCT02517398|39922411|FG007|Overall Study|Withdrew Consent|0|||
16513125|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513126|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513127|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513128|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
16513129|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
16513130|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
16513131|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
16513132|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513133|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513134|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16393957|NCT02517398|39922412|FG008|Overall Study|Withdrew Consent|0|||
16393958|NCT02517398|39922413|FG009|Overall Study|Withdrew Consent|2|||
16393959|NCT02517398|39922414|FG010|Overall Study|Withdrew Consent|7|||
16393960|NCT02517398|39922415|FG011|Overall Study|Withdrew Consent|1|||
16393961|NCT02517398|39922416|FG012|Overall Study|Withdrew Consent|5|||
16393962|NCT02517398|39922417|FG013|Overall Study|Withdrew Consent|4|||
16393963|NCT02517398|39922418|FG014|Overall Study|Withdrew Consent|2|||
16393964|NCT02517398|39922419|FG015|Overall Study|Withdrew Consent|5|||
16393965|NCT02517398|39922420|FG016|Overall Study|Withdrew Consent|4|||
16393966|NCT02517398|39922421|FG017|Overall Study|Withdrew Consent|2|||
16393967|NCT02517398|39922422|FG018|Overall Study|Withdrew Consent|3|||
16393968|NCT02517398|39922423|FG019|Overall Study|Withdrew Consent|2|||
16393969|NCT02517398|39922424|FG020|Overall Study|Withdrew Consent|9|||
16393970|NCT02517398|39922425|FG021|Overall Study|Withdrew Consent|3|||
16319071|NCT03474731|39651114|FG000|Overall Study|Participant moved from area|1|||
16319072|NCT03474731|39651115|FG001|Overall Study|Participant moved from area|0|||
16319073|NCT03474731|39651116|FG002|Overall Study|Participant moved from area|0|||
16319074|NCT03474731|39651117|FG003|Overall Study|Participant moved from area|0|||
16319075|NCT03474731|39651114|FG000|Overall Study|Lost to Follow-up|11|||
16319076|NCT03474731|39651115|FG001|Overall Study|Lost to Follow-up|3|||
16319077|NCT03474731|39651116|FG002|Overall Study|Lost to Follow-up|18|||
16319078|NCT03474731|39651117|FG003|Overall Study|Lost to Follow-up|17|||
16319079|NCT03474731|39651114|FG000|Overall Study|Death|0|||
16319080|NCT03474731|39651115|FG001|Overall Study|Death|1|||
16319081|NCT03474731|39651116|FG002|Overall Study|Death|0|||
16393971|NCT02517398|39922426|FG022|Overall Study|Withdrew Consent|1|||
16393972|NCT02964273|39922427|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
16393973|NCT02964273|39922428|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
16201245|NCT00523341|39211956|FG001|Overall Study|Adverse Event|155|||
16319082|NCT03474731|39651117|FG003|Overall Study|Death|0|||
16319083|NCT03474731|39651114|FG000|Overall Study|Participant Removed|0|||
16319084|NCT03474731|39651115|FG001|Overall Study|Participant Removed|0|||
16319085|NCT03474731|39651116|FG002|Overall Study|Participant Removed|0|||
16319086|NCT03474731|39651117|FG003|Overall Study|Participant Removed|1|||
16393974|NCT02964273|39922429|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
16513135|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513136|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513137|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513138|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16513139|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16090311|NCT01915914|38820179|FG001|Acute Phase|Withdrawal by Subject|0|||
16090312|NCT01915914|38820180|FG002|Acute Phase|Withdrawal by Subject|0|||
16090313|NCT01915914|38820181|FG003|Acute Phase|Withdrawal by Subject|0|||
16090314|NCT01915914|38820178|FG000|Acute Phase|Lost to Follow-up|4|||
16090315|NCT01915914|38820179|FG001|Acute Phase|Lost to Follow-up|0|||
16090316|NCT01915914|38820180|FG002|Acute Phase|Lost to Follow-up|0|||
16090317|NCT01915914|38820181|FG003|Acute Phase|Lost to Follow-up|0|||
16090318|NCT01915914|38820178|FG000|Acute Phase|Physician Decision|1|||
16090319|NCT01915914|38820179|FG001|Acute Phase|Physician Decision|0|||
16090320|NCT01915914|38820180|FG002|Acute Phase|Physician Decision|0|||
16090321|NCT01915914|38820181|FG003|Acute Phase|Physician Decision|0|||
16090322|NCT01915914|38820178|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
16090323|NCT01915914|38820179|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
16090324|NCT01915914|38820180|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
16090325|NCT01915914|38820181|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
16090326|NCT01915914|38820178|FG000|Acute Phase|"Not Achieved treatment success"|1|||
16090327|NCT01915914|38820179|FG001|Acute Phase|"Not Achieved treatment success"|0|||
16090328|NCT01915914|38820180|FG002|Acute Phase|"Not Achieved treatment success"|0|||
16090329|NCT01915914|38820181|FG003|Acute Phase|"Not Achieved treatment success"|0|||
16090330|NCT01915914|38820178|FG000|Acute Phase|Missing|1|||
16090331|NCT01915914|38820179|FG001|Acute Phase|Missing|0|||
16090332|NCT01915914|38820180|FG002|Acute Phase|Missing|0|||
16090333|NCT01915914|38820181|FG003|Acute Phase|Missing|0|||
16090334|NCT01915914|38820178|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16090335|NCT01915914|38820179|FG001|Maintenance Phase|Withdrawal by Subject|1|||
16090336|NCT01915914|38820180|FG002|Maintenance Phase|Withdrawal by Subject|1|||
16090337|NCT01915914|38820181|FG003|Maintenance Phase|Withdrawal by Subject|0|||
16090338|NCT01915914|38820178|FG000|Maintenance Phase|Lost to Follow-up|0|||
16090339|NCT01915914|38820179|FG001|Maintenance Phase|Lost to Follow-up|4|||
16090340|NCT01915914|38820180|FG002|Maintenance Phase|Lost to Follow-up|1|||
16090341|NCT01915914|38820181|FG003|Maintenance Phase|Lost to Follow-up|0|||
16090342|NCT01915914|38820178|FG000|Maintenance Phase|Missing|0|||
16090343|NCT01915914|38820179|FG001|Maintenance Phase|Missing|1|||
16090344|NCT01915914|38820180|FG002|Maintenance Phase|Missing|0|||
16090345|NCT01915914|38820181|FG003|Maintenance Phase|Missing|0|||
16090346|NCT01915914|38820178|FG000|Follow-up Phase|Withdrawal by Subject|0|||
16513140|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513141|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513142|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513143|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513144|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513145|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513146|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513147|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513148|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513149|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513150|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513151|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513152|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
16513153|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513154|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
16513155|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513156|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513157|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513158|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16090347|NCT01915914|38820179|FG001|Follow-up Phase|Withdrawal by Subject|0|||
16090348|NCT01915914|38820180|FG002|Follow-up Phase|Withdrawal by Subject|0|||
16090349|NCT01915914|38820181|FG003|Follow-up Phase|Withdrawal by Subject|1|||
16090350|NCT01915914|38820178|FG000|Follow-up Phase|Physician Decision|0|||
16090351|NCT01915914|38820179|FG001|Follow-up Phase|Physician Decision|0|||
16090352|NCT01915914|38820180|FG002|Follow-up Phase|Physician Decision|0|||
16090353|NCT01915914|38820181|FG003|Follow-up Phase|Physician Decision|1|||
16090354|NCT03015220|38820187|FG000|Overall Study|Withdrawal by Subject|3|||
16090355|NCT03015220|38820188|FG001|Overall Study|Withdrawal by Subject|2|||
16090356|NCT03015220|38820189|FG002|Overall Study|Withdrawal by Subject|2|||
16090357|NCT03015220|38820190|FG003|Overall Study|Withdrawal by Subject|2|||
16090358|NCT03015220|38820187|FG000|Overall Study|Lost to Follow-up|0|||
16090359|NCT03015220|38820188|FG001|Overall Study|Lost to Follow-up|0|||
16090360|NCT03015220|38820189|FG002|Overall Study|Lost to Follow-up|1|||
16090361|NCT03015220|38820190|FG003|Overall Study|Lost to Follow-up|0|||
16090362|NCT02038049|38820191|FG000|Overall Study|Lost to Follow-up|1|||
16090363|NCT02038049|38820192|FG001|Overall Study|Lost to Follow-up|0|||
16090364|NCT04749797|38820199|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
16513159|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513160|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513161|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513162|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16513163|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513164|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513165|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513166|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513167|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513168|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513169|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513170|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513171|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513172|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513173|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513174|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513175|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513176|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513177|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
16513178|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513179|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513180|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513181|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513182|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513183|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513184|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513185|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513186|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16513187|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513188|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513189|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513190|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513191|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513192|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16513193|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16513194|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16513195|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16513196|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513197|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16513198|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
16513199|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513200|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
16513201|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
16513202|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
16513203|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16513204|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513205|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513206|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513207|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513208|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513209|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513210|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16513211|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513212|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513213|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16319087|NCT00630825|39651118|FG000|Overall Study|Adverse Event|4|||
16319088|NCT00630825|39651119|FG001|Overall Study|Adverse Event|4|||
16201246|NCT00523341|39211955|FG000|Overall Study|Death|101|||
16319089|NCT00630825|39651120|FG002|Overall Study|Adverse Event|3|||
16513214|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513215|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513216|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513217|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513218|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513219|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513220|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16319090|NCT00630825|39651121|FG003|Overall Study|Adverse Event|1|||
16319091|NCT00630825|39651118|FG000|Overall Study|Entry Criteria Not Met|1|||
16319092|NCT00630825|39651119|FG001|Overall Study|Entry Criteria Not Met|0|||
16319093|NCT00630825|39651120|FG002|Overall Study|Entry Criteria Not Met|2|||
16319094|NCT00630825|39651121|FG003|Overall Study|Entry Criteria Not Met|1|||
16319095|NCT00630825|39651118|FG000|Overall Study|Lost to Follow-up|1|||
16319096|NCT00630825|39651119|FG001|Overall Study|Lost to Follow-up|1|||
16319097|NCT00630825|39651120|FG002|Overall Study|Lost to Follow-up|1|||
16319098|NCT00630825|39651121|FG003|Overall Study|Lost to Follow-up|1|||
16319099|NCT00630825|39651118|FG000|Overall Study|Physician Decision|1|||
16319100|NCT00630825|39651119|FG001|Overall Study|Physician Decision|0|||
16319101|NCT00630825|39651120|FG002|Overall Study|Physician Decision|0|||
16319102|NCT00630825|39651121|FG003|Overall Study|Physician Decision|0|||
16319103|NCT00630825|39651118|FG000|Overall Study|Withdrawal by Subject|2|||
16319104|NCT00630825|39651119|FG001|Overall Study|Withdrawal by Subject|2|||
16513221|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513222|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513223|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513224|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
16513225|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
16513226|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
16319105|NCT00630825|39651120|FG002|Overall Study|Withdrawal by Subject|2|||
16393975|NCT02964273|39922430|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
16513227|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
16513228|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513229|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513230|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513231|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513232|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513233|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513234|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16513235|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513236|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513237|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513238|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513239|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513240|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513241|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
16513242|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513243|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513244|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513245|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513246|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513247|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513248|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513249|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513250|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513251|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513252|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513253|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513254|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513255|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513256|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513257|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16319106|NCT00630825|39651121|FG003|Overall Study|Withdrawal by Subject|3|||
16393976|NCT02964273|39922427|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
16319107|NCT02821754|39651122|FG000|Overall Study|Procedure not required prior to amendment change|13|||
16319108|NCT02821754|39651123|FG001|Overall Study|Procedure not required prior to amendment change|11|||
16513258|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
16513259|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513260|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513261|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513262|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513263|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513264|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513265|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513266|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513267|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
16201247|NCT00523341|39211956|FG001|Overall Study|Death|110|||
16201248|NCT00523341|39211955|FG000|Overall Study|Lost to Follow-up|73|||
16201249|NCT00523341|39211956|FG001|Overall Study|Lost to Follow-up|61|||
16201250|NCT00523341|39211955|FG000|Overall Study|Non-compliance|20|||
16201251|NCT00523341|39211956|FG001|Overall Study|Non-compliance|13|||
16201252|NCT00523341|39211955|FG000|Overall Study|Physician Decision|14|||
16201253|NCT00523341|39211956|FG001|Overall Study|Physician Decision|13|||
16201254|NCT00523341|39211955|FG000|Overall Study|Requirement for Alternative Therapy|4|||
16201255|NCT00523341|39211956|FG001|Overall Study|Requirement for Alternative Therapy|14|||
16201256|NCT00523341|39211955|FG000|Overall Study|Protocol Deviation|6|||
16201257|NCT00523341|39211956|FG001|Overall Study|Protocol Deviation|5|||
16201258|NCT00523341|39211955|FG000|Overall Study|Ineligibility Determined|3|||
16201259|NCT00523341|39211956|FG001|Overall Study|Ineligibility Determined|4|||
16201260|NCT00523341|39211955|FG000|Overall Study|Disease Progression|1|||
16201261|NCT00523341|39211956|FG001|Overall Study|Disease Progression|0|||
16201262|NCT03833817|39211957|FG000|Overall Study|Withdrawal by Subject|3|||
16201263|NCT03833817|39211958|FG001|Overall Study|Withdrawal by Subject|3|||
16201264|NCT03833817|39211957|FG000|Overall Study|Lost to Follow-up|3|||
16201265|NCT03833817|39211958|FG001|Overall Study|Lost to Follow-up|3|||
16201266|NCT00664209|39211959|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
16201267|NCT00664209|39211959|FG000|Study Treatment Period|Physician Decision|4|||
16201268|NCT00664209|39211959|FG000|Study Treatment Period|Withdrawal by Subject|2|||
16201269|NCT02483078|39211960|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
16201270|NCT02483078|39211961|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
16201271|NCT02483078|39211960|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
16201272|NCT02483078|39211961|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
16201273|NCT02483078|39211960|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
16201274|NCT02483078|39211961|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
16201275|NCT02483078|39211960|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
16319109|NCT02821754|39651124|FG002|Overall Study|Procedure not required prior to amendment change|0|||
16319110|NCT02821754|39651122|FG000|Overall Study|Participant's Clinical status|2|||
16319111|NCT02821754|39651123|FG001|Overall Study|Participant's Clinical status|0|||
16319112|NCT02821754|39651124|FG002|Overall Study|Participant's Clinical status|0|||
16319113|NCT02821754|39651122|FG000|Overall Study|Participant removed for noncompliance|1|||
16319114|NCT02821754|39651123|FG001|Overall Study|Participant removed for noncompliance|0|||
16513268|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513269|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16201276|NCT02483078|39211961|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
16201277|NCT02483078|39211960|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
16201278|NCT02483078|39211961|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
16201279|NCT02483078|39211960|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
16201280|NCT02483078|39211961|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
16201281|NCT04724733|39211964|FG000|Overall Study|Lost to Follow-up|1|||
16201282|NCT04724733|39211965|FG001|Overall Study|Lost to Follow-up|1|||
16201283|NCT04724733|39211966|FG002|Overall Study|Lost to Follow-up|1|||
16201284|NCT03987919|39211970|FG000|Overall Study|Adverse Event|1|||
16201285|NCT03987919|39211971|FG001|Overall Study|Adverse Event|4|||
16201286|NCT03987919|39211972|FG002|Overall Study|Adverse Event|1|||
16201287|NCT03987919|39211973|FG003|Overall Study|Adverse Event|3|||
16201288|NCT03987919|39211970|FG000|Overall Study|Death|4|||
16201289|NCT03987919|39211971|FG001|Overall Study|Death|4|||
16201290|NCT03987919|39211972|FG002|Overall Study|Death|4|||
16319115|NCT02821754|39651124|FG002|Overall Study|Participant removed for noncompliance|0|||
16513270|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
16319116|NCT02821754|39651122|FG000|Overall Study|Drug not available.|0|||
16319117|NCT02821754|39651123|FG001|Overall Study|Drug not available.|0|||
16513271|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513272|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
16513273|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
16201291|NCT03987919|39211973|FG003|Overall Study|Death|1|||
16201292|NCT03987919|39211970|FG000|Overall Study|Lost to Follow-up|5|||
16201293|NCT03987919|39211971|FG001|Overall Study|Lost to Follow-up|6|||
16201294|NCT03987919|39211972|FG002|Overall Study|Lost to Follow-up|8|||
16201295|NCT03987919|39211973|FG003|Overall Study|Lost to Follow-up|12|||
16513274|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16201296|NCT03987919|39211970|FG000|Overall Study|Physician Decision|0|||
16513275|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513276|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513277|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513278|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513279|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513280|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513281|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513282|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
16513283|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513284|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513285|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513286|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513287|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513288|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513289|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513290|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513291|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513292|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
16513293|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513294|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513295|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513296|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513297|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513298|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513299|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513300|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513301|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513302|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513303|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513304|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513305|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513306|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
16513307|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513308|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513309|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513310|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513311|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513312|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513313|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513314|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513315|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513316|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513317|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
16513318|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513319|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513320|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513321|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16201297|NCT03987919|39211971|FG001|Overall Study|Physician Decision|2|||
16201298|NCT03987919|39211972|FG002|Overall Study|Physician Decision|0|||
16513322|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513323|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513324|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513325|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513326|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513327|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513328|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513329|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513330|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
16513331|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513332|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513333|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513334|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513335|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513336|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513337|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513338|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513339|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513340|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513341|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513342|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513343|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513344|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513345|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
16513346|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513347|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16201299|NCT03987919|39211973|FG003|Overall Study|Physician Decision|4|||
16201300|NCT03987919|39211970|FG000|Overall Study|Pregnancy|1|||
16201301|NCT03987919|39211971|FG001|Overall Study|Pregnancy|0|||
16201302|NCT03987919|39211972|FG002|Overall Study|Pregnancy|1|||
16201303|NCT03987919|39211973|FG003|Overall Study|Pregnancy|1|||
16201304|NCT03987919|39211970|FG000|Overall Study|Protocol Violation|0|||
16201305|NCT03987919|39211971|FG001|Overall Study|Protocol Violation|1|||
16201306|NCT03987919|39211972|FG002|Overall Study|Protocol Violation|0|||
16201307|NCT03987919|39211973|FG003|Overall Study|Protocol Violation|0|||
16201308|NCT03987919|39211970|FG000|Overall Study|Site terminated by Sponsor|0|||
16201309|NCT03987919|39211971|FG001|Overall Study|Site terminated by Sponsor|0|||
16201310|NCT03987919|39211972|FG002|Overall Study|Site terminated by Sponsor|0|||
16201311|NCT03987919|39211973|FG003|Overall Study|Site terminated by Sponsor|1|||
16201312|NCT03987919|39211970|FG000|Overall Study|Withdrawal by Subject|7|||
16201313|NCT03987919|39211971|FG001|Overall Study|Withdrawal by Subject|7|||
16201314|NCT03987919|39211972|FG002|Overall Study|Withdrawal by Subject|8|||
16201315|NCT03987919|39211973|FG003|Overall Study|Withdrawal by Subject|4|||
16201316|NCT03987919|39211970|FG000|Overall Study|Other - as reported by the investigator|1|||
16201317|NCT03987919|39211971|FG001|Overall Study|Other - as reported by the investigator|3|||
16201318|NCT03987919|39211972|FG002|Overall Study|Other - as reported by the investigator|2|||
16201319|NCT03987919|39211973|FG003|Overall Study|Other - as reported by the investigator|0|||
16201320|NCT04585451|39211976|FG000|Overall Study|Withdrawal by Subject|26|||
16201321|NCT04585451|39211977|FG001|Overall Study|Withdrawal by Subject|0|||
16201322|NCT00600028|39211978|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
16201323|NCT00600028|39211979|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
16201324|NCT00600028|39211978|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
16201325|NCT00600028|39211979|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
16201326|NCT00600028|39211978|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
16201327|NCT00600028|39211979|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
16201328|NCT00668200|39211980|FG000|Overall Study|Withdrawal by Subject|2|||
16201329|NCT00668200|39211980|FG000|Overall Study|Lost to Follow-up|1|||
16201330|NCT00839423|39211981|FG000|Overall Study|Adverse Event|4|||
16201331|NCT00839423|39211982|FG001|Overall Study|Adverse Event|3|||
16201332|NCT00839423|39211983|FG002|Overall Study|Adverse Event|7|||
16201333|NCT00839423|39211984|FG003|Overall Study|Adverse Event|16|||
16201334|NCT00839423|39211981|FG000|Overall Study|Lack of Efficacy|6|||
16201335|NCT00839423|39211982|FG001|Overall Study|Lack of Efficacy|6|||
16201336|NCT00839423|39211983|FG002|Overall Study|Lack of Efficacy|3|||
16201337|NCT00839423|39211984|FG003|Overall Study|Lack of Efficacy|2|||
16201338|NCT00839423|39211981|FG000|Overall Study|Non-compliance|0|||
16201339|NCT00839423|39211982|FG001|Overall Study|Non-compliance|0|||
16201340|NCT00839423|39211983|FG002|Overall Study|Non-compliance|0|||
16201341|NCT00839423|39211984|FG003|Overall Study|Non-compliance|1|||
16201342|NCT00839423|39211981|FG000|Overall Study|Protocol Violation|0|||
16201343|NCT00839423|39211982|FG001|Overall Study|Protocol Violation|1|||
16201344|NCT00839423|39211983|FG002|Overall Study|Protocol Violation|2|||
16201345|NCT00839423|39211984|FG003|Overall Study|Protocol Violation|0|||
16201346|NCT00839423|39211981|FG000|Overall Study|Withdrawal of consent|4|||
16201347|NCT00839423|39211982|FG001|Overall Study|Withdrawal of consent|0|||
16201348|NCT00839423|39211983|FG002|Overall Study|Withdrawal of consent|4|||
16201349|NCT00839423|39211984|FG003|Overall Study|Withdrawal of consent|1|||
16319118|NCT02821754|39651124|FG002|Overall Study|Drug not available.|1|||
16319119|NCT02821754|39651122|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
16513348|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513349|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513350|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513351|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513352|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513353|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16201350|NCT00839423|39211981|FG000|Overall Study|Lost to Follow-up|1|||
16319120|NCT02821754|39651123|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
16319121|NCT02821754|39651124|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
16319122|NCT02748356|39651125|FG000|Overall Study|Withdrawal by Subject|1|||
16319123|NCT03515811|39651126|FG000|Overall Study|Lost to Follow-up|2|||
16319124|NCT03515811|39651127|FG001|Overall Study|Lost to Follow-up|1|||
16319125|NCT03515811|39651126|FG000|Overall Study|Protocol Violation|1|||
16319126|NCT03515811|39651127|FG001|Overall Study|Protocol Violation|1|||
16319127|NCT03515811|39651126|FG000|Overall Study|Death|1|||
16319128|NCT03515811|39651127|FG001|Overall Study|Death|1|||
16319129|NCT03515811|39651126|FG000|Overall Study|Withdrawal by Subject|0|||
16319130|NCT03515811|39651127|FG001|Overall Study|Withdrawal by Subject|2|||
16319131|NCT03515811|39651126|FG000|Overall Study|Technical Problems|1|||
16319132|NCT03515811|39651127|FG001|Overall Study|Technical Problems|0|||
16319133|NCT03515811|39651126|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
16319134|NCT03515811|39651127|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
16319135|NCT03515811|39651126|FG000|Overall Study|COVID-19|0|||
16319136|NCT03515811|39651127|FG001|Overall Study|COVID-19|1|||
16319137|NCT00430573|39651128|FG000|Overall Study|Withdrawal by Subject|5|||
16319138|NCT02644668|39651129|FG000|Overall Study|Adverse Event|2|||
16319139|NCT02644668|39651130|FG001|Overall Study|Adverse Event|0|||
16319140|NCT02644668|39651131|FG002|Overall Study|Adverse Event|1|||
16319141|NCT02644668|39651129|FG000|Overall Study|Protocol Violation|0|||
16319142|NCT02644668|39651130|FG001|Overall Study|Protocol Violation|0|||
16319143|NCT02644668|39651131|FG002|Overall Study|Protocol Violation|1|||
16319144|NCT02644668|39651129|FG000|Overall Study|Withdrawal by Subject|0|||
16319145|NCT02644668|39651130|FG001|Overall Study|Withdrawal by Subject|0|||
16319146|NCT02644668|39651131|FG002|Overall Study|Withdrawal by Subject|1|||
16319147|NCT01876810|39651132|FG000|Overall Study|Physician Decision|0|||
16319148|NCT01876810|39651133|FG001|Overall Study|Physician Decision|1|||
16319149|NCT03656068|39651136|FG000|Overall Study|Withdrawal by Subject|4|||
16319150|NCT03656068|39651136|FG000|Overall Study|Adverse Event|1|||
16319151|NCT02504827|39651137|FG000|Overall Study|Could not produce sputum|1|||
16319152|NCT00326716|39651138|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
16319153|NCT00326716|39651139|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
16319154|NCT00326716|39651140|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
16319155|NCT00326716|39651141|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
16319156|NCT02169271|39651142|FG000|Overall Study|Protocol Violation|1|||
16319157|NCT02169271|39651143|FG001|Overall Study|Protocol Violation|2|||
16319158|NCT04164732|39651144|FG000|Treatment run-in Period|Adverse Event|4|||
16319159|NCT04164732|39651145|FG001|Treatment run-in Period|Adverse Event|0|||
16319160|NCT04164732|39651146|FG002|Treatment run-in Period|Adverse Event|0|||
16319161|NCT04164732|39651144|FG000|Treatment run-in Period|Physician Decision|1|||
16201351|NCT00839423|39211982|FG001|Overall Study|Lost to Follow-up|0|||
16319162|NCT04164732|39651145|FG001|Treatment run-in Period|Physician Decision|0|||
16319163|NCT04164732|39651146|FG002|Treatment run-in Period|Physician Decision|0|||
16319164|NCT04164732|39651144|FG000|Treatment run-in Period|Screen Failure|1|||
16201352|NCT00839423|39211983|FG002|Overall Study|Lost to Follow-up|1|||
16201353|NCT00839423|39211984|FG003|Overall Study|Lost to Follow-up|0|||
16319165|NCT04164732|39651145|FG001|Treatment run-in Period|Screen Failure|0|||
16319166|NCT04164732|39651146|FG002|Treatment run-in Period|Screen Failure|0|||
16319167|NCT04164732|39651144|FG000|Randomized Treatment Period|Adverse Event|0|||
16319168|NCT04164732|39651145|FG001|Randomized Treatment Period|Adverse Event|1|||
16319169|NCT04164732|39651146|FG002|Randomized Treatment Period|Adverse Event|0|||
16319170|NCT04164732|39651144|FG000|Randomized Treatment Period|Protocol Deviation|0|||
16319171|NCT04164732|39651145|FG001|Randomized Treatment Period|Protocol Deviation|1|||
16319172|NCT04164732|39651146|FG002|Randomized Treatment Period|Protocol Deviation|1|||
16319173|NCT04164732|39651144|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
16319174|NCT04164732|39651145|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
16319175|NCT04164732|39651146|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
16319176|NCT00789698|39651147|FG000|Overall Study|Lack of Efficacy|10|||
16319177|NCT00789698|39651148|FG001|Overall Study|Lack of Efficacy|4|||
16319178|NCT00789698|39651149|FG002|Overall Study|Lack of Efficacy|5|||
16319179|NCT00789698|39651150|FG003|Overall Study|Lack of Efficacy|18|||
16319180|NCT00789698|39651147|FG000|Overall Study|Adverse Event|5|||
16319181|NCT00789698|39651148|FG001|Overall Study|Adverse Event|5|||
16319182|NCT00789698|39651149|FG002|Overall Study|Adverse Event|3|||
16319183|NCT00789698|39651150|FG003|Overall Study|Adverse Event|4|||
16319184|NCT00789698|39651147|FG000|Overall Study|Lost to Follow-up|5|||
16319185|NCT00789698|39651148|FG001|Overall Study|Lost to Follow-up|5|||
16319186|NCT00789698|39651149|FG002|Overall Study|Lost to Follow-up|2|||
16319187|NCT00789698|39651150|FG003|Overall Study|Lost to Follow-up|9|||
16319188|NCT00789698|39651147|FG000|Overall Study|Protocol Violation|6|||
16319189|NCT00789698|39651148|FG001|Overall Study|Protocol Violation|1|||
16319190|NCT00789698|39651149|FG002|Overall Study|Protocol Violation|2|||
16319191|NCT00789698|39651150|FG003|Overall Study|Protocol Violation|1|||
16513354|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
16513355|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513356|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513357|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513358|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513359|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513360|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513361|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513362|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513363|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513364|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513365|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513366|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513367|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513368|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513369|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
16513370|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513371|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513372|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513373|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513374|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513375|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513376|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16319192|NCT00789698|39651147|FG000|Overall Study|Withdrawal by Subject|14|||
16319193|NCT00789698|39651148|FG001|Overall Study|Withdrawal by Subject|15|||
16319194|NCT00789698|39651149|FG002|Overall Study|Withdrawal by Subject|12|||
16319195|NCT00789698|39651150|FG003|Overall Study|Withdrawal by Subject|19|||
16319196|NCT00789698|39651147|FG000|Overall Study|Administrative|0|||
16319197|NCT00789698|39651148|FG001|Overall Study|Administrative|3|||
16319198|NCT00789698|39651149|FG002|Overall Study|Administrative|3|||
16319199|NCT00789698|39651150|FG003|Overall Study|Administrative|1|||
16319200|NCT04630002|39651151|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
16319201|NCT04630002|39651152|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
16319202|NCT04630002|39651153|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
16319203|NCT04630002|39651151|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
16319204|NCT04630002|39651152|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
16319205|NCT04630002|39651153|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
16319206|NCT04630002|39651151|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
16319207|NCT04630002|39651152|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
16319208|NCT04630002|39651153|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
16319209|NCT04630002|39651151|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
16319210|NCT04630002|39651152|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
16319211|NCT04630002|39651153|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
16319212|NCT04630002|39651151|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
16319213|NCT04630002|39651152|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
16319214|NCT04630002|39651153|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
16319215|NCT04630002|39651151|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
16319216|NCT04630002|39651152|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
16319217|NCT04630002|39651153|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
16319218|NCT04630002|39651151|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
16319219|NCT04630002|39651152|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
16319220|NCT04630002|39651153|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
16319221|NCT04630002|39651151|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
16513377|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513378|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
16513379|NCT02346240|40351059|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513380|NCT02346240|40351060|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513381|NCT02346240|40351061|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513382|NCT02346240|40351062|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513383|NCT02346240|40351063|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513384|NCT02346240|40351064|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513385|NCT02346240|40351065|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513386|NCT02346240|40351066|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513387|NCT02346240|40351067|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513388|NCT02346240|40351068|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513389|NCT02346240|40351069|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513390|NCT02346240|40351070|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513391|NCT02346240|40351071|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513392|NCT02346240|40351072|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513393|NCT02346240|40351073|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
16513394|NCT02346240|40351074|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513395|NCT02346240|40351075|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513396|NCT02346240|40351076|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513397|NCT02346240|40351077|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513398|NCT02346240|40351078|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513399|NCT02346240|40351079|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513400|NCT02346240|40351080|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513401|NCT02346240|40351081|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513402|NCT02346240|40351082|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
16513403|NCT02346240|40351059|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16319222|NCT04630002|39651152|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
16513404|NCT02346240|40351060|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513405|NCT02346240|40351061|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513406|NCT02346240|40351062|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513407|NCT02346240|40351063|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513408|NCT02346240|40351064|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513409|NCT02346240|40351065|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513410|NCT02346240|40351066|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513411|NCT02346240|40351067|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513412|NCT02346240|40351068|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513413|NCT02346240|40351069|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513414|NCT02346240|40351070|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513415|NCT02346240|40351071|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513416|NCT02346240|40351072|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513417|NCT02346240|40351073|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513418|NCT02346240|40351074|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513419|NCT02346240|40351075|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
16513420|NCT02346240|40351076|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
16513421|NCT02346240|40351077|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
16513422|NCT02346240|40351078|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
16513423|NCT02346240|40351079|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
16513424|NCT02346240|40351080|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
16513425|NCT02346240|40351081|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
16513426|NCT02346240|40351082|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
16513427|NCT02346240|40351059|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513428|NCT02346240|40351060|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513429|NCT02346240|40351061|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513430|NCT02346240|40351062|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513431|NCT02346240|40351063|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513432|NCT02346240|40351064|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513433|NCT02346240|40351065|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513434|NCT02346240|40351066|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513435|NCT02346240|40351067|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513436|NCT02346240|40351068|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513437|NCT02346240|40351069|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513438|NCT02346240|40351070|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513439|NCT02346240|40351071|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513440|NCT02346240|40351072|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513441|NCT02346240|40351073|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513442|NCT02346240|40351074|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513443|NCT02346240|40351075|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513444|NCT02346240|40351076|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513445|NCT02346240|40351077|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
16513446|NCT02346240|40351078|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
16513447|NCT02346240|40351079|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513448|NCT02346240|40351080|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
16513449|NCT02346240|40351081|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513450|NCT02346240|40351082|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
16513451|NCT02346240|40351059|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513452|NCT02346240|40351060|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16319223|NCT04630002|39651153|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
16319224|NCT03668119|39651156|FG000|Pre-treatment|Disease Progression|1|||
16319225|NCT03668119|39651157|FG001|Pre-treatment|Disease Progression|0|||
16319226|NCT03668119|39651156|FG000|Treatment|Disease Progression|76|||
16319227|NCT03668119|39651157|FG001|Treatment|Disease Progression|57|||
16319228|NCT03668119|39651156|FG000|Treatment|Study drug toxicity|19|||
16319229|NCT03668119|39651157|FG001|Treatment|Study drug toxicity|1|||
16319230|NCT03668119|39651156|FG000|Treatment|Death|3|||
16513453|NCT02346240|40351061|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513454|NCT02346240|40351062|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513455|NCT02346240|40351063|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513456|NCT02346240|40351064|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513457|NCT02346240|40351065|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513458|NCT02346240|40351066|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513459|NCT02346240|40351067|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513460|NCT02346240|40351068|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513461|NCT02346240|40351069|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16319231|NCT03668119|39651157|FG001|Treatment|Death|0|||
16319232|NCT03668119|39651156|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
16319233|NCT03668119|39651157|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
16513462|NCT02346240|40351070|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513463|NCT02346240|40351071|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513464|NCT02346240|40351072|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513465|NCT02346240|40351073|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513466|NCT02346240|40351074|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513467|NCT02346240|40351075|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513468|NCT02346240|40351076|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16319234|NCT03668119|39651156|FG000|Treatment|Withdrawal by Subject|1|||
16319235|NCT03668119|39651157|FG001|Treatment|Withdrawal by Subject|1|||
16319236|NCT03668119|39651156|FG000|Treatment|Participant request to discontinue study treatment|3|||
16319237|NCT03668119|39651157|FG001|Treatment|Participant request to discontinue study treatment|1|||
16319238|NCT03668119|39651156|FG000|Treatment|Maximum Clinical Benefit|0|||
16319239|NCT03668119|39651157|FG001|Treatment|Maximum Clinical Benefit|1|||
16319240|NCT03668119|39651156|FG000|Treatment|Participants completed treatment|27|||
16319241|NCT03668119|39651157|FG001|Treatment|Participants completed treatment|11|||
16319242|NCT03668119|39651156|FG000|Treatment|Other reasons|2|||
16319243|NCT03668119|39651157|FG001|Treatment|Other reasons|1|||
16319244|NCT00031590|39651160|FG000|Overall Study|Adverse Event|1|||
16319245|NCT00031590|39651160|FG000|Overall Study|Withdrawal by parents|2|||
16319246|NCT01129102|39651163|FG000|Overall Study|No study drug treatment|2|||
16319247|NCT01129102|39651164|FG001|Overall Study|No study drug treatment|3|||
16319248|NCT01129102|39651165|FG002|Overall Study|No study drug treatment|1|||
16319249|NCT01129102|39651163|FG000|Overall Study|Withdrawal by Subject|2|||
16319250|NCT01129102|39651164|FG001|Overall Study|Withdrawal by Subject|0|||
16319251|NCT01129102|39651165|FG002|Overall Study|Withdrawal by Subject|3|||
16319252|NCT01129102|39651163|FG000|Overall Study|Protocol Violation|0|||
16319253|NCT01129102|39651164|FG001|Overall Study|Protocol Violation|1|||
16319254|NCT01129102|39651165|FG002|Overall Study|Protocol Violation|1|||
16319255|NCT01129102|39651163|FG000|Overall Study|Pregnancy|0|||
16319256|NCT01129102|39651164|FG001|Overall Study|Pregnancy|0|||
16319257|NCT01129102|39651165|FG002|Overall Study|Pregnancy|1|||
16319258|NCT01129102|39651163|FG000|Overall Study|Adverse Event|2|||
16319259|NCT01129102|39651164|FG001|Overall Study|Adverse Event|2|||
16319260|NCT01129102|39651165|FG002|Overall Study|Adverse Event|1|||
16319261|NCT01129102|39651163|FG000|Overall Study|Lost to Follow-up|2|||
16319262|NCT01129102|39651164|FG001|Overall Study|Lost to Follow-up|0|||
16319263|NCT01129102|39651165|FG002|Overall Study|Lost to Follow-up|0|||
16319264|NCT00425750|39651166|FG000|Overall Study|Death|1|||
16319265|NCT00425750|39651166|FG000|Overall Study|Withdrawal by Subject|3|||
16319266|NCT00425750|39651166|FG000|Overall Study|Adverse Event|3|||
16319267|NCT00425750|39651166|FG000|Overall Study|Progression of disease|18|||
16319268|NCT03963232|39651180|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
16319269|NCT03963232|39651181|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
16319270|NCT03963232|39651180|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
16319271|NCT03963232|39651181|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
16319272|NCT03963232|39651180|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
16319273|NCT03963232|39651181|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
16319274|NCT03963232|39651180|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
16319275|NCT03963232|39651181|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
16319276|NCT03963232|39651180|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
16319277|NCT03963232|39651181|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
16319278|NCT03963232|39651180|FG000|Open-Label Treatment Phase|Adverse Event|1|||
16319279|NCT03963232|39651181|FG001|Open-Label Treatment Phase|Adverse Event|2|||
16319280|NCT03963232|39651180|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
16319281|NCT03963232|39651181|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
16319282|NCT03963232|39651180|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
16319283|NCT03963232|39651181|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
16319284|NCT03963232|39651180|FG000|Open-Label Treatment Phase|Pregnancy|1|||
16319285|NCT03963232|39651181|FG001|Open-Label Treatment Phase|Pregnancy|0|||
16319286|NCT03963232|39651180|FG000|Follow-up Phase|Withdrawal by Subject|7|||
16319287|NCT03963232|39651181|FG001|Follow-up Phase|Withdrawal by Subject|5|||
16319288|NCT03963232|39651180|FG000|Follow-up Phase|Protocol Violation|0|||
16319289|NCT03963232|39651181|FG001|Follow-up Phase|Protocol Violation|2|||
16319290|NCT03963232|39651180|FG000|Follow-up Phase|Adverse Event|0|||
16319291|NCT03963232|39651181|FG001|Follow-up Phase|Adverse Event|1|||
16319292|NCT03963232|39651180|FG000|Follow-up Phase|Lost to Follow-up|0|||
16319293|NCT03963232|39651181|FG001|Follow-up Phase|Lost to Follow-up|1|||
16513469|NCT02346240|40351077|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16513470|NCT02346240|40351078|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16319294|NCT02556775|39651182|FG000|Overall Study|Withdrawal by Subject|1|||
16319295|NCT02556775|39651183|FG001|Overall Study|Withdrawal by Subject|0|||
16319296|NCT02556775|39651184|FG002|Overall Study|Withdrawal by Subject|1|||
16319297|NCT02556775|39651185|FG003|Overall Study|Withdrawal by Subject|0|||
16319298|NCT02556775|39651182|FG000|Overall Study|Lost to Follow-up|1|||
16393977|NCT02964273|39922428|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
16393978|NCT02964273|39922429|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
16393979|NCT02964273|39922430|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
16393980|NCT02964273|39922427|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
16393981|NCT02964273|39922428|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
16393982|NCT02964273|39922429|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
16393983|NCT02964273|39922430|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
16393984|NCT02964273|39922427|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
16393985|NCT02964273|39922428|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
16393986|NCT02964273|39922429|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
16393987|NCT02964273|39922430|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
16393988|NCT02964273|39922427|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
16393989|NCT02964273|39922428|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
16393990|NCT02964273|39922429|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
16393991|NCT02964273|39922430|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
16393992|NCT02964273|39922427|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
16393993|NCT02964273|39922428|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
16393994|NCT02964273|39922429|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
16393995|NCT02964273|39922430|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
16393996|NCT01309204|39922433|FG000|Overall Study|Adverse Event|48|||
16393997|NCT01309204|39922434|FG001|Overall Study|Adverse Event|58|||
16393998|NCT01309204|39922433|FG000|Overall Study|Lost to Follow-up|2|||
16393999|NCT01309204|39922434|FG001|Overall Study|Lost to Follow-up|2|||
16394000|NCT01309204|39922433|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
16394001|NCT01309204|39922434|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
16394002|NCT01309204|39922433|FG000|Overall Study|Inadequate control of IOP|4|||
16394003|NCT01309204|39922434|FG001|Overall Study|Inadequate control of IOP|4|||
16394004|NCT01309204|39922433|FG000|Overall Study|Other|4|||
16394005|NCT01309204|39922434|FG001|Overall Study|Other|1|||
16394006|NCT00049257|39922435|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
16394007|NCT00049257|39922435|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
16394008|NCT00049257|39922435|FG000|Carboplatin, Paclitaxel|Death|2|||
16394009|NCT00049257|39922435|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
16394010|NCT06164691|39922436|FG000|Overall Study|Withdrawal by Subject|2|||
16394011|NCT06164691|39922437|FG001|Overall Study|Withdrawal by Subject|0|||
16394012|NCT06164691|39922438|FG002|Overall Study|Withdrawal by Subject|0|||
16394013|NCT01853462|39922439|FG000|Overall Study|Withdrawal by Subject|1|||
16513471|NCT02346240|40351079|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513472|NCT02346240|40351080|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16513473|NCT02346240|40351081|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513474|NCT02346240|40351082|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16513475|NCT02346240|40351059|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513476|NCT02346240|40351060|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513477|NCT02346240|40351061|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513478|NCT02346240|40351062|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513479|NCT02346240|40351063|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513480|NCT02346240|40351064|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513481|NCT02346240|40351065|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513482|NCT02346240|40351066|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513483|NCT02346240|40351067|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513484|NCT02346240|40351068|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16319299|NCT02556775|39651183|FG001|Overall Study|Lost to Follow-up|0|||
16319300|NCT02556775|39651184|FG002|Overall Study|Lost to Follow-up|0|||
16319301|NCT02556775|39651185|FG003|Overall Study|Lost to Follow-up|0|||
16319302|NCT00651261|39651186|FG000|Overall Study|Adverse Event|32|||
16319303|NCT00651261|39651187|FG001|Overall Study|Adverse Event|22|||
16319304|NCT00651261|39651186|FG000|Overall Study|Death|18|||
16319305|NCT00651261|39651187|FG001|Overall Study|Death|18|||
16319306|NCT00651261|39651186|FG000|Overall Study|Withdrawal by Subject|22|||
16319307|NCT00651261|39651187|FG001|Overall Study|Withdrawal by Subject|40|||
16319308|NCT00651261|39651186|FG000|Overall Study|Induction failure|24|||
16394014|NCT01853462|39922440|FG001|Overall Study|Withdrawal by Subject|1|||
16394015|NCT04466384|39922441|FG000|First Phase|Protocol Violation|1|||
16394016|NCT04466384|39922442|FG001|First Phase|Protocol Violation|0|||
16394017|NCT04466384|39922441|FG000|First Phase|Missing data|1|||
16513485|NCT02346240|40351069|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16319309|NCT00651261|39651187|FG001|Overall Study|Induction failure|35|||
16319310|NCT00651261|39651186|FG000|Overall Study|Disease progression|58|||
16513486|NCT02346240|40351070|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513487|NCT02346240|40351071|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513488|NCT02346240|40351072|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513489|NCT02346240|40351073|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513490|NCT02346240|40351074|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513491|NCT02346240|40351075|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513492|NCT02346240|40351076|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513493|NCT02346240|40351077|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513494|NCT02346240|40351078|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513495|NCT02346240|40351079|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513496|NCT02346240|40351080|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
16513497|NCT02346240|40351081|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513498|NCT02346240|40351082|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
16513499|NCT02346240|40351059|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513500|NCT02346240|40351060|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513501|NCT02346240|40351061|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513502|NCT02346240|40351062|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513503|NCT02346240|40351063|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513504|NCT02346240|40351064|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513505|NCT02346240|40351065|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513506|NCT02346240|40351066|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513507|NCT02346240|40351067|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513508|NCT02346240|40351068|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513509|NCT02346240|40351069|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513510|NCT02346240|40351070|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513511|NCT02346240|40351071|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513512|NCT02346240|40351072|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513513|NCT02346240|40351073|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513514|NCT02346240|40351074|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513515|NCT02346240|40351075|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513516|NCT02346240|40351076|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
16513517|NCT02346240|40351077|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
16513518|NCT02346240|40351078|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
16513519|NCT02346240|40351079|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16513520|NCT02346240|40351080|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
16513521|NCT02346240|40351081|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
16513522|NCT02346240|40351082|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
16513523|NCT02346240|40351059|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513524|NCT02346240|40351060|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513525|NCT02346240|40351061|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513526|NCT02346240|40351062|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513527|NCT02346240|40351063|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513528|NCT02346240|40351064|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513529|NCT02346240|40351065|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513530|NCT02346240|40351066|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513531|NCT02346240|40351067|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513532|NCT02346240|40351068|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513533|NCT02346240|40351069|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513534|NCT02346240|40351070|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16319311|NCT00651261|39651187|FG001|Overall Study|Disease progression|58|||
16394018|NCT04466384|39922442|FG001|First Phase|Missing data|0|||
16513535|NCT02346240|40351071|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513536|NCT02346240|40351072|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513537|NCT02346240|40351073|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513538|NCT02346240|40351074|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513539|NCT02346240|40351075|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513540|NCT02346240|40351076|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513541|NCT02346240|40351077|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
16513542|NCT02346240|40351078|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
16513543|NCT02346240|40351079|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16513544|NCT02346240|40351080|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
16513545|NCT02346240|40351081|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
16513546|NCT02346240|40351082|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
16513547|NCT02346240|40351059|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513548|NCT02346240|40351060|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513549|NCT02346240|40351061|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513550|NCT02346240|40351062|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513551|NCT02346240|40351063|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513552|NCT02346240|40351064|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513553|NCT02346240|40351065|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513554|NCT02346240|40351066|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513555|NCT02346240|40351067|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513556|NCT02346240|40351068|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513557|NCT02346240|40351069|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513558|NCT02346240|40351070|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513559|NCT02346240|40351071|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513560|NCT02346240|40351072|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513561|NCT02346240|40351073|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513562|NCT02346240|40351074|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513563|NCT02346240|40351075|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513564|NCT02346240|40351076|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513565|NCT02346240|40351077|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
16513566|NCT02346240|40351078|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513567|NCT02346240|40351079|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
16513568|NCT02346240|40351080|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
16513569|NCT02346240|40351081|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
16319312|NCT00651261|39651186|FG000|Overall Study|Alternative therapy|109|||
16319313|NCT00651261|39651187|FG001|Overall Study|Alternative therapy|107|||
16513570|NCT02346240|40351082|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
16513571|NCT02346240|40351059|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513572|NCT02346240|40351060|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513573|NCT02346240|40351061|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513574|NCT02346240|40351062|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513575|NCT02346240|40351063|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513576|NCT02346240|40351064|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513577|NCT02346240|40351065|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513578|NCT02346240|40351066|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513579|NCT02346240|40351067|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513580|NCT02346240|40351068|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513581|NCT02346240|40351069|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513582|NCT02346240|40351070|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513583|NCT02346240|40351071|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513584|NCT02346240|40351072|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513585|NCT02346240|40351073|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513586|NCT02346240|40351074|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513587|NCT02346240|40351075|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513588|NCT02346240|40351076|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513589|NCT02346240|40351077|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
16513590|NCT02346240|40351078|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513591|NCT02346240|40351079|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513592|NCT02346240|40351080|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513593|NCT02346240|40351081|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16394019|NCT04466384|39922441|FG000|Cross Over Phase|Physician Decision|1|||
16394020|NCT04466384|39922442|FG001|Cross Over Phase|Physician Decision|0|||
16513594|NCT02346240|40351082|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
16513595|NCT02501096|40351083|FG000|Overall Study|Lost to Follow-up|0|||
16513596|NCT02501096|40351084|FG001|Overall Study|Lost to Follow-up|0|||
16513597|NCT02501096|40351085|FG002|Overall Study|Lost to Follow-up|0|||
16513598|NCT02501096|40351086|FG003|Overall Study|Lost to Follow-up|0|||
16513599|NCT02501096|40351087|FG004|Overall Study|Lost to Follow-up|1|||
16513600|NCT02501096|40351088|FG005|Overall Study|Lost to Follow-up|1|||
16513601|NCT02501096|40351089|FG006|Overall Study|Lost to Follow-up|3|||
16513602|NCT02501096|40351090|FG007|Overall Study|Lost to Follow-up|0|||
16513603|NCT02501096|40351091|FG008|Overall Study|Lost to Follow-up|0|||
16513604|NCT02501096|40351083|FG000|Overall Study|Withdrawal by Subject|1|||
16513605|NCT02501096|40351084|FG001|Overall Study|Withdrawal by Subject|0|||
16513606|NCT02501096|40351085|FG002|Overall Study|Withdrawal by Subject|7|||
16513607|NCT02501096|40351086|FG003|Overall Study|Withdrawal by Subject|13|||
16513608|NCT02501096|40351087|FG004|Overall Study|Withdrawal by Subject|2|||
16513609|NCT02501096|40351088|FG005|Overall Study|Withdrawal by Subject|2|||
16513610|NCT02501096|40351089|FG006|Overall Study|Withdrawal by Subject|2|||
16513611|NCT02501096|40351090|FG007|Overall Study|Withdrawal by Subject|3|||
16513612|NCT02501096|40351091|FG008|Overall Study|Withdrawal by Subject|0|||
16513613|NCT02501096|40351083|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
16513614|NCT02501096|40351084|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
16513615|NCT02501096|40351085|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
16513616|NCT02501096|40351086|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
16513617|NCT02501096|40351087|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
16513618|NCT02501096|40351088|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
16513619|NCT02501096|40351089|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
16319314|NCT00651261|39651186|FG000|Overall Study|Other disease or participant decisions|23|||
16319315|NCT00651261|39651187|FG001|Overall Study|Other disease or participant decisions|23|||
16319316|NCT00651261|39651186|FG000|Overall Study|Never treated|5|||
16513620|NCT02501096|40351090|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
16513621|NCT02501096|40351091|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
16513622|NCT02501096|40351083|FG000|Overall Study|Death|1|||
16513623|NCT02501096|40351084|FG001|Overall Study|Death|1|||
16513624|NCT02501096|40351085|FG002|Overall Study|Death|88|||
16513625|NCT02501096|40351086|FG003|Overall Study|Death|74|||
16513626|NCT02501096|40351087|FG004|Overall Study|Death|15|||
16513627|NCT02501096|40351088|FG005|Overall Study|Death|16|||
16513628|NCT02501096|40351089|FG006|Overall Study|Death|15|||
16513629|NCT02501096|40351090|FG007|Overall Study|Death|16|||
16513630|NCT02501096|40351091|FG008|Overall Study|Death|1|||
16513631|NCT01282216|40351092|FG000|Overall Study|Graft failure|0|||
16513632|NCT01282216|40351093|FG001|Overall Study|Graft failure|0|||
16513633|NCT01282216|40351094|FG002|Overall Study|Graft failure|3|||
16513634|NCT01282216|40351095|FG003|Overall Study|Graft failure|2|||
16513635|NCT01282216|40351092|FG000|Overall Study|Physician Decision|0|||
16513636|NCT01282216|40351093|FG001|Overall Study|Physician Decision|0|||
16513637|NCT01282216|40351094|FG002|Overall Study|Physician Decision|11|||
16513638|NCT01282216|40351095|FG003|Overall Study|Physician Decision|0|||
16513639|NCT01282216|40351092|FG000|Overall Study|Relapse|0|||
16513640|NCT01282216|40351093|FG001|Overall Study|Relapse|0|||
16513641|NCT01282216|40351094|FG002|Overall Study|Relapse|17|||
16513642|NCT01282216|40351095|FG003|Overall Study|Relapse|6|||
16513643|NCT01282216|40351092|FG000|Overall Study|Death|0|||
16513644|NCT01282216|40351093|FG001|Overall Study|Death|0|||
16513645|NCT01282216|40351094|FG002|Overall Study|Death|2|||
16513646|NCT01282216|40351095|FG003|Overall Study|Death|0|||
16513647|NCT02310672|40351100|FG000|Overall Study|Death|1|||
16513648|NCT02310672|40351100|FG000|Overall Study|Lost to Follow-up|1|||
16513649|NCT02310672|40351100|FG000|Overall Study|Withdrawal by Subject|1|||
16513650|NCT02310672|40351100|FG000|Overall Study|Sponsor's decision|12|||
16513651|NCT02272413|40351103|FG000|Randomized Through Treatment Start|Not treated|3|||
16319317|NCT00651261|39651187|FG001|Overall Study|Never treated|3|||
16319318|NCT05027451|39651188|FG000|Overall Study|Lost to Follow-up|1|||
16319319|NCT05027451|39651189|FG001|Overall Study|Lost to Follow-up|1|||
16513652|NCT02272413|40351104|FG001|Randomized Through Treatment Start|Not treated|5|||
16513653|NCT02272413|40351103|FG000|Pre-switch Period|Adverse Event|38|||
16513654|NCT02272413|40351104|FG001|Pre-switch Period|Adverse Event|37|||
16513655|NCT02272413|40351103|FG000|Pre-switch Period|Death|26|||
16513656|NCT02272413|40351104|FG001|Pre-switch Period|Death|26|||
16513657|NCT02272413|40351103|FG000|Pre-switch Period|Withdrawal by Subject|27|||
16513658|NCT02272413|40351104|FG001|Pre-switch Period|Withdrawal by Subject|15|||
16513659|NCT02272413|40351103|FG000|Pre-switch Period|Physician Decision|6|||
16513660|NCT02272413|40351104|FG001|Pre-switch Period|Physician Decision|18|||
16513661|NCT02272413|40351103|FG000|Pre-switch Period|Progressive disease|185|||
16513662|NCT02272413|40351104|FG001|Pre-switch Period|Progressive disease|173|||
16513663|NCT02272413|40351103|FG000|Pre-switch Period|Lost to Follow-up|0|||
16513664|NCT02272413|40351104|FG001|Pre-switch Period|Lost to Follow-up|2|||
16513665|NCT02272413|40351103|FG000|Pre-switch Period|Protocol Violation|1|||
16513666|NCT02272413|40351104|FG001|Pre-switch Period|Protocol Violation|0|||
16513667|NCT02272413|40351103|FG000|Pre-switch Period|Other than listed|10|||
16513668|NCT02272413|40351104|FG001|Pre-switch Period|Other than listed|11|||
16513669|NCT02272413|40351103|FG000|Post-switch Period|Adverse Event|4|||
16513670|NCT02272413|40351104|FG001|Post-switch Period|Adverse Event|4|||
16513671|NCT02272413|40351103|FG000|Post-switch Period|Death|3|||
16513672|NCT02272413|40351104|FG001|Post-switch Period|Death|2|||
16513673|NCT02272413|40351103|FG000|Post-switch Period|Withdrawal by Subject|1|||
16513674|NCT02272413|40351104|FG001|Post-switch Period|Withdrawal by Subject|2|||
16513675|NCT02272413|40351103|FG000|Post-switch Period|Physician Decision|1|||
16513676|NCT02272413|40351104|FG001|Post-switch Period|Physician Decision|1|||
16513677|NCT02272413|40351103|FG000|Post-switch Period|Progressive disease|21|||
16513678|NCT02272413|40351104|FG001|Post-switch Period|Progressive disease|21|||
16513679|NCT02272413|40351103|FG000|Post-switch Period|Study terminated by sponsor|8|||
16513680|NCT02272413|40351104|FG001|Post-switch Period|Study terminated by sponsor|11|||
16513681|NCT02272413|40351103|FG000|Post-switch Period|Other than listed|4|||
16513682|NCT02272413|40351104|FG001|Post-switch Period|Other than listed|5|||
16513683|NCT01585766|40351105|FG000|Overall Study|Withdrawal by Subject|0|||
16513684|NCT01585766|40351106|FG001|Overall Study|Withdrawal by Subject|1|||
16513685|NCT01585766|40351107|FG002|Overall Study|Withdrawal by Subject|1|||
16513686|NCT01585766|40351108|FG003|Overall Study|Withdrawal by Subject|0|||
16513687|NCT01585766|40351109|FG004|Overall Study|Withdrawal by Subject|0|||
16513688|NCT01585766|40351110|FG005|Overall Study|Withdrawal by Subject|0|||
16513689|NCT01585766|40351105|FG000|Overall Study|Death|0|||
16513690|NCT01585766|40351106|FG001|Overall Study|Death|1|||
16513691|NCT01585766|40351107|FG002|Overall Study|Death|0|||
16513692|NCT01585766|40351108|FG003|Overall Study|Death|0|||
16513693|NCT01585766|40351109|FG004|Overall Study|Death|0|||
16513694|NCT01585766|40351110|FG005|Overall Study|Death|0|||
16513695|NCT01585766|40351105|FG000|Overall Study|Physician Decision|0|||
16513696|NCT01585766|40351106|FG001|Overall Study|Physician Decision|0|||
16513697|NCT01585766|40351107|FG002|Overall Study|Physician Decision|1|||
16513698|NCT01585766|40351108|FG003|Overall Study|Physician Decision|0|||
16513699|NCT01585766|40351109|FG004|Overall Study|Physician Decision|0|||
16513700|NCT01585766|40351110|FG005|Overall Study|Physician Decision|0|||
16513701|NCT01552772|40351111|FG000|Overall Study|Lost to Follow-up|2|||
16513702|NCT01552772|40351111|FG000|Overall Study|Adverse Event|1|||
16513703|NCT01552772|40351111|FG000|Overall Study|Protocol Deviation|1|||
16513704|NCT00337103|40351112|FG000|Overall Study|Progressive Disease|414|||
16513705|NCT00337103|40351113|FG001|Overall Study|Progressive Disease|410|||
16513706|NCT00337103|40351112|FG000|Overall Study|Adverse Event|45|||
16513707|NCT00337103|40351113|FG001|Overall Study|Adverse Event|59|||
16513708|NCT00337103|40351112|FG000|Overall Study|Subject Choice|34|||
16513709|NCT00337103|40351113|FG001|Overall Study|Subject Choice|27|||
16513710|NCT00337103|40351112|FG000|Overall Study|Clinical Progression|27|||
16513711|NCT00337103|40351113|FG001|Overall Study|Clinical Progression|24|||
16513712|NCT00337103|40351112|FG000|Overall Study|Physician Decision|15|||
16513713|NCT00337103|40351113|FG001|Overall Study|Physician Decision|14|||
16513714|NCT00337103|40351112|FG000|Overall Study|Withdrawal by Subject|8|||
16513715|NCT00337103|40351113|FG001|Overall Study|Withdrawal by Subject|5|||
16513716|NCT00337103|40351112|FG000|Overall Study|Other|5|||
16513717|NCT00337103|40351113|FG001|Overall Study|Other|6|||
16513718|NCT00337103|40351112|FG000|Overall Study|Entry Criteria Not Met|4|||
16513719|NCT00337103|40351113|FG001|Overall Study|Entry Criteria Not Met|1|||
16513720|NCT00337103|40351112|FG000|Overall Study|Lost to Follow-up|1|||
16513721|NCT00337103|40351113|FG001|Overall Study|Lost to Follow-up|2|||
16513722|NCT00337103|40351112|FG000|Overall Study|Death|1|||
16513723|NCT00337103|40351113|FG001|Overall Study|Death|0|||
16513724|NCT00057746|40351119|FG000|Overall Study|Withdrawal by Subject|0|||
16513725|NCT00057746|40351120|FG001|Overall Study|Withdrawal by Subject|0|||
16513726|NCT00057746|40351121|FG002|Overall Study|Withdrawal by Subject|1|||
16513727|NCT01466270|40351126|FG000|Overall Study|Withdrawal by Subject|4|||
16513728|NCT01466270|40351127|FG001|Overall Study|Withdrawal by Subject|1|||
16513729|NCT01466270|40351126|FG000|Overall Study|Physician Decision|1|||
16513730|NCT01466270|40351127|FG001|Overall Study|Physician Decision|0|||
16513731|NCT01466270|40351126|FG000|Overall Study|Lost to Follow-up|1|||
16513732|NCT01466270|40351127|FG001|Overall Study|Lost to Follow-up|3|||
16513733|NCT01466270|40351126|FG000|Overall Study|Progression|1|||
16513734|NCT01466270|40351127|FG001|Overall Study|Progression|0|||
16513735|NCT01466270|40351126|FG000|Overall Study|Toxicity|4|||
16513736|NCT01466270|40351127|FG001|Overall Study|Toxicity|1|||
16513737|NCT01466270|40351126|FG000|Overall Study|Multiple|1|||
16513738|NCT01466270|40351127|FG001|Overall Study|Multiple|1|||
16513739|NCT00159588|40351128|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
16513740|NCT00159588|40351129|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
16513741|NCT00159588|40351130|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
16513742|NCT00344773|40351131|FG000|Overall Study|Adverse Event|2|||
16513743|NCT00344773|40351131|FG000|Overall Study|Objective Disease Progression|16|||
16513744|NCT00344773|40351131|FG000|Overall Study|Withdrawal by Subject|1|||
16513745|NCT00344773|40351131|FG000|Overall Study|Not Eligible for the study|2|||
16513746|NCT00594464|40351132|FG000|Overall Study|Withdrawal by Subject|1|||
16513747|NCT00594464|40351132|FG000|Overall Study|Delay in operation|2|||
16513748|NCT01603875|40351133|FG000|Overall Study|Preexisting rabies antibody|3|||
16513749|NCT01603875|40351134|FG001|Overall Study|Preexisting rabies antibody|4|||
16513750|NCT01603875|40351135|FG002|Overall Study|Preexisting rabies antibody|3|||
16513751|NCT01603875|40351133|FG000|Overall Study|Lost to Follow-up|4|||
16513752|NCT01603875|40351134|FG001|Overall Study|Lost to Follow-up|3|||
16513753|NCT01603875|40351135|FG002|Overall Study|Lost to Follow-up|6|||
16513754|NCT01603875|40351133|FG000|Overall Study|Protocol Violation|0|||
16201354|NCT00839423|39211981|FG000|Overall Study|Administrative or other reasons|3|||
16201355|NCT00839423|39211982|FG001|Overall Study|Administrative or other reasons|0|||
16201356|NCT00839423|39211983|FG002|Overall Study|Administrative or other reasons|1|||
16201357|NCT00839423|39211984|FG003|Overall Study|Administrative or other reasons|0|||
16394021|NCT04466384|39922441|FG000|Cross Over Phase|Withdrawal by Subject|0|||
16394022|NCT04466384|39922442|FG001|Cross Over Phase|Withdrawal by Subject|1|||
16394023|NCT02565147|39922446|FG000|Overall Study|Withdrawal by Subject|5|||
16394024|NCT02565147|39922447|FG001|Overall Study|Withdrawal by Subject|1|||
16394025|NCT02565147|39922446|FG000|Overall Study|Lost to Follow-up|0|||
16394026|NCT02565147|39922447|FG001|Overall Study|Lost to Follow-up|1|||
16394027|NCT02565147|39922446|FG000|Overall Study|Death|1|||
16394028|NCT02565147|39922447|FG001|Overall Study|Death|1|||
16394029|NCT01947283|39924557|FG000|Overall Study|Death|1|||
16394030|NCT01947283|39924558|FG001|Overall Study|Death|1|||
16201358|NCT02939599|39215199|FG000|Overall Study|Adverse Event|1|||
16201359|NCT02939599|39215200|FG001|Overall Study|Adverse Event|0|||
16201360|NCT02939599|39215199|FG000|Overall Study|Study Terminated By Sponsor|2|||
16201361|NCT02939599|39215200|FG001|Overall Study|Study Terminated By Sponsor|2|||
16201362|NCT01245764|39215201|FG000|Study Phase A|Other|3|||
16201363|NCT01245764|39215202|FG001|Study Phase A|Other|2|||
16201364|NCT01245764|39215203|FG002|Study Phase A|Other|3|||
16201365|NCT01245764|39215204|FG003|Study Phase A|Other|1|||
16201366|NCT01245764|39215201|FG000|Study Phase A|Protocol Violation|6|||
16201367|NCT01245764|39215202|FG001|Study Phase A|Protocol Violation|3|||
16201368|NCT01245764|39215203|FG002|Study Phase A|Protocol Violation|2|||
16201369|NCT01245764|39215204|FG003|Study Phase A|Protocol Violation|2|||
16201370|NCT01245764|39215201|FG000|Study Phase A|Lost to Follow-up|0|||
16201371|NCT01245764|39215202|FG001|Study Phase A|Lost to Follow-up|0|||
16201372|NCT01245764|39215203|FG002|Study Phase A|Lost to Follow-up|5|||
16201373|NCT01245764|39215204|FG003|Study Phase A|Lost to Follow-up|0|||
16201374|NCT01181778|39215210|FG000|Overall Study|Physician Decision|48|||
16201375|NCT02261883|39215212|FG000|Overall Study|Death|3|||
16201376|NCT02261883|39215213|FG001|Overall Study|Death|2|||
16201377|NCT02261883|39215212|FG000|Overall Study|Physician Decision|1|||
16201378|NCT02261883|39215213|FG001|Overall Study|Physician Decision|0|||
16201379|NCT02261883|39215212|FG000|Overall Study|Protocol Violation|1|||
16201380|NCT02261883|39215213|FG001|Overall Study|Protocol Violation|0|||
16201381|NCT02261883|39215212|FG000|Overall Study|Withdrawal by Subject|0|||
16201382|NCT02261883|39215213|FG001|Overall Study|Withdrawal by Subject|1|||
16201383|NCT02261883|39215212|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
16201384|NCT02261883|39215213|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
16201385|NCT02007954|39215215|FG000|Overall Study|Received liver transplant|3|||
16201386|NCT02007954|39215215|FG000|Overall Study|Switch in treatment modality|2|||
16201387|NCT02007954|39215215|FG000|Overall Study|Disease progression and unrelated AE|1|||
16201388|NCT02007954|39215215|FG000|Overall Study|Death|1|||
16201389|NCT03846219|39215216|FG000|Overall Study|Withdrawal by Subject|3|||
16201390|NCT03846219|39215217|FG001|Overall Study|Withdrawal by Subject|2|||
16201391|NCT03846219|39215218|FG002|Overall Study|Withdrawal by Subject|2|||
16201392|NCT03846219|39215216|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
16201393|NCT03846219|39215217|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
16201394|NCT03846219|39215218|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
16201395|NCT03846219|39215216|FG000|Overall Study|Physician Decision|0|||
16201396|NCT03846219|39215217|FG001|Overall Study|Physician Decision|0|||
16201397|NCT03846219|39215218|FG002|Overall Study|Physician Decision|2|||
16201398|NCT00842361|39215219|FG000|Overall Study|Protocol Violation|1|||
16201399|NCT00842361|39215220|FG001|Overall Study|Protocol Violation|0|||
16201400|NCT00842361|39215219|FG000|Overall Study|Unclassified|0|||
16394031|NCT01947283|39924559|FG002|Overall Study|Death|1|||
16513755|NCT01603875|40351134|FG001|Overall Study|Protocol Violation|1|||
16513756|NCT01603875|40351135|FG002|Overall Study|Protocol Violation|0|||
16201401|NCT00842361|39215220|FG001|Overall Study|Unclassified|2|||
16201402|NCT00289185|39215221|FG000|Overall Study|Withdrawal by Subject|4|||
16201403|NCT00289185|39215222|FG001|Overall Study|Withdrawal by Subject|8|||
16201404|NCT00289185|39215221|FG000|Overall Study|Lost to Follow-up|23|||
16201405|NCT00289185|39215222|FG001|Overall Study|Lost to Follow-up|17|||
16394032|NCT01947283|39924560|FG003|Overall Study|Death|0|||
16394033|NCT01947283|39924561|FG004|Overall Study|Death|0|||
16394034|NCT01947283|39924562|FG005|Overall Study|Death|0|||
16513757|NCT01516879|40351139|FG000|Overall Study|Withdrawal by Subject|9|||
16513758|NCT01516879|40351140|FG001|Overall Study|Withdrawal by Subject|11|||
16513759|NCT01516879|40351139|FG000|Overall Study|Death|0|||
16201406|NCT00289185|39215221|FG000|Overall Study|Death|1|||
16201407|NCT00289185|39215222|FG001|Overall Study|Death|1|||
16394035|NCT01947283|39924563|FG006|Overall Study|Death|0|||
16201408|NCT02767856|39215223|FG000|Overall Study|Lost to Follow-up|9|||
16201409|NCT02767856|39215224|FG001|Overall Study|Lost to Follow-up|1|||
16201410|NCT02767856|39215223|FG000|Overall Study|Withdrawal by Subject|2|||
16201411|NCT02767856|39215224|FG001|Overall Study|Withdrawal by Subject|1|||
16201412|NCT00793182|39215225|FG000|Overall Study|Adverse Event|0|||
16201413|NCT00793182|39215226|FG001|Overall Study|Adverse Event|1|||
16201414|NCT01188096|39215227|FG000|Overall Study|progression of disease|4|||
16201415|NCT01188096|39215227|FG000|Overall Study|Withdrawal by Subject|2|||
16201416|NCT03505749|39215232|FG000|Overall Study|Lost to Follow-up|7|||
16201417|NCT03505749|39215233|FG001|Overall Study|Lost to Follow-up|11|||
16201418|NCT03505749|39215232|FG000|Overall Study|Withdrawal by Subject|6|||
16201419|NCT03505749|39215233|FG001|Overall Study|Withdrawal by Subject|0|||
16201420|NCT03505749|39215232|FG000|Overall Study|Discharged from treatment|3|||
16201421|NCT03505749|39215233|FG001|Overall Study|Discharged from treatment|6|||
16201422|NCT01431144|39215241|FG000|Overall Study|Implant mobility and removal|2|||
16201423|NCT01431144|39215242|FG001|Overall Study|Implant mobility and removal|0|||
16201424|NCT01082367|39215248|FG000|Double-blind Period|Administrative problems|0|||
16201425|NCT01082367|39215249|FG001|Double-blind Period|Administrative problems|1|||
16201426|NCT01082367|39215248|FG000|Double-blind Period|Lack of Efficacy|5|||
16201427|NCT01082367|39215249|FG001|Double-blind Period|Lack of Efficacy|11|||
16201428|NCT01082367|39215248|FG000|Double-blind Period|Adverse Event|0|||
16201429|NCT01082367|39215249|FG001|Double-blind Period|Adverse Event|1|||
16201430|NCT01082367|39215248|FG000|Follow-up (F-U) Period|Administrative problems|1|||
16201431|NCT01082367|39215249|FG001|Follow-up (F-U) Period|Administrative problems|0|||
16201432|NCT01082367|39215248|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
16201433|NCT01082367|39215249|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
16201434|NCT01082367|39215248|FG000|Follow-up (F-U) Period|Adverse Event|0|||
16201435|NCT01082367|39215249|FG001|Follow-up (F-U) Period|Adverse Event|1|||
16201436|NCT01928082|39215256|FG000|Overall Study|Study terminated.|1|||
16201437|NCT05563714|39215257|FG000|Overall Study|Death|2|||
16201438|NCT05563714|39215258|FG001|Overall Study|Death|2|||
16201439|NCT05563714|39215259|FG002|Overall Study|Death|0|||
16201440|NCT05563714|39215260|FG003|Overall Study|Death|0|||
16201441|NCT05563714|39215257|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
16513760|NCT01516879|40351140|FG001|Overall Study|Death|2|||
16201442|NCT05563714|39215258|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
16201443|NCT05563714|39215259|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
16201444|NCT05563714|39215260|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
16201445|NCT05563714|39215257|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
16201446|NCT05563714|39215258|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
16201447|NCT05563714|39215259|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
16201448|NCT05563714|39215260|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
16201449|NCT05563714|39215257|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
16201450|NCT05563714|39215258|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
16201451|NCT05563714|39215259|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
16201452|NCT05563714|39215260|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
16201453|NCT05563714|39215257|FG000|Overall Study|Lost to Follow-up|22|||
16201454|NCT05563714|39215258|FG001|Overall Study|Lost to Follow-up|19|||
16201455|NCT05563714|39215259|FG002|Overall Study|Lost to Follow-up|0|||
16201456|NCT05563714|39215260|FG003|Overall Study|Lost to Follow-up|0|||
16201457|NCT03101514|39215262|FG000|Overall Study|Withdrawal by Subject|4|||
16201458|NCT03101514|39215262|FG000|Overall Study|Protocol Violation|2|||
16201459|NCT03101514|39215262|FG000|Overall Study|patient's information was incomplete|1|||
16201460|NCT01406652|39215266|FG000|Overall Study|Lost-to-follow-up|3|||
16201461|NCT01406652|39215267|FG001|Overall Study|Lost-to-follow-up|4|||
16201462|NCT01406652|39215266|FG000|Overall Study|Withdrawal by Subject|2|||
16201463|NCT01406652|39215267|FG001|Overall Study|Withdrawal by Subject|2|||
16201464|NCT01406652|39215266|FG000|Overall Study|Insufficient follow-up|5|||
16201465|NCT01406652|39215267|FG001|Overall Study|Insufficient follow-up|4|||
16201466|NCT01406652|39215266|FG000|Overall Study|Infection not sure|10|||
16201467|NCT01406652|39215267|FG001|Overall Study|Infection not sure|10|||
16201468|NCT02702518|39215268|FG000|Overall Study|Lost to Follow-up|3|||
16201469|NCT02702518|39215269|FG001|Overall Study|Lost to Follow-up|4|||
16201470|NCT00014911|39215270|FG000|Overall Study|Adverse Event|1|||
16201471|NCT00014911|39215270|FG000|Overall Study|Lost to Follow-up|1|||
16201472|NCT00014911|39215270|FG000|Overall Study|Withdrawal by Subject|6|||
16201473|NCT00014911|39215270|FG000|Overall Study|Unknown Reasons|2|||
16319320|NCT02509507|39651190|FG000|Overall Study|Death|21|||
16513761|NCT01516879|40351139|FG000|Overall Study|Lost to Follow-up|2|||
16513762|NCT01516879|40351140|FG001|Overall Study|Lost to Follow-up|11|||
16513763|NCT01516879|40351139|FG000|Overall Study|Other|5|||
16201474|NCT00014911|39215270|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
16201475|NCT01578785|39215271|FG000|Overall Study|Withdrawal by Subject|0|||
16201476|NCT01578785|39215272|FG001|Overall Study|Withdrawal by Subject|1|||
16201477|NCT01578785|39215271|FG000|Overall Study|Study terminated by sponsor|59|||
16201478|NCT01578785|39215272|FG001|Overall Study|Study terminated by sponsor|118|||
16201479|NCT02260648|39215280|FG000|Overall Study|Adverse Event|3|||
16201480|NCT02260648|39215281|FG001|Overall Study|Adverse Event|0|||
16201481|NCT02260648|39215282|FG002|Overall Study|Adverse Event|1|||
16201482|NCT02260648|39215280|FG000|Overall Study|Withdrawal by Subject|1|||
16201483|NCT02260648|39215281|FG001|Overall Study|Withdrawal by Subject|1|||
16201484|NCT02260648|39215282|FG002|Overall Study|Withdrawal by Subject|0|||
16201485|NCT02260648|39215280|FG000|Overall Study|Protocol Violation|1|||
16201486|NCT02260648|39215281|FG001|Overall Study|Protocol Violation|0|||
16201487|NCT02260648|39215282|FG002|Overall Study|Protocol Violation|0|||
16201488|NCT02260648|39215280|FG000|Overall Study|Discontinue Due to Study Termination|13|||
16201489|NCT02260648|39215281|FG001|Overall Study|Discontinue Due to Study Termination|12|||
16201490|NCT02260648|39215282|FG002|Overall Study|Discontinue Due to Study Termination|7|||
16201491|NCT02034552|39215284|FG000|Overall Study|Never treated|3|||
16201492|NCT02034552|39215285|FG001|Overall Study|Never treated|2|||
16201493|NCT02034552|39215286|FG002|Overall Study|Never treated|0|||
16201494|NCT02034552|39215284|FG000|Overall Study|Radiological progression|3|||
16201495|NCT02034552|39215285|FG001|Overall Study|Radiological progression|5|||
16201496|NCT02034552|39215286|FG002|Overall Study|Radiological progression|4|||
16201497|NCT02034552|39215284|FG000|Overall Study|AE not assoc. with disease progression|1|||
16201498|NCT02034552|39215285|FG001|Overall Study|AE not assoc. with disease progression|4|||
16201499|NCT02034552|39215286|FG002|Overall Study|AE not assoc. with disease progression|2|||
16201500|NCT02034552|39215284|FG000|Overall Study|AE associated with disease progression|0|||
16201501|NCT02034552|39215285|FG001|Overall Study|AE associated with disease progression|1|||
16201502|NCT02034552|39215286|FG002|Overall Study|AE associated with disease progression|0|||
16394036|NCT01947283|39924557|FG000|Overall Study|Lost to Follow-up|4|||
16394037|NCT01947283|39924558|FG001|Overall Study|Lost to Follow-up|6|||
16394038|NCT01947283|39924559|FG002|Overall Study|Lost to Follow-up|5|||
16513764|NCT01516879|40351140|FG001|Overall Study|Other|10|||
16513765|NCT04208412|40351141|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
16513766|NCT04208412|40351142|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
16513767|NCT04208412|40351141|FG000|Overall Study|Withdrawal by Subject|1|||
16513768|NCT04208412|40351142|FG001|Overall Study|Withdrawal by Subject|0|||
16513769|NCT04208412|40351141|FG000|Overall Study|Lost to Follow-up|0|||
16513770|NCT04208412|40351142|FG001|Overall Study|Lost to Follow-up|1|||
16513771|NCT01420081|40351143|FG000|Overall Study|Death|1|||
16513772|NCT01420081|40351144|FG001|Overall Study|Death|0|||
16513773|NCT01420081|40351145|FG002|Overall Study|Death|8|||
16513774|NCT01420081|40351146|FG003|Overall Study|Death|0|||
16513775|NCT01420081|40351147|FG004|Overall Study|Death|7|||
16513776|NCT01420081|40351148|FG005|Overall Study|Death|12|||
16513777|NCT01420081|40351149|FG006|Overall Study|Death|0|||
16513778|NCT01420081|40351150|FG007|Overall Study|Death|1|||
16201503|NCT02034552|39215284|FG000|Overall Study|Withdrawal by Subject|2|||
16201504|NCT02034552|39215285|FG001|Overall Study|Withdrawal by Subject|1|||
16513779|NCT01420081|40351151|FG008|Overall Study|Death|1|||
16201505|NCT02034552|39215286|FG002|Overall Study|Withdrawal by Subject|1|||
16201506|NCT02034552|39215284|FG000|Overall Study|Non-compliance with study drug|0|||
16201507|NCT02034552|39215285|FG001|Overall Study|Non-compliance with study drug|0|||
16201508|NCT02034552|39215286|FG002|Overall Study|Non-compliance with study drug|1|||
16513780|NCT01420081|40351143|FG000|Overall Study|Lost to Follow-up|0|||
16319321|NCT02509507|39651191|FG001|Overall Study|Death|3|||
16319322|NCT02509507|39651192|FG002|Overall Study|Death|22|||
16319323|NCT02509507|39651193|FG003|Overall Study|Death|14|||
16319324|NCT02509507|39651194|FG004|Overall Study|Death|8|||
16319325|NCT02509507|39651195|FG005|Overall Study|Death|12|||
16513781|NCT01420081|40351144|FG001|Overall Study|Lost to Follow-up|0|||
16513782|NCT01420081|40351145|FG002|Overall Study|Lost to Follow-up|0|||
16319326|NCT02509507|39651196|FG006|Overall Study|Death|5|||
16319327|NCT02509507|39651197|FG007|Overall Study|Death|4|||
16319328|NCT02509507|39651198|FG008|Overall Study|Death|8|||
16319329|NCT02509507|39651190|FG000|Overall Study|Lost to Follow-up|0|||
16319330|NCT02509507|39651191|FG001|Overall Study|Lost to Follow-up|1|||
16319331|NCT02509507|39651192|FG002|Overall Study|Lost to Follow-up|0|||
16319332|NCT02509507|39651193|FG003|Overall Study|Lost to Follow-up|0|||
16319333|NCT02509507|39651194|FG004|Overall Study|Lost to Follow-up|0|||
16319334|NCT02509507|39651195|FG005|Overall Study|Lost to Follow-up|2|||
16319335|NCT02509507|39651196|FG006|Overall Study|Lost to Follow-up|0|||
16319336|NCT02509507|39651197|FG007|Overall Study|Lost to Follow-up|0|||
16319337|NCT02509507|39651198|FG008|Overall Study|Lost to Follow-up|0|||
16513783|NCT01420081|40351146|FG003|Overall Study|Lost to Follow-up|0|||
16513784|NCT01420081|40351147|FG004|Overall Study|Lost to Follow-up|1|||
16513785|NCT01420081|40351148|FG005|Overall Study|Lost to Follow-up|1|||
16513786|NCT01420081|40351149|FG006|Overall Study|Lost to Follow-up|0|||
16513787|NCT01420081|40351150|FG007|Overall Study|Lost to Follow-up|0|||
16513788|NCT01420081|40351151|FG008|Overall Study|Lost to Follow-up|0|||
16513789|NCT01420081|40351143|FG000|Overall Study|Study Terminated by Sponsor|2|||
16513790|NCT01420081|40351144|FG001|Overall Study|Study Terminated by Sponsor|1|||
16513791|NCT01420081|40351145|FG002|Overall Study|Study Terminated by Sponsor|1|||
16513792|NCT01420081|40351146|FG003|Overall Study|Study Terminated by Sponsor|3|||
16513793|NCT01420081|40351147|FG004|Overall Study|Study Terminated by Sponsor|11|||
16090365|NCT04749797|38820200|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
16090366|NCT04749797|38820201|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
16319338|NCT02509507|39651190|FG000|Overall Study|Withdrawal by Subject|2|||
16513794|NCT01420081|40351148|FG005|Overall Study|Study Terminated by Sponsor|7|||
16319339|NCT02509507|39651191|FG001|Overall Study|Withdrawal by Subject|0|||
16513795|NCT01420081|40351149|FG006|Overall Study|Study Terminated by Sponsor|3|||
16513796|NCT01420081|40351150|FG007|Overall Study|Study Terminated by Sponsor|2|||
16513797|NCT01420081|40351151|FG008|Overall Study|Study Terminated by Sponsor|2|||
16513798|NCT01420081|40351143|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
16513799|NCT01420081|40351144|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
16513800|NCT01420081|40351145|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
16513801|NCT01420081|40351146|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
16513802|NCT01420081|40351147|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
16513803|NCT01420081|40351148|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
16513804|NCT01420081|40351149|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
16513805|NCT01420081|40351150|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
16513806|NCT01420081|40351151|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
16513807|NCT01420081|40351143|FG000|Overall Study|Other Reasons|0|||
16513808|NCT01420081|40351144|FG001|Overall Study|Other Reasons|0|||
16513809|NCT01420081|40351145|FG002|Overall Study|Other Reasons|1|||
16513810|NCT01420081|40351146|FG003|Overall Study|Other Reasons|0|||
16513811|NCT01420081|40351147|FG004|Overall Study|Other Reasons|0|||
16513812|NCT01420081|40351148|FG005|Overall Study|Other Reasons|0|||
16090367|NCT02113449|38820206|FG000|Overall Study|Adverse Event|4|||
16513813|NCT01420081|40351149|FG006|Overall Study|Other Reasons|0|||
16090368|NCT02188459|38820213|FG000|Overall Study|Lost to Follow-up|3|||
16090369|NCT02188459|38820214|FG001|Overall Study|Lost to Follow-up|4|||
16201509|NCT02034552|39215284|FG000|Overall Study|Clinical progression|5|||
16090370|NCT02188459|38820213|FG000|Overall Study|Early Termination|0|||
16513814|NCT01420081|40351150|FG007|Overall Study|Other Reasons|0|||
16090371|NCT02188459|38820214|FG001|Overall Study|Early Termination|3|||
16090372|NCT02067663|38820217|FG000|Overall Study|Lost to Follow-up|13|||
16090373|NCT02067663|38820218|FG001|Overall Study|Lost to Follow-up|14|||
16090374|NCT01190124|38820224|FG000|Overall Study|Death|3|||
16090375|NCT01190124|38820225|FG001|Overall Study|Death|0|||
16090376|NCT01190124|38820226|FG002|Overall Study|Death|0|||
16090377|NCT01190124|38820224|FG000|Overall Study|Therapeutic Failure|12|||
16090378|NCT01190124|38820225|FG001|Overall Study|Therapeutic Failure|0|||
16090379|NCT01190124|38820226|FG002|Overall Study|Therapeutic Failure|1|||
16090380|NCT01190124|38820224|FG000|Overall Study|Lost to Follow-up|2|||
16090381|NCT01190124|38820225|FG001|Overall Study|Lost to Follow-up|0|||
16090382|NCT01190124|38820226|FG002|Overall Study|Lost to Follow-up|0|||
16319340|NCT02509507|39651192|FG002|Overall Study|Withdrawal by Subject|1|||
16319341|NCT02509507|39651193|FG003|Overall Study|Withdrawal by Subject|4|||
16319342|NCT02509507|39651194|FG004|Overall Study|Withdrawal by Subject|1|||
16319343|NCT02509507|39651195|FG005|Overall Study|Withdrawal by Subject|3|||
16319344|NCT02509507|39651196|FG006|Overall Study|Withdrawal by Subject|4|||
16319345|NCT02509507|39651197|FG007|Overall Study|Withdrawal by Subject|0|||
16319346|NCT02509507|39651198|FG008|Overall Study|Withdrawal by Subject|1|||
16319347|NCT01831635|39651208|FG000|Overall Study|Withdrawal by Subject|0|||
16319348|NCT01831635|39651209|FG001|Overall Study|Withdrawal by Subject|2|||
16319349|NCT01831635|39651210|FG002|Overall Study|Withdrawal by Subject|0|||
16319350|NCT06110494|39651217|FG000|Overall Study|Protocol Violation|2|||
16319351|NCT06110494|39651218|FG001|Overall Study|Protocol Violation|0|||
16319352|NCT06110494|39651219|FG002|Overall Study|Protocol Violation|1|||
16319353|NCT06110494|39651217|FG000|Overall Study|Dixon's test for outlier analysis|1|||
16319354|NCT06110494|39651218|FG001|Overall Study|Dixon's test for outlier analysis|1|||
16319355|NCT06110494|39651219|FG002|Overall Study|Dixon's test for outlier analysis|0|||
16319356|NCT04387435|39651220|FG000|Overall Study|Physician Decision|1|||
16319357|NCT04471428|39651221|FG000|Overall Study|Withdrawal by Subject|29|||
16319358|NCT04471428|39651222|FG001|Overall Study|Withdrawal by Subject|1|||
16319359|NCT04471428|39651221|FG000|Overall Study|Physician Decision|0|||
16319360|NCT04471428|39651222|FG001|Overall Study|Physician Decision|1|||
16319361|NCT04471428|39651221|FG000|Overall Study|Reason Not Specified|0|||
16319362|NCT04471428|39651222|FG001|Overall Study|Reason Not Specified|2|||
16319363|NCT04471428|39651221|FG000|Overall Study|Death|106|||
16319364|NCT04471428|39651222|FG001|Overall Study|Death|114|||
16319365|NCT04471428|39651221|FG000|Overall Study|Ongoing in the study|45|||
16319366|NCT04471428|39651222|FG001|Overall Study|Ongoing in the study|68|||
16319367|NCT01168232|39651223|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
16319368|NCT01168232|39651223|FG000|Overall Study|Ineligible- Wrong cell type|6|||
16319369|NCT01168232|39651223|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
16319370|NCT01741688|39651224|FG000|Overall Study|Lack of insurance coverage|2|||
16319371|NCT01741688|39651224|FG000|Overall Study|Withdrawal by Subject|1|||
16319372|NCT01401361|39651226|FG000|Overall Study|Withdrawal by Subject|16|||
16319373|NCT01401361|39651226|FG000|Overall Study|Lack of Efficacy|6|||
16319374|NCT01401361|39651226|FG000|Overall Study|Physician Decision|1|||
16319375|NCT01401361|39651226|FG000|Overall Study|Lost to Follow-up|3|||
16319376|NCT01401361|39651226|FG000|Overall Study|Subject/family decision post procedure|2|||
16319377|NCT01560234|39653990|FG000|Overall Study|Lost to Follow-up|3|||
16319378|NCT01560234|39653991|FG001|Overall Study|Lost to Follow-up|0|||
16319379|NCT01560234|39653992|FG002|Overall Study|Lost to Follow-up|1|||
16319380|NCT01560234|39653993|FG003|Overall Study|Lost to Follow-up|0|||
16319381|NCT01560234|39653994|FG004|Overall Study|Lost to Follow-up|0|||
16319382|NCT01560234|39653995|FG005|Overall Study|Lost to Follow-up|2|||
16319383|NCT01560234|39653996|FG006|Overall Study|Lost to Follow-up|0|||
16319384|NCT01560234|39653997|FG007|Overall Study|Lost to Follow-up|2|||
16319385|NCT01288937|39653998|FG000|Overall Study|Adverse Event|1|||
16319386|NCT01288937|39653999|FG001|Overall Study|Adverse Event|0|||
16319387|NCT02019264|39654001|FG000|Overall Study|Not treated|6|||
16319388|NCT02019264|39654002|FG001|Overall Study|Not treated|4|||
16319389|NCT02019264|39654001|FG000|Overall Study|Lost to Follow-up|50|||
16319390|NCT02019264|39654002|FG001|Overall Study|Lost to Follow-up|47|||
16319391|NCT02019264|39654001|FG000|Overall Study|Withdrawal by Subject|142|||
16319392|NCT02019264|39654002|FG001|Overall Study|Withdrawal by Subject|117|||
16319393|NCT02019264|39654001|FG000|Overall Study|Administrative reason|36|||
16319394|NCT02019264|39654002|FG001|Overall Study|Administrative reason|28|||
16319395|NCT02019264|39654001|FG000|Overall Study|Missing|14|||
16319396|NCT02019264|39654002|FG001|Overall Study|Missing|11|||
16319397|NCT03340454|39654007|FG000|Overall Study|Lost to Follow-up|0|||
16319398|NCT03340454|39654008|FG001|Overall Study|Lost to Follow-up|4|||
16319399|NCT00333983|39654009|FG000|Overall Study|Lost to Follow-up|2|||
16090383|NCT03654326|38823371|FG000|Overall Study|Withdrawal by Subject|5|||
16319400|NCT00333983|39654010|FG001|Overall Study|Lost to Follow-up|1|||
16319401|NCT00333983|39654011|FG002|Overall Study|Lost to Follow-up|0|||
16319402|NCT00333983|39654009|FG000|Overall Study|Adverse Event|1|||
16319403|NCT00333983|39654010|FG001|Overall Study|Adverse Event|1|||
16319404|NCT00333983|39654011|FG002|Overall Study|Adverse Event|1|||
16513815|NCT01420081|40351151|FG008|Overall Study|Other Reasons|0|||
16513816|NCT01440322|40351152|FG000|Overall Study|Discomfort|2|||
16513817|NCT01440322|40351153|FG001|Overall Study|Discomfort|0|||
16513818|NCT01440322|40351152|FG000|Overall Study|Biomicroscopy|1|||
16513819|NCT01440322|40351153|FG001|Overall Study|Biomicroscopy|0|||
16513820|NCT01440322|40351152|FG000|Overall Study|Symptoms and Problems|1|||
16513821|NCT01440322|40351153|FG001|Overall Study|Symptoms and Problems|0|||
16513822|NCT01440322|40351152|FG000|Overall Study|Unacceptable Subjective Vision|1|||
16513823|NCT01440322|40351153|FG001|Overall Study|Unacceptable Subjective Vision|0|||
16513824|NCT01440322|40351152|FG000|Overall Study|Other Product Related|1|||
16513825|NCT01440322|40351153|FG001|Overall Study|Other Product Related|0|||
16513826|NCT01440322|40351152|FG000|Overall Study|Unrelated Medical Problem|0|||
16513827|NCT01440322|40351153|FG001|Overall Study|Unrelated Medical Problem|1|||
16513828|NCT01440322|40351152|FG000|Overall Study|Other Non-Product Related|1|||
16513829|NCT01440322|40351153|FG001|Overall Study|Other Non-Product Related|0|||
16513830|NCT00934544|40351154|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
16513831|NCT00934544|40351155|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
16513832|NCT00934544|40351156|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
16513833|NCT00934544|40351154|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
16513834|NCT00934544|40351155|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
16513835|NCT00934544|40351156|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
16513836|NCT00934544|40351154|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
16513837|NCT00934544|40351155|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
16513838|NCT00934544|40351156|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
16513839|NCT00934544|40351154|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
16513840|NCT00934544|40351155|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
16513841|NCT00934544|40351156|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
16513842|NCT00934544|40351154|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
16513843|NCT00934544|40351155|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
16513844|NCT00934544|40351156|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
16513845|NCT00934544|40351154|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
16513846|NCT00934544|40351155|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
16513847|NCT00934544|40351156|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
16513848|NCT00934544|40351154|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
16513849|NCT00934544|40351155|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
16513850|NCT00934544|40351156|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
16513851|NCT00934544|40351154|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
16513852|NCT00934544|40351155|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
16513853|NCT00934544|40351156|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
16513854|NCT00934544|40351154|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
16513855|NCT00934544|40351155|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
16513856|NCT00934544|40351156|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
16513857|NCT00934544|40351154|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
16513858|NCT00934544|40351155|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
16513859|NCT00934544|40351156|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
16513860|NCT00934544|40351154|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
16513861|NCT00934544|40351155|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
16513862|NCT00934544|40351156|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
16513863|NCT00934544|40351154|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
16513864|NCT00934544|40351155|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
16513865|NCT00934544|40351156|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
16513866|NCT00934544|40351154|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
16513867|NCT00934544|40351155|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
16513868|NCT00934544|40351156|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
16513869|NCT00934544|40351154|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
16513870|NCT00934544|40351155|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
16513871|NCT00934544|40351156|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
16513872|NCT00934544|40351154|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
16513873|NCT00934544|40351155|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
16513874|NCT00934544|40351156|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
16513875|NCT00934544|40351154|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
16513876|NCT00934544|40351155|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
16513877|NCT00934544|40351156|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
16513878|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
16394039|NCT01947283|39924560|FG003|Overall Study|Lost to Follow-up|5|||
16394040|NCT01947283|39924561|FG004|Overall Study|Lost to Follow-up|0|||
16394041|NCT01947283|39924562|FG005|Overall Study|Lost to Follow-up|2|||
16394042|NCT01947283|39924563|FG006|Overall Study|Lost to Follow-up|5|||
16394043|NCT01947283|39924557|FG000|Overall Study|Withdrawal by Subject|10|||
16394044|NCT01947283|39924558|FG001|Overall Study|Withdrawal by Subject|8|||
16394045|NCT01947283|39924559|FG002|Overall Study|Withdrawal by Subject|4|||
16394046|NCT01947283|39924560|FG003|Overall Study|Withdrawal by Subject|1|||
16394047|NCT01947283|39924561|FG004|Overall Study|Withdrawal by Subject|0|||
16394048|NCT01947283|39924562|FG005|Overall Study|Withdrawal by Subject|0|||
16394049|NCT01947283|39924563|FG006|Overall Study|Withdrawal by Subject|2|||
16394050|NCT01947283|39924557|FG000|Overall Study|No Clinical Recording|12|||
16394051|NCT01947283|39924558|FG001|Overall Study|No Clinical Recording|6|||
16394052|NCT01947283|39924559|FG002|Overall Study|No Clinical Recording|8|||
16394053|NCT01947283|39924560|FG003|Overall Study|No Clinical Recording|10|||
16394054|NCT01947283|39924561|FG004|Overall Study|No Clinical Recording|0|||
16201510|NCT02034552|39215285|FG001|Overall Study|Clinical progression|7|||
16394055|NCT01947283|39924562|FG005|Overall Study|No Clinical Recording|0|||
16394056|NCT01947283|39924563|FG006|Overall Study|No Clinical Recording|0|||
16394057|NCT01947283|39924557|FG000|Overall Study|Non-coding Clinical Recording language|0|||
16394058|NCT01947283|39924558|FG001|Overall Study|Non-coding Clinical Recording language|0|||
16394059|NCT01947283|39924559|FG002|Overall Study|Non-coding Clinical Recording language|0|||
16394060|NCT01947283|39924560|FG003|Overall Study|Non-coding Clinical Recording language|1|||
16394061|NCT01947283|39924561|FG004|Overall Study|Non-coding Clinical Recording language|0|||
16394062|NCT01947283|39924562|FG005|Overall Study|Non-coding Clinical Recording language|0|||
16394063|NCT01947283|39924563|FG006|Overall Study|Non-coding Clinical Recording language|0|||
16513879|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
16201511|NCT02034552|39215286|FG002|Overall Study|Clinical progression|9|||
16201512|NCT00844285|39215287|FG000|Overall Study|Other|0|||
16201513|NCT00844285|39215288|FG001|Overall Study|Other|1|||
16201514|NCT00844285|39215289|FG002|Overall Study|Other|0|||
16201515|NCT00844285|39215287|FG000|Overall Study|Other than specified|95|||
16201516|NCT00844285|39215288|FG001|Overall Study|Other than specified|129|||
16201517|NCT00844285|39215289|FG002|Overall Study|Other than specified|12|||
16513880|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
16513881|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
16513882|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
16513883|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
16319405|NCT00333983|39654009|FG000|Overall Study|Withdrawal by Subject|0|||
16319406|NCT00333983|39654010|FG001|Overall Study|Withdrawal by Subject|3|||
16319407|NCT00333983|39654011|FG002|Overall Study|Withdrawal by Subject|1|||
16319408|NCT01002989|39654014|FG000|Overall Study|exclusion criteria, no consent|5|||
16319409|NCT01732640|39654016|FG000|Overall Study|Adverse Event|0|||
16319410|NCT01732640|39654017|FG001|Overall Study|Adverse Event|1|||
16319411|NCT01732640|39654016|FG000|Overall Study|Death|0|||
16319412|NCT01732640|39654017|FG001|Overall Study|Death|1|||
16319413|NCT02858583|39654020|FG000|Overall Study|Declined consent|1|||
16319414|NCT02858583|39654021|FG001|Overall Study|Declined consent|1|||
16319415|NCT00984568|39654023|FG000|Overall Study|Withdrawal by Subject|1|||
16319416|NCT00984568|39654024|FG001|Overall Study|Withdrawal by Subject|2|||
16319417|NCT00984568|39654023|FG000|Overall Study|Lack of Efficacy|2|||
16513884|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
16513885|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
16513886|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
16513887|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
16513888|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
16513889|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
16201518|NCT00844285|39215287|FG000|Overall Study|Site closure|256|||
16513890|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
16513891|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
16513892|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
16513893|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
16513894|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
16513895|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
16513896|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Death|0|||
16513897|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Death|0|||
16513898|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Death|1|||
16513899|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Death|0|||
16513900|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Death|0|||
16513901|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Death|0|||
16513902|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Death|0|||
16513903|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Death|0|||
16513904|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Death|0|||
16513905|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
16513906|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
16513907|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
16513908|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
16513909|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
16513910|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
16513911|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
16513912|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
16513913|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
16513914|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
16513915|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
16513916|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
16513917|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
16201519|NCT00844285|39215288|FG001|Overall Study|Site closure|450|||
16201520|NCT00844285|39215289|FG002|Overall Study|Site closure|50|||
16201521|NCT00844285|39215287|FG000|Overall Study|Follow-up < 8 years|16|||
16201522|NCT00844285|39215288|FG001|Overall Study|Follow-up < 8 years|23|||
16319418|NCT00984568|39654024|FG001|Overall Study|Lack of Efficacy|0|||
16319419|NCT00984568|39654023|FG000|Overall Study|Adverse Event|2|||
16394064|NCT01947283|39924557|FG000|Overall Study|Missing Follow-up Assessment|2|||
16201523|NCT00844285|39215289|FG002|Overall Study|Follow-up < 8 years|4|||
16201524|NCT00844285|39215287|FG000|Overall Study|Protocol Violation|26|||
16201525|NCT00844285|39215288|FG001|Overall Study|Protocol Violation|28|||
16513918|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
16513919|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
16513920|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
16513921|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
16513922|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
16513923|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
16513924|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
16513925|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
16513926|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
16513927|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
16513928|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
16513929|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
16513930|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
16513931|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
16513932|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
16513933|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
16513934|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
16513935|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
16513936|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
16513937|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
16513938|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
16513939|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
16513940|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
16513941|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
16513942|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
16513943|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
16513944|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
16513945|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
16513946|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
16513947|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
16513948|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
16513949|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
16513950|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
16513951|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
16513952|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
16201526|NCT00844285|39215289|FG002|Overall Study|Protocol Violation|54|||
16201527|NCT00844285|39215287|FG000|Overall Study|Death|22|||
16201528|NCT00844285|39215288|FG001|Overall Study|Death|21|||
16513953|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
16513954|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
16513955|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
16513956|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
16513957|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
16513958|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
16513959|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
16319420|NCT00984568|39654024|FG001|Overall Study|Adverse Event|0|||
16090384|NCT03654326|38823372|FG001|Overall Study|Withdrawal by Subject|3|||
16090385|NCT03654326|38823371|FG000|Overall Study|Physician Decision|0|||
16319421|NCT00984568|39654023|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
16319422|NCT00984568|39654024|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
16319423|NCT00984568|39654023|FG000|Overall Study|Lost to Follow-up|0|||
16513960|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
16319424|NCT00984568|39654024|FG001|Overall Study|Lost to Follow-up|1|||
16319425|NCT00984568|39654023|FG000|Overall Study|Opportunistic Infection|1|||
16319426|NCT00984568|39654024|FG001|Overall Study|Opportunistic Infection|0|||
16319427|NCT00984568|39654023|FG000|Overall Study|Unknown Reason|1|||
16319428|NCT00984568|39654024|FG001|Overall Study|Unknown Reason|3|||
16319429|NCT00576420|39654027|FG000|Overall Study|Death|0|||
16319430|NCT00576420|39654028|FG001|Overall Study|Death|0|||
16319431|NCT00576420|39654029|FG002|Overall Study|Death|1|||
16090386|NCT03654326|38823372|FG001|Overall Study|Physician Decision|1|||
16090387|NCT03654326|38823371|FG000|Overall Study|Unable to adhere to study schedule|0|||
16090388|NCT03654326|38823372|FG001|Overall Study|Unable to adhere to study schedule|1|||
16090389|NCT03654326|38823371|FG000|Overall Study|Lost to Follow-up|1|||
16090390|NCT03654326|38823372|FG001|Overall Study|Lost to Follow-up|1|||
16090391|NCT03939897|38823373|FG000|Overall Study|Still receiving active treatment|0|||
16090392|NCT03939897|38823374|FG001|Overall Study|Still receiving active treatment|0|||
16090393|NCT03939897|38823375|FG002|Overall Study|Still receiving active treatment|1|||
16090394|NCT03939897|38823376|FG003|Overall Study|Still receiving active treatment|0|||
16090395|NCT03939897|38823377|FG004|Overall Study|Still receiving active treatment|0|||
16090396|NCT03939897|38823378|FG005|Overall Study|Still receiving active treatment|0|||
16090397|NCT02671266|38823379|FG000|Overall Study|Withdrawal by Subject|1|||
16090398|NCT02671266|38823380|FG001|Overall Study|Withdrawal by Subject|1|||
16090399|NCT02699099|38823381|FG000|Overall Study|Adverse Event|1|||
16090400|NCT02699099|38823382|FG001|Overall Study|Adverse Event|0|||
16090401|NCT02699099|38823383|FG002|Overall Study|Adverse Event|2|||
16090402|NCT02699099|38823381|FG000|Overall Study|Lost to Follow-up|0|||
16090403|NCT02699099|38823382|FG001|Overall Study|Lost to Follow-up|1|||
16090404|NCT02699099|38823383|FG002|Overall Study|Lost to Follow-up|0|||
16090405|NCT02699099|38823381|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
16090406|NCT02699099|38823382|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
16090407|NCT02699099|38823383|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
16090408|NCT00264576|38823387|FG000|Overall Study|Lost to Follow-up|1|||
16090409|NCT00264576|38823388|FG001|Overall Study|Lost to Follow-up|1|||
16090410|NCT01698918|38823392|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
16090411|NCT01698918|38823392|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
16090412|NCT01698918|38823392|FG000|First Line Treatment (Core+Extension)|Death|2|||
16090413|NCT01698918|38823392|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
16090414|NCT01698918|38823392|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
16090415|NCT01698918|38823392|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
16090416|NCT01698918|38823392|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
16090417|NCT01698918|38823392|FG000|Second Line Treatment (Core+Extension)|Death|1|||
16319432|NCT01430754|39654030|FG000|Run-In Phase|Circadian Period Ineligible|24|||
16513961|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
16513962|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
16513963|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
16513964|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
16319433|NCT01430754|39654031|FG001|Run-In Phase|Circadian Period Ineligible|0|||
16319434|NCT01430754|39654030|FG000|Run-In Phase|Protocol Violation|6|||
16319435|NCT01430754|39654031|FG001|Run-In Phase|Protocol Violation|0|||
16319436|NCT01430754|39654030|FG000|Run-In Phase|Adverse Event|2|||
16513965|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
16513966|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
16513967|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
16513968|NCT00404352|40351157|FG000|Double Blind (up to 24 Month)|Other|0|||
16513969|NCT00404352|40351158|FG001|Double Blind (up to 24 Month)|Other|1|||
16513970|NCT00404352|40351159|FG002|Double Blind (up to 24 Month)|Other|0|||
16513971|NCT00404352|40351160|FG003|Double Blind (up to 24 Month)|Other|0|||
16513972|NCT00404352|40351161|FG004|Double Blind (up to 24 Month)|Other|0|||
16513973|NCT00404352|40351162|FG005|Double Blind (up to 24 Month)|Other|0|||
16513974|NCT00404352|40351163|FG006|Double Blind (up to 24 Month)|Other|0|||
16513975|NCT00404352|40351164|FG007|Double Blind (up to 24 Month)|Other|0|||
16513976|NCT00404352|40351165|FG008|Double Blind (up to 24 Month)|Other|0|||
16513977|NCT00404352|40351157|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
16513978|NCT00404352|40351158|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
16513979|NCT00404352|40351159|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
16513980|NCT00404352|40351160|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
16513981|NCT00404352|40351161|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
16513982|NCT00404352|40351162|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
16513983|NCT00404352|40351163|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
16513984|NCT00404352|40351164|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
16513985|NCT00404352|40351165|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
16513986|NCT00404352|40351157|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
16513987|NCT00404352|40351158|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
16513988|NCT00404352|40351159|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
16513989|NCT00404352|40351160|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
16513990|NCT00404352|40351161|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
16513991|NCT00404352|40351162|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
16513992|NCT00404352|40351163|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
16513993|NCT00404352|40351164|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
16513994|NCT00404352|40351165|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
16513995|NCT00404352|40351157|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
16513996|NCT00404352|40351158|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
16513997|NCT00404352|40351159|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
16513998|NCT00404352|40351160|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
16513999|NCT00404352|40351161|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
16514000|NCT00404352|40351162|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
16514001|NCT00404352|40351163|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
16514002|NCT00404352|40351164|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
16514003|NCT00404352|40351165|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
16514004|NCT00404352|40351157|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
16514005|NCT00404352|40351158|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
16514006|NCT00404352|40351159|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
16514007|NCT00404352|40351160|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
16514008|NCT00404352|40351161|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
16514009|NCT00404352|40351162|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
16514010|NCT00404352|40351163|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
16514011|NCT00404352|40351164|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
16514012|NCT00404352|40351165|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
16514013|NCT00404352|40351157|FG000|Open Label (up to 24 Month)|Disease progression|0|||
16514014|NCT00404352|40351158|FG001|Open Label (up to 24 Month)|Disease progression|0|||
16514015|NCT00404352|40351159|FG002|Open Label (up to 24 Month)|Disease progression|0|||
16514016|NCT00404352|40351160|FG003|Open Label (up to 24 Month)|Disease progression|1|||
16514017|NCT00404352|40351161|FG004|Open Label (up to 24 Month)|Disease progression|0|||
16514018|NCT00404352|40351162|FG005|Open Label (up to 24 Month)|Disease progression|0|||
16514019|NCT00404352|40351163|FG006|Open Label (up to 24 Month)|Disease progression|0|||
16514020|NCT00404352|40351164|FG007|Open Label (up to 24 Month)|Disease progression|0|||
16514021|NCT00404352|40351165|FG008|Open Label (up to 24 Month)|Disease progression|0|||
16514022|NCT00404352|40351157|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
16514023|NCT00404352|40351158|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
16514024|NCT00404352|40351159|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
16514025|NCT00404352|40351160|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
16514026|NCT00404352|40351161|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
16514027|NCT00404352|40351162|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
16514028|NCT00404352|40351163|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
16514029|NCT00404352|40351164|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
16514030|NCT00404352|40351165|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
16514031|NCT00404352|40351157|FG000|Open Label Extension (up to 36 Months)|Other|0|||
16514032|NCT00404352|40351158|FG001|Open Label Extension (up to 36 Months)|Other|0|||
16514033|NCT00404352|40351159|FG002|Open Label Extension (up to 36 Months)|Other|0|||
16514034|NCT00404352|40351160|FG003|Open Label Extension (up to 36 Months)|Other|0|||
16514035|NCT00404352|40351161|FG004|Open Label Extension (up to 36 Months)|Other|0|||
16514036|NCT00404352|40351162|FG005|Open Label Extension (up to 36 Months)|Other|0|||
16514037|NCT00404352|40351163|FG006|Open Label Extension (up to 36 Months)|Other|0|||
16514038|NCT00404352|40351164|FG007|Open Label Extension (up to 36 Months)|Other|0|||
16514039|NCT00404352|40351165|FG008|Open Label Extension (up to 36 Months)|Other|2|||
16514040|NCT03149237|40351166|FG000|Overall Study|Withdrawal by Subject|4|||
16514041|NCT03149237|40351167|FG001|Overall Study|Withdrawal by Subject|5|||
16514042|NCT01433263|40351168|FG000|Overall Study|Adverse Event|3|||
16514043|NCT01433263|40351169|FG001|Overall Study|Adverse Event|1|||
16514044|NCT01433263|40351168|FG000|Overall Study|Death|5|||
16514045|NCT01433263|40351169|FG001|Overall Study|Death|3|||
16514046|NCT01433263|40351168|FG000|Overall Study|Lost to Follow-up|0|||
16514047|NCT01433263|40351169|FG001|Overall Study|Lost to Follow-up|1|||
16514048|NCT01433263|40351168|FG000|Overall Study|Protocol Deviation|1|||
16514049|NCT01433263|40351169|FG001|Overall Study|Protocol Deviation|0|||
16514050|NCT01433263|40351168|FG000|Overall Study|Withdrawal by Subject|10|||
16514051|NCT01433263|40351169|FG001|Overall Study|Withdrawal by Subject|7|||
16514052|NCT01762943|40351170|FG000|Overall Study|Physician Decision|1|||
16514053|NCT01762943|40351171|FG001|Overall Study|Physician Decision|1|||
16514054|NCT01762943|40351170|FG000|Overall Study|Protocol Violation|1|||
16514055|NCT01762943|40351171|FG001|Overall Study|Protocol Violation|0|||
16514056|NCT01762943|40351170|FG000|Overall Study|Withdrawal by Subject|2|||
16514057|NCT01762943|40351171|FG001|Overall Study|Withdrawal by Subject|1|||
16514058|NCT01559311|40351172|FG000|Overall Study|Protocol Violation|0|||
16514059|NCT01559311|40351173|FG001|Overall Study|Protocol Violation|0|||
16514060|NCT01559311|40351174|FG002|Overall Study|Protocol Violation|2|||
16514061|NCT01559311|40351172|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
16514062|NCT01559311|40351173|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
16514063|NCT01559311|40351174|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
16514064|NCT01559311|40351172|FG000|Overall Study|Withdrawal by Subject|2|||
16514065|NCT01559311|40351173|FG001|Overall Study|Withdrawal by Subject|1|||
16090418|NCT01698918|38823392|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
16090419|NCT01698918|38823392|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
16090420|NCT00786188|38823403|FG000|Overall Study|Adverse Event|3|||
16090421|NCT00786188|38823404|FG001|Overall Study|Adverse Event|1|||
16090422|NCT00786188|38823403|FG000|Overall Study|Withdrawal by Subject|2|||
16090423|NCT00786188|38823404|FG001|Overall Study|Withdrawal by Subject|0|||
16201529|NCT00844285|39215289|FG002|Overall Study|Death|8|||
16514066|NCT01559311|40351174|FG002|Overall Study|Withdrawal by Subject|0|||
16201530|NCT00844285|39215287|FG000|Overall Study|Withdrew Consent|344|||
16201531|NCT00844285|39215288|FG001|Overall Study|Withdrew Consent|466|||
16201532|NCT00844285|39215289|FG002|Overall Study|Withdrew Consent|70|||
16201533|NCT00844285|39215287|FG000|Overall Study|Lost to Follow-up|330|||
16201534|NCT00844285|39215288|FG001|Overall Study|Lost to Follow-up|486|||
16201535|NCT00844285|39215289|FG002|Overall Study|Lost to Follow-up|74|||
16201536|NCT04095442|39215290|FG000|Overall Study|Lost to Follow-up|0|||
16201537|NCT04095442|39215291|FG001|Overall Study|Lost to Follow-up|1|||
16201538|NCT04095442|39215290|FG000|Overall Study|Screen failure|1|||
16201539|NCT04095442|39215291|FG001|Overall Study|Screen failure|0|||
16201540|NCT00108953|39215292|FG000|Follow-up|Death|18|||
16201541|NCT00108953|39215293|FG001|Follow-up|Death|26|||
16201542|NCT00108953|39215292|FG000|Follow-up|Lost to Follow-up|1|||
16201543|NCT00108953|39215293|FG001|Follow-up|Lost to Follow-up|1|||
16201544|NCT00108953|39215292|FG000|Follow-up|Study terminated by sponsor|10|||
16319437|NCT01430754|39654031|FG001|Run-In Phase|Adverse Event|0|||
16319438|NCT01430754|39654030|FG000|Run-In Phase|Other|2|||
16319439|NCT01430754|39654031|FG001|Run-In Phase|Other|0|||
16319440|NCT01430754|39654030|FG000|Run-In Phase|Withdrawal by Subject|2|||
16319441|NCT01430754|39654031|FG001|Run-In Phase|Withdrawal by Subject|0|||
16319442|NCT01430754|39654030|FG000|Run-In Phase|Lost to Follow-up|1|||
16319443|NCT01430754|39654031|FG001|Run-In Phase|Lost to Follow-up|0|||
16319444|NCT01295827|39654032|FG000|Overall Study|Adverse Event|1|||
16319445|NCT01295827|39654033|FG001|Overall Study|Adverse Event|2|||
16319446|NCT01295827|39654034|FG002|Overall Study|Adverse Event|2|||
16319447|NCT01295827|39654035|FG003|Overall Study|Adverse Event|1|||
16319448|NCT01295827|39654036|FG004|Overall Study|Adverse Event|1|||
16514067|NCT01559311|40351172|FG000|Overall Study|Death|0|||
16514068|NCT01559311|40351173|FG001|Overall Study|Death|2|||
16090424|NCT00458783|38823406|FG000|Overall Study|Protocol Violation|1228|||
16201545|NCT00108953|39215293|FG001|Follow-up|Study terminated by sponsor|6|||
16201546|NCT00479557|39215298|FG000|Overall Study|Death|0|||
16201547|NCT00479557|39215299|FG001|Overall Study|Death|0|||
16514069|NCT01559311|40351174|FG002|Overall Study|Death|3|||
16514070|NCT01559311|40351172|FG000|Overall Study|Lost to Follow-up|0|||
16514071|NCT01559311|40351173|FG001|Overall Study|Lost to Follow-up|3|||
16514072|NCT01559311|40351174|FG002|Overall Study|Lost to Follow-up|2|||
16514073|NCT01559311|40351172|FG000|Overall Study|Adverse Event|0|||
16090425|NCT00458783|38823407|FG001|Overall Study|Protocol Violation|1220|||
16201548|NCT00479557|39215300|FG002|Overall Study|Death|0|||
16201549|NCT00479557|39215301|FG003|Overall Study|Death|0|||
16319449|NCT01295827|39654037|FG005|Overall Study|Adverse Event|4|||
16394065|NCT01947283|39924558|FG001|Overall Study|Missing Follow-up Assessment|2|||
16394066|NCT01947283|39924559|FG002|Overall Study|Missing Follow-up Assessment|3|||
16394067|NCT01947283|39924560|FG003|Overall Study|Missing Follow-up Assessment|0|||
16394068|NCT01947283|39924561|FG004|Overall Study|Missing Follow-up Assessment|0|||
16394069|NCT01947283|39924562|FG005|Overall Study|Missing Follow-up Assessment|2|||
16394070|NCT01947283|39924563|FG006|Overall Study|Missing Follow-up Assessment|0|||
16394071|NCT01947283|39924557|FG000|Overall Study|No patients were enrolled in study|0|||
16394072|NCT01947283|39924558|FG001|Overall Study|No patients were enrolled in study|0|||
16394073|NCT01947283|39924559|FG002|Overall Study|No patients were enrolled in study|0|||
16394074|NCT01947283|39924560|FG003|Overall Study|No patients were enrolled in study|0|||
16394075|NCT01947283|39924561|FG004|Overall Study|No patients were enrolled in study|0|||
16394076|NCT01947283|39924562|FG005|Overall Study|No patients were enrolled in study|3|||
16394077|NCT01947283|39924563|FG006|Overall Study|No patients were enrolled in study|1|||
16394078|NCT03472495|39924569|FG000|Overall Study|Treatment no longer indicated|1|||
16394079|NCT03472495|39924570|FG001|Overall Study|Treatment no longer indicated|2|||
16514074|NCT01559311|40351173|FG001|Overall Study|Adverse Event|0|||
16514075|NCT01559311|40351174|FG002|Overall Study|Adverse Event|1|||
16514076|NCT00353366|40351175|FG000|Overall Study|Adverse Event|8|||
16394080|NCT03472495|39924569|FG000|Overall Study|Physician Decision|0|||
16394081|NCT03472495|39924570|FG001|Overall Study|Physician Decision|2|||
16394082|NCT00211172|39924573|FG000|Overall Study|Died or lost health plan eligibility|39|||
16394083|NCT00211172|39924574|FG001|Overall Study|Died or lost health plan eligibility|32|||
16394084|NCT01693250|39924575|FG000|Overall Study|Lost to Follow-up|2|||
16394085|NCT01693250|39924576|FG001|Overall Study|Lost to Follow-up|2|||
16394086|NCT02125838|39924578|FG000|Overall Study|Lost to Follow-up|4|||
16319450|NCT01295827|39654038|FG006|Overall Study|Adverse Event|15|||
16319451|NCT01295827|39654039|FG007|Overall Study|Adverse Event|49|||
16319452|NCT01295827|39654040|FG008|Overall Study|Adverse Event|22|||
16319453|NCT01295827|39654041|FG009|Overall Study|Adverse Event|7|||
16319454|NCT01295827|39654042|FG010|Overall Study|Adverse Event|50|||
16319455|NCT01295827|39654043|FG011|Overall Study|Adverse Event|21|||
16319456|NCT01295827|39654044|FG012|Overall Study|Adverse Event|0|||
16319457|NCT01295827|39654045|FG013|Overall Study|Adverse Event|0|||
16319458|NCT01295827|39654046|FG014|Overall Study|Adverse Event|0|||
16319459|NCT01295827|39654032|FG000|Overall Study|Lost to Follow-up|0|||
16319460|NCT01295827|39654033|FG001|Overall Study|Lost to Follow-up|0|||
16319461|NCT01295827|39654034|FG002|Overall Study|Lost to Follow-up|3|||
16319462|NCT01295827|39654035|FG003|Overall Study|Lost to Follow-up|0|||
16319463|NCT01295827|39654036|FG004|Overall Study|Lost to Follow-up|1|||
16319464|NCT01295827|39654037|FG005|Overall Study|Lost to Follow-up|0|||
16319465|NCT01295827|39654038|FG006|Overall Study|Lost to Follow-up|4|||
16319466|NCT01295827|39654039|FG007|Overall Study|Lost to Follow-up|8|||
16319467|NCT01295827|39654040|FG008|Overall Study|Lost to Follow-up|7|||
16319468|NCT01295827|39654041|FG009|Overall Study|Lost to Follow-up|4|||
16319469|NCT01295827|39654042|FG010|Overall Study|Lost to Follow-up|7|||
16319470|NCT01295827|39654043|FG011|Overall Study|Lost to Follow-up|3|||
16319471|NCT01295827|39654044|FG012|Overall Study|Lost to Follow-up|0|||
16319472|NCT01295827|39654045|FG013|Overall Study|Lost to Follow-up|0|||
16319473|NCT01295827|39654046|FG014|Overall Study|Lost to Follow-up|0|||
16319474|NCT01295827|39654032|FG000|Overall Study|Not Reported|0|||
16319475|NCT01295827|39654033|FG001|Overall Study|Not Reported|0|||
16319476|NCT01295827|39654034|FG002|Overall Study|Not Reported|0|||
16319477|NCT01295827|39654035|FG003|Overall Study|Not Reported|1|||
16319478|NCT01295827|39654036|FG004|Overall Study|Not Reported|0|||
16319479|NCT01295827|39654037|FG005|Overall Study|Not Reported|0|||
16319480|NCT01295827|39654038|FG006|Overall Study|Not Reported|24|||
16319481|NCT01295827|39654039|FG007|Overall Study|Not Reported|58|||
16319482|NCT01295827|39654040|FG008|Overall Study|Not Reported|41|||
16319483|NCT01295827|39654041|FG009|Overall Study|Not Reported|2|||
16319484|NCT01295827|39654042|FG010|Overall Study|Not Reported|23|||
16319485|NCT01295827|39654043|FG011|Overall Study|Not Reported|13|||
16319486|NCT01295827|39654044|FG012|Overall Study|Not Reported|0|||
16319487|NCT01295827|39654045|FG013|Overall Study|Not Reported|0|||
16514077|NCT00353366|40351175|FG000|Overall Study|Protocol Violation|12|||
16514078|NCT00353366|40351175|FG000|Overall Study|Withdrawal by Subject|12|||
16514079|NCT00353366|40351175|FG000|Overall Study|Lost to Follow-up|92|||
16514080|NCT00353366|40351175|FG000|Overall Study|Other|19|||
16514081|NCT00378014|40351176|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
16514082|NCT00378014|40351177|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
16514083|NCT00378014|40351176|FG000|Core (Randomization to Month 11)|Graft loss|1|||
16514084|NCT00378014|40351177|FG001|Core (Randomization to Month 11)|Graft loss|2|||
16514085|NCT00378014|40351176|FG000|Core (Randomization to Month 11)|Death|5|||
16319488|NCT01295827|39654046|FG014|Overall Study|Not Reported|0|||
16319489|NCT01295827|39654032|FG000|Overall Study|Progressive Disease|2|||
16319490|NCT01295827|39654033|FG001|Overall Study|Progressive Disease|1|||
16319491|NCT01295827|39654034|FG002|Overall Study|Progressive Disease|5|||
16319492|NCT01295827|39654035|FG003|Overall Study|Progressive Disease|2|||
16394087|NCT02125838|39924579|FG001|Overall Study|Lost to Follow-up|4|||
16394088|NCT02079909|39924580|FG000|Overall Study|Adverse Event|23|||
16394089|NCT02079909|39924581|FG001|Overall Study|Adverse Event|23|||
16394090|NCT02079909|39924582|FG002|Overall Study|Adverse Event|7|||
16394091|NCT02079909|39924580|FG000|Overall Study|Withdrawal by Subject|9|||
16394092|NCT02079909|39924581|FG001|Overall Study|Withdrawal by Subject|17|||
16394093|NCT02079909|39924582|FG002|Overall Study|Withdrawal by Subject|4|||
16394094|NCT02079909|39924580|FG000|Overall Study|Lost to Follow-up|2|||
16394095|NCT02079909|39924581|FG001|Overall Study|Lost to Follow-up|3|||
16394096|NCT02079909|39924582|FG002|Overall Study|Lost to Follow-up|1|||
16394097|NCT02079909|39924580|FG000|Overall Study|Death|2|||
16201550|NCT00479557|39215302|FG004|Overall Study|Death|0|||
16201551|NCT00479557|39215303|FG005|Overall Study|Death|1|||
16201552|NCT00479557|39215304|FG006|Overall Study|Death|0|||
16201553|NCT00479557|39215298|FG000|Overall Study|Lack of Efficacy|1|||
16201554|NCT00479557|39215299|FG001|Overall Study|Lack of Efficacy|0|||
16201555|NCT00479557|39215300|FG002|Overall Study|Lack of Efficacy|0|||
16201556|NCT00479557|39215301|FG003|Overall Study|Lack of Efficacy|0|||
16201557|NCT00479557|39215302|FG004|Overall Study|Lack of Efficacy|0|||
16201558|NCT00479557|39215303|FG005|Overall Study|Lack of Efficacy|0|||
16201559|NCT00479557|39215304|FG006|Overall Study|Lack of Efficacy|0|||
16201560|NCT00479557|39215298|FG000|Overall Study|Lost to Follow-up|0|||
16201561|NCT00479557|39215299|FG001|Overall Study|Lost to Follow-up|2|||
16201562|NCT00479557|39215300|FG002|Overall Study|Lost to Follow-up|0|||
16201563|NCT00479557|39215301|FG003|Overall Study|Lost to Follow-up|2|||
16201564|NCT00479557|39215302|FG004|Overall Study|Lost to Follow-up|0|||
16201565|NCT00479557|39215303|FG005|Overall Study|Lost to Follow-up|0|||
16201566|NCT00479557|39215304|FG006|Overall Study|Lost to Follow-up|0|||
16201567|NCT00479557|39215298|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
16201568|NCT00479557|39215299|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
16201569|NCT00479557|39215300|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
16201570|NCT00479557|39215301|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
16201571|NCT00479557|39215302|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
16201572|NCT00479557|39215303|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
16201573|NCT00479557|39215304|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
16201574|NCT00479557|39215298|FG000|Overall Study|AE not related to Study Drug|1|||
16201575|NCT00479557|39215299|FG001|Overall Study|AE not related to Study Drug|3|||
16201576|NCT00479557|39215300|FG002|Overall Study|AE not related to Study Drug|0|||
16201577|NCT00479557|39215301|FG003|Overall Study|AE not related to Study Drug|0|||
16201578|NCT00479557|39215302|FG004|Overall Study|AE not related to Study Drug|2|||
16201579|NCT00479557|39215303|FG005|Overall Study|AE not related to Study Drug|2|||
16201580|NCT00479557|39215304|FG006|Overall Study|AE not related to Study Drug|1|||
16201581|NCT00479557|39215298|FG000|Overall Study|Caregiver Request|2|||
16201582|NCT00479557|39215299|FG001|Overall Study|Caregiver Request|2|||
16201583|NCT00479557|39215300|FG002|Overall Study|Caregiver Request|2|||
16201584|NCT00479557|39215301|FG003|Overall Study|Caregiver Request|0|||
16201585|NCT00479557|39215302|FG004|Overall Study|Caregiver Request|1|||
16201586|NCT00479557|39215303|FG005|Overall Study|Caregiver Request|2|||
16201587|NCT00479557|39215304|FG006|Overall Study|Caregiver Request|0|||
16201588|NCT00479557|39215298|FG000|Overall Study|Investigator Request|0|||
16201589|NCT00479557|39215299|FG001|Overall Study|Investigator Request|0|||
16201590|NCT00479557|39215300|FG002|Overall Study|Investigator Request|1|||
16201591|NCT00479557|39215301|FG003|Overall Study|Investigator Request|0|||
16201592|NCT00479557|39215302|FG004|Overall Study|Investigator Request|0|||
16201593|NCT00479557|39215303|FG005|Overall Study|Investigator Request|0|||
16201594|NCT00479557|39215304|FG006|Overall Study|Investigator Request|0|||
16201595|NCT00479557|39215298|FG000|Overall Study|Subject Request|3|||
16201596|NCT00479557|39215299|FG001|Overall Study|Subject Request|0|||
16201597|NCT00479557|39215300|FG002|Overall Study|Subject Request|1|||
16201598|NCT00479557|39215301|FG003|Overall Study|Subject Request|1|||
16201599|NCT00479557|39215302|FG004|Overall Study|Subject Request|1|||
16201600|NCT00479557|39215303|FG005|Overall Study|Subject Request|4|||
16201601|NCT00479557|39215304|FG006|Overall Study|Subject Request|1|||
16201602|NCT00479557|39215298|FG000|Overall Study|Other|2|||
16394098|NCT02079909|39924581|FG001|Overall Study|Death|2|||
16201603|NCT00479557|39215299|FG001|Overall Study|Other|3|||
16201604|NCT00479557|39215300|FG002|Overall Study|Other|1|||
16201605|NCT00479557|39215301|FG003|Overall Study|Other|0|||
16201606|NCT00479557|39215302|FG004|Overall Study|Other|0|||
16201607|NCT00479557|39215303|FG005|Overall Study|Other|3|||
16201608|NCT00479557|39215304|FG006|Overall Study|Other|0|||
16201609|NCT03728140|39215305|FG000|Overall Study|Abnormal embryo transfer operation|10|||
16201610|NCT03728140|39215306|FG001|Overall Study|Abnormal embryo transfer operation|7|||
16201611|NCT01595438|39215307|FG000|Overall Study|Lost to Follow-up|20|||
16394099|NCT02079909|39924582|FG002|Overall Study|Death|0|||
16201612|NCT01595438|39215308|FG001|Overall Study|Lost to Follow-up|20|||
16394100|NCT02079909|39924580|FG000|Overall Study|Lack of Efficacy|0|||
16319493|NCT01295827|39654036|FG004|Overall Study|Progressive Disease|0|||
16319494|NCT01295827|39654037|FG005|Overall Study|Progressive Disease|1|||
16319495|NCT01295827|39654038|FG006|Overall Study|Progressive Disease|87|||
16319496|NCT01295827|39654039|FG007|Overall Study|Progressive Disease|144|||
16319497|NCT01295827|39654040|FG008|Overall Study|Progressive Disease|85|||
16319498|NCT01295827|39654041|FG009|Overall Study|Progressive Disease|40|||
16319499|NCT01295827|39654042|FG010|Overall Study|Progressive Disease|175|||
16319500|NCT01295827|39654043|FG011|Overall Study|Progressive Disease|136|||
16319501|NCT01295827|39654044|FG012|Overall Study|Progressive Disease|0|||
16319502|NCT01295827|39654045|FG013|Overall Study|Progressive Disease|0|||
16319503|NCT01295827|39654046|FG014|Overall Study|Progressive Disease|0|||
16319504|NCT01295827|39654032|FG000|Overall Study|Screen Failure|0|||
16319505|NCT01295827|39654033|FG001|Overall Study|Screen Failure|0|||
16319506|NCT01295827|39654034|FG002|Overall Study|Screen Failure|0|||
16514086|NCT00378014|40351177|FG001|Core (Randomization to Month 11)|Death|3|||
16514087|NCT00378014|40351176|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
16514088|NCT00378014|40351177|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
16514089|NCT00378014|40351176|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
16319507|NCT01295827|39654035|FG003|Overall Study|Screen Failure|0|||
16319508|NCT01295827|39654036|FG004|Overall Study|Screen Failure|0|||
16319509|NCT01295827|39654037|FG005|Overall Study|Screen Failure|0|||
16319510|NCT01295827|39654038|FG006|Overall Study|Screen Failure|2|||
16319511|NCT01295827|39654039|FG007|Overall Study|Screen Failure|2|||
16319512|NCT01295827|39654040|FG008|Overall Study|Screen Failure|2|||
16319513|NCT01295827|39654041|FG009|Overall Study|Screen Failure|0|||
16319514|NCT01295827|39654042|FG010|Overall Study|Screen Failure|1|||
16319515|NCT01295827|39654043|FG011|Overall Study|Screen Failure|0|||
16319516|NCT01295827|39654044|FG012|Overall Study|Screen Failure|0|||
16319517|NCT01295827|39654045|FG013|Overall Study|Screen Failure|0|||
16319518|NCT01295827|39654046|FG014|Overall Study|Screen Failure|0|||
16319519|NCT01295827|39654032|FG000|Overall Study|Withdrawal by Subject|1|||
16319520|NCT01295827|39654033|FG001|Overall Study|Withdrawal by Subject|0|||
16319521|NCT01295827|39654034|FG002|Overall Study|Withdrawal by Subject|2|||
16319522|NCT01295827|39654035|FG003|Overall Study|Withdrawal by Subject|0|||
16319523|NCT01295827|39654036|FG004|Overall Study|Withdrawal by Subject|0|||
16319524|NCT01295827|39654037|FG005|Overall Study|Withdrawal by Subject|1|||
16319525|NCT01295827|39654038|FG006|Overall Study|Withdrawal by Subject|13|||
16319526|NCT01295827|39654039|FG007|Overall Study|Withdrawal by Subject|35|||
16319527|NCT01295827|39654040|FG008|Overall Study|Withdrawal by Subject|11|||
16319528|NCT01295827|39654041|FG009|Overall Study|Withdrawal by Subject|2|||
16319529|NCT01295827|39654042|FG010|Overall Study|Withdrawal by Subject|18|||
16319530|NCT01295827|39654043|FG011|Overall Study|Withdrawal by Subject|13|||
16319531|NCT01295827|39654044|FG012|Overall Study|Withdrawal by Subject|0|||
16319532|NCT01295827|39654045|FG013|Overall Study|Withdrawal by Subject|0|||
16319533|NCT01295827|39654046|FG014|Overall Study|Withdrawal by Subject|0|||
16319534|NCT01295827|39654032|FG000|Overall Study|Other|0|||
16319535|NCT01295827|39654033|FG001|Overall Study|Other|0|||
16201613|NCT01595438|39215307|FG000|Overall Study|Withdrawal by Subject|12|||
16319536|NCT01295827|39654034|FG002|Overall Study|Other|0|||
16319537|NCT01295827|39654035|FG003|Overall Study|Other|0|||
16201614|NCT01595438|39215308|FG001|Overall Study|Withdrawal by Subject|12|||
16201615|NCT01595438|39215307|FG000|Overall Study|Other Eligibility criteria|11|||
16201616|NCT01595438|39215308|FG001|Overall Study|Other Eligibility criteria|9|||
16201617|NCT00213980|39215321|FG000|Overall Study|Withdrawal by Subject|3|||
16201618|NCT00213980|39215322|FG001|Overall Study|Withdrawal by Subject|1|||
16201619|NCT00213980|39215321|FG000|Overall Study|Adverse Event|1|||
16201620|NCT00213980|39215322|FG001|Overall Study|Adverse Event|1|||
16201621|NCT00213980|39215321|FG000|Overall Study|Disease progression|0|||
16201622|NCT00213980|39215322|FG001|Overall Study|Disease progression|2|||
16201623|NCT00213980|39215321|FG000|Overall Study|Developed ovarian cancer|1|||
16201624|NCT00213980|39215322|FG001|Overall Study|Developed ovarian cancer|0|||
16201625|NCT00213980|39215321|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
16201626|NCT00213980|39215322|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
16319538|NCT01295827|39654036|FG004|Overall Study|Other|0|||
16319539|NCT01295827|39654037|FG005|Overall Study|Other|0|||
16319540|NCT01295827|39654038|FG006|Overall Study|Other|1|||
16319541|NCT01295827|39654039|FG007|Overall Study|Other|1|||
16319542|NCT01295827|39654040|FG008|Overall Study|Other|1|||
16319543|NCT01295827|39654041|FG009|Overall Study|Other|0|||
16514090|NCT00378014|40351177|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
16319544|NCT01295827|39654042|FG010|Overall Study|Other|2|||
16514091|NCT00378014|40351176|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
16514092|NCT00378014|40351177|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
16514093|NCT00378014|40351176|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
16514094|NCT00378014|40351177|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
16319545|NCT01295827|39654043|FG011|Overall Study|Other|0|||
16319546|NCT01295827|39654044|FG012|Overall Study|Other|0|||
16319547|NCT01295827|39654045|FG013|Overall Study|Other|0|||
16201627|NCT00992186|39215323|FG000|Overall Study|Withdrawal by Subject|2|||
16201628|NCT00992186|39215323|FG000|Overall Study|Protocol Violation|1|||
16201629|NCT00992186|39215323|FG000|Overall Study|Physician Decision|1|||
16201630|NCT00992186|39215323|FG000|Overall Study|Adverse Event|9|||
16201631|NCT00992186|39215323|FG000|Overall Study|Progressive Disease|30|||
16319548|NCT01295827|39654046|FG014|Overall Study|Other|0|||
16319549|NCT04266795|39654052|FG000|Overall Study|Adverse Event|10|||
16319550|NCT04266795|39654053|FG001|Overall Study|Adverse Event|19|||
16319551|NCT04266795|39654052|FG000|Overall Study|Death|7|||
16319552|NCT04266795|39654053|FG001|Overall Study|Death|8|||
16319553|NCT04266795|39654052|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
16319554|NCT04266795|39654053|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
16319555|NCT04266795|39654052|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
16319556|NCT04266795|39654053|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
16319557|NCT04266795|39654052|FG000|Overall Study|Progressive Disease|12|||
16319558|NCT04266795|39654053|FG001|Overall Study|Progressive Disease|9|||
16319559|NCT04266795|39654052|FG000|Overall Study|Withdrawal by Patient|5|||
16319560|NCT04266795|39654053|FG001|Overall Study|Withdrawal by Patient|6|||
16319561|NCT04266795|39654052|FG000|Overall Study|Disease Relapse|3|||
16319562|NCT04266795|39654053|FG001|Overall Study|Disease Relapse|6|||
16319563|NCT04266795|39654052|FG000|Overall Study|Reason not Specified|12|||
16319564|NCT04266795|39654053|FG001|Overall Study|Reason not Specified|10|||
16394101|NCT02079909|39924581|FG001|Overall Study|Lack of Efficacy|0|||
16514095|NCT00378014|40351176|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
16514096|NCT00378014|40351177|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
16514097|NCT00378014|40351176|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
16514098|NCT00378014|40351177|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
16514099|NCT00378014|40351176|FG000|Extension (Month 12 to Month 59)|Death|1|||
16514100|NCT00378014|40351177|FG001|Extension (Month 12 to Month 59)|Death|2|||
16514101|NCT00378014|40351176|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
16514102|NCT00378014|40351177|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
16514103|NCT00378014|40351176|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
16514104|NCT00378014|40351177|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
16514105|NCT00378014|40351176|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
16514106|NCT00378014|40351177|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
16514107|NCT00378014|40351176|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
16514108|NCT00378014|40351177|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
16514109|NCT01687166|40351178|FG000|Overall Study|Attempt subject|2|||
16514110|NCT01687166|40351179|FG001|Overall Study|Attempt subject|3|||
16514111|NCT01687166|40351180|FG002|Overall Study|Attempt subject|2|||
16514112|NCT01687166|40351181|FG003|Overall Study|Attempt subject|0|||
16514113|NCT01687166|40351178|FG000|Overall Study|Did not meet eligibility criteria|4|||
16514114|NCT01687166|40351179|FG001|Overall Study|Did not meet eligibility criteria|6|||
16514115|NCT01687166|40351180|FG002|Overall Study|Did not meet eligibility criteria|1|||
16514116|NCT01687166|40351181|FG003|Overall Study|Did not meet eligibility criteria|1|||
16514117|NCT01687166|40351178|FG000|Overall Study|Adverse Event|2|||
16514118|NCT01687166|40351179|FG001|Overall Study|Adverse Event|1|||
16514119|NCT01687166|40351180|FG002|Overall Study|Adverse Event|0|||
16514120|NCT01687166|40351181|FG003|Overall Study|Adverse Event|0|||
16514121|NCT01687166|40351178|FG000|Overall Study|Physician Decision|3|||
16514122|NCT01687166|40351179|FG001|Overall Study|Physician Decision|2|||
16514123|NCT01687166|40351180|FG002|Overall Study|Physician Decision|1|||
16514124|NCT01687166|40351181|FG003|Overall Study|Physician Decision|0|||
16514125|NCT01687166|40351178|FG000|Overall Study|Withdrawal by Subject|11|||
16514126|NCT01687166|40351179|FG001|Overall Study|Withdrawal by Subject|4|||
16514127|NCT01687166|40351180|FG002|Overall Study|Withdrawal by Subject|3|||
16514128|NCT01687166|40351181|FG003|Overall Study|Withdrawal by Subject|0|||
16514129|NCT01687166|40351178|FG000|Overall Study|Lost to Follow-up|2|||
16514130|NCT01687166|40351179|FG001|Overall Study|Lost to Follow-up|5|||
16514131|NCT01687166|40351180|FG002|Overall Study|Lost to Follow-up|1|||
16514132|NCT01687166|40351181|FG003|Overall Study|Lost to Follow-up|0|||
16514133|NCT01687166|40351178|FG000|Overall Study|Equipment/Device Availability|0|||
16514134|NCT01687166|40351179|FG001|Overall Study|Equipment/Device Availability|1|||
16514135|NCT01687166|40351180|FG002|Overall Study|Equipment/Device Availability|0|||
16201632|NCT00992186|39215323|FG000|Overall Study|Refusal To Receive Study Agent|3|||
16201633|NCT02029638|39215324|FG000|Overall Study|Death|0|||
16514136|NCT01687166|40351181|FG003|Overall Study|Equipment/Device Availability|0|||
16514137|NCT01687166|40351178|FG000|Overall Study|Death|1|||
16514138|NCT01687166|40351179|FG001|Overall Study|Death|1|||
16514139|NCT01687166|40351180|FG002|Overall Study|Death|0|||
16514140|NCT01687166|40351181|FG003|Overall Study|Death|0|||
16514141|NCT01687166|40351178|FG000|Overall Study|Protocol Violation|1|||
16514142|NCT01687166|40351179|FG001|Overall Study|Protocol Violation|1|||
16514143|NCT01687166|40351180|FG002|Overall Study|Protocol Violation|1|||
16514144|NCT01687166|40351181|FG003|Overall Study|Protocol Violation|0|||
16201634|NCT02029638|39215325|FG001|Overall Study|Death|0|||
16319565|NCT04266795|39654052|FG000|Overall Study|Participants Ongoing on Treatment|25|||
16319566|NCT04266795|39654053|FG001|Overall Study|Participants Ongoing on Treatment|23|||
16319567|NCT00550043|39654054|FG000|Overall Study|Adverse Event|0|||
16319568|NCT00550043|39654055|FG001|Overall Study|Adverse Event|0|||
16319569|NCT00550043|39654056|FG002|Overall Study|Adverse Event|0|||
16319570|NCT00550043|39654057|FG003|Overall Study|Adverse Event|1|||
16319571|NCT00550043|39654058|FG004|Overall Study|Adverse Event|1|||
16319572|NCT00550043|39654054|FG000|Overall Study|Subject Withdrew Consent|0|||
16319573|NCT00550043|39654055|FG001|Overall Study|Subject Withdrew Consent|2|||
16319574|NCT00550043|39654056|FG002|Overall Study|Subject Withdrew Consent|1|||
16319575|NCT00550043|39654057|FG003|Overall Study|Subject Withdrew Consent|0|||
16319576|NCT00550043|39654058|FG004|Overall Study|Subject Withdrew Consent|0|||
16319577|NCT00550043|39654054|FG000|Overall Study|Other Reasons- Unspecified|0|||
16319578|NCT00550043|39654055|FG001|Overall Study|Other Reasons- Unspecified|1|||
16319579|NCT00550043|39654056|FG002|Overall Study|Other Reasons- Unspecified|0|||
16319580|NCT00550043|39654057|FG003|Overall Study|Other Reasons- Unspecified|1|||
16319581|NCT00550043|39654058|FG004|Overall Study|Other Reasons- Unspecified|0|||
16319582|NCT03058705|39654063|FG000|Overall Study|Withdrawal by Subject|2|||
16319583|NCT03058705|39654063|FG000|Overall Study|Physician Decision|2|||
16319584|NCT01479465|39654066|FG000|Overall Study|Disease Progression|9|||
16394102|NCT02079909|39924582|FG002|Overall Study|Lack of Efficacy|1|||
16201635|NCT02029638|39215326|FG002|Overall Study|Death|1|||
16201636|NCT02029638|39215324|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
16394103|NCT02079909|39924580|FG000|Overall Study|Protocol Violation|0|||
16319585|NCT01479465|39654067|FG001|Overall Study|Disease Progression|61|||
16319586|NCT01479465|39654068|FG002|Overall Study|Disease Progression|65|||
16319587|NCT01479465|39654069|FG003|Overall Study|Disease Progression|70|||
16201637|NCT02029638|39215325|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
16319588|NCT01479465|39654066|FG000|Overall Study|Study Discontinued by Sponsor|0|||
16201638|NCT02029638|39215326|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
16201639|NCT00190983|39215327|FG000|Overall Study|Inevaluable (never treated)|2|||
16201640|NCT00776555|39215328|FG000|Overall Study|Study terminated|3|||
16514145|NCT01687166|40351178|FG000|Overall Study|Subject moved out of state|0|||
16514146|NCT01687166|40351179|FG001|Overall Study|Subject moved out of state|1|||
16201641|NCT00776555|39215329|FG001|Overall Study|Study terminated|0|||
16201642|NCT02270684|39215330|FG000|Overall Study|Lost to Follow-up|0|||
16514147|NCT01687166|40351180|FG002|Overall Study|Subject moved out of state|0|||
16201643|NCT02270684|39215331|FG001|Overall Study|Lost to Follow-up|3|||
16201644|NCT02270684|39215330|FG000|Overall Study|Study terminated|1|||
16201645|NCT02270684|39215331|FG001|Overall Study|Study terminated|0|||
16201646|NCT00628758|39215336|FG000|Overall Study|Adverse Event|2|||
16201647|NCT00628758|39215337|FG001|Overall Study|Adverse Event|3|||
16201648|NCT00628758|39215336|FG000|Overall Study|Withdrawal by Subject|6|||
16201649|NCT00628758|39215337|FG001|Overall Study|Withdrawal by Subject|3|||
16201650|NCT00628758|39215336|FG000|Overall Study|Death|1|||
16201651|NCT00628758|39215337|FG001|Overall Study|Death|0|||
16201652|NCT00628758|39215336|FG000|Overall Study|Protocol Violation|5|||
16201653|NCT00628758|39215337|FG001|Overall Study|Protocol Violation|1|||
16201654|NCT00628758|39215336|FG000|Overall Study|Lost to Follow-up|25|||
16201655|NCT00628758|39215337|FG001|Overall Study|Lost to Follow-up|31|||
16201656|NCT00628758|39215336|FG000|Overall Study|Pregnancy|2|||
16201657|NCT00628758|39215337|FG001|Overall Study|Pregnancy|2|||
16201658|NCT00628758|39215336|FG000|Overall Study|Investigator Moved|3|||
16201659|NCT00628758|39215337|FG001|Overall Study|Investigator Moved|0|||
16514148|NCT01687166|40351181|FG003|Overall Study|Subject moved out of state|0|||
16514149|NCT01687166|40351178|FG000|Overall Study|Patient unable to be compliant|1|||
16514150|NCT01687166|40351179|FG001|Overall Study|Patient unable to be compliant|0|||
16514151|NCT01687166|40351180|FG002|Overall Study|Patient unable to be compliant|0|||
16514152|NCT01687166|40351181|FG003|Overall Study|Patient unable to be compliant|0|||
16514153|NCT01687166|40351178|FG000|Overall Study|Physician choice to use different device|1|||
16514154|NCT01687166|40351179|FG001|Overall Study|Physician choice to use different device|2|||
16514155|NCT01687166|40351180|FG002|Overall Study|Physician choice to use different device|4|||
16514156|NCT01687166|40351181|FG003|Overall Study|Physician choice to use different device|0|||
16514157|NCT01687166|40351178|FG000|Overall Study|Insurance|0|||
16514158|NCT01687166|40351179|FG001|Overall Study|Insurance|0|||
16514159|NCT01687166|40351180|FG002|Overall Study|Insurance|1|||
16514160|NCT01687166|40351181|FG003|Overall Study|Insurance|1|||
16514161|NCT00640510|40351187|FG000|Overall Study|Lack of Efficacy|0|||
16514162|NCT00640510|40351188|FG001|Overall Study|Lack of Efficacy|1|||
16514163|NCT00640510|40351187|FG000|Overall Study|Protocol Violation|1|||
16514164|NCT00640510|40351188|FG001|Overall Study|Protocol Violation|0|||
16514165|NCT00640510|40351187|FG000|Overall Study|Physician Decision|0|||
16514166|NCT00640510|40351188|FG001|Overall Study|Physician Decision|1|||
16514167|NCT01565291|40351189|FG000|Overall Study|Withdrawal by Subject|1|||
16514168|NCT01565291|40351190|FG001|Overall Study|Withdrawal by Subject|0|||
16514169|NCT02643251|40351191|FG000|Overall Study|Adverse Event|3|||
16514170|NCT02643251|40351192|FG001|Overall Study|Adverse Event|1|||
16514171|NCT02643251|40351191|FG000|Overall Study|Withdrawal by Subject|2|||
16514172|NCT02643251|40351192|FG001|Overall Study|Withdrawal by Subject|0|||
16514173|NCT02643251|40351191|FG000|Overall Study|Lost to Follow-up|4|||
16514174|NCT02643251|40351192|FG001|Overall Study|Lost to Follow-up|1|||
16514175|NCT02643251|40351191|FG000|Overall Study|Protocol Violation|1|||
16514176|NCT02643251|40351192|FG001|Overall Study|Protocol Violation|0|||
16514177|NCT02643251|40351191|FG000|Overall Study|PI Decision to terminate patient|1|||
16514178|NCT02643251|40351192|FG001|Overall Study|PI Decision to terminate patient|0|||
16514179|NCT02708680|40351197|FG000|Overall Study|Withdrawal by Subject|4|||
16514180|NCT02708680|40351198|FG001|Overall Study|Withdrawal by Subject|12|||
16514181|NCT02708680|40351199|FG002|Overall Study|Withdrawal by Subject|12|||
16514182|NCT02708680|40351197|FG000|Overall Study|Death|4|||
16514183|NCT02708680|40351198|FG001|Overall Study|Death|19|||
16201660|NCT00628758|39215336|FG000|Overall Study|Treatment Failure|0|||
16201661|NCT00628758|39215337|FG001|Overall Study|Treatment Failure|2|||
16201662|NCT03097614|39215341|FG000|Overall Study|Adverse Event|3|||
16201663|NCT02810951|39215347|FG000|Overall Study|Adverse Event|1|||
16201664|NCT00426556|39215350|FG000|Phase I - Core Phase|Disease Progression|0|||
16514184|NCT02708680|40351199|FG002|Overall Study|Death|21|||
16514185|NCT02708680|40351197|FG000|Overall Study|Lost to Follow-up|0|||
16514186|NCT02708680|40351198|FG001|Overall Study|Lost to Follow-up|3|||
16514187|NCT02708680|40351199|FG002|Overall Study|Lost to Follow-up|3|||
16514188|NCT02708680|40351197|FG000|Overall Study|Study Terminated By Sponsor|0|||
16514189|NCT02708680|40351198|FG001|Overall Study|Study Terminated By Sponsor|5|||
16514190|NCT02708680|40351199|FG002|Overall Study|Study Terminated By Sponsor|4|||
16201665|NCT00426556|39215351|FG001|Phase I - Core Phase|Disease Progression|6|||
16201666|NCT00426556|39215352|FG002|Phase I - Core Phase|Disease Progression|2|||
16201667|NCT00426556|39215353|FG003|Phase I - Core Phase|Disease Progression|0|||
16201668|NCT00426556|39215350|FG000|Phase I - Core Phase|Adverse Event|1|||
16201669|NCT00426556|39215351|FG001|Phase I - Core Phase|Adverse Event|3|||
16319589|NCT01479465|39654067|FG001|Overall Study|Study Discontinued by Sponsor|7|||
16319590|NCT01479465|39654068|FG002|Overall Study|Study Discontinued by Sponsor|5|||
16319591|NCT01479465|39654069|FG003|Overall Study|Study Discontinued by Sponsor|3|||
16319592|NCT01479465|39654066|FG000|Overall Study|Adverse Event|0|||
16319593|NCT01479465|39654067|FG001|Overall Study|Adverse Event|3|||
16319594|NCT01479465|39654068|FG002|Overall Study|Adverse Event|6|||
16319595|NCT01479465|39654069|FG003|Overall Study|Adverse Event|4|||
16319596|NCT01479465|39654066|FG000|Overall Study|Investigator Discretion|1|||
16319597|NCT01479465|39654067|FG001|Overall Study|Investigator Discretion|4|||
16319598|NCT01479465|39654068|FG002|Overall Study|Investigator Discretion|2|||
16319599|NCT01479465|39654069|FG003|Overall Study|Investigator Discretion|4|||
16319600|NCT01479465|39654066|FG000|Overall Study|Subject Request|1|||
16319601|NCT01479465|39654067|FG001|Overall Study|Subject Request|3|||
16319602|NCT01479465|39654068|FG002|Overall Study|Subject Request|4|||
16319603|NCT01479465|39654069|FG003|Overall Study|Subject Request|2|||
16319604|NCT01479465|39654066|FG000|Overall Study|Subject Withdrew Consent|0|||
16319605|NCT01479465|39654067|FG001|Overall Study|Subject Withdrew Consent|5|||
16319606|NCT01479465|39654068|FG002|Overall Study|Subject Withdrew Consent|2|||
16201670|NCT00426556|39215352|FG002|Phase I - Core Phase|Adverse Event|1|||
16201671|NCT00426556|39215353|FG003|Phase I - Core Phase|Adverse Event|0|||
16201672|NCT00426556|39215350|FG000|Phase I - Core Phase|Death|0|||
16201673|NCT00426556|39215351|FG001|Phase I - Core Phase|Death|1|||
16201674|NCT00426556|39215352|FG002|Phase I - Core Phase|Death|0|||
16201675|NCT00426556|39215353|FG003|Phase I - Core Phase|Death|0|||
16201676|NCT00426556|39215350|FG000|Phase I - Extension Phase|Adverse Event|0|||
16201677|NCT00426556|39215351|FG001|Phase I - Extension Phase|Adverse Event|1|||
16201678|NCT00426556|39215352|FG002|Phase I - Extension Phase|Adverse Event|1|||
16201679|NCT00426556|39215353|FG003|Phase I - Extension Phase|Adverse Event|0|||
16201680|NCT00426556|39215350|FG000|Phase I - Extension Phase|Disease Progression|5|||
16201681|NCT00426556|39215351|FG001|Phase I - Extension Phase|Disease Progression|5|||
16319607|NCT01479465|39654069|FG003|Overall Study|Subject Withdrew Consent|1|||
16319608|NCT01479465|39654066|FG000|Overall Study|Protocol Violation|0|||
16319609|NCT01479465|39654067|FG001|Overall Study|Protocol Violation|1|||
16319610|NCT01479465|39654068|FG002|Overall Study|Protocol Violation|1|||
16319611|NCT01479465|39654069|FG003|Overall Study|Protocol Violation|0|||
16319612|NCT01479465|39654066|FG000|Overall Study|Death|0|||
16319613|NCT01479465|39654067|FG001|Overall Study|Death|0|||
16319614|NCT01479465|39654068|FG002|Overall Study|Death|0|||
16201682|NCT00426556|39215352|FG002|Phase I - Extension Phase|Disease Progression|6|||
16201683|NCT00426556|39215353|FG003|Phase I - Extension Phase|Disease Progression|0|||
16319615|NCT01479465|39654069|FG003|Overall Study|Death|1|||
16319616|NCT01479465|39654066|FG000|Overall Study|Lost to Follow-up|0|||
16319617|NCT01479465|39654067|FG001|Overall Study|Lost to Follow-up|0|||
16319618|NCT01479465|39654068|FG002|Overall Study|Lost to Follow-up|1|||
16319619|NCT01479465|39654069|FG003|Overall Study|Lost to Follow-up|0|||
16319620|NCT03363776|39654078|FG000|Overall Study|Progressive disease|2|||
16319621|NCT03363776|39654079|FG001|Overall Study|Progressive disease|3|||
16201684|NCT00426556|39215350|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
16201685|NCT00426556|39215351|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
16201686|NCT00426556|39215352|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
16201687|NCT00426556|39215353|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
16201688|NCT00426556|39215350|FG000|Phase II - Core Phase|Disease Progression|0|||
16201689|NCT00426556|39215351|FG001|Phase II - Core Phase|Disease Progression|0|||
16201690|NCT00426556|39215352|FG002|Phase II - Core Phase|Disease Progression|0|||
16514191|NCT02708680|40351197|FG000|Overall Study|Other than Specified|0|||
16514192|NCT02708680|40351198|FG001|Overall Study|Other than Specified|0|||
16514193|NCT02708680|40351199|FG002|Overall Study|Other than Specified|1|||
16514194|NCT02708680|40351197|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
16514195|NCT02708680|40351198|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
16514196|NCT02708680|40351199|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
16514197|NCT03450707|40351200|FG000|Overall Study|Outside enrollment window|4|||
16514198|NCT03450707|40351201|FG001|Overall Study|Outside enrollment window|1|||
16514199|NCT03450707|40351200|FG000|Overall Study|Death|1|||
16514200|NCT03450707|40351201|FG001|Overall Study|Death|0|||
16514201|NCT03450707|40351200|FG000|Overall Study|Indication for thiamine|1|||
16514202|NCT03450707|40351201|FG001|Overall Study|Indication for thiamine|1|||
16514203|NCT03450707|40351200|FG000|Overall Study|Evidence of traumatic brain injury|1|||
16514204|NCT03450707|40351201|FG001|Overall Study|Evidence of traumatic brain injury|0|||
16514205|NCT03450707|40351200|FG000|Overall Study|Following commands|0|||
16201691|NCT00426556|39215353|FG003|Phase II - Core Phase|Disease Progression|16|||
16201692|NCT00426556|39215350|FG000|Phase II - Core Phase|Adverse Event|0|||
16201693|NCT00426556|39215351|FG001|Phase II - Core Phase|Adverse Event|0|||
16201694|NCT00426556|39215352|FG002|Phase II - Core Phase|Adverse Event|0|||
16201695|NCT00426556|39215353|FG003|Phase II - Core Phase|Adverse Event|8|||
16201696|NCT00426556|39215350|FG000|Phase II - Extension Phase|Disease Progression|0|||
16201697|NCT00426556|39215351|FG001|Phase II - Extension Phase|Disease Progression|0|||
16201698|NCT00426556|39215352|FG002|Phase II - Extension Phase|Disease Progression|0|||
16201699|NCT00426556|39215353|FG003|Phase II - Extension Phase|Disease Progression|21|||
16201700|NCT00426556|39215350|FG000|Phase II - Extension Phase|Adverse Event|0|||
16201701|NCT00426556|39215351|FG001|Phase II - Extension Phase|Adverse Event|0|||
16201702|NCT00426556|39215352|FG002|Phase II - Extension Phase|Adverse Event|0|||
16201703|NCT00426556|39215353|FG003|Phase II - Extension Phase|Adverse Event|2|||
16201704|NCT02614287|39215356|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
16201705|NCT02614287|39215357|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
16201706|NCT02614287|39215356|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
16201707|NCT02614287|39215357|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
16201708|NCT02614287|39215356|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
16201709|NCT02614287|39215357|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
16201710|NCT02614287|39215356|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
16201711|NCT02614287|39215357|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
16394104|NCT02079909|39924581|FG001|Overall Study|Protocol Violation|1|||
16394105|NCT02079909|39924582|FG002|Overall Study|Protocol Violation|1|||
16514206|NCT03450707|40351201|FG001|Overall Study|Following commands|3|||
16514207|NCT03450707|40351200|FG000|Overall Study|Lactate < 3.5|0|||
16201712|NCT02614287|39215356|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
16201713|NCT02614287|39215357|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
16394106|NCT02079909|39924580|FG000|Overall Study|Physician Decision|0|||
16514208|NCT03450707|40351201|FG001|Overall Study|Lactate < 3.5|2|||
16201714|NCT02614287|39215356|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
16201715|NCT02614287|39215357|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
16201716|NCT02614287|39215356|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
16201717|NCT02614287|39215357|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
16201718|NCT02614287|39215356|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
16201719|NCT02614287|39215357|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
16201720|NCT00615914|39215360|FG000|Overall Study|Adverse Event|274|||
16201721|NCT00615914|39215360|FG000|Overall Study|Death|20|||
16201722|NCT00615914|39215360|FG000|Overall Study|Lack of Efficacy|59|||
16201723|NCT00615914|39215360|FG000|Overall Study|Lost to Follow-up|187|||
16201724|NCT00615914|39215360|FG000|Overall Study|Withdrawal by Subject|16|||
16201725|NCT00615914|39215360|FG000|Overall Study|Physician Decision|4|||
16201726|NCT00615914|39215360|FG000|Overall Study|No data was collected.|65|||
16201727|NCT00615914|39215360|FG000|Overall Study|No treatment|2|||
16201728|NCT00615914|39215360|FG000|Overall Study|Irregularly enrolled patients|10|||
16201729|NCT02273037|39215366|FG000|Overall Study|Lost to Follow-up|1|||
16201730|NCT02273037|39215367|FG001|Overall Study|Lost to Follow-up|0|||
16201731|NCT02273037|39215366|FG000|Overall Study|Delivered before monitoring initiated|1|||
16201732|NCT02273037|39215367|FG001|Overall Study|Delivered before monitoring initiated|3|||
16201733|NCT02273037|39215366|FG000|Overall Study|Breech delivery|2|||
16319622|NCT03363776|39654080|FG002|Overall Study|Progressive disease|1|||
16319623|NCT03363776|39654078|FG000|Overall Study|Study drug toxicity|0|||
16319624|NCT03363776|39654079|FG001|Overall Study|Study drug toxicity|0|||
16319625|NCT03363776|39654080|FG002|Overall Study|Study drug toxicity|1|||
16319626|NCT03363776|39654078|FG000|Overall Study|Death|1|||
16319627|NCT03363776|39654079|FG001|Overall Study|Death|0|||
16319628|NCT03363776|39654080|FG002|Overall Study|Death|0|||
16319629|NCT02230904|39654082|FG000|Overall Study|Safety follow up could not take place|0|||
16319630|NCT02230904|39654083|FG001|Overall Study|Safety follow up could not take place|1|||
16319631|NCT01019694|39654084|FG000|Overall Study|Adverse Event|12|||
16514209|NCT03450707|40351200|FG000|Overall Study|Rearrest with ECMO|0|||
16514210|NCT03450707|40351201|FG001|Overall Study|Rearrest with ECMO|1|||
16514211|NCT03450707|40351200|FG000|Overall Study|Indication for thiamine + head CT results|0|||
16514212|NCT03450707|40351201|FG001|Overall Study|Indication for thiamine + head CT results|1|||
16514213|NCT03450707|40351200|FG000|Overall Study|Family/patient goals of care|0|||
16514214|NCT03450707|40351201|FG001|Overall Study|Family/patient goals of care|1|||
16514215|NCT00829296|40351202|FG000|Overall Study|Adverse Event|5|||
16514216|NCT00829296|40351203|FG001|Overall Study|Adverse Event|4|||
16514217|NCT04074317|40351204|FG000|Third Period|Withdrawal by Subject|0|||
16514218|NCT04074317|40351205|FG001|Third Period|Withdrawal by Subject|0|||
16514219|NCT04074317|40351206|FG002|Third Period|Withdrawal by Subject|0|||
16514220|NCT04074317|40351207|FG003|Third Period|Withdrawal by Subject|1|||
16514221|NCT04074317|40351208|FG004|Third Period|Withdrawal by Subject|0|||
16514222|NCT04074317|40351209|FG005|Third Period|Withdrawal by Subject|0|||
16514223|NCT03851016|40351214|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16514224|NCT03851016|40351215|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
16319632|NCT01019694|39654085|FG001|Overall Study|Adverse Event|16|||
16319633|NCT01019694|39654086|FG002|Overall Study|Adverse Event|19|||
16319634|NCT01019694|39654084|FG000|Overall Study|Protocol Violation|2|||
16319635|NCT01019694|39654085|FG001|Overall Study|Protocol Violation|6|||
16319636|NCT01019694|39654086|FG002|Overall Study|Protocol Violation|4|||
16319637|NCT01019694|39654084|FG000|Overall Study|Lost to Follow-up|5|||
16319638|NCT01019694|39654085|FG001|Overall Study|Lost to Follow-up|3|||
16319639|NCT01019694|39654086|FG002|Overall Study|Lost to Follow-up|3|||
16319640|NCT01019694|39654084|FG000|Overall Study|Withdrawal by Subject|4|||
16514225|NCT00430092|40351216|FG000|Overall Study|Adverse Event|0|||
16514226|NCT00430092|40351217|FG001|Overall Study|Adverse Event|0|||
16514227|NCT00430092|40351218|FG002|Overall Study|Adverse Event|1|||
16514228|NCT00430092|40351216|FG000|Overall Study|Lack of Efficacy|5|||
16514229|NCT00430092|40351217|FG001|Overall Study|Lack of Efficacy|2|||
16514230|NCT00430092|40351218|FG002|Overall Study|Lack of Efficacy|54|||
16514231|NCT00430092|40351216|FG000|Overall Study|Lost to Follow-up|1|||
16514232|NCT00430092|40351217|FG001|Overall Study|Lost to Follow-up|0|||
16514233|NCT00430092|40351218|FG002|Overall Study|Lost to Follow-up|0|||
16514234|NCT00430092|40351216|FG000|Overall Study|Protocol Violation|0|||
16514235|NCT00430092|40351217|FG001|Overall Study|Protocol Violation|1|||
16514236|NCT00430092|40351218|FG002|Overall Study|Protocol Violation|1|||
16090426|NCT02106884|38823408|FG000|Overall Study|Change of diagnosis/exclusion|0|||
16319641|NCT01019694|39654085|FG001|Overall Study|Withdrawal by Subject|6|||
16319642|NCT01019694|39654086|FG002|Overall Study|Withdrawal by Subject|12|||
16514237|NCT00430092|40351216|FG000|Overall Study|Withdrawal by Subject|0|||
16201734|NCT02273037|39215367|FG001|Overall Study|Breech delivery|3|||
16201735|NCT02273037|39215366|FG000|Overall Study|Multiple delivery|2|||
16201736|NCT02273037|39215367|FG001|Overall Study|Multiple delivery|2|||
16201737|NCT02273037|39215366|FG000|Overall Study|Other complication|2|||
16514238|NCT00430092|40351217|FG001|Overall Study|Withdrawal by Subject|1|||
16514239|NCT00430092|40351218|FG002|Overall Study|Withdrawal by Subject|1|||
16201738|NCT02273037|39215367|FG001|Overall Study|Other complication|0|||
16201739|NCT01125293|39215368|FG000|Overall Study|Disease Progression|1|||
16201740|NCT01125293|39215369|FG001|Overall Study|Disease Progression|3|||
16201741|NCT01125293|39215370|FG002|Overall Study|Disease Progression|4|||
16201742|NCT01125293|39215371|FG003|Overall Study|Disease Progression|3|||
16201743|NCT01125293|39215372|FG004|Overall Study|Disease Progression|5|||
16201744|NCT01125293|39215373|FG005|Overall Study|Disease Progression|12|||
16201745|NCT01125293|39215368|FG000|Overall Study|Adverse Event|1|||
16201746|NCT01125293|39215369|FG001|Overall Study|Adverse Event|0|||
16201747|NCT01125293|39215370|FG002|Overall Study|Adverse Event|0|||
16201748|NCT01125293|39215371|FG003|Overall Study|Adverse Event|0|||
16201749|NCT01125293|39215372|FG004|Overall Study|Adverse Event|2|||
16201750|NCT01125293|39215373|FG005|Overall Study|Adverse Event|8|||
16201751|NCT01125293|39215368|FG000|Overall Study|Symptomatic Deterioration|1|||
16201752|NCT01125293|39215369|FG001|Overall Study|Symptomatic Deterioration|0|||
16201753|NCT01125293|39215370|FG002|Overall Study|Symptomatic Deterioration|0|||
16201754|NCT01125293|39215371|FG003|Overall Study|Symptomatic Deterioration|0|||
16201755|NCT01125293|39215372|FG004|Overall Study|Symptomatic Deterioration|0|||
16201756|NCT01125293|39215373|FG005|Overall Study|Symptomatic Deterioration|0|||
16201757|NCT01125293|39215368|FG000|Overall Study|Death|0|||
16201758|NCT01125293|39215369|FG001|Overall Study|Death|0|||
16201759|NCT01125293|39215370|FG002|Overall Study|Death|0|||
16201760|NCT01125293|39215371|FG003|Overall Study|Death|0|||
16394107|NCT02079909|39924581|FG001|Overall Study|Physician Decision|1|||
16394108|NCT02079909|39924582|FG002|Overall Study|Physician Decision|1|||
16394109|NCT02079909|39924580|FG000|Overall Study|Relocation etc.|2|||
16394110|NCT02079909|39924581|FG001|Overall Study|Relocation etc.|2|||
16394111|NCT02079909|39924582|FG002|Overall Study|Relocation etc.|3|||
16394112|NCT01437111|39924585|FG000|Overall Study|Adverse Event|2|||
16394113|NCT01437111|39924585|FG000|Overall Study|Withdrawal by Subject|4|||
16394114|NCT01437111|39924585|FG000|Overall Study|Not reported|5|||
16394115|NCT01437111|39924585|FG000|Overall Study|Physician Decision|1|||
16394116|NCT01437111|39924585|FG000|Overall Study|Lost to Follow-up|5|||
16394117|NCT01437111|39924585|FG000|Overall Study|Protocol Violation|1|||
16394118|NCT03850093|39924586|FG000|Overall Study|Withdrawal by Subject|1|||
16394119|NCT03850093|39924587|FG001|Overall Study|Withdrawal by Subject|0|||
16394120|NCT03850093|39924588|FG002|Overall Study|Withdrawal by Subject|2|||
16394121|NCT03367403|39924589|FG000|Overall Study|Adverse Event|20|||
16394122|NCT03367403|39924590|FG001|Overall Study|Adverse Event|6|||
16394123|NCT03367403|39924591|FG002|Overall Study|Adverse Event|2|||
16394124|NCT03367403|39924589|FG000|Overall Study|Withdrawal by Subject|12|||
16394125|NCT03367403|39924590|FG001|Overall Study|Withdrawal by Subject|13|||
16394126|NCT03367403|39924591|FG002|Overall Study|Withdrawal by Subject|1|||
16394127|NCT03367403|39924589|FG000|Overall Study|Death|1|||
16394128|NCT03367403|39924590|FG001|Overall Study|Death|2|||
16394129|NCT03367403|39924591|FG002|Overall Study|Death|0|||
16394130|NCT03367403|39924589|FG000|Overall Study|Physician Decision|0|||
16394131|NCT03367403|39924590|FG001|Overall Study|Physician Decision|1|||
16394132|NCT03367403|39924591|FG002|Overall Study|Physician Decision|0|||
16394133|NCT03367403|39924589|FG000|Overall Study|Protocol Violation|1|||
16394134|NCT03367403|39924590|FG001|Overall Study|Protocol Violation|1|||
16394135|NCT03367403|39924591|FG002|Overall Study|Protocol Violation|0|||
16394136|NCT03367403|39924589|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
16394137|NCT03367403|39924590|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
16394138|NCT03367403|39924591|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
16394139|NCT03367403|39924589|FG000|Overall Study|COVID-19|3|||
16394140|NCT03367403|39924590|FG001|Overall Study|COVID-19|6|||
16394141|NCT03367403|39924591|FG002|Overall Study|COVID-19|0|||
16394142|NCT03367403|39924589|FG000|Overall Study|Abuse of Alcohol Intake|0|||
16394143|NCT03367403|39924590|FG001|Overall Study|Abuse of Alcohol Intake|1|||
16394144|NCT03367403|39924591|FG002|Overall Study|Abuse of Alcohol Intake|0|||
16394145|NCT03367403|39924589|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
16394146|NCT03367403|39924590|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
16394147|NCT03367403|39924591|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
16394148|NCT01118780|39924596|FG000|Overall Study|Adverse Event|15|||
16394149|NCT01118780|39924597|FG001|Overall Study|Adverse Event|15|||
16394150|NCT01118780|39924596|FG000|Overall Study|Death|1|||
16394151|NCT01118780|39924597|FG001|Overall Study|Death|0|||
16394152|NCT01118780|39924596|FG000|Overall Study|Lack of Efficacy|2|||
16201761|NCT01125293|39215372|FG004|Overall Study|Death|1|||
16201762|NCT01125293|39215373|FG005|Overall Study|Death|0|||
16394153|NCT01118780|39924597|FG001|Overall Study|Lack of Efficacy|6|||
16394154|NCT01118780|39924596|FG000|Overall Study|Physician Decision|2|||
16394155|NCT01118780|39924597|FG001|Overall Study|Physician Decision|0|||
16201763|NCT01125293|39215368|FG000|Overall Study|Withdrawal by Subject|0|||
16201764|NCT01125293|39215369|FG001|Overall Study|Withdrawal by Subject|0|||
16201765|NCT01125293|39215370|FG002|Overall Study|Withdrawal by Subject|0|||
16201766|NCT01125293|39215371|FG003|Overall Study|Withdrawal by Subject|0|||
16394156|NCT01118780|39924596|FG000|Overall Study|Protocol Violation|3|||
16394157|NCT01118780|39924597|FG001|Overall Study|Protocol Violation|6|||
16394158|NCT01118780|39924596|FG000|Overall Study|Withdrawal by Subject|13|||
16394159|NCT01118780|39924597|FG001|Overall Study|Withdrawal by Subject|8|||
16394160|NCT00107900|39924601|FG000|Overall Study|Adverse Event|3|||
16394161|NCT00107900|39924602|FG001|Overall Study|Adverse Event|2|||
16394162|NCT00107900|39924603|FG002|Overall Study|Adverse Event|10|||
16394163|NCT00107900|39924604|FG003|Overall Study|Adverse Event|3|||
16394164|NCT00107900|39924605|FG004|Overall Study|Adverse Event|5|||
16394165|NCT00107900|39924606|FG005|Overall Study|Adverse Event|3|||
16394166|NCT00107900|39924601|FG000|Overall Study|Death|0|||
16394167|NCT00107900|39924602|FG001|Overall Study|Death|0|||
16394168|NCT00107900|39924603|FG002|Overall Study|Death|0|||
16201767|NCT01125293|39215372|FG004|Overall Study|Withdrawal by Subject|2|||
16201768|NCT01125293|39215373|FG005|Overall Study|Withdrawal by Subject|1|||
16201769|NCT01125293|39215368|FG000|Overall Study|Physician Decision|0|||
16201770|NCT01125293|39215369|FG001|Overall Study|Physician Decision|0|||
16201771|NCT01125293|39215370|FG002|Overall Study|Physician Decision|0|||
16201772|NCT01125293|39215371|FG003|Overall Study|Physician Decision|0|||
16319643|NCT01019694|39654084|FG000|Overall Study|Not treated|0|||
16319644|NCT01019694|39654085|FG001|Overall Study|Not treated|2|||
16319645|NCT01019694|39654086|FG002|Overall Study|Not treated|3|||
16319646|NCT01019694|39654084|FG000|Overall Study|Other reason (not specified)|1|||
16319647|NCT01019694|39654085|FG001|Overall Study|Other reason (not specified)|5|||
16319648|NCT01019694|39654086|FG002|Overall Study|Other reason (not specified)|6|||
16319649|NCT00912743|39654087|FG000|Overall Study|Adverse Event|3|||
16319650|NCT00912743|39654088|FG001|Overall Study|Adverse Event|1|||
16319651|NCT00912743|39654087|FG000|Overall Study|Lack of Efficacy|9|||
16319652|NCT00912743|39654088|FG001|Overall Study|Lack of Efficacy|18|||
16319653|NCT00912743|39654087|FG000|Overall Study|Toxicity|0|||
16319654|NCT00912743|39654088|FG001|Overall Study|Toxicity|1|||
16319655|NCT00912743|39654087|FG000|Overall Study|End of treatment form was not collected|1|||
16319656|NCT00912743|39654088|FG001|Overall Study|End of treatment form was not collected|0|||
16319657|NCT01754129|39654089|FG000|Overall Study|Death|13|||
16319658|NCT01754129|39654089|FG000|Overall Study|Duodopa discontinuation|9|||
16319659|NCT01754129|39654089|FG000|Overall Study|Lost to Follow-up|7|||
16319660|NCT01754129|39654089|FG000|Overall Study|Withdrew consent|1|||
16319661|NCT01754129|39654089|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
16319662|NCT02640664|39654094|FG000|Epoch 1|Withdrawal of informed consent|1|||
16319663|NCT02640664|39654095|FG001|Epoch 1|Withdrawal of informed consent|0|||
16319664|NCT02640664|39654096|FG002|Epoch 1|Withdrawal of informed consent|0|||
16319665|NCT02640664|39654094|FG000|Epoch 1|Death|0|||
16319666|NCT02640664|39654095|FG001|Epoch 1|Death|0|||
16319667|NCT02640664|39654096|FG002|Epoch 1|Death|1|||
16394169|NCT00107900|39924604|FG003|Overall Study|Death|0|||
16394170|NCT00107900|39924605|FG004|Overall Study|Death|1|||
16394171|NCT00107900|39924606|FG005|Overall Study|Death|0|||
16394172|NCT00107900|39924601|FG000|Overall Study|Lost to Follow-up|4|||
16394173|NCT00107900|39924602|FG001|Overall Study|Lost to Follow-up|1|||
16201773|NCT01125293|39215372|FG004|Overall Study|Physician Decision|0|||
16201774|NCT01125293|39215373|FG005|Overall Study|Physician Decision|2|||
16201775|NCT00304915|39215376|FG000|Overall Study|Lost to Follow-up|11|||
16201776|NCT00304915|39215377|FG001|Overall Study|Lost to Follow-up|11|||
16394174|NCT00107900|39924603|FG002|Overall Study|Lost to Follow-up|3|||
16394175|NCT00107900|39924604|FG003|Overall Study|Lost to Follow-up|2|||
16394176|NCT00107900|39924605|FG004|Overall Study|Lost to Follow-up|5|||
16394177|NCT00107900|39924606|FG005|Overall Study|Lost to Follow-up|5|||
16394178|NCT00107900|39924601|FG000|Overall Study|Protocol Violation|1|||
16394179|NCT00107900|39924602|FG001|Overall Study|Protocol Violation|0|||
16394180|NCT00107900|39924603|FG002|Overall Study|Protocol Violation|5|||
16394181|NCT00107900|39924604|FG003|Overall Study|Protocol Violation|5|||
16394182|NCT00107900|39924605|FG004|Overall Study|Protocol Violation|7|||
16201777|NCT00304915|39215376|FG000|Overall Study|Death|4|||
16201778|NCT00304915|39215377|FG001|Overall Study|Death|5|||
16201779|NCT00304915|39215376|FG000|Overall Study|Withdrawal by Subject|3|||
16201780|NCT00304915|39215377|FG001|Overall Study|Withdrawal by Subject|0|||
16201781|NCT02198651|39215385|FG000|Lead-in Period|Withdrew consent|13|||
16201782|NCT02198651|39215386|FG001|Lead-in Period|Withdrew consent|0|||
16319668|NCT02640664|39654094|FG000|Epoch 2|Withdrawal of informed consent|3|||
16319669|NCT02640664|39654095|FG001|Epoch 2|Withdrawal of informed consent|4|||
16319670|NCT02640664|39654096|FG002|Epoch 2|Withdrawal of informed consent|2|||
16394183|NCT00107900|39924606|FG005|Overall Study|Protocol Violation|0|||
16394184|NCT00107900|39924601|FG000|Overall Study|Withdrawal by Subject|1|||
16394185|NCT00107900|39924602|FG001|Overall Study|Withdrawal by Subject|0|||
16201783|NCT02198651|39215387|FG002|Lead-in Period|Withdrew consent|0|||
16394186|NCT00107900|39924603|FG002|Overall Study|Withdrawal by Subject|5|||
16319671|NCT02640664|39654094|FG000|Epoch 2|Subject/guardian decision|0|||
16319672|NCT02640664|39654095|FG001|Epoch 2|Subject/guardian decision|2|||
16319673|NCT02640664|39654096|FG002|Epoch 2|Subject/guardian decision|2|||
16394187|NCT00107900|39924604|FG003|Overall Study|Withdrawal by Subject|0|||
16201784|NCT02198651|39215388|FG003|Lead-in Period|Withdrew consent|0|||
16201785|NCT02198651|39215389|FG004|Lead-in Period|Withdrew consent|0|||
16394188|NCT00107900|39924605|FG004|Overall Study|Withdrawal by Subject|1|||
16394189|NCT00107900|39924606|FG005|Overall Study|Withdrawal by Subject|1|||
16394190|NCT00107900|39924601|FG000|Overall Study|Administrative Reasons|1|||
16394191|NCT00107900|39924602|FG001|Overall Study|Administrative Reasons|0|||
16394192|NCT00107900|39924603|FG002|Overall Study|Administrative Reasons|2|||
16394193|NCT00107900|39924604|FG003|Overall Study|Administrative Reasons|2|||
16394194|NCT00107900|39924605|FG004|Overall Study|Administrative Reasons|2|||
16394195|NCT00107900|39924606|FG005|Overall Study|Administrative Reasons|0|||
16319674|NCT02640664|39654094|FG000|Epoch 2|Lost to Follow-up|3|||
16319675|NCT02640664|39654095|FG001|Epoch 2|Lost to Follow-up|4|||
16319676|NCT02640664|39654096|FG002|Epoch 2|Lost to Follow-up|1|||
16319677|NCT02640664|39654094|FG000|Epoch 2|Death|0|||
16319678|NCT02640664|39654095|FG001|Epoch 2|Death|0|||
16319679|NCT02640664|39654096|FG002|Epoch 2|Death|1|||
16319680|NCT03482453|39654097|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16319681|NCT03482453|39654098|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16319682|NCT03482453|39654099|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16319683|NCT03482453|39654100|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16201786|NCT02198651|39215385|FG000|Lead-in Period|Adverse Event|2|||
16319684|NCT03482453|39654101|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16394196|NCT00833469|39924609|FG000|Overall Study|Withdrawal by Subject|1|||
16394197|NCT00833469|39924609|FG000|Overall Study|Lost to Follow-up|1|||
16514240|NCT00700011|40351219|FG000|Overall Study|Death|0|||
16514241|NCT00700011|40351220|FG001|Overall Study|Death|1|||
16514242|NCT00376168|40351223|FG000|Overall Study|Adverse Event|1|||
16514243|NCT00376168|40351224|FG001|Overall Study|Adverse Event|1|||
16201787|NCT02198651|39215386|FG001|Lead-in Period|Adverse Event|0|||
16201788|NCT02198651|39215387|FG002|Lead-in Period|Adverse Event|0|||
16201789|NCT02198651|39215388|FG003|Lead-in Period|Adverse Event|0|||
16201790|NCT02198651|39215389|FG004|Lead-in Period|Adverse Event|0|||
16201791|NCT02198651|39215385|FG000|Lead-in Period|Other, not specified|22|||
16201792|NCT02198651|39215386|FG001|Lead-in Period|Other, not specified|0|||
16514244|NCT00376168|40351223|FG000|Overall Study|Pregnancy|1|||
16514245|NCT00376168|40351224|FG001|Overall Study|Pregnancy|0|||
16514246|NCT03878134|40351225|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
16201793|NCT02198651|39215387|FG002|Lead-in Period|Other, not specified|0|||
16201794|NCT02198651|39215388|FG003|Lead-in Period|Other, not specified|0|||
16201795|NCT02198651|39215389|FG004|Lead-in Period|Other, not specified|0|||
16201796|NCT02198651|39215385|FG000|Double-blind Period|Withdrew consent|0|||
16201797|NCT02198651|39215386|FG001|Double-blind Period|Withdrew consent|4|||
16201798|NCT02198651|39215387|FG002|Double-blind Period|Withdrew consent|0|||
16201799|NCT02198651|39215388|FG003|Double-blind Period|Withdrew consent|0|||
16201800|NCT02198651|39215389|FG004|Double-blind Period|Withdrew consent|0|||
16201801|NCT02198651|39215385|FG000|Double-blind Period|Adverse Event|0|||
16319685|NCT03482453|39654102|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16319686|NCT03482453|39654103|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16319687|NCT03482453|39654104|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16319688|NCT03482453|39654105|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16319689|NCT03482453|39654106|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16319690|NCT03482453|39654107|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
16319691|NCT03482453|39654108|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
16319692|NCT00684411|39654113|FG000|Overall Study|New Primary Cancer|1|||
16514247|NCT00964392|40351226|FG000|Overall Study|Withdrawal by Subject|4|||
16319693|NCT00684411|39654113|FG000|Overall Study|Disease Progression|10|||
16319694|NCT00684411|39654113|FG000|Overall Study|Adverse Event|1|||
16514248|NCT00964392|40351227|FG001|Overall Study|Withdrawal by Subject|6|||
16514249|NCT00964392|40351226|FG000|Overall Study|Lost to Follow-up|4|||
16201802|NCT02198651|39215386|FG001|Double-blind Period|Adverse Event|1|||
16319695|NCT03318861|39654114|FG000|Overall Study|Death|2|||
16319696|NCT03318861|39654115|FG001|Overall Study|Death|3|||
16319697|NCT03318861|39654116|FG002|Overall Study|Death|3|||
16319698|NCT03318861|39654117|FG003|Overall Study|Death|2|||
16394198|NCT00529243|39924610|FG000|Overall Study|Adverse Event|1|||
16394199|NCT00529243|39924610|FG000|Overall Study|Death|1|||
16394200|NCT00529243|39924610|FG000|Overall Study|Relocated|1|||
16514250|NCT00964392|40351227|FG001|Overall Study|Lost to Follow-up|10|||
16201803|NCT02198651|39215387|FG002|Double-blind Period|Adverse Event|0|||
16201804|NCT02198651|39215388|FG003|Double-blind Period|Adverse Event|0|||
16201805|NCT02198651|39215389|FG004|Double-blind Period|Adverse Event|0|||
16201806|NCT02198651|39215385|FG000|Double-blind Period|Other, not specified|0|||
16201807|NCT02198651|39215386|FG001|Double-blind Period|Other, not specified|4|||
16201808|NCT02198651|39215387|FG002|Double-blind Period|Other, not specified|1|||
16201809|NCT02198651|39215388|FG003|Double-blind Period|Other, not specified|0|||
16201810|NCT02198651|39215389|FG004|Double-blind Period|Other, not specified|0|||
16319699|NCT03318861|39654118|FG004|Overall Study|Death|2|||
16319700|NCT03318861|39654114|FG000|Overall Study|Enrolled But Never Treated|0|||
16319701|NCT03318861|39654115|FG001|Overall Study|Enrolled But Never Treated|1|||
16319702|NCT03318861|39654116|FG002|Overall Study|Enrolled But Never Treated|0|||
16319703|NCT03318861|39654117|FG003|Overall Study|Enrolled But Never Treated|1|||
16319704|NCT03318861|39654118|FG004|Overall Study|Enrolled But Never Treated|1|||
16319705|NCT03318861|39654114|FG000|Overall Study|Informed Consent Withdraw|0|||
16319706|NCT03318861|39654115|FG001|Overall Study|Informed Consent Withdraw|0|||
16319707|NCT03318861|39654116|FG002|Overall Study|Informed Consent Withdraw|0|||
16514251|NCT00964392|40351226|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
16514252|NCT00964392|40351227|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
16514253|NCT00964392|40351226|FG000|Overall Study|Not completed|44|||
16514254|NCT00964392|40351227|FG001|Overall Study|Not completed|168|||
16514255|NCT03881696|40351228|FG000|Overall Study|Adverse Event|2|||
16514256|NCT03881696|40351229|FG001|Overall Study|Adverse Event|0|||
16514257|NCT03881696|40351228|FG000|Overall Study|Withdrawal by Subject|2|||
16514258|NCT03881696|40351229|FG001|Overall Study|Withdrawal by Subject|0|||
16514259|NCT03881696|40351228|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
16514260|NCT03881696|40351229|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
16514261|NCT03881696|40351228|FG000|Overall Study|Failure to meet continuation criteria|1|||
16514262|NCT03881696|40351229|FG001|Overall Study|Failure to meet continuation criteria|0|||
16514263|NCT02412631|40351230|FG000|Overall Study|Adverse Event|1|||
16514264|NCT02412631|40351231|FG001|Overall Study|Adverse Event|2|||
16514265|NCT02412631|40351230|FG000|Overall Study|Lost to Follow-up|5|||
16514266|NCT02412631|40351231|FG001|Overall Study|Lost to Follow-up|9|||
16514267|NCT02412631|40351230|FG000|Overall Study|Withdrawal by Subject|9|||
16514268|NCT02412631|40351231|FG001|Overall Study|Withdrawal by Subject|3|||
16514269|NCT02412631|40351230|FG000|Overall Study|Early stop by FDA|5|||
16514270|NCT02412631|40351231|FG001|Overall Study|Early stop by FDA|2|||
16514271|NCT02412631|40351230|FG000|Overall Study|Unspecified reason|6|||
16514272|NCT02412631|40351231|FG001|Overall Study|Unspecified reason|8|||
16514273|NCT02256891|40351232|FG000|Overall Study|Death|0|||
16514274|NCT02256891|40351233|FG001|Overall Study|Death|2|||
16514275|NCT02256891|40351232|FG000|Overall Study|Lost to Follow-up|0|||
16514276|NCT02256891|40351233|FG001|Overall Study|Lost to Follow-up|3|||
16514277|NCT02256891|40351232|FG000|Overall Study|Physician Decision|7|||
16514278|NCT02256891|40351233|FG001|Overall Study|Physician Decision|3|||
16514279|NCT02256891|40351232|FG000|Overall Study|Screen Fail|5|||
16514280|NCT02256891|40351233|FG001|Overall Study|Screen Fail|4|||
16514281|NCT02256891|40351232|FG000|Overall Study|Equipment Malfunction|0|||
16514282|NCT02256891|40351233|FG001|Overall Study|Equipment Malfunction|1|||
16514283|NCT00259857|40351236|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
16514284|NCT00259857|40351237|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
16514285|NCT00259857|40351236|FG000|24 Months Treatment|Lost to Follow-up|0|||
16514286|NCT00259857|40351237|FG001|24 Months Treatment|Lost to Follow-up|3|||
16514287|NCT03643562|40351238|FG000|Overall Study|Adverse Event|1|||
16514288|NCT03643562|40351239|FG001|Overall Study|Adverse Event|0|||
16514289|NCT03643562|40351238|FG000|Overall Study|Lack of Efficacy|0|||
16514290|NCT03643562|40351239|FG001|Overall Study|Lack of Efficacy|1|||
16514291|NCT03643562|40351238|FG000|Overall Study|Physician Decision|0|||
16514292|NCT03643562|40351239|FG001|Overall Study|Physician Decision|1|||
16514293|NCT03643562|40351238|FG000|Overall Study|Study Terminated by Sponsor|2|||
16514294|NCT03643562|40351239|FG001|Overall Study|Study Terminated by Sponsor|10|||
16514295|NCT03643562|40351238|FG000|Overall Study|Withdrawal by Subject|2|||
16514296|NCT03643562|40351239|FG001|Overall Study|Withdrawal by Subject|2|||
16514297|NCT03643562|40351238|FG000|Overall Study|Other than specified|3|||
16514298|NCT03643562|40351239|FG001|Overall Study|Other than specified|2|||
16514299|NCT00326612|40351242|FG000|Overall Study|They did not have a seizure requiring tx|129|||
16514300|NCT00326612|40351243|FG001|Overall Study|They did not have a seizure requiring tx|137|||
16514301|NCT05091307|40351245|FG000|Overall Study|Death|0|||
16514302|NCT05091307|40351246|FG001|Overall Study|Death|0|||
16514303|NCT05091307|40351247|FG002|Overall Study|Death|1|||
16514304|NCT05091307|40351248|FG003|Overall Study|Death|0|||
16514305|NCT05091307|40351245|FG000|Overall Study|Lost to Follow-up|33|||
16201811|NCT02198651|39215385|FG000|Open-label Rescue Period|Withdrew consent|0|||
16201812|NCT02198651|39215386|FG001|Open-label Rescue Period|Withdrew consent|0|||
16201813|NCT02198651|39215387|FG002|Open-label Rescue Period|Withdrew consent|0|||
16201814|NCT02198651|39215388|FG003|Open-label Rescue Period|Withdrew consent|2|||
16514306|NCT05091307|40351246|FG001|Overall Study|Lost to Follow-up|33|||
16514307|NCT05091307|40351247|FG002|Overall Study|Lost to Follow-up|2|||
16514308|NCT05091307|40351248|FG003|Overall Study|Lost to Follow-up|0|||
16514309|NCT05091307|40351245|FG000|Overall Study|Physician Decision|1|||
16514310|NCT05091307|40351246|FG001|Overall Study|Physician Decision|0|||
16514311|NCT05091307|40351247|FG002|Overall Study|Physician Decision|0|||
16514312|NCT05091307|40351248|FG003|Overall Study|Physician Decision|0|||
16514313|NCT05091307|40351245|FG000|Overall Study|Protocol Violation|1|||
16514314|NCT05091307|40351246|FG001|Overall Study|Protocol Violation|0|||
16514315|NCT05091307|40351247|FG002|Overall Study|Protocol Violation|0|||
16514316|NCT05091307|40351248|FG003|Overall Study|Protocol Violation|0|||
16514317|NCT05091307|40351245|FG000|Overall Study|Withdrawal by Subject|16|||
16514318|NCT05091307|40351246|FG001|Overall Study|Withdrawal by Subject|16|||
16090427|NCT02106884|38823409|FG001|Overall Study|Change of diagnosis/exclusion|1|||
16201815|NCT02198651|39215389|FG004|Open-label Rescue Period|Withdrew consent|0|||
16201816|NCT02198651|39215385|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
16201817|NCT02198651|39215386|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
16319708|NCT03318861|39654117|FG003|Overall Study|Informed Consent Withdraw|1|||
16319709|NCT03318861|39654118|FG004|Overall Study|Informed Consent Withdraw|0|||
16319710|NCT03318861|39654114|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
16319711|NCT03318861|39654115|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
16319712|NCT03318861|39654116|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
16319713|NCT03318861|39654117|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
16319714|NCT03318861|39654118|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
16319715|NCT00818766|39654121|FG000|Overall Study|Could not be Contacted on Day 28|11|||
16319716|NCT00818766|39654122|FG001|Overall Study|Could not be Contacted on Day 28|10|||
16319717|NCT00818766|39654121|FG000|Overall Study|Death|1|||
16319718|NCT00818766|39654122|FG001|Overall Study|Death|0|||
16319719|NCT00818766|39654121|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
16319720|NCT00818766|39654122|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
16319721|NCT01575834|39654123|FG000|Overall Study|Withdrawal by Subject|352|||
16319722|NCT01575834|39654124|FG001|Overall Study|Withdrawal by Subject|390|||
16319723|NCT01575834|39654123|FG000|Overall Study|Death|81|||
16319724|NCT01575834|39654124|FG001|Overall Study|Death|74|||
16319725|NCT01575834|39654123|FG000|Overall Study|Other|70|||
16319726|NCT01575834|39654124|FG001|Overall Study|Other|70|||
16319727|NCT01575834|39654123|FG000|Overall Study|Adverse Event|63|||
16319728|NCT01575834|39654124|FG001|Overall Study|Adverse Event|61|||
16319729|NCT01575834|39654123|FG000|Overall Study|Lost to Follow-up|55|||
16319730|NCT01575834|39654124|FG001|Overall Study|Lost to Follow-up|68|||
16319731|NCT01575834|39654123|FG000|Overall Study|Noncompliance|52|||
16319732|NCT01575834|39654124|FG001|Overall Study|Noncompliance|27|||
16319733|NCT01575834|39654123|FG000|Overall Study|Administrative decision|15|||
16319734|NCT01575834|39654124|FG001|Overall Study|Administrative decision|33|||
16319735|NCT01575834|39654123|FG000|Overall Study|Ineligibility Determined|5|||
16319736|NCT01575834|39654124|FG001|Overall Study|Ineligibility Determined|8|||
16319737|NCT01575834|39654123|FG000|Overall Study|Protocol Deviation|4|||
16319738|NCT01575834|39654124|FG001|Overall Study|Protocol Deviation|3|||
16319739|NCT01575834|39654123|FG000|Overall Study|Requirement for Alternative Therapy|2|||
16319740|NCT01575834|39654124|FG001|Overall Study|Requirement for Alternative Therapy|4|||
16319741|NCT03806933|39654125|FG000|Main Period|Physician Decision|0|||
16319742|NCT03806933|39654126|FG001|Main Period|Physician Decision|0|||
16319743|NCT03806933|39654127|FG002|Main Period|Physician Decision|0|||
16319744|NCT03806933|39654128|FG003|Main Period|Physician Decision|1|||
16319745|NCT03806933|39654125|FG000|Main Period|Pregnancy|0|||
16319746|NCT03806933|39654126|FG001|Main Period|Pregnancy|0|||
16319747|NCT03806933|39654127|FG002|Main Period|Pregnancy|1|||
16319748|NCT03806933|39654128|FG003|Main Period|Pregnancy|0|||
16319749|NCT03806933|39654125|FG000|Main Period|Withdrawal by Subject|2|||
16319750|NCT03806933|39654126|FG001|Main Period|Withdrawal by Subject|1|||
16319751|NCT03806933|39654127|FG002|Main Period|Withdrawal by Subject|1|||
16319752|NCT03806933|39654128|FG003|Main Period|Withdrawal by Subject|2|||
16319753|NCT03806933|39654125|FG000|Main Period|Lost to Follow-up|2|||
16319754|NCT03806933|39654126|FG001|Main Period|Lost to Follow-up|2|||
16319755|NCT03806933|39654127|FG002|Main Period|Lost to Follow-up|0|||
16319756|NCT03806933|39654128|FG003|Main Period|Lost to Follow-up|0|||
16319757|NCT03806933|39654125|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
16319758|NCT03806933|39654126|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
16319759|NCT03806933|39654127|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
16319760|NCT03806933|39654128|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
16319761|NCT00686829|39654129|FG000|Overall Study|Adverse Event|5|||
16319762|NCT00686829|39654129|FG000|Overall Study|Lack of Efficacy|6|||
16319763|NCT00686829|39654129|FG000|Overall Study|Lost to Follow-up|4|||
16514319|NCT05091307|40351247|FG002|Overall Study|Withdrawal by Subject|0|||
16514320|NCT05091307|40351248|FG003|Overall Study|Withdrawal by Subject|1|||
16514321|NCT05091307|40351245|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
16201818|NCT02198651|39215387|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
16514322|NCT05091307|40351246|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
16514323|NCT05091307|40351247|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
16514324|NCT05091307|40351248|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
16514325|NCT05091307|40351245|FG000|Overall Study|Initiated Prohibited Medication|1|||
16514326|NCT05091307|40351246|FG001|Overall Study|Initiated Prohibited Medication|0|||
16514327|NCT05091307|40351247|FG002|Overall Study|Initiated Prohibited Medication|0|||
16514328|NCT05091307|40351248|FG003|Overall Study|Initiated Prohibited Medication|0|||
16514329|NCT05091307|40351245|FG000|Overall Study|Other|4|||
16514330|NCT05091307|40351246|FG001|Overall Study|Other|4|||
16514331|NCT05091307|40351247|FG002|Overall Study|Other|0|||
16514332|NCT05091307|40351248|FG003|Overall Study|Other|0|||
16514333|NCT05091307|40351245|FG000|Overall Study|Randomized but not vaccinated|0|||
16514334|NCT05091307|40351246|FG001|Overall Study|Randomized but not vaccinated|2|||
16514335|NCT05091307|40351247|FG002|Overall Study|Randomized but not vaccinated|0|||
16514336|NCT05091307|40351248|FG003|Overall Study|Randomized but not vaccinated|0|||
16514337|NCT04765358|40351249|FG000|Overall Study|Withdrawal by Subject|1|||
16514338|NCT02357576|40351250|FG000|Treatment Period|Withdrawal by Subject|0|||
16514339|NCT02357576|40351251|FG001|Treatment Period|Withdrawal by Subject|1|||
16514340|NCT02357576|40351250|FG000|Treatment Period|Physician Decision|0|||
16514341|NCT02357576|40351251|FG001|Treatment Period|Physician Decision|1|||
16514342|NCT02357576|40351250|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
16514343|NCT02357576|40351251|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
16514344|NCT02357576|40351250|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
16514345|NCT02357576|40351251|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
16514346|NCT02357576|40351250|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
16514347|NCT02357576|40351251|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
16514348|NCT02357576|40351250|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
16514349|NCT02357576|40351251|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
16514350|NCT00348556|40351252|FG000|Overall Study|Adverse Event|1|||
16514351|NCT00838565|40351253|FG000|Overall Study|Withdrawal by Subject|0|||
16090428|NCT00853593|38823412|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
16090429|NCT00853593|38823412|FG000|Overall Study|Model 4396 lead not attempted|29|||
16090430|NCT00853593|38823412|FG000|Overall Study|Implant not attempted|4|||
16090431|NCT01970878|38823415|FG000|Overall Study|Withdrawal by Subject|11|||
16514352|NCT00838565|40351254|FG001|Overall Study|Withdrawal by Subject|0|||
16514353|NCT00838565|40351255|FG002|Overall Study|Withdrawal by Subject|1|||
16514354|NCT00838565|40351256|FG003|Overall Study|Withdrawal by Subject|0|||
16514355|NCT00838565|40351257|FG004|Overall Study|Withdrawal by Subject|0|||
16514356|NCT00838565|40351258|FG005|Overall Study|Withdrawal by Subject|2|||
16514357|NCT00838565|40351253|FG000|Overall Study|Other|0|||
16514358|NCT00838565|40351254|FG001|Overall Study|Other|2|||
16514359|NCT00838565|40351255|FG002|Overall Study|Other|0|||
16514360|NCT00838565|40351256|FG003|Overall Study|Other|0|||
16514361|NCT00838565|40351257|FG004|Overall Study|Other|0|||
16514362|NCT00838565|40351258|FG005|Overall Study|Other|0|||
16514363|NCT00838565|40351253|FG000|Overall Study|Randomized but not Treated|0|||
16514364|NCT00838565|40351254|FG001|Overall Study|Randomized but not Treated|1|||
16514365|NCT00838565|40351255|FG002|Overall Study|Randomized but not Treated|0|||
16514366|NCT00838565|40351256|FG003|Overall Study|Randomized but not Treated|0|||
16514367|NCT00838565|40351257|FG004|Overall Study|Randomized but not Treated|0|||
16514368|NCT00838565|40351258|FG005|Overall Study|Randomized but not Treated|0|||
16514369|NCT04601103|40351260|FG000|Overall Study|Needed crown & cleaning|0|||
16514370|NCT04601103|40351261|FG001|Overall Study|Needed crown & cleaning|0|||
16514371|NCT04601103|40351262|FG002|Overall Study|Needed crown & cleaning|1|||
16514372|NCT04601103|40351260|FG000|Overall Study|study was terminated|18|||
16514373|NCT04601103|40351261|FG001|Overall Study|study was terminated|18|||
16514374|NCT04601103|40351262|FG002|Overall Study|study was terminated|16|||
16514375|NCT00308711|40351265|FG000|Overall Study|Withdrawal by Subject|1|||
16514376|NCT00308711|40351266|FG001|Overall Study|Withdrawal by Subject|0|||
16514377|NCT00308711|40351267|FG002|Overall Study|Withdrawal by Subject|1|||
16514378|NCT00308711|40351265|FG000|Overall Study|Protocol Violation|0|||
16514379|NCT00308711|40351266|FG001|Overall Study|Protocol Violation|1|||
16514380|NCT00308711|40351267|FG002|Overall Study|Protocol Violation|1|||
16514381|NCT00308711|40351265|FG000|Overall Study|Lost to Follow-up|0|||
16514382|NCT00308711|40351266|FG001|Overall Study|Lost to Follow-up|1|||
16514383|NCT00308711|40351267|FG002|Overall Study|Lost to Follow-up|0|||
16514384|NCT00308711|40351265|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
16514385|NCT00308711|40351266|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
16090432|NCT01970878|38823416|FG001|Overall Study|Withdrawal by Subject|10|||
16514386|NCT00308711|40351267|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
16514387|NCT00308711|40351265|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
16514388|NCT00308711|40351266|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
16514389|NCT00308711|40351267|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
16514390|NCT01524770|40351269|FG000|First Intervention|Withdrawal by Subject|1|||
16514391|NCT01524770|40351270|FG001|First Intervention|Withdrawal by Subject|0|||
16514392|NCT01524770|40351269|FG000|First Intervention|Adverse Event|1|||
16514393|NCT01524770|40351270|FG001|First Intervention|Adverse Event|1|||
16514394|NCT01524770|40351269|FG000|First Intervention|Protocol Violation|1|||
16514395|NCT01524770|40351270|FG001|First Intervention|Protocol Violation|0|||
16514396|NCT00805766|40351273|FG000|Screening Period|Adverse Event|1|||
16514397|NCT00805766|40351273|FG000|Screening Period|Lack of Efficacy|2|||
16514398|NCT00805766|40351273|FG000|Screening Period|Pregnancy|1|||
16514399|NCT00805766|40351273|FG000|Screening Period|Responder|2|||
16514400|NCT00805766|40351273|FG000|Increased Dose Period|Adverse Event|4|||
16514401|NCT00805766|40351273|FG000|Increased Dose Period|Lack of Efficacy|7|||
16514402|NCT00805766|40351273|FG000|Increased Dose Period|Pregnancy|1|||
16514403|NCT00805766|40351273|FG000|Increased Dose Period|Withdrawal by Subject|1|||
16514404|NCT00500370|40351274|FG000|Overall Study|Adverse Event|9|||
16514405|NCT00500370|40351275|FG001|Overall Study|Adverse Event|3|||
16514406|NCT00500370|40351274|FG000|Overall Study|Lost to Follow-up|10|||
16514407|NCT00500370|40351275|FG001|Overall Study|Lost to Follow-up|10|||
16514408|NCT00500370|40351274|FG000|Overall Study|Protocol Violation|2|||
16514409|NCT00500370|40351275|FG001|Overall Study|Protocol Violation|4|||
16514410|NCT00500370|40351274|FG000|Overall Study|Sponsor Decision|2|||
16514411|NCT00500370|40351275|FG001|Overall Study|Sponsor Decision|0|||
16514412|NCT00500370|40351274|FG000|Overall Study|Subject Decision|10|||
16514413|NCT00500370|40351275|FG001|Overall Study|Subject Decision|17|||
16514414|NCT03554291|40351276|FG000|Overall Study|Death|2|||
16514415|NCT03554291|40351277|FG001|Overall Study|Death|1|||
16514416|NCT03554291|40351276|FG000|Overall Study|Lost to Follow-up|1|||
16514417|NCT03554291|40351277|FG001|Overall Study|Lost to Follow-up|0|||
16514418|NCT03554291|40351276|FG000|Overall Study|Withdrawal by Subject|1|||
16514419|NCT03554291|40351277|FG001|Overall Study|Withdrawal by Subject|0|||
16514420|NCT03554291|40351276|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
16514421|NCT03554291|40351277|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
16514422|NCT00660348|40351278|FG000|Overall Study|Withdrawal by Subject|1|||
16514423|NCT00660348|40351279|FG001|Overall Study|Withdrawal by Subject|0|||
16514424|NCT01466192|40351284|FG000|Overall Study|Physician Decision|1|||
16514425|NCT01466192|40351284|FG000|Overall Study|Withdrawal by Subject|3|||
16514426|NCT00779675|40351287|FG000|Treatment Period|Adverse Event|87|||
16514427|NCT00779675|40351287|FG000|Treatment Period|Treatment Failure|80|||
16514428|NCT00779675|40351287|FG000|Treatment Period|Transferred to Another Study|38|||
16514429|NCT00779675|40351287|FG000|Treatment Period|Lost to Follow-up|23|||
16514430|NCT00779675|40351287|FG000|Treatment Period|Withdrawal by Subject|46|||
16514431|NCT00779675|40351287|FG000|Treatment Period|Protocol Violation|54|||
16514432|NCT00779675|40351287|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
16514433|NCT00779675|40351287|FG000|Treatment Period|Administrative|3|||
16201819|NCT02198651|39215388|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
16201820|NCT02198651|39215389|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
16201821|NCT00818207|39215391|FG000|Overall Study|Adverse Event|6|||
16201822|NCT00818207|39215392|FG001|Overall Study|Adverse Event|0|||
16201823|NCT00818207|39215391|FG000|Overall Study|Lost to Follow-up|160|||
16201824|NCT00818207|39215392|FG001|Overall Study|Lost to Follow-up|146|||
16201825|NCT00818207|39215391|FG000|Overall Study|Multiple reasons|11|||
16201826|NCT00818207|39215392|FG001|Overall Study|Multiple reasons|12|||
16201827|NCT00818207|39215391|FG000|Overall Study|Withdrawal by Subject|42|||
16201828|NCT00818207|39215392|FG001|Overall Study|Withdrawal by Subject|104|||
16201829|NCT00818207|39215391|FG000|Overall Study|Death|3|||
16201830|NCT00818207|39215392|FG001|Overall Study|Death|5|||
16201831|NCT02494778|39215393|FG000|Overall Study|Death|3|||
16201832|NCT02494778|39215393|FG000|Overall Study|Other|173|||
16201833|NCT02494778|39215393|FG000|Overall Study|Lack of Efficacy|4|||
16201834|NCT02494778|39215393|FG000|Overall Study|Adverse Event|18|||
16201835|NCT02494778|39215393|FG000|Overall Study|Withdrawal by Subject|20|||
16319764|NCT00686829|39654129|FG000|Overall Study|Withdrawal by Subject|14|||
16319765|NCT00686829|39654129|FG000|Overall Study|Protocol Violation|3|||
16319766|NCT00686829|39654129|FG000|Overall Study|Sponsor discontinued VCV|47|||
16319767|NCT04654468|39654135|FG000|Overall Study|Death|1|||
16319768|NCT04654468|39654135|FG000|Overall Study|Ongoing in the Study|50|||
16319769|NCT03691207|39654138|FG000|Overall Study|Death|41|||
16319770|NCT03691207|39654139|FG001|Overall Study|Death|26|||
16319771|NCT03691207|39654138|FG000|Overall Study|Lost to Follow-up|1|||
16201836|NCT02494778|39215393|FG000|Overall Study|Lost to Follow-up|2|||
16201837|NCT02494778|39215393|FG000|Overall Study|Noncompliant with study drug admin.|1|||
16201838|NCT00673894|39215399|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
16319772|NCT03691207|39654139|FG001|Overall Study|Lost to Follow-up|1|||
16319773|NCT03691207|39654138|FG000|Overall Study|Withdrawal by Subject|2|||
16514434|NCT00779675|40351287|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
16514435|NCT00779675|40351287|FG000|Extended Treatment Period|Protocol Violation|13|||
16514436|NCT00779675|40351287|FG000|Extended Treatment Period|Adverse Event|6|||
16514437|NCT00779675|40351287|FG000|Extended Treatment Period|Treatment Failure|11|||
16319774|NCT03691207|39654139|FG001|Overall Study|Withdrawal by Subject|8|||
16201839|NCT00673894|39215400|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
16319775|NCT03691207|39654138|FG000|Overall Study|Sponsor decision|1|||
16319776|NCT03691207|39654139|FG001|Overall Study|Sponsor decision|7|||
16319777|NCT02431676|39654148|FG000|Overall Study|no lab obtained|0|||
16319778|NCT02431676|39654149|FG001|Overall Study|no lab obtained|1|||
16319779|NCT02431676|39654150|FG002|Overall Study|no lab obtained|2|||
16319780|NCT01735916|39654151|FG000|Overall Study|Subject not eligible to be randomized|11|||
16319781|NCT01735916|39654152|FG001|Overall Study|Subject not eligible to be randomized|0|||
16319782|NCT01735916|39654153|FG002|Overall Study|Subject not eligible to be randomized|0|||
16319783|NCT01735916|39654151|FG000|Overall Study|Early termination of study by sponsor|4|||
16319784|NCT01735916|39654152|FG001|Overall Study|Early termination of study by sponsor|19|||
16319785|NCT01735916|39654153|FG002|Overall Study|Early termination of study by sponsor|7|||
16319786|NCT01735916|39654151|FG000|Overall Study|Withdrawal by Subject|3|||
16319787|NCT01735916|39654152|FG001|Overall Study|Withdrawal by Subject|0|||
16319788|NCT01735916|39654153|FG002|Overall Study|Withdrawal by Subject|0|||
16319789|NCT04157296|39654154|FG000|Overall Study|Withdrawal by Subject|0|||
16319790|NCT04157296|39654155|FG001|Overall Study|Withdrawal by Subject|1|||
16319791|NCT04157296|39654154|FG000|Overall Study|Did not obtain second fMRI.|0|||
16319792|NCT04157296|39654155|FG001|Overall Study|Did not obtain second fMRI.|1|||
16319793|NCT04157296|39654154|FG000|Overall Study|MRI failed/no second fMRI|0|||
16319794|NCT04157296|39654155|FG001|Overall Study|MRI failed/no second fMRI|1|||
16319795|NCT05140382|39654162|FG000|Overall Study|Death|3|||
16319796|NCT05140382|39654163|FG001|Overall Study|Death|0|||
16319797|NCT05140382|39654164|FG002|Overall Study|Death|0|||
16319798|NCT05140382|39654162|FG000|Overall Study|Investigator decision|1|||
16319799|NCT05140382|39654163|FG001|Overall Study|Investigator decision|0|||
16319800|NCT05140382|39654164|FG002|Overall Study|Investigator decision|0|||
16319801|NCT05140382|39654162|FG000|Overall Study|Other|4|||
16514438|NCT00779675|40351287|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
16514439|NCT00779675|40351287|FG000|Extended Treatment Period|Lost to Follow-up|6|||
16514440|NCT01632891|40351288|FG000|Overall Study|Lost to Follow-up|0|||
16514441|NCT01632891|40351289|FG001|Overall Study|Lost to Follow-up|1|||
16514442|NCT01632891|40351288|FG000|Overall Study|Withdrawal by Subject|1|||
16514443|NCT01632891|40351289|FG001|Overall Study|Withdrawal by Subject|0|||
16319802|NCT05140382|39654163|FG001|Overall Study|Other|0|||
16319803|NCT05140382|39654164|FG002|Overall Study|Other|1|||
16319804|NCT05140382|39654162|FG000|Overall Study|Progressive disease|20|||
16319805|NCT05140382|39654163|FG001|Overall Study|Progressive disease|1|||
16319806|NCT05140382|39654164|FG002|Overall Study|Progressive disease|12|||
16319807|NCT05140382|39654162|FG000|Overall Study|Subjective disease progression|2|||
16319808|NCT05140382|39654163|FG001|Overall Study|Subjective disease progression|1|||
16319809|NCT05140382|39654164|FG002|Overall Study|Subjective disease progression|0|||
16319810|NCT05140382|39654162|FG000|Overall Study|Unknown at data cut-off|0|||
16319811|NCT05140382|39654163|FG001|Overall Study|Unknown at data cut-off|0|||
16319812|NCT05140382|39654164|FG002|Overall Study|Unknown at data cut-off|1|||
16394201|NCT01670279|39924621|FG000|Overall Study|Adverse Event|0|||
16394202|NCT01670279|39924622|FG001|Overall Study|Adverse Event|1|||
16394203|NCT01670279|39924623|FG002|Overall Study|Adverse Event|0|||
16394204|NCT01670279|39924624|FG003|Overall Study|Adverse Event|0|||
16394205|NCT01670279|39924621|FG000|Overall Study|Physician Decision|0|||
16394206|NCT01670279|39924622|FG001|Overall Study|Physician Decision|1|||
16394207|NCT01670279|39924623|FG002|Overall Study|Physician Decision|0|||
16394208|NCT01670279|39924624|FG003|Overall Study|Physician Decision|0|||
16394209|NCT01670279|39924621|FG000|Overall Study|Participant met withdrawal criteria|0|||
16394210|NCT01670279|39924622|FG001|Overall Study|Participant met withdrawal criteria|0|||
16394211|NCT01670279|39924623|FG002|Overall Study|Participant met withdrawal criteria|0|||
16394212|NCT01670279|39924624|FG003|Overall Study|Participant met withdrawal criteria|1|||
16394213|NCT02709577|39924625|FG000|Overall Study|non-accommodating anatomy|0|||
16394214|NCT02709577|39924626|FG001|Overall Study|non-accommodating anatomy|1|||
16394215|NCT02709577|39924627|FG002|Overall Study|non-accommodating anatomy|0|||
16394216|NCT02709577|39924628|FG003|Overall Study|non-accommodating anatomy|0|||
16394217|NCT02709577|39924625|FG000|Overall Study|procedural complication|0|||
16394218|NCT02709577|39924626|FG001|Overall Study|procedural complication|1|||
16394219|NCT02709577|39924627|FG002|Overall Study|procedural complication|0|||
16394220|NCT02709577|39924628|FG003|Overall Study|procedural complication|0|||
16394221|NCT02709577|39924625|FG000|Overall Study|Withdrawal by Subject|2|||
16514444|NCT01987427|40351291|FG000|Overall Study|Adverse Event|4|||
16514445|NCT01987427|40351292|FG001|Overall Study|Adverse Event|2|||
16319813|NCT05140382|39654162|FG000|Overall Study|Withdrawal by Subject|1|||
16319814|NCT05140382|39654163|FG001|Overall Study|Withdrawal by Subject|0|||
16319815|NCT05140382|39654164|FG002|Overall Study|Withdrawal by Subject|4|||
16394222|NCT02709577|39924626|FG001|Overall Study|Withdrawal by Subject|3|||
16394223|NCT02709577|39924627|FG002|Overall Study|Withdrawal by Subject|2|||
16394224|NCT02709577|39924628|FG003|Overall Study|Withdrawal by Subject|0|||
16514446|NCT01987427|40351293|FG002|Overall Study|Adverse Event|8|||
16201840|NCT00673894|39215399|FG000|First Intervention 4 Weeks|Adverse Event|1|||
16201841|NCT00673894|39215400|FG001|First Intervention 4 Weeks|Adverse Event|0|||
16201842|NCT00971425|39215407|FG000|Overall Study|Adverse Event|1|||
16201843|NCT00971425|39215408|FG001|Overall Study|Adverse Event|1|||
16201844|NCT00971425|39215407|FG000|Overall Study|Withdrawal by Subject|0|||
16201845|NCT00971425|39215408|FG001|Overall Study|Withdrawal by Subject|1|||
16201846|NCT03172481|39215409|FG000|Double-blind|Withdrawal by Subject|1|||
16201847|NCT03172481|39215410|FG001|Double-blind|Withdrawal by Subject|0|||
16201848|NCT03517449|39215413|FG000|Overall Study|Death|184|||
16201849|NCT03517449|39215414|FG001|Overall Study|Death|236|||
16201850|NCT03517449|39215413|FG000|Overall Study|Lost to Follow-up|0|||
16201851|NCT03517449|39215414|FG001|Overall Study|Lost to Follow-up|2|||
16201852|NCT03517449|39215413|FG000|Overall Study|Withdrawal by Subject|7|||
16201853|NCT03517449|39215414|FG001|Overall Study|Withdrawal by Subject|26|||
16201854|NCT03517449|39215413|FG000|Overall Study|Participants Ongoing|220|||
16201855|NCT03517449|39215414|FG001|Overall Study|Participants Ongoing|152|||
16201856|NCT02674685|39215415|FG000|Overall Study|Withdrawal by Subject|4|||
16201857|NCT01819506|39215416|FG000|Overall Study|Physician Decision|5|||
16201858|NCT01819506|39215417|FG001|Overall Study|Physician Decision|2|||
16201859|NCT01819506|39215416|FG000|Overall Study|Withdrawal by Subject|3|||
16201860|NCT01819506|39215417|FG001|Overall Study|Withdrawal by Subject|3|||
16201861|NCT02218372|39215419|FG000|Overall Study|Adverse Event|1|||
16201862|NCT02218372|39215420|FG001|Overall Study|Adverse Event|1|||
16201863|NCT02218372|39215419|FG000|Overall Study|Miscellaneous|2|||
16201864|NCT02218372|39215420|FG001|Overall Study|Miscellaneous|1|||
16201865|NCT02218372|39215419|FG000|Overall Study|Randomized but did not receive treatment|2|||
16201866|NCT02218372|39215420|FG001|Overall Study|Randomized but did not receive treatment|3|||
16201867|NCT02218372|39215419|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16201868|NCT02218372|39215420|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16201869|NCT02120157|39215421|FG000|Overall Study|Death|8|||
16201870|NCT03084718|39215422|FG000|Overall Study|Withdrawal by Subject|4|||
16201871|NCT03084718|39215423|FG001|Overall Study|Withdrawal by Subject|3|||
16201872|NCT03084718|39215424|FG002|Overall Study|Withdrawal by Subject|4|||
16201873|NCT03084718|39215425|FG003|Overall Study|Withdrawal by Subject|0|||
16201874|NCT03084718|39215426|FG004|Overall Study|Withdrawal by Subject|0|||
16201875|NCT03084718|39215422|FG000|Overall Study|Physician Decision|1|||
16201876|NCT03084718|39215423|FG001|Overall Study|Physician Decision|0|||
16201877|NCT03084718|39215424|FG002|Overall Study|Physician Decision|0|||
16201878|NCT03084718|39215425|FG003|Overall Study|Physician Decision|0|||
16201879|NCT03084718|39215426|FG004|Overall Study|Physician Decision|0|||
16201880|NCT03084718|39215422|FG000|Overall Study|Adverse Event|3|||
16201881|NCT03084718|39215423|FG001|Overall Study|Adverse Event|5|||
16201882|NCT03084718|39215424|FG002|Overall Study|Adverse Event|5|||
16201883|NCT03084718|39215425|FG003|Overall Study|Adverse Event|8|||
16201884|NCT03084718|39215426|FG004|Overall Study|Adverse Event|2|||
16201885|NCT03084718|39215422|FG000|Overall Study|Lack of Efficacy|2|||
16201886|NCT03084718|39215423|FG001|Overall Study|Lack of Efficacy|0|||
16201887|NCT03084718|39215424|FG002|Overall Study|Lack of Efficacy|1|||
16201888|NCT03084718|39215425|FG003|Overall Study|Lack of Efficacy|4|||
16201889|NCT03084718|39215426|FG004|Overall Study|Lack of Efficacy|0|||
16201890|NCT03084718|39215422|FG000|Overall Study|Lost to Follow-up|0|||
16201891|NCT03084718|39215423|FG001|Overall Study|Lost to Follow-up|1|||
16201892|NCT03084718|39215424|FG002|Overall Study|Lost to Follow-up|0|||
16201893|NCT03084718|39215425|FG003|Overall Study|Lost to Follow-up|0|||
16201894|NCT03084718|39215426|FG004|Overall Study|Lost to Follow-up|2|||
16201895|NCT03084718|39215422|FG000|Overall Study|Protocol Violation|0|||
16201896|NCT03084718|39215423|FG001|Overall Study|Protocol Violation|0|||
16201897|NCT03084718|39215424|FG002|Overall Study|Protocol Violation|1|||
16201898|NCT03084718|39215425|FG003|Overall Study|Protocol Violation|0|||
16201899|NCT03084718|39215426|FG004|Overall Study|Protocol Violation|0|||
16201900|NCT03084718|39215422|FG000|Overall Study|Death|0|||
16201901|NCT03084718|39215423|FG001|Overall Study|Death|1|||
16201902|NCT03084718|39215424|FG002|Overall Study|Death|0|||
16201903|NCT03084718|39215425|FG003|Overall Study|Death|0|||
16201904|NCT03084718|39215426|FG004|Overall Study|Death|0|||
16201905|NCT03084718|39215422|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
16201906|NCT03084718|39215423|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
16201907|NCT03084718|39215424|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
16201908|NCT03084718|39215425|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
16514447|NCT01987427|40351291|FG000|Overall Study|Lost to Follow-up|6|||
16514448|NCT01987427|40351292|FG001|Overall Study|Lost to Follow-up|6|||
16514449|NCT01987427|40351293|FG002|Overall Study|Lost to Follow-up|9|||
16514450|NCT01987427|40351291|FG000|Overall Study|Withdrawal by Subject|2|||
16514451|NCT01987427|40351292|FG001|Overall Study|Withdrawal by Subject|1|||
16514452|NCT01987427|40351293|FG002|Overall Study|Withdrawal by Subject|3|||
16514453|NCT01987427|40351291|FG000|Overall Study|Lack of Efficacy|1|||
16201909|NCT03084718|39215426|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
16201910|NCT02700919|39215428|FG000|Overall Study|Physician Decision|1|||
16201911|NCT02700919|39215429|FG001|Overall Study|Physician Decision|0|||
16201912|NCT02700919|39215430|FG002|Overall Study|Physician Decision|0|||
16201913|NCT02700919|39215428|FG000|Overall Study|Protocol Violation|1|||
16201914|NCT02700919|39215429|FG001|Overall Study|Protocol Violation|0|||
16201915|NCT02700919|39215430|FG002|Overall Study|Protocol Violation|0|||
16201916|NCT02700919|39215428|FG000|Overall Study|Adverse Event|1|||
16201917|NCT02700919|39215429|FG001|Overall Study|Adverse Event|3|||
16201918|NCT02700919|39215430|FG002|Overall Study|Adverse Event|1|||
16201919|NCT02700919|39215428|FG000|Overall Study|Withdrawal by Subject|5|||
16201920|NCT02700919|39215429|FG001|Overall Study|Withdrawal by Subject|8|||
16201921|NCT02700919|39215430|FG002|Overall Study|Withdrawal by Subject|2|||
16201922|NCT02700919|39215428|FG000|Overall Study|Lost to Follow-up|2|||
16201923|NCT02700919|39215429|FG001|Overall Study|Lost to Follow-up|0|||
16201924|NCT02700919|39215430|FG002|Overall Study|Lost to Follow-up|0|||
16201925|NCT02700919|39215428|FG000|Overall Study|Other|2|||
16201926|NCT02700919|39215429|FG001|Overall Study|Other|1|||
16201927|NCT02700919|39215430|FG002|Overall Study|Other|1|||
16201928|NCT02017899|39215431|FG000|Overall Study|Withdrawal by Subject|0|||
16201929|NCT02017899|39215432|FG001|Overall Study|Withdrawal by Subject|0|||
16201930|NCT02017899|39215433|FG002|Overall Study|Withdrawal by Subject|0|||
16201931|NCT02017899|39215434|FG003|Overall Study|Withdrawal by Subject|1|||
16201932|NCT02017899|39215435|FG004|Overall Study|Withdrawal by Subject|1|||
16201933|NCT02017899|39215436|FG005|Overall Study|Withdrawal by Subject|0|||
16201934|NCT01459068|39215437|FG000|Overall Study|Withdrawal by Subject|8|||
16201935|NCT01459068|39215438|FG001|Overall Study|Withdrawal by Subject|18|||
16201936|NCT01459068|39215437|FG000|Overall Study|Lost to Follow-up|31|||
16201937|NCT01459068|39215438|FG001|Overall Study|Lost to Follow-up|15|||
16201938|NCT01459068|39215437|FG000|Overall Study|Death|0|||
16201939|NCT01459068|39215438|FG001|Overall Study|Death|1|||
16201940|NCT00418379|39215439|FG000|Year 1|Adverse Event|9|||
16201941|NCT00418379|39215440|FG001|Year 1|Adverse Event|15|||
16201942|NCT00418379|39215441|FG002|Year 1|Adverse Event|3|||
16201943|NCT00418379|39215439|FG000|Year 1|Withdrawal by Subject|7|||
16201944|NCT00418379|39215440|FG001|Year 1|Withdrawal by Subject|8|||
16201945|NCT00418379|39215441|FG002|Year 1|Withdrawal by Subject|5|||
16201946|NCT00418379|39215439|FG000|Year 1|Any other reason not above-mentioned|2|||
16201947|NCT00418379|39215440|FG001|Year 1|Any other reason not above-mentioned|5|||
16201948|NCT00418379|39215441|FG002|Year 1|Any other reason not above-mentioned|7|||
16201949|NCT00418379|39215439|FG000|Year 2|Adverse Event|5|||
16201950|NCT00418379|39215440|FG001|Year 2|Adverse Event|2|||
16201951|NCT00418379|39215441|FG002|Year 2|Adverse Event|1|||
16201952|NCT00418379|39215439|FG000|Year 2|Withdrawal by Subject|1|||
16201953|NCT00418379|39215440|FG001|Year 2|Withdrawal by Subject|1|||
16201954|NCT00418379|39215441|FG002|Year 2|Withdrawal by Subject|3|||
16201955|NCT00418379|39215439|FG000|Year 2|Any other reason not above-mentioned|2|||
16201956|NCT00418379|39215440|FG001|Year 2|Any other reason not above-mentioned|1|||
16201957|NCT00418379|39215441|FG002|Year 2|Any other reason not above-mentioned|6|||
16201958|NCT00418379|39215439|FG000|Year 3|Withdrawal by Subject|1|||
16201959|NCT00418379|39215440|FG001|Year 3|Withdrawal by Subject|1|||
16201960|NCT00418379|39215441|FG002|Year 3|Withdrawal by Subject|2|||
16201961|NCT00418379|39215439|FG000|Year 3|Any other reason not above-mentioned|2|||
16201962|NCT00418379|39215440|FG001|Year 3|Any other reason not above-mentioned|1|||
16201963|NCT00418379|39215441|FG002|Year 3|Any other reason not above-mentioned|1|||
16201964|NCT00418379|39215439|FG000|Year 4|Adverse Event|0|||
16201965|NCT00418379|39215440|FG001|Year 4|Adverse Event|1|||
16201966|NCT00418379|39215441|FG002|Year 4|Adverse Event|0|||
16201967|NCT00418379|39215439|FG000|Year 4|Withdrawal by Subject|2|||
16201968|NCT00418379|39215440|FG001|Year 4|Withdrawal by Subject|3|||
16201969|NCT00418379|39215441|FG002|Year 4|Withdrawal by Subject|2|||
16201970|NCT00418379|39215439|FG000|Year 4|Any other reason not above-mentioned|1|||
16201971|NCT00418379|39215440|FG001|Year 4|Any other reason not above-mentioned|1|||
16201972|NCT00418379|39215441|FG002|Year 4|Any other reason not above-mentioned|0|||
16201973|NCT00418379|39215439|FG000|Year 5|Adverse Event|0|||
16201974|NCT00418379|39215440|FG001|Year 5|Adverse Event|1|||
16201975|NCT00418379|39215441|FG002|Year 5|Adverse Event|0|||
16201976|NCT00418379|39215439|FG000|Year 5|Any other reason not above-mentioned|2|||
16201977|NCT00418379|39215440|FG001|Year 5|Any other reason not above-mentioned|4|||
16201978|NCT00418379|39215441|FG002|Year 5|Any other reason not above-mentioned|3|||
16201979|NCT02148211|39215449|FG000|Overall Study|Lost to Follow-up|352|||
16201980|NCT04142216|39215450|FG000|Overall Study|Hospitalization|0|||
16201981|NCT04142216|39215451|FG001|Overall Study|Hospitalization|2|||
16201982|NCT04142216|39215450|FG000|Overall Study|Death|3|||
16201983|NCT04142216|39215451|FG001|Overall Study|Death|1|||
16201984|NCT04142216|39215450|FG000|Overall Study|Referral to another hemodialysis unit|3|||
16201985|NCT04142216|39215451|FG001|Overall Study|Referral to another hemodialysis unit|2|||
16201986|NCT04142216|39215450|FG000|Overall Study|Use of clove|0|||
16201987|NCT04142216|39215451|FG001|Overall Study|Use of clove|1|||
16201988|NCT02293902|39215452|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
16201989|NCT02293902|39215453|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
16201990|NCT02293902|39215454|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
16201991|NCT02293902|39215455|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
16201992|NCT02293902|39215456|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
16201993|NCT02293902|39215452|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
16201994|NCT02293902|39215453|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
16201995|NCT02293902|39215454|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
16201996|NCT02293902|39215455|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
16201997|NCT02293902|39215456|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
16201998|NCT02293902|39215452|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
16514454|NCT01987427|40351292|FG001|Overall Study|Lack of Efficacy|0|||
16514455|NCT01987427|40351293|FG002|Overall Study|Lack of Efficacy|0|||
16514456|NCT01987427|40351291|FG000|Overall Study|Other|1|||
16201999|NCT02293902|39215453|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
16202000|NCT02293902|39215454|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
16202001|NCT02293902|39215455|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
16202002|NCT02293902|39215456|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
16202003|NCT02293902|39215452|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
16202004|NCT02293902|39215453|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
16202005|NCT02293902|39215454|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
16202006|NCT02293902|39215455|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
16202007|NCT02293902|39215456|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
16202008|NCT02293902|39215452|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
16202009|NCT02293902|39215453|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
16202010|NCT02293902|39215454|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
16202011|NCT02293902|39215455|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
16202012|NCT02293902|39215456|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
16202013|NCT01359046|39215457|FG000|Overall Study|Did not receive allocated intervention|6|||
16202014|NCT01359046|39215458|FG001|Overall Study|Did not receive allocated intervention|6|||
16202015|NCT01359046|39215457|FG000|Overall Study|Physician Decision|1|||
16202016|NCT01359046|39215458|FG001|Overall Study|Physician Decision|11|||
16202017|NCT00369967|39215461|FG000|Overall Study|Lost to Follow-up|23|||
16202018|NCT00369967|39215462|FG001|Overall Study|Lost to Follow-up|12|||
16202019|NCT02227849|39215469|FG000|Overall Study|Adverse Event|4|||
16202020|NCT02227849|39215469|FG000|Overall Study|Physician Decision|1|||
16202021|NCT02227849|39215469|FG000|Overall Study|Withdrawal by Subject|3|||
16202022|NCT03287245|39215470|FG000|Overall Study|Study terminated by sponsor|3|||
16202023|NCT03287245|39215471|FG001|Overall Study|Study terminated by sponsor|0|||
16319816|NCT05140382|39654162|FG000|Overall Study|Withdrawal of consent|0|||
16319817|NCT05140382|39654163|FG001|Overall Study|Withdrawal of consent|0|||
16319818|NCT05140382|39654164|FG002|Overall Study|Withdrawal of consent|1|||
16319819|NCT00892151|39654165|FG000|Overall Study|Protocol Violation|1|||
16319820|NCT00740792|39654167|FG000|Overall Study|Adverse Event|3|||
16319821|NCT00740792|39654168|FG001|Overall Study|Adverse Event|1|||
16319822|NCT00740792|39654169|FG002|Overall Study|Adverse Event|1|||
16319823|NCT00740792|39654170|FG003|Overall Study|Adverse Event|3|||
16319824|NCT00740792|39654167|FG000|Overall Study|Lack of Efficacy|1|||
16319825|NCT00740792|39654168|FG001|Overall Study|Lack of Efficacy|1|||
16319826|NCT00740792|39654169|FG002|Overall Study|Lack of Efficacy|0|||
16319827|NCT00740792|39654170|FG003|Overall Study|Lack of Efficacy|3|||
16319828|NCT00740792|39654167|FG000|Overall Study|Lost to Follow-up|2|||
16319829|NCT00740792|39654168|FG001|Overall Study|Lost to Follow-up|1|||
16319830|NCT00740792|39654169|FG002|Overall Study|Lost to Follow-up|0|||
16319831|NCT00740792|39654170|FG003|Overall Study|Lost to Follow-up|0|||
16319832|NCT00740792|39654167|FG000|Overall Study|Protocol Violation|0|||
16514457|NCT01987427|40351292|FG001|Overall Study|Other|1|||
16514458|NCT01987427|40351293|FG002|Overall Study|Other|0|||
16090433|NCT01970878|38823417|FG002|Overall Study|Withdrawal by Subject|14|||
16090434|NCT01970878|38823418|FG003|Overall Study|Withdrawal by Subject|7|||
16090435|NCT01970878|38823415|FG000|Overall Study|Lost to Follow-up|1|||
16090436|NCT01970878|38823416|FG001|Overall Study|Lost to Follow-up|3|||
16090437|NCT01970878|38823417|FG002|Overall Study|Lost to Follow-up|2|||
16090438|NCT01970878|38823418|FG003|Overall Study|Lost to Follow-up|4|||
16090439|NCT01970878|38823415|FG000|Overall Study|Administrative Reasons|1|||
16090440|NCT01970878|38823416|FG001|Overall Study|Administrative Reasons|0|||
16090441|NCT01970878|38823417|FG002|Overall Study|Administrative Reasons|0|||
16090442|NCT01970878|38823418|FG003|Overall Study|Administrative Reasons|4|||
16090443|NCT01970878|38823415|FG000|Overall Study|Lack of Efficacy|2|||
16090444|NCT01970878|38823416|FG001|Overall Study|Lack of Efficacy|1|||
16319833|NCT00740792|39654168|FG001|Overall Study|Protocol Violation|1|||
16319834|NCT00740792|39654169|FG002|Overall Study|Protocol Violation|0|||
16514459|NCT02118428|40351297|FG000|Overall Study|Physician Decision|0|||
16090445|NCT01970878|38823417|FG002|Overall Study|Lack of Efficacy|2|||
16090446|NCT01970878|38823418|FG003|Overall Study|Lack of Efficacy|0|||
16514460|NCT02118428|40351298|FG001|Overall Study|Physician Decision|1|||
16319835|NCT00740792|39654170|FG003|Overall Study|Protocol Violation|2|||
16319836|NCT00740792|39654167|FG000|Overall Study|Withdrawal by Subject|1|||
16319837|NCT00740792|39654168|FG001|Overall Study|Withdrawal by Subject|1|||
16319838|NCT00740792|39654169|FG002|Overall Study|Withdrawal by Subject|0|||
16319839|NCT00740792|39654170|FG003|Overall Study|Withdrawal by Subject|0|||
16514461|NCT02118428|40351299|FG002|Overall Study|Physician Decision|0|||
16514462|NCT02118428|40351297|FG000|Overall Study|Withdrawal by Subject|2|||
16514463|NCT02118428|40351298|FG001|Overall Study|Withdrawal by Subject|2|||
16514464|NCT02118428|40351299|FG002|Overall Study|Withdrawal by Subject|0|||
16514465|NCT02118428|40351297|FG000|Overall Study|Death|7|||
16514466|NCT02118428|40351298|FG001|Overall Study|Death|5|||
16514467|NCT02118428|40351299|FG002|Overall Study|Death|0|||
16514468|NCT02118428|40351297|FG000|Overall Study|Lost to Follow-up|3|||
16514469|NCT02118428|40351298|FG001|Overall Study|Lost to Follow-up|1|||
16514470|NCT02118428|40351299|FG002|Overall Study|Lost to Follow-up|0|||
16514471|NCT02118428|40351297|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
16514472|NCT02118428|40351298|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
16514473|NCT02118428|40351299|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
16514474|NCT01701258|40351305|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
16514475|NCT01701258|40351306|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
16514476|NCT01701258|40351307|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
16514477|NCT01701258|40351308|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
16514478|NCT01701258|40351309|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
16514479|NCT01701258|40351310|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
16514480|NCT01701258|40351311|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
16514481|NCT01701258|40351312|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
16514482|NCT01701258|40351313|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
16514483|NCT01701258|40351314|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
16514484|NCT01701258|40351315|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
16514485|NCT01701258|40351316|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
16514486|NCT01701258|40351317|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
16514487|NCT01701258|40351305|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
16514488|NCT01701258|40351306|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
16514489|NCT01701258|40351307|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
16514490|NCT01701258|40351308|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
16514491|NCT01701258|40351309|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
16514492|NCT01701258|40351310|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
16514493|NCT01701258|40351311|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
16514494|NCT01701258|40351312|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
16514495|NCT01701258|40351313|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
16514496|NCT01701258|40351314|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
16514497|NCT01701258|40351315|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
16514498|NCT01701258|40351316|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
16514499|NCT01701258|40351317|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
16319840|NCT00740792|39654167|FG000|Overall Study|administrative|3|||
16319841|NCT00740792|39654168|FG001|Overall Study|administrative|3|||
16319842|NCT00740792|39654169|FG002|Overall Study|administrative|8|||
16319843|NCT00740792|39654170|FG003|Overall Study|administrative|2|||
16319844|NCT00379080|39654173|FG000|Overall Study|Withdrawal by Subject|0|||
16319845|NCT00379080|39654174|FG001|Overall Study|Withdrawal by Subject|4|||
16319846|NCT00379080|39654175|FG002|Overall Study|Withdrawal by Subject|0|||
16319847|NCT02222545|39654176|FG000|Overall Study|Adverse Event|1|||
16319848|NCT02222545|39654177|FG001|Overall Study|Adverse Event|0|||
16319849|NCT02222545|39654178|FG002|Overall Study|Adverse Event|2|||
16319850|NCT02222545|39654176|FG000|Overall Study|Death|0|||
16319851|NCT02222545|39654177|FG001|Overall Study|Death|0|||
16319852|NCT02222545|39654178|FG002|Overall Study|Death|9|||
16319853|NCT02222545|39654176|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
16319854|NCT02222545|39654177|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
16319855|NCT02222545|39654178|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
16319856|NCT02222545|39654176|FG000|Overall Study|Withdrawal by Subject|0|||
16319857|NCT02222545|39654177|FG001|Overall Study|Withdrawal by Subject|0|||
16319858|NCT02222545|39654178|FG002|Overall Study|Withdrawal by Subject|3|||
16514500|NCT01701258|40351305|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
16319859|NCT02222545|39654176|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
16319860|NCT02222545|39654177|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
16319861|NCT02222545|39654178|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
16319862|NCT00746564|39654184|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
16319863|NCT02518048|39654185|FG000|Overall Study|Withdrawal by Subject|1|||
16319864|NCT03831113|39654189|FG000|Overall Study|Withdrawal by Subject|0|||
16319865|NCT03831113|39654190|FG001|Overall Study|Withdrawal by Subject|2|||
16319866|NCT03831113|39654189|FG000|Overall Study|Protocol Violation|0|||
16319867|NCT03831113|39654190|FG001|Overall Study|Protocol Violation|9|||
16319868|NCT03476187|39654191|FG000|Overall Study|Protocol Violation|7|||
16319869|NCT03476187|39654191|FG000|Overall Study|Physician Decision|5|||
16319870|NCT02920008|39654192|FG000|Overall Study|Death|117|||
16319871|NCT02920008|39654193|FG001|Overall Study|Death|127|||
16319872|NCT02920008|39654192|FG000|Overall Study|Withdrawal by Subject|3|||
16319873|NCT02920008|39654193|FG001|Overall Study|Withdrawal by Subject|6|||
16319874|NCT02920008|39654192|FG000|Overall Study|Lost to Follow-up|0|||
16319875|NCT02920008|39654193|FG001|Overall Study|Lost to Follow-up|1|||
16319876|NCT01757535|39654194|FG000|Overall Study|Disease Relapse|143|||
16319877|NCT01757535|39654195|FG001|Overall Study|Disease Relapse|180|||
16319878|NCT01757535|39654194|FG000|Overall Study|Adverse Event|29|||
16319879|NCT01757535|39654195|FG001|Overall Study|Adverse Event|11|||
16319880|NCT01757535|39654194|FG000|Overall Study|Withdrawal by Subject|9|||
16319881|NCT01757535|39654195|FG001|Overall Study|Withdrawal by Subject|13|||
16319882|NCT01757535|39654194|FG000|Overall Study|Miscellaneous|5|||
16319883|NCT01757535|39654195|FG001|Overall Study|Miscellaneous|2|||
16319884|NCT01757535|39654194|FG000|Overall Study|Physician Decision|6|||
16319885|NCT01757535|39654195|FG001|Overall Study|Physician Decision|0|||
16319886|NCT01757535|39654194|FG000|Overall Study|Death|1|||
16319887|NCT01757535|39654195|FG001|Overall Study|Death|2|||
16319888|NCT00582608|39654202|FG000|Overall Study|Not Treated|7|||
16319889|NCT00582608|39654202|FG000|Overall Study|Patient Ineligible|1|||
16319890|NCT00582608|39654202|FG000|Overall Study|Lack of accrual|4|||
16319891|NCT03645395|39654210|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
16319892|NCT03645395|39654211|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
16319893|NCT03645395|39654212|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
16319894|NCT03645395|39654213|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
16319895|NCT03645395|39654210|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
16319896|NCT03645395|39654211|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
16319897|NCT03645395|39654212|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
16319898|NCT03645395|39654213|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
16319899|NCT03645395|39654210|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
16319900|NCT03645395|39654211|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
16319901|NCT03645395|39654212|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
16319902|NCT03645395|39654213|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
16319903|NCT03645395|39654210|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
16319904|NCT03645395|39654211|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
16319905|NCT03645395|39654212|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
16319906|NCT03645395|39654213|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
16319907|NCT04177095|39654214|FG000|Overall Study|Withdrawal by Subject|3|||
16319908|NCT04177095|39654214|FG000|Overall Study|Screen Failure|3|||
16319909|NCT04177095|39654214|FG000|Overall Study|Problems with the Trugraf assay|1|||
16319910|NCT06098339|39654215|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
16319911|NCT06098339|39654216|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
16319912|NCT06098339|39654215|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
16319913|NCT06098339|39654216|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
16319914|NCT00454246|39654217|FG000|Overall Study|Adverse Event|2|||
16319915|NCT00454246|39654218|FG001|Overall Study|Adverse Event|2|||
16319916|NCT00454246|39654219|FG002|Overall Study|Adverse Event|0|||
16319917|NCT00454246|39654217|FG000|Overall Study|Violation of selection criteria at entry|6|||
16319918|NCT00454246|39654218|FG001|Overall Study|Violation of selection criteria at entry|0|||
16319919|NCT00454246|39654219|FG002|Overall Study|Violation of selection criteria at entry|0|||
16319920|NCT00454246|39654217|FG000|Overall Study|Protocol Violation|1|||
16319921|NCT00454246|39654218|FG001|Overall Study|Protocol Violation|0|||
16319922|NCT00454246|39654219|FG002|Overall Study|Protocol Violation|0|||
16319923|NCT00454246|39654217|FG000|Overall Study|Refused Treatment|1|||
16319924|NCT00454246|39654218|FG001|Overall Study|Refused Treatment|1|||
16319925|NCT00454246|39654219|FG002|Overall Study|Refused Treatment|0|||
16319926|NCT00454246|39654217|FG000|Overall Study|Failure to return|1|||
16319927|NCT00454246|39654218|FG001|Overall Study|Failure to return|0|||
16319928|NCT00454246|39654219|FG002|Overall Study|Failure to return|0|||
16319929|NCT00454246|39654217|FG000|Overall Study|Early termination of study|62|||
16319930|NCT00454246|39654218|FG001|Overall Study|Early termination of study|26|||
16319931|NCT00454246|39654219|FG002|Overall Study|Early termination of study|9|||
16319932|NCT03793842|39654222|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
16394225|NCT04396795|39924629|FG000|Month 1|Lost to Follow-up|2|||
16319933|NCT03793842|39654223|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
16319934|NCT03793842|39654222|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
16319935|NCT03793842|39654223|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
16319936|NCT02308540|39654224|FG000|Overall Study|Lost to Follow-up|0|||
16319937|NCT02308540|39654225|FG001|Overall Study|Lost to Follow-up|0|||
16319938|NCT02308540|39654226|FG002|Overall Study|Lost to Follow-up|0|||
16319939|NCT02308540|39654227|FG003|Overall Study|Lost to Follow-up|0|||
16319940|NCT02308540|39654228|FG004|Overall Study|Lost to Follow-up|0|||
16319941|NCT02308540|39654229|FG005|Overall Study|Lost to Follow-up|1|||
16319942|NCT01554527|39654232|FG000|Overall Study|Withdrawal by Subject|1|||
16319943|NCT01554527|39654233|FG001|Overall Study|Withdrawal by Subject|0|||
16319944|NCT01554527|39654234|FG002|Overall Study|Withdrawal by Subject|3|||
16319945|NCT01554527|39654232|FG000|Overall Study|Lost to Follow-up|0|||
16319946|NCT01554527|39654233|FG001|Overall Study|Lost to Follow-up|0|||
16319947|NCT01554527|39654234|FG002|Overall Study|Lost to Follow-up|4|||
16319948|NCT01554527|39654232|FG000|Overall Study|Physician Decision|0|||
16319949|NCT01554527|39654233|FG001|Overall Study|Physician Decision|0|||
16319950|NCT01554527|39654234|FG002|Overall Study|Physician Decision|1|||
16319951|NCT01464164|39654235|FG000|Overall Study|Screen failure|0|||
16319952|NCT01464164|39654236|FG001|Overall Study|Screen failure|1|||
16319953|NCT01464164|39654237|FG002|Overall Study|Screen failure|2|||
16319954|NCT01464164|39654238|FG003|Overall Study|Screen failure|0|||
16319955|NCT01464164|39654239|FG004|Overall Study|Screen failure|0|||
16319956|NCT01464164|39654240|FG005|Overall Study|Screen failure|0|||
16319957|NCT01464164|39654241|FG006|Overall Study|Screen failure|0|||
16319958|NCT01464164|39654235|FG000|Overall Study|Physician Decision|0|||
16319959|NCT01464164|39654236|FG001|Overall Study|Physician Decision|1|||
16319960|NCT01464164|39654237|FG002|Overall Study|Physician Decision|0|||
16319961|NCT01464164|39654238|FG003|Overall Study|Physician Decision|0|||
16319962|NCT01464164|39654239|FG004|Overall Study|Physician Decision|0|||
16319963|NCT01464164|39654240|FG005|Overall Study|Physician Decision|0|||
16319964|NCT01464164|39654241|FG006|Overall Study|Physician Decision|2|||
16319965|NCT02955355|39654242|FG000|Overall Study|Adverse Event|4|||
16319966|NCT02955355|39654242|FG000|Overall Study|Death|1|||
16319967|NCT02955355|39654242|FG000|Overall Study|Physician Decision|21|||
16319968|NCT02955355|39654242|FG000|Overall Study|Site Terminated by Sponsor|35|||
16319969|NCT02955355|39654242|FG000|Overall Study|Withdrawal by Subject|19|||
16319970|NCT02955355|39654242|FG000|Overall Study|Reason Not Specified|5|||
16319971|NCT02576847|39654245|FG000|Overall Study|Adverse Event|27|||
16319972|NCT02576847|39654245|FG000|Overall Study|Lost to Follow-up|22|||
16319973|NCT02576847|39654245|FG000|Overall Study|Physician Decision|1|||
16319974|NCT02576847|39654245|FG000|Overall Study|Pregnancy|1|||
16319975|NCT02576847|39654245|FG000|Overall Study|Protocol Violation|3|||
16319976|NCT02576847|39654245|FG000|Overall Study|Withdrawal by Subject|78|||
16319977|NCT02576847|39654245|FG000|Overall Study|Other|5|||
16319978|NCT03291431|39654249|FG000|Overall Study|Protocol Violation|2|||
16090447|NCT01970878|38823415|FG000|Overall Study|Adverse Event|12|||
16090448|NCT01970878|38823416|FG001|Overall Study|Adverse Event|7|||
16090449|NCT01970878|38823417|FG002|Overall Study|Adverse Event|4|||
16090450|NCT01970878|38823418|FG003|Overall Study|Adverse Event|3|||
16090451|NCT01970878|38823415|FG000|Overall Study|Protocol Specified Criteria|10|||
16090452|NCT01970878|38823416|FG001|Overall Study|Protocol Specified Criteria|4|||
16319979|NCT03291431|39654250|FG001|Overall Study|Protocol Violation|1|||
16319980|NCT03291431|39654249|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
16319981|NCT03291431|39654250|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
16319982|NCT03291431|39654249|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
16319983|NCT03291431|39654250|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
16319984|NCT04520997|39654251|FG000|Overall Study|Lost to Follow-up|1|||
16319985|NCT04520997|39654252|FG001|Overall Study|Lost to Follow-up|1|||
16319986|NCT04520997|39654251|FG000|Overall Study|Withdrawal by Subject|1|||
16319987|NCT04520997|39654252|FG001|Overall Study|Withdrawal by Subject|0|||
16319988|NCT04520997|39654251|FG000|Overall Study|Not Treated|0|||
16319989|NCT04520997|39654252|FG001|Overall Study|Not Treated|1|||
16319990|NCT02134015|39657139|FG000|Overall Study|Protocol Violation|0|||
16319991|NCT02134015|39657140|FG001|Overall Study|Protocol Violation|1|||
16394226|NCT04396795|39924630|FG001|Month 1|Lost to Follow-up|3|||
16090453|NCT01970878|38823417|FG002|Overall Study|Protocol Specified Criteria|3|||
16319992|NCT02134015|39657139|FG000|Overall Study|Death|2|||
16319993|NCT02134015|39657140|FG001|Overall Study|Death|1|||
16319994|NCT02134015|39657139|FG000|Overall Study|Reason not provided|1|||
16090454|NCT01970878|38823418|FG003|Overall Study|Protocol Specified Criteria|6|||
16090455|NCT01970878|38823415|FG000|Overall Study|Physician Decision|0|||
16090456|NCT01970878|38823416|FG001|Overall Study|Physician Decision|1|||
16090457|NCT01970878|38823417|FG002|Overall Study|Physician Decision|1|||
16090458|NCT01970878|38823418|FG003|Overall Study|Physician Decision|0|||
16090459|NCT01970878|38823415|FG000|Overall Study|No Completion Status|0|||
16090460|NCT01970878|38823416|FG001|Overall Study|No Completion Status|1|||
16090461|NCT01970878|38823417|FG002|Overall Study|No Completion Status|0|||
16090462|NCT01970878|38823418|FG003|Overall Study|No Completion Status|0|||
16090463|NCT00346398|38823424|FG000|Overall Study|Lost to Follow-up|3|||
16090464|NCT00346398|38823425|FG001|Overall Study|Lost to Follow-up|0|||
16319995|NCT02134015|39657140|FG001|Overall Study|Reason not provided|2|||
16319996|NCT02134015|39657139|FG000|Overall Study|Clinical progression|14|||
16319997|NCT02134015|39657140|FG001|Overall Study|Clinical progression|7|||
16319998|NCT02134015|39657139|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
16319999|NCT02134015|39657140|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
16320000|NCT02134015|39657139|FG000|Overall Study|Study terminated by sponsor|2|||
16320001|NCT02134015|39657140|FG001|Overall Study|Study terminated by sponsor|3|||
16320002|NCT02134015|39657139|FG000|Overall Study|Adverse Event|9|||
16320003|NCT02134015|39657140|FG001|Overall Study|Adverse Event|10|||
16320004|NCT02134015|39657139|FG000|Overall Study|Withdrawal by Subject|3|||
16320005|NCT02134015|39657140|FG001|Overall Study|Withdrawal by Subject|7|||
16320006|NCT00492648|39657143|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
16320007|NCT00492648|39657144|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
16320008|NCT05326529|39657145|FG000|Overall Study|Lack of Efficacy|0|||
16320009|NCT05326529|39657146|FG001|Overall Study|Lack of Efficacy|1|||
16320010|NCT05326529|39657147|FG002|Overall Study|Lack of Efficacy|0|||
16320011|NCT05326529|39657145|FG000|Overall Study|Physician Decision|0|||
16320012|NCT05326529|39657146|FG001|Overall Study|Physician Decision|0|||
16320013|NCT05326529|39657147|FG002|Overall Study|Physician Decision|2|||
16320014|NCT00356148|39657151|FG000|Overall Study|Reoperation within 30 days|2|||
16320015|NCT00356148|39657152|FG001|Overall Study|Reoperation within 30 days|1|||
16320016|NCT02473250|39657153|FG000|Overall Study|Lost to Follow-up|10|||
16320017|NCT02473250|39657153|FG000|Overall Study|Physician Decision|5|||
16320018|NCT02473250|39657153|FG000|Overall Study|Did not tolerate medication washout|3|||
16320019|NCT02473250|39657153|FG000|Overall Study|Antidepressant effect of divalproex|2|||
16320020|NCT03003494|39657154|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
16320021|NCT00356122|39657155|FG000|TREATMENT|Lack of Efficacy|26|||
16320022|NCT00356122|39657155|FG000|TREATMENT|Adverse Event|10|||
16320023|NCT00356122|39657155|FG000|TREATMENT|Subject's request|4|||
16320024|NCT00356122|39657155|FG000|TREATMENT|Other|4|||
16320025|NCT00356122|39657155|FG000|TREATMENT|Did not receive study medication|1|||
16320026|NCT00356122|39657155|FG000|FOLLOW-UP|Death|37|||
16320027|NCT00356122|39657155|FG000|FOLLOW-UP|Lost to Follow-up|2|||
16320028|NCT00356122|39657155|FG000|FOLLOW-UP|Other|2|||
16320029|NCT01326104|39657159|FG000|Overall Study|progressed prior to vaccine|0|||
16320030|NCT01326104|39657160|FG001|Overall Study|progressed prior to vaccine|2|||
16320031|NCT01326104|39657159|FG000|Overall Study|unable to make vaccine|0|||
16320032|NCT01326104|39657160|FG001|Overall Study|unable to make vaccine|2|||
16320033|NCT00546377|39657161|FG000|Overall Study|Deemed ineligible|1|||
16320034|NCT00546377|39657161|FG000|Overall Study|Adverse Event|6|||
16320035|NCT01455597|39657167|FG000|Overall Study|Adverse Event|7|||
16320036|NCT01455597|39657168|FG001|Overall Study|Adverse Event|0|||
16320037|NCT01455597|39657169|FG002|Overall Study|Adverse Event|5|||
16320038|NCT01455597|39657170|FG003|Overall Study|Adverse Event|1|||
16320039|NCT01455597|39657167|FG000|Overall Study|Lack of Efficacy|0|||
16320040|NCT01455597|39657168|FG001|Overall Study|Lack of Efficacy|1|||
16320041|NCT01455597|39657169|FG002|Overall Study|Lack of Efficacy|2|||
16514501|NCT01701258|40351306|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
16514502|NCT01701258|40351307|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
16090465|NCT00346398|38823424|FG000|Overall Study|Withdrawal by Subject|0|||
16320042|NCT01455597|39657170|FG003|Overall Study|Lack of Efficacy|0|||
16320043|NCT01455597|39657167|FG000|Overall Study|Lost to Follow-up|3|||
16320044|NCT01455597|39657168|FG001|Overall Study|Lost to Follow-up|0|||
16320045|NCT01455597|39657169|FG002|Overall Study|Lost to Follow-up|2|||
16320046|NCT01455597|39657170|FG003|Overall Study|Lost to Follow-up|1|||
16320047|NCT01455597|39657167|FG000|Overall Study|Withdrew Consent|6|||
16320048|NCT01455597|39657168|FG001|Overall Study|Withdrew Consent|5|||
16320049|NCT01455597|39657169|FG002|Overall Study|Withdrew Consent|8|||
16320050|NCT01455597|39657170|FG003|Overall Study|Withdrew Consent|5|||
16090466|NCT00346398|38823425|FG001|Overall Study|Withdrawal by Subject|2|||
16320051|NCT01455597|39657167|FG000|Overall Study|Reason not Specified|1|||
16320052|NCT01455597|39657168|FG001|Overall Study|Reason not Specified|2|||
16320053|NCT01455597|39657169|FG002|Overall Study|Reason not Specified|3|||
16320054|NCT01455597|39657170|FG003|Overall Study|Reason not Specified|3|||
16320055|NCT00593684|39657171|FG000|Overall Study|Death|2|||
16320056|NCT00593684|39657172|FG001|Overall Study|Death|1|||
16394227|NCT04396795|39924629|FG000|Month 3|Lost to Follow-up|1|||
16202024|NCT03287245|39215472|FG002|Overall Study|Study terminated by sponsor|3|||
16202025|NCT03287245|39215473|FG003|Overall Study|Study terminated by sponsor|1|||
16202026|NCT03287245|39215470|FG000|Overall Study|Adverse Event|1|||
16202027|NCT03287245|39215471|FG001|Overall Study|Adverse Event|0|||
16202028|NCT03287245|39215472|FG002|Overall Study|Adverse Event|0|||
16202029|NCT03287245|39215473|FG003|Overall Study|Adverse Event|0|||
16202030|NCT03287245|39215470|FG000|Overall Study|Withdrawal by Subject|8|||
16202031|NCT03287245|39215471|FG001|Overall Study|Withdrawal by Subject|3|||
16202032|NCT03287245|39215472|FG002|Overall Study|Withdrawal by Subject|3|||
16394228|NCT04396795|39924630|FG001|Month 3|Lost to Follow-up|3|||
16394229|NCT04396795|39924629|FG000|Month 6|Lost to Follow-up|3|||
16394230|NCT04396795|39924630|FG001|Month 6|Lost to Follow-up|3|||
16394231|NCT00288015|39924631|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
16394232|NCT00288015|39924631|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
16394233|NCT00288015|39924631|FG000|First Response Assessment|Withdrawal by Subject|1|||
16394234|NCT00288015|39924631|FG000|First Response Assessment|Death|1|||
16394235|NCT00288015|39924631|FG000|First Response Assessment|Physician Decision|2|||
16394236|NCT00288015|39924631|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
16202033|NCT03287245|39215473|FG003|Overall Study|Withdrawal by Subject|0|||
16394237|NCT00288015|39924631|FG000|Follow up for Survival x 2 Years|Death|13|||
16394238|NCT00288015|39924631|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
16394239|NCT00288015|39924631|FG000|Follow up for Survival x 2 Years|Other|9|||
16394240|NCT01463696|39924632|FG000|Overall Study|Adverse Event|0|||
16394241|NCT01463696|39924633|FG001|Overall Study|Adverse Event|1|||
16394242|NCT01463696|39924634|FG002|Overall Study|Adverse Event|0|||
16394243|NCT01463696|39924635|FG003|Overall Study|Adverse Event|2|||
16394244|NCT01463696|39924636|FG004|Overall Study|Adverse Event|0|||
16394245|NCT01463696|39924637|FG005|Overall Study|Adverse Event|1|||
16394246|NCT01463696|39924638|FG006|Overall Study|Adverse Event|3|||
16394247|NCT01463696|39924639|FG007|Overall Study|Adverse Event|2|||
16394248|NCT01463696|39924632|FG000|Overall Study|Lost to Follow-up|0|||
16394249|NCT01463696|39924633|FG001|Overall Study|Lost to Follow-up|0|||
16394250|NCT01463696|39924634|FG002|Overall Study|Lost to Follow-up|1|||
16394251|NCT01463696|39924635|FG003|Overall Study|Lost to Follow-up|0|||
16394252|NCT01463696|39924636|FG004|Overall Study|Lost to Follow-up|0|||
16202034|NCT03287245|39215470|FG000|Overall Study|Physician Decision|3|||
16320057|NCT00791778|39657175|FG000|Double-blind Treatment|Adverse Event|49|||
16320058|NCT00791778|39657176|FG001|Double-blind Treatment|Adverse Event|9|||
16320059|NCT00791778|39657175|FG000|Double-blind Treatment|Physician Decision|6|||
16320060|NCT00791778|39657176|FG001|Double-blind Treatment|Physician Decision|26|||
16320061|NCT00791778|39657175|FG000|Double-blind Treatment|Protocol Violation|0|||
16320062|NCT00791778|39657176|FG001|Double-blind Treatment|Protocol Violation|4|||
16320063|NCT00791778|39657175|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
16320064|NCT00791778|39657176|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
16320065|NCT00791778|39657175|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
16320066|NCT00791778|39657176|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
16320067|NCT00791778|39657175|FG000|Follow-up|Withdrawal by Subject|3|||
16320068|NCT00791778|39657176|FG001|Follow-up|Withdrawal by Subject|0|||
16320069|NCT00791778|39657175|FG000|Follow-up|Lost to Follow-up|2|||
16320070|NCT00791778|39657176|FG001|Follow-up|Lost to Follow-up|1|||
16320071|NCT03018080|39657177|FG000|Overall Study|Death|12|||
16320072|NCT03018080|39657178|FG001|Overall Study|Death|19|||
16320073|NCT00758485|39657189|FG000|Overall Study|Lost to Follow-up|0|||
16320074|NCT00758485|39657190|FG001|Overall Study|Lost to Follow-up|1|||
16320075|NCT00758485|39657189|FG000|Overall Study|Not Treated|1|||
16320076|NCT00758485|39657190|FG001|Overall Study|Not Treated|2|||
16320077|NCT02519348|39657191|FG000|Overall Study|Death|31|||
16320078|NCT02519348|39657192|FG001|Overall Study|Death|74|||
16394253|NCT01463696|39924637|FG005|Overall Study|Lost to Follow-up|0|||
16394254|NCT01463696|39924638|FG006|Overall Study|Lost to Follow-up|0|||
16394255|NCT01463696|39924639|FG007|Overall Study|Lost to Follow-up|0|||
16394256|NCT01463696|39924632|FG000|Overall Study|Progressive Disease|0|||
16394257|NCT01463696|39924633|FG001|Overall Study|Progressive Disease|1|||
16394258|NCT01463696|39924634|FG002|Overall Study|Progressive Disease|0|||
16394259|NCT01463696|39924635|FG003|Overall Study|Progressive Disease|1|||
16394260|NCT01463696|39924636|FG004|Overall Study|Progressive Disease|0|||
16394261|NCT01463696|39924637|FG005|Overall Study|Progressive Disease|1|||
16320079|NCT02519348|39657193|FG002|Overall Study|Death|47|||
16320080|NCT02519348|39657194|FG003|Overall Study|Death|54|||
16320081|NCT02519348|39657195|FG004|Overall Study|Death|63|||
16320082|NCT02519348|39657196|FG005|Overall Study|Death|18|||
16320083|NCT02519348|39657197|FG006|Overall Study|Death|2|||
16394262|NCT01463696|39924638|FG006|Overall Study|Progressive Disease|4|||
16202035|NCT03287245|39215471|FG001|Overall Study|Physician Decision|2|||
16320084|NCT02519348|39657198|FG007|Overall Study|Death|5|||
16320085|NCT02519348|39657199|FG008|Overall Study|Death|5|||
16320086|NCT02519348|39657191|FG000|Overall Study|Withdrawal by Subject|4|||
16320087|NCT02519348|39657192|FG001|Overall Study|Withdrawal by Subject|7|||
16320088|NCT02519348|39657193|FG002|Overall Study|Withdrawal by Subject|4|||
16394263|NCT01463696|39924639|FG007|Overall Study|Progressive Disease|2|||
16394264|NCT01463696|39924632|FG000|Overall Study|Withdrawal by Subject|0|||
16394265|NCT01463696|39924633|FG001|Overall Study|Withdrawal by Subject|0|||
16394266|NCT01463696|39924634|FG002|Overall Study|Withdrawal by Subject|0|||
16394267|NCT01463696|39924635|FG003|Overall Study|Withdrawal by Subject|1|||
16320089|NCT02519348|39657194|FG003|Overall Study|Withdrawal by Subject|3|||
16320090|NCT02519348|39657195|FG004|Overall Study|Withdrawal by Subject|3|||
16320091|NCT02519348|39657196|FG005|Overall Study|Withdrawal by Subject|2|||
16320092|NCT02519348|39657197|FG006|Overall Study|Withdrawal by Subject|0|||
16320093|NCT02519348|39657198|FG007|Overall Study|Withdrawal by Subject|0|||
16320094|NCT02519348|39657199|FG008|Overall Study|Withdrawal by Subject|1|||
16320095|NCT02519348|39657191|FG000|Overall Study|Lost to Follow-up|0|||
16320096|NCT02519348|39657192|FG001|Overall Study|Lost to Follow-up|0|||
16320097|NCT02519348|39657193|FG002|Overall Study|Lost to Follow-up|1|||
16320098|NCT02519348|39657194|FG003|Overall Study|Lost to Follow-up|0|||
16320099|NCT02519348|39657195|FG004|Overall Study|Lost to Follow-up|2|||
16320100|NCT02519348|39657196|FG005|Overall Study|Lost to Follow-up|1|||
16320101|NCT02519348|39657197|FG006|Overall Study|Lost to Follow-up|1|||
16320102|NCT02519348|39657198|FG007|Overall Study|Lost to Follow-up|0|||
16320103|NCT02519348|39657199|FG008|Overall Study|Lost to Follow-up|0|||
16320104|NCT02519348|39657191|FG000|Overall Study|Other|0|||
16320105|NCT02519348|39657192|FG001|Overall Study|Other|3|||
16320106|NCT02519348|39657193|FG002|Overall Study|Other|0|||
16320107|NCT02519348|39657194|FG003|Overall Study|Other|0|||
16394268|NCT01463696|39924636|FG004|Overall Study|Withdrawal by Subject|1|||
16394269|NCT01463696|39924637|FG005|Overall Study|Withdrawal by Subject|1|||
16394270|NCT01463696|39924638|FG006|Overall Study|Withdrawal by Subject|2|||
16394271|NCT01463696|39924639|FG007|Overall Study|Withdrawal by Subject|0|||
16394272|NCT01463696|39924632|FG000|Overall Study|Not Treated|0|||
16394273|NCT01463696|39924633|FG001|Overall Study|Not Treated|0|||
16394274|NCT01463696|39924634|FG002|Overall Study|Not Treated|0|||
16394275|NCT01463696|39924635|FG003|Overall Study|Not Treated|0|||
16394276|NCT01463696|39924636|FG004|Overall Study|Not Treated|0|||
16394277|NCT01463696|39924637|FG005|Overall Study|Not Treated|0|||
16394278|NCT01463696|39924638|FG006|Overall Study|Not Treated|1|||
16394279|NCT01463696|39924639|FG007|Overall Study|Not Treated|0|||
16394280|NCT00282087|39924640|FG000|Overall Study|Death|1|||
16394281|NCT00451958|39924641|FG000|CS21A (NCT00451958)|Adverse Event|21|||
16394282|NCT00451958|39924642|FG001|CS21A (NCT00451958)|Adverse Event|34|||
16320108|NCT02519348|39657195|FG004|Overall Study|Other|1|||
16320109|NCT02519348|39657196|FG005|Overall Study|Other|0|||
16320110|NCT02519348|39657197|FG006|Overall Study|Other|0|||
16320111|NCT02519348|39657198|FG007|Overall Study|Other|0|||
16320112|NCT02519348|39657199|FG008|Overall Study|Other|0|||
16394283|NCT00451958|39924643|FG002|CS21A (NCT00451958)|Adverse Event|14|||
16394284|NCT00451958|39924644|FG003|CS21A (NCT00451958)|Adverse Event|17|||
16394285|NCT00451958|39924645|FG004|CS21A (NCT00451958)|Adverse Event|0|||
16320113|NCT02519348|39657191|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
16320114|NCT02519348|39657192|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
16320115|NCT02519348|39657193|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
16090467|NCT01084772|38823429|FG000|Baseline|Withdrawal by Subject|7|||
16090468|NCT01084772|38823430|FG001|Baseline|Withdrawal by Subject|6|||
16090469|NCT01084772|38823429|FG000|3 Months|Death|1|||
16090470|NCT01084772|38823430|FG001|3 Months|Death|0|||
16090471|NCT01084772|38823429|FG000|3 Months|Study Termination|2|||
16090472|NCT01084772|38823430|FG001|3 Months|Study Termination|2|||
16202036|NCT03287245|39215472|FG002|Overall Study|Physician Decision|0|||
16394286|NCT00451958|39924641|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
16320116|NCT02519348|39657194|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
16320117|NCT02519348|39657195|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
16514503|NCT01701258|40351308|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
16514504|NCT01701258|40351309|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
16514505|NCT01701258|40351310|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
16514506|NCT01701258|40351311|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
16514507|NCT01701258|40351312|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
16514508|NCT01701258|40351313|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
16514509|NCT01701258|40351314|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
16514510|NCT01701258|40351315|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
16202037|NCT03287245|39215473|FG003|Overall Study|Physician Decision|0|||
16202038|NCT01026389|39215474|FG000|Overall Study|Withdrawal by Subject|1|||
16202039|NCT01026389|39215475|FG001|Overall Study|Withdrawal by Subject|3|||
16202040|NCT01026389|39215474|FG000|Overall Study|change of treatment, patient moved|4|||
16202041|NCT01026389|39215475|FG001|Overall Study|change of treatment, patient moved|2|||
16202042|NCT00756886|39215476|FG000|Overall Study|Lost to Follow-up|1|||
16202043|NCT00756886|39215477|FG001|Overall Study|Lost to Follow-up|0|||
16202044|NCT00756886|39215476|FG000|Overall Study|Adverse Event|0|||
16202045|NCT00756886|39215477|FG001|Overall Study|Adverse Event|3|||
16202046|NCT00756886|39215476|FG000|Overall Study|Lack of Efficacy|1|||
16202047|NCT00756886|39215477|FG001|Overall Study|Lack of Efficacy|0|||
16202048|NCT00756886|39215476|FG000|Overall Study|Ineligible|9|||
16202049|NCT00756886|39215477|FG001|Overall Study|Ineligible|4|||
16202050|NCT05101486|39215478|FG000|Overall Study|Death|1|||
16202051|NCT05101486|39215479|FG001|Overall Study|Death|0|||
16320118|NCT02519348|39657196|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
16320119|NCT02519348|39657197|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
16320120|NCT02519348|39657198|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
16514511|NCT01701258|40351316|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
16514512|NCT01701258|40351317|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
16514513|NCT01701258|40351305|FG000|Assessment and Scheduling|Investigator Terminated|2|||
16514514|NCT01701258|40351306|FG001|Assessment and Scheduling|Investigator Terminated|0|||
16514515|NCT01701258|40351307|FG002|Assessment and Scheduling|Investigator Terminated|0|||
16320121|NCT02519348|39657199|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
16514516|NCT01701258|40351308|FG003|Assessment and Scheduling|Investigator Terminated|0|||
16514517|NCT01701258|40351309|FG004|Assessment and Scheduling|Investigator Terminated|0|||
16514518|NCT01701258|40351310|FG005|Assessment and Scheduling|Investigator Terminated|0|||
16514519|NCT01701258|40351311|FG006|Assessment and Scheduling|Investigator Terminated|0|||
16514520|NCT01701258|40351312|FG007|Assessment and Scheduling|Investigator Terminated|0|||
16514521|NCT01701258|40351313|FG008|Assessment and Scheduling|Investigator Terminated|0|||
16514522|NCT01701258|40351314|FG009|Assessment and Scheduling|Investigator Terminated|0|||
16514523|NCT01701258|40351315|FG010|Assessment and Scheduling|Investigator Terminated|0|||
16514524|NCT01701258|40351316|FG011|Assessment and Scheduling|Investigator Terminated|0|||
16514525|NCT01701258|40351317|FG012|Assessment and Scheduling|Investigator Terminated|0|||
16514526|NCT01988571|40351318|FG000|Overall Study|Death|3|||
16320122|NCT00356603|39657200|FG000|Overall Study|Other|6|||
16320123|NCT00356603|39657201|FG001|Overall Study|Other|3|||
16320124|NCT02654977|39657202|FG000|Overall Study|Death|1|||
16320125|NCT02654977|39657202|FG000|Overall Study|Lost to Follow-up|1|||
16320126|NCT02654977|39657202|FG000|Overall Study|Adverse Event|1|||
16320127|NCT02654977|39657202|FG000|Overall Study|Withdrawal by Subject|1|||
16320128|NCT02654977|39657202|FG000|Overall Study|Lack of Efficacy|3|||
16394287|NCT00451958|39924642|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
16514527|NCT01988571|40351319|FG001|Overall Study|Death|1|||
16514528|NCT01988571|40351318|FG000|Overall Study|Physician Decision|2|||
16514529|NCT01988571|40351319|FG001|Overall Study|Physician Decision|1|||
16514530|NCT01988571|40351318|FG000|Overall Study|Lost to Follow-up|3|||
16202052|NCT05101486|39215480|FG002|Overall Study|Death|1|||
16320129|NCT03055338|39657203|FG000|Overall Study|Lost to Follow-up|9|||
16320130|NCT03055338|39657204|FG001|Overall Study|Lost to Follow-up|2|||
16320131|NCT03055338|39657205|FG002|Overall Study|Lost to Follow-up|3|||
16320132|NCT03055338|39657203|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
16320133|NCT03055338|39657204|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
16320134|NCT03055338|39657205|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
16514531|NCT01988571|40351319|FG001|Overall Study|Lost to Follow-up|0|||
16090473|NCT01084772|38823429|FG000|1 Year|Withdrawal by Subject|0|||
16202053|NCT05101486|39215478|FG000|Overall Study|Lost to Follow-up|12|||
16202054|NCT05101486|39215479|FG001|Overall Study|Lost to Follow-up|8|||
16320135|NCT03055338|39657203|FG000|Overall Study|Physician Decision|0|||
16090474|NCT01084772|38823430|FG001|1 Year|Withdrawal by Subject|1|||
16090475|NCT01084772|38823429|FG000|1 Year|Lost to Follow-up|3|||
16320136|NCT03055338|39657204|FG001|Overall Study|Physician Decision|0|||
16320137|NCT03055338|39657205|FG002|Overall Study|Physician Decision|2|||
16320138|NCT03055338|39657203|FG000|Overall Study|Withdrawal by Subject|9|||
16514532|NCT01988571|40351318|FG000|Overall Study|Withdrawal by Subject|31|||
16514533|NCT01988571|40351319|FG001|Overall Study|Withdrawal by Subject|33|||
16514534|NCT02316717|40351320|FG000|Overall Study|Adverse Event|2|||
16514535|NCT02316717|40351321|FG001|Overall Study|Adverse Event|2|||
16202055|NCT05101486|39215480|FG002|Overall Study|Lost to Follow-up|17|||
16320139|NCT03055338|39657204|FG001|Overall Study|Withdrawal by Subject|8|||
16320140|NCT03055338|39657205|FG002|Overall Study|Withdrawal by Subject|7|||
16514536|NCT02316717|40351322|FG002|Overall Study|Adverse Event|0|||
16514537|NCT02316717|40351320|FG000|Overall Study|Lost to Follow-up|1|||
16514538|NCT02316717|40351321|FG001|Overall Study|Lost to Follow-up|2|||
16514539|NCT02316717|40351322|FG002|Overall Study|Lost to Follow-up|1|||
16514540|NCT02316717|40351320|FG000|Overall Study|Non compliance|3|||
16514541|NCT02316717|40351321|FG001|Overall Study|Non compliance|1|||
16514542|NCT02316717|40351322|FG002|Overall Study|Non compliance|0|||
16514543|NCT02316717|40351320|FG000|Overall Study|Protocol Violation|2|||
16514544|NCT02316717|40351321|FG001|Overall Study|Protocol Violation|0|||
16514545|NCT02316717|40351322|FG002|Overall Study|Protocol Violation|0|||
16514546|NCT02316717|40351320|FG000|Overall Study|Withdrawal by Subject|2|||
16514547|NCT02316717|40351321|FG001|Overall Study|Withdrawal by Subject|1|||
16514548|NCT02316717|40351322|FG002|Overall Study|Withdrawal by Subject|1|||
16202056|NCT05101486|39215478|FG000|Overall Study|Physician Decision|1|||
16202057|NCT05101486|39215479|FG001|Overall Study|Physician Decision|0|||
16202058|NCT05101486|39215480|FG002|Overall Study|Physician Decision|0|||
16202059|NCT05101486|39215478|FG000|Overall Study|Protocol Violation|0|||
16202060|NCT05101486|39215479|FG001|Overall Study|Protocol Violation|0|||
16202061|NCT05101486|39215480|FG002|Overall Study|Protocol Violation|1|||
16202062|NCT05101486|39215478|FG000|Overall Study|Withdrawal by Subject|5|||
16090476|NCT01084772|38823430|FG001|1 Year|Lost to Follow-up|0|||
16202063|NCT05101486|39215479|FG001|Overall Study|Withdrawal by Subject|2|||
16202064|NCT05101486|39215480|FG002|Overall Study|Withdrawal by Subject|4|||
16320141|NCT00568061|39657206|FG000|Overall Study|Inclusion / exclusion criteria|5|||
16514549|NCT02316717|40351320|FG000|Overall Study|Death|0|||
16514550|NCT02316717|40351321|FG001|Overall Study|Death|0|||
16320142|NCT00568061|39657207|FG001|Overall Study|Inclusion / exclusion criteria|1|||
16514551|NCT02316717|40351322|FG002|Overall Study|Death|1|||
16514552|NCT02316717|40351320|FG000|Overall Study|Physician Decision|0|||
16320143|NCT00568061|39657206|FG000|Overall Study|Adverse Event|0|||
16514553|NCT02316717|40351321|FG001|Overall Study|Physician Decision|1|||
16514554|NCT02316717|40351322|FG002|Overall Study|Physician Decision|0|||
16320144|NCT00568061|39657207|FG001|Overall Study|Adverse Event|1|||
16320145|NCT02199795|39657208|FG000|Overall Study|no longer met inclusion criteria|1|||
16514555|NCT02316717|40351320|FG000|Overall Study|TBC|1|||
16514556|NCT02316717|40351321|FG001|Overall Study|TBC|0|||
16514557|NCT02316717|40351322|FG002|Overall Study|TBC|0|||
16514558|NCT02920983|40351325|FG000|Dispense 1|Unacceptable Lens Fit|0|||
16514559|NCT02920983|40351326|FG001|Dispense 1|Unacceptable Lens Fit|0|||
16514560|NCT02920983|40351327|FG002|Dispense 1|Unacceptable Lens Fit|0|||
16514561|NCT02920983|40351328|FG003|Dispense 1|Unacceptable Lens Fit|0|||
16514562|NCT02920983|40351329|FG004|Dispense 1|Unacceptable Lens Fit|1|||
16514563|NCT02920983|40351330|FG005|Dispense 1|Unacceptable Lens Fit|0|||
16514564|NCT02920983|40351325|FG000|Dispense 2|Unscceptable lens fit|1|||
16514565|NCT02920983|40351326|FG001|Dispense 2|Unscceptable lens fit|0|||
16514566|NCT02920983|40351327|FG002|Dispense 2|Unscceptable lens fit|0|||
16514567|NCT02920983|40351328|FG003|Dispense 2|Unscceptable lens fit|0|||
16514568|NCT02920983|40351329|FG004|Dispense 2|Unscceptable lens fit|1|||
16514569|NCT02920983|40351330|FG005|Dispense 2|Unscceptable lens fit|0|||
16514570|NCT02920983|40351325|FG000|Dispense 3|Unacceptable Lens Fit|1|||
16514571|NCT02920983|40351326|FG001|Dispense 3|Unacceptable Lens Fit|1|||
16514572|NCT02920983|40351327|FG002|Dispense 3|Unacceptable Lens Fit|0|||
16514573|NCT02920983|40351328|FG003|Dispense 3|Unacceptable Lens Fit|0|||
16514574|NCT02920983|40351329|FG004|Dispense 3|Unacceptable Lens Fit|1|||
16514575|NCT02920983|40351330|FG005|Dispense 3|Unacceptable Lens Fit|0|||
16514576|NCT04587193|40351331|FG000|Overall Study|Screen failure after consent|3|||
16514577|NCT04587193|40351332|FG001|Overall Study|Screen failure after consent|0|||
16514578|NCT04587193|40351331|FG000|Overall Study|Device broke during study|3|||
16514579|NCT04587193|40351332|FG001|Overall Study|Device broke during study|2|||
16090477|NCT01084772|38823429|FG000|1 Year|Study Termination|0|||
16090478|NCT01084772|38823430|FG001|1 Year|Study Termination|7|||
16514580|NCT02474199|40351336|FG000|Overall Study|Lost to Follow-up|1|||
16514581|NCT02474199|40351337|FG001|Overall Study|Lost to Follow-up|0|||
16514582|NCT02474199|40351338|FG002|Overall Study|Lost to Follow-up|0|||
16514583|NCT02474199|40351339|FG003|Overall Study|Lost to Follow-up|0|||
16514584|NCT02474199|40351336|FG000|Overall Study|Withdrawal by Subject|1|||
16514585|NCT02474199|40351337|FG001|Overall Study|Withdrawal by Subject|2|||
16514586|NCT02474199|40351338|FG002|Overall Study|Withdrawal by Subject|0|||
16514587|NCT02474199|40351339|FG003|Overall Study|Withdrawal by Subject|1|||
16514588|NCT02474199|40351336|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
16514589|NCT02474199|40351337|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
16514590|NCT02474199|40351338|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
16514591|NCT02474199|40351339|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
16514592|NCT02474199|40351336|FG000|Overall Study|Did not meet eligibility criteria|0|||
16514593|NCT02474199|40351337|FG001|Overall Study|Did not meet eligibility criteria|0|||
16514594|NCT02474199|40351338|FG002|Overall Study|Did not meet eligibility criteria|2|||
16514595|NCT02474199|40351339|FG003|Overall Study|Did not meet eligibility criteria|2|||
16514596|NCT00578175|40351341|FG000|Overall Study|Adverse Event|0|||
16514597|NCT00578175|40351342|FG001|Overall Study|Adverse Event|1|||
16514598|NCT00578175|40351343|FG002|Overall Study|Adverse Event|1|||
16514599|NCT00578175|40351341|FG000|Overall Study|Other reasons|70|||
16514600|NCT00578175|40351342|FG001|Overall Study|Other reasons|42|||
16514601|NCT00578175|40351343|FG002|Overall Study|Other reasons|23|||
16514602|NCT01857063|40351344|FG000|Period 1 (7 Days)|Adverse Event|0|||
16514603|NCT01857063|40351345|FG001|Period 1 (7 Days)|Adverse Event|1|||
16514604|NCT01857063|40351344|FG000|Period 1 (7 Days)|Physician Decision|1|||
16514605|NCT01857063|40351345|FG001|Period 1 (7 Days)|Physician Decision|0|||
16514606|NCT01857063|40351344|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
16514607|NCT01857063|40351345|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
16514608|NCT01857063|40351344|FG000|Period 2 (7 Days)|Adverse Event|2|||
16514609|NCT01857063|40351345|FG001|Period 2 (7 Days)|Adverse Event|1|||
16514610|NCT01857063|40351344|FG000|Period 2 (7 Days)|Physician Decision|1|||
16514611|NCT01857063|40351345|FG001|Period 2 (7 Days)|Physician Decision|1|||
16514612|NCT01857063|40351344|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
16514613|NCT01857063|40351345|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
16514614|NCT02356783|40351346|FG000|Overall Study|Lost to Follow-up|1|||
16514615|NCT02356783|40351347|FG001|Overall Study|Lost to Follow-up|3|||
16514616|NCT04116710|40351354|FG000|Overall Study|Death|4|||
16514617|NCT04116710|40351355|FG001|Overall Study|Death|6|||
16514618|NCT04116710|40351356|FG002|Overall Study|Death|3|||
16514619|NCT04116710|40351357|FG003|Overall Study|Death|1|||
16514620|NCT04116710|40351354|FG000|Overall Study|Withdrawal by Subject|0|||
16514621|NCT04116710|40351355|FG001|Overall Study|Withdrawal by Subject|0|||
16514622|NCT04116710|40351356|FG002|Overall Study|Withdrawal by Subject|0|||
16514623|NCT04116710|40351357|FG003|Overall Study|Withdrawal by Subject|1|||
16514624|NCT01207778|40351359|FG000|Overall Study|Lost to Follow-up|0|||
16090479|NCT01084772|38823429|FG000|2 Years|Withdrawal by Subject|1|||
16514625|NCT01207778|40351360|FG001|Overall Study|Lost to Follow-up|3|||
16514626|NCT01207778|40351361|FG002|Overall Study|Lost to Follow-up|3|||
16514627|NCT00283439|40351362|FG000|Overall Study|Adverse Event|0|||
16514628|NCT00283439|40351363|FG001|Overall Study|Adverse Event|0|||
16514629|NCT00283439|40351364|FG002|Overall Study|Adverse Event|0|||
16514630|NCT00283439|40351365|FG003|Overall Study|Adverse Event|1|||
16514631|NCT00283439|40351362|FG000|Overall Study|Death|0|||
16514632|NCT00283439|40351363|FG001|Overall Study|Death|0|||
16514633|NCT00283439|40351364|FG002|Overall Study|Death|1|||
16514634|NCT00283439|40351365|FG003|Overall Study|Death|0|||
16514635|NCT00283439|40351362|FG000|Overall Study|Disease progression|0|||
16514636|NCT00283439|40351363|FG001|Overall Study|Disease progression|1|||
16514637|NCT00283439|40351364|FG002|Overall Study|Disease progression|0|||
16514638|NCT00283439|40351365|FG003|Overall Study|Disease progression|0|||
16514639|NCT00283439|40351362|FG000|Overall Study|Requirement for alternative therapy|1|||
16514640|NCT00283439|40351363|FG001|Overall Study|Requirement for alternative therapy|2|||
16514641|NCT00283439|40351364|FG002|Overall Study|Requirement for alternative therapy|5|||
16514642|NCT00283439|40351365|FG003|Overall Study|Requirement for alternative therapy|2|||
16514643|NCT00283439|40351362|FG000|Overall Study|Stem cell transplant|6|||
16514644|NCT00283439|40351363|FG001|Overall Study|Stem cell transplant|6|||
16514645|NCT00283439|40351364|FG002|Overall Study|Stem cell transplant|4|||
16514646|NCT00283439|40351365|FG003|Overall Study|Stem cell transplant|3|||
16514647|NCT00283439|40351362|FG000|Overall Study|Treatment discontinued|0|||
16514648|NCT00283439|40351363|FG001|Overall Study|Treatment discontinued|2|||
16514649|NCT00283439|40351364|FG002|Overall Study|Treatment discontinued|1|||
16514650|NCT00283439|40351365|FG003|Overall Study|Treatment discontinued|3|||
16514651|NCT00283439|40351362|FG000|Overall Study|Other|1|||
16514652|NCT00283439|40351363|FG001|Overall Study|Other|0|||
16514653|NCT00283439|40351364|FG002|Overall Study|Other|0|||
16514654|NCT00283439|40351365|FG003|Overall Study|Other|0|||
16514655|NCT01454934|40351370|FG000|Overall Study|Clinical progression|28|||
16514656|NCT01454934|40351371|FG001|Overall Study|Clinical progression|25|||
16514657|NCT01454934|40351370|FG000|Overall Study|Other|6|||
16514658|NCT01454934|40351371|FG001|Overall Study|Other|17|||
16514659|NCT01454934|40351370|FG000|Overall Study|Adverse Event|28|||
16514660|NCT01454934|40351371|FG001|Overall Study|Adverse Event|24|||
16514661|NCT01454934|40351370|FG000|Overall Study|Withdrawn consent|2|||
16514662|NCT01454934|40351371|FG001|Overall Study|Withdrawn consent|5|||
16514663|NCT01454934|40351370|FG000|Overall Study|Withdrawal by Subject|11|||
16514664|NCT01454934|40351371|FG001|Overall Study|Withdrawal by Subject|15|||
16514665|NCT01454934|40351370|FG000|Overall Study|Disease progression|194|||
16514666|NCT01454934|40351371|FG001|Overall Study|Disease progression|181|||
16514667|NCT01454934|40351370|FG000|Overall Study|Lost to Follow-up|0|||
16514668|NCT01454934|40351371|FG001|Overall Study|Lost to Follow-up|1|||
16514669|NCT01454934|40351370|FG000|Overall Study|Not treated|1|||
16514670|NCT01454934|40351371|FG001|Overall Study|Not treated|2|||
16514671|NCT00600756|40351372|FG000|Analysis After 6 Months|Adverse Event|43|||
16514672|NCT00600756|40351373|FG001|Analysis After 6 Months|Adverse Event|33|||
16514673|NCT00600756|40351372|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
16514674|NCT00600756|40351373|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
16514675|NCT00600756|40351372|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
16514676|NCT00600756|40351373|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
16514677|NCT00600756|40351372|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
16514678|NCT00600756|40351373|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
16514679|NCT00600756|40351372|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
16514680|NCT00600756|40351373|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
16514681|NCT00600756|40351372|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
16514682|NCT00600756|40351373|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
16514683|NCT00600756|40351372|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
16514684|NCT00600756|40351373|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
16514685|NCT00600756|40351372|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
16514686|NCT00600756|40351373|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
16514687|NCT00600756|40351372|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
16514688|NCT00600756|40351373|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
16514689|NCT00600756|40351372|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
16090480|NCT01084772|38823430|FG001|2 Years|Withdrawal by Subject|0|||
16090481|NCT01084772|38823429|FG000|2 Years|Lost to Follow-up|5|||
16090482|NCT01084772|38823430|FG001|2 Years|Lost to Follow-up|2|||
16090483|NCT01084772|38823429|FG000|2 Years|Study Termination|3|||
16090484|NCT01084772|38823430|FG001|2 Years|Study Termination|2|||
16514690|NCT00600756|40351373|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
16514691|NCT00600756|40351372|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
16090485|NCT02644122|38823431|FG000|Overall Study|Withdrawal by Subject|1|||
16514692|NCT00600756|40351373|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
16514693|NCT00600756|40351372|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
16514694|NCT00600756|40351373|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
16514695|NCT00600756|40351372|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
16514696|NCT00600756|40351373|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
16514697|NCT00600756|40351372|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
16514698|NCT00600756|40351373|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
16514699|NCT02547129|40351377|FG000|Overall Study|Difficulty with ongoing infection|1|||
16514700|NCT02547129|40351378|FG001|Overall Study|Difficulty with ongoing infection|0|||
16514701|NCT02797262|40355368|FG000|Overall Study|Withdrawal by Subject|5|||
16514702|NCT02797262|40355369|FG001|Overall Study|Withdrawal by Subject|1|||
16514703|NCT02797262|40355368|FG000|Overall Study|Lost to Follow-up|10|||
16514704|NCT02797262|40355369|FG001|Overall Study|Lost to Follow-up|7|||
16514705|NCT02797262|40355368|FG000|Overall Study|Death|1|||
16514706|NCT02797262|40355369|FG001|Overall Study|Death|2|||
16514707|NCT02797262|40355368|FG000|Overall Study|Adverse Event|1|||
16514708|NCT02797262|40355369|FG001|Overall Study|Adverse Event|0|||
16514709|NCT02797262|40355368|FG000|Overall Study|COVID-19|2|||
16514710|NCT02797262|40355369|FG001|Overall Study|COVID-19|1|||
16514711|NCT02797262|40355368|FG000|Overall Study|Out-of-country|1|||
16514712|NCT02797262|40355369|FG001|Overall Study|Out-of-country|0|||
16514713|NCT02059148|40355372|FG000|Treatment 1|Protocol Violation|0|||
16514714|NCT02059148|40355373|FG001|Treatment 1|Protocol Violation|0|||
16514715|NCT02059148|40355374|FG002|Treatment 1|Protocol Violation|0|||
16514716|NCT02059148|40355375|FG003|Treatment 1|Protocol Violation|0|||
16514717|NCT02059148|40355376|FG004|Treatment 1|Protocol Violation|0|||
16514718|NCT02059148|40355377|FG005|Treatment 1|Protocol Violation|1|||
16514719|NCT04545515|40355381|FG000|Overall Study|Adverse Event|1|||
16514720|NCT04545515|40355381|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
16514721|NCT04545515|40355381|FG000|Overall Study|Commercial drug is available for participant|7|||
16514722|NCT03742141|40355382|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
16514723|NCT02821962|40355383|FG000|Overall Study|Lost to Follow-up|2|||
16514724|NCT02821962|40355384|FG001|Overall Study|Lost to Follow-up|0|||
16514725|NCT01256593|40355385|FG000|Overall Study|Protocol Violation|26|||
16514726|NCT01256593|40355385|FG000|Overall Study|No Drug Administration Information|2|||
16514727|NCT01256593|40355385|FG000|Overall Study|No Visit After Treatment|186|||
16514728|NCT03139916|40355393|FG000|Overall Study|Withdrawal by Subject|2|||
16514729|NCT03139916|40355393|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
16514730|NCT01470469|40355394|FG000|Overall Study|Withdrawal by Subject|4|||
16514731|NCT01470469|40355395|FG001|Overall Study|Withdrawal by Subject|6|||
16514732|NCT01470469|40355394|FG000|Overall Study|Lack of Efficacy|1|||
16514733|NCT01470469|40355395|FG001|Overall Study|Lack of Efficacy|7|||
16514734|NCT01470469|40355394|FG000|Overall Study|Adverse Event|0|||
16514735|NCT01470469|40355395|FG001|Overall Study|Adverse Event|7|||
16514736|NCT01470469|40355394|FG000|Overall Study|Lost to Follow-up|2|||
16514737|NCT01470469|40355395|FG001|Overall Study|Lost to Follow-up|2|||
16514738|NCT01470469|40355394|FG000|Overall Study|Protocol Violation|1|||
16514739|NCT01470469|40355395|FG001|Overall Study|Protocol Violation|1|||
16514740|NCT01470469|40355394|FG000|Overall Study|Other|2|||
16514741|NCT01470469|40355395|FG001|Overall Study|Other|1|||
16514742|NCT02447497|40355396|FG000|Overall Study|Did not meet treatment day baseline.|6|||
16514743|NCT02447497|40355397|FG001|Overall Study|Did not meet treatment day baseline.|5|||
16514744|NCT02447497|40355398|FG002|Overall Study|Did not meet treatment day baseline.|2|||
16514745|NCT02447497|40355399|FG003|Overall Study|Did not meet treatment day baseline.|2|||
16514746|NCT02447497|40355396|FG000|Overall Study|Dressing was compromised|0|||
16514747|NCT02447497|40355397|FG001|Overall Study|Dressing was compromised|1|||
16514748|NCT02447497|40355398|FG002|Overall Study|Dressing was compromised|0|||
16514749|NCT02447497|40355399|FG003|Overall Study|Dressing was compromised|0|||
16514750|NCT02852265|40355400|FG000|3-month Follow-up|Lost to Follow-up|1|||
16514751|NCT02852265|40355401|FG001|3-month Follow-up|Lost to Follow-up|1|||
16514752|NCT01109316|40355403|FG000|Study Period 1|Adverse Event|0|||
16514753|NCT01109316|40355404|FG001|Study Period 1|Adverse Event|0|||
16514754|NCT01109316|40355405|FG002|Study Period 1|Adverse Event|1|||
16514755|NCT01109316|40355406|FG003|Study Period 1|Adverse Event|0|||
16514756|NCT01109316|40355407|FG004|Study Period 1|Adverse Event|0|||
16514757|NCT01109316|40355408|FG005|Study Period 1|Adverse Event|0|||
16514758|NCT01109316|40355403|FG000|Study Period 1|Lost to Follow-up|0|||
16514759|NCT01109316|40355404|FG001|Study Period 1|Lost to Follow-up|0|||
16514760|NCT01109316|40355405|FG002|Study Period 1|Lost to Follow-up|1|||
16514761|NCT01109316|40355406|FG003|Study Period 1|Lost to Follow-up|1|||
16514762|NCT01109316|40355407|FG004|Study Period 1|Lost to Follow-up|0|||
16514763|NCT01109316|40355408|FG005|Study Period 1|Lost to Follow-up|0|||
16514764|NCT01109316|40355403|FG000|Study Period 1|Withdrawal by Subject|0|||
16514765|NCT01109316|40355404|FG001|Study Period 1|Withdrawal by Subject|0|||
16514766|NCT01109316|40355405|FG002|Study Period 1|Withdrawal by Subject|1|||
16514767|NCT01109316|40355406|FG003|Study Period 1|Withdrawal by Subject|0|||
16514768|NCT01109316|40355407|FG004|Study Period 1|Withdrawal by Subject|2|||
16514769|NCT01109316|40355408|FG005|Study Period 1|Withdrawal by Subject|0|||
16514770|NCT01109316|40355403|FG000|Study Period 1|Sponsor Decision|0|||
16514771|NCT01109316|40355404|FG001|Study Period 1|Sponsor Decision|0|||
16514772|NCT01109316|40355405|FG002|Study Period 1|Sponsor Decision|0|||
16514773|NCT01109316|40355406|FG003|Study Period 1|Sponsor Decision|0|||
16514774|NCT01109316|40355407|FG004|Study Period 1|Sponsor Decision|0|||
16514775|NCT01109316|40355408|FG005|Study Period 1|Sponsor Decision|2|||
16514776|NCT01109316|40355403|FG000|Study Period 2|Entry Criteria Not Met|0|||
16514777|NCT01109316|40355404|FG001|Study Period 2|Entry Criteria Not Met|1|||
16514778|NCT01109316|40355405|FG002|Study Period 2|Entry Criteria Not Met|0|||
16514779|NCT01109316|40355406|FG003|Study Period 2|Entry Criteria Not Met|0|||
16514780|NCT01109316|40355407|FG004|Study Period 2|Entry Criteria Not Met|0|||
16514781|NCT01109316|40355408|FG005|Study Period 2|Entry Criteria Not Met|0|||
16514782|NCT01109316|40355403|FG000|Study Period 2|Physician Decision|0|||
16514783|NCT01109316|40355404|FG001|Study Period 2|Physician Decision|0|||
16514784|NCT01109316|40355405|FG002|Study Period 2|Physician Decision|0|||
16514785|NCT01109316|40355406|FG003|Study Period 2|Physician Decision|1|||
16514786|NCT01109316|40355407|FG004|Study Period 2|Physician Decision|0|||
16514787|NCT01109316|40355408|FG005|Study Period 2|Physician Decision|0|||
16514788|NCT01109316|40355403|FG000|Study Period 2|Protocol Violation|1|||
16514789|NCT01109316|40355404|FG001|Study Period 2|Protocol Violation|0|||
16514790|NCT01109316|40355405|FG002|Study Period 2|Protocol Violation|0|||
16514791|NCT01109316|40355406|FG003|Study Period 2|Protocol Violation|0|||
16514792|NCT01109316|40355407|FG004|Study Period 2|Protocol Violation|0|||
16514793|NCT01109316|40355408|FG005|Study Period 2|Protocol Violation|0|||
16514794|NCT01109316|40355403|FG000|Study Period 2|Withdrawal by Subject|0|||
16514795|NCT01109316|40355404|FG001|Study Period 2|Withdrawal by Subject|0|||
16514796|NCT01109316|40355405|FG002|Study Period 2|Withdrawal by Subject|1|||
16514797|NCT01109316|40355406|FG003|Study Period 2|Withdrawal by Subject|0|||
16514798|NCT01109316|40355407|FG004|Study Period 2|Withdrawal by Subject|0|||
16514799|NCT01109316|40355408|FG005|Study Period 2|Withdrawal by Subject|1|||
16514800|NCT01109316|40355403|FG000|Study Period 3|Lost to Follow-up|0|||
16514801|NCT01109316|40355404|FG001|Study Period 3|Lost to Follow-up|0|||
16514802|NCT01109316|40355405|FG002|Study Period 3|Lost to Follow-up|0|||
16514803|NCT01109316|40355406|FG003|Study Period 3|Lost to Follow-up|0|||
16514804|NCT01109316|40355407|FG004|Study Period 3|Lost to Follow-up|1|||
16514805|NCT01109316|40355408|FG005|Study Period 3|Lost to Follow-up|0|||
16514806|NCT01109316|40355403|FG000|Study Period 3|Withdrawal by Subject|1|||
16514807|NCT01109316|40355404|FG001|Study Period 3|Withdrawal by Subject|0|||
16514808|NCT01109316|40355405|FG002|Study Period 3|Withdrawal by Subject|0|||
16514809|NCT01109316|40355406|FG003|Study Period 3|Withdrawal by Subject|0|||
16514810|NCT01109316|40355407|FG004|Study Period 3|Withdrawal by Subject|1|||
16514811|NCT01109316|40355408|FG005|Study Period 3|Withdrawal by Subject|0|||
16514812|NCT01387607|40355409|FG000|Overall Study|Adverse Event|23|||
16514813|NCT01387607|40355410|FG001|Overall Study|Adverse Event|11|||
16514814|NCT01387607|40355409|FG000|Overall Study|Lack of Efficacy|8|||
16514815|NCT01387607|40355410|FG001|Overall Study|Lack of Efficacy|6|||
16514816|NCT01387607|40355409|FG000|Overall Study|Lost to Follow-up|2|||
16514817|NCT01387607|40355410|FG001|Overall Study|Lost to Follow-up|1|||
16514818|NCT01387607|40355409|FG000|Overall Study|No longer meets eligibility criteria|0|||
16514819|NCT01387607|40355410|FG001|Overall Study|No longer meets eligibility criteria|1|||
16514820|NCT01387607|40355409|FG000|Overall Study|Protocol Violation|1|||
16514821|NCT01387607|40355410|FG001|Overall Study|Protocol Violation|5|||
16514822|NCT01387607|40355409|FG000|Overall Study|Withdrawal by Subject|13|||
16514823|NCT01387607|40355410|FG001|Overall Study|Withdrawal by Subject|14|||
16514824|NCT01387607|40355409|FG000|Overall Study|Other|1|||
16514825|NCT01387607|40355410|FG001|Overall Study|Other|1|||
16514826|NCT01387607|40355409|FG000|Overall Study|Randomized, not treated|3|||
16514827|NCT01387607|40355410|FG001|Overall Study|Randomized, not treated|6|||
16514828|NCT00414661|40355411|FG000|Overall Study|Death|2|||
16514829|NCT00414661|40355412|FG001|Overall Study|Death|5|||
16514830|NCT00414661|40355413|FG002|Overall Study|Death|0|||
16514831|NCT00414661|40355414|FG003|Overall Study|Death|0|||
16514832|NCT00414661|40355411|FG000|Overall Study|Lost to Follow-up|1|||
16514833|NCT00414661|40355412|FG001|Overall Study|Lost to Follow-up|4|||
16514834|NCT00414661|40355413|FG002|Overall Study|Lost to Follow-up|0|||
16514835|NCT00414661|40355414|FG003|Overall Study|Lost to Follow-up|1|||
16514836|NCT00414661|40355411|FG000|Overall Study|Withdrawal by Subject|5|||
16514837|NCT00414661|40355412|FG001|Overall Study|Withdrawal by Subject|2|||
16514838|NCT00414661|40355413|FG002|Overall Study|Withdrawal by Subject|2|||
16514839|NCT00414661|40355414|FG003|Overall Study|Withdrawal by Subject|2|||
16514840|NCT00414661|40355411|FG000|Overall Study|Other|6|||
16514841|NCT00414661|40355412|FG001|Overall Study|Other|3|||
16514842|NCT00414661|40355413|FG002|Overall Study|Other|0|||
16514843|NCT00414661|40355414|FG003|Overall Study|Other|0|||
16202065|NCT05101486|39215478|FG000|Overall Study|Randomized but not vaccinated|1|||
16202066|NCT05101486|39215479|FG001|Overall Study|Randomized but not vaccinated|1|||
16202067|NCT05101486|39215480|FG002|Overall Study|Randomized but not vaccinated|1|||
16202068|NCT00166517|39215481|FG000|Overall Study|Lost to Follow-up|1|||
16202069|NCT00166517|39215482|FG001|Overall Study|Lost to Follow-up|0|||
16202070|NCT00166517|39215481|FG000|Overall Study|Protocol Violation|4|||
16202071|NCT00166517|39215482|FG001|Overall Study|Protocol Violation|1|||
16202072|NCT00166517|39215481|FG000|Overall Study|Withdrawal by Subject|0|||
16202073|NCT00166517|39215482|FG001|Overall Study|Withdrawal by Subject|1|||
16202074|NCT03196193|39215489|FG000|Overall Study|Adverse Event|1|||
16202075|NCT03196193|39215490|FG001|Overall Study|Adverse Event|0|||
16202076|NCT03196193|39215489|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
16202077|NCT03196193|39215490|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
16202078|NCT01074658|39215497|FG000|Overall Study|No implant attempted|19|||
16394288|NCT00451958|39924643|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
16394289|NCT00451958|39924644|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
16394290|NCT00451958|39924645|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
16514844|NCT04551898|40355415|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
16202079|NCT03495453|39215498|FG000|Overall Study|Withdrawal by Subject|0|||
16202080|NCT03495453|39215499|FG001|Overall Study|Withdrawal by Subject|1|||
16202081|NCT01071096|39215501|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
16202082|NCT01071096|39215502|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
16202083|NCT03371732|39215503|FG000|Overall Study|Withdrawal by Subject|9|||
16202084|NCT03371732|39215504|FG001|Overall Study|Withdrawal by Subject|3|||
16202085|NCT03371732|39215503|FG000|Overall Study|Refusal to continue|3|||
16202086|NCT03371732|39215504|FG001|Overall Study|Refusal to continue|4|||
16202087|NCT00187889|39215506|FG000|Overall Study|Withdrawal by Subject|6|||
16202088|NCT00187889|39215507|FG001|Overall Study|Withdrawal by Subject|4|||
16202089|NCT04449276|39215508|FG000|Overall Study|Adverse Event|1|||
16202090|NCT04449276|39215509|FG001|Overall Study|Adverse Event|2|||
16202091|NCT04449276|39215510|FG002|Overall Study|Adverse Event|0|||
16320146|NCT02199795|39657209|FG001|Overall Study|no longer met inclusion criteria|0|||
16320147|NCT02199795|39657208|FG000|Overall Study|withdrew due to shoulder pain|1|||
16320148|NCT02199795|39657209|FG001|Overall Study|withdrew due to shoulder pain|0|||
16320149|NCT01372995|39657210|FG000|Overall Study|Spouse withdrew participant from study|0|||
16320150|NCT01372995|39657211|FG001|Overall Study|Spouse withdrew participant from study|1|||
16320151|NCT01372995|39657212|FG002|Overall Study|Spouse withdrew participant from study|0|||
16320152|NCT01372995|39657210|FG000|Overall Study|Physician Decision|0|||
16320153|NCT01372995|39657211|FG001|Overall Study|Physician Decision|0|||
16320154|NCT01372995|39657212|FG002|Overall Study|Physician Decision|1|||
16320155|NCT03759587|39657213|FG000|Overall Study|Adverse Event|5|||
16320156|NCT03759587|39657213|FG000|Overall Study|Progressive Disease|10|||
16320157|NCT03759587|39657213|FG000|Overall Study|Site Terminated by Sponsor|3|||
16320158|NCT03759587|39657213|FG000|Overall Study|Withdrawal by Subject|1|||
16320159|NCT02282631|39657214|FG000|Overall Study|Lost to Follow-up|2|||
16320160|NCT02282631|39657215|FG001|Overall Study|Lost to Follow-up|0|||
16320161|NCT01068730|39657216|FG000|Period 3|Personal reason|1|||
16320162|NCT01068730|39657217|FG001|Period 3|Personal reason|0|||
16320163|NCT01068730|39657218|FG002|Period 3|Personal reason|0|||
16320164|NCT01068730|39657219|FG003|Period 3|Personal reason|0|||
16320165|NCT01068730|39657216|FG000|Period 4|Family emergency|0|||
16320166|NCT01068730|39657217|FG001|Period 4|Family emergency|1|||
16320167|NCT01068730|39657218|FG002|Period 4|Family emergency|0|||
16320168|NCT01068730|39657219|FG003|Period 4|Family emergency|0|||
16320169|NCT03670836|39657220|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
16320170|NCT03670836|39657221|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
16320171|NCT03670836|39657220|FG000|Per Protocol Population (PP)|Physician Decision|9|||
16320172|NCT03670836|39657221|FG001|Per Protocol Population (PP)|Physician Decision|10|||
16320173|NCT03670836|39657220|FG000|Per Protocol Population (PP)|Physician Decision|4|||
16320174|NCT03670836|39657221|FG001|Per Protocol Population (PP)|Physician Decision|6|||
16320175|NCT03670836|39657220|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
16320176|NCT03670836|39657221|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
16320177|NCT02875613|39657222|FG000|Overall Study|Withdrawal by Subject|1|||
16320178|NCT02875613|39657222|FG000|Overall Study|Screen Failure|1|||
16320179|NCT02964507|39657223|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
16320180|NCT02964507|39657224|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
16320181|NCT02964507|39657225|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
16320182|NCT02964507|39657226|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
16320183|NCT02964507|39657227|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
16320184|NCT02964507|39657228|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
16320185|NCT02964507|39657229|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
16320186|NCT02964507|39657230|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
16320187|NCT02964507|39657223|FG000|Overall Study|Study terminated by Sponsor|9|||
16394291|NCT00451958|39924641|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
16394292|NCT00451958|39924642|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
16394293|NCT00451958|39924643|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
16320188|NCT02964507|39657224|FG001|Overall Study|Study terminated by Sponsor|1|||
16320189|NCT02964507|39657225|FG002|Overall Study|Study terminated by Sponsor|9|||
16320190|NCT02964507|39657226|FG003|Overall Study|Study terminated by Sponsor|3|||
16320191|NCT02964507|39657227|FG004|Overall Study|Study terminated by Sponsor|3|||
16320192|NCT02964507|39657228|FG005|Overall Study|Study terminated by Sponsor|2|||
16394294|NCT00451958|39924644|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
16394295|NCT00451958|39924645|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
16394296|NCT00451958|39924641|FG000|CS21A (NCT00451958)|Physician Decision|2|||
16394297|NCT00451958|39924642|FG001|CS21A (NCT00451958)|Physician Decision|4|||
16394298|NCT00451958|39924643|FG002|CS21A (NCT00451958)|Physician Decision|4|||
16394299|NCT00451958|39924644|FG003|CS21A (NCT00451958)|Physician Decision|4|||
16394300|NCT00451958|39924645|FG004|CS21A (NCT00451958)|Physician Decision|0|||
16394301|NCT00451958|39924641|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
16394302|NCT00451958|39924642|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
16394303|NCT00451958|39924643|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
16394304|NCT00451958|39924644|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
16394305|NCT00451958|39924645|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
16394306|NCT00451958|39924641|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
16394307|NCT00451958|39924642|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
16320193|NCT02964507|39657229|FG006|Overall Study|Study terminated by Sponsor|0|||
16320194|NCT02964507|39657230|FG007|Overall Study|Study terminated by Sponsor|0|||
16320195|NCT02964507|39657223|FG000|Overall Study|Other|3|||
16320196|NCT02964507|39657224|FG001|Overall Study|Other|0|||
16320197|NCT02964507|39657225|FG002|Overall Study|Other|0|||
16320198|NCT02964507|39657226|FG003|Overall Study|Other|0|||
16320199|NCT02964507|39657227|FG004|Overall Study|Other|1|||
16320200|NCT02964507|39657228|FG005|Overall Study|Other|0|||
16320201|NCT02964507|39657229|FG006|Overall Study|Other|0|||
16394308|NCT00451958|39924643|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
16394309|NCT00451958|39924644|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
16394310|NCT00451958|39924645|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
16514845|NCT04551898|40355416|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
16514846|NCT04551898|40355417|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
16514847|NCT04551898|40355418|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
16514848|NCT04551898|40355415|FG000|Overall Study|Withdrawal by Subject|5|||
16514849|NCT04551898|40355416|FG001|Overall Study|Withdrawal by Subject|1|||
16514850|NCT04551898|40355417|FG002|Overall Study|Withdrawal by Subject|2|||
16514851|NCT04551898|40355418|FG003|Overall Study|Withdrawal by Subject|2|||
16514852|NCT04551898|40355415|FG000|Overall Study|Lost to Follow-up|2|||
16514853|NCT04551898|40355416|FG001|Overall Study|Lost to Follow-up|1|||
16514854|NCT04551898|40355417|FG002|Overall Study|Lost to Follow-up|2|||
16514855|NCT04551898|40355418|FG003|Overall Study|Lost to Follow-up|2|||
16514856|NCT04551898|40355415|FG000|Overall Study|Death|1|||
16514857|NCT04551898|40355416|FG001|Overall Study|Death|0|||
16514858|NCT04551898|40355417|FG002|Overall Study|Death|0|||
16514859|NCT04551898|40355418|FG003|Overall Study|Death|0|||
16514860|NCT04551898|40355415|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
16514861|NCT04551898|40355416|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
16514862|NCT04551898|40355417|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
16514863|NCT04551898|40355418|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
16514864|NCT01828034|40355421|FG000|Overall Study|Withdrawal by Subject|0|||
16514865|NCT01828034|40355422|FG001|Overall Study|Withdrawal by Subject|0|||
16514866|NCT01828034|40355423|FG002|Overall Study|Withdrawal by Subject|0|||
16514867|NCT01828034|40355424|FG003|Overall Study|Withdrawal by Subject|1|||
16514868|NCT01344447|40355425|FG000|Overall Study|Adverse Event|1|||
16514869|NCT01344447|40355425|FG000|Overall Study|Protocol Violation|1|||
16514870|NCT01344447|40355425|FG000|Overall Study|Withdrawal by Subject|1|||
16514871|NCT01344447|40355425|FG000|Overall Study|The contrast was not seen|1|||
16514872|NCT01344447|40355425|FG000|Overall Study|Physician Decision|1|||
16514873|NCT01344447|40355425|FG000|Overall Study|MRA unsuccessful|1|||
16514874|NCT01344447|40355425|FG000|Overall Study|Bolus tracking failed|1|||
16514875|NCT01344447|40355425|FG000|Overall Study|Error of power injector|1|||
16320202|NCT02964507|39657230|FG007|Overall Study|Other|0|||
16320203|NCT02964507|39657223|FG000|Overall Study|Death|11|||
16394311|NCT03423238|39924653|FG000|Overall Study|Lost to Follow-up|1|||
16394312|NCT03423238|39924654|FG001|Overall Study|Lost to Follow-up|0|||
16514876|NCT02460224|40355426|FG000|Overall Study|Adverse Event|0|||
16514877|NCT02460224|40355427|FG001|Overall Study|Adverse Event|0|||
16514878|NCT02460224|40355428|FG002|Overall Study|Adverse Event|0|||
16514879|NCT02460224|40355429|FG003|Overall Study|Adverse Event|0|||
16514880|NCT02460224|40355430|FG004|Overall Study|Adverse Event|0|||
16514881|NCT02460224|40355431|FG005|Overall Study|Adverse Event|0|||
16320204|NCT02964507|39657224|FG001|Overall Study|Death|9|||
16320205|NCT02964507|39657225|FG002|Overall Study|Death|12|||
16320206|NCT02964507|39657226|FG003|Overall Study|Death|2|||
16320207|NCT02964507|39657227|FG004|Overall Study|Death|10|||
16320208|NCT02964507|39657228|FG005|Overall Study|Death|5|||
16320209|NCT02964507|39657229|FG006|Overall Study|Death|0|||
16320210|NCT02964507|39657230|FG007|Overall Study|Death|0|||
16320211|NCT02964507|39657223|FG000|Overall Study|Withdrawal by Subject|1|||
16320212|NCT02964507|39657224|FG001|Overall Study|Withdrawal by Subject|0|||
16320213|NCT02964507|39657225|FG002|Overall Study|Withdrawal by Subject|1|||
16320214|NCT02964507|39657226|FG003|Overall Study|Withdrawal by Subject|1|||
16320215|NCT02964507|39657227|FG004|Overall Study|Withdrawal by Subject|0|||
16320216|NCT02964507|39657228|FG005|Overall Study|Withdrawal by Subject|1|||
16320217|NCT02964507|39657229|FG006|Overall Study|Withdrawal by Subject|0|||
16320218|NCT02964507|39657230|FG007|Overall Study|Withdrawal by Subject|0|||
16320219|NCT02964507|39657223|FG000|Overall Study|Physician Decision|2|||
16320220|NCT02964507|39657224|FG001|Overall Study|Physician Decision|0|||
16320221|NCT02964507|39657225|FG002|Overall Study|Physician Decision|3|||
16320222|NCT02964507|39657226|FG003|Overall Study|Physician Decision|0|||
16320223|NCT02964507|39657227|FG004|Overall Study|Physician Decision|1|||
16320224|NCT02964507|39657228|FG005|Overall Study|Physician Decision|0|||
16320225|NCT02964507|39657229|FG006|Overall Study|Physician Decision|0|||
16320226|NCT02964507|39657230|FG007|Overall Study|Physician Decision|0|||
16320227|NCT03728426|39657231|FG000|Overall Study|Death|3|||
16320228|NCT01592786|39657234|FG000|Overall Study|Adverse Event|60|||
16320229|NCT01592786|39657234|FG000|Overall Study|Lack of Efficacy|19|||
16320230|NCT01592786|39657234|FG000|Overall Study|Protocol Violation|14|||
16320231|NCT01592786|39657234|FG000|Overall Study|Withdrawal by Subject|23|||
16320232|NCT01592786|39657234|FG000|Overall Study|Lost to Follow-up|19|||
16320233|NCT01592786|39657234|FG000|Overall Study|Other|3|||
16320234|NCT02737930|39657235|FG000|Overall Study|Withdrawal by Subject|0|||
16320235|NCT02737930|39657236|FG001|Overall Study|Withdrawal by Subject|1|||
16320236|NCT04112043|39657237|FG000|Overall Study|Withdrawal by Subject|1|||
16320237|NCT04112043|39657238|FG001|Overall Study|Withdrawal by Subject|1|||
16320238|NCT04112043|39657239|FG002|Overall Study|Withdrawal by Subject|1|||
16320239|NCT04112043|39657237|FG000|Overall Study|Taking NR supplement|1|||
16320240|NCT04112043|39657238|FG001|Overall Study|Taking NR supplement|0|||
16320241|NCT04112043|39657239|FG002|Overall Study|Taking NR supplement|0|||
16320242|NCT04112043|39657237|FG000|Overall Study|Adverse Event|0|||
16320243|NCT04112043|39657238|FG001|Overall Study|Adverse Event|1|||
16320244|NCT04112043|39657239|FG002|Overall Study|Adverse Event|0|||
16320245|NCT02492984|39657240|FG000|Overall Study|Adverse Event|1|||
16320246|NCT02492984|39657241|FG001|Overall Study|Adverse Event|0|||
16320247|NCT02492984|39657240|FG000|Overall Study|Protocol Violation|1|||
16320248|NCT02492984|39657241|FG001|Overall Study|Protocol Violation|0|||
16320249|NCT02492984|39657240|FG000|Overall Study|Withdrawal by Subject|1|||
16320250|NCT02492984|39657241|FG001|Overall Study|Withdrawal by Subject|0|||
16320251|NCT00427648|39657247|FG000|Overall Study|Protocol Violation|1|||
16320252|NCT00427648|39657248|FG001|Overall Study|Protocol Violation|2|||
16320253|NCT00427648|39657247|FG000|Overall Study|Adverse Event|0|||
16320254|NCT00427648|39657248|FG001|Overall Study|Adverse Event|1|||
16320255|NCT00464490|39657251|FG000|Overall Study|Physician Decision|11|||
16320256|NCT00464490|39657252|FG001|Overall Study|Physician Decision|11|||
16320257|NCT01470248|39657259|FG000|Overall Study|Withdrawal by Subject|1|||
16320258|NCT02589626|39657263|FG000|Overall Study|Other than the reason specified|1|||
16320259|NCT02589626|39657264|FG001|Overall Study|Other than the reason specified|0|||
16320260|NCT02589626|39657263|FG000|Overall Study|Withdrawal by Subject|1|||
16320261|NCT02589626|39657264|FG001|Overall Study|Withdrawal by Subject|1|||
16320262|NCT02589626|39657263|FG000|Overall Study|Adverse Event|1|||
16320263|NCT02589626|39657264|FG001|Overall Study|Adverse Event|1|||
16320264|NCT00441129|39657265|FG000|Overall Study|Withdrawal by Subject|6|||
16320265|NCT00441129|39657266|FG001|Overall Study|Withdrawal by Subject|14|||
16320266|NCT00485732|39657271|FG000|Overall Study|Protocol Violation|1|||
16320267|NCT00485732|39657272|FG001|Overall Study|Protocol Violation|3|||
16320268|NCT00485732|39657271|FG000|Overall Study|Withdrawal by Subject|5|||
16320269|NCT00485732|39657272|FG001|Overall Study|Withdrawal by Subject|4|||
16320270|NCT00485732|39657271|FG000|Overall Study|Lost to Follow-up|2|||
16320271|NCT00485732|39657272|FG001|Overall Study|Lost to Follow-up|2|||
16320272|NCT00458536|39657278|FG000|Overall Study|Disease progression prior to treatment|7|||
16320273|NCT00458536|39657278|FG000|Overall Study|Unable to make vaccine|3|||
16320274|NCT00458536|39657278|FG000|Overall Study|No measurable disease after surgery|2|||
16320275|NCT00458536|39657278|FG000|Overall Study|Did not have renal cell carcinoma|2|||
16320276|NCT00458536|39657278|FG000|Overall Study|Patient did not have surgery|1|||
16514882|NCT02460224|40355432|FG006|Overall Study|Adverse Event|1|||
16320277|NCT00458536|39657278|FG000|Overall Study|Ineligible due to toxicity|1|||
16320278|NCT00458536|39657278|FG000|Overall Study|Withdrawal by Subject|1|||
16320279|NCT00458536|39657278|FG000|Overall Study|Progressive disease during treatment|2|||
16320280|NCT04967885|39657283|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
16320281|NCT04967885|39657284|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
16394313|NCT03423238|39924653|FG000|Overall Study|Withdrawal by Subject|1|||
16394314|NCT03423238|39924654|FG001|Overall Study|Withdrawal by Subject|0|||
16394315|NCT00391053|39924657|FG000|Overall Study|Serious Adverse Events|1|||
16394316|NCT00391053|39924658|FG001|Overall Study|Serious Adverse Events|0|||
16394317|NCT00391053|39924659|FG002|Overall Study|Serious Adverse Events|1|||
16394318|NCT00391053|39924660|FG003|Overall Study|Serious Adverse Events|4|||
16394319|NCT00391053|39924657|FG000|Overall Study|Protocol Violation|2|||
16394320|NCT00391053|39924658|FG001|Overall Study|Protocol Violation|0|||
16394321|NCT00391053|39924659|FG002|Overall Study|Protocol Violation|0|||
16394322|NCT00391053|39924660|FG003|Overall Study|Protocol Violation|0|||
16320282|NCT04967885|39657283|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
16320283|NCT04967885|39657284|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
16320284|NCT04967885|39657283|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
16320285|NCT04967885|39657284|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
16320286|NCT04967885|39657283|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
16320287|NCT04967885|39657284|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
16320288|NCT04967885|39657283|FG000|EMI-II Intervention|Lost to Follow-up|14|||
16320289|NCT04967885|39657284|FG001|EMI-II Intervention|Lost to Follow-up|10|||
16320290|NCT03588910|39657293|FG000|Overall Study|Withdrawal by Subject|1|||
16320291|NCT03588910|39657294|FG001|Overall Study|Withdrawal by Subject|0|||
16394323|NCT00391053|39924657|FG000|Overall Study|Lost to Follow-up|1|||
16394324|NCT00391053|39924658|FG001|Overall Study|Lost to Follow-up|0|||
16394325|NCT00391053|39924659|FG002|Overall Study|Lost to Follow-up|0|||
16394326|NCT00391053|39924660|FG003|Overall Study|Lost to Follow-up|5|||
16394327|NCT00391053|39924657|FG000|Overall Study|Withdrawal by Subject|5|||
16394328|NCT00391053|39924658|FG001|Overall Study|Withdrawal by Subject|1|||
16394329|NCT00391053|39924659|FG002|Overall Study|Withdrawal by Subject|1|||
16394330|NCT00391053|39924660|FG003|Overall Study|Withdrawal by Subject|1|||
16394331|NCT00705250|39924661|FG000|Overall Study|Withdrawal by Subject|1|||
16394332|NCT00705250|39924661|FG000|Overall Study|Patient died in car accident|1|||
16394333|NCT00326001|39924664|FG000|Overall Study|Adverse Event|4|||
16394334|NCT00326001|39924665|FG001|Overall Study|Adverse Event|5|||
16394335|NCT00326001|39924664|FG000|Overall Study|Physician Decision|3|||
16394336|NCT00326001|39924665|FG001|Overall Study|Physician Decision|3|||
16394337|NCT03799952|39924668|FG000|Overall Study|Program was too easy, discontinued|1|||
16394338|NCT03799952|39924669|FG001|Overall Study|Program was too easy, discontinued|0|||
16394339|NCT03799952|39924668|FG000|Overall Study|Lost to Follow-up|0|||
16394340|NCT03799952|39924669|FG001|Overall Study|Lost to Follow-up|2|||
16394341|NCT02688192|39924671|FG000|Overall Study|Lost to Follow-up|11|||
16394342|NCT02688192|39924672|FG001|Overall Study|Lost to Follow-up|5|||
16394343|NCT02688192|39924671|FG000|Overall Study|Physician Decision|1|||
16394344|NCT02688192|39924672|FG001|Overall Study|Physician Decision|0|||
16394345|NCT00703846|39924673|FG000|Overall Study|Adverse Event|8|||
16394346|NCT00703846|39924673|FG000|Overall Study|Lost to Follow-up|55|||
16394347|NCT00703846|39924673|FG000|Overall Study|Lack of Efficacy|15|||
16394348|NCT00703846|39924673|FG000|Overall Study|Noncompliance with Study Treatment|2|||
16394349|NCT00703846|39924673|FG000|Overall Study|Withdrawal by Subject|40|||
16394350|NCT00703846|39924673|FG000|Overall Study|Death|1|||
16394351|NCT00703846|39924673|FG000|Overall Study|Other|14|||
16394352|NCT00703846|39924673|FG000|Overall Study|Did Not Receive Study Drug|2|||
16394353|NCT01232127|39924677|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
16394354|NCT01232127|39924678|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
16394355|NCT01232127|39924679|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
16394356|NCT02298868|39924680|FG000|Overall Study|Adverse Event|1|||
16394357|NCT02298868|39924680|FG000|Overall Study|Death|1|||
16394358|NCT02298868|39924680|FG000|Overall Study|Patient underwent transplant|1|||
16394359|NCT02391311|39924681|FG000|Overall Study|Lost to Follow-up|2|||
16394360|NCT02391311|39924682|FG001|Overall Study|Lost to Follow-up|1|||
16394361|NCT02391311|39924681|FG000|Overall Study|deemed ineligible after baseline|1|||
16394362|NCT02391311|39924682|FG001|Overall Study|deemed ineligible after baseline|1|||
16394363|NCT01234480|39924684|FG000|Overall Study|Pregnancy|88|||
16394364|NCT01234480|39924684|FG000|Overall Study|>36/Normal History|50|||
16394365|NCT01234480|39924684|FG000|Overall Study|Age|3|||
16394366|NCT01234480|39924684|FG000|Overall Study|HPV Vaccine History|28|||
16394367|NCT01234480|39924684|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
16394368|NCT01234480|39924684|FG000|Overall Study|Hysterectomy|2|||
16394369|NCT01234480|39924684|FG000|Overall Study|Hysterectomy post enrollment|1|||
16394370|NCT01234480|39924684|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
16394371|NCT01234480|39924684|FG000|Overall Study|Informed Consent Form Violation|30|||
16090486|NCT03029585|38823439|FG000|Overall Study|Death|1|||
16090487|NCT03029585|38823440|FG001|Overall Study|Death|1|||
16394372|NCT01234480|39924684|FG000|Overall Study|Incorrect Visit|3|||
16394373|NCT01234480|39924684|FG000|Overall Study|No Florida Lab License|20|||
16090488|NCT03029585|38823439|FG000|Overall Study|Withdrawal by Subject|1|||
16394374|NCT01234480|39924684|FG000|Overall Study|Out of Window|42|||
16394375|NCT01234480|39924684|FG000|Overall Study|Sample Processing/Storage|92|||
16394376|NCT01234480|39924684|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
16394377|NCT01234480|39924684|FG000|Overall Study|Site/Subject non-compliance|44|||
16394378|NCT01234480|39924684|FG000|Overall Study|Missing Sample|9|||
16394379|NCT03374358|39924685|FG000|Overall Study|Withdrawal by Subject|0|||
16394380|NCT03374358|39924686|FG001|Overall Study|Withdrawal by Subject|2|||
16394381|NCT01220401|39924687|FG000|Overall Study|Withdrawal by Subject|2|||
16394382|NCT01220401|39924687|FG000|Overall Study|Protocol Violation|1|||
16394383|NCT02336815|39924690|FG000|Overall Study|Disease Progression|45|||
16394384|NCT02336815|39924691|FG001|Overall Study|Disease Progression|70|||
16394385|NCT02336815|39924690|FG000|Overall Study|Adverse Event|18|||
16394386|NCT02336815|39924691|FG001|Overall Study|Adverse Event|39|||
16394387|NCT02336815|39924690|FG000|Overall Study|Physician Decision|11|||
16394388|NCT02336815|39924691|FG001|Overall Study|Physician Decision|4|||
16394389|NCT02336815|39924690|FG000|Overall Study|Withdrawal by Subject|3|||
16394390|NCT02336815|39924691|FG001|Overall Study|Withdrawal by Subject|2|||
16394391|NCT02336815|39924690|FG000|Overall Study|Lost to Follow-up|1|||
16394392|NCT02336815|39924691|FG001|Overall Study|Lost to Follow-up|3|||
16394393|NCT02336815|39924690|FG000|Overall Study|Other|1|||
16394394|NCT02336815|39924691|FG001|Overall Study|Other|5|||
16394395|NCT01673646|39924692|FG000|Overall Study|Adverse Event|2|||
16394396|NCT01673646|39924693|FG001|Overall Study|Adverse Event|1|||
16394397|NCT01673646|39924694|FG002|Overall Study|Adverse Event|1|||
16394398|NCT01673646|39924692|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16394399|NCT01673646|39924693|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16320292|NCT03588910|39657293|FG000|Overall Study|Allergy|2|||
16320293|NCT03588910|39657294|FG001|Overall Study|Allergy|0|||
16320294|NCT03588910|39657293|FG000|Overall Study|Protocol Violation|0|||
16320295|NCT03588910|39657294|FG001|Overall Study|Protocol Violation|3|||
16320296|NCT03588910|39657293|FG000|Overall Study|Did not complete Day 1 Survey|5|||
16320297|NCT03588910|39657294|FG001|Overall Study|Did not complete Day 1 Survey|10|||
16320298|NCT03588910|39657293|FG000|Overall Study|Did not complete Day 7 Survey|5|||
16320299|NCT03588910|39657294|FG001|Overall Study|Did not complete Day 7 Survey|2|||
16320300|NCT02155283|39657297|FG000|Overall Study|Lost to Follow-up|3|||
16320301|NCT02155283|39657297|FG000|Overall Study|Withdrawal by Subject|1|||
16320302|NCT02155283|39657297|FG000|Overall Study|Protocol Violation|3|||
16320303|NCT02122887|39657298|FG000|Overall Study|Withdrawal by Subject|20|||
16320304|NCT02122887|39657299|FG001|Overall Study|Withdrawal by Subject|2|||
16320305|NCT00178685|39657303|FG000|Overall Study|Death|3|||
16320306|NCT00178685|39657304|FG001|Overall Study|Death|3|||
16320307|NCT00178685|39657305|FG002|Overall Study|Death|6|||
16320308|NCT00178685|39657303|FG000|Overall Study|Lost to Follow-up|100|||
16320309|NCT00178685|39657304|FG001|Overall Study|Lost to Follow-up|187|||
16320310|NCT00178685|39657305|FG002|Overall Study|Lost to Follow-up|183|||
16320311|NCT00178685|39657303|FG000|Overall Study|Withdrawal by Subject|8|||
16320312|NCT00178685|39657304|FG001|Overall Study|Withdrawal by Subject|14|||
16320313|NCT00178685|39657305|FG002|Overall Study|Withdrawal by Subject|7|||
16320314|NCT01177293|39657309|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
16394400|NCT01673646|39924694|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16394401|NCT01673646|39924692|FG000|Overall Study|Condition no longer requires study drug|0|||
16394402|NCT01673646|39924693|FG001|Overall Study|Condition no longer requires study drug|1|||
16394403|NCT01673646|39924694|FG002|Overall Study|Condition no longer requires study drug|0|||
16394404|NCT01673646|39924692|FG000|Overall Study|Withdrawal by Subject|0|||
16394405|NCT01673646|39924693|FG001|Overall Study|Withdrawal by Subject|2|||
16394406|NCT01673646|39924694|FG002|Overall Study|Withdrawal by Subject|2|||
16394407|NCT01673646|39924692|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
16394408|NCT01673646|39924693|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
16394409|NCT01673646|39924694|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
16394410|NCT03835481|39924696|FG000|Double-blind Period|Other not stated below|0|||
16394411|NCT03835481|39924697|FG001|Double-blind Period|Other not stated below|0|||
16320315|NCT01177293|39657310|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
16320316|NCT01582854|39657311|FG000|Overall Study|Death|8|||
16394412|NCT03835481|39924698|FG002|Double-blind Period|Other not stated below|0|||
16394413|NCT03835481|39924699|FG003|Double-blind Period|Other not stated below|1|||
16394414|NCT03835481|39924700|FG004|Double-blind Period|Other not stated below|1|||
16394415|NCT03835481|39924696|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
16394416|NCT03835481|39924697|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
16394417|NCT03835481|39924698|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
16320317|NCT01582854|39657312|FG001|Overall Study|Death|5|||
16394418|NCT03835481|39924699|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
16394419|NCT03835481|39924700|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
16394420|NCT03835481|39924696|FG000|Double-blind Period|Withdrawal by Subject|0|||
16320318|NCT01582854|39657311|FG000|Overall Study|Adverse Event|2|||
16320319|NCT01582854|39657312|FG001|Overall Study|Adverse Event|3|||
16320320|NCT01582854|39657311|FG000|Overall Study|Withdrawal by Participant|8|||
16320321|NCT01582854|39657312|FG001|Overall Study|Withdrawal by Participant|11|||
16320322|NCT01582854|39657311|FG000|Overall Study|Lost to Follow-up|1|||
16320323|NCT01582854|39657312|FG001|Overall Study|Lost to Follow-up|2|||
16320324|NCT01582854|39657311|FG000|Overall Study|Physician Decision|0|||
16320325|NCT01582854|39657312|FG001|Overall Study|Physician Decision|1|||
16320326|NCT01582854|39657311|FG000|Overall Study|Recurrent Stroke|13|||
16320327|NCT01582854|39657312|FG001|Overall Study|Recurrent Stroke|8|||
16320328|NCT01582854|39657311|FG000|Overall Study|Disallowed Concomitant Medication|3|||
16320329|NCT01582854|39657312|FG001|Overall Study|Disallowed Concomitant Medication|2|||
16320330|NCT01582854|39657311|FG000|Overall Study|Carotid or Neurosurgery|0|||
16320331|NCT01582854|39657312|FG001|Overall Study|Carotid or Neurosurgery|1|||
16320332|NCT01582854|39657311|FG000|Overall Study|General Anaesthesia|0|||
16320333|NCT01582854|39657312|FG001|Overall Study|General Anaesthesia|1|||
16320334|NCT01582854|39657311|FG000|Overall Study|Other Miscellaneous Reason|1|||
16320335|NCT01582854|39657312|FG001|Overall Study|Other Miscellaneous Reason|0|||
16320336|NCT03412734|39657313|FG000|Overall Study|Incorrect labeling of samples|2|||
16320337|NCT03412734|39657314|FG001|Overall Study|Incorrect labeling of samples|0|||
16320338|NCT03412734|39657313|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
16320339|NCT03412734|39657314|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
16320340|NCT03512210|39657316|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
16320341|NCT03512210|39657316|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
16320342|NCT03512210|39657316|FG000|Step 2:Post-MINMON|Death|2|||
16320343|NCT03512210|39657316|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
16320344|NCT03512210|39657316|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
16320345|NCT02201108|39657323|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
16320346|NCT02201108|39657324|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
16320347|NCT02201108|39657323|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
16320348|NCT02201108|39657324|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
16320349|NCT02201108|39657323|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
16320350|NCT02201108|39657324|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
16320351|NCT02201108|39657323|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
16320352|NCT02201108|39657324|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
16320353|NCT02201108|39657323|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
16320354|NCT02201108|39657324|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
16320355|NCT02201108|39657323|FG000|Open Label Period (up to Week 192)|Other reason|4|||
16320356|NCT02201108|39657324|FG001|Open Label Period (up to Week 192)|Other reason|7|||
16320357|NCT02201108|39657323|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
16320358|NCT02201108|39657324|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
16320359|NCT01841762|39657325|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
16320360|NCT01841762|39657325|FG000|Treatment Period|Adverse Event|16|||
16320361|NCT01841762|39657325|FG000|Treatment Period|Death|1|||
16320362|NCT01841762|39657325|FG000|Treatment Period|Withdrawal by Subject|7|||
16320363|NCT01841762|39657325|FG000|Treatment Period|Lost to Follow-up|1|||
16320364|NCT01841762|39657325|FG000|Treatment Period|Physician Decision|2|||
16320365|NCT01841762|39657325|FG000|Treatment Period|Other, including non-compliance|5|||
16320366|NCT01841762|39657325|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
16320367|NCT01841762|39657325|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
16320368|NCT01841762|39657325|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
16320369|NCT01841762|39657325|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
16320370|NCT02596971|39657326|FG000|Overall Study|Death|5|||
16320371|NCT02596971|39657327|FG001|Overall Study|Death|1|||
16320372|NCT02596971|39657328|FG002|Overall Study|Death|5|||
16320373|NCT02596971|39657326|FG000|Overall Study|Withdrawal by Subject|5|||
16320374|NCT02596971|39657327|FG001|Overall Study|Withdrawal by Subject|1|||
16320375|NCT02596971|39657328|FG002|Overall Study|Withdrawal by Subject|4|||
16320376|NCT05966584|39657329|FG000|Overall Study|Lost to Follow-up|1|||
16320377|NCT01682226|39657330|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
16320378|NCT01682226|39657330|FG000|Overall Study|Participants did not receive treatment|2|||
16320379|NCT01682226|39657330|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
16320380|NCT01623310|39657356|FG000|Overall Study|Adverse Event|21|||
16320381|NCT01623310|39657356|FG000|Overall Study|Lost to Follow-up|18|||
16320382|NCT01623310|39657356|FG000|Overall Study|Lack of Efficacy|6|||
16320383|NCT01623310|39657356|FG000|Overall Study|Protocol Violation|6|||
16320384|NCT01623310|39657356|FG000|Overall Study|Withdrawal by Subject|25|||
16320385|NCT01623310|39657356|FG000|Overall Study|Became potentially child-bearing|1|||
16320386|NCT01623310|39657356|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
16320387|NCT01623310|39657356|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
16320388|NCT03020992|39657360|FG000|Overall Study|Adverse Event|5|||
16320389|NCT03020992|39657360|FG000|Overall Study|Withdrawal by Subject|1|||
16320390|NCT04498182|39657363|FG000|Overall Study|Adverse Event|2|||
16320391|NCT04498182|39657364|FG001|Overall Study|Adverse Event|3|||
16320392|NCT04498182|39657365|FG002|Overall Study|Adverse Event|2|||
16320393|NCT04498182|39657363|FG000|Overall Study|Withdrawal of Consent|3|||
16320394|NCT04498182|39657364|FG001|Overall Study|Withdrawal of Consent|4|||
16320395|NCT04498182|39657365|FG002|Overall Study|Withdrawal of Consent|3|||
16320396|NCT04498182|39657363|FG000|Overall Study|Non-Compliant|1|||
16320397|NCT04498182|39657364|FG001|Overall Study|Non-Compliant|0|||
16320398|NCT04498182|39657365|FG002|Overall Study|Non-Compliant|1|||
16320399|NCT04498182|39657363|FG000|Overall Study|Lost to Follow-up|0|||
16320400|NCT04498182|39657364|FG001|Overall Study|Lost to Follow-up|0|||
16320401|NCT04498182|39657365|FG002|Overall Study|Lost to Follow-up|1|||
16320402|NCT04498182|39657363|FG000|Overall Study|Investigator Decision|0|||
16320403|NCT04498182|39657364|FG001|Overall Study|Investigator Decision|0|||
16320404|NCT04498182|39657365|FG002|Overall Study|Investigator Decision|1|||
16320405|NCT04498182|39657363|FG000|Overall Study|Protocol Violation|1|||
16320406|NCT04498182|39657364|FG001|Overall Study|Protocol Violation|0|||
16320407|NCT04498182|39657365|FG002|Overall Study|Protocol Violation|2|||
16320408|NCT03278613|39657368|FG000|Overall Study|Lost to Follow-up|3|||
16320409|NCT03278613|39657369|FG001|Overall Study|Lost to Follow-up|1|||
16320410|NCT02525783|39657371|FG000|Overall Study|Lost to Follow-up|10|||
16320411|NCT00931528|39657372|FG000|Overall Study|Protocol Violation|9|||
16320412|NCT00931528|39657373|FG001|Overall Study|Protocol Violation|12|||
16320413|NCT00931528|39657372|FG000|Overall Study|Withdrawal by Subject|4|||
16320414|NCT00931528|39657373|FG001|Overall Study|Withdrawal by Subject|12|||
16320415|NCT00931528|39657372|FG000|Overall Study|Lost to Follow-up|6|||
16320416|NCT00931528|39657373|FG001|Overall Study|Lost to Follow-up|13|||
16320417|NCT00931528|39657372|FG000|Overall Study|Assessment outside of Time Frame|22|||
16394421|NCT03835481|39924697|FG001|Double-blind Period|Withdrawal by Subject|0|||
16514883|NCT02460224|40355433|FG007|Overall Study|Adverse Event|0|||
16514884|NCT02460224|40355434|FG008|Overall Study|Adverse Event|0|||
16514885|NCT02460224|40355435|FG009|Overall Study|Adverse Event|0|||
16514886|NCT02460224|40355436|FG010|Overall Study|Adverse Event|0|||
16514887|NCT02460224|40355437|FG011|Overall Study|Adverse Event|0|||
16514888|NCT02460224|40355438|FG012|Overall Study|Adverse Event|1|||
16514889|NCT02460224|40355439|FG013|Overall Study|Adverse Event|0|||
16514890|NCT02460224|40355440|FG014|Overall Study|Adverse Event|0|||
16514891|NCT02460224|40355441|FG015|Overall Study|Adverse Event|0|||
16514892|NCT02460224|40355442|FG016|Overall Study|Adverse Event|1|||
16514893|NCT02460224|40355443|FG017|Overall Study|Adverse Event|0|||
16514894|NCT02460224|40355444|FG018|Overall Study|Adverse Event|1|||
16514895|NCT02460224|40355445|FG019|Overall Study|Adverse Event|0|||
16514896|NCT02460224|40355446|FG020|Overall Study|Adverse Event|1|||
16514897|NCT02460224|40355447|FG021|Overall Study|Adverse Event|1|||
16514898|NCT02460224|40355448|FG022|Overall Study|Adverse Event|1|||
16514899|NCT02460224|40355449|FG023|Overall Study|Adverse Event|0|||
16514900|NCT02460224|40355450|FG024|Overall Study|Adverse Event|0|||
16514901|NCT02460224|40355451|FG025|Overall Study|Adverse Event|0|||
16514902|NCT02460224|40355452|FG026|Overall Study|Adverse Event|11|||
16514903|NCT02460224|40355453|FG027|Overall Study|Adverse Event|1|||
16320418|NCT00931528|39657373|FG001|Overall Study|Assessment outside of Time Frame|23|||
16320419|NCT02612623|39657375|FG000|Overall Study|Withdrawal by Subject|0|||
16320420|NCT02612623|39657376|FG001|Overall Study|Withdrawal by Subject|1|||
16320421|NCT02612623|39657377|FG002|Overall Study|Withdrawal by Subject|0|||
16320422|NCT02612623|39657378|FG003|Overall Study|Withdrawal by Subject|0|||
16320423|NCT02612623|39657375|FG000|Overall Study|Adverse Event|1|||
16320424|NCT02612623|39657376|FG001|Overall Study|Adverse Event|0|||
16320425|NCT02612623|39657377|FG002|Overall Study|Adverse Event|1|||
16320426|NCT02612623|39657378|FG003|Overall Study|Adverse Event|0|||
16320427|NCT02237196|39657379|FG000|Overall Study|Adverse Event|0|||
16090489|NCT03029585|38823440|FG001|Overall Study|Withdrawal by Subject|0|||
16202092|NCT04449276|39215511|FG003|Overall Study|Adverse Event|0|||
16202093|NCT04449276|39215512|FG004|Overall Study|Adverse Event|2|||
16202094|NCT04449276|39215513|FG005|Overall Study|Adverse Event|0|||
16202095|NCT04449276|39215514|FG006|Overall Study|Adverse Event|0|||
16202096|NCT04449276|39215515|FG007|Overall Study|Adverse Event|1|||
16202097|NCT04449276|39215508|FG000|Overall Study|Withdrawal by Subject|2|||
16202098|NCT04449276|39215509|FG001|Overall Study|Withdrawal by Subject|0|||
16320428|NCT02237196|39657380|FG001|Overall Study|Adverse Event|1|||
16320429|NCT02237196|39657381|FG002|Overall Study|Adverse Event|1|||
16514904|NCT02460224|40355454|FG028|Overall Study|Adverse Event|6|||
16514905|NCT02460224|40355426|FG000|Overall Study|Death|0|||
16514906|NCT02460224|40355427|FG001|Overall Study|Death|0|||
16514907|NCT02460224|40355428|FG002|Overall Study|Death|0|||
16514908|NCT02460224|40355429|FG003|Overall Study|Death|0|||
16514909|NCT02460224|40355430|FG004|Overall Study|Death|0|||
16514910|NCT02460224|40355431|FG005|Overall Study|Death|2|||
16514911|NCT02460224|40355432|FG006|Overall Study|Death|1|||
16514912|NCT02460224|40355433|FG007|Overall Study|Death|0|||
16514913|NCT02460224|40355434|FG008|Overall Study|Death|0|||
16514914|NCT02460224|40355435|FG009|Overall Study|Death|1|||
16514915|NCT02460224|40355436|FG010|Overall Study|Death|0|||
16514916|NCT02460224|40355437|FG011|Overall Study|Death|0|||
16320430|NCT02237196|39657382|FG003|Overall Study|Adverse Event|0|||
16320431|NCT02237196|39657379|FG000|Overall Study|Lost to Follow-up|4|||
16320432|NCT02237196|39657380|FG001|Overall Study|Lost to Follow-up|2|||
16320433|NCT02237196|39657381|FG002|Overall Study|Lost to Follow-up|4|||
16320434|NCT02237196|39657382|FG003|Overall Study|Lost to Follow-up|6|||
16514917|NCT02460224|40355438|FG012|Overall Study|Death|0|||
16202099|NCT04449276|39215510|FG002|Overall Study|Withdrawal by Subject|0|||
16514918|NCT02460224|40355439|FG013|Overall Study|Death|1|||
16320435|NCT02237196|39657379|FG000|Overall Study|Physician Decision|2|||
16320436|NCT02237196|39657380|FG001|Overall Study|Physician Decision|0|||
16320437|NCT02237196|39657381|FG002|Overall Study|Physician Decision|0|||
16320438|NCT02237196|39657382|FG003|Overall Study|Physician Decision|1|||
16320439|NCT02237196|39657379|FG000|Overall Study|Pregnancy|0|||
16320440|NCT02237196|39657380|FG001|Overall Study|Pregnancy|0|||
16320441|NCT02237196|39657381|FG002|Overall Study|Pregnancy|1|||
16320442|NCT02237196|39657382|FG003|Overall Study|Pregnancy|1|||
16320443|NCT02237196|39657379|FG000|Overall Study|Withdrawal by Subject|1|||
16320444|NCT02237196|39657380|FG001|Overall Study|Withdrawal by Subject|1|||
16320445|NCT02237196|39657381|FG002|Overall Study|Withdrawal by Subject|4|||
16320446|NCT02237196|39657382|FG003|Overall Study|Withdrawal by Subject|1|||
16320447|NCT02237196|39657379|FG000|Overall Study|Site Error|1|||
16320448|NCT02237196|39657380|FG001|Overall Study|Site Error|2|||
16320449|NCT02237196|39657381|FG002|Overall Study|Site Error|0|||
16320450|NCT02237196|39657382|FG003|Overall Study|Site Error|2|||
16320451|NCT00410813|39657383|FG000|Overall Study|Adverse Event|6|||
16320452|NCT00410813|39657384|FG001|Overall Study|Adverse Event|11|||
16320453|NCT00410813|39657383|FG000|Overall Study|Progression|32|||
16320454|NCT00410813|39657384|FG001|Overall Study|Progression|21|||
16320455|NCT00410813|39657383|FG000|Overall Study|Not protocol specified|3|||
16320456|NCT00410813|39657384|FG001|Overall Study|Not protocol specified|4|||
16320457|NCT00410813|39657383|FG000|Overall Study|Ineligible|2|||
16514919|NCT02460224|40355440|FG014|Overall Study|Death|0|||
16514920|NCT02460224|40355441|FG015|Overall Study|Death|0|||
16514921|NCT02460224|40355442|FG016|Overall Study|Death|2|||
16514922|NCT02460224|40355443|FG017|Overall Study|Death|1|||
16514923|NCT02460224|40355444|FG018|Overall Study|Death|0|||
16514924|NCT02460224|40355445|FG019|Overall Study|Death|2|||
16514925|NCT02460224|40355446|FG020|Overall Study|Death|0|||
16320458|NCT00410813|39657384|FG001|Overall Study|Ineligible|4|||
16320459|NCT00410813|39657383|FG000|Overall Study|Death|0|||
16320460|NCT00410813|39657384|FG001|Overall Study|Death|2|||
16320461|NCT02042950|39657385|FG000|Overall Study|Progressive Disease|4|||
16320462|NCT01964222|39657388|FG000|Overall Study|Lost to Follow-up|7|||
16320463|NCT01964222|39657389|FG001|Overall Study|Lost to Follow-up|5|||
16320464|NCT01964222|39657388|FG000|Overall Study|Withdrawal by Subject|6|||
16320465|NCT01964222|39657389|FG001|Overall Study|Withdrawal by Subject|6|||
16320466|NCT01964222|39657388|FG000|Overall Study|Screening Failure|2|||
16320467|NCT01964222|39657389|FG001|Overall Study|Screening Failure|0|||
16320468|NCT01931475|39657390|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
16320469|NCT01931475|39657391|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
16320470|NCT01931475|39657390|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
16320471|NCT01931475|39657391|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
16320472|NCT01931475|39657390|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
16320473|NCT01931475|39657391|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
16320474|NCT01931475|39657390|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
16320475|NCT01931475|39657391|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
16320476|NCT01931475|39657390|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
16320477|NCT01931475|39657391|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
16320478|NCT01931475|39657390|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
16320479|NCT01931475|39657391|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
16320480|NCT01931475|39657390|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
16320481|NCT01931475|39657391|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
16320482|NCT01931475|39657390|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
16320483|NCT01931475|39657391|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
16320484|NCT01931475|39657390|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
16320485|NCT01931475|39657391|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
16320486|NCT01931475|39657390|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
16320487|NCT01931475|39657391|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
16320488|NCT01931475|39657390|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
16320489|NCT01931475|39657391|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
16320490|NCT01784068|39657394|FG000|NTCS Phase|Adverse Event|5|||
16320491|NCT01784068|39657395|FG001|NTCS Phase|Adverse Event|0|||
16320492|NCT01784068|39657394|FG000|NTCS Phase|Physician Decision|2|||
16320493|NCT01784068|39657395|FG001|NTCS Phase|Physician Decision|0|||
16320494|NCT01784068|39657394|FG000|NTCS Phase|Patient/guardian decision|3|||
16320495|NCT01784068|39657395|FG001|NTCS Phase|Patient/guardian decision|0|||
16514926|NCT02460224|40355447|FG021|Overall Study|Death|0|||
16514927|NCT02460224|40355448|FG022|Overall Study|Death|0|||
16514928|NCT02460224|40355449|FG023|Overall Study|Death|0|||
16514929|NCT02460224|40355450|FG024|Overall Study|Death|1|||
16514930|NCT02460224|40355451|FG025|Overall Study|Death|1|||
16514931|NCT02460224|40355452|FG026|Overall Study|Death|5|||
16514932|NCT02460224|40355453|FG027|Overall Study|Death|0|||
16514933|NCT02460224|40355454|FG028|Overall Study|Death|1|||
16514934|NCT02460224|40355426|FG000|Overall Study|Lost to Follow-up|0|||
16320496|NCT01784068|39657394|FG000|NTCS Phase|Death|2|||
16320497|NCT01784068|39657395|FG001|NTCS Phase|Death|0|||
16320498|NCT01784068|39657394|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
16320499|NCT01784068|39657395|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
16320500|NCT01784068|39657394|FG000|TFR Phase|Physician Decision|0|||
16320501|NCT01784068|39657395|FG001|TFR Phase|Physician Decision|1|||
16320502|NCT01784068|39657394|FG000|TFR Phase|Patient/guardian decision|0|||
16320503|NCT01784068|39657395|FG001|TFR Phase|Patient/guardian decision|3|||
16320504|NCT01784068|39657394|FG000|TFR Phase|Death|0|||
16320505|NCT01784068|39657395|FG001|TFR Phase|Death|1|||
16320506|NCT01784068|39657394|FG000|TFR Phase|Lack of Efficacy|0|||
16320507|NCT01784068|39657395|FG001|TFR Phase|Lack of Efficacy|88|||
16320508|NCT01628198|39657402|FG000|Overall Study|Lost to Follow-up|7|||
16320509|NCT01628198|39657402|FG000|Overall Study|Withdrawal by Subject|10|||
16320510|NCT01628198|39657402|FG000|Overall Study|Screen failure|1|||
16320511|NCT00566020|39657404|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
16320512|NCT00566020|39657405|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
16320513|NCT00566020|39657404|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
16320514|NCT00566020|39657405|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
16320515|NCT00566020|39657404|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
16320516|NCT00566020|39657405|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
16320517|NCT00566020|39657404|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
16320518|NCT00566020|39657405|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
16320519|NCT00566020|39657404|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
16320520|NCT00566020|39657405|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
16320521|NCT00566020|39657404|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
16320522|NCT00566020|39657405|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
16320523|NCT03321968|39657406|FG000|Overall Study|Withdrawal by Subject|1|||
16320524|NCT03321968|39657407|FG001|Overall Study|Withdrawal by Subject|2|||
16320525|NCT03321968|39657408|FG002|Overall Study|Withdrawal by Subject|1|||
16320526|NCT03321968|39657406|FG000|Overall Study|Lost to Follow-up|2|||
16320527|NCT03321968|39657407|FG001|Overall Study|Lost to Follow-up|0|||
16320528|NCT03321968|39657408|FG002|Overall Study|Lost to Follow-up|1|||
16320529|NCT03321968|39657406|FG000|Overall Study|Other than specified|0|||
16320530|NCT03321968|39657407|FG001|Overall Study|Other than specified|0|||
16320531|NCT03321968|39657408|FG002|Overall Study|Other than specified|1|||
16346323|NCT03201965|39753289|FG002|Overall Study|Withdrawal by Subject|4|||
16346324|NCT03201965|39753287|FG000|Overall Study|Ongoing|20|||
16346325|NCT03201965|39753288|FG001|Overall Study|Ongoing|152|||
16346326|NCT03201965|39753289|FG002|Overall Study|Ongoing|164|||
16346327|NCT02367040|39753293|FG000|Overall Study|Lost to Follow-up|1|||
16346328|NCT02367040|39753294|FG001|Overall Study|Lost to Follow-up|1|||
16346329|NCT02367040|39753293|FG000|Overall Study|Lack of Efficacy|1|||
16346330|NCT02367040|39753294|FG001|Overall Study|Lack of Efficacy|0|||
16346331|NCT02367040|39753293|FG000|Overall Study|Additional primary malignancy|0|||
16346332|NCT02367040|39753294|FG001|Overall Study|Additional primary malignancy|1|||
16346333|NCT02367040|39753293|FG000|Overall Study|AE not associated with clinical disease progression|114|||
16346334|NCT02367040|39753294|FG001|Overall Study|AE not associated with clinical disease progression|11|||
16346335|NCT02367040|39753293|FG000|Overall Study|AE associated with clinical disease progression|1|||
16346336|NCT02367040|39753294|FG001|Overall Study|AE associated with clinical disease progression|3|||
16346337|NCT02367040|39753293|FG000|Overall Study|Physician Decision|2|||
16346338|NCT02367040|39753294|FG001|Overall Study|Physician Decision|8|||
16346339|NCT02367040|39753293|FG000|Overall Study|Non-compliance with study drug|1|||
16346340|NCT02367040|39753294|FG001|Overall Study|Non-compliance with study drug|0|||
16346341|NCT02367040|39753293|FG000|Overall Study|Failure to meet continuation criteria|1|||
16346342|NCT02367040|39753294|FG001|Overall Study|Failure to meet continuation criteria|0|||
16346343|NCT02367040|39753293|FG000|Overall Study|Switching to other therapy|2|||
16346344|NCT02367040|39753294|FG001|Overall Study|Switching to other therapy|0|||
16346345|NCT02367040|39753293|FG000|Overall Study|Withdrawal by Subject|46|||
16346346|NCT02367040|39753294|FG001|Overall Study|Withdrawal by Subject|16|||
16346347|NCT02367040|39753293|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
16346348|NCT02367040|39753294|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
16346349|NCT02367040|39753293|FG000|Overall Study|Patient decision|39|||
16346350|NCT02367040|39753294|FG001|Overall Study|Patient decision|14|||
16346351|NCT02367040|39753293|FG000|Overall Study|Required procedure failed|1|||
16346352|NCT02367040|39753294|FG001|Overall Study|Required procedure failed|0|||
16346353|NCT02367040|39753293|FG000|Overall Study|Randomized by mistake with study treatment|1|||
16346354|NCT02367040|39753294|FG001|Overall Study|Randomized by mistake with study treatment|0|||
16346355|NCT02367040|39753293|FG000|Overall Study|Protocol Violation|1|||
16346356|NCT02367040|39753294|FG001|Overall Study|Protocol Violation|0|||
16346357|NCT02367040|39753293|FG000|Overall Study|Progressive disease - radiological progression|51|||
16514935|NCT02460224|40355427|FG001|Overall Study|Lost to Follow-up|0|||
16090490|NCT03122548|38823443|FG000|Overall Study|Death|2|||
16090491|NCT03122548|38823443|FG000|Overall Study|Progression - subject went into hospice|1|||
16090492|NCT03122548|38823443|FG000|Overall Study|Study Terminated by Sponsor|2|||
16090493|NCT01567852|38823444|FG000|Overall Study|Withdrawal by Subject|3|||
16090494|NCT01567852|38823445|FG001|Overall Study|Withdrawal by Subject|6|||
16090495|NCT01567852|38823444|FG000|Overall Study|ECT discontinued|1|||
16090496|NCT01567852|38823445|FG001|Overall Study|ECT discontinued|1|||
16090497|NCT02950961|38823446|FG000|Overall Study|Study had to stop due to COVID.|7|||
16090498|NCT02340806|38823447|FG000|Overall Study|Protocol Violation|2|||
16090499|NCT02340806|38823448|FG001|Overall Study|Protocol Violation|0|||
16090500|NCT02340806|38823447|FG000|Overall Study|epidural catheter replaced|2|||
16090501|NCT02340806|38823448|FG001|Overall Study|epidural catheter replaced|1|||
16090502|NCT02340806|38823447|FG000|Overall Study|history of chronic pain medication|1|||
16090503|NCT02340806|38823448|FG001|Overall Study|history of chronic pain medication|0|||
16394422|NCT03835481|39924698|FG002|Double-blind Period|Withdrawal by Subject|1|||
16394423|NCT03835481|39924699|FG003|Double-blind Period|Withdrawal by Subject|0|||
16514936|NCT02460224|40355428|FG002|Overall Study|Lost to Follow-up|0|||
16514937|NCT02460224|40355429|FG003|Overall Study|Lost to Follow-up|0|||
16514938|NCT02460224|40355430|FG004|Overall Study|Lost to Follow-up|0|||
16514939|NCT02460224|40355431|FG005|Overall Study|Lost to Follow-up|0|||
16514940|NCT02460224|40355432|FG006|Overall Study|Lost to Follow-up|0|||
16514941|NCT02460224|40355433|FG007|Overall Study|Lost to Follow-up|0|||
16514942|NCT02460224|40355434|FG008|Overall Study|Lost to Follow-up|0|||
16514943|NCT02460224|40355435|FG009|Overall Study|Lost to Follow-up|0|||
16514944|NCT02460224|40355436|FG010|Overall Study|Lost to Follow-up|0|||
16514945|NCT02460224|40355437|FG011|Overall Study|Lost to Follow-up|0|||
16514946|NCT02460224|40355438|FG012|Overall Study|Lost to Follow-up|0|||
16514947|NCT02460224|40355439|FG013|Overall Study|Lost to Follow-up|0|||
16514948|NCT02460224|40355440|FG014|Overall Study|Lost to Follow-up|0|||
16514949|NCT02460224|40355441|FG015|Overall Study|Lost to Follow-up|0|||
16514950|NCT02460224|40355442|FG016|Overall Study|Lost to Follow-up|0|||
16514951|NCT02460224|40355443|FG017|Overall Study|Lost to Follow-up|0|||
16514952|NCT02460224|40355444|FG018|Overall Study|Lost to Follow-up|0|||
16514953|NCT02460224|40355445|FG019|Overall Study|Lost to Follow-up|0|||
16090504|NCT02340806|38823447|FG000|Overall Study|re-dose < 90 min of CSE|1|||
16394424|NCT03835481|39924700|FG004|Double-blind Period|Withdrawal by Subject|5|||
16394425|NCT03835481|39924696|FG000|Double-blind Period|Lost to Follow-up|0|||
16394426|NCT03835481|39924697|FG001|Double-blind Period|Lost to Follow-up|0|||
16394427|NCT03835481|39924698|FG002|Double-blind Period|Lost to Follow-up|0|||
16394428|NCT03835481|39924699|FG003|Double-blind Period|Lost to Follow-up|1|||
16514954|NCT02460224|40355446|FG020|Overall Study|Lost to Follow-up|0|||
16514955|NCT02460224|40355447|FG021|Overall Study|Lost to Follow-up|0|||
16514956|NCT02460224|40355448|FG022|Overall Study|Lost to Follow-up|1|||
16514957|NCT02460224|40355449|FG023|Overall Study|Lost to Follow-up|0|||
16514958|NCT02460224|40355450|FG024|Overall Study|Lost to Follow-up|0|||
16514959|NCT02460224|40355451|FG025|Overall Study|Lost to Follow-up|0|||
16514960|NCT02460224|40355452|FG026|Overall Study|Lost to Follow-up|0|||
16514961|NCT02460224|40355453|FG027|Overall Study|Lost to Follow-up|0|||
16514962|NCT02460224|40355454|FG028|Overall Study|Lost to Follow-up|0|||
16514963|NCT02460224|40355426|FG000|Overall Study|Physician Decision|0|||
16514964|NCT02460224|40355427|FG001|Overall Study|Physician Decision|1|||
16514965|NCT02460224|40355428|FG002|Overall Study|Physician Decision|0|||
16514966|NCT02460224|40355429|FG003|Overall Study|Physician Decision|0|||
16514967|NCT02460224|40355430|FG004|Overall Study|Physician Decision|1|||
16514968|NCT02460224|40355431|FG005|Overall Study|Physician Decision|0|||
16514969|NCT02460224|40355432|FG006|Overall Study|Physician Decision|0|||
16514970|NCT02460224|40355433|FG007|Overall Study|Physician Decision|1|||
16514971|NCT02460224|40355434|FG008|Overall Study|Physician Decision|0|||
16514972|NCT02460224|40355435|FG009|Overall Study|Physician Decision|0|||
16090505|NCT02340806|38823448|FG001|Overall Study|re-dose < 90 min of CSE|3|||
16090506|NCT00428714|38823449|FG000|Overall Study|Progressive Disease|28|||
16090507|NCT00428714|38823450|FG001|Overall Study|Progressive Disease|36|||
16514973|NCT02460224|40355436|FG010|Overall Study|Physician Decision|0|||
16514974|NCT02460224|40355437|FG011|Overall Study|Physician Decision|1|||
16514975|NCT02460224|40355438|FG012|Overall Study|Physician Decision|0|||
16514976|NCT02460224|40355439|FG013|Overall Study|Physician Decision|1|||
16394429|NCT03835481|39924700|FG004|Double-blind Period|Lost to Follow-up|0|||
16394430|NCT03835481|39924696|FG000|Double-blind Period|Protocol Violation|0|||
16394431|NCT03835481|39924697|FG001|Double-blind Period|Protocol Violation|2|||
16394432|NCT03835481|39924698|FG002|Double-blind Period|Protocol Violation|0|||
16394433|NCT03835481|39924699|FG003|Double-blind Period|Protocol Violation|1|||
16394434|NCT03835481|39924700|FG004|Double-blind Period|Protocol Violation|0|||
16394435|NCT03835481|39924696|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
16394436|NCT03835481|39924697|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
16320532|NCT04109391|39660325|FG000|Overall Study|Adverse Event|2|||
16320533|NCT04109391|39660326|FG001|Overall Study|Adverse Event|2|||
16320534|NCT04109391|39660327|FG002|Overall Study|Adverse Event|0|||
16320535|NCT04109391|39660325|FG000|Overall Study|Withdrawal by Subject|2|||
16320536|NCT04109391|39660326|FG001|Overall Study|Withdrawal by Subject|0|||
16320537|NCT04109391|39660327|FG002|Overall Study|Withdrawal by Subject|0|||
16320538|NCT04109391|39660325|FG000|Overall Study|Pregnancy|1|||
16320539|NCT04109391|39660326|FG001|Overall Study|Pregnancy|0|||
16320540|NCT04109391|39660327|FG002|Overall Study|Pregnancy|0|||
16320541|NCT04109391|39660325|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
16320542|NCT04109391|39660326|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
16320543|NCT04109391|39660327|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
16320544|NCT04109391|39660325|FG000|Overall Study|Lost to Follow-up|0|||
16320545|NCT04109391|39660326|FG001|Overall Study|Lost to Follow-up|0|||
16320546|NCT04109391|39660327|FG002|Overall Study|Lost to Follow-up|1|||
16320547|NCT04109391|39660325|FG000|Overall Study|Lack of Efficacy|2|||
16320548|NCT04109391|39660326|FG001|Overall Study|Lack of Efficacy|2|||
16320549|NCT04109391|39660327|FG002|Overall Study|Lack of Efficacy|3|||
16320550|NCT02343939|39660328|FG000|Overall Study|Death|0|||
16320551|NCT02343939|39660329|FG001|Overall Study|Death|15|||
16320552|NCT02343939|39660330|FG002|Overall Study|Death|4|||
16320553|NCT02343939|39660331|FG003|Overall Study|Death|2|||
16320554|NCT02343939|39660332|FG004|Overall Study|Death|5|||
16320555|NCT02343939|39660333|FG005|Overall Study|Death|11|||
16394437|NCT03835481|39924698|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
16394438|NCT03835481|39924699|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
16394439|NCT03835481|39924700|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
16394440|NCT03835481|39924696|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
16090508|NCT00428714|38823449|FG000|Overall Study|Withdrawal by Subject|0|||
16090509|NCT00428714|38823450|FG001|Overall Study|Withdrawal by Subject|3|||
16394441|NCT03835481|39924697|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
16394442|NCT03835481|39924698|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
16394443|NCT03835481|39924699|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
16394444|NCT03835481|39924700|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
16394445|NCT03835481|39924696|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
16394446|NCT03835481|39924697|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
16394447|NCT03835481|39924698|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
16394448|NCT03835481|39924699|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
16394449|NCT03835481|39924700|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
16394450|NCT03835481|39924696|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
16394451|NCT03835481|39924697|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
16394452|NCT03835481|39924698|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
16394453|NCT03835481|39924699|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
16394454|NCT03835481|39924700|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
16394455|NCT03835481|39924696|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
16394456|NCT03835481|39924697|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
16394457|NCT03835481|39924698|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
16514977|NCT02460224|40355440|FG014|Overall Study|Physician Decision|0|||
16514978|NCT02460224|40355441|FG015|Overall Study|Physician Decision|0|||
16514979|NCT02460224|40355442|FG016|Overall Study|Physician Decision|2|||
16514980|NCT02460224|40355443|FG017|Overall Study|Physician Decision|1|||
16514981|NCT02460224|40355444|FG018|Overall Study|Physician Decision|1|||
16514982|NCT02460224|40355445|FG019|Overall Study|Physician Decision|2|||
16514983|NCT02460224|40355446|FG020|Overall Study|Physician Decision|1|||
16514984|NCT02460224|40355447|FG021|Overall Study|Physician Decision|1|||
16514985|NCT02460224|40355448|FG022|Overall Study|Physician Decision|0|||
16514986|NCT02460224|40355449|FG023|Overall Study|Physician Decision|0|||
16202100|NCT04449276|39215511|FG003|Overall Study|Withdrawal by Subject|1|||
16409963|NCT03757130|39981848|FG005|Overall Study|Withdrawal by Subject|0|||
16202101|NCT04449276|39215512|FG004|Overall Study|Withdrawal by Subject|0|||
16320556|NCT02343939|39660334|FG006|Overall Study|Death|8|||
16320557|NCT02343939|39660335|FG007|Overall Study|Death|22|||
16320558|NCT02343939|39660336|FG008|Overall Study|Death|1|||
16514987|NCT02460224|40355450|FG024|Overall Study|Physician Decision|1|||
16514988|NCT02460224|40355451|FG025|Overall Study|Physician Decision|0|||
16514989|NCT02460224|40355452|FG026|Overall Study|Physician Decision|14|||
16514990|NCT02460224|40355453|FG027|Overall Study|Physician Decision|1|||
16514991|NCT02460224|40355454|FG028|Overall Study|Physician Decision|6|||
16514992|NCT02460224|40355426|FG000|Overall Study|Progressive disease|15|||
16514993|NCT02460224|40355427|FG001|Overall Study|Progressive disease|11|||
16514994|NCT02460224|40355428|FG002|Overall Study|Progressive disease|5|||
16514995|NCT02460224|40355429|FG003|Overall Study|Progressive disease|6|||
16514996|NCT02460224|40355430|FG004|Overall Study|Progressive disease|3|||
16514997|NCT02460224|40355431|FG005|Overall Study|Progressive disease|26|||
16514998|NCT02460224|40355432|FG006|Overall Study|Progressive disease|28|||
16514999|NCT02460224|40355433|FG007|Overall Study|Progressive disease|4|||
16515000|NCT02460224|40355434|FG008|Overall Study|Progressive disease|5|||
16515001|NCT02460224|40355435|FG009|Overall Study|Progressive disease|9|||
16515002|NCT02460224|40355436|FG010|Overall Study|Progressive disease|5|||
16515003|NCT02460224|40355437|FG011|Overall Study|Progressive disease|4|||
16515004|NCT02460224|40355438|FG012|Overall Study|Progressive disease|5|||
16515005|NCT02460224|40355439|FG013|Overall Study|Progressive disease|4|||
16515006|NCT02460224|40355440|FG014|Overall Study|Progressive disease|5|||
16515007|NCT02460224|40355441|FG015|Overall Study|Progressive disease|5|||
16515008|NCT02460224|40355442|FG016|Overall Study|Progressive disease|15|||
16515009|NCT02460224|40355443|FG017|Overall Study|Progressive disease|3|||
16515010|NCT02460224|40355444|FG018|Overall Study|Progressive disease|8|||
16515011|NCT02460224|40355445|FG019|Overall Study|Progressive disease|3|||
16515012|NCT02460224|40355446|FG020|Overall Study|Progressive disease|4|||
16515013|NCT02460224|40355447|FG021|Overall Study|Progressive disease|9|||
16515014|NCT02460224|40355448|FG022|Overall Study|Progressive disease|4|||
16515015|NCT02460224|40355449|FG023|Overall Study|Progressive disease|11|||
16515016|NCT02460224|40355450|FG024|Overall Study|Progressive disease|4|||
16515017|NCT02460224|40355451|FG025|Overall Study|Progressive disease|5|||
16515018|NCT02460224|40355452|FG026|Overall Study|Progressive disease|85|||
16515019|NCT02460224|40355453|FG027|Overall Study|Progressive disease|17|||
16515020|NCT02460224|40355454|FG028|Overall Study|Progressive disease|77|||
16515021|NCT02460224|40355426|FG000|Overall Study|Subject/guardian decision|2|||
16515022|NCT02460224|40355427|FG001|Overall Study|Subject/guardian decision|0|||
16515023|NCT02460224|40355428|FG002|Overall Study|Subject/guardian decision|1|||
16515024|NCT02460224|40355429|FG003|Overall Study|Subject/guardian decision|0|||
16515025|NCT02460224|40355430|FG004|Overall Study|Subject/guardian decision|2|||
16515026|NCT02460224|40355431|FG005|Overall Study|Subject/guardian decision|2|||
16515027|NCT02460224|40355432|FG006|Overall Study|Subject/guardian decision|0|||
16515028|NCT02460224|40355433|FG007|Overall Study|Subject/guardian decision|0|||
16515029|NCT02460224|40355434|FG008|Overall Study|Subject/guardian decision|1|||
16515030|NCT02460224|40355435|FG009|Overall Study|Subject/guardian decision|1|||
16515031|NCT02460224|40355436|FG010|Overall Study|Subject/guardian decision|0|||
16515032|NCT02460224|40355437|FG011|Overall Study|Subject/guardian decision|1|||
16515033|NCT02460224|40355438|FG012|Overall Study|Subject/guardian decision|0|||
16515034|NCT02460224|40355439|FG013|Overall Study|Subject/guardian decision|0|||
16515035|NCT02460224|40355440|FG014|Overall Study|Subject/guardian decision|0|||
16515036|NCT02460224|40355441|FG015|Overall Study|Subject/guardian decision|1|||
16515037|NCT02460224|40355442|FG016|Overall Study|Subject/guardian decision|0|||
16515038|NCT02460224|40355443|FG017|Overall Study|Subject/guardian decision|1|||
16515039|NCT02460224|40355444|FG018|Overall Study|Subject/guardian decision|2|||
16515040|NCT02460224|40355445|FG019|Overall Study|Subject/guardian decision|0|||
16515041|NCT02460224|40355446|FG020|Overall Study|Subject/guardian decision|0|||
16515042|NCT02460224|40355447|FG021|Overall Study|Subject/guardian decision|1|||
16515043|NCT02460224|40355448|FG022|Overall Study|Subject/guardian decision|0|||
16515044|NCT02460224|40355449|FG023|Overall Study|Subject/guardian decision|0|||
16515045|NCT02460224|40355450|FG024|Overall Study|Subject/guardian decision|0|||
16515046|NCT02460224|40355451|FG025|Overall Study|Subject/guardian decision|0|||
16515047|NCT02460224|40355452|FG026|Overall Study|Subject/guardian decision|6|||
16515048|NCT02460224|40355453|FG027|Overall Study|Subject/guardian decision|2|||
16515049|NCT02460224|40355454|FG028|Overall Study|Subject/guardian decision|3|||
16515050|NCT04033003|40355455|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
16515051|NCT04033003|40355456|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
16515052|NCT04033003|40355455|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
16515053|NCT04033003|40355456|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
16515054|NCT04033003|40355455|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
16515055|NCT04033003|40355456|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
16515056|NCT04033003|40355455|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
16515057|NCT04033003|40355456|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
16515058|NCT04033003|40355455|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
16515059|NCT04033003|40355456|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
16515060|NCT04033003|40355455|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
16515061|NCT04033003|40355456|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
16515062|NCT04033003|40355455|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
16515063|NCT04033003|40355456|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
16515064|NCT04033003|40355455|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
16515065|NCT04033003|40355456|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
16515066|NCT04033003|40355455|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
16515067|NCT04033003|40355456|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
16515068|NCT04033003|40355455|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
16515069|NCT04033003|40355456|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
16515070|NCT04033003|40355455|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
16515071|NCT04033003|40355456|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
16515072|NCT04033003|40355455|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
16515073|NCT04033003|40355456|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
16515074|NCT04033003|40355455|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
16515075|NCT04033003|40355456|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
16515076|NCT00096044|40355460|FG000|Overall Study|Withdrawal by Subject|9|||
16515077|NCT00096044|40355460|FG000|Overall Study|Adverse Event|21|||
16515078|NCT00096044|40355460|FG000|Overall Study|Disease Progression|4|||
16515079|NCT02399085|40355461|FG000|Overall Study|Adverse Event|16|||
16515080|NCT02399085|40355461|FG000|Overall Study|Death|2|||
16515081|NCT02399085|40355461|FG000|Overall Study|Withdrawal by Subject|8|||
16515082|NCT02399085|40355461|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
16515083|NCT02399085|40355461|FG000|Overall Study|Physician Decision|5|||
16515084|NCT00586469|40355462|FG000|Overall Study|Adverse Event|0|||
16515085|NCT00586469|40355463|FG001|Overall Study|Adverse Event|1|||
16515086|NCT00261716|40355467|FG000|Overall Study|Withdrawal by Subject|6|||
16515087|NCT00261716|40355468|FG001|Overall Study|Withdrawal by Subject|8|||
16515088|NCT00261716|40355467|FG000|Overall Study|Lost to Follow-up|0|||
16515089|NCT00261716|40355468|FG001|Overall Study|Lost to Follow-up|2|||
16515090|NCT00797667|40355471|FG000|Overall Study|Lack of Efficacy|0|||
16515091|NCT00797667|40355472|FG001|Overall Study|Lack of Efficacy|1|||
16515092|NCT00797667|40355473|FG002|Overall Study|Lack of Efficacy|0|||
16515093|NCT00797667|40355471|FG000|Overall Study|Lost to Follow-up|8|||
16515094|NCT00797667|40355472|FG001|Overall Study|Lost to Follow-up|12|||
16515095|NCT00797667|40355473|FG002|Overall Study|Lost to Follow-up|2|||
16515096|NCT00797667|40355471|FG000|Overall Study|Physician Decision|3|||
16515097|NCT00797667|40355472|FG001|Overall Study|Physician Decision|1|||
16515098|NCT00797667|40355473|FG002|Overall Study|Physician Decision|0|||
16515099|NCT00797667|40355471|FG000|Overall Study|Pregnancy|2|||
16515100|NCT00797667|40355472|FG001|Overall Study|Pregnancy|0|||
16515101|NCT00797667|40355473|FG002|Overall Study|Pregnancy|0|||
16515102|NCT00797667|40355471|FG000|Overall Study|Protocol Violation|2|||
16515103|NCT00797667|40355472|FG001|Overall Study|Protocol Violation|7|||
16515104|NCT00797667|40355473|FG002|Overall Study|Protocol Violation|0|||
16515105|NCT00797667|40355471|FG000|Overall Study|Study Terminated by Sponsor|217|||
16515106|NCT00797667|40355472|FG001|Overall Study|Study Terminated by Sponsor|216|||
16515107|NCT00797667|40355473|FG002|Overall Study|Study Terminated by Sponsor|115|||
16515108|NCT00797667|40355471|FG000|Overall Study|Withdrawal by Subject|9|||
16515109|NCT00797667|40355472|FG001|Overall Study|Withdrawal by Subject|14|||
16515110|NCT00797667|40355473|FG002|Overall Study|Withdrawal by Subject|2|||
16515111|NCT00797667|40355471|FG000|Overall Study|Adverse Event|19|||
16515112|NCT00797667|40355472|FG001|Overall Study|Adverse Event|8|||
16515113|NCT00797667|40355473|FG002|Overall Study|Adverse Event|8|||
16515114|NCT02506816|40355477|FG000|Overall Study|Adverse Event|3|||
16515115|NCT01968707|40355478|FG000|Overall Study|Did not meet treatment day baseline|49|||
16515116|NCT01968707|40355479|FG001|Overall Study|Did not meet treatment day baseline|12|||
16515117|NCT01968707|40355480|FG002|Overall Study|Did not meet treatment day baseline|41|||
16515118|NCT01968707|40355481|FG003|Overall Study|Did not meet treatment day baseline|44|||
16515119|NCT01968707|40355482|FG004|Overall Study|Did not meet treatment day baseline|36|||
16515120|NCT01968707|40355483|FG005|Overall Study|Did not meet treatment day baseline|11|||
16515121|NCT01968707|40355484|FG006|Overall Study|Did not meet treatment day baseline|34|||
16515122|NCT01968707|40355485|FG007|Overall Study|Did not meet treatment day baseline|35|||
16515123|NCT01069289|40355486|FG000|Overall Study|Withdrawal by Subject|15|||
16515124|NCT01069289|40355487|FG001|Overall Study|Withdrawal by Subject|26|||
16515125|NCT01069289|40355486|FG000|Overall Study|Adverse Event|21|||
16515126|NCT01069289|40355487|FG001|Overall Study|Adverse Event|28|||
16515127|NCT01069289|40355486|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16515128|NCT01069289|40355487|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16202102|NCT04449276|39215513|FG005|Overall Study|Withdrawal by Subject|0|||
16202103|NCT04449276|39215514|FG006|Overall Study|Withdrawal by Subject|0|||
16202104|NCT04449276|39215515|FG007|Overall Study|Withdrawal by Subject|0|||
16202105|NCT04449276|39215508|FG000|Overall Study|Other|0|||
16202106|NCT04449276|39215509|FG001|Overall Study|Other|2|||
16202107|NCT04449276|39215510|FG002|Overall Study|Other|3|||
16202108|NCT04449276|39215511|FG003|Overall Study|Other|2|||
16320559|NCT02343939|39660328|FG000|Overall Study|Study terminated by sponsor|0|||
16320560|NCT02343939|39660329|FG001|Overall Study|Study terminated by sponsor|27|||
16320561|NCT02343939|39660330|FG002|Overall Study|Study terminated by sponsor|0|||
16320562|NCT02343939|39660331|FG003|Overall Study|Study terminated by sponsor|1|||
16202109|NCT04449276|39215512|FG004|Overall Study|Other|0|||
16202110|NCT04449276|39215513|FG005|Overall Study|Other|0|||
16202111|NCT04449276|39215514|FG006|Overall Study|Other|0|||
16202112|NCT04449276|39215515|FG007|Overall Study|Other|1|||
16202113|NCT02581982|39215516|FG000|Overall Study|Lack of Efficacy|12|||
16202114|NCT02581982|39215516|FG000|Overall Study|Adverse Event|3|||
16202115|NCT02581982|39215516|FG000|Overall Study|Physician Decision|1|||
16202116|NCT04685499|39215519|FG000|Overall Study|Study Terminated Early|1|||
16202117|NCT02146833|39218751|FG000|Overall Study|Death|10|||
16202118|NCT02146833|39218751|FG000|Overall Study|No longer consented to study treatment|1|||
16202119|NCT05109702|39218752|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
16202120|NCT05109702|39218753|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
16202121|NCT05109702|39218754|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
16202122|NCT05109702|39218752|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
16202123|NCT05109702|39218753|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
16202124|NCT05109702|39218754|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
16202125|NCT05109702|39218752|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
16202126|NCT05109702|39218753|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
16202127|NCT05109702|39218754|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
16202128|NCT05109702|39218752|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
16202129|NCT05109702|39218753|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
16202130|NCT05109702|39218754|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
16202131|NCT05109702|39218752|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
16202132|NCT05109702|39218753|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
16202133|NCT05109702|39218754|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
16202134|NCT04179786|39218755|FG000|Overall Study|Withdrawal by Subject|8|||
16202135|NCT01958125|39218759|FG000|Overall Study|Missing diary data|2|||
16202136|NCT01958125|39218760|FG001|Overall Study|Missing diary data|6|||
16202137|NCT01958125|39218759|FG000|Overall Study|No headache attacks|0|||
16202138|NCT01958125|39218760|FG001|Overall Study|No headache attacks|2|||
16202139|NCT01203787|39218763|FG000|Overall Study|Death|12|||
16202140|NCT01203787|39218764|FG001|Overall Study|Death|10|||
16202141|NCT01203787|39218763|FG000|Overall Study|Withdrawal by Subject|6|||
16202142|NCT01203787|39218764|FG001|Overall Study|Withdrawal by Subject|2|||
16202143|NCT01203787|39218763|FG000|Overall Study|Lost to Follow-up|2|||
16202144|NCT01203787|39218764|FG001|Overall Study|Lost to Follow-up|0|||
16202145|NCT01203787|39218763|FG000|Overall Study|Adverse Event|11|||
16202146|NCT01203787|39218764|FG001|Overall Study|Adverse Event|15|||
16202147|NCT01610206|39218765|FG000|Overall Study|Adverse Event|10|||
16320563|NCT02343939|39660332|FG004|Overall Study|Study terminated by sponsor|1|||
16320564|NCT02343939|39660333|FG005|Overall Study|Study terminated by sponsor|5|||
16320565|NCT02343939|39660334|FG006|Overall Study|Study terminated by sponsor|3|||
16320566|NCT02343939|39660335|FG007|Overall Study|Study terminated by sponsor|4|||
16394458|NCT03835481|39924699|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
16394459|NCT03835481|39924700|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
16394460|NCT03835481|39924696|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
16394461|NCT03835481|39924697|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
16394462|NCT03835481|39924698|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
16394463|NCT03835481|39924699|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
16394464|NCT03835481|39924700|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
16394465|NCT03072043|39924701|FG000|Overall Study|Death|0|||
16394466|NCT03072043|39924702|FG001|Overall Study|Death|0|||
16394467|NCT03072043|39924703|FG002|Overall Study|Death|3|||
16394468|NCT03072043|39924701|FG000|Overall Study|Adverse Event|0|||
16202148|NCT01610206|39218766|FG001|Overall Study|Adverse Event|30|||
16202149|NCT01207388|39218767|FG000|Overall Study|Death|67|||
16202150|NCT01207388|39218767|FG000|Overall Study|Withdrawal by Subject|1|||
16202151|NCT04507776|39218769|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
16202152|NCT00973622|39218770|FG000|Overall Study|did not attend MRI|14|||
16394469|NCT03072043|39924702|FG001|Overall Study|Adverse Event|0|||
16394470|NCT03072043|39924703|FG002|Overall Study|Adverse Event|2|||
16394471|NCT03072043|39924701|FG000|Overall Study|Withdrawal by Subject|0|||
16202153|NCT00973622|39218771|FG001|Overall Study|did not attend MRI|3|||
16202154|NCT00973622|39218770|FG000|Overall Study|did not pass MRI screen|6|||
16202155|NCT00973622|39218771|FG001|Overall Study|did not pass MRI screen|0|||
16320567|NCT02343939|39660336|FG008|Overall Study|Study terminated by sponsor|0|||
16320568|NCT02343939|39660328|FG000|Overall Study|Withdrew consent|3|||
16320569|NCT02343939|39660329|FG001|Overall Study|Withdrew consent|6|||
16320570|NCT02343939|39660330|FG002|Overall Study|Withdrew consent|1|||
16320571|NCT02343939|39660331|FG003|Overall Study|Withdrew consent|2|||
16320572|NCT02343939|39660332|FG004|Overall Study|Withdrew consent|2|||
16320573|NCT02343939|39660333|FG005|Overall Study|Withdrew consent|0|||
16320574|NCT02343939|39660334|FG006|Overall Study|Withdrew consent|0|||
16320575|NCT02343939|39660335|FG007|Overall Study|Withdrew consent|8|||
16320576|NCT02343939|39660336|FG008|Overall Study|Withdrew consent|6|||
16320577|NCT02343939|39660328|FG000|Overall Study|Treatment failure|0|||
16320578|NCT02343939|39660329|FG001|Overall Study|Treatment failure|0|||
16320579|NCT02343939|39660330|FG002|Overall Study|Treatment failure|0|||
16320580|NCT02343939|39660331|FG003|Overall Study|Treatment failure|0|||
16320581|NCT02343939|39660332|FG004|Overall Study|Treatment failure|0|||
16320582|NCT02343939|39660333|FG005|Overall Study|Treatment failure|0|||
16320583|NCT02343939|39660334|FG006|Overall Study|Treatment failure|2|||
16320584|NCT02343939|39660335|FG007|Overall Study|Treatment failure|1|||
16320585|NCT02343939|39660336|FG008|Overall Study|Treatment failure|0|||
16320586|NCT02343939|39660328|FG000|Overall Study|Investigator's discretion|0|||
16320587|NCT02343939|39660329|FG001|Overall Study|Investigator's discretion|0|||
16515129|NCT01069289|40355486|FG000|Overall Study|Severe non-compliance to protocol|3|||
16320588|NCT02343939|39660330|FG002|Overall Study|Investigator's discretion|0|||
16320589|NCT02343939|39660331|FG003|Overall Study|Investigator's discretion|1|||
16320590|NCT02343939|39660332|FG004|Overall Study|Investigator's discretion|0|||
16320591|NCT02343939|39660333|FG005|Overall Study|Investigator's discretion|0|||
16320592|NCT02343939|39660334|FG006|Overall Study|Investigator's discretion|1|||
16515130|NCT01069289|40355487|FG001|Overall Study|Severe non-compliance to protocol|2|||
16515131|NCT01069289|40355486|FG000|Overall Study|Due to deteriorating health condition|1|||
16515132|NCT01069289|40355487|FG001|Overall Study|Due to deteriorating health condition|0|||
16515133|NCT02107703|40355488|FG000|Overall Study|Withdrawal by Subject|46|||
16515134|NCT02107703|40355489|FG001|Overall Study|Withdrawal by Subject|21|||
16515135|NCT02107703|40355488|FG000|Overall Study|Lost to Follow-up|20|||
16515136|NCT02107703|40355489|FG001|Overall Study|Lost to Follow-up|9|||
16515137|NCT02107703|40355488|FG000|Overall Study|On study treatment/follow up|48|||
16515138|NCT02107703|40355489|FG001|Overall Study|On study treatment/follow up|5|||
16515139|NCT01944059|40355490|FG000|Overall Study|Lost to Follow-up|1|||
16515140|NCT01944059|40355490|FG000|Overall Study|Physician Decision|3|||
16515141|NCT01944059|40355490|FG000|Overall Study|Withdrawal by Subject|1|||
16515142|NCT01944059|40355490|FG000|Overall Study|Adverse Event|2|||
16515143|NCT03027466|40355491|FG000|Overall Study|Opting out of the app|1869|||
16515144|NCT03027466|40355492|FG001|Overall Study|Opting out of the app|1819|||
16515145|NCT03027466|40355493|FG002|Overall Study|Opting out of the app|1743|||
16515146|NCT03027466|40355494|FG003|Overall Study|Opting out of the app|1821|||
16515147|NCT02052739|40355496|FG000|Overall Study|Withdrew due to Adverse Event|3|||
16515148|NCT02052739|40355497|FG001|Overall Study|Withdrew due to Adverse Event|0|||
16515149|NCT02052739|40355496|FG000|Overall Study|Participant Died|2|||
16515150|NCT02052739|40355497|FG001|Overall Study|Participant Died|1|||
16515151|NCT00582933|40355498|FG000|Overall Study|Physician Decision|3|||
16515152|NCT01252290|40355501|FG000|Overall Study|Withdrawal by Subject|1|||
16515153|NCT00437034|40355509|FG000|Overall Study|Adverse Event|1|||
16515154|NCT00437034|40355509|FG000|Overall Study|Disease progression during treatment|5|||
16515155|NCT01631474|40355510|FG000|Overall Study|Lost to Follow-up|8|||
16515156|NCT01631474|40355511|FG001|Overall Study|Lost to Follow-up|5|||
16515157|NCT01631474|40355512|FG002|Overall Study|Lost to Follow-up|7|||
16515158|NCT01631474|40355513|FG003|Overall Study|Lost to Follow-up|5|||
16515159|NCT01631474|40355514|FG004|Overall Study|Lost to Follow-up|5|||
16515160|NCT01631474|40355510|FG000|Overall Study|Withdrawal by Subject|4|||
16515161|NCT01631474|40355511|FG001|Overall Study|Withdrawal by Subject|4|||
16090510|NCT00428714|38823449|FG000|Overall Study|Adverse Event|0|||
16320593|NCT02343939|39660335|FG007|Overall Study|Investigator's discretion|0|||
16515162|NCT01631474|40355512|FG002|Overall Study|Withdrawal by Subject|2|||
16515163|NCT01631474|40355513|FG003|Overall Study|Withdrawal by Subject|6|||
16515164|NCT01631474|40355514|FG004|Overall Study|Withdrawal by Subject|5|||
16515165|NCT01631474|40355510|FG000|Overall Study|Lack of Efficacy|2|||
16515166|NCT01631474|40355511|FG001|Overall Study|Lack of Efficacy|2|||
16320594|NCT02343939|39660336|FG008|Overall Study|Investigator's discretion|0|||
16320595|NCT02343939|39660328|FG000|Overall Study|Adverse Event|0|||
16320596|NCT02343939|39660329|FG001|Overall Study|Adverse Event|0|||
16202156|NCT00973622|39218770|FG000|Overall Study|did not complete rTMS sessions|11|||
16320597|NCT02343939|39660330|FG002|Overall Study|Adverse Event|0|||
16320598|NCT02343939|39660331|FG003|Overall Study|Adverse Event|0|||
16320599|NCT02343939|39660332|FG004|Overall Study|Adverse Event|0|||
16202157|NCT00973622|39218771|FG001|Overall Study|did not complete rTMS sessions|2|||
16202158|NCT01815580|39218772|FG000|Overall Study|Lost to Follow-up|4|||
16202159|NCT01815580|39218773|FG001|Overall Study|Lost to Follow-up|7|||
16202160|NCT01815580|39218772|FG000|Overall Study|Withdrawal by Subject|3|||
16202161|NCT01815580|39218773|FG001|Overall Study|Withdrawal by Subject|4|||
16202162|NCT01815580|39218772|FG000|Overall Study|Excluded from analysis|5|||
16202163|NCT01815580|39218773|FG001|Overall Study|Excluded from analysis|4|||
16202164|NCT01610076|39218774|FG000|Overall Study|Technical issue with video|0|||
16202165|NCT01610076|39218775|FG001|Overall Study|Technical issue with video|1|||
16202166|NCT01610076|39218774|FG000|Overall Study|Lost to Follow-up|3|||
16202167|NCT01610076|39218775|FG001|Overall Study|Lost to Follow-up|4|||
16202168|NCT02133742|39218776|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
16202169|NCT02133742|39218776|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
16202170|NCT02133742|39218776|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
16202171|NCT02133742|39218776|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
16202172|NCT02133742|39218776|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
16202173|NCT02156804|39218777|FG000|Overall Study|Withdrawal by Subject|1|||
16202174|NCT01117012|39218778|FG000|Overall Study|Adverse Event|0|||
16202175|NCT01117012|39218779|FG001|Overall Study|Adverse Event|1|||
16202176|NCT01117012|39218778|FG000|Overall Study|Death|1|||
16202177|NCT01117012|39218779|FG001|Overall Study|Death|1|||
16202178|NCT01117012|39218778|FG000|Overall Study|Withdrawal by Subject|3|||
16202179|NCT01117012|39218779|FG001|Overall Study|Withdrawal by Subject|0|||
16202180|NCT01117012|39218778|FG000|Overall Study|Undefined|4|||
16202181|NCT01117012|39218779|FG001|Overall Study|Undefined|3|||
16202182|NCT00405652|39218780|FG000|Overall Study|Adverse Event|4|||
16202183|NCT03803202|39218781|FG000|Overall Study|Other|0|||
16202184|NCT03803202|39218782|FG001|Overall Study|Other|1|||
16202185|NCT03803202|39218783|FG002|Overall Study|Other|0|||
16202186|NCT03803202|39218784|FG003|Overall Study|Other|0|||
16202187|NCT03803202|39218785|FG004|Overall Study|Other|0|||
16202188|NCT03803202|39218786|FG005|Overall Study|Other|0|||
16202189|NCT03803202|39218787|FG006|Overall Study|Other|0|||
16202190|NCT03803202|39218788|FG007|Overall Study|Other|0|||
16202191|NCT03803202|39218789|FG008|Overall Study|Other|0|||
16202192|NCT03803202|39218781|FG000|Overall Study|Death|0|||
16320600|NCT02343939|39660333|FG005|Overall Study|Adverse Event|1|||
16202193|NCT03803202|39218782|FG001|Overall Study|Death|0|||
16202194|NCT03803202|39218783|FG002|Overall Study|Death|0|||
16320601|NCT02343939|39660334|FG006|Overall Study|Adverse Event|0|||
16202195|NCT03803202|39218784|FG003|Overall Study|Death|0|||
16202196|NCT03803202|39218785|FG004|Overall Study|Death|0|||
16202197|NCT03803202|39218786|FG005|Overall Study|Death|1|||
16202198|NCT03803202|39218787|FG006|Overall Study|Death|0|||
16202199|NCT03803202|39218788|FG007|Overall Study|Death|0|||
16202200|NCT03803202|39218789|FG008|Overall Study|Death|0|||
16202201|NCT03803202|39218781|FG000|Overall Study|Withdrawal by Subject|0|||
16202202|NCT03803202|39218782|FG001|Overall Study|Withdrawal by Subject|0|||
16202203|NCT03803202|39218783|FG002|Overall Study|Withdrawal by Subject|1|||
16202204|NCT03803202|39218784|FG003|Overall Study|Withdrawal by Subject|0|||
16202205|NCT03803202|39218785|FG004|Overall Study|Withdrawal by Subject|0|||
16202206|NCT03803202|39218786|FG005|Overall Study|Withdrawal by Subject|0|||
16202207|NCT03803202|39218787|FG006|Overall Study|Withdrawal by Subject|0|||
16202208|NCT03803202|39218788|FG007|Overall Study|Withdrawal by Subject|1|||
16202209|NCT03803202|39218789|FG008|Overall Study|Withdrawal by Subject|0|||
16202210|NCT03803202|39218781|FG000|Overall Study|Lost to Follow-up|0|||
16202211|NCT03803202|39218782|FG001|Overall Study|Lost to Follow-up|0|||
16202212|NCT03803202|39218783|FG002|Overall Study|Lost to Follow-up|0|||
16202213|NCT03803202|39218784|FG003|Overall Study|Lost to Follow-up|1|||
16202214|NCT03803202|39218785|FG004|Overall Study|Lost to Follow-up|1|||
16202215|NCT03803202|39218786|FG005|Overall Study|Lost to Follow-up|0|||
16202216|NCT03803202|39218787|FG006|Overall Study|Lost to Follow-up|1|||
16202217|NCT03803202|39218788|FG007|Overall Study|Lost to Follow-up|0|||
16202218|NCT03803202|39218789|FG008|Overall Study|Lost to Follow-up|0|||
16202219|NCT03595384|39218790|FG000|Overall Study|Other time commitments|8|||
16202220|NCT03595384|39218790|FG000|Overall Study|Changes to session time|7|||
16202221|NCT03595384|39218790|FG000|Overall Study|Relocation out of country|1|||
16202222|NCT01231607|39218791|FG000|Overall Study|Adverse Event|0|||
16202223|NCT01231607|39218792|FG001|Overall Study|Adverse Event|8|||
16202224|NCT01231607|39218793|FG002|Overall Study|Adverse Event|4|||
16202225|NCT01231607|39218794|FG003|Overall Study|Adverse Event|4|||
16202226|NCT01231607|39218795|FG004|Overall Study|Adverse Event|5|||
16202227|NCT01231607|39218791|FG000|Overall Study|Lost to Follow-up|13|||
16202228|NCT01231607|39218792|FG001|Overall Study|Lost to Follow-up|11|||
16202229|NCT01231607|39218793|FG002|Overall Study|Lost to Follow-up|10|||
16202230|NCT01231607|39218794|FG003|Overall Study|Lost to Follow-up|10|||
16202231|NCT01231607|39218795|FG004|Overall Study|Lost to Follow-up|4|||
16202232|NCT01231607|39218791|FG000|Overall Study|Physician Decision|4|||
16202233|NCT01231607|39218792|FG001|Overall Study|Physician Decision|4|||
16202234|NCT01231607|39218793|FG002|Overall Study|Physician Decision|3|||
16202235|NCT01231607|39218794|FG003|Overall Study|Physician Decision|5|||
16202236|NCT01231607|39218795|FG004|Overall Study|Physician Decision|4|||
16202237|NCT01231607|39218791|FG000|Overall Study|Protocol Violation|3|||
16202238|NCT01231607|39218792|FG001|Overall Study|Protocol Violation|2|||
16202239|NCT01231607|39218793|FG002|Overall Study|Protocol Violation|0|||
16202240|NCT01231607|39218794|FG003|Overall Study|Protocol Violation|2|||
16202241|NCT01231607|39218795|FG004|Overall Study|Protocol Violation|2|||
16202242|NCT01231607|39218791|FG000|Overall Study|Withdrawal by Subject|9|||
16202243|NCT01231607|39218792|FG001|Overall Study|Withdrawal by Subject|9|||
16202244|NCT01231607|39218793|FG002|Overall Study|Withdrawal by Subject|14|||
16202245|NCT01231607|39218794|FG003|Overall Study|Withdrawal by Subject|17|||
16202246|NCT01231607|39218795|FG004|Overall Study|Withdrawal by Subject|9|||
16202247|NCT03454412|39218796|FG000|Baseline Assesment|Physician Decision|12|||
16202248|NCT02585999|39218797|FG000|Overall Study|Lost to Follow-up|1|||
16202249|NCT02585999|39218797|FG000|Overall Study|Protocol Violation|1|||
16202250|NCT02871401|39218798|FG000|Overall Study|Adverse Event|1|||
16202251|NCT02871401|39218799|FG001|Overall Study|Adverse Event|0|||
16202252|NCT00618995|39218801|FG000|Period 1|Adverse Event|0|||
16202253|NCT00618995|39218802|FG001|Period 1|Adverse Event|0|||
16202254|NCT00618995|39218803|FG002|Period 1|Adverse Event|1|||
16202255|NCT00618995|39218804|FG003|Period 1|Adverse Event|0|||
16202256|NCT00618995|39218801|FG000|Period 1|Protocol Violation|0|||
16202257|NCT00618995|39218802|FG001|Period 1|Protocol Violation|1|||
16202258|NCT00618995|39218803|FG002|Period 1|Protocol Violation|1|||
16202259|NCT00618995|39218804|FG003|Period 1|Protocol Violation|0|||
16202260|NCT00618995|39218801|FG000|Period 2|Protocol Violation|0|||
16202261|NCT00618995|39218802|FG001|Period 2|Protocol Violation|0|||
16202262|NCT00618995|39218803|FG002|Period 2|Protocol Violation|1|||
16202263|NCT00618995|39218804|FG003|Period 2|Protocol Violation|0|||
16202264|NCT00618995|39218801|FG000|Period 4|Adverse Event|1|||
16202265|NCT00618995|39218802|FG001|Period 4|Adverse Event|0|||
16202266|NCT00618995|39218803|FG002|Period 4|Adverse Event|0|||
16202267|NCT00618995|39218804|FG003|Period 4|Adverse Event|0|||
16202268|NCT00856986|39218805|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
16202269|NCT00856986|39218806|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
16202270|NCT00856986|39218807|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
16202271|NCT00856986|39218808|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
16202272|NCT00856986|39218809|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
16202273|NCT00856986|39218805|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
16202274|NCT00856986|39218806|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
16515167|NCT01631474|40355512|FG002|Overall Study|Lack of Efficacy|0|||
16515168|NCT01631474|40355513|FG003|Overall Study|Lack of Efficacy|0|||
16515169|NCT01631474|40355514|FG004|Overall Study|Lack of Efficacy|2|||
16515170|NCT01631474|40355510|FG000|Overall Study|Noncompliance with Study Drug|0|||
16515171|NCT01631474|40355511|FG001|Overall Study|Noncompliance with Study Drug|0|||
16515172|NCT01631474|40355512|FG002|Overall Study|Noncompliance with Study Drug|0|||
16515173|NCT01631474|40355513|FG003|Overall Study|Noncompliance with Study Drug|0|||
16515174|NCT01631474|40355514|FG004|Overall Study|Noncompliance with Study Drug|1|||
16515175|NCT01631474|40355510|FG000|Overall Study|Adverse Event|0|||
16515176|NCT01631474|40355511|FG001|Overall Study|Adverse Event|1|||
16515177|NCT01631474|40355512|FG002|Overall Study|Adverse Event|0|||
16515178|NCT01631474|40355513|FG003|Overall Study|Adverse Event|0|||
16515179|NCT01631474|40355514|FG004|Overall Study|Adverse Event|0|||
16515180|NCT01400841|40355517|FG000|Initial Study Phase (6 Months)|Death|1|||
16515181|NCT01400841|40355517|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
16515182|NCT00218543|40355519|FG000|Overall Study|Lost to Follow-up|8|||
16515183|NCT00218543|40355519|FG000|Overall Study|relocated|1|||
16515184|NCT00218543|40355519|FG000|Overall Study|Withdrawal by Subject|1|||
16515185|NCT00218543|40355519|FG000|Overall Study|Physician Decision|3|||
16515186|NCT00218543|40355519|FG000|Overall Study|Adverse Event|2|||
16515187|NCT00749775|40355520|FG000|Overall Study|Protocol Violation|24|||
16515188|NCT00749775|40355520|FG000|Overall Study|Lost to Follow-up|36|||
16515189|NCT00749775|40355520|FG000|Overall Study|No visit after first day of treatment|44|||
16515190|NCT00749775|40355520|FG000|Overall Study|No drug administration|3|||
16515191|NCT02410811|40355525|FG000|Overall Study|Withdrawal by Subject|0|||
16515192|NCT02410811|40355526|FG001|Overall Study|Withdrawal by Subject|0|||
16515193|NCT02410811|40355527|FG002|Overall Study|Withdrawal by Subject|1|||
16515194|NCT02410811|40355528|FG003|Overall Study|Withdrawal by Subject|0|||
16515195|NCT01485861|40355529|FG000|Phase Ib|Death|1|||
16515196|NCT01485861|40355530|FG001|Phase Ib|Death|0|||
16515197|NCT01485861|40355531|FG002|Phase Ib|Death|0|||
16515198|NCT01485861|40355532|FG003|Phase Ib|Death|0|||
16515199|NCT01485861|40355533|FG004|Phase Ib|Death|0|||
16515200|NCT01485861|40355534|FG005|Phase Ib|Death|0|||
16515201|NCT01485861|40355529|FG000|Phase Ib|Physician Decision|1|||
16515202|NCT01485861|40355530|FG001|Phase Ib|Physician Decision|1|||
16515203|NCT01485861|40355531|FG002|Phase Ib|Physician Decision|0|||
16515204|NCT01485861|40355532|FG003|Phase Ib|Physician Decision|0|||
16320602|NCT02343939|39660335|FG007|Overall Study|Adverse Event|0|||
16515205|NCT01485861|40355533|FG004|Phase Ib|Physician Decision|0|||
16515206|NCT01485861|40355534|FG005|Phase Ib|Physician Decision|0|||
16515207|NCT01485861|40355529|FG000|Phase Ib|Adverse Event|0|||
16515208|NCT01485861|40355530|FG001|Phase Ib|Adverse Event|4|||
16515209|NCT01485861|40355531|FG002|Phase Ib|Adverse Event|0|||
16515210|NCT01485861|40355532|FG003|Phase Ib|Adverse Event|0|||
16515211|NCT01485861|40355533|FG004|Phase Ib|Adverse Event|0|||
16515212|NCT01485861|40355534|FG005|Phase Ib|Adverse Event|0|||
16515213|NCT01485861|40355529|FG000|Phase Ib|Progression of disease|5|||
16515214|NCT01485861|40355530|FG001|Phase Ib|Progression of disease|0|||
16202275|NCT00856986|39218807|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
16202276|NCT00856986|39218808|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
16515215|NCT01485861|40355531|FG002|Phase Ib|Progression of disease|0|||
16515216|NCT01485861|40355532|FG003|Phase Ib|Progression of disease|0|||
16515217|NCT01485861|40355533|FG004|Phase Ib|Progression of disease|0|||
16515218|NCT01485861|40355534|FG005|Phase Ib|Progression of disease|0|||
16515219|NCT01485861|40355529|FG000|Phase Ib|Other|3|||
16090511|NCT00428714|38823450|FG001|Overall Study|Adverse Event|2|||
16090512|NCT00428714|38823449|FG000|Overall Study|Physician Decision|1|||
16090513|NCT00428714|38823450|FG001|Overall Study|Physician Decision|1|||
16090514|NCT00428714|38823449|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
16090515|NCT00428714|38823450|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
16090516|NCT00428714|38823449|FG000|Overall Study|Death due to other then PD|1|||
16090517|NCT00428714|38823450|FG001|Overall Study|Death due to other then PD|0|||
16090518|NCT00388726|38823451|FG000|Overall Study|Adverse Event|50|||
16090519|NCT00388726|38823452|FG001|Overall Study|Adverse Event|24|||
16090520|NCT00388726|38823451|FG000|Overall Study|Progressive Disease|336|||
16202277|NCT00856986|39218809|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
16202278|NCT00856986|39218805|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
16202279|NCT00856986|39218806|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
16202280|NCT00856986|39218807|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
16202281|NCT00856986|39218808|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
16202282|NCT00856986|39218809|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
16090521|NCT00388726|38823452|FG001|Overall Study|Progressive Disease|153|||
16090522|NCT00388726|38823451|FG000|Overall Study|Clinical Progression|61|||
16090523|NCT00388726|38823452|FG001|Overall Study|Clinical Progression|36|||
16090524|NCT00388726|38823451|FG000|Overall Study|Withdrawal by Subject|10|||
16090525|NCT00388726|38823452|FG001|Overall Study|Withdrawal by Subject|7|||
16090526|NCT00388726|38823451|FG000|Overall Study|Administrative|6|||
16090527|NCT00388726|38823452|FG001|Overall Study|Administrative|9|||
16090528|NCT00388726|38823451|FG000|Overall Study|Physician Decision|18|||
16090529|NCT00388726|38823452|FG001|Overall Study|Physician Decision|13|||
16090530|NCT00388726|38823451|FG000|Overall Study|Death|3|||
16090531|NCT00388726|38823452|FG001|Overall Study|Death|2|||
16090532|NCT00446095|38823453|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
16202283|NCT00856986|39218805|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
16202284|NCT00856986|39218806|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
16202285|NCT00856986|39218807|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
16202286|NCT00856986|39218808|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
16202287|NCT00856986|39218809|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
16202288|NCT00856986|39218805|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
16202289|NCT00856986|39218806|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
16394472|NCT03072043|39924702|FG001|Overall Study|Withdrawal by Subject|0|||
16394473|NCT03072043|39924703|FG002|Overall Study|Withdrawal by Subject|4|||
16394474|NCT01162473|39924704|FG000|Overall Study|Adverse Event|2|||
16394475|NCT01162473|39924705|FG001|Overall Study|Adverse Event|1|||
16394476|NCT01162473|39924704|FG000|Overall Study|Withdrawal by Subject|0|||
16394477|NCT01162473|39924705|FG001|Overall Study|Withdrawal by Subject|4|||
16515220|NCT01485861|40355530|FG001|Phase Ib|Other|0|||
16515221|NCT01485861|40355531|FG002|Phase Ib|Other|0|||
16515222|NCT01485861|40355532|FG003|Phase Ib|Other|0|||
16515223|NCT01485861|40355533|FG004|Phase Ib|Other|0|||
16090533|NCT00446095|38823454|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
16090534|NCT00446095|38823455|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
16090535|NCT00446095|38823456|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
16202290|NCT00856986|39218807|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
16320603|NCT02343939|39660336|FG008|Overall Study|Adverse Event|0|||
16394478|NCT03802630|39924706|FG000|Overall Study|Study terminated by sponsor|130|||
16515224|NCT01485861|40355534|FG005|Phase Ib|Other|0|||
16090536|NCT00446095|38823457|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
16515225|NCT01485861|40355529|FG000|Phase Ib|Withdrawal by Subject|4|||
16515226|NCT01485861|40355530|FG001|Phase Ib|Withdrawal by Subject|1|||
16090537|NCT00446095|38823453|FG000|Phase II (8 Weeks)|Adverse Event|0|||
16090538|NCT00446095|38823454|FG001|Phase II (8 Weeks)|Adverse Event|1|||
16090539|NCT00446095|38823455|FG002|Phase II (8 Weeks)|Adverse Event|1|||
16090540|NCT00446095|38823456|FG003|Phase II (8 Weeks)|Adverse Event|0|||
16090541|NCT00446095|38823457|FG004|Phase II (8 Weeks)|Adverse Event|0|||
16090542|NCT00446095|38823453|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
16090543|NCT00446095|38823454|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
16090544|NCT00446095|38823455|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
16090545|NCT00446095|38823456|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
16090546|NCT00446095|38823457|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
16090547|NCT00446095|38823453|FG000|Phase II (8 Weeks)|Physician Decision|1|||
16090548|NCT00446095|38823454|FG001|Phase II (8 Weeks)|Physician Decision|0|||
16090549|NCT00446095|38823455|FG002|Phase II (8 Weeks)|Physician Decision|0|||
16090550|NCT00446095|38823456|FG003|Phase II (8 Weeks)|Physician Decision|0|||
16090551|NCT00446095|38823457|FG004|Phase II (8 Weeks)|Physician Decision|0|||
16090552|NCT00446095|38823453|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
16090553|NCT00446095|38823454|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
16090554|NCT00446095|38823455|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
16090555|NCT00446095|38823456|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
16090556|NCT00446095|38823457|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
16090557|NCT00446095|38823453|FG000|Phase II (8 Weeks)|Ongoing|0|||
16090558|NCT00446095|38823454|FG001|Phase II (8 Weeks)|Ongoing|0|||
16090559|NCT00446095|38823455|FG002|Phase II (8 Weeks)|Ongoing|1|||
16090560|NCT00446095|38823456|FG003|Phase II (8 Weeks)|Ongoing|0|||
16090561|NCT00446095|38823457|FG004|Phase II (8 Weeks)|Ongoing|0|||
16090562|NCT00446095|38823453|FG000|Phase I (28 Days)|Adverse Event|0|||
16090563|NCT00446095|38823454|FG001|Phase I (28 Days)|Adverse Event|0|||
16090564|NCT00446095|38823455|FG002|Phase I (28 Days)|Adverse Event|0|||
16090565|NCT00446095|38823456|FG003|Phase I (28 Days)|Adverse Event|1|||
16090566|NCT00446095|38823457|FG004|Phase I (28 Days)|Adverse Event|0|||
16090567|NCT00446095|38823453|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
16090568|NCT00446095|38823454|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
16090569|NCT00446095|38823455|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
16090570|NCT00446095|38823456|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
16090571|NCT00446095|38823457|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
16090572|NCT00963924|38823460|FG000|Overall Study|Adverse Event|1|||
16090573|NCT00963924|38823461|FG001|Overall Study|Adverse Event|0|||
16090574|NCT00963924|38823460|FG000|Overall Study|Withdrawal by Subject|0|||
16090575|NCT00963924|38823461|FG001|Overall Study|Withdrawal by Subject|1|||
16090576|NCT00963924|38823460|FG000|Overall Study|Changed antipsychotic|0|||
16090577|NCT00963924|38823461|FG001|Overall Study|Changed antipsychotic|1|||
16090578|NCT00963924|38823460|FG000|Overall Study|Lost to Follow-up|0|||
16090579|NCT00963924|38823461|FG001|Overall Study|Lost to Follow-up|1|||
16090580|NCT00739934|38823462|FG000|Voriconazole IV|Adverse Event|6|||
16090581|NCT00739934|38823462|FG000|Voriconazole Oral|Other|3|||
16090582|NCT02993926|38823470|FG000|Enantone Treatment Phase|Adverse Event|1|||
16090583|NCT02993926|38823471|FG001|Enantone Treatment Phase|Adverse Event|0|||
16090584|NCT02993926|38823472|FG002|Enantone Treatment Phase|Adverse Event|0|||
16090585|NCT02993926|38823470|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
16090586|NCT02993926|38823471|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
16090587|NCT02993926|38823472|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
16090588|NCT02993926|38823470|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
16090589|NCT02993926|38823471|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
16090590|NCT02993926|38823472|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
16090591|NCT02993926|38823470|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
16090592|NCT02993926|38823471|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
16090593|NCT02993926|38823472|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
16090594|NCT00266656|38823473|FG000|Overall Study|Death|1|||
16090595|NCT00266656|38823474|FG001|Overall Study|Death|0|||
16090596|NCT00266656|38823473|FG000|Overall Study|Lost to Follow-up|4|||
16202291|NCT00856986|39218808|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
16202292|NCT00856986|39218809|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
16515227|NCT01485861|40355531|FG002|Phase Ib|Withdrawal by Subject|0|||
16515228|NCT01485861|40355532|FG003|Phase Ib|Withdrawal by Subject|0|||
16515229|NCT01485861|40355533|FG004|Phase Ib|Withdrawal by Subject|0|||
16515230|NCT01485861|40355534|FG005|Phase Ib|Withdrawal by Subject|0|||
16515231|NCT01485861|40355529|FG000|Phase II|Death|0|||
16515232|NCT01485861|40355530|FG001|Phase II|Death|0|||
16090597|NCT00266656|38823474|FG001|Overall Study|Lost to Follow-up|1|||
16090598|NCT00266656|38823473|FG000|Overall Study|Withdrawal by Subject|4|||
16090599|NCT00266656|38823474|FG001|Overall Study|Withdrawal by Subject|2|||
16090600|NCT00266656|38823473|FG000|Overall Study|Did Not Reach Final Height|4|||
16202293|NCT00856986|39218805|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
16202294|NCT00856986|39218806|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
16515233|NCT01485861|40355531|FG002|Phase II|Death|67|||
16515234|NCT01485861|40355532|FG003|Phase II|Death|71|||
16515235|NCT01485861|40355533|FG004|Phase II|Death|68|||
16090601|NCT00266656|38823474|FG001|Overall Study|Did Not Reach Final Height|8|||
16515236|NCT01485861|40355534|FG005|Phase II|Death|0|||
16515237|NCT01485861|40355529|FG000|Phase II|Progression of Disease|0|||
16320604|NCT02343939|39660328|FG000|Overall Study|Never Treated With ENTO|0|||
16320605|NCT02343939|39660329|FG001|Overall Study|Never Treated With ENTO|0|||
16320606|NCT02343939|39660330|FG002|Overall Study|Never Treated With ENTO|0|||
16320607|NCT02343939|39660331|FG003|Overall Study|Never Treated With ENTO|0|||
16320608|NCT02343939|39660332|FG004|Overall Study|Never Treated With ENTO|0|||
16320609|NCT02343939|39660333|FG005|Overall Study|Never Treated With ENTO|0|||
16320610|NCT02343939|39660334|FG006|Overall Study|Never Treated With ENTO|1|||
16320611|NCT02343939|39660335|FG007|Overall Study|Never Treated With ENTO|2|||
16320612|NCT02343939|39660336|FG008|Overall Study|Never Treated With ENTO|0|||
16320613|NCT03991299|39660337|FG000|Overall Study|Study closed, sponsor decision|3|||
16320614|NCT03991299|39660337|FG000|Overall Study|Withdrawal by Subject|1|||
16320615|NCT00831311|39660338|FG000|Overall Study|Definitive Contraindication|3|||
16394479|NCT03802630|39924707|FG001|Overall Study|Study terminated by sponsor|134|||
16394480|NCT03802630|39924706|FG000|Overall Study|Subject decision|16|||
16394481|NCT03802630|39924707|FG001|Overall Study|Subject decision|9|||
16394482|NCT03802630|39924706|FG000|Overall Study|Adverse Event|3|||
16394483|NCT03802630|39924707|FG001|Overall Study|Adverse Event|1|||
16394484|NCT03802630|39924706|FG000|Overall Study|Lost to Follow-up|2|||
16394485|NCT03802630|39924707|FG001|Overall Study|Lost to Follow-up|2|||
16394486|NCT03802630|39924706|FG000|Overall Study|Physician Decision|2|||
16394487|NCT03802630|39924707|FG001|Overall Study|Physician Decision|0|||
16394488|NCT03802630|39924706|FG000|Overall Study|Death|0|||
16394489|NCT03802630|39924707|FG001|Overall Study|Death|2|||
16394490|NCT00992056|39924711|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
16394491|NCT00992056|39924712|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
16394492|NCT00992056|39924711|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
16394493|NCT00992056|39924712|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
16394494|NCT01772550|39924713|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
16394495|NCT01772550|39924714|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
16320616|NCT00831311|39660339|FG001|Overall Study|Definitive Contraindication|3|||
16320617|NCT00831311|39660338|FG000|Overall Study|Lost to Follow-up|3|||
16320618|NCT00831311|39660339|FG001|Overall Study|Lost to Follow-up|0|||
16320619|NCT00831311|39660338|FG000|Overall Study|Physician Decision|0|||
16320620|NCT00831311|39660339|FG001|Overall Study|Physician Decision|1|||
16320621|NCT00831311|39660338|FG000|Overall Study|Withdrawal by Subject|6|||
16320622|NCT00831311|39660339|FG001|Overall Study|Withdrawal by Subject|4|||
16394496|NCT01772550|39924715|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
16394497|NCT01772550|39924713|FG000|Overall Study|Adverse Event|0|||
16394498|NCT01772550|39924714|FG001|Overall Study|Adverse Event|0|||
16394499|NCT01772550|39924715|FG002|Overall Study|Adverse Event|1|||
16394500|NCT00041470|39924717|FG000|Overall Study|Loss of Funding|38|||
16394501|NCT02858440|39924723|FG000|Overall Study|Lost to Follow-up|3|||
16394502|NCT02858440|39924723|FG000|Overall Study|Protocol Violation|2|||
16394503|NCT02858440|39924723|FG000|Overall Study|Consent withdrawal|3|||
16394504|NCT02858440|39924723|FG000|Overall Study|Migrated/moved from study area|4|||
16394505|NCT01248728|39924726|FG000|Overall Study|Adverse Event|1|||
16394506|NCT01248728|39924727|FG001|Overall Study|Adverse Event|1|||
16394507|NCT01248728|39924726|FG000|Overall Study|Withdrawal by Subject|2|||
16320623|NCT03889418|39660340|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
16320624|NCT03889418|39660341|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
16320625|NCT03889418|39660342|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
16320626|NCT03889418|39660343|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
16320627|NCT03889418|39660344|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
16320628|NCT03889418|39660345|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
16320629|NCT03889418|39660346|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
16320630|NCT03889418|39660347|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
16320631|NCT03889418|39660348|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
16320632|NCT03889418|39660349|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
16320633|NCT03889418|39660340|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
16320634|NCT03889418|39660341|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
16320635|NCT03889418|39660342|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
16320636|NCT03889418|39660343|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
16320637|NCT03889418|39660344|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
16320638|NCT03889418|39660345|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
16320639|NCT03889418|39660346|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
16320640|NCT03889418|39660347|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
16320641|NCT03889418|39660348|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
16394508|NCT01248728|39924727|FG001|Overall Study|Withdrawal by Subject|1|||
16394509|NCT01248728|39924726|FG000|Overall Study|Lack of Efficacy|1|||
16394510|NCT01248728|39924727|FG001|Overall Study|Lack of Efficacy|0|||
16394511|NCT02969915|39924728|FG000|Overall Study|Death|104|||
16394512|NCT02969915|39924729|FG001|Overall Study|Death|125|||
16394513|NCT02969915|39924728|FG000|Overall Study|Lost to Follow-up|108|||
16394514|NCT02969915|39924729|FG001|Overall Study|Lost to Follow-up|112|||
16515238|NCT01485861|40355530|FG001|Phase II|Progression of Disease|0|||
16320642|NCT03889418|39660349|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
16320643|NCT03889418|39660340|FG000|October-December 2019 (Month 7-9)|Death|0|||
16320644|NCT03889418|39660341|FG001|October-December 2019 (Month 7-9)|Death|0|||
16320645|NCT03889418|39660342|FG002|October-December 2019 (Month 7-9)|Death|0|||
16320646|NCT03889418|39660343|FG003|October-December 2019 (Month 7-9)|Death|0|||
16320647|NCT03889418|39660344|FG004|October-December 2019 (Month 7-9)|Death|0|||
16320648|NCT03889418|39660345|FG005|October-December 2019 (Month 7-9)|Death|0|||
16320649|NCT03889418|39660346|FG006|October-December 2019 (Month 7-9)|Death|0|||
16320650|NCT03889418|39660347|FG007|October-December 2019 (Month 7-9)|Death|0|||
16320651|NCT03889418|39660348|FG008|October-December 2019 (Month 7-9)|Death|1|||
16320652|NCT03889418|39660349|FG009|October-December 2019 (Month 7-9)|Death|0|||
16320653|NCT03889418|39660340|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
16320654|NCT03889418|39660341|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
16320655|NCT03889418|39660342|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
16320656|NCT03889418|39660343|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
16320657|NCT03889418|39660344|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
16320658|NCT03889418|39660345|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
16320659|NCT03889418|39660346|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
16394515|NCT02969915|39924728|FG000|Overall Study|Censored due to COVID-19|481|||
16394516|NCT02969915|39924729|FG001|Overall Study|Censored due to COVID-19|471|||
16394517|NCT02454530|39924736|FG000|Overall Study|Other|8|||
16394518|NCT02454530|39924737|FG001|Overall Study|Other|13|||
16394519|NCT02454530|39924736|FG000|Overall Study|Missing information|56|||
16394520|NCT02454530|39924737|FG001|Overall Study|Missing information|69|||
16394521|NCT02454530|39924736|FG000|Overall Study|Death|2|||
16394522|NCT02454530|39924737|FG001|Overall Study|Death|41|||
16394523|NCT02454530|39924736|FG000|Overall Study|Lost to Follow-up|4|||
16394524|NCT02454530|39924737|FG001|Overall Study|Lost to Follow-up|4|||
16394525|NCT02581891|39924740|FG000|Overall Study|Adverse Event|4|||
16394526|NCT02581891|39924741|FG001|Overall Study|Adverse Event|6|||
16394527|NCT02581891|39924740|FG000|Overall Study|Death|3|||
16394528|NCT02581891|39924741|FG001|Overall Study|Death|4|||
16394529|NCT02581891|39924740|FG000|Overall Study|Lost to Follow-up|1|||
16394530|NCT02581891|39924741|FG001|Overall Study|Lost to Follow-up|2|||
16394531|NCT02581891|39924740|FG000|Overall Study|Physician Decision|0|||
16394532|NCT02581891|39924741|FG001|Overall Study|Physician Decision|1|||
16394533|NCT02581891|39924740|FG000|Overall Study|Withdrawal by Subject|4|||
16394534|NCT02581891|39924741|FG001|Overall Study|Withdrawal by Subject|5|||
16394535|NCT02581891|39924740|FG000|Overall Study|Other Reasons|3|||
16394536|NCT02581891|39924741|FG001|Overall Study|Other Reasons|1|||
16394537|NCT02581891|39924740|FG000|Overall Study|Discontinued during followup|1|||
16394538|NCT02581891|39924741|FG001|Overall Study|Discontinued during followup|0|||
16394539|NCT03525600|39924746|FG000|Overall Study|Adverse Event|9|||
16394540|NCT03525600|39924747|FG001|Overall Study|Adverse Event|6|||
16394541|NCT03525600|39924748|FG002|Overall Study|Adverse Event|5|||
16394542|NCT03525600|39924749|FG003|Overall Study|Adverse Event|3|||
16394543|NCT03525600|39924746|FG000|Overall Study|Lost to Follow-up|2|||
16394544|NCT03525600|39924747|FG001|Overall Study|Lost to Follow-up|4|||
16394545|NCT03525600|39924748|FG002|Overall Study|Lost to Follow-up|4|||
16394546|NCT03525600|39924749|FG003|Overall Study|Lost to Follow-up|0|||
16394547|NCT03525600|39924746|FG000|Overall Study|Physician Decision|1|||
16394548|NCT03525600|39924747|FG001|Overall Study|Physician Decision|0|||
16320660|NCT03889418|39660347|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
16394549|NCT03525600|39924748|FG002|Overall Study|Physician Decision|2|||
16394550|NCT03525600|39924749|FG003|Overall Study|Physician Decision|0|||
16394551|NCT03525600|39924746|FG000|Overall Study|Consent withdrawal|36|||
16394552|NCT03525600|39924747|FG001|Overall Study|Consent withdrawal|20|||
16394553|NCT03525600|39924748|FG002|Overall Study|Consent withdrawal|6|||
16394554|NCT03525600|39924749|FG003|Overall Study|Consent withdrawal|13|||
16515239|NCT01485861|40355531|FG002|Phase II|Progression of Disease|1|||
16515240|NCT01485861|40355532|FG003|Phase II|Progression of Disease|0|||
16090602|NCT00266656|38823473|FG000|Overall Study|Parent/Caregiver Decision|1|||
16090603|NCT00266656|38823474|FG001|Overall Study|Parent/Caregiver Decision|2|||
16090604|NCT00799409|38823475|FG000|Overall Study|Withdrawal by Subject|1|||
16090605|NCT00799409|38823476|FG001|Overall Study|Withdrawal by Subject|0|||
16202295|NCT00856986|39218807|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
16202296|NCT00856986|39218808|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
16202297|NCT00856986|39218809|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
16202298|NCT00856986|39218805|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
16202299|NCT00856986|39218806|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
16202300|NCT00856986|39218807|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
16202301|NCT00856986|39218808|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
16202302|NCT00856986|39218809|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
16202303|NCT00856986|39218805|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
16202304|NCT00856986|39218806|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
16202305|NCT00856986|39218807|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
16202306|NCT00856986|39218808|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
16202307|NCT00856986|39218809|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
16202308|NCT00856986|39218805|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
16090606|NCT00799409|38823477|FG002|Overall Study|Withdrawal by Subject|0|||
16090607|NCT00799409|38823475|FG000|Overall Study|Lost to Follow-up|1|||
16090608|NCT00799409|38823476|FG001|Overall Study|Lost to Follow-up|0|||
16090609|NCT00799409|38823477|FG002|Overall Study|Lost to Follow-up|0|||
16090610|NCT00799409|38823475|FG000|Overall Study|Optimal Dose Not Achieved|2|||
16090611|NCT00799409|38823476|FG001|Overall Study|Optimal Dose Not Achieved|0|||
16090612|NCT00799409|38823477|FG002|Overall Study|Optimal Dose Not Achieved|0|||
16090613|NCT00799409|38823475|FG000|Overall Study|Failure to follow study protocol)|1|||
16090614|NCT00799409|38823476|FG001|Overall Study|Failure to follow study protocol)|0|||
16090615|NCT00799409|38823477|FG002|Overall Study|Failure to follow study protocol)|0|||
16090616|NCT00799409|38823475|FG000|Overall Study|Did not attend lab school day 1|1|||
16090617|NCT00799409|38823476|FG001|Overall Study|Did not attend lab school day 1|0|||
16090618|NCT00799409|38823477|FG002|Overall Study|Did not attend lab school day 1|0|||
16090619|NCT00799409|38823475|FG000|Overall Study|medication compliance|1|||
16090620|NCT00799409|38823476|FG001|Overall Study|medication compliance|0|||
16202309|NCT00856986|39218806|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
16202310|NCT00856986|39218807|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
16202311|NCT00856986|39218808|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
16202312|NCT00856986|39218809|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
16202313|NCT00856986|39218805|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
16202314|NCT00856986|39218806|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
16202315|NCT00856986|39218807|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
16202316|NCT00856986|39218808|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
16202317|NCT00856986|39218809|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
16202318|NCT00856986|39218805|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
16202319|NCT00856986|39218806|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
16202320|NCT00856986|39218807|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
16202321|NCT00856986|39218808|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
16202322|NCT00856986|39218809|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
16202323|NCT00856986|39218805|FG000|Main Period, Weeks 0-26|Unclassified|7|||
16202324|NCT00856986|39218806|FG001|Main Period, Weeks 0-26|Unclassified|6|||
16202325|NCT00856986|39218807|FG002|Main Period, Weeks 0-26|Unclassified|7|||
16202326|NCT00856986|39218808|FG003|Main Period, Weeks 0-26|Unclassified|0|||
16202327|NCT00856986|39218809|FG004|Main Period, Weeks 0-26|Unclassified|0|||
16202328|NCT00856986|39218805|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
16202329|NCT00856986|39218806|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
16202330|NCT00856986|39218807|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
16202331|NCT00856986|39218808|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
16202332|NCT00856986|39218809|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
16202333|NCT00856986|39218805|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
16202334|NCT00856986|39218806|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
16202335|NCT00856986|39218807|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
16202336|NCT00856986|39218808|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
16202337|NCT00856986|39218809|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
16202338|NCT00856986|39218805|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
16202339|NCT00856986|39218806|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
16202340|NCT00856986|39218807|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
16090621|NCT00799409|38823477|FG002|Overall Study|medication compliance|0|||
16090622|NCT03695185|38823480|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
16090623|NCT03695185|38823480|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
16202341|NCT00856986|39218808|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
16202342|NCT00856986|39218809|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
16202343|NCT00856986|39218805|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
16394555|NCT03525600|39924746|FG000|Overall Study|Death|7|||
16394556|NCT03525600|39924747|FG001|Overall Study|Death|6|||
16394557|NCT03525600|39924748|FG002|Overall Study|Death|4|||
16394558|NCT03525600|39924749|FG003|Overall Study|Death|3|||
16394559|NCT03525600|39924746|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
16394560|NCT03525600|39924747|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
16394561|NCT03525600|39924748|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
16394562|NCT03525600|39924749|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
16394563|NCT03525600|39924746|FG000|Overall Study|Other|0|||
16394564|NCT03525600|39924747|FG001|Overall Study|Other|1|||
16394565|NCT03525600|39924748|FG002|Overall Study|Other|0|||
16394566|NCT03525600|39924749|FG003|Overall Study|Other|0|||
16394567|NCT00135330|39924750|FG000|Overall Study|Adverse Event|2|||
16394568|NCT00135330|39924751|FG001|Overall Study|Adverse Event|5|||
16394569|NCT00135330|39924752|FG002|Overall Study|Adverse Event|1|||
16394570|NCT00135330|39924750|FG000|Overall Study|Lost to Follow-up|0|||
16394571|NCT00135330|39924751|FG001|Overall Study|Lost to Follow-up|2|||
16090624|NCT03695185|38823480|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
16090625|NCT03695185|38823480|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
16090626|NCT03695185|38823480|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
16394572|NCT00135330|39924752|FG002|Overall Study|Lost to Follow-up|3|||
16394573|NCT00135330|39924750|FG000|Overall Study|Physician Decision|1|||
16394574|NCT00135330|39924751|FG001|Overall Study|Physician Decision|1|||
16394575|NCT00135330|39924752|FG002|Overall Study|Physician Decision|0|||
16394576|NCT00135330|39924750|FG000|Overall Study|Protocol Violation|4|||
16090627|NCT03695185|38823480|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
16394577|NCT00135330|39924751|FG001|Overall Study|Protocol Violation|3|||
16394578|NCT00135330|39924752|FG002|Overall Study|Protocol Violation|3|||
16394579|NCT00135330|39924750|FG000|Overall Study|Patient Decision|5|||
16090628|NCT00486954|38823492|FG000|Pilot Part|Adverse Event|4|||
16394580|NCT00135330|39924751|FG001|Overall Study|Patient Decision|1|||
16320661|NCT03889418|39660348|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
16320662|NCT03889418|39660349|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
16320663|NCT03889418|39660340|FG000|April - June 2020 (Month 13-15)|Death|0|||
16320664|NCT03889418|39660341|FG001|April - June 2020 (Month 13-15)|Death|1|||
16320665|NCT03889418|39660342|FG002|April - June 2020 (Month 13-15)|Death|0|||
16320666|NCT03889418|39660343|FG003|April - June 2020 (Month 13-15)|Death|0|||
16320667|NCT03889418|39660344|FG004|April - June 2020 (Month 13-15)|Death|0|||
16320668|NCT03889418|39660345|FG005|April - June 2020 (Month 13-15)|Death|0|||
16320669|NCT03889418|39660346|FG006|April - June 2020 (Month 13-15)|Death|0|||
16320670|NCT03889418|39660347|FG007|April - June 2020 (Month 13-15)|Death|0|||
16320671|NCT03889418|39660348|FG008|April - June 2020 (Month 13-15)|Death|0|||
16320672|NCT03889418|39660349|FG009|April - June 2020 (Month 13-15)|Death|0|||
16320673|NCT03889418|39660340|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
16320674|NCT03889418|39660341|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
16320675|NCT03889418|39660342|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
16320676|NCT03889418|39660343|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
16320677|NCT03889418|39660344|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
16320678|NCT03889418|39660345|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
16394581|NCT00135330|39924752|FG002|Overall Study|Patient Decision|4|||
16394582|NCT00135330|39924750|FG000|Overall Study|Sponsor Decision|0|||
16394583|NCT00135330|39924751|FG001|Overall Study|Sponsor Decision|1|||
16394584|NCT00135330|39924752|FG002|Overall Study|Sponsor Decision|0|||
16394585|NCT02318368|39924753|FG000|Overall Study|Withdrawal by Subject|2|||
16394586|NCT02318368|39924754|FG001|Overall Study|Withdrawal by Subject|0|||
16394587|NCT02318368|39924753|FG000|Overall Study|Study terminated by the sponsor|5|||
16394588|NCT02318368|39924754|FG001|Overall Study|Study terminated by the sponsor|2|||
16394589|NCT02318368|39924753|FG000|Overall Study|Death|0|||
16394590|NCT02318368|39924754|FG001|Overall Study|Death|1|||
16394591|NCT03050450|39924755|FG000|Overall Study|Physician Decision|1|||
16394592|NCT03050450|39924756|FG001|Overall Study|Physician Decision|0|||
16394593|NCT03050450|39924757|FG002|Overall Study|Physician Decision|0|||
16394594|NCT03050450|39924758|FG003|Overall Study|Physician Decision|0|||
16394595|NCT03050450|39924759|FG004|Overall Study|Physician Decision|0|||
16394596|NCT02623205|39924760|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
16394597|NCT02623205|39924761|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
16394598|NCT01681186|39924762|FG000|Washout Period From Second Intervention|Adverse Event|0|||
16394599|NCT01681186|39924763|FG001|Washout Period From Second Intervention|Adverse Event|0|||
16394600|NCT01681186|39924764|FG002|Washout Period From Second Intervention|Adverse Event|0|||
16394601|NCT01681186|39924765|FG003|Washout Period From Second Intervention|Adverse Event|0|||
16394602|NCT01681186|39924766|FG004|Washout Period From Second Intervention|Adverse Event|0|||
16394603|NCT01681186|39924767|FG005|Washout Period From Second Intervention|Adverse Event|0|||
16394604|NCT01681186|39924768|FG006|Washout Period From Second Intervention|Adverse Event|1|||
16394605|NCT01681186|39924769|FG007|Washout Period From Second Intervention|Adverse Event|0|||
16394606|NCT01681186|39924762|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
16394607|NCT01681186|39924763|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
16394608|NCT01681186|39924764|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
16394609|NCT01681186|39924765|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
16394610|NCT01681186|39924766|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
16394611|NCT01681186|39924767|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
16394612|NCT01681186|39924768|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
16394613|NCT01681186|39924769|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
16394614|NCT01681186|39924762|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
16394615|NCT01681186|39924763|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
16394616|NCT01681186|39924764|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
16394617|NCT01681186|39924765|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
16394618|NCT01681186|39924766|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
16394619|NCT01681186|39924767|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
16394620|NCT01681186|39924768|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
16394621|NCT01681186|39924769|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
16394622|NCT01681186|39924762|FG000|Fourth Intervention|Protocol Violation|0|||
16394623|NCT01681186|39924763|FG001|Fourth Intervention|Protocol Violation|0|||
16394624|NCT01681186|39924764|FG002|Fourth Intervention|Protocol Violation|0|||
16394625|NCT01681186|39924765|FG003|Fourth Intervention|Protocol Violation|0|||
16394626|NCT01681186|39924766|FG004|Fourth Intervention|Protocol Violation|0|||
16394627|NCT01681186|39924767|FG005|Fourth Intervention|Protocol Violation|0|||
16394628|NCT01681186|39924768|FG006|Fourth Intervention|Protocol Violation|0|||
16394629|NCT01681186|39924769|FG007|Fourth Intervention|Protocol Violation|1|||
16394630|NCT03083665|39924776|FG000|Double-Blind Period|Adverse Event|5|||
16394631|NCT03083665|39924777|FG001|Double-Blind Period|Adverse Event|4|||
16394632|NCT03083665|39924778|FG002|Double-Blind Period|Adverse Event|5|||
16394633|NCT03083665|39924779|FG003|Double-Blind Period|Adverse Event|0|||
16394634|NCT03083665|39924780|FG004|Double-Blind Period|Adverse Event|0|||
16394635|NCT03083665|39924781|FG005|Double-Blind Period|Adverse Event|0|||
16394636|NCT03083665|39924776|FG000|Double-Blind Period|Lack of Efficacy|0|||
16394637|NCT03083665|39924777|FG001|Double-Blind Period|Lack of Efficacy|0|||
16394638|NCT03083665|39924778|FG002|Double-Blind Period|Lack of Efficacy|1|||
16394639|NCT03083665|39924779|FG003|Double-Blind Period|Lack of Efficacy|0|||
16394640|NCT03083665|39924780|FG004|Double-Blind Period|Lack of Efficacy|0|||
16090629|NCT00486954|38823493|FG001|Pilot Part|Adverse Event|0|||
16320679|NCT03889418|39660346|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
16320680|NCT03889418|39660347|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
16320681|NCT03889418|39660348|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
16320682|NCT03889418|39660349|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
16320683|NCT03889418|39660340|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
16320684|NCT03889418|39660341|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
16320685|NCT03889418|39660342|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
16320686|NCT03889418|39660343|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
16320687|NCT03889418|39660344|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
16320688|NCT03889418|39660345|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
16320689|NCT03889418|39660346|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
16320690|NCT03889418|39660347|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
16320691|NCT03889418|39660348|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
16320692|NCT03889418|39660349|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
16320693|NCT03889418|39660340|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
16320694|NCT03889418|39660341|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
16320695|NCT03889418|39660342|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
16320696|NCT03889418|39660343|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
16320697|NCT03889418|39660344|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
16320698|NCT03889418|39660345|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
16320699|NCT03889418|39660346|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
16320700|NCT03889418|39660347|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
16320701|NCT03889418|39660348|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
16320702|NCT03889418|39660349|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
16320703|NCT01262287|39660352|FG000|Overall Study|Lost to Follow-up|2|||
16320704|NCT01262287|39660353|FG001|Overall Study|Lost to Follow-up|1|||
16320705|NCT04168112|39660357|FG000|Overall Study|Lost to Follow-up|1|||
16320706|NCT04168112|39660358|FG001|Overall Study|Lost to Follow-up|0|||
16320707|NCT04168112|39660357|FG000|Overall Study|Withdrawal by Subject|1|||
16320708|NCT04168112|39660358|FG001|Overall Study|Withdrawal by Subject|0|||
16320709|NCT03343704|39660364|FG000|Overall Study|Refused to complete follow up|0|||
16320710|NCT03343704|39660365|FG001|Overall Study|Refused to complete follow up|1|||
16320711|NCT03343704|39660364|FG000|Overall Study|Death|0|||
16320712|NCT03343704|39660365|FG001|Overall Study|Death|1|||
16320713|NCT03343704|39660364|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
16320714|NCT03343704|39660365|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
16320715|NCT02609607|39660366|FG000|Overall Study|Lost to Follow-up|0|||
16394641|NCT03083665|39924781|FG005|Double-Blind Period|Lack of Efficacy|0|||
16394642|NCT03083665|39924776|FG000|Double-Blind Period|Protocol Violation|1|||
16394643|NCT03083665|39924777|FG001|Double-Blind Period|Protocol Violation|0|||
16320716|NCT02609607|39660367|FG001|Overall Study|Lost to Follow-up|1|||
16320717|NCT03309943|39660368|FG000|Overall Study|Withdrawal by Subject|0|||
16320718|NCT03309943|39660369|FG001|Overall Study|Withdrawal by Subject|1|||
16394644|NCT03083665|39924778|FG002|Double-Blind Period|Protocol Violation|1|||
16394645|NCT03083665|39924779|FG003|Double-Blind Period|Protocol Violation|0|||
16394646|NCT03083665|39924780|FG004|Double-Blind Period|Protocol Violation|0|||
16394647|NCT03083665|39924781|FG005|Double-Blind Period|Protocol Violation|0|||
16394648|NCT03083665|39924776|FG000|Double-Blind Period|Lost to Follow-up|1|||
16394649|NCT03083665|39924777|FG001|Double-Blind Period|Lost to Follow-up|0|||
16394650|NCT03083665|39924778|FG002|Double-Blind Period|Lost to Follow-up|1|||
16394651|NCT03083665|39924779|FG003|Double-Blind Period|Lost to Follow-up|0|||
16394652|NCT03083665|39924780|FG004|Double-Blind Period|Lost to Follow-up|0|||
16394653|NCT03083665|39924781|FG005|Double-Blind Period|Lost to Follow-up|0|||
16394654|NCT03083665|39924776|FG000|Double-Blind Period|Withdrawal by Subject|3|||
16394655|NCT03083665|39924777|FG001|Double-Blind Period|Withdrawal by Subject|0|||
16320719|NCT03309943|39660368|FG000|Overall Study|Inappropriate behavior towards staff|0|||
16394656|NCT03083665|39924778|FG002|Double-Blind Period|Withdrawal by Subject|0|||
16394657|NCT03083665|39924779|FG003|Double-Blind Period|Withdrawal by Subject|0|||
16394658|NCT03083665|39924780|FG004|Double-Blind Period|Withdrawal by Subject|0|||
16320720|NCT03309943|39660369|FG001|Overall Study|Inappropriate behavior towards staff|1|||
16320721|NCT03809663|39660375|FG000|Overall Study|Decision by sponsor|24|||
16320722|NCT03809663|39660376|FG001|Overall Study|Decision by sponsor|18|||
16320723|NCT03809663|39660377|FG002|Overall Study|Decision by sponsor|20|||
16320724|NCT03809663|39660378|FG003|Overall Study|Decision by sponsor|20|||
16320725|NCT03809663|39660379|FG004|Overall Study|Decision by sponsor|0|||
16320726|NCT03809663|39660380|FG005|Overall Study|Decision by sponsor|0|||
16320727|NCT03809663|39660375|FG000|Overall Study|Withdrawal by Subject|26|||
16320728|NCT03809663|39660376|FG001|Overall Study|Withdrawal by Subject|22|||
16320729|NCT03809663|39660377|FG002|Overall Study|Withdrawal by Subject|27|||
16320730|NCT03809663|39660378|FG003|Overall Study|Withdrawal by Subject|26|||
16320731|NCT03809663|39660379|FG004|Overall Study|Withdrawal by Subject|0|||
16320732|NCT03809663|39660380|FG005|Overall Study|Withdrawal by Subject|0|||
16320733|NCT03809663|39660375|FG000|Overall Study|Lost to Follow-up|1|||
16320734|NCT03809663|39660376|FG001|Overall Study|Lost to Follow-up|4|||
16320735|NCT03809663|39660377|FG002|Overall Study|Lost to Follow-up|1|||
16320736|NCT03809663|39660378|FG003|Overall Study|Lost to Follow-up|1|||
16320737|NCT03809663|39660379|FG004|Overall Study|Lost to Follow-up|0|||
16320738|NCT03809663|39660380|FG005|Overall Study|Lost to Follow-up|0|||
16320739|NCT02142959|39660384|FG000|Overall Study|Adverse Event|1|||
16320740|NCT02142959|39660385|FG001|Overall Study|Adverse Event|0|||
16320741|NCT02142959|39660386|FG002|Overall Study|Adverse Event|0|||
16320742|NCT02142959|39660384|FG000|Overall Study|Death|0|||
16320743|NCT02142959|39660385|FG001|Overall Study|Death|1|||
16320744|NCT02142959|39660386|FG002|Overall Study|Death|0|||
16320745|NCT02142959|39660384|FG000|Overall Study|Withdrawal by Subject|3|||
16320746|NCT02142959|39660385|FG001|Overall Study|Withdrawal by Subject|1|||
16320747|NCT02142959|39660386|FG002|Overall Study|Withdrawal by Subject|3|||
16320748|NCT02142959|39660384|FG000|Overall Study|Administrative Reasons|1|||
16320749|NCT02142959|39660385|FG001|Overall Study|Administrative Reasons|0|||
16320750|NCT02142959|39660386|FG002|Overall Study|Administrative Reasons|1|||
16320751|NCT02142959|39660384|FG000|Overall Study|Missing|0|||
16320752|NCT02142959|39660385|FG001|Overall Study|Missing|1|||
16320753|NCT02142959|39660386|FG002|Overall Study|Missing|0|||
16320754|NCT02142959|39660384|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
16320755|NCT02142959|39660385|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
16394659|NCT03083665|39924781|FG005|Double-Blind Period|Withdrawal by Subject|0|||
16394660|NCT03083665|39924776|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
16394661|NCT03083665|39924777|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
16394662|NCT03083665|39924778|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
16394663|NCT03083665|39924779|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
16320756|NCT02142959|39660386|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
16394664|NCT03083665|39924780|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
16394665|NCT03083665|39924781|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
16320757|NCT02142959|39660384|FG000|Overall Study|Patient didn't complete end of study visit|0|||
16320758|NCT02142959|39660385|FG001|Overall Study|Patient didn't complete end of study visit|0|||
16320759|NCT02142959|39660386|FG002|Overall Study|Patient didn't complete end of study visit|1|||
16320760|NCT02498444|39660387|FG000|Overall Study|Withdrawal by Subject|3|||
16320761|NCT02498444|39660388|FG001|Overall Study|Withdrawal by Subject|0|||
16320762|NCT02498444|39660387|FG000|Overall Study|Physician Decision|1|||
16320763|NCT02498444|39660388|FG001|Overall Study|Physician Decision|0|||
16320764|NCT00833105|39660389|FG000|Overall Study|Withdrawal by Subject|1|||
16320765|NCT00833105|39660389|FG000|Overall Study|Adverse Event|2|||
16320766|NCT03287635|39660399|FG000|Overall Study|Lost to Follow-up|5|||
16320767|NCT03287635|39660399|FG000|Overall Study|Withdrawal by Subject|1|||
16320768|NCT03287635|39660399|FG000|Overall Study|Physician Decision|1|||
16320769|NCT03337113|39660400|FG000|Overall Study|Adverse Event|1|||
16320770|NCT03337113|39660401|FG001|Overall Study|Adverse Event|1|||
16320771|NCT03337113|39660402|FG002|Overall Study|Adverse Event|0|||
16320772|NCT03337113|39660403|FG003|Overall Study|Adverse Event|1|||
16320773|NCT03337113|39660400|FG000|Overall Study|Physician Decision|0|||
16320774|NCT03337113|39660401|FG001|Overall Study|Physician Decision|2|||
16320775|NCT03337113|39660402|FG002|Overall Study|Physician Decision|0|||
16320776|NCT03337113|39660403|FG003|Overall Study|Physician Decision|1|||
16320777|NCT03337113|39660400|FG000|Overall Study|Withdrawal by Subject|0|||
16320778|NCT03337113|39660401|FG001|Overall Study|Withdrawal by Subject|0|||
16320779|NCT03337113|39660402|FG002|Overall Study|Withdrawal by Subject|1|||
16320780|NCT03337113|39660403|FG003|Overall Study|Withdrawal by Subject|0|||
16090630|NCT00486954|38823494|FG002|Pilot Part|Adverse Event|5|||
16090631|NCT00486954|38823495|FG003|Pilot Part|Adverse Event|0|||
16090632|NCT00486954|38823496|FG004|Pilot Part|Adverse Event|0|||
16090633|NCT00486954|38823492|FG000|Pilot Part|Disease Progression|2|||
16090634|NCT00486954|38823493|FG001|Pilot Part|Disease Progression|0|||
16090635|NCT00486954|38823494|FG002|Pilot Part|Disease Progression|1|||
16090636|NCT00486954|38823495|FG003|Pilot Part|Disease Progression|0|||
16090637|NCT00486954|38823496|FG004|Pilot Part|Disease Progression|0|||
16090638|NCT00486954|38823492|FG000|Randomized Part|Lost to Follow-up|0|||
16090639|NCT00486954|38823493|FG001|Randomized Part|Lost to Follow-up|0|||
16090640|NCT00486954|38823494|FG002|Randomized Part|Lost to Follow-up|0|||
16090641|NCT00486954|38823495|FG003|Randomized Part|Lost to Follow-up|0|||
16090642|NCT00486954|38823496|FG004|Randomized Part|Lost to Follow-up|1|||
16090643|NCT00486954|38823492|FG000|Randomized Part|Withdrawal by Subject|0|||
16090644|NCT00486954|38823493|FG001|Randomized Part|Withdrawal by Subject|0|||
16090645|NCT00486954|38823494|FG002|Randomized Part|Withdrawal by Subject|0|||
16090646|NCT00486954|38823495|FG003|Randomized Part|Withdrawal by Subject|1|||
16090647|NCT00486954|38823496|FG004|Randomized Part|Withdrawal by Subject|0|||
16090648|NCT00486954|38823492|FG000|Randomized Part|Sponsor Terminated Study|0|||
16320781|NCT04134767|39660404|FG000|Overall Study|Death|0|||
16090649|NCT00486954|38823493|FG001|Randomized Part|Sponsor Terminated Study|0|||
16090650|NCT00486954|38823494|FG002|Randomized Part|Sponsor Terminated Study|0|||
16090651|NCT00486954|38823495|FG003|Randomized Part|Sponsor Terminated Study|19|||
16090652|NCT00486954|38823496|FG004|Randomized Part|Sponsor Terminated Study|13|||
16090653|NCT01911819|38823499|FG000|Overall Study|Adverse Event|0|||
16090654|NCT01911819|38823500|FG001|Overall Study|Adverse Event|1|||
16090655|NCT01911819|38823501|FG002|Overall Study|Adverse Event|0|||
16320782|NCT04134767|39660405|FG001|Overall Study|Death|1|||
16090656|NCT01911819|38823499|FG000|Overall Study|Withdrawal by Subject|1|||
16394666|NCT03083665|39924776|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
16394667|NCT03083665|39924777|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
16394668|NCT03083665|39924778|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
16394669|NCT03083665|39924779|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
16090657|NCT01911819|38823500|FG001|Overall Study|Withdrawal by Subject|1|||
16090658|NCT01911819|38823501|FG002|Overall Study|Withdrawal by Subject|0|||
16515241|NCT01485861|40355533|FG004|Phase II|Progression of Disease|0|||
16515242|NCT01485861|40355534|FG005|Phase II|Progression of Disease|0|||
16515243|NCT01485861|40355529|FG000|Phase II|Other|0|||
16515244|NCT01485861|40355530|FG001|Phase II|Other|0|||
16515245|NCT01485861|40355531|FG002|Phase II|Other|0|||
16515246|NCT01485861|40355532|FG003|Phase II|Other|1|||
16515247|NCT01485861|40355533|FG004|Phase II|Other|0|||
16515248|NCT01485861|40355534|FG005|Phase II|Other|0|||
16515249|NCT01485861|40355529|FG000|Phase II|Withdrawal by Subject|0|||
16515250|NCT01485861|40355530|FG001|Phase II|Withdrawal by Subject|0|||
16515251|NCT01485861|40355531|FG002|Phase II|Withdrawal by Subject|6|||
16515252|NCT01485861|40355532|FG003|Phase II|Withdrawal by Subject|3|||
16515253|NCT01485861|40355533|FG004|Phase II|Withdrawal by Subject|4|||
16515254|NCT01485861|40355534|FG005|Phase II|Withdrawal by Subject|0|||
16515255|NCT01485861|40355529|FG000|Phase II|Lost to Follow-up|0|||
16515256|NCT01485861|40355530|FG001|Phase II|Lost to Follow-up|0|||
16515257|NCT01485861|40355531|FG002|Phase II|Lost to Follow-up|2|||
16515258|NCT01485861|40355532|FG003|Phase II|Lost to Follow-up|3|||
16515259|NCT01485861|40355533|FG004|Phase II|Lost to Follow-up|5|||
16515260|NCT01485861|40355534|FG005|Phase II|Lost to Follow-up|0|||
16515261|NCT01485861|40355529|FG000|Phase II|Study Ended|0|||
16515262|NCT01485861|40355530|FG001|Phase II|Study Ended|0|||
16515263|NCT01485861|40355531|FG002|Phase II|Study Ended|7|||
16515264|NCT01485861|40355532|FG003|Phase II|Study Ended|8|||
16515265|NCT01485861|40355533|FG004|Phase II|Study Ended|6|||
16202344|NCT00856986|39218806|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
16202345|NCT00856986|39218807|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
16202346|NCT00856986|39218808|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
16202347|NCT00856986|39218809|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
16202348|NCT00856986|39218805|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
16202349|NCT00856986|39218806|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
16202350|NCT00856986|39218807|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
16202351|NCT00856986|39218808|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
16515266|NCT01485861|40355534|FG005|Phase II|Study Ended|0|||
16515267|NCT01485861|40355529|FG000|Safety Phase|Death|0|||
16515268|NCT01485861|40355530|FG001|Safety Phase|Death|0|||
16515269|NCT01485861|40355531|FG002|Safety Phase|Death|0|||
16515270|NCT01485861|40355532|FG003|Safety Phase|Death|0|||
16515271|NCT01485861|40355533|FG004|Safety Phase|Death|0|||
16515272|NCT01485861|40355534|FG005|Safety Phase|Death|2|||
16515273|NCT01485861|40355529|FG000|Safety Phase|Adverse Event|0|||
16515274|NCT01485861|40355530|FG001|Safety Phase|Adverse Event|0|||
16515275|NCT01485861|40355531|FG002|Safety Phase|Adverse Event|0|||
16515276|NCT01485861|40355532|FG003|Safety Phase|Adverse Event|0|||
16515277|NCT01485861|40355533|FG004|Safety Phase|Adverse Event|0|||
16515278|NCT01485861|40355534|FG005|Safety Phase|Adverse Event|1|||
16515279|NCT01485861|40355529|FG000|Safety Phase|Other|0|||
16515280|NCT01485861|40355530|FG001|Safety Phase|Other|0|||
16515281|NCT01485861|40355531|FG002|Safety Phase|Other|0|||
16515282|NCT01485861|40355532|FG003|Safety Phase|Other|0|||
16515283|NCT01485861|40355533|FG004|Safety Phase|Other|0|||
16515284|NCT01485861|40355534|FG005|Safety Phase|Other|5|||
16515285|NCT01485861|40355529|FG000|Safety Phase|Progression of Disease|0|||
16515286|NCT01485861|40355530|FG001|Safety Phase|Progression of Disease|0|||
16515287|NCT01485861|40355531|FG002|Safety Phase|Progression of Disease|0|||
16515288|NCT01485861|40355532|FG003|Safety Phase|Progression of Disease|0|||
16515289|NCT01485861|40355533|FG004|Safety Phase|Progression of Disease|0|||
16515290|NCT01485861|40355534|FG005|Safety Phase|Progression of Disease|9|||
16515291|NCT01485861|40355529|FG000|Safety Phase|Withdrawal by Subject|0|||
16515292|NCT01485861|40355530|FG001|Safety Phase|Withdrawal by Subject|0|||
16515293|NCT01485861|40355531|FG002|Safety Phase|Withdrawal by Subject|0|||
16515294|NCT01485861|40355532|FG003|Safety Phase|Withdrawal by Subject|0|||
16515295|NCT01485861|40355533|FG004|Safety Phase|Withdrawal by Subject|0|||
16515296|NCT01485861|40355534|FG005|Safety Phase|Withdrawal by Subject|6|||
16515297|NCT01485861|40355529|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
16202352|NCT00856986|39218809|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
16202353|NCT00856986|39218805|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
16320783|NCT04134767|39660404|FG000|Overall Study|Removed for harassing staff|0|||
16320784|NCT04134767|39660405|FG001|Overall Study|Removed for harassing staff|1|||
16515298|NCT01485861|40355530|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
16515299|NCT01485861|40355531|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
16515300|NCT01485861|40355532|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
16515301|NCT01485861|40355533|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
16515302|NCT01485861|40355534|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
16515303|NCT02774681|40355535|FG000|Treatment on Study|Progressive Disease|7|||
16515304|NCT02774681|40355535|FG000|Follow-Up for 3 Years|Death|11|||
16515305|NCT02774681|40355535|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
16515306|NCT02777125|40355537|FG000|Overall Study|Consent form violation|14|||
16515307|NCT02777125|40355538|FG001|Overall Study|Consent form violation|12|||
16515308|NCT02777125|40355537|FG000|Overall Study|Assent form violation|21|||
16515309|NCT02777125|40355538|FG001|Overall Study|Assent form violation|23|||
16515310|NCT02777125|40355537|FG000|Overall Study|Protocol Violation|8|||
16515311|NCT02777125|40355538|FG001|Overall Study|Protocol Violation|12|||
16515312|NCT02908529|40355539|FG000|Overall Study|Lost to Follow-up|0|||
16515313|NCT02908529|40355540|FG001|Overall Study|Lost to Follow-up|2|||
16515314|NCT00785486|40355541|FG000|Midazolam Alone|Withdrawal by Subject|1|||
16515315|NCT01864291|40355544|FG000|Overall Study|need for revision surgery|2|||
16320785|NCT04134767|39660404|FG000|Overall Study|Lost to Follow-up|44|||
16515316|NCT00910715|40355547|FG000|Overall Study|Lost to Follow-up|22|||
16515317|NCT00910715|40355548|FG001|Overall Study|Lost to Follow-up|26|||
16515318|NCT00910715|40355549|FG002|Overall Study|Lost to Follow-up|0|||
16515319|NCT01589822|40355552|FG000|Overall Study|Withdrawal by Subject|1|||
16515320|NCT01589822|40355553|FG001|Overall Study|Withdrawal by Subject|2|||
16515321|NCT01589822|40355554|FG002|Overall Study|Withdrawal by Subject|0|||
16320786|NCT04134767|39660405|FG001|Overall Study|Lost to Follow-up|40|||
16320787|NCT01948193|39660406|FG000|Overall Study|Serious event|2|||
16320788|NCT01948193|39660406|FG000|Overall Study|Lost to Follow-up|7|||
16320789|NCT00026494|39660407|FG000|Overall Study|Withdrawal by Subject|1|||
16320790|NCT00026494|39660408|FG001|Overall Study|Withdrawal by Subject|0|||
16320791|NCT00026494|39660409|FG002|Overall Study|Withdrawal by Subject|1|||
16320792|NCT00026494|39660410|FG003|Overall Study|Withdrawal by Subject|0|||
16320793|NCT00026494|39660407|FG000|Overall Study|Patient non-compliance|1|||
16320794|NCT00026494|39660408|FG001|Overall Study|Patient non-compliance|0|||
16320795|NCT00026494|39660409|FG002|Overall Study|Patient non-compliance|0|||
16320796|NCT00026494|39660410|FG003|Overall Study|Patient non-compliance|0|||
16320797|NCT00026494|39660407|FG000|Overall Study|Patient not treated|0|||
16320798|NCT00026494|39660408|FG001|Overall Study|Patient not treated|0|||
16320799|NCT00026494|39660409|FG002|Overall Study|Patient not treated|2|||
16320800|NCT00026494|39660410|FG003|Overall Study|Patient not treated|0|||
16320801|NCT00026494|39660407|FG000|Overall Study|Clinical progression|0|||
16320802|NCT00026494|39660408|FG001|Overall Study|Clinical progression|0|||
16320803|NCT00026494|39660409|FG002|Overall Study|Clinical progression|3|||
16320804|NCT00026494|39660410|FG003|Overall Study|Clinical progression|0|||
16320805|NCT04578457|39660415|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
16320806|NCT04578457|39660415|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
16320807|NCT04578457|39660415|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
16320808|NCT04578457|39660415|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
16320809|NCT00356135|39660416|FG000|Overall Study|Protocol Violation|1|||
16320810|NCT00356135|39660417|FG001|Overall Study|Protocol Violation|0|||
16320811|NCT00356135|39660418|FG002|Overall Study|Protocol Violation|0|||
16320812|NCT00356135|39660416|FG000|Overall Study|Adverse Event|1|||
16320813|NCT00356135|39660417|FG001|Overall Study|Adverse Event|0|||
16320814|NCT00356135|39660418|FG002|Overall Study|Adverse Event|0|||
16320815|NCT00356135|39660416|FG000|Overall Study|Lost to Follow-up|0|||
16320816|NCT00356135|39660417|FG001|Overall Study|Lost to Follow-up|0|||
16320817|NCT00356135|39660418|FG002|Overall Study|Lost to Follow-up|1|||
16320818|NCT00356135|39660416|FG000|Overall Study|Physician Decision|1|||
16320819|NCT00356135|39660417|FG001|Overall Study|Physician Decision|1|||
16320820|NCT00356135|39660418|FG002|Overall Study|Physician Decision|1|||
16320821|NCT00356135|39660416|FG000|Overall Study|Subject non-compliance|1|||
16320822|NCT00356135|39660417|FG001|Overall Study|Subject non-compliance|1|||
16320823|NCT00356135|39660418|FG002|Overall Study|Subject non-compliance|3|||
16320824|NCT04087720|39660419|FG000|Overall Study|Withdrawal by Subject|2|||
16320825|NCT04087720|39660419|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
16320826|NCT01627574|39660421|FG000|Overall Study|Withdrawal by Subject|8|||
16320827|NCT01627574|39660422|FG001|Overall Study|Withdrawal by Subject|5|||
16320828|NCT01627574|39660421|FG000|Overall Study|Lost to Follow-up|13|||
16320829|NCT01627574|39660422|FG001|Overall Study|Lost to Follow-up|13|||
16320830|NCT00520533|39660427|FG000|Overall Study|Death|1|||
16320831|NCT00520533|39660427|FG000|Overall Study|Suspension of the study for safety reasons|1|||
16320832|NCT00520533|39660427|FG000|Overall Study|Withdrawal by Subject|1|||
16320833|NCT00520533|39660427|FG000|Overall Study|Physician Decision|1|||
16320834|NCT01222520|39660432|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
16320835|NCT01222520|39660433|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
16320836|NCT01222520|39660432|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
16320837|NCT01222520|39660433|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
16320838|NCT01222520|39660432|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
16320839|NCT01222520|39660433|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
16320840|NCT01222520|39660432|FG000|Double-blind Period|Adverse Event|0|||
16320841|NCT01222520|39660433|FG001|Double-blind Period|Adverse Event|1|||
16320842|NCT01222520|39660432|FG000|Double-blind Period|Lack of Efficacy|0|||
16320843|NCT01222520|39660433|FG001|Double-blind Period|Lack of Efficacy|1|||
16320844|NCT01222520|39660432|FG000|Double-blind Period|Study medication stolen|1|||
16320845|NCT01222520|39660433|FG001|Double-blind Period|Study medication stolen|0|||
16320846|NCT02112045|39660434|FG000|Overall Study|Withdrawal by Subject|1|||
16320847|NCT02112045|39660435|FG001|Overall Study|Withdrawal by Subject|0|||
16320848|NCT02981082|39660436|FG000|Overall Study|Withdrawal by Subject|2|||
16320849|NCT02981082|39660437|FG001|Overall Study|Withdrawal by Subject|0|||
16320850|NCT02981082|39660436|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
16320851|NCT02981082|39660437|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
16320852|NCT02981082|39660436|FG000|Overall Study|Adverse Event|0|||
16320853|NCT02981082|39660437|FG001|Overall Study|Adverse Event|1|||
16320854|NCT02120833|39660438|FG000|Overall Study|Adverse Event|1|||
16515322|NCT01589822|40355552|FG000|Overall Study|Death|1|||
16515323|NCT01589822|40355553|FG001|Overall Study|Death|0|||
16515324|NCT01589822|40355554|FG002|Overall Study|Death|0|||
16515325|NCT01589822|40355552|FG000|Overall Study|Missed 90 day visit|2|||
16515326|NCT01589822|40355553|FG001|Overall Study|Missed 90 day visit|1|||
16515327|NCT01589822|40355554|FG002|Overall Study|Missed 90 day visit|1|||
16515328|NCT04251533|40355555|FG000|Overall Study|Progressive disease|33|||
16515329|NCT04251533|40355556|FG001|Overall Study|Progressive disease|29|||
16515330|NCT04251533|40355557|FG002|Overall Study|Progressive disease|22|||
16515331|NCT04251533|40355555|FG000|Overall Study|Death|5|||
16515332|NCT04251533|40355556|FG001|Overall Study|Death|1|||
16515333|NCT04251533|40355557|FG002|Overall Study|Death|3|||
16515334|NCT04251533|40355555|FG000|Overall Study|Physician Decision|3|||
16515335|NCT04251533|40355556|FG001|Overall Study|Physician Decision|2|||
16515336|NCT04251533|40355557|FG002|Overall Study|Physician Decision|4|||
16515337|NCT04251533|40355555|FG000|Overall Study|Participant decision|1|||
16515338|NCT04251533|40355556|FG001|Overall Study|Participant decision|3|||
16515339|NCT04251533|40355557|FG002|Overall Study|Participant decision|1|||
16515340|NCT04251533|40355555|FG000|Overall Study|Adverse Event|2|||
16090659|NCT02022670|38823502|FG000|Overall Study|Adverse Event|1|||
16090660|NCT02022670|38823503|FG001|Overall Study|Adverse Event|0|||
16090661|NCT02022670|38823504|FG002|Overall Study|Adverse Event|1|||
16090662|NCT02138838|38823505|FG000|Overall Study|Study Closure|7|||
16090663|NCT02138838|38823506|FG001|Overall Study|Study Closure|6|||
16090664|NCT02138838|38823505|FG000|Overall Study|Withdrawal by Subject|1|||
16090665|NCT02138838|38823506|FG001|Overall Study|Withdrawal by Subject|5|||
16090666|NCT03601715|38823507|FG000|Second Intervention|Lost to Follow-up|1|||
16090667|NCT03601715|38823508|FG001|Second Intervention|Lost to Follow-up|1|||
16090668|NCT03601715|38823509|FG002|Second Intervention|Lost to Follow-up|0|||
16090669|NCT02634307|38823510|FG000|Overall Study|Adverse Event|50|||
16090670|NCT02634307|38823511|FG001|Overall Study|Adverse Event|24|||
16090671|NCT02634307|38823512|FG002|Overall Study|Adverse Event|14|||
16090672|NCT02634307|38823510|FG000|Overall Study|Lost to Follow-up|21|||
16090673|NCT02634307|38823511|FG001|Overall Study|Lost to Follow-up|5|||
16090674|NCT02634307|38823512|FG002|Overall Study|Lost to Follow-up|6|||
16090675|NCT02634307|38823510|FG000|Overall Study|Pregnancy|5|||
16090676|NCT02634307|38823511|FG001|Overall Study|Pregnancy|1|||
16090677|NCT02634307|38823512|FG002|Overall Study|Pregnancy|3|||
16090678|NCT02634307|38823510|FG000|Overall Study|Withdrawal by Subject|38|||
16090679|NCT02634307|38823511|FG001|Overall Study|Withdrawal by Subject|24|||
16090680|NCT02634307|38823512|FG002|Overall Study|Withdrawal by Subject|18|||
16090681|NCT02634307|38823510|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16090682|NCT02634307|38823511|FG001|Overall Study|Non-Compliance with Study Drug|2|||
16090683|NCT02634307|38823512|FG002|Overall Study|Non-Compliance with Study Drug|2|||
16090684|NCT02634307|38823510|FG000|Overall Study|Lack of Efficacy|1|||
16090685|NCT02634307|38823511|FG001|Overall Study|Lack of Efficacy|5|||
16090686|NCT02634307|38823512|FG002|Overall Study|Lack of Efficacy|3|||
16090687|NCT02634307|38823510|FG000|Overall Study|Physician Decision|7|||
16090688|NCT02634307|38823511|FG001|Overall Study|Physician Decision|5|||
16090689|NCT02634307|38823512|FG002|Overall Study|Physician Decision|5|||
16090690|NCT02634307|38823510|FG000|Overall Study|Reason not Specified|3|||
16090691|NCT02634307|38823511|FG001|Overall Study|Reason not Specified|5|||
16090692|NCT02634307|38823512|FG002|Overall Study|Reason not Specified|10|||
16090693|NCT00942266|38823513|FG000|Overall Study|Withdrawal by Subject|1|||
16090694|NCT00942266|38823514|FG001|Overall Study|Withdrawal by Subject|0|||
16090695|NCT00942266|38823513|FG000|Overall Study|Adverse Event|2|||
16090696|NCT00942266|38823514|FG001|Overall Study|Adverse Event|1|||
16090697|NCT00942266|38823513|FG000|Overall Study|Disease Progression|38|||
16090698|NCT00942266|38823514|FG001|Overall Study|Disease Progression|11|||
16090699|NCT00942266|38823513|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
16090700|NCT00942266|38823514|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
16090701|NCT00942266|38823513|FG000|Overall Study|Intercurrent illness|0|||
16090702|NCT00942266|38823514|FG001|Overall Study|Intercurrent illness|1|||
16320855|NCT02120833|39660439|FG001|Overall Study|Adverse Event|0|||
16320856|NCT02120833|39660438|FG000|Overall Study|Withdrawal by Subject|2|||
16320857|NCT02120833|39660439|FG001|Overall Study|Withdrawal by Subject|0|||
16515341|NCT04251533|40355556|FG001|Overall Study|Adverse Event|1|||
16515342|NCT04251533|40355557|FG002|Overall Study|Adverse Event|1|||
16515343|NCT00302003|40355558|FG000|Overall Study|Lack of Efficacy|62|||
16090703|NCT00942266|38823513|FG000|Overall Study|Physician Decision|2|||
16090704|NCT00942266|38823514|FG001|Overall Study|Physician Decision|0|||
16090705|NCT00942266|38823513|FG000|Overall Study|medical deterioration (pneumonia)|0|||
16090706|NCT00942266|38823514|FG001|Overall Study|medical deterioration (pneumonia)|1|||
16090707|NCT02630186|38823515|FG000|Overall Study|Withdrawal by Subject|1|||
16090708|NCT01801007|38823517|FG000|Overall Study|Adverse Event|2|||
16090709|NCT01801007|38823517|FG000|Overall Study|Lost to Follow-up|4|||
16090710|NCT01801007|38823517|FG000|Overall Study|Withdrawal by Subject|5|||
16515344|NCT00302003|40355558|FG000|Overall Study|Lost to Follow-up|1|||
16515345|NCT00302003|40355558|FG000|Overall Study|Physician Decision|2|||
16090711|NCT01529632|38823518|FG000|Overall Study|Administrative problem|2|||
16090712|NCT01529632|38823519|FG001|Overall Study|Administrative problem|1|||
16090713|NCT01529632|38823518|FG000|Overall Study|Protocol Violation|0|||
16090714|NCT01529632|38823519|FG001|Overall Study|Protocol Violation|1|||
16090715|NCT01529632|38823518|FG000|Overall Study|Adverse Event|1|||
16515346|NCT00302003|40355558|FG000|Overall Study|Withdrawal by Subject|5|||
16515347|NCT00302003|40355558|FG000|Overall Study|Ineligible|9|||
16515348|NCT00302003|40355558|FG000|Overall Study|Protocol Violation|1|||
16515349|NCT00403273|40355561|FG000|Overall Study|Lost to Follow-up|3|||
16515350|NCT00403273|40355562|FG001|Overall Study|Lost to Follow-up|2|||
16515351|NCT00403273|40355561|FG000|Overall Study|Physician Decision|0|||
16515352|NCT00403273|40355562|FG001|Overall Study|Physician Decision|1|||
16515353|NCT00403273|40355561|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
16515354|NCT00403273|40355562|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
16515355|NCT04999111|40355564|FG000|Overall Study|Lost to Follow-up|21|||
16515356|NCT04999111|40355565|FG001|Overall Study|Lost to Follow-up|16|||
16515357|NCT04999111|40355566|FG002|Overall Study|Lost to Follow-up|2|||
16515358|NCT04999111|40355567|FG003|Overall Study|Lost to Follow-up|26|||
16515359|NCT04999111|40355568|FG004|Overall Study|Lost to Follow-up|30|||
16515360|NCT04999111|40355569|FG005|Overall Study|Lost to Follow-up|6|||
16515361|NCT04999111|40355564|FG000|Overall Study|Physician Decision|1|||
16515362|NCT04999111|40355565|FG001|Overall Study|Physician Decision|3|||
16515363|NCT04999111|40355566|FG002|Overall Study|Physician Decision|0|||
16515364|NCT04999111|40355567|FG003|Overall Study|Physician Decision|1|||
16515365|NCT04999111|40355568|FG004|Overall Study|Physician Decision|2|||
16515366|NCT04999111|40355569|FG005|Overall Study|Physician Decision|0|||
16515367|NCT04999111|40355564|FG000|Overall Study|Withdrawal by Subject|23|||
16515368|NCT04999111|40355565|FG001|Overall Study|Withdrawal by Subject|29|||
16515369|NCT04999111|40355566|FG002|Overall Study|Withdrawal by Subject|15|||
16515370|NCT04999111|40355567|FG003|Overall Study|Withdrawal by Subject|30|||
16515371|NCT04999111|40355568|FG004|Overall Study|Withdrawal by Subject|35|||
16515372|NCT04999111|40355569|FG005|Overall Study|Withdrawal by Subject|10|||
16515373|NCT04999111|40355564|FG000|Overall Study|Other|6|||
16515374|NCT04999111|40355565|FG001|Overall Study|Other|6|||
16515375|NCT04999111|40355566|FG002|Overall Study|Other|3|||
16515376|NCT04999111|40355567|FG003|Overall Study|Other|8|||
16515377|NCT04999111|40355568|FG004|Overall Study|Other|8|||
16515378|NCT04999111|40355569|FG005|Overall Study|Other|5|||
16515379|NCT04999111|40355564|FG000|Overall Study|Non-compliance with study schedule|1|||
16515380|NCT04999111|40355565|FG001|Overall Study|Non-compliance with study schedule|0|||
16515381|NCT04999111|40355566|FG002|Overall Study|Non-compliance with study schedule|0|||
16515382|NCT04999111|40355567|FG003|Overall Study|Non-compliance with study schedule|1|||
16515383|NCT04999111|40355568|FG004|Overall Study|Non-compliance with study schedule|1|||
16515384|NCT04999111|40355569|FG005|Overall Study|Non-compliance with study schedule|1|||
16515385|NCT04999111|40355564|FG000|Overall Study|Randomized but not vaccinated|1|||
16090716|NCT01529632|38823519|FG001|Overall Study|Adverse Event|1|||
16090717|NCT01867307|38823520|FG000|Overall Study|Protocol Violation|2|||
16320858|NCT02120833|39660438|FG000|Overall Study|Lost to Follow-up|1|||
16320859|NCT02120833|39660439|FG001|Overall Study|Lost to Follow-up|1|||
16320860|NCT00996125|39660440|FG000|Overall Study|Adverse Event|0|||
16320861|NCT00996125|39660441|FG001|Overall Study|Adverse Event|2|||
16320862|NCT00996125|39660440|FG000|Overall Study|Lost to Follow-up|1|||
16320863|NCT00996125|39660441|FG001|Overall Study|Lost to Follow-up|6|||
16320864|NCT00996125|39660440|FG000|Overall Study|Withdrawal by Subject|4|||
16320865|NCT00996125|39660441|FG001|Overall Study|Withdrawal by Subject|3|||
16320866|NCT00667823|39660451|FG000|Overall Study|Lost to Follow-up|5|||
16320867|NCT00667823|39660451|FG000|Overall Study|Adverse Event|7|||
16320868|NCT00667823|39660451|FG000|Overall Study|Death|182|||
16320869|NCT00667823|39660451|FG000|Overall Study|Withdrawal by Subject|12|||
16320870|NCT00667823|39660451|FG000|Overall Study|Other|8|||
16320871|NCT00667823|39660451|FG000|Overall Study|Missing (completion page missing)|2|||
16320872|NCT00570687|39660452|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320873|NCT00570687|39660453|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320874|NCT00570687|39660454|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320875|NCT00570687|39660455|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320876|NCT00570687|39660456|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
16320877|NCT00570687|39660457|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
16515386|NCT04999111|40355565|FG001|Overall Study|Randomized but not vaccinated|2|||
16202354|NCT00856986|39218806|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
16202355|NCT00856986|39218807|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
16202356|NCT00856986|39218808|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
16202357|NCT00856986|39218809|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
16202358|NCT00351819|39218810|FG000|Overall Study|Lost to Follow-up|4|||
16202359|NCT00351819|39218811|FG001|Overall Study|Lost to Follow-up|4|||
16202360|NCT00351819|39218810|FG000|Overall Study|Withdrawal by Subject|0|||
16202361|NCT00351819|39218811|FG001|Overall Study|Withdrawal by Subject|4|||
16202362|NCT00351819|39218810|FG000|Overall Study|Elevated PSA|1|||
16202363|NCT00351819|39218811|FG001|Overall Study|Elevated PSA|1|||
16202364|NCT00351819|39218810|FG000|Overall Study|Traumatic ankle fracture|1|||
16202365|NCT00351819|39218811|FG001|Overall Study|Traumatic ankle fracture|0|||
16202366|NCT00351819|39218810|FG000|Overall Study|Unprofessional behavior|1|||
16202367|NCT00351819|39218811|FG001|Overall Study|Unprofessional behavior|0|||
16202368|NCT00351819|39218810|FG000|Overall Study|Non-compliance|0|||
16202369|NCT00351819|39218811|FG001|Overall Study|Non-compliance|1|||
16202370|NCT00351819|39218810|FG000|Overall Study|Incarcerated|0|||
16202371|NCT00351819|39218811|FG001|Overall Study|Incarcerated|1|||
16202372|NCT00351819|39218810|FG000|Overall Study|Enrolled in another trial|0|||
16202373|NCT00351819|39218811|FG001|Overall Study|Enrolled in another trial|1|||
16202374|NCT01419080|39218812|FG000|Overall Study|Withdrawal by Subject|75|||
16202375|NCT01419080|39218812|FG000|Overall Study|Death|30|||
16202376|NCT01419080|39218812|FG000|Overall Study|Lost to Follow-up|23|||
16202377|NCT01419080|39218812|FG000|Overall Study|Too Ill|3|||
16202378|NCT01332019|39218820|FG000|Overall Study|Was Not Dosed|1|||
16202379|NCT01332019|39218821|FG001|Overall Study|Was Not Dosed|0|||
16202380|NCT01332019|39218820|FG000|Overall Study|Other|16|||
16202381|NCT01332019|39218821|FG001|Overall Study|Other|18|||
16202382|NCT01332019|39218820|FG000|Overall Study|Death|2|||
16202383|NCT01332019|39218821|FG001|Overall Study|Death|1|||
16202384|NCT01332019|39218820|FG000|Overall Study|Physician Decision|4|||
16202385|NCT01332019|39218821|FG001|Overall Study|Physician Decision|3|||
16202386|NCT01332019|39218820|FG000|Overall Study|Withdrawal by Subject|73|||
16320878|NCT00570687|39660458|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
16515387|NCT04999111|40355566|FG002|Overall Study|Randomized but not vaccinated|0|||
16515388|NCT04999111|40355567|FG003|Overall Study|Randomized but not vaccinated|3|||
16515389|NCT04999111|40355568|FG004|Overall Study|Randomized but not vaccinated|3|||
16515390|NCT04999111|40355569|FG005|Overall Study|Randomized but not vaccinated|0|||
16515391|NCT04999111|40355564|FG000|Overall Study|Adverse Event|1|||
16515392|NCT04999111|40355565|FG001|Overall Study|Adverse Event|1|||
16515393|NCT04999111|40355566|FG002|Overall Study|Adverse Event|0|||
16515394|NCT04999111|40355567|FG003|Overall Study|Adverse Event|0|||
16515395|NCT04999111|40355568|FG004|Overall Study|Adverse Event|0|||
16515396|NCT04999111|40355569|FG005|Overall Study|Adverse Event|0|||
16515397|NCT04999111|40355564|FG000|Overall Study|Initiated prohibited medication|0|||
16515398|NCT04999111|40355565|FG001|Overall Study|Initiated prohibited medication|0|||
16515399|NCT04999111|40355566|FG002|Overall Study|Initiated prohibited medication|0|||
16515400|NCT04999111|40355567|FG003|Overall Study|Initiated prohibited medication|0|||
16515401|NCT04999111|40355568|FG004|Overall Study|Initiated prohibited medication|1|||
16515402|NCT04999111|40355569|FG005|Overall Study|Initiated prohibited medication|0|||
16515403|NCT01600586|40355574|FG000|Overall Study|Physician Decision|3|||
16515404|NCT01600586|40355575|FG001|Overall Study|Physician Decision|3|||
16515405|NCT00508742|40355583|FG000|Period 1: Infant Series|Adverse Event|5|||
16515406|NCT00508742|40355584|FG001|Period 1: Infant Series|Adverse Event|4|||
16515407|NCT00508742|40355583|FG000|Period 1: Infant Series|Protocol Violation|1|||
16515408|NCT00508742|40355584|FG001|Period 1: Infant Series|Protocol Violation|0|||
16515409|NCT00508742|40355583|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
16515410|NCT00508742|40355584|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
16515411|NCT00508742|40355583|FG000|Period 1: Infant Series|Physician Decision|1|||
16515412|NCT00508742|40355584|FG001|Period 1: Infant Series|Physician Decision|0|||
16202387|NCT01332019|39218821|FG001|Overall Study|Withdrawal by Subject|71|||
16202388|NCT01332019|39218820|FG000|Overall Study|Lost to Follow-up|4|||
16394670|NCT03083665|39924780|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
16320879|NCT00570687|39660459|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
16394671|NCT03083665|39924781|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
16394672|NCT03083665|39924776|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
16320880|NCT00570687|39660460|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
16320881|NCT00570687|39660461|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
16320882|NCT00570687|39660452|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320883|NCT00570687|39660453|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320884|NCT00570687|39660454|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16515413|NCT00508742|40355583|FG000|Period 1: Infant Series|Other|4|||
16515414|NCT00508742|40355584|FG001|Period 1: Infant Series|Other|1|||
16515415|NCT00508742|40355583|FG000|Period 2: After Infant Series|Adverse Event|2|||
16202389|NCT01332019|39218821|FG001|Overall Study|Lost to Follow-up|7|||
16320885|NCT00570687|39660455|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320886|NCT00570687|39660456|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320887|NCT00570687|39660457|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16515416|NCT00508742|40355584|FG001|Period 2: After Infant Series|Adverse Event|6|||
16515417|NCT00508742|40355583|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
16515418|NCT00508742|40355584|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
16515419|NCT00508742|40355583|FG000|Period 2: After Infant Series|Protocol Violation|1|||
16515420|NCT00508742|40355584|FG001|Period 2: After Infant Series|Protocol Violation|0|||
16515421|NCT00508742|40355583|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
16515422|NCT00508742|40355584|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
16515423|NCT00508742|40355583|FG000|Period 2: After Infant Series|Failed to Return|1|||
16515424|NCT00508742|40355584|FG001|Period 2: After Infant Series|Failed to Return|0|||
16515425|NCT00508742|40355583|FG000|Period 2: After Infant Series|Other|2|||
16515426|NCT00508742|40355584|FG001|Period 2: After Infant Series|Other|1|||
16320888|NCT00570687|39660458|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320889|NCT00570687|39660459|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16394673|NCT03083665|39924777|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
16394674|NCT03083665|39924778|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
16394675|NCT03083665|39924779|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
16394676|NCT03083665|39924780|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
16394677|NCT03083665|39924781|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
16394678|NCT03083665|39924776|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
16394679|NCT03083665|39924777|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
16394680|NCT03083665|39924778|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
16394681|NCT03083665|39924779|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
16394682|NCT03083665|39924780|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
16394683|NCT03083665|39924781|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
16394684|NCT03083665|39924776|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
16394685|NCT03083665|39924777|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
16394686|NCT03083665|39924778|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
16394687|NCT03083665|39924779|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
16394688|NCT03083665|39924780|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
16394689|NCT03083665|39924781|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
16394690|NCT03083665|39924776|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
16394691|NCT03083665|39924777|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
16394692|NCT03083665|39924778|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
16394693|NCT03083665|39924779|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
16394694|NCT03083665|39924780|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
16394695|NCT03083665|39924781|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
16394696|NCT03083665|39924776|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
16394697|NCT03083665|39924777|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
16394698|NCT03083665|39924778|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
16394699|NCT03083665|39924779|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
16394700|NCT03083665|39924780|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
16394701|NCT03083665|39924781|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
16394702|NCT03083665|39924776|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
16394703|NCT03083665|39924777|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
16320890|NCT00570687|39660460|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
16320891|NCT00570687|39660461|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16394704|NCT03083665|39924778|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
16394705|NCT03083665|39924779|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
16320892|NCT00570687|39660452|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16394706|NCT03083665|39924780|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
16394707|NCT03083665|39924781|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
16394708|NCT03083665|39924776|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
16090718|NCT01867307|38823521|FG001|Overall Study|Protocol Violation|0|||
16320893|NCT00570687|39660453|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16394709|NCT03083665|39924777|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
16394710|NCT03083665|39924778|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
16394711|NCT03083665|39924779|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
16394712|NCT03083665|39924780|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
16394713|NCT03083665|39924781|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
16394714|NCT02297815|39924782|FG000|Overall Study|Lost to Follow-up|236|||
16394715|NCT02297815|39924783|FG001|Overall Study|Lost to Follow-up|140|||
16394716|NCT00600106|39924784|FG000|Overall Study|Withdrawal by Subject|1|||
16394717|NCT00600106|39924785|FG001|Overall Study|Withdrawal by Subject|1|||
16394718|NCT00104728|39924788|FG000|Overall Study|screen failures|19|||
16394719|NCT05332392|39924795|FG000|Overall Study|Did not meet inclusion criteria|25|||
16394720|NCT05332392|39924795|FG000|Overall Study|Principal Investigator's decision|17|||
16394721|NCT05332392|39924795|FG000|Overall Study|Adverse Event|1|||
16394722|NCT05332392|39924795|FG000|Overall Study|Subject's decision|1|||
16394723|NCT04721158|39924798|FG000|Overall Study|Lost to Follow-up|4|||
16394724|NCT04721158|39924798|FG000|Overall Study|Device did not connect|1|||
16394725|NCT05002985|39924799|FG000|Overall Study|Withdrawal by Subject|1|||
16394726|NCT01642901|39924800|FG000|12-month Follow-up|Withdrawal by Subject|1|||
16394727|NCT01642901|39924801|FG001|12-month Follow-up|Withdrawal by Subject|0|||
16394728|NCT01336712|39924803|FG000|Overall Study|Death|2|||
16394729|NCT01336712|39924803|FG000|Overall Study|Lack of Efficacy|1|||
16394730|NCT02817594|39928018|FG000|Overall Study|Withdrawal by Subject|1|||
16394731|NCT02817594|39928018|FG000|Overall Study|Other|1|||
16394732|NCT02817594|39928018|FG000|Overall Study|Did Not Receive Treatment|1|||
16394733|NCT02485639|39928019|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
16394734|NCT02485639|39928019|FG000|Overall Study|Early termination|4|||
16394735|NCT02485639|39928019|FG000|Overall Study|Withdrawal by Subject|4|||
16394736|NCT02364037|39928030|FG000|Overall Study|Withdrawal by Subject|7|||
16394737|NCT02364037|39928031|FG001|Overall Study|Withdrawal by Subject|4|||
16394738|NCT02364037|39928030|FG000|Overall Study|Lost to Follow-up|37|||
16394739|NCT02364037|39928031|FG001|Overall Study|Lost to Follow-up|49|||
16394740|NCT00349349|39928034|FG000|Overall Study|Adverse Event|5|||
16394741|NCT00349349|39928035|FG001|Overall Study|Adverse Event|6|||
16394742|NCT00349349|39928036|FG002|Overall Study|Adverse Event|2|||
16394743|NCT00349349|39928034|FG000|Overall Study|Withdrawal by Subject|5|||
16394744|NCT00349349|39928035|FG001|Overall Study|Withdrawal by Subject|2|||
16394745|NCT00349349|39928036|FG002|Overall Study|Withdrawal by Subject|1|||
16394746|NCT00349349|39928034|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
16394747|NCT00349349|39928035|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
16394748|NCT00349349|39928036|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
16394749|NCT00349349|39928034|FG000|Overall Study|Death|13|||
16394750|NCT00349349|39928035|FG001|Overall Study|Death|10|||
16394751|NCT00349349|39928036|FG002|Overall Study|Death|1|||
16394752|NCT00349349|39928034|FG000|Overall Study|Other Treatment Selected|2|||
16394753|NCT00349349|39928035|FG001|Overall Study|Other Treatment Selected|0|||
16394754|NCT00349349|39928036|FG002|Overall Study|Other Treatment Selected|0|||
16394755|NCT00349349|39928034|FG000|Overall Study|Participant Reduced General Condition|0|||
16394756|NCT00349349|39928035|FG001|Overall Study|Participant Reduced General Condition|1|||
16394757|NCT00349349|39928036|FG002|Overall Study|Participant Reduced General Condition|0|||
16394758|NCT00349349|39928034|FG000|Overall Study|Physician Decision|1|||
16394759|NCT00349349|39928035|FG001|Overall Study|Physician Decision|2|||
16394760|NCT00349349|39928036|FG002|Overall Study|Physician Decision|1|||
16394761|NCT00349349|39928034|FG000|Overall Study|No Response|0|||
16394762|NCT00349349|39928035|FG001|Overall Study|No Response|3|||
16394763|NCT00349349|39928036|FG002|Overall Study|No Response|0|||
16394764|NCT00349349|39928034|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
16394765|NCT00349349|39928035|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
16394766|NCT00349349|39928036|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
16394767|NCT00889603|39928037|FG000|Overall Study|Adverse Event|7|||
16394768|NCT00889603|39928037|FG000|Overall Study|Death|3|||
16394769|NCT00889603|39928037|FG000|Overall Study|Lost to Follow-up|19|||
16394770|NCT00889603|39928037|FG000|Overall Study|No longer willing to participant in stud|4|||
16394771|NCT00889603|39928037|FG000|Overall Study|Other|4|||
16394772|NCT02520388|39928038|FG000|Overall Study|Physician Decision|1|||
16394773|NCT02520388|39928039|FG001|Overall Study|Physician Decision|0|||
16394774|NCT02520388|39928038|FG000|Overall Study|Subject or parent/guardian request|0|||
16394775|NCT02520388|39928039|FG001|Overall Study|Subject or parent/guardian request|6|||
16394776|NCT02520388|39928038|FG000|Overall Study|Adverse Event|1|||
16090719|NCT01867307|38823520|FG000|Overall Study|Other Adverse Event|1|||
16394777|NCT02520388|39928039|FG001|Overall Study|Adverse Event|4|||
16394778|NCT02520388|39928038|FG000|Overall Study|Lost to Follow-up|3|||
16394779|NCT02520388|39928039|FG001|Overall Study|Lost to Follow-up|2|||
16394780|NCT02520388|39928038|FG000|Overall Study|Other (reason not defined)|4|||
16394781|NCT02520388|39928039|FG001|Overall Study|Other (reason not defined)|4|||
16202390|NCT01332019|39218820|FG000|Overall Study|Adverse Event|13|||
16202391|NCT01332019|39218821|FG001|Overall Study|Adverse Event|22|||
16202392|NCT01199055|39218824|FG000|Overall Study|Death|0|||
16320894|NCT00570687|39660454|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16394782|NCT03146663|39928040|FG000|Overall Study|Did not receive study treatment|1|||
16394783|NCT03146663|39928041|FG001|Overall Study|Did not receive study treatment|1|||
16394784|NCT00506454|39928042|FG000|Overall Study|Withdrawal by Subject|1|||
16394785|NCT00506454|39928043|FG001|Overall Study|Withdrawal by Subject|1|||
16320895|NCT00570687|39660455|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320896|NCT00570687|39660456|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320897|NCT00570687|39660457|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320898|NCT00570687|39660458|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
16320899|NCT00570687|39660459|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320900|NCT00570687|39660460|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320901|NCT00570687|39660461|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
16320902|NCT01017874|39660464|FG000|Overall Study|Withdrawal by Subject|23|||
16320903|NCT01017874|39660465|FG001|Overall Study|Withdrawal by Subject|20|||
16320904|NCT01017874|39660464|FG000|Overall Study|Sponsor decision|3|||
16320905|NCT01017874|39660465|FG001|Overall Study|Sponsor decision|1|||
16320906|NCT01017874|39660464|FG000|Overall Study|Lost to Follow-up|3|||
16394786|NCT04601532|39928044|FG000|Overall Study|Lost to Follow-up|1|||
16394787|NCT04601532|39928045|FG001|Overall Study|Lost to Follow-up|2|||
16394788|NCT04601532|39928044|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
16394789|NCT04601532|39928045|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
16515427|NCT00508742|40355583|FG000|Period 3: Toddler Dose|Adverse Event|1|||
16320907|NCT01017874|39660465|FG001|Overall Study|Lost to Follow-up|2|||
16320908|NCT01017874|39660464|FG000|Overall Study|Physician Decision|1|||
16320909|NCT01017874|39660465|FG001|Overall Study|Physician Decision|3|||
16320910|NCT01684943|39660466|FG000|Overall Study|Inadequate Venous Access|3|||
16320911|NCT01684943|39660467|FG001|Overall Study|Inadequate Venous Access|0|||
16320912|NCT01684943|39660468|FG002|Overall Study|Inadequate Venous Access|0|||
16320913|NCT01684943|39660466|FG000|Overall Study|Principal Investigator Determination|1|||
16320914|NCT01684943|39660467|FG001|Overall Study|Principal Investigator Determination|0|||
16320915|NCT01684943|39660468|FG002|Overall Study|Principal Investigator Determination|0|||
16320916|NCT01684943|39660466|FG000|Overall Study|Excluded from Analysis|1|||
16320917|NCT01684943|39660467|FG001|Overall Study|Excluded from Analysis|1|||
16320918|NCT01684943|39660468|FG002|Overall Study|Excluded from Analysis|1|||
16320919|NCT01684943|39660466|FG000|Overall Study|Lost to Follow-up|3|||
16320920|NCT01684943|39660467|FG001|Overall Study|Lost to Follow-up|0|||
16320921|NCT01684943|39660468|FG002|Overall Study|Lost to Follow-up|0|||
16320922|NCT01684943|39660466|FG000|Overall Study|Planning Pregnancy|1|||
16320923|NCT01684943|39660467|FG001|Overall Study|Planning Pregnancy|0|||
16320924|NCT01684943|39660468|FG002|Overall Study|Planning Pregnancy|0|||
16320925|NCT00610155|39660470|FG000|Period 1|Withdrawal by Subject|0|||
16320926|NCT00610155|39660471|FG001|Period 1|Withdrawal by Subject|0|||
16320927|NCT00610155|39660472|FG002|Period 1|Withdrawal by Subject|1|||
16320928|NCT00610155|39660473|FG003|Period 1|Withdrawal by Subject|0|||
16320929|NCT00610155|39660474|FG004|Period 1|Withdrawal by Subject|0|||
16320930|NCT00610155|39660475|FG005|Period 1|Withdrawal by Subject|0|||
16320931|NCT00610155|39660470|FG000|Period 3|Adverse Event|1|||
16320932|NCT00610155|39660471|FG001|Period 3|Adverse Event|0|||
16320933|NCT00610155|39660472|FG002|Period 3|Adverse Event|0|||
16320934|NCT00610155|39660473|FG003|Period 3|Adverse Event|0|||
16320935|NCT00610155|39660474|FG004|Period 3|Adverse Event|0|||
16320936|NCT00610155|39660475|FG005|Period 3|Adverse Event|0|||
16320937|NCT01921101|39660478|FG000|Overall Study|Death|16|||
16320938|NCT01921101|39660479|FG001|Overall Study|Death|6|||
16320939|NCT01355575|39660480|FG000|Overall Study|Withdrawal by Subject|2|||
16320940|NCT01077154|39660481|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
16320941|NCT01077154|39660482|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
16320942|NCT01077154|39660481|FG000|Overall Study|Withdrawal by Subject|369|||
16320943|NCT01077154|39660482|FG001|Overall Study|Withdrawal by Subject|385|||
16320944|NCT01077154|39660481|FG000|Overall Study|Death|215|||
16320945|NCT01077154|39660482|FG001|Overall Study|Death|214|||
16320946|NCT01077154|39660481|FG000|Overall Study|Lost to Follow-up|43|||
16320947|NCT01077154|39660482|FG001|Overall Study|Lost to Follow-up|35|||
16394790|NCT02229825|39928046|FG000|Overall Study|Personal Reasons|0|||
16394791|NCT02229825|39928047|FG001|Overall Study|Personal Reasons|1|||
16515428|NCT00508742|40355584|FG001|Period 3: Toddler Dose|Adverse Event|0|||
16515429|NCT00508742|40355583|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
16515430|NCT00508742|40355584|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
16320948|NCT01077154|39660481|FG000|Overall Study|Noncompliance|22|||
16515431|NCT00508742|40355583|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
16320949|NCT01077154|39660482|FG001|Overall Study|Noncompliance|20|||
16320950|NCT01077154|39660481|FG000|Overall Study|Disease Progression|18|||
16320951|NCT01077154|39660482|FG001|Overall Study|Disease Progression|20|||
16202393|NCT01199055|39218825|FG001|Overall Study|Death|1|||
16202394|NCT01199055|39218826|FG002|Overall Study|Death|0|||
16202395|NCT01199055|39218824|FG000|Overall Study|Physician Decision|0|||
16202396|NCT01199055|39218825|FG001|Overall Study|Physician Decision|1|||
16394792|NCT02229825|39928046|FG000|Overall Study|Refused continuing medication|7|||
16202397|NCT01199055|39218826|FG002|Overall Study|Physician Decision|1|||
16394793|NCT02229825|39928047|FG001|Overall Study|Refused continuing medication|6|||
16394794|NCT02229825|39928046|FG000|Overall Study|Lost to Follow-up|1|||
16394795|NCT02229825|39928047|FG001|Overall Study|Lost to Follow-up|2|||
16515432|NCT00508742|40355584|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
16394796|NCT02229825|39928046|FG000|Overall Study|Protocol Violation|1|||
16394797|NCT02229825|39928047|FG001|Overall Study|Protocol Violation|1|||
16394798|NCT02229825|39928046|FG000|Overall Study|Lack of Efficacy|4|||
16394799|NCT02229825|39928047|FG001|Overall Study|Lack of Efficacy|10|||
16394800|NCT02229825|39928046|FG000|Overall Study|Adverse Event|11|||
16394801|NCT02229825|39928047|FG001|Overall Study|Adverse Event|9|||
16394802|NCT02229825|39928046|FG000|Overall Study|Not treated|0|||
16394803|NCT02229825|39928047|FG001|Overall Study|Not treated|1|||
16394804|NCT02388165|39928054|FG000|Overall Study|Study terminated by sponsor|5|||
16394805|NCT02388165|39928055|FG001|Overall Study|Study terminated by sponsor|5|||
16394806|NCT02388165|39928054|FG000|Overall Study|Other|11|||
16515433|NCT00508742|40355583|FG000|Period 3: Toddler Dose|Other|5|||
16515434|NCT00508742|40355584|FG001|Period 3: Toddler Dose|Other|4|||
16515435|NCT04280783|40355585|FG000|Overall Study|Family issues unrelated to the study.|1|||
16515436|NCT04280783|40355586|FG001|Overall Study|Family issues unrelated to the study.|0|||
16515437|NCT04280783|40355585|FG000|Overall Study|Withdrawal by Subject|0|||
16515438|NCT04280783|40355586|FG001|Overall Study|Withdrawal by Subject|1|||
16515439|NCT00183872|40355591|FG000|Overall Study|Death|3|||
16515440|NCT00183872|40355591|FG000|Overall Study|Adverse Event|9|||
16515441|NCT00183872|40355591|FG000|Overall Study|Withdrawal by Subject|2|||
16515442|NCT00183872|40355591|FG000|Overall Study|Drug delayed more than 28 days|2|||
16515443|NCT00670228|40355592|FG000|Overall Study|Adverse Event|1|||
16515444|NCT00670228|40355593|FG001|Overall Study|Adverse Event|0|||
16515445|NCT00670228|40355592|FG000|Overall Study|Death or MACE|0|||
16515446|NCT00670228|40355593|FG001|Overall Study|Death or MACE|1|||
16515447|NCT00670228|40355592|FG000|Overall Study|Not treated|2|||
16515448|NCT00670228|40355593|FG001|Overall Study|Not treated|2|||
16515449|NCT00670228|40355592|FG000|Overall Study|Not meeting the selection criteria|2|||
16515450|NCT00670228|40355593|FG001|Overall Study|Not meeting the selection criteria|0|||
16515451|NCT00701129|40355594|FG000|Overall Study|Death|2|||
16515452|NCT01574352|40355597|FG000|Overall Study|Withdrawal by Subject|6|||
16515453|NCT01574352|40355598|FG001|Overall Study|Withdrawal by Subject|13|||
16515454|NCT01574352|40355597|FG000|Overall Study|Injury in non-camp related sport|1|||
16515455|NCT01574352|40355598|FG001|Overall Study|Injury in non-camp related sport|0|||
16515456|NCT03192150|40355599|FG000|Overall Study|Adverse Event|14|||
16515457|NCT03192150|40355600|FG001|Overall Study|Adverse Event|12|||
16515458|NCT03192150|40355599|FG000|Overall Study|Lack of Efficacy|23|||
16515459|NCT03192150|40355600|FG001|Overall Study|Lack of Efficacy|30|||
16515460|NCT03192150|40355599|FG000|Overall Study|Lost to Follow-up|1|||
16515461|NCT03192150|40355600|FG001|Overall Study|Lost to Follow-up|1|||
16515462|NCT03192150|40355599|FG000|Overall Study|Withdrawal by Subject|4|||
16515463|NCT03192150|40355600|FG001|Overall Study|Withdrawal by Subject|2|||
16515464|NCT03192150|40355599|FG000|Overall Study|Protocol Violation|5|||
16515465|NCT03192150|40355600|FG001|Overall Study|Protocol Violation|2|||
16515466|NCT03192150|40355599|FG000|Overall Study|Surgery Canceled|6|||
16515467|NCT03192150|40355600|FG001|Overall Study|Surgery Canceled|2|||
16515468|NCT03192150|40355599|FG000|Overall Study|Other-Various Administrative Reasons|2|||
16090720|NCT01867307|38823521|FG001|Overall Study|Other Adverse Event|3|||
16090721|NCT00148122|38823522|FG000|Overall Study|Withdrawal by Subject|2|||
16090722|NCT02771366|38823523|FG000|Period 1|Withdrawal by Subject|0|||
16515469|NCT03192150|40355600|FG001|Overall Study|Other-Various Administrative Reasons|5|||
16515470|NCT00548808|40355601|FG000|Overall Study|Lost to Follow-up|9|||
16515471|NCT00548808|40355602|FG001|Overall Study|Lost to Follow-up|3|||
16515472|NCT00548808|40355601|FG000|Overall Study|Protocol Violation|8|||
16515473|NCT00548808|40355602|FG001|Overall Study|Protocol Violation|8|||
16515474|NCT00548808|40355601|FG000|Overall Study|Withdrawal by Subject|8|||
16515475|NCT00548808|40355602|FG001|Overall Study|Withdrawal by Subject|4|||
16515476|NCT00548808|40355601|FG000|Overall Study|Physician Decision|6|||
16515477|NCT00548808|40355602|FG001|Overall Study|Physician Decision|3|||
16090723|NCT02771366|38823524|FG001|Period 1|Withdrawal by Subject|2|||
16090724|NCT02771366|38823523|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
16394807|NCT02388165|39928055|FG001|Overall Study|Other|13|||
16394808|NCT02388165|39928054|FG000|Overall Study|No longer meet eligibility criteria|40|||
16394809|NCT02388165|39928055|FG001|Overall Study|No longer meet eligibility criteria|43|||
16090725|NCT02771366|38823524|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
16090726|NCT01802333|38823525|FG000|Overall Study|Ineligible|2|||
16090727|NCT01802333|38823526|FG001|Overall Study|Ineligible|6|||
16090728|NCT01802333|38823527|FG002|Overall Study|Ineligible|8|||
16090729|NCT01802333|38823525|FG000|Overall Study|Adverse Event|1|||
16090730|NCT01802333|38823526|FG001|Overall Study|Adverse Event|8|||
16090731|NCT01802333|38823527|FG002|Overall Study|Adverse Event|8|||
16090732|NCT01802333|38823525|FG000|Overall Study|Withdrawal by Subject|6|||
16090733|NCT01802333|38823526|FG001|Overall Study|Withdrawal by Subject|6|||
16090734|NCT01802333|38823527|FG002|Overall Study|Withdrawal by Subject|5|||
16090735|NCT01802333|38823525|FG000|Overall Study|Progression/relapse|1|||
16090736|NCT01802333|38823526|FG001|Overall Study|Progression/relapse|3|||
16090737|NCT01802333|38823527|FG002|Overall Study|Progression/relapse|0|||
16090738|NCT01802333|38823525|FG000|Overall Study|Death|7|||
16090739|NCT01802333|38823526|FG001|Overall Study|Death|14|||
16090740|NCT01802333|38823527|FG002|Overall Study|Death|13|||
16090741|NCT01802333|38823525|FG000|Overall Study|Other - not protocol specified|32|||
16090742|NCT01802333|38823526|FG001|Overall Study|Other - not protocol specified|22|||
16090743|NCT01802333|38823527|FG002|Overall Study|Other - not protocol specified|24|||
16090744|NCT01802333|38823525|FG000|Overall Study|Did not start treatment|0|||
16090745|NCT01802333|38823526|FG001|Overall Study|Did not start treatment|2|||
16090746|NCT01802333|38823527|FG002|Overall Study|Did not start treatment|5|||
16090747|NCT02325154|38823530|FG000|Overall Study|Physician Decision|1|||
16090748|NCT03979040|38823531|FG000|Overall Study|Withdrawal by Subject|24|||
16090749|NCT03979040|38823532|FG001|Overall Study|Withdrawal by Subject|32|||
16090750|NCT03979040|38823531|FG000|Overall Study|randomized but never started treatment|32|||
16090751|NCT03979040|38823532|FG001|Overall Study|randomized but never started treatment|39|||
16090752|NCT03979040|38823531|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
16090753|NCT03979040|38823532|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
16090754|NCT04895085|38823534|FG000|Overall Study|Death|1|||
16090755|NCT04895085|38823534|FG000|Overall Study|Withdrawal by Subject|1|||
16090756|NCT04895085|38823534|FG000|Overall Study|No longer eligible: Moved from area|1|||
16090757|NCT03176407|38823535|FG000|Overall Study|Protocol Violation|1|||
16090758|NCT03176407|38823535|FG000|Overall Study|human failure|1|||
16090759|NCT03176407|38823535|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
16090760|NCT00240994|38823539|FG000|Overall Study|Lost to Follow-up|1|||
16090761|NCT00240994|38823539|FG000|Overall Study|Protocol Violation|1|||
16090762|NCT00240994|38823539|FG000|Overall Study|Graft failure|1|||
16090763|NCT00551421|38823540|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
16090764|NCT01661972|38823541|FG000|Overall Study|Adverse Event|1|||
16090765|NCT01661972|38823542|FG001|Overall Study|Adverse Event|2|||
16090766|NCT01661972|38823541|FG000|Overall Study|Death during Treatment period|1|||
16090767|NCT01661972|38823542|FG001|Overall Study|Death during Treatment period|1|||
16090768|NCT01661972|38823541|FG000|Overall Study|Withdrawal by Subject|0|||
16090769|NCT01661972|38823542|FG001|Overall Study|Withdrawal by Subject|1|||
16090770|NCT02039401|38823544|FG000|Overall Study|Adverse Event|0|||
16090771|NCT02039401|38823545|FG001|Overall Study|Adverse Event|1|||
16090772|NCT01640951|38823546|FG000|Overall Study|Adverse Event|8|||
16090773|NCT01640951|38823547|FG001|Overall Study|Adverse Event|3|||
16090774|NCT01640951|38823548|FG002|Overall Study|Adverse Event|10|||
16090775|NCT01640951|38823549|FG003|Overall Study|Adverse Event|6|||
16090776|NCT01640951|38823550|FG004|Overall Study|Adverse Event|1|||
16090777|NCT01640951|38823551|FG005|Overall Study|Adverse Event|11|||
16090778|NCT01640951|38823552|FG006|Overall Study|Adverse Event|1|||
16090779|NCT01640951|38823553|FG007|Overall Study|Adverse Event|3|||
16090780|NCT01640951|38823546|FG000|Overall Study|Lack of Efficacy|20|||
16090781|NCT01640951|38823547|FG001|Overall Study|Lack of Efficacy|1|||
16090782|NCT01640951|38823548|FG002|Overall Study|Lack of Efficacy|7|||
16090783|NCT01640951|38823549|FG003|Overall Study|Lack of Efficacy|14|||
16090784|NCT01640951|38823550|FG004|Overall Study|Lack of Efficacy|0|||
16090785|NCT01640951|38823551|FG005|Overall Study|Lack of Efficacy|6|||
16090786|NCT01640951|38823552|FG006|Overall Study|Lack of Efficacy|5|||
16090787|NCT01640951|38823553|FG007|Overall Study|Lack of Efficacy|6|||
16090788|NCT01640951|38823546|FG000|Overall Study|Lost to Follow-up|1|||
16090789|NCT01640951|38823547|FG001|Overall Study|Lost to Follow-up|0|||
16090790|NCT01640951|38823548|FG002|Overall Study|Lost to Follow-up|6|||
16090791|NCT01640951|38823549|FG003|Overall Study|Lost to Follow-up|2|||
16090792|NCT01640951|38823550|FG004|Overall Study|Lost to Follow-up|2|||
16394810|NCT02388165|39928054|FG000|Overall Study|Withdrawal of consent|31|||
16394811|NCT02388165|39928055|FG001|Overall Study|Withdrawal of consent|32|||
16090793|NCT01640951|38823551|FG005|Overall Study|Lost to Follow-up|3|||
16090794|NCT01640951|38823552|FG006|Overall Study|Lost to Follow-up|1|||
16090795|NCT01640951|38823553|FG007|Overall Study|Lost to Follow-up|1|||
16394812|NCT02388165|39928054|FG000|Overall Study|Lost to Follow-up|19|||
16090796|NCT01640951|38823546|FG000|Overall Study|Non-compliance with study treatment|0|||
16090797|NCT01640951|38823547|FG001|Overall Study|Non-compliance with study treatment|0|||
16090798|NCT01640951|38823548|FG002|Overall Study|Non-compliance with study treatment|1|||
16394813|NCT02388165|39928055|FG001|Overall Study|Lost to Follow-up|20|||
16394814|NCT02388165|39928054|FG000|Overall Study|Death|13|||
16394815|NCT02388165|39928055|FG001|Overall Study|Death|10|||
16394816|NCT02388165|39928054|FG000|Overall Study|Adverse Event|3|||
16394817|NCT02388165|39928055|FG001|Overall Study|Adverse Event|5|||
16394818|NCT02388165|39928054|FG000|Overall Study|Did not meet entrance criteria|5|||
16394819|NCT02388165|39928055|FG001|Overall Study|Did not meet entrance criteria|2|||
16394820|NCT02147197|39928057|FG000|Overall Study|Adverse Event|1|||
16394821|NCT02147197|39928058|FG001|Overall Study|Adverse Event|0|||
16394822|NCT02147197|39928059|FG002|Overall Study|Adverse Event|0|||
16394823|NCT02147197|39928057|FG000|Overall Study|Withdrawal of Consent|4|||
16394824|NCT02147197|39928058|FG001|Overall Study|Withdrawal of Consent|3|||
16394825|NCT02147197|39928059|FG002|Overall Study|Withdrawal of Consent|2|||
16394826|NCT02147197|39928057|FG000|Overall Study|Lost to Follow-up|2|||
16394827|NCT02147197|39928058|FG001|Overall Study|Lost to Follow-up|3|||
16394828|NCT02147197|39928059|FG002|Overall Study|Lost to Follow-up|1|||
16394829|NCT02147197|39928057|FG000|Overall Study|Protocol Violation|1|||
16320952|NCT01077154|39660481|FG000|Overall Study|Ineligibility Determined|10|||
16320953|NCT01077154|39660482|FG001|Overall Study|Ineligibility Determined|14|||
16320954|NCT01077154|39660481|FG000|Overall Study|Other|14|||
16320955|NCT01077154|39660482|FG001|Overall Study|Other|11|||
16320956|NCT01077154|39660481|FG000|Overall Study|Adverse Event|9|||
16320957|NCT01077154|39660482|FG001|Overall Study|Adverse Event|9|||
16320958|NCT01077154|39660481|FG000|Overall Study|Administrative Decision|1|||
16320959|NCT01077154|39660482|FG001|Overall Study|Administrative Decision|6|||
16320960|NCT01077154|39660481|FG000|Overall Study|Protocol Deviation|1|||
16320961|NCT01077154|39660482|FG001|Overall Study|Protocol Deviation|0|||
16320962|NCT00384839|39660483|FG000|Overall Study|Adverse Event|4|||
16320963|NCT00384839|39660483|FG000|Overall Study|Investigator Request|1|||
16320964|NCT00384839|39660483|FG000|Overall Study|Patient Request|1|||
16320965|NCT00384839|39660483|FG000|Overall Study|Ineligible|2|||
16320966|NCT03423173|39660484|FG000|Overall Study|Randomized but not vaccinated|1|||
16320967|NCT03423173|39660485|FG001|Overall Study|Randomized but not vaccinated|0|||
16320968|NCT03423173|39660486|FG002|Overall Study|Randomized but not vaccinated|2|||
16320969|NCT03423173|39660487|FG003|Overall Study|Randomized but not vaccinated|1|||
16320970|NCT03423173|39660484|FG000|Overall Study|Adverse Event|1|||
16320971|NCT03423173|39660485|FG001|Overall Study|Adverse Event|1|||
16320972|NCT03423173|39660486|FG002|Overall Study|Adverse Event|1|||
16320973|NCT03423173|39660487|FG003|Overall Study|Adverse Event|1|||
16320974|NCT03423173|39660484|FG000|Overall Study|Lost to Follow-up|10|||
16394830|NCT02147197|39928058|FG001|Overall Study|Protocol Violation|0|||
16394831|NCT02147197|39928059|FG002|Overall Study|Protocol Violation|3|||
16394832|NCT02147197|39928057|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16394833|NCT02147197|39928058|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16394834|NCT02147197|39928059|FG002|Overall Study|Other Miscellaneous Reasons|3|||
16090799|NCT01640951|38823549|FG003|Overall Study|Non-compliance with study treatment|1|||
16090800|NCT01640951|38823550|FG004|Overall Study|Non-compliance with study treatment|1|||
16090801|NCT01640951|38823551|FG005|Overall Study|Non-compliance with study treatment|4|||
16090802|NCT01640951|38823552|FG006|Overall Study|Non-compliance with study treatment|1|||
16090803|NCT01640951|38823553|FG007|Overall Study|Non-compliance with study treatment|0|||
16090804|NCT01640951|38823546|FG000|Overall Study|Physician Decision|2|||
16090805|NCT01640951|38823547|FG001|Overall Study|Physician Decision|5|||
16090806|NCT01640951|38823548|FG002|Overall Study|Physician Decision|2|||
16320975|NCT03423173|39660485|FG001|Overall Study|Lost to Follow-up|19|||
16320976|NCT03423173|39660486|FG002|Overall Study|Lost to Follow-up|17|||
16320977|NCT03423173|39660487|FG003|Overall Study|Lost to Follow-up|22|||
16394835|NCT02676895|39928060|FG000|Overall Study|Administrative reason|1|||
16090807|NCT01640951|38823549|FG003|Overall Study|Physician Decision|2|||
16320978|NCT03423173|39660484|FG000|Overall Study|Withdrawal of consent|4|||
16320979|NCT03423173|39660485|FG001|Overall Study|Withdrawal of consent|10|||
16394836|NCT02676895|39928061|FG001|Overall Study|Administrative reason|0|||
16394837|NCT02676895|39928062|FG002|Overall Study|Administrative reason|0|||
16394838|NCT02676895|39928060|FG000|Overall Study|Protocol Violation|1|||
16394839|NCT02676895|39928061|FG001|Overall Study|Protocol Violation|0|||
16394840|NCT02676895|39928062|FG002|Overall Study|Protocol Violation|0|||
16090808|NCT01640951|38823550|FG004|Overall Study|Physician Decision|2|||
16090809|NCT01640951|38823551|FG005|Overall Study|Physician Decision|3|||
16090810|NCT01640951|38823552|FG006|Overall Study|Physician Decision|3|||
16090811|NCT01640951|38823553|FG007|Overall Study|Physician Decision|0|||
16090812|NCT01640951|38823546|FG000|Overall Study|Pregnancy|3|||
16090813|NCT01640951|38823547|FG001|Overall Study|Pregnancy|0|||
16090814|NCT01640951|38823548|FG002|Overall Study|Pregnancy|0|||
16090815|NCT01640951|38823549|FG003|Overall Study|Pregnancy|4|||
16090816|NCT01640951|38823550|FG004|Overall Study|Pregnancy|0|||
16090817|NCT01640951|38823551|FG005|Overall Study|Pregnancy|0|||
16090818|NCT01640951|38823552|FG006|Overall Study|Pregnancy|2|||
16090819|NCT01640951|38823553|FG007|Overall Study|Pregnancy|0|||
16202398|NCT01199055|39218824|FG000|Overall Study|Progressive disease|2|||
16090820|NCT01640951|38823546|FG000|Overall Study|Protocol Deviation|0|||
16090821|NCT01640951|38823547|FG001|Overall Study|Protocol Deviation|1|||
16202399|NCT01199055|39218825|FG001|Overall Study|Progressive disease|1|||
16090822|NCT01640951|38823548|FG002|Overall Study|Protocol Deviation|2|||
16090823|NCT01640951|38823549|FG003|Overall Study|Protocol Deviation|1|||
16090824|NCT01640951|38823550|FG004|Overall Study|Protocol Deviation|0|||
16090825|NCT01640951|38823551|FG005|Overall Study|Protocol Deviation|1|||
16090826|NCT01640951|38823552|FG006|Overall Study|Protocol Deviation|0|||
16090827|NCT01640951|38823553|FG007|Overall Study|Protocol Deviation|0|||
16090828|NCT01640951|38823546|FG000|Overall Study|Subject/Guardian decision|12|||
16090829|NCT01640951|38823547|FG001|Overall Study|Subject/Guardian decision|4|||
16090830|NCT01640951|38823548|FG002|Overall Study|Subject/Guardian decision|13|||
16090831|NCT01640951|38823549|FG003|Overall Study|Subject/Guardian decision|15|||
16090832|NCT01640951|38823550|FG004|Overall Study|Subject/Guardian decision|7|||
16090833|NCT01640951|38823551|FG005|Overall Study|Subject/Guardian decision|19|||
16090834|NCT01640951|38823552|FG006|Overall Study|Subject/Guardian decision|5|||
16090835|NCT01640951|38823553|FG007|Overall Study|Subject/Guardian decision|4|||
16090836|NCT01640951|38823546|FG000|Overall Study|Death|0|||
16090837|NCT01640951|38823547|FG001|Overall Study|Death|1|||
16090838|NCT01640951|38823548|FG002|Overall Study|Death|1|||
16090839|NCT01640951|38823549|FG003|Overall Study|Death|0|||
16090840|NCT01640951|38823550|FG004|Overall Study|Death|0|||
16090841|NCT01640951|38823551|FG005|Overall Study|Death|0|||
16090842|NCT01640951|38823552|FG006|Overall Study|Death|0|||
16090843|NCT01640951|38823553|FG007|Overall Study|Death|2|||
16090844|NCT03131713|38823554|FG000|Overall Study|Lost to Follow-up|5|||
16090845|NCT03131713|38823555|FG001|Overall Study|Lost to Follow-up|0|||
16090846|NCT03964974|38823556|FG000|Overall Study|Lost to Follow-up|3|||
16090847|NCT03964974|38823557|FG001|Overall Study|Lost to Follow-up|2|||
16090848|NCT03964974|38823556|FG000|Overall Study|Withdrawal by Subject|0|||
16090849|NCT03964974|38823557|FG001|Overall Study|Withdrawal by Subject|3|||
16090850|NCT00237809|38823558|FG000|Overall Study|Lost to Follow-up|11|||
16090851|NCT00237809|38823559|FG001|Overall Study|Lost to Follow-up|10|||
16090852|NCT00237809|38823560|FG002|Overall Study|Lost to Follow-up|9|||
16090853|NCT00237809|38823561|FG003|Overall Study|Lost to Follow-up|9|||
16090854|NCT01853384|38823562|FG000|Randomized|Adverse Event|5|||
16090855|NCT01853384|38823563|FG001|Randomized|Adverse Event|3|||
16090856|NCT01853384|38823562|FG000|Randomized|Death|1|||
16090857|NCT01853384|38823563|FG001|Randomized|Death|2|||
16090858|NCT01853384|38823562|FG000|Randomized|Lost to Follow-up|1|||
16090859|NCT01853384|38823563|FG001|Randomized|Lost to Follow-up|1|||
16090860|NCT01853384|38823562|FG000|Randomized|Withdrawal by Subject|5|||
16090861|NCT01853384|38823563|FG001|Randomized|Withdrawal by Subject|3|||
16090862|NCT01853384|38823562|FG000|Randomized|Sponsor Decision|47|||
16090863|NCT01853384|38823563|FG001|Randomized|Sponsor Decision|34|||
16090864|NCT01853384|38823562|FG000|Randomized|Other|3|||
16090865|NCT01853384|38823563|FG001|Randomized|Other|3|||
16090866|NCT01853384|38823562|FG000|Completed Follow up Visit 1|Early Termination|13|||
16090867|NCT01853384|38823563|FG001|Completed Follow up Visit 1|Early Termination|9|||
16090868|NCT01853384|38823562|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
16090869|NCT01853384|38823563|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
16090870|NCT01853384|38823562|FG000|Completed Follow up Visit 2|Adverse Event|1|||
16090871|NCT01853384|38823563|FG001|Completed Follow up Visit 2|Adverse Event|0|||
16090872|NCT01853384|38823562|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
16090873|NCT01853384|38823563|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
16090874|NCT01853384|38823562|FG000|Completed Follow up Visit 2|Death|1|||
16090875|NCT01853384|38823563|FG001|Completed Follow up Visit 2|Death|0|||
16090876|NCT01853384|38823562|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
16090877|NCT01853384|38823563|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
16090878|NCT01930188|38823564|FG000|Overall Study|unclassified|4|||
16090879|NCT01930188|38823565|FG001|Overall Study|unclassified|5|||
16090880|NCT01930188|38823566|FG002|Overall Study|unclassified|3|||
16090881|NCT01930188|38823564|FG000|Overall Study|Missing follow-up information|2|||
16090882|NCT01930188|38823565|FG001|Overall Study|Missing follow-up information|2|||
16090883|NCT01930188|38823566|FG002|Overall Study|Missing follow-up information|3|||
16090884|NCT01930188|38823564|FG000|Overall Study|Lost to Follow-up|5|||
16090885|NCT01930188|38823565|FG001|Overall Study|Lost to Follow-up|2|||
16090886|NCT01930188|38823566|FG002|Overall Study|Lost to Follow-up|2|||
16090887|NCT01930188|38823564|FG000|Overall Study|Death|2|||
16090888|NCT01930188|38823565|FG001|Overall Study|Death|1|||
16090889|NCT01930188|38823566|FG002|Overall Study|Death|3|||
16090890|NCT01930188|38823564|FG000|Overall Study|Withdrawal by Subject|9|||
16090891|NCT01930188|38823565|FG001|Overall Study|Withdrawal by Subject|11|||
16090892|NCT01930188|38823566|FG002|Overall Study|Withdrawal by Subject|8|||
16090893|NCT01794299|38823567|FG000|Overall Study|ATIR manufacturing not possible|1|||
16090894|NCT01794299|38823567|FG000|Overall Study|Death|14|||
16090895|NCT01794299|38823567|FG000|Overall Study|Graft failure|1|||
16090896|NCT01794299|38823567|FG000|Overall Study|ATIR batch rejected|2|||
16090897|NCT01794299|38823567|FG000|Overall Study|Relapse|2|||
16090898|NCT01794299|38823567|FG000|Overall Study|Discontinued from active follow-up|1|||
16090899|NCT01794299|38823567|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
16090900|NCT00704340|38823572|FG000|Overall Study|Lost to Follow-up|2|||
16090901|NCT00704340|38823573|FG001|Overall Study|Lost to Follow-up|1|||
16320980|NCT03423173|39660486|FG002|Overall Study|Withdrawal of consent|4|||
16320981|NCT03423173|39660487|FG003|Overall Study|Withdrawal of consent|5|||
16320982|NCT03423173|39660484|FG000|Overall Study|Death|1|||
16320983|NCT03423173|39660485|FG001|Overall Study|Death|0|||
16320984|NCT03423173|39660486|FG002|Overall Study|Death|0|||
16320985|NCT03423173|39660487|FG003|Overall Study|Death|0|||
16320986|NCT03423173|39660484|FG000|Overall Study|Reason not Specified|2|||
16320987|NCT03423173|39660485|FG001|Overall Study|Reason not Specified|5|||
16320988|NCT03423173|39660486|FG002|Overall Study|Reason not Specified|3|||
16320989|NCT03423173|39660487|FG003|Overall Study|Reason not Specified|1|||
16320990|NCT02347774|39660489|FG000|Study Participation|Lost to Follow-up|3|||
16320991|NCT02347774|39660490|FG001|Study Participation|Lost to Follow-up|6|||
16320992|NCT02347774|39660491|FG002|Study Participation|Lost to Follow-up|2|||
16320993|NCT02347774|39660489|FG000|Study Participation|Withdrawal by Subject|8|||
16320994|NCT02347774|39660490|FG001|Study Participation|Withdrawal by Subject|9|||
16320995|NCT02347774|39660491|FG002|Study Participation|Withdrawal by Subject|15|||
16320996|NCT02347774|39660489|FG000|Study Participation|Adverse Event|1|||
16320997|NCT02347774|39660490|FG001|Study Participation|Adverse Event|4|||
16320998|NCT02347774|39660491|FG002|Study Participation|Adverse Event|6|||
16320999|NCT02347774|39660489|FG000|Study Participation|withdrew consent|1|||
16321000|NCT02347774|39660490|FG001|Study Participation|withdrew consent|1|||
16321001|NCT02347774|39660491|FG002|Study Participation|withdrew consent|1|||
16321002|NCT02347774|39660489|FG000|Study Participation|Met Prolonged QT criteria|1|||
16321003|NCT02347774|39660490|FG001|Study Participation|Met Prolonged QT criteria|0|||
16321004|NCT02347774|39660491|FG002|Study Participation|Met Prolonged QT criteria|0|||
16321005|NCT02347774|39660489|FG000|Study Participation|non-compliance with study drug|0|||
16321006|NCT02347774|39660490|FG001|Study Participation|non-compliance with study drug|1|||
16321007|NCT02347774|39660491|FG002|Study Participation|non-compliance with study drug|0|||
16321008|NCT02347774|39660489|FG000|Study Participation|incarceration|1|||
16321009|NCT02347774|39660490|FG001|Study Participation|incarceration|0|||
16321010|NCT02347774|39660491|FG002|Study Participation|incarceration|0|||
16321011|NCT02347774|39660489|FG000|Study Participation|randomized in error|0|||
16321012|NCT02347774|39660490|FG001|Study Participation|randomized in error|0|||
16321013|NCT02347774|39660491|FG002|Study Participation|randomized in error|1|||
16321014|NCT02347774|39660489|FG000|On Study Treatment|Adverse Event|9|||
16321015|NCT02347774|39660490|FG001|On Study Treatment|Adverse Event|15|||
16321016|NCT02347774|39660491|FG002|On Study Treatment|Adverse Event|19|||
16321017|NCT02347774|39660489|FG000|On Study Treatment|Lack of Efficacy|3|||
16321018|NCT02347774|39660490|FG001|On Study Treatment|Lack of Efficacy|0|||
16321019|NCT02347774|39660491|FG002|On Study Treatment|Lack of Efficacy|2|||
16321020|NCT02347774|39660489|FG000|On Study Treatment|non-complicance with study medication|0|||
16321021|NCT02347774|39660490|FG001|On Study Treatment|non-complicance with study medication|2|||
16321022|NCT02347774|39660491|FG002|On Study Treatment|non-complicance with study medication|0|||
16321023|NCT02347774|39660489|FG000|On Study Treatment|Protocol Violation|0|||
16321024|NCT02347774|39660490|FG001|On Study Treatment|Protocol Violation|0|||
16321025|NCT02347774|39660491|FG002|On Study Treatment|Protocol Violation|1|||
16321026|NCT02347774|39660489|FG000|On Study Treatment|withdrew consent|9|||
16321027|NCT02347774|39660490|FG001|On Study Treatment|withdrew consent|8|||
16321028|NCT02347774|39660491|FG002|On Study Treatment|withdrew consent|12|||
16321029|NCT02347774|39660489|FG000|On Study Treatment|Lost to Follow-up|2|||
16321030|NCT02347774|39660490|FG001|On Study Treatment|Lost to Follow-up|6|||
16321031|NCT02347774|39660491|FG002|On Study Treatment|Lost to Follow-up|1|||
16515478|NCT00548808|40355601|FG000|Overall Study|Adverse Event|4|||
16515479|NCT00548808|40355602|FG001|Overall Study|Adverse Event|5|||
16515480|NCT00548808|40355601|FG000|Overall Study|Death|2|||
16515481|NCT00548808|40355602|FG001|Overall Study|Death|0|||
16515482|NCT00548808|40355601|FG000|Overall Study|Entry Criteria Not Met|2|||
16515483|NCT00548808|40355602|FG001|Overall Study|Entry Criteria Not Met|2|||
16515484|NCT00548808|40355601|FG000|Overall Study|Lack of Efficacy|2|||
16515485|NCT00548808|40355602|FG001|Overall Study|Lack of Efficacy|0|||
16515486|NCT00548808|40355601|FG000|Overall Study|Sponsor Decision|1|||
16515487|NCT00548808|40355602|FG001|Overall Study|Sponsor Decision|1|||
16515488|NCT00595582|40355603|FG000|Overall Study|Pilot study that PI terminated|2|||
16515489|NCT00595582|40355603|FG000|Overall Study|Lost to Follow-up|1|||
16515490|NCT00595582|40355603|FG000|Overall Study|Adverse Event|2|||
16515491|NCT00595582|40355603|FG000|Overall Study|Physician Decision|5|||
16515492|NCT00463060|40355604|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
16515493|NCT00463060|40355604|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
16515494|NCT00436748|40355605|FG000|Overall Study|Ineligibility Determined|1|||
16515495|NCT00436748|40355606|FG001|Overall Study|Ineligibility Determined|1|||
16515496|NCT00436748|40355605|FG000|Overall Study|Adverse Event|0|||
16515497|NCT00436748|40355606|FG001|Overall Study|Adverse Event|2|||
16515498|NCT00436748|40355605|FG000|Overall Study|Consent Withdrawn|1|||
16515499|NCT00436748|40355606|FG001|Overall Study|Consent Withdrawn|4|||
16515500|NCT00436748|40355605|FG000|Overall Study|Administrative Decision|1|||
16515501|NCT00436748|40355606|FG001|Overall Study|Administrative Decision|0|||
16515502|NCT00436748|40355605|FG000|Overall Study|Lost to Follow-up|0|||
16515503|NCT00436748|40355606|FG001|Overall Study|Lost to Follow-up|1|||
16515504|NCT00436748|40355605|FG000|Overall Study|Protocol-specified Criteria|5|||
16515505|NCT00436748|40355606|FG001|Overall Study|Protocol-specified Criteria|4|||
16515506|NCT00436748|40355605|FG000|Overall Study|Other|3|||
16515507|NCT00436748|40355606|FG001|Overall Study|Other|0|||
16515508|NCT00578565|40355607|FG000|Overall Study|Adverse Event|3|||
16515509|NCT03240575|40355608|FG000|Overall Study|Adverse Event|0|||
16515510|NCT03240575|40355609|FG001|Overall Study|Adverse Event|2|||
16515511|NCT03240575|40355610|FG002|Overall Study|Adverse Event|0|||
16515512|NCT03240575|40355611|FG003|Overall Study|Adverse Event|1|||
16515513|NCT03240575|40355608|FG000|Overall Study|Withdrawal by Subject|2|||
16515514|NCT03240575|40355609|FG001|Overall Study|Withdrawal by Subject|11|||
16515515|NCT03240575|40355610|FG002|Overall Study|Withdrawal by Subject|0|||
16515516|NCT03240575|40355611|FG003|Overall Study|Withdrawal by Subject|1|||
16515517|NCT03240575|40355608|FG000|Overall Study|Other|0|||
16515518|NCT03240575|40355609|FG001|Overall Study|Other|1|||
16515519|NCT03240575|40355610|FG002|Overall Study|Other|0|||
16515520|NCT03240575|40355611|FG003|Overall Study|Other|0|||
16515521|NCT01957475|40355614|FG000|Test Period 1|Withdrawal by Subject|1|||
16515522|NCT01957475|40355615|FG001|Test Period 1|Withdrawal by Subject|0|||
16515523|NCT01957475|40355614|FG000|Test Period 1|Other|1|||
16515524|NCT01957475|40355615|FG001|Test Period 1|Other|0|||
16515525|NCT01957475|40355614|FG000|Test Period 1|Lack of Efficacy|0|||
16321032|NCT02347774|39660489|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
16321033|NCT02347774|39660490|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
16321034|NCT02347774|39660491|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
16321035|NCT02347774|39660489|FG000|On Study Treatment|ranomized in error|0|||
16321036|NCT02347774|39660490|FG001|On Study Treatment|ranomized in error|0|||
16321037|NCT02347774|39660491|FG002|On Study Treatment|ranomized in error|1|||
16321038|NCT02593097|39660492|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
16321039|NCT02593097|39660493|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
16321040|NCT02593097|39660492|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
16321041|NCT02593097|39660493|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
16321042|NCT02593097|39660492|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
16321043|NCT02593097|39660493|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
16321044|NCT02593097|39660492|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
16321045|NCT02593097|39660493|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
16321046|NCT02593097|39660492|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
16394841|NCT02676895|39928060|FG000|Overall Study|Adverse Event|0|||
16515526|NCT01957475|40355615|FG001|Test Period 1|Lack of Efficacy|1|||
16515527|NCT01957475|40355614|FG000|Test Period 2|Adverse Event|1|||
16515528|NCT01957475|40355615|FG001|Test Period 2|Adverse Event|0|||
16515529|NCT01914666|40355617|FG000|Treatment Period|Lack of Efficacy|0|||
16515530|NCT01914666|40355618|FG001|Treatment Period|Lack of Efficacy|0|||
16515531|NCT01914666|40355619|FG002|Treatment Period|Lack of Efficacy|2|||
16515532|NCT01914666|40355617|FG000|Treatment Period|Adverse Event|10|||
16515533|NCT01914666|40355618|FG001|Treatment Period|Adverse Event|4|||
16321047|NCT02593097|39660493|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
16515534|NCT01914666|40355619|FG002|Treatment Period|Adverse Event|2|||
16515535|NCT01914666|40355617|FG000|Treatment Period|Withdrawal by Subject|3|||
16515536|NCT01914666|40355618|FG001|Treatment Period|Withdrawal by Subject|2|||
16515537|NCT01914666|40355619|FG002|Treatment Period|Withdrawal by Subject|2|||
16515538|NCT01914666|40355617|FG000|Treatment Period|Physician Decision|0|||
16515539|NCT01914666|40355618|FG001|Treatment Period|Physician Decision|0|||
16515540|NCT01914666|40355619|FG002|Treatment Period|Physician Decision|2|||
16515541|NCT02755831|40355620|FG000|Overall Study|Lost to Follow-up|3|||
16515542|NCT02755831|40355621|FG001|Overall Study|Lost to Follow-up|3|||
16515543|NCT02042924|40355622|FG000|Overall Study|Early Death|1|||
16515544|NCT01239368|40355629|FG000|Overall Study|Principal investigator discretion|1|||
16515545|NCT01239368|40355630|FG001|Overall Study|Principal investigator discretion|0|||
16515546|NCT01239368|40355631|FG002|Overall Study|Principal investigator discretion|0|||
16515547|NCT01239368|40355632|FG003|Overall Study|Principal investigator discretion|0|||
16515548|NCT01239368|40355633|FG004|Overall Study|Principal investigator discretion|1|||
16515549|NCT01239368|40355634|FG005|Overall Study|Principal investigator discretion|2|||
16515550|NCT01239368|40355635|FG006|Overall Study|Principal investigator discretion|0|||
16515551|NCT01239368|40355636|FG007|Overall Study|Principal investigator discretion|0|||
16515552|NCT01239368|40355637|FG008|Overall Study|Principal investigator discretion|0|||
16515553|NCT01239368|40355638|FG009|Overall Study|Principal investigator discretion|1|||
16515554|NCT01239368|40355629|FG000|Overall Study|Disease progression on study|1|||
16515555|NCT01239368|40355630|FG001|Overall Study|Disease progression on study|1|||
16515556|NCT01239368|40355631|FG002|Overall Study|Disease progression on study|1|||
16515557|NCT01239368|40355632|FG003|Overall Study|Disease progression on study|1|||
16515558|NCT01239368|40355633|FG004|Overall Study|Disease progression on study|4|||
16515559|NCT01239368|40355634|FG005|Overall Study|Disease progression on study|2|||
16515560|NCT01239368|40355635|FG006|Overall Study|Disease progression on study|5|||
16515561|NCT01239368|40355636|FG007|Overall Study|Disease progression on study|0|||
16515562|NCT01239368|40355637|FG008|Overall Study|Disease progression on study|0|||
16515563|NCT01239368|40355638|FG009|Overall Study|Disease progression on study|2|||
16515564|NCT01239368|40355629|FG000|Overall Study|Refused further treatment|0|||
16515565|NCT01239368|40355630|FG001|Overall Study|Refused further treatment|0|||
16515566|NCT01239368|40355631|FG002|Overall Study|Refused further treatment|0|||
16515567|NCT01239368|40355632|FG003|Overall Study|Refused further treatment|0|||
16515568|NCT01239368|40355633|FG004|Overall Study|Refused further treatment|0|||
16515569|NCT01239368|40355634|FG005|Overall Study|Refused further treatment|0|||
16515570|NCT01239368|40355635|FG006|Overall Study|Refused further treatment|0|||
16515571|NCT01239368|40355636|FG007|Overall Study|Refused further treatment|0|||
16515572|NCT01239368|40355637|FG008|Overall Study|Refused further treatment|0|||
16515573|NCT01239368|40355638|FG009|Overall Study|Refused further treatment|1|||
16515574|NCT01239368|40355629|FG000|Overall Study|Death|0|||
16515575|NCT01239368|40355630|FG001|Overall Study|Death|0|||
16515576|NCT01239368|40355631|FG002|Overall Study|Death|0|||
16515577|NCT01239368|40355632|FG003|Overall Study|Death|0|||
16515578|NCT01239368|40355633|FG004|Overall Study|Death|0|||
16515579|NCT01239368|40355634|FG005|Overall Study|Death|0|||
16515580|NCT01239368|40355635|FG006|Overall Study|Death|1|||
16515581|NCT01239368|40355636|FG007|Overall Study|Death|0|||
16515582|NCT01239368|40355637|FG008|Overall Study|Death|0|||
16515583|NCT01239368|40355638|FG009|Overall Study|Death|0|||
16515584|NCT02434770|40355639|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
16515585|NCT02434770|40355640|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
16515586|NCT02434770|40355641|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
16321048|NCT03811093|39660494|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
16321049|NCT03811093|39660495|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
16321050|NCT03811093|39660494|FG000|Overall Study|Unable to measure body fat percentage|2|||
16321051|NCT03811093|39660495|FG001|Overall Study|Unable to measure body fat percentage|0|||
16321052|NCT01668173|39660496|FG000|Overall Study|Adverse Event|3|||
16321053|NCT01668173|39660496|FG000|Overall Study|Trial suspension|4|||
16321054|NCT00003830|39660497|FG000|Overall Study|No follow up data|3|||
16321055|NCT00003830|39660498|FG001|Overall Study|No follow up data|0|||
16321056|NCT00003830|39660497|FG000|Overall Study|Sentinel node positive patients|829|||
16321057|NCT00003830|39660498|FG001|Overall Study|Sentinel node positive patients|793|||
16321058|NCT00591565|39660499|FG000|Overall Study|lost follow up, withdrawn|5|||
16321059|NCT02187198|39660504|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
16321060|NCT02187198|39660505|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
16515587|NCT02434770|40355639|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
16515588|NCT02434770|40355640|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
16321061|NCT02187198|39660504|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
16515589|NCT02434770|40355641|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
16515590|NCT02434770|40355639|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
16515591|NCT02434770|40355640|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
16515592|NCT02434770|40355641|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
16321062|NCT02187198|39660505|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
16321063|NCT02278939|39660514|FG000|Overall Study|lack of time|1|||
16321064|NCT02278939|39660515|FG001|Overall Study|lack of time|0|||
16321065|NCT02278939|39660514|FG000|Overall Study|Lost to Follow-up|1|||
16321066|NCT02278939|39660515|FG001|Overall Study|Lost to Follow-up|1|||
16321067|NCT02278939|39660514|FG000|Overall Study|death in family|1|||
16321068|NCT02278939|39660515|FG001|Overall Study|death in family|0|||
16321069|NCT02278939|39660514|FG000|Overall Study|family emergency unable to commit|2|||
16321070|NCT02278939|39660515|FG001|Overall Study|family emergency unable to commit|0|||
16321071|NCT00734162|39660516|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
16321072|NCT00734162|39660517|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
16321073|NCT00734162|39660518|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
16321074|NCT00734162|39660519|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
16515593|NCT02434770|40355639|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
16515594|NCT02434770|40355640|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
16515595|NCT02434770|40355641|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
16515596|NCT02434770|40355639|FG000|Week 1 to Week 18|Death|1|||
16515597|NCT02434770|40355640|FG001|Week 1 to Week 18|Death|0|||
16515598|NCT02434770|40355641|FG002|Week 1 to Week 18|Death|0|||
16515599|NCT02434770|40355639|FG000|Week 18 to Week|Lost to Follow-up|2|||
16515600|NCT02434770|40355640|FG001|Week 18 to Week|Lost to Follow-up|2|||
16515601|NCT02434770|40355641|FG002|Week 18 to Week|Lost to Follow-up|1|||
16515602|NCT02434770|40355639|FG000|Week 18 to Week|Withdrawal by Subject|0|||
16515603|NCT02434770|40355640|FG001|Week 18 to Week|Withdrawal by Subject|0|||
16515604|NCT02434770|40355641|FG002|Week 18 to Week|Withdrawal by Subject|2|||
16515605|NCT02434770|40355639|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
16515606|NCT02434770|40355640|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
16515607|NCT02434770|40355641|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
16515608|NCT02731729|40355642|FG000|Overall Study|Death|2|||
16515609|NCT02731729|40355643|FG001|Overall Study|Death|2|||
16515610|NCT02731729|40355642|FG000|Overall Study|Study terminated by Sponsor|6|||
16515611|NCT02731729|40355643|FG001|Overall Study|Study terminated by Sponsor|6|||
16515612|NCT02731729|40355642|FG000|Overall Study|Withdrawal by Subject|1|||
16515613|NCT02731729|40355643|FG001|Overall Study|Withdrawal by Subject|0|||
16515614|NCT02586012|40355645|FG000|Overall Study|Withdrawal by Subject|1|||
16515615|NCT02586012|40355646|FG001|Overall Study|Withdrawal by Subject|1|||
16515616|NCT02586012|40355647|FG002|Overall Study|Withdrawal by Subject|0|||
16515617|NCT02586012|40355648|FG003|Overall Study|Withdrawal by Subject|1|||
16515618|NCT02586012|40355649|FG004|Overall Study|Withdrawal by Subject|0|||
16515619|NCT02586012|40355650|FG005|Overall Study|Withdrawal by Subject|2|||
16515620|NCT02586012|40355645|FG000|Overall Study|Protocol Violation|0|||
16515621|NCT02586012|40355646|FG001|Overall Study|Protocol Violation|0|||
16515622|NCT02586012|40355647|FG002|Overall Study|Protocol Violation|0|||
16515623|NCT02586012|40355648|FG003|Overall Study|Protocol Violation|0|||
16515624|NCT02586012|40355649|FG004|Overall Study|Protocol Violation|0|||
16515625|NCT02586012|40355650|FG005|Overall Study|Protocol Violation|1|||
16515626|NCT02586012|40355645|FG000|Overall Study|study terminated|0|||
16515627|NCT02586012|40355646|FG001|Overall Study|study terminated|2|||
16515628|NCT02586012|40355647|FG002|Overall Study|study terminated|1|||
16515629|NCT02586012|40355648|FG003|Overall Study|study terminated|1|||
16515630|NCT02586012|40355649|FG004|Overall Study|study terminated|1|||
16515631|NCT02586012|40355650|FG005|Overall Study|study terminated|0|||
16515632|NCT00715793|40355651|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
16515633|NCT00715793|40355652|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
16515634|NCT00715793|40355651|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
16515635|NCT00715793|40355652|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
16515636|NCT03591575|40355653|FG000|Overall Study|Adverse Event|2|||
16515637|NCT03591575|40355654|FG001|Overall Study|Adverse Event|0|||
16515638|NCT03591575|40355653|FG000|Overall Study|Withdrawal by Subject|4|||
16515639|NCT03591575|40355654|FG001|Overall Study|Withdrawal by Subject|1|||
16515640|NCT00071812|40355655|FG000|24-Week Double-Blind Period|Adverse Event|2|||
16515641|NCT00071812|40355656|FG001|24-Week Double-Blind Period|Adverse Event|3|||
16515642|NCT00071812|40355657|FG002|24-Week Double-Blind Period|Adverse Event|4|||
16321075|NCT00734162|39660516|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
16515643|NCT00071812|40355658|FG003|24-Week Double-Blind Period|Adverse Event|4|||
16515644|NCT00071812|40355655|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
16515645|NCT00071812|40355656|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
16515646|NCT00071812|40355657|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
16515647|NCT00071812|40355658|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
16515648|NCT00071812|40355655|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
16515649|NCT00071812|40355656|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
16515650|NCT00071812|40355657|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
16515651|NCT00071812|40355658|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
16515652|NCT00071812|40355655|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
16515653|NCT00071812|40355656|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
16515654|NCT00071812|40355657|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
16321076|NCT00734162|39660517|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
16321077|NCT00734162|39660518|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
16321078|NCT00734162|39660519|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
16321079|NCT00734162|39660516|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
16321080|NCT00734162|39660517|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
16321081|NCT00734162|39660518|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
16321082|NCT00734162|39660519|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
16515655|NCT00071812|40355658|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
16515656|NCT00071812|40355655|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
16515657|NCT00071812|40355656|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
16515658|NCT00071812|40355657|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
16515659|NCT00071812|40355658|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
16515660|NCT00071812|40355655|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
16515661|NCT00071812|40355656|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
16515662|NCT00071812|40355657|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
16515663|NCT00071812|40355658|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
16515664|NCT00071812|40355655|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
16515665|NCT00071812|40355656|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
16515666|NCT00071812|40355657|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
16515667|NCT00071812|40355658|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
16515668|NCT00071812|40355655|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
16515669|NCT00071812|40355656|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
16515670|NCT00071812|40355657|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
16515671|NCT00071812|40355658|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
16515672|NCT00071812|40355655|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
16515673|NCT00071812|40355656|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
16515674|NCT00071812|40355657|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
16515675|NCT00071812|40355658|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
16515676|NCT00071812|40355655|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
16515677|NCT00071812|40355656|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
16515678|NCT00071812|40355657|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
16515679|NCT00071812|40355658|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
16515680|NCT02342704|40355659|FG000|Overall Study|Physician Decision|0|||
16515681|NCT02342704|40355660|FG001|Overall Study|Physician Decision|3|||
16515682|NCT02342704|40355659|FG000|Overall Study|Sponsor Termination|49|||
16515683|NCT02342704|40355660|FG001|Overall Study|Sponsor Termination|43|||
16515684|NCT02342704|40355659|FG000|Overall Study|Other|0|||
16515685|NCT02342704|40355660|FG001|Overall Study|Other|1|||
16515686|NCT02342704|40355659|FG000|Overall Study|Withdrawal by Subject|1|||
16515687|NCT02342704|40355660|FG001|Overall Study|Withdrawal by Subject|0|||
16515688|NCT02342704|40355659|FG000|Overall Study|Lost to Follow-up|2|||
16515689|NCT02342704|40355660|FG001|Overall Study|Lost to Follow-up|1|||
16515690|NCT02342704|40355659|FG000|Overall Study|Adverse Event|1|||
16515691|NCT02342704|40355660|FG001|Overall Study|Adverse Event|3|||
16515692|NCT02376166|40355661|FG000|Overall Study|Adverse Event|1|||
16515693|NCT02376166|40355661|FG000|Overall Study|Discontinued metformin early|2|||
16515694|NCT04206293|40355662|FG000|Overall Study|Consent withdrawal|1|||
16515695|NCT01986829|40355663|FG000|Overall Study|Death|1|||
16515696|NCT00678561|40355664|FG000|Overall Study|Adverse Event|0|||
16515697|NCT00678561|40355665|FG001|Overall Study|Adverse Event|1|||
16515698|NCT00678561|40355666|FG002|Overall Study|Adverse Event|1|||
16515699|NCT00678561|40355667|FG003|Overall Study|Adverse Event|0|||
16515700|NCT00678561|40355668|FG004|Overall Study|Adverse Event|1|||
16515701|NCT00678561|40355669|FG005|Overall Study|Adverse Event|0|||
16515702|NCT00678561|40355670|FG006|Overall Study|Adverse Event|0|||
16515703|NCT00678561|40355671|FG007|Overall Study|Adverse Event|0|||
16515704|NCT00678561|40355664|FG000|Overall Study|Protocol Violation|0|||
16515705|NCT00678561|40355665|FG001|Overall Study|Protocol Violation|0|||
16515706|NCT00678561|40355666|FG002|Overall Study|Protocol Violation|0|||
16515707|NCT00678561|40355667|FG003|Overall Study|Protocol Violation|0|||
16202400|NCT01199055|39218826|FG002|Overall Study|Progressive disease|2|||
16515708|NCT00678561|40355668|FG004|Overall Study|Protocol Violation|1|||
16515709|NCT00678561|40355669|FG005|Overall Study|Protocol Violation|1|||
16515710|NCT00678561|40355670|FG006|Overall Study|Protocol Violation|0|||
16515711|NCT00678561|40355671|FG007|Overall Study|Protocol Violation|0|||
16515712|NCT00678561|40355664|FG000|Overall Study|Withdrawal by Subject|0|||
16515713|NCT00678561|40355665|FG001|Overall Study|Withdrawal by Subject|0|||
16515714|NCT00678561|40355666|FG002|Overall Study|Withdrawal by Subject|0|||
16515715|NCT00678561|40355667|FG003|Overall Study|Withdrawal by Subject|0|||
16515716|NCT00678561|40355668|FG004|Overall Study|Withdrawal by Subject|0|||
16515717|NCT00678561|40355669|FG005|Overall Study|Withdrawal by Subject|0|||
16515718|NCT00678561|40355670|FG006|Overall Study|Withdrawal by Subject|0|||
16515719|NCT00678561|40355671|FG007|Overall Study|Withdrawal by Subject|1|||
16515720|NCT01956110|40355672|FG000|Overall Study|Protocol Violation|25|||
16515721|NCT01956110|40355673|FG001|Overall Study|Protocol Violation|11|||
16515722|NCT01956110|40355672|FG000|Overall Study|Adverse Event|9|||
16515723|NCT01956110|40355673|FG001|Overall Study|Adverse Event|10|||
16515724|NCT01956110|40355672|FG000|Overall Study|Personal reasons|1|||
16515725|NCT01956110|40355673|FG001|Overall Study|Personal reasons|1|||
16515726|NCT02472756|40355674|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
16515727|NCT02472756|40355674|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
16515728|NCT02472756|40355674|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
16515729|NCT02472756|40355674|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
16515730|NCT02472756|40355674|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
16515731|NCT00646204|40355675|FG000|Overall Study|Adverse Event|3|||
16515732|NCT00646204|40355676|FG001|Overall Study|Adverse Event|0|||
16515733|NCT00646204|40355675|FG000|Overall Study|Withdrawal by Subject|1|||
16515734|NCT00646204|40355676|FG001|Overall Study|Withdrawal by Subject|0|||
16515735|NCT01660711|40355677|FG000|Overall Study|Adverse Event|7|||
16515736|NCT01660711|40355677|FG000|Overall Study|Withdrawal by Subject|1|||
16515737|NCT03921411|40355680|FG000|Overall Study|Withdrawal by Subject|1|||
16515738|NCT03921411|40355680|FG000|Overall Study|Protocol Deviation|2|||
16515739|NCT03921411|40355680|FG000|Overall Study|Enrolled, but never treated|2|||
16515740|NCT01232296|40355681|FG000|Overall Study|Adverse Event|24|||
16515741|NCT01232296|40355682|FG001|Overall Study|Adverse Event|12|||
16515742|NCT01232296|40355681|FG000|Overall Study|Physician Decision|1|||
16515743|NCT01232296|40355682|FG001|Overall Study|Physician Decision|1|||
16515744|NCT01232296|40355681|FG000|Overall Study|Progressive disease|43|||
16515745|NCT01232296|40355682|FG001|Overall Study|Progressive disease|61|||
16515746|NCT01232296|40355681|FG000|Overall Study|Study terminated by sponsor|0|||
16515747|NCT01232296|40355682|FG001|Overall Study|Study terminated by sponsor|1|||
16515748|NCT01232296|40355681|FG000|Overall Study|Technical problems|3|||
16515749|NCT01232296|40355682|FG001|Overall Study|Technical problems|0|||
16515750|NCT01232296|40355681|FG000|Overall Study|Subject/guardian decision|10|||
16515751|NCT01232296|40355682|FG001|Overall Study|Subject/guardian decision|2|||
16515752|NCT01232296|40355681|FG000|Overall Study|Death|1|||
16515753|NCT01232296|40355682|FG001|Overall Study|Death|6|||
16515754|NCT00720876|40355683|FG000|Overall Study|found to be ineligible after starting tx|2|||
16515755|NCT01467076|40355684|FG000|Overall Study|Lost to Follow-up|1|||
16515756|NCT01467076|40355685|FG001|Overall Study|Lost to Follow-up|0|||
16515757|NCT01467076|40355686|FG002|Overall Study|Lost to Follow-up|0|||
16515758|NCT02932891|40355687|FG000|Overall Study|Lost to Follow-up|2|||
16515759|NCT02932891|40355687|FG000|Overall Study|HPA Suppress|2|||
16515760|NCT05044234|40355688|FG000|Overall Study|Lost to Follow-up|2|||
16515761|NCT05044234|40355689|FG001|Overall Study|Lost to Follow-up|1|||
16515762|NCT05044234|40355690|FG002|Overall Study|Lost to Follow-up|1|||
16515763|NCT05044234|40355691|FG003|Overall Study|Lost to Follow-up|2|||
16515764|NCT05044234|40355688|FG000|Overall Study|Withdrawal by Subject|6|||
16515765|NCT05044234|40355689|FG001|Overall Study|Withdrawal by Subject|4|||
16515766|NCT05044234|40355690|FG002|Overall Study|Withdrawal by Subject|5|||
16515767|NCT05044234|40355691|FG003|Overall Study|Withdrawal by Subject|8|||
16515768|NCT05044234|40355688|FG000|Overall Study|Study terminated by Sponsor|21|||
16515769|NCT05044234|40355689|FG001|Overall Study|Study terminated by Sponsor|21|||
16515770|NCT05044234|40355690|FG002|Overall Study|Study terminated by Sponsor|20|||
16515771|NCT05044234|40355691|FG003|Overall Study|Study terminated by Sponsor|14|||
16515772|NCT05044234|40355688|FG000|Overall Study|Other, not specified|0|||
16515773|NCT05044234|40355689|FG001|Overall Study|Other, not specified|0|||
16515774|NCT05044234|40355690|FG002|Overall Study|Other, not specified|1|||
16515775|NCT05044234|40355691|FG003|Overall Study|Other, not specified|2|||
16515776|NCT05044234|40355688|FG000|Overall Study|Delayed data entry|0|||
16515777|NCT05044234|40355689|FG001|Overall Study|Delayed data entry|0|||
16515778|NCT05044234|40355690|FG002|Overall Study|Delayed data entry|0|||
16515779|NCT05044234|40355691|FG003|Overall Study|Delayed data entry|1|||
16515780|NCT01888497|40355692|FG000|Washout Period 1|Withdrawal by Subject|0|||
16090902|NCT00704340|38823572|FG000|Overall Study|Death|0|||
16394842|NCT02676895|39928061|FG001|Overall Study|Adverse Event|3|||
16515781|NCT01888497|40355693|FG001|Washout Period 1|Withdrawal by Subject|0|||
16515782|NCT01888497|40355694|FG002|Washout Period 1|Withdrawal by Subject|1|||
16515783|NCT01888497|40355695|FG003|Washout Period 1|Withdrawal by Subject|1|||
16515784|NCT01888497|40355692|FG000|Washout Period 2|Adverse Event|0|||
16515785|NCT01888497|40355693|FG001|Washout Period 2|Adverse Event|0|||
16515786|NCT01888497|40355694|FG002|Washout Period 2|Adverse Event|0|||
16515787|NCT01888497|40355695|FG003|Washout Period 2|Adverse Event|1|||
16515788|NCT01888497|40355692|FG000|Washout Period 2|Withdrawal by Subject|0|||
16515789|NCT01888497|40355693|FG001|Washout Period 2|Withdrawal by Subject|0|||
16515790|NCT01888497|40355694|FG002|Washout Period 2|Withdrawal by Subject|0|||
16515791|NCT01888497|40355695|FG003|Washout Period 2|Withdrawal by Subject|1|||
16515792|NCT00958880|40355696|FG000|Overall Study|Lost to Follow-up|2|||
16515793|NCT00958880|40355697|FG001|Overall Study|Lost to Follow-up|2|||
16090903|NCT00704340|38823573|FG001|Overall Study|Death|1|||
16090904|NCT02659540|38823574|FG000|Overall Study|Adverse Event|3|||
16090905|NCT02659540|38823575|FG001|Overall Study|Adverse Event|2|||
16090906|NCT02659540|38823574|FG000|Overall Study|Death|1|||
16090907|NCT02659540|38823575|FG001|Overall Study|Death|0|||
16090908|NCT02659540|38823574|FG000|Overall Study|Progressive disease|2|||
16090909|NCT02659540|38823575|FG001|Overall Study|Progressive disease|6|||
16090910|NCT02157948|38823577|FG000|Overall Study|Withdrawal by Subject|4|||
16090911|NCT02157948|38823578|FG001|Overall Study|Withdrawal by Subject|5|||
16090912|NCT02157948|38823577|FG000|Overall Study|Lost to Follow-up|3|||
16090913|NCT02157948|38823578|FG001|Overall Study|Lost to Follow-up|2|||
16090914|NCT02157948|38823577|FG000|Overall Study|Protocol Specified Criteria|2|||
16090915|NCT02157948|38823578|FG001|Overall Study|Protocol Specified Criteria|1|||
16090916|NCT02157948|38823577|FG000|Overall Study|Decision by Sponsor|0|||
16090917|NCT02157948|38823578|FG001|Overall Study|Decision by Sponsor|1|||
16090918|NCT01220999|38823579|FG000|Overall Study|Progressive disease|0|||
16090919|NCT01220999|38823580|FG001|Overall Study|Progressive disease|0|||
16090920|NCT01220999|38823581|FG002|Overall Study|Progressive disease|1|||
16090921|NCT01220999|38823582|FG003|Overall Study|Progressive disease|0|||
16090922|NCT01220999|38823583|FG004|Overall Study|Progressive disease|0|||
16090923|NCT02006641|38823584|FG000|Overall Study|Withdrawal before treatment|2|||
16090924|NCT02006641|38823585|FG001|Overall Study|Withdrawal before treatment|5|||
16090925|NCT02006641|38823586|FG002|Overall Study|Withdrawal before treatment|3|||
16090926|NCT02006641|38823584|FG000|Overall Study|Adverse Event|15|||
16090927|NCT02006641|38823585|FG001|Overall Study|Adverse Event|11|||
16090928|NCT02006641|38823586|FG002|Overall Study|Adverse Event|15|||
16090929|NCT02006641|38823584|FG000|Overall Study|Protocol Violation|0|||
16090930|NCT02006641|38823585|FG001|Overall Study|Protocol Violation|2|||
16090931|NCT02006641|38823586|FG002|Overall Study|Protocol Violation|2|||
16090932|NCT02006641|38823584|FG000|Overall Study|Lost to Follow-up|0|||
16090933|NCT02006641|38823585|FG001|Overall Study|Lost to Follow-up|1|||
16090934|NCT02006641|38823586|FG002|Overall Study|Lost to Follow-up|0|||
16090935|NCT02006641|38823584|FG000|Overall Study|Withdrawal by Subject|7|||
16090936|NCT02006641|38823585|FG001|Overall Study|Withdrawal by Subject|12|||
16090937|NCT02006641|38823586|FG002|Overall Study|Withdrawal by Subject|11|||
16090938|NCT02006641|38823584|FG000|Overall Study|Other reason: patient didn't show up|1|||
16090939|NCT02006641|38823585|FG001|Overall Study|Other reason: patient didn't show up|0|||
16090940|NCT02006641|38823586|FG002|Overall Study|Other reason: patient didn't show up|0|||
16090941|NCT02006641|38823584|FG000|Overall Study|Other reason:patient didn't want to come|0|||
16090942|NCT02006641|38823585|FG001|Overall Study|Other reason:patient didn't want to come|0|||
16090943|NCT02006641|38823586|FG002|Overall Study|Other reason:patient didn't want to come|1|||
16090944|NCT02006641|38823584|FG000|Overall Study|Other reason: patient has moved|1|||
16090945|NCT02006641|38823585|FG001|Overall Study|Other reason: patient has moved|0|||
16090946|NCT02006641|38823586|FG002|Overall Study|Other reason: patient has moved|1|||
16090947|NCT02006641|38823584|FG000|Overall Study|Other reason: caregiver in hospital|0|||
16090948|NCT02006641|38823585|FG001|Overall Study|Other reason: caregiver in hospital|1|||
16090949|NCT02006641|38823586|FG002|Overall Study|Other reason: caregiver in hospital|0|||
16090950|NCT02006641|38823584|FG000|Overall Study|Other reason: patient's wife has died|0|||
16090951|NCT02006641|38823585|FG001|Overall Study|Other reason: patient's wife has died|0|||
16090952|NCT02006641|38823586|FG002|Overall Study|Other reason: patient's wife has died|1|||
16090953|NCT02006641|38823584|FG000|Overall Study|Other reason: hospitalisation|0|||
16090954|NCT02006641|38823585|FG001|Overall Study|Other reason: hospitalisation|1|||
16090955|NCT02006641|38823586|FG002|Overall Study|Other reason: hospitalisation|0|||
16090956|NCT02006641|38823584|FG000|Overall Study|Other reason: caregiver impossibility|0|||
16090957|NCT02006641|38823585|FG001|Overall Study|Other reason: caregiver impossibility|0|||
16090958|NCT02006641|38823586|FG002|Overall Study|Other reason: caregiver impossibility|1|||
16090959|NCT02006641|38823584|FG000|Overall Study|Other reason: protocol non-compliance|0|||
16090960|NCT02006641|38823585|FG001|Overall Study|Other reason: protocol non-compliance|0|||
16090961|NCT02006641|38823586|FG002|Overall Study|Other reason: protocol non-compliance|1|||
16090962|NCT00326183|38823587|FG000|Overall Study|Lost to Follow-up|104|||
16090963|NCT00326183|38823588|FG001|Overall Study|Lost to Follow-up|56|||
16090964|NCT00326183|38823587|FG000|Overall Study|Protocol Violation|6|||
16090965|NCT00326183|38823588|FG001|Overall Study|Protocol Violation|3|||
16090966|NCT00326183|38823587|FG000|Overall Study|Withdrawal by Subject|35|||
16090967|NCT00326183|38823588|FG001|Overall Study|Withdrawal by Subject|7|||
16090968|NCT00326183|38823587|FG000|Overall Study|Subject Moved|7|||
16394843|NCT02676895|39928062|FG002|Overall Study|Adverse Event|1|||
16394844|NCT02676895|39928060|FG000|Overall Study|Lost to Follow-up|0|||
16515794|NCT03548584|40355698|FG000|Overall Study|Lost to Follow-up|0|||
16090969|NCT00326183|38823588|FG001|Overall Study|Subject Moved|4|||
16090970|NCT00326183|38823587|FG000|Overall Study|Other|47|||
16090971|NCT00326183|38823588|FG001|Overall Study|Other|13|||
16090972|NCT00326183|38823587|FG000|Overall Study|Adverse Event|1|||
16090973|NCT00326183|38823588|FG001|Overall Study|Adverse Event|0|||
16090974|NCT00990314|38823591|FG000|Overall Study|Death|2|||
16394845|NCT02676895|39928061|FG001|Overall Study|Lost to Follow-up|0|||
16515795|NCT03548584|40355699|FG001|Overall Study|Lost to Follow-up|0|||
16515796|NCT03548584|40355700|FG002|Overall Study|Lost to Follow-up|1|||
16515797|NCT03548584|40355698|FG000|Overall Study|Adverse Event|1|||
16515798|NCT03548584|40355699|FG001|Overall Study|Adverse Event|11|||
16515799|NCT03548584|40355700|FG002|Overall Study|Adverse Event|5|||
16515800|NCT03548584|40355698|FG000|Overall Study|Site Terminated by Sponsor|1|||
16515801|NCT03548584|40355699|FG001|Overall Study|Site Terminated by Sponsor|3|||
16515802|NCT03548584|40355700|FG002|Overall Study|Site Terminated by Sponsor|2|||
16515803|NCT03548584|40355698|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
16515804|NCT03548584|40355699|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
16515805|NCT03548584|40355700|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
16515806|NCT03548584|40355698|FG000|Overall Study|Lack of Efficacy|0|||
16515807|NCT03548584|40355699|FG001|Overall Study|Lack of Efficacy|1|||
16515808|NCT03548584|40355700|FG002|Overall Study|Lack of Efficacy|0|||
16515809|NCT03548584|40355698|FG000|Overall Study|Non-compliance with Study Drug|0|||
16515810|NCT03548584|40355699|FG001|Overall Study|Non-compliance with Study Drug|1|||
16515811|NCT03548584|40355700|FG002|Overall Study|Non-compliance with Study Drug|0|||
16515812|NCT03548584|40355698|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
16515813|NCT03548584|40355699|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
16515814|NCT03548584|40355700|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
16515815|NCT00774995|40355701|FG000|Overall Study|Protocol Violation|0|||
16515816|NCT00774995|40355702|FG001|Overall Study|Protocol Violation|0|||
16515817|NCT00774995|40355703|FG002|Overall Study|Protocol Violation|1|||
16515818|NCT00774995|40355704|FG003|Overall Study|Protocol Violation|0|||
16515819|NCT02603809|40355710|FG000|Overall Study|Withdrawal by Subject|4|||
16515820|NCT02603809|40355711|FG001|Overall Study|Withdrawal by Subject|1|||
16515821|NCT02603809|40355712|FG002|Overall Study|Withdrawal by Subject|2|||
16515822|NCT02603809|40355713|FG003|Overall Study|Withdrawal by Subject|3|||
16515823|NCT02603809|40355714|FG004|Overall Study|Withdrawal by Subject|3|||
16515824|NCT02603809|40355715|FG005|Overall Study|Withdrawal by Subject|4|||
16515825|NCT02603809|40355710|FG000|Overall Study|Lost to Follow-up|2|||
16515826|NCT02603809|40355711|FG001|Overall Study|Lost to Follow-up|3|||
16515827|NCT02603809|40355712|FG002|Overall Study|Lost to Follow-up|1|||
16515828|NCT02603809|40355713|FG003|Overall Study|Lost to Follow-up|4|||
16515829|NCT02603809|40355714|FG004|Overall Study|Lost to Follow-up|2|||
16515830|NCT02603809|40355715|FG005|Overall Study|Lost to Follow-up|2|||
16515831|NCT02603809|40355710|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
16515832|NCT02603809|40355711|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
16515833|NCT02603809|40355712|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
16515834|NCT02603809|40355713|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
16515835|NCT02603809|40355714|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
16515836|NCT02603809|40355715|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
16515837|NCT02603809|40355710|FG000|Overall Study|Physician Decision|0|||
16515838|NCT02603809|40355711|FG001|Overall Study|Physician Decision|0|||
16515839|NCT02603809|40355712|FG002|Overall Study|Physician Decision|0|||
16515840|NCT02603809|40355713|FG003|Overall Study|Physician Decision|1|||
16515841|NCT02603809|40355714|FG004|Overall Study|Physician Decision|2|||
16515842|NCT02603809|40355715|FG005|Overall Study|Physician Decision|1|||
16515843|NCT02603809|40355710|FG000|Overall Study|Adverse Event|3|||
16515844|NCT02603809|40355711|FG001|Overall Study|Adverse Event|0|||
16515845|NCT02603809|40355712|FG002|Overall Study|Adverse Event|2|||
16321083|NCT00734162|39660516|FG000|Open-Label Phase|Withdrew Consent|1|||
16321084|NCT00734162|39660517|FG001|Open-Label Phase|Withdrew Consent|0|||
16321085|NCT00734162|39660518|FG002|Open-Label Phase|Withdrew Consent|1|||
16321086|NCT00734162|39660519|FG003|Open-Label Phase|Withdrew Consent|1|||
16321087|NCT00734162|39660516|FG000|Open-Label Phase|Lost to Follow-up|1|||
16321088|NCT00734162|39660517|FG001|Open-Label Phase|Lost to Follow-up|2|||
16321089|NCT00734162|39660518|FG002|Open-Label Phase|Lost to Follow-up|0|||
16321090|NCT00734162|39660519|FG003|Open-Label Phase|Lost to Follow-up|1|||
16321091|NCT00734162|39660516|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
16321092|NCT00734162|39660517|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
16321093|NCT00734162|39660518|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
16321094|NCT00734162|39660519|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
16515846|NCT02603809|40355713|FG003|Overall Study|Adverse Event|2|||
16515847|NCT02603809|40355714|FG004|Overall Study|Adverse Event|1|||
16515848|NCT02603809|40355715|FG005|Overall Study|Adverse Event|1|||
16515849|NCT02603809|40355710|FG000|Overall Study|Lack of Efficacy|0|||
16515850|NCT02603809|40355711|FG001|Overall Study|Lack of Efficacy|1|||
16515851|NCT02603809|40355712|FG002|Overall Study|Lack of Efficacy|0|||
16515852|NCT02603809|40355713|FG003|Overall Study|Lack of Efficacy|0|||
16321095|NCT01540487|39660520|FG000|Overall Study|Protocol Violation|1|||
16515853|NCT02603809|40355714|FG004|Overall Study|Lack of Efficacy|0|||
16515854|NCT02603809|40355715|FG005|Overall Study|Lack of Efficacy|1|||
16515855|NCT04171414|40355716|FG000|Overall Study|Death|1|||
16515856|NCT04171414|40355716|FG000|Overall Study|Withdrawal by Subject|1|||
16321096|NCT01540487|39660521|FG001|Overall Study|Protocol Violation|0|||
16321097|NCT01568034|39660522|FG000|Overall Study|Withdrawal by Subject|1|||
16321098|NCT01568034|39660523|FG001|Overall Study|Withdrawal by Subject|0|||
16321099|NCT01568034|39660524|FG002|Overall Study|Withdrawal by Subject|0|||
16321100|NCT01568034|39660525|FG003|Overall Study|Withdrawal by Subject|0|||
16321101|NCT02235077|39660528|FG000|Overall Study|Death|5|||
16321102|NCT02235077|39660529|FG001|Overall Study|Death|7|||
16321103|NCT02235077|39660528|FG000|Overall Study|Lost to Follow-up|5|||
16321104|NCT02235077|39660529|FG001|Overall Study|Lost to Follow-up|6|||
16321105|NCT02235077|39660528|FG000|Overall Study|Withdrawal by Subject|8|||
16321106|NCT02235077|39660529|FG001|Overall Study|Withdrawal by Subject|5|||
16321107|NCT02235077|39660528|FG000|Overall Study|Physician Decision|0|||
16321108|NCT02235077|39660529|FG001|Overall Study|Physician Decision|1|||
16321109|NCT00813813|39660533|FG000|Overall Study|Withdrawal by Subject|1|||
16321110|NCT00813813|39660534|FG001|Overall Study|Withdrawal by Subject|1|||
16321111|NCT00813813|39660533|FG000|Overall Study|Lost to Follow-up|2|||
16321112|NCT00813813|39660534|FG001|Overall Study|Lost to Follow-up|7|||
16321113|NCT00813813|39660533|FG000|Overall Study|Other|0|||
16321114|NCT00813813|39660534|FG001|Overall Study|Other|1|||
16321115|NCT00113763|39660537|FG000|Overall Study|Adverse Event|5|||
16321116|NCT00113763|39660538|FG001|Overall Study|Adverse Event|2|||
16321117|NCT00113763|39660537|FG000|Overall Study|Disease Progression|28|||
16321118|NCT00113763|39660538|FG001|Overall Study|Disease Progression|14|||
16321119|NCT00113763|39660537|FG000|Overall Study|Lost to Follow-up|10|||
16321120|NCT00113763|39660538|FG001|Overall Study|Lost to Follow-up|0|||
16321121|NCT00113763|39660537|FG000|Overall Study|Withdrawal by Subject|1|||
16321122|NCT00113763|39660538|FG001|Overall Study|Withdrawal by Subject|4|||
16321123|NCT00113763|39660537|FG000|Overall Study|Other|27|||
16321124|NCT00113763|39660538|FG001|Overall Study|Other|6|||
16321125|NCT00113763|39660537|FG000|Overall Study|Non-compliance|1|||
16321126|NCT00113763|39660538|FG001|Overall Study|Non-compliance|0|||
16321127|NCT00113763|39660537|FG000|Overall Study|Ongoing|1|||
16321128|NCT00113763|39660538|FG001|Overall Study|Ongoing|0|||
16321129|NCT00665431|39660539|FG000|Overall Study|Adverse Event|16|||
16321130|NCT00665431|39660540|FG001|Overall Study|Adverse Event|22|||
16321131|NCT00665431|39660541|FG002|Overall Study|Adverse Event|6|||
16321132|NCT00665431|39660539|FG000|Overall Study|Withdrawal by Subject|17|||
16321133|NCT00665431|39660540|FG001|Overall Study|Withdrawal by Subject|25|||
16321134|NCT00665431|39660541|FG002|Overall Study|Withdrawal by Subject|15|||
16321135|NCT00665431|39660539|FG000|Overall Study|Lost to Follow-up|3|||
16321136|NCT00665431|39660540|FG001|Overall Study|Lost to Follow-up|3|||
16321137|NCT00665431|39660541|FG002|Overall Study|Lost to Follow-up|1|||
16321138|NCT00665431|39660539|FG000|Overall Study|Other|4|||
16321139|NCT00665431|39660540|FG001|Overall Study|Other|7|||
16321140|NCT00665431|39660541|FG002|Overall Study|Other|2|||
16321141|NCT01842633|39660544|FG000|Overall Study|Screen Failure|1|||
16321142|NCT01842633|39660545|FG001|Overall Study|Screen Failure|0|||
16321143|NCT01842633|39660546|FG002|Overall Study|Screen Failure|0|||
16321144|NCT01842633|39660544|FG000|Overall Study|Adverse Event|1|||
16321145|NCT01842633|39660545|FG001|Overall Study|Adverse Event|1|||
16321146|NCT01842633|39660546|FG002|Overall Study|Adverse Event|0|||
16515857|NCT02052466|40355722|FG000|Overall Study|Withdrawal by Subject|1|||
16515858|NCT02052466|40355722|FG000|Overall Study|Acromial fracture|1|||
16515859|NCT01337297|40358458|FG000|Overall Study|They entered to single anodal tDCS|4|||
16515860|NCT01337297|40358459|FG001|Overall Study|They entered to single anodal tDCS|3|||
16515861|NCT01337297|40358458|FG000|Overall Study|Lost to Follow-up|1|||
16515862|NCT01337297|40358459|FG001|Overall Study|Lost to Follow-up|3|||
16515863|NCT01633944|40358460|FG000|Open-label Titration Phase|Adverse Event|109|||
16515864|NCT01633944|40358461|FG001|Open-label Titration Phase|Adverse Event|0|||
16515865|NCT01633944|40358462|FG002|Open-label Titration Phase|Adverse Event|0|||
16515866|NCT01633944|40358460|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
16515867|NCT01633944|40358461|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
16515868|NCT01633944|40358462|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
16515869|NCT01633944|40358460|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
16321147|NCT01842633|39660544|FG000|Overall Study|Withdrawal by Subject|0|||
16321148|NCT01842633|39660545|FG001|Overall Study|Withdrawal by Subject|1|||
16321149|NCT01842633|39660546|FG002|Overall Study|Withdrawal by Subject|0|||
16515870|NCT01633944|40358461|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
16515871|NCT01633944|40358462|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
16321150|NCT01842633|39660544|FG000|Overall Study|Technical issues|1|||
16321151|NCT01842633|39660545|FG001|Overall Study|Technical issues|0|||
16321152|NCT01842633|39660546|FG002|Overall Study|Technical issues|0|||
16321153|NCT04537234|39660552|FG000|Overall Study|Withdrawal by Subject|2|||
16321154|NCT04537234|39660553|FG001|Overall Study|Withdrawal by Subject|0|||
16321155|NCT03878446|39660554|FG000|Overall Study|Withdrawn by parent or guardian|1|||
16321156|NCT03878446|39660555|FG001|Overall Study|Withdrawn by parent or guardian|0|||
16321157|NCT03878446|39660556|FG002|Overall Study|Withdrawn by parent or guardian|0|||
16515872|NCT01633944|40358460|FG000|Open-label Titration Phase|Protocol Violation|24|||
16515873|NCT01633944|40358461|FG001|Open-label Titration Phase|Protocol Violation|0|||
16515874|NCT01633944|40358462|FG002|Open-label Titration Phase|Protocol Violation|0|||
16515875|NCT01633944|40358460|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
16321158|NCT03878446|39660557|FG003|Overall Study|Withdrawn by parent or guardian|0|||
16321159|NCT03878446|39660558|FG004|Overall Study|Withdrawn by parent or guardian|0|||
16321160|NCT04606394|39660561|FG000|Overall Study|Withdrawal by Subject|3|||
16321161|NCT04606394|39660561|FG000|Overall Study|Exclusion criteria screen failure|12|||
16515876|NCT01633944|40358461|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
16515877|NCT01633944|40358462|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
16515878|NCT01633944|40358460|FG000|Open-label Titration Phase|Other|68|||
16515879|NCT01633944|40358461|FG001|Open-label Titration Phase|Other|0|||
16321162|NCT01996254|39660562|FG000|Overall Study|Change in Eligibility|0|||
16321163|NCT01996254|39660563|FG001|Overall Study|Change in Eligibility|2|||
16321164|NCT01996254|39660564|FG002|Overall Study|Change in Eligibility|0|||
16321165|NCT01996254|39660562|FG000|Overall Study|Withdrawal by Subject|0|||
16321166|NCT01996254|39660563|FG001|Overall Study|Withdrawal by Subject|3|||
16321167|NCT01996254|39660564|FG002|Overall Study|Withdrawal by Subject|4|||
16321168|NCT01996254|39660562|FG000|Overall Study|Lost to Follow-up|1|||
16321169|NCT01996254|39660563|FG001|Overall Study|Lost to Follow-up|0|||
16321170|NCT01996254|39660564|FG002|Overall Study|Lost to Follow-up|4|||
16321171|NCT02027545|39660575|FG000|Overall Study|Failed to sign HIPAA|0|||
16321172|NCT02027545|39660576|FG001|Overall Study|Failed to sign HIPAA|2|||
16321173|NCT02027545|39660575|FG000|Overall Study|Failed to attend study visit|2|||
16321174|NCT02027545|39660576|FG001|Overall Study|Failed to attend study visit|0|||
16321175|NCT02027545|39660575|FG000|Overall Study|Protocol Violation|1|||
16321176|NCT02027545|39660576|FG001|Overall Study|Protocol Violation|0|||
16321177|NCT02490371|39660577|FG000|Overall Study|Lost to Follow-up|1|||
16321178|NCT02490371|39660578|FG001|Overall Study|Lost to Follow-up|1|||
16321179|NCT01986933|39660581|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
16321180|NCT01986933|39660582|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
16321181|NCT01986933|39660583|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
16321182|NCT01986933|39660584|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
16321183|NCT01986933|39660585|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
16321184|NCT01986933|39660581|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
16321185|NCT01986933|39660582|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
16515880|NCT01633944|40358462|FG002|Open-label Titration Phase|Other|0|||
16515881|NCT01633944|40358460|FG000|Double-blind Treatment Phase|Adverse Event|0|||
16515882|NCT01633944|40358461|FG001|Double-blind Treatment Phase|Adverse Event|13|||
16515883|NCT01633944|40358462|FG002|Double-blind Treatment Phase|Adverse Event|7|||
16515884|NCT01633944|40358460|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
16515885|NCT01633944|40358461|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
16515886|NCT01633944|40358462|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
16515887|NCT01633944|40358460|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16515888|NCT01633944|40358461|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
16515889|NCT01633944|40358462|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
16515890|NCT01633944|40358460|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
16515891|NCT01633944|40358461|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
16515892|NCT01633944|40358462|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
16515893|NCT01633944|40358460|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
16515894|NCT01633944|40358461|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
16515895|NCT01633944|40358462|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
16515896|NCT01633944|40358460|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
16515897|NCT01633944|40358461|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
16321186|NCT01986933|39660583|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
16321187|NCT01986933|39660584|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
16321188|NCT01986933|39660585|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
16321189|NCT01986933|39660581|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
16321190|NCT01986933|39660582|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
16321191|NCT01986933|39660583|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
16321192|NCT01986933|39660584|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
16321193|NCT01986933|39660585|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
16321194|NCT01986933|39660581|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
16321195|NCT01986933|39660582|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
16321196|NCT01986933|39660583|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
16321197|NCT01986933|39660584|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
16515898|NCT01633944|40358462|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
16515899|NCT01633944|40358460|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
16515900|NCT01633944|40358461|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
16515901|NCT01633944|40358462|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
16515902|NCT01633944|40358460|FG000|Double-blind Treatment Phase|Other|0|||
16321198|NCT01986933|39660585|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
16321199|NCT01986933|39660581|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
16321200|NCT01986933|39660582|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
16515903|NCT01633944|40358461|FG001|Double-blind Treatment Phase|Other|7|||
16515904|NCT01633944|40358462|FG002|Double-blind Treatment Phase|Other|0|||
16515905|NCT02849548|40358463|FG000|Overall Study|Lost to Follow-up|1|||
16515906|NCT02849548|40358464|FG001|Overall Study|Lost to Follow-up|2|||
16515907|NCT02849548|40358463|FG000|Overall Study|Protocol Violation|1|||
16515908|NCT02849548|40358464|FG001|Overall Study|Protocol Violation|0|||
16515909|NCT00333229|40358467|FG000|Overall Study|Lack of Efficacy|0|||
16090975|NCT00990314|38823591|FG000|Overall Study|Adverse Event|2|||
16090976|NCT00990314|38823591|FG000|Overall Study|Withdrawal by Subject|3|||
16090977|NCT00990314|38823591|FG000|Overall Study|Non-Compliance|1|||
16090978|NCT00990314|38823591|FG000|Overall Study|Physician Decision|3|||
16090979|NCT00990314|38823591|FG000|Overall Study|Lack of Efficacy|1|||
16090980|NCT01640288|38823592|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
16090981|NCT01640288|38823593|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
16090982|NCT01640288|38823592|FG000|Overall Study|Screen Failure|20|||
16090983|NCT01640288|38823593|FG001|Overall Study|Screen Failure|18|||
16090984|NCT01640288|38823592|FG000|Overall Study|Withdrawn by PI|5|||
16090985|NCT01640288|38823593|FG001|Overall Study|Withdrawn by PI|0|||
16090986|NCT01640288|38823592|FG000|Overall Study|Withdrawal by Subject|1|||
16090987|NCT01640288|38823593|FG001|Overall Study|Withdrawal by Subject|0|||
16090988|NCT00638456|38823596|FG000|Overall Study|Withdrawal by Subject|6|||
16090989|NCT00638456|38823597|FG001|Overall Study|Withdrawal by Subject|2|||
16090990|NCT00378898|38823598|FG000|Overall Study|Withdrawal by Subject|10|||
16515910|NCT00333229|40358468|FG001|Overall Study|Lack of Efficacy|1|||
16515911|NCT02871375|40358469|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
16515912|NCT02871375|40358470|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
16515913|NCT02553421|40358476|FG000|Overall Study|Lost to Follow-up|21|||
16515914|NCT02553421|40358477|FG001|Overall Study|Lost to Follow-up|1|||
16515915|NCT02553421|40358476|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
16515916|NCT02553421|40358477|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
16515917|NCT02553421|40358476|FG000|Overall Study|Improper Device Placement|3|||
16515918|NCT02553421|40358477|FG001|Overall Study|Improper Device Placement|0|||
16515919|NCT03571516|40358478|FG000|Overall Study|Severe diarrhea|1|||
16515920|NCT03571516|40358479|FG001|Overall Study|Severe diarrhea|0|||
16321201|NCT01986933|39660583|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
16321202|NCT01986933|39660584|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
16321203|NCT01986933|39660585|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
16321204|NCT01986933|39660581|FG000|Active-to-active (Part B)|Adverse Event|0|||
16321205|NCT01986933|39660582|FG001|Active-to-active (Part B)|Adverse Event|2|||
16321206|NCT01986933|39660583|FG002|Active-to-active (Part B)|Adverse Event|0|||
16321207|NCT01986933|39660584|FG003|Active-to-active (Part B)|Adverse Event|1|||
16321208|NCT01986933|39660585|FG004|Active-to-active (Part B)|Adverse Event|3|||
16321209|NCT01986933|39660581|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
16321210|NCT01986933|39660582|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
16321211|NCT01986933|39660583|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
16321212|NCT01986933|39660584|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
16321213|NCT01986933|39660585|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
16321214|NCT01986933|39660581|FG000|Active-to-active (Part B)|Pregnancy|0|||
16321215|NCT01986933|39660582|FG001|Active-to-active (Part B)|Pregnancy|0|||
16321216|NCT01986933|39660583|FG002|Active-to-active (Part B)|Pregnancy|0|||
16321217|NCT01986933|39660584|FG003|Active-to-active (Part B)|Pregnancy|0|||
16321218|NCT01986933|39660585|FG004|Active-to-active (Part B)|Pregnancy|1|||
16321219|NCT01986933|39660581|FG000|Active-to-active (Part B)|Physician Decision|0|||
16321220|NCT01986933|39660582|FG001|Active-to-active (Part B)|Physician Decision|0|||
16321221|NCT01986933|39660583|FG002|Active-to-active (Part B)|Physician Decision|1|||
16321222|NCT01986933|39660584|FG003|Active-to-active (Part B)|Physician Decision|1|||
16321223|NCT01986933|39660585|FG004|Active-to-active (Part B)|Physician Decision|0|||
16321224|NCT01986933|39660581|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
16321225|NCT01986933|39660582|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
16515921|NCT03571516|40358478|FG000|Overall Study|Withdrawal by Subject|0|||
16515922|NCT03571516|40358479|FG001|Overall Study|Withdrawal by Subject|1|||
16515923|NCT01898793|40358480|FG000|Overall Study|Death|2|||
16515924|NCT01898793|40358481|FG001|Overall Study|Death|1|||
16515925|NCT01898793|40358482|FG002|Overall Study|Death|4|||
16515926|NCT01898793|40358483|FG003|Overall Study|Death|0|||
16515927|NCT01898793|40358484|FG004|Overall Study|Death|0|||
16515928|NCT01898793|40358485|FG005|Overall Study|Death|0|||
16090991|NCT00378898|38823599|FG001|Overall Study|Withdrawal by Subject|5|||
16090992|NCT00378898|38823598|FG000|Overall Study|Protocol Violation|1|||
16090993|NCT00378898|38823599|FG001|Overall Study|Protocol Violation|1|||
16090994|NCT03072862|38823611|FG000|Overall Study|Withdrawal by Subject|4|||
16321226|NCT01986933|39660583|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
16321227|NCT01986933|39660584|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
16321228|NCT01986933|39660585|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
16321229|NCT01986933|39660581|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
16321230|NCT01986933|39660582|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
16321231|NCT01986933|39660583|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
16321232|NCT01986933|39660584|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
16321233|NCT01986933|39660585|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
16321234|NCT01986933|39660581|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
16321235|NCT01986933|39660582|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
16321236|NCT01986933|39660583|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
16321237|NCT01986933|39660584|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
16321238|NCT01986933|39660585|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
16321239|NCT01986933|39660581|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
16321240|NCT01986933|39660582|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
16321241|NCT01986933|39660583|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
16321242|NCT01986933|39660584|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
16321243|NCT01986933|39660585|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
16321244|NCT01986933|39660581|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
16321245|NCT01986933|39660582|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
16321246|NCT01986933|39660583|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
16321247|NCT01986933|39660584|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
16321248|NCT01986933|39660585|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
16321249|NCT01986933|39660581|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
16321250|NCT01986933|39660582|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
16321251|NCT01986933|39660583|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
16321252|NCT01986933|39660584|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
16321253|NCT01986933|39660585|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
16321254|NCT01986933|39660581|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
16321255|NCT01986933|39660582|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
16321256|NCT01986933|39660583|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
16321257|NCT01986933|39660584|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
16321258|NCT01986933|39660585|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
16321259|NCT01986933|39660581|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
16321260|NCT01986933|39660582|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
16321261|NCT01986933|39660583|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
16321262|NCT01986933|39660584|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
16321263|NCT01986933|39660585|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
16321264|NCT00839800|39660590|FG000|Overall Study|Adverse Event|8|||
16321265|NCT00839800|39660591|FG001|Overall Study|Adverse Event|12|||
16321266|NCT00839800|39660590|FG000|Overall Study|Lost to Follow-up|31|||
16321267|NCT00839800|39660591|FG001|Overall Study|Lost to Follow-up|26|||
16321268|NCT00839800|39660590|FG000|Overall Study|Withdrawal by Subject|28|||
16321269|NCT00839800|39660591|FG001|Overall Study|Withdrawal by Subject|34|||
16321270|NCT00839800|39660590|FG000|Overall Study|Incorrect Enrolment|3|||
16321271|NCT00839800|39660591|FG001|Overall Study|Incorrect Enrolment|3|||
16321272|NCT00839800|39660590|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
16321273|NCT00839800|39660591|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
16321274|NCT00839800|39660590|FG000|Overall Study|Safety Reasons|2|||
16321275|NCT00839800|39660591|FG001|Overall Study|Safety Reasons|1|||
16321276|NCT00839800|39660590|FG000|Overall Study|Other|8|||
16321277|NCT00839800|39660591|FG001|Overall Study|Other|14|||
16321278|NCT00839800|39660590|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
16321279|NCT00839800|39660591|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
16321280|NCT00789854|39660601|FG000|Overall Study|Adverse Event|28|||
16321281|NCT00789854|39660602|FG001|Overall Study|Adverse Event|23|||
16321282|NCT00789854|39660603|FG002|Overall Study|Adverse Event|18|||
16321283|NCT00789854|39660601|FG000|Overall Study|Lost to Follow-up|1|||
16321284|NCT00789854|39660602|FG001|Overall Study|Lost to Follow-up|1|||
16321285|NCT00789854|39660603|FG002|Overall Study|Lost to Follow-up|4|||
16321286|NCT00789854|39660601|FG000|Overall Study|Withdrawal by Subject|9|||
16321287|NCT00789854|39660602|FG001|Overall Study|Withdrawal by Subject|6|||
16321288|NCT00789854|39660603|FG002|Overall Study|Withdrawal by Subject|17|||
16321289|NCT00789854|39660601|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16321290|NCT00789854|39660602|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
16321291|NCT00789854|39660603|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
16321292|NCT00789854|39660601|FG000|Overall Study|Severe non-compliance to the protocol|3|||
16321293|NCT00789854|39660602|FG001|Overall Study|Severe non-compliance to the protocol|0|||
16321294|NCT00789854|39660603|FG002|Overall Study|Severe non-compliance to the protocol|0|||
16321295|NCT00789854|39660601|FG000|Overall Study|Safety reasons|0|||
16321296|NCT00789854|39660602|FG001|Overall Study|Safety reasons|0|||
16321297|NCT00789854|39660603|FG002|Overall Study|Safety reasons|2|||
16321298|NCT00789854|39660601|FG000|Overall Study|Other|6|||
16321299|NCT00789854|39660602|FG001|Overall Study|Other|0|||
16321300|NCT00789854|39660603|FG002|Overall Study|Other|5|||
16321301|NCT01580670|39660604|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
16321302|NCT01580670|39660604|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
16321303|NCT02919969|39660608|FG000|Overall Study|Lack of Efficacy|22|||
16321304|NCT02919969|39660608|FG000|Overall Study|Death|4|||
16321305|NCT02919969|39660608|FG000|Overall Study|Physician Decision|3|||
16394846|NCT02676895|39928062|FG002|Overall Study|Lost to Follow-up|1|||
16394847|NCT02676895|39928060|FG000|Overall Study|Withdrawal by Subject|0|||
16394848|NCT02676895|39928061|FG001|Overall Study|Withdrawal by Subject|0|||
16394849|NCT02676895|39928062|FG002|Overall Study|Withdrawal by Subject|1|||
16394850|NCT00880269|39928063|FG000|Overall Study|Protocol Violation|1|||
16202401|NCT01199055|39218824|FG000|Overall Study|Withdrawal by Subject|0|||
16202402|NCT01199055|39218825|FG001|Overall Study|Withdrawal by Subject|0|||
16202403|NCT01199055|39218826|FG002|Overall Study|Withdrawal by Subject|1|||
16202404|NCT02716194|39218827|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
16202405|NCT02716194|39218828|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
16321306|NCT02919969|39660608|FG000|Overall Study|Withdrawal by Subject|2|||
16321307|NCT02729051|39660609|FG000|Overall Study|Adverse Event|21|||
16321308|NCT02729051|39660610|FG001|Overall Study|Adverse Event|11|||
16321309|NCT02729051|39660609|FG000|Overall Study|Lack of Efficacy|1|||
16321310|NCT02729051|39660610|FG001|Overall Study|Lack of Efficacy|1|||
16321311|NCT02729051|39660609|FG000|Overall Study|Lost to Follow-up|1|||
16515929|NCT01898793|40358486|FG006|Overall Study|Death|0|||
16515930|NCT01451424|40358490|FG000|Overall Study|Withdrawal by Subject|1|||
16515931|NCT01451424|40358491|FG001|Overall Study|Withdrawal by Subject|1|||
16515932|NCT01451424|40358492|FG002|Overall Study|Withdrawal by Subject|0|||
16515933|NCT01451424|40358493|FG003|Overall Study|Withdrawal by Subject|2|||
16515934|NCT01451424|40358490|FG000|Overall Study|Lost to Follow-up|0|||
16515935|NCT01451424|40358491|FG001|Overall Study|Lost to Follow-up|1|||
16515936|NCT01451424|40358492|FG002|Overall Study|Lost to Follow-up|0|||
16515937|NCT01451424|40358493|FG003|Overall Study|Lost to Follow-up|1|||
16515938|NCT01451424|40358490|FG000|Overall Study|Physician Decision|0|||
16515939|NCT01451424|40358491|FG001|Overall Study|Physician Decision|0|||
16515940|NCT01451424|40358492|FG002|Overall Study|Physician Decision|1|||
16515941|NCT01451424|40358493|FG003|Overall Study|Physician Decision|1|||
16515942|NCT01451424|40358490|FG000|Overall Study|Adverse Event|0|||
16515943|NCT01451424|40358491|FG001|Overall Study|Adverse Event|0|||
16515944|NCT01451424|40358492|FG002|Overall Study|Adverse Event|0|||
16515945|NCT01451424|40358493|FG003|Overall Study|Adverse Event|1|||
16515946|NCT02262728|40358496|FG000|Follow-up Phase (3 Years)|Death|0|||
16515947|NCT02262728|40358497|FG001|Follow-up Phase (3 Years)|Death|1|||
16515948|NCT02262728|40358496|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
16515949|NCT02262728|40358497|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
16515950|NCT02262728|40358496|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
16515951|NCT02262728|40358497|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
16515952|NCT02023151|40358498|FG000|Overall Study|Lost to Follow-up|4|||
16515953|NCT01020019|40358499|FG000|Overall Study|Lost to Follow-up|21|||
16515954|NCT01020019|40358500|FG001|Overall Study|Lost to Follow-up|18|||
16515955|NCT01020019|40358499|FG000|Overall Study|Adverse Event|1|||
16515956|NCT01020019|40358500|FG001|Overall Study|Adverse Event|5|||
16515957|NCT01020019|40358499|FG000|Overall Study|not interested in treatment|4|||
16515958|NCT01020019|40358500|FG001|Overall Study|not interested in treatment|4|||
16515959|NCT01020019|40358499|FG000|Overall Study|moving|0|||
16515960|NCT01020019|40358500|FG001|Overall Study|moving|2|||
16515961|NCT00699972|40358501|FG000|Overall Study|Adverse Event|7|||
16515962|NCT00699972|40358502|FG001|Overall Study|Adverse Event|9|||
16515963|NCT00699972|40358503|FG002|Overall Study|Adverse Event|24|||
16515964|NCT00699972|40358501|FG000|Overall Study|Lost to Follow-up|0|||
16515965|NCT00699972|40358502|FG001|Overall Study|Lost to Follow-up|2|||
16515966|NCT00699972|40358503|FG002|Overall Study|Lost to Follow-up|0|||
16515967|NCT00699972|40358501|FG000|Overall Study|Withdrawal by Subject|3|||
16321312|NCT02729051|39660610|FG001|Overall Study|Lost to Follow-up|2|||
16321313|NCT02729051|39660609|FG000|Overall Study|Physician Decision|1|||
16321314|NCT02729051|39660610|FG001|Overall Study|Physician Decision|1|||
16394851|NCT00880269|39928064|FG001|Overall Study|Protocol Violation|0|||
16515968|NCT00699972|40358502|FG001|Overall Study|Withdrawal by Subject|7|||
16515969|NCT00699972|40358503|FG002|Overall Study|Withdrawal by Subject|4|||
16515970|NCT00699972|40358501|FG000|Overall Study|Lack of Efficacy|2|||
16515971|NCT00699972|40358502|FG001|Overall Study|Lack of Efficacy|0|||
16394852|NCT00880269|39928063|FG000|Overall Study|Disease Progression|13|||
16394853|NCT00880269|39928064|FG001|Overall Study|Disease Progression|11|||
16394854|NCT00880269|39928063|FG000|Overall Study|New Cancer Therapy|1|||
16394855|NCT00880269|39928064|FG001|Overall Study|New Cancer Therapy|0|||
16394856|NCT00880269|39928063|FG000|Overall Study|Death|4|||
16394857|NCT00880269|39928064|FG001|Overall Study|Death|2|||
16394858|NCT00880269|39928063|FG000|Overall Study|Lost to Follow-up|0|||
16090995|NCT03072862|38823611|FG000|Overall Study|Lost to Follow-up|6|||
16090996|NCT03072862|38823611|FG000|Overall Study|Protocol Violation|4|||
16090997|NCT03072862|38823611|FG000|Overall Study|Physician Decision|2|||
16090998|NCT03072862|38823611|FG000|Overall Study|Death|1|||
16394859|NCT00880269|39928064|FG001|Overall Study|Lost to Follow-up|1|||
16090999|NCT03072862|38823611|FG000|Overall Study|Adverse Event|1|||
16091000|NCT01294644|38823612|FG000|Overall Study|Adverse Event|2|||
16091001|NCT01294644|38823613|FG001|Overall Study|Adverse Event|0|||
16091002|NCT01294644|38823614|FG002|Overall Study|Adverse Event|1|||
16091003|NCT01294644|38823612|FG000|Overall Study|Withdrawal by Subject|3|||
16091004|NCT01294644|38823613|FG001|Overall Study|Withdrawal by Subject|7|||
16091005|NCT01294644|38823614|FG002|Overall Study|Withdrawal by Subject|4|||
16091006|NCT01294644|38823612|FG000|Overall Study|Lost to Follow-up|3|||
16091007|NCT01294644|38823613|FG001|Overall Study|Lost to Follow-up|2|||
16091008|NCT01294644|38823614|FG002|Overall Study|Lost to Follow-up|5|||
16091009|NCT01294644|38823612|FG000|Overall Study|Miscellaneous Reason|2|||
16091010|NCT01294644|38823613|FG001|Overall Study|Miscellaneous Reason|1|||
16091011|NCT01294644|38823614|FG002|Overall Study|Miscellaneous Reason|4|||
16091012|NCT03146845|38823617|FG000|Overall Study|Reference ulcer healed|1|||
16202406|NCT02716194|39218829|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
16202407|NCT01409993|39218830|FG000|Overall Study|Adverse Event|4|||
16202408|NCT01409993|39218831|FG001|Overall Study|Adverse Event|4|||
16202409|NCT01409993|39218832|FG002|Overall Study|Adverse Event|3|||
16202410|NCT01409993|39218833|FG003|Overall Study|Adverse Event|1|||
16202411|NCT01409993|39218830|FG000|Overall Study|Withdrawal by Subject|0|||
16394860|NCT00880269|39928063|FG000|Overall Study|Withdrawal by Subject|3|||
16515972|NCT00699972|40358503|FG002|Overall Study|Lack of Efficacy|2|||
16515973|NCT00699972|40358501|FG000|Overall Study|Administrative/Other|3|||
16091013|NCT03146845|38823618|FG001|Overall Study|Reference ulcer healed|0|||
16091014|NCT03146845|38823617|FG000|Overall Study|Physician Decision|1|||
16091015|NCT03146845|38823618|FG001|Overall Study|Physician Decision|0|||
16091016|NCT03146845|38823617|FG000|Overall Study|Adverse Event|1|||
16091017|NCT03146845|38823618|FG001|Overall Study|Adverse Event|0|||
16091018|NCT03146845|38823617|FG000|Overall Study|Withdrawal by Subject|2|||
16091019|NCT03146845|38823618|FG001|Overall Study|Withdrawal by Subject|0|||
16091020|NCT03146845|38823617|FG000|Overall Study|Noncompliance|0|||
16091021|NCT03146845|38823618|FG001|Overall Study|Noncompliance|1|||
16091022|NCT03146845|38823617|FG000|Overall Study|Protocol Violation|0|||
16091023|NCT03146845|38823618|FG001|Overall Study|Protocol Violation|2|||
16091024|NCT03146845|38823617|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
16091025|NCT03146845|38823618|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
16091026|NCT03019289|38823623|FG000|Overall Study|Adverse Event|1|||
16091027|NCT03019289|38823624|FG001|Overall Study|Adverse Event|0|||
16091028|NCT03019289|38823625|FG002|Overall Study|Adverse Event|0|||
16091029|NCT03019289|38823626|FG003|Overall Study|Adverse Event|0|||
16091030|NCT03019289|38823627|FG004|Overall Study|Adverse Event|0|||
16091031|NCT03019289|38823628|FG005|Overall Study|Adverse Event|0|||
16091032|NCT03019289|38823629|FG006|Overall Study|Adverse Event|0|||
16091033|NCT03019289|38823630|FG007|Overall Study|Adverse Event|0|||
16515974|NCT00699972|40358502|FG001|Overall Study|Administrative/Other|1|||
16515975|NCT00699972|40358503|FG002|Overall Study|Administrative/Other|4|||
16515976|NCT00699972|40358501|FG000|Overall Study|Randomized, Not Treated|1|||
16515977|NCT00699972|40358502|FG001|Overall Study|Randomized, Not Treated|0|||
16515978|NCT00699972|40358503|FG002|Overall Study|Randomized, Not Treated|1|||
16515979|NCT00705575|40358505|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16202412|NCT01409993|39218831|FG001|Overall Study|Withdrawal by Subject|0|||
16394861|NCT00880269|39928064|FG001|Overall Study|Withdrawal by Subject|4|||
16515980|NCT00705575|40358506|FG001|Overall Study|Abnormal laboratory value(s)|3|||
16515981|NCT00705575|40358505|FG000|Overall Study|Abnormal test procedure result(s)|2|||
16515982|NCT00705575|40358506|FG001|Overall Study|Abnormal test procedure result(s)|12|||
16091034|NCT03019289|38823631|FG008|Overall Study|Adverse Event|1|||
16091035|NCT03019289|38823623|FG000|Overall Study|Other|1|||
16091036|NCT03019289|38823624|FG001|Overall Study|Other|0|||
16091037|NCT03019289|38823625|FG002|Overall Study|Other|0|||
16091038|NCT03019289|38823626|FG003|Overall Study|Other|0|||
16091039|NCT03019289|38823627|FG004|Overall Study|Other|0|||
16091040|NCT03019289|38823628|FG005|Overall Study|Other|0|||
16091041|NCT03019289|38823629|FG006|Overall Study|Other|0|||
16091042|NCT03019289|38823630|FG007|Overall Study|Other|0|||
16394862|NCT00880269|39928063|FG000|Overall Study|Adverse Event|10|||
16394863|NCT00880269|39928064|FG001|Overall Study|Adverse Event|9|||
16394864|NCT00075764|39928067|FG000|Overall Study|Adverse Event|5|||
16515983|NCT00705575|40358505|FG000|Overall Study|Adverse Event|11|||
16091043|NCT03019289|38823631|FG008|Overall Study|Other|0|||
16091044|NCT02161458|38823639|FG000|Overall Study|Withdrawal by Subject|0|||
16091045|NCT02161458|38823640|FG001|Overall Study|Withdrawal by Subject|4|||
16091046|NCT02161458|38823641|FG002|Overall Study|Withdrawal by Subject|4|||
16091047|NCT02161458|38823642|FG003|Overall Study|Withdrawal by Subject|0|||
16091048|NCT02161458|38823639|FG000|Overall Study|Lost to Follow-up|0|||
16091049|NCT02161458|38823640|FG001|Overall Study|Lost to Follow-up|2|||
16091050|NCT02161458|38823641|FG002|Overall Study|Lost to Follow-up|1|||
16091051|NCT02161458|38823642|FG003|Overall Study|Lost to Follow-up|0|||
16091052|NCT02007070|38823645|FG000|Overall Study|Adverse Event|4|||
16091053|NCT02007070|38823645|FG000|Overall Study|Clinical Progression|4|||
16091054|NCT02007070|38823645|FG000|Overall Study|Death|1|||
16091055|NCT02007070|38823645|FG000|Overall Study|Protocol Violation|2|||
16091056|NCT02007070|38823645|FG000|Overall Study|Physician Decision|1|||
16091057|NCT02007070|38823645|FG000|Overall Study|Progressive Disease|21|||
16091058|NCT03136159|38823648|FG000|Overall Study|chorioamnionitis|2|||
16091059|NCT03136159|38823649|FG001|Overall Study|chorioamnionitis|0|||
16091060|NCT03136159|38823648|FG000|Overall Study|vertical skin incision|1|||
16091061|NCT03136159|38823649|FG001|Overall Study|vertical skin incision|0|||
16091062|NCT03136159|38823648|FG000|Overall Study|additional dressing|1|||
16091063|NCT03136159|38823649|FG001|Overall Study|additional dressing|0|||
16091064|NCT03136159|38823648|FG000|Overall Study|never got dressing placed|1|||
16091065|NCT03136159|38823649|FG001|Overall Study|never got dressing placed|0|||
16091066|NCT02106325|38823650|FG000|Phase 1|Lost to Follow-up|2|||
16091067|NCT02106325|38823651|FG001|Phase 1|Lost to Follow-up|2|||
16091068|NCT02106325|38823650|FG000|Phase 2|Lost to Follow-up|2|||
16091069|NCT02106325|38823651|FG001|Phase 2|Lost to Follow-up|3|||
16091070|NCT02106325|38823650|FG000|Phase 3|Lost to Follow-up|2|||
16091071|NCT02106325|38823651|FG001|Phase 3|Lost to Follow-up|1|||
16394865|NCT00075764|39928068|FG001|Overall Study|Adverse Event|12|||
16515984|NCT00705575|40358506|FG001|Overall Study|Adverse Event|15|||
16515985|NCT00705575|40358505|FG000|Overall Study|Lost to Follow-up|3|||
16515986|NCT00705575|40358506|FG001|Overall Study|Lost to Follow-up|4|||
16515987|NCT00705575|40358505|FG000|Overall Study|Protocol Violation|2|||
16515988|NCT00705575|40358506|FG001|Overall Study|Protocol Violation|2|||
16515989|NCT00705575|40358505|FG000|Overall Study|Withdrawal by Subject|5|||
16515990|NCT00705575|40358506|FG001|Overall Study|Withdrawal by Subject|10|||
16515991|NCT02442830|40358510|FG000|Overall Study|Technical Failure|0|||
16515992|NCT02442830|40358511|FG001|Overall Study|Technical Failure|1|||
16515993|NCT01849588|40358512|FG000|Overall Study|Lack of Efficacy|3|||
16515994|NCT01610791|40358513|FG000|Overall Study|Lost to Follow-up|7|||
16515995|NCT01610791|40358513|FG000|Overall Study|Adverse Event|6|||
16091072|NCT04803734|38823656|FG000|Overall Study|Withdrawal by Subject|0|||
16091073|NCT04803734|38823657|FG001|Overall Study|Withdrawal by Subject|1|||
16091074|NCT04803734|38823656|FG000|Overall Study|Protocol Violation|0|||
16515996|NCT01610791|40358513|FG000|Overall Study|Physician Decision|1|||
16091075|NCT04803734|38823657|FG001|Overall Study|Protocol Violation|1|||
16515997|NCT01610791|40358513|FG000|Overall Study|Adverse event and Investigator decision|1|||
16515998|NCT01610791|40358513|FG000|Overall Study|Death|1|||
16515999|NCT01610791|40358513|FG000|Overall Study|Not determined|5|||
16091076|NCT02169414|38823659|FG000|Overall Study|Withdrawal by Subject|1|||
16091077|NCT02169414|38823660|FG001|Overall Study|Withdrawal by Subject|0|||
16091078|NCT02169414|38823661|FG002|Overall Study|Withdrawal by Subject|0|||
16091079|NCT02169414|38823662|FG003|Overall Study|Withdrawal by Subject|0|||
16394866|NCT00075764|39928067|FG000|Overall Study|Death|4|||
16516000|NCT01205165|40358514|FG000|Overall Study|Lost to Follow-up|2|||
16516001|NCT04152447|40358515|FG000|Overall Study|Lost to Follow-up|1|||
16516002|NCT04152447|40358516|FG001|Overall Study|Lost to Follow-up|0|||
16516003|NCT04152447|40358515|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
16516004|NCT04152447|40358516|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
16516005|NCT04152447|40358515|FG000|Overall Study|Withdrawal by Subject|0|||
16516006|NCT04152447|40358516|FG001|Overall Study|Withdrawal by Subject|1|||
16516007|NCT04152447|40358515|FG000|Overall Study|Found ineligible after enrolling|1|||
16516008|NCT04152447|40358516|FG001|Overall Study|Found ineligible after enrolling|1|||
16516009|NCT04152447|40358515|FG000|Overall Study|Did not receive VR headset in time.|0|||
16516010|NCT04152447|40358516|FG001|Overall Study|Did not receive VR headset in time.|2|||
16516011|NCT01448850|40358517|FG000|Overall Study|Death|3|||
16516012|NCT01448850|40358518|FG001|Overall Study|Death|6|||
16516013|NCT01448850|40358517|FG000|Overall Study|Withdrawal by Subject|13|||
16516014|NCT01448850|40358518|FG001|Overall Study|Withdrawal by Subject|21|||
16516015|NCT01448850|40358517|FG000|Overall Study|Lost to Follow-up|3|||
16516016|NCT01448850|40358518|FG001|Overall Study|Lost to Follow-up|1|||
16516017|NCT01448850|40358517|FG000|Overall Study|Other|15|||
16516018|NCT01448850|40358518|FG001|Overall Study|Other|12|||
16516019|NCT02554656|40358520|FG000|Overall Study|Protocol Violation|3|||
16516020|NCT01282424|40358522|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
16516021|NCT01282424|40358522|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
16516022|NCT01282424|40358522|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
16516023|NCT01282424|40358522|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
16516024|NCT01282424|40358522|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
16516025|NCT01282424|40358522|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
16516026|NCT01282424|40358522|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
16516027|NCT01282424|40358522|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
16516028|NCT03325166|40358527|FG000|Overall Study|Adverse Event|1|||
16516029|NCT00179647|40358528|FG000|Overall Study|Adverse Event|294|||
16091080|NCT02169414|38823659|FG000|Overall Study|Adverse Event|0|||
16091081|NCT02169414|38823660|FG001|Overall Study|Adverse Event|1|||
16091082|NCT02169414|38823661|FG002|Overall Study|Adverse Event|0|||
16091083|NCT02169414|38823662|FG003|Overall Study|Adverse Event|0|||
16091084|NCT03052517|38823663|FG000|Overall Study|Study Terminated By Sponsor|928|||
16091085|NCT03052517|38823664|FG001|Overall Study|Study Terminated By Sponsor|938|||
16202413|NCT01409993|39218832|FG002|Overall Study|Withdrawal by Subject|0|||
16202414|NCT01409993|39218833|FG003|Overall Study|Withdrawal by Subject|4|||
16202415|NCT01409993|39218830|FG000|Overall Study|Lost to Follow-up|0|||
16202416|NCT01409993|39218831|FG001|Overall Study|Lost to Follow-up|1|||
16202417|NCT01409993|39218832|FG002|Overall Study|Lost to Follow-up|0|||
16202418|NCT01409993|39218833|FG003|Overall Study|Lost to Follow-up|0|||
16202419|NCT01575899|39218834|FG000|Overall Study|Lost to Follow-up|3|||
16202420|NCT01575899|39218835|FG001|Overall Study|Lost to Follow-up|4|||
16202421|NCT01575899|39218836|FG002|Overall Study|Lost to Follow-up|2|||
16202422|NCT01575899|39218834|FG000|Overall Study|Protocol Violation|2|||
16202423|NCT01575899|39218835|FG001|Overall Study|Protocol Violation|1|||
16202424|NCT01575899|39218836|FG002|Overall Study|Protocol Violation|0|||
16202425|NCT02395653|39218839|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
16202426|NCT02395653|39218839|FG000|Overall Study|Consent Withdrawn at Screening|1|||
16202427|NCT02395653|39218839|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
16202428|NCT02395653|39218839|FG000|Overall Study|Investigator Decision at Screening|1|||
16202429|NCT02395653|39218839|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
16202430|NCT02395653|39218839|FG000|Overall Study|Withdrawal by Subject|1|||
16202431|NCT02395653|39218839|FG000|Overall Study|Lost to Follow-up|1|||
16202432|NCT01830816|39218840|FG000|Overall Study|Progressive Disease|12|||
16202433|NCT01830816|39218841|FG001|Overall Study|Progressive Disease|7|||
16202434|NCT01830816|39218842|FG002|Overall Study|Progressive Disease|7|||
16202435|NCT01830816|39218840|FG000|Overall Study|Adverse Event|3|||
16202436|NCT01830816|39218841|FG001|Overall Study|Adverse Event|4|||
16202437|NCT01830816|39218842|FG002|Overall Study|Adverse Event|0|||
16202438|NCT01830816|39218840|FG000|Overall Study|Study Terminated by Sponsor|1|||
16516030|NCT00179647|40358528|FG000|Overall Study|Lack of Efficacy|478|||
16516031|NCT00179647|40358528|FG000|Overall Study|Withdrawal by Subject|83|||
16516032|NCT00179647|40358528|FG000|Overall Study|Lost to Follow-up|4|||
16516033|NCT00179647|40358528|FG000|Overall Study|Death|94|||
16516034|NCT00179647|40358528|FG000|Overall Study|Other|960|||
16516035|NCT00414050|40358529|FG000|Overall Study|Adverse Event|1|||
16516036|NCT00414050|40358530|FG001|Overall Study|Adverse Event|1|||
16516037|NCT00414050|40358531|FG002|Overall Study|Adverse Event|1|||
16516038|NCT00414050|40358532|FG003|Overall Study|Adverse Event|1|||
16516039|NCT00414050|40358529|FG000|Overall Study|Lost to Follow-up|2|||
16516040|NCT00414050|40358530|FG001|Overall Study|Lost to Follow-up|2|||
16091086|NCT03052517|38823665|FG002|Overall Study|Study Terminated By Sponsor|296|||
16091087|NCT03052517|38823663|FG000|Overall Study|Subject/Guardian Decision|50|||
16516041|NCT00414050|40358531|FG002|Overall Study|Lost to Follow-up|1|||
16516042|NCT00414050|40358532|FG003|Overall Study|Lost to Follow-up|1|||
16516043|NCT00414050|40358529|FG000|Overall Study|Withdrawal by Subject|5|||
16516044|NCT00414050|40358530|FG001|Overall Study|Withdrawal by Subject|3|||
16516045|NCT00414050|40358531|FG002|Overall Study|Withdrawal by Subject|2|||
16516046|NCT00414050|40358532|FG003|Overall Study|Withdrawal by Subject|4|||
16091088|NCT03052517|38823664|FG001|Overall Study|Subject/Guardian Decision|45|||
16091089|NCT03052517|38823665|FG002|Overall Study|Subject/Guardian Decision|22|||
16091090|NCT03052517|38823663|FG000|Overall Study|Lack of Efficacy|23|||
16091091|NCT03052517|38823664|FG001|Overall Study|Lack of Efficacy|14|||
16091092|NCT03052517|38823665|FG002|Overall Study|Lack of Efficacy|7|||
16091093|NCT03052517|38823663|FG000|Overall Study|Adverse Event|6|||
16091094|NCT03052517|38823664|FG001|Overall Study|Adverse Event|5|||
16091095|NCT03052517|38823665|FG002|Overall Study|Adverse Event|0|||
16091096|NCT03052517|38823663|FG000|Overall Study|Physician Decision|4|||
16091097|NCT03052517|38823664|FG001|Overall Study|Physician Decision|5|||
16091098|NCT03052517|38823665|FG002|Overall Study|Physician Decision|1|||
16091099|NCT03052517|38823663|FG000|Overall Study|Death|3|||
16091100|NCT03052517|38823664|FG001|Overall Study|Death|0|||
16091101|NCT03052517|38823665|FG002|Overall Study|Death|1|||
16091102|NCT03052517|38823663|FG000|Overall Study|Lost to Follow-up|2|||
16091103|NCT03052517|38823664|FG001|Overall Study|Lost to Follow-up|4|||
16091104|NCT03052517|38823665|FG002|Overall Study|Lost to Follow-up|0|||
16091105|NCT03052517|38823663|FG000|Overall Study|Pregnancy|1|||
16091106|NCT03052517|38823664|FG001|Overall Study|Pregnancy|0|||
16091107|NCT03052517|38823665|FG002|Overall Study|Pregnancy|1|||
16091108|NCT03052517|38823663|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
16091109|NCT03052517|38823664|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
16091110|NCT03052517|38823665|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
16091111|NCT03052517|38823663|FG000|Overall Study|Technical Problems|0|||
16091112|NCT03052517|38823664|FG001|Overall Study|Technical Problems|1|||
16091113|NCT03052517|38823665|FG002|Overall Study|Technical Problems|0|||
16091114|NCT01480258|38823666|FG000|Infant Series|Protocol Violation|2|||
16091115|NCT01480258|38823667|FG001|Infant Series|Protocol Violation|0|||
16091116|NCT01480258|38823666|FG000|Infant Series|Physician Decision|0|||
16091117|NCT01480258|38823667|FG001|Infant Series|Physician Decision|1|||
16091118|NCT01480258|38823666|FG000|Infant Series|Not Vaccinated|3|||
16091119|NCT01480258|38823667|FG001|Infant Series|Not Vaccinated|0|||
16091120|NCT01480258|38823666|FG000|Infant Series|Adverse Event|1|||
16091121|NCT01480258|38823667|FG001|Infant Series|Adverse Event|1|||
16091122|NCT01480258|38823666|FG000|Infant Series|Withdrawal by Subject|1|||
16091123|NCT01480258|38823667|FG001|Infant Series|Withdrawal by Subject|6|||
16091124|NCT01480258|38823666|FG000|Interim Period|Lost to Follow-up|0|||
16091125|NCT01480258|38823667|FG001|Interim Period|Lost to Follow-up|2|||
16091126|NCT01480258|38823666|FG000|Interim Period|Physician Decision|1|||
16091127|NCT01480258|38823667|FG001|Interim Period|Physician Decision|0|||
16091128|NCT01480258|38823666|FG000|Interim Period|Protocol Violation|0|||
16091129|NCT01480258|38823667|FG001|Interim Period|Protocol Violation|1|||
16091130|NCT01480258|38823666|FG000|Interim Period|Withdrawal by Subject|9|||
16091131|NCT01480258|38823667|FG001|Interim Period|Withdrawal by Subject|6|||
16091132|NCT00454194|38823668|FG000|Overall Study|Adverse Event|7|||
16091133|NCT00454194|38823669|FG001|Overall Study|Adverse Event|2|||
16091134|NCT00454194|38823668|FG000|Overall Study|Withdrawal by Subject|12|||
16091135|NCT00454194|38823669|FG001|Overall Study|Withdrawal by Subject|8|||
16091136|NCT00454194|38823668|FG000|Overall Study|Other Medical Problems|1|||
16091137|NCT00454194|38823669|FG001|Overall Study|Other Medical Problems|2|||
16091138|NCT00454194|38823668|FG000|Overall Study|Other Unspecified Reason|2|||
16091139|NCT00454194|38823669|FG001|Overall Study|Other Unspecified Reason|2|||
16091140|NCT00985088|38823670|FG000|Overall Study|Serious Adverse Event|1|||
16091141|NCT00985088|38823671|FG001|Overall Study|Serious Adverse Event|1|||
16091142|NCT00985088|38823672|FG002|Overall Study|Serious Adverse Event|0|||
16091143|NCT00985088|38823673|FG003|Overall Study|Serious Adverse Event|0|||
16321315|NCT02729051|39660609|FG000|Overall Study|Withdrawal by Subject|6|||
16516047|NCT00414050|40358529|FG000|Overall Study|Subject discontinued for other reason|1|||
16516048|NCT00414050|40358530|FG001|Overall Study|Subject discontinued for other reason|2|||
16091144|NCT00985088|38823674|FG004|Overall Study|Serious Adverse Event|0|||
16091145|NCT00985088|38823675|FG005|Overall Study|Serious Adverse Event|0|||
16091146|NCT00985088|38823676|FG006|Overall Study|Serious Adverse Event|0|||
16091147|NCT00985088|38823677|FG007|Overall Study|Serious Adverse Event|1|||
16091148|NCT00985088|38823670|FG000|Overall Study|Adverse Event|0|||
16091149|NCT00985088|38823671|FG001|Overall Study|Adverse Event|0|||
16091150|NCT00985088|38823672|FG002|Overall Study|Adverse Event|1|||
16091151|NCT00985088|38823673|FG003|Overall Study|Adverse Event|0|||
16091152|NCT00985088|38823674|FG004|Overall Study|Adverse Event|0|||
16091153|NCT00985088|38823675|FG005|Overall Study|Adverse Event|0|||
16091154|NCT00985088|38823676|FG006|Overall Study|Adverse Event|0|||
16091155|NCT00985088|38823677|FG007|Overall Study|Adverse Event|0|||
16091156|NCT00985088|38823670|FG000|Overall Study|Withdrawal by Subject|4|||
16091157|NCT00985088|38823671|FG001|Overall Study|Withdrawal by Subject|0|||
16091158|NCT00985088|38823672|FG002|Overall Study|Withdrawal by Subject|0|||
16516049|NCT00414050|40358531|FG002|Overall Study|Subject discontinued for other reason|2|||
16516050|NCT00414050|40358532|FG003|Overall Study|Subject discontinued for other reason|1|||
16516051|NCT00414050|40358529|FG000|Overall Study|Subject Moved|0|||
16516052|NCT00414050|40358530|FG001|Overall Study|Subject Moved|0|||
16516053|NCT00414050|40358531|FG002|Overall Study|Subject Moved|0|||
16516054|NCT00414050|40358532|FG003|Overall Study|Subject Moved|1|||
16516055|NCT02624284|40358535|FG000|Overall Study|Withdrawal by Subject|3|||
16516056|NCT02624284|40358536|FG001|Overall Study|Withdrawal by Subject|6|||
16516057|NCT02624284|40358537|FG002|Overall Study|Withdrawal by Subject|3|||
16516058|NCT02624284|40358535|FG000|Overall Study|Protocol Violation|9|||
16516059|NCT02624284|40358536|FG001|Overall Study|Protocol Violation|10|||
16516060|NCT02624284|40358537|FG002|Overall Study|Protocol Violation|7|||
16516061|NCT02624284|40358535|FG000|Overall Study|Revealed exclusionary condition|2|||
16516062|NCT02624284|40358536|FG001|Overall Study|Revealed exclusionary condition|2|||
16516063|NCT02624284|40358537|FG002|Overall Study|Revealed exclusionary condition|0|||
16516064|NCT02624284|40358535|FG000|Overall Study|Adverse Event|0|||
16091159|NCT00985088|38823673|FG003|Overall Study|Withdrawal by Subject|1|||
16091160|NCT00985088|38823674|FG004|Overall Study|Withdrawal by Subject|3|||
16091161|NCT00985088|38823675|FG005|Overall Study|Withdrawal by Subject|2|||
16091162|NCT00985088|38823676|FG006|Overall Study|Withdrawal by Subject|1|||
16091163|NCT00985088|38823677|FG007|Overall Study|Withdrawal by Subject|2|||
16202439|NCT01830816|39218841|FG001|Overall Study|Study Terminated by Sponsor|1|||
16202440|NCT01830816|39218842|FG002|Overall Study|Study Terminated by Sponsor|0|||
16091164|NCT00985088|38823670|FG000|Overall Study|Migrated/moved from study area|0|||
16394867|NCT00075764|39928068|FG001|Overall Study|Death|8|||
16394868|NCT00075764|39928067|FG000|Overall Study|Withdrawal by Subject|28|||
16394869|NCT00075764|39928068|FG001|Overall Study|Withdrawal by Subject|18|||
16394870|NCT00075764|39928067|FG000|Overall Study|Progression|269|||
16394871|NCT00075764|39928068|FG001|Overall Study|Progression|274|||
16394872|NCT00075764|39928067|FG000|Overall Study|Still on treatment|8|||
16394873|NCT00075764|39928068|FG001|Overall Study|Still on treatment|15|||
16394874|NCT00075764|39928067|FG000|Overall Study|Delinquent|4|||
16394875|NCT00075764|39928068|FG001|Overall Study|Delinquent|2|||
16394876|NCT00075764|39928067|FG000|Overall Study|Not protocol specified|27|||
16394877|NCT00075764|39928068|FG001|Overall Study|Not protocol specified|19|||
16394878|NCT00075764|39928067|FG000|Overall Study|Under review|0|||
16394879|NCT00075764|39928068|FG001|Overall Study|Under review|1|||
16394880|NCT01901614|39928071|FG000|Overall Study|Adverse Event|0|||
16394881|NCT01901614|39928072|FG001|Overall Study|Adverse Event|1|||
16394882|NCT01901614|39928071|FG000|Overall Study|Lost to Follow-up|1|||
16394883|NCT01901614|39928072|FG001|Overall Study|Lost to Follow-up|0|||
16202441|NCT01830816|39218840|FG000|Overall Study|Withdrawal by Subject|1|||
16516065|NCT02624284|40358536|FG001|Overall Study|Adverse Event|0|||
16516066|NCT02624284|40358537|FG002|Overall Study|Adverse Event|1|||
16516067|NCT00706966|40358538|FG000|Overall Study|Adverse Event|1|||
16516068|NCT01802775|40358539|FG000|Overall Study|Death|0|||
16394884|NCT01901614|39928071|FG000|Overall Study|Screen Fail|1|||
16394885|NCT01901614|39928072|FG001|Overall Study|Screen Fail|0|||
16394886|NCT03248167|39928073|FG000|Overall Study|Withdrawal by Subject|2|||
16202442|NCT01830816|39218841|FG001|Overall Study|Withdrawal by Subject|1|||
16202443|NCT01830816|39218842|FG002|Overall Study|Withdrawal by Subject|0|||
16202444|NCT01830816|39218840|FG000|Overall Study|Lost to Follow-up|0|||
16202445|NCT01830816|39218841|FG001|Overall Study|Lost to Follow-up|1|||
16202446|NCT01830816|39218842|FG002|Overall Study|Lost to Follow-up|0|||
16202447|NCT01830816|39218840|FG000|Overall Study|Symptomatic Deterioration|1|||
16202448|NCT01830816|39218841|FG001|Overall Study|Symptomatic Deterioration|0|||
16202449|NCT01830816|39218842|FG002|Overall Study|Symptomatic Deterioration|0|||
16202450|NCT01830816|39218840|FG000|Overall Study|Reason not Specified|2|||
16394887|NCT03248167|39928074|FG001|Overall Study|Withdrawal by Subject|2|||
16394888|NCT03248167|39928073|FG000|Overall Study|Physician Decision|0|||
16394889|NCT03248167|39928074|FG001|Overall Study|Physician Decision|1|||
16394890|NCT03248167|39928073|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
16394891|NCT03248167|39928074|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
16394892|NCT03248167|39928073|FG000|Overall Study|Lost to Follow-up|1|||
16394893|NCT03248167|39928074|FG001|Overall Study|Lost to Follow-up|0|||
16394894|NCT03559517|39928079|FG000|Overall Study|Withdrawal by Subject|1|||
16394895|NCT03559517|39928080|FG001|Overall Study|Withdrawal by Subject|0|||
16394896|NCT03559517|39928081|FG002|Overall Study|Withdrawal by Subject|0|||
16394897|NCT03183063|39928085|FG000|Overall Study|Withdrawal by Subject|2|||
16394898|NCT03183063|39928086|FG001|Overall Study|Withdrawal by Subject|0|||
16394899|NCT03183063|39928087|FG002|Overall Study|Withdrawal by Subject|0|||
16394900|NCT03183063|39928085|FG000|Overall Study|Physician Decision|3|||
16394901|NCT03183063|39928086|FG001|Overall Study|Physician Decision|4|||
16394902|NCT03183063|39928087|FG002|Overall Study|Physician Decision|4|||
16394903|NCT03470194|39928088|FG000|Overall Study|Lost to Follow-up|11|||
16394904|NCT03470194|39928089|FG001|Overall Study|Lost to Follow-up|17|||
16394905|NCT02195700|39928090|FG000|Overall Study|Protocol Violation|0|||
16394906|NCT02195700|39928091|FG001|Overall Study|Protocol Violation|2|||
16394907|NCT02195700|39928090|FG000|Overall Study|Noncompliance|1|||
16394908|NCT02195700|39928091|FG001|Overall Study|Noncompliance|0|||
16394909|NCT02195700|39928090|FG000|Overall Study|Adverse Event|1|||
16394910|NCT02195700|39928091|FG001|Overall Study|Adverse Event|2|||
16394911|NCT02195700|39928090|FG000|Overall Study|Withdrawal by Subject|3|||
16394912|NCT02195700|39928091|FG001|Overall Study|Withdrawal by Subject|2|||
16394913|NCT02195700|39928090|FG000|Overall Study|Lost to Follow-up|1|||
16394914|NCT02195700|39928091|FG001|Overall Study|Lost to Follow-up|1|||
16202451|NCT01830816|39218841|FG001|Overall Study|Reason not Specified|0|||
16202452|NCT01830816|39218842|FG002|Overall Study|Reason not Specified|0|||
16202453|NCT00168064|39218846|FG000|Overall Study|Adverse Event|26|||
16202454|NCT00168064|39218847|FG001|Overall Study|Adverse Event|22|||
16202455|NCT00168064|39218846|FG000|Overall Study|Withdrawal by Subject|3|||
16202456|NCT00168064|39218847|FG001|Overall Study|Withdrawal by Subject|4|||
16202457|NCT00168064|39218846|FG000|Overall Study|Lack of Efficacy|4|||
16202458|NCT00168064|39218847|FG001|Overall Study|Lack of Efficacy|4|||
16202459|NCT00168064|39218846|FG000|Overall Study|Lost to Follow-up|4|||
16321316|NCT02729051|39660610|FG001|Overall Study|Withdrawal by Subject|17|||
16321317|NCT04747886|39663875|FG000|Overall Study|Withdrawal by Subject|1|||
16321318|NCT04747886|39663876|FG001|Overall Study|Withdrawal by Subject|4|||
16321319|NCT00930774|39663884|FG000|Overall Study|Withdrawal by Subject|1|||
16321320|NCT00930774|39663885|FG001|Overall Study|Withdrawal by Subject|9|||
16321321|NCT00930774|39663886|FG002|Overall Study|Withdrawal by Subject|2|||
16321322|NCT00930774|39663887|FG003|Overall Study|Withdrawal by Subject|0|||
16321323|NCT02203721|39663889|FG000|Overall Study|Lost to Follow-up|1|||
16321324|NCT02203721|39663890|FG001|Overall Study|Lost to Follow-up|0|||
16321325|NCT02203721|39663889|FG000|Overall Study|Death|0|||
16321326|NCT02203721|39663890|FG001|Overall Study|Death|2|||
16321327|NCT02203721|39663889|FG000|Overall Study|Illness|0|||
16202460|NCT00168064|39218847|FG001|Overall Study|Lost to Follow-up|3|||
16202461|NCT00168064|39218846|FG000|Overall Study|Non-compliance|2|||
16321328|NCT02203721|39663890|FG001|Overall Study|Illness|1|||
16321329|NCT02126579|39663891|FG000|Overall Study|disease progression|0|||
16321330|NCT02126579|39663892|FG001|Overall Study|disease progression|0|||
16321331|NCT02126579|39663893|FG002|Overall Study|disease progression|0|||
16321332|NCT02126579|39663894|FG003|Overall Study|disease progression|1|||
16394915|NCT00771927|39928092|FG000|Overall Study|Adverse Event|100|||
16394916|NCT00771927|39928093|FG001|Overall Study|Adverse Event|105|||
16394917|NCT00771927|39928092|FG000|Overall Study|Lack of Efficacy|70|||
16321333|NCT02126579|39663895|FG004|Overall Study|disease progression|0|||
16394918|NCT00771927|39928093|FG001|Overall Study|Lack of Efficacy|42|||
16321334|NCT02126579|39663896|FG005|Overall Study|disease progression|0|||
16394919|NCT00771927|39928092|FG000|Overall Study|Lost to Follow-up|46|||
16321335|NCT02126579|39663897|FG006|Overall Study|disease progression|1|||
16321336|NCT00247611|39663898|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
16321337|NCT00247611|39663899|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
16321338|NCT00247611|39663898|FG000|Baselined|Completed baseline only|9|||
16321339|NCT00247611|39663899|FG001|Baselined|Completed baseline only|8|||
16321340|NCT01862250|39663900|FG000|Overall Study|Adverse Event|4|||
16321341|NCT02282813|39663901|FG000|Overall Study|Withdrawal by Subject|4|||
16321342|NCT02282813|39663902|FG001|Overall Study|Withdrawal by Subject|5|||
16321343|NCT02282813|39663903|FG002|Overall Study|Withdrawal by Subject|0|||
16321344|NCT02282813|39663901|FG000|Overall Study|Adverse Event|3|||
16321345|NCT02282813|39663902|FG001|Overall Study|Adverse Event|10|||
16321346|NCT02282813|39663903|FG002|Overall Study|Adverse Event|1|||
16321347|NCT02282813|39663901|FG000|Overall Study|Subject non-compliance|1|||
16321348|NCT02282813|39663902|FG001|Overall Study|Subject non-compliance|4|||
16321349|NCT02282813|39663903|FG002|Overall Study|Subject non-compliance|0|||
16321350|NCT02282813|39663901|FG000|Overall Study|Physician Decision|0|||
16321351|NCT02282813|39663902|FG001|Overall Study|Physician Decision|3|||
16321352|NCT02282813|39663903|FG002|Overall Study|Physician Decision|1|||
16321353|NCT02282813|39663901|FG000|Overall Study|Lost to Follow-up|2|||
16321354|NCT02282813|39663902|FG001|Overall Study|Lost to Follow-up|0|||
16321355|NCT02282813|39663903|FG002|Overall Study|Lost to Follow-up|1|||
16321356|NCT02282813|39663901|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
16394920|NCT00771927|39928093|FG001|Overall Study|Lost to Follow-up|46|||
16394921|NCT00771927|39928092|FG000|Overall Study|Withdrawal by Subject|16|||
16394922|NCT00771927|39928093|FG001|Overall Study|Withdrawal by Subject|17|||
16202462|NCT00168064|39218847|FG001|Overall Study|Non-compliance|3|||
16202463|NCT00168064|39218846|FG000|Overall Study|Concurrent Illness|4|||
16202464|NCT00168064|39218847|FG001|Overall Study|Concurrent Illness|3|||
16202465|NCT00168064|39218846|FG000|Overall Study|Subject's Best interest|2|||
16394923|NCT00771927|39928092|FG000|Overall Study|Other reason|23|||
16394924|NCT00771927|39928093|FG001|Overall Study|Other reason|27|||
16394925|NCT01665911|39928098|FG000|Overall Study|Protocol Violation|4|||
16394926|NCT01665911|39928098|FG000|Overall Study|Withdrawal by Subject|1|||
16394927|NCT01665911|39928098|FG000|Overall Study|Adverse Event|1|||
16394928|NCT00902850|39928099|FG000|Overall Study|Physician Decision|2|||
16394929|NCT00902850|39928100|FG001|Overall Study|Physician Decision|2|||
16394930|NCT02982772|39928102|FG000|Intervention|Lost to Follow-up|19|||
16394931|NCT02982772|39928103|FG001|Intervention|Lost to Follow-up|13|||
16394932|NCT02982772|39928102|FG000|1M Follow-Up|Lost to Follow-up|21|||
16394933|NCT02982772|39928103|FG001|1M Follow-Up|Lost to Follow-up|18|||
16394934|NCT02982772|39928102|FG000|3M Follow-Up|Lost to Follow-up|17|||
16394935|NCT02982772|39928103|FG001|3M Follow-Up|Lost to Follow-up|11|||
16394936|NCT02982772|39928102|FG000|6M Follow-Up|Lost to Follow-up|11|||
16394937|NCT02982772|39928103|FG001|6M Follow-Up|Lost to Follow-up|9|||
16394938|NCT02982772|39928102|FG000|12M Follow-Up|Lost to Follow-up|11|||
16394939|NCT02982772|39928103|FG001|12M Follow-Up|Lost to Follow-up|5|||
16394940|NCT05141175|39928107|FG000|Overall Study|Withdrawal by Subject|1|||
16394941|NCT00851552|39928108|FG000|Overall Study|Death|2|||
16394942|NCT00851552|39928108|FG000|Overall Study|Adverse Event|1|||
16394943|NCT00851552|39928108|FG000|Overall Study|Disease Progression|4|||
16091165|NCT00985088|38823671|FG001|Overall Study|Migrated/moved from study area|0|||
16091166|NCT00985088|38823672|FG002|Overall Study|Migrated/moved from study area|1|||
16202466|NCT00168064|39218847|FG001|Overall Study|Subject's Best interest|2|||
16202467|NCT00168064|39218846|FG000|Overall Study|Various|4|||
16202468|NCT00168064|39218847|FG001|Overall Study|Various|3|||
16202469|NCT02282982|39218848|FG000|Overall Study|Lost to Follow-up|15|||
16202470|NCT02282982|39218848|FG000|Overall Study|Withdrew consent|2|||
16202471|NCT02282982|39218848|FG000|Overall Study|Death|4|||
16202472|NCT02282982|39218848|FG000|Overall Study|Lack of product|156|||
16202473|NCT02282982|39218848|FG000|Overall Study|Palivizumab is ended|11|||
16091167|NCT00985088|38823673|FG003|Overall Study|Migrated/moved from study area|0|||
16091168|NCT00985088|38823674|FG004|Overall Study|Migrated/moved from study area|0|||
16091169|NCT00985088|38823675|FG005|Overall Study|Migrated/moved from study area|0|||
16202474|NCT02282982|39218848|FG000|Overall Study|Other, not specified|18|||
16202475|NCT01253187|39218861|FG000|Period 2|Withdrawal by Subject|0|||
16202476|NCT01253187|39218862|FG001|Period 2|Withdrawal by Subject|0|||
16321357|NCT02282813|39663902|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
16321358|NCT02282813|39663903|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
16321359|NCT02282813|39663901|FG000|Overall Study|Lack of Efficacy|1|||
16321360|NCT02282813|39663902|FG001|Overall Study|Lack of Efficacy|0|||
16321361|NCT02282813|39663903|FG002|Overall Study|Lack of Efficacy|0|||
16321362|NCT02282813|39663901|FG000|Overall Study|Administrative reasons|0|||
16394944|NCT02036580|39928109|FG000|Overall Study|Withdrawal by Subject|0|||
16516069|NCT01802775|40358540|FG001|Overall Study|Death|3|||
16202477|NCT01253187|39218863|FG002|Period 2|Withdrawal by Subject|0|||
16321363|NCT02282813|39663902|FG001|Overall Study|Administrative reasons|1|||
16321364|NCT02282813|39663903|FG002|Overall Study|Administrative reasons|0|||
16321365|NCT03436693|39663905|FG000|Overall Study|Adverse Event|22|||
16202478|NCT01253187|39218864|FG003|Period 2|Withdrawal by Subject|0|||
16202479|NCT01253187|39218865|FG004|Period 2|Withdrawal by Subject|1|||
16202480|NCT01253187|39218866|FG005|Period 2|Withdrawal by Subject|0|||
16202481|NCT01253187|39218861|FG000|Period 3|Pregnancy|1|||
16202482|NCT01253187|39218862|FG001|Period 3|Pregnancy|0|||
16202483|NCT01253187|39218863|FG002|Period 3|Pregnancy|0|||
16202484|NCT01253187|39218864|FG003|Period 3|Pregnancy|0|||
16202485|NCT01253187|39218865|FG004|Period 3|Pregnancy|0|||
16202486|NCT01253187|39218866|FG005|Period 3|Pregnancy|0|||
16202487|NCT01253187|39218861|FG000|Period 3|difficulty with blood sampling|0|||
16202488|NCT01253187|39218862|FG001|Period 3|difficulty with blood sampling|1|||
16202489|NCT01253187|39218863|FG002|Period 3|difficulty with blood sampling|0|||
16202490|NCT01253187|39218864|FG003|Period 3|difficulty with blood sampling|0|||
16202491|NCT01253187|39218865|FG004|Period 3|difficulty with blood sampling|0|||
16202492|NCT01253187|39218866|FG005|Period 3|difficulty with blood sampling|0|||
16202493|NCT01253187|39218861|FG000|Period 3|non-compliance|0|||
16202494|NCT01253187|39218862|FG001|Period 3|non-compliance|0|||
16202495|NCT01253187|39218863|FG002|Period 3|non-compliance|0|||
16202496|NCT01253187|39218864|FG003|Period 3|non-compliance|0|||
16202497|NCT01253187|39218865|FG004|Period 3|non-compliance|1|||
16202498|NCT01253187|39218866|FG005|Period 3|non-compliance|0|||
16202499|NCT01185704|39218867|FG000|Overall Study|Randomized but not treated|3|||
16202500|NCT01185704|39218868|FG001|Overall Study|Randomized but not treated|3|||
16202501|NCT01185704|39218867|FG000|Overall Study|Lack of ovarian response|5|||
16202502|NCT01185704|39218868|FG001|Overall Study|Lack of ovarian response|1|||
16202503|NCT01185704|39218867|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
16202504|NCT01185704|39218868|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
16321366|NCT03436693|39663906|FG001|Overall Study|Adverse Event|10|||
16321367|NCT03436693|39663905|FG000|Overall Study|Physician Decision|3|||
16321368|NCT03436693|39663906|FG001|Overall Study|Physician Decision|3|||
16321369|NCT03436693|39663905|FG000|Overall Study|Withdrawal by Subject|4|||
16321370|NCT03436693|39663906|FG001|Overall Study|Withdrawal by Subject|13|||
16321371|NCT03436693|39663905|FG000|Overall Study|Progressive Disease|1|||
16516070|NCT01802775|40358539|FG000|Overall Study|Reason not provided|0|||
16516071|NCT01802775|40358540|FG001|Overall Study|Reason not provided|1|||
16516072|NCT01802775|40358539|FG000|Overall Study|Physician Decision|1|||
16516073|NCT01802775|40358540|FG001|Overall Study|Physician Decision|0|||
16516074|NCT01802775|40358539|FG000|Overall Study|Adverse Event|1|||
16516075|NCT01802775|40358540|FG001|Overall Study|Adverse Event|1|||
16516076|NCT01802775|40358539|FG000|Overall Study|Withdrawal by Subject|3|||
16516077|NCT01802775|40358540|FG001|Overall Study|Withdrawal by Subject|5|||
16516078|NCT01802775|40358539|FG000|Overall Study|Lost to Follow-up|1|||
16516079|NCT01802775|40358540|FG001|Overall Study|Lost to Follow-up|2|||
16516080|NCT02517905|40358543|FG000|Overall Study|Lost to Follow-up|4|||
16516081|NCT02517905|40358544|FG001|Overall Study|Lost to Follow-up|0|||
16516082|NCT02517905|40358543|FG000|Overall Study|Withdrawal by Subject|4|||
16516083|NCT02517905|40358544|FG001|Overall Study|Withdrawal by Subject|0|||
16516084|NCT02517905|40358543|FG000|Overall Study|Screen failure|2|||
16091170|NCT00985088|38823676|FG006|Overall Study|Migrated/moved from study area|0|||
16091171|NCT00985088|38823677|FG007|Overall Study|Migrated/moved from study area|1|||
16091172|NCT00985088|38823670|FG000|Overall Study|Lost to Follow-up|6|||
16091173|NCT00985088|38823671|FG001|Overall Study|Lost to Follow-up|1|||
16202505|NCT01185704|39218867|FG000|Overall Study|Ectopic pregnancy|0|||
16202506|NCT01185704|39218868|FG001|Overall Study|Ectopic pregnancy|1|||
16202507|NCT02472795|39218869|FG000|Overall Study|Adverse Event|0|||
16321372|NCT03436693|39663906|FG001|Overall Study|Progressive Disease|1|||
16321373|NCT01750697|39663907|FG000|Overall Study|Transferred Back to Local Hospital|1|||
16321374|NCT01750697|39663907|FG000|Overall Study|Physician and Family Decision|1|||
16321375|NCT01750697|39663907|FG000|Overall Study|Transferred to Adult Services|5|||
16202508|NCT02472795|39218870|FG001|Overall Study|Adverse Event|1|||
16202509|NCT02472795|39218871|FG002|Overall Study|Adverse Event|0|||
16202510|NCT02472795|39218872|FG003|Overall Study|Adverse Event|0|||
16321376|NCT01750697|39663907|FG000|Overall Study|Physician Decision|1|||
16321377|NCT01750697|39663907|FG000|Overall Study|Withdrawal by Subject|1|||
16321378|NCT00887315|39663914|FG000|Overall Study|Study termination|7|||
16202511|NCT02472795|39218873|FG004|Overall Study|Adverse Event|2|||
16202512|NCT02472795|39218869|FG000|Overall Study|Withdrawal by Subject|0|||
16321379|NCT00887315|39663915|FG001|Overall Study|Study termination|4|||
16321380|NCT03164564|39663916|FG000|Overall Study|Death|3|||
16516085|NCT02517905|40358544|FG001|Overall Study|Screen failure|2|||
16516086|NCT00529386|40358549|FG000|Overall Study|Lost to Follow-up|1|||
16202513|NCT02472795|39218870|FG001|Overall Study|Withdrawal by Subject|0|||
16516087|NCT01714310|40358550|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
16321381|NCT03164564|39663917|FG001|Overall Study|Death|0|||
16091174|NCT00985088|38823672|FG002|Overall Study|Lost to Follow-up|2|||
16202514|NCT02472795|39218871|FG002|Overall Study|Withdrawal by Subject|0|||
16321382|NCT03164564|39663916|FG000|Overall Study|Withdrawal by Subject|20|||
16516088|NCT01714310|40358551|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
16516089|NCT01714310|40358552|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
16516090|NCT01714310|40358550|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
16516091|NCT01714310|40358551|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
16516092|NCT01714310|40358552|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
16516093|NCT01714310|40358550|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
16516094|NCT01714310|40358551|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
16516095|NCT01714310|40358552|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
16516096|NCT01714310|40358550|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
16516097|NCT01714310|40358551|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
16516098|NCT01714310|40358552|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
16516099|NCT02884089|40358553|FG000|Period 1|Dosing error|2|||
16516100|NCT02884089|40358554|FG001|Period 1|Dosing error|2|||
16516101|NCT02884089|40358555|FG002|Period 1|Dosing error|0|||
16202515|NCT02472795|39218872|FG003|Overall Study|Withdrawal by Subject|0|||
16202516|NCT02472795|39218873|FG004|Overall Study|Withdrawal by Subject|1|||
16202517|NCT02267278|39218874|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
16202518|NCT02267278|39218874|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
16202519|NCT02267278|39218874|FG000|Overall Study|Developed new cancer diagnoses|2|||
16202520|NCT02267278|39218874|FG000|Overall Study|prescribed prohibited medication|1|||
16202521|NCT00118911|39218875|FG000|Overall Study|Withdrawal by Subject|2|||
16202522|NCT00118911|39218876|FG001|Overall Study|Withdrawal by Subject|5|||
16202523|NCT04031404|39218877|FG000|Baseline|Lost to Follow-up|0|||
16202524|NCT04031404|39218878|FG001|Baseline|Lost to Follow-up|1|||
16202525|NCT04031404|39218877|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
16202526|NCT04031404|39218878|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
16516102|NCT02884089|40358556|FG003|Period 1|Dosing error|0|||
16516103|NCT02884089|40358553|FG000|Washout Period 1|Lost to Follow-up|0|||
16516104|NCT02884089|40358554|FG001|Washout Period 1|Lost to Follow-up|1|||
16516105|NCT02884089|40358555|FG002|Washout Period 1|Lost to Follow-up|0|||
16516106|NCT02884089|40358556|FG003|Washout Period 1|Lost to Follow-up|1|||
16516107|NCT02884089|40358553|FG000|Washout Period 1|Withdrawal by Subject|0|||
16516108|NCT02884089|40358554|FG001|Washout Period 1|Withdrawal by Subject|1|||
16516109|NCT02884089|40358555|FG002|Washout Period 1|Withdrawal by Subject|0|||
16516110|NCT02884089|40358556|FG003|Washout Period 1|Withdrawal by Subject|0|||
16516111|NCT02884089|40358553|FG000|Period 2|Adverse Event|1|||
16516112|NCT02884089|40358554|FG001|Period 2|Adverse Event|0|||
16516113|NCT02884089|40358555|FG002|Period 2|Adverse Event|0|||
16516114|NCT02884089|40358556|FG003|Period 2|Adverse Event|0|||
16516115|NCT02884089|40358553|FG000|Period 3|Withdrawal by Subject|0|||
16516116|NCT02884089|40358554|FG001|Period 3|Withdrawal by Subject|0|||
16516117|NCT02884089|40358555|FG002|Period 3|Withdrawal by Subject|1|||
16516118|NCT02884089|40358556|FG003|Period 3|Withdrawal by Subject|0|||
16516119|NCT02884089|40358553|FG000|Washout Period 3|Withdrawal by Subject|0|||
16516120|NCT02884089|40358554|FG001|Washout Period 3|Withdrawal by Subject|0|||
16516121|NCT02884089|40358555|FG002|Washout Period 3|Withdrawal by Subject|1|||
16516122|NCT02884089|40358556|FG003|Washout Period 3|Withdrawal by Subject|0|||
16516123|NCT02884089|40358553|FG000|Washout Period 3|Lost to Follow-up|0|||
16516124|NCT02884089|40358554|FG001|Washout Period 3|Lost to Follow-up|0|||
16516125|NCT02884089|40358555|FG002|Washout Period 3|Lost to Follow-up|0|||
16516126|NCT02884089|40358556|FG003|Washout Period 3|Lost to Follow-up|1|||
16516127|NCT02884089|40358553|FG000|Period 4|Withdrawal by Subject|0|||
16516128|NCT02884089|40358554|FG001|Period 4|Withdrawal by Subject|1|||
16516129|NCT02884089|40358555|FG002|Period 4|Withdrawal by Subject|0|||
16516130|NCT02884089|40358556|FG003|Period 4|Withdrawal by Subject|0|||
16516131|NCT02884089|40358553|FG000|Period 4|Lost to Follow-up|1|||
16091175|NCT00985088|38823673|FG003|Overall Study|Lost to Follow-up|6|||
16516132|NCT02884089|40358554|FG001|Period 4|Lost to Follow-up|0|||
16516133|NCT02884089|40358555|FG002|Period 4|Lost to Follow-up|0|||
16516134|NCT02884089|40358556|FG003|Period 4|Lost to Follow-up|0|||
16516135|NCT02884089|40358553|FG000|Follow-up Visit|Withdrawal by Subject|1|||
16516136|NCT02884089|40358554|FG001|Follow-up Visit|Withdrawal by Subject|0|||
16516137|NCT02884089|40358555|FG002|Follow-up Visit|Withdrawal by Subject|0|||
16516138|NCT02884089|40358556|FG003|Follow-up Visit|Withdrawal by Subject|1|||
16516139|NCT02388997|40358557|FG000|Overall Study|Adverse Event|1|||
16516140|NCT02388997|40358558|FG001|Overall Study|Adverse Event|2|||
16516141|NCT02388997|40358557|FG000|Overall Study|Withdrawal by Subject|2|||
16516142|NCT02388997|40358558|FG001|Overall Study|Withdrawal by Subject|1|||
16202527|NCT04031404|39218877|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
16091176|NCT00985088|38823674|FG004|Overall Study|Lost to Follow-up|6|||
16091177|NCT00985088|38823675|FG005|Overall Study|Lost to Follow-up|5|||
16091178|NCT00985088|38823676|FG006|Overall Study|Lost to Follow-up|3|||
16091179|NCT00985088|38823677|FG007|Overall Study|Lost to Follow-up|2|||
16202528|NCT04031404|39218878|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
16202529|NCT04031404|39218877|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
16202530|NCT04031404|39218878|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
16202531|NCT04031404|39218877|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
16202532|NCT04031404|39218878|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
16202533|NCT04721977|39218883|FG000|Overall Study|Death|15|||
16202534|NCT04721977|39218883|FG000|Overall Study|Ongoing|51|||
16202535|NCT00525785|39218884|FG000|Overall Study|Withdrawal by Subject|1|||
16202536|NCT00525785|39218884|FG000|Overall Study|Lack of Efficacy|1|||
16202537|NCT00525785|39218884|FG000|Overall Study|Physician Decision|1|||
16202538|NCT01363713|39218887|FG000|Overall Study|Adverse Event|1|||
16202539|NCT01363713|39218887|FG000|Overall Study|Protocol Violation|3|||
16202540|NCT01363713|39218887|FG000|Overall Study|Withdrawal by Subject|2|||
16202541|NCT01280266|39218888|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
16202542|NCT01280266|39218889|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
16202543|NCT01280266|39218888|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
16202544|NCT01280266|39218889|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
16202545|NCT01419015|39218890|FG000|Overall Study|Death|2|||
16202546|NCT00196196|39218891|FG000|Overall Study|Withdrawal by Subject|2|||
16202547|NCT00196196|39218891|FG000|Overall Study|Did not have required condition (hydroce|5|||
16202548|NCT04325906|39218892|FG000|Overall Study|Withdrawal by Subject|2|||
16202549|NCT04325906|39218893|FG001|Overall Study|Withdrawal by Subject|0|||
16202550|NCT00871377|39218894|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
16202551|NCT00871377|39218895|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
16202552|NCT00871377|39218896|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
16202553|NCT00871377|39218897|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
16202554|NCT00871377|39218898|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
16202555|NCT00871377|39218899|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
16202556|NCT00871377|39218894|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
16202557|NCT00871377|39218895|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
16202558|NCT00871377|39218896|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
16202559|NCT00871377|39218897|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
16202560|NCT00871377|39218898|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
16202561|NCT00871377|39218899|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
16516143|NCT02388997|40358557|FG000|Overall Study|Lung function exclusion criteria|0|||
16516144|NCT02388997|40358558|FG001|Overall Study|Lung function exclusion criteria|2|||
16516145|NCT02388997|40358557|FG000|Overall Study|Tested positive for virus during run-in|0|||
16516146|NCT02388997|40358558|FG001|Overall Study|Tested positive for virus during run-in|1|||
16516147|NCT02127307|40358559|FG000|Overall Study|Protocol Violation|36|||
16516148|NCT02127307|40358559|FG000|Overall Study|Lost to Follow-up|2|||
16516149|NCT02127307|40358559|FG000|Overall Study|Death|101|||
16516150|NCT02127307|40358559|FG000|Overall Study|Other than specified above|169|||
16516151|NCT03120013|40358561|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16516152|NCT03120013|40358562|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
16516153|NCT01709318|40358563|FG000|Overall Study|Adverse Event|3|||
16516154|NCT01709318|40358564|FG001|Overall Study|Adverse Event|4|||
16516155|NCT01709318|40358565|FG002|Overall Study|Adverse Event|2|||
16516156|NCT01709318|40358566|FG003|Overall Study|Adverse Event|2|||
16516157|NCT01709318|40358567|FG004|Overall Study|Adverse Event|0|||
16516158|NCT01709318|40358568|FG005|Overall Study|Adverse Event|1|||
16516159|NCT01709318|40358569|FG006|Overall Study|Adverse Event|2|||
16516160|NCT01709318|40358563|FG000|Overall Study|Lost to Follow-up|2|||
16516161|NCT01709318|40358564|FG001|Overall Study|Lost to Follow-up|0|||
16516162|NCT01709318|40358565|FG002|Overall Study|Lost to Follow-up|0|||
16516163|NCT01709318|40358566|FG003|Overall Study|Lost to Follow-up|0|||
16516164|NCT01709318|40358567|FG004|Overall Study|Lost to Follow-up|1|||
16516165|NCT01709318|40358568|FG005|Overall Study|Lost to Follow-up|1|||
16516166|NCT01709318|40358569|FG006|Overall Study|Lost to Follow-up|1|||
16516167|NCT01709318|40358563|FG000|Overall Study|Non-compliance with Study Drug|0|||
16516168|NCT01709318|40358564|FG001|Overall Study|Non-compliance with Study Drug|2|||
16516169|NCT01709318|40358565|FG002|Overall Study|Non-compliance with Study Drug|1|||
16516170|NCT01709318|40358566|FG003|Overall Study|Non-compliance with Study Drug|1|||
16516171|NCT01709318|40358567|FG004|Overall Study|Non-compliance with Study Drug|0|||
16091180|NCT03065400|38823680|FG000|Overall Study|Adverse Event|1|||
16202562|NCT00871377|39218894|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
16202563|NCT00871377|39218895|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
16202564|NCT00871377|39218896|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
16202565|NCT00871377|39218897|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
16202566|NCT00871377|39218898|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
16516172|NCT01709318|40358568|FG005|Overall Study|Non-compliance with Study Drug|0|||
16202567|NCT00871377|39218899|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
16202568|NCT00871377|39218894|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
16202569|NCT00871377|39218895|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
16202570|NCT00871377|39218896|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
16202571|NCT00871377|39218897|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
16202572|NCT00871377|39218898|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
16202573|NCT00871377|39218899|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
16202574|NCT00871377|39218894|FG000|Third Intervention (10 Weeks)|Death|0|||
16202575|NCT00871377|39218895|FG001|Third Intervention (10 Weeks)|Death|0|||
16202576|NCT00871377|39218896|FG002|Third Intervention (10 Weeks)|Death|0|||
16202577|NCT00871377|39218897|FG003|Third Intervention (10 Weeks)|Death|1|||
16202578|NCT00871377|39218898|FG004|Third Intervention (10 Weeks)|Death|0|||
16202579|NCT00871377|39218899|FG005|Third Intervention (10 Weeks)|Death|0|||
16202580|NCT01337167|39218904|FG000|Infant Series|Adverse Event|1|||
16202581|NCT01337167|39218905|FG001|Infant Series|Adverse Event|1|||
16202582|NCT01337167|39218904|FG000|Infant Series|Death|1|||
16202583|NCT01337167|39218905|FG001|Infant Series|Death|1|||
16202584|NCT01337167|39218904|FG000|Infant Series|Lost to Follow-up|13|||
16202585|NCT01337167|39218905|FG001|Infant Series|Lost to Follow-up|7|||
16394945|NCT02036580|39928110|FG001|Overall Study|Withdrawal by Subject|1|||
16394946|NCT02036580|39928111|FG002|Overall Study|Withdrawal by Subject|0|||
16394947|NCT02036580|39928109|FG000|Overall Study|Adverse Event|1|||
16394948|NCT02036580|39928110|FG001|Overall Study|Adverse Event|0|||
16394949|NCT02036580|39928111|FG002|Overall Study|Adverse Event|0|||
16394950|NCT01262638|39928112|FG000|Overall Study|Adverse Event|3|||
16394951|NCT01262638|39928113|FG001|Overall Study|Adverse Event|4|||
16394952|NCT01262638|39928114|FG002|Overall Study|Adverse Event|3|||
16394953|NCT01262638|39928115|FG003|Overall Study|Adverse Event|4|||
16394954|NCT01262638|39928112|FG000|Overall Study|Protocol Violation|1|||
16202586|NCT01337167|39218904|FG000|Infant Series|Non-compliance with study drug|2|||
16202587|NCT01337167|39218905|FG001|Infant Series|Non-compliance with study drug|1|||
16202588|NCT01337167|39218904|FG000|Infant Series|Physician Decision|3|||
16516173|NCT01709318|40358569|FG006|Overall Study|Non-compliance with Study Drug|2|||
16516174|NCT01709318|40358563|FG000|Overall Study|Physician Decision|0|||
16516175|NCT01709318|40358564|FG001|Overall Study|Physician Decision|0|||
16516176|NCT01709318|40358565|FG002|Overall Study|Physician Decision|0|||
16516177|NCT01709318|40358566|FG003|Overall Study|Physician Decision|0|||
16516178|NCT01709318|40358567|FG004|Overall Study|Physician Decision|0|||
16516179|NCT01709318|40358568|FG005|Overall Study|Physician Decision|0|||
16516180|NCT01709318|40358569|FG006|Overall Study|Physician Decision|1|||
16516181|NCT01709318|40358563|FG000|Overall Study|Pregnancy|0|||
16516182|NCT01709318|40358564|FG001|Overall Study|Pregnancy|0|||
16516183|NCT01709318|40358565|FG002|Overall Study|Pregnancy|0|||
16516184|NCT01709318|40358566|FG003|Overall Study|Pregnancy|0|||
16516185|NCT01709318|40358567|FG004|Overall Study|Pregnancy|1|||
16516186|NCT01709318|40358568|FG005|Overall Study|Pregnancy|0|||
16516187|NCT01709318|40358569|FG006|Overall Study|Pregnancy|0|||
16516188|NCT01709318|40358563|FG000|Overall Study|Protocol Violation|0|||
16516189|NCT01709318|40358564|FG001|Overall Study|Protocol Violation|0|||
16516190|NCT01709318|40358565|FG002|Overall Study|Protocol Violation|0|||
16516191|NCT01709318|40358566|FG003|Overall Study|Protocol Violation|0|||
16516192|NCT01709318|40358567|FG004|Overall Study|Protocol Violation|2|||
16516193|NCT01709318|40358568|FG005|Overall Study|Protocol Violation|0|||
16516194|NCT01709318|40358569|FG006|Overall Study|Protocol Violation|1|||
16516195|NCT01709318|40358563|FG000|Overall Study|Technical Problems|1|||
16516196|NCT01709318|40358564|FG001|Overall Study|Technical Problems|0|||
16516197|NCT01709318|40358565|FG002|Overall Study|Technical Problems|0|||
16516198|NCT01709318|40358566|FG003|Overall Study|Technical Problems|0|||
16516199|NCT01709318|40358567|FG004|Overall Study|Technical Problems|0|||
16516200|NCT01709318|40358568|FG005|Overall Study|Technical Problems|0|||
16516201|NCT01709318|40358569|FG006|Overall Study|Technical Problems|0|||
16516202|NCT01709318|40358563|FG000|Overall Study|Withdrawal by Subject|3|||
16516203|NCT01709318|40358564|FG001|Overall Study|Withdrawal by Subject|0|||
16516204|NCT01709318|40358565|FG002|Overall Study|Withdrawal by Subject|3|||
16516205|NCT01709318|40358566|FG003|Overall Study|Withdrawal by Subject|3|||
16516206|NCT01709318|40358567|FG004|Overall Study|Withdrawal by Subject|0|||
16516207|NCT01709318|40358568|FG005|Overall Study|Withdrawal by Subject|2|||
16516208|NCT01709318|40358569|FG006|Overall Study|Withdrawal by Subject|4|||
16516209|NCT01709318|40358563|FG000|Overall Study|Other Protocol Specified Criteria|0|||
16516210|NCT01709318|40358564|FG001|Overall Study|Other Protocol Specified Criteria|1|||
16516211|NCT01709318|40358565|FG002|Overall Study|Other Protocol Specified Criteria|0|||
16516212|NCT01709318|40358566|FG003|Overall Study|Other Protocol Specified Criteria|0|||
16516213|NCT01709318|40358567|FG004|Overall Study|Other Protocol Specified Criteria|0|||
16516214|NCT01709318|40358568|FG005|Overall Study|Other Protocol Specified Criteria|0|||
16516215|NCT01709318|40358569|FG006|Overall Study|Other Protocol Specified Criteria|0|||
16516216|NCT00770120|40358571|FG000|Overall Study|Progression|31|||
16516217|NCT00770120|40358571|FG000|Overall Study|Adverse Event|11|||
16516218|NCT00770120|40358571|FG000|Overall Study|Not Protocol Specified|11|||
16516219|NCT00770120|40358571|FG000|Overall Study|Death|3|||
16516220|NCT00770120|40358571|FG000|Overall Study|Withdrawal by Subject|2|||
16516221|NCT00770120|40358571|FG000|Overall Study|Ineligible|1|||
16516222|NCT00770120|40358571|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
16516223|NCT00770120|40358571|FG000|Overall Study|Reason under Review|1|||
16516224|NCT04055116|40358572|FG000|First Intervention|Physician Decision|2|||
16516225|NCT04055116|40358573|FG001|First Intervention|Physician Decision|7|||
16516226|NCT00931307|40358574|FG000|Overall Study|Lack of Efficacy|12|||
16516227|NCT00931307|40358574|FG000|Overall Study|Biomicroscopy|1|||
16516228|NCT03912233|40358577|FG000|Overall Study|Adverse Event|1|||
16516229|NCT03912233|40358578|FG001|Overall Study|Adverse Event|0|||
16516230|NCT03912233|40358579|FG002|Overall Study|Adverse Event|0|||
16516231|NCT03912233|40358580|FG003|Overall Study|Adverse Event|0|||
16516232|NCT03912233|40358581|FG004|Overall Study|Adverse Event|0|||
16516233|NCT03912233|40358582|FG005|Overall Study|Adverse Event|0|||
16516234|NCT03912233|40358577|FG000|Overall Study|Physician Decision|1|||
16516235|NCT03912233|40358578|FG001|Overall Study|Physician Decision|0|||
16394955|NCT01262638|39928113|FG001|Overall Study|Protocol Violation|0|||
16516236|NCT03912233|40358579|FG002|Overall Study|Physician Decision|0|||
16516237|NCT03912233|40358580|FG003|Overall Study|Physician Decision|0|||
16516238|NCT03912233|40358581|FG004|Overall Study|Physician Decision|0|||
16516239|NCT03912233|40358582|FG005|Overall Study|Physician Decision|0|||
16516240|NCT03912233|40358577|FG000|Overall Study|Other|0|||
16516241|NCT03912233|40358578|FG001|Overall Study|Other|0|||
16516242|NCT03912233|40358579|FG002|Overall Study|Other|0|||
16516243|NCT03912233|40358580|FG003|Overall Study|Other|0|||
16516244|NCT03912233|40358581|FG004|Overall Study|Other|7|||
16516245|NCT03912233|40358582|FG005|Overall Study|Other|12|||
16516246|NCT00670800|40358584|FG000|Overall Study|2 controls were insulin resistant|0|||
16516247|NCT00670800|40358585|FG001|Overall Study|2 controls were insulin resistant|2|||
16516248|NCT00727714|40358588|FG000|Overall Study|Lost to Follow-up|2|||
16516249|NCT01800916|40358593|FG000|Test Period 1 (1 Week)|Convex product user|0|||
16516250|NCT01800916|40358594|FG001|Test Period 1 (1 Week)|Convex product user|0|||
16091181|NCT03065400|38823680|FG000|Overall Study|Physician Decision|3|||
16516251|NCT01800916|40358595|FG002|Test Period 1 (1 Week)|Convex product user|0|||
16516252|NCT01800916|40358596|FG003|Test Period 1 (1 Week)|Convex product user|1|||
16516253|NCT01800916|40358597|FG004|Test Period 1 (1 Week)|Convex product user|0|||
16516254|NCT01800916|40358598|FG005|Test Period 1 (1 Week)|Convex product user|0|||
16516255|NCT01800916|40358599|FG006|Test Period 1 (1 Week)|Convex product user|0|||
16516256|NCT01800916|40358600|FG007|Test Period 1 (1 Week)|Convex product user|0|||
16516257|NCT01800916|40358601|FG008|Test Period 1 (1 Week)|Convex product user|0|||
16516258|NCT01800916|40358593|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
16516259|NCT01800916|40358594|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
16516260|NCT01800916|40358595|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
16516261|NCT01800916|40358596|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
16516262|NCT01800916|40358597|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
16516263|NCT01800916|40358598|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
16516264|NCT01800916|40358599|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
16516265|NCT01800916|40358600|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
16516266|NCT01800916|40358601|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
16516267|NCT03235024|40358602|FG000|Overall Study|Adverse Event|2|||
16516268|NCT03235024|40358603|FG001|Overall Study|Adverse Event|2|||
16516269|NCT03235024|40358602|FG000|Overall Study|Death|1|||
16516270|NCT03235024|40358603|FG001|Overall Study|Death|0|||
16516271|NCT03235024|40358602|FG000|Overall Study|Lost to Follow-up|2|||
16516272|NCT03235024|40358603|FG001|Overall Study|Lost to Follow-up|5|||
16516273|NCT03235024|40358602|FG000|Overall Study|Protocol Violation|1|||
16516274|NCT03235024|40358603|FG001|Overall Study|Protocol Violation|0|||
16516275|NCT03235024|40358602|FG000|Overall Study|Withdrawal by Subject|0|||
16516276|NCT03235024|40358603|FG001|Overall Study|Withdrawal by Subject|3|||
16516277|NCT02047110|40358609|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
16516278|NCT02047110|40358610|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
16516279|NCT02047110|40358611|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
16516280|NCT02047110|40358612|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
16516281|NCT02047110|40358609|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
16516282|NCT02047110|40358610|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
16516283|NCT02047110|40358611|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
16516284|NCT02047110|40358612|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
16516285|NCT02047110|40358609|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
16516286|NCT02047110|40358610|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
16516287|NCT02047110|40358611|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
16516288|NCT02047110|40358612|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
16516289|NCT02047110|40358609|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
16516290|NCT02047110|40358610|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
16516291|NCT02047110|40358611|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
16091182|NCT03065400|38823680|FG000|Overall Study|Withdrawal by Subject|1|||
16091183|NCT03065400|38823680|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
16394956|NCT01262638|39928114|FG002|Overall Study|Protocol Violation|0|||
16394957|NCT01262638|39928115|FG003|Overall Study|Protocol Violation|1|||
16516292|NCT02047110|40358612|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
16516293|NCT02047110|40358609|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
16516294|NCT02047110|40358610|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
16516295|NCT02047110|40358611|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
16516296|NCT02047110|40358612|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
16516297|NCT02047110|40358609|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
16516298|NCT02047110|40358610|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
16516299|NCT02047110|40358611|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
16516300|NCT02047110|40358612|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
16516301|NCT02047110|40358609|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
16516302|NCT02047110|40358610|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
16516303|NCT02047110|40358611|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
16516304|NCT02047110|40358612|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
16516305|NCT02047110|40358609|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
16516306|NCT02047110|40358610|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
16516307|NCT02047110|40358611|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
16516308|NCT02047110|40358612|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
16516309|NCT02047110|40358609|FG000|Escape Treatment Period|Adverse Event|1|||
16516310|NCT02047110|40358610|FG001|Escape Treatment Period|Adverse Event|2|||
16516311|NCT02047110|40358611|FG002|Escape Treatment Period|Adverse Event|2|||
16516312|NCT02047110|40358612|FG003|Escape Treatment Period|Adverse Event|0|||
16516313|NCT02047110|40358609|FG000|Escape Treatment Period|Other than specified|1|||
16516314|NCT02047110|40358610|FG001|Escape Treatment Period|Other than specified|2|||
16516315|NCT02047110|40358611|FG002|Escape Treatment Period|Other than specified|0|||
16516316|NCT02047110|40358612|FG003|Escape Treatment Period|Other than specified|1|||
16516317|NCT02047110|40358609|FG000|OLE Treatment Period|Other than specified|0|||
16516318|NCT02047110|40358610|FG001|OLE Treatment Period|Other than specified|0|||
16516319|NCT02047110|40358611|FG002|OLE Treatment Period|Other than specified|1|||
16516320|NCT02047110|40358612|FG003|OLE Treatment Period|Other than specified|0|||
16516321|NCT02178475|40358616|FG000|Overall Study|Withdrawal by Subject|7|||
16516322|NCT02178475|40358616|FG000|Overall Study|Lost to Follow-up|10|||
16516323|NCT02178475|40358616|FG000|Overall Study|Death|13|||
16516324|NCT02178475|40358616|FG000|Overall Study|Protocol-specified Criteria|99|||
16516325|NCT00958776|40358617|FG000|Overall Study|Adverse Event|0|||
16516326|NCT00958776|40358618|FG001|Overall Study|Adverse Event|1|||
16516327|NCT00958776|40358617|FG000|Overall Study|Physician Decision|1|||
16516328|NCT00958776|40358618|FG001|Overall Study|Physician Decision|0|||
16516329|NCT00958776|40358617|FG000|Overall Study|Lost to Follow-up|2|||
16516330|NCT00958776|40358618|FG001|Overall Study|Lost to Follow-up|6|||
16516331|NCT00958776|40358617|FG000|Overall Study|Withdrawal by Subject|7|||
16516332|NCT00958776|40358618|FG001|Overall Study|Withdrawal by Subject|16|||
16516333|NCT00958776|40358617|FG000|Overall Study|Protocol Violation|1|||
16516334|NCT00958776|40358618|FG001|Overall Study|Protocol Violation|1|||
16516335|NCT00958776|40358617|FG000|Overall Study|Death|2|||
16516336|NCT00958776|40358618|FG001|Overall Study|Death|1|||
16516337|NCT00958776|40358617|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
16516338|NCT00958776|40358618|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
16516339|NCT00958776|40358617|FG000|Overall Study|Missing|1|||
16516340|NCT00958776|40358618|FG001|Overall Study|Missing|1|||
16516341|NCT05009251|40358619|FG000|Overall Study|Protocol Violation|100|||
16516342|NCT05009251|40358620|FG001|Overall Study|Protocol Violation|105|||
16516343|NCT05009251|40358621|FG002|Overall Study|Protocol Violation|119|||
16516344|NCT05009251|40358622|FG003|Overall Study|Protocol Violation|120|||
16516345|NCT05009251|40358623|FG004|Overall Study|Protocol Violation|119|||
16516346|NCT05009251|40358619|FG000|Overall Study|Death|25|||
16516347|NCT05009251|40358620|FG001|Overall Study|Death|22|||
16516348|NCT05009251|40358621|FG002|Overall Study|Death|24|||
16516349|NCT05009251|40358622|FG003|Overall Study|Death|19|||
16516350|NCT05009251|40358623|FG004|Overall Study|Death|15|||
16516351|NCT02953821|40358624|FG000|Overall Study|Adverse Event|0|||
16516352|NCT02953821|40358625|FG001|Overall Study|Adverse Event|4|||
16516353|NCT02953821|40358624|FG000|Overall Study|Death|1|||
16516354|NCT02953821|40358625|FG001|Overall Study|Death|0|||
16516355|NCT02953821|40358624|FG000|Overall Study|Progressive Disease|5|||
16516356|NCT02953821|40358625|FG001|Overall Study|Progressive Disease|1|||
16516357|NCT02953821|40358624|FG000|Overall Study|Lost to Follow-up|2|||
16516358|NCT02953821|40358625|FG001|Overall Study|Lost to Follow-up|0|||
16516359|NCT02953821|40358624|FG000|Overall Study|Physician Decision|1|||
16516360|NCT02953821|40358625|FG001|Overall Study|Physician Decision|1|||
16516361|NCT02953821|40358624|FG000|Overall Study|Withdrawal by Subject|3|||
16516362|NCT02953821|40358625|FG001|Overall Study|Withdrawal by Subject|3|||
16516363|NCT02953821|40358624|FG000|Overall Study|Change of address|0|||
16516364|NCT02953821|40358625|FG001|Overall Study|Change of address|1|||
16516365|NCT02953821|40358624|FG000|Overall Study|Lack of Efficacy|1|||
16516366|NCT02953821|40358625|FG001|Overall Study|Lack of Efficacy|0|||
16516367|NCT02953821|40358624|FG000|Overall Study|Out of state for indeterminate time|0|||
16516368|NCT02953821|40358625|FG001|Overall Study|Out of state for indeterminate time|1|||
16516369|NCT02953821|40358624|FG000|Overall Study|No improvement|0|||
16516370|NCT02953821|40358625|FG001|Overall Study|No improvement|1|||
16516371|NCT02953821|40358624|FG000|Overall Study|Refused follow-up visit|2|||
16516372|NCT02953821|40358625|FG001|Overall Study|Refused follow-up visit|1|||
16516373|NCT02778204|40358626|FG000|Overall Study|Adverse Event|1|||
16516374|NCT02778204|40358627|FG001|Overall Study|Adverse Event|0|||
16516375|NCT02778204|40358628|FG002|Overall Study|Adverse Event|0|||
16516376|NCT02778204|40358629|FG003|Overall Study|Adverse Event|0|||
16516377|NCT02778204|40358626|FG000|Overall Study|Withdrawal by Subject|0|||
16516378|NCT02778204|40358627|FG001|Overall Study|Withdrawal by Subject|0|||
16516379|NCT02778204|40358628|FG002|Overall Study|Withdrawal by Subject|1|||
16516380|NCT02778204|40358629|FG003|Overall Study|Withdrawal by Subject|2|||
16516381|NCT02778204|40358626|FG000|Overall Study|Lost to Follow-up|1|||
16516382|NCT02778204|40358627|FG001|Overall Study|Lost to Follow-up|0|||
16516383|NCT02778204|40358628|FG002|Overall Study|Lost to Follow-up|2|||
16091184|NCT02165202|38823681|FG000|Oral Phase|Refused further participation|5|||
16091185|NCT02165202|38823682|FG001|Oral Phase|Refused further participation|1|||
16091186|NCT02165202|38823681|FG000|Oral Phase|Study product Related Toxicity|1|||
16091187|NCT02165202|38823682|FG001|Oral Phase|Study product Related Toxicity|0|||
16516384|NCT02778204|40358629|FG003|Overall Study|Lost to Follow-up|1|||
16091188|NCT02165202|38823681|FG000|Oral Phase|Unable to contact Participant|1|||
16091189|NCT02165202|38823682|FG001|Oral Phase|Unable to contact Participant|1|||
16091190|NCT02165202|38823681|FG000|Oral Phase|Clinical reasons|1|||
16091191|NCT02165202|38823682|FG001|Oral Phase|Clinical reasons|0|||
16091192|NCT02165202|38823681|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
16091193|NCT02165202|38823682|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
16091194|NCT02165202|38823681|FG000|Oral Phase|CMC advised termination|1|||
16091195|NCT02165202|38823682|FG001|Oral Phase|CMC advised termination|0|||
16091196|NCT02165202|38823681|FG000|Oral Phase|Relocated, no follow-up planned|1|||
16091197|NCT02165202|38823682|FG001|Oral Phase|Relocated, no follow-up planned|0|||
16091198|NCT02165202|38823681|FG000|Oral Phase|Abnormal EKG|0|||
16091199|NCT02165202|38823682|FG001|Oral Phase|Abnormal EKG|1|||
16091200|NCT02165202|38823681|FG000|Injection Phase|Abnormal Lab Value|5|||
16091201|NCT02165202|38823682|FG001|Injection Phase|Abnormal Lab Value|1|||
16091202|NCT02165202|38823681|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
16091203|NCT02165202|38823682|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
16091204|NCT02165202|38823681|FG000|Injection Phase|Unable to attend within Visit Window|1|||
16091205|NCT02165202|38823682|FG001|Injection Phase|Unable to attend within Visit Window|0|||
16091206|NCT02165202|38823681|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
16091207|NCT02165202|38823682|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
16091208|NCT02165202|38823681|FG000|Injection Phase|End of Study|2|||
16091209|NCT02165202|38823682|FG001|Injection Phase|End of Study|1|||
16091210|NCT02165202|38823681|FG000|Injection Phase|Study Product related Toxicity|1|||
16091211|NCT02165202|38823682|FG001|Injection Phase|Study Product related Toxicity|0|||
16091212|NCT02165202|38823681|FG000|Injection Phase|No longer interested|0|||
16091213|NCT02165202|38823682|FG001|Injection Phase|No longer interested|1|||
16091214|NCT02165202|38823681|FG000|Injection Phase|Participant unwilling to comply|1|||
16091215|NCT02165202|38823682|FG001|Injection Phase|Participant unwilling to comply|0|||
16091216|NCT05445557|38823683|FG000|Double Blind Part|Lost to Follow-up|1|||
16091217|NCT02268851|38823684|FG000|Overall Study|Death|0|||
16091218|NCT02268851|38823685|FG001|Overall Study|Death|0|||
16091219|NCT02268851|38823686|FG002|Overall Study|Death|0|||
16091220|NCT02268851|38823687|FG003|Overall Study|Death|1|||
16091221|NCT02268851|38823688|FG004|Overall Study|Death|2|||
16091222|NCT02268851|38823689|FG005|Overall Study|Death|1|||
16091223|NCT02268851|38823684|FG000|Overall Study|Adverse Event|0|||
16516385|NCT02778204|40358626|FG000|Overall Study|Protocol Violation|0|||
16091224|NCT02268851|38823685|FG001|Overall Study|Adverse Event|0|||
16091225|NCT02268851|38823686|FG002|Overall Study|Adverse Event|0|||
16091226|NCT02268851|38823687|FG003|Overall Study|Adverse Event|0|||
16091227|NCT02268851|38823688|FG004|Overall Study|Adverse Event|2|||
16091228|NCT02268851|38823689|FG005|Overall Study|Adverse Event|2|||
16091229|NCT02268851|38823684|FG000|Overall Study|Withdrawal by Subject|0|||
16091230|NCT02268851|38823685|FG001|Overall Study|Withdrawal by Subject|0|||
16091231|NCT02268851|38823686|FG002|Overall Study|Withdrawal by Subject|0|||
16091232|NCT02268851|38823687|FG003|Overall Study|Withdrawal by Subject|2|||
16091233|NCT02268851|38823688|FG004|Overall Study|Withdrawal by Subject|0|||
16091234|NCT02268851|38823689|FG005|Overall Study|Withdrawal by Subject|1|||
16516386|NCT02778204|40358627|FG001|Overall Study|Protocol Violation|0|||
16516387|NCT02778204|40358628|FG002|Overall Study|Protocol Violation|1|||
16516388|NCT02778204|40358629|FG003|Overall Study|Protocol Violation|0|||
16321383|NCT03164564|39663917|FG001|Overall Study|Withdrawal by Subject|15|||
16321384|NCT03164564|39663916|FG000|Overall Study|Lost to Follow-up|2|||
16321385|NCT03164564|39663917|FG001|Overall Study|Lost to Follow-up|0|||
16321386|NCT03164564|39663916|FG000|Overall Study|Physician Decision|0|||
16321387|NCT03164564|39663917|FG001|Overall Study|Physician Decision|1|||
16321388|NCT03164564|39663916|FG000|Overall Study|Adverse Event|0|||
16321389|NCT03164564|39663917|FG001|Overall Study|Adverse Event|1|||
16321390|NCT03164564|39663916|FG000|Overall Study|Ongoing|1586|||
16321391|NCT03164564|39663917|FG001|Overall Study|Ongoing|1586|||
16321392|NCT02111577|39663918|FG000|Overall Study|Protocol Violation|2|||
16321393|NCT02111577|39663919|FG001|Overall Study|Protocol Violation|0|||
16321394|NCT02111577|39663918|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
16516389|NCT02778204|40358626|FG000|Overall Study|Eligibility Violation|0|||
16516390|NCT02778204|40358627|FG001|Overall Study|Eligibility Violation|0|||
16516391|NCT02778204|40358628|FG002|Overall Study|Eligibility Violation|0|||
16516392|NCT02778204|40358629|FG003|Overall Study|Eligibility Violation|1|||
16516393|NCT04497987|40358633|FG000|Overall Study|Adverse Event|1|||
16516394|NCT04497987|40358634|FG001|Overall Study|Adverse Event|0|||
16516395|NCT04497987|40358633|FG000|Overall Study|Death|21|||
16516396|NCT04497987|40358634|FG001|Overall Study|Death|13|||
16516397|NCT04497987|40358633|FG000|Overall Study|Lost to Follow-up|19|||
16516398|NCT04497987|40358634|FG001|Overall Study|Lost to Follow-up|17|||
16516399|NCT04497987|40358633|FG000|Overall Study|Other - as reported by the investigator|22|||
16516400|NCT04497987|40358634|FG001|Overall Study|Other - as reported by the investigator|16|||
16516401|NCT04497987|40358633|FG000|Overall Study|Physician Decision|1|||
16516402|NCT04497987|40358634|FG001|Overall Study|Physician Decision|0|||
16516403|NCT04497987|40358633|FG000|Overall Study|Withdrawal by Subject|35|||
16516404|NCT04497987|40358634|FG001|Overall Study|Withdrawal by Subject|21|||
16516405|NCT03149328|40358636|FG000|Overall Study|Withdrawal by Subject|30|||
16091235|NCT02268851|38823684|FG000|Overall Study|Progressive Disease|1|||
16091236|NCT02268851|38823685|FG001|Overall Study|Progressive Disease|3|||
16091237|NCT02268851|38823686|FG002|Overall Study|Progressive Disease|0|||
16091238|NCT02268851|38823687|FG003|Overall Study|Progressive Disease|0|||
16091239|NCT02268851|38823688|FG004|Overall Study|Progressive Disease|1|||
16091240|NCT02268851|38823689|FG005|Overall Study|Progressive Disease|4|||
16091241|NCT02268851|38823684|FG000|Overall Study|Physician Decision|0|||
16091242|NCT02268851|38823685|FG001|Overall Study|Physician Decision|0|||
16091243|NCT02268851|38823686|FG002|Overall Study|Physician Decision|1|||
16091244|NCT02268851|38823687|FG003|Overall Study|Physician Decision|0|||
16091245|NCT02268851|38823688|FG004|Overall Study|Physician Decision|0|||
16091246|NCT02268851|38823689|FG005|Overall Study|Physician Decision|1|||
16091247|NCT02268851|38823684|FG000|Overall Study|Patient Compliance|0|||
16091248|NCT02268851|38823685|FG001|Overall Study|Patient Compliance|0|||
16091249|NCT02268851|38823686|FG002|Overall Study|Patient Compliance|0|||
16091250|NCT02268851|38823687|FG003|Overall Study|Patient Compliance|0|||
16091251|NCT02268851|38823688|FG004|Overall Study|Patient Compliance|1|||
16091252|NCT02268851|38823689|FG005|Overall Study|Patient Compliance|1|||
16091253|NCT02268851|38823684|FG000|Overall Study|Co-Morbid Condition|0|||
16091254|NCT02268851|38823685|FG001|Overall Study|Co-Morbid Condition|0|||
16091255|NCT02268851|38823686|FG002|Overall Study|Co-Morbid Condition|0|||
16091256|NCT02268851|38823687|FG003|Overall Study|Co-Morbid Condition|0|||
16091257|NCT02268851|38823688|FG004|Overall Study|Co-Morbid Condition|1|||
16091258|NCT02268851|38823689|FG005|Overall Study|Co-Morbid Condition|1|||
16091259|NCT03142932|38826722|FG000|Overall Study|Lost to Follow-up|2|||
16091260|NCT03142932|38826723|FG001|Overall Study|Lost to Follow-up|11|||
16091261|NCT02009865|38826724|FG000|Overall Study|Adverse Event|0|||
16091262|NCT02009865|38826725|FG001|Overall Study|Adverse Event|2|||
16091263|NCT02009865|38826724|FG000|Overall Study|Protocol Violation|0|||
16091264|NCT02009865|38826725|FG001|Overall Study|Protocol Violation|2|||
16091265|NCT02009865|38826724|FG000|Overall Study|Withdrawal by Subject|1|||
16202589|NCT01337167|39218905|FG001|Infant Series|Physician Decision|1|||
16202590|NCT01337167|39218904|FG000|Infant Series|Protocol Violation|22|||
16202591|NCT01337167|39218905|FG001|Infant Series|Protocol Violation|9|||
16321395|NCT02111577|39663919|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
16321396|NCT02111577|39663918|FG000|Overall Study|Failure to produce study treatment|6|||
16321397|NCT02111577|39663919|FG001|Overall Study|Failure to produce study treatment|0|||
16516406|NCT03149328|40358637|FG001|Overall Study|Withdrawal by Subject|26|||
16516407|NCT03149328|40358636|FG000|Overall Study|Changed Dialysis Modality|18|||
16516408|NCT03149328|40358637|FG001|Overall Study|Changed Dialysis Modality|1|||
16516409|NCT03149328|40358636|FG000|Overall Study|Transplant|9|||
16516410|NCT03149328|40358637|FG001|Overall Study|Transplant|1|||
16091266|NCT02009865|38826725|FG001|Overall Study|Withdrawal by Subject|1|||
16091267|NCT01381549|38826726|FG000|Overall Study|Ineligible: No organisms isolated|0|||
16091268|NCT01381549|38826727|FG001|Overall Study|Ineligible: No organisms isolated|0|||
16091269|NCT01381549|38826728|FG002|Overall Study|Ineligible: No organisms isolated|1|||
16202592|NCT01337167|39218904|FG000|Infant Series|Withdrawal by Subject|15|||
16516411|NCT03149328|40358636|FG000|Overall Study|Lost to Follow-up|25|||
16516412|NCT03149328|40358637|FG001|Overall Study|Lost to Follow-up|16|||
16516413|NCT03149328|40358636|FG000|Overall Study|Left Study Site|1|||
16516414|NCT03149328|40358637|FG001|Overall Study|Left Study Site|2|||
16516415|NCT03149328|40358636|FG000|Overall Study|Language Barrier|1|||
16516416|NCT03149328|40358637|FG001|Overall Study|Language Barrier|0|||
16516417|NCT00355238|40358640|FG000|Overall Study|Adverse event unrelated to study drug|2|||
16516418|NCT00355238|40358641|FG001|Overall Study|Adverse event unrelated to study drug|2|||
16516419|NCT00355238|40358642|FG002|Overall Study|Adverse event unrelated to study drug|0|||
16516420|NCT00355238|40358643|FG003|Overall Study|Adverse event unrelated to study drug|1|||
16516421|NCT00355238|40358640|FG000|Overall Study|Death|1|||
16516422|NCT00355238|40358641|FG001|Overall Study|Death|0|||
16516423|NCT00355238|40358642|FG002|Overall Study|Death|0|||
16516424|NCT00355238|40358643|FG003|Overall Study|Death|0|||
16516425|NCT00355238|40358640|FG000|Overall Study|Disease progression|37|||
16516426|NCT00355238|40358641|FG001|Overall Study|Disease progression|36|||
16091270|NCT00824850|38826729|FG000|Overall Study|Withdrawal by Subject|0|||
16091271|NCT00824850|38826730|FG001|Overall Study|Withdrawal by Subject|1|||
16091272|NCT00439218|38826731|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
16091273|NCT02981953|38826732|FG000|Overall Study|Death|9|||
16091274|NCT02981953|38826732|FG000|Overall Study|Withdrawal by Subject|1|||
16091275|NCT02981953|38826732|FG000|Overall Study|Withdrawal to non-compliance|1|||
16091276|NCT02309892|38826733|FG000|Overall Study|Physician Decision|1|||
16091277|NCT02309892|38826734|FG001|Overall Study|Physician Decision|0|||
16091278|NCT02309892|38826735|FG002|Overall Study|Physician Decision|0|||
16091279|NCT02309892|38826736|FG003|Overall Study|Physician Decision|0|||
16091280|NCT02309892|38826737|FG004|Overall Study|Physician Decision|0|||
16091281|NCT02309892|38826738|FG005|Overall Study|Physician Decision|0|||
16091282|NCT02309892|38826739|FG006|Overall Study|Physician Decision|0|||
16091283|NCT02309892|38826733|FG000|Overall Study|Adverse Event|1|||
16091284|NCT02309892|38826734|FG001|Overall Study|Adverse Event|0|||
16091285|NCT02309892|38826735|FG002|Overall Study|Adverse Event|1|||
16091286|NCT02309892|38826736|FG003|Overall Study|Adverse Event|0|||
16516427|NCT00355238|40358642|FG002|Overall Study|Disease progression|16|||
16516428|NCT00355238|40358643|FG003|Overall Study|Disease progression|11|||
16516429|NCT00355238|40358640|FG000|Overall Study|Study drug toxicity|11|||
16516430|NCT00355238|40358641|FG001|Overall Study|Study drug toxicity|7|||
16516431|NCT00355238|40358642|FG002|Overall Study|Study drug toxicity|5|||
16516432|NCT00355238|40358643|FG003|Overall Study|Study drug toxicity|2|||
16516433|NCT00355238|40358640|FG000|Overall Study|Participant withdrew consent|3|||
16516434|NCT00355238|40358641|FG001|Overall Study|Participant withdrew consent|1|||
16516435|NCT00355238|40358642|FG002|Overall Study|Participant withdrew consent|0|||
16516436|NCT00355238|40358643|FG003|Overall Study|Participant withdrew consent|0|||
16516437|NCT00355238|40358640|FG000|Overall Study|Participant request to discontinue study treatment|1|||
16516438|NCT00355238|40358641|FG001|Overall Study|Participant request to discontinue study treatment|0|||
16516439|NCT00355238|40358642|FG002|Overall Study|Participant request to discontinue study treatment|1|||
16516440|NCT00355238|40358643|FG003|Overall Study|Participant request to discontinue study treatment|0|||
16516441|NCT01797536|40358644|FG000|Overall Study|Adverse Event|0|||
16516442|NCT01797536|40358645|FG001|Overall Study|Adverse Event|1|||
16516443|NCT01797536|40358646|FG002|Overall Study|Adverse Event|0|||
16516444|NCT01797536|40358647|FG003|Overall Study|Adverse Event|0|||
16516445|NCT01978184|40358648|FG000|Overall Study|Progressive disease|5|||
16516446|NCT01978184|40358649|FG001|Overall Study|Progressive disease|5|||
16516447|NCT01978184|40358648|FG000|Overall Study|Other than PDA|2|||
16516448|NCT01978184|40358649|FG001|Overall Study|Other than PDA|2|||
16516449|NCT01978184|40358648|FG000|Overall Study|Physician Decision|0|||
16516450|NCT01978184|40358649|FG001|Overall Study|Physician Decision|3|||
16516451|NCT01978184|40358648|FG000|Overall Study|Noncompliance|1|||
16516452|NCT01978184|40358649|FG001|Overall Study|Noncompliance|2|||
16516453|NCT01978184|40358648|FG000|Overall Study|Death|1|||
16516454|NCT01978184|40358649|FG001|Overall Study|Death|0|||
16516455|NCT01978184|40358648|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
16091287|NCT02309892|38826737|FG004|Overall Study|Adverse Event|0|||
16091288|NCT02309892|38826738|FG005|Overall Study|Adverse Event|0|||
16091289|NCT02309892|38826739|FG006|Overall Study|Adverse Event|0|||
16516456|NCT01978184|40358649|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
16516457|NCT01782313|40358650|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
16516458|NCT01782313|40358650|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
16394958|NCT01262638|39928112|FG000|Overall Study|Withdrawal by Subject|2|||
16394959|NCT01262638|39928113|FG001|Overall Study|Withdrawal by Subject|1|||
16394960|NCT01262638|39928114|FG002|Overall Study|Withdrawal by Subject|0|||
16394961|NCT01262638|39928115|FG003|Overall Study|Withdrawal by Subject|1|||
16394962|NCT01262638|39928112|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
16394963|NCT01262638|39928113|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
16394964|NCT01262638|39928114|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
16394965|NCT01262638|39928115|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
16394966|NCT01262638|39928112|FG000|Overall Study|Lost to Follow-up|1|||
16394967|NCT01262638|39928113|FG001|Overall Study|Lost to Follow-up|1|||
16394968|NCT01262638|39928114|FG002|Overall Study|Lost to Follow-up|1|||
16394969|NCT01262638|39928115|FG003|Overall Study|Lost to Follow-up|1|||
16394970|NCT01262638|39928112|FG000|Overall Study|Participant Went Out of Town|0|||
16394971|NCT01262638|39928113|FG001|Overall Study|Participant Went Out of Town|0|||
16394972|NCT01262638|39928114|FG002|Overall Study|Participant Went Out of Town|1|||
16394973|NCT01262638|39928115|FG003|Overall Study|Participant Went Out of Town|0|||
16394974|NCT00269113|39928118|FG000|Overall Study|Adverse Event|14|||
16394975|NCT00269113|39928119|FG001|Overall Study|Adverse Event|7|||
16394976|NCT00269113|39928118|FG000|Overall Study|Lack of Efficacy|35|||
16394977|NCT00269113|39928119|FG001|Overall Study|Lack of Efficacy|18|||
16394978|NCT00269113|39928118|FG000|Overall Study|Early Improvement|2|||
16394979|NCT00269113|39928119|FG001|Overall Study|Early Improvement|0|||
16394980|NCT00269113|39928118|FG000|Overall Study|Withdrawal by Subject|0|||
16394981|NCT00269113|39928119|FG001|Overall Study|Withdrawal by Subject|2|||
16394982|NCT00269113|39928118|FG000|Overall Study|Death|6|||
16394983|NCT00269113|39928119|FG001|Overall Study|Death|2|||
16394984|NCT00269113|39928118|FG000|Overall Study|Lost to Follow-up|2|||
16394985|NCT00269113|39928119|FG001|Overall Study|Lost to Follow-up|1|||
16394986|NCT00269113|39928118|FG000|Overall Study|Protocol Violation|15|||
16394987|NCT00269113|39928119|FG001|Overall Study|Protocol Violation|5|||
16394988|NCT00269113|39928118|FG000|Overall Study|Other|0|||
16394989|NCT00269113|39928119|FG001|Overall Study|Other|2|||
16394990|NCT02595866|39928120|FG000|Overall Study|Adverse Event|2|||
16394991|NCT02595866|39928121|FG001|Overall Study|Adverse Event|5|||
16394992|NCT02595866|39928120|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
16394993|NCT02595866|39928121|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
16394994|NCT02595866|39928120|FG000|Overall Study|Death|0|||
16394995|NCT02595866|39928121|FG001|Overall Study|Death|1|||
16394996|NCT02595866|39928120|FG000|Overall Study|Incarceration|1|||
16394997|NCT02595866|39928121|FG001|Overall Study|Incarceration|0|||
16394998|NCT02595866|39928120|FG000|Overall Study|Lack of Efficacy|17|||
16394999|NCT02595866|39928121|FG001|Overall Study|Lack of Efficacy|7|||
16395000|NCT02595866|39928120|FG000|Overall Study|Physician Decision|4|||
16395001|NCT02595866|39928121|FG001|Overall Study|Physician Decision|3|||
16395002|NCT02595866|39928120|FG000|Overall Study|Switched to Alternative Treatment|1|||
16395003|NCT02595866|39928121|FG001|Overall Study|Switched to Alternative Treatment|0|||
16395004|NCT02595866|39928120|FG000|Overall Study|Study Terminated|0|||
16395005|NCT02595866|39928121|FG001|Overall Study|Study Terminated|4|||
16395006|NCT02595866|39928120|FG000|Overall Study|Withdrawal by Subject|6|||
16395007|NCT02595866|39928121|FG001|Overall Study|Withdrawal by Subject|1|||
16395008|NCT00770562|39928122|FG000|Overall Study|Did not take treatment|1|||
16395009|NCT00770562|39928123|FG001|Overall Study|Did not take treatment|1|||
16395010|NCT01803880|39928125|FG000|Overall Study|Adverse Event|1|||
16395011|NCT01803880|39928126|FG001|Overall Study|Adverse Event|0|||
16395012|NCT01803880|39928127|FG002|Overall Study|Adverse Event|0|||
16395013|NCT01803880|39928125|FG000|Overall Study|Withdrawal by Subject|1|||
16395014|NCT01803880|39928126|FG001|Overall Study|Withdrawal by Subject|1|||
16395015|NCT01803880|39928127|FG002|Overall Study|Withdrawal by Subject|4|||
16395016|NCT01803880|39928125|FG000|Overall Study|Physician Decision|0|||
16395017|NCT01803880|39928126|FG001|Overall Study|Physician Decision|0|||
16395018|NCT01803880|39928127|FG002|Overall Study|Physician Decision|1|||
16395019|NCT01803880|39928125|FG000|Overall Study|Unable to return for follow-up visits|0|||
16395020|NCT01803880|39928126|FG001|Overall Study|Unable to return for follow-up visits|1|||
16395021|NCT01803880|39928127|FG002|Overall Study|Unable to return for follow-up visits|2|||
16395022|NCT01803880|39928125|FG000|Overall Study|Lost to Follow-up|1|||
16395023|NCT01803880|39928126|FG001|Overall Study|Lost to Follow-up|2|||
16395024|NCT01803880|39928127|FG002|Overall Study|Lost to Follow-up|3|||
16395025|NCT01803880|39928125|FG000|Overall Study|Protocol Violation|1|||
16395026|NCT01803880|39928126|FG001|Overall Study|Protocol Violation|0|||
16395027|NCT01803880|39928127|FG002|Overall Study|Protocol Violation|0|||
16395028|NCT01803880|39928125|FG000|Overall Study|Early study termination|0|||
16395029|NCT01803880|39928126|FG001|Overall Study|Early study termination|6|||
16395030|NCT01803880|39928127|FG002|Overall Study|Early study termination|5|||
16395031|NCT01803880|39928125|FG000|Overall Study|Incomplete data entry by sites|2|||
16395032|NCT01803880|39928126|FG001|Overall Study|Incomplete data entry by sites|0|||
16395033|NCT01803880|39928127|FG002|Overall Study|Incomplete data entry by sites|0|||
16395034|NCT01048242|39928136|FG000|Overall Study|See study flow chart|4|||
16395035|NCT01048242|39928137|FG001|Overall Study|See study flow chart|2|||
16395036|NCT01823198|39928138|FG000|Overall Study|Physician Decision|0|||
16395037|NCT01823198|39928139|FG001|Overall Study|Physician Decision|1|||
16395038|NCT01823198|39928140|FG002|Overall Study|Physician Decision|0|||
16395039|NCT01823198|39928141|FG003|Overall Study|Physician Decision|0|||
16395040|NCT01823198|39928142|FG004|Overall Study|Physician Decision|0|||
16395041|NCT01823198|39928143|FG005|Overall Study|Physician Decision|3|||
16395042|NCT01823198|39928144|FG006|Overall Study|Physician Decision|3|||
16395043|NCT01667133|39928145|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
16395044|NCT01667133|39928146|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
16395045|NCT01667133|39928147|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
16395046|NCT01667133|39928148|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
16395047|NCT01667133|39928149|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
16395048|NCT01667133|39928150|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
16395049|NCT01667133|39928151|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
16395050|NCT01667133|39928152|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
16395051|NCT01667133|39928153|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
16395052|NCT01667133|39928154|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
16395053|NCT01667133|39928155|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
16395054|NCT01667133|39928156|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
16395055|NCT01667133|39928145|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16395056|NCT01667133|39928146|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16395057|NCT01667133|39928147|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
16395058|NCT01667133|39928148|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16395059|NCT01667133|39928149|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16395060|NCT01667133|39928150|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16395061|NCT01667133|39928151|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16395062|NCT01667133|39928152|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16395063|NCT01667133|39928153|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16395064|NCT01667133|39928154|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16395065|NCT01667133|39928155|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16516459|NCT01782313|40358650|FG000|Treated Cycle 3|Progressive Disease|21|||
16516460|NCT01782313|40358650|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
16516461|NCT01782313|40358650|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
16516462|NCT01782313|40358650|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
16395066|NCT01667133|39928156|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
16395067|NCT01667133|39928145|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
16395068|NCT01667133|39928146|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
16395069|NCT01667133|39928147|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
16395070|NCT01667133|39928148|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
16395071|NCT01667133|39928149|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
16395072|NCT01667133|39928150|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
16395073|NCT01667133|39928151|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
16395074|NCT01667133|39928152|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
16395075|NCT01667133|39928153|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
16395076|NCT01667133|39928154|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
16395077|NCT01667133|39928155|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
16395078|NCT01667133|39928156|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
16395079|NCT01667133|39928145|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395080|NCT01667133|39928146|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395081|NCT01667133|39928147|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395082|NCT01667133|39928148|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
16395083|NCT01667133|39928149|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395084|NCT01667133|39928150|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395085|NCT01667133|39928151|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395086|NCT01667133|39928152|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395087|NCT01667133|39928153|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395088|NCT01667133|39928154|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395089|NCT01667133|39928155|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395090|NCT01667133|39928156|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
16395091|NCT01667133|39928145|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
16516463|NCT01782313|40358650|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
16516464|NCT01782313|40358650|FG000|Survival Follow up|Lost to Follow-up|1|||
16516465|NCT00577122|40358654|FG000|Overall Study|Adverse Event|0|||
16516466|NCT00577122|40358655|FG001|Overall Study|Adverse Event|2|||
16516467|NCT00577122|40358654|FG000|Overall Study|Progression, relapse during active trt|6|||
16516468|NCT00577122|40358655|FG001|Overall Study|Progression, relapse during active trt|8|||
16516469|NCT00577122|40358654|FG000|Overall Study|Prog, refract disease during active trt|8|||
16395092|NCT01667133|39928146|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
16516470|NCT00577122|40358655|FG001|Overall Study|Prog, refract disease during active trt|5|||
16516471|NCT00577122|40358654|FG000|Overall Study|Alternative Therapy|0|||
16516472|NCT00577122|40358655|FG001|Overall Study|Alternative Therapy|1|||
16516473|NCT02177266|40358656|FG000|Overall Study|Adverse Event|0|||
16516474|NCT02177266|40358657|FG001|Overall Study|Adverse Event|1|||
16516475|NCT02177266|40358656|FG000|Overall Study|Withdrawal by Subject|1|||
16516476|NCT02177266|40358657|FG001|Overall Study|Withdrawal by Subject|0|||
16516477|NCT01140477|40358663|FG000|Overall Study|Lost to Follow-up|4|||
16516478|NCT01140477|40358664|FG001|Overall Study|Lost to Follow-up|0|||
16516479|NCT01140477|40358663|FG000|Overall Study|Withdrawal by Subject|1|||
16516480|NCT01140477|40358664|FG001|Overall Study|Withdrawal by Subject|4|||
16516481|NCT01140477|40358663|FG000|Overall Study|Surgical complication preventing implant|2|||
16516482|NCT01140477|40358664|FG001|Overall Study|Surgical complication preventing implant|0|||
16516483|NCT01140477|40358663|FG000|Overall Study|Death|1|||
16516484|NCT01140477|40358664|FG001|Overall Study|Death|1|||
16516485|NCT01140477|40358663|FG000|Overall Study|Subject explanted|0|||
16516486|NCT01140477|40358664|FG001|Overall Study|Subject explanted|1|||
16516487|NCT01866709|40358666|FG000|Overall Study|Adverse Event|1|||
16516488|NCT01866709|40358667|FG001|Overall Study|Adverse Event|0|||
16516489|NCT00480636|40358670|FG000|Overall Study|Death|12|||
16516490|NCT00480636|40358670|FG000|Overall Study|Lost to Follow-up|4|||
16516491|NCT00480636|40358670|FG000|Overall Study|Other|2|||
16516492|NCT00480636|40358670|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
16516493|NCT01577758|40358676|FG000|Dose Escalation Phase|Adverse Event|0|||
16516494|NCT01577758|40358677|FG001|Dose Escalation Phase|Adverse Event|0|||
16516495|NCT01577758|40358678|FG002|Dose Escalation Phase|Adverse Event|0|||
16516496|NCT01577758|40358679|FG003|Dose Escalation Phase|Adverse Event|0|||
16516497|NCT01577758|40358680|FG004|Dose Escalation Phase|Adverse Event|0|||
16516498|NCT01577758|40358681|FG005|Dose Escalation Phase|Adverse Event|2|||
16516499|NCT01577758|40358682|FG006|Dose Escalation Phase|Adverse Event|1|||
16516500|NCT01577758|40358683|FG007|Dose Escalation Phase|Adverse Event|0|||
16516501|NCT01577758|40358676|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
16516502|NCT01577758|40358677|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
16516503|NCT01577758|40358678|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
16516504|NCT01577758|40358679|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
16516505|NCT01577758|40358680|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
16516506|NCT01577758|40358681|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
16516507|NCT01577758|40358682|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
16516508|NCT01577758|40358683|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
16516509|NCT01577758|40358676|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
16516510|NCT01577758|40358677|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
16395093|NCT01667133|39928147|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
16395094|NCT01667133|39928148|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
16395095|NCT01667133|39928149|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
16395096|NCT01667133|39928150|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
16395097|NCT01667133|39928151|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
16395098|NCT01667133|39928152|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
16395099|NCT01667133|39928153|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
16395100|NCT01667133|39928154|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
16395101|NCT01667133|39928155|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
16395102|NCT01667133|39928156|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
16395103|NCT01667133|39928145|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395104|NCT01667133|39928146|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395105|NCT01667133|39928147|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395106|NCT01667133|39928148|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395107|NCT01667133|39928149|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395108|NCT01667133|39928150|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395109|NCT01667133|39928151|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395110|NCT01667133|39928152|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395111|NCT01667133|39928153|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395112|NCT01667133|39928154|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
16395113|NCT01667133|39928155|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395114|NCT01667133|39928156|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
16395115|NCT01667133|39928145|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
16395116|NCT01667133|39928146|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
16395117|NCT01667133|39928147|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
16395118|NCT01667133|39928148|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
16395119|NCT01667133|39928149|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
16516511|NCT01577758|40358678|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
16516512|NCT01577758|40358679|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16516513|NCT01577758|40358680|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
16395120|NCT01667133|39928150|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
16395121|NCT01667133|39928151|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
16395122|NCT01667133|39928152|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
16395123|NCT01667133|39928153|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
16395124|NCT01667133|39928154|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
16395125|NCT01667133|39928155|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
16395126|NCT01667133|39928156|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
16395127|NCT01667133|39928145|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16395128|NCT01667133|39928146|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16395129|NCT01667133|39928147|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16395130|NCT01667133|39928148|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16395131|NCT01667133|39928149|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16395132|NCT01667133|39928150|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16395133|NCT01667133|39928151|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16091290|NCT02309892|38826733|FG000|Overall Study|Progressive Disease|0|||
16091291|NCT02309892|38826734|FG001|Overall Study|Progressive Disease|1|||
16091292|NCT02309892|38826735|FG002|Overall Study|Progressive Disease|0|||
16091293|NCT02309892|38826736|FG003|Overall Study|Progressive Disease|0|||
16091294|NCT02309892|38826737|FG004|Overall Study|Progressive Disease|1|||
16091295|NCT02309892|38826738|FG005|Overall Study|Progressive Disease|0|||
16091296|NCT02309892|38826739|FG006|Overall Study|Progressive Disease|0|||
16395134|NCT01667133|39928152|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16395135|NCT01667133|39928153|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16395136|NCT01667133|39928154|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
16091297|NCT02309892|38826733|FG000|Overall Study|Death|0|||
16395137|NCT01667133|39928155|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16395138|NCT01667133|39928156|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
16395139|NCT01667133|39928145|FG000|Phase 2: Dose-expansion|Death|0|||
16395140|NCT01667133|39928146|FG001|Phase 2: Dose-expansion|Death|0|||
16395141|NCT01667133|39928147|FG002|Phase 2: Dose-expansion|Death|0|||
16395142|NCT01667133|39928148|FG003|Phase 2: Dose-expansion|Death|0|||
16395143|NCT01667133|39928149|FG004|Phase 2: Dose-expansion|Death|0|||
16395144|NCT01667133|39928150|FG005|Phase 2: Dose-expansion|Death|0|||
16395145|NCT01667133|39928151|FG006|Phase 2: Dose-expansion|Death|0|||
16395146|NCT01667133|39928152|FG007|Phase 2: Dose-expansion|Death|0|||
16395147|NCT01667133|39928153|FG008|Phase 2: Dose-expansion|Death|0|||
16395148|NCT01667133|39928154|FG009|Phase 2: Dose-expansion|Death|1|||
16395149|NCT01667133|39928155|FG010|Phase 2: Dose-expansion|Death|0|||
16395150|NCT01667133|39928156|FG011|Phase 2: Dose-expansion|Death|0|||
16395151|NCT01667133|39928145|FG000|Phase 2: Dose-expansion|Other|0|||
16395152|NCT01667133|39928146|FG001|Phase 2: Dose-expansion|Other|0|||
16395153|NCT01667133|39928147|FG002|Phase 2: Dose-expansion|Other|0|||
16395154|NCT01667133|39928148|FG003|Phase 2: Dose-expansion|Other|0|||
16395155|NCT01667133|39928149|FG004|Phase 2: Dose-expansion|Other|0|||
16395156|NCT01667133|39928150|FG005|Phase 2: Dose-expansion|Other|0|||
16395157|NCT01667133|39928151|FG006|Phase 2: Dose-expansion|Other|0|||
16395158|NCT01667133|39928152|FG007|Phase 2: Dose-expansion|Other|0|||
16395159|NCT01667133|39928153|FG008|Phase 2: Dose-expansion|Other|0|||
16395160|NCT01667133|39928154|FG009|Phase 2: Dose-expansion|Other|0|||
16395161|NCT01667133|39928155|FG010|Phase 2: Dose-expansion|Other|0|||
16395162|NCT01667133|39928156|FG011|Phase 2: Dose-expansion|Other|1|||
16395163|NCT02314156|39928165|FG000|Overall Study|Adverse Event|1|||
16395164|NCT02314156|39928166|FG001|Overall Study|Adverse Event|0|||
16395165|NCT02314156|39928165|FG000|Overall Study|Withdrawal by Subject|1|||
16395166|NCT02314156|39928166|FG001|Overall Study|Withdrawal by Subject|0|||
16395167|NCT03333928|39928170|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
16395168|NCT03333928|39928171|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
16395169|NCT03333928|39928172|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
16395170|NCT03333928|39928170|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
16395171|NCT03333928|39928171|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
16395172|NCT03333928|39928172|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
16395173|NCT03333928|39928170|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
16395174|NCT03333928|39928171|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
16395175|NCT03333928|39928172|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
16395176|NCT03333928|39928170|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
16395177|NCT03333928|39928171|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
16395178|NCT03333928|39928172|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
16395179|NCT03333928|39928170|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
16395180|NCT03333928|39928171|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
16395181|NCT03333928|39928172|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
16395182|NCT03333928|39928170|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
16395183|NCT03333928|39928171|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
16395184|NCT03333928|39928172|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
16395185|NCT03333928|39928170|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
16395186|NCT03333928|39928171|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
16395187|NCT03333928|39928172|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
16395188|NCT03333928|39928170|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
16395189|NCT03333928|39928171|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
16395190|NCT03333928|39928172|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
16395191|NCT03122145|39928173|FG000|Overall Study|Concurrent respiratory disease|3|||
16395192|NCT03122145|39928174|FG001|Overall Study|Concurrent respiratory disease|0|||
16395193|NCT02237001|39928175|FG000|Overall Study|Lost to Follow-up|2|||
16395194|NCT02237001|39928175|FG000|Overall Study|Withdrawal by Subject|1|||
16395195|NCT02237001|39928175|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
16395196|NCT02237001|39928175|FG000|Overall Study|Re-operation|4|||
16395197|NCT02237001|39928175|FG000|Overall Study|Incarceration|1|||
16395198|NCT01773967|39928176|FG000|Overall Study|Lost to Follow-up|15|||
16395199|NCT01773967|39928177|FG001|Overall Study|Lost to Follow-up|13|||
16395200|NCT02103062|39928178|FG000|Overall Study|Adverse Event|1|||
16395201|NCT02103062|39928179|FG001|Overall Study|Adverse Event|2|||
16395202|NCT02103062|39928178|FG000|Overall Study|Progressive Disease|17|||
16395203|NCT02103062|39928179|FG001|Overall Study|Progressive Disease|20|||
16395204|NCT02103062|39928178|FG000|Overall Study|Death|0|||
16395205|NCT02103062|39928179|FG001|Overall Study|Death|1|||
16321398|NCT02111577|39663918|FG000|Overall Study|Death|518|||
16321399|NCT02111577|39663919|FG001|Overall Study|Death|254|||
16321400|NCT02111577|39663918|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
16321401|NCT02111577|39663919|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
16321402|NCT02111577|39663918|FG000|Overall Study|Adverse Event|1|||
16321403|NCT02111577|39663919|FG001|Overall Study|Adverse Event|1|||
16321404|NCT02111577|39663918|FG000|Overall Study|Withdrawal by Subject|51|||
16321405|NCT02111577|39663919|FG001|Overall Study|Withdrawal by Subject|23|||
16321406|NCT02111577|39663918|FG000|Overall Study|Disease progression|0|||
16321407|NCT02111577|39663919|FG001|Overall Study|Disease progression|1|||
16321408|NCT02111577|39663918|FG000|Overall Study|Lost to Follow-up|19|||
16321409|NCT02111577|39663919|FG001|Overall Study|Lost to Follow-up|10|||
16321410|NCT00857896|39663922|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
16321411|NCT01827267|39663923|FG000|Overall Study|Did not receive study drug|1|||
16321412|NCT01827267|39663924|FG001|Overall Study|Did not receive study drug|1|||
16321413|NCT01827267|39663923|FG000|Overall Study|Physician Decision|1|||
16321414|NCT01827267|39663924|FG001|Overall Study|Physician Decision|0|||
16321415|NCT01827267|39663923|FG000|Overall Study|Disease Progression|1|||
16321416|NCT01827267|39663924|FG001|Overall Study|Disease Progression|1|||
16321417|NCT01827267|39663923|FG000|Overall Study|Sponsor Discontinued Study|2|||
16321418|NCT01827267|39663924|FG001|Overall Study|Sponsor Discontinued Study|8|||
16321419|NCT01827267|39663923|FG000|Overall Study|Still on study|0|||
16321420|NCT01827267|39663924|FG001|Overall Study|Still on study|2|||
16321421|NCT01166438|39663927|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
16321422|NCT01166438|39663928|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
16321423|NCT01166438|39663927|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
16321424|NCT01166438|39663928|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
16321425|NCT01166438|39663927|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
16321426|NCT01166438|39663928|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
16321427|NCT01166438|39663927|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
16321428|NCT01166438|39663928|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
16321429|NCT01166438|39663927|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
16321430|NCT01166438|39663928|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
16321431|NCT01166438|39663927|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
16321432|NCT01166438|39663928|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
16321433|NCT02411396|39663929|FG000|Overall Study|Lost to Follow-up|31|||
16321434|NCT02411396|39663929|FG000|Overall Study|Death|10|||
16321435|NCT03610737|39663930|FG000|Overall Study|Withdrawal by Subject|1|||
16321436|NCT03610737|39663931|FG001|Overall Study|Withdrawal by Subject|5|||
16321437|NCT03610737|39663930|FG000|Overall Study|Death|1|||
16321438|NCT03610737|39663931|FG001|Overall Study|Death|0|||
16321439|NCT03610737|39663930|FG000|Overall Study|Not treated|5|||
16321440|NCT03610737|39663931|FG001|Overall Study|Not treated|2|||
16321441|NCT03610737|39663930|FG000|Overall Study|Missed Visit|1|||
16321442|NCT03610737|39663931|FG001|Overall Study|Missed Visit|2|||
16321443|NCT02844543|39663932|FG000|Overall Study|Withdrawal by Subject|4|||
16321444|NCT02844543|39663932|FG000|Overall Study|Did not meet eligibility criteria|1|||
16321445|NCT04740827|39663933|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
16321446|NCT04740827|39663934|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
16321447|NCT04740827|39663933|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
16321448|NCT04740827|39663934|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
16321449|NCT04740827|39663933|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
16321450|NCT04740827|39663934|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
16321451|NCT04740827|39663933|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
16321452|NCT04740827|39663934|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
16321453|NCT04740827|39663933|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
16321454|NCT04740827|39663934|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
16321455|NCT04740827|39663933|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
16321456|NCT04740827|39663934|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
16321457|NCT02035202|39663935|FG000|Overall Study|Lost to Follow-up|8|||
16321458|NCT02035202|39663936|FG001|Overall Study|Lost to Follow-up|16|||
16321459|NCT02035202|39663937|FG002|Overall Study|Lost to Follow-up|2|||
16321460|NCT00712543|39663938|FG000|Day 8-14|Lost to Follow-up|0|||
16321461|NCT00712543|39663939|FG001|Day 8-14|Lost to Follow-up|2|||
16091298|NCT02309892|38826734|FG001|Overall Study|Death|0|||
16091299|NCT02309892|38826735|FG002|Overall Study|Death|0|||
16091300|NCT02309892|38826736|FG003|Overall Study|Death|0|||
16091301|NCT02309892|38826737|FG004|Overall Study|Death|0|||
16091302|NCT02309892|38826738|FG005|Overall Study|Death|1|||
16091303|NCT02309892|38826739|FG006|Overall Study|Death|0|||
16091304|NCT01138657|38826743|FG000|Overall Study|Adverse Event|3|||
16091305|NCT01138657|38826744|FG001|Overall Study|Adverse Event|10|||
16091306|NCT01138657|38826743|FG000|Overall Study|Lack of Efficacy|2|||
16091307|NCT01138657|38826744|FG001|Overall Study|Lack of Efficacy|1|||
16091308|NCT01138657|38826743|FG000|Overall Study|Lost to Follow-up|0|||
16091309|NCT01138657|38826744|FG001|Overall Study|Lost to Follow-up|3|||
16091310|NCT01138657|38826743|FG000|Overall Study|Miscellaneous Reasons|3|||
16091311|NCT01138657|38826744|FG001|Overall Study|Miscellaneous Reasons|4|||
16091312|NCT00257556|38826750|FG000|Overall Study|Adverse Event|1|||
16091313|NCT00257556|38826751|FG001|Overall Study|Adverse Event|4|||
16091314|NCT00257556|38826750|FG000|Overall Study|Physician Decision|6|||
16091315|NCT00257556|38826751|FG001|Overall Study|Physician Decision|0|||
16091316|NCT00257556|38826750|FG000|Overall Study|Did not meet hCG criterion|3|||
16091317|NCT00257556|38826751|FG001|Overall Study|Did not meet hCG criterion|0|||
16091318|NCT00257556|38826750|FG000|Overall Study|other reason|4|||
16091319|NCT00257556|38826751|FG001|Overall Study|other reason|6|||
16091320|NCT00658632|38826752|FG000|Overall Study|Adverse Event|13|||
16091321|NCT00658632|38826753|FG001|Overall Study|Adverse Event|11|||
16091322|NCT00658632|38826752|FG000|Overall Study|Lost to Follow-up|25|||
16091323|NCT00658632|38826753|FG001|Overall Study|Lost to Follow-up|23|||
16091324|NCT00658632|38826752|FG000|Overall Study|Withdrawal by Subject|10|||
16091325|NCT00658632|38826753|FG001|Overall Study|Withdrawal by Subject|7|||
16091326|NCT00658632|38826752|FG000|Overall Study|Lack of Efficacy|0|||
16091327|NCT00658632|38826753|FG001|Overall Study|Lack of Efficacy|1|||
16091328|NCT00658632|38826752|FG000|Overall Study|Withdrawal of consent|8|||
16091329|NCT00658632|38826753|FG001|Overall Study|Withdrawal of consent|14|||
16091330|NCT00658632|38826752|FG000|Overall Study|Pregnancy|1|||
16091331|NCT00658632|38826753|FG001|Overall Study|Pregnancy|1|||
16516514|NCT01577758|40358681|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
16516515|NCT01577758|40358682|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
16516516|NCT01577758|40358683|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
16516517|NCT01577758|40358676|FG000|Dose Escalation Phase|Progression Disease|2|||
16516518|NCT01577758|40358677|FG001|Dose Escalation Phase|Progression Disease|2|||
16516519|NCT01577758|40358678|FG002|Dose Escalation Phase|Progression Disease|1|||
16516520|NCT01577758|40358679|FG003|Dose Escalation Phase|Progression Disease|2|||
16516521|NCT01577758|40358680|FG004|Dose Escalation Phase|Progression Disease|5|||
16516522|NCT01577758|40358681|FG005|Dose Escalation Phase|Progression Disease|0|||
16091332|NCT00658632|38826752|FG000|Overall Study|Other|7|||
16091333|NCT00658632|38826753|FG001|Overall Study|Other|8|||
16091334|NCT02833948|38826754|FG000|Overall Study|Death|2|||
16091335|NCT02833948|38826755|FG001|Overall Study|Death|3|||
16091336|NCT02833948|38826754|FG000|Overall Study|were not scanned|8|||
16091337|NCT02833948|38826755|FG001|Overall Study|were not scanned|13|||
16091338|NCT02833948|38826754|FG000|Overall Study|scans could not be evaluated|5|||
16091339|NCT02833948|38826755|FG001|Overall Study|scans could not be evaluated|2|||
16091340|NCT00424476|38826757|FG000|Overall Study|Withdrawal by Subject|7|||
16091341|NCT00424476|38826758|FG001|Overall Study|Withdrawal by Subject|6|||
16091342|NCT00424476|38826759|FG002|Overall Study|Withdrawal by Subject|3|||
16091343|NCT00424476|38826757|FG000|Overall Study|Adverse Event|19|||
16091344|NCT00424476|38826758|FG001|Overall Study|Adverse Event|16|||
16091345|NCT00424476|38826759|FG002|Overall Study|Adverse Event|15|||
16091346|NCT00424476|38826757|FG000|Overall Study|Lack of Efficacy|16|||
16091347|NCT00424476|38826758|FG001|Overall Study|Lack of Efficacy|12|||
16091348|NCT00424476|38826759|FG002|Overall Study|Lack of Efficacy|12|||
16091349|NCT00424476|38826757|FG000|Overall Study|Lack of Compliance|1|||
16091350|NCT00424476|38826758|FG001|Overall Study|Lack of Compliance|1|||
16091351|NCT00424476|38826759|FG002|Overall Study|Lack of Compliance|1|||
16091352|NCT00424476|38826757|FG000|Overall Study|Lost to Follow-up|4|||
16091353|NCT00424476|38826758|FG001|Overall Study|Lost to Follow-up|6|||
16091354|NCT00424476|38826759|FG002|Overall Study|Lost to Follow-up|3|||
16091355|NCT00424476|38826757|FG000|Overall Study|Protocol Violation|7|||
16091356|NCT00424476|38826758|FG001|Overall Study|Protocol Violation|2|||
16091357|NCT00424476|38826759|FG002|Overall Study|Protocol Violation|3|||
16091358|NCT00424476|38826757|FG000|Overall Study|Physician Decision|3|||
16091359|NCT00424476|38826758|FG001|Overall Study|Physician Decision|2|||
16091360|NCT00424476|38826759|FG002|Overall Study|Physician Decision|3|||
16091361|NCT00424476|38826757|FG000|Overall Study|Other|4|||
16091362|NCT00424476|38826758|FG001|Overall Study|Other|3|||
16091363|NCT00424476|38826759|FG002|Overall Study|Other|9|||
16091364|NCT00768755|38826762|FG000|Phase 1|Death|6|||
16091365|NCT00768755|38826763|FG001|Phase 1|Death|0|||
16091366|NCT00768755|38826764|FG002|Phase 1|Death|0|||
16091367|NCT00768755|38826765|FG003|Phase 1|Death|0|||
16091368|NCT00768755|38826762|FG000|Phase 1|Other|4|||
16516523|NCT01577758|40358682|FG006|Dose Escalation Phase|Progression Disease|0|||
16395206|NCT00325130|39928180|FG000|Overall Study|Lost to Follow-up|6|||
16395207|NCT00325130|39928181|FG001|Overall Study|Lost to Follow-up|14|||
16395208|NCT00325130|39928180|FG000|Overall Study|Withdrawal by Subject|12|||
16395209|NCT00325130|39928181|FG001|Overall Study|Withdrawal by Subject|14|||
16395210|NCT00325130|39928180|FG000|Overall Study|Protocol Deviation|0|||
16395211|NCT00325130|39928181|FG001|Overall Study|Protocol Deviation|1|||
16395212|NCT00325130|39928180|FG000|Overall Study|Moved|0|||
16395213|NCT00325130|39928181|FG001|Overall Study|Moved|1|||
16395214|NCT00325130|39928180|FG000|Overall Study|Patient Discontinued for Other|1|||
16395215|NCT00325130|39928181|FG001|Overall Study|Patient Discontinued for Other|0|||
16395216|NCT00620373|39928182|FG000|Overall Study|Unverified cancer status|33|||
16395217|NCT00124072|39928183|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
16395218|NCT00124072|39928184|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
16395219|NCT00124072|39928185|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
16395220|NCT00124072|39928186|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
16395221|NCT00124072|39928183|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
16395222|NCT00124072|39928184|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
16395223|NCT00124072|39928185|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
16395224|NCT00124072|39928186|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
16395225|NCT00124072|39928183|FG000|Overall Study|Death|499|||
16395226|NCT00124072|39928184|FG001|Overall Study|Death|484|||
16395227|NCT00124072|39928185|FG002|Overall Study|Death|471|||
16395228|NCT00124072|39928186|FG003|Overall Study|Death|480|||
16395229|NCT04830215|39928187|FG000|Overall Study|Adverse Event|6|||
16395230|NCT04830215|39928187|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
16395231|NCT04830215|39928187|FG000|Overall Study|Withdrawal by Subject|3|||
16395232|NCT04830215|39928187|FG000|Overall Study|Protocol Deviation|1|||
16395233|NCT03036852|39928189|FG000|Overall Study|Death|2|||
16395234|NCT03036852|39928189|FG000|Overall Study|Lack of Efficacy|2|||
16395235|NCT03036852|39928189|FG000|Overall Study|Adverse Event|1|||
16395236|NCT03036852|39928189|FG000|Overall Study|Lost to Follow-up|1|||
16395237|NCT01133665|39928193|FG000|Overall Study|Physician Decision|2|||
16395238|NCT00460655|39928194|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
16395239|NCT00460655|39928195|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
16395240|NCT00460655|39928196|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
16395241|NCT00460655|39928197|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
16395242|NCT00460655|39928194|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
16395243|NCT00460655|39928195|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
16395244|NCT00460655|39928196|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
16395245|NCT00460655|39928197|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
16395246|NCT00460655|39928194|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
16395247|NCT00460655|39928195|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
16395248|NCT00460655|39928196|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
16395249|NCT00460655|39928197|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
16395250|NCT00460655|39928194|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
16395251|NCT00460655|39928195|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
16395252|NCT00460655|39928196|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
16395253|NCT00460655|39928197|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
16395254|NCT00460655|39928194|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
16395255|NCT00460655|39928195|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
16395256|NCT00460655|39928196|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
16395257|NCT00460655|39928197|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
16395258|NCT00460655|39928194|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
16395259|NCT00460655|39928195|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
16395260|NCT00460655|39928196|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
16395261|NCT00460655|39928197|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
16395262|NCT01253369|39928198|FG000|Overall Study|Adverse Event|4|||
16395263|NCT01253369|39928198|FG000|Overall Study|Withdrawal by Subject|2|||
16395264|NCT01253369|39928198|FG000|Overall Study|Death|1|||
16395265|NCT01253369|39928198|FG000|Overall Study|Progressive disease|23|||
16395266|NCT01253369|39928198|FG000|Overall Study|Not Evaluable|3|||
16395267|NCT01119066|39928204|FG000|Overall Study|Withdrawal by Subject|4|||
16395268|NCT01119066|39928205|FG001|Overall Study|Withdrawal by Subject|6|||
16395269|NCT01119066|39928206|FG002|Overall Study|Withdrawal by Subject|0|||
16395270|NCT01119066|39928207|FG003|Overall Study|Withdrawal by Subject|0|||
16395271|NCT01119066|39928204|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
16395272|NCT01119066|39928205|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
16395273|NCT01119066|39928206|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
16395274|NCT01119066|39928207|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
16395275|NCT01119066|39928204|FG000|Overall Study|Relapse identified before transplant|1|||
16395276|NCT01119066|39928205|FG001|Overall Study|Relapse identified before transplant|0|||
16395277|NCT01119066|39928206|FG002|Overall Study|Relapse identified before transplant|0|||
16395278|NCT01119066|39928207|FG003|Overall Study|Relapse identified before transplant|0|||
16395279|NCT01119066|39928204|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
16395280|NCT01119066|39928205|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
16395281|NCT01119066|39928206|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
16395282|NCT01119066|39928207|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
16395283|NCT01119066|39928204|FG000|Overall Study|Relapse identified before transplant|0|||
16395284|NCT01119066|39928205|FG001|Overall Study|Relapse identified before transplant|4|||
16395285|NCT01119066|39928206|FG002|Overall Study|Relapse identified before transplant|0|||
16395286|NCT01119066|39928207|FG003|Overall Study|Relapse identified before transplant|0|||
16395287|NCT00456755|39928208|FG000|Overall Study|Lost to Follow-up|2|||
16395288|NCT00456755|39928209|FG001|Overall Study|Lost to Follow-up|1|||
16395289|NCT01144416|39928216|FG000|Intervention Period|Adverse Event|5|||
16395290|NCT01144416|39928217|FG001|Intervention Period|Adverse Event|6|||
16395291|NCT01144416|39928216|FG000|Intervention Period|Insufficient ovarian response|11|||
16395292|NCT01144416|39928217|FG001|Intervention Period|Insufficient ovarian response|17|||
16395293|NCT01144416|39928216|FG000|Intervention Period|Risk of OHSS|0|||
16395294|NCT01144416|39928217|FG001|Intervention Period|Risk of OHSS|1|||
16395295|NCT01144416|39928216|FG000|Intervention Period|Too high ovarian response|4|||
16395296|NCT01144416|39928217|FG001|Intervention Period|Too high ovarian response|2|||
16395297|NCT01144416|39928216|FG000|Intervention Period|No/too few/bad oocytes|7|||
16395298|NCT01144416|39928217|FG001|Intervention Period|No/too few/bad oocytes|5|||
16395299|NCT01144416|39928216|FG000|Intervention Period|No or abnormal fertilization|25|||
16395300|NCT01144416|39928217|FG001|Intervention Period|No or abnormal fertilization|10|||
16395301|NCT01144416|39928216|FG000|Intervention Period|No/too few/bad quality embryos|3|||
16395302|NCT01144416|39928217|FG001|Intervention Period|No/too few/bad quality embryos|3|||
16395303|NCT01144416|39928216|FG000|Intervention Period|Other|7|||
16395304|NCT01144416|39928217|FG001|Intervention Period|Other|5|||
16395305|NCT02201329|39928220|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
16395306|NCT02201329|39928220|FG000|Overall Study|Withdrawal by Subject|2|||
16395307|NCT02712983|39928221|FG000|Treatment Phase|Adverse Event|3|||
16395308|NCT02712983|39928222|FG001|Treatment Phase|Adverse Event|1|||
16395309|NCT02712983|39928223|FG002|Treatment Phase|Adverse Event|1|||
16091369|NCT00768755|38826763|FG001|Phase 1|Other|0|||
16091370|NCT00768755|38826764|FG002|Phase 1|Other|0|||
16091371|NCT00768755|38826765|FG003|Phase 1|Other|0|||
16091372|NCT00768755|38826762|FG000|Phase 2|Death|0|||
16395310|NCT02712983|39928224|FG003|Treatment Phase|Adverse Event|4|||
16395311|NCT02712983|39928225|FG004|Treatment Phase|Adverse Event|3|||
16516524|NCT01577758|40358683|FG007|Dose Escalation Phase|Progression Disease|0|||
16516525|NCT01577758|40358676|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16516526|NCT01577758|40358677|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16516527|NCT01577758|40358678|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16516528|NCT01577758|40358679|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16516529|NCT01577758|40358680|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16516530|NCT01577758|40358681|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16516531|NCT01577758|40358682|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
16516532|NCT01577758|40358683|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
16516533|NCT01577758|40358676|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
16516534|NCT01577758|40358677|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
16516535|NCT01577758|40358678|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
16516536|NCT01577758|40358679|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
16516537|NCT01577758|40358680|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
16516538|NCT01577758|40358681|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
16516539|NCT01577758|40358682|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
16516540|NCT01577758|40358683|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
16516541|NCT01577758|40358676|FG000|mCRC Expansion Phase|Progression Disease|0|||
16516542|NCT01577758|40358677|FG001|mCRC Expansion Phase|Progression Disease|0|||
16516543|NCT01577758|40358678|FG002|mCRC Expansion Phase|Progression Disease|0|||
16516544|NCT01577758|40358679|FG003|mCRC Expansion Phase|Progression Disease|0|||
16516545|NCT01577758|40358680|FG004|mCRC Expansion Phase|Progression Disease|0|||
16395312|NCT02712983|39928226|FG005|Treatment Phase|Adverse Event|0|||
16395313|NCT02712983|39928227|FG006|Treatment Phase|Adverse Event|6|||
16395314|NCT02712983|39928228|FG007|Treatment Phase|Adverse Event|6|||
16395315|NCT02712983|39928229|FG008|Treatment Phase|Adverse Event|1|||
16395316|NCT02712983|39928221|FG000|Treatment Phase|Protocol Deviation|0|||
16395317|NCT02712983|39928222|FG001|Treatment Phase|Protocol Deviation|0|||
16395318|NCT02712983|39928223|FG002|Treatment Phase|Protocol Deviation|0|||
16395319|NCT02712983|39928224|FG003|Treatment Phase|Protocol Deviation|2|||
16516546|NCT01577758|40358681|FG005|mCRC Expansion Phase|Progression Disease|0|||
16091373|NCT00768755|38826763|FG001|Phase 2|Death|37|||
16091374|NCT00768755|38826764|FG002|Phase 2|Death|48|||
16091375|NCT00768755|38826765|FG003|Phase 2|Death|31|||
16091376|NCT00768755|38826762|FG000|Phase 2|Protocol Violation|0|||
16395320|NCT02712983|39928225|FG004|Treatment Phase|Protocol Deviation|0|||
16516547|NCT01577758|40358682|FG006|mCRC Expansion Phase|Progression Disease|0|||
16516548|NCT01577758|40358683|FG007|mCRC Expansion Phase|Progression Disease|19|||
16516549|NCT02919670|40358685|FG000|Overall Study|Only 17 participants met compliance|43|||
16091377|NCT00768755|38826763|FG001|Phase 2|Protocol Violation|2|||
16091378|NCT00768755|38826764|FG002|Phase 2|Protocol Violation|0|||
16091379|NCT00768755|38826765|FG003|Phase 2|Protocol Violation|1|||
16091380|NCT00768755|38826762|FG000|Phase 2|Lost to Follow-up|0|||
16091381|NCT00768755|38826763|FG001|Phase 2|Lost to Follow-up|1|||
16091382|NCT00768755|38826764|FG002|Phase 2|Lost to Follow-up|1|||
16091383|NCT00768755|38826765|FG003|Phase 2|Lost to Follow-up|4|||
16091384|NCT00768755|38826762|FG000|Phase 2|Withdrawal by Subject|0|||
16091385|NCT00768755|38826763|FG001|Phase 2|Withdrawal by Subject|1|||
16091386|NCT00768755|38826764|FG002|Phase 2|Withdrawal by Subject|0|||
16091387|NCT00768755|38826765|FG003|Phase 2|Withdrawal by Subject|1|||
16091388|NCT00768755|38826762|FG000|Phase 2|Other|0|||
16091389|NCT00768755|38826763|FG001|Phase 2|Other|1|||
16091390|NCT00768755|38826764|FG002|Phase 2|Other|2|||
16091391|NCT00768755|38826765|FG003|Phase 2|Other|4|||
16091392|NCT00768755|38826762|FG000|Phase 2|Study Terminated by Sponsor|0|||
16091393|NCT00768755|38826763|FG001|Phase 2|Study Terminated by Sponsor|13|||
16516550|NCT02919670|40358686|FG001|Overall Study|Only 17 participants met compliance|39|||
16516551|NCT02043015|40358687|FG000|Overall Study|Lost to Follow-up|4|||
16516552|NCT02043015|40358687|FG000|Overall Study|Withdrawal by Subject|4|||
16516553|NCT02043015|40358687|FG000|Overall Study|Removed once target enrollment reached|15|||
16516554|NCT02043015|40358687|FG000|Overall Study|Participant moved away from study city|4|||
16516555|NCT02043015|40358687|FG000|Overall Study|Incarceration|1|||
16516556|NCT01852292|40358690|FG000|Overall Study|Untreated - did not receive study drug|3|||
16516557|NCT01852292|40358691|FG001|Overall Study|Untreated - did not receive study drug|1|||
16516558|NCT01852292|40358690|FG000|Overall Study|Death|9|||
16516559|NCT01852292|40358691|FG001|Overall Study|Death|8|||
16516560|NCT01852292|40358690|FG000|Overall Study|Patient/guardian decision|8|||
16516561|NCT01852292|40358691|FG001|Overall Study|Patient/guardian decision|4|||
16516562|NCT01852292|40358690|FG000|Overall Study|Adverse Event|8|||
16516563|NCT01852292|40358691|FG001|Overall Study|Adverse Event|11|||
16516564|NCT01852292|40358690|FG000|Overall Study|Physician Decision|6|||
16516565|NCT01852292|40358691|FG001|Overall Study|Physician Decision|2|||
16516566|NCT01852292|40358690|FG000|Overall Study|Protocol Violation|2|||
16516567|NCT01852292|40358691|FG001|Overall Study|Protocol Violation|0|||
16516568|NCT01852292|40358690|FG000|Overall Study|Non-compliance with study treatment|1|||
16516569|NCT01852292|40358691|FG001|Overall Study|Non-compliance with study treatment|0|||
16516570|NCT01852292|40358690|FG000|Overall Study|Study terminated by Sponsor|0|||
16516571|NCT01852292|40358691|FG001|Overall Study|Study terminated by Sponsor|1|||
16516572|NCT01852292|40358690|FG000|Overall Study|Progressive disease|42|||
16516573|NCT01852292|40358691|FG001|Overall Study|Progressive disease|52|||
16516574|NCT00499603|40358696|FG000|Overall Study|Adverse Event|0|||
16516575|NCT00499603|40358697|FG001|Overall Study|Adverse Event|1|||
16516576|NCT00293384|40358698|FG000|Overall Study|Non-compliance|2|||
16516577|NCT00293384|40358698|FG000|Overall Study|Missed dosage/study drug|1|||
16516578|NCT00293384|40358698|FG000|Overall Study|Ineligible|2|||
16516579|NCT00720941|40358714|FG000|Overall Study|Death|334|||
16516580|NCT00720941|40358715|FG001|Overall Study|Death|335|||
16516581|NCT00720941|40358714|FG000|Overall Study|Protocol Violation|0|||
16516582|NCT00720941|40358715|FG001|Overall Study|Protocol Violation|2|||
16516583|NCT00720941|40358714|FG000|Overall Study|Lost to Follow-up|17|||
16516584|NCT00720941|40358715|FG001|Overall Study|Lost to Follow-up|15|||
16516585|NCT00720941|40358714|FG000|Overall Study|Physician Decision|1|||
16516586|NCT00720941|40358715|FG001|Overall Study|Physician Decision|5|||
16516587|NCT00720941|40358714|FG000|Overall Study|Withdrawal by Subject|27|||
16516588|NCT00720941|40358715|FG001|Overall Study|Withdrawal by Subject|35|||
16516589|NCT00720941|40358714|FG000|Overall Study|Ongoing|34|||
16516590|NCT00720941|40358715|FG001|Overall Study|Ongoing|23|||
16516591|NCT00622635|40358716|FG000|Treatment Period 1|Adverse Event|0|||
16516592|NCT00622635|40358717|FG001|Treatment Period 1|Adverse Event|0|||
16516593|NCT00622635|40358718|FG002|Treatment Period 1|Adverse Event|1|||
16516594|NCT00622635|40358719|FG003|Treatment Period 1|Adverse Event|0|||
16516595|NCT00622635|40358720|FG004|Treatment Period 1|Adverse Event|0|||
16516596|NCT00622635|40358721|FG005|Treatment Period 1|Adverse Event|0|||
16091394|NCT00768755|38826764|FG002|Phase 2|Study Terminated by Sponsor|7|||
16516597|NCT00622635|40358716|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16516598|NCT00622635|40358717|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16516599|NCT00622635|40358718|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16516600|NCT00622635|40358719|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16516601|NCT00622635|40358720|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16516602|NCT00622635|40358721|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16091395|NCT00768755|38826765|FG003|Phase 2|Study Terminated by Sponsor|14|||
16091396|NCT00768755|38826762|FG000|Phase 2|Randomized but not treated|0|||
16091397|NCT00768755|38826763|FG001|Phase 2|Randomized but not treated|0|||
16516603|NCT00622635|40358716|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
16516604|NCT00622635|40358717|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
16321462|NCT01704495|39663947|FG000|Subjects Randomized|Other Reason|3|||
16321463|NCT01704495|39663948|FG001|Subjects Randomized|Other Reason|2|||
16321464|NCT01704495|39663949|FG002|Subjects Randomized|Other Reason|3|||
16321465|NCT01704495|39663950|FG003|Subjects Randomized|Other Reason|2|||
16321466|NCT01704495|39663947|FG000|Subjects Randomized|Discontinuation criteria met|4|||
16321467|NCT01704495|39663948|FG001|Subjects Randomized|Discontinuation criteria met|2|||
16321468|NCT01704495|39663949|FG002|Subjects Randomized|Discontinuation criteria met|2|||
16321469|NCT01704495|39663950|FG003|Subjects Randomized|Discontinuation criteria met|0|||
16321470|NCT01704495|39663947|FG000|Subjects Randomized|Adverse Event|8|||
16321471|NCT01704495|39663948|FG001|Subjects Randomized|Adverse Event|2|||
16321472|NCT01704495|39663949|FG002|Subjects Randomized|Adverse Event|0|||
16321473|NCT01704495|39663950|FG003|Subjects Randomized|Adverse Event|7|||
16321474|NCT01704495|39663947|FG000|Subjects Randomized|Withdrawal by Subject|5|||
16321475|NCT01704495|39663948|FG001|Subjects Randomized|Withdrawal by Subject|5|||
16321476|NCT01704495|39663949|FG002|Subjects Randomized|Withdrawal by Subject|5|||
16321477|NCT01704495|39663950|FG003|Subjects Randomized|Withdrawal by Subject|5|||
16321478|NCT01704495|39663947|FG000|Subjects Randomized|Protocol Violation|1|||
16321479|NCT01704495|39663948|FG001|Subjects Randomized|Protocol Violation|1|||
16321480|NCT01704495|39663949|FG002|Subjects Randomized|Protocol Violation|2|||
16395321|NCT02712983|39928226|FG005|Treatment Phase|Protocol Deviation|0|||
16395322|NCT02712983|39928227|FG006|Treatment Phase|Protocol Deviation|1|||
16395323|NCT02712983|39928228|FG007|Treatment Phase|Protocol Deviation|0|||
16395324|NCT02712983|39928229|FG008|Treatment Phase|Protocol Deviation|0|||
16395325|NCT02712983|39928221|FG000|Treatment Phase|Technical Problems|0|||
16395326|NCT02712983|39928222|FG001|Treatment Phase|Technical Problems|0|||
16395327|NCT02712983|39928223|FG002|Treatment Phase|Technical Problems|0|||
16395328|NCT02712983|39928224|FG003|Treatment Phase|Technical Problems|0|||
16395329|NCT02712983|39928225|FG004|Treatment Phase|Technical Problems|0|||
16395330|NCT02712983|39928226|FG005|Treatment Phase|Technical Problems|0|||
16395331|NCT02712983|39928227|FG006|Treatment Phase|Technical Problems|1|||
16395332|NCT02712983|39928228|FG007|Treatment Phase|Technical Problems|0|||
16395333|NCT02712983|39928229|FG008|Treatment Phase|Technical Problems|0|||
16395334|NCT02712983|39928221|FG000|Treatment Phase|Physician Decision|0|||
16395335|NCT02712983|39928222|FG001|Treatment Phase|Physician Decision|0|||
16395336|NCT02712983|39928223|FG002|Treatment Phase|Physician Decision|0|||
16395337|NCT02712983|39928224|FG003|Treatment Phase|Physician Decision|0|||
16395338|NCT02712983|39928225|FG004|Treatment Phase|Physician Decision|0|||
16395339|NCT02712983|39928226|FG005|Treatment Phase|Physician Decision|0|||
16321481|NCT01704495|39663950|FG003|Subjects Randomized|Protocol Violation|0|||
16321482|NCT01704495|39663947|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
16321483|NCT01704495|39663948|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
16321484|NCT01704495|39663949|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
16321485|NCT01704495|39663950|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
16321486|NCT01704495|39663947|FG000|Optional Safety Extension|Adverse Event|0|||
16321487|NCT01704495|39663948|FG001|Optional Safety Extension|Adverse Event|4|||
16321488|NCT01704495|39663949|FG002|Optional Safety Extension|Adverse Event|0|||
16321489|NCT01704495|39663950|FG003|Optional Safety Extension|Adverse Event|1|||
16321490|NCT01704495|39663947|FG000|Optional Safety Extension|Other reason|27|||
16321491|NCT01704495|39663948|FG001|Optional Safety Extension|Other reason|29|||
16395340|NCT02712983|39928227|FG006|Treatment Phase|Physician Decision|0|||
16516605|NCT00622635|40358718|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
16516606|NCT00622635|40358719|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
16516607|NCT00622635|40358720|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
16516608|NCT00622635|40358721|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
16516609|NCT00622635|40358716|FG000|Treatment Period 2|Adverse Event|1|||
16516610|NCT00622635|40358717|FG001|Treatment Period 2|Adverse Event|0|||
16516611|NCT00622635|40358718|FG002|Treatment Period 2|Adverse Event|0|||
16516612|NCT00622635|40358719|FG003|Treatment Period 2|Adverse Event|0|||
16516613|NCT00622635|40358720|FG004|Treatment Period 2|Adverse Event|0|||
16516614|NCT00622635|40358721|FG005|Treatment Period 2|Adverse Event|0|||
16516615|NCT00622635|40358716|FG000|Treatment Period 3|Adverse Event|0|||
16516616|NCT00622635|40358717|FG001|Treatment Period 3|Adverse Event|0|||
16516617|NCT00622635|40358718|FG002|Treatment Period 3|Adverse Event|0|||
16516618|NCT00622635|40358719|FG003|Treatment Period 3|Adverse Event|2|||
16395341|NCT02712983|39928228|FG007|Treatment Phase|Physician Decision|1|||
16395342|NCT02712983|39928229|FG008|Treatment Phase|Physician Decision|1|||
16395343|NCT02712983|39928221|FG000|Treatment Phase|Subject Decision|2|||
16091398|NCT00768755|38826764|FG002|Phase 2|Randomized but not treated|0|||
16091399|NCT00768755|38826765|FG003|Phase 2|Randomized but not treated|2|||
16091400|NCT00498797|38826766|FG000|Overall Study|Withdrawal by Subject|4|||
16091401|NCT00498797|38826767|FG001|Overall Study|Withdrawal by Subject|2|||
16091402|NCT00498797|38826766|FG000|Overall Study|Adverse Event|12|||
16202593|NCT01337167|39218905|FG001|Infant Series|Withdrawal by Subject|4|||
16516619|NCT00622635|40358720|FG004|Treatment Period 3|Adverse Event|0|||
16516620|NCT00622635|40358721|FG005|Treatment Period 3|Adverse Event|0|||
16516621|NCT00622635|40358716|FG000|Treatment Period 3|Withdrawal by Subject|0|||
16516622|NCT00622635|40358717|FG001|Treatment Period 3|Withdrawal by Subject|0|||
16516623|NCT00622635|40358718|FG002|Treatment Period 3|Withdrawal by Subject|0|||
16516624|NCT00622635|40358719|FG003|Treatment Period 3|Withdrawal by Subject|1|||
16516625|NCT00622635|40358720|FG004|Treatment Period 3|Withdrawal by Subject|0|||
16516626|NCT00622635|40358721|FG005|Treatment Period 3|Withdrawal by Subject|0|||
16516627|NCT04360824|40358726|FG000|Overall Study|Withdrawal by Subject|2|||
16516628|NCT04360824|40358727|FG001|Overall Study|Withdrawal by Subject|1|||
16516629|NCT04360824|40358726|FG000|Overall Study|Did not receive assigned treatment|1|||
16516630|NCT04360824|40358727|FG001|Overall Study|Did not receive assigned treatment|3|||
16516631|NCT00424372|40358728|FG000|Overall Study|Death|1|||
16516632|NCT00424372|40358728|FG000|Overall Study|Adverse Event|18|||
16516633|NCT00424372|40358728|FG000|Overall Study|Lack of Efficacy|6|||
16516634|NCT00424372|40358728|FG000|Overall Study|Withdrawal by Subject|4|||
16516635|NCT00424372|40358728|FG000|Overall Study|Protocol Violation|1|||
16516636|NCT00424372|40358728|FG000|Overall Study|Health deterioration|1|||
16516637|NCT00004412|40358729|FG000|Randomized Period|Moved to Crossover Period|3|||
16516638|NCT00004412|40358730|FG001|Randomized Period|Moved to Crossover Period|0|||
16516639|NCT00004412|40358731|FG002|Randomized Period|Moved to Crossover Period|0|||
16516640|NCT01649856|40358736|FG000|Overall Study|Withdrawal by Subject|14|||
16516641|NCT01649856|40358737|FG001|Overall Study|Withdrawal by Subject|14|||
16516642|NCT01649856|40358736|FG000|Overall Study|Protocol Violation|4|||
16516643|NCT01649856|40358737|FG001|Overall Study|Protocol Violation|4|||
16516644|NCT01649856|40358736|FG000|Overall Study|Treatment Failure|1|||
16516645|NCT01649856|40358737|FG001|Overall Study|Treatment Failure|1|||
16516646|NCT01649856|40358736|FG000|Overall Study|Death|69|||
16516647|NCT01649856|40358737|FG001|Overall Study|Death|34|||
16516648|NCT01649856|40358736|FG000|Overall Study|Stable or Progressed Disease|5|||
16516649|NCT01649856|40358737|FG001|Overall Study|Stable or Progressed Disease|3|||
16516650|NCT01649856|40358736|FG000|Overall Study|Lost to Follow-up|20|||
16516651|NCT01649856|40358737|FG001|Overall Study|Lost to Follow-up|16|||
16516652|NCT01649856|40358736|FG000|Overall Study|Lack of Compliance|6|||
16516653|NCT01649856|40358737|FG001|Overall Study|Lack of Compliance|1|||
16321492|NCT01704495|39663949|FG002|Optional Safety Extension|Other reason|30|||
16321493|NCT01704495|39663950|FG003|Optional Safety Extension|Other reason|28|||
16321494|NCT01704495|39663947|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
16321495|NCT01704495|39663948|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
16321496|NCT01704495|39663949|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
16321497|NCT01704495|39663950|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
16321498|NCT00708214|39663951|FG000|Overall Study|Other Adverse Event|3|||
16516654|NCT01649856|40358736|FG000|Overall Study|Other|20|||
16091403|NCT00498797|38826767|FG001|Overall Study|Adverse Event|5|||
16091404|NCT00498797|38826766|FG000|Overall Study|Condition under investigation worsened|19|||
16091405|NCT00498797|38826767|FG001|Overall Study|Condition under investigation worsened|21|||
16091406|NCT00498797|38826766|FG000|Overall Study|Other|3|||
16091407|NCT00498797|38826767|FG001|Overall Study|Other|1|||
16091408|NCT01205126|38826768|FG000|Titration Phase|Adverse Event|5|||
16091409|NCT01205126|38826769|FG001|Titration Phase|Adverse Event|3|||
16516655|NCT01649856|40358737|FG001|Overall Study|Other|5|||
16091410|NCT01205126|38826768|FG000|Titration Phase|Withdrawal by Subject|5|||
16091411|NCT01205126|38826769|FG001|Titration Phase|Withdrawal by Subject|5|||
16091412|NCT01205126|38826768|FG000|Titration Phase|Lost to Follow-up|2|||
16091413|NCT01205126|38826769|FG001|Titration Phase|Lost to Follow-up|2|||
16091414|NCT01205126|38826768|FG000|Titration Phase|No stable titration dose|1|||
16091415|NCT01205126|38826769|FG001|Titration Phase|No stable titration dose|0|||
16091416|NCT01205126|38826768|FG000|Titration Phase|More than maximum dosage required|2|||
16091417|NCT01205126|38826769|FG001|Titration Phase|More than maximum dosage required|3|||
16091418|NCT01205126|38826768|FG000|Titration Phase|Other|8|||
16091419|NCT01205126|38826769|FG001|Titration Phase|Other|6|||
16091420|NCT01205126|38826768|FG000|Between Titration & Maintenance Phase|Other|0|||
16091421|NCT01205126|38826769|FG001|Between Titration & Maintenance Phase|Other|4|||
16091422|NCT01205126|38826768|FG000|Maintenance Phase|Adverse Event|3|||
16091423|NCT01205126|38826769|FG001|Maintenance Phase|Adverse Event|7|||
16091424|NCT01205126|38826768|FG000|Maintenance Phase|Death|4|||
16091425|NCT01205126|38826769|FG001|Maintenance Phase|Death|4|||
16091426|NCT01205126|38826768|FG000|Maintenance Phase|More than the maximum dosage required|5|||
16091427|NCT01205126|38826769|FG001|Maintenance Phase|More than the maximum dosage required|5|||
16091428|NCT01205126|38826768|FG000|Maintenance Phase|Prohibited drugs used|1|||
16091429|NCT01205126|38826769|FG001|Maintenance Phase|Prohibited drugs used|0|||
16091430|NCT01205126|38826768|FG000|Maintenance Phase|Other|11|||
16091431|NCT01205126|38826769|FG001|Maintenance Phase|Other|8|||
16321499|NCT00708214|39663952|FG001|Overall Study|Other Adverse Event|6|||
16516656|NCT04122443|40358738|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
16516657|NCT04122443|40358739|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
16516658|NCT04122443|40358740|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
16516659|NCT04122443|40358738|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
16516660|NCT04122443|40358739|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
16516661|NCT04122443|40358740|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
16516662|NCT01158924|40358741|FG000|Overall Study|Withdrawal by Subject|1|||
16516663|NCT01158924|40358742|FG001|Overall Study|Withdrawal by Subject|2|||
16516664|NCT01158924|40358741|FG000|Overall Study|Lost to Follow-up|0|||
16321500|NCT00708214|39663953|FG002|Overall Study|Other Adverse Event|2|||
16091432|NCT01205126|38826768|FG000|Maintenance Phase|Lost to Follow-up|5|||
16091433|NCT01205126|38826769|FG001|Maintenance Phase|Lost to Follow-up|5|||
16321501|NCT00708214|39663951|FG000|Overall Study|Other|0|||
16321502|NCT00708214|39663952|FG001|Overall Study|Other|1|||
16516665|NCT01158924|40358742|FG001|Overall Study|Lost to Follow-up|1|||
16091434|NCT01205126|38826768|FG000|Maintenance Phase|Withdrawal by Subject|8|||
16321503|NCT00708214|39663953|FG002|Overall Study|Other|1|||
16321504|NCT00708214|39663951|FG000|Overall Study|Progressive Disease|4|||
16321505|NCT00708214|39663952|FG001|Overall Study|Progressive Disease|6|||
16321506|NCT00708214|39663953|FG002|Overall Study|Progressive Disease|5|||
16321507|NCT02861586|39663954|FG000|Overall Study|Withdrawal by Subject|1|||
16321508|NCT02861586|39663955|FG001|Overall Study|Withdrawal by Subject|2|||
16321509|NCT02861586|39663956|FG002|Overall Study|Withdrawal by Subject|0|||
16321510|NCT02861586|39663957|FG003|Overall Study|Withdrawal by Subject|0|||
16321511|NCT02861586|39663958|FG004|Overall Study|Withdrawal by Subject|0|||
16321512|NCT02861586|39663959|FG005|Overall Study|Withdrawal by Subject|1|||
16321513|NCT02861586|39663960|FG006|Overall Study|Withdrawal by Subject|1|||
16321514|NCT02861586|39663961|FG007|Overall Study|Withdrawal by Subject|0|||
16321515|NCT02861586|39663954|FG000|Overall Study|Lost to Follow-up|3|||
16321516|NCT02861586|39663955|FG001|Overall Study|Lost to Follow-up|1|||
16321517|NCT02861586|39663956|FG002|Overall Study|Lost to Follow-up|1|||
16321518|NCT02861586|39663957|FG003|Overall Study|Lost to Follow-up|0|||
16321519|NCT02861586|39663958|FG004|Overall Study|Lost to Follow-up|0|||
16321520|NCT02861586|39663959|FG005|Overall Study|Lost to Follow-up|3|||
16321521|NCT02861586|39663960|FG006|Overall Study|Lost to Follow-up|0|||
16321522|NCT02861586|39663961|FG007|Overall Study|Lost to Follow-up|0|||
16321523|NCT02861586|39663954|FG000|Overall Study|Adverse Event|0|||
16321524|NCT02861586|39663955|FG001|Overall Study|Adverse Event|0|||
16321525|NCT02861586|39663956|FG002|Overall Study|Adverse Event|0|||
16321526|NCT02861586|39663957|FG003|Overall Study|Adverse Event|0|||
16321527|NCT02861586|39663958|FG004|Overall Study|Adverse Event|0|||
16321528|NCT02861586|39663959|FG005|Overall Study|Adverse Event|1|||
16321529|NCT02861586|39663960|FG006|Overall Study|Adverse Event|0|||
16321530|NCT02861586|39663961|FG007|Overall Study|Adverse Event|0|||
16321531|NCT03339726|39663967|FG000|Overall Study|Withdrawal by Subject|1|||
16321532|NCT03339726|39663968|FG001|Overall Study|Withdrawal by Subject|0|||
16321533|NCT03339726|39663969|FG002|Overall Study|Withdrawal by Subject|0|||
16321534|NCT03339726|39663967|FG000|Overall Study|Lost to Follow-up|0|||
16321535|NCT03339726|39663968|FG001|Overall Study|Lost to Follow-up|1|||
16321536|NCT03339726|39663969|FG002|Overall Study|Lost to Follow-up|0|||
16321537|NCT00877487|39663970|FG000|Open-label Treatment Phase|Adverse Event|1|||
16321538|NCT00877487|39663971|FG001|Open-label Treatment Phase|Adverse Event|0|||
16321539|NCT00877487|39663970|FG000|Open-label Treatment Phase|Protocol Violation|3|||
16321540|NCT00877487|39663971|FG001|Open-label Treatment Phase|Protocol Violation|0|||
16321541|NCT00877487|39663970|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
16321542|NCT00877487|39663971|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
16321543|NCT00877487|39663970|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
16321544|NCT00877487|39663971|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
16321545|NCT00877487|39663970|FG000|Open-label Treatment Phase|Out of country for business|1|||
16321546|NCT00877487|39663971|FG001|Open-label Treatment Phase|Out of country for business|0|||
16321547|NCT00877487|39663970|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
16321548|NCT00877487|39663971|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
16321549|NCT00877487|39663970|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
16321550|NCT00877487|39663971|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
16321551|NCT00877487|39663970|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
16321552|NCT00877487|39663971|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
16321553|NCT00877487|39663970|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
16321554|NCT00877487|39663971|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
16321555|NCT01737710|39663972|FG000|Overall Study|Lost to Follow-up|0|||
16321556|NCT01737710|39663973|FG001|Overall Study|Lost to Follow-up|2|||
16321557|NCT01737710|39663974|FG002|Overall Study|Lost to Follow-up|2|||
16321558|NCT01737710|39663975|FG003|Overall Study|Lost to Follow-up|0|||
16321559|NCT01737710|39663976|FG004|Overall Study|Lost to Follow-up|0|||
16321560|NCT01737710|39663972|FG000|Overall Study|Withdrawal by Subject|1|||
16321561|NCT01737710|39663973|FG001|Overall Study|Withdrawal by Subject|1|||
16516666|NCT04879745|40358745|FG000|Overall Study|Lost to Follow-up|4|||
16516667|NCT04879745|40358746|FG001|Overall Study|Lost to Follow-up|1|||
16516668|NCT02948842|40358747|FG000|Overall Study|Withdrawal by Subject|4|||
16091435|NCT01205126|38826769|FG001|Maintenance Phase|Withdrawal by Subject|11|||
16321562|NCT01737710|39663974|FG002|Overall Study|Withdrawal by Subject|1|||
16321563|NCT01737710|39663975|FG003|Overall Study|Withdrawal by Subject|0|||
16321564|NCT01737710|39663976|FG004|Overall Study|Withdrawal by Subject|0|||
16321565|NCT01737710|39663972|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
16321566|NCT01737710|39663973|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
16321567|NCT01737710|39663974|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
16321568|NCT01737710|39663975|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
16321569|NCT01737710|39663976|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
16321570|NCT00406367|39663977|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
16321571|NCT00406367|39663978|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
16091436|NCT00990184|38826773|FG000|Overall Study|Physician Decision|1|||
16321572|NCT00406367|39663977|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
16321573|NCT00406367|39663978|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
16321574|NCT00406367|39663977|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
16321575|NCT00406367|39663978|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
16321576|NCT00406367|39663977|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
16321577|NCT00406367|39663978|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
16321578|NCT00406367|39663977|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
16321579|NCT00406367|39663978|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
16321580|NCT00406367|39663977|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
16321581|NCT00406367|39663978|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
16321582|NCT00406367|39663977|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
16321583|NCT00406367|39663978|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
16321584|NCT00406367|39663977|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
16321585|NCT00406367|39663978|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
16321586|NCT00406367|39663977|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
16321587|NCT00406367|39663978|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
16321588|NCT00406367|39663977|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
16321589|NCT00406367|39663978|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
16321590|NCT00406367|39663977|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
16321591|NCT00406367|39663978|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
16321592|NCT00406367|39663977|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
16321593|NCT00406367|39663978|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
16321594|NCT03656692|39663979|FG000|Overall Study|Worsening of disease activity|2|||
16321595|NCT03656692|39663979|FG000|Overall Study|Physician Decision|1|||
16321596|NCT02582684|39663980|FG000|Overall Study|Unable to contact subject/parent|4|||
16321597|NCT02582684|39663980|FG000|Overall Study|Subject not able to get to clinic|10|||
16321598|NCT02582684|39663980|FG000|Overall Study|Subject withdrew consent|1|||
16321599|NCT02582684|39663980|FG000|Overall Study|Found to be ineligible after enrollment|2|||
16321600|NCT03192306|39663981|FG000|Overall Study|Did not treat cold sore during study|149|||
16321601|NCT03192306|39663982|FG001|Overall Study|Did not treat cold sore during study|143|||
16321602|NCT03192306|39663981|FG000|Overall Study|Withdrawal by Subject|1|||
16321603|NCT03192306|39663982|FG001|Overall Study|Withdrawal by Subject|1|||
16321604|NCT03192306|39663981|FG000|Overall Study|Lost to Follow-up|1|||
16321605|NCT03192306|39663982|FG001|Overall Study|Lost to Follow-up|0|||
16321606|NCT03192306|39663981|FG000|Overall Study|Protocol Violation|1|||
16321607|NCT03192306|39663982|FG001|Overall Study|Protocol Violation|1|||
16321608|NCT00986921|39663984|FG000|Overall Study|Physician Decision|1|||
16321609|NCT00986921|39663985|FG001|Overall Study|Physician Decision|0|||
16321610|NCT00952068|39663986|FG000|Overall Study|Adverse Event|3|||
16321611|NCT00952068|39663986|FG000|Overall Study|Withdrawal by Subject|4|||
16321612|NCT01102257|39663987|FG000|Overall Study|Adverse Event|1|||
16321613|NCT01102257|39663988|FG001|Overall Study|Adverse Event|0|||
16321614|NCT01102257|39663987|FG000|Overall Study|Adverse Event|1|||
16321615|NCT01102257|39663988|FG001|Overall Study|Adverse Event|0|||
16321616|NCT00713258|39663989|FG000|Overall Study|Adverse Event|2|||
16321617|NCT00713258|39663990|FG001|Overall Study|Adverse Event|4|||
16321618|NCT00713258|39663989|FG000|Overall Study|Non-Compliance|2|||
16321619|NCT00713258|39663990|FG001|Overall Study|Non-Compliance|1|||
16321620|NCT00713258|39663989|FG000|Overall Study|Other|1|||
16091437|NCT01190436|38826775|FG000|Overall Study|Lost to Follow-up|35|||
16091438|NCT01190436|38826775|FG000|Overall Study|Other|4|||
16321621|NCT00713258|39663990|FG001|Overall Study|Other|1|||
16321622|NCT03876743|39663994|FG000|Overall Study|Lost to Follow-up|6|||
16321623|NCT03876743|39663995|FG001|Overall Study|Lost to Follow-up|4|||
16321624|NCT03876743|39663996|FG002|Overall Study|Lost to Follow-up|4|||
16321625|NCT03876743|39663997|FG003|Overall Study|Lost to Follow-up|7|||
16321626|NCT02977572|39663998|FG000|Overall Study|Exclusion criterion|2|||
16321627|NCT02977572|39663999|FG001|Overall Study|Exclusion criterion|2|||
16321628|NCT02058537|39664000|FG000|Overall Study|Withdrawal by Subject|1|||
16321629|NCT02693002|39664004|FG000|Overall Study|Withdrawal by Subject|1|||
16321630|NCT02693002|39664005|FG001|Overall Study|Withdrawal by Subject|0|||
16321631|NCT01732458|39664006|FG000|Overall Study|Lost to Follow-up|0|||
16091439|NCT02574286|38826776|FG000|Overall Study|Adverse Event|3|||
16321632|NCT01732458|39664007|FG001|Overall Study|Lost to Follow-up|2|||
16321633|NCT01732458|39664008|FG002|Overall Study|Lost to Follow-up|0|||
16321634|NCT01732458|39664009|FG003|Overall Study|Lost to Follow-up|0|||
16321635|NCT01732458|39664006|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16321636|NCT01732458|39664007|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16321637|NCT01732458|39664008|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16321638|NCT01732458|39664009|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16321639|NCT01732458|39664006|FG000|Overall Study|Physician Decision|1|||
16321640|NCT01732458|39664007|FG001|Overall Study|Physician Decision|2|||
16321641|NCT01732458|39664008|FG002|Overall Study|Physician Decision|2|||
16321642|NCT01732458|39664009|FG003|Overall Study|Physician Decision|0|||
16321643|NCT01732458|39664006|FG000|Overall Study|Protocol Violation|2|||
16321644|NCT01732458|39664007|FG001|Overall Study|Protocol Violation|0|||
16321645|NCT01732458|39664008|FG002|Overall Study|Protocol Violation|0|||
16321646|NCT01732458|39664009|FG003|Overall Study|Protocol Violation|2|||
16321647|NCT01732458|39664006|FG000|Overall Study|Screen Failure|0|||
16321648|NCT01732458|39664007|FG001|Overall Study|Screen Failure|1|||
16321649|NCT01732458|39664008|FG002|Overall Study|Screen Failure|0|||
16321650|NCT01732458|39664009|FG003|Overall Study|Screen Failure|0|||
16321651|NCT00489307|39664012|FG000|Overall Study|Death|1|||
16321652|NCT00489307|39664013|FG001|Overall Study|Death|1|||
16321653|NCT00489307|39664012|FG000|Overall Study|Lost to Follow-up|2|||
16321654|NCT00489307|39664013|FG001|Overall Study|Lost to Follow-up|2|||
16321655|NCT00489307|39664012|FG000|Overall Study|Physician Decision|1|||
16321656|NCT00489307|39664013|FG001|Overall Study|Physician Decision|0|||
16321657|NCT00489307|39664012|FG000|Overall Study|Withdrawal by Subject|2|||
16516669|NCT01438541|40358753|FG000|Overall Study|Physician Decision|1|||
16516670|NCT01438541|40358753|FG000|Overall Study|Withdrawal by Subject|1|||
16516671|NCT01438541|40358753|FG000|Overall Study|discharge from the hospital|5|||
16516672|NCT01440946|40358754|FG000|Overall Study|Lost to Follow-up|1|||
16516673|NCT01440946|40358755|FG001|Overall Study|Lost to Follow-up|1|||
16516674|NCT01440946|40358754|FG000|Overall Study|Physician Decision|1|||
16516675|NCT01440946|40358755|FG001|Overall Study|Physician Decision|0|||
16516676|NCT02130765|40358756|FG000|Overall Study|Did not receive treatment|4|||
16516677|NCT02130765|40358757|FG001|Overall Study|Did not receive treatment|0|||
16091440|NCT02574286|38826776|FG000|Overall Study|Withdrawal by Subject|2|||
16091441|NCT03456856|38826777|FG000|Overall Study|Lost to Follow-up|2|||
16091442|NCT03456856|38826777|FG000|Overall Study|Withdrawal by Subject|1|||
16091443|NCT01005602|38826778|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
16091444|NCT01005602|38826779|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
16091445|NCT01828021|38826780|FG000|Overall Study|Adverse Event|5|||
16091446|NCT01828021|38826780|FG000|Overall Study|Lack of Efficacy|17|||
16091447|NCT01828021|38826780|FG000|Overall Study|Withdrawal by Subject|2|||
16091448|NCT01828021|38826780|FG000|Overall Study|Ileal obstruction, unrelated|1|||
16091449|NCT01021748|38826782|FG000|Overall Study|Adverse Event|2|||
16091450|NCT01021748|38826783|FG001|Overall Study|Adverse Event|1|||
16091451|NCT01021748|38826784|FG002|Overall Study|Adverse Event|2|||
16091452|NCT01021748|38826785|FG003|Overall Study|Adverse Event|0|||
16091453|NCT01021748|38826786|FG004|Overall Study|Adverse Event|2|||
16202594|NCT01337167|39218904|FG000|Infant Series|Randomized but not vaccinated|5|||
16202595|NCT01337167|39218905|FG001|Infant Series|Randomized but not vaccinated|3|||
16202596|NCT01337167|39218904|FG000|Interim Period|Lost to Follow-up|51|||
16202597|NCT01337167|39218905|FG001|Interim Period|Lost to Follow-up|23|||
16202598|NCT01337167|39218904|FG000|Interim Period|Non-compliance with study drug|1|||
16202599|NCT01337167|39218905|FG001|Interim Period|Non-compliance with study drug|0|||
16202600|NCT01337167|39218904|FG000|Interim Period|Physician Decision|6|||
16202601|NCT01337167|39218905|FG001|Interim Period|Physician Decision|3|||
16202602|NCT01337167|39218904|FG000|Interim Period|Protocol Violation|5|||
16202603|NCT01337167|39218905|FG001|Interim Period|Protocol Violation|3|||
16202604|NCT01337167|39218904|FG000|Interim Period|Withdrawal by Subject|18|||
16202605|NCT01337167|39218905|FG001|Interim Period|Withdrawal by Subject|10|||
16516678|NCT02130765|40358758|FG002|Overall Study|Did not receive treatment|0|||
16516679|NCT02130765|40358759|FG003|Overall Study|Did not receive treatment|0|||
16516680|NCT00853658|40358760|FG000|Overall Study|Death|713|||
16091454|NCT01021748|38826787|FG005|Overall Study|Adverse Event|0|||
16091455|NCT01021748|38826788|FG006|Overall Study|Adverse Event|1|||
16091456|NCT01021748|38826789|FG007|Overall Study|Adverse Event|0|||
16091457|NCT01021748|38826790|FG008|Overall Study|Adverse Event|7|||
16321658|NCT00489307|39664013|FG001|Overall Study|Withdrawal by Subject|4|||
16321659|NCT00489307|39664012|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
16321660|NCT00489307|39664013|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
16516681|NCT00853658|40358761|FG001|Overall Study|Death|768|||
16321661|NCT00489307|39664012|FG000|Overall Study|Surgery after assignment|1|||
16321662|NCT00489307|39664013|FG001|Overall Study|Surgery after assignment|0|||
16321663|NCT00489307|39664012|FG000|Overall Study|Did not fill up the forms|2|||
16321664|NCT00489307|39664013|FG001|Overall Study|Did not fill up the forms|1|||
16321665|NCT00489307|39664012|FG000|Overall Study|Patient or family refusal|5|||
16516682|NCT00853658|40358762|FG002|Overall Study|Death|753|||
16516683|NCT00853658|40358760|FG000|Overall Study|Lost to Follow-up|11|||
16091458|NCT01021748|38826782|FG000|Overall Study|Physician Decision|1|||
16091459|NCT01021748|38826783|FG001|Overall Study|Physician Decision|0|||
16091460|NCT01021748|38826784|FG002|Overall Study|Physician Decision|1|||
16202606|NCT01337167|39218904|FG000|Interim Period|Other protocol criterion not met|0|||
16202607|NCT01337167|39218905|FG001|Interim Period|Other protocol criterion not met|1|||
16321666|NCT00489307|39664013|FG001|Overall Study|Patient or family refusal|9|||
16202608|NCT01337167|39218904|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
16202609|NCT01337167|39218905|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
16202610|NCT01337167|39218904|FG000|Toddler Vaccinations|Protocol Violation|0|||
16202611|NCT01337167|39218905|FG001|Toddler Vaccinations|Protocol Violation|1|||
16202612|NCT01337167|39218904|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
16202613|NCT01337167|39218905|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
16202614|NCT00318565|39218906|FG000|Overall Study|Excluded per protocol|24|||
16202615|NCT00178464|39218907|FG000|Overall Study|Withdrawal by Subject|1|||
16202616|NCT00178464|39218907|FG000|Overall Study|Physician Decision|1|||
16202617|NCT00792701|39218910|FG000|Overall Study|Adverse Event|0|||
16202618|NCT00792701|39218911|FG001|Overall Study|Adverse Event|22|||
16202619|NCT00792701|39218910|FG000|Overall Study|Ineligible|1|||
16202620|NCT00792701|39218911|FG001|Overall Study|Ineligible|3|||
16202621|NCT00792701|39218910|FG000|Overall Study|Withdrawal by Subject|1|||
16202622|NCT00792701|39218911|FG001|Overall Study|Withdrawal by Subject|19|||
16202623|NCT00792701|39218910|FG000|Overall Study|Not protocol specified|17|||
16202624|NCT00792701|39218911|FG001|Overall Study|Not protocol specified|0|||
16202625|NCT01255306|39218912|FG000|Overall Study|Physician Decision|1|||
16202626|NCT01255306|39218913|FG001|Overall Study|Physician Decision|1|||
16202627|NCT02553317|39218915|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
16202628|NCT02553317|39218916|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
16202629|NCT02553317|39218915|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
16202630|NCT02553317|39218916|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
16202631|NCT02553317|39218915|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
16202632|NCT02553317|39218916|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
16202633|NCT02553317|39218915|FG000|Overall Treatment Period + Follow-up|Death|1|||
16202634|NCT02553317|39218916|FG001|Overall Treatment Period + Follow-up|Death|3|||
16202635|NCT02553317|39218915|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
16202636|NCT02553317|39218916|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
16202637|NCT02553317|39218915|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
16202638|NCT02553317|39218916|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
16202639|NCT02553317|39218915|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
16202640|NCT02553317|39218916|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
16202641|NCT02553317|39218915|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
16202642|NCT02553317|39218916|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
16202643|NCT02553317|39218915|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
16202644|NCT02553317|39218916|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
16202645|NCT02553317|39218915|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
16202646|NCT02553317|39218916|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
16202647|NCT04247815|39218917|FG000|Overall Study|Adverse Event|1|||
16202648|NCT04247815|39218918|FG001|Overall Study|Adverse Event|0|||
16202649|NCT04247815|39218917|FG000|Overall Study|Withdrawal by Subject|1|||
16202650|NCT04247815|39218918|FG001|Overall Study|Withdrawal by Subject|0|||
16202651|NCT04247815|39218917|FG000|Overall Study|Protocol Violation|0|||
16202652|NCT04247815|39218918|FG001|Overall Study|Protocol Violation|1|||
16202653|NCT02528253|39218919|FG000|Overall Study|Adverse Event|3|||
16202654|NCT02528253|39218920|FG001|Overall Study|Adverse Event|4|||
16202655|NCT02528253|39218921|FG002|Overall Study|Adverse Event|4|||
16202656|NCT02528253|39218922|FG003|Overall Study|Adverse Event|8|||
16202657|NCT02528253|39218923|FG004|Overall Study|Adverse Event|18|||
16202658|NCT02528253|39218919|FG000|Overall Study|Death|2|||
16202659|NCT02528253|39218920|FG001|Overall Study|Death|2|||
16202660|NCT02528253|39218921|FG002|Overall Study|Death|1|||
16202661|NCT02528253|39218922|FG003|Overall Study|Death|0|||
16202662|NCT02528253|39218923|FG004|Overall Study|Death|1|||
16202663|NCT02528253|39218919|FG000|Overall Study|Insufficient clinical response|7|||
16202664|NCT02528253|39218920|FG001|Overall Study|Insufficient clinical response|10|||
16202665|NCT02528253|39218921|FG002|Overall Study|Insufficient clinical response|13|||
16202666|NCT02528253|39218922|FG003|Overall Study|Insufficient clinical response|12|||
16202667|NCT02528253|39218923|FG004|Overall Study|Insufficient clinical response|16|||
16202668|NCT02528253|39218919|FG000|Overall Study|Lost to Follow-up|16|||
16202669|NCT02528253|39218920|FG001|Overall Study|Lost to Follow-up|9|||
16516684|NCT00853658|40358761|FG001|Overall Study|Lost to Follow-up|6|||
16516685|NCT00853658|40358762|FG002|Overall Study|Lost to Follow-up|11|||
16516686|NCT00853658|40358760|FG000|Overall Study|H.A. Request|26|||
16516687|NCT00853658|40358761|FG001|Overall Study|H.A. Request|23|||
16516688|NCT00853658|40358762|FG002|Overall Study|H.A. Request|19|||
16516689|NCT00853658|40358760|FG000|Overall Study|IRB request|0|||
16516690|NCT00853658|40358761|FG001|Overall Study|IRB request|0|||
16516691|NCT00853658|40358762|FG002|Overall Study|IRB request|2|||
16516692|NCT00853658|40358760|FG000|Overall Study|Vital Status known (alive) at study end|2|||
16202670|NCT02528253|39218921|FG002|Overall Study|Lost to Follow-up|31|||
16202671|NCT02528253|39218922|FG003|Overall Study|Lost to Follow-up|16|||
16202672|NCT02528253|39218923|FG004|Overall Study|Lost to Follow-up|34|||
16202673|NCT02528253|39218919|FG000|Overall Study|Other|21|||
16202674|NCT02528253|39218920|FG001|Overall Study|Other|22|||
16202675|NCT02528253|39218921|FG002|Overall Study|Other|58|||
16202676|NCT02528253|39218922|FG003|Overall Study|Other|52|||
16202677|NCT02528253|39218923|FG004|Overall Study|Other|76|||
16202678|NCT02528253|39218919|FG000|Overall Study|Withdrawal by Subject|25|||
16202679|NCT02528253|39218920|FG001|Overall Study|Withdrawal by Subject|20|||
16202680|NCT02528253|39218921|FG002|Overall Study|Withdrawal by Subject|29|||
16202681|NCT02528253|39218922|FG003|Overall Study|Withdrawal by Subject|48|||
16202682|NCT02528253|39218923|FG004|Overall Study|Withdrawal by Subject|73|||
16202683|NCT02528253|39218919|FG000|Overall Study|Protocol Violation|1|||
16202684|NCT02528253|39218920|FG001|Overall Study|Protocol Violation|2|||
16202685|NCT02528253|39218921|FG002|Overall Study|Protocol Violation|4|||
16202686|NCT02528253|39218922|FG003|Overall Study|Protocol Violation|0|||
16202687|NCT02528253|39218923|FG004|Overall Study|Protocol Violation|4|||
16202688|NCT02528253|39218919|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
16202689|NCT02528253|39218920|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
16202690|NCT02528253|39218921|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
16202691|NCT02528253|39218922|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
16202692|NCT02528253|39218923|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
16202693|NCT04900038|39218924|FG000|Overall Study|Adverse Event|1|||
16202694|NCT04900038|39218925|FG001|Overall Study|Adverse Event|0|||
16202695|NCT04900038|39218926|FG002|Overall Study|Adverse Event|1|||
16202696|NCT04900038|39218927|FG003|Overall Study|Adverse Event|1|||
16202697|NCT04900038|39218924|FG000|Overall Study|Withdrawal by Subject|0|||
16202698|NCT04900038|39218925|FG001|Overall Study|Withdrawal by Subject|1|||
16202699|NCT04900038|39218926|FG002|Overall Study|Withdrawal by Subject|0|||
16202700|NCT04900038|39218927|FG003|Overall Study|Withdrawal by Subject|0|||
16202701|NCT04900038|39218924|FG000|Overall Study|Study terminated by sponsor|18|||
16202702|NCT04900038|39218925|FG001|Overall Study|Study terminated by sponsor|15|||
16202703|NCT04900038|39218926|FG002|Overall Study|Study terminated by sponsor|17|||
16202704|NCT04900038|39218927|FG003|Overall Study|Study terminated by sponsor|14|||
16202705|NCT04900038|39218924|FG000|Overall Study|Protocol Deviation|1|||
16202706|NCT04900038|39218925|FG001|Overall Study|Protocol Deviation|1|||
16202707|NCT04900038|39218926|FG002|Overall Study|Protocol Deviation|0|||
16202708|NCT04900038|39218927|FG003|Overall Study|Protocol Deviation|0|||
16202709|NCT04900038|39218924|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
16202710|NCT04900038|39218925|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
16202711|NCT04900038|39218926|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
16202712|NCT04900038|39218927|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
16202713|NCT04900038|39218924|FG000|Overall Study|Lost to Follow-up|0|||
16202714|NCT04900038|39218925|FG001|Overall Study|Lost to Follow-up|0|||
16202715|NCT04900038|39218926|FG002|Overall Study|Lost to Follow-up|0|||
16202716|NCT04900038|39218927|FG003|Overall Study|Lost to Follow-up|1|||
16202717|NCT04209400|39218928|FG000|Overall Study|Withdrawal by Subject|0|||
16202718|NCT04209400|39218929|FG001|Overall Study|Withdrawal by Subject|1|||
16202719|NCT03205982|39218930|FG000|Overall Study|Lost to Follow-up|20|||
16202720|NCT03205982|39218931|FG001|Overall Study|Lost to Follow-up|19|||
16202721|NCT03205982|39218930|FG000|Overall Study|Withdrawal by Subject|4|||
16202722|NCT03205982|39218931|FG001|Overall Study|Withdrawal by Subject|3|||
16202723|NCT03205982|39218930|FG000|Overall Study|Withdrawal by PI|0|||
16202724|NCT03205982|39218931|FG001|Overall Study|Withdrawal by PI|1|||
16202725|NCT00862654|39218933|FG000|Overall Study|Lack of Efficacy|1|||
16202726|NCT00862654|39218934|FG001|Overall Study|Lack of Efficacy|0|||
16202727|NCT00862654|39218935|FG002|Overall Study|Lack of Efficacy|1|||
16202728|NCT00862654|39218936|FG003|Overall Study|Lack of Efficacy|0|||
16202729|NCT00862654|39218933|FG000|Overall Study|Lost to Follow-up|1|||
16202730|NCT00862654|39218934|FG001|Overall Study|Lost to Follow-up|2|||
16202731|NCT00862654|39218935|FG002|Overall Study|Lost to Follow-up|1|||
16321667|NCT01266291|39664019|FG000|Overall Study|Adverse Event|1|||
16202732|NCT00862654|39218936|FG003|Overall Study|Lost to Follow-up|3|||
16202733|NCT00862654|39218933|FG000|Overall Study|Adverse Event|0|||
16202734|NCT00862654|39218934|FG001|Overall Study|Adverse Event|1|||
16202735|NCT00862654|39218935|FG002|Overall Study|Adverse Event|1|||
16202736|NCT00862654|39218936|FG003|Overall Study|Adverse Event|0|||
16202737|NCT00862654|39218933|FG000|Overall Study|Pregnancy|1|||
16202738|NCT00862654|39218934|FG001|Overall Study|Pregnancy|1|||
16202739|NCT00862654|39218935|FG002|Overall Study|Pregnancy|0|||
16202740|NCT00862654|39218936|FG003|Overall Study|Pregnancy|0|||
16202741|NCT00862654|39218933|FG000|Overall Study|Withdrawal by Subject|2|||
16202742|NCT00862654|39218934|FG001|Overall Study|Withdrawal by Subject|2|||
16202743|NCT00862654|39218935|FG002|Overall Study|Withdrawal by Subject|2|||
16202744|NCT00862654|39218936|FG003|Overall Study|Withdrawal by Subject|3|||
16202745|NCT00862654|39218933|FG000|Overall Study|Subject mistake|0|||
16202746|NCT00862654|39218934|FG001|Overall Study|Subject mistake|1|||
16202747|NCT00862654|39218935|FG002|Overall Study|Subject mistake|0|||
16202748|NCT00862654|39218936|FG003|Overall Study|Subject mistake|0|||
16202749|NCT00862654|39218933|FG000|Overall Study|Familly constraint|0|||
16202750|NCT00862654|39218934|FG001|Overall Study|Familly constraint|1|||
16202751|NCT00862654|39218935|FG002|Overall Study|Familly constraint|0|||
16202752|NCT00862654|39218936|FG003|Overall Study|Familly constraint|0|||
16202753|NCT00862654|39218933|FG000|Overall Study|Never used study drugs|1|||
16202754|NCT00862654|39218934|FG001|Overall Study|Never used study drugs|0|||
16202755|NCT00862654|39218935|FG002|Overall Study|Never used study drugs|0|||
16202756|NCT00862654|39218936|FG003|Overall Study|Never used study drugs|0|||
16202757|NCT00862654|39218933|FG000|Overall Study|Included after end of inclusions|0|||
16202758|NCT00862654|39218934|FG001|Overall Study|Included after end of inclusions|0|||
16202759|NCT00862654|39218935|FG002|Overall Study|Included after end of inclusions|1|||
16202760|NCT00862654|39218936|FG003|Overall Study|Included after end of inclusions|0|||
16202761|NCT02566109|39218939|FG000|Overall Study|Withdrawal by Subject|1|||
16202762|NCT05200455|39218941|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
16202763|NCT02513771|39218942|FG000|Overall Study|Lost to Follow-up|1|||
16202764|NCT02513771|39218943|FG001|Overall Study|Lost to Follow-up|1|||
16202765|NCT02513771|39218942|FG000|Overall Study|Not being able to get to clinic|1|||
16202766|NCT02513771|39218943|FG001|Overall Study|Not being able to get to clinic|0|||
16202767|NCT02146248|39218946|FG000|Overall Study|Withdrawal by Subject|2|||
16202768|NCT01824693|39218947|FG000|Overall Study|Death|0|||
16202769|NCT01824693|39218948|FG001|Overall Study|Death|1|||
16202770|NCT01824693|39218949|FG002|Overall Study|Death|0|||
16202771|NCT01824693|39218947|FG000|Overall Study|Physician Decision|1|||
16202772|NCT01824693|39218948|FG001|Overall Study|Physician Decision|1|||
16202773|NCT01824693|39218949|FG002|Overall Study|Physician Decision|1|||
16202774|NCT01824693|39218947|FG000|Overall Study|Withdrawal by Subject|0|||
16202775|NCT01824693|39218948|FG001|Overall Study|Withdrawal by Subject|0|||
16202776|NCT01824693|39218949|FG002|Overall Study|Withdrawal by Subject|1|||
16202777|NCT01824693|39218947|FG000|Overall Study|Progressive Disease|0|||
16202778|NCT01824693|39218948|FG001|Overall Study|Progressive Disease|5|||
16202779|NCT01824693|39218949|FG002|Overall Study|Progressive Disease|0|||
16202780|NCT01824693|39218947|FG000|Overall Study|Ineligible|0|||
16202781|NCT01824693|39218948|FG001|Overall Study|Ineligible|0|||
16202782|NCT01824693|39218949|FG002|Overall Study|Ineligible|3|||
16202783|NCT01824693|39218947|FG000|Overall Study|No Transplant Planned|0|||
16202784|NCT01824693|39218948|FG001|Overall Study|No Transplant Planned|0|||
16202785|NCT01824693|39218949|FG002|Overall Study|No Transplant Planned|10|||
16202786|NCT04354155|39218951|FG000|Overall Study|Withdrawal by Subject|1|||
16202787|NCT04354155|39218951|FG000|Overall Study|Did not meet criteria for study intervention|1|||
16202788|NCT00174785|39218952|FG000|Overall Study|Adverse Event|293|||
16202789|NCT00174785|39218953|FG001|Overall Study|Adverse Event|191|||
16202790|NCT00174785|39218952|FG000|Overall Study|Protocol Violation|14|||
16202791|NCT00174785|39218953|FG001|Overall Study|Protocol Violation|14|||
16202792|NCT00174785|39218952|FG000|Overall Study|Withdrawal by Subject|173|||
16202793|NCT00174785|39218953|FG001|Overall Study|Withdrawal by Subject|175|||
16202794|NCT00174785|39218952|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
16202795|NCT00174785|39218953|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
16202796|NCT00174785|39218952|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
16202797|NCT00174785|39218953|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
16202798|NCT00174785|39218952|FG000|Overall Study|Other prohibited medication|5|||
16202799|NCT00174785|39218953|FG001|Overall Study|Other prohibited medication|3|||
16202800|NCT00174785|39218952|FG000|Overall Study|Family request|6|||
16202801|NCT00174785|39218953|FG001|Overall Study|Family request|8|||
16202802|NCT00174785|39218952|FG000|Overall Study|Not pre-specified/Not coded|56|||
16202803|NCT00174785|39218953|FG001|Overall Study|Not pre-specified/Not coded|70|||
16202804|NCT02247401|39218954|FG000|Overall Study|Adverse Event|1|||
16202805|NCT02247401|39218955|FG001|Overall Study|Adverse Event|0|||
16202806|NCT02247401|39218956|FG002|Overall Study|Adverse Event|0|||
16202807|NCT02247401|39218954|FG000|Overall Study|Withdrawal by Subject|4|||
16202808|NCT02247401|39218955|FG001|Overall Study|Withdrawal by Subject|1|||
16202809|NCT02247401|39218956|FG002|Overall Study|Withdrawal by Subject|1|||
16202810|NCT02247401|39218954|FG000|Overall Study|Lost to Follow-up|1|||
16516693|NCT00853658|40358761|FG001|Overall Study|Vital Status known (alive) at study end|3|||
16202811|NCT02247401|39218955|FG001|Overall Study|Lost to Follow-up|1|||
16202812|NCT02247401|39218956|FG002|Overall Study|Lost to Follow-up|1|||
16202813|NCT00804843|39218966|FG000|Overall Study|Protocol Violation|1|||
16516694|NCT00853658|40358762|FG002|Overall Study|Vital Status known (alive) at study end|3|||
16202814|NCT00804843|39218967|FG001|Overall Study|Protocol Violation|0|||
16202815|NCT00804843|39218966|FG000|Overall Study|Adverse Event|8|||
16202816|NCT00804843|39218967|FG001|Overall Study|Adverse Event|5|||
16202817|NCT00804843|39218966|FG000|Overall Study|Withdrawal by Subject|1|||
16202818|NCT00804843|39218967|FG001|Overall Study|Withdrawal by Subject|2|||
16202819|NCT01677624|39218971|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
16202820|NCT00004732|39218979|FG000|Overall Study|Withdrawal by Subject|36|||
16202821|NCT00004732|39218980|FG001|Overall Study|Withdrawal by Subject|64|||
16516695|NCT00853658|40358760|FG000|Overall Study|Vital Status unknown at study end|1|||
16516696|NCT00853658|40358761|FG001|Overall Study|Vital Status unknown at study end|1|||
16516697|NCT00853658|40358762|FG002|Overall Study|Vital Status unknown at study end|0|||
16516698|NCT00853658|40358760|FG000|Overall Study|Vital Status at study end N/A|8|||
16516699|NCT00853658|40358761|FG001|Overall Study|Vital Status at study end N/A|10|||
16516700|NCT00853658|40358762|FG002|Overall Study|Vital Status at study end N/A|10|||
16516701|NCT00853658|40358760|FG000|Overall Study|Patient's request|21|||
16516702|NCT00853658|40358761|FG001|Overall Study|Patient's request|17|||
16516703|NCT00853658|40358762|FG002|Overall Study|Patient's request|11|||
16516704|NCT00853658|40358760|FG000|Overall Study|Missing study completion information|5|||
16202822|NCT00004732|39218979|FG000|Overall Study|Lost to Follow-up|33|||
16202823|NCT00004732|39218980|FG001|Overall Study|Lost to Follow-up|47|||
16202824|NCT02616185|39218989|FG000|Overall Study|Death|0|||
16202825|NCT02616185|39218990|FG001|Overall Study|Death|0|||
16202826|NCT02616185|39218991|FG002|Overall Study|Death|0|||
16202827|NCT02616185|39218992|FG003|Overall Study|Death|1|||
16202828|NCT02616185|39218993|FG004|Overall Study|Death|2|||
16202829|NCT02616185|39218994|FG005|Overall Study|Death|0|||
16202830|NCT02616185|39218995|FG006|Overall Study|Death|0|||
16202831|NCT02616185|39218996|FG007|Overall Study|Death|2|||
16202832|NCT02616185|39218997|FG008|Overall Study|Death|1|||
16202833|NCT02616185|39218989|FG000|Overall Study|Study terminated by sponsor|0|||
16202834|NCT02616185|39218990|FG001|Overall Study|Study terminated by sponsor|0|||
16202835|NCT02616185|39218991|FG002|Overall Study|Study terminated by sponsor|1|||
16202836|NCT02616185|39218992|FG003|Overall Study|Study terminated by sponsor|0|||
16202837|NCT02616185|39218993|FG004|Overall Study|Study terminated by sponsor|0|||
16202838|NCT02616185|39218994|FG005|Overall Study|Study terminated by sponsor|0|||
16202839|NCT02616185|39218995|FG006|Overall Study|Study terminated by sponsor|5|||
16202840|NCT02616185|39218996|FG007|Overall Study|Study terminated by sponsor|2|||
16202841|NCT02616185|39218997|FG008|Overall Study|Study terminated by sponsor|0|||
16202842|NCT02616185|39218989|FG000|Overall Study|Participant refused further follow-up|1|||
16202843|NCT02616185|39218990|FG001|Overall Study|Participant refused further follow-up|1|||
16202844|NCT02616185|39218991|FG002|Overall Study|Participant refused further follow-up|2|||
16202845|NCT02616185|39218992|FG003|Overall Study|Participant refused further follow-up|3|||
16202846|NCT02616185|39218993|FG004|Overall Study|Participant refused further follow-up|4|||
16202847|NCT02616185|39218994|FG005|Overall Study|Participant refused further follow-up|0|||
16202848|NCT02616185|39218995|FG006|Overall Study|Participant refused further follow-up|3|||
16202849|NCT02616185|39218996|FG007|Overall Study|Participant refused further follow-up|4|||
16202850|NCT02616185|39218997|FG008|Overall Study|Participant refused further follow-up|3|||
16516705|NCT00853658|40358761|FG001|Overall Study|Missing study completion information|4|||
16516706|NCT00853658|40358762|FG002|Overall Study|Missing study completion information|6|||
16516707|NCT04177108|40358763|FG000|Overall Study|Withdrawal by Subject|4|||
16516708|NCT04177108|40358764|FG001|Overall Study|Withdrawal by Subject|8|||
16516709|NCT04177108|40358765|FG002|Overall Study|Withdrawal by Subject|9|||
16202851|NCT02616185|39218989|FG000|Overall Study|Not reported|0|||
16202852|NCT02616185|39218990|FG001|Overall Study|Not reported|0|||
16516710|NCT04177108|40358766|FG003|Overall Study|Withdrawal by Subject|11|||
16516711|NCT04177108|40358767|FG004|Overall Study|Withdrawal by Subject|13|||
16091461|NCT01021748|38826785|FG003|Overall Study|Physician Decision|1|||
16202853|NCT02616185|39218991|FG002|Overall Study|Not reported|0|||
16202854|NCT02616185|39218992|FG003|Overall Study|Not reported|1|||
16516712|NCT04177108|40358763|FG000|Overall Study|Physician Decision|23|||
16091462|NCT01021748|38826786|FG004|Overall Study|Physician Decision|0|||
16091463|NCT01021748|38826787|FG005|Overall Study|Physician Decision|0|||
16091464|NCT01021748|38826788|FG006|Overall Study|Physician Decision|1|||
16091465|NCT01021748|38826789|FG007|Overall Study|Physician Decision|1|||
16091466|NCT01021748|38826790|FG008|Overall Study|Physician Decision|2|||
16091467|NCT01021748|38826782|FG000|Overall Study|Progressive Disease|3|||
16091468|NCT01021748|38826783|FG001|Overall Study|Progressive Disease|3|||
16091469|NCT01021748|38826784|FG002|Overall Study|Progressive Disease|4|||
16091470|NCT01021748|38826785|FG003|Overall Study|Progressive Disease|6|||
16091471|NCT01021748|38826786|FG004|Overall Study|Progressive Disease|7|||
16091472|NCT01021748|38826787|FG005|Overall Study|Progressive Disease|3|||
16091473|NCT01021748|38826788|FG006|Overall Study|Progressive Disease|0|||
16091474|NCT01021748|38826789|FG007|Overall Study|Progressive Disease|5|||
16091475|NCT01021748|38826790|FG008|Overall Study|Progressive Disease|6|||
16091476|NCT01021748|38826782|FG000|Overall Study|Withdrawal by Subject|0|||
16091477|NCT01021748|38826783|FG001|Overall Study|Withdrawal by Subject|0|||
16091478|NCT01021748|38826784|FG002|Overall Study|Withdrawal by Subject|0|||
16091479|NCT01021748|38826785|FG003|Overall Study|Withdrawal by Subject|0|||
16091480|NCT01021748|38826786|FG004|Overall Study|Withdrawal by Subject|0|||
16091481|NCT01021748|38826787|FG005|Overall Study|Withdrawal by Subject|0|||
16091482|NCT01021748|38826788|FG006|Overall Study|Withdrawal by Subject|1|||
16091483|NCT01021748|38826789|FG007|Overall Study|Withdrawal by Subject|0|||
16091484|NCT01021748|38826790|FG008|Overall Study|Withdrawal by Subject|1|||
16091485|NCT01021748|38826782|FG000|Overall Study|Not Treated|0|||
16091486|NCT01021748|38826783|FG001|Overall Study|Not Treated|1|||
16091487|NCT01021748|38826784|FG002|Overall Study|Not Treated|0|||
16091488|NCT01021748|38826785|FG003|Overall Study|Not Treated|0|||
16091489|NCT01021748|38826786|FG004|Overall Study|Not Treated|0|||
16091490|NCT01021748|38826787|FG005|Overall Study|Not Treated|0|||
16091491|NCT01021748|38826788|FG006|Overall Study|Not Treated|0|||
16091492|NCT01021748|38826789|FG007|Overall Study|Not Treated|0|||
16091493|NCT01021748|38826790|FG008|Overall Study|Not Treated|0|||
16091494|NCT03989232|38826793|FG000|Overall Study|Lost to Follow-up|3|||
16091495|NCT03989232|38826794|FG001|Overall Study|Lost to Follow-up|10|||
16091496|NCT03989232|38826793|FG000|Overall Study|Withdrawal by Subject|6|||
16091497|NCT03989232|38826794|FG001|Overall Study|Withdrawal by Subject|6|||
16091498|NCT03989232|38826793|FG000|Overall Study|Death|1|||
16091499|NCT03989232|38826794|FG001|Overall Study|Death|2|||
16091500|NCT00448344|38826795|FG000|Overall Study|Lost to Follow-up|20|||
16091501|NCT00448344|38826796|FG001|Overall Study|Lost to Follow-up|22|||
16091502|NCT00448344|38826795|FG000|Overall Study|Withdrawal by Subject|6|||
16091503|NCT00448344|38826796|FG001|Overall Study|Withdrawal by Subject|8|||
16091504|NCT00448344|38826795|FG000|Overall Study|Death|3|||
16091505|NCT00448344|38826796|FG001|Overall Study|Death|4|||
16321668|NCT01106911|39664020|FG000|Overall Study|Physician Decision|2|||
16321669|NCT01106911|39664020|FG000|Overall Study|deemed ineligible after screening|3|||
16321670|NCT02423343|39664021|FG000|Overall Study|Withdrawal by Subject|0|||
16321671|NCT02423343|39664022|FG001|Overall Study|Withdrawal by Subject|1|||
16321672|NCT02423343|39664023|FG002|Overall Study|Withdrawal by Subject|0|||
16321673|NCT02423343|39664024|FG003|Overall Study|Withdrawal by Subject|0|||
16321674|NCT02423343|39664025|FG004|Overall Study|Withdrawal by Subject|0|||
16321675|NCT02423343|39664026|FG005|Overall Study|Withdrawal by Subject|0|||
16321676|NCT02423343|39664021|FG000|Overall Study|Progressive Disease|0|||
16321677|NCT02423343|39664022|FG001|Overall Study|Progressive Disease|0|||
16321678|NCT02423343|39664023|FG002|Overall Study|Progressive Disease|0|||
16321679|NCT02423343|39664024|FG003|Overall Study|Progressive Disease|0|||
16321680|NCT02423343|39664025|FG004|Overall Study|Progressive Disease|2|||
16321681|NCT02423343|39664026|FG005|Overall Study|Progressive Disease|0|||
16321682|NCT02423343|39664021|FG000|Overall Study|Adverse Event|0|||
16091506|NCT00448344|38826795|FG000|Overall Study|Physician Decision|1|||
16091507|NCT00448344|38826796|FG001|Overall Study|Physician Decision|2|||
16321683|NCT02423343|39664022|FG001|Overall Study|Adverse Event|0|||
16091508|NCT02128269|38826797|FG000|Treatment Period|Adverse Event|1|||
16091509|NCT02128269|38826797|FG000|Treatment Period|Physician Decision|1|||
16091510|NCT01437540|38826798|FG000|Overall Study|Not listed below|7|||
16091511|NCT01437540|38826799|FG001|Overall Study|Not listed below|6|||
16091512|NCT01437540|38826798|FG000|Overall Study|COPD exacerbation|13|||
16321684|NCT02423343|39664023|FG002|Overall Study|Adverse Event|0|||
16091513|NCT01437540|38826799|FG001|Overall Study|COPD exacerbation|3|||
16321685|NCT02423343|39664024|FG003|Overall Study|Adverse Event|0|||
16091514|NCT01437540|38826798|FG000|Overall Study|Lost to Follow-up|3|||
16091515|NCT01437540|38826799|FG001|Overall Study|Lost to Follow-up|5|||
16091516|NCT01437540|38826798|FG000|Overall Study|Lack of Efficacy|23|||
16091517|NCT01437540|38826799|FG001|Overall Study|Lack of Efficacy|11|||
16091518|NCT01437540|38826798|FG000|Overall Study|Protocol Violation|24|||
16091519|NCT01437540|38826799|FG001|Overall Study|Protocol Violation|12|||
16091520|NCT01437540|38826798|FG000|Overall Study|Adverse Event|26|||
16091521|NCT01437540|38826799|FG001|Overall Study|Adverse Event|13|||
16091522|NCT01437540|38826798|FG000|Overall Study|Withdrawal by Subject|31|||
16091523|NCT01437540|38826799|FG001|Overall Study|Withdrawal by Subject|15|||
16091524|NCT01986348|38826801|FG000|Overall Study|Death|8|||
16091525|NCT01986348|38826802|FG001|Overall Study|Death|22|||
16091526|NCT01986348|38826803|FG002|Overall Study|Death|10|||
16091527|NCT01986348|38826804|FG003|Overall Study|Death|21|||
16091528|NCT01986348|38826801|FG000|Overall Study|Lost to Follow-up|0|||
16091529|NCT01986348|38826802|FG001|Overall Study|Lost to Follow-up|0|||
16091530|NCT01986348|38826803|FG002|Overall Study|Lost to Follow-up|0|||
16091531|NCT01986348|38826804|FG003|Overall Study|Lost to Follow-up|2|||
16091532|NCT01986348|38826801|FG000|Overall Study|Physician Decision|0|||
16202855|NCT02616185|39218993|FG004|Overall Study|Not reported|3|||
16091533|NCT01986348|38826802|FG001|Overall Study|Physician Decision|0|||
16091534|NCT01986348|38826803|FG002|Overall Study|Physician Decision|0|||
16091535|NCT01986348|38826804|FG003|Overall Study|Physician Decision|1|||
16091536|NCT01986348|38826801|FG000|Overall Study|Progressive Disease|0|||
16091537|NCT01986348|38826802|FG001|Overall Study|Progressive Disease|0|||
16091538|NCT01986348|38826803|FG002|Overall Study|Progressive Disease|2|||
16091539|NCT01986348|38826804|FG003|Overall Study|Progressive Disease|0|||
16091540|NCT01986348|38826801|FG000|Overall Study|Withdrawal by Participant|0|||
16091541|NCT01986348|38826802|FG001|Overall Study|Withdrawal by Participant|1|||
16091542|NCT01986348|38826803|FG002|Overall Study|Withdrawal by Participant|2|||
16091543|NCT01986348|38826804|FG003|Overall Study|Withdrawal by Participant|1|||
16091544|NCT01986348|38826801|FG000|Overall Study|Study Terminated by Sponsor|0|||
16091545|NCT01986348|38826802|FG001|Overall Study|Study Terminated by Sponsor|0|||
16091546|NCT01986348|38826803|FG002|Overall Study|Study Terminated by Sponsor|0|||
16091547|NCT01986348|38826804|FG003|Overall Study|Study Terminated by Sponsor|3|||
16091548|NCT01986348|38826801|FG000|Overall Study|Other-unspecified|0|||
16091549|NCT01986348|38826802|FG001|Overall Study|Other-unspecified|1|||
16091550|NCT01986348|38826803|FG002|Overall Study|Other-unspecified|0|||
16091551|NCT01986348|38826804|FG003|Overall Study|Other-unspecified|2|||
16091552|NCT04131556|38826812|FG000|Overall Study|Adverse Event|1|||
16091553|NCT04131556|38826812|FG000|Overall Study|Withdrawal by Subject|1|||
16091554|NCT04693637|38826813|FG000|Overall Study|Death|4|||
16091555|NCT04693637|38826813|FG000|Overall Study|Withdrawal by Subject|3|||
16091556|NCT04693637|38826813|FG000|Overall Study|Physician Decision|2|||
16091557|NCT04693637|38826813|FG000|Overall Study|Lost to Follow-up|1|||
16091558|NCT02442622|38826814|FG000|Overall Study|Withdrawal by Subject|3|||
16091559|NCT02442622|38826815|FG001|Overall Study|Withdrawal by Subject|1|||
16091560|NCT00929526|38826816|FG000|Overall Study|Withdrawal by Subject|1|||
16091561|NCT00929526|38826817|FG001|Overall Study|Withdrawal by Subject|11|||
16395344|NCT02712983|39928222|FG001|Treatment Phase|Subject Decision|0|||
16395345|NCT02712983|39928223|FG002|Treatment Phase|Subject Decision|0|||
16395346|NCT02712983|39928224|FG003|Treatment Phase|Subject Decision|2|||
16395347|NCT02712983|39928225|FG004|Treatment Phase|Subject Decision|1|||
16395348|NCT02712983|39928226|FG005|Treatment Phase|Subject Decision|0|||
16091562|NCT00929526|38826816|FG000|Overall Study|Lost to Follow-up|8|||
16321686|NCT02423343|39664025|FG004|Overall Study|Adverse Event|2|||
16321687|NCT02423343|39664026|FG005|Overall Study|Adverse Event|0|||
16321688|NCT02423343|39664021|FG000|Overall Study|Death|0|||
16321689|NCT02423343|39664022|FG001|Overall Study|Death|0|||
16321690|NCT02423343|39664023|FG002|Overall Study|Death|0|||
16321691|NCT02423343|39664024|FG003|Overall Study|Death|0|||
16321692|NCT02423343|39664025|FG004|Overall Study|Death|1|||
16321693|NCT02423343|39664026|FG005|Overall Study|Death|0|||
16321694|NCT00423332|39664030|FG000|Overall Study|Adverse Event|6|||
16321695|NCT00423332|39664031|FG001|Overall Study|Adverse Event|2|||
16321696|NCT00423332|39664030|FG000|Overall Study|Withdrawal by Subject|1|||
16516713|NCT04177108|40358764|FG001|Overall Study|Physician Decision|15|||
16516714|NCT04177108|40358765|FG002|Overall Study|Physician Decision|18|||
16321697|NCT00423332|39664031|FG001|Overall Study|Withdrawal by Subject|0|||
16321698|NCT00423332|39664030|FG000|Overall Study|Condition under investigation worsened|1|||
16321699|NCT00423332|39664031|FG001|Overall Study|Condition under investigation worsened|1|||
16321700|NCT00423332|39664030|FG000|Overall Study|Progressive at Week 6|0|||
16321701|NCT00423332|39664031|FG001|Overall Study|Progressive at Week 6|1|||
16321702|NCT00423332|39664030|FG000|Overall Study|Unblinded before 12 weeks|1|||
16395349|NCT02712983|39928227|FG006|Treatment Phase|Subject Decision|1|||
16395350|NCT02712983|39928228|FG007|Treatment Phase|Subject Decision|2|||
16395351|NCT02712983|39928229|FG008|Treatment Phase|Subject Decision|0|||
16395352|NCT02712983|39928221|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16395353|NCT02712983|39928222|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
16395354|NCT02712983|39928223|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16395355|NCT02712983|39928224|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16395356|NCT02712983|39928225|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16395357|NCT02712983|39928226|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16516715|NCT04177108|40358766|FG003|Overall Study|Physician Decision|29|||
16516716|NCT04177108|40358767|FG004|Overall Study|Physician Decision|23|||
16516717|NCT04177108|40358763|FG000|Overall Study|Reason Not Specified|0|||
16516718|NCT04177108|40358764|FG001|Overall Study|Reason Not Specified|1|||
16516719|NCT04177108|40358765|FG002|Overall Study|Reason Not Specified|0|||
16516720|NCT04177108|40358766|FG003|Overall Study|Reason Not Specified|0|||
16516721|NCT04177108|40358767|FG004|Overall Study|Reason Not Specified|2|||
16516722|NCT04177108|40358763|FG000|Overall Study|Lost to Follow-up|0|||
16091563|NCT00929526|38826817|FG001|Overall Study|Lost to Follow-up|12|||
16091564|NCT00929526|38826816|FG000|Overall Study|Other|8|||
16091565|NCT00929526|38826817|FG001|Overall Study|Other|6|||
16091566|NCT01380145|38826818|FG000|Overall Study|Progressive disease|4|||
16091567|NCT00512902|38826823|FG000|Overall Study|Adverse Event|7|||
16321703|NCT00423332|39664031|FG001|Overall Study|Unblinded before 12 weeks|3|||
16321704|NCT02411448|39664035|FG000|Overall Study|Withdrawal by Subject|1|||
16395358|NCT02712983|39928227|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
16091568|NCT00512902|38826823|FG000|Overall Study|Lost to Follow-up|1|||
16321705|NCT02411448|39664036|FG001|Overall Study|Withdrawal by Subject|14|||
16516723|NCT04177108|40358764|FG001|Overall Study|Lost to Follow-up|0|||
16516724|NCT04177108|40358765|FG002|Overall Study|Lost to Follow-up|1|||
16516725|NCT04177108|40358766|FG003|Overall Study|Lost to Follow-up|1|||
16395359|NCT02712983|39928228|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
16395360|NCT02712983|39928229|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16395361|NCT02712983|39928221|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16395362|NCT02712983|39928222|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16395363|NCT02712983|39928223|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16395364|NCT02712983|39928224|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
16395365|NCT02712983|39928225|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16395366|NCT02712983|39928226|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16395367|NCT02712983|39928227|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16395368|NCT02712983|39928228|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16395369|NCT02712983|39928229|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
16395370|NCT02712983|39928221|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
16516726|NCT04177108|40358767|FG004|Overall Study|Lost to Follow-up|1|||
16516727|NCT04177108|40358763|FG000|Overall Study|Death|16|||
16516728|NCT04177108|40358764|FG001|Overall Study|Death|19|||
16516729|NCT04177108|40358765|FG002|Overall Study|Death|13|||
16516730|NCT04177108|40358766|FG003|Overall Study|Death|17|||
16516731|NCT04177108|40358767|FG004|Overall Study|Death|18|||
16516732|NCT02488629|40358768|FG000|Overall Study|Lack of Efficacy|3|||
16516733|NCT02488629|40358769|FG001|Overall Study|Lack of Efficacy|1|||
16516734|NCT02488629|40358770|FG002|Overall Study|Lack of Efficacy|0|||
16516735|NCT02488629|40358771|FG003|Overall Study|Lack of Efficacy|0|||
16516736|NCT02488629|40358768|FG000|Overall Study|Withdrawal by Subject|0|||
16516737|NCT02488629|40358769|FG001|Overall Study|Withdrawal by Subject|1|||
16091569|NCT03137459|38826828|FG000|2-month Assessment|Withdrawal by Subject|13|||
16091570|NCT03137459|38826829|FG001|2-month Assessment|Withdrawal by Subject|3|||
16091571|NCT03137459|38826828|FG000|2-month Assessment|Unable to reach|42|||
16091572|NCT03137459|38826829|FG001|2-month Assessment|Unable to reach|32|||
16091573|NCT03137459|38826828|FG000|2-month Assessment|Refused assessment|7|||
16091574|NCT03137459|38826829|FG001|2-month Assessment|Refused assessment|5|||
16091575|NCT03137459|38826828|FG000|2-month Assessment|Acutely ill|6|||
16091576|NCT03137459|38826829|FG001|2-month Assessment|Acutely ill|2|||
16091577|NCT03137459|38826828|FG000|4-month Assessment|Death|4|||
16091578|NCT03137459|38826829|FG001|4-month Assessment|Death|2|||
16091579|NCT03137459|38826828|FG000|4-month Assessment|Withdrawal by Subject|4|||
16091580|NCT03137459|38826829|FG001|4-month Assessment|Withdrawal by Subject|2|||
16321706|NCT02411448|39664037|FG002|Overall Study|Withdrawal by Subject|9|||
16091581|NCT03137459|38826828|FG000|4-month Assessment|Unable to reach|44|||
16091582|NCT03137459|38826829|FG001|4-month Assessment|Unable to reach|29|||
16321707|NCT02411448|39664035|FG000|Overall Study|Other|0|||
16321708|NCT02411448|39664036|FG001|Overall Study|Other|2|||
16321709|NCT02411448|39664037|FG002|Overall Study|Other|0|||
16321710|NCT02411448|39664035|FG000|Overall Study|Did not receive study treatment|0|||
16321711|NCT02411448|39664036|FG001|Overall Study|Did not receive study treatment|3|||
16321712|NCT02411448|39664037|FG002|Overall Study|Did not receive study treatment|0|||
16321713|NCT02411448|39664035|FG000|Overall Study|Alive on study treatment|3|||
16321714|NCT02411448|39664036|FG001|Overall Study|Alive on study treatment|64|||
16321715|NCT02411448|39664037|FG002|Overall Study|Alive on study treatment|43|||
16321716|NCT00533702|39664038|FG000|Overall Study|Withdrawal by Subject|3|||
16321717|NCT00533702|39664039|FG001|Overall Study|Withdrawal by Subject|1|||
16321718|NCT00533702|39664038|FG000|Overall Study|Found ineligible after randomization|2|||
16321719|NCT00533702|39664039|FG001|Overall Study|Found ineligible after randomization|1|||
16321720|NCT01127451|39664040|FG000|Overall Study|Other|2|||
16321721|NCT01127451|39664041|FG001|Overall Study|Other|1|||
16321722|NCT01127451|39664040|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
16321723|NCT01127451|39664041|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
16321724|NCT01127451|39664040|FG000|Overall Study|Death|22|||
16321725|NCT01127451|39664041|FG001|Overall Study|Death|17|||
16321726|NCT01127451|39664040|FG000|Overall Study|Lost to Follow-up|3|||
16321727|NCT01127451|39664041|FG001|Overall Study|Lost to Follow-up|0|||
16321728|NCT01127451|39664040|FG000|Overall Study|Administrative Reason by Sponsor|2|||
16321729|NCT01127451|39664041|FG001|Overall Study|Administrative Reason by Sponsor|2|||
16321730|NCT03056638|39664042|FG000|Overall Study|Death|1|||
16321731|NCT03056638|39664043|FG001|Overall Study|Death|0|||
16321732|NCT00110396|39664044|FG000|Overall Study|Adverse Event|15|||
16321733|NCT00110396|39664044|FG000|Overall Study|Lost to Follow-up|1|||
16321734|NCT00110396|39664044|FG000|Overall Study|Administration of plasmapheresis|1|||
16321735|NCT00110396|39664044|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
16321736|NCT00110396|39664044|FG000|Overall Study|Lack of Efficacy|1|||
16321737|NCT00110396|39664044|FG000|Overall Study|Decided not to continue treatment|1|||
16321738|NCT00110396|39664044|FG000|Overall Study|Patient non-compliance|1|||
16091583|NCT03137459|38826828|FG000|4-month Assessment|Refused assessment|24|||
16091584|NCT03137459|38826829|FG001|4-month Assessment|Refused assessment|10|||
16091585|NCT03137459|38826828|FG000|4-month Assessment|Acutely ill|2|||
16091586|NCT03137459|38826829|FG001|4-month Assessment|Acutely ill|3|||
16091587|NCT03137459|38826828|FG000|6-months|Lost to Follow-up|14|||
16091588|NCT03137459|38826829|FG001|6-months|Lost to Follow-up|11|||
16091589|NCT03137459|38826828|FG000|6-months|Death|0|||
16321739|NCT00110396|39664044|FG000|Overall Study|Patient refused to continue|1|||
16321740|NCT00110396|39664044|FG000|Overall Study|Patient refused to participate|1|||
16321741|NCT00110396|39664044|FG000|Overall Study|Patient will|1|||
16321742|NCT00110396|39664044|FG000|Overall Study|Patient's decision|1|||
16321743|NCT00110396|39664044|FG000|Overall Study|Participation in MS vaccine study|1|||
16321744|NCT00110396|39664044|FG000|Overall Study|Pregnancy|1|||
16321745|NCT00110396|39664044|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
16321746|NCT00110396|39664044|FG000|Overall Study|Protocol Violation|2|||
16321747|NCT00110396|39664044|FG000|Overall Study|Patient refused to come back|1|||
16321748|NCT00110396|39664044|FG000|Overall Study|The patient has refused|2|||
16321749|NCT00110396|39664044|FG000|Overall Study|The patient has refused to visit site|1|||
16321750|NCT00110396|39664044|FG000|Overall Study|Patient is to be administered copaxone|1|||
16516738|NCT02488629|40358770|FG002|Overall Study|Withdrawal by Subject|0|||
16516739|NCT02488629|40358771|FG003|Overall Study|Withdrawal by Subject|0|||
16516740|NCT00279708|40358773|FG000|Overall Study|Withdrawal by Subject|2|||
16516741|NCT00279708|40358774|FG001|Overall Study|Withdrawal by Subject|3|||
16516742|NCT00279708|40358773|FG000|Overall Study|Adverse Event|1|||
16516743|NCT00279708|40358774|FG001|Overall Study|Adverse Event|1|||
16516744|NCT01183975|40358775|FG000|Overall Study|Lost to Follow-up|73|||
16516745|NCT00654628|40358776|FG000|6-week Active Treatment Period|Adverse Event|9|||
16516746|NCT00654628|40358776|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
16516747|NCT00654628|40358776|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
16516748|NCT00654628|40358776|FG000|6-week Active Treatment Period|Out of window period|1|||
16516749|NCT00654628|40358776|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
16516750|NCT00654628|40358776|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
16516751|NCT00724451|40358777|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
16516752|NCT00724451|40358777|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
16516753|NCT00724451|40358777|FG000|Overall Study|Not Eligible for Treatment|431|||
16516754|NCT00724451|40358777|FG000|Overall Study|Participant Refused Treatment|89|||
16516755|NCT00724451|40358777|FG000|Overall Study|Never Started Treatment|89|||
16516756|NCT00724451|40358777|FG000|Overall Study|Unknown; No Data Sources Available|9|||
16516757|NCT00724451|40358777|FG000|Overall Study|Physician Decision|116|||
16516758|NCT00724451|40358777|FG000|Overall Study|Withdrawal by Subject|45|||
16516759|NCT00724451|40358777|FG000|Overall Study|Investigator + Participant Decision|13|||
16516760|NCT02181556|40358778|FG000|Overall Study|Withdrawal by Subject|1|||
16516761|NCT02448875|40358780|FG000|Overall Study|Adverse Event|2|||
16516762|NCT02448875|40358781|FG001|Overall Study|Adverse Event|1|||
16516763|NCT02448875|40358782|FG002|Overall Study|Adverse Event|0|||
16516764|NCT02448875|40358780|FG000|Overall Study|Lost to Follow-up|1|||
16516765|NCT02448875|40358781|FG001|Overall Study|Lost to Follow-up|0|||
16516766|NCT02448875|40358782|FG002|Overall Study|Lost to Follow-up|0|||
16516767|NCT02448875|40358780|FG000|Overall Study|Investigator Decision|3|||
16516768|NCT02448875|40358781|FG001|Overall Study|Investigator Decision|0|||
16516769|NCT02448875|40358782|FG002|Overall Study|Investigator Decision|1|||
16516770|NCT02448875|40358780|FG000|Overall Study|Withdrawal by Subject|1|||
16516771|NCT02448875|40358781|FG001|Overall Study|Withdrawal by Subject|0|||
16321751|NCT02049814|39664045|FG000|Overall Study|Reason not Specified|4|||
16321752|NCT02049814|39664046|FG001|Overall Study|Reason not Specified|3|||
16321753|NCT02049814|39664045|FG000|Overall Study|Pregnancy|1|||
16516772|NCT02448875|40358782|FG002|Overall Study|Withdrawal by Subject|0|||
16516773|NCT03795922|40358786|FG000|Overall Study|Adverse Event|2|||
16516774|NCT03795922|40358787|FG001|Overall Study|Adverse Event|1|||
16516775|NCT03795922|40358786|FG000|Overall Study|Withdrawal by Subject|5|||
16516776|NCT03795922|40358787|FG001|Overall Study|Withdrawal by Subject|13|||
16516777|NCT03795922|40358786|FG000|Overall Study|Lost to Follow-up|2|||
16091590|NCT03137459|38826829|FG001|6-months|Death|2|||
16091591|NCT03137459|38826828|FG000|6-months|Refused assessment|6|||
16091592|NCT03137459|38826829|FG001|6-months|Refused assessment|3|||
16091593|NCT03137459|38826828|FG000|6-months|Acutely ill|1|||
16091594|NCT03137459|38826829|FG001|6-months|Acutely ill|1|||
16091595|NCT04237792|38826830|FG000|Treatment (Day 1)|Adverse Event|1|||
16091596|NCT04237792|38826831|FG001|Treatment (Day 1)|Adverse Event|0|||
16091597|NCT04237792|38826832|FG002|Treatment (Day 1)|Adverse Event|0|||
16091598|NCT04237792|38826833|FG003|Treatment (Day 1)|Adverse Event|0|||
16091599|NCT04237792|38826834|FG004|Treatment (Day 1)|Adverse Event|1|||
16091600|NCT04237792|38826835|FG005|Treatment (Day 1)|Adverse Event|1|||
16091601|NCT04237792|38826830|FG000|Treatment (Day 1)|Other|0|||
16091602|NCT04237792|38826831|FG001|Treatment (Day 1)|Other|0|||
16516778|NCT03795922|40358787|FG001|Overall Study|Lost to Follow-up|3|||
16516779|NCT03795922|40358786|FG000|Overall Study|Pregnancy|0|||
16091603|NCT04237792|38826832|FG002|Treatment (Day 1)|Other|1|||
16091604|NCT04237792|38826833|FG003|Treatment (Day 1)|Other|0|||
16516780|NCT03795922|40358787|FG001|Overall Study|Pregnancy|1|||
16516781|NCT03795922|40358786|FG000|Overall Study|Physician Decision|1|||
16516782|NCT03795922|40358787|FG001|Overall Study|Physician Decision|2|||
16516783|NCT03795922|40358786|FG000|Overall Study|Protocol Violation|0|||
16091605|NCT04237792|38826834|FG004|Treatment (Day 1)|Other|0|||
16091606|NCT04237792|38826835|FG005|Treatment (Day 1)|Other|1|||
16091607|NCT04237792|38826830|FG000|Treatment (Day 1)|Not treated|1|||
16091608|NCT04237792|38826831|FG001|Treatment (Day 1)|Not treated|1|||
16091609|NCT04237792|38826832|FG002|Treatment (Day 1)|Not treated|2|||
16091610|NCT04237792|38826833|FG003|Treatment (Day 1)|Not treated|1|||
16091611|NCT04237792|38826834|FG004|Treatment (Day 1)|Not treated|0|||
16091612|NCT04237792|38826835|FG005|Treatment (Day 1)|Not treated|1|||
16091613|NCT03345407|38826837|FG000|Overall Study|Withdrawal by Subject|11|||
16091614|NCT03345407|38826838|FG001|Overall Study|Withdrawal by Subject|1|||
16091615|NCT03345407|38826839|FG002|Overall Study|Withdrawal by Subject|5|||
16091616|NCT03345407|38826840|FG003|Overall Study|Withdrawal by Subject|6|||
16516784|NCT03795922|40358787|FG001|Overall Study|Protocol Violation|1|||
16516785|NCT03795922|40358786|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
16516786|NCT03795922|40358787|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
16516787|NCT04524403|40361959|FG000|Overall Study|Withdrawal by Subject|10|||
16516788|NCT04524403|40361960|FG001|Overall Study|Withdrawal by Subject|3|||
16516789|NCT04524403|40361961|FG002|Overall Study|Withdrawal by Subject|8|||
16516790|NCT04524403|40361959|FG000|Overall Study|Lost to Follow-up|3|||
16091617|NCT03345407|38826841|FG004|Overall Study|Withdrawal by Subject|3|||
16091618|NCT03345407|38826842|FG005|Overall Study|Withdrawal by Subject|6|||
16091619|NCT03345407|38826843|FG006|Overall Study|Withdrawal by Subject|16|||
16091620|NCT03345407|38826837|FG000|Overall Study|Physician Decision|3|||
16091621|NCT03345407|38826838|FG001|Overall Study|Physician Decision|1|||
16321754|NCT02049814|39664046|FG001|Overall Study|Pregnancy|0|||
16091622|NCT03345407|38826839|FG002|Overall Study|Physician Decision|0|||
16091623|NCT03345407|38826840|FG003|Overall Study|Physician Decision|0|||
16091624|NCT03345407|38826841|FG004|Overall Study|Physician Decision|1|||
16091625|NCT03345407|38826842|FG005|Overall Study|Physician Decision|2|||
16091626|NCT03345407|38826843|FG006|Overall Study|Physician Decision|3|||
16516791|NCT04524403|40361960|FG001|Overall Study|Lost to Follow-up|4|||
16516792|NCT04524403|40361961|FG002|Overall Study|Lost to Follow-up|3|||
16516793|NCT04524403|40361959|FG000|Overall Study|Adverse Event|3|||
16516794|NCT04524403|40361960|FG001|Overall Study|Adverse Event|1|||
16516795|NCT04524403|40361961|FG002|Overall Study|Adverse Event|4|||
16516796|NCT04524403|40361959|FG000|Overall Study|Non-compliant with study drug|1|||
16516797|NCT04524403|40361960|FG001|Overall Study|Non-compliant with study drug|2|||
16516798|NCT04524403|40361961|FG002|Overall Study|Non-compliant with study drug|3|||
16516799|NCT04524403|40361959|FG000|Overall Study|Moved|0|||
16516800|NCT04524403|40361960|FG001|Overall Study|Moved|1|||
16516801|NCT04524403|40361961|FG002|Overall Study|Moved|0|||
16091627|NCT03345407|38826837|FG000|Overall Study|Lost to Follow-up|2|||
16091628|NCT03345407|38826838|FG001|Overall Study|Lost to Follow-up|0|||
16091629|NCT03345407|38826839|FG002|Overall Study|Lost to Follow-up|1|||
16091630|NCT03345407|38826840|FG003|Overall Study|Lost to Follow-up|0|||
16091631|NCT03345407|38826841|FG004|Overall Study|Lost to Follow-up|1|||
16091632|NCT03345407|38826842|FG005|Overall Study|Lost to Follow-up|2|||
16091633|NCT03345407|38826843|FG006|Overall Study|Lost to Follow-up|3|||
16091634|NCT03345407|38826837|FG000|Overall Study|Protocol-defined stopping criteria|9|||
16091635|NCT03345407|38826838|FG001|Overall Study|Protocol-defined stopping criteria|0|||
16091636|NCT03345407|38826839|FG002|Overall Study|Protocol-defined stopping criteria|0|||
16091637|NCT03345407|38826840|FG003|Overall Study|Protocol-defined stopping criteria|0|||
16091638|NCT03345407|38826841|FG004|Overall Study|Protocol-defined stopping criteria|2|||
16091639|NCT03345407|38826842|FG005|Overall Study|Protocol-defined stopping criteria|1|||
16091640|NCT03345407|38826843|FG006|Overall Study|Protocol-defined stopping criteria|1|||
16091641|NCT03345407|38826837|FG000|Overall Study|Protocol Violation|2|||
16091642|NCT03345407|38826838|FG001|Overall Study|Protocol Violation|0|||
16091643|NCT03345407|38826839|FG002|Overall Study|Protocol Violation|0|||
16091644|NCT03345407|38826840|FG003|Overall Study|Protocol Violation|0|||
16091645|NCT03345407|38826841|FG004|Overall Study|Protocol Violation|1|||
16091646|NCT03345407|38826842|FG005|Overall Study|Protocol Violation|0|||
16091647|NCT03345407|38826843|FG006|Overall Study|Protocol Violation|3|||
16091648|NCT03345407|38826837|FG000|Overall Study|Lack of Efficacy|1|||
16091649|NCT03345407|38826838|FG001|Overall Study|Lack of Efficacy|1|||
16091650|NCT03345407|38826839|FG002|Overall Study|Lack of Efficacy|1|||
16091651|NCT03345407|38826840|FG003|Overall Study|Lack of Efficacy|1|||
16091652|NCT03345407|38826841|FG004|Overall Study|Lack of Efficacy|1|||
16091653|NCT03345407|38826842|FG005|Overall Study|Lack of Efficacy|0|||
16091654|NCT03345407|38826843|FG006|Overall Study|Lack of Efficacy|3|||
16091655|NCT03345407|38826837|FG000|Overall Study|Adverse Event|4|||
16091656|NCT03345407|38826838|FG001|Overall Study|Adverse Event|0|||
16091657|NCT03345407|38826839|FG002|Overall Study|Adverse Event|5|||
16091658|NCT03345407|38826840|FG003|Overall Study|Adverse Event|4|||
16091659|NCT03345407|38826841|FG004|Overall Study|Adverse Event|6|||
16091660|NCT03345407|38826842|FG005|Overall Study|Adverse Event|5|||
16091661|NCT03345407|38826843|FG006|Overall Study|Adverse Event|16|||
16091662|NCT02170207|38826844|FG000|Overall Study|Case report forms unavailable|5|||
16091663|NCT01052714|38826849|FG000|Overall Study|Adverse Event|6|||
16091664|NCT01052714|38826850|FG001|Overall Study|Adverse Event|3|||
16091665|NCT01052714|38826851|FG002|Overall Study|Adverse Event|0|||
16091666|NCT01052714|38826849|FG000|Overall Study|Death|1|||
16091667|NCT01052714|38826850|FG001|Overall Study|Death|2|||
16091668|NCT01052714|38826851|FG002|Overall Study|Death|0|||
16091669|NCT01052714|38826849|FG000|Overall Study|Lost to Follow-up|2|||
16091670|NCT01052714|38826850|FG001|Overall Study|Lost to Follow-up|3|||
16091671|NCT01052714|38826851|FG002|Overall Study|Lost to Follow-up|0|||
16091672|NCT01052714|38826849|FG000|Overall Study|Physician Decision|9|||
16091673|NCT01052714|38826850|FG001|Overall Study|Physician Decision|9|||
16091674|NCT01052714|38826851|FG002|Overall Study|Physician Decision|1|||
16091675|NCT01052714|38826849|FG000|Overall Study|Withdrawal by Subject|7|||
16091676|NCT01052714|38826850|FG001|Overall Study|Withdrawal by Subject|12|||
16091677|NCT01052714|38826851|FG002|Overall Study|Withdrawal by Subject|1|||
16091678|NCT00442559|38826852|FG000|Overall Study|Lost to Follow-up|32|||
16091679|NCT00442559|38826853|FG001|Overall Study|Lost to Follow-up|34|||
16516802|NCT02583256|40361962|FG000|Overall Study|Withdrawal by Subject|0|||
16516803|NCT02583256|40361963|FG001|Overall Study|Withdrawal by Subject|1|||
16091680|NCT00442559|38826852|FG000|Overall Study|Protocol Violation|1|||
16091681|NCT00442559|38826853|FG001|Overall Study|Protocol Violation|1|||
16091682|NCT00442559|38826852|FG000|Overall Study|Withdrawal by Subject|1|||
16091683|NCT00442559|38826853|FG001|Overall Study|Withdrawal by Subject|0|||
16091684|NCT02548585|38826854|FG000|Overall Study|Withdrawal by Subject|0|||
16091685|NCT02548585|38826855|FG001|Overall Study|Withdrawal by Subject|0|||
16091686|NCT02548585|38826856|FG002|Overall Study|Withdrawal by Subject|0|||
16091687|NCT02548585|38826857|FG003|Overall Study|Withdrawal by Subject|0|||
16091688|NCT02548585|38826858|FG004|Overall Study|Withdrawal by Subject|0|||
16091689|NCT02548585|38826859|FG005|Overall Study|Withdrawal by Subject|1|||
16091690|NCT02548585|38826860|FG006|Overall Study|Withdrawal by Subject|0|||
16091691|NCT02548585|38826854|FG000|Overall Study|Lost to Follow-up|1|||
16091692|NCT02548585|38826855|FG001|Overall Study|Lost to Follow-up|0|||
16516804|NCT02583256|40361964|FG002|Overall Study|Withdrawal by Subject|1|||
16516805|NCT02583256|40361965|FG003|Overall Study|Withdrawal by Subject|0|||
16321755|NCT02049814|39664045|FG000|Overall Study|Lost to Follow-up|2|||
16321756|NCT02049814|39664046|FG001|Overall Study|Lost to Follow-up|3|||
16321757|NCT02049814|39664045|FG000|Overall Study|Serious Protocol Violation|5|||
16395371|NCT02712983|39928222|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
16395372|NCT02712983|39928223|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
16395373|NCT02712983|39928224|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
16321758|NCT02049814|39664046|FG001|Overall Study|Serious Protocol Violation|7|||
16321759|NCT02049814|39664045|FG000|Overall Study|Study Termination|0|||
16321760|NCT02049814|39664046|FG001|Overall Study|Study Termination|1|||
16321761|NCT02049814|39664045|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
16321762|NCT02049814|39664046|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
16321763|NCT02049814|39664045|FG000|Overall Study|Voluntary withdrawal|9|||
16321764|NCT02049814|39664046|FG001|Overall Study|Voluntary withdrawal|8|||
16321765|NCT01029782|39664049|FG000|Overall Study|Lost to Follow-up|2|||
16321766|NCT01029782|39664050|FG001|Overall Study|Lost to Follow-up|2|||
16321767|NCT01029782|39664049|FG000|Overall Study|Diagnosis changed|1|||
16321768|NCT01029782|39664050|FG001|Overall Study|Diagnosis changed|1|||
16321769|NCT01029782|39664049|FG000|Overall Study|Adverse Event|0|||
16321770|NCT01029782|39664050|FG001|Overall Study|Adverse Event|1|||
16321771|NCT01029782|39664049|FG000|Overall Study|Physician Decision|0|||
16321772|NCT01029782|39664050|FG001|Overall Study|Physician Decision|1|||
16321773|NCT01029782|39664049|FG000|Overall Study|Protocol Violation|0|||
16321774|NCT01029782|39664050|FG001|Overall Study|Protocol Violation|2|||
16321775|NCT01029782|39664049|FG000|Overall Study|Withdrawal by Subject|0|||
16321776|NCT01029782|39664050|FG001|Overall Study|Withdrawal by Subject|1|||
16321777|NCT01681212|39664055|FG000|Overall Study|No longer met study criteria|5|||
16321778|NCT01681212|39664055|FG000|Overall Study|Administrative reason by sponsor|1|||
16321779|NCT01960907|39664056|FG000|Overall Study|Death|4|||
16321780|NCT01960907|39664057|FG001|Overall Study|Death|3|||
16321781|NCT01960907|39664056|FG000|Overall Study|Withdrawal by Subject|32|||
16321782|NCT01960907|39664057|FG001|Overall Study|Withdrawal by Subject|42|||
16321783|NCT01091662|39664058|FG000|Overall Study|Adverse Event|1|||
16321784|NCT01091662|39664059|FG001|Overall Study|Adverse Event|9|||
16321785|NCT01091662|39664058|FG000|Overall Study|Physician Decision|1|||
16321786|NCT01091662|39664059|FG001|Overall Study|Physician Decision|1|||
16321787|NCT01091662|39664058|FG000|Overall Study|Withdrawal by Subject|7|||
16321788|NCT01091662|39664059|FG001|Overall Study|Withdrawal by Subject|6|||
16321789|NCT01091662|39664058|FG000|Overall Study|met exit criteria|7|||
16321790|NCT01091662|39664059|FG001|Overall Study|met exit criteria|13|||
16321791|NCT01091662|39664058|FG000|Overall Study|met exclusion criteria|1|||
16395374|NCT02712983|39928225|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
16395375|NCT02712983|39928226|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
16516806|NCT02583256|40361962|FG000|Overall Study|Lost to Follow-up|1|||
16516807|NCT02583256|40361963|FG001|Overall Study|Lost to Follow-up|1|||
16516808|NCT02583256|40361964|FG002|Overall Study|Lost to Follow-up|0|||
16516809|NCT02583256|40361965|FG003|Overall Study|Lost to Follow-up|1|||
16516810|NCT02583256|40361962|FG000|Overall Study|Administrative/Other|2|||
16516811|NCT02583256|40361963|FG001|Overall Study|Administrative/Other|0|||
16395376|NCT02712983|39928227|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
16395377|NCT02712983|39928228|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
16395378|NCT02712983|39928229|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
16395379|NCT00399568|39928234|FG000|Overall Study|Adverse Event|1|||
16395380|NCT00399568|39928235|FG001|Overall Study|Adverse Event|2|||
16516812|NCT02583256|40361964|FG002|Overall Study|Administrative/Other|1|||
16516813|NCT02583256|40361965|FG003|Overall Study|Administrative/Other|2|||
16516814|NCT02057757|40361967|FG000|Overall Study|Withdrawal by Subject|3|||
16516815|NCT02057757|40361968|FG001|Overall Study|Withdrawal by Subject|5|||
16516816|NCT02057757|40361967|FG000|Overall Study|Death|2|||
16516817|NCT02057757|40361968|FG001|Overall Study|Death|0|||
16516818|NCT02057757|40361967|FG000|Overall Study|Lost to Follow-up|8|||
16516819|NCT02057757|40361968|FG001|Overall Study|Lost to Follow-up|3|||
16516820|NCT02057757|40361967|FG000|Overall Study|Non-compliance|1|||
16516821|NCT02057757|40361968|FG001|Overall Study|Non-compliance|0|||
16321792|NCT01091662|39664059|FG001|Overall Study|met exclusion criteria|0|||
16321793|NCT01091662|39664058|FG000|Overall Study|Lost to Follow-up|0|||
16321794|NCT01091662|39664059|FG001|Overall Study|Lost to Follow-up|1|||
16321795|NCT01091662|39664058|FG000|Overall Study|Pregnancy|0|||
16321796|NCT01091662|39664059|FG001|Overall Study|Pregnancy|1|||
16321797|NCT01091662|39664058|FG000|Overall Study|Protocol Violation|0|||
16321798|NCT01091662|39664059|FG001|Overall Study|Protocol Violation|2|||
16321799|NCT01091662|39664058|FG000|Overall Study|unable to swallow capsule|0|||
16321800|NCT01091662|39664059|FG001|Overall Study|unable to swallow capsule|1|||
16516822|NCT00512096|40361969|FG000|Overall Study|Adverse Event|2|||
16516823|NCT00512096|40361969|FG000|Overall Study|Withdrawal by Subject|2|||
16516824|NCT00512096|40361969|FG000|Overall Study|Lack of Efficacy|3|||
16516825|NCT01430585|40361979|FG000|Overall Study|Death|1|||
16516826|NCT01430585|40361979|FG000|Overall Study|Objective Progression or Relapse|3|||
16321801|NCT01436370|39664070|FG000|Overall Study|Lost to Follow-up|0|||
16321802|NCT01436370|39664071|FG001|Overall Study|Lost to Follow-up|0|||
16516827|NCT01430585|40361979|FG000|Overall Study|Study Terminated by Sponsor|3|||
16321803|NCT01436370|39664072|FG002|Overall Study|Lost to Follow-up|0|||
16321804|NCT01436370|39664073|FG003|Overall Study|Lost to Follow-up|0|||
16321805|NCT01436370|39664074|FG004|Overall Study|Lost to Follow-up|1|||
16321806|NCT01436370|39664075|FG005|Overall Study|Lost to Follow-up|0|||
16321807|NCT01436370|39664076|FG006|Overall Study|Lost to Follow-up|0|||
16321808|NCT01436370|39664077|FG007|Overall Study|Lost to Follow-up|0|||
16321809|NCT02107859|39664078|FG000|Overall Study|Withdrawal by Subject|14|||
16321810|NCT02107859|39664078|FG000|Overall Study|Adverse Event|3|||
16321811|NCT02107859|39664078|FG000|Overall Study|Study closure|41|||
16321812|NCT02107859|39664078|FG000|Overall Study|Other than specified|3|||
16321813|NCT01500382|39664079|FG000|Washout Period|Study site went out of business|0|||
16321814|NCT01500382|39664080|FG001|Washout Period|Study site went out of business|0|||
16321815|NCT01500382|39664081|FG002|Washout Period|Study site went out of business|1|||
16321816|NCT01500382|39664082|FG003|Washout Period|Study site went out of business|0|||
16516828|NCT01430585|40361979|FG000|Overall Study|Other|7|||
16516829|NCT02940691|40361982|FG000|Overall Study|Lost to Follow-up|5|||
16516830|NCT02940691|40361982|FG000|Overall Study|Incarceration|1|||
16516831|NCT04300296|40361988|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
16516832|NCT04300296|40361989|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
16516833|NCT04300296|40361990|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
16516834|NCT04300296|40361991|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
16516835|NCT04300296|40361992|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
16516836|NCT04300296|40361993|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
16516837|NCT04300296|40361988|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
16516838|NCT04300296|40361989|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
16516839|NCT04300296|40361990|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
16516840|NCT04300296|40361991|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
16516841|NCT04300296|40361992|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
16516842|NCT04300296|40361993|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
16516843|NCT04300296|40361988|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
16516844|NCT04300296|40361989|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
16516845|NCT04300296|40361990|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
16516846|NCT04300296|40361991|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
16516847|NCT04300296|40361992|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
16516848|NCT04300296|40361993|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
16516849|NCT04300296|40361988|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
16516850|NCT04300296|40361989|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
16516851|NCT04300296|40361990|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
16516852|NCT04300296|40361991|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
16516853|NCT04300296|40361992|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
16516854|NCT04300296|40361993|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
16516855|NCT04300296|40361988|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
16516856|NCT04300296|40361989|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
16516857|NCT04300296|40361990|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
16516858|NCT04300296|40361991|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
16516859|NCT04300296|40361992|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
16516860|NCT04300296|40361993|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
16516861|NCT04300296|40361988|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
16516862|NCT04300296|40361989|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
16516863|NCT04300296|40361990|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
16516864|NCT04300296|40361991|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
16516865|NCT04300296|40361992|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
16516866|NCT04300296|40361993|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
16516867|NCT04300296|40361988|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
16516868|NCT04300296|40361989|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
16516869|NCT04300296|40361990|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
16395381|NCT00399568|39928234|FG000|Overall Study|Withdrawal by Subject|7|||
16395382|NCT00399568|39928235|FG001|Overall Study|Withdrawal by Subject|3|||
16395383|NCT00399568|39928234|FG000|Overall Study|Protocol non-compliance|2|||
16516870|NCT04300296|40361991|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
16516871|NCT04300296|40361992|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
16321817|NCT00402688|39664085|FG000|Overall Study|Adverse Event|12|||
16321818|NCT00402688|39664086|FG001|Overall Study|Adverse Event|9|||
16516872|NCT04300296|40361993|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
16516873|NCT03354429|40361999|FG000|Overall Study|Withdrawal by Subject|8|||
16516874|NCT03354429|40362000|FG001|Overall Study|Withdrawal by Subject|7|||
16516875|NCT03354429|40361999|FG000|Overall Study|Lost to Follow-up|1|||
16202856|NCT02616185|39218994|FG005|Overall Study|Not reported|1|||
16202857|NCT02616185|39218995|FG006|Overall Study|Not reported|0|||
16202858|NCT02616185|39218996|FG007|Overall Study|Not reported|5|||
16202859|NCT02616185|39218997|FG008|Overall Study|Not reported|2|||
16202860|NCT03372603|39218998|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
16202861|NCT03372603|39218999|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
16202862|NCT03372603|39218998|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
16202863|NCT03372603|39218999|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
16202864|NCT01235728|39219000|FG000|Overall Study|Protocol Violation|0|||
16202865|NCT01235728|39219001|FG001|Overall Study|Protocol Violation|0|||
16202866|NCT01235728|39219002|FG002|Overall Study|Protocol Violation|0|||
16202867|NCT01235728|39219003|FG003|Overall Study|Protocol Violation|1|||
16395384|NCT00399568|39928235|FG001|Overall Study|Protocol non-compliance|2|||
16395385|NCT00399568|39928234|FG000|Overall Study|Lost to Follow-up|2|||
16395386|NCT00399568|39928235|FG001|Overall Study|Lost to Follow-up|2|||
16395387|NCT00559104|39928242|FG000|Overall Study|Lack of Efficacy|9|||
16395388|NCT00559104|39928243|FG001|Overall Study|Lack of Efficacy|0|||
16395389|NCT02628600|39928244|FG000|Overall Study|Death|2|||
16395390|NCT02628600|39928245|FG001|Overall Study|Death|1|||
16395391|NCT02628600|39928244|FG000|Overall Study|Adverse Event|3|||
16395392|NCT02628600|39928245|FG001|Overall Study|Adverse Event|20|||
16395393|NCT02628600|39928244|FG000|Overall Study|Protocol Violation|0|||
16395394|NCT02628600|39928245|FG001|Overall Study|Protocol Violation|1|||
16395395|NCT02628600|39928244|FG000|Overall Study|Lack of Efficacy|2|||
16395396|NCT02628600|39928245|FG001|Overall Study|Lack of Efficacy|0|||
16395397|NCT02628600|39928244|FG000|Overall Study|Withdrawal by Subject|13|||
16395398|NCT02628600|39928245|FG001|Overall Study|Withdrawal by Subject|8|||
16395399|NCT02628600|39928244|FG000|Overall Study|Lost to Follow-up|1|||
16395400|NCT02628600|39928245|FG001|Overall Study|Lost to Follow-up|0|||
16395401|NCT02628600|39928244|FG000|Overall Study|Physician Decision|2|||
16395402|NCT02628600|39928245|FG001|Overall Study|Physician Decision|2|||
16395403|NCT02628600|39928244|FG000|Overall Study|Other not specified|1|||
16395404|NCT02628600|39928245|FG001|Overall Study|Other not specified|0|||
16395405|NCT02038946|39928246|FG000|Overall Study|Death|5|||
16395406|NCT02038946|39928246|FG000|Overall Study|Withdrawal by Subject|3|||
16395407|NCT02038946|39928246|FG000|Overall Study|Lost to Follow-up|2|||
16395408|NCT02038946|39928246|FG000|Overall Study|Other reasons|2|||
16395409|NCT01973231|39928253|FG000|Overall Study|Protocol Violation|1|||
16395410|NCT01973231|39928254|FG001|Overall Study|Protocol Violation|1|||
16395411|NCT01973231|39928253|FG000|Overall Study|Lost to Follow-up|1|||
16395412|NCT01973231|39928254|FG001|Overall Study|Lost to Follow-up|1|||
16395413|NCT01973231|39928253|FG000|Overall Study|unclassified|2|||
16395414|NCT01973231|39928254|FG001|Overall Study|unclassified|1|||
16395415|NCT01973231|39928253|FG000|Overall Study|Withdrawal by Subject|7|||
16395416|NCT01973231|39928254|FG001|Overall Study|Withdrawal by Subject|9|||
16395417|NCT01032070|39928255|FG000|Overall Study|Disease progression|13|||
16395418|NCT01032070|39928256|FG001|Overall Study|Disease progression|8|||
16395419|NCT01032070|39928255|FG000|Overall Study|Medical or ethical reasons|0|||
16395420|NCT01032070|39928256|FG001|Overall Study|Medical or ethical reasons|2|||
16395421|NCT01032070|39928255|FG000|Overall Study|Withdrawal by Subject|0|||
16395422|NCT01032070|39928256|FG001|Overall Study|Withdrawal by Subject|2|||
16395423|NCT03604497|39928257|FG000|Overall Study|Protocol Violation|52|||
16395424|NCT00334737|39928258|FG000|Hospital Phase|Death|1|||
16395425|NCT00334737|39928259|FG001|Hospital Phase|Death|2|||
16395426|NCT00334737|39928260|FG002|Hospital Phase|Death|3|||
16516876|NCT03354429|40362000|FG001|Overall Study|Lost to Follow-up|0|||
16516877|NCT04537806|40362001|FG000|Overall Study|Randomized but not treated|1|||
16516878|NCT04537806|40362002|FG001|Overall Study|Randomized but not treated|0|||
16516879|NCT04537806|40362001|FG000|Overall Study|Adverse Event|1|||
16516880|NCT04537806|40362002|FG001|Overall Study|Adverse Event|1|||
16516881|NCT02556710|40362003|FG000|Overall Study|Surgical treatment|3|||
16516882|NCT02556710|40362004|FG001|Overall Study|Surgical treatment|0|||
16516883|NCT02556710|40362003|FG000|Overall Study|Required proscribed pain medication|2|||
16202868|NCT01235728|39219004|FG004|Overall Study|Protocol Violation|0|||
16202869|NCT01235728|39219005|FG005|Overall Study|Protocol Violation|0|||
16395427|NCT00334737|39928258|FG000|Hospital Phase|Withdrawal by Subject|0|||
16395428|NCT00334737|39928259|FG001|Hospital Phase|Withdrawal by Subject|0|||
16395429|NCT00334737|39928260|FG002|Hospital Phase|Withdrawal by Subject|1|||
16395430|NCT00334737|39928258|FG000|Hospital Phase|Did not receive study drug|1|||
16516884|NCT02556710|40362004|FG001|Overall Study|Required proscribed pain medication|1|||
16516885|NCT02556710|40362003|FG000|Overall Study|Lack of Efficacy|1|||
16516886|NCT02556710|40362004|FG001|Overall Study|Lack of Efficacy|0|||
16202870|NCT01235728|39219006|FG006|Overall Study|Protocol Violation|0|||
16202871|NCT01235728|39219007|FG007|Overall Study|Protocol Violation|0|||
16202872|NCT00089479|39219013|FG000|Overall Study|Death|108|||
16202873|NCT00089479|39219014|FG001|Overall Study|Death|75|||
16202874|NCT00089479|39219013|FG000|Overall Study|Withdrawal by Subject|86|||
16202875|NCT00089479|39219014|FG001|Overall Study|Withdrawal by Subject|107|||
16202876|NCT00089479|39219013|FG000|Overall Study|Lost to Follow-up|137|||
16202877|NCT00089479|39219014|FG001|Overall Study|Lost to Follow-up|107|||
16202878|NCT01957787|39219016|FG000|Overall Study|Death|18|||
16202879|NCT01957787|39219016|FG000|Overall Study|Lost to Follow-up|3|||
16202880|NCT01957787|39219016|FG000|Overall Study|Withdrawal by Subject|3|||
16202881|NCT01957787|39219016|FG000|Overall Study|Entered Hospice or Similar Program|2|||
16202882|NCT01957787|39219016|FG000|Overall Study|Index Tumor(s) Resected|2|||
16202883|NCT01957787|39219016|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
16202884|NCT01957787|39219016|FG000|Overall Study|Local therapy, not cryoablation|6|||
16202885|NCT02394795|39219019|FG000|Overall Study|Adverse Event|92|||
16202886|NCT02394795|39219020|FG001|Overall Study|Adverse Event|70|||
16202887|NCT02394795|39219019|FG000|Overall Study|Lost to Follow-up|0|||
16202888|NCT02394795|39219020|FG001|Overall Study|Lost to Follow-up|1|||
16202889|NCT02394795|39219019|FG000|Overall Study|Withdrawal by Subject|17|||
16202890|NCT02394795|39219020|FG001|Overall Study|Withdrawal by Subject|26|||
16202891|NCT02394795|39219019|FG000|Overall Study|Lack of Efficacy|181|||
16202892|NCT02394795|39219020|FG001|Overall Study|Lack of Efficacy|211|||
16202893|NCT02394795|39219019|FG000|Overall Study|Death|4|||
16202894|NCT02394795|39219020|FG001|Overall Study|Death|5|||
16202895|NCT02394795|39219019|FG000|Overall Study|Physician Decision|109|||
16202896|NCT02394795|39219020|FG001|Overall Study|Physician Decision|93|||
16516887|NCT02556710|40362003|FG000|Overall Study|Worsening osteoarthritis|1|||
16516888|NCT02556710|40362004|FG001|Overall Study|Worsening osteoarthritis|0|||
16516889|NCT02556710|40362003|FG000|Overall Study|Moved out of state|1|||
16091693|NCT02548585|38826856|FG002|Overall Study|Lost to Follow-up|0|||
16091694|NCT02548585|38826857|FG003|Overall Study|Lost to Follow-up|0|||
16091695|NCT02548585|38826858|FG004|Overall Study|Lost to Follow-up|0|||
16091696|NCT02548585|38826859|FG005|Overall Study|Lost to Follow-up|0|||
16091697|NCT02548585|38826860|FG006|Overall Study|Lost to Follow-up|0|||
16091698|NCT02548585|38826854|FG000|Overall Study|Other|1|||
16091699|NCT02548585|38826855|FG001|Overall Study|Other|0|||
16091700|NCT02548585|38826856|FG002|Overall Study|Other|0|||
16091701|NCT02548585|38826857|FG003|Overall Study|Other|2|||
16091702|NCT02548585|38826858|FG004|Overall Study|Other|3|||
16091703|NCT02548585|38826859|FG005|Overall Study|Other|0|||
16091704|NCT02548585|38826860|FG006|Overall Study|Other|1|||
16091705|NCT02548585|38826854|FG000|Overall Study|Randomized but not treated|0|||
16091706|NCT02548585|38826855|FG001|Overall Study|Randomized but not treated|0|||
16516890|NCT02556710|40362004|FG001|Overall Study|Moved out of state|0|||
16516891|NCT02556710|40362003|FG000|Overall Study|Missing reason|3|||
16516892|NCT02556710|40362004|FG001|Overall Study|Missing reason|1|||
16516893|NCT02556710|40362003|FG000|Overall Study|Pain as lack of efficacy|0|||
16516894|NCT02556710|40362004|FG001|Overall Study|Pain as lack of efficacy|4|||
16516895|NCT04382612|40362005|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
16516896|NCT02487394|40362006|FG000|Phase 1|Withdrawal by Subject|0|||
16516897|NCT02487394|40362007|FG001|Phase 1|Withdrawal by Subject|1|||
16091707|NCT02548585|38826856|FG002|Overall Study|Randomized but not treated|0|||
16091708|NCT02548585|38826857|FG003|Overall Study|Randomized but not treated|0|||
16091709|NCT02548585|38826858|FG004|Overall Study|Randomized but not treated|0|||
16091710|NCT02548585|38826859|FG005|Overall Study|Randomized but not treated|1|||
16091711|NCT02548585|38826860|FG006|Overall Study|Randomized but not treated|0|||
16091712|NCT02232737|38826864|FG000|Overall Study|Lost to Follow-up|18|||
16091713|NCT02232737|38826865|FG001|Overall Study|Lost to Follow-up|28|||
16091714|NCT02232737|38826866|FG002|Overall Study|Lost to Follow-up|33|||
16091715|NCT02232737|38826864|FG000|Overall Study|Personal reasons|7|||
16091716|NCT02232737|38826865|FG001|Overall Study|Personal reasons|8|||
16091717|NCT02232737|38826866|FG002|Overall Study|Personal reasons|14|||
16091718|NCT02232737|38826864|FG000|Overall Study|Adverse Event|6|||
16091719|NCT02232737|38826865|FG001|Overall Study|Adverse Event|3|||
16091720|NCT02232737|38826866|FG002|Overall Study|Adverse Event|8|||
16091721|NCT02232737|38826864|FG000|Overall Study|Incarcerated|2|||
16091722|NCT02232737|38826865|FG001|Overall Study|Incarcerated|1|||
16091723|NCT02232737|38826866|FG002|Overall Study|Incarcerated|2|||
16091724|NCT02232737|38826864|FG000|Overall Study|Withdrawal by Subject|0|||
16091725|NCT02232737|38826865|FG001|Overall Study|Withdrawal by Subject|1|||
16091726|NCT02232737|38826866|FG002|Overall Study|Withdrawal by Subject|2|||
16202897|NCT01641991|39219021|FG000|Overall Study|Physician Decision|0|||
16202898|NCT01641991|39219022|FG001|Overall Study|Physician Decision|1|||
16202899|NCT01641991|39219023|FG002|Overall Study|Physician Decision|7|||
16091727|NCT02232737|38826864|FG000|Overall Study|Death|0|||
16516898|NCT00952341|40362008|FG000|Cycle 1|Adverse Event|4|||
16516899|NCT00952341|40362009|FG001|Cycle 1|Adverse Event|1|||
16516900|NCT00952341|40362008|FG000|Cycle 1|Withdrawal by Subject|3|||
16516901|NCT00952341|40362009|FG001|Cycle 1|Withdrawal by Subject|8|||
16091728|NCT02232737|38826865|FG001|Overall Study|Death|1|||
16091729|NCT02232737|38826866|FG002|Overall Study|Death|1|||
16091730|NCT02232737|38826864|FG000|Overall Study|Physician Decision|1|||
16091731|NCT02232737|38826865|FG001|Overall Study|Physician Decision|3|||
16091732|NCT02232737|38826866|FG002|Overall Study|Physician Decision|1|||
16091733|NCT02232737|38826864|FG000|Overall Study|Protocol Violation|1|||
16091734|NCT02232737|38826865|FG001|Overall Study|Protocol Violation|0|||
16091735|NCT02232737|38826866|FG002|Overall Study|Protocol Violation|1|||
16091736|NCT02232737|38826864|FG000|Overall Study|Reason unknown|1|||
16091737|NCT02232737|38826865|FG001|Overall Study|Reason unknown|0|||
16091738|NCT02232737|38826866|FG002|Overall Study|Reason unknown|0|||
16091739|NCT00392197|38826867|FG000|Overall Study|Adverse Event|4|||
16091740|NCT00392197|38826868|FG001|Overall Study|Adverse Event|12|||
16091741|NCT00392197|38826867|FG000|Overall Study|Lack of Efficacy|3|||
16091742|NCT00392197|38826868|FG001|Overall Study|Lack of Efficacy|4|||
16091743|NCT00392197|38826867|FG000|Overall Study|Lost to Follow-up|0|||
16091744|NCT00392197|38826868|FG001|Overall Study|Lost to Follow-up|1|||
16091745|NCT00392197|38826867|FG000|Overall Study|Physician Decision|3|||
16091746|NCT00392197|38826868|FG001|Overall Study|Physician Decision|2|||
16091747|NCT00392197|38826867|FG000|Overall Study|Protocol Violation|7|||
16091748|NCT00392197|38826868|FG001|Overall Study|Protocol Violation|5|||
16091749|NCT00392197|38826867|FG000|Overall Study|Withdrawal by Subject|4|||
16091750|NCT00392197|38826868|FG001|Overall Study|Withdrawal by Subject|6|||
16091751|NCT04222088|38826869|FG000|Overall Study|Lost to Follow-up|5|||
16091752|NCT04222088|38826870|FG001|Overall Study|Lost to Follow-up|1|||
16091753|NCT04222088|38826869|FG000|Overall Study|Withdrawal by Subject|4|||
16091754|NCT04222088|38826870|FG001|Overall Study|Withdrawal by Subject|0|||
16091755|NCT02332824|38826872|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
16091756|NCT02332824|38826873|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
16091757|NCT02332824|38826874|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
16091758|NCT02332824|38826875|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
16091759|NCT02332824|38826876|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
16091760|NCT02332824|38826877|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
16091761|NCT02332824|38826872|FG000|Overall Study|Voluntary Withdrawal|1|||
16091762|NCT02332824|38826873|FG001|Overall Study|Voluntary Withdrawal|0|||
16091763|NCT02332824|38826874|FG002|Overall Study|Voluntary Withdrawal|0|||
16091764|NCT02332824|38826875|FG003|Overall Study|Voluntary Withdrawal|0|||
16091765|NCT02332824|38826876|FG004|Overall Study|Voluntary Withdrawal|0|||
16091766|NCT02332824|38826877|FG005|Overall Study|Voluntary Withdrawal|0|||
16091767|NCT02332824|38826872|FG000|Overall Study|Inconvenient schedule|1|||
16091768|NCT02332824|38826873|FG001|Overall Study|Inconvenient schedule|1|||
16091769|NCT02332824|38826874|FG002|Overall Study|Inconvenient schedule|0|||
16091770|NCT02332824|38826875|FG003|Overall Study|Inconvenient schedule|0|||
16321819|NCT00402688|39664087|FG002|Overall Study|Adverse Event|3|||
16321820|NCT00402688|39664085|FG000|Overall Study|Withdrawal by Subject|3|||
16321821|NCT00402688|39664086|FG001|Overall Study|Withdrawal by Subject|1|||
16321822|NCT00402688|39664087|FG002|Overall Study|Withdrawal by Subject|1|||
16321823|NCT00402688|39664085|FG000|Overall Study|Physician Decision|0|||
16321824|NCT00402688|39664086|FG001|Overall Study|Physician Decision|0|||
16321825|NCT00402688|39664087|FG002|Overall Study|Physician Decision|1|||
16321826|NCT00402688|39664085|FG000|Overall Study|Lack of Efficacy|4|||
16395431|NCT00334737|39928259|FG001|Hospital Phase|Did not receive study drug|0|||
16395432|NCT00334737|39928260|FG002|Hospital Phase|Did not receive study drug|0|||
16395433|NCT00334737|39928258|FG000|Follow up Phase|Lost to Follow-up|5|||
16395434|NCT00334737|39928259|FG001|Follow up Phase|Lost to Follow-up|3|||
16395435|NCT00334737|39928260|FG002|Follow up Phase|Lost to Follow-up|6|||
16395436|NCT04512001|39928270|FG000|Week 0 to Week 24|Adverse Event|14|||
16395437|NCT04512001|39928271|FG001|Week 0 to Week 24|Adverse Event|10|||
16395438|NCT04512001|39928272|FG002|Week 0 to Week 24|Adverse Event|0|||
16395439|NCT04512001|39928273|FG003|Week 0 to Week 24|Adverse Event|0|||
16395440|NCT04512001|39928274|FG004|Week 0 to Week 24|Adverse Event|0|||
16395441|NCT04512001|39928270|FG000|Week 0 to Week 24|Death|0|||
16091771|NCT02332824|38826876|FG004|Overall Study|Inconvenient schedule|0|||
16091772|NCT02332824|38826877|FG005|Overall Study|Inconvenient schedule|0|||
16091773|NCT02332824|38826872|FG000|Overall Study|Transfer|0|||
16091774|NCT02332824|38826873|FG001|Overall Study|Transfer|0|||
16091775|NCT02332824|38826874|FG002|Overall Study|Transfer|1|||
16091776|NCT02332824|38826875|FG003|Overall Study|Transfer|1|||
16091777|NCT02332824|38826876|FG004|Overall Study|Transfer|0|||
16091778|NCT02332824|38826877|FG005|Overall Study|Transfer|0|||
16091779|NCT04571944|38826878|FG000|Overall Study|Death|1|||
16091780|NCT04571944|38826879|FG001|Overall Study|Death|0|||
16091781|NCT04571944|38826878|FG000|Overall Study|Withdrawal by Subject|3|||
16091782|NCT04571944|38826879|FG001|Overall Study|Withdrawal by Subject|0|||
16091783|NCT04571944|38826878|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
16321827|NCT00402688|39664086|FG001|Overall Study|Lack of Efficacy|4|||
16321828|NCT00402688|39664087|FG002|Overall Study|Lack of Efficacy|5|||
16395442|NCT04512001|39928271|FG001|Week 0 to Week 24|Death|2|||
16395443|NCT04512001|39928272|FG002|Week 0 to Week 24|Death|0|||
16091784|NCT04571944|38826879|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
16091785|NCT02137785|38826882|FG000|Overall Study|Lost to Follow-up|1|||
16091786|NCT02137785|38826883|FG001|Overall Study|Lost to Follow-up|0|||
16091787|NCT02137785|38826882|FG000|Overall Study|Withdrawal by Subject|1|||
16091788|NCT02137785|38826883|FG001|Overall Study|Withdrawal by Subject|4|||
16091789|NCT02137785|38826882|FG000|Overall Study|subject moved out of state|1|||
16091790|NCT02137785|38826883|FG001|Overall Study|subject moved out of state|0|||
16091791|NCT00901459|38826884|FG000|Overall Study|Withdrawal by Subject|6|||
16091792|NCT00452114|38826887|FG000|Overall Study|Physician Decision|3|||
16091793|NCT00452114|38826888|FG001|Overall Study|Physician Decision|3|||
16091794|NCT00413283|38826891|FG000|Overall Study|Withdrawal by Subject|1|||
16091795|NCT00413283|38826892|FG001|Overall Study|Withdrawal by Subject|0|||
16091796|NCT00413283|38826893|FG002|Overall Study|Withdrawal by Subject|0|||
16091797|NCT00413283|38826894|FG003|Overall Study|Withdrawal by Subject|1|||
16091798|NCT00413283|38826891|FG000|Overall Study|Death|0|||
16202900|NCT01641991|39219024|FG003|Overall Study|Physician Decision|5|||
16202901|NCT01641991|39219021|FG000|Overall Study|Withdrawal by Subject|4|||
16516902|NCT00952341|40362008|FG000|Cycle 1|Protocol Violation|2|||
16516903|NCT00952341|40362009|FG001|Cycle 1|Protocol Violation|1|||
16516904|NCT00952341|40362008|FG000|Cycle 1|Lost to Follow-up|11|||
16516905|NCT00952341|40362009|FG001|Cycle 1|Lost to Follow-up|2|||
16516906|NCT00952341|40362008|FG000|Cycle 1|Physician Decision|0|||
16516907|NCT00952341|40362009|FG001|Cycle 1|Physician Decision|1|||
16516908|NCT00952341|40362008|FG000|Cycle 2|Withdrawal by Subject|1|||
16516909|NCT00952341|40362009|FG001|Cycle 2|Withdrawal by Subject|1|||
16516910|NCT00952341|40362008|FG000|Cycle 2|Protocol Violation|1|||
16516911|NCT00952341|40362009|FG001|Cycle 2|Protocol Violation|0|||
16516912|NCT00952341|40362008|FG000|Cycle 2|Lost to Follow-up|6|||
16516913|NCT00952341|40362009|FG001|Cycle 2|Lost to Follow-up|9|||
16516914|NCT00952341|40362008|FG000|Cycle 2|Physician Decision|1|||
16516915|NCT00952341|40362009|FG001|Cycle 2|Physician Decision|1|||
16516916|NCT00952341|40362008|FG000|Cycle 2|Progressive Disease|0|||
16516917|NCT00952341|40362009|FG001|Cycle 2|Progressive Disease|1|||
16202902|NCT01641991|39219022|FG001|Overall Study|Withdrawal by Subject|2|||
16202903|NCT01641991|39219023|FG002|Overall Study|Withdrawal by Subject|1|||
16516918|NCT01227512|40362013|FG000|Overall Study|Physician Decision|6|||
16516919|NCT01227512|40362014|FG001|Overall Study|Physician Decision|6|||
16091799|NCT00413283|38826892|FG001|Overall Study|Death|0|||
16516920|NCT01227512|40362013|FG000|Overall Study|Adverse Event|4|||
16516921|NCT01227512|40362014|FG001|Overall Study|Adverse Event|3|||
16516922|NCT01227512|40362013|FG000|Overall Study|Withdrawal by Subject|3|||
16516923|NCT01227512|40362014|FG001|Overall Study|Withdrawal by Subject|0|||
16516924|NCT01227512|40362013|FG000|Overall Study|Participant met withdrawal criteria|0|||
16516925|NCT01227512|40362014|FG001|Overall Study|Participant met withdrawal criteria|1|||
16091800|NCT00413283|38826893|FG002|Overall Study|Death|1|||
16202904|NCT01641991|39219024|FG003|Overall Study|Withdrawal by Subject|5|||
16202905|NCT01641991|39219021|FG000|Overall Study|Adverse Event|2|||
16516926|NCT01641367|40362015|FG000|Cohorts|Death|18|||
16516927|NCT01641367|40362016|FG001|Cohorts|Death|1|||
16516928|NCT01641367|40362017|FG002|Cohorts|Death|2|||
16516929|NCT01641367|40362018|FG003|Cohorts|Death|0|||
16516930|NCT01641367|40362019|FG004|Cohorts|Death|1|||
16516931|NCT01641367|40362020|FG005|Cohorts|Death|1|||
16516932|NCT01641367|40362021|FG006|Cohorts|Death|0|||
16516933|NCT01641367|40362022|FG007|Cohorts|Death|0|||
16516934|NCT01641367|40362015|FG000|Cohorts|Lost to Follow-up|16|||
16516935|NCT01641367|40362016|FG001|Cohorts|Lost to Follow-up|0|||
16516936|NCT01641367|40362017|FG002|Cohorts|Lost to Follow-up|2|||
16516937|NCT01641367|40362018|FG003|Cohorts|Lost to Follow-up|0|||
16516938|NCT01641367|40362019|FG004|Cohorts|Lost to Follow-up|2|||
16516939|NCT01641367|40362020|FG005|Cohorts|Lost to Follow-up|0|||
16516940|NCT01641367|40362021|FG006|Cohorts|Lost to Follow-up|0|||
16516941|NCT01641367|40362022|FG007|Cohorts|Lost to Follow-up|0|||
16516942|NCT01641367|40362015|FG000|Randomized Adherence Intervention|Death|0|||
16516943|NCT01641367|40362016|FG001|Randomized Adherence Intervention|Death|0|||
16516944|NCT01641367|40362017|FG002|Randomized Adherence Intervention|Death|0|||
16516945|NCT01641367|40362018|FG003|Randomized Adherence Intervention|Death|0|||
16516946|NCT01641367|40362019|FG004|Randomized Adherence Intervention|Death|0|||
16516947|NCT01641367|40362020|FG005|Randomized Adherence Intervention|Death|0|||
16516948|NCT01641367|40362021|FG006|Randomized Adherence Intervention|Death|11|||
16516949|NCT01641367|40362022|FG007|Randomized Adherence Intervention|Death|12|||
16395444|NCT04512001|39928273|FG003|Week 0 to Week 24|Death|0|||
16395445|NCT04512001|39928274|FG004|Week 0 to Week 24|Death|0|||
16395446|NCT04512001|39928270|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
16395447|NCT04512001|39928271|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
16395448|NCT04512001|39928272|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
16516950|NCT01641367|40362015|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
16516951|NCT01641367|40362016|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
16516952|NCT01641367|40362017|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
16516953|NCT01641367|40362018|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
16395449|NCT04512001|39928273|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
16395450|NCT04512001|39928274|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
16202906|NCT01641991|39219022|FG001|Overall Study|Adverse Event|1|||
16395451|NCT04512001|39928270|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
16516954|NCT01641367|40362019|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
16516955|NCT01641367|40362020|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
16516956|NCT01641367|40362021|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
16321829|NCT00402688|39664085|FG000|Overall Study|Protocol Violation|1|||
16321830|NCT00402688|39664086|FG001|Overall Study|Protocol Violation|1|||
16321831|NCT00402688|39664087|FG002|Overall Study|Protocol Violation|1|||
16321832|NCT00402688|39664085|FG000|Overall Study|Lost to Follow-up|1|||
16321833|NCT00402688|39664086|FG001|Overall Study|Lost to Follow-up|0|||
16321834|NCT00402688|39664087|FG002|Overall Study|Lost to Follow-up|2|||
16516957|NCT01641367|40362022|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
16321835|NCT00402688|39664085|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
16516958|NCT00767676|40362023|FG000|Overall Study|Investigator error|54|||
16516959|NCT00689481|40362024|FG000|Overall Study|Adverse Event|7|||
16516960|NCT00689481|40362025|FG001|Overall Study|Adverse Event|1|||
16516961|NCT00689481|40362024|FG000|Overall Study|Lost to Follow-up|4|||
16516962|NCT00689481|40362025|FG001|Overall Study|Lost to Follow-up|3|||
16516963|NCT00689481|40362024|FG000|Overall Study|Lack of Efficacy|4|||
16516964|NCT00689481|40362025|FG001|Overall Study|Lack of Efficacy|3|||
16516965|NCT00689481|40362024|FG000|Overall Study|Non-compliance with study treatment|1|||
16321836|NCT00402688|39664086|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
16321837|NCT00402688|39664087|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
16321838|NCT00402688|39664085|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
16321839|NCT00402688|39664086|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
16321840|NCT00402688|39664087|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
16516966|NCT00689481|40362025|FG001|Overall Study|Non-compliance with study treatment|1|||
16321841|NCT00402688|39664085|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
16516967|NCT00689481|40362024|FG000|Overall Study|Withdrawal by Subject|8|||
16516968|NCT00689481|40362025|FG001|Overall Study|Withdrawal by Subject|4|||
16516969|NCT00689481|40362024|FG000|Overall Study|Excluded medication started during study|0|||
16516970|NCT00689481|40362025|FG001|Overall Study|Excluded medication started during study|1|||
16516971|NCT00689481|40362024|FG000|Overall Study|Subject early term, left on vacation|0|||
16516972|NCT00689481|40362025|FG001|Overall Study|Subject early term, left on vacation|1|||
16516973|NCT02759120|40362031|FG000|Overall Study|Death|34|||
16516974|NCT02759120|40362032|FG001|Overall Study|Death|36|||
16516975|NCT02759120|40362031|FG000|Overall Study|Lost to Follow-up|4|||
16516976|NCT02759120|40362032|FG001|Overall Study|Lost to Follow-up|7|||
16516977|NCT02759120|40362031|FG000|Overall Study|Physician Decision|3|||
16516978|NCT02759120|40362032|FG001|Overall Study|Physician Decision|0|||
16516979|NCT02759120|40362031|FG000|Overall Study|Withdrawal by Subject|28|||
16516980|NCT02759120|40362032|FG001|Overall Study|Withdrawal by Subject|15|||
16516981|NCT02759120|40362031|FG000|Overall Study|Moved out of area|3|||
16516982|NCT02759120|40362032|FG001|Overall Study|Moved out of area|4|||
16516983|NCT02759120|40362031|FG000|Overall Study|Lung transplant|3|||
16516984|NCT02759120|40362032|FG001|Overall Study|Lung transplant|5|||
16516985|NCT02759120|40362031|FG000|Overall Study|Other reason not completed|10|||
16516986|NCT02759120|40362032|FG001|Overall Study|Other reason not completed|12|||
16516987|NCT05091528|40362033|FG000|Overall Study|Study Termination by Sponsor|0|||
16516988|NCT05091528|40362034|FG001|Overall Study|Study Termination by Sponsor|1|||
16516989|NCT05091528|40362035|FG002|Overall Study|Study Termination by Sponsor|0|||
16516990|NCT05091528|40362036|FG003|Overall Study|Study Termination by Sponsor|1|||
16516991|NCT02148003|40362045|FG000|Overall Study|Failed inclusion criteria|1|||
16202907|NCT01641991|39219023|FG002|Overall Study|Adverse Event|2|||
16202908|NCT01641991|39219024|FG003|Overall Study|Adverse Event|1|||
16202909|NCT01641991|39219021|FG000|Overall Study|Lost to Follow-up|0|||
16202910|NCT01641991|39219022|FG001|Overall Study|Lost to Follow-up|2|||
16202911|NCT01641991|39219023|FG002|Overall Study|Lost to Follow-up|3|||
16202912|NCT01641991|39219024|FG003|Overall Study|Lost to Follow-up|1|||
16202913|NCT01641991|39219021|FG000|Overall Study|Protocol Violation|1|||
16202914|NCT01641991|39219022|FG001|Overall Study|Protocol Violation|1|||
16202915|NCT01641991|39219023|FG002|Overall Study|Protocol Violation|3|||
16516992|NCT02148003|40362046|FG001|Overall Study|Failed inclusion criteria|0|||
16516993|NCT02148003|40362045|FG000|Overall Study|Met exclusion criteria|0|||
16516994|NCT02148003|40362046|FG001|Overall Study|Met exclusion criteria|1|||
16516995|NCT02148003|40362045|FG000|Overall Study|Withdrawal by Subject|0|||
16202916|NCT01641991|39219024|FG003|Overall Study|Protocol Violation|0|||
16202917|NCT01641991|39219021|FG000|Overall Study|Pregnancy|0|||
16321842|NCT00402688|39664086|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
16091801|NCT00413283|38826894|FG003|Overall Study|Death|1|||
16091802|NCT00413283|38826891|FG000|Overall Study|Adverse Event|0|||
16091803|NCT00413283|38826892|FG001|Overall Study|Adverse Event|0|||
16091804|NCT00413283|38826893|FG002|Overall Study|Adverse Event|0|||
16091805|NCT00413283|38826894|FG003|Overall Study|Adverse Event|1|||
16091806|NCT00413283|38826891|FG000|Overall Study|Ineligibility determined|0|||
16091807|NCT00413283|38826892|FG001|Overall Study|Ineligibility determined|0|||
16091808|NCT00413283|38826893|FG002|Overall Study|Ineligibility determined|0|||
16202918|NCT01641991|39219022|FG001|Overall Study|Pregnancy|0|||
16202919|NCT01641991|39219023|FG002|Overall Study|Pregnancy|1|||
16321843|NCT00402688|39664087|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
16321844|NCT02147158|39664088|FG000|Treatment Course 1|Adverse Event|1|||
16321845|NCT02147158|39664089|FG001|Treatment Course 1|Adverse Event|4|||
16202920|NCT01641991|39219024|FG003|Overall Study|Pregnancy|0|||
16202921|NCT01641991|39219021|FG000|Overall Study|no longer eligible|2|||
16321846|NCT02147158|39664090|FG002|Treatment Course 1|Adverse Event|3|||
16091809|NCT00413283|38826894|FG003|Overall Study|Ineligibility determined|1|||
16091810|NCT00413283|38826891|FG000|Overall Study|Protocol deviation|0|||
16091811|NCT00413283|38826892|FG001|Overall Study|Protocol deviation|1|||
16091812|NCT00413283|38826893|FG002|Overall Study|Protocol deviation|0|||
16091813|NCT00413283|38826894|FG003|Overall Study|Protocol deviation|0|||
16091814|NCT00413283|38826891|FG000|Overall Study|Requirement for alternative therapy|0|||
16091815|NCT00413283|38826892|FG001|Overall Study|Requirement for alternative therapy|2|||
16091816|NCT00413283|38826893|FG002|Overall Study|Requirement for alternative therapy|0|||
16091817|NCT00413283|38826894|FG003|Overall Study|Requirement for alternative therapy|0|||
16091818|NCT00413283|38826891|FG000|Overall Study|Other|0|||
16091819|NCT00413283|38826892|FG001|Overall Study|Other|0|||
16091820|NCT00413283|38826893|FG002|Overall Study|Other|1|||
16091821|NCT00413283|38826894|FG003|Overall Study|Other|0|||
16091822|NCT01584648|38826895|FG000|Overall Study|Death|136|||
16091823|NCT01584648|38826896|FG001|Overall Study|Death|146|||
16091824|NCT01584648|38826895|FG000|Overall Study|Lost to Follow-up|9|||
16091825|NCT01584648|38826896|FG001|Overall Study|Lost to Follow-up|9|||
16091826|NCT01584648|38826895|FG000|Overall Study|Investigator discretion|3|||
16091827|NCT01584648|38826896|FG001|Overall Study|Investigator discretion|2|||
16091828|NCT01584648|38826895|FG000|Overall Study|Withdrew consent|13|||
16091829|NCT01584648|38826896|FG001|Overall Study|Withdrew consent|4|||
16091830|NCT01584648|38826895|FG000|Overall Study|Study closed/terminated|50|||
16091831|NCT01584648|38826896|FG001|Overall Study|Study closed/terminated|23|||
16091832|NCT01584648|38826895|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
16516996|NCT02148003|40362046|FG001|Overall Study|Withdrawal by Subject|1|||
16516997|NCT00978731|40362047|FG000|Overall Study|Death|4|||
16516998|NCT00978731|40362048|FG001|Overall Study|Death|1|||
16516999|NCT00978731|40362049|FG002|Overall Study|Death|1|||
16517000|NCT00978731|40362050|FG003|Overall Study|Death|0|||
16517001|NCT00978731|40362047|FG000|Overall Study|Lost to Follow-up|0|||
16517002|NCT00978731|40362048|FG001|Overall Study|Lost to Follow-up|0|||
16517003|NCT00978731|40362049|FG002|Overall Study|Lost to Follow-up|0|||
16517004|NCT00978731|40362050|FG003|Overall Study|Lost to Follow-up|1|||
16091833|NCT01584648|38826896|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
16091834|NCT04382053|38826897|FG000|Overall Study|Death|6|||
16091835|NCT04382053|38826898|FG001|Overall Study|Death|8|||
16091836|NCT04382053|38826897|FG000|Overall Study|Lost to Follow-up|0|||
16091837|NCT04382053|38826898|FG001|Overall Study|Lost to Follow-up|2|||
16091838|NCT04382053|38826897|FG000|Overall Study|Protocol Deviation|1|||
16091839|NCT04382053|38826898|FG001|Overall Study|Protocol Deviation|2|||
16091840|NCT04382053|38826897|FG000|Overall Study|Withdrawal by Subject|2|||
16091841|NCT04382053|38826898|FG001|Overall Study|Withdrawal by Subject|1|||
16091842|NCT03678688|38826899|FG000|Overall Study|Reason not Specified|0|||
16091843|NCT03678688|38826900|FG001|Overall Study|Reason not Specified|0|||
16091844|NCT03678688|38826901|FG002|Overall Study|Reason not Specified|3|||
16091845|NCT03678688|38826902|FG003|Overall Study|Reason not Specified|0|||
16091846|NCT03678688|38826903|FG004|Overall Study|Reason not Specified|1|||
16091847|NCT03678688|38826904|FG005|Overall Study|Reason not Specified|0|||
16091848|NCT03678688|38826905|FG006|Overall Study|Reason not Specified|0|||
16091849|NCT03678688|38826906|FG007|Overall Study|Reason not Specified|0|||
16091850|NCT03678688|38826907|FG008|Overall Study|Reason not Specified|0|||
16091851|NCT03678688|38826899|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
16091852|NCT03678688|38826900|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
16091853|NCT03678688|38826901|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
16091854|NCT03678688|38826902|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
16091855|NCT03678688|38826903|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
16091856|NCT03678688|38826904|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
16091857|NCT03678688|38826905|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
16091858|NCT03678688|38826906|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
16091859|NCT03678688|38826907|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
16091860|NCT03678688|38826899|FG000|Overall Study|Covid Related Adverse Event|0|||
16091861|NCT03678688|38826900|FG001|Overall Study|Covid Related Adverse Event|0|||
16091862|NCT03678688|38826901|FG002|Overall Study|Covid Related Adverse Event|0|||
16091863|NCT03678688|38826902|FG003|Overall Study|Covid Related Adverse Event|0|||
16091864|NCT03678688|38826903|FG004|Overall Study|Covid Related Adverse Event|0|||
16091865|NCT03678688|38826904|FG005|Overall Study|Covid Related Adverse Event|3|||
16091866|NCT03678688|38826905|FG006|Overall Study|Covid Related Adverse Event|1|||
16091867|NCT03678688|38826906|FG007|Overall Study|Covid Related Adverse Event|1|||
16091868|NCT03678688|38826907|FG008|Overall Study|Covid Related Adverse Event|0|||
16091869|NCT03678688|38826899|FG000|Overall Study|Physician Decision|0|||
16091870|NCT03678688|38826900|FG001|Overall Study|Physician Decision|0|||
16091871|NCT03678688|38826901|FG002|Overall Study|Physician Decision|0|||
16091872|NCT03678688|38826902|FG003|Overall Study|Physician Decision|0|||
16091873|NCT03678688|38826903|FG004|Overall Study|Physician Decision|0|||
16091874|NCT03678688|38826904|FG005|Overall Study|Physician Decision|1|||
16091875|NCT03678688|38826905|FG006|Overall Study|Physician Decision|0|||
16091876|NCT03678688|38826906|FG007|Overall Study|Physician Decision|0|||
16517005|NCT00978731|40362047|FG000|Overall Study|Adverse Event|5|||
16091877|NCT03678688|38826907|FG008|Overall Study|Physician Decision|0|||
16091878|NCT03678688|38826899|FG000|Overall Study|Withdrawal by Subject|0|||
16091879|NCT03678688|38826900|FG001|Overall Study|Withdrawal by Subject|0|||
16091880|NCT03678688|38826901|FG002|Overall Study|Withdrawal by Subject|0|||
16091881|NCT03678688|38826902|FG003|Overall Study|Withdrawal by Subject|0|||
16091882|NCT03678688|38826903|FG004|Overall Study|Withdrawal by Subject|0|||
16091883|NCT03678688|38826904|FG005|Overall Study|Withdrawal by Subject|0|||
16091884|NCT03678688|38826905|FG006|Overall Study|Withdrawal by Subject|2|||
16091885|NCT03678688|38826906|FG007|Overall Study|Withdrawal by Subject|1|||
16091886|NCT03678688|38826907|FG008|Overall Study|Withdrawal by Subject|0|||
16091887|NCT01248715|38826908|FG000|Overall Study|Not influenza positive|501|||
16091888|NCT01248715|38826909|FG001|Overall Study|Not influenza positive|510|||
16091889|NCT00805441|38826910|FG000|Overall Study|Adverse Event|5|||
16091890|NCT00805441|38826911|FG001|Overall Study|Adverse Event|2|||
16091891|NCT00805441|38826910|FG000|Overall Study|Lack of Efficacy|0|||
16091892|NCT00805441|38826911|FG001|Overall Study|Lack of Efficacy|2|||
16091893|NCT00805441|38826910|FG000|Overall Study|Protocol Violation|4|||
16091894|NCT00805441|38826911|FG001|Overall Study|Protocol Violation|8|||
16091895|NCT00805441|38826910|FG000|Overall Study|Lost to Follow-up|10|||
16091896|NCT00805441|38826911|FG001|Overall Study|Lost to Follow-up|13|||
16091897|NCT00805441|38826910|FG000|Overall Study|Withdrawal by Subject|15|||
16091898|NCT00805441|38826911|FG001|Overall Study|Withdrawal by Subject|9|||
16091899|NCT00805441|38826910|FG000|Overall Study|Physician Decision|0|||
16091900|NCT00805441|38826911|FG001|Overall Study|Physician Decision|1|||
16091901|NCT00805441|38826910|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
16091902|NCT00805441|38826911|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
16091903|NCT01019135|38826912|FG000|Overall Study|Did not receive allocated intervention|12|||
16091904|NCT01019135|38826913|FG001|Overall Study|Did not receive allocated intervention|6|||
16091905|NCT01019135|38826914|FG002|Overall Study|Did not receive allocated intervention|25|||
16091906|NCT01019135|38826912|FG000|Overall Study|Did not attend CR|8|||
16091907|NCT01019135|38826913|FG001|Overall Study|Did not attend CR|13|||
16091908|NCT01019135|38826914|FG002|Overall Study|Did not attend CR|6|||
16091909|NCT01186809|38826915|FG000|Overall Study|Death|30|||
16091910|NCT04559698|38826916|FG000|Overall Study|Lost to Follow-up|14|||
16091911|NCT04559698|38826917|FG001|Overall Study|Lost to Follow-up|15|||
16091912|NCT04559698|38826916|FG000|Overall Study|Withdrawal by Subject|0|||
16091913|NCT04559698|38826917|FG001|Overall Study|Withdrawal by Subject|1|||
16091914|NCT00537914|38826918|FG000|Overall Study|Death|1|||
16091915|NCT00537914|38826918|FG000|Overall Study|Adverse Event|7|||
16091916|NCT00537914|38826918|FG000|Overall Study|Treatment failure|10|||
16091917|NCT00537914|38826918|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
16091918|NCT00537914|38826918|FG000|Overall Study|Lost to Follow-up|19|||
16091919|NCT00537914|38826918|FG000|Overall Study|Withdrawal of informed consent|59|||
16091920|NCT01836523|38826919|FG000|Overall Study|Adverse Event|15|||
16091921|NCT01836523|38826920|FG001|Overall Study|Adverse Event|41|||
16091922|NCT01836523|38826921|FG002|Overall Study|Adverse Event|49|||
16091923|NCT01836523|38826922|FG003|Overall Study|Adverse Event|14|||
16091924|NCT01836523|38826919|FG000|Overall Study|Protocol Violation|6|||
16202922|NCT01641991|39219022|FG001|Overall Study|no longer eligible|1|||
16202923|NCT01641991|39219023|FG002|Overall Study|no longer eligible|0|||
16091925|NCT01836523|38826920|FG001|Overall Study|Protocol Violation|3|||
16091926|NCT01836523|38826921|FG002|Overall Study|Protocol Violation|2|||
16091927|NCT01836523|38826922|FG003|Overall Study|Protocol Violation|4|||
16091928|NCT01836523|38826919|FG000|Overall Study|Met Withdrawal Criteria|13|||
16091929|NCT01836523|38826920|FG001|Overall Study|Met Withdrawal Criteria|13|||
16091930|NCT01836523|38826921|FG002|Overall Study|Met Withdrawal Criteria|21|||
16091931|NCT01836523|38826922|FG003|Overall Study|Met Withdrawal Criteria|27|||
16091932|NCT01836523|38826919|FG000|Overall Study|Unclassified|17|||
16091933|NCT01836523|38826920|FG001|Overall Study|Unclassified|28|||
16321847|NCT02147158|39664091|FG003|Treatment Course 1|Adverse Event|4|||
16321848|NCT02147158|39664092|FG004|Treatment Course 1|Adverse Event|1|||
16517006|NCT00978731|40362048|FG001|Overall Study|Adverse Event|2|||
16091934|NCT01836523|38826921|FG002|Overall Study|Unclassified|19|||
16517007|NCT00978731|40362049|FG002|Overall Study|Adverse Event|0|||
16517008|NCT00978731|40362050|FG003|Overall Study|Adverse Event|0|||
16517009|NCT00978731|40362047|FG000|Overall Study|Participant's request|1|||
16517010|NCT00978731|40362048|FG001|Overall Study|Participant's request|0|||
16517011|NCT00978731|40362049|FG002|Overall Study|Participant's request|0|||
16517012|NCT00978731|40362050|FG003|Overall Study|Participant's request|0|||
16517013|NCT00978731|40362047|FG000|Overall Study|Administrative reason|3|||
16517014|NCT00978731|40362048|FG001|Overall Study|Administrative reason|3|||
16517015|NCT00978731|40362049|FG002|Overall Study|Administrative reason|1|||
16517016|NCT00978731|40362050|FG003|Overall Study|Administrative reason|0|||
16091935|NCT01836523|38826922|FG003|Overall Study|Unclassified|29|||
16091936|NCT05376397|38826924|FG000|Overall Study|Lost to Follow-up|1|||
16091937|NCT00624377|38826927|FG000|Overall Study|Lost to Follow-up|355|||
16091938|NCT00624377|38826927|FG000|Overall Study|Withdrawal by Subject|100|||
16321849|NCT02147158|39664093|FG005|Treatment Course 1|Adverse Event|2|||
16202924|NCT01641991|39219024|FG003|Overall Study|no longer eligible|4|||
16202925|NCT01425749|39222860|FG000|Overall Study|progression of melanoma|0|||
16202926|NCT01425749|39222861|FG001|Overall Study|progression of melanoma|1|||
16202927|NCT00851253|39222863|FG000|Overall Study|Disease Progression|1|||
16202928|NCT00851253|39222864|FG001|Overall Study|Disease Progression|0|||
16202929|NCT02586077|39222867|FG000|Overall Study|Withdrawal by Subject|1|||
16202930|NCT02586077|39222867|FG000|Overall Study|Physician Decision|4|||
16202931|NCT02586077|39222867|FG000|Overall Study|Lost to Follow-up|3|||
16517017|NCT00978731|40362047|FG000|Overall Study|Deterioration without progression|0|||
16517018|NCT00978731|40362048|FG001|Overall Study|Deterioration without progression|1|||
16517019|NCT00978731|40362049|FG002|Overall Study|Deterioration without progression|0|||
16517020|NCT00978731|40362050|FG003|Overall Study|Deterioration without progression|0|||
16517021|NCT00978731|40362047|FG000|Overall Study|Disease progression/relapse|5|||
16517022|NCT00978731|40362048|FG001|Overall Study|Disease progression/relapse|4|||
16517023|NCT00978731|40362049|FG002|Overall Study|Disease progression/relapse|2|||
16517024|NCT00978731|40362050|FG003|Overall Study|Disease progression/relapse|2|||
16517025|NCT00978731|40362047|FG000|Overall Study|Study closure|3|||
16517026|NCT00978731|40362048|FG001|Overall Study|Study closure|4|||
16517027|NCT00978731|40362049|FG002|Overall Study|Study closure|1|||
16517028|NCT00978731|40362050|FG003|Overall Study|Study closure|1|||
16517029|NCT00978731|40362047|FG000|Overall Study|No response|1|||
16517030|NCT00978731|40362048|FG001|Overall Study|No response|0|||
16517031|NCT00978731|40362049|FG002|Overall Study|No response|0|||
16517032|NCT00978731|40362050|FG003|Overall Study|No response|0|||
16517033|NCT03265119|40362051|FG000|Overall Study|Adverse Event|2|||
16517034|NCT03265119|40362052|FG001|Overall Study|Adverse Event|1|||
16517035|NCT03265119|40362051|FG000|Overall Study|Lack of Efficacy|3|||
16517036|NCT03265119|40362052|FG001|Overall Study|Lack of Efficacy|0|||
16517037|NCT03265119|40362051|FG000|Overall Study|Protocol Violation|1|||
16517038|NCT03265119|40362052|FG001|Overall Study|Protocol Violation|2|||
16517039|NCT03265119|40362051|FG000|Overall Study|Withdrawal by Subject|2|||
16517040|NCT03265119|40362052|FG001|Overall Study|Withdrawal by Subject|4|||
16517041|NCT03265119|40362051|FG000|Overall Study|Lost to Follow-up|1|||
16517042|NCT03265119|40362052|FG001|Overall Study|Lost to Follow-up|0|||
16517043|NCT03265119|40362051|FG000|Overall Study|Lack of Compliance|1|||
16517044|NCT03265119|40362052|FG001|Overall Study|Lack of Compliance|0|||
16517045|NCT00850200|40362055|FG000|Overall Study|Physician Decision|2|||
16517046|NCT00850200|40362055|FG000|Overall Study|Did not recieve treatment|2|||
16517047|NCT00850200|40362055|FG000|Overall Study|Withdrawal by Subject|1|||
16517048|NCT02047604|40362056|FG000|Overall Study|Withdrawal by Subject|0|||
16517049|NCT02047604|40362057|FG001|Overall Study|Withdrawal by Subject|0|||
16517050|NCT02047604|40362058|FG002|Overall Study|Withdrawal by Subject|0|||
16517051|NCT02047604|40362059|FG003|Overall Study|Withdrawal by Subject|0|||
16517052|NCT02047604|40362060|FG004|Overall Study|Withdrawal by Subject|1|||
16517053|NCT02047604|40362061|FG005|Overall Study|Withdrawal by Subject|1|||
16517054|NCT03135522|40362062|FG000|Overall Study|Adverse Event|1|||
16517055|NCT03135522|40362063|FG001|Overall Study|Adverse Event|0|||
16517056|NCT01465802|40362066|FG000|Overall Study|Study terminated by sponsor|1|||
16517057|NCT01465802|40362067|FG001|Overall Study|Study terminated by sponsor|0|||
16517058|NCT01465802|40362068|FG002|Overall Study|Study terminated by sponsor|0|||
16517059|NCT01465802|40362069|FG003|Overall Study|Study terminated by sponsor|1|||
16517060|NCT01465802|40362070|FG004|Overall Study|Study terminated by sponsor|7|||
16517061|NCT01465802|40362066|FG000|Overall Study|Withdrawal by Subject|7|||
16517062|NCT01465802|40362067|FG001|Overall Study|Withdrawal by Subject|7|||
16517063|NCT01465802|40362068|FG002|Overall Study|Withdrawal by Subject|0|||
16517064|NCT01465802|40362069|FG003|Overall Study|Withdrawal by Subject|8|||
16517065|NCT01465802|40362070|FG004|Overall Study|Withdrawal by Subject|1|||
16517066|NCT01465802|40362066|FG000|Overall Study|Lost to Follow-up|1|||
16517067|NCT01465802|40362067|FG001|Overall Study|Lost to Follow-up|1|||
16517068|NCT01465802|40362068|FG002|Overall Study|Lost to Follow-up|0|||
16517069|NCT01465802|40362069|FG003|Overall Study|Lost to Follow-up|0|||
16517070|NCT01465802|40362070|FG004|Overall Study|Lost to Follow-up|0|||
16517071|NCT01465802|40362066|FG000|Overall Study|Reason not specified|9|||
16517072|NCT01465802|40362067|FG001|Overall Study|Reason not specified|4|||
16517073|NCT01465802|40362068|FG002|Overall Study|Reason not specified|0|||
16517074|NCT01465802|40362069|FG003|Overall Study|Reason not specified|10|||
16517075|NCT01465802|40362070|FG004|Overall Study|Reason not specified|2|||
16517076|NCT01465802|40362066|FG000|Overall Study|Death|15|||
16517077|NCT01465802|40362067|FG001|Overall Study|Death|12|||
16202932|NCT00587301|39222871|FG000|Overall Study|Screen Failure|9|||
16517078|NCT01465802|40362068|FG002|Overall Study|Death|0|||
16517079|NCT01465802|40362069|FG003|Overall Study|Death|10|||
16517080|NCT01465802|40362070|FG004|Overall Study|Death|2|||
16517081|NCT02644967|40362071|FG000|Overall Study|Death|26|||
16517082|NCT02644967|40362071|FG000|Overall Study|Physician Decision|1|||
16517083|NCT02644967|40362071|FG000|Overall Study|Withdrawal by Subject|2|||
16517084|NCT02644967|40362071|FG000|Overall Study|Protocol Violation|1|||
16517085|NCT02644967|40362071|FG000|Overall Study|Progressive Disease|1|||
16517086|NCT02644967|40362071|FG000|Overall Study|Study Terminated by Sponsor|4|||
16091939|NCT00624377|38826927|FG000|Overall Study|Adverse Event|14|||
16091940|NCT00624377|38826927|FG000|Overall Study|Other|91|||
16202933|NCT00587301|39222871|FG000|Overall Study|Lost to Follow-up|22|||
16321850|NCT02147158|39664088|FG000|Treatment Course 1|Lost to Follow-up|2|||
16321851|NCT02147158|39664089|FG001|Treatment Course 1|Lost to Follow-up|4|||
16321852|NCT02147158|39664090|FG002|Treatment Course 1|Lost to Follow-up|3|||
16321853|NCT02147158|39664091|FG003|Treatment Course 1|Lost to Follow-up|3|||
16321854|NCT02147158|39664092|FG004|Treatment Course 1|Lost to Follow-up|2|||
16321855|NCT02147158|39664093|FG005|Treatment Course 1|Lost to Follow-up|4|||
16321856|NCT02147158|39664088|FG000|Treatment Course 1|Protocol Violation|0|||
16321857|NCT02147158|39664089|FG001|Treatment Course 1|Protocol Violation|0|||
16321858|NCT02147158|39664090|FG002|Treatment Course 1|Protocol Violation|1|||
16321859|NCT02147158|39664091|FG003|Treatment Course 1|Protocol Violation|1|||
16321860|NCT02147158|39664092|FG004|Treatment Course 1|Protocol Violation|0|||
16321861|NCT02147158|39664093|FG005|Treatment Course 1|Protocol Violation|0|||
16321862|NCT02147158|39664088|FG000|Treatment Course 1|Withdrawal of Consent|1|||
16321863|NCT02147158|39664089|FG001|Treatment Course 1|Withdrawal of Consent|1|||
16321864|NCT02147158|39664090|FG002|Treatment Course 1|Withdrawal of Consent|1|||
16321865|NCT02147158|39664091|FG003|Treatment Course 1|Withdrawal of Consent|5|||
16321866|NCT02147158|39664092|FG004|Treatment Course 1|Withdrawal of Consent|3|||
16321867|NCT02147158|39664093|FG005|Treatment Course 1|Withdrawal of Consent|2|||
16321868|NCT02147158|39664088|FG000|Off-Treatment Interval 1|Adverse Event|1|||
16321869|NCT02147158|39664089|FG001|Off-Treatment Interval 1|Adverse Event|0|||
16321870|NCT02147158|39664090|FG002|Off-Treatment Interval 1|Adverse Event|0|||
16321871|NCT02147158|39664091|FG003|Off-Treatment Interval 1|Adverse Event|1|||
16517087|NCT03394391|40362073|FG000|Overall Study|Lost to Follow-up|1|||
16517088|NCT03394391|40362074|FG001|Overall Study|Lost to Follow-up|2|||
16517089|NCT02896400|40362085|FG000|1 Month Follow-up|Lost to Follow-up|7|||
16517090|NCT02896400|40362086|FG001|1 Month Follow-up|Lost to Follow-up|7|||
16517091|NCT02896400|40362087|FG002|1 Month Follow-up|Lost to Follow-up|5|||
16517092|NCT02896400|40362088|FG003|1 Month Follow-up|Lost to Follow-up|8|||
16517093|NCT02896400|40362089|FG004|1 Month Follow-up|Lost to Follow-up|9|||
16517094|NCT02896400|40362090|FG005|1 Month Follow-up|Lost to Follow-up|6|||
16517095|NCT02896400|40362091|FG006|1 Month Follow-up|Lost to Follow-up|5|||
16517096|NCT02896400|40362092|FG007|1 Month Follow-up|Lost to Follow-up|6|||
16517097|NCT02896400|40362093|FG008|1 Month Follow-up|Lost to Follow-up|4|||
16517098|NCT02896400|40362094|FG009|1 Month Follow-up|Lost to Follow-up|7|||
16517099|NCT02896400|40362095|FG010|1 Month Follow-up|Lost to Follow-up|5|||
16517100|NCT02896400|40362096|FG011|1 Month Follow-up|Lost to Follow-up|5|||
16517101|NCT02896400|40362097|FG012|1 Month Follow-up|Lost to Follow-up|3|||
16517102|NCT02896400|40362098|FG013|1 Month Follow-up|Lost to Follow-up|4|||
16517103|NCT02896400|40362099|FG014|1 Month Follow-up|Lost to Follow-up|1|||
16517104|NCT02896400|40362100|FG015|1 Month Follow-up|Lost to Follow-up|2|||
16517105|NCT02896400|40362085|FG000|1 Month Follow-up|Death|0|||
16517106|NCT02896400|40362086|FG001|1 Month Follow-up|Death|0|||
16517107|NCT02896400|40362087|FG002|1 Month Follow-up|Death|0|||
16517108|NCT02896400|40362088|FG003|1 Month Follow-up|Death|0|||
16517109|NCT02896400|40362089|FG004|1 Month Follow-up|Death|0|||
16517110|NCT02896400|40362090|FG005|1 Month Follow-up|Death|0|||
16517111|NCT02896400|40362091|FG006|1 Month Follow-up|Death|0|||
16517112|NCT02896400|40362092|FG007|1 Month Follow-up|Death|0|||
16517113|NCT02896400|40362093|FG008|1 Month Follow-up|Death|0|||
16517114|NCT02896400|40362094|FG009|1 Month Follow-up|Death|0|||
16517115|NCT02896400|40362095|FG010|1 Month Follow-up|Death|0|||
16517116|NCT02896400|40362096|FG011|1 Month Follow-up|Death|0|||
16517117|NCT02896400|40362097|FG012|1 Month Follow-up|Death|0|||
16517118|NCT02896400|40362098|FG013|1 Month Follow-up|Death|0|||
16517119|NCT02896400|40362099|FG014|1 Month Follow-up|Death|0|||
16517120|NCT02896400|40362100|FG015|1 Month Follow-up|Death|1|||
16202934|NCT00587301|39222871|FG000|Overall Study|Withdrawal by Subject|7|||
16202935|NCT00587301|39222871|FG000|Overall Study|Protocol Violation|7|||
16202936|NCT03587584|39222872|FG000|Overall Study|SOC deviations|4|||
16321872|NCT02147158|39664092|FG004|Off-Treatment Interval 1|Adverse Event|0|||
16321873|NCT02147158|39664093|FG005|Off-Treatment Interval 1|Adverse Event|0|||
16321874|NCT02147158|39664088|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
16321875|NCT02147158|39664089|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
16321876|NCT02147158|39664090|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
16321877|NCT02147158|39664091|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
16321878|NCT02147158|39664092|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
16321879|NCT02147158|39664093|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
16517121|NCT02896400|40362085|FG000|3 Month Follow-up|Lost to Follow-up|6|||
16517122|NCT02896400|40362086|FG001|3 Month Follow-up|Lost to Follow-up|3|||
16517123|NCT02896400|40362087|FG002|3 Month Follow-up|Lost to Follow-up|6|||
16517124|NCT02896400|40362088|FG003|3 Month Follow-up|Lost to Follow-up|11|||
16517125|NCT02896400|40362089|FG004|3 Month Follow-up|Lost to Follow-up|12|||
16517126|NCT02896400|40362090|FG005|3 Month Follow-up|Lost to Follow-up|6|||
16517127|NCT02896400|40362091|FG006|3 Month Follow-up|Lost to Follow-up|4|||
16517128|NCT02896400|40362092|FG007|3 Month Follow-up|Lost to Follow-up|3|||
16202937|NCT03587584|39222873|FG001|Overall Study|SOC deviations|6|||
16202938|NCT03587584|39222872|FG000|Overall Study|Incomplete data|0|||
16202939|NCT03587584|39222873|FG001|Overall Study|Incomplete data|3|||
16321880|NCT02147158|39664088|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
16321881|NCT02147158|39664089|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
16321882|NCT02147158|39664090|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
16321883|NCT02147158|39664091|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
16321884|NCT02147158|39664092|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
16321885|NCT02147158|39664093|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
16321886|NCT02147158|39664088|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
16321887|NCT02147158|39664089|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
16321888|NCT02147158|39664090|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
16321889|NCT02147158|39664091|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
16321890|NCT02147158|39664092|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
16321891|NCT02147158|39664093|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
16321892|NCT02147158|39664088|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
16321893|NCT02147158|39664089|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
16321894|NCT02147158|39664090|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
16321895|NCT02147158|39664091|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
16321896|NCT02147158|39664092|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
16321897|NCT02147158|39664093|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
16321898|NCT02147158|39664088|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
16321899|NCT02147158|39664089|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
16321900|NCT02147158|39664090|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
16321901|NCT02147158|39664091|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
16321902|NCT02147158|39664092|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
16321903|NCT02147158|39664093|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
16321904|NCT02147158|39664088|FG000|Treatment Course 2|Adverse Event|0|||
16321905|NCT02147158|39664089|FG001|Treatment Course 2|Adverse Event|4|||
16321906|NCT02147158|39664090|FG002|Treatment Course 2|Adverse Event|2|||
16321907|NCT02147158|39664091|FG003|Treatment Course 2|Adverse Event|1|||
16321908|NCT02147158|39664092|FG004|Treatment Course 2|Adverse Event|0|||
16517129|NCT02896400|40362093|FG008|3 Month Follow-up|Lost to Follow-up|6|||
16517130|NCT02896400|40362094|FG009|3 Month Follow-up|Lost to Follow-up|5|||
16517131|NCT02896400|40362095|FG010|3 Month Follow-up|Lost to Follow-up|6|||
16517132|NCT02896400|40362096|FG011|3 Month Follow-up|Lost to Follow-up|6|||
16517133|NCT02896400|40362097|FG012|3 Month Follow-up|Lost to Follow-up|3|||
16517134|NCT02896400|40362098|FG013|3 Month Follow-up|Lost to Follow-up|5|||
16517135|NCT02896400|40362099|FG014|3 Month Follow-up|Lost to Follow-up|3|||
16517136|NCT02896400|40362100|FG015|3 Month Follow-up|Lost to Follow-up|2|||
16517137|NCT02896400|40362085|FG000|3 Month Follow-up|Death|0|||
16517138|NCT02896400|40362086|FG001|3 Month Follow-up|Death|0|||
16517139|NCT02896400|40362087|FG002|3 Month Follow-up|Death|0|||
16517140|NCT02896400|40362088|FG003|3 Month Follow-up|Death|0|||
16517141|NCT02896400|40362089|FG004|3 Month Follow-up|Death|0|||
16517142|NCT02896400|40362090|FG005|3 Month Follow-up|Death|0|||
16517143|NCT02896400|40362091|FG006|3 Month Follow-up|Death|0|||
16517144|NCT02896400|40362092|FG007|3 Month Follow-up|Death|0|||
16517145|NCT02896400|40362093|FG008|3 Month Follow-up|Death|0|||
16517146|NCT02896400|40362094|FG009|3 Month Follow-up|Death|0|||
16517147|NCT02896400|40362095|FG010|3 Month Follow-up|Death|0|||
16517148|NCT02896400|40362096|FG011|3 Month Follow-up|Death|0|||
16517149|NCT02896400|40362097|FG012|3 Month Follow-up|Death|0|||
16517150|NCT02896400|40362098|FG013|3 Month Follow-up|Death|1|||
16517151|NCT02896400|40362099|FG014|3 Month Follow-up|Death|1|||
16517152|NCT02896400|40362100|FG015|3 Month Follow-up|Death|0|||
16517153|NCT02896400|40362085|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
16517154|NCT02896400|40362086|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
16517155|NCT02896400|40362087|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
16517156|NCT02896400|40362088|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
16517157|NCT02896400|40362089|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
16517158|NCT02896400|40362090|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
16517159|NCT02896400|40362091|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
16517160|NCT02896400|40362092|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
16517161|NCT02896400|40362093|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
16517162|NCT02896400|40362094|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
16517163|NCT02896400|40362095|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
16517164|NCT02896400|40362096|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
16517165|NCT02896400|40362097|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
16517166|NCT02896400|40362098|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
16517167|NCT02896400|40362099|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
16517168|NCT02896400|40362100|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
16517169|NCT02896400|40362085|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
16091941|NCT00624377|38826927|FG000|Overall Study|Non-evaluable population|84|||
16091942|NCT02309515|38826930|FG000|Overall Study|Withdrawal by Subject|0|||
16091943|NCT02309515|38826931|FG001|Overall Study|Withdrawal by Subject|1|||
16091944|NCT01794689|38826932|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
16091945|NCT01794689|38826933|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
16091946|NCT01794689|38826934|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
16091947|NCT01794689|38826935|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
16091948|NCT01794689|38826932|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
16321909|NCT02147158|39664093|FG005|Treatment Course 2|Adverse Event|1|||
16091949|NCT01794689|38826933|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
16321910|NCT02147158|39664088|FG000|Treatment Course 2|Withdrawal of Consent|0|||
16321911|NCT02147158|39664089|FG001|Treatment Course 2|Withdrawal of Consent|1|||
16321912|NCT02147158|39664090|FG002|Treatment Course 2|Withdrawal of Consent|2|||
16321913|NCT02147158|39664091|FG003|Treatment Course 2|Withdrawal of Consent|3|||
16321914|NCT02147158|39664092|FG004|Treatment Course 2|Withdrawal of Consent|0|||
16321915|NCT02147158|39664093|FG005|Treatment Course 2|Withdrawal of Consent|0|||
16321916|NCT02147158|39664088|FG000|Treatment Course 2|Lost to Follow-up|1|||
16321917|NCT02147158|39664089|FG001|Treatment Course 2|Lost to Follow-up|0|||
16321918|NCT02147158|39664090|FG002|Treatment Course 2|Lost to Follow-up|1|||
16321919|NCT02147158|39664091|FG003|Treatment Course 2|Lost to Follow-up|1|||
16321920|NCT02147158|39664092|FG004|Treatment Course 2|Lost to Follow-up|0|||
16321921|NCT02147158|39664093|FG005|Treatment Course 2|Lost to Follow-up|1|||
16321922|NCT02147158|39664088|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
16321923|NCT02147158|39664089|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
16321924|NCT02147158|39664090|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
16321925|NCT02147158|39664091|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
16321926|NCT02147158|39664092|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
16321927|NCT02147158|39664093|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
16321928|NCT02147158|39664088|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
16321929|NCT02147158|39664089|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
16321930|NCT02147158|39664090|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
16321931|NCT02147158|39664091|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
16321932|NCT02147158|39664092|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
16321933|NCT02147158|39664093|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
16321934|NCT02147158|39664088|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
16321935|NCT02147158|39664089|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
16321936|NCT02147158|39664090|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
16321937|NCT02147158|39664091|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
16321938|NCT02147158|39664092|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
16321939|NCT02147158|39664093|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
16321940|NCT02147158|39664088|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
16321941|NCT02147158|39664089|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
16321942|NCT02147158|39664090|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
16321943|NCT02147158|39664091|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
16321944|NCT02147158|39664092|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
16321945|NCT02147158|39664093|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
16321946|NCT02147158|39664088|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
16321947|NCT02147158|39664089|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
16321948|NCT02147158|39664090|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
16321949|NCT02147158|39664091|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
16321950|NCT02147158|39664092|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
16321951|NCT02147158|39664093|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
16517170|NCT02896400|40362086|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
16517171|NCT02896400|40362087|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
16517172|NCT02896400|40362088|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
16517173|NCT02896400|40362089|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
16517174|NCT02896400|40362090|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
16517175|NCT02896400|40362091|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
16517176|NCT02896400|40362092|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
16517177|NCT02896400|40362093|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
16517178|NCT02896400|40362094|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
16517179|NCT02896400|40362095|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
16517180|NCT02896400|40362096|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
16517181|NCT02896400|40362097|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
16517182|NCT02896400|40362098|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
16517183|NCT02896400|40362099|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
16517184|NCT02896400|40362100|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
16517185|NCT00482391|40362101|FG000|Overall Study|Withdrawal by Subject|1|||
16517186|NCT00482391|40362101|FG000|Overall Study|Adverse Event|1|||
16517187|NCT00482391|40362101|FG000|Overall Study|Death|1|||
16517188|NCT03191903|40362107|FG000|Overall Study|Withdrawal by Subject|6|||
16517189|NCT03191903|40362108|FG001|Overall Study|Withdrawal by Subject|5|||
16517190|NCT03191903|40362109|FG002|Overall Study|Withdrawal by Subject|4|||
16517191|NCT03191903|40362107|FG000|Overall Study|Adverse Event|1|||
16517192|NCT03191903|40362108|FG001|Overall Study|Adverse Event|0|||
16517193|NCT03191903|40362109|FG002|Overall Study|Adverse Event|0|||
16517194|NCT00519649|40362110|FG000|Overall Study|Withdrawal by Subject|1|||
16517195|NCT01434823|40362111|FG000|Overall Study|Incomplete data in medical record|4|||
16517196|NCT01434823|40362112|FG001|Overall Study|Incomplete data in medical record|7|||
16517197|NCT00546715|40362113|FG000|Overall Study|Withdrawal by Subject|0|||
16517198|NCT00546715|40362114|FG001|Overall Study|Withdrawal by Subject|1|||
16517199|NCT00546715|40362115|FG002|Overall Study|Withdrawal by Subject|0|||
16517200|NCT00546715|40362116|FG003|Overall Study|Withdrawal by Subject|0|||
16517201|NCT02489981|40362126|FG000|Overall Study|Adverse Event|21|||
16517202|NCT02489981|40362126|FG000|Overall Study|Insufficient effectiveness|16|||
16091950|NCT01794689|38826934|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
16091951|NCT01794689|38826935|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
16091952|NCT01794689|38826932|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
16091953|NCT01794689|38826933|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
16091954|NCT01794689|38826934|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
16091955|NCT01794689|38826935|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
16091956|NCT01794689|38826932|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
16091957|NCT01794689|38826933|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
16091958|NCT01794689|38826934|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
16091959|NCT01794689|38826935|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
16091960|NCT00696241|38826936|FG000|Overall Study|Adverse Event|11|||
16091961|NCT00696241|38826937|FG001|Overall Study|Adverse Event|3|||
16091962|NCT00696241|38826938|FG002|Overall Study|Adverse Event|6|||
16091963|NCT00696241|38826939|FG003|Overall Study|Adverse Event|4|||
16321952|NCT02285166|39664094|FG000|Overall Study|Case Report Forms Uncollected|564|||
16321953|NCT02285166|39664094|FG000|Overall Study|Protocol Deviation|402|||
16321954|NCT00977314|39664097|FG000|Overall Study|Withdrawal by Subject|1|||
16321955|NCT00977314|39664098|FG001|Overall Study|Withdrawal by Subject|0|||
16321956|NCT00977314|39664097|FG000|Overall Study|Physician Decision|1|||
16321957|NCT00977314|39664098|FG001|Overall Study|Physician Decision|0|||
16321958|NCT01672710|39664099|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
16321959|NCT01672710|39664100|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
16321960|NCT01672710|39664099|FG000|3 Month Follow up|Lost to Follow-up|2|||
16321961|NCT01672710|39664100|FG001|3 Month Follow up|Lost to Follow-up|3|||
16321962|NCT01672710|39664099|FG000|3 Month Follow up|follow up due after termination date|4|||
16321963|NCT01672710|39664100|FG001|3 Month Follow up|follow up due after termination date|1|||
16321964|NCT02616146|39664103|FG000|Overall Study|Adverse Event|64|||
16321965|NCT02616146|39664104|FG001|Overall Study|Adverse Event|24|||
16321966|NCT02616146|39664103|FG000|Overall Study|Lost to Follow-up|23|||
16091964|NCT00696241|38826940|FG004|Overall Study|Adverse Event|5|||
16321967|NCT02616146|39664104|FG001|Overall Study|Lost to Follow-up|13|||
16321968|NCT02616146|39664103|FG000|Overall Study|Non-compliance with study protocol|2|||
16321969|NCT02616146|39664104|FG001|Overall Study|Non-compliance with study protocol|0|||
16321970|NCT02616146|39664103|FG000|Overall Study|Non-compliance with study drug|4|||
16321971|NCT02616146|39664104|FG001|Overall Study|Non-compliance with study drug|2|||
16517203|NCT02489981|40362126|FG000|Overall Study|Improved|31|||
16517204|NCT02489981|40362126|FG000|Overall Study|Lost to Follow-up|31|||
16321972|NCT02616146|39664103|FG000|Overall Study|Pregnancy|2|||
16321973|NCT02616146|39664104|FG001|Overall Study|Pregnancy|2|||
16321974|NCT02616146|39664103|FG000|Overall Study|Pregnancy wish|3|||
16321975|NCT02616146|39664104|FG001|Overall Study|Pregnancy wish|0|||
16321976|NCT02616146|39664103|FG000|Overall Study|Protocol Violation|6|||
16321977|NCT02616146|39664104|FG001|Overall Study|Protocol Violation|3|||
16321978|NCT02616146|39664103|FG000|Overall Study|Study terminated by sponsor|1372|||
16091965|NCT00696241|38826936|FG000|Overall Study|Protocol Violation|1|||
16091966|NCT00696241|38826937|FG001|Overall Study|Protocol Violation|1|||
16091967|NCT00696241|38826938|FG002|Overall Study|Protocol Violation|2|||
16091968|NCT00696241|38826939|FG003|Overall Study|Protocol Violation|0|||
16321979|NCT02616146|39664104|FG001|Overall Study|Study terminated by sponsor|432|||
16321980|NCT02616146|39664103|FG000|Overall Study|Participant moved|4|||
16321981|NCT02616146|39664104|FG001|Overall Study|Participant moved|3|||
16321982|NCT02616146|39664103|FG000|Overall Study|Withdrawal by Subject|30|||
16321983|NCT02616146|39664104|FG001|Overall Study|Withdrawal by Subject|24|||
16321984|NCT02616146|39664103|FG000|Overall Study|Physician Decision|2|||
16321985|NCT02616146|39664104|FG001|Overall Study|Physician Decision|1|||
16321986|NCT03051100|39664105|FG000|Overall Study|Withdrawal by Subject|1|||
16321987|NCT03051100|39664106|FG001|Overall Study|Withdrawal by Subject|0|||
16321988|NCT03508726|39664107|FG000|Overall Study|Withdrawal by Subject|0|||
16321989|NCT03508726|39664108|FG001|Overall Study|Withdrawal by Subject|1|||
16321990|NCT00656292|39664109|FG000|Overall Study|Withdrawal by Subject|2|||
16517205|NCT02489981|40362126|FG000|Overall Study|Other than listed|28|||
16517206|NCT00413413|40362127|FG000|Single-Blind|Adverse Event|0|||
16517207|NCT00413413|40362128|FG001|Single-Blind|Adverse Event|9|||
16517208|NCT00413413|40362129|FG002|Single-Blind|Adverse Event|0|||
16517209|NCT00413413|40362127|FG000|Single-Blind|Lack of Efficacy|0|||
16517210|NCT00413413|40362128|FG001|Single-Blind|Lack of Efficacy|5|||
16517211|NCT00413413|40362129|FG002|Single-Blind|Lack of Efficacy|0|||
16517212|NCT00413413|40362127|FG000|Single-Blind|Subject no longer requires study drug|0|||
16517213|NCT00413413|40362128|FG001|Single-Blind|Subject no longer requires study drug|151|||
16517214|NCT00413413|40362129|FG002|Single-Blind|Subject no longer requires study drug|0|||
16517215|NCT00413413|40362127|FG000|Single-Blind|Protocol Violation|0|||
16517216|NCT00413413|40362128|FG001|Single-Blind|Protocol Violation|16|||
16517217|NCT00413413|40362129|FG002|Single-Blind|Protocol Violation|0|||
16517218|NCT00413413|40362127|FG000|Single-Blind|Withdrawal by Subject|0|||
16517219|NCT00413413|40362128|FG001|Single-Blind|Withdrawal by Subject|27|||
16517220|NCT00413413|40362129|FG002|Single-Blind|Withdrawal by Subject|0|||
16517221|NCT00413413|40362127|FG000|Single-Blind|Lost to Follow-up|0|||
16517222|NCT00413413|40362128|FG001|Single-Blind|Lost to Follow-up|8|||
16517223|NCT00413413|40362129|FG002|Single-Blind|Lost to Follow-up|0|||
16517224|NCT00413413|40362127|FG000|Double-Blind|Adverse Event|6|||
16517225|NCT00413413|40362128|FG001|Double-Blind|Adverse Event|0|||
16517226|NCT00413413|40362129|FG002|Double-Blind|Adverse Event|5|||
16517227|NCT00413413|40362127|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
16517228|NCT00413413|40362128|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
16517229|NCT00413413|40362129|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
16517230|NCT00413413|40362127|FG000|Double-Blind|Protocol deviation|1|||
16517231|NCT00413413|40362128|FG001|Double-Blind|Protocol deviation|2|||
16517232|NCT00413413|40362129|FG002|Double-Blind|Protocol deviation|1|||
16517233|NCT00413413|40362127|FG000|Double-Blind|Subject withdrew consent|4|||
16517234|NCT00413413|40362128|FG001|Double-Blind|Subject withdrew consent|6|||
16517235|NCT00413413|40362129|FG002|Double-Blind|Subject withdrew consent|9|||
16517236|NCT00413413|40362127|FG000|Double-Blind|Lost to Follow-up|3|||
16517237|NCT00413413|40362128|FG001|Double-Blind|Lost to Follow-up|4|||
16517238|NCT00413413|40362129|FG002|Double-Blind|Lost to Follow-up|2|||
16517239|NCT02141516|40362130|FG000|Overall Study|Adverse Event|0|||
16517240|NCT02141516|40362131|FG001|Overall Study|Adverse Event|1|||
16517241|NCT02141516|40362132|FG002|Overall Study|Adverse Event|0|||
16517242|NCT02141516|40362130|FG000|Overall Study|Lost to Follow-up|0|||
16517243|NCT02141516|40362131|FG001|Overall Study|Lost to Follow-up|1|||
16517244|NCT02141516|40362132|FG002|Overall Study|Lost to Follow-up|0|||
16517245|NCT02141516|40362130|FG000|Overall Study|Other|0|||
16091969|NCT00696241|38826940|FG004|Overall Study|Protocol Violation|3|||
16091970|NCT00696241|38826936|FG000|Overall Study|Lost to Follow-up|1|||
16091971|NCT00696241|38826937|FG001|Overall Study|Lost to Follow-up|4|||
16321991|NCT00656292|39664110|FG001|Overall Study|Withdrawal by Subject|3|||
16321992|NCT00656292|39664109|FG000|Overall Study|Screen failure|1|||
16517246|NCT02141516|40362131|FG001|Overall Study|Other|3|||
16517247|NCT02141516|40362132|FG002|Overall Study|Other|0|||
16517248|NCT02649972|40362135|FG000|Overall Study|Not treated|1|||
16517249|NCT01632800|40362136|FG000|Overall Study|Subject did not fit in apparatus|1|||
16517250|NCT02383758|40362137|FG000|Overall Study|Withdrawal by Subject|0|||
16517251|NCT02383758|40362138|FG001|Overall Study|Withdrawal by Subject|2|||
16517252|NCT00718042|40362148|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
16517253|NCT00718042|40362149|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
16517254|NCT00718042|40362150|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
16091972|NCT00696241|38826938|FG002|Overall Study|Lost to Follow-up|1|||
16091973|NCT00696241|38826939|FG003|Overall Study|Lost to Follow-up|2|||
16202940|NCT00363051|39222874|FG000|Overall Study|Adminstrative problems|1|||
16202941|NCT00363051|39222875|FG001|Overall Study|Adminstrative problems|1|||
16202942|NCT00363051|39222874|FG000|Overall Study|Adverse Event|21|||
16202943|NCT00363051|39222875|FG001|Overall Study|Adverse Event|12|||
16202944|NCT00363051|39222874|FG000|Overall Study|New Cancer Therapy|2|||
16202945|NCT00363051|39222875|FG001|Overall Study|New Cancer Therapy|1|||
16202946|NCT00363051|39222874|FG000|Overall Study|Withdrawal by Subject|11|||
16202947|NCT00363051|39222875|FG001|Overall Study|Withdrawal by Subject|3|||
16091974|NCT00696241|38826940|FG004|Overall Study|Lost to Follow-up|0|||
16091975|NCT00696241|38826936|FG000|Overall Study|Withdrawal by Subject|4|||
16091976|NCT00696241|38826937|FG001|Overall Study|Withdrawal by Subject|8|||
16091977|NCT00696241|38826938|FG002|Overall Study|Withdrawal by Subject|6|||
16091978|NCT00696241|38826939|FG003|Overall Study|Withdrawal by Subject|1|||
16091979|NCT00696241|38826940|FG004|Overall Study|Withdrawal by Subject|0|||
16091980|NCT00696241|38826936|FG000|Overall Study|Lack of Efficacy|1|||
16091981|NCT00696241|38826937|FG001|Overall Study|Lack of Efficacy|5|||
16091982|NCT00696241|38826938|FG002|Overall Study|Lack of Efficacy|4|||
16091983|NCT00696241|38826939|FG003|Overall Study|Lack of Efficacy|5|||
16091984|NCT00696241|38826940|FG004|Overall Study|Lack of Efficacy|3|||
16091985|NCT00696241|38826936|FG000|Overall Study|Other|6|||
16091986|NCT00696241|38826937|FG001|Overall Study|Other|1|||
16091987|NCT00696241|38826938|FG002|Overall Study|Other|5|||
16091988|NCT00696241|38826939|FG003|Overall Study|Other|2|||
16202948|NCT00363051|39222874|FG000|Overall Study|Lost to Follow-up|0|||
16202949|NCT00363051|39222875|FG001|Overall Study|Lost to Follow-up|1|||
16202950|NCT00363051|39222874|FG000|Overall Study|Protocol Violation|0|||
16202951|NCT00363051|39222875|FG001|Overall Study|Protocol Violation|2|||
16202952|NCT00363051|39222874|FG000|Overall Study|Death|3|||
16202953|NCT00363051|39222875|FG001|Overall Study|Death|2|||
16202954|NCT03819218|39222876|FG000|Overall Study|Protocol Violation|1|||
16202955|NCT00441103|39222879|FG000|Overall Study|Adverse Event|2|||
16091989|NCT00696241|38826940|FG004|Overall Study|Other|1|||
16091990|NCT01613599|38826943|FG000|Overall Study|Death|9|||
16091991|NCT01613599|38826943|FG000|Overall Study|Lost to Follow-up|5|||
16202956|NCT00441103|39222880|FG001|Overall Study|Adverse Event|1|||
16202957|NCT00441103|39222879|FG000|Overall Study|Death|1|||
16202958|NCT00441103|39222880|FG001|Overall Study|Death|0|||
16202959|NCT00441103|39222879|FG000|Overall Study|Disease Progression|2|||
16202960|NCT00441103|39222880|FG001|Overall Study|Disease Progression|0|||
16202961|NCT00441103|39222879|FG000|Overall Study|Lost to Follow-up|1|||
16202962|NCT00441103|39222880|FG001|Overall Study|Lost to Follow-up|0|||
16202963|NCT00441103|39222879|FG000|Overall Study|Protocol Violation|1|||
16202964|NCT00441103|39222880|FG001|Overall Study|Protocol Violation|0|||
16202965|NCT00441103|39222879|FG000|Overall Study|Participant unable to use Rebiject II|1|||
16202966|NCT00441103|39222880|FG001|Overall Study|Participant unable to use Rebiject II|0|||
16202967|NCT00441103|39222879|FG000|Overall Study|Participant refused MRI|1|||
16202968|NCT00441103|39222880|FG001|Overall Study|Participant refused MRI|0|||
16202969|NCT00441103|39222879|FG000|Overall Study|Inclusion criteria absent|1|||
16202970|NCT00441103|39222880|FG001|Overall Study|Inclusion criteria absent|0|||
16202971|NCT00441103|39222879|FG000|Overall Study|Non-compliant|0|||
16202972|NCT00441103|39222880|FG001|Overall Study|Non-compliant|1|||
16202973|NCT00441103|39222879|FG000|Overall Study|Participant decided to withdraw|1|||
16202974|NCT00441103|39222880|FG001|Overall Study|Participant decided to withdraw|0|||
16202975|NCT00441103|39222879|FG000|Overall Study|Participant's reason|0|||
16202976|NCT00441103|39222880|FG001|Overall Study|Participant's reason|1|||
16202977|NCT00441103|39222879|FG000|Overall Study|Participant decided to stop|0|||
16202978|NCT00441103|39222880|FG001|Overall Study|Participant decided to stop|1|||
16202979|NCT01705587|39222881|FG000|Overall Study|Withdrawal by Subject|0|||
16202980|NCT01705587|39222882|FG001|Overall Study|Withdrawal by Subject|1|||
16202981|NCT01646398|39222883|FG000|Overall Study|Withdrawal by Subject|1|||
16202982|NCT01646398|39222884|FG001|Overall Study|Withdrawal by Subject|0|||
16091992|NCT01613599|38826943|FG000|Overall Study|Withdrawal by Subject|8|||
16091993|NCT01613599|38826943|FG000|Overall Study|Reason not specified|3|||
16091994|NCT01916109|38826944|FG000|Overall Study|Withdrawal by Subject|1|||
16091995|NCT01517282|38826947|FG000|Overall Study|Consent withdrawn|0|||
16091996|NCT01517282|38826948|FG001|Overall Study|Consent withdrawn|1|||
16091997|NCT01517282|38826949|FG002|Overall Study|Consent withdrawn|1|||
16091998|NCT01517282|38826950|FG003|Overall Study|Consent withdrawn|1|||
16202983|NCT00453180|39222887|FG000|Overall Study|Lost to Follow-up|2|||
16202984|NCT00453180|39222888|FG001|Overall Study|Lost to Follow-up|1|||
16202985|NCT00453180|39222887|FG000|Overall Study|Adverse Event|1|||
16202986|NCT00453180|39222888|FG001|Overall Study|Adverse Event|2|||
16202987|NCT02031432|39222889|FG000|Overall Study|Protocol Violation|1|||
16202988|NCT02031432|39222889|FG000|Overall Study|Lack of Efficacy|5|||
16202989|NCT02031432|39222889|FG000|Overall Study|Cancer Progression|2|||
16202990|NCT02031432|39222889|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
16091999|NCT01517282|38826947|FG000|Overall Study|Physician Decision|1|||
16321993|NCT00656292|39664110|FG001|Overall Study|Screen failure|2|||
16321994|NCT01609543|39664113|FG000|Overall Study|Disease Progression|28|||
16321995|NCT01609543|39664113|FG000|Overall Study|Adverse Event|5|||
16321996|NCT01609543|39664113|FG000|Overall Study|Withdrawal by Subject|1|||
16321997|NCT01609543|39664113|FG000|Overall Study|Protocol Violation|1|||
16321998|NCT01609543|39664113|FG000|Overall Study|Death|7|||
16321999|NCT01920958|39664114|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
16322000|NCT00766636|39664120|FG000|Overall Study|Withdrawal by Subject|1|||
16322001|NCT00766636|39664121|FG001|Overall Study|Withdrawal by Subject|1|||
16322002|NCT00766636|39664120|FG000|Overall Study|Incomplete Treatment|0|||
16322003|NCT00766636|39664121|FG001|Overall Study|Incomplete Treatment|1|||
16322004|NCT00766636|39664120|FG000|Overall Study|Adverse Event|1|||
16322005|NCT00766636|39664121|FG001|Overall Study|Adverse Event|0|||
16322006|NCT00766636|39664120|FG000|Overall Study|Disease Progression|1|||
16322007|NCT00766636|39664121|FG001|Overall Study|Disease Progression|0|||
16322008|NCT01868022|39664122|FG000|Overall Study|Withdrawal by Subject|0|||
16322009|NCT01868022|39664123|FG001|Overall Study|Withdrawal by Subject|0|||
16322010|NCT01868022|39664124|FG002|Overall Study|Withdrawal by Subject|1|||
16322011|NCT01868022|39664125|FG003|Overall Study|Withdrawal by Subject|1|||
16322012|NCT01868022|39664126|FG004|Overall Study|Withdrawal by Subject|0|||
16322013|NCT01868022|39664127|FG005|Overall Study|Withdrawal by Subject|0|||
16322014|NCT01868022|39664128|FG006|Overall Study|Withdrawal by Subject|0|||
16322015|NCT01868022|39664129|FG007|Overall Study|Withdrawal by Subject|1|||
16322016|NCT01868022|39664130|FG008|Overall Study|Withdrawal by Subject|0|||
16322017|NCT01868022|39664122|FG000|Overall Study|Adverse Event|0|||
16322018|NCT01868022|39664123|FG001|Overall Study|Adverse Event|0|||
16322019|NCT01868022|39664124|FG002|Overall Study|Adverse Event|0|||
16322020|NCT01868022|39664125|FG003|Overall Study|Adverse Event|0|||
16322021|NCT01868022|39664126|FG004|Overall Study|Adverse Event|2|||
16322022|NCT01868022|39664127|FG005|Overall Study|Adverse Event|0|||
16322023|NCT01868022|39664128|FG006|Overall Study|Adverse Event|0|||
16322024|NCT01868022|39664129|FG007|Overall Study|Adverse Event|2|||
16322025|NCT01868022|39664130|FG008|Overall Study|Adverse Event|2|||
16322026|NCT01868022|39664122|FG000|Overall Study|Physician Decision|0|||
16322027|NCT01868022|39664123|FG001|Overall Study|Physician Decision|0|||
16322028|NCT01868022|39664124|FG002|Overall Study|Physician Decision|0|||
16322029|NCT01868022|39664125|FG003|Overall Study|Physician Decision|0|||
16322030|NCT01868022|39664126|FG004|Overall Study|Physician Decision|0|||
16322031|NCT01868022|39664127|FG005|Overall Study|Physician Decision|1|||
16322032|NCT01868022|39664128|FG006|Overall Study|Physician Decision|0|||
16517255|NCT00718042|40362151|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
16517256|NCT00718042|40362152|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
16517257|NCT00718042|40362153|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
16517258|NCT00718042|40362148|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
16517259|NCT00718042|40362149|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
16517260|NCT00718042|40362150|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
16517261|NCT00718042|40362151|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
16517262|NCT00718042|40362152|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
16517263|NCT00718042|40362153|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
16517264|NCT00718042|40362148|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
16517265|NCT00718042|40362149|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
16517266|NCT00718042|40362150|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
16517267|NCT00718042|40362151|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
16517268|NCT00718042|40362152|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
16517269|NCT00718042|40362153|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
16517270|NCT00718042|40362148|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
16517271|NCT00718042|40362149|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
16517272|NCT00718042|40362150|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
16517273|NCT00718042|40362151|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
16517274|NCT00718042|40362152|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
16517275|NCT00718042|40362153|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
16517276|NCT00718042|40362148|FG000|Donor Follow-up|Lost to Follow-up|13|||
16517277|NCT00718042|40362149|FG001|Donor Follow-up|Lost to Follow-up|0|||
16517278|NCT00718042|40362150|FG002|Donor Follow-up|Lost to Follow-up|0|||
16092000|NCT01517282|38826948|FG001|Overall Study|Physician Decision|0|||
16092001|NCT01517282|38826949|FG002|Overall Study|Physician Decision|0|||
16092002|NCT01517282|38826950|FG003|Overall Study|Physician Decision|0|||
16092003|NCT01681511|38826951|FG000|Overall Study|No Treatment Received|1|||
16322033|NCT01868022|39664129|FG007|Overall Study|Physician Decision|2|||
16322034|NCT01868022|39664130|FG008|Overall Study|Physician Decision|0|||
16322035|NCT01868022|39664122|FG000|Overall Study|Study closed/terminated|0|||
16322036|NCT01868022|39664123|FG001|Overall Study|Study closed/terminated|0|||
16322037|NCT01868022|39664124|FG002|Overall Study|Study closed/terminated|0|||
16322038|NCT01868022|39664125|FG003|Overall Study|Study closed/terminated|0|||
16517279|NCT00718042|40362151|FG003|Donor Follow-up|Lost to Follow-up|0|||
16517280|NCT00718042|40362152|FG004|Donor Follow-up|Lost to Follow-up|19|||
16517281|NCT00718042|40362153|FG005|Donor Follow-up|Lost to Follow-up|0|||
16517282|NCT00098839|40362154|FG000|Overall Study|Adverse Event|5|||
16517283|NCT00098839|40362155|FG001|Overall Study|Adverse Event|2|||
16517284|NCT00098839|40362154|FG000|Overall Study|Death|1|||
16517285|NCT00098839|40362155|FG001|Overall Study|Death|2|||
16517286|NCT00098839|40362154|FG000|Overall Study|Physician Decision|4|||
16202991|NCT02031432|39222889|FG000|Overall Study|Adverse Event|8|||
16395452|NCT04512001|39928271|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
16517287|NCT00098839|40362155|FG001|Overall Study|Physician Decision|14|||
16517288|NCT00098839|40362154|FG000|Overall Study|Withdrawal by Subject|1|||
16517289|NCT00098839|40362155|FG001|Overall Study|Withdrawal by Subject|0|||
16517290|NCT00098839|40362154|FG000|Overall Study|Refusal of further protocol therapy|3|||
16517291|NCT00098839|40362155|FG001|Overall Study|Refusal of further protocol therapy|1|||
16322039|NCT01868022|39664126|FG004|Overall Study|Study closed/terminated|0|||
16517292|NCT00098839|40362154|FG000|Overall Study|Relapse|6|||
16517293|NCT00098839|40362155|FG001|Overall Study|Relapse|3|||
16517294|NCT00098839|40362154|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
16517295|NCT00098839|40362155|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
16517296|NCT00098839|40362154|FG000|Overall Study|Ineligible|2|||
16517297|NCT00098839|40362155|FG001|Overall Study|Ineligible|0|||
16322040|NCT01868022|39664127|FG005|Overall Study|Study closed/terminated|0|||
16322041|NCT01868022|39664128|FG006|Overall Study|Study closed/terminated|0|||
16322042|NCT01868022|39664129|FG007|Overall Study|Study closed/terminated|1|||
16322043|NCT01868022|39664130|FG008|Overall Study|Study closed/terminated|0|||
16517298|NCT00006184|40362159|FG000|Overall Study|Death|1|||
16517299|NCT00006184|40362160|FG001|Overall Study|Death|0|||
16322044|NCT01868022|39664122|FG000|Overall Study|Ongoing|0|||
16322045|NCT01868022|39664123|FG001|Overall Study|Ongoing|0|||
16322046|NCT01868022|39664124|FG002|Overall Study|Ongoing|0|||
16322047|NCT01868022|39664125|FG003|Overall Study|Ongoing|0|||
16322048|NCT01868022|39664126|FG004|Overall Study|Ongoing|0|||
16322049|NCT01868022|39664127|FG005|Overall Study|Ongoing|0|||
16322050|NCT01868022|39664128|FG006|Overall Study|Ongoing|0|||
16322051|NCT01868022|39664129|FG007|Overall Study|Ongoing|3|||
16322052|NCT01868022|39664130|FG008|Overall Study|Ongoing|0|||
16322053|NCT02993250|39664131|FG000|Overall Study|Lost to Follow-up|0|||
16322054|NCT02993250|39664132|FG001|Overall Study|Lost to Follow-up|1|||
16322055|NCT00267969|39664133|FG000|Controlled Period|Adverse Event|6|||
16322056|NCT00267969|39664134|FG001|Controlled Period|Adverse Event|0|||
16322057|NCT00267969|39664135|FG002|Controlled Period|Adverse Event|2|||
16395453|NCT04512001|39928272|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
16395454|NCT04512001|39928273|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
16395455|NCT04512001|39928274|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
16395456|NCT04512001|39928270|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
16517300|NCT02143843|40362163|FG000|Overall Study|Adverse Event|8|||
16517301|NCT02143843|40362163|FG000|Overall Study|Lack of Efficacy|2|||
16202992|NCT02031432|39222889|FG000|Overall Study|Withdrawal by Subject|5|||
16395457|NCT04512001|39928271|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
16395458|NCT04512001|39928272|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
16517302|NCT02143843|40362163|FG000|Overall Study|Withdrawal by Subject|2|||
16322058|NCT00267969|39664136|FG003|Controlled Period|Adverse Event|0|||
16322059|NCT00267969|39664137|FG004|Controlled Period|Adverse Event|0|||
16322060|NCT00267969|39664138|FG005|Controlled Period|Adverse Event|0|||
16322061|NCT00267969|39664139|FG006|Controlled Period|Adverse Event|0|||
16517303|NCT03945981|40362164|FG000|Overall Study|Lost to Follow-up|12|||
16517304|NCT03945981|40362164|FG000|Overall Study|Physician Decision|4|||
16517305|NCT03945981|40362164|FG000|Overall Study|Withdrawal by Subject|6|||
16517306|NCT03945981|40362164|FG000|Overall Study|Protocol Violation|1|||
16517307|NCT01575561|40362165|FG000|Overall Study|Adverse Event|9|||
16517308|NCT01575561|40362165|FG000|Overall Study|Lack of Efficacy|8|||
16517309|NCT01575561|40362165|FG000|Overall Study|Lost to Follow-up|6|||
16517310|NCT01575561|40362165|FG000|Overall Study|Protocol Violation|4|||
16517311|NCT01575561|40362165|FG000|Overall Study|Withdrawal by Subject|11|||
16517312|NCT01575561|40362165|FG000|Overall Study|administration|1|||
16517313|NCT03246958|40362171|FG000|Overall Study|Withdrawal by Subject|0|||
16517314|NCT03246958|40362172|FG001|Overall Study|Withdrawal by Subject|1|||
16517315|NCT03246958|40362173|FG002|Overall Study|Withdrawal by Subject|0|||
16517316|NCT03246958|40362174|FG003|Overall Study|Withdrawal by Subject|0|||
16517317|NCT03246958|40362175|FG004|Overall Study|Withdrawal by Subject|0|||
16517318|NCT03246958|40362176|FG005|Overall Study|Withdrawal by Subject|1|||
16517319|NCT03246958|40362177|FG006|Overall Study|Withdrawal by Subject|0|||
16517320|NCT03246958|40362171|FG000|Overall Study|Progression|13|||
16517321|NCT03246958|40362172|FG001|Overall Study|Progression|9|||
16517322|NCT03246958|40362173|FG002|Overall Study|Progression|3|||
16517323|NCT03246958|40362174|FG003|Overall Study|Progression|2|||
16517324|NCT03246958|40362175|FG004|Overall Study|Progression|1|||
16517325|NCT03246958|40362176|FG005|Overall Study|Progression|2|||
16517326|NCT03246958|40362177|FG006|Overall Study|Progression|1|||
16517327|NCT03246958|40362171|FG000|Overall Study|Adverse Event|2|||
16517328|NCT03246958|40362172|FG001|Overall Study|Adverse Event|2|||
16517329|NCT03246958|40362173|FG002|Overall Study|Adverse Event|0|||
16517330|NCT03246958|40362174|FG003|Overall Study|Adverse Event|1|||
16202993|NCT02031432|39222889|FG000|Overall Study|Lost to Follow-up|1|||
16202994|NCT02031432|39222889|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
16202995|NCT02031432|39222889|FG000|Overall Study|Death|10|||
16202996|NCT01947894|39222891|FG000|Overall Study|Other|3|||
16202997|NCT01947894|39222892|FG001|Overall Study|Other|4|||
16202998|NCT01947894|39222893|FG002|Overall Study|Other|3|||
16202999|NCT01947894|39222891|FG000|Overall Study|Withdrawal by Subject|12|||
16203000|NCT01947894|39222892|FG001|Overall Study|Withdrawal by Subject|4|||
16203001|NCT01947894|39222893|FG002|Overall Study|Withdrawal by Subject|1|||
16203002|NCT01947894|39222891|FG000|Overall Study|Death|12|||
16203003|NCT01947894|39222892|FG001|Overall Study|Death|1|||
16203004|NCT01947894|39222893|FG002|Overall Study|Death|0|||
16203005|NCT01947894|39222891|FG000|Overall Study|Physician Decision|2|||
16203006|NCT01947894|39222892|FG001|Overall Study|Physician Decision|0|||
16203007|NCT01947894|39222893|FG002|Overall Study|Physician Decision|0|||
16203008|NCT01947894|39222891|FG000|Overall Study|Adverse Event|5|||
16203009|NCT01947894|39222892|FG001|Overall Study|Adverse Event|1|||
16203010|NCT01947894|39222893|FG002|Overall Study|Adverse Event|0|||
16203011|NCT01947894|39222891|FG000|Overall Study|Switched to other growth hormone brand|53|||
16203012|NCT01947894|39222892|FG001|Overall Study|Switched to other growth hormone brand|8|||
16203013|NCT01947894|39222893|FG002|Overall Study|Switched to other growth hormone brand|23|||
16203014|NCT03332303|39222895|FG000|Overall Study|Participant did not dose|1|||
16203015|NCT03332303|39222896|FG001|Overall Study|Participant did not dose|2|||
16203016|NCT03332303|39222897|FG002|Overall Study|Participant did not dose|0|||
16203017|NCT03332303|39222895|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
16203018|NCT03332303|39222896|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
16203019|NCT03332303|39222897|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
16203020|NCT03332303|39222895|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
16203021|NCT03332303|39222896|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
16203022|NCT03332303|39222897|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
16203023|NCT03332303|39222895|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
16322062|NCT00267969|39664133|FG000|Controlled Period|Lack of Efficacy|3|||
16517331|NCT03246958|40362175|FG004|Overall Study|Adverse Event|1|||
16517332|NCT03246958|40362176|FG005|Overall Study|Adverse Event|0|||
16322063|NCT00267969|39664134|FG001|Controlled Period|Lack of Efficacy|0|||
16322064|NCT00267969|39664135|FG002|Controlled Period|Lack of Efficacy|1|||
16322065|NCT00267969|39664136|FG003|Controlled Period|Lack of Efficacy|0|||
16322066|NCT00267969|39664137|FG004|Controlled Period|Lack of Efficacy|0|||
16203024|NCT03332303|39222896|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
16203025|NCT03332303|39222897|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
16322067|NCT00267969|39664138|FG005|Controlled Period|Lack of Efficacy|0|||
16322068|NCT00267969|39664139|FG006|Controlled Period|Lack of Efficacy|0|||
16517333|NCT03246958|40362177|FG006|Overall Study|Adverse Event|2|||
16517334|NCT03246958|40362171|FG000|Overall Study|Death|0|||
16517335|NCT03246958|40362172|FG001|Overall Study|Death|1|||
16517336|NCT03246958|40362173|FG002|Overall Study|Death|0|||
16517337|NCT03246958|40362174|FG003|Overall Study|Death|0|||
16517338|NCT03246958|40362175|FG004|Overall Study|Death|0|||
16517339|NCT03246958|40362176|FG005|Overall Study|Death|0|||
16517340|NCT03246958|40362177|FG006|Overall Study|Death|0|||
16517341|NCT03246958|40362171|FG000|Overall Study|Physician Decision|0|||
16517342|NCT03246958|40362172|FG001|Overall Study|Physician Decision|0|||
16517343|NCT03246958|40362173|FG002|Overall Study|Physician Decision|0|||
16517344|NCT03246958|40362174|FG003|Overall Study|Physician Decision|1|||
16517345|NCT03246958|40362175|FG004|Overall Study|Physician Decision|0|||
16517346|NCT03246958|40362176|FG005|Overall Study|Physician Decision|0|||
16517347|NCT03246958|40362177|FG006|Overall Study|Physician Decision|0|||
16517348|NCT03246958|40362171|FG000|Overall Study|Never start treatment|1|||
16517349|NCT03246958|40362172|FG001|Overall Study|Never start treatment|0|||
16517350|NCT03246958|40362173|FG002|Overall Study|Never start treatment|0|||
16517351|NCT03246958|40362174|FG003|Overall Study|Never start treatment|0|||
16517352|NCT03246958|40362175|FG004|Overall Study|Never start treatment|0|||
16517353|NCT03246958|40362176|FG005|Overall Study|Never start treatment|0|||
16517354|NCT03246958|40362177|FG006|Overall Study|Never start treatment|0|||
16517355|NCT03246958|40362171|FG000|Overall Study|Over enrollment|0|||
16517356|NCT03246958|40362172|FG001|Overall Study|Over enrollment|2|||
16517357|NCT03246958|40362173|FG002|Overall Study|Over enrollment|0|||
16517358|NCT03246958|40362174|FG003|Overall Study|Over enrollment|0|||
16517359|NCT03246958|40362175|FG004|Overall Study|Over enrollment|0|||
16517360|NCT03246958|40362176|FG005|Overall Study|Over enrollment|0|||
16517361|NCT03246958|40362177|FG006|Overall Study|Over enrollment|0|||
16517362|NCT02579616|40362178|FG000|Overall Study|Participants did not receive treatment|3|||
16517363|NCT04709575|40362181|FG000|Overall Study|Withdrawal by Subject|6|||
16517364|NCT04709575|40362182|FG001|Overall Study|Withdrawal by Subject|2|||
16517365|NCT04709575|40362181|FG000|Overall Study|Lost to Follow-up|2|||
16517366|NCT04709575|40362182|FG001|Overall Study|Lost to Follow-up|2|||
16517367|NCT04709575|40362181|FG000|Overall Study|Adverse Event|1|||
16517368|NCT04709575|40362182|FG001|Overall Study|Adverse Event|0|||
16517369|NCT04709575|40362181|FG000|Overall Study|Protocol Violation|1|||
16517370|NCT04709575|40362182|FG001|Overall Study|Protocol Violation|1|||
16517371|NCT00503685|40362183|FG000|Overall Study|Adverse Event|0|||
16517372|NCT00503685|40362184|FG001|Overall Study|Adverse Event|0|||
16517373|NCT00503685|40362185|FG002|Overall Study|Adverse Event|2|||
16517374|NCT00503685|40362183|FG000|Overall Study|Withdrawal by Subject|0|||
16517375|NCT00503685|40362184|FG001|Overall Study|Withdrawal by Subject|1|||
16517376|NCT00503685|40362185|FG002|Overall Study|Withdrawal by Subject|0|||
16517377|NCT00503685|40362183|FG000|Overall Study|Protocol Violation|0|||
16517378|NCT00503685|40362184|FG001|Overall Study|Protocol Violation|1|||
16517379|NCT00503685|40362185|FG002|Overall Study|Protocol Violation|0|||
16517380|NCT00503685|40362183|FG000|Overall Study|Eligibility Criteria Not Met|0|||
16517381|NCT00503685|40362184|FG001|Overall Study|Eligibility Criteria Not Met|1|||
16517382|NCT00503685|40362185|FG002|Overall Study|Eligibility Criteria Not Met|0|||
16517383|NCT00699699|40362195|FG000|Overall Study|Adverse Event|36|||
16092004|NCT01681511|38826952|FG001|Overall Study|No Treatment Received|3|||
16092005|NCT01681511|38826951|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
16092006|NCT01681511|38826952|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
16092007|NCT01681511|38826951|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
16092008|NCT01681511|38826952|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
16092009|NCT01681511|38826951|FG000|Overall Study|No Daily Urine Sample Collected|0|||
16092010|NCT01681511|38826952|FG001|Overall Study|No Daily Urine Sample Collected|1|||
16092011|NCT01681511|38826951|FG000|Overall Study|No post-catheter sample collected|11|||
16092012|NCT01681511|38826952|FG001|Overall Study|No post-catheter sample collected|4|||
16517384|NCT00699699|40362195|FG000|Overall Study|Individual different reasons|21|||
16517385|NCT00451282|40362196|FG000|Overall Study|Lost to Follow-up|6|||
16517386|NCT00451282|40362197|FG001|Overall Study|Lost to Follow-up|5|||
16517387|NCT00298896|40362200|FG000|Overall Study|Death|3|||
16517388|NCT00298896|40362200|FG000|Overall Study|Physician Decision|2|||
16517389|NCT00298896|40362200|FG000|Overall Study|Intercurrent Illness|1|||
16517390|NCT00298896|40362200|FG000|Overall Study|Disease Progression|41|||
16517391|NCT00298896|40362200|FG000|Overall Study|Withdrawal by Subject|2|||
16517392|NCT00298896|40362200|FG000|Overall Study|Assigned to treatment in error|1|||
16517393|NCT01000051|40362201|FG000|Overall Study|Withdrawal by Subject|1|||
16517394|NCT01000051|40362202|FG001|Overall Study|Withdrawal by Subject|1|||
16517395|NCT01000051|40362201|FG000|Overall Study|Disease Progression|1|||
16517396|NCT01000051|40362202|FG001|Overall Study|Disease Progression|0|||
16517397|NCT01000051|40362201|FG000|Overall Study|Serious noncompliance|1|||
16517398|NCT01000051|40362202|FG001|Overall Study|Serious noncompliance|0|||
16517399|NCT00937547|40362203|FG000|Overall Study|misdiagnosis|1|||
16517400|NCT00937547|40362204|FG001|Overall Study|misdiagnosis|6|||
16517401|NCT00937547|40362205|FG002|Overall Study|misdiagnosis|7|||
16517402|NCT03019627|40362206|FG000|Overall Study|Adverse Event|8|||
16517403|NCT03019627|40362207|FG001|Overall Study|Adverse Event|0|||
16517404|NCT03019627|40362206|FG000|Overall Study|Unrelated to adverse event|1|||
16517405|NCT03019627|40362207|FG001|Overall Study|Unrelated to adverse event|3|||
16092013|NCT04323800|38826957|FG000|Overall Study|Withdrawal by Subject|4|||
16203026|NCT03332303|39222895|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
16203027|NCT03332303|39222896|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
16203028|NCT03332303|39222897|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
16203029|NCT03332303|39222895|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
16203030|NCT03332303|39222896|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
16203031|NCT03332303|39222897|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
16517406|NCT03019627|40362206|FG000|Overall Study|Lost to Follow-up|2|||
16517407|NCT03019627|40362207|FG001|Overall Study|Lost to Follow-up|1|||
16517408|NCT03019627|40362206|FG000|Overall Study|not compliance|2|||
16517409|NCT03019627|40362207|FG001|Overall Study|not compliance|2|||
16092014|NCT04323800|38826958|FG001|Overall Study|Withdrawal by Subject|4|||
16092015|NCT04323800|38826957|FG000|Overall Study|Incomplete transfusion|1|||
16092016|NCT04323800|38826958|FG001|Overall Study|Incomplete transfusion|0|||
16092017|NCT04323800|38826957|FG000|Overall Study|Other|0|||
16092018|NCT04323800|38826958|FG001|Overall Study|Other|1|||
16092019|NCT04323800|38826957|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
16092020|NCT04323800|38826958|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
16092021|NCT01536093|38826961|FG000|Overall Study|Death|1|||
16517410|NCT03019627|40362206|FG000|Overall Study|Other|2|||
16517411|NCT03019627|40362207|FG001|Overall Study|Other|2|||
16517412|NCT00782210|40362219|FG000|Overall Study|Adverse Event|21|||
16517413|NCT00782210|40362220|FG001|Overall Study|Adverse Event|17|||
16092022|NCT01536093|38826962|FG001|Overall Study|Death|2|||
16092023|NCT01536093|38826961|FG000|Overall Study|absence of maternal colostrum|2|||
16092024|NCT01536093|38826962|FG001|Overall Study|absence of maternal colostrum|0|||
16092025|NCT01536093|38826961|FG000|Overall Study|Withdrawal by Subject|0|||
16092026|NCT01536093|38826962|FG001|Overall Study|Withdrawal by Subject|1|||
16092027|NCT02400749|38826963|FG000|Week 0 -16|Withdrawal by Subject|5|||
16092028|NCT02400749|38826964|FG001|Week 0 -16|Withdrawal by Subject|5|||
16517414|NCT00782210|40362221|FG002|Overall Study|Adverse Event|16|||
16092029|NCT02400749|38826963|FG000|Week 0 -16|Adverse Event|3|||
16092030|NCT02400749|38826964|FG001|Week 0 -16|Adverse Event|1|||
16092031|NCT02400749|38826963|FG000|Week 0 -16|Lost to Follow-up|2|||
16092032|NCT02400749|38826964|FG001|Week 0 -16|Lost to Follow-up|0|||
16092033|NCT02400749|38826963|FG000|Week 0 -16|Protocol Violation|1|||
16092034|NCT02400749|38826964|FG001|Week 0 -16|Protocol Violation|0|||
16092035|NCT02400749|38826963|FG000|Week 17 - 32|Withdrawal by Subject|3|||
16092036|NCT02400749|38826964|FG001|Week 17 - 32|Withdrawal by Subject|2|||
16092037|NCT02400749|38826963|FG000|Week 17 - 32|Adverse Event|2|||
16092038|NCT02400749|38826964|FG001|Week 17 - 32|Adverse Event|1|||
16092039|NCT01884571|38826965|FG000|Overall Study|Adverse Event|1|||
16092040|NCT01884571|38826965|FG000|Overall Study|Death|2|||
16092041|NCT01884571|38826965|FG000|Overall Study|Withdrawal by Subject|2|||
16092042|NCT01884571|38826965|FG000|Overall Study|Disease progression|3|||
16092043|NCT02060487|38826966|FG000|Overall Study|Other|1|||
16092044|NCT02060487|38826967|FG001|Overall Study|Other|2|||
16092045|NCT02060487|38826968|FG002|Overall Study|Other|1|||
16092046|NCT02060487|38826966|FG000|Overall Study|Lack of Efficacy|0|||
16092047|NCT02060487|38826967|FG001|Overall Study|Lack of Efficacy|1|||
16092048|NCT02060487|38826968|FG002|Overall Study|Lack of Efficacy|0|||
16092049|NCT02060487|38826966|FG000|Overall Study|Withdrawal by Subject|3|||
16092050|NCT02060487|38826967|FG001|Overall Study|Withdrawal by Subject|10|||
16092051|NCT02060487|38826968|FG002|Overall Study|Withdrawal by Subject|4|||
16092052|NCT02060487|38826966|FG000|Overall Study|Study Terminated By Sponsor|87|||
16092053|NCT02060487|38826967|FG001|Overall Study|Study Terminated By Sponsor|89|||
16092054|NCT02060487|38826968|FG002|Overall Study|Study Terminated By Sponsor|100|||
16092055|NCT02060487|38826966|FG000|Overall Study|Randomized in error|1|||
16092056|NCT02060487|38826967|FG001|Overall Study|Randomized in error|0|||
16092057|NCT02060487|38826968|FG002|Overall Study|Randomized in error|0|||
16092058|NCT02060487|38826966|FG000|Overall Study|Protocol Violation|0|||
16092059|NCT02060487|38826967|FG001|Overall Study|Protocol Violation|1|||
16092060|NCT02060487|38826968|FG002|Overall Study|Protocol Violation|1|||
16092061|NCT02060487|38826966|FG000|Overall Study|Lost to Follow-up|3|||
16092062|NCT02060487|38826967|FG001|Overall Study|Lost to Follow-up|0|||
16092063|NCT02060487|38826968|FG002|Overall Study|Lost to Follow-up|2|||
16092064|NCT02060487|38826966|FG000|Overall Study|Death|34|||
16092065|NCT02060487|38826967|FG001|Overall Study|Death|25|||
16092066|NCT02060487|38826968|FG002|Overall Study|Death|19|||
16092067|NCT02060487|38826966|FG000|Overall Study|Adverse Event|0|||
16092068|NCT02060487|38826967|FG001|Overall Study|Adverse Event|0|||
16092069|NCT02060487|38826968|FG002|Overall Study|Adverse Event|1|||
16092070|NCT01945086|38826969|FG000|Overall Study|Withdrawal by Subject|1|||
16092071|NCT01945086|38826970|FG001|Overall Study|Withdrawal by Subject|0|||
16092072|NCT01945086|38826971|FG002|Overall Study|Withdrawal by Subject|1|||
16092073|NCT01945086|38826969|FG000|Overall Study|Adverse Event|0|||
16092074|NCT01945086|38826970|FG001|Overall Study|Adverse Event|0|||
16092075|NCT01945086|38826971|FG002|Overall Study|Adverse Event|1|||
16092076|NCT02002689|38826975|FG000|Overall Study|Disease Progression|7|||
16092077|NCT02002689|38826975|FG000|Overall Study|Adverse Event|3|||
16092078|NCT00089609|38826982|FG000|Overall Study|Withdrawal by Subject|3|||
16092079|NCT00089609|38826983|FG001|Overall Study|Withdrawal by Subject|1|||
16092080|NCT00600353|38826984|FG000|Overall Study|history of malignancy within 5 years|1|||
16092081|NCT00600353|38826985|FG001|Overall Study|history of malignancy within 5 years|0|||
16092082|NCT00600353|38826984|FG000|Overall Study|History of prepartive regimen|0|||
16092083|NCT00600353|38826985|FG001|Overall Study|History of prepartive regimen|1|||
16092084|NCT00048932|38826986|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
16092085|NCT00048932|38826987|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
16092086|NCT00048932|38826988|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
16092087|NCT00048932|38826986|FG000|Double Blind Period (DB)|Adverse Event|51|||
16092088|NCT00048932|38826987|FG001|Double Blind Period (DB)|Adverse Event|19|||
16092089|NCT00048932|38826988|FG002|Double Blind Period (DB)|Adverse Event|0|||
16092090|NCT00048932|38826986|FG000|Double Blind Period (DB)|Death|5|||
16092091|NCT00048932|38826987|FG001|Double Blind Period (DB)|Death|3|||
16092092|NCT00048932|38826988|FG002|Double Blind Period (DB)|Death|0|||
16092093|NCT00048932|38826986|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
16092094|NCT00048932|38826987|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
16092095|NCT00048932|38826988|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
16092096|NCT00048932|38826986|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
16517415|NCT00782210|40362219|FG000|Overall Study|Lost to Follow-up|2|||
16517416|NCT00782210|40362220|FG001|Overall Study|Lost to Follow-up|1|||
16517417|NCT00782210|40362221|FG002|Overall Study|Lost to Follow-up|2|||
16092097|NCT00048932|38826987|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
16092098|NCT00048932|38826988|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
16092099|NCT00048932|38826986|FG000|Double Blind Period (DB)|Relocation|1|||
16092100|NCT00048932|38826987|FG001|Double Blind Period (DB)|Relocation|0|||
16092101|NCT00048932|38826988|FG002|Double Blind Period (DB)|Relocation|0|||
16092102|NCT00048932|38826986|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
16092103|NCT00048932|38826987|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
16092104|NCT00048932|38826988|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
16092105|NCT00048932|38826986|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
16092106|NCT00048932|38826987|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
16092107|NCT00048932|38826988|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
16092108|NCT00048932|38826986|FG000|Double Blind Period (DB)|Pregnancy|1|||
16092109|NCT00048932|38826987|FG001|Double Blind Period (DB)|Pregnancy|0|||
16203032|NCT03332303|39222895|FG000|Overall Study|Participant had a significant protocol deviation|0|||
16517418|NCT00782210|40362219|FG000|Overall Study|Withdrawal by Subject|11|||
16092110|NCT00048932|38826988|FG002|Double Blind Period (DB)|Pregnancy|0|||
16092111|NCT00048932|38826986|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
16092112|NCT00048932|38826987|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
16092113|NCT00048932|38826988|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
16092114|NCT00048932|38826986|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
16092115|NCT00048932|38826987|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
16092116|NCT00048932|38826988|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
16092117|NCT00048932|38826986|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
16092118|NCT00048932|38826987|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
16092119|NCT00048932|38826988|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
16092120|NCT00048932|38826986|FG000|Open Label Period (OL)|Death|0|||
16092121|NCT00048932|38826987|FG001|Open Label Period (OL)|Death|0|||
16092122|NCT00048932|38826988|FG002|Open Label Period (OL)|Death|25|||
16092123|NCT00048932|38826986|FG000|Open Label Period (OL)|Adverse Event|0|||
16092124|NCT00048932|38826987|FG001|Open Label Period (OL)|Adverse Event|0|||
16092125|NCT00048932|38826988|FG002|Open Label Period (OL)|Adverse Event|103|||
16092126|NCT00048932|38826986|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
16092127|NCT00048932|38826987|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
16092128|NCT00048932|38826988|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
16092129|NCT00048932|38826986|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
16092130|NCT00048932|38826987|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
16092131|NCT00048932|38826988|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
16092132|NCT00048932|38826986|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
16092133|NCT00048932|38826987|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
16092134|NCT00048932|38826988|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
16092135|NCT00048932|38826986|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
16092136|NCT00048932|38826987|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
16092137|NCT00048932|38826988|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
16092138|NCT00048932|38826986|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
16092139|NCT00048932|38826987|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
16092140|NCT00048932|38826988|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
16092141|NCT00048932|38826986|FG000|Open Label Period (OL)|Pregnancy|0|||
16092142|NCT00048932|38826987|FG001|Open Label Period (OL)|Pregnancy|0|||
16092143|NCT00048932|38826988|FG002|Open Label Period (OL)|Pregnancy|6|||
16092144|NCT00048932|38826986|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
16092145|NCT00048932|38826987|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
16092146|NCT00048932|38826988|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
16092147|NCT00048932|38826986|FG000|Open Label Period (OL)|Investigator Retiring|0|||
16092148|NCT00048932|38826987|FG001|Open Label Period (OL)|Investigator Retiring|0|||
16092149|NCT00048932|38826988|FG002|Open Label Period (OL)|Investigator Retiring|2|||
16092150|NCT00048932|38826986|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
16092151|NCT00048932|38826987|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
16092152|NCT00048932|38826988|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
16092153|NCT00048932|38826986|FG000|Open Label Period (OL)|Participant Relocated|0|||
16092154|NCT00048932|38826987|FG001|Open Label Period (OL)|Participant Relocated|0|||
16092155|NCT00048932|38826988|FG002|Open Label Period (OL)|Participant Relocated|6|||
16092156|NCT00048932|38826986|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
16092157|NCT00048932|38826987|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
16092158|NCT00048932|38826988|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
16092159|NCT00048932|38826986|FG000|Open Label Period (OL)|Site Closure|0|||
16092160|NCT00048932|38826987|FG001|Open Label Period (OL)|Site Closure|0|||
16092161|NCT00048932|38826988|FG002|Open Label Period (OL)|Site Closure|3|||
16092162|NCT00048932|38826986|FG000|Open Label Period (OL)|Trial Terminated|0|||
16092163|NCT00048932|38826987|FG001|Open Label Period (OL)|Trial Terminated|0|||
16092164|NCT00048932|38826988|FG002|Open Label Period (OL)|Trial Terminated|1|||
16517419|NCT00782210|40362220|FG001|Overall Study|Withdrawal by Subject|8|||
16092165|NCT00048932|38826986|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
16092166|NCT00048932|38826987|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
16092167|NCT00048932|38826988|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
16092168|NCT00048932|38826986|FG000|Open Label Period (OL)|Patient Decision|0|||
16092169|NCT00048932|38826987|FG001|Open Label Period (OL)|Patient Decision|0|||
16092170|NCT00048932|38826988|FG002|Open Label Period (OL)|Patient Decision|4|||
16092171|NCT00048932|38826986|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
16092172|NCT00048932|38826987|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
16092173|NCT00048932|38826988|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
16092174|NCT00048932|38826986|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
16203033|NCT03332303|39222896|FG001|Overall Study|Participant had a significant protocol deviation|1|||
16203034|NCT03332303|39222897|FG002|Overall Study|Participant had a significant protocol deviation|0|||
16203035|NCT01167153|39222898|FG000|Overall Study|Non-effective therapy|1|||
16203036|NCT01167153|39222899|FG001|Overall Study|Non-effective therapy|4|||
16203037|NCT01167153|39222898|FG000|Overall Study|AE including clinical laboratory AE|2|||
16203038|NCT01167153|39222899|FG001|Overall Study|AE including clinical laboratory AE|8|||
16203039|NCT01167153|39222898|FG000|Overall Study|Hypotension|1|||
16203040|NCT01167153|39222899|FG001|Overall Study|Hypotension|0|||
16203041|NCT01167153|39222898|FG000|Overall Study|Lost to Follow-up|7|||
16203042|NCT01167153|39222899|FG001|Overall Study|Lost to Follow-up|9|||
16203043|NCT01167153|39222898|FG000|Overall Study|Non-compliance to concomitant medication|0|||
16203044|NCT01167153|39222899|FG001|Overall Study|Non-compliance to concomitant medication|2|||
16203045|NCT01167153|39222898|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
16203046|NCT01167153|39222899|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
16203047|NCT01167153|39222898|FG000|Overall Study|Withdrawal consent|1|||
16203048|NCT01167153|39222899|FG001|Overall Study|Withdrawal consent|1|||
16203049|NCT01167153|39222898|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
16203050|NCT01167153|39222899|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
16203051|NCT00062647|39222900|FG000|Overall Study|Death|2|||
16203052|NCT00062647|39222901|FG001|Overall Study|Death|2|||
16203053|NCT00062647|39222900|FG000|Overall Study|Adverse Event|1|||
16203054|NCT00062647|39222901|FG001|Overall Study|Adverse Event|1|||
16322069|NCT00267969|39664133|FG000|Controlled Period|Lost to Follow-up|1|||
16322070|NCT00267969|39664134|FG001|Controlled Period|Lost to Follow-up|0|||
16322071|NCT00267969|39664135|FG002|Controlled Period|Lost to Follow-up|1|||
16322072|NCT00267969|39664136|FG003|Controlled Period|Lost to Follow-up|0|||
16322073|NCT00267969|39664137|FG004|Controlled Period|Lost to Follow-up|0|||
16322074|NCT00267969|39664138|FG005|Controlled Period|Lost to Follow-up|0|||
16322075|NCT00267969|39664139|FG006|Controlled Period|Lost to Follow-up|0|||
16322076|NCT00267969|39664133|FG000|Controlled Period|Randomized but not treated|0|||
16203055|NCT00062647|39222900|FG000|Overall Study|Withdrawal by Subject|2|||
16203056|NCT00062647|39222901|FG001|Overall Study|Withdrawal by Subject|1|||
16203057|NCT00062647|39222900|FG000|Overall Study|Protocol Violation|1|||
16203058|NCT00062647|39222901|FG001|Overall Study|Protocol Violation|0|||
16203059|NCT00062647|39222900|FG000|Overall Study|Lost to Follow-up|1|||
16203060|NCT00062647|39222901|FG001|Overall Study|Lost to Follow-up|2|||
16203061|NCT00062647|39222900|FG000|Overall Study|Failed continuation criteria|4|||
16203062|NCT00062647|39222901|FG001|Overall Study|Failed continuation criteria|2|||
16203063|NCT00062647|39222900|FG000|Overall Study|Other|4|||
16203064|NCT00062647|39222901|FG001|Overall Study|Other|4|||
16203065|NCT00062647|39222900|FG000|Overall Study|Never received study treatment|1|||
16203066|NCT00062647|39222901|FG001|Overall Study|Never received study treatment|1|||
16203067|NCT02917629|39222902|FG000|Overall Study|Withdrawal by Subject|0|||
16322077|NCT00267969|39664134|FG001|Controlled Period|Randomized but not treated|0|||
16517420|NCT00782210|40362221|FG002|Overall Study|Withdrawal by Subject|11|||
16517421|NCT00782210|40362219|FG000|Overall Study|Non compliance with protocol|0|||
16517422|NCT00782210|40362220|FG001|Overall Study|Non compliance with protocol|3|||
16517423|NCT00782210|40362221|FG002|Overall Study|Non compliance with protocol|2|||
16517424|NCT00782210|40362219|FG000|Overall Study|Lack of Efficacy|13|||
16517425|NCT00782210|40362220|FG001|Overall Study|Lack of Efficacy|4|||
16517426|NCT00782210|40362221|FG002|Overall Study|Lack of Efficacy|1|||
16517427|NCT00782210|40362219|FG000|Overall Study|Other reason not described above|3|||
16517428|NCT00782210|40362220|FG001|Overall Study|Other reason not described above|2|||
16517429|NCT00782210|40362221|FG002|Overall Study|Other reason not described above|3|||
16517430|NCT04346615|40362222|FG000|Overall Study|Lost to Follow-up|0|||
16517431|NCT04346615|40362223|FG001|Overall Study|Lost to Follow-up|2|||
16517432|NCT04346615|40362222|FG000|Overall Study|Withdrawal by Subject|1|||
16517433|NCT04346615|40362223|FG001|Overall Study|Withdrawal by Subject|0|||
16517434|NCT04346615|40362222|FG000|Overall Study|Death|5|||
16517435|NCT04346615|40362223|FG001|Overall Study|Death|1|||
16517436|NCT04346615|40362222|FG000|Overall Study|Other|0|||
16517437|NCT04346615|40362223|FG001|Overall Study|Other|2|||
16517438|NCT04346615|40362222|FG000|Overall Study|Randomized not treated|1|||
16517439|NCT04346615|40362223|FG001|Overall Study|Randomized not treated|0|||
16517440|NCT00515827|40362224|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
16517441|NCT00515827|40362225|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
16517442|NCT00515827|40362224|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
16517443|NCT00515827|40362225|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
16203068|NCT02917629|39222903|FG001|Overall Study|Withdrawal by Subject|1|||
16203069|NCT02151682|39222904|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
16203070|NCT02151682|39222905|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
16203071|NCT02151682|39222906|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
16203072|NCT02151682|39222907|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
16203073|NCT02151682|39222908|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
16203074|NCT02151682|39222909|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
16203075|NCT02151682|39222904|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
16395459|NCT04512001|39928273|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
16395460|NCT04512001|39928274|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
16395461|NCT04512001|39928270|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
16203076|NCT02151682|39222905|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
16203077|NCT02151682|39222906|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
16203078|NCT02151682|39222907|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
16203079|NCT02151682|39222908|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
16203080|NCT02151682|39222909|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
16203081|NCT02151682|39222904|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
16203082|NCT02151682|39222905|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
16203083|NCT02151682|39222906|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
16203084|NCT02151682|39222907|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
16203085|NCT02151682|39222908|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
16203086|NCT02151682|39222909|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
16203087|NCT02151682|39222904|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
16203088|NCT02151682|39222905|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
16203089|NCT02151682|39222906|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
16203090|NCT02151682|39222907|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
16203091|NCT02151682|39222908|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
16517444|NCT04115358|40362231|FG000|Overall Study|exfoliation|0|||
16517445|NCT04115358|40362232|FG001|Overall Study|exfoliation|0|||
16517446|NCT04115358|40362233|FG002|Overall Study|exfoliation|1|||
16517447|NCT01777997|40362234|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
16517448|NCT01777997|40362234|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
16517449|NCT01777997|40362234|FG000|Weeks 48 to 72/96 on ART|Death|1|||
16517450|NCT01777997|40362234|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
16517451|NCT02460198|40362237|FG000|Overall Study|Adverse Event|1|||
16517452|NCT02460198|40362238|FG001|Overall Study|Adverse Event|3|||
16517453|NCT02460198|40362237|FG000|Overall Study|Death|36|||
16517454|NCT02460198|40362238|FG001|Overall Study|Death|28|||
16517455|NCT02460198|40362237|FG000|Overall Study|Lost to Follow-up|1|||
16517456|NCT02460198|40362238|FG001|Overall Study|Lost to Follow-up|1|||
16395462|NCT04512001|39928271|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
16395463|NCT04512001|39928272|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
16395464|NCT04512001|39928273|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
16395465|NCT04512001|39928274|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
16395466|NCT04512001|39928270|FG000|Week 24 to Week 63|Adverse Event|0|||
16395467|NCT04512001|39928271|FG001|Week 24 to Week 63|Adverse Event|0|||
16395468|NCT04512001|39928272|FG002|Week 24 to Week 63|Adverse Event|13|||
16395469|NCT04512001|39928273|FG003|Week 24 to Week 63|Adverse Event|8|||
16395470|NCT04512001|39928274|FG004|Week 24 to Week 63|Adverse Event|6|||
16395471|NCT04512001|39928270|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
16395472|NCT04512001|39928271|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
16395473|NCT04512001|39928272|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
16517457|NCT02460198|40362237|FG000|Overall Study|Transferred to Extension Study|15|||
16517458|NCT02460198|40362238|FG001|Overall Study|Transferred to Extension Study|15|||
16517459|NCT02460198|40362237|FG000|Overall Study|Withdrawal by Subject|2|||
16517460|NCT02460198|40362238|FG001|Overall Study|Withdrawal by Subject|4|||
16517461|NCT02460198|40362237|FG000|Overall Study|Site Terminated By Sponsor|0|||
16203092|NCT02151682|39222909|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
16203093|NCT02151682|39222904|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
16203094|NCT02151682|39222905|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
16203095|NCT02151682|39222906|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
16203096|NCT02151682|39222907|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
16203097|NCT02151682|39222908|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
16203098|NCT02151682|39222909|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
16203099|NCT02151682|39222904|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
16203100|NCT02151682|39222905|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
16203101|NCT02151682|39222906|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
16395474|NCT04512001|39928273|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
16395475|NCT04512001|39928274|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
16203102|NCT02151682|39222907|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
16203103|NCT02151682|39222908|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
16203104|NCT02151682|39222909|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
16395476|NCT04512001|39928270|FG000|Week 24 to Week 63|Death|0|||
16395477|NCT04512001|39928271|FG001|Week 24 to Week 63|Death|0|||
16395478|NCT04512001|39928272|FG002|Week 24 to Week 63|Death|0|||
16395479|NCT04512001|39928273|FG003|Week 24 to Week 63|Death|1|||
16395480|NCT04512001|39928274|FG004|Week 24 to Week 63|Death|1|||
16395481|NCT04512001|39928270|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
16395482|NCT04512001|39928271|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
16322078|NCT00267969|39664135|FG002|Controlled Period|Randomized but not treated|1|||
16322079|NCT00267969|39664136|FG003|Controlled Period|Randomized but not treated|0|||
16322080|NCT00267969|39664137|FG004|Controlled Period|Randomized but not treated|0|||
16322081|NCT00267969|39664138|FG005|Controlled Period|Randomized but not treated|0|||
16322082|NCT00267969|39664139|FG006|Controlled Period|Randomized but not treated|0|||
16322083|NCT00267969|39664133|FG000|Controlled Period|Other|2|||
16322084|NCT00267969|39664134|FG001|Controlled Period|Other|1|||
16322085|NCT00267969|39664135|FG002|Controlled Period|Other|6|||
16322086|NCT00267969|39664136|FG003|Controlled Period|Other|0|||
16322087|NCT00267969|39664137|FG004|Controlled Period|Other|0|||
16322088|NCT00267969|39664138|FG005|Controlled Period|Other|0|||
16322089|NCT00267969|39664139|FG006|Controlled Period|Other|0|||
16322090|NCT00267969|39664133|FG000|After Controlled Period|Adverse Event|0|||
16322091|NCT00267969|39664134|FG001|After Controlled Period|Adverse Event|0|||
16322092|NCT00267969|39664135|FG002|After Controlled Period|Adverse Event|0|||
16322093|NCT00267969|39664136|FG003|After Controlled Period|Adverse Event|7|||
16322094|NCT00267969|39664137|FG004|After Controlled Period|Adverse Event|8|||
16322095|NCT00267969|39664138|FG005|After Controlled Period|Adverse Event|23|||
16322096|NCT00267969|39664139|FG006|After Controlled Period|Adverse Event|21|||
16322097|NCT00267969|39664133|FG000|After Controlled Period|Death|0|||
16322098|NCT00267969|39664134|FG001|After Controlled Period|Death|0|||
16322099|NCT00267969|39664135|FG002|After Controlled Period|Death|0|||
16322100|NCT00267969|39664136|FG003|After Controlled Period|Death|1|||
16322101|NCT00267969|39664137|FG004|After Controlled Period|Death|2|||
16322102|NCT00267969|39664138|FG005|After Controlled Period|Death|0|||
16322103|NCT00267969|39664139|FG006|After Controlled Period|Death|1|||
16322104|NCT00267969|39664133|FG000|After Controlled Period|Lack of Efficacy|0|||
16322105|NCT00267969|39664134|FG001|After Controlled Period|Lack of Efficacy|0|||
16322106|NCT00267969|39664135|FG002|After Controlled Period|Lack of Efficacy|0|||
16322107|NCT00267969|39664136|FG003|After Controlled Period|Lack of Efficacy|10|||
16322108|NCT00267969|39664137|FG004|After Controlled Period|Lack of Efficacy|6|||
16322109|NCT00267969|39664138|FG005|After Controlled Period|Lack of Efficacy|28|||
16322110|NCT00267969|39664139|FG006|After Controlled Period|Lack of Efficacy|15|||
16322111|NCT00267969|39664133|FG000|After Controlled Period|Lost to Follow-up|0|||
16395483|NCT04512001|39928272|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
16395484|NCT04512001|39928273|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
16322112|NCT00267969|39664134|FG001|After Controlled Period|Lost to Follow-up|0|||
16322113|NCT00267969|39664135|FG002|After Controlled Period|Lost to Follow-up|0|||
16322114|NCT00267969|39664136|FG003|After Controlled Period|Lost to Follow-up|5|||
16322115|NCT00267969|39664137|FG004|After Controlled Period|Lost to Follow-up|8|||
16322116|NCT00267969|39664138|FG005|After Controlled Period|Lost to Follow-up|9|||
16322117|NCT00267969|39664139|FG006|After Controlled Period|Lost to Follow-up|10|||
16322118|NCT00267969|39664133|FG000|After Controlled Period|Other|0|||
16322119|NCT00267969|39664134|FG001|After Controlled Period|Other|0|||
16322120|NCT00267969|39664135|FG002|After Controlled Period|Other|0|||
16322121|NCT00267969|39664136|FG003|After Controlled Period|Other|13|||
16322122|NCT00267969|39664137|FG004|After Controlled Period|Other|11|||
16322123|NCT00267969|39664138|FG005|After Controlled Period|Other|22|||
16322124|NCT00267969|39664139|FG006|After Controlled Period|Other|25|||
16322125|NCT01014988|39664140|FG000|Overall Study|Adverse Event|20|||
16322126|NCT01014988|39664141|FG001|Overall Study|Adverse Event|0|||
16322127|NCT01014988|39664142|FG002|Overall Study|Adverse Event|1|||
16322128|NCT01014988|39664143|FG003|Overall Study|Adverse Event|0|||
16322129|NCT01014988|39664144|FG004|Overall Study|Adverse Event|1|||
16322130|NCT01014988|39664145|FG005|Overall Study|Adverse Event|3|||
16322131|NCT01014988|39664140|FG000|Overall Study|Lost to Follow-up|1|||
16395485|NCT04512001|39928274|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
16395486|NCT04512001|39928270|FG000|Week 24 to Week 63|Miscellaneous|0|||
16395487|NCT04512001|39928271|FG001|Week 24 to Week 63|Miscellaneous|0|||
16092175|NCT00048932|38826987|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
16322132|NCT01014988|39664141|FG001|Overall Study|Lost to Follow-up|0|||
16322133|NCT01014988|39664142|FG002|Overall Study|Lost to Follow-up|1|||
16322134|NCT01014988|39664143|FG003|Overall Study|Lost to Follow-up|0|||
16322135|NCT01014988|39664144|FG004|Overall Study|Lost to Follow-up|0|||
16322136|NCT01014988|39664145|FG005|Overall Study|Lost to Follow-up|0|||
16322137|NCT01014988|39664140|FG000|Overall Study|Physician Decision|1|||
16322138|NCT01014988|39664141|FG001|Overall Study|Physician Decision|0|||
16395488|NCT04512001|39928272|FG002|Week 24 to Week 63|Miscellaneous|3|||
16322139|NCT01014988|39664142|FG002|Overall Study|Physician Decision|0|||
16322140|NCT01014988|39664143|FG003|Overall Study|Physician Decision|0|||
16322141|NCT01014988|39664144|FG004|Overall Study|Physician Decision|0|||
16322142|NCT01014988|39664145|FG005|Overall Study|Physician Decision|0|||
16322143|NCT01014988|39664140|FG000|Overall Study|Withdrawal by Subject|1|||
16322144|NCT01014988|39664141|FG001|Overall Study|Withdrawal by Subject|0|||
16322145|NCT01014988|39664142|FG002|Overall Study|Withdrawal by Subject|0|||
16322146|NCT01014988|39664143|FG003|Overall Study|Withdrawal by Subject|0|||
16322147|NCT01014988|39664144|FG004|Overall Study|Withdrawal by Subject|0|||
16322148|NCT01014988|39664145|FG005|Overall Study|Withdrawal by Subject|0|||
16322149|NCT02780713|39664146|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
16322150|NCT02780713|39664147|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
16322151|NCT02780713|39664148|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
16322152|NCT02780713|39664149|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
16322153|NCT02780713|39664150|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
16322154|NCT03625466|39664151|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
16322155|NCT03625466|39664152|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
16322156|NCT03625466|39664153|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
16322157|NCT03625466|39664151|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
16322158|NCT03625466|39664152|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
16322159|NCT03625466|39664153|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
16322160|NCT03625466|39664151|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
16322161|NCT03625466|39664152|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
16322162|NCT03625466|39664153|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
16517462|NCT02460198|40362238|FG001|Overall Study|Site Terminated By Sponsor|1|||
16517463|NCT02460198|40362237|FG000|Overall Study|Did Not Continue on Extension Study|6|||
16517464|NCT02460198|40362238|FG001|Overall Study|Did Not Continue on Extension Study|11|||
16517465|NCT00714259|40362239|FG000|Overall Study|Death|2|||
16322163|NCT02040857|39664156|FG000|Overall Study|Adverse Event|14|||
16322164|NCT02040857|39664156|FG000|Overall Study|Physician Decision|5|||
16322165|NCT02040857|39664156|FG000|Overall Study|Withdrawal by Subject|31|||
16322166|NCT02040857|39664156|FG000|Overall Study|patient non-compliance|3|||
16322167|NCT02040857|39664156|FG000|Overall Study|Lost to Follow-up|2|||
16322168|NCT02040857|39664156|FG000|Overall Study|recurrence|4|||
16322169|NCT02040857|39664156|FG000|Overall Study|ineligible|1|||
16322170|NCT01726270|39664157|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
16322171|NCT01726270|39664157|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
16322172|NCT01726270|39664157|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
16322173|NCT01726270|39664157|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
16322174|NCT01726270|39664157|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
16322175|NCT01726270|39664157|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
16322176|NCT00442897|39664158|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
16322177|NCT00442897|39664159|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
16517466|NCT01256710|40362240|FG000|Overall Study|Death|449|||
16517467|NCT01256710|40362240|FG000|Overall Study|System Explant|67|||
16517468|NCT01256710|40362240|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
16322178|NCT00442897|39664158|FG000|Base Study (12 Week Follow-up)|Death|0|||
16322179|NCT00442897|39664159|FG001|Base Study (12 Week Follow-up)|Death|1|||
16322180|NCT00442897|39664158|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
16322181|NCT00442897|39664159|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
16322182|NCT00442897|39664158|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
16322183|NCT00442897|39664159|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
16322184|NCT00442897|39664158|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
16322185|NCT00442897|39664159|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
16322186|NCT00442897|39664158|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
16322187|NCT00442897|39664159|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
16322188|NCT00442897|39664158|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
16322189|NCT00442897|39664159|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
16322190|NCT00442897|39664158|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
16322191|NCT00442897|39664159|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
16322192|NCT00603590|39664160|FG000|Overall Study|Did not attend study clinic|39|||
16322193|NCT00603590|39664161|FG001|Overall Study|Did not attend study clinic|30|||
16322194|NCT00603590|39664160|FG000|Overall Study|Refused blood test|5|||
16322195|NCT00603590|39664161|FG001|Overall Study|Refused blood test|1|||
16322196|NCT00603590|39664160|FG000|Overall Study|Patient discontinued study drug|22|||
16322197|NCT00603590|39664161|FG001|Overall Study|Patient discontinued study drug|15|||
16322198|NCT00603590|39664160|FG000|Overall Study|Adverse Event|2|||
16322199|NCT00603590|39664161|FG001|Overall Study|Adverse Event|0|||
16322200|NCT00603590|39664160|FG000|Overall Study|Lost to Follow-up|8|||
16395489|NCT04512001|39928273|FG003|Week 24 to Week 63|Miscellaneous|2|||
16395490|NCT04512001|39928274|FG004|Week 24 to Week 63|Miscellaneous|1|||
16322201|NCT00603590|39664161|FG001|Overall Study|Lost to Follow-up|4|||
16322202|NCT00603590|39664160|FG000|Overall Study|Cardiovascular event|0|||
16322203|NCT00603590|39664161|FG001|Overall Study|Cardiovascular event|1|||
16517469|NCT01256710|40362240|FG000|Overall Study|Lost to Follow-up|67|||
16517470|NCT01256710|40362240|FG000|Overall Study|Withdrawal by Subject|29|||
16517471|NCT01256710|40362240|FG000|Overall Study|Physician Decision|9|||
16517472|NCT01256710|40362240|FG000|Overall Study|Subject Noncompliance|2|||
16517473|NCT01256710|40362240|FG000|Overall Study|Study Terminated by Sponsor|273|||
16517474|NCT02652624|40362245|FG000|Randomized Phase|Pregnancy|3|||
16517475|NCT02652624|40362246|FG001|Randomized Phase|Pregnancy|1|||
16517476|NCT02652624|40362245|FG000|Randomized Phase|Investigator's Discretion|0|||
16517477|NCT02652624|40362246|FG001|Randomized Phase|Investigator's Discretion|2|||
16517478|NCT02652624|40362245|FG000|Randomized Phase|Death|0|||
16322204|NCT00457002|39664162|FG000|Overall Study|Death|40|||
16322205|NCT00457002|39664163|FG001|Overall Study|Death|47|||
16322206|NCT00457002|39664162|FG000|Overall Study|Adverse Event|284|||
16322207|NCT00457002|39664163|FG001|Overall Study|Adverse Event|260|||
16322208|NCT00457002|39664162|FG000|Overall Study|Withdrawal by Subject|299|||
16322209|NCT00457002|39664163|FG001|Overall Study|Withdrawal by Subject|271|||
16322210|NCT00457002|39664162|FG000|Overall Study|Lost to Follow-up|72|||
16322211|NCT00457002|39664163|FG001|Overall Study|Lost to Follow-up|71|||
16322212|NCT00457002|39664162|FG000|Overall Study|Poor/Non-compliance|46|||
16322213|NCT00457002|39664163|FG001|Overall Study|Poor/Non-compliance|33|||
16322214|NCT00457002|39664162|FG000|Overall Study|No longer met criteria|41|||
16322215|NCT00457002|39664163|FG001|Overall Study|No longer met criteria|37|||
16322216|NCT00457002|39664162|FG000|Overall Study|Administrative reason by Sponsor|1|||
16322217|NCT00457002|39664163|FG001|Overall Study|Administrative reason by Sponsor|0|||
16322218|NCT00457002|39664162|FG000|Overall Study|non-specified|29|||
16322219|NCT00457002|39664163|FG001|Overall Study|non-specified|38|||
16322220|NCT00457002|39664162|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
16322221|NCT00457002|39664163|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
16322222|NCT03887442|39664164|FG000|Overall Study|Adverse Event|1|||
16322223|NCT03887442|39664165|FG001|Overall Study|Adverse Event|0|||
16322224|NCT02760004|39664166|FG000|Overall Study|Lost to Follow-up|13|||
16322225|NCT02760004|39664167|FG001|Overall Study|Lost to Follow-up|22|||
16322226|NCT01942486|39664168|FG000|Overall Study|Lost to Follow-up|27|||
16322227|NCT00729612|39664169|FG000|Overall Study|Non evaluable for response|10|||
16322228|NCT00708552|39664170|FG000|Overall Study|Adverse Event|10|||
16322229|NCT00708552|39664171|FG001|Overall Study|Adverse Event|3|||
16322230|NCT00708552|39664172|FG002|Overall Study|Adverse Event|4|||
16322231|NCT00708552|39664173|FG003|Overall Study|Adverse Event|6|||
16322232|NCT00708552|39664170|FG000|Overall Study|Lack of Efficacy|0|||
16322233|NCT00708552|39664171|FG001|Overall Study|Lack of Efficacy|4|||
16517479|NCT02652624|40362246|FG001|Randomized Phase|Death|1|||
16517480|NCT02652624|40362245|FG000|Randomized Phase|Lost to Follow-up|0|||
16517481|NCT02652624|40362246|FG001|Randomized Phase|Lost to Follow-up|1|||
16517482|NCT02652624|40362245|FG000|Extension Phase|Lost to Follow-up|3|||
16517483|NCT02652624|40362246|FG001|Extension Phase|Lost to Follow-up|1|||
16517484|NCT02652624|40362245|FG000|Extension Phase|Pregnancy|1|||
16322234|NCT00708552|39664172|FG002|Overall Study|Lack of Efficacy|1|||
16322235|NCT00708552|39664173|FG003|Overall Study|Lack of Efficacy|0|||
16322236|NCT00708552|39664170|FG000|Overall Study|Protocol Violation|0|||
16322237|NCT00708552|39664171|FG001|Overall Study|Protocol Violation|0|||
16322238|NCT00708552|39664172|FG002|Overall Study|Protocol Violation|2|||
16322239|NCT00708552|39664173|FG003|Overall Study|Protocol Violation|4|||
16322240|NCT00708552|39664170|FG000|Overall Study|Lost to Follow-up|4|||
16322241|NCT00708552|39664171|FG001|Overall Study|Lost to Follow-up|2|||
16322242|NCT00708552|39664172|FG002|Overall Study|Lost to Follow-up|0|||
16322243|NCT00708552|39664173|FG003|Overall Study|Lost to Follow-up|1|||
16322244|NCT00708552|39664170|FG000|Overall Study|Physician Decision|1|||
16322245|NCT00708552|39664171|FG001|Overall Study|Physician Decision|2|||
16322246|NCT00708552|39664172|FG002|Overall Study|Physician Decision|0|||
16322247|NCT00708552|39664173|FG003|Overall Study|Physician Decision|0|||
16322248|NCT00708552|39664170|FG000|Overall Study|Withdrawal by Subject|12|||
16322249|NCT00708552|39664171|FG001|Overall Study|Withdrawal by Subject|7|||
16322250|NCT00708552|39664172|FG002|Overall Study|Withdrawal by Subject|8|||
16322251|NCT00708552|39664173|FG003|Overall Study|Withdrawal by Subject|10|||
16322252|NCT02530125|39664174|FG000|Completed Treatment|Early termination of study|1|||
16322253|NCT02530125|39664174|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
16322254|NCT00454363|39664175|FG000|Overall Study|Adverse Event|1|||
16322255|NCT00454363|39664176|FG001|Overall Study|Adverse Event|2|||
16322256|NCT00454363|39664175|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
16517485|NCT02652624|40362246|FG001|Extension Phase|Pregnancy|1|||
16322257|NCT00454363|39664176|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
16322258|NCT00300885|39664177|FG000|Treatment|Adverse Event|134|||
16322259|NCT00300885|39664178|FG001|Treatment|Adverse Event|82|||
16322260|NCT00300885|39664177|FG000|Treatment|Death|20|||
16322261|NCT00300885|39664178|FG001|Treatment|Death|7|||
16322262|NCT00300885|39664177|FG000|Treatment|Lack of Efficacy|1|||
16517486|NCT02652624|40362245|FG000|Extension Phase|Adverse Event|0|||
16322263|NCT00300885|39664178|FG001|Treatment|Lack of Efficacy|1|||
16395491|NCT04560816|39928275|FG000|Overall Study|Withdrawal by Subject|1|||
16395492|NCT04560816|39928276|FG001|Overall Study|Withdrawal by Subject|1|||
16395493|NCT04560816|39928277|FG002|Overall Study|Withdrawal by Subject|1|||
16395494|NCT04560816|39928278|FG003|Overall Study|Withdrawal by Subject|0|||
16395495|NCT04560816|39928279|FG004|Overall Study|Withdrawal by Subject|3|||
16395496|NCT04560816|39928280|FG005|Overall Study|Withdrawal by Subject|0|||
16395497|NCT04560816|39928275|FG000|Overall Study|Lost to Follow-up|1|||
16395498|NCT04560816|39928276|FG001|Overall Study|Lost to Follow-up|0|||
16395499|NCT04560816|39928277|FG002|Overall Study|Lost to Follow-up|0|||
16395500|NCT04560816|39928278|FG003|Overall Study|Lost to Follow-up|0|||
16395501|NCT04560816|39928279|FG004|Overall Study|Lost to Follow-up|0|||
16395502|NCT04560816|39928280|FG005|Overall Study|Lost to Follow-up|0|||
16517487|NCT02652624|40362246|FG001|Extension Phase|Adverse Event|1|||
16517488|NCT02652624|40362245|FG000|Extension Phase|Withdrew Consent|0|||
16517489|NCT02652624|40362246|FG001|Extension Phase|Withdrew Consent|1|||
16517490|NCT01599650|40362248|FG000|Overall Study|Administrative issue|1|||
16203105|NCT02151682|39222904|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
16322264|NCT00300885|39664177|FG000|Treatment|Lost to Follow-up|3|||
16322265|NCT00300885|39664178|FG001|Treatment|Lost to Follow-up|2|||
16322266|NCT00300885|39664177|FG000|Treatment|Physician Decision|4|||
16322267|NCT00300885|39664178|FG001|Treatment|Physician Decision|5|||
16322268|NCT00300885|39664177|FG000|Treatment|Protocol Violation|11|||
16322269|NCT00300885|39664178|FG001|Treatment|Protocol Violation|11|||
16322270|NCT00300885|39664177|FG000|Treatment|Withdrawal by Subject|26|||
16322271|NCT00300885|39664178|FG001|Treatment|Withdrawal by Subject|23|||
16322272|NCT00300885|39664177|FG000|Treatment|Disease progression|171|||
16322273|NCT00300885|39664178|FG001|Treatment|Disease progression|238|||
16322274|NCT00300885|39664177|FG000|Treatment|Random code broken (subject died)|0|||
16322275|NCT00300885|39664178|FG001|Treatment|Random code broken (subject died)|1|||
16322276|NCT00300885|39664177|FG000|Treatment|Non-compliant with study medication|3|||
16322277|NCT00300885|39664178|FG001|Treatment|Non-compliant with study medication|4|||
16322278|NCT00300885|39664177|FG000|Follow-up|Death|141|||
16322279|NCT00300885|39664178|FG001|Follow-up|Death|163|||
16322280|NCT00300885|39664177|FG000|Follow-up|Lost to Follow-up|11|||
16322281|NCT00300885|39664178|FG001|Follow-up|Lost to Follow-up|7|||
16517491|NCT01599650|40362249|FG001|Overall Study|Administrative issue|0|||
16517492|NCT01599650|40362250|FG002|Overall Study|Administrative issue|1|||
16517493|NCT01599650|40362248|FG000|Overall Study|Physician Decision|2|||
16517494|NCT01599650|40362249|FG001|Overall Study|Physician Decision|0|||
16517495|NCT01599650|40362250|FG002|Overall Study|Physician Decision|7|||
16517496|NCT01599650|40362248|FG000|Overall Study|Protocol Violation|0|||
16517497|NCT01599650|40362249|FG001|Overall Study|Protocol Violation|3|||
16517498|NCT01599650|40362250|FG002|Overall Study|Protocol Violation|0|||
16517499|NCT01599650|40362248|FG000|Overall Study|Death|2|||
16517500|NCT01599650|40362249|FG001|Overall Study|Death|1|||
16517501|NCT01599650|40362250|FG002|Overall Study|Death|2|||
16517502|NCT01599650|40362248|FG000|Overall Study|Lost to Follow-up|3|||
16517503|NCT01599650|40362249|FG001|Overall Study|Lost to Follow-up|3|||
16517504|NCT01599650|40362250|FG002|Overall Study|Lost to Follow-up|3|||
16517505|NCT01599650|40362248|FG000|Overall Study|Withdrawal by Subject|11|||
16517506|NCT01599650|40362249|FG001|Overall Study|Withdrawal by Subject|11|||
16322282|NCT00300885|39664177|FG000|Follow-up|Withdrawal by Subject|26|||
16322283|NCT00300885|39664178|FG001|Follow-up|Withdrawal by Subject|25|||
16517507|NCT01599650|40362250|FG002|Overall Study|Withdrawal by Subject|10|||
16517508|NCT01599650|40362248|FG000|Overall Study|Adverse Event|3|||
16517509|NCT01599650|40362249|FG001|Overall Study|Adverse Event|8|||
16322284|NCT03103321|39664179|FG000|Overall Study|Protocol Violation|1|||
16322285|NCT03103321|39664180|FG001|Overall Study|Protocol Violation|1|||
16322286|NCT03103321|39664181|FG002|Overall Study|Protocol Violation|1|||
16322287|NCT03103321|39664182|FG003|Overall Study|Protocol Violation|0|||
16322288|NCT04657198|39664185|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
16322289|NCT04657198|39664186|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
16322290|NCT04657198|39664187|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
16395503|NCT04560816|39928275|FG000|Overall Study|Protocol Violation|1|||
16517510|NCT01599650|40362250|FG002|Overall Study|Adverse Event|4|||
16517511|NCT00953329|40362251|FG000|Overall Study|Lack of Efficacy|1|||
16203106|NCT02151682|39222905|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
16395504|NCT04560816|39928276|FG001|Overall Study|Protocol Violation|0|||
16517512|NCT00502697|40362252|FG000|Overall Study|Withdrawal by Subject|3|||
16517513|NCT00502697|40362253|FG001|Overall Study|Withdrawal by Subject|1|||
16517514|NCT00502697|40362252|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
16322291|NCT05486091|39664193|FG000|Overall Study|Withdrawal by Subject|1|||
16322292|NCT05486091|39664193|FG000|Overall Study|Lost to Follow-up|2|||
16322293|NCT00022698|39664194|FG000|Overall Study|Adverse Event|5|||
16322294|NCT00022698|39664195|FG001|Overall Study|Adverse Event|9|||
16322295|NCT00022698|39664194|FG000|Overall Study|Death|0|||
16322296|NCT00022698|39664195|FG001|Overall Study|Death|2|||
16395505|NCT04560816|39928277|FG002|Overall Study|Protocol Violation|0|||
16322297|NCT00022698|39664194|FG000|Overall Study|Failure to return|0|||
16203107|NCT02151682|39222906|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
16203108|NCT02151682|39222907|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
16322298|NCT00022698|39664195|FG001|Overall Study|Failure to return|1|||
16322299|NCT00022698|39664194|FG000|Overall Study|Refused treatment|0|||
16322300|NCT00022698|39664195|FG001|Overall Study|Refused treatment|2|||
16322301|NCT00022698|39664194|FG000|Overall Study|Insufficient therapeutic response|2|||
16322302|NCT00022698|39664195|FG001|Overall Study|Insufficient therapeutic response|14|||
16322303|NCT00022698|39664194|FG000|Overall Study|Administrative /other|1|||
16322304|NCT00022698|39664195|FG001|Overall Study|Administrative /other|7|||
16322305|NCT01221272|39667420|FG000|Period 1|Adverse Event|2|||
16322306|NCT01221272|39667421|FG001|Period 1|Adverse Event|0|||
16322307|NCT01221272|39667420|FG000|Period 1|Consent Withdrawal|0|||
16322308|NCT01221272|39667421|FG001|Period 1|Consent Withdrawal|1|||
16322309|NCT01221272|39667420|FG000|Period 1|Significant Dosing Noncompliance|0|||
16322310|NCT01221272|39667421|FG001|Period 1|Significant Dosing Noncompliance|1|||
16322311|NCT01221272|39667420|FG000|Period 2|Adverse Event|0|||
16322312|NCT01221272|39667421|FG001|Period 2|Adverse Event|2|||
16322313|NCT00975611|39667424|FG000|Overall Study|Screen Fail|16|||
16322314|NCT00975611|39667424|FG000|Overall Study|Physician Decision|1|||
16322315|NCT00427921|39667425|FG000|Overall Study|Adverse Event|26|||
16322316|NCT00427921|39667425|FG000|Overall Study|Withdrawal by Subject|4|||
16322317|NCT00427921|39667425|FG000|Overall Study|Lost to Follow-up|2|||
16322318|NCT00427921|39667425|FG000|Overall Study|Other reason not specified|10|||
16203109|NCT02151682|39222908|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
16203110|NCT02151682|39222909|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
16203111|NCT02151682|39222904|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
16203112|NCT02151682|39222905|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
16517515|NCT00502697|40362253|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
16517516|NCT00502697|40362252|FG000|Overall Study|found not to meet eligibility criteria|3|||
16517517|NCT00502697|40362253|FG001|Overall Study|found not to meet eligibility criteria|4|||
16517518|NCT00502697|40362252|FG000|Overall Study|did not meet assignment criteria|4|||
16517519|NCT00502697|40362253|FG001|Overall Study|did not meet assignment criteria|2|||
16517520|NCT03511560|40362256|FG000|Overall Study|Death|0|||
16517521|NCT03511560|40362257|FG001|Overall Study|Death|1|||
16203113|NCT02151682|39222906|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
16203114|NCT02151682|39222907|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
16203115|NCT02151682|39222908|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
16203116|NCT02151682|39222909|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
16203117|NCT02151682|39222904|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
16517522|NCT03511560|40362256|FG000|Overall Study|Adverse Event|0|||
16517523|NCT03511560|40362257|FG001|Overall Study|Adverse Event|2|||
16517524|NCT03511560|40362256|FG000|Overall Study|Transplant cancelled|0|||
16517525|NCT03511560|40362257|FG001|Overall Study|Transplant cancelled|1|||
16517526|NCT03511560|40362256|FG000|Overall Study|Patient switched to another drug|1|||
16517527|NCT03511560|40362257|FG001|Overall Study|Patient switched to another drug|0|||
16517528|NCT02673775|40362271|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
16517529|NCT02673775|40362272|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
16517530|NCT02673775|40362271|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
16517531|NCT02673775|40362272|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
16517532|NCT02673775|40362271|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
16517533|NCT02673775|40362272|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
16517534|NCT02673775|40362271|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
16203118|NCT02151682|39222905|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
16322319|NCT00427921|39667425|FG000|Overall Study|Adverse Event + Hospitalization|1|||
16517535|NCT02673775|40362272|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
16322320|NCT00427921|39667425|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
16322321|NCT00427921|39667425|FG000|Overall Study|Adverse Event + No Response|1|||
16517536|NCT00418691|40362273|FG000|Overall Study|Lost to Follow-up|1|||
16517537|NCT00418691|40362274|FG001|Overall Study|Lost to Follow-up|2|||
16517538|NCT00418691|40362275|FG002|Overall Study|Lost to Follow-up|3|||
16517539|NCT00418691|40362273|FG000|Overall Study|Started new medication voiding entry|0|||
16322322|NCT00427921|39667425|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
16322323|NCT00427921|39667425|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
16322324|NCT00427921|39667425|FG000|Overall Study|Adverse Event + Lost Response|1|||
16322325|NCT00427921|39667425|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
16322326|NCT00427921|39667425|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
16322327|NCT01136356|39667426|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
16322328|NCT01136356|39667427|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
16322329|NCT01136356|39667426|FG000|First 18-day Withdrawal|Physician Decision|1|||
16322330|NCT01136356|39667427|FG001|First 18-day Withdrawal|Physician Decision|0|||
16322331|NCT01136356|39667426|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
16517540|NCT00418691|40362274|FG001|Overall Study|Started new medication voiding entry|0|||
16517541|NCT00418691|40362275|FG002|Overall Study|Started new medication voiding entry|1|||
16517542|NCT00418691|40362273|FG000|Overall Study|Progressive Disease|1|||
16517543|NCT00418691|40362274|FG001|Overall Study|Progressive Disease|0|||
16517544|NCT00418691|40362275|FG002|Overall Study|Progressive Disease|1|||
16517545|NCT02212730|40362276|FG000|Overall Study|Tumor not of the required cell histology|1|||
16517546|NCT02212730|40362277|FG001|Overall Study|Tumor not of the required cell histology|0|||
16517547|NCT02212730|40362276|FG000|Overall Study|Withdrawal by Subject|1|||
16517548|NCT02212730|40362277|FG001|Overall Study|Withdrawal by Subject|0|||
16517549|NCT02212730|40362276|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
16517550|NCT02212730|40362277|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
16517551|NCT03614793|40362283|FG000|Overall Study|Lost to Follow-up|1|||
16517552|NCT03614793|40362284|FG001|Overall Study|Lost to Follow-up|2|||
16517553|NCT03614793|40362283|FG000|Overall Study|Lack of Efficacy|0|||
16517554|NCT03614793|40362284|FG001|Overall Study|Lack of Efficacy|5|||
16517555|NCT03614793|40362283|FG000|Overall Study|Withdrawal by Subject|0|||
16517556|NCT03614793|40362284|FG001|Overall Study|Withdrawal by Subject|1|||
16517557|NCT03614793|40362283|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
16517558|NCT03614793|40362284|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
16517559|NCT00654381|40362288|FG000|1st Stage|Adverse Event|3|||
16517560|NCT00654381|40362289|FG001|1st Stage|Adverse Event|3|||
16517561|NCT00654381|40362290|FG002|1st Stage|Adverse Event|3|||
16517562|NCT00654381|40362291|FG003|1st Stage|Adverse Event|3|||
16517563|NCT00654381|40362292|FG004|1st Stage|Adverse Event|2|||
16517564|NCT00654381|40362293|FG005|1st Stage|Adverse Event|1|||
16322332|NCT01136356|39667427|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
16322333|NCT02288091|39667428|FG000|Overall Study|Lost to Follow-up|1|||
16322334|NCT02288091|39667428|FG000|Overall Study|Screen fail|7|||
16517565|NCT00654381|40362288|FG000|1st Stage|Withdrawal by Subject|0|||
16517566|NCT00654381|40362289|FG001|1st Stage|Withdrawal by Subject|0|||
16517567|NCT00654381|40362290|FG002|1st Stage|Withdrawal by Subject|0|||
16517568|NCT00654381|40362291|FG003|1st Stage|Withdrawal by Subject|1|||
16517569|NCT00654381|40362292|FG004|1st Stage|Withdrawal by Subject|0|||
16517570|NCT00654381|40362293|FG005|1st Stage|Withdrawal by Subject|1|||
16517571|NCT00654381|40362288|FG000|1st Stage|Investigator's decision|0|||
16517572|NCT00654381|40362289|FG001|1st Stage|Investigator's decision|0|||
16517573|NCT00654381|40362290|FG002|1st Stage|Investigator's decision|0|||
16517574|NCT00654381|40362291|FG003|1st Stage|Investigator's decision|1|||
16517575|NCT00654381|40362292|FG004|1st Stage|Investigator's decision|0|||
16517576|NCT00654381|40362293|FG005|1st Stage|Investigator's decision|0|||
16322335|NCT01344824|39667431|FG000|Overall Study|Adverse Event|15|||
16322336|NCT01344824|39667431|FG000|Overall Study|Withdrawal by Subject|6|||
16322337|NCT01344824|39667431|FG000|Overall Study|Other complicating disease|1|||
16322338|NCT01344824|39667431|FG000|Overall Study|Progression|15|||
16322339|NCT00471822|39667448|FG000|Overall Study|Protocol Violation|2|||
16322340|NCT01769508|39667449|FG000|Overall Study|Death|3|||
16322341|NCT01769508|39667449|FG000|Overall Study|Withdrawal by Subject|1|||
16322342|NCT01769508|39667449|FG000|Overall Study|Adverse Event|1|||
16322343|NCT01769508|39667449|FG000|Overall Study|Lost to Follow-up|1|||
16322344|NCT01894100|39667459|FG000|Overall Study|Lost to Follow-up|0|||
16322345|NCT01894100|39667460|FG001|Overall Study|Lost to Follow-up|1|||
16322346|NCT01894100|39667459|FG000|Overall Study|Withdrawal by Subject|3|||
16322347|NCT01894100|39667460|FG001|Overall Study|Withdrawal by Subject|0|||
16322348|NCT00820248|39667470|FG000|Overall Study|No treated|4|||
16322349|NCT00820248|39667471|FG001|Overall Study|No treated|1|||
16322350|NCT00347009|39667473|FG000|Overall Study|Death|1|||
16322351|NCT00347009|39667473|FG000|Overall Study|Adverse Event|6|||
16322352|NCT00347009|39667473|FG000|Overall Study|Withdrawal by Subject|3|||
16322353|NCT00347009|39667473|FG000|Overall Study|Physician Decision|5|||
16322354|NCT00347009|39667473|FG000|Overall Study|Lost to Follow-up|4|||
16322355|NCT00347009|39667473|FG000|Overall Study|Protocol Violation|2|||
16517577|NCT00654381|40362288|FG000|2nd Stage|Adverse Event|2|||
16517578|NCT00654381|40362289|FG001|2nd Stage|Adverse Event|0|||
16517579|NCT00654381|40362290|FG002|2nd Stage|Adverse Event|2|||
16203119|NCT02151682|39222906|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
16517580|NCT00654381|40362291|FG003|2nd Stage|Adverse Event|3|||
16517581|NCT00654381|40362292|FG004|2nd Stage|Adverse Event|7|||
16517582|NCT00654381|40362293|FG005|2nd Stage|Adverse Event|2|||
16517583|NCT00654381|40362288|FG000|2nd Stage|Withdrawal by Subject|0|||
16517584|NCT00654381|40362289|FG001|2nd Stage|Withdrawal by Subject|0|||
16203120|NCT02151682|39222907|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
16203121|NCT02151682|39222908|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
16203122|NCT02151682|39222909|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
16203123|NCT02151682|39222904|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
16203124|NCT02151682|39222905|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
16203125|NCT02151682|39222906|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
16203126|NCT02151682|39222907|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
16203127|NCT02151682|39222908|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
16203128|NCT02151682|39222909|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
16203129|NCT02151682|39222904|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
16203130|NCT02151682|39222905|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
16203131|NCT02151682|39222906|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
16203132|NCT02151682|39222907|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
16203133|NCT02151682|39222908|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
16203134|NCT02151682|39222909|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
16203135|NCT02151682|39222904|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
16203136|NCT02151682|39222905|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
16203137|NCT02151682|39222906|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
16203138|NCT02151682|39222907|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
16203139|NCT02151682|39222908|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
16203140|NCT02151682|39222909|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
16203141|NCT02151682|39222904|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
16203142|NCT02151682|39222905|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
16203143|NCT02151682|39222906|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
16203144|NCT02151682|39222907|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
16203145|NCT02151682|39222908|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
16203146|NCT02151682|39222909|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
16322356|NCT00347009|39667473|FG000|Overall Study|Adverse Laboratory Experience|1|||
16322357|NCT00347009|39667473|FG000|Overall Study|Insufficient Viral Suppression|3|||
16517585|NCT00654381|40362290|FG002|2nd Stage|Withdrawal by Subject|0|||
16517586|NCT00654381|40362291|FG003|2nd Stage|Withdrawal by Subject|0|||
16517587|NCT00654381|40362292|FG004|2nd Stage|Withdrawal by Subject|1|||
16517588|NCT00654381|40362293|FG005|2nd Stage|Withdrawal by Subject|1|||
16517589|NCT00654381|40362288|FG000|2nd Stage|Investigator's decision|0|||
16517590|NCT00654381|40362289|FG001|2nd Stage|Investigator's decision|0|||
16203147|NCT02151682|39222904|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
16203148|NCT02151682|39222905|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
16203149|NCT02151682|39222906|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
16203150|NCT02151682|39222907|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
16203151|NCT02151682|39222908|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
16203152|NCT02151682|39222909|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
16203153|NCT02151682|39222904|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
16203154|NCT02151682|39222905|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
16517591|NCT00654381|40362290|FG002|2nd Stage|Investigator's decision|1|||
16203155|NCT02151682|39222906|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
16203156|NCT02151682|39222907|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
16203157|NCT02151682|39222908|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
16203158|NCT02151682|39222909|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
16203159|NCT02151682|39222904|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
16203160|NCT02151682|39222905|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
16203161|NCT02151682|39222906|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
16203162|NCT02151682|39222907|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
16203163|NCT02151682|39222908|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
16203164|NCT02151682|39222909|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
16203165|NCT02151682|39222904|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
16203166|NCT02151682|39222905|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
16203167|NCT02151682|39222906|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
16203168|NCT02151682|39222907|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
16203169|NCT02151682|39222908|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
16203170|NCT02151682|39222909|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
16203171|NCT02151682|39222904|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
16203172|NCT02151682|39222905|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
16203173|NCT02151682|39222906|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
16203174|NCT02151682|39222907|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
16203175|NCT02151682|39222908|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
16203176|NCT02151682|39222909|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
16203177|NCT00120289|39222910|FG000|Overall Study|Death|96|||
16203178|NCT00120289|39222911|FG001|Overall Study|Death|82|||
16203179|NCT00120289|39222910|FG000|Overall Study|Lost to Follow-up|11|||
16203180|NCT00120289|39222911|FG001|Overall Study|Lost to Follow-up|14|||
16203181|NCT00120289|39222910|FG000|Overall Study|Withdrawal by Subject|14|||
16203182|NCT00120289|39222911|FG001|Overall Study|Withdrawal by Subject|13|||
16203183|NCT02759861|39222912|FG000|Overall Study|Death|1|||
16203184|NCT01103778|39222913|FG000|Overall Study|Lost to Follow-up|1|||
16203185|NCT01103778|39222913|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
16203186|NCT01103778|39222913|FG000|Overall Study|Screen failure|1|||
16203187|NCT01381718|39222916|FG000|Overall Study|Withdrawal by Subject|2|||
16203188|NCT01381718|39222917|FG001|Overall Study|Withdrawal by Subject|5|||
16203189|NCT01381718|39222916|FG000|Overall Study|Lost to Follow-up|3|||
16203190|NCT01381718|39222917|FG001|Overall Study|Lost to Follow-up|5|||
16203191|NCT01381718|39222916|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
16203192|NCT01381718|39222917|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
16203193|NCT03444870|39222918|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
16203194|NCT03444870|39222919|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
16203195|NCT03444870|39222920|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
16203196|NCT03444870|39222921|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
16203197|NCT03444870|39222922|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
16203198|NCT03444870|39222923|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
16203199|NCT03444870|39222918|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
16203200|NCT03444870|39222919|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
16203201|NCT03444870|39222920|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
16203202|NCT03444870|39222921|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
16203203|NCT03444870|39222922|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
16203204|NCT03444870|39222923|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
16203205|NCT03444870|39222918|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
16203206|NCT03444870|39222919|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
16203207|NCT03444870|39222920|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
16203208|NCT03444870|39222921|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
16517592|NCT00654381|40362291|FG003|2nd Stage|Investigator's decision|1|||
16517593|NCT00654381|40362292|FG004|2nd Stage|Investigator's decision|0|||
16517594|NCT00654381|40362293|FG005|2nd Stage|Investigator's decision|0|||
16092176|NCT00048932|38826988|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
16517595|NCT00654381|40362288|FG000|Extension Stage|Adverse Event|1|||
16517596|NCT00654381|40362289|FG001|Extension Stage|Adverse Event|2|||
16517597|NCT00654381|40362290|FG002|Extension Stage|Adverse Event|9|||
16517598|NCT00654381|40362291|FG003|Extension Stage|Adverse Event|7|||
16517599|NCT00654381|40362292|FG004|Extension Stage|Adverse Event|1|||
16517600|NCT00654381|40362293|FG005|Extension Stage|Adverse Event|1|||
16517601|NCT00654381|40362288|FG000|Extension Stage|Protocol Violation|0|||
16517602|NCT00654381|40362289|FG001|Extension Stage|Protocol Violation|0|||
16517603|NCT00654381|40362290|FG002|Extension Stage|Protocol Violation|0|||
16517604|NCT00654381|40362291|FG003|Extension Stage|Protocol Violation|1|||
16517605|NCT00654381|40362292|FG004|Extension Stage|Protocol Violation|0|||
16322358|NCT00347009|39667473|FG000|Overall Study|Increased ALT/HBV DNA|1|||
16322359|NCT00347009|39667473|FG000|Overall Study|Serious Adverse Event|1|||
16322360|NCT03491462|39667477|FG000|Overall Study|Lost to Follow-up|2|||
16517606|NCT00654381|40362293|FG005|Extension Stage|Protocol Violation|0|||
16517607|NCT00654381|40362288|FG000|Extension Stage|Lack of Efficacy|0|||
16322361|NCT03491462|39667478|FG001|Overall Study|Lost to Follow-up|0|||
16322362|NCT03491462|39667477|FG000|Overall Study|Adverse Event|11|||
16322363|NCT03491462|39667478|FG001|Overall Study|Adverse Event|1|||
16322364|NCT03491462|39667477|FG000|Overall Study|Physician Decision|3|||
16322365|NCT03491462|39667478|FG001|Overall Study|Physician Decision|0|||
16322366|NCT03491462|39667477|FG000|Overall Study|Withdrawal by Subject|22|||
16517608|NCT00654381|40362289|FG001|Extension Stage|Lack of Efficacy|0|||
16517609|NCT00654381|40362290|FG002|Extension Stage|Lack of Efficacy|1|||
16517610|NCT00654381|40362291|FG003|Extension Stage|Lack of Efficacy|0|||
16517611|NCT00654381|40362292|FG004|Extension Stage|Lack of Efficacy|0|||
16517612|NCT00654381|40362293|FG005|Extension Stage|Lack of Efficacy|0|||
16517613|NCT00654381|40362288|FG000|Extension Stage|Withdrawal by Subject|0|||
16517614|NCT00654381|40362289|FG001|Extension Stage|Withdrawal by Subject|0|||
16517615|NCT00654381|40362290|FG002|Extension Stage|Withdrawal by Subject|1|||
16517616|NCT00654381|40362291|FG003|Extension Stage|Withdrawal by Subject|1|||
16517617|NCT00654381|40362292|FG004|Extension Stage|Withdrawal by Subject|1|||
16517618|NCT00654381|40362293|FG005|Extension Stage|Withdrawal by Subject|1|||
16517619|NCT00654381|40362288|FG000|Extension Stage|Closure of the trial site|0|||
16517620|NCT00654381|40362289|FG001|Extension Stage|Closure of the trial site|0|||
16517621|NCT00654381|40362290|FG002|Extension Stage|Closure of the trial site|0|||
16517622|NCT00654381|40362291|FG003|Extension Stage|Closure of the trial site|0|||
16092177|NCT00048932|38826986|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
16322367|NCT03491462|39667478|FG001|Overall Study|Withdrawal by Subject|15|||
16322368|NCT03615144|39667483|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
16322369|NCT03615144|39667484|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
16322370|NCT01938430|39667485|FG000|Overall Study|Randomized but Not Treated|0|||
16322371|NCT01938430|39667486|FG001|Overall Study|Randomized but Not Treated|0|||
16322372|NCT01938430|39667487|FG002|Overall Study|Randomized but Not Treated|0|||
16322373|NCT01938430|39667488|FG003|Overall Study|Randomized but Not Treated|0|||
16322374|NCT01938430|39667489|FG004|Overall Study|Randomized but Not Treated|0|||
16322375|NCT01938430|39667490|FG005|Overall Study|Randomized but Not Treated|0|||
16092178|NCT00048932|38826987|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
16092179|NCT00048932|38826988|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
16092180|NCT00048932|38826986|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
16092181|NCT00048932|38826987|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
16092182|NCT00048932|38826988|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
16203209|NCT03444870|39222922|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
16092183|NCT00048932|38826986|FG000|Open Label Period (OL)|Investigator Decision|0|||
16092184|NCT00048932|38826987|FG001|Open Label Period (OL)|Investigator Decision|0|||
16092185|NCT00048932|38826988|FG002|Open Label Period (OL)|Investigator Decision|4|||
16092186|NCT00048932|38826986|FG000|Open Label Period (OL)|Site Staff Issues|0|||
16092187|NCT00048932|38826987|FG001|Open Label Period (OL)|Site Staff Issues|0|||
16092188|NCT00048932|38826988|FG002|Open Label Period (OL)|Site Staff Issues|2|||
16092189|NCT00048932|38826986|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
16092190|NCT00048932|38826987|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
16203210|NCT03444870|39222923|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
16203211|NCT03444870|39222918|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
16322376|NCT01938430|39667491|FG006|Overall Study|Randomized but Not Treated|0|||
16322377|NCT01938430|39667492|FG007|Overall Study|Randomized but Not Treated|0|||
16322378|NCT01938430|39667493|FG008|Overall Study|Randomized but Not Treated|0|||
16322379|NCT01938430|39667494|FG009|Overall Study|Randomized but Not Treated|0|||
16322380|NCT01938430|39667495|FG010|Overall Study|Randomized but Not Treated|1|||
16322381|NCT01938430|39667496|FG011|Overall Study|Randomized but Not Treated|0|||
16517623|NCT00654381|40362292|FG004|Extension Stage|Closure of the trial site|1|||
16517624|NCT00654381|40362293|FG005|Extension Stage|Closure of the trial site|1|||
16517625|NCT03852316|40362294|FG000|Overall Study|Protocol Violation|1|||
16517626|NCT03852316|40362294|FG000|Overall Study|Withdrawal by Subject|2|||
16092191|NCT00048932|38826988|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
16092192|NCT00048932|38826986|FG000|Open Label Period (OL)|Participant Surgery|0|||
16092193|NCT00048932|38826987|FG001|Open Label Period (OL)|Participant Surgery|0|||
16092194|NCT00048932|38826988|FG002|Open Label Period (OL)|Participant Surgery|1|||
16092195|NCT00754325|38826989|FG000|Initial Treatment|Continuing Active Treatment|4|||
16092196|NCT00754325|38826990|FG001|Initial Treatment|Continuing Active Treatment|5|||
16092197|NCT00754325|38826989|FG000|Initial Treatment|Adverse Event|7|||
16092198|NCT00754325|38826990|FG001|Initial Treatment|Adverse Event|6|||
16092199|NCT00754325|38826989|FG000|Initial Treatment|Withdrawal by Subject|2|||
16092200|NCT00754325|38826990|FG001|Initial Treatment|Withdrawal by Subject|2|||
16092201|NCT00754325|38826989|FG000|Initial Treatment|Physician Decision|2|||
16092202|NCT00754325|38826990|FG001|Initial Treatment|Physician Decision|0|||
16092203|NCT00754325|38826989|FG000|Initial Treatment|Sponsor Request|0|||
16092204|NCT00754325|38826990|FG001|Initial Treatment|Sponsor Request|1|||
16092205|NCT00754325|38826989|FG000|Initial Treatment|Disease Progression|35|||
16092206|NCT00754325|38826990|FG001|Initial Treatment|Disease Progression|35|||
16092207|NCT03390166|38826991|FG000|Overall Study|Death|0|||
16092208|NCT03390166|38826992|FG001|Overall Study|Death|1|||
16203212|NCT03444870|39222919|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
16203213|NCT03444870|39222920|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
16203214|NCT03444870|39222921|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
16203215|NCT03444870|39222922|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
16517627|NCT03852316|40362294|FG000|Overall Study|Enrolled but Device not Utilized|1|||
16517628|NCT02806726|40364912|FG000|Overall Study|Lost to Follow-up|1|||
16517629|NCT01375049|40364913|FG000|Overall Study|Adverse Event|2|||
16517630|NCT01375049|40364913|FG000|Overall Study|Lost to Follow-up|1|||
16517631|NCT01375049|40364913|FG000|Overall Study|Withdrawal by Subject|2|||
16203216|NCT03444870|39222923|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
16322382|NCT01938430|39667497|FG012|Overall Study|Randomized but Not Treated|0|||
16322383|NCT01938430|39667498|FG013|Overall Study|Randomized but Not Treated|1|||
16322384|NCT01938430|39667485|FG000|Overall Study|Adverse Event|0|||
16322385|NCT01938430|39667486|FG001|Overall Study|Adverse Event|0|||
16322386|NCT01938430|39667487|FG002|Overall Study|Adverse Event|0|||
16322387|NCT01938430|39667488|FG003|Overall Study|Adverse Event|0|||
16322388|NCT01938430|39667489|FG004|Overall Study|Adverse Event|0|||
16322389|NCT01938430|39667490|FG005|Overall Study|Adverse Event|0|||
16322390|NCT01938430|39667491|FG006|Overall Study|Adverse Event|1|||
16322391|NCT01938430|39667492|FG007|Overall Study|Adverse Event|0|||
16517632|NCT01375049|40364913|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
16517633|NCT00458484|40364915|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
16322392|NCT01938430|39667493|FG008|Overall Study|Adverse Event|0|||
16322393|NCT01938430|39667494|FG009|Overall Study|Adverse Event|0|||
16517634|NCT00458484|40364916|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
16092209|NCT03390166|38826991|FG000|Overall Study|Lost to Follow-up|6|||
16092210|NCT03390166|38826992|FG001|Overall Study|Lost to Follow-up|4|||
16203217|NCT03444870|39222918|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
16203218|NCT03444870|39222919|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
16322394|NCT01938430|39667495|FG010|Overall Study|Adverse Event|0|||
16322395|NCT01938430|39667496|FG011|Overall Study|Adverse Event|0|||
16322396|NCT01938430|39667497|FG012|Overall Study|Adverse Event|0|||
16322397|NCT01938430|39667498|FG013|Overall Study|Adverse Event|0|||
16322398|NCT01938430|39667485|FG000|Overall Study|Death|1|||
16322399|NCT01938430|39667486|FG001|Overall Study|Death|2|||
16203219|NCT03444870|39222920|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
16203220|NCT03444870|39222921|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
16203221|NCT03444870|39222922|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
16322400|NCT01938430|39667487|FG002|Overall Study|Death|2|||
16322401|NCT01938430|39667488|FG003|Overall Study|Death|1|||
16322402|NCT01938430|39667489|FG004|Overall Study|Death|0|||
16322403|NCT01938430|39667490|FG005|Overall Study|Death|0|||
16322404|NCT01938430|39667491|FG006|Overall Study|Death|1|||
16322405|NCT01938430|39667492|FG007|Overall Study|Death|1|||
16322406|NCT01938430|39667493|FG008|Overall Study|Death|2|||
16322407|NCT01938430|39667494|FG009|Overall Study|Death|3|||
16322408|NCT01938430|39667495|FG010|Overall Study|Death|0|||
16322409|NCT01938430|39667496|FG011|Overall Study|Death|0|||
16517635|NCT00458484|40364917|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
16517636|NCT00458484|40364918|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
16517637|NCT00458484|40364919|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
16517638|NCT00458484|40364920|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
16517639|NCT00458484|40364921|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
16517640|NCT00326911|40364924|FG000|Overall Study|Hospitalization prior to treatment|0|||
16517641|NCT00326911|40364925|FG001|Overall Study|Hospitalization prior to treatment|1|||
16517642|NCT00326911|40364924|FG000|Overall Study|Physician decision prior to treatment|1|||
16517643|NCT00326911|40364925|FG001|Overall Study|Physician decision prior to treatment|0|||
16517644|NCT00326911|40364924|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
16517645|NCT00326911|40364925|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
16517646|NCT00298038|40364926|FG000|Overall Study|Lost to Follow-up|0|||
16517647|NCT00298038|40364927|FG001|Overall Study|Lost to Follow-up|1|||
16517648|NCT00298038|40364926|FG000|Overall Study|Liver Transplant|0|||
16517649|NCT00298038|40364927|FG001|Overall Study|Liver Transplant|1|||
16517650|NCT00298038|40364926|FG000|Overall Study|Protocol Violation|1|||
16517651|NCT00298038|40364927|FG001|Overall Study|Protocol Violation|3|||
16517652|NCT00298038|40364926|FG000|Overall Study|Death|6|||
16517653|NCT00298038|40364927|FG001|Overall Study|Death|3|||
16517654|NCT00298038|40364926|FG000|Overall Study|Withdrawal by Subject|6|||
16517655|NCT00298038|40364927|FG001|Overall Study|Withdrawal by Subject|9|||
16517656|NCT00298038|40364926|FG000|Overall Study|Adverse Event|8|||
16517657|NCT00298038|40364927|FG001|Overall Study|Adverse Event|7|||
16517658|NCT00298038|40364926|FG000|Overall Study|Breakthrough overt HE episode|28|||
16203222|NCT03444870|39222923|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
16203223|NCT03444870|39222918|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
16203224|NCT03444870|39222919|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
16203225|NCT03444870|39222920|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
16203226|NCT03444870|39222921|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
16203227|NCT03444870|39222922|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
16203228|NCT03444870|39222923|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
16203229|NCT03444870|39222918|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
16203230|NCT03444870|39222919|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
16203231|NCT03444870|39222920|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
16203232|NCT03444870|39222921|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
16203233|NCT03444870|39222922|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
16203234|NCT03444870|39222923|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
16203235|NCT03444870|39222918|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
16203236|NCT03444870|39222919|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
16203237|NCT03444870|39222920|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
16203238|NCT03444870|39222921|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
16203239|NCT03444870|39222922|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
16203240|NCT03444870|39222923|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
16203241|NCT03444870|39222918|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
16203242|NCT03444870|39222919|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
16203243|NCT03444870|39222920|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
16203244|NCT03444870|39222921|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
16203245|NCT03444870|39222922|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
16203246|NCT03444870|39222923|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
16203247|NCT03444870|39222918|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
16203248|NCT03444870|39222919|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
16203249|NCT03444870|39222920|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
16203250|NCT03444870|39222921|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
16203251|NCT03444870|39222922|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
16203252|NCT03444870|39222923|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
16203253|NCT03444870|39222918|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
16203254|NCT03444870|39222919|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
16203255|NCT03444870|39222920|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
16203256|NCT03444870|39222921|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
16203257|NCT03444870|39222922|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
16203258|NCT03444870|39222923|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
16203259|NCT03444870|39222918|FG000|Open-Label Extension (OLE) Period|Death|0|||
16203260|NCT03444870|39222919|FG001|Open-Label Extension (OLE) Period|Death|0|||
16203261|NCT03444870|39222920|FG002|Open-Label Extension (OLE) Period|Death|0|||
16203262|NCT03444870|39222921|FG003|Open-Label Extension (OLE) Period|Death|0|||
16203263|NCT03444870|39222922|FG004|Open-Label Extension (OLE) Period|Death|1|||
16203264|NCT03444870|39222923|FG005|Open-Label Extension (OLE) Period|Death|0|||
16517659|NCT00298038|40364927|FG001|Overall Study|Breakthrough overt HE episode|69|||
16517660|NCT00298038|40364926|FG000|Overall Study|Noncompliance|1|||
16517661|NCT00298038|40364927|FG001|Overall Study|Noncompliance|0|||
16517662|NCT00298038|40364926|FG000|Overall Study|Cocaine Abuse|1|||
16203265|NCT02224638|39222924|FG000|Overall Study|Adverse Event|1|||
16203266|NCT02224638|39222925|FG001|Overall Study|Adverse Event|1|||
16517663|NCT00298038|40364927|FG001|Overall Study|Cocaine Abuse|0|||
16517664|NCT00298038|40364926|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
16517665|NCT00298038|40364927|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
16517666|NCT00965848|40364941|FG000|Overall Study|Protocol Violation|3|||
16517667|NCT00965848|40364942|FG001|Overall Study|Protocol Violation|0|||
16517668|NCT00965848|40364943|FG002|Overall Study|Protocol Violation|1|||
16517669|NCT00965848|40364941|FG000|Overall Study|Death|11|||
16517670|NCT00965848|40364942|FG001|Overall Study|Death|1|||
16517671|NCT00965848|40364943|FG002|Overall Study|Death|5|||
16203267|NCT01293006|39222926|FG000|Period 2|Lost to Follow-up|1|||
16203268|NCT01293006|39222927|FG001|Period 2|Lost to Follow-up|0|||
16203269|NCT01293006|39222928|FG002|Period 2|Lost to Follow-up|0|||
16203270|NCT01293006|39222929|FG003|Period 2|Lost to Follow-up|0|||
16203271|NCT03485222|39222930|FG000|Overall Study|Death|0|||
16203272|NCT03485222|39222931|FG001|Overall Study|Death|1|||
16203273|NCT03485222|39222930|FG000|Overall Study|Lost to Follow-up|2|||
16203274|NCT03485222|39222931|FG001|Overall Study|Lost to Follow-up|1|||
16203275|NCT01464788|39222933|FG000|Overall Study|Lost to Follow-up|0|||
16203276|NCT01464788|39222934|FG001|Overall Study|Lost to Follow-up|1|||
16203277|NCT01464788|39222935|FG002|Overall Study|Lost to Follow-up|0|||
16203278|NCT01464788|39222933|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
16203279|NCT01464788|39222934|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
16203280|NCT01464788|39222935|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
16203281|NCT02287402|39222936|FG000|Treatment Period|Adverse Event|17|||
16203282|NCT02287402|39222936|FG000|Treatment Period|Voluntary Withdrawal|10|||
16203283|NCT02287402|39222936|FG000|Follow-up|Lost to Follow-up|1|||
16203284|NCT02287402|39222936|FG000|Follow-up|Voluntary Withdrawal|2|||
16203285|NCT02924688|39222939|FG000|Overall Study|Adverse Event|9|||
16203286|NCT02924688|39222940|FG001|Overall Study|Adverse Event|3|||
16203287|NCT02924688|39222941|FG002|Overall Study|Adverse Event|2|||
16203288|NCT02924688|39222942|FG003|Overall Study|Adverse Event|2|||
16203289|NCT02924688|39222943|FG004|Overall Study|Adverse Event|3|||
16203290|NCT02924688|39222944|FG005|Overall Study|Adverse Event|2|||
16203291|NCT02924688|39222939|FG000|Overall Study|Lack of Efficacy|2|||
16203292|NCT02924688|39222940|FG001|Overall Study|Lack of Efficacy|3|||
16203293|NCT02924688|39222941|FG002|Overall Study|Lack of Efficacy|4|||
16203294|NCT02924688|39222942|FG003|Overall Study|Lack of Efficacy|2|||
16203295|NCT02924688|39222943|FG004|Overall Study|Lack of Efficacy|1|||
16203296|NCT02924688|39222944|FG005|Overall Study|Lack of Efficacy|1|||
16203297|NCT02924688|39222939|FG000|Overall Study|Protocol Violation|3|||
16203298|NCT02924688|39222940|FG001|Overall Study|Protocol Violation|7|||
16203299|NCT02924688|39222941|FG002|Overall Study|Protocol Violation|5|||
16203300|NCT02924688|39222942|FG003|Overall Study|Protocol Violation|6|||
16203301|NCT02924688|39222943|FG004|Overall Study|Protocol Violation|2|||
16203302|NCT02924688|39222944|FG005|Overall Study|Protocol Violation|2|||
16203303|NCT02924688|39222939|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
16203304|NCT02924688|39222940|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
16203305|NCT02924688|39222941|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
16203306|NCT02924688|39222942|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
16203307|NCT02924688|39222943|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
16203308|NCT02924688|39222944|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
16203309|NCT02924688|39222939|FG000|Overall Study|Lost to Follow-up|2|||
16203310|NCT02924688|39222940|FG001|Overall Study|Lost to Follow-up|4|||
16203311|NCT02924688|39222941|FG002|Overall Study|Lost to Follow-up|2|||
16203312|NCT02924688|39222942|FG003|Overall Study|Lost to Follow-up|4|||
16203313|NCT02924688|39222943|FG004|Overall Study|Lost to Follow-up|2|||
16203314|NCT02924688|39222944|FG005|Overall Study|Lost to Follow-up|4|||
16203315|NCT02924688|39222939|FG000|Overall Study|Physician Decision|2|||
16203316|NCT02924688|39222940|FG001|Overall Study|Physician Decision|1|||
16203317|NCT02924688|39222941|FG002|Overall Study|Physician Decision|0|||
16203318|NCT02924688|39222942|FG003|Overall Study|Physician Decision|1|||
16203319|NCT02924688|39222943|FG004|Overall Study|Physician Decision|1|||
16203320|NCT02924688|39222944|FG005|Overall Study|Physician Decision|1|||
16203321|NCT02924688|39222939|FG000|Overall Study|Withdrawal by Subject|14|||
16322410|NCT01938430|39667497|FG012|Overall Study|Death|0|||
16517672|NCT00965848|40364941|FG000|Overall Study|Lost to Follow-up|0|||
16203322|NCT02924688|39222940|FG001|Overall Study|Withdrawal by Subject|13|||
16203323|NCT02924688|39222941|FG002|Overall Study|Withdrawal by Subject|9|||
16203324|NCT02924688|39222942|FG003|Overall Study|Withdrawal by Subject|12|||
16203325|NCT02924688|39222943|FG004|Overall Study|Withdrawal by Subject|13|||
16203326|NCT02924688|39222944|FG005|Overall Study|Withdrawal by Subject|14|||
16203327|NCT00425113|39222945|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
16203328|NCT00425113|39222946|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
16203329|NCT00425113|39222945|FG000|Overall Study|diagnosis of abdominal TB|0|||
16322411|NCT01938430|39667498|FG013|Overall Study|Death|0|||
16517673|NCT00965848|40364942|FG001|Overall Study|Lost to Follow-up|0|||
16203330|NCT00425113|39222946|FG001|Overall Study|diagnosis of abdominal TB|1|||
16203331|NCT00425113|39222945|FG000|Overall Study|missing study drug more than 14 days|0|||
16203332|NCT00425113|39222946|FG001|Overall Study|missing study drug more than 14 days|1|||
16203333|NCT00425113|39222945|FG000|Overall Study|Withdrawal by Subject|1|||
16203334|NCT00425113|39222946|FG001|Overall Study|Withdrawal by Subject|0|||
16203335|NCT00903370|39222949|FG000|Overall Study|Death|13|||
16203336|NCT00903370|39222950|FG001|Overall Study|Death|10|||
16203337|NCT00903370|39222949|FG000|Overall Study|Withdrawal by Subject|9|||
16203338|NCT00903370|39222950|FG001|Overall Study|Withdrawal by Subject|6|||
16203339|NCT00903370|39222949|FG000|Overall Study|Lost to Follow-up|6|||
16203340|NCT00903370|39222950|FG001|Overall Study|Lost to Follow-up|8|||
16203341|NCT03805971|39222951|FG000|Overall Study|Withdrawal by Subject|1|||
16203342|NCT03805971|39222951|FG000|Overall Study|Protocol Violation|2|||
16203343|NCT03097029|39222955|FG000|Overall Study|Withdrawal by Subject|1|||
16203344|NCT05567393|39222956|FG000|Overall Study|Voluntary Withdrawal|0|||
16203345|NCT05567393|39222957|FG001|Overall Study|Voluntary Withdrawal|0|||
16203346|NCT05567393|39222958|FG002|Overall Study|Voluntary Withdrawal|0|||
16203347|NCT05567393|39222959|FG003|Overall Study|Voluntary Withdrawal|0|||
16203348|NCT05567393|39222960|FG004|Overall Study|Voluntary Withdrawal|0|||
16203349|NCT05567393|39222961|FG005|Overall Study|Voluntary Withdrawal|0|||
16203350|NCT05567393|39222962|FG006|Overall Study|Voluntary Withdrawal|0|||
16203351|NCT05567393|39222963|FG007|Overall Study|Voluntary Withdrawal|0|||
16203352|NCT05567393|39222964|FG008|Overall Study|Voluntary Withdrawal|0|||
16203353|NCT05567393|39222965|FG009|Overall Study|Voluntary Withdrawal|0|||
16203354|NCT05567393|39222966|FG010|Overall Study|Voluntary Withdrawal|0|||
16203355|NCT05567393|39222967|FG011|Overall Study|Voluntary Withdrawal|0|||
16203356|NCT05567393|39222968|FG012|Overall Study|Voluntary Withdrawal|0|||
16203357|NCT05567393|39222969|FG013|Overall Study|Voluntary Withdrawal|1|||
16203358|NCT05567393|39222970|FG014|Overall Study|Voluntary Withdrawal|0|||
16203359|NCT05567393|39222971|FG015|Overall Study|Voluntary Withdrawal|0|||
16203360|NCT05567393|39222972|FG016|Overall Study|Voluntary Withdrawal|0|||
16203361|NCT05567393|39222973|FG017|Overall Study|Voluntary Withdrawal|0|||
16203362|NCT03841526|39222976|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
16203363|NCT03841526|39222977|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
16203364|NCT03841526|39222978|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
16203365|NCT03841526|39222979|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
16203366|NCT03841526|39222980|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
16203367|NCT03841526|39222981|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
16203368|NCT03841526|39222976|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
16203369|NCT03841526|39222977|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
16203370|NCT03841526|39222978|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
16203371|NCT03841526|39222979|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
16203372|NCT03841526|39222980|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
16203373|NCT03841526|39222981|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
16203374|NCT03841526|39222976|FG000|Outpatient Phase Treatment|Physician Decision|0|||
16203375|NCT03841526|39222977|FG001|Outpatient Phase Treatment|Physician Decision|1|||
16203376|NCT03841526|39222978|FG002|Outpatient Phase Treatment|Physician Decision|0|||
16203377|NCT03841526|39222979|FG003|Outpatient Phase Treatment|Physician Decision|0|||
16203378|NCT03841526|39222980|FG004|Outpatient Phase Treatment|Physician Decision|0|||
16203379|NCT03841526|39222981|FG005|Outpatient Phase Treatment|Physician Decision|0|||
16203380|NCT03841526|39222976|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
16203381|NCT03841526|39222977|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
16203382|NCT03841526|39222978|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
16203383|NCT03841526|39222979|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
16203384|NCT03841526|39222980|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
16203385|NCT03841526|39222981|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
16203386|NCT02119026|39222982|FG000|1st-line Treatment|Adverse Event|9|||
16203387|NCT02119026|39222983|FG001|1st-line Treatment|Adverse Event|14|||
16203388|NCT02119026|39222982|FG000|1st-line Treatment|Physician Decision|3|||
16203389|NCT02119026|39222983|FG001|1st-line Treatment|Physician Decision|8|||
16203390|NCT02119026|39222982|FG000|1st-line Treatment|Withdrawal by Subject|4|||
16203391|NCT02119026|39222983|FG001|1st-line Treatment|Withdrawal by Subject|10|||
16203392|NCT02119026|39222982|FG000|1st-line Treatment|Patient condition or compliance|6|||
16203393|NCT02119026|39222983|FG001|1st-line Treatment|Patient condition or compliance|4|||
16203394|NCT02119026|39222982|FG000|1st-line Treatment|Surgery of metastases|2|||
16203395|NCT02119026|39222983|FG001|1st-line Treatment|Surgery of metastases|1|||
16203396|NCT02119026|39222982|FG000|1st-line Treatment|Death|2|||
16203397|NCT02119026|39222983|FG001|1st-line Treatment|Death|1|||
16203398|NCT02119026|39222982|FG000|2nd-line Treatment|Lost to Follow-up|2|||
16203399|NCT02119026|39222983|FG001|2nd-line Treatment|Lost to Follow-up|0|||
16203400|NCT02119026|39222982|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
16203401|NCT02119026|39222983|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
16203402|NCT02119026|39222982|FG000|2nd-line Treatment|Adverse Event|4|||
16203403|NCT02119026|39222983|FG001|2nd-line Treatment|Adverse Event|1|||
16203404|NCT01807949|39222984|FG000|Overall Study|Adverse Event|1|||
16203405|NCT01807949|39222985|FG001|Overall Study|Adverse Event|2|||
16203406|NCT01807949|39222986|FG002|Overall Study|Adverse Event|2|||
16203407|NCT01807949|39222984|FG000|Overall Study|Withdrawal by Subject|1|||
16203408|NCT01807949|39222985|FG001|Overall Study|Withdrawal by Subject|2|||
16203409|NCT01807949|39222986|FG002|Overall Study|Withdrawal by Subject|2|||
16203410|NCT01807949|39222984|FG000|Overall Study|Non-Compliance|0|||
16203411|NCT01807949|39222985|FG001|Overall Study|Non-Compliance|0|||
16203412|NCT01807949|39222986|FG002|Overall Study|Non-Compliance|1|||
16203413|NCT01807949|39222984|FG000|Overall Study|Undefined|0|||
16203414|NCT01807949|39222985|FG001|Overall Study|Undefined|1|||
16203415|NCT01807949|39222986|FG002|Overall Study|Undefined|2|||
16203416|NCT01807949|39222984|FG000|Overall Study|Randomized But Not Treated|0|||
16203417|NCT01807949|39222985|FG001|Overall Study|Randomized But Not Treated|2|||
16203418|NCT01807949|39222986|FG002|Overall Study|Randomized But Not Treated|2|||
16203419|NCT01068717|39222987|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
16203420|NCT01068717|39222988|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
16203421|NCT01068717|39222989|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
16203422|NCT01068717|39222990|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
16203423|NCT01179347|39222991|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
16203424|NCT01179347|39222992|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
16203425|NCT01179347|39222991|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
16203426|NCT01179347|39222992|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
16203427|NCT01179347|39222991|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
16203428|NCT01179347|39222992|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
16203429|NCT01179347|39222991|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
16203430|NCT01179347|39222992|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
16203431|NCT01179347|39222991|FG000|Double-blind Period (12 Weeks)|Other|2|||
16203432|NCT01179347|39222992|FG001|Double-blind Period (12 Weeks)|Other|4|||
16203433|NCT01179347|39222991|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
16203434|NCT01179347|39222992|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
16203435|NCT01179347|39222991|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
16203436|NCT01179347|39222992|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
16203437|NCT01179347|39222991|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
16203438|NCT01179347|39222992|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
16203439|NCT01179347|39222991|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
16203440|NCT01179347|39222992|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
16322412|NCT01938430|39667485|FG000|Overall Study|Investigator's Discretion|0|||
16203441|NCT01179347|39222991|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
16203442|NCT01179347|39222992|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
16203443|NCT01179347|39222991|FG000|Open-label Period (12 Weeks)|Other|7|||
16203444|NCT01179347|39222992|FG001|Open-label Period (12 Weeks)|Other|4|||
16203445|NCT00377429|39222993|FG000|Overall Study|Withdrawal by Subject|5|||
16203446|NCT00377429|39222993|FG000|Overall Study|Adverse Event|8|||
16203447|NCT00377429|39222993|FG000|Overall Study|Physician Decision|1|||
16203448|NCT00377429|39222993|FG000|Overall Study|Patient non-compliance|1|||
16203449|NCT01548417|39222999|FG000|Overall Study|Withdrawal by Subject|0|||
16203450|NCT01548417|39223000|FG001|Overall Study|Withdrawal by Subject|2|||
16203451|NCT02079519|39223001|FG000|Overall Study|Disease Progression|9|||
16203452|NCT02079519|39223001|FG000|Overall Study|Adverse Event|1|||
16203453|NCT00753688|39223002|FG000|Overall Study|Death|102|||
16203454|NCT00753688|39223003|FG001|Overall Study|Death|203|||
16203455|NCT00753688|39223002|FG000|Overall Study|Missing|4|||
16203456|NCT00753688|39223003|FG001|Overall Study|Missing|9|||
16203457|NCT00753688|39223002|FG000|Overall Study|Participant Withdrew Consent|2|||
16203458|NCT00753688|39223003|FG001|Overall Study|Participant Withdrew Consent|2|||
16203459|NCT00753688|39223002|FG000|Overall Study|Ongoing - in Follow-up|15|||
16203460|NCT00753688|39223003|FG001|Overall Study|Ongoing - in Follow-up|31|||
16203461|NCT00753688|39223002|FG000|Overall Study|Adverse Event|0|||
16203462|NCT00753688|39223003|FG001|Overall Study|Adverse Event|1|||
16203463|NCT01148693|39223004|FG000|Overall Study|Attempts for cannulation were failed|13|||
16322413|NCT01938430|39667486|FG001|Overall Study|Investigator's Discretion|0|||
16322414|NCT01938430|39667487|FG002|Overall Study|Investigator's Discretion|1|||
16322415|NCT01938430|39667488|FG003|Overall Study|Investigator's Discretion|0|||
16322416|NCT01938430|39667489|FG004|Overall Study|Investigator's Discretion|0|||
16322417|NCT01938430|39667490|FG005|Overall Study|Investigator's Discretion|0|||
16203464|NCT01148693|39223005|FG001|Overall Study|Attempts for cannulation were failed|10|||
16203465|NCT03228394|39223006|FG000|Overall Study|Lost to Follow-up|0|||
16203466|NCT03228394|39223007|FG001|Overall Study|Lost to Follow-up|0|||
16203467|NCT03228394|39223008|FG002|Overall Study|Lost to Follow-up|1|||
16203468|NCT03228394|39223009|FG003|Overall Study|Lost to Follow-up|1|||
16203469|NCT03228394|39223010|FG004|Overall Study|Lost to Follow-up|0|||
16322418|NCT01938430|39667491|FG006|Overall Study|Investigator's Discretion|0|||
16395506|NCT04560816|39928278|FG003|Overall Study|Protocol Violation|0|||
16203470|NCT03228394|39223011|FG005|Overall Study|Lost to Follow-up|0|||
16203471|NCT03228394|39223012|FG006|Overall Study|Lost to Follow-up|2|||
16203472|NCT03228394|39223013|FG007|Overall Study|Lost to Follow-up|0|||
16203473|NCT03228394|39223006|FG000|Overall Study|Withdrawal by Subject|0|||
16203474|NCT03228394|39223007|FG001|Overall Study|Withdrawal by Subject|0|||
16203475|NCT03228394|39223008|FG002|Overall Study|Withdrawal by Subject|1|||
16203476|NCT03228394|39223009|FG003|Overall Study|Withdrawal by Subject|0|||
16203477|NCT03228394|39223010|FG004|Overall Study|Withdrawal by Subject|0|||
16203478|NCT03228394|39223011|FG005|Overall Study|Withdrawal by Subject|0|||
16203479|NCT03228394|39223012|FG006|Overall Study|Withdrawal by Subject|1|||
16203480|NCT03228394|39223013|FG007|Overall Study|Withdrawal by Subject|3|||
16203481|NCT03228394|39223006|FG000|Overall Study|Protocol Violation|0|||
16203482|NCT03228394|39223007|FG001|Overall Study|Protocol Violation|0|||
16203483|NCT03228394|39223008|FG002|Overall Study|Protocol Violation|0|||
16203484|NCT03228394|39223009|FG003|Overall Study|Protocol Violation|1|||
16203485|NCT03228394|39223010|FG004|Overall Study|Protocol Violation|0|||
16203486|NCT03228394|39223011|FG005|Overall Study|Protocol Violation|0|||
16203487|NCT03228394|39223012|FG006|Overall Study|Protocol Violation|0|||
16203488|NCT03228394|39223013|FG007|Overall Study|Protocol Violation|0|||
16203489|NCT03228394|39223006|FG000|Overall Study|Physician Decision|0|||
16203490|NCT03228394|39223007|FG001|Overall Study|Physician Decision|0|||
16203491|NCT03228394|39223008|FG002|Overall Study|Physician Decision|0|||
16203492|NCT03228394|39223009|FG003|Overall Study|Physician Decision|0|||
16203493|NCT03228394|39223010|FG004|Overall Study|Physician Decision|0|||
16203494|NCT03228394|39223011|FG005|Overall Study|Physician Decision|0|||
16203495|NCT03228394|39223012|FG006|Overall Study|Physician Decision|1|||
16203496|NCT03228394|39223013|FG007|Overall Study|Physician Decision|0|||
16203497|NCT03228394|39223006|FG000|Overall Study|Noncompliance|0|||
16203498|NCT03228394|39223007|FG001|Overall Study|Noncompliance|0|||
16203499|NCT03228394|39223008|FG002|Overall Study|Noncompliance|0|||
16517674|NCT00965848|40364943|FG002|Overall Study|Lost to Follow-up|1|||
16517675|NCT00965848|40364941|FG000|Overall Study|Withdrawal by Subject|1|||
16517676|NCT00965848|40364942|FG001|Overall Study|Withdrawal by Subject|0|||
16517677|NCT00965848|40364943|FG002|Overall Study|Withdrawal by Subject|0|||
16517678|NCT00965848|40364941|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
16517679|NCT00965848|40364942|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
16517680|NCT00965848|40364943|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
16517681|NCT00965848|40364941|FG000|Overall Study|Not Clinically Evaluable|7|||
16517682|NCT00965848|40364942|FG001|Overall Study|Not Clinically Evaluable|1|||
16517683|NCT00965848|40364943|FG002|Overall Study|Not Clinically Evaluable|1|||
16517684|NCT00965848|40364941|FG000|Overall Study|Other|5|||
16517685|NCT00965848|40364942|FG001|Overall Study|Other|0|||
16517686|NCT00965848|40364943|FG002|Overall Study|Other|1|||
16517687|NCT04327934|40364945|FG000|Overall Study|Did not qualify|7|||
16517688|NCT04327934|40364946|FG001|Overall Study|Did not qualify|4|||
16517689|NCT04327934|40364945|FG000|Overall Study|Physician Decision|0|||
16517690|NCT04327934|40364946|FG001|Overall Study|Physician Decision|1|||
16517691|NCT00501540|40364949|FG000|Overall Study|Death|5|||
16517692|NCT04622254|40364950|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
16517693|NCT04622254|40364951|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
16517694|NCT04622254|40364952|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
16517695|NCT04622254|40364953|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
16517696|NCT04622254|40364954|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
16517697|NCT04622254|40364955|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
16517698|NCT04622254|40364950|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
16517699|NCT04622254|40364951|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
16517700|NCT04622254|40364952|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
16517701|NCT04622254|40364953|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
16517702|NCT04622254|40364954|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
16203500|NCT03228394|39223009|FG003|Overall Study|Noncompliance|0|||
16203501|NCT03228394|39223010|FG004|Overall Study|Noncompliance|0|||
16203502|NCT03228394|39223011|FG005|Overall Study|Noncompliance|0|||
16203503|NCT03228394|39223012|FG006|Overall Study|Noncompliance|1|||
16203504|NCT03228394|39223013|FG007|Overall Study|Noncompliance|0|||
16203505|NCT03365947|39223014|FG000|Overall Study|Lost to Follow-up|0|||
16203506|NCT03365947|39223015|FG001|Overall Study|Lost to Follow-up|0|||
16203507|NCT03365947|39223016|FG002|Overall Study|Lost to Follow-up|0|||
16203508|NCT03365947|39223017|FG003|Overall Study|Lost to Follow-up|0|||
16203509|NCT03365947|39223018|FG004|Overall Study|Lost to Follow-up|0|||
16203510|NCT03365947|39223019|FG005|Overall Study|Lost to Follow-up|1|||
16203511|NCT03365947|39223020|FG006|Overall Study|Lost to Follow-up|0|||
16203512|NCT03365947|39223021|FG007|Overall Study|Lost to Follow-up|0|||
16203513|NCT03365947|39223022|FG008|Overall Study|Lost to Follow-up|0|||
16203514|NCT03365947|39223023|FG009|Overall Study|Lost to Follow-up|0|||
16203515|NCT03365947|39223024|FG010|Overall Study|Lost to Follow-up|0|||
16203516|NCT03365947|39223025|FG011|Overall Study|Lost to Follow-up|0|||
16203517|NCT03365947|39223026|FG012|Overall Study|Lost to Follow-up|0|||
16203518|NCT03365947|39223027|FG013|Overall Study|Lost to Follow-up|0|||
16203519|NCT03365947|39223028|FG014|Overall Study|Lost to Follow-up|0|||
16203520|NCT03365947|39223029|FG015|Overall Study|Lost to Follow-up|0|||
16203521|NCT03365947|39223030|FG016|Overall Study|Lost to Follow-up|0|||
16203522|NCT03365947|39223031|FG017|Overall Study|Lost to Follow-up|0|||
16203523|NCT03365947|39223032|FG018|Overall Study|Lost to Follow-up|0|||
16203524|NCT01453998|39223040|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
16203525|NCT01453998|39223041|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
16203526|NCT01453998|39223042|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
16203527|NCT01342952|39223043|FG000|Overall Study|Adverse Event|0|||
16203528|NCT01342952|39223044|FG001|Overall Study|Adverse Event|5|||
16203529|NCT01342952|39223045|FG002|Overall Study|Adverse Event|1|||
16203530|NCT01342952|39223046|FG003|Overall Study|Adverse Event|0|||
16203531|NCT01342952|39223043|FG000|Overall Study|Lost to Follow-up|0|||
16203532|NCT01342952|39223044|FG001|Overall Study|Lost to Follow-up|2|||
16203533|NCT01342952|39223045|FG002|Overall Study|Lost to Follow-up|0|||
16203534|NCT01342952|39223046|FG003|Overall Study|Lost to Follow-up|0|||
16203535|NCT01342952|39223043|FG000|Overall Study|Withdrawal by Subject|1|||
16203536|NCT01342952|39223044|FG001|Overall Study|Withdrawal by Subject|1|||
16203537|NCT01342952|39223045|FG002|Overall Study|Withdrawal by Subject|0|||
16203538|NCT01342952|39223046|FG003|Overall Study|Withdrawal by Subject|0|||
16203539|NCT01342952|39223043|FG000|Overall Study|Physician Decision|3|||
16203540|NCT01342952|39223044|FG001|Overall Study|Physician Decision|3|||
16203541|NCT01342952|39223045|FG002|Overall Study|Physician Decision|1|||
16203542|NCT01342952|39223046|FG003|Overall Study|Physician Decision|0|||
16203543|NCT01170702|39223047|FG000|Overall Study|Exclusion criteria met after consent|1|||
16203544|NCT01170702|39223048|FG001|Overall Study|Exclusion criteria met after consent|2|||
16203545|NCT01170702|39223049|FG002|Overall Study|Exclusion criteria met after consent|0|||
16203546|NCT01170702|39223050|FG003|Overall Study|Exclusion criteria met after consent|2|||
16203547|NCT00290589|39223054|FG000|Overall Study|Lost to Follow-up|2|||
16203548|NCT00290589|39223055|FG001|Overall Study|Lost to Follow-up|2|||
16203549|NCT00990249|39223059|FG000|Overall Study|Disease Progression|8|||
16203550|NCT00990249|39223059|FG000|Overall Study|Non-Compliance|1|||
16203551|NCT00990249|39223059|FG000|Overall Study|Death|2|||
16203552|NCT00990249|39223059|FG000|Overall Study|Not treated|2|||
16203553|NCT02126670|39223062|FG000|Overall Study|Withdrawal by Subject|1|||
16203554|NCT02126670|39223063|FG001|Overall Study|Withdrawal by Subject|0|||
16203555|NCT02126670|39223064|FG002|Overall Study|Withdrawal by Subject|0|||
16203556|NCT02126670|39223065|FG003|Overall Study|Withdrawal by Subject|1|||
16203557|NCT00326417|39223067|FG000|Overall Study|Withdrawal by Subject|0|||
16203558|NCT00326417|39223068|FG001|Overall Study|Withdrawal by Subject|0|||
16203559|NCT00326417|39223069|FG002|Overall Study|Withdrawal by Subject|1|||
16203560|NCT00326417|39223070|FG003|Overall Study|Withdrawal by Subject|0|||
16203561|NCT00326417|39223067|FG000|Overall Study|Arm Closed|7|||
16203562|NCT00326417|39223068|FG001|Overall Study|Arm Closed|0|||
16203563|NCT00326417|39223069|FG002|Overall Study|Arm Closed|0|||
16203564|NCT00326417|39223070|FG003|Overall Study|Arm Closed|3|||
16203565|NCT00326417|39223067|FG000|Overall Study|Death|7|||
16203566|NCT00326417|39223068|FG001|Overall Study|Death|0|||
16203567|NCT00326417|39223069|FG002|Overall Study|Death|0|||
16203568|NCT00326417|39223070|FG003|Overall Study|Death|0|||
16203569|NCT02475395|39223078|FG000|Overall Study|Protocol Violation|30|||
16203570|NCT02475395|39223079|FG001|Overall Study|Protocol Violation|3|||
16203571|NCT02501902|39223080|FG000|Overall Study|Subject Refused Further Follow-up|0|||
16203572|NCT02501902|39223081|FG001|Overall Study|Subject Refused Further Follow-up|0|||
16203573|NCT02501902|39223082|FG002|Overall Study|Subject Refused Further Follow-up|0|||
16203574|NCT02501902|39223083|FG003|Overall Study|Subject Refused Further Follow-up|0|||
16203575|NCT02501902|39223084|FG004|Overall Study|Subject Refused Further Follow-up|0|||
16203576|NCT02501902|39223085|FG005|Overall Study|Subject Refused Further Follow-up|0|||
16203577|NCT02501902|39223086|FG006|Overall Study|Subject Refused Further Follow-up|0|||
16203578|NCT02501902|39223087|FG007|Overall Study|Subject Refused Further Follow-up|1|||
16203579|NCT02501902|39223080|FG000|Overall Study|Study Terminated by Sponsor|0|||
16203580|NCT02501902|39223081|FG001|Overall Study|Study Terminated by Sponsor|3|||
16203581|NCT02501902|39223082|FG002|Overall Study|Study Terminated by Sponsor|0|||
16203582|NCT02501902|39223083|FG003|Overall Study|Study Terminated by Sponsor|1|||
16203583|NCT02501902|39223084|FG004|Overall Study|Study Terminated by Sponsor|1|||
16203584|NCT02501902|39223085|FG005|Overall Study|Study Terminated by Sponsor|0|||
16203585|NCT02501902|39223086|FG006|Overall Study|Study Terminated by Sponsor|2|||
16203586|NCT02501902|39223087|FG007|Overall Study|Study Terminated by Sponsor|4|||
16203587|NCT02501902|39223080|FG000|Overall Study|Death|3|||
16203588|NCT02501902|39223081|FG001|Overall Study|Death|4|||
16203589|NCT02501902|39223082|FG002|Overall Study|Death|4|||
16203590|NCT02501902|39223083|FG003|Overall Study|Death|10|||
16203591|NCT02501902|39223084|FG004|Overall Study|Death|10|||
16203592|NCT02501902|39223085|FG005|Overall Study|Death|11|||
16203593|NCT02501902|39223086|FG006|Overall Study|Death|7|||
16203594|NCT02501902|39223087|FG007|Overall Study|Death|15|||
16203595|NCT01467661|39223090|FG000|Overall Study|Adverse Event|16|||
16203596|NCT01467661|39223090|FG000|Overall Study|Withdrawal by Subject|1|||
16203597|NCT01467661|39223090|FG000|Overall Study|Lack of Efficacy|3|||
16203598|NCT01467661|39223090|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
16203599|NCT01455415|39223094|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
16203600|NCT01455415|39223095|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
16203601|NCT01455415|39223094|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
16203602|NCT01455415|39223095|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
16203603|NCT01455415|39223094|FG000|Period 1|Drug Error not Associated to AE|0|||
16203604|NCT01455415|39223095|FG001|Period 1|Drug Error not Associated to AE|1|||
16203605|NCT01455415|39223094|FG000|Period 1|AE Not Related to Study Drug|2|||
16203606|NCT01455415|39223095|FG001|Period 1|AE Not Related to Study Drug|6|||
16203607|NCT01455415|39223094|FG000|Period 1|Withdrawal by Subject|4|||
16203608|NCT01455415|39223095|FG001|Period 1|Withdrawal by Subject|5|||
16203609|NCT01455415|39223094|FG000|Period 1|Unspecified Reason|1|||
16203610|NCT01455415|39223095|FG001|Period 1|Unspecified Reason|1|||
16203611|NCT01455415|39223094|FG000|Period 1|Protocol Violation|0|||
16203612|NCT01455415|39223095|FG001|Period 1|Protocol Violation|2|||
16203613|NCT01455415|39223094|FG000|Washout|AE Related to Study Drug|2|||
16203614|NCT01455415|39223095|FG001|Washout|AE Related to Study Drug|0|||
16203615|NCT01455415|39223094|FG000|Washout|Lost to Follow-up|1|||
16203616|NCT01455415|39223095|FG001|Washout|Lost to Follow-up|0|||
16203617|NCT01455415|39223094|FG000|Washout|Drug Error not Associated to AE|2|||
16203618|NCT01455415|39223095|FG001|Washout|Drug Error not Associated to AE|1|||
16203619|NCT01455415|39223094|FG000|Washout|AE Not Related to Study Drug|2|||
16203620|NCT01455415|39223095|FG001|Washout|AE Not Related to Study Drug|3|||
16203621|NCT01455415|39223094|FG000|Washout|Unspecified Reason|1|||
16203622|NCT01455415|39223095|FG001|Washout|Unspecified Reason|2|||
16203623|NCT01455415|39223094|FG000|Washout|Protocol Violation|0|||
16203624|NCT01455415|39223095|FG001|Washout|Protocol Violation|1|||
16203625|NCT01455415|39223094|FG000|Period 2|AE Related to Study Drug|1|||
16203626|NCT01455415|39223095|FG001|Period 2|AE Related to Study Drug|2|||
16203627|NCT01455415|39223094|FG000|Period 2|Lost to Follow-up|2|||
16203628|NCT01455415|39223095|FG001|Period 2|Lost to Follow-up|1|||
16203629|NCT01455415|39223094|FG000|Period 2|AE Not Related to Study Drug|2|||
16203630|NCT01455415|39223095|FG001|Period 2|AE Not Related to Study Drug|1|||
16203631|NCT01455415|39223094|FG000|Period 2|Lack of Efficacy|2|||
16203632|NCT01455415|39223095|FG001|Period 2|Lack of Efficacy|0|||
16203633|NCT01455415|39223094|FG000|Period 2|Withdrawal by Subject|2|||
16203634|NCT01455415|39223095|FG001|Period 2|Withdrawal by Subject|3|||
16203635|NCT01455415|39223094|FG000|Period 2|Unspecified Reason|2|||
16203636|NCT01455415|39223095|FG001|Period 2|Unspecified Reason|3|||
16203637|NCT01455415|39223094|FG000|Period 2|Protocol Violation|2|||
16203638|NCT01455415|39223095|FG001|Period 2|Protocol Violation|0|||
16203639|NCT01455415|39223094|FG000|Follow-up|AE Related to Study Drug|0|||
16203640|NCT01455415|39223095|FG001|Follow-up|AE Related to Study Drug|1|||
16203641|NCT01455415|39223094|FG000|Follow-up|Lack of Efficacy|0|||
16203642|NCT01455415|39223095|FG001|Follow-up|Lack of Efficacy|1|||
16203643|NCT01455415|39223094|FG000|Follow-up|Withdrawal by Subject|2|||
16203644|NCT01455415|39223095|FG001|Follow-up|Withdrawal by Subject|0|||
16203645|NCT01455415|39223094|FG000|Follow-up|Unspecified Reason|1|||
16203646|NCT01455415|39223095|FG001|Follow-up|Unspecified Reason|0|||
16203647|NCT03219567|39223096|FG000|Overall Study|Withdrawal by Subject|0|||
16203648|NCT03219567|39223097|FG001|Overall Study|Withdrawal by Subject|1|||
16203649|NCT02293993|39223098|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
16203650|NCT02293993|39223099|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
16203651|NCT02293993|39223100|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
16203652|NCT02293993|39223101|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
16203653|NCT02293993|39223098|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
16203654|NCT02293993|39223099|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
16203655|NCT02293993|39223100|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
16203656|NCT02293993|39223101|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
16203657|NCT02293993|39223098|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
16203658|NCT02293993|39223099|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
16203659|NCT02293993|39223100|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
16203660|NCT02293993|39223101|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
16203661|NCT02293993|39223098|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
16203662|NCT02293993|39223099|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
16395507|NCT04560816|39928279|FG004|Overall Study|Protocol Violation|0|||
16203663|NCT02293993|39223100|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
16203664|NCT02293993|39223101|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
16203665|NCT02293993|39223098|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
16203666|NCT02293993|39223099|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
16203667|NCT02293993|39223100|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
16203668|NCT02293993|39223101|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
16203669|NCT01504971|39223103|FG000|Overall Study|Physician Decision|13|||
16203670|NCT00141037|39223110|FG000|Overall Study|Physician Decision|1|||
16203671|NCT00141037|39223111|FG001|Overall Study|Physician Decision|2|||
16203672|NCT00141037|39223110|FG000|Overall Study|Lost to Follow-up|3|||
16203673|NCT00141037|39223111|FG001|Overall Study|Lost to Follow-up|1|||
16203674|NCT00141037|39223110|FG000|Overall Study|Protocol Violation|0|||
16203675|NCT00141037|39223111|FG001|Overall Study|Protocol Violation|2|||
16203676|NCT00141037|39223110|FG000|Overall Study|Withdrawal by Subject|2|||
16203677|NCT00141037|39223111|FG001|Overall Study|Withdrawal by Subject|1|||
16203678|NCT00141037|39223110|FG000|Overall Study|Other|0|||
16203679|NCT00141037|39223111|FG001|Overall Study|Other|1|||
16203680|NCT00141037|39223110|FG000|Overall Study|Moved from area|1|||
16203681|NCT00141037|39223111|FG001|Overall Study|Moved from area|7|||
16203682|NCT00141037|39223110|FG000|Overall Study|Graft Failure|3|||
16203683|NCT00141037|39223111|FG001|Overall Study|Graft Failure|4|||
16203684|NCT03199638|39223112|FG000|Overall Study|inability to drink glutamine during regularly|0|||
16203685|NCT03199638|39223113|FG001|Overall Study|inability to drink glutamine during regularly|2|||
16203686|NCT01225172|39223116|FG000|Overall Study|Subject decision to stop|1|||
16203687|NCT01225172|39223117|FG001|Overall Study|Subject decision to stop|0|||
16203688|NCT01225172|39223116|FG000|Overall Study|Subject request to discontinue treatment|3|||
16203689|NCT01225172|39223117|FG001|Overall Study|Subject request to discontinue treatment|1|||
16203690|NCT01225172|39223116|FG000|Overall Study|Subject no longer meets study criteria|1|||
16203691|NCT01225172|39223117|FG001|Overall Study|Subject no longer meets study criteria|0|||
16203692|NCT01225172|39223116|FG000|Overall Study|Withdrawal by Subject|1|||
16203693|NCT01225172|39223117|FG001|Overall Study|Withdrawal by Subject|0|||
16203694|NCT02678312|39223122|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
16203695|NCT02678312|39223123|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
16203696|NCT02678312|39223124|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
16203697|NCT02678312|39223125|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
16203698|NCT02678312|39223126|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
16203699|NCT02678312|39223122|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
16203700|NCT02678312|39223123|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
16203701|NCT02678312|39223124|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
16203702|NCT02678312|39223125|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
16203703|NCT02678312|39223126|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
16203704|NCT02678312|39223122|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
16203705|NCT02678312|39223123|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
16203706|NCT02678312|39223124|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
16203707|NCT02678312|39223125|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
16203708|NCT02678312|39223126|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
16203709|NCT02678312|39223122|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
16203710|NCT02678312|39223123|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
16203711|NCT02678312|39223124|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
16203712|NCT02678312|39223125|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
16203713|NCT02678312|39223126|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
16203714|NCT02678312|39223122|FG000|Part 2 Double Blind Epoch|Death|0|||
16203715|NCT02678312|39223123|FG001|Part 2 Double Blind Epoch|Death|0|||
16203716|NCT02678312|39223124|FG002|Part 2 Double Blind Epoch|Death|0|||
16203717|NCT02678312|39223125|FG003|Part 2 Double Blind Epoch|Death|8|||
16203718|NCT02678312|39223126|FG004|Part 2 Double Blind Epoch|Death|12|||
16203719|NCT02678312|39223122|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
16203720|NCT02678312|39223123|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
16203721|NCT02678312|39223124|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
16203722|NCT02678312|39223125|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
16203723|NCT02678312|39223126|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
16203724|NCT02678312|39223122|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
16203725|NCT02678312|39223123|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
16203726|NCT02678312|39223124|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
16203727|NCT02678312|39223125|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
16203728|NCT02678312|39223126|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
16203729|NCT02678312|39223122|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
16203730|NCT02678312|39223123|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
16203731|NCT02678312|39223124|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
16203732|NCT02678312|39223125|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
16203733|NCT02678312|39223126|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
16203734|NCT03395223|39223129|FG000|Overall Study|Lost to Follow-up|3|||
16322419|NCT01938430|39667492|FG007|Overall Study|Investigator's Discretion|0|||
16322420|NCT01938430|39667493|FG008|Overall Study|Investigator's Discretion|0|||
16322421|NCT01938430|39667494|FG009|Overall Study|Investigator's Discretion|0|||
16322422|NCT01938430|39667495|FG010|Overall Study|Investigator's Discretion|0|||
16322423|NCT01938430|39667496|FG011|Overall Study|Investigator's Discretion|0|||
16322424|NCT01938430|39667497|FG012|Overall Study|Investigator's Discretion|0|||
16322425|NCT01938430|39667498|FG013|Overall Study|Investigator's Discretion|0|||
16322426|NCT01938430|39667485|FG000|Overall Study|Lack of Efficacy|3|||
16092211|NCT03390166|38826991|FG000|Overall Study|Physician Decision|2|||
16092212|NCT03390166|38826992|FG001|Overall Study|Physician Decision|1|||
16322427|NCT01938430|39667486|FG001|Overall Study|Lack of Efficacy|1|||
16322428|NCT01938430|39667487|FG002|Overall Study|Lack of Efficacy|1|||
16322429|NCT01938430|39667488|FG003|Overall Study|Lack of Efficacy|1|||
16517703|NCT04622254|40364955|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
16517704|NCT04622254|40364950|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
16517705|NCT04622254|40364951|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
16203735|NCT03395223|39223129|FG000|Overall Study|Other|1|||
16203736|NCT01602549|39223130|FG000|Overall Study|Protocol Violation|0|||
16203737|NCT01602549|39223131|FG001|Overall Study|Protocol Violation|1|||
16203738|NCT01602549|39223130|FG000|Overall Study|Withdrawal by Subject|1|||
16203739|NCT01602549|39223131|FG001|Overall Study|Withdrawal by Subject|0|||
16203740|NCT02966353|39223132|FG000|Overall Study|Withdrawal by Subject|7|||
16203741|NCT02966353|39223132|FG000|Overall Study|Adverse Event|4|||
16203742|NCT02966353|39223132|FG000|Overall Study|Death|4|||
16203743|NCT02966353|39223132|FG000|Overall Study|Physician Decision|3|||
16203744|NCT02966353|39223132|FG000|Overall Study|Progressive disease|2|||
16203745|NCT02966353|39223132|FG000|Overall Study|Protocol deviation|2|||
16203746|NCT04295356|39223133|FG000|Overall Study|Physician Decision|1|||
16203747|NCT04295356|39223134|FG001|Overall Study|Physician Decision|0|||
16203748|NCT04295356|39223133|FG000|Overall Study|Lost to Follow-up|0|||
16203749|NCT04295356|39223134|FG001|Overall Study|Lost to Follow-up|3|||
16203750|NCT04295356|39223133|FG000|Overall Study|Protocol Violation|0|||
16203751|NCT04295356|39223134|FG001|Overall Study|Protocol Violation|1|||
16203752|NCT03750240|39223137|FG000|Overall Study|Technical Difficulties|2|||
16203753|NCT00098020|39223138|FG000|Overall Study|Adverse Event|2|||
16203754|NCT00098020|39223138|FG000|Overall Study|Lost to Follow-up|1|||
16203755|NCT00098020|39223138|FG000|Overall Study|elevated liver enzymes|1|||
16203756|NCT00098020|39223138|FG000|Overall Study|Low urine PCR|1|||
16203757|NCT00098020|39223138|FG000|Overall Study|Low epidermal growth factor receptor|1|||
16203758|NCT04348656|39223139|FG000|Overall Study|Withdrawal by Subject|2|||
16203759|NCT04348656|39223140|FG001|Overall Study|Withdrawal by Subject|0|||
16203760|NCT04348656|39223139|FG000|Overall Study|Lost to Follow-up|11|||
16203761|NCT04348656|39223140|FG001|Overall Study|Lost to Follow-up|6|||
16203762|NCT00630812|39223144|FG000|Randomisation to First Dose|Adverse Event|1|||
16203763|NCT00630812|39223145|FG001|Randomisation to First Dose|Adverse Event|1|||
16203764|NCT00630812|39223144|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
16203765|NCT00630812|39223145|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
16203766|NCT00630812|39223144|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
16203767|NCT00630812|39223145|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
16203768|NCT00630812|39223144|FG000|Randomisation to First Dose|Protocol Violation|4|||
16203769|NCT00630812|39223145|FG001|Randomisation to First Dose|Protocol Violation|1|||
16517706|NCT04622254|40364952|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
16517707|NCT04622254|40364953|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
16517708|NCT04622254|40364954|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
16517709|NCT04622254|40364955|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
16517710|NCT04622254|40364950|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
16517711|NCT04622254|40364951|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
16517712|NCT04622254|40364952|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
16517713|NCT04622254|40364953|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
16203770|NCT00630812|39223144|FG000|Double Blind Treatment Period|Adverse Event|13|||
16517714|NCT04622254|40364954|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
16203771|NCT00630812|39223145|FG001|Double Blind Treatment Period|Adverse Event|5|||
16203772|NCT00630812|39223144|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
16203773|NCT00630812|39223145|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
16203774|NCT00630812|39223144|FG000|Double Blind Treatment Period|Physician Decision|2|||
16322430|NCT01938430|39667489|FG004|Overall Study|Lack of Efficacy|0|||
16203775|NCT00630812|39223145|FG001|Double Blind Treatment Period|Physician Decision|1|||
16203776|NCT00630812|39223144|FG000|Double Blind Treatment Period|Protocol Violation|1|||
16203777|NCT00630812|39223145|FG001|Double Blind Treatment Period|Protocol Violation|0|||
16203778|NCT00630812|39223144|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
16203779|NCT00630812|39223145|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
16203780|NCT00630812|39223144|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
16203781|NCT00630812|39223145|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
16203782|NCT00630812|39223144|FG000|Double Blind Treatment Period|Non-compliance|0|||
16203783|NCT00630812|39223145|FG001|Double Blind Treatment Period|Non-compliance|1|||
16517715|NCT04622254|40364955|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
16517716|NCT04622254|40364950|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
16203784|NCT03657810|39223146|FG000|Overall Study|Adverse Event|0|||
16203785|NCT03657810|39223147|FG001|Overall Study|Adverse Event|1|||
16203786|NCT03657810|39223148|FG002|Overall Study|Adverse Event|0|||
16203787|NCT03657810|39223146|FG000|Overall Study|Lack of Efficacy|4|||
16203788|NCT03657810|39223147|FG001|Overall Study|Lack of Efficacy|1|||
16203789|NCT03657810|39223148|FG002|Overall Study|Lack of Efficacy|3|||
16203790|NCT03657810|39223146|FG000|Overall Study|Protocol Violation|1|||
16203791|NCT03657810|39223147|FG001|Overall Study|Protocol Violation|0|||
16203792|NCT03657810|39223148|FG002|Overall Study|Protocol Violation|0|||
16203793|NCT03657810|39223146|FG000|Overall Study|Lost to Follow-up|0|||
16203794|NCT03657810|39223147|FG001|Overall Study|Lost to Follow-up|1|||
16203795|NCT03657810|39223148|FG002|Overall Study|Lost to Follow-up|0|||
16203796|NCT03657810|39223146|FG000|Overall Study|Not provided|0|||
16203797|NCT03657810|39223147|FG001|Overall Study|Not provided|1|||
16203798|NCT03657810|39223148|FG002|Overall Study|Not provided|0|||
16203799|NCT01303380|39223149|FG000|Overall Study|Lack of compliance to study procedures|1|||
16203800|NCT00131664|39223152|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
16203801|NCT00131664|39223153|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
16203802|NCT00131664|39223154|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
16203803|NCT00131664|39223155|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
16203804|NCT00131664|39223156|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
16203805|NCT00131664|39223157|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
16203806|NCT00131664|39223152|FG000|First Period (First 6 Months)|Death|0|||
16517717|NCT04622254|40364951|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
16517718|NCT04622254|40364952|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
16517719|NCT04622254|40364953|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
16517720|NCT04622254|40364954|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
16517721|NCT04622254|40364955|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
16517722|NCT04622254|40364950|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
16517723|NCT04622254|40364951|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
16517724|NCT04622254|40364952|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
16517725|NCT04622254|40364953|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
16517726|NCT04622254|40364954|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
16517727|NCT04622254|40364955|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
16517728|NCT04622254|40364950|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
16517729|NCT04622254|40364951|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
16517730|NCT04622254|40364952|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
16517731|NCT04622254|40364953|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
16517732|NCT04622254|40364954|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
16517733|NCT04622254|40364955|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
16203807|NCT00131664|39223153|FG001|First Period (First 6 Months)|Death|1|||
16203808|NCT00131664|39223154|FG002|First Period (First 6 Months)|Death|0|||
16203809|NCT00131664|39223155|FG003|First Period (First 6 Months)|Death|0|||
16203810|NCT00131664|39223156|FG004|First Period (First 6 Months)|Death|0|||
16203811|NCT00131664|39223157|FG005|First Period (First 6 Months)|Death|0|||
16203812|NCT00131664|39223152|FG000|First Period (First 6 Months)|Protocol Violation|2|||
16203813|NCT00131664|39223153|FG001|First Period (First 6 Months)|Protocol Violation|2|||
16203814|NCT00131664|39223154|FG002|First Period (First 6 Months)|Protocol Violation|1|||
16203815|NCT00131664|39223155|FG003|First Period (First 6 Months)|Protocol Violation|0|||
16203816|NCT00131664|39223156|FG004|First Period (First 6 Months)|Protocol Violation|0|||
16322431|NCT01938430|39667490|FG005|Overall Study|Lack of Efficacy|0|||
16322432|NCT01938430|39667491|FG006|Overall Study|Lack of Efficacy|0|||
16322433|NCT01938430|39667492|FG007|Overall Study|Lack of Efficacy|0|||
16517734|NCT04622254|40364950|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
16203817|NCT00131664|39223157|FG005|First Period (First 6 Months)|Protocol Violation|0|||
16203818|NCT00131664|39223152|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
16203819|NCT00131664|39223153|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
16203820|NCT00131664|39223154|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
16203821|NCT00131664|39223155|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
16203822|NCT00131664|39223156|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
16322434|NCT01938430|39667493|FG008|Overall Study|Lack of Efficacy|1|||
16322435|NCT01938430|39667494|FG009|Overall Study|Lack of Efficacy|0|||
16322436|NCT01938430|39667495|FG010|Overall Study|Lack of Efficacy|2|||
16322437|NCT01938430|39667496|FG011|Overall Study|Lack of Efficacy|1|||
16203823|NCT00131664|39223157|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
16203824|NCT00131664|39223152|FG000|First Period (First 6 Months)|Adverse Event|9|||
16203825|NCT00131664|39223153|FG001|First Period (First 6 Months)|Adverse Event|4|||
16322438|NCT01938430|39667497|FG012|Overall Study|Lack of Efficacy|0|||
16322439|NCT01938430|39667498|FG013|Overall Study|Lack of Efficacy|0|||
16322440|NCT01938430|39667485|FG000|Overall Study|Lost to Follow-up|0|||
16322441|NCT01938430|39667486|FG001|Overall Study|Lost to Follow-up|0|||
16203826|NCT00131664|39223154|FG002|First Period (First 6 Months)|Adverse Event|5|||
16203827|NCT00131664|39223155|FG003|First Period (First 6 Months)|Adverse Event|0|||
16203828|NCT00131664|39223156|FG004|First Period (First 6 Months)|Adverse Event|0|||
16203829|NCT00131664|39223157|FG005|First Period (First 6 Months)|Adverse Event|0|||
16203830|NCT00131664|39223152|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
16203831|NCT00131664|39223153|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
16203832|NCT00131664|39223154|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
16203833|NCT00131664|39223155|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
16203834|NCT00131664|39223156|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
16203835|NCT00131664|39223157|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
16203836|NCT00131664|39223152|FG000|First Period (First 6 Months)|Administrative reasons|2|||
16203837|NCT00131664|39223153|FG001|First Period (First 6 Months)|Administrative reasons|0|||
16203838|NCT00131664|39223154|FG002|First Period (First 6 Months)|Administrative reasons|5|||
16203839|NCT00131664|39223155|FG003|First Period (First 6 Months)|Administrative reasons|0|||
16203840|NCT00131664|39223156|FG004|First Period (First 6 Months)|Administrative reasons|0|||
16203841|NCT00131664|39223157|FG005|First Period (First 6 Months)|Administrative reasons|0|||
16203842|NCT00131664|39223152|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
16203843|NCT00131664|39223153|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
16203844|NCT00131664|39223154|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
16203845|NCT00131664|39223155|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
16203846|NCT00131664|39223156|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
16203847|NCT00131664|39223157|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
16203848|NCT00131664|39223152|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
16203849|NCT00131664|39223153|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
16203850|NCT00131664|39223154|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
16203851|NCT00131664|39223155|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
16203852|NCT00131664|39223156|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
16203853|NCT00131664|39223157|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
16203854|NCT00131664|39223152|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
16203855|NCT00131664|39223153|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
16203856|NCT00131664|39223154|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
16203857|NCT00131664|39223155|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
16203858|NCT00131664|39223156|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
16203859|NCT00131664|39223157|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
16203860|NCT00131664|39223152|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
16203861|NCT00131664|39223153|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
16322442|NCT01938430|39667487|FG002|Overall Study|Lost to Follow-up|1|||
16322443|NCT01938430|39667488|FG003|Overall Study|Lost to Follow-up|0|||
16322444|NCT01938430|39667489|FG004|Overall Study|Lost to Follow-up|0|||
16322445|NCT01938430|39667490|FG005|Overall Study|Lost to Follow-up|1|||
16322446|NCT01938430|39667491|FG006|Overall Study|Lost to Follow-up|0|||
16322447|NCT01938430|39667492|FG007|Overall Study|Lost to Follow-up|0|||
16322448|NCT01938430|39667493|FG008|Overall Study|Lost to Follow-up|0|||
16322449|NCT01938430|39667494|FG009|Overall Study|Lost to Follow-up|0|||
16322450|NCT01938430|39667495|FG010|Overall Study|Lost to Follow-up|0|||
16322451|NCT01938430|39667496|FG011|Overall Study|Lost to Follow-up|0|||
16322452|NCT01938430|39667497|FG012|Overall Study|Lost to Follow-up|0|||
16517735|NCT04622254|40364951|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
16517736|NCT04622254|40364952|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
16517737|NCT04622254|40364953|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
16517738|NCT04622254|40364954|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
16517739|NCT04622254|40364955|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
16517740|NCT04622254|40364950|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
16517741|NCT04622254|40364951|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
16517742|NCT04622254|40364952|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
16517743|NCT04622254|40364953|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
16517744|NCT04622254|40364954|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
16203862|NCT00131664|39223154|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
16203863|NCT00131664|39223155|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
16203864|NCT00131664|39223156|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
16203865|NCT00131664|39223157|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
16203866|NCT00131664|39223152|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
16517745|NCT04622254|40364955|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
16517746|NCT04622254|40364950|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
16517747|NCT04622254|40364951|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
16517748|NCT04622254|40364952|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
16517749|NCT04622254|40364953|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
16517750|NCT04622254|40364954|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
16517751|NCT04622254|40364955|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
16517752|NCT04622254|40364950|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
16517753|NCT04622254|40364951|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
16517754|NCT04622254|40364952|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
16517755|NCT04622254|40364953|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
16517756|NCT04622254|40364954|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
16517757|NCT04622254|40364955|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
16092213|NCT03390166|38826991|FG000|Overall Study|Move from study area|3|||
16092214|NCT03390166|38826992|FG001|Overall Study|Move from study area|2|||
16322453|NCT01938430|39667498|FG013|Overall Study|Lost to Follow-up|0|||
16322454|NCT01938430|39667485|FG000|Overall Study|Withdrew Consent|0|||
16322455|NCT01938430|39667486|FG001|Overall Study|Withdrew Consent|0|||
16322456|NCT01938430|39667487|FG002|Overall Study|Withdrew Consent|0|||
16322457|NCT01938430|39667488|FG003|Overall Study|Withdrew Consent|0|||
16322458|NCT01938430|39667489|FG004|Overall Study|Withdrew Consent|0|||
16322459|NCT01938430|39667490|FG005|Overall Study|Withdrew Consent|0|||
16322460|NCT01938430|39667491|FG006|Overall Study|Withdrew Consent|0|||
16092215|NCT03390166|38826991|FG000|Overall Study|To militarycamp for conscript|1|||
16092216|NCT03390166|38826992|FG001|Overall Study|To militarycamp for conscript|0|||
16092217|NCT03390166|38826991|FG000|Overall Study|To drug therapy course|0|||
16092218|NCT03390166|38826992|FG001|Overall Study|To drug therapy course|1|||
16092219|NCT03390166|38826991|FG000|Overall Study|Move to work oversea|0|||
16203867|NCT00131664|39223153|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
16203868|NCT00131664|39223154|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
16322461|NCT01938430|39667492|FG007|Overall Study|Withdrew Consent|0|||
16322462|NCT01938430|39667493|FG008|Overall Study|Withdrew Consent|1|||
16322463|NCT01938430|39667494|FG009|Overall Study|Withdrew Consent|0|||
16322464|NCT01938430|39667495|FG010|Overall Study|Withdrew Consent|0|||
16322465|NCT01938430|39667496|FG011|Overall Study|Withdrew Consent|0|||
16322466|NCT01938430|39667497|FG012|Overall Study|Withdrew Consent|0|||
16322467|NCT01938430|39667498|FG013|Overall Study|Withdrew Consent|0|||
16322468|NCT00782795|39667500|FG000|Overall Study|Withdrawal by Subject|1|||
16322469|NCT00782795|39667501|FG001|Overall Study|Withdrawal by Subject|2|||
16322470|NCT00325156|39667504|FG000|Overall Study|Protocol Violation|8|||
16322471|NCT00325156|39667504|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
16322472|NCT00325156|39667504|FG000|Overall Study|Migrated/moved from study area|12|||
16322473|NCT00325156|39667504|FG000|Overall Study|Adverse event, non-fatal|3|||
16322474|NCT00325156|39667504|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
16322475|NCT00325156|39667504|FG000|Overall Study|Other|1|||
16322476|NCT00325156|39667504|FG000|Overall Study|Withdrawal by Subject|31|||
16092220|NCT03390166|38826992|FG001|Overall Study|Move to work oversea|1|||
16092221|NCT00878189|38830086|FG000|Overall Study|Death|0|||
16092222|NCT00878189|38830087|FG001|Overall Study|Death|1|||
16092223|NCT00878189|38830088|FG002|Overall Study|Death|0|||
16092224|NCT00878189|38830089|FG003|Overall Study|Death|1|||
16092225|NCT00878189|38830090|FG004|Overall Study|Death|0|||
16092226|NCT00878189|38830091|FG005|Overall Study|Death|0|||
16092227|NCT00878189|38830092|FG006|Overall Study|Death|0|||
16092228|NCT00878189|38830093|FG007|Overall Study|Death|0|||
16092229|NCT00878189|38830094|FG008|Overall Study|Death|1|||
16092230|NCT00878189|38830086|FG000|Overall Study|Participant Refused to Follow-up|0|||
16092231|NCT00878189|38830087|FG001|Overall Study|Participant Refused to Follow-up|0|||
16092232|NCT00878189|38830088|FG002|Overall Study|Participant Refused to Follow-up|0|||
16092233|NCT00878189|38830089|FG003|Overall Study|Participant Refused to Follow-up|0|||
16092234|NCT00878189|38830090|FG004|Overall Study|Participant Refused to Follow-up|0|||
16092235|NCT00878189|38830091|FG005|Overall Study|Participant Refused to Follow-up|4|||
16092236|NCT00878189|38830092|FG006|Overall Study|Participant Refused to Follow-up|0|||
16092237|NCT00878189|38830093|FG007|Overall Study|Participant Refused to Follow-up|0|||
16092238|NCT00878189|38830094|FG008|Overall Study|Participant Refused to Follow-up|0|||
16092239|NCT00878189|38830086|FG000|Overall Study|Other|3|||
16092240|NCT00878189|38830087|FG001|Overall Study|Other|2|||
16092241|NCT00878189|38830088|FG002|Overall Study|Other|4|||
16092242|NCT00878189|38830089|FG003|Overall Study|Other|7|||
16092243|NCT00878189|38830090|FG004|Overall Study|Other|4|||
16092244|NCT00878189|38830091|FG005|Overall Study|Other|18|||
16092245|NCT00878189|38830092|FG006|Overall Study|Other|15|||
16092246|NCT00878189|38830093|FG007|Overall Study|Other|3|||
16092247|NCT00878189|38830094|FG008|Overall Study|Other|4|||
16092248|NCT00878189|38830086|FG000|Overall Study|Lost to Follow-up|0|||
16092249|NCT00878189|38830087|FG001|Overall Study|Lost to Follow-up|0|||
16092250|NCT00878189|38830088|FG002|Overall Study|Lost to Follow-up|0|||
16092251|NCT00878189|38830089|FG003|Overall Study|Lost to Follow-up|0|||
16092252|NCT00878189|38830090|FG004|Overall Study|Lost to Follow-up|0|||
16092253|NCT00878189|38830091|FG005|Overall Study|Lost to Follow-up|1|||
16092254|NCT00878189|38830092|FG006|Overall Study|Lost to Follow-up|1|||
16092255|NCT00878189|38830093|FG007|Overall Study|Lost to Follow-up|0|||
16092256|NCT00878189|38830094|FG008|Overall Study|Lost to Follow-up|0|||
16092257|NCT00878189|38830086|FG000|Overall Study|Objection Progression or Relapse|0|||
16092258|NCT00878189|38830087|FG001|Overall Study|Objection Progression or Relapse|0|||
16092259|NCT00878189|38830088|FG002|Overall Study|Objection Progression or Relapse|0|||
16092260|NCT00878189|38830089|FG003|Overall Study|Objection Progression or Relapse|0|||
16092261|NCT00878189|38830090|FG004|Overall Study|Objection Progression or Relapse|0|||
16092262|NCT00878189|38830091|FG005|Overall Study|Objection Progression or Relapse|0|||
16092263|NCT00878189|38830092|FG006|Overall Study|Objection Progression or Relapse|0|||
16092264|NCT00878189|38830093|FG007|Overall Study|Objection Progression or Relapse|0|||
16092265|NCT00878189|38830094|FG008|Overall Study|Objection Progression or Relapse|3|||
16092266|NCT00608959|38830095|FG000|Part 1|Did not meet eligibility criteria|1|||
16092267|NCT03122860|38830096|FG000|Overall Study|Discontinued Before Treatment|1|||
16092268|NCT03122860|38830097|FG001|Overall Study|Discontinued Before Treatment|1|||
16092269|NCT03122860|38830098|FG002|Overall Study|Discontinued Before Treatment|2|||
16092270|NCT03122860|38830099|FG003|Overall Study|Discontinued Before Treatment|0|||
16092271|NCT03122860|38830100|FG004|Overall Study|Discontinued Before Treatment|1|||
16092272|NCT03122860|38830101|FG005|Overall Study|Discontinued Before Treatment|0|||
16092273|NCT03122860|38830096|FG000|Overall Study|Adverse Event|1|||
16092274|NCT03122860|38830097|FG001|Overall Study|Adverse Event|0|||
16092275|NCT03122860|38830098|FG002|Overall Study|Adverse Event|1|||
16092276|NCT03122860|38830099|FG003|Overall Study|Adverse Event|1|||
16092277|NCT03122860|38830100|FG004|Overall Study|Adverse Event|0|||
16092278|NCT03122860|38830101|FG005|Overall Study|Adverse Event|0|||
16092279|NCT03122860|38830096|FG000|Overall Study|Lost to Follow-up|5|||
16092280|NCT03122860|38830097|FG001|Overall Study|Lost to Follow-up|2|||
16092281|NCT03122860|38830098|FG002|Overall Study|Lost to Follow-up|3|||
16092282|NCT03122860|38830099|FG003|Overall Study|Lost to Follow-up|3|||
16092283|NCT03122860|38830100|FG004|Overall Study|Lost to Follow-up|5|||
16092284|NCT03122860|38830101|FG005|Overall Study|Lost to Follow-up|4|||
16092285|NCT03122860|38830096|FG000|Overall Study|Subject Non-Compliance|0|||
16092286|NCT03122860|38830097|FG001|Overall Study|Subject Non-Compliance|0|||
16092287|NCT03122860|38830098|FG002|Overall Study|Subject Non-Compliance|1|||
16092288|NCT03122860|38830099|FG003|Overall Study|Subject Non-Compliance|0|||
16092289|NCT03122860|38830100|FG004|Overall Study|Subject Non-Compliance|0|||
16092290|NCT03122860|38830101|FG005|Overall Study|Subject Non-Compliance|0|||
16092291|NCT03122860|38830096|FG000|Overall Study|Withdrawal by Subject|3|||
16092292|NCT03122860|38830097|FG001|Overall Study|Withdrawal by Subject|2|||
16092293|NCT03122860|38830098|FG002|Overall Study|Withdrawal by Subject|5|||
16092294|NCT03122860|38830099|FG003|Overall Study|Withdrawal by Subject|7|||
16092295|NCT03122860|38830100|FG004|Overall Study|Withdrawal by Subject|9|||
16092296|NCT03122860|38830101|FG005|Overall Study|Withdrawal by Subject|8|||
16092297|NCT00535626|38830107|FG000|Overall Study|Death|15|||
16322477|NCT01217476|39667505|FG000|Overall Study|Adverse Event|6|||
16092298|NCT00535626|38830107|FG000|Overall Study|Lost to Follow-up|29|||
16092299|NCT00535626|38830107|FG000|Overall Study|Withdrawal by Subject|20|||
16092300|NCT00535626|38830107|FG000|Overall Study|Removal/revision of study component|8|||
16092301|NCT00535626|38830107|FG000|Overall Study|Subject terminated|31|||
16092302|NCT00535626|38830107|FG000|Overall Study|Unable to return|2|||
16092303|NCT00489554|38830111|FG000|Overall Study|Adverse Event|2|||
16322478|NCT01217476|39667506|FG001|Overall Study|Adverse Event|1|||
16322479|NCT01217476|39667505|FG000|Overall Study|Physician Decision|0|||
16322480|NCT01217476|39667506|FG001|Overall Study|Physician Decision|1|||
16092304|NCT00489554|38830111|FG000|Overall Study|Withdrawal by Subject|1|||
16092305|NCT00489554|38830111|FG000|Overall Study|Lost to Follow-up|1|||
16092306|NCT03611556|38830112|FG000|Overall Study|Death|7|||
16092307|NCT03611556|38830113|FG001|Overall Study|Death|7|||
16092308|NCT03611556|38830114|FG002|Overall Study|Death|3|||
16092309|NCT03611556|38830115|FG003|Overall Study|Death|8|||
16092310|NCT03611556|38830116|FG004|Overall Study|Death|47|||
16092311|NCT03611556|38830117|FG005|Overall Study|Death|32|||
16092312|NCT03611556|38830118|FG006|Overall Study|Death|53|||
16092313|NCT03611556|38830112|FG000|Overall Study|Withdrawal by Subject|0|||
16322481|NCT01217476|39667505|FG000|Overall Study|Withdrawal by Subject|3|||
16322482|NCT01217476|39667506|FG001|Overall Study|Withdrawal by Subject|3|||
16322483|NCT01217476|39667505|FG000|Overall Study|Surgery on the Target Limb|0|||
16322484|NCT01217476|39667506|FG001|Overall Study|Surgery on the Target Limb|2|||
16322485|NCT01217476|39667505|FG000|Overall Study|Protocol Deviation|1|||
16223457|NCT02275780|39298682|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
16322486|NCT01217476|39667506|FG001|Overall Study|Protocol Deviation|0|||
16092314|NCT03611556|38830113|FG001|Overall Study|Withdrawal by Subject|0|||
16322487|NCT01217476|39667505|FG000|Overall Study|Other|2|||
16322488|NCT01217476|39667506|FG001|Overall Study|Other|0|||
16092315|NCT03611556|38830114|FG002|Overall Study|Withdrawal by Subject|0|||
16092316|NCT03611556|38830115|FG003|Overall Study|Withdrawal by Subject|0|||
16322489|NCT01094301|39667509|FG000|Trial Stage|Withdrawal by Subject|1|||
16322490|NCT01094301|39667509|FG000|Implant Stage|Adverse Event|1|||
16322491|NCT01094301|39667509|FG000|Implant Stage|Protocol Violation|1|||
16322492|NCT01094301|39667509|FG000|Implant Stage|Withdrawal by Subject|2|||
16203869|NCT00131664|39223155|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
16203870|NCT00131664|39223156|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
16203871|NCT00131664|39223157|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
16322493|NCT01094301|39667509|FG000|Implant Stage|No return of pain|4|||
16322494|NCT00468481|39667510|FG000|Overall Study|Adverse Event|13|||
16322495|NCT00468481|39667511|FG001|Overall Study|Adverse Event|3|||
16322496|NCT00468481|39667510|FG000|Overall Study|Lost to Follow-up|25|||
16322497|NCT00468481|39667511|FG001|Overall Study|Lost to Follow-up|8|||
16322498|NCT00468481|39667510|FG000|Overall Study|Pregnancy|2|||
16322499|NCT00468481|39667511|FG001|Overall Study|Pregnancy|0|||
16322500|NCT00468481|39667510|FG000|Overall Study|Protocol Violation|18|||
16322501|NCT00468481|39667511|FG001|Overall Study|Protocol Violation|8|||
16322502|NCT00468481|39667510|FG000|Overall Study|Withdrawal by Subject|12|||
16322503|NCT00468481|39667511|FG001|Overall Study|Withdrawal by Subject|3|||
16322504|NCT00468481|39667510|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
16322505|NCT00468481|39667511|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
16322506|NCT00468481|39667510|FG000|Overall Study|Prohibited Medication|1|||
16322507|NCT00468481|39667511|FG001|Overall Study|Prohibited Medication|1|||
16322508|NCT00468481|39667510|FG000|Overall Study|Egg Donor|1|||
16322509|NCT00468481|39667511|FG001|Overall Study|Egg Donor|0|||
16322510|NCT00468481|39667510|FG000|Overall Study|Moved out of area|4|||
16322511|NCT00468481|39667511|FG001|Overall Study|Moved out of area|1|||
16322512|NCT00468481|39667510|FG000|Overall Study|Non-Compliance|5|||
16322513|NCT00468481|39667511|FG001|Overall Study|Non-Compliance|0|||
16322514|NCT00468481|39667510|FG000|Overall Study|Other|6|||
16322515|NCT00468481|39667511|FG001|Overall Study|Other|0|||
16322516|NCT00652626|39667513|FG000|Initial Treatment Phase|Adverse Event|0|||
16322517|NCT00652626|39667514|FG001|Initial Treatment Phase|Adverse Event|0|||
16322518|NCT00652626|39667515|FG002|Initial Treatment Phase|Adverse Event|0|||
16322519|NCT00652626|39667516|FG003|Initial Treatment Phase|Adverse Event|0|||
16322520|NCT00652626|39667517|FG004|Initial Treatment Phase|Adverse Event|1|||
16322521|NCT00652626|39667518|FG005|Initial Treatment Phase|Adverse Event|0|||
16322522|NCT00652626|39667519|FG006|Initial Treatment Phase|Adverse Event|0|||
16322523|NCT00652626|39667513|FG000|Initial Treatment Phase|Protocol Violation|0|||
16322524|NCT00652626|39667514|FG001|Initial Treatment Phase|Protocol Violation|0|||
16322525|NCT00652626|39667515|FG002|Initial Treatment Phase|Protocol Violation|0|||
16322526|NCT00652626|39667516|FG003|Initial Treatment Phase|Protocol Violation|1|||
16322527|NCT00652626|39667517|FG004|Initial Treatment Phase|Protocol Violation|0|||
16322528|NCT00652626|39667518|FG005|Initial Treatment Phase|Protocol Violation|0|||
16322529|NCT00652626|39667519|FG006|Initial Treatment Phase|Protocol Violation|0|||
16322530|NCT00652626|39667513|FG000|Initial Treatment Phase|Physician Decision|0|||
16203872|NCT00131664|39223152|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
16203873|NCT00131664|39223153|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
16203874|NCT00131664|39223154|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
16203875|NCT00131664|39223155|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
16203876|NCT00131664|39223156|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
16322531|NCT00652626|39667514|FG001|Initial Treatment Phase|Physician Decision|0|||
16322532|NCT00652626|39667515|FG002|Initial Treatment Phase|Physician Decision|0|||
16322533|NCT00652626|39667516|FG003|Initial Treatment Phase|Physician Decision|0|||
16322534|NCT00652626|39667517|FG004|Initial Treatment Phase|Physician Decision|1|||
16322535|NCT00652626|39667518|FG005|Initial Treatment Phase|Physician Decision|0|||
16322536|NCT00652626|39667519|FG006|Initial Treatment Phase|Physician Decision|0|||
16322537|NCT00652626|39667513|FG000|Initial Treatment Phase|Sponsor Request|0|||
16322538|NCT00652626|39667514|FG001|Initial Treatment Phase|Sponsor Request|0|||
16322539|NCT00652626|39667515|FG002|Initial Treatment Phase|Sponsor Request|1|||
16322540|NCT00652626|39667516|FG003|Initial Treatment Phase|Sponsor Request|0|||
16322541|NCT00652626|39667517|FG004|Initial Treatment Phase|Sponsor Request|0|||
16203877|NCT00131664|39223157|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
16203878|NCT01617655|39223158|FG000|Overall Study|Adverse Event|2|||
16322542|NCT00652626|39667518|FG005|Initial Treatment Phase|Sponsor Request|0|||
16322543|NCT00652626|39667519|FG006|Initial Treatment Phase|Sponsor Request|0|||
16322544|NCT00652626|39667513|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
16322545|NCT00652626|39667514|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
16322546|NCT00652626|39667515|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
16322547|NCT00652626|39667516|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
16322548|NCT00652626|39667517|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
16322549|NCT00652626|39667518|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
16322550|NCT00652626|39667519|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
16322551|NCT00652626|39667513|FG000|Extension Phase|Withdrawal by Subject|0|||
16322552|NCT00652626|39667514|FG001|Extension Phase|Withdrawal by Subject|0|||
16322553|NCT00652626|39667515|FG002|Extension Phase|Withdrawal by Subject|0|||
16322554|NCT00652626|39667516|FG003|Extension Phase|Withdrawal by Subject|0|||
16322555|NCT00652626|39667517|FG004|Extension Phase|Withdrawal by Subject|0|||
16322556|NCT00652626|39667518|FG005|Extension Phase|Withdrawal by Subject|2|||
16203879|NCT01617655|39223159|FG001|Overall Study|Adverse Event|3|||
16322557|NCT00652626|39667519|FG006|Extension Phase|Withdrawal by Subject|0|||
16322558|NCT00652626|39667513|FG000|Extension Phase|Adverse Event|0|||
16203880|NCT01617655|39223158|FG000|Overall Study|Poor compliance to protocol|1|||
16203881|NCT01617655|39223159|FG001|Overall Study|Poor compliance to protocol|4|||
16203882|NCT01617655|39223158|FG000|Overall Study|Participants moved|0|||
16203883|NCT01617655|39223159|FG001|Overall Study|Participants moved|4|||
16092317|NCT03611556|38830116|FG004|Overall Study|Withdrawal by Subject|4|||
16092318|NCT03611556|38830117|FG005|Overall Study|Withdrawal by Subject|2|||
16092319|NCT03611556|38830118|FG006|Overall Study|Withdrawal by Subject|4|||
16092320|NCT03611556|38830112|FG000|Overall Study|Sponsor decision|0|||
16092321|NCT03611556|38830113|FG001|Overall Study|Sponsor decision|0|||
16092322|NCT03611556|38830114|FG002|Overall Study|Sponsor decision|0|||
16092323|NCT03611556|38830115|FG003|Overall Study|Sponsor decision|0|||
16092324|NCT03611556|38830116|FG004|Overall Study|Sponsor decision|9|||
16092325|NCT03611556|38830117|FG005|Overall Study|Sponsor decision|4|||
16092326|NCT03611556|38830118|FG006|Overall Study|Sponsor decision|12|||
16092327|NCT03611556|38830112|FG000|Overall Study|Reasons|0|||
16092328|NCT03611556|38830113|FG001|Overall Study|Reasons|0|||
16092329|NCT03611556|38830114|FG002|Overall Study|Reasons|0|||
16092330|NCT03611556|38830115|FG003|Overall Study|Reasons|0|||
16092331|NCT03611556|38830116|FG004|Overall Study|Reasons|2|||
16092332|NCT03611556|38830117|FG005|Overall Study|Reasons|0|||
16092333|NCT03611556|38830118|FG006|Overall Study|Reasons|1|||
16092334|NCT01494467|38830119|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
16092335|NCT01494467|38830120|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
16092336|NCT01494467|38830119|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
16092337|NCT01494467|38830120|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
16092338|NCT01494467|38830119|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
16322559|NCT00652626|39667514|FG001|Extension Phase|Adverse Event|0|||
16092339|NCT01494467|38830120|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
16092340|NCT01494467|38830119|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
16092341|NCT01494467|38830120|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
16203884|NCT01617655|39223158|FG000|Overall Study|Consent withdrawn by participant|1|||
16203885|NCT01617655|39223159|FG001|Overall Study|Consent withdrawn by participant|1|||
16203886|NCT01617655|39223158|FG000|Overall Study|Last visit outside protocol visit window|1|||
16203887|NCT01617655|39223159|FG001|Overall Study|Last visit outside protocol visit window|10|||
16322560|NCT00652626|39667515|FG002|Extension Phase|Adverse Event|0|||
16322561|NCT00652626|39667516|FG003|Extension Phase|Adverse Event|0|||
16322562|NCT00652626|39667517|FG004|Extension Phase|Adverse Event|0|||
16322563|NCT00652626|39667518|FG005|Extension Phase|Adverse Event|2|||
16322564|NCT00652626|39667519|FG006|Extension Phase|Adverse Event|1|||
16322565|NCT00652626|39667513|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
16203888|NCT01617655|39223158|FG000|Overall Study|Site closure|3|||
16203889|NCT01617655|39223159|FG001|Overall Study|Site closure|5|||
16203890|NCT01617655|39223158|FG000|Overall Study|Other than specified above|1|||
16203891|NCT01617655|39223159|FG001|Overall Study|Other than specified above|2|||
16203892|NCT02758613|39223160|FG000|Treatment|Physician and Sponsor Decision|1|||
16203893|NCT02758613|39223161|FG001|Treatment|Physician and Sponsor Decision|0|||
16203894|NCT02758613|39223162|FG002|Treatment|Physician and Sponsor Decision|0|||
16203895|NCT02758613|39223163|FG003|Treatment|Physician and Sponsor Decision|0|||
16203896|NCT02758613|39223160|FG000|Treatment|Withdrawal by Subject|1|||
16203897|NCT02758613|39223161|FG001|Treatment|Withdrawal by Subject|0|||
16203898|NCT02758613|39223162|FG002|Treatment|Withdrawal by Subject|1|||
16203899|NCT02758613|39223163|FG003|Treatment|Withdrawal by Subject|0|||
16203900|NCT00065442|39223166|FG000|Overall Study|Lost to Follow-up|1|||
16203901|NCT00065442|39223167|FG001|Overall Study|Lost to Follow-up|1|||
16203902|NCT00065442|39223166|FG000|Overall Study|Death|121|||
16203903|NCT00065442|39223167|FG001|Overall Study|Death|210|||
16203904|NCT00065442|39223166|FG000|Overall Study|Withdrawal by Subject|3|||
16203905|NCT00065442|39223167|FG001|Overall Study|Withdrawal by Subject|9|||
16203906|NCT01924299|39223168|FG000|Period 2|Withdrawal by Subject|1|||
16203907|NCT01924299|39223169|FG001|Period 2|Withdrawal by Subject|0|||
16203908|NCT01924299|39223168|FG000|Period 2|Adverse Event|0|||
16203909|NCT01924299|39223169|FG001|Period 2|Adverse Event|1|||
16322566|NCT00652626|39667514|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
16203910|NCT03483116|39223170|FG000|Overall Study|Adverse Event|0|||
16322567|NCT00652626|39667515|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
16092342|NCT01494467|38830119|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
16092343|NCT01494467|38830120|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
16092344|NCT01494467|38830119|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
16092345|NCT01494467|38830120|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
16092346|NCT01494467|38830119|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
16092347|NCT01494467|38830120|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
16092348|NCT01494467|38830119|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
16092349|NCT01494467|38830120|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
16092350|NCT01494467|38830119|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
16092351|NCT01494467|38830120|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
16092352|NCT01494467|38830119|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
16092353|NCT01494467|38830120|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
16092354|NCT01494467|38830119|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
16092355|NCT01494467|38830120|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
16092356|NCT01494467|38830119|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
16092357|NCT01494467|38830120|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
16092358|NCT01494467|38830119|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
16092359|NCT01494467|38830120|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
16092360|NCT01494467|38830119|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
16092361|NCT01494467|38830120|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
16092362|NCT03042767|38830123|FG000|Overall Study|Lost to Follow-up|1|||
16092363|NCT03042767|38830124|FG001|Overall Study|Lost to Follow-up|2|||
16092364|NCT00595764|38830125|FG000|Overall Study|Protocol Violation|24|||
16092365|NCT00595764|38830126|FG001|Overall Study|Protocol Violation|19|||
16092366|NCT00595764|38830125|FG000|Overall Study|Missed Medication >1 week|10|||
16092367|NCT00595764|38830126|FG001|Overall Study|Missed Medication >1 week|17|||
16092368|NCT00595764|38830125|FG000|Overall Study|Missed 3 PM visits|1|||
16092369|NCT00595764|38830126|FG001|Overall Study|Missed 3 PM visits|7|||
16092370|NCT00595764|38830125|FG000|Overall Study|Withdrawal by Subject|4|||
16092371|NCT00595764|38830126|FG001|Overall Study|Withdrawal by Subject|0|||
16092372|NCT00659373|38830127|FG000|Overall Study|Withdrawal by Subject|3|||
16092373|NCT00659373|38830128|FG001|Overall Study|Withdrawal by Subject|5|||
16092374|NCT00659373|38830127|FG000|Overall Study|Assessment Missed|2|||
16092375|NCT00659373|38830128|FG001|Overall Study|Assessment Missed|2|||
16092376|NCT02095145|38830130|FG000|Overall Study|Withdrawal by Subject|1|||
16092377|NCT02095145|38830131|FG001|Overall Study|Withdrawal by Subject|0|||
16092378|NCT04070105|38830132|FG000|Overall Study|Lost to Follow-up|0|||
16092379|NCT04070105|38830133|FG001|Overall Study|Lost to Follow-up|0|||
16092380|NCT04070105|38830134|FG002|Overall Study|Lost to Follow-up|0|||
16092381|NCT04070105|38830135|FG003|Overall Study|Lost to Follow-up|0|||
16092382|NCT04070105|38830136|FG004|Overall Study|Lost to Follow-up|0|||
16092383|NCT04070105|38830137|FG005|Overall Study|Lost to Follow-up|1|||
16092384|NCT02010684|38830144|FG000|Overall Study|Lost to Follow-up|8|||
16092385|NCT02010684|38830145|FG001|Overall Study|Lost to Follow-up|18|||
16517758|NCT04380857|40364959|FG000|Overall Study|Lost to Follow-up|3|||
16517759|NCT04380857|40364960|FG001|Overall Study|Lost to Follow-up|3|||
16092386|NCT02010684|38830144|FG000|Overall Study|Withdrawal by Subject|4|||
16092387|NCT02010684|38830145|FG001|Overall Study|Withdrawal by Subject|5|||
16092388|NCT02612285|38830149|FG000|Overall Study|Withdrawal by Subject|1|||
16092389|NCT02279732|38830150|FG000|Overall Study|Death|23|||
16092390|NCT02279732|38830151|FG001|Overall Study|Death|20|||
16092391|NCT02279732|38830150|FG000|Overall Study|Disease Progression|13|||
16092392|NCT02279732|38830151|FG001|Overall Study|Disease Progression|3|||
16092393|NCT02279732|38830150|FG000|Overall Study|Withdrawal by Subject|2|||
16092394|NCT02279732|38830151|FG001|Overall Study|Withdrawal by Subject|7|||
16092395|NCT02279732|38830150|FG000|Overall Study|Adverse Event|1|||
16092396|NCT02279732|38830151|FG001|Overall Study|Adverse Event|2|||
16092397|NCT02279732|38830150|FG000|Overall Study|Administrative Reason By Sponsor|0|||
16092398|NCT02279732|38830151|FG001|Overall Study|Administrative Reason By Sponsor|2|||
16092399|NCT02279732|38830150|FG000|Overall Study|Study Drug Toxicity|2|||
16092400|NCT02279732|38830151|FG001|Overall Study|Study Drug Toxicity|0|||
16092401|NCT02279732|38830150|FG000|Overall Study|Lost to Follow-up|0|||
16092402|NCT02279732|38830151|FG001|Overall Study|Lost to Follow-up|1|||
16092403|NCT02279732|38830150|FG000|Overall Study|Maximum Clinical Benefit|1|||
16092404|NCT02279732|38830151|FG001|Overall Study|Maximum Clinical Benefit|0|||
16092405|NCT02279732|38830150|FG000|Overall Study|Subject Requested to Discontinue|0|||
16092406|NCT02279732|38830151|FG001|Overall Study|Subject Requested to Discontinue|1|||
16092407|NCT02279732|38830150|FG000|Overall Study|Other|53|||
16092408|NCT02279732|38830151|FG001|Overall Study|Other|67|||
16092409|NCT02279732|38830150|FG000|Overall Study|Other|3|||
16092410|NCT02279732|38830151|FG001|Overall Study|Other|3|||
16092411|NCT02152384|38830152|FG000|Period 1|Withdrawal by Subject|0|||
16092412|NCT02152384|38830153|FG001|Period 1|Withdrawal by Subject|1|||
16092413|NCT02152384|38830152|FG000|Period 1|Adverse Event|1|||
16092414|NCT02152384|38830153|FG001|Period 1|Adverse Event|1|||
16092415|NCT02367794|38830155|FG000|Overall Study|Death|252|||
16092416|NCT02367794|38830156|FG001|Overall Study|Death|245|||
16517760|NCT02097134|40364962|FG000|Overall Study|Physician Decision|4|||
16092417|NCT02367794|38830157|FG002|Overall Study|Death|243|||
16092418|NCT02367794|38830155|FG000|Overall Study|Lost to Follow-up|1|||
16092419|NCT02367794|38830156|FG001|Overall Study|Lost to Follow-up|2|||
16092420|NCT02367794|38830157|FG002|Overall Study|Lost to Follow-up|2|||
16092421|NCT02367794|38830155|FG000|Overall Study|Physician Decision|0|||
16092422|NCT02367794|38830156|FG001|Overall Study|Physician Decision|5|||
16092423|NCT02367794|38830157|FG002|Overall Study|Physician Decision|3|||
16092424|NCT02367794|38830155|FG000|Overall Study|Protocol Violation|1|||
16092425|NCT02367794|38830156|FG001|Overall Study|Protocol Violation|0|||
16092426|NCT02367794|38830157|FG002|Overall Study|Protocol Violation|1|||
16092427|NCT02367794|38830155|FG000|Overall Study|Withdrawal by Subject|25|||
16092428|NCT02367794|38830156|FG001|Overall Study|Withdrawal by Subject|12|||
16092429|NCT02367794|38830157|FG002|Overall Study|Withdrawal by Subject|20|||
16092430|NCT02367794|38830155|FG000|Overall Study|Brain metastasis|1|||
16092431|NCT02367794|38830156|FG001|Overall Study|Brain metastasis|0|||
16092432|NCT02367794|38830157|FG002|Overall Study|Brain metastasis|0|||
16092433|NCT02367794|38830155|FG000|Overall Study|Randomized in error|0|||
16092434|NCT02367794|38830156|FG001|Overall Study|Randomized in error|0|||
16092435|NCT02367794|38830157|FG002|Overall Study|Randomized in error|1|||
16092436|NCT02367794|38830155|FG000|Overall Study|Patient unable to receive carboplatin|0|||
16092437|NCT02367794|38830156|FG001|Overall Study|Patient unable to receive carboplatin|0|||
16092438|NCT02367794|38830157|FG002|Overall Study|Patient unable to receive carboplatin|1|||
16092439|NCT02367794|38830155|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
16092440|NCT02367794|38830156|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
16092441|NCT02367794|38830157|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
16092442|NCT02367794|38830155|FG000|Overall Study|Adverse Event|0|||
16092443|NCT02367794|38830156|FG001|Overall Study|Adverse Event|0|||
16092444|NCT02367794|38830157|FG002|Overall Study|Adverse Event|2|||
16092445|NCT02367794|38830155|FG000|Overall Study|Study Terminated By Sponsor|0|||
16092446|NCT02367794|38830156|FG001|Overall Study|Study Terminated By Sponsor|1|||
16092447|NCT02367794|38830157|FG002|Overall Study|Study Terminated By Sponsor|1|||
16092448|NCT02367794|38830155|FG000|Overall Study|Moved to Roll-Over Study|0|||
16092449|NCT02367794|38830156|FG001|Overall Study|Moved to Roll-Over Study|15|||
16092450|NCT02367794|38830157|FG002|Overall Study|Moved to Roll-Over Study|13|||
16092451|NCT02367794|38830155|FG000|Overall Study|Sponsor Request|60|||
16092452|NCT02367794|38830156|FG001|Overall Study|Sponsor Request|57|||
16092453|NCT02367794|38830157|FG002|Overall Study|Sponsor Request|45|||
16092454|NCT02367794|38830155|FG000|Overall Study|Moved into PTAP Study|0|||
16092455|NCT02367794|38830156|FG001|Overall Study|Moved into PTAP Study|2|||
16092456|NCT02367794|38830157|FG002|Overall Study|Moved into PTAP Study|3|||
16092457|NCT02367794|38830155|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
16092458|NCT02367794|38830156|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
16092459|NCT02367794|38830157|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
16092460|NCT02367794|38830155|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
16092461|NCT02367794|38830156|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
16092462|NCT02367794|38830157|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
16092463|NCT02367794|38830155|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
16092464|NCT02367794|38830156|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
16092465|NCT02367794|38830157|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
16092466|NCT02367794|38830155|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
16092467|NCT02367794|38830156|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
16092468|NCT02367794|38830157|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
16092469|NCT02256553|38830158|FG000|Period I|Adverse Event|5|||
16092470|NCT02256553|38830158|FG000|Period I|Protocol Violation|1|||
16092471|NCT02256553|38830158|FG000|Period II|Adverse Event|1|||
16092472|NCT02256553|38830158|FG000|Period II|Subject Moved|1|||
16092473|NCT02256553|38830158|FG000|Period III|Adverse Event|3|||
16092474|NCT02382640|38830159|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
16092475|NCT02382640|38830160|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
16092476|NCT02382640|38830161|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
16092477|NCT02382640|38830162|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
16092478|NCT00925548|38830166|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
16092479|NCT00925548|38830167|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
16092480|NCT05260437|38830170|FG000|Overall Study|Lost to Follow-up|5|||
16092481|NCT05260437|38830171|FG001|Overall Study|Lost to Follow-up|2|||
16322568|NCT00652626|39667516|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
16092482|NCT05260437|38830172|FG002|Overall Study|Lost to Follow-up|1|||
16092483|NCT05260437|38830173|FG003|Overall Study|Lost to Follow-up|2|||
16092484|NCT05260437|38830174|FG004|Overall Study|Lost to Follow-up|2|||
16092485|NCT05260437|38830170|FG000|Overall Study|Withdrawal by Subject|3|||
16092486|NCT05260437|38830171|FG001|Overall Study|Withdrawal by Subject|0|||
16092487|NCT05260437|38830172|FG002|Overall Study|Withdrawal by Subject|4|||
16092488|NCT05260437|38830173|FG003|Overall Study|Withdrawal by Subject|5|||
16092489|NCT05260437|38830174|FG004|Overall Study|Withdrawal by Subject|0|||
16092490|NCT05260437|38830170|FG000|Overall Study|Vaccine Not Administered|0|||
16092491|NCT05260437|38830171|FG001|Overall Study|Vaccine Not Administered|1|||
16092492|NCT05260437|38830172|FG002|Overall Study|Vaccine Not Administered|0|||
16092493|NCT05260437|38830173|FG003|Overall Study|Vaccine Not Administered|0|||
16092494|NCT05260437|38830174|FG004|Overall Study|Vaccine Not Administered|0|||
16092495|NCT01944774|38830175|FG000|Overall Study|Withdrawal by Subject|2|||
16092496|NCT01944774|38830176|FG001|Overall Study|Withdrawal by Subject|3|||
16092497|NCT01944774|38830177|FG002|Overall Study|Withdrawal by Subject|3|||
16092498|NCT01944774|38830175|FG000|Overall Study|Adverse Event|3|||
16092499|NCT01944774|38830176|FG001|Overall Study|Adverse Event|2|||
16092500|NCT01944774|38830177|FG002|Overall Study|Adverse Event|3|||
16092501|NCT01944774|38830175|FG000|Overall Study|Lack of Efficacy|1|||
16092502|NCT01944774|38830176|FG001|Overall Study|Lack of Efficacy|2|||
16092503|NCT01944774|38830177|FG002|Overall Study|Lack of Efficacy|2|||
16092504|NCT01944774|38830175|FG000|Overall Study|Lost to Follow-up|0|||
16092505|NCT01944774|38830176|FG001|Overall Study|Lost to Follow-up|1|||
16092506|NCT01944774|38830177|FG002|Overall Study|Lost to Follow-up|0|||
16092507|NCT00805792|38830178|FG000|Overall Study|Death|3|||
16092508|NCT00805792|38830178|FG000|Overall Study|Lost to Follow-up|2|||
16092509|NCT01760876|38830182|FG000|Overall Study|Non-cardiac death (head injury)|1|||
16092510|NCT01760876|38830182|FG000|Overall Study|Carcinoma of prostate|1|||
16092511|NCT01760876|38830182|FG000|Overall Study|Impaired renal function|1|||
16092512|NCT01760876|38830182|FG000|Overall Study|Major depression|1|||
16092513|NCT01760876|38830182|FG000|Overall Study|Very poor baseline OCT quality|2|||
16092514|NCT01065779|38830187|FG000|Overall Study|Duplicate Investigation|1|||
16092515|NCT01065779|38830187|FG000|Overall Study|Investigation Before Contract Date|37|||
16092516|NCT01065779|38830187|FG000|Overall Study|Non-enrollment Period Administration|10|||
16092517|NCT01065779|38830187|FG000|Overall Study|Not Administered With Study Drug|17|||
16322569|NCT00652626|39667517|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
16322570|NCT00652626|39667518|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
16322571|NCT00652626|39667519|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
16322572|NCT00652626|39667513|FG000|Extension Phase|Physician Decision|0|||
16322573|NCT00652626|39667514|FG001|Extension Phase|Physician Decision|0|||
16322574|NCT00652626|39667515|FG002|Extension Phase|Physician Decision|0|||
16322575|NCT00652626|39667516|FG003|Extension Phase|Physician Decision|0|||
16322576|NCT00652626|39667517|FG004|Extension Phase|Physician Decision|0|||
16322577|NCT00652626|39667518|FG005|Extension Phase|Physician Decision|1|||
16322578|NCT00652626|39667519|FG006|Extension Phase|Physician Decision|1|||
16322579|NCT00652626|39667513|FG000|Extension Phase|Death|0|||
16322580|NCT00652626|39667514|FG001|Extension Phase|Death|0|||
16322581|NCT00652626|39667515|FG002|Extension Phase|Death|0|||
16322582|NCT00652626|39667516|FG003|Extension Phase|Death|0|||
16322583|NCT00652626|39667517|FG004|Extension Phase|Death|0|||
16322584|NCT00652626|39667518|FG005|Extension Phase|Death|1|||
16322585|NCT00652626|39667519|FG006|Extension Phase|Death|1|||
16322586|NCT00644917|39667520|FG000|Overall Study|Withdrawal by Subject|2|||
16322587|NCT00280397|39667521|FG000|Overall Study|Adverse Event|1|||
16322588|NCT03226769|39667523|FG000|Overall Study|Withdrawal by Subject|0|||
16322589|NCT03226769|39667524|FG001|Overall Study|Withdrawal by Subject|1|||
16322590|NCT02418156|39667528|FG000|Overall Study|Lost to Follow-up|12|||
16322591|NCT02418156|39667528|FG000|Overall Study|Death|2|||
16322592|NCT02418156|39667528|FG000|Overall Study|Physician Decision|1|||
16322593|NCT02418156|39667528|FG000|Overall Study|Withdrawal by Subject|1|||
16322594|NCT02418156|39667528|FG000|Overall Study|Subject refused to return|1|||
16322595|NCT00319592|39667534|FG000|Overall Study|Protocol Violation|1|||
16322596|NCT00319592|39667535|FG001|Overall Study|Protocol Violation|0|||
16322597|NCT00319592|39667534|FG000|Overall Study|Physician Decision|0|||
16322598|NCT00319592|39667535|FG001|Overall Study|Physician Decision|1|||
16322599|NCT00723008|39667538|FG000|Enrollment|Lost to Follow-up|1|||
16322600|NCT00723008|39667539|FG001|Enrollment|Lost to Follow-up|0|||
16092518|NCT01065779|38830187|FG000|Overall Study|Failed to Follow-up|10|||
16092519|NCT01065779|38830187|FG000|Overall Study|Inclusion Criteria Violation|7|||
16092520|NCT05124210|38830188|FG000|Overall Study|Lost to Follow-up|1|||
16092521|NCT05124210|38830189|FG001|Overall Study|Lost to Follow-up|0|||
16092522|NCT05124210|38830188|FG000|Overall Study|Withdrawal by Subject|1|||
16092523|NCT05124210|38830189|FG001|Overall Study|Withdrawal by Subject|0|||
16092524|NCT00632736|38830190|FG000|Overall Study|Adverse Event|104|||
16092525|NCT00632736|38830190|FG000|Overall Study|Lost to Follow-up|15|||
16092526|NCT00632736|38830190|FG000|Overall Study|Protocol Violation|14|||
16092527|NCT00632736|38830190|FG000|Overall Study|Withdrawal by Subject|99|||
16092528|NCT00632736|38830190|FG000|Overall Study|Lack of Efficacy|5|||
16092529|NCT00632736|38830190|FG000|Overall Study|Sponsor terminated study|5|||
16092530|NCT00632736|38830190|FG000|Overall Study|Non-compliance|10|||
16092531|NCT00632736|38830190|FG000|Overall Study|Other|16|||
16092532|NCT00882050|38830192|FG000|Overall Study|Physician Decision|1|||
16322601|NCT00723008|39667538|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
16322602|NCT00723008|39667539|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
16322603|NCT00723008|39667538|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
16322604|NCT00723008|39667539|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
16322605|NCT00723008|39667538|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
16322606|NCT00723008|39667539|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
16322607|NCT00723008|39667538|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
16322608|NCT00723008|39667539|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
16322609|NCT00723008|39667538|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
16322610|NCT00723008|39667539|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
16322611|NCT00474045|39667541|FG000|Overall Study|Adverse Event|18|||
16322612|NCT00474045|39667542|FG001|Overall Study|Adverse Event|8|||
16322613|NCT00474045|39667541|FG000|Overall Study|Unclassified|1|||
16203911|NCT03483116|39223171|FG001|Overall Study|Adverse Event|1|||
16203912|NCT03483116|39223172|FG002|Overall Study|Adverse Event|0|||
16322614|NCT00474045|39667542|FG001|Overall Study|Unclassified|3|||
16322615|NCT00474045|39667541|FG000|Overall Study|Lack of Efficacy|0|||
16322616|NCT00474045|39667542|FG001|Overall Study|Lack of Efficacy|9|||
16092533|NCT00882050|38830193|FG001|Overall Study|Physician Decision|0|||
16092534|NCT00882050|38830194|FG002|Overall Study|Physician Decision|0|||
16092535|NCT01560429|38830197|FG000|Overall Study|Protocol Violation|3|||
16092536|NCT01560429|38830198|FG001|Overall Study|Protocol Violation|6|||
16092537|NCT00657709|38830199|FG000|Overall Study|AE or Death|7|||
16092538|NCT00657709|38830200|FG001|Overall Study|AE or Death|7|||
16092539|NCT00657709|38830201|FG002|Overall Study|AE or Death|6|||
16092540|NCT00657709|38830202|FG003|Overall Study|AE or Death|7|||
16092541|NCT00657709|38830203|FG004|Overall Study|AE or Death|1|||
16092542|NCT00657709|38830199|FG000|Overall Study|Withdrawal by Subject|7|||
16092543|NCT00657709|38830200|FG001|Overall Study|Withdrawal by Subject|15|||
16092544|NCT00657709|38830201|FG002|Overall Study|Withdrawal by Subject|15|||
16092545|NCT00657709|38830202|FG003|Overall Study|Withdrawal by Subject|5|||
16092546|NCT00657709|38830203|FG004|Overall Study|Withdrawal by Subject|9|||
16092547|NCT00657709|38830199|FG000|Overall Study|Lost to Follow-up|9|||
16092548|NCT00657709|38830200|FG001|Overall Study|Lost to Follow-up|9|||
16092549|NCT00657709|38830201|FG002|Overall Study|Lost to Follow-up|7|||
16092550|NCT00657709|38830202|FG003|Overall Study|Lost to Follow-up|1|||
16092551|NCT00657709|38830203|FG004|Overall Study|Lost to Follow-up|21|||
16092552|NCT00657709|38830199|FG000|Overall Study|Protocol Violation|0|||
16092553|NCT00657709|38830200|FG001|Overall Study|Protocol Violation|2|||
16092554|NCT00657709|38830201|FG002|Overall Study|Protocol Violation|0|||
16092555|NCT00657709|38830202|FG003|Overall Study|Protocol Violation|1|||
16092556|NCT00657709|38830203|FG004|Overall Study|Protocol Violation|2|||
16092557|NCT01829711|38830204|FG000|Overall Study|Lost to Follow-up|2|||
16092558|NCT01829711|38830204|FG000|Overall Study|Withdrawal by Subject|3|||
16092559|NCT01829711|38830204|FG000|Overall Study|Death|4|||
16092560|NCT01829711|38830204|FG000|Overall Study|Started new therapies|17|||
16092561|NCT01829711|38830204|FG000|Overall Study|Adverse Event|3|||
16092562|NCT01829711|38830204|FG000|Overall Study|Due to progression of disease|13|||
16517761|NCT02097134|40364962|FG000|Overall Study|Non-Protocol Therapy|1|||
16517762|NCT02097134|40364962|FG000|Overall Study|Progressive Disease|3|||
16092563|NCT01829711|38830204|FG000|Overall Study|Due to lack of response|1|||
16517763|NCT02097134|40364962|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
16517764|NCT03351049|40364969|FG000|Overall Study|Withdrawal|26|||
16517765|NCT03351049|40364970|FG001|Overall Study|Withdrawal|22|||
16517766|NCT03306264|40364974|FG000|Overall Study|Death|33|||
16517767|NCT03306264|40364975|FG001|Overall Study|Death|25|||
16517768|NCT03306264|40364976|FG002|Overall Study|Death|34|||
16517769|NCT03306264|40364977|FG003|Overall Study|Death|34|||
16517770|NCT03306264|40364974|FG000|Overall Study|Complete Consent Withdrawal|4|||
16517771|NCT03306264|40364975|FG001|Overall Study|Complete Consent Withdrawal|4|||
16517772|NCT03306264|40364976|FG002|Overall Study|Complete Consent Withdrawal|1|||
16517773|NCT03306264|40364977|FG003|Overall Study|Complete Consent Withdrawal|8|||
16517774|NCT03306264|40364974|FG000|Overall Study|Lost to Follow-up|1|||
16517775|NCT03306264|40364975|FG001|Overall Study|Lost to Follow-up|0|||
16517776|NCT03306264|40364976|FG002|Overall Study|Lost to Follow-up|1|||
16517777|NCT03306264|40364977|FG003|Overall Study|Lost to Follow-up|0|||
16517778|NCT03306264|40364974|FG000|Overall Study|Rollover to ASTX727-06|10|||
16517779|NCT03306264|40364975|FG001|Overall Study|Rollover to ASTX727-06|18|||
16517780|NCT03306264|40364976|FG002|Overall Study|Rollover to ASTX727-06|4|||
16517781|NCT03306264|40364977|FG003|Overall Study|Rollover to ASTX727-06|2|||
16517782|NCT03306264|40364974|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
16517783|NCT03306264|40364975|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
16517784|NCT03306264|40364976|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
16517785|NCT03306264|40364977|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
16517786|NCT01306617|40364980|FG000|Overall Study|Adverse Event|1|||
16517787|NCT01306617|40364981|FG001|Overall Study|Adverse Event|0|||
16517788|NCT01306617|40364982|FG002|Overall Study|Adverse Event|0|||
16517789|NCT01306617|40364980|FG000|Overall Study|Virologic Failure|0|||
16517790|NCT01306617|40364981|FG001|Overall Study|Virologic Failure|0|||
16092564|NCT02446015|38830209|FG000|Overall Study|Adverse Event|0|||
16092565|NCT02446015|38830210|FG001|Overall Study|Adverse Event|1|||
16092566|NCT02446015|38830209|FG000|Overall Study|Withdrawal by Subject|1|||
16092567|NCT02446015|38830210|FG001|Overall Study|Withdrawal by Subject|0|||
16092568|NCT03136861|38830216|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
16517791|NCT01306617|40364982|FG002|Overall Study|Virologic Failure|5|||
16517792|NCT01306617|40364980|FG000|Overall Study|Non-compliance|0|||
16517793|NCT01306617|40364981|FG001|Overall Study|Non-compliance|1|||
16517794|NCT01306617|40364982|FG002|Overall Study|Non-compliance|0|||
16092569|NCT03136861|38830217|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
16517795|NCT02504866|40364983|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
16517796|NCT02504866|40364984|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
16517797|NCT02504866|40364985|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
16517798|NCT01430130|40364986|FG000|Overall Study|Lost to Follow-up|1|||
16092570|NCT03136861|38830218|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
16092571|NCT03136861|38830219|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
16092572|NCT03136861|38830220|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
16203913|NCT03483116|39223173|FG003|Overall Study|Adverse Event|1|||
16203914|NCT03483116|39223170|FG000|Overall Study|Protocol Violation|1|||
16395508|NCT04560816|39928280|FG005|Overall Study|Protocol Violation|0|||
16395509|NCT02689206|39928281|FG000|Overall Study|Adverse Event|0|||
16395510|NCT02689206|39928282|FG001|Overall Study|Adverse Event|0|||
16203915|NCT03483116|39223171|FG001|Overall Study|Protocol Violation|0|||
16395511|NCT02689206|39928283|FG002|Overall Study|Adverse Event|1|||
16395512|NCT02689206|39928284|FG003|Overall Study|Adverse Event|0|||
16395513|NCT02689206|39928285|FG004|Overall Study|Adverse Event|2|||
16395514|NCT02689206|39928281|FG000|Overall Study|Protocol Violation|1|||
16395515|NCT02689206|39928282|FG001|Overall Study|Protocol Violation|0|||
16395516|NCT02689206|39928283|FG002|Overall Study|Protocol Violation|0|||
16395517|NCT02689206|39928284|FG003|Overall Study|Protocol Violation|1|||
16395518|NCT02689206|39928285|FG004|Overall Study|Protocol Violation|2|||
16395519|NCT02689206|39928281|FG000|Overall Study|Other: Reached stopping criteria|0|||
16395520|NCT02689206|39928282|FG001|Overall Study|Other: Reached stopping criteria|1|||
16395521|NCT02689206|39928283|FG002|Overall Study|Other: Reached stopping criteria|2|||
16517799|NCT01430130|40364986|FG000|Overall Study|Infection on Control Side of Incision|1|||
16517800|NCT00813761|40364988|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
16517801|NCT00813761|40364989|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
16517802|NCT00813761|40364990|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
16203916|NCT03483116|39223172|FG002|Overall Study|Protocol Violation|0|||
16203917|NCT03483116|39223173|FG003|Overall Study|Protocol Violation|7|||
16203918|NCT03483116|39223170|FG000|Overall Study|Lost to Follow-up|9|||
16203919|NCT03483116|39223171|FG001|Overall Study|Lost to Follow-up|4|||
16203920|NCT03483116|39223172|FG002|Overall Study|Lost to Follow-up|9|||
16203921|NCT03483116|39223173|FG003|Overall Study|Lost to Follow-up|5|||
16203922|NCT03483116|39223170|FG000|Overall Study|Death|1|||
16203923|NCT03483116|39223171|FG001|Overall Study|Death|0|||
16203924|NCT03483116|39223172|FG002|Overall Study|Death|2|||
16203925|NCT03483116|39223173|FG003|Overall Study|Death|1|||
16203926|NCT03483116|39223170|FG000|Overall Study|Withdrawal by Subject|14|||
16517803|NCT00813761|40364991|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
16517804|NCT00813761|40364988|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
16517805|NCT00813761|40364989|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
16517806|NCT00813761|40364990|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
16517807|NCT00813761|40364991|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
16517808|NCT00813761|40364988|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
16517809|NCT00813761|40364989|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
16517810|NCT00813761|40364990|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
16517811|NCT00813761|40364991|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
16517812|NCT00813761|40364988|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
16517813|NCT00813761|40364989|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
16517814|NCT00813761|40364990|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
16517815|NCT00813761|40364991|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
16517816|NCT00813761|40364988|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
16517817|NCT00813761|40364989|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
16517818|NCT00813761|40364990|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
16517819|NCT00813761|40364991|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
16517820|NCT00813761|40364988|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
16517821|NCT00813761|40364989|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
16517822|NCT00813761|40364990|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
16517823|NCT00813761|40364991|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
16517824|NCT00813761|40364988|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
16517825|NCT00813761|40364989|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
16517826|NCT00813761|40364990|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
16092573|NCT03136861|38830221|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
16203927|NCT03483116|39223171|FG001|Overall Study|Withdrawal by Subject|16|||
16395522|NCT02689206|39928284|FG003|Overall Study|Other: Reached stopping criteria|3|||
16395523|NCT02689206|39928285|FG004|Overall Study|Other: Reached stopping criteria|4|||
16395524|NCT02689206|39928281|FG000|Overall Study|Physician Decision|1|||
16517827|NCT00813761|40364991|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
16517828|NCT00813761|40364988|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
16517829|NCT00813761|40364989|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
16517830|NCT00813761|40364990|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
16517831|NCT00813761|40364991|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
16517832|NCT00813761|40364988|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
16517833|NCT00813761|40364989|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
16203928|NCT03483116|39223172|FG002|Overall Study|Withdrawal by Subject|14|||
16395525|NCT02689206|39928282|FG001|Overall Study|Physician Decision|0|||
16203929|NCT03483116|39223173|FG003|Overall Study|Withdrawal by Subject|16|||
16203930|NCT03483116|39223170|FG000|Overall Study|Unknown other reason|3|||
16203931|NCT03483116|39223171|FG001|Overall Study|Unknown other reason|2|||
16203932|NCT03483116|39223172|FG002|Overall Study|Unknown other reason|1|||
16203933|NCT03483116|39223173|FG003|Overall Study|Unknown other reason|1|||
16517834|NCT00813761|40364990|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
16517835|NCT00813761|40364991|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
16517836|NCT00813761|40364988|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
16092574|NCT03136861|38830222|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
16203934|NCT00781963|39223174|FG000|Overall Study|Death|3|||
16203935|NCT00781963|39223175|FG001|Overall Study|Death|0|||
16203936|NCT00781963|39223174|FG000|Overall Study|Lost to Follow-up|2|||
16203937|NCT00781963|39223175|FG001|Overall Study|Lost to Follow-up|1|||
16203938|NCT00781963|39223174|FG000|Overall Study|Withdrawal by Subject|3|||
16203939|NCT00781963|39223175|FG001|Overall Study|Withdrawal by Subject|1|||
16203940|NCT00781963|39223174|FG000|Overall Study|Refused follow-up|9|||
16203941|NCT00781963|39223175|FG001|Overall Study|Refused follow-up|0|||
16203942|NCT01677507|39223176|FG000|Initial Assignment|Adverse Event|0|||
16203943|NCT01677507|39223177|FG001|Initial Assignment|Adverse Event|1|||
16203944|NCT01677507|39223176|FG000|Initial Assignment|Protocol Violation|0|||
16203945|NCT01677507|39223177|FG001|Initial Assignment|Protocol Violation|1|||
16203946|NCT01677507|39223176|FG000|Second Assigment|Withdrawal by Subject|2|||
16203947|NCT01677507|39223177|FG001|Second Assigment|Withdrawal by Subject|2|||
16203948|NCT01677507|39223176|FG000|Second Assigment|Adverse Event|1|||
16203949|NCT01677507|39223177|FG001|Second Assigment|Adverse Event|3|||
16203950|NCT00880763|39223178|FG000|Extension Period (Part 2)|Adverse Event|0|||
16203951|NCT00880763|39223179|FG001|Extension Period (Part 2)|Adverse Event|0|||
16203952|NCT00880763|39223180|FG002|Extension Period (Part 2)|Adverse Event|1|||
16203953|NCT00880763|39223181|FG003|Extension Period (Part 2)|Adverse Event|1|||
16203954|NCT00880763|39223178|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
16203955|NCT00880763|39223179|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
16203956|NCT00880763|39223180|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
16203957|NCT00880763|39223181|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
16203958|NCT00880763|39223178|FG000|Extension Period (Part 2)|Physician Decision|0|||
16203959|NCT00880763|39223179|FG001|Extension Period (Part 2)|Physician Decision|1|||
16203960|NCT00880763|39223180|FG002|Extension Period (Part 2)|Physician Decision|1|||
16203961|NCT00880763|39223181|FG003|Extension Period (Part 2)|Physician Decision|0|||
16203962|NCT00880763|39223178|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
16203963|NCT00880763|39223179|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
16203964|NCT00880763|39223180|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
16203965|NCT00880763|39223181|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
16203966|NCT02980692|39223182|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
16203967|NCT02980692|39223183|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
16203968|NCT02980692|39223184|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
16203969|NCT02980692|39223185|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
16203970|NCT02980692|39223186|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
16203971|NCT02980692|39223182|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
16203972|NCT02980692|39223183|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
16203973|NCT02980692|39223184|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
16203974|NCT02980692|39223185|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
16203975|NCT02980692|39223186|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
16203976|NCT02980692|39223182|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
16203977|NCT02980692|39223183|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
16203978|NCT02980692|39223184|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
16203979|NCT02980692|39223185|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
16203980|NCT02980692|39223186|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
16203981|NCT02980692|39223182|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
16203982|NCT02980692|39223183|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
16203983|NCT02980692|39223184|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
16203984|NCT02980692|39223185|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
16203985|NCT02980692|39223186|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
16203986|NCT02980692|39223182|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
16203987|NCT02980692|39223183|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
16203988|NCT02980692|39223184|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
16203989|NCT02980692|39223185|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
16203990|NCT02980692|39223186|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
16203991|NCT02980692|39223182|FG000|Double Blind Placebo Controlled Period|Other|1|||
16092575|NCT03136861|38830216|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
16517837|NCT00813761|40364989|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
16517838|NCT00813761|40364990|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
16203992|NCT02980692|39223183|FG001|Double Blind Placebo Controlled Period|Other|0|||
16203993|NCT02980692|39223184|FG002|Double Blind Placebo Controlled Period|Other|0|||
16203994|NCT02980692|39223185|FG003|Double Blind Placebo Controlled Period|Other|0|||
16203995|NCT02980692|39223186|FG004|Double Blind Placebo Controlled Period|Other|1|||
16203996|NCT02980692|39223182|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
16203997|NCT02980692|39223183|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
16203998|NCT02980692|39223184|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
16203999|NCT02980692|39223185|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
16204000|NCT02980692|39223186|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
16204001|NCT02980692|39223182|FG000|Double-blind Follow-up Period|Adverse Event|0|||
16204002|NCT02980692|39223183|FG001|Double-blind Follow-up Period|Adverse Event|0|||
16204003|NCT02980692|39223184|FG002|Double-blind Follow-up Period|Adverse Event|0|||
16204004|NCT02980692|39223185|FG003|Double-blind Follow-up Period|Adverse Event|1|||
16204005|NCT02980692|39223186|FG004|Double-blind Follow-up Period|Adverse Event|1|||
16204006|NCT02980692|39223182|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
16204007|NCT02980692|39223183|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
16204008|NCT02980692|39223184|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
16204009|NCT02980692|39223185|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
16204010|NCT02980692|39223186|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
16204011|NCT02980692|39223182|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
16204012|NCT02980692|39223183|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
16204013|NCT02980692|39223184|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
16204014|NCT02980692|39223185|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
16204015|NCT02980692|39223186|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
16204016|NCT02980692|39223182|FG000|Double-blind Follow-up Period|Pregnancy|0|||
16204017|NCT02980692|39223183|FG001|Double-blind Follow-up Period|Pregnancy|0|||
16204018|NCT02980692|39223184|FG002|Double-blind Follow-up Period|Pregnancy|1|||
16204019|NCT02980692|39223185|FG003|Double-blind Follow-up Period|Pregnancy|1|||
16204020|NCT02980692|39223186|FG004|Double-blind Follow-up Period|Pregnancy|0|||
16204021|NCT02980692|39223182|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
16204022|NCT02980692|39223183|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
16204023|NCT02980692|39223184|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
16204024|NCT02980692|39223185|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
16204025|NCT02980692|39223186|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
16204026|NCT02980692|39223182|FG000|Double-blind Follow-up Period|Other|0|||
16204027|NCT02980692|39223183|FG001|Double-blind Follow-up Period|Other|0|||
16204028|NCT02980692|39223184|FG002|Double-blind Follow-up Period|Other|1|||
16204029|NCT02980692|39223185|FG003|Double-blind Follow-up Period|Other|1|||
16204030|NCT02980692|39223186|FG004|Double-blind Follow-up Period|Other|3|||
16204031|NCT01296698|39223187|FG000|Overall Study|Adverse Event|1|||
16204032|NCT01296698|39223188|FG001|Overall Study|Adverse Event|0|||
16204033|NCT01296698|39223187|FG000|Overall Study|Death|1|||
16204034|NCT01296698|39223188|FG001|Overall Study|Death|0|||
16204035|NCT01296698|39223187|FG000|Overall Study|Lost to Follow-up|19|||
16204036|NCT01296698|39223188|FG001|Overall Study|Lost to Follow-up|1|||
16204037|NCT01296698|39223187|FG000|Overall Study|Withdrawal by Subject|12|||
16204038|NCT01296698|39223188|FG001|Overall Study|Withdrawal by Subject|0|||
16204039|NCT01296698|39223187|FG000|Overall Study|Difficulty Contacting Subject|2|||
16204040|NCT01296698|39223188|FG001|Overall Study|Difficulty Contacting Subject|0|||
16204041|NCT01296698|39223187|FG000|Overall Study|Study Terminated by Sponsor|209|||
16204042|NCT01296698|39223188|FG001|Overall Study|Study Terminated by Sponsor|12|||
16204043|NCT01410799|39223189|FG000|Overall Study|PI decision|13|||
16204044|NCT01357980|39223190|FG000|Overall Study|Lack of Efficacy|0|||
16204045|NCT01357980|39223191|FG001|Overall Study|Lack of Efficacy|1|||
16204046|NCT01357980|39223192|FG002|Overall Study|Lack of Efficacy|0|||
16204047|NCT01357980|39223193|FG003|Overall Study|Lack of Efficacy|0|||
16204048|NCT01357980|39223190|FG000|Overall Study|Consent withdrawn|0|||
16322617|NCT00474045|39667541|FG000|Overall Study|Lost to Follow-up|1|||
16322618|NCT00474045|39667542|FG001|Overall Study|Lost to Follow-up|1|||
16322619|NCT00474045|39667541|FG000|Overall Study|Protocol Violation|10|||
16322620|NCT00474045|39667542|FG001|Overall Study|Protocol Violation|12|||
16322621|NCT00474045|39667541|FG000|Overall Study|Withdrawal by Subject|16|||
16322622|NCT00474045|39667542|FG001|Overall Study|Withdrawal by Subject|18|||
16322623|NCT00474045|39667541|FG000|Overall Study|Withdrawal criteria|60|||
16322624|NCT00474045|39667542|FG001|Overall Study|Withdrawal criteria|50|||
16322625|NCT02632409|39667553|FG000|Randomized|AE unrelated to study Drug|0|||
16395526|NCT02689206|39928283|FG002|Overall Study|Physician Decision|0|||
16204049|NCT01357980|39223191|FG001|Overall Study|Consent withdrawn|0|||
16204050|NCT01357980|39223192|FG002|Overall Study|Consent withdrawn|1|||
16204051|NCT01357980|39223193|FG003|Overall Study|Consent withdrawn|0|||
16204052|NCT00270998|39223194|FG000|3 Month Follow-up|Adverse Event|1|||
16204053|NCT00270998|39223195|FG001|3 Month Follow-up|Adverse Event|0|||
16204054|NCT00270998|39223196|FG002|3 Month Follow-up|Adverse Event|0|||
16204055|NCT00270998|39223194|FG000|3 Month Follow-up|Lack of Efficacy|1|||
16204056|NCT00270998|39223195|FG001|3 Month Follow-up|Lack of Efficacy|2|||
16322626|NCT02632409|39667554|FG001|Randomized|AE unrelated to study Drug|1|||
16204057|NCT00270998|39223196|FG002|3 Month Follow-up|Lack of Efficacy|1|||
16204058|NCT00270998|39223194|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
16204059|NCT00270998|39223195|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
16204060|NCT00270998|39223196|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
16204061|NCT00270998|39223194|FG000|3 Month Follow-up|Pessary did not fit|12|||
16204062|NCT00270998|39223195|FG001|3 Month Follow-up|Pessary did not fit|0|||
16204063|NCT00270998|39223196|FG002|3 Month Follow-up|Pessary did not fit|0|||
16204064|NCT00270998|39223194|FG000|3 Month Follow-up|Personal/family health|1|||
16204065|NCT00270998|39223195|FG001|3 Month Follow-up|Personal/family health|1|||
16204066|NCT00270998|39223196|FG002|3 Month Follow-up|Personal/family health|0|||
16204067|NCT00270998|39223194|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
16204068|NCT00270998|39223195|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
16204069|NCT00270998|39223196|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
16204070|NCT00270998|39223194|FG000|12 Month Follow-up|Lack of Efficacy|5|||
16204071|NCT00270998|39223195|FG001|12 Month Follow-up|Lack of Efficacy|4|||
16204072|NCT00270998|39223196|FG002|12 Month Follow-up|Lack of Efficacy|3|||
16204073|NCT00270998|39223194|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
16204074|NCT00270998|39223195|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
16204075|NCT00270998|39223196|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
16204076|NCT00270998|39223194|FG000|12 Month Follow-up|Pessary did not fit|1|||
16204077|NCT00270998|39223195|FG001|12 Month Follow-up|Pessary did not fit|0|||
16204078|NCT00270998|39223196|FG002|12 Month Follow-up|Pessary did not fit|0|||
16204079|NCT00270998|39223194|FG000|12 Month Follow-up|Personal/family health|0|||
16204080|NCT00270998|39223195|FG001|12 Month Follow-up|Personal/family health|5|||
16204081|NCT00270998|39223196|FG002|12 Month Follow-up|Personal/family health|1|||
16204082|NCT00270998|39223194|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
16204083|NCT00270998|39223195|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
16204084|NCT00270998|39223196|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
16204085|NCT03986190|39223197|FG000|Overall Study|Withdrawal by Subject|12|||
16204086|NCT03986190|39223198|FG001|Overall Study|Withdrawal by Subject|0|||
16204087|NCT00603733|39223199|FG000|Active Phase ITT|Adverse Event|8|||
16204088|NCT00603733|39223200|FG001|Active Phase ITT|Adverse Event|7|||
16204089|NCT00603733|39223199|FG000|Active Phase ITT|Withdrawal by Subject|0|||
16204090|NCT00603733|39223200|FG001|Active Phase ITT|Withdrawal by Subject|3|||
16204091|NCT00603733|39223199|FG000|Active Phase ITT|Lost to Follow-up|0|||
16204092|NCT00603733|39223200|FG001|Active Phase ITT|Lost to Follow-up|1|||
16204093|NCT00603733|39223199|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
16204094|NCT00603733|39223200|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
16204095|NCT00603733|39223199|FG000|Active Phase ITT|Lack of Efficacy|1|||
16204096|NCT00603733|39223200|FG001|Active Phase ITT|Lack of Efficacy|2|||
16204097|NCT00603733|39223199|FG000|Active Phase ITT|Subject moved, site closed|1|||
16517839|NCT00813761|40364991|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
16204098|NCT00603733|39223200|FG001|Active Phase ITT|Subject moved, site closed|1|||
16204099|NCT00603733|39223199|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
16322627|NCT02632409|39667553|FG000|Randomized|Participant withdrew consent|2|||
16322628|NCT02632409|39667554|FG001|Randomized|Participant withdrew consent|1|||
16322629|NCT02632409|39667553|FG000|Randomized|No Longer meets study criteria|5|||
16322630|NCT02632409|39667554|FG001|Randomized|No Longer meets study criteria|0|||
16322631|NCT02632409|39667553|FG000|Randomized|other reasons|1|||
16322632|NCT02632409|39667554|FG001|Randomized|other reasons|0|||
16322633|NCT02632409|39667553|FG000|Treatment Period|Ongoing Treatment|20|||
16322634|NCT02632409|39667554|FG001|Treatment Period|Ongoing Treatment|21|||
16204100|NCT00603733|39223200|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
16204101|NCT00603733|39223199|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
16204102|NCT00603733|39223200|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
16204103|NCT00603733|39223199|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
16204104|NCT00603733|39223200|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
16204105|NCT00603733|39223199|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
16204106|NCT00603733|39223200|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
16204107|NCT00603733|39223199|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
16204108|NCT00603733|39223200|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
16204109|NCT00603733|39223199|FG000|Maintenance Phase ITT|Adverse Event|3|||
16204110|NCT00603733|39223200|FG001|Maintenance Phase ITT|Adverse Event|6|||
16204111|NCT00603733|39223199|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
16322635|NCT02632409|39667553|FG000|Treatment Period|Disease Recurrence|147|||
16517840|NCT00813761|40364988|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
16395527|NCT02689206|39928284|FG003|Overall Study|Physician Decision|0|||
16204112|NCT00603733|39223200|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
16204113|NCT00603733|39223199|FG000|Maintenance Phase ITT|Protocol Violation|1|||
16204114|NCT00603733|39223200|FG001|Maintenance Phase ITT|Protocol Violation|1|||
16204115|NCT00603733|39223199|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
16204116|NCT00603733|39223200|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
16204117|NCT00603733|39223199|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
16204118|NCT00603733|39223200|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
16204119|NCT00603733|39223199|FG000|Maintenance Phase ITT|Physician Decision|0|||
16204120|NCT00603733|39223200|FG001|Maintenance Phase ITT|Physician Decision|1|||
16204121|NCT00603733|39223199|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
16204122|NCT00603733|39223200|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
16204123|NCT02228564|39223201|FG000|Overall Study|Withdrawal by Subject|10|||
16204124|NCT02228564|39223201|FG000|Overall Study|Death|11|||
16204125|NCT02228564|39223201|FG000|Overall Study|Physician Decision|5|||
16204126|NCT02228564|39223201|FG000|Overall Study|Lost to Follow-up|17|||
16204127|NCT02228564|39223201|FG000|Overall Study|Other|6|||
16204128|NCT01181102|39223202|FG000|Overall Study|Adverse Event|28|||
16204129|NCT01181102|39223203|FG001|Overall Study|Adverse Event|26|||
16204130|NCT01181102|39223202|FG000|Overall Study|Lack of Efficacy|3|||
16204131|NCT01181102|39223203|FG001|Overall Study|Lack of Efficacy|1|||
16204132|NCT01181102|39223202|FG000|Overall Study|Lost to Follow-up|2|||
16204133|NCT01181102|39223203|FG001|Overall Study|Lost to Follow-up|0|||
16204134|NCT01181102|39223202|FG000|Overall Study|Physician Decision|3|||
16204135|NCT01181102|39223203|FG001|Overall Study|Physician Decision|1|||
16204136|NCT01181102|39223202|FG000|Overall Study|Protocol Violation|5|||
16204137|NCT01181102|39223203|FG001|Overall Study|Protocol Violation|6|||
16204138|NCT01181102|39223202|FG000|Overall Study|Withdrawal by Subject|10|||
16204139|NCT01181102|39223203|FG001|Overall Study|Withdrawal by Subject|12|||
16204140|NCT04511819|39223204|FG000|Overall Study|Non-compliance with study drug|5|||
16204141|NCT04511819|39223205|FG001|Overall Study|Non-compliance with study drug|1|||
16204142|NCT04511819|39223204|FG000|Overall Study|Withdrawal by Subject|0|||
16204143|NCT04511819|39223205|FG001|Overall Study|Withdrawal by Subject|3|||
16204144|NCT04511819|39223204|FG000|Overall Study|Adverse Event|0|||
16204145|NCT04511819|39223205|FG001|Overall Study|Adverse Event|1|||
16204146|NCT04511819|39223204|FG000|Overall Study|Protocol deviation|1|||
16204147|NCT04511819|39223205|FG001|Overall Study|Protocol deviation|0|||
16204148|NCT03341923|39223206|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
16204149|NCT03341923|39223207|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
16204150|NCT03310580|39223210|FG000|Overall Study|Adverse Event|0|||
16204151|NCT03310580|39223211|FG001|Overall Study|Adverse Event|1|||
16204152|NCT03310580|39223212|FG002|Overall Study|Adverse Event|0|||
16204153|NCT00179517|39226007|FG000|Overall Study|Withdrawal by Subject|2|||
16322636|NCT02632409|39667554|FG001|Treatment Period|Disease Recurrence|90|||
16322637|NCT02632409|39667553|FG000|Treatment Period|Study Drug Toxicity|8|||
16322638|NCT02632409|39667554|FG001|Treatment Period|Study Drug Toxicity|49|||
16322639|NCT02632409|39667553|FG000|Treatment Period|Death|1|||
16322640|NCT02632409|39667554|FG001|Treatment Period|Death|0|||
16322641|NCT02632409|39667553|FG000|Treatment Period|AE unrelated to study drug|15|||
16322642|NCT02632409|39667554|FG001|Treatment Period|AE unrelated to study drug|16|||
16322643|NCT02632409|39667553|FG000|Treatment Period|Request to discontinue treatment|4|||
16517841|NCT00813761|40364989|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
16517842|NCT00813761|40364990|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
16517843|NCT00813761|40364991|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
16517844|NCT00813761|40364988|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
16517845|NCT00813761|40364989|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
16517846|NCT00813761|40364990|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
16517847|NCT00813761|40364991|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
16517848|NCT02103478|40364992|FG000|Overall Study|Adverse Event|0|||
16517849|NCT02103478|40364993|FG001|Overall Study|Adverse Event|0|||
16517850|NCT02103478|40364994|FG002|Overall Study|Adverse Event|1|||
16517851|NCT02103478|40364995|FG003|Overall Study|Adverse Event|1|||
16204154|NCT00179517|39226008|FG001|Overall Study|Withdrawal by Subject|1|||
16204155|NCT00376246|39226013|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
16204156|NCT00376246|39226014|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
16204157|NCT00376246|39226013|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
16204158|NCT00376246|39226014|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
16322644|NCT02632409|39667554|FG001|Treatment Period|Request to discontinue treatment|19|||
16322645|NCT02632409|39667553|FG000|Treatment Period|Participant withdrew consent|7|||
16322646|NCT02632409|39667554|FG001|Treatment Period|Participant withdrew consent|5|||
16322647|NCT02632409|39667553|FG000|Treatment Period|Lost to Follow-up|0|||
16517852|NCT02103478|40364996|FG004|Overall Study|Adverse Event|2|||
16517853|NCT02103478|40364997|FG005|Overall Study|Adverse Event|1|||
16517854|NCT02103478|40364998|FG006|Overall Study|Adverse Event|0|||
16204159|NCT00376246|39226013|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
16204160|NCT00376246|39226014|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16204161|NCT03820726|39226019|FG000|Overall Study|Other than listed|23|||
16204162|NCT03820726|39226019|FG000|Overall Study|Withdrawal by Subject|37|||
16204163|NCT03820726|39226019|FG000|Overall Study|Lost to Follow-up|3|||
16204164|NCT03820726|39226019|FG000|Overall Study|Protocol deviation|1|||
16204165|NCT03820726|39226019|FG000|Overall Study|Adverse Event|146|||
16204166|NCT03820726|39226019|FG000|Overall Study|Not treated|1|||
16204167|NCT00085917|39226020|FG000|Overall Study|Adverse Event|4|||
16204168|NCT00085917|39226021|FG001|Overall Study|Adverse Event|3|||
16204169|NCT01360762|39226022|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
16204170|NCT01360762|39226022|FG000|Main Study Period (12-month Treatment)|Death|5|||
16204171|NCT01360762|39226022|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
16204172|NCT01360762|39226022|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
16204173|NCT01360762|39226022|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
16204174|NCT01360762|39226022|FG000|Whole Study Period|Lost to Follow-up|10|||
16204175|NCT01360762|39226022|FG000|Whole Study Period|Death|7|||
16204176|NCT01360762|39226022|FG000|Whole Study Period|Patient relapsed|18|||
16204177|NCT01360762|39226022|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
16204178|NCT02574481|39226027|FG000|Overall Study|Withdrawal by Subject|29|||
16204179|NCT02574481|39226028|FG001|Overall Study|Withdrawal by Subject|15|||
16204180|NCT02574481|39226029|FG002|Overall Study|Withdrawal by Subject|4|||
16204181|NCT02574481|39226030|FG003|Overall Study|Withdrawal by Subject|1|||
16204182|NCT02574481|39226027|FG000|Overall Study|Adverse Event|5|||
16204183|NCT02574481|39226028|FG001|Overall Study|Adverse Event|1|||
16204184|NCT02574481|39226029|FG002|Overall Study|Adverse Event|1|||
16204185|NCT02574481|39226030|FG003|Overall Study|Adverse Event|0|||
16204186|NCT02574481|39226027|FG000|Overall Study|Visit Missed|15|||
16204187|NCT02574481|39226028|FG001|Overall Study|Visit Missed|7|||
16204188|NCT02574481|39226029|FG002|Overall Study|Visit Missed|5|||
16204189|NCT02574481|39226030|FG003|Overall Study|Visit Missed|0|||
16204190|NCT02574481|39226027|FG000|Overall Study|Other|7|||
16204191|NCT02574481|39226028|FG001|Overall Study|Other|2|||
16204192|NCT02574481|39226029|FG002|Overall Study|Other|0|||
16204193|NCT02574481|39226030|FG003|Overall Study|Other|0|||
16204194|NCT02574481|39226027|FG000|Overall Study|Death|48|||
16204195|NCT02574481|39226028|FG001|Overall Study|Death|26|||
16204196|NCT02574481|39226029|FG002|Overall Study|Death|12|||
16204197|NCT02574481|39226030|FG003|Overall Study|Death|4|||
16204198|NCT02574481|39226027|FG000|Overall Study|Physician Decision|5|||
16204199|NCT02574481|39226028|FG001|Overall Study|Physician Decision|2|||
16204200|NCT02574481|39226029|FG002|Overall Study|Physician Decision|0|||
16204201|NCT02574481|39226030|FG003|Overall Study|Physician Decision|0|||
16204202|NCT02574481|39226027|FG000|Overall Study|Lost to Follow-up|5|||
16204203|NCT02574481|39226028|FG001|Overall Study|Lost to Follow-up|1|||
16204204|NCT02574481|39226029|FG002|Overall Study|Lost to Follow-up|3|||
16204205|NCT02574481|39226030|FG003|Overall Study|Lost to Follow-up|0|||
16204206|NCT01188538|39226031|FG000|Overall Study|Lost to Follow-up|0|||
16204207|NCT01188538|39226032|FG001|Overall Study|Lost to Follow-up|1|||
16204208|NCT00205699|39226035|FG000|Overall Study|Lost to Follow-up|1|||
16517855|NCT02103478|40364999|FG007|Overall Study|Adverse Event|0|||
16517856|NCT02103478|40365000|FG008|Overall Study|Adverse Event|0|||
16517857|NCT02103478|40364992|FG000|Overall Study|Death|2|||
16517858|NCT02103478|40364993|FG001|Overall Study|Death|2|||
16517859|NCT02103478|40364994|FG002|Overall Study|Death|1|||
16517860|NCT02103478|40364995|FG003|Overall Study|Death|1|||
16517861|NCT02103478|40364996|FG004|Overall Study|Death|5|||
16517862|NCT02103478|40364997|FG005|Overall Study|Death|15|||
16517863|NCT02103478|40364998|FG006|Overall Study|Death|14|||
16517864|NCT02103478|40364999|FG007|Overall Study|Death|10|||
16517865|NCT02103478|40365000|FG008|Overall Study|Death|11|||
16517866|NCT02103478|40364992|FG000|Overall Study|Progressive Disease|2|||
16204209|NCT00205699|39226036|FG001|Overall Study|Lost to Follow-up|3|||
16204210|NCT00205699|39226037|FG002|Overall Study|Lost to Follow-up|5|||
16204211|NCT00205699|39226035|FG000|Overall Study|Adverse Event|1|||
16204212|NCT00205699|39226036|FG001|Overall Study|Adverse Event|0|||
16204213|NCT00205699|39226037|FG002|Overall Study|Adverse Event|0|||
16204214|NCT00205699|39226035|FG000|Overall Study|Withdrawal by Subject|1|||
16204215|NCT00205699|39226036|FG001|Overall Study|Withdrawal by Subject|2|||
16204216|NCT00205699|39226037|FG002|Overall Study|Withdrawal by Subject|1|||
16204217|NCT00205699|39226035|FG000|Overall Study|Lack of Efficacy|0|||
16204218|NCT00205699|39226036|FG001|Overall Study|Lack of Efficacy|1|||
16204219|NCT00205699|39226037|FG002|Overall Study|Lack of Efficacy|0|||
16204220|NCT02514772|39226038|FG000|Overall Study|Adverse Event|1|||
16204221|NCT02514772|39226039|FG001|Overall Study|Adverse Event|0|||
16204222|NCT02514772|39226038|FG000|Overall Study|Death|0|||
16517867|NCT02103478|40364993|FG001|Overall Study|Progressive Disease|1|||
16517868|NCT02103478|40364994|FG002|Overall Study|Progressive Disease|2|||
16204223|NCT02514772|39226039|FG001|Overall Study|Death|1|||
16517869|NCT02103478|40364995|FG003|Overall Study|Progressive Disease|0|||
16204224|NCT02514772|39226038|FG000|Overall Study|Withdrawal by Subject|2|||
16204225|NCT02514772|39226039|FG001|Overall Study|Withdrawal by Subject|1|||
16204226|NCT03034057|39226041|FG000|Overall Study|Withdrawal by Subject|10|||
16204227|NCT03034057|39226041|FG000|Overall Study|Protocol Violation|1|||
16204228|NCT03034057|39226041|FG000|Overall Study|Not defined|2|||
16204229|NCT03034057|39226041|FG000|Overall Study|Lost to Follow-up|19|||
16204230|NCT03034057|39226041|FG000|Overall Study|Adverse Event|22|||
16204231|NCT03034057|39226041|FG000|Overall Study|Medication error without associated AE|1|||
16204232|NCT03447821|39226042|FG000|Overall Study|Withdrawal by Subject|1|||
16204233|NCT03447821|39226043|FG001|Overall Study|Withdrawal by Subject|1|||
16204234|NCT03447821|39226044|FG002|Overall Study|Withdrawal by Subject|0|||
16204235|NCT03447821|39226042|FG000|Overall Study|Lost to Follow-up|0|||
16204236|NCT03447821|39226043|FG001|Overall Study|Lost to Follow-up|0|||
16204237|NCT03447821|39226044|FG002|Overall Study|Lost to Follow-up|1|||
16204238|NCT02667457|39226045|FG000|Overall Study|Withdrawal by Subject|1|||
16204239|NCT02667457|39226046|FG001|Overall Study|Withdrawal by Subject|0|||
16204240|NCT02667457|39226045|FG000|Overall Study|Other Reason|0|||
16204241|NCT02667457|39226046|FG001|Overall Study|Other Reason|2|||
16204242|NCT02168803|39226047|FG000|Overall Study|Lost to Follow-up|1|||
16204243|NCT02168803|39226048|FG001|Overall Study|Lost to Follow-up|0|||
16204244|NCT02168803|39226049|FG002|Overall Study|Lost to Follow-up|1|||
16204245|NCT02168803|39226047|FG000|Overall Study|Withdrawal by Subject|1|||
16204246|NCT02168803|39226048|FG001|Overall Study|Withdrawal by Subject|1|||
16204247|NCT02168803|39226049|FG002|Overall Study|Withdrawal by Subject|2|||
16204248|NCT02168803|39226047|FG000|Overall Study|Physician Decision|0|||
16204249|NCT02168803|39226048|FG001|Overall Study|Physician Decision|1|||
16204250|NCT02168803|39226049|FG002|Overall Study|Physician Decision|0|||
16204251|NCT02168803|39226047|FG000|Overall Study|Adverse Event|0|||
16204252|NCT02168803|39226048|FG001|Overall Study|Adverse Event|1|||
16204253|NCT02168803|39226049|FG002|Overall Study|Adverse Event|1|||
16204254|NCT02168803|39226047|FG000|Overall Study|Death|0|||
16204255|NCT02168803|39226048|FG001|Overall Study|Death|0|||
16204256|NCT02168803|39226049|FG002|Overall Study|Death|1|||
16204257|NCT02168803|39226047|FG000|Overall Study|Sponsor Decision|0|||
16204258|NCT02168803|39226048|FG001|Overall Study|Sponsor Decision|0|||
16204259|NCT02168803|39226049|FG002|Overall Study|Sponsor Decision|1|||
16204260|NCT02661464|39226050|FG000|Overall Study|Lost to Follow-up|28|||
16204261|NCT02661464|39226051|FG001|Overall Study|Lost to Follow-up|0|||
16204262|NCT02661464|39226052|FG002|Overall Study|Lost to Follow-up|0|||
16204263|NCT02661464|39226053|FG003|Overall Study|Lost to Follow-up|0|||
16204264|NCT02661464|39226050|FG000|Overall Study|Withdrawal by Subject|3|||
16204265|NCT02661464|39226051|FG001|Overall Study|Withdrawal by Subject|1|||
16204266|NCT02661464|39226052|FG002|Overall Study|Withdrawal by Subject|0|||
16204267|NCT02661464|39226053|FG003|Overall Study|Withdrawal by Subject|0|||
16204268|NCT02661464|39226050|FG000|Overall Study|Participants terminated prematurely|288|||
16204269|NCT02661464|39226051|FG001|Overall Study|Participants terminated prematurely|52|||
16204270|NCT02661464|39226052|FG002|Overall Study|Participants terminated prematurely|1|||
16204271|NCT02661464|39226053|FG003|Overall Study|Participants terminated prematurely|1|||
16204272|NCT02661464|39226050|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
16204273|NCT02661464|39226051|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
16204274|NCT02661464|39226052|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
16204275|NCT02661464|39226053|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
16204276|NCT00884221|39226054|FG000|Overall Study|Withdrawal by Subject|0|||
16204277|NCT00884221|39226055|FG001|Overall Study|Withdrawal by Subject|3|||
16204278|NCT00884221|39226054|FG000|Overall Study|Adverse Event|6|||
16204279|NCT00884221|39226055|FG001|Overall Study|Adverse Event|3|||
16204280|NCT00884221|39226054|FG000|Overall Study|Protocol Violation|16|||
16204281|NCT00884221|39226055|FG001|Overall Study|Protocol Violation|13|||
16204282|NCT00884221|39226054|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
16204283|NCT00884221|39226055|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
16204284|NCT01061567|39226056|FG000|Overall Study|Adverse Event|32|||
16204285|NCT01061567|39226056|FG000|Overall Study|Death|2|||
16204286|NCT01061567|39226056|FG000|Overall Study|Lack of Efficacy|3|||
16204287|NCT01061567|39226056|FG000|Overall Study|Lost to Follow-up|24|||
16204288|NCT01061567|39226056|FG000|Overall Study|Protocol Violation|1|||
16204289|NCT01061567|39226056|FG000|Overall Study|Withdrawal by Subject|11|||
16204290|NCT01061567|39226056|FG000|Overall Study|Other reason than stated above|3|||
16204291|NCT01957709|39226057|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
16204292|NCT02910583|39226059|FG000|Overall Study|Withdrawal by Subject|6|||
16204293|NCT02910583|39226060|FG001|Overall Study|Withdrawal by Subject|7|||
16204294|NCT02910583|39226059|FG000|Overall Study|Other, Not Specified|1|||
16204295|NCT02910583|39226060|FG001|Overall Study|Other, Not Specified|0|||
16204296|NCT02580240|39226061|FG000|Overall Study|Physician Decision|2|||
16204297|NCT02580240|39226062|FG001|Overall Study|Physician Decision|0|||
16204298|NCT01998880|39226064|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
16204299|NCT01998880|39226065|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
16204300|NCT01998880|39226064|FG000|Overall Study|Disease Progression|1|||
16204301|NCT01998880|39226065|FG001|Overall Study|Disease Progression|8|||
16204302|NCT01998880|39226064|FG000|Overall Study|Withdrew Consent|2|||
16204303|NCT01998880|39226065|FG001|Overall Study|Withdrew Consent|1|||
16204304|NCT01998880|39226064|FG000|Overall Study|Death|3|||
16204305|NCT01998880|39226065|FG001|Overall Study|Death|6|||
16204306|NCT01998880|39226064|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16204307|NCT01998880|39226065|FG001|Overall Study|Insufficient Therapeutic Response|5|||
16204308|NCT01998880|39226064|FG000|Overall Study|Administrative/Other|1|||
16204309|NCT01998880|39226065|FG001|Overall Study|Administrative/Other|1|||
16204310|NCT01998880|39226064|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
16204311|NCT01998880|39226065|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
16204312|NCT01998880|39226064|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
16204313|NCT01998880|39226065|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
16092576|NCT03136861|38830217|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
16092577|NCT03136861|38830218|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
16092578|NCT03136861|38830219|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
16092579|NCT03136861|38830220|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
16092580|NCT03136861|38830221|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
16092581|NCT03136861|38830222|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
16204314|NCT01998880|39226064|FG000|Overall Study|Did Not Receive Treatment|3|||
16204315|NCT01998880|39226065|FG001|Overall Study|Did Not Receive Treatment|2|||
16204316|NCT00936117|39226068|FG000|Overall Study|Adverse Event|7|||
16204317|NCT00936117|39226068|FG000|Overall Study|Unable to continue oral medication|3|||
16204318|NCT02759562|39226069|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
16204319|NCT02759562|39226070|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
16204320|NCT02759562|39226069|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
16204321|NCT02759562|39226070|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
16204322|NCT00345540|39226071|FG000|Overall Study|Withdrawal by Subject|1|||
16204323|NCT00719953|39226072|FG000|Overall Study|Adverse Event|4|||
16204324|NCT00387348|39226073|FG000|Overall Study|Death|1|||
16204325|NCT00387348|39226074|FG001|Overall Study|Death|1|||
16204326|NCT00387348|39226075|FG002|Overall Study|Death|0|||
16204327|NCT00387348|39226073|FG000|Overall Study|Physician Decision|1|||
16204328|NCT00387348|39226074|FG001|Overall Study|Physician Decision|0|||
16204329|NCT00387348|39226075|FG002|Overall Study|Physician Decision|1|||
16204330|NCT00387348|39226073|FG000|Overall Study|Withdrawal by Subject|0|||
16204331|NCT00387348|39226074|FG001|Overall Study|Withdrawal by Subject|2|||
16204332|NCT00387348|39226075|FG002|Overall Study|Withdrawal by Subject|2|||
16204333|NCT00387348|39226073|FG000|Overall Study|Adverse Event|1|||
16204334|NCT00387348|39226074|FG001|Overall Study|Adverse Event|0|||
16204335|NCT00387348|39226075|FG002|Overall Study|Adverse Event|1|||
16204336|NCT00422903|39226076|FG000|Overall Study|Disease Progression|3|||
16322648|NCT02632409|39667554|FG001|Treatment Period|Lost to Follow-up|1|||
16322649|NCT02632409|39667553|FG000|Treatment Period|Maximum clinical benefit|1|||
16322650|NCT02632409|39667554|FG001|Treatment Period|Maximum clinical benefit|0|||
16322651|NCT02632409|39667553|FG000|Treatment Period|No longer meets study criteria|3|||
16322652|NCT02632409|39667554|FG001|Treatment Period|No longer meets study criteria|0|||
16322653|NCT02632409|39667553|FG000|Treatment Period|Administrative Reason by sponsor|0|||
16322654|NCT02632409|39667554|FG001|Treatment Period|Administrative Reason by sponsor|1|||
16322655|NCT02632409|39667553|FG000|Treatment Period|Other Reasons|10|||
16322656|NCT02632409|39667554|FG001|Treatment Period|Other Reasons|6|||
16322657|NCT01046903|39667557|FG000|Overall Study|Lost to Follow-up|16|||
16322658|NCT01046903|39667557|FG000|Overall Study|Adverse Event|4|||
16322659|NCT01046903|39667557|FG000|Overall Study|Withdrawal by Subject|3|||
16322660|NCT01046903|39667557|FG000|Overall Study|Other|5|||
16322661|NCT01295671|39667560|FG000|Overall Study|Lost to Follow-up|4|||
16322662|NCT01295671|39667561|FG001|Overall Study|Lost to Follow-up|6|||
16322663|NCT01295671|39667562|FG002|Overall Study|Lost to Follow-up|3|||
16322664|NCT01295671|39667560|FG000|Overall Study|Withdrawal by Subject|3|||
16322665|NCT01295671|39667561|FG001|Overall Study|Withdrawal by Subject|1|||
16322666|NCT01295671|39667562|FG002|Overall Study|Withdrawal by Subject|0|||
16322667|NCT00089778|39667564|FG000|Overall Study|Protocol Violation|0|||
16322668|NCT00089778|39667565|FG001|Overall Study|Protocol Violation|0|||
16322669|NCT00089778|39667566|FG002|Overall Study|Protocol Violation|1|||
16322670|NCT01435018|39667576|FG000|Overall Study|Death|37|||
16204337|NCT00422903|39226077|FG001|Overall Study|Disease Progression|1|||
16204338|NCT00422903|39226076|FG000|Overall Study|Adverse Event|0|||
16204339|NCT00422903|39226077|FG001|Overall Study|Adverse Event|2|||
16204340|NCT00422903|39226076|FG000|Overall Study|Informed Consent Withdrawn|1|||
16322671|NCT01435018|39667577|FG001|Overall Study|Death|18|||
16322672|NCT01435018|39667578|FG002|Overall Study|Death|25|||
16322673|NCT01435018|39667576|FG000|Overall Study|Site is closing|4|||
16322674|NCT01435018|39667577|FG001|Overall Study|Site is closing|9|||
16322675|NCT01435018|39667578|FG002|Overall Study|Site is closing|7|||
16322676|NCT01435018|39667576|FG000|Overall Study|Withdrew consent|0|||
16204341|NCT00422903|39226077|FG001|Overall Study|Informed Consent Withdrawn|2|||
16204342|NCT01747811|39226080|FG000|Overall Study|Lack of Efficacy|2|||
16204343|NCT01747811|39226081|FG001|Overall Study|Lack of Efficacy|4|||
16204344|NCT02670915|39226082|FG000|Overall Study|Withdrawal by Subject|0|||
16204345|NCT02670915|39226083|FG001|Overall Study|Withdrawal by Subject|1|||
16204346|NCT02670915|39226084|FG002|Overall Study|Withdrawal by Subject|4|||
16204347|NCT02670915|39226082|FG000|Overall Study|Withdrawal by parent/guardian|4|||
16204348|NCT02670915|39226083|FG001|Overall Study|Withdrawal by parent/guardian|4|||
16204349|NCT02670915|39226084|FG002|Overall Study|Withdrawal by parent/guardian|1|||
16204350|NCT02670915|39226082|FG000|Overall Study|Unclassified|0|||
16204351|NCT02670915|39226083|FG001|Overall Study|Unclassified|3|||
16204352|NCT02670915|39226084|FG002|Overall Study|Unclassified|0|||
16204353|NCT00796003|39226088|FG000|Overall Study|Disease Progression|2|||
16204354|NCT00796003|39226089|FG001|Overall Study|Disease Progression|13|||
16204355|NCT00796003|39226088|FG000|Overall Study|Adverse Event|1|||
16204356|NCT00796003|39226089|FG001|Overall Study|Adverse Event|7|||
16204357|NCT00796003|39226088|FG000|Overall Study|Specified organ function not met|0|||
16204358|NCT00796003|39226089|FG001|Overall Study|Specified organ function not met|1|||
16204359|NCT00796003|39226088|FG000|Overall Study|Physician Decision|0|||
16204360|NCT00796003|39226089|FG001|Overall Study|Physician Decision|4|||
16322677|NCT01435018|39667577|FG001|Overall Study|Withdrew consent|3|||
16322678|NCT01435018|39667578|FG002|Overall Study|Withdrew consent|1|||
16322679|NCT01435018|39667576|FG000|Overall Study|Not willing to adhere to requirements|0|||
16322680|NCT01435018|39667577|FG001|Overall Study|Not willing to adhere to requirements|2|||
16395528|NCT02689206|39928285|FG004|Overall Study|Physician Decision|0|||
16395529|NCT02689206|39928281|FG000|Overall Study|Withdrawal by Subject|1|||
16204361|NCT00796003|39226088|FG000|Overall Study|Withdrawal by Subject|0|||
16322681|NCT01435018|39667578|FG002|Overall Study|Not willing to adhere to requirements|3|||
16322682|NCT01435018|39667576|FG000|Overall Study|Not able to get to clinic|2|||
16322683|NCT01435018|39667577|FG001|Overall Study|Not able to get to clinic|0|||
16322684|NCT01435018|39667578|FG002|Overall Study|Not able to get to clinic|2|||
16322685|NCT01435018|39667576|FG000|Overall Study|Severe debilitation, unable to continue|0|||
16322686|NCT01435018|39667577|FG001|Overall Study|Severe debilitation, unable to continue|0|||
16322687|NCT01435018|39667578|FG002|Overall Study|Severe debilitation, unable to continue|1|||
16322688|NCT01435018|39667576|FG000|Overall Study|Unable to contact participant/parent|1|||
16322689|NCT01435018|39667577|FG001|Overall Study|Unable to contact participant/parent|1|||
16322690|NCT01435018|39667578|FG002|Overall Study|Unable to contact participant/parent|1|||
16322691|NCT01435018|39667576|FG000|Overall Study|Enrollment Violation|0|||
16322692|NCT01435018|39667577|FG001|Overall Study|Enrollment Violation|1|||
16322693|NCT01435018|39667578|FG002|Overall Study|Enrollment Violation|0|||
16322694|NCT01435018|39667576|FG000|Overall Study|Never started chemotherapy|3|||
16322695|NCT01435018|39667577|FG001|Overall Study|Never started chemotherapy|0|||
16322696|NCT01435018|39667578|FG002|Overall Study|Never started chemotherapy|1|||
16322697|NCT01868438|39667579|FG000|First Intervention|Withdrawal by Subject|5|||
16322698|NCT01868438|39667580|FG001|First Intervention|Withdrawal by Subject|1|||
16322699|NCT01868438|39667579|FG000|First Intervention|Lost to Follow-up|2|||
16322700|NCT01868438|39667580|FG001|First Intervention|Lost to Follow-up|3|||
16322701|NCT01868438|39667579|FG000|First Intervention|Meeting the non-redosing criteria|0|||
16322702|NCT01868438|39667580|FG001|First Intervention|Meeting the non-redosing criteria|1|||
16322703|NCT01868438|39667579|FG000|Second Intervention|Adverse Event|3|||
16322704|NCT01868438|39667580|FG001|Second Intervention|Adverse Event|3|||
16322705|NCT02101736|39667583|FG000|Overall Study|Protocol Violation|3|||
16322706|NCT02101736|39667584|FG001|Overall Study|Protocol Violation|0|||
16322707|NCT02101736|39667583|FG000|Overall Study|Withdrawal by Subject|1|||
16322708|NCT02101736|39667584|FG001|Overall Study|Withdrawal by Subject|1|||
16322709|NCT00529308|39667587|FG000|Overall Study|Withdrawal by Subject|1|||
16322710|NCT00529308|39667588|FG001|Overall Study|Withdrawal by Subject|1|||
16322711|NCT02217410|39667589|FG000|Overall Study|Graft Loss|0|||
16322712|NCT02217410|39667590|FG001|Overall Study|Graft Loss|0|||
16322713|NCT02217410|39667591|FG002|Overall Study|Graft Loss|2|||
16322714|NCT02217410|39667589|FG000|Overall Study|Withdrawal by Subject|0|||
16204362|NCT00796003|39226089|FG001|Overall Study|Withdrawal by Subject|1|||
16204363|NCT00796003|39226088|FG000|Overall Study|Other|0|||
16204364|NCT00796003|39226089|FG001|Overall Study|Other|1|||
16204365|NCT00796003|39226088|FG000|Overall Study|Participants Not treated|0|||
16204366|NCT00796003|39226089|FG001|Overall Study|Participants Not treated|2|||
16204367|NCT04671342|39226100|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
16322715|NCT02217410|39667590|FG001|Overall Study|Withdrawal by Subject|0|||
16322716|NCT02217410|39667591|FG002|Overall Study|Withdrawal by Subject|2|||
16322717|NCT02217410|39667589|FG000|Overall Study|Lost to Follow-up|0|||
16322718|NCT02217410|39667590|FG001|Overall Study|Lost to Follow-up|0|||
16322719|NCT02217410|39667591|FG002|Overall Study|Lost to Follow-up|1|||
16395530|NCT02689206|39928282|FG001|Overall Study|Withdrawal by Subject|0|||
16322720|NCT02217410|39667589|FG000|Overall Study|Lack of Efficacy|0|||
16322721|NCT02217410|39667590|FG001|Overall Study|Lack of Efficacy|1|||
16322722|NCT02217410|39667591|FG002|Overall Study|Lack of Efficacy|0|||
16092582|NCT03136861|38830216|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
16092583|NCT03136861|38830217|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
16092584|NCT03136861|38830218|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
16092585|NCT03136861|38830219|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
16092586|NCT03136861|38830220|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
16092587|NCT03136861|38830221|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
16092588|NCT03136861|38830222|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
16322723|NCT02217410|39667589|FG000|Overall Study|Physician Decision|1|||
16322724|NCT02217410|39667590|FG001|Overall Study|Physician Decision|3|||
16322725|NCT02217410|39667591|FG002|Overall Study|Physician Decision|0|||
16322726|NCT01343277|39667604|FG000|Overall Study|Other|3|||
16322727|NCT01343277|39667605|FG001|Overall Study|Other|3|||
16322728|NCT01343277|39667604|FG000|Overall Study|Withdrawal by Subject|18|||
16322729|NCT01343277|39667605|FG001|Overall Study|Withdrawal by Subject|13|||
16322730|NCT01343277|39667604|FG000|Overall Study|Physician Decision|1|||
16322731|NCT01343277|39667605|FG001|Overall Study|Physician Decision|2|||
16322732|NCT01343277|39667604|FG000|Overall Study|Death|10|||
16322733|NCT01343277|39667605|FG001|Overall Study|Death|1|||
16322734|NCT01343277|39667604|FG000|Overall Study|Adverse Event|67|||
16322735|NCT01343277|39667605|FG001|Overall Study|Adverse Event|13|||
16322736|NCT01343277|39667604|FG000|Overall Study|Disease progression|270|||
16322737|NCT01343277|39667605|FG001|Overall Study|Disease progression|138|||
16322738|NCT01343277|39667604|FG000|Overall Study|Randomized not treated|6|||
16204368|NCT04671342|39226100|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
16204369|NCT04671342|39226100|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
16204370|NCT04671342|39226100|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
16517870|NCT02103478|40364996|FG004|Overall Study|Progressive Disease|9|||
16517871|NCT02103478|40364997|FG005|Overall Study|Progressive Disease|1|||
16517872|NCT02103478|40364998|FG006|Overall Study|Progressive Disease|2|||
16092589|NCT03136861|38830216|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
16092590|NCT03136861|38830217|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
16092591|NCT03136861|38830218|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
16092592|NCT03136861|38830219|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
16092593|NCT03136861|38830220|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
16517873|NCT02103478|40364999|FG007|Overall Study|Progressive Disease|0|||
16517874|NCT02103478|40365000|FG008|Overall Study|Progressive Disease|1|||
16517875|NCT02103478|40364992|FG000|Overall Study|Withdrawal by Subject|2|||
16517876|NCT02103478|40364993|FG001|Overall Study|Withdrawal by Subject|0|||
16517877|NCT02103478|40364994|FG002|Overall Study|Withdrawal by Subject|0|||
16517878|NCT02103478|40364995|FG003|Overall Study|Withdrawal by Subject|4|||
16517879|NCT02103478|40364996|FG004|Overall Study|Withdrawal by Subject|0|||
16517880|NCT02103478|40364997|FG005|Overall Study|Withdrawal by Subject|0|||
16517881|NCT02103478|40364998|FG006|Overall Study|Withdrawal by Subject|1|||
16517882|NCT02103478|40364999|FG007|Overall Study|Withdrawal by Subject|1|||
16517883|NCT02103478|40365000|FG008|Overall Study|Withdrawal by Subject|0|||
16517884|NCT02103478|40364992|FG000|Overall Study|Lost to Follow-up|0|||
16517885|NCT02103478|40364993|FG001|Overall Study|Lost to Follow-up|0|||
16517886|NCT02103478|40364994|FG002|Overall Study|Lost to Follow-up|0|||
16517887|NCT02103478|40364995|FG003|Overall Study|Lost to Follow-up|0|||
16517888|NCT02103478|40364996|FG004|Overall Study|Lost to Follow-up|0|||
16517889|NCT02103478|40364997|FG005|Overall Study|Lost to Follow-up|0|||
16517890|NCT02103478|40364998|FG006|Overall Study|Lost to Follow-up|0|||
16517891|NCT02103478|40364999|FG007|Overall Study|Lost to Follow-up|1|||
16517892|NCT02103478|40365000|FG008|Overall Study|Lost to Follow-up|0|||
16517893|NCT02103478|40364992|FG000|Overall Study|Other|1|||
16517894|NCT02103478|40364993|FG001|Overall Study|Other|3|||
16517895|NCT02103478|40364994|FG002|Overall Study|Other|2|||
16517896|NCT02103478|40364995|FG003|Overall Study|Other|0|||
16517897|NCT02103478|40364996|FG004|Overall Study|Other|3|||
16517898|NCT02103478|40364997|FG005|Overall Study|Other|8|||
16517899|NCT02103478|40364998|FG006|Overall Study|Other|8|||
16517900|NCT02103478|40364999|FG007|Overall Study|Other|4|||
16517901|NCT02103478|40365000|FG008|Overall Study|Other|2|||
16517902|NCT00550836|40365009|FG000|Overall Study|Withdrawal by Subject|3|||
16517903|NCT00550836|40365010|FG001|Overall Study|Withdrawal by Subject|9|||
16517904|NCT05204134|40365014|FG000|Overall Study|Withdrawal by Subject|3|||
16517905|NCT05204134|40365014|FG000|Overall Study|Physician Decision|1|||
16517906|NCT02388737|40365015|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
16517907|NCT02388737|40365016|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
16517908|NCT02388737|40365017|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
16517909|NCT02388737|40365015|FG000|Overall Study|Major Protocol Deviation|18|||
16517910|NCT02388737|40365016|FG001|Overall Study|Major Protocol Deviation|25|||
16517911|NCT02388737|40365017|FG002|Overall Study|Major Protocol Deviation|22|||
16517912|NCT02388737|40365015|FG000|Overall Study|Lost to Follow-up|5|||
16517913|NCT02388737|40365016|FG001|Overall Study|Lost to Follow-up|1|||
16517914|NCT02388737|40365017|FG002|Overall Study|Lost to Follow-up|4|||
16517915|NCT02388737|40365015|FG000|Overall Study|Voluntary Withdrawal|10|||
16517916|NCT02388737|40365016|FG001|Overall Study|Voluntary Withdrawal|18|||
16517917|NCT02388737|40365017|FG002|Overall Study|Voluntary Withdrawal|17|||
16517918|NCT02388737|40365015|FG000|Overall Study|Lack of Efficacy|3|||
16517919|NCT02388737|40365016|FG001|Overall Study|Lack of Efficacy|0|||
16517920|NCT02388737|40365017|FG002|Overall Study|Lack of Efficacy|3|||
16517921|NCT02388737|40365015|FG000|Overall Study|Reason Not Specified|5|||
16517922|NCT02388737|40365016|FG001|Overall Study|Reason Not Specified|5|||
16517923|NCT02388737|40365017|FG002|Overall Study|Reason Not Specified|4|||
16517924|NCT04532112|40365018|FG000|Overall Study|Adverse Event|3|||
16517925|NCT04532112|40365019|FG001|Overall Study|Adverse Event|0|||
16517926|NCT00080223|40365021|FG000|Overall Study|Adverse Event|23|||
16517927|NCT00080223|40365021|FG000|Overall Study|Death|21|||
16517928|NCT00080223|40365021|FG000|Overall Study|Withdrawal by Subject|13|||
16517929|NCT00080223|40365021|FG000|Overall Study|Lung Transplantation|9|||
16517930|NCT00080223|40365021|FG000|Overall Study|Non-compliance With Study Treatment|7|||
16517931|NCT00080223|40365021|FG000|Overall Study|Participant unwilling to continue|2|||
16517932|NCT00080223|40365021|FG000|Overall Study|Physician Decision|1|||
16517933|NCT02520531|40365024|FG000|Overall Study|Revision of study device components|2|||
16517934|NCT02520531|40365025|FG001|Overall Study|Revision of study device components|2|||
16517935|NCT02520531|40365024|FG000|Overall Study|Death|1|||
16517936|NCT02520531|40365025|FG001|Overall Study|Death|2|||
16517937|NCT02520531|40365024|FG000|Overall Study|Lost to Follow-up|1|||
16395531|NCT02689206|39928283|FG002|Overall Study|Withdrawal by Subject|1|||
16395532|NCT02689206|39928284|FG003|Overall Study|Withdrawal by Subject|0|||
16395533|NCT02689206|39928285|FG004|Overall Study|Withdrawal by Subject|0|||
16395534|NCT02974140|39928286|FG000|Overall Study|Adverse Event|2|||
16395535|NCT02974140|39928286|FG000|Overall Study|Lost to Follow-up|1|||
16395536|NCT02974140|39928286|FG000|Overall Study|Study Terminated by Sponsor|36|||
16395537|NCT00720356|39928287|FG000|Registration to Study|Determined to have methylated MGMT|67|||
16395538|NCT00720356|39928287|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
16395539|NCT00720356|39928287|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
16395540|NCT00720356|39928287|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
16092594|NCT03136861|38830221|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
16322739|NCT01343277|39667605|FG001|Overall Study|Randomized not treated|21|||
16322740|NCT01343277|39667604|FG000|Overall Study|Treatment ongoing|8|||
16322741|NCT01343277|39667605|FG001|Overall Study|Treatment ongoing|2|||
16322742|NCT01343277|39667604|FG000|Overall Study|Subsequent anticancer therapy|1|||
16322743|NCT01343277|39667605|FG001|Overall Study|Subsequent anticancer therapy|0|||
16322744|NCT01397825|39667606|FG000|Overall Study|Progressive Disease|10|||
16322745|NCT01397825|39667607|FG001|Overall Study|Progressive Disease|3|||
16322746|NCT01397825|39667608|FG002|Overall Study|Progressive Disease|11|||
16322747|NCT01397825|39667609|FG003|Overall Study|Progressive Disease|1|||
16322748|NCT01397825|39667610|FG004|Overall Study|Progressive Disease|0|||
16322749|NCT01397825|39667606|FG000|Overall Study|Symptomatic Deterioration|2|||
16395541|NCT00720356|39928287|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
16322750|NCT01397825|39667607|FG001|Overall Study|Symptomatic Deterioration|0|||
16322751|NCT01397825|39667608|FG002|Overall Study|Symptomatic Deterioration|4|||
16322752|NCT01397825|39667609|FG003|Overall Study|Symptomatic Deterioration|0|||
16322753|NCT01397825|39667610|FG004|Overall Study|Symptomatic Deterioration|0|||
16322754|NCT01397825|39667606|FG000|Overall Study|Adverse Event|0|||
16322755|NCT01397825|39667607|FG001|Overall Study|Adverse Event|1|||
16322756|NCT01397825|39667608|FG002|Overall Study|Adverse Event|5|||
16322757|NCT01397825|39667609|FG003|Overall Study|Adverse Event|1|||
16322758|NCT01397825|39667610|FG004|Overall Study|Adverse Event|0|||
16322759|NCT01397825|39667606|FG000|Overall Study|Withdrawal by Subject|1|||
16322760|NCT01397825|39667607|FG001|Overall Study|Withdrawal by Subject|0|||
16322761|NCT01397825|39667608|FG002|Overall Study|Withdrawal by Subject|5|||
16322762|NCT01397825|39667609|FG003|Overall Study|Withdrawal by Subject|1|||
16322763|NCT01397825|39667610|FG004|Overall Study|Withdrawal by Subject|0|||
16322764|NCT00459290|39667613|FG000|Overall Study|Adverse Event|3|||
16322765|NCT00459290|39667613|FG000|Overall Study|Ineligible|2|||
16322766|NCT04533412|39667615|FG000|Overall Study|Withdrawal by Subject|1|||
16322767|NCT04533412|39667616|FG001|Overall Study|Withdrawal by Subject|1|||
16322768|NCT04533412|39667615|FG000|Overall Study|Lost to Follow-up|1|||
16395542|NCT00720356|39928287|FG000|Follow up Until Death|Withdrawal by Subject|1|||
16395543|NCT00720356|39928287|FG000|Follow up Until Death|Alive at last data collection|4|||
16517938|NCT02520531|40365025|FG001|Overall Study|Lost to Follow-up|1|||
16517939|NCT02520531|40365024|FG000|Overall Study|Meet exclusion criterion|0|||
16517940|NCT02520531|40365025|FG001|Overall Study|Meet exclusion criterion|1|||
16517941|NCT02520531|40365024|FG000|Overall Study|Withdrawal by Subject|1|||
16517942|NCT02520531|40365025|FG001|Overall Study|Withdrawal by Subject|0|||
16517943|NCT02520531|40365024|FG000|Overall Study|Not study device|1|||
16517944|NCT02520531|40365025|FG001|Overall Study|Not study device|0|||
16517945|NCT00691210|40365026|FG000|Overall Study|Progression of Disease|0|||
16517946|NCT00691210|40365027|FG001|Overall Study|Progression of Disease|0|||
16517947|NCT00691210|40365028|FG002|Overall Study|Progression of Disease|0|||
16517948|NCT00691210|40365029|FG003|Overall Study|Progression of Disease|2|||
16517949|NCT00691210|40365030|FG004|Overall Study|Progression of Disease|0|||
16517950|NCT00691210|40365031|FG005|Overall Study|Progression of Disease|0|||
16517951|NCT00691210|40365032|FG006|Overall Study|Progression of Disease|0|||
16517952|NCT00691210|40365033|FG007|Overall Study|Progression of Disease|0|||
16517953|NCT00691210|40365026|FG000|Overall Study|Lack of Efficacy|0|||
16517954|NCT00691210|40365027|FG001|Overall Study|Lack of Efficacy|0|||
16517955|NCT00691210|40365028|FG002|Overall Study|Lack of Efficacy|0|||
16517956|NCT00691210|40365029|FG003|Overall Study|Lack of Efficacy|1|||
16517957|NCT00691210|40365030|FG004|Overall Study|Lack of Efficacy|0|||
16517958|NCT00691210|40365031|FG005|Overall Study|Lack of Efficacy|1|||
16517959|NCT00691210|40365032|FG006|Overall Study|Lack of Efficacy|0|||
16517960|NCT00691210|40365033|FG007|Overall Study|Lack of Efficacy|0|||
16517961|NCT03403634|40365034|FG000|Overall Study|Disease progression|3|||
16517962|NCT03403634|40365034|FG000|Overall Study|Did not meet eligibility criteria|4|||
16517963|NCT00120042|40365035|FG000|Overall Study|all completed protocl|0|||
16517964|NCT00120042|40365036|FG001|Overall Study|all completed protocl|0|||
16322769|NCT04533412|39667616|FG001|Overall Study|Lost to Follow-up|4|||
16322770|NCT03386994|39667617|FG000|Overall Study|Lung transplant|1|||
16322771|NCT03386994|39667617|FG000|Overall Study|Adverse Event|14|||
16322772|NCT03386994|39667617|FG000|Overall Study|Lost to Follow-up|4|||
16322773|NCT03386994|39667617|FG000|Overall Study|Withdrawal by Subject|3|||
16092595|NCT03136861|38830222|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
16092596|NCT03136861|38830216|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
16092597|NCT03136861|38830217|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
16092598|NCT03136861|38830218|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
16204371|NCT04671342|39226100|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
16204372|NCT04671342|39226100|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
16204373|NCT02527148|39226101|FG000|Overall Study|Did not receive study intervention|1|||
16322774|NCT03386994|39667617|FG000|Overall Study|Death|16|||
16322775|NCT01334918|39667621|FG000|Overall Study|Did not receive study drug|6|||
16322776|NCT01334918|39667622|FG001|Overall Study|Did not receive study drug|0|||
16322777|NCT01334918|39667621|FG000|Overall Study|Adverse Event|2|||
16322778|NCT01334918|39667622|FG001|Overall Study|Adverse Event|0|||
16322779|NCT01334918|39667621|FG000|Overall Study|Withdrawal by Subject|0|||
16322780|NCT01334918|39667622|FG001|Overall Study|Withdrawal by Subject|1|||
16322781|NCT01075256|39667623|FG000|Overall Study|Withdrawal by Subject|1|||
16322782|NCT01075256|39667624|FG001|Overall Study|Withdrawal by Subject|0|||
16322783|NCT01075256|39667625|FG002|Overall Study|Withdrawal by Subject|0|||
16322784|NCT03865316|39667626|FG000|Overall Study|Procedure Cancelled|4|||
16322785|NCT03865316|39667626|FG000|Overall Study|Equipment failure|4|||
16322786|NCT00355147|39667627|FG000|Overall Study|Lost to Follow-up|10|||
16322787|NCT00355147|39667628|FG001|Overall Study|Lost to Follow-up|8|||
16322788|NCT00355147|39667627|FG000|Overall Study|Withdrawal by Subject|8|||
16322789|NCT00355147|39667628|FG001|Overall Study|Withdrawal by Subject|12|||
16322790|NCT02275546|39667631|FG000|Treatment Period 2|Withdrawal by Subject|2|||
16322791|NCT02275546|39667632|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16322792|NCT02275546|39667631|FG000|Treatment Period 2|Protocol Violation|0|||
16322793|NCT02275546|39667632|FG001|Treatment Period 2|Protocol Violation|1|||
16322794|NCT00931255|39667633|FG000|Overall Study|Follow up biopsy not done|2|||
16322795|NCT00931255|39667634|FG001|Overall Study|Follow up biopsy not done|3|||
16322796|NCT01340872|39667635|FG000|Double-blind Phase|Adverse Event|6|||
16322797|NCT01340872|39667636|FG001|Double-blind Phase|Adverse Event|4|||
16204374|NCT02527148|39226102|FG001|Overall Study|Did not receive study intervention|0|||
16322798|NCT01340872|39667637|FG002|Double-blind Phase|Adverse Event|0|||
16322799|NCT01340872|39667638|FG003|Double-blind Phase|Adverse Event|0|||
16322800|NCT01340872|39667635|FG000|Double-blind Phase|Withdrawal by Subject|3|||
16322801|NCT01340872|39667636|FG001|Double-blind Phase|Withdrawal by Subject|5|||
16322802|NCT01340872|39667637|FG002|Double-blind Phase|Withdrawal by Subject|0|||
16322803|NCT01340872|39667638|FG003|Double-blind Phase|Withdrawal by Subject|0|||
16322804|NCT01340872|39667635|FG000|Double-blind Phase|Lost to Follow-up|0|||
16322805|NCT01340872|39667636|FG001|Double-blind Phase|Lost to Follow-up|1|||
16322806|NCT01340872|39667637|FG002|Double-blind Phase|Lost to Follow-up|0|||
16322807|NCT01340872|39667638|FG003|Double-blind Phase|Lost to Follow-up|0|||
16517965|NCT00120042|40365037|FG002|Overall Study|all completed protocl|0|||
16517966|NCT03049813|40365038|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
16517967|NCT03049813|40365039|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
16517968|NCT03049813|40365040|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
16517969|NCT03049813|40365041|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
16517970|NCT03049813|40365038|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
16517971|NCT03049813|40365039|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
16517972|NCT03049813|40365040|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
16517973|NCT03049813|40365041|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
16517974|NCT03049813|40365038|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
16517975|NCT03049813|40365039|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
16517976|NCT03049813|40365040|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
16517977|NCT03049813|40365041|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
16517978|NCT03049813|40365038|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
16517979|NCT03049813|40365039|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
16517980|NCT03049813|40365040|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
16517981|NCT03049813|40365041|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
16517982|NCT01976845|40365042|FG000|Overall Study|Physician Decision|8|||
16517983|NCT01976845|40365043|FG001|Overall Study|Physician Decision|8|||
16517984|NCT01976845|40365044|FG002|Overall Study|Physician Decision|3|||
16517985|NCT00912405|40365046|FG000|Overall Study|Lost to Follow-up|5|||
16517986|NCT00983814|40365048|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
16517987|NCT00983814|40365049|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
16517988|NCT00983814|40365050|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
16517989|NCT00983814|40365048|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
16517990|NCT00983814|40365049|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
16517991|NCT00983814|40365050|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
16517992|NCT00983814|40365048|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
16517993|NCT00983814|40365049|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
16517994|NCT00983814|40365050|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
16092599|NCT03136861|38830219|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
16395544|NCT00469833|39928288|FG000|Overall Study|No IV access|2|||
16092600|NCT03136861|38830220|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
16092601|NCT03136861|38830221|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
16204375|NCT00669032|39226103|FG000|Overall Study|Lost to Follow-up|6|||
16204376|NCT00669032|39226104|FG001|Overall Study|Lost to Follow-up|5|||
16322808|NCT01340872|39667635|FG000|Double-blind Phase|Protocol Violation|0|||
16322809|NCT01340872|39667636|FG001|Double-blind Phase|Protocol Violation|1|||
16322810|NCT01340872|39667637|FG002|Double-blind Phase|Protocol Violation|0|||
16322811|NCT01340872|39667638|FG003|Double-blind Phase|Protocol Violation|0|||
16322812|NCT01340872|39667635|FG000|Open-label Phase|Physician Decision|0|||
16322813|NCT01340872|39667636|FG001|Open-label Phase|Physician Decision|0|||
16322814|NCT01340872|39667637|FG002|Open-label Phase|Physician Decision|2|||
16322815|NCT01340872|39667638|FG003|Open-label Phase|Physician Decision|1|||
16322816|NCT01340872|39667635|FG000|Open-label Phase|Pregnancy|0|||
16322817|NCT01340872|39667636|FG001|Open-label Phase|Pregnancy|0|||
16322818|NCT01340872|39667637|FG002|Open-label Phase|Pregnancy|1|||
16322819|NCT01340872|39667638|FG003|Open-label Phase|Pregnancy|0|||
16322820|NCT01340872|39667635|FG000|Open-label Phase|Adverse Event|0|||
16322821|NCT01340872|39667636|FG001|Open-label Phase|Adverse Event|0|||
16092602|NCT03136861|38830222|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
16092603|NCT03136861|38830216|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
16092604|NCT03136861|38830217|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
16092605|NCT03136861|38830218|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
16092606|NCT03136861|38830219|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
16092607|NCT03136861|38830220|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
16092608|NCT03136861|38830221|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
16092609|NCT03136861|38830222|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
16092610|NCT03136861|38830216|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
16092611|NCT03136861|38830217|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
16092612|NCT03136861|38830218|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
16092613|NCT03136861|38830219|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
16092614|NCT03136861|38830220|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
16092615|NCT03136861|38830221|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
16092616|NCT03136861|38830222|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
16092617|NCT03136861|38830216|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
16092618|NCT03136861|38830217|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
16092619|NCT03136861|38830218|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
16092620|NCT03136861|38830219|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
16092621|NCT03136861|38830220|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
16092622|NCT03136861|38830221|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
16092623|NCT03136861|38830222|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
16092624|NCT03406507|38830226|FG000|Extension Period|Lack of Efficacy|0|||
16092625|NCT03406507|38830227|FG001|Extension Period|Lack of Efficacy|1|||
16092626|NCT00316121|38830228|FG000|Overall Study|Death|1|||
16092627|NCT00316121|38830229|FG001|Overall Study|Death|0|||
16092628|NCT00316121|38830228|FG000|Overall Study|Lost to Follow-up|14|||
16092629|NCT00316121|38830229|FG001|Overall Study|Lost to Follow-up|8|||
16092630|NCT00316121|38830228|FG000|Overall Study|Withdrawal by Subject|2|||
16092631|NCT00316121|38830229|FG001|Overall Study|Withdrawal by Subject|0|||
16092632|NCT00316121|38830228|FG000|Overall Study|Reason is missing|1|||
16092633|NCT00316121|38830229|FG001|Overall Study|Reason is missing|0|||
16092634|NCT00316121|38830228|FG000|Overall Study|Subject relocated|1|||
16092635|NCT00316121|38830229|FG001|Overall Study|Subject relocated|1|||
16092636|NCT00316121|38830228|FG000|Overall Study|Subject refused to return|1|||
16092637|NCT00316121|38830229|FG001|Overall Study|Subject refused to return|0|||
16092638|NCT00316121|38830228|FG000|Overall Study|Subject no show for visit x 3|1|||
16092639|NCT00316121|38830229|FG001|Overall Study|Subject no show for visit x 3|0|||
16092640|NCT00316121|38830228|FG000|Overall Study|Subject did not have 24 month visit|1|||
16092641|NCT00316121|38830229|FG001|Overall Study|Subject did not have 24 month visit|0|||
16092642|NCT00886834|38830231|FG000|Overall Study|Protocol Violation|0|||
16092643|NCT00886834|38830232|FG001|Overall Study|Protocol Violation|3|||
16322822|NCT01340872|39667637|FG002|Open-label Phase|Adverse Event|8|||
16322823|NCT01340872|39667638|FG003|Open-label Phase|Adverse Event|4|||
16395545|NCT00780143|39928290|FG000|Overall Study|Progressive disease|1|||
16092644|NCT02889900|38830233|FG000|Overall Study|Adverse Event|11|||
16092645|NCT02889900|38830233|FG000|Overall Study|Condition under investigation worsened|32|||
16092646|NCT02889900|38830233|FG000|Overall Study|Other|5|||
16092647|NCT02889900|38830233|FG000|Overall Study|Withdrawal by Subject|7|||
16322824|NCT01340872|39667635|FG000|Open-label Phase|Withdrawal by Subject|0|||
16395546|NCT00780143|39928290|FG000|Overall Study|Toxicity|1|||
16092648|NCT02889900|38830233|FG000|Overall Study|Not treated|2|||
16092649|NCT00220805|38830234|FG000|Overall Study|Adverse Event|1|||
16092650|NCT00220805|38830235|FG001|Overall Study|Adverse Event|3|||
16092651|NCT00220805|38830234|FG000|Overall Study|Withdrawal by Subject|3|||
16092652|NCT00220805|38830235|FG001|Overall Study|Withdrawal by Subject|0|||
16092653|NCT00220805|38830234|FG000|Overall Study|Lack of Efficacy|1|||
16092654|NCT00220805|38830235|FG001|Overall Study|Lack of Efficacy|0|||
16092655|NCT00220805|38830234|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
16092656|NCT00220805|38830235|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
16092657|NCT03692871|38830238|FG000|Overall Study|Death|1|||
16092658|NCT03692871|38830239|FG001|Overall Study|Death|1|||
16092659|NCT03692871|38830238|FG000|Overall Study|Lost to Follow-up|24|||
16092660|NCT03692871|38830239|FG001|Overall Study|Lost to Follow-up|9|||
16092661|NCT03692871|38830238|FG000|Overall Study|Physician Decision|22|||
16517995|NCT00983814|40365048|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
16517996|NCT00983814|40365049|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
16092662|NCT03692871|38830239|FG001|Overall Study|Physician Decision|7|||
16092663|NCT03692871|38830238|FG000|Overall Study|Protocol Deviation|1|||
16092664|NCT03692871|38830239|FG001|Overall Study|Protocol Deviation|0|||
16092665|NCT03692871|38830238|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
16092666|NCT03692871|38830239|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
16092667|NCT03031782|38830242|FG000|Treatment Period 1|Lack of Efficacy|3|||
16092668|NCT03031782|38830243|FG001|Treatment Period 1|Lack of Efficacy|0|||
16092669|NCT03031782|38830244|FG002|Treatment Period 1|Lack of Efficacy|0|||
16092670|NCT03031782|38830245|FG003|Treatment Period 1|Lack of Efficacy|0|||
16092671|NCT03031782|38830246|FG004|Treatment Period 1|Lack of Efficacy|0|||
16092672|NCT03031782|38830242|FG000|Treatment Period 2|Physician Decision|0|||
16092673|NCT03031782|38830243|FG001|Treatment Period 2|Physician Decision|1|||
16092674|NCT03031782|38830244|FG002|Treatment Period 2|Physician Decision|0|||
16092675|NCT03031782|38830245|FG003|Treatment Period 2|Physician Decision|0|||
16092676|NCT03031782|38830246|FG004|Treatment Period 2|Physician Decision|3|||
16092677|NCT03031782|38830242|FG000|Treatment Period 2|Lack of Efficacy|0|||
16092678|NCT03031782|38830243|FG001|Treatment Period 2|Lack of Efficacy|1|||
16092679|NCT03031782|38830244|FG002|Treatment Period 2|Lack of Efficacy|0|||
16092680|NCT03031782|38830245|FG003|Treatment Period 2|Lack of Efficacy|0|||
16092681|NCT03031782|38830246|FG004|Treatment Period 2|Lack of Efficacy|1|||
16092682|NCT03031782|38830242|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16092683|NCT03031782|38830243|FG001|Treatment Period 2|Withdrawal by Subject|3|||
16092684|NCT03031782|38830244|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16092685|NCT03031782|38830245|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16092686|NCT03031782|38830246|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16092687|NCT03031782|38830242|FG000|Treatment Period 2|Adverse Event|0|||
16517997|NCT00983814|40365050|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
16517998|NCT00983814|40365048|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
16517999|NCT00983814|40365049|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
16518000|NCT00983814|40365050|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
16518001|NCT00325234|40365051|FG000|Overall Study|Adverse Event|10|||
16518002|NCT00325234|40365052|FG001|Overall Study|Adverse Event|7|||
16518003|NCT00325234|40365051|FG000|Overall Study|Death due to Study Disease|1|||
16092688|NCT03031782|38830243|FG001|Treatment Period 2|Adverse Event|1|||
16092689|NCT03031782|38830244|FG002|Treatment Period 2|Adverse Event|2|||
16092690|NCT03031782|38830245|FG003|Treatment Period 2|Adverse Event|0|||
16092691|NCT03031782|38830246|FG004|Treatment Period 2|Adverse Event|0|||
16092692|NCT03031782|38830242|FG000|Treatment Period 3|Withdrawal by Subject|0|||
16092693|NCT03031782|38830243|FG001|Treatment Period 3|Withdrawal by Subject|0|||
16092694|NCT03031782|38830244|FG002|Treatment Period 3|Withdrawal by Subject|0|||
16092695|NCT03031782|38830245|FG003|Treatment Period 3|Withdrawal by Subject|1|||
16092696|NCT03031782|38830246|FG004|Treatment Period 3|Withdrawal by Subject|0|||
16092697|NCT01562275|38830247|FG000|Stage 1|Adverse Event|0|||
16092698|NCT01562275|38830248|FG001|Stage 1|Adverse Event|0|||
16092699|NCT01562275|38830249|FG002|Stage 1|Adverse Event|0|||
16092700|NCT01562275|38830250|FG003|Stage 1|Adverse Event|1|||
16518004|NCT00325234|40365052|FG001|Overall Study|Death due to Study Disease|0|||
16092701|NCT01562275|38830251|FG004|Stage 1|Adverse Event|1|||
16092702|NCT01562275|38830252|FG005|Stage 1|Adverse Event|0|||
16518005|NCT00325234|40365051|FG000|Overall Study|Entry Criteria Not Met|1|||
16092703|NCT01562275|38830253|FG006|Stage 1|Adverse Event|0|||
16092704|NCT01562275|38830254|FG007|Stage 1|Adverse Event|0|||
16092705|NCT01562275|38830255|FG008|Stage 1|Adverse Event|0|||
16092706|NCT01562275|38830256|FG009|Stage 1|Adverse Event|1|||
16092707|NCT01562275|38830257|FG010|Stage 1|Adverse Event|0|||
16092708|NCT01562275|38830258|FG011|Stage 1|Adverse Event|0|||
16092709|NCT01562275|38830259|FG012|Stage 1|Adverse Event|0|||
16092710|NCT01562275|38830247|FG000|Stage 1|Death|1|||
16092711|NCT01562275|38830248|FG001|Stage 1|Death|0|||
16092712|NCT01562275|38830249|FG002|Stage 1|Death|0|||
16092713|NCT01562275|38830250|FG003|Stage 1|Death|0|||
16092714|NCT01562275|38830251|FG004|Stage 1|Death|0|||
16092715|NCT01562275|38830252|FG005|Stage 1|Death|0|||
16322825|NCT01340872|39667636|FG001|Open-label Phase|Withdrawal by Subject|0|||
16322826|NCT01340872|39667637|FG002|Open-label Phase|Withdrawal by Subject|1|||
16322827|NCT01340872|39667638|FG003|Open-label Phase|Withdrawal by Subject|6|||
16518006|NCT00325234|40365052|FG001|Overall Study|Entry Criteria Not Met|2|||
16518007|NCT00325234|40365051|FG000|Overall Study|Subject Decision|6|||
16322828|NCT01340872|39667635|FG000|Open-label Phase|Worsening of IBD|0|||
16322829|NCT01340872|39667636|FG001|Open-label Phase|Worsening of IBD|0|||
16322830|NCT01340872|39667637|FG002|Open-label Phase|Worsening of IBD|1|||
16322831|NCT01340872|39667638|FG003|Open-label Phase|Worsening of IBD|0|||
16322832|NCT01122394|39667639|FG000|Overall Study|Withdrawal by Subject|1|||
16322833|NCT01122394|39667640|FG001|Overall Study|Withdrawal by Subject|1|||
16322834|NCT01122394|39667639|FG000|Overall Study|Lost to Follow-up|2|||
16322835|NCT01122394|39667640|FG001|Overall Study|Lost to Follow-up|2|||
16322836|NCT01122394|39667639|FG000|Overall Study|Adverse Event|0|||
16322837|NCT01122394|39667640|FG001|Overall Study|Adverse Event|1|||
16322838|NCT00039871|39667643|FG000|Overall Study|Adverse Event|165|||
16322839|NCT00039871|39667643|FG000|Overall Study|Lost to Follow-up|18|||
16322840|NCT00039871|39667643|FG000|Overall Study|Protocol Violation|24|||
16322841|NCT00039871|39667643|FG000|Overall Study|Withdrawal by Subject|97|||
16322842|NCT00039871|39667643|FG000|Overall Study|Did not meet eligibility criteria|11|||
16322843|NCT00039871|39667643|FG000|Overall Study|Administrative|1|||
16322844|NCT00039871|39667643|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
16322845|NCT00039871|39667643|FG000|Overall Study|Never entered follow-up|7|||
16322846|NCT01857583|39667649|FG000|Overall Study|Adverse Event|0|||
16322847|NCT01857583|39667650|FG001|Overall Study|Adverse Event|0|||
16322848|NCT01857583|39667651|FG002|Overall Study|Adverse Event|1|||
16322849|NCT01857583|39667652|FG003|Overall Study|Adverse Event|1|||
16322850|NCT01857583|39667649|FG000|Overall Study|Death|0|||
16322851|NCT01857583|39667650|FG001|Overall Study|Death|1|||
16322852|NCT01857583|39667651|FG002|Overall Study|Death|1|||
16322853|NCT01857583|39667652|FG003|Overall Study|Death|0|||
16518008|NCT00325234|40365052|FG001|Overall Study|Subject Decision|8|||
16518009|NCT00325234|40365051|FG000|Overall Study|Physician Decision|17|||
16518010|NCT00325234|40365052|FG001|Overall Study|Physician Decision|12|||
16518011|NCT00325234|40365051|FG000|Overall Study|Progressive Disease|34|||
16518012|NCT00325234|40365052|FG001|Overall Study|Progressive Disease|37|||
16518013|NCT03495908|40365054|FG000|Overall Study|Withdrawal by Subject|3|||
16518014|NCT03495908|40365055|FG001|Overall Study|Withdrawal by Subject|1|||
16518015|NCT03495908|40365054|FG000|Overall Study|Lost to Follow-up|1|||
16518016|NCT03495908|40365055|FG001|Overall Study|Lost to Follow-up|4|||
16518017|NCT03495908|40365054|FG000|Overall Study|Adverse Event|0|||
16518018|NCT03495908|40365055|FG001|Overall Study|Adverse Event|2|||
16518019|NCT03495908|40365054|FG000|Overall Study|Death|1|||
16518020|NCT03495908|40365055|FG001|Overall Study|Death|0|||
16518021|NCT03495908|40365054|FG000|Overall Study|Physician Decision|5|||
16518022|NCT03495908|40365055|FG001|Overall Study|Physician Decision|4|||
16518023|NCT03495908|40365054|FG000|Overall Study|No documented reason|0|||
16518024|NCT03495908|40365055|FG001|Overall Study|No documented reason|2|||
16518025|NCT03228680|40365058|FG000|Overall Study|Adverse Event|13|||
16518026|NCT03228680|40365059|FG001|Overall Study|Adverse Event|18|||
16518027|NCT03228680|40365058|FG000|Overall Study|Randomization failure|0|||
16518028|NCT03228680|40365059|FG001|Overall Study|Randomization failure|1|||
16518029|NCT03228680|40365058|FG000|Overall Study|Withdrawal by Subject|1|||
16518030|NCT03228680|40365059|FG001|Overall Study|Withdrawal by Subject|0|||
16518031|NCT03228680|40365058|FG000|Overall Study|Other|9|||
16518032|NCT03228680|40365059|FG001|Overall Study|Other|16|||
16518033|NCT03364049|40365060|FG000|Overall Study|Death|6|||
16322854|NCT01857583|39667649|FG000|Overall Study|Physician Decision|0|||
16322855|NCT01857583|39667650|FG001|Overall Study|Physician Decision|0|||
16518034|NCT03364049|40365061|FG001|Overall Study|Death|4|||
16518035|NCT03364049|40365062|FG002|Overall Study|Death|5|||
16322856|NCT01857583|39667651|FG002|Overall Study|Physician Decision|0|||
16322857|NCT01857583|39667652|FG003|Overall Study|Physician Decision|1|||
16518036|NCT03364049|40365063|FG003|Overall Study|Death|14|||
16322858|NCT01857583|39667649|FG000|Overall Study|Withdrawal by Subject|1|||
16322859|NCT01857583|39667650|FG001|Overall Study|Withdrawal by Subject|0|||
16322860|NCT01857583|39667651|FG002|Overall Study|Withdrawal by Subject|1|||
16322861|NCT01857583|39667652|FG003|Overall Study|Withdrawal by Subject|2|||
16322862|NCT01068678|39667653|FG000|Overall Study|Lack of Efficacy|3|||
16322863|NCT01068678|39667654|FG001|Overall Study|Lack of Efficacy|2|||
16322864|NCT01068678|39667653|FG000|Overall Study|Protocol Violation|5|||
16322865|NCT01068678|39667654|FG001|Overall Study|Protocol Violation|1|||
16322866|NCT01068678|39667653|FG000|Overall Study|Withdrawal criteria|12|||
16322867|NCT01068678|39667654|FG001|Overall Study|Withdrawal criteria|6|||
16322868|NCT01068678|39667653|FG000|Overall Study|Unclassified|18|||
16322869|NCT01068678|39667654|FG001|Overall Study|Unclassified|15|||
16322870|NCT00090493|39667658|FG000|Overall Study|Physician Decision|2|||
16322871|NCT01085630|39667659|FG000|Overall Study|Insufficient data|1|||
16322872|NCT01085630|39667660|FG001|Overall Study|Insufficient data|0|||
16322873|NCT01085630|39667659|FG000|Overall Study|Ineligible|3|||
16322874|NCT01085630|39667660|FG001|Overall Study|Ineligible|0|||
16322875|NCT03086967|39667666|FG000|Overall Study|Screen Failure|2|||
16322876|NCT03086967|39667667|FG001|Overall Study|Screen Failure|2|||
16322877|NCT00507819|39667670|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
16322878|NCT00507819|39667671|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
16322879|NCT00285207|39667672|FG000|Overall Study|Lost to Follow-up|3|||
16322880|NCT00285207|39667673|FG001|Overall Study|Lost to Follow-up|2|||
16322881|NCT00285207|39667672|FG000|Overall Study|Withdrawal by Subject|5|||
16322882|NCT00285207|39667673|FG001|Overall Study|Withdrawal by Subject|2|||
16322883|NCT00285207|39667672|FG000|Overall Study|Pregnancy|1|||
16322884|NCT00285207|39667673|FG001|Overall Study|Pregnancy|1|||
16322885|NCT00285207|39667672|FG000|Overall Study|non-compliance|0|||
16322886|NCT00285207|39667673|FG001|Overall Study|non-compliance|1|||
16322887|NCT02527434|39667676|FG000|Overall Study|Lost to Follow-up|2|||
16322888|NCT02527434|39667677|FG001|Overall Study|Lost to Follow-up|2|||
16322889|NCT02527434|39667678|FG002|Overall Study|Lost to Follow-up|0|||
16322890|NCT02527434|39667676|FG000|Overall Study|Death|19|||
16322891|NCT02527434|39667677|FG001|Overall Study|Death|6|||
16322892|NCT02527434|39667678|FG002|Overall Study|Death|17|||
16322893|NCT02527434|39667676|FG000|Overall Study|Withdrawal by Subject|5|||
16322894|NCT02527434|39667677|FG001|Overall Study|Withdrawal by Subject|3|||
16518037|NCT03364049|40365060|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
16518038|NCT03364049|40365061|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
16518039|NCT03364049|40365062|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
16518040|NCT03364049|40365063|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
16518041|NCT03364049|40365060|FG000|Overall Study|Withdrawal by Subject|0|||
16518042|NCT03364049|40365061|FG001|Overall Study|Withdrawal by Subject|1|||
16518043|NCT03364049|40365062|FG002|Overall Study|Withdrawal by Subject|1|||
16518044|NCT03364049|40365063|FG003|Overall Study|Withdrawal by Subject|1|||
16518045|NCT01040871|40365068|FG000|Overall Study|Adverse Event|6|||
16518046|NCT01040871|40365069|FG001|Overall Study|Adverse Event|2|||
16518047|NCT01040871|40365068|FG000|Overall Study|Withdrawal by Subject|2|||
16518048|NCT01040871|40365069|FG001|Overall Study|Withdrawal by Subject|0|||
16518049|NCT01040871|40365068|FG000|Overall Study|Death|1|||
16518050|NCT01040871|40365069|FG001|Overall Study|Death|3|||
16518051|NCT01040871|40365068|FG000|Overall Study|Lack of Efficacy|1|||
16518052|NCT01040871|40365069|FG001|Overall Study|Lack of Efficacy|1|||
16518053|NCT01040871|40365068|FG000|Overall Study|drug supply issue|1|||
16518054|NCT01040871|40365069|FG001|Overall Study|drug supply issue|0|||
16518055|NCT01040871|40365068|FG000|Overall Study|Randomized and Not Treated|2|||
16518056|NCT01040871|40365069|FG001|Overall Study|Randomized and Not Treated|1|||
16518057|NCT00718718|40365070|FG000|Prior to Week 12|Adverse Event|0|||
16518058|NCT00718718|40365071|FG001|Prior to Week 12|Adverse Event|0|||
16518059|NCT00718718|40365072|FG002|Prior to Week 12|Adverse Event|0|||
16518060|NCT00718718|40365073|FG003|Prior to Week 12|Adverse Event|0|||
16518061|NCT00718718|40365074|FG004|Prior to Week 12|Adverse Event|0|||
16518062|NCT00718718|40365075|FG005|Prior to Week 12|Adverse Event|0|||
16518063|NCT00718718|40365076|FG006|Prior to Week 12|Adverse Event|0|||
16518064|NCT00718718|40365077|FG007|Prior to Week 12|Adverse Event|1|||
16518065|NCT00718718|40365078|FG008|Prior to Week 12|Adverse Event|1|||
16518066|NCT00718718|40365079|FG009|Prior to Week 12|Adverse Event|0|||
16518067|NCT00718718|40365070|FG000|Prior to Week 12|Withdrawal by Subject|0|||
16518068|NCT00718718|40365071|FG001|Prior to Week 12|Withdrawal by Subject|0|||
16518069|NCT00718718|40365072|FG002|Prior to Week 12|Withdrawal by Subject|0|||
16322895|NCT02527434|39667678|FG002|Overall Study|Withdrawal by Subject|3|||
16518070|NCT00718718|40365073|FG003|Prior to Week 12|Withdrawal by Subject|0|||
16518071|NCT00718718|40365074|FG004|Prior to Week 12|Withdrawal by Subject|3|||
16518072|NCT00718718|40365075|FG005|Prior to Week 12|Withdrawal by Subject|0|||
16518073|NCT00718718|40365076|FG006|Prior to Week 12|Withdrawal by Subject|1|||
16322896|NCT02527434|39667676|FG000|Overall Study|Reason Not Specified|1|||
16092716|NCT01562275|38830253|FG006|Stage 1|Death|0|||
16092717|NCT01562275|38830254|FG007|Stage 1|Death|0|||
16092718|NCT01562275|38830255|FG008|Stage 1|Death|0|||
16092719|NCT01562275|38830256|FG009|Stage 1|Death|0|||
16092720|NCT01562275|38830257|FG010|Stage 1|Death|0|||
16092721|NCT01562275|38830258|FG011|Stage 1|Death|0|||
16092722|NCT01562275|38830259|FG012|Stage 1|Death|0|||
16092723|NCT01562275|38830247|FG000|Stage 1|Non Compliance|0|||
16092724|NCT01562275|38830248|FG001|Stage 1|Non Compliance|0|||
16092725|NCT01562275|38830249|FG002|Stage 1|Non Compliance|1|||
16092726|NCT01562275|38830250|FG003|Stage 1|Non Compliance|0|||
16518074|NCT00718718|40365077|FG007|Prior to Week 12|Withdrawal by Subject|1|||
16092727|NCT01562275|38830251|FG004|Stage 1|Non Compliance|0|||
16092728|NCT01562275|38830252|FG005|Stage 1|Non Compliance|0|||
16092729|NCT01562275|38830253|FG006|Stage 1|Non Compliance|0|||
16092730|NCT01562275|38830254|FG007|Stage 1|Non Compliance|0|||
16092731|NCT01562275|38830255|FG008|Stage 1|Non Compliance|0|||
16092732|NCT01562275|38830256|FG009|Stage 1|Non Compliance|0|||
16092733|NCT01562275|38830257|FG010|Stage 1|Non Compliance|0|||
16518075|NCT00718718|40365078|FG008|Prior to Week 12|Withdrawal by Subject|1|||
16518076|NCT00718718|40365079|FG009|Prior to Week 12|Withdrawal by Subject|0|||
16518077|NCT00718718|40365070|FG000|Prior to Week 12|Other|1|||
16518078|NCT00718718|40365071|FG001|Prior to Week 12|Other|0|||
16518079|NCT00718718|40365072|FG002|Prior to Week 12|Other|1|||
16322897|NCT02527434|39667677|FG001|Overall Study|Reason Not Specified|0|||
16092734|NCT01562275|38830258|FG011|Stage 1|Non Compliance|0|||
16092735|NCT01562275|38830259|FG012|Stage 1|Non Compliance|0|||
16322898|NCT02527434|39667678|FG002|Overall Study|Reason Not Specified|0|||
16322899|NCT02527434|39667676|FG000|Overall Study|Site closure|1|||
16322900|NCT02527434|39667677|FG001|Overall Study|Site closure|0|||
16322901|NCT02527434|39667678|FG002|Overall Study|Site closure|0|||
16322902|NCT00596817|39667682|FG000|Open-label Period|Adverse Event|0|||
16322903|NCT00596817|39667683|FG001|Open-label Period|Adverse Event|49|||
16322904|NCT00596817|39667682|FG000|Open-label Period|Lack of Efficacy|0|||
16322905|NCT00596817|39667683|FG001|Open-label Period|Lack of Efficacy|33|||
16322906|NCT00596817|39667682|FG000|Open-label Period|Other Reasons|0|||
16322907|NCT00596817|39667683|FG001|Open-label Period|Other Reasons|65|||
16322908|NCT00596817|39667682|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
16322909|NCT00596817|39667683|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
16322910|NCT00596817|39667682|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
16322911|NCT00596817|39667683|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
16322912|NCT00596817|39667682|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
16322913|NCT00596817|39667683|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
16322914|NCT00596817|39667682|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
16322915|NCT00596817|39667683|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
16322916|NCT00596817|39667682|FG000|Double-blind Period|Adverse Event|5|||
16322917|NCT00596817|39667683|FG001|Double-blind Period|Adverse Event|16|||
16322918|NCT00596817|39667682|FG000|Double-blind Period|Lack of Efficacy|52|||
16322919|NCT00596817|39667683|FG001|Double-blind Period|Lack of Efficacy|28|||
16322920|NCT00596817|39667682|FG000|Double-blind Period|Non-compliance With Study Product|3|||
16322921|NCT00596817|39667683|FG001|Double-blind Period|Non-compliance With Study Product|4|||
16322922|NCT00596817|39667682|FG000|Double-blind Period|Protocol Violation|11|||
16322923|NCT00596817|39667683|FG001|Double-blind Period|Protocol Violation|8|||
16518080|NCT00718718|40365073|FG003|Prior to Week 12|Other|0|||
16092736|NCT01562275|38830247|FG000|Stage 1|Physician Decision|0|||
16092737|NCT01562275|38830248|FG001|Stage 1|Physician Decision|0|||
16092738|NCT01562275|38830249|FG002|Stage 1|Physician Decision|0|||
16092739|NCT01562275|38830250|FG003|Stage 1|Physician Decision|0|||
16092740|NCT01562275|38830251|FG004|Stage 1|Physician Decision|1|||
16322924|NCT00596817|39667682|FG000|Double-blind Period|Withdrawal of Consent|7|||
16322925|NCT00596817|39667683|FG001|Double-blind Period|Withdrawal of Consent|3|||
16518081|NCT00718718|40365074|FG004|Prior to Week 12|Other|0|||
16518082|NCT00718718|40365075|FG005|Prior to Week 12|Other|0|||
16518083|NCT00718718|40365076|FG006|Prior to Week 12|Other|0|||
16518084|NCT00718718|40365077|FG007|Prior to Week 12|Other|0|||
16518085|NCT00718718|40365078|FG008|Prior to Week 12|Other|0|||
16518086|NCT00718718|40365079|FG009|Prior to Week 12|Other|0|||
16518087|NCT00718718|40365070|FG000|Week 12 to End of Study|Adverse Event|0|||
16518088|NCT00718718|40365071|FG001|Week 12 to End of Study|Adverse Event|0|||
16518089|NCT00718718|40365072|FG002|Week 12 to End of Study|Adverse Event|0|||
16518090|NCT00718718|40365073|FG003|Week 12 to End of Study|Adverse Event|0|||
16518091|NCT00718718|40365074|FG004|Week 12 to End of Study|Adverse Event|0|||
16518092|NCT00718718|40365075|FG005|Week 12 to End of Study|Adverse Event|0|||
16518093|NCT00718718|40365076|FG006|Week 12 to End of Study|Adverse Event|0|||
16518094|NCT00718718|40365077|FG007|Week 12 to End of Study|Adverse Event|1|||
16518095|NCT00718718|40365078|FG008|Week 12 to End of Study|Adverse Event|0|||
16518096|NCT00718718|40365079|FG009|Week 12 to End of Study|Adverse Event|0|||
16518097|NCT00718718|40365070|FG000|Week 12 to End of Study|Death|0|||
16518098|NCT00718718|40365071|FG001|Week 12 to End of Study|Death|0|||
16518099|NCT00718718|40365072|FG002|Week 12 to End of Study|Death|0|||
16518100|NCT00718718|40365073|FG003|Week 12 to End of Study|Death|0|||
16518101|NCT00718718|40365074|FG004|Week 12 to End of Study|Death|0|||
16518102|NCT00718718|40365075|FG005|Week 12 to End of Study|Death|1|||
16518103|NCT00718718|40365076|FG006|Week 12 to End of Study|Death|0|||
16518104|NCT00718718|40365077|FG007|Week 12 to End of Study|Death|0|||
16518105|NCT00718718|40365078|FG008|Week 12 to End of Study|Death|0|||
16518106|NCT00718718|40365079|FG009|Week 12 to End of Study|Death|0|||
16518107|NCT00718718|40365070|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
16518108|NCT00718718|40365071|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
16518109|NCT00718718|40365072|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
16518110|NCT00718718|40365073|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
16518111|NCT00718718|40365074|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
16518112|NCT00718718|40365075|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
16518113|NCT00718718|40365076|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
16518114|NCT00718718|40365077|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
16518115|NCT00718718|40365078|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
16518116|NCT00718718|40365079|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
16518117|NCT00718718|40365070|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
16518118|NCT00718718|40365071|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
16518119|NCT00718718|40365072|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
16518120|NCT00718718|40365073|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
16518121|NCT00718718|40365074|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
16518122|NCT00718718|40365075|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
16518123|NCT00718718|40365076|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
16518124|NCT00718718|40365077|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
16518125|NCT00718718|40365078|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
16518126|NCT00718718|40365079|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
16518127|NCT00718718|40365070|FG000|Week 12 to End of Study|Other|0|||
16518128|NCT00718718|40365071|FG001|Week 12 to End of Study|Other|1|||
16518129|NCT00718718|40365072|FG002|Week 12 to End of Study|Other|0|||
16518130|NCT00718718|40365073|FG003|Week 12 to End of Study|Other|1|||
16518131|NCT00718718|40365074|FG004|Week 12 to End of Study|Other|0|||
16518132|NCT00718718|40365075|FG005|Week 12 to End of Study|Other|0|||
16518133|NCT00718718|40365076|FG006|Week 12 to End of Study|Other|1|||
16518134|NCT00718718|40365077|FG007|Week 12 to End of Study|Other|0|||
16518135|NCT00718718|40365078|FG008|Week 12 to End of Study|Other|0|||
16518136|NCT00718718|40365079|FG009|Week 12 to End of Study|Other|0|||
16322926|NCT00596817|39667682|FG000|Double-blind Period|Lost to Follow-up|0|||
16518137|NCT03256552|40365080|FG000|Overall Study|Protocol Violation|1|||
16518138|NCT03256552|40365080|FG000|Overall Study|Physician Decision|1|||
16518139|NCT03256552|40365080|FG000|Overall Study|Adverse Event|1|||
16518140|NCT03256552|40365080|FG000|Overall Study|Withdrawal by Subject|2|||
16322927|NCT00596817|39667683|FG001|Double-blind Period|Lost to Follow-up|2|||
16518141|NCT01707004|40365081|FG000|Overall Study|Physician Decision|3|||
16518142|NCT00559962|40365082|FG000|Overall Study|Adverse Event|1|||
16518143|NCT00559962|40365083|FG001|Overall Study|Adverse Event|7|||
16518144|NCT00559962|40365084|FG002|Overall Study|Adverse Event|8|||
16518145|NCT00559962|40365085|FG003|Overall Study|Adverse Event|5|||
16518146|NCT00559962|40365086|FG004|Overall Study|Adverse Event|11|||
16518147|NCT00559962|40365087|FG005|Overall Study|Adverse Event|4|||
16518148|NCT00559962|40365088|FG006|Overall Study|Adverse Event|4|||
16518149|NCT00559962|40365089|FG007|Overall Study|Adverse Event|2|||
16518150|NCT00559962|40365082|FG000|Overall Study|Lost to Follow-up|0|||
16518151|NCT00559962|40365083|FG001|Overall Study|Lost to Follow-up|1|||
16518152|NCT00559962|40365084|FG002|Overall Study|Lost to Follow-up|0|||
16518153|NCT00559962|40365085|FG003|Overall Study|Lost to Follow-up|0|||
16518154|NCT00559962|40365086|FG004|Overall Study|Lost to Follow-up|0|||
16518155|NCT00559962|40365087|FG005|Overall Study|Lost to Follow-up|0|||
16518156|NCT00559962|40365088|FG006|Overall Study|Lost to Follow-up|0|||
16518157|NCT00559962|40365089|FG007|Overall Study|Lost to Follow-up|0|||
16518158|NCT00559962|40365082|FG000|Overall Study|Withdrawal by Subject|1|||
16518159|NCT00559962|40365083|FG001|Overall Study|Withdrawal by Subject|1|||
16518160|NCT00559962|40365084|FG002|Overall Study|Withdrawal by Subject|2|||
16518161|NCT00559962|40365085|FG003|Overall Study|Withdrawal by Subject|0|||
16518162|NCT00559962|40365086|FG004|Overall Study|Withdrawal by Subject|3|||
16518163|NCT00559962|40365087|FG005|Overall Study|Withdrawal by Subject|1|||
16518164|NCT00559962|40365088|FG006|Overall Study|Withdrawal by Subject|0|||
16518165|NCT00559962|40365089|FG007|Overall Study|Withdrawal by Subject|2|||
16518166|NCT00559962|40365082|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
16518167|NCT00559962|40365083|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
16518168|NCT00559962|40365084|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
16518169|NCT00559962|40365085|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
16518170|NCT00559962|40365086|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
16518171|NCT00559962|40365087|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
16518172|NCT00559962|40365088|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
16518173|NCT00559962|40365089|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
16518174|NCT00775437|40365097|FG000|Overall Study|Loss of efficacy|2|||
16518175|NCT00775437|40365097|FG000|Overall Study|Withdrawal by Subject|3|||
16518176|NCT00775437|40365097|FG000|Overall Study|Lost to Follow-up|1|||
16518177|NCT02666768|40365098|FG000|Overall Study|Withdrawal by Subject|4|||
16518178|NCT04013191|40365099|FG000|Overall Study|Adverse Event|1|||
16518179|NCT04013191|40365100|FG001|Overall Study|Adverse Event|0|||
16518180|NCT02696096|40365103|FG000|Overall Study|ruled out at screening|1|||
16518181|NCT02696096|40365103|FG000|Overall Study|did not attend second fMRI|1|||
16518182|NCT03773757|40365104|FG000|Overall Study|Withdrawal by Subject|2|||
16518183|NCT03773757|40365105|FG001|Overall Study|Withdrawal by Subject|4|||
16518184|NCT02331446|40365110|FG000|Overall Study|Lost to Follow-up|2|||
16518185|NCT02331446|40365111|FG001|Overall Study|Lost to Follow-up|1|||
16518186|NCT02331446|40365112|FG002|Overall Study|Lost to Follow-up|0|||
16518187|NCT02331446|40365113|FG003|Overall Study|Lost to Follow-up|1|||
16518188|NCT02331446|40365110|FG000|Overall Study|Personal Problem|2|||
16518189|NCT02331446|40365111|FG001|Overall Study|Personal Problem|0|||
16518190|NCT02331446|40365112|FG002|Overall Study|Personal Problem|0|||
16518191|NCT02331446|40365113|FG003|Overall Study|Personal Problem|0|||
16518192|NCT02331446|40365110|FG000|Overall Study|Disease|0|||
16518193|NCT02331446|40365111|FG001|Overall Study|Disease|2|||
16518194|NCT02331446|40365112|FG002|Overall Study|Disease|2|||
16518195|NCT02331446|40365113|FG003|Overall Study|Disease|1|||
16518196|NCT02331446|40365110|FG000|Overall Study|Physician Decision|0|||
16518197|NCT02331446|40365111|FG001|Overall Study|Physician Decision|1|||
16518198|NCT02331446|40365112|FG002|Overall Study|Physician Decision|0|||
16518199|NCT02331446|40365113|FG003|Overall Study|Physician Decision|1|||
16518200|NCT02331446|40365110|FG000|Overall Study|Lost before baseline analysis|0|||
16518201|NCT02331446|40365111|FG001|Overall Study|Lost before baseline analysis|1|||
16518202|NCT02331446|40365112|FG002|Overall Study|Lost before baseline analysis|1|||
16518203|NCT02331446|40365113|FG003|Overall Study|Lost before baseline analysis|0|||
16518204|NCT01083433|40365114|FG000|Overall Study|Lost to Follow-up|2|||
16518205|NCT01083433|40365115|FG001|Overall Study|Lost to Follow-up|1|||
16518206|NCT01083433|40365116|FG002|Overall Study|Lost to Follow-up|1|||
16518207|NCT01083433|40365114|FG000|Overall Study|Withdrawal by Subject|0|||
16518208|NCT01083433|40365115|FG001|Overall Study|Withdrawal by Subject|5|||
16518209|NCT01083433|40365116|FG002|Overall Study|Withdrawal by Subject|3|||
16518210|NCT01083433|40365114|FG000|Overall Study|Pregnancy|0|||
16518211|NCT01083433|40365115|FG001|Overall Study|Pregnancy|0|||
16518212|NCT01083433|40365116|FG002|Overall Study|Pregnancy|1|||
16518213|NCT00796861|40365123|FG000|Overall Study|Withdrawal by Subject|2|||
16518214|NCT00796861|40365123|FG000|Overall Study|Death|2|||
16518215|NCT01110239|40365124|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
16518216|NCT01110239|40365125|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
16518217|NCT01110239|40365126|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
16518218|NCT01110239|40365127|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
16518219|NCT01110239|40365124|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
16518220|NCT01110239|40365125|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
16518221|NCT01110239|40365126|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
16518222|NCT01110239|40365127|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
16518223|NCT00079274|40365128|FG000|Overall Study|Withdrawal by Subject|111|||
16518224|NCT00079274|40365129|FG001|Overall Study|Withdrawal by Subject|10|||
16518225|NCT00079274|40365130|FG002|Overall Study|Withdrawal by Subject|12|||
16518226|NCT00079274|40365131|FG003|Overall Study|Withdrawal by Subject|163|||
16518227|NCT00079274|40365132|FG004|Overall Study|Withdrawal by Subject|7|||
16092741|NCT01562275|38830252|FG005|Stage 1|Physician Decision|0|||
16518228|NCT00079274|40365133|FG005|Overall Study|Withdrawal by Subject|8|||
16518229|NCT00079274|40365134|FG006|Overall Study|Withdrawal by Subject|0|||
16518230|NCT00079274|40365128|FG000|Overall Study|Adverse Event|130|||
16518231|NCT00079274|40365129|FG001|Overall Study|Adverse Event|8|||
16518232|NCT00079274|40365130|FG002|Overall Study|Adverse Event|8|||
16518233|NCT00079274|40365131|FG003|Overall Study|Adverse Event|184|||
16518234|NCT00079274|40365132|FG004|Overall Study|Adverse Event|7|||
16518235|NCT00079274|40365133|FG005|Overall Study|Adverse Event|8|||
16518236|NCT00079274|40365134|FG006|Overall Study|Adverse Event|0|||
16518237|NCT00079274|40365128|FG000|Overall Study|Recurrence|21|||
16518238|NCT00079274|40365129|FG001|Overall Study|Recurrence|0|||
16518239|NCT00079274|40365130|FG002|Overall Study|Recurrence|1|||
16518240|NCT00079274|40365131|FG003|Overall Study|Recurrence|15|||
16518241|NCT00079274|40365132|FG004|Overall Study|Recurrence|0|||
16518242|NCT00079274|40365133|FG005|Overall Study|Recurrence|2|||
16518243|NCT00079274|40365134|FG006|Overall Study|Recurrence|0|||
16518244|NCT00079274|40365128|FG000|Overall Study|Alternate Treatment|6|||
16518245|NCT00079274|40365129|FG001|Overall Study|Alternate Treatment|1|||
16518246|NCT00079274|40365130|FG002|Overall Study|Alternate Treatment|0|||
16518247|NCT00079274|40365131|FG003|Overall Study|Alternate Treatment|3|||
16518248|NCT00079274|40365132|FG004|Overall Study|Alternate Treatment|0|||
16518249|NCT00079274|40365133|FG005|Overall Study|Alternate Treatment|0|||
16204377|NCT00669032|39226103|FG000|Overall Study|Lack of Efficacy|8|||
16204378|NCT00669032|39226104|FG001|Overall Study|Lack of Efficacy|19|||
16204379|NCT00669032|39226103|FG000|Overall Study|Withdrawal by Subject|12|||
16204380|NCT00669032|39226104|FG001|Overall Study|Withdrawal by Subject|13|||
16204381|NCT00669032|39226103|FG000|Overall Study|Adverse Event|12|||
16204382|NCT00669032|39226104|FG001|Overall Study|Adverse Event|16|||
16204383|NCT00669032|39226103|FG000|Overall Study|Physician Decision|1|||
16204384|NCT00669032|39226104|FG001|Overall Study|Physician Decision|1|||
16204385|NCT00669032|39226103|FG000|Overall Study|No fulfilment of the selection criteria|5|||
16204386|NCT00669032|39226104|FG001|Overall Study|No fulfilment of the selection criteria|5|||
16204387|NCT01494987|39226105|FG000|Overall Study|Adverse Event|6|||
16322928|NCT00596817|39667682|FG000|Double-blind Period|Other Reasons|10|||
16204388|NCT01494987|39226106|FG001|Overall Study|Adverse Event|5|||
16518250|NCT00079274|40365134|FG006|Overall Study|Alternate Treatment|0|||
16518251|NCT00079274|40365128|FG000|Overall Study|Other Medical Problems|6|||
16518252|NCT00079274|40365129|FG001|Overall Study|Other Medical Problems|1|||
16518253|NCT00079274|40365130|FG002|Overall Study|Other Medical Problems|0|||
16518254|NCT00079274|40365131|FG003|Overall Study|Other Medical Problems|7|||
16518255|NCT00079274|40365132|FG004|Overall Study|Other Medical Problems|0|||
16518256|NCT00079274|40365133|FG005|Overall Study|Other Medical Problems|0|||
16518257|NCT00079274|40365134|FG006|Overall Study|Other Medical Problems|0|||
16518258|NCT00079274|40365128|FG000|Overall Study|Death|4|||
16518259|NCT00079274|40365129|FG001|Overall Study|Death|0|||
16518260|NCT00079274|40365130|FG002|Overall Study|Death|1|||
16518261|NCT00079274|40365131|FG003|Overall Study|Death|15|||
16518262|NCT00079274|40365132|FG004|Overall Study|Death|0|||
16518263|NCT00079274|40365133|FG005|Overall Study|Death|0|||
16518264|NCT00079274|40365134|FG006|Overall Study|Death|0|||
16518265|NCT00079274|40365128|FG000|Overall Study|Cytogenetic resistance|0|||
16518266|NCT00079274|40365129|FG001|Overall Study|Cytogenetic resistance|0|||
16518267|NCT00079274|40365130|FG002|Overall Study|Cytogenetic resistance|0|||
16518268|NCT00079274|40365131|FG003|Overall Study|Cytogenetic resistance|2|||
16518269|NCT00079274|40365132|FG004|Overall Study|Cytogenetic resistance|0|||
16518270|NCT00079274|40365133|FG005|Overall Study|Cytogenetic resistance|0|||
16518271|NCT00079274|40365134|FG006|Overall Study|Cytogenetic resistance|0|||
16518272|NCT00079274|40365128|FG000|Overall Study|Other|43|||
16518273|NCT00079274|40365129|FG001|Overall Study|Other|7|||
16518274|NCT00079274|40365130|FG002|Overall Study|Other|5|||
16518275|NCT00079274|40365131|FG003|Overall Study|Other|55|||
16518276|NCT00079274|40365132|FG004|Overall Study|Other|1|||
16518277|NCT00079274|40365133|FG005|Overall Study|Other|2|||
16518278|NCT00079274|40365134|FG006|Overall Study|Other|0|||
16518279|NCT02477020|40365137|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
16518280|NCT02477020|40365138|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
16518281|NCT02477020|40365137|FG000|Overall Study|Voluntary Withdrawal|7|||
16518282|NCT02477020|40365138|FG001|Overall Study|Voluntary Withdrawal|16|||
16518283|NCT02477020|40365137|FG000|Overall Study|Reason not Specified|3|||
16518284|NCT02477020|40365138|FG001|Overall Study|Reason not Specified|1|||
16518285|NCT02477020|40365137|FG000|Overall Study|Lack of Efficacy|14|||
16518286|NCT02477020|40365138|FG001|Overall Study|Lack of Efficacy|5|||
16518287|NCT01234467|40365140|FG000|Overall Study|Adverse Event|3|||
16518288|NCT01234467|40365140|FG000|Overall Study|Death|2|||
16518289|NCT01234467|40365140|FG000|Overall Study|Withdrawal by Subject|2|||
16518290|NCT01234467|40365140|FG000|Overall Study|Disease Progression|2|||
16518291|NCT01234467|40365140|FG000|Overall Study|Clinical deterioration|1|||
16518292|NCT01234467|40365140|FG000|Overall Study|Physician Decision|1|||
16518293|NCT01234467|40365140|FG000|Overall Study|Other complicating disease (stroke)|1|||
16518294|NCT01752933|40365141|FG000|Treatment|Disease Progression|3|||
16518295|NCT01752933|40365142|FG001|Treatment|Disease Progression|29|||
16518296|NCT01752933|40365141|FG000|Treatment|Withdrawal by Subject|0|||
16518297|NCT01752933|40365142|FG001|Treatment|Withdrawal by Subject|5|||
16518298|NCT01752933|40365141|FG000|Treatment|Adverse Event|1|||
16518299|NCT01752933|40365142|FG001|Treatment|Adverse Event|4|||
16518300|NCT01752933|40365141|FG000|Treatment|Physician Decision|0|||
16518301|NCT01752933|40365142|FG001|Treatment|Physician Decision|3|||
16518302|NCT01752933|40365141|FG000|Treatment|Death|0|||
16518303|NCT01752933|40365142|FG001|Treatment|Death|2|||
16518304|NCT01752933|40365141|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
16518305|NCT01752933|40365142|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
16518306|NCT01752933|40365141|FG000|Treatment|Patient noncompliant|0|||
16518307|NCT01752933|40365142|FG001|Treatment|Patient noncompliant|1|||
16518308|NCT01752933|40365141|FG000|Treatment|Patient unable to travel to appointments|0|||
16518309|NCT01752933|40365142|FG001|Treatment|Patient unable to travel to appointments|1|||
16518310|NCT01752933|40365141|FG000|Overall Study and Follow-up|Death|4|||
16518311|NCT01752933|40365142|FG001|Overall Study and Follow-up|Death|34|||
16518312|NCT01752933|40365141|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
16518313|NCT01752933|40365142|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
16518314|NCT01752933|40365141|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
16518315|NCT01752933|40365142|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
16518316|NCT01752933|40365141|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
16518317|NCT01752933|40365142|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
16092742|NCT01562275|38830253|FG006|Stage 1|Physician Decision|1|||
16204389|NCT01494987|39226105|FG000|Overall Study|Hyperglycemia|6|||
16518318|NCT02896127|40365143|FG000|COMPLETED WEEK 52|Adverse Event|9|||
16518319|NCT02896127|40365144|FG001|COMPLETED WEEK 52|Adverse Event|2|||
16518320|NCT02896127|40365143|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
16518321|NCT02896127|40365144|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
16518322|NCT02896127|40365143|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
16518323|NCT02896127|40365144|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
16518324|NCT02896127|40365143|FG000|COMPLETED WEEK 52|Physician Decision|1|||
16518325|NCT02896127|40365144|FG001|COMPLETED WEEK 52|Physician Decision|1|||
16518326|NCT02896127|40365143|FG000|COMPLETED WEEK 52|Pregnancy|2|||
16518327|NCT02896127|40365144|FG001|COMPLETED WEEK 52|Pregnancy|0|||
16518328|NCT02896127|40365143|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
16518329|NCT02896127|40365144|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
16518330|NCT02896127|40365143|FG000|COMPLETED WEEK 52|Technical problems|1|||
16518331|NCT02896127|40365144|FG001|COMPLETED WEEK 52|Technical problems|0|||
16518332|NCT02896127|40365143|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
16518333|NCT02896127|40365144|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
16518334|NCT02896127|40365143|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
16518335|NCT02896127|40365144|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
16518336|NCT02896127|40365143|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
16518337|NCT02896127|40365144|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
16518338|NCT02896127|40365143|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
16518339|NCT02896127|40365144|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
16518340|NCT02896127|40365143|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
16518341|NCT02896127|40365144|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
16518342|NCT02465528|40365145|FG000|Overall Study|Progressive disease|0|||
16518343|NCT02465528|40365146|FG001|Overall Study|Progressive disease|2|||
16518344|NCT02465528|40365147|FG002|Overall Study|Progressive disease|9|||
16518345|NCT02465528|40365148|FG003|Overall Study|Progressive disease|4|||
16518346|NCT02465528|40365145|FG000|Overall Study|Study terminated by sponsor|1|||
16518347|NCT02465528|40365146|FG001|Overall Study|Study terminated by sponsor|2|||
16518348|NCT02465528|40365147|FG002|Overall Study|Study terminated by sponsor|0|||
16518349|NCT02465528|40365148|FG003|Overall Study|Study terminated by sponsor|0|||
16518350|NCT02465528|40365145|FG000|Overall Study|Withdrawal by Subject|0|||
16518351|NCT02465528|40365146|FG001|Overall Study|Withdrawal by Subject|0|||
16518352|NCT02465528|40365147|FG002|Overall Study|Withdrawal by Subject|2|||
16518353|NCT02465528|40365148|FG003|Overall Study|Withdrawal by Subject|0|||
16518354|NCT02465528|40365145|FG000|Overall Study|Adverse Event|0|||
16518355|NCT02465528|40365146|FG001|Overall Study|Adverse Event|0|||
16518356|NCT02465528|40365147|FG002|Overall Study|Adverse Event|0|||
16518357|NCT02465528|40365148|FG003|Overall Study|Adverse Event|1|||
16518358|NCT02465528|40365145|FG000|Overall Study|Physician Decision|0|||
16518359|NCT02465528|40365146|FG001|Overall Study|Physician Decision|0|||
16322929|NCT00596817|39667683|FG001|Double-blind Period|Other Reasons|18|||
16322930|NCT00976820|39667684|FG000|Overall Study|Lost to Follow-up|5|||
16322931|NCT00976820|39667685|FG001|Overall Study|Lost to Follow-up|16|||
16322932|NCT00976820|39667686|FG002|Overall Study|Lost to Follow-up|2|||
16322933|NCT00976820|39667687|FG003|Overall Study|Lost to Follow-up|3|||
16395547|NCT00780143|39928290|FG000|Overall Study|Adverse Event|1|||
16518360|NCT02465528|40365147|FG002|Overall Study|Physician Decision|1|||
16518361|NCT02465528|40365148|FG003|Overall Study|Physician Decision|0|||
16518362|NCT00440271|40365149|FG000|Overall Study|Protocol Violation|1|||
16204390|NCT01494987|39226106|FG001|Overall Study|Hyperglycemia|4|||
16204391|NCT01494987|39226105|FG000|Overall Study|Investigator's Discretion|1|||
16204392|NCT01494987|39226106|FG001|Overall Study|Investigator's Discretion|2|||
16204393|NCT01494987|39226105|FG000|Overall Study|Lost to Follow-up|1|||
16204394|NCT01494987|39226106|FG001|Overall Study|Lost to Follow-up|1|||
16204395|NCT01494987|39226105|FG000|Overall Study|Protocol Violation|3|||
16204396|NCT01494987|39226106|FG001|Overall Study|Protocol Violation|3|||
16204397|NCT01494987|39226105|FG000|Overall Study|Subject Non-Compliance|9|||
16204398|NCT01494987|39226106|FG001|Overall Study|Subject Non-Compliance|10|||
16204399|NCT01494987|39226105|FG000|Overall Study|Subject Withdrew Consent|2|||
16204400|NCT01494987|39226106|FG001|Overall Study|Subject Withdrew Consent|3|||
16204401|NCT03434418|39226109|FG000|Overall Study|Disease Progression|11|||
16204402|NCT03434418|39226109|FG000|Overall Study|Adverse Event|2|||
16204403|NCT03434418|39226109|FG000|Overall Study|Physician Decision|1|||
16204404|NCT03434418|39226109|FG000|Overall Study|Decline in Performance Status (PS)|1|||
16204405|NCT01079195|39226110|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
16204406|NCT01079195|39226110|FG000|Overall Study|No Documentation Available|437|||
16204407|NCT01079195|39226110|FG000|Overall Study|Adverse Event|157|||
16204408|NCT01079195|39226110|FG000|Overall Study|Reason Unknown|39|||
16204409|NCT01079195|39226110|FG000|Overall Study|Withdrawal by Subject|18|||
16204410|NCT01079195|39226110|FG000|Overall Study|Financial Reasons|15|||
16204411|NCT01079195|39226110|FG000|Overall Study|Lack of Effectiveness|12|||
16204412|NCT01079195|39226110|FG000|Overall Study|Physician Decision|4|||
16204413|NCT01079195|39226110|FG000|Overall Study|Improved Status of Participant|4|||
16204414|NCT01079195|39226110|FG000|Overall Study|No Follow-up Documentation Available|4|||
16204415|NCT01079195|39226110|FG000|Overall Study|Non-compliance|2|||
16204416|NCT00091026|39226111|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
16204417|NCT00091026|39226112|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
16204418|NCT00091026|39226111|FG000|Overall Study|Patient withdrew and never received trea|0|||
16518363|NCT00440271|40365150|FG001|Overall Study|Protocol Violation|1|||
16518364|NCT00440271|40365149|FG000|Overall Study|Adverse Event|0|||
16518365|NCT00440271|40365150|FG001|Overall Study|Adverse Event|1|||
16204419|NCT00091026|39226112|FG001|Overall Study|Patient withdrew and never received trea|2|||
16204420|NCT00091026|39226111|FG000|Overall Study|Unknown-never received treatment|0|||
16204421|NCT00091026|39226112|FG001|Overall Study|Unknown-never received treatment|1|||
16204422|NCT00879437|39226113|FG000|Overall Study|Protocol Violation|0|||
16204423|NCT00879437|39226114|FG001|Overall Study|Protocol Violation|1|||
16092743|NCT01562275|38830254|FG007|Stage 1|Physician Decision|0|||
16092744|NCT01562275|38830255|FG008|Stage 1|Physician Decision|1|||
16092745|NCT01562275|38830256|FG009|Stage 1|Physician Decision|0|||
16092746|NCT01562275|38830257|FG010|Stage 1|Physician Decision|0|||
16092747|NCT01562275|38830258|FG011|Stage 1|Physician Decision|0|||
16092748|NCT01562275|38830259|FG012|Stage 1|Physician Decision|0|||
16092749|NCT01562275|38830247|FG000|Stage 1|Progression of Disease|2|||
16092750|NCT01562275|38830248|FG001|Stage 1|Progression of Disease|6|||
16092751|NCT01562275|38830249|FG002|Stage 1|Progression of Disease|2|||
16092752|NCT01562275|38830250|FG003|Stage 1|Progression of Disease|1|||
16092753|NCT01562275|38830251|FG004|Stage 1|Progression of Disease|2|||
16092754|NCT01562275|38830252|FG005|Stage 1|Progression of Disease|4|||
16092755|NCT01562275|38830253|FG006|Stage 1|Progression of Disease|1|||
16092756|NCT01562275|38830254|FG007|Stage 1|Progression of Disease|7|||
16092757|NCT01562275|38830255|FG008|Stage 1|Progression of Disease|2|||
16092758|NCT01562275|38830256|FG009|Stage 1|Progression of Disease|5|||
16092759|NCT01562275|38830257|FG010|Stage 1|Progression of Disease|3|||
16092760|NCT01562275|38830258|FG011|Stage 1|Progression of Disease|0|||
16092761|NCT01562275|38830259|FG012|Stage 1|Progression of Disease|0|||
16092762|NCT01562275|38830247|FG000|Stage 1|Withdrawal by Subject|0|||
16092763|NCT01562275|38830248|FG001|Stage 1|Withdrawal by Subject|1|||
16092764|NCT01562275|38830249|FG002|Stage 1|Withdrawal by Subject|0|||
16092765|NCT01562275|38830250|FG003|Stage 1|Withdrawal by Subject|2|||
16092766|NCT01562275|38830251|FG004|Stage 1|Withdrawal by Subject|0|||
16092767|NCT01562275|38830252|FG005|Stage 1|Withdrawal by Subject|0|||
16092768|NCT01562275|38830253|FG006|Stage 1|Withdrawal by Subject|1|||
16092769|NCT01562275|38830254|FG007|Stage 1|Withdrawal by Subject|0|||
16092770|NCT01562275|38830255|FG008|Stage 1|Withdrawal by Subject|0|||
16204424|NCT00879437|39226113|FG000|Overall Study|Death|1|||
16395548|NCT00661726|39928291|FG000|Overall Study|Adverse Event|1|||
16518366|NCT00440271|40365149|FG000|Overall Study|Lost to Follow-up|1|||
16518367|NCT00440271|40365150|FG001|Overall Study|Lost to Follow-up|0|||
16518368|NCT00440271|40365149|FG000|Overall Study|Withdrawal by Subject|0|||
16518369|NCT00440271|40365150|FG001|Overall Study|Withdrawal by Subject|2|||
16518370|NCT00440271|40365149|FG000|Overall Study|Lack of Efficacy|0|||
16518371|NCT00440271|40365150|FG001|Overall Study|Lack of Efficacy|1|||
16518372|NCT00440271|40365149|FG000|Overall Study|Due to closure of trial|8|||
16518373|NCT00440271|40365150|FG001|Overall Study|Due to closure of trial|10|||
16518374|NCT00440271|40365149|FG000|Overall Study|Other|2|||
16518375|NCT00440271|40365150|FG001|Overall Study|Other|0|||
16518376|NCT01038778|40365152|FG000|Overall Study|Withdrawal by Subject|0|||
16518377|NCT01038778|40365153|FG001|Overall Study|Withdrawal by Subject|2|||
16518378|NCT01038778|40365154|FG002|Overall Study|Withdrawal by Subject|3|||
16518379|NCT00587587|40365155|FG000|Overall Study|Lost to Follow-up|6|||
16518380|NCT00587587|40365156|FG001|Overall Study|Lost to Follow-up|1|||
16518381|NCT00528528|40365159|FG000|Overall Study|Lost to Follow-up|0|||
16518382|NCT00528528|40365160|FG001|Overall Study|Lost to Follow-up|0|||
16518383|NCT00528528|40365161|FG002|Overall Study|Lost to Follow-up|1|||
16518384|NCT00528528|40365162|FG003|Overall Study|Lost to Follow-up|1|||
16518385|NCT00528528|40365159|FG000|Overall Study|Ineligible to continue the trial|0|||
16518386|NCT00528528|40365160|FG001|Overall Study|Ineligible to continue the trial|0|||
16518387|NCT00528528|40365161|FG002|Overall Study|Ineligible to continue the trial|0|||
16518388|NCT00528528|40365162|FG003|Overall Study|Ineligible to continue the trial|1|||
16518389|NCT00528528|40365159|FG000|Overall Study|Other|0|||
16518390|NCT00528528|40365160|FG001|Overall Study|Other|1|||
16518391|NCT00528528|40365161|FG002|Overall Study|Other|0|||
16518392|NCT00528528|40365162|FG003|Overall Study|Other|0|||
16518393|NCT00528528|40365159|FG000|Overall Study|Withdrawal by Subject|3|||
16518394|NCT00528528|40365160|FG001|Overall Study|Withdrawal by Subject|2|||
16518395|NCT00528528|40365161|FG002|Overall Study|Withdrawal by Subject|1|||
16518396|NCT00528528|40365162|FG003|Overall Study|Withdrawal by Subject|1|||
16518397|NCT00528528|40365159|FG000|Overall Study|Ongoing participant|0|||
16518398|NCT00528528|40365160|FG001|Overall Study|Ongoing participant|0|||
16518399|NCT00528528|40365161|FG002|Overall Study|Ongoing participant|1|||
16518400|NCT00528528|40365162|FG003|Overall Study|Ongoing participant|0|||
16518401|NCT02840877|40365163|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
16518402|NCT02840877|40365163|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
16518403|NCT02840877|40365163|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
16518404|NCT02840877|40365163|FG000|Baseline to 12 Weeks|Death|1|||
16092771|NCT01562275|38830256|FG009|Stage 1|Withdrawal by Subject|1|||
16092772|NCT01562275|38830257|FG010|Stage 1|Withdrawal by Subject|0|||
16092773|NCT01562275|38830258|FG011|Stage 1|Withdrawal by Subject|0|||
16092774|NCT01562275|38830259|FG012|Stage 1|Withdrawal by Subject|0|||
16092775|NCT01562275|38830247|FG000|Stage 2|Death|0|||
16092776|NCT01562275|38830248|FG001|Stage 2|Death|0|||
16518405|NCT02840877|40365163|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
16518406|NCT02840877|40365163|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
16518407|NCT02840877|40365163|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
16518408|NCT02840877|40365163|FG000|12 Weeks to 6 Months|Treatment failure|1|||
16204425|NCT00879437|39226114|FG001|Overall Study|Death|0|||
16204426|NCT01975246|39226115|FG000|Overall Study|Adverse Event|2|||
16204427|NCT01975246|39226116|FG001|Overall Study|Adverse Event|1|||
16204428|NCT01975246|39226115|FG000|Overall Study|Lack of Efficacy|1|||
16204429|NCT01975246|39226116|FG001|Overall Study|Lack of Efficacy|0|||
16204430|NCT01975246|39226115|FG000|Overall Study|Protocol Violation|1|||
16204431|NCT01975246|39226116|FG001|Overall Study|Protocol Violation|0|||
16204432|NCT01975246|39226115|FG000|Overall Study|Other than stated|0|||
16204433|NCT01975246|39226116|FG001|Overall Study|Other than stated|1|||
16204434|NCT02141217|39226117|FG000|Overall Study|Adverse Event|1|||
16204435|NCT02141217|39226118|FG001|Overall Study|Adverse Event|2|||
16204436|NCT02141217|39226117|FG000|Overall Study|Protocol Violation|1|||
16204437|NCT02141217|39226118|FG001|Overall Study|Protocol Violation|4|||
16204438|NCT02141217|39226117|FG000|Overall Study|Withdrawal by Subject|6|||
16204439|NCT02141217|39226118|FG001|Overall Study|Withdrawal by Subject|0|||
16204440|NCT02141217|39226117|FG000|Overall Study|Lost to Follow-up|1|||
16204441|NCT02141217|39226118|FG001|Overall Study|Lost to Follow-up|1|||
16204442|NCT02141217|39226117|FG000|Overall Study|Physician Decision|1|||
16204443|NCT02141217|39226118|FG001|Overall Study|Physician Decision|0|||
16204444|NCT02141217|39226117|FG000|Overall Study|Surgical Intervention|1|||
16204445|NCT02141217|39226118|FG001|Overall Study|Surgical Intervention|1|||
16204446|NCT03258593|39226119|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
16204447|NCT03258593|39226120|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
16204448|NCT03258593|39226121|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
16204449|NCT03258593|39226122|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
16204450|NCT03258593|39226119|FG000|Run-In Maintenance Phase|Disease progression|3|||
16204451|NCT03258593|39226120|FG001|Run-In Maintenance Phase|Disease progression|0|||
16204452|NCT03258593|39226121|FG002|Run-In Maintenance Phase|Disease progression|0|||
16204453|NCT03258593|39226122|FG003|Run-In Maintenance Phase|Disease progression|0|||
16204454|NCT03258593|39226119|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
16204455|NCT03258593|39226120|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
16204456|NCT03258593|39226121|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
16204457|NCT03258593|39226122|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
16204458|NCT03258593|39226119|FG000|Expansion Maintenance Phase|Physician Decision|0|||
16204459|NCT03258593|39226120|FG001|Expansion Maintenance Phase|Physician Decision|1|||
16204460|NCT03258593|39226121|FG002|Expansion Maintenance Phase|Physician Decision|0|||
16204461|NCT03258593|39226122|FG003|Expansion Maintenance Phase|Physician Decision|0|||
16204462|NCT00802867|39226126|FG000|Overall Study|Lost to Follow-up|6|||
16204463|NCT00802867|39226126|FG000|Overall Study|Protocol Violation|6|||
16204464|NCT00802867|39226126|FG000|Overall Study|Withdrawal by Subject|1|||
16204465|NCT01993615|39226131|FG000|Overall Study|Death|1|||
16204466|NCT01993615|39226132|FG001|Overall Study|Death|0|||
16204467|NCT01688635|39226137|FG000|Washout 1|Withdrawal by Subject|1|||
16204468|NCT01688635|39226138|FG001|Washout 1|Withdrawal by Subject|0|||
16204469|NCT01688635|39226137|FG000|Washout 1|Adverse Event|0|||
16204470|NCT01688635|39226138|FG001|Washout 1|Adverse Event|1|||
16204471|NCT01688635|39226137|FG000|Washout 1|Physician Decision|0|||
16204472|NCT01688635|39226138|FG001|Washout 1|Physician Decision|1|||
16204473|NCT01688635|39226137|FG000|Washout 2|Physician Decision|1|||
16204474|NCT01688635|39226138|FG001|Washout 2|Physician Decision|0|||
16204475|NCT01688635|39226137|FG000|Washout 2|Withdrawal by Subject|1|||
16204476|NCT01688635|39226138|FG001|Washout 2|Withdrawal by Subject|0|||
16204477|NCT01688635|39226137|FG000|Washout 2|Sponsor Decision|1|||
16204478|NCT01688635|39226138|FG001|Washout 2|Sponsor Decision|2|||
16204479|NCT01688635|39226137|FG000|Washout 3|Withdrawal by Subject|1|||
16204480|NCT01688635|39226138|FG001|Washout 3|Withdrawal by Subject|0|||
16204481|NCT00260429|39226139|FG000|Overall Study|failure to follow appointments|1|||
16204482|NCT00260429|39226140|FG001|Overall Study|failure to follow appointments|0|||
16204483|NCT00260429|39226139|FG000|Overall Study|scheduled hand surgery|1|||
16204484|NCT00260429|39226140|FG001|Overall Study|scheduled hand surgery|0|||
16204485|NCT02016898|39226141|FG000|Overall Study|Death|1|||
16204486|NCT02016898|39226142|FG001|Overall Study|Death|1|||
16204487|NCT02016898|39226141|FG000|Overall Study|Lost to Follow-up|4|||
16204488|NCT02016898|39226142|FG001|Overall Study|Lost to Follow-up|4|||
16204489|NCT00194025|39226143|FG000|Overall Study|Adverse Event|1|||
16204490|NCT00194025|39226143|FG000|Overall Study|non-adherence with study medication|4|||
16204491|NCT03654755|39226145|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
16204492|NCT03654755|39226146|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
16204493|NCT03654755|39226147|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
16204494|NCT03654755|39226145|FG000|Overall Study|Withdrawal by Subject|2|||
16204495|NCT03654755|39226146|FG001|Overall Study|Withdrawal by Subject|4|||
16204496|NCT03654755|39226147|FG002|Overall Study|Withdrawal by Subject|8|||
16204497|NCT03654755|39226145|FG000|Overall Study|Lost to Follow-up|1|||
16204498|NCT03654755|39226146|FG001|Overall Study|Lost to Follow-up|3|||
16204499|NCT03654755|39226147|FG002|Overall Study|Lost to Follow-up|7|||
16204500|NCT03654755|39226145|FG000|Overall Study|Physician Decision|0|||
16204501|NCT03654755|39226146|FG001|Overall Study|Physician Decision|1|||
16204502|NCT03654755|39226147|FG002|Overall Study|Physician Decision|0|||
16204503|NCT03654755|39226145|FG000|Overall Study|Adverse Event|0|||
16204504|NCT03654755|39226146|FG001|Overall Study|Adverse Event|0|||
16204505|NCT03654755|39226147|FG002|Overall Study|Adverse Event|4|||
16204506|NCT03654755|39226145|FG000|Overall Study|Lack of Efficacy|0|||
16204507|NCT03654755|39226146|FG001|Overall Study|Lack of Efficacy|0|||
16204508|NCT03654755|39226147|FG002|Overall Study|Lack of Efficacy|1|||
16204509|NCT05552859|39226148|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
16204510|NCT05552859|39226149|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
16204511|NCT04019795|39226153|FG000|Overall Study|Withdrawal by Subject|1|||
16204512|NCT04019795|39226154|FG001|Overall Study|Withdrawal by Subject|2|||
16518409|NCT02840877|40365163|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
16518410|NCT02840877|40365163|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
16518411|NCT02840877|40365163|FG000|12 Weeks to 6 Months|Death|1|||
16518412|NCT02840877|40365163|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
16518413|NCT02840877|40365163|FG000|6 Months to 18 Months|Treatment failure|7|||
16518414|NCT02840877|40365163|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
16204513|NCT04019795|39226155|FG002|Overall Study|Withdrawal by Subject|2|||
16204514|NCT04019795|39226156|FG003|Overall Study|Withdrawal by Subject|1|||
16204515|NCT04019795|39226153|FG000|Overall Study|Lost to Follow-up|0|||
16204516|NCT04019795|39226154|FG001|Overall Study|Lost to Follow-up|1|||
16204517|NCT04019795|39226155|FG002|Overall Study|Lost to Follow-up|1|||
16204518|NCT04019795|39226156|FG003|Overall Study|Lost to Follow-up|2|||
16204519|NCT04019795|39226153|FG000|Overall Study|Treatment non-compliance|3|||
16204520|NCT04019795|39226154|FG001|Overall Study|Treatment non-compliance|1|||
16204521|NCT04019795|39226155|FG002|Overall Study|Treatment non-compliance|2|||
16204522|NCT04019795|39226156|FG003|Overall Study|Treatment non-compliance|0|||
16204523|NCT04019795|39226153|FG000|Overall Study|Physician Decision|0|||
16204524|NCT04019795|39226154|FG001|Overall Study|Physician Decision|0|||
16204525|NCT04019795|39226155|FG002|Overall Study|Physician Decision|1|||
16204526|NCT04019795|39226156|FG003|Overall Study|Physician Decision|0|||
16204527|NCT04019795|39226153|FG000|Overall Study|Adverse Event|1|||
16204528|NCT04019795|39226154|FG001|Overall Study|Adverse Event|0|||
16204529|NCT04019795|39226155|FG002|Overall Study|Adverse Event|0|||
16204530|NCT04019795|39226156|FG003|Overall Study|Adverse Event|0|||
16204531|NCT02807844|39226160|FG000|Overall Study|Physician Decision|0|||
16204532|NCT02807844|39226161|FG001|Overall Study|Physician Decision|0|||
16204533|NCT02807844|39226162|FG002|Overall Study|Physician Decision|0|||
16204534|NCT02807844|39226163|FG003|Overall Study|Physician Decision|0|||
16204535|NCT02807844|39226164|FG004|Overall Study|Physician Decision|0|||
16204536|NCT02807844|39226165|FG005|Overall Study|Physician Decision|0|||
16204537|NCT02807844|39226166|FG006|Overall Study|Physician Decision|3|||
16204538|NCT02807844|39226167|FG007|Overall Study|Physician Decision|0|||
16204539|NCT02807844|39226168|FG008|Overall Study|Physician Decision|1|||
16204540|NCT02807844|39226169|FG009|Overall Study|Physician Decision|2|||
16204541|NCT02807844|39226160|FG000|Overall Study|Death|0|||
16204542|NCT02807844|39226161|FG001|Overall Study|Death|0|||
16204543|NCT02807844|39226162|FG002|Overall Study|Death|2|||
16204544|NCT02807844|39226163|FG003|Overall Study|Death|4|||
16204545|NCT02807844|39226164|FG004|Overall Study|Death|1|||
16204546|NCT02807844|39226165|FG005|Overall Study|Death|2|||
16204547|NCT02807844|39226166|FG006|Overall Study|Death|1|||
16204548|NCT02807844|39226167|FG007|Overall Study|Death|2|||
16204549|NCT02807844|39226168|FG008|Overall Study|Death|0|||
16204550|NCT02807844|39226169|FG009|Overall Study|Death|1|||
16204551|NCT02807844|39226160|FG000|Overall Study|Withdrawal by Subject|0|||
16204552|NCT02807844|39226161|FG001|Overall Study|Withdrawal by Subject|0|||
16204553|NCT02807844|39226162|FG002|Overall Study|Withdrawal by Subject|2|||
16204554|NCT02807844|39226163|FG003|Overall Study|Withdrawal by Subject|1|||
16204555|NCT02807844|39226164|FG004|Overall Study|Withdrawal by Subject|1|||
16204556|NCT02807844|39226165|FG005|Overall Study|Withdrawal by Subject|0|||
16204557|NCT02807844|39226166|FG006|Overall Study|Withdrawal by Subject|1|||
16204558|NCT02807844|39226167|FG007|Overall Study|Withdrawal by Subject|0|||
16204559|NCT02807844|39226168|FG008|Overall Study|Withdrawal by Subject|0|||
16204560|NCT02807844|39226169|FG009|Overall Study|Withdrawal by Subject|0|||
16204561|NCT02807844|39226160|FG000|Overall Study|Progressive disease|5|||
16204562|NCT02807844|39226161|FG001|Overall Study|Progressive disease|12|||
16204563|NCT02807844|39226162|FG002|Overall Study|Progressive disease|8|||
16204564|NCT02807844|39226163|FG003|Overall Study|Progressive disease|8|||
16518415|NCT02840877|40365163|FG000|6 Months to 18 Months|Moved/transferred out|6|||
16518416|NCT02840877|40365163|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
16518417|NCT02840877|40365163|FG000|6 Months to 18 Months|Death|4|||
16092777|NCT01562275|38830249|FG002|Stage 2|Death|0|||
16204565|NCT02807844|39226164|FG004|Overall Study|Progressive disease|3|||
16204566|NCT02807844|39226165|FG005|Overall Study|Progressive disease|8|||
16204567|NCT02807844|39226166|FG006|Overall Study|Progressive disease|14|||
16204568|NCT02807844|39226167|FG007|Overall Study|Progressive disease|17|||
16518418|NCT02840877|40365163|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
16204569|NCT02807844|39226168|FG008|Overall Study|Progressive disease|19|||
16204570|NCT02807844|39226169|FG009|Overall Study|Progressive disease|15|||
16204571|NCT02807844|39226160|FG000|Overall Study|Adverse Event|1|||
16204572|NCT02807844|39226161|FG001|Overall Study|Adverse Event|0|||
16204573|NCT02807844|39226162|FG002|Overall Study|Adverse Event|0|||
16204574|NCT02807844|39226163|FG003|Overall Study|Adverse Event|0|||
16204575|NCT02807844|39226164|FG004|Overall Study|Adverse Event|1|||
16204576|NCT02807844|39226165|FG005|Overall Study|Adverse Event|1|||
16204577|NCT02807844|39226166|FG006|Overall Study|Adverse Event|1|||
16204578|NCT02807844|39226167|FG007|Overall Study|Adverse Event|1|||
16204579|NCT02807844|39226168|FG008|Overall Study|Adverse Event|1|||
16204580|NCT02807844|39226169|FG009|Overall Study|Adverse Event|2|||
16204581|NCT01019252|39226170|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
16204582|NCT01019252|39226171|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
16204583|NCT01019252|39226170|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
16204584|NCT01019252|39226171|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
16204585|NCT01019252|39226170|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
16204586|NCT01019252|39226171|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
16204587|NCT01019252|39226170|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
16204588|NCT01019252|39226171|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
16204589|NCT03170258|39226172|FG000|Overall Study|Physician Decision|4|||
16204590|NCT03170258|39226173|FG001|Overall Study|Physician Decision|0|||
16204591|NCT03170258|39226172|FG000|Overall Study|Equipment issues|1|||
16204592|NCT03170258|39226173|FG001|Overall Study|Equipment issues|0|||
16204593|NCT03170258|39226172|FG000|Overall Study|Medication|1|||
16518419|NCT02840877|40365163|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
16518420|NCT02840877|40365163|FG000|6 Months to 18 Months|Still in study.|14|||
16204594|NCT03170258|39226173|FG001|Overall Study|Medication|0|||
16204595|NCT03170258|39226172|FG000|Overall Study|Sleep issues|1|||
16204596|NCT03170258|39226173|FG001|Overall Study|Sleep issues|0|||
16204597|NCT01162304|39226175|FG000|Overall Study|Beck scale to high|11|||
16204598|NCT02174861|39226176|FG000|Overall Study|Decision by sponsor|8|||
16204599|NCT02174861|39226176|FG000|Overall Study|Withdrawal by Subject|124|||
16204600|NCT02174861|39226176|FG000|Overall Study|Lost to Follow-up|26|||
16204601|NCT04083235|39226177|FG000|Overall Study|Death|252|||
16204602|NCT04083235|39226178|FG001|Overall Study|Death|277|||
16204603|NCT04083235|39226177|FG000|Overall Study|Withdrawal by Subject|13|||
16204604|NCT04083235|39226178|FG001|Overall Study|Withdrawal by Subject|17|||
16204605|NCT04083235|39226177|FG000|Overall Study|Lost to Follow-up|1|||
16204606|NCT04083235|39226178|FG001|Overall Study|Lost to Follow-up|1|||
16204607|NCT04083235|39226177|FG000|Overall Study|Does not meet entry criteria|1|||
16204608|NCT04083235|39226178|FG001|Overall Study|Does not meet entry criteria|0|||
16204609|NCT04083235|39226177|FG000|Overall Study|Did not receive treatment|13|||
16518421|NCT02287896|40365164|FG000|Second Injection Visit|Withdrawal by Subject|0|||
16518422|NCT02287896|40365165|FG001|Second Injection Visit|Withdrawal by Subject|1|||
16518423|NCT00773097|40365166|FG000|Overall Study|Withdrawal by Subject|1|||
16518424|NCT00773097|40365166|FG000|Overall Study|Physician Decision|6|||
16518425|NCT01175382|40365169|FG000|Overall Study|Lost to Follow-up|4|||
16518426|NCT01175382|40365170|FG001|Overall Study|Lost to Follow-up|3|||
16518427|NCT01175382|40365171|FG002|Overall Study|Lost to Follow-up|1|||
16518428|NCT01175382|40365169|FG000|Overall Study|Physician Decision|0|||
16518429|NCT01175382|40365170|FG001|Overall Study|Physician Decision|1|||
16518430|NCT01175382|40365171|FG002|Overall Study|Physician Decision|0|||
16518431|NCT01175382|40365169|FG000|Overall Study|Withdrawal by Subject|0|||
16518432|NCT01175382|40365170|FG001|Overall Study|Withdrawal by Subject|0|||
16518433|NCT01175382|40365171|FG002|Overall Study|Withdrawal by Subject|1|||
16518434|NCT01175382|40365169|FG000|Overall Study|No longer having problem|1|||
16518435|NCT01175382|40365170|FG001|Overall Study|No longer having problem|0|||
16518436|NCT01175382|40365171|FG002|Overall Study|No longer having problem|1|||
16518437|NCT01175382|40365169|FG000|Overall Study|Unable/unwilling to attend visits|3|||
16518438|NCT01175382|40365170|FG001|Overall Study|Unable/unwilling to attend visits|1|||
16518439|NCT01175382|40365171|FG002|Overall Study|Unable/unwilling to attend visits|2|||
16518440|NCT01175382|40365169|FG000|Overall Study|Unwilling to follow protocol|0|||
16518441|NCT01175382|40365170|FG001|Overall Study|Unwilling to follow protocol|1|||
16518442|NCT01175382|40365171|FG002|Overall Study|Unwilling to follow protocol|0|||
16518443|NCT01175382|40365169|FG000|Overall Study|Unable to tolerate study meds|0|||
16518444|NCT01175382|40365170|FG001|Overall Study|Unable to tolerate study meds|1|||
16518445|NCT01175382|40365171|FG002|Overall Study|Unable to tolerate study meds|1|||
16518446|NCT01209624|40365176|FG000|Overall Study|Death|2|||
16518447|NCT01209624|40365176|FG000|Overall Study|Adverse Event|13|||
16518448|NCT01209624|40365176|FG000|Overall Study|Lack of Efficacy|17|||
16518449|NCT01209624|40365176|FG000|Overall Study|Lost to Follow-up|290|||
16518450|NCT01209624|40365176|FG000|Overall Study|Other|4|||
16204610|NCT04083235|39226178|FG001|Overall Study|Did not receive treatment|8|||
16204611|NCT04083235|39226177|FG000|Overall Study|Ongoing at the time of DCO|44|||
16518451|NCT03096782|40365180|FG000|Overall Study|Death|1|||
16518452|NCT03096782|40365180|FG000|Overall Study|Participant Relapsed|1|||
16518453|NCT03592641|40365183|FG000|Overall Study|Withdrawal by Subject|1|||
16518454|NCT00574405|40365184|FG000|Overall Study|Withdrawal by Subject|3|||
16518455|NCT00574405|40365185|FG001|Overall Study|Withdrawal by Subject|2|||
16518456|NCT02985736|40365186|FG000|Overall Study|Lost to Follow-up|3|||
16518457|NCT03146650|40365193|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
16518458|NCT03146650|40365193|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
16518459|NCT03146650|40365193|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
16518460|NCT03146650|40365193|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
16518461|NCT03146650|40365193|FG000|2 Year Follow-up|Death|11|||
16518462|NCT03146650|40365193|FG000|2 Year Follow-up|Still in follow-up|7|||
16518463|NCT03146650|40365193|FG000|2 Year Follow-up|Lost to Follow-up|1|||
16518464|NCT00575588|40365199|FG000|Overall Study|Adverse Event|11|||
16518465|NCT00575588|40365200|FG001|Overall Study|Adverse Event|13|||
16518466|NCT00575588|40365199|FG000|Overall Study|Withdrawal by Subject|27|||
16518467|NCT00575588|40365200|FG001|Overall Study|Withdrawal by Subject|31|||
16518468|NCT00575588|40365199|FG000|Overall Study|Lost to Follow-up|1|||
16518469|NCT00575588|40365200|FG001|Overall Study|Lost to Follow-up|3|||
16518470|NCT00575588|40365199|FG000|Overall Study|Death|4|||
16518471|NCT00575588|40365200|FG001|Overall Study|Death|2|||
16518472|NCT00575588|40365199|FG000|Overall Study|Incorrect enrollment|8|||
16518473|NCT00575588|40365200|FG001|Overall Study|Incorrect enrollment|4|||
16518474|NCT00575588|40365199|FG000|Overall Study|Study specific discontinuation criteria|203|||
16204612|NCT04083235|39226178|FG001|Overall Study|Ongoing at the time of DCO|7|||
16204613|NCT03326869|39226179|FG000|Overall Study|Study data has been lost to natural disa|1|||
16204614|NCT03326869|39226180|FG001|Overall Study|Study data has been lost to natural disa|1|||
16204615|NCT01797445|39226187|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
16204616|NCT01797445|39226188|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
16204617|NCT01797445|39226187|FG000|Double-Blind Phase|Adverse Event|3|||
16204618|NCT01797445|39226188|FG001|Double-Blind Phase|Adverse Event|0|||
16204619|NCT01797445|39226187|FG000|Double-Blind Phase|Death|5|||
16518475|NCT00575588|40365200|FG001|Overall Study|Study specific discontinuation criteria|218|||
16204620|NCT01797445|39226188|FG001|Double-Blind Phase|Death|4|||
16204621|NCT01797445|39226187|FG000|Double-Blind Phase|Pregnancy|0|||
16204622|NCT01797445|39226188|FG001|Double-Blind Phase|Pregnancy|1|||
16204623|NCT01797445|39226187|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16204624|NCT01797445|39226188|FG001|Double-Blind Phase|Lack of Efficacy|2|||
16204625|NCT01797445|39226187|FG000|Double-Blind Phase|Investigator's Discretion|15|||
16204626|NCT01797445|39226188|FG001|Double-Blind Phase|Investigator's Discretion|17|||
16204627|NCT01797445|39226187|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
16204628|NCT01797445|39226188|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
16204629|NCT01797445|39226187|FG000|Double-Blind Phase|Protocol Violation|0|||
16204630|NCT01797445|39226188|FG001|Double-Blind Phase|Protocol Violation|1|||
16204631|NCT01797445|39226187|FG000|Double-Blind Phase|Withdrew Consent|20|||
16204632|NCT01797445|39226188|FG001|Double-Blind Phase|Withdrew Consent|35|||
16204633|NCT01797445|39226187|FG000|Double-Blind Phase|Lost to Follow-up|34|||
16204634|NCT01797445|39226188|FG001|Double-Blind Phase|Lost to Follow-up|26|||
16204635|NCT01797445|39226187|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
16204636|NCT01797445|39226188|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
16204637|NCT00924729|39226194|FG000|Overall Study|insufficient volume for analysis|1|||
16204638|NCT00924729|39226195|FG001|Overall Study|insufficient volume for analysis|0|||
16204639|NCT00924729|39226194|FG000|Overall Study|Protocol Violation|1|||
16204640|NCT00924729|39226195|FG001|Overall Study|Protocol Violation|0|||
16204641|NCT02306161|39226196|FG000|Overall Study|Death|1|||
16518476|NCT00575588|40365199|FG000|Overall Study|Severe non-compliance to protocol|5|||
16518477|NCT00575588|40365200|FG001|Overall Study|Severe non-compliance to protocol|7|||
16518478|NCT00575588|40365199|FG000|Overall Study|Safety reasons|2|||
16518479|NCT00575588|40365200|FG001|Overall Study|Safety reasons|1|||
16518480|NCT00575588|40365199|FG000|Overall Study|Elevated triglyceride|1|||
16518481|NCT00575588|40365200|FG001|Overall Study|Elevated triglyceride|0|||
16518482|NCT00575588|40365199|FG000|Overall Study|Patient moved|1|||
16518483|NCT00575588|40365200|FG001|Overall Study|Patient moved|3|||
16518484|NCT00575588|40365199|FG000|Overall Study|Impossible to determine HbA1c|0|||
16518485|NCT00575588|40365200|FG001|Overall Study|Impossible to determine HbA1c|1|||
16518486|NCT01818336|40365203|FG000|Overall Study|Declined retest visit|0|||
16518487|NCT01818336|40365204|FG001|Overall Study|Declined retest visit|11|||
16204642|NCT02306161|39226197|FG001|Overall Study|Death|3|||
16204643|NCT02306161|39226196|FG000|Overall Study|Lack of Efficacy|20|||
16204644|NCT02306161|39226197|FG001|Overall Study|Lack of Efficacy|43|||
16204645|NCT02306161|39226196|FG000|Overall Study|Physician Decision|30|||
16518488|NCT01818336|40365203|FG000|Overall Study|Lost to Follow-up|0|||
16518489|NCT01818336|40365204|FG001|Overall Study|Lost to Follow-up|1|||
16518490|NCT04258839|40365205|FG000|Overall Study|Adverse Event|2|||
16518491|NCT04258839|40365206|FG001|Overall Study|Adverse Event|4|||
16518492|NCT04258839|40365205|FG000|Overall Study|Lack of Efficacy|0|||
16518493|NCT04258839|40365206|FG001|Overall Study|Lack of Efficacy|2|||
16518494|NCT04258839|40365205|FG000|Overall Study|Lost to Follow-up|2|||
16518495|NCT04258839|40365206|FG001|Overall Study|Lost to Follow-up|0|||
16518496|NCT04258839|40365205|FG000|Overall Study|Withdrawal by Subject|1|||
16518497|NCT04258839|40365206|FG001|Overall Study|Withdrawal by Subject|2|||
16518498|NCT04258839|40365205|FG000|Overall Study|Withdrawal by Caregiver|5|||
16518499|NCT04258839|40365206|FG001|Overall Study|Withdrawal by Caregiver|6|||
16518500|NCT04258839|40365205|FG000|Overall Study|Reason not Specified|0|||
16518501|NCT04258839|40365206|FG001|Overall Study|Reason not Specified|1|||
16518502|NCT01410110|40365207|FG000|Overall Study|Withdrawal by Subject|4|||
16518503|NCT01410110|40365208|FG001|Overall Study|Withdrawal by Subject|2|||
16518504|NCT02907359|40365209|FG000|Overall Study|Death|234|||
16518505|NCT02907359|40365210|FG001|Overall Study|Death|117|||
16518506|NCT02907359|40365209|FG000|Overall Study|Withdrawal by Subject|6|||
16518507|NCT02907359|40365210|FG001|Overall Study|Withdrawal by Subject|11|||
16518508|NCT02907359|40365209|FG000|Overall Study|Lost to Follow-up|1|||
16518509|NCT02907359|40365210|FG001|Overall Study|Lost to Follow-up|0|||
16518510|NCT01786629|40365211|FG000|Overall Study|Lack of Efficacy|0|||
16518511|NCT01786629|40365212|FG001|Overall Study|Lack of Efficacy|4|||
16518512|NCT01786629|40365211|FG000|Overall Study|Adverse Event|0|||
16518513|NCT01786629|40365212|FG001|Overall Study|Adverse Event|1|||
16518514|NCT00667342|40368364|FG000|Overall Study|Protocol Violation|1|||
16518515|NCT00667342|40368365|FG001|Overall Study|Protocol Violation|0|||
16518516|NCT00667342|40368366|FG002|Overall Study|Protocol Violation|0|||
16518517|NCT00667342|40368364|FG000|Overall Study|Withdrawal by Subject|1|||
16518518|NCT00667342|40368365|FG001|Overall Study|Withdrawal by Subject|0|||
16518519|NCT00667342|40368366|FG002|Overall Study|Withdrawal by Subject|0|||
16518520|NCT00667342|40368364|FG000|Overall Study|Physician Decision|3|||
16518521|NCT00667342|40368365|FG001|Overall Study|Physician Decision|0|||
16518522|NCT00667342|40368366|FG002|Overall Study|Physician Decision|0|||
16518523|NCT00667342|40368364|FG000|Overall Study|Relapse or tumor progression|9|||
16518524|NCT00667342|40368365|FG001|Overall Study|Relapse or tumor progression|0|||
16518525|NCT00667342|40368366|FG002|Overall Study|Relapse or tumor progression|7|||
16204646|NCT02306161|39226197|FG001|Overall Study|Physician Decision|18|||
16204647|NCT02306161|39226196|FG000|Overall Study|Withdrawal by Subject|4|||
16204648|NCT02306161|39226197|FG001|Overall Study|Withdrawal by Subject|0|||
16204649|NCT02306161|39226196|FG000|Overall Study|Ineligible|9|||
16204650|NCT02306161|39226197|FG001|Overall Study|Ineligible|5|||
16204651|NCT01135017|39226200|FG000|Overall Study|Adverse Event|3|||
16204652|NCT01135017|39226201|FG001|Overall Study|Adverse Event|8|||
16204653|NCT01135017|39226200|FG000|Overall Study|Other than above|3|||
16204654|NCT01135017|39226201|FG001|Overall Study|Other than above|4|||
16204655|NCT01601704|39226202|FG000|Overall Study|Randomized but not dispensed study med|1|||
16204656|NCT01601704|39226203|FG001|Overall Study|Randomized but not dispensed study med|4|||
16204657|NCT00340834|39226204|FG000|Core Phase of Study|Adverse Event|26|||
16204658|NCT00340834|39226205|FG001|Core Phase of Study|Adverse Event|9|||
16204659|NCT00340834|39226206|FG002|Core Phase of Study|Adverse Event|9|||
16204660|NCT00340834|39226207|FG003|Core Phase of Study|Adverse Event|0|||
16204661|NCT00340834|39226208|FG004|Core Phase of Study|Adverse Event|0|||
16204662|NCT00340834|39226204|FG000|Core Phase of Study|Withdrawal by Subject|11|||
16204663|NCT00340834|39226205|FG001|Core Phase of Study|Withdrawal by Subject|9|||
16204664|NCT00340834|39226206|FG002|Core Phase of Study|Withdrawal by Subject|16|||
16204665|NCT00340834|39226207|FG003|Core Phase of Study|Withdrawal by Subject|0|||
16204666|NCT00340834|39226208|FG004|Core Phase of Study|Withdrawal by Subject|0|||
16204667|NCT00340834|39226204|FG000|Core Phase of Study|Administrative Problems|6|||
16204668|NCT00340834|39226205|FG001|Core Phase of Study|Administrative Problems|2|||
16204669|NCT00340834|39226206|FG002|Core Phase of Study|Administrative Problems|7|||
16204670|NCT00340834|39226207|FG003|Core Phase of Study|Administrative Problems|0|||
16204671|NCT00340834|39226208|FG004|Core Phase of Study|Administrative Problems|0|||
16204672|NCT00340834|39226204|FG000|Core Phase of Study|Lack of Efficacy|3|||
16204673|NCT00340834|39226205|FG001|Core Phase of Study|Lack of Efficacy|3|||
16204674|NCT00340834|39226206|FG002|Core Phase of Study|Lack of Efficacy|7|||
16204675|NCT00340834|39226207|FG003|Core Phase of Study|Lack of Efficacy|0|||
16204676|NCT00340834|39226208|FG004|Core Phase of Study|Lack of Efficacy|0|||
16204677|NCT00340834|39226204|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
16204678|NCT00340834|39226205|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
16204679|NCT00340834|39226206|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
16204680|NCT00340834|39226207|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
16204681|NCT00340834|39226208|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
16204682|NCT00340834|39226204|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
16518526|NCT00667342|40368364|FG000|Overall Study|Adverse Event|0|||
16518527|NCT00667342|40368365|FG001|Overall Study|Adverse Event|0|||
16518528|NCT00667342|40368366|FG002|Overall Study|Adverse Event|1|||
16518529|NCT00667342|40368364|FG000|Overall Study|Ineligible|0|||
16518530|NCT00667342|40368365|FG001|Overall Study|Ineligible|0|||
16518531|NCT00667342|40368366|FG002|Overall Study|Ineligible|1|||
16518532|NCT02039427|40368367|FG000|Overall Study|Duration of surgery > 3h|1|||
16204683|NCT00340834|39226205|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
16204684|NCT00340834|39226206|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
16204685|NCT00340834|39226207|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
16204686|NCT00340834|39226208|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
16204687|NCT00340834|39226204|FG000|Core Phase of Study|Lost to Follow-up|1|||
16204688|NCT00340834|39226205|FG001|Core Phase of Study|Lost to Follow-up|1|||
16204689|NCT00340834|39226206|FG002|Core Phase of Study|Lost to Follow-up|4|||
16204690|NCT00340834|39226207|FG003|Core Phase of Study|Lost to Follow-up|0|||
16204691|NCT00340834|39226208|FG004|Core Phase of Study|Lost to Follow-up|0|||
16204692|NCT00340834|39226204|FG000|Core Phase of Study|Death|2|||
16204693|NCT00340834|39226205|FG001|Core Phase of Study|Death|0|||
16204694|NCT00340834|39226206|FG002|Core Phase of Study|Death|0|||
16204695|NCT00340834|39226207|FG003|Core Phase of Study|Death|0|||
16204696|NCT00340834|39226208|FG004|Core Phase of Study|Death|0|||
16204697|NCT00340834|39226204|FG000|Core Phase of Study|Protocol Violation|0|||
16204698|NCT00340834|39226205|FG001|Core Phase of Study|Protocol Violation|0|||
16204699|NCT00340834|39226206|FG002|Core Phase of Study|Protocol Violation|2|||
16204700|NCT00340834|39226207|FG003|Core Phase of Study|Protocol Violation|0|||
16204701|NCT00340834|39226208|FG004|Core Phase of Study|Protocol Violation|0|||
16204702|NCT00340834|39226204|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
16204703|NCT00340834|39226205|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
16204704|NCT00340834|39226206|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
16204705|NCT00340834|39226207|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
16204706|NCT00340834|39226208|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
16204707|NCT00340834|39226204|FG000|Extension Phase of Study|Subject withdrew consent|26|||
16204708|NCT00340834|39226205|FG001|Extension Phase of Study|Subject withdrew consent|31|||
16204709|NCT00340834|39226206|FG002|Extension Phase of Study|Subject withdrew consent|0|||
16204710|NCT00340834|39226207|FG003|Extension Phase of Study|Subject withdrew consent|12|||
16204711|NCT00340834|39226208|FG004|Extension Phase of Study|Subject withdrew consent|15|||
16204712|NCT00340834|39226204|FG000|Extension Phase of Study|Adverse Event|21|||
16204713|NCT00340834|39226205|FG001|Extension Phase of Study|Adverse Event|22|||
16204714|NCT00340834|39226206|FG002|Extension Phase of Study|Adverse Event|0|||
16204715|NCT00340834|39226207|FG003|Extension Phase of Study|Adverse Event|19|||
16204716|NCT00340834|39226208|FG004|Extension Phase of Study|Adverse Event|7|||
16204717|NCT00340834|39226204|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
16204718|NCT00340834|39226205|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
16204719|NCT00340834|39226206|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
16204720|NCT00340834|39226207|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
16204721|NCT00340834|39226208|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
16204722|NCT00340834|39226204|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
16204723|NCT00340834|39226205|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
16204724|NCT00340834|39226206|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
16204725|NCT00340834|39226207|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
16204726|NCT00340834|39226208|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
16204727|NCT00340834|39226204|FG000|Extension Phase of Study|Lost to Follow-up|1|||
16204728|NCT00340834|39226205|FG001|Extension Phase of Study|Lost to Follow-up|1|||
16204729|NCT00340834|39226206|FG002|Extension Phase of Study|Lost to Follow-up|0|||
16204730|NCT00340834|39226207|FG003|Extension Phase of Study|Lost to Follow-up|2|||
16204731|NCT00340834|39226208|FG004|Extension Phase of Study|Lost to Follow-up|3|||
16204732|NCT00340834|39226204|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
16204733|NCT00340834|39226205|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
16204734|NCT00340834|39226206|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
16204735|NCT00340834|39226207|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
16204736|NCT00340834|39226208|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
16204737|NCT00340834|39226204|FG000|Extension Phase of Study|Administrative problems|3|||
16204738|NCT00340834|39226205|FG001|Extension Phase of Study|Administrative problems|0|||
16204739|NCT00340834|39226206|FG002|Extension Phase of Study|Administrative problems|0|||
16204740|NCT00340834|39226207|FG003|Extension Phase of Study|Administrative problems|1|||
16204741|NCT00340834|39226208|FG004|Extension Phase of Study|Administrative problems|1|||
16204742|NCT00340834|39226204|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
16204743|NCT00340834|39226205|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
16204744|NCT00340834|39226206|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
16204745|NCT00340834|39226207|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
16204746|NCT00340834|39226208|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
16204747|NCT00340834|39226204|FG000|Extension Phase of Study|Protocol Violation|3|||
16204748|NCT00340834|39226205|FG001|Extension Phase of Study|Protocol Violation|0|||
16204749|NCT00340834|39226206|FG002|Extension Phase of Study|Protocol Violation|0|||
16204750|NCT00340834|39226207|FG003|Extension Phase of Study|Protocol Violation|0|||
16204751|NCT00340834|39226208|FG004|Extension Phase of Study|Protocol Violation|0|||
16204752|NCT00340834|39226204|FG000|Extension Phase of Study|Death|0|||
16204753|NCT00340834|39226205|FG001|Extension Phase of Study|Death|0|||
16204754|NCT00340834|39226206|FG002|Extension Phase of Study|Death|0|||
16204755|NCT00340834|39226207|FG003|Extension Phase of Study|Death|0|||
16204756|NCT00340834|39226208|FG004|Extension Phase of Study|Death|1|||
16204757|NCT01624506|39226209|FG000|Overall Study|Lost to Follow-up|29|||
16204758|NCT01624506|39226210|FG001|Overall Study|Lost to Follow-up|15|||
16204759|NCT01624506|39226209|FG000|Overall Study|Withdrawal by Subject|9|||
16204760|NCT01624506|39226210|FG001|Overall Study|Withdrawal by Subject|2|||
16204761|NCT01624506|39226209|FG000|Overall Study|Death|1|||
16204762|NCT01624506|39226210|FG001|Overall Study|Death|0|||
16204763|NCT01624506|39226209|FG000|Overall Study|LINX explants|23|||
16204764|NCT01624506|39226210|FG001|Overall Study|LINX explants|0|||
16204765|NCT01624506|39226209|FG000|Overall Study|Adverse Event|3|||
16204766|NCT01624506|39226210|FG001|Overall Study|Adverse Event|0|||
16204767|NCT02337686|39226211|FG000|Overall Study|Adverse Event|1|||
16204768|NCT01590212|39226212|FG000|Overall Study|Withdrawal by Subject|2|||
16204769|NCT01590212|39226213|FG001|Overall Study|Withdrawal by Subject|2|||
16204770|NCT01590212|39226214|FG002|Overall Study|Withdrawal by Subject|2|||
16204771|NCT01590212|39226212|FG000|Overall Study|Lost to Follow-up|1|||
16204772|NCT01590212|39226213|FG001|Overall Study|Lost to Follow-up|2|||
16204773|NCT01590212|39226214|FG002|Overall Study|Lost to Follow-up|3|||
16204774|NCT02067533|39226215|FG000|Overall Study|Lost to Follow-up|4|||
16204775|NCT02067533|39226216|FG001|Overall Study|Lost to Follow-up|2|||
16204776|NCT01270958|39226217|FG000|Overall Study|Lost to Follow-up|2|||
16204777|NCT01270958|39226217|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
16204778|NCT01090102|39226218|FG000|First 12 Weeks|Withdrawal by Subject|1|||
16204779|NCT01090102|39226219|FG001|First 12 Weeks|Withdrawal by Subject|1|||
16204780|NCT01090102|39226218|FG000|First 12 Weeks|Adverse Event|2|||
16204781|NCT01090102|39226219|FG001|First 12 Weeks|Adverse Event|0|||
16204782|NCT01090102|39226218|FG000|First 12 Weeks|Death|1|||
16204783|NCT01090102|39226219|FG001|First 12 Weeks|Death|1|||
16204784|NCT01090102|39226218|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
16204785|NCT01090102|39226219|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
16204786|NCT02650895|39226220|FG000|Overall Study|Withdrawal by Subject|0|||
16204787|NCT02650895|39226221|FG001|Overall Study|Withdrawal by Subject|1|||
16204788|NCT02650895|39226222|FG002|Overall Study|Withdrawal by Subject|0|||
16204789|NCT02650895|39226223|FG003|Overall Study|Withdrawal by Subject|0|||
16204790|NCT02650895|39226224|FG004|Overall Study|Withdrawal by Subject|0|||
16204791|NCT02650895|39226225|FG005|Overall Study|Withdrawal by Subject|0|||
16204792|NCT01369849|39226226|FG000|Overall Study|Ineligible prior to treatment|0|||
16204793|NCT01369849|39226227|FG001|Overall Study|Ineligible prior to treatment|0|||
16204794|NCT01369849|39226228|FG002|Overall Study|Ineligible prior to treatment|1|||
16204795|NCT01369849|39226226|FG000|Overall Study|Ineligible after receiving treatment|0|||
16204796|NCT01369849|39226227|FG001|Overall Study|Ineligible after receiving treatment|1|||
16204797|NCT01369849|39226228|FG002|Overall Study|Ineligible after receiving treatment|0|||
16204798|NCT02988219|39226232|FG000|Overall Study|Lack of Efficacy|1|||
16204799|NCT02988219|39226233|FG001|Overall Study|Lack of Efficacy|1|||
16204800|NCT02988219|39226232|FG000|Overall Study|Withdrawal by Subject|0|||
16204801|NCT02988219|39226233|FG001|Overall Study|Withdrawal by Subject|2|||
16204802|NCT04294095|39226234|FG000|Overall Study|Adverse Event|1|||
16204803|NCT04294095|39226235|FG001|Overall Study|Adverse Event|0|||
16204804|NCT00023712|39226236|FG000|Overall Study|Not platinum sensitive|1|||
16204805|NCT00023712|39226237|FG001|Overall Study|Not platinum sensitive|0|||
16204806|NCT00023712|39226236|FG000|Overall Study|Never treated|1|||
16204807|NCT00023712|39226237|FG001|Overall Study|Never treated|1|||
16204808|NCT00653328|39226244|FG000|Overall Study|Withdrawal by Subject|1|||
16204809|NCT00653328|39226244|FG000|Overall Study|Adverse Event|2|||
16204810|NCT00653328|39226244|FG000|Overall Study|Disease progression|10|||
16204811|NCT00653328|39226244|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
16204812|NCT02177175|39226245|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
16204813|NCT02177175|39226246|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
16204814|NCT00961116|39226247|FG000|Washout Period of 7 Days|Adverse Event|1|||
16204815|NCT00961116|39226248|FG001|Washout Period of 7 Days|Adverse Event|1|||
16204816|NCT00961116|39226247|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
16204817|NCT00961116|39226248|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16204818|NCT00961116|39226247|FG000|Washout Period of 7 Days|Protocol Violation|0|||
16204819|NCT00961116|39226248|FG001|Washout Period of 7 Days|Protocol Violation|1|||
16204820|NCT00912340|39226249|FG000|Overall Study|Adverse Event|2|||
16204821|NCT00912340|39226250|FG001|Overall Study|Adverse Event|4|||
16204822|NCT00912340|39226251|FG002|Overall Study|Adverse Event|0|||
16204823|NCT00912340|39226249|FG000|Overall Study|Protocol revised to remove arm|0|||
16204824|NCT00912340|39226250|FG001|Overall Study|Protocol revised to remove arm|0|||
16204825|NCT00912340|39226251|FG002|Overall Study|Protocol revised to remove arm|4|||
16204826|NCT02899377|39226252|FG000|Overall Study|Adverse Event|1|||
16204827|NCT02899377|39226253|FG001|Overall Study|Adverse Event|0|||
16204828|NCT00888615|39226254|FG000|Overall Study|No treatment|2|||
16204829|NCT03479216|39226255|FG000|Overall Study|Withdrawal by Subject|3|||
16204830|NCT03479216|39226256|FG001|Overall Study|Withdrawal by Subject|2|||
16204831|NCT03479216|39226255|FG000|Overall Study|Physician Decision|2|||
16204832|NCT03479216|39226256|FG001|Overall Study|Physician Decision|3|||
16204833|NCT00637377|39226258|FG000|Overall Study|Adverse Event|2|||
16204834|NCT00637377|39226259|FG001|Overall Study|Adverse Event|6|||
16204835|NCT00637377|39226260|FG002|Overall Study|Adverse Event|8|||
16204836|NCT00637377|39226261|FG003|Overall Study|Adverse Event|9|||
16204837|NCT00637377|39226258|FG000|Overall Study|Death|1|||
16204838|NCT00637377|39226259|FG001|Overall Study|Death|3|||
16204839|NCT00637377|39226260|FG002|Overall Study|Death|2|||
16204840|NCT00637377|39226261|FG003|Overall Study|Death|1|||
16204841|NCT00637377|39226258|FG000|Overall Study|Lack of Efficacy|0|||
16204842|NCT00637377|39226259|FG001|Overall Study|Lack of Efficacy|0|||
16204843|NCT00637377|39226260|FG002|Overall Study|Lack of Efficacy|1|||
16204844|NCT00637377|39226261|FG003|Overall Study|Lack of Efficacy|1|||
16204845|NCT00637377|39226258|FG000|Overall Study|Lost to Follow-up|4|||
16204846|NCT00637377|39226259|FG001|Overall Study|Lost to Follow-up|1|||
16204847|NCT00637377|39226260|FG002|Overall Study|Lost to Follow-up|2|||
16204848|NCT00637377|39226261|FG003|Overall Study|Lost to Follow-up|2|||
16204849|NCT00637377|39226258|FG000|Overall Study|Protocol Violation|2|||
16204850|NCT00637377|39226259|FG001|Overall Study|Protocol Violation|1|||
16204851|NCT00637377|39226260|FG002|Overall Study|Protocol Violation|1|||
16204852|NCT00637377|39226261|FG003|Overall Study|Protocol Violation|0|||
16204853|NCT00637377|39226258|FG000|Overall Study|Withdrawal by Subject|11|||
16204854|NCT00637377|39226259|FG001|Overall Study|Withdrawal by Subject|15|||
16204855|NCT00637377|39226260|FG002|Overall Study|Withdrawal by Subject|13|||
16204856|NCT00637377|39226261|FG003|Overall Study|Withdrawal by Subject|11|||
16204857|NCT00637377|39226258|FG000|Overall Study|Other (no further information available)|7|||
16204858|NCT00637377|39226259|FG001|Overall Study|Other (no further information available)|6|||
16204859|NCT00637377|39226260|FG002|Overall Study|Other (no further information available)|10|||
16204860|NCT00637377|39226261|FG003|Overall Study|Other (no further information available)|5|||
16204861|NCT03594110|39226262|FG000|Overall Study|Participant concerned about study treatment|23|||
16204862|NCT03594110|39226263|FG001|Overall Study|Participant concerned about study treatment|28|||
16204863|NCT03594110|39226262|FG000|Overall Study|Doctor advice|38|||
16204864|NCT03594110|39226263|FG001|Overall Study|Doctor advice|40|||
16204865|NCT03594110|39226262|FG000|Overall Study|Participants' wish|89|||
16204866|NCT03594110|39226263|FG001|Overall Study|Participants' wish|68|||
16204867|NCT03594110|39226262|FG000|Overall Study|Adverse Event|119|||
16204868|NCT03594110|39226263|FG001|Overall Study|Adverse Event|116|||
16204869|NCT03594110|39226262|FG000|Overall Study|Study drug stopped, reason missing|337|||
16518533|NCT02039427|40368368|FG001|Overall Study|Duration of surgery > 3h|1|||
16518534|NCT02039427|40368369|FG002|Overall Study|Duration of surgery > 3h|0|||
16518535|NCT02039427|40368370|FG003|Overall Study|Duration of surgery > 3h|0|||
16518536|NCT02039427|40368367|FG000|Overall Study|Withdrawal on concent|0|||
16518537|NCT02039427|40368368|FG001|Overall Study|Withdrawal on concent|0|||
16518538|NCT02039427|40368369|FG002|Overall Study|Withdrawal on concent|0|||
16518539|NCT02039427|40368370|FG003|Overall Study|Withdrawal on concent|1|||
16204870|NCT03594110|39226263|FG001|Overall Study|Study drug stopped, reason missing|295|||
16204871|NCT03594110|39226262|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
16204872|NCT03594110|39226263|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
16204873|NCT03594110|39226262|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
16204874|NCT03594110|39226263|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
16204875|NCT03594110|39226262|FG000|Overall Study|Contraindicated drug started|32|||
16204876|NCT03594110|39226263|FG001|Overall Study|Contraindicated drug started|18|||
16204877|NCT03594110|39226262|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
16204878|NCT03594110|39226263|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
16204879|NCT03594110|39226262|FG000|Overall Study|Death|129|||
16204880|NCT03594110|39226263|FG001|Overall Study|Death|120|||
16204881|NCT04024462|39226264|FG000|Overall Study|Withdrawal by Subject|6|||
16204882|NCT04024462|39226265|FG001|Overall Study|Withdrawal by Subject|7|||
16204883|NCT04024462|39226264|FG000|Overall Study|Progressive Disease|0|||
16204884|NCT04024462|39226265|FG001|Overall Study|Progressive Disease|1|||
16204885|NCT04024462|39226264|FG000|Overall Study|Adverse Event|0|||
16204886|NCT04024462|39226265|FG001|Overall Study|Adverse Event|1|||
16204887|NCT04024462|39226264|FG000|Overall Study|Death|0|||
16204888|NCT04024462|39226265|FG001|Overall Study|Death|1|||
16204889|NCT04024462|39226264|FG000|Overall Study|Lost to Follow-up|1|||
16204890|NCT04024462|39226265|FG001|Overall Study|Lost to Follow-up|0|||
16204891|NCT04024462|39226264|FG000|Overall Study|Ongoing in the Study|94|||
16518540|NCT02039427|40368367|FG000|Overall Study|Cancellation of surgery|0|||
16204892|NCT04024462|39226265|FG001|Overall Study|Ongoing in the Study|89|||
16204893|NCT03032510|39226268|FG000|Overall Study|Adverse Event|5|||
16204894|NCT03032510|39226269|FG001|Overall Study|Adverse Event|2|||
16204895|NCT03032510|39226268|FG000|Overall Study|Lost to Follow-up|8|||
16204896|NCT03032510|39226269|FG001|Overall Study|Lost to Follow-up|7|||
16204897|NCT03032510|39226268|FG000|Overall Study|Withdrawal by Subject|8|||
16204898|NCT03032510|39226269|FG001|Overall Study|Withdrawal by Subject|7|||
16204899|NCT03032510|39226268|FG000|Overall Study|Subject noncompliance|4|||
16204900|NCT03032510|39226269|FG001|Overall Study|Subject noncompliance|2|||
16204901|NCT03032510|39226268|FG000|Overall Study|Physician Decision|2|||
16204902|NCT03032510|39226269|FG001|Overall Study|Physician Decision|0|||
16204903|NCT01938001|39226272|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
16204904|NCT01938001|39226273|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
16204905|NCT01938001|39226272|FG000|Pre-Treatment|Death|1|||
16204906|NCT01938001|39226273|FG001|Pre-Treatment|Death|0|||
16204907|NCT01938001|39226272|FG000|Treatment|Death|2|||
16204908|NCT01938001|39226273|FG001|Treatment|Death|0|||
16204909|NCT01938001|39226272|FG000|Treatment|Adverse Event|14|||
16204910|NCT01938001|39226273|FG001|Treatment|Adverse Event|8|||
16204911|NCT01938001|39226272|FG000|Treatment|Progressive Disease|21|||
16204912|NCT01938001|39226273|FG001|Treatment|Progressive Disease|54|||
16204913|NCT01938001|39226272|FG000|Treatment|Withdrawal by Subject|13|||
16204914|NCT01938001|39226273|FG001|Treatment|Withdrawal by Subject|7|||
16204915|NCT01938001|39226272|FG000|Treatment|Other reasons|2|||
16204916|NCT01938001|39226273|FG001|Treatment|Other reasons|1|||
16204917|NCT00830115|39229647|FG000|Overall Study|Adverse Event|2|||
16204918|NCT00830115|39229647|FG000|Overall Study|Improvement/recovery|1|||
16204919|NCT00510484|39229654|FG000|Wash-out Period|Adverse Event|0|||
16204920|NCT00510484|39229655|FG001|Wash-out Period|Adverse Event|1|||
16204921|NCT01015820|39229656|FG000|Overall Study|Suboptimal measurements|1|||
16204922|NCT01015820|39229657|FG001|Overall Study|Suboptimal measurements|0|||
16204923|NCT02379390|39229658|FG000|Overall Study|Adverse Event|1|||
16204924|NCT02379390|39229659|FG001|Overall Study|Adverse Event|1|||
16204925|NCT02379390|39229658|FG000|Overall Study|Investigator's decision|1|||
16204926|NCT02379390|39229659|FG001|Overall Study|Investigator's decision|0|||
16204927|NCT02379390|39229658|FG000|Overall Study|Study Termination|0|||
16204928|NCT02379390|39229659|FG001|Overall Study|Study Termination|1|||
16204929|NCT03271307|39229663|FG000|Overall Study|Lost to Follow-up|0|||
16204930|NCT03271307|39229664|FG001|Overall Study|Lost to Follow-up|0|||
16204931|NCT03271307|39229665|FG002|Overall Study|Lost to Follow-up|0|||
16204932|NCT03271307|39229666|FG003|Overall Study|Lost to Follow-up|28|||
16204933|NCT03271307|39229667|FG004|Overall Study|Lost to Follow-up|91|||
16204934|NCT01018511|39229668|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
16204935|NCT01018511|39229669|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
16204936|NCT01018511|39229670|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
16204937|NCT01018511|39229671|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
16204938|NCT01018511|39229668|FG000|Overall Study|Adverse Event|5|||
16204939|NCT01018511|39229669|FG001|Overall Study|Adverse Event|9|||
16204940|NCT01018511|39229670|FG002|Overall Study|Adverse Event|13|||
16204941|NCT01018511|39229671|FG003|Overall Study|Adverse Event|10|||
16204942|NCT01018511|39229668|FG000|Overall Study|Lack of Efficacy|4|||
16204943|NCT01018511|39229669|FG001|Overall Study|Lack of Efficacy|1|||
16204944|NCT01018511|39229670|FG002|Overall Study|Lack of Efficacy|1|||
16204945|NCT01018511|39229671|FG003|Overall Study|Lack of Efficacy|2|||
16204946|NCT01018511|39229668|FG000|Overall Study|Withdrawal by Subject|6|||
16204947|NCT01018511|39229669|FG001|Overall Study|Withdrawal by Subject|5|||
16204948|NCT01018511|39229670|FG002|Overall Study|Withdrawal by Subject|11|||
16204949|NCT01018511|39229671|FG003|Overall Study|Withdrawal by Subject|9|||
16204950|NCT01018511|39229668|FG000|Overall Study|Lost to Follow-up|0|||
16204951|NCT01018511|39229669|FG001|Overall Study|Lost to Follow-up|0|||
16204952|NCT01018511|39229670|FG002|Overall Study|Lost to Follow-up|1|||
16322934|NCT00976820|39667684|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
16204953|NCT01018511|39229671|FG003|Overall Study|Lost to Follow-up|0|||
16204954|NCT01018511|39229668|FG000|Overall Study|Protocol Violation|5|||
16204955|NCT01018511|39229669|FG001|Overall Study|Protocol Violation|8|||
16204956|NCT01018511|39229670|FG002|Overall Study|Protocol Violation|7|||
16204957|NCT01018511|39229671|FG003|Overall Study|Protocol Violation|9|||
16204958|NCT01018511|39229668|FG000|Overall Study|Miscellaneous|0|||
16204959|NCT01018511|39229669|FG001|Overall Study|Miscellaneous|2|||
16204960|NCT01018511|39229670|FG002|Overall Study|Miscellaneous|0|||
16204961|NCT01018511|39229671|FG003|Overall Study|Miscellaneous|0|||
16204962|NCT02137837|39229672|FG000|Overall Study|Adverse Event|0|||
16204963|NCT02137837|39229673|FG001|Overall Study|Adverse Event|2|||
16204964|NCT02137837|39229674|FG002|Overall Study|Adverse Event|1|||
16204965|NCT02137837|39229672|FG000|Overall Study|Refusal unrelated to adverse event|2|||
16204966|NCT02137837|39229673|FG001|Overall Study|Refusal unrelated to adverse event|2|||
16204967|NCT02137837|39229674|FG002|Overall Study|Refusal unrelated to adverse event|1|||
16204968|NCT02137837|39229672|FG000|Overall Study|Progression/relapse|9|||
16322935|NCT00976820|39667685|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
16204969|NCT02137837|39229673|FG001|Overall Study|Progression/relapse|7|||
16204970|NCT02137837|39229674|FG002|Overall Study|Progression/relapse|7|||
16204971|NCT02137837|39229672|FG000|Overall Study|Not protocol specified|2|||
16204972|NCT02137837|39229673|FG001|Overall Study|Not protocol specified|1|||
16204973|NCT02137837|39229674|FG002|Overall Study|Not protocol specified|3|||
16204974|NCT00966693|39229675|FG000|Overall Study|Adverse Event|0|||
16204975|NCT00966693|39229676|FG001|Overall Study|Adverse Event|0|||
16204976|NCT00966693|39229677|FG002|Overall Study|Adverse Event|1|||
16204977|NCT00966693|39229678|FG003|Overall Study|Adverse Event|2|||
16204978|NCT00966693|39229675|FG000|Overall Study|Death|0|||
16204979|NCT00966693|39229676|FG001|Overall Study|Death|0|||
16204980|NCT00966693|39229677|FG002|Overall Study|Death|1|||
16204981|NCT00966693|39229678|FG003|Overall Study|Death|0|||
16204982|NCT00966693|39229675|FG000|Overall Study|Withdrawal by Subject|1|||
16204983|NCT00966693|39229676|FG001|Overall Study|Withdrawal by Subject|0|||
16204984|NCT00966693|39229677|FG002|Overall Study|Withdrawal by Subject|0|||
16204985|NCT00966693|39229678|FG003|Overall Study|Withdrawal by Subject|5|||
16204986|NCT00966693|39229675|FG000|Overall Study|Disease Progression|0|||
16204987|NCT00966693|39229676|FG001|Overall Study|Disease Progression|0|||
16204988|NCT00966693|39229677|FG002|Overall Study|Disease Progression|1|||
16204989|NCT00966693|39229678|FG003|Overall Study|Disease Progression|16|||
16204990|NCT03488238|39229683|FG000|Overall Study|Equipment malfunction|1|||
16204991|NCT03488238|39229683|FG000|Overall Study|Adverse Event|1|||
16204992|NCT00323310|39229684|FG000|Overall Study|Withdrawal by Subject|1|||
16204993|NCT00323310|39229684|FG000|Overall Study|a parent refused blood draw|1|||
16322936|NCT00976820|39667686|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
16322937|NCT00976820|39667687|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
16322938|NCT00976820|39667684|FG000|Overall Study|Withdrawal by Subject|2|||
16322939|NCT00976820|39667685|FG001|Overall Study|Withdrawal by Subject|4|||
16322940|NCT00976820|39667686|FG002|Overall Study|Withdrawal by Subject|1|||
16322941|NCT00976820|39667687|FG003|Overall Study|Withdrawal by Subject|4|||
16322942|NCT01062113|39667688|FG000|Overall Study|Adverse Event|1|||
16322943|NCT01062113|39667689|FG001|Overall Study|Adverse Event|0|||
16322944|NCT01062113|39667690|FG002|Overall Study|Adverse Event|0|||
16322945|NCT01062113|39667688|FG000|Overall Study|Lack of Efficacy|38|||
16322946|NCT01062113|39667689|FG001|Overall Study|Lack of Efficacy|22|||
16092778|NCT01562275|38830250|FG003|Stage 2|Death|0|||
16092779|NCT01562275|38830251|FG004|Stage 2|Death|0|||
16092780|NCT01562275|38830252|FG005|Stage 2|Death|0|||
16092781|NCT01562275|38830253|FG006|Stage 2|Death|0|||
16092782|NCT01562275|38830254|FG007|Stage 2|Death|0|||
16092783|NCT01562275|38830255|FG008|Stage 2|Death|0|||
16092784|NCT01562275|38830256|FG009|Stage 2|Death|0|||
16092785|NCT01562275|38830257|FG010|Stage 2|Death|0|||
16092786|NCT01562275|38830258|FG011|Stage 2|Death|2|||
16092787|NCT01562275|38830259|FG012|Stage 2|Death|1|||
16092788|NCT01562275|38830247|FG000|Stage 2|Progression of Disease|0|||
16092789|NCT01562275|38830248|FG001|Stage 2|Progression of Disease|0|||
16092790|NCT01562275|38830249|FG002|Stage 2|Progression of Disease|0|||
16092791|NCT01562275|38830250|FG003|Stage 2|Progression of Disease|0|||
16092792|NCT01562275|38830251|FG004|Stage 2|Progression of Disease|0|||
16092793|NCT01562275|38830252|FG005|Stage 2|Progression of Disease|0|||
16204994|NCT00323310|39229684|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
16204995|NCT00094835|39229685|FG000|Overall Study|Physician Decision|1|||
16204996|NCT00094835|39229686|FG001|Overall Study|Physician Decision|0|||
16322947|NCT01062113|39667690|FG002|Overall Study|Lack of Efficacy|31|||
16204997|NCT00094835|39229687|FG002|Overall Study|Physician Decision|0|||
16322948|NCT01062113|39667688|FG000|Overall Study|Withdrawal by Subject|1|||
16092794|NCT01562275|38830253|FG006|Stage 2|Progression of Disease|0|||
16092795|NCT01562275|38830254|FG007|Stage 2|Progression of Disease|0|||
16092796|NCT01562275|38830255|FG008|Stage 2|Progression of Disease|0|||
16092797|NCT01562275|38830256|FG009|Stage 2|Progression of Disease|0|||
16092798|NCT01562275|38830257|FG010|Stage 2|Progression of Disease|0|||
16092799|NCT01562275|38830258|FG011|Stage 2|Progression of Disease|12|||
16204998|NCT00094835|39229688|FG003|Overall Study|Physician Decision|0|||
16204999|NCT00094835|39229689|FG004|Overall Study|Physician Decision|0|||
16205000|NCT00094835|39229690|FG005|Overall Study|Physician Decision|1|||
16205001|NCT00094835|39229691|FG006|Overall Study|Physician Decision|0|||
16205002|NCT00094835|39229685|FG000|Overall Study|Withdrawal by Subject|0|||
16205003|NCT00094835|39229686|FG001|Overall Study|Withdrawal by Subject|0|||
16205004|NCT00094835|39229687|FG002|Overall Study|Withdrawal by Subject|0|||
16518541|NCT02039427|40368368|FG001|Overall Study|Cancellation of surgery|0|||
16518542|NCT02039427|40368369|FG002|Overall Study|Cancellation of surgery|1|||
16518543|NCT02039427|40368370|FG003|Overall Study|Cancellation of surgery|0|||
16518544|NCT02039427|40368367|FG000|Overall Study|Loss of follow - up|1|||
16518545|NCT02039427|40368368|FG001|Overall Study|Loss of follow - up|0|||
16518546|NCT02039427|40368369|FG002|Overall Study|Loss of follow - up|2|||
16518547|NCT02039427|40368370|FG003|Overall Study|Loss of follow - up|4|||
16518548|NCT02039427|40368367|FG000|Overall Study|Steroid Use|1|||
16518549|NCT02039427|40368368|FG001|Overall Study|Steroid Use|0|||
16518550|NCT02039427|40368369|FG002|Overall Study|Steroid Use|0|||
16518551|NCT02039427|40368370|FG003|Overall Study|Steroid Use|0|||
16518552|NCT02266381|40368373|FG000|Overall Study|Physician Decision|3|||
16518553|NCT02266381|40368374|FG001|Overall Study|Physician Decision|5|||
16518554|NCT02266381|40368375|FG002|Overall Study|Physician Decision|4|||
16518555|NCT00304070|40368380|FG000|Overall Study|Death|0|||
16518556|NCT00304070|40368381|FG001|Overall Study|Death|0|||
16518557|NCT00304070|40368382|FG002|Overall Study|Death|3|||
16518558|NCT00304070|40368380|FG000|Overall Study|Lost to Follow-up|0|||
16518559|NCT00304070|40368381|FG001|Overall Study|Lost to Follow-up|0|||
16518560|NCT00304070|40368382|FG002|Overall Study|Lost to Follow-up|1|||
16518561|NCT00304070|40368380|FG000|Overall Study|Physician Decision|0|||
16518562|NCT00304070|40368381|FG001|Overall Study|Physician Decision|0|||
16518563|NCT00304070|40368382|FG002|Overall Study|Physician Decision|3|||
16518564|NCT00304070|40368380|FG000|Overall Study|Withdrawal by Subject|0|||
16518565|NCT00304070|40368381|FG001|Overall Study|Withdrawal by Subject|0|||
16518566|NCT00304070|40368382|FG002|Overall Study|Withdrawal by Subject|1|||
16518567|NCT00304070|40368380|FG000|Overall Study|Progressive Disease|3|||
16518568|NCT00304070|40368381|FG001|Overall Study|Progressive Disease|7|||
16518569|NCT00304070|40368382|FG002|Overall Study|Progressive Disease|4|||
16518570|NCT01023659|40368391|FG000|Overall Study|Lost to Follow-up|73|||
16518571|NCT01023659|40368392|FG001|Overall Study|Lost to Follow-up|228|||
16518572|NCT01023659|40368393|FG002|Overall Study|Lost to Follow-up|99|||
16518573|NCT01545817|40368398|FG000|Pazopanib|Disease progression|51|||
16518574|NCT01545817|40368399|FG001|Pazopanib|Disease progression|0|||
16518575|NCT01545817|40368398|FG000|Pazopanib|Adverse Event|19|||
16518576|NCT01545817|40368399|FG001|Pazopanib|Adverse Event|0|||
16518577|NCT01545817|40368398|FG000|Pazopanib|Other reason|4|||
16518578|NCT01545817|40368399|FG001|Pazopanib|Other reason|0|||
16518579|NCT01545817|40368398|FG000|Everolimus|Other reason|0|||
16518580|NCT01545817|40368399|FG001|Everolimus|Other reason|7|||
16518581|NCT01545817|40368398|FG000|Everolimus|Disease progression|0|||
16518582|NCT01545817|40368399|FG001|Everolimus|Disease progression|25|||
16518583|NCT01545817|40368398|FG000|Everolimus|Adverse Event|0|||
16518584|NCT01545817|40368399|FG001|Everolimus|Adverse Event|6|||
16518585|NCT01276327|40368400|FG000|Overall Study|Adverse Event|1|||
16518586|NCT01276327|40368401|FG001|Overall Study|Adverse Event|3|||
16518587|NCT01276327|40368400|FG000|Overall Study|Withdrawal by Subject|1|||
16518588|NCT01276327|40368401|FG001|Overall Study|Withdrawal by Subject|0|||
16518589|NCT01096784|40368402|FG000|Overall Study|Withdrawal by Subject|2|||
16518590|NCT01096784|40368403|FG001|Overall Study|Withdrawal by Subject|1|||
16518591|NCT01096784|40368402|FG000|Overall Study|Adverse Event|11|||
16518592|NCT01096784|40368403|FG001|Overall Study|Adverse Event|9|||
16205005|NCT00094835|39229688|FG003|Overall Study|Withdrawal by Subject|0|||
16205006|NCT00094835|39229689|FG004|Overall Study|Withdrawal by Subject|0|||
16205007|NCT00094835|39229690|FG005|Overall Study|Withdrawal by Subject|0|||
16518593|NCT01096784|40368402|FG000|Overall Study|Protocol Deviation|2|||
16518594|NCT01096784|40368403|FG001|Overall Study|Protocol Deviation|2|||
16518595|NCT01096784|40368402|FG000|Overall Study|Administrative Decision|0|||
16518596|NCT01096784|40368403|FG001|Overall Study|Administrative Decision|1|||
16518597|NCT01096784|40368402|FG000|Overall Study|Other Unspecified|0|||
16518598|NCT01096784|40368403|FG001|Overall Study|Other Unspecified|1|||
16518599|NCT01328002|40368404|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
16518600|NCT01328002|40368405|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
16518601|NCT01328002|40368404|FG000|Open-Label Period|Adverse Event|8|||
16205008|NCT00094835|39229691|FG006|Overall Study|Withdrawal by Subject|1|||
16205009|NCT00094835|39229685|FG000|Overall Study|Lost to Follow-up|0|||
16205010|NCT00094835|39229686|FG001|Overall Study|Lost to Follow-up|0|||
16205011|NCT00094835|39229687|FG002|Overall Study|Lost to Follow-up|0|||
16205012|NCT00094835|39229688|FG003|Overall Study|Lost to Follow-up|0|||
16205013|NCT00094835|39229689|FG004|Overall Study|Lost to Follow-up|1|||
16205014|NCT00094835|39229690|FG005|Overall Study|Lost to Follow-up|0|||
16205015|NCT00094835|39229691|FG006|Overall Study|Lost to Follow-up|0|||
16205016|NCT00094835|39229685|FG000|Overall Study|Death|1|||
16205017|NCT00094835|39229686|FG001|Overall Study|Death|0|||
16205018|NCT00094835|39229687|FG002|Overall Study|Death|0|||
16205019|NCT00094835|39229688|FG003|Overall Study|Death|0|||
16205020|NCT00094835|39229689|FG004|Overall Study|Death|1|||
16205021|NCT00094835|39229690|FG005|Overall Study|Death|0|||
16205022|NCT00094835|39229691|FG006|Overall Study|Death|0|||
16205023|NCT00094835|39229685|FG000|Overall Study|Non-compliance|1|||
16205024|NCT00094835|39229686|FG001|Overall Study|Non-compliance|2|||
16205025|NCT00094835|39229687|FG002|Overall Study|Non-compliance|2|||
16205026|NCT00094835|39229688|FG003|Overall Study|Non-compliance|0|||
16205027|NCT00094835|39229689|FG004|Overall Study|Non-compliance|2|||
16205028|NCT00094835|39229690|FG005|Overall Study|Non-compliance|2|||
16205029|NCT00094835|39229691|FG006|Overall Study|Non-compliance|1|||
16205030|NCT00094835|39229685|FG000|Overall Study|Other|1|||
16205031|NCT00094835|39229686|FG001|Overall Study|Other|1|||
16205032|NCT00094835|39229687|FG002|Overall Study|Other|1|||
16205033|NCT00094835|39229688|FG003|Overall Study|Other|1|||
16205034|NCT00094835|39229689|FG004|Overall Study|Other|0|||
16205035|NCT00094835|39229690|FG005|Overall Study|Other|0|||
16518602|NCT01328002|40368405|FG001|Open-Label Period|Adverse Event|0|||
16518603|NCT01328002|40368404|FG000|Open-Label Period|Lack of Efficacy|3|||
16518604|NCT01328002|40368405|FG001|Open-Label Period|Lack of Efficacy|0|||
16518605|NCT01328002|40368404|FG000|Open-Label Period|Protocol Violation|2|||
16518606|NCT01328002|40368405|FG001|Open-Label Period|Protocol Violation|0|||
16518607|NCT01328002|40368404|FG000|Open-Label Period|Withdrawal by Subject|9|||
16518608|NCT01328002|40368405|FG001|Open-Label Period|Withdrawal by Subject|0|||
16518609|NCT01328002|40368404|FG000|Open-Label Period|Lost to Follow-up|6|||
16518610|NCT01328002|40368405|FG001|Open-Label Period|Lost to Follow-up|0|||
16518611|NCT01328002|40368404|FG000|Open-Label Period|Other Reason|2|||
16518612|NCT01328002|40368405|FG001|Open-Label Period|Other Reason|0|||
16518613|NCT01328002|40368404|FG000|Double-Blind Period|Adverse Event|1|||
16518614|NCT01328002|40368405|FG001|Double-Blind Period|Adverse Event|0|||
16518615|NCT01328002|40368404|FG000|Double-Blind Period|Lack of Efficacy|1|||
16518616|NCT01328002|40368405|FG001|Double-Blind Period|Lack of Efficacy|0|||
16518617|NCT00048724|40368413|FG000|Overall Study|Adverse Event|53|||
16518618|NCT00048724|40368414|FG001|Overall Study|Adverse Event|12|||
16518619|NCT00048724|40368413|FG000|Overall Study|Withdrawal by Subject|34|||
16518620|NCT00048724|40368414|FG001|Overall Study|Withdrawal by Subject|54|||
16518621|NCT00048724|40368413|FG000|Overall Study|Lost to Follow-up|5|||
16518622|NCT00048724|40368414|FG001|Overall Study|Lost to Follow-up|5|||
16518623|NCT00048724|40368413|FG000|Overall Study|Protocol-defined Clinical Event|17|||
16518624|NCT00048724|40368414|FG001|Overall Study|Protocol-defined Clinical Event|32|||
16518625|NCT00048724|40368413|FG000|Overall Study|Noncompliance With Protocol|4|||
16518626|NCT00048724|40368414|FG001|Overall Study|Noncompliance With Protocol|12|||
16518627|NCT00048724|40368413|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
16205036|NCT00094835|39229691|FG006|Overall Study|Other|0|||
16205037|NCT00249795|39229693|FG000|Overall Study|Not treated|16|||
16518628|NCT00048724|40368414|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
16518629|NCT00048724|40368413|FG000|Overall Study|Administrative|1|||
16518630|NCT00048724|40368414|FG001|Overall Study|Administrative|1|||
16205038|NCT00249795|39229694|FG001|Overall Study|Not treated|14|||
16205039|NCT00249795|39229693|FG000|Overall Study|Symptomatic hypotension|127|||
16205040|NCT00249795|39229694|FG001|Overall Study|Symptomatic hypotension|64|||
16205041|NCT00249795|39229693|FG000|Overall Study|Other Serious Adverse Event|84|||
16518631|NCT02496884|40368417|FG000|Overall Study|Counted twice as enrolled|2|||
16518632|NCT02496884|40368418|FG001|Overall Study|Counted twice as enrolled|0|||
16518633|NCT02496884|40368419|FG002|Overall Study|Counted twice as enrolled|0|||
16518634|NCT02496884|40368420|FG003|Overall Study|Counted twice as enrolled|0|||
16518635|NCT02496884|40368417|FG000|Overall Study|Withdrawal by Subject|0|||
16518636|NCT02496884|40368418|FG001|Overall Study|Withdrawal by Subject|3|||
16518637|NCT02496884|40368419|FG002|Overall Study|Withdrawal by Subject|0|||
16518638|NCT02496884|40368420|FG003|Overall Study|Withdrawal by Subject|0|||
16092800|NCT01562275|38830259|FG012|Stage 2|Progression of Disease|4|||
16092801|NCT02009332|38830260|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
16092802|NCT02009332|38830261|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
16092803|NCT02009332|38830262|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
16092804|NCT02009332|38830263|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
16092805|NCT02009332|38830264|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
16092806|NCT02009332|38830265|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
16092807|NCT02009332|38830260|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
16092808|NCT02009332|38830261|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
16322949|NCT01062113|39667689|FG001|Overall Study|Withdrawal by Subject|0|||
16322950|NCT01062113|39667690|FG002|Overall Study|Withdrawal by Subject|0|||
16322951|NCT00685399|39667691|FG000|Treatment Period 1|Withdrawal by Subject|2|||
16322952|NCT00685399|39667692|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16322953|NCT00685399|39667693|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16322954|NCT00685399|39667694|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16322955|NCT00685399|39667695|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16322956|NCT00685399|39667696|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16518639|NCT01229436|40368421|FG000|Overall Study|Withdrawal by Subject|2|||
16518640|NCT01229436|40368421|FG000|Overall Study|Lost to Follow-up|3|||
16518641|NCT00612313|40368422|FG000|Overall Study|Withdrawal by Subject|6|||
16518642|NCT00612313|40368423|FG001|Overall Study|Withdrawal by Subject|9|||
16518643|NCT00612313|40368422|FG000|Overall Study|Lost to Follow-up|11|||
16518644|NCT00612313|40368423|FG001|Overall Study|Lost to Follow-up|4|||
16518645|NCT03042312|40368426|FG000|Overall Study|Administrative Reason|1|||
16518646|NCT03042312|40368427|FG001|Overall Study|Administrative Reason|1|||
16518647|NCT03042312|40368426|FG000|Overall Study|Adverse Event|0|||
16518648|NCT03042312|40368427|FG001|Overall Study|Adverse Event|1|||
16518649|NCT03042312|40368426|FG000|Overall Study|Lost to Follow-up|1|||
16518650|NCT03042312|40368427|FG001|Overall Study|Lost to Follow-up|3|||
16518651|NCT03042312|40368426|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
16518652|NCT03042312|40368427|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
16518653|NCT03042312|40368426|FG000|Overall Study|Withdrawal by Subject|4|||
16518654|NCT03042312|40368427|FG001|Overall Study|Withdrawal by Subject|5|||
16518655|NCT03285646|40368428|FG000|Overall Study|Adverse Event|1|||
16518656|NCT03285646|40368429|FG001|Overall Study|Adverse Event|0|||
16518657|NCT03285646|40368428|FG000|Overall Study|Withdrawal by Subject|10|||
16518658|NCT03285646|40368429|FG001|Overall Study|Withdrawal by Subject|2|||
16518659|NCT03285646|40368428|FG000|Overall Study|Lost to Follow-up|2|||
16518660|NCT03285646|40368429|FG001|Overall Study|Lost to Follow-up|1|||
16518661|NCT03285646|40368428|FG000|Overall Study|Investigator/Sponsor Decision|0|||
16518662|NCT03285646|40368429|FG001|Overall Study|Investigator/Sponsor Decision|1|||
16518663|NCT00807092|40368430|FG000|Overall Study|Adverse Event|0|||
16518664|NCT00807092|40368431|FG001|Overall Study|Adverse Event|1|||
16518665|NCT00807092|40368430|FG000|Overall Study|Protocol Violation|0|||
16518666|NCT00807092|40368431|FG001|Overall Study|Protocol Violation|2|||
16518667|NCT00807092|40368430|FG000|Overall Study|Withdrawal by Subject|1|||
16518668|NCT00807092|40368431|FG001|Overall Study|Withdrawal by Subject|0|||
16518669|NCT00807092|40368430|FG000|Overall Study|CGMS data collection failed|0|||
16518670|NCT00807092|40368431|FG001|Overall Study|CGMS data collection failed|1|||
16518671|NCT02707640|40368436|FG000|Overall Study|Adverse Event|4|||
16518672|NCT02707640|40368437|FG001|Overall Study|Adverse Event|2|||
16518673|NCT02707640|40368436|FG000|Overall Study|Death|1|||
16518674|NCT02707640|40368437|FG001|Overall Study|Death|2|||
16518675|NCT02707640|40368436|FG000|Overall Study|Physician Decision|2|||
16518676|NCT02707640|40368437|FG001|Overall Study|Physician Decision|0|||
16518677|NCT02707640|40368436|FG000|Overall Study|Withdrawal by Subject|0|||
16518678|NCT02707640|40368437|FG001|Overall Study|Withdrawal by Subject|1|||
16518679|NCT02707640|40368436|FG000|Overall Study|Participant's Personal Decision|1|||
16518680|NCT02707640|40368437|FG001|Overall Study|Participant's Personal Decision|2|||
16518681|NCT02707640|40368436|FG000|Overall Study|Sponsor Discretion|1|||
16518682|NCT02707640|40368437|FG001|Overall Study|Sponsor Discretion|0|||
16518683|NCT01260922|40368438|FG000|First Intervention|Withdrawal by Subject|0|||
16518684|NCT01260922|40368439|FG001|First Intervention|Withdrawal by Subject|1|||
16518685|NCT01260922|40368438|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
16092809|NCT02009332|38830262|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
16322957|NCT00685399|39667697|FG006|Treatment Period 1|Withdrawal by Subject|0|||
16518686|NCT01260922|40368439|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
16518687|NCT01260922|40368438|FG000|Second Intervention|Emesis|0|||
16322958|NCT00685399|39667698|FG007|Treatment Period 1|Withdrawal by Subject|0|||
16322959|NCT00685399|39667691|FG000|Treatment Period 1|Protocol Violation|1|||
16322960|NCT00685399|39667692|FG001|Treatment Period 1|Protocol Violation|0|||
16092810|NCT02009332|38830263|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
16322961|NCT00685399|39667693|FG002|Treatment Period 1|Protocol Violation|0|||
16322962|NCT00685399|39667694|FG003|Treatment Period 1|Protocol Violation|0|||
16322963|NCT00685399|39667695|FG004|Treatment Period 1|Protocol Violation|0|||
16322964|NCT00685399|39667696|FG005|Treatment Period 1|Protocol Violation|0|||
16322965|NCT00685399|39667697|FG006|Treatment Period 1|Protocol Violation|0|||
16322966|NCT00685399|39667698|FG007|Treatment Period 1|Protocol Violation|0|||
16322967|NCT00685399|39667691|FG000|Treatment Period 1|Administrative|2|||
16322968|NCT00685399|39667692|FG001|Treatment Period 1|Administrative|0|||
16322969|NCT00685399|39667693|FG002|Treatment Period 1|Administrative|0|||
16322970|NCT00685399|39667694|FG003|Treatment Period 1|Administrative|0|||
16322971|NCT00685399|39667695|FG004|Treatment Period 1|Administrative|0|||
16322972|NCT00685399|39667696|FG005|Treatment Period 1|Administrative|0|||
16322973|NCT00685399|39667697|FG006|Treatment Period 1|Administrative|0|||
16322974|NCT00685399|39667698|FG007|Treatment Period 1|Administrative|0|||
16322975|NCT00685399|39667691|FG000|Treatment Period 1|Lack of Efficacy|1|||
16322976|NCT00685399|39667692|FG001|Treatment Period 1|Lack of Efficacy|0|||
16322977|NCT00685399|39667693|FG002|Treatment Period 1|Lack of Efficacy|0|||
16322978|NCT00685399|39667694|FG003|Treatment Period 1|Lack of Efficacy|0|||
16322979|NCT00685399|39667695|FG004|Treatment Period 1|Lack of Efficacy|0|||
16322980|NCT00685399|39667696|FG005|Treatment Period 1|Lack of Efficacy|0|||
16322981|NCT00685399|39667697|FG006|Treatment Period 1|Lack of Efficacy|0|||
16322982|NCT00685399|39667698|FG007|Treatment Period 1|Lack of Efficacy|0|||
16322983|NCT00685399|39667691|FG000|Treatment Period 2|Administrative Problems|0|||
16322984|NCT00685399|39667692|FG001|Treatment Period 2|Administrative Problems|2|||
16322985|NCT00685399|39667693|FG002|Treatment Period 2|Administrative Problems|1|||
16322986|NCT00685399|39667694|FG003|Treatment Period 2|Administrative Problems|0|||
16322987|NCT00685399|39667695|FG004|Treatment Period 2|Administrative Problems|0|||
16322988|NCT00685399|39667696|FG005|Treatment Period 2|Administrative Problems|0|||
16322989|NCT00685399|39667697|FG006|Treatment Period 2|Administrative Problems|0|||
16322990|NCT00685399|39667698|FG007|Treatment Period 2|Administrative Problems|0|||
16322991|NCT00685399|39667691|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16322992|NCT00685399|39667692|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16322993|NCT00685399|39667693|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16322994|NCT00685399|39667694|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16322995|NCT00685399|39667695|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16322996|NCT00685399|39667696|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16322997|NCT00685399|39667697|FG006|Treatment Period 2|Withdrawal by Subject|0|||
16395549|NCT05069597|39928297|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
16395550|NCT05069597|39928298|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
16395551|NCT00294671|39928305|FG000|Overall Study|Lack of Efficacy|11|||
16395552|NCT00294671|39928306|FG001|Overall Study|Lack of Efficacy|23|||
16395553|NCT00294671|39928305|FG000|Overall Study|Liver transplant|7|||
16395554|NCT00294671|39928306|FG001|Overall Study|Liver transplant|9|||
16395555|NCT00294671|39928305|FG000|Overall Study|Drug related adverse event (AE)|4|||
16518688|NCT01260922|40368439|FG001|Second Intervention|Emesis|2|||
16518689|NCT00723801|40368440|FG000|Overall Study|Lost to Follow-up|1|||
16518690|NCT00723801|40368441|FG001|Overall Study|Lost to Follow-up|2|||
16322998|NCT00685399|39667698|FG007|Treatment Period 2|Withdrawal by Subject|2|||
16518691|NCT00723801|40368440|FG000|Overall Study|Protocol Violation|2|||
16518692|NCT00723801|40368441|FG001|Overall Study|Protocol Violation|1|||
16518693|NCT01479621|40368444|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
16518694|NCT01479621|40368445|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16518695|NCT01479621|40368446|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16518696|NCT01479621|40368447|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16518697|NCT01479621|40368448|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16518698|NCT01479621|40368449|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16518699|NCT01479621|40368450|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16518700|NCT01479621|40368444|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
16518701|NCT01479621|40368445|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16518702|NCT01479621|40368446|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16518703|NCT01479621|40368447|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16518704|NCT01479621|40368448|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16518705|NCT01479621|40368449|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16518706|NCT01479621|40368450|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16518707|NCT01479621|40368444|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
16518708|NCT01479621|40368445|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16518709|NCT01479621|40368446|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16395556|NCT00294671|39928306|FG001|Overall Study|Drug related adverse event (AE)|2|||
16395557|NCT00294671|39928305|FG000|Overall Study|Non-drug related AE|3|||
16395558|NCT00294671|39928306|FG001|Overall Study|Non-drug related AE|2|||
16395559|NCT00294671|39928305|FG000|Overall Study|Lost to Follow-up|1|||
16395560|NCT00294671|39928306|FG001|Overall Study|Lost to Follow-up|3|||
16395561|NCT00294671|39928305|FG000|Overall Study|Non-compliance|1|||
16395562|NCT00294671|39928306|FG001|Overall Study|Non-compliance|0|||
16395563|NCT00294671|39928305|FG000|Overall Study|Death|0|||
16395564|NCT00294671|39928306|FG001|Overall Study|Death|1|||
16395565|NCT01815424|39928308|FG000|Week 0 to 16|Adverse Event|1|||
16395566|NCT01815424|39928309|FG001|Week 0 to 16|Adverse Event|3|||
16395567|NCT01815424|39928310|FG002|Week 0 to 16|Adverse Event|3|||
16322999|NCT00685399|39667691|FG000|Treatment Period 2|Adverse Event|0|||
16323000|NCT00685399|39667692|FG001|Treatment Period 2|Adverse Event|0|||
16323001|NCT00685399|39667693|FG002|Treatment Period 2|Adverse Event|0|||
16323002|NCT00685399|39667694|FG003|Treatment Period 2|Adverse Event|0|||
16323003|NCT00685399|39667695|FG004|Treatment Period 2|Adverse Event|0|||
16323004|NCT00685399|39667696|FG005|Treatment Period 2|Adverse Event|1|||
16323005|NCT00685399|39667697|FG006|Treatment Period 2|Adverse Event|0|||
16323006|NCT00685399|39667698|FG007|Treatment Period 2|Adverse Event|0|||
16323007|NCT00685399|39667691|FG000|Treatment Period 2|Lack of Efficacy|0|||
16323008|NCT00685399|39667692|FG001|Treatment Period 2|Lack of Efficacy|10|||
16323009|NCT00685399|39667693|FG002|Treatment Period 2|Lack of Efficacy|2|||
16323010|NCT00685399|39667694|FG003|Treatment Period 2|Lack of Efficacy|0|||
16323011|NCT00685399|39667695|FG004|Treatment Period 2|Lack of Efficacy|0|||
16323012|NCT00685399|39667696|FG005|Treatment Period 2|Lack of Efficacy|1|||
16323013|NCT00685399|39667697|FG006|Treatment Period 2|Lack of Efficacy|0|||
16323014|NCT00685399|39667698|FG007|Treatment Period 2|Lack of Efficacy|0|||
16323015|NCT00685399|39667691|FG000|Extension|Administrative Issues|0|||
16323016|NCT00685399|39667692|FG001|Extension|Administrative Issues|0|||
16323017|NCT00685399|39667693|FG002|Extension|Administrative Issues|0|||
16323018|NCT00685399|39667694|FG003|Extension|Administrative Issues|1|||
16323019|NCT00685399|39667695|FG004|Extension|Administrative Issues|0|||
16323020|NCT00685399|39667696|FG005|Extension|Administrative Issues|0|||
16323021|NCT00685399|39667697|FG006|Extension|Administrative Issues|0|||
16323022|NCT00685399|39667698|FG007|Extension|Administrative Issues|0|||
16323023|NCT00685399|39667691|FG000|Extension|Withdrawal by Subject|0|||
16323024|NCT00685399|39667692|FG001|Extension|Withdrawal by Subject|0|||
16323025|NCT00685399|39667693|FG002|Extension|Withdrawal by Subject|0|||
16323026|NCT00685399|39667694|FG003|Extension|Withdrawal by Subject|1|||
16323027|NCT00685399|39667695|FG004|Extension|Withdrawal by Subject|0|||
16323028|NCT00685399|39667696|FG005|Extension|Withdrawal by Subject|0|||
16323029|NCT00685399|39667697|FG006|Extension|Withdrawal by Subject|0|||
16323030|NCT00685399|39667698|FG007|Extension|Withdrawal by Subject|0|||
16323031|NCT00685399|39667691|FG000|Extension|Protocol Violation|0|||
16323032|NCT00685399|39667692|FG001|Extension|Protocol Violation|0|||
16323033|NCT00685399|39667693|FG002|Extension|Protocol Violation|0|||
16323034|NCT00685399|39667694|FG003|Extension|Protocol Violation|1|||
16323035|NCT00685399|39667695|FG004|Extension|Protocol Violation|0|||
16323036|NCT00685399|39667696|FG005|Extension|Protocol Violation|0|||
16323037|NCT00685399|39667697|FG006|Extension|Protocol Violation|0|||
16323038|NCT00685399|39667698|FG007|Extension|Protocol Violation|0|||
16323039|NCT00685399|39667691|FG000|Extension|Lack of Efficacy|0|||
16323040|NCT00685399|39667692|FG001|Extension|Lack of Efficacy|0|||
16323041|NCT00685399|39667693|FG002|Extension|Lack of Efficacy|0|||
16395568|NCT01815424|39928311|FG003|Week 0 to 16|Adverse Event|0|||
16395569|NCT01815424|39928312|FG004|Week 0 to 16|Adverse Event|0|||
16323042|NCT00685399|39667694|FG003|Extension|Lack of Efficacy|2|||
16323043|NCT00685399|39667695|FG004|Extension|Lack of Efficacy|0|||
16323044|NCT00685399|39667696|FG005|Extension|Lack of Efficacy|0|||
16323045|NCT00685399|39667697|FG006|Extension|Lack of Efficacy|0|||
16323046|NCT00685399|39667698|FG007|Extension|Lack of Efficacy|0|||
16323047|NCT00685399|39667691|FG000|Extension|Adverse Event|0|||
16323048|NCT00685399|39667692|FG001|Extension|Adverse Event|0|||
16323049|NCT00685399|39667693|FG002|Extension|Adverse Event|0|||
16323050|NCT00685399|39667694|FG003|Extension|Adverse Event|2|||
16323051|NCT00685399|39667695|FG004|Extension|Adverse Event|0|||
16323052|NCT00685399|39667696|FG005|Extension|Adverse Event|0|||
16323053|NCT00685399|39667697|FG006|Extension|Adverse Event|0|||
16323054|NCT00685399|39667698|FG007|Extension|Adverse Event|0|||
16323055|NCT02316548|39667699|FG000|Overall Study|Protocol Violation|0|||
16323056|NCT02316548|39667700|FG001|Overall Study|Protocol Violation|1|||
16323057|NCT00977080|39667701|FG000|Overall Study|Adverse Event|2|||
16323058|NCT00977080|39667702|FG001|Overall Study|Adverse Event|7|||
16395570|NCT01815424|39928308|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
16395571|NCT01815424|39928309|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
16323059|NCT00977080|39667703|FG002|Overall Study|Adverse Event|7|||
16323060|NCT00977080|39667704|FG003|Overall Study|Adverse Event|7|||
16395572|NCT01815424|39928310|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
16518710|NCT01479621|40368447|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16518711|NCT01479621|40368448|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16518712|NCT01479621|40368449|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16518713|NCT01479621|40368450|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16323061|NCT00977080|39667701|FG000|Overall Study|Withdrawal by Subject|1|||
16323062|NCT00977080|39667702|FG001|Overall Study|Withdrawal by Subject|5|||
16323063|NCT00977080|39667703|FG002|Overall Study|Withdrawal by Subject|1|||
16323064|NCT00977080|39667704|FG003|Overall Study|Withdrawal by Subject|5|||
16323065|NCT00977080|39667701|FG000|Overall Study|Protocol Violation|7|||
16323066|NCT00977080|39667702|FG001|Overall Study|Protocol Violation|3|||
16323067|NCT00977080|39667703|FG002|Overall Study|Protocol Violation|4|||
16323068|NCT00977080|39667704|FG003|Overall Study|Protocol Violation|3|||
16323069|NCT00977080|39667701|FG000|Overall Study|Noncompliance|0|||
16323070|NCT00977080|39667702|FG001|Overall Study|Noncompliance|2|||
16323071|NCT00977080|39667703|FG002|Overall Study|Noncompliance|1|||
16323072|NCT00977080|39667704|FG003|Overall Study|Noncompliance|0|||
16323073|NCT00977080|39667701|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
16323074|NCT00977080|39667702|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
16323075|NCT00977080|39667703|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
16323076|NCT00977080|39667704|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
16323077|NCT00977080|39667701|FG000|Overall Study|Required kidney transplantation|1|||
16395573|NCT01815424|39928311|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
16395574|NCT01815424|39928312|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
16395575|NCT01815424|39928308|FG000|Week 0 to 16|Lost to Follow-up|0|||
16395576|NCT01815424|39928309|FG001|Week 0 to 16|Lost to Follow-up|1|||
16395577|NCT01815424|39928310|FG002|Week 0 to 16|Lost to Follow-up|0|||
16395578|NCT01815424|39928311|FG003|Week 0 to 16|Lost to Follow-up|0|||
16395579|NCT01815424|39928312|FG004|Week 0 to 16|Lost to Follow-up|0|||
16395580|NCT01815424|39928308|FG000|Week 0 to 16|Withdrawal by Subject|0|||
16395581|NCT01815424|39928309|FG001|Week 0 to 16|Withdrawal by Subject|0|||
16395582|NCT01815424|39928310|FG002|Week 0 to 16|Withdrawal by Subject|1|||
16395583|NCT01815424|39928311|FG003|Week 0 to 16|Withdrawal by Subject|0|||
16518714|NCT01479621|40368444|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
16518715|NCT01479621|40368445|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16518716|NCT01479621|40368446|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16518717|NCT01479621|40368447|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16518718|NCT01479621|40368448|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16518719|NCT01479621|40368449|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16518720|NCT01479621|40368450|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16518721|NCT01479621|40368444|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
16518722|NCT01479621|40368445|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16518723|NCT01479621|40368446|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16518724|NCT01479621|40368447|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16518725|NCT01479621|40368448|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16518726|NCT01479621|40368449|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16518727|NCT01479621|40368450|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16518728|NCT01479621|40368444|FG000|Treatment Period|Adverse Event|0|||
16518729|NCT01479621|40368445|FG001|Treatment Period|Adverse Event|0|||
16518730|NCT01479621|40368446|FG002|Treatment Period|Adverse Event|0|||
16518731|NCT01479621|40368447|FG003|Treatment Period|Adverse Event|0|||
16518732|NCT01479621|40368448|FG004|Treatment Period|Adverse Event|1|||
16518733|NCT01479621|40368449|FG005|Treatment Period|Adverse Event|2|||
16518734|NCT01479621|40368450|FG006|Treatment Period|Adverse Event|2|||
16518735|NCT01479621|40368444|FG000|Treatment Period|Withdrawal by Subject|0|||
16518736|NCT01479621|40368445|FG001|Treatment Period|Withdrawal by Subject|4|||
16518737|NCT01479621|40368446|FG002|Treatment Period|Withdrawal by Subject|2|||
16518738|NCT01479621|40368447|FG003|Treatment Period|Withdrawal by Subject|2|||
16518739|NCT01479621|40368448|FG004|Treatment Period|Withdrawal by Subject|5|||
16518740|NCT01479621|40368449|FG005|Treatment Period|Withdrawal by Subject|5|||
16518741|NCT01479621|40368450|FG006|Treatment Period|Withdrawal by Subject|1|||
16518742|NCT01479621|40368444|FG000|Treatment Period|Physician Decision|0|||
16323078|NCT00977080|39667702|FG001|Overall Study|Required kidney transplantation|3|||
16323079|NCT00977080|39667703|FG002|Overall Study|Required kidney transplantation|3|||
16323080|NCT00977080|39667704|FG003|Overall Study|Required kidney transplantation|1|||
16323081|NCT00977080|39667701|FG000|Overall Study|Travel for family reasons|1|||
16323082|NCT00977080|39667702|FG001|Overall Study|Travel for family reasons|0|||
16323083|NCT00977080|39667703|FG002|Overall Study|Travel for family reasons|0|||
16395584|NCT01815424|39928312|FG004|Week 0 to 16|Withdrawal by Subject|0|||
16395585|NCT01815424|39928308|FG000|Week 0 to 16|Other|1|||
16323084|NCT00977080|39667704|FG003|Overall Study|Travel for family reasons|0|||
16323085|NCT02256982|39667705|FG000|Overall Study|Disease Progression|0|||
16323086|NCT02256982|39667706|FG001|Overall Study|Disease Progression|1|||
16323087|NCT01053663|39667709|FG000|Overall Study|Death|2|||
16323088|NCT01053663|39667709|FG000|Overall Study|Lost to Follow-up|1|||
16323089|NCT01053663|39667709|FG000|Overall Study|Poor IV Access|1|||
16323090|NCT01053663|39667709|FG000|Overall Study|Transferred to Another Hospital|1|||
16323091|NCT01053663|39667709|FG000|Overall Study|Negative Influenza Diagnosis|1|||
16323092|NCT00679029|39667712|FG000|Overall Study|Adverse Event|3|||
16323093|NCT00679029|39667712|FG000|Overall Study|Withdrawal by Subject|1|||
16323094|NCT00679029|39667712|FG000|Overall Study|Lost to Follow-up|1|||
16323095|NCT02651155|39667713|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16323096|NCT02651155|39667714|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
16323097|NCT02651155|39667713|FG000|Overall Study|Voluntary Withdrawal|5|||
16323098|NCT02651155|39667714|FG001|Overall Study|Voluntary Withdrawal|0|||
16323099|NCT00491556|39670791|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
16323100|NCT00491556|39670792|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
16323101|NCT00491556|39670791|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
16323102|NCT00491556|39670792|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
16323103|NCT00491556|39670791|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
16323104|NCT00491556|39670792|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
16323105|NCT00491556|39670791|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
16323106|NCT00491556|39670792|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
16323107|NCT00491556|39670791|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
16323108|NCT00491556|39670792|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
16323109|NCT00491556|39670791|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
16323110|NCT00491556|39670792|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
16323111|NCT00491556|39670791|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
16323112|NCT00491556|39670792|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
16323113|NCT00491556|39670791|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
16323114|NCT00491556|39670792|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
16323115|NCT00491556|39670791|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
16323116|NCT00491556|39670792|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
16323117|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
16323118|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
16395586|NCT01815424|39928309|FG001|Week 0 to 16|Other|0|||
16395587|NCT01815424|39928310|FG002|Week 0 to 16|Other|3|||
16395588|NCT01815424|39928311|FG003|Week 0 to 16|Other|0|||
16395589|NCT01815424|39928312|FG004|Week 0 to 16|Other|0|||
16395590|NCT01815424|39928308|FG000|Week 0 to 16|Protocol Violation|1|||
16395591|NCT01815424|39928309|FG001|Week 0 to 16|Protocol Violation|0|||
16395592|NCT01815424|39928310|FG002|Week 0 to 16|Protocol Violation|0|||
16395593|NCT01815424|39928311|FG003|Week 0 to 16|Protocol Violation|0|||
16395594|NCT01815424|39928312|FG004|Week 0 to 16|Protocol Violation|0|||
16395595|NCT01815424|39928308|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
16395596|NCT01815424|39928309|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
16395597|NCT01815424|39928310|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
16395598|NCT01815424|39928311|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
16395599|NCT01815424|39928312|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
16395600|NCT01815424|39928308|FG000|Week 16 to 52|Other|0|||
16395601|NCT01815424|39928309|FG001|Week 16 to 52|Other|1|||
16395602|NCT01815424|39928310|FG002|Week 16 to 52|Other|0|||
16395603|NCT01815424|39928311|FG003|Week 16 to 52|Other|0|||
16395604|NCT01815424|39928312|FG004|Week 16 to 52|Other|0|||
16395605|NCT01815424|39928308|FG000|Week 16 to 52|Adverse Event|0|||
16395606|NCT01815424|39928309|FG001|Week 16 to 52|Adverse Event|0|||
16395607|NCT01815424|39928310|FG002|Week 16 to 52|Adverse Event|0|||
16395608|NCT01815424|39928311|FG003|Week 16 to 52|Adverse Event|0|||
16395609|NCT01815424|39928312|FG004|Week 16 to 52|Adverse Event|1|||
16395610|NCT01815424|39928308|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
16395611|NCT01815424|39928309|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
16395612|NCT01815424|39928310|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
16395613|NCT01815424|39928311|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
16395614|NCT01815424|39928312|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
16395615|NCT01815424|39928308|FG000|Week 16 to 52|Lost to Follow-up|0|||
16092811|NCT02009332|38830264|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
16205042|NCT00249795|39229694|FG001|Overall Study|Other Serious Adverse Event|93|||
16323119|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
16323120|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
16323121|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
16323122|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
16323123|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
16323124|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
16323125|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
16323126|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
16323127|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
16323128|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
16323129|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
16323130|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
16395616|NCT01815424|39928309|FG001|Week 16 to 52|Lost to Follow-up|2|||
16395617|NCT01815424|39928310|FG002|Week 16 to 52|Lost to Follow-up|0|||
16395618|NCT01815424|39928311|FG003|Week 16 to 52|Lost to Follow-up|2|||
16395619|NCT01815424|39928312|FG004|Week 16 to 52|Lost to Follow-up|1|||
16395620|NCT01815424|39928308|FG000|Week 16 to 52|Withdrawal by Subject|1|||
16518743|NCT01479621|40368445|FG001|Treatment Period|Physician Decision|0|||
16518744|NCT01479621|40368446|FG002|Treatment Period|Physician Decision|0|||
16518745|NCT01479621|40368447|FG003|Treatment Period|Physician Decision|0|||
16518746|NCT01479621|40368448|FG004|Treatment Period|Physician Decision|1|||
16518747|NCT01479621|40368449|FG005|Treatment Period|Physician Decision|1|||
16518748|NCT01479621|40368450|FG006|Treatment Period|Physician Decision|0|||
16518749|NCT01479621|40368444|FG000|Treatment Period|Non-compliance to study drug|0|||
16518750|NCT01479621|40368445|FG001|Treatment Period|Non-compliance to study drug|1|||
16518751|NCT01479621|40368446|FG002|Treatment Period|Non-compliance to study drug|0|||
16518752|NCT01479621|40368447|FG003|Treatment Period|Non-compliance to study drug|0|||
16518753|NCT01479621|40368448|FG004|Treatment Period|Non-compliance to study drug|0|||
16518754|NCT01479621|40368449|FG005|Treatment Period|Non-compliance to study drug|0|||
16518755|NCT01479621|40368450|FG006|Treatment Period|Non-compliance to study drug|1|||
16518756|NCT01479621|40368444|FG000|Treatment Period|Protocol Violation|0|||
16518757|NCT01479621|40368445|FG001|Treatment Period|Protocol Violation|9|||
16518758|NCT01479621|40368446|FG002|Treatment Period|Protocol Violation|6|||
16518759|NCT01479621|40368447|FG003|Treatment Period|Protocol Violation|5|||
16518760|NCT01479621|40368448|FG004|Treatment Period|Protocol Violation|2|||
16518761|NCT01479621|40368449|FG005|Treatment Period|Protocol Violation|10|||
16518762|NCT01479621|40368450|FG006|Treatment Period|Protocol Violation|6|||
16518763|NCT01479621|40368444|FG000|Treatment Period|Pregnancy|0|||
16518764|NCT01479621|40368445|FG001|Treatment Period|Pregnancy|0|||
16518765|NCT01479621|40368446|FG002|Treatment Period|Pregnancy|2|||
16518766|NCT01479621|40368447|FG003|Treatment Period|Pregnancy|0|||
16518767|NCT01479621|40368448|FG004|Treatment Period|Pregnancy|0|||
16518768|NCT01479621|40368449|FG005|Treatment Period|Pregnancy|0|||
16518769|NCT01479621|40368450|FG006|Treatment Period|Pregnancy|0|||
16518770|NCT01479621|40368444|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
16518771|NCT01479621|40368445|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
16518772|NCT01479621|40368446|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
16518773|NCT01479621|40368447|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
16518774|NCT01479621|40368448|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
16518775|NCT01479621|40368449|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
16518776|NCT01479621|40368450|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
16518777|NCT01479621|40368444|FG000|Treatment Period|Lost to Follow-up|0|||
16518778|NCT01479621|40368445|FG001|Treatment Period|Lost to Follow-up|0|||
16518779|NCT01479621|40368446|FG002|Treatment Period|Lost to Follow-up|1|||
16518780|NCT01479621|40368447|FG003|Treatment Period|Lost to Follow-up|0|||
16518781|NCT01479621|40368448|FG004|Treatment Period|Lost to Follow-up|2|||
16518782|NCT01479621|40368449|FG005|Treatment Period|Lost to Follow-up|2|||
16518783|NCT01479621|40368450|FG006|Treatment Period|Lost to Follow-up|1|||
16518784|NCT01479621|40368444|FG000|Treatment Period|Met stopping criteria|0|||
16518785|NCT01479621|40368445|FG001|Treatment Period|Met stopping criteria|8|||
16518786|NCT01479621|40368446|FG002|Treatment Period|Met stopping criteria|7|||
16518787|NCT01479621|40368447|FG003|Treatment Period|Met stopping criteria|4|||
16518788|NCT01479621|40368448|FG004|Treatment Period|Met stopping criteria|9|||
16518789|NCT01479621|40368449|FG005|Treatment Period|Met stopping criteria|20|||
16518790|NCT01479621|40368450|FG006|Treatment Period|Met stopping criteria|6|||
16518791|NCT00563797|40368451|FG000|Overall Study|Lost to Follow-up|7|||
16518792|NCT00563797|40368452|FG001|Overall Study|Lost to Follow-up|2|||
16518793|NCT04709237|40368453|FG000|Overall Study|Lost to Follow-up|1|||
16518794|NCT04709237|40368454|FG001|Overall Study|Lost to Follow-up|0|||
16518795|NCT04709237|40368455|FG002|Overall Study|Lost to Follow-up|0|||
16518796|NCT00779766|40368461|FG000|Month 24|Serious Adverse Event|2|||
16395621|NCT01815424|39928309|FG001|Week 16 to 52|Withdrawal by Subject|2|||
16395622|NCT01815424|39928310|FG002|Week 16 to 52|Withdrawal by Subject|0|||
16395623|NCT01815424|39928311|FG003|Week 16 to 52|Withdrawal by Subject|0|||
16395624|NCT01815424|39928312|FG004|Week 16 to 52|Withdrawal by Subject|0|||
16395625|NCT01650831|39928313|FG000|Overall Study|Screen failure|1|||
16395626|NCT01648023|39928314|FG000|Overall Study|Screen Fail Post Randomization|1|||
16395627|NCT01648023|39928315|FG001|Overall Study|Screen Fail Post Randomization|2|||
16395628|NCT00175916|39928316|FG000|Overall Study|Death|19|||
16323131|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
16323132|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
16092812|NCT02009332|38830265|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
16205043|NCT00249795|39229693|FG000|Overall Study|Qualifying condition not present|26|||
16323133|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
16323134|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
16323135|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
16323136|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
16323137|NCT00491556|39670791|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
16323138|NCT00491556|39670792|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
16395629|NCT00175916|39928316|FG000|Overall Study|Adverse Event|81|||
16395630|NCT00175916|39928316|FG000|Overall Study|Lack of Efficacy|354|||
16395631|NCT00175916|39928316|FG000|Overall Study|Lost to Follow-up|17|||
16518797|NCT00779766|40368462|FG001|Month 24|Serious Adverse Event|3|||
16518798|NCT00779766|40368461|FG000|Month 24|Adverse Event|3|||
16518799|NCT00779766|40368462|FG001|Month 24|Adverse Event|3|||
16518800|NCT00779766|40368461|FG000|Month 24|Protocol Violation|3|||
16518801|NCT00779766|40368462|FG001|Month 24|Protocol Violation|1|||
16518802|NCT00779766|40368461|FG000|Month 24|Withdrawal by Subject|159|||
16518803|NCT00779766|40368462|FG001|Month 24|Withdrawal by Subject|127|||
16518804|NCT00779766|40368461|FG000|Month 24|Migrated/moved from study area|138|||
16518805|NCT00779766|40368462|FG001|Month 24|Migrated/moved from study area|162|||
16518806|NCT00779766|40368461|FG000|Month 24|Lost to Follow-up|9|||
16518807|NCT00779766|40368462|FG001|Month 24|Lost to Follow-up|9|||
16092813|NCT02009332|38830260|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
16092814|NCT02009332|38830261|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
16395632|NCT00175916|39928316|FG000|Overall Study|Subject Choice|98|||
16518808|NCT00779766|40368461|FG000|Month 24|Other|18|||
16518809|NCT00779766|40368462|FG001|Month 24|Other|27|||
16518810|NCT00779766|40368461|FG000|Month 48|Withdrawal by Subject|68|||
16518811|NCT00779766|40368462|FG001|Month 48|Withdrawal by Subject|63|||
16518812|NCT00779766|40368461|FG000|Month 48|Migrated/moved from study area|76|||
16518813|NCT00779766|40368462|FG001|Month 48|Migrated/moved from study area|75|||
16518814|NCT00779766|40368461|FG000|Month 48|Lost to Follow-up|29|||
16518815|NCT00779766|40368462|FG001|Month 48|Lost to Follow-up|30|||
16518816|NCT00779766|40368461|FG000|Month 48|Other|1|||
16518817|NCT00779766|40368462|FG001|Month 48|Other|0|||
16518818|NCT00779766|40368461|FG000|Month 72|Withdrawal by Subject|55|||
16518819|NCT00779766|40368462|FG001|Month 72|Withdrawal by Subject|71|||
16518820|NCT00779766|40368461|FG000|Month 72|Migrated/moved from study area|124|||
16518821|NCT00779766|40368462|FG001|Month 72|Migrated/moved from study area|109|||
16518822|NCT00779766|40368461|FG000|Month 72|Lost to Follow-up|6|||
16518823|NCT00779766|40368462|FG001|Month 72|Lost to Follow-up|8|||
16518824|NCT00779766|40368461|FG000|Month 72|Other|0|||
16518825|NCT00779766|40368462|FG001|Month 72|Other|1|||
16518826|NCT02247349|40368463|FG000|Overall Study|Disease Progression|7|||
16518827|NCT02247349|40368464|FG001|Overall Study|Disease Progression|4|||
16518828|NCT02247349|40368465|FG002|Overall Study|Disease Progression|26|||
16518829|NCT02247349|40368466|FG003|Overall Study|Disease Progression|31|||
16518830|NCT02247349|40368467|FG004|Overall Study|Disease Progression|16|||
16518831|NCT02247349|40368468|FG005|Overall Study|Disease Progression|6|||
16518832|NCT02247349|40368463|FG000|Overall Study|Study drug toxicity|0|||
16518833|NCT02247349|40368464|FG001|Overall Study|Study drug toxicity|1|||
16323139|NCT00638404|39670793|FG000|Overall Study|Physician Decision|8|||
16395633|NCT00175916|39928316|FG000|Overall Study|Lack of compliance|8|||
16395634|NCT00175916|39928316|FG000|Overall Study|Patient cannot record seizures|1|||
16395635|NCT00175916|39928316|FG000|Overall Study|Sponsor decision|17|||
16395636|NCT00175916|39928316|FG000|Overall Study|Vigabatrin intake|1|||
16395637|NCT00175916|39928316|FG000|Overall Study|Suicidal behaviour|1|||
16395638|NCT00175916|39928316|FG000|Overall Study|Withdrawal by Subject|1|||
16395639|NCT00175916|39928316|FG000|Overall Study|Seizure - free|4|||
16395640|NCT00175916|39928316|FG000|Overall Study|Administrative reason|1|||
16395641|NCT00175916|39928316|FG000|Overall Study|Pregnancy|1|||
16395642|NCT00175916|39928316|FG000|Overall Study|Patient's request|2|||
16395643|NCT00175916|39928316|FG000|Overall Study|Treating physiciant's choice|1|||
16395644|NCT00175916|39928316|FG000|Overall Study|Moved overseas|1|||
16395645|NCT00175916|39928316|FG000|Overall Study|Loss of job and economic burden|1|||
16395646|NCT00175916|39928316|FG000|Overall Study|Site was closed|9|||
16395647|NCT00175916|39928316|FG000|Overall Study|Patient went to prison|1|||
16395648|NCT03028129|39928317|FG000|Overall Study|Adverse Event|13|||
16395649|NCT03028129|39928318|FG001|Overall Study|Adverse Event|2|||
16395650|NCT03028129|39928317|FG000|Overall Study|Lost to Follow-up|50|||
16395651|NCT03028129|39928318|FG001|Overall Study|Lost to Follow-up|38|||
16395652|NCT03028129|39928317|FG000|Overall Study|Physician Decision|0|||
16395653|NCT03028129|39928318|FG001|Overall Study|Physician Decision|1|||
16395654|NCT03028129|39928317|FG000|Overall Study|Protocol Violation|1|||
16395655|NCT03028129|39928318|FG001|Overall Study|Protocol Violation|1|||
16395656|NCT03028129|39928317|FG000|Overall Study|Withdrawal by Subject|62|||
16395657|NCT03028129|39928318|FG001|Overall Study|Withdrawal by Subject|45|||
16395658|NCT00078806|39928321|FG000|Part 1A|Adverse Event|2|||
16395659|NCT00078806|39928322|FG001|Part 1A|Adverse Event|0|||
16395660|NCT00078806|39928323|FG002|Part 1A|Adverse Event|0|||
16395661|NCT00078806|39928324|FG003|Part 1A|Adverse Event|0|||
16395662|NCT00078806|39928321|FG000|Part 1A|Lack of Efficacy|7|||
16395663|NCT00078806|39928322|FG001|Part 1A|Lack of Efficacy|0|||
16395664|NCT00078806|39928323|FG002|Part 1A|Lack of Efficacy|0|||
16518834|NCT02247349|40368465|FG002|Overall Study|Study drug toxicity|1|||
16518835|NCT02247349|40368466|FG003|Overall Study|Study drug toxicity|1|||
16518836|NCT02247349|40368467|FG004|Overall Study|Study drug toxicity|2|||
16518837|NCT02247349|40368468|FG005|Overall Study|Study drug toxicity|2|||
16518838|NCT02247349|40368463|FG000|Overall Study|Death|0|||
16518839|NCT02247349|40368464|FG001|Overall Study|Death|0|||
16518840|NCT02247349|40368465|FG002|Overall Study|Death|0|||
16518841|NCT02247349|40368466|FG003|Overall Study|Death|1|||
16518842|NCT02247349|40368467|FG004|Overall Study|Death|0|||
16518843|NCT02247349|40368468|FG005|Overall Study|Death|0|||
16518844|NCT02247349|40368463|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
16518845|NCT02247349|40368464|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
16518846|NCT02247349|40368465|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
16518847|NCT02247349|40368466|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
16518848|NCT02247349|40368467|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
16518849|NCT02247349|40368468|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
16518850|NCT02247349|40368463|FG000|Overall Study|Participant request to discontinue study treatment|0|||
16518851|NCT02247349|40368464|FG001|Overall Study|Participant request to discontinue study treatment|0|||
16518852|NCT02247349|40368465|FG002|Overall Study|Participant request to discontinue study treatment|1|||
16518853|NCT02247349|40368466|FG003|Overall Study|Participant request to discontinue study treatment|2|||
16518854|NCT02247349|40368467|FG004|Overall Study|Participant request to discontinue study treatment|1|||
16518855|NCT02247349|40368468|FG005|Overall Study|Participant request to discontinue study treatment|0|||
16518856|NCT02247349|40368463|FG000|Overall Study|Withdrawal by Subject|0|||
16518857|NCT02247349|40368464|FG001|Overall Study|Withdrawal by Subject|1|||
16518858|NCT02247349|40368465|FG002|Overall Study|Withdrawal by Subject|0|||
16518859|NCT02247349|40368466|FG003|Overall Study|Withdrawal by Subject|0|||
16518860|NCT02247349|40368467|FG004|Overall Study|Withdrawal by Subject|0|||
16518861|NCT02247349|40368468|FG005|Overall Study|Withdrawal by Subject|0|||
16092815|NCT02009332|38830262|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
16092816|NCT02009332|38830263|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
16092817|NCT02009332|38830264|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
16092818|NCT02009332|38830265|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
16092819|NCT02607956|38830266|FG000|Double-Blinded Phase|Withdrew Consent|17|||
16092820|NCT02607956|38830267|FG001|Double-Blinded Phase|Withdrew Consent|19|||
16092821|NCT02607956|38830268|FG002|Double-Blinded Phase|Withdrew Consent|0|||
16092822|NCT02607956|38830269|FG003|Double-Blinded Phase|Withdrew Consent|0|||
16092823|NCT02607956|38830266|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
16092824|NCT02607956|38830267|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
16092825|NCT02607956|38830268|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
16092826|NCT02607956|38830269|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
16092827|NCT02607956|38830266|FG000|Double-Blinded Phase|Randomized but never treated|7|||
16092828|NCT02607956|38830267|FG001|Double-Blinded Phase|Randomized but never treated|5|||
16092829|NCT02607956|38830268|FG002|Double-Blinded Phase|Randomized but never treated|0|||
16092830|NCT02607956|38830269|FG003|Double-Blinded Phase|Randomized but never treated|0|||
16092831|NCT02607956|38830266|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
16092832|NCT02607956|38830267|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
16092833|NCT02607956|38830268|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
16092834|NCT02607956|38830269|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
16092835|NCT02607956|38830266|FG000|Double-Blinded Phase|Death|4|||
16092836|NCT02607956|38830267|FG001|Double-Blinded Phase|Death|4|||
16092837|NCT02607956|38830268|FG002|Double-Blinded Phase|Death|0|||
16092838|NCT02607956|38830269|FG003|Double-Blinded Phase|Death|0|||
16092839|NCT02607956|38830266|FG000|Double-Blinded Phase|Adverse Event|4|||
16092840|NCT02607956|38830267|FG001|Double-Blinded Phase|Adverse Event|3|||
16092841|NCT02607956|38830268|FG002|Double-Blinded Phase|Adverse Event|0|||
16092842|NCT02607956|38830269|FG003|Double-Blinded Phase|Adverse Event|0|||
16092843|NCT02607956|38830266|FG000|Double-Blinded Phase|Protocol Violation|3|||
16092844|NCT02607956|38830267|FG001|Double-Blinded Phase|Protocol Violation|1|||
16092845|NCT02607956|38830268|FG002|Double-Blinded Phase|Protocol Violation|0|||
16092846|NCT02607956|38830269|FG003|Double-Blinded Phase|Protocol Violation|0|||
16092847|NCT02607956|38830266|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
16092848|NCT02607956|38830267|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
16092849|NCT02607956|38830268|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
16092850|NCT02607956|38830269|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
16092851|NCT02607956|38830266|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
16092852|NCT02607956|38830267|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
16092853|NCT02607956|38830268|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
16092854|NCT02607956|38830269|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
16092855|NCT02607956|38830266|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
16092856|NCT02607956|38830267|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
16092857|NCT02607956|38830268|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
16092858|NCT02607956|38830269|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
16092859|NCT02607956|38830266|FG000|Open-Label Extension Phase|Death|0|||
16092860|NCT02607956|38830267|FG001|Open-Label Extension Phase|Death|0|||
16092861|NCT02607956|38830268|FG002|Open-Label Extension Phase|Death|1|||
16092862|NCT02607956|38830269|FG003|Open-Label Extension Phase|Death|3|||
16092863|NCT02607956|38830266|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
16205044|NCT00249795|39229694|FG001|Overall Study|Qualifying condition not present|29|||
16205045|NCT00249795|39229693|FG000|Overall Study|Withdrawal by Subject|678|||
16205046|NCT00249795|39229694|FG001|Overall Study|Withdrawal by Subject|742|||
16205047|NCT00249795|39229693|FG000|Overall Study|Thromboembolic / outcome event|39|||
16205048|NCT00249795|39229694|FG001|Overall Study|Thromboembolic / outcome event|45|||
16205049|NCT00249795|39229693|FG000|Overall Study|Oral anticoagulant required|2|||
16205050|NCT00249795|39229694|FG001|Overall Study|Oral anticoagulant required|0|||
16205051|NCT00249795|39229693|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
16205052|NCT00249795|39229694|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
16205053|NCT00249795|39229693|FG000|Overall Study|Non-compliance|71|||
16205054|NCT00249795|39229694|FG001|Overall Study|Non-compliance|69|||
16205055|NCT00249795|39229693|FG000|Overall Study|Study drug intolerance|3|||
16205056|NCT00249795|39229694|FG001|Overall Study|Study drug intolerance|3|||
16205057|NCT00249795|39229693|FG000|Overall Study|Other adverse events (non-serious)|188|||
16205058|NCT00249795|39229694|FG001|Overall Study|Other adverse events (non-serious)|159|||
16205059|NCT00249795|39229693|FG000|Overall Study|Physician withdrew consent|71|||
16205060|NCT00249795|39229694|FG001|Overall Study|Physician withdrew consent|63|||
16205061|NCT00249795|39229693|FG000|Overall Study|Surgery / procedure|4|||
16205062|NCT00249795|39229694|FG001|Overall Study|Surgery / procedure|5|||
16205063|NCT00249795|39229693|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
16205064|NCT00249795|39229694|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
16205065|NCT00249795|39229693|FG000|Overall Study|Lightheadedness / dizziness|15|||
16205066|NCT00249795|39229694|FG001|Overall Study|Lightheadedness / dizziness|11|||
16205067|NCT00249795|39229693|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
16205068|NCT00249795|39229694|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
16205069|NCT00249795|39229693|FG000|Overall Study|Other contraindicated medication|1|||
16205070|NCT00249795|39229694|FG001|Overall Study|Other contraindicated medication|1|||
16205071|NCT00249795|39229693|FG000|Overall Study|Event related to cardiac condition|17|||
16205072|NCT00249795|39229694|FG001|Overall Study|Event related to cardiac condition|16|||
16205073|NCT00249795|39229693|FG000|Overall Study|Patient not wish to continue after May08|4|||
16205074|NCT00249795|39229694|FG001|Overall Study|Patient not wish to continue after May08|6|||
16205075|NCT00249795|39229693|FG000|Overall Study|Site not agree to continue after May08|1|||
16205076|NCT00249795|39229694|FG001|Overall Study|Site not agree to continue after May08|1|||
16205077|NCT00249795|39229693|FG000|Overall Study|Lost to Follow-up|0|||
16205078|NCT00249795|39229694|FG001|Overall Study|Lost to Follow-up|2|||
16205079|NCT00249795|39229693|FG000|Overall Study|Missing|0|||
16205080|NCT00249795|39229694|FG001|Overall Study|Missing|1|||
16205081|NCT00656084|39229695|FG000|Overall Study|Adverse Event|4|||
16205082|NCT00656084|39229695|FG000|Overall Study|Withdrawal by Subject|1|||
16205083|NCT00656084|39229695|FG000|Overall Study|Patient Request|1|||
16205084|NCT00656084|39229695|FG000|Overall Study|Investigator Request|1|||
16205085|NCT00436982|39229696|FG000|Overall Study|Withdrawal by Subject|3|||
16205086|NCT00436982|39229697|FG001|Overall Study|Withdrawal by Subject|1|||
16205087|NCT00436982|39229696|FG000|Overall Study|Did not receive allocated intervention|0|||
16205088|NCT00436982|39229697|FG001|Overall Study|Did not receive allocated intervention|1|||
16205089|NCT00436982|39229696|FG000|Overall Study|no RSA data|1|||
16205090|NCT00436982|39229697|FG001|Overall Study|no RSA data|2|||
16205091|NCT02896192|39229704|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
16205092|NCT02896192|39229704|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
16205093|NCT02896192|39229704|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
16205094|NCT00418717|39229705|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
16205095|NCT00418717|39229705|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
16205096|NCT04377672|39229707|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
16205097|NCT02910219|39229708|FG000|Overall Study|Withdrawal by Subject|1|||
16205098|NCT02910219|39229709|FG001|Overall Study|Withdrawal by Subject|1|||
16205099|NCT03039738|39229710|FG000|Overall Study|Incomplete data sets|54|||
16205100|NCT03039738|39229711|FG001|Overall Study|Incomplete data sets|0|||
16205101|NCT01153841|39229716|FG000|Overall Study|Adverse Event|1|||
16205102|NCT01153841|39229717|FG001|Overall Study|Adverse Event|0|||
16205103|NCT01153841|39229716|FG000|Overall Study|Withdrawal by Subject|1|||
16205104|NCT01153841|39229717|FG001|Overall Study|Withdrawal by Subject|0|||
16205105|NCT01153841|39229716|FG000|Overall Study|Protocol Violation|2|||
16205106|NCT01153841|39229717|FG001|Overall Study|Protocol Violation|0|||
16205107|NCT01153841|39229716|FG000|Overall Study|Lost to Follow-up|2|||
16205108|NCT01153841|39229717|FG001|Overall Study|Lost to Follow-up|0|||
16205109|NCT03146403|39229720|FG000|Overall Study|Withdrawal by Subject|0|||
16205110|NCT03146403|39229721|FG001|Overall Study|Withdrawal by Subject|3|||
16205111|NCT03146403|39229720|FG000|Overall Study|Lost to Follow-up|2|||
16205112|NCT03146403|39229721|FG001|Overall Study|Lost to Follow-up|0|||
16205113|NCT01042938|39229722|FG000|Overall Study|Withdrawal by Subject|1|||
16205114|NCT01042938|39229723|FG001|Overall Study|Withdrawal by Subject|1|||
16205115|NCT01042938|39229722|FG000|Overall Study|Protocol Violation|1|||
16205116|NCT01042938|39229723|FG001|Overall Study|Protocol Violation|1|||
16205117|NCT01042938|39229722|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
16205118|NCT01042938|39229723|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
16205119|NCT01998399|39229728|FG000|Overall Study|Lost to Follow-up|1|||
16205120|NCT01998399|39229729|FG001|Overall Study|Lost to Follow-up|3|||
16205121|NCT01998399|39229728|FG000|Overall Study|Death|4|||
16205122|NCT01998399|39229729|FG001|Overall Study|Death|2|||
16205123|NCT01998399|39229728|FG000|Overall Study|Study stopped before dosing completed|3|||
16205124|NCT01998399|39229729|FG001|Overall Study|Study stopped before dosing completed|3|||
16205125|NCT01998399|39229728|FG000|Overall Study|Withdrawal by Subject|0|||
16205126|NCT01998399|39229729|FG001|Overall Study|Withdrawal by Subject|1|||
16205127|NCT00435994|39229730|FG000|Overall Study|Lost to Follow-up|7|||
16205128|NCT00435994|39229731|FG001|Overall Study|Lost to Follow-up|0|||
16092864|NCT02607956|38830267|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
16092865|NCT02607956|38830268|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
16205129|NCT00435994|39229732|FG002|Overall Study|Lost to Follow-up|0|||
16205130|NCT01451398|39229734|FG000|Overall Study|Adverse Event|7|||
16205131|NCT01451398|39229735|FG001|Overall Study|Adverse Event|9|||
16205132|NCT01451398|39229734|FG000|Overall Study|Protocol Violation|1|||
16205133|NCT01451398|39229735|FG001|Overall Study|Protocol Violation|2|||
16205134|NCT01451398|39229734|FG000|Overall Study|Physician Decision|1|||
16205135|NCT01451398|39229735|FG001|Overall Study|Physician Decision|1|||
16205136|NCT01451398|39229734|FG000|Overall Study|Withdrawal by Subject|10|||
16205137|NCT01451398|39229735|FG001|Overall Study|Withdrawal by Subject|14|||
16205138|NCT01451398|39229734|FG000|Overall Study|Lost to Follow-up|6|||
16205139|NCT01451398|39229735|FG001|Overall Study|Lost to Follow-up|4|||
16205140|NCT01451398|39229734|FG000|Overall Study|Non-compliance with study drug|1|||
16205141|NCT01451398|39229735|FG001|Overall Study|Non-compliance with study drug|3|||
16205142|NCT01451398|39229734|FG000|Overall Study|Non-compliance with protocol|1|||
16205143|NCT01451398|39229735|FG001|Overall Study|Non-compliance with protocol|1|||
16205144|NCT01451398|39229734|FG000|Overall Study|Moved out of country|0|||
16205145|NCT01451398|39229735|FG001|Overall Study|Moved out of country|1|||
16205146|NCT01451398|39229734|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
16205147|NCT01451398|39229735|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
16205148|NCT01451398|39229734|FG000|Overall Study|Lack of Efficacy|0|||
16205149|NCT01451398|39229735|FG001|Overall Study|Lack of Efficacy|1|||
16205150|NCT00877006|39229737|FG000|Treatment Period|Death|2|||
16205151|NCT00877006|39229738|FG001|Treatment Period|Death|1|||
16205152|NCT00877006|39229737|FG000|Treatment Period|Adverse Event|10|||
16205153|NCT00877006|39229738|FG001|Treatment Period|Adverse Event|3|||
16205154|NCT00877006|39229737|FG000|Treatment Period|Withdrawal by Subject|2|||
16205155|NCT00877006|39229738|FG001|Treatment Period|Withdrawal by Subject|3|||
16205156|NCT00877006|39229737|FG000|Treatment Period|Protocol Violation|1|||
16205157|NCT00877006|39229738|FG001|Treatment Period|Protocol Violation|0|||
16205158|NCT00877006|39229737|FG000|Treatment Period|Lost to Follow-up|0|||
16205159|NCT00877006|39229738|FG001|Treatment Period|Lost to Follow-up|1|||
16205160|NCT00877006|39229737|FG000|Treatment Period|Disease Progression|1|||
16205161|NCT00877006|39229738|FG001|Treatment Period|Disease Progression|2|||
16205162|NCT00877006|39229737|FG000|Treatment Period|Started New Treatment Regimen|2|||
16205163|NCT00877006|39229738|FG001|Treatment Period|Started New Treatment Regimen|5|||
16205164|NCT00877006|39229737|FG000|Treatment Period|Other|4|||
16205165|NCT00877006|39229738|FG001|Treatment Period|Other|4|||
16205166|NCT00877006|39229737|FG000|Treatment Period|Randomized but Not Treated|3|||
16205167|NCT00877006|39229738|FG001|Treatment Period|Randomized but Not Treated|8|||
16205168|NCT00877006|39229737|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
16205169|NCT00877006|39229738|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
16092866|NCT02607956|38830269|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
16092867|NCT02607956|38830266|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
16092868|NCT02607956|38830267|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
16092869|NCT02607956|38830268|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
16092870|NCT02607956|38830269|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
16092871|NCT02607956|38830266|FG000|Open-Label Extension Phase|Protocol Violation|0|||
16092872|NCT02607956|38830267|FG001|Open-Label Extension Phase|Protocol Violation|0|||
16092873|NCT02607956|38830268|FG002|Open-Label Extension Phase|Protocol Violation|0|||
16092874|NCT02607956|38830269|FG003|Open-Label Extension Phase|Protocol Violation|2|||
16092875|NCT02607956|38830266|FG000|Open-Label Extension Phase|Pregnancy|0|||
16092876|NCT02607956|38830267|FG001|Open-Label Extension Phase|Pregnancy|0|||
16092877|NCT02607956|38830268|FG002|Open-Label Extension Phase|Pregnancy|0|||
16092878|NCT02607956|38830269|FG003|Open-Label Extension Phase|Pregnancy|1|||
16092879|NCT01052272|38830273|FG000|Overall Study|Death|0|||
16205170|NCT00877006|39229737|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
16092880|NCT01052272|38830274|FG001|Overall Study|Death|0|||
16205171|NCT00877006|39229738|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
16205172|NCT00877006|39229737|FG000|Long-Term Follow-up Period|Death|26|||
16205173|NCT00877006|39229738|FG001|Long-Term Follow-up Period|Death|18|||
16205174|NCT00877006|39229737|FG000|Long-Term Follow-up Period|Other|7|||
16205175|NCT00877006|39229738|FG001|Long-Term Follow-up Period|Other|9|||
16205176|NCT02186561|39229739|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
16205177|NCT02186561|39229739|FG000|Enrollment|Enrollment Cap Reached|5|||
16205178|NCT02186561|39229739|FG000|Enrollment|Insurance Denial|2|||
16205179|NCT02186561|39229739|FG000|Enrollment|Withdrawal by Subject|2|||
16205180|NCT02186561|39229739|FG000|Enrollment|Investigator Withdrew Consent|1|||
16205181|NCT02186561|39229739|FG000|30-Day Post Index Procedure Visit|Death|1|||
16205182|NCT02186561|39229739|FG000|1- Year Post Index Procedure Visit|Death|1|||
16205183|NCT02186561|39229739|FG000|1- Year Post Index Procedure Visit|Missed|1|||
16205184|NCT02378883|39229742|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
16205185|NCT02378883|39229742|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
16205186|NCT02378883|39229742|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
16205187|NCT02378883|39229742|FG000|30 Day Follow-Up|Physician Decision|2|||
16205188|NCT02378883|39229742|FG000|30 Day Follow-Up|Missed Visit|2|||
16205189|NCT02378883|39229742|FG000|30 Day Follow-Up|Death|1|||
16205190|NCT02378883|39229742|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
16205191|NCT02378883|39229742|FG000|12 Months Follow-Up|Death|2|||
16205192|NCT02057068|39229745|FG000|Overall Study|Withdrawal by Subject|2|||
16205193|NCT02057068|39229746|FG001|Overall Study|Withdrawal by Subject|2|||
16205194|NCT02057068|39229745|FG000|Overall Study|Caregiver (CG) Health|0|||
16205195|NCT02057068|39229746|FG001|Overall Study|Caregiver (CG) Health|2|||
16205196|NCT02057068|39229745|FG000|Overall Study|Carepartner (CP) Health|4|||
16205197|NCT02057068|39229746|FG001|Overall Study|Carepartner (CP) Health|2|||
16205198|NCT02057068|39229745|FG000|Overall Study|Lost to Follow-up|2|||
16205199|NCT02057068|39229746|FG001|Overall Study|Lost to Follow-up|2|||
16205200|NCT01810380|39229747|FG000|Overall Study|Randomised not treated|2|||
16205201|NCT01810380|39229748|FG001|Overall Study|Randomised not treated|1|||
16205202|NCT01810380|39229749|FG002|Overall Study|Randomised not treated|1|||
16205203|NCT01810380|39229747|FG000|Overall Study|Adverse Event|11|||
16205204|NCT01810380|39229748|FG001|Overall Study|Adverse Event|14|||
16205205|NCT01810380|39229749|FG002|Overall Study|Adverse Event|4|||
16205206|NCT01810380|39229747|FG000|Overall Study|Lack of Efficacy|24|||
16205207|NCT01810380|39229748|FG001|Overall Study|Lack of Efficacy|10|||
16205208|NCT01810380|39229749|FG002|Overall Study|Lack of Efficacy|11|||
16205209|NCT01810380|39229747|FG000|Overall Study|Protocol Violation|1|||
16205210|NCT01810380|39229748|FG001|Overall Study|Protocol Violation|0|||
16205211|NCT01810380|39229749|FG002|Overall Study|Protocol Violation|1|||
16205212|NCT01810380|39229747|FG000|Overall Study|Withdrawal by Subject|6|||
16205213|NCT01810380|39229748|FG001|Overall Study|Withdrawal by Subject|0|||
16205214|NCT01810380|39229749|FG002|Overall Study|Withdrawal by Subject|6|||
16205215|NCT01810380|39229747|FG000|Overall Study|Administrative or other reasons|11|||
16205216|NCT01810380|39229748|FG001|Overall Study|Administrative or other reasons|13|||
16205217|NCT01810380|39229749|FG002|Overall Study|Administrative or other reasons|9|||
16205218|NCT02062398|39229752|FG000|Overall Study|Implant removal|1|||
16205219|NCT02023112|39229753|FG000|Overall Study|Withdrawal by Subject|2|||
16205220|NCT02023112|39229754|FG001|Overall Study|Withdrawal by Subject|1|||
16205221|NCT01306032|39229755|FG000|First Intervention|Adverse Event|1|||
16205222|NCT01306032|39229756|FG001|First Intervention|Adverse Event|0|||
16205223|NCT01306032|39229757|FG002|First Intervention|Adverse Event|1|||
16205224|NCT01306032|39229758|FG003|First Intervention|Adverse Event|0|||
16205225|NCT01306032|39229759|FG004|First Intervention|Adverse Event|0|||
16205226|NCT01306032|39229760|FG005|First Intervention|Adverse Event|1|||
16205227|NCT01306032|39229755|FG000|First Intervention|Withdrawal by Subject|0|||
16205228|NCT01306032|39229756|FG001|First Intervention|Withdrawal by Subject|2|||
16205229|NCT01306032|39229757|FG002|First Intervention|Withdrawal by Subject|0|||
16205230|NCT01306032|39229758|FG003|First Intervention|Withdrawal by Subject|1|||
16518862|NCT02247349|40368463|FG000|Overall Study|Administrative reason by sponsor|0|||
16518863|NCT02247349|40368464|FG001|Overall Study|Administrative reason by sponsor|0|||
16518864|NCT02247349|40368465|FG002|Overall Study|Administrative reason by sponsor|0|||
16518865|NCT02247349|40368466|FG003|Overall Study|Administrative reason by sponsor|0|||
16518866|NCT02247349|40368467|FG004|Overall Study|Administrative reason by sponsor|1|||
16518867|NCT02247349|40368468|FG005|Overall Study|Administrative reason by sponsor|0|||
16518868|NCT02247349|40368463|FG000|Overall Study|Other reasons|0|||
16518869|NCT02247349|40368464|FG001|Overall Study|Other reasons|0|||
16518870|NCT02247349|40368465|FG002|Overall Study|Other reasons|1|||
16518871|NCT02247349|40368466|FG003|Overall Study|Other reasons|0|||
16518872|NCT02247349|40368467|FG004|Overall Study|Other reasons|0|||
16518873|NCT02247349|40368468|FG005|Overall Study|Other reasons|0|||
16518874|NCT02880371|40368469|FG000|Phase 1b|Lost to Follow-up|1|||
16205231|NCT01306032|39229759|FG004|First Intervention|Withdrawal by Subject|0|||
16205232|NCT01306032|39229760|FG005|First Intervention|Withdrawal by Subject|0|||
16205233|NCT01306032|39229755|FG000|First Intervention|Death|0|||
16205234|NCT01306032|39229756|FG001|First Intervention|Death|0|||
16205235|NCT01306032|39229757|FG002|First Intervention|Death|1|||
16205236|NCT01306032|39229758|FG003|First Intervention|Death|0|||
16205237|NCT01306032|39229759|FG004|First Intervention|Death|0|||
16518875|NCT02880371|40368470|FG001|Phase 1b|Lost to Follow-up|0|||
16205238|NCT01306032|39229760|FG005|First Intervention|Death|0|||
16205239|NCT01306032|39229755|FG000|First Intervention|Ineligible|0|||
16518876|NCT02880371|40368471|FG002|Phase 1b|Lost to Follow-up|0|||
16518877|NCT02880371|40368472|FG003|Phase 1b|Lost to Follow-up|0|||
16518878|NCT02880371|40368473|FG004|Phase 1b|Lost to Follow-up|0|||
16518879|NCT02880371|40368474|FG005|Phase 1b|Lost to Follow-up|0|||
16518880|NCT02880371|40368475|FG006|Phase 1b|Lost to Follow-up|0|||
16518881|NCT02880371|40368476|FG007|Phase 1b|Lost to Follow-up|0|||
16518882|NCT02880371|40368469|FG000|Phase 1b|Participants terminated by Sponsor|1|||
16518883|NCT02880371|40368470|FG001|Phase 1b|Participants terminated by Sponsor|0|||
16518884|NCT02880371|40368471|FG002|Phase 1b|Participants terminated by Sponsor|0|||
16518885|NCT02880371|40368472|FG003|Phase 1b|Participants terminated by Sponsor|0|||
16518886|NCT02880371|40368473|FG004|Phase 1b|Participants terminated by Sponsor|0|||
16518887|NCT02880371|40368474|FG005|Phase 1b|Participants terminated by Sponsor|0|||
16518888|NCT02880371|40368475|FG006|Phase 1b|Participants terminated by Sponsor|0|||
16518889|NCT02880371|40368476|FG007|Phase 1b|Participants terminated by Sponsor|0|||
16518890|NCT02880371|40368469|FG000|Phase 1b|Withdrawal by Subject|0|||
16518891|NCT02880371|40368470|FG001|Phase 1b|Withdrawal by Subject|0|||
16518892|NCT02880371|40368471|FG002|Phase 1b|Withdrawal by Subject|1|||
16518893|NCT02880371|40368472|FG003|Phase 1b|Withdrawal by Subject|0|||
16518894|NCT02880371|40368473|FG004|Phase 1b|Withdrawal by Subject|0|||
16518895|NCT02880371|40368474|FG005|Phase 1b|Withdrawal by Subject|0|||
16518896|NCT02880371|40368475|FG006|Phase 1b|Withdrawal by Subject|0|||
16518897|NCT02880371|40368476|FG007|Phase 1b|Withdrawal by Subject|0|||
16518898|NCT02880371|40368469|FG000|Phase 1b|Death|4|||
16518899|NCT02880371|40368470|FG001|Phase 1b|Death|6|||
16518900|NCT02880371|40368471|FG002|Phase 1b|Death|5|||
16518901|NCT02880371|40368472|FG003|Phase 1b|Death|1|||
16205240|NCT01306032|39229756|FG001|First Intervention|Ineligible|0|||
16205241|NCT01306032|39229757|FG002|First Intervention|Ineligible|0|||
16205242|NCT01306032|39229758|FG003|First Intervention|Ineligible|0|||
16205243|NCT01306032|39229759|FG004|First Intervention|Ineligible|0|||
16205244|NCT01306032|39229760|FG005|First Intervention|Ineligible|1|||
16205245|NCT01306032|39229755|FG000|First Intervention|Progressive disease|0|||
16205246|NCT01306032|39229756|FG001|First Intervention|Progressive disease|0|||
16205247|NCT01306032|39229757|FG002|First Intervention|Progressive disease|0|||
16205248|NCT01306032|39229758|FG003|First Intervention|Progressive disease|0|||
16518902|NCT02880371|40368473|FG004|Phase 1b|Death|0|||
16518903|NCT02880371|40368474|FG005|Phase 1b|Death|0|||
16518904|NCT02880371|40368475|FG006|Phase 1b|Death|0|||
16518905|NCT02880371|40368476|FG007|Phase 1b|Death|0|||
16518906|NCT02880371|40368469|FG000|Phase 1b|Enrolled but not Treated|0|||
16518907|NCT02880371|40368470|FG001|Phase 1b|Enrolled but not Treated|1|||
16205249|NCT01306032|39229759|FG004|First Intervention|Progressive disease|2|||
16205250|NCT01306032|39229760|FG005|First Intervention|Progressive disease|0|||
16205251|NCT01306032|39229755|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
16205252|NCT01306032|39229756|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
16205253|NCT01306032|39229757|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
16205254|NCT01306032|39229758|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
16205255|NCT01306032|39229759|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
16205256|NCT01306032|39229760|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
16205257|NCT01306032|39229755|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
16205258|NCT01306032|39229756|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
16205259|NCT01306032|39229757|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
16205260|NCT01306032|39229758|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
16205261|NCT01306032|39229759|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
16205262|NCT01306032|39229760|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
16205263|NCT03549429|39229761|FG000|Overall Study|Protocol Violation|5|||
16205264|NCT03549429|39229762|FG001|Overall Study|Protocol Violation|3|||
16205265|NCT00636441|39229765|FG000|Overall Study|Adverse Event|0|||
16205266|NCT00636441|39229766|FG001|Overall Study|Adverse Event|1|||
16205267|NCT00636441|39229767|FG002|Overall Study|Adverse Event|1|||
16205268|NCT00636441|39229768|FG003|Overall Study|Adverse Event|0|||
16205269|NCT00636441|39229769|FG004|Overall Study|Adverse Event|0|||
16205270|NCT00636441|39229770|FG005|Overall Study|Adverse Event|1|||
16205271|NCT00636441|39229771|FG006|Overall Study|Adverse Event|0|||
16205272|NCT00636441|39229765|FG000|Overall Study|Late, ineligible|0|||
16205273|NCT00636441|39229766|FG001|Overall Study|Late, ineligible|0|||
16205274|NCT00636441|39229767|FG002|Overall Study|Late, ineligible|0|||
16205275|NCT00636441|39229768|FG003|Overall Study|Late, ineligible|0|||
16205276|NCT00636441|39229769|FG004|Overall Study|Late, ineligible|0|||
16205277|NCT00636441|39229770|FG005|Overall Study|Late, ineligible|0|||
16205278|NCT00636441|39229771|FG006|Overall Study|Late, ineligible|1|||
16518908|NCT02880371|40368471|FG002|Phase 1b|Enrolled but not Treated|0|||
16518909|NCT02880371|40368472|FG003|Phase 1b|Enrolled but not Treated|0|||
16518910|NCT02880371|40368473|FG004|Phase 1b|Enrolled but not Treated|0|||
16092881|NCT01052272|38830275|FG002|Overall Study|Death|1|||
16205279|NCT00636441|39229765|FG000|Overall Study|Screen Failure|0|||
16518911|NCT02880371|40368474|FG005|Phase 1b|Enrolled but not Treated|0|||
16205280|NCT00636441|39229766|FG001|Overall Study|Screen Failure|0|||
16205281|NCT00636441|39229767|FG002|Overall Study|Screen Failure|0|||
16205282|NCT00636441|39229768|FG003|Overall Study|Screen Failure|0|||
16205283|NCT00636441|39229769|FG004|Overall Study|Screen Failure|0|||
16205284|NCT00636441|39229770|FG005|Overall Study|Screen Failure|0|||
16205285|NCT00636441|39229771|FG006|Overall Study|Screen Failure|17|||
16205286|NCT01576406|39229772|FG000|Overall Study|Lost to Follow-up|1|||
16205287|NCT01576406|39229773|FG001|Overall Study|Lost to Follow-up|2|||
16205288|NCT01576406|39229774|FG002|Overall Study|Lost to Follow-up|0|||
16205289|NCT01576406|39229775|FG003|Overall Study|Lost to Follow-up|0|||
16205290|NCT01576406|39229776|FG004|Overall Study|Lost to Follow-up|0|||
16205291|NCT01576406|39229777|FG005|Overall Study|Lost to Follow-up|0|||
16205292|NCT01576406|39229772|FG000|Overall Study|Death|3|||
16205293|NCT01576406|39229773|FG001|Overall Study|Death|4|||
16205294|NCT01576406|39229774|FG002|Overall Study|Death|8|||
16205295|NCT01576406|39229775|FG003|Overall Study|Death|5|||
16205296|NCT01576406|39229776|FG004|Overall Study|Death|7|||
16205297|NCT01576406|39229777|FG005|Overall Study|Death|9|||
16205298|NCT01576406|39229772|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
16205299|NCT01576406|39229773|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
16205300|NCT01576406|39229774|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
16205301|NCT01576406|39229775|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
16205302|NCT01576406|39229776|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
16205303|NCT01576406|39229777|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
16205304|NCT01576406|39229772|FG000|Overall Study|Withdrawal the consent|2|||
16205305|NCT01576406|39229773|FG001|Overall Study|Withdrawal the consent|2|||
16205306|NCT01576406|39229774|FG002|Overall Study|Withdrawal the consent|5|||
16205307|NCT01576406|39229775|FG003|Overall Study|Withdrawal the consent|1|||
16205308|NCT01576406|39229776|FG004|Overall Study|Withdrawal the consent|1|||
16205309|NCT01576406|39229777|FG005|Overall Study|Withdrawal the consent|3|||
16205310|NCT01576406|39229772|FG000|Overall Study|Other|0|||
16205311|NCT01576406|39229773|FG001|Overall Study|Other|0|||
16205312|NCT01576406|39229774|FG002|Overall Study|Other|2|||
16205313|NCT01576406|39229775|FG003|Overall Study|Other|2|||
16205314|NCT01576406|39229776|FG004|Overall Study|Other|0|||
16205315|NCT01576406|39229777|FG005|Overall Study|Other|0|||
16205316|NCT00050960|39229780|FG000|Overall Study|Progressive Disease|137|||
16205317|NCT00050960|39229781|FG001|Overall Study|Progressive Disease|93|||
16205318|NCT00050960|39229780|FG000|Overall Study|Stable Disease|19|||
16205319|NCT00050960|39229781|FG001|Overall Study|Stable Disease|48|||
16205320|NCT00050960|39229780|FG000|Overall Study|Partial Response|14|||
16205321|NCT00050960|39229781|FG001|Overall Study|Partial Response|19|||
16205322|NCT00050960|39229780|FG000|Overall Study|Complete Response|0|||
16205323|NCT00050960|39229781|FG001|Overall Study|Complete Response|2|||
16205324|NCT00050960|39229780|FG000|Overall Study|Adverse Event|62|||
16205325|NCT00050960|39229781|FG001|Overall Study|Adverse Event|61|||
16205326|NCT00050960|39229780|FG000|Overall Study|Lost to Follow-up|0|||
16205327|NCT00050960|39229781|FG001|Overall Study|Lost to Follow-up|1|||
16205328|NCT00050960|39229780|FG000|Overall Study|Withdrawal by Subject|23|||
16205329|NCT00050960|39229781|FG001|Overall Study|Withdrawal by Subject|18|||
16205330|NCT00050960|39229780|FG000|Overall Study|Administrative|31|||
16205331|NCT00050960|39229781|FG001|Overall Study|Administrative|46|||
16205332|NCT00050960|39229780|FG000|Overall Study|Non-compliance|3|||
16205333|NCT00050960|39229781|FG001|Overall Study|Non-compliance|1|||
16205334|NCT00050960|39229780|FG000|Overall Study|Death|13|||
16205335|NCT00050960|39229781|FG001|Overall Study|Death|15|||
16205336|NCT00871572|39229782|FG000|Overall Study|Adverse Event|0|||
16205337|NCT00871572|39229783|FG001|Overall Study|Adverse Event|2|||
16205338|NCT00871572|39229784|FG002|Overall Study|Adverse Event|0|||
16205339|NCT00871572|39229785|FG003|Overall Study|Adverse Event|3|||
16205340|NCT00871572|39229782|FG000|Overall Study|Investigator Decision|0|||
16205341|NCT00871572|39229783|FG001|Overall Study|Investigator Decision|1|||
16205342|NCT00871572|39229784|FG002|Overall Study|Investigator Decision|0|||
16205343|NCT00871572|39229785|FG003|Overall Study|Investigator Decision|1|||
16092882|NCT01052272|38830276|FG003|Overall Study|Death|1|||
16518912|NCT02880371|40368475|FG006|Phase 1b|Enrolled but not Treated|0|||
16518913|NCT02880371|40368476|FG007|Phase 1b|Enrolled but not Treated|0|||
16205344|NCT00871572|39229782|FG000|Overall Study|Lost to Follow-up|0|||
16205345|NCT00871572|39229783|FG001|Overall Study|Lost to Follow-up|1|||
16205346|NCT00871572|39229784|FG002|Overall Study|Lost to Follow-up|0|||
16205347|NCT00871572|39229785|FG003|Overall Study|Lost to Follow-up|1|||
16205348|NCT00871572|39229782|FG000|Overall Study|Protocol Violation|0|||
16205349|NCT00871572|39229783|FG001|Overall Study|Protocol Violation|0|||
16205350|NCT00871572|39229784|FG002|Overall Study|Protocol Violation|1|||
16205351|NCT00871572|39229785|FG003|Overall Study|Protocol Violation|1|||
16205352|NCT00871572|39229782|FG000|Overall Study|Sponsor Decision|1|||
16205353|NCT00871572|39229783|FG001|Overall Study|Sponsor Decision|0|||
16205354|NCT00871572|39229784|FG002|Overall Study|Sponsor Decision|0|||
16205355|NCT00871572|39229785|FG003|Overall Study|Sponsor Decision|0|||
16205356|NCT00871572|39229782|FG000|Overall Study|Withdrawal by Subject|1|||
16205357|NCT00871572|39229783|FG001|Overall Study|Withdrawal by Subject|2|||
16205358|NCT00871572|39229784|FG002|Overall Study|Withdrawal by Subject|3|||
16205359|NCT00871572|39229785|FG003|Overall Study|Withdrawal by Subject|1|||
16205360|NCT02727660|39229786|FG000|Overall Study|Lack of Efficacy|40|||
16205361|NCT02727660|39229787|FG001|Overall Study|Lack of Efficacy|40|||
16205362|NCT02727660|39229788|FG002|Overall Study|Lack of Efficacy|70|||
16205363|NCT02727660|39229786|FG000|Overall Study|Adverse Event|28|||
16205364|NCT02727660|39229787|FG001|Overall Study|Adverse Event|21|||
16205365|NCT02727660|39229788|FG002|Overall Study|Adverse Event|32|||
16205366|NCT02727660|39229786|FG000|Overall Study|Withdrawal by Subject|26|||
16205367|NCT02727660|39229787|FG001|Overall Study|Withdrawal by Subject|25|||
16205368|NCT02727660|39229788|FG002|Overall Study|Withdrawal by Subject|30|||
16205369|NCT02727660|39229786|FG000|Overall Study|Physician Decision|3|||
16205370|NCT02727660|39229787|FG001|Overall Study|Physician Decision|8|||
16205371|NCT02727660|39229788|FG002|Overall Study|Physician Decision|14|||
16205372|NCT02727660|39229786|FG000|Overall Study|Lost to Follow-up|5|||
16205373|NCT02727660|39229787|FG001|Overall Study|Lost to Follow-up|9|||
16205374|NCT02727660|39229788|FG002|Overall Study|Lost to Follow-up|8|||
16205375|NCT02727660|39229786|FG000|Overall Study|Protocol Violation|7|||
16205376|NCT02727660|39229787|FG001|Overall Study|Protocol Violation|5|||
16205377|NCT02727660|39229788|FG002|Overall Study|Protocol Violation|5|||
16205378|NCT02727660|39229786|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
16205379|NCT02727660|39229787|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
16205380|NCT02727660|39229788|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
16205381|NCT02727660|39229786|FG000|Overall Study|Administrative Reasons|2|||
16205382|NCT02727660|39229787|FG001|Overall Study|Administrative Reasons|3|||
16205383|NCT02727660|39229788|FG002|Overall Study|Administrative Reasons|4|||
16205384|NCT01599806|39229789|FG000|Overall Study|Lost to Follow-up|20|||
16205385|NCT01599806|39229790|FG001|Overall Study|Lost to Follow-up|20|||
16205386|NCT01599806|39229789|FG000|Overall Study|Withdrawal by Subject|12|||
16205387|NCT01599806|39229790|FG001|Overall Study|Withdrawal by Subject|12|||
16205388|NCT01599806|39229789|FG000|Overall Study|Other Eligibility criteria|11|||
16205389|NCT01599806|39229790|FG001|Overall Study|Other Eligibility criteria|9|||
16205390|NCT03549117|39229792|FG000|Overall Study|Withdrawal by Subject|1|||
16205391|NCT03549117|39229793|FG001|Overall Study|Withdrawal by Subject|0|||
16205392|NCT04992546|39229794|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
16205393|NCT04992546|39229794|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
16205394|NCT04992546|39229794|FG000|Open-Label Treatment Period|Adverse Event|3|||
16205395|NCT04992546|39229794|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
16205396|NCT03024255|39229795|FG000|Overall Study|Adverse Event|1|||
16205397|NCT03024255|39229796|FG001|Overall Study|Adverse Event|4|||
16205398|NCT03024255|39229797|FG002|Overall Study|Adverse Event|8|||
16205399|NCT03024255|39229798|FG003|Overall Study|Adverse Event|0|||
16205400|NCT03024255|39229795|FG000|Overall Study|Withdrawal by Subject|3|||
16205401|NCT03024255|39229796|FG001|Overall Study|Withdrawal by Subject|1|||
16205402|NCT03024255|39229797|FG002|Overall Study|Withdrawal by Subject|0|||
16205403|NCT03024255|39229798|FG003|Overall Study|Withdrawal by Subject|3|||
16205404|NCT03024255|39229795|FG000|Overall Study|Protocol Violation|0|||
16205405|NCT03024255|39229796|FG001|Overall Study|Protocol Violation|0|||
16395665|NCT00078806|39928324|FG003|Part 1A|Lack of Efficacy|0|||
16395666|NCT00078806|39928321|FG000|Part 1A|Other|1|||
16395667|NCT00078806|39928322|FG001|Part 1A|Other|0|||
16395668|NCT00078806|39928323|FG002|Part 1A|Other|0|||
16395669|NCT00078806|39928324|FG003|Part 1A|Other|0|||
16395670|NCT00078806|39928321|FG000|Part 1B|Adverse Event|1|||
16395671|NCT00078806|39928322|FG001|Part 1B|Adverse Event|0|||
16205406|NCT03024255|39229797|FG002|Overall Study|Protocol Violation|2|||
16205407|NCT03024255|39229798|FG003|Overall Study|Protocol Violation|0|||
16205408|NCT03024255|39229795|FG000|Overall Study|Lost to Follow-up|1|||
16205409|NCT03024255|39229796|FG001|Overall Study|Lost to Follow-up|2|||
16205410|NCT03024255|39229797|FG002|Overall Study|Lost to Follow-up|1|||
16205411|NCT03024255|39229798|FG003|Overall Study|Lost to Follow-up|1|||
16205412|NCT03024255|39229795|FG000|Overall Study|Lack of Efficacy|1|||
16205413|NCT03024255|39229796|FG001|Overall Study|Lack of Efficacy|0|||
16323140|NCT00638404|39670794|FG001|Overall Study|Physician Decision|0|||
16323141|NCT01683266|39670797|FG000|Overall Study|Adverse Event|5|||
16323142|NCT01683266|39670798|FG001|Overall Study|Adverse Event|4|||
16323143|NCT01683266|39670797|FG000|Overall Study|Lack of Efficacy|5|||
16323144|NCT01683266|39670798|FG001|Overall Study|Lack of Efficacy|2|||
16323145|NCT01683266|39670797|FG000|Overall Study|Protocol Violation|13|||
16323146|NCT01683266|39670798|FG001|Overall Study|Protocol Violation|6|||
16323147|NCT01683266|39670797|FG000|Overall Study|Personal Reason|17|||
16323148|NCT01683266|39670798|FG001|Overall Study|Personal Reason|25|||
16323149|NCT01683266|39670797|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
16323150|NCT01683266|39670798|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
16323151|NCT01683266|39670797|FG000|Overall Study|Lost to Follow-up|5|||
16395672|NCT00078806|39928323|FG002|Part 1B|Adverse Event|0|||
16395673|NCT00078806|39928324|FG003|Part 1B|Adverse Event|0|||
16395674|NCT00078806|39928321|FG000|Part 1B|Lack of Efficacy|7|||
16205414|NCT03024255|39229797|FG002|Overall Study|Lack of Efficacy|0|||
16205415|NCT03024255|39229798|FG003|Overall Study|Lack of Efficacy|0|||
16205416|NCT03024255|39229795|FG000|Overall Study|Protocol Noncompliance|1|||
16205417|NCT03024255|39229796|FG001|Overall Study|Protocol Noncompliance|1|||
16205418|NCT03024255|39229797|FG002|Overall Study|Protocol Noncompliance|0|||
16205419|NCT03024255|39229798|FG003|Overall Study|Protocol Noncompliance|1|||
16205420|NCT03363919|39229799|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
16205421|NCT03363919|39229800|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
16205422|NCT03363919|39229799|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
16205423|NCT03363919|39229800|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
16205424|NCT00718523|39229804|FG000|Overall Study|Withdrawal by Subject|5|||
16205425|NCT00718523|39229805|FG001|Overall Study|Withdrawal by Subject|7|||
16205426|NCT00718523|39229804|FG000|Overall Study|Death|13|||
16205427|NCT00718523|39229805|FG001|Overall Study|Death|17|||
16205428|NCT01946412|39229808|FG000|Overall Study|Adverse Event|1|||
16205429|NCT01946412|39229808|FG000|Overall Study|Non-Compliance|1|||
16205430|NCT01946412|39229808|FG000|Overall Study|Continued with commercial Kalydeco|2|||
16205431|NCT01946412|39229808|FG000|Overall Study|Difficulty in swallowing|1|||
16205432|NCT03094611|39229809|FG000|Overall Study|Lack of Efficacy|1|||
16205433|NCT03094611|39229809|FG000|Overall Study|Stem Cell Transplant|1|||
16205434|NCT02150213|39229810|FG000|Overall Study|Lost to Follow-up|1|||
16205435|NCT02150213|39229810|FG000|Overall Study|Withdrawal by Subject|1|||
16205436|NCT00391807|39229813|FG000|Overall Study|Did not receive study medication|23|||
16205437|NCT00391807|39229813|FG000|Overall Study|Adverse Event|177|||
16205438|NCT00391807|39229813|FG000|Overall Study|Pregnancy|25|||
16205439|NCT00391807|39229813|FG000|Overall Study|Lost to Follow-up|227|||
16205440|NCT00391807|39229813|FG000|Overall Study|Withdrawal by Subject|147|||
16205441|NCT00391807|39229813|FG000|Overall Study|Protocol Violation|20|||
16205442|NCT00391807|39229813|FG000|Overall Study|Various|96|||
16205443|NCT04581863|39229814|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
16205444|NCT04581863|39229815|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
16205445|NCT01838590|39229818|FG000|Overall Study|Lack of Efficacy|12|||
16205446|NCT01838590|39229819|FG001|Overall Study|Lack of Efficacy|4|||
16205447|NCT01838590|39229818|FG000|Overall Study|Lost to Follow-up|0|||
16205448|NCT01838590|39229819|FG001|Overall Study|Lost to Follow-up|1|||
16205449|NCT01544478|39229823|FG000|Overall Study|Adverse Event|1|||
16205450|NCT01544478|39229823|FG000|Overall Study|Death|1|||
16205451|NCT01544478|39229823|FG000|Overall Study|Lost to Follow-up|48|||
16205452|NCT01544478|39229823|FG000|Overall Study|Physician Decision|15|||
16205453|NCT01544478|39229823|FG000|Overall Study|Pregnancy|1|||
16205454|NCT01544478|39229823|FG000|Overall Study|Withdrawal by Subject|52|||
16205455|NCT02290340|39229829|FG000|Overall Study|Lost to Follow-up|0|||
16205456|NCT02290340|39229830|FG001|Overall Study|Lost to Follow-up|0|||
16205457|NCT02290340|39229831|FG002|Overall Study|Lost to Follow-up|0|||
16205458|NCT02290340|39229832|FG003|Overall Study|Lost to Follow-up|1|||
16205459|NCT02290340|39229829|FG000|Overall Study|Withdrawal by Subject|1|||
16205460|NCT02290340|39229830|FG001|Overall Study|Withdrawal by Subject|0|||
16205461|NCT02290340|39229831|FG002|Overall Study|Withdrawal by Subject|0|||
16205462|NCT02290340|39229832|FG003|Overall Study|Withdrawal by Subject|0|||
16205463|NCT02290340|39229829|FG000|Overall Study|Other|1|||
16205464|NCT02290340|39229830|FG001|Overall Study|Other|0|||
16205465|NCT02290340|39229831|FG002|Overall Study|Other|0|||
16205466|NCT02290340|39229832|FG003|Overall Study|Other|1|||
16205467|NCT03673956|39229835|FG000|Overall Study|Lost to Follow-up|1|||
16205468|NCT03673956|39229836|FG001|Overall Study|Lost to Follow-up|0|||
16205469|NCT03673956|39229837|FG002|Overall Study|Lost to Follow-up|0|||
16518914|NCT02880371|40368469|FG000|Phase 2|Enrolled but not Treated|0|||
16518915|NCT02880371|40368470|FG001|Phase 2|Enrolled but not Treated|0|||
16518916|NCT02880371|40368471|FG002|Phase 2|Enrolled but not Treated|0|||
16518917|NCT02880371|40368472|FG003|Phase 2|Enrolled but not Treated|0|||
16518918|NCT02880371|40368473|FG004|Phase 2|Enrolled but not Treated|0|||
16518919|NCT02880371|40368474|FG005|Phase 2|Enrolled but not Treated|1|||
16518920|NCT02880371|40368475|FG006|Phase 2|Enrolled but not Treated|1|||
16518921|NCT02880371|40368476|FG007|Phase 2|Enrolled but not Treated|0|||
16518922|NCT02880371|40368469|FG000|Phase 2|Other|0|||
16518923|NCT02880371|40368470|FG001|Phase 2|Other|0|||
16518924|NCT02880371|40368471|FG002|Phase 2|Other|0|||
16518925|NCT02880371|40368472|FG003|Phase 2|Other|0|||
16518926|NCT02880371|40368473|FG004|Phase 2|Other|0|||
16518927|NCT02880371|40368474|FG005|Phase 2|Other|1|||
16205470|NCT03673956|39229838|FG003|Overall Study|Lost to Follow-up|0|||
16205471|NCT03673956|39229835|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
16205472|NCT03673956|39229836|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
16205473|NCT03673956|39229837|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
16205474|NCT03673956|39229838|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
16518928|NCT02880371|40368475|FG006|Phase 2|Other|2|||
16518929|NCT02880371|40368476|FG007|Phase 2|Other|1|||
16518930|NCT02880371|40368469|FG000|Phase 2|Participants terminated by Sponsor|0|||
16518931|NCT02880371|40368470|FG001|Phase 2|Participants terminated by Sponsor|0|||
16518932|NCT02880371|40368471|FG002|Phase 2|Participants terminated by Sponsor|0|||
16518933|NCT02880371|40368472|FG003|Phase 2|Participants terminated by Sponsor|0|||
16518934|NCT02880371|40368473|FG004|Phase 2|Participants terminated by Sponsor|1|||
16518935|NCT02880371|40368474|FG005|Phase 2|Participants terminated by Sponsor|6|||
16518936|NCT02880371|40368475|FG006|Phase 2|Participants terminated by Sponsor|1|||
16518937|NCT02880371|40368476|FG007|Phase 2|Participants terminated by Sponsor|5|||
16518938|NCT02880371|40368469|FG000|Phase 2|Death|0|||
16518939|NCT02880371|40368470|FG001|Phase 2|Death|0|||
16205475|NCT00996593|39229839|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
16205476|NCT00996593|39229839|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
16205477|NCT00996593|39229839|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
16205478|NCT00996593|39229839|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
16205479|NCT00996593|39229839|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
16205480|NCT00996593|39229839|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
16205481|NCT00996593|39229839|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
16205482|NCT00996593|39229839|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
16205483|NCT00996593|39229839|FG000|Long-Term Follow-Up|Site Closed|1|||
16205484|NCT04857892|39229840|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
16205485|NCT04857892|39229841|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
16205486|NCT04857892|39229842|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
16205487|NCT04857892|39229843|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
16205488|NCT04857892|39229844|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
16205489|NCT04857892|39229840|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
16205490|NCT04857892|39229841|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
16205491|NCT04857892|39229842|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
16205492|NCT04857892|39229843|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
16205493|NCT04857892|39229844|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
16205494|NCT04857892|39229840|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
16205495|NCT04857892|39229841|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
16205496|NCT04857892|39229842|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
16205497|NCT04857892|39229843|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
16205498|NCT04857892|39229844|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
16205499|NCT00691093|39229851|FG000|Overall Study|Adverse Event|1|||
16205500|NCT00691093|39229851|FG000|Overall Study|Lost to Follow-up|1|||
16205501|NCT00691093|39229851|FG000|Overall Study|Lack of Efficacy|1|||
16205502|NCT00691093|39229851|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
16205503|NCT03814005|39229852|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
16323152|NCT01683266|39670798|FG001|Overall Study|Lost to Follow-up|0|||
16323153|NCT01683266|39670797|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
16323154|NCT01683266|39670798|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
16323155|NCT01683266|39670797|FG000|Overall Study|Nonserious Hypoglycemia|0|||
16518940|NCT02880371|40368471|FG002|Phase 2|Death|0|||
16518941|NCT02880371|40368472|FG003|Phase 2|Death|0|||
16518942|NCT02880371|40368473|FG004|Phase 2|Death|1|||
16518943|NCT02880371|40368474|FG005|Phase 2|Death|10|||
16518944|NCT02880371|40368475|FG006|Phase 2|Death|20|||
16518945|NCT02880371|40368476|FG007|Phase 2|Death|5|||
16518946|NCT02880371|40368469|FG000|Phase 2|Lost to Follow-up|0|||
16518947|NCT02880371|40368470|FG001|Phase 2|Lost to Follow-up|0|||
16518948|NCT02880371|40368471|FG002|Phase 2|Lost to Follow-up|0|||
16518949|NCT02880371|40368472|FG003|Phase 2|Lost to Follow-up|0|||
16518950|NCT02880371|40368473|FG004|Phase 2|Lost to Follow-up|0|||
16518951|NCT02880371|40368474|FG005|Phase 2|Lost to Follow-up|0|||
16518952|NCT02880371|40368475|FG006|Phase 2|Lost to Follow-up|3|||
16518953|NCT02880371|40368476|FG007|Phase 2|Lost to Follow-up|0|||
16518954|NCT02880371|40368469|FG000|Phase 2|Withdrawal by Subject|0|||
16323156|NCT01683266|39670798|FG001|Overall Study|Nonserious Hypoglycemia|3|||
16323157|NCT01683266|39670797|FG000|Overall Study|Perceived Lack of Efficacy|1|||
16323158|NCT01683266|39670798|FG001|Overall Study|Perceived Lack of Efficacy|1|||
16323159|NCT01683266|39670797|FG000|Overall Study|Possibly Hypoglycemia|1|||
16518955|NCT02880371|40368470|FG001|Phase 2|Withdrawal by Subject|0|||
16518956|NCT02880371|40368471|FG002|Phase 2|Withdrawal by Subject|0|||
16518957|NCT02880371|40368472|FG003|Phase 2|Withdrawal by Subject|0|||
16518958|NCT02880371|40368473|FG004|Phase 2|Withdrawal by Subject|0|||
16518959|NCT02880371|40368474|FG005|Phase 2|Withdrawal by Subject|1|||
16205504|NCT03814005|39229853|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
16323160|NCT01683266|39670798|FG001|Overall Study|Possibly Hypoglycemia|0|||
16518960|NCT02880371|40368475|FG006|Phase 2|Withdrawal by Subject|1|||
16323161|NCT01683266|39670797|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
16395675|NCT00078806|39928322|FG001|Part 1B|Lack of Efficacy|0|||
16518961|NCT02880371|40368476|FG007|Phase 2|Withdrawal by Subject|0|||
16518962|NCT02880371|40368469|FG000|Phase 2|End of Study page not completed by error|0|||
16323162|NCT01683266|39670798|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
16323163|NCT03674112|39670799|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
16323164|NCT03674112|39670800|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
16323165|NCT03674112|39670799|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
16323166|NCT03674112|39670800|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
16323167|NCT03674112|39670799|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
16323168|NCT03674112|39670800|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
16323169|NCT03674112|39670799|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
16323170|NCT03674112|39670800|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
16323171|NCT03674112|39670799|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
16323172|NCT03674112|39670800|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
16323173|NCT03674112|39670799|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
16395676|NCT00078806|39928323|FG002|Part 1B|Lack of Efficacy|0|||
16395677|NCT00078806|39928324|FG003|Part 1B|Lack of Efficacy|0|||
16395678|NCT00078806|39928321|FG000|Part 2|Adverse Event|0|||
16395679|NCT00078806|39928322|FG001|Part 2|Adverse Event|1|||
16395680|NCT00078806|39928323|FG002|Part 2|Adverse Event|0|||
16395681|NCT00078806|39928324|FG003|Part 2|Adverse Event|0|||
16395682|NCT00322049|39928325|FG000|Overall Study|Moved out of area|0|||
16395683|NCT00322049|39928326|FG001|Overall Study|Moved out of area|0|||
16395684|NCT00322049|39928327|FG002|Overall Study|Moved out of area|0|||
16395685|NCT00322049|39928328|FG003|Overall Study|Moved out of area|1|||
16395686|NCT00322049|39928325|FG000|Overall Study|Infected with Dengue during study|0|||
16395687|NCT00322049|39928326|FG001|Overall Study|Infected with Dengue during study|1|||
16395688|NCT00322049|39928327|FG002|Overall Study|Infected with Dengue during study|0|||
16395689|NCT00322049|39928328|FG003|Overall Study|Infected with Dengue during study|0|||
16395690|NCT00570778|39928329|FG000|Overall Study|Protocol deviation|2|||
16395691|NCT00570778|39928330|FG001|Overall Study|Protocol deviation|1|||
16395692|NCT00570778|39928331|FG002|Overall Study|Protocol deviation|2|||
16395693|NCT00570778|39928332|FG003|Overall Study|Protocol deviation|2|||
16395694|NCT00570778|39928329|FG000|Overall Study|Adverse Event|0|||
16395695|NCT00570778|39928330|FG001|Overall Study|Adverse Event|1|||
16395696|NCT00570778|39928331|FG002|Overall Study|Adverse Event|4|||
16395697|NCT00570778|39928332|FG003|Overall Study|Adverse Event|1|||
16395698|NCT00570778|39928329|FG000|Overall Study|Subject withdrew consent|0|||
16395699|NCT00570778|39928330|FG001|Overall Study|Subject withdrew consent|1|||
16395700|NCT00570778|39928331|FG002|Overall Study|Subject withdrew consent|0|||
16395701|NCT00570778|39928332|FG003|Overall Study|Subject withdrew consent|1|||
16395702|NCT00570778|39928329|FG000|Overall Study|Abnormal test procedure|1|||
16395703|NCT00570778|39928330|FG001|Overall Study|Abnormal test procedure|0|||
16395704|NCT00570778|39928331|FG002|Overall Study|Abnormal test procedure|0|||
16395705|NCT00570778|39928332|FG003|Overall Study|Abnormal test procedure|0|||
16395706|NCT00570778|39928329|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16395707|NCT00570778|39928330|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16395708|NCT00570778|39928331|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16395709|NCT00570778|39928332|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
16395710|NCT00570778|39928329|FG000|Overall Study|Lost to Follow-up|0|||
16395711|NCT00570778|39928330|FG001|Overall Study|Lost to Follow-up|0|||
16395712|NCT00570778|39928331|FG002|Overall Study|Lost to Follow-up|1|||
16395713|NCT00570778|39928332|FG003|Overall Study|Lost to Follow-up|0|||
16395714|NCT00570778|39928329|FG000|Overall Study|Subject no longer requires study drug|0|||
16395715|NCT00570778|39928330|FG001|Overall Study|Subject no longer requires study drug|1|||
16395716|NCT00570778|39928331|FG002|Overall Study|Subject no longer requires study drug|0|||
16395717|NCT00570778|39928332|FG003|Overall Study|Subject no longer requires study drug|0|||
16395718|NCT00375505|39928333|FG000|Overall Study|Adverse Event|1|||
16395719|NCT00375505|39928334|FG001|Overall Study|Adverse Event|2|||
16409964|NCT03757130|39981849|FG006|Overall Study|Withdrawal by Subject|1|||
16409965|NCT03757130|39981850|FG007|Overall Study|Withdrawal by Subject|0|||
16409966|NCT03777917|39981851|FG000|Overall Study|Withdrawal by Subject|1|||
16409967|NCT03777917|39981852|FG001|Overall Study|Withdrawal by Subject|0|||
16409968|NCT03777917|39981851|FG000|Overall Study|Physician Decision|1|||
16409969|NCT03777917|39981852|FG001|Overall Study|Physician Decision|0|||
16409970|NCT03777917|39981851|FG000|Overall Study|Lost to Follow-up|6|||
16409971|NCT03777917|39981852|FG001|Overall Study|Lost to Follow-up|2|||
16409972|NCT03777917|39981851|FG000|Overall Study|Other|1|||
16409973|NCT03777917|39981852|FG001|Overall Study|Other|0|||
16409974|NCT01779869|39981853|FG000|Overall Study|Physician Decision|2|||
16409975|NCT02536300|39981854|FG000|Overall Study|Investigator's Discretion|17|||
16518963|NCT02880371|40368470|FG001|Phase 2|End of Study page not completed by error|0|||
16409976|NCT02536300|39981855|FG001|Overall Study|Investigator's Discretion|11|||
16409977|NCT02536300|39981856|FG002|Overall Study|Investigator's Discretion|2|||
16409978|NCT02536300|39981854|FG000|Overall Study|Progressive Disease|11|||
16409979|NCT02536300|39981855|FG001|Overall Study|Progressive Disease|7|||
16409980|NCT02536300|39981856|FG002|Overall Study|Progressive Disease|6|||
16518964|NCT02880371|40368471|FG002|Phase 2|End of Study page not completed by error|0|||
16395720|NCT03640507|39931142|FG000|Overall Study|Withdrawal by Subject|0|||
16395721|NCT03640507|39931143|FG001|Overall Study|Withdrawal by Subject|0|||
16395722|NCT03640507|39931144|FG002|Overall Study|Withdrawal by Subject|1|||
16395723|NCT01309997|39931146|FG000|Overall Study|Adverse Event|1|||
16395724|NCT01309997|39931147|FG001|Overall Study|Adverse Event|0|||
16518965|NCT02880371|40368472|FG003|Phase 2|End of Study page not completed by error|0|||
16518966|NCT02880371|40368473|FG004|Phase 2|End of Study page not completed by error|0|||
16205505|NCT03814005|39229854|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
16205506|NCT03814005|39229852|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
16205507|NCT03814005|39229853|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
16205508|NCT03814005|39229854|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
16205509|NCT03814005|39229852|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
16205510|NCT03814005|39229853|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
16205511|NCT03814005|39229854|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
16205512|NCT03814005|39229852|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
16518967|NCT02880371|40368474|FG005|Phase 2|End of Study page not completed by error|1|||
16323174|NCT03674112|39670800|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
16323175|NCT03674112|39670799|FG000|Follow-Up Period (≥3 Years)|Death|2|||
16323176|NCT03674112|39670800|FG001|Follow-Up Period (≥3 Years)|Death|0|||
16323177|NCT03674112|39670799|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
16323178|NCT03674112|39670800|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
16323179|NCT02393950|39670801|FG000|Overall Study|Adverse Event|1|||
16323180|NCT02393950|39670802|FG001|Overall Study|Adverse Event|0|||
16323181|NCT02393950|39670801|FG000|Overall Study|Withdrawal by Subject|0|||
16395725|NCT01309997|39931146|FG000|Overall Study|Death|1|||
16518968|NCT02880371|40368475|FG006|Phase 2|End of Study page not completed by error|0|||
16518969|NCT02880371|40368476|FG007|Phase 2|End of Study page not completed by error|0|||
16518970|NCT00456092|40368483|FG000|Extension Phase|Grade 2 or Greater AE|2|||
16518971|NCT00456092|40368484|FG001|Extension Phase|Grade 2 or Greater AE|2|||
16518972|NCT00456092|40368485|FG002|Extension Phase|Grade 2 or Greater AE|0|||
16518973|NCT00456092|40368486|FG003|Extension Phase|Grade 2 or Greater AE|0|||
16518974|NCT00456092|40368487|FG004|Extension Phase|Grade 2 or Greater AE|2|||
16518975|NCT00456092|40368483|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
16518976|NCT00456092|40368484|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
16518977|NCT00456092|40368485|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
16518978|NCT00456092|40368486|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
16518979|NCT00456092|40368487|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
16518980|NCT00456092|40368483|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
16518981|NCT00456092|40368484|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
16518982|NCT00456092|40368485|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
16518983|NCT00456092|40368486|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
16518984|NCT00456092|40368487|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
16518985|NCT00456092|40368483|FG000|Extension Phase|Withdrew Consent|2|||
16518986|NCT00456092|40368484|FG001|Extension Phase|Withdrew Consent|0|||
16518987|NCT00456092|40368485|FG002|Extension Phase|Withdrew Consent|0|||
16518988|NCT00456092|40368486|FG003|Extension Phase|Withdrew Consent|0|||
16518989|NCT00456092|40368487|FG004|Extension Phase|Withdrew Consent|0|||
16518990|NCT00456092|40368483|FG000|Extension Phase|Lost to Follow-up|1|||
16518991|NCT00456092|40368484|FG001|Extension Phase|Lost to Follow-up|1|||
16518992|NCT00456092|40368485|FG002|Extension Phase|Lost to Follow-up|0|||
16323182|NCT02393950|39670802|FG001|Overall Study|Withdrawal by Subject|1|||
16323183|NCT04105218|39670803|FG000|Overall Study|Withdrawal by Subject|3|||
16323184|NCT04105218|39670804|FG001|Overall Study|Withdrawal by Subject|2|||
16395726|NCT01309997|39931147|FG001|Overall Study|Death|3|||
16518993|NCT00456092|40368486|FG003|Extension Phase|Lost to Follow-up|0|||
16518994|NCT00456092|40368487|FG004|Extension Phase|Lost to Follow-up|1|||
16518995|NCT00456092|40368483|FG000|Extension Phase|Other|2|||
16518996|NCT00456092|40368484|FG001|Extension Phase|Other|0|||
16395727|NCT01309997|39931146|FG000|Overall Study|Lack of Efficacy|2|||
16395728|NCT01309997|39931147|FG001|Overall Study|Lack of Efficacy|2|||
16518997|NCT00456092|40368485|FG002|Extension Phase|Other|0|||
16518998|NCT00456092|40368486|FG003|Extension Phase|Other|1|||
16518999|NCT00456092|40368487|FG004|Extension Phase|Other|1|||
16519000|NCT00456092|40368483|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
16519001|NCT00456092|40368484|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
16519002|NCT00456092|40368485|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
16519003|NCT00456092|40368486|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
16519004|NCT00456092|40368487|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
16519005|NCT00456092|40368483|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
16519006|NCT00456092|40368484|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
16519007|NCT00456092|40368485|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
16519008|NCT00456092|40368486|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
16519009|NCT00456092|40368487|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
16205513|NCT03814005|39229853|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
16205514|NCT03814005|39229854|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
16205515|NCT03814005|39229852|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
16205516|NCT03814005|39229853|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
16323185|NCT04105218|39670803|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
16323186|NCT04105218|39670804|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
16323187|NCT04105218|39670803|FG000|Overall Study|Failed screening tests|2|||
16323188|NCT04105218|39670804|FG001|Overall Study|Failed screening tests|1|||
16323189|NCT04468347|39670807|FG000|Overall Study|Withdrawal by Subject|0|||
16323190|NCT04468347|39670808|FG001|Overall Study|Withdrawal by Subject|1|||
16323191|NCT04468347|39670809|FG002|Overall Study|Withdrawal by Subject|3|||
16323192|NCT04468347|39670810|FG003|Overall Study|Withdrawal by Subject|3|||
16323193|NCT04468347|39670807|FG000|Overall Study|Lost to Follow-up|0|||
16323194|NCT04468347|39670808|FG001|Overall Study|Lost to Follow-up|0|||
16323195|NCT04468347|39670809|FG002|Overall Study|Lost to Follow-up|1|||
16323196|NCT04468347|39670810|FG003|Overall Study|Lost to Follow-up|1|||
16323197|NCT04468347|39670807|FG000|Overall Study|Physician Decision|1|||
16323198|NCT04468347|39670808|FG001|Overall Study|Physician Decision|0|||
16323199|NCT04468347|39670809|FG002|Overall Study|Physician Decision|2|||
16323200|NCT04468347|39670810|FG003|Overall Study|Physician Decision|0|||
16323201|NCT04468347|39670807|FG000|Overall Study|Protocol Violation|1|||
16323202|NCT04468347|39670808|FG001|Overall Study|Protocol Violation|0|||
16323203|NCT04468347|39670809|FG002|Overall Study|Protocol Violation|0|||
16323204|NCT04468347|39670810|FG003|Overall Study|Protocol Violation|0|||
16323205|NCT02029989|39670811|FG000|Overall Study|Withdrawal by Subject|1|||
16323206|NCT02029989|39670812|FG001|Overall Study|Withdrawal by Subject|0|||
16323207|NCT02029989|39670811|FG000|Overall Study|Withdrawal: Fear of needles|1|||
16323208|NCT02029989|39670812|FG001|Overall Study|Withdrawal: Fear of needles|0|||
16323209|NCT02029989|39670811|FG000|Overall Study|Change of location|2|||
16323210|NCT02029989|39670812|FG001|Overall Study|Change of location|3|||
16323211|NCT02029989|39670811|FG000|Overall Study|Physician Decision|2|||
16323212|NCT02029989|39670812|FG001|Overall Study|Physician Decision|0|||
16323213|NCT02029989|39670811|FG000|Overall Study|Lost to Follow-up|9|||
16323214|NCT02029989|39670812|FG001|Overall Study|Lost to Follow-up|7|||
16323215|NCT02029989|39670811|FG000|Overall Study|Death|0|||
16323216|NCT02029989|39670812|FG001|Overall Study|Death|1|||
16323217|NCT02029989|39670811|FG000|Overall Study|Protocol Violation|1|||
16323218|NCT02029989|39670812|FG001|Overall Study|Protocol Violation|0|||
16323219|NCT01289639|39670817|FG000|Overall Study|Lost to Follow-up|1|||
16323220|NCT01289639|39670818|FG001|Overall Study|Lost to Follow-up|0|||
16323221|NCT01289639|39670819|FG002|Overall Study|Lost to Follow-up|0|||
16323222|NCT00594100|39670820|FG000|Procedure|Technical Failure|9|||
16323223|NCT00594100|39670820|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
16323224|NCT00594100|39670820|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
16323225|NCT00594100|39670820|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
16205517|NCT03814005|39229854|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
16205518|NCT03814005|39229852|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
16205519|NCT03814005|39229853|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
16323226|NCT00378508|39670823|FG000|Overall Study|Withdrawal by Subject|1|||
16323227|NCT00378508|39670824|FG001|Overall Study|Withdrawal by Subject|3|||
16395729|NCT01309997|39931146|FG000|Overall Study|Withdrawal by Subject|1|||
16395730|NCT01309997|39931147|FG001|Overall Study|Withdrawal by Subject|1|||
16395731|NCT01846299|39931149|FG000|Overall Study|Physician Decision|4|||
16323228|NCT00378508|39670823|FG000|Overall Study|Lost to Follow-up|1|||
16323229|NCT00378508|39670824|FG001|Overall Study|Lost to Follow-up|0|||
16323230|NCT02278120|39670825|FG000|Treatment Period|Progressive disease|234|||
16323231|NCT02278120|39670826|FG001|Treatment Period|Progressive disease|260|||
16323232|NCT02278120|39670825|FG000|Treatment Period|Subject/guardian decision|23|||
16323233|NCT02278120|39670826|FG001|Treatment Period|Subject/guardian decision|20|||
16395732|NCT01846299|39931150|FG001|Overall Study|Physician Decision|2|||
16323234|NCT02278120|39670825|FG000|Treatment Period|Adverse Event|16|||
16323235|NCT02278120|39670826|FG001|Treatment Period|Adverse Event|14|||
16323236|NCT02278120|39670825|FG000|Treatment Period|Physician Decision|14|||
16323237|NCT02278120|39670826|FG001|Treatment Period|Physician Decision|27|||
16323238|NCT02278120|39670825|FG000|Treatment Period|Death|3|||
16323239|NCT02278120|39670826|FG001|Treatment Period|Death|3|||
16323240|NCT02278120|39670825|FG000|Treatment Period|Lost to Follow-up|2|||
16323241|NCT02278120|39670826|FG001|Treatment Period|Lost to Follow-up|0|||
16323242|NCT02278120|39670825|FG000|Treatment Period|Protocol deviation|0|||
16323243|NCT02278120|39670826|FG001|Treatment Period|Protocol deviation|2|||
16323244|NCT02278120|39670825|FG000|Treatment Period|Study terminated as per protocol|43|||
16323245|NCT02278120|39670826|FG001|Treatment Period|Study terminated as per protocol|11|||
16323246|NCT02278120|39670825|FG000|Post-treatment Efficacy Follow-up|Death|0|||
16323247|NCT02278120|39670826|FG001|Post-treatment Efficacy Follow-up|Death|1|||
16323248|NCT02278120|39670825|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
16323249|NCT02278120|39670826|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
16323250|NCT02278120|39670825|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
16323251|NCT02278120|39670826|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
16323252|NCT02278120|39670825|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
16323253|NCT02278120|39670826|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
16323254|NCT02278120|39670825|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
16323255|NCT02278120|39670826|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
16323256|NCT01194999|39670831|FG000|Overall Study|Lost to Follow-up|17|||
16323257|NCT05087966|39670832|FG000|Overall Study|Lost to Follow-up|1|||
16323258|NCT05087966|39670832|FG000|Overall Study|Withdrawal by Subject|5|||
16323259|NCT04413552|39670833|FG000|Overall Study|Adverse Event|0|||
16323260|NCT04413552|39670834|FG001|Overall Study|Adverse Event|0|||
16323261|NCT04413552|39670835|FG002|Overall Study|Adverse Event|0|||
16323262|NCT04413552|39670836|FG003|Overall Study|Adverse Event|0|||
16323263|NCT04413552|39670837|FG004|Overall Study|Adverse Event|0|||
16323264|NCT04413552|39670838|FG005|Overall Study|Adverse Event|0|||
16323265|NCT04413552|39670839|FG006|Overall Study|Adverse Event|1|||
16323266|NCT04413552|39670840|FG007|Overall Study|Adverse Event|0|||
16323267|NCT04413552|39670841|FG008|Overall Study|Adverse Event|0|||
16323268|NCT04413552|39670842|FG009|Overall Study|Adverse Event|0|||
16323269|NCT03429244|39670843|FG000|Overall Study|Withdrawal by Subject|2|||
16323270|NCT03429244|39670844|FG001|Overall Study|Withdrawal by Subject|1|||
16323271|NCT03429244|39670845|FG002|Overall Study|Withdrawal by Subject|1|||
16323272|NCT01598090|39670846|FG000|Treatment Period|Poor/non-compliance|0|||
16323273|NCT01598090|39670847|FG001|Treatment Period|Poor/non-compliance|2|||
16323274|NCT01598090|39670848|FG002|Treatment Period|Poor/non-compliance|0|||
16519010|NCT00456092|40368483|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
16519011|NCT00456092|40368484|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
16519012|NCT00456092|40368485|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
16519013|NCT00456092|40368486|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
16092883|NCT01052272|38830273|FG000|Overall Study|Physician Decision|0|||
16092884|NCT01052272|38830274|FG001|Overall Study|Physician Decision|1|||
16092885|NCT01052272|38830275|FG002|Overall Study|Physician Decision|0|||
16092886|NCT01052272|38830276|FG003|Overall Study|Physician Decision|0|||
16092887|NCT01052272|38830273|FG000|Overall Study|patient refuses follow-up|5|||
16092888|NCT01052272|38830274|FG001|Overall Study|patient refuses follow-up|4|||
16092889|NCT01052272|38830275|FG002|Overall Study|patient refuses follow-up|2|||
16323275|NCT01598090|39670846|FG000|Treatment Period|No longer meet study criteria|0|||
16519014|NCT00456092|40368487|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
16519015|NCT00456092|40368483|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
16519016|NCT00456092|40368484|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
16519017|NCT00456092|40368485|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
16519018|NCT00456092|40368486|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
16519019|NCT00456092|40368487|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
16519020|NCT00456092|40368483|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
16519021|NCT00456092|40368484|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
16519022|NCT00456092|40368485|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
16519023|NCT00456092|40368486|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
16519024|NCT00456092|40368487|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
16323276|NCT01598090|39670847|FG001|Treatment Period|No longer meet study criteria|1|||
16323277|NCT01598090|39670848|FG002|Treatment Period|No longer meet study criteria|0|||
16323278|NCT01598090|39670846|FG000|Treatment Period|Lack of Efficacy|5|||
16519025|NCT00456092|40368483|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
16519026|NCT00456092|40368484|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
16519027|NCT00456092|40368485|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
16092890|NCT01052272|38830276|FG003|Overall Study|patient refuses follow-up|4|||
16092891|NCT01052272|38830273|FG000|Overall Study|Withdrawal by Subject|0|||
16323279|NCT01598090|39670847|FG001|Treatment Period|Lack of Efficacy|14|||
16323280|NCT01598090|39670848|FG002|Treatment Period|Lack of Efficacy|6|||
16323281|NCT01598090|39670846|FG000|Treatment Period|Adverse Event|2|||
16323282|NCT01598090|39670847|FG001|Treatment Period|Adverse Event|33|||
16323283|NCT01598090|39670848|FG002|Treatment Period|Adverse Event|17|||
16323284|NCT01598090|39670846|FG000|Treatment Period|Other reasons|0|||
16323285|NCT01598090|39670847|FG001|Treatment Period|Other reasons|4|||
16323286|NCT01598090|39670848|FG002|Treatment Period|Other reasons|1|||
16323287|NCT01598090|39670846|FG000|Treatment Period|Withdrawal by Subject|3|||
16323288|NCT01598090|39670847|FG001|Treatment Period|Withdrawal by Subject|13|||
16323289|NCT01598090|39670848|FG002|Treatment Period|Withdrawal by Subject|10|||
16323290|NCT01598090|39670846|FG000|Treatment Period|Lost to Follow-up|1|||
16323291|NCT01598090|39670847|FG001|Treatment Period|Lost to Follow-up|5|||
16323292|NCT01598090|39670848|FG002|Treatment Period|Lost to Follow-up|1|||
16323293|NCT01598090|39670846|FG000|Follow-up Period|Death|0|||
16323294|NCT01598090|39670847|FG001|Follow-up Period|Death|1|||
16323295|NCT01598090|39670848|FG002|Follow-up Period|Death|0|||
16323296|NCT01598090|39670846|FG000|Follow-up Period|No longer required per protocol|1|||
16323297|NCT01598090|39670847|FG001|Follow-up Period|No longer required per protocol|3|||
16323298|NCT01598090|39670848|FG002|Follow-up Period|No longer required per protocol|2|||
16323299|NCT01598090|39670846|FG000|Follow-up Period|Not reported|0|||
16323300|NCT01598090|39670847|FG001|Follow-up Period|Not reported|10|||
16323301|NCT01598090|39670848|FG002|Follow-up Period|Not reported|4|||
16323302|NCT01598090|39670846|FG000|Follow-up Period|Withdrawal by Subject|0|||
16323303|NCT01598090|39670847|FG001|Follow-up Period|Withdrawal by Subject|3|||
16323304|NCT01598090|39670848|FG002|Follow-up Period|Withdrawal by Subject|2|||
16323305|NCT01598090|39670846|FG000|Follow-up Period|Other reasons|2|||
16323306|NCT01598090|39670847|FG001|Follow-up Period|Other reasons|8|||
16323307|NCT01598090|39670848|FG002|Follow-up Period|Other reasons|8|||
16323308|NCT01598090|39670846|FG000|Follow-up Period|Lost to Follow-up|2|||
16323309|NCT01598090|39670847|FG001|Follow-up Period|Lost to Follow-up|10|||
16323310|NCT01598090|39670848|FG002|Follow-up Period|Lost to Follow-up|12|||
16323311|NCT01011465|39670857|FG000|Overall Study|Withdrawal by Subject|2|||
16323312|NCT01011465|39670858|FG001|Overall Study|Withdrawal by Subject|1|||
16323313|NCT01011465|39670859|FG002|Overall Study|Withdrawal by Subject|0|||
16323314|NCT01011465|39670860|FG003|Overall Study|Withdrawal by Subject|0|||
16323315|NCT01011465|39670861|FG004|Overall Study|Withdrawal by Subject|1|||
16323316|NCT01011465|39670862|FG005|Overall Study|Withdrawal by Subject|0|||
16323317|NCT01011465|39670863|FG006|Overall Study|Withdrawal by Subject|1|||
16323318|NCT01011465|39670864|FG007|Overall Study|Withdrawal by Subject|0|||
16323319|NCT02424630|39670865|FG000|Overall Study|No rotator cuff tear|1|||
16323320|NCT02424630|39670866|FG001|Overall Study|No rotator cuff tear|2|||
16323321|NCT02424630|39670865|FG000|Overall Study|Open procedure|0|||
16323322|NCT02424630|39670866|FG001|Overall Study|Open procedure|1|||
16323323|NCT01609010|39670867|FG000|Overall Study|Stable disease (SD)|22|||
16323324|NCT01609010|39670868|FG001|Overall Study|Stable disease (SD)|16|||
16323325|NCT01609010|39670867|FG000|Overall Study|Progressive disease (PD)|8|||
16323326|NCT01609010|39670868|FG001|Overall Study|Progressive disease (PD)|10|||
16323327|NCT01609010|39670867|FG000|Overall Study|Adverse Event|3|||
16323328|NCT01609010|39670868|FG001|Overall Study|Adverse Event|6|||
16323329|NCT01609010|39670867|FG000|Overall Study|Withdrawal by Subject|2|||
16323330|NCT01609010|39670868|FG001|Overall Study|Withdrawal by Subject|2|||
16323331|NCT01609010|39670867|FG000|Overall Study|Other|2|||
16323332|NCT01609010|39670868|FG001|Overall Study|Other|0|||
16323333|NCT01609010|39670867|FG000|Overall Study|Other malignancy|1|||
16323334|NCT01609010|39670868|FG001|Overall Study|Other malignancy|0|||
16323335|NCT01609010|39670867|FG000|Overall Study|Pathology review|2|||
16323336|NCT01609010|39670868|FG001|Overall Study|Pathology review|1|||
16323337|NCT01609010|39670867|FG000|Overall Study|Protocol Violation|1|||
16323338|NCT01609010|39670868|FG001|Overall Study|Protocol Violation|1|||
16323339|NCT01609010|39670867|FG000|Overall Study|New cancer|1|||
16323340|NCT01609010|39670868|FG001|Overall Study|New cancer|0|||
16323341|NCT01609010|39670867|FG000|Overall Study|Lost to Follow-up|1|||
16519028|NCT00456092|40368486|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
16519029|NCT00456092|40368487|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
16519030|NCT00456092|40368483|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
16323342|NCT01609010|39670868|FG001|Overall Study|Lost to Follow-up|1|||
16323343|NCT01399047|39670872|FG000|Overall Study|Withdrawal by Subject|0|||
16323344|NCT01399047|39670873|FG001|Overall Study|Withdrawal by Subject|1|||
16323345|NCT01866111|39670876|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
16323346|NCT01866111|39670877|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
16323347|NCT01866111|39670878|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
16323348|NCT01866111|39670879|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
16323349|NCT01866111|39670876|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
16323350|NCT01866111|39670877|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
16323351|NCT01866111|39670878|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
16323352|NCT01866111|39670879|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
16323353|NCT01570361|39670883|FG000|Overall Study|Subject discontinued|1|||
16323354|NCT01570361|39670884|FG001|Overall Study|Subject discontinued|2|||
16323355|NCT01570361|39670883|FG000|Overall Study|Sponsor closing the study|51|||
16323356|NCT01570361|39670884|FG001|Overall Study|Sponsor closing the study|50|||
16323357|NCT01570361|39670883|FG000|Overall Study|Subject excluded|5|||
16323358|NCT01570361|39670884|FG001|Overall Study|Subject excluded|3|||
16323359|NCT01570361|39670883|FG000|Overall Study|Subject withdrew consent|14|||
16323360|NCT01570361|39670884|FG001|Overall Study|Subject withdrew consent|9|||
16323361|NCT01570361|39670883|FG000|Overall Study|Adverse Event|2|||
16323362|NCT01570361|39670884|FG001|Overall Study|Adverse Event|1|||
16323363|NCT01570361|39670883|FG000|Overall Study|Lost to Follow-up|4|||
16323364|NCT01570361|39670884|FG001|Overall Study|Lost to Follow-up|4|||
16323365|NCT01570361|39670883|FG000|Overall Study|Death|5|||
16323366|NCT01570361|39670884|FG001|Overall Study|Death|4|||
16323367|NCT01570361|39670883|FG000|Overall Study|Other|0|||
16323368|NCT01570361|39670884|FG001|Overall Study|Other|2|||
16323369|NCT01814696|39670893|FG000|Overall Study|Withdrawal by Subject|1|||
16323370|NCT01814696|39670894|FG001|Overall Study|Withdrawal by Subject|0|||
16323371|NCT01814696|39670893|FG000|Overall Study|Randomized to wrong group|1|||
16323372|NCT01814696|39670894|FG001|Overall Study|Randomized to wrong group|0|||
16323373|NCT00932373|39670895|FG000|Overall Study|Progressive disease|3|||
16323374|NCT00932373|39670896|FG001|Overall Study|Progressive disease|1|||
16323375|NCT00932373|39670897|FG002|Overall Study|Progressive disease|0|||
16323376|NCT00932373|39670898|FG003|Overall Study|Progressive disease|0|||
16323377|NCT00932373|39670899|FG004|Overall Study|Progressive disease|10|||
16323378|NCT00932373|39670900|FG005|Overall Study|Progressive disease|1|||
16323379|NCT00932373|39670901|FG006|Overall Study|Progressive disease|0|||
16323380|NCT00932373|39670902|FG007|Overall Study|Progressive disease|2|||
16323381|NCT00932373|39670903|FG008|Overall Study|Progressive disease|1|||
16323382|NCT00932373|39670904|FG009|Overall Study|Progressive disease|9|||
16323383|NCT00932373|39670905|FG010|Overall Study|Progressive disease|2|||
16323384|NCT00932373|39670895|FG000|Overall Study|Adverse Event|0|||
16323385|NCT00932373|39670896|FG001|Overall Study|Adverse Event|0|||
16323386|NCT00932373|39670897|FG002|Overall Study|Adverse Event|0|||
16323387|NCT00932373|39670898|FG003|Overall Study|Adverse Event|0|||
16323388|NCT00932373|39670899|FG004|Overall Study|Adverse Event|2|||
16323389|NCT00932373|39670900|FG005|Overall Study|Adverse Event|1|||
16323390|NCT00932373|39670901|FG006|Overall Study|Adverse Event|0|||
16323391|NCT00932373|39670902|FG007|Overall Study|Adverse Event|1|||
16323392|NCT00932373|39670903|FG008|Overall Study|Adverse Event|0|||
16323393|NCT00932373|39670904|FG009|Overall Study|Adverse Event|2|||
16323394|NCT00932373|39670905|FG010|Overall Study|Adverse Event|1|||
16323395|NCT00932373|39670895|FG000|Overall Study|Physician Decision|0|||
16323396|NCT00932373|39670896|FG001|Overall Study|Physician Decision|0|||
16323397|NCT00932373|39670897|FG002|Overall Study|Physician Decision|1|||
16323398|NCT00932373|39670898|FG003|Overall Study|Physician Decision|0|||
16323399|NCT00932373|39670899|FG004|Overall Study|Physician Decision|2|||
16323400|NCT00932373|39670900|FG005|Overall Study|Physician Decision|0|||
16323401|NCT00932373|39670901|FG006|Overall Study|Physician Decision|0|||
16323402|NCT00932373|39670902|FG007|Overall Study|Physician Decision|0|||
16323403|NCT00932373|39670903|FG008|Overall Study|Physician Decision|0|||
16323404|NCT00932373|39670904|FG009|Overall Study|Physician Decision|1|||
16323405|NCT00932373|39670905|FG010|Overall Study|Physician Decision|0|||
16323406|NCT00932373|39670895|FG000|Overall Study|Dose limiting toxicity|0|||
16323407|NCT00932373|39670896|FG001|Overall Study|Dose limiting toxicity|0|||
16323408|NCT00932373|39670897|FG002|Overall Study|Dose limiting toxicity|0|||
16323409|NCT00932373|39670898|FG003|Overall Study|Dose limiting toxicity|0|||
16519031|NCT00456092|40368484|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
16519032|NCT00456092|40368485|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
16519033|NCT00456092|40368486|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
16519034|NCT00456092|40368487|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
16519035|NCT00456092|40368483|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
16519036|NCT00456092|40368484|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
16519037|NCT00456092|40368485|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
16519038|NCT00456092|40368486|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
16519039|NCT00456092|40368487|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
16519040|NCT00456092|40368483|FG000|Treatment Phase (12 Weeks)|Other|1|||
16519041|NCT00456092|40368484|FG001|Treatment Phase (12 Weeks)|Other|0|||
16519042|NCT00456092|40368485|FG002|Treatment Phase (12 Weeks)|Other|1|||
16323410|NCT00932373|39670899|FG004|Overall Study|Dose limiting toxicity|0|||
16323411|NCT00932373|39670900|FG005|Overall Study|Dose limiting toxicity|1|||
16323412|NCT00932373|39670901|FG006|Overall Study|Dose limiting toxicity|0|||
16323413|NCT00932373|39670902|FG007|Overall Study|Dose limiting toxicity|0|||
16323414|NCT00932373|39670903|FG008|Overall Study|Dose limiting toxicity|0|||
16519043|NCT00456092|40368486|FG003|Treatment Phase (12 Weeks)|Other|0|||
16519044|NCT00456092|40368487|FG004|Treatment Phase (12 Weeks)|Other|0|||
16519045|NCT02337829|40368488|FG000|Overall Study|Death|0|||
16519046|NCT02337829|40368489|FG001|Overall Study|Death|1|||
16519047|NCT02337829|40368490|FG002|Overall Study|Death|0|||
16519048|NCT02337829|40368491|FG003|Overall Study|Death|0|||
16519049|NCT02337829|40368488|FG000|Overall Study|Study terminated by sponsor|12|||
16519050|NCT02337829|40368489|FG001|Overall Study|Study terminated by sponsor|10|||
16519051|NCT02337829|40368490|FG002|Overall Study|Study terminated by sponsor|5|||
16519052|NCT02337829|40368491|FG003|Overall Study|Study terminated by sponsor|6|||
16519053|NCT02337829|40368488|FG000|Overall Study|discontinued for other reasons|6|||
16205520|NCT03814005|39229854|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
16323415|NCT00932373|39670904|FG009|Overall Study|Dose limiting toxicity|0|||
16323416|NCT00932373|39670905|FG010|Overall Study|Dose limiting toxicity|0|||
16323417|NCT00932373|39670895|FG000|Overall Study|Withdrawal by Subject|0|||
16323418|NCT00932373|39670896|FG001|Overall Study|Withdrawal by Subject|0|||
16323419|NCT00932373|39670897|FG002|Overall Study|Withdrawal by Subject|0|||
16323420|NCT00932373|39670898|FG003|Overall Study|Withdrawal by Subject|0|||
16323421|NCT00932373|39670899|FG004|Overall Study|Withdrawal by Subject|0|||
16323422|NCT00932373|39670900|FG005|Overall Study|Withdrawal by Subject|0|||
16323423|NCT00932373|39670901|FG006|Overall Study|Withdrawal by Subject|0|||
16323424|NCT00932373|39670902|FG007|Overall Study|Withdrawal by Subject|0|||
16323425|NCT00932373|39670903|FG008|Overall Study|Withdrawal by Subject|1|||
16323426|NCT00932373|39670904|FG009|Overall Study|Withdrawal by Subject|0|||
16323427|NCT00932373|39670905|FG010|Overall Study|Withdrawal by Subject|0|||
16323428|NCT00932373|39670895|FG000|Overall Study|Clinical progression|0|||
16323429|NCT00932373|39670896|FG001|Overall Study|Clinical progression|0|||
16323430|NCT00932373|39670897|FG002|Overall Study|Clinical progression|0|||
16323431|NCT00932373|39670898|FG003|Overall Study|Clinical progression|0|||
16323432|NCT00932373|39670899|FG004|Overall Study|Clinical progression|0|||
16323433|NCT00932373|39670900|FG005|Overall Study|Clinical progression|0|||
16323434|NCT00932373|39670901|FG006|Overall Study|Clinical progression|1|||
16323435|NCT00932373|39670902|FG007|Overall Study|Clinical progression|0|||
16323436|NCT00932373|39670903|FG008|Overall Study|Clinical progression|0|||
16323437|NCT00932373|39670904|FG009|Overall Study|Clinical progression|0|||
16323438|NCT00932373|39670905|FG010|Overall Study|Clinical progression|0|||
16323439|NCT00932373|39670895|FG000|Overall Study|Lack of Efficacy|0|||
16323440|NCT00932373|39670896|FG001|Overall Study|Lack of Efficacy|0|||
16323441|NCT00932373|39670897|FG002|Overall Study|Lack of Efficacy|0|||
16323442|NCT00932373|39670898|FG003|Overall Study|Lack of Efficacy|0|||
16323443|NCT00932373|39670899|FG004|Overall Study|Lack of Efficacy|0|||
16323444|NCT00932373|39670900|FG005|Overall Study|Lack of Efficacy|0|||
16323445|NCT00932373|39670901|FG006|Overall Study|Lack of Efficacy|0|||
16323446|NCT00932373|39670902|FG007|Overall Study|Lack of Efficacy|0|||
16323447|NCT00932373|39670903|FG008|Overall Study|Lack of Efficacy|0|||
16323448|NCT00932373|39670904|FG009|Overall Study|Lack of Efficacy|1|||
16323449|NCT00932373|39670905|FG010|Overall Study|Lack of Efficacy|0|||
16323450|NCT02811861|39670908|FG000|Overall Study|Radiological Disease Progression|123|||
16323451|NCT02811861|39670909|FG001|Overall Study|Radiological Disease Progression|97|||
16323452|NCT02811861|39670910|FG002|Overall Study|Radiological Disease Progression|174|||
16323453|NCT02811861|39670908|FG000|Overall Study|Clinical Disease Progression|20|||
16323454|NCT02811861|39670909|FG001|Overall Study|Clinical Disease Progression|19|||
16323455|NCT02811861|39670910|FG002|Overall Study|Clinical Disease Progression|22|||
16323456|NCT02811861|39670908|FG000|Overall Study|Adverse Event|63|||
16323457|NCT02811861|39670909|FG001|Overall Study|Adverse Event|60|||
16323458|NCT02811861|39670910|FG002|Overall Study|Adverse Event|41|||
16323459|NCT02811861|39670908|FG000|Overall Study|Lost to Follow-up|0|||
16323460|NCT02811861|39670909|FG001|Overall Study|Lost to Follow-up|0|||
16323461|NCT02811861|39670910|FG002|Overall Study|Lost to Follow-up|1|||
16323462|NCT02811861|39670908|FG000|Overall Study|Subject Choice|29|||
16323463|NCT02811861|39670909|FG001|Overall Study|Subject Choice|17|||
16323464|NCT02811861|39670910|FG002|Overall Study|Subject Choice|23|||
16323465|NCT02811861|39670908|FG000|Overall Study|Withdrawal by Subject|4|||
16323466|NCT02811861|39670909|FG001|Overall Study|Withdrawal by Subject|4|||
16323467|NCT02811861|39670910|FG002|Overall Study|Withdrawal by Subject|9|||
16323468|NCT02811861|39670908|FG000|Overall Study|Other|4|||
16323469|NCT02811861|39670909|FG001|Overall Study|Other|13|||
16323470|NCT02811861|39670910|FG002|Overall Study|Other|3|||
16323471|NCT02811861|39670908|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
16519054|NCT02337829|40368489|FG001|Overall Study|discontinued for other reasons|3|||
16519055|NCT02337829|40368490|FG002|Overall Study|discontinued for other reasons|1|||
16519056|NCT02337829|40368491|FG003|Overall Study|discontinued for other reasons|4|||
16323472|NCT02811861|39670909|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
16323473|NCT02811861|39670910|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
16323474|NCT02811861|39670908|FG000|Overall Study|Randomized but not treated|2|||
16323475|NCT02811861|39670909|FG001|Overall Study|Randomized but not treated|3|||
16323476|NCT02811861|39670910|FG002|Overall Study|Randomized but not treated|17|||
16395733|NCT01846299|39931149|FG000|Overall Study|Protocol deviation|1|||
16395734|NCT01846299|39931150|FG001|Overall Study|Protocol deviation|0|||
16395735|NCT01846299|39931149|FG000|Overall Study|Death|1|||
16395736|NCT01846299|39931150|FG001|Overall Study|Death|2|||
16395737|NCT01846299|39931149|FG000|Overall Study|Lost to Follow-up|3|||
16395738|NCT01846299|39931150|FG001|Overall Study|Lost to Follow-up|0|||
16395739|NCT01846299|39931149|FG000|Overall Study|Withdrawal by Subject|1|||
16519057|NCT00833924|40368492|FG000|Overall Study|Death|21|||
16519058|NCT00833924|40368492|FG000|Overall Study|Conversion|2|||
16519059|NCT00833924|40368492|FG000|Overall Study|Lost to Follow-up|2|||
16519060|NCT00833924|40368492|FG000|Overall Study|Withdrawal by Subject|13|||
16519061|NCT00833924|40368492|FG000|Overall Study|In study follow-up|71|||
16519062|NCT03252522|40368498|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
16519063|NCT03252522|40368499|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
16519064|NCT03252522|40368500|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
16519065|NCT03252522|40368498|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
16519066|NCT03252522|40368499|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
16519067|NCT03252522|40368500|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
16519068|NCT03252522|40368498|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
16519069|NCT03252522|40368499|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
16519070|NCT03252522|40368500|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
16519071|NCT03252522|40368498|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
16519072|NCT03252522|40368499|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
16519073|NCT03252522|40368500|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
16519074|NCT03252522|40368498|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
16519075|NCT03252522|40368499|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
16519076|NCT03252522|40368500|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
16519077|NCT03252522|40368498|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
16519078|NCT03252522|40368499|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
16519079|NCT03252522|40368500|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
16519080|NCT03252522|40368498|FG000|Phase 2: Open Label|Adverse Event|0|||
16519081|NCT03252522|40368499|FG001|Phase 2: Open Label|Adverse Event|0|||
16519082|NCT03252522|40368500|FG002|Phase 2: Open Label|Adverse Event|2|||
16519083|NCT03252522|40368498|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
16519084|NCT03252522|40368499|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
16519085|NCT03252522|40368500|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
16519086|NCT03459196|40368503|FG000|Overall Study|Subject didn't receive study catheter|2|||
16519087|NCT00991302|40368506|FG000|Overall Study|Death|0|||
16519088|NCT00991302|40368507|FG001|Overall Study|Death|1|||
16519089|NCT00991302|40368506|FG000|Overall Study|Lost to Follow-up|14|||
16519090|NCT00991302|40368507|FG001|Overall Study|Lost to Follow-up|12|||
16519091|NCT03417141|40368511|FG000|Overall Study|Withdrawal by Subject|1|||
16519092|NCT03417141|40368511|FG000|Overall Study|Protocol Violation|3|||
16519093|NCT02082522|40368514|FG000|Overall Study|Sponsor termination|5|||
16519094|NCT02082522|40368515|FG001|Overall Study|Sponsor termination|3|||
16519095|NCT02082522|40368514|FG000|Overall Study|Withdrawal by Subject|2|||
16519096|NCT02082522|40368515|FG001|Overall Study|Withdrawal by Subject|4|||
16519097|NCT02082522|40368514|FG000|Overall Study|Death|1|||
16519098|NCT02082522|40368515|FG001|Overall Study|Death|0|||
16519099|NCT02082522|40368514|FG000|Overall Study|Lost to Follow-up|1|||
16519100|NCT02082522|40368515|FG001|Overall Study|Lost to Follow-up|0|||
16519101|NCT02082522|40368514|FG000|Overall Study|Physician Decision|3|||
16519102|NCT02082522|40368515|FG001|Overall Study|Physician Decision|1|||
16519103|NCT02082522|40368514|FG000|Overall Study|Disease progression|2|||
16519104|NCT02082522|40368515|FG001|Overall Study|Disease progression|2|||
16519105|NCT02082522|40368514|FG000|Overall Study|Chemotherapy change|1|||
16519106|NCT02082522|40368515|FG001|Overall Study|Chemotherapy change|3|||
16519107|NCT01416805|40368522|FG000|Overall Study|Lost to Follow-up|4|||
16519108|NCT01416805|40368523|FG001|Overall Study|Lost to Follow-up|4|||
16519109|NCT01114516|40368528|FG000|Overall Study|Lost to Follow-up|2|||
16519110|NCT01114516|40368529|FG001|Overall Study|Lost to Follow-up|1|||
16519111|NCT00813124|40368535|FG000|Overall Study|Death|2|||
16519112|NCT00813124|40368535|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
16519113|NCT00813124|40368535|FG000|Overall Study|Withdrawal by Subject|1|||
16519114|NCT00781326|40368536|FG000|Phase I|Adverse Event|1|||
16519115|NCT00781326|40368536|FG000|Phase I|Withdrawal by Subject|1|||
16519116|NCT00781326|40368536|FG000|Phase I|Physician Decision|2|||
16395740|NCT01846299|39931150|FG001|Overall Study|Withdrawal by Subject|6|||
16323477|NCT00886743|39670911|FG000|Overall Study|Adverse Event|3|||
16323478|NCT00886743|39670911|FG000|Overall Study|Other|1|||
16323479|NCT00101166|39670912|FG000|Overall Study|progressive disease|10|||
16323480|NCT03063086|39670918|FG000|Overall Study|technical problems|1|||
16323481|NCT03063086|39670919|FG001|Overall Study|technical problems|0|||
16323482|NCT03063086|39670920|FG002|Overall Study|technical problems|0|||
16323483|NCT03063086|39670921|FG003|Overall Study|technical problems|0|||
16323484|NCT03063086|39670922|FG004|Overall Study|technical problems|0|||
16323485|NCT03063086|39670923|FG005|Overall Study|technical problems|0|||
16323486|NCT03063086|39670918|FG000|Overall Study|Adverse Event|1|||
16323487|NCT03063086|39670919|FG001|Overall Study|Adverse Event|1|||
16323488|NCT03063086|39670920|FG002|Overall Study|Adverse Event|1|||
16323489|NCT03063086|39670921|FG003|Overall Study|Adverse Event|1|||
16323490|NCT03063086|39670922|FG004|Overall Study|Adverse Event|0|||
16323491|NCT03063086|39670923|FG005|Overall Study|Adverse Event|0|||
16323492|NCT03063086|39670918|FG000|Overall Study|subject/guardian decision|1|||
16323493|NCT03063086|39670919|FG001|Overall Study|subject/guardian decision|0|||
16323494|NCT03063086|39670920|FG002|Overall Study|subject/guardian decision|0|||
16323495|NCT03063086|39670921|FG003|Overall Study|subject/guardian decision|0|||
16323496|NCT03063086|39670922|FG004|Overall Study|subject/guardian decision|0|||
16323497|NCT03063086|39670923|FG005|Overall Study|subject/guardian decision|0|||
16323498|NCT03063086|39670918|FG000|Overall Study|Non-compliance with study treatment|0|||
16323499|NCT03063086|39670919|FG001|Overall Study|Non-compliance with study treatment|0|||
16323500|NCT03063086|39670920|FG002|Overall Study|Non-compliance with study treatment|0|||
16323501|NCT03063086|39670921|FG003|Overall Study|Non-compliance with study treatment|1|||
16323502|NCT03063086|39670922|FG004|Overall Study|Non-compliance with study treatment|0|||
16323503|NCT03063086|39670923|FG005|Overall Study|Non-compliance with study treatment|1|||
16323504|NCT03063086|39670918|FG000|Overall Study|Physician Decision|0|||
16519117|NCT00061048|40368538|FG000|Overall Study|Adverse Event|2|||
16519118|NCT00061048|40368538|FG000|Overall Study|disease progression|20|||
16519119|NCT04086472|40368539|FG000|Overall Study|Lost to Follow-up|1|||
16519120|NCT04086472|40368540|FG001|Overall Study|Lost to Follow-up|0|||
16519121|NCT04086472|40368541|FG002|Overall Study|Lost to Follow-up|0|||
16519122|NCT04086472|40368542|FG003|Overall Study|Lost to Follow-up|0|||
16519123|NCT04086472|40368543|FG004|Overall Study|Lost to Follow-up|1|||
16519124|NCT04086472|40368539|FG000|Overall Study|Physician Decision|0|||
16519125|NCT04086472|40368540|FG001|Overall Study|Physician Decision|1|||
16519126|NCT04086472|40368541|FG002|Overall Study|Physician Decision|1|||
16519127|NCT04086472|40368542|FG003|Overall Study|Physician Decision|0|||
16519128|NCT04086472|40368543|FG004|Overall Study|Physician Decision|0|||
16519129|NCT04086472|40368539|FG000|Overall Study|Withdrawal by Subject|1|||
16519130|NCT04086472|40368540|FG001|Overall Study|Withdrawal by Subject|1|||
16519131|NCT04086472|40368541|FG002|Overall Study|Withdrawal by Subject|1|||
16519132|NCT04086472|40368542|FG003|Overall Study|Withdrawal by Subject|0|||
16519133|NCT04086472|40368543|FG004|Overall Study|Withdrawal by Subject|0|||
16519134|NCT04086472|40368539|FG000|Overall Study|Various reasons|2|||
16519135|NCT04086472|40368540|FG001|Overall Study|Various reasons|0|||
16519136|NCT04086472|40368541|FG002|Overall Study|Various reasons|0|||
16519137|NCT04086472|40368542|FG003|Overall Study|Various reasons|3|||
16519138|NCT04086472|40368543|FG004|Overall Study|Various reasons|1|||
16519139|NCT00555438|40368544|FG000|10 Days Post-operative|Death|4|||
16519140|NCT00555438|40368544|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
16519141|NCT00938431|40368545|FG000|Overall Study|Adverse Event|5|||
16519142|NCT00938431|40368546|FG001|Overall Study|Adverse Event|8|||
16519143|NCT00938431|40368547|FG002|Overall Study|Adverse Event|6|||
16519144|NCT00938431|40368545|FG000|Overall Study|Lack of Efficacy|0|||
16519145|NCT00938431|40368546|FG001|Overall Study|Lack of Efficacy|1|||
16519146|NCT00938431|40368547|FG002|Overall Study|Lack of Efficacy|0|||
16519147|NCT00938431|40368545|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
16519148|NCT00938431|40368546|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
16519149|NCT00938431|40368547|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
16519150|NCT00938431|40368545|FG000|Overall Study|Dosing compliance issue|0|||
16519151|NCT00938431|40368546|FG001|Overall Study|Dosing compliance issue|0|||
16519152|NCT00938431|40368547|FG002|Overall Study|Dosing compliance issue|1|||
16519153|NCT00938431|40368545|FG000|Overall Study|Reached maximum dose early|0|||
16519154|NCT00938431|40368546|FG001|Overall Study|Reached maximum dose early|0|||
16519155|NCT00938431|40368547|FG002|Overall Study|Reached maximum dose early|1|||
16323505|NCT03063086|39670919|FG001|Overall Study|Physician Decision|0|||
16323506|NCT03063086|39670920|FG002|Overall Study|Physician Decision|0|||
16323507|NCT03063086|39670921|FG003|Overall Study|Physician Decision|1|||
16519156|NCT00436280|40368548|FG000|Period 1: Induction|Adverse Event|8|||
16519157|NCT00436280|40368548|FG000|Period 1: Induction|Progressive Disease|12|||
16519158|NCT00436280|40368548|FG000|Period 1: Induction|Stable Disease|6|||
16519159|NCT00436280|40368548|FG000|Period 1: Induction|Withdrawal by Subject|1|||
16519160|NCT00436280|40368548|FG000|Period 1: Induction|Death|1|||
16519161|NCT00436280|40368548|FG000|Period 2: Consolidation|Adverse Event|1|||
16519162|NCT00436280|40368548|FG000|Period 2: Consolidation|Progressive Disease|10|||
16519163|NCT00436280|40368548|FG000|Period 2: Consolidation|Stable Disease|1|||
16519164|NCT00436280|40368548|FG000|Period 2: Consolidation|Physician Decision|2|||
16519165|NCT00436280|40368548|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
16519166|NCT00436280|40368548|FG000|Period 2: Consolidation|Death|1|||
16519167|NCT00436280|40368548|FG000|Period 3: Maintenance|Adverse Event|6|||
16519168|NCT00436280|40368548|FG000|Period 3: Maintenance|Progressive Disease|12|||
16519169|NCT00428610|40368549|FG000|Overall Study|Death Due to Adverse Event|3|||
16519170|NCT00428610|40368550|FG001|Overall Study|Death Due to Adverse Event|0|||
16519171|NCT00428610|40368551|FG002|Overall Study|Death Due to Adverse Event|5|||
16519172|NCT00428610|40368549|FG000|Overall Study|Death Due to Progressive Disease|0|||
16519173|NCT00428610|40368550|FG001|Overall Study|Death Due to Progressive Disease|0|||
16519174|NCT00428610|40368551|FG002|Overall Study|Death Due to Progressive Disease|2|||
16519175|NCT00428610|40368549|FG000|Overall Study|Adverse Event|2|||
16519176|NCT00428610|40368550|FG001|Overall Study|Adverse Event|3|||
16519177|NCT00428610|40368551|FG002|Overall Study|Adverse Event|2|||
16519178|NCT00428610|40368549|FG000|Overall Study|Investigator Decision|2|||
16519179|NCT00428610|40368550|FG001|Overall Study|Investigator Decision|1|||
16519180|NCT00428610|40368551|FG002|Overall Study|Investigator Decision|1|||
16519181|NCT00428610|40368549|FG000|Overall Study|Progressive Disease|42|||
16519182|NCT00428610|40368550|FG001|Overall Study|Progressive Disease|14|||
16519183|NCT00428610|40368551|FG002|Overall Study|Progressive Disease|22|||
16519184|NCT00428610|40368549|FG000|Overall Study|Withdrawal by Subject|4|||
16519185|NCT00428610|40368550|FG001|Overall Study|Withdrawal by Subject|0|||
16519186|NCT00428610|40368551|FG002|Overall Study|Withdrawal by Subject|0|||
16519187|NCT04121962|40368552|FG000|Overall Study|Lost to Follow-up|42|||
16519188|NCT04121962|40368553|FG001|Overall Study|Lost to Follow-up|39|||
16519189|NCT02473445|40368554|FG000|Overall Study|Withdrawal by Subject|2|||
16519190|NCT02473445|40368554|FG000|Overall Study|Sponsor Decision|20|||
16519191|NCT00773175|40368555|FG000|Overall Study|Adverse Event|2|||
16519192|NCT00773175|40368556|FG001|Overall Study|Adverse Event|0|||
16519193|NCT00773175|40368555|FG000|Overall Study|Consent Withdrawn|0|||
16519194|NCT00773175|40368556|FG001|Overall Study|Consent Withdrawn|2|||
16519195|NCT04496258|40368564|FG000|Overall Study|Withdrawal by Subject|2|||
16519196|NCT04496258|40368565|FG001|Overall Study|Withdrawal by Subject|1|||
16519197|NCT01340976|40368566|FG000|Overall Study|Physician Decision|2|||
16519198|NCT01340976|40368567|FG001|Overall Study|Physician Decision|0|||
16323508|NCT03063086|39670922|FG004|Overall Study|Physician Decision|0|||
16323509|NCT03063086|39670923|FG005|Overall Study|Physician Decision|0|||
16323510|NCT04236141|39670924|FG000|Overall Study|Death|18|||
16323511|NCT04236141|39670925|FG001|Overall Study|Death|10|||
16323512|NCT04236141|39670924|FG000|Overall Study|Withdrawal by Participant|1|||
16323513|NCT04236141|39670925|FG001|Overall Study|Withdrawal by Participant|0|||
16323514|NCT04236141|39670924|FG000|Overall Study|Reason not Specified|1|||
16323515|NCT04236141|39670925|FG001|Overall Study|Reason not Specified|0|||
16323516|NCT04236141|39670924|FG000|Overall Study|Study terminated by Sponsor|8|||
16323517|NCT04236141|39670925|FG001|Overall Study|Study terminated by Sponsor|4|||
16323518|NCT01186692|39670931|FG000|Overall Study|Not Catheterized|11|||
16323519|NCT01186692|39670931|FG000|Overall Study|Futher testing contraindicated implant|19|||
16323520|NCT01186692|39670931|FG000|Overall Study|Adverse Event|2|||
16323521|NCT01613222|39670932|FG000|Overall Study|Physician Decision|1|||
16323522|NCT01613222|39670932|FG000|Overall Study|Unable to place arterial line|1|||
16323523|NCT01613222|39670932|FG000|Overall Study|Reused disposable sensors|10|||
16323524|NCT01250873|39670937|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
16323525|NCT01250873|39670937|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
16323526|NCT01339923|39670939|FG000|Overall Study|Adverse Event|1|||
16323527|NCT01339923|39670940|FG001|Overall Study|Adverse Event|1|||
16323528|NCT01339923|39670941|FG002|Overall Study|Adverse Event|1|||
16323529|NCT01339923|39670942|FG003|Overall Study|Adverse Event|0|||
16323530|NCT01339923|39670943|FG004|Overall Study|Adverse Event|0|||
16323531|NCT01339923|39670944|FG005|Overall Study|Adverse Event|0|||
16323532|NCT01339923|39670945|FG006|Overall Study|Adverse Event|1|||
16323533|NCT01339923|39670939|FG000|Overall Study|Inappropriate Enrollment|1|||
16323534|NCT01339923|39670940|FG001|Overall Study|Inappropriate Enrollment|0|||
16323535|NCT01339923|39670941|FG002|Overall Study|Inappropriate Enrollment|0|||
16323536|NCT01339923|39670942|FG003|Overall Study|Inappropriate Enrollment|0|||
16323537|NCT01339923|39670943|FG004|Overall Study|Inappropriate Enrollment|0|||
16323538|NCT01339923|39670944|FG005|Overall Study|Inappropriate Enrollment|1|||
16323539|NCT01339923|39670945|FG006|Overall Study|Inappropriate Enrollment|0|||
16323540|NCT01339923|39670939|FG000|Overall Study|Lost to Follow-up|4|||
16323541|NCT01339923|39670940|FG001|Overall Study|Lost to Follow-up|4|||
16519199|NCT01340976|40368568|FG002|Overall Study|Physician Decision|1|||
16519200|NCT01340976|40368569|FG003|Overall Study|Physician Decision|1|||
16519201|NCT01340976|40368570|FG004|Overall Study|Physician Decision|1|||
16519202|NCT01340976|40368571|FG005|Overall Study|Physician Decision|0|||
16519203|NCT01340976|40368566|FG000|Overall Study|Death|0|||
16519204|NCT01340976|40368567|FG001|Overall Study|Death|1|||
16519205|NCT01340976|40368568|FG002|Overall Study|Death|0|||
16519206|NCT01340976|40368569|FG003|Overall Study|Death|0|||
16323542|NCT01339923|39670941|FG002|Overall Study|Lost to Follow-up|0|||
16323543|NCT01339923|39670942|FG003|Overall Study|Lost to Follow-up|3|||
16323544|NCT01339923|39670943|FG004|Overall Study|Lost to Follow-up|1|||
16323545|NCT01339923|39670944|FG005|Overall Study|Lost to Follow-up|1|||
16323546|NCT01339923|39670945|FG006|Overall Study|Lost to Follow-up|5|||
16323547|NCT01339923|39670939|FG000|Overall Study|Protocol Violation|0|||
16323548|NCT01339923|39670940|FG001|Overall Study|Protocol Violation|0|||
16323549|NCT01339923|39670941|FG002|Overall Study|Protocol Violation|0|||
16323550|NCT01339923|39670942|FG003|Overall Study|Protocol Violation|0|||
16323551|NCT01339923|39670943|FG004|Overall Study|Protocol Violation|0|||
16323552|NCT01339923|39670944|FG005|Overall Study|Protocol Violation|3|||
16323553|NCT01339923|39670945|FG006|Overall Study|Protocol Violation|1|||
16323554|NCT01339923|39670939|FG000|Overall Study|Unable to Classify|1|||
16323555|NCT01339923|39670940|FG001|Overall Study|Unable to Classify|0|||
16323556|NCT01339923|39670941|FG002|Overall Study|Unable to Classify|1|||
16323557|NCT01339923|39670942|FG003|Overall Study|Unable to Classify|0|||
16323558|NCT01339923|39670943|FG004|Overall Study|Unable to Classify|0|||
16323559|NCT01339923|39670944|FG005|Overall Study|Unable to Classify|1|||
16323560|NCT01339923|39670945|FG006|Overall Study|Unable to Classify|5|||
16323561|NCT01339923|39670939|FG000|Overall Study|Withdrawal by Subject|7|||
16323562|NCT01339923|39670940|FG001|Overall Study|Withdrawal by Subject|11|||
16323563|NCT01339923|39670941|FG002|Overall Study|Withdrawal by Subject|6|||
16323564|NCT01339923|39670942|FG003|Overall Study|Withdrawal by Subject|1|||
16323565|NCT01339923|39670943|FG004|Overall Study|Withdrawal by Subject|4|||
16323566|NCT01339923|39670944|FG005|Overall Study|Withdrawal by Subject|3|||
16323567|NCT01339923|39670945|FG006|Overall Study|Withdrawal by Subject|2|||
16323568|NCT01163851|39670949|FG000|Overall Study|Site Closure|0|||
16323569|NCT01163851|39670950|FG001|Overall Study|Site Closure|1|||
16323570|NCT01163851|39670949|FG000|Overall Study|Enrolled but not treated|1|||
16323571|NCT01163851|39670950|FG001|Overall Study|Enrolled but not treated|0|||
16323572|NCT02005692|39670953|FG000|Overall Study|Protocol Violation|1|||
16323573|NCT02005692|39670953|FG000|Overall Study|Withdrawal by Subject|1|||
16323574|NCT02005692|39670953|FG000|Overall Study|Discharged earlier than anticipated|5|||
16323575|NCT01953601|39670957|FG000|Part 1 (Base Study)|Adverse Event|24|||
16323576|NCT01953601|39670958|FG001|Part 1 (Base Study)|Adverse Event|37|||
16323577|NCT01953601|39670959|FG002|Part 1 (Base Study)|Adverse Event|15|||
16323578|NCT01953601|39670957|FG000|Part 1 (Base Study)|Death|2|||
16323579|NCT01953601|39670958|FG001|Part 1 (Base Study)|Death|0|||
16323580|NCT01953601|39670959|FG002|Part 1 (Base Study)|Death|3|||
16323581|NCT01953601|39670957|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
16323582|NCT01953601|39670958|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
16519207|NCT01340976|40368570|FG004|Overall Study|Death|0|||
16519208|NCT01340976|40368571|FG005|Overall Study|Death|0|||
16519209|NCT01340976|40368566|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
16519210|NCT01340976|40368567|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
16519211|NCT01340976|40368568|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
16519212|NCT01340976|40368569|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
16519213|NCT01340976|40368570|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
16519214|NCT01340976|40368571|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
16519215|NCT01340976|40368566|FG000|Overall Study|Withdrawal by Subject|0|||
16519216|NCT01340976|40368567|FG001|Overall Study|Withdrawal by Subject|0|||
16519217|NCT01340976|40368568|FG002|Overall Study|Withdrawal by Subject|0|||
16519218|NCT01340976|40368569|FG003|Overall Study|Withdrawal by Subject|1|||
16519219|NCT01340976|40368570|FG004|Overall Study|Withdrawal by Subject|1|||
16519220|NCT01340976|40368571|FG005|Overall Study|Withdrawal by Subject|0|||
16519221|NCT01340976|40368566|FG000|Overall Study|Other anemia treatment|1|||
16519222|NCT01340976|40368567|FG001|Overall Study|Other anemia treatment|0|||
16519223|NCT01340976|40368568|FG002|Overall Study|Other anemia treatment|2|||
16519224|NCT01340976|40368569|FG003|Overall Study|Other anemia treatment|1|||
16519225|NCT01340976|40368570|FG004|Overall Study|Other anemia treatment|0|||
16519226|NCT01340976|40368571|FG005|Overall Study|Other anemia treatment|1|||
16519227|NCT01340976|40368566|FG000|Overall Study|Adverse Event|0|||
16519228|NCT01340976|40368567|FG001|Overall Study|Adverse Event|1|||
16519229|NCT01340976|40368568|FG002|Overall Study|Adverse Event|0|||
16519230|NCT01340976|40368569|FG003|Overall Study|Adverse Event|0|||
16519231|NCT01340976|40368570|FG004|Overall Study|Adverse Event|0|||
16323583|NCT01953601|39670959|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
16323584|NCT01953601|39670957|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
16323585|NCT01953601|39670958|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
16323586|NCT01953601|39670959|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
16323587|NCT01953601|39670957|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
16323588|NCT01953601|39670958|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
16323589|NCT01953601|39670959|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
16323590|NCT01953601|39670957|FG000|Part 1 (Base Study)|Physician Decision|3|||
16323591|NCT01953601|39670958|FG001|Part 1 (Base Study)|Physician Decision|7|||
16519232|NCT01340976|40368571|FG005|Overall Study|Adverse Event|0|||
16519233|NCT04666441|40368575|FG000|Overall Study|Lost to Follow-up|1|||
16519234|NCT04666441|40368576|FG001|Overall Study|Lost to Follow-up|4|||
16519235|NCT04666441|40368577|FG002|Overall Study|Lost to Follow-up|1|||
16519236|NCT04666441|40368578|FG003|Overall Study|Lost to Follow-up|3|||
16519237|NCT04666441|40368579|FG004|Overall Study|Lost to Follow-up|0|||
16519238|NCT04666441|40368580|FG005|Overall Study|Lost to Follow-up|2|||
16519239|NCT04666441|40368581|FG006|Overall Study|Lost to Follow-up|2|||
16519240|NCT04666441|40368582|FG007|Overall Study|Lost to Follow-up|2|||
16519241|NCT04666441|40368575|FG000|Overall Study|Subject Decision|1|||
16519242|NCT04666441|40368576|FG001|Overall Study|Subject Decision|1|||
16519243|NCT04666441|40368577|FG002|Overall Study|Subject Decision|3|||
16519244|NCT04666441|40368578|FG003|Overall Study|Subject Decision|1|||
16519245|NCT04666441|40368579|FG004|Overall Study|Subject Decision|0|||
16519246|NCT04666441|40368580|FG005|Overall Study|Subject Decision|1|||
16519247|NCT04666441|40368581|FG006|Overall Study|Subject Decision|3|||
16519248|NCT04666441|40368582|FG007|Overall Study|Subject Decision|2|||
16519249|NCT04439240|40368583|FG000|Overall Study|Ineligible|2|||
16519250|NCT04439240|40368583|FG000|Overall Study|Never started treatment|2|||
16519251|NCT04439240|40368583|FG000|Overall Study|Adverse Event|12|||
16519252|NCT04439240|40368583|FG000|Overall Study|Death|2|||
16519253|NCT04439240|40368583|FG000|Overall Study|Disease progression|25|||
16519254|NCT04439240|40368583|FG000|Overall Study|Other diseases|2|||
16519255|NCT04439240|40368583|FG000|Overall Study|Withdrawal by Subject|3|||
16519256|NCT04439240|40368583|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
16519257|NCT04439240|40368583|FG000|Overall Study|Symptomatic decline|1|||
16519258|NCT04439240|40368583|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
16519259|NCT04439240|40368583|FG000|Overall Study|Clinical progression|1|||
16519260|NCT01208233|40368584|FG000|Overall Study|Adverse Event|0|||
16519261|NCT01208233|40368585|FG001|Overall Study|Adverse Event|1|||
16519262|NCT01208233|40368586|FG002|Overall Study|Adverse Event|2|||
16519263|NCT01208233|40368587|FG003|Overall Study|Adverse Event|0|||
16519264|NCT01208233|40368588|FG004|Overall Study|Adverse Event|3|||
16519265|NCT01208233|40368589|FG005|Overall Study|Adverse Event|5|||
16519266|NCT01208233|40368584|FG000|Overall Study|Death|0|||
16519267|NCT01208233|40368585|FG001|Overall Study|Death|0|||
16519268|NCT01208233|40368586|FG002|Overall Study|Death|0|||
16519269|NCT01208233|40368587|FG003|Overall Study|Death|0|||
16519270|NCT01208233|40368588|FG004|Overall Study|Death|3|||
16519271|NCT01208233|40368589|FG005|Overall Study|Death|5|||
16519272|NCT01208233|40368584|FG000|Overall Study|Did not meet entrance criteria|2|||
16519273|NCT01208233|40368585|FG001|Overall Study|Did not meet entrance criteria|1|||
16519274|NCT01208233|40368586|FG002|Overall Study|Did not meet entrance criteria|1|||
16519275|NCT01208233|40368587|FG003|Overall Study|Did not meet entrance criteria|0|||
16519276|NCT01208233|40368588|FG004|Overall Study|Did not meet entrance criteria|1|||
16519277|NCT01208233|40368589|FG005|Overall Study|Did not meet entrance criteria|0|||
16519278|NCT01208233|40368584|FG000|Overall Study|Medication error without adverse event|0|||
16519279|NCT01208233|40368585|FG001|Overall Study|Medication error without adverse event|0|||
16519280|NCT01208233|40368586|FG002|Overall Study|Medication error without adverse event|0|||
16519281|NCT01208233|40368587|FG003|Overall Study|Medication error without adverse event|0|||
16519282|NCT01208233|40368588|FG004|Overall Study|Medication error without adverse event|0|||
16519283|NCT01208233|40368589|FG005|Overall Study|Medication error without adverse event|1|||
16519284|NCT01208233|40368584|FG000|Overall Study|Study terminated by sponsor|0|||
16519285|NCT01208233|40368585|FG001|Overall Study|Study terminated by sponsor|0|||
16519286|NCT01208233|40368586|FG002|Overall Study|Study terminated by sponsor|0|||
16519287|NCT01208233|40368587|FG003|Overall Study|Study terminated by sponsor|0|||
16519288|NCT01208233|40368588|FG004|Overall Study|Study terminated by sponsor|10|||
16519289|NCT01208233|40368589|FG005|Overall Study|Study terminated by sponsor|7|||
16519290|NCT01208233|40368584|FG000|Overall Study|Protocol Violation|0|||
16519291|NCT01208233|40368585|FG001|Overall Study|Protocol Violation|0|||
16519292|NCT01208233|40368586|FG002|Overall Study|Protocol Violation|0|||
16519293|NCT01208233|40368587|FG003|Overall Study|Protocol Violation|0|||
16519294|NCT01208233|40368588|FG004|Overall Study|Protocol Violation|3|||
16519295|NCT01208233|40368589|FG005|Overall Study|Protocol Violation|0|||
16519296|NCT01208233|40368584|FG000|Overall Study|Other|2|||
16519297|NCT01208233|40368585|FG001|Overall Study|Other|1|||
16519298|NCT01208233|40368586|FG002|Overall Study|Other|0|||
16519299|NCT01208233|40368587|FG003|Overall Study|Other|0|||
16519300|NCT01208233|40368588|FG004|Overall Study|Other|0|||
16519301|NCT01208233|40368589|FG005|Overall Study|Other|1|||
16519302|NCT01208233|40368584|FG000|Overall Study|Withdrawal by Subject|1|||
16519303|NCT01208233|40368585|FG001|Overall Study|Withdrawal by Subject|0|||
16519304|NCT01208233|40368586|FG002|Overall Study|Withdrawal by Subject|1|||
16519305|NCT01208233|40368587|FG003|Overall Study|Withdrawal by Subject|1|||
16519306|NCT01208233|40368588|FG004|Overall Study|Withdrawal by Subject|4|||
16519307|NCT01208233|40368589|FG005|Overall Study|Withdrawal by Subject|2|||
16519308|NCT01706250|40368595|FG000|Overall Study|Lost to Follow-up|2|||
16519309|NCT03337724|40368600|FG000|Overall Study|Reason not Specified|12|||
16519310|NCT03337724|40368601|FG001|Overall Study|Reason not Specified|21|||
16519311|NCT03337724|40368602|FG002|Overall Study|Reason not Specified|9|||
16519312|NCT03337724|40368603|FG003|Overall Study|Reason not Specified|9|||
16519313|NCT03337724|40368604|FG004|Overall Study|Reason not Specified|29|||
16519314|NCT03337724|40368600|FG000|Overall Study|Withdrawal by Subject|13|||
16519315|NCT03337724|40368601|FG001|Overall Study|Withdrawal by Subject|15|||
16519316|NCT03337724|40368602|FG002|Overall Study|Withdrawal by Subject|4|||
16519317|NCT03337724|40368603|FG003|Overall Study|Withdrawal by Subject|15|||
16519318|NCT03337724|40368604|FG004|Overall Study|Withdrawal by Subject|6|||
16519319|NCT03337724|40368600|FG000|Overall Study|Protocol Deviation|0|||
16519320|NCT03337724|40368601|FG001|Overall Study|Protocol Deviation|1|||
16519321|NCT03337724|40368602|FG002|Overall Study|Protocol Deviation|1|||
16519322|NCT03337724|40368603|FG003|Overall Study|Protocol Deviation|1|||
16519323|NCT03337724|40368604|FG004|Overall Study|Protocol Deviation|0|||
16519324|NCT03337724|40368600|FG000|Overall Study|Adverse Event|1|||
16519325|NCT03337724|40368601|FG001|Overall Study|Adverse Event|1|||
16519326|NCT03337724|40368602|FG002|Overall Study|Adverse Event|0|||
16519327|NCT03337724|40368603|FG003|Overall Study|Adverse Event|1|||
16519328|NCT03337724|40368604|FG004|Overall Study|Adverse Event|0|||
16519329|NCT03337724|40368600|FG000|Overall Study|Death|40|||
16519330|NCT03337724|40368601|FG001|Overall Study|Death|89|||
16519331|NCT03337724|40368602|FG002|Overall Study|Death|43|||
16519332|NCT03337724|40368603|FG003|Overall Study|Death|76|||
16519333|NCT03337724|40368604|FG004|Overall Study|Death|50|||
16519334|NCT03337724|40368600|FG000|Overall Study|Lost to Follow-up|5|||
16519335|NCT03337724|40368601|FG001|Overall Study|Lost to Follow-up|5|||
16519336|NCT03337724|40368602|FG002|Overall Study|Lost to Follow-up|4|||
16519337|NCT03337724|40368603|FG003|Overall Study|Lost to Follow-up|7|||
16519338|NCT03337724|40368604|FG004|Overall Study|Lost to Follow-up|4|||
16519339|NCT03337724|40368600|FG000|Overall Study|Physician Decision|16|||
16519340|NCT03337724|40368601|FG001|Overall Study|Physician Decision|34|||
16519341|NCT03337724|40368602|FG002|Overall Study|Physician Decision|14|||
16519342|NCT03337724|40368603|FG003|Overall Study|Physician Decision|34|||
16519343|NCT03337724|40368604|FG004|Overall Study|Physician Decision|13|||
16519344|NCT03337724|40368600|FG000|Overall Study|Progressive Disease|0|||
16519345|NCT03337724|40368601|FG001|Overall Study|Progressive Disease|2|||
16519346|NCT03337724|40368602|FG002|Overall Study|Progressive Disease|1|||
16519347|NCT03337724|40368603|FG003|Overall Study|Progressive Disease|2|||
16519348|NCT03337724|40368604|FG004|Overall Study|Progressive Disease|0|||
16519349|NCT03337724|40368600|FG000|Overall Study|Symptomatic Deterioration|0|||
16519350|NCT03337724|40368601|FG001|Overall Study|Symptomatic Deterioration|0|||
16519351|NCT03337724|40368602|FG002|Overall Study|Symptomatic Deterioration|0|||
16519352|NCT03337724|40368603|FG003|Overall Study|Symptomatic Deterioration|1|||
16519353|NCT03337724|40368604|FG004|Overall Study|Symptomatic Deterioration|0|||
16519354|NCT03085927|40368605|FG000|Overall Study|Withdrawal by Subject|1|||
16519355|NCT03085927|40368606|FG001|Overall Study|Withdrawal by Subject|4|||
16519356|NCT03085927|40368605|FG000|Overall Study|Lost to Follow-up|3|||
16519357|NCT03085927|40368606|FG001|Overall Study|Lost to Follow-up|1|||
16519358|NCT03085927|40368605|FG000|Overall Study|Death|1|||
16519359|NCT03085927|40368606|FG001|Overall Study|Death|0|||
16519360|NCT03085927|40368605|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
16519361|NCT03085927|40368606|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
16519362|NCT03085927|40368605|FG000|Overall Study|Dyad Became Ineligible|0|||
16519363|NCT03085927|40368606|FG001|Overall Study|Dyad Became Ineligible|1|||
16519364|NCT01700179|40368607|FG000|Overall Study|Physician Decision|2|||
16519365|NCT00382733|40368608|FG000|Overall Study|Withdrawal by Subject|0|||
16519366|NCT00382733|40368609|FG001|Overall Study|Withdrawal by Subject|1|||
16519367|NCT00382733|40368610|FG002|Overall Study|Withdrawal by Subject|0|||
16519368|NCT00382733|40368611|FG003|Overall Study|Withdrawal by Subject|0|||
16519369|NCT00382733|40368612|FG004|Overall Study|Withdrawal by Subject|0|||
16519370|NCT03941860|40368617|FG000|Overall Study|Withdrawal by Subject|0|||
16519371|NCT03941860|40368618|FG001|Overall Study|Withdrawal by Subject|1|||
16519372|NCT00179413|40368619|FG000|Overall Study|Adverse Event|38|||
16519373|NCT00179413|40368620|FG001|Overall Study|Adverse Event|20|||
16519374|NCT00179413|40368619|FG000|Overall Study|Withdrawal by Subject|87|||
16519375|NCT00179413|40368620|FG001|Overall Study|Withdrawal by Subject|95|||
16519376|NCT01581593|40368621|FG000|Overall Study|Withdrawal by Subject|1|||
16519377|NCT00844545|40368622|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
16519378|NCT00844545|40368622|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
16519379|NCT00844545|40368622|FG000|Extension Treatment Period|Adverse Event|2|||
16519380|NCT00844545|40368622|FG000|Post Treatment Period|Withdrawal by Subject|1|||
16519381|NCT02566759|40368625|FG000|All Parts|Withdrawal by Subject|0|||
16519382|NCT02566759|40368626|FG001|All Parts|Withdrawal by Subject|1|||
16519383|NCT02566759|40368627|FG002|All Parts|Withdrawal by Subject|0|||
16519384|NCT02566759|40368628|FG003|All Parts|Withdrawal by Subject|0|||
16519385|NCT02566759|40368629|FG004|All Parts|Withdrawal by Subject|0|||
16519386|NCT02566759|40368630|FG005|All Parts|Withdrawal by Subject|0|||
16519387|NCT02566759|40368631|FG006|All Parts|Withdrawal by Subject|0|||
16519388|NCT02566759|40368632|FG007|All Parts|Withdrawal by Subject|0|||
16519389|NCT02566759|40368633|FG008|All Parts|Withdrawal by Subject|0|||
16519390|NCT02566759|40368634|FG009|All Parts|Withdrawal by Subject|0|||
16519391|NCT02566759|40368635|FG010|All Parts|Withdrawal by Subject|0|||
16519392|NCT02566759|40368636|FG011|All Parts|Withdrawal by Subject|0|||
16519393|NCT02566759|40368637|FG012|All Parts|Withdrawal by Subject|0|||
16519394|NCT02566759|40368638|FG013|All Parts|Withdrawal by Subject|0|||
16519395|NCT02566759|40368639|FG014|All Parts|Withdrawal by Subject|0|||
16519396|NCT02566759|40368640|FG015|All Parts|Withdrawal by Subject|0|||
16519397|NCT02566759|40368641|FG016|All Parts|Withdrawal by Subject|0|||
16519398|NCT02566759|40368625|FG000|All Parts|Adverse Event|0|||
16519399|NCT02566759|40368626|FG001|All Parts|Adverse Event|0|||
16519400|NCT02566759|40368627|FG002|All Parts|Adverse Event|0|||
16519401|NCT02566759|40368628|FG003|All Parts|Adverse Event|0|||
16519402|NCT02566759|40368629|FG004|All Parts|Adverse Event|0|||
16519403|NCT02566759|40368630|FG005|All Parts|Adverse Event|0|||
16519404|NCT02566759|40368631|FG006|All Parts|Adverse Event|0|||
16519405|NCT02566759|40368632|FG007|All Parts|Adverse Event|0|||
16519406|NCT02566759|40368633|FG008|All Parts|Adverse Event|0|||
16519407|NCT02566759|40368634|FG009|All Parts|Adverse Event|0|||
16519408|NCT02566759|40368635|FG010|All Parts|Adverse Event|0|||
16519409|NCT02566759|40368636|FG011|All Parts|Adverse Event|0|||
16519410|NCT02566759|40368637|FG012|All Parts|Adverse Event|1|||
16519411|NCT02566759|40368638|FG013|All Parts|Adverse Event|3|||
16519412|NCT02566759|40368639|FG014|All Parts|Adverse Event|0|||
16519413|NCT02566759|40368640|FG015|All Parts|Adverse Event|0|||
16519414|NCT02566759|40368641|FG016|All Parts|Adverse Event|0|||
16519415|NCT02566759|40368625|FG000|All Parts|Other|0|||
16519416|NCT02566759|40368626|FG001|All Parts|Other|0|||
16519417|NCT02566759|40368627|FG002|All Parts|Other|0|||
16519418|NCT02566759|40368628|FG003|All Parts|Other|0|||
16519419|NCT02566759|40368629|FG004|All Parts|Other|0|||
16519420|NCT02566759|40368630|FG005|All Parts|Other|0|||
16519421|NCT02566759|40368631|FG006|All Parts|Other|0|||
16519422|NCT02566759|40368632|FG007|All Parts|Other|0|||
16519423|NCT02566759|40368633|FG008|All Parts|Other|0|||
16519424|NCT02566759|40368634|FG009|All Parts|Other|0|||
16519425|NCT02566759|40368635|FG010|All Parts|Other|0|||
16519426|NCT02566759|40368636|FG011|All Parts|Other|0|||
16519427|NCT02566759|40368637|FG012|All Parts|Other|0|||
16519428|NCT02566759|40368638|FG013|All Parts|Other|2|||
16519429|NCT02566759|40368639|FG014|All Parts|Other|0|||
16519430|NCT02566759|40368640|FG015|All Parts|Other|0|||
16519431|NCT02566759|40368641|FG016|All Parts|Other|0|||
16519432|NCT02566759|40368625|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519433|NCT02566759|40368626|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519434|NCT02566759|40368627|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519435|NCT02566759|40368628|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519436|NCT02566759|40368629|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519437|NCT02566759|40368630|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519438|NCT02566759|40368631|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519439|NCT02566759|40368632|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519440|NCT02566759|40368633|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519441|NCT02566759|40368634|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519442|NCT02566759|40368635|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519443|NCT02566759|40368636|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519444|NCT02566759|40368637|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519445|NCT02566759|40368638|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519446|NCT02566759|40368639|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519447|NCT02566759|40368640|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
16519448|NCT02566759|40368641|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
16519449|NCT01863446|40368642|FG000|Overall Study|Withdrawal by Subject|1|||
16519450|NCT01863446|40368643|FG001|Overall Study|Withdrawal by Subject|0|||
16519451|NCT01863446|40368644|FG002|Overall Study|Withdrawal by Subject|1|||
16519452|NCT01863446|40368645|FG003|Overall Study|Withdrawal by Subject|2|||
16519453|NCT01863446|40368642|FG000|Overall Study|Physician Decision|0|||
16519454|NCT01863446|40368643|FG001|Overall Study|Physician Decision|0|||
16519455|NCT01863446|40368644|FG002|Overall Study|Physician Decision|1|||
16519456|NCT01863446|40368645|FG003|Overall Study|Physician Decision|0|||
16519457|NCT01168999|40368646|FG000|Overall Study|Lost to Follow-up|2|||
16519458|NCT01168999|40368647|FG001|Overall Study|Lost to Follow-up|1|||
16519459|NCT01168999|40368648|FG002|Overall Study|Lost to Follow-up|0|||
16519460|NCT01168999|40368649|FG003|Overall Study|Lost to Follow-up|0|||
16519461|NCT01565993|40368650|FG000|Overall Study|Physician Decision|0|||
16205521|NCT01213264|39229856|FG000|Overall Study|Adverse Event|1|||
16519462|NCT01565993|40368651|FG001|Overall Study|Physician Decision|3|||
16519463|NCT03304379|40368657|FG000|Overall Study|Protocol Violation|8|||
16519464|NCT03304379|40368658|FG001|Overall Study|Protocol Violation|10|||
16519465|NCT03304379|40368659|FG002|Overall Study|Protocol Violation|5|||
16519466|NCT03304379|40368660|FG003|Overall Study|Protocol Violation|0|||
16519467|NCT03304379|40368661|FG004|Overall Study|Protocol Violation|2|||
16519468|NCT03304379|40368657|FG000|Overall Study|Adverse Event|4|||
16205522|NCT01213264|39229857|FG001|Overall Study|Adverse Event|0|||
16205523|NCT01213264|39229858|FG002|Overall Study|Adverse Event|0|||
16205524|NCT01213264|39229856|FG000|Overall Study|Lost to Follow-up|1|||
16205525|NCT01213264|39229857|FG001|Overall Study|Lost to Follow-up|2|||
16205526|NCT01213264|39229858|FG002|Overall Study|Lost to Follow-up|6|||
16092892|NCT01052272|38830274|FG001|Overall Study|Withdrawal by Subject|2|||
16092893|NCT01052272|38830275|FG002|Overall Study|Withdrawal by Subject|3|||
16092894|NCT01052272|38830276|FG003|Overall Study|Withdrawal by Subject|2|||
16092895|NCT01052272|38830273|FG000|Overall Study|placed in long-term care|0|||
16205527|NCT02806947|39229859|FG000|Overall Study|Withdrawal by Subject|5|||
16205528|NCT02806947|39229860|FG001|Overall Study|Withdrawal by Subject|1|||
16205529|NCT04929613|39229863|FG000|Overall Study|Withdrawal by Subject|12|||
16205530|NCT00970268|39229864|FG000|Overall Study|Withdrawal by Subject|12|||
16205531|NCT00970268|39229865|FG001|Overall Study|Withdrawal by Subject|19|||
16205532|NCT00970268|39229864|FG000|Overall Study|Adverse Event|15|||
16205533|NCT00970268|39229865|FG001|Overall Study|Adverse Event|12|||
16205534|NCT00970268|39229864|FG000|Overall Study|Lack of Efficacy|3|||
16092896|NCT01052272|38830274|FG001|Overall Study|placed in long-term care|0|||
16092897|NCT01052272|38830275|FG002|Overall Study|placed in long-term care|1|||
16092898|NCT01052272|38830276|FG003|Overall Study|placed in long-term care|0|||
16092899|NCT01052272|38830273|FG000|Overall Study|decline in health|0|||
16092900|NCT01052272|38830274|FG001|Overall Study|decline in health|0|||
16092901|NCT01052272|38830275|FG002|Overall Study|decline in health|1|||
16092902|NCT01052272|38830276|FG003|Overall Study|decline in health|0|||
16092903|NCT01241448|38830277|FG000|Overall Study|Adverse Event|1|||
16092904|NCT01241448|38830278|FG001|Overall Study|Adverse Event|0|||
16092905|NCT01241448|38830279|FG002|Overall Study|Adverse Event|2|||
16092906|NCT01241448|38830280|FG003|Overall Study|Adverse Event|2|||
16092907|NCT01241448|38830277|FG000|Overall Study|Lost to Follow-up|2|||
16092908|NCT01241448|38830278|FG001|Overall Study|Lost to Follow-up|1|||
16092909|NCT01241448|38830279|FG002|Overall Study|Lost to Follow-up|1|||
16092910|NCT01241448|38830280|FG003|Overall Study|Lost to Follow-up|1|||
16092911|NCT01241448|38830277|FG000|Overall Study|Physician Decision|0|||
16092912|NCT01241448|38830278|FG001|Overall Study|Physician Decision|2|||
16092913|NCT01241448|38830279|FG002|Overall Study|Physician Decision|0|||
16092914|NCT01241448|38830280|FG003|Overall Study|Physician Decision|0|||
16092915|NCT01241448|38830277|FG000|Overall Study|Protocol Violation|10|||
16092916|NCT01241448|38830278|FG001|Overall Study|Protocol Violation|5|||
16092917|NCT01241448|38830279|FG002|Overall Study|Protocol Violation|3|||
16092918|NCT01241448|38830280|FG003|Overall Study|Protocol Violation|6|||
16092919|NCT01241448|38830277|FG000|Overall Study|Sponsor Decision|17|||
16092920|NCT01241448|38830278|FG001|Overall Study|Sponsor Decision|14|||
16092921|NCT01241448|38830279|FG002|Overall Study|Sponsor Decision|12|||
16092922|NCT01241448|38830280|FG003|Overall Study|Sponsor Decision|6|||
16092923|NCT01241448|38830277|FG000|Overall Study|Withdrawal by Subject|4|||
16092924|NCT01241448|38830278|FG001|Overall Study|Withdrawal by Subject|5|||
16092925|NCT01241448|38830279|FG002|Overall Study|Withdrawal by Subject|3|||
16092926|NCT01241448|38830280|FG003|Overall Study|Withdrawal by Subject|6|||
16092927|NCT01241448|38830277|FG000|Overall Study|Excluded due to data integrity issues|3|||
16092928|NCT01241448|38830278|FG001|Overall Study|Excluded due to data integrity issues|2|||
16205535|NCT00970268|39229865|FG001|Overall Study|Lack of Efficacy|6|||
16205536|NCT00970268|39229864|FG000|Overall Study|Protocol Violation|4|||
16205537|NCT00970268|39229865|FG001|Overall Study|Protocol Violation|7|||
16092929|NCT01241448|38830279|FG002|Overall Study|Excluded due to data integrity issues|2|||
16092930|NCT01241448|38830280|FG003|Overall Study|Excluded due to data integrity issues|2|||
16092931|NCT02291549|38830283|FG000|Overall Study|Lost to Follow-up|1|||
16205538|NCT00970268|39229864|FG000|Overall Study|Other Reason|3|||
16205539|NCT00970268|39229865|FG001|Overall Study|Other Reason|1|||
16205540|NCT00970268|39229864|FG000|Overall Study|COPD Exacerbation|4|||
16205541|NCT00970268|39229865|FG001|Overall Study|COPD Exacerbation|2|||
16205542|NCT00970268|39229864|FG000|Overall Study|Lost to Follow-up|1|||
16205543|NCT00970268|39229865|FG001|Overall Study|Lost to Follow-up|2|||
16205544|NCT00970268|39229864|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
16205545|NCT00970268|39229865|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
16205546|NCT02548351|39229866|FG000|Overall Study|Withdrawal by Subject|149|||
16205547|NCT02548351|39229867|FG001|Overall Study|Withdrawal by Subject|154|||
16205548|NCT02548351|39229868|FG002|Overall Study|Withdrawal by Subject|152|||
16519469|NCT03304379|40368658|FG001|Overall Study|Adverse Event|20|||
16519470|NCT03304379|40368659|FG002|Overall Study|Adverse Event|17|||
16519471|NCT03304379|40368660|FG003|Overall Study|Adverse Event|1|||
16519472|NCT03304379|40368661|FG004|Overall Study|Adverse Event|0|||
16519473|NCT03304379|40368657|FG000|Overall Study|Lack of Efficacy|17|||
16519474|NCT03304379|40368658|FG001|Overall Study|Lack of Efficacy|16|||
16205549|NCT02548351|39229866|FG000|Overall Study|Death|11|||
16205550|NCT02548351|39229867|FG001|Overall Study|Death|15|||
16205551|NCT02548351|39229868|FG002|Overall Study|Death|12|||
16205552|NCT02548351|39229866|FG000|Overall Study|Adverse Event|22|||
16205553|NCT02548351|39229867|FG001|Overall Study|Adverse Event|56|||
16205554|NCT02548351|39229868|FG002|Overall Study|Adverse Event|36|||
16205555|NCT02548351|39229866|FG000|Overall Study|Study Terminated by Sponsor|549|||
16205556|NCT02548351|39229867|FG001|Overall Study|Study Terminated by Sponsor|509|||
16205557|NCT02548351|39229868|FG002|Overall Study|Study Terminated by Sponsor|528|||
16205558|NCT02548351|39229866|FG000|Overall Study|Site Closure|14|||
16205559|NCT02548351|39229867|FG001|Overall Study|Site Closure|5|||
16205560|NCT02548351|39229868|FG002|Overall Study|Site Closure|7|||
16205561|NCT02548351|39229866|FG000|Overall Study|Non-compliance with Study Drug|4|||
16205562|NCT02548351|39229867|FG001|Overall Study|Non-compliance with Study Drug|2|||
16205563|NCT02548351|39229868|FG002|Overall Study|Non-compliance with Study Drug|0|||
16205564|NCT02548351|39229866|FG000|Overall Study|Protocol Violation|2|||
16205565|NCT02548351|39229867|FG001|Overall Study|Protocol Violation|1|||
16205566|NCT02548351|39229868|FG002|Overall Study|Protocol Violation|2|||
16205567|NCT02548351|39229866|FG000|Overall Study|Physician Decision|11|||
16205568|NCT02548351|39229867|FG001|Overall Study|Physician Decision|18|||
16205569|NCT02548351|39229868|FG002|Overall Study|Physician Decision|11|||
16205570|NCT02548351|39229866|FG000|Overall Study|Lost to Follow-up|43|||
16205571|NCT02548351|39229867|FG001|Overall Study|Lost to Follow-up|50|||
16205572|NCT02548351|39229868|FG002|Overall Study|Lost to Follow-up|57|||
16205573|NCT02548351|39229866|FG000|Overall Study|Other|19|||
16205574|NCT02548351|39229867|FG001|Overall Study|Other|16|||
16205575|NCT02548351|39229868|FG002|Overall Study|Other|20|||
16205576|NCT02548351|39229866|FG000|Overall Study|Missing|1|||
16205577|NCT02548351|39229867|FG001|Overall Study|Missing|1|||
16205578|NCT02548351|39229868|FG002|Overall Study|Missing|0|||
16092932|NCT02291549|38830284|FG001|Overall Study|Lost to Follow-up|0|||
16092933|NCT02291549|38830283|FG000|Overall Study|Withdrawal by Subject|0|||
16092934|NCT02291549|38830284|FG001|Overall Study|Withdrawal by Subject|1|||
16092935|NCT00141271|38830288|FG000|Overall Study|Adverse Event|31|||
16205579|NCT04397796|39229869|FG000|Overall Study|Death|3|||
16205580|NCT04397796|39229870|FG001|Overall Study|Death|1|||
16205581|NCT01354431|39229871|FG000|Pre-Treatment Period|Not reported|1|||
16205582|NCT01354431|39229872|FG001|Pre-Treatment Period|Not reported|0|||
16205583|NCT01354431|39229873|FG002|Pre-Treatment Period|Not reported|0|||
16205584|NCT01354431|39229871|FG000|Treatment Period|Disease Progression|50|||
16205585|NCT01354431|39229872|FG001|Treatment Period|Disease Progression|40|||
16205586|NCT01354431|39229873|FG002|Treatment Period|Disease Progression|44|||
16205587|NCT01354431|39229871|FG000|Treatment Period|Study Drug Toxicity|5|||
16519475|NCT03304379|40368659|FG002|Overall Study|Lack of Efficacy|20|||
16519476|NCT03304379|40368660|FG003|Overall Study|Lack of Efficacy|0|||
16519477|NCT03304379|40368661|FG004|Overall Study|Lack of Efficacy|0|||
16519478|NCT03304379|40368657|FG000|Overall Study|Physician Decision|6|||
16519479|NCT03304379|40368658|FG001|Overall Study|Physician Decision|10|||
16519480|NCT03304379|40368659|FG002|Overall Study|Physician Decision|6|||
16519481|NCT03304379|40368660|FG003|Overall Study|Physician Decision|9|||
16519482|NCT03304379|40368661|FG004|Overall Study|Physician Decision|10|||
16519483|NCT03304379|40368657|FG000|Overall Study|Withdrawal by Subject|26|||
16205588|NCT01354431|39229872|FG001|Treatment Period|Study Drug Toxicity|8|||
16205589|NCT01354431|39229873|FG002|Treatment Period|Study Drug Toxicity|4|||
16205590|NCT01354431|39229871|FG000|Treatment Period|Death|0|||
16519484|NCT03304379|40368658|FG001|Overall Study|Withdrawal by Subject|58|||
16519485|NCT03304379|40368659|FG002|Overall Study|Withdrawal by Subject|66|||
16092936|NCT00141271|38830289|FG001|Overall Study|Adverse Event|19|||
16092937|NCT00141271|38830290|FG002|Overall Study|Adverse Event|17|||
16205591|NCT01354431|39229872|FG001|Treatment Period|Death|1|||
16205592|NCT01354431|39229873|FG002|Treatment Period|Death|0|||
16205593|NCT01354431|39229871|FG000|Treatment Period|AE unrelated to study drug|1|||
16519486|NCT03304379|40368660|FG003|Overall Study|Withdrawal by Subject|3|||
16519487|NCT03304379|40368661|FG004|Overall Study|Withdrawal by Subject|5|||
16205594|NCT01354431|39229872|FG001|Treatment Period|AE unrelated to study drug|2|||
16205595|NCT01354431|39229873|FG002|Treatment Period|AE unrelated to study drug|5|||
16205596|NCT01354431|39229871|FG000|Treatment Period|Participant request to discontinue|2|||
16205597|NCT01354431|39229872|FG001|Treatment Period|Participant request to discontinue|2|||
16205598|NCT01354431|39229873|FG002|Treatment Period|Participant request to discontinue|1|||
16205599|NCT01354431|39229871|FG000|Treatment Period|Participant withdrew consent|0|||
16205600|NCT01354431|39229872|FG001|Treatment Period|Participant withdrew consent|1|||
16205601|NCT01354431|39229873|FG002|Treatment Period|Participant withdrew consent|0|||
16205602|NCT01354431|39229871|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
16205603|NCT01354431|39229872|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
16205604|NCT01354431|39229873|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
16205605|NCT00949910|39229874|FG000|Overall Study|Progressive Disease|3750|||
16205606|NCT00949910|39229874|FG000|Overall Study|Symptomatic Deterioration|1088|||
16205607|NCT00949910|39229874|FG000|Overall Study|Lost to Follow-up|100|||
16205608|NCT00949910|39229874|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
16205609|NCT00949910|39229874|FG000|Overall Study|Participant Refusal|390|||
16205610|NCT00949910|39229874|FG000|Overall Study|Death Due to Malignant Disease|456|||
16205611|NCT00949910|39229874|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
16205612|NCT00949910|39229874|FG000|Overall Study|Death Due to Adverse Event|115|||
16205613|NCT00949910|39229874|FG000|Overall Study|Death Due to Toxicity|3|||
16205614|NCT00949910|39229874|FG000|Overall Study|Death from Unknown Cause|5|||
16205615|NCT00949910|39229874|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
16205616|NCT00949910|39229874|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
16205617|NCT00949910|39229874|FG000|Overall Study|Switched to Commercial Treatment|4|||
16205618|NCT00949910|39229874|FG000|Overall Study|Violation of Eligibility|23|||
16205619|NCT00949910|39229874|FG000|Overall Study|Logistical Reasons|13|||
16205620|NCT00949910|39229874|FG000|Overall Study|Non-Compliance|10|||
16205621|NCT00949910|39229874|FG000|Overall Study|Prolonged Dosing Interruption|4|||
16205622|NCT00949910|39229874|FG000|Overall Study|Adverse Event|83|||
16205623|NCT00949910|39229874|FG000|Overall Study|Serious Adverse Event|6|||
16205624|NCT00949910|39229874|FG000|Overall Study|Physician/Participant Decision|7|||
16205625|NCT00949910|39229874|FG000|Overall Study|Other|4|||
16205626|NCT00949910|39229874|FG000|Overall Study|No Data|9|||
16205627|NCT02384395|39229875|FG000|Overall Study|Physician Decision|4|||
16205628|NCT02384395|39229875|FG000|Overall Study|Withdrawal by Subject|3|||
16205629|NCT02384395|39229875|FG000|Overall Study|Lost to Follow-up|3|||
16205630|NCT00807014|39229876|FG000|Overall Study|Participant Considered Disease Cured|13|||
16205631|NCT00807014|39229877|FG001|Overall Study|Participant Considered Disease Cured|2|||
16205632|NCT00807014|39229876|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
16205633|NCT00807014|39229877|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
16205634|NCT00807014|39229876|FG000|Overall Study|Protocol Violation|2|||
16205635|NCT00807014|39229877|FG001|Overall Study|Protocol Violation|8|||
16205636|NCT00807014|39229876|FG000|Overall Study|Adverse Event|0|||
16205637|NCT00807014|39229877|FG001|Overall Study|Adverse Event|2|||
16205638|NCT00807014|39229876|FG000|Overall Study|Lost to Follow-up|9|||
16519488|NCT03304379|40368657|FG000|Overall Study|Lost to Follow-up|8|||
16519489|NCT03304379|40368658|FG001|Overall Study|Lost to Follow-up|24|||
16519490|NCT03304379|40368659|FG002|Overall Study|Lost to Follow-up|35|||
16519491|NCT03304379|40368660|FG003|Overall Study|Lost to Follow-up|4|||
16519492|NCT03304379|40368661|FG004|Overall Study|Lost to Follow-up|0|||
16519493|NCT03304379|40368657|FG000|Overall Study|Death|1|||
16519494|NCT03304379|40368658|FG001|Overall Study|Death|2|||
16519495|NCT03304379|40368659|FG002|Overall Study|Death|0|||
16519496|NCT03304379|40368660|FG003|Overall Study|Death|0|||
16519497|NCT03304379|40368661|FG004|Overall Study|Death|0|||
16519498|NCT03304379|40368657|FG000|Overall Study|Other|0|||
16519499|NCT03304379|40368658|FG001|Overall Study|Other|1|||
16519500|NCT03304379|40368659|FG002|Overall Study|Other|0|||
16519501|NCT03304379|40368660|FG003|Overall Study|Other|0|||
16519502|NCT03304379|40368661|FG004|Overall Study|Other|0|||
16519503|NCT02265705|40368662|FG000|Treatment Period Week 0-24|Adverse Event|3|||
16519504|NCT02265705|40368663|FG001|Treatment Period Week 0-24|Adverse Event|2|||
16519505|NCT02265705|40368664|FG002|Treatment Period Week 0-24|Adverse Event|0|||
16519506|NCT02265705|40368665|FG003|Treatment Period Week 0-24|Adverse Event|0|||
16519507|NCT02265705|40368666|FG004|Treatment Period Week 0-24|Adverse Event|0|||
16519508|NCT02265705|40368667|FG005|Treatment Period Week 0-24|Adverse Event|0|||
16519509|NCT02265705|40368668|FG006|Treatment Period Week 0-24|Adverse Event|0|||
16519510|NCT02265705|40368662|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
16519511|NCT02265705|40368663|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
16519512|NCT02265705|40368664|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
16519513|NCT02265705|40368665|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
16519514|NCT02265705|40368666|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
16519515|NCT02265705|40368667|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
16519516|NCT02265705|40368668|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
16519517|NCT02265705|40368662|FG000|Treatment Period Week 0-24|Physician Decision|1|||
16092938|NCT00141271|38830288|FG000|Overall Study|Laboratory Abnormality|2|||
16092939|NCT00141271|38830289|FG001|Overall Study|Laboratory Abnormality|1|||
16092940|NCT00141271|38830290|FG002|Overall Study|Laboratory Abnormality|1|||
16092941|NCT00141271|38830288|FG000|Overall Study|Lack of Efficacy|7|||
16092942|NCT00141271|38830289|FG001|Overall Study|Lack of Efficacy|7|||
16092943|NCT00141271|38830290|FG002|Overall Study|Lack of Efficacy|3|||
16092944|NCT00141271|38830288|FG000|Overall Study|Lost to Follow-up|15|||
16092945|NCT00141271|38830289|FG001|Overall Study|Lost to Follow-up|15|||
16092946|NCT00141271|38830290|FG002|Overall Study|Lost to Follow-up|21|||
16092947|NCT00141271|38830288|FG000|Overall Study|Withdrawal by Subject|14|||
16092948|NCT00141271|38830289|FG001|Overall Study|Withdrawal by Subject|9|||
16092949|NCT00141271|38830290|FG002|Overall Study|Withdrawal by Subject|10|||
16092950|NCT00141271|38830288|FG000|Overall Study|Other|11|||
16092951|NCT00141271|38830289|FG001|Overall Study|Other|12|||
16092952|NCT00141271|38830290|FG002|Overall Study|Other|5|||
16092953|NCT01278030|38830297|FG000|Overall Study|Withdrawal by Subject|8|||
16092954|NCT01278030|38830298|FG001|Overall Study|Withdrawal by Subject|4|||
16092955|NCT01123200|38830299|FG000|Overall Study|Withdrawal by Subject|1|||
16092956|NCT01528605|38830300|FG000|Overall Study|Lost to Follow-up|1|||
16092957|NCT01528605|38830301|FG001|Overall Study|Lost to Follow-up|0|||
16092958|NCT01528605|38830302|FG002|Overall Study|Lost to Follow-up|1|||
16092959|NCT01528605|38830303|FG003|Overall Study|Lost to Follow-up|1|||
16092960|NCT01528605|38830304|FG004|Overall Study|Lost to Follow-up|0|||
16323592|NCT01953601|39670959|FG002|Part 1 (Base Study)|Physician Decision|4|||
16519518|NCT02265705|40368663|FG001|Treatment Period Week 0-24|Physician Decision|0|||
16519519|NCT02265705|40368664|FG002|Treatment Period Week 0-24|Physician Decision|0|||
16519520|NCT02265705|40368665|FG003|Treatment Period Week 0-24|Physician Decision|0|||
16519521|NCT02265705|40368666|FG004|Treatment Period Week 0-24|Physician Decision|0|||
16519522|NCT02265705|40368667|FG005|Treatment Period Week 0-24|Physician Decision|0|||
16519523|NCT02265705|40368668|FG006|Treatment Period Week 0-24|Physician Decision|0|||
16519524|NCT02265705|40368662|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
16519525|NCT02265705|40368663|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
16519526|NCT02265705|40368664|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
16519527|NCT02265705|40368665|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
16519528|NCT02265705|40368666|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
16519529|NCT02265705|40368667|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
16519530|NCT02265705|40368668|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
16519531|NCT02265705|40368662|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
16519532|NCT02265705|40368663|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
16323593|NCT01953601|39670957|FG000|Part 1 (Base Study)|Screen failure|1|||
16323594|NCT01953601|39670958|FG001|Part 1 (Base Study)|Screen failure|0|||
16323595|NCT01953601|39670959|FG002|Part 1 (Base Study)|Screen failure|1|||
16323596|NCT01953601|39670957|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
16323597|NCT01953601|39670958|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
16323598|NCT01953601|39670959|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
16323599|NCT01953601|39670957|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
16323600|NCT01953601|39670958|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
16519533|NCT02265705|40368664|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
16519534|NCT02265705|40368665|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
16092961|NCT01528605|38830305|FG005|Overall Study|Lost to Follow-up|0|||
16092962|NCT01528605|38830300|FG000|Overall Study|Death|1|||
16092963|NCT01528605|38830301|FG001|Overall Study|Death|0|||
16092964|NCT01528605|38830302|FG002|Overall Study|Death|0|||
16092965|NCT01528605|38830303|FG003|Overall Study|Death|0|||
16323601|NCT01953601|39670959|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
16092966|NCT01528605|38830304|FG004|Overall Study|Death|0|||
16092967|NCT01528605|38830305|FG005|Overall Study|Death|0|||
16519535|NCT02265705|40368666|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
16519536|NCT02265705|40368667|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
16205639|NCT00807014|39229877|FG001|Overall Study|Lost to Follow-up|7|||
16205640|NCT00807014|39229876|FG000|Overall Study|Recovery|1|||
16205641|NCT00807014|39229877|FG001|Overall Study|Recovery|0|||
16205642|NCT00807014|39229876|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
16205643|NCT00807014|39229877|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
16205644|NCT00965146|39229878|FG000|Overall Study|Death|7|||
16205645|NCT00965146|39229878|FG000|Overall Study|Lost to Follow-up|22|||
16205646|NCT00965146|39229878|FG000|Overall Study|Withdrawal by Subject|17|||
16205647|NCT00965146|39229878|FG000|Overall Study|Unable to return|1|||
16205648|NCT00965146|39229878|FG000|Overall Study|Unwilling to return|11|||
16205649|NCT00965146|39229878|FG000|Overall Study|Intercurrent illness|1|||
16205650|NCT00965146|39229878|FG000|Overall Study|Revision / Removal of Study Implant|6|||
16205651|NCT00965146|39229878|FG000|Overall Study|Overall Study Termination|145|||
16205652|NCT03559192|39229884|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
16205653|NCT03559192|39229885|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
16205654|NCT03559192|39229886|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
16205655|NCT03559192|39229884|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
16205656|NCT03559192|39229885|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
16205657|NCT03559192|39229886|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
16205658|NCT03559192|39229884|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
16205659|NCT03559192|39229885|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
16205660|NCT03559192|39229886|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
16205661|NCT03559192|39229884|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
16205662|NCT03559192|39229885|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
16205663|NCT03559192|39229886|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
16205664|NCT03559192|39229884|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
16205665|NCT03559192|39229885|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
16205666|NCT03559192|39229886|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
16519537|NCT02265705|40368668|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
16519538|NCT02265705|40368662|FG000|Rescue Period|Withdrawal by Subject|0|||
16519539|NCT02265705|40368663|FG001|Rescue Period|Withdrawal by Subject|0|||
16519540|NCT02265705|40368664|FG002|Rescue Period|Withdrawal by Subject|1|||
16519541|NCT02265705|40368665|FG003|Rescue Period|Withdrawal by Subject|0|||
16519542|NCT02265705|40368666|FG004|Rescue Period|Withdrawal by Subject|0|||
16519543|NCT02265705|40368667|FG005|Rescue Period|Withdrawal by Subject|0|||
16519544|NCT02265705|40368668|FG006|Rescue Period|Withdrawal by Subject|0|||
16519545|NCT02265705|40368662|FG000|Rescue Period|Death|0|||
16519546|NCT02265705|40368663|FG001|Rescue Period|Death|0|||
16519547|NCT02265705|40368664|FG002|Rescue Period|Death|1|||
16519548|NCT02265705|40368665|FG003|Rescue Period|Death|0|||
16519549|NCT02265705|40368666|FG004|Rescue Period|Death|0|||
16519550|NCT02265705|40368667|FG005|Rescue Period|Death|0|||
16519551|NCT02265705|40368668|FG006|Rescue Period|Death|0|||
16519552|NCT02265705|40368662|FG000|Rescue Period|Lack of Efficacy|0|||
16519553|NCT02265705|40368663|FG001|Rescue Period|Lack of Efficacy|0|||
16519554|NCT02265705|40368664|FG002|Rescue Period|Lack of Efficacy|1|||
16519555|NCT02265705|40368665|FG003|Rescue Period|Lack of Efficacy|0|||
16519556|NCT02265705|40368666|FG004|Rescue Period|Lack of Efficacy|0|||
16519557|NCT02265705|40368667|FG005|Rescue Period|Lack of Efficacy|0|||
16519558|NCT02265705|40368668|FG006|Rescue Period|Lack of Efficacy|0|||
16519559|NCT02265705|40368662|FG000|Open Label Period|Adverse Event|0|||
16519560|NCT02265705|40368663|FG001|Open Label Period|Adverse Event|0|||
16519561|NCT02265705|40368664|FG002|Open Label Period|Adverse Event|0|||
16519562|NCT02265705|40368665|FG003|Open Label Period|Adverse Event|2|||
16519563|NCT02265705|40368666|FG004|Open Label Period|Adverse Event|2|||
16519564|NCT02265705|40368667|FG005|Open Label Period|Adverse Event|0|||
16519565|NCT02265705|40368668|FG006|Open Label Period|Adverse Event|0|||
16519566|NCT02265705|40368662|FG000|Open Label Period|Physician Decision|0|||
16519567|NCT02265705|40368663|FG001|Open Label Period|Physician Decision|0|||
16519568|NCT02265705|40368664|FG002|Open Label Period|Physician Decision|0|||
16519569|NCT02265705|40368665|FG003|Open Label Period|Physician Decision|0|||
16519570|NCT02265705|40368666|FG004|Open Label Period|Physician Decision|1|||
16519571|NCT02265705|40368667|FG005|Open Label Period|Physician Decision|0|||
16205667|NCT03559192|39229884|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
16205668|NCT03559192|39229885|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
16205669|NCT03559192|39229886|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
16205670|NCT03559192|39229884|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
16519572|NCT02265705|40368668|FG006|Open Label Period|Physician Decision|0|||
16519573|NCT02265705|40368662|FG000|Open Label Period|Withdrawal by Subject|0|||
16519574|NCT02265705|40368663|FG001|Open Label Period|Withdrawal by Subject|0|||
16519575|NCT02265705|40368664|FG002|Open Label Period|Withdrawal by Subject|0|||
16519576|NCT02265705|40368665|FG003|Open Label Period|Withdrawal by Subject|0|||
16519577|NCT02265705|40368666|FG004|Open Label Period|Withdrawal by Subject|2|||
16519578|NCT02265705|40368667|FG005|Open Label Period|Withdrawal by Subject|0|||
16519579|NCT02265705|40368668|FG006|Open Label Period|Withdrawal by Subject|0|||
16519580|NCT02265705|40368662|FG000|Follow-up Period|Sponsor Decision|0|||
16519581|NCT02265705|40368663|FG001|Follow-up Period|Sponsor Decision|0|||
16519582|NCT02265705|40368664|FG002|Follow-up Period|Sponsor Decision|0|||
16519583|NCT02265705|40368665|FG003|Follow-up Period|Sponsor Decision|0|||
16519584|NCT02265705|40368666|FG004|Follow-up Period|Sponsor Decision|0|||
16519585|NCT02265705|40368667|FG005|Follow-up Period|Sponsor Decision|1|||
16519586|NCT02265705|40368668|FG006|Follow-up Period|Sponsor Decision|6|||
16519587|NCT02265705|40368662|FG000|Follow-up Period|Adverse Event|0|||
16519588|NCT02265705|40368663|FG001|Follow-up Period|Adverse Event|0|||
16519589|NCT02265705|40368664|FG002|Follow-up Period|Adverse Event|0|||
16519590|NCT02265705|40368665|FG003|Follow-up Period|Adverse Event|0|||
16519591|NCT02265705|40368666|FG004|Follow-up Period|Adverse Event|0|||
16519592|NCT02265705|40368667|FG005|Follow-up Period|Adverse Event|0|||
16519593|NCT02265705|40368668|FG006|Follow-up Period|Adverse Event|3|||
16519594|NCT02265705|40368662|FG000|Follow-up Period|Physician Decision|0|||
16519595|NCT02265705|40368663|FG001|Follow-up Period|Physician Decision|0|||
16519596|NCT02265705|40368664|FG002|Follow-up Period|Physician Decision|0|||
16519597|NCT02265705|40368665|FG003|Follow-up Period|Physician Decision|0|||
16519598|NCT02265705|40368666|FG004|Follow-up Period|Physician Decision|0|||
16519599|NCT02265705|40368667|FG005|Follow-up Period|Physician Decision|0|||
16519600|NCT02265705|40368668|FG006|Follow-up Period|Physician Decision|1|||
16519601|NCT02265705|40368662|FG000|Follow-up Period|Withdrawal by Subject|0|||
16519602|NCT02265705|40368663|FG001|Follow-up Period|Withdrawal by Subject|0|||
16205671|NCT03559192|39229885|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
16205672|NCT03559192|39229886|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
16205673|NCT03559192|39229884|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
16205674|NCT03559192|39229885|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
16205675|NCT03559192|39229886|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
16323602|NCT01953601|39670957|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
16323603|NCT01953601|39670958|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
16323604|NCT01953601|39670959|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
16323605|NCT01953601|39670957|FG000|Part 1 (Base Study)|Subject moved|2|||
16519603|NCT02265705|40368664|FG002|Follow-up Period|Withdrawal by Subject|0|||
16519604|NCT02265705|40368665|FG003|Follow-up Period|Withdrawal by Subject|0|||
16323606|NCT01953601|39670958|FG001|Part 1 (Base Study)|Subject moved|2|||
16323607|NCT01953601|39670959|FG002|Part 1 (Base Study)|Subject moved|1|||
16323608|NCT01953601|39670957|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
16323609|NCT01953601|39670958|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
16323610|NCT01953601|39670959|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
16323611|NCT01953601|39670957|FG000|Part 2 (Extension Study)|Adverse Event|1|||
16323612|NCT01953601|39670958|FG001|Part 2 (Extension Study)|Adverse Event|1|||
16323613|NCT01953601|39670959|FG002|Part 2 (Extension Study)|Adverse Event|10|||
16323614|NCT01953601|39670957|FG000|Part 2 (Extension Study)|Death|0|||
16323615|NCT01953601|39670958|FG001|Part 2 (Extension Study)|Death|3|||
16323616|NCT01953601|39670959|FG002|Part 2 (Extension Study)|Death|0|||
16323617|NCT01953601|39670957|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
16323618|NCT01953601|39670958|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
16395741|NCT01846299|39931149|FG000|Overall Study|Adverse Event|2|||
16519605|NCT02265705|40368666|FG004|Follow-up Period|Withdrawal by Subject|0|||
16519606|NCT02265705|40368667|FG005|Follow-up Period|Withdrawal by Subject|0|||
16519607|NCT02265705|40368668|FG006|Follow-up Period|Withdrawal by Subject|1|||
16519608|NCT01336738|40368674|FG000|Overall Study|Adverse Event|0|||
16519609|NCT01336738|40368675|FG001|Overall Study|Adverse Event|3|||
16519610|NCT01336738|40368676|FG002|Overall Study|Adverse Event|2|||
16519611|NCT01336738|40368677|FG003|Overall Study|Adverse Event|1|||
16519612|NCT01336738|40368678|FG004|Overall Study|Adverse Event|3|||
16519613|NCT01336738|40368674|FG000|Overall Study|Lost to Follow-up|2|||
16519614|NCT01336738|40368675|FG001|Overall Study|Lost to Follow-up|1|||
16519615|NCT01336738|40368676|FG002|Overall Study|Lost to Follow-up|2|||
16519616|NCT01336738|40368677|FG003|Overall Study|Lost to Follow-up|2|||
16519617|NCT01336738|40368678|FG004|Overall Study|Lost to Follow-up|2|||
16323619|NCT01953601|39670959|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
16323620|NCT01953601|39670957|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
16323621|NCT01953601|39670958|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
16323622|NCT01953601|39670959|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
16519618|NCT01336738|40368674|FG000|Overall Study|Did not meet entrance criteria|0|||
16519619|NCT01336738|40368675|FG001|Overall Study|Did not meet entrance criteria|1|||
16519620|NCT01336738|40368676|FG002|Overall Study|Did not meet entrance criteria|0|||
16519621|NCT01336738|40368677|FG003|Overall Study|Did not meet entrance criteria|0|||
16323623|NCT01953601|39670957|FG000|Part 2 (Extension Study)|Physician Decision|2|||
16323624|NCT01953601|39670958|FG001|Part 2 (Extension Study)|Physician Decision|0|||
16323625|NCT01953601|39670959|FG002|Part 2 (Extension Study)|Physician Decision|2|||
16323626|NCT01953601|39670957|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
16323627|NCT01953601|39670958|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
16323628|NCT01953601|39670959|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
16323629|NCT01953601|39670957|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
16092968|NCT04328467|38830306|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
16323630|NCT01953601|39670958|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
16323631|NCT01953601|39670959|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
16323632|NCT01953601|39670957|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
16323633|NCT01953601|39670958|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
16323634|NCT01953601|39670959|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
16323635|NCT01953601|39670957|FG000|Part 2 (Extension Study)|Subject moved|0|||
16323636|NCT01953601|39670958|FG001|Part 2 (Extension Study)|Subject moved|0|||
16323637|NCT01953601|39670959|FG002|Part 2 (Extension Study)|Subject moved|1|||
16323638|NCT01953601|39670957|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
16519622|NCT01336738|40368678|FG004|Overall Study|Did not meet entrance criteria|0|||
16519623|NCT01336738|40368674|FG000|Overall Study|Protocol Violation|0|||
16519624|NCT01336738|40368675|FG001|Overall Study|Protocol Violation|1|||
16519625|NCT01336738|40368676|FG002|Overall Study|Protocol Violation|0|||
16519626|NCT01336738|40368677|FG003|Overall Study|Protocol Violation|0|||
16519627|NCT01336738|40368678|FG004|Overall Study|Protocol Violation|0|||
16519628|NCT01336738|40368674|FG000|Overall Study|Withdrawal by Subject|2|||
16519629|NCT01336738|40368675|FG001|Overall Study|Withdrawal by Subject|0|||
16519630|NCT01336738|40368676|FG002|Overall Study|Withdrawal by Subject|2|||
16519631|NCT01336738|40368677|FG003|Overall Study|Withdrawal by Subject|1|||
16519632|NCT01336738|40368678|FG004|Overall Study|Withdrawal by Subject|1|||
16519633|NCT01336738|40368674|FG000|Overall Study|Other|3|||
16519634|NCT01336738|40368675|FG001|Overall Study|Other|3|||
16519635|NCT01336738|40368676|FG002|Overall Study|Other|2|||
16519636|NCT01336738|40368677|FG003|Overall Study|Other|3|||
16519637|NCT01336738|40368678|FG004|Overall Study|Other|4|||
16519638|NCT01101841|40372068|FG000|Overall Study|Adverse Event|15|||
16519639|NCT01101841|40372069|FG001|Overall Study|Adverse Event|15|||
16519640|NCT01101841|40372068|FG000|Overall Study|Lost to Follow-up|9|||
16519641|NCT01101841|40372069|FG001|Overall Study|Lost to Follow-up|3|||
16519642|NCT01101841|40372068|FG000|Overall Study|Withdrawal by Subject|21|||
16205676|NCT03559192|39229884|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
16205677|NCT03559192|39229885|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
16205678|NCT03559192|39229886|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
16205679|NCT00967226|39229887|FG000|Overall Study|Adverse Event|0|||
16205680|NCT00967226|39229888|FG001|Overall Study|Adverse Event|5|||
16205681|NCT00967226|39229887|FG000|Overall Study|Protocol Violation|2|||
16205682|NCT00967226|39229888|FG001|Overall Study|Protocol Violation|0|||
16205683|NCT00967226|39229887|FG000|Overall Study|Physician Decision|0|||
16205684|NCT00967226|39229888|FG001|Overall Study|Physician Decision|1|||
16205685|NCT00047008|39229889|FG000|Overall Study|Withdrawn consent|2|||
16205686|NCT00047008|39229890|FG001|Overall Study|Withdrawn consent|3|||
16205687|NCT00047008|39229889|FG000|Overall Study|Ineligible|9|||
16205688|NCT00047008|39229890|FG001|Overall Study|Ineligible|8|||
16205689|NCT00606177|39229894|FG000|Overall Study|Adverse Event|9|||
16205690|NCT00606177|39229895|FG001|Overall Study|Adverse Event|5|||
16205691|NCT00606177|39229894|FG000|Overall Study|Lack of Efficacy|3|||
16205692|NCT00606177|39229895|FG001|Overall Study|Lack of Efficacy|7|||
16205693|NCT00606177|39229894|FG000|Overall Study|Physician Decision|1|||
16323639|NCT01953601|39670958|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
16323640|NCT01953601|39670959|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
16323641|NCT02782923|39670960|FG000|Overall Study|Lost to Follow-up|15|||
16323642|NCT02792192|39670961|FG000|Overall Study|Death|1|||
16323643|NCT02792192|39670962|FG001|Overall Study|Death|0|||
16323644|NCT02792192|39670963|FG002|Overall Study|Death|0|||
16323645|NCT02792192|39670964|FG003|Overall Study|Death|0|||
16323646|NCT02792192|39670961|FG000|Overall Study|Informed Consent Withdrawn|4|||
16323647|NCT02792192|39670962|FG001|Overall Study|Informed Consent Withdrawn|0|||
16323648|NCT02792192|39670963|FG002|Overall Study|Informed Consent Withdrawn|0|||
16323649|NCT02792192|39670964|FG003|Overall Study|Informed Consent Withdrawn|0|||
16519643|NCT01101841|40372069|FG001|Overall Study|Withdrawal by Subject|40|||
16519644|NCT01101841|40372068|FG000|Overall Study|Protocol Violation|1|||
16205694|NCT00606177|39229895|FG001|Overall Study|Physician Decision|0|||
16205695|NCT00606177|39229894|FG000|Overall Study|Protocol Violation|1|||
16205696|NCT00606177|39229895|FG001|Overall Study|Protocol Violation|4|||
16519645|NCT01101841|40372069|FG001|Overall Study|Protocol Violation|1|||
16205697|NCT00606177|39229894|FG000|Overall Study|Withdrawal by Subject|5|||
16323650|NCT02792192|39670961|FG000|Overall Study|Physician Decision|1|||
16323651|NCT02792192|39670962|FG001|Overall Study|Physician Decision|0|||
16323652|NCT02792192|39670963|FG002|Overall Study|Physician Decision|0|||
16323653|NCT02792192|39670964|FG003|Overall Study|Physician Decision|0|||
16323654|NCT02792192|39670961|FG000|Overall Study|Progressive Disease|0|||
16323655|NCT02792192|39670962|FG001|Overall Study|Progressive Disease|1|||
16323656|NCT02792192|39670963|FG002|Overall Study|Progressive Disease|0|||
16323657|NCT02792192|39670964|FG003|Overall Study|Progressive Disease|0|||
16323658|NCT02792192|39670961|FG000|Overall Study|Study Terminated By Sponsor|6|||
16323659|NCT02792192|39670962|FG001|Overall Study|Study Terminated By Sponsor|10|||
16323660|NCT02792192|39670963|FG002|Overall Study|Study Terminated By Sponsor|0|||
16323661|NCT02792192|39670964|FG003|Overall Study|Study Terminated By Sponsor|0|||
16323662|NCT01482065|39670965|FG000|Overall Study|Withdrawal by Subject|0|||
16323663|NCT01482065|39670966|FG001|Overall Study|Withdrawal by Subject|1|||
16323664|NCT00237458|39670967|FG000|Overall Study|Lack of Efficacy|1|||
16323665|NCT00237458|39670967|FG000|Overall Study|Adverse Event|1|||
16323666|NCT00237458|39670967|FG000|Overall Study|Withdrawal by Subject|1|||
16323667|NCT00570141|39670970|FG000|Overall Study|Adverse Event|1|||
16323668|NCT00570141|39670970|FG000|Overall Study|Missed visits|1|||
16519646|NCT01101841|40372068|FG000|Overall Study|Physician Decision|0|||
16323669|NCT00570141|39670970|FG000|Overall Study|Lost to Follow-up|1|||
16323670|NCT02276560|39670975|FG000|Overall Study|Adverse Event|1|||
16323671|NCT02276560|39670976|FG001|Overall Study|Adverse Event|0|||
16519647|NCT01101841|40372069|FG001|Overall Study|Physician Decision|2|||
16519648|NCT01101841|40372068|FG000|Overall Study|Lack of Efficacy|0|||
16519649|NCT01101841|40372069|FG001|Overall Study|Lack of Efficacy|2|||
16519650|NCT01101841|40372068|FG000|Overall Study|Other|0|||
16519651|NCT01101841|40372069|FG001|Overall Study|Other|1|||
16519652|NCT01101841|40372068|FG000|Overall Study|Suicidality Tracking Scale|3|||
16519653|NCT01101841|40372069|FG001|Overall Study|Suicidality Tracking Scale|1|||
16519654|NCT01101841|40372068|FG000|Overall Study|Eligibility Criteria|1|||
16519655|NCT01101841|40372069|FG001|Overall Study|Eligibility Criteria|2|||
16519656|NCT00861705|40372070|FG000|Overall Study|Never Began Treatment|7|||
16519657|NCT00861705|40372071|FG001|Overall Study|Never Began Treatment|3|||
16519658|NCT00861705|40372072|FG002|Overall Study|Never Began Treatment|0|||
16519659|NCT00861705|40372073|FG003|Overall Study|Never Began Treatment|1|||
16519660|NCT01181895|40372076|FG000|Overall Study|Adverse Event|3|||
16519661|NCT01181895|40372077|FG001|Overall Study|Adverse Event|1|||
16519662|NCT01181895|40372078|FG002|Overall Study|Adverse Event|1|||
16519663|NCT01181895|40372076|FG000|Overall Study|Lack of Efficacy|8|||
16519664|NCT01181895|40372077|FG001|Overall Study|Lack of Efficacy|9|||
16519665|NCT01181895|40372078|FG002|Overall Study|Lack of Efficacy|9|||
16519666|NCT01181895|40372076|FG000|Overall Study|Protocol Violation|2|||
16205698|NCT00606177|39229895|FG001|Overall Study|Withdrawal by Subject|6|||
16323672|NCT02276560|39670977|FG002|Overall Study|Adverse Event|0|||
16323673|NCT02048826|39670978|FG000|Overall Study|Withdrawal by Subject|1|||
16323674|NCT02048826|39670979|FG001|Overall Study|Withdrawal by Subject|0|||
16519667|NCT01181895|40372077|FG001|Overall Study|Protocol Violation|1|||
16519668|NCT01181895|40372078|FG002|Overall Study|Protocol Violation|0|||
16519669|NCT01181895|40372076|FG000|Overall Study|Lost to Follow-up|0|||
16519670|NCT01181895|40372077|FG001|Overall Study|Lost to Follow-up|1|||
16519671|NCT01181895|40372078|FG002|Overall Study|Lost to Follow-up|2|||
16519672|NCT01181895|40372076|FG000|Overall Study|Investigator Discretion|1|||
16519673|NCT01181895|40372077|FG001|Overall Study|Investigator Discretion|2|||
16519674|NCT01181895|40372078|FG002|Overall Study|Investigator Discretion|1|||
16205699|NCT00606177|39229894|FG000|Overall Study|Progression to depressive phase|6|||
16205700|NCT00606177|39229895|FG001|Overall Study|Progression to depressive phase|1|||
16205701|NCT00606177|39229894|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
16205702|NCT00606177|39229895|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
16205703|NCT00606177|39229894|FG000|Overall Study|Change of residence or other commitments|1|||
16205704|NCT00606177|39229895|FG001|Overall Study|Change of residence or other commitments|1|||
16323675|NCT02752165|39670980|FG000|Overall Study|Withdrawal by Subject|6|||
16323676|NCT02752165|39670981|FG001|Overall Study|Withdrawal by Subject|6|||
16323677|NCT02752165|39670980|FG000|Overall Study|Protocol Violation|6|||
16519675|NCT01181895|40372076|FG000|Overall Study|Withdrawal by Subject|3|||
16323678|NCT02752165|39670981|FG001|Overall Study|Protocol Violation|5|||
16092969|NCT04328467|38830307|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
16092970|NCT04328467|38830308|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
16092971|NCT00952523|38830311|FG000|Overall Study|Withdrawal by Subject|7|||
16323679|NCT02752165|39670980|FG000|Overall Study|Lost to Follow-up|33|||
16092972|NCT03693989|38830312|FG000|Overall Study|Protocol Violation|3|||
16205705|NCT03862495|39229896|FG000|Overall Study|Lost to Follow-up|37|||
16323680|NCT02752165|39670981|FG001|Overall Study|Lost to Follow-up|38|||
16323681|NCT00960986|39670987|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
16323682|NCT00960986|39670988|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
16323683|NCT00960986|39670989|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
16519676|NCT01181895|40372077|FG001|Overall Study|Withdrawal by Subject|0|||
16519677|NCT01181895|40372078|FG002|Overall Study|Withdrawal by Subject|5|||
16323684|NCT00960986|39670990|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
16323685|NCT00960986|39670987|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
16323686|NCT00960986|39670988|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
16323687|NCT00960986|39670989|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
16323688|NCT00960986|39670990|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
16323689|NCT00960986|39670987|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
16323690|NCT00960986|39670988|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
16323691|NCT00960986|39670989|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
16395742|NCT01846299|39931150|FG001|Overall Study|Adverse Event|0|||
16395743|NCT01532921|39931152|FG000|Overall Study|Death|3|||
16519678|NCT02167035|40372087|FG000|Overall Study|Adverse Event|2|||
16519679|NCT02167035|40372088|FG001|Overall Study|Adverse Event|2|||
16519680|NCT02167035|40372087|FG000|Overall Study|Lost to Follow-up|3|||
16323692|NCT00960986|39670990|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
16395744|NCT01532921|39931152|FG000|Overall Study|Withdrawal by Subject|2|||
16519681|NCT02167035|40372088|FG001|Overall Study|Lost to Follow-up|3|||
16092973|NCT03693989|38830313|FG001|Overall Study|Protocol Violation|4|||
16092974|NCT00910962|38830317|FG000|Overall Study|Adverse Event|5|||
16092975|NCT00910962|38830318|FG001|Overall Study|Adverse Event|20|||
16519682|NCT02167035|40372087|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
16519683|NCT02167035|40372088|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
16519684|NCT02863354|40372089|FG000|Year 1|Lost to Follow-up|1|||
16519685|NCT02863354|40372090|FG001|Year 1|Lost to Follow-up|1|||
16519686|NCT02863354|40372089|FG000|Year 1|Withdrawal by Subject|3|||
16519687|NCT02863354|40372090|FG001|Year 1|Withdrawal by Subject|0|||
16092976|NCT00910962|38830319|FG002|Overall Study|Adverse Event|17|||
16092977|NCT00910962|38830317|FG000|Overall Study|Protocol Violation|1|||
16092978|NCT00910962|38830318|FG001|Overall Study|Protocol Violation|3|||
16092979|NCT00910962|38830319|FG002|Overall Study|Protocol Violation|3|||
16092980|NCT00910962|38830317|FG000|Overall Study|Lost to Follow-up|0|||
16092981|NCT00910962|38830318|FG001|Overall Study|Lost to Follow-up|3|||
16092982|NCT00910962|38830319|FG002|Overall Study|Lost to Follow-up|1|||
16092983|NCT00910962|38830317|FG000|Overall Study|Physician Decision|0|||
16092984|NCT00910962|38830318|FG001|Overall Study|Physician Decision|6|||
16092985|NCT00910962|38830319|FG002|Overall Study|Physician Decision|6|||
16519688|NCT02863354|40372089|FG000|Year 1|Death|0|||
16519689|NCT02863354|40372090|FG001|Year 1|Death|1|||
16519690|NCT02863354|40372089|FG000|Year 2|Lost to Follow-up|2|||
16092986|NCT00910962|38830317|FG000|Overall Study|Withdrawal by Subject|25|||
16092987|NCT00910962|38830318|FG001|Overall Study|Withdrawal by Subject|32|||
16092988|NCT00910962|38830319|FG002|Overall Study|Withdrawal by Subject|32|||
16092989|NCT00910962|38830317|FG000|Overall Study|Reached defined stopping criteria|12|||
16092990|NCT00910962|38830318|FG001|Overall Study|Reached defined stopping criteria|14|||
16092991|NCT00910962|38830319|FG002|Overall Study|Reached defined stopping criteria|17|||
16092992|NCT03316170|38830327|FG000|Overall Study|Death|1|||
16092993|NCT03316170|38830328|FG001|Overall Study|Death|0|||
16092994|NCT03316170|38830327|FG000|Overall Study|Lost to Follow-up|6|||
16092995|NCT03316170|38830328|FG001|Overall Study|Lost to Follow-up|7|||
16092996|NCT02935673|38830330|FG000|Overall Study|Adverse Event|0|||
16092997|NCT02935673|38830331|FG001|Overall Study|Adverse Event|1|||
16092998|NCT02935673|38830332|FG002|Overall Study|Adverse Event|0|||
16092999|NCT02935673|38830330|FG000|Overall Study|Withdrawal by Subject|1|||
16093000|NCT02935673|38830331|FG001|Overall Study|Withdrawal by Subject|2|||
16093001|NCT02935673|38830332|FG002|Overall Study|Withdrawal by Subject|0|||
16093002|NCT02354417|38830338|FG000|Overall Study|Physician Decision|1|||
16093003|NCT02598388|38830339|FG000|Overall Study|Lost to Follow-up|1|||
16093004|NCT02598388|38830340|FG001|Overall Study|Lost to Follow-up|0|||
16093005|NCT02598388|38830341|FG002|Overall Study|Lost to Follow-up|1|||
16093006|NCT02598388|38830342|FG003|Overall Study|Lost to Follow-up|0|||
16093007|NCT02598388|38830343|FG004|Overall Study|Lost to Follow-up|5|||
16093008|NCT02598388|38830344|FG005|Overall Study|Lost to Follow-up|1|||
16093009|NCT02598388|38830345|FG006|Overall Study|Lost to Follow-up|2|||
16093010|NCT02598388|38830346|FG007|Overall Study|Lost to Follow-up|1|||
16093011|NCT02598388|38830347|FG008|Overall Study|Lost to Follow-up|0|||
16093012|NCT02598388|38830348|FG009|Overall Study|Lost to Follow-up|0|||
16093013|NCT02598388|38830349|FG010|Overall Study|Lost to Follow-up|1|||
16093014|NCT02598388|38830350|FG011|Overall Study|Lost to Follow-up|0|||
16093015|NCT02598388|38830339|FG000|Overall Study|Withdrawal by Subject|0|||
16093016|NCT02598388|38830340|FG001|Overall Study|Withdrawal by Subject|0|||
16093017|NCT02598388|38830341|FG002|Overall Study|Withdrawal by Subject|0|||
16519691|NCT02863354|40372090|FG001|Year 2|Lost to Follow-up|2|||
16093018|NCT02598388|38830342|FG003|Overall Study|Withdrawal by Subject|0|||
16093019|NCT02598388|38830343|FG004|Overall Study|Withdrawal by Subject|2|||
16093020|NCT02598388|38830344|FG005|Overall Study|Withdrawal by Subject|0|||
16093021|NCT02598388|38830345|FG006|Overall Study|Withdrawal by Subject|2|||
16093022|NCT02598388|38830346|FG007|Overall Study|Withdrawal by Subject|0|||
16093023|NCT02598388|38830347|FG008|Overall Study|Withdrawal by Subject|0|||
16093024|NCT02598388|38830348|FG009|Overall Study|Withdrawal by Subject|1|||
16093025|NCT02598388|38830349|FG010|Overall Study|Withdrawal by Subject|0|||
16093026|NCT02598388|38830350|FG011|Overall Study|Withdrawal by Subject|0|||
16093027|NCT02598388|38830339|FG000|Overall Study|Other|0|||
16093028|NCT02598388|38830340|FG001|Overall Study|Other|0|||
16093029|NCT02598388|38830341|FG002|Overall Study|Other|1|||
16519692|NCT03766009|40372091|FG000|Usual Care|Death|0|||
16519693|NCT03766009|40372092|FG001|Usual Care|Death|0|||
16205706|NCT03862495|39229897|FG001|Overall Study|Lost to Follow-up|35|||
16205707|NCT01072448|39229898|FG000|Overall Study|Adverse Event|9|||
16205708|NCT01072448|39229899|FG001|Overall Study|Adverse Event|10|||
16205709|NCT01072448|39229898|FG000|Overall Study|Subject withdrew consent|4|||
16205710|NCT01072448|39229899|FG001|Overall Study|Subject withdrew consent|9|||
16205711|NCT01072448|39229898|FG000|Overall Study|Protocol deviation|3|||
16205712|NCT01072448|39229899|FG001|Overall Study|Protocol deviation|4|||
16205713|NCT01072448|39229898|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16205714|NCT01072448|39229899|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16205715|NCT01072448|39229898|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16205716|NCT01072448|39229899|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16205717|NCT01072448|39229898|FG000|Overall Study|Lost to Follow-up|1|||
16205718|NCT01072448|39229899|FG001|Overall Study|Lost to Follow-up|1|||
16205719|NCT01072448|39229898|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16205720|NCT01072448|39229899|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16205721|NCT01072448|39229898|FG000|Overall Study|Death|0|||
16205722|NCT01072448|39229899|FG001|Overall Study|Death|2|||
16205723|NCT02983799|39229902|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
16323693|NCT00960986|39670987|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
16323694|NCT00960986|39670988|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
16323695|NCT00960986|39670989|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
16323696|NCT00960986|39670990|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
16323697|NCT00960986|39670987|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
16323698|NCT00960986|39670988|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
16323699|NCT00960986|39670989|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
16323700|NCT00960986|39670990|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
16323701|NCT00960986|39670987|FG000|Period 3 (7-week Therapy Period)|Death|0|||
16323702|NCT00960986|39670988|FG001|Period 3 (7-week Therapy Period)|Death|0|||
16323703|NCT00960986|39670989|FG002|Period 3 (7-week Therapy Period)|Death|1|||
16323704|NCT00960986|39670990|FG003|Period 3 (7-week Therapy Period)|Death|0|||
16323705|NCT00960986|39670987|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
16323706|NCT00960986|39670988|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
16323707|NCT00960986|39670989|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
16323708|NCT00960986|39670990|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
16323709|NCT00960986|39670987|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
16323710|NCT00960986|39670988|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
16323711|NCT00960986|39670989|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
16323712|NCT00960986|39670990|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
16323713|NCT00960986|39670987|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
16323714|NCT00960986|39670988|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
16323715|NCT00960986|39670989|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
16323716|NCT00960986|39670990|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
16323717|NCT00960986|39670987|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
16323718|NCT00960986|39670988|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
16323719|NCT00960986|39670989|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
16323720|NCT00960986|39670990|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
16323721|NCT00793624|39670991|FG000|Overall Study|Adverse Event|18|||
16323722|NCT00793624|39670992|FG001|Overall Study|Adverse Event|16|||
16323723|NCT00793624|39670993|FG002|Overall Study|Adverse Event|15|||
16323724|NCT00793624|39670994|FG003|Overall Study|Adverse Event|20|||
16323725|NCT00793624|39670991|FG000|Overall Study|Lost to Follow-up|2|||
16323726|NCT00793624|39670992|FG001|Overall Study|Lost to Follow-up|2|||
16323727|NCT00793624|39670993|FG002|Overall Study|Lost to Follow-up|4|||
16323728|NCT00793624|39670994|FG003|Overall Study|Lost to Follow-up|0|||
16323729|NCT00793624|39670991|FG000|Overall Study|Withdrawal by Subject|20|||
16323730|NCT00793624|39670992|FG001|Overall Study|Withdrawal by Subject|9|||
16323731|NCT00793624|39670993|FG002|Overall Study|Withdrawal by Subject|11|||
16323732|NCT00793624|39670994|FG003|Overall Study|Withdrawal by Subject|14|||
16323733|NCT00793624|39670991|FG000|Overall Study|Lack of Efficacy|9|||
16323734|NCT00793624|39670992|FG001|Overall Study|Lack of Efficacy|2|||
16323735|NCT00793624|39670993|FG002|Overall Study|Lack of Efficacy|1|||
16323736|NCT00793624|39670994|FG003|Overall Study|Lack of Efficacy|3|||
16323737|NCT00793624|39670991|FG000|Overall Study|Non compliance with protocol|2|||
16323738|NCT00793624|39670992|FG001|Overall Study|Non compliance with protocol|3|||
16323739|NCT00793624|39670993|FG002|Overall Study|Non compliance with protocol|2|||
16205724|NCT02983799|39229903|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
16205725|NCT02983799|39229904|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
16323740|NCT00793624|39670994|FG003|Overall Study|Non compliance with protocol|3|||
16323741|NCT00793624|39670991|FG000|Overall Study|Other reason not described above|6|||
16323742|NCT00793624|39670992|FG001|Overall Study|Other reason not described above|4|||
16323743|NCT00793624|39670993|FG002|Overall Study|Other reason not described above|6|||
16323744|NCT00793624|39670994|FG003|Overall Study|Other reason not described above|3|||
16205726|NCT02983799|39229905|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
16205727|NCT02983799|39229906|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
16205728|NCT02983799|39229902|FG000|Overall Study|Death|20|||
16205729|NCT02983799|39229903|FG001|Overall Study|Death|5|||
16093030|NCT02598388|38830342|FG003|Overall Study|Other|0|||
16205730|NCT02983799|39229904|FG002|Overall Study|Death|23|||
16205731|NCT02983799|39229905|FG003|Overall Study|Death|47|||
16205732|NCT02983799|39229906|FG004|Overall Study|Death|7|||
16205733|NCT02983799|39229902|FG000|Overall Study|Withdrawal by Subject|1|||
16205734|NCT02983799|39229903|FG001|Overall Study|Withdrawal by Subject|0|||
16205735|NCT02983799|39229904|FG002|Overall Study|Withdrawal by Subject|3|||
16205736|NCT02983799|39229905|FG003|Overall Study|Withdrawal by Subject|4|||
16205737|NCT02983799|39229906|FG004|Overall Study|Withdrawal by Subject|1|||
16519694|NCT03766009|40372093|FG002|Usual Care|Death|0|||
16519695|NCT03766009|40372094|FG003|Usual Care|Death|1|||
16519696|NCT03766009|40372095|FG004|Usual Care|Death|0|||
16519697|NCT03766009|40372096|FG005|Usual Care|Death|0|||
16519698|NCT03766009|40372091|FG000|Usual Care|Lost to Follow-up|0|||
16519699|NCT03766009|40372092|FG001|Usual Care|Lost to Follow-up|0|||
16519700|NCT03766009|40372093|FG002|Usual Care|Lost to Follow-up|0|||
16519701|NCT03766009|40372094|FG003|Usual Care|Lost to Follow-up|1|||
16519702|NCT03766009|40372095|FG004|Usual Care|Lost to Follow-up|0|||
16519703|NCT03766009|40372096|FG005|Usual Care|Lost to Follow-up|0|||
16519704|NCT03766009|40372091|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
16519705|NCT03766009|40372092|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
16519706|NCT03766009|40372093|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
16519707|NCT03766009|40372094|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
16519708|NCT03766009|40372095|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
16519709|NCT03766009|40372096|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
16519710|NCT03766009|40372091|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
16519711|NCT03766009|40372092|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
16519712|NCT03766009|40372093|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
16519713|NCT03766009|40372094|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
16205738|NCT02983799|39229902|FG000|Overall Study|Protocol Violation|0|||
16205739|NCT02983799|39229903|FG001|Overall Study|Protocol Violation|1|||
16205740|NCT02983799|39229904|FG002|Overall Study|Protocol Violation|0|||
16205741|NCT02983799|39229905|FG003|Overall Study|Protocol Violation|0|||
16205742|NCT02983799|39229906|FG004|Overall Study|Protocol Violation|1|||
16205743|NCT02983799|39229902|FG000|Overall Study|Lost to Follow-up|1|||
16205744|NCT02983799|39229903|FG001|Overall Study|Lost to Follow-up|0|||
16205745|NCT02983799|39229904|FG002|Overall Study|Lost to Follow-up|1|||
16205746|NCT02983799|39229905|FG003|Overall Study|Lost to Follow-up|0|||
16205747|NCT02983799|39229906|FG004|Overall Study|Lost to Follow-up|0|||
16205748|NCT00239356|39229910|FG000|Overall Study|Lack of Efficacy|1|||
16205749|NCT00239356|39229911|FG001|Overall Study|Lack of Efficacy|0|||
16205750|NCT00239356|39229910|FG000|Overall Study|Adverse Event|6|||
16205751|NCT00239356|39229911|FG001|Overall Study|Adverse Event|0|||
16205752|NCT00239356|39229910|FG000|Overall Study|Withdrawal by Subject|15|||
16205753|NCT00239356|39229911|FG001|Overall Study|Withdrawal by Subject|6|||
16205754|NCT00239356|39229910|FG000|Overall Study|Lost to Follow-up|3|||
16205755|NCT00239356|39229911|FG001|Overall Study|Lost to Follow-up|0|||
16205756|NCT00239356|39229910|FG000|Overall Study|poor/non-compliance|2|||
16205757|NCT00239356|39229911|FG001|Overall Study|poor/non-compliance|0|||
16205758|NCT00239356|39229910|FG000|Overall Study|Pregnancy|1|||
16205759|NCT00239356|39229911|FG001|Overall Study|Pregnancy|0|||
16205760|NCT00239356|39229910|FG000|Overall Study|Administrative reason|0|||
16205761|NCT00239356|39229911|FG001|Overall Study|Administrative reason|1|||
16205762|NCT00239356|39229910|FG000|Overall Study|Drug available on market|11|||
16205763|NCT00239356|39229911|FG001|Overall Study|Drug available on market|2|||
16205764|NCT05441540|39233696|FG000|Overall Study|Withdrawal by Subject|2|||
16205765|NCT01335698|39233697|FG000|Treatment Stage 1|Lack of Efficacy|3|||
16205766|NCT01335698|39233698|FG001|Treatment Stage 1|Lack of Efficacy|1|||
16205767|NCT01335698|39233699|FG002|Treatment Stage 1|Lack of Efficacy|3|||
16205768|NCT01335698|39233700|FG003|Treatment Stage 1|Lack of Efficacy|3|||
16205769|NCT01335698|39233701|FG004|Treatment Stage 1|Lack of Efficacy|1|||
16205770|NCT01335698|39233697|FG000|Treatment Stage 1|Adverse Event|1|||
16205771|NCT01335698|39233698|FG001|Treatment Stage 1|Adverse Event|2|||
16093031|NCT02598388|38830343|FG004|Overall Study|Other|3|||
16205772|NCT01335698|39233699|FG002|Treatment Stage 1|Adverse Event|2|||
16205773|NCT01335698|39233700|FG003|Treatment Stage 1|Adverse Event|1|||
16205774|NCT01335698|39233701|FG004|Treatment Stage 1|Adverse Event|1|||
16205775|NCT01335698|39233697|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
16205776|NCT01335698|39233698|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
16205777|NCT01335698|39233699|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
16519714|NCT03766009|40372095|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
16093032|NCT02598388|38830344|FG005|Overall Study|Other|0|||
16093033|NCT02598388|38830345|FG006|Overall Study|Other|1|||
16093034|NCT02598388|38830346|FG007|Overall Study|Other|0|||
16093035|NCT02598388|38830347|FG008|Overall Study|Other|0|||
16093036|NCT02598388|38830348|FG009|Overall Study|Other|0|||
16093037|NCT02598388|38830349|FG010|Overall Study|Other|0|||
16093038|NCT02598388|38830350|FG011|Overall Study|Other|0|||
16093039|NCT03442777|38830351|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
16093040|NCT03442777|38830352|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
16093041|NCT03442777|38830353|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
16093042|NCT02133131|38830354|FG000|Overall Study|Adverse Event|0|||
16093043|NCT02133131|38830355|FG001|Overall Study|Adverse Event|0|||
16093044|NCT02133131|38830356|FG002|Overall Study|Adverse Event|0|||
16093045|NCT02133131|38830357|FG003|Overall Study|Adverse Event|1|||
16093046|NCT02133131|38830358|FG004|Overall Study|Adverse Event|0|||
16093047|NCT02133131|38830359|FG005|Overall Study|Adverse Event|0|||
16093048|NCT02133131|38830360|FG006|Overall Study|Adverse Event|0|||
16093049|NCT02133131|38830354|FG000|Overall Study|Lost to Follow-up|1|||
16093050|NCT02133131|38830355|FG001|Overall Study|Lost to Follow-up|0|||
16093051|NCT02133131|38830356|FG002|Overall Study|Lost to Follow-up|0|||
16093052|NCT02133131|38830357|FG003|Overall Study|Lost to Follow-up|1|||
16093053|NCT02133131|38830358|FG004|Overall Study|Lost to Follow-up|0|||
16093054|NCT02133131|38830359|FG005|Overall Study|Lost to Follow-up|0|||
16093055|NCT02133131|38830360|FG006|Overall Study|Lost to Follow-up|0|||
16093056|NCT02133131|38830354|FG000|Overall Study|Status not recorded|4|||
16093057|NCT02133131|38830355|FG001|Overall Study|Status not recorded|5|||
16093058|NCT02133131|38830356|FG002|Overall Study|Status not recorded|1|||
16093059|NCT02133131|38830357|FG003|Overall Study|Status not recorded|4|||
16093060|NCT02133131|38830358|FG004|Overall Study|Status not recorded|0|||
16093061|NCT02133131|38830359|FG005|Overall Study|Status not recorded|0|||
16093062|NCT02133131|38830360|FG006|Overall Study|Status not recorded|0|||
16093063|NCT02133131|38830354|FG000|Overall Study|Ongoing in study|0|||
16093064|NCT02133131|38830355|FG001|Overall Study|Ongoing in study|0|||
16093065|NCT02133131|38830356|FG002|Overall Study|Ongoing in study|0|||
16093066|NCT02133131|38830357|FG003|Overall Study|Ongoing in study|0|||
16093067|NCT02133131|38830358|FG004|Overall Study|Ongoing in study|15|||
16093068|NCT02133131|38830359|FG005|Overall Study|Ongoing in study|14|||
16093069|NCT02133131|38830360|FG006|Overall Study|Ongoing in study|11|||
16093070|NCT02133131|38830354|FG000|Overall Study|Protocol Violation|0|||
16093071|NCT02133131|38830355|FG001|Overall Study|Protocol Violation|0|||
16093072|NCT02133131|38830356|FG002|Overall Study|Protocol Violation|0|||
16093073|NCT02133131|38830357|FG003|Overall Study|Protocol Violation|0|||
16093074|NCT02133131|38830358|FG004|Overall Study|Protocol Violation|0|||
16093075|NCT02133131|38830359|FG005|Overall Study|Protocol Violation|0|||
16093076|NCT02133131|38830360|FG006|Overall Study|Protocol Violation|1|||
16093077|NCT01721109|38830361|FG000|Overall Study|Lack of Efficacy|1|||
16093078|NCT01721109|38830361|FG000|Overall Study|Non- Compliance with Study Drug|3|||
16093079|NCT01721109|38830361|FG000|Overall Study|Withdrew Consent|1|||
16093080|NCT01721109|38830361|FG000|Overall Study|Lost to Follow-up|2|||
16093081|NCT03236779|38830366|FG000|Overall Study|Lost to Follow-up|13|||
16093082|NCT03236779|38830367|FG001|Overall Study|Lost to Follow-up|21|||
16093083|NCT02085941|38830370|FG000|Overall Study|Lack of Efficacy|1|||
16093084|NCT02085941|38830371|FG001|Overall Study|Lack of Efficacy|0|||
16093085|NCT02085941|38830370|FG000|Overall Study|Death|6|||
16093086|NCT02085941|38830371|FG001|Overall Study|Death|1|||
16093087|NCT02085941|38830370|FG000|Overall Study|Lost to Follow-up|1|||
16093088|NCT02085941|38830371|FG001|Overall Study|Lost to Follow-up|0|||
16093089|NCT02085941|38830370|FG000|Overall Study|Physician Decision|0|||
16093090|NCT02085941|38830371|FG001|Overall Study|Physician Decision|2|||
16093091|NCT02584257|38830377|FG000|Period 1|Withdrawal by Subject|0|||
16323745|NCT02366637|39670996|FG000|First Intervention Period|Adverse Event|0|||
16323746|NCT02366637|39670997|FG001|First Intervention Period|Adverse Event|1|||
16093092|NCT02584257|38830378|FG001|Period 1|Withdrawal by Subject|0|||
16093093|NCT02584257|38830379|FG002|Period 1|Withdrawal by Subject|0|||
16093094|NCT02584257|38830380|FG003|Period 1|Withdrawal by Subject|0|||
16093095|NCT02584257|38830381|FG004|Period 1|Withdrawal by Subject|0|||
16093096|NCT02584257|38830382|FG005|Period 1|Withdrawal by Subject|0|||
16093097|NCT02584257|38830383|FG006|Period 1|Withdrawal by Subject|1|||
16093098|NCT02584257|38830384|FG007|Period 1|Withdrawal by Subject|0|||
16093099|NCT02584257|38830385|FG008|Period 1|Withdrawal by Subject|0|||
16093100|NCT02584257|38830377|FG000|Period 2|Physician Decision|1|||
16093101|NCT02584257|38830378|FG001|Period 2|Physician Decision|0|||
16093102|NCT02584257|38830379|FG002|Period 2|Physician Decision|0|||
16093103|NCT02584257|38830380|FG003|Period 2|Physician Decision|0|||
16093104|NCT02584257|38830381|FG004|Period 2|Physician Decision|0|||
16093105|NCT02584257|38830382|FG005|Period 2|Physician Decision|0|||
16093106|NCT02584257|38830383|FG006|Period 2|Physician Decision|0|||
16093107|NCT02584257|38830384|FG007|Period 2|Physician Decision|0|||
16323747|NCT02366637|39670996|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
16205778|NCT01335698|39233700|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
16205779|NCT01335698|39233701|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
16205780|NCT01335698|39233697|FG000|Treatment Stage 1|Lost to Follow-up|1|||
16205781|NCT01335698|39233698|FG001|Treatment Stage 1|Lost to Follow-up|1|||
16205782|NCT01335698|39233699|FG002|Treatment Stage 1|Lost to Follow-up|0|||
16205783|NCT01335698|39233700|FG003|Treatment Stage 1|Lost to Follow-up|0|||
16205784|NCT01335698|39233701|FG004|Treatment Stage 1|Lost to Follow-up|0|||
16205785|NCT01335698|39233697|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
16205786|NCT01335698|39233698|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
16205787|NCT01335698|39233699|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
16205788|NCT01335698|39233700|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
16205789|NCT01335698|39233701|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
16205790|NCT01335698|39233697|FG000|Treatment Stage 1|No longer meets study criteria|1|||
16205791|NCT01335698|39233698|FG001|Treatment Stage 1|No longer meets study criteria|1|||
16205792|NCT01335698|39233699|FG002|Treatment Stage 1|No longer meets study criteria|0|||
16205793|NCT01335698|39233700|FG003|Treatment Stage 1|No longer meets study criteria|1|||
16205794|NCT01335698|39233701|FG004|Treatment Stage 1|No longer meets study criteria|0|||
16205795|NCT01335698|39233697|FG000|Treatment Stage 1|Other|1|||
16205796|NCT01335698|39233698|FG001|Treatment Stage 1|Other|0|||
16205797|NCT01335698|39233699|FG002|Treatment Stage 1|Other|0|||
16205798|NCT01335698|39233700|FG003|Treatment Stage 1|Other|1|||
16205799|NCT01335698|39233701|FG004|Treatment Stage 1|Other|0|||
16205800|NCT01335698|39233697|FG000|Treatment Stage 2|Lack of Efficacy|2|||
16205801|NCT01335698|39233698|FG001|Treatment Stage 2|Lack of Efficacy|1|||
16205802|NCT01335698|39233699|FG002|Treatment Stage 2|Lack of Efficacy|3|||
16205803|NCT01335698|39233700|FG003|Treatment Stage 2|Lack of Efficacy|1|||
16205804|NCT01335698|39233701|FG004|Treatment Stage 2|Lack of Efficacy|0|||
16205805|NCT01335698|39233697|FG000|Treatment Stage 2|Adverse Event|2|||
16205806|NCT01335698|39233698|FG001|Treatment Stage 2|Adverse Event|0|||
16205807|NCT01335698|39233699|FG002|Treatment Stage 2|Adverse Event|0|||
16205808|NCT01335698|39233700|FG003|Treatment Stage 2|Adverse Event|3|||
16205809|NCT01335698|39233701|FG004|Treatment Stage 2|Adverse Event|0|||
16205810|NCT01335698|39233697|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
16205811|NCT01335698|39233698|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
16205812|NCT01335698|39233699|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
16205813|NCT01335698|39233700|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
16205814|NCT01335698|39233701|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
16205815|NCT01335698|39233697|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
16205816|NCT01335698|39233698|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
16205817|NCT01335698|39233699|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
16205818|NCT01335698|39233700|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
16205819|NCT01335698|39233701|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
16205820|NCT01335698|39233697|FG000|Treatment Stage 2|Lost to Follow-up|1|||
16205821|NCT01335698|39233698|FG001|Treatment Stage 2|Lost to Follow-up|0|||
16205822|NCT01335698|39233699|FG002|Treatment Stage 2|Lost to Follow-up|0|||
16205823|NCT01335698|39233700|FG003|Treatment Stage 2|Lost to Follow-up|0|||
16205824|NCT01335698|39233701|FG004|Treatment Stage 2|Lost to Follow-up|0|||
16205825|NCT01335698|39233697|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
16205826|NCT01335698|39233698|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
16205827|NCT01335698|39233699|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
16205828|NCT01335698|39233700|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
16205829|NCT01335698|39233701|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
16205830|NCT01335698|39233697|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
16205831|NCT01335698|39233698|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
16205832|NCT01335698|39233699|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
16205833|NCT01335698|39233700|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
16205834|NCT01335698|39233701|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
16205835|NCT01335698|39233697|FG000|Treatment Stage 2|Switched to another formulation|1|||
16205836|NCT01335698|39233698|FG001|Treatment Stage 2|Switched to another formulation|1|||
16205837|NCT01335698|39233699|FG002|Treatment Stage 2|Switched to another formulation|0|||
16205838|NCT01335698|39233700|FG003|Treatment Stage 2|Switched to another formulation|0|||
16205839|NCT01335698|39233701|FG004|Treatment Stage 2|Switched to another formulation|0|||
16205840|NCT01297309|39233702|FG000|Overall Study|Eligibility failure|2|||
16205841|NCT01297309|39233702|FG000|Overall Study|Screen failure|2|||
16205842|NCT01297309|39233702|FG000|Overall Study|Withdrawal by Subject|5|||
16205843|NCT01297309|39233702|FG000|Overall Study|Adverse Event|1|||
16205844|NCT01297309|39233702|FG000|Overall Study|Investigator Decision|2|||
16205845|NCT01297309|39233702|FG000|Overall Study|Death|1|||
16205846|NCT01297309|39233702|FG000|Overall Study|Participant not entering extensionperiod|1|||
16205847|NCT00810810|39233703|FG000|Overall Study|Withdrawal by Subject|0|||
16205848|NCT00810810|39233704|FG001|Overall Study|Withdrawal by Subject|8|||
16205849|NCT00810810|39233705|FG002|Overall Study|Withdrawal by Subject|10|||
16205850|NCT00810810|39233706|FG003|Overall Study|Withdrawal by Subject|8|||
16205851|NCT00810810|39233703|FG000|Overall Study|Physician Decision|0|||
16205852|NCT00810810|39233704|FG001|Overall Study|Physician Decision|3|||
16519715|NCT03766009|40372096|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
16519716|NCT03766009|40372091|FG000|Usual Care|No treatment or declined surgery|0|||
16519717|NCT03766009|40372092|FG001|Usual Care|No treatment or declined surgery|0|||
16519718|NCT03766009|40372093|FG002|Usual Care|No treatment or declined surgery|0|||
16519719|NCT03766009|40372094|FG003|Usual Care|No treatment or declined surgery|2|||
16093108|NCT02584257|38830385|FG008|Period 2|Physician Decision|0|||
16093109|NCT02584257|38830377|FG000|Period 2|Adverse Event|0|||
16519720|NCT03766009|40372095|FG004|Usual Care|No treatment or declined surgery|0|||
16519721|NCT03766009|40372096|FG005|Usual Care|No treatment or declined surgery|0|||
16519722|NCT03766009|40372091|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
16519723|NCT03766009|40372092|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
16519724|NCT03766009|40372093|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
16519725|NCT03766009|40372094|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
16519726|NCT03766009|40372095|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
16093110|NCT02584257|38830378|FG001|Period 2|Adverse Event|1|||
16093111|NCT02584257|38830379|FG002|Period 2|Adverse Event|0|||
16093112|NCT02584257|38830380|FG003|Period 2|Adverse Event|0|||
16093113|NCT02584257|38830381|FG004|Period 2|Adverse Event|0|||
16093114|NCT02584257|38830382|FG005|Period 2|Adverse Event|0|||
16093115|NCT02584257|38830383|FG006|Period 2|Adverse Event|0|||
16093116|NCT02584257|38830384|FG007|Period 2|Adverse Event|0|||
16093117|NCT02584257|38830385|FG008|Period 2|Adverse Event|0|||
16093118|NCT01416285|38830386|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
16093119|NCT01416285|38830387|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
16093120|NCT02312258|38832937|FG000|Overall Study|Lost to Follow-up|8|||
16093121|NCT02312258|38832938|FG001|Overall Study|Lost to Follow-up|8|||
16093122|NCT02312258|38832937|FG000|Overall Study|Withdrawal by Patient|49|||
16093123|NCT02312258|38832938|FG001|Overall Study|Withdrawal by Patient|76|||
16205853|NCT00810810|39233705|FG002|Overall Study|Physician Decision|1|||
16205854|NCT00810810|39233706|FG003|Overall Study|Physician Decision|5|||
16205855|NCT04605159|39233707|FG000|Overall Study|Adverse Event|6|||
16519727|NCT03766009|40372096|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
16519728|NCT03766009|40372091|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
16519729|NCT03766009|40372092|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
16519730|NCT03766009|40372093|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
16519731|NCT03766009|40372094|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
16519732|NCT03766009|40372095|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
16519733|NCT03766009|40372096|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
16519734|NCT03766009|40372091|FG000|Usual Care|Ineligible|0|||
16519735|NCT03766009|40372092|FG001|Usual Care|Ineligible|1|||
16519736|NCT03766009|40372093|FG002|Usual Care|Ineligible|0|||
16519737|NCT03766009|40372094|FG003|Usual Care|Ineligible|0|||
16519738|NCT03766009|40372095|FG004|Usual Care|Ineligible|0|||
16519739|NCT03766009|40372096|FG005|Usual Care|Ineligible|0|||
16519740|NCT03766009|40372091|FG000|Usual Care|Other: Staff turnover|0|||
16093124|NCT02312258|38832937|FG000|Overall Study|Reason not Specified|107|||
16093125|NCT02312258|38832938|FG001|Overall Study|Reason not Specified|159|||
16093126|NCT02312258|38832937|FG000|Overall Study|Missing|2|||
16093127|NCT02312258|38832938|FG001|Overall Study|Missing|1|||
16093128|NCT02312258|38832937|FG000|Overall Study|Death|115|||
16093129|NCT02312258|38832938|FG001|Overall Study|Death|181|||
16093130|NCT04035486|38832941|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
16205856|NCT04605159|39233708|FG001|Overall Study|Adverse Event|3|||
16205857|NCT04605159|39233709|FG002|Overall Study|Adverse Event|21|||
16205858|NCT04605159|39233710|FG003|Overall Study|Adverse Event|4|||
16205859|NCT04605159|39233707|FG000|Overall Study|Lost to Follow-up|74|||
16205860|NCT04605159|39233708|FG001|Overall Study|Lost to Follow-up|45|||
16205861|NCT04605159|39233709|FG002|Overall Study|Lost to Follow-up|119|||
16205862|NCT04605159|39233710|FG003|Overall Study|Lost to Follow-up|80|||
16205863|NCT04605159|39233707|FG000|Overall Study|Protocol Violation|4|||
16205864|NCT04605159|39233708|FG001|Overall Study|Protocol Violation|5|||
16205865|NCT04605159|39233709|FG002|Overall Study|Protocol Violation|2|||
16205866|NCT04605159|39233710|FG003|Overall Study|Protocol Violation|0|||
16205867|NCT04605159|39233707|FG000|Overall Study|Withdrawal by Subject|66|||
16519741|NCT03766009|40372092|FG001|Usual Care|Other: Staff turnover|0|||
16519742|NCT03766009|40372093|FG002|Usual Care|Other: Staff turnover|0|||
16519743|NCT03766009|40372094|FG003|Usual Care|Other: Staff turnover|0|||
16519744|NCT03766009|40372095|FG004|Usual Care|Other: Staff turnover|0|||
16519745|NCT03766009|40372096|FG005|Usual Care|Other: Staff turnover|2|||
16519746|NCT02554773|40372098|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
16519747|NCT02554773|40372099|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
16519748|NCT02554773|40372098|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
16519749|NCT02554773|40372099|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
16205868|NCT04605159|39233708|FG001|Overall Study|Withdrawal by Subject|37|||
16205869|NCT04605159|39233709|FG002|Overall Study|Withdrawal by Subject|68|||
16205870|NCT04605159|39233710|FG003|Overall Study|Withdrawal by Subject|50|||
16205871|NCT04605159|39233707|FG000|Overall Study|Migrated / moved from the study area|32|||
16205872|NCT04605159|39233708|FG001|Overall Study|Migrated / moved from the study area|22|||
16205873|NCT04605159|39233709|FG002|Overall Study|Migrated / moved from the study area|41|||
16205874|NCT04605159|39233710|FG003|Overall Study|Migrated / moved from the study area|21|||
16205875|NCT04605159|39233707|FG000|Overall Study|Other|1|||
16205876|NCT04605159|39233708|FG001|Overall Study|Other|2|||
16205877|NCT04605159|39233709|FG002|Overall Study|Other|7|||
16205878|NCT04605159|39233710|FG003|Overall Study|Other|3|||
16205879|NCT01927068|39233711|FG000|Overall Study|Death|37|||
16205880|NCT01927068|39233712|FG001|Overall Study|Death|3|||
16205881|NCT01927068|39233711|FG000|Overall Study|Withdrawal by Subject|50|||
16205882|NCT01927068|39233712|FG001|Overall Study|Withdrawal by Subject|3|||
16205883|NCT01927068|39233711|FG000|Overall Study|Lost to Follow-up|10|||
16205884|NCT01927068|39233712|FG001|Overall Study|Lost to Follow-up|2|||
16205885|NCT01927068|39233711|FG000|Overall Study|Physician Decision|9|||
16205886|NCT01927068|39233712|FG001|Overall Study|Physician Decision|0|||
16205887|NCT01927068|39233711|FG000|Overall Study|Missed last follow-up visit|2|||
16205888|NCT01927068|39233712|FG001|Overall Study|Missed last follow-up visit|0|||
16205889|NCT00050622|39233717|FG000|Overall Study|Adverse Event|1|||
16205890|NCT00861380|39233721|FG000|Overall Study|Withdrawal Information not recorded|8427|||
16205891|NCT00861380|39233722|FG001|Overall Study|Withdrawal Information not recorded|9112|||
16205892|NCT00861380|39233723|FG002|Overall Study|Withdrawal Information not recorded|8872|||
16205893|NCT00861380|39233724|FG003|Overall Study|Withdrawal Information not recorded|3689|||
16205894|NCT00861380|39233725|FG004|Overall Study|Withdrawal Information not recorded|1812|||
16205895|NCT00861380|39233726|FG005|Overall Study|Withdrawal Information not recorded|6249|||
16205896|NCT00861380|39233727|FG006|Overall Study|Withdrawal Information not recorded|3020|||
16205897|NCT01814826|39233728|FG000|Overall Study|Other|3|||
16205898|NCT01814826|39233729|FG001|Overall Study|Other|5|||
16205899|NCT01814826|39233730|FG002|Overall Study|Other|0|||
16205900|NCT01814826|39233728|FG000|Overall Study|Death|29|||
16205901|NCT01814826|39233729|FG001|Overall Study|Death|24|||
16205902|NCT01814826|39233730|FG002|Overall Study|Death|3|||
16205903|NCT00719537|39233752|FG000|Overall Study|Withdrawal by Subject|1|||
16205904|NCT00719537|39233753|FG001|Overall Study|Withdrawal by Subject|0|||
16205905|NCT00719537|39233752|FG000|Overall Study|Lost to Follow-up|0|||
16205906|NCT00719537|39233753|FG001|Overall Study|Lost to Follow-up|1|||
16205907|NCT01828099|39233754|FG000|Overall Study|Adverse Event|15|||
16205908|NCT01828099|39233755|FG001|Overall Study|Adverse Event|18|||
16205909|NCT01828099|39233754|FG000|Overall Study|Death|9|||
16205910|NCT01828099|39233755|FG001|Overall Study|Death|11|||
16205911|NCT01828099|39233754|FG000|Overall Study|Lost to Follow-up|2|||
16205912|NCT01828099|39233755|FG001|Overall Study|Lost to Follow-up|0|||
16205913|NCT01828099|39233754|FG000|Overall Study|Non-compliance with study treatment|2|||
16205914|NCT01828099|39233755|FG001|Overall Study|Non-compliance with study treatment|0|||
16205915|NCT01828099|39233754|FG000|Overall Study|Physician Decision|7|||
16205916|NCT01828099|39233755|FG001|Overall Study|Physician Decision|11|||
16205917|NCT01828099|39233754|FG000|Overall Study|Progressive disease|51|||
16205918|NCT01828099|39233755|FG001|Overall Study|Progressive disease|94|||
16205919|NCT01828099|39233754|FG000|Overall Study|Protocol Violation|1|||
16205920|NCT01828099|39233755|FG001|Overall Study|Protocol Violation|0|||
16205921|NCT01828099|39233754|FG000|Overall Study|Subject/guardian decision|7|||
16205922|NCT01828099|39233755|FG001|Overall Study|Subject/guardian decision|23|||
16205923|NCT00367432|39233756|FG000|First Period (16 Weeks)|Adverse Event|6|||
16519750|NCT02554773|40372098|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
16205924|NCT00367432|39233757|FG001|First Period (16 Weeks)|Adverse Event|0|||
16519751|NCT02554773|40372099|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
16205925|NCT00367432|39233756|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
16205926|NCT00367432|39233757|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
16205927|NCT00367432|39233756|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
16205928|NCT00367432|39233757|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
16205929|NCT00367432|39233756|FG000|First Period (16 Weeks)|Other Reason|2|||
16519752|NCT02554773|40372098|FG000|Original Dose Regimen (SAS 1)|Death|1|||
16519753|NCT02554773|40372099|FG001|Original Dose Regimen (SAS 1)|Death|0|||
16519754|NCT02554773|40372098|FG000|Original Dose Regimen (SAS 1)|Other|4|||
16519755|NCT02554773|40372099|FG001|Original Dose Regimen (SAS 1)|Other|0|||
16519756|NCT02554773|40372098|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
16519757|NCT02554773|40372099|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
16519758|NCT02554773|40372098|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
16519759|NCT02554773|40372099|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
16519760|NCT02554773|40372098|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
16519761|NCT02554773|40372099|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
16519762|NCT02554773|40372098|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
16519763|NCT02554773|40372099|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
16519764|NCT02965716|40372100|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
16519765|NCT02965716|40372101|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
16519766|NCT02965716|40372100|FG000|Overall Study|Progression/Relapse|8|||
16519767|NCT02965716|40372101|FG001|Overall Study|Progression/Relapse|16|||
16519768|NCT02965716|40372100|FG000|Overall Study|Death|1|||
16205930|NCT00367432|39233757|FG001|First Period (16 Weeks)|Other Reason|0|||
16205931|NCT00367432|39233756|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
16205932|NCT00367432|39233757|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
16205933|NCT00367432|39233756|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
16205934|NCT00367432|39233757|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
16205935|NCT00367432|39233756|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
16205936|NCT00367432|39233757|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
16205937|NCT00367432|39233756|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
16205938|NCT00367432|39233757|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
16205939|NCT00367432|39233756|FG000|Second Period (up to 54 Months)|Other Reason|6|||
16205940|NCT00367432|39233757|FG001|Second Period (up to 54 Months)|Other Reason|2|||
16205941|NCT00910728|39233758|FG000|Overall Study|Lack of Efficacy|2|||
16205942|NCT00910728|39233759|FG001|Overall Study|Lack of Efficacy|3|||
16205943|NCT00910728|39233760|FG002|Overall Study|Lack of Efficacy|1|||
16205944|NCT00910728|39233761|FG003|Overall Study|Lack of Efficacy|2|||
16205945|NCT00910728|39233762|FG004|Overall Study|Lack of Efficacy|1|||
16205946|NCT00910728|39233763|FG005|Overall Study|Lack of Efficacy|0|||
16205947|NCT00910728|39233764|FG006|Overall Study|Lack of Efficacy|2|||
16205948|NCT00910728|39233765|FG007|Overall Study|Lack of Efficacy|2|||
16205949|NCT00910728|39233766|FG008|Overall Study|Lack of Efficacy|2|||
16205950|NCT00910728|39233758|FG000|Overall Study|Withdrawal by Subject|0|||
16205951|NCT00910728|39233759|FG001|Overall Study|Withdrawal by Subject|0|||
16205952|NCT00910728|39233760|FG002|Overall Study|Withdrawal by Subject|0|||
16205953|NCT00910728|39233761|FG003|Overall Study|Withdrawal by Subject|0|||
16205954|NCT00910728|39233762|FG004|Overall Study|Withdrawal by Subject|3|||
16205955|NCT00910728|39233763|FG005|Overall Study|Withdrawal by Subject|1|||
16205956|NCT00910728|39233764|FG006|Overall Study|Withdrawal by Subject|2|||
16205957|NCT00910728|39233765|FG007|Overall Study|Withdrawal by Subject|0|||
16519769|NCT02965716|40372101|FG001|Overall Study|Death|0|||
16205958|NCT00910728|39233766|FG008|Overall Study|Withdrawal by Subject|0|||
16205959|NCT00910728|39233758|FG000|Overall Study|(not specified)|2|||
16205960|NCT00910728|39233759|FG001|Overall Study|(not specified)|0|||
16205961|NCT00910728|39233760|FG002|Overall Study|(not specified)|1|||
16205962|NCT00910728|39233761|FG003|Overall Study|(not specified)|0|||
16205963|NCT00910728|39233762|FG004|Overall Study|(not specified)|1|||
16205964|NCT00910728|39233763|FG005|Overall Study|(not specified)|0|||
16205965|NCT00910728|39233764|FG006|Overall Study|(not specified)|0|||
16519770|NCT02965716|40372100|FG000|Overall Study|Not Protocol Specified|1|||
16519771|NCT02965716|40372101|FG001|Overall Study|Not Protocol Specified|3|||
16519772|NCT02711800|40372102|FG000|Overall Study|Lost to Follow-up|1|||
16519773|NCT02711800|40372102|FG000|Overall Study|Withdrawal by Subject|1|||
16205966|NCT00910728|39233765|FG007|Overall Study|(not specified)|0|||
16205967|NCT00910728|39233766|FG008|Overall Study|(not specified)|0|||
16205968|NCT00910728|39233758|FG000|Overall Study|Adverse Event|2|||
16205969|NCT00910728|39233759|FG001|Overall Study|Adverse Event|0|||
16205970|NCT00910728|39233760|FG002|Overall Study|Adverse Event|1|||
16205971|NCT00910728|39233761|FG003|Overall Study|Adverse Event|1|||
16323748|NCT02366637|39670997|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
16323749|NCT02366637|39670996|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
16323750|NCT02366637|39670997|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
16323751|NCT02135107|39670999|FG000|Treatment Period|Withdrawal by Subject|11|||
16323752|NCT02135107|39671000|FG001|Treatment Period|Withdrawal by Subject|0|||
16323753|NCT02135107|39671001|FG002|Treatment Period|Withdrawal by Subject|0|||
16323754|NCT02135107|39671002|FG003|Treatment Period|Withdrawal by Subject|0|||
16519774|NCT00927927|40372103|FG000|Overall Study|Withdrawal by Subject|0|||
16519775|NCT00927927|40372104|FG001|Overall Study|Withdrawal by Subject|0|||
16519776|NCT00927927|40372105|FG002|Overall Study|Withdrawal by Subject|0|||
16519777|NCT00927927|40372106|FG003|Overall Study|Withdrawal by Subject|0|||
16519778|NCT00927927|40372107|FG004|Overall Study|Withdrawal by Subject|0|||
16519779|NCT00927927|40372108|FG005|Overall Study|Withdrawal by Subject|0|||
16519780|NCT00927927|40372109|FG006|Overall Study|Withdrawal by Subject|0|||
16519781|NCT00927927|40372110|FG007|Overall Study|Withdrawal by Subject|2|||
16205972|NCT00910728|39233762|FG004|Overall Study|Adverse Event|0|||
16205973|NCT00910728|39233763|FG005|Overall Study|Adverse Event|0|||
16519782|NCT00927927|40372111|FG008|Overall Study|Withdrawal by Subject|0|||
16205974|NCT00910728|39233764|FG006|Overall Study|Adverse Event|2|||
16205975|NCT00910728|39233765|FG007|Overall Study|Adverse Event|1|||
16323755|NCT02135107|39670999|FG000|Treatment Period|Adverse Event|5|||
16323756|NCT02135107|39671000|FG001|Treatment Period|Adverse Event|2|||
16519783|NCT00927927|40372112|FG009|Overall Study|Withdrawal by Subject|0|||
16205976|NCT00910728|39233766|FG008|Overall Study|Adverse Event|1|||
16205977|NCT02873208|39233767|FG000|Overall Study|Withdrawal by Subject|36|||
16323757|NCT02135107|39671001|FG002|Treatment Period|Adverse Event|0|||
16323758|NCT02135107|39671002|FG003|Treatment Period|Adverse Event|0|||
16323759|NCT02135107|39670999|FG000|Treatment Period|Pregnancy|1|||
16323760|NCT02135107|39671000|FG001|Treatment Period|Pregnancy|0|||
16323761|NCT02135107|39671001|FG002|Treatment Period|Pregnancy|0|||
16323762|NCT02135107|39671002|FG003|Treatment Period|Pregnancy|0|||
16323763|NCT02135107|39670999|FG000|Treatment Period|Other|115|||
16323764|NCT02135107|39671000|FG001|Treatment Period|Other|24|||
16323765|NCT02135107|39671001|FG002|Treatment Period|Other|0|||
16323766|NCT02135107|39671002|FG003|Treatment Period|Other|0|||
16323767|NCT02135107|39670999|FG000|Maintenance Therapy Period|Adverse Event|0|||
16323768|NCT02135107|39671000|FG001|Maintenance Therapy Period|Adverse Event|0|||
16323769|NCT02135107|39671001|FG002|Maintenance Therapy Period|Adverse Event|3|||
16323770|NCT02135107|39671002|FG003|Maintenance Therapy Period|Adverse Event|7|||
16323771|NCT02135107|39670999|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
16323772|NCT02135107|39671000|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
16323773|NCT02135107|39671001|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
16323774|NCT02135107|39671002|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
16323775|NCT02135107|39670999|FG000|Maintenance Therapy Period|Pregnancy|0|||
16323776|NCT02135107|39671000|FG001|Maintenance Therapy Period|Pregnancy|0|||
16323777|NCT02135107|39671001|FG002|Maintenance Therapy Period|Pregnancy|0|||
16323778|NCT02135107|39671002|FG003|Maintenance Therapy Period|Pregnancy|1|||
16323779|NCT02135107|39670999|FG000|Maintenance Therapy Period|Other|0|||
16323780|NCT02135107|39671000|FG001|Maintenance Therapy Period|Other|0|||
16323781|NCT02135107|39671001|FG002|Maintenance Therapy Period|Other|7|||
16323782|NCT02135107|39671002|FG003|Maintenance Therapy Period|Other|8|||
16323783|NCT04382755|39671008|FG000|Overall Study|Withdrawal by Subject|1|||
16323784|NCT04382755|39671009|FG001|Overall Study|Withdrawal by Subject|0|||
16519784|NCT00927927|40372113|FG010|Overall Study|Withdrawal by Subject|0|||
16519785|NCT00927927|40372114|FG011|Overall Study|Withdrawal by Subject|2|||
16519786|NCT00927927|40372115|FG012|Overall Study|Withdrawal by Subject|0|||
16519787|NCT00927927|40372116|FG013|Overall Study|Withdrawal by Subject|0|||
16519788|NCT00927927|40372117|FG014|Overall Study|Withdrawal by Subject|0|||
16519789|NCT00589108|40372118|FG000|Overall Study|Lost to Follow-up|1|||
16519790|NCT00589108|40372119|FG001|Overall Study|Lost to Follow-up|1|||
16519791|NCT00589108|40372120|FG002|Overall Study|Lost to Follow-up|1|||
16519792|NCT00589108|40372118|FG000|Overall Study|Death|3|||
16519793|NCT00589108|40372119|FG001|Overall Study|Death|3|||
16519794|NCT00589108|40372120|FG002|Overall Study|Death|4|||
16519795|NCT04632940|40372121|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
16323785|NCT04382755|39671008|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
16323786|NCT04382755|39671009|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
16323787|NCT04382755|39671008|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
16346358|NCT02367040|39753294|FG001|Overall Study|Progressive disease - radiological progression|78|||
16519796|NCT04632940|40372122|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
16519797|NCT04632940|40372121|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
16205978|NCT02873208|39233767|FG000|Overall Study|Lost to Follow-up|22|||
16205979|NCT02873208|39233767|FG000|Overall Study|Adverse Event|15|||
16205980|NCT02873208|39233767|FG000|Overall Study|Non-compliance with study drug|12|||
16205981|NCT02873208|39233767|FG000|Overall Study|Protocol Violation|8|||
16205982|NCT02873208|39233767|FG000|Overall Study|Pregnancy|2|||
16205983|NCT02873208|39233767|FG000|Overall Study|Incarceration|1|||
16205984|NCT02873208|39233767|FG000|Overall Study|Lack of Efficacy|1|||
16205985|NCT02873208|39233767|FG000|Overall Study|Physician Decision|1|||
16205986|NCT00305604|39233770|FG000|Overall Study|Adverse Event|6|||
16205987|NCT00305604|39233771|FG001|Overall Study|Adverse Event|3|||
16205988|NCT00305604|39233770|FG000|Overall Study|Lack of Efficacy|11|||
16205989|NCT00305604|39233771|FG001|Overall Study|Lack of Efficacy|18|||
16205990|NCT00305604|39233770|FG000|Overall Study|Lost to Follow-up|0|||
16205991|NCT00305604|39233771|FG001|Overall Study|Lost to Follow-up|4|||
16205992|NCT00305604|39233770|FG000|Overall Study|Protocol Violation|2|||
16205993|NCT00305604|39233771|FG001|Overall Study|Protocol Violation|1|||
16205994|NCT00305604|39233770|FG000|Overall Study|Withdrawal by Subject|12|||
16205995|NCT00305604|39233771|FG001|Overall Study|Withdrawal by Subject|21|||
16205996|NCT00305604|39233770|FG000|Overall Study|Patient moved|1|||
16205997|NCT00305604|39233771|FG001|Overall Study|Patient moved|0|||
16205998|NCT01732107|39233772|FG000|Overall Study|Adverse Event|2|||
16205999|NCT01732107|39233772|FG000|Overall Study|Disease Progression|8|||
16206000|NCT01732107|39233772|FG000|Overall Study|Physician Decision|1|||
16206001|NCT01732107|39233772|FG000|Overall Study|Withdrawal by Subject|2|||
16206002|NCT00268463|39233773|FG000|Overall Study|study terminated due to low accrual|10|||
16206003|NCT00268463|39233774|FG001|Overall Study|study terminated due to low accrual|12|||
16206004|NCT00505752|39233775|FG000|Overall Study|Adverse Event|1|||
16206005|NCT00505752|39233776|FG001|Overall Study|Adverse Event|0|||
16206006|NCT00505752|39233777|FG002|Overall Study|Adverse Event|1|||
16206007|NCT00505752|39233778|FG003|Overall Study|Adverse Event|0|||
16206008|NCT00505752|39233775|FG000|Overall Study|Lost to Follow-up|1|||
16206009|NCT00505752|39233776|FG001|Overall Study|Lost to Follow-up|0|||
16206010|NCT00505752|39233777|FG002|Overall Study|Lost to Follow-up|0|||
16519798|NCT04632940|40372122|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
16519799|NCT04632940|40372121|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
16519800|NCT04632940|40372122|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
16519801|NCT04632940|40372121|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
16519802|NCT04632940|40372122|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
16519803|NCT04632940|40372121|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
16519804|NCT04632940|40372122|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
16519805|NCT04632940|40372121|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
16519806|NCT04632940|40372122|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
16519807|NCT04632940|40372121|FG000|OLE Period (52 Weeks)|Other than specified|0|||
16519808|NCT04632940|40372122|FG001|OLE Period (52 Weeks)|Other than specified|1|||
16519809|NCT04632940|40372121|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
16519810|NCT04632940|40372122|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
16519811|NCT01148810|40372123|FG000|Overall Study|Adverse Event|0|||
16519812|NCT01148810|40372124|FG001|Overall Study|Adverse Event|2|||
16519813|NCT01148810|40372123|FG000|Overall Study|Lack of Efficacy|0|||
16519814|NCT01148810|40372124|FG001|Overall Study|Lack of Efficacy|1|||
16519815|NCT01148810|40372123|FG000|Overall Study|Withdrawal by Subject|0|||
16519816|NCT01148810|40372124|FG001|Overall Study|Withdrawal by Subject|2|||
16519817|NCT01148810|40372123|FG000|Overall Study|Protocol Violation|1|||
16519818|NCT01148810|40372124|FG001|Overall Study|Protocol Violation|0|||
16519819|NCT00097591|40372125|FG000|Overall Study|Withdrawal of consent|342|||
16519820|NCT00097591|40372126|FG001|Overall Study|Withdrawal of consent|323|||
16519821|NCT00097591|40372125|FG000|Overall Study|Less than 6 months on study drug|9|||
16519822|NCT00097591|40372126|FG001|Overall Study|Less than 6 months on study drug|7|||
16519823|NCT00097591|40372125|FG000|Overall Study|Unable to attend termination visit|53|||
16519824|NCT00097591|40372126|FG001|Overall Study|Unable to attend termination visit|51|||
16519825|NCT00097591|40372125|FG000|Overall Study|Lost to follow up|6|||
16206011|NCT00505752|39233778|FG003|Overall Study|Lost to Follow-up|0|||
16206012|NCT00505752|39233775|FG000|Overall Study|Lack of ovarian response|1|||
16206013|NCT00505752|39233776|FG001|Overall Study|Lack of ovarian response|3|||
16206014|NCT00505752|39233777|FG002|Overall Study|Lack of ovarian response|0|||
16206015|NCT00505752|39233778|FG003|Overall Study|Lack of ovarian response|0|||
16206016|NCT00505752|39233775|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
16206017|NCT00505752|39233776|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
16206018|NCT00505752|39233777|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
16206019|NCT00505752|39233778|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
16206020|NCT00505752|39233775|FG000|Overall Study|No oocytes retrieved|0|||
16206021|NCT00505752|39233776|FG001|Overall Study|No oocytes retrieved|2|||
16206022|NCT00505752|39233777|FG002|Overall Study|No oocytes retrieved|0|||
16206023|NCT00505752|39233778|FG003|Overall Study|No oocytes retrieved|1|||
16206024|NCT00505752|39233775|FG000|Overall Study|No Fertilization|1|||
16206025|NCT00505752|39233776|FG001|Overall Study|No Fertilization|1|||
16206026|NCT00505752|39233777|FG002|Overall Study|No Fertilization|2|||
16323788|NCT04382755|39671009|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
16395745|NCT01532921|39931152|FG000|Overall Study|Lost to Follow-up|3|||
16395746|NCT01532921|39931152|FG000|Overall Study|Physician Decision|7|||
16395747|NCT01532921|39931152|FG000|Overall Study|Device was explanted during procedure|1|||
16093131|NCT04035486|38832942|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
16093132|NCT04035486|38832943|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
16093133|NCT04035486|38832944|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
16093134|NCT04035486|38832941|FG000|Overall Study|Death|6|||
16395748|NCT01673854|39931153|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
16395749|NCT01673854|39931153|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
16093135|NCT04035486|38832942|FG001|Overall Study|Death|3|||
16093136|NCT04035486|38832943|FG002|Overall Study|Death|70|||
16093137|NCT04035486|38832944|FG003|Overall Study|Death|77|||
16093138|NCT04035486|38832941|FG000|Overall Study|Screen Failure|0|||
16093139|NCT04035486|38832942|FG001|Overall Study|Screen Failure|0|||
16093140|NCT04035486|38832943|FG002|Overall Study|Screen Failure|1|||
16093141|NCT04035486|38832944|FG003|Overall Study|Screen Failure|1|||
16093142|NCT04035486|38832941|FG000|Overall Study|Withdrawal by Subject|1|||
16093143|NCT04035486|38832942|FG001|Overall Study|Withdrawal by Subject|1|||
16093144|NCT04035486|38832943|FG002|Overall Study|Withdrawal by Subject|11|||
16093145|NCT04035486|38832944|FG003|Overall Study|Withdrawal by Subject|9|||
16323789|NCT00869999|39671018|FG000|Overall Study|Withdrawal by Subject|1|||
16323790|NCT00869999|39671018|FG000|Overall Study|removed prior to starting therapy|1|||
16395750|NCT01673854|39931153|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
16519826|NCT00097591|40372126|FG001|Overall Study|Lost to follow up|10|||
16519827|NCT00097591|40372125|FG000|Overall Study|Other|0|||
16519828|NCT00097591|40372126|FG001|Overall Study|Other|3|||
16519829|NCT03370341|40372127|FG000|Overall Study|Lost to Follow-up|0|||
16519830|NCT03370341|40372128|FG001|Overall Study|Lost to Follow-up|1|||
16323791|NCT02841280|39671019|FG000|Overall Study|Adverse Event|2|||
16323792|NCT02841280|39671020|FG001|Overall Study|Adverse Event|1|||
16323793|NCT02841280|39671019|FG000|Overall Study|Death|1|||
16519831|NCT00861341|40372135|FG000|Overall Study|Withdrawal by Subject|2|||
16519832|NCT02252081|40372136|FG000|Overall Study|Withdrawal by Subject|2|||
16519833|NCT02252081|40372137|FG001|Overall Study|Withdrawal by Subject|1|||
16519834|NCT02252081|40372136|FG000|Overall Study|Adverse Event|4|||
16519835|NCT02252081|40372137|FG001|Overall Study|Adverse Event|1|||
16519836|NCT02252081|40372136|FG000|Overall Study|non compliance & others|0|||
16519837|NCT02252081|40372137|FG001|Overall Study|non compliance & others|2|||
16519838|NCT05070897|40372140|FG000|Overall Study|Protocol Violation|123|||
16519839|NCT05070897|40372141|FG001|Overall Study|Protocol Violation|68|||
16519840|NCT00129259|40372145|FG000|Overall Study|Lost to Follow-up|1|||
16519841|NCT00129259|40372146|FG001|Overall Study|Lost to Follow-up|1|||
16519842|NCT00129259|40372145|FG000|Overall Study|Withdrawal by Subject|2|||
16519843|NCT00129259|40372146|FG001|Overall Study|Withdrawal by Subject|1|||
16519844|NCT00129259|40372145|FG000|Overall Study|Only available minimal phone assessments|0|||
16519845|NCT00129259|40372146|FG001|Overall Study|Only available minimal phone assessments|1|||
16519846|NCT02091167|40372147|FG000|Overall Study|Lost to Follow-up|0|||
16519847|NCT02091167|40372148|FG001|Overall Study|Lost to Follow-up|2|||
16519848|NCT03194646|40372149|FG000|Overall Study|Adverse Event|24|||
16519849|NCT03194646|40372150|FG001|Overall Study|Adverse Event|25|||
16519850|NCT03194646|40372151|FG002|Overall Study|Adverse Event|14|||
16519851|NCT03194646|40372152|FG003|Overall Study|Adverse Event|17|||
16093146|NCT01544309|38832947|FG000|Overall Study|Withdrawal by Subject|12|||
16323794|NCT02841280|39671020|FG001|Overall Study|Death|0|||
16323795|NCT02841280|39671019|FG000|Overall Study|Lost to Follow-up|2|||
16395751|NCT01673854|39931153|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
16519852|NCT03194646|40372149|FG000|Overall Study|Lack of Efficacy|4|||
16093147|NCT01544309|38832948|FG001|Overall Study|Withdrawal by Subject|7|||
16093148|NCT01544309|38832947|FG000|Overall Study|Protocol Violation|2|||
16323796|NCT02841280|39671020|FG001|Overall Study|Lost to Follow-up|2|||
16519853|NCT03194646|40372150|FG001|Overall Study|Lack of Efficacy|2|||
16519854|NCT03194646|40372151|FG002|Overall Study|Lack of Efficacy|2|||
16093149|NCT01544309|38832948|FG001|Overall Study|Protocol Violation|1|||
16093150|NCT01544309|38832947|FG000|Overall Study|Physician Decision|4|||
16093151|NCT01544309|38832948|FG001|Overall Study|Physician Decision|1|||
16206027|NCT00505752|39233778|FG003|Overall Study|No Fertilization|1|||
16093152|NCT01544309|38832947|FG000|Overall Study|Not performed pre-dose examination|1|||
16093153|NCT01544309|38832948|FG001|Overall Study|Not performed pre-dose examination|2|||
16093154|NCT01544309|38832947|FG000|Overall Study|Administered prohibit prior medication|1|||
16323797|NCT02841280|39671019|FG000|Overall Study|Withdrawal by Subject|7|||
16323798|NCT02841280|39671020|FG001|Overall Study|Withdrawal by Subject|3|||
16093155|NCT01544309|38832948|FG001|Overall Study|Administered prohibit prior medication|0|||
16093156|NCT01075815|38832951|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
16093157|NCT01075815|38832952|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
16323799|NCT02841280|39671019|FG000|Overall Study|Stop Point: BP above threshold|2|||
16323800|NCT02841280|39671020|FG001|Overall Study|Stop Point: BP above threshold|0|||
16323801|NCT02291601|39671022|FG000|Abdomen|Did not qualify|333|||
16323802|NCT02291601|39671023|FG001|Abdomen|Did not qualify|54|||
16519855|NCT03194646|40372152|FG003|Overall Study|Lack of Efficacy|12|||
16519856|NCT03194646|40372149|FG000|Overall Study|Lost to Follow-up|30|||
16519857|NCT03194646|40372150|FG001|Overall Study|Lost to Follow-up|22|||
16519858|NCT03194646|40372151|FG002|Overall Study|Lost to Follow-up|12|||
16519859|NCT03194646|40372152|FG003|Overall Study|Lost to Follow-up|35|||
16519860|NCT03194646|40372149|FG000|Overall Study|Non-compliance with study drug|4|||
16519861|NCT03194646|40372150|FG001|Overall Study|Non-compliance with study drug|0|||
16519862|NCT03194646|40372151|FG002|Overall Study|Non-compliance with study drug|1|||
16519863|NCT03194646|40372152|FG003|Overall Study|Non-compliance with study drug|1|||
16519864|NCT03194646|40372149|FG000|Overall Study|Other|89|||
16519865|NCT03194646|40372150|FG001|Overall Study|Other|68|||
16519866|NCT03194646|40372151|FG002|Overall Study|Other|34|||
16519867|NCT03194646|40372152|FG003|Overall Study|Other|31|||
16519868|NCT03194646|40372149|FG000|Overall Study|Physician Decision|7|||
16519869|NCT03194646|40372150|FG001|Overall Study|Physician Decision|9|||
16519870|NCT03194646|40372151|FG002|Overall Study|Physician Decision|5|||
16519871|NCT03194646|40372152|FG003|Overall Study|Physician Decision|4|||
16519872|NCT03194646|40372149|FG000|Overall Study|Pregnancy|4|||
16519873|NCT03194646|40372150|FG001|Overall Study|Pregnancy|5|||
16519874|NCT03194646|40372151|FG002|Overall Study|Pregnancy|1|||
16519875|NCT03194646|40372152|FG003|Overall Study|Pregnancy|2|||
16519876|NCT03194646|40372149|FG000|Overall Study|Protocol Violation|4|||
16519877|NCT03194646|40372150|FG001|Overall Study|Protocol Violation|2|||
16519878|NCT03194646|40372151|FG002|Overall Study|Protocol Violation|1|||
16519879|NCT03194646|40372152|FG003|Overall Study|Protocol Violation|1|||
16519880|NCT03194646|40372149|FG000|Overall Study|Site terminated by sponsor|0|||
16519881|NCT03194646|40372150|FG001|Overall Study|Site terminated by sponsor|0|||
16519882|NCT03194646|40372151|FG002|Overall Study|Site terminated by sponsor|2|||
16519883|NCT03194646|40372152|FG003|Overall Study|Site terminated by sponsor|0|||
16519884|NCT03194646|40372149|FG000|Overall Study|Study terminated by sponsor|62|||
16519885|NCT03194646|40372150|FG001|Overall Study|Study terminated by sponsor|61|||
16519886|NCT03194646|40372151|FG002|Overall Study|Study terminated by sponsor|30|||
16519887|NCT03194646|40372152|FG003|Overall Study|Study terminated by sponsor|34|||
16519888|NCT03194646|40372149|FG000|Overall Study|Withdrawal by Subject|75|||
16519889|NCT03194646|40372150|FG001|Overall Study|Withdrawal by Subject|74|||
16519890|NCT03194646|40372151|FG002|Overall Study|Withdrawal by Subject|36|||
16519891|NCT03194646|40372152|FG003|Overall Study|Withdrawal by Subject|131|||
16519892|NCT03194646|40372149|FG000|Overall Study|Missing|1|||
16519893|NCT03194646|40372150|FG001|Overall Study|Missing|0|||
16519894|NCT03194646|40372151|FG002|Overall Study|Missing|1|||
16519895|NCT03194646|40372152|FG003|Overall Study|Missing|12|||
16519896|NCT01049919|40372158|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
16519897|NCT01049919|40372159|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
16519898|NCT01049919|40372158|FG000|Overall Study|Withdrawal by Subject|5|||
16519899|NCT01049919|40372159|FG001|Overall Study|Withdrawal by Subject|0|||
16519900|NCT01049919|40372158|FG000|Overall Study|Lost to Follow-up|6|||
16519901|NCT01049919|40372159|FG001|Overall Study|Lost to Follow-up|1|||
16519902|NCT01049919|40372158|FG000|Overall Study|Physician Decision|2|||
16519903|NCT01049919|40372159|FG001|Overall Study|Physician Decision|0|||
16519904|NCT01049919|40372158|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
16519905|NCT01049919|40372159|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
16519906|NCT01049919|40372158|FG000|Overall Study|Early study termination by sponsor.|2|||
16519907|NCT01049919|40372159|FG001|Overall Study|Early study termination by sponsor.|0|||
16519908|NCT03662750|40372162|FG000|Overall Study|Withdrawal by Subject|1|||
16519909|NCT03525834|40372170|FG000|Overall Study|Progressive disease|1|||
16519910|NCT01126541|40372174|FG000|Overall Study|Adverse Event|0|||
16093158|NCT01075815|38832951|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
16323803|NCT02291601|39671024|FG002|Abdomen|Did not qualify|339|||
16323804|NCT02291601|39671022|FG000|Groin|Did not qualify|183|||
16519911|NCT01126541|40372175|FG001|Overall Study|Adverse Event|2|||
16519912|NCT01126541|40372176|FG002|Overall Study|Adverse Event|4|||
16519913|NCT01126541|40372174|FG000|Overall Study|Death|0|||
16519914|NCT01126541|40372175|FG001|Overall Study|Death|1|||
16519915|NCT01126541|40372176|FG002|Overall Study|Death|0|||
16519916|NCT01126541|40372174|FG000|Overall Study|Lack of Efficacy|6|||
16519917|NCT01126541|40372175|FG001|Overall Study|Lack of Efficacy|1|||
16519918|NCT01126541|40372176|FG002|Overall Study|Lack of Efficacy|11|||
16519919|NCT01126541|40372174|FG000|Overall Study|Lost to Follow-up|1|||
16519920|NCT01126541|40372175|FG001|Overall Study|Lost to Follow-up|2|||
16519921|NCT01126541|40372176|FG002|Overall Study|Lost to Follow-up|2|||
16519922|NCT01126541|40372174|FG000|Overall Study|Withdrawal by Subject|2|||
16323805|NCT02291601|39671023|FG001|Groin|Did not qualify|30|||
16323806|NCT02291601|39671024|FG002|Groin|Did not qualify|177|||
16323807|NCT02438826|39671026|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
16323808|NCT02438826|39671027|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
16323809|NCT02438826|39671028|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
16323810|NCT02438826|39671029|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
16519923|NCT01126541|40372175|FG001|Overall Study|Withdrawal by Subject|5|||
16519924|NCT01126541|40372176|FG002|Overall Study|Withdrawal by Subject|6|||
16519925|NCT01126541|40372174|FG000|Overall Study|Protocol Violation|0|||
16519926|NCT01126541|40372175|FG001|Overall Study|Protocol Violation|0|||
16519927|NCT01126541|40372176|FG002|Overall Study|Protocol Violation|1|||
16519928|NCT01126541|40372174|FG000|Overall Study|Administrative reason or other|1|||
16519929|NCT01126541|40372175|FG001|Overall Study|Administrative reason or other|1|||
16519930|NCT01126541|40372176|FG002|Overall Study|Administrative reason or other|2|||
16519931|NCT00826267|40372177|FG000|Overall Study|Other Adverse Event|1|||
16519932|NCT00826267|40372178|FG001|Overall Study|Other Adverse Event|0|||
16519933|NCT00826267|40372179|FG002|Overall Study|Other Adverse Event|0|||
16519934|NCT03160703|40372180|FG000|Overall Study|Withdrawal by Subject|0|||
16519935|NCT03160703|40372181|FG001|Overall Study|Withdrawal by Subject|0|||
16519936|NCT03160703|40372182|FG002|Overall Study|Withdrawal by Subject|0|||
16519937|NCT03160703|40372183|FG003|Overall Study|Withdrawal by Subject|1|||
16519938|NCT04068181|40372184|FG000|Overall Study|Withdrawal by Subject|2|||
16519939|NCT04068181|40372185|FG001|Overall Study|Withdrawal by Subject|0|||
16519940|NCT04068181|40372186|FG002|Overall Study|Withdrawal by Subject|0|||
16519941|NCT04068181|40372187|FG003|Overall Study|Withdrawal by Subject|0|||
16519942|NCT04068181|40372184|FG000|Overall Study|Lost to Follow-up|1|||
16519943|NCT04068181|40372185|FG001|Overall Study|Lost to Follow-up|0|||
16519944|NCT04068181|40372186|FG002|Overall Study|Lost to Follow-up|0|||
16519945|NCT04068181|40372187|FG003|Overall Study|Lost to Follow-up|0|||
16519946|NCT04068181|40372184|FG000|Overall Study|Death|8|||
16519947|NCT04068181|40372185|FG001|Overall Study|Death|8|||
16519948|NCT04068181|40372186|FG002|Overall Study|Death|4|||
16519949|NCT04068181|40372187|FG003|Overall Study|Death|2|||
16519950|NCT04068181|40372184|FG000|Overall Study|Continuing Study|16|||
16519951|NCT04068181|40372185|FG001|Overall Study|Continuing Study|7|||
16519952|NCT04068181|40372186|FG002|Overall Study|Continuing Study|11|||
16519953|NCT04068181|40372187|FG003|Overall Study|Continuing Study|13|||
16519954|NCT03746522|40372190|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
16519955|NCT03746522|40372191|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
16519956|NCT03746522|40372192|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
16093159|NCT01075815|38832952|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
16093160|NCT01075815|38832951|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
16093161|NCT01075815|38832952|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
16093162|NCT03746015|38832953|FG000|Overall Study|Withdrawal of Consent|1|||
16093163|NCT03746015|38832954|FG001|Overall Study|Withdrawal of Consent|0|||
16093164|NCT03746015|38832955|FG002|Overall Study|Withdrawal of Consent|0|||
16093165|NCT01071317|38832956|FG000|Overall Study|Lost to Follow-up|2|||
16093166|NCT01071317|38832957|FG001|Overall Study|Lost to Follow-up|2|||
16093167|NCT02547974|38832958|FG000|Overall Study|Withdrawal by Subject|1|||
16093168|NCT02547974|38832959|FG001|Overall Study|Withdrawal by Subject|0|||
16093169|NCT02547974|38832960|FG002|Overall Study|Withdrawal by Subject|0|||
16093170|NCT02547974|38832961|FG003|Overall Study|Withdrawal by Subject|0|||
16093171|NCT00578344|38832962|FG000|Overall Study|Insurance problems|1|||
16093172|NCT00578344|38832962|FG000|Overall Study|Graft failure|1|||
16093173|NCT00460434|38832965|FG000|Overall Study|Lost to Follow-up|3|||
16093174|NCT00460434|38832966|FG001|Overall Study|Lost to Follow-up|7|||
16093175|NCT01137682|38832968|FG000|Overall Study|Adverse Event-CORE|2|||
16093176|NCT01137682|38832969|FG001|Overall Study|Adverse Event-CORE|4|||
16093177|NCT01137682|38832970|FG002|Overall Study|Adverse Event-CORE|0|||
16093178|NCT01137682|38832968|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
16093179|NCT01137682|38832969|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
16323811|NCT02438826|39671026|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
16323812|NCT02438826|39671027|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16519957|NCT03746522|40372190|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
16093180|NCT01137682|38832970|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
16093181|NCT01137682|38832968|FG000|Overall Study|Administrative problems-CORE|2|||
16093182|NCT01137682|38832969|FG001|Overall Study|Administrative problems-CORE|1|||
16519958|NCT03746522|40372191|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
16519959|NCT03746522|40372192|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
16519960|NCT03746522|40372190|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
16093183|NCT01137682|38832970|FG002|Overall Study|Administrative problems-CORE|0|||
16093184|NCT01137682|38832968|FG000|Overall Study|Protocol Violation-CORE|0|||
16093185|NCT01137682|38832969|FG001|Overall Study|Protocol Violation-CORE|1|||
16093186|NCT01137682|38832970|FG002|Overall Study|Protocol Violation-CORE|1|||
16093187|NCT01137682|38832968|FG000|Overall Study|Adverse Event-Extension|4|||
16093188|NCT01137682|38832969|FG001|Overall Study|Adverse Event-Extension|8|||
16093189|NCT01137682|38832970|FG002|Overall Study|Adverse Event-Extension|7|||
16093190|NCT01137682|38832968|FG000|Overall Study|Lack of Efficacy-Extension|15|||
16093191|NCT01137682|38832969|FG001|Overall Study|Lack of Efficacy-Extension|9|||
16093192|NCT01137682|38832970|FG002|Overall Study|Lack of Efficacy-Extension|13|||
16093193|NCT01137682|38832968|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
16093194|NCT01137682|38832969|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
16093195|NCT01137682|38832970|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
16093196|NCT01137682|38832968|FG000|Overall Study|Lost to Follow Up-Extension|0|||
16093197|NCT01137682|38832969|FG001|Overall Study|Lost to Follow Up-Extension|1|||
16093198|NCT01137682|38832970|FG002|Overall Study|Lost to Follow Up-Extension|0|||
16093199|NCT01137682|38832968|FG000|Overall Study|Administrative problems-Extension|0|||
16093200|NCT01137682|38832969|FG001|Overall Study|Administrative problems-Extension|2|||
16093201|NCT01137682|38832970|FG002|Overall Study|Administrative problems-Extension|0|||
16093202|NCT01137682|38832968|FG000|Overall Study|Death-Extension|2|||
16093203|NCT01137682|38832969|FG001|Overall Study|Death-Extension|0|||
16093204|NCT01137682|38832970|FG002|Overall Study|Death-Extension|0|||
16093205|NCT01137682|38832968|FG000|Overall Study|Protocol Violation-Extension|2|||
16093206|NCT01137682|38832969|FG001|Overall Study|Protocol Violation-Extension|1|||
16093207|NCT01137682|38832970|FG002|Overall Study|Protocol Violation-Extension|0|||
16093208|NCT01137682|38832968|FG000|Overall Study|Did not enter extension|2|||
16093209|NCT01137682|38832969|FG001|Overall Study|Did not enter extension|3|||
16093210|NCT01137682|38832970|FG002|Overall Study|Did not enter extension|2|||
16093211|NCT01137682|38832968|FG000|Overall Study|Did not receive treatment in extension|0|||
16093212|NCT01137682|38832969|FG001|Overall Study|Did not receive treatment in extension|0|||
16093213|NCT01137682|38832970|FG002|Overall Study|Did not receive treatment in extension|1|||
16093214|NCT02710669|38832971|FG000|Overall Study|Physician Decision|2|||
16093215|NCT02710669|38832972|FG001|Overall Study|Physician Decision|1|||
16093216|NCT02710669|38832973|FG002|Overall Study|Physician Decision|0|||
16093217|NCT02710669|38832971|FG000|Overall Study|Institutional delays (including COVID)|2|||
16093218|NCT02710669|38832972|FG001|Overall Study|Institutional delays (including COVID)|2|||
16093219|NCT02710669|38832973|FG002|Overall Study|Institutional delays (including COVID)|0|||
16093220|NCT02710669|38832971|FG000|Overall Study|arrived in afib/aflutter|10|||
16093221|NCT02710669|38832972|FG001|Overall Study|arrived in afib/aflutter|8|||
16093222|NCT02710669|38832973|FG002|Overall Study|arrived in afib/aflutter|2|||
16093223|NCT01722097|38832974|FG000|Overall Study|Patient sheets not returned|6|||
16093224|NCT01722097|38832975|FG001|Overall Study|Patient sheets not returned|5|||
16093225|NCT01732757|38832976|FG000|Overall Study|Lost to Follow-up|1|||
16093226|NCT01732757|38832977|FG001|Overall Study|Lost to Follow-up|0|||
16093227|NCT01732757|38832978|FG002|Overall Study|Lost to Follow-up|0|||
16093228|NCT03262389|38832982|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
16093229|NCT03262389|38832982|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
16093230|NCT03262389|38832982|FG000|Overall Study|opted out of PET/MR|1|||
16093231|NCT02132195|38832985|FG000|Initial Assignment|Relapsed|14|||
16093232|NCT02132195|38832986|FG001|Initial Assignment|Relapsed|0|||
16093233|NCT02132195|38832987|FG002|Initial Assignment|Relapsed|0|||
16093234|NCT02132195|38832985|FG000|Rescue Therapy|Relapsed|0|||
16093235|NCT02132195|38832986|FG001|Rescue Therapy|Relapsed|0|||
16093236|NCT02132195|38832987|FG002|Rescue Therapy|Relapsed|7|||
16093237|NCT02132195|38832985|FG000|Rescue Therapy|Physician Decision|0|||
16093238|NCT02132195|38832986|FG001|Rescue Therapy|Physician Decision|0|||
16093239|NCT02132195|38832987|FG002|Rescue Therapy|Physician Decision|1|||
16093240|NCT02132195|38832985|FG000|Rescue Therapy|Withdrawal by Subject|0|||
16093241|NCT02132195|38832986|FG001|Rescue Therapy|Withdrawal by Subject|0|||
16093242|NCT02132195|38832987|FG002|Rescue Therapy|Withdrawal by Subject|1|||
16093243|NCT02132195|38832985|FG000|Rescue Therapy|Adverse Event|0|||
16519961|NCT03746522|40372191|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
16093244|NCT02132195|38832986|FG001|Rescue Therapy|Adverse Event|0|||
16093245|NCT02132195|38832987|FG002|Rescue Therapy|Adverse Event|2|||
16093246|NCT00923078|38832988|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
16093247|NCT00923078|38832989|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
16093248|NCT00923078|38832990|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
16093249|NCT00923078|38832988|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
16093250|NCT00923078|38832989|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
16093251|NCT00923078|38832990|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
16093252|NCT02449902|38832991|FG000|Overall Study|Adverse Event|0|||
16093253|NCT02449902|38832992|FG001|Overall Study|Adverse Event|1|||
16093254|NCT02449902|38832991|FG000|Overall Study|Withdrawal by Subject|0|||
16093255|NCT02449902|38832992|FG001|Overall Study|Withdrawal by Subject|1|||
16206028|NCT00505752|39233775|FG000|Overall Study|All embryos/blastocysts discarded|0|||
16206029|NCT00505752|39233776|FG001|Overall Study|All embryos/blastocysts discarded|0|||
16206030|NCT00505752|39233777|FG002|Overall Study|All embryos/blastocysts discarded|1|||
16206031|NCT00505752|39233778|FG003|Overall Study|All embryos/blastocysts discarded|1|||
16206032|NCT00505752|39233775|FG000|Overall Study|Other|1|||
16206033|NCT00505752|39233776|FG001|Overall Study|Other|2|||
16323813|NCT02438826|39671028|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16323814|NCT02438826|39671029|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16206034|NCT00505752|39233777|FG002|Overall Study|Other|1|||
16206035|NCT00505752|39233778|FG003|Overall Study|Other|2|||
16206036|NCT00064077|39233779|FG000|Overall Study|Improper prior treatment|1|||
16206037|NCT00064077|39233780|FG001|Overall Study|Improper prior treatment|0|||
16206038|NCT00064077|39233781|FG002|Overall Study|Improper prior treatment|0|||
16206039|NCT00064077|39233782|FG003|Overall Study|Improper prior treatment|0|||
16206040|NCT00064077|39233779|FG000|Overall Study|Poor risk|2|||
16206041|NCT00064077|39233780|FG001|Overall Study|Poor risk|0|||
16206042|NCT00064077|39233781|FG002|Overall Study|Poor risk|1|||
16206043|NCT00064077|39233782|FG003|Overall Study|Poor risk|1|||
16206044|NCT00064077|39233779|FG000|Overall Study|Pathology|10|||
16206045|NCT00064077|39233780|FG001|Overall Study|Pathology|7|||
16206046|NCT00064077|39233781|FG002|Overall Study|Pathology|3|||
16206047|NCT00064077|39233782|FG003|Overall Study|Pathology|4|||
16206048|NCT00064077|39233779|FG000|Overall Study|No surgery|0|||
16206049|NCT00064077|39233780|FG001|Overall Study|No surgery|0|||
16206050|NCT00064077|39233781|FG002|Overall Study|No surgery|1|||
16206051|NCT00064077|39233782|FG003|Overall Study|No surgery|0|||
16206052|NCT00064077|39233779|FG000|Overall Study|No tumor|0|||
16206053|NCT00064077|39233780|FG001|Overall Study|No tumor|0|||
16206054|NCT00064077|39233781|FG002|Overall Study|No tumor|1|||
16206055|NCT00064077|39233782|FG003|Overall Study|No tumor|0|||
16206056|NCT00064077|39233779|FG000|Overall Study|Other reasons|2|||
16206057|NCT00064077|39233780|FG001|Overall Study|Other reasons|2|||
16206058|NCT00064077|39233781|FG002|Overall Study|Other reasons|1|||
16206059|NCT00064077|39233782|FG003|Overall Study|Other reasons|2|||
16206060|NCT04362813|39233783|FG000|Overall Study|Death|12|||
16206061|NCT04362813|39233784|FG001|Overall Study|Death|16|||
16206062|NCT04362813|39233783|FG000|Overall Study|Withdrawal by Subject|3|||
16206063|NCT04362813|39233784|FG001|Overall Study|Withdrawal by Subject|1|||
16206064|NCT04362813|39233783|FG000|Overall Study|Protocol Violation|0|||
16206065|NCT04362813|39233784|FG001|Overall Study|Protocol Violation|3|||
16206066|NCT04362813|39233783|FG000|Overall Study|Lost to Follow-up|1|||
16206067|NCT04362813|39233784|FG001|Overall Study|Lost to Follow-up|1|||
16206068|NCT04362813|39233783|FG000|Overall Study|Enrolled but did not receive treatment|2|||
16206069|NCT04362813|39233784|FG001|Overall Study|Enrolled but did not receive treatment|4|||
16206070|NCT01357889|39233785|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
16206071|NCT01357889|39233786|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
16206072|NCT01357889|39233785|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
16206073|NCT01357889|39233786|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
16206074|NCT01357889|39233785|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
16206075|NCT01357889|39233786|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
16206076|NCT01357889|39233785|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
16206077|NCT01357889|39233786|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
16206078|NCT01357889|39233785|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
16206079|NCT01357889|39233786|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
16206080|NCT01357889|39233785|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
16206081|NCT01357889|39233786|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
16206082|NCT01357889|39233785|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
16206083|NCT01357889|39233786|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
16206084|NCT01357889|39233785|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
16206085|NCT01357889|39233786|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
16206086|NCT01357889|39233785|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
16206087|NCT01357889|39233786|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
16206088|NCT01357889|39233785|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
16206089|NCT01357889|39233786|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
16206090|NCT01357889|39233785|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
16206091|NCT01357889|39233786|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
16206092|NCT01357889|39233785|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
16206093|NCT01357889|39233786|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
16206094|NCT01357889|39233785|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
16206095|NCT01357889|39233786|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
16206096|NCT02204410|39233789|FG000|Overall Study|Lost to Follow-up|5|||
16206097|NCT02204410|39233789|FG000|Overall Study|Physician Decision|2|||
16206098|NCT02204410|39233789|FG000|Overall Study|Protocol Violation|1|||
16206099|NCT02204410|39233789|FG000|Overall Study|Withdrawal by Subject|3|||
16206100|NCT03136484|39233791|FG000|Overall Study|Withdrawal by Subject|19|||
16206101|NCT03136484|39233792|FG001|Overall Study|Withdrawal by Subject|14|||
16206102|NCT03136484|39233791|FG000|Overall Study|Lost to Follow-up|7|||
16206103|NCT03136484|39233792|FG001|Overall Study|Lost to Follow-up|8|||
16206104|NCT03136484|39233791|FG000|Overall Study|Death|1|||
16206105|NCT03136484|39233792|FG001|Overall Study|Death|0|||
16206106|NCT03911869|39233793|FG000|Safety Lead-in Phase|Death|7|||
16206107|NCT03911869|39233794|FG001|Safety Lead-in Phase|Death|0|||
16206108|NCT03911869|39233795|FG002|Safety Lead-in Phase|Death|0|||
16206109|NCT03911869|39233793|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
16206110|NCT03911869|39233794|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
16206111|NCT03911869|39233795|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
16206112|NCT03911869|39233793|FG000|Safety Lead-in Phase|Other|1|||
16206113|NCT03911869|39233794|FG001|Safety Lead-in Phase|Other|0|||
16206114|NCT03911869|39233795|FG002|Safety Lead-in Phase|Other|0|||
16206115|NCT03911869|39233793|FG000|Phase 2|Death|0|||
16206116|NCT03911869|39233794|FG001|Phase 2|Death|3|||
16206117|NCT03911869|39233795|FG002|Phase 2|Death|0|||
16206118|NCT01742078|39233796|FG000|Overall Study|Withdrawal by Subject|0|||
16206119|NCT01742078|39233797|FG001|Overall Study|Withdrawal by Subject|0|||
16206120|NCT01742078|39233798|FG002|Overall Study|Withdrawal by Subject|0|||
16206121|NCT01742078|39233799|FG003|Overall Study|Withdrawal by Subject|1|||
16206122|NCT01742078|39233800|FG004|Overall Study|Withdrawal by Subject|0|||
16206123|NCT01742078|39233801|FG005|Overall Study|Withdrawal by Subject|0|||
16206124|NCT01742078|39233802|FG006|Overall Study|Withdrawal by Subject|0|||
16206125|NCT01742078|39233803|FG007|Overall Study|Withdrawal by Subject|0|||
16206126|NCT01742078|39233804|FG008|Overall Study|Withdrawal by Subject|0|||
16206127|NCT01313039|39233808|FG000|Overall Study|Physician Decision|1|||
16206128|NCT01313039|39233808|FG000|Overall Study|Adverse Event|1|||
16206129|NCT02384993|39233809|FG000|Overall Study|Adverse Event|0|||
16206130|NCT02384993|39233810|FG001|Overall Study|Adverse Event|1|||
16206131|NCT00033371|39233815|FG000|Overall Study|Adverse Event|1|||
16206132|NCT00033371|39233816|FG001|Overall Study|Adverse Event|5|||
16206133|NCT00033371|39233815|FG000|Overall Study|Lost to Follow-up|2|||
16206134|NCT00033371|39233816|FG001|Overall Study|Lost to Follow-up|1|||
16206135|NCT00033371|39233815|FG000|Overall Study|Withdrawal by Subject|3|||
16206136|NCT00033371|39233816|FG001|Overall Study|Withdrawal by Subject|3|||
16206137|NCT00033371|39233815|FG000|Overall Study|Disease Progression|0|||
16206138|NCT00033371|39233816|FG001|Overall Study|Disease Progression|1|||
16206139|NCT01373918|39233817|FG000|Overall Study|Physician Decision|0|||
16206140|NCT01373918|39233818|FG001|Overall Study|Physician Decision|1|||
16206141|NCT02699125|39233823|FG000|Placebo|Lost to Follow-up|2|||
16206142|NCT02699125|39233824|FG001|Placebo|Lost to Follow-up|0|||
16206143|NCT02699125|39233823|FG000|Placebo|Protocol Violation|1|||
16206144|NCT02699125|39233824|FG001|Placebo|Protocol Violation|0|||
16206145|NCT02699125|39233823|FG000|Placebo|Withdrawal by Subject|0|||
16206146|NCT02699125|39233824|FG001|Placebo|Withdrawal by Subject|4|||
16206147|NCT02699125|39233823|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
16206148|NCT02699125|39233824|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
16206149|NCT00379236|39233832|FG000|Double-blind|Adverse Event|11|||
16206150|NCT00379236|39233833|FG001|Double-blind|Adverse Event|6|||
16206151|NCT00379236|39233834|FG002|Double-blind|Adverse Event|0|||
16206152|NCT00379236|39233832|FG000|Double-blind|Protocol Violation|3|||
16206153|NCT00379236|39233833|FG001|Double-blind|Protocol Violation|3|||
16206154|NCT00379236|39233834|FG002|Double-blind|Protocol Violation|0|||
16206155|NCT00379236|39233832|FG000|Double-blind|Withdrawal by Subject|12|||
16206156|NCT00379236|39233833|FG001|Double-blind|Withdrawal by Subject|13|||
16206157|NCT00379236|39233834|FG002|Double-blind|Withdrawal by Subject|0|||
16206158|NCT00379236|39233832|FG000|Double-blind|Lost to Follow-up|4|||
16206159|NCT00379236|39233833|FG001|Double-blind|Lost to Follow-up|3|||
16206160|NCT00379236|39233834|FG002|Double-blind|Lost to Follow-up|0|||
16206161|NCT00379236|39233832|FG000|Double-blind|Use of exclusionary medication|1|||
16323815|NCT02438826|39671026|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
16206162|NCT00379236|39233833|FG001|Double-blind|Use of exclusionary medication|2|||
16323816|NCT02438826|39671027|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
16323817|NCT02438826|39671028|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16323818|NCT02438826|39671029|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16206163|NCT00379236|39233834|FG002|Double-blind|Use of exclusionary medication|0|||
16206164|NCT00379236|39233832|FG000|Double-blind|Other|3|||
16206165|NCT00379236|39233833|FG001|Double-blind|Other|7|||
16206166|NCT00379236|39233834|FG002|Double-blind|Other|0|||
16206167|NCT00379236|39233832|FG000|Double-blind|Data could not be retrieved|2|||
16206168|NCT00379236|39233833|FG001|Double-blind|Data could not be retrieved|2|||
16206169|NCT00379236|39233834|FG002|Double-blind|Data could not be retrieved|0|||
16206170|NCT00379236|39233832|FG000|Open-label Extension|Adverse Event|0|||
16519962|NCT03746522|40372192|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
16519963|NCT03746522|40372190|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
16519964|NCT03746522|40372191|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
16519965|NCT03746522|40372192|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
16519966|NCT03746522|40372190|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
16519967|NCT03746522|40372191|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
16519968|NCT03746522|40372192|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
16519969|NCT04394351|40372193|FG000|Part A (16 Weeks)|Adverse Event|1|||
16519970|NCT04394351|40372194|FG001|Part A (16 Weeks)|Adverse Event|0|||
16519971|NCT04394351|40372195|FG002|Part A (16 Weeks)|Adverse Event|0|||
16519972|NCT04394351|40372196|FG003|Part A (16 Weeks)|Adverse Event|0|||
16519973|NCT04394351|40372197|FG004|Part A (16 Weeks)|Adverse Event|0|||
16519974|NCT04394351|40372198|FG005|Part A (16 Weeks)|Adverse Event|0|||
16519975|NCT04394351|40372199|FG006|Part A (16 Weeks)|Adverse Event|0|||
16519976|NCT04394351|40372200|FG007|Part A (16 Weeks)|Adverse Event|0|||
16519977|NCT04394351|40372193|FG000|Part A (16 Weeks)|Physician Decision|0|||
16519978|NCT04394351|40372194|FG001|Part A (16 Weeks)|Physician Decision|1|||
16519979|NCT04394351|40372195|FG002|Part A (16 Weeks)|Physician Decision|0|||
16519980|NCT04394351|40372196|FG003|Part A (16 Weeks)|Physician Decision|0|||
16519981|NCT04394351|40372197|FG004|Part A (16 Weeks)|Physician Decision|0|||
16519982|NCT04394351|40372198|FG005|Part A (16 Weeks)|Physician Decision|0|||
16519983|NCT04394351|40372199|FG006|Part A (16 Weeks)|Physician Decision|0|||
16519984|NCT04394351|40372200|FG007|Part A (16 Weeks)|Physician Decision|0|||
16323819|NCT02438826|39671026|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
16323820|NCT02438826|39671027|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
16323821|NCT02438826|39671028|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
16323822|NCT02438826|39671029|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
16323823|NCT02438826|39671026|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
16323824|NCT02438826|39671027|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
16323825|NCT02438826|39671028|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
16323826|NCT02438826|39671029|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
16323827|NCT02438826|39671026|FG000|Open-Label Treatment Phase|Adverse Event|11|||
16519985|NCT04394351|40372193|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
16519986|NCT04394351|40372194|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
16519987|NCT04394351|40372195|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
16519988|NCT04394351|40372196|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
16519989|NCT04394351|40372197|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
16519990|NCT04394351|40372198|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
16519991|NCT04394351|40372199|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
16519992|NCT04394351|40372200|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
16519993|NCT04394351|40372193|FG000|Part B (36 Weeks)|Adverse Event|0|||
16519994|NCT04394351|40372194|FG001|Part B (36 Weeks)|Adverse Event|0|||
16519995|NCT04394351|40372195|FG002|Part B (36 Weeks)|Adverse Event|0|||
16519996|NCT04394351|40372196|FG003|Part B (36 Weeks)|Adverse Event|0|||
16519997|NCT04394351|40372197|FG004|Part B (36 Weeks)|Adverse Event|0|||
16519998|NCT04394351|40372198|FG005|Part B (36 Weeks)|Adverse Event|0|||
16519999|NCT04394351|40372199|FG006|Part B (36 Weeks)|Adverse Event|1|||
16520000|NCT04394351|40372200|FG007|Part B (36 Weeks)|Adverse Event|0|||
16520001|NCT02742103|40372201|FG000|Overall Study|Protocol Violation|1|||
16520002|NCT02742103|40372202|FG001|Overall Study|Protocol Violation|0|||
16520003|NCT02742103|40372201|FG000|Overall Study|Death|2|||
16520004|NCT02742103|40372202|FG001|Overall Study|Death|2|||
16520005|NCT02742103|40372201|FG000|Overall Study|Adverse Event|1|||
16520006|NCT02742103|40372202|FG001|Overall Study|Adverse Event|0|||
16520007|NCT02742103|40372201|FG000|Overall Study|Moved to another town|0|||
16520008|NCT02742103|40372202|FG001|Overall Study|Moved to another town|1|||
16520009|NCT02742103|40372201|FG000|Overall Study|Withdrawal by Subject|5|||
16323828|NCT02438826|39671027|FG001|Open-Label Treatment Phase|Adverse Event|6|||
16093256|NCT01468597|38832997|FG000|Overall Study|Found ineligible|17|||
16093257|NCT01468597|38832997|FG000|Overall Study|concomitant valves|12|||
16093258|NCT01468597|38832997|FG000|Overall Study|off-pump CABG|1|||
16093259|NCT01468597|38832997|FG000|Overall Study|no platelet function data|5|||
16093260|NCT02708498|38833002|FG000|Overall Study|Death|20|||
16093261|NCT02708498|38833003|FG001|Overall Study|Death|19|||
16093262|NCT02708498|38833004|FG002|Overall Study|Death|0|||
16093263|NCT02708498|38833005|FG003|Overall Study|Death|0|||
16093264|NCT02708498|38833006|FG004|Overall Study|Death|1|||
16093265|NCT02708498|38833007|FG005|Overall Study|Death|0|||
16093266|NCT02708498|38833008|FG006|Overall Study|Death|0|||
16093267|NCT02708498|38833009|FG007|Overall Study|Death|0|||
16093268|NCT02708498|38833002|FG000|Overall Study|Unknown reason, missing data|0|||
16093269|NCT02708498|38833003|FG001|Overall Study|Unknown reason, missing data|0|||
16093270|NCT02708498|38833004|FG002|Overall Study|Unknown reason, missing data|62|||
16093271|NCT02708498|38833005|FG003|Overall Study|Unknown reason, missing data|51|||
16093272|NCT02708498|38833006|FG004|Overall Study|Unknown reason, missing data|195|||
16093273|NCT02708498|38833007|FG005|Overall Study|Unknown reason, missing data|132|||
16093274|NCT02708498|38833008|FG006|Overall Study|Unknown reason, missing data|0|||
16093275|NCT02708498|38833009|FG007|Overall Study|Unknown reason, missing data|0|||
16093276|NCT00403845|38833013|FG000|Treatment Period 1|Subject withdrew consent|1|||
16093277|NCT00403845|38833014|FG001|Treatment Period 1|Subject withdrew consent|0|||
16093278|NCT00403845|38833015|FG002|Treatment Period 1|Subject withdrew consent|0|||
16093279|NCT00403845|38833016|FG003|Treatment Period 1|Subject withdrew consent|0|||
16093280|NCT00403845|38833013|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
16093281|NCT00403845|38833014|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
16093282|NCT00403845|38833015|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
16093283|NCT00403845|38833016|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
16093284|NCT00403845|38833013|FG000|Treatment Period 2|Subject withdrew consent|1|||
16093285|NCT00403845|38833014|FG001|Treatment Period 2|Subject withdrew consent|0|||
16093286|NCT00403845|38833015|FG002|Treatment Period 2|Subject withdrew consent|0|||
16093287|NCT00403845|38833016|FG003|Treatment Period 2|Subject withdrew consent|0|||
16093288|NCT00403845|38833013|FG000|Treatment Period 3|Subject withdrew consent|0|||
16093289|NCT00403845|38833014|FG001|Treatment Period 3|Subject withdrew consent|0|||
16093290|NCT00403845|38833015|FG002|Treatment Period 3|Subject withdrew consent|0|||
16093291|NCT00403845|38833016|FG003|Treatment Period 3|Subject withdrew consent|1|||
16093292|NCT00403845|38833013|FG000|Treatment Period 3|Adverse Event|0|||
16093293|NCT00403845|38833014|FG001|Treatment Period 3|Adverse Event|0|||
16206171|NCT00379236|39233833|FG001|Open-label Extension|Adverse Event|0|||
16206172|NCT00379236|39233834|FG002|Open-label Extension|Adverse Event|13|||
16206173|NCT00379236|39233832|FG000|Open-label Extension|Protocol Violation|0|||
16206174|NCT00379236|39233833|FG001|Open-label Extension|Protocol Violation|0|||
16206175|NCT00379236|39233834|FG002|Open-label Extension|Protocol Violation|7|||
16206176|NCT00379236|39233832|FG000|Open-label Extension|Withdrawal by Subject|0|||
16206177|NCT00379236|39233833|FG001|Open-label Extension|Withdrawal by Subject|0|||
16206178|NCT00379236|39233834|FG002|Open-label Extension|Withdrawal by Subject|13|||
16206179|NCT00379236|39233832|FG000|Open-label Extension|Lost to Follow-up|0|||
16206180|NCT00379236|39233833|FG001|Open-label Extension|Lost to Follow-up|0|||
16206181|NCT00379236|39233834|FG002|Open-label Extension|Lost to Follow-up|12|||
16206182|NCT00379236|39233832|FG000|Open-label Extension|Use of exclusionary medication|0|||
16206183|NCT00379236|39233833|FG001|Open-label Extension|Use of exclusionary medication|0|||
16206184|NCT00379236|39233834|FG002|Open-label Extension|Use of exclusionary medication|3|||
16206185|NCT00379236|39233832|FG000|Open-label Extension|Other|0|||
16206186|NCT00379236|39233833|FG001|Open-label Extension|Other|0|||
16206187|NCT00379236|39233834|FG002|Open-label Extension|Other|7|||
16206188|NCT02843178|39233835|FG000|Overall Study|Lost to Follow-up|8|||
16206189|NCT02843178|39233836|FG001|Overall Study|Lost to Follow-up|8|||
16206190|NCT02843178|39233837|FG002|Overall Study|Lost to Follow-up|6|||
16206191|NCT02843178|39233838|FG003|Overall Study|Lost to Follow-up|3|||
16206192|NCT02843178|39233835|FG000|Overall Study|Withdrawal by Subject|0|||
16206193|NCT02843178|39233836|FG001|Overall Study|Withdrawal by Subject|0|||
16206194|NCT02843178|39233837|FG002|Overall Study|Withdrawal by Subject|1|||
16206195|NCT02843178|39233838|FG003|Overall Study|Withdrawal by Subject|1|||
16206196|NCT02460978|39233841|FG000|Overall Study|Adverse Event|17|||
16206197|NCT02460978|39233842|FG001|Overall Study|Adverse Event|11|||
16206198|NCT02460978|39233843|FG002|Overall Study|Adverse Event|11|||
16206199|NCT02460978|39233841|FG000|Overall Study|Withdrawal by Subject|5|||
16206200|NCT02460978|39233842|FG001|Overall Study|Withdrawal by Subject|5|||
16206201|NCT02460978|39233843|FG002|Overall Study|Withdrawal by Subject|14|||
16206202|NCT02460978|39233841|FG000|Overall Study|Lost to Follow-up|2|||
16206203|NCT02460978|39233842|FG001|Overall Study|Lost to Follow-up|3|||
16206204|NCT02460978|39233843|FG002|Overall Study|Lost to Follow-up|1|||
16206205|NCT02460978|39233841|FG000|Overall Study|Protocol Violation|1|||
16206206|NCT02460978|39233842|FG001|Overall Study|Protocol Violation|1|||
16206207|NCT02460978|39233843|FG002|Overall Study|Protocol Violation|1|||
16206208|NCT02460978|39233841|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
16206209|NCT02460978|39233842|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
16206210|NCT02460978|39233843|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
16206211|NCT02460978|39233841|FG000|Overall Study|Pregnancy|0|||
16206212|NCT02460978|39233842|FG001|Overall Study|Pregnancy|0|||
16206213|NCT02460978|39233843|FG002|Overall Study|Pregnancy|2|||
16206214|NCT00845845|39233849|FG000|Overall Study|Lost to Follow-up|0|||
16206215|NCT00845845|39233850|FG001|Overall Study|Lost to Follow-up|4|||
16206216|NCT00814307|39233851|FG000|Overall Study|Randomized but not treated|1|||
16206217|NCT00814307|39233852|FG001|Overall Study|Randomized but not treated|0|||
16206218|NCT00814307|39233853|FG002|Overall Study|Randomized but not treated|0|||
16206219|NCT00814307|39233854|FG003|Overall Study|Randomized but not treated|0|||
16206220|NCT00814307|39233851|FG000|Overall Study|Adverse Event|3|||
16206221|NCT00814307|39233852|FG001|Overall Study|Adverse Event|9|||
16206222|NCT00814307|39233853|FG002|Overall Study|Adverse Event|3|||
16206223|NCT00814307|39233854|FG003|Overall Study|Adverse Event|2|||
16206224|NCT00814307|39233851|FG000|Overall Study|Lack of Efficacy|1|||
16206225|NCT00814307|39233852|FG001|Overall Study|Lack of Efficacy|1|||
16206226|NCT00814307|39233853|FG002|Overall Study|Lack of Efficacy|3|||
16206227|NCT00814307|39233854|FG003|Overall Study|Lack of Efficacy|4|||
16206228|NCT00814307|39233851|FG000|Overall Study|Other|1|||
16206229|NCT00814307|39233852|FG001|Overall Study|Other|2|||
16206230|NCT00814307|39233853|FG002|Overall Study|Other|0|||
16206231|NCT00814307|39233854|FG003|Overall Study|Other|1|||
16206232|NCT00814307|39233851|FG000|Overall Study|Protocol Violation|2|||
16206233|NCT00814307|39233852|FG001|Overall Study|Protocol Violation|8|||
16206234|NCT00814307|39233853|FG002|Overall Study|Protocol Violation|1|||
16206235|NCT00814307|39233854|FG003|Overall Study|Protocol Violation|1|||
16206236|NCT00814307|39233851|FG000|Overall Study|Withdrawal by Subject|4|||
16206237|NCT00814307|39233852|FG001|Overall Study|Withdrawal by Subject|6|||
16206238|NCT00814307|39233853|FG002|Overall Study|Withdrawal by Subject|0|||
16206239|NCT00814307|39233854|FG003|Overall Study|Withdrawal by Subject|2|||
16206240|NCT00814307|39233851|FG000|Overall Study|Death|0|||
16206241|NCT00814307|39233852|FG001|Overall Study|Death|1|||
16206242|NCT00814307|39233853|FG002|Overall Study|Death|0|||
16206243|NCT00814307|39233854|FG003|Overall Study|Death|0|||
16206244|NCT04839393|39233855|FG000|Overall Study|Adverse Event|0|||
16206245|NCT04839393|39233856|FG001|Overall Study|Adverse Event|0|||
16206246|NCT04839393|39233857|FG002|Overall Study|Adverse Event|2|||
16206247|NCT04839393|39233855|FG000|Overall Study|Withdrawal by participant|0|||
16206248|NCT04839393|39233856|FG001|Overall Study|Withdrawal by participant|0|||
16206249|NCT04839393|39233857|FG002|Overall Study|Withdrawal by participant|1|||
16206250|NCT01809197|39233858|FG000|Overall Study|Lost to Follow-up|4|||
16206251|NCT01809197|39233859|FG001|Overall Study|Lost to Follow-up|2|||
16206252|NCT01809197|39233858|FG000|Overall Study|Adverse Event|2|||
16206253|NCT01809197|39233859|FG001|Overall Study|Adverse Event|3|||
16206254|NCT01809197|39233858|FG000|Overall Study|Failed slit lamp exam|1|||
16206255|NCT01809197|39233859|FG001|Overall Study|Failed slit lamp exam|0|||
16206256|NCT01809197|39233858|FG000|Overall Study|Non-Compliance|1|||
16206257|NCT01809197|39233859|FG001|Overall Study|Non-Compliance|1|||
16206258|NCT01809197|39233858|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
16206259|NCT01809197|39233859|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
16206260|NCT01809197|39233858|FG000|Overall Study|Withdrawal by Subject|1|||
16206261|NCT01809197|39233859|FG001|Overall Study|Withdrawal by Subject|1|||
16206262|NCT01809197|39233858|FG000|Overall Study|Product not available|0|||
16206263|NCT01809197|39233859|FG001|Overall Study|Product not available|1|||
16206264|NCT00105560|39233860|FG000|Overall Study|Lost to Follow-up|1|||
16206265|NCT02685995|39233862|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
16206266|NCT02685995|39233863|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
16206267|NCT00701103|39233866|FG000|Overall Study|Adverse Event|0|||
16206268|NCT00701103|39233867|FG001|Overall Study|Adverse Event|0|||
16206269|NCT00701103|39233868|FG002|Overall Study|Adverse Event|1|||
16206270|NCT00701103|39233869|FG003|Overall Study|Adverse Event|1|||
16206271|NCT00701103|39233870|FG004|Overall Study|Adverse Event|0|||
16206272|NCT00701103|39233871|FG005|Overall Study|Adverse Event|1|||
16206273|NCT00701103|39233872|FG006|Overall Study|Adverse Event|1|||
16206274|NCT00701103|39233873|FG007|Overall Study|Adverse Event|0|||
16206275|NCT00701103|39233874|FG008|Overall Study|Adverse Event|0|||
16206276|NCT00701103|39233875|FG009|Overall Study|Adverse Event|2|||
16206277|NCT00701103|39233876|FG010|Overall Study|Adverse Event|0|||
16206278|NCT00701103|39233866|FG000|Overall Study|Progressive Disease|5|||
16206279|NCT00701103|39233867|FG001|Overall Study|Progressive Disease|2|||
16206280|NCT00701103|39233868|FG002|Overall Study|Progressive Disease|6|||
16206281|NCT00701103|39233869|FG003|Overall Study|Progressive Disease|5|||
16206282|NCT00701103|39233870|FG004|Overall Study|Progressive Disease|6|||
16206283|NCT00701103|39233871|FG005|Overall Study|Progressive Disease|5|||
16206284|NCT00701103|39233872|FG006|Overall Study|Progressive Disease|7|||
16206285|NCT00701103|39233873|FG007|Overall Study|Progressive Disease|7|||
16206286|NCT00701103|39233874|FG008|Overall Study|Progressive Disease|8|||
16206287|NCT00701103|39233875|FG009|Overall Study|Progressive Disease|8|||
16206288|NCT00701103|39233876|FG010|Overall Study|Progressive Disease|11|||
16206289|NCT00701103|39233866|FG000|Overall Study|Withdrawal by Subject|0|||
16206290|NCT00701103|39233867|FG001|Overall Study|Withdrawal by Subject|1|||
16206291|NCT00701103|39233868|FG002|Overall Study|Withdrawal by Subject|1|||
16206292|NCT00701103|39233869|FG003|Overall Study|Withdrawal by Subject|0|||
16206293|NCT00701103|39233870|FG004|Overall Study|Withdrawal by Subject|0|||
16206294|NCT00701103|39233871|FG005|Overall Study|Withdrawal by Subject|0|||
16206295|NCT00701103|39233872|FG006|Overall Study|Withdrawal by Subject|0|||
16206296|NCT00701103|39233873|FG007|Overall Study|Withdrawal by Subject|0|||
16206297|NCT00701103|39233874|FG008|Overall Study|Withdrawal by Subject|0|||
16206298|NCT00701103|39233875|FG009|Overall Study|Withdrawal by Subject|0|||
16206299|NCT00701103|39233876|FG010|Overall Study|Withdrawal by Subject|0|||
16323829|NCT02438826|39671028|FG002|Open-Label Treatment Phase|Adverse Event|0|||
16323830|NCT02438826|39671029|FG003|Open-Label Treatment Phase|Adverse Event|0|||
16206300|NCT00701103|39233866|FG000|Overall Study|Other|0|||
16206301|NCT00701103|39233867|FG001|Overall Study|Other|0|||
16206302|NCT00701103|39233868|FG002|Overall Study|Other|0|||
16206303|NCT00701103|39233869|FG003|Overall Study|Other|0|||
16206304|NCT00701103|39233870|FG004|Overall Study|Other|0|||
16206305|NCT00701103|39233871|FG005|Overall Study|Other|0|||
16206306|NCT00701103|39233872|FG006|Overall Study|Other|0|||
16206307|NCT00701103|39233873|FG007|Overall Study|Other|0|||
16206308|NCT00701103|39233874|FG008|Overall Study|Other|1|||
16206309|NCT00701103|39233875|FG009|Overall Study|Other|1|||
16206310|NCT00701103|39233876|FG010|Overall Study|Other|0|||
16206311|NCT03351478|39233877|FG000|Overall Study|At the subject's own request|11|||
16206312|NCT03351478|39233878|FG001|Overall Study|At the subject's own request|12|||
16206313|NCT03351478|39233879|FG002|Overall Study|At the subject's own request|5|||
16206314|NCT03351478|39233877|FG000|Overall Study|Adverse Event|1|||
16206315|NCT03351478|39233878|FG001|Overall Study|Adverse Event|2|||
16206316|NCT03351478|39233879|FG002|Overall Study|Adverse Event|1|||
16206317|NCT03351478|39233877|FG000|Overall Study|Poor compliance to protocol|1|||
16206318|NCT03351478|39233878|FG001|Overall Study|Poor compliance to protocol|0|||
16206319|NCT03351478|39233879|FG002|Overall Study|Poor compliance to protocol|0|||
16206320|NCT03351478|39233877|FG000|Overall Study|Reason not Specified|1|||
16206321|NCT03351478|39233878|FG001|Overall Study|Reason not Specified|3|||
16206322|NCT03351478|39233879|FG002|Overall Study|Reason not Specified|0|||
16206323|NCT03351478|39233877|FG000|Overall Study|Lost to Follow-up|0|||
16206324|NCT03351478|39233878|FG001|Overall Study|Lost to Follow-up|0|||
16206325|NCT03351478|39233879|FG002|Overall Study|Lost to Follow-up|1|||
16206326|NCT00994162|39233880|FG000|Overall Study|Withdrawal by Subject|1|||
16206327|NCT00994162|39233880|FG000|Overall Study|Lost to Follow-up|2|||
16206328|NCT00994162|39233880|FG000|Overall Study|Product Complaint|1|||
16206329|NCT00994162|39233880|FG000|Overall Study|Poor Compliance|5|||
16206330|NCT00994162|39233880|FG000|Overall Study|Lack of Response|3|||
16206331|NCT00994162|39233880|FG000|Overall Study|Discharged from Hospital|4|||
16206332|NCT00994162|39233880|FG000|Overall Study|Death|2|||
16206333|NCT00994162|39233880|FG000|Overall Study|Care Transferred to Another Physician|2|||
16206334|NCT00994162|39233880|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
16206335|NCT00994162|39233880|FG000|Overall Study|Physician Decision|2|||
16206336|NCT00994162|39233880|FG000|Overall Study|Surrounding Wound Erythematous|1|||
16206337|NCT00994162|39233880|FG000|Overall Study|Machine Losing Vaccum|1|||
16206338|NCT00994162|39233880|FG000|Overall Study|Patient Lived Too Far Away|1|||
16206339|NCT00994162|39233880|FG000|Overall Study|Above Knee Amputation|1|||
16206340|NCT00994162|39233880|FG000|Overall Study|Reason Not Reported By Site|1|||
16206341|NCT01153893|39233892|FG000|Overall Study|Adverse Event|1|||
16206342|NCT01153893|39233893|FG001|Overall Study|Adverse Event|0|||
16206343|NCT00517413|39233894|FG000|Overall Study|Adverse Event|7|||
16206344|NCT00517413|39233894|FG000|Overall Study|Death|13|||
16206345|NCT00517413|39233894|FG000|Overall Study|Protocol Violation|15|||
16206346|NCT00517413|39233894|FG000|Overall Study|Withdrawal by Subject|2|||
16206347|NCT00517413|39233894|FG000|Overall Study|Failure to return|1|||
16206348|NCT00517413|39233894|FG000|Overall Study|Other-Reasons|23|||
16206349|NCT00696436|39233895|FG000|Overall Study|Adverse Event|7|||
16206350|NCT00696436|39233896|FG001|Overall Study|Adverse Event|9|||
16206351|NCT00696436|39233897|FG002|Overall Study|Adverse Event|8|||
16206352|NCT00696436|39233898|FG003|Overall Study|Adverse Event|6|||
16206353|NCT00696436|39233899|FG004|Overall Study|Adverse Event|4|||
16206354|NCT00696436|39233895|FG000|Overall Study|Protocol Violation|3|||
16206355|NCT00696436|39233896|FG001|Overall Study|Protocol Violation|2|||
16206356|NCT00696436|39233897|FG002|Overall Study|Protocol Violation|2|||
16206357|NCT00696436|39233898|FG003|Overall Study|Protocol Violation|0|||
16206358|NCT00696436|39233899|FG004|Overall Study|Protocol Violation|1|||
16206359|NCT00696436|39233895|FG000|Overall Study|Lost to Follow-up|1|||
16206360|NCT00696436|39233896|FG001|Overall Study|Lost to Follow-up|6|||
16206361|NCT00696436|39233897|FG002|Overall Study|Lost to Follow-up|2|||
16206362|NCT00696436|39233898|FG003|Overall Study|Lost to Follow-up|4|||
16206363|NCT00696436|39233899|FG004|Overall Study|Lost to Follow-up|3|||
16206364|NCT00696436|39233895|FG000|Overall Study|Withdrawal by Subject|4|||
16206365|NCT00696436|39233896|FG001|Overall Study|Withdrawal by Subject|11|||
16206366|NCT00696436|39233897|FG002|Overall Study|Withdrawal by Subject|5|||
16206367|NCT00696436|39233898|FG003|Overall Study|Withdrawal by Subject|7|||
16206368|NCT00696436|39233899|FG004|Overall Study|Withdrawal by Subject|1|||
16206369|NCT00696436|39233895|FG000|Overall Study|Lack of Efficacy|3|||
16206370|NCT00696436|39233896|FG001|Overall Study|Lack of Efficacy|1|||
16206371|NCT00696436|39233897|FG002|Overall Study|Lack of Efficacy|5|||
16206372|NCT00696436|39233898|FG003|Overall Study|Lack of Efficacy|2|||
16206373|NCT00696436|39233899|FG004|Overall Study|Lack of Efficacy|4|||
16206374|NCT00696436|39233895|FG000|Overall Study|Participant Unavailability|2|||
16206375|NCT00696436|39233896|FG001|Overall Study|Participant Unavailability|0|||
16206376|NCT00696436|39233897|FG002|Overall Study|Participant Unavailability|2|||
16206377|NCT00696436|39233898|FG003|Overall Study|Participant Unavailability|1|||
16206378|NCT00696436|39233899|FG004|Overall Study|Participant Unavailability|0|||
16206379|NCT00696436|39233895|FG000|Overall Study|Administrative Error|2|||
16206380|NCT00696436|39233896|FG001|Overall Study|Administrative Error|0|||
16206381|NCT00696436|39233897|FG002|Overall Study|Administrative Error|2|||
16206382|NCT00696436|39233898|FG003|Overall Study|Administrative Error|0|||
16206383|NCT00696436|39233899|FG004|Overall Study|Administrative Error|0|||
16395752|NCT01673854|39931153|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
16395753|NCT01673854|39931153|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
16206384|NCT00696436|39233895|FG000|Overall Study|Participant Non-compliance|0|||
16206385|NCT00696436|39233896|FG001|Overall Study|Participant Non-compliance|0|||
16206386|NCT00696436|39233897|FG002|Overall Study|Participant Non-compliance|1|||
16206387|NCT00696436|39233898|FG003|Overall Study|Participant Non-compliance|2|||
16206388|NCT00696436|39233899|FG004|Overall Study|Participant Non-compliance|0|||
16520010|NCT02742103|40372202|FG001|Overall Study|Withdrawal by Subject|2|||
16520011|NCT01513291|40372205|FG000|Treatment Period|Adverse Event|8|||
16520012|NCT01513291|40372206|FG001|Treatment Period|Adverse Event|4|||
16520013|NCT01513291|40372207|FG002|Treatment Period|Adverse Event|0|||
16520014|NCT01513291|40372208|FG003|Treatment Period|Adverse Event|0|||
16520015|NCT01513291|40372209|FG004|Treatment Period|Adverse Event|0|||
16520016|NCT01513291|40372205|FG000|Treatment Period|Lack of Efficacy|3|||
16520017|NCT01513291|40372206|FG001|Treatment Period|Lack of Efficacy|0|||
16520018|NCT01513291|40372207|FG002|Treatment Period|Lack of Efficacy|0|||
16520019|NCT01513291|40372208|FG003|Treatment Period|Lack of Efficacy|0|||
16520020|NCT01513291|40372209|FG004|Treatment Period|Lack of Efficacy|0|||
16520021|NCT01513291|40372205|FG000|Treatment Period|Lost to Follow-up|2|||
16520022|NCT01513291|40372206|FG001|Treatment Period|Lost to Follow-up|3|||
16520023|NCT01513291|40372207|FG002|Treatment Period|Lost to Follow-up|0|||
16520024|NCT01513291|40372208|FG003|Treatment Period|Lost to Follow-up|0|||
16520025|NCT01513291|40372209|FG004|Treatment Period|Lost to Follow-up|0|||
16520026|NCT01513291|40372205|FG000|Treatment Period|Physician Decision|1|||
16520027|NCT01513291|40372206|FG001|Treatment Period|Physician Decision|0|||
16520028|NCT01513291|40372207|FG002|Treatment Period|Physician Decision|0|||
16520029|NCT01513291|40372208|FG003|Treatment Period|Physician Decision|0|||
16520030|NCT01513291|40372209|FG004|Treatment Period|Physician Decision|0|||
16520031|NCT01513291|40372205|FG000|Treatment Period|Protocol Violation|1|||
16520032|NCT01513291|40372206|FG001|Treatment Period|Protocol Violation|2|||
16520033|NCT01513291|40372207|FG002|Treatment Period|Protocol Violation|0|||
16520034|NCT01513291|40372208|FG003|Treatment Period|Protocol Violation|0|||
16520035|NCT01513291|40372209|FG004|Treatment Period|Protocol Violation|0|||
16520036|NCT01513291|40372205|FG000|Treatment Period|Withdrawal by Subject|8|||
16520037|NCT01513291|40372206|FG001|Treatment Period|Withdrawal by Subject|5|||
16520038|NCT01513291|40372207|FG002|Treatment Period|Withdrawal by Subject|0|||
16520039|NCT01513291|40372208|FG003|Treatment Period|Withdrawal by Subject|0|||
16520040|NCT01513291|40372209|FG004|Treatment Period|Withdrawal by Subject|0|||
16520041|NCT01513291|40372205|FG000|Treatment Period|Randomized not treated|0|||
16520042|NCT01513291|40372206|FG001|Treatment Period|Randomized not treated|2|||
16520043|NCT01513291|40372207|FG002|Treatment Period|Randomized not treated|0|||
16520044|NCT01513291|40372208|FG003|Treatment Period|Randomized not treated|0|||
16520045|NCT01513291|40372209|FG004|Treatment Period|Randomized not treated|0|||
16323831|NCT02438826|39671026|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
16520046|NCT01513291|40372205|FG000|Run-out Period|Lost to Follow-up|0|||
16520047|NCT01513291|40372206|FG001|Run-out Period|Lost to Follow-up|0|||
16520048|NCT01513291|40372207|FG002|Run-out Period|Lost to Follow-up|0|||
16520049|NCT01513291|40372208|FG003|Run-out Period|Lost to Follow-up|1|||
16520050|NCT01513291|40372209|FG004|Run-out Period|Lost to Follow-up|0|||
16520051|NCT01513291|40372205|FG000|Run-out Period|Withdrawal by Subject|0|||
16323832|NCT02438826|39671027|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
16323833|NCT02438826|39671028|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
16323834|NCT02438826|39671029|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
16323835|NCT02438826|39671026|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
16323836|NCT02438826|39671027|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
16323837|NCT02438826|39671028|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
16323838|NCT02438826|39671029|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
16323839|NCT02438826|39671026|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
16323840|NCT02438826|39671027|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
16323841|NCT02438826|39671028|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
16323842|NCT02438826|39671029|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
16323843|NCT02438826|39671026|FG000|Post-Treatment Phase|Adverse Event|3|||
16323844|NCT02438826|39671027|FG001|Post-Treatment Phase|Adverse Event|0|||
16520052|NCT01513291|40372206|FG001|Run-out Period|Withdrawal by Subject|0|||
16520053|NCT01513291|40372207|FG002|Run-out Period|Withdrawal by Subject|0|||
16520054|NCT01513291|40372208|FG003|Run-out Period|Withdrawal by Subject|1|||
16520055|NCT01513291|40372209|FG004|Run-out Period|Withdrawal by Subject|0|||
16520056|NCT03555396|40372214|FG000|Overall Study|Death|3|||
16520057|NCT03555396|40372215|FG001|Overall Study|Death|1|||
16520058|NCT03555396|40372214|FG000|Overall Study|Lost to Follow-up|0|||
16520059|NCT03555396|40372215|FG001|Overall Study|Lost to Follow-up|2|||
16520060|NCT01175824|40372216|FG000|Overall Study|Adverse Event|2|||
16520061|NCT01175824|40372217|FG001|Overall Study|Adverse Event|1|||
16520062|NCT01175824|40372216|FG000|Overall Study|Lack of Efficacy|2|||
16520063|NCT01175824|40372217|FG001|Overall Study|Lack of Efficacy|0|||
16323845|NCT02438826|39671028|FG002|Post-Treatment Phase|Adverse Event|0|||
16520064|NCT01175824|40372216|FG000|Overall Study|Lost to Follow-up|0|||
16520065|NCT01175824|40372217|FG001|Overall Study|Lost to Follow-up|1|||
16520066|NCT01175824|40372216|FG000|Overall Study|Physician Decision|0|||
16323846|NCT02438826|39671029|FG003|Post-Treatment Phase|Adverse Event|0|||
16323847|NCT02438826|39671026|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
16520067|NCT01175824|40372217|FG001|Overall Study|Physician Decision|4|||
16520068|NCT01175824|40372216|FG000|Overall Study|Protocol Violation|2|||
16520069|NCT01175824|40372217|FG001|Overall Study|Protocol Violation|5|||
16206389|NCT00696436|39233895|FG000|Overall Study|Administrative Decision|1|||
16206390|NCT00696436|39233896|FG001|Overall Study|Administrative Decision|0|||
16206391|NCT00696436|39233897|FG002|Overall Study|Administrative Decision|0|||
16206392|NCT00696436|39233898|FG003|Overall Study|Administrative Decision|0|||
16323848|NCT02438826|39671027|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
16323849|NCT02438826|39671028|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
16323850|NCT02438826|39671029|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
16323851|NCT02438826|39671026|FG000|Post-Treatment Phase|Physician Decision|1|||
16323852|NCT02438826|39671027|FG001|Post-Treatment Phase|Physician Decision|0|||
16323853|NCT02438826|39671028|FG002|Post-Treatment Phase|Physician Decision|0|||
16323854|NCT02438826|39671029|FG003|Post-Treatment Phase|Physician Decision|0|||
16323855|NCT02438826|39671026|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
16520070|NCT01175824|40372216|FG000|Overall Study|Withdrawal by Subject|3|||
16520071|NCT01175824|40372217|FG001|Overall Study|Withdrawal by Subject|7|||
16520072|NCT01175824|40372216|FG000|Overall Study|Sponsor Decision|1|||
16520073|NCT01175824|40372217|FG001|Overall Study|Sponsor Decision|0|||
16520074|NCT01175824|40372216|FG000|Overall Study|Entry Criteria Not Met|6|||
16520075|NCT01175824|40372217|FG001|Overall Study|Entry Criteria Not Met|4|||
16520076|NCT02822794|40372222|FG000|Overall Study|Withdrew Consent|1|||
16520077|NCT02822794|40372223|FG001|Overall Study|Withdrew Consent|0|||
16520078|NCT01933334|40372232|FG000|Overall Study|Adverse Event|5|||
16520079|NCT01933334|40372233|FG001|Overall Study|Adverse Event|1|||
16206393|NCT00696436|39233899|FG004|Overall Study|Administrative Decision|0|||
16323856|NCT02438826|39671027|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
16520080|NCT01933334|40372232|FG000|Overall Study|Withdrawal by Subject|0|||
16520081|NCT01933334|40372233|FG001|Overall Study|Withdrawal by Subject|1|||
16520082|NCT03525678|40372240|FG000|Overall Study|Withdrawal by Subject|8|||
16520083|NCT03525678|40372241|FG001|Overall Study|Withdrawal by Subject|2|||
16520084|NCT03525678|40372242|FG002|Overall Study|Withdrawal by Subject|2|||
16520085|NCT03525678|40372240|FG000|Overall Study|Physician Decision|2|||
16520086|NCT03525678|40372241|FG001|Overall Study|Physician Decision|4|||
16520087|NCT03525678|40372242|FG002|Overall Study|Physician Decision|0|||
16520088|NCT03525678|40372240|FG000|Overall Study|Lost to Follow-up|2|||
16520089|NCT03525678|40372241|FG001|Overall Study|Lost to Follow-up|1|||
16520090|NCT03525678|40372242|FG002|Overall Study|Lost to Follow-up|2|||
16520091|NCT03525678|40372240|FG000|Overall Study|Death|70|||
16520092|NCT03525678|40372241|FG001|Overall Study|Death|80|||
16520093|NCT03525678|40372242|FG002|Overall Study|Death|16|||
16520094|NCT03525678|40372240|FG000|Overall Study|other reasons|14|||
16520095|NCT03525678|40372241|FG001|Overall Study|other reasons|10|||
16520096|NCT03525678|40372242|FG002|Overall Study|other reasons|5|||
16520097|NCT03525678|40372240|FG000|Overall Study|ongoing at the time of analysis|1|||
16520098|NCT03525678|40372241|FG001|Overall Study|ongoing at the time of analysis|2|||
16323857|NCT02438826|39671028|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
16323858|NCT02438826|39671029|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
16323859|NCT03039621|39671030|FG000|Overall Study|Violation of inclusion criteria|3|||
16520099|NCT03525678|40372242|FG002|Overall Study|ongoing at the time of analysis|0|||
16323860|NCT03039621|39671031|FG001|Overall Study|Violation of inclusion criteria|2|||
16323861|NCT03039621|39671030|FG000|Overall Study|Non-compliance with protocol requirement|4|||
16323862|NCT03039621|39671031|FG001|Overall Study|Non-compliance with protocol requirement|5|||
16520100|NCT03535740|40372247|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
16520101|NCT03535740|40372247|FG000|Overall Study|Death|34|||
16323863|NCT03039621|39671030|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
16323864|NCT03039621|39671031|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
16323865|NCT03039621|39671030|FG000|Overall Study|Violation of non-inclusion criteria|1|||
16323866|NCT03039621|39671031|FG001|Overall Study|Violation of non-inclusion criteria|2|||
16323867|NCT02778074|39671032|FG000|Overall Study|Lost to Follow-up|7|||
16323868|NCT02778074|39671033|FG001|Overall Study|Lost to Follow-up|10|||
16323869|NCT00803790|39671038|FG000|Period 1|Adverse Event|0|||
16323870|NCT00803790|39671039|FG001|Period 1|Adverse Event|1|||
16323871|NCT00803790|39671040|FG002|Period 1|Adverse Event|0|||
16323872|NCT00803790|39671041|FG003|Period 1|Adverse Event|0|||
16323873|NCT00803790|39671038|FG000|Period 1|Lost to Follow-up|1|||
16323874|NCT00803790|39671039|FG001|Period 1|Lost to Follow-up|2|||
16323875|NCT00803790|39671040|FG002|Period 1|Lost to Follow-up|0|||
16323876|NCT00803790|39671041|FG003|Period 1|Lost to Follow-up|0|||
16323877|NCT00803790|39671038|FG000|Period 1|Withdrawal by Subject|8|||
16323878|NCT00803790|39671039|FG001|Period 1|Withdrawal by Subject|6|||
16323879|NCT00803790|39671040|FG002|Period 1|Withdrawal by Subject|0|||
16323880|NCT00803790|39671041|FG003|Period 1|Withdrawal by Subject|0|||
16323881|NCT00803790|39671038|FG000|Period 1|positive drug screen or personal reasons|0|||
16323882|NCT00803790|39671039|FG001|Period 1|positive drug screen or personal reasons|3|||
16323883|NCT00803790|39671040|FG002|Period 1|positive drug screen or personal reasons|0|||
16323884|NCT00803790|39671041|FG003|Period 1|positive drug screen or personal reasons|4|||
16323885|NCT00803790|39671038|FG000|Period 1|Protocol Violation|0|||
16323886|NCT00803790|39671039|FG001|Period 1|Protocol Violation|0|||
16323887|NCT00803790|39671040|FG002|Period 1|Protocol Violation|1|||
16323888|NCT00803790|39671041|FG003|Period 1|Protocol Violation|0|||
16323889|NCT00803790|39671038|FG000|Period 2|Adverse Event|0|||
16323890|NCT00803790|39671039|FG001|Period 2|Adverse Event|0|||
16323891|NCT00803790|39671040|FG002|Period 2|Adverse Event|1|||
16323892|NCT00803790|39671041|FG003|Period 2|Adverse Event|1|||
16323893|NCT00803790|39671038|FG000|Period 2|Withdrawal by Subject|1|||
16323894|NCT00803790|39671039|FG001|Period 2|Withdrawal by Subject|0|||
16323895|NCT00803790|39671040|FG002|Period 2|Withdrawal by Subject|0|||
16323896|NCT00803790|39671041|FG003|Period 2|Withdrawal by Subject|0|||
16520102|NCT03535740|40372247|FG000|Overall Study|Lost to Follow-up|1|||
16520103|NCT03535740|40372247|FG000|Overall Study|Withdrawal by Subject|13|||
16520104|NCT02139644|40372248|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
16323897|NCT00803790|39671038|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
16520105|NCT02139644|40372249|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16520106|NCT02139644|40372250|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16520107|NCT02139644|40372251|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16520108|NCT02139644|40372252|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16520109|NCT02139644|40372253|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16520110|NCT02139644|40372248|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
16520111|NCT02139644|40372249|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16520112|NCT02139644|40372250|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16323898|NCT00803790|39671039|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
16520113|NCT02139644|40372251|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16520114|NCT02139644|40372252|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16520115|NCT02139644|40372253|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16520116|NCT02139644|40372248|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
16520117|NCT02139644|40372249|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16520118|NCT02139644|40372250|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16520119|NCT02139644|40372251|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16520120|NCT02139644|40372252|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16520121|NCT02139644|40372253|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16520122|NCT02139644|40372248|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
16520123|NCT02139644|40372249|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16520124|NCT02139644|40372250|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16520125|NCT02139644|40372251|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16520126|NCT02139644|40372252|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16520127|NCT02139644|40372253|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16520128|NCT02139644|40372248|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
16520129|NCT02139644|40372249|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16323899|NCT00803790|39671040|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
16323900|NCT00803790|39671041|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
16323901|NCT01015131|39671042|FG000|Overall Study|Physician Decision|1|||
16323902|NCT01015131|39671042|FG000|Overall Study|Protocol Violation|1|||
16323903|NCT01015131|39671042|FG000|Overall Study|Withdrawal by Subject|2|||
16323904|NCT01015131|39671042|FG000|Overall Study|Other Protocol Specified Criteria|4|||
16323905|NCT04481789|39671043|FG000|Period 1|Withdrawal by Subject|1|||
16323906|NCT04481789|39671044|FG001|Period 1|Withdrawal by Subject|0|||
16323907|NCT04481789|39671045|FG002|Period 1|Withdrawal by Subject|0|||
16323908|NCT04481789|39671046|FG003|Period 1|Withdrawal by Subject|0|||
16323909|NCT04481789|39671047|FG004|Period 1|Withdrawal by Subject|0|||
16323910|NCT04481789|39671048|FG005|Period 1|Withdrawal by Subject|0|||
16323911|NCT02073929|39671049|FG000|Overall Study|Lost to Follow-up|2|||
16323912|NCT02073929|39671050|FG001|Overall Study|Lost to Follow-up|1|||
16323913|NCT02073929|39671049|FG000|Overall Study|Adverse Event|2|||
16323914|NCT02073929|39671050|FG001|Overall Study|Adverse Event|1|||
16323915|NCT02073929|39671049|FG000|Overall Study|Withdrawal by Subject|0|||
16323916|NCT02073929|39671050|FG001|Overall Study|Withdrawal by Subject|1|||
16323917|NCT04480424|39671052|FG000|Overall Study|Withdrawal by Subject|0|||
16323918|NCT04480424|39671053|FG001|Overall Study|Withdrawal by Subject|2|||
16323919|NCT04480424|39671052|FG000|Overall Study|Lost to Follow-up|3|||
16323920|NCT04480424|39671053|FG001|Overall Study|Lost to Follow-up|3|||
16323921|NCT04480424|39671052|FG000|Overall Study|Death|14|||
16323922|NCT04480424|39671053|FG001|Overall Study|Death|16|||
16323923|NCT04480424|39671052|FG000|Overall Study|Reason not Specified|5|||
16323924|NCT04480424|39671053|FG001|Overall Study|Reason not Specified|5|||
16323925|NCT00959374|39671055|FG000|Overall Study|Withdrawal by Subject|2|||
16323926|NCT00959374|39671055|FG000|Overall Study|Lost to Follow-up|14|||
16323927|NCT00959374|39671055|FG000|Overall Study|Death|1|||
16323928|NCT00959374|39671055|FG000|Overall Study|Protocol Violation|1|||
16323929|NCT00959374|39671055|FG000|Overall Study|Implant Removed/Not Replaced|4|||
16323930|NCT00959374|39671055|FG000|Overall Study|Physician Decision|1|||
16323931|NCT01718535|39671056|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
16323932|NCT01718535|39671057|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
16323933|NCT01718535|39671058|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
16323934|NCT01718535|39671059|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
16323935|NCT01718535|39671060|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
16323936|NCT01718535|39671061|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
16323937|NCT01718535|39671062|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
16323938|NCT01718535|39671063|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
16323939|NCT01718535|39671064|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
16323940|NCT01718535|39671065|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
16323941|NCT01417156|39671066|FG000|Overall Study|Adverse Event|12|||
16323942|NCT01417156|39671066|FG000|Overall Study|Protocol Violation|2|||
16323943|NCT02833844|39671067|FG000|Double-Blind Period|Withdrawal by Subject|2|||
16323944|NCT02833844|39671068|FG001|Double-Blind Period|Withdrawal by Subject|3|||
16323945|NCT02833844|39671067|FG000|Double-Blind Period|Protocol Violation|0|||
16323946|NCT02833844|39671068|FG001|Double-Blind Period|Protocol Violation|4|||
16323947|NCT02833844|39671067|FG000|Open-Label Period|Death|0|||
16323948|NCT02833844|39671068|FG001|Open-Label Period|Death|2|||
16323949|NCT02833844|39671067|FG000|Open-Label Period|Lost to Follow-up|1|||
16323950|NCT02833844|39671068|FG001|Open-Label Period|Lost to Follow-up|0|||
16323951|NCT02833844|39671067|FG000|Open-Label Period|Withdrawal by Subject|1|||
16323952|NCT02833844|39671068|FG001|Open-Label Period|Withdrawal by Subject|0|||
16323953|NCT00582816|39671071|FG000|Overall Study|Engraftment Failure|3|||
16323954|NCT00471081|39671072|FG000|Active Phase|Protocol Violation|1|||
16520130|NCT02139644|40372250|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16520131|NCT02139644|40372251|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16520132|NCT02139644|40372252|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16520133|NCT02139644|40372253|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16520134|NCT02139644|40372248|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
16520135|NCT02139644|40372249|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
16520136|NCT02139644|40372250|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
16520137|NCT02139644|40372251|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
16520138|NCT02139644|40372252|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
16520139|NCT02139644|40372253|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
16520140|NCT02139644|40372248|FG000|Run-In Period (Pre-assignment)|Other|6|||
16520141|NCT02139644|40372249|FG001|Run-In Period (Pre-assignment)|Other|0|||
16520142|NCT02139644|40372250|FG002|Run-In Period (Pre-assignment)|Other|0|||
16520143|NCT02139644|40372251|FG003|Run-In Period (Pre-assignment)|Other|0|||
16520144|NCT02139644|40372252|FG004|Run-In Period (Pre-assignment)|Other|0|||
16520145|NCT02139644|40372253|FG005|Run-In Period (Pre-assignment)|Other|0|||
16520146|NCT02139644|40372248|FG000|Treatment Period|Adverse Event|0|||
16520147|NCT02139644|40372249|FG001|Treatment Period|Adverse Event|0|||
16520148|NCT02139644|40372250|FG002|Treatment Period|Adverse Event|3|||
16520149|NCT02139644|40372251|FG003|Treatment Period|Adverse Event|2|||
16520150|NCT02139644|40372252|FG004|Treatment Period|Adverse Event|1|||
16520151|NCT02139644|40372253|FG005|Treatment Period|Adverse Event|6|||
16520152|NCT02139644|40372248|FG000|Treatment Period|Withdrawal by Subject|0|||
16520153|NCT02139644|40372249|FG001|Treatment Period|Withdrawal by Subject|0|||
16520154|NCT02139644|40372250|FG002|Treatment Period|Withdrawal by Subject|2|||
16520155|NCT02139644|40372251|FG003|Treatment Period|Withdrawal by Subject|2|||
16520156|NCT02139644|40372252|FG004|Treatment Period|Withdrawal by Subject|3|||
16520157|NCT02139644|40372253|FG005|Treatment Period|Withdrawal by Subject|2|||
16520158|NCT02139644|40372248|FG000|Treatment Period|Non-compliance|0|||
16520159|NCT02139644|40372249|FG001|Treatment Period|Non-compliance|0|||
16520160|NCT02139644|40372250|FG002|Treatment Period|Non-compliance|0|||
16520161|NCT02139644|40372251|FG003|Treatment Period|Non-compliance|1|||
16520162|NCT02139644|40372252|FG004|Treatment Period|Non-compliance|0|||
16520163|NCT02139644|40372253|FG005|Treatment Period|Non-compliance|0|||
16520164|NCT02139644|40372248|FG000|Treatment Period|Protocol Violation|0|||
16520165|NCT02139644|40372249|FG001|Treatment Period|Protocol Violation|0|||
16520166|NCT02139644|40372250|FG002|Treatment Period|Protocol Violation|0|||
16520167|NCT02139644|40372251|FG003|Treatment Period|Protocol Violation|1|||
16520168|NCT02139644|40372252|FG004|Treatment Period|Protocol Violation|1|||
16520169|NCT02139644|40372253|FG005|Treatment Period|Protocol Violation|1|||
16520170|NCT02139644|40372248|FG000|Treatment Period|Disease progression|0|||
16520171|NCT02139644|40372249|FG001|Treatment Period|Disease progression|0|||
16520172|NCT02139644|40372250|FG002|Treatment Period|Disease progression|0|||
16520173|NCT02139644|40372251|FG003|Treatment Period|Disease progression|1|||
16520174|NCT02139644|40372252|FG004|Treatment Period|Disease progression|1|||
16520175|NCT02139644|40372253|FG005|Treatment Period|Disease progression|2|||
16520176|NCT02139644|40372248|FG000|Treatment Period|Lost to Follow-up|0|||
16520177|NCT02139644|40372249|FG001|Treatment Period|Lost to Follow-up|0|||
16520178|NCT02139644|40372250|FG002|Treatment Period|Lost to Follow-up|1|||
16520179|NCT02139644|40372251|FG003|Treatment Period|Lost to Follow-up|1|||
16520180|NCT02139644|40372252|FG004|Treatment Period|Lost to Follow-up|1|||
16520181|NCT02139644|40372253|FG005|Treatment Period|Lost to Follow-up|1|||
16520182|NCT02139644|40372248|FG000|Treatment Period|Lack of Efficacy|0|||
16520183|NCT02139644|40372249|FG001|Treatment Period|Lack of Efficacy|0|||
16323955|NCT00471081|39671073|FG001|Active Phase|Protocol Violation|1|||
16323956|NCT00471081|39671072|FG000|Active Phase|Withdrawal by Subject|0|||
16323957|NCT00471081|39671073|FG001|Active Phase|Withdrawal by Subject|3|||
16093294|NCT00403845|38833015|FG002|Treatment Period 3|Adverse Event|0|||
16323958|NCT00471081|39671072|FG000|Active Phase|Lost to Follow-up|0|||
16323959|NCT00471081|39671073|FG001|Active Phase|Lost to Follow-up|1|||
16323960|NCT00471081|39671072|FG000|Active Phase|Lost health plan/insurance|1|||
16323961|NCT00471081|39671073|FG001|Active Phase|Lost health plan/insurance|8|||
16323962|NCT00471081|39671072|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
16323963|NCT00471081|39671073|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
16323964|NCT00471081|39671072|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
16520184|NCT02139644|40372250|FG002|Treatment Period|Lack of Efficacy|1|||
16520185|NCT02139644|40372251|FG003|Treatment Period|Lack of Efficacy|0|||
16520186|NCT02139644|40372252|FG004|Treatment Period|Lack of Efficacy|1|||
16520187|NCT02139644|40372253|FG005|Treatment Period|Lack of Efficacy|4|||
16520188|NCT02139644|40372248|FG000|Treatment Period|Other|0|||
16520189|NCT02139644|40372249|FG001|Treatment Period|Other|3|||
16520190|NCT02139644|40372250|FG002|Treatment Period|Other|1|||
16093295|NCT00403845|38833016|FG003|Treatment Period 3|Adverse Event|1|||
16323965|NCT00471081|39671073|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
16520191|NCT02139644|40372251|FG003|Treatment Period|Other|1|||
16520192|NCT02139644|40372252|FG004|Treatment Period|Other|0|||
16520193|NCT02139644|40372253|FG005|Treatment Period|Other|1|||
16520194|NCT01344057|40372254|FG000|Overall Study|Premature Withdrawal|1|||
16520195|NCT03246529|40372255|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
16520196|NCT03246529|40372256|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
16520197|NCT03246529|40372257|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
16520198|NCT03246529|40372255|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
16520199|NCT03246529|40372256|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
16520200|NCT03246529|40372257|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
16520201|NCT03246529|40372255|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
16520202|NCT03246529|40372256|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
16520203|NCT03246529|40372257|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
16520204|NCT03246529|40372255|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
16520205|NCT03246529|40372256|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
16520206|NCT03246529|40372257|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
16520207|NCT03246529|40372255|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
16520208|NCT03246529|40372256|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
16520209|NCT03246529|40372257|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
16520210|NCT03246529|40372255|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
16520211|NCT03246529|40372256|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
16520212|NCT03246529|40372257|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
16520213|NCT03246529|40372255|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
16520214|NCT03246529|40372256|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
16520215|NCT03246529|40372257|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
16520216|NCT03246529|40372255|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
16520217|NCT03246529|40372256|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
16520218|NCT03246529|40372257|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
16520219|NCT03246529|40372255|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
16520220|NCT03246529|40372256|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
16520221|NCT03246529|40372257|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
16520222|NCT00727194|40372258|FG000|Screening Period|Low QMG scores|0|||
16520223|NCT00727194|40372259|FG001|Screening Period|Low QMG scores|0|||
16520224|NCT00727194|40372260|FG002|Screening Period|Low QMG scores|6|||
16520225|NCT00727194|40372258|FG000|Screening Period|Lacked AChR antibodies|0|||
16520226|NCT00727194|40372259|FG001|Screening Period|Lacked AChR antibodies|0|||
16520227|NCT00727194|40372260|FG002|Screening Period|Lacked AChR antibodies|5|||
16520228|NCT00727194|40372258|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
16520229|NCT00727194|40372259|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
16520230|NCT00727194|40372260|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
16520231|NCT00727194|40372258|FG000|Screening Period|Severe infections|0|||
16520232|NCT00727194|40372259|FG001|Screening Period|Severe infections|0|||
16520233|NCT00727194|40372260|FG002|Screening Period|Severe infections|2|||
16520234|NCT00727194|40372258|FG000|Screening Period|History of thymoma|0|||
16520235|NCT00727194|40372259|FG001|Screening Period|History of thymoma|0|||
16520236|NCT00727194|40372260|FG002|Screening Period|History of thymoma|1|||
16520237|NCT00727194|40372258|FG000|Treatment Period 2|Lack of Efficacy|0|||
16520238|NCT00727194|40372259|FG001|Treatment Period 2|Lack of Efficacy|1|||
16520239|NCT00727194|40372260|FG002|Treatment Period 2|Lack of Efficacy|0|||
16520240|NCT02984020|40372261|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
16520241|NCT02984020|40372261|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
16323966|NCT00471081|39671072|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
16323967|NCT00471081|39671073|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
16206394|NCT00696436|39233895|FG000|Overall Study|Missing|0|||
16520242|NCT02984020|40372261|FG000|Overall Study|Other significant protocol violation|2|||
16520243|NCT01743092|40372262|FG000|Overall Study|Lost to Follow-up|14|||
16520244|NCT01743092|40372263|FG001|Overall Study|Lost to Follow-up|15|||
16323968|NCT02720744|39671074|FG000|Overall Study|Protocol Violation|0|||
16323969|NCT02720744|39671075|FG001|Overall Study|Protocol Violation|2|||
16323970|NCT02720744|39671074|FG000|Overall Study|Pregnancy|2|||
16323971|NCT02720744|39671075|FG001|Overall Study|Pregnancy|0|||
16323972|NCT02720744|39671074|FG000|Overall Study|Lack of Efficacy|2|||
16323973|NCT02720744|39671075|FG001|Overall Study|Lack of Efficacy|8|||
16323974|NCT02720744|39671074|FG000|Overall Study|Adverse Event|21|||
16323975|NCT02720744|39671075|FG001|Overall Study|Adverse Event|3|||
16323976|NCT02720744|39671074|FG000|Overall Study|Withdrawal by Subject|11|||
16323977|NCT02720744|39671075|FG001|Overall Study|Withdrawal by Subject|11|||
16323978|NCT02720744|39671074|FG000|Overall Study|Lost to follow up|2|||
16206395|NCT00696436|39233896|FG001|Overall Study|Missing|1|||
16323979|NCT02720744|39671075|FG001|Overall Study|Lost to follow up|0|||
16323980|NCT02720744|39671074|FG000|Overall Study|Non Compliance with Investigational Product|0|||
16323981|NCT02720744|39671075|FG001|Overall Study|Non Compliance with Investigational Product|1|||
16323982|NCT02720744|39671074|FG000|Overall Study|Excluded Concomitant Medication|0|||
16323983|NCT02720744|39671075|FG001|Overall Study|Excluded Concomitant Medication|1|||
16323984|NCT01421225|39674357|FG000|Overall Study|Withdrawal by Subject|0|||
16323985|NCT01421225|39674358|FG001|Overall Study|Withdrawal by Subject|1|||
16323986|NCT03224598|39674361|FG000|Overall Study|Lost to Follow-up|0|||
16323987|NCT03224598|39674362|FG001|Overall Study|Lost to Follow-up|2|||
16323988|NCT03224598|39674363|FG002|Overall Study|Lost to Follow-up|0|||
16323989|NCT03224598|39674361|FG000|Overall Study|Other|0|||
16323990|NCT03224598|39674362|FG001|Overall Study|Other|1|||
16323991|NCT03224598|39674363|FG002|Overall Study|Other|0|||
16323992|NCT00157248|39674364|FG000|Overall Study|Adverse Event|36|||
16323993|NCT00157248|39674365|FG001|Overall Study|Adverse Event|25|||
16323994|NCT00157248|39674366|FG002|Overall Study|Adverse Event|13|||
16323995|NCT00157248|39674367|FG003|Overall Study|Adverse Event|33|||
16323996|NCT00157248|39674364|FG000|Overall Study|Protocol Violation|4|||
16323997|NCT00157248|39674365|FG001|Overall Study|Protocol Violation|0|||
16323998|NCT00157248|39674366|FG002|Overall Study|Protocol Violation|2|||
16323999|NCT00157248|39674367|FG003|Overall Study|Protocol Violation|2|||
16324000|NCT00157248|39674364|FG000|Overall Study|Lost to Follow-up|0|||
16324001|NCT00157248|39674365|FG001|Overall Study|Lost to Follow-up|1|||
16324002|NCT00157248|39674366|FG002|Overall Study|Lost to Follow-up|0|||
16324003|NCT00157248|39674367|FG003|Overall Study|Lost to Follow-up|0|||
16324004|NCT00157248|39674364|FG000|Overall Study|Withdrawal by Subject|1|||
16324005|NCT00157248|39674365|FG001|Overall Study|Withdrawal by Subject|4|||
16324006|NCT00157248|39674366|FG002|Overall Study|Withdrawal by Subject|3|||
16324007|NCT00157248|39674367|FG003|Overall Study|Withdrawal by Subject|3|||
16324008|NCT00157248|39674364|FG000|Overall Study|site closures, subject moving|7|||
16520245|NCT01034397|40372264|FG000|Overall Study|Lack of compliance|0|||
16520246|NCT01034397|40372265|FG001|Overall Study|Lack of compliance|1|||
16520247|NCT01034397|40372264|FG000|Overall Study|Lack of Efficacy|3|||
16520248|NCT01034397|40372265|FG001|Overall Study|Lack of Efficacy|0|||
16520249|NCT01034397|40372264|FG000|Overall Study|Adverse Event|4|||
16520250|NCT01034397|40372265|FG001|Overall Study|Adverse Event|0|||
16520251|NCT01034397|40372264|FG000|Overall Study|Other|0|||
16520252|NCT01034397|40372265|FG001|Overall Study|Other|1|||
16520253|NCT00403455|40372270|FG000|Overall Study|Withdrawal by Subject|1|||
16520254|NCT01827904|40372271|FG000|Main Study|Withdrawal by Subject|1|||
16520255|NCT01827904|40372272|FG001|Main Study|Withdrawal by Subject|0|||
16520256|NCT01827904|40372273|FG002|Main Study|Withdrawal by Subject|0|||
16520257|NCT01827904|40372271|FG000|Main Study|Adverse Event|1|||
16520258|NCT01827904|40372272|FG001|Main Study|Adverse Event|0|||
16520259|NCT01827904|40372273|FG002|Main Study|Adverse Event|0|||
16520260|NCT01827904|40372271|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
16520261|NCT01827904|40372272|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
16520262|NCT01827904|40372273|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
16520263|NCT01827904|40372271|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
16520264|NCT01827904|40372272|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
16520265|NCT01827904|40372273|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
16520266|NCT01827904|40372271|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
16520267|NCT01827904|40372272|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
16520268|NCT01827904|40372273|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
16520269|NCT01827904|40372271|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
16520270|NCT01827904|40372272|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
16520271|NCT01827904|40372273|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
16520272|NCT01827904|40372271|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
16206396|NCT00696436|39233897|FG002|Overall Study|Missing|1|||
16324009|NCT00157248|39674365|FG001|Overall Study|site closures, subject moving|7|||
16324010|NCT00157248|39674366|FG002|Overall Study|site closures, subject moving|3|||
16324011|NCT00157248|39674367|FG003|Overall Study|site closures, subject moving|9|||
16324012|NCT03301844|39674368|FG000|Overall Study|suspected colon cancer|1|||
16324013|NCT03301844|39674369|FG001|Overall Study|suspected colon cancer|1|||
16324014|NCT01701193|39674372|FG000|Overall Study|Withdrawal by Subject|2|||
16324015|NCT01701193|39674373|FG001|Overall Study|Withdrawal by Subject|2|||
16324016|NCT01701193|39674374|FG002|Overall Study|Withdrawal by Subject|1|||
16324017|NCT01701193|39674375|FG003|Overall Study|Withdrawal by Subject|2|||
16324018|NCT01701193|39674372|FG000|Overall Study|Adverse Event|1|||
16520273|NCT01827904|40372272|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
16324019|NCT01701193|39674373|FG001|Overall Study|Adverse Event|0|||
16520274|NCT01827904|40372273|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
16520275|NCT01827904|40372271|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
16520276|NCT01827904|40372272|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
16520277|NCT01827904|40372273|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
16520278|NCT01827904|40372271|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
16520279|NCT01827904|40372272|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
16520280|NCT01827904|40372273|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
16520281|NCT01827904|40372271|FG000|Long-term Annual Follow-up|Physician Decision|1|||
16520282|NCT01827904|40372272|FG001|Long-term Annual Follow-up|Physician Decision|0|||
16520283|NCT01827904|40372273|FG002|Long-term Annual Follow-up|Physician Decision|0|||
16520284|NCT01827904|40372271|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
16520285|NCT01827904|40372272|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
16520286|NCT01827904|40372273|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
16520287|NCT01827904|40372271|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
16520288|NCT01827904|40372272|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
16520289|NCT01827904|40372273|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
16520290|NCT02007512|40372274|FG000|Double Blind Treatment Period|Adverse Event|4|||
16520291|NCT02007512|40372275|FG001|Double Blind Treatment Period|Adverse Event|2|||
16520292|NCT02007512|40372276|FG002|Double Blind Treatment Period|Adverse Event|6|||
16520293|NCT02007512|40372277|FG003|Double Blind Treatment Period|Adverse Event|2|||
16520294|NCT02007512|40372274|FG000|Double Blind Treatment Period|Death|1|||
16520295|NCT02007512|40372275|FG001|Double Blind Treatment Period|Death|0|||
16520296|NCT02007512|40372276|FG002|Double Blind Treatment Period|Death|0|||
16520297|NCT02007512|40372277|FG003|Double Blind Treatment Period|Death|0|||
16520298|NCT02007512|40372274|FG000|Double Blind Treatment Period|Disease progression|44|||
16520299|NCT02007512|40372275|FG001|Double Blind Treatment Period|Disease progression|49|||
16520300|NCT02007512|40372276|FG002|Double Blind Treatment Period|Disease progression|45|||
16520301|NCT02007512|40372277|FG003|Double Blind Treatment Period|Disease progression|51|||
16520302|NCT02007512|40372274|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
16520303|NCT02007512|40372275|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
16520304|NCT02007512|40372276|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
16520305|NCT02007512|40372277|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
16520306|NCT02007512|40372274|FG000|Double Blind Treatment Period|Protocol Violation|0|||
16520307|NCT02007512|40372275|FG001|Double Blind Treatment Period|Protocol Violation|0|||
16520308|NCT02007512|40372276|FG002|Double Blind Treatment Period|Protocol Violation|0|||
16520309|NCT02007512|40372277|FG003|Double Blind Treatment Period|Protocol Violation|1|||
16520310|NCT02007512|40372274|FG000|Double Blind Treatment Period|Other|0|||
16206397|NCT00696436|39233898|FG003|Overall Study|Missing|0|||
16206398|NCT00696436|39233899|FG004|Overall Study|Missing|0|||
16206399|NCT01532570|39233902|FG000|Overall Study|Lack of Efficacy|1|||
16206400|NCT01532570|39233903|FG001|Overall Study|Lack of Efficacy|0|||
16206401|NCT01532570|39233904|FG002|Overall Study|Lack of Efficacy|0|||
16206402|NCT01532570|39233905|FG003|Overall Study|Lack of Efficacy|0|||
16206403|NCT01532570|39233902|FG000|Overall Study|Withdrawal by Subject|0|||
16206404|NCT01532570|39233903|FG001|Overall Study|Withdrawal by Subject|1|||
16206405|NCT01532570|39233904|FG002|Overall Study|Withdrawal by Subject|0|||
16206406|NCT01532570|39233905|FG003|Overall Study|Withdrawal by Subject|0|||
16206407|NCT01149343|39233906|FG000|Overall Study|Withdrawal by Subject|1|||
16206408|NCT01149343|39233907|FG001|Overall Study|Withdrawal by Subject|1|||
16206409|NCT01149343|39233908|FG002|Overall Study|Withdrawal by Subject|1|||
16206410|NCT01149343|39233909|FG003|Overall Study|Withdrawal by Subject|5|||
16206411|NCT01149343|39233906|FG000|Overall Study|Death|10|||
16206412|NCT01149343|39233907|FG001|Overall Study|Death|13|||
16206413|NCT01149343|39233908|FG002|Overall Study|Death|18|||
16206414|NCT01149343|39233909|FG003|Overall Study|Death|18|||
16206415|NCT01149343|39233906|FG000|Overall Study|Lost to Follow-up|1|||
16206416|NCT01149343|39233907|FG001|Overall Study|Lost to Follow-up|0|||
16206417|NCT01149343|39233908|FG002|Overall Study|Lost to Follow-up|0|||
16206418|NCT01149343|39233909|FG003|Overall Study|Lost to Follow-up|1|||
16206419|NCT01149343|39233906|FG000|Overall Study|Other|8|||
16206420|NCT01149343|39233907|FG001|Overall Study|Other|10|||
16206421|NCT01149343|39233908|FG002|Overall Study|Other|2|||
16206422|NCT01149343|39233909|FG003|Overall Study|Other|14|||
16206423|NCT01149343|39233906|FG000|Overall Study|Sponsor study termination|0|||
16206424|NCT01149343|39233907|FG001|Overall Study|Sponsor study termination|0|||
16206425|NCT01149343|39233908|FG002|Overall Study|Sponsor study termination|0|||
16206426|NCT01149343|39233909|FG003|Overall Study|Sponsor study termination|2|||
16206427|NCT01149343|39233906|FG000|Overall Study|Recurrence / Progressive disease|0|||
16206428|NCT01149343|39233907|FG001|Overall Study|Recurrence / Progressive disease|0|||
16206429|NCT01149343|39233908|FG002|Overall Study|Recurrence / Progressive disease|1|||
16206430|NCT01149343|39233909|FG003|Overall Study|Recurrence / Progressive disease|0|||
16206431|NCT00719862|39233910|FG000|Overall Study|Adverse Event|1|||
16206432|NCT00719862|39233911|FG001|Overall Study|Adverse Event|2|||
16206433|NCT00719862|39233910|FG000|Overall Study|Lack of Efficacy|3|||
16206434|NCT00719862|39233911|FG001|Overall Study|Lack of Efficacy|0|||
16206435|NCT00719862|39233910|FG000|Overall Study|Non-Compliance|1|||
16206436|NCT00719862|39233911|FG001|Overall Study|Non-Compliance|0|||
16206437|NCT00719862|39233910|FG000|Overall Study|Withdrawal by Subject|1|||
16206438|NCT00719862|39233911|FG001|Overall Study|Withdrawal by Subject|0|||
16206439|NCT00719862|39233910|FG000|Overall Study|Lost to Follow-up|0|||
16206440|NCT00719862|39233911|FG001|Overall Study|Lost to Follow-up|1|||
16206441|NCT00719862|39233910|FG000|Overall Study|Other|2|||
16206442|NCT00719862|39233911|FG001|Overall Study|Other|3|||
16206443|NCT00282867|39233912|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
16206444|NCT00282867|39233913|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
16206445|NCT00282867|39233914|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
16206446|NCT00555568|39233917|FG000|Overall Study|Lost to Follow-up|26|||
16206447|NCT00555568|39233918|FG001|Overall Study|Lost to Follow-up|16|||
16206448|NCT00555568|39233919|FG002|Overall Study|Lost to Follow-up|16|||
16206449|NCT05159362|39233920|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
16206450|NCT05159362|39233921|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
16206451|NCT05159362|39233922|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
16206452|NCT01061736|39233929|FG000|Overall Study|Dose regimen not selected|0|||
16206453|NCT01061736|39233930|FG001|Overall Study|Dose regimen not selected|0|||
16206454|NCT01061736|39233931|FG002|Overall Study|Dose regimen not selected|0|||
16206455|NCT01061736|39233932|FG003|Overall Study|Dose regimen not selected|0|||
16206456|NCT01061736|39233933|FG004|Overall Study|Dose regimen not selected|0|||
16206457|NCT01061736|39233934|FG005|Overall Study|Dose regimen not selected|0|||
16206458|NCT01061736|39233935|FG006|Overall Study|Dose regimen not selected|79|||
16206459|NCT01061736|39233936|FG007|Overall Study|Dose regimen not selected|0|||
16206460|NCT01061736|39233937|FG008|Overall Study|Dose regimen not selected|0|||
16206461|NCT01061736|39233938|FG009|Overall Study|Dose regimen not selected|0|||
16206462|NCT01061736|39233929|FG000|Overall Study|Adverse Event|13|||
16206463|NCT01061736|39233930|FG001|Overall Study|Adverse Event|1|||
16206464|NCT01061736|39233931|FG002|Overall Study|Adverse Event|3|||
16206465|NCT01061736|39233932|FG003|Overall Study|Adverse Event|2|||
16206466|NCT01061736|39233933|FG004|Overall Study|Adverse Event|4|||
16206467|NCT01061736|39233934|FG005|Overall Study|Adverse Event|1|||
16206468|NCT01061736|39233935|FG006|Overall Study|Adverse Event|4|||
16206469|NCT01061736|39233936|FG007|Overall Study|Adverse Event|63|||
16206470|NCT01061736|39233937|FG008|Overall Study|Adverse Event|67|||
16206471|NCT01061736|39233938|FG009|Overall Study|Adverse Event|34|||
16206472|NCT01061736|39233929|FG000|Overall Study|Lack of Efficacy|0|||
16206473|NCT01061736|39233930|FG001|Overall Study|Lack of Efficacy|2|||
16520311|NCT02007512|40372275|FG001|Double Blind Treatment Period|Other|0|||
16520312|NCT02007512|40372276|FG002|Double Blind Treatment Period|Other|1|||
16520313|NCT02007512|40372277|FG003|Double Blind Treatment Period|Other|2|||
16520314|NCT02007512|40372274|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
16520315|NCT02007512|40372275|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
16520316|NCT02007512|40372276|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
16520317|NCT02007512|40372277|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
16520318|NCT02007512|40372274|FG000|Open Label Treatment Period|Adverse Event|0|||
16520319|NCT02007512|40372275|FG001|Open Label Treatment Period|Adverse Event|1|||
16520320|NCT02007512|40372276|FG002|Open Label Treatment Period|Adverse Event|0|||
16520321|NCT02007512|40372277|FG003|Open Label Treatment Period|Adverse Event|0|||
16520322|NCT02007512|40372274|FG000|Open Label Treatment Period|Other|0|||
16520323|NCT02007512|40372275|FG001|Open Label Treatment Period|Other|0|||
16520324|NCT02007512|40372276|FG002|Open Label Treatment Period|Other|0|||
16520325|NCT02007512|40372277|FG003|Open Label Treatment Period|Other|1|||
16520326|NCT02007512|40372274|FG000|Open Label Treatment Period|Disease progression|0|||
16520327|NCT02007512|40372275|FG001|Open Label Treatment Period|Disease progression|17|||
16324020|NCT01701193|39674374|FG002|Overall Study|Adverse Event|0|||
16324021|NCT01701193|39674375|FG003|Overall Study|Adverse Event|0|||
16324022|NCT00090220|39674376|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
16520328|NCT02007512|40372276|FG002|Open Label Treatment Period|Disease progression|0|||
16520329|NCT02007512|40372277|FG003|Open Label Treatment Period|Disease progression|11|||
16520330|NCT02007512|40372274|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
16520331|NCT02007512|40372275|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
16520332|NCT02007512|40372276|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
16520333|NCT02007512|40372277|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
16520334|NCT00377676|40372278|FG000|Overall Study|Adverse Event|498|||
16520335|NCT00377676|40372279|FG001|Overall Study|Adverse Event|107|||
16520336|NCT00377676|40372278|FG000|Overall Study|Protocol Violation|33|||
16520337|NCT00377676|40372279|FG001|Overall Study|Protocol Violation|27|||
16520338|NCT00377676|40372278|FG000|Overall Study|Death|5|||
16520339|NCT00377676|40372279|FG001|Overall Study|Death|2|||
16206474|NCT01061736|39233931|FG002|Overall Study|Lack of Efficacy|1|||
16206475|NCT01061736|39233932|FG003|Overall Study|Lack of Efficacy|1|||
16206476|NCT01061736|39233933|FG004|Overall Study|Lack of Efficacy|1|||
16206477|NCT01061736|39233934|FG005|Overall Study|Lack of Efficacy|2|||
16206478|NCT01061736|39233935|FG006|Overall Study|Lack of Efficacy|1|||
16206479|NCT01061736|39233936|FG007|Overall Study|Lack of Efficacy|9|||
16206480|NCT01061736|39233937|FG008|Overall Study|Lack of Efficacy|9|||
16206481|NCT01061736|39233938|FG009|Overall Study|Lack of Efficacy|10|||
16206482|NCT01061736|39233929|FG000|Overall Study|Poor compliance to protocol|0|||
16206483|NCT01061736|39233930|FG001|Overall Study|Poor compliance to protocol|0|||
16206484|NCT01061736|39233931|FG002|Overall Study|Poor compliance to protocol|0|||
16206485|NCT01061736|39233932|FG003|Overall Study|Poor compliance to protocol|0|||
16206486|NCT01061736|39233933|FG004|Overall Study|Poor compliance to protocol|0|||
16206487|NCT01061736|39233934|FG005|Overall Study|Poor compliance to protocol|0|||
16206488|NCT01061736|39233935|FG006|Overall Study|Poor compliance to protocol|0|||
16206489|NCT01061736|39233936|FG007|Overall Study|Poor compliance to protocol|2|||
16206490|NCT01061736|39233937|FG008|Overall Study|Poor compliance to protocol|5|||
16206491|NCT01061736|39233938|FG009|Overall Study|Poor compliance to protocol|9|||
16206492|NCT01061736|39233929|FG000|Overall Study|Not treated|0|||
16206493|NCT01061736|39233930|FG001|Overall Study|Not treated|0|||
16206494|NCT01061736|39233931|FG002|Overall Study|Not treated|0|||
16206495|NCT01061736|39233932|FG003|Overall Study|Not treated|0|||
16206496|NCT01061736|39233933|FG004|Overall Study|Not treated|1|||
16206497|NCT01061736|39233934|FG005|Overall Study|Not treated|0|||
16206498|NCT01061736|39233935|FG006|Overall Study|Not treated|0|||
16206499|NCT01061736|39233936|FG007|Overall Study|Not treated|2|||
16206500|NCT01061736|39233937|FG008|Overall Study|Not treated|1|||
16324023|NCT00090220|39674377|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
16324024|NCT00090220|39674378|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
16324025|NCT00090220|39674379|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
16324026|NCT00090220|39674380|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
16324027|NCT00090220|39674381|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
16324028|NCT00090220|39674376|FG000|Base Study Vaccination Period|Adverse Event|6|||
16324029|NCT00090220|39674377|FG001|Base Study Vaccination Period|Adverse Event|1|||
16324030|NCT00090220|39674378|FG002|Base Study Vaccination Period|Adverse Event|0|||
16520340|NCT00377676|40372278|FG000|Overall Study|Withdrawal by Subject|187|||
16520341|NCT00377676|40372279|FG001|Overall Study|Withdrawal by Subject|72|||
16520342|NCT00377676|40372278|FG000|Overall Study|Lost to Follow-up|120|||
16206501|NCT01061736|39233938|FG009|Overall Study|Not treated|0|||
16206502|NCT01061736|39233929|FG000|Overall Study|Other than specified above|0|||
16206503|NCT01061736|39233930|FG001|Overall Study|Other than specified above|1|||
16206504|NCT01061736|39233931|FG002|Overall Study|Other than specified above|2|||
16206505|NCT01061736|39233932|FG003|Overall Study|Other than specified above|0|||
16206506|NCT01061736|39233933|FG004|Overall Study|Other than specified above|1|||
16206507|NCT01061736|39233934|FG005|Overall Study|Other than specified above|0|||
16206508|NCT01061736|39233935|FG006|Overall Study|Other than specified above|0|||
16206509|NCT01061736|39233936|FG007|Overall Study|Other than specified above|18|||
16206510|NCT01061736|39233937|FG008|Overall Study|Other than specified above|15|||
16206511|NCT01061736|39233938|FG009|Overall Study|Other than specified above|21|||
16206512|NCT02120352|39233939|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
16206513|NCT02120352|39233940|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
16206514|NCT02120352|39233941|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
16206515|NCT02120352|39233942|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
16206516|NCT02120352|39233943|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
16206517|NCT02120352|39233944|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
16206518|NCT02120352|39233945|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
16206519|NCT02120352|39233939|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
16206520|NCT02120352|39233940|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
16206521|NCT02120352|39233941|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
16206522|NCT02120352|39233942|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
16206523|NCT02120352|39233943|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
16206524|NCT02120352|39233944|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
16206525|NCT02120352|39233945|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
16206526|NCT02120352|39233939|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
16206527|NCT02120352|39233940|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
16206528|NCT02120352|39233941|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
16206529|NCT02120352|39233942|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
16206530|NCT02120352|39233943|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
16206531|NCT02120352|39233944|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
16206532|NCT02120352|39233945|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
16206533|NCT02120352|39233939|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
16206534|NCT02120352|39233940|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
16206535|NCT02120352|39233941|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
16206536|NCT02120352|39233942|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
16206537|NCT02120352|39233943|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
16520343|NCT00377676|40372279|FG001|Overall Study|Lost to Follow-up|56|||
16520344|NCT00377676|40372278|FG000|Overall Study|Other|118|||
16520345|NCT00377676|40372279|FG001|Overall Study|Other|58|||
16520346|NCT00132769|40372283|FG000|Overall Study|Withdrawal by Subject|1|||
16520347|NCT00132769|40372284|FG001|Overall Study|Withdrawal by Subject|3|||
16520348|NCT00132769|40372283|FG000|Overall Study|Lack of Efficacy|7|||
16520349|NCT00132769|40372284|FG001|Overall Study|Lack of Efficacy|6|||
16520350|NCT00132769|40372283|FG000|Overall Study|Adverse Event|2|||
16520351|NCT00132769|40372284|FG001|Overall Study|Adverse Event|1|||
16206538|NCT02120352|39233944|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
16206539|NCT02120352|39233945|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
16395754|NCT01673854|39931153|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
16520352|NCT00132769|40372283|FG000|Overall Study|Protocol Violation|1|||
16520353|NCT00132769|40372284|FG001|Overall Study|Protocol Violation|1|||
16520354|NCT03832192|40372285|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
16520355|NCT03832192|40372286|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
16520356|NCT00679341|40372297|FG000|Overall Study|Disease progression|42|||
16206540|NCT02120352|39233939|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
16206541|NCT02120352|39233940|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
16206542|NCT02120352|39233941|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
16206543|NCT02120352|39233942|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
16206544|NCT02120352|39233943|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
16206545|NCT02120352|39233944|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
16206546|NCT02120352|39233945|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
16206547|NCT02120352|39233939|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
16206548|NCT02120352|39233940|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
16206549|NCT02120352|39233941|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
16206550|NCT02120352|39233942|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
16206551|NCT02120352|39233943|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
16520357|NCT00679341|40372298|FG001|Overall Study|Disease progression|36|||
16520358|NCT00679341|40372297|FG000|Overall Study|Adverse Event|5|||
16520359|NCT00679341|40372298|FG001|Overall Study|Adverse Event|6|||
16520360|NCT00679341|40372297|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
16520361|NCT00679341|40372298|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
16520362|NCT00679341|40372297|FG000|Overall Study|Death|1|||
16520363|NCT00679341|40372298|FG001|Overall Study|Death|1|||
16520364|NCT00679341|40372297|FG000|Overall Study|Other|1|||
16520365|NCT00679341|40372298|FG001|Overall Study|Other|0|||
16520366|NCT00679341|40372297|FG000|Overall Study|Physician Decision|1|||
16520367|NCT00679341|40372298|FG001|Overall Study|Physician Decision|0|||
16206552|NCT02120352|39233944|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
16206553|NCT02120352|39233945|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
16206554|NCT02120352|39233939|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
16206555|NCT02120352|39233940|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
16206556|NCT02120352|39233941|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
16206557|NCT02120352|39233942|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
16206558|NCT02120352|39233943|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
16395755|NCT01673854|39931153|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
16395756|NCT01673854|39931153|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
16395757|NCT01673854|39931153|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
16395758|NCT01673854|39931153|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
16395759|NCT01673854|39931153|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
16206559|NCT02120352|39233944|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
16206560|NCT02120352|39233945|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
16206561|NCT02120352|39233939|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
16206562|NCT02120352|39233940|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
16206563|NCT02120352|39233941|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
16206564|NCT02120352|39233942|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
16206565|NCT02120352|39233943|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
16206566|NCT02120352|39233944|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
16206567|NCT02120352|39233945|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
16206568|NCT02120352|39233939|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
16206569|NCT02120352|39233940|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
16206570|NCT02120352|39233941|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
16206571|NCT02120352|39233942|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
16206572|NCT02120352|39233943|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
16206573|NCT02120352|39233944|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
16206574|NCT02120352|39233945|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
16206575|NCT02120352|39233939|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
16206576|NCT02120352|39233940|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
16206577|NCT02120352|39233941|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
16206578|NCT02120352|39233942|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
16206579|NCT02120352|39233943|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
16206580|NCT02120352|39233944|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
16206581|NCT02120352|39233945|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
16206582|NCT02120352|39233939|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
16206583|NCT02120352|39233940|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
16206584|NCT02120352|39233941|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
16206585|NCT02120352|39233942|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
16206586|NCT02120352|39233943|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
16206587|NCT02120352|39233944|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
16206588|NCT02120352|39233945|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
16206589|NCT02120352|39233939|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
16395760|NCT01061723|39931154|FG000|Overall Study|Adverse Event|0|||
16520368|NCT00679341|40372297|FG000|Overall Study|Not treated|0|||
16520369|NCT00679341|40372298|FG001|Overall Study|Not treated|2|||
16206590|NCT02120352|39233940|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
16206591|NCT02120352|39233941|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
16206592|NCT02120352|39233942|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
16206593|NCT02120352|39233943|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
16206594|NCT02120352|39233944|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
16206595|NCT02120352|39233945|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
16206596|NCT02120352|39233939|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
16206597|NCT02120352|39233940|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
16206598|NCT02120352|39233941|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
16206599|NCT02120352|39233942|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
16206600|NCT02120352|39233943|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
16206601|NCT02120352|39233944|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
16206602|NCT02120352|39233945|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
16206603|NCT02120352|39233939|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
16206604|NCT02120352|39233940|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
16206605|NCT02120352|39233941|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
16206606|NCT02120352|39233942|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
16206607|NCT02120352|39233943|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
16206608|NCT02120352|39233944|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
16206609|NCT02120352|39233945|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
16206610|NCT02120352|39233939|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
16206611|NCT02120352|39233940|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
16206612|NCT02120352|39233941|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
16206613|NCT02120352|39233942|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
16206614|NCT02120352|39233943|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
16206615|NCT02120352|39233944|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
16206616|NCT02120352|39233945|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
16206617|NCT02120352|39233939|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
16206618|NCT02120352|39233940|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
16206619|NCT02120352|39233941|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
16206620|NCT02120352|39233942|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
16206621|NCT02120352|39233943|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
16206622|NCT02120352|39233944|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
16206623|NCT02120352|39233945|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
16206624|NCT02120352|39233939|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
16206625|NCT02120352|39233940|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
16206626|NCT02120352|39233941|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
16206627|NCT02120352|39233942|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
16206628|NCT02120352|39233943|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
16206629|NCT02120352|39233944|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
16206630|NCT02120352|39233945|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
16206631|NCT02120352|39233939|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
16206632|NCT02120352|39233940|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
16206633|NCT02120352|39233941|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
16206634|NCT02120352|39233942|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
16206635|NCT02120352|39233943|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
16206636|NCT02120352|39233944|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
16206637|NCT02120352|39233945|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
16206638|NCT02120352|39233939|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
16206639|NCT02120352|39233940|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
16206640|NCT02120352|39233941|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
16206641|NCT02120352|39233942|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
16206642|NCT02120352|39233943|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
16206643|NCT02120352|39233944|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
16206644|NCT02120352|39233945|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
16206645|NCT02120352|39233939|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
16206646|NCT02120352|39233940|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
16206647|NCT02120352|39233941|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
16206648|NCT02120352|39233942|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
16206649|NCT02120352|39233943|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
16520370|NCT00679341|40372297|FG000|Overall Study|Physician/patient decision to withdraw|0|||
16520371|NCT00679341|40372298|FG001|Overall Study|Physician/patient decision to withdraw|6|||
16520372|NCT00723606|40372303|FG000|Overall Study|Adverse Event|2|||
16520373|NCT00723606|40372304|FG001|Overall Study|Adverse Event|5|||
16520374|NCT00723606|40372303|FG000|Overall Study|Other|2|||
16520375|NCT00723606|40372304|FG001|Overall Study|Other|0|||
16520376|NCT00723606|40372303|FG000|Overall Study|Withdrawal by Subject|0|||
16520377|NCT00723606|40372304|FG001|Overall Study|Withdrawal by Subject|2|||
16520378|NCT03698773|40372308|FG000|Overall Study|Lost to Follow-up|2|||
16206650|NCT02120352|39233944|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
16206651|NCT02120352|39233945|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
16206652|NCT02120352|39233939|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
16206653|NCT02120352|39233940|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
16206654|NCT02120352|39233941|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
16206655|NCT02120352|39233942|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
16206656|NCT02120352|39233943|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
16206657|NCT02120352|39233944|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
16206658|NCT02120352|39233945|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
16206659|NCT02120352|39233939|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
16206660|NCT02120352|39233940|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
16206661|NCT02120352|39233941|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
16206662|NCT02120352|39233942|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
16206663|NCT02120352|39233943|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
16206664|NCT02120352|39233944|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
16206665|NCT02120352|39233945|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
16206666|NCT00606294|39233960|FG000|Overall Study|Withdrawal by Subject|36|||
16206667|NCT00606294|39233961|FG001|Overall Study|Withdrawal by Subject|0|||
16206668|NCT03625141|39233962|FG000|Overall Study|Adverse Event|0|||
16206669|NCT03625141|39233963|FG001|Overall Study|Adverse Event|2|||
16206670|NCT03625141|39233962|FG000|Overall Study|Study Terminated By Sponsor|1|||
16206671|NCT03625141|39233963|FG001|Overall Study|Study Terminated By Sponsor|13|||
16206672|NCT03625141|39233962|FG000|Overall Study|Withdrawal by Subject|3|||
16520379|NCT03698773|40372309|FG001|Overall Study|Lost to Follow-up|1|||
16520380|NCT01940705|40372310|FG000|Overall Study|Lost to Follow-up|1|||
16520381|NCT01940705|40372311|FG001|Overall Study|Lost to Follow-up|3|||
16520382|NCT01940705|40372312|FG002|Overall Study|Lost to Follow-up|2|||
16520383|NCT01940705|40372313|FG003|Overall Study|Lost to Follow-up|2|||
16520384|NCT01940705|40372310|FG000|Overall Study|Withdrawal by Subject|2|||
16520385|NCT01940705|40372311|FG001|Overall Study|Withdrawal by Subject|2|||
16520386|NCT01940705|40372312|FG002|Overall Study|Withdrawal by Subject|3|||
16520387|NCT01940705|40372313|FG003|Overall Study|Withdrawal by Subject|2|||
16520388|NCT01940705|40372310|FG000|Overall Study|Intervention not given|0|||
16520389|NCT01940705|40372311|FG001|Overall Study|Intervention not given|3|||
16520390|NCT01940705|40372312|FG002|Overall Study|Intervention not given|3|||
16520391|NCT01940705|40372313|FG003|Overall Study|Intervention not given|0|||
16520392|NCT01940705|40372310|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
16520393|NCT01940705|40372311|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
16520394|NCT01940705|40372312|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
16520395|NCT01940705|40372313|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
16206673|NCT03625141|39233963|FG001|Overall Study|Withdrawal by Subject|0|||
16206674|NCT03625141|39233962|FG000|Overall Study|Withdrawal Of Consent|0|||
16206675|NCT03625141|39233963|FG001|Overall Study|Withdrawal Of Consent|1|||
16206676|NCT03625141|39233962|FG000|Overall Study|Death|11|||
16206677|NCT03625141|39233963|FG001|Overall Study|Death|47|||
16206678|NCT03625141|39233962|FG000|Overall Study|Progressive Disease|0|||
16206679|NCT03625141|39233963|FG001|Overall Study|Progressive Disease|2|||
16206680|NCT01803711|39233964|FG000|Overall Study|Adverse Event|1|||
16206681|NCT01803711|39233965|FG001|Overall Study|Adverse Event|1|||
16206682|NCT00762268|39233966|FG000|Overall Study|Withdrawal by Subject|3|||
16206683|NCT00762268|39233967|FG001|Overall Study|Withdrawal by Subject|3|||
16206684|NCT03970824|39233969|FG000|Overall Study|Withdrawal by Subject|1|||
16206685|NCT03970824|39233970|FG001|Overall Study|Withdrawal by Subject|1|||
16206686|NCT03970824|39233971|FG002|Overall Study|Withdrawal by Subject|3|||
16206687|NCT03970824|39233969|FG000|Overall Study|Lost to Follow-up|0|||
16206688|NCT03970824|39233970|FG001|Overall Study|Lost to Follow-up|2|||
16206689|NCT03970824|39233971|FG002|Overall Study|Lost to Follow-up|1|||
16206690|NCT03970824|39233969|FG000|Overall Study|Adverse Event|1|||
16206691|NCT03970824|39233970|FG001|Overall Study|Adverse Event|0|||
16395761|NCT01061723|39931155|FG001|Overall Study|Adverse Event|2|||
16520396|NCT00633984|40372315|FG000|Overall Study|Lost to Follow-up|0|||
16206692|NCT03970824|39233971|FG002|Overall Study|Adverse Event|0|||
16206693|NCT00813917|39233972|FG000|Overall Study|Adverse Event|0|||
16206694|NCT00813917|39233973|FG001|Overall Study|Adverse Event|1|||
16206695|NCT00813917|39233972|FG000|Overall Study|Withdrawal by Subject|3|||
16520397|NCT00633984|40372316|FG001|Overall Study|Lost to Follow-up|6|||
16206696|NCT00813917|39233973|FG001|Overall Study|Withdrawal by Subject|4|||
16206697|NCT00813917|39233972|FG000|Overall Study|Lost to Follow-up|3|||
16206698|NCT00813917|39233973|FG001|Overall Study|Lost to Follow-up|1|||
16206699|NCT03175562|39233975|FG000|Overall Study|Adverse Event|1|||
16206700|NCT03175562|39233975|FG000|Overall Study|Lost to Follow-up|3|||
16206701|NCT03175562|39233975|FG000|Overall Study|Withdrawal by Subject|7|||
16206702|NCT03175562|39233975|FG000|Overall Study|Other (Not Specified)|5|||
16206703|NCT04583969|39233978|FG000|Overall Study|Death|31|||
16206704|NCT04583969|39233979|FG001|Overall Study|Death|38|||
16206705|NCT04583969|39233978|FG000|Overall Study|Lost to Follow-up|16|||
16206706|NCT04583969|39233979|FG001|Overall Study|Lost to Follow-up|13|||
16206707|NCT04583969|39233978|FG000|Overall Study|Protocol Violation|1|||
16206708|NCT04583969|39233979|FG001|Overall Study|Protocol Violation|0|||
16206709|NCT04583969|39233978|FG000|Overall Study|Withdrawal by Subject|3|||
16206710|NCT04583969|39233979|FG001|Overall Study|Withdrawal by Subject|3|||
16206711|NCT04583969|39233978|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
16206712|NCT04583969|39233979|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
16520398|NCT00633984|40372315|FG000|Overall Study|Withdrawal by Subject|8|||
16520399|NCT00633984|40372316|FG001|Overall Study|Withdrawal by Subject|7|||
16206713|NCT04583969|39233978|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
16206714|NCT04583969|39233979|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
16206715|NCT04583969|39233978|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
16206716|NCT04583969|39233979|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
16206717|NCT04583969|39233978|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
16206718|NCT04583969|39233979|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
16206719|NCT04583969|39233978|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
16206720|NCT04583969|39233979|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
16206721|NCT04285853|39233980|FG000|Overall Study|Withdrawal by Subject|1|||
16206722|NCT04285853|39233981|FG001|Overall Study|Withdrawal by Subject|0|||
16206723|NCT04285853|39233980|FG000|Overall Study|Lost to Follow-up|9|||
16206724|NCT04285853|39233981|FG001|Overall Study|Lost to Follow-up|5|||
16206725|NCT04681729|39233983|FG000|Overall Study|Lack of Efficacy|2|||
16206726|NCT04681729|39233984|FG001|Overall Study|Lack of Efficacy|2|||
16206727|NCT04681729|39233983|FG000|Overall Study|Withdrawal by Subject|8|||
16206728|NCT04681729|39233984|FG001|Overall Study|Withdrawal by Subject|9|||
16206729|NCT03000686|39233985|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
16206730|NCT03000686|39233986|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
16206731|NCT03000686|39233987|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
16206732|NCT03000686|39233988|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
16206733|NCT00981747|39233989|FG000|Losartan|Withdrawal by Subject|1|||
16520400|NCT00633984|40372315|FG000|Overall Study|Hospitalized|1|||
16520401|NCT00633984|40372316|FG001|Overall Study|Hospitalized|0|||
16520402|NCT00499369|40372317|FG000|Overall Study|Adverse Event|2|||
16520403|NCT00499369|40372318|FG001|Overall Study|Adverse Event|2|||
16520404|NCT00499369|40372319|FG002|Overall Study|Adverse Event|3|||
16520405|NCT00499369|40372320|FG003|Overall Study|Adverse Event|1|||
16520406|NCT00499369|40372321|FG004|Overall Study|Adverse Event|2|||
16520407|NCT00499369|40372317|FG000|Overall Study|Withdrawal by Subject|0|||
16520408|NCT00499369|40372318|FG001|Overall Study|Withdrawal by Subject|1|||
16520409|NCT00499369|40372319|FG002|Overall Study|Withdrawal by Subject|1|||
16520410|NCT00499369|40372320|FG003|Overall Study|Withdrawal by Subject|0|||
16520411|NCT00499369|40372321|FG004|Overall Study|Withdrawal by Subject|0|||
16520412|NCT00499369|40372317|FG000|Overall Study|Progression|10|||
16520413|NCT00499369|40372318|FG001|Overall Study|Progression|12|||
16093296|NCT03849300|38833017|FG000|Overall Study|move out to different area|1|||
16520414|NCT00499369|40372319|FG002|Overall Study|Progression|9|||
16520415|NCT00499369|40372320|FG003|Overall Study|Progression|6|||
16520416|NCT00499369|40372321|FG004|Overall Study|Progression|10|||
16520417|NCT00499369|40372317|FG000|Overall Study|Death|0|||
16520418|NCT00499369|40372318|FG001|Overall Study|Death|1|||
16520419|NCT00499369|40372319|FG002|Overall Study|Death|0|||
16520420|NCT00499369|40372320|FG003|Overall Study|Death|0|||
16093297|NCT03849300|38833018|FG001|Overall Study|move out to different area|3|||
16093298|NCT03849300|38833019|FG002|Overall Study|move out to different area|1|||
16093299|NCT03849300|38833020|FG003|Overall Study|move out to different area|4|||
16093300|NCT03849300|38833017|FG000|Overall Study|scheduling/transportation conflict|4|||
16206734|NCT00981747|39233989|FG000|Losartan|Death|1|||
16206735|NCT00981747|39233989|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
16206736|NCT02571972|39233991|FG000|Overall Study|Protocol Violation|2|||
16206737|NCT02571972|39233991|FG000|Overall Study|Withdrawal by Subject|2|||
16206738|NCT03339401|39233992|FG000|Overall Study|Death|2|||
16206739|NCT03339401|39233993|FG001|Overall Study|Death|1|||
16395762|NCT01061723|39931156|FG002|Overall Study|Adverse Event|5|||
16520421|NCT00499369|40372321|FG004|Overall Study|Death|0|||
16520422|NCT00499369|40372317|FG000|Overall Study|Not protocol specified|2|||
16520423|NCT00499369|40372318|FG001|Overall Study|Not protocol specified|0|||
16520424|NCT00499369|40372319|FG002|Overall Study|Not protocol specified|3|||
16520425|NCT00499369|40372320|FG003|Overall Study|Not protocol specified|1|||
16093301|NCT03849300|38833018|FG001|Overall Study|scheduling/transportation conflict|4|||
16093302|NCT03849300|38833019|FG002|Overall Study|scheduling/transportation conflict|3|||
16324031|NCT00090220|39674379|FG003|Base Study Vaccination Period|Adverse Event|0|||
16324032|NCT00090220|39674380|FG004|Base Study Vaccination Period|Adverse Event|0|||
16324033|NCT00090220|39674381|FG005|Base Study Vaccination Period|Adverse Event|0|||
16093303|NCT03849300|38833020|FG003|Overall Study|scheduling/transportation conflict|2|||
16093304|NCT03873038|38833023|FG000|Part 2|Withdrawal by Subject|0|||
16093305|NCT03873038|38833024|FG001|Part 2|Withdrawal by Subject|0|||
16093306|NCT03873038|38833025|FG002|Part 2|Withdrawal by Subject|0|||
16093307|NCT03873038|38833026|FG003|Part 2|Withdrawal by Subject|0|||
16093308|NCT03873038|38833027|FG004|Part 2|Withdrawal by Subject|0|||
16093309|NCT03873038|38833028|FG005|Part 2|Withdrawal by Subject|1|||
16093310|NCT03873038|38833023|FG000|Part 2|Unknon|0|||
16093311|NCT03873038|38833024|FG001|Part 2|Unknon|0|||
16093312|NCT03873038|38833025|FG002|Part 2|Unknon|0|||
16093313|NCT03873038|38833026|FG003|Part 2|Unknon|0|||
16093314|NCT03873038|38833027|FG004|Part 2|Unknon|1|||
16093315|NCT03873038|38833028|FG005|Part 2|Unknon|0|||
16093316|NCT02268526|38833030|FG000|Overall Study|Adverse Event|0|||
16093317|NCT02268526|38833031|FG001|Overall Study|Adverse Event|2|||
16093318|NCT02268526|38833032|FG002|Overall Study|Adverse Event|1|||
16093319|NCT02268526|38833030|FG000|Overall Study|Death|1|||
16093320|NCT02268526|38833031|FG001|Overall Study|Death|11|||
16093321|NCT02268526|38833032|FG002|Overall Study|Death|0|||
16093322|NCT02268526|38833030|FG000|Overall Study|protocol deviation|0|||
16093323|NCT02268526|38833031|FG001|Overall Study|protocol deviation|1|||
16093324|NCT02268526|38833032|FG002|Overall Study|protocol deviation|0|||
16093325|NCT02268526|38833030|FG000|Overall Study|Physician Decision|0|||
16093326|NCT02268526|38833031|FG001|Overall Study|Physician Decision|0|||
16093327|NCT02268526|38833032|FG002|Overall Study|Physician Decision|1|||
16093328|NCT02268526|38833030|FG000|Overall Study|Subject/guardian decision|0|||
16093329|NCT02268526|38833031|FG001|Overall Study|Subject/guardian decision|7|||
16093330|NCT02268526|38833032|FG002|Overall Study|Subject/guardian decision|3|||
16093331|NCT02097056|38833033|FG000|Overall Study|Protocol Violation|2|||
16093332|NCT02097056|38833033|FG000|Overall Study|Withdrawal by Subject|15|||
16093333|NCT02097056|38833033|FG000|Overall Study|Lost to Follow-up|2|||
16093334|NCT02097056|38833033|FG000|Overall Study|Adverse Event|37|||
16093335|NCT02097056|38833033|FG000|Overall Study|Other|2|||
16093336|NCT04938453|38833038|FG000|Washout Period 1|Adverse Event|1|||
16093337|NCT04938453|38833039|FG001|Washout Period 1|Adverse Event|0|||
16093338|NCT04938453|38833038|FG000|Washout Period 1|Physician Decision|0|||
16093339|NCT04938453|38833039|FG001|Washout Period 1|Physician Decision|1|||
16093340|NCT00905255|38833040|FG000|Overall Study|Adverse Event|7|||
16093341|NCT00905255|38833041|FG001|Overall Study|Adverse Event|5|||
16093342|NCT00905255|38833040|FG000|Overall Study|Withdrawal by Subject|5|||
16093343|NCT00905255|38833041|FG001|Overall Study|Withdrawal by Subject|4|||
16093344|NCT00905255|38833040|FG000|Overall Study|Familial and Personal Reasons|1|||
16093345|NCT00905255|38833041|FG001|Overall Study|Familial and Personal Reasons|0|||
16093346|NCT00596960|38833042|FG000|Overall Study|Death|1|||
16093347|NCT00596960|38833043|FG001|Overall Study|Death|2|||
16093348|NCT00596960|38833042|FG000|Overall Study|Lost to Follow-up|6|||
16093349|NCT00596960|38833043|FG001|Overall Study|Lost to Follow-up|5|||
16093350|NCT00596960|38833042|FG000|Overall Study|Withdrawal by Subject|1|||
16324034|NCT00090220|39674376|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
16324035|NCT00090220|39674377|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
16324036|NCT00090220|39674378|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
16324037|NCT00090220|39674379|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
16324038|NCT00090220|39674380|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
16324039|NCT00090220|39674381|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
16324040|NCT00090220|39674376|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
16324041|NCT00090220|39674377|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
16324042|NCT00090220|39674378|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
16324043|NCT00090220|39674379|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
16093351|NCT00596960|38833043|FG001|Overall Study|Withdrawal by Subject|0|||
16093352|NCT00596960|38833042|FG000|Overall Study|Incarcerated|2|||
16093353|NCT00596960|38833043|FG001|Overall Study|Incarcerated|0|||
16093354|NCT00596960|38833042|FG000|Overall Study|Physician Decision|1|||
16093355|NCT00596960|38833043|FG001|Overall Study|Physician Decision|0|||
16093356|NCT00596960|38833042|FG000|Overall Study|Protocol Violation|0|||
16093357|NCT00596960|38833043|FG001|Overall Study|Protocol Violation|1|||
16093358|NCT00596960|38833042|FG000|Overall Study|No alcohol use data|0|||
16093359|NCT00596960|38833043|FG001|Overall Study|No alcohol use data|1|||
16093360|NCT04765046|38833047|FG000|Overall Study|Screen Failure|2|||
16093361|NCT04765046|38833047|FG000|Overall Study|Withdrawal by Subject|4|||
16093362|NCT04765046|38833047|FG000|Overall Study|Physician Decision|4|||
16093363|NCT04765046|38833047|FG000|Overall Study|Surgery Cancelled|8|||
16093364|NCT03326856|38833050|FG000|Overall Study|Lost to Follow-up|1|||
16093365|NCT03326856|38833051|FG001|Overall Study|Lost to Follow-up|1|||
16206740|NCT03339401|39233992|FG000|Overall Study|Withdrawal by Subject|2|||
16206741|NCT03339401|39233993|FG001|Overall Study|Withdrawal by Subject|0|||
16206742|NCT03339401|39233992|FG000|Overall Study|Study terminated|4|||
16206743|NCT03339401|39233993|FG001|Overall Study|Study terminated|3|||
16520426|NCT00499369|40372321|FG004|Overall Study|Not protocol specified|0|||
16520427|NCT00499369|40372317|FG000|Overall Study|Ineligible|2|||
16520428|NCT00499369|40372318|FG001|Overall Study|Ineligible|2|||
16520429|NCT00499369|40372319|FG002|Overall Study|Ineligible|1|||
16520430|NCT00499369|40372320|FG003|Overall Study|Ineligible|1|||
16520431|NCT00499369|40372321|FG004|Overall Study|Ineligible|0|||
16520432|NCT00320216|40372324|FG000|Overall Study|Adverse Event|0|||
16520433|NCT00320216|40372325|FG001|Overall Study|Adverse Event|6|||
16520434|NCT00320216|40372326|FG002|Overall Study|Adverse Event|0|||
16520435|NCT00320216|40372327|FG003|Overall Study|Adverse Event|2|||
16520436|NCT00320216|40372328|FG004|Overall Study|Adverse Event|2|||
16520437|NCT00320216|40372324|FG000|Overall Study|Lack of Efficacy|6|||
16520438|NCT00320216|40372325|FG001|Overall Study|Lack of Efficacy|2|||
16520439|NCT00320216|40372326|FG002|Overall Study|Lack of Efficacy|1|||
16520440|NCT00320216|40372327|FG003|Overall Study|Lack of Efficacy|0|||
16520441|NCT00320216|40372328|FG004|Overall Study|Lack of Efficacy|1|||
16520442|NCT00320216|40372324|FG000|Overall Study|Lost to Follow-up|3|||
16520443|NCT00320216|40372325|FG001|Overall Study|Lost to Follow-up|0|||
16520444|NCT00320216|40372326|FG002|Overall Study|Lost to Follow-up|0|||
16520445|NCT00320216|40372327|FG003|Overall Study|Lost to Follow-up|0|||
16520446|NCT00320216|40372328|FG004|Overall Study|Lost to Follow-up|0|||
16520447|NCT00320216|40372324|FG000|Overall Study|Other|7|||
16520448|NCT00320216|40372325|FG001|Overall Study|Other|2|||
16520449|NCT00320216|40372326|FG002|Overall Study|Other|5|||
16520450|NCT00320216|40372327|FG003|Overall Study|Other|1|||
16395763|NCT01061723|39931157|FG003|Overall Study|Adverse Event|5|||
16395764|NCT01061723|39931158|FG004|Overall Study|Adverse Event|2|||
16395765|NCT01061723|39931159|FG005|Overall Study|Adverse Event|6|||
16206744|NCT03339401|39233992|FG000|Overall Study|Investigator Decision|1|||
16206745|NCT03339401|39233993|FG001|Overall Study|Investigator Decision|0|||
16206746|NCT01711541|39233996|FG000|Overall Study|Cancel prior to treatment|0|||
16206747|NCT01711541|39233997|FG001|Overall Study|Cancel prior to treatment|0|||
16206748|NCT01711541|39233998|FG002|Overall Study|Cancel prior to treatment|0|||
16206749|NCT01711541|39233999|FG003|Overall Study|Cancel prior to treatment|1|||
16206750|NCT01711541|39234000|FG004|Overall Study|Cancel prior to treatment|0|||
16206751|NCT01711541|39233996|FG000|Overall Study|Ineligible|0|||
16206752|NCT01711541|39233997|FG001|Overall Study|Ineligible|1|||
16206753|NCT01711541|39233998|FG002|Overall Study|Ineligible|0|||
16206754|NCT01711541|39233999|FG003|Overall Study|Ineligible|0|||
16206755|NCT01711541|39234000|FG004|Overall Study|Ineligible|0|||
16206756|NCT01896856|39234002|FG000|Overall Study|Transportation issues / Non-compliance|0|||
16206757|NCT01896856|39234003|FG001|Overall Study|Transportation issues / Non-compliance|0|||
16206758|NCT01896856|39234004|FG002|Overall Study|Transportation issues / Non-compliance|1|||
16206759|NCT01896856|39234005|FG003|Overall Study|Transportation issues / Non-compliance|0|||
16206760|NCT01896856|39234006|FG004|Overall Study|Transportation issues / Non-compliance|0|||
16206761|NCT01896856|39234007|FG005|Overall Study|Transportation issues / Non-compliance|0|||
16206762|NCT02633046|39234008|FG000|Overall Study|Adverse Event|8|||
16206763|NCT02633046|39234008|FG000|Overall Study|Physician Decision|7|||
16206764|NCT02633046|39234008|FG000|Overall Study|Withdrawal by Subject|8|||
16206765|NCT02633046|39234008|FG000|Overall Study|Increased proteinuria|2|||
16395766|NCT01061723|39931154|FG000|Overall Study|Lack of Efficacy|2|||
16520451|NCT00320216|40372328|FG004|Overall Study|Other|3|||
16206766|NCT02633046|39234008|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
16520452|NCT01312961|40372329|FG000|Overall Study|Adverse Event|3|||
16520453|NCT01312961|40372330|FG001|Overall Study|Adverse Event|3|||
16520454|NCT01312961|40372329|FG000|Overall Study|Lack of Efficacy|11|||
16206767|NCT02633046|39234008|FG000|Overall Study|Mutual decision patient and physician|1|||
16206768|NCT00732641|39234009|FG000|Overall Study|Relapse or Progressive Disease|65|||
16206769|NCT00732641|39234010|FG001|Overall Study|Relapse or Progressive Disease|101|||
16520455|NCT01312961|40372330|FG001|Overall Study|Lack of Efficacy|1|||
16520456|NCT01312961|40372329|FG000|Overall Study|Poor compliance to protocol|1|||
16520457|NCT01312961|40372330|FG001|Overall Study|Poor compliance to protocol|0|||
16520458|NCT01312961|40372329|FG000|Overall Study|Other than specified above|2|||
16520459|NCT01312961|40372330|FG001|Overall Study|Other than specified above|3|||
16520460|NCT01461096|40372342|FG000|Overall Study|Death|3|||
16520461|NCT01461096|40372343|FG001|Overall Study|Death|6|||
16520462|NCT01461096|40372342|FG000|Overall Study|Severe debilitation, unable to continue|1|||
16520463|NCT01461096|40372343|FG001|Overall Study|Severe debilitation, unable to continue|1|||
16520464|NCT01461096|40372342|FG000|Overall Study|Subj not able to get to clinic|15|||
16520465|NCT01461096|40372343|FG001|Overall Study|Subj not able to get to clinic|13|||
16520466|NCT01461096|40372342|FG000|Overall Study|Site is closing|27|||
16520467|NCT01461096|40372343|FG001|Overall Study|Site is closing|30|||
16520468|NCT01461096|40372342|FG000|Overall Study|Withdrawal by Subject|5|||
16520469|NCT01461096|40372343|FG001|Overall Study|Withdrawal by Subject|3|||
16520470|NCT01461096|40372342|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
16520471|NCT01461096|40372343|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
16520472|NCT01461096|40372342|FG000|Overall Study|Lost to Follow-up|8|||
16520473|NCT01461096|40372343|FG001|Overall Study|Lost to Follow-up|4|||
16520474|NCT01578551|40372350|FG000|Overall Study|Adverse Event|1|||
16520475|NCT01578551|40372351|FG001|Overall Study|Adverse Event|0|||
16520476|NCT03075644|40372352|FG000|Overall Study|Withdrawal by Subject|1|||
16520477|NCT03075644|40372353|FG001|Overall Study|Withdrawal by Subject|1|||
16520478|NCT03100825|40372354|FG000|Overall Study|Participant/Guardian Decision|7|||
16520479|NCT03100825|40372354|FG000|Overall Study|Physician Decision|1|||
16520480|NCT04442737|40372355|FG000|Overall Study|Lost to Follow-up|1|||
16520481|NCT04442737|40372356|FG001|Overall Study|Lost to Follow-up|3|||
16520482|NCT04442737|40372355|FG000|Overall Study|Withdrawal by Subject|3|||
16520483|NCT04442737|40372356|FG001|Overall Study|Withdrawal by Subject|2|||
16520484|NCT04442737|40372355|FG000|Overall Study|Adverse Event|3|||
16520485|NCT04442737|40372356|FG001|Overall Study|Adverse Event|2|||
16520486|NCT04442737|40372355|FG000|Overall Study|Death|0|||
16520487|NCT04442737|40372356|FG001|Overall Study|Death|1|||
16520488|NCT04442737|40372355|FG000|Overall Study|Protocol Violation|0|||
16520489|NCT04442737|40372356|FG001|Overall Study|Protocol Violation|2|||
16520490|NCT04442737|40372355|FG000|Overall Study|Other|1|||
16520491|NCT04442737|40372356|FG001|Overall Study|Other|1|||
16520492|NCT01332149|40372357|FG000|Overall Study|Adverse Event|11|||
16520493|NCT01332149|40372358|FG001|Overall Study|Adverse Event|9|||
16520494|NCT01332149|40372357|FG000|Overall Study|Other unspecified|5|||
16520495|NCT01332149|40372358|FG001|Overall Study|Other unspecified|7|||
16520496|NCT01332149|40372357|FG000|Overall Study|Protocol Violation|1|||
16520497|NCT01332149|40372358|FG001|Overall Study|Protocol Violation|3|||
16520498|NCT01332149|40372357|FG000|Overall Study|Withdrawal by Subject|4|||
16520499|NCT01332149|40372358|FG001|Overall Study|Withdrawal by Subject|5|||
16520500|NCT01332149|40372357|FG000|Overall Study|Lost to Follow-up|1|||
16520501|NCT01332149|40372358|FG001|Overall Study|Lost to Follow-up|1|||
16520502|NCT01332149|40372357|FG000|Overall Study|Insufficient clinical response|4|||
16520503|NCT01332149|40372358|FG001|Overall Study|Insufficient clinical response|7|||
16520504|NCT01332149|40372357|FG000|Overall Study|Did not meet entrance criteria|3|||
16520505|NCT01332149|40372358|FG001|Overall Study|Did not meet entrance criteria|4|||
16520506|NCT01332149|40372357|FG000|Overall Study|Randomized but not treated|1|||
16520507|NCT01332149|40372358|FG001|Overall Study|Randomized but not treated|2|||
16520508|NCT01632579|40372359|FG000|Washout Period|Adverse Event|1|||
16520509|NCT01632579|40372360|FG001|Washout Period|Adverse Event|0|||
16520510|NCT01632579|40372361|FG002|Washout Period|Adverse Event|0|||
16520511|NCT01632579|40372362|FG003|Washout Period|Adverse Event|0|||
16520512|NCT01632579|40372363|FG004|Washout Period|Adverse Event|0|||
16520513|NCT01632579|40372364|FG005|Washout Period|Adverse Event|0|||
16520514|NCT01632579|40372365|FG006|Washout Period|Adverse Event|0|||
16520515|NCT01632579|40372366|FG007|Washout Period|Adverse Event|0|||
16520516|NCT01632579|40372367|FG008|Washout Period|Adverse Event|0|||
16520517|NCT01632579|40372359|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
16520518|NCT01632579|40372360|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
16520519|NCT01632579|40372361|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
16520520|NCT01632579|40372362|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
16520521|NCT01632579|40372363|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
16520522|NCT01632579|40372364|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
16520523|NCT01632579|40372365|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
16520524|NCT01632579|40372366|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
16520525|NCT01632579|40372367|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
16520526|NCT01067352|40372368|FG000|Overall Study|Withdrawal by Subject|1|||
16520527|NCT01067352|40372369|FG001|Overall Study|Withdrawal by Subject|2|||
16520528|NCT01067352|40372370|FG002|Overall Study|Withdrawal by Subject|1|||
16520529|NCT01067352|40372368|FG000|Overall Study|Physician Decision|0|||
16520530|NCT01067352|40372369|FG001|Overall Study|Physician Decision|1|||
16520531|NCT01067352|40372370|FG002|Overall Study|Physician Decision|0|||
16520532|NCT04796610|40372371|FG000|Overall Study|Withdrawal by Subject|1|||
16520533|NCT04796610|40372372|FG001|Overall Study|Withdrawal by Subject|0|||
16206770|NCT00732641|39234009|FG000|Overall Study|Serious Adverse Events|12|||
16206771|NCT00732641|39234010|FG001|Overall Study|Serious Adverse Events|3|||
16206772|NCT00732641|39234009|FG000|Overall Study|Physician Decision|6|||
16206773|NCT00732641|39234010|FG001|Overall Study|Physician Decision|0|||
16206774|NCT00732641|39234009|FG000|Overall Study|Withdrawal by Subject|4|||
16206775|NCT00732641|39234010|FG001|Overall Study|Withdrawal by Subject|2|||
16206776|NCT00732641|39234009|FG000|Overall Study|Unable to Complete|1|||
16206777|NCT00732641|39234010|FG001|Overall Study|Unable to Complete|1|||
16206778|NCT00732641|39234009|FG000|Overall Study|Other|18|||
16206779|NCT00732641|39234010|FG001|Overall Study|Other|5|||
16206780|NCT04114539|39234018|FG000|Overall Study|Adverse Event|14|||
16206781|NCT04114539|39234018|FG000|Overall Study|Lost to Follow-up|2|||
16206782|NCT04114539|39234018|FG000|Overall Study|Non-compliance with Protocol|2|||
16206783|NCT04114539|39234018|FG000|Overall Study|Non-compliance with Study Drug|1|||
16206784|NCT04114539|39234018|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
16206785|NCT04114539|39234018|FG000|Overall Study|Withdrew consent|10|||
16206786|NCT04114539|39234018|FG000|Overall Study|Others not specified|5|||
16206787|NCT04114539|39234018|FG000|Overall Study|Investigator Decision|2|||
16206788|NCT05742841|39234023|FG000|Overall Study|Withdrawal by Subject|1|||
16206789|NCT05742841|39234023|FG000|Overall Study|Lost to Follow-up|1|||
16206790|NCT00469209|39234024|FG000|Overall Study|Adverse Event|1|||
16206791|NCT00469209|39234025|FG001|Overall Study|Adverse Event|0|||
16206792|NCT00469209|39234026|FG002|Overall Study|Adverse Event|1|||
16206793|NCT00212758|39234029|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
16206794|NCT00212758|39234030|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
16324044|NCT00090220|39674380|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
16324045|NCT00090220|39674381|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
16324046|NCT00090220|39674376|FG000|Base Study Vaccination Period|Patient Moved|6|||
16324047|NCT00090220|39674377|FG001|Base Study Vaccination Period|Patient Moved|2|||
16324048|NCT00090220|39674378|FG002|Base Study Vaccination Period|Patient Moved|0|||
16324049|NCT00090220|39674379|FG003|Base Study Vaccination Period|Patient Moved|0|||
16520534|NCT04796610|40372373|FG002|Overall Study|Withdrawal by Subject|0|||
16520535|NCT04796610|40372374|FG003|Overall Study|Withdrawal by Subject|0|||
16520536|NCT04796610|40372371|FG000|Overall Study|Lost to Follow-up|2|||
16520537|NCT04796610|40372372|FG001|Overall Study|Lost to Follow-up|0|||
16324050|NCT00090220|39674380|FG004|Base Study Vaccination Period|Patient Moved|0|||
16324051|NCT00090220|39674381|FG005|Base Study Vaccination Period|Patient Moved|0|||
16324052|NCT00090220|39674376|FG000|Base Study Vaccination Period|Other|4|||
16324053|NCT00090220|39674377|FG001|Base Study Vaccination Period|Other|4|||
16324054|NCT00090220|39674378|FG002|Base Study Vaccination Period|Other|0|||
16324055|NCT00090220|39674379|FG003|Base Study Vaccination Period|Other|0|||
16324056|NCT00090220|39674380|FG004|Base Study Vaccination Period|Other|0|||
16324057|NCT00090220|39674381|FG005|Base Study Vaccination Period|Other|0|||
16520538|NCT04796610|40372373|FG002|Overall Study|Lost to Follow-up|1|||
16520539|NCT04796610|40372374|FG003|Overall Study|Lost to Follow-up|1|||
16520540|NCT00827372|40372375|FG000|Overall Study|Adverse Event|5|||
16520541|NCT00827372|40372375|FG000|Overall Study|Lack of Efficacy|3|||
16520542|NCT03603964|40372379|FG000|Overall Study|Death|9|||
16520543|NCT03603964|40372379|FG000|Overall Study|Withdrawal by participant|7|||
16520544|NCT03603964|40372379|FG000|Overall Study|Study terminated by Sponsor|19|||
16520545|NCT03786783|40372380|FG000|Overall Study|Death|1|||
16520546|NCT03786783|40372380|FG000|Overall Study|Physician Decision|6|||
16520547|NCT03786783|40372380|FG000|Overall Study|Withdrawal by Subject|2|||
16520548|NCT03786783|40372380|FG000|Overall Study|Disease Progression|7|||
16520549|NCT03786783|40372380|FG000|Overall Study|Patient/Parent Refusal|4|||
16520550|NCT01824303|40372385|FG000|Randomized Study|Withdrawal by Subject|1|||
16520551|NCT01824303|40372386|FG001|Randomized Study|Withdrawal by Subject|1|||
16520552|NCT01824303|40372385|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
16324058|NCT00090220|39674376|FG000|Base Study Follow-up Period|Adverse Event|6|||
16324059|NCT00090220|39674377|FG001|Base Study Follow-up Period|Adverse Event|1|||
16520553|NCT01824303|40372386|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
16520554|NCT01639040|40372387|FG000|Overall Study|Adverse Event|1|||
16206795|NCT00212758|39234029|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
16206796|NCT00212758|39234030|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
16206797|NCT01437267|39234039|FG000|Overall Study|Withdrawal by Subject|0|||
16206798|NCT01437267|39234040|FG001|Overall Study|Withdrawal by Subject|0|||
16206799|NCT01437267|39234041|FG002|Overall Study|Withdrawal by Subject|0|||
16324060|NCT00090220|39674378|FG002|Base Study Follow-up Period|Adverse Event|0|||
16324061|NCT00090220|39674379|FG003|Base Study Follow-up Period|Adverse Event|0|||
16520555|NCT01639040|40372388|FG001|Overall Study|Adverse Event|0|||
16546338|NCT01986881|40464783|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
16546339|NCT01986881|40464784|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
16546340|NCT01986881|40464785|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
16546341|NCT01986881|40464783|FG000|Overall Study|Withdrawal by Subject|41|||
16546342|NCT01986881|40464784|FG001|Overall Study|Withdrawal by Subject|60|||
16546343|NCT01986881|40464785|FG002|Overall Study|Withdrawal by Subject|45|||
16546344|NCT01986881|40464783|FG000|Overall Study|Subject Moved|0|||
16546345|NCT01986881|40464784|FG001|Overall Study|Subject Moved|1|||
16546346|NCT01986881|40464785|FG002|Overall Study|Subject Moved|0|||
16546347|NCT01986881|40464783|FG000|Overall Study|Other|1|||
16546348|NCT01986881|40464784|FG001|Overall Study|Other|2|||
16546349|NCT01986881|40464785|FG002|Overall Study|Other|2|||
16546350|NCT00118092|40464786|FG000|Overall Study|Withdrawal by Subject|1|||
16546351|NCT00118092|40464786|FG000|Overall Study|Protocol Violation|1|||
16546352|NCT02204579|40464787|FG000|Overall Study|Screen failures|2|||
16546353|NCT04461795|40464788|FG000|Overall Study|Lost to Follow-up|2|||
16546354|NCT04461795|40464788|FG000|Overall Study|Withdrawal by Subject|2|||
16546355|NCT04461795|40464788|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
16546356|NCT00792103|40464789|FG000|Overall Study|Enrolled, not treated|15|||
16546357|NCT00792103|40464789|FG000|Overall Study|Lost to Follow-up|17|||
16546358|NCT00792103|40464789|FG000|Overall Study|Adverse Event|25|||
16546359|NCT00792103|40464789|FG000|Overall Study|Withdrawal by Subject|52|||
16546360|NCT00792103|40464789|FG000|Overall Study|Protocol Violation|10|||
16546361|NCT00792103|40464789|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
16546362|NCT03673462|40464790|FG000|Overall Study|Adverse Event|11|||
16546363|NCT03673462|40464791|FG001|Overall Study|Adverse Event|1|||
16546364|NCT03673462|40464790|FG000|Overall Study|Protocol Violation|25|||
16324062|NCT00090220|39674380|FG004|Base Study Follow-up Period|Adverse Event|0|||
16324063|NCT00090220|39674381|FG005|Base Study Follow-up Period|Adverse Event|0|||
16324064|NCT00090220|39674376|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
16324065|NCT00090220|39674377|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
16324066|NCT00090220|39674378|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
16324067|NCT00090220|39674379|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
16324068|NCT00090220|39674380|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
16324069|NCT00090220|39674381|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
16324070|NCT00090220|39674376|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
16324071|NCT00090220|39674377|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
16324072|NCT00090220|39674378|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
16324073|NCT00090220|39674379|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
16324074|NCT00090220|39674380|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
16324075|NCT00090220|39674381|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
16324076|NCT00090220|39674376|FG000|Base Study Follow-up Period|Patient Moved|20|||
16324077|NCT00090220|39674377|FG001|Base Study Follow-up Period|Patient Moved|28|||
16324078|NCT00090220|39674378|FG002|Base Study Follow-up Period|Patient Moved|0|||
16324079|NCT00090220|39674379|FG003|Base Study Follow-up Period|Patient Moved|0|||
16324080|NCT00090220|39674380|FG004|Base Study Follow-up Period|Patient Moved|0|||
16324081|NCT00090220|39674381|FG005|Base Study Follow-up Period|Patient Moved|0|||
16324082|NCT00090220|39674376|FG000|Base Study Follow-up Period|Other|19|||
16324083|NCT00090220|39674377|FG001|Base Study Follow-up Period|Other|21|||
16324084|NCT00090220|39674378|FG002|Base Study Follow-up Period|Other|0|||
16324085|NCT00090220|39674379|FG003|Base Study Follow-up Period|Other|0|||
16324086|NCT00090220|39674380|FG004|Base Study Follow-up Period|Other|0|||
16324087|NCT00090220|39674381|FG005|Base Study Follow-up Period|Other|0|||
16324088|NCT00090220|39674376|FG000|Extension 1 (EXT1)|Adverse Event|0|||
16324089|NCT00090220|39674377|FG001|Extension 1 (EXT1)|Adverse Event|0|||
16324090|NCT00090220|39674378|FG002|Extension 1 (EXT1)|Adverse Event|4|||
16324091|NCT00090220|39674379|FG003|Extension 1 (EXT1)|Adverse Event|0|||
16324092|NCT00090220|39674380|FG004|Extension 1 (EXT1)|Adverse Event|0|||
16324093|NCT00090220|39674381|FG005|Extension 1 (EXT1)|Adverse Event|0|||
16324094|NCT00090220|39674376|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
16546365|NCT03673462|40464791|FG001|Overall Study|Protocol Violation|11|||
16546366|NCT03673462|40464790|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
16546367|NCT03673462|40464791|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
16546368|NCT03673462|40464790|FG000|Overall Study|Lost to Follow-up|102|||
16546369|NCT03673462|40464791|FG001|Overall Study|Lost to Follow-up|19|||
16546370|NCT01662063|40464796|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
16324095|NCT00090220|39674377|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
16324096|NCT00090220|39674378|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
16324097|NCT00090220|39674379|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
16324098|NCT00090220|39674380|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
16324099|NCT00090220|39674381|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
16324100|NCT00090220|39674376|FG000|Extension 1 (EXT1)|Moved|0|||
16546371|NCT01662063|40464797|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
16324101|NCT00090220|39674377|FG001|Extension 1 (EXT1)|Moved|0|||
16324102|NCT00090220|39674378|FG002|Extension 1 (EXT1)|Moved|2|||
16324103|NCT00090220|39674379|FG003|Extension 1 (EXT1)|Moved|1|||
16324104|NCT00090220|39674380|FG004|Extension 1 (EXT1)|Moved|0|||
16324105|NCT00090220|39674381|FG005|Extension 1 (EXT1)|Moved|0|||
16324106|NCT00090220|39674376|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
16324107|NCT00090220|39674377|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
16324108|NCT00090220|39674378|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
16324109|NCT00090220|39674379|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
16324110|NCT00090220|39674380|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
16324111|NCT00090220|39674381|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
16324112|NCT00090220|39674376|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
16324113|NCT00090220|39674377|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
16324114|NCT00090220|39674378|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
16324115|NCT00090220|39674379|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
16324116|NCT00090220|39674380|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
16324117|NCT00090220|39674381|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
16324118|NCT00090220|39674376|FG000|Extension 1 (EXT1)|Other reason|0|||
16324119|NCT00090220|39674377|FG001|Extension 1 (EXT1)|Other reason|0|||
16324120|NCT00090220|39674378|FG002|Extension 1 (EXT1)|Other reason|2|||
16324121|NCT00090220|39674379|FG003|Extension 1 (EXT1)|Other reason|0|||
16324122|NCT00090220|39674380|FG004|Extension 1 (EXT1)|Other reason|0|||
16324123|NCT00090220|39674381|FG005|Extension 1 (EXT1)|Other reason|0|||
16324124|NCT00090220|39674376|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
16324125|NCT00090220|39674377|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
16324126|NCT00090220|39674378|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
16324127|NCT00090220|39674379|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
16324128|NCT00090220|39674380|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
16324129|NCT00090220|39674381|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
16324130|NCT00090220|39674376|FG000|Long-term Follow-up (EXT2)|Death|0|||
16324131|NCT00090220|39674377|FG001|Long-term Follow-up (EXT2)|Death|0|||
16324132|NCT00090220|39674378|FG002|Long-term Follow-up (EXT2)|Death|0|||
16324133|NCT00090220|39674379|FG003|Long-term Follow-up (EXT2)|Death|0|||
16324134|NCT00090220|39674380|FG004|Long-term Follow-up (EXT2)|Death|1|||
16324135|NCT00090220|39674381|FG005|Long-term Follow-up (EXT2)|Death|1|||
16324136|NCT00090220|39674376|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
16324137|NCT00090220|39674377|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
16324138|NCT00090220|39674378|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
16324139|NCT00090220|39674379|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
16324140|NCT00090220|39674380|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
16324141|NCT00090220|39674381|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
16324142|NCT00090220|39674376|FG000|Long-term Follow-up (EXT2)|Other|0|||
16324143|NCT00090220|39674377|FG001|Long-term Follow-up (EXT2)|Other|0|||
16324144|NCT00090220|39674378|FG002|Long-term Follow-up (EXT2)|Other|0|||
16324145|NCT00090220|39674379|FG003|Long-term Follow-up (EXT2)|Other|0|||
16324146|NCT00090220|39674380|FG004|Long-term Follow-up (EXT2)|Other|1|||
16324147|NCT00090220|39674381|FG005|Long-term Follow-up (EXT2)|Other|0|||
16324148|NCT03070002|39674383|FG000|Follow up for 2 Years|Death|1|||
16324149|NCT01790828|39674387|FG000|Overall Study|Other|34|||
16324150|NCT03030989|39674388|FG000|Overall Study|Fever|2|||
16324151|NCT03030989|39674389|FG001|Overall Study|Fever|2|||
16324152|NCT03030989|39674388|FG000|Overall Study|Rash|2|||
16324153|NCT03030989|39674389|FG001|Overall Study|Rash|1|||
16324154|NCT03030989|39674388|FG000|Overall Study|Fatigue/Overwhelmed|1|||
16324155|NCT03030989|39674389|FG001|Overall Study|Fatigue/Overwhelmed|5|||
16324156|NCT03030989|39674388|FG000|Overall Study|Positive Blood Cultures|2|||
16324157|NCT03030989|39674389|FG001|Overall Study|Positive Blood Cultures|1|||
16324158|NCT03030989|39674388|FG000|Overall Study|Line Removed|0|||
16324159|NCT03030989|39674389|FG001|Overall Study|Line Removed|2|||
16324160|NCT03030989|39674388|FG000|Overall Study|No longer interested|5|||
16324161|NCT03030989|39674389|FG001|Overall Study|No longer interested|3|||
16324162|NCT02361346|39674390|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
16324163|NCT02361346|39674391|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
16324164|NCT02361346|39674392|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
16324165|NCT02361346|39674393|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
16324166|NCT02361346|39674394|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
16324167|NCT02361346|39674395|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
16324168|NCT02361346|39674396|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
16324169|NCT02361346|39674397|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
16520556|NCT01312467|40376231|FG000|Overall Study|Adverse Event|4|||
16520557|NCT01312467|40376231|FG000|Overall Study|Lost to Follow-up|1|||
16520558|NCT01312467|40376231|FG000|Overall Study|Withdrawal by Subject|2|||
16520559|NCT01312467|40376231|FG000|Overall Study|Deported to country of origin|1|||
16520560|NCT01312467|40376231|FG000|Overall Study|Another medical condition|1|||
16520561|NCT01312467|40376231|FG000|Overall Study|Ineligible|4|||
16520562|NCT02031276|40376232|FG000|Period 1 Double-blind IV|Adverse Event|6|||
16520563|NCT02031276|40376233|FG001|Period 1 Double-blind IV|Adverse Event|5|||
16520564|NCT02031276|40376234|FG002|Period 1 Double-blind IV|Adverse Event|1|||
16206800|NCT01437267|39234042|FG003|Overall Study|Withdrawal by Subject|1|||
16206801|NCT01437267|39234043|FG004|Overall Study|Withdrawal by Subject|0|||
16324170|NCT02361346|39674398|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
16324171|NCT02361346|39674390|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16324172|NCT02361346|39674391|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16520565|NCT02031276|40376232|FG000|Period 1 Double-blind IV|Other|0|||
16324173|NCT02361346|39674392|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16324174|NCT02361346|39674393|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16324175|NCT02361346|39674394|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
16324176|NCT02361346|39674395|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16520566|NCT02031276|40376233|FG001|Period 1 Double-blind IV|Other|1|||
16520567|NCT02031276|40376234|FG002|Period 1 Double-blind IV|Other|0|||
16520568|NCT02031276|40376232|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
16520569|NCT02031276|40376233|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
16520570|NCT02031276|40376234|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
16520571|NCT02031276|40376232|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
16520572|NCT02031276|40376233|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
16520573|NCT02031276|40376234|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
16520574|NCT02031276|40376232|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
16520575|NCT02031276|40376233|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
16520576|NCT02031276|40376234|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
16520577|NCT02031276|40376232|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
16520578|NCT02031276|40376233|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
16520579|NCT02031276|40376234|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
16520580|NCT02031276|40376232|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
16520581|NCT02031276|40376233|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
16520582|NCT02031276|40376234|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
16520583|NCT02031276|40376232|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
16520584|NCT02031276|40376233|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
16520585|NCT02031276|40376234|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
16520586|NCT02031276|40376232|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
16520587|NCT02031276|40376233|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
16520588|NCT02031276|40376234|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
16520589|NCT00774787|40376235|FG000|Overall Study|Lost to Follow-up|1|||
16520590|NCT05789875|40376240|FG000|Overall Study|Lost to Follow-up|6|||
16520591|NCT02019719|40376241|FG000|Overall Study|Adverse Event|1|||
16520592|NCT02019719|40376242|FG001|Overall Study|Adverse Event|0|||
16520593|NCT02019719|40376243|FG002|Overall Study|Adverse Event|0|||
16520594|NCT02019719|40376244|FG003|Overall Study|Adverse Event|1|||
16520595|NCT02019719|40376245|FG004|Overall Study|Adverse Event|1|||
16520596|NCT02019719|40376241|FG000|Overall Study|Protocol Violation|1|||
16520597|NCT02019719|40376242|FG001|Overall Study|Protocol Violation|1|||
16520598|NCT02019719|40376243|FG002|Overall Study|Protocol Violation|0|||
16520599|NCT02019719|40376244|FG003|Overall Study|Protocol Violation|0|||
16520600|NCT02019719|40376245|FG004|Overall Study|Protocol Violation|0|||
16520601|NCT02019719|40376241|FG000|Overall Study|Protocol defined stopping criteria|2|||
16520602|NCT02019719|40376242|FG001|Overall Study|Protocol defined stopping criteria|0|||
16520603|NCT02019719|40376243|FG002|Overall Study|Protocol defined stopping criteria|0|||
16520604|NCT02019719|40376244|FG003|Overall Study|Protocol defined stopping criteria|1|||
16520605|NCT02019719|40376245|FG004|Overall Study|Protocol defined stopping criteria|1|||
16520606|NCT02019719|40376241|FG000|Overall Study|Physician Decision|2|||
16520607|NCT02019719|40376242|FG001|Overall Study|Physician Decision|0|||
16520608|NCT02019719|40376243|FG002|Overall Study|Physician Decision|0|||
16520609|NCT02019719|40376244|FG003|Overall Study|Physician Decision|0|||
16520610|NCT02019719|40376245|FG004|Overall Study|Physician Decision|0|||
16520611|NCT02348489|40376246|FG000|Overall Study|Death|336|||
16520612|NCT02348489|40376247|FG001|Overall Study|Death|335|||
16520613|NCT02348489|40376246|FG000|Overall Study|Withdrawal by Subject|14|||
16520614|NCT02348489|40376247|FG001|Overall Study|Withdrawal by Subject|27|||
16520615|NCT02348489|40376246|FG000|Overall Study|Lost to Follow-up|3|||
16520616|NCT02348489|40376247|FG001|Overall Study|Lost to Follow-up|5|||
16520617|NCT01609556|40376248|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16520618|NCT01609556|40376249|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16520619|NCT01609556|40376250|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16520620|NCT01609556|40376251|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16520621|NCT01609556|40376252|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
16324177|NCT02361346|39674396|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16520622|NCT01609556|40376253|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16520623|NCT01609556|40376254|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16520624|NCT01609556|40376255|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
16520625|NCT01609556|40376256|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
16520626|NCT01609556|40376257|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16324178|NCT02361346|39674397|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16324179|NCT02361346|39674398|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
16324180|NCT02361346|39674390|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
16324181|NCT02361346|39674391|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
16324182|NCT02361346|39674392|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
16324183|NCT02361346|39674393|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
16324184|NCT02361346|39674394|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
16324185|NCT02361346|39674395|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
16324186|NCT02361346|39674396|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
16324187|NCT02361346|39674397|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
16324188|NCT02361346|39674398|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
16324189|NCT02361346|39674390|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16324190|NCT02361346|39674391|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16324191|NCT02361346|39674392|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16324192|NCT02361346|39674393|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16324193|NCT02361346|39674394|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16324194|NCT02361346|39674395|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16324195|NCT02361346|39674396|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16324196|NCT02361346|39674397|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
16324197|NCT02361346|39674398|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
16324198|NCT02361346|39674390|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16324199|NCT02361346|39674391|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16324200|NCT02361346|39674392|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16324201|NCT02361346|39674393|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16324202|NCT02361346|39674394|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16324203|NCT02361346|39674395|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16324204|NCT02361346|39674396|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16324205|NCT02361346|39674397|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
16324206|NCT02361346|39674398|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
16324207|NCT02361346|39674390|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16324208|NCT02361346|39674391|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16324209|NCT02361346|39674392|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16324210|NCT02361346|39674393|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16324211|NCT02361346|39674394|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16324212|NCT02361346|39674395|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16395767|NCT01061723|39931155|FG001|Overall Study|Lack of Efficacy|3|||
16395768|NCT01061723|39931156|FG002|Overall Study|Lack of Efficacy|4|||
16395769|NCT01061723|39931157|FG003|Overall Study|Lack of Efficacy|2|||
16395770|NCT01061723|39931158|FG004|Overall Study|Lack of Efficacy|1|||
16395771|NCT01061723|39931159|FG005|Overall Study|Lack of Efficacy|1|||
16395772|NCT01061723|39931154|FG000|Overall Study|Randomized but not treated|0|||
16395773|NCT01061723|39931155|FG001|Overall Study|Randomized but not treated|0|||
16395774|NCT01061723|39931156|FG002|Overall Study|Randomized but not treated|0|||
16395775|NCT01061723|39931157|FG003|Overall Study|Randomized but not treated|0|||
16395776|NCT01061723|39931158|FG004|Overall Study|Randomized but not treated|0|||
16395777|NCT01061723|39931159|FG005|Overall Study|Randomized but not treated|1|||
16395778|NCT01061723|39931154|FG000|Overall Study|Other than specified above|2|||
16395779|NCT01061723|39931155|FG001|Overall Study|Other than specified above|1|||
16395780|NCT01061723|39931156|FG002|Overall Study|Other than specified above|1|||
16395781|NCT01061723|39931157|FG003|Overall Study|Other than specified above|1|||
16395782|NCT01061723|39931158|FG004|Overall Study|Other than specified above|0|||
16395783|NCT01061723|39931159|FG005|Overall Study|Other than specified above|1|||
16395784|NCT01523743|39931162|FG000|Period 1|Adverse Event|1|||
16395785|NCT01523743|39931163|FG001|Period 1|Adverse Event|0|||
16395786|NCT01523743|39931162|FG000|Period 1|Withdrawal by Subject|6|||
16395787|NCT01523743|39931163|FG001|Period 1|Withdrawal by Subject|2|||
16395788|NCT01523743|39931162|FG000|Period 1|Lost to Follow-up|1|||
16395789|NCT01523743|39931163|FG001|Period 1|Lost to Follow-up|0|||
16395790|NCT01523743|39931162|FG000|Period 1|Lack of Efficacy|1|||
16395791|NCT01523743|39931163|FG001|Period 1|Lack of Efficacy|0|||
16324213|NCT02361346|39674396|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16324214|NCT02361346|39674397|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
16324215|NCT02361346|39674398|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
16324216|NCT02730377|39674407|FG000|Overall Study|Other|5|||
16324217|NCT02730377|39674408|FG001|Overall Study|Other|4|||
16324218|NCT02730377|39674407|FG000|Overall Study|Death|1|||
16324219|NCT02730377|39674408|FG001|Overall Study|Death|8|||
16395792|NCT01523743|39931162|FG000|Period 1|Felt unable to empty bladder|1|||
16520627|NCT01609556|40376258|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
16520628|NCT01609556|40376259|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
16520629|NCT01609556|40376260|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16520630|NCT01609556|40376261|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16520631|NCT01609556|40376262|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16520632|NCT01609556|40376263|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
16520633|NCT01609556|40376248|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
16520634|NCT01609556|40376249|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
16520635|NCT01609556|40376250|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
16520636|NCT01609556|40376251|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
16520637|NCT01609556|40376252|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
16520638|NCT01609556|40376253|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
16520639|NCT01609556|40376254|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
16520640|NCT01609556|40376255|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
16520641|NCT01609556|40376256|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
16520642|NCT01609556|40376257|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
16520643|NCT01609556|40376258|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
16520644|NCT01609556|40376259|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
16395793|NCT01523743|39931163|FG001|Period 1|Felt unable to empty bladder|0|||
16395794|NCT01523743|39931162|FG000|Period 2|Withdrawal by Subject|0|||
16395795|NCT01523743|39931163|FG001|Period 2|Withdrawal by Subject|2|||
16395796|NCT01523743|39931162|FG000|Period 2|Adverse Event|1|||
16395797|NCT01523743|39931163|FG001|Period 2|Adverse Event|0|||
16395798|NCT02236572|39931167|FG000|Overall Study|Withdrawal by Subject|1|||
16395799|NCT02236572|39931167|FG000|Overall Study|Protocol Violation|1|||
16395800|NCT02236572|39931167|FG000|Overall Study|Lost to Follow-up|1|||
16395801|NCT02526212|39931168|FG000|Overall Study|Incarceration|1|||
16395802|NCT02526212|39931169|FG001|Overall Study|Incarceration|0|||
16395803|NCT02526212|39931168|FG000|Overall Study|Lost to Follow-up|1|||
16395804|NCT02526212|39931169|FG001|Overall Study|Lost to Follow-up|0|||
16395805|NCT02526212|39931168|FG000|Overall Study|Death|0|||
16395806|NCT02526212|39931169|FG001|Overall Study|Death|1|||
16520645|NCT01609556|40376260|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
16324220|NCT02730377|39674407|FG000|Overall Study|Inadequate glycaemic control|368|||
16395807|NCT00082368|39931175|FG000|Overall Study|Not treated-pt had poor IV access|1|||
16395808|NCT00995436|39931176|FG000|Overall Study|Withdrawal by Subject|2|||
16395809|NCT00995436|39931177|FG001|Overall Study|Withdrawal by Subject|5|||
16395810|NCT00995436|39931178|FG002|Overall Study|Withdrawal by Subject|0|||
16395811|NCT02936869|39931179|FG000|Overall Study|Lost to Follow-up|1|||
16395812|NCT02936869|39931180|FG001|Overall Study|Lost to Follow-up|3|||
16395813|NCT02936869|39931179|FG000|Overall Study|Death|0|||
16395814|NCT02936869|39931180|FG001|Overall Study|Death|1|||
16093366|NCT03326856|38833052|FG002|Overall Study|Lost to Follow-up|0|||
16093367|NCT03326856|38833053|FG003|Overall Study|Lost to Follow-up|0|||
16093368|NCT03326856|38833054|FG004|Overall Study|Lost to Follow-up|0|||
16093369|NCT04739306|38833055|FG000|Main Study Period|Adverse Event|6|||
16093370|NCT04739306|38833056|FG001|Main Study Period|Adverse Event|7|||
16093371|NCT04739306|38833055|FG000|Main Study Period|Lost to Follow-up|4|||
16093372|NCT04739306|38833056|FG001|Main Study Period|Lost to Follow-up|6|||
16093373|NCT04739306|38833055|FG000|Main Study Period|Physician Decision|1|||
16093374|NCT04739306|38833056|FG001|Main Study Period|Physician Decision|1|||
16093375|NCT04739306|38833055|FG000|Main Study Period|Withdrawal by Subject|8|||
16093376|NCT04739306|38833056|FG001|Main Study Period|Withdrawal by Subject|6|||
16093377|NCT04739306|38833055|FG000|Main Study Period|Protocol Violation|0|||
16093378|NCT04739306|38833056|FG001|Main Study Period|Protocol Violation|1|||
16093379|NCT04739306|38833055|FG000|Main Study Period|War in Ukraine|1|||
16093380|NCT04739306|38833056|FG001|Main Study Period|War in Ukraine|1|||
16324221|NCT02730377|39674408|FG001|Overall Study|Inadequate glycaemic control|473|||
16324222|NCT02730377|39674407|FG000|Overall Study|Adverse Event|79|||
16324223|NCT02730377|39674408|FG001|Overall Study|Adverse Event|41|||
16324224|NCT02730377|39674407|FG000|Overall Study|Protocol Violation|23|||
16324225|NCT02730377|39674408|FG001|Overall Study|Protocol Violation|30|||
16324226|NCT02730377|39674407|FG000|Overall Study|Lack of Efficacy|4|||
16324227|NCT02730377|39674408|FG001|Overall Study|Lack of Efficacy|13|||
16324228|NCT02730377|39674407|FG000|Overall Study|Pregnancy|0|||
16324229|NCT02730377|39674408|FG001|Overall Study|Pregnancy|1|||
16324230|NCT02730377|39674407|FG000|Overall Study|Withdrawal by Subject|45|||
16324231|NCT02730377|39674408|FG001|Overall Study|Withdrawal by Subject|42|||
16324232|NCT02730377|39674407|FG000|Overall Study|Lost to Follow-up|25|||
16324233|NCT02730377|39674408|FG001|Overall Study|Lost to Follow-up|21|||
16324234|NCT01817582|39674409|FG000|Overall Study|Withdrawal by Subject|0|||
16324235|NCT01817582|39674410|FG001|Overall Study|Withdrawal by Subject|1|||
16324236|NCT01817582|39674411|FG002|Overall Study|Withdrawal by Subject|0|||
16324237|NCT01817582|39674409|FG000|Overall Study|Participant revealed masked treatment|1|||
16324238|NCT01817582|39674410|FG001|Overall Study|Participant revealed masked treatment|0|||
16324239|NCT01817582|39674411|FG002|Overall Study|Participant revealed masked treatment|0|||
16324240|NCT01817582|39674409|FG000|Overall Study|Randomized but exclusion criteria met|1|||
16324241|NCT01817582|39674410|FG001|Overall Study|Randomized but exclusion criteria met|0|||
16324242|NCT01817582|39674411|FG002|Overall Study|Randomized but exclusion criteria met|0|||
16324243|NCT01508130|39674416|FG000|Overall Study|Adverse Event|81|||
16324244|NCT01508130|39674417|FG001|Overall Study|Adverse Event|28|||
16324245|NCT01508130|39674416|FG000|Overall Study|Death|3|||
16324246|NCT01508130|39674417|FG001|Overall Study|Death|1|||
16520646|NCT01609556|40376261|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
16520647|NCT01609556|40376262|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
16520648|NCT01609556|40376263|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
16520649|NCT01609556|40376248|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16520650|NCT01609556|40376249|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16520651|NCT01609556|40376250|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16324247|NCT01508130|39674416|FG000|Overall Study|Protocol Violation|2|||
16324248|NCT01508130|39674417|FG001|Overall Study|Protocol Violation|0|||
16324249|NCT01508130|39674416|FG000|Overall Study|Lost to Follow-up|25|||
16324250|NCT01508130|39674417|FG001|Overall Study|Lost to Follow-up|2|||
16520652|NCT01609556|40376251|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16520653|NCT01609556|40376252|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16520654|NCT01609556|40376253|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
16520655|NCT01609556|40376254|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
16520656|NCT01609556|40376255|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16520657|NCT01609556|40376256|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16520658|NCT01609556|40376257|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
16520659|NCT01609556|40376258|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
16520660|NCT01609556|40376259|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
16520661|NCT01609556|40376260|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16520662|NCT01609556|40376261|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16093381|NCT01393600|38833059|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
16093382|NCT01393600|38833060|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
16093383|NCT01393600|38833061|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
16093384|NCT01393600|38833062|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
16324251|NCT01508130|39674416|FG000|Overall Study|Withdrawal by Subject|3|||
16324252|NCT01508130|39674417|FG001|Overall Study|Withdrawal by Subject|3|||
16324253|NCT01508130|39674416|FG000|Overall Study|Subject's substantial non-compliance|25|||
16324254|NCT01508130|39674417|FG001|Overall Study|Subject's substantial non-compliance|9|||
16324255|NCT01508130|39674416|FG000|Overall Study|Insufficient therapeutic response|74|||
16324256|NCT01508130|39674417|FG001|Overall Study|Insufficient therapeutic response|23|||
16324257|NCT01508130|39674416|FG000|Overall Study|Administrative|14|||
16395815|NCT02936869|39931179|FG000|Overall Study|Legal Case|0|||
16395816|NCT02936869|39931180|FG001|Overall Study|Legal Case|1|||
16395817|NCT02936869|39931179|FG000|Overall Study|Protocol Violation|1|||
16395818|NCT02936869|39931180|FG001|Overall Study|Protocol Violation|0|||
16395819|NCT01555073|39931181|FG000|Overall Study|Lost to Follow-up|1|||
16395820|NCT01555073|39931182|FG001|Overall Study|Lost to Follow-up|2|||
16395821|NCT01555073|39931183|FG002|Overall Study|Lost to Follow-up|0|||
16395822|NCT01555073|39931184|FG003|Overall Study|Lost to Follow-up|5|||
16395823|NCT01897727|39931185|FG000|Overall Study|Exclusion: central sleep apnea|0|||
16395824|NCT01897727|39931186|FG001|Overall Study|Exclusion: central sleep apnea|1|||
16395825|NCT03046446|39931187|FG000|Overall Study|Lack of Efficacy|7|||
16395826|NCT03046446|39931187|FG000|Overall Study|Adverse Event|6|||
16395827|NCT03046446|39931187|FG000|Overall Study|Lost to Follow-up|3|||
16395828|NCT03046446|39931187|FG000|Overall Study|Withdrawal by Subject|14|||
16395829|NCT03046446|39931187|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
16395830|NCT03046446|39931187|FG000|Overall Study|Disease Progression (see caveats)|25|||
16395831|NCT03046446|39931187|FG000|Overall Study|Non OA related knee surgery|1|||
16395832|NCT00958360|39931188|FG000|Overall Study|Withdrawal by Subject|3|||
16395833|NCT00958360|39931189|FG001|Overall Study|Withdrawal by Subject|1|||
16395834|NCT00958360|39931188|FG000|Overall Study|Death|6|||
16395835|NCT00958360|39931189|FG001|Overall Study|Death|7|||
16395836|NCT00958360|39931188|FG000|Overall Study|Physician Decision|2|||
16395837|NCT00958360|39931189|FG001|Overall Study|Physician Decision|1|||
16395838|NCT00958360|39931188|FG000|Overall Study|Lost to Follow-up|0|||
16395839|NCT00958360|39931189|FG001|Overall Study|Lost to Follow-up|1|||
16395840|NCT01864148|39931190|FG000|Overall Study|Other|2|||
16395841|NCT01864148|39931191|FG001|Overall Study|Other|1|||
16324258|NCT01508130|39674417|FG001|Overall Study|Administrative|3|||
16395842|NCT01864148|39931192|FG002|Overall Study|Other|1|||
16395843|NCT01864148|39931193|FG003|Overall Study|Other|3|||
16324259|NCT01736397|39674418|FG000|Overall Study|Lack of Efficacy|1|||
16324260|NCT01736397|39674419|FG001|Overall Study|Lack of Efficacy|11|||
16324261|NCT01736397|39674418|FG000|Overall Study|Withdrawal by Subject|6|||
16324262|NCT01736397|39674419|FG001|Overall Study|Withdrawal by Subject|5|||
16324263|NCT01736397|39674418|FG000|Overall Study|Lost to Follow-up|0|||
16324264|NCT01736397|39674419|FG001|Overall Study|Lost to Follow-up|1|||
16324265|NCT01736397|39674418|FG000|Overall Study|Adverse Event|6|||
16324266|NCT01736397|39674419|FG001|Overall Study|Adverse Event|3|||
16324267|NCT01736397|39674418|FG000|Overall Study|Not stated|1|||
16324268|NCT01736397|39674419|FG001|Overall Study|Not stated|4|||
16324269|NCT01252563|39674420|FG000|Overall Study|Contract Deviation|41|||
16324270|NCT01252563|39674420|FG000|Overall Study|Centralized Registration Deviation|30|||
16324271|NCT01252563|39674420|FG000|Overall Study|Lost to Follow-up|161|||
16324272|NCT01252563|39674420|FG000|Overall Study|No visit after first day of treatment|194|||
16324273|NCT01252563|39674420|FG000|Overall Study|No drug administration|6|||
16324274|NCT02309411|39674425|FG000|Overall Study|Physician Decision|1|||
16324275|NCT02309411|39674426|FG001|Overall Study|Physician Decision|0|||
16324276|NCT02309411|39674427|FG002|Overall Study|Physician Decision|0|||
16324277|NCT02309411|39674425|FG000|Overall Study|Withdrawal by Subject|1|||
16324278|NCT02309411|39674426|FG001|Overall Study|Withdrawal by Subject|1|||
16324279|NCT02309411|39674427|FG002|Overall Study|Withdrawal by Subject|0|||
16324280|NCT01860040|39674430|FG000|Overall Study|Withdrawal by Subject|1|||
16324281|NCT01860040|39674431|FG001|Overall Study|Withdrawal by Subject|0|||
16324282|NCT05483686|39674434|FG000|Overall Study|Lost to Follow-up|5|||
16324283|NCT05483686|39674435|FG001|Overall Study|Lost to Follow-up|7|||
16324284|NCT02805660|39674436|FG000|Overall Study|Death|5|||
16324285|NCT02805660|39674437|FG001|Overall Study|Death|2|||
16324286|NCT02805660|39674438|FG002|Overall Study|Death|9|||
16395844|NCT01864148|39931194|FG004|Overall Study|Other|1|||
16395845|NCT01864148|39931190|FG000|Overall Study|Death|0|||
16395846|NCT01864148|39931191|FG001|Overall Study|Death|0|||
16395847|NCT01864148|39931192|FG002|Overall Study|Death|0|||
16395848|NCT01864148|39931193|FG003|Overall Study|Death|1|||
16395849|NCT01864148|39931194|FG004|Overall Study|Death|0|||
16395850|NCT01864148|39931190|FG000|Overall Study|Investigator Decision|5|||
16395851|NCT01864148|39931191|FG001|Overall Study|Investigator Decision|0|||
16395852|NCT01864148|39931192|FG002|Overall Study|Investigator Decision|0|||
16324287|NCT02805660|39674439|FG003|Overall Study|Death|5|||
16324288|NCT02805660|39674440|FG004|Overall Study|Death|0|||
16324289|NCT02805660|39674441|FG005|Overall Study|Death|14|||
16324290|NCT02805660|39674442|FG006|Overall Study|Death|12|||
16395853|NCT01864148|39931193|FG003|Overall Study|Investigator Decision|4|||
16395854|NCT01864148|39931194|FG004|Overall Study|Investigator Decision|6|||
16395855|NCT01864148|39931190|FG000|Overall Study|Withdrawal by Subject|9|||
16324291|NCT02805660|39674436|FG000|Overall Study|Lost to Follow-up|0|||
16324292|NCT02805660|39674437|FG001|Overall Study|Lost to Follow-up|1|||
16324293|NCT02805660|39674438|FG002|Overall Study|Lost to Follow-up|1|||
16324294|NCT02805660|39674439|FG003|Overall Study|Lost to Follow-up|2|||
16395856|NCT01864148|39931191|FG001|Overall Study|Withdrawal by Subject|2|||
16324295|NCT02805660|39674440|FG004|Overall Study|Lost to Follow-up|0|||
16520663|NCT01609556|40376262|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16520664|NCT01609556|40376263|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
16520665|NCT01609556|40376248|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520666|NCT01609556|40376249|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520667|NCT01609556|40376250|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520668|NCT01609556|40376251|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520669|NCT01609556|40376252|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520670|NCT01609556|40376253|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
16520671|NCT01609556|40376254|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520672|NCT01609556|40376255|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520673|NCT01609556|40376256|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520674|NCT01609556|40376257|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520675|NCT01609556|40376258|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520676|NCT01609556|40376259|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
16520677|NCT01609556|40376260|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520678|NCT01609556|40376261|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520679|NCT01609556|40376262|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520680|NCT01609556|40376263|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
16520681|NCT01609556|40376248|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520682|NCT01609556|40376249|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520683|NCT01609556|40376250|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520684|NCT01609556|40376251|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520685|NCT01609556|40376252|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520686|NCT01609556|40376253|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
16520687|NCT01609556|40376254|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520688|NCT01609556|40376255|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520689|NCT01609556|40376256|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520690|NCT01609556|40376257|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520691|NCT01609556|40376258|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520692|NCT01609556|40376259|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520693|NCT01609556|40376260|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520694|NCT01609556|40376261|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520695|NCT01609556|40376262|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520696|NCT01609556|40376263|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
16520697|NCT01609556|40376248|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520698|NCT01609556|40376249|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520699|NCT01609556|40376250|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520700|NCT01609556|40376251|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520701|NCT01609556|40376252|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520702|NCT01609556|40376253|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520703|NCT01609556|40376254|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520704|NCT01609556|40376255|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520705|NCT01609556|40376256|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
16520706|NCT01609556|40376257|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520707|NCT01609556|40376258|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520708|NCT01609556|40376259|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520709|NCT01609556|40376260|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520710|NCT01609556|40376261|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520711|NCT01609556|40376262|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16520712|NCT01609556|40376263|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
16093385|NCT01393600|38833059|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
16093386|NCT01393600|38833060|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
16093387|NCT01393600|38833061|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
16324296|NCT02805660|39674441|FG005|Overall Study|Lost to Follow-up|0|||
16324297|NCT02805660|39674442|FG006|Overall Study|Lost to Follow-up|0|||
16324298|NCT02805660|39674436|FG000|Overall Study|Withdrawal by Subject|0|||
16324299|NCT02805660|39674437|FG001|Overall Study|Withdrawal by Subject|0|||
16324300|NCT02805660|39674438|FG002|Overall Study|Withdrawal by Subject|0|||
16324301|NCT02805660|39674439|FG003|Overall Study|Withdrawal by Subject|3|||
16324302|NCT02805660|39674440|FG004|Overall Study|Withdrawal by Subject|1|||
16324303|NCT02805660|39674441|FG005|Overall Study|Withdrawal by Subject|0|||
16324304|NCT02805660|39674442|FG006|Overall Study|Withdrawal by Subject|2|||
16324305|NCT02805660|39674436|FG000|Overall Study|Study terminated by Sponsor|0|||
16324306|NCT02805660|39674437|FG001|Overall Study|Study terminated by Sponsor|0|||
16324307|NCT02805660|39674438|FG002|Overall Study|Study terminated by Sponsor|1|||
16324308|NCT02805660|39674439|FG003|Overall Study|Study terminated by Sponsor|4|||
16324309|NCT02805660|39674440|FG004|Overall Study|Study terminated by Sponsor|2|||
16324310|NCT02805660|39674441|FG005|Overall Study|Study terminated by Sponsor|3|||
16324311|NCT02805660|39674442|FG006|Overall Study|Study terminated by Sponsor|1|||
16324312|NCT02805660|39674436|FG000|Overall Study|Miscellaneous|0|||
16324313|NCT02805660|39674437|FG001|Overall Study|Miscellaneous|1|||
16324314|NCT02805660|39674438|FG002|Overall Study|Miscellaneous|0|||
16324315|NCT02805660|39674439|FG003|Overall Study|Miscellaneous|4|||
16324316|NCT02805660|39674440|FG004|Overall Study|Miscellaneous|0|||
16324317|NCT02805660|39674441|FG005|Overall Study|Miscellaneous|6|||
16324318|NCT02805660|39674442|FG006|Overall Study|Miscellaneous|4|||
16324319|NCT01867710|39674443|FG000|Overall Study|Death|25|||
16324320|NCT01867710|39674444|FG001|Overall Study|Death|15|||
16324321|NCT01867710|39674445|FG002|Overall Study|Death|27|||
16324322|NCT01867710|39674446|FG003|Overall Study|Death|20|||
16324323|NCT01867710|39674443|FG000|Overall Study|Lost to Follow-up|3|||
16324324|NCT01867710|39674444|FG001|Overall Study|Lost to Follow-up|4|||
16324325|NCT01867710|39674445|FG002|Overall Study|Lost to Follow-up|3|||
16324326|NCT01867710|39674446|FG003|Overall Study|Lost to Follow-up|2|||
16324327|NCT01867710|39674443|FG000|Overall Study|Withdrawal of consent|2|||
16324328|NCT01867710|39674444|FG001|Overall Study|Withdrawal of consent|5|||
16324329|NCT01867710|39674445|FG002|Overall Study|Withdrawal of consent|1|||
16324330|NCT01867710|39674446|FG003|Overall Study|Withdrawal of consent|2|||
16324331|NCT01867710|39674443|FG000|Overall Study|Study Terminated by Sponsor|9|||
16324332|NCT01867710|39674444|FG001|Overall Study|Study Terminated by Sponsor|13|||
16324333|NCT01867710|39674445|FG002|Overall Study|Study Terminated by Sponsor|8|||
16324334|NCT01867710|39674446|FG003|Overall Study|Study Terminated by Sponsor|16|||
16324335|NCT01867710|39674443|FG000|Overall Study|Biochemical progression|0|||
16324336|NCT01867710|39674444|FG001|Overall Study|Biochemical progression|1|||
16324337|NCT01867710|39674445|FG002|Overall Study|Biochemical progression|0|||
16324338|NCT01867710|39674446|FG003|Overall Study|Biochemical progression|0|||
16324339|NCT01867710|39674443|FG000|Overall Study|Clinical progression|0|||
16324340|NCT01867710|39674444|FG001|Overall Study|Clinical progression|0|||
16324341|NCT01867710|39674445|FG002|Overall Study|Clinical progression|1|||
16324342|NCT01867710|39674446|FG003|Overall Study|Clinical progression|0|||
16324343|NCT01867710|39674443|FG000|Overall Study|Disease progression|1|||
16324344|NCT01867710|39674444|FG001|Overall Study|Disease progression|0|||
16324345|NCT01867710|39674445|FG002|Overall Study|Disease progression|0|||
16324346|NCT01867710|39674446|FG003|Overall Study|Disease progression|0|||
16324347|NCT01867710|39674443|FG000|Overall Study|Patient decision|0|||
16324348|NCT01867710|39674444|FG001|Overall Study|Patient decision|0|||
16324349|NCT01867710|39674445|FG002|Overall Study|Patient decision|0|||
16324350|NCT01867710|39674446|FG003|Overall Study|Patient decision|1|||
16324351|NCT01867710|39674443|FG000|Overall Study|Patient to follow subsequent treatment|0|||
16324352|NCT01867710|39674444|FG001|Overall Study|Patient to follow subsequent treatment|1|||
16093388|NCT01393600|38833062|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
16093389|NCT01393600|38833059|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
16093390|NCT01393600|38833060|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
16093391|NCT01393600|38833061|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
16093392|NCT01393600|38833062|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
16093393|NCT01393600|38833059|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
16093394|NCT01393600|38833060|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
16093395|NCT01393600|38833061|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
16093396|NCT01393600|38833062|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
16093397|NCT01393600|38833059|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
16093398|NCT01393600|38833060|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
16093399|NCT01393600|38833061|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
16093400|NCT01393600|38833062|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
16093401|NCT01393600|38833059|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
16093402|NCT01393600|38833060|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
16093403|NCT01393600|38833061|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
16093404|NCT01393600|38833062|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
16324353|NCT01867710|39674445|FG002|Overall Study|Patient to follow subsequent treatment|0|||
16324354|NCT01867710|39674446|FG003|Overall Study|Patient to follow subsequent treatment|0|||
16324355|NCT01867710|39674443|FG000|Overall Study|Progressive disease|1|||
16324356|NCT01867710|39674444|FG001|Overall Study|Progressive disease|0|||
16324357|NCT01867710|39674445|FG002|Overall Study|Progressive disease|0|||
16324358|NCT01867710|39674446|FG003|Overall Study|Progressive disease|0|||
16324359|NCT01867710|39674443|FG000|Overall Study|Protocol Violation|0|||
16324360|NCT01867710|39674444|FG001|Overall Study|Protocol Violation|0|||
16324361|NCT01867710|39674445|FG002|Overall Study|Protocol Violation|0|||
16324362|NCT01867710|39674446|FG003|Overall Study|Protocol Violation|1|||
16324363|NCT01867710|39674443|FG000|Overall Study|PSA-progression|0|||
16324364|NCT01867710|39674444|FG001|Overall Study|PSA-progression|1|||
16395857|NCT01864148|39931192|FG002|Overall Study|Withdrawal by Subject|6|||
16395858|NCT01864148|39931193|FG003|Overall Study|Withdrawal by Subject|8|||
16395859|NCT01864148|39931194|FG004|Overall Study|Withdrawal by Subject|8|||
16395860|NCT01864148|39931190|FG000|Overall Study|Lost to Follow-up|0|||
16395861|NCT01864148|39931191|FG001|Overall Study|Lost to Follow-up|0|||
16324365|NCT01867710|39674445|FG002|Overall Study|PSA-progression|0|||
16324366|NCT01867710|39674446|FG003|Overall Study|PSA-progression|0|||
16324367|NCT01867710|39674443|FG000|Overall Study|Study medication no longer effective|0|||
16324368|NCT01867710|39674444|FG001|Overall Study|Study medication no longer effective|1|||
16324369|NCT01867710|39674445|FG002|Overall Study|Study medication no longer effective|0|||
16324370|NCT01867710|39674446|FG003|Overall Study|Study medication no longer effective|0|||
16324371|NCT03348930|39674447|FG000|Washout (1 Week)|Lost to Follow-up|1|||
16324372|NCT03348930|39674448|FG001|Washout (1 Week)|Lost to Follow-up|1|||
16324373|NCT00435487|39674449|FG000|Overall Study|Death|3|||
16324374|NCT00435487|39674450|FG001|Overall Study|Death|4|||
16324375|NCT00435487|39674449|FG000|Overall Study|Adverse Event|0|||
16324376|NCT00435487|39674450|FG001|Overall Study|Adverse Event|3|||
16324377|NCT00435487|39674449|FG000|Overall Study|Lost to Follow-up|2|||
16324378|NCT00435487|39674450|FG001|Overall Study|Lost to Follow-up|2|||
16324379|NCT00435487|39674449|FG000|Overall Study|Other|5|||
16324380|NCT00435487|39674450|FG001|Overall Study|Other|2|||
16324381|NCT00435487|39674449|FG000|Overall Study|Withdrawal by Subject|2|||
16324382|NCT00435487|39674450|FG001|Overall Study|Withdrawal by Subject|1|||
16324383|NCT00435487|39674449|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
16324384|NCT00435487|39674450|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
16324385|NCT00435487|39674449|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
16324386|NCT00435487|39674450|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
16324387|NCT02055365|39674451|FG000|Overall Study|Prematurely Withdrawn|1|||
16324388|NCT00068393|39674452|FG000|Overall Study|Adverse Event|2|||
16324389|NCT00068393|39674452|FG000|Overall Study|Death|3|||
16324390|NCT00068393|39674452|FG000|Overall Study|Withdrawal by Subject|3|||
16395862|NCT01864148|39931192|FG002|Overall Study|Lost to Follow-up|0|||
16395863|NCT01864148|39931193|FG003|Overall Study|Lost to Follow-up|2|||
16395864|NCT01864148|39931194|FG004|Overall Study|Lost to Follow-up|1|||
16395865|NCT01864148|39931190|FG000|Overall Study|Adverse Event|4|||
16395866|NCT01864148|39931191|FG001|Overall Study|Adverse Event|2|||
16395867|NCT01864148|39931192|FG002|Overall Study|Adverse Event|4|||
16395868|NCT01864148|39931193|FG003|Overall Study|Adverse Event|7|||
16395869|NCT01864148|39931194|FG004|Overall Study|Adverse Event|7|||
16395870|NCT01864148|39931190|FG000|Overall Study|Not Dosed|0|||
16520713|NCT01609556|40376248|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
16520714|NCT01609556|40376249|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16520715|NCT01609556|40376250|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16520716|NCT01609556|40376251|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16520717|NCT01609556|40376252|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16520718|NCT01609556|40376253|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
16520719|NCT01609556|40376254|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16206802|NCT01437267|39234044|FG005|Overall Study|Withdrawal by Subject|0|||
16206803|NCT01437267|39234039|FG000|Overall Study|Protocol Violation|0|||
16206804|NCT01437267|39234040|FG001|Overall Study|Protocol Violation|1|||
16206805|NCT01437267|39234041|FG002|Overall Study|Protocol Violation|0|||
16206806|NCT01437267|39234042|FG003|Overall Study|Protocol Violation|0|||
16206807|NCT01437267|39234043|FG004|Overall Study|Protocol Violation|0|||
16206808|NCT01437267|39234044|FG005|Overall Study|Protocol Violation|0|||
16395871|NCT01864148|39931191|FG001|Overall Study|Not Dosed|0|||
16395872|NCT01864148|39931192|FG002|Overall Study|Not Dosed|0|||
16395873|NCT01864148|39931193|FG003|Overall Study|Not Dosed|1|||
16395874|NCT01864148|39931194|FG004|Overall Study|Not Dosed|0|||
16395875|NCT00177294|39931195|FG000|Overall Study|Withdrawal by Subject|7|||
16395876|NCT00177294|39931196|FG001|Overall Study|Withdrawal by Subject|5|||
16395877|NCT02943070|39931197|FG000|Overall Study|Physician Decision|1|||
16395878|NCT02943070|39931197|FG000|Overall Study|Adverse Event|2|||
16395879|NCT02943070|39931197|FG000|Overall Study|Death|2|||
16520720|NCT01609556|40376255|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16206809|NCT00438464|39234045|FG000|Overall Study|Terminated Early|14|||
16324391|NCT00068393|39674452|FG000|Overall Study|Alternative treatment|1|||
16324392|NCT00068393|39674452|FG000|Overall Study|Quality of life worsening|1|||
16324393|NCT02865499|39674454|FG000|Baseline|Adverse Event|1|||
16324394|NCT02865499|39674454|FG000|Baseline|Withdrawal by Subject|1|||
16324395|NCT00994461|39674455|FG000|Overall Study|Adverse Event|2|||
16395880|NCT02943070|39931197|FG000|Overall Study|Withdrawal by Subject|3|||
16395881|NCT02943070|39931197|FG000|Overall Study|Lost to Follow-up|4|||
16395882|NCT02943070|39931197|FG000|Overall Study|Retreatment or TURP|13|||
16395883|NCT02943070|39931197|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
16520721|NCT01609556|40376256|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16520722|NCT01609556|40376257|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16324396|NCT00994461|39674456|FG001|Overall Study|Adverse Event|1|||
16093405|NCT01393600|38833059|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
16093406|NCT01393600|38833060|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
16093407|NCT01393600|38833061|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
16093408|NCT01393600|38833062|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
16093409|NCT00671853|38833063|FG000|Overall Study|Lack of Efficacy|3|||
16093410|NCT00671853|38833064|FG001|Overall Study|Lack of Efficacy|7|||
16093411|NCT00671853|38833063|FG000|Overall Study|Adverse Event|7|||
16093412|NCT00671853|38833064|FG001|Overall Study|Adverse Event|1|||
16093413|NCT00671853|38833063|FG000|Overall Study|Withdrawal by Subject|1|||
16093414|NCT00671853|38833064|FG001|Overall Study|Withdrawal by Subject|5|||
16093415|NCT00671853|38833063|FG000|Overall Study|Lost to Follow-up|8|||
16093416|NCT00671853|38833064|FG001|Overall Study|Lost to Follow-up|8|||
16093417|NCT00671853|38833063|FG000|Overall Study|Physician Decision|0|||
16093418|NCT00671853|38833064|FG001|Overall Study|Physician Decision|2|||
16093419|NCT00671853|38833063|FG000|Overall Study|Non-adherence with study procedures|1|||
16093420|NCT00671853|38833064|FG001|Overall Study|Non-adherence with study procedures|4|||
16093421|NCT00617708|38833065|FG000|Overall Study|Adverse Event|0|||
16093422|NCT00617708|38833066|FG001|Overall Study|Adverse Event|6|||
16093423|NCT00617708|38833067|FG002|Overall Study|Adverse Event|9|||
16093424|NCT00617708|38833065|FG000|Overall Study|Withdrawal by Subject|1|||
16093425|NCT00617708|38833066|FG001|Overall Study|Withdrawal by Subject|1|||
16093426|NCT00617708|38833067|FG002|Overall Study|Withdrawal by Subject|7|||
16093427|NCT00617708|38833065|FG000|Overall Study|Death|0|||
16093428|NCT00617708|38833066|FG001|Overall Study|Death|6|||
16093429|NCT00617708|38833067|FG002|Overall Study|Death|5|||
16093430|NCT00617708|38833065|FG000|Overall Study|Progression/Relapse|7|||
16093431|NCT00617708|38833066|FG001|Overall Study|Progression/Relapse|40|||
16093432|NCT00617708|38833067|FG002|Overall Study|Progression/Relapse|36|||
16093433|NCT00617708|38833065|FG000|Overall Study|Not protocol specified|1|||
16093434|NCT00617708|38833066|FG001|Overall Study|Not protocol specified|4|||
16093435|NCT00617708|38833067|FG002|Overall Study|Not protocol specified|2|||
16093436|NCT00617708|38833065|FG000|Overall Study|Not eligible|1|||
16093437|NCT00617708|38833066|FG001|Overall Study|Not eligible|3|||
16093438|NCT00617708|38833067|FG002|Overall Study|Not eligible|5|||
16093439|NCT00703092|38833074|FG000|Overall Study|Withdrawal by Subject|2|||
16093440|NCT02721147|38833075|FG000|Overall Study|Lost to Follow-up|2|||
16520723|NCT01609556|40376258|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
16520724|NCT01609556|40376259|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16520725|NCT01609556|40376260|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16520726|NCT01609556|40376261|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16520727|NCT01609556|40376262|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16520728|NCT01609556|40376263|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
16520729|NCT01609556|40376248|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16520730|NCT01609556|40376249|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16520731|NCT01609556|40376250|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16093441|NCT02721147|38833076|FG001|Overall Study|Lost to Follow-up|0|||
16093442|NCT02721147|38833077|FG002|Overall Study|Lost to Follow-up|0|||
16093443|NCT02637063|38833078|FG000|Overall Study|Lost to Follow-up|3|||
16093444|NCT02637063|38833079|FG001|Overall Study|Lost to Follow-up|2|||
16093445|NCT02637063|38833080|FG002|Overall Study|Lost to Follow-up|3|||
16093446|NCT02637063|38833078|FG000|Overall Study|Withdrawal by Subject|2|||
16093447|NCT02637063|38833079|FG001|Overall Study|Withdrawal by Subject|2|||
16093448|NCT02637063|38833080|FG002|Overall Study|Withdrawal by Subject|3|||
16093449|NCT00584909|38833083|FG000|Overall Study|Adverse Event|4|||
16093450|NCT02362789|38833086|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
16093451|NCT02362789|38833087|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
16093452|NCT02362789|38833088|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
16093453|NCT02362789|38833086|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
16093454|NCT02362789|38833087|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
16093455|NCT02362789|38833088|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
16093456|NCT02362789|38833086|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
16324397|NCT00994461|39674457|FG002|Overall Study|Adverse Event|0|||
16324398|NCT01167881|39674458|FG000|Overall Study|Adverse Event|47|||
16324399|NCT01167881|39674459|FG001|Overall Study|Adverse Event|51|||
16324400|NCT01167881|39674458|FG000|Overall Study|Lack of Efficacy|4|||
16324401|NCT01167881|39674459|FG001|Overall Study|Lack of Efficacy|7|||
16324402|NCT01167881|39674458|FG000|Overall Study|Non compliant with protocol|9|||
16324403|NCT01167881|39674459|FG001|Overall Study|Non compliant with protocol|18|||
16324404|NCT01167881|39674458|FG000|Overall Study|Lost to Follow-up|19|||
16324405|NCT01167881|39674459|FG001|Overall Study|Lost to Follow-up|20|||
16324406|NCT01167881|39674458|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
16324407|NCT01167881|39674459|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
16520732|NCT01609556|40376251|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16520733|NCT01609556|40376252|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16520734|NCT01609556|40376253|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16206810|NCT00438464|39234046|FG001|Overall Study|Terminated Early|5|||
16324408|NCT01167881|39674458|FG000|Overall Study|Not treated|4|||
16324409|NCT01167881|39674459|FG001|Overall Study|Not treated|0|||
16324410|NCT01167881|39674458|FG000|Overall Study|Other not defined above|31|||
16324411|NCT01167881|39674459|FG001|Overall Study|Other not defined above|55|||
16324412|NCT02429778|39674460|FG000|Overall Study|Lost to Follow-up|2|||
16324413|NCT02429778|39674461|FG001|Overall Study|Lost to Follow-up|0|||
16324414|NCT02429778|39674460|FG000|Overall Study|Withdrawal by Subject|5|||
16324415|NCT02429778|39674461|FG001|Overall Study|Withdrawal by Subject|0|||
16324416|NCT03233529|39674462|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
16324417|NCT03233529|39674462|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
16324418|NCT03689374|39674463|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
16324419|NCT03689374|39674464|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
16324420|NCT03689374|39674465|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
16324421|NCT03689374|39674463|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
16324422|NCT03689374|39674464|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
16324423|NCT03689374|39674465|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
16324424|NCT03689374|39674463|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
16324425|NCT03689374|39674464|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
16324426|NCT03689374|39674465|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
16324427|NCT03689374|39674463|FG000|Treatment Period (Week 0 to 52)|Death|0|||
16324428|NCT03689374|39674464|FG001|Treatment Period (Week 0 to 52)|Death|11|||
16324429|NCT03689374|39674465|FG002|Treatment Period (Week 0 to 52)|Death|1|||
16324430|NCT01680861|39674466|FG000|Early Post-transplant Period|Protocol Violation|1|||
16324431|NCT01680861|39674467|FG001|Early Post-transplant Period|Protocol Violation|1|||
16324432|NCT00231114|39674470|FG000|Randomized|Withdrawal by Subject|6|||
16324433|NCT00231114|39674471|FG001|Randomized|Withdrawal by Subject|3|||
16324434|NCT00231114|39674470|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
16324435|NCT00231114|39674471|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
16324436|NCT00231114|39674470|FG000|Post-Treatment Period|Lost to Follow-up|6|||
16324437|NCT00231114|39674471|FG001|Post-Treatment Period|Lost to Follow-up|1|||
16324438|NCT00231114|39674470|FG000|Post-Treatment Period|Physician Decision|1|||
16324439|NCT00231114|39674471|FG001|Post-Treatment Period|Physician Decision|0|||
16395884|NCT04294459|39931202|FG000|Overall Study|Adverse Event|0|||
16520735|NCT01609556|40376254|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16520736|NCT01609556|40376255|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16520737|NCT01609556|40376256|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16520738|NCT01609556|40376257|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16520739|NCT01609556|40376258|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16520740|NCT01609556|40376259|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
16520741|NCT01609556|40376260|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
16520742|NCT01609556|40376261|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
16520743|NCT01609556|40376262|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
16520744|NCT01609556|40376263|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
16520745|NCT01609556|40376248|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520746|NCT01609556|40376249|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520747|NCT01609556|40376250|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520748|NCT01609556|40376251|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520749|NCT01609556|40376252|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520750|NCT01609556|40376253|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520751|NCT01609556|40376254|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520752|NCT01609556|40376255|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520753|NCT01609556|40376256|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520754|NCT01609556|40376257|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520755|NCT01609556|40376258|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520756|NCT01609556|40376259|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
16520757|NCT01609556|40376260|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
16520758|NCT01609556|40376261|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
16520759|NCT01609556|40376262|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
16520760|NCT01609556|40376263|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
16520761|NCT01609556|40376248|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520762|NCT01609556|40376249|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520763|NCT01609556|40376250|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520764|NCT01609556|40376251|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520765|NCT01609556|40376252|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520766|NCT01609556|40376253|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520767|NCT01609556|40376254|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520768|NCT01609556|40376255|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520769|NCT01609556|40376256|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520770|NCT01609556|40376257|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520771|NCT01609556|40376258|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520772|NCT01609556|40376259|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
16520773|NCT01609556|40376260|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
16520774|NCT01609556|40376261|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
16520775|NCT01609556|40376262|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
16520776|NCT01609556|40376263|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
16520777|NCT01609556|40376248|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520778|NCT01609556|40376249|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520779|NCT01609556|40376250|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520780|NCT01609556|40376251|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520781|NCT01609556|40376252|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520782|NCT01609556|40376253|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520783|NCT01609556|40376254|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520784|NCT01609556|40376255|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520785|NCT01609556|40376256|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520786|NCT01609556|40376257|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520787|NCT01609556|40376258|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520788|NCT01609556|40376259|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520789|NCT01609556|40376260|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
16520790|NCT01609556|40376261|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520791|NCT01609556|40376262|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520792|NCT01609556|40376263|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
16520793|NCT01609556|40376248|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520794|NCT01609556|40376249|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520795|NCT01609556|40376250|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520796|NCT01609556|40376251|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520797|NCT01609556|40376252|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520798|NCT01609556|40376253|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520799|NCT01609556|40376254|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520800|NCT01609556|40376255|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520801|NCT01609556|40376256|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520802|NCT01609556|40376257|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520803|NCT01609556|40376258|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520804|NCT01609556|40376259|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
16520805|NCT01609556|40376260|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
16520806|NCT01609556|40376261|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
16206811|NCT00438464|39234045|FG000|Overall Study|Incomplete data submission|0|||
16206812|NCT00438464|39234046|FG001|Overall Study|Incomplete data submission|2|||
16206813|NCT04186663|39237017|FG000|Overall Study|Lost to Follow-up|1|||
16324440|NCT00231114|39674470|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
16324441|NCT00231114|39674471|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
16324442|NCT01878084|39674472|FG000|Overall Study|Physician Decision|2|||
16324443|NCT01899742|39674479|FG000|Overall Study|Adverse Event|5|||
16324444|NCT01899742|39674480|FG001|Overall Study|Adverse Event|4|||
16324445|NCT01899742|39674479|FG000|Overall Study|Lack of Efficacy|1|||
16324446|NCT01899742|39674480|FG001|Overall Study|Lack of Efficacy|5|||
16324447|NCT01899742|39674479|FG000|Overall Study|Protocol Violation|2|||
16324448|NCT01899742|39674480|FG001|Overall Study|Protocol Violation|2|||
16324449|NCT01899742|39674479|FG000|Overall Study|Withdrawal by Subject|9|||
16324450|NCT01899742|39674480|FG001|Overall Study|Withdrawal by Subject|5|||
16324451|NCT02587598|39674483|FG000|Overall Study|Death|4|||
16324452|NCT02587598|39674484|FG001|Overall Study|Death|8|||
16324453|NCT02587598|39674485|FG002|Overall Study|Death|4|||
16324454|NCT02587598|39674486|FG003|Overall Study|Death|16|||
16324455|NCT02587598|39674487|FG004|Overall Study|Death|9|||
16324456|NCT02587598|39674488|FG005|Overall Study|Death|4|||
16206814|NCT04186663|39237017|FG000|Overall Study|Unable to complete blood draw|3|||
16206815|NCT03276572|39237019|FG000|Overall Study|In follow-up|0|||
16206816|NCT03276572|39237020|FG001|Overall Study|In follow-up|0|||
16520807|NCT01609556|40376262|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
16520808|NCT01609556|40376263|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
16520809|NCT01609556|40376248|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16093457|NCT02362789|38833087|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
16093458|NCT02362789|38833088|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
16093459|NCT02362789|38833086|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
16093460|NCT02362789|38833087|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
16093461|NCT02362789|38833088|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
16093462|NCT02362789|38833086|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
16093463|NCT02362789|38833087|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
16093464|NCT02362789|38833088|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
16093465|NCT01375777|38833089|FG000|Overall Study|Withdrawal by Subject|0|||
16093466|NCT01375777|38833090|FG001|Overall Study|Withdrawal by Subject|2|||
16093467|NCT01375777|38833091|FG002|Overall Study|Withdrawal by Subject|1|||
16093468|NCT01375777|38833092|FG003|Overall Study|Withdrawal by Subject|0|||
16093469|NCT01375777|38833093|FG004|Overall Study|Withdrawal by Subject|1|||
16093470|NCT01375777|38833094|FG005|Overall Study|Withdrawal by Subject|1|||
16093471|NCT01375777|38833095|FG006|Overall Study|Withdrawal by Subject|1|||
16093472|NCT01375777|38833096|FG007|Overall Study|Withdrawal by Subject|2|||
16093473|NCT01375777|38833097|FG008|Overall Study|Withdrawal by Subject|1|||
16093474|NCT01375777|38833089|FG000|Overall Study|Lost to Follow-up|1|||
16093475|NCT01375777|38833090|FG001|Overall Study|Lost to Follow-up|0|||
16093476|NCT01375777|38833091|FG002|Overall Study|Lost to Follow-up|0|||
16093477|NCT01375777|38833092|FG003|Overall Study|Lost to Follow-up|0|||
16093478|NCT01375777|38833093|FG004|Overall Study|Lost to Follow-up|0|||
16093479|NCT01375777|38833094|FG005|Overall Study|Lost to Follow-up|0|||
16093480|NCT01375777|38833095|FG006|Overall Study|Lost to Follow-up|1|||
16093481|NCT01375777|38833096|FG007|Overall Study|Lost to Follow-up|0|||
16093482|NCT01375777|38833097|FG008|Overall Study|Lost to Follow-up|0|||
16093483|NCT01375777|38833089|FG000|Overall Study|Other|1|||
16093484|NCT01375777|38833090|FG001|Overall Study|Other|1|||
16093485|NCT01375777|38833091|FG002|Overall Study|Other|0|||
16093486|NCT01375777|38833092|FG003|Overall Study|Other|0|||
16093487|NCT01375777|38833093|FG004|Overall Study|Other|0|||
16093488|NCT01375777|38833094|FG005|Overall Study|Other|0|||
16093489|NCT01375777|38833095|FG006|Overall Study|Other|0|||
16093490|NCT01375777|38833096|FG007|Overall Study|Other|0|||
16093491|NCT01375777|38833097|FG008|Overall Study|Other|1|||
16093492|NCT00417885|38833098|FG000|Overall Study|Adverse Event|1|||
16093493|NCT00417885|38833098|FG000|Overall Study|Objective Progression or Relapse|3|||
16093494|NCT00417885|38833098|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
16093495|NCT00589628|38833099|FG000|Overall Study|Lost to Follow-up|0|||
16093496|NCT00589628|38833100|FG001|Overall Study|Lost to Follow-up|1|||
16093497|NCT01156675|38833101|FG000|Overall Study|Death|5|||
16093498|NCT01156675|38833102|FG001|Overall Study|Death|3|||
16093499|NCT01156675|38833103|FG002|Overall Study|Death|0|||
16093500|NCT01156675|38833101|FG000|Overall Study|No data|29|||
16093501|NCT01156675|38833102|FG001|Overall Study|No data|22|||
16093502|NCT01156675|38833103|FG002|Overall Study|No data|2|||
16093503|NCT02935894|38833104|FG000|Overall Study|Subject dismissed|1|||
16093504|NCT02109172|38833107|FG000|Overall Study|Withdrawal by Subject|1|||
16093505|NCT02109172|38833108|FG001|Overall Study|Withdrawal by Subject|0|||
16093506|NCT02109172|38833109|FG002|Overall Study|Withdrawal by Subject|0|||
16093507|NCT02109172|38833110|FG003|Overall Study|Withdrawal by Subject|1|||
16093508|NCT02109172|38833111|FG004|Overall Study|Withdrawal by Subject|0|||
16395885|NCT04294459|39931203|FG001|Overall Study|Adverse Event|1|||
16520810|NCT01609556|40376249|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16093509|NCT02109172|38833112|FG005|Overall Study|Withdrawal by Subject|0|||
16093510|NCT02109172|38833107|FG000|Overall Study|Adverse Event|0|||
16093511|NCT02109172|38833108|FG001|Overall Study|Adverse Event|0|||
16093512|NCT02109172|38833109|FG002|Overall Study|Adverse Event|1|||
16093513|NCT02109172|38833110|FG003|Overall Study|Adverse Event|0|||
16093514|NCT02109172|38833111|FG004|Overall Study|Adverse Event|0|||
16093515|NCT02109172|38833112|FG005|Overall Study|Adverse Event|1|||
16093516|NCT02109172|38833107|FG000|Overall Study|Death|0|||
16093517|NCT02109172|38833108|FG001|Overall Study|Death|0|||
16093518|NCT02109172|38833109|FG002|Overall Study|Death|0|||
16093519|NCT02109172|38833110|FG003|Overall Study|Death|0|||
16093520|NCT02109172|38833111|FG004|Overall Study|Death|1|||
16093521|NCT02109172|38833112|FG005|Overall Study|Death|0|||
16093522|NCT01399905|38833113|FG000|Overall Study|Withdrawal by Subject|1|||
16093523|NCT01399905|38833114|FG001|Overall Study|Withdrawal by Subject|1|||
16093524|NCT02604199|38833115|FG000|Overall Study|Pregnancy|0|||
16093525|NCT02604199|38833116|FG001|Overall Study|Pregnancy|0|||
16206817|NCT03276572|39237021|FG002|Overall Study|In follow-up|0|||
16520811|NCT01609556|40376250|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520812|NCT01609556|40376251|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520813|NCT01609556|40376252|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520814|NCT01609556|40376253|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520815|NCT01609556|40376254|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520816|NCT01609556|40376255|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520817|NCT01609556|40376256|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520818|NCT01609556|40376257|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520819|NCT01609556|40376258|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520820|NCT01609556|40376259|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520821|NCT01609556|40376260|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520822|NCT01609556|40376261|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520823|NCT01609556|40376262|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
16520824|NCT01609556|40376263|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
16520825|NCT01609556|40376248|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520826|NCT01609556|40376249|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
16324457|NCT02587598|39674489|FG006|Overall Study|Death|6|||
16324458|NCT02587598|39674490|FG007|Overall Study|Death|7|||
16324459|NCT02587598|39674491|FG008|Overall Study|Death|9|||
16324460|NCT02587598|39674492|FG009|Overall Study|Death|1|||
16324461|NCT02587598|39674493|FG010|Overall Study|Death|3|||
16324462|NCT02587598|39674483|FG000|Overall Study|Study Terminated by the Sponsor|0|||
16324463|NCT02587598|39674484|FG001|Overall Study|Study Terminated by the Sponsor|1|||
16324464|NCT02587598|39674485|FG002|Overall Study|Study Terminated by the Sponsor|0|||
16324465|NCT02587598|39674486|FG003|Overall Study|Study Terminated by the Sponsor|3|||
16324466|NCT02587598|39674487|FG004|Overall Study|Study Terminated by the Sponsor|0|||
16324467|NCT02587598|39674488|FG005|Overall Study|Study Terminated by the Sponsor|1|||
16324468|NCT02587598|39674489|FG006|Overall Study|Study Terminated by the Sponsor|0|||
16324469|NCT02587598|39674490|FG007|Overall Study|Study Terminated by the Sponsor|0|||
16324470|NCT02587598|39674491|FG008|Overall Study|Study Terminated by the Sponsor|0|||
16324471|NCT02587598|39674492|FG009|Overall Study|Study Terminated by the Sponsor|1|||
16324472|NCT02587598|39674493|FG010|Overall Study|Study Terminated by the Sponsor|6|||
16520827|NCT01609556|40376250|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520828|NCT01609556|40376251|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520829|NCT01609556|40376252|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520830|NCT01609556|40376253|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520831|NCT01609556|40376254|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520832|NCT01609556|40376255|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520833|NCT01609556|40376256|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520834|NCT01609556|40376257|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520835|NCT01609556|40376258|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520836|NCT01609556|40376259|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520837|NCT01609556|40376260|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
16520838|NCT01609556|40376261|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
16324473|NCT02587598|39674483|FG000|Overall Study|Reason for study withdrawal not specified|0|||
16324474|NCT02587598|39674484|FG001|Overall Study|Reason for study withdrawal not specified|1|||
16324475|NCT02587598|39674485|FG002|Overall Study|Reason for study withdrawal not specified|0|||
16324476|NCT02587598|39674486|FG003|Overall Study|Reason for study withdrawal not specified|0|||
16324477|NCT02587598|39674487|FG004|Overall Study|Reason for study withdrawal not specified|0|||
16395886|NCT00923351|39931204|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
16520839|NCT01609556|40376262|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
16520840|NCT01609556|40376263|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
16520841|NCT01609556|40376248|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520842|NCT01609556|40376249|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520843|NCT01609556|40376250|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520844|NCT01609556|40376251|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520845|NCT01609556|40376252|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520846|NCT01609556|40376253|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520847|NCT01609556|40376254|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520848|NCT01609556|40376255|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520849|NCT01609556|40376256|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520850|NCT01609556|40376257|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16093526|NCT02604199|38833117|FG002|Overall Study|Pregnancy|0|||
16324478|NCT02587598|39674488|FG005|Overall Study|Reason for study withdrawal not specified|0|||
16324479|NCT02587598|39674489|FG006|Overall Study|Reason for study withdrawal not specified|0|||
16324480|NCT02587598|39674490|FG007|Overall Study|Reason for study withdrawal not specified|0|||
16324481|NCT02587598|39674491|FG008|Overall Study|Reason for study withdrawal not specified|0|||
16520851|NCT01609556|40376258|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16395887|NCT00923351|39931205|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
16520852|NCT01609556|40376259|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16324482|NCT02587598|39674492|FG009|Overall Study|Reason for study withdrawal not specified|0|||
16324483|NCT02587598|39674493|FG010|Overall Study|Reason for study withdrawal not specified|0|||
16324484|NCT02587598|39674483|FG000|Overall Study|Withdrawal by Subject|0|||
16324485|NCT02587598|39674484|FG001|Overall Study|Withdrawal by Subject|1|||
16324486|NCT02587598|39674485|FG002|Overall Study|Withdrawal by Subject|0|||
16324487|NCT02587598|39674486|FG003|Overall Study|Withdrawal by Subject|2|||
16324488|NCT02587598|39674487|FG004|Overall Study|Withdrawal by Subject|3|||
16324489|NCT02587598|39674488|FG005|Overall Study|Withdrawal by Subject|1|||
16324490|NCT02587598|39674489|FG006|Overall Study|Withdrawal by Subject|0|||
16206818|NCT03276572|39237022|FG003|Overall Study|In follow-up|0|||
16324491|NCT02587598|39674490|FG007|Overall Study|Withdrawal by Subject|0|||
16324492|NCT02587598|39674491|FG008|Overall Study|Withdrawal by Subject|0|||
16520853|NCT01609556|40376260|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
16520854|NCT01609556|40376261|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520855|NCT01609556|40376262|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520856|NCT01609556|40376263|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
16520857|NCT02443298|40376264|FG000|Overall Study|Adverse Event|3|||
16520858|NCT02443298|40376265|FG001|Overall Study|Adverse Event|3|||
16520859|NCT02443298|40376264|FG000|Overall Study|Withdrawal by Subject|1|||
16520860|NCT02443298|40376265|FG001|Overall Study|Withdrawal by Subject|2|||
16520861|NCT00334815|40376266|FG000|Overall Study|Adverse Event|3|||
16520862|NCT00334815|40376267|FG001|Overall Study|Adverse Event|2|||
16520863|NCT00334815|40376266|FG000|Overall Study|Death|0|||
16520864|NCT00334815|40376267|FG001|Overall Study|Death|2|||
16520865|NCT00334815|40376266|FG000|Overall Study|Progression|1|||
16520866|NCT00334815|40376267|FG001|Overall Study|Progression|0|||
16520867|NCT00334815|40376266|FG000|Overall Study|ineligible|1|||
16520868|NCT00334815|40376267|FG001|Overall Study|ineligible|1|||
16520869|NCT00334815|40376266|FG000|Overall Study|patient refused treatment|0|||
16520870|NCT00334815|40376267|FG001|Overall Study|patient refused treatment|1|||
16520871|NCT00334815|40376266|FG000|Overall Study|Physician Decision|2|||
16520872|NCT00334815|40376267|FG001|Overall Study|Physician Decision|4|||
16520873|NCT01431508|40376268|FG000|Overall Study|Lack of Efficacy|1|||
16520874|NCT01431508|40376268|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
16520875|NCT01813019|40376269|FG000|Overall Study|Adverse Event|0|||
16520876|NCT01813019|40376270|FG001|Overall Study|Adverse Event|3|||
16520877|NCT01813019|40376269|FG000|Overall Study|Withdrawal by Subject|3|||
16520878|NCT01813019|40376270|FG001|Overall Study|Withdrawal by Subject|2|||
16520879|NCT01813019|40376269|FG000|Overall Study|administrative problems|2|||
16520880|NCT01813019|40376270|FG001|Overall Study|administrative problems|0|||
16520881|NCT01813019|40376269|FG000|Overall Study|Protocol Deviation|2|||
16520882|NCT01813019|40376270|FG001|Overall Study|Protocol Deviation|1|||
16520883|NCT04919499|40376271|FG000|Overall Study|Adverse Event|0|||
16520884|NCT04919499|40376272|FG001|Overall Study|Adverse Event|0|||
16520885|NCT04919499|40376273|FG002|Overall Study|Adverse Event|0|||
16520886|NCT04919499|40376274|FG003|Overall Study|Adverse Event|0|||
16520887|NCT04919499|40376275|FG004|Overall Study|Adverse Event|2|||
16206819|NCT03276572|39237023|FG004|Overall Study|In follow-up|0|||
16206820|NCT03276572|39237024|FG005|Overall Study|In follow-up|1|||
16206821|NCT03276572|39237025|FG006|Overall Study|In follow-up|1|||
16206822|NCT03276572|39237019|FG000|Overall Study|Lost to Follow-up|0|||
16206823|NCT03276572|39237020|FG001|Overall Study|Lost to Follow-up|0|||
16206824|NCT03276572|39237021|FG002|Overall Study|Lost to Follow-up|0|||
16206825|NCT03276572|39237022|FG003|Overall Study|Lost to Follow-up|0|||
16206826|NCT03276572|39237023|FG004|Overall Study|Lost to Follow-up|0|||
16206827|NCT03276572|39237024|FG005|Overall Study|Lost to Follow-up|0|||
16206828|NCT03276572|39237025|FG006|Overall Study|Lost to Follow-up|1|||
16395888|NCT00923351|39931206|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
16206829|NCT00651313|39237026|FG000|Overall Study|Adverse Event|0|||
16206830|NCT00651313|39237027|FG001|Overall Study|Adverse Event|1|||
16206831|NCT00651313|39237026|FG000|Overall Study|Withdrawal by Subject|3|||
16520888|NCT04919499|40376271|FG000|Overall Study|Not treated|0|||
16520889|NCT04919499|40376272|FG001|Overall Study|Not treated|0|||
16520890|NCT04919499|40376273|FG002|Overall Study|Not treated|0|||
16520891|NCT04919499|40376274|FG003|Overall Study|Not treated|1|||
16520892|NCT04919499|40376275|FG004|Overall Study|Not treated|0|||
16206832|NCT00651313|39237027|FG001|Overall Study|Withdrawal by Subject|1|||
16520893|NCT01075321|40376276|FG000|Overall Study|Withdrawal by Subject|0|||
16520894|NCT01075321|40376277|FG001|Overall Study|Withdrawal by Subject|0|||
16324493|NCT02587598|39674492|FG009|Overall Study|Withdrawal by Subject|1|||
16520895|NCT01075321|40376278|FG002|Overall Study|Withdrawal by Subject|1|||
16520896|NCT01075321|40376279|FG003|Overall Study|Withdrawal by Subject|1|||
16520897|NCT01075321|40376276|FG000|Overall Study|Protocol Violation|0|||
16520898|NCT01075321|40376277|FG001|Overall Study|Protocol Violation|0|||
16520899|NCT01075321|40376278|FG002|Overall Study|Protocol Violation|1|||
16520900|NCT01075321|40376279|FG003|Overall Study|Protocol Violation|0|||
16520901|NCT01075321|40376276|FG000|Overall Study|Treatment Incomplete due to progression|1|||
16520902|NCT01075321|40376277|FG001|Overall Study|Treatment Incomplete due to progression|0|||
16520903|NCT01075321|40376278|FG002|Overall Study|Treatment Incomplete due to progression|0|||
16520904|NCT01075321|40376279|FG003|Overall Study|Treatment Incomplete due to progression|0|||
16520905|NCT01075321|40376276|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
16520906|NCT01075321|40376277|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
16520907|NCT01075321|40376278|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
16520908|NCT01075321|40376279|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
16520909|NCT01933932|40376284|FG000|Overall Study|Death|173|||
16520910|NCT01933932|40376285|FG001|Overall Study|Death|163|||
16520911|NCT01933932|40376284|FG000|Overall Study|Withdrawal by Subject|11|||
16520912|NCT01933932|40376285|FG001|Overall Study|Withdrawal by Subject|14|||
16520913|NCT01933932|40376284|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16520914|NCT01933932|40376285|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16520915|NCT02180867|40376286|FG000|Overall Study|Adverse Event|3|||
16520916|NCT02180867|40376287|FG001|Overall Study|Adverse Event|4|||
16520917|NCT02180867|40376288|FG002|Overall Study|Adverse Event|1|||
16520918|NCT02180867|40376289|FG003|Overall Study|Adverse Event|5|||
16520919|NCT02180867|40376290|FG004|Overall Study|Adverse Event|0|||
16520920|NCT02180867|40376291|FG005|Overall Study|Adverse Event|0|||
16520921|NCT02180867|40376292|FG006|Overall Study|Adverse Event|0|||
16520922|NCT02180867|40376286|FG000|Overall Study|Death|0|||
16520923|NCT02180867|40376287|FG001|Overall Study|Death|0|||
16520924|NCT02180867|40376288|FG002|Overall Study|Death|0|||
16520925|NCT02180867|40376289|FG003|Overall Study|Death|0|||
16520926|NCT02180867|40376290|FG004|Overall Study|Death|1|||
16520927|NCT02180867|40376291|FG005|Overall Study|Death|0|||
16520928|NCT02180867|40376292|FG006|Overall Study|Death|0|||
16520929|NCT02180867|40376286|FG000|Overall Study|Lack of Efficacy|0|||
16520930|NCT02180867|40376287|FG001|Overall Study|Lack of Efficacy|2|||
16520931|NCT02180867|40376288|FG002|Overall Study|Lack of Efficacy|0|||
16520932|NCT02180867|40376289|FG003|Overall Study|Lack of Efficacy|1|||
16520933|NCT02180867|40376290|FG004|Overall Study|Lack of Efficacy|6|||
16520934|NCT02180867|40376291|FG005|Overall Study|Lack of Efficacy|0|||
16520935|NCT02180867|40376292|FG006|Overall Study|Lack of Efficacy|1|||
16520936|NCT02180867|40376286|FG000|Overall Study|Physician Decision|1|||
16520937|NCT02180867|40376287|FG001|Overall Study|Physician Decision|3|||
16520938|NCT02180867|40376288|FG002|Overall Study|Physician Decision|1|||
16520939|NCT02180867|40376289|FG003|Overall Study|Physician Decision|10|||
16520940|NCT02180867|40376290|FG004|Overall Study|Physician Decision|9|||
16324494|NCT02587598|39674493|FG010|Overall Study|Withdrawal by Subject|2|||
16324495|NCT02587598|39674483|FG000|Overall Study|Physician Decision|0|||
16324496|NCT02587598|39674484|FG001|Overall Study|Physician Decision|0|||
16324497|NCT02587598|39674485|FG002|Overall Study|Physician Decision|0|||
16324498|NCT02587598|39674486|FG003|Overall Study|Physician Decision|0|||
16324499|NCT02587598|39674487|FG004|Overall Study|Physician Decision|0|||
16324500|NCT02587598|39674488|FG005|Overall Study|Physician Decision|0|||
16324501|NCT02587598|39674489|FG006|Overall Study|Physician Decision|0|||
16324502|NCT02587598|39674490|FG007|Overall Study|Physician Decision|0|||
16324503|NCT02587598|39674491|FG008|Overall Study|Physician Decision|0|||
16324504|NCT02587598|39674492|FG009|Overall Study|Physician Decision|0|||
16324505|NCT02587598|39674493|FG010|Overall Study|Physician Decision|3|||
16520941|NCT02180867|40376291|FG005|Overall Study|Physician Decision|3|||
16324506|NCT03499899|39674510|FG000|Overall Study|Adverse Event|2|||
16520942|NCT02180867|40376292|FG006|Overall Study|Physician Decision|4|||
16520943|NCT02180867|40376286|FG000|Overall Study|Withdrawal by Subject|0|||
16520944|NCT02180867|40376287|FG001|Overall Study|Withdrawal by Subject|0|||
16520945|NCT02180867|40376288|FG002|Overall Study|Withdrawal by Subject|0|||
16520946|NCT02180867|40376289|FG003|Overall Study|Withdrawal by Subject|1|||
16520947|NCT02180867|40376290|FG004|Overall Study|Withdrawal by Subject|1|||
16520948|NCT02180867|40376291|FG005|Overall Study|Withdrawal by Subject|0|||
16520949|NCT02180867|40376292|FG006|Overall Study|Withdrawal by Subject|0|||
16324507|NCT03499899|39674511|FG001|Overall Study|Adverse Event|3|||
16324508|NCT03499899|39674512|FG002|Overall Study|Adverse Event|3|||
16206833|NCT00651313|39237026|FG000|Overall Study|Lost to Follow-up|1|||
16206834|NCT00651313|39237027|FG001|Overall Study|Lost to Follow-up|1|||
16206835|NCT00651313|39237026|FG000|Overall Study|Adminstrative Discontinuation|2|||
16206836|NCT00651313|39237027|FG001|Overall Study|Adminstrative Discontinuation|3|||
16206837|NCT03934541|39237028|FG000|Overall Study|Study Terminated by Sponsor|0|||
16395889|NCT01268046|39931207|FG000|Overall Study|Withdrawal by Subject|1|||
16395890|NCT01268046|39931208|FG001|Overall Study|Withdrawal by Subject|0|||
16520950|NCT02180867|40376286|FG000|Overall Study|Ineligible|1|||
16520951|NCT02180867|40376287|FG001|Overall Study|Ineligible|2|||
16206838|NCT03934541|39237029|FG001|Overall Study|Study Terminated by Sponsor|1|||
16206839|NCT03934541|39237030|FG002|Overall Study|Study Terminated by Sponsor|0|||
16206840|NCT03934541|39237031|FG003|Overall Study|Study Terminated by Sponsor|0|||
16206841|NCT01449955|39237032|FG000|Overall Study|Withdrawal by Subject|1|||
16206842|NCT01449955|39237033|FG001|Overall Study|Withdrawal by Subject|2|||
16206843|NCT02088541|39237041|FG000|Overall Study|Adverse Event|3|||
16206844|NCT02088541|39237042|FG001|Overall Study|Adverse Event|0|||
16206845|NCT02088541|39237043|FG002|Overall Study|Adverse Event|3|||
16206846|NCT02088541|39237044|FG003|Overall Study|Adverse Event|3|||
16520952|NCT02180867|40376288|FG002|Overall Study|Ineligible|0|||
16520953|NCT02180867|40376289|FG003|Overall Study|Ineligible|3|||
16520954|NCT02180867|40376290|FG004|Overall Study|Ineligible|5|||
16520955|NCT02180867|40376291|FG005|Overall Study|Ineligible|0|||
16206847|NCT02088541|39237045|FG004|Overall Study|Adverse Event|0|||
16206848|NCT02088541|39237041|FG000|Overall Study|Death|51|||
16206849|NCT02088541|39237042|FG001|Overall Study|Death|21|||
16206850|NCT02088541|39237043|FG002|Overall Study|Death|85|||
16206851|NCT02088541|39237044|FG003|Overall Study|Death|28|||
16206852|NCT02088541|39237045|FG004|Overall Study|Death|38|||
16206853|NCT02088541|39237041|FG000|Overall Study|Lost to Follow-up|2|||
16206854|NCT02088541|39237042|FG001|Overall Study|Lost to Follow-up|0|||
16206855|NCT02088541|39237043|FG002|Overall Study|Lost to Follow-up|1|||
16206856|NCT02088541|39237044|FG003|Overall Study|Lost to Follow-up|0|||
16206857|NCT02088541|39237045|FG004|Overall Study|Lost to Follow-up|0|||
16206858|NCT02088541|39237041|FG000|Overall Study|Physician Decision|2|||
16206859|NCT02088541|39237042|FG001|Overall Study|Physician Decision|1|||
16206860|NCT02088541|39237043|FG002|Overall Study|Physician Decision|2|||
16206861|NCT02088541|39237044|FG003|Overall Study|Physician Decision|0|||
16206862|NCT02088541|39237045|FG004|Overall Study|Physician Decision|2|||
16520956|NCT02180867|40376292|FG006|Overall Study|Ineligible|0|||
16520957|NCT02180867|40376286|FG000|Overall Study|Repeat Eligibility Studies|0|||
16520958|NCT02180867|40376287|FG001|Overall Study|Repeat Eligibility Studies|0|||
16520959|NCT02180867|40376288|FG002|Overall Study|Repeat Eligibility Studies|0|||
16520960|NCT02180867|40376289|FG003|Overall Study|Repeat Eligibility Studies|0|||
16520961|NCT02180867|40376290|FG004|Overall Study|Repeat Eligibility Studies|1|||
16520962|NCT02180867|40376291|FG005|Overall Study|Repeat Eligibility Studies|0|||
16520963|NCT02180867|40376292|FG006|Overall Study|Repeat Eligibility Studies|0|||
16520964|NCT02180867|40376286|FG000|Overall Study|Refusal of further protocol therapy|1|||
16520965|NCT02180867|40376287|FG001|Overall Study|Refusal of further protocol therapy|0|||
16520966|NCT02180867|40376288|FG002|Overall Study|Refusal of further protocol therapy|2|||
16520967|NCT02180867|40376289|FG003|Overall Study|Refusal of further protocol therapy|6|||
16520968|NCT02180867|40376290|FG004|Overall Study|Refusal of further protocol therapy|4|||
16520969|NCT02180867|40376291|FG005|Overall Study|Refusal of further protocol therapy|0|||
16520970|NCT02180867|40376292|FG006|Overall Study|Refusal of further protocol therapy|0|||
16520971|NCT01079234|40376299|FG000|Main: Week 0 to 26|Adverse Event|5|||
16520972|NCT01079234|40376300|FG001|Main: Week 0 to 26|Adverse Event|4|||
16520973|NCT01079234|40376301|FG002|Main: Week 0 to 26|Adverse Event|1|||
16520974|NCT01079234|40376302|FG003|Main: Week 0 to 26|Adverse Event|0|||
16520975|NCT01079234|40376299|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
16520976|NCT01079234|40376300|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
16520977|NCT01079234|40376301|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
16520978|NCT01079234|40376302|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
16520979|NCT01079234|40376299|FG000|Main: Week 0 to 26|Protocol Violation|6|||
16206863|NCT02088541|39237041|FG000|Overall Study|Disease progression|7|||
16206864|NCT02088541|39237042|FG001|Overall Study|Disease progression|1|||
16206865|NCT02088541|39237043|FG002|Overall Study|Disease progression|2|||
16206866|NCT02088541|39237044|FG003|Overall Study|Disease progression|3|||
16206867|NCT02088541|39237045|FG004|Overall Study|Disease progression|1|||
16206868|NCT02088541|39237041|FG000|Overall Study|Study terminated by sponsor|1|||
16206869|NCT02088541|39237042|FG001|Overall Study|Study terminated by sponsor|1|||
16206870|NCT02088541|39237043|FG002|Overall Study|Study terminated by sponsor|12|||
16395891|NCT01268046|39931209|FG002|Overall Study|Withdrawal by Subject|0|||
16520980|NCT01079234|40376300|FG001|Main: Week 0 to 26|Protocol Violation|2|||
16520981|NCT01079234|40376301|FG002|Main: Week 0 to 26|Protocol Violation|4|||
16520982|NCT01079234|40376302|FG003|Main: Week 0 to 26|Protocol Violation|0|||
16206871|NCT02088541|39237044|FG003|Overall Study|Study terminated by sponsor|2|||
16206872|NCT02088541|39237045|FG004|Overall Study|Study terminated by sponsor|6|||
16206873|NCT02088541|39237041|FG000|Overall Study|Withdrawal by Subject|3|||
16206874|NCT02088541|39237042|FG001|Overall Study|Withdrawal by Subject|2|||
16206875|NCT02088541|39237043|FG002|Overall Study|Withdrawal by Subject|9|||
16206876|NCT02088541|39237044|FG003|Overall Study|Withdrawal by Subject|7|||
16206877|NCT02088541|39237045|FG004|Overall Study|Withdrawal by Subject|10|||
16206878|NCT02088541|39237041|FG000|Overall Study|Other|2|||
16395892|NCT01268046|39931210|FG003|Overall Study|Withdrawal by Subject|1|||
16395893|NCT01268046|39931207|FG000|Overall Study|Lost to Follow-up|0|||
16206879|NCT02088541|39237042|FG001|Overall Study|Other|1|||
16206880|NCT02088541|39237043|FG002|Overall Study|Other|3|||
16206881|NCT02088541|39237044|FG003|Overall Study|Other|1|||
16520983|NCT01079234|40376299|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
16520984|NCT01079234|40376300|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
16520985|NCT01079234|40376301|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
16520986|NCT01079234|40376302|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
16520987|NCT01079234|40376299|FG000|Main: Week 0 to 26|Unclassified|7|||
16520988|NCT01079234|40376300|FG001|Main: Week 0 to 26|Unclassified|13|||
16520989|NCT01079234|40376301|FG002|Main: Week 0 to 26|Unclassified|4|||
16520990|NCT01079234|40376302|FG003|Main: Week 0 to 26|Unclassified|0|||
16520991|NCT01079234|40376299|FG000|Extension: Week 27 to 52|Adverse Event|0|||
16520992|NCT01079234|40376300|FG001|Extension: Week 27 to 52|Adverse Event|0|||
16520993|NCT01079234|40376301|FG002|Extension: Week 27 to 52|Adverse Event|1|||
16520994|NCT01079234|40376302|FG003|Extension: Week 27 to 52|Adverse Event|0|||
16520995|NCT01079234|40376299|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
16520996|NCT01079234|40376300|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
16520997|NCT01079234|40376301|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
16520998|NCT01079234|40376302|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
16520999|NCT01079234|40376299|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
16521000|NCT01079234|40376300|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
16521001|NCT01079234|40376301|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
16521002|NCT01079234|40376302|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
16093527|NCT02604199|38833118|FG003|Overall Study|Pregnancy|1|||
16093528|NCT02604199|38833115|FG000|Overall Study|Study terminated by sponsor|0|||
16093529|NCT02604199|38833116|FG001|Overall Study|Study terminated by sponsor|2|||
16093530|NCT02604199|38833117|FG002|Overall Study|Study terminated by sponsor|0|||
16093531|NCT02604199|38833118|FG003|Overall Study|Study terminated by sponsor|2|||
16093532|NCT02604199|38833115|FG000|Overall Study|Withdrawal by Subject|0|||
16093533|NCT02604199|38833116|FG001|Overall Study|Withdrawal by Subject|1|||
16093534|NCT02604199|38833117|FG002|Overall Study|Withdrawal by Subject|0|||
16093535|NCT02604199|38833118|FG003|Overall Study|Withdrawal by Subject|0|||
16093536|NCT01029925|38833119|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
16206882|NCT02088541|39237045|FG004|Overall Study|Other|1|||
16206883|NCT02905825|39237048|FG000|Overall Study|Protocol Violation|11|||
16206884|NCT02905825|39237048|FG000|Overall Study|Device Malfunction|1|||
16206885|NCT02920450|39237049|FG000|Overall Study|Death|1|||
16206886|NCT02920450|39237050|FG001|Overall Study|Death|0|||
16206887|NCT02920450|39237051|FG002|Overall Study|Death|0|||
16206888|NCT02920450|39237052|FG003|Overall Study|Death|0|||
16206889|NCT02920450|39237049|FG000|Overall Study|Withdrawal by Subject|1|||
16395894|NCT01268046|39931208|FG001|Overall Study|Lost to Follow-up|0|||
16395895|NCT01268046|39931209|FG002|Overall Study|Lost to Follow-up|1|||
16395896|NCT01268046|39931210|FG003|Overall Study|Lost to Follow-up|0|||
16093537|NCT01029925|38833119|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
16395897|NCT01047007|39931211|FG000|Overall Study|Adverse Event|0|||
16395898|NCT01047007|39931212|FG001|Overall Study|Adverse Event|2|||
16395899|NCT01047007|39931213|FG002|Overall Study|Adverse Event|1|||
16395900|NCT01047007|39931214|FG003|Overall Study|Adverse Event|0|||
16395901|NCT01047007|39931211|FG000|Overall Study|Progressive Disease|2|||
16395902|NCT01047007|39931212|FG001|Overall Study|Progressive Disease|4|||
16395903|NCT01047007|39931213|FG002|Overall Study|Progressive Disease|1|||
16395904|NCT01047007|39931214|FG003|Overall Study|Progressive Disease|0|||
16395905|NCT01140867|39931215|FG000|Overall Study|Adverse Event|22|||
16395906|NCT01140867|39931215|FG000|Overall Study|Lack of Efficacy|3|||
16093538|NCT01029925|38833119|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
16206890|NCT02920450|39237050|FG001|Overall Study|Withdrawal by Subject|0|||
16395907|NCT01140867|39931215|FG000|Overall Study|Lost to Follow-up|2|||
16395908|NCT01140867|39931215|FG000|Overall Study|Withdrawal by Subject|1|||
16521003|NCT01079234|40376299|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
16521004|NCT01079234|40376300|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
16521005|NCT01079234|40376301|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
16521006|NCT01079234|40376302|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
16521007|NCT01079234|40376299|FG000|Extension: Week 27 to 52|Unclassified|0|||
16093539|NCT02203513|38833129|FG000|Overall Study|Refused further treatment|2|||
16093540|NCT02203513|38833130|FG001|Overall Study|Refused further treatment|0|||
16206891|NCT02920450|39237051|FG002|Overall Study|Withdrawal by Subject|0|||
16206892|NCT02920450|39237052|FG003|Overall Study|Withdrawal by Subject|0|||
16206893|NCT01851863|39237053|FG000|Overall Study|Did not receive study medication|2|||
16395909|NCT01140867|39931215|FG000|Overall Study|Protocol Violation|1|||
16206894|NCT01851863|39237054|FG001|Overall Study|Did not receive study medication|5|||
16206895|NCT01851863|39237055|FG002|Overall Study|Did not receive study medication|3|||
16206896|NCT01851863|39237056|FG003|Overall Study|Did not receive study medication|0|||
16206897|NCT01851863|39237053|FG000|Overall Study|Lost to Follow-up|3|||
16206898|NCT01851863|39237054|FG001|Overall Study|Lost to Follow-up|4|||
16206899|NCT01851863|39237055|FG002|Overall Study|Lost to Follow-up|2|||
16206900|NCT01851863|39237056|FG003|Overall Study|Lost to Follow-up|3|||
16206901|NCT03788967|39237057|FG000|Overall Study|Lost to Follow-up|14|||
16206902|NCT03788967|39237058|FG001|Overall Study|Lost to Follow-up|10|||
16206903|NCT03788967|39237057|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
16206904|NCT03788967|39237058|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
16206905|NCT03788967|39237057|FG000|Overall Study|Participant Withdrawal of Consent|13|||
16206906|NCT03788967|39237058|FG001|Overall Study|Participant Withdrawal of Consent|5|||
16206907|NCT03788967|39237057|FG000|Overall Study|Adverse Event|1|||
16206908|NCT03788967|39237058|FG001|Overall Study|Adverse Event|1|||
16206909|NCT03788967|39237057|FG000|Overall Study|COVID-19|1|||
16206910|NCT03788967|39237058|FG001|Overall Study|COVID-19|2|||
16206911|NCT02517268|39237059|FG000|Overall Study|Withdrawal by Subject|1|||
16206912|NCT02517268|39237060|FG001|Overall Study|Withdrawal by Subject|0|||
16206913|NCT03332017|39237061|FG000|Overall Study|Lost to Follow-up|1|||
16206914|NCT03332017|39237062|FG001|Overall Study|Lost to Follow-up|2|||
16206915|NCT03332017|39237061|FG000|Overall Study|Death|17|||
16206916|NCT03332017|39237062|FG001|Overall Study|Death|16|||
16206917|NCT03332017|39237061|FG000|Overall Study|Withdrawal by Subject|6|||
16206918|NCT03332017|39237062|FG001|Overall Study|Withdrawal by Subject|14|||
16206919|NCT03332017|39237061|FG000|Overall Study|Other|1|||
16206920|NCT03332017|39237062|FG001|Overall Study|Other|3|||
16206921|NCT03332017|39237061|FG000|Overall Study|Remained in Study (Ongoing)|47|||
16206922|NCT03332017|39237062|FG001|Overall Study|Remained in Study (Ongoing)|110|||
16206923|NCT03148756|39237067|FG000|Overall Study|Study Terminated|0|||
16206924|NCT03148756|39237068|FG001|Overall Study|Study Terminated|1|||
16206925|NCT01906476|39237069|FG000|Overall Study|Lost to Follow-up|17|||
16206926|NCT01906476|39237070|FG001|Overall Study|Lost to Follow-up|16|||
16206927|NCT00764946|39237071|FG000|Overall Study|Lack of Efficacy|1|||
16206928|NCT00764946|39237072|FG001|Overall Study|Lack of Efficacy|0|||
16206929|NCT00764946|39237073|FG002|Overall Study|Lack of Efficacy|0|||
16206930|NCT00764946|39237071|FG000|Overall Study|Lost to Follow-up|3|||
16206931|NCT00764946|39237072|FG001|Overall Study|Lost to Follow-up|4|||
16206932|NCT00764946|39237073|FG002|Overall Study|Lost to Follow-up|0|||
16206933|NCT00764946|39237071|FG000|Overall Study|Physician Decision|2|||
16206934|NCT00764946|39237072|FG001|Overall Study|Physician Decision|4|||
16206935|NCT00764946|39237073|FG002|Overall Study|Physician Decision|0|||
16206936|NCT00764946|39237071|FG000|Overall Study|Adverse Event|3|||
16206937|NCT00764946|39237072|FG001|Overall Study|Adverse Event|2|||
16206938|NCT00764946|39237073|FG002|Overall Study|Adverse Event|1|||
16206939|NCT00764946|39237071|FG000|Overall Study|Withdrawal by Subject|3|||
16206940|NCT00764946|39237072|FG001|Overall Study|Withdrawal by Subject|6|||
16206941|NCT00764946|39237073|FG002|Overall Study|Withdrawal by Subject|2|||
16206942|NCT00764946|39237071|FG000|Overall Study|Never Treated|1|||
16206943|NCT00764946|39237072|FG001|Overall Study|Never Treated|1|||
16206944|NCT00764946|39237073|FG002|Overall Study|Never Treated|1|||
16206945|NCT03943446|39237075|FG000|Overall Study|Lost to Follow-up|0|||
16206946|NCT03943446|39237076|FG001|Overall Study|Lost to Follow-up|0|||
16206947|NCT03943446|39237077|FG002|Overall Study|Lost to Follow-up|1|||
16206948|NCT03943446|39237075|FG000|Overall Study|Withdrawal by Subject|1|||
16206949|NCT03943446|39237076|FG001|Overall Study|Withdrawal by Subject|1|||
16206950|NCT03943446|39237077|FG002|Overall Study|Withdrawal by Subject|2|||
16206951|NCT03943446|39237075|FG000|Overall Study|Study Terminated by Sponsor|1|||
16206952|NCT03943446|39237076|FG001|Overall Study|Study Terminated by Sponsor|2|||
16206953|NCT03943446|39237077|FG002|Overall Study|Study Terminated by Sponsor|1|||
16206954|NCT03943446|39237075|FG000|Overall Study|Reason not Specified|5|||
16206955|NCT03943446|39237076|FG001|Overall Study|Reason not Specified|1|||
16206956|NCT03943446|39237077|FG002|Overall Study|Reason not Specified|3|||
16206957|NCT02064205|39237078|FG000|Overall Study|Withdrawal by Subject|1|||
16206958|NCT01202760|39237083|FG000|Overall Study|Entry Criteria Not Met|0|||
16206959|NCT01202760|39237084|FG001|Overall Study|Entry Criteria Not Met|3|||
16206960|NCT01202760|39237085|FG002|Overall Study|Entry Criteria Not Met|1|||
16206961|NCT01202760|39237083|FG000|Overall Study|Adverse Event|11|||
16206962|NCT01202760|39237084|FG001|Overall Study|Adverse Event|9|||
16206963|NCT01202760|39237085|FG002|Overall Study|Adverse Event|10|||
16206964|NCT01202760|39237083|FG000|Overall Study|Death|2|||
16206965|NCT01202760|39237084|FG001|Overall Study|Death|1|||
16206966|NCT01202760|39237085|FG002|Overall Study|Death|0|||
16206967|NCT01202760|39237083|FG000|Overall Study|Lack of Efficacy|6|||
16206968|NCT01202760|39237084|FG001|Overall Study|Lack of Efficacy|8|||
16206969|NCT01202760|39237085|FG002|Overall Study|Lack of Efficacy|7|||
16206970|NCT01202760|39237083|FG000|Overall Study|Lost to Follow-up|0|||
16206971|NCT01202760|39237084|FG001|Overall Study|Lost to Follow-up|2|||
16206972|NCT01202760|39237085|FG002|Overall Study|Lost to Follow-up|1|||
16206973|NCT01202760|39237083|FG000|Overall Study|Parent / Caregiver Decision|0|||
16206974|NCT01202760|39237084|FG001|Overall Study|Parent / Caregiver Decision|1|||
16206975|NCT01202760|39237085|FG002|Overall Study|Parent / Caregiver Decision|0|||
16206976|NCT01202760|39237083|FG000|Overall Study|Withdrawal by Subject|17|||
16206977|NCT01202760|39237084|FG001|Overall Study|Withdrawal by Subject|18|||
16206978|NCT01202760|39237085|FG002|Overall Study|Withdrawal by Subject|14|||
16206979|NCT01202760|39237083|FG000|Overall Study|Physician Decision|0|||
16206980|NCT01202760|39237084|FG001|Overall Study|Physician Decision|1|||
16206981|NCT01202760|39237085|FG002|Overall Study|Physician Decision|0|||
16206982|NCT01202760|39237083|FG000|Overall Study|Protocol Violation|7|||
16206983|NCT01202760|39237084|FG001|Overall Study|Protocol Violation|5|||
16206984|NCT01202760|39237085|FG002|Overall Study|Protocol Violation|2|||
16206985|NCT01202760|39237083|FG000|Overall Study|Sponsor Decision|4|||
16206986|NCT01202760|39237084|FG001|Overall Study|Sponsor Decision|4|||
16206987|NCT01202760|39237085|FG002|Overall Study|Sponsor Decision|0|||
16206988|NCT00424346|39237088|FG000|Core Study|Adverse Event|5|||
16206989|NCT00424346|39237089|FG001|Core Study|Adverse Event|3|||
16206990|NCT00424346|39237090|FG002|Core Study|Adverse Event|1|||
16206991|NCT00424346|39237091|FG003|Core Study|Adverse Event|1|||
16206992|NCT00424346|39237088|FG000|Core Study|Abnormal Laboratory Values|0|||
16206993|NCT00424346|39237089|FG001|Core Study|Abnormal Laboratory Values|1|||
16206994|NCT00424346|39237090|FG002|Core Study|Abnormal Laboratory Values|0|||
16206995|NCT00424346|39237091|FG003|Core Study|Abnormal Laboratory Values|0|||
16206996|NCT00424346|39237088|FG000|Core Study|Lack of Efficacy|1|||
16206997|NCT00424346|39237089|FG001|Core Study|Lack of Efficacy|3|||
16206998|NCT00424346|39237090|FG002|Core Study|Lack of Efficacy|0|||
16206999|NCT00424346|39237091|FG003|Core Study|Lack of Efficacy|4|||
16207000|NCT00424346|39237088|FG000|Core Study|Withdrawal by Subject|1|||
16207001|NCT00424346|39237089|FG001|Core Study|Withdrawal by Subject|0|||
16207002|NCT00424346|39237090|FG002|Core Study|Withdrawal by Subject|0|||
16207003|NCT00424346|39237091|FG003|Core Study|Withdrawal by Subject|2|||
16207004|NCT00424346|39237088|FG000|Core Study|Lost to Follow-up|1|||
16207005|NCT00424346|39237089|FG001|Core Study|Lost to Follow-up|1|||
16207006|NCT00424346|39237090|FG002|Core Study|Lost to Follow-up|0|||
16207007|NCT00424346|39237091|FG003|Core Study|Lost to Follow-up|0|||
16207008|NCT00424346|39237088|FG000|Core Study|Administrative Problems|1|||
16207009|NCT00424346|39237089|FG001|Core Study|Administrative Problems|0|||
16207010|NCT00424346|39237090|FG002|Core Study|Administrative Problems|1|||
16207011|NCT00424346|39237091|FG003|Core Study|Administrative Problems|0|||
16207012|NCT00424346|39237088|FG000|Core Study|Protocol Violation|0|||
16207013|NCT00424346|39237089|FG001|Core Study|Protocol Violation|0|||
16207014|NCT00424346|39237090|FG002|Core Study|Protocol Violation|2|||
16207015|NCT00424346|39237091|FG003|Core Study|Protocol Violation|0|||
16207016|NCT00424346|39237088|FG000|Extension Phase|Adverse Event|0|||
16207017|NCT00424346|39237089|FG001|Extension Phase|Adverse Event|9|||
16207018|NCT00424346|39237090|FG002|Extension Phase|Adverse Event|5|||
16207019|NCT00424346|39237091|FG003|Extension Phase|Adverse Event|4|||
16207020|NCT00424346|39237088|FG000|Extension Phase|Lack of Efficacy|0|||
16207021|NCT00424346|39237089|FG001|Extension Phase|Lack of Efficacy|16|||
16207022|NCT00424346|39237090|FG002|Extension Phase|Lack of Efficacy|14|||
16207023|NCT00424346|39237091|FG003|Extension Phase|Lack of Efficacy|11|||
16207024|NCT00424346|39237088|FG000|Extension Phase|Withdrawal by Subject|0|||
16207025|NCT00424346|39237089|FG001|Extension Phase|Withdrawal by Subject|5|||
16207026|NCT00424346|39237090|FG002|Extension Phase|Withdrawal by Subject|3|||
16207027|NCT00424346|39237091|FG003|Extension Phase|Withdrawal by Subject|4|||
16207028|NCT00424346|39237088|FG000|Extension Phase|Lost to Follow-up|0|||
16207029|NCT00424346|39237089|FG001|Extension Phase|Lost to Follow-up|2|||
16207030|NCT00424346|39237090|FG002|Extension Phase|Lost to Follow-up|0|||
16207031|NCT00424346|39237091|FG003|Extension Phase|Lost to Follow-up|0|||
16207032|NCT00424346|39237088|FG000|Extension Phase|Administrative Problems|0|||
16207033|NCT00424346|39237089|FG001|Extension Phase|Administrative Problems|69|||
16207034|NCT00424346|39237090|FG002|Extension Phase|Administrative Problems|32|||
16207035|NCT00424346|39237091|FG003|Extension Phase|Administrative Problems|35|||
16207036|NCT00424346|39237088|FG000|Extension Phase|Death|0|||
16207037|NCT00424346|39237089|FG001|Extension Phase|Death|0|||
16207038|NCT00424346|39237090|FG002|Extension Phase|Death|0|||
16207039|NCT00424346|39237091|FG003|Extension Phase|Death|1|||
16207040|NCT00424346|39237088|FG000|Extension Phase|Protocol Violation|0|||
16207041|NCT00424346|39237089|FG001|Extension Phase|Protocol Violation|1|||
16207042|NCT00424346|39237090|FG002|Extension Phase|Protocol Violation|1|||
16207043|NCT00424346|39237091|FG003|Extension Phase|Protocol Violation|0|||
16207044|NCT01827319|39237092|FG000|Overall Study|Lost to Follow-up|3|||
16207045|NCT03287869|39237098|FG000|Overall Study|Adverse Event|14|||
16207046|NCT03287869|39237099|FG001|Overall Study|Adverse Event|12|||
16207047|NCT03287869|39237098|FG000|Overall Study|Lack of Efficacy|1|||
16207048|NCT03287869|39237099|FG001|Overall Study|Lack of Efficacy|0|||
16207049|NCT03287869|39237098|FG000|Overall Study|Lost to Follow-up|13|||
16207050|NCT03287869|39237099|FG001|Overall Study|Lost to Follow-up|19|||
16207051|NCT03287869|39237098|FG000|Overall Study|Non-Compliance With Study Drug|5|||
16395910|NCT01140867|39931215|FG000|Overall Study|Uncooperative patient|2|||
16395911|NCT01140867|39931215|FG000|Overall Study|Medication Noncompliance|2|||
16395912|NCT03711370|39931216|FG000|Overall Study|Lost to Follow-up|16|||
16395913|NCT03711370|39931217|FG001|Overall Study|Lost to Follow-up|10|||
16395914|NCT03711370|39931216|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
16395915|NCT03711370|39931217|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
16395916|NCT02836717|39931218|FG000|Test Phase|Lack of Efficacy|14|||
16395917|NCT02836717|39931219|FG001|Test Phase|Lack of Efficacy|8|||
16395918|NCT02836717|39931220|FG002|Test Phase|Lack of Efficacy|0|||
16395919|NCT02836717|39931218|FG000|Study Phase|Adverse Event|2|||
16395920|NCT02836717|39931219|FG001|Study Phase|Adverse Event|0|||
16395921|NCT02836717|39931220|FG002|Study Phase|Adverse Event|0|||
16395922|NCT02836717|39931218|FG000|Study Phase|Lack of Efficacy|8|||
16395923|NCT02836717|39931219|FG001|Study Phase|Lack of Efficacy|6|||
16395924|NCT02836717|39931220|FG002|Study Phase|Lack of Efficacy|1|||
16395925|NCT02836717|39931218|FG000|Study Phase|Withdrawal by Subject|1|||
16395926|NCT02836717|39931219|FG001|Study Phase|Withdrawal by Subject|0|||
16395927|NCT02836717|39931220|FG002|Study Phase|Withdrawal by Subject|0|||
16395928|NCT02836717|39931218|FG000|Study Phase|Death|1|||
16395929|NCT02836717|39931219|FG001|Study Phase|Death|0|||
16521008|NCT01079234|40376300|FG001|Extension: Week 27 to 52|Unclassified|0|||
16521009|NCT01079234|40376301|FG002|Extension: Week 27 to 52|Unclassified|4|||
16521010|NCT01079234|40376302|FG003|Extension: Week 27 to 52|Unclassified|7|||
16521011|NCT05101252|40376303|FG000|Overall Study|Unsatisfactory Test Article|1|||
16521012|NCT05101252|40376304|FG001|Overall Study|Unsatisfactory Test Article|0|||
16521013|NCT05101252|40376303|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
16521014|NCT05101252|40376304|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
16521015|NCT05101252|40376303|FG000|Overall Study|Withdrew Consent during study|0|||
16521016|NCT05101252|40376304|FG001|Overall Study|Withdrew Consent during study|1|||
16521017|NCT05101252|40376303|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
16521018|NCT05101252|40376304|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
16521019|NCT00646958|40376305|FG000|Overall Study|Lack of Efficacy|1|||
16521020|NCT00646958|40376306|FG001|Overall Study|Lack of Efficacy|0|||
16521021|NCT00646958|40376307|FG002|Overall Study|Lack of Efficacy|0|||
16093541|NCT02203513|38833131|FG002|Overall Study|Refused further treatment|1|||
16093542|NCT02203513|38833132|FG003|Overall Study|Refused further treatment|0|||
16093543|NCT02203513|38833133|FG004|Overall Study|Refused further treatment|0|||
16093544|NCT02203513|38833129|FG000|Overall Study|Switched to alternative treatment|3|||
16093545|NCT02203513|38833130|FG001|Overall Study|Switched to alternative treatment|4|||
16093546|NCT02203513|38833131|FG002|Overall Study|Switched to alternative treatment|0|||
16093547|NCT02203513|38833132|FG003|Overall Study|Switched to alternative treatment|0|||
16093548|NCT02203513|38833133|FG004|Overall Study|Switched to alternative treatment|4|||
16093549|NCT02203513|38833129|FG000|Overall Study|Did not receive investigational product (IP)|0|||
16093550|NCT02203513|38833130|FG001|Overall Study|Did not receive investigational product (IP)|1|||
16093551|NCT02203513|38833131|FG002|Overall Study|Did not receive investigational product (IP)|0|||
16093552|NCT02203513|38833132|FG003|Overall Study|Did not receive investigational product (IP)|0|||
16093553|NCT02203513|38833133|FG004|Overall Study|Did not receive investigational product (IP)|0|||
16093554|NCT02203513|38833129|FG000|Overall Study|Death (unrelated to study therapy)|1|||
16093555|NCT02203513|38833130|FG001|Overall Study|Death (unrelated to study therapy)|3|||
16093556|NCT02203513|38833131|FG002|Overall Study|Death (unrelated to study therapy)|1|||
16093557|NCT02203513|38833132|FG003|Overall Study|Death (unrelated to study therapy)|0|||
16093558|NCT02203513|38833133|FG004|Overall Study|Death (unrelated to study therapy)|2|||
16093559|NCT02203513|38833129|FG000|Overall Study|Lost to Follow-up|0|||
16093560|NCT02203513|38833130|FG001|Overall Study|Lost to Follow-up|0|||
16093561|NCT02203513|38833131|FG002|Overall Study|Lost to Follow-up|1|||
16093562|NCT02203513|38833132|FG003|Overall Study|Lost to Follow-up|1|||
16093563|NCT02203513|38833133|FG004|Overall Study|Lost to Follow-up|0|||
16093564|NCT03166215|38833134|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
16093565|NCT03166215|38833135|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
16093566|NCT03166215|38833136|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
16093567|NCT03166215|38833134|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
16093568|NCT03166215|38833135|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
16093569|NCT03166215|38833136|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
16093570|NCT01124045|38833137|FG000|Overall Study|Lost to Follow-up|0|||
16093571|NCT01124045|38833138|FG001|Overall Study|Lost to Follow-up|1|||
16395930|NCT02836717|39931220|FG002|Study Phase|Death|0|||
16395931|NCT02836717|39931218|FG000|Study Phase|abdominal surgeries|2|||
16395932|NCT02836717|39931219|FG001|Study Phase|abdominal surgeries|1|||
16093572|NCT01124045|38833137|FG000|Overall Study|Physician Decision|0|||
16093573|NCT01124045|38833138|FG001|Overall Study|Physician Decision|2|||
16093574|NCT02143713|38833139|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
16395933|NCT02836717|39931220|FG002|Study Phase|abdominal surgeries|0|||
16521022|NCT00646958|40376305|FG000|Overall Study|Adverse Event|4|||
16521023|NCT00646958|40376306|FG001|Overall Study|Adverse Event|0|||
16521024|NCT00646958|40376307|FG002|Overall Study|Adverse Event|0|||
16521025|NCT00646958|40376305|FG000|Overall Study|Lost to Follow-up|1|||
16521026|NCT00646958|40376306|FG001|Overall Study|Lost to Follow-up|5|||
16521027|NCT00646958|40376307|FG002|Overall Study|Lost to Follow-up|7|||
16521028|NCT00646958|40376305|FG000|Overall Study|Protocol Violation|1|||
16521029|NCT00646958|40376306|FG001|Overall Study|Protocol Violation|1|||
16521030|NCT00646958|40376307|FG002|Overall Study|Protocol Violation|0|||
16521031|NCT00646958|40376305|FG000|Overall Study|Abnormal screening lab tests|1|||
16521032|NCT00646958|40376306|FG001|Overall Study|Abnormal screening lab tests|1|||
16521033|NCT00646958|40376307|FG002|Overall Study|Abnormal screening lab tests|0|||
16521034|NCT00646958|40376305|FG000|Overall Study|Withdrawal by Subject|1|||
16521035|NCT00646958|40376306|FG001|Overall Study|Withdrawal by Subject|2|||
16521036|NCT00646958|40376307|FG002|Overall Study|Withdrawal by Subject|0|||
16521037|NCT00646958|40376305|FG000|Overall Study|Did not receive study drug|2|||
16521038|NCT00646958|40376306|FG001|Overall Study|Did not receive study drug|0|||
16521039|NCT00646958|40376307|FG002|Overall Study|Did not receive study drug|2|||
16521040|NCT00673452|40376319|FG000|Acute Double-Blind Phase|Adverse Event|41|||
16521041|NCT00673452|40376320|FG001|Acute Double-Blind Phase|Adverse Event|24|||
16521042|NCT00673452|40376319|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
16521043|NCT00673452|40376320|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
16521044|NCT00673452|40376319|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
16521045|NCT00673452|40376320|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
16521046|NCT00673452|40376319|FG000|Acute Double-Blind Phase|Physician Decision|0|||
16521047|NCT00673452|40376320|FG001|Acute Double-Blind Phase|Physician Decision|6|||
16521048|NCT00673452|40376319|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
16521049|NCT00673452|40376320|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
16521050|NCT00673452|40376319|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
16521051|NCT00673452|40376320|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
16521052|NCT00673452|40376319|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
16521053|NCT00673452|40376320|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
16521054|NCT00673452|40376319|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
16521055|NCT00673452|40376320|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
16521056|NCT00673452|40376319|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
16521057|NCT00673452|40376320|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
16521058|NCT00673452|40376319|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
16521059|NCT00673452|40376320|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
16521060|NCT00673452|40376319|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
16521061|NCT00673452|40376320|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
16521062|NCT00673452|40376319|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
16521063|NCT00673452|40376320|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
16521064|NCT00673452|40376319|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
16521065|NCT00673452|40376320|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
16521066|NCT00673452|40376319|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
16521067|NCT00673452|40376320|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
16093575|NCT02143713|38833140|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
16093576|NCT02143713|38833141|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
16093577|NCT02143713|38833142|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
16093578|NCT02143713|38833139|FG000|Treatment Period (6 Months)|Adverse Event|7|||
16093579|NCT02143713|38833140|FG001|Treatment Period (6 Months)|Adverse Event|8|||
16093580|NCT02143713|38833141|FG002|Treatment Period (6 Months)|Adverse Event|8|||
16093581|NCT02143713|38833142|FG003|Treatment Period (6 Months)|Adverse Event|9|||
16093582|NCT02143713|38833139|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
16093583|NCT02143713|38833140|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
16324509|NCT03499899|39674510|FG000|Overall Study|Death|0|||
16324510|NCT03499899|39674511|FG001|Overall Study|Death|0|||
16324511|NCT03499899|39674512|FG002|Overall Study|Death|1|||
16093584|NCT02143713|38833141|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
16324512|NCT03499899|39674510|FG000|Overall Study|Physician Decision|3|||
16207052|NCT03287869|39237099|FG001|Overall Study|Non-Compliance With Study Drug|9|||
16207053|NCT03287869|39237098|FG000|Overall Study|Progressive Disease|1|||
16207054|NCT03287869|39237099|FG001|Overall Study|Progressive Disease|0|||
16207055|NCT03287869|39237098|FG000|Overall Study|Protocol Deviation|2|||
16207056|NCT03287869|39237099|FG001|Overall Study|Protocol Deviation|1|||
16207057|NCT03287869|39237098|FG000|Overall Study|Withdrawal by Subject|36|||
16207058|NCT03287869|39237099|FG001|Overall Study|Withdrawal by Subject|43|||
16207059|NCT03287869|39237098|FG000|Overall Study|Early Closure of the Site|0|||
16521068|NCT00673452|40376319|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
16521069|NCT00673452|40376320|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
16207060|NCT03287869|39237099|FG001|Overall Study|Early Closure of the Site|1|||
16207061|NCT03287869|39237098|FG000|Overall Study|Physician Decision|5|||
16207062|NCT03287869|39237099|FG001|Overall Study|Physician Decision|5|||
16207063|NCT03287869|39237098|FG000|Overall Study|Reason not Specified|6|||
16207064|NCT03287869|39237099|FG001|Overall Study|Reason not Specified|3|||
16521070|NCT01302964|40376324|FG000|Overall Study|Adverse Event|1|||
16207065|NCT02197897|39237100|FG000|Overall Study|not eligible|1|||
16207066|NCT02516241|39237104|FG000|Overall Study|Death|255|||
16207067|NCT02516241|39237105|FG001|Overall Study|Death|262|||
16207068|NCT02516241|39237106|FG002|Overall Study|Death|270|||
16207069|NCT02516241|39237104|FG000|Overall Study|Lost to Follow-up|1|||
16207070|NCT02516241|39237105|FG001|Overall Study|Lost to Follow-up|1|||
16207071|NCT02516241|39237106|FG002|Overall Study|Lost to Follow-up|3|||
16207072|NCT02516241|39237104|FG000|Overall Study|Withdrawal by Subject|2|||
16207073|NCT02516241|39237105|FG001|Overall Study|Withdrawal by Subject|7|||
16207074|NCT02516241|39237106|FG002|Overall Study|Withdrawal by Subject|12|||
16521071|NCT01302964|40376325|FG001|Overall Study|Adverse Event|0|||
16521072|NCT03586869|40376328|FG000|Overall Study|Progressive Disease|3|||
16521073|NCT04116229|40376331|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
16521074|NCT04116229|40376332|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
16521075|NCT04116229|40376331|FG000|Overall Study|Scheduling not possible.|0|||
16521076|NCT04116229|40376332|FG001|Overall Study|Scheduling not possible.|1|||
16521077|NCT04661033|40376333|FG000|Overall Study|Adverse Event|0|||
16521078|NCT04661033|40376334|FG001|Overall Study|Adverse Event|0|||
16521079|NCT04661033|40376335|FG002|Overall Study|Adverse Event|1|||
16521080|NCT04661033|40376336|FG003|Overall Study|Adverse Event|0|||
16521081|NCT04661033|40376333|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
16521082|NCT04661033|40376334|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
16207075|NCT02516241|39237104|FG000|Overall Study|participants ongoing at data cut-off|84|||
16207076|NCT02516241|39237105|FG001|Overall Study|participants ongoing at data cut-off|76|||
16207077|NCT02516241|39237106|FG002|Overall Study|participants ongoing at data cut-off|59|||
16207078|NCT01742091|39237107|FG000|Overall Study|Adverse Event|0|||
16207079|NCT01742091|39237108|FG001|Overall Study|Adverse Event|0|||
16207080|NCT01742091|39237109|FG002|Overall Study|Adverse Event|0|||
16207081|NCT01742091|39237110|FG003|Overall Study|Adverse Event|0|||
16207082|NCT01742091|39237111|FG004|Overall Study|Adverse Event|1|||
16207083|NCT01742091|39237112|FG005|Overall Study|Adverse Event|0|||
16207084|NCT01742091|39237107|FG000|Overall Study|Physician Decision|0|||
16207085|NCT01742091|39237108|FG001|Overall Study|Physician Decision|0|||
16207086|NCT01742091|39237109|FG002|Overall Study|Physician Decision|0|||
16207087|NCT01742091|39237110|FG003|Overall Study|Physician Decision|0|||
16207088|NCT01742091|39237111|FG004|Overall Study|Physician Decision|0|||
16207089|NCT01742091|39237112|FG005|Overall Study|Physician Decision|1|||
16207090|NCT01742091|39237107|FG000|Overall Study|Withdrawal by Subject|0|||
16207091|NCT01742091|39237108|FG001|Overall Study|Withdrawal by Subject|0|||
16207092|NCT01742091|39237109|FG002|Overall Study|Withdrawal by Subject|0|||
16207093|NCT01742091|39237110|FG003|Overall Study|Withdrawal by Subject|1|||
16207094|NCT01742091|39237111|FG004|Overall Study|Withdrawal by Subject|0|||
16207095|NCT01742091|39237112|FG005|Overall Study|Withdrawal by Subject|0|||
16207096|NCT01742091|39237107|FG000|Overall Study|Lost to Follow-up|0|||
16207097|NCT01742091|39237108|FG001|Overall Study|Lost to Follow-up|0|||
16521083|NCT04661033|40376335|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
16521084|NCT04661033|40376336|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
16521085|NCT04661033|40376333|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
16521086|NCT04661033|40376334|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
16521087|NCT04661033|40376335|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
16521088|NCT04661033|40376336|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
16521089|NCT04661033|40376333|FG000|Overall Study|Early discontinuation as per PI|1|||
16521090|NCT04661033|40376334|FG001|Overall Study|Early discontinuation as per PI|0|||
16521091|NCT04661033|40376335|FG002|Overall Study|Early discontinuation as per PI|0|||
16521092|NCT04661033|40376336|FG003|Overall Study|Early discontinuation as per PI|0|||
16521093|NCT01732835|40376343|FG000|6-month Primary Endpoint|Did not receive device|19|||
16521094|NCT01732835|40376343|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
16521095|NCT01732835|40376343|FG000|6-month Primary Endpoint|Adverse Event|3|||
16521096|NCT01732835|40376343|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
16521097|NCT01732835|40376343|FG000|2-year Extended Follow-up|Adverse Event|3|||
16521098|NCT01732835|40376343|FG000|2-year Extended Follow-up|Death|1|||
16521099|NCT00733824|40376346|FG000|Phase I|Withdrawal by Subject|1|||
16521100|NCT00733824|40376347|FG001|Phase I|Withdrawal by Subject|0|||
16521101|NCT00733824|40376348|FG002|Phase I|Withdrawal by Subject|0|||
16521102|NCT00733824|40376349|FG003|Phase I|Withdrawal by Subject|0|||
16521103|NCT00733824|40376350|FG004|Phase I|Withdrawal by Subject|0|||
16521104|NCT02752048|40376351|FG000|Overall Study|Withdrawal by Subject|0|||
16521105|NCT02752048|40376352|FG001|Overall Study|Withdrawal by Subject|0|||
16521106|NCT02752048|40376353|FG002|Overall Study|Withdrawal by Subject|3|||
16521107|NCT03099382|40376354|FG000|Overall Study|Protocol Violation|2|||
16521108|NCT03099382|40376355|FG001|Overall Study|Protocol Violation|3|||
16521109|NCT00087568|40376356|FG000|Overall Study|Adverse Event|4|||
16521110|NCT00087568|40376357|FG001|Overall Study|Adverse Event|0|||
16521111|NCT00087568|40376356|FG000|Overall Study|Withdrawal by Subject|1|||
16521112|NCT00087568|40376357|FG001|Overall Study|Withdrawal by Subject|1|||
16521113|NCT00087568|40376356|FG000|Overall Study|Lost to Follow-up|1|||
16521114|NCT00087568|40376357|FG001|Overall Study|Lost to Follow-up|0|||
16521115|NCT00087568|40376356|FG000|Overall Study|Lack of Efficacy|24|||
16521116|NCT00087568|40376357|FG001|Overall Study|Lack of Efficacy|1|||
16521117|NCT01826825|40376362|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
16521118|NCT01826825|40376363|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
16521119|NCT00534352|40376366|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
16521120|NCT00534352|40376366|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
16521121|NCT00534352|40376366|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
16521122|NCT00534352|40376366|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
16521123|NCT00534352|40376366|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
16521124|NCT00534352|40376366|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
16521125|NCT00306592|40376367|FG000|Overall Study|Adverse Event|8|||
16521126|NCT00306592|40376368|FG001|Overall Study|Adverse Event|15|||
16521127|NCT00306592|40376367|FG000|Overall Study|Lost to Follow-up|1|||
16521128|NCT00306592|40376368|FG001|Overall Study|Lost to Follow-up|0|||
16521129|NCT00306592|40376367|FG000|Overall Study|Noncompliance|0|||
16521130|NCT00306592|40376368|FG001|Overall Study|Noncompliance|2|||
16521131|NCT00306592|40376367|FG000|Overall Study|Persistent Antibodies|6|||
16521132|NCT00306592|40376368|FG001|Overall Study|Persistent Antibodies|3|||
16521133|NCT00306592|40376367|FG000|Overall Study|Voluntary|10|||
16521134|NCT00306592|40376368|FG001|Overall Study|Voluntary|6|||
16521135|NCT00306592|40376367|FG000|Overall Study|Other|5|||
16521136|NCT00306592|40376368|FG001|Overall Study|Other|10|||
16521137|NCT00306592|40376367|FG000|Overall Study|Other|1|||
16521138|NCT00306592|40376368|FG001|Overall Study|Other|2|||
16521139|NCT00306592|40376367|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
16521140|NCT00306592|40376368|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
16521141|NCT01898195|40376369|FG000|Smoking Abstinence|Did not have good measurements|35|||
16521142|NCT01898195|40376370|FG001|Smoking Abstinence|Did not have good measurements|38|||
16521143|NCT01898195|40376371|FG002|Smoking Abstinence|Did not have good measurements|36|||
16521144|NCT03219333|40376372|FG000|Overall Study|Withdrawal by Subject|9|||
16521145|NCT03219333|40376373|FG001|Overall Study|Withdrawal by Subject|4|||
16521146|NCT03219333|40376372|FG000|Overall Study|Lost to Follow-up|1|||
16521147|NCT03219333|40376373|FG001|Overall Study|Lost to Follow-up|1|||
16521148|NCT03219333|40376372|FG000|Overall Study|Death|104|||
16521149|NCT03219333|40376373|FG001|Overall Study|Death|72|||
16521150|NCT03219333|40376372|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
16521151|NCT03219333|40376373|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
16521152|NCT03219333|40376372|FG000|Overall Study|Other|2|||
16521153|NCT03219333|40376373|FG001|Overall Study|Other|2|||
16521154|NCT05008055|40376374|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
16521155|NCT05008055|40376375|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
16521156|NCT05008055|40376376|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
16521157|NCT01611259|40376377|FG000|Overall Study|Physician Decision|1|||
16521158|NCT01611259|40376377|FG000|Overall Study|Lack of Efficacy|2|||
16521159|NCT01611259|40376377|FG000|Overall Study|Adverse Event|4|||
16521160|NCT01611259|40376377|FG000|Overall Study|Withdrawal by Subject|7|||
16521161|NCT02788175|40376378|FG000|Overall Study|Protocol Violation|3|||
16521162|NCT02788175|40376378|FG000|Overall Study|Withdrawal by Subject|4|||
16521163|NCT02788175|40376378|FG000|Overall Study|Ineligible prior to study agent|6|||
16521164|NCT03509948|40376379|FG000|Overall Study|Protocol Violation|0|||
16521165|NCT03509948|40376380|FG001|Overall Study|Protocol Violation|1|||
16521166|NCT03653429|40376381|FG000|Overall Study|Physician Decision|4|||
16521167|NCT03653429|40376382|FG001|Overall Study|Physician Decision|10|||
16521168|NCT03268811|40376383|FG000|Overall Study|Adverse Event|0|||
16521169|NCT03268811|40376384|FG001|Overall Study|Adverse Event|1|||
16521170|NCT00441337|40376385|FG000|Overall Study|Disease Progression|6|||
16521171|NCT00441337|40376386|FG001|Overall Study|Disease Progression|6|||
16521172|NCT00441337|40376387|FG002|Overall Study|Disease Progression|4|||
16521173|NCT00441337|40376388|FG003|Overall Study|Disease Progression|18|||
16521174|NCT00441337|40376385|FG000|Overall Study|Lost to Follow-up|0|||
16521175|NCT00441337|40376386|FG001|Overall Study|Lost to Follow-up|0|||
16521176|NCT00441337|40376387|FG002|Overall Study|Lost to Follow-up|0|||
16521177|NCT00441337|40376388|FG003|Overall Study|Lost to Follow-up|1|||
16521178|NCT00441337|40376385|FG000|Overall Study|Sponsor Decision|0|||
16521179|NCT00441337|40376386|FG001|Overall Study|Sponsor Decision|0|||
16521180|NCT00441337|40376387|FG002|Overall Study|Sponsor Decision|1|||
16521181|NCT00441337|40376388|FG003|Overall Study|Sponsor Decision|2|||
16521182|NCT00441337|40376385|FG000|Overall Study|Did not meet inclusion criteria|0|||
16521183|NCT00441337|40376386|FG001|Overall Study|Did not meet inclusion criteria|0|||
16521184|NCT00441337|40376387|FG002|Overall Study|Did not meet inclusion criteria|1|||
16521185|NCT00441337|40376388|FG003|Overall Study|Did not meet inclusion criteria|0|||
16521186|NCT02758236|40376390|FG000|Overall Study|Investigator discretion|43|||
16521187|NCT03286140|40376391|FG000|Overall Study|Withdrawal by Subject|10|||
16521188|NCT03286140|40376392|FG001|Overall Study|Withdrawal by Subject|5|||
16521189|NCT03286140|40376391|FG000|Overall Study|Lost to Follow-up|5|||
16521190|NCT03286140|40376392|FG001|Overall Study|Lost to Follow-up|10|||
16521191|NCT03286140|40376391|FG000|Overall Study|Failure to comply|0|||
16395934|NCT01701362|39931221|FG000|Overall Study|Adverse events not related to study drug|1|||
16395935|NCT01701362|39931222|FG001|Overall Study|Adverse events not related to study drug|6|||
16395936|NCT01701362|39931221|FG000|Overall Study|Adverse events related to study drug|12|||
16395937|NCT01701362|39931222|FG001|Overall Study|Adverse events related to study drug|10|||
16395938|NCT01701362|39931221|FG000|Overall Study|Protocol Violation|5|||
16395939|NCT01701362|39931222|FG001|Overall Study|Protocol Violation|3|||
16395940|NCT01701362|39931221|FG000|Overall Study|No longer willing to participate|8|||
16395941|NCT01701362|39931222|FG001|Overall Study|No longer willing to participate|14|||
16395942|NCT01701362|39931221|FG000|Overall Study|Lost to Follow-up|6|||
16395943|NCT01701362|39931222|FG001|Overall Study|Lost to Follow-up|9|||
16395944|NCT01701362|39931221|FG000|Overall Study|Insufficient clinical response|6|||
16395945|NCT01701362|39931222|FG001|Overall Study|Insufficient clinical response|6|||
16395946|NCT01701362|39931221|FG000|Overall Study|Death|0|||
16395947|NCT01701362|39931222|FG001|Overall Study|Death|1|||
16395948|NCT01701362|39931221|FG000|Overall Study|Randomized but not treated|1|||
16395949|NCT01701362|39931222|FG001|Overall Study|Randomized but not treated|2|||
16395950|NCT01701362|39931221|FG000|Overall Study|Reasons other than those mentioned above|3|||
16395951|NCT01701362|39931222|FG001|Overall Study|Reasons other than those mentioned above|5|||
16395952|NCT04474197|39931227|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
16395953|NCT04474197|39931228|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
16395954|NCT04474197|39931229|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
16395955|NCT04474197|39931230|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
16395956|NCT00613327|39931233|FG000|Overall Study|Adverse Event|38|||
16395957|NCT00613327|39931233|FG000|Overall Study|Lost to Follow-up|8|||
16395958|NCT00613327|39931233|FG000|Overall Study|Withdrawal by Subject|6|||
16395959|NCT00613327|39931233|FG000|Overall Study|Protocol Violation|2|||
16395960|NCT00613327|39931233|FG000|Overall Study|Other|47|||
16521192|NCT03286140|40376392|FG001|Overall Study|Failure to comply|1|||
16395961|NCT04072835|39931236|FG000|Overall Study|Overall trial ended|603|||
16395962|NCT04072835|39931236|FG000|Overall Study|Ablation|97|||
16521193|NCT00274716|40376394|FG000|Phase A|Other non-reported reason|4|||
16521194|NCT00274716|40376395|FG001|Phase A|Other non-reported reason|2|||
16521195|NCT00274716|40376396|FG002|Phase A|Other non-reported reason|1|||
16521196|NCT00274716|40376397|FG003|Phase A|Other non-reported reason|2|||
16521197|NCT00274716|40376398|FG004|Phase A|Other non-reported reason|0|||
16521198|NCT00274716|40376399|FG005|Phase A|Other non-reported reason|1|||
16521199|NCT00274716|40376394|FG000|Phase A|Participant moved|0|||
16521200|NCT00274716|40376395|FG001|Phase A|Participant moved|0|||
16521201|NCT00274716|40376396|FG002|Phase A|Participant moved|1|||
16521202|NCT00274716|40376397|FG003|Phase A|Participant moved|0|||
16521203|NCT00274716|40376398|FG004|Phase A|Participant moved|0|||
16395963|NCT04072835|39931236|FG000|Overall Study|Withdrawal of consent|66|||
16395964|NCT04072835|39931236|FG000|Overall Study|Physician Decision|50|||
16395965|NCT04072835|39931236|FG000|Overall Study|Lost to Follow-up|39|||
16395966|NCT04072835|39931236|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
16395967|NCT04072835|39931236|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
16395968|NCT04072835|39931236|FG000|Overall Study|Adverse Event|25|||
16395969|NCT04072835|39931236|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
16395970|NCT04072835|39931236|FG000|Overall Study|Death|11|||
16395971|NCT04072835|39931236|FG000|Overall Study|Participant felt the drug did not work|8|||
16395972|NCT04072835|39931236|FG000|Overall Study|Participant tolerability|5|||
16395973|NCT04072835|39931236|FG000|Overall Study|Missing|5|||
16395974|NCT04072835|39931236|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
16395975|NCT04072835|39931236|FG000|Overall Study|Pregnancy|3|||
16395976|NCT01104545|39931240|FG000|Overall Study|Adverse Event|0|||
16395977|NCT01104545|39931241|FG001|Overall Study|Adverse Event|1|||
16395978|NCT01104545|39931242|FG002|Overall Study|Adverse Event|2|||
16395979|NCT02253433|39931249|FG000|Overall Study|Unable to Contact|9|||
16395980|NCT02253433|39931250|FG001|Overall Study|Unable to Contact|16|||
16395981|NCT02253433|39931249|FG000|Overall Study|Death|1|||
16395982|NCT02253433|39931250|FG001|Overall Study|Death|1|||
16395983|NCT02253433|39931249|FG000|Overall Study|No Longer Interested|3|||
16395984|NCT02253433|39931250|FG001|Overall Study|No Longer Interested|15|||
16395985|NCT02253433|39931249|FG000|Overall Study|Out of Study Area|2|||
16395986|NCT02253433|39931250|FG001|Overall Study|Out of Study Area|7|||
16395987|NCT02253433|39931249|FG000|Overall Study|Uncomfortable with home visitors|0|||
16395988|NCT02253433|39931250|FG001|Overall Study|Uncomfortable with home visitors|3|||
16395989|NCT02253433|39931249|FG000|Overall Study|Unstable Housing/Homeless|0|||
16395990|NCT02253433|39931250|FG001|Overall Study|Unstable Housing/Homeless|7|||
16395991|NCT02253433|39931249|FG000|Overall Study|Too Busy|0|||
16395992|NCT02253433|39931250|FG001|Overall Study|Too Busy|4|||
16521204|NCT00274716|40376399|FG005|Phase A|Participant moved|1|||
16521205|NCT00274716|40376394|FG000|Phase A|Site Terminated|0|||
16521206|NCT00274716|40376395|FG001|Phase A|Site Terminated|0|||
16521207|NCT00274716|40376396|FG002|Phase A|Site Terminated|0|||
16521208|NCT00274716|40376397|FG003|Phase A|Site Terminated|1|||
16521209|NCT00274716|40376398|FG004|Phase A|Site Terminated|0|||
16521210|NCT00274716|40376399|FG005|Phase A|Site Terminated|0|||
16521211|NCT00274716|40376394|FG000|Phase A|Protocol Violation|1|||
16521212|NCT00274716|40376395|FG001|Phase A|Protocol Violation|0|||
16521213|NCT00274716|40376396|FG002|Phase A|Protocol Violation|0|||
16521214|NCT00274716|40376397|FG003|Phase A|Protocol Violation|1|||
16521215|NCT00274716|40376398|FG004|Phase A|Protocol Violation|0|||
16521216|NCT00274716|40376399|FG005|Phase A|Protocol Violation|0|||
16521217|NCT00274716|40376394|FG000|Phase A|Met criteria for discontinuation|1|||
16521218|NCT00274716|40376395|FG001|Phase A|Met criteria for discontinuation|1|||
16521219|NCT00274716|40376396|FG002|Phase A|Met criteria for discontinuation|0|||
16521220|NCT00274716|40376397|FG003|Phase A|Met criteria for discontinuation|0|||
16521221|NCT00274716|40376398|FG004|Phase A|Met criteria for discontinuation|0|||
16521222|NCT00274716|40376399|FG005|Phase A|Met criteria for discontinuation|0|||
16521223|NCT00274716|40376394|FG000|Phase A|Withdrawal by Subject|2|||
16521224|NCT00274716|40376395|FG001|Phase A|Withdrawal by Subject|2|||
16521225|NCT00274716|40376396|FG002|Phase A|Withdrawal by Subject|1|||
16521226|NCT00274716|40376397|FG003|Phase A|Withdrawal by Subject|3|||
16521227|NCT00274716|40376398|FG004|Phase A|Withdrawal by Subject|0|||
16521228|NCT00274716|40376399|FG005|Phase A|Withdrawal by Subject|1|||
16521229|NCT00274716|40376394|FG000|Phase A|Adverse Event|2|||
16521230|NCT00274716|40376395|FG001|Phase A|Adverse Event|3|||
16521231|NCT00274716|40376396|FG002|Phase A|Adverse Event|3|||
16521232|NCT00274716|40376397|FG003|Phase A|Adverse Event|0|||
16521233|NCT00274716|40376398|FG004|Phase A|Adverse Event|2|||
16521234|NCT00274716|40376399|FG005|Phase A|Adverse Event|0|||
16521235|NCT00274716|40376394|FG000|Phase A|Completed but did not enter Phase B|1|||
16521236|NCT00274716|40376395|FG001|Phase A|Completed but did not enter Phase B|2|||
16521237|NCT00274716|40376396|FG002|Phase A|Completed but did not enter Phase B|2|||
16395993|NCT02253433|39931249|FG000|Overall Study|Medical or Other Concerns|1|||
16521238|NCT00274716|40376397|FG003|Phase A|Completed but did not enter Phase B|2|||
16521239|NCT00274716|40376398|FG004|Phase A|Completed but did not enter Phase B|1|||
16521240|NCT00274716|40376399|FG005|Phase A|Completed but did not enter Phase B|1|||
16521241|NCT00274716|40376394|FG000|Phase B|Adverse Event|0|||
16395994|NCT02253433|39931250|FG001|Overall Study|Medical or Other Concerns|2|||
16395995|NCT02277691|39931253|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
16395996|NCT02277691|39931253|FG000|Overall Study|Voluntary Withdrawal|7|||
16521242|NCT00274716|40376395|FG001|Phase B|Adverse Event|0|||
16521243|NCT00274716|40376396|FG002|Phase B|Adverse Event|2|||
16521244|NCT00274716|40376397|FG003|Phase B|Adverse Event|0|||
16521245|NCT00274716|40376398|FG004|Phase B|Adverse Event|0|||
16521246|NCT00274716|40376399|FG005|Phase B|Adverse Event|1|||
16521247|NCT00274716|40376394|FG000|Phase B|Protocol Violation|0|||
16521248|NCT00274716|40376395|FG001|Phase B|Protocol Violation|2|||
16521249|NCT00274716|40376396|FG002|Phase B|Protocol Violation|0|||
16521250|NCT00274716|40376397|FG003|Phase B|Protocol Violation|0|||
16521251|NCT00274716|40376398|FG004|Phase B|Protocol Violation|0|||
16521252|NCT00274716|40376399|FG005|Phase B|Protocol Violation|0|||
16521253|NCT00274716|40376394|FG000|Phase B|Withdrawal by Subject|0|||
16521254|NCT00274716|40376395|FG001|Phase B|Withdrawal by Subject|1|||
16521255|NCT00274716|40376396|FG002|Phase B|Withdrawal by Subject|0|||
16521256|NCT00274716|40376397|FG003|Phase B|Withdrawal by Subject|0|||
16521257|NCT00274716|40376398|FG004|Phase B|Withdrawal by Subject|0|||
16521258|NCT00274716|40376399|FG005|Phase B|Withdrawal by Subject|0|||
16395997|NCT02277691|39931253|FG000|Overall Study|Lack of Efficacy|5|||
16395998|NCT02277691|39931253|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
16521259|NCT00274716|40376394|FG000|Phase B|Participant moved|1|||
16521260|NCT00274716|40376395|FG001|Phase B|Participant moved|0|||
16521261|NCT00274716|40376396|FG002|Phase B|Participant moved|0|||
16521262|NCT00274716|40376397|FG003|Phase B|Participant moved|0|||
16521263|NCT00274716|40376398|FG004|Phase B|Participant moved|0|||
16521264|NCT00274716|40376399|FG005|Phase B|Participant moved|0|||
16521265|NCT00274716|40376394|FG000|Phase B|Other non-reported reason|0|||
16521266|NCT00274716|40376395|FG001|Phase B|Other non-reported reason|0|||
16521267|NCT00274716|40376396|FG002|Phase B|Other non-reported reason|1|||
16521268|NCT00274716|40376397|FG003|Phase B|Other non-reported reason|1|||
16521269|NCT00274716|40376398|FG004|Phase B|Other non-reported reason|0|||
16521270|NCT00274716|40376399|FG005|Phase B|Other non-reported reason|0|||
16521271|NCT00274716|40376394|FG000|Phase B|Lost to Follow-up|0|||
16395999|NCT00759876|39931254|FG000|Overall Study|Sponsor terminated study early|36|||
16396000|NCT01926444|39931255|FG000|Overall Study|Colonoscopy not performed|0|||
16396001|NCT01926444|39931256|FG001|Overall Study|Colonoscopy not performed|0|||
16521272|NCT00274716|40376395|FG001|Phase B|Lost to Follow-up|1|||
16521273|NCT00274716|40376396|FG002|Phase B|Lost to Follow-up|0|||
16521274|NCT00274716|40376397|FG003|Phase B|Lost to Follow-up|0|||
16521275|NCT00274716|40376398|FG004|Phase B|Lost to Follow-up|0|||
16396002|NCT01926444|39931257|FG002|Overall Study|Colonoscopy not performed|4|||
16396003|NCT01926444|39931258|FG003|Overall Study|Colonoscopy not performed|2|||
16396004|NCT02370368|39931259|FG000|Overall Study|Adverse Event|1|||
16396005|NCT02370368|39931260|FG001|Overall Study|Adverse Event|2|||
16521276|NCT00274716|40376399|FG005|Phase B|Lost to Follow-up|0|||
16521277|NCT04558346|40376400|FG000|Overall Study|Withdrawal by Subject|2|||
16396006|NCT02370368|39931259|FG000|Overall Study|Withdrawal by Subject|5|||
16396007|NCT02370368|39931260|FG001|Overall Study|Withdrawal by Subject|4|||
16396008|NCT02997865|39931261|FG000|Overall Study|Death|2|||
16396009|NCT02997865|39931262|FG001|Overall Study|Death|1|||
16396010|NCT02997865|39931261|FG000|Overall Study|Lost to Follow-up|6|||
16396011|NCT02997865|39931262|FG001|Overall Study|Lost to Follow-up|3|||
16396012|NCT02997865|39931261|FG000|Overall Study|Withdrawal by Subject|5|||
16396013|NCT02997865|39931262|FG001|Overall Study|Withdrawal by Subject|0|||
16396014|NCT01871545|39931263|FG000|Overall Study|Death|2|||
16396015|NCT01871545|39931264|FG001|Overall Study|Death|0|||
16396016|NCT01871545|39931263|FG000|Overall Study|Lack of Efficacy|11|||
16396017|NCT01871545|39931264|FG001|Overall Study|Lack of Efficacy|2|||
16396018|NCT01871545|39931263|FG000|Overall Study|Physician Decision|4|||
16521278|NCT04558346|40376401|FG001|Overall Study|Withdrawal by Subject|0|||
16521279|NCT04558346|40376400|FG000|Overall Study|Lost to Follow-up|0|||
16521280|NCT04558346|40376401|FG001|Overall Study|Lost to Follow-up|1|||
16396019|NCT01871545|39931264|FG001|Overall Study|Physician Decision|0|||
16396020|NCT01871545|39931263|FG000|Overall Study|Withdrawal by Subject|0|||
16521281|NCT04558346|40376400|FG000|Overall Study|Adverse Event|0|||
16521282|NCT04558346|40376401|FG001|Overall Study|Adverse Event|1|||
16207098|NCT01742091|39237109|FG002|Overall Study|Lost to Follow-up|0|||
16396021|NCT01871545|39931264|FG001|Overall Study|Withdrawal by Subject|1|||
16521283|NCT00499889|40376403|FG000|Overall Study|Infection prior to treatment|1|||
16521284|NCT04452344|40376404|FG000|Overall Study|Withdrawal by Subject|3|||
16093585|NCT02143713|38833142|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
16521285|NCT04452344|40376405|FG001|Overall Study|Withdrawal by Subject|6|||
16521286|NCT04452344|40376404|FG000|Overall Study|Adverse Event|1|||
16521287|NCT04452344|40376405|FG001|Overall Study|Adverse Event|2|||
16521288|NCT04452344|40376404|FG000|Overall Study|Lost to Follow-up|2|||
16521289|NCT04452344|40376405|FG001|Overall Study|Lost to Follow-up|2|||
16521290|NCT04452344|40376404|FG000|Overall Study|No Post-Op Visit|6|||
16521291|NCT04452344|40376405|FG001|Overall Study|No Post-Op Visit|7|||
16093586|NCT02143713|38833139|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
16093587|NCT02143713|38833140|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
16093588|NCT02143713|38833141|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
16093589|NCT02143713|38833142|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
16093590|NCT02143713|38833139|FG000|Treatment Period (6 Months)|Pregnancy|0|||
16093591|NCT02143713|38833140|FG001|Treatment Period (6 Months)|Pregnancy|2|||
16093592|NCT02143713|38833141|FG002|Treatment Period (6 Months)|Pregnancy|2|||
16093593|NCT02143713|38833142|FG003|Treatment Period (6 Months)|Pregnancy|0|||
16093594|NCT02143713|38833139|FG000|Treatment Period (6 Months)|Non-compliance|1|||
16093595|NCT02143713|38833140|FG001|Treatment Period (6 Months)|Non-compliance|0|||
16093596|NCT02143713|38833141|FG002|Treatment Period (6 Months)|Non-compliance|0|||
16093597|NCT02143713|38833142|FG003|Treatment Period (6 Months)|Non-compliance|3|||
16093598|NCT02143713|38833139|FG000|Treatment Period (6 Months)|Other|3|||
16093599|NCT02143713|38833140|FG001|Treatment Period (6 Months)|Other|0|||
16093600|NCT02143713|38833141|FG002|Treatment Period (6 Months)|Other|3|||
16093601|NCT02143713|38833142|FG003|Treatment Period (6 Months)|Other|2|||
16093602|NCT02143713|38833139|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
16093603|NCT02143713|38833140|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
16093604|NCT02143713|38833141|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
16093605|NCT02143713|38833142|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
16093606|NCT02143713|38833139|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
16093607|NCT02143713|38833140|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
16521292|NCT00616967|40376406|FG000|Overall Study|Withdrawal by Subject|0|||
16521293|NCT00616967|40376407|FG001|Overall Study|Withdrawal by Subject|0|||
16521294|NCT00616967|40376408|FG002|Overall Study|Withdrawal by Subject|1|||
16521295|NCT02664038|40376409|FG000|13 Week|Lost to Follow-up|7|||
16521296|NCT02664038|40376410|FG001|13 Week|Lost to Follow-up|14|||
16521297|NCT02664038|40376409|FG000|13 Week|Withdrawal by Subject|1|||
16521298|NCT02664038|40376410|FG001|13 Week|Withdrawal by Subject|0|||
16521299|NCT02664038|40376409|FG000|26 Week|Lost to Follow-up|5|||
16521300|NCT02664038|40376410|FG001|26 Week|Lost to Follow-up|4|||
16521301|NCT03251924|40376411|FG000|Overall Study|Disease Progression|6|||
16521302|NCT03251924|40376412|FG001|Overall Study|Disease Progression|6|||
16093608|NCT02143713|38833141|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
16093609|NCT02143713|38833142|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
16093610|NCT02143713|38833139|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
16324513|NCT03499899|39674511|FG001|Overall Study|Physician Decision|6|||
16324514|NCT03499899|39674512|FG002|Overall Study|Physician Decision|6|||
16093611|NCT02143713|38833140|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
16324515|NCT03499899|39674510|FG000|Overall Study|Progressive disease|15|||
16324516|NCT03499899|39674511|FG001|Overall Study|Progressive disease|23|||
16324517|NCT03499899|39674512|FG002|Overall Study|Progressive disease|23|||
16324518|NCT03499899|39674510|FG000|Overall Study|Patient decision|0|||
16324519|NCT03499899|39674511|FG001|Overall Study|Patient decision|1|||
16324520|NCT03499899|39674512|FG002|Overall Study|Patient decision|1|||
16324521|NCT03499899|39674510|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
16324522|NCT03499899|39674511|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
16324523|NCT03499899|39674512|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
16324524|NCT02880865|39674513|FG000|Overall Study|Adverse Event|1|||
16324525|NCT02880865|39674514|FG001|Overall Study|Adverse Event|0|||
16324526|NCT02880865|39674513|FG000|Overall Study|Withdrawal by Subject|0|||
16324527|NCT02880865|39674514|FG001|Overall Study|Withdrawal by Subject|2|||
16324528|NCT02880865|39674513|FG000|Overall Study|Physician Decision|0|||
16324529|NCT02880865|39674514|FG001|Overall Study|Physician Decision|1|||
16324530|NCT01684423|39674515|FG000|Overall Study|Withdrawal by Subject|0|||
16324531|NCT01684423|39674516|FG001|Overall Study|Withdrawal by Subject|0|||
16324532|NCT01684423|39674517|FG002|Overall Study|Withdrawal by Subject|1|||
16324533|NCT01684423|39674518|FG003|Overall Study|Withdrawal by Subject|0|||
16324534|NCT01684423|39674519|FG004|Overall Study|Withdrawal by Subject|0|||
16324535|NCT01322490|39674520|FG000|Treatment Period|Adverse Event|12|||
16521303|NCT03251924|40376413|FG002|Overall Study|Disease Progression|7|||
16521304|NCT03251924|40376414|FG003|Overall Study|Disease Progression|8|||
16521305|NCT03251924|40376415|FG004|Overall Study|Disease Progression|8|||
16521306|NCT03251924|40376416|FG005|Overall Study|Disease Progression|7|||
16093612|NCT02143713|38833141|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
16521307|NCT03251924|40376417|FG006|Overall Study|Disease Progression|6|||
16396022|NCT03629223|39931266|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
16396023|NCT03629223|39931267|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
16396024|NCT03629223|39931268|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
16396025|NCT03629223|39931269|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
16396026|NCT03629223|39931270|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
16396027|NCT03629223|39931271|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
16396028|NCT03629223|39931266|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
16396029|NCT03629223|39931267|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
16396030|NCT03629223|39931268|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
16396031|NCT03629223|39931269|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
16324536|NCT01322490|39674521|FG001|Treatment Period|Adverse Event|18|||
16396032|NCT03629223|39931270|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
16396033|NCT03629223|39931271|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
16396034|NCT03629223|39931266|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
16396035|NCT03629223|39931267|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
16396036|NCT03629223|39931268|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
16396037|NCT03629223|39931269|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
16396038|NCT03629223|39931270|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
16396039|NCT03629223|39931271|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
16396040|NCT03629223|39931266|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
16324537|NCT01322490|39674522|FG002|Treatment Period|Adverse Event|15|||
16324538|NCT01322490|39674520|FG000|Treatment Period|Death|5|||
16324539|NCT01322490|39674521|FG001|Treatment Period|Death|7|||
16324540|NCT01322490|39674522|FG002|Treatment Period|Death|3|||
16324541|NCT01322490|39674520|FG000|Treatment Period|Lack of Efficacy|89|||
16324542|NCT01322490|39674521|FG001|Treatment Period|Lack of Efficacy|100|||
16324543|NCT01322490|39674522|FG002|Treatment Period|Lack of Efficacy|112|||
16324544|NCT01322490|39674520|FG000|Treatment Period|Physician Decision|0|||
16324545|NCT01322490|39674521|FG001|Treatment Period|Physician Decision|2|||
16324546|NCT01322490|39674522|FG002|Treatment Period|Physician Decision|1|||
16396041|NCT03629223|39931267|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
16396042|NCT03629223|39931268|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
16396043|NCT03629223|39931269|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
16396044|NCT03629223|39931270|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
16396045|NCT03629223|39931271|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
16396046|NCT03629223|39931266|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
16396047|NCT03629223|39931267|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
16396048|NCT03629223|39931268|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
16396049|NCT03629223|39931269|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
16396050|NCT03629223|39931270|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
16396051|NCT03629223|39931271|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
16396052|NCT02342288|39931272|FG000|Overall Study|no protocol anesthesiologist available|3|||
16396053|NCT02342288|39931273|FG001|Overall Study|no protocol anesthesiologist available|2|||
16396054|NCT02342288|39931272|FG000|Overall Study|anesthesia leak in system|1|||
16396055|NCT02342288|39931273|FG001|Overall Study|anesthesia leak in system|0|||
16396056|NCT02342288|39931272|FG000|Overall Study|Withdrawal by Subject|1|||
16396057|NCT02342288|39931273|FG001|Overall Study|Withdrawal by Subject|0|||
16396058|NCT02342288|39931272|FG000|Overall Study|coordinator contaminated with blood|0|||
16396059|NCT02342288|39931273|FG001|Overall Study|coordinator contaminated with blood|1|||
16396060|NCT02342288|39931272|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
16396061|NCT02342288|39931273|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
16396062|NCT02342288|39931272|FG000|Overall Study|coordinator not available|0|||
16396063|NCT02342288|39931273|FG001|Overall Study|coordinator not available|2|||
16396064|NCT00500357|39931274|FG000|Overall Study|Death|1|||
16396065|NCT01534351|39931279|FG000|Overall Study|Study Terminated Early|1|||
16396066|NCT01534351|39931280|FG001|Overall Study|Study Terminated Early|0|||
16396067|NCT01534351|39931281|FG002|Overall Study|Study Terminated Early|0|||
16521308|NCT03251924|40376418|FG007|Overall Study|Disease Progression|10|||
16324547|NCT01322490|39674520|FG000|Treatment Period|Protocol Violation|7|||
16324548|NCT01322490|39674521|FG001|Treatment Period|Protocol Violation|5|||
16396068|NCT01804049|39931282|FG000|Overall Study|Adverse Event|2|||
16396069|NCT01804049|39931283|FG001|Overall Study|Adverse Event|10|||
16396070|NCT01804049|39931282|FG000|Overall Study|Lost to Follow-up|2|||
16396071|NCT01804049|39931283|FG001|Overall Study|Lost to Follow-up|1|||
16396072|NCT01804049|39931282|FG000|Overall Study|Decreased interest/personal|4|||
16396073|NCT01804049|39931283|FG001|Overall Study|Decreased interest/personal|5|||
16521309|NCT03251924|40376419|FG008|Overall Study|Disease Progression|6|||
16521310|NCT03251924|40376411|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
16521311|NCT03251924|40376412|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
16521312|NCT03251924|40376413|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
16521313|NCT03251924|40376414|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
16521314|NCT03251924|40376415|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
16093613|NCT02143713|38833142|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
16093614|NCT02143713|38833139|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
16093615|NCT02143713|38833140|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
16093616|NCT02143713|38833141|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
16093617|NCT02143713|38833142|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
16093618|NCT02143713|38833139|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
16093619|NCT02143713|38833140|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
16093620|NCT02143713|38833141|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
16093621|NCT02143713|38833142|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
16093622|NCT02143713|38833139|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
16093623|NCT02143713|38833140|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
16093624|NCT02143713|38833141|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
16093625|NCT02143713|38833142|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
16093626|NCT02143713|38833139|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
16093627|NCT02143713|38833140|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
16093628|NCT02143713|38833141|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
16093629|NCT02143713|38833142|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
16093630|NCT02143713|38833139|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
16093631|NCT02143713|38833140|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
16093632|NCT02143713|38833141|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
16207099|NCT01742091|39237110|FG003|Overall Study|Lost to Follow-up|0|||
16396074|NCT01804049|39931282|FG000|Overall Study|Other health concerns|2|||
16396075|NCT01804049|39931283|FG001|Overall Study|Other health concerns|7|||
16396076|NCT01804049|39931282|FG000|Overall Study|Moved out of area|0|||
16396077|NCT01804049|39931283|FG001|Overall Study|Moved out of area|7|||
16396078|NCT01804049|39931282|FG000|Overall Study|other MD recommended|1|||
16396079|NCT01804049|39931283|FG001|Overall Study|other MD recommended|1|||
16396080|NCT01804049|39931282|FG000|Overall Study|Enrollment in dual studies|0|||
16396081|NCT01804049|39931283|FG001|Overall Study|Enrollment in dual studies|1|||
16396082|NCT00783835|39931284|FG000|Overall Study|Adverse Event|3|||
16396083|NCT00783835|39931284|FG000|Overall Study|Medical Criteria|1|||
16396084|NCT00783835|39931284|FG000|Overall Study|Withdrawal by Subject|2|||
16396085|NCT00783835|39931284|FG000|Overall Study|Lost to Follow-up|1|||
16396086|NCT00783835|39931284|FG000|Overall Study|Participant not Adherent|3|||
16396087|NCT00814580|39931287|FG000|Overall Study|Adverse Event|6|||
16396088|NCT00814580|39931288|FG001|Overall Study|Adverse Event|15|||
16396089|NCT00814580|39931287|FG000|Overall Study|Lack of Efficacy|18|||
16396090|NCT00814580|39931288|FG001|Overall Study|Lack of Efficacy|25|||
16396091|NCT00814580|39931287|FG000|Overall Study|Protocol Violation|2|||
16396092|NCT00814580|39931288|FG001|Overall Study|Protocol Violation|0|||
16396093|NCT00814580|39931287|FG000|Overall Study|Withdrawal by Subject|2|||
16396094|NCT00814580|39931288|FG001|Overall Study|Withdrawal by Subject|2|||
16396095|NCT00814580|39931287|FG000|Overall Study|Other|1|||
16396096|NCT00814580|39931288|FG001|Overall Study|Other|3|||
16396097|NCT00814580|39931287|FG000|Overall Study|Did Not Take Drug|2|||
16396098|NCT00814580|39931288|FG001|Overall Study|Did Not Take Drug|2|||
16396099|NCT05559905|39931291|FG000|Overall Study|Withdrawal by Subject|1|||
16396100|NCT05559905|39931292|FG001|Overall Study|Withdrawal by Subject|0|||
16396101|NCT05559905|39931293|FG002|Overall Study|Withdrawal by Subject|0|||
16396102|NCT05559905|39931291|FG000|Overall Study|Not Reported|1|||
16396103|NCT05559905|39931292|FG001|Overall Study|Not Reported|0|||
16396104|NCT05559905|39931293|FG002|Overall Study|Not Reported|0|||
16396105|NCT01823107|39931294|FG000|Overall Study|Withdrawal by Subject|1|||
16396106|NCT04154293|39931295|FG000|Overall Study|Withdrawal by Subject|2|||
16396107|NCT04154293|39931296|FG001|Overall Study|Withdrawal by Subject|3|||
16396108|NCT04154293|39931297|FG002|Overall Study|Withdrawal by Subject|1|||
16396109|NCT04154293|39931295|FG000|Overall Study|Physician Decision|0|||
16396110|NCT04154293|39931296|FG001|Overall Study|Physician Decision|0|||
16396111|NCT04154293|39931297|FG002|Overall Study|Physician Decision|1|||
16396112|NCT00700882|39931298|FG000|Overall Study|Never received treatment|6|||
16396113|NCT00700882|39931298|FG000|Overall Study|Ineligible|2|||
16396114|NCT00700882|39931298|FG000|Overall Study|No KIT mutation|51|||
16396115|NCT02097719|39931299|FG000|Overall Study|Subject Withdrew Consent|1|||
16521315|NCT03251924|40376416|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
16521316|NCT03251924|40376417|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
16521317|NCT03251924|40376418|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
16521318|NCT03251924|40376419|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
16521319|NCT03251924|40376411|FG000|Overall Study|Death|0|||
16521320|NCT03251924|40376412|FG001|Overall Study|Death|1|||
16521321|NCT03251924|40376413|FG002|Overall Study|Death|0|||
16521322|NCT03251924|40376414|FG003|Overall Study|Death|1|||
16521323|NCT03251924|40376415|FG004|Overall Study|Death|1|||
16521324|NCT03251924|40376416|FG005|Overall Study|Death|1|||
16521325|NCT03251924|40376417|FG006|Overall Study|Death|0|||
16093633|NCT02143713|38833142|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
16093634|NCT02143713|38833139|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
16093635|NCT02143713|38833140|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
16093636|NCT02143713|38833141|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
16093637|NCT02143713|38833142|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
16093638|NCT00603798|38833145|FG000|Overall Study|Adverse Event|4|||
16093639|NCT00603798|38833146|FG001|Overall Study|Adverse Event|2|||
16093640|NCT00603798|38833147|FG002|Overall Study|Adverse Event|1|||
16093641|NCT00603798|38833145|FG000|Overall Study|Withdrawal by Subject|4|||
16093642|NCT00603798|38833146|FG001|Overall Study|Withdrawal by Subject|3|||
16093643|NCT00603798|38833147|FG002|Overall Study|Withdrawal by Subject|4|||
16093644|NCT00603798|38833145|FG000|Overall Study|Lost to Follow-up|1|||
16093645|NCT00603798|38833146|FG001|Overall Study|Lost to Follow-up|0|||
16093646|NCT00603798|38833147|FG002|Overall Study|Lost to Follow-up|1|||
16093647|NCT00603798|38833145|FG000|Overall Study|Non-compliance with study procedures|0|||
16093648|NCT00603798|38833146|FG001|Overall Study|Non-compliance with study procedures|1|||
16093649|NCT00603798|38833147|FG002|Overall Study|Non-compliance with study procedures|0|||
16093650|NCT00603798|38833145|FG000|Overall Study|Not due to AE|1|||
16093651|NCT00603798|38833146|FG001|Overall Study|Not due to AE|1|||
16093652|NCT00603798|38833147|FG002|Overall Study|Not due to AE|4|||
16093653|NCT00267865|38833150|FG000|Induction Treatment|Died before completing.|2|||
16093654|NCT00267865|38833150|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
16093655|NCT04425252|38833151|FG000|Overall Study|Withdrawal by Subject|2|||
16093656|NCT04425252|38833152|FG001|Overall Study|Withdrawal by Subject|1|||
16093657|NCT04425252|38833151|FG000|Overall Study|Lost to Follow-up|1|||
16093658|NCT04425252|38833152|FG001|Overall Study|Lost to Follow-up|0|||
16093659|NCT04425252|38833151|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
16093660|NCT04425252|38833152|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
16093661|NCT03150589|38833153|FG000|Overall Study|Withdrawal by Subject|16|||
16093662|NCT03150589|38833154|FG001|Overall Study|Withdrawal by Subject|9|||
16093663|NCT03150589|38833153|FG000|Overall Study|Adverse Event|7|||
16093664|NCT03150589|38833154|FG001|Overall Study|Adverse Event|6|||
16093665|NCT03150589|38833153|FG000|Overall Study|Protocol Violation|4|||
16093666|NCT03150589|38833154|FG001|Overall Study|Protocol Violation|3|||
16093667|NCT03150589|38833153|FG000|Overall Study|Lost to Follow-up|3|||
16093668|NCT03150589|38833154|FG001|Overall Study|Lost to Follow-up|3|||
16093669|NCT03150589|38833153|FG000|Overall Study|Death|2|||
16093670|NCT03150589|38833154|FG001|Overall Study|Death|3|||
16093671|NCT03150589|38833153|FG000|Overall Study|IP non-compliance and other reasons|12|||
16093672|NCT03150589|38833154|FG001|Overall Study|IP non-compliance and other reasons|3|||
16093673|NCT02713594|38833157|FG000|Overall Study|Withdrawal by Subject|32|||
16093674|NCT02713594|38833158|FG001|Overall Study|Withdrawal by Subject|22|||
16093675|NCT02713594|38833157|FG000|Overall Study|Lost to Follow-up|358|||
16093676|NCT02713594|38833158|FG001|Overall Study|Lost to Follow-up|374|||
16093677|NCT03602053|38833160|FG000|Overall Study|Withdrawal by Subject|7|||
16093678|NCT03602053|38833161|FG001|Overall Study|Withdrawal by Subject|9|||
16093679|NCT03602053|38833162|FG002|Overall Study|Withdrawal by Subject|7|||
16093680|NCT03602053|38833160|FG000|Overall Study|Lost to Follow-up|5|||
16093681|NCT03602053|38833161|FG001|Overall Study|Lost to Follow-up|6|||
16093682|NCT03602053|38833162|FG002|Overall Study|Lost to Follow-up|0|||
16093683|NCT03602053|38833160|FG000|Overall Study|Protocol Violation|3|||
16093684|NCT03602053|38833161|FG001|Overall Study|Protocol Violation|0|||
16093685|NCT03602053|38833162|FG002|Overall Study|Protocol Violation|4|||
16093686|NCT03602053|38833160|FG000|Overall Study|Physician Decision|1|||
16093687|NCT03602053|38833161|FG001|Overall Study|Physician Decision|0|||
16093688|NCT03602053|38833162|FG002|Overall Study|Physician Decision|0|||
16093689|NCT03602053|38833160|FG000|Overall Study|migration|2|||
16093690|NCT03602053|38833161|FG001|Overall Study|migration|3|||
16093691|NCT03602053|38833162|FG002|Overall Study|migration|0|||
16093692|NCT03602053|38833160|FG000|Overall Study|Other|1|||
16093693|NCT03602053|38833161|FG001|Overall Study|Other|0|||
16093694|NCT03602053|38833162|FG002|Overall Study|Other|0|||
16093695|NCT01668355|38833163|FG000|Overall Study|Death|3|||
16093696|NCT01668355|38833164|FG001|Overall Study|Death|1|||
16093697|NCT01668355|38833163|FG000|Overall Study|Withdrawal by Subject|6|||
16207100|NCT01742091|39237111|FG004|Overall Study|Lost to Follow-up|0|||
16093698|NCT01668355|38833164|FG001|Overall Study|Withdrawal by Subject|1|||
16093699|NCT04766996|38833168|FG000|Overall Study|Withdrawal by Subject|1|||
16093700|NCT04766996|38833169|FG001|Overall Study|Withdrawal by Subject|0|||
16093701|NCT04766996|38833170|FG002|Overall Study|Withdrawal by Subject|13|||
16093702|NCT01000649|38833171|FG000|Overall Study|Adverse Event|5|||
16093703|NCT01000649|38833172|FG001|Overall Study|Adverse Event|1|||
16093704|NCT01000649|38833173|FG002|Overall Study|Adverse Event|2|||
16093705|NCT01000649|38833174|FG003|Overall Study|Adverse Event|4|||
16093706|NCT01000649|38833171|FG000|Overall Study|Lost to Follow-up|0|||
16093707|NCT01000649|38833172|FG001|Overall Study|Lost to Follow-up|2|||
16093708|NCT01000649|38833173|FG002|Overall Study|Lost to Follow-up|0|||
16093709|NCT01000649|38833174|FG003|Overall Study|Lost to Follow-up|2|||
16093710|NCT00749944|38833175|FG000|Overall Study|Lost to Follow-up|2|||
16093711|NCT00749944|38833176|FG001|Overall Study|Lost to Follow-up|1|||
16093712|NCT00749944|38833175|FG000|Overall Study|Other|1|||
16093713|NCT00749944|38833176|FG001|Overall Study|Other|0|||
16093714|NCT00749944|38833175|FG000|Overall Study|Withdrawal by Subject|2|||
16093715|NCT00749944|38833176|FG001|Overall Study|Withdrawal by Subject|0|||
16093716|NCT01970527|38833177|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
16093717|NCT01970527|38833178|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
16093718|NCT01970527|38833177|FG000|Treatment|Disease progression|0|||
16093719|NCT01970527|38833178|FG001|Treatment|Disease progression|1|||
16093720|NCT01970527|38833177|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
16093721|NCT01970527|38833178|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
16093722|NCT01970527|38833177|FG000|Treatment|Death|0|||
16093723|NCT01970527|38833178|FG001|Treatment|Death|1|||
16093724|NCT01970527|38833177|FG000|Follow-up Clinic Visit|Disease progression|1|||
16093725|NCT01970527|38833178|FG001|Follow-up Clinic Visit|Disease progression|1|||
16093726|NCT01970527|38833177|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
16093727|NCT01970527|38833178|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
16093728|NCT01970527|38833177|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
16093729|NCT01970527|38833178|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
16093730|NCT02753075|38833179|FG000|Overall Study|Adverse Event|2|||
16093731|NCT02753075|38833180|FG001|Overall Study|Adverse Event|1|||
16093732|NCT02753075|38833181|FG002|Overall Study|Adverse Event|0|||
16093733|NCT02753075|38833179|FG000|Overall Study|Lost to Follow-up|2|||
16093734|NCT02753075|38833180|FG001|Overall Study|Lost to Follow-up|0|||
16093735|NCT02753075|38833181|FG002|Overall Study|Lost to Follow-up|0|||
16093736|NCT02753075|38833179|FG000|Overall Study|Withdrawal of Consent|1|||
16093737|NCT02753075|38833180|FG001|Overall Study|Withdrawal of Consent|1|||
16093738|NCT02753075|38833181|FG002|Overall Study|Withdrawal of Consent|3|||
16093739|NCT02753075|38833179|FG000|Overall Study|Physician Decision|3|||
16093740|NCT02753075|38833180|FG001|Overall Study|Physician Decision|1|||
16093741|NCT02753075|38833181|FG002|Overall Study|Physician Decision|0|||
16093742|NCT02058992|38833184|FG000|Overall Study|Lost to Follow-up|4|||
16093743|NCT02058992|38833184|FG000|Overall Study|Protocol Violation|92|||
16093744|NCT02058992|38833184|FG000|Overall Study|CRF Uncollected|20|||
16093745|NCT00355784|38833185|FG000|Overall Study|Withdrawal by Subject|0|||
16093746|NCT00355784|38833186|FG001|Overall Study|Withdrawal by Subject|0|||
16093747|NCT00355784|38833187|FG002|Overall Study|Withdrawal by Subject|2|||
16093748|NCT00636168|38833188|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
16093749|NCT00636168|38833189|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
16093750|NCT00636168|38833188|FG000|Randomized to Study Drug|Adverse Event|1|||
16093751|NCT00636168|38833189|FG001|Randomized to Study Drug|Adverse Event|0|||
16093752|NCT00636168|38833188|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
16093753|NCT00636168|38833189|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
16093754|NCT00636168|38833188|FG000|Treated With Study Drug|Recurrence of disease|135|||
16093755|NCT00636168|38833189|FG001|Treated With Study Drug|Recurrence of disease|282|||
16521326|NCT03251924|40376418|FG007|Overall Study|Death|0|||
16521327|NCT03251924|40376419|FG008|Overall Study|Death|0|||
16521328|NCT03251924|40376411|FG000|Overall Study|Study Drug Toxicity|0|||
16521329|NCT03251924|40376412|FG001|Overall Study|Study Drug Toxicity|0|||
16521330|NCT03251924|40376413|FG002|Overall Study|Study Drug Toxicity|0|||
16521331|NCT03251924|40376414|FG003|Overall Study|Study Drug Toxicity|1|||
16521332|NCT03251924|40376415|FG004|Overall Study|Study Drug Toxicity|0|||
16521333|NCT03251924|40376416|FG005|Overall Study|Study Drug Toxicity|0|||
16521334|NCT03251924|40376417|FG006|Overall Study|Study Drug Toxicity|0|||
16521335|NCT03251924|40376418|FG007|Overall Study|Study Drug Toxicity|0|||
16521336|NCT03251924|40376419|FG008|Overall Study|Study Drug Toxicity|1|||
16521337|NCT03251924|40376411|FG000|Overall Study|Other Reasons|0|||
16521338|NCT03251924|40376412|FG001|Overall Study|Other Reasons|0|||
16521339|NCT03251924|40376413|FG002|Overall Study|Other Reasons|0|||
16521340|NCT03251924|40376414|FG003|Overall Study|Other Reasons|0|||
16521341|NCT03251924|40376415|FG004|Overall Study|Other Reasons|0|||
16521342|NCT03251924|40376416|FG005|Overall Study|Other Reasons|0|||
16093756|NCT00636168|38833188|FG000|Treated With Study Drug|Adverse Event|250|||
16093757|NCT00636168|38833189|FG001|Treated With Study Drug|Adverse Event|22|||
16093758|NCT00636168|38833188|FG000|Treated With Study Drug|Participant withdrew consent|16|||
16093759|NCT00636168|38833189|FG001|Treated With Study Drug|Participant withdrew consent|21|||
16093760|NCT00636168|38833188|FG000|Treated With Study Drug|Poor/non-compliance|1|||
16093761|NCT00636168|38833189|FG001|Treated With Study Drug|Poor/non-compliance|3|||
16093762|NCT00636168|38833188|FG000|Treated With Study Drug|Death|3|||
16093763|NCT00636168|38833189|FG001|Treated With Study Drug|Death|0|||
16093764|NCT00636168|38833188|FG000|Treated With Study Drug|Pregnancy|1|||
16093765|NCT00636168|38833189|FG001|Treated With Study Drug|Pregnancy|0|||
16521343|NCT03251924|40376417|FG006|Overall Study|Other Reasons|0|||
16521344|NCT03251924|40376418|FG007|Overall Study|Other Reasons|0|||
16521345|NCT03251924|40376419|FG008|Overall Study|Other Reasons|1|||
16521346|NCT03251924|40376411|FG000|Overall Study|Participant request to discontinue study treatment|0|||
16521347|NCT03251924|40376412|FG001|Overall Study|Participant request to discontinue study treatment|0|||
16521348|NCT03251924|40376413|FG002|Overall Study|Participant request to discontinue study treatment|0|||
16521349|NCT03251924|40376414|FG003|Overall Study|Participant request to discontinue study treatment|0|||
16521350|NCT03251924|40376415|FG004|Overall Study|Participant request to discontinue study treatment|0|||
16521351|NCT03251924|40376416|FG005|Overall Study|Participant request to discontinue study treatment|0|||
16521352|NCT03251924|40376417|FG006|Overall Study|Participant request to discontinue study treatment|0|||
16521353|NCT03251924|40376418|FG007|Overall Study|Participant request to discontinue study treatment|1|||
16521354|NCT03251924|40376419|FG008|Overall Study|Participant request to discontinue study treatment|0|||
16521355|NCT00403546|40376420|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
16521356|NCT00403546|40376421|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
16521357|NCT00403546|40376422|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
16521358|NCT00403546|40376420|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
16521359|NCT00403546|40376421|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
16521360|NCT00403546|40376422|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
16521361|NCT00403546|40376420|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
16521362|NCT00403546|40376421|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
16093766|NCT00636168|38833188|FG000|Treated With Study Drug|No longer meets study criteria|1|||
16093767|NCT00636168|38833189|FG001|Treated With Study Drug|No longer meets study criteria|0|||
16093768|NCT00636168|38833188|FG000|Treated With Study Drug|Other reason|1|||
16093769|NCT00636168|38833189|FG001|Treated With Study Drug|Other reason|3|||
16093770|NCT00636168|38833188|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
16093771|NCT00636168|38833189|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
16093772|NCT00636168|38833188|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
16093773|NCT00636168|38833189|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
16093774|NCT00636168|38833188|FG000|Long Term Follow-Up|Death|8|||
16093775|NCT00636168|38833189|FG001|Long Term Follow-Up|Death|9|||
16093776|NCT00663923|38833190|FG000|Overall Study|Lost to Follow-up|2|||
16093777|NCT01328756|38833191|FG000|Overall Study|Protocol Violation|4|||
16093778|NCT01328756|38833191|FG000|Overall Study|Adverse Event|39|||
16093779|NCT01328756|38833191|FG000|Overall Study|Lack of Efficacy|5|||
16093780|NCT01328756|38833191|FG000|Overall Study|Withdrawal by Subject|41|||
16093781|NCT01328756|38833191|FG000|Overall Study|Lost to Follow-up|5|||
16093782|NCT01328756|38833191|FG000|Overall Study|Other|29|||
16093783|NCT01279447|38833192|FG000|Overall Study|Lost to Follow-up|3|||
16093784|NCT01279447|38833193|FG001|Overall Study|Lost to Follow-up|1|||
16324549|NCT01322490|39674522|FG002|Treatment Period|Protocol Violation|4|||
16324550|NCT01322490|39674520|FG000|Treatment Period|Withdrawal by Subject|14|||
16324551|NCT01322490|39674521|FG001|Treatment Period|Withdrawal by Subject|16|||
16324552|NCT01322490|39674522|FG002|Treatment Period|Withdrawal by Subject|11|||
16324553|NCT01322490|39674520|FG000|Treatment Period|Non-compliance with study drug|0|||
16324554|NCT01322490|39674521|FG001|Treatment Period|Non-compliance with study drug|0|||
16324555|NCT01322490|39674522|FG002|Treatment Period|Non-compliance with study drug|1|||
16521363|NCT00403546|40376422|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
16521364|NCT00403546|40376420|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
16521365|NCT00403546|40376421|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
16521366|NCT00403546|40376422|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
16521367|NCT00403546|40376420|FG000|Screening Phase|Screening Failure|22|||
16521368|NCT00403546|40376421|FG001|Screening Phase|Screening Failure|0|||
16521369|NCT00403546|40376422|FG002|Screening Phase|Screening Failure|0|||
16521370|NCT00403546|40376420|FG000|Screening Phase|Adverse Event|1|||
16521371|NCT00403546|40376421|FG001|Screening Phase|Adverse Event|0|||
16521372|NCT00403546|40376422|FG002|Screening Phase|Adverse Event|0|||
16521373|NCT00403546|40376420|FG000|Screening Phase|Terminated Prior to Randomization|5|||
16521374|NCT00403546|40376421|FG001|Screening Phase|Terminated Prior to Randomization|0|||
16521375|NCT00403546|40376422|FG002|Screening Phase|Terminated Prior to Randomization|0|||
16521376|NCT00403546|40376420|FG000|Randomized Trial|Early Terminations|0|||
16521377|NCT00403546|40376421|FG001|Randomized Trial|Early Terminations|17|||
16521378|NCT00403546|40376422|FG002|Randomized Trial|Early Terminations|16|||
16521379|NCT02886572|40376425|FG000|Overall Study|Death|8|||
16521380|NCT00941733|40376426|FG000|Overall Study|Death|24|||
16521381|NCT00941733|40376427|FG001|Overall Study|Death|10|||
16521382|NCT00941733|40376426|FG000|Overall Study|Withdrawal by Subject|14|||
16324556|NCT01322490|39674520|FG000|Treatment Period|Other per report|2|||
16324557|NCT01322490|39674521|FG001|Treatment Period|Other per report|2|||
16324558|NCT01322490|39674522|FG002|Treatment Period|Other per report|1|||
16324559|NCT01322490|39674520|FG000|Treatment Period|Randomized but Not Treated|3|||
16521383|NCT00941733|40376427|FG001|Overall Study|Withdrawal by Subject|6|||
16093785|NCT04633200|38833194|FG000|Overall Study|Lost to Follow-up|3|||
16093786|NCT04633200|38833195|FG001|Overall Study|Lost to Follow-up|5|||
16093787|NCT02144285|38833197|FG000|Overall Study|Withdrawal by Subject|0|||
16093788|NCT02144285|38833198|FG001|Overall Study|Withdrawal by Subject|0|||
16324560|NCT01322490|39674521|FG001|Treatment Period|Randomized but Not Treated|3|||
16324561|NCT01322490|39674522|FG002|Treatment Period|Randomized but Not Treated|5|||
16324562|NCT01322490|39674520|FG000|Long Term Follow-up Period|Death|235|||
16324563|NCT01322490|39674521|FG001|Long Term Follow-up Period|Death|239|||
16324564|NCT01322490|39674522|FG002|Long Term Follow-up Period|Death|236|||
16324565|NCT01322490|39674520|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
16324566|NCT01322490|39674521|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
16324567|NCT01322490|39674522|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
16324568|NCT01322490|39674520|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
16396116|NCT02097719|39931300|FG001|Overall Study|Subject Withdrew Consent|0|||
16396117|NCT02097719|39931299|FG000|Overall Study|Lost to Follow-up|0|||
16396118|NCT02097719|39931300|FG001|Overall Study|Lost to Follow-up|1|||
16396119|NCT02097719|39931299|FG000|Overall Study|Adverse Event|2|||
16396120|NCT02097719|39931300|FG001|Overall Study|Adverse Event|0|||
16396121|NCT03107052|39931302|FG000|Overall Study|Adverse Event|6|||
16396122|NCT03107052|39931303|FG001|Overall Study|Adverse Event|1|||
16396123|NCT03107052|39931304|FG002|Overall Study|Adverse Event|2|||
16396124|NCT03107052|39931302|FG000|Overall Study|Withdrawal by Subject|9|||
16396125|NCT03107052|39931303|FG001|Overall Study|Withdrawal by Subject|5|||
16396126|NCT03107052|39931304|FG002|Overall Study|Withdrawal by Subject|8|||
16396127|NCT03107052|39931302|FG000|Overall Study|Protocol Violation|6|||
16521384|NCT00941733|40376426|FG000|Overall Study|Adverse Event|20|||
16521385|NCT00941733|40376427|FG001|Overall Study|Adverse Event|4|||
16396128|NCT03107052|39931303|FG001|Overall Study|Protocol Violation|0|||
16396129|NCT03107052|39931304|FG002|Overall Study|Protocol Violation|3|||
16396130|NCT03107052|39931302|FG000|Overall Study|Lost to Follow-up|4|||
16396131|NCT03107052|39931303|FG001|Overall Study|Lost to Follow-up|0|||
16396132|NCT03107052|39931304|FG002|Overall Study|Lost to Follow-up|1|||
16396133|NCT03107052|39931302|FG000|Overall Study|Lack of Efficacy|23|||
16396134|NCT03107052|39931303|FG001|Overall Study|Lack of Efficacy|7|||
16396135|NCT03107052|39931304|FG002|Overall Study|Lack of Efficacy|4|||
16396136|NCT03107052|39931302|FG000|Overall Study|Other than specified|4|||
16396137|NCT03107052|39931303|FG001|Overall Study|Other than specified|2|||
16396138|NCT03107052|39931304|FG002|Overall Study|Other than specified|0|||
16396139|NCT03107052|39931302|FG000|Overall Study|Study terminated due to futility|67|||
16396140|NCT03107052|39931303|FG001|Overall Study|Study terminated due to futility|31|||
16396141|NCT03107052|39931304|FG002|Overall Study|Study terminated due to futility|23|||
16396142|NCT00935493|39931305|FG000|Overall Study|Lost to Follow-up|1|||
16396143|NCT00935493|39931306|FG001|Overall Study|Lost to Follow-up|1|||
16396144|NCT00935493|39931307|FG002|Overall Study|Lost to Follow-up|1|||
16396145|NCT00935493|39931305|FG000|Overall Study|Treatment Discontinued|0|||
16396146|NCT00935493|39931306|FG001|Overall Study|Treatment Discontinued|1|||
16396147|NCT00935493|39931307|FG002|Overall Study|Treatment Discontinued|0|||
16396148|NCT00255723|39931308|FG000|Overall Study|Adverse Event|1|||
16521386|NCT00941733|40376426|FG000|Overall Study|Lost to Follow-up|1|||
16521387|NCT00941733|40376427|FG001|Overall Study|Lost to Follow-up|2|||
16521388|NCT00941733|40376426|FG000|Overall Study|Protocol Violation|15|||
16521389|NCT00941733|40376427|FG001|Overall Study|Protocol Violation|6|||
16521390|NCT01243944|40376428|FG000|Overall Study|Adverse Event|15|||
16521391|NCT01243944|40376429|FG001|Overall Study|Adverse Event|13|||
16521392|NCT01243944|40376428|FG000|Overall Study|Lost to Follow-up|2|||
16521393|NCT01243944|40376429|FG001|Overall Study|Lost to Follow-up|1|||
16521394|NCT01243944|40376428|FG000|Overall Study|Physician Decision|2|||
16521395|NCT01243944|40376429|FG001|Overall Study|Physician Decision|7|||
16521396|NCT01243944|40376428|FG000|Overall Study|Disease progression|12|||
16521397|NCT01243944|40376429|FG001|Overall Study|Disease progression|11|||
16521398|NCT01243944|40376428|FG000|Overall Study|Protocol deviation|1|||
16521399|NCT01243944|40376429|FG001|Overall Study|Protocol deviation|1|||
16521400|NCT01243944|40376428|FG000|Overall Study|Participant decision|10|||
16521401|NCT01243944|40376429|FG001|Overall Study|Participant decision|15|||
16521402|NCT01243944|40376428|FG000|Overall Study|Death|2|||
16521403|NCT01243944|40376429|FG001|Overall Study|Death|3|||
16521404|NCT01243944|40376428|FG000|Overall Study|Non-compliance with study treatment|1|||
16521405|NCT01243944|40376429|FG001|Overall Study|Non-compliance with study treatment|0|||
16521406|NCT02992899|40376433|FG000|Overall Study|Withdrawal by Subject|1|||
16396149|NCT00255723|39931309|FG001|Overall Study|Adverse Event|1|||
16396150|NCT00255723|39931308|FG000|Overall Study|Death|0|||
16396151|NCT00255723|39931309|FG001|Overall Study|Death|1|||
16396152|NCT00255723|39931308|FG000|Overall Study|Response Data Not Available|1|||
16521407|NCT02992899|40376434|FG001|Overall Study|Withdrawal by Subject|0|||
16521408|NCT02992899|40376433|FG000|Overall Study|Lost to Follow-up|1|||
16521409|NCT02992899|40376434|FG001|Overall Study|Lost to Follow-up|3|||
16324569|NCT01322490|39674521|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
16396153|NCT00255723|39931309|FG001|Overall Study|Response Data Not Available|0|||
16396154|NCT00289289|39931310|FG000|Overall Study|Withdrawal by Subject|5|||
16396155|NCT00289289|39931311|FG001|Overall Study|Withdrawal by Subject|3|||
16521410|NCT00533949|40376435|FG000|Overall Study|Protocol Violation|12|||
16324570|NCT01322490|39674522|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
16324571|NCT01322490|39674520|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
16324572|NCT01322490|39674521|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
16324573|NCT01322490|39674522|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
16324574|NCT01322490|39674520|FG000|Long Term Follow-up Period|Other per report|3|||
16324575|NCT01322490|39674521|FG001|Long Term Follow-up Period|Other per report|2|||
16521411|NCT00533949|40376436|FG001|Overall Study|Protocol Violation|12|||
16521412|NCT00533949|40376437|FG002|Overall Study|Protocol Violation|9|||
16521413|NCT00533949|40376438|FG003|Overall Study|Protocol Violation|9|||
16521414|NCT00533949|40376435|FG000|Overall Study|Withdrawal by Subject|3|||
16521415|NCT00533949|40376436|FG001|Overall Study|Withdrawal by Subject|2|||
16521416|NCT00533949|40376437|FG002|Overall Study|Withdrawal by Subject|1|||
16521417|NCT00533949|40376438|FG003|Overall Study|Withdrawal by Subject|1|||
16521418|NCT00281840|40376439|FG000|Overall Study|Adverse Event|12|||
16521419|NCT00281840|40376439|FG000|Overall Study|Physician Decision|6|||
16521420|NCT00281840|40376439|FG000|Overall Study|Withdrawal by Subject|3|||
16521421|NCT00281840|40376439|FG000|Overall Study|Disease Progression|2|||
16521422|NCT00281840|40376439|FG000|Overall Study|exceed maximum delay in treatment|1|||
16521423|NCT00281840|40376439|FG000|Overall Study|Complicating Disease|1|||
16521424|NCT01909453|40376440|FG000|Overall Study|Ongoing|118|||
16521425|NCT01909453|40376441|FG001|Overall Study|Ongoing|103|||
16521426|NCT01909453|40376442|FG002|Overall Study|Ongoing|83|||
16521427|NCT01909453|40376443|FG003|Overall Study|Ongoing|164|||
16521428|NCT01909453|40376444|FG004|Overall Study|Ongoing|50|||
16521429|NCT01909453|40376440|FG000|Overall Study|Death|69|||
16521430|NCT01909453|40376441|FG001|Overall Study|Death|74|||
16521431|NCT01909453|40376442|FG002|Overall Study|Death|88|||
16521432|NCT01909453|40376443|FG003|Overall Study|Death|86|||
16521433|NCT01909453|40376444|FG004|Overall Study|Death|29|||
16521434|NCT01909453|40376440|FG000|Overall Study|Lost to Follow-up|3|||
16521435|NCT01909453|40376441|FG001|Overall Study|Lost to Follow-up|4|||
16521436|NCT01909453|40376442|FG002|Overall Study|Lost to Follow-up|4|||
16324576|NCT01322490|39674522|FG002|Long Term Follow-up Period|Other per report|2|||
16521437|NCT01909453|40376443|FG003|Overall Study|Lost to Follow-up|3|||
16521438|NCT01909453|40376444|FG004|Overall Study|Lost to Follow-up|3|||
16521439|NCT01909453|40376440|FG000|Overall Study|Withdrawal by Subject|2|||
16521440|NCT01909453|40376441|FG001|Overall Study|Withdrawal by Subject|13|||
16521441|NCT01909453|40376442|FG002|Overall Study|Withdrawal by Subject|16|||
16521442|NCT01909453|40376443|FG003|Overall Study|Withdrawal by Subject|5|||
16521443|NCT01909453|40376444|FG004|Overall Study|Withdrawal by Subject|4|||
16521444|NCT00439140|40376445|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
16521445|NCT00439140|40376446|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
16521446|NCT00439140|40376447|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
16521447|NCT00439140|40376445|FG000|Treatment Cycle 1|Personal reasons|0|||
16521448|NCT00439140|40376446|FG001|Treatment Cycle 1|Personal reasons|2|||
16521449|NCT00439140|40376447|FG002|Treatment Cycle 1|Personal reasons|0|||
16521450|NCT00439140|40376445|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
16521451|NCT00439140|40376446|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
16521452|NCT00439140|40376447|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
16521453|NCT00439140|40376445|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
16521454|NCT00439140|40376446|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
16521455|NCT00439140|40376447|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
16521456|NCT00439140|40376445|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
16521457|NCT00439140|40376446|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
16521458|NCT00439140|40376447|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
16521459|NCT01723904|40376449|FG000|Overall Study|Noncompliant|3|||
16521460|NCT01723904|40376449|FG000|Overall Study|Adverse Event|5|||
16521461|NCT01723904|40376449|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
16521462|NCT02370888|40376452|FG000|Overall Study|disease progression|2|||
16521463|NCT02370888|40376452|FG000|Overall Study|did not meet chimerism criteria|6|||
16521464|NCT02564471|40376457|FG000|Overall Study|Adverse Event|1|||
16521465|NCT02564471|40376458|FG001|Overall Study|Adverse Event|0|||
16521466|NCT02564471|40376459|FG002|Overall Study|Adverse Event|0|||
16521467|NCT02564471|40376460|FG003|Overall Study|Adverse Event|0|||
16521468|NCT02564471|40376457|FG000|Overall Study|Withdrawal by Subject|2|||
16521469|NCT02564471|40376458|FG001|Overall Study|Withdrawal by Subject|1|||
16324577|NCT01322490|39674520|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
16521470|NCT02564471|40376459|FG002|Overall Study|Withdrawal by Subject|3|||
16521471|NCT02564471|40376460|FG003|Overall Study|Withdrawal by Subject|0|||
16324578|NCT01322490|39674521|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
16521472|NCT02564471|40376457|FG000|Overall Study|Lost to Follow-up|0|||
16521473|NCT02564471|40376458|FG001|Overall Study|Lost to Follow-up|2|||
16521474|NCT02564471|40376459|FG002|Overall Study|Lost to Follow-up|0|||
16521475|NCT02564471|40376460|FG003|Overall Study|Lost to Follow-up|0|||
16521476|NCT01573624|40376463|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
16521477|NCT01573624|40376464|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
16521478|NCT01573624|40376465|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
16324579|NCT01322490|39674522|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
16324580|NCT01154088|39674523|FG000|Overall Study|Lost to Follow-up|4|||
16324581|NCT01154088|39674524|FG001|Overall Study|Lost to Follow-up|6|||
16324582|NCT01154088|39674525|FG002|Overall Study|Lost to Follow-up|7|||
16207101|NCT01742091|39237112|FG005|Overall Study|Lost to Follow-up|1|||
16324583|NCT02016105|39674528|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
16324584|NCT02016105|39674529|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
16324585|NCT02016105|39674530|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
16324586|NCT02016105|39674531|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
16324587|NCT02016105|39674532|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
16324588|NCT02016105|39674533|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
16324589|NCT02016105|39674528|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
16324590|NCT02016105|39674529|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
16324591|NCT02016105|39674530|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
16324592|NCT02016105|39674531|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
16324593|NCT02016105|39674532|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
16324594|NCT02016105|39674533|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
16324595|NCT02016105|39674528|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
16324596|NCT02016105|39674529|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
16324597|NCT02016105|39674530|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
16324598|NCT02016105|39674531|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
16324599|NCT02016105|39674532|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
16324600|NCT02016105|39674533|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
16324601|NCT02016105|39674528|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
16324602|NCT02016105|39674529|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
16324603|NCT02016105|39674530|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
16324604|NCT02016105|39674531|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
16324605|NCT02016105|39674532|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
16324606|NCT02016105|39674533|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
16324607|NCT02016105|39674528|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
16324608|NCT02016105|39674529|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
16324609|NCT02016105|39674530|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
16324610|NCT02016105|39674531|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
16324611|NCT02016105|39674532|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
16324612|NCT02016105|39674533|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
16324613|NCT02016105|39674528|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
16324614|NCT02016105|39674529|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
16324615|NCT02016105|39674530|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
16324616|NCT02016105|39674531|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
16324617|NCT02016105|39674532|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
16324618|NCT02016105|39674533|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
16324619|NCT02016105|39674528|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
16324620|NCT02016105|39674529|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
16324621|NCT02016105|39674530|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
16324622|NCT02016105|39674531|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
16324623|NCT02016105|39674532|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
16324624|NCT02016105|39674533|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
16324625|NCT02016105|39674528|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
16324626|NCT02016105|39674529|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
16324627|NCT02016105|39674530|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
16324628|NCT02016105|39674531|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
16324629|NCT02016105|39674532|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
16324630|NCT02016105|39674533|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
16324631|NCT02016105|39674528|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
16324632|NCT02016105|39674529|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
16324633|NCT02016105|39674530|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
16324634|NCT02016105|39674531|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
16324635|NCT02016105|39674532|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
16324636|NCT02016105|39674533|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
16324637|NCT02016105|39674528|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
16324638|NCT02016105|39674529|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
16324639|NCT02016105|39674530|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
16324640|NCT02016105|39674531|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
16324641|NCT02016105|39674532|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
16324642|NCT02016105|39674533|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
16324643|NCT02016105|39674528|FG000|TREATMENT PERIOD 2|Death|0|||
16324644|NCT02016105|39674529|FG001|TREATMENT PERIOD 2|Death|0|||
16324645|NCT02016105|39674530|FG002|TREATMENT PERIOD 2|Death|0|||
16324646|NCT02016105|39674531|FG003|TREATMENT PERIOD 2|Death|0|||
16324647|NCT02016105|39674532|FG004|TREATMENT PERIOD 2|Death|0|||
16324648|NCT02016105|39674533|FG005|TREATMENT PERIOD 2|Death|1|||
16324649|NCT02016105|39674528|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
16324650|NCT02016105|39674529|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
16324651|NCT02016105|39674530|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
16521479|NCT01573624|40376466|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
16521480|NCT01573624|40376467|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
16521481|NCT01573624|40376468|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
16521482|NCT01573624|40376469|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
16521483|NCT01573624|40376463|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
16521484|NCT01573624|40376464|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
16324652|NCT02016105|39674531|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
16324653|NCT02016105|39674532|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
16324654|NCT02016105|39674533|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
16324655|NCT02016105|39674528|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
16324656|NCT02016105|39674529|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
16324657|NCT02016105|39674530|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
16324658|NCT02016105|39674531|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
16324659|NCT02016105|39674532|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
16324660|NCT02016105|39674533|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
16324661|NCT02016105|39674528|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
16324662|NCT02016105|39674529|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
16324663|NCT02016105|39674530|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
16324664|NCT02016105|39674531|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
16324665|NCT02016105|39674532|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
16324666|NCT02016105|39674533|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
16324667|NCT02016105|39674528|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
16324668|NCT02016105|39674529|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
16324669|NCT02016105|39674530|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
16324670|NCT02016105|39674531|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
16324671|NCT02016105|39674532|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
16324672|NCT02016105|39674533|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
16324673|NCT02016105|39674528|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
16521485|NCT01573624|40376465|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
16521486|NCT01573624|40376466|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
16521487|NCT01573624|40376467|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
16521488|NCT01573624|40376468|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16521489|NCT01573624|40376469|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
16521490|NCT01573624|40376463|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
16521491|NCT01573624|40376464|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16521492|NCT01573624|40376465|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16521493|NCT01573624|40376466|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16521494|NCT01573624|40376467|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16521495|NCT01573624|40376468|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16521496|NCT01573624|40376469|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
16521497|NCT01573624|40376463|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16521498|NCT01573624|40376464|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16521499|NCT01573624|40376465|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16521500|NCT01573624|40376466|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16521501|NCT01573624|40376467|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16521502|NCT01573624|40376468|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
16521503|NCT01573624|40376469|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16521504|NCT01573624|40376463|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
16521505|NCT01573624|40376464|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
16521506|NCT01573624|40376465|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
16521507|NCT01573624|40376466|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
16521508|NCT01573624|40376467|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
16521509|NCT01573624|40376468|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
16521510|NCT01573624|40376469|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
16521511|NCT01573624|40376463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16521512|NCT01573624|40376464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16521513|NCT01573624|40376465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16521514|NCT01573624|40376466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16521515|NCT01573624|40376467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16521516|NCT01573624|40376468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
16521517|NCT01573624|40376469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
16324674|NCT02016105|39674529|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
16324675|NCT02016105|39674530|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
16324676|NCT02016105|39674531|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
16324677|NCT02016105|39674532|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
16324678|NCT02016105|39674533|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
16324679|NCT02016105|39674528|FG000|EXTENSION PERIOD|Adverse Event|0|||
16324680|NCT02016105|39674529|FG001|EXTENSION PERIOD|Adverse Event|0|||
16324681|NCT02016105|39674530|FG002|EXTENSION PERIOD|Adverse Event|2|||
16324682|NCT02016105|39674531|FG003|EXTENSION PERIOD|Adverse Event|0|||
16324683|NCT02016105|39674532|FG004|EXTENSION PERIOD|Adverse Event|1|||
16324684|NCT02016105|39674533|FG005|EXTENSION PERIOD|Adverse Event|0|||
16324685|NCT02016105|39674528|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
16324686|NCT02016105|39674529|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
16324687|NCT02016105|39674530|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
16324688|NCT02016105|39674531|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
16324689|NCT02016105|39674532|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
16324690|NCT02016105|39674533|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
16324691|NCT02016105|39674528|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
16324692|NCT02016105|39674529|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
16093789|NCT02144285|38833199|FG002|Overall Study|Withdrawal by Subject|0|||
16093790|NCT02144285|38833200|FG003|Overall Study|Withdrawal by Subject|0|||
16093791|NCT02144285|38833201|FG004|Overall Study|Withdrawal by Subject|1|||
16093792|NCT02144285|38833202|FG005|Overall Study|Withdrawal by Subject|0|||
16093793|NCT02144285|38833203|FG006|Overall Study|Withdrawal by Subject|0|||
16093794|NCT02144285|38833204|FG007|Overall Study|Withdrawal by Subject|0|||
16093795|NCT02144285|38833205|FG008|Overall Study|Withdrawal by Subject|0|||
16093796|NCT02144285|38833206|FG009|Overall Study|Withdrawal by Subject|0|||
16324693|NCT02016105|39674530|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
16324694|NCT02016105|39674531|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
16324695|NCT02016105|39674532|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
16324696|NCT02016105|39674533|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
16324697|NCT02016105|39674528|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
16324698|NCT02016105|39674529|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
16324699|NCT02016105|39674530|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
16324700|NCT02016105|39674531|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
16324701|NCT02016105|39674532|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
16324702|NCT02016105|39674533|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
16324703|NCT01031836|39674534|FG000|Stage I|Adverse Event|1|||
16324704|NCT01031836|39674535|FG001|Stage I|Adverse Event|1|||
16324705|NCT01031836|39674536|FG002|Stage I|Adverse Event|0|||
16324706|NCT01031836|39674537|FG003|Stage I|Adverse Event|0|||
16324707|NCT01031836|39674538|FG004|Stage I|Adverse Event|0|||
16324708|NCT01031836|39674539|FG005|Stage I|Adverse Event|0|||
16324709|NCT01031836|39674534|FG000|Stage I|Other|0|||
16324710|NCT01031836|39674535|FG001|Stage I|Other|1|||
16324711|NCT01031836|39674536|FG002|Stage I|Other|0|||
16324712|NCT01031836|39674537|FG003|Stage I|Other|0|||
16324713|NCT01031836|39674538|FG004|Stage I|Other|0|||
16324714|NCT01031836|39674539|FG005|Stage I|Other|1|||
16324715|NCT01031836|39674534|FG000|Stage II|Adverse Event|0|||
16324716|NCT01031836|39674535|FG001|Stage II|Adverse Event|0|||
16324717|NCT01031836|39674536|FG002|Stage II|Adverse Event|2|||
16324718|NCT01031836|39674537|FG003|Stage II|Adverse Event|2|||
16324719|NCT01031836|39674538|FG004|Stage II|Adverse Event|1|||
16324720|NCT01031836|39674539|FG005|Stage II|Adverse Event|1|||
16324721|NCT01031836|39674534|FG000|Stage II|Other|2|||
16324722|NCT01031836|39674535|FG001|Stage II|Other|0|||
16324723|NCT01031836|39674536|FG002|Stage II|Other|0|||
16324724|NCT01031836|39674537|FG003|Stage II|Other|1|||
16324725|NCT01031836|39674538|FG004|Stage II|Other|1|||
16324726|NCT01031836|39674539|FG005|Stage II|Other|0|||
16324727|NCT01377922|39674540|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
16324728|NCT01377922|39674541|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
16324729|NCT00794040|39674543|FG000|Overall Study|Withdrawal by Subject|3|||
16324730|NCT00794040|39674544|FG001|Overall Study|Withdrawal by Subject|4|||
16324731|NCT00794040|39674543|FG000|Overall Study|Physician Decision|0|||
16093797|NCT01214200|38833207|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
16324732|NCT00794040|39674544|FG001|Overall Study|Physician Decision|1|||
16324733|NCT00617890|39674545|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
16324734|NCT00617890|39674546|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
16324735|NCT00617890|39674547|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
16324736|NCT00617890|39674548|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
16324737|NCT00617890|39674545|FG000|Overall Study|Lack of Efficacy|23|||
16324738|NCT00617890|39674546|FG001|Overall Study|Lack of Efficacy|26|||
16324739|NCT00617890|39674547|FG002|Overall Study|Lack of Efficacy|30|||
16324740|NCT00617890|39674548|FG003|Overall Study|Lack of Efficacy|97|||
16324741|NCT00617890|39674545|FG000|Overall Study|Lost to Follow-up|0|||
16324742|NCT00617890|39674546|FG001|Overall Study|Lost to Follow-up|0|||
16324743|NCT00617890|39674547|FG002|Overall Study|Lost to Follow-up|1|||
16324744|NCT00617890|39674548|FG003|Overall Study|Lost to Follow-up|2|||
16324745|NCT00617890|39674545|FG000|Overall Study|Withdrawal by Subject|4|||
16324746|NCT00617890|39674546|FG001|Overall Study|Withdrawal by Subject|1|||
16324747|NCT00617890|39674547|FG002|Overall Study|Withdrawal by Subject|0|||
16324748|NCT00617890|39674548|FG003|Overall Study|Withdrawal by Subject|2|||
16324749|NCT00617890|39674545|FG000|Overall Study|Protocol Violation|2|||
16324750|NCT00617890|39674546|FG001|Overall Study|Protocol Violation|1|||
16324751|NCT00617890|39674547|FG002|Overall Study|Protocol Violation|0|||
16324752|NCT00617890|39674548|FG003|Overall Study|Protocol Violation|0|||
16324753|NCT00617890|39674545|FG000|Overall Study|Adverse Event|1|||
16324754|NCT00617890|39674546|FG001|Overall Study|Adverse Event|0|||
16324755|NCT00617890|39674547|FG002|Overall Study|Adverse Event|3|||
16324756|NCT00617890|39674548|FG003|Overall Study|Adverse Event|8|||
16324757|NCT00617890|39674545|FG000|Overall Study|Not treated|1|||
16324758|NCT00617890|39674546|FG001|Overall Study|Not treated|0|||
16324759|NCT00617890|39674547|FG002|Overall Study|Not treated|1|||
16324760|NCT00617890|39674548|FG003|Overall Study|Not treated|1|||
16324761|NCT05020665|39674549|FG000|Overall Study|Study terminated by Sponsor|5|||
16324762|NCT05020665|39674550|FG001|Overall Study|Study terminated by Sponsor|4|||
16324763|NCT05020665|39674549|FG000|Overall Study|Death|2|||
16324764|NCT05020665|39674550|FG001|Overall Study|Death|1|||
16324765|NCT05020665|39674549|FG000|Overall Study|Physician Decision|0|||
16324766|NCT05020665|39674550|FG001|Overall Study|Physician Decision|1|||
16324767|NCT05020665|39674549|FG000|Overall Study|Withdrawal by Subject|0|||
16324768|NCT05020665|39674550|FG001|Overall Study|Withdrawal by Subject|1|||
16324769|NCT05020665|39674549|FG000|Overall Study|Reason not specified|1|||
16324770|NCT05020665|39674550|FG001|Overall Study|Reason not specified|0|||
16324771|NCT02640677|39674551|FG000|Overall Study|Lost to Follow-up|1|||
16324772|NCT02640677|39674551|FG000|Overall Study|Withdrawal by Subject|1|||
16324773|NCT00941863|39674556|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
16324774|NCT00941863|39674557|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
16324775|NCT00941863|39674558|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
16324776|NCT00941863|39674559|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
16324777|NCT00941863|39674560|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
16324778|NCT00941863|39674556|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
16324779|NCT00941863|39674557|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
16324780|NCT00941863|39674558|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
16324781|NCT00941863|39674559|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
16324782|NCT00941863|39674560|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
16324783|NCT00941863|39674556|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
16324784|NCT00941863|39674557|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
16324785|NCT00941863|39674558|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
16324786|NCT00941863|39674559|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
16396156|NCT00289289|39931312|FG002|Overall Study|Withdrawal by Subject|15|||
16324787|NCT00941863|39674560|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
16324788|NCT00941863|39674556|FG000|Until Primary Completion Date (PCD)|Death|0|||
16324789|NCT00941863|39674557|FG001|Until Primary Completion Date (PCD)|Death|0|||
16324790|NCT00941863|39674558|FG002|Until Primary Completion Date (PCD)|Death|1|||
16324791|NCT00941863|39674559|FG003|Until Primary Completion Date (PCD)|Death|2|||
16324792|NCT00941863|39674560|FG004|Until Primary Completion Date (PCD)|Death|7|||
16324793|NCT00941863|39674556|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
16324794|NCT00941863|39674557|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
16324795|NCT00941863|39674558|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
16324796|NCT00941863|39674559|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
16324797|NCT00941863|39674560|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
16324798|NCT00941863|39674556|FG000|Continued After PCD|Withdrawal by Subject|0|||
16324799|NCT00941863|39674557|FG001|Continued After PCD|Withdrawal by Subject|0|||
16324800|NCT00941863|39674558|FG002|Continued After PCD|Withdrawal by Subject|0|||
16324801|NCT00941863|39674559|FG003|Continued After PCD|Withdrawal by Subject|0|||
16324802|NCT00941863|39674560|FG004|Continued After PCD|Withdrawal by Subject|1|||
16324803|NCT00941863|39674556|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
16324804|NCT00941863|39674557|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
16324805|NCT00941863|39674558|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
16324806|NCT00941863|39674559|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
16324807|NCT00941863|39674560|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
16324808|NCT02257489|39674563|FG000|Overall Study|Withdrawal by Subject|0|||
16324809|NCT02257489|39674564|FG001|Overall Study|Withdrawal by Subject|0|||
16324810|NCT02257489|39674565|FG002|Overall Study|Withdrawal by Subject|0|||
16093798|NCT01214200|38833207|FG000|Overall Study|Withdrawal by Subject|2|||
16093799|NCT03689452|38833208|FG000|Overall Study|Lost to Follow-up|1|||
16093800|NCT03689452|38833209|FG001|Overall Study|Lost to Follow-up|1|||
16093801|NCT03884478|38833210|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
16093802|NCT03884478|38833211|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
16093803|NCT03884478|38833212|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
16093804|NCT03884478|38833210|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
16093805|NCT03884478|38833211|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
16093806|NCT03884478|38833212|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
16093807|NCT03884478|38833210|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
16093808|NCT03884478|38833211|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
16093809|NCT03884478|38833212|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
16093810|NCT03884478|38833210|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
16093811|NCT03884478|38833211|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
16093812|NCT03884478|38833212|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
16093813|NCT02764320|38833213|FG000|Overall Study|Withdrawal by Subject|35|||
16093814|NCT02764320|38833214|FG001|Overall Study|Withdrawal by Subject|38|||
16093815|NCT02764320|38833213|FG000|Overall Study|Protocol Violation|11|||
16093816|NCT02764320|38833214|FG001|Overall Study|Protocol Violation|6|||
16093817|NCT02764320|38833213|FG000|Overall Study|Adverse Event|2|||
16093818|NCT02764320|38833214|FG001|Overall Study|Adverse Event|0|||
16093819|NCT02764320|38833213|FG000|Overall Study|Health Issues unable to continue|2|||
16093820|NCT02764320|38833214|FG001|Overall Study|Health Issues unable to continue|0|||
16093821|NCT02764320|38833213|FG000|Overall Study|Did not meet inclusion criteria|1|||
16093822|NCT02764320|38833214|FG001|Overall Study|Did not meet inclusion criteria|0|||
16093823|NCT02764320|38833213|FG000|Overall Study|Subject moved|0|||
16093824|NCT02764320|38833214|FG001|Overall Study|Subject moved|2|||
16093825|NCT02764320|38833213|FG000|Overall Study|Overused medication unavailable|0|||
16093826|NCT02764320|38833214|FG001|Overall Study|Overused medication unavailable|1|||
16093827|NCT02764320|38833213|FG000|Overall Study|Seeking care outside site|0|||
16093828|NCT02764320|38833214|FG001|Overall Study|Seeking care outside site|1|||
16093829|NCT02764320|38833213|FG000|Overall Study|Technology barriers|0|||
16093830|NCT02764320|38833214|FG001|Overall Study|Technology barriers|1|||
16093831|NCT01543204|38833215|FG000|Overall Study|Non-compliance|1|||
16093832|NCT01543204|38833215|FG000|Overall Study|Adverse Event|1|||
16093833|NCT01543204|38833215|FG000|Overall Study|Withdrawal by Subject|4|||
16093834|NCT01543204|38833215|FG000|Overall Study|Requirement for Alternative Therapy|1|||
16093835|NCT01543204|38833215|FG000|Overall Study|Lost to Follow-up|1|||
16093836|NCT04743999|38833216|FG000|3-month Questionnaire|Death|1|||
16093837|NCT04743999|38833216|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
16093838|NCT04743999|38833216|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
16093839|NCT04743999|38833216|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
16093840|NCT04085614|38836289|FG000|Overall Study|Protocol Violation|9|||
16093841|NCT04085614|38836290|FG001|Overall Study|Protocol Violation|6|||
16093842|NCT01974206|38836291|FG000|Overall Study|Did Not Take Study Drug|0|||
16093843|NCT01974206|38836292|FG001|Overall Study|Did Not Take Study Drug|1|||
16093844|NCT01974206|38836291|FG000|Overall Study|Physician Decision|1|||
16093845|NCT01974206|38836292|FG001|Overall Study|Physician Decision|0|||
16093846|NCT01974206|38836291|FG000|Overall Study|Withdrawal by Subject|3|||
16324811|NCT02257489|39674566|FG003|Overall Study|Withdrawal by Subject|1|||
16324812|NCT02257489|39674567|FG004|Overall Study|Withdrawal by Subject|0|||
16396157|NCT00289289|39931310|FG000|Overall Study|Lost to Follow-up|1|||
16093847|NCT01974206|38836292|FG001|Overall Study|Withdrawal by Subject|0|||
16324813|NCT02257489|39674568|FG005|Overall Study|Withdrawal by Subject|0|||
16324814|NCT02257489|39674569|FG006|Overall Study|Withdrawal by Subject|0|||
16324815|NCT02257489|39674570|FG007|Overall Study|Withdrawal by Subject|0|||
16324816|NCT02257489|39674571|FG008|Overall Study|Withdrawal by Subject|0|||
16324817|NCT02691013|39674576|FG000|Overall Study|Withdrawal by Subject|3|||
16324818|NCT02691013|39674577|FG001|Overall Study|Withdrawal by Subject|0|||
16324819|NCT01253174|39674578|FG000|Period 1|Randomized but not treated|0|||
16324820|NCT01253174|39674579|FG001|Period 1|Randomized but not treated|1|||
16324821|NCT01253174|39674580|FG002|Period 1|Randomized but not treated|1|||
16521518|NCT01573624|40376463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
16521519|NCT01573624|40376464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
16521520|NCT01573624|40376465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
16521521|NCT01573624|40376466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
16521522|NCT01573624|40376467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
16521523|NCT01573624|40376468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
16521524|NCT01573624|40376469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
16521525|NCT01573624|40376463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
16521526|NCT01573624|40376464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16521527|NCT01573624|40376465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
16521528|NCT01573624|40376466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
16521529|NCT01573624|40376467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16521530|NCT01573624|40376468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16521531|NCT01573624|40376469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
16521532|NCT01573624|40376463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16521533|NCT01573624|40376464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16521534|NCT01573624|40376465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16521535|NCT01573624|40376466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16521536|NCT01573624|40376467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16521537|NCT01573624|40376468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
16521538|NCT01573624|40376469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
16521539|NCT01573624|40376463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16521540|NCT01573624|40376464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16521541|NCT01573624|40376465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16521542|NCT01573624|40376466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
16521543|NCT01573624|40376467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16521544|NCT01573624|40376468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
16521545|NCT01573624|40376469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
16521546|NCT01573624|40376463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
16521547|NCT01573624|40376464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
16521548|NCT01573624|40376465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
16521549|NCT01573624|40376466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
16521550|NCT01573624|40376467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
16521551|NCT01573624|40376468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
16521552|NCT01573624|40376469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
16521553|NCT01573624|40376463|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
16521554|NCT01573624|40376464|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
16521555|NCT01573624|40376465|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
16521556|NCT01573624|40376466|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
16521557|NCT01573624|40376467|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
16521558|NCT01573624|40376468|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
16521559|NCT01573624|40376469|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
16521560|NCT01573624|40376463|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
16521561|NCT01573624|40376464|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
16521562|NCT01573624|40376465|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
16521563|NCT01573624|40376466|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
16521564|NCT01573624|40376467|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
16521565|NCT01573624|40376468|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
16521566|NCT01573624|40376469|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
16521567|NCT01573624|40376463|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
16521568|NCT01573624|40376464|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16324822|NCT01253174|39674581|FG003|Period 1|Randomized but not treated|0|||
16324823|NCT01253174|39674582|FG004|Period 1|Randomized but not treated|1|||
16521569|NCT01573624|40376465|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16093848|NCT01974206|38836291|FG000|Overall Study|Lost to Follow-up|1|||
16093849|NCT01974206|38836292|FG001|Overall Study|Lost to Follow-up|0|||
16093850|NCT01974206|38836291|FG000|Overall Study|Death|1|||
16093851|NCT01974206|38836292|FG001|Overall Study|Death|0|||
16093852|NCT00795639|38836293|FG000|Overall Study|Death|1|||
16093853|NCT00795639|38836294|FG001|Overall Study|Death|6|||
16093854|NCT00795639|38836293|FG000|Overall Study|Withdrawal by Subject|1|||
16093855|NCT00795639|38836294|FG001|Overall Study|Withdrawal by Subject|3|||
16207102|NCT02420795|39237123|FG000|Overall Study|Withdrawal by Subject|1|||
16324824|NCT01253174|39674583|FG005|Period 1|Randomized but not treated|0|||
16324825|NCT01253174|39674578|FG000|Period 2|Adverse Event|0|||
16324826|NCT01253174|39674579|FG001|Period 2|Adverse Event|0|||
16324827|NCT01253174|39674580|FG002|Period 2|Adverse Event|1|||
16324828|NCT01253174|39674581|FG003|Period 2|Adverse Event|0|||
16324829|NCT01253174|39674582|FG004|Period 2|Adverse Event|0|||
16324830|NCT01253174|39674583|FG005|Period 2|Adverse Event|0|||
16324831|NCT01253174|39674578|FG000|Period 3|Withdrawal by Subject|0|||
16324832|NCT01253174|39674579|FG001|Period 3|Withdrawal by Subject|1|||
16093856|NCT00795639|38836293|FG000|Overall Study|Pregnancy|1|||
16093857|NCT00795639|38836294|FG001|Overall Study|Pregnancy|0|||
16207103|NCT02420795|39237124|FG001|Overall Study|Withdrawal by Subject|0|||
16324833|NCT01253174|39674580|FG002|Period 3|Withdrawal by Subject|0|||
16324834|NCT01253174|39674581|FG003|Period 3|Withdrawal by Subject|0|||
16324835|NCT01253174|39674582|FG004|Period 3|Withdrawal by Subject|1|||
16093858|NCT00795639|38836293|FG000|Overall Study|Adverse Event|5|||
16324836|NCT01253174|39674583|FG005|Period 3|Withdrawal by Subject|0|||
16324837|NCT01253174|39674578|FG000|Period 3|Pregnancy|0|||
16324838|NCT01253174|39674579|FG001|Period 3|Pregnancy|0|||
16324839|NCT01253174|39674580|FG002|Period 3|Pregnancy|1|||
16324840|NCT01253174|39674581|FG003|Period 3|Pregnancy|0|||
16324841|NCT01253174|39674582|FG004|Period 3|Pregnancy|0|||
16324842|NCT01253174|39674583|FG005|Period 3|Pregnancy|0|||
16324843|NCT02211638|39674584|FG000|Overall Study|Case Report Forms Uncollected|291|||
16324844|NCT02211638|39674584|FG000|Overall Study|Protocol Violation|692|||
16324845|NCT00761280|39674593|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
16324846|NCT00761280|39674594|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
16324847|NCT00761280|39674593|FG000|Randomization to First Dose|Sponsor decision|1|||
16324848|NCT00761280|39674594|FG001|Randomization to First Dose|Sponsor decision|0|||
16324849|NCT00761280|39674593|FG000|Randomization to First Dose|Other|1|||
16324850|NCT00761280|39674594|FG001|Randomization to First Dose|Other|0|||
16324851|NCT00761280|39674593|FG000|First Dose to End of Study|End of trial|5|||
16324852|NCT00761280|39674594|FG001|First Dose to End of Study|End of trial|5|||
16324853|NCT00761280|39674593|FG000|First Dose to End of Study|Progressive disease|5|||
16324854|NCT00761280|39674594|FG001|First Dose to End of Study|Progressive disease|3|||
16324855|NCT00761280|39674593|FG000|First Dose to End of Study|Sponsor decision|1|||
16324856|NCT00761280|39674594|FG001|First Dose to End of Study|Sponsor decision|2|||
16324857|NCT00761280|39674593|FG000|First Dose to End of Study|Death|1|||
16521570|NCT01573624|40376466|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16521571|NCT01573624|40376467|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16521572|NCT01573624|40376468|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16521573|NCT01573624|40376469|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
16521574|NCT01573624|40376463|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16521575|NCT01573624|40376464|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
16521576|NCT01573624|40376465|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
16521577|NCT01573624|40376466|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16521578|NCT01573624|40376467|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16521579|NCT01573624|40376468|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
16521580|NCT01573624|40376469|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16521581|NCT01573624|40376463|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
16521582|NCT01573624|40376464|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16521583|NCT01573624|40376465|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16521584|NCT01573624|40376466|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16521585|NCT01573624|40376467|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16521586|NCT01573624|40376468|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16521587|NCT01573624|40376469|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
16521588|NCT01573624|40376463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
16324858|NCT00761280|39674594|FG001|First Dose to End of Study|Death|0|||
16324859|NCT00761280|39674593|FG000|First Dose to End of Study|Lost to Follow-up|0|||
16324860|NCT00761280|39674594|FG001|First Dose to End of Study|Lost to Follow-up|1|||
16324861|NCT01081769|39674597|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
16521589|NCT01573624|40376464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
16521590|NCT01573624|40376465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
16521591|NCT01573624|40376466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
16521592|NCT01573624|40376467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
16093859|NCT00795639|38836294|FG001|Overall Study|Adverse Event|2|||
16093860|NCT00795639|38836293|FG000|Overall Study|Other|0|||
16093861|NCT00795639|38836294|FG001|Overall Study|Other|2|||
16093862|NCT00795639|38836293|FG000|Overall Study|Terminated by sponsor|13|||
16093863|NCT00795639|38836294|FG001|Overall Study|Terminated by sponsor|12|||
16093864|NCT00795639|38836293|FG000|Overall Study|Randomized and not treated|0|||
16093865|NCT00795639|38836294|FG001|Overall Study|Randomized and not treated|1|||
16093866|NCT03409276|38836296|FG000|Overall Study|Withdrawal by Subject|0|||
16093867|NCT03409276|38836297|FG001|Overall Study|Withdrawal by Subject|0|||
16093868|NCT03409276|38836298|FG002|Overall Study|Withdrawal by Subject|0|||
16093869|NCT03409276|38836299|FG003|Overall Study|Withdrawal by Subject|0|||
16093870|NCT03409276|38836300|FG004|Overall Study|Withdrawal by Subject|1|||
16093871|NCT03409276|38836296|FG000|Overall Study|Lost to Follow-up|0|||
16093872|NCT03409276|38836297|FG001|Overall Study|Lost to Follow-up|0|||
16093873|NCT03409276|38836298|FG002|Overall Study|Lost to Follow-up|0|||
16093874|NCT03409276|38836299|FG003|Overall Study|Lost to Follow-up|2|||
16093875|NCT03409276|38836300|FG004|Overall Study|Lost to Follow-up|2|||
16093876|NCT01535261|38836303|FG000|Overall Study|Physician Decision|8|||
16093877|NCT01535261|38836303|FG000|Overall Study|Protocol Violation|3|||
16093878|NCT01535261|38836303|FG000|Overall Study|Death|5|||
16093879|NCT01535261|38836303|FG000|Overall Study|Lost to Follow-up|8|||
16093880|NCT01535261|38836303|FG000|Overall Study|Withdrawal by Subject|14|||
16093881|NCT01535261|38836303|FG000|Overall Study|Adverse Event|12|||
16093882|NCT00096278|38836306|FG000|Overall Study|No follow-up data|15|||
16093883|NCT00096278|38836307|FG001|Overall Study|No follow-up data|18|||
16093884|NCT00096278|38836306|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
16093885|NCT00096278|38836307|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
16093886|NCT02691702|38836311|FG000|Overall Study|Adverse Event|1|||
16093887|NCT02691702|38836312|FG001|Overall Study|Adverse Event|0|||
16093888|NCT02691702|38836313|FG002|Overall Study|Adverse Event|0|||
16093889|NCT02691702|38836314|FG003|Overall Study|Adverse Event|0|||
16093890|NCT02691702|38836315|FG004|Overall Study|Adverse Event|0|||
16093891|NCT02691702|38836316|FG005|Overall Study|Adverse Event|0|||
16093892|NCT02691702|38836317|FG006|Overall Study|Adverse Event|0|||
16093893|NCT02691702|38836318|FG007|Overall Study|Adverse Event|0|||
16093894|NCT02691702|38836319|FG008|Overall Study|Adverse Event|1|||
16093895|NCT02691702|38836320|FG009|Overall Study|Adverse Event|0|||
16093896|NCT02691702|38836321|FG010|Overall Study|Adverse Event|1|||
16093897|NCT02691702|38836311|FG000|Overall Study|Lost to Follow-up|0|||
16093898|NCT02691702|38836312|FG001|Overall Study|Lost to Follow-up|0|||
16093899|NCT02691702|38836313|FG002|Overall Study|Lost to Follow-up|1|||
16521593|NCT01573624|40376468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
16521594|NCT01573624|40376469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
16521595|NCT01573624|40376463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
16521596|NCT01573624|40376464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
16521597|NCT01573624|40376465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
16521598|NCT01573624|40376466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
16521599|NCT01573624|40376467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
16521600|NCT01573624|40376468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
16521601|NCT01573624|40376469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
16093900|NCT02691702|38836314|FG003|Overall Study|Lost to Follow-up|0|||
16093901|NCT02691702|38836315|FG004|Overall Study|Lost to Follow-up|0|||
16093902|NCT02691702|38836316|FG005|Overall Study|Lost to Follow-up|2|||
16093903|NCT02691702|38836317|FG006|Overall Study|Lost to Follow-up|0|||
16093904|NCT02691702|38836318|FG007|Overall Study|Lost to Follow-up|0|||
16093905|NCT02691702|38836319|FG008|Overall Study|Lost to Follow-up|0|||
16093906|NCT02691702|38836320|FG009|Overall Study|Lost to Follow-up|0|||
16093907|NCT02691702|38836321|FG010|Overall Study|Lost to Follow-up|1|||
16093908|NCT02691702|38836311|FG000|Overall Study|Withdrawal by Subject|1|||
16093909|NCT02691702|38836312|FG001|Overall Study|Withdrawal by Subject|1|||
16093910|NCT02691702|38836313|FG002|Overall Study|Withdrawal by Subject|0|||
16521602|NCT01573624|40376463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16521603|NCT01573624|40376464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
16521604|NCT01573624|40376465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16521605|NCT01573624|40376466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16521606|NCT01573624|40376467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16521607|NCT01573624|40376468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16521608|NCT01573624|40376469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
16521609|NCT01573624|40376463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16521610|NCT01573624|40376464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
16521611|NCT01573624|40376465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16521612|NCT01573624|40376466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16521613|NCT01573624|40376467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16521614|NCT01573624|40376468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16521615|NCT01573624|40376469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
16521616|NCT01573624|40376463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16521617|NCT01573624|40376464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16521618|NCT01573624|40376465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16521619|NCT01573624|40376466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16521620|NCT01573624|40376467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
16521621|NCT01573624|40376468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
16521622|NCT01573624|40376469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
16521623|NCT01573624|40376463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
16521624|NCT01573624|40376464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
16521625|NCT01573624|40376465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
16207104|NCT02420795|39237125|FG002|Overall Study|Withdrawal by Subject|0|||
16521626|NCT01573624|40376466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
16521627|NCT01573624|40376467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
16521628|NCT01573624|40376468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
16521629|NCT01573624|40376469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
16521630|NCT01573624|40376463|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
16521631|NCT01573624|40376464|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16521632|NCT01573624|40376465|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16521633|NCT01573624|40376466|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16521634|NCT01573624|40376467|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
16521635|NCT01573624|40376468|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
16521636|NCT01573624|40376469|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
16521637|NCT01573624|40376463|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
16521638|NCT01573624|40376464|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
16521639|NCT01573624|40376465|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
16521640|NCT01573624|40376466|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
16521641|NCT01573624|40376467|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
16324862|NCT01081769|39674598|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
16324863|NCT01081769|39674597|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
16521642|NCT01573624|40376468|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
16521643|NCT01573624|40376469|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
16521644|NCT01573624|40376463|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
16521645|NCT01573624|40376464|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16521646|NCT01573624|40376465|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16521647|NCT01573624|40376466|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16521648|NCT01573624|40376467|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16521649|NCT01573624|40376468|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16521650|NCT01573624|40376469|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
16521651|NCT01573624|40376463|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
16521652|NCT01573624|40376464|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
16521653|NCT01573624|40376465|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
16521654|NCT01573624|40376466|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
16521655|NCT01573624|40376467|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
16521656|NCT01573624|40376468|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
16521657|NCT01573624|40376469|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
16521658|NCT01573624|40376463|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
16521659|NCT01573624|40376464|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16521660|NCT01573624|40376465|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16521661|NCT01573624|40376466|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16521662|NCT01573624|40376467|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16521663|NCT01573624|40376468|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16521664|NCT01573624|40376469|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
16521665|NCT00226941|40376470|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
16521666|NCT00226941|40376471|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
16521667|NCT00226941|40376472|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
16521668|NCT00226941|40376473|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
16521669|NCT00226941|40376470|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
16521670|NCT00226941|40376471|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
16521671|NCT00226941|40376472|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
16521672|NCT00226941|40376473|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
16521673|NCT03207750|40376479|FG000|Overall Study|Adverse Event|3|||
16521674|NCT03207750|40376480|FG001|Overall Study|Adverse Event|2|||
16521675|NCT03207750|40376479|FG000|Overall Study|Lost to Follow-up|21|||
16521676|NCT03207750|40376480|FG001|Overall Study|Lost to Follow-up|29|||
16521677|NCT03207750|40376479|FG000|Overall Study|Protocol Violation|0|||
16521678|NCT03207750|40376480|FG001|Overall Study|Protocol Violation|1|||
16521679|NCT03207750|40376479|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
16521680|NCT03207750|40376480|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
16324864|NCT01081769|39674598|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
16324865|NCT01081769|39674597|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
16324866|NCT01081769|39674598|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
16324867|NCT01081769|39674597|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
16521681|NCT03207750|40376479|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
16521682|NCT03207750|40376480|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
16324868|NCT01081769|39674598|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
16324869|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Adverse Event|14|||
16396158|NCT00289289|39931311|FG001|Overall Study|Lost to Follow-up|0|||
16521683|NCT03207750|40376479|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
16324870|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Adverse Event|11|||
16521684|NCT03207750|40376480|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
16324871|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Death|1|||
16324872|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Death|1|||
16324873|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
16324874|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
16324875|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
16324876|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
16324877|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Pregnancy|1|||
16324878|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Pregnancy|0|||
16324879|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
16324880|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
16324881|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
16324882|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
16324883|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Other|0|||
16324884|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Other|1|||
16521685|NCT03207750|40376479|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
16521686|NCT03207750|40376480|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
16521687|NCT03207750|40376479|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
16521688|NCT03207750|40376480|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
16521689|NCT01850004|40376492|FG000|Overall Study|Poor/Non-compliance|1|||
16521690|NCT01850004|40376492|FG000|Overall Study|Participant Withdrew Consent|9|||
16521691|NCT01850004|40376492|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
16521692|NCT01850004|40376492|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
16521693|NCT01850004|40376492|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
16521694|NCT01850004|40376492|FG000|Overall Study|Other Reasons|2|||
16521695|NCT01850004|40376492|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
16521696|NCT01850004|40376492|FG000|Overall Study|Maximum Clinical Benefit|4|||
16521697|NCT02738775|40376494|FG000|Overall Study|Withdrawal by Subject|0|||
16521698|NCT02738775|40376495|FG001|Overall Study|Withdrawal by Subject|1|||
16521699|NCT02738775|40376496|FG002|Overall Study|Withdrawal by Subject|0|||
16521700|NCT02738775|40376497|FG003|Overall Study|Withdrawal by Subject|0|||
16521701|NCT02738775|40376498|FG004|Overall Study|Withdrawal by Subject|0|||
16521702|NCT02738775|40376499|FG005|Overall Study|Withdrawal by Subject|0|||
16521703|NCT02738775|40376494|FG000|Overall Study|Adverse Event|0|||
16521704|NCT02738775|40376495|FG001|Overall Study|Adverse Event|0|||
16521705|NCT02738775|40376496|FG002|Overall Study|Adverse Event|0|||
16521706|NCT02738775|40376497|FG003|Overall Study|Adverse Event|1|||
16521707|NCT02738775|40376498|FG004|Overall Study|Adverse Event|0|||
16521708|NCT02738775|40376499|FG005|Overall Study|Adverse Event|0|||
16521709|NCT02738775|40376494|FG000|Overall Study|Pregnancy|0|||
16521710|NCT02738775|40376495|FG001|Overall Study|Pregnancy|1|||
16521711|NCT02738775|40376496|FG002|Overall Study|Pregnancy|0|||
16521712|NCT02738775|40376497|FG003|Overall Study|Pregnancy|0|||
16521713|NCT02738775|40376498|FG004|Overall Study|Pregnancy|0|||
16521714|NCT02738775|40376499|FG005|Overall Study|Pregnancy|0|||
16521715|NCT02738775|40376494|FG000|Overall Study|Missing|0|||
16521716|NCT02738775|40376495|FG001|Overall Study|Missing|0|||
16521717|NCT02738775|40376496|FG002|Overall Study|Missing|0|||
16521718|NCT02738775|40376497|FG003|Overall Study|Missing|0|||
16521719|NCT02738775|40376498|FG004|Overall Study|Missing|0|||
16521720|NCT02738775|40376499|FG005|Overall Study|Missing|1|||
16521721|NCT01529645|40376500|FG000|Overall Study|Lost to Follow-up|0|||
16521722|NCT01529645|40376501|FG001|Overall Study|Lost to Follow-up|1|||
16521723|NCT01529645|40376502|FG002|Overall Study|Lost to Follow-up|1|||
16521724|NCT01529645|40376503|FG003|Overall Study|Lost to Follow-up|1|||
16521725|NCT01529645|40376504|FG004|Overall Study|Lost to Follow-up|1|||
16521726|NCT01529645|40376505|FG005|Overall Study|Lost to Follow-up|0|||
16521727|NCT01529645|40376506|FG006|Overall Study|Lost to Follow-up|2|||
16521728|NCT01529645|40376507|FG007|Overall Study|Lost to Follow-up|0|||
16521729|NCT01529645|40376508|FG008|Overall Study|Lost to Follow-up|1|||
16521730|NCT01529645|40376509|FG009|Overall Study|Lost to Follow-up|0|||
16521731|NCT01529645|40376500|FG000|Overall Study|SAE - Premature contractions|0|||
16093911|NCT02691702|38836314|FG003|Overall Study|Withdrawal by Subject|0|||
16324885|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Ineligibility|3|||
16521732|NCT01529645|40376501|FG001|Overall Study|SAE - Premature contractions|0|||
16521733|NCT01529645|40376502|FG002|Overall Study|SAE - Premature contractions|1|||
16521734|NCT01529645|40376503|FG003|Overall Study|SAE - Premature contractions|0|||
16521735|NCT01529645|40376504|FG004|Overall Study|SAE - Premature contractions|0|||
16521736|NCT01529645|40376505|FG005|Overall Study|SAE - Premature contractions|0|||
16521737|NCT01529645|40376506|FG006|Overall Study|SAE - Premature contractions|0|||
16521738|NCT01529645|40376507|FG007|Overall Study|SAE - Premature contractions|0|||
16521739|NCT01529645|40376508|FG008|Overall Study|SAE - Premature contractions|0|||
16521740|NCT01529645|40376509|FG009|Overall Study|SAE - Premature contractions|0|||
16324886|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Ineligibility|4|||
16324887|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
16324888|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
16521741|NCT01529645|40376500|FG000|Overall Study|Withdrawal by Subject|2|||
16521742|NCT01529645|40376501|FG001|Overall Study|Withdrawal by Subject|0|||
16521743|NCT01529645|40376502|FG002|Overall Study|Withdrawal by Subject|0|||
16521744|NCT01529645|40376503|FG003|Overall Study|Withdrawal by Subject|1|||
16521745|NCT01529645|40376504|FG004|Overall Study|Withdrawal by Subject|1|||
16521746|NCT01529645|40376505|FG005|Overall Study|Withdrawal by Subject|1|||
16521747|NCT01529645|40376506|FG006|Overall Study|Withdrawal by Subject|0|||
16521748|NCT01529645|40376507|FG007|Overall Study|Withdrawal by Subject|0|||
16521749|NCT01529645|40376508|FG008|Overall Study|Withdrawal by Subject|0|||
16521750|NCT01529645|40376509|FG009|Overall Study|Withdrawal by Subject|0|||
16521751|NCT01696032|40376514|FG000|Overall Study|Withdrawal by Subject|0|||
16521752|NCT01696032|40376515|FG001|Overall Study|Withdrawal by Subject|0|||
16521753|NCT01696032|40376516|FG002|Overall Study|Withdrawal by Subject|1|||
16521754|NCT01696032|40376517|FG003|Overall Study|Withdrawal by Subject|2|||
16521755|NCT01696032|40376514|FG000|Overall Study|Death|14|||
16521756|NCT01696032|40376515|FG001|Overall Study|Death|4|||
16521757|NCT01696032|40376516|FG002|Overall Study|Death|43|||
16521758|NCT01696032|40376517|FG003|Overall Study|Death|18|||
16521759|NCT01696032|40376514|FG000|Overall Study|Lost to Follow-up|0|||
16521760|NCT01696032|40376515|FG001|Overall Study|Lost to Follow-up|1|||
16521761|NCT01696032|40376516|FG002|Overall Study|Lost to Follow-up|0|||
16521762|NCT01696032|40376517|FG003|Overall Study|Lost to Follow-up|0|||
16521763|NCT01696032|40376514|FG000|Overall Study|Database lock|0|||
16521764|NCT01696032|40376515|FG001|Overall Study|Database lock|1|||
16521765|NCT01696032|40376516|FG002|Overall Study|Database lock|7|||
16521766|NCT01696032|40376517|FG003|Overall Study|Database lock|2|||
16093912|NCT02691702|38836315|FG004|Overall Study|Withdrawal by Subject|0|||
16207105|NCT02420795|39237123|FG000|Overall Study|Adverse Event|1|||
16207106|NCT02420795|39237124|FG001|Overall Study|Adverse Event|0|||
16207107|NCT02420795|39237125|FG002|Overall Study|Adverse Event|0|||
16207108|NCT02420795|39237123|FG000|Overall Study|Progressive disease|2|||
16207109|NCT02420795|39237124|FG001|Overall Study|Progressive disease|2|||
16207110|NCT02420795|39237125|FG002|Overall Study|Progressive disease|4|||
16207111|NCT02420795|39237123|FG000|Overall Study|Death|0|||
16207112|NCT02420795|39237124|FG001|Overall Study|Death|0|||
16207113|NCT02420795|39237125|FG002|Overall Study|Death|1|||
16207114|NCT03057951|39237129|FG000|Overall Study|Adverse Event|553|||
16207115|NCT03057951|39237130|FG001|Overall Study|Adverse Event|575|||
16207116|NCT03057951|39237129|FG000|Overall Study|Protocol Violation|30|||
16207117|NCT03057951|39237130|FG001|Overall Study|Protocol Violation|24|||
16396159|NCT00289289|39931312|FG002|Overall Study|Lost to Follow-up|1|||
16396160|NCT00289289|39931310|FG000|Overall Study|Death|4|||
16396161|NCT00289289|39931311|FG001|Overall Study|Death|2|||
16396162|NCT00289289|39931312|FG002|Overall Study|Death|5|||
16207118|NCT03057951|39237129|FG000|Overall Study|Lost to Follow-up|6|||
16207119|NCT03057951|39237130|FG001|Overall Study|Lost to Follow-up|16|||
16396163|NCT00289289|39931310|FG000|Overall Study|No implant attempted|0|||
16396164|NCT00289289|39931311|FG001|Overall Study|No implant attempted|0|||
16396165|NCT00289289|39931312|FG002|Overall Study|No implant attempted|1|||
16396166|NCT00289289|39931310|FG000|Overall Study|Physician Decision|1|||
16521767|NCT02809976|40376518|FG000|Overall Study|Lost to Follow-up|1|||
16207120|NCT03057951|39237129|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
16207121|NCT03057951|39237130|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
16207122|NCT03057951|39237129|FG000|Overall Study|Study drug stopped, reason missing|6|||
16207123|NCT03057951|39237130|FG001|Overall Study|Study drug stopped, reason missing|1|||
16207124|NCT03057951|39237129|FG000|Overall Study|Medical advice|6|||
16207125|NCT03057951|39237130|FG001|Overall Study|Medical advice|2|||
16207126|NCT03057951|39237129|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
16207127|NCT03057951|39237130|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
16207128|NCT03057951|39237129|FG000|Overall Study|Investigator decision|2|||
16324889|NCT01081769|39674597|FG000|CORE Intent-To-Treat|Patient Moved|2|||
16324890|NCT01081769|39674598|FG001|CORE Intent-To-Treat|Patient Moved|2|||
16324891|NCT00443079|39674599|FG000|Overall Study|Lost to Follow-up|0|||
16324892|NCT00443079|39674600|FG001|Overall Study|Lost to Follow-up|1|||
16324893|NCT03617770|39674608|FG000|Overall Study|Lost to Follow-up|1|||
16324894|NCT03617770|39674609|FG001|Overall Study|Lost to Follow-up|0|||
16324895|NCT04526509|39674614|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
16521768|NCT02809976|40376518|FG000|Overall Study|Withdrawal by Subject|1|||
16521769|NCT00009737|40376519|FG000|Overall Study|Adverse Event|112|||
16521770|NCT00009737|40376520|FG001|Overall Study|Adverse Event|75|||
16207129|NCT03057951|39237130|FG001|Overall Study|Investigator decision|0|||
16207130|NCT03057951|39237129|FG000|Overall Study|Patient decision|5|||
16521771|NCT00009737|40376519|FG000|Overall Study|Death|4|||
16324896|NCT04526509|39674615|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
16396167|NCT00289289|39931311|FG001|Overall Study|Physician Decision|0|||
16396168|NCT00289289|39931312|FG002|Overall Study|Physician Decision|6|||
16396169|NCT00289289|39931310|FG000|Overall Study|Non-study device implanted|2|||
16396170|NCT00289289|39931311|FG001|Overall Study|Non-study device implanted|1|||
16324897|NCT04526509|39674616|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
16324898|NCT04526509|39674617|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
16324899|NCT04526509|39674618|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
16324900|NCT04526509|39674619|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
16324901|NCT04526509|39674620|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
16324902|NCT04526509|39674614|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
16324903|NCT04526509|39674615|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
16324904|NCT04526509|39674616|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
16324905|NCT04526509|39674617|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
16324906|NCT04526509|39674618|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
16324907|NCT04526509|39674619|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
16324908|NCT04526509|39674620|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
16324909|NCT04526509|39674614|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
16324910|NCT04526509|39674615|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
16324911|NCT04526509|39674616|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
16324912|NCT04526509|39674617|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
16324913|NCT04526509|39674618|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
16324914|NCT04526509|39674619|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
16396171|NCT00289289|39931312|FG002|Overall Study|Non-study device implanted|3|||
16396172|NCT00289289|39931310|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
16396173|NCT00289289|39931311|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
16396174|NCT00289289|39931312|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
16396175|NCT00289289|39931310|FG000|Overall Study|Other Exit Reason|6|||
16396176|NCT00289289|39931311|FG001|Overall Study|Other Exit Reason|4|||
16396177|NCT00289289|39931312|FG002|Overall Study|Other Exit Reason|12|||
16521772|NCT00009737|40376520|FG001|Overall Study|Death|6|||
16521773|NCT00009737|40376519|FG000|Overall Study|Lack of Efficacy|17|||
16521774|NCT00009737|40376520|FG001|Overall Study|Lack of Efficacy|15|||
16521775|NCT00009737|40376519|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
16521776|NCT00009737|40376520|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
16521777|NCT00009737|40376519|FG000|Overall Study|Other Protocol Violation|1|||
16521778|NCT00009737|40376520|FG001|Overall Study|Other Protocol Violation|0|||
16521779|NCT00009737|40376519|FG000|Overall Study|Refused Treatment|15|||
16521780|NCT00009737|40376520|FG001|Overall Study|Refused Treatment|16|||
16521781|NCT00009737|40376519|FG000|Overall Study|Lost to Follow-up|1|||
16521782|NCT00009737|40376520|FG001|Overall Study|Lost to Follow-up|1|||
16521783|NCT00009737|40376519|FG000|Overall Study|Administrative/Other Reasons|7|||
16521784|NCT00009737|40376520|FG001|Overall Study|Administrative/Other Reasons|1|||
16521785|NCT04983901|40376521|FG000|Overall Study|Death|1|||
16521786|NCT04983901|40376522|FG001|Overall Study|Death|4|||
16521787|NCT04983901|40376521|FG000|Overall Study|Lost to Follow-up|3|||
16521788|NCT04983901|40376522|FG001|Overall Study|Lost to Follow-up|0|||
16521789|NCT04983901|40376521|FG000|Overall Study|Protocol Violation|1|||
16521790|NCT04983901|40376522|FG001|Overall Study|Protocol Violation|0|||
16521791|NCT04983901|40376521|FG000|Overall Study|Withdrawal by Subject|1|||
16521792|NCT04983901|40376522|FG001|Overall Study|Withdrawal by Subject|2|||
16521793|NCT00982319|40376525|FG000|Overall Study|Surgery date change|1|||
16521794|NCT00982319|40376526|FG001|Overall Study|Surgery date change|0|||
16521795|NCT00982319|40376525|FG000|Overall Study|Preop values out of acceptable range|1|||
16521796|NCT00982319|40376526|FG001|Overall Study|Preop values out of acceptable range|1|||
16521797|NCT00982319|40376525|FG000|Overall Study|Pregnancy|0|||
16521798|NCT00982319|40376526|FG001|Overall Study|Pregnancy|1|||
16521799|NCT03348904|40376533|FG000|Overall Study|Administrative reason by the sponsor|0|||
16521800|NCT03348904|40376534|FG001|Overall Study|Administrative reason by the sponsor|1|||
16521801|NCT03348904|40376535|FG002|Overall Study|Administrative reason by the sponsor|0|||
16521802|NCT00023452|40376536|FG000|Overall Study|Ineligible for Study|163|||
16521803|NCT00023452|40376537|FG001|Overall Study|Ineligible for Study|159|||
16521804|NCT00023452|40376536|FG000|Overall Study|Out of Window|129|||
16521805|NCT00023452|40376537|FG001|Overall Study|Out of Window|69|||
16521806|NCT00023452|40376536|FG000|Overall Study|Death|2|||
16521807|NCT00023452|40376537|FG001|Overall Study|Death|0|||
16093913|NCT02691702|38836316|FG005|Overall Study|Withdrawal by Subject|1|||
16207131|NCT03057951|39237130|FG001|Overall Study|Patient decision|2|||
16207132|NCT03057951|39237129|FG000|Overall Study|Not attending study visits|3|||
16521808|NCT00023452|40376536|FG000|Overall Study|Withdrawal by Subject|66|||
16521809|NCT00023452|40376537|FG001|Overall Study|Withdrawal by Subject|54|||
16521810|NCT00023452|40376536|FG000|Overall Study|Adverse Event|139|||
16521811|NCT00023452|40376537|FG001|Overall Study|Adverse Event|196|||
16207133|NCT03057951|39237130|FG001|Overall Study|Not attending study visits|0|||
16207134|NCT03057951|39237129|FG000|Overall Study|Patient moved away|3|||
16207135|NCT03057951|39237130|FG001|Overall Study|Patient moved away|4|||
16207136|NCT03057951|39237129|FG000|Overall Study|Other reason than stated above|23|||
16207137|NCT03057951|39237130|FG001|Overall Study|Other reason than stated above|29|||
16207138|NCT03057951|39237129|FG000|Overall Study|Not treated|2|||
16207139|NCT03057951|39237130|FG001|Overall Study|Not treated|1|||
16207140|NCT02455388|39237134|FG000|Overall Study|Protocol Violation|1|||
16207141|NCT02455388|39237135|FG001|Overall Study|Protocol Violation|0|||
16207142|NCT02455388|39237136|FG002|Overall Study|Protocol Violation|4|||
16207143|NCT02455388|39237134|FG000|Overall Study|Withdrawal by Subject|0|||
16207144|NCT02455388|39237135|FG001|Overall Study|Withdrawal by Subject|0|||
16207145|NCT02455388|39237136|FG002|Overall Study|Withdrawal by Subject|7|||
16207146|NCT04038385|39237137|FG000|Overall Study|Completed baseline assessment only|7|||
16207147|NCT04038385|39237138|FG001|Overall Study|Completed baseline assessment only|4|||
16207148|NCT04038385|39237137|FG000|Overall Study|Moved out of area|4|||
16207149|NCT04038385|39237138|FG001|Overall Study|Moved out of area|2|||
16207150|NCT04038385|39237137|FG000|Overall Study|Discontinued study involvement|6|||
16207151|NCT04038385|39237138|FG001|Overall Study|Discontinued study involvement|1|||
16207152|NCT00709124|39237144|FG000|Overall Study|Death|3|||
16207153|NCT00709124|39237145|FG001|Overall Study|Death|1|||
16207154|NCT00709124|39237144|FG000|Overall Study|encephalopathy; can't do assessment|1|||
16207155|NCT00709124|39237145|FG001|Overall Study|encephalopathy; can't do assessment|0|||
16207156|NCT04968353|39237146|FG000|Overall Study|Non-compliance|1|||
16207157|NCT04968353|39237147|FG001|Overall Study|Non-compliance|0|||
16207158|NCT04968353|39237148|FG002|Overall Study|Non-compliance|2|||
16207159|NCT04968353|39237149|FG003|Overall Study|Non-compliance|0|||
16207160|NCT03215667|39237154|FG000|Overall Study|Physician Decision|4|||
16521812|NCT00023452|40376536|FG000|Overall Study|Lost to Follow-up|293|||
16521813|NCT00023452|40376537|FG001|Overall Study|Lost to Follow-up|60|||
16521814|NCT00023452|40376536|FG000|Overall Study|Physician Decision|49|||
16207161|NCT00089999|39237155|FG000|Overall Study|Adverse Event|4|||
16207162|NCT00089999|39237156|FG001|Overall Study|Adverse Event|7|||
16207163|NCT00089999|39237155|FG000|Overall Study|Withdrawal by Subject|0|||
16207164|NCT00089999|39237156|FG001|Overall Study|Withdrawal by Subject|4|||
16207165|NCT00089999|39237155|FG000|Overall Study|Lost to Follow-up|2|||
16207166|NCT00089999|39237156|FG001|Overall Study|Lost to Follow-up|1|||
16207167|NCT00089999|39237155|FG000|Overall Study|Radiological Progression of Cancer|52|||
16207168|NCT00089999|39237156|FG001|Overall Study|Radiological Progression of Cancer|44|||
16207169|NCT00089999|39237155|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
16324915|NCT04526509|39674620|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
16324916|NCT04526509|39674614|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
16324917|NCT04526509|39674615|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
16324918|NCT04526509|39674616|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
16324919|NCT04526509|39674617|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
16324920|NCT04526509|39674618|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
16324921|NCT04526509|39674619|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
16324922|NCT04526509|39674620|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
16324923|NCT04526509|39674614|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
16346359|NCT02367040|39753293|FG000|Overall Study|Progressive disease - clinical progression|6|||
16346360|NCT02367040|39753294|FG001|Overall Study|Progressive disease - clinical progression|6|||
16346361|NCT02367040|39753293|FG000|Overall Study|Drug not administered|3|||
16521815|NCT00023452|40376537|FG001|Overall Study|Physician Decision|21|||
16207170|NCT00089999|39237156|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
16207171|NCT00089999|39237155|FG000|Overall Study|Death|3|||
16207172|NCT00089999|39237156|FG001|Overall Study|Death|3|||
16324924|NCT04526509|39674615|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
16324925|NCT04526509|39674616|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
16324926|NCT04526509|39674617|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
16324927|NCT04526509|39674618|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
16324928|NCT04526509|39674619|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
16346362|NCT02367040|39753294|FG001|Overall Study|Drug not administered|2|||
16521816|NCT00023452|40376536|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
16521817|NCT00023452|40376537|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
16521818|NCT00023452|40376536|FG000|Overall Study|Pregnant|53|||
16521819|NCT00023452|40376537|FG001|Overall Study|Pregnant|20|||
16521820|NCT00023452|40376536|FG000|Overall Study|Other|204|||
16521821|NCT00023452|40376537|FG001|Overall Study|Other|69|||
16521822|NCT01663636|40376538|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
16521823|NCT01663636|40376539|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
16521824|NCT01018264|40376540|FG000|Overall Study|Withdrawal by Subject|1|||
16521825|NCT01018264|40376541|FG001|Overall Study|Withdrawal by Subject|0|||
16521826|NCT01018264|40376540|FG000|Overall Study|Lost to Follow-up|0|||
16521827|NCT01018264|40376541|FG001|Overall Study|Lost to Follow-up|1|||
16093914|NCT02691702|38836317|FG006|Overall Study|Withdrawal by Subject|2|||
16093915|NCT02691702|38836318|FG007|Overall Study|Withdrawal by Subject|0|||
16093916|NCT02691702|38836319|FG008|Overall Study|Withdrawal by Subject|0|||
16093917|NCT02691702|38836320|FG009|Overall Study|Withdrawal by Subject|0|||
16093918|NCT02691702|38836321|FG010|Overall Study|Withdrawal by Subject|0|||
16093919|NCT02691702|38836311|FG000|Overall Study|Other|0|||
16093920|NCT02691702|38836312|FG001|Overall Study|Other|0|||
16093921|NCT02691702|38836313|FG002|Overall Study|Other|0|||
16093922|NCT02691702|38836314|FG003|Overall Study|Other|0|||
16093923|NCT02691702|38836315|FG004|Overall Study|Other|0|||
16093924|NCT02691702|38836316|FG005|Overall Study|Other|0|||
16093925|NCT02691702|38836317|FG006|Overall Study|Other|1|||
16093926|NCT02691702|38836318|FG007|Overall Study|Other|0|||
16093927|NCT02691702|38836319|FG008|Overall Study|Other|1|||
16093928|NCT02691702|38836320|FG009|Overall Study|Other|0|||
16093929|NCT02691702|38836321|FG010|Overall Study|Other|0|||
16093930|NCT02691702|38836311|FG000|Overall Study|Protocol Violation|0|||
16093931|NCT02691702|38836312|FG001|Overall Study|Protocol Violation|0|||
16093932|NCT02691702|38836313|FG002|Overall Study|Protocol Violation|0|||
16093933|NCT02691702|38836314|FG003|Overall Study|Protocol Violation|0|||
16093934|NCT02691702|38836315|FG004|Overall Study|Protocol Violation|0|||
16521828|NCT04369469|40376542|FG000|Overall Study|Lost to Follow-up|2|||
16521829|NCT04369469|40376543|FG001|Overall Study|Lost to Follow-up|4|||
16093935|NCT02691702|38836316|FG005|Overall Study|Protocol Violation|0|||
16093936|NCT02691702|38836317|FG006|Overall Study|Protocol Violation|0|||
16093937|NCT02691702|38836318|FG007|Overall Study|Protocol Violation|0|||
16093938|NCT02691702|38836319|FG008|Overall Study|Protocol Violation|0|||
16093939|NCT02691702|38836320|FG009|Overall Study|Protocol Violation|2|||
16093940|NCT02691702|38836321|FG010|Overall Study|Protocol Violation|0|||
16093941|NCT00787176|38836325|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
16093942|NCT00787176|38836326|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
16093943|NCT00787176|38836327|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
16093944|NCT00787176|38836328|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
16093945|NCT00312845|38836329|FG000|Overall Study|Adverse Event|19|||
16093946|NCT00312845|38836330|FG001|Overall Study|Adverse Event|5|||
16093947|NCT00312845|38836329|FG000|Overall Study|Death|2|||
16093948|NCT00312845|38836330|FG001|Overall Study|Death|2|||
16093949|NCT00312845|38836329|FG000|Overall Study|Withdrawal by Subject|14|||
16093950|NCT00312845|38836330|FG001|Overall Study|Withdrawal by Subject|6|||
16093951|NCT00312845|38836329|FG000|Overall Study|Disease Progression|56|||
16093952|NCT00312845|38836330|FG001|Overall Study|Disease Progression|77|||
16093953|NCT00312845|38836329|FG000|Overall Study|Lost to Follow-up|2|||
16093954|NCT00312845|38836330|FG001|Overall Study|Lost to Follow-up|0|||
16093955|NCT00312845|38836329|FG000|Overall Study|Other|6|||
16093956|NCT00312845|38836330|FG001|Overall Study|Other|5|||
16093957|NCT00721734|38836331|FG000|Overall Study|Progressive Disease|3|||
16093958|NCT00721734|38836332|FG001|Overall Study|Progressive Disease|10|||
16093959|NCT00721734|38836333|FG002|Overall Study|Progressive Disease|4|||
16093960|NCT00721734|38836334|FG003|Overall Study|Progressive Disease|5|||
16093961|NCT00721734|38836335|FG004|Overall Study|Progressive Disease|2|||
16093962|NCT00721734|38836331|FG000|Overall Study|Adverse Event|3|||
16093963|NCT00721734|38836332|FG001|Overall Study|Adverse Event|1|||
16093964|NCT00721734|38836333|FG002|Overall Study|Adverse Event|4|||
16093965|NCT00721734|38836334|FG003|Overall Study|Adverse Event|0|||
16093966|NCT00721734|38836335|FG004|Overall Study|Adverse Event|3|||
16093967|NCT00721734|38836331|FG000|Overall Study|Withdrawal by Subject|2|||
16093968|NCT00721734|38836332|FG001|Overall Study|Withdrawal by Subject|1|||
16093969|NCT00721734|38836333|FG002|Overall Study|Withdrawal by Subject|0|||
16093970|NCT00721734|38836334|FG003|Overall Study|Withdrawal by Subject|0|||
16093971|NCT00721734|38836335|FG004|Overall Study|Withdrawal by Subject|1|||
16093972|NCT00721734|38836331|FG000|Overall Study|Other|0|||
16093973|NCT00721734|38836332|FG001|Overall Study|Other|0|||
16093974|NCT00721734|38836333|FG002|Overall Study|Other|0|||
16093975|NCT00721734|38836334|FG003|Overall Study|Other|1|||
16093976|NCT00721734|38836335|FG004|Overall Study|Other|0|||
16093977|NCT02245620|38836336|FG000|Overall Study|Physician Decision|1|||
16093978|NCT02245620|38836337|FG001|Overall Study|Physician Decision|1|||
16093979|NCT02163499|38836338|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
16093980|NCT02163499|38836338|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
16093981|NCT02163499|38836338|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
16093982|NCT02163499|38836338|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
16093983|NCT02163499|38836338|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
16093984|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
16093985|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
16093986|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
16093987|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
16093988|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
16093989|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
16093990|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
16093991|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
16093992|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
16093993|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Death|8|||
16093994|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
16093995|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
16093996|NCT02163499|38836338|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
16093997|NCT00091572|38836343|FG000|Overall Study|Lost to Follow-up|1|||
16093998|NCT00091572|38836344|FG001|Overall Study|Lost to Follow-up|1|||
16093999|NCT00091572|38836343|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
16094000|NCT00091572|38836344|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
16094001|NCT00091572|38836343|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
16094002|NCT00091572|38836344|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
16094003|NCT00091572|38836343|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
16094004|NCT00091572|38836344|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
16094005|NCT00091572|38836343|FG000|Overall Study|Other Reason|6|||
16094006|NCT00091572|38836344|FG001|Overall Study|Other Reason|13|||
16094007|NCT00091572|38836343|FG000|Overall Study|Ongoing (still on treatment)|8|||
16094008|NCT00091572|38836344|FG001|Overall Study|Ongoing (still on treatment)|12|||
16094009|NCT00091572|38836343|FG000|Overall Study|Major Protocol Violation|2|||
16094010|NCT00091572|38836344|FG001|Overall Study|Major Protocol Violation|0|||
16521830|NCT04369469|40376542|FG000|Overall Study|Physician Decision|2|||
16094011|NCT00091572|38836343|FG000|Overall Study|Toxicity (Related AE)|53|||
16094012|NCT00091572|38836344|FG001|Overall Study|Toxicity (Related AE)|9|||
16094013|NCT03529942|38836345|FG000|Overall Study|Withdrawal by Subject|13|||
16521831|NCT04369469|40376543|FG001|Overall Study|Physician Decision|1|||
16094014|NCT03529942|38836345|FG000|Overall Study|Physician Decision|1|||
16094015|NCT03529942|38836345|FG000|Overall Study|Lost to Follow-up|7|||
16094016|NCT03529942|38836345|FG000|Overall Study|Needle inserted but no drug administered|1|||
16521832|NCT04369469|40376542|FG000|Overall Study|Withdrawal by Subject|2|||
16521833|NCT04369469|40376543|FG001|Overall Study|Withdrawal by Subject|3|||
16521834|NCT04369469|40376542|FG000|Overall Study|Adverse Event|1|||
16521835|NCT04369469|40376543|FG001|Overall Study|Adverse Event|0|||
16521836|NCT04369469|40376542|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
16521837|NCT04369469|40376543|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
16521838|NCT04369469|40376542|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
16521839|NCT04369469|40376543|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
16521840|NCT04369469|40376542|FG000|Overall Study|Unable to Provide Consent|0|||
16521841|NCT04369469|40376543|FG001|Overall Study|Unable to Provide Consent|1|||
16521842|NCT02720484|40376551|FG000|Treatment on Study|Adverse Event|1|||
16521843|NCT02720484|40376551|FG000|Treatment on Study|Withdrawal by Subject|1|||
16521844|NCT02720484|40376551|FG000|Treatment on Study|Progressive Disease|4|||
16521845|NCT02720484|40376551|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
16094017|NCT03529942|38836345|FG000|Overall Study|Personal reasons|1|||
16094018|NCT01072149|38836349|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094019|NCT01072149|38836350|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094020|NCT01072149|38836351|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
16094021|NCT01072149|38836352|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094022|NCT01072149|38836353|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094023|NCT01072149|38836354|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16207173|NCT00089999|39237155|FG000|Overall Study|Poor General Condition|1|||
16324929|NCT04526509|39674620|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
16521846|NCT02720484|40376551|FG000|Follow Up for 2 Years|Death|3|||
16521847|NCT02720484|40376551|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
16521848|NCT02805257|40376552|FG000|Overall Study|Lost to Follow-up|7|||
16521849|NCT02805257|40376553|FG001|Overall Study|Lost to Follow-up|6|||
16521850|NCT02805257|40376552|FG000|Overall Study|Death|0|||
16521851|NCT02805257|40376553|FG001|Overall Study|Death|1|||
16521852|NCT01358981|40376554|FG000|Period 1|Withdrawal by Subject|0|||
16521853|NCT01358981|40376555|FG001|Period 1|Withdrawal by Subject|0|||
16521854|NCT01358981|40376556|FG002|Period 1|Withdrawal by Subject|0|||
16521855|NCT01358981|40376557|FG003|Period 1|Withdrawal by Subject|1|||
16521856|NCT01358981|40376558|FG004|Period 1|Withdrawal by Subject|0|||
16521857|NCT01358981|40376559|FG005|Period 1|Withdrawal by Subject|0|||
16521858|NCT01358981|40376560|FG006|Period 1|Withdrawal by Subject|0|||
16521859|NCT00503841|40376561|FG000|Overall Study|All screen failures|44|||
16521860|NCT01343056|40376562|FG000|Overall Study|Lost to Follow-up|7|||
16521861|NCT01343056|40376563|FG001|Overall Study|Lost to Follow-up|5|||
16521862|NCT01343056|40376564|FG002|Overall Study|Lost to Follow-up|3|||
16521863|NCT01343056|40376565|FG003|Overall Study|Lost to Follow-up|9|||
16521864|NCT01785524|40376566|FG000|Overall Study|Withdrawal by Subject|2|||
16521865|NCT01785524|40376567|FG001|Overall Study|Withdrawal by Subject|2|||
16521866|NCT02573324|40376576|FG000|Overall Study|Withdrawal by Subject|26|||
16521867|NCT02573324|40376577|FG001|Overall Study|Withdrawal by Subject|23|||
16521868|NCT02573324|40376578|FG002|Overall Study|Withdrawal by Subject|3|||
16521869|NCT02573324|40376576|FG000|Overall Study|Lost to Follow-up|4|||
16521870|NCT02573324|40376577|FG001|Overall Study|Lost to Follow-up|5|||
16521871|NCT02573324|40376578|FG002|Overall Study|Lost to Follow-up|0|||
16324930|NCT04526509|39674614|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
16324931|NCT04526509|39674615|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
16324932|NCT04526509|39674616|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
16324933|NCT04526509|39674617|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
16521872|NCT02573324|40376576|FG000|Overall Study|Study Terminated by Sponsor|107|||
16521873|NCT02573324|40376577|FG001|Overall Study|Study Terminated by Sponsor|89|||
16521874|NCT02573324|40376578|FG002|Overall Study|Study Terminated by Sponsor|2|||
16521875|NCT02573324|40376576|FG000|Overall Study|Death|182|||
16324934|NCT04526509|39674618|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
16346363|NCT02367040|39753293|FG000|Overall Study|Progressive disease|0|||
16521876|NCT02573324|40376577|FG001|Overall Study|Death|200|||
16521877|NCT02573324|40376578|FG002|Overall Study|Death|1|||
16521878|NCT02573324|40376576|FG000|Overall Study|Other, Not Specified|20|||
16521879|NCT02573324|40376577|FG001|Overall Study|Other, Not Specified|27|||
16521880|NCT02573324|40376578|FG002|Overall Study|Other, Not Specified|0|||
16521881|NCT02573324|40376576|FG000|Overall Study|Unknown Reason|2|||
16521882|NCT02573324|40376577|FG001|Overall Study|Unknown Reason|0|||
16521883|NCT02573324|40376578|FG002|Overall Study|Unknown Reason|0|||
16094024|NCT01072149|38836355|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16521884|NCT00110266|40376579|FG000|Overall Study|Adverse Event|27|||
16521885|NCT00110266|40376579|FG000|Overall Study|Abnormal laboratory value|15|||
16521886|NCT00110266|40376579|FG000|Overall Study|Withdrawal by Subject|16|||
16521887|NCT00110266|40376579|FG000|Overall Study|Death|17|||
16521888|NCT00110266|40376579|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16521889|NCT00110266|40376579|FG000|Overall Study|Participant condition no longer requires study drug|1|||
16521890|NCT00779246|40376580|FG000|Overall Study|Missing sufficient data for analysis|33|||
16521891|NCT00779246|40376581|FG001|Overall Study|Missing sufficient data for analysis|53|||
16521892|NCT02610192|40376582|FG000|Overall Study|Received other treatment|8|||
16521893|NCT02610192|40376582|FG000|Overall Study|Physician Decision|1|||
16521894|NCT02604589|40376583|FG000|Overall Study|catheter dislodgement|0|||
16521895|NCT02604589|40376584|FG001|Overall Study|catheter dislodgement|0|||
16521896|NCT02604589|40376585|FG002|Overall Study|catheter dislodgement|1|||
16207174|NCT00089999|39237156|FG001|Overall Study|Poor General Condition|0|||
16324935|NCT04526509|39674619|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
16324936|NCT04526509|39674620|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
16207175|NCT00089999|39237155|FG000|Overall Study|Clinical Progression|1|||
16207176|NCT00089999|39237156|FG001|Overall Study|Clinical Progression|2|||
16207177|NCT00089999|39237155|FG000|Overall Study|Physician Decision|2|||
16207178|NCT00089999|39237156|FG001|Overall Study|Physician Decision|2|||
16521897|NCT02606136|40376587|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
16521898|NCT02606136|40376587|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
16521899|NCT02606136|40376587|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
16521900|NCT02606136|40376587|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
16521901|NCT04317586|40376588|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
16521902|NCT04317586|40376588|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
16521903|NCT03003676|40376589|FG000|Overall Study|Lack of Efficacy|5|||
16521904|NCT03003676|40376590|FG001|Overall Study|Lack of Efficacy|7|||
16521905|NCT03003676|40376589|FG000|Overall Study|Withdrawal by Subject|0|||
16521906|NCT03003676|40376590|FG001|Overall Study|Withdrawal by Subject|1|||
16521907|NCT03003676|40376589|FG000|Overall Study|Hepatitis B infection|1|||
16521908|NCT03003676|40376590|FG001|Overall Study|Hepatitis B infection|0|||
16207179|NCT00089999|39237155|FG000|Overall Study|Patient Underwent Surgery|2|||
16207180|NCT00089999|39237156|FG001|Overall Study|Patient Underwent Surgery|0|||
16207181|NCT00089999|39237155|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
16207182|NCT00089999|39237156|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
16207183|NCT01690988|39237158|FG000|Overall Study|Withdrawal by Subject|2|||
16207184|NCT01690988|39237159|FG001|Overall Study|Withdrawal by Subject|2|||
16207185|NCT01690988|39237160|FG002|Overall Study|Withdrawal by Subject|3|||
16207186|NCT01690988|39237158|FG000|Overall Study|Physician Decision|0|||
16207187|NCT01690988|39237159|FG001|Overall Study|Physician Decision|0|||
16207188|NCT01690988|39237160|FG002|Overall Study|Physician Decision|1|||
16207189|NCT01690988|39237158|FG000|Overall Study|Operation Cancelled|1|||
16207190|NCT01690988|39237159|FG001|Overall Study|Operation Cancelled|1|||
16207191|NCT01690988|39237160|FG002|Overall Study|Operation Cancelled|0|||
16207192|NCT01690988|39237158|FG000|Overall Study|Determined ineligible|1|||
16207193|NCT01690988|39237159|FG001|Overall Study|Determined ineligible|0|||
16207194|NCT01690988|39237160|FG002|Overall Study|Determined ineligible|0|||
16324937|NCT04526509|39674614|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
16324938|NCT04526509|39674615|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
16521909|NCT01715805|40380065|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
16521910|NCT01715805|40380066|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
16521911|NCT01715805|40380067|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
16521912|NCT01715805|40380068|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
16521913|NCT01715805|40380065|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
16521914|NCT01715805|40380066|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
16521915|NCT01715805|40380067|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
16521916|NCT01715805|40380068|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
16521917|NCT01715805|40380065|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
16521918|NCT01715805|40380066|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
16521919|NCT01715805|40380067|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
16521920|NCT01715805|40380068|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
16346364|NCT02367040|39753294|FG001|Overall Study|Progressive disease|1|||
16207195|NCT01690988|39237158|FG000|Overall Study|Death|1|||
16207196|NCT01690988|39237159|FG001|Overall Study|Death|1|||
16521921|NCT01715805|40380065|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
16521922|NCT01715805|40380066|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
16521923|NCT01715805|40380067|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
16521924|NCT01715805|40380068|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
16521925|NCT01715805|40380065|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
16521926|NCT01715805|40380066|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
16521927|NCT01715805|40380067|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
16521928|NCT01715805|40380068|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
16521929|NCT01715805|40380065|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
16521930|NCT01715805|40380066|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
16521931|NCT01715805|40380067|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
16521932|NCT01715805|40380068|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
16521933|NCT01715805|40380065|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
16521934|NCT01715805|40380066|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
16521935|NCT01715805|40380067|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
16521936|NCT01715805|40380068|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
16521937|NCT01715805|40380065|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
16521938|NCT01715805|40380066|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
16521939|NCT01715805|40380067|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
16521940|NCT01715805|40380068|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
16521941|NCT01715805|40380065|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
16521942|NCT01715805|40380066|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
16521943|NCT01715805|40380067|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
16521944|NCT01715805|40380068|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
16521945|NCT01715805|40380065|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
16521946|NCT01715805|40380066|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
16521947|NCT01715805|40380067|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
16521948|NCT01715805|40380068|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
16521949|NCT01715805|40380065|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
16521950|NCT01715805|40380066|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
16521951|NCT01715805|40380067|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
16521952|NCT01715805|40380068|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
16207197|NCT01690988|39237160|FG002|Overall Study|Death|1|||
16207198|NCT01690988|39237158|FG000|Overall Study|Sedated|1|||
16207199|NCT01690988|39237159|FG001|Overall Study|Sedated|1|||
16207200|NCT01690988|39237160|FG002|Overall Study|Sedated|2|||
16207201|NCT02944513|39237161|FG000|Overall Study|Withdrawal by Subject|4|||
16207202|NCT02944513|39237162|FG001|Overall Study|Withdrawal by Subject|1|||
16207203|NCT00605722|39237163|FG000|Overall Study|Adverse Event|6|||
16207204|NCT00605722|39237163|FG000|Overall Study|Insufficient therapeutic response|44|||
16207205|NCT00605722|39237163|FG000|Overall Study|Failure to return|1|||
16207206|NCT01000025|39237165|FG000|Overall Study|Adverse Event|43|||
16207207|NCT01000025|39237166|FG001|Overall Study|Adverse Event|2|||
16207208|NCT01000025|39237165|FG000|Overall Study|Withdrawal by Subject|13|||
16207209|NCT01000025|39237166|FG001|Overall Study|Withdrawal by Subject|8|||
16396178|NCT00652743|39931313|FG000|Months 12-18|Lost to Follow-up|1|||
16521953|NCT01715805|40380065|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
16207210|NCT01000025|39237165|FG000|Overall Study|Death|23|||
16207211|NCT01000025|39237166|FG001|Overall Study|Death|13|||
16521954|NCT01715805|40380066|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
16521955|NCT01715805|40380067|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
16207212|NCT01000025|39237165|FG000|Overall Study|Lack of Efficacy|363|||
16207213|NCT01000025|39237166|FG001|Overall Study|Lack of Efficacy|208|||
16207214|NCT01000025|39237165|FG000|Overall Study|Intercurrent Illness|26|||
16207215|NCT01000025|39237166|FG001|Overall Study|Intercurrent Illness|7|||
16207216|NCT03628599|39237167|FG000|Overall Study|Adverse Event|0|||
16207217|NCT03628599|39237168|FG001|Overall Study|Adverse Event|1|||
16207218|NCT01925612|39237172|FG000|Overall Study|Progressive Disease|1|||
16207219|NCT01925612|39237173|FG001|Overall Study|Progressive Disease|1|||
16207220|NCT01925612|39237174|FG002|Overall Study|Progressive Disease|1|||
16207221|NCT01925612|39237175|FG003|Overall Study|Progressive Disease|0|||
16207222|NCT01925612|39237176|FG004|Overall Study|Progressive Disease|0|||
16207223|NCT01925612|39237172|FG000|Overall Study|Adverse Event|3|||
16207224|NCT01925612|39237173|FG001|Overall Study|Adverse Event|3|||
16207225|NCT01925612|39237174|FG002|Overall Study|Adverse Event|0|||
16396179|NCT00652743|39931314|FG001|Months 12-18|Lost to Follow-up|2|||
16521956|NCT01715805|40380068|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
16094025|NCT01072149|38836356|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16207226|NCT01925612|39237175|FG003|Overall Study|Adverse Event|1|||
16207227|NCT01925612|39237176|FG004|Overall Study|Adverse Event|2|||
16207228|NCT00659126|39237177|FG000|Overall Study|Adverse Event|2|||
16207229|NCT00659126|39237178|FG001|Overall Study|Adverse Event|2|||
16207230|NCT00659126|39237177|FG000|Overall Study|Screen failure|1|||
16207231|NCT00659126|39237178|FG001|Overall Study|Screen failure|1|||
16207232|NCT00659126|39237177|FG000|Overall Study|Technical problems with MRI|0|||
16207233|NCT00659126|39237178|FG001|Overall Study|Technical problems with MRI|1|||
16207234|NCT01316939|39237181|FG000|Overall Study|Study closed/terminated|26|||
16207235|NCT01316939|39237182|FG001|Overall Study|Study closed/terminated|25|||
16207236|NCT01316939|39237183|FG002|Overall Study|Study closed/terminated|23|||
16207237|NCT01316939|39237181|FG000|Overall Study|Lack of Efficacy|24|||
16207238|NCT01316939|39237182|FG001|Overall Study|Lack of Efficacy|25|||
16207239|NCT01316939|39237183|FG002|Overall Study|Lack of Efficacy|25|||
16207240|NCT01316939|39237181|FG000|Overall Study|Adverse Event|9|||
16207241|NCT01316939|39237182|FG001|Overall Study|Adverse Event|12|||
16207242|NCT01316939|39237183|FG002|Overall Study|Adverse Event|11|||
16207243|NCT01316939|39237181|FG000|Overall Study|Withdrawal by Subject|1|||
16207244|NCT01316939|39237182|FG001|Overall Study|Withdrawal by Subject|3|||
16207245|NCT01316939|39237183|FG002|Overall Study|Withdrawal by Subject|6|||
16207246|NCT01316939|39237181|FG000|Overall Study|Physician Decision|2|||
16207247|NCT01316939|39237182|FG001|Overall Study|Physician Decision|2|||
16207248|NCT01316939|39237183|FG002|Overall Study|Physician Decision|1|||
16324939|NCT04526509|39674616|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
16324940|NCT04526509|39674617|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
16324941|NCT04526509|39674618|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
16324942|NCT04526509|39674619|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
16324943|NCT04526509|39674620|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
16324944|NCT04526509|39674614|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
16324945|NCT04526509|39674615|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
16324946|NCT04526509|39674616|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
16324947|NCT04526509|39674617|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
16324948|NCT04526509|39674618|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
16346365|NCT02367040|39753293|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
16094026|NCT01072149|38836357|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16207249|NCT01316939|39237181|FG000|Overall Study|Lost to Follow-up|0|||
16207250|NCT01316939|39237182|FG001|Overall Study|Lost to Follow-up|0|||
16207251|NCT01316939|39237183|FG002|Overall Study|Lost to Follow-up|2|||
16324949|NCT04526509|39674619|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
16324950|NCT04526509|39674620|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
16324951|NCT04526509|39674614|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
16324952|NCT04526509|39674615|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
16094027|NCT01072149|38836358|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094028|NCT01072149|38836359|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094029|NCT01072149|38836360|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094030|NCT01072149|38836361|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094031|NCT01072149|38836362|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094032|NCT01072149|38836363|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094033|NCT01072149|38836364|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094034|NCT01072149|38836365|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094035|NCT01072149|38836366|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16094036|NCT01072149|38836349|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094037|NCT01072149|38836350|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094038|NCT01072149|38836351|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094039|NCT01072149|38836352|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094040|NCT01072149|38836353|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094041|NCT01072149|38836354|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094042|NCT01072149|38836355|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094043|NCT01072149|38836356|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094044|NCT01072149|38836357|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16324953|NCT04526509|39674616|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
16324954|NCT04526509|39674617|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
16094045|NCT01072149|38836358|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094046|NCT01072149|38836359|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094047|NCT01072149|38836360|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094048|NCT01072149|38836361|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094049|NCT01072149|38836362|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094050|NCT01072149|38836363|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094051|NCT01072149|38836364|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094052|NCT01072149|38836365|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
16094053|NCT01072149|38836366|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
16094054|NCT01072149|38836349|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094055|NCT01072149|38836350|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094056|NCT01072149|38836351|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094057|NCT01072149|38836352|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094058|NCT01072149|38836353|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094059|NCT01072149|38836354|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094060|NCT01072149|38836355|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094061|NCT01072149|38836356|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094062|NCT01072149|38836357|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094063|NCT01072149|38836358|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094064|NCT01072149|38836359|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
16094065|NCT01072149|38836360|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094066|NCT01072149|38836361|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094067|NCT01072149|38836362|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094068|NCT01072149|38836363|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094069|NCT01072149|38836364|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094070|NCT01072149|38836365|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094071|NCT01072149|38836366|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16094072|NCT01072149|38836349|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094073|NCT01072149|38836350|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
16094074|NCT01072149|38836351|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094075|NCT01072149|38836352|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16324955|NCT04526509|39674618|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
16324956|NCT04526509|39674619|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
16324957|NCT04526509|39674620|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
16324958|NCT04526509|39674614|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
16324959|NCT04526509|39674615|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
16324960|NCT04526509|39674616|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
16396180|NCT00652743|39931315|FG002|Months 12-18|Lost to Follow-up|7|||
16324961|NCT04526509|39674617|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
16324962|NCT04526509|39674618|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
16324963|NCT04526509|39674619|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
16324964|NCT04526509|39674620|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
16324965|NCT04526509|39674614|FG000|Enrolled|Study Terminated by Sponsor|0|||
16396181|NCT00652743|39931313|FG000|Months 24-30|Other|5|||
16396182|NCT00652743|39931314|FG001|Months 24-30|Other|1|||
16396183|NCT00652743|39931315|FG002|Months 24-30|Other|11|||
16396184|NCT00652743|39931313|FG000|Months 36-42|Serious Adverse Events|0|||
16396185|NCT00652743|39931314|FG001|Months 36-42|Serious Adverse Events|1|||
16396186|NCT00652743|39931315|FG002|Months 36-42|Serious Adverse Events|1|||
16396187|NCT00652743|39931313|FG000|Months 36-42|Withdrawal by Subject|1|||
16396188|NCT00652743|39931314|FG001|Months 36-42|Withdrawal by Subject|1|||
16396189|NCT00652743|39931315|FG002|Months 36-42|Withdrawal by Subject|0|||
16396190|NCT00652743|39931313|FG000|Months 36-42|Lost to Follow-up|0|||
16396191|NCT00652743|39931314|FG001|Months 36-42|Lost to Follow-up|1|||
16396192|NCT00652743|39931315|FG002|Months 36-42|Lost to Follow-up|0|||
16396193|NCT00652743|39931313|FG000|Months 36-42|Migrated/moved from study area|1|||
16396194|NCT00652743|39931314|FG001|Months 36-42|Migrated/moved from study area|0|||
16396195|NCT00652743|39931315|FG002|Months 36-42|Migrated/moved from study area|0|||
16396196|NCT00652743|39931313|FG000|Months 36-42|Other|4|||
16396197|NCT00652743|39931314|FG001|Months 36-42|Other|2|||
16396198|NCT00652743|39931315|FG002|Months 36-42|Other|8|||
16396199|NCT00438360|39931316|FG000|Overall Study|Adverse Event|6|||
16396200|NCT00438360|39931317|FG001|Overall Study|Adverse Event|1|||
16396201|NCT00438360|39931316|FG000|Overall Study|Lack of Efficacy|42|||
16396202|NCT00438360|39931317|FG001|Overall Study|Lack of Efficacy|27|||
16396203|NCT00438360|39931316|FG000|Overall Study|Other|24|||
16396204|NCT00438360|39931317|FG001|Overall Study|Other|15|||
16396205|NCT02702609|39931320|FG000|Overall Study|Lost to Follow-up|8|||
16396206|NCT02702609|39931321|FG001|Overall Study|Lost to Follow-up|4|||
16396207|NCT02702609|39931320|FG000|Overall Study|Physician Decision|1|||
16396208|NCT02702609|39931321|FG001|Overall Study|Physician Decision|0|||
16396209|NCT00854724|39931322|FG000|First Intervention|Withdrawal by Subject|1|||
16396210|NCT00854724|39931323|FG001|First Intervention|Withdrawal by Subject|1|||
16396211|NCT00854724|39931322|FG000|Washout|Protocol Violation|1|||
16396212|NCT00854724|39931323|FG001|Washout|Protocol Violation|0|||
16396213|NCT00854724|39931322|FG000|Washout|Withdrawal by Subject|0|||
16396214|NCT00854724|39931323|FG001|Washout|Withdrawal by Subject|1|||
16396215|NCT00854724|39931322|FG000|Second Intervention|Protocol Violation|1|||
16396216|NCT00854724|39931323|FG001|Second Intervention|Protocol Violation|0|||
16396217|NCT00854724|39931322|FG000|Second Intervention|Physician Decision|0|||
16396218|NCT00854724|39931323|FG001|Second Intervention|Physician Decision|1|||
16396219|NCT00260832|39931325|FG000|Overall Study|Adverse Event|26|||
16396220|NCT00260832|39931326|FG001|Overall Study|Adverse Event|19|||
16396221|NCT00260832|39931325|FG000|Overall Study|Progression|116|||
16521957|NCT01715805|40380065|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
16521958|NCT01715805|40380066|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
16207252|NCT01316939|39237181|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
16207253|NCT01316939|39237182|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
16207254|NCT01316939|39237183|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
16207255|NCT01316939|39237181|FG000|Overall Study|Protocol Violation|0|||
16324966|NCT04526509|39674615|FG001|Enrolled|Study Terminated by Sponsor|0|||
16324967|NCT04526509|39674616|FG002|Enrolled|Study Terminated by Sponsor|0|||
16324968|NCT04526509|39674617|FG003|Enrolled|Study Terminated by Sponsor|0|||
16521959|NCT01715805|40380067|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
16521960|NCT01715805|40380068|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
16521961|NCT01715805|40380065|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
16521962|NCT01715805|40380066|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
16521963|NCT01715805|40380067|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
16396222|NCT00260832|39931326|FG001|Overall Study|Progression|96|||
16396223|NCT00260832|39931325|FG000|Overall Study|Withdrawal by Subject|15|||
16396224|NCT00260832|39931326|FG001|Overall Study|Withdrawal by Subject|17|||
16396225|NCT00260832|39931325|FG000|Overall Study|Physician Decision|15|||
16396226|NCT00260832|39931326|FG001|Overall Study|Physician Decision|9|||
16396227|NCT00260832|39931325|FG000|Overall Study|Death|43|||
16396228|NCT00260832|39931326|FG001|Overall Study|Death|62|||
16396229|NCT00260832|39931325|FG000|Overall Study|Other|10|||
16396230|NCT00260832|39931326|FG001|Overall Study|Other|7|||
16396231|NCT00260832|39931325|FG000|Overall Study|Protocol Violation|3|||
16396232|NCT00260832|39931326|FG001|Overall Study|Protocol Violation|1|||
16324969|NCT04526509|39674618|FG004|Enrolled|Study Terminated by Sponsor|0|||
16324970|NCT04526509|39674619|FG005|Enrolled|Study Terminated by Sponsor|0|||
16324971|NCT04526509|39674620|FG006|Enrolled|Study Terminated by Sponsor|1|||
16324972|NCT04526509|39674614|FG000|Enrolled|Death prior to lymphodepletion|0|||
16324973|NCT04526509|39674615|FG001|Enrolled|Death prior to lymphodepletion|0|||
16324974|NCT04526509|39674616|FG002|Enrolled|Death prior to lymphodepletion|0|||
16324975|NCT04526509|39674617|FG003|Enrolled|Death prior to lymphodepletion|1|||
16324976|NCT04526509|39674618|FG004|Enrolled|Death prior to lymphodepletion|0|||
16324977|NCT04526509|39674619|FG005|Enrolled|Death prior to lymphodepletion|0|||
16324978|NCT04526509|39674620|FG006|Enrolled|Death prior to lymphodepletion|0|||
16324979|NCT04526509|39674614|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
16324980|NCT04526509|39674615|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
16324981|NCT04526509|39674616|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
16324982|NCT04526509|39674617|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
16324983|NCT04526509|39674618|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
16324984|NCT04526509|39674619|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
16324985|NCT04526509|39674620|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
16324986|NCT04526509|39674614|FG000|Enrolled|Physician Decision|0|||
16324987|NCT04526509|39674615|FG001|Enrolled|Physician Decision|1|||
16324988|NCT04526509|39674616|FG002|Enrolled|Physician Decision|0|||
16324989|NCT04526509|39674617|FG003|Enrolled|Physician Decision|0|||
16396233|NCT03462641|39931327|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
16396234|NCT03462641|39931328|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
16396235|NCT03462641|39931327|FG000|Visit 2|Withdrawal by Subject|0|||
16396236|NCT03462641|39931328|FG001|Visit 2|Withdrawal by Subject|1|||
16396237|NCT03820986|39931329|FG000|Overall Study|Death|177|||
16396238|NCT03820986|39931330|FG001|Overall Study|Death|156|||
16396239|NCT03820986|39931329|FG000|Overall Study|Lost to Follow-up|0|||
16396240|NCT03820986|39931330|FG001|Overall Study|Lost to Follow-up|1|||
16396241|NCT03820986|39931329|FG000|Overall Study|Withdrawal by Subject|8|||
16396242|NCT03820986|39931330|FG001|Overall Study|Withdrawal by Subject|3|||
16396243|NCT03820986|39931329|FG000|Overall Study|Ongoing|149|||
16396244|NCT03820986|39931330|FG001|Overall Study|Ongoing|180|||
16396245|NCT00583752|39931332|FG000|Overall Study|Lost to Follow-up|5|||
16396246|NCT00583752|39931333|FG001|Overall Study|Lost to Follow-up|5|||
16396247|NCT00690794|39931334|FG000|Overall Study|Adverse Event|12|||
16396248|NCT00690794|39931335|FG001|Overall Study|Adverse Event|10|||
16396249|NCT00690794|39931334|FG000|Overall Study|Lost to Follow-up|1|||
16396250|NCT00690794|39931335|FG001|Overall Study|Lost to Follow-up|4|||
16396251|NCT00690794|39931334|FG000|Overall Study|Withdrawal by Subject|0|||
16396252|NCT00690794|39931335|FG001|Overall Study|Withdrawal by Subject|9|||
16324990|NCT04526509|39674618|FG004|Enrolled|Physician Decision|0|||
16324991|NCT04526509|39674619|FG005|Enrolled|Physician Decision|0|||
16324992|NCT04526509|39674620|FG006|Enrolled|Physician Decision|0|||
16324993|NCT01258998|39674632|FG000|Overall Study|Ineligible|1|||
16324994|NCT00900159|39674633|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
16324995|NCT00900159|39674634|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
16396253|NCT00690794|39931334|FG000|Overall Study|Protocol Violation|6|||
16324996|NCT03706430|39674636|FG000|Overall Study|No A-Line placed|5|||
16324997|NCT03706430|39674636|FG000|Overall Study|Subject had gel nail polish|1|||
16324998|NCT03706430|39674636|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
16324999|NCT03706430|39674636|FG000|Overall Study|Cancelled Case|6|||
16325000|NCT03706430|39674636|FG000|Overall Study|Physician Decision|2|||
16325001|NCT02477332|39674639|FG000|Overall Study|Adverse Event|0|||
16325002|NCT02477332|39674640|FG001|Overall Study|Adverse Event|1|||
16325003|NCT02477332|39674641|FG002|Overall Study|Adverse Event|1|||
16521964|NCT01715805|40380068|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
16521965|NCT02349711|40380072|FG000|Overall Study|Withdrawal by Subject|2|||
16207256|NCT01316939|39237182|FG001|Overall Study|Protocol Violation|1|||
16207257|NCT01316939|39237183|FG002|Overall Study|Protocol Violation|0|||
16207258|NCT00865189|39237184|FG000|Overall Study|Other|1|||
16207259|NCT00865189|39237185|FG001|Overall Study|Other|2|||
16207260|NCT00865189|39237184|FG000|Overall Study|Death|4|||
16325004|NCT02477332|39674642|FG003|Overall Study|Adverse Event|2|||
16325005|NCT02477332|39674643|FG004|Overall Study|Adverse Event|1|||
16325006|NCT02477332|39674644|FG005|Overall Study|Adverse Event|2|||
16325007|NCT02477332|39674639|FG000|Overall Study|Lack of Efficacy|1|||
16325008|NCT02477332|39674640|FG001|Overall Study|Lack of Efficacy|2|||
16325009|NCT02477332|39674641|FG002|Overall Study|Lack of Efficacy|1|||
16325010|NCT02477332|39674642|FG003|Overall Study|Lack of Efficacy|2|||
16396254|NCT00690794|39931335|FG001|Overall Study|Protocol Violation|7|||
16396255|NCT00690794|39931334|FG000|Overall Study|Noncompliance|1|||
16396256|NCT00690794|39931335|FG001|Overall Study|Noncompliance|2|||
16396257|NCT00690794|39931334|FG000|Overall Study|Other not specified|1|||
16396258|NCT00690794|39931335|FG001|Overall Study|Other not specified|3|||
16521966|NCT02349711|40380073|FG001|Overall Study|Withdrawal by Subject|1|||
16207261|NCT00865189|39237185|FG001|Overall Study|Death|11|||
16207262|NCT00865189|39237184|FG000|Overall Study|Lost to Follow-up|6|||
16325011|NCT02477332|39674643|FG004|Overall Study|Lack of Efficacy|1|||
16325012|NCT02477332|39674644|FG005|Overall Study|Lack of Efficacy|1|||
16325013|NCT02477332|39674639|FG000|Overall Study|Non-compliance with study treatment|0|||
16325014|NCT02477332|39674640|FG001|Overall Study|Non-compliance with study treatment|1|||
16325015|NCT02477332|39674641|FG002|Overall Study|Non-compliance with study treatment|2|||
16325016|NCT02477332|39674642|FG003|Overall Study|Non-compliance with study treatment|0|||
16325017|NCT02477332|39674643|FG004|Overall Study|Non-compliance with study treatment|0|||
16325018|NCT02477332|39674644|FG005|Overall Study|Non-compliance with study treatment|0|||
16325019|NCT02477332|39674639|FG000|Overall Study|Pregnancy|0|||
16325020|NCT02477332|39674640|FG001|Overall Study|Pregnancy|0|||
16325021|NCT02477332|39674641|FG002|Overall Study|Pregnancy|0|||
16325022|NCT02477332|39674642|FG003|Overall Study|Pregnancy|1|||
16325023|NCT02477332|39674643|FG004|Overall Study|Pregnancy|0|||
16325024|NCT02477332|39674644|FG005|Overall Study|Pregnancy|0|||
16325025|NCT02477332|39674639|FG000|Overall Study|Protocol Violation|2|||
16325026|NCT02477332|39674640|FG001|Overall Study|Protocol Violation|0|||
16325027|NCT02477332|39674641|FG002|Overall Study|Protocol Violation|3|||
16325028|NCT02477332|39674642|FG003|Overall Study|Protocol Violation|3|||
16325029|NCT02477332|39674643|FG004|Overall Study|Protocol Violation|1|||
16325030|NCT02477332|39674644|FG005|Overall Study|Protocol Violation|1|||
16325031|NCT02477332|39674639|FG000|Overall Study|Technical problems|0|||
16325032|NCT02477332|39674640|FG001|Overall Study|Technical problems|0|||
16094076|NCT01072149|38836353|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16325033|NCT02477332|39674641|FG002|Overall Study|Technical problems|1|||
16325034|NCT02477332|39674642|FG003|Overall Study|Technical problems|0|||
16325035|NCT02477332|39674643|FG004|Overall Study|Technical problems|0|||
16325036|NCT02477332|39674644|FG005|Overall Study|Technical problems|0|||
16325037|NCT02477332|39674639|FG000|Overall Study|Lost to Follow-up|0|||
16325038|NCT02477332|39674640|FG001|Overall Study|Lost to Follow-up|0|||
16325039|NCT02477332|39674641|FG002|Overall Study|Lost to Follow-up|2|||
16325040|NCT02477332|39674642|FG003|Overall Study|Lost to Follow-up|0|||
16325041|NCT02477332|39674643|FG004|Overall Study|Lost to Follow-up|0|||
16325042|NCT02477332|39674644|FG005|Overall Study|Lost to Follow-up|0|||
16396259|NCT02674464|39931338|FG000|Overall Study|Death|10|||
16396260|NCT02674464|39931339|FG001|Overall Study|Death|21|||
16396261|NCT02674464|39931338|FG000|Overall Study|Withdrawal by Subject|24|||
16396262|NCT02674464|39931339|FG001|Overall Study|Withdrawal by Subject|44|||
16396263|NCT02674464|39931338|FG000|Overall Study|Lost to Follow-up|97|||
16396264|NCT02674464|39931339|FG001|Overall Study|Lost to Follow-up|92|||
16396265|NCT02674464|39931338|FG000|Overall Study|Outside survey window|6|||
16396266|NCT02674464|39931339|FG001|Overall Study|Outside survey window|3|||
16396267|NCT03989349|39931340|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
16396268|NCT03989349|39931341|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
16094077|NCT01072149|38836354|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094078|NCT01072149|38836355|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094079|NCT01072149|38836356|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094080|NCT01072149|38836357|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16396269|NCT03989349|39931342|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
16396270|NCT03989349|39931343|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
16396271|NCT03989349|39931344|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
16396272|NCT03989349|39931345|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
16396273|NCT03989349|39931340|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
16396274|NCT03989349|39931341|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
16396275|NCT03989349|39931342|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
16396276|NCT03989349|39931343|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
16396277|NCT03989349|39931344|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
16396278|NCT03989349|39931345|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
16396279|NCT03989349|39931340|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
16396280|NCT03989349|39931341|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
16396281|NCT03989349|39931342|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
16396282|NCT03989349|39931343|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
16094081|NCT01072149|38836358|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094082|NCT01072149|38836359|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16207263|NCT00865189|39237185|FG001|Overall Study|Lost to Follow-up|6|||
16325043|NCT02477332|39674639|FG000|Overall Study|Physician Decision|0|||
16325044|NCT02477332|39674640|FG001|Overall Study|Physician Decision|0|||
16325045|NCT02477332|39674641|FG002|Overall Study|Physician Decision|1|||
16325046|NCT02477332|39674642|FG003|Overall Study|Physician Decision|3|||
16396283|NCT03989349|39931344|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
16396284|NCT03989349|39931345|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
16396285|NCT03989349|39931340|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
16094083|NCT01072149|38836360|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16325047|NCT02477332|39674643|FG004|Overall Study|Physician Decision|0|||
16094084|NCT01072149|38836361|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094085|NCT01072149|38836362|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094086|NCT01072149|38836363|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094087|NCT01072149|38836364|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094088|NCT01072149|38836365|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094089|NCT01072149|38836366|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16094090|NCT01072149|38836349|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094091|NCT01072149|38836350|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094092|NCT01072149|38836351|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
16094093|NCT01072149|38836352|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094094|NCT01072149|38836353|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094095|NCT01072149|38836354|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094096|NCT01072149|38836355|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094097|NCT01072149|38836356|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094098|NCT01072149|38836357|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094099|NCT01072149|38836358|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094100|NCT01072149|38836359|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094101|NCT01072149|38836360|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094102|NCT01072149|38836361|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094103|NCT01072149|38836362|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094104|NCT01072149|38836363|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094105|NCT01072149|38836364|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094106|NCT01072149|38836365|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094107|NCT01072149|38836366|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
16094108|NCT01072149|38836349|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094109|NCT01072149|38836350|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094110|NCT01072149|38836351|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094111|NCT01072149|38836352|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094112|NCT01072149|38836353|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094113|NCT01072149|38836354|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094114|NCT01072149|38836355|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094115|NCT01072149|38836356|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
16094116|NCT01072149|38836357|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094117|NCT01072149|38836358|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094118|NCT01072149|38836359|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094119|NCT01072149|38836360|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094120|NCT01072149|38836361|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094121|NCT01072149|38836362|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094122|NCT01072149|38836363|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094123|NCT01072149|38836364|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094124|NCT01072149|38836365|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094125|NCT01072149|38836366|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
16094126|NCT01072149|38836349|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
16094127|NCT01072149|38836350|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
16094128|NCT01072149|38836351|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
16094129|NCT01072149|38836352|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
16094130|NCT01072149|38836353|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
16325048|NCT02477332|39674644|FG005|Overall Study|Physician Decision|1|||
16325049|NCT02477332|39674639|FG000|Overall Study|Withdrawal by Subject|0|||
16325050|NCT02477332|39674640|FG001|Overall Study|Withdrawal by Subject|3|||
16325051|NCT02477332|39674641|FG002|Overall Study|Withdrawal by Subject|1|||
16325052|NCT02477332|39674642|FG003|Overall Study|Withdrawal by Subject|2|||
16325053|NCT02477332|39674643|FG004|Overall Study|Withdrawal by Subject|1|||
16325054|NCT02477332|39674644|FG005|Overall Study|Withdrawal by Subject|0|||
16325055|NCT01082211|39674645|FG000|Overall Study|Protocol Violation|4|||
16325056|NCT01082211|39674645|FG000|Overall Study|No protocol treatment received|3|||
16325057|NCT00596687|39674646|FG000|Overall Study|< 24 hours of insulin treatment|8|||
16325058|NCT00596687|39674647|FG001|Overall Study|< 24 hours of insulin treatment|6|||
16325059|NCT00596687|39674646|FG000|Overall Study|continuous insulin infusion during TPN|2|||
16325060|NCT00596687|39674647|FG001|Overall Study|continuous insulin infusion during TPN|1|||
16325061|NCT00596687|39674646|FG000|Overall Study|Withdrawal by Subject|3|||
16325062|NCT00596687|39674647|FG001|Overall Study|Withdrawal by Subject|1|||
16325063|NCT00596687|39674646|FG000|Overall Study|cancelled surgery|1|||
16325064|NCT00596687|39674647|FG001|Overall Study|cancelled surgery|1|||
16325065|NCT02541669|39674654|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
16325066|NCT02541669|39674655|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
16325067|NCT02541669|39674656|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
16325068|NCT02541669|39674657|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
16325069|NCT02541669|39674658|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
16094131|NCT01072149|38836354|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
16094132|NCT01072149|38836355|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
16094133|NCT01072149|38836356|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
16094134|NCT01072149|38836357|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
16094135|NCT01072149|38836358|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
16094136|NCT01072149|38836359|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
16094137|NCT01072149|38836360|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
16094138|NCT01072149|38836361|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
16094139|NCT01072149|38836362|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
16094140|NCT01072149|38836363|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
16094141|NCT01072149|38836364|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
16094142|NCT01072149|38836365|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
16094143|NCT01072149|38836366|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
16094144|NCT01072149|38836349|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094145|NCT01072149|38836350|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094146|NCT01072149|38836351|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094147|NCT01072149|38836352|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094148|NCT01072149|38836353|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094149|NCT01072149|38836354|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094150|NCT01072149|38836355|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094151|NCT01072149|38836356|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094152|NCT01072149|38836357|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094153|NCT01072149|38836358|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094154|NCT01072149|38836359|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094155|NCT01072149|38836360|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094156|NCT01072149|38836361|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094157|NCT01072149|38836362|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094158|NCT01072149|38836363|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094159|NCT01072149|38836364|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
16094160|NCT01072149|38836365|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094161|NCT01072149|38836366|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
16094162|NCT01072149|38836349|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
16094163|NCT01072149|38836350|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
16094164|NCT01072149|38836351|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
16094165|NCT01072149|38836352|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
16094166|NCT01072149|38836353|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
16094167|NCT01072149|38836354|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
16094168|NCT01072149|38836355|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
16094169|NCT01072149|38836356|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
16094170|NCT01072149|38836357|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
16094171|NCT01072149|38836358|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
16094172|NCT01072149|38836359|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
16094173|NCT01072149|38836360|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
16094174|NCT01072149|38836361|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
16094175|NCT01072149|38836362|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
16094176|NCT01072149|38836363|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
16094177|NCT01072149|38836364|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
16094178|NCT01072149|38836365|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
16094179|NCT01072149|38836366|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
16094180|NCT01072149|38836349|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094181|NCT01072149|38836350|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094182|NCT01072149|38836351|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094183|NCT01072149|38836352|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094184|NCT01072149|38836353|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094185|NCT01072149|38836354|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094186|NCT01072149|38836355|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094187|NCT01072149|38836356|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094188|NCT01072149|38836357|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094189|NCT01072149|38836358|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094190|NCT01072149|38836359|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094191|NCT01072149|38836360|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094192|NCT01072149|38836361|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
16094193|NCT01072149|38836362|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094194|NCT01072149|38836363|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094195|NCT01072149|38836364|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094196|NCT01072149|38836365|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094197|NCT01072149|38836366|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
16094198|NCT01072149|38836349|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094199|NCT01072149|38836350|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094200|NCT01072149|38836351|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
16094201|NCT01072149|38836352|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094202|NCT01072149|38836353|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094203|NCT01072149|38836354|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094204|NCT01072149|38836355|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094205|NCT01072149|38836356|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094206|NCT01072149|38836357|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094207|NCT01072149|38836358|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094208|NCT01072149|38836359|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094209|NCT01072149|38836360|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094210|NCT01072149|38836361|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094211|NCT01072149|38836362|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
16094212|NCT01072149|38836363|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094213|NCT01072149|38836364|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094214|NCT01072149|38836365|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094215|NCT01072149|38836366|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
16094216|NCT04184622|38836370|FG000|Overall Study|Adverse Event|7|||
16094217|NCT04184622|38836371|FG001|Overall Study|Adverse Event|7|||
16094218|NCT04184622|38836372|FG002|Overall Study|Adverse Event|11|||
16094219|NCT04184622|38836373|FG003|Overall Study|Adverse Event|8|||
16094220|NCT04184622|38836370|FG000|Overall Study|Death|4|||
16094221|NCT04184622|38836371|FG001|Overall Study|Death|4|||
16094222|NCT04184622|38836372|FG002|Overall Study|Death|2|||
16094223|NCT04184622|38836373|FG003|Overall Study|Death|1|||
16094224|NCT04184622|38836370|FG000|Overall Study|Lost to Follow-up|41|||
16094225|NCT04184622|38836371|FG001|Overall Study|Lost to Follow-up|19|||
16094226|NCT04184622|38836372|FG002|Overall Study|Lost to Follow-up|20|||
16094227|NCT04184622|38836373|FG003|Overall Study|Lost to Follow-up|15|||
16094228|NCT04184622|38836370|FG000|Overall Study|Missing Weight at Week 72|1|||
16094229|NCT04184622|38836371|FG001|Overall Study|Missing Weight at Week 72|0|||
16094230|NCT04184622|38836372|FG002|Overall Study|Missing Weight at Week 72|1|||
16094231|NCT04184622|38836373|FG003|Overall Study|Missing Weight at Week 72|0|||
16094232|NCT04184622|38836370|FG000|Overall Study|Other - as reported by the investigator|22|||
16325070|NCT03379753|39674659|FG000|Overall Study|Withdrawal by Subject|2|||
16396286|NCT03989349|39931341|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
16396287|NCT03989349|39931342|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
16396288|NCT03989349|39931343|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
16396289|NCT03989349|39931344|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
16396290|NCT03989349|39931345|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
16396291|NCT03989349|39931340|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
16396292|NCT03989349|39931341|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
16396293|NCT03989349|39931342|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
16396294|NCT03989349|39931343|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
16325071|NCT03379753|39674660|FG001|Overall Study|Withdrawal by Subject|1|||
16325072|NCT03379753|39674659|FG000|Overall Study|not having correct procedure|1|||
16325073|NCT03379753|39674660|FG001|Overall Study|not having correct procedure|2|||
16325074|NCT03379753|39674659|FG000|Overall Study|No primary outcome|12|||
16325075|NCT03379753|39674660|FG001|Overall Study|No primary outcome|22|||
16325076|NCT01866657|39674661|FG000|Overall Study|Surgery canceled|2|||
16325077|NCT01866657|39674662|FG001|Overall Study|Surgery canceled|0|||
16325078|NCT02295020|39674666|FG000|Overall Study|Adverse Event|0|||
16325079|NCT02295020|39674667|FG001|Overall Study|Adverse Event|1|||
16325080|NCT02295020|39674666|FG000|Overall Study|Withdrawal by Subject|3|||
16325081|NCT02295020|39674667|FG001|Overall Study|Withdrawal by Subject|2|||
16325082|NCT02129777|39674668|FG000|Double-Blind Period|Adverse Event|0|||
16094233|NCT04184622|38836371|FG001|Overall Study|Other - as reported by the investigator|7|||
16094234|NCT04184622|38836372|FG002|Overall Study|Other - as reported by the investigator|5|||
16094235|NCT04184622|38836373|FG003|Overall Study|Other - as reported by the investigator|12|||
16094236|NCT04184622|38836370|FG000|Overall Study|Physician Decision|0|||
16094237|NCT04184622|38836371|FG001|Overall Study|Physician Decision|0|||
16094238|NCT04184622|38836372|FG002|Overall Study|Physician Decision|3|||
16094239|NCT04184622|38836373|FG003|Overall Study|Physician Decision|1|||
16094240|NCT04184622|38836370|FG000|Overall Study|Pregnancy|4|||
16094241|NCT04184622|38836371|FG001|Overall Study|Pregnancy|4|||
16094242|NCT04184622|38836372|FG002|Overall Study|Pregnancy|3|||
16094243|NCT04184622|38836373|FG003|Overall Study|Pregnancy|5|||
16094244|NCT04184622|38836370|FG000|Overall Study|Protocol Deviation|1|||
16094245|NCT04184622|38836371|FG001|Overall Study|Protocol Deviation|0|||
16094246|NCT04184622|38836372|FG002|Overall Study|Protocol Deviation|0|||
16325083|NCT02129777|39674669|FG001|Double-Blind Period|Adverse Event|0|||
16094247|NCT04184622|38836373|FG003|Overall Study|Protocol Deviation|0|||
16094248|NCT04184622|38836370|FG000|Overall Study|Withdrawal by Subject|68|||
16325084|NCT02129777|39674670|FG002|Double-Blind Period|Adverse Event|0|||
16325085|NCT02129777|39674671|FG003|Double-Blind Period|Adverse Event|0|||
16325086|NCT02129777|39674672|FG004|Double-Blind Period|Adverse Event|1|||
16094249|NCT04184622|38836371|FG001|Overall Study|Withdrawal by Subject|28|||
16094250|NCT04184622|38836372|FG002|Overall Study|Withdrawal by Subject|29|||
16094251|NCT04184622|38836373|FG003|Overall Study|Withdrawal by Subject|22|||
16094252|NCT00853957|38836374|FG000|Overall Study|Adverse Event|9|||
16094253|NCT00853957|38836375|FG001|Overall Study|Adverse Event|3|||
16094254|NCT00853957|38836374|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16094255|NCT00853957|38836375|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16521967|NCT02349711|40380072|FG000|Overall Study|Lost to Follow-up|1|||
16521968|NCT02349711|40380073|FG001|Overall Study|Lost to Follow-up|1|||
16325087|NCT02129777|39674673|FG005|Double-Blind Period|Adverse Event|0|||
16325088|NCT02129777|39674674|FG006|Double-Blind Period|Adverse Event|0|||
16325089|NCT02129777|39674668|FG000|Double-Blind Period|Lost to Follow-up|1|||
16325090|NCT02129777|39674669|FG001|Double-Blind Period|Lost to Follow-up|1|||
16325091|NCT02129777|39674670|FG002|Double-Blind Period|Lost to Follow-up|1|||
16325092|NCT02129777|39674671|FG003|Double-Blind Period|Lost to Follow-up|2|||
16325093|NCT02129777|39674672|FG004|Double-Blind Period|Lost to Follow-up|0|||
16325094|NCT02129777|39674673|FG005|Double-Blind Period|Lost to Follow-up|0|||
16325095|NCT02129777|39674674|FG006|Double-Blind Period|Lost to Follow-up|0|||
16325096|NCT02129777|39674668|FG000|Double-Blind Period|Withdrawal by Subject|2|||
16325097|NCT02129777|39674669|FG001|Double-Blind Period|Withdrawal by Subject|4|||
16325098|NCT02129777|39674670|FG002|Double-Blind Period|Withdrawal by Subject|3|||
16325099|NCT02129777|39674671|FG003|Double-Blind Period|Withdrawal by Subject|2|||
16325100|NCT02129777|39674672|FG004|Double-Blind Period|Withdrawal by Subject|3|||
16325101|NCT02129777|39674673|FG005|Double-Blind Period|Withdrawal by Subject|0|||
16325102|NCT02129777|39674674|FG006|Double-Blind Period|Withdrawal by Subject|0|||
16325103|NCT02129777|39674668|FG000|Double-Blind Period|Pregnancy|0|||
16325104|NCT02129777|39674669|FG001|Double-Blind Period|Pregnancy|0|||
16325105|NCT02129777|39674670|FG002|Double-Blind Period|Pregnancy|0|||
16325106|NCT02129777|39674671|FG003|Double-Blind Period|Pregnancy|0|||
16325107|NCT02129777|39674672|FG004|Double-Blind Period|Pregnancy|1|||
16325108|NCT02129777|39674673|FG005|Double-Blind Period|Pregnancy|0|||
16325109|NCT02129777|39674674|FG006|Double-Blind Period|Pregnancy|0|||
16325110|NCT02129777|39674668|FG000|Double-Blind Period|Lack of Efficacy|3|||
16325111|NCT02129777|39674669|FG001|Double-Blind Period|Lack of Efficacy|1|||
16325112|NCT02129777|39674670|FG002|Double-Blind Period|Lack of Efficacy|0|||
16325113|NCT02129777|39674671|FG003|Double-Blind Period|Lack of Efficacy|3|||
16325114|NCT02129777|39674672|FG004|Double-Blind Period|Lack of Efficacy|2|||
16325115|NCT02129777|39674673|FG005|Double-Blind Period|Lack of Efficacy|0|||
16325116|NCT02129777|39674674|FG006|Double-Blind Period|Lack of Efficacy|0|||
16325117|NCT02129777|39674668|FG000|Double-Blind Period|Other|1|||
16325118|NCT02129777|39674669|FG001|Double-Blind Period|Other|2|||
16325119|NCT02129777|39674670|FG002|Double-Blind Period|Other|0|||
16325120|NCT02129777|39674671|FG003|Double-Blind Period|Other|0|||
16325121|NCT02129777|39674672|FG004|Double-Blind Period|Other|0|||
16325122|NCT02129777|39674673|FG005|Double-Blind Period|Other|0|||
16325123|NCT02129777|39674674|FG006|Double-Blind Period|Other|0|||
16325124|NCT02129777|39674668|FG000|Open-Label Period|Lack of Efficacy|0|||
16325125|NCT02129777|39674669|FG001|Open-Label Period|Lack of Efficacy|0|||
16325126|NCT02129777|39674670|FG002|Open-Label Period|Lack of Efficacy|0|||
16325127|NCT02129777|39674671|FG003|Open-Label Period|Lack of Efficacy|0|||
16325128|NCT02129777|39674672|FG004|Open-Label Period|Lack of Efficacy|0|||
16325129|NCT02129777|39674673|FG005|Open-Label Period|Lack of Efficacy|0|||
16325130|NCT02129777|39674674|FG006|Open-Label Period|Lack of Efficacy|5|||
16325131|NCT02129777|39674668|FG000|Open-Label Period|Lost to Follow-up|0|||
16325132|NCT02129777|39674669|FG001|Open-Label Period|Lost to Follow-up|0|||
16521969|NCT03732638|40380074|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
16521970|NCT03732638|40380075|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
16094256|NCT00853957|38836374|FG000|Overall Study|Subject withdrew consent|4|||
16094257|NCT00853957|38836375|FG001|Overall Study|Subject withdrew consent|5|||
16325133|NCT02129777|39674670|FG002|Open-Label Period|Lost to Follow-up|0|||
16325134|NCT02129777|39674671|FG003|Open-Label Period|Lost to Follow-up|0|||
16325135|NCT02129777|39674672|FG004|Open-Label Period|Lost to Follow-up|0|||
16325136|NCT02129777|39674673|FG005|Open-Label Period|Lost to Follow-up|1|||
16325137|NCT02129777|39674674|FG006|Open-Label Period|Lost to Follow-up|1|||
16325138|NCT02129777|39674668|FG000|Open-Label Period|Withdrawal by Subject|0|||
16325139|NCT02129777|39674669|FG001|Open-Label Period|Withdrawal by Subject|0|||
16325140|NCT02129777|39674670|FG002|Open-Label Period|Withdrawal by Subject|0|||
16396295|NCT03989349|39931344|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
16325141|NCT02129777|39674671|FG003|Open-Label Period|Withdrawal by Subject|0|||
16521971|NCT03732638|40380074|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
16325142|NCT02129777|39674672|FG004|Open-Label Period|Withdrawal by Subject|0|||
16325143|NCT02129777|39674673|FG005|Open-Label Period|Withdrawal by Subject|1|||
16325144|NCT02129777|39674674|FG006|Open-Label Period|Withdrawal by Subject|3|||
16325145|NCT02129777|39674668|FG000|Open-Label Period|Study Termination|0|||
16325146|NCT02129777|39674669|FG001|Open-Label Period|Study Termination|0|||
16325147|NCT02129777|39674670|FG002|Open-Label Period|Study Termination|0|||
16325148|NCT02129777|39674671|FG003|Open-Label Period|Study Termination|0|||
16325149|NCT02129777|39674672|FG004|Open-Label Period|Study Termination|0|||
16325150|NCT02129777|39674673|FG005|Open-Label Period|Study Termination|10|||
16325151|NCT02129777|39674674|FG006|Open-Label Period|Study Termination|39|||
16325152|NCT05033262|39674675|FG000|Overall Study|Lost to Follow-up|1|||
16325153|NCT05033262|39674676|FG001|Overall Study|Lost to Follow-up|0|||
16325154|NCT05033262|39674677|FG002|Overall Study|Lost to Follow-up|0|||
16325155|NCT05033262|39674678|FG003|Overall Study|Lost to Follow-up|1|||
16396296|NCT03989349|39931345|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
16396297|NCT03989349|39931340|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
16396298|NCT03989349|39931341|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
16396299|NCT03989349|39931342|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
16396300|NCT03989349|39931343|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
16396301|NCT03989349|39931344|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
16396302|NCT03989349|39931345|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
16396303|NCT03989349|39931340|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
16396304|NCT03989349|39931341|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
16396305|NCT03989349|39931342|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
16396306|NCT03989349|39931343|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
16396307|NCT03989349|39931344|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
16396308|NCT03989349|39931345|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
16396309|NCT03989349|39931340|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
16396310|NCT03989349|39931341|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
16396311|NCT03989349|39931342|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
16396312|NCT03989349|39931343|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
16396313|NCT03989349|39931344|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
16396314|NCT03989349|39931345|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
16521972|NCT03732638|40380075|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
16521973|NCT03732638|40380074|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
16521974|NCT03732638|40380075|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
16521975|NCT03732638|40380074|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
16521976|NCT03732638|40380075|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
16521977|NCT03732638|40380074|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
16521978|NCT03732638|40380075|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
16521979|NCT03732638|40380074|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
16521980|NCT03732638|40380075|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
16521981|NCT03732638|40380074|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
16521982|NCT03732638|40380075|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
16521983|NCT03732638|40380074|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
16521984|NCT03732638|40380075|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
16325156|NCT03640559|39674679|FG000|Overall Study|Physician Decision|1|||
16325157|NCT03640559|39674680|FG001|Overall Study|Physician Decision|1|||
16325158|NCT03640559|39674679|FG000|Overall Study|Withdrawal by Subject|1|||
16325159|NCT03640559|39674680|FG001|Overall Study|Withdrawal by Subject|0|||
16521985|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
16521986|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
16396315|NCT03989349|39931340|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
16396316|NCT03989349|39931341|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
16396317|NCT03989349|39931342|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
16396318|NCT03989349|39931343|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
16396319|NCT03989349|39931344|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
16396320|NCT03989349|39931345|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
16396321|NCT03989349|39931340|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
16396322|NCT03989349|39931341|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
16325160|NCT01972438|39674681|FG000|Baseline-Month 3 Crossover Period|Death|1|||
16325161|NCT01972438|39674682|FG001|Baseline-Month 3 Crossover Period|Death|0|||
16325162|NCT01972438|39674681|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
16325163|NCT01972438|39674682|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
16325164|NCT01972438|39674681|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
16325165|NCT01972438|39674682|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
16325166|NCT01972438|39674681|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
16325167|NCT01972438|39674682|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
16325168|NCT01972438|39674681|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
16325169|NCT01972438|39674682|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
16325170|NCT01972438|39674681|FG000|Months 6-12 Study Period|Death|1|||
16325171|NCT01972438|39674682|FG001|Months 6-12 Study Period|Death|0|||
16325172|NCT01972438|39674681|FG000|Months 6-12 Study Period|Early Study Closure|2|||
16325173|NCT01972438|39674682|FG001|Months 6-12 Study Period|Early Study Closure|2|||
16325174|NCT01972438|39674681|FG000|Post Month 12 Study Period|Early Study Closure|3|||
16325175|NCT01972438|39674682|FG001|Post Month 12 Study Period|Early Study Closure|4|||
16325176|NCT00550745|39674683|FG000|Overall Study|Death|20|||
16325177|NCT00550745|39674684|FG001|Overall Study|Death|16|||
16325178|NCT00550745|39674683|FG000|Overall Study|Lost to Follow-up|45|||
16325179|NCT00550745|39674684|FG001|Overall Study|Lost to Follow-up|30|||
16325180|NCT00550745|39674683|FG000|Overall Study|Physician Decision|0|||
16325181|NCT00550745|39674684|FG001|Overall Study|Physician Decision|2|||
16325182|NCT00550745|39674683|FG000|Overall Study|Protocol Violation|4|||
16325183|NCT00550745|39674684|FG001|Overall Study|Protocol Violation|2|||
16325184|NCT00550745|39674683|FG000|Overall Study|Withdrawal by Subject|17|||
16325185|NCT00550745|39674684|FG001|Overall Study|Withdrawal by Subject|10|||
16325186|NCT00550745|39674683|FG000|Overall Study|Screen failure|1|||
16325187|NCT00550745|39674684|FG001|Overall Study|Screen failure|0|||
16325188|NCT02009397|39674686|FG000|Overall Study|Protocol Violation|6|||
16325189|NCT02009397|39674686|FG000|Overall Study|Death|8|||
16396323|NCT03989349|39931342|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
16396324|NCT03989349|39931343|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
16396325|NCT03989349|39931344|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
16521987|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
16521988|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
16521989|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
16521990|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
16521991|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
16521992|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
16521993|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
16521994|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
16521995|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
16521996|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
16521997|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
16521998|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
16521999|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
16396326|NCT03989349|39931345|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
16522000|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
16325190|NCT02009397|39674686|FG000|Overall Study|Lost to Follow-up|6|||
16325191|NCT02797080|39674689|FG000|Overall Study|Lost to Follow-up|1|||
16325192|NCT02797080|39674689|FG000|Overall Study|Withdrawal by Subject|1|||
16325193|NCT03180684|39674692|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
16325194|NCT03180684|39674693|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
16522001|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
16522002|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
16396327|NCT03989349|39931340|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16396328|NCT03989349|39931341|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16396329|NCT03989349|39931342|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
16396330|NCT03989349|39931343|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16396331|NCT03989349|39931344|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
16396332|NCT03989349|39931345|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16396333|NCT03989349|39931340|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
16396334|NCT03989349|39931341|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
16396335|NCT03989349|39931342|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
16396336|NCT03989349|39931343|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
16396337|NCT03989349|39931344|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
16396338|NCT03989349|39931345|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
16396339|NCT03989349|39931340|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
16325195|NCT03180684|39674692|FG000|Overall Study|Physician Decision|1|||
16325196|NCT03180684|39674693|FG001|Overall Study|Physician Decision|0|||
16325197|NCT03180684|39674692|FG000|Overall Study|Lost to Follow-up|1|||
16325198|NCT03180684|39674693|FG001|Overall Study|Lost to Follow-up|0|||
16396340|NCT03989349|39931341|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
16396341|NCT03989349|39931342|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
16396342|NCT03989349|39931343|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
16396343|NCT03989349|39931344|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
16396344|NCT03989349|39931345|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
16396345|NCT03989349|39931340|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
16396346|NCT03989349|39931341|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
16396347|NCT03989349|39931342|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
16522003|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
16522004|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
16522005|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
16522006|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
16522007|NCT03732638|40380074|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
16522008|NCT03732638|40380075|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
16522009|NCT03732638|40380074|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
16522010|NCT03732638|40380075|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
16522011|NCT03732638|40380074|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
16522012|NCT03732638|40380075|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
16522013|NCT03732638|40380074|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
16522014|NCT03732638|40380075|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
16522015|NCT03732638|40380074|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
16325199|NCT03180684|39674692|FG000|Overall Study|Progressive Disease|1|||
16325200|NCT03180684|39674693|FG001|Overall Study|Progressive Disease|0|||
16325201|NCT02111785|39674698|FG000|Overall Study|Death|0|||
16325202|NCT02111785|39674699|FG001|Overall Study|Death|1|||
16325203|NCT02111785|39674700|FG002|Overall Study|Death|0|||
16325204|NCT02111785|39674701|FG003|Overall Study|Death|0|||
16325205|NCT01108341|39674702|FG000|Overall Study|Death|2|||
16325206|NCT01108341|39674702|FG000|Overall Study|Withdrawal by Subject|1|||
16325207|NCT01108341|39674702|FG000|Overall Study|Lost to Follow-up|1|||
16325208|NCT01108341|39674702|FG000|Overall Study|Other|1|||
16325209|NCT01880086|39678025|FG000|Overall Study|Lost to Follow-up|1|||
16325210|NCT01880086|39678026|FG001|Overall Study|Lost to Follow-up|1|||
16325211|NCT03467217|39678027|FG000|Overall Study|Trial stopped early|5|||
16325212|NCT03467217|39678028|FG001|Overall Study|Trial stopped early|2|||
16325213|NCT03467217|39678027|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
16325214|NCT03467217|39678028|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
16325215|NCT03467217|39678027|FG000|Overall Study|Lost to Follow-up|0|||
16325216|NCT03467217|39678028|FG001|Overall Study|Lost to Follow-up|2|||
16325217|NCT02419612|39678031|FG000|Short-term Treatment Period|Adverse Event|1|||
16325218|NCT02419612|39678032|FG001|Short-term Treatment Period|Adverse Event|1|||
16325219|NCT02419612|39678031|FG000|Short-term Treatment Period|Death|0|||
16325220|NCT02419612|39678032|FG001|Short-term Treatment Period|Death|2|||
16522016|NCT03732638|40380075|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
16522017|NCT02170727|40380076|FG000|Overall Study|Lost to Follow-up|1|||
16325221|NCT02419612|39678031|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
16325222|NCT02419612|39678032|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
16396348|NCT03989349|39931343|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
16522018|NCT02170727|40380077|FG001|Overall Study|Lost to Follow-up|0|||
16325223|NCT02419612|39678031|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
16325224|NCT02419612|39678032|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
16325225|NCT02419612|39678031|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
16522019|NCT02170727|40380076|FG000|Overall Study|Withdrawal by Subject|2|||
16522020|NCT02170727|40380077|FG001|Overall Study|Withdrawal by Subject|0|||
16522021|NCT01532687|40380078|FG000|Overall Study|Death|2|||
16522022|NCT01532687|40380079|FG001|Overall Study|Death|0|||
16522023|NCT01532687|40380078|FG000|Overall Study|Adverse Event|6|||
16522024|NCT01532687|40380079|FG001|Overall Study|Adverse Event|1|||
16522025|NCT01532687|40380078|FG000|Overall Study|Withdrawal by Subject|1|||
16522026|NCT01532687|40380079|FG001|Overall Study|Withdrawal by Subject|0|||
16522027|NCT01532687|40380078|FG000|Overall Study|Physician Decision|2|||
16522028|NCT01532687|40380079|FG001|Overall Study|Physician Decision|1|||
16522029|NCT01532687|40380078|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
16522030|NCT01532687|40380079|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
16522031|NCT02550652|40380080|FG000|Overall Study|Death|1|||
16522032|NCT02550652|40380081|FG001|Overall Study|Death|4|||
16522033|NCT02550652|40380080|FG000|Overall Study|Lack of Efficacy|1|||
16522034|NCT02550652|40380081|FG001|Overall Study|Lack of Efficacy|0|||
16522035|NCT02550652|40380080|FG000|Overall Study|Withdrawal by Subject|4|||
16522036|NCT02550652|40380081|FG001|Overall Study|Withdrawal by Subject|7|||
16522037|NCT02550652|40380080|FG000|Overall Study|Post Trial Access|1|||
16522038|NCT02550652|40380081|FG001|Overall Study|Post Trial Access|0|||
16522039|NCT02550652|40380080|FG000|Overall Study|Lost to Follow-up|1|||
16522040|NCT02550652|40380081|FG001|Overall Study|Lost to Follow-up|3|||
16522041|NCT02550652|40380080|FG000|Overall Study|Physician Decision|0|||
16522042|NCT02550652|40380081|FG001|Overall Study|Physician Decision|2|||
16522043|NCT02550652|40380080|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
16522044|NCT02550652|40380081|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
16522045|NCT03864614|40380084|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
16522046|NCT03864614|40380085|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
16522047|NCT03864614|40380086|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
16522048|NCT03864614|40380087|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
16522049|NCT03864614|40380084|FG000|Overall Study|Withdrawal by Subject|72|||
16522050|NCT03864614|40380085|FG001|Overall Study|Withdrawal by Subject|100|||
16522051|NCT03864614|40380086|FG002|Overall Study|Withdrawal by Subject|1|||
16522052|NCT03864614|40380087|FG003|Overall Study|Withdrawal by Subject|21|||
16522053|NCT03864614|40380084|FG000|Overall Study|Lost to Follow-up|45|||
16522054|NCT03864614|40380085|FG001|Overall Study|Lost to Follow-up|54|||
16522055|NCT03864614|40380086|FG002|Overall Study|Lost to Follow-up|0|||
16522056|NCT03864614|40380087|FG003|Overall Study|Lost to Follow-up|9|||
16522057|NCT03864614|40380084|FG000|Overall Study|Adverse Event|42|||
16522058|NCT03864614|40380085|FG001|Overall Study|Adverse Event|30|||
16522059|NCT03864614|40380086|FG002|Overall Study|Adverse Event|1|||
16522060|NCT03864614|40380087|FG003|Overall Study|Adverse Event|9|||
16522061|NCT03864614|40380084|FG000|Overall Study|Protocol Deviation|6|||
16522062|NCT03864614|40380085|FG001|Overall Study|Protocol Deviation|26|||
16522063|NCT03864614|40380086|FG002|Overall Study|Protocol Deviation|0|||
16094258|NCT00853957|38836374|FG000|Overall Study|Lost to Follow-up|1|||
16094259|NCT00853957|38836375|FG001|Overall Study|Lost to Follow-up|6|||
16094260|NCT00853957|38836374|FG000|Overall Study|Protocol deviation|0|||
16094261|NCT00853957|38836375|FG001|Overall Study|Protocol deviation|3|||
16094262|NCT03242863|38836380|FG000|Study Week 1|Withdrawal by Subject|0|||
16094263|NCT03242863|38836381|FG001|Study Week 1|Withdrawal by Subject|1|||
16094264|NCT03242863|38836382|FG002|Study Week 1|Withdrawal by Subject|0|||
16396349|NCT03989349|39931344|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
16396350|NCT03989349|39931345|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
16396351|NCT00104416|39931350|FG000|Double-Blind Phase|Adverse Event|2|||
16396352|NCT00104416|39931351|FG001|Double-Blind Phase|Adverse Event|1|||
16396353|NCT00104416|39931352|FG002|Double-Blind Phase|Adverse Event|0|||
16396354|NCT00104416|39931353|FG003|Double-Blind Phase|Adverse Event|0|||
16396355|NCT00104416|39931354|FG004|Double-Blind Phase|Adverse Event|0|||
16396356|NCT00104416|39931350|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16396357|NCT00104416|39931351|FG001|Double-Blind Phase|Lost to Follow-up|1|||
16396358|NCT00104416|39931352|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16522064|NCT03864614|40380087|FG003|Overall Study|Protocol Deviation|1|||
16522065|NCT03864614|40380084|FG000|Overall Study|Physician Decision|7|||
16522066|NCT03864614|40380085|FG001|Overall Study|Physician Decision|10|||
16522067|NCT03864614|40380086|FG002|Overall Study|Physician Decision|1|||
16522068|NCT03864614|40380087|FG003|Overall Study|Physician Decision|5|||
16522069|NCT03864614|40380084|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
16094265|NCT03242863|38836383|FG003|Study Week 1|Withdrawal by Subject|0|||
16396359|NCT00104416|39931353|FG003|Double-Blind Phase|Lost to Follow-up|0|||
16522070|NCT03864614|40380085|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
16522071|NCT03864614|40380086|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
16522072|NCT03864614|40380087|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
16522073|NCT03864614|40380084|FG000|Overall Study|Sponsor Decision|1|||
16094266|NCT03242863|38836384|FG004|Study Week 1|Withdrawal by Subject|3|||
16522074|NCT03864614|40380085|FG001|Overall Study|Sponsor Decision|2|||
16522075|NCT03864614|40380086|FG002|Overall Study|Sponsor Decision|0|||
16522076|NCT03864614|40380087|FG003|Overall Study|Sponsor Decision|0|||
16522077|NCT03864614|40380084|FG000|Overall Study|Pregnancy|0|||
16325226|NCT02419612|39678032|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
16325227|NCT02419612|39678031|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
16325228|NCT02419612|39678032|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
16325229|NCT02419612|39678031|FG000|Short-term Treatment Period|Worsening of liver function|0|||
16325230|NCT02419612|39678032|FG001|Short-term Treatment Period|Worsening of liver function|1|||
16325231|NCT02419612|39678031|FG000|Short-term Treatment Period|Subject moved out of state|0|||
16325232|NCT02419612|39678032|FG001|Short-term Treatment Period|Subject moved out of state|1|||
16325233|NCT02419612|39678031|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
16325234|NCT02419612|39678032|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
16325235|NCT02419612|39678031|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
16325236|NCT02419612|39678032|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
16325237|NCT02419612|39678031|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
16325238|NCT02419612|39678032|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
16325239|NCT02419612|39678031|FG000|Long-term Treatment Period|Death|0|||
16522078|NCT03864614|40380085|FG001|Overall Study|Pregnancy|1|||
16522079|NCT03864614|40380086|FG002|Overall Study|Pregnancy|0|||
16522080|NCT03864614|40380087|FG003|Overall Study|Pregnancy|0|||
16522081|NCT03864614|40380084|FG000|Overall Study|Other|7|||
16325240|NCT02419612|39678032|FG001|Long-term Treatment Period|Death|1|||
16325241|NCT02419612|39678031|FG000|Long-term Treatment Period|Adverse Event|0|||
16325242|NCT02419612|39678032|FG001|Long-term Treatment Period|Adverse Event|5|||
16325243|NCT02419612|39678031|FG000|Long-term Treatment Period|Other|4|||
16325244|NCT02419612|39678032|FG001|Long-term Treatment Period|Other|4|||
16325245|NCT02419612|39678031|FG000|Long-term Treatment Period|Subject Decision|2|||
16325246|NCT02419612|39678032|FG001|Long-term Treatment Period|Subject Decision|4|||
16325247|NCT02419612|39678031|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
16325248|NCT02419612|39678032|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
16325249|NCT00655733|39678040|FG000|Overall Study|Lost to Follow-up|2|||
16325250|NCT00655733|39678041|FG001|Overall Study|Lost to Follow-up|2|||
16325251|NCT00655733|39678040|FG000|Overall Study|Adverse Event|2|||
16325252|NCT00655733|39678041|FG001|Overall Study|Adverse Event|2|||
16325253|NCT00655733|39678040|FG000|Overall Study|Withdrawal by Subject|3|||
16325254|NCT00655733|39678041|FG001|Overall Study|Withdrawal by Subject|3|||
16325255|NCT00655733|39678040|FG000|Overall Study|Physician Decision|0|||
16325256|NCT00655733|39678041|FG001|Overall Study|Physician Decision|1|||
16325257|NCT01089608|39678048|FG000|Overall Study|Adverse Event|0|||
16325258|NCT01089608|39678049|FG001|Overall Study|Adverse Event|4|||
16325259|NCT01089608|39678048|FG000|Overall Study|Lost to Follow-up|0|||
16325260|NCT01089608|39678049|FG001|Overall Study|Lost to Follow-up|2|||
16325261|NCT04016779|39678050|FG000|Overall Study|Adverse Event|9|||
16325262|NCT04016779|39678051|FG001|Overall Study|Adverse Event|17|||
16325263|NCT04016779|39678050|FG000|Overall Study|Lack of Efficacy|4|||
16325264|NCT04016779|39678051|FG001|Overall Study|Lack of Efficacy|1|||
16325265|NCT04016779|39678050|FG000|Overall Study|Lost to Follow-up|5|||
16325266|NCT04016779|39678051|FG001|Overall Study|Lost to Follow-up|14|||
16325267|NCT04016779|39678050|FG000|Overall Study|Physician Decision|1|||
16325268|NCT04016779|39678051|FG001|Overall Study|Physician Decision|3|||
16325269|NCT04016779|39678050|FG000|Overall Study|Withdrawal by Subject|6|||
16325270|NCT04016779|39678051|FG001|Overall Study|Withdrawal by Subject|8|||
16325271|NCT04016779|39678050|FG000|Overall Study|Non-compliance with Study Drug|2|||
16325272|NCT04016779|39678051|FG001|Overall Study|Non-compliance with Study Drug|3|||
16325273|NCT04016779|39678050|FG000|Overall Study|Other, Multiple categories|17|||
16522082|NCT03864614|40380085|FG001|Overall Study|Other|9|||
16522083|NCT03864614|40380086|FG002|Overall Study|Other|1|||
16325274|NCT04016779|39678051|FG001|Overall Study|Other, Multiple categories|17|||
16325275|NCT00808639|39678052|FG000|Overall Study|Disease progression before surgery.|1|||
16325276|NCT00833482|39678057|FG000|Days 11-20|Adverse Event|0|||
16325277|NCT00833482|39678058|FG001|Days 11-20|Adverse Event|2|||
16325278|NCT00833482|39678059|FG002|Days 11-20|Adverse Event|0|||
16325279|NCT00833482|39678060|FG003|Days 11-20|Adverse Event|0|||
16325280|NCT00833482|39678061|FG004|Days 11-20|Adverse Event|0|||
16522084|NCT03864614|40380087|FG003|Overall Study|Other|4|||
16522085|NCT03864614|40380084|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
16522086|NCT03864614|40380085|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
16522087|NCT03864614|40380086|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
16325281|NCT00833482|39678062|FG005|Days 11-20|Adverse Event|0|||
16325282|NCT00833482|39678057|FG000|Days 11-20|Withdrawal by Subject|0|||
16325283|NCT00833482|39678058|FG001|Days 11-20|Withdrawal by Subject|1|||
16325284|NCT00833482|39678059|FG002|Days 11-20|Withdrawal by Subject|0|||
16325285|NCT00833482|39678060|FG003|Days 11-20|Withdrawal by Subject|0|||
16522088|NCT03864614|40380087|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
16094267|NCT03242863|38836385|FG005|Study Week 1|Withdrawal by Subject|0|||
16094268|NCT03341312|38836386|FG000|Period 1|Withdrawal by Subject|0|||
16094269|NCT03341312|38836387|FG001|Period 1|Withdrawal by Subject|1|||
16094270|NCT03341312|38836388|FG002|Period 1|Withdrawal by Subject|0|||
16094271|NCT03341312|38836389|FG003|Period 1|Withdrawal by Subject|0|||
16094272|NCT01215253|38836392|FG000|Overall Study|Withdrawal by Subject|57|||
16094273|NCT01215253|38836393|FG001|Overall Study|Withdrawal by Subject|35|||
16094274|NCT01215253|38836392|FG000|Overall Study|Physician Decision|9|||
16094275|NCT01215253|38836393|FG001|Overall Study|Physician Decision|12|||
16094276|NCT01215253|38836392|FG000|Overall Study|Lost to Follow-up|6|||
16094277|NCT01215253|38836393|FG001|Overall Study|Lost to Follow-up|4|||
16094278|NCT01215253|38836392|FG000|Overall Study|Other|14|||
16522089|NCT02041429|40380092|FG000|Overall Study|Progressive Disease|2|||
16325286|NCT00833482|39678061|FG004|Days 11-20|Withdrawal by Subject|0|||
16325287|NCT00833482|39678062|FG005|Days 11-20|Withdrawal by Subject|0|||
16325288|NCT00833482|39678057|FG000|Days 21-30|Adverse Event|0|||
16325289|NCT00833482|39678058|FG001|Days 21-30|Adverse Event|0|||
16325290|NCT00833482|39678059|FG002|Days 21-30|Adverse Event|1|||
16325291|NCT00833482|39678060|FG003|Days 21-30|Adverse Event|0|||
16325292|NCT00833482|39678061|FG004|Days 21-30|Adverse Event|0|||
16325293|NCT00833482|39678062|FG005|Days 21-30|Adverse Event|0|||
16325294|NCT00833482|39678057|FG000|Days 21-30|Withdrawal by Subject|0|||
16325295|NCT00833482|39678058|FG001|Days 21-30|Withdrawal by Subject|0|||
16325296|NCT00833482|39678059|FG002|Days 21-30|Withdrawal by Subject|0|||
16325297|NCT00833482|39678060|FG003|Days 21-30|Withdrawal by Subject|0|||
16325298|NCT00833482|39678061|FG004|Days 21-30|Withdrawal by Subject|1|||
16325299|NCT00833482|39678062|FG005|Days 21-30|Withdrawal by Subject|0|||
16325300|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
16325301|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
16325302|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
16325303|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
16325304|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Death|0|||
16325305|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Death|0|||
16325306|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Death|1|||
16325307|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Death|0|||
16325308|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
16325309|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
16325310|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
16325311|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
16325312|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
16325313|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
16325314|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
16325315|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
16325316|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
16325317|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
16325318|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
16325319|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
16325320|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
16325321|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
16325322|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
16325323|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
16325324|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
16325325|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
16325326|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
16325327|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
16325328|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
16325329|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
16522090|NCT02041429|40380093|FG001|Overall Study|Progressive Disease|2|||
16522091|NCT02041429|40380094|FG002|Overall Study|Progressive Disease|3|||
16522092|NCT02041429|40380095|FG003|Overall Study|Progressive Disease|2|||
16522093|NCT02041429|40380092|FG000|Overall Study|Toxicity|0|||
16094279|NCT01215253|38836393|FG001|Overall Study|Other|12|||
16094280|NCT00538629|38836396|FG000|Overall Study|At subject's request|1|||
16094281|NCT00538629|38836396|FG000|Overall Study|Adverse Event|2|||
16325330|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
16325331|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
16325332|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
16522094|NCT02041429|40380093|FG001|Overall Study|Toxicity|1|||
16094282|NCT00538629|38836396|FG000|Overall Study|Lack of Efficacy|12|||
16396360|NCT00104416|39931354|FG004|Double-Blind Phase|Lost to Follow-up|0|||
16522095|NCT02041429|40380094|FG002|Overall Study|Toxicity|4|||
16522096|NCT02041429|40380095|FG003|Overall Study|Toxicity|2|||
16094283|NCT00538629|38836396|FG000|Overall Study|Lost to Follow-up|6|||
16522097|NCT02041429|40380092|FG000|Overall Study|Withdrawal by Subject|0|||
16522098|NCT02041429|40380093|FG001|Overall Study|Withdrawal by Subject|1|||
16522099|NCT02041429|40380094|FG002|Overall Study|Withdrawal by Subject|0|||
16522100|NCT02041429|40380095|FG003|Overall Study|Withdrawal by Subject|0|||
16522101|NCT02041429|40380092|FG000|Overall Study|On Maintenance Therapy|1|||
16522102|NCT02041429|40380093|FG001|Overall Study|On Maintenance Therapy|0|||
16522103|NCT02041429|40380094|FG002|Overall Study|On Maintenance Therapy|0|||
16522104|NCT02041429|40380095|FG003|Overall Study|On Maintenance Therapy|2|||
16325333|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
16325334|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16325335|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16325336|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
16325337|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
16325338|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
16325339|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
16325340|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
16325341|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
16325342|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
16325343|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
16325344|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Other|8|||
16325345|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Other|14|||
16325346|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Other|8|||
16325347|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Other|23|||
16325348|NCT01106677|39678067|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
16325349|NCT01106677|39678068|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
16325350|NCT01106677|39678069|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
16325351|NCT01106677|39678070|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
16325352|NCT01106677|39678067|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
16325353|NCT01106677|39678068|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
16325354|NCT01106677|39678069|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
16325355|NCT01106677|39678070|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
16325356|NCT01106677|39678067|FG000|Extension Period: Week 26 to Week 52|Death|0|||
16325357|NCT01106677|39678068|FG001|Extension Period: Week 26 to Week 52|Death|0|||
16325358|NCT01106677|39678069|FG002|Extension Period: Week 26 to Week 52|Death|0|||
16325359|NCT01106677|39678070|FG003|Extension Period: Week 26 to Week 52|Death|1|||
16325360|NCT01106677|39678067|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
16325361|NCT01106677|39678068|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
16325362|NCT01106677|39678069|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
16325363|NCT01106677|39678070|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
16325364|NCT01106677|39678067|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16522105|NCT00701051|40380096|FG000|Screening|Failed Screening|40|||
16522106|NCT00701051|40380097|FG001|Screening|Failed Screening|0|||
16522107|NCT00701051|40380098|FG002|Screening|Failed Screening|0|||
16522108|NCT00701051|40380096|FG000|Screening|Time conflicts|19|||
16522109|NCT00701051|40380097|FG001|Screening|Time conflicts|0|||
16522110|NCT00701051|40380098|FG002|Screening|Time conflicts|0|||
16522111|NCT00701051|40380096|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
16522112|NCT00701051|40380097|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
16522113|NCT00701051|40380098|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
16522114|NCT02970968|40380099|FG000|Overall Study|Withdrawal by Subject|3|||
16522115|NCT02970968|40380100|FG001|Overall Study|Withdrawal by Subject|3|||
16522116|NCT02970968|40380099|FG000|Overall Study|Adverse Event|1|||
16522117|NCT02970968|40380100|FG001|Overall Study|Adverse Event|2|||
16207264|NCT00865189|39237184|FG000|Overall Study|Withdrawal by Subject|1|||
16207265|NCT00865189|39237185|FG001|Overall Study|Withdrawal by Subject|0|||
16325365|NCT01106677|39678068|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
16325366|NCT01106677|39678069|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
16325367|NCT01106677|39678070|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
16325368|NCT01106677|39678067|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
16522118|NCT02970968|40380099|FG000|Overall Study|Lost to Follow-up|1|||
16522119|NCT02970968|40380100|FG001|Overall Study|Lost to Follow-up|1|||
16522120|NCT02970968|40380099|FG000|Overall Study|Non-Compliance|0|||
16522121|NCT02970968|40380100|FG001|Overall Study|Non-Compliance|1|||
16522122|NCT00096941|40380115|FG000|Overall Study|disease progression|3|||
16522123|NCT04788147|40380116|FG000|Overall Study|Screen Failure|3|||
16522124|NCT04788147|40380117|FG001|Overall Study|Screen Failure|10|||
16522125|NCT04788147|40380116|FG000|Overall Study|Incomplete RMRS image session|2|||
16522126|NCT04788147|40380117|FG001|Overall Study|Incomplete RMRS image session|0|||
16522127|NCT02660359|40380118|FG000|Overall Study|Protocol Deviation|0|||
16522128|NCT02660359|40380119|FG001|Overall Study|Protocol Deviation|0|||
16325369|NCT01106677|39678068|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
16325370|NCT01106677|39678069|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
16325371|NCT01106677|39678070|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
16325372|NCT01106677|39678067|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
16325373|NCT01106677|39678068|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16325374|NCT01106677|39678069|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16325375|NCT01106677|39678070|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
16325376|NCT01106677|39678067|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16325377|NCT01106677|39678068|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
16325378|NCT01106677|39678069|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
16325379|NCT01106677|39678070|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16325380|NCT01106677|39678067|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
16325381|NCT01106677|39678068|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
16325382|NCT01106677|39678069|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
16522129|NCT02660359|40380120|FG002|Overall Study|Protocol Deviation|1|||
16522130|NCT02660359|40380118|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
16522131|NCT02660359|40380119|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
16522132|NCT02660359|40380120|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
16522133|NCT02660359|40380118|FG000|Overall Study|Lack of Efficacy|1|||
16522134|NCT02660359|40380119|FG001|Overall Study|Lack of Efficacy|1|||
16522135|NCT02660359|40380120|FG002|Overall Study|Lack of Efficacy|1|||
16522136|NCT02660359|40380118|FG000|Overall Study|Adverse Event|0|||
16522137|NCT02660359|40380119|FG001|Overall Study|Adverse Event|1|||
16522138|NCT02660359|40380120|FG002|Overall Study|Adverse Event|0|||
16522139|NCT02660359|40380118|FG000|Overall Study|Other|2|||
16522140|NCT02660359|40380119|FG001|Overall Study|Other|1|||
16522141|NCT02660359|40380120|FG002|Overall Study|Other|3|||
16522142|NCT02660359|40380118|FG000|Overall Study|Withdrawal by Subject|7|||
16522143|NCT02660359|40380119|FG001|Overall Study|Withdrawal by Subject|5|||
16522144|NCT02660359|40380120|FG002|Overall Study|Withdrawal by Subject|8|||
16522145|NCT02660359|40380118|FG000|Overall Study|Lost to Follow-up|3|||
16522146|NCT02660359|40380119|FG001|Overall Study|Lost to Follow-up|3|||
16522147|NCT02660359|40380120|FG002|Overall Study|Lost to Follow-up|0|||
16522148|NCT03732248|40380123|FG000|Overall Study|Withdrawal by Subject|1|||
16522149|NCT03732248|40380124|FG001|Overall Study|Withdrawal by Subject|0|||
16522150|NCT01858194|40380125|FG000|Overall Study|Total Artificial Heart Implant|0|||
16325383|NCT01106677|39678070|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
16325384|NCT01106677|39678067|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16325385|NCT01106677|39678068|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16325386|NCT01106677|39678069|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16522151|NCT01858194|40380126|FG001|Overall Study|Total Artificial Heart Implant|1|||
16522152|NCT01858194|40380125|FG000|Overall Study|Lost to Follow-up|0|||
16522153|NCT01858194|40380126|FG001|Overall Study|Lost to Follow-up|1|||
16522154|NCT03779841|40380129|FG000|Randomized Population|Did Not Receive Treatment|3|||
16522155|NCT03779841|40380130|FG001|Randomized Population|Did Not Receive Treatment|1|||
16522156|NCT03779841|40380131|FG002|Randomized Population|Did Not Receive Treatment|0|||
16522157|NCT03779841|40380129|FG000|Treated (Safety) Population|Adverse Event|1|||
16522158|NCT03779841|40380130|FG001|Treated (Safety) Population|Adverse Event|1|||
16325387|NCT01106677|39678070|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
16325388|NCT01106677|39678067|FG000|Extension Period: Week 26 to Week 52|Other|6|||
16325389|NCT01106677|39678068|FG001|Extension Period: Week 26 to Week 52|Other|5|||
16325390|NCT01106677|39678069|FG002|Extension Period: Week 26 to Week 52|Other|8|||
16325391|NCT01106677|39678070|FG003|Extension Period: Week 26 to Week 52|Other|5|||
16325392|NCT01893281|39678071|FG000|Overall Study|Adverse Event|1|||
16325393|NCT01893281|39678071|FG000|Overall Study|Protocol Violation|1|||
16325394|NCT01893281|39678071|FG000|Overall Study|Withdrawal by Subject|1|||
16325395|NCT00619892|39678072|FG000|Overall Study|Adverse Event|3|||
16325396|NCT00619892|39678073|FG001|Overall Study|Adverse Event|0|||
16325397|NCT00619892|39678072|FG000|Overall Study|Lost to Follow-up|0|||
16522159|NCT03779841|40380131|FG002|Treated (Safety) Population|Adverse Event|0|||
16522160|NCT03779841|40380129|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
16522161|NCT03779841|40380130|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
16522162|NCT03779841|40380131|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
16522163|NCT03779841|40380129|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
16522164|NCT03779841|40380130|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
16522165|NCT03779841|40380131|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
16522166|NCT03779841|40380129|FG000|Treated (Safety) Population|Death|1|||
16522167|NCT03779841|40380130|FG001|Treated (Safety) Population|Death|0|||
16522168|NCT03779841|40380131|FG002|Treated (Safety) Population|Death|2|||
16325398|NCT00619892|39678073|FG001|Overall Study|Lost to Follow-up|1|||
16522169|NCT04934670|40380132|FG000|Overall Study|Death|4|||
16325399|NCT00619892|39678072|FG000|Overall Study|Intercurrent illness|0|||
16325400|NCT00619892|39678073|FG001|Overall Study|Intercurrent illness|1|||
16325401|NCT01738503|39678074|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
16325402|NCT01738503|39678075|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
16325403|NCT01738503|39678076|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
16325404|NCT01738503|39678077|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
16325405|NCT01738503|39678078|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
16325406|NCT01738503|39678079|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
16325407|NCT01738503|39678080|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
16325408|NCT01738503|39678074|FG000|Treatment Period|Adverse Event|0|||
16325409|NCT01738503|39678075|FG001|Treatment Period|Adverse Event|1|||
16325410|NCT01738503|39678076|FG002|Treatment Period|Adverse Event|0|||
16325411|NCT01738503|39678077|FG003|Treatment Period|Adverse Event|1|||
16325412|NCT01738503|39678078|FG004|Treatment Period|Adverse Event|2|||
16325413|NCT01738503|39678079|FG005|Treatment Period|Adverse Event|2|||
16325414|NCT01738503|39678080|FG006|Treatment Period|Adverse Event|2|||
16325415|NCT01738503|39678074|FG000|Treatment Period|Lost to Follow-up|0|||
16325416|NCT01738503|39678075|FG001|Treatment Period|Lost to Follow-up|0|||
16325417|NCT01738503|39678076|FG002|Treatment Period|Lost to Follow-up|3|||
16325418|NCT01738503|39678077|FG003|Treatment Period|Lost to Follow-up|4|||
16325419|NCT01738503|39678078|FG004|Treatment Period|Lost to Follow-up|1|||
16325420|NCT01738503|39678079|FG005|Treatment Period|Lost to Follow-up|1|||
16325421|NCT01738503|39678080|FG006|Treatment Period|Lost to Follow-up|5|||
16325422|NCT01738503|39678074|FG000|Treatment Period|Withdrawal by Subject|0|||
16325423|NCT01738503|39678075|FG001|Treatment Period|Withdrawal by Subject|1|||
16325424|NCT01738503|39678076|FG002|Treatment Period|Withdrawal by Subject|0|||
16207266|NCT02709109|39237186|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
16522170|NCT04934670|40380133|FG001|Overall Study|Death|0|||
16522171|NCT04934670|40380132|FG000|Overall Study|Lost to Follow-up|1|||
16522172|NCT04934670|40380133|FG001|Overall Study|Lost to Follow-up|4|||
16522173|NCT00653224|40380134|FG000|Overall Study|Adverse Event|2|||
16522174|NCT00653224|40380135|FG001|Overall Study|Adverse Event|1|||
16522175|NCT00653224|40380134|FG000|Overall Study|Lack of Efficacy|1|||
16522176|NCT00653224|40380135|FG001|Overall Study|Lack of Efficacy|2|||
16522177|NCT00653224|40380134|FG000|Overall Study|Loss of efficacy|1|||
16522178|NCT00653224|40380135|FG001|Overall Study|Loss of efficacy|0|||
16522179|NCT00653224|40380134|FG000|Overall Study|Lost to Follow-up|1|||
16522180|NCT00653224|40380135|FG001|Overall Study|Lost to Follow-up|0|||
16522181|NCT00653224|40380134|FG000|Overall Study|Other|2|||
16522182|NCT00653224|40380135|FG001|Overall Study|Other|4|||
16522183|NCT02732847|40380140|FG000|Overall Study|some filled early|42|||
16522184|NCT02732847|40380141|FG001|Overall Study|some filled early|42|||
16522185|NCT00530023|40380155|FG000|Overall Study|Withdrawal by Subject|0|||
16522186|NCT00530023|40380156|FG001|Overall Study|Withdrawal by Subject|1|||
16522187|NCT02486406|40380157|FG000|Overall Study|Withdrew consent|1|||
16522188|NCT02486406|40380158|FG001|Overall Study|Withdrew consent|0|||
16094284|NCT00538629|38836396|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
16207267|NCT02709109|39237187|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
16207268|NCT02709109|39237188|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
16207269|NCT02709109|39237189|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
16207270|NCT02709109|39237186|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
16207271|NCT02709109|39237187|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
16207272|NCT02709109|39237188|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
16207273|NCT02709109|39237189|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
16207274|NCT02709109|39237186|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
16207275|NCT02709109|39237187|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
16325425|NCT01738503|39678077|FG003|Treatment Period|Withdrawal by Subject|1|||
16325426|NCT01738503|39678078|FG004|Treatment Period|Withdrawal by Subject|1|||
16325427|NCT01738503|39678079|FG005|Treatment Period|Withdrawal by Subject|1|||
16325428|NCT01738503|39678080|FG006|Treatment Period|Withdrawal by Subject|1|||
16325429|NCT01738503|39678074|FG000|Treatment Period|Protocol Violation|0|||
16522189|NCT02486406|40380159|FG002|Overall Study|Withdrew consent|0|||
16522190|NCT02486406|40380160|FG003|Overall Study|Withdrew consent|1|||
16522191|NCT02486406|40380157|FG000|Overall Study|Lost to Follow-up|1|||
16522192|NCT02486406|40380158|FG001|Overall Study|Lost to Follow-up|3|||
16522193|NCT02486406|40380159|FG002|Overall Study|Lost to Follow-up|1|||
16522194|NCT02486406|40380160|FG003|Overall Study|Lost to Follow-up|3|||
16207276|NCT02709109|39237188|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
16207277|NCT02709109|39237189|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
16207278|NCT02709109|39237186|FG000|Washout Period (28 Days)|Other|2|||
16207279|NCT02709109|39237187|FG001|Washout Period (28 Days)|Other|2|||
16396361|NCT00104416|39931350|FG000|Double-Blind Phase|Protocol Violation|0|||
16396362|NCT00104416|39931351|FG001|Double-Blind Phase|Protocol Violation|1|||
16396363|NCT00104416|39931352|FG002|Double-Blind Phase|Protocol Violation|0|||
16396364|NCT00104416|39931353|FG003|Double-Blind Phase|Protocol Violation|0|||
16396365|NCT00104416|39931354|FG004|Double-Blind Phase|Protocol Violation|0|||
16396366|NCT00104416|39931350|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
16396367|NCT00104416|39931351|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
16396368|NCT00104416|39931352|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
16396369|NCT00104416|39931353|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
16396370|NCT00104416|39931354|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
16396371|NCT00104416|39931350|FG000|Double-Blind Phase|Pregnancy|1|||
16396372|NCT00104416|39931351|FG001|Double-Blind Phase|Pregnancy|0|||
16396373|NCT00104416|39931352|FG002|Double-Blind Phase|Pregnancy|0|||
16396374|NCT00104416|39931353|FG003|Double-Blind Phase|Pregnancy|0|||
16396375|NCT00104416|39931354|FG004|Double-Blind Phase|Pregnancy|0|||
16396376|NCT00104416|39931350|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
16396377|NCT00104416|39931351|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
16396378|NCT00104416|39931352|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
16396379|NCT00104416|39931353|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
16396380|NCT00104416|39931354|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
16396381|NCT00104416|39931350|FG000|Continuation Phase|Adverse Event|0|||
16396382|NCT00104416|39931351|FG001|Continuation Phase|Adverse Event|0|||
16396383|NCT00104416|39931352|FG002|Continuation Phase|Adverse Event|2|||
16396384|NCT00104416|39931353|FG003|Continuation Phase|Adverse Event|0|||
16396385|NCT00104416|39931354|FG004|Continuation Phase|Adverse Event|2|||
16396386|NCT00104416|39931350|FG000|Continuation Phase|Lost to Follow-up|0|||
16396387|NCT00104416|39931351|FG001|Continuation Phase|Lost to Follow-up|0|||
16396388|NCT00104416|39931352|FG002|Continuation Phase|Lost to Follow-up|1|||
16396389|NCT00104416|39931353|FG003|Continuation Phase|Lost to Follow-up|0|||
16396390|NCT00104416|39931354|FG004|Continuation Phase|Lost to Follow-up|1|||
16396391|NCT00104416|39931350|FG000|Continuation Phase|Withdrawal by Subject|0|||
16396392|NCT00104416|39931351|FG001|Continuation Phase|Withdrawal by Subject|0|||
16396393|NCT00104416|39931352|FG002|Continuation Phase|Withdrawal by Subject|2|||
16396394|NCT00104416|39931353|FG003|Continuation Phase|Withdrawal by Subject|1|||
16396395|NCT00104416|39931354|FG004|Continuation Phase|Withdrawal by Subject|1|||
16396396|NCT00104416|39931350|FG000|Continuation Phase|Pregnancy|0|||
16396397|NCT00104416|39931351|FG001|Continuation Phase|Pregnancy|0|||
16396398|NCT00104416|39931352|FG002|Continuation Phase|Pregnancy|1|||
16396399|NCT00104416|39931353|FG003|Continuation Phase|Pregnancy|1|||
16396400|NCT00104416|39931354|FG004|Continuation Phase|Pregnancy|0|||
16396401|NCT00104416|39931350|FG000|Continuation Phase|Non-compliance|0|||
16396402|NCT00104416|39931351|FG001|Continuation Phase|Non-compliance|0|||
16396403|NCT00104416|39931352|FG002|Continuation Phase|Non-compliance|0|||
16396404|NCT00104416|39931353|FG003|Continuation Phase|Non-compliance|0|||
16396405|NCT00104416|39931354|FG004|Continuation Phase|Non-compliance|1|||
16396406|NCT01270880|39931355|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
16396407|NCT04262882|39931357|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
16207280|NCT02709109|39237188|FG002|Washout Period (28 Days)|Other|3|||
16207281|NCT02709109|39237189|FG003|Washout Period (28 Days)|Other|0|||
16207282|NCT02709109|39237186|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
16207283|NCT02709109|39237187|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
16207284|NCT02709109|39237188|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
16396408|NCT04262882|39931358|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
16396409|NCT04262882|39931357|FG000|Overall Study|Lost to Follow-up|1|||
16396410|NCT04262882|39931358|FG001|Overall Study|Lost to Follow-up|0|||
16396411|NCT00758069|39931364|FG000|Overall Study|Lack of Efficacy|0|||
16396412|NCT00758069|39931365|FG001|Overall Study|Lack of Efficacy|0|||
16396413|NCT00758069|39931366|FG002|Overall Study|Lack of Efficacy|1|||
16396414|NCT00758069|39931364|FG000|Overall Study|Incorrect Study Drug|1|||
16396415|NCT00758069|39931365|FG001|Overall Study|Incorrect Study Drug|0|||
16396416|NCT00758069|39931366|FG002|Overall Study|Incorrect Study Drug|0|||
16396417|NCT02413996|39931369|FG000|Overall Study|not comfortable with the intervention|9|||
16396418|NCT02413996|39931370|FG001|Overall Study|not comfortable with the intervention|2|||
16094285|NCT02830893|38836401|FG000|Overall Study|Relocation to out of the country|1|||
16207285|NCT02709109|39237189|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
16207286|NCT02709109|39237186|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
16207287|NCT02709109|39237187|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
16207288|NCT02709109|39237188|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
16207289|NCT02709109|39237189|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
16207290|NCT02709109|39237186|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
16207291|NCT02709109|39237187|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
16207292|NCT02709109|39237188|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
16207293|NCT02709109|39237189|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
16207294|NCT02709109|39237186|FG000|Treatment Period 2 (28 Days)|Other|0|||
16207295|NCT02709109|39237187|FG001|Treatment Period 2 (28 Days)|Other|0|||
16207296|NCT02709109|39237188|FG002|Treatment Period 2 (28 Days)|Other|1|||
16207297|NCT02709109|39237189|FG003|Treatment Period 2 (28 Days)|Other|0|||
16207298|NCT00617591|39237195|FG000|Overall Study|Withdrew consent during Induction|4|||
16207299|NCT00617591|39237195|FG000|Overall Study|Withdrew consent during Maintenance|6|||
16207300|NCT01981109|39237198|FG000|Overall Study|Death|36|||
16207301|NCT01981109|39237198|FG000|Overall Study|Withdrawal by Subject|40|||
16207302|NCT01981109|39237198|FG000|Overall Study|Lost to Follow-up|9|||
16396419|NCT02482428|39931372|FG000|Overall Study|Lost to Follow-up|4|||
16325430|NCT01738503|39678075|FG001|Treatment Period|Protocol Violation|3|||
16325431|NCT01738503|39678076|FG002|Treatment Period|Protocol Violation|1|||
16325432|NCT01738503|39678077|FG003|Treatment Period|Protocol Violation|0|||
16325433|NCT01738503|39678078|FG004|Treatment Period|Protocol Violation|4|||
16325434|NCT01738503|39678079|FG005|Treatment Period|Protocol Violation|2|||
16325435|NCT01738503|39678080|FG006|Treatment Period|Protocol Violation|0|||
16325436|NCT01738503|39678074|FG000|Treatment Period|Other|0|||
16325437|NCT01738503|39678075|FG001|Treatment Period|Other|0|||
16325438|NCT01738503|39678076|FG002|Treatment Period|Other|1|||
16325439|NCT01738503|39678077|FG003|Treatment Period|Other|0|||
16325440|NCT01738503|39678078|FG004|Treatment Period|Other|0|||
16325441|NCT01738503|39678079|FG005|Treatment Period|Other|0|||
16325442|NCT01738503|39678080|FG006|Treatment Period|Other|0|||
16325443|NCT01738503|39678074|FG000|PET Imaging Sub-study|Adverse Event|0|||
16325444|NCT01738503|39678075|FG001|PET Imaging Sub-study|Adverse Event|0|||
16325445|NCT01738503|39678076|FG002|PET Imaging Sub-study|Adverse Event|0|||
16325446|NCT01738503|39678077|FG003|PET Imaging Sub-study|Adverse Event|0|||
16325447|NCT01738503|39678078|FG004|PET Imaging Sub-study|Adverse Event|0|||
16325448|NCT01738503|39678079|FG005|PET Imaging Sub-study|Adverse Event|1|||
16325449|NCT01738503|39678080|FG006|PET Imaging Sub-study|Adverse Event|0|||
16325450|NCT01738503|39678074|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
16325451|NCT01738503|39678075|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
16325452|NCT01738503|39678076|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
16325453|NCT01738503|39678077|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
16325454|NCT01738503|39678078|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
16325455|NCT01738503|39678079|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
16325456|NCT01738503|39678080|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
16325457|NCT00160706|39678081|FG000|Overall Study|Adverse Event|53|||
16325458|NCT00160706|39678081|FG000|Overall Study|Adverse Event and Other Reason|105|||
16325459|NCT00160706|39678081|FG000|Overall Study|Protocol Violation|3|||
16325460|NCT00160706|39678081|FG000|Overall Study|Withdrawal by Subject|41|||
16325461|NCT00160706|39678081|FG000|Overall Study|Withdrawal by Subject and Other|12|||
16325462|NCT00160706|39678081|FG000|Overall Study|Physician Decision|10|||
16325463|NCT00160706|39678081|FG000|Overall Study|Physician Decision and Other|3|||
16325464|NCT00160706|39678081|FG000|Overall Study|Lost to Follow-up|4|||
16325465|NCT00160706|39678081|FG000|Overall Study|Lost to Follow-up and Other|1|||
16325466|NCT00160706|39678081|FG000|Overall Study|Lack of Efficacy|42|||
16325467|NCT00160706|39678081|FG000|Overall Study|Lack of Efficacy and Other|1|||
16325468|NCT00160706|39678081|FG000|Overall Study|Other Reason|11|||
16325469|NCT02640404|39678086|FG000|Overall Study|Protocol Violation|1|||
16325470|NCT02640404|39678087|FG001|Overall Study|Protocol Violation|0|||
16325471|NCT02640404|39678086|FG000|Overall Study|Withdrawal by Subject|1|||
16325472|NCT02640404|39678087|FG001|Overall Study|Withdrawal by Subject|0|||
16325473|NCT02649439|39678094|FG000|Overall Study|Switched to alternative treatment|6|||
16325474|NCT02649439|39678095|FG001|Overall Study|Switched to alternative treatment|4|||
16325475|NCT02649439|39678094|FG000|Overall Study|Patient decision|1|||
16325476|NCT02649439|39678095|FG001|Overall Study|Patient decision|0|||
16325477|NCT02649439|39678094|FG000|Overall Study|Patient going out of country|1|||
16325478|NCT02649439|39678095|FG001|Overall Study|Patient going out of country|0|||
16325479|NCT02649439|39678094|FG000|Overall Study|To start finasteride|1|||
16325480|NCT02649439|39678095|FG001|Overall Study|To start finasteride|0|||
16325481|NCT02649439|39678094|FG000|Overall Study|Physician Decision|1|||
16325482|NCT02649439|39678095|FG001|Overall Study|Physician Decision|0|||
16325483|NCT02649439|39678094|FG000|Overall Study|Disease progression on study|12|||
16325484|NCT02649439|39678095|FG001|Overall Study|Disease progression on study|13|||
16325485|NCT02649439|39678094|FG000|Overall Study|Refused further treatment|1|||
16325486|NCT02649439|39678095|FG001|Overall Study|Refused further treatment|0|||
16325487|NCT02649439|39678094|FG000|Overall Study|Refused further follow up|2|||
16325488|NCT02649439|39678095|FG001|Overall Study|Refused further follow up|7|||
16325489|NCT02649439|39678094|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
16325490|NCT02649439|39678095|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
16325491|NCT02649439|39678094|FG000|Overall Study|No treatment, per protocol|1|||
16396420|NCT02482428|39931373|FG001|Overall Study|Lost to Follow-up|9|||
16396421|NCT02482428|39931374|FG002|Overall Study|Lost to Follow-up|1|||
16396422|NCT02482428|39931375|FG003|Overall Study|Lost to Follow-up|2|||
16396423|NCT02482428|39931376|FG004|Overall Study|Lost to Follow-up|4|||
16396424|NCT02482428|39931372|FG000|Overall Study|Physician Decision|0|||
16396425|NCT02482428|39931373|FG001|Overall Study|Physician Decision|0|||
16396426|NCT02482428|39931374|FG002|Overall Study|Physician Decision|0|||
16207303|NCT01981109|39237198|FG000|Overall Study|No Discontinuation Documentation|37|||
16207304|NCT01981109|39237198|FG000|Overall Study|Study Termination|100|||
16207305|NCT01981109|39237198|FG000|Overall Study|No data available|2|||
16207306|NCT00565812|39237199|FG000|Overall Study|Death|2|||
16207307|NCT00565812|39237200|FG001|Overall Study|Death|1|||
16207308|NCT00565812|39237201|FG002|Overall Study|Death|3|||
16207309|NCT00565812|39237199|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
16207310|NCT00565812|39237200|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
16207311|NCT00565812|39237201|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
16207312|NCT00565812|39237199|FG000|Overall Study|Lost to Follow-up|10|||
16207313|NCT00565812|39237200|FG001|Overall Study|Lost to Follow-up|8|||
16207314|NCT00565812|39237201|FG002|Overall Study|Lost to Follow-up|8|||
16207315|NCT00565812|39237199|FG000|Overall Study|Withdrawal by Subject|58|||
16396427|NCT02482428|39931375|FG003|Overall Study|Physician Decision|0|||
16396428|NCT02482428|39931376|FG004|Overall Study|Physician Decision|1|||
16396429|NCT02482428|39931372|FG000|Overall Study|protocol deviation|1|||
16396430|NCT02482428|39931373|FG001|Overall Study|protocol deviation|1|||
16396431|NCT02482428|39931374|FG002|Overall Study|protocol deviation|0|||
16396432|NCT02482428|39931375|FG003|Overall Study|protocol deviation|0|||
16396433|NCT02482428|39931376|FG004|Overall Study|protocol deviation|0|||
16325492|NCT02649439|39678095|FG001|Overall Study|No treatment, per protocol|0|||
16325493|NCT02649439|39678094|FG000|Overall Study|PSA DT makes ineligible|0|||
16325494|NCT02649439|39678095|FG001|Overall Study|PSA DT makes ineligible|1|||
16325495|NCT02649439|39678094|FG000|Overall Study|Rising PSA No Mets|0|||
16325496|NCT02649439|39678095|FG001|Overall Study|Rising PSA No Mets|1|||
16094286|NCT02830893|38836402|FG001|Overall Study|Relocation to out of the country|0|||
16094287|NCT02830893|38836401|FG000|Overall Study|Lost to Follow-up|0|||
16094288|NCT02830893|38836402|FG001|Overall Study|Lost to Follow-up|2|||
16094289|NCT02830893|38836401|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
16094290|NCT02830893|38836402|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
16094291|NCT02676778|38836408|FG000|Overall Study|Disease Progression|7|||
16094292|NCT02676778|38836409|FG001|Overall Study|Disease Progression|3|||
16094293|NCT02676778|38836410|FG002|Overall Study|Disease Progression|1|||
16094294|NCT02676778|38836408|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
16094295|NCT02676778|38836409|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
16325497|NCT02649439|39678094|FG000|Overall Study|Rising PSA|0|||
16325498|NCT02649439|39678095|FG001|Overall Study|Rising PSA|1|||
16325499|NCT02649439|39678094|FG000|Overall Study|Signed follow up protocol|0|||
16094296|NCT02676778|38836410|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
16094297|NCT02676778|38836408|FG000|Overall Study|Withdrawal by Subject|3|||
16094298|NCT02676778|38836409|FG001|Overall Study|Withdrawal by Subject|2|||
16094299|NCT02676778|38836410|FG002|Overall Study|Withdrawal by Subject|0|||
16094300|NCT02676778|38836408|FG000|Overall Study|Other|4|||
16094301|NCT02676778|38836409|FG001|Overall Study|Other|3|||
16094302|NCT02676778|38836410|FG002|Overall Study|Other|0|||
16094303|NCT02676778|38836408|FG000|Overall Study|Adverse Event|2|||
16094304|NCT02676778|38836409|FG001|Overall Study|Adverse Event|3|||
16094305|NCT02676778|38836410|FG002|Overall Study|Adverse Event|0|||
16094306|NCT00134056|38836413|FG000|Randomization|Not eligible for assigned treatment|22|||
16094307|NCT00134056|38836414|FG001|Randomization|Not eligible for assigned treatment|20|||
16094308|NCT00134056|38836413|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
16094309|NCT00134056|38836414|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
16094310|NCT00134056|38836413|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
16094311|NCT00134056|38836414|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
16094312|NCT00134056|38836413|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
16094313|NCT00134056|38836414|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
16094314|NCT00134056|38836413|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
16094315|NCT00134056|38836414|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
16094316|NCT03020914|38836417|FG000|Overall Study|Surgery Cancelled|1|||
16094317|NCT03020914|38836418|FG001|Overall Study|Surgery Cancelled|0|||
16094318|NCT02659059|38836423|FG000|Overall Study|Other reasons|6|||
16094319|NCT02659059|38836424|FG001|Overall Study|Other reasons|1|||
16094320|NCT02659059|38836423|FG000|Overall Study|Disease Progression|143|||
16094321|NCT02659059|38836424|FG001|Overall Study|Disease Progression|16|||
16094322|NCT02659059|38836423|FG000|Overall Study|Study Drug toxicity|56|||
16094323|NCT02659059|38836424|FG001|Overall Study|Study Drug toxicity|9|||
16094324|NCT02659059|38836423|FG000|Overall Study|Death|3|||
16094325|NCT02659059|38836424|FG001|Overall Study|Death|1|||
16094326|NCT02659059|38836423|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
16094327|NCT02659059|38836424|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
16094328|NCT02659059|38836423|FG000|Overall Study|Participant request to discontinue study treatment|5|||
16094329|NCT02659059|38836424|FG001|Overall Study|Participant request to discontinue study treatment|0|||
16094330|NCT02659059|38836423|FG000|Overall Study|Participant withdrew consent|6|||
16094331|NCT02659059|38836424|FG001|Overall Study|Participant withdrew consent|1|||
16094332|NCT01185340|38836432|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
16094333|NCT01185340|38836433|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16094334|NCT01185340|38836434|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16094335|NCT01185340|38836435|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16094336|NCT01185340|38836432|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
16325500|NCT02649439|39678095|FG001|Overall Study|Signed follow up protocol|1|||
16325501|NCT04434469|39678096|FG000|Overall Study|Death|2|||
16325502|NCT04434469|39678097|FG001|Overall Study|Death|3|||
16325503|NCT04434469|39678098|FG002|Overall Study|Death|2|||
16325504|NCT04434469|39678099|FG003|Overall Study|Death|2|||
16325505|NCT04434469|39678100|FG004|Overall Study|Death|2|||
16325506|NCT04434469|39678101|FG005|Overall Study|Death|0|||
16325507|NCT04434469|39678096|FG000|Overall Study|Lost to Follow-up|0|||
16325508|NCT04434469|39678097|FG001|Overall Study|Lost to Follow-up|0|||
16325509|NCT04434469|39678098|FG002|Overall Study|Lost to Follow-up|0|||
16396434|NCT02482428|39931372|FG000|Overall Study|subject/guardian decision|4|||
16325510|NCT04434469|39678099|FG003|Overall Study|Lost to Follow-up|1|||
16325511|NCT04434469|39678100|FG004|Overall Study|Lost to Follow-up|1|||
16396435|NCT02482428|39931373|FG001|Overall Study|subject/guardian decision|2|||
16207316|NCT00565812|39237200|FG001|Overall Study|Withdrawal by Subject|47|||
16325512|NCT04434469|39678101|FG005|Overall Study|Lost to Follow-up|0|||
16325513|NCT04434469|39678096|FG000|Overall Study|Study terminated by sponsor|1|||
16325514|NCT04434469|39678097|FG001|Overall Study|Study terminated by sponsor|1|||
16325515|NCT04434469|39678098|FG002|Overall Study|Study terminated by sponsor|1|||
16325516|NCT04434469|39678099|FG003|Overall Study|Study terminated by sponsor|2|||
16325517|NCT04434469|39678100|FG004|Overall Study|Study terminated by sponsor|3|||
16325518|NCT04434469|39678101|FG005|Overall Study|Study terminated by sponsor|3|||
16325519|NCT04434469|39678096|FG000|Overall Study|Withdrawal by Subject|0|||
16325520|NCT04434469|39678097|FG001|Overall Study|Withdrawal by Subject|0|||
16325521|NCT04434469|39678098|FG002|Overall Study|Withdrawal by Subject|1|||
16325522|NCT04434469|39678099|FG003|Overall Study|Withdrawal by Subject|0|||
16325523|NCT04434469|39678100|FG004|Overall Study|Withdrawal by Subject|0|||
16325524|NCT04434469|39678101|FG005|Overall Study|Withdrawal by Subject|0|||
16325525|NCT02693106|39678106|FG000|Overall Study|No time|3|||
16325526|NCT03485495|39678107|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
16325527|NCT03485495|39678108|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
16325528|NCT00688701|39678109|FG000|Overall Study|Adverse Event|1|||
16325529|NCT00688701|39678110|FG001|Overall Study|Adverse Event|0|||
16325530|NCT00688701|39678111|FG002|Overall Study|Adverse Event|5|||
16325531|NCT00688701|39678112|FG003|Overall Study|Adverse Event|3|||
16325532|NCT00688701|39678109|FG000|Overall Study|Lack of Efficacy|0|||
16325533|NCT00688701|39678110|FG001|Overall Study|Lack of Efficacy|1|||
16325534|NCT00688701|39678111|FG002|Overall Study|Lack of Efficacy|0|||
16325535|NCT00688701|39678112|FG003|Overall Study|Lack of Efficacy|0|||
16325536|NCT00688701|39678109|FG000|Overall Study|Withdrawal by Subject|3|||
16325537|NCT00688701|39678110|FG001|Overall Study|Withdrawal by Subject|3|||
16325538|NCT00688701|39678111|FG002|Overall Study|Withdrawal by Subject|4|||
16325539|NCT00688701|39678112|FG003|Overall Study|Withdrawal by Subject|8|||
16325540|NCT00688701|39678109|FG000|Overall Study|Poor compliance to protocol|0|||
16325541|NCT00688701|39678110|FG001|Overall Study|Poor compliance to protocol|1|||
16325542|NCT00688701|39678111|FG002|Overall Study|Poor compliance to protocol|1|||
16325543|NCT00688701|39678112|FG003|Overall Study|Poor compliance to protocol|0|||
16325544|NCT04666259|39678113|FG000|Overall Study|ongoing at data cut-off|6|||
16325545|NCT04666259|39678114|FG001|Overall Study|ongoing at data cut-off|14|||
16325546|NCT04666259|39678115|FG002|Overall Study|ongoing at data cut-off|0|||
16325547|NCT04666259|39678113|FG000|Overall Study|Progressive Disease|0|||
16325548|NCT04666259|39678114|FG001|Overall Study|Progressive Disease|1|||
16325549|NCT04666259|39678115|FG002|Overall Study|Progressive Disease|0|||
16325550|NCT04666259|39678113|FG000|Overall Study|Physician Decision|9|||
16325551|NCT04666259|39678114|FG001|Overall Study|Physician Decision|3|||
16325552|NCT04666259|39678115|FG002|Overall Study|Physician Decision|3|||
16325553|NCT04666259|39678113|FG000|Overall Study|Adverse Event|3|||
16325554|NCT04666259|39678114|FG001|Overall Study|Adverse Event|1|||
16325555|NCT04666259|39678115|FG002|Overall Study|Adverse Event|0|||
16325556|NCT04666259|39678113|FG000|Overall Study|Withdrawal by Subject|1|||
16325557|NCT04666259|39678114|FG001|Overall Study|Withdrawal by Subject|2|||
16325558|NCT04666259|39678115|FG002|Overall Study|Withdrawal by Subject|0|||
16325559|NCT04666259|39678113|FG000|Overall Study|Enrolled but not treated and discontinued|1|||
16325560|NCT04666259|39678114|FG001|Overall Study|Enrolled but not treated and discontinued|0|||
16325561|NCT04666259|39678115|FG002|Overall Study|Enrolled but not treated and discontinued|0|||
16325562|NCT02727777|39678116|FG000|Overall Study|Screen Failure|2|||
16325563|NCT02727777|39678117|FG001|Overall Study|Screen Failure|0|||
16325564|NCT02727777|39678118|FG002|Overall Study|Screen Failure|0|||
16325565|NCT02727777|39678116|FG000|Overall Study|Progressive disease|2|||
16325566|NCT02727777|39678117|FG001|Overall Study|Progressive disease|0|||
16325567|NCT02727777|39678118|FG002|Overall Study|Progressive disease|0|||
16325568|NCT05088603|39678119|FG000|Overall Study|Protocol Violation|6|||
16325569|NCT05088603|39678120|FG001|Overall Study|Protocol Violation|1|||
16522195|NCT02486406|40380157|FG000|Overall Study|Other, not specified|0|||
16522196|NCT02486406|40380158|FG001|Overall Study|Other, not specified|0|||
16522197|NCT02486406|40380159|FG002|Overall Study|Other, not specified|1|||
16522198|NCT02486406|40380160|FG003|Overall Study|Other, not specified|0|||
16522199|NCT03738150|40380166|FG000|Base Study|Withdrawal by Subject|1|||
16522200|NCT03738150|40380166|FG000|Extension Study|Withdrawal by Subject|1|||
16522201|NCT03003520|40380167|FG000|Overall Study|Adverse Event|9|||
16522202|NCT03003520|40380168|FG001|Overall Study|Adverse Event|0|||
16522203|NCT03003520|40380167|FG000|Overall Study|Death|1|||
16522204|NCT03003520|40380168|FG001|Overall Study|Death|0|||
16207317|NCT00565812|39237201|FG002|Overall Study|Withdrawal by Subject|48|||
16325570|NCT00812981|39678121|FG000|Overall Study|Other|0|||
16325571|NCT00812981|39678122|FG001|Overall Study|Other|1|||
16325572|NCT01878149|39678124|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
16325573|NCT01878149|39678125|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
16325574|NCT01430403|39678128|FG000|Overall Study|Lost to Follow-up|5|||
16325575|NCT01430403|39678129|FG001|Overall Study|Lost to Follow-up|5|||
16522205|NCT03003520|40380167|FG000|Overall Study|Other reasons|4|||
16094337|NCT01185340|38836433|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16094338|NCT01185340|38836434|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16094339|NCT01185340|38836435|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16094340|NCT01185340|38836432|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
16094341|NCT01185340|38836433|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16094342|NCT01185340|38836434|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16094343|NCT01185340|38836435|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16094344|NCT01185340|38836432|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
16094345|NCT01185340|38836433|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16094346|NCT01185340|38836434|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16094347|NCT01185340|38836435|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16094348|NCT01185340|38836432|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
16094349|NCT01185340|38836433|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16094350|NCT01185340|38836434|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16094351|NCT01185340|38836435|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16094352|NCT01185340|38836432|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
16094353|NCT01185340|38836433|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16094354|NCT01185340|38836434|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16094355|NCT01185340|38836435|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16094356|NCT01185340|38836432|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
16094357|NCT01185340|38836433|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16094358|NCT01185340|38836434|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16094359|NCT01185340|38836435|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16094360|NCT01185340|38836432|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
16094361|NCT01185340|38836433|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
16094362|NCT01185340|38836434|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
16325576|NCT01430403|39678130|FG002|Overall Study|Lost to Follow-up|3|||
16325577|NCT01430403|39678128|FG000|Overall Study|Physician Decision|1|||
16325578|NCT01430403|39678129|FG001|Overall Study|Physician Decision|0|||
16325579|NCT01430403|39678130|FG002|Overall Study|Physician Decision|0|||
16325580|NCT01430403|39678128|FG000|Overall Study|Protocol Violation|2|||
16325581|NCT01430403|39678129|FG001|Overall Study|Protocol Violation|3|||
16325582|NCT01430403|39678130|FG002|Overall Study|Protocol Violation|2|||
16325583|NCT01430403|39678128|FG000|Overall Study|Withdrawal by Subject|9|||
16325584|NCT01430403|39678129|FG001|Overall Study|Withdrawal by Subject|1|||
16325585|NCT01430403|39678130|FG002|Overall Study|Withdrawal by Subject|3|||
16396436|NCT02482428|39931374|FG002|Overall Study|subject/guardian decision|0|||
16094363|NCT01185340|38836435|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
16325586|NCT00675428|39678131|FG000|Overall Study|Disease Progression|2|||
16325587|NCT00675428|39678132|FG001|Overall Study|Disease Progression|2|||
16325588|NCT00675428|39678131|FG000|Overall Study|No Disease Response After Cycle 6|0|||
16325589|NCT00675428|39678132|FG001|Overall Study|No Disease Response After Cycle 6|1|||
16325590|NCT00675428|39678131|FG000|Overall Study|Physician Decision|1|||
16325591|NCT00675428|39678132|FG001|Overall Study|Physician Decision|0|||
16325592|NCT03075891|39678133|FG000|Overall Study|Withdrawal by Subject|3|||
16325593|NCT03075891|39678134|FG001|Overall Study|Withdrawal by Subject|6|||
16325594|NCT03075891|39678133|FG000|Overall Study|Lost to Follow-up|1|||
16325595|NCT03075891|39678134|FG001|Overall Study|Lost to Follow-up|0|||
16325596|NCT03075891|39678133|FG000|Overall Study|Pregnancy|3|||
16325597|NCT03075891|39678134|FG001|Overall Study|Pregnancy|1|||
16325598|NCT03075891|39678133|FG000|Overall Study|visits not performed (no time)|1|||
16325599|NCT03075891|39678134|FG001|Overall Study|visits not performed (no time)|0|||
16325600|NCT03075891|39678133|FG000|Overall Study|Drug abuse relapse issue|0|||
16325601|NCT03075891|39678134|FG001|Overall Study|Drug abuse relapse issue|1|||
16325602|NCT03075891|39678133|FG000|Overall Study|Participant requiring study withdrawal|0|||
16325603|NCT03075891|39678134|FG001|Overall Study|Participant requiring study withdrawal|1|||
16325604|NCT03075891|39678133|FG000|Overall Study|Adverse event, non-fatal|1|||
16325605|NCT03075891|39678134|FG001|Overall Study|Adverse event, non-fatal|4|||
16325606|NCT00627445|39678137|FG000|Overall Study|Adverse Event|3|||
16325607|NCT00627445|39678138|FG001|Overall Study|Adverse Event|3|||
16325608|NCT00627445|39678137|FG000|Overall Study|Lack of Efficacy|0|||
16396437|NCT02482428|39931375|FG003|Overall Study|subject/guardian decision|0|||
16094364|NCT01185340|38836432|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
16094365|NCT01185340|38836433|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
16094366|NCT01185340|38836434|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
16396438|NCT02482428|39931376|FG004|Overall Study|subject/guardian decision|2|||
16522206|NCT03003520|40380168|FG001|Overall Study|Other reasons|0|||
16094367|NCT01185340|38836435|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
16094368|NCT01185340|38836432|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
16094369|NCT01185340|38836433|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
16207318|NCT00565812|39237199|FG000|Overall Study|Work Schedule|5|||
16325609|NCT00627445|39678138|FG001|Overall Study|Lack of Efficacy|1|||
16325610|NCT00627445|39678137|FG000|Overall Study|Other|6|||
16522207|NCT03003520|40380167|FG000|Overall Study|Withdrawal by Subject|6|||
16522208|NCT03003520|40380168|FG001|Overall Study|Withdrawal by Subject|0|||
16522209|NCT03003520|40380167|FG000|Overall Study|Progressive disease|9|||
16522210|NCT03003520|40380168|FG001|Overall Study|Progressive disease|1|||
16522211|NCT00437489|40380169|FG000|Overall Study|Study terminated by sponsor|23|||
16522212|NCT00437489|40380170|FG001|Overall Study|Study terminated by sponsor|21|||
16522213|NCT00437489|40380169|FG000|Overall Study|Lost to Follow-up|0|||
16522214|NCT00437489|40380170|FG001|Overall Study|Lost to Follow-up|1|||
16522215|NCT01591681|40380171|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
16522216|NCT01591681|40380171|FG000|Overall Study|Failed to use system during run-in|1|||
16522217|NCT00844194|40380172|FG000|Overall Study|Adverse Event|17|||
16522218|NCT00844194|40380173|FG001|Overall Study|Adverse Event|5|||
16522219|NCT00844194|40380172|FG000|Overall Study|Protocol Violation|1|||
16522220|NCT00844194|40380173|FG001|Overall Study|Protocol Violation|1|||
16522221|NCT00844194|40380172|FG000|Overall Study|Lost to Follow-up|1|||
16522222|NCT00844194|40380173|FG001|Overall Study|Lost to Follow-up|1|||
16522223|NCT00844194|40380172|FG000|Overall Study|Withdrawal by Subject|2|||
16522224|NCT00844194|40380173|FG001|Overall Study|Withdrawal by Subject|1|||
16094370|NCT01185340|38836434|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
16522225|NCT00844194|40380172|FG000|Overall Study|Lack of Efficacy|3|||
16522226|NCT00844194|40380173|FG001|Overall Study|Lack of Efficacy|0|||
16522227|NCT00844194|40380172|FG000|Overall Study|Other reason (not specified)|1|||
16522228|NCT00844194|40380173|FG001|Overall Study|Other reason (not specified)|0|||
16522229|NCT03822468|40380174|FG000|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|110|||
16522230|NCT03822468|40380175|FG001|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|107|||
16522231|NCT03822468|40380174|FG000|Treatment Period|Progressive disease|50|||
16522232|NCT03822468|40380175|FG001|Treatment Period|Progressive disease|51|||
16522233|NCT03822468|40380174|FG000|Treatment Period|Adverse Event|16|||
16522234|NCT03822468|40380175|FG001|Treatment Period|Adverse Event|18|||
16522235|NCT03822468|40380174|FG000|Treatment Period|Patient decision|4|||
16522236|NCT03822468|40380175|FG001|Treatment Period|Patient decision|5|||
16522237|NCT03822468|40380174|FG000|Treatment Period|Physician Decision|4|||
16522238|NCT03822468|40380175|FG001|Treatment Period|Physician Decision|5|||
16522239|NCT03822468|40380174|FG000|Treatment Period|Protocol deviation|2|||
16522240|NCT03822468|40380175|FG001|Treatment Period|Protocol deviation|1|||
16094371|NCT01185340|38836435|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
16325611|NCT00627445|39678138|FG001|Overall Study|Other|8|||
16325612|NCT03813147|39678145|FG000|Overall Study|Lack of Efficacy|4|||
16325613|NCT03813147|39678146|FG001|Overall Study|Lack of Efficacy|4|||
16325614|NCT03813147|39678145|FG000|Overall Study|Physician Decision|2|||
16325615|NCT03813147|39678146|FG001|Overall Study|Physician Decision|1|||
16325616|NCT02244463|39678149|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
16325617|NCT02244463|39678150|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
16325618|NCT02244463|39678151|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
16325619|NCT02244463|39678152|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
16325620|NCT02244463|39678153|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
16325621|NCT02244463|39678154|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
16325622|NCT02244463|39678149|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
16325623|NCT02244463|39678150|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
16325624|NCT02244463|39678151|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
16325625|NCT02244463|39678152|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
16325626|NCT02244463|39678153|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
16325627|NCT02244463|39678154|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
16325628|NCT02244463|39678149|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
16325629|NCT02244463|39678150|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
16325630|NCT02244463|39678151|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
16325631|NCT02244463|39678152|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
16325632|NCT02244463|39678153|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
16325633|NCT02244463|39678154|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
16325634|NCT02244463|39678149|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
16325635|NCT02244463|39678150|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
16325636|NCT02244463|39678151|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
16325637|NCT02244463|39678152|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
16522241|NCT03822468|40380174|FG000|Treatment Period|Death|1|||
16207319|NCT00565812|39237200|FG001|Overall Study|Work Schedule|3|||
16207320|NCT00565812|39237201|FG002|Overall Study|Work Schedule|1|||
16522242|NCT03822468|40380175|FG001|Treatment Period|Death|1|||
16522243|NCT03822468|40380174|FG000|Treatment Period|Lost to Follow-up|1|||
16522244|NCT03822468|40380175|FG001|Treatment Period|Lost to Follow-up|0|||
16522245|NCT03822468|40380174|FG000|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|12|||
16522246|NCT03822468|40380175|FG001|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|13|||
16522247|NCT03822468|40380174|FG000|Post-treatment Efficacy Follow-up|Progressive disease|3|||
16522248|NCT03822468|40380175|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
16522249|NCT03822468|40380174|FG000|Post-treatment Efficacy Follow-up|Patient decision|3|||
16522250|NCT03822468|40380175|FG001|Post-treatment Efficacy Follow-up|Patient decision|1|||
16522251|NCT03822468|40380174|FG000|Post-treatment Efficacy Follow-up|Death|1|||
16522252|NCT03822468|40380175|FG001|Post-treatment Efficacy Follow-up|Death|0|||
16522253|NCT03822468|40380174|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
16522254|NCT03822468|40380175|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
16522255|NCT03136068|40380176|FG000|Overall Study|Lost to Follow-up|1|||
16522256|NCT03136068|40380177|FG001|Overall Study|Lost to Follow-up|1|||
16522257|NCT03136068|40380176|FG000|Overall Study|Protocol Violation|1|||
16522258|NCT03136068|40380177|FG001|Overall Study|Protocol Violation|0|||
16522259|NCT02447991|40380178|FG000|Overall Study|Withdrawn by subject - no data|0|||
16522260|NCT02447991|40380179|FG001|Overall Study|Withdrawn by subject - no data|2|||
16522261|NCT02447991|40380178|FG000|Overall Study|Withdrawn by Subject - with data|4|||
16522262|NCT02447991|40380179|FG001|Overall Study|Withdrawn by Subject - with data|4|||
16522263|NCT02447991|40380178|FG000|Overall Study|Lost to Follow-up - no data|3|||
16522264|NCT02447991|40380179|FG001|Overall Study|Lost to Follow-up - no data|6|||
16522265|NCT02447991|40380178|FG000|Overall Study|Lost to follow-up - with data|0|||
16522266|NCT02447991|40380179|FG001|Overall Study|Lost to follow-up - with data|3|||
16522267|NCT02447991|40380178|FG000|Overall Study|End of study - no treatment results|3|||
16522268|NCT02447991|40380179|FG001|Overall Study|End of study - no treatment results|6|||
16522269|NCT02447991|40380178|FG000|Overall Study|End of study - partial treatment results|0|||
16522270|NCT02447991|40380179|FG001|Overall Study|End of study - partial treatment results|9|||
16522271|NCT01959581|40380180|FG000|Overall Study|Lost to Follow-up|5|||
16522272|NCT03766646|40380184|FG000|Overall Study|Withdrawal by Subject|1|||
16522273|NCT03766646|40380185|FG001|Overall Study|Withdrawal by Subject|0|||
16522274|NCT03766646|40380184|FG000|Overall Study|Protocol Violation|0|||
16522275|NCT03766646|40380185|FG001|Overall Study|Protocol Violation|3|||
16522276|NCT03832946|40380186|FG000|Overall Study|Adverse Event|3|||
16522277|NCT03832946|40380187|FG001|Overall Study|Adverse Event|1|||
16522278|NCT03832946|40380186|FG000|Overall Study|Lost to Follow-up|1|||
16522279|NCT03832946|40380187|FG001|Overall Study|Lost to Follow-up|0|||
16522280|NCT03832946|40380186|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
16522281|NCT03832946|40380187|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
16522282|NCT03832946|40380186|FG000|Overall Study|Lack of Efficacy|1|||
16522283|NCT03832946|40380187|FG001|Overall Study|Lack of Efficacy|0|||
16094372|NCT01185340|38836432|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16094373|NCT01185340|38836433|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
16094374|NCT01185340|38836434|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16325638|NCT02244463|39678153|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
16325639|NCT02244463|39678154|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
16325640|NCT02244463|39678149|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
16325641|NCT02244463|39678150|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
16325642|NCT02244463|39678151|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
16325643|NCT02244463|39678152|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
16325644|NCT02244463|39678153|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
16325645|NCT02244463|39678154|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
16325646|NCT02244463|39678149|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
16325647|NCT02244463|39678150|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
16325648|NCT02244463|39678151|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
16325649|NCT02244463|39678152|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
16325650|NCT02244463|39678153|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
16325651|NCT02244463|39678154|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
16325652|NCT02244463|39678149|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
16325653|NCT02244463|39678150|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
16325654|NCT02244463|39678151|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
16325655|NCT02244463|39678152|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
16325656|NCT02244463|39678153|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
16325657|NCT02244463|39678154|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
16325658|NCT02244463|39678149|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
16325659|NCT02244463|39678150|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
16325660|NCT02244463|39678151|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
16325661|NCT02244463|39678152|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
16325662|NCT02244463|39678153|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
16325663|NCT02244463|39678154|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
16522284|NCT03832946|40380186|FG000|Overall Study|Withdrawal by Subject|12|||
16522285|NCT03832946|40380187|FG001|Overall Study|Withdrawal by Subject|9|||
16207321|NCT00565812|39237199|FG000|Overall Study|Protocol Violation|2|||
16522286|NCT02673697|40380188|FG000|Overall Study|Adverse Event|2|||
16325664|NCT02244463|39678149|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
16325665|NCT02244463|39678150|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
16325666|NCT02244463|39678151|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
16325667|NCT02244463|39678152|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
16325668|NCT02244463|39678153|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
16325669|NCT02244463|39678154|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
16325670|NCT02244463|39678149|FG000|Period 5: Phase II|Disease Progression|0|||
16325671|NCT02244463|39678150|FG001|Period 5: Phase II|Disease Progression|0|||
16325672|NCT02244463|39678151|FG002|Period 5: Phase II|Disease Progression|0|||
16325673|NCT02244463|39678152|FG003|Period 5: Phase II|Disease Progression|0|||
16325674|NCT02244463|39678153|FG004|Period 5: Phase II|Disease Progression|10|||
16325675|NCT02244463|39678154|FG005|Period 5: Phase II|Disease Progression|11|||
16325676|NCT02244463|39678149|FG000|Period 5: Phase II|Physician Decision|0|||
16325677|NCT02244463|39678150|FG001|Period 5: Phase II|Physician Decision|0|||
16325678|NCT02244463|39678151|FG002|Period 5: Phase II|Physician Decision|0|||
16325679|NCT02244463|39678152|FG003|Period 5: Phase II|Physician Decision|0|||
16325680|NCT02244463|39678153|FG004|Period 5: Phase II|Physician Decision|3|||
16325681|NCT02244463|39678154|FG005|Period 5: Phase II|Physician Decision|2|||
16325682|NCT02244463|39678149|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
16325683|NCT02244463|39678150|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
16325684|NCT02244463|39678151|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
16325685|NCT02244463|39678152|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
16325686|NCT02244463|39678153|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
16325687|NCT02244463|39678154|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
16325688|NCT02244463|39678149|FG000|Period 5: Phase II|Intercurrent Illness|0|||
16325689|NCT02244463|39678150|FG001|Period 5: Phase II|Intercurrent Illness|0|||
16325690|NCT02244463|39678151|FG002|Period 5: Phase II|Intercurrent Illness|0|||
16325691|NCT02244463|39678152|FG003|Period 5: Phase II|Intercurrent Illness|0|||
16325692|NCT02244463|39678153|FG004|Period 5: Phase II|Intercurrent Illness|2|||
16325693|NCT02244463|39678154|FG005|Period 5: Phase II|Intercurrent Illness|0|||
16325694|NCT02244463|39678149|FG000|Period 5: Phase II|Adverse Event|0|||
16325695|NCT02244463|39678150|FG001|Period 5: Phase II|Adverse Event|0|||
16325696|NCT02244463|39678151|FG002|Period 5: Phase II|Adverse Event|0|||
16325697|NCT02244463|39678152|FG003|Period 5: Phase II|Adverse Event|0|||
16325698|NCT02244463|39678153|FG004|Period 5: Phase II|Adverse Event|0|||
16325699|NCT02244463|39678154|FG005|Period 5: Phase II|Adverse Event|2|||
16325700|NCT02244463|39678149|FG000|Period 5: Phase II|Still On treatment|0|||
16325701|NCT02244463|39678150|FG001|Period 5: Phase II|Still On treatment|0|||
16325702|NCT02244463|39678151|FG002|Period 5: Phase II|Still On treatment|0|||
16325703|NCT02244463|39678152|FG003|Period 5: Phase II|Still On treatment|0|||
16325704|NCT02244463|39678153|FG004|Period 5: Phase II|Still On treatment|0|||
16325705|NCT02244463|39678154|FG005|Period 5: Phase II|Still On treatment|3|||
16325706|NCT01876784|39678155|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
16325707|NCT01876784|39678156|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
16325708|NCT01876784|39678155|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
16325709|NCT01876784|39678156|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
16396439|NCT00739310|39931378|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
16396440|NCT00739310|39931378|FG000|Overall Study|Withdrawal by Subject|1|||
16396441|NCT00739310|39931378|FG000|Overall Study|Lost to Follow-up|2|||
16522287|NCT02673697|40380189|FG001|Overall Study|Adverse Event|0|||
16522288|NCT02673697|40380188|FG000|Overall Study|Death|32|||
16522289|NCT02673697|40380189|FG001|Overall Study|Death|24|||
16522290|NCT02673697|40380188|FG000|Overall Study|Lost to Follow-up|5|||
16522291|NCT02673697|40380189|FG001|Overall Study|Lost to Follow-up|2|||
16522292|NCT02673697|40380188|FG000|Overall Study|Physician Decision|2|||
16522293|NCT02673697|40380189|FG001|Overall Study|Physician Decision|1|||
16522294|NCT02673697|40380188|FG000|Overall Study|Withdrawal by Subject|10|||
16522295|NCT02673697|40380189|FG001|Overall Study|Withdrawal by Subject|7|||
16522296|NCT02673697|40380188|FG000|Overall Study|Change subj medical status|1|||
16522297|NCT02673697|40380189|FG001|Overall Study|Change subj medical status|2|||
16522298|NCT02673697|40380188|FG000|Overall Study|Explant|10|||
16522299|NCT02673697|40380189|FG001|Overall Study|Explant|5|||
16522300|NCT02673697|40380188|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
16522301|NCT02673697|40380189|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
16207322|NCT00565812|39237200|FG001|Overall Study|Protocol Violation|6|||
16325710|NCT01876784|39678155|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
16325711|NCT01876784|39678156|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
16325712|NCT01876784|39678155|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
16522302|NCT00194012|40380196|FG000|Randomized Phase|Lack of Efficacy|8|||
16522303|NCT00194012|40380197|FG001|Randomized Phase|Lack of Efficacy|18|||
16094375|NCT01185340|38836435|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
16094376|NCT01185340|38836432|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
16094377|NCT01185340|38836433|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
16094378|NCT01185340|38836434|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
16094379|NCT01185340|38836435|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
16325713|NCT01876784|39678156|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
16325714|NCT01876784|39678155|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
16325715|NCT01876784|39678156|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
16325716|NCT01876784|39678155|FG000|Randomized Treatment Period (40 Months)|Death|1|||
16325717|NCT01876784|39678156|FG001|Randomized Treatment Period (40 Months)|Death|0|||
16325718|NCT01876784|39678155|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
16325719|NCT01876784|39678156|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
16325720|NCT01876784|39678155|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
16325721|NCT01876784|39678156|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
16094380|NCT01185340|38836432|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
16094381|NCT01185340|38836433|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
16094382|NCT01185340|38836434|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
16094383|NCT01185340|38836435|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
16094384|NCT01185340|38836432|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16094385|NCT01185340|38836433|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16207323|NCT00565812|39237201|FG002|Overall Study|Protocol Violation|4|||
16325722|NCT01876784|39678155|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
16325723|NCT01876784|39678156|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
16325724|NCT01876784|39678155|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
16325725|NCT01876784|39678156|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
16325726|NCT01876784|39678155|FG000|Open-label Period (31 Months)|Adverse Event|2|||
16325727|NCT01876784|39678156|FG001|Open-label Period (31 Months)|Adverse Event|6|||
16325728|NCT01876784|39678155|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
16325729|NCT01876784|39678156|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
16325730|NCT01876784|39678155|FG000|Open-label Period (31 Months)|Progressive disease|4|||
16325731|NCT01876784|39678156|FG001|Open-label Period (31 Months)|Progressive disease|35|||
16325732|NCT01876784|39678155|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
16325733|NCT01876784|39678156|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
16325734|NCT01876784|39678155|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
16325735|NCT01876784|39678156|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
16325736|NCT01876784|39678155|FG000|Open-label Period (31 Months)|Death|0|||
16325737|NCT01876784|39678156|FG001|Open-label Period (31 Months)|Death|1|||
16325738|NCT01876784|39678155|FG000|Open-label Period (31 Months)|Other than specified above|9|||
16325739|NCT01876784|39678156|FG001|Open-label Period (31 Months)|Other than specified above|18|||
16325740|NCT00562302|39678161|FG000|Overall Study|Lost to Follow-up|3|||
16325741|NCT00562302|39678162|FG001|Overall Study|Lost to Follow-up|3|||
16325742|NCT00562302|39678161|FG000|Overall Study|Adverse Event|0|||
16325743|NCT00562302|39678162|FG001|Overall Study|Adverse Event|6|||
16325744|NCT00562302|39678161|FG000|Overall Study|Non-compliance|1|||
16094386|NCT01185340|38836434|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
16094387|NCT01185340|38836435|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
16094388|NCT00794573|38836436|FG000|Overall Study|Death|3|||
16094389|NCT00794573|38836437|FG001|Overall Study|Death|0|||
16094390|NCT00794573|38836436|FG000|Overall Study|Withdrawal by Subject|9|||
16094391|NCT00794573|38836437|FG001|Overall Study|Withdrawal by Subject|12|||
16094392|NCT00794573|38836436|FG000|Overall Study|Lost to Follow-up|26|||
16094393|NCT00794573|38836437|FG001|Overall Study|Lost to Follow-up|33|||
16094394|NCT00732498|38836444|FG000|Overall Study|Ineligible|1|||
16094395|NCT00732498|38836444|FG000|Overall Study|Adverse Event|2|||
16094396|NCT00732498|38836444|FG000|Overall Study|Physician Decision|3|||
16094397|NCT01757288|38836446|FG000|Overall Study|Consent withdrawal|0|||
16094398|NCT01757288|38836447|FG001|Overall Study|Consent withdrawal|4|||
16094399|NCT01757288|38836448|FG002|Overall Study|Consent withdrawal|4|||
16094400|NCT01757288|38836446|FG000|Overall Study|Patient off study, IRB hold.|0|||
16094401|NCT01757288|38836447|FG001|Overall Study|Patient off study, IRB hold.|0|||
16094402|NCT01757288|38836448|FG002|Overall Study|Patient off study, IRB hold.|1|||
16094403|NCT01757288|38836446|FG000|Overall Study|Patient death prior to starting treatment|0|||
16094404|NCT01757288|38836447|FG001|Overall Study|Patient death prior to starting treatment|0|||
16094405|NCT01757288|38836448|FG002|Overall Study|Patient death prior to starting treatment|1|||
16094406|NCT01757288|38836446|FG000|Overall Study|Wrong medication administered|0|||
16094407|NCT01757288|38836447|FG001|Overall Study|Wrong medication administered|1|||
16094408|NCT01757288|38836448|FG002|Overall Study|Wrong medication administered|0|||
16094409|NCT01757288|38836446|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
16094410|NCT01757288|38836447|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
16094411|NCT01757288|38836448|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
16094412|NCT01757288|38836446|FG000|Overall Study|Not meeting protocol constraints|0|||
16094413|NCT01757288|38836447|FG001|Overall Study|Not meeting protocol constraints|1|||
16094414|NCT01757288|38836448|FG002|Overall Study|Not meeting protocol constraints|1|||
16094415|NCT01757288|38836446|FG000|Overall Study|Multiple missed appointments|0|||
16094416|NCT01757288|38836447|FG001|Overall Study|Multiple missed appointments|1|||
16094417|NCT01757288|38836448|FG002|Overall Study|Multiple missed appointments|0|||
16094418|NCT01757288|38836446|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
16094419|NCT01757288|38836447|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
16094420|NCT01757288|38836448|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
16094421|NCT01757288|38836446|FG000|Overall Study|>2 weeks treatment break|0|||
16094422|NCT01757288|38836447|FG001|Overall Study|>2 weeks treatment break|0|||
16094423|NCT01757288|38836448|FG002|Overall Study|>2 weeks treatment break|1|||
16094424|NCT00103857|38836449|FG000|54-Week Base Study|Adverse Event|12|||
16094425|NCT00103857|38836450|FG001|54-Week Base Study|Adverse Event|9|||
16094426|NCT00103857|38836451|FG002|54-Week Base Study|Adverse Event|11|||
16094427|NCT00103857|38836452|FG003|54-Week Base Study|Adverse Event|6|||
16094428|NCT00103857|38836453|FG004|54-Week Base Study|Adverse Event|5|||
16094429|NCT00103857|38836454|FG005|54-Week Base Study|Adverse Event|11|||
16094430|NCT00103857|38836455|FG006|54-Week Base Study|Adverse Event|3|||
16094431|NCT00103857|38836449|FG000|54-Week Base Study|Death|0|||
16094432|NCT00103857|38836450|FG001|54-Week Base Study|Death|0|||
16094433|NCT00103857|38836451|FG002|54-Week Base Study|Death|0|||
16094434|NCT00103857|38836452|FG003|54-Week Base Study|Death|0|||
16094435|NCT00103857|38836453|FG004|54-Week Base Study|Death|1|||
16094436|NCT00103857|38836454|FG005|54-Week Base Study|Death|1|||
16094437|NCT00103857|38836455|FG006|54-Week Base Study|Death|0|||
16094438|NCT00103857|38836449|FG000|54-Week Base Study|Lack of Efficacy|11|||
16094439|NCT00103857|38836450|FG001|54-Week Base Study|Lack of Efficacy|14|||
16094440|NCT00103857|38836451|FG002|54-Week Base Study|Lack of Efficacy|8|||
16094441|NCT00103857|38836452|FG003|54-Week Base Study|Lack of Efficacy|4|||
16094442|NCT00103857|38836453|FG004|54-Week Base Study|Lack of Efficacy|3|||
16094443|NCT00103857|38836454|FG005|54-Week Base Study|Lack of Efficacy|14|||
16094444|NCT00103857|38836455|FG006|54-Week Base Study|Lack of Efficacy|19|||
16094445|NCT00103857|38836449|FG000|54-Week Base Study|Lost to Follow-up|5|||
16094446|NCT00103857|38836450|FG001|54-Week Base Study|Lost to Follow-up|4|||
16522304|NCT00194012|40380196|FG000|Randomized Phase|Study nonadherence|2|||
16522305|NCT00194012|40380197|FG001|Randomized Phase|Study nonadherence|1|||
16522306|NCT00194012|40380196|FG000|Randomized Phase|Withdrawal by Subject|3|||
16522307|NCT00194012|40380197|FG001|Randomized Phase|Withdrawal by Subject|3|||
16522308|NCT00194012|40380196|FG000|Randomized Phase|Adverse Event|2|||
16522309|NCT00194012|40380197|FG001|Randomized Phase|Adverse Event|1|||
16522310|NCT00194012|40380196|FG000|Randomized Phase|Participant reported having a rash|1|||
16522311|NCT00194012|40380197|FG001|Randomized Phase|Participant reported having a rash|0|||
16522312|NCT00194012|40380196|FG000|Randomized Phase|Emesis and enuresis|0|||
16522313|NCT00194012|40380197|FG001|Randomized Phase|Emesis and enuresis|1|||
16522314|NCT00194012|40380196|FG000|Randomized Phase|Oral/nasal twitching|0|||
16522315|NCT00194012|40380197|FG001|Randomized Phase|Oral/nasal twitching|1|||
16522316|NCT00194012|40380196|FG000|Open Label Extension (OLE)|Weight Gain|1|||
16522317|NCT00194012|40380197|FG001|Open Label Extension (OLE)|Weight Gain|0|||
16522318|NCT00194012|40380196|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
16522319|NCT00194012|40380197|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
16522320|NCT00194012|40380196|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
16522321|NCT00194012|40380197|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
16522322|NCT00194012|40380196|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
16522323|NCT00194012|40380197|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
16522324|NCT00162136|40380198|FG000|Overall Study|Adverse Event|1|||
16522325|NCT00162136|40380198|FG000|Overall Study|Death|1|||
16522326|NCT00162136|40380198|FG000|Overall Study|Disease Progression/Relapse|23|||
16522327|NCT00162136|40380198|FG000|Overall Study|Investigator Request|5|||
16522328|NCT00162136|40380198|FG000|Overall Study|Study Drug Toxicity|4|||
16522329|NCT00162136|40380198|FG000|Overall Study|Withdrawal by Subject|1|||
16522330|NCT04028388|40380201|FG000|Overall Study|Evaluations missing|3|||
16522331|NCT04028388|40380202|FG001|Overall Study|Evaluations missing|6|||
16522332|NCT04028388|40380201|FG000|Overall Study|Not started|2|||
16522333|NCT04028388|40380202|FG001|Overall Study|Not started|0|||
16522334|NCT02819726|40380207|FG000|Part A (All Participants)|Lost to Follow-up|0|||
16522335|NCT02819726|40380208|FG001|Part A (All Participants)|Lost to Follow-up|1|||
16522336|NCT02819726|40380209|FG002|Part A (All Participants)|Lost to Follow-up|0|||
16325745|NCT00562302|39678162|FG001|Overall Study|Non-compliance|2|||
16325746|NCT00562302|39678161|FG000|Overall Study|Withdrawal by Subject|7|||
16325747|NCT00562302|39678162|FG001|Overall Study|Withdrawal by Subject|8|||
16325748|NCT00562302|39678161|FG000|Overall Study|Death|1|||
16325749|NCT00562302|39678162|FG001|Overall Study|Death|2|||
16325750|NCT00562302|39678161|FG000|Overall Study|Lung resection prior to study completion|7|||
16325751|NCT00562302|39678162|FG001|Overall Study|Lung resection prior to study completion|7|||
16325752|NCT00562302|39678161|FG000|Overall Study|Not stated|1|||
16325753|NCT00562302|39678162|FG001|Overall Study|Not stated|4|||
16325754|NCT01270464|39678166|FG000|Overall Study|Protocol Violation|4|||
16325755|NCT01270464|39678167|FG001|Overall Study|Protocol Violation|3|||
16325756|NCT01270464|39678168|FG002|Overall Study|Protocol Violation|2|||
16325757|NCT01270464|39678166|FG000|Overall Study|Lack of Efficacy|2|||
16325758|NCT01270464|39678167|FG001|Overall Study|Lack of Efficacy|3|||
16325759|NCT01270464|39678168|FG002|Overall Study|Lack of Efficacy|1|||
16325760|NCT01270464|39678166|FG000|Overall Study|Adverse Event|9|||
16325761|NCT01270464|39678167|FG001|Overall Study|Adverse Event|1|||
16325762|NCT01270464|39678168|FG002|Overall Study|Adverse Event|7|||
16325763|NCT01270464|39678166|FG000|Overall Study|Withdrawal by Subject|2|||
16325764|NCT01270464|39678167|FG001|Overall Study|Withdrawal by Subject|1|||
16325765|NCT01270464|39678168|FG002|Overall Study|Withdrawal by Subject|4|||
16325766|NCT01270464|39678166|FG000|Overall Study|Lost to Follow-up|2|||
16325767|NCT01270464|39678167|FG001|Overall Study|Lost to Follow-up|3|||
16325768|NCT01270464|39678168|FG002|Overall Study|Lost to Follow-up|1|||
16325769|NCT01270464|39678166|FG000|Overall Study|Other|1|||
16325770|NCT01270464|39678167|FG001|Overall Study|Other|1|||
16325771|NCT01270464|39678168|FG002|Overall Study|Other|3|||
16325772|NCT03053063|39678174|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
16325773|NCT03053063|39678175|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
16325774|NCT03053063|39678176|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
16325775|NCT03053063|39678177|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
16325776|NCT03053063|39678174|FG000|Randomized Phase|Withdrew consent|8|||
16325777|NCT03053063|39678175|FG001|Randomized Phase|Withdrew consent|11|||
16522337|NCT02819726|40380210|FG003|Part A (All Participants)|Lost to Follow-up|0|||
16522338|NCT02819726|40380207|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
16522339|NCT02819726|40380208|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
16325778|NCT03053063|39678176|FG002|Randomized Phase|Withdrew consent|5|||
16325779|NCT03053063|39678177|FG003|Randomized Phase|Withdrew consent|0|||
16325780|NCT03053063|39678174|FG000|Randomized Phase|Investigator's Discretion|8|||
16325781|NCT03053063|39678175|FG001|Randomized Phase|Investigator's Discretion|6|||
16522340|NCT02819726|40380209|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
16325782|NCT03053063|39678176|FG002|Randomized Phase|Investigator's Discretion|2|||
16325783|NCT03053063|39678177|FG003|Randomized Phase|Investigator's Discretion|0|||
16325784|NCT03053063|39678174|FG000|Randomized Phase|Lost to Follow-up|3|||
16325785|NCT03053063|39678175|FG001|Randomized Phase|Lost to Follow-up|5|||
16325786|NCT03053063|39678176|FG002|Randomized Phase|Lost to Follow-up|1|||
16325787|NCT03053063|39678177|FG003|Randomized Phase|Lost to Follow-up|0|||
16325788|NCT03053063|39678174|FG000|Randomized Phase|Adverse Event|0|||
16325789|NCT03053063|39678175|FG001|Randomized Phase|Adverse Event|1|||
16325790|NCT03053063|39678176|FG002|Randomized Phase|Adverse Event|0|||
16325791|NCT03053063|39678177|FG003|Randomized Phase|Adverse Event|0|||
16325792|NCT03053063|39678174|FG000|Randomized Phase|Randomized but Never Treated|1|||
16325793|NCT03053063|39678175|FG001|Randomized Phase|Randomized but Never Treated|3|||
16325794|NCT03053063|39678176|FG002|Randomized Phase|Randomized but Never Treated|2|||
16325795|NCT03053063|39678177|FG003|Randomized Phase|Randomized but Never Treated|0|||
16325796|NCT03053063|39678174|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
16522341|NCT02819726|40380210|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
16522342|NCT02819726|40380207|FG000|Part A (All Participants)|Protocol non-compliance|3|||
16522343|NCT02819726|40380208|FG001|Part A (All Participants)|Protocol non-compliance|4|||
16522344|NCT02819726|40380209|FG002|Part A (All Participants)|Protocol non-compliance|5|||
16522345|NCT02819726|40380210|FG003|Part A (All Participants)|Protocol non-compliance|0|||
16522346|NCT02819726|40380207|FG000|Part B (All Participants)|Lost to Follow-up|1|||
16522347|NCT02819726|40380208|FG001|Part B (All Participants)|Lost to Follow-up|1|||
16522348|NCT02819726|40380209|FG002|Part B (All Participants)|Lost to Follow-up|2|||
16522349|NCT02819726|40380210|FG003|Part B (All Participants)|Lost to Follow-up|2|||
16522350|NCT02819726|40380207|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
16325797|NCT03053063|39678175|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
16325798|NCT03053063|39678176|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
16325799|NCT03053063|39678177|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
16325800|NCT03053063|39678174|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
16325801|NCT03053063|39678175|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
16522351|NCT02819726|40380208|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
16522352|NCT02819726|40380209|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
16522353|NCT02819726|40380210|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
16522354|NCT02819726|40380207|FG000|Part B (All Participants)|Protocol non-compliance|0|||
16522355|NCT02819726|40380208|FG001|Part B (All Participants)|Protocol non-compliance|0|||
16522356|NCT02819726|40380209|FG002|Part B (All Participants)|Protocol non-compliance|1|||
16522357|NCT02819726|40380210|FG003|Part B (All Participants)|Protocol non-compliance|0|||
16522358|NCT03231371|40380212|FG000|Overall Study|Withdrawal by Subject|1|||
16522359|NCT03231371|40380212|FG000|Overall Study|chose or were ineligible to have MRI|12|||
16522360|NCT01794949|40380224|FG000|Overall Study|Lost to Follow-up|1|||
16522361|NCT01794949|40380225|FG001|Overall Study|Lost to Follow-up|0|||
16522362|NCT01218646|40380226|FG000|Overall Study|Adverse Event|0|||
16325802|NCT03053063|39678176|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
16325803|NCT03053063|39678177|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
16325804|NCT03053063|39678174|FG000|Open-Label Phase|Death|0|||
16325805|NCT03053063|39678175|FG001|Open-Label Phase|Death|0|||
16522363|NCT01218646|40380227|FG001|Overall Study|Adverse Event|0|||
16325806|NCT03053063|39678176|FG002|Open-Label Phase|Death|0|||
16325807|NCT03053063|39678177|FG003|Open-Label Phase|Death|2|||
16325808|NCT03053063|39678174|FG000|Open-Label Phase|Investigator's discretion|0|||
16325809|NCT03053063|39678175|FG001|Open-Label Phase|Investigator's discretion|0|||
16325810|NCT03053063|39678176|FG002|Open-Label Phase|Investigator's discretion|0|||
16325811|NCT03053063|39678177|FG003|Open-Label Phase|Investigator's discretion|2|||
16325812|NCT01931956|39678178|FG000|Overall Study|Death|42|||
16325813|NCT01931956|39678179|FG001|Overall Study|Death|7|||
16325814|NCT01931956|39678180|FG002|Overall Study|Death|379|||
16325815|NCT01931956|39678181|FG003|Overall Study|Death|96|||
16522364|NCT01218646|40380228|FG002|Overall Study|Adverse Event|1|||
16207324|NCT00565812|39237199|FG000|Overall Study|Adverse Event|41|||
16207325|NCT00565812|39237200|FG001|Overall Study|Adverse Event|54|||
16207326|NCT00565812|39237201|FG002|Overall Study|Adverse Event|40|||
16207327|NCT00565812|39237199|FG000|Overall Study|Jury Duty|1|||
16207328|NCT00565812|39237200|FG001|Overall Study|Jury Duty|0|||
16207329|NCT00565812|39237201|FG002|Overall Study|Jury Duty|0|||
16207330|NCT00565812|39237199|FG000|Overall Study|Relocated Out of Area|5|||
16207331|NCT00565812|39237200|FG001|Overall Study|Relocated Out of Area|8|||
16207332|NCT00565812|39237201|FG002|Overall Study|Relocated Out of Area|9|||
16207333|NCT00565812|39237199|FG000|Overall Study|Sponsor Decision|1|||
16207334|NCT00565812|39237200|FG001|Overall Study|Sponsor Decision|5|||
16207335|NCT00565812|39237201|FG002|Overall Study|Sponsor Decision|1|||
16207336|NCT00565812|39237199|FG000|Overall Study|Domestic Reasons|7|||
16325816|NCT01931956|39678178|FG000|Overall Study|Withdrawal by Subject|5|||
16325817|NCT01931956|39678179|FG001|Overall Study|Withdrawal by Subject|0|||
16325818|NCT01931956|39678180|FG002|Overall Study|Withdrawal by Subject|70|||
16325819|NCT01931956|39678181|FG003|Overall Study|Withdrawal by Subject|30|||
16325820|NCT01931956|39678178|FG000|Overall Study|Lost to Follow-up|2|||
16325821|NCT01931956|39678179|FG001|Overall Study|Lost to Follow-up|0|||
16325822|NCT01931956|39678180|FG002|Overall Study|Lost to Follow-up|11|||
16522365|NCT01218646|40380229|FG003|Overall Study|Adverse Event|0|||
16522366|NCT01218646|40380226|FG000|Overall Study|Lost to Follow-up|1|||
16522367|NCT01218646|40380227|FG001|Overall Study|Lost to Follow-up|0|||
16522368|NCT01218646|40380228|FG002|Overall Study|Lost to Follow-up|0|||
16522369|NCT01218646|40380229|FG003|Overall Study|Lost to Follow-up|0|||
16522370|NCT01218646|40380226|FG000|Overall Study|Protocol Violation|0|||
16522371|NCT01218646|40380227|FG001|Overall Study|Protocol Violation|0|||
16522372|NCT01218646|40380228|FG002|Overall Study|Protocol Violation|1|||
16522373|NCT01218646|40380229|FG003|Overall Study|Protocol Violation|1|||
16522374|NCT01412424|40380234|FG000|Core Treatment Period|Treatment Failure|24|||
16522375|NCT01412424|40380234|FG000|Core Treatment Period|Adverse Event|21|||
16522376|NCT01412424|40380234|FG000|Core Treatment Period|Patient Request|5|||
16522377|NCT01412424|40380234|FG000|Core Treatment Period|Lost to Follow-up|2|||
16522378|NCT01412424|40380234|FG000|Core Treatment Period|Sponsor Request|1|||
16522379|NCT01412424|40380234|FG000|Extension Treatment Period|Adverse Event|2|||
16522380|NCT01412424|40380234|FG000|Extension Treatment Period|Treatment Failure|2|||
16522381|NCT01412424|40380234|FG000|Extension Treatment Period|Patient Request|2|||
16522382|NCT03930745|40380235|FG000|Overall Study|Lost to Follow-up|10|||
16522383|NCT03930745|40380236|FG001|Overall Study|Lost to Follow-up|5|||
16522384|NCT03930745|40380235|FG000|Overall Study|Withdrawal by Subject|1|||
16522385|NCT03930745|40380236|FG001|Overall Study|Withdrawal by Subject|2|||
16522386|NCT03930745|40380235|FG000|Overall Study|Protocol Violation|2|||
16522387|NCT03930745|40380236|FG001|Overall Study|Protocol Violation|2|||
16522388|NCT03930745|40380235|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
16522389|NCT03930745|40380236|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
16522390|NCT03930745|40380235|FG000|Overall Study|Adverse Event|0|||
16522391|NCT03930745|40380236|FG001|Overall Study|Adverse Event|1|||
16207337|NCT00565812|39237200|FG001|Overall Study|Domestic Reasons|1|||
16207338|NCT00565812|39237201|FG002|Overall Study|Domestic Reasons|3|||
16207339|NCT00565812|39237199|FG000|Overall Study|Research Site Closure|6|||
16207340|NCT00565812|39237200|FG001|Overall Study|Research Site Closure|1|||
16207341|NCT00565812|39237201|FG002|Overall Study|Research Site Closure|8|||
16207342|NCT00565812|39237199|FG000|Overall Study|Surgical Intervention|0|||
16207343|NCT00565812|39237200|FG001|Overall Study|Surgical Intervention|1|||
16207344|NCT00565812|39237201|FG002|Overall Study|Surgical Intervention|2|||
16207345|NCT00565812|39237199|FG000|Overall Study|Low Compliance|1|||
16207346|NCT00565812|39237200|FG001|Overall Study|Low Compliance|0|||
16207347|NCT00565812|39237201|FG002|Overall Study|Low Compliance|1|||
16207348|NCT00565812|39237199|FG000|Overall Study|Follow-up Visit Not Completed|2|||
16207349|NCT00565812|39237200|FG001|Overall Study|Follow-up Visit Not Completed|0|||
16325823|NCT01931956|39678181|FG003|Overall Study|Lost to Follow-up|7|||
16325824|NCT01931956|39678178|FG000|Overall Study|Expected|2|||
16325825|NCT01931956|39678179|FG001|Overall Study|Expected|0|||
16325826|NCT01931956|39678180|FG002|Overall Study|Expected|6|||
16325827|NCT01931956|39678181|FG003|Overall Study|Expected|0|||
16207350|NCT00565812|39237201|FG002|Overall Study|Follow-up Visit Not Completed|1|||
16325828|NCT01931956|39678178|FG000|Overall Study|Not due|0|||
16325829|NCT01931956|39678179|FG001|Overall Study|Not due|0|||
16522392|NCT03930745|40380235|FG000|Overall Study|Pregnancy|0|||
16522393|NCT03930745|40380236|FG001|Overall Study|Pregnancy|1|||
16522394|NCT01337245|40380238|FG000|Overall Study|Lost to Follow-up|1|||
16207351|NCT00565812|39237199|FG000|Overall Study|Physician Decision|2|||
16325830|NCT01931956|39678180|FG002|Overall Study|Not due|21|||
16325831|NCT01931956|39678181|FG003|Overall Study|Not due|0|||
16325832|NCT05113979|39678193|FG000|Overall Study|Death|2|||
16207352|NCT00565812|39237200|FG001|Overall Study|Physician Decision|0|||
16207353|NCT00565812|39237201|FG002|Overall Study|Physician Decision|0|||
16207354|NCT00724815|39237207|FG000|Overall Study|Randomized, not treated|31|||
16207355|NCT00724815|39237208|FG001|Overall Study|Randomized, not treated|30|||
16522395|NCT01047683|40380241|FG000|Overall Study|Adverse Event|3|||
16522396|NCT01047683|40380242|FG001|Overall Study|Adverse Event|1|||
16522397|NCT01047683|40380243|FG002|Overall Study|Adverse Event|0|||
16522398|NCT01047683|40380241|FG000|Overall Study|Withdrew Consent|1|||
16522399|NCT01047683|40380242|FG001|Overall Study|Withdrew Consent|4|||
16522400|NCT01047683|40380243|FG002|Overall Study|Withdrew Consent|2|||
16522401|NCT01047683|40380241|FG000|Overall Study|Lost to Follow-up|0|||
16522402|NCT01047683|40380242|FG001|Overall Study|Lost to Follow-up|1|||
16207356|NCT00724815|39237207|FG000|Overall Study|Adverse Event|5|||
16207357|NCT00724815|39237208|FG001|Overall Study|Adverse Event|3|||
16207358|NCT00724815|39237207|FG000|Overall Study|Lost to Follow-up|4|||
16207359|NCT00724815|39237208|FG001|Overall Study|Lost to Follow-up|1|||
16207360|NCT00724815|39237207|FG000|Overall Study|Other Various|3|||
16207361|NCT00724815|39237208|FG001|Overall Study|Other Various|5|||
16207362|NCT00524043|39237209|FG000|Overall Study|Lack of Efficacy|15|||
16207363|NCT00524043|39237210|FG001|Overall Study|Lack of Efficacy|13|||
16522403|NCT01047683|40380243|FG002|Overall Study|Lost to Follow-up|0|||
16522404|NCT01047683|40380241|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
16522405|NCT01047683|40380242|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
16522406|NCT01047683|40380243|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
16522407|NCT01692197|40380252|FG000|Overall Study|Failed Screening|3|||
16522408|NCT01046643|40380253|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
16522409|NCT01046643|40380254|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
16522410|NCT01046643|40380255|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
16522411|NCT01046643|40380256|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
16522412|NCT02663128|40380257|FG000|Period 2|Physician Decision|0|||
16522413|NCT02663128|40380258|FG001|Period 2|Physician Decision|0|||
16522414|NCT02663128|40380259|FG002|Period 2|Physician Decision|0|||
16522415|NCT02663128|40380260|FG003|Period 2|Physician Decision|0|||
16522416|NCT02663128|40380261|FG004|Period 2|Physician Decision|1|||
16522417|NCT02663128|40380262|FG005|Period 2|Physician Decision|0|||
16522418|NCT00600821|40380263|FG000|Overall Study|Death|45|||
16522419|NCT00600821|40380264|FG001|Overall Study|Death|46|||
16522420|NCT00600821|40380263|FG000|Overall Study|Lost to Follow-up|2|||
16207364|NCT00524043|39237211|FG002|Overall Study|Lack of Efficacy|14|||
16207365|NCT00524043|39237209|FG000|Overall Study|Withdrawal by Subject|5|||
16207366|NCT00524043|39237210|FG001|Overall Study|Withdrawal by Subject|7|||
16207367|NCT00524043|39237211|FG002|Overall Study|Withdrawal by Subject|7|||
16207368|NCT00524043|39237209|FG000|Overall Study|Adverse Event|5|||
16207369|NCT00524043|39237210|FG001|Overall Study|Adverse Event|2|||
16207370|NCT00524043|39237211|FG002|Overall Study|Adverse Event|7|||
16207371|NCT00524043|39237209|FG000|Overall Study|Lost to Follow-up|3|||
16207372|NCT00524043|39237210|FG001|Overall Study|Lost to Follow-up|5|||
16207373|NCT00524043|39237211|FG002|Overall Study|Lost to Follow-up|3|||
16207374|NCT00524043|39237209|FG000|Overall Study|Various (eg, incarceration)|2|||
16207375|NCT00524043|39237210|FG001|Overall Study|Various (eg, incarceration)|1|||
16207376|NCT00524043|39237211|FG002|Overall Study|Various (eg, incarceration)|0|||
16207377|NCT03446612|39237220|FG000|Overall Study|Protocol defined stopping criteria|0|||
16207378|NCT03446612|39237221|FG001|Overall Study|Protocol defined stopping criteria|1|||
16207379|NCT02260388|39237222|FG000|Overall Study|Lost to Follow-up|2|||
16207380|NCT02260388|39237223|FG001|Overall Study|Lost to Follow-up|8|||
16207381|NCT02260388|39237224|FG002|Overall Study|Lost to Follow-up|3|||
16207382|NCT02260388|39237225|FG003|Overall Study|Lost to Follow-up|4|||
16207383|NCT00801892|39237228|FG000|Main Study Period|Withdrawal by Subject|0|||
16207384|NCT00801892|39237229|FG001|Main Study Period|Withdrawal by Subject|1|||
16207385|NCT00801892|39237228|FG000|Sham Crossover Period|Lost to Follow-up|0|||
16207386|NCT00801892|39237229|FG001|Sham Crossover Period|Lost to Follow-up|2|||
16207387|NCT00415519|39237233|FG000|Overall Study|Adverse Event|1|||
16207388|NCT00415519|39237234|FG001|Overall Study|Adverse Event|0|||
16325833|NCT05113979|39678193|FG000|Overall Study|Lost to Follow-up|1|||
16522421|NCT00600821|40380264|FG001|Overall Study|Lost to Follow-up|2|||
16094447|NCT00103857|38836451|FG002|54-Week Base Study|Lost to Follow-up|7|||
16207389|NCT00415519|39237233|FG000|Overall Study|Withdrawal by Subject|2|||
16207390|NCT00415519|39237234|FG001|Overall Study|Withdrawal by Subject|0|||
16522422|NCT00600821|40380263|FG000|Overall Study|Withdrawal by Subject|1|||
16522423|NCT00600821|40380264|FG001|Overall Study|Withdrawal by Subject|1|||
16522424|NCT00600821|40380263|FG000|Overall Study|Terminated by sponsor|8|||
16522425|NCT00600821|40380264|FG001|Overall Study|Terminated by sponsor|6|||
16522426|NCT00600821|40380263|FG000|Overall Study|Objective progression or relapse|0|||
16207391|NCT00415519|39237233|FG000|Overall Study|Patient's convenience|1|||
16207392|NCT00415519|39237234|FG001|Overall Study|Patient's convenience|0|||
16207393|NCT01634113|39237235|FG000|Overall Study|Not treated|0|||
16207394|NCT01634113|39237236|FG001|Overall Study|Not treated|0|||
16207395|NCT01634113|39237237|FG002|Overall Study|Not treated|1|||
16522427|NCT00600821|40380264|FG001|Overall Study|Objective progression or relapse|1|||
16207396|NCT00209170|39237238|FG000|Overall Study|Adverse Event|0|||
16207397|NCT00209170|39237239|FG001|Overall Study|Adverse Event|1|||
16207398|NCT00209170|39237238|FG000|Overall Study|Withdrawal by Subject|2|||
16207399|NCT00209170|39237239|FG001|Overall Study|Withdrawal by Subject|1|||
16207400|NCT00209170|39237238|FG000|Overall Study|Lack of Efficacy|0|||
16207401|NCT00209170|39237239|FG001|Overall Study|Lack of Efficacy|1|||
16207402|NCT01779648|39237246|FG000|Overall Study|Protocol Violation|1|||
16207403|NCT01779648|39237247|FG001|Overall Study|Protocol Violation|0|||
16207404|NCT03209362|39237248|FG000|Overall Study|Adverse Event|0|||
16207405|NCT03209362|39237249|FG001|Overall Study|Adverse Event|1|||
16207406|NCT03209362|39237248|FG000|Overall Study|Lost to Follow-up|0|||
16207407|NCT03209362|39237249|FG001|Overall Study|Lost to Follow-up|1|||
16207408|NCT03209362|39237248|FG000|Overall Study|Withdrawal by Subject|2|||
16207409|NCT03209362|39237249|FG001|Overall Study|Withdrawal by Subject|0|||
16207410|NCT03209362|39237248|FG000|Overall Study|Other|0|||
16207411|NCT03209362|39237249|FG001|Overall Study|Other|1|||
16207412|NCT00132314|39237250|FG000|Overall Study|Lost to Follow-up|70|||
16207413|NCT00132314|39237251|FG001|Overall Study|Lost to Follow-up|62|||
16207414|NCT00132314|39237250|FG000|Overall Study|Lacked SSN|1|||
16207415|NCT00132314|39237251|FG001|Overall Study|Lacked SSN|3|||
16207416|NCT00132314|39237250|FG000|Overall Study|Refused intervention at baseline|2|||
16207417|NCT00132314|39237251|FG001|Overall Study|Refused intervention at baseline|7|||
16207418|NCT00355134|39237252|FG000|Core Phase|Withdrawal by Subject|35|||
16207419|NCT00355134|39237253|FG001|Core Phase|Withdrawal by Subject|24|||
16207420|NCT00355134|39237254|FG002|Core Phase|Withdrawal by Subject|35|||
16207421|NCT00355134|39237255|FG003|Core Phase|Withdrawal by Subject|0|||
16207422|NCT00355134|39237256|FG004|Core Phase|Withdrawal by Subject|0|||
16207423|NCT00355134|39237252|FG000|Core Phase|Adverse Event|28|||
16207424|NCT00355134|39237253|FG001|Core Phase|Adverse Event|22|||
16207425|NCT00355134|39237254|FG002|Core Phase|Adverse Event|16|||
16207426|NCT00355134|39237255|FG003|Core Phase|Adverse Event|0|||
16207427|NCT00355134|39237256|FG004|Core Phase|Adverse Event|0|||
16207428|NCT00355134|39237252|FG000|Core Phase|Lost to Follow-up|17|||
16207429|NCT00355134|39237253|FG001|Core Phase|Lost to Follow-up|13|||
16207430|NCT00355134|39237254|FG002|Core Phase|Lost to Follow-up|21|||
16207431|NCT00355134|39237255|FG003|Core Phase|Lost to Follow-up|0|||
16207432|NCT00355134|39237256|FG004|Core Phase|Lost to Follow-up|0|||
16207433|NCT00355134|39237252|FG000|Core Phase|Abnormal laboratory value(s)|19|||
16207434|NCT00355134|39237253|FG001|Core Phase|Abnormal laboratory value(s)|14|||
16207435|NCT00355134|39237254|FG002|Core Phase|Abnormal laboratory value(s)|2|||
16207436|NCT00355134|39237255|FG003|Core Phase|Abnormal laboratory value(s)|0|||
16207437|NCT00355134|39237256|FG004|Core Phase|Abnormal laboratory value(s)|0|||
16325834|NCT01387516|39678196|FG000|Overall Study|Lost to Follow-up|4|||
16325835|NCT01387516|39678197|FG001|Overall Study|Lost to Follow-up|4|||
16325836|NCT01387516|39678198|FG002|Overall Study|Lost to Follow-up|2|||
16325837|NCT01387516|39678199|FG003|Overall Study|Lost to Follow-up|3|||
16396442|NCT02808897|39931381|FG000|Overall Study|Lost to Follow-up|9|||
16396443|NCT02808897|39931382|FG001|Overall Study|Lost to Follow-up|11|||
16396444|NCT01822899|39931383|FG000|Overall Study|Adverse Event|6|||
16396445|NCT01822899|39931384|FG001|Overall Study|Adverse Event|5|||
16396446|NCT01822899|39931383|FG000|Overall Study|Lack of Efficacy|6|||
16396447|NCT01822899|39931384|FG001|Overall Study|Lack of Efficacy|3|||
16396448|NCT01822899|39931383|FG000|Overall Study|Protocol Violation|6|||
16396449|NCT01822899|39931384|FG001|Overall Study|Protocol Violation|3|||
16396450|NCT01822899|39931383|FG000|Overall Study|Lost to Follow-up|1|||
16396451|NCT01822899|39931384|FG001|Overall Study|Lost to Follow-up|0|||
16396452|NCT01822899|39931383|FG000|Overall Study|Withdrawal by Subject|5|||
16522428|NCT00600821|40380263|FG000|Overall Study|Randomized but not treated|0|||
16522429|NCT00600821|40380264|FG001|Overall Study|Randomized but not treated|1|||
16522430|NCT00600821|40380263|FG000|Overall Study|Other|2|||
16522431|NCT00600821|40380264|FG001|Overall Study|Other|3|||
16522432|NCT00211081|40380266|FG000|Overall Study|Withdrawal by Subject|2|||
16207438|NCT00355134|39237252|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
16325838|NCT01387516|39678196|FG000|Overall Study|Withdrawal by Subject|1|||
16325839|NCT01387516|39678197|FG001|Overall Study|Withdrawal by Subject|1|||
16325840|NCT01387516|39678198|FG002|Overall Study|Withdrawal by Subject|2|||
16396453|NCT01822899|39931384|FG001|Overall Study|Withdrawal by Subject|7|||
16396454|NCT00778336|39931386|FG000|Index Procedure-Discharge|Death|6|||
16396455|NCT00778336|39931387|FG001|Index Procedure-Discharge|Death|3|||
16207439|NCT00355134|39237253|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
16207440|NCT00355134|39237254|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
16396456|NCT00778336|39931388|FG002|Index Procedure-Discharge|Death|2|||
16207441|NCT00355134|39237255|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
16207442|NCT00355134|39237256|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
16207443|NCT00355134|39237252|FG000|Core Phase|Administrative problems|5|||
16207444|NCT00355134|39237253|FG001|Core Phase|Administrative problems|3|||
16325841|NCT01387516|39678199|FG003|Overall Study|Withdrawal by Subject|0|||
16522433|NCT01975389|40380267|FG000|Overall Study|Adverse Event|10|||
16207445|NCT00355134|39237254|FG002|Core Phase|Administrative problems|5|||
16207446|NCT00355134|39237255|FG003|Core Phase|Administrative problems|0|||
16396457|NCT00778336|39931389|FG003|Index Procedure-Discharge|Death|0|||
16396458|NCT00778336|39931386|FG000|3 Month Follow Up|Lost to Follow-up|15|||
16396459|NCT00778336|39931387|FG001|3 Month Follow Up|Lost to Follow-up|20|||
16396460|NCT00778336|39931388|FG002|3 Month Follow Up|Lost to Follow-up|3|||
16396461|NCT00778336|39931389|FG003|3 Month Follow Up|Lost to Follow-up|0|||
16396462|NCT00778336|39931386|FG000|3 Month Follow Up|Death|8|||
16396463|NCT00778336|39931387|FG001|3 Month Follow Up|Death|3|||
16396464|NCT00778336|39931388|FG002|3 Month Follow Up|Death|2|||
16396465|NCT00778336|39931389|FG003|3 Month Follow Up|Death|0|||
16396466|NCT02063984|39931390|FG000|Overall Study|Lost to Follow-up|6|||
16396467|NCT02063984|39931391|FG001|Overall Study|Lost to Follow-up|5|||
16396468|NCT01905943|39931394|FG000|Overall Study|Withdrawal of consent|90|||
16396469|NCT01905943|39931394|FG000|Overall Study|Lost to Follow-up|16|||
16396470|NCT01905943|39931394|FG000|Overall Study|Investigator discretion|7|||
16396471|NCT01905943|39931394|FG000|Overall Study|Death|186|||
16396472|NCT01905943|39931394|FG000|Overall Study|Adverse Event|3|||
16396473|NCT01905943|39931394|FG000|Overall Study|Other|12|||
16396474|NCT01643408|39931397|FG000|Overall Study|Adverse Event|12|||
16396475|NCT01643408|39931397|FG000|Overall Study|Other|2|||
16396476|NCT03326063|39931402|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
16396477|NCT03326063|39931403|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
16396478|NCT03604172|39931404|FG000|Overall Study|Lost to Follow-up|1|||
16207447|NCT00355134|39237256|FG004|Core Phase|Administrative problems|0|||
16207448|NCT00355134|39237252|FG000|Core Phase|Protocol Violation|3|||
16207449|NCT00355134|39237253|FG001|Core Phase|Protocol Violation|2|||
16207450|NCT00355134|39237254|FG002|Core Phase|Protocol Violation|2|||
16207451|NCT00355134|39237255|FG003|Core Phase|Protocol Violation|0|||
16207452|NCT00355134|39237256|FG004|Core Phase|Protocol Violation|0|||
16207453|NCT00355134|39237252|FG000|Core Phase|Abnormal test procedure result(s)|1|||
16207454|NCT00355134|39237253|FG001|Core Phase|Abnormal test procedure result(s)|2|||
16207455|NCT00355134|39237254|FG002|Core Phase|Abnormal test procedure result(s)|1|||
16207456|NCT00355134|39237255|FG003|Core Phase|Abnormal test procedure result(s)|0|||
16396479|NCT03604172|39931405|FG001|Overall Study|Lost to Follow-up|2|||
16396480|NCT01713582|39931407|FG000|Overall Study|Disease progression|3|||
16396481|NCT01713582|39931408|FG001|Overall Study|Disease progression|3|||
16207457|NCT00355134|39237256|FG004|Core Phase|Abnormal test procedure result(s)|0|||
16207458|NCT00355134|39237252|FG000|Core Phase|Condition no longer requires study drug|1|||
16207459|NCT00355134|39237253|FG001|Core Phase|Condition no longer requires study drug|0|||
16325842|NCT01387516|39678196|FG000|Overall Study|Death|0|||
16325843|NCT01387516|39678197|FG001|Overall Study|Death|0|||
16325844|NCT01387516|39678198|FG002|Overall Study|Death|0|||
16325845|NCT01387516|39678199|FG003|Overall Study|Death|1|||
16325846|NCT01895270|39678204|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
16325847|NCT01895270|39678205|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
16325848|NCT01895270|39678204|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
16325849|NCT01895270|39678205|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
16325850|NCT01895270|39678204|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
16325851|NCT01895270|39678205|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
16325852|NCT01895270|39678204|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
16325853|NCT01895270|39678205|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
16396482|NCT01713582|39931409|FG002|Overall Study|Disease progression|3|||
16396483|NCT01713582|39931410|FG003|Overall Study|Disease progression|2|||
16207460|NCT00355134|39237254|FG002|Core Phase|Condition no longer requires study drug|1|||
16207461|NCT00355134|39237255|FG003|Core Phase|Condition no longer requires study drug|0|||
16207462|NCT00355134|39237256|FG004|Core Phase|Condition no longer requires study drug|0|||
16207463|NCT00355134|39237252|FG000|Extension Phase|Withdrawal by Subject|7|||
16325854|NCT01895270|39678204|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
16325855|NCT01895270|39678205|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
16325856|NCT01895270|39678204|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
16325857|NCT01895270|39678205|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
16325858|NCT01895270|39678204|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
16396484|NCT01713582|39931411|FG004|Overall Study|Disease progression|3|||
16396485|NCT01713582|39931412|FG005|Overall Study|Disease progression|3|||
16396486|NCT01713582|39931413|FG006|Overall Study|Disease progression|3|||
16396487|NCT01713582|39931414|FG007|Overall Study|Disease progression|3|||
16396488|NCT01713582|39931415|FG008|Overall Study|Disease progression|3|||
16207464|NCT00355134|39237253|FG001|Extension Phase|Withdrawal by Subject|11|||
16207465|NCT00355134|39237254|FG002|Extension Phase|Withdrawal by Subject|0|||
16207466|NCT00355134|39237255|FG003|Extension Phase|Withdrawal by Subject|7|||
16207467|NCT00355134|39237256|FG004|Extension Phase|Withdrawal by Subject|5|||
16325859|NCT01895270|39678205|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
16325860|NCT00095238|39678206|FG000|Overall Study|Lack of Efficacy|9|||
16325861|NCT00095238|39678207|FG001|Overall Study|Lack of Efficacy|9|||
16325862|NCT00095238|39678206|FG000|Overall Study|Adverse Event|331|||
16325863|NCT00095238|39678207|FG001|Overall Study|Adverse Event|287|||
16325864|NCT00095238|39678206|FG000|Overall Study|Subject Withdrew Consent|208|||
16325865|NCT00095238|39678207|FG001|Overall Study|Subject Withdrew Consent|223|||
16325866|NCT00095238|39678206|FG000|Overall Study|Death|154|||
16325867|NCT00095238|39678207|FG001|Overall Study|Death|170|||
16325868|NCT00095238|39678206|FG000|Overall Study|Lost to Follow-up|19|||
16325869|NCT00095238|39678207|FG001|Overall Study|Lost to Follow-up|24|||
16325870|NCT00095238|39678206|FG000|Overall Study|Noncompliance|44|||
16325871|NCT00095238|39678207|FG001|Overall Study|Noncompliance|45|||
16325872|NCT00095238|39678206|FG000|Overall Study|No longer met study criteria|4|||
16325873|NCT00095238|39678207|FG001|Overall Study|No longer met study criteria|5|||
16325874|NCT00095238|39678206|FG000|Overall Study|Study terminated by sponsor|0|||
16325875|NCT00095238|39678207|FG001|Overall Study|Study terminated by sponsor|1|||
16325876|NCT00095238|39678206|FG000|Overall Study|Missing|1|||
16522434|NCT01975389|40380268|FG001|Overall Study|Adverse Event|6|||
16522435|NCT01975389|40380267|FG000|Overall Study|Death|61|||
16522436|NCT01975389|40380268|FG001|Overall Study|Death|54|||
16522437|NCT01975389|40380267|FG000|Overall Study|Lost to Follow-up|81|||
16522438|NCT01975389|40380268|FG001|Overall Study|Lost to Follow-up|86|||
16522439|NCT01975389|40380267|FG000|Overall Study|Withdrawal by Subject|90|||
16522440|NCT01975389|40380268|FG001|Overall Study|Withdrawal by Subject|76|||
16522441|NCT01975389|40380267|FG000|Overall Study|Other|6|||
16207468|NCT00355134|39237252|FG000|Extension Phase|Adverse Event|13|||
16207469|NCT00355134|39237253|FG001|Extension Phase|Adverse Event|9|||
16207470|NCT00355134|39237254|FG002|Extension Phase|Adverse Event|0|||
16207471|NCT00355134|39237255|FG003|Extension Phase|Adverse Event|3|||
16325877|NCT00095238|39678207|FG001|Overall Study|Missing|0|||
16325878|NCT00095238|39678206|FG000|Overall Study|Other Reasons|87|||
16207472|NCT00355134|39237256|FG004|Extension Phase|Adverse Event|5|||
16325879|NCT00095238|39678207|FG001|Overall Study|Other Reasons|88|||
16325880|NCT02163447|39678208|FG000|Overall Study|Withdrawal by Subject|2|||
16325881|NCT02163447|39678209|FG001|Overall Study|Withdrawal by Subject|0|||
16325882|NCT02163447|39678210|FG002|Overall Study|Withdrawal by Subject|1|||
16325883|NCT02163447|39678208|FG000|Overall Study|Lost to Follow-up|1|||
16325884|NCT02163447|39678209|FG001|Overall Study|Lost to Follow-up|3|||
16325885|NCT02163447|39678210|FG002|Overall Study|Lost to Follow-up|0|||
16325886|NCT02163447|39678208|FG000|Overall Study|Moved out of study area|2|||
16325887|NCT02163447|39678209|FG001|Overall Study|Moved out of study area|3|||
16325888|NCT02163447|39678210|FG002|Overall Study|Moved out of study area|2|||
16325889|NCT02163447|39678208|FG000|Overall Study|Became HIV infected at time of delivery|1|||
16325890|NCT02163447|39678209|FG001|Overall Study|Became HIV infected at time of delivery|0|||
16325891|NCT02163447|39678210|FG002|Overall Study|Became HIV infected at time of delivery|0|||
16325892|NCT03702010|39678213|FG000|Follow-up (30days)|Lack of Efficacy|2|||
16325893|NCT03702010|39678214|FG001|Follow-up (30days)|Lack of Efficacy|2|||
16325894|NCT00626821|39678215|FG000|Overall Study|Adverse Event|44|||
16325895|NCT00626821|39678215|FG000|Overall Study|Protocol Violation|33|||
16325896|NCT00626821|39678215|FG000|Overall Study|Withdrawal by Subject|10|||
16522442|NCT01975389|40380268|FG001|Overall Study|Other|9|||
16522443|NCT01975389|40380267|FG000|Overall Study|Randomized, not treated|4|||
16325897|NCT00626821|39678215|FG000|Overall Study|Physician Decision|9|||
16325898|NCT00626821|39678215|FG000|Overall Study|Product dysfunction|21|||
16325899|NCT00626821|39678215|FG000|Overall Study|other/unknown reason|104|||
16207473|NCT00355134|39237252|FG000|Extension Phase|Lost to Follow-up|2|||
16207474|NCT00355134|39237253|FG001|Extension Phase|Lost to Follow-up|6|||
16207475|NCT00355134|39237254|FG002|Extension Phase|Lost to Follow-up|0|||
16207476|NCT00355134|39237255|FG003|Extension Phase|Lost to Follow-up|2|||
16207477|NCT00355134|39237256|FG004|Extension Phase|Lost to Follow-up|4|||
16207478|NCT00355134|39237252|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
16207479|NCT00355134|39237253|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
16207480|NCT00355134|39237254|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
16396489|NCT01713582|39931416|FG009|Overall Study|Disease progression|11|||
16396490|NCT01713582|39931417|FG010|Overall Study|Disease progression|10|||
16207481|NCT00355134|39237255|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
16207482|NCT00355134|39237256|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
16396491|NCT01713582|39931418|FG011|Overall Study|Disease progression|5|||
16396492|NCT01713582|39931419|FG012|Overall Study|Disease progression|3|||
16396493|NCT01713582|39931420|FG013|Overall Study|Disease progression|3|||
16396494|NCT01713582|39931421|FG014|Overall Study|Disease progression|6|||
16396495|NCT01713582|39931422|FG015|Overall Study|Disease progression|6|||
16396496|NCT01713582|39931423|FG016|Overall Study|Disease progression|5|||
16396497|NCT01713582|39931424|FG017|Overall Study|Disease progression|2|||
16396498|NCT01713582|39931425|FG018|Overall Study|Disease progression|3|||
16396499|NCT01713582|39931426|FG019|Overall Study|Disease progression|5|||
16396500|NCT01713582|39931427|FG020|Overall Study|Disease progression|15|||
16396501|NCT01713582|39931407|FG000|Overall Study|Death|0|||
16396502|NCT01713582|39931408|FG001|Overall Study|Death|0|||
16396503|NCT01713582|39931409|FG002|Overall Study|Death|0|||
16396504|NCT01713582|39931410|FG003|Overall Study|Death|1|||
16207483|NCT00355134|39237252|FG000|Extension Phase|Administrative problems|2|||
16325900|NCT00721279|39678220|FG000|Overall Study|Lack of Efficacy|6|||
16325901|NCT00721279|39678221|FG001|Overall Study|Lack of Efficacy|3|||
16325902|NCT00721279|39678220|FG000|Overall Study|Tolerability insufficient|5|||
16325903|NCT00721279|39678221|FG001|Overall Study|Tolerability insufficient|2|||
16325904|NCT00721279|39678220|FG000|Overall Study|Withdrawal by Subject|13|||
16325905|NCT00721279|39678221|FG001|Overall Study|Withdrawal by Subject|3|||
16325906|NCT00721279|39678220|FG000|Overall Study|Other|12|||
16325907|NCT00721279|39678221|FG001|Overall Study|Other|16|||
16325908|NCT01696929|39678222|FG000|Overall Study|Physician Decision|1|||
16325909|NCT01680159|39678230|FG000|Screening Period|Not meet criteria for dose-up period|7|||
16325910|NCT01680159|39678230|FG000|Increased Dose Period|Adverse Event|6|||
16325911|NCT01680159|39678230|FG000|Increased Dose Period|Withdrawal by Subject|2|||
16325912|NCT03502070|39678231|FG000|Overall Study|Withdrawal by Subject|1|||
16325913|NCT03502070|39678231|FG000|Overall Study|Screen Failure|1|||
16325914|NCT02640950|39678238|FG000|Overall Study|Adverse Event|1|||
16325915|NCT02640950|39678238|FG000|Overall Study|Withdrawal by Subject|1|||
16325916|NCT01515865|39678239|FG000|Part A (Open-label)|Other|3|||
16325917|NCT01515865|39678240|FG001|Part A (Open-label)|Other|0|||
16325918|NCT01515865|39678241|FG002|Part A (Open-label)|Other|0|||
16325919|NCT01515865|39678239|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
16325920|NCT01515865|39678240|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
16325921|NCT01515865|39678241|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
16325922|NCT01515865|39678239|FG000|Part B (Open-label)|Other|1|||
16325923|NCT01515865|39678240|FG001|Part B (Open-label)|Other|0|||
16325924|NCT01515865|39678241|FG002|Part B (Open-label)|Other|0|||
16325925|NCT01264081|39678242|FG000|Participants Screened|Screening failures|30|||
16325926|NCT01264081|39678242|FG000|Started Treatment|Withdrawal by Subject|1|||
16325927|NCT01264081|39678242|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
16325928|NCT00381238|39678243|FG000|Overall Study|Adverse Event|3|||
16325929|NCT00381238|39678243|FG000|Overall Study|Protocol Violation|1|||
16325930|NCT00381238|39678243|FG000|Overall Study|Withdrawal by Subject|4|||
16325931|NCT00381238|39678243|FG000|Overall Study|Lack of Efficacy|2|||
16325932|NCT00381238|39678243|FG000|Overall Study|Withdrew by physician|1|||
16325933|NCT00381238|39678243|FG000|Overall Study|Disease progression|1|||
16325934|NCT04545567|39678244|FG000|Overall Study|tested positive for SARS-co-V2|1|||
16325935|NCT04545567|39678245|FG001|Overall Study|tested positive for SARS-co-V2|1|||
16325936|NCT04545567|39678244|FG000|Overall Study|Withdrawal by Subject|0|||
16325937|NCT04545567|39678245|FG001|Overall Study|Withdrawal by Subject|1|||
16325938|NCT01023256|39678248|FG000|Overall Study|Protocol Violation|2|||
16325939|NCT01023256|39678249|FG001|Overall Study|Protocol Violation|3|||
16325940|NCT01023256|39678250|FG002|Overall Study|Protocol Violation|0|||
16325941|NCT01023256|39678251|FG003|Overall Study|Protocol Violation|0|||
16325942|NCT01023256|39678248|FG000|Overall Study|Randomized but not treated|1|||
16325943|NCT01023256|39678249|FG001|Overall Study|Randomized but not treated|0|||
16325944|NCT01023256|39678250|FG002|Overall Study|Randomized but not treated|1|||
16325945|NCT01023256|39678251|FG003|Overall Study|Randomized but not treated|0|||
16325946|NCT01023256|39678248|FG000|Overall Study|Other|1|||
16325947|NCT01023256|39678249|FG001|Overall Study|Other|0|||
16325948|NCT01023256|39678250|FG002|Overall Study|Other|0|||
16325949|NCT01023256|39678251|FG003|Overall Study|Other|2|||
16325950|NCT01023256|39678248|FG000|Overall Study|Adverse Event|0|||
16396505|NCT01713582|39931411|FG004|Overall Study|Death|1|||
16325951|NCT01023256|39678249|FG001|Overall Study|Adverse Event|0|||
16325952|NCT01023256|39678250|FG002|Overall Study|Adverse Event|0|||
16325953|NCT01023256|39678251|FG003|Overall Study|Adverse Event|1|||
16325954|NCT01023256|39678248|FG000|Overall Study|Withdrawal by Subject|0|||
16325955|NCT01023256|39678249|FG001|Overall Study|Withdrawal by Subject|0|||
16325956|NCT01023256|39678250|FG002|Overall Study|Withdrawal by Subject|0|||
16325957|NCT01023256|39678251|FG003|Overall Study|Withdrawal by Subject|2|||
16325958|NCT00689104|39678254|FG000|Overall Study|Eligibility criterion not met|5|||
16325959|NCT00689104|39678255|FG001|Overall Study|Eligibility criterion not met|8|||
16325960|NCT00689104|39678256|FG002|Overall Study|Eligibility criterion not met|0|||
16325961|NCT00689104|39678257|FG003|Overall Study|Eligibility criterion not met|4|||
16325962|NCT00689104|39678254|FG000|Overall Study|Adverse Event|13|||
16325963|NCT00689104|39678255|FG001|Overall Study|Adverse Event|25|||
16325964|NCT00689104|39678256|FG002|Overall Study|Adverse Event|16|||
16325965|NCT00689104|39678257|FG003|Overall Study|Adverse Event|24|||
16325966|NCT00689104|39678254|FG000|Overall Study|Lack of Efficacy|5|||
16325967|NCT00689104|39678255|FG001|Overall Study|Lack of Efficacy|6|||
16522444|NCT01975389|40380268|FG001|Overall Study|Randomized, not treated|5|||
16522445|NCT00003498|40380272|FG000|Overall Study|Not evaluable.|4|||
16522446|NCT01519518|40380273|FG000|Overall Study|Consent not available|7|||
16522447|NCT01519518|40380274|FG001|Overall Study|Consent not available|10|||
16522448|NCT01775137|40380275|FG000|Overall Study|Death|1|||
16522449|NCT01775137|40380275|FG000|Overall Study|Protocol deviation|2|||
16522450|NCT01775137|40380275|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16522451|NCT01775137|40380275|FG000|Overall Study|Adverse Event|1|||
16522452|NCT01775137|40380275|FG000|Overall Study|Withdrawal by participants|5|||
16522453|NCT01427712|40380281|FG000|Overall Study|Transfer to a different hospital|2|||
16522454|NCT01427712|40380281|FG000|Overall Study|Lost to Follow-up|1|||
16522455|NCT01427712|40380281|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
16522456|NCT01427712|40380281|FG000|Overall Study|Failure to visit|1|||
16522457|NCT02647359|40380282|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
16522458|NCT02647359|40380283|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
16522459|NCT02647359|40380282|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
16522460|NCT02647359|40380283|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
16522461|NCT02647359|40380282|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
16522462|NCT02647359|40380283|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
16522463|NCT02647359|40380282|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
16522464|NCT02647359|40380283|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
16522465|NCT02647359|40380282|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
16522466|NCT02647359|40380283|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
16522467|NCT02647359|40380282|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
16522468|NCT02647359|40380283|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
16522469|NCT01358526|40380284|FG000|Open-label Titration Period|Adverse Event|95|||
16522470|NCT01358526|40380285|FG001|Open-label Titration Period|Adverse Event|0|||
16522471|NCT01358526|40380286|FG002|Open-label Titration Period|Adverse Event|0|||
16522472|NCT01358526|40380284|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
16522473|NCT01358526|40380285|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
16522474|NCT01358526|40380286|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
16522475|NCT01358526|40380284|FG000|Open-label Titration Period|Lost to Follow-up|25|||
16522476|NCT01358526|40380285|FG001|Open-label Titration Period|Lost to Follow-up|0|||
16522477|NCT01358526|40380286|FG002|Open-label Titration Period|Lost to Follow-up|0|||
16522478|NCT01358526|40380284|FG000|Open-label Titration Period|Lack of Efficacy|107|||
16522479|NCT01358526|40380285|FG001|Open-label Titration Period|Lack of Efficacy|0|||
16522480|NCT01358526|40380286|FG002|Open-label Titration Period|Lack of Efficacy|0|||
16522481|NCT01358526|40380284|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
16522482|NCT01358526|40380285|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
16325968|NCT00689104|39678256|FG002|Overall Study|Lack of Efficacy|2|||
16325969|NCT00689104|39678257|FG003|Overall Study|Lack of Efficacy|3|||
16325970|NCT00689104|39678254|FG000|Overall Study|Withdrawal by Subject|12|||
16325971|NCT00689104|39678255|FG001|Overall Study|Withdrawal by Subject|11|||
16325972|NCT00689104|39678256|FG002|Overall Study|Withdrawal by Subject|18|||
16522483|NCT01358526|40380286|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
16522484|NCT01358526|40380284|FG000|Open-label Titration Period|Administrative|8|||
16522485|NCT01358526|40380285|FG001|Open-label Titration Period|Administrative|0|||
16522486|NCT01358526|40380286|FG002|Open-label Titration Period|Administrative|0|||
16522487|NCT01358526|40380284|FG000|Open-label Titration Period|Did not qualify|178|||
16522488|NCT01358526|40380285|FG001|Open-label Titration Period|Did not qualify|0|||
16522489|NCT01358526|40380286|FG002|Open-label Titration Period|Did not qualify|0|||
16522490|NCT01358526|40380284|FG000|Double-blind Phase|Adverse Event|0|||
16522491|NCT01358526|40380285|FG001|Double-blind Phase|Adverse Event|24|||
16522492|NCT01358526|40380286|FG002|Double-blind Phase|Adverse Event|23|||
16522493|NCT01358526|40380284|FG000|Double-blind Phase|Withdrawal by Subject|0|||
16522494|NCT01358526|40380285|FG001|Double-blind Phase|Withdrawal by Subject|10|||
16522495|NCT01358526|40380286|FG002|Double-blind Phase|Withdrawal by Subject|8|||
16094448|NCT00103857|38836452|FG003|54-Week Base Study|Lost to Follow-up|5|||
16094449|NCT00103857|38836453|FG004|54-Week Base Study|Lost to Follow-up|10|||
16094450|NCT00103857|38836454|FG005|54-Week Base Study|Lost to Follow-up|9|||
16094451|NCT00103857|38836455|FG006|54-Week Base Study|Lost to Follow-up|3|||
16094452|NCT00103857|38836449|FG000|54-Week Base Study|Physician Decision|1|||
16094453|NCT00103857|38836450|FG001|54-Week Base Study|Physician Decision|1|||
16094454|NCT00103857|38836451|FG002|54-Week Base Study|Physician Decision|0|||
16094455|NCT00103857|38836452|FG003|54-Week Base Study|Physician Decision|0|||
16094456|NCT00103857|38836453|FG004|54-Week Base Study|Physician Decision|1|||
16094457|NCT00103857|38836454|FG005|54-Week Base Study|Physician Decision|0|||
16094458|NCT00103857|38836455|FG006|54-Week Base Study|Physician Decision|0|||
16094459|NCT00103857|38836449|FG000|54-Week Base Study|Pregnancy|1|||
16094460|NCT00103857|38836450|FG001|54-Week Base Study|Pregnancy|0|||
16094461|NCT00103857|38836451|FG002|54-Week Base Study|Pregnancy|0|||
16094462|NCT00103857|38836452|FG003|54-Week Base Study|Pregnancy|0|||
16094463|NCT00103857|38836453|FG004|54-Week Base Study|Pregnancy|1|||
16094464|NCT00103857|38836454|FG005|54-Week Base Study|Pregnancy|0|||
16094465|NCT00103857|38836455|FG006|54-Week Base Study|Pregnancy|1|||
16094466|NCT00103857|38836449|FG000|54-Week Base Study|Protocol Violation|6|||
16094467|NCT00103857|38836450|FG001|54-Week Base Study|Protocol Violation|4|||
16094468|NCT00103857|38836451|FG002|54-Week Base Study|Protocol Violation|2|||
16094469|NCT00103857|38836452|FG003|54-Week Base Study|Protocol Violation|4|||
16094470|NCT00103857|38836453|FG004|54-Week Base Study|Protocol Violation|0|||
16094471|NCT00103857|38836454|FG005|54-Week Base Study|Protocol Violation|3|||
16094472|NCT00103857|38836455|FG006|54-Week Base Study|Protocol Violation|3|||
16207484|NCT00355134|39237253|FG001|Extension Phase|Administrative problems|4|||
16207485|NCT00355134|39237254|FG002|Extension Phase|Administrative problems|0|||
16207486|NCT00355134|39237255|FG003|Extension Phase|Administrative problems|1|||
16207487|NCT00355134|39237256|FG004|Extension Phase|Administrative problems|1|||
16207488|NCT00355134|39237252|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
16207489|NCT00355134|39237253|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
16207490|NCT00355134|39237254|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
16207491|NCT00355134|39237255|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
16207492|NCT00355134|39237256|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
16207493|NCT00355134|39237252|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
16207494|NCT00355134|39237253|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
16207495|NCT00355134|39237254|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
16207496|NCT00355134|39237255|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
16207497|NCT00355134|39237256|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
16325973|NCT00689104|39678257|FG003|Overall Study|Withdrawal by Subject|11|||
16325974|NCT00689104|39678254|FG000|Overall Study|Lost to Follow-up|4|||
16325975|NCT00689104|39678255|FG001|Overall Study|Lost to Follow-up|3|||
16325976|NCT00689104|39678256|FG002|Overall Study|Lost to Follow-up|2|||
16325977|NCT00689104|39678257|FG003|Overall Study|Lost to Follow-up|5|||
16325978|NCT00689104|39678254|FG000|Overall Study|Protocol Violation|2|||
16094473|NCT00103857|38836449|FG000|54-Week Base Study|Withdrawal by Subject|17|||
16094474|NCT00103857|38836450|FG001|54-Week Base Study|Withdrawal by Subject|16|||
16094475|NCT00103857|38836451|FG002|54-Week Base Study|Withdrawal by Subject|16|||
16094476|NCT00103857|38836452|FG003|54-Week Base Study|Withdrawal by Subject|15|||
16094477|NCT00103857|38836453|FG004|54-Week Base Study|Withdrawal by Subject|10|||
16094478|NCT00103857|38836454|FG005|54-Week Base Study|Withdrawal by Subject|15|||
16094479|NCT00103857|38836455|FG006|54-Week Base Study|Withdrawal by Subject|4|||
16094480|NCT00103857|38836449|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
16094481|NCT00103857|38836450|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
16094482|NCT00103857|38836451|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
16094483|NCT00103857|38836452|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
16094484|NCT00103857|38836453|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
16094485|NCT00103857|38836454|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
16094486|NCT00103857|38836455|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
16094487|NCT00103857|38836449|FG000|54-Week Base Study|patient moved|0|||
16094488|NCT00103857|38836450|FG001|54-Week Base Study|patient moved|1|||
16094489|NCT00103857|38836451|FG002|54-Week Base Study|patient moved|1|||
16094490|NCT00103857|38836452|FG003|54-Week Base Study|patient moved|2|||
16094491|NCT00103857|38836453|FG004|54-Week Base Study|patient moved|3|||
16094492|NCT00103857|38836454|FG005|54-Week Base Study|patient moved|1|||
16094493|NCT00103857|38836455|FG006|54-Week Base Study|patient moved|0|||
16094494|NCT00103857|38836449|FG000|54-Week Base Study|non-compliance with study procedures|1|||
16094495|NCT00103857|38836450|FG001|54-Week Base Study|non-compliance with study procedures|2|||
16094496|NCT00103857|38836451|FG002|54-Week Base Study|non-compliance with study procedures|0|||
16094497|NCT00103857|38836452|FG003|54-Week Base Study|non-compliance with study procedures|0|||
16094498|NCT00103857|38836453|FG004|54-Week Base Study|non-compliance with study procedures|0|||
16325979|NCT00689104|39678255|FG001|Overall Study|Protocol Violation|3|||
16325980|NCT00689104|39678256|FG002|Overall Study|Protocol Violation|5|||
16325981|NCT00689104|39678257|FG003|Overall Study|Protocol Violation|3|||
16207498|NCT00355134|39237252|FG000|Extension Phase|Protocol Violation|0|||
16207499|NCT00355134|39237253|FG001|Extension Phase|Protocol Violation|0|||
16207500|NCT00355134|39237254|FG002|Extension Phase|Protocol Violation|0|||
16207501|NCT00355134|39237255|FG003|Extension Phase|Protocol Violation|1|||
16207502|NCT00355134|39237256|FG004|Extension Phase|Protocol Violation|0|||
16325982|NCT00689104|39678254|FG000|Overall Study|Randomized but never received study drug|2|||
16325983|NCT00689104|39678255|FG001|Overall Study|Randomized but never received study drug|1|||
16396506|NCT01713582|39931412|FG005|Overall Study|Death|3|||
16325984|NCT00689104|39678256|FG002|Overall Study|Randomized but never received study drug|1|||
16325985|NCT00689104|39678257|FG003|Overall Study|Randomized but never received study drug|0|||
16325986|NCT00689104|39678254|FG000|Overall Study|Physician Decision|1|||
16325987|NCT00689104|39678255|FG001|Overall Study|Physician Decision|0|||
16325988|NCT00689104|39678256|FG002|Overall Study|Physician Decision|0|||
16325989|NCT00689104|39678257|FG003|Overall Study|Physician Decision|0|||
16325990|NCT00689104|39678254|FG000|Overall Study|Non-compliance with study procedures|0|||
16325991|NCT00689104|39678255|FG001|Overall Study|Non-compliance with study procedures|0|||
16325992|NCT00689104|39678256|FG002|Overall Study|Non-compliance with study procedures|1|||
16325993|NCT00689104|39678257|FG003|Overall Study|Non-compliance with study procedures|0|||
16325994|NCT00623935|39678258|FG000|Overall Study|Death|1|||
16325995|NCT00623935|39678258|FG000|Overall Study|Patient Declined Transplant|1|||
16325996|NCT02907892|39678261|FG000|Overall Study|Lost to Follow-up|27|||
16396507|NCT01713582|39931413|FG006|Overall Study|Death|3|||
16396508|NCT01713582|39931414|FG007|Overall Study|Death|2|||
16396509|NCT01713582|39931415|FG008|Overall Study|Death|3|||
16396510|NCT01713582|39931416|FG009|Overall Study|Death|4|||
16396511|NCT01713582|39931417|FG010|Overall Study|Death|3|||
16396512|NCT01713582|39931418|FG011|Overall Study|Death|0|||
16396513|NCT01713582|39931419|FG012|Overall Study|Death|0|||
16396514|NCT01713582|39931420|FG013|Overall Study|Death|0|||
16396515|NCT01713582|39931421|FG014|Overall Study|Death|0|||
16396516|NCT01713582|39931422|FG015|Overall Study|Death|0|||
16396517|NCT01713582|39931423|FG016|Overall Study|Death|0|||
16396518|NCT01713582|39931424|FG017|Overall Study|Death|0|||
16396519|NCT01713582|39931425|FG018|Overall Study|Death|0|||
16396520|NCT01713582|39931426|FG019|Overall Study|Death|0|||
16396521|NCT01713582|39931427|FG020|Overall Study|Death|0|||
16396522|NCT01713582|39931407|FG000|Overall Study|Adverse event-related|0|||
16396523|NCT01713582|39931408|FG001|Overall Study|Adverse event-related|0|||
16396524|NCT01713582|39931409|FG002|Overall Study|Adverse event-related|0|||
16396525|NCT01713582|39931410|FG003|Overall Study|Adverse event-related|0|||
16207503|NCT01655069|39237264|FG000|Overall Study|Physician Decision|0|||
16396526|NCT01713582|39931411|FG004|Overall Study|Adverse event-related|0|||
16094499|NCT00103857|38836454|FG005|54-Week Base Study|non-compliance with study procedures|2|||
16094500|NCT00103857|38836455|FG006|54-Week Base Study|non-compliance with study procedures|0|||
16396527|NCT01713582|39931412|FG005|Overall Study|Adverse event-related|0|||
16207504|NCT01655069|39237265|FG001|Overall Study|Physician Decision|0|||
16325997|NCT02907892|39678262|FG001|Overall Study|Lost to Follow-up|40|||
16325998|NCT02572076|39678263|FG000|Overall Study|Protocol Violation|1|||
16325999|NCT01273623|39678266|FG000|Overall Study|did not meet IVUS criteria|29|||
16326000|NCT01669174|39678267|FG000|Overall Study|Subject withdrew consent|2|||
16396528|NCT01713582|39931413|FG006|Overall Study|Adverse event-related|0|||
16094501|NCT00103857|38836449|FG000|54-Week Base Study|patient incarcerated|0|||
16094502|NCT00103857|38836450|FG001|54-Week Base Study|patient incarcerated|0|||
16094503|NCT00103857|38836451|FG002|54-Week Base Study|patient incarcerated|0|||
16094504|NCT00103857|38836452|FG003|54-Week Base Study|patient incarcerated|0|||
16094505|NCT00103857|38836453|FG004|54-Week Base Study|patient incarcerated|1|||
16094506|NCT00103857|38836454|FG005|54-Week Base Study|patient incarcerated|1|||
16094507|NCT00103857|38836455|FG006|54-Week Base Study|patient incarcerated|0|||
16094508|NCT00103857|38836449|FG000|54-Week Base Study|laboratory reporting error|0|||
16094509|NCT00103857|38836450|FG001|54-Week Base Study|laboratory reporting error|0|||
16094510|NCT00103857|38836451|FG002|54-Week Base Study|laboratory reporting error|0|||
16094511|NCT00103857|38836452|FG003|54-Week Base Study|laboratory reporting error|0|||
16094512|NCT00103857|38836453|FG004|54-Week Base Study|laboratory reporting error|1|||
16094513|NCT00103857|38836454|FG005|54-Week Base Study|laboratory reporting error|0|||
16094514|NCT00103857|38836455|FG006|54-Week Base Study|laboratory reporting error|0|||
16094515|NCT00103857|38836449|FG000|54-Week Base Study|site error|0|||
16094516|NCT00103857|38836450|FG001|54-Week Base Study|site error|0|||
16094517|NCT00103857|38836451|FG002|54-Week Base Study|site error|0|||
16094518|NCT00103857|38836452|FG003|54-Week Base Study|site error|0|||
16094519|NCT00103857|38836453|FG004|54-Week Base Study|site error|0|||
16094520|NCT00103857|38836454|FG005|54-Week Base Study|site error|1|||
16094521|NCT00103857|38836455|FG006|54-Week Base Study|site error|0|||
16094522|NCT00103857|38836449|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
16094523|NCT00103857|38836450|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
16094524|NCT00103857|38836451|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
16094525|NCT00103857|38836452|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
16094526|NCT00103857|38836453|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
16094527|NCT00103857|38836454|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
16094528|NCT00103857|38836455|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
16094529|NCT00103857|38836449|FG000|50-Week Extension Study|Adverse Event|2|||
16094530|NCT00103857|38836450|FG001|50-Week Extension Study|Adverse Event|3|||
16094531|NCT00103857|38836451|FG002|50-Week Extension Study|Adverse Event|2|||
16094532|NCT00103857|38836452|FG003|50-Week Extension Study|Adverse Event|0|||
16094533|NCT00103857|38836453|FG004|50-Week Extension Study|Adverse Event|1|||
16094534|NCT00103857|38836454|FG005|50-Week Extension Study|Adverse Event|1|||
16094535|NCT00103857|38836455|FG006|50-Week Extension Study|Adverse Event|0|||
16094536|NCT00103857|38836449|FG000|50-Week Extension Study|Death|0|||
16094537|NCT00103857|38836450|FG001|50-Week Extension Study|Death|0|||
16094538|NCT00103857|38836451|FG002|50-Week Extension Study|Death|0|||
16094539|NCT00103857|38836452|FG003|50-Week Extension Study|Death|1|||
16094540|NCT00103857|38836453|FG004|50-Week Extension Study|Death|0|||
16094541|NCT00103857|38836454|FG005|50-Week Extension Study|Death|1|||
16094542|NCT00103857|38836455|FG006|50-Week Extension Study|Death|0|||
16094543|NCT00103857|38836449|FG000|50-Week Extension Study|Lack of Efficacy|26|||
16094544|NCT00103857|38836450|FG001|50-Week Extension Study|Lack of Efficacy|15|||
16094545|NCT00103857|38836451|FG002|50-Week Extension Study|Lack of Efficacy|13|||
16094546|NCT00103857|38836452|FG003|50-Week Extension Study|Lack of Efficacy|16|||
16094547|NCT00103857|38836453|FG004|50-Week Extension Study|Lack of Efficacy|8|||
16207505|NCT01655069|39237266|FG002|Overall Study|Physician Decision|0|||
16326001|NCT01669174|39678268|FG001|Overall Study|Subject withdrew consent|2|||
16326002|NCT01669174|39678267|FG000|Overall Study|Lost to Follow-up|1|||
16326003|NCT01669174|39678268|FG001|Overall Study|Lost to Follow-up|0|||
16326004|NCT01669174|39678267|FG000|Overall Study|Adverse Event|2|||
16326005|NCT01669174|39678268|FG001|Overall Study|Adverse Event|2|||
16326006|NCT01669174|39678267|FG000|Overall Study|Administrative problems|1|||
16326007|NCT01669174|39678268|FG001|Overall Study|Administrative problems|2|||
16326008|NCT02004886|39678269|FG000|Overall Study|Adverse Event|0|||
16326009|NCT02004886|39678270|FG001|Overall Study|Adverse Event|1|||
16326010|NCT02004886|39678271|FG002|Overall Study|Adverse Event|0|||
16326011|NCT02004886|39678272|FG003|Overall Study|Adverse Event|0|||
16396529|NCT01713582|39931414|FG007|Overall Study|Adverse event-related|0|||
16396530|NCT01713582|39931415|FG008|Overall Study|Adverse event-related|0|||
16396531|NCT01713582|39931416|FG009|Overall Study|Adverse event-related|1|||
16094548|NCT00103857|38836454|FG005|50-Week Extension Study|Lack of Efficacy|8|||
16094549|NCT00103857|38836455|FG006|50-Week Extension Study|Lack of Efficacy|0|||
16094550|NCT00103857|38836449|FG000|50-Week Extension Study|Lost to Follow-up|4|||
16094551|NCT00103857|38836450|FG001|50-Week Extension Study|Lost to Follow-up|0|||
16094552|NCT00103857|38836451|FG002|50-Week Extension Study|Lost to Follow-up|1|||
16094553|NCT00103857|38836452|FG003|50-Week Extension Study|Lost to Follow-up|4|||
16094554|NCT00103857|38836453|FG004|50-Week Extension Study|Lost to Follow-up|3|||
16094555|NCT00103857|38836454|FG005|50-Week Extension Study|Lost to Follow-up|3|||
16094556|NCT00103857|38836455|FG006|50-Week Extension Study|Lost to Follow-up|0|||
16326012|NCT02004886|39678269|FG000|Overall Study|Unable to attend future visits|1|||
16396532|NCT01713582|39931417|FG010|Overall Study|Adverse event-related|1|||
16094557|NCT00103857|38836449|FG000|50-Week Extension Study|Physician Decision|0|||
16326013|NCT02004886|39678270|FG001|Overall Study|Unable to attend future visits|0|||
16326014|NCT02004886|39678271|FG002|Overall Study|Unable to attend future visits|0|||
16094558|NCT00103857|38836450|FG001|50-Week Extension Study|Physician Decision|1|||
16094559|NCT00103857|38836451|FG002|50-Week Extension Study|Physician Decision|1|||
16094560|NCT00103857|38836452|FG003|50-Week Extension Study|Physician Decision|0|||
16094561|NCT00103857|38836453|FG004|50-Week Extension Study|Physician Decision|0|||
16094562|NCT00103857|38836454|FG005|50-Week Extension Study|Physician Decision|0|||
16094563|NCT00103857|38836455|FG006|50-Week Extension Study|Physician Decision|0|||
16094564|NCT00103857|38836449|FG000|50-Week Extension Study|Pregnancy|0|||
16094565|NCT00103857|38836450|FG001|50-Week Extension Study|Pregnancy|0|||
16094566|NCT00103857|38836451|FG002|50-Week Extension Study|Pregnancy|1|||
16094567|NCT00103857|38836452|FG003|50-Week Extension Study|Pregnancy|0|||
16094568|NCT00103857|38836453|FG004|50-Week Extension Study|Pregnancy|1|||
16094569|NCT00103857|38836454|FG005|50-Week Extension Study|Pregnancy|0|||
16094570|NCT00103857|38836455|FG006|50-Week Extension Study|Pregnancy|0|||
16094571|NCT00103857|38836449|FG000|50-Week Extension Study|Protocol Violation|1|||
16094572|NCT00103857|38836450|FG001|50-Week Extension Study|Protocol Violation|1|||
16094573|NCT00103857|38836451|FG002|50-Week Extension Study|Protocol Violation|1|||
16094574|NCT00103857|38836452|FG003|50-Week Extension Study|Protocol Violation|2|||
16094575|NCT00103857|38836453|FG004|50-Week Extension Study|Protocol Violation|0|||
16094576|NCT00103857|38836454|FG005|50-Week Extension Study|Protocol Violation|1|||
16094577|NCT00103857|38836455|FG006|50-Week Extension Study|Protocol Violation|0|||
16094578|NCT00103857|38836449|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
16094579|NCT00103857|38836450|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
16094580|NCT00103857|38836451|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
16094581|NCT00103857|38836452|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
16094582|NCT00103857|38836453|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
16094583|NCT00103857|38836454|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
16094584|NCT00103857|38836455|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
16094585|NCT00103857|38836449|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
16094586|NCT00103857|38836450|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
16094587|NCT00103857|38836451|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
16094588|NCT00103857|38836452|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
16522496|NCT01358526|40380284|FG000|Double-blind Phase|Lost to Follow-up|0|||
16522497|NCT01358526|40380285|FG001|Double-blind Phase|Lost to Follow-up|4|||
16522498|NCT01358526|40380286|FG002|Double-blind Phase|Lost to Follow-up|1|||
16522499|NCT01358526|40380284|FG000|Double-blind Phase|Lack of Efficacy|0|||
16522500|NCT01358526|40380285|FG001|Double-blind Phase|Lack of Efficacy|31|||
16522501|NCT01358526|40380286|FG002|Double-blind Phase|Lack of Efficacy|73|||
16522502|NCT01358526|40380284|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
16522503|NCT01358526|40380285|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
16522504|NCT01358526|40380286|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
16522505|NCT01358526|40380284|FG000|Double-blind Phase|Administrative|0|||
16522506|NCT01358526|40380285|FG001|Double-blind Phase|Administrative|6|||
16522507|NCT01358526|40380286|FG002|Double-blind Phase|Administrative|10|||
16522508|NCT03323099|40380287|FG000|Overall Study|Withdrawal by Subject|6|||
16522509|NCT03323099|40380288|FG001|Overall Study|Withdrawal by Subject|12|||
16522510|NCT03323099|40380287|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
16522511|NCT03323099|40380288|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
16522512|NCT00767000|40380289|FG000|54-week Study|Adverse Event|4|||
16522513|NCT00767000|40380290|FG001|54-week Study|Adverse Event|6|||
16522514|NCT00767000|40380291|FG002|54-week Study|Adverse Event|6|||
16522515|NCT00767000|40380292|FG003|54-week Study|Adverse Event|8|||
16522516|NCT00767000|40380293|FG004|54-week Study|Adverse Event|4|||
16522517|NCT00767000|40380289|FG000|54-week Study|Creaninine/creatinine clearance|2|||
16522518|NCT00767000|40380290|FG001|54-week Study|Creaninine/creatinine clearance|1|||
16094589|NCT00103857|38836453|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
16094590|NCT00103857|38836454|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
16094591|NCT00103857|38836455|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
16094592|NCT00103857|38836449|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
16094593|NCT00103857|38836450|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
16094594|NCT00103857|38836451|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
16094595|NCT00103857|38836452|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
16094596|NCT00103857|38836453|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
16094597|NCT00103857|38836454|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
16094598|NCT00103857|38836455|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
16094599|NCT00103857|38836449|FG000|50-Week Extension Study|patient moved|0|||
16094600|NCT00103857|38836450|FG001|50-Week Extension Study|patient moved|0|||
16094601|NCT00103857|38836451|FG002|50-Week Extension Study|patient moved|1|||
16094602|NCT00103857|38836452|FG003|50-Week Extension Study|patient moved|2|||
16094603|NCT00103857|38836453|FG004|50-Week Extension Study|patient moved|0|||
16522519|NCT00767000|40380291|FG002|54-week Study|Creaninine/creatinine clearance|2|||
16522520|NCT00767000|40380292|FG003|54-week Study|Creaninine/creatinine clearance|2|||
16094604|NCT00103857|38836454|FG005|50-Week Extension Study|patient moved|0|||
16094605|NCT00103857|38836455|FG006|50-Week Extension Study|patient moved|0|||
16094606|NCT00103857|38836449|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
16094607|NCT00103857|38836450|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
16094608|NCT00103857|38836451|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
16094609|NCT00103857|38836452|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
16094610|NCT00103857|38836453|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
16094611|NCT00103857|38836454|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
16094612|NCT00103857|38836455|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
16094613|NCT00103857|38836449|FG000|50-Week Extension Study|reason unspecified|0|||
16094614|NCT00103857|38836450|FG001|50-Week Extension Study|reason unspecified|0|||
16094615|NCT00103857|38836451|FG002|50-Week Extension Study|reason unspecified|0|||
16094616|NCT00103857|38836452|FG003|50-Week Extension Study|reason unspecified|0|||
16094617|NCT00103857|38836453|FG004|50-Week Extension Study|reason unspecified|1|||
16094618|NCT00103857|38836454|FG005|50-Week Extension Study|reason unspecified|0|||
16094619|NCT00103857|38836455|FG006|50-Week Extension Study|reason unspecified|0|||
16094620|NCT00648895|38836468|FG000|Overall Study|Lack of Efficacy|0|||
16094621|NCT00648895|38836469|FG001|Overall Study|Lack of Efficacy|1|||
16094622|NCT02784834|38836472|FG000|Overall Study|Lack of Efficacy|1|||
16094623|NCT01721759|38836473|FG000|Treatment Period|Disease Progression|85|||
16094624|NCT01721759|38836473|FG000|Treatment Period|Study drug toxicity|14|||
16094625|NCT01721759|38836473|FG000|Treatment Period|Death|1|||
16094626|NCT01721759|38836473|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
16094627|NCT01721759|38836473|FG000|Treatment Period|Participant request to withdraw|3|||
16094628|NCT01721759|38836473|FG000|Treatment Period|Other Reasons|3|||
16094629|NCT01721759|38836473|FG000|End of Study Period|Participant Withdrew Consent|5|||
16094630|NCT01721759|38836473|FG000|End of Study Period|Death|101|||
16094631|NCT01721759|38836473|FG000|End of Study Period|Lost to Follow-up|1|||
16094632|NCT01721759|38836473|FG000|End of Study Period|Other Reasons|10|||
16094633|NCT00603278|38836474|FG000|Overall Study|Lack of Efficacy|35|||
16094634|NCT00603278|38836475|FG001|Overall Study|Lack of Efficacy|10|||
16094635|NCT00603278|38836476|FG002|Overall Study|Lack of Efficacy|11|||
16094636|NCT00603278|38836477|FG003|Overall Study|Lack of Efficacy|8|||
16094637|NCT00603278|38836478|FG004|Overall Study|Lack of Efficacy|7|||
16094638|NCT00603278|38836479|FG005|Overall Study|Lack of Efficacy|14|||
16094639|NCT00603278|38836474|FG000|Overall Study|Adverse Event|0|||
16094640|NCT00603278|38836475|FG001|Overall Study|Adverse Event|3|||
16094641|NCT00603278|38836476|FG002|Overall Study|Adverse Event|1|||
16396533|NCT01713582|39931418|FG011|Overall Study|Adverse event-related|0|||
16396534|NCT01713582|39931419|FG012|Overall Study|Adverse event-related|0|||
16396535|NCT01713582|39931420|FG013|Overall Study|Adverse event-related|0|||
16396536|NCT01713582|39931421|FG014|Overall Study|Adverse event-related|0|||
16396537|NCT01713582|39931422|FG015|Overall Study|Adverse event-related|0|||
16396538|NCT01713582|39931423|FG016|Overall Study|Adverse event-related|0|||
16396539|NCT01713582|39931424|FG017|Overall Study|Adverse event-related|0|||
16396540|NCT01713582|39931425|FG018|Overall Study|Adverse event-related|1|||
16396541|NCT01713582|39931426|FG019|Overall Study|Adverse event-related|0|||
16396542|NCT01713582|39931427|FG020|Overall Study|Adverse event-related|0|||
16396543|NCT01713582|39931407|FG000|Overall Study|Adverse event-unrelated|0|||
16396544|NCT01713582|39931408|FG001|Overall Study|Adverse event-unrelated|0|||
16396545|NCT01713582|39931409|FG002|Overall Study|Adverse event-unrelated|0|||
16396546|NCT01713582|39931410|FG003|Overall Study|Adverse event-unrelated|0|||
16396547|NCT01713582|39931411|FG004|Overall Study|Adverse event-unrelated|0|||
16396548|NCT01713582|39931412|FG005|Overall Study|Adverse event-unrelated|1|||
16396549|NCT01713582|39931413|FG006|Overall Study|Adverse event-unrelated|1|||
16396550|NCT01713582|39931414|FG007|Overall Study|Adverse event-unrelated|1|||
16396551|NCT01713582|39931415|FG008|Overall Study|Adverse event-unrelated|0|||
16396552|NCT01713582|39931416|FG009|Overall Study|Adverse event-unrelated|0|||
16396553|NCT01713582|39931417|FG010|Overall Study|Adverse event-unrelated|0|||
16396554|NCT01713582|39931418|FG011|Overall Study|Adverse event-unrelated|0|||
16396555|NCT01713582|39931419|FG012|Overall Study|Adverse event-unrelated|0|||
16396556|NCT01713582|39931420|FG013|Overall Study|Adverse event-unrelated|1|||
16396557|NCT01713582|39931421|FG014|Overall Study|Adverse event-unrelated|1|||
16396558|NCT01713582|39931422|FG015|Overall Study|Adverse event-unrelated|0|||
16396559|NCT01713582|39931423|FG016|Overall Study|Adverse event-unrelated|0|||
16396560|NCT01713582|39931424|FG017|Overall Study|Adverse event-unrelated|0|||
16396561|NCT01713582|39931425|FG018|Overall Study|Adverse event-unrelated|0|||
16396562|NCT01713582|39931426|FG019|Overall Study|Adverse event-unrelated|0|||
16094642|NCT00603278|38836477|FG003|Overall Study|Adverse Event|0|||
16094643|NCT00603278|38836478|FG004|Overall Study|Adverse Event|2|||
16094644|NCT00603278|38836479|FG005|Overall Study|Adverse Event|1|||
16094645|NCT00603278|38836474|FG000|Overall Study|Withdrawal by Subject|2|||
16094646|NCT00603278|38836475|FG001|Overall Study|Withdrawal by Subject|3|||
16094647|NCT00603278|38836476|FG002|Overall Study|Withdrawal by Subject|1|||
16094648|NCT00603278|38836477|FG003|Overall Study|Withdrawal by Subject|2|||
16094649|NCT00603278|38836478|FG004|Overall Study|Withdrawal by Subject|1|||
16094650|NCT00603278|38836479|FG005|Overall Study|Withdrawal by Subject|2|||
16094651|NCT00603278|38836474|FG000|Overall Study|Protocol Violation|3|||
16094652|NCT00603278|38836475|FG001|Overall Study|Protocol Violation|0|||
16094653|NCT00603278|38836476|FG002|Overall Study|Protocol Violation|1|||
16094654|NCT00603278|38836477|FG003|Overall Study|Protocol Violation|1|||
16094655|NCT00603278|38836478|FG004|Overall Study|Protocol Violation|0|||
16522521|NCT00767000|40380293|FG004|54-week Study|Creaninine/creatinine clearance|4|||
16522522|NCT00767000|40380289|FG000|54-week Study|Hyperglycemia|0|||
16522523|NCT00767000|40380290|FG001|54-week Study|Hyperglycemia|0|||
16522524|NCT00767000|40380291|FG002|54-week Study|Hyperglycemia|1|||
16522525|NCT00767000|40380292|FG003|54-week Study|Hyperglycemia|0|||
16522526|NCT00767000|40380293|FG004|54-week Study|Hyperglycemia|1|||
16522527|NCT00767000|40380289|FG000|54-week Study|Hypoglycemia|0|||
16522528|NCT00767000|40380290|FG001|54-week Study|Hypoglycemia|1|||
16522529|NCT00767000|40380291|FG002|54-week Study|Hypoglycemia|0|||
16522530|NCT00767000|40380292|FG003|54-week Study|Hypoglycemia|0|||
16522531|NCT00767000|40380293|FG004|54-week Study|Hypoglycemia|0|||
16522532|NCT00767000|40380289|FG000|54-week Study|Interruption of study medication|0|||
16522533|NCT00767000|40380290|FG001|54-week Study|Interruption of study medication|0|||
16522534|NCT00767000|40380291|FG002|54-week Study|Interruption of study medication|1|||
16522535|NCT00767000|40380292|FG003|54-week Study|Interruption of study medication|0|||
16522536|NCT00767000|40380293|FG004|54-week Study|Interruption of study medication|0|||
16522537|NCT00767000|40380289|FG000|54-week Study|Lack of Efficacy|2|||
16522538|NCT00767000|40380290|FG001|54-week Study|Lack of Efficacy|0|||
16522539|NCT00767000|40380291|FG002|54-week Study|Lack of Efficacy|1|||
16522540|NCT00767000|40380292|FG003|54-week Study|Lack of Efficacy|0|||
16522541|NCT00767000|40380293|FG004|54-week Study|Lack of Efficacy|5|||
16522542|NCT00767000|40380289|FG000|54-week Study|Lost to Follow-up|4|||
16522543|NCT00767000|40380290|FG001|54-week Study|Lost to Follow-up|0|||
16522544|NCT00767000|40380291|FG002|54-week Study|Lost to Follow-up|1|||
16522545|NCT00767000|40380292|FG003|54-week Study|Lost to Follow-up|4|||
16522546|NCT00767000|40380293|FG004|54-week Study|Lost to Follow-up|2|||
16522547|NCT00767000|40380289|FG000|54-week Study|Physician Decision|4|||
16522548|NCT00767000|40380290|FG001|54-week Study|Physician Decision|0|||
16522549|NCT00767000|40380291|FG002|54-week Study|Physician Decision|1|||
16522550|NCT00767000|40380292|FG003|54-week Study|Physician Decision|1|||
16522551|NCT00767000|40380293|FG004|54-week Study|Physician Decision|1|||
16522552|NCT00767000|40380289|FG000|54-week Study|Progressive disease|0|||
16522553|NCT00767000|40380290|FG001|54-week Study|Progressive disease|0|||
16522554|NCT00767000|40380291|FG002|54-week Study|Progressive disease|1|||
16522555|NCT00767000|40380292|FG003|54-week Study|Progressive disease|0|||
16522556|NCT00767000|40380293|FG004|54-week Study|Progressive disease|0|||
16522557|NCT00767000|40380289|FG000|54-week Study|Protocol Violation|0|||
16522558|NCT00767000|40380290|FG001|54-week Study|Protocol Violation|0|||
16522559|NCT00767000|40380291|FG002|54-week Study|Protocol Violation|1|||
16522560|NCT00767000|40380292|FG003|54-week Study|Protocol Violation|2|||
16522561|NCT00767000|40380293|FG004|54-week Study|Protocol Violation|0|||
16522562|NCT00767000|40380289|FG000|54-week Study|Withdrawal by Subject|2|||
16522563|NCT00767000|40380290|FG001|54-week Study|Withdrawal by Subject|3|||
16522564|NCT00767000|40380291|FG002|54-week Study|Withdrawal by Subject|5|||
16522565|NCT00767000|40380292|FG003|54-week Study|Withdrawal by Subject|11|||
16522566|NCT00767000|40380293|FG004|54-week Study|Withdrawal by Subject|13|||
16522567|NCT00767000|40380289|FG000|54-week Study|Study terminated by sponsor|90|||
16522568|NCT00767000|40380290|FG001|54-week Study|Study terminated by sponsor|102|||
16522569|NCT00767000|40380291|FG002|54-week Study|Study terminated by sponsor|89|||
16522570|NCT00767000|40380292|FG003|54-week Study|Study terminated by sponsor|196|||
16522571|NCT00767000|40380293|FG004|54-week Study|Study terminated by sponsor|194|||
16522572|NCT00767000|40380289|FG000|54-week Study|Reason not reported|0|||
16522573|NCT00767000|40380290|FG001|54-week Study|Reason not reported|0|||
16522574|NCT00767000|40380291|FG002|54-week Study|Reason not reported|0|||
16522575|NCT00767000|40380292|FG003|54-week Study|Reason not reported|1|||
16522576|NCT00767000|40380293|FG004|54-week Study|Reason not reported|0|||
16522577|NCT00767000|40380289|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
16522578|NCT00767000|40380290|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
16522579|NCT00767000|40380291|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
16522580|NCT00767000|40380292|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
16522581|NCT00767000|40380293|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
16522582|NCT01110915|40380296|FG000|Overall Study|Death|2|||
16522583|NCT01110915|40380297|FG001|Overall Study|Death|1|||
16522584|NCT01110915|40380296|FG000|Overall Study|Lost to Follow-up|1|||
16522585|NCT01110915|40380297|FG001|Overall Study|Lost to Follow-up|0|||
16522586|NCT01110915|40380296|FG000|Overall Study|Withdrawal by Subject|7|||
16094656|NCT00603278|38836479|FG005|Overall Study|Protocol Violation|1|||
16094657|NCT00603278|38836474|FG000|Overall Study|Physician Decision|0|||
16522587|NCT01110915|40380297|FG001|Overall Study|Withdrawal by Subject|1|||
16522588|NCT04321460|40380298|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
16326015|NCT02004886|39678272|FG003|Overall Study|Unable to attend future visits|0|||
16326016|NCT02163226|39678276|FG000|Overall Study|Death|2|||
16326017|NCT02163226|39678277|FG001|Overall Study|Death|1|||
16326018|NCT02163226|39678276|FG000|Overall Study|Withdrawal by Subject|5|||
16326019|NCT02163226|39678277|FG001|Overall Study|Withdrawal by Subject|2|||
16326020|NCT02163226|39678276|FG000|Overall Study|Returned home, local radiotherapy|3|||
16326021|NCT02163226|39678277|FG001|Overall Study|Returned home, local radiotherapy|0|||
16326022|NCT02163226|39678276|FG000|Overall Study|Repeat imaging showed no disease|2|||
16396563|NCT01713582|39931427|FG020|Overall Study|Adverse event-unrelated|0|||
16396564|NCT01713582|39931407|FG000|Overall Study|Withdrawal of consent|0|||
16396565|NCT01713582|39931408|FG001|Overall Study|Withdrawal of consent|0|||
16396566|NCT01713582|39931409|FG002|Overall Study|Withdrawal of consent|1|||
16396567|NCT01713582|39931410|FG003|Overall Study|Withdrawal of consent|0|||
16396568|NCT01713582|39931411|FG004|Overall Study|Withdrawal of consent|0|||
16396569|NCT01713582|39931412|FG005|Overall Study|Withdrawal of consent|1|||
16396570|NCT01713582|39931413|FG006|Overall Study|Withdrawal of consent|0|||
16396571|NCT01713582|39931414|FG007|Overall Study|Withdrawal of consent|0|||
16396572|NCT01713582|39931415|FG008|Overall Study|Withdrawal of consent|0|||
16396573|NCT01713582|39931416|FG009|Overall Study|Withdrawal of consent|1|||
16396574|NCT01713582|39931417|FG010|Overall Study|Withdrawal of consent|0|||
16396575|NCT01713582|39931418|FG011|Overall Study|Withdrawal of consent|0|||
16396576|NCT01713582|39931419|FG012|Overall Study|Withdrawal of consent|0|||
16396577|NCT01713582|39931420|FG013|Overall Study|Withdrawal of consent|0|||
16396578|NCT01713582|39931421|FG014|Overall Study|Withdrawal of consent|0|||
16396579|NCT01713582|39931422|FG015|Overall Study|Withdrawal of consent|0|||
16396580|NCT01713582|39931423|FG016|Overall Study|Withdrawal of consent|0|||
16396581|NCT01713582|39931424|FG017|Overall Study|Withdrawal of consent|0|||
16396582|NCT01713582|39931425|FG018|Overall Study|Withdrawal of consent|1|||
16396583|NCT01713582|39931426|FG019|Overall Study|Withdrawal of consent|0|||
16396584|NCT01713582|39931427|FG020|Overall Study|Withdrawal of consent|0|||
16396585|NCT01713582|39931407|FG000|Overall Study|Lack of Efficacy|0|||
16396586|NCT01713582|39931408|FG001|Overall Study|Lack of Efficacy|0|||
16396587|NCT01713582|39931409|FG002|Overall Study|Lack of Efficacy|0|||
16396588|NCT01713582|39931410|FG003|Overall Study|Lack of Efficacy|0|||
16396589|NCT01713582|39931411|FG004|Overall Study|Lack of Efficacy|0|||
16396590|NCT01713582|39931412|FG005|Overall Study|Lack of Efficacy|0|||
16396591|NCT01713582|39931413|FG006|Overall Study|Lack of Efficacy|0|||
16396592|NCT01713582|39931414|FG007|Overall Study|Lack of Efficacy|0|||
16396593|NCT01713582|39931415|FG008|Overall Study|Lack of Efficacy|0|||
16396594|NCT01713582|39931416|FG009|Overall Study|Lack of Efficacy|1|||
16326023|NCT02163226|39678277|FG001|Overall Study|Repeat imaging showed no disease|0|||
16326024|NCT02163226|39678276|FG000|Overall Study|Incomplete radiotherapy|3|||
16326025|NCT02163226|39678277|FG001|Overall Study|Incomplete radiotherapy|0|||
16396595|NCT01713582|39931417|FG010|Overall Study|Lack of Efficacy|2|||
16396596|NCT01713582|39931418|FG011|Overall Study|Lack of Efficacy|0|||
16396597|NCT01713582|39931419|FG012|Overall Study|Lack of Efficacy|0|||
16396598|NCT01713582|39931420|FG013|Overall Study|Lack of Efficacy|0|||
16396599|NCT01713582|39931421|FG014|Overall Study|Lack of Efficacy|0|||
16326026|NCT02163226|39678276|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
16326027|NCT02163226|39678277|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
16326028|NCT02163226|39678276|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
16326029|NCT02163226|39678277|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
16326030|NCT02163226|39678276|FG000|Overall Study|ineligible|0|||
16326031|NCT02163226|39678277|FG001|Overall Study|ineligible|3|||
16326032|NCT02759055|39678283|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
16326033|NCT02759055|39678284|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
16326034|NCT02394340|39678291|FG000|Overall Study|Failed drug screen test|1|||
16326035|NCT02394340|39678291|FG000|Overall Study|Adverse Event|1|||
16326036|NCT02218736|39678292|FG000|Overall Study|Withdrawal by Subject|10|||
16326037|NCT02218736|39678293|FG001|Overall Study|Withdrawal by Subject|9|||
16326038|NCT02218736|39678292|FG000|Overall Study|Protocol Violation|2|||
16326039|NCT02218736|39678293|FG001|Overall Study|Protocol Violation|0|||
16326040|NCT04672252|39678294|FG000|Overall Study|Protocol Violation|1|||
16396600|NCT01713582|39931422|FG015|Overall Study|Lack of Efficacy|0|||
16396601|NCT01713582|39931423|FG016|Overall Study|Lack of Efficacy|0|||
16396602|NCT01713582|39931424|FG017|Overall Study|Lack of Efficacy|0|||
16396603|NCT01713582|39931425|FG018|Overall Study|Lack of Efficacy|0|||
16396604|NCT01713582|39931426|FG019|Overall Study|Lack of Efficacy|0|||
16396605|NCT01713582|39931427|FG020|Overall Study|Lack of Efficacy|0|||
16396606|NCT01713582|39931407|FG000|Overall Study|Withdrawal by Subject|0|||
16396607|NCT01713582|39931408|FG001|Overall Study|Withdrawal by Subject|0|||
16326041|NCT04672252|39678295|FG001|Overall Study|Protocol Violation|0|||
16326042|NCT00814333|39678296|FG000|Enrollment|Lost to Follow-up|1|||
16396608|NCT01713582|39931409|FG002|Overall Study|Withdrawal by Subject|0|||
16326043|NCT00814333|39678297|FG001|Enrollment|Lost to Follow-up|0|||
16522589|NCT04321460|40380299|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
16522590|NCT01310413|40380300|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
16522591|NCT01310413|40380301|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
16522592|NCT01310413|40380302|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
16522593|NCT01310413|40380303|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
16522594|NCT01310413|40380304|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
16522595|NCT01310413|40380305|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
16522596|NCT01310413|40380306|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
16522597|NCT01310413|40380300|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
16522598|NCT01310413|40380301|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
16522599|NCT01310413|40380302|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
16522600|NCT01310413|40380303|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
16522601|NCT01310413|40380304|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
16522602|NCT01310413|40380305|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
16522603|NCT01310413|40380306|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
16522604|NCT01310413|40380300|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
16522605|NCT01310413|40380301|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
16522606|NCT01310413|40380302|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
16522607|NCT01310413|40380303|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
16522608|NCT01310413|40380304|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
16522609|NCT01310413|40380305|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
16522610|NCT01310413|40380306|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
16522611|NCT01310413|40380300|FG000|Day 0 to Day 385|Other|1|||
16522612|NCT01310413|40380301|FG001|Day 0 to Day 385|Other|0|||
16522613|NCT01310413|40380302|FG002|Day 0 to Day 385|Other|3|||
16522614|NCT01310413|40380303|FG003|Day 0 to Day 385|Other|0|||
16522615|NCT01310413|40380304|FG004|Day 0 to Day 385|Other|0|||
16522616|NCT01310413|40380305|FG005|Day 0 to Day 385|Other|0|||
16522617|NCT01310413|40380306|FG006|Day 0 to Day 385|Other|0|||
16522618|NCT01310413|40380300|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
16522619|NCT01310413|40380301|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
16522620|NCT01310413|40380302|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
16522621|NCT01310413|40380303|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
16522622|NCT01310413|40380304|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
16522623|NCT01310413|40380305|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
16522624|NCT01310413|40380306|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
16522625|NCT01310413|40380300|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
16522626|NCT01310413|40380301|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
16522627|NCT01310413|40380302|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
16522628|NCT01310413|40380303|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
16522629|NCT01310413|40380304|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
16522630|NCT01310413|40380305|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
16522631|NCT01310413|40380306|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
16522632|NCT00724971|40380307|FG000|Overall Study|Adverse Event|5|||
16522633|NCT00724971|40380307|FG000|Overall Study|Withdrawal by Subject|1|||
16522634|NCT02158039|40380311|FG000|Overall Study|Withdrawal by Subject|1|||
16522635|NCT02158039|40380311|FG000|Overall Study|Screen Failure|9|||
16522636|NCT02602288|40380312|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
16522637|NCT02602288|40380313|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
16522638|NCT02602288|40380312|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
16522639|NCT02602288|40380313|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
16522640|NCT02602288|40380312|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
16522641|NCT02602288|40380313|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
16522642|NCT02602288|40380312|FG000|12 Month Follow-up|Lost to Follow-up|0|||
16522643|NCT02602288|40380313|FG001|12 Month Follow-up|Lost to Follow-up|4|||
16522644|NCT02602288|40380312|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
16522645|NCT02602288|40380313|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
16522646|NCT01816139|40380316|FG000|Overall Study|Adverse Event|6|||
16522647|NCT01816139|40380317|FG001|Overall Study|Adverse Event|8|||
16522648|NCT01816139|40380316|FG000|Overall Study|Lack of Efficacy|1|||
16522649|NCT01816139|40380317|FG001|Overall Study|Lack of Efficacy|2|||
16522650|NCT01816139|40380316|FG000|Overall Study|Lost to Follow-up|5|||
16522651|NCT01816139|40380317|FG001|Overall Study|Lost to Follow-up|3|||
16522652|NCT01816139|40380316|FG000|Overall Study|Withdrew Consent|6|||
16522653|NCT01816139|40380317|FG001|Overall Study|Withdrew Consent|4|||
16522654|NCT01816139|40380316|FG000|Overall Study|Protocol Violation|6|||
16522655|NCT01816139|40380317|FG001|Overall Study|Protocol Violation|3|||
16522656|NCT01816139|40380316|FG000|Overall Study|Reason not Specified|4|||
16522657|NCT01816139|40380317|FG001|Overall Study|Reason not Specified|2|||
16522658|NCT01163682|40380318|FG000|Overall Study|Lost to Follow-up|6|||
16522659|NCT01163682|40380319|FG001|Overall Study|Lost to Follow-up|9|||
16522660|NCT02530619|40380324|FG000|Registered for Study|Withdrawal by Subject|2|||
16522661|NCT02530619|40380324|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
16522662|NCT02530619|40380324|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
16522663|NCT02530619|40380324|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
16522664|NCT02530619|40380324|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
16522665|NCT02530619|40380324|FG000|Follow-up Period (6 Months)|Death|4|||
16522666|NCT02530619|40380324|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
16522667|NCT02530619|40380324|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
16522668|NCT02033889|40380325|FG000|Overall Study|Adverse Event|3|||
16522669|NCT02033889|40380326|FG001|Overall Study|Adverse Event|1|||
16522670|NCT02033889|40380327|FG002|Overall Study|Adverse Event|3|||
16522671|NCT02033889|40380325|FG000|Overall Study|Death|3|||
16522672|NCT02033889|40380326|FG001|Overall Study|Death|1|||
16522673|NCT02033889|40380327|FG002|Overall Study|Death|2|||
16522674|NCT02033889|40380325|FG000|Overall Study|Excluded Medication|1|||
16522675|NCT02033889|40380326|FG001|Overall Study|Excluded Medication|1|||
16522676|NCT02033889|40380327|FG002|Overall Study|Excluded Medication|0|||
16522677|NCT02033889|40380325|FG000|Overall Study|Lost to Follow-up|8|||
16522678|NCT02033889|40380326|FG001|Overall Study|Lost to Follow-up|5|||
16522679|NCT02033889|40380327|FG002|Overall Study|Lost to Follow-up|6|||
16522680|NCT02033889|40380325|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16522681|NCT02033889|40380326|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16522682|NCT02033889|40380327|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16522683|NCT02033889|40380325|FG000|Overall Study|Physician Decision|0|||
16522684|NCT02033889|40380326|FG001|Overall Study|Physician Decision|1|||
16522685|NCT02033889|40380327|FG002|Overall Study|Physician Decision|1|||
16522686|NCT02033889|40380325|FG000|Overall Study|Participant moved|0|||
16522687|NCT02033889|40380326|FG001|Overall Study|Participant moved|1|||
16522688|NCT02033889|40380327|FG002|Overall Study|Participant moved|0|||
16522689|NCT02033889|40380325|FG000|Overall Study|Withdrawal by Subject|18|||
16522690|NCT02033889|40380326|FG001|Overall Study|Withdrawal by Subject|10|||
16522691|NCT02033889|40380327|FG002|Overall Study|Withdrawal by Subject|13|||
16522692|NCT02838017|40380333|FG000|Overall Study|Lost to Follow-up|14|||
16522693|NCT02838017|40380334|FG001|Overall Study|Lost to Follow-up|11|||
16522694|NCT04102501|40380343|FG000|Overall Study|Withdrawal by Subject|7|||
16522695|NCT04102501|40380344|FG001|Overall Study|Withdrawal by Subject|9|||
16522696|NCT04102501|40380343|FG000|Overall Study|Adverse Event|1|||
16522697|NCT04102501|40380344|FG001|Overall Study|Adverse Event|3|||
16522698|NCT04982029|40380349|FG000|Overall Study|Lost to Follow-up|2|||
16522699|NCT04982029|40380350|FG001|Overall Study|Lost to Follow-up|3|||
16522700|NCT00766415|40380355|FG000|Overall Study|Withdrawal by Subject|0|||
16522701|NCT00766415|40380356|FG001|Overall Study|Withdrawal by Subject|1|||
16522702|NCT01751568|40380359|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
16522703|NCT01751568|40380360|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
16522704|NCT01751568|40380361|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
16522705|NCT01994395|40380364|FG000|Overall Study|Withdrawal by Subject|1|||
16522706|NCT01994395|40380365|FG001|Overall Study|Withdrawal by Subject|2|||
16522707|NCT02899728|40380366|FG000|Overall Study|Withdrawal by Subject|1|||
16522708|NCT02899728|40380367|FG001|Overall Study|Withdrawal by Subject|1|||
16522709|NCT04535037|40380368|FG000|Overall Study|Protocol Violation|1|||
16522710|NCT04535037|40380369|FG001|Overall Study|Protocol Violation|0|||
16522711|NCT04535037|40380368|FG000|Overall Study|Withdrawal by Subject|8|||
16326044|NCT04064411|39678299|FG000|Overall Study|Adverse Event|29|||
16522712|NCT04535037|40380369|FG001|Overall Study|Withdrawal by Subject|9|||
16522713|NCT04535037|40380368|FG000|Overall Study|Migrated / moved from the study area|1|||
16522714|NCT04535037|40380369|FG001|Overall Study|Migrated / moved from the study area|4|||
16522715|NCT04535037|40380368|FG000|Overall Study|Other|2|||
16522716|NCT04535037|40380369|FG001|Overall Study|Other|5|||
16522717|NCT00459134|40380374|FG000|Overall Study|Physician Decision|1|||
16522718|NCT00459134|40380375|FG001|Overall Study|Physician Decision|1|||
16522719|NCT00459134|40380374|FG000|Overall Study|Withdrawal by Subject|8|||
16522720|NCT00459134|40380375|FG001|Overall Study|Withdrawal by Subject|7|||
16522721|NCT00459134|40380374|FG000|Overall Study|Lost to Follow-up|6|||
16522722|NCT00459134|40380375|FG001|Overall Study|Lost to Follow-up|7|||
16522723|NCT00459134|40380374|FG000|Overall Study|Surgery|1|||
16522724|NCT00459134|40380375|FG001|Overall Study|Surgery|2|||
16522725|NCT00459134|40380374|FG000|Overall Study|Toxicity|4|||
16522726|NCT00459134|40380375|FG001|Overall Study|Toxicity|5|||
16522727|NCT00459134|40380374|FG000|Overall Study|Progression|1|||
16522728|NCT00459134|40380375|FG001|Overall Study|Progression|0|||
16522729|NCT00459134|40380374|FG000|Overall Study|Multiple Reasons|2|||
16522730|NCT00459134|40380375|FG001|Overall Study|Multiple Reasons|3|||
16522731|NCT00142909|40380376|FG000|Randomization|Various Reasons|7|||
16522732|NCT00142909|40380377|FG001|Randomization|Various Reasons|10|||
16522733|NCT00142909|40380376|FG000|Medications Begin|Protocol Violation|2|||
16326045|NCT04064411|39678300|FG001|Overall Study|Adverse Event|19|||
16522734|NCT00142909|40380377|FG001|Medications Begin|Protocol Violation|0|||
16522735|NCT00142909|40380376|FG000|Medications Begin|Withdrawal by Subject|5|||
16522736|NCT00142909|40380377|FG001|Medications Begin|Withdrawal by Subject|3|||
16522737|NCT00142909|40380376|FG000|Medications Begin|Withdrawal by Subject|2|||
16326046|NCT04064411|39678299|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
16326047|NCT04064411|39678300|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
16326048|NCT04064411|39678299|FG000|Overall Study|Protocol Deviation|0|||
16326049|NCT04064411|39678300|FG001|Overall Study|Protocol Deviation|2|||
16326050|NCT04064411|39678299|FG000|Overall Study|Withdrawal by Subject|25|||
16326051|NCT04064411|39678300|FG001|Overall Study|Withdrawal by Subject|29|||
16326052|NCT04064411|39678299|FG000|Overall Study|Lost to Follow-up|5|||
16326053|NCT04064411|39678300|FG001|Overall Study|Lost to Follow-up|2|||
16326054|NCT04064411|39678299|FG000|Overall Study|Other than Specified|4|||
16326055|NCT04064411|39678300|FG001|Overall Study|Other than Specified|1|||
16326056|NCT04064411|39678299|FG000|Overall Study|Death|1|||
16326057|NCT04064411|39678300|FG001|Overall Study|Death|0|||
16326058|NCT03425396|39678301|FG000|Overall Study|Lost to Follow-up|2|||
16326059|NCT03425396|39678302|FG001|Overall Study|Lost to Follow-up|5|||
16326060|NCT03425396|39678303|FG002|Overall Study|Lost to Follow-up|2|||
16326061|NCT03425396|39678304|FG003|Overall Study|Lost to Follow-up|0|||
16326062|NCT03425396|39678305|FG004|Overall Study|Lost to Follow-up|0|||
16326063|NCT03425396|39678301|FG000|Overall Study|Withdrawal by Subject|0|||
16326064|NCT03425396|39678302|FG001|Overall Study|Withdrawal by Subject|1|||
16326065|NCT03425396|39678303|FG002|Overall Study|Withdrawal by Subject|0|||
16326066|NCT03425396|39678304|FG003|Overall Study|Withdrawal by Subject|1|||
16326067|NCT03425396|39678305|FG004|Overall Study|Withdrawal by Subject|0|||
16326068|NCT03425396|39678301|FG000|Overall Study|Other|0|||
16326069|NCT03425396|39678302|FG001|Overall Study|Other|1|||
16326070|NCT03425396|39678303|FG002|Overall Study|Other|1|||
16326071|NCT03425396|39678304|FG003|Overall Study|Other|0|||
16326072|NCT03425396|39678305|FG004|Overall Study|Other|1|||
16326073|NCT02702388|39678308|FG000|Overall Study|Disease Progression|18|||
16326074|NCT02702388|39678309|FG001|Overall Study|Disease Progression|25|||
16326075|NCT02702388|39678308|FG000|Overall Study|Withdrawal by Subject|9|||
16396609|NCT01713582|39931410|FG003|Overall Study|Withdrawal by Subject|0|||
16396610|NCT01713582|39931411|FG004|Overall Study|Withdrawal by Subject|0|||
16396611|NCT01713582|39931412|FG005|Overall Study|Withdrawal by Subject|0|||
16396612|NCT01713582|39931413|FG006|Overall Study|Withdrawal by Subject|0|||
16396613|NCT01713582|39931414|FG007|Overall Study|Withdrawal by Subject|0|||
16396614|NCT01713582|39931415|FG008|Overall Study|Withdrawal by Subject|0|||
16396615|NCT01713582|39931416|FG009|Overall Study|Withdrawal by Subject|0|||
16396616|NCT01713582|39931417|FG010|Overall Study|Withdrawal by Subject|0|||
16396617|NCT01713582|39931418|FG011|Overall Study|Withdrawal by Subject|0|||
16396618|NCT01713582|39931419|FG012|Overall Study|Withdrawal by Subject|0|||
16396619|NCT01713582|39931420|FG013|Overall Study|Withdrawal by Subject|0|||
16396620|NCT01713582|39931421|FG014|Overall Study|Withdrawal by Subject|0|||
16396621|NCT01713582|39931422|FG015|Overall Study|Withdrawal by Subject|0|||
16396622|NCT01713582|39931423|FG016|Overall Study|Withdrawal by Subject|0|||
16396623|NCT01713582|39931424|FG017|Overall Study|Withdrawal by Subject|1|||
16396624|NCT01713582|39931425|FG018|Overall Study|Withdrawal by Subject|0|||
16396625|NCT01713582|39931426|FG019|Overall Study|Withdrawal by Subject|0|||
16396626|NCT01713582|39931427|FG020|Overall Study|Withdrawal by Subject|0|||
16396627|NCT01713582|39931407|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
16396628|NCT01713582|39931408|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
16396629|NCT01713582|39931409|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
16396630|NCT01713582|39931410|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
16396631|NCT01713582|39931411|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
16396632|NCT01713582|39931412|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
16396633|NCT01713582|39931413|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
16396634|NCT01713582|39931414|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
16396635|NCT01713582|39931415|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
16522738|NCT00142909|40380377|FG001|Medications Begin|Withdrawal by Subject|0|||
16522739|NCT01459796|40380380|FG000|Overall Study|Non compliance with protocol|2|||
16326076|NCT02702388|39678309|FG001|Overall Study|Withdrawal by Subject|7|||
16326077|NCT02702388|39678308|FG000|Overall Study|Adverse Event|11|||
16326078|NCT02702388|39678309|FG001|Overall Study|Adverse Event|15|||
16326079|NCT02702388|39678308|FG000|Overall Study|Other|2|||
16326080|NCT02702388|39678309|FG001|Overall Study|Other|4|||
16326081|NCT00102531|39678311|FG000|Overall Study|Adverse Event|0|||
16326082|NCT00102531|39678312|FG001|Overall Study|Adverse Event|1|||
16396636|NCT01713582|39931416|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
16396637|NCT01713582|39931417|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
16396638|NCT01713582|39931418|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
16396639|NCT01713582|39931419|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
16396640|NCT01713582|39931420|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
16396641|NCT01713582|39931421|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
16396642|NCT01713582|39931422|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
16396643|NCT01713582|39931423|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
16522740|NCT01459796|40380381|FG001|Overall Study|Non compliance with protocol|4|||
16522741|NCT01459796|40380380|FG000|Overall Study|Adverse Event|5|||
16522742|NCT01459796|40380381|FG001|Overall Study|Adverse Event|5|||
16522743|NCT01459796|40380380|FG000|Overall Study|Withdrawal by Subject|6|||
16522744|NCT01459796|40380381|FG001|Overall Study|Withdrawal by Subject|3|||
16522745|NCT01459796|40380380|FG000|Overall Study|Lost to Follow-up|5|||
16522746|NCT01459796|40380381|FG001|Overall Study|Lost to Follow-up|4|||
16522747|NCT01459796|40380380|FG000|Overall Study|Reason unspecified|1|||
16522748|NCT01459796|40380381|FG001|Overall Study|Reason unspecified|2|||
16522749|NCT01459796|40380380|FG000|Overall Study|Decision by the sponsor|75|||
16522750|NCT01459796|40380381|FG001|Overall Study|Decision by the sponsor|108|||
16522751|NCT00812929|40383580|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
16522752|NCT00812929|40383581|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
16522753|NCT00812929|40383582|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
16522754|NCT00812929|40383583|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
16522755|NCT00812929|40383584|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
16522756|NCT00812929|40383585|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
16522757|NCT00812929|40383586|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
16094658|NCT00603278|38836475|FG001|Overall Study|Physician Decision|1|||
16094659|NCT00603278|38836476|FG002|Overall Study|Physician Decision|0|||
16094660|NCT00603278|38836477|FG003|Overall Study|Physician Decision|0|||
16094661|NCT00603278|38836478|FG004|Overall Study|Physician Decision|2|||
16094662|NCT00603278|38836479|FG005|Overall Study|Physician Decision|1|||
16094663|NCT00603278|38836474|FG000|Overall Study|Lost to Follow-up|1|||
16094664|NCT00603278|38836475|FG001|Overall Study|Lost to Follow-up|0|||
16094665|NCT00603278|38836476|FG002|Overall Study|Lost to Follow-up|0|||
16094666|NCT00603278|38836477|FG003|Overall Study|Lost to Follow-up|0|||
16094667|NCT00603278|38836478|FG004|Overall Study|Lost to Follow-up|1|||
16094668|NCT00603278|38836479|FG005|Overall Study|Lost to Follow-up|0|||
16094669|NCT01090739|38836480|FG000|Enrollment|Withdrawal by Subject|24|||
16094670|NCT01090739|38836480|FG000|Enrollment|Protocol Violation|14|||
16094671|NCT01090739|38836480|FG000|Enrollment|Lost to Follow-up|5|||
16094672|NCT01090739|38836480|FG000|Enrollment|Physician Decision|5|||
16094673|NCT01090739|38836480|FG000|Enrollment|Sponsor termination of site|4|||
16094674|NCT01090739|38836480|FG000|Enrollment|Study implant limit reached|2|||
16094675|NCT01090739|38836480|FG000|Enrollment|Adverse Event|1|||
16094676|NCT01090739|38836480|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
16094677|NCT01090739|38836480|FG000|12 Month Follow-up|Lost to Follow-up|1|||
16094678|NCT01090739|38836480|FG000|12 Month Follow-up|Physician Decision|1|||
16094679|NCT01090739|38836480|FG000|12 Month Follow-up|Death|1|||
16094680|NCT01090739|38836480|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
16094681|NCT01090739|38836480|FG000|24 Month Follow-up|Lost to Follow-up|1|||
16094682|NCT01090739|38836480|FG000|24 Month Follow-up|Death|1|||
16094683|NCT01090739|38836480|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
16094684|NCT01090739|38836480|FG000|36 Month Follow-up|Visit still pending|17|||
16094685|NCT01768572|38836484|FG000|Overall Study|Adverse Event|7|||
16094686|NCT01768572|38836485|FG001|Overall Study|Adverse Event|8|||
16094687|NCT01768572|38836486|FG002|Overall Study|Adverse Event|4|||
16094688|NCT01768572|38836484|FG000|Overall Study|Lack of Efficacy|1|||
16094689|NCT01768572|38836485|FG001|Overall Study|Lack of Efficacy|3|||
16094690|NCT01768572|38836486|FG002|Overall Study|Lack of Efficacy|1|||
16094691|NCT01768572|38836484|FG000|Overall Study|Other, Not due to an adverse event|1|||
16094692|NCT01768572|38836485|FG001|Overall Study|Other, Not due to an adverse event|1|||
16094693|NCT01768572|38836486|FG002|Overall Study|Other, Not due to an adverse event|1|||
16094694|NCT03503188|38836487|FG000|Overall Study|Non eligible in the sub study|0|||
16094695|NCT03503188|38836488|FG001|Overall Study|Non eligible in the sub study|1|||
16094696|NCT02254278|38836489|FG000|Overall Study|Protocol Violation|1|||
16094697|NCT02254278|38836490|FG001|Overall Study|Protocol Violation|1|||
16094698|NCT01316913|38836491|FG000|Overall Study|Adverse Event|17|||
16094699|NCT01316913|38836492|FG001|Overall Study|Adverse Event|20|||
16094700|NCT01316913|38836493|FG002|Overall Study|Adverse Event|15|||
16094701|NCT01316913|38836494|FG003|Overall Study|Adverse Event|11|||
16094702|NCT01316913|38836491|FG000|Overall Study|Lack of Efficacy|22|||
16094703|NCT01316913|38836492|FG001|Overall Study|Lack of Efficacy|12|||
16094704|NCT01316913|38836493|FG002|Overall Study|Lack of Efficacy|9|||
16522758|NCT00812929|40383587|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
16522759|NCT00812929|40383588|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
16522760|NCT00812929|40383589|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
16094705|NCT01316913|38836494|FG003|Overall Study|Lack of Efficacy|13|||
16094706|NCT01316913|38836491|FG000|Overall Study|Protocol Violation|1|||
16094707|NCT01316913|38836492|FG001|Overall Study|Protocol Violation|4|||
16094708|NCT01316913|38836493|FG002|Overall Study|Protocol Violation|4|||
16094709|NCT01316913|38836494|FG003|Overall Study|Protocol Violation|1|||
16094710|NCT01316913|38836491|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
16094711|NCT01316913|38836492|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
16094712|NCT01316913|38836493|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
16207506|NCT01655069|39237267|FG003|Overall Study|Physician Decision|1|||
16396644|NCT01713582|39931424|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
16396645|NCT01713582|39931425|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
16396646|NCT01713582|39931426|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
16396647|NCT01713582|39931427|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
16396648|NCT01713582|39931407|FG000|Overall Study|Disease progression and adverse event|0|||
16396649|NCT01713582|39931408|FG001|Overall Study|Disease progression and adverse event|0|||
16396650|NCT01713582|39931409|FG002|Overall Study|Disease progression and adverse event|0|||
16396651|NCT01713582|39931410|FG003|Overall Study|Disease progression and adverse event|0|||
16326083|NCT00102531|39678311|FG000|Overall Study|Disease Progression|5|||
16326084|NCT00102531|39678312|FG001|Overall Study|Disease Progression|9|||
16326085|NCT00102531|39678311|FG000|Overall Study|Physician Decision|0|||
16326086|NCT00102531|39678312|FG001|Overall Study|Physician Decision|1|||
16326087|NCT01931995|39678313|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
16326088|NCT01931995|39678314|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
16094713|NCT01316913|38836494|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
16094714|NCT01316913|38836491|FG000|Overall Study|Lost to Follow-up|0|||
16094715|NCT01316913|38836492|FG001|Overall Study|Lost to Follow-up|1|||
16094716|NCT01316913|38836493|FG002|Overall Study|Lost to Follow-up|0|||
16094717|NCT01316913|38836494|FG003|Overall Study|Lost to Follow-up|2|||
16326089|NCT01931995|39678313|FG000|First Intervention (1 Day)|Physician Decision|1|||
16326090|NCT01931995|39678314|FG001|First Intervention (1 Day)|Physician Decision|1|||
16326091|NCT01931995|39678313|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
16326092|NCT01931995|39678314|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
16326093|NCT04791319|39681491|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
16326094|NCT04791319|39681492|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
16326095|NCT04791319|39681493|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
16326096|NCT04791319|39681494|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
16326097|NCT04791319|39681495|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16326098|NCT04791319|39681496|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16326099|NCT04791319|39681497|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16326100|NCT04791319|39681498|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16326101|NCT04791319|39681499|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16326102|NCT04791319|39681500|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16326103|NCT04791319|39681501|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
16326104|NCT04791319|39681491|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
16326105|NCT04791319|39681492|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16326106|NCT04791319|39681493|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
16326107|NCT04791319|39681494|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
16326108|NCT04791319|39681495|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16326109|NCT04791319|39681496|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16326110|NCT04791319|39681497|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16326111|NCT04791319|39681498|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16326112|NCT04791319|39681499|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16326113|NCT04791319|39681500|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16326114|NCT04791319|39681501|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
16326115|NCT04791319|39681491|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
16326116|NCT04791319|39681492|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
16326117|NCT04791319|39681493|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
16326118|NCT04791319|39681494|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
16326119|NCT04791319|39681495|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16326120|NCT04791319|39681496|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16326121|NCT04791319|39681497|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16326122|NCT04791319|39681498|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16326123|NCT04791319|39681499|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16326124|NCT04791319|39681500|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16326125|NCT04791319|39681501|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
16326126|NCT04791319|39681491|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
16326127|NCT04791319|39681492|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
16326128|NCT04791319|39681493|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
16396652|NCT01713582|39931411|FG004|Overall Study|Disease progression and adverse event|0|||
16396653|NCT01713582|39931412|FG005|Overall Study|Disease progression and adverse event|0|||
16396654|NCT01713582|39931413|FG006|Overall Study|Disease progression and adverse event|0|||
16396655|NCT01713582|39931414|FG007|Overall Study|Disease progression and adverse event|0|||
16396656|NCT01713582|39931415|FG008|Overall Study|Disease progression and adverse event|0|||
16094718|NCT01316913|38836491|FG000|Overall Study|Withdrawal by Subject|10|||
16207507|NCT01655069|39237264|FG000|Overall Study|Adverse Event|6|||
16326129|NCT04791319|39681494|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
16522761|NCT00812929|40383580|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
16522762|NCT00812929|40383581|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
16522763|NCT00812929|40383582|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
16522764|NCT00812929|40383583|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
16522765|NCT00812929|40383584|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
16522766|NCT00812929|40383585|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
16522767|NCT00812929|40383586|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
16522768|NCT00812929|40383587|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
16522769|NCT00812929|40383588|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
16522770|NCT00812929|40383589|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
16522771|NCT00812929|40383580|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
16522772|NCT00812929|40383581|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
16522773|NCT00812929|40383582|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
16522774|NCT00812929|40383583|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
16522775|NCT00812929|40383584|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
16522776|NCT00812929|40383585|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
16522777|NCT00812929|40383586|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
16522778|NCT00812929|40383587|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
16522779|NCT00812929|40383588|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
16522780|NCT00812929|40383589|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
16522781|NCT01854554|40383598|FG000|Overall Study|Denial of Insurance Coverage|12|||
16522782|NCT01854554|40383599|FG001|Overall Study|Denial of Insurance Coverage|0|||
16522783|NCT01854554|40383598|FG000|Overall Study|Decided to get treatment locally|1|||
16522784|NCT01854554|40383599|FG001|Overall Study|Decided to get treatment locally|5|||
16522785|NCT01854554|40383598|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
16522786|NCT01854554|40383599|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
16522787|NCT01854554|40383598|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
16522788|NCT01854554|40383599|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
16522789|NCT01854554|40383598|FG000|Overall Study|Progression|0|||
16522790|NCT01854554|40383599|FG001|Overall Study|Progression|1|||
16522791|NCT01854554|40383598|FG000|Overall Study|Lost to Follow-up|0|||
16522792|NCT01854554|40383599|FG001|Overall Study|Lost to Follow-up|1|||
16522793|NCT01153633|40383601|FG000|Overall Study|Protocol Violation|1|||
16522794|NCT01153633|40383602|FG001|Overall Study|Protocol Violation|1|||
16522795|NCT01153633|40383601|FG000|Overall Study|Therapeutic failure|3|||
16094719|NCT01316913|38836492|FG001|Overall Study|Withdrawal by Subject|9|||
16094720|NCT01316913|38836493|FG002|Overall Study|Withdrawal by Subject|10|||
16094721|NCT01316913|38836494|FG003|Overall Study|Withdrawal by Subject|6|||
16094722|NCT01020435|38836497|FG000|Overall Study|Lost to Follow-up|0|||
16094723|NCT01020435|38836498|FG001|Overall Study|Lost to Follow-up|1|||
16094724|NCT02942771|38836499|FG000|Overall Study|Adverse Event|1|||
16094725|NCT02942771|38836500|FG001|Overall Study|Adverse Event|0|||
16094726|NCT02942771|38836501|FG002|Overall Study|Adverse Event|0|||
16094727|NCT02942771|38836502|FG003|Overall Study|Adverse Event|0|||
16094728|NCT02942771|38836503|FG004|Overall Study|Adverse Event|2|||
16094729|NCT02942771|38836499|FG000|Overall Study|Lost to Follow-up|1|||
16094730|NCT02942771|38836500|FG001|Overall Study|Lost to Follow-up|0|||
16094731|NCT02942771|38836501|FG002|Overall Study|Lost to Follow-up|0|||
16094732|NCT02942771|38836502|FG003|Overall Study|Lost to Follow-up|0|||
16094733|NCT02942771|38836503|FG004|Overall Study|Lost to Follow-up|0|||
16094734|NCT02942771|38836499|FG000|Overall Study|Withdrawal by Subject|1|||
16326130|NCT04791319|39681495|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16326131|NCT04791319|39681496|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16326132|NCT04791319|39681497|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16326133|NCT04791319|39681498|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16522796|NCT01153633|40383602|FG001|Overall Study|Therapeutic failure|3|||
16522797|NCT00359762|40383603|FG000|Period II|Adverse Event|17|||
16522798|NCT00359762|40383604|FG001|Period II|Adverse Event|0|||
16522799|NCT00359762|40383605|FG002|Period II|Adverse Event|0|||
16522800|NCT00359762|40383606|FG003|Period II|Adverse Event|0|||
16522801|NCT00359762|40383607|FG004|Period II|Adverse Event|49|||
16522802|NCT00359762|40383603|FG000|Period II|Protocol Violation|18|||
16522803|NCT00359762|40383604|FG001|Period II|Protocol Violation|0|||
16522804|NCT00359762|40383605|FG002|Period II|Protocol Violation|0|||
16522805|NCT00359762|40383606|FG003|Period II|Protocol Violation|0|||
16522806|NCT00359762|40383607|FG004|Period II|Protocol Violation|11|||
16522807|NCT00359762|40383603|FG000|Period II|Physician Decision|17|||
16522808|NCT00359762|40383604|FG001|Period II|Physician Decision|0|||
16522809|NCT00359762|40383605|FG002|Period II|Physician Decision|0|||
16522810|NCT00359762|40383606|FG003|Period II|Physician Decision|0|||
16094735|NCT02942771|38836500|FG001|Overall Study|Withdrawal by Subject|0|||
16094736|NCT02942771|38836501|FG002|Overall Study|Withdrawal by Subject|0|||
16094737|NCT02942771|38836502|FG003|Overall Study|Withdrawal by Subject|0|||
16207508|NCT01655069|39237265|FG001|Overall Study|Adverse Event|7|||
16207509|NCT01655069|39237266|FG002|Overall Study|Adverse Event|2|||
16396657|NCT01713582|39931416|FG009|Overall Study|Disease progression and adverse event|0|||
16396658|NCT01713582|39931417|FG010|Overall Study|Disease progression and adverse event|0|||
16396659|NCT01713582|39931418|FG011|Overall Study|Disease progression and adverse event|0|||
16396660|NCT01713582|39931419|FG012|Overall Study|Disease progression and adverse event|0|||
16396661|NCT01713582|39931420|FG013|Overall Study|Disease progression and adverse event|0|||
16396662|NCT01713582|39931421|FG014|Overall Study|Disease progression and adverse event|0|||
16396663|NCT01713582|39931422|FG015|Overall Study|Disease progression and adverse event|0|||
16396664|NCT01713582|39931423|FG016|Overall Study|Disease progression and adverse event|1|||
16396665|NCT01713582|39931424|FG017|Overall Study|Disease progression and adverse event|0|||
16396666|NCT01713582|39931425|FG018|Overall Study|Disease progression and adverse event|0|||
16396667|NCT01713582|39931426|FG019|Overall Study|Disease progression and adverse event|0|||
16396668|NCT01713582|39931427|FG020|Overall Study|Disease progression and adverse event|0|||
16396669|NCT02644096|39931428|FG000|Overall Study|Withdrawal by Subject|28|||
16396670|NCT02644096|39931429|FG001|Overall Study|Withdrawal by Subject|25|||
16396671|NCT01536561|39931431|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
16396672|NCT01536561|39931431|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
16396673|NCT01536561|39931431|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
16396674|NCT01536561|39931431|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
16396675|NCT01536561|39931431|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
16396676|NCT01536561|39931431|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
16396677|NCT00293813|39935255|FG000|Overall Study|Physician Decision|0|||
16396678|NCT00293813|39935256|FG001|Overall Study|Physician Decision|1|||
16396679|NCT00293813|39935257|FG002|Overall Study|Physician Decision|0|||
16396680|NCT00293813|39935255|FG000|Overall Study|Adverse Event|3|||
16396681|NCT00293813|39935256|FG001|Overall Study|Adverse Event|1|||
16396682|NCT00293813|39935257|FG002|Overall Study|Adverse Event|1|||
16396683|NCT00293813|39935255|FG000|Overall Study|Withdrawal by Subject|7|||
16396684|NCT00293813|39935256|FG001|Overall Study|Withdrawal by Subject|4|||
16396685|NCT00293813|39935257|FG002|Overall Study|Withdrawal by Subject|4|||
16396686|NCT00293813|39935255|FG000|Overall Study|Lost to Follow-up|3|||
16396687|NCT00293813|39935256|FG001|Overall Study|Lost to Follow-up|2|||
16396688|NCT00293813|39935257|FG002|Overall Study|Lost to Follow-up|3|||
16396689|NCT00293813|39935255|FG000|Overall Study|Noncompliance|0|||
16396690|NCT00293813|39935256|FG001|Overall Study|Noncompliance|1|||
16396691|NCT00293813|39935257|FG002|Overall Study|Noncompliance|0|||
16396692|NCT04660552|39935258|FG000|Overall Study|Withdrawal by Subject|3|||
16396693|NCT04660552|39935259|FG001|Overall Study|Withdrawal by Subject|1|||
16396694|NCT02582814|39935260|FG000|Overall Study|Study-specific withdrawal criteria|1|||
16396695|NCT02582814|39935261|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16396696|NCT02582814|39935260|FG000|Overall Study|Withdrawal by Subject|4|||
16396697|NCT02582814|39935261|FG001|Overall Study|Withdrawal by Subject|3|||
16396698|NCT02582814|39935260|FG000|Overall Study|Adverse Event|4|||
16396699|NCT02582814|39935261|FG001|Overall Study|Adverse Event|4|||
16396700|NCT00553436|39935263|FG000|Overall Study|Conversion to another procedure|1|||
16396701|NCT00249808|39935264|FG000|Overall Study|Other|27|||
16396702|NCT00249808|39935264|FG000|Overall Study|Protocol Violation|3|||
16396703|NCT00249808|39935264|FG000|Overall Study|Lost to Follow-up|8|||
16396704|NCT00249808|39935264|FG000|Overall Study|Adverse Event|81|||
16396705|NCT00249808|39935264|FG000|Overall Study|Lack of Efficacy|52|||
16396706|NCT00249808|39935264|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
16396707|NCT05005273|39935268|FG000|Overall Study|Study Terminated|1|||
16396708|NCT05005273|39935269|FG001|Overall Study|Study Terminated|0|||
16396709|NCT01208324|39935270|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
16396710|NCT01208324|39935271|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
16396711|NCT01208324|39935272|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
16396712|NCT01208324|39935273|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
16522811|NCT00359762|40383607|FG004|Period II|Physician Decision|23|||
16522812|NCT00359762|40383603|FG000|Period II|Death|2|||
16522813|NCT00359762|40383604|FG001|Period II|Death|0|||
16522814|NCT00359762|40383605|FG002|Period II|Death|0|||
16522815|NCT00359762|40383606|FG003|Period II|Death|0|||
16522816|NCT00359762|40383607|FG004|Period II|Death|4|||
16522817|NCT00359762|40383603|FG000|Period II|Lack of Efficacy|11|||
16522818|NCT00359762|40383604|FG001|Period II|Lack of Efficacy|0|||
16396713|NCT02719691|39935276|FG000|Overall Study|Physician Decision|0|||
16396714|NCT02719691|39935277|FG001|Overall Study|Physician Decision|0|||
16396715|NCT02719691|39935278|FG002|Overall Study|Physician Decision|1|||
16396716|NCT02719691|39935279|FG003|Overall Study|Physician Decision|0|||
16207510|NCT01655069|39237267|FG003|Overall Study|Adverse Event|3|||
16396717|NCT02719691|39935280|FG004|Overall Study|Physician Decision|0|||
16396718|NCT02719691|39935281|FG005|Overall Study|Physician Decision|0|||
16522819|NCT00359762|40383605|FG002|Period II|Lack of Efficacy|0|||
16522820|NCT00359762|40383606|FG003|Period II|Lack of Efficacy|0|||
16522821|NCT00359762|40383607|FG004|Period II|Lack of Efficacy|8|||
16094738|NCT02942771|38836503|FG004|Overall Study|Withdrawal by Subject|2|||
16094739|NCT00195819|38836504|FG000|Double-Blind|Withdrawal by Subject|1|||
16094740|NCT00195819|38836505|FG001|Double-Blind|Withdrawal by Subject|0|||
16094741|NCT00195819|38836504|FG000|Double-Blind|Moved|1|||
16094742|NCT00195819|38836505|FG001|Double-Blind|Moved|0|||
16094743|NCT00195819|38836504|FG000|Open-label|Adverse Event|0|||
16094744|NCT00195819|38836505|FG001|Open-label|Adverse Event|9|||
16094745|NCT00195819|38836504|FG000|Open-label|Lack of Efficacy|0|||
16094746|NCT00195819|38836505|FG001|Open-label|Lack of Efficacy|2|||
16094747|NCT00195819|38836504|FG000|Open-label|Pregnancy|0|||
16094748|NCT00195819|38836505|FG001|Open-label|Pregnancy|1|||
16094749|NCT00195819|38836504|FG000|Open-label|Protocol Violation|0|||
16094750|NCT00195819|38836505|FG001|Open-label|Protocol Violation|2|||
16094751|NCT00195819|38836504|FG000|Open-label|Moved|0|||
16094752|NCT00195819|38836505|FG001|Open-label|Moved|1|||
16094753|NCT00195819|38836504|FG000|Open-label|Withdrawal by Subject|0|||
16094754|NCT00195819|38836505|FG001|Open-label|Withdrawal by Subject|5|||
16094755|NCT00042939|38836506|FG000|Overall Study|Adverse Event|6|||
16522822|NCT00359762|40383603|FG000|Period II|Lost to follow up|5|||
16522823|NCT00359762|40383604|FG001|Period II|Lost to follow up|0|||
16522824|NCT00359762|40383605|FG002|Period II|Lost to follow up|0|||
16522825|NCT00359762|40383606|FG003|Period II|Lost to follow up|0|||
16522826|NCT00359762|40383607|FG004|Period II|Lost to follow up|5|||
16522827|NCT00359762|40383603|FG000|Period II|Entry Criteria Not Met|8|||
16522828|NCT00359762|40383604|FG001|Period II|Entry Criteria Not Met|0|||
16094756|NCT00042939|38836507|FG001|Overall Study|Adverse Event|7|||
16094757|NCT00042939|38836506|FG000|Overall Study|Death|3|||
16094758|NCT00042939|38836507|FG001|Overall Study|Death|2|||
16094759|NCT00042939|38836506|FG000|Overall Study|Withdrawal by Subject|3|||
16094760|NCT00042939|38836507|FG001|Overall Study|Withdrawal by Subject|4|||
16326134|NCT04791319|39681499|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16326135|NCT04791319|39681500|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16326136|NCT04791319|39681501|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
16522829|NCT00359762|40383605|FG002|Period II|Entry Criteria Not Met|0|||
16522830|NCT00359762|40383606|FG003|Period II|Entry Criteria Not Met|0|||
16522831|NCT00359762|40383607|FG004|Period II|Entry Criteria Not Met|4|||
16522832|NCT00359762|40383603|FG000|Period II|Subject Decision|50|||
16522833|NCT00359762|40383604|FG001|Period II|Subject Decision|0|||
16522834|NCT00359762|40383605|FG002|Period II|Subject Decision|0|||
16326137|NCT04791319|39681491|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16326138|NCT04791319|39681492|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16326139|NCT04791319|39681493|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16522835|NCT00359762|40383606|FG003|Period II|Subject Decision|0|||
16522836|NCT00359762|40383607|FG004|Period II|Subject Decision|70|||
16522837|NCT00359762|40383603|FG000|Period III|Protocol Violation|0|||
16522838|NCT00359762|40383604|FG001|Period III|Protocol Violation|5|||
16522839|NCT00359762|40383605|FG002|Period III|Protocol Violation|3|||
16522840|NCT00359762|40383606|FG003|Period III|Protocol Violation|8|||
16522841|NCT00359762|40383607|FG004|Period III|Protocol Violation|0|||
16522842|NCT00359762|40383603|FG000|Period III|Adverse Event|0|||
16522843|NCT00359762|40383604|FG001|Period III|Adverse Event|3|||
16522844|NCT00359762|40383605|FG002|Period III|Adverse Event|4|||
16522845|NCT00359762|40383606|FG003|Period III|Adverse Event|10|||
16522846|NCT00359762|40383607|FG004|Period III|Adverse Event|0|||
16522847|NCT00359762|40383603|FG000|Period III|Physician Decision|0|||
16522848|NCT00359762|40383604|FG001|Period III|Physician Decision|5|||
16522849|NCT00359762|40383605|FG002|Period III|Physician Decision|9|||
16522850|NCT00359762|40383606|FG003|Period III|Physician Decision|15|||
16522851|NCT00359762|40383607|FG004|Period III|Physician Decision|0|||
16522852|NCT00359762|40383603|FG000|Period III|Lack of Efficacy|0|||
16522853|NCT00359762|40383604|FG001|Period III|Lack of Efficacy|7|||
16326140|NCT04791319|39681494|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
16326141|NCT04791319|39681495|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16326142|NCT04791319|39681496|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16326143|NCT04791319|39681497|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16326144|NCT04791319|39681498|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16326145|NCT04791319|39681499|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16396719|NCT02719691|39935282|FG006|Overall Study|Physician Decision|0|||
16522854|NCT00359762|40383605|FG002|Period III|Lack of Efficacy|5|||
16522855|NCT00359762|40383606|FG003|Period III|Lack of Efficacy|9|||
16522856|NCT00359762|40383607|FG004|Period III|Lack of Efficacy|0|||
16522857|NCT00359762|40383603|FG000|Period III|Lost to follow up|0|||
16522858|NCT00359762|40383604|FG001|Period III|Lost to follow up|1|||
16522859|NCT00359762|40383605|FG002|Period III|Lost to follow up|1|||
16326146|NCT04791319|39681500|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16522860|NCT00359762|40383606|FG003|Period III|Lost to follow up|2|||
16522861|NCT00359762|40383607|FG004|Period III|Lost to follow up|0|||
16522862|NCT00359762|40383603|FG000|Period III|Entry Criteria Not Met|0|||
16522863|NCT00359762|40383604|FG001|Period III|Entry Criteria Not Met|1|||
16522864|NCT00359762|40383605|FG002|Period III|Entry Criteria Not Met|0|||
16522865|NCT00359762|40383606|FG003|Period III|Entry Criteria Not Met|1|||
16522866|NCT00359762|40383607|FG004|Period III|Entry Criteria Not Met|0|||
16522867|NCT00359762|40383603|FG000|Period III|Subject Decision|0|||
16522868|NCT00359762|40383604|FG001|Period III|Subject Decision|7|||
16522869|NCT00359762|40383605|FG002|Period III|Subject Decision|8|||
16522870|NCT00359762|40383606|FG003|Period III|Subject Decision|20|||
16522871|NCT00359762|40383607|FG004|Period III|Subject Decision|0|||
16522872|NCT02984995|40383608|FG000|Overall Study|Required stem cell transplant|13|||
16522873|NCT02984995|40383609|FG001|Overall Study|Required stem cell transplant|2|||
16522874|NCT02984995|40383608|FG000|Overall Study|Progressive disease|11|||
16522875|NCT02984995|40383609|FG001|Overall Study|Progressive disease|1|||
16522876|NCT02984995|40383608|FG000|Overall Study|Adverse Event|1|||
16522877|NCT02984995|40383609|FG001|Overall Study|Adverse Event|0|||
16522878|NCT02334748|40383610|FG000|Overall Study|Adverse Event|1|||
16522879|NCT02334748|40383610|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
16522880|NCT02334748|40383610|FG000|Overall Study|Patient no longer required study drug|2|||
16522881|NCT02334748|40383610|FG000|Overall Study|Lack of Efficacy|4|||
16522882|NCT00432380|40383611|FG000|Overall Study|Migrated/moved from study area|3|||
16522883|NCT00432380|40383612|FG001|Overall Study|Migrated/moved from study area|4|||
16522884|NCT00432380|40383613|FG002|Overall Study|Migrated/moved from study area|1|||
16522885|NCT00432380|40383611|FG000|Overall Study|Adverse Event|1|||
16522886|NCT00432380|40383612|FG001|Overall Study|Adverse Event|0|||
16522887|NCT00432380|40383613|FG002|Overall Study|Adverse Event|0|||
16522888|NCT00608829|40383614|FG000|Overall Study|Death|6|||
16522889|NCT00608829|40383614|FG000|Overall Study|Withdrawal by Subject|4|||
16522890|NCT00608829|40383614|FG000|Overall Study|Subject refuses to follow up or return.|5|||
16522891|NCT01640301|40383615|FG000|Overall Study|Death|0|||
16522892|NCT01640301|40383616|FG001|Overall Study|Death|8|||
16522893|NCT02731131|40383617|FG000|Overall Study|Psychiatric Disorder|0|||
16522894|NCT02731131|40383618|FG001|Overall Study|Psychiatric Disorder|1|||
16522895|NCT02731131|40383617|FG000|Overall Study|Refused Therapy|0|||
16522896|NCT02731131|40383618|FG001|Overall Study|Refused Therapy|1|||
16522897|NCT04964089|40383619|FG000|Overall Study|Adverse Event|8|||
16522898|NCT04964089|40383620|FG001|Overall Study|Adverse Event|6|||
16522899|NCT04964089|40383619|FG000|Overall Study|Non-compliance with study schedule|1|||
16522900|NCT04964089|40383620|FG001|Overall Study|Non-compliance with study schedule|0|||
16522901|NCT04964089|40383619|FG000|Overall Study|Withdrawal by Subject|6|||
16522902|NCT04964089|40383620|FG001|Overall Study|Withdrawal by Subject|5|||
16522903|NCT04964089|40383619|FG000|Overall Study|Lost to Follow-up|1|||
16522904|NCT04964089|40383620|FG001|Overall Study|Lost to Follow-up|1|||
16522905|NCT04964089|40383619|FG000|Overall Study|Progressive disease|4|||
16522906|NCT04964089|40383620|FG001|Overall Study|Progressive disease|0|||
16522907|NCT04964089|40383619|FG000|Overall Study|Physician Decision|1|||
16522908|NCT04964089|40383620|FG001|Overall Study|Physician Decision|0|||
16522909|NCT04964089|40383619|FG000|Overall Study|Participant did not want to continue study treatment|1|||
16522910|NCT04964089|40383620|FG001|Overall Study|Participant did not want to continue study treatment|0|||
16522911|NCT04964089|40383619|FG000|Overall Study|Participant moved to different state|1|||
16522912|NCT04964089|40383620|FG001|Overall Study|Participant moved to different state|0|||
16522913|NCT04964089|40383619|FG000|Overall Study|Participant decided to discontinue|0|||
16522914|NCT04964089|40383620|FG001|Overall Study|Participant decided to discontinue|1|||
16522915|NCT03634579|40383623|FG000|Overall Study|study termination|9|||
16522916|NCT02610140|40383624|FG000|Randomization and Treatment Period|Radiological progression|23|||
16522917|NCT02610140|40383625|FG001|Randomization and Treatment Period|Radiological progression|15|||
16522918|NCT02610140|40383624|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
16522919|NCT02610140|40383625|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
16522920|NCT02610140|40383624|FG000|Randomization and Treatment Period|Protocol Violation|1|||
16522921|NCT02610140|40383625|FG001|Randomization and Treatment Period|Protocol Violation|0|||
16522922|NCT02610140|40383624|FG000|Randomization and Treatment Period|Physician Decision|0|||
16522923|NCT02610140|40383625|FG001|Randomization and Treatment Period|Physician Decision|1|||
16522924|NCT02610140|40383624|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
16522925|NCT02610140|40383625|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
16522926|NCT02610140|40383624|FG000|Randomization and Treatment Period|Death|7|||
16522927|NCT02610140|40383625|FG001|Randomization and Treatment Period|Death|1|||
16522928|NCT02610140|40383624|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
16522929|NCT02610140|40383625|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
16522930|NCT02610140|40383624|FG000|Randomization and Treatment Period|Adverse Event|44|||
16522931|NCT02610140|40383625|FG001|Randomization and Treatment Period|Adverse Event|13|||
16522932|NCT02610140|40383624|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
16094761|NCT00042939|38836506|FG000|Overall Study|Other disease|1|||
16094762|NCT00042939|38836507|FG001|Overall Study|Other disease|0|||
16326147|NCT04791319|39681501|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
16396720|NCT02719691|39935276|FG000|Overall Study|Withdrawal by Subject|0|||
16396721|NCT02719691|39935277|FG001|Overall Study|Withdrawal by Subject|0|||
16396722|NCT02719691|39935278|FG002|Overall Study|Withdrawal by Subject|0|||
16396723|NCT02719691|39935279|FG003|Overall Study|Withdrawal by Subject|0|||
16396724|NCT02719691|39935280|FG004|Overall Study|Withdrawal by Subject|0|||
16396725|NCT02719691|39935281|FG005|Overall Study|Withdrawal by Subject|1|||
16396726|NCT02719691|39935282|FG006|Overall Study|Withdrawal by Subject|0|||
16396727|NCT01813058|39935283|FG000|Overall Study|Withdrawal by Subject|5|||
16396728|NCT01813058|39935284|FG001|Overall Study|Withdrawal by Subject|4|||
16396729|NCT00564733|39935285|FG000|Overall Study|Withdrawal by Subject|4|||
16396730|NCT00564733|39935285|FG000|Overall Study|Ineligible|5|||
16396731|NCT01057693|39935286|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
16396732|NCT01057693|39935287|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
16396733|NCT01057693|39935288|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
16396734|NCT01057693|39935286|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
16396735|NCT01057693|39935287|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
16396736|NCT01057693|39935288|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
16396737|NCT01057693|39935286|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
16396738|NCT01057693|39935287|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
16396739|NCT01057693|39935288|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
16396740|NCT01057693|39935286|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
16396741|NCT01057693|39935287|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
16396742|NCT01057693|39935288|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
16396743|NCT01057693|39935286|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
16396744|NCT01057693|39935287|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
16396745|NCT01057693|39935288|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
16396746|NCT01057693|39935286|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
16396747|NCT01057693|39935287|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
16396748|NCT01057693|39935288|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
16396749|NCT01057693|39935286|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
16396750|NCT01057693|39935287|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
16396751|NCT01057693|39935288|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
16396752|NCT01057693|39935286|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
16396753|NCT01057693|39935287|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
16396754|NCT01057693|39935288|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
16396755|NCT01057693|39935286|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
16396756|NCT01057693|39935287|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
16326148|NCT04791319|39681491|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16326149|NCT04791319|39681492|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16396757|NCT01057693|39935288|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
16396758|NCT01057693|39935286|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
16326150|NCT04791319|39681493|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16326151|NCT04791319|39681494|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16326152|NCT04791319|39681495|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
16326153|NCT04791319|39681496|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
16326154|NCT04791319|39681497|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
16326155|NCT04791319|39681498|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16326156|NCT04791319|39681499|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16326157|NCT04791319|39681500|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
16326158|NCT04791319|39681501|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
16326159|NCT04791319|39681491|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16326160|NCT04791319|39681492|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16326161|NCT04791319|39681493|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16396759|NCT01057693|39935287|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
16522933|NCT02610140|40383625|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
16522934|NCT02610140|40383624|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
16522935|NCT02610140|40383625|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
16522936|NCT02610140|40383624|FG000|Randomization and Treatment Period|Not treated|3|||
16522937|NCT02610140|40383625|FG001|Randomization and Treatment Period|Not treated|10|||
16522938|NCT02610140|40383624|FG000|Safety Follow-up|Other|0|||
16522939|NCT02610140|40383625|FG001|Safety Follow-up|Other|2|||
16522940|NCT02610140|40383624|FG000|Safety Follow-up|Lost to Follow-up|1|||
16522941|NCT02610140|40383625|FG001|Safety Follow-up|Lost to Follow-up|0|||
16522942|NCT02610140|40383624|FG000|Safety Follow-up|No follow-up|5|||
16326162|NCT04791319|39681494|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16326163|NCT04791319|39681495|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16326164|NCT04791319|39681496|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16326165|NCT04791319|39681497|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16326166|NCT04791319|39681498|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16326167|NCT04791319|39681499|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16326168|NCT04791319|39681500|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
16326169|NCT04791319|39681501|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
16326170|NCT04791319|39681491|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
16326171|NCT04791319|39681492|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
16326172|NCT04791319|39681493|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
16326173|NCT04791319|39681494|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
16326174|NCT04791319|39681495|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
16326175|NCT04791319|39681496|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
16326176|NCT04791319|39681497|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
16326177|NCT04791319|39681498|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
16326178|NCT04791319|39681499|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
16326179|NCT04791319|39681500|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
16326180|NCT04791319|39681501|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
16326181|NCT04791319|39681491|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
16326182|NCT04791319|39681492|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
16326183|NCT04791319|39681493|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
16326184|NCT04791319|39681494|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
16326185|NCT04791319|39681495|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
16326186|NCT04791319|39681496|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
16326187|NCT04791319|39681497|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
16326188|NCT04791319|39681498|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
16326189|NCT04791319|39681499|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
16326190|NCT04791319|39681500|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
16326191|NCT04791319|39681501|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
16326192|NCT03214380|39681502|FG000|Lead-in|Adverse Event|3|||
16326193|NCT03214380|39681503|FG001|Lead-in|Adverse Event|0|||
16326194|NCT03214380|39681504|FG002|Lead-in|Adverse Event|0|||
16326195|NCT03214380|39681505|FG003|Lead-in|Adverse Event|1|||
16326196|NCT03214380|39681506|FG004|Lead-in|Adverse Event|0|||
16326197|NCT03214380|39681507|FG005|Lead-in|Adverse Event|0|||
16326198|NCT03214380|39681502|FG000|Lead-in|Lost to Follow-up|4|||
16326199|NCT03214380|39681503|FG001|Lead-in|Lost to Follow-up|0|||
16326200|NCT03214380|39681504|FG002|Lead-in|Lost to Follow-up|0|||
16326201|NCT03214380|39681505|FG003|Lead-in|Lost to Follow-up|1|||
16207511|NCT01655069|39237264|FG000|Overall Study|Lack of Efficacy|0|||
16326202|NCT03214380|39681506|FG004|Lead-in|Lost to Follow-up|0|||
16326203|NCT03214380|39681507|FG005|Lead-in|Lost to Follow-up|0|||
16326204|NCT03214380|39681502|FG000|Lead-in|Eligibility Criteria|3|||
16326205|NCT03214380|39681503|FG001|Lead-in|Eligibility Criteria|0|||
16326206|NCT03214380|39681504|FG002|Lead-in|Eligibility Criteria|0|||
16326207|NCT03214380|39681505|FG003|Lead-in|Eligibility Criteria|0|||
16326208|NCT03214380|39681506|FG004|Lead-in|Eligibility Criteria|0|||
16326209|NCT03214380|39681507|FG005|Lead-in|Eligibility Criteria|0|||
16326210|NCT03214380|39681502|FG000|Lead-in|Physician Decision|6|||
16326211|NCT03214380|39681503|FG001|Lead-in|Physician Decision|0|||
16326212|NCT03214380|39681504|FG002|Lead-in|Physician Decision|0|||
16326213|NCT03214380|39681505|FG003|Lead-in|Physician Decision|0|||
16326214|NCT03214380|39681506|FG004|Lead-in|Physician Decision|0|||
16326215|NCT03214380|39681507|FG005|Lead-in|Physician Decision|0|||
16326216|NCT03214380|39681502|FG000|Lead-in|Protocol Deviation|7|||
16326217|NCT03214380|39681503|FG001|Lead-in|Protocol Deviation|0|||
16326218|NCT03214380|39681504|FG002|Lead-in|Protocol Deviation|0|||
16326219|NCT03214380|39681505|FG003|Lead-in|Protocol Deviation|3|||
16326220|NCT03214380|39681506|FG004|Lead-in|Protocol Deviation|0|||
16522943|NCT02610140|40383625|FG001|Safety Follow-up|No follow-up|3|||
16522944|NCT02610140|40383624|FG000|Safety Follow-up|Death|12|||
16522945|NCT02610140|40383625|FG001|Safety Follow-up|Death|2|||
16522946|NCT02610140|40383624|FG000|Safety Follow-up|Deterioration of general conditions|15|||
16522947|NCT02610140|40383625|FG001|Safety Follow-up|Deterioration of general conditions|5|||
16522948|NCT02610140|40383624|FG000|Safety Follow-up|Withdrawal by Subject|12|||
16326221|NCT03214380|39681507|FG005|Lead-in|Protocol Deviation|0|||
16522949|NCT02610140|40383625|FG001|Safety Follow-up|Withdrawal by Subject|12|||
16522950|NCT02610140|40383624|FG000|Active Follow-up|Progressive disease - radiological|30|||
16326222|NCT03214380|39681502|FG000|Lead-in|Withdrawal by Subject|41|||
16326223|NCT03214380|39681503|FG001|Lead-in|Withdrawal by Subject|0|||
16326224|NCT03214380|39681504|FG002|Lead-in|Withdrawal by Subject|0|||
16326225|NCT03214380|39681505|FG003|Lead-in|Withdrawal by Subject|14|||
16326226|NCT03214380|39681506|FG004|Lead-in|Withdrawal by Subject|0|||
16326227|NCT03214380|39681507|FG005|Lead-in|Withdrawal by Subject|0|||
16094763|NCT00042939|38836506|FG000|Overall Study|Ineligible|2|||
16094764|NCT00042939|38836507|FG001|Overall Study|Ineligible|2|||
16094765|NCT00042939|38836506|FG000|Overall Study|Deterioration of health|3|||
16094766|NCT00042939|38836507|FG001|Overall Study|Deterioration of health|4|||
16094767|NCT00042939|38836506|FG000|Overall Study|QOL diminished|1|||
16094768|NCT00042939|38836507|FG001|Overall Study|QOL diminished|0|||
16094769|NCT00042939|38836506|FG000|Overall Study|Rising ca 19-9|1|||
16094770|NCT00042939|38836507|FG001|Overall Study|Rising ca 19-9|0|||
16326228|NCT03214380|39681502|FG000|Lead-in|Family Emergency|1|||
16326229|NCT03214380|39681503|FG001|Lead-in|Family Emergency|0|||
16326230|NCT03214380|39681504|FG002|Lead-in|Family Emergency|0|||
16326231|NCT03214380|39681505|FG003|Lead-in|Family Emergency|0|||
16326232|NCT03214380|39681506|FG004|Lead-in|Family Emergency|0|||
16326233|NCT03214380|39681507|FG005|Lead-in|Family Emergency|0|||
16326234|NCT03214380|39681502|FG000|Lead-in|Natural Disaster|9|||
16326235|NCT03214380|39681503|FG001|Lead-in|Natural Disaster|0|||
16396760|NCT01057693|39935288|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
16396761|NCT01057693|39935286|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
16396762|NCT01057693|39935287|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
16396763|NCT01057693|39935288|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
16522951|NCT02610140|40383625|FG001|Active Follow-up|Progressive disease - radiological|22|||
16522952|NCT02610140|40383624|FG000|Active Follow-up|Death|8|||
16522953|NCT02610140|40383625|FG001|Active Follow-up|Death|1|||
16522954|NCT02610140|40383624|FG000|Active Follow-up|Withdrawal by Subject|4|||
16396764|NCT01057693|39935286|FG000|Between Single-Blind and Double-Blind|Other|6|||
16396765|NCT01057693|39935287|FG001|Between Single-Blind and Double-Blind|Other|0|||
16396766|NCT01057693|39935288|FG002|Between Single-Blind and Double-Blind|Other|0|||
16522955|NCT02610140|40383625|FG001|Active Follow-up|Withdrawal by Subject|0|||
16522956|NCT02610140|40383624|FG000|Active Follow-up|Progressive disease - clinical|1|||
16522957|NCT02610140|40383625|FG001|Active Follow-up|Progressive disease - clinical|2|||
16522958|NCT02610140|40383624|FG000|Active Follow-up|Deterioration of general conditions|1|||
16522959|NCT02610140|40383625|FG001|Active Follow-up|Deterioration of general conditions|0|||
16522960|NCT02610140|40383624|FG000|Active Follow-up|Ongoing but not completed|4|||
16522961|NCT02610140|40383625|FG001|Active Follow-up|Ongoing but not completed|1|||
16522962|NCT02610140|40383624|FG000|Long-term Follow-up|Death|86|||
16522963|NCT02610140|40383625|FG001|Long-term Follow-up|Death|44|||
16522964|NCT02610140|40383624|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
16522965|NCT02610140|40383625|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
16522966|NCT02610140|40383624|FG000|Long-term Follow-up|Lost to Follow-up|1|||
16522967|NCT02610140|40383625|FG001|Long-term Follow-up|Lost to Follow-up|2|||
16522968|NCT02610140|40383624|FG000|Long-term Follow-up|Ongoing but not completed|30|||
16522969|NCT02610140|40383625|FG001|Long-term Follow-up|Ongoing but not completed|17|||
16522970|NCT00812812|40383626|FG000|Overall Study|Adverse Event|2|||
16522971|NCT00812812|40383627|FG001|Overall Study|Adverse Event|1|||
16522972|NCT00812812|40383626|FG000|Overall Study|Lack of Efficacy|1|||
16522973|NCT00812812|40383627|FG001|Overall Study|Lack of Efficacy|0|||
16522974|NCT00812812|40383626|FG000|Overall Study|Lost to Follow-up|0|||
16522975|NCT00812812|40383627|FG001|Overall Study|Lost to Follow-up|1|||
16522976|NCT00812812|40383626|FG000|Overall Study|Withdrawal by Subject|0|||
16522977|NCT00812812|40383627|FG001|Overall Study|Withdrawal by Subject|2|||
16094771|NCT00042939|38836506|FG000|Overall Study|Patient non-compliance|1|||
16207512|NCT01655069|39237265|FG001|Overall Study|Lack of Efficacy|1|||
16207513|NCT01655069|39237266|FG002|Overall Study|Lack of Efficacy|0|||
16207514|NCT01655069|39237267|FG003|Overall Study|Lack of Efficacy|0|||
16396767|NCT01057693|39935286|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
16396768|NCT01057693|39935287|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
16522978|NCT00690755|40383628|FG000|Overall Study|Physician Decision|2|||
16522979|NCT00690755|40383629|FG001|Overall Study|Physician Decision|0|||
16522980|NCT00690755|40383630|FG002|Overall Study|Physician Decision|46|||
16522981|NCT00690755|40383631|FG003|Overall Study|Physician Decision|5|||
16094772|NCT00042939|38836507|FG001|Overall Study|Patient non-compliance|0|||
16522982|NCT00690755|40383632|FG004|Overall Study|Physician Decision|0|||
16207515|NCT01655069|39237264|FG000|Overall Study|No Treatment Needed|0|||
16207516|NCT01655069|39237265|FG001|Overall Study|No Treatment Needed|1|||
16326236|NCT03214380|39681504|FG002|Lead-in|Natural Disaster|0|||
16522983|NCT00690755|40383633|FG005|Overall Study|Physician Decision|4|||
16522984|NCT00690755|40383634|FG006|Overall Study|Physician Decision|0|||
16326237|NCT03214380|39681505|FG003|Lead-in|Natural Disaster|0|||
16326238|NCT03214380|39681506|FG004|Lead-in|Natural Disaster|0|||
16326239|NCT03214380|39681507|FG005|Lead-in|Natural Disaster|0|||
16396769|NCT01057693|39935288|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
16396770|NCT01057693|39935286|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
16396771|NCT01057693|39935287|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
16396772|NCT01057693|39935288|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
16396773|NCT01057693|39935286|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
16396774|NCT01057693|39935287|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
16396775|NCT01057693|39935288|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
16396776|NCT01057693|39935286|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
16522985|NCT02120924|40383635|FG000|Overall Study|Lack of Efficacy|1|||
16522986|NCT02120924|40383636|FG001|Overall Study|Lack of Efficacy|2|||
16522987|NCT02120924|40383637|FG002|Overall Study|Lack of Efficacy|3|||
16207517|NCT01655069|39237266|FG002|Overall Study|No Treatment Needed|0|||
16207518|NCT01655069|39237267|FG003|Overall Study|No Treatment Needed|0|||
16522988|NCT02120924|40383635|FG000|Overall Study|Adverse Event|0|||
16522989|NCT02120924|40383636|FG001|Overall Study|Adverse Event|1|||
16522990|NCT02120924|40383637|FG002|Overall Study|Adverse Event|3|||
16522991|NCT02120924|40383635|FG000|Overall Study|Withdrawal by Subject|16|||
16522992|NCT02120924|40383636|FG001|Overall Study|Withdrawal by Subject|20|||
16522993|NCT02120924|40383637|FG002|Overall Study|Withdrawal by Subject|8|||
16522994|NCT02120924|40383635|FG000|Overall Study|Lost to Follow-up|14|||
16522995|NCT02120924|40383636|FG001|Overall Study|Lost to Follow-up|14|||
16522996|NCT02120924|40383637|FG002|Overall Study|Lost to Follow-up|11|||
16522997|NCT02120924|40383635|FG000|Overall Study|Pregnancy|2|||
16522998|NCT02120924|40383636|FG001|Overall Study|Pregnancy|0|||
16522999|NCT02120924|40383637|FG002|Overall Study|Pregnancy|0|||
16523000|NCT02120924|40383635|FG000|Overall Study|Protocol Violation|3|||
16523001|NCT02120924|40383636|FG001|Overall Study|Protocol Violation|7|||
16523002|NCT02120924|40383637|FG002|Overall Study|Protocol Violation|2|||
16523003|NCT02120924|40383635|FG000|Overall Study|Physician Decision|0|||
16523004|NCT02120924|40383636|FG001|Overall Study|Physician Decision|1|||
16523005|NCT02120924|40383637|FG002|Overall Study|Physician Decision|1|||
16523006|NCT02120924|40383635|FG000|Overall Study|Death|1|||
16523007|NCT02120924|40383636|FG001|Overall Study|Death|0|||
16523008|NCT02120924|40383637|FG002|Overall Study|Death|0|||
16523009|NCT02120924|40383635|FG000|Overall Study|Compliance with IP|5|||
16523010|NCT02120924|40383636|FG001|Overall Study|Compliance with IP|1|||
16207519|NCT01655069|39237264|FG000|Overall Study|Withdrawal by Subject|2|||
16207520|NCT01655069|39237265|FG001|Overall Study|Withdrawal by Subject|3|||
16523011|NCT02120924|40383637|FG002|Overall Study|Compliance with IP|1|||
16523012|NCT04354831|40383638|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
16523013|NCT04354831|40383639|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
16523014|NCT02066298|40383640|FG000|Overall Study|Lost to Follow-up|3|||
16523015|NCT02066298|40383641|FG001|Overall Study|Lost to Follow-up|2|||
16523016|NCT02066298|40383642|FG002|Overall Study|Lost to Follow-up|3|||
16523017|NCT02066298|40383643|FG003|Overall Study|Lost to Follow-up|2|||
16523018|NCT02066298|40383644|FG004|Overall Study|Lost to Follow-up|3|||
16207521|NCT01655069|39237266|FG002|Overall Study|Withdrawal by Subject|0|||
16523019|NCT02066298|40383645|FG005|Overall Study|Lost to Follow-up|4|||
16523020|NCT02066298|40383640|FG000|Overall Study|Withdrawal by Subject|6|||
16523021|NCT02066298|40383641|FG001|Overall Study|Withdrawal by Subject|6|||
16523022|NCT02066298|40383642|FG002|Overall Study|Withdrawal by Subject|6|||
16523023|NCT02066298|40383643|FG003|Overall Study|Withdrawal by Subject|4|||
16523024|NCT02066298|40383644|FG004|Overall Study|Withdrawal by Subject|5|||
16523025|NCT02066298|40383645|FG005|Overall Study|Withdrawal by Subject|8|||
16523026|NCT02066298|40383640|FG000|Overall Study|Physician Decision|0|||
16326240|NCT03214380|39681502|FG000|Lead-in|Non Compliance|1|||
16396777|NCT01057693|39935287|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
16396778|NCT01057693|39935288|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
16396779|NCT01057693|39935286|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
16396780|NCT01057693|39935287|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
16396781|NCT01057693|39935288|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
16396782|NCT01057693|39935286|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
16396783|NCT01057693|39935287|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
16396784|NCT01057693|39935288|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
16396785|NCT01057693|39935286|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
16396786|NCT01057693|39935287|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
16396787|NCT01057693|39935288|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
16396788|NCT00344318|39935289|FG000|Overall Study|Adverse Event|0|||
16523027|NCT02066298|40383641|FG001|Overall Study|Physician Decision|0|||
16523028|NCT02066298|40383642|FG002|Overall Study|Physician Decision|1|||
16523029|NCT02066298|40383643|FG003|Overall Study|Physician Decision|0|||
16326241|NCT03214380|39681503|FG001|Lead-in|Non Compliance|0|||
16326242|NCT03214380|39681504|FG002|Lead-in|Non Compliance|0|||
16326243|NCT03214380|39681505|FG003|Lead-in|Non Compliance|0|||
16326244|NCT03214380|39681506|FG004|Lead-in|Non Compliance|0|||
16326245|NCT03214380|39681507|FG005|Lead-in|Non Compliance|0|||
16326246|NCT03214380|39681502|FG000|Lead-in|Participant Schedule|2|||
16326247|NCT03214380|39681503|FG001|Lead-in|Participant Schedule|0|||
16326248|NCT03214380|39681504|FG002|Lead-in|Participant Schedule|0|||
16326249|NCT03214380|39681505|FG003|Lead-in|Participant Schedule|0|||
16326250|NCT03214380|39681506|FG004|Lead-in|Participant Schedule|0|||
16326251|NCT03214380|39681507|FG005|Lead-in|Participant Schedule|0|||
16326252|NCT03214380|39681502|FG000|Treatment Period|Adverse Event|0|||
16326253|NCT03214380|39681503|FG001|Treatment Period|Adverse Event|1|||
16326254|NCT03214380|39681504|FG002|Treatment Period|Adverse Event|1|||
16326255|NCT03214380|39681505|FG003|Treatment Period|Adverse Event|0|||
16326256|NCT03214380|39681506|FG004|Treatment Period|Adverse Event|1|||
16326257|NCT03214380|39681507|FG005|Treatment Period|Adverse Event|0|||
16326258|NCT03214380|39681502|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
16326259|NCT03214380|39681503|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
16326260|NCT03214380|39681504|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
16396789|NCT00344318|39935290|FG001|Overall Study|Adverse Event|3|||
16396790|NCT00344318|39935291|FG002|Overall Study|Adverse Event|0|||
16396791|NCT00344318|39935292|FG003|Overall Study|Adverse Event|1|||
16396792|NCT00344318|39935289|FG000|Overall Study|Withdrawal by Subject|2|||
16396793|NCT00344318|39935290|FG001|Overall Study|Withdrawal by Subject|2|||
16396794|NCT00344318|39935291|FG002|Overall Study|Withdrawal by Subject|0|||
16396795|NCT00344318|39935292|FG003|Overall Study|Withdrawal by Subject|2|||
16396796|NCT00344318|39935289|FG000|Overall Study|Lost to Follow-up|2|||
16396797|NCT00344318|39935290|FG001|Overall Study|Lost to Follow-up|0|||
16396798|NCT00344318|39935291|FG002|Overall Study|Lost to Follow-up|1|||
16396799|NCT00344318|39935292|FG003|Overall Study|Lost to Follow-up|0|||
16396800|NCT01734785|39935293|FG000|Open-Label Period|Adverse Event|0|||
16396801|NCT01734785|39935294|FG001|Open-Label Period|Adverse Event|0|||
16396802|NCT01734785|39935295|FG002|Open-Label Period|Adverse Event|0|||
16396803|NCT01734785|39935296|FG003|Open-Label Period|Adverse Event|9|||
16396804|NCT01734785|39935293|FG000|Open-Label Period|Lack of Efficacy|0|||
16396805|NCT01734785|39935294|FG001|Open-Label Period|Lack of Efficacy|0|||
16396806|NCT01734785|39935295|FG002|Open-Label Period|Lack of Efficacy|0|||
16396807|NCT01734785|39935296|FG003|Open-Label Period|Lack of Efficacy|1|||
16396808|NCT01734785|39935293|FG000|Open-Label Period|Protocol Violation|0|||
16396809|NCT01734785|39935294|FG001|Open-Label Period|Protocol Violation|0|||
16396810|NCT01734785|39935295|FG002|Open-Label Period|Protocol Violation|0|||
16396811|NCT01734785|39935296|FG003|Open-Label Period|Protocol Violation|13|||
16396812|NCT01734785|39935293|FG000|Open-Label Period|Lost to Follow-up|0|||
16396813|NCT01734785|39935294|FG001|Open-Label Period|Lost to Follow-up|0|||
16396814|NCT01734785|39935295|FG002|Open-Label Period|Lost to Follow-up|0|||
16396815|NCT01734785|39935296|FG003|Open-Label Period|Lost to Follow-up|14|||
16396816|NCT01734785|39935293|FG000|Open-Label Period|Withdrawal by Subject|0|||
16396817|NCT01734785|39935294|FG001|Open-Label Period|Withdrawal by Subject|0|||
16396818|NCT01734785|39935295|FG002|Open-Label Period|Withdrawal by Subject|0|||
16396819|NCT01734785|39935296|FG003|Open-Label Period|Withdrawal by Subject|12|||
16396820|NCT01734785|39935293|FG000|Open-Label Period|Other Reasons|0|||
16396821|NCT01734785|39935294|FG001|Open-Label Period|Other Reasons|0|||
16396822|NCT01734785|39935295|FG002|Open-Label Period|Other Reasons|0|||
16523030|NCT02066298|40383644|FG004|Overall Study|Physician Decision|1|||
16523031|NCT02066298|40383645|FG005|Overall Study|Physician Decision|0|||
16326261|NCT03214380|39681505|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
16326262|NCT03214380|39681506|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
16326263|NCT03214380|39681507|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
16326264|NCT03214380|39681502|FG000|Treatment Period|Withdrawal by Subject|0|||
16396823|NCT01734785|39935296|FG003|Open-Label Period|Other Reasons|224|||
16396824|NCT01734785|39935293|FG000|Double-Blind Period|Adverse Event|0|||
16396825|NCT01734785|39935294|FG001|Double-Blind Period|Adverse Event|3|||
16396826|NCT01734785|39935295|FG002|Double-Blind Period|Adverse Event|2|||
16396827|NCT01734785|39935296|FG003|Double-Blind Period|Adverse Event|0|||
16396828|NCT01734785|39935293|FG000|Double-Blind Period|Lack of Efficacy|0|||
16396829|NCT01734785|39935294|FG001|Double-Blind Period|Lack of Efficacy|1|||
16396830|NCT01734785|39935295|FG002|Double-Blind Period|Lack of Efficacy|0|||
16396831|NCT01734785|39935296|FG003|Double-Blind Period|Lack of Efficacy|0|||
16396832|NCT01734785|39935293|FG000|Double-Blind Period|Protocol Violation|0|||
16326265|NCT03214380|39681503|FG001|Treatment Period|Withdrawal by Subject|10|||
16326266|NCT03214380|39681504|FG002|Treatment Period|Withdrawal by Subject|8|||
16326267|NCT03214380|39681505|FG003|Treatment Period|Withdrawal by Subject|0|||
16326268|NCT03214380|39681506|FG004|Treatment Period|Withdrawal by Subject|7|||
16326269|NCT03214380|39681507|FG005|Treatment Period|Withdrawal by Subject|11|||
16326270|NCT03214380|39681502|FG000|Treatment Period|Death|0|||
16326271|NCT03214380|39681503|FG001|Treatment Period|Death|1|||
16326272|NCT03214380|39681504|FG002|Treatment Period|Death|2|||
16326273|NCT03214380|39681505|FG003|Treatment Period|Death|0|||
16326274|NCT03214380|39681506|FG004|Treatment Period|Death|0|||
16326275|NCT03214380|39681507|FG005|Treatment Period|Death|0|||
16326276|NCT03214380|39681502|FG000|Treatment Period|Lost to Follow-up|0|||
16326277|NCT03214380|39681503|FG001|Treatment Period|Lost to Follow-up|6|||
16326278|NCT03214380|39681504|FG002|Treatment Period|Lost to Follow-up|3|||
16326279|NCT03214380|39681505|FG003|Treatment Period|Lost to Follow-up|0|||
16326280|NCT03214380|39681506|FG004|Treatment Period|Lost to Follow-up|0|||
16326281|NCT03214380|39681507|FG005|Treatment Period|Lost to Follow-up|0|||
16326282|NCT03214380|39681502|FG000|Treatment Period|Participant schedule|0|||
16326283|NCT03214380|39681503|FG001|Treatment Period|Participant schedule|0|||
16326284|NCT03214380|39681504|FG002|Treatment Period|Participant schedule|1|||
16326285|NCT03214380|39681505|FG003|Treatment Period|Participant schedule|0|||
16396833|NCT01734785|39935294|FG001|Double-Blind Period|Protocol Violation|1|||
16396834|NCT01734785|39935295|FG002|Double-Blind Period|Protocol Violation|1|||
16396835|NCT01734785|39935296|FG003|Double-Blind Period|Protocol Violation|0|||
16396836|NCT01734785|39935293|FG000|Double-Blind Period|Lost to Follow-up|2|||
16396837|NCT01734785|39935294|FG001|Double-Blind Period|Lost to Follow-up|4|||
16396838|NCT01734785|39935295|FG002|Double-Blind Period|Lost to Follow-up|2|||
16207522|NCT01655069|39237267|FG003|Overall Study|Withdrawal by Subject|0|||
16207523|NCT00646113|39237268|FG000|Overall Study|Lost to Follow-up|5|||
16207524|NCT00646113|39237268|FG000|Overall Study|Adverse Event|3|||
16396839|NCT01734785|39935296|FG003|Double-Blind Period|Lost to Follow-up|0|||
16207525|NCT00770224|39237269|FG000|Step 1: Induction|Adverse Event|3|||
16207526|NCT00770224|39237270|FG001|Step 1: Induction|Adverse Event|0|||
16396840|NCT01734785|39935293|FG000|Double-Blind Period|Withdrawal by Subject|2|||
16326286|NCT03214380|39681506|FG004|Treatment Period|Participant schedule|0|||
16326287|NCT03214380|39681507|FG005|Treatment Period|Participant schedule|0|||
16326288|NCT03214380|39681502|FG000|Treatment Period|Treatment Interruption|0|||
16396841|NCT01734785|39935294|FG001|Double-Blind Period|Withdrawal by Subject|0|||
16207527|NCT00770224|39237269|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
16094773|NCT00042939|38836506|FG000|Overall Study|Still on treatment|1|||
16523032|NCT03465540|40383646|FG000|Overall Study|Withdrawal by Subject|0|||
16523033|NCT03465540|40383647|FG001|Overall Study|Withdrawal by Subject|0|||
16523034|NCT03465540|40383648|FG002|Overall Study|Withdrawal by Subject|1|||
16523035|NCT03465540|40383649|FG003|Overall Study|Withdrawal by Subject|1|||
16523036|NCT03465540|40383650|FG004|Overall Study|Withdrawal by Subject|1|||
16523037|NCT03465540|40383651|FG005|Overall Study|Withdrawal by Subject|0|||
16523038|NCT03465540|40383646|FG000|Overall Study|Lost to Follow-up|0|||
16523039|NCT03465540|40383647|FG001|Overall Study|Lost to Follow-up|1|||
16523040|NCT03465540|40383648|FG002|Overall Study|Lost to Follow-up|0|||
16523041|NCT03465540|40383649|FG003|Overall Study|Lost to Follow-up|0|||
16523042|NCT03465540|40383650|FG004|Overall Study|Lost to Follow-up|1|||
16523043|NCT03465540|40383651|FG005|Overall Study|Lost to Follow-up|0|||
16094774|NCT00042939|38836507|FG001|Overall Study|Still on treatment|0|||
16094775|NCT00042939|38836506|FG000|Overall Study|Treatment break > 4 weeks|0|||
16094776|NCT00042939|38836507|FG001|Overall Study|Treatment break > 4 weeks|1|||
16094777|NCT00042939|38836506|FG000|Overall Study|Did not start treatment|2|||
16094778|NCT00042939|38836507|FG001|Overall Study|Did not start treatment|1|||
16094779|NCT00304278|38836508|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
16094780|NCT00304278|38836508|FG000|Overall Study|PT had medical condition preventing TX|1|||
16094781|NCT00936065|38836509|FG000|Overall Study|Adverse Event|1|||
16094782|NCT00936065|38836510|FG001|Overall Study|Adverse Event|0|||
16094783|NCT00936065|38836511|FG002|Overall Study|Adverse Event|1|||
16094784|NCT00936065|38836509|FG000|Overall Study|Lack of Efficacy|1|||
16094785|NCT00936065|38836510|FG001|Overall Study|Lack of Efficacy|0|||
16094786|NCT00936065|38836511|FG002|Overall Study|Lack of Efficacy|1|||
16094787|NCT00936065|38836509|FG000|Overall Study|Lost to Follow-up|1|||
16094788|NCT00936065|38836510|FG001|Overall Study|Lost to Follow-up|0|||
16094789|NCT00936065|38836511|FG002|Overall Study|Lost to Follow-up|0|||
16094790|NCT00936065|38836509|FG000|Overall Study|Protocol Violation|1|||
16094791|NCT00936065|38836510|FG001|Overall Study|Protocol Violation|2|||
16094792|NCT00936065|38836511|FG002|Overall Study|Protocol Violation|1|||
16094793|NCT00936065|38836509|FG000|Overall Study|Withdrawal by Subject|0|||
16094794|NCT00936065|38836510|FG001|Overall Study|Withdrawal by Subject|2|||
16094795|NCT00936065|38836511|FG002|Overall Study|Withdrawal by Subject|4|||
16094796|NCT01322386|38836512|FG000|Overall Study|Protocol Violation|0|||
16094797|NCT01322386|38836513|FG001|Overall Study|Protocol Violation|1|||
16094798|NCT01322386|38836512|FG000|Overall Study|Physician Decision|0|||
16094799|NCT01322386|38836513|FG001|Overall Study|Physician Decision|1|||
16094800|NCT02660086|38836514|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
16094801|NCT02660086|38836515|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
16094802|NCT02660086|38836514|FG000|Overall Study- 12-month|Left full-time employment|12|||
16094803|NCT02660086|38836515|FG001|Overall Study- 12-month|Left full-time employment|20|||
16094804|NCT02660086|38836514|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
16094805|NCT02660086|38836515|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
16094806|NCT02660086|38836514|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
16094807|NCT02660086|38836515|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
16094808|NCT02660086|38836514|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
16094809|NCT02660086|38836515|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
16094810|NCT02660086|38836514|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
16094811|NCT02660086|38836515|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
16094812|NCT02135445|38836516|FG000|Overall Study|Lost to Follow-up|1|||
16094813|NCT02135445|38836517|FG001|Overall Study|Lost to Follow-up|0|||
16094814|NCT02135445|38836516|FG000|Overall Study|Withdrawal by Subject|1|||
16094815|NCT02135445|38836517|FG001|Overall Study|Withdrawal by Subject|0|||
16094816|NCT00668746|38836518|FG000|Overall Study|Lost to Follow-up|2|||
16094817|NCT00668746|38836519|FG001|Overall Study|Lost to Follow-up|1|||
16094818|NCT01102426|38836525|FG000|Overall Study|Randomized but not treated|4|||
16094819|NCT01102426|38836526|FG001|Overall Study|Randomized but not treated|1|||
16094820|NCT01102426|38836525|FG000|Overall Study|Adverse Events (treatment-related)|15|||
16094821|NCT01102426|38836526|FG001|Overall Study|Adverse Events (treatment-related)|8|||
16094822|NCT01102426|38836525|FG000|Overall Study|Physician Decision|9|||
16094823|NCT01102426|38836526|FG001|Overall Study|Physician Decision|6|||
16094824|NCT01102426|38836525|FG000|Overall Study|Progressive Disease|85|||
16094825|NCT01102426|38836526|FG001|Overall Study|Progressive Disease|44|||
16094826|NCT01102426|38836525|FG000|Overall Study|Adverse Events (unrelated to|9|||
16523044|NCT03465540|40383646|FG000|Overall Study|Death|1|||
16094827|NCT01102426|38836526|FG001|Overall Study|Adverse Events (unrelated to|1|||
16094828|NCT01102426|38836525|FG000|Overall Study|Patient Refusal|24|||
16094829|NCT01102426|38836526|FG001|Overall Study|Patient Refusal|12|||
16094830|NCT01102426|38836525|FG000|Overall Study|Death (due to adverse events|0|||
16094831|NCT01102426|38836526|FG001|Overall Study|Death (due to adverse events|1|||
16094832|NCT01102426|38836525|FG000|Overall Study|Death (non-related to the study|19|||
16523045|NCT03465540|40383647|FG001|Overall Study|Death|1|||
16523046|NCT03465540|40383648|FG002|Overall Study|Death|0|||
16523047|NCT03465540|40383649|FG003|Overall Study|Death|2|||
16094833|NCT01102426|38836526|FG001|Overall Study|Death (non-related to the study|8|||
16094834|NCT02825550|38836529|FG000|Overall Study|Physician Decision|1|||
16094835|NCT00813709|38836536|FG000|Double Blind Period|Adverse Event|4|||
16094836|NCT00813709|38836537|FG001|Double Blind Period|Adverse Event|1|||
16094837|NCT00813709|38836538|FG002|Double Blind Period|Adverse Event|4|||
16094838|NCT00813709|38836539|FG003|Double Blind Period|Adverse Event|0|||
16094839|NCT00813709|38836540|FG004|Double Blind Period|Adverse Event|0|||
16094840|NCT00813709|38836541|FG005|Double Blind Period|Adverse Event|0|||
16094841|NCT00813709|38836536|FG000|Double Blind Period|Lost to Follow-up|3|||
16094842|NCT00813709|38836537|FG001|Double Blind Period|Lost to Follow-up|2|||
16094843|NCT00813709|38836538|FG002|Double Blind Period|Lost to Follow-up|2|||
16094844|NCT00813709|38836539|FG003|Double Blind Period|Lost to Follow-up|0|||
16094845|NCT00813709|38836540|FG004|Double Blind Period|Lost to Follow-up|0|||
16094846|NCT00813709|38836541|FG005|Double Blind Period|Lost to Follow-up|0|||
16094847|NCT00813709|38836536|FG000|Double Blind Period|Switched to open label phase|9|||
16094848|NCT00813709|38836537|FG001|Double Blind Period|Switched to open label phase|26|||
16094849|NCT00813709|38836538|FG002|Double Blind Period|Switched to open label phase|18|||
16094850|NCT00813709|38836539|FG003|Double Blind Period|Switched to open label phase|0|||
16094851|NCT00813709|38836540|FG004|Double Blind Period|Switched to open label phase|0|||
16094852|NCT00813709|38836541|FG005|Double Blind Period|Switched to open label phase|0|||
16094853|NCT00813709|38836536|FG000|Double Blind Period|Randomized but not treated|1|||
16094854|NCT00813709|38836537|FG001|Double Blind Period|Randomized but not treated|3|||
16094855|NCT00813709|38836538|FG002|Double Blind Period|Randomized but not treated|1|||
16094856|NCT00813709|38836539|FG003|Double Blind Period|Randomized but not treated|0|||
16094857|NCT00813709|38836540|FG004|Double Blind Period|Randomized but not treated|0|||
16094858|NCT00813709|38836541|FG005|Double Blind Period|Randomized but not treated|0|||
16094859|NCT00813709|38836536|FG000|Double Blind Period|Other|14|||
16094860|NCT00813709|38836537|FG001|Double Blind Period|Other|9|||
16094861|NCT00813709|38836538|FG002|Double Blind Period|Other|6|||
16207528|NCT00770224|39237270|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
16207529|NCT00770224|39237269|FG000|Step 1: Induction|Other reason not protocol specified|2|||
16207530|NCT00770224|39237270|FG001|Step 1: Induction|Other reason not protocol specified|0|||
16207531|NCT00770224|39237269|FG000|Step 1: Induction|Ineligible|2|||
16207532|NCT00770224|39237270|FG001|Step 1: Induction|Ineligible|0|||
16207533|NCT00770224|39237269|FG000|Step 1: Induction|No protocol treatment given|1|||
16207534|NCT00770224|39237270|FG001|Step 1: Induction|No protocol treatment given|0|||
16207535|NCT00770224|39237269|FG000|Step 2: Maintenance|Adverse Event|0|||
16207536|NCT00770224|39237270|FG001|Step 2: Maintenance|Adverse Event|10|||
16207537|NCT00770224|39237269|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
16207538|NCT00770224|39237270|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
16207539|NCT00770224|39237269|FG000|Step 2: Maintenance|Progression/relapse|0|||
16207540|NCT00770224|39237270|FG001|Step 2: Maintenance|Progression/relapse|1|||
16207541|NCT00770224|39237269|FG000|Step 2: Maintenance|Death|0|||
16207542|NCT00770224|39237270|FG001|Step 2: Maintenance|Death|2|||
16207543|NCT00770224|39237269|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
16207544|NCT00770224|39237270|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
16207545|NCT00770224|39237269|FG000|Step 2: Maintenance|Ineligible|0|||
16207546|NCT00770224|39237270|FG001|Step 2: Maintenance|Ineligible|2|||
16207547|NCT03077243|39237271|FG000|Overall Study|Death|1|||
16207548|NCT03077243|39237272|FG001|Overall Study|Death|2|||
16207549|NCT03077243|39237273|FG002|Overall Study|Death|0|||
16207550|NCT03077243|39237274|FG003|Overall Study|Death|0|||
16207551|NCT03077243|39237271|FG000|Overall Study|Withdrawal by Subject|1|||
16207552|NCT03077243|39237272|FG001|Overall Study|Withdrawal by Subject|3|||
16207553|NCT03077243|39237273|FG002|Overall Study|Withdrawal by Subject|0|||
16207554|NCT03077243|39237274|FG003|Overall Study|Withdrawal by Subject|0|||
16207555|NCT03077243|39237271|FG000|Overall Study|Physician Decision|1|||
16207556|NCT03077243|39237272|FG001|Overall Study|Physician Decision|0|||
16207557|NCT03077243|39237273|FG002|Overall Study|Physician Decision|0|||
16207558|NCT03077243|39237274|FG003|Overall Study|Physician Decision|0|||
16207559|NCT03077243|39237271|FG000|Overall Study|Research at two study sites terminated early|0|||
16207560|NCT03077243|39237272|FG001|Overall Study|Research at two study sites terminated early|0|||
16207561|NCT03077243|39237273|FG002|Overall Study|Research at two study sites terminated early|0|||
16207562|NCT03077243|39237274|FG003|Overall Study|Research at two study sites terminated early|69|||
16207563|NCT00510068|39237275|FG000|Double-blind Period|Disease progression|98|||
16523048|NCT03465540|40383650|FG004|Overall Study|Death|0|||
16094862|NCT00813709|38836539|FG003|Double Blind Period|Other|0|||
16094863|NCT00813709|38836540|FG004|Double Blind Period|Other|0|||
16094864|NCT00813709|38836541|FG005|Double Blind Period|Other|0|||
16094865|NCT00813709|38836536|FG000|Open Label Period|Adverse Event|0|||
16094866|NCT00813709|38836537|FG001|Open Label Period|Adverse Event|0|||
16207564|NCT00510068|39237276|FG001|Double-blind Period|Disease progression|169|||
16207565|NCT00510068|39237275|FG000|Double-blind Period|Final primary analysis|52|||
16207566|NCT00510068|39237276|FG001|Double-blind Period|Final primary analysis|18|||
16207567|NCT00510068|39237275|FG000|Double-blind Period|Adverse Event|37|||
16523049|NCT03465540|40383651|FG005|Overall Study|Death|2|||
16207568|NCT00510068|39237276|FG001|Double-blind Period|Adverse Event|7|||
16207569|NCT00510068|39237275|FG000|Double-blind Period|Withdrawal by Subject|8|||
16207570|NCT00510068|39237276|FG001|Double-blind Period|Withdrawal by Subject|6|||
16207571|NCT00510068|39237275|FG000|Double-blind Period|Death|4|||
16207572|NCT00510068|39237276|FG001|Double-blind Period|Death|3|||
16207573|NCT00510068|39237275|FG000|Double-blind Period|Abnormal test result (s)|1|||
16207574|NCT00510068|39237276|FG001|Double-blind Period|Abnormal test result (s)|0|||
16207575|NCT00510068|39237275|FG000|Double-blind Period|Lost to Follow-up|1|||
16207576|NCT00510068|39237276|FG001|Double-blind Period|Lost to Follow-up|0|||
16207577|NCT00510068|39237275|FG000|Double-blind Period|Protocol Violation|6|||
16523050|NCT03465540|40383646|FG000|Overall Study|Protocol specified criteria|0|||
16523051|NCT03465540|40383647|FG001|Overall Study|Protocol specified criteria|2|||
16523052|NCT03465540|40383648|FG002|Overall Study|Protocol specified criteria|2|||
16523053|NCT03465540|40383649|FG003|Overall Study|Protocol specified criteria|0|||
16523054|NCT03465540|40383650|FG004|Overall Study|Protocol specified criteria|2|||
16523055|NCT03465540|40383651|FG005|Overall Study|Protocol specified criteria|0|||
16523056|NCT00022516|40383654|FG000|Overall Study|Adverse Event|0|||
16523057|NCT00022516|40383655|FG001|Overall Study|Adverse Event|59|||
16523058|NCT00022516|40383654|FG000|Overall Study|Lack of Efficacy|0|||
16523059|NCT00022516|40383655|FG001|Overall Study|Lack of Efficacy|27|||
16523060|NCT00022516|40383654|FG000|Overall Study|Physician Decision|0|||
16523061|NCT00022516|40383655|FG001|Overall Study|Physician Decision|1|||
16523062|NCT00022516|40383654|FG000|Overall Study|Protocol Violation|1|||
16523063|NCT00022516|40383655|FG001|Overall Study|Protocol Violation|3|||
16523064|NCT00022516|40383654|FG000|Overall Study|Withdrawal by Subject|2|||
16523065|NCT00022516|40383655|FG001|Overall Study|Withdrawal by Subject|113|||
16523066|NCT00022516|40383654|FG000|Overall Study|Incomplete documentation|0|||
16523067|NCT00022516|40383655|FG001|Overall Study|Incomplete documentation|27|||
16523068|NCT04382326|40383656|FG000|Overall Study|Adverse Event, not serious|1|||
16523069|NCT04382326|40383657|FG001|Overall Study|Adverse Event, not serious|2|||
16523070|NCT04382326|40383656|FG000|Overall Study|Other|1|||
16523071|NCT04382326|40383657|FG001|Overall Study|Other|0|||
16523072|NCT04382326|40383656|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
16523073|NCT04382326|40383657|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
16523074|NCT04382326|40383656|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
16523075|NCT04382326|40383657|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
16523076|NCT04382326|40383656|FG000|Overall Study|Protocol Violation|29|||
16523077|NCT04382326|40383657|FG001|Overall Study|Protocol Violation|23|||
16523078|NCT04382326|40383656|FG000|Overall Study|Physician Decision|0|||
16523079|NCT04382326|40383657|FG001|Overall Study|Physician Decision|1|||
16523080|NCT04382326|40383656|FG000|Overall Study|Lost to Follow-up|48|||
16523081|NCT04382326|40383657|FG001|Overall Study|Lost to Follow-up|63|||
16523082|NCT04382326|40383656|FG000|Overall Study|Adverse Event, non-fatal|1|||
16523083|NCT04382326|40383657|FG001|Overall Study|Adverse Event, non-fatal|1|||
16523084|NCT02199691|40383658|FG000|Overall Study|Protocol Violation|3|||
16523085|NCT02199691|40383659|FG001|Overall Study|Protocol Violation|3|||
16523086|NCT02199691|40383660|FG002|Overall Study|Protocol Violation|6|||
16523087|NCT02199691|40383661|FG003|Overall Study|Protocol Violation|7|||
16523088|NCT02199691|40383658|FG000|Overall Study|Withdrawal by Subject|5|||
16523089|NCT02199691|40383659|FG001|Overall Study|Withdrawal by Subject|3|||
16523090|NCT02199691|40383660|FG002|Overall Study|Withdrawal by Subject|12|||
16523091|NCT02199691|40383661|FG003|Overall Study|Withdrawal by Subject|13|||
16523092|NCT02199691|40383658|FG000|Overall Study|Lost to Follow-up|2|||
16523093|NCT02199691|40383659|FG001|Overall Study|Lost to Follow-up|1|||
16523094|NCT02199691|40383660|FG002|Overall Study|Lost to Follow-up|9|||
16523095|NCT02199691|40383661|FG003|Overall Study|Lost to Follow-up|10|||
16523096|NCT04726709|40383662|FG000|Overall Study|Withdrawal by Subject|2|||
16523097|NCT04726709|40383663|FG001|Overall Study|Withdrawal by Subject|2|||
16523098|NCT01344460|40383672|FG000|Overall Study|Withdrawal by Subject|1|||
16523099|NCT01344460|40383672|FG000|Overall Study|Lost to Follow-up|2|||
16523100|NCT02096835|40383673|FG000|Overall Study|Withdrawal by Subject|1|||
16523101|NCT02096835|40383674|FG001|Overall Study|Withdrawal by Subject|0|||
16523102|NCT02096835|40383675|FG002|Overall Study|Withdrawal by Subject|0|||
16523103|NCT02096835|40383673|FG000|Overall Study|converted to open procedures|1|||
16523104|NCT02096835|40383674|FG001|Overall Study|converted to open procedures|0|||
16207578|NCT00510068|39237276|FG001|Double-blind Period|Protocol Violation|0|||
16523105|NCT02096835|40383675|FG002|Overall Study|converted to open procedures|0|||
16523106|NCT02096835|40383673|FG000|Overall Study|Lost to Follow-up|1|||
16523107|NCT02096835|40383674|FG001|Overall Study|Lost to Follow-up|0|||
16523108|NCT02096835|40383675|FG002|Overall Study|Lost to Follow-up|1|||
16523109|NCT00660010|40383676|FG000|Overall Study|Withdrawal by Subject|2|||
16523110|NCT00660010|40383676|FG000|Overall Study|Lost to Follow-up|3|||
16523111|NCT00660010|40383676|FG000|Overall Study|Adverse Event|1|||
16207579|NCT00510068|39237275|FG000|Open-label Period|Disease Progression|124|||
16523112|NCT00660010|40383676|FG000|Overall Study|Noncompliance with visit schedule|3|||
16523113|NCT01060384|40383677|FG000|Overall Study|Withdrawal by Subject|0|||
16523114|NCT01060384|40383678|FG001|Overall Study|Withdrawal by Subject|1|||
16094867|NCT00813709|38836538|FG002|Open Label Period|Adverse Event|0|||
16094868|NCT00813709|38836539|FG003|Open Label Period|Adverse Event|5|||
16094869|NCT00813709|38836540|FG004|Open Label Period|Adverse Event|4|||
16094870|NCT00813709|38836541|FG005|Open Label Period|Adverse Event|3|||
16094871|NCT00813709|38836536|FG000|Open Label Period|Lack of Efficacy|0|||
16094872|NCT00813709|38836537|FG001|Open Label Period|Lack of Efficacy|0|||
16094873|NCT00813709|38836538|FG002|Open Label Period|Lack of Efficacy|0|||
16094874|NCT00813709|38836539|FG003|Open Label Period|Lack of Efficacy|3|||
16094875|NCT00813709|38836540|FG004|Open Label Period|Lack of Efficacy|1|||
16094876|NCT00813709|38836541|FG005|Open Label Period|Lack of Efficacy|1|||
16094877|NCT00813709|38836536|FG000|Open Label Period|Randomized but not treated|0|||
16094878|NCT00813709|38836537|FG001|Open Label Period|Randomized but not treated|0|||
16094879|NCT00813709|38836538|FG002|Open Label Period|Randomized but not treated|0|||
16094880|NCT00813709|38836539|FG003|Open Label Period|Randomized but not treated|1|||
16094881|NCT00813709|38836540|FG004|Open Label Period|Randomized but not treated|0|||
16094882|NCT00813709|38836541|FG005|Open Label Period|Randomized but not treated|1|||
16094883|NCT00813709|38836536|FG000|Open Label Period|Other|0|||
16094884|NCT00813709|38836537|FG001|Open Label Period|Other|0|||
16094885|NCT00813709|38836538|FG002|Open Label Period|Other|0|||
16094886|NCT00813709|38836539|FG003|Open Label Period|Other|11|||
16094887|NCT00813709|38836540|FG004|Open Label Period|Other|5|||
16094888|NCT00813709|38836541|FG005|Open Label Period|Other|6|||
16094889|NCT02092909|38836542|FG000|Overall Study|Adverse Event|0|||
16094890|NCT02092909|38836543|FG001|Overall Study|Adverse Event|0|||
16094891|NCT02092909|38836544|FG002|Overall Study|Adverse Event|4|||
16094892|NCT02092909|38836545|FG003|Overall Study|Adverse Event|2|||
16094893|NCT02092909|38836542|FG000|Overall Study|Lack of Efficacy|0|||
16094894|NCT02092909|38836543|FG001|Overall Study|Lack of Efficacy|2|||
16094895|NCT02092909|38836544|FG002|Overall Study|Lack of Efficacy|1|||
16094896|NCT02092909|38836545|FG003|Overall Study|Lack of Efficacy|0|||
16094897|NCT02092909|38836542|FG000|Overall Study|Withdrawal by Subject|0|||
16094898|NCT02092909|38836543|FG001|Overall Study|Withdrawal by Subject|0|||
16094899|NCT02092909|38836544|FG002|Overall Study|Withdrawal by Subject|2|||
16094900|NCT02092909|38836545|FG003|Overall Study|Withdrawal by Subject|1|||
16094901|NCT02092909|38836542|FG000|Overall Study|Study terminated by Sponsor|0|||
16094902|NCT02092909|38836543|FG001|Overall Study|Study terminated by Sponsor|0|||
16094903|NCT02092909|38836544|FG002|Overall Study|Study terminated by Sponsor|0|||
16094904|NCT02092909|38836545|FG003|Overall Study|Study terminated by Sponsor|2|||
16094905|NCT02092909|38836542|FG000|Overall Study|Miscellaneous|1|||
16094906|NCT02092909|38836543|FG001|Overall Study|Miscellaneous|1|||
16094907|NCT02092909|38836544|FG002|Overall Study|Miscellaneous|2|||
16094908|NCT02092909|38836545|FG003|Overall Study|Miscellaneous|1|||
16094909|NCT02959866|38836546|FG000|Overall Study|Withdrawal by Subject|1|||
16094910|NCT02037568|38836547|FG000|Overall Study|Withdrawal by Subject|17|||
16094911|NCT02037568|38836548|FG001|Overall Study|Withdrawal by Subject|24|||
16094912|NCT02037568|38836547|FG000|Overall Study|Lost to Follow-up|16|||
16094913|NCT02037568|38836548|FG001|Overall Study|Lost to Follow-up|13|||
16094914|NCT02037568|38836547|FG000|Overall Study|Screen Failure|3|||
16094915|NCT02037568|38836548|FG001|Overall Study|Screen Failure|1|||
16094916|NCT02037568|38836547|FG000|Overall Study|Patient did not receive transplant|0|||
16094917|NCT02037568|38836548|FG001|Overall Study|Patient did not receive transplant|1|||
16094918|NCT01858688|38836551|FG000|Overall Study|Withdrawal by Subject|8|||
16094919|NCT01858688|38836551|FG000|Overall Study|Participant began another therapy|3|||
16094920|NCT01858688|38836551|FG000|Overall Study|Physician Decision|2|||
16094921|NCT01858688|38836551|FG000|Overall Study|Progressive Disease|2|||
16094922|NCT01858688|38836551|FG000|Overall Study|Reason not reproted|5|||
16094923|NCT02889809|38836552|FG000|Overall Study|Withdrawal by Subject|30|||
16094924|NCT02889809|38836553|FG001|Overall Study|Withdrawal by Subject|21|||
16094925|NCT02889809|38836552|FG000|Overall Study|Lost to Follow-up|1|||
16094926|NCT02889809|38836553|FG001|Overall Study|Lost to Follow-up|1|||
16094927|NCT02889809|38836552|FG000|Overall Study|Site Closed|12|||
16094928|NCT02889809|38836553|FG001|Overall Study|Site Closed|11|||
16094929|NCT01287832|38836554|FG000|Overall Study|Adverse Event|1|||
16094930|NCT01287832|38836555|FG001|Overall Study|Adverse Event|0|||
16094931|NCT01287832|38836554|FG000|Overall Study|Death|0|||
16523115|NCT01060384|40383679|FG002|Overall Study|Withdrawal by Subject|0|||
16094932|NCT01287832|38836555|FG001|Overall Study|Death|1|||
16094933|NCT00307489|38836557|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
16094934|NCT00307489|38836558|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
16094935|NCT00307489|38836557|FG000|Baseline Through Week 48|Physician Decision|1|||
16094936|NCT00307489|38836558|FG001|Baseline Through Week 48|Physician Decision|0|||
16094937|NCT00307489|38836557|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
16094938|NCT00307489|38836558|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
16094939|NCT00307489|38836557|FG000|Week 48 Through Week 168|Adverse Event|1|||
16094940|NCT00307489|38836558|FG001|Week 48 Through Week 168|Adverse Event|0|||
16094941|NCT00307489|38836557|FG000|Week 48 Through Week 168|Physician Decision|1|||
16094942|NCT00307489|38836558|FG001|Week 48 Through Week 168|Physician Decision|0|||
16094943|NCT00307489|38836557|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
16094944|NCT00307489|38836558|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
16094945|NCT00307489|38836557|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
16094946|NCT00307489|38836558|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
16094947|NCT00307489|38836557|FG000|Week 48 Through Week 168|Death|0|||
16094948|NCT00307489|38836558|FG001|Week 48 Through Week 168|Death|1|||
16094949|NCT00307489|38836557|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
16094950|NCT00307489|38836558|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
16094951|NCT00307489|38836557|FG000|Week 48 Through Week 168|Seroconversion|1|||
16094952|NCT00307489|38836558|FG001|Week 48 Through Week 168|Seroconversion|0|||
16094953|NCT01288729|38836560|FG000|Overall Study|Withdrawal by Subject|1|||
16094954|NCT01288729|38836561|FG001|Overall Study|Withdrawal by Subject|0|||
16094955|NCT03708744|38836562|FG000|Overall Study|Withdrawal by Subject|0|||
16094956|NCT03708744|38836563|FG001|Overall Study|Withdrawal by Subject|0|||
16094957|NCT03708744|38836564|FG002|Overall Study|Withdrawal by Subject|1|||
16094958|NCT03708744|38836565|FG003|Overall Study|Withdrawal by Subject|0|||
16094959|NCT03605745|38836566|FG000|Overall Study|Study was terminated for business reasons|47|||
16094960|NCT03162614|38836567|FG000|Overall Study|Lost to Follow-up|2|||
16094961|NCT03162614|38836568|FG001|Overall Study|Lost to Follow-up|1|||
16094962|NCT03162614|38836569|FG002|Overall Study|Lost to Follow-up|1|||
16094963|NCT03162614|38836570|FG003|Overall Study|Lost to Follow-up|1|||
16094964|NCT03162614|38836571|FG004|Overall Study|Lost to Follow-up|2|||
16396842|NCT01734785|39935295|FG002|Double-Blind Period|Withdrawal by Subject|0|||
16094965|NCT03162614|38836572|FG005|Overall Study|Lost to Follow-up|0|||
16094966|NCT03162614|38836567|FG000|Overall Study|Protocol Violation|0|||
16094967|NCT03162614|38836568|FG001|Overall Study|Protocol Violation|1|||
16094968|NCT03162614|38836569|FG002|Overall Study|Protocol Violation|0|||
16094969|NCT03162614|38836570|FG003|Overall Study|Protocol Violation|1|||
16094970|NCT03162614|38836571|FG004|Overall Study|Protocol Violation|0|||
16094971|NCT03162614|38836572|FG005|Overall Study|Protocol Violation|0|||
16094972|NCT03162614|38836567|FG000|Overall Study|Withdrawal by Subject|2|||
16094973|NCT03162614|38836568|FG001|Overall Study|Withdrawal by Subject|1|||
16094974|NCT03162614|38836569|FG002|Overall Study|Withdrawal by Subject|1|||
16094975|NCT03162614|38836570|FG003|Overall Study|Withdrawal by Subject|1|||
16094976|NCT03162614|38836571|FG004|Overall Study|Withdrawal by Subject|0|||
16094977|NCT03162614|38836572|FG005|Overall Study|Withdrawal by Subject|0|||
16094978|NCT03162614|38836567|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
16094979|NCT03162614|38836568|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
16094980|NCT03162614|38836569|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
16094981|NCT03162614|38836570|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
16094982|NCT03162614|38836571|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
16094983|NCT03162614|38836572|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
16094984|NCT03840993|38836573|FG000|Overall Study|Adverse Event|1|||
16094985|NCT03840993|38836574|FG001|Overall Study|Adverse Event|0|||
16094986|NCT03840993|38836573|FG000|Overall Study|Lost to Follow-up|4|||
16094987|NCT03840993|38836574|FG001|Overall Study|Lost to Follow-up|0|||
16094988|NCT03840993|38836573|FG000|Overall Study|Physician Decision|0|||
16094989|NCT03840993|38836574|FG001|Overall Study|Physician Decision|1|||
16094990|NCT03840993|38836573|FG000|Overall Study|Pregnancy|0|||
16094991|NCT03840993|38836574|FG001|Overall Study|Pregnancy|1|||
16094992|NCT03840993|38836573|FG000|Overall Study|Withdrawal by Subject|1|||
16094993|NCT03840993|38836574|FG001|Overall Study|Withdrawal by Subject|3|||
16094994|NCT03840993|38836573|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
16094995|NCT03840993|38836574|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
16094996|NCT00113529|38836575|FG000|Overall Study|Adverse Event|4|||
16094997|NCT00113529|38836575|FG000|Overall Study|Lack of Efficacy|20|||
16094998|NCT00113529|38836575|FG000|Overall Study|Decision of sponsor|6|||
16094999|NCT00113529|38836575|FG000|Overall Study|Withdrawal by Subject|4|||
16095000|NCT02865083|38836576|FG000|Overall Study|Early Termination|3|||
16095001|NCT02865083|38836577|FG001|Overall Study|Early Termination|1|||
16095002|NCT01812707|38836578|FG000|Overall Study|Adverse Event|0|||
16095003|NCT01812707|38836579|FG001|Overall Study|Adverse Event|0|||
16095004|NCT01812707|38836580|FG002|Overall Study|Adverse Event|0|||
16095005|NCT01812707|38836581|FG003|Overall Study|Adverse Event|2|||
16207580|NCT00510068|39237276|FG001|Open-label Period|Disease Progression|0|||
16095006|NCT01812707|38836578|FG000|Overall Study|Poor compliance to protocol|1|||
16095007|NCT01812707|38836579|FG001|Overall Study|Poor compliance to protocol|0|||
16095008|NCT01812707|38836580|FG002|Overall Study|Poor compliance to protocol|0|||
16095009|NCT01812707|38836581|FG003|Overall Study|Poor compliance to protocol|0|||
16095010|NCT01812707|38836578|FG000|Overall Study|Consent withdrawn by participant|1|||
16095011|NCT01812707|38836579|FG001|Overall Study|Consent withdrawn by participant|0|||
16207581|NCT00510068|39237275|FG000|Open-label Period|Adverse Event|46|||
16095012|NCT01812707|38836580|FG002|Overall Study|Consent withdrawn by participant|0|||
16095013|NCT01812707|38836581|FG003|Overall Study|Consent withdrawn by participant|0|||
16111461|NCT00760747|38897275|FG001|Study Period II|Protocol Violation|3|||
16111462|NCT00760747|38897274|FG000|Study Period II|Withdrawal by Subject|1|||
16095014|NCT01441596|38839327|FG000|Overall Study|Other reason not defined below|0|||
16095015|NCT01441596|38839328|FG001|Overall Study|Other reason not defined below|2|||
16095016|NCT01441596|38839329|FG002|Overall Study|Other reason not defined below|1|||
16095017|NCT01441596|38839327|FG000|Overall Study|Withdrawal by Subject|4|||
16095018|NCT01441596|38839328|FG001|Overall Study|Withdrawal by Subject|0|||
16095019|NCT01441596|38839329|FG002|Overall Study|Withdrawal by Subject|2|||
16095020|NCT01441596|38839327|FG000|Overall Study|Not treated|0|||
16095021|NCT01441596|38839328|FG001|Overall Study|Not treated|1|||
16095022|NCT01441596|38839329|FG002|Overall Study|Not treated|1|||
16095023|NCT01204775|38839330|FG000|Overall Study|Poor/non-compliance|0|||
16095024|NCT01204775|38839331|FG001|Overall Study|Poor/non-compliance|1|||
16095025|NCT01204775|38839330|FG000|Overall Study|Withdrawal by Subject|1|||
16095026|NCT01204775|38839331|FG001|Overall Study|Withdrawal by Subject|0|||
16095027|NCT00753896|38839332|FG000|Overall Study|Adverse Event|4|||
16095028|NCT00753896|38839332|FG000|Overall Study|Death|1|||
16095029|NCT00753896|38839332|FG000|Overall Study|Lost to Follow-up|2|||
16095030|NCT00753896|38839332|FG000|Overall Study|Protocol Violation|1|||
16095031|NCT00753896|38839332|FG000|Overall Study|Withdrawal by Subject|4|||
16095032|NCT00753896|38839332|FG000|Overall Study|Entry Criteria Not Met|4|||
16095033|NCT03761849|38839333|FG000|Overall Study|transferred to OpenLabelExtension|35|||
16095034|NCT03761849|38839334|FG001|Overall Study|transferred to OpenLabelExtension|34|||
16095035|NCT03761849|38839335|FG002|Overall Study|transferred to OpenLabelExtension|36|||
16095036|NCT03761849|38839336|FG003|Overall Study|transferred to OpenLabelExtension|0|||
16095037|NCT03761849|38839337|FG004|Overall Study|transferred to OpenLabelExtension|0|||
16095038|NCT03761849|38839338|FG005|Overall Study|transferred to OpenLabelExtension|0|||
16095039|NCT03761849|38839333|FG000|Overall Study|Adverse Event|1|||
16095040|NCT03761849|38839334|FG001|Overall Study|Adverse Event|0|||
16095041|NCT03761849|38839335|FG002|Overall Study|Adverse Event|0|||
16095042|NCT03761849|38839336|FG003|Overall Study|Adverse Event|0|||
16095043|NCT03761849|38839337|FG004|Overall Study|Adverse Event|2|||
16095044|NCT03761849|38839338|FG005|Overall Study|Adverse Event|3|||
16095045|NCT03761849|38839333|FG000|Overall Study|Withdrawal by Subject|0|||
16095046|NCT03761849|38839334|FG001|Overall Study|Withdrawal by Subject|0|||
16095047|NCT03761849|38839335|FG002|Overall Study|Withdrawal by Subject|0|||
16095048|NCT03761849|38839336|FG003|Overall Study|Withdrawal by Subject|41|||
16095049|NCT03761849|38839337|FG004|Overall Study|Withdrawal by Subject|43|||
16095050|NCT03761849|38839338|FG005|Overall Study|Withdrawal by Subject|35|||
16095051|NCT03761849|38839333|FG000|Overall Study|Lost to Follow-up|0|||
16095052|NCT03761849|38839334|FG001|Overall Study|Lost to Follow-up|1|||
16207582|NCT00510068|39237276|FG001|Open-label Period|Adverse Event|0|||
16523116|NCT01060384|40383680|FG003|Overall Study|Withdrawal by Subject|0|||
16523117|NCT01060384|40383681|FG004|Overall Study|Withdrawal by Subject|0|||
16523118|NCT01060384|40383677|FG000|Overall Study|Death|0|||
16523119|NCT01060384|40383678|FG001|Overall Study|Death|0|||
16523120|NCT01060384|40383679|FG002|Overall Study|Death|0|||
16523121|NCT01060384|40383680|FG003|Overall Study|Death|0|||
16523122|NCT01060384|40383681|FG004|Overall Study|Death|1|||
16523123|NCT01060384|40383677|FG000|Overall Study|Intercurrent illness|0|||
16523124|NCT01060384|40383678|FG001|Overall Study|Intercurrent illness|0|||
16523125|NCT01060384|40383679|FG002|Overall Study|Intercurrent illness|0|||
16523126|NCT01060384|40383680|FG003|Overall Study|Intercurrent illness|0|||
16523127|NCT01060384|40383681|FG004|Overall Study|Intercurrent illness|1|||
16523128|NCT02338362|40383682|FG000|Overall Study|Withdrawal by Subject|1|||
16523129|NCT02338362|40383683|FG001|Overall Study|Withdrawal by Subject|1|||
16523130|NCT01263873|40383687|FG000|Overall Study|One provider unable to complete numbers|1|||
16523131|NCT01263873|40383688|FG001|Overall Study|One provider unable to complete numbers|1|||
16523132|NCT00562159|40383690|FG000|Overall Study|Adverse Event|11|||
16523133|NCT00562159|40383691|FG001|Overall Study|Adverse Event|8|||
16523134|NCT00562159|40383690|FG000|Overall Study|Lost to Follow-up|5|||
16523135|NCT00562159|40383691|FG001|Overall Study|Lost to Follow-up|4|||
16523136|NCT00562159|40383690|FG000|Overall Study|Withdrawal by Subject|9|||
16523137|NCT00562159|40383691|FG001|Overall Study|Withdrawal by Subject|8|||
16523138|NCT00562159|40383690|FG000|Overall Study|Protocol Violation|12|||
16523139|NCT00562159|40383691|FG001|Overall Study|Protocol Violation|12|||
16523140|NCT00562159|40383690|FG000|Overall Study|Did not meet protocol eligibility|1|||
16523141|NCT00562159|40383691|FG001|Overall Study|Did not meet protocol eligibility|1|||
16523142|NCT03588572|40383692|FG000|Visitation 1|Lack of Efficacy|1|||
16523143|NCT03588572|40383693|FG001|Visitation 1|Lack of Efficacy|1|||
16523144|NCT03588572|40383692|FG000|Visitation 2|Lost to Follow-up|1|||
16523145|NCT03588572|40383693|FG001|Visitation 2|Lost to Follow-up|1|||
16523146|NCT03588572|40383692|FG000|Visitation 2|Lack of Efficacy|0|||
16523147|NCT03588572|40383693|FG001|Visitation 2|Lack of Efficacy|1|||
16523148|NCT03588572|40383692|FG000|Visitation 2|Withdrawal by Subject|1|||
16523149|NCT03588572|40383693|FG001|Visitation 2|Withdrawal by Subject|0|||
16523150|NCT03588572|40383692|FG000|Visitation 3|Lost to Follow-up|1|||
16523151|NCT03588572|40383693|FG001|Visitation 3|Lost to Follow-up|1|||
16523152|NCT03588572|40383692|FG000|Visitation 3|Physician Decision|1|||
16523153|NCT03588572|40383693|FG001|Visitation 3|Physician Decision|1|||
16523154|NCT03588572|40383692|FG000|Visitation 3|Withdrawal by Subject|1|||
16523155|NCT03588572|40383693|FG001|Visitation 3|Withdrawal by Subject|0|||
16523156|NCT01694706|40383696|FG000|Overall Study|Adverse Event|0|||
16523157|NCT01694706|40383697|FG001|Overall Study|Adverse Event|1|||
16523158|NCT01694706|40383698|FG002|Overall Study|Adverse Event|0|||
16523159|NCT01694706|40383696|FG000|Overall Study|other reason not defined above|1|||
16523160|NCT01694706|40383697|FG001|Overall Study|other reason not defined above|0|||
16095053|NCT03761849|38839335|FG002|Overall Study|Lost to Follow-up|0|||
16326289|NCT03214380|39681503|FG001|Treatment Period|Treatment Interruption|0|||
16095054|NCT03761849|38839336|FG003|Overall Study|Lost to Follow-up|2|||
16095055|NCT03761849|38839337|FG004|Overall Study|Lost to Follow-up|4|||
16095056|NCT03761849|38839338|FG005|Overall Study|Lost to Follow-up|5|||
16095057|NCT03761849|38839333|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
16095058|NCT03761849|38839334|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
16095059|NCT03761849|38839335|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
16095060|NCT03761849|38839336|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
16095061|NCT03761849|38839337|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
16095062|NCT03761849|38839338|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
16095063|NCT03761849|38839333|FG000|Overall Study|Physician Decision|0|||
16095064|NCT03761849|38839334|FG001|Overall Study|Physician Decision|0|||
16095065|NCT03761849|38839335|FG002|Overall Study|Physician Decision|0|||
16095066|NCT03761849|38839336|FG003|Overall Study|Physician Decision|1|||
16095067|NCT03761849|38839337|FG004|Overall Study|Physician Decision|4|||
16095068|NCT03761849|38839338|FG005|Overall Study|Physician Decision|4|||
16207583|NCT00510068|39237275|FG000|Open-label Period|Withdrawal by Subject|21|||
16207584|NCT00510068|39237276|FG001|Open-label Period|Withdrawal by Subject|0|||
16207585|NCT00510068|39237275|FG000|Open-label Period|Administrative problems|17|||
16326290|NCT03214380|39681504|FG002|Treatment Period|Treatment Interruption|1|||
16326291|NCT03214380|39681505|FG003|Treatment Period|Treatment Interruption|0|||
16326292|NCT03214380|39681506|FG004|Treatment Period|Treatment Interruption|0|||
16207586|NCT00510068|39237276|FG001|Open-label Period|Administrative problems|0|||
16207587|NCT00510068|39237275|FG000|Open-label Period|Death|7|||
16207588|NCT00510068|39237276|FG001|Open-label Period|Death|0|||
16207589|NCT00510068|39237275|FG000|Open-label Period|New cancer therapy|7|||
16207590|NCT00510068|39237276|FG001|Open-label Period|New cancer therapy|0|||
16207591|NCT00510068|39237275|FG000|Open-label Period|Protocol Violation|2|||
16207592|NCT00510068|39237276|FG001|Open-label Period|Protocol Violation|0|||
16207593|NCT00510068|39237275|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
16207594|NCT00510068|39237276|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
16207595|NCT01438307|39237278|FG000|Overall Study|Death|1|||
16207596|NCT01438307|39237279|FG001|Overall Study|Death|1|||
16207597|NCT01369225|39237281|FG000|Overall Study|Withdrawal by Subject|1|||
16207598|NCT01369225|39237282|FG001|Overall Study|Withdrawal by Subject|0|||
16207599|NCT01369225|39237283|FG002|Overall Study|Withdrawal by Subject|2|||
16326293|NCT03214380|39681507|FG005|Treatment Period|Treatment Interruption|0|||
16326294|NCT00738881|39681514|FG000|Overall Study|Withdrawal by Subject|0|||
16326295|NCT00738881|39681515|FG001|Overall Study|Withdrawal by Subject|2|||
16326296|NCT02475265|39681517|FG000|Overall Study|Physician Decision|1|||
16326297|NCT02475265|39681517|FG000|Overall Study|Withdrawal by Subject|2|||
16326298|NCT03201874|39681521|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
16326299|NCT03201874|39681522|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
16523161|NCT01694706|40383698|FG002|Overall Study|other reason not defined above|0|||
16523162|NCT01700946|40383699|FG000|Overall Study|Lost to Follow-up|1|||
16523163|NCT01700946|40383700|FG001|Overall Study|Lost to Follow-up|0|||
16523164|NCT01700946|40383699|FG000|Overall Study|Physician Decision|7|||
16523165|NCT01700946|40383700|FG001|Overall Study|Physician Decision|12|||
16523166|NCT01700946|40383699|FG000|Overall Study|Withdrawal by Subject|0|||
16523167|NCT01700946|40383700|FG001|Overall Study|Withdrawal by Subject|2|||
16523168|NCT01700946|40383699|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
16523169|NCT01700946|40383700|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
16523170|NCT01700946|40383699|FG000|Overall Study|Relapse|2|||
16523171|NCT01700946|40383700|FG001|Overall Study|Relapse|1|||
16523172|NCT01700946|40383699|FG000|Overall Study|Unacceptable toxicity|1|||
16523173|NCT01700946|40383700|FG001|Overall Study|Unacceptable toxicity|0|||
16523174|NCT00818441|40383701|FG000|Overall Study|Death|69|||
16523175|NCT00818441|40383702|FG001|Overall Study|Death|26|||
16523176|NCT00818441|40383701|FG000|Overall Study|Other|5|||
16523177|NCT00818441|40383702|FG001|Overall Study|Other|0|||
16095069|NCT03761849|38839333|FG000|Overall Study|Death|0|||
16095070|NCT03761849|38839334|FG001|Overall Study|Death|0|||
16326300|NCT03201874|39681521|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
16523178|NCT00818441|40383701|FG000|Overall Study|Lost to Follow-up|2|||
16523179|NCT00818441|40383702|FG001|Overall Study|Lost to Follow-up|1|||
16095071|NCT03761849|38839335|FG002|Overall Study|Death|0|||
16095072|NCT03761849|38839336|FG003|Overall Study|Death|1|||
16095073|NCT03761849|38839337|FG004|Overall Study|Death|1|||
16095074|NCT03761849|38839338|FG005|Overall Study|Death|3|||
16095075|NCT03761849|38839333|FG000|Overall Study|Protocol Violation|0|||
16095076|NCT03761849|38839334|FG001|Overall Study|Protocol Violation|0|||
16523180|NCT00818441|40383701|FG000|Overall Study|Withdrawal by Subject|2|||
16523181|NCT00818441|40383702|FG001|Overall Study|Withdrawal by Subject|0|||
16523182|NCT00818441|40383701|FG000|Overall Study|Adverse Event|0|||
16523183|NCT00818441|40383702|FG001|Overall Study|Adverse Event|1|||
16523184|NCT00818441|40383701|FG000|Overall Study|Study terminated by sponsor|11|||
16523185|NCT00818441|40383702|FG001|Overall Study|Study terminated by sponsor|2|||
16523186|NCT04713748|40383703|FG000|Overall Study|Not enough kits allocated|35|||
16523187|NCT04067141|40383708|FG000|First Intervention|Withdrawal by Subject|0|||
16523188|NCT04067141|40383709|FG001|First Intervention|Withdrawal by Subject|1|||
16523189|NCT04067141|40383708|FG000|Second Intervention|Adverse Event|0|||
16523190|NCT04067141|40383709|FG001|Second Intervention|Adverse Event|2|||
16523191|NCT00148343|40383715|FG000|Overall Study|Withdrawal by Subject|12|||
16523192|NCT00148343|40383716|FG001|Overall Study|Withdrawal by Subject|7|||
16523193|NCT00148343|40383715|FG000|Overall Study|Physician Decision|3|||
16523194|NCT00148343|40383716|FG001|Overall Study|Physician Decision|4|||
16523195|NCT00968617|40383726|FG000|Overall Study|Study terminated by sponsor|6|||
16523196|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
16523197|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
16523198|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
16095077|NCT03761849|38839335|FG002|Overall Study|Protocol Violation|0|||
16095078|NCT03761849|38839336|FG003|Overall Study|Protocol Violation|2|||
16095079|NCT03761849|38839337|FG004|Overall Study|Protocol Violation|2|||
16095080|NCT03761849|38839338|FG005|Overall Study|Protocol Violation|1|||
16095081|NCT03761849|38839333|FG000|Overall Study|Participant could not come to site|0|||
16095082|NCT03761849|38839334|FG001|Overall Study|Participant could not come to site|0|||
16095083|NCT03761849|38839335|FG002|Overall Study|Participant could not come to site|0|||
16095084|NCT03761849|38839336|FG003|Overall Study|Participant could not come to site|0|||
16095085|NCT03761849|38839337|FG004|Overall Study|Participant could not come to site|1|||
16095086|NCT03761849|38839338|FG005|Overall Study|Participant could not come to site|0|||
16095087|NCT03761849|38839333|FG000|Overall Study|SF- safety Finding|0|||
16095088|NCT03761849|38839334|FG001|Overall Study|SF- safety Finding|0|||
16095089|NCT03761849|38839335|FG002|Overall Study|SF- safety Finding|0|||
16095090|NCT03761849|38839336|FG003|Overall Study|SF- safety Finding|0|||
16523199|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
16523200|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
16523201|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
16523202|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
16523203|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
16523204|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
16523205|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
16523206|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
16523207|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
16523208|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
16523209|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
16523210|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
16523211|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
16095091|NCT03761849|38839337|FG004|Overall Study|SF- safety Finding|0|||
16095092|NCT03761849|38839338|FG005|Overall Study|SF- safety Finding|1|||
16095093|NCT03761849|38839333|FG000|Overall Study|Patient did not attend visit|0|||
16207600|NCT01369225|39237284|FG003|Overall Study|Withdrawal by Subject|1|||
16523212|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
16523213|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
16523214|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
16523215|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
16523216|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
16095094|NCT03761849|38839334|FG001|Overall Study|Patient did not attend visit|0|||
16095095|NCT03761849|38839335|FG002|Overall Study|Patient did not attend visit|0|||
16207601|NCT01369225|39237285|FG004|Overall Study|Withdrawal by Subject|0|||
16207602|NCT01369225|39237286|FG005|Overall Study|Withdrawal by Subject|0|||
16207603|NCT01369225|39237281|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
16207604|NCT01369225|39237282|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
16207605|NCT01369225|39237283|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
16207606|NCT01369225|39237284|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
16207607|NCT01369225|39237285|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
16207608|NCT01369225|39237286|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
16207609|NCT01369225|39237281|FG000|Overall Study|Other|1|||
16207610|NCT01369225|39237282|FG001|Overall Study|Other|0|||
16523217|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
16523218|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
16523219|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
16523220|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
16523221|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
16523222|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
16207611|NCT01369225|39237283|FG002|Overall Study|Other|0|||
16207612|NCT01369225|39237284|FG003|Overall Study|Other|0|||
16207613|NCT01369225|39237285|FG004|Overall Study|Other|1|||
16207614|NCT01369225|39237286|FG005|Overall Study|Other|0|||
16207615|NCT01369225|39237281|FG000|Overall Study|Adverse Event|0|||
16207616|NCT01369225|39237282|FG001|Overall Study|Adverse Event|0|||
16523223|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
16523224|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
16523225|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
16523226|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
16523227|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
16523228|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
16523229|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
16523230|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
16523231|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
16523232|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
16523233|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
16523234|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
16523235|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
16207617|NCT01369225|39237283|FG002|Overall Study|Adverse Event|0|||
16207618|NCT01369225|39237284|FG003|Overall Study|Adverse Event|1|||
16207619|NCT01369225|39237285|FG004|Overall Study|Adverse Event|1|||
16207620|NCT01369225|39237286|FG005|Overall Study|Adverse Event|0|||
16207621|NCT01685203|39237287|FG000|Overall Study|Lost to Follow-up|3|||
16207622|NCT01685203|39237288|FG001|Overall Study|Lost to Follow-up|3|||
16207623|NCT01685203|39237289|FG002|Overall Study|Lost to Follow-up|0|||
16207624|NCT01685203|39237290|FG003|Overall Study|Lost to Follow-up|1|||
16207625|NCT01685203|39237291|FG004|Overall Study|Lost to Follow-up|0|||
16207626|NCT01685203|39237292|FG005|Overall Study|Lost to Follow-up|0|||
16207627|NCT01685203|39237293|FG006|Overall Study|Lost to Follow-up|0|||
16207628|NCT01685203|39237287|FG000|Overall Study|Adverse Event|0|||
16207629|NCT01685203|39237288|FG001|Overall Study|Adverse Event|0|||
16326301|NCT03201874|39681522|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
16326302|NCT00915876|39681527|FG000|Overall Study|Adverse Event|0|||
16326303|NCT00915876|39681528|FG001|Overall Study|Adverse Event|1|||
16326304|NCT03483961|39681529|FG000|Overall Study|Lost to Follow-up|7|||
16326305|NCT03483961|39681530|FG001|Overall Study|Lost to Follow-up|6|||
16326306|NCT03483961|39681531|FG002|Overall Study|Lost to Follow-up|6|||
16326307|NCT03483961|39681532|FG003|Overall Study|Lost to Follow-up|6|||
16207630|NCT01685203|39237289|FG002|Overall Study|Adverse Event|0|||
16207631|NCT01685203|39237290|FG003|Overall Study|Adverse Event|0|||
16207632|NCT01685203|39237291|FG004|Overall Study|Adverse Event|0|||
16207633|NCT01685203|39237292|FG005|Overall Study|Adverse Event|2|||
16207634|NCT01685203|39237293|FG006|Overall Study|Adverse Event|0|||
16207635|NCT01685203|39237287|FG000|Overall Study|Adverse event and withdrew consent|1|||
16207636|NCT01685203|39237288|FG001|Overall Study|Adverse event and withdrew consent|0|||
16207637|NCT01685203|39237289|FG002|Overall Study|Adverse event and withdrew consent|0|||
16095096|NCT03761849|38839336|FG003|Overall Study|Patient did not attend visit|0|||
16207638|NCT01685203|39237290|FG003|Overall Study|Adverse event and withdrew consent|0|||
16207639|NCT01685203|39237291|FG004|Overall Study|Adverse event and withdrew consent|0|||
16207640|NCT01685203|39237292|FG005|Overall Study|Adverse event and withdrew consent|0|||
16207641|NCT01685203|39237293|FG006|Overall Study|Adverse event and withdrew consent|0|||
16207642|NCT01685203|39237287|FG000|Overall Study|Patient's decision|0|||
16207643|NCT01685203|39237288|FG001|Overall Study|Patient's decision|0|||
16207644|NCT01685203|39237289|FG002|Overall Study|Patient's decision|0|||
16207645|NCT01685203|39237290|FG003|Overall Study|Patient's decision|0|||
16207646|NCT01685203|39237291|FG004|Overall Study|Patient's decision|0|||
16207647|NCT01685203|39237292|FG005|Overall Study|Patient's decision|1|||
16207648|NCT01685203|39237293|FG006|Overall Study|Patient's decision|0|||
16207649|NCT01040845|39237302|FG000|Overall Study|Withdrawal by Subject|1|||
16207650|NCT01040845|39237303|FG001|Overall Study|Withdrawal by Subject|1|||
16207651|NCT01040845|39237302|FG000|Overall Study|Physician Decision|1|||
16207652|NCT01040845|39237303|FG001|Overall Study|Physician Decision|0|||
16207653|NCT03371251|39237304|FG000|Overall Study|Withdrawal by Subject|1|||
16207654|NCT03371251|39237305|FG001|Overall Study|Withdrawal by Subject|0|||
16207655|NCT03371251|39237306|FG002|Overall Study|Withdrawal by Subject|1|||
16207656|NCT03371251|39237307|FG003|Overall Study|Withdrawal by Subject|0|||
16207657|NCT03371251|39237308|FG004|Overall Study|Withdrawal by Subject|2|||
16207658|NCT03371251|39237309|FG005|Overall Study|Withdrawal by Subject|2|||
16207659|NCT03371251|39237304|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
16326308|NCT03483961|39681533|FG004|Overall Study|Lost to Follow-up|6|||
16326309|NCT03483961|39681534|FG005|Overall Study|Lost to Follow-up|4|||
16326310|NCT03483961|39681535|FG006|Overall Study|Lost to Follow-up|4|||
16207660|NCT03371251|39237305|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
16207661|NCT03371251|39237306|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
16207662|NCT03371251|39237307|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
16207663|NCT03371251|39237308|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
16207664|NCT03371251|39237309|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
16207665|NCT03371251|39237304|FG000|Overall Study|Adverse Event|0|||
16207666|NCT03371251|39237305|FG001|Overall Study|Adverse Event|0|||
16207667|NCT03371251|39237306|FG002|Overall Study|Adverse Event|0|||
16207668|NCT03371251|39237307|FG003|Overall Study|Adverse Event|0|||
16207669|NCT03371251|39237308|FG004|Overall Study|Adverse Event|1|||
16207670|NCT03371251|39237309|FG005|Overall Study|Adverse Event|0|||
16207671|NCT03371251|39237304|FG000|Overall Study|Decision by Sponsor|0|||
16207672|NCT03371251|39237305|FG001|Overall Study|Decision by Sponsor|0|||
16207673|NCT03371251|39237306|FG002|Overall Study|Decision by Sponsor|0|||
16207674|NCT03371251|39237307|FG003|Overall Study|Decision by Sponsor|0|||
16207675|NCT03371251|39237308|FG004|Overall Study|Decision by Sponsor|2|||
16207676|NCT03371251|39237309|FG005|Overall Study|Decision by Sponsor|0|||
16207677|NCT00443846|39237311|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
16207678|NCT00443846|39237312|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
16207679|NCT00443846|39237311|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
16207680|NCT00443846|39237312|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
16207681|NCT00443846|39237311|FG000|Overall Study|Adverse Event|0|||
16207682|NCT00443846|39237312|FG001|Overall Study|Adverse Event|1|||
16207683|NCT00443846|39237311|FG000|Overall Study|Personal reason|8|||
16207684|NCT00443846|39237312|FG001|Overall Study|Personal reason|3|||
16207685|NCT00443846|39237311|FG000|Overall Study|Lost to Follow-up|1|||
16207686|NCT00443846|39237312|FG001|Overall Study|Lost to Follow-up|2|||
16207687|NCT00045630|39239889|FG000|Overall Study|Adverse Event|1|||
16207688|NCT00045630|39239889|FG000|Overall Study|Refusal unrelated to adverse event|1|||
16207689|NCT00045630|39239889|FG000|Overall Study|Progression/relapse|1|||
16207690|NCT00045630|39239889|FG000|Overall Study|Death|1|||
16207691|NCT00045630|39239889|FG000|Overall Study|Ineligible|2|||
16207692|NCT02725268|39239890|FG000|Overall Study|Death|58|||
16207693|NCT02725268|39239891|FG001|Overall Study|Death|59|||
16207694|NCT02725268|39239892|FG002|Overall Study|Death|30|||
16207695|NCT02725268|39239893|FG003|Overall Study|Death|16|||
16207696|NCT02725268|39239890|FG000|Overall Study|Lost to Follow-up|4|||
16207697|NCT02725268|39239891|FG001|Overall Study|Lost to Follow-up|3|||
16207698|NCT02725268|39239892|FG002|Overall Study|Lost to Follow-up|0|||
16207699|NCT02725268|39239893|FG003|Overall Study|Lost to Follow-up|1|||
16207700|NCT02725268|39239890|FG000|Overall Study|Site Terminated by Sponsor|0|||
16207701|NCT02725268|39239891|FG001|Overall Study|Site Terminated by Sponsor|1|||
16207702|NCT02725268|39239892|FG002|Overall Study|Site Terminated by Sponsor|0|||
16207703|NCT02725268|39239893|FG003|Overall Study|Site Terminated by Sponsor|0|||
16207704|NCT02725268|39239890|FG000|Overall Study|Withdrawal by Subject|8|||
16207705|NCT02725268|39239891|FG001|Overall Study|Withdrawal by Subject|6|||
16207706|NCT02725268|39239892|FG002|Overall Study|Withdrawal by Subject|8|||
16207707|NCT02725268|39239893|FG003|Overall Study|Withdrawal by Subject|1|||
16207708|NCT02725268|39239890|FG000|Overall Study|Reason not Specified|2|||
16523236|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
16523237|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
16523238|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
16523239|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
16523240|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
16523241|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
16523242|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
16523243|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
16207709|NCT02725268|39239891|FG001|Overall Study|Reason not Specified|1|||
16396843|NCT01734785|39935296|FG003|Double-Blind Period|Withdrawal by Subject|0|||
16396844|NCT01734785|39935293|FG000|Double-Blind Period|Not treated|1|||
16396845|NCT01734785|39935294|FG001|Double-Blind Period|Not treated|0|||
16396846|NCT01734785|39935295|FG002|Double-Blind Period|Not treated|0|||
16396847|NCT01734785|39935296|FG003|Double-Blind Period|Not treated|0|||
16396848|NCT01076205|39935297|FG000|Overall Study|Adverse Drug Reaction|299|||
16396849|NCT01076205|39935297|FG000|Overall Study|Lack of Effectiveness|1423|||
16396850|NCT01076205|39935297|FG000|Overall Study|Other Reason|1075|||
16396851|NCT01076205|39935297|FG000|Overall Study|Unknown Reason|71|||
16396852|NCT01076205|39935297|FG000|Overall Study|Lost to Follow-up|3151|||
16523244|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
16396853|NCT01681069|39935298|FG000|Overall Study|Withdrawal by Subject|4|||
16396854|NCT01681069|39935299|FG001|Overall Study|Withdrawal by Subject|5|||
16207710|NCT02725268|39239892|FG002|Overall Study|Reason not Specified|0|||
16207711|NCT02725268|39239893|FG003|Overall Study|Reason not Specified|0|||
16207712|NCT02583711|39239896|FG000|Overall Study|Withdrawal by Subject|0|||
16207713|NCT02583711|39239897|FG001|Overall Study|Withdrawal by Subject|10|||
16207714|NCT02583711|39239898|FG002|Overall Study|Withdrawal by Subject|0|||
16207715|NCT01263093|39239901|FG000|Washout|Physician Decision|1|||
16207716|NCT01263093|39239902|FG001|Washout|Physician Decision|0|||
16207717|NCT01263093|39239901|FG000|Period 2|Adverse Event|1|||
16207718|NCT01263093|39239902|FG001|Period 2|Adverse Event|0|||
16207719|NCT02091921|39239904|FG000|Overall Study|Adverse Event|3|||
16396855|NCT01681069|39935298|FG000|Overall Study|Protocol Violation|1|||
16396856|NCT01681069|39935299|FG001|Overall Study|Protocol Violation|1|||
16396857|NCT01681069|39935298|FG000|Overall Study|Adverse Event|0|||
16396858|NCT01681069|39935299|FG001|Overall Study|Adverse Event|1|||
16207720|NCT00262314|39239907|FG000|Overall Study|Changing physicians|38|||
16207721|NCT00262314|39239907|FG000|Overall Study|Death|12|||
16396859|NCT04222699|39935300|FG000|Overall Study|Lost to Follow-up|2|||
16396860|NCT01262560|39935303|FG000|Overall Study|Protocol Violation|0|||
16396861|NCT01262560|39935304|FG001|Overall Study|Protocol Violation|1|||
16396862|NCT01262560|39935305|FG002|Overall Study|Protocol Violation|2|||
16396863|NCT01238991|39935306|FG000|Overall Study|Adverse Event|1|||
16396864|NCT01238991|39935307|FG001|Overall Study|Adverse Event|0|||
16207722|NCT00262314|39239907|FG000|Overall Study|Patient's decision|92|||
16207723|NCT00262314|39239907|FG000|Overall Study|Other|95|||
16207724|NCT00262314|39239907|FG000|Overall Study|Lost to Follow-up|70|||
16207725|NCT00262314|39239907|FG000|Overall Study|Administrative withdrawal|30|||
16207726|NCT03382262|39239908|FG000|Overall Study|Physician Decision|0|||
16207727|NCT03382262|39239909|FG001|Overall Study|Physician Decision|0|||
16207728|NCT03382262|39239910|FG002|Overall Study|Physician Decision|1|||
16207729|NCT03382262|39239911|FG003|Overall Study|Physician Decision|0|||
16396865|NCT01238991|39935308|FG002|Overall Study|Adverse Event|3|||
16396866|NCT01238991|39935309|FG003|Overall Study|Adverse Event|1|||
16396867|NCT01238991|39935310|FG004|Overall Study|Adverse Event|1|||
16396868|NCT01238991|39935311|FG005|Overall Study|Adverse Event|0|||
16396869|NCT01238991|39935312|FG006|Overall Study|Adverse Event|1|||
16396870|NCT01238991|39935313|FG007|Overall Study|Adverse Event|1|||
16396871|NCT01238991|39935314|FG008|Overall Study|Adverse Event|0|||
16396872|NCT01238991|39935315|FG009|Overall Study|Adverse Event|0|||
16396873|NCT01238991|39935306|FG000|Overall Study|Death|0|||
16396874|NCT01238991|39935307|FG001|Overall Study|Death|0|||
16396875|NCT01238991|39935308|FG002|Overall Study|Death|0|||
16396876|NCT01238991|39935309|FG003|Overall Study|Death|1|||
16207730|NCT03382262|39239908|FG000|Overall Study|Withdrawal by Subject|0|||
16207731|NCT03382262|39239909|FG001|Overall Study|Withdrawal by Subject|0|||
16207732|NCT03382262|39239910|FG002|Overall Study|Withdrawal by Subject|0|||
16207733|NCT03382262|39239911|FG003|Overall Study|Withdrawal by Subject|1|||
16207734|NCT05406440|39239920|FG000|Overall Study|Lost to Follow-up|0|||
16207735|NCT05406440|39239921|FG001|Overall Study|Lost to Follow-up|0|||
16207736|NCT05406440|39239922|FG002|Overall Study|Lost to Follow-up|0|||
16207737|NCT05406440|39239923|FG003|Overall Study|Lost to Follow-up|0|||
16207738|NCT05406440|39239924|FG004|Overall Study|Lost to Follow-up|2|||
16207739|NCT05406440|39239925|FG005|Overall Study|Lost to Follow-up|0|||
16207740|NCT05406440|39239926|FG006|Overall Study|Lost to Follow-up|0|||
16207741|NCT05406440|39239920|FG000|Overall Study|Physician Decision|0|||
16207742|NCT05406440|39239921|FG001|Overall Study|Physician Decision|0|||
16207743|NCT05406440|39239922|FG002|Overall Study|Physician Decision|0|||
16207744|NCT05406440|39239923|FG003|Overall Study|Physician Decision|0|||
16207745|NCT05406440|39239924|FG004|Overall Study|Physician Decision|1|||
16207746|NCT05406440|39239925|FG005|Overall Study|Physician Decision|0|||
16207747|NCT05406440|39239926|FG006|Overall Study|Physician Decision|0|||
16207748|NCT05406440|39239920|FG000|Overall Study|Withdrawal by Subject|0|||
16207749|NCT05406440|39239921|FG001|Overall Study|Withdrawal by Subject|0|||
16207750|NCT05406440|39239922|FG002|Overall Study|Withdrawal by Subject|0|||
16207751|NCT05406440|39239923|FG003|Overall Study|Withdrawal by Subject|0|||
16207752|NCT05406440|39239924|FG004|Overall Study|Withdrawal by Subject|0|||
16207753|NCT05406440|39239925|FG005|Overall Study|Withdrawal by Subject|2|||
16207754|NCT05406440|39239926|FG006|Overall Study|Withdrawal by Subject|0|||
16207755|NCT02820038|39239930|FG000|Overall Study|Lost to Follow-up|7|||
16207756|NCT02820038|39239931|FG001|Overall Study|Lost to Follow-up|11|||
16207757|NCT02820038|39239932|FG002|Overall Study|Lost to Follow-up|2|||
16207758|NCT02820038|39239933|FG003|Overall Study|Lost to Follow-up|9|||
16207759|NCT02820038|39239930|FG000|Overall Study|Withdrawal by Subject|3|||
16207760|NCT02820038|39239931|FG001|Overall Study|Withdrawal by Subject|14|||
16207761|NCT02820038|39239932|FG002|Overall Study|Withdrawal by Subject|3|||
16396877|NCT01238991|39935310|FG004|Overall Study|Death|0|||
16396878|NCT01238991|39935311|FG005|Overall Study|Death|0|||
16396879|NCT01238991|39935312|FG006|Overall Study|Death|0|||
16207762|NCT02820038|39239933|FG003|Overall Study|Withdrawal by Subject|13|||
16207763|NCT01989572|39239934|FG000|Overall Study|Lack of Efficacy|35|||
16207764|NCT01989572|39239935|FG001|Overall Study|Lack of Efficacy|48|||
16396880|NCT01238991|39935313|FG007|Overall Study|Death|0|||
16396881|NCT01238991|39935314|FG008|Overall Study|Death|0|||
16207765|NCT01989572|39239936|FG002|Overall Study|Lack of Efficacy|48|||
16396882|NCT01238991|39935315|FG009|Overall Study|Death|0|||
16207766|NCT01989572|39239937|FG003|Overall Study|Lack of Efficacy|43|||
16207767|NCT01989572|39239938|FG004|Overall Study|Lack of Efficacy|71|||
16396883|NCT01238991|39935306|FG000|Overall Study|Lack of Efficacy|0|||
16207768|NCT01989572|39239939|FG005|Overall Study|Lack of Efficacy|79|||
16207769|NCT01989572|39239934|FG000|Overall Study|Adverse Event|2|||
16207770|NCT01989572|39239935|FG001|Overall Study|Adverse Event|1|||
16396884|NCT01238991|39935307|FG001|Overall Study|Lack of Efficacy|0|||
16207771|NCT01989572|39239936|FG002|Overall Study|Adverse Event|3|||
16207772|NCT01989572|39239937|FG003|Overall Study|Adverse Event|0|||
16207773|NCT01989572|39239938|FG004|Overall Study|Adverse Event|3|||
16207774|NCT01989572|39239939|FG005|Overall Study|Adverse Event|0|||
16207775|NCT01989572|39239934|FG000|Overall Study|Death|0|||
16207776|NCT01989572|39239935|FG001|Overall Study|Death|0|||
16207777|NCT01989572|39239936|FG002|Overall Study|Death|0|||
16207778|NCT01989572|39239937|FG003|Overall Study|Death|0|||
16207779|NCT01989572|39239938|FG004|Overall Study|Death|1|||
16207780|NCT01989572|39239939|FG005|Overall Study|Death|0|||
16207781|NCT01989572|39239934|FG000|Overall Study|Withdrawal by Subject|4|||
16207782|NCT01989572|39239935|FG001|Overall Study|Withdrawal by Subject|1|||
16207783|NCT01989572|39239936|FG002|Overall Study|Withdrawal by Subject|5|||
16207784|NCT01989572|39239937|FG003|Overall Study|Withdrawal by Subject|1|||
16207785|NCT01989572|39239938|FG004|Overall Study|Withdrawal by Subject|12|||
16207786|NCT01989572|39239939|FG005|Overall Study|Withdrawal by Subject|4|||
16207787|NCT01989572|39239934|FG000|Overall Study|complicating disease|1|||
16207788|NCT01989572|39239935|FG001|Overall Study|complicating disease|1|||
16207789|NCT01989572|39239936|FG002|Overall Study|complicating disease|2|||
16207790|NCT01989572|39239937|FG003|Overall Study|complicating disease|0|||
16207791|NCT01989572|39239938|FG004|Overall Study|complicating disease|1|||
16396885|NCT01238991|39935308|FG002|Overall Study|Lack of Efficacy|1|||
16396886|NCT01238991|39935309|FG003|Overall Study|Lack of Efficacy|0|||
16396887|NCT01238991|39935310|FG004|Overall Study|Lack of Efficacy|0|||
16207792|NCT01989572|39239939|FG005|Overall Study|complicating disease|0|||
16207793|NCT01989572|39239934|FG000|Overall Study|error|2|||
16207794|NCT01989572|39239935|FG001|Overall Study|error|1|||
16207795|NCT01989572|39239936|FG002|Overall Study|error|1|||
16207796|NCT01989572|39239937|FG003|Overall Study|error|1|||
16207797|NCT01989572|39239938|FG004|Overall Study|error|1|||
16207798|NCT01989572|39239939|FG005|Overall Study|error|1|||
16207799|NCT01989572|39239934|FG000|Overall Study|maximum dose reached|0|||
16207800|NCT01989572|39239935|FG001|Overall Study|maximum dose reached|1|||
16207801|NCT01989572|39239936|FG002|Overall Study|maximum dose reached|0|||
16207802|NCT01989572|39239937|FG003|Overall Study|maximum dose reached|0|||
16207803|NCT01989572|39239938|FG004|Overall Study|maximum dose reached|1|||
16207804|NCT01989572|39239939|FG005|Overall Study|maximum dose reached|0|||
16396888|NCT01238991|39935311|FG005|Overall Study|Lack of Efficacy|0|||
16396889|NCT01238991|39935312|FG006|Overall Study|Lack of Efficacy|0|||
16396890|NCT01238991|39935313|FG007|Overall Study|Lack of Efficacy|0|||
16396891|NCT01238991|39935314|FG008|Overall Study|Lack of Efficacy|1|||
16207805|NCT01989572|39239934|FG000|Overall Study|unknown/not specify|3|||
16207806|NCT01989572|39239935|FG001|Overall Study|unknown/not specify|4|||
16207807|NCT01989572|39239936|FG002|Overall Study|unknown/not specify|1|||
16207808|NCT01989572|39239937|FG003|Overall Study|unknown/not specify|3|||
16207809|NCT01989572|39239938|FG004|Overall Study|unknown/not specify|3|||
16207810|NCT01989572|39239939|FG005|Overall Study|unknown/not specify|5|||
16207811|NCT01989572|39239934|FG000|Overall Study|not start protocol therapy|5|||
16207812|NCT01989572|39239935|FG001|Overall Study|not start protocol therapy|1|||
16207813|NCT01989572|39239936|FG002|Overall Study|not start protocol therapy|2|||
16207814|NCT01989572|39239937|FG003|Overall Study|not start protocol therapy|3|||
16207815|NCT01989572|39239938|FG004|Overall Study|not start protocol therapy|4|||
16207816|NCT01989572|39239939|FG005|Overall Study|not start protocol therapy|18|||
16207817|NCT01989572|39239934|FG000|Overall Study|alternative therapy|3|||
16207818|NCT01989572|39239935|FG001|Overall Study|alternative therapy|0|||
16207819|NCT01989572|39239936|FG002|Overall Study|alternative therapy|0|||
16207820|NCT01989572|39239937|FG003|Overall Study|alternative therapy|0|||
16207821|NCT01989572|39239938|FG004|Overall Study|alternative therapy|1|||
16207822|NCT01989572|39239939|FG005|Overall Study|alternative therapy|3|||
16207823|NCT00389441|39239942|FG000|Overall Study|Adverse Event|7|||
16207824|NCT00389441|39239942|FG000|Overall Study|Death|4|||
16207825|NCT00389441|39239942|FG000|Overall Study|Lost to Follow-up|2|||
16207826|NCT00389441|39239942|FG000|Overall Study|Withdrawal by Subject|4|||
16207827|NCT00389441|39239942|FG000|Overall Study|Physician Decision|1|||
16207828|NCT00389441|39239942|FG000|Overall Study|Protocol Violation|1|||
16207829|NCT00389441|39239942|FG000|Overall Study|Global deterioration of health status|4|||
16207830|NCT00389441|39239942|FG000|Overall Study|Objective progression or relapse|26|||
16207831|NCT00389441|39239942|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
16396892|NCT01238991|39935315|FG009|Overall Study|Lack of Efficacy|0|||
16396893|NCT01238991|39935306|FG000|Overall Study|Withdrawal by Subject|0|||
16396894|NCT01238991|39935307|FG001|Overall Study|Withdrawal by Subject|0|||
16207832|NCT00389441|39239942|FG000|Overall Study|Clinical progression|1|||
16207833|NCT01444898|39239943|FG000|Overall Study|Withdrawal by Subject|1|||
16207834|NCT01146951|39239946|FG000|Overall Study|Adverse Event|4|||
16207835|NCT01146951|39239947|FG001|Overall Study|Adverse Event|1|||
16207836|NCT01448707|39239950|FG000|Overall Study|Adverse Event|3|||
16207837|NCT01448707|39239951|FG001|Overall Study|Adverse Event|1|||
16207838|NCT01448707|39239950|FG000|Overall Study|Lost to Follow-up|2|||
16207839|NCT01448707|39239951|FG001|Overall Study|Lost to Follow-up|6|||
16207840|NCT01448707|39239950|FG000|Overall Study|Withdrawal by Subject|6|||
16396895|NCT01238991|39935308|FG002|Overall Study|Withdrawal by Subject|1|||
16396896|NCT01238991|39935309|FG003|Overall Study|Withdrawal by Subject|0|||
16396897|NCT01238991|39935310|FG004|Overall Study|Withdrawal by Subject|0|||
16396898|NCT01238991|39935311|FG005|Overall Study|Withdrawal by Subject|0|||
16396899|NCT01238991|39935312|FG006|Overall Study|Withdrawal by Subject|0|||
16396900|NCT01238991|39935313|FG007|Overall Study|Withdrawal by Subject|0|||
16396901|NCT01238991|39935314|FG008|Overall Study|Withdrawal by Subject|0|||
16396902|NCT01238991|39935315|FG009|Overall Study|Withdrawal by Subject|0|||
16396903|NCT01238991|39935306|FG000|Overall Study|Study Terminated by Sponsor|0|||
16396904|NCT01238991|39935307|FG001|Overall Study|Study Terminated by Sponsor|0|||
16396905|NCT01238991|39935308|FG002|Overall Study|Study Terminated by Sponsor|0|||
16396906|NCT01238991|39935309|FG003|Overall Study|Study Terminated by Sponsor|0|||
16396907|NCT01238991|39935310|FG004|Overall Study|Study Terminated by Sponsor|1|||
16396908|NCT01238991|39935311|FG005|Overall Study|Study Terminated by Sponsor|0|||
16396909|NCT01238991|39935312|FG006|Overall Study|Study Terminated by Sponsor|7|||
16396910|NCT01238991|39935313|FG007|Overall Study|Study Terminated by Sponsor|4|||
16095097|NCT03761849|38839337|FG004|Overall Study|Patient did not attend visit|0|||
16396911|NCT01238991|39935314|FG008|Overall Study|Study Terminated by Sponsor|2|||
16396912|NCT01238991|39935315|FG009|Overall Study|Study Terminated by Sponsor|2|||
16396913|NCT01238991|39935306|FG000|Overall Study|Caregiver's request|0|||
16396914|NCT01238991|39935307|FG001|Overall Study|Caregiver's request|0|||
16396915|NCT01238991|39935308|FG002|Overall Study|Caregiver's request|0|||
16396916|NCT01238991|39935309|FG003|Overall Study|Caregiver's request|0|||
16396917|NCT01238991|39935310|FG004|Overall Study|Caregiver's request|0|||
16396918|NCT01238991|39935311|FG005|Overall Study|Caregiver's request|0|||
16396919|NCT01238991|39935312|FG006|Overall Study|Caregiver's request|0|||
16396920|NCT01238991|39935313|FG007|Overall Study|Caregiver's request|0|||
16396921|NCT01238991|39935314|FG008|Overall Study|Caregiver's request|1|||
16396922|NCT01238991|39935315|FG009|Overall Study|Caregiver's request|0|||
16396923|NCT01238991|39935306|FG000|Overall Study|Admission to a nursing home|1|||
16396924|NCT01238991|39935307|FG001|Overall Study|Admission to a nursing home|0|||
16396925|NCT01238991|39935308|FG002|Overall Study|Admission to a nursing home|1|||
16396926|NCT01238991|39935309|FG003|Overall Study|Admission to a nursing home|0|||
16095098|NCT03761849|38839338|FG005|Overall Study|Patient did not attend visit|1|||
16095099|NCT03493282|38839339|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
16095100|NCT03493282|38839340|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
16095101|NCT03493282|38839341|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
16095102|NCT03493282|38839339|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
16095103|NCT03493282|38839340|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
16095104|NCT03493282|38839341|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
16095105|NCT01999335|38839343|FG000|Overall Study|Discontinued before receiving treatment|0|||
16095106|NCT01999335|38839344|FG001|Overall Study|Discontinued before receiving treatment|0|||
16095107|NCT01999335|38839345|FG002|Overall Study|Discontinued before receiving treatment|0|||
16095108|NCT01999335|38839346|FG003|Overall Study|Discontinued before receiving treatment|0|||
16095109|NCT01999335|38839347|FG004|Overall Study|Discontinued before receiving treatment|2|||
16095110|NCT04175392|38839350|FG000|Overall Study|Withdrawal by Subject|3|||
16095111|NCT04175392|38839351|FG001|Overall Study|Withdrawal by Subject|2|||
16095112|NCT01365546|38839354|FG000|Overall Study|Withdrawal by Subject|1|||
16095113|NCT01365546|38839354|FG000|Overall Study|Screen failure|9|||
16095114|NCT01365546|38839354|FG000|Overall Study|Study termination|1|||
16095115|NCT02305797|38839355|FG000|Overall Study|Adverse Event|11|||
16095116|NCT02305797|38839356|FG001|Overall Study|Adverse Event|2|||
16095117|NCT02305797|38839355|FG000|Overall Study|Withdrawal by Subject|9|||
16095118|NCT02305797|38839356|FG001|Overall Study|Withdrawal by Subject|10|||
16095119|NCT02305797|38839355|FG000|Overall Study|Lack of Efficacy|6|||
16095120|NCT02305797|38839356|FG001|Overall Study|Lack of Efficacy|0|||
16095121|NCT02305797|38839355|FG000|Overall Study|Lost to Follow-up|5|||
16095122|NCT02305797|38839356|FG001|Overall Study|Lost to Follow-up|11|||
16095123|NCT02305797|38839355|FG000|Overall Study|Pregnancy|0|||
16095124|NCT02305797|38839356|FG001|Overall Study|Pregnancy|2|||
16095125|NCT02305797|38839355|FG000|Overall Study|Noncompliance|14|||
16095126|NCT02305797|38839356|FG001|Overall Study|Noncompliance|12|||
16095127|NCT02305797|38839355|FG000|Overall Study|Reason not collected|0|||
16095128|NCT02305797|38839356|FG001|Overall Study|Reason not collected|1|||
16207841|NCT01448707|39239951|FG001|Overall Study|Withdrawal by Subject|7|||
16396927|NCT01238991|39935310|FG004|Overall Study|Admission to a nursing home|0|||
16396928|NCT01238991|39935311|FG005|Overall Study|Admission to a nursing home|0|||
16396929|NCT01238991|39935312|FG006|Overall Study|Admission to a nursing home|0|||
16396930|NCT01238991|39935313|FG007|Overall Study|Admission to a nursing home|0|||
16396931|NCT01238991|39935314|FG008|Overall Study|Admission to a nursing home|0|||
16095129|NCT01737398|38839357|FG000|Overall Study|Adverse event or SAE|16|||
16095130|NCT01737398|38839358|FG001|Overall Study|Adverse event or SAE|1|||
16095131|NCT01737398|38839357|FG000|Overall Study|Stopping rule met|2|||
16095132|NCT01737398|38839358|FG001|Overall Study|Stopping rule met|1|||
16523245|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
16523246|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
16523247|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
16523248|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
16523249|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
16523250|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
16523251|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
16523252|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
16523253|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
16523254|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
16523255|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
16523256|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
16523257|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
16523258|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
16523259|NCT01884350|40383727|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
16523260|NCT01884350|40383728|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
16523261|NCT01884350|40383729|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
16523262|NCT02219932|40383730|FG000|Overall Study|Other|5|||
16523263|NCT02219932|40383731|FG001|Overall Study|Other|11|||
16523264|NCT02219932|40383730|FG000|Overall Study|Death|1|||
16523265|NCT02219932|40383731|FG001|Overall Study|Death|1|||
16523266|NCT02219932|40383730|FG000|Overall Study|Investigator Decision|0|||
16523267|NCT02219932|40383731|FG001|Overall Study|Investigator Decision|1|||
16523268|NCT02219932|40383730|FG000|Overall Study|Consent Withdrawn|11|||
16523269|NCT02219932|40383731|FG001|Overall Study|Consent Withdrawn|7|||
16523270|NCT02219932|40383730|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
16523271|NCT02219932|40383731|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
16523272|NCT02219932|40383730|FG000|Overall Study|Protocol Violation|10|||
16523273|NCT02219932|40383731|FG001|Overall Study|Protocol Violation|6|||
16523274|NCT02219932|40383730|FG000|Overall Study|Pregnancy|1|||
16523275|NCT02219932|40383731|FG001|Overall Study|Pregnancy|0|||
16523276|NCT02219932|40383730|FG000|Overall Study|Lost to Follow-up|4|||
16523277|NCT02219932|40383731|FG001|Overall Study|Lost to Follow-up|2|||
16523278|NCT02219932|40383730|FG000|Overall Study|Adverse Event|23|||
16523279|NCT02219932|40383731|FG001|Overall Study|Adverse Event|21|||
16523280|NCT01802411|40383732|FG000|Overall Study|Death|2|||
16523281|NCT01802411|40383733|FG001|Overall Study|Death|1|||
16207842|NCT01448707|39239950|FG000|Overall Study|Other|7|||
16523282|NCT01802411|40383732|FG000|Overall Study|Adverse Event|2|||
16523283|NCT01802411|40383733|FG001|Overall Study|Adverse Event|7|||
16523284|NCT01802411|40383732|FG000|Overall Study|Lack of Efficacy|8|||
16523285|NCT01802411|40383733|FG001|Overall Study|Lack of Efficacy|10|||
16523286|NCT01802411|40383732|FG000|Overall Study|Withdrawal by Subject|0|||
16523287|NCT01802411|40383733|FG001|Overall Study|Withdrawal by Subject|2|||
16523288|NCT01802411|40383732|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
16523289|NCT01802411|40383733|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
16523290|NCT01802411|40383732|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
16523291|NCT01802411|40383733|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
16523292|NCT01802411|40383732|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
16523293|NCT01802411|40383733|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
16523294|NCT01462344|40383736|FG000|Overall Study|Withdrawal by Subject|245|||
16523295|NCT01462344|40383737|FG001|Overall Study|Withdrawal by Subject|226|||
16523296|NCT01462344|40383736|FG000|Overall Study|Adverse Event|24|||
16523297|NCT01462344|40383737|FG001|Overall Study|Adverse Event|23|||
16523298|NCT01462344|40383736|FG000|Overall Study|Asthma Exacerbation|34|||
16523299|NCT01462344|40383737|FG001|Overall Study|Asthma Exacerbation|35|||
16523300|NCT01462344|40383736|FG000|Overall Study|Lack of Efficacy|5|||
16523301|NCT01462344|40383737|FG001|Overall Study|Lack of Efficacy|6|||
16523302|NCT01462344|40383736|FG000|Overall Study|Protocol Violation|68|||
16523303|NCT01462344|40383737|FG001|Overall Study|Protocol Violation|53|||
16523304|NCT01462344|40383736|FG000|Overall Study|Lost to Follow-up|7|||
16523305|NCT01462344|40383737|FG001|Overall Study|Lost to Follow-up|7|||
16523306|NCT00093145|40383738|FG000|Overall Study|Unacceptable Toxicity Only|2|||
16523307|NCT00093145|40383738|FG000|Overall Study|Physician Decision|5|||
16523308|NCT00093145|40383738|FG000|Overall Study|Withdrawal by Subject|9|||
16523309|NCT00093145|40383738|FG000|Overall Study|Other|1|||
16523310|NCT03893448|40383739|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
16523311|NCT03893448|40383740|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
16523312|NCT03893448|40383739|FG000|Overall Study|Physician Decision|8|||
16523313|NCT03893448|40383740|FG001|Overall Study|Physician Decision|14|||
16523314|NCT03893448|40383739|FG000|Overall Study|Lost to Follow-up|34|||
16523315|NCT03893448|40383740|FG001|Overall Study|Lost to Follow-up|27|||
16523316|NCT03893448|40383739|FG000|Overall Study|Death|1|||
16523317|NCT03893448|40383740|FG001|Overall Study|Death|0|||
16523318|NCT02460991|40383741|FG000|Overall Study|Withdrawal by Subject|0|||
16523319|NCT02460991|40383742|FG001|Overall Study|Withdrawal by Subject|2|||
16523320|NCT04574362|40383743|FG000|Overall Study|Other|0|||
16523321|NCT04574362|40383744|FG001|Overall Study|Other|5|||
16523322|NCT04574362|40383743|FG000|Overall Study|COVID-19|0|||
16523323|NCT04574362|40383744|FG001|Overall Study|COVID-19|1|||
16523324|NCT04574362|40383743|FG000|Overall Study|Adverse Event|1|||
16523325|NCT04574362|40383744|FG001|Overall Study|Adverse Event|1|||
16523326|NCT04574362|40383743|FG000|Overall Study|Withdrawal by Subject|2|||
16523327|NCT04574362|40383744|FG001|Overall Study|Withdrawal by Subject|4|||
16523328|NCT04574362|40383743|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
16523329|NCT04574362|40383744|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
16523330|NCT04574362|40383743|FG000|Overall Study|Participant refused to come to the hospital|1|||
16523331|NCT04574362|40383744|FG001|Overall Study|Participant refused to come to the hospital|0|||
16523332|NCT04574362|40383743|FG000|Overall Study|Participant refused the visit|1|||
16523333|NCT04574362|40383744|FG001|Overall Study|Participant refused the visit|0|||
16523334|NCT04574362|40383743|FG000|Overall Study|Participant quit early because of business trip|1|||
16523335|NCT04574362|40383744|FG001|Overall Study|Participant quit early because of business trip|0|||
16523336|NCT00614939|40383745|FG000|Overall Study|Withdrawal by Subject|10|||
16523337|NCT00614939|40383746|FG001|Overall Study|Withdrawal by Subject|17|||
16095133|NCT01737398|38839357|FG000|Overall Study|Voluntary withdrawal|2|||
16095134|NCT01737398|38839358|FG001|Overall Study|Voluntary withdrawal|3|||
16095135|NCT01737398|38839357|FG000|Overall Study|Ineligibility|1|||
16095136|NCT01737398|38839358|FG001|Overall Study|Ineligibility|0|||
16095137|NCT01737398|38839357|FG000|Overall Study|Liver transplant|1|||
16095138|NCT01737398|38839358|FG001|Overall Study|Liver transplant|0|||
16095139|NCT01737398|38839357|FG000|Overall Study|Disease progression|2|||
16095140|NCT01737398|38839358|FG001|Overall Study|Disease progression|3|||
16095141|NCT01737398|38839357|FG000|Overall Study|Sponsor's decision|2|||
16095142|NCT01737398|38839358|FG001|Overall Study|Sponsor's decision|0|||
16095143|NCT01525875|38839362|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
16095144|NCT01525875|38839363|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
16095145|NCT01525875|38839362|FG000|Open-label Period|Lost to Follow-up|0|||
16095146|NCT01525875|38839363|FG001|Open-label Period|Lost to Follow-up|2|||
16095147|NCT01261793|38839365|FG000|Overall Study|Lack of Efficacy|44|||
16095148|NCT01261793|38839366|FG001|Overall Study|Lack of Efficacy|37|||
16095149|NCT01261793|38839367|FG002|Overall Study|Lack of Efficacy|32|||
16095150|NCT01261793|38839365|FG000|Overall Study|Protocol Violation|3|||
16095151|NCT01261793|38839366|FG001|Overall Study|Protocol Violation|5|||
16095152|NCT01261793|38839367|FG002|Overall Study|Protocol Violation|6|||
16095153|NCT01261793|38839365|FG000|Overall Study|Lost to Follow-up|10|||
16095154|NCT01261793|38839366|FG001|Overall Study|Lost to Follow-up|3|||
16095155|NCT01261793|38839367|FG002|Overall Study|Lost to Follow-up|7|||
16095156|NCT01261793|38839365|FG000|Overall Study|Withdrawal by Subject|12|||
16095157|NCT01261793|38839366|FG001|Overall Study|Withdrawal by Subject|14|||
16095158|NCT01261793|38839367|FG002|Overall Study|Withdrawal by Subject|14|||
16095159|NCT01261793|38839365|FG000|Overall Study|Death|3|||
16095160|NCT01261793|38839366|FG001|Overall Study|Death|1|||
16095161|NCT01261793|38839367|FG002|Overall Study|Death|0|||
16095162|NCT01261793|38839365|FG000|Overall Study|Adverse Event|9|||
16095163|NCT01261793|38839366|FG001|Overall Study|Adverse Event|24|||
16095164|NCT01261793|38839367|FG002|Overall Study|Adverse Event|19|||
16095165|NCT01261793|38839365|FG000|Overall Study|Patient non-availability|1|||
16095166|NCT01261793|38839366|FG001|Overall Study|Patient non-availability|1|||
16095167|NCT01261793|38839367|FG002|Overall Study|Patient non-availability|1|||
16095168|NCT01261793|38839365|FG000|Overall Study|Suspected pregnancy|1|||
16095169|NCT01261793|38839366|FG001|Overall Study|Suspected pregnancy|1|||
16095170|NCT01261793|38839367|FG002|Overall Study|Suspected pregnancy|0|||
16095171|NCT01261793|38839365|FG000|Overall Study|Patient non-compliance|1|||
16095172|NCT01261793|38839366|FG001|Overall Study|Patient non-compliance|0|||
16095173|NCT01261793|38839367|FG002|Overall Study|Patient non-compliance|1|||
16095174|NCT01261793|38839365|FG000|Overall Study|Patient pregnant|1|||
16095175|NCT01261793|38839366|FG001|Overall Study|Patient pregnant|0|||
16095176|NCT01261793|38839367|FG002|Overall Study|Patient pregnant|0|||
16095177|NCT01261793|38839365|FG000|Overall Study|Outside the study area|0|||
16095178|NCT01261793|38839366|FG001|Overall Study|Outside the study area|2|||
16095179|NCT01261793|38839367|FG002|Overall Study|Outside the study area|1|||
16095180|NCT01261793|38839365|FG000|Overall Study|Lack of efficacy & patient not available|0|||
16095181|NCT01261793|38839366|FG001|Overall Study|Lack of efficacy & patient not available|1|||
16523338|NCT00614939|40383745|FG000|Overall Study|Study specific discontinuation criteris|13|||
16095182|NCT01261793|38839367|FG002|Overall Study|Lack of efficacy & patient not available|0|||
16095183|NCT01261793|38839365|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
16095184|NCT01261793|38839366|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
16095185|NCT01261793|38839367|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
16095186|NCT01261793|38839365|FG000|Overall Study|Randomization error|0|||
16095187|NCT01261793|38839366|FG001|Overall Study|Randomization error|1|||
16095188|NCT01261793|38839367|FG002|Overall Study|Randomization error|0|||
16095189|NCT01261793|38839365|FG000|Overall Study|Patient unable to start IV line|0|||
16095190|NCT01261793|38839366|FG001|Overall Study|Patient unable to start IV line|0|||
16095191|NCT01261793|38839367|FG002|Overall Study|Patient unable to start IV line|1|||
16095192|NCT01774929|38839368|FG000|Overall Study|Adverse Event|3|||
16095193|NCT00308113|38839369|FG000|Overall Study|Protocol closure|0|||
16095194|NCT00308113|38839370|FG001|Overall Study|Protocol closure|0|||
16095195|NCT00308113|38839371|FG002|Overall Study|Protocol closure|0|||
16095196|NCT00308113|38839372|FG003|Overall Study|Protocol closure|1|||
16095197|NCT01061775|38839373|FG000|Overall Study|Physician Decision|2|||
16095198|NCT01061775|38839373|FG000|Overall Study|Lost to Follow-up|1|||
16095199|NCT01377844|38839374|FG000|Overall Study|Withdrawal by Subject|25|||
16095200|NCT01377844|38839375|FG001|Overall Study|Withdrawal by Subject|28|||
16095201|NCT01377844|38839374|FG000|Overall Study|Protocol Violation|2|||
16095202|NCT01377844|38839375|FG001|Overall Study|Protocol Violation|3|||
16095203|NCT01377844|38839374|FG000|Overall Study|Adverse Event|3|||
16326311|NCT03483961|39681536|FG007|Overall Study|Lost to Follow-up|11|||
16326312|NCT03483961|39681537|FG008|Overall Study|Lost to Follow-up|1|||
16095204|NCT01377844|38839375|FG001|Overall Study|Adverse Event|0|||
16095205|NCT01377844|38839374|FG000|Overall Study|Physician Decision|6|||
16095206|NCT01377844|38839375|FG001|Overall Study|Physician Decision|3|||
16095207|NCT01377844|38839374|FG000|Overall Study|Study terminated by Sponsor|0|||
16095208|NCT01377844|38839375|FG001|Overall Study|Study terminated by Sponsor|1|||
16095209|NCT03769090|38839376|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
16095210|NCT03769090|38839377|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
16326313|NCT03483961|39681538|FG009|Overall Study|Lost to Follow-up|0|||
16095211|NCT03769090|38839378|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
16095212|NCT03769090|38839376|FG000|Overall Study|Withdrawal by Subject|52|||
16095213|NCT03769090|38839377|FG001|Overall Study|Withdrawal by Subject|62|||
16095214|NCT03769090|38839378|FG002|Overall Study|Withdrawal by Subject|74|||
16095215|NCT03769090|38839376|FG000|Overall Study|Death|4|||
16095216|NCT03769090|38839377|FG001|Overall Study|Death|2|||
16095217|NCT03769090|38839378|FG002|Overall Study|Death|2|||
16095218|NCT03769090|38839376|FG000|Overall Study|Adverse Event|7|||
16095219|NCT03769090|38839377|FG001|Overall Study|Adverse Event|7|||
16095220|NCT03769090|38839378|FG002|Overall Study|Adverse Event|8|||
16095221|NCT03769090|38839376|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
16095222|NCT03769090|38839377|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
16095223|NCT03769090|38839378|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
16095224|NCT03769090|38839376|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
16095225|NCT03769090|38839377|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
16095226|NCT03769090|38839378|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
16095227|NCT03769090|38839376|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
16095228|NCT03769090|38839377|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
16095229|NCT03769090|38839378|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
16095230|NCT03769090|38839376|FG000|Overall Study|Protocol Violation|5|||
16095231|NCT03769090|38839377|FG001|Overall Study|Protocol Violation|6|||
16095232|NCT03769090|38839378|FG002|Overall Study|Protocol Violation|8|||
16095233|NCT03769090|38839376|FG000|Overall Study|Pregnancy|1|||
16095234|NCT03769090|38839377|FG001|Overall Study|Pregnancy|0|||
16095235|NCT03769090|38839378|FG002|Overall Study|Pregnancy|3|||
16095236|NCT03769090|38839376|FG000|Overall Study|Lost to Follow-up|19|||
16095237|NCT03769090|38839377|FG001|Overall Study|Lost to Follow-up|25|||
16095238|NCT03769090|38839378|FG002|Overall Study|Lost to Follow-up|21|||
16326314|NCT03483961|39681529|FG000|Overall Study|Withdrawal by Subject|3|||
16326315|NCT03483961|39681530|FG001|Overall Study|Withdrawal by Subject|4|||
16523339|NCT00614939|40383746|FG001|Overall Study|Study specific discontinuation criteris|16|||
16523340|NCT00614939|40383745|FG000|Overall Study|Adverse Event|2|||
16523341|NCT00614939|40383746|FG001|Overall Study|Adverse Event|5|||
16523342|NCT00614939|40383745|FG000|Overall Study|Incorrect enrollment|1|||
16523343|NCT00614939|40383746|FG001|Overall Study|Incorrect enrollment|2|||
16523344|NCT00614939|40383745|FG000|Overall Study|Death|4|||
16523345|NCT00614939|40383746|FG001|Overall Study|Death|3|||
16523346|NCT00614939|40383745|FG000|Overall Study|Poor/non-compliance|4|||
16523347|NCT00614939|40383746|FG001|Overall Study|Poor/non-compliance|0|||
16095239|NCT03769090|38839376|FG000|Overall Study|Condition under investigation worsened|2|||
16095240|NCT03769090|38839377|FG001|Overall Study|Condition under investigation worsened|0|||
16095241|NCT03769090|38839378|FG002|Overall Study|Condition under investigation worsened|1|||
16095242|NCT03769090|38839376|FG000|Overall Study|Lack of Efficacy|1|||
16095243|NCT03769090|38839377|FG001|Overall Study|Lack of Efficacy|2|||
16095244|NCT03769090|38839378|FG002|Overall Study|Lack of Efficacy|2|||
16095245|NCT03769090|38839376|FG000|Overall Study|Other reasons|8|||
16095246|NCT03769090|38839377|FG001|Overall Study|Other reasons|12|||
16095247|NCT03769090|38839378|FG002|Overall Study|Other reasons|15|||
16095248|NCT01277302|38839379|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
16326316|NCT03483961|39681531|FG002|Overall Study|Withdrawal by Subject|5|||
16523348|NCT00614939|40383745|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
16095249|NCT01277302|38839380|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
16095250|NCT01277302|38839381|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
16095251|NCT01277302|38839379|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
16095252|NCT01277302|38839380|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
16095253|NCT01277302|38839381|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
16095254|NCT01277302|38839379|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
16095255|NCT01277302|38839380|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
16095256|NCT01277302|38839381|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
16095257|NCT01277302|38839379|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
16095258|NCT01277302|38839380|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
16095259|NCT01277302|38839381|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
16095260|NCT01277302|38839379|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
16095261|NCT01277302|38839380|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
16207843|NCT01448707|39239951|FG001|Overall Study|Other|4|||
16207844|NCT01002742|39239952|FG000|Overall Study|Determined to be ineligible|0|||
16207845|NCT01002742|39239953|FG001|Overall Study|Determined to be ineligible|1|||
16207846|NCT01300767|39239954|FG000|Overall Study|Discomfort|2|||
16207847|NCT01300767|39239954|FG000|Overall Study|Biomicroscopy|1|||
16207848|NCT01300767|39239954|FG000|Overall Study|Unacceptable fit|1|||
16207849|NCT00571688|39239965|FG000|Overall Study|Lost to Follow-up|3|||
16207850|NCT00571688|39239966|FG001|Overall Study|Lost to Follow-up|6|||
16207851|NCT00571688|39239965|FG000|Overall Study|subject did not tolerate Consta|1|||
16207852|NCT00571688|39239966|FG001|Overall Study|subject did not tolerate Consta|0|||
16207853|NCT00571688|39239965|FG000|Overall Study|subject moved out of the area|1|||
16207854|NCT00571688|39239966|FG001|Overall Study|subject moved out of the area|0|||
16396932|NCT01238991|39935315|FG009|Overall Study|Admission to a nursing home|0|||
16396933|NCT00933608|39935318|FG000|Overall Study|Adverse Event|4|||
16396934|NCT00933608|39935319|FG001|Overall Study|Adverse Event|2|||
16396935|NCT00933608|39935318|FG000|Overall Study|Physician Decision|1|||
16396936|NCT00933608|39935319|FG001|Overall Study|Physician Decision|0|||
16523349|NCT00614939|40383746|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
16523350|NCT02223390|40383747|FG000|Overall Study|Lost to Follow-up|9|||
16523351|NCT02223390|40383748|FG001|Overall Study|Lost to Follow-up|4|||
16523352|NCT01055639|40383749|FG000|Overall Study|Adverse Event|0|||
16523353|NCT01055639|40383750|FG001|Overall Study|Adverse Event|1|||
16523354|NCT01055639|40383749|FG000|Overall Study|Lack of Efficacy|0|||
16523355|NCT01055639|40383750|FG001|Overall Study|Lack of Efficacy|1|||
16523356|NCT01055639|40383749|FG000|Overall Study|Lost to Follow-up|8|||
16523357|NCT01055639|40383750|FG001|Overall Study|Lost to Follow-up|11|||
16523358|NCT01055639|40383749|FG000|Overall Study|Protocol Violation|5|||
16523359|NCT01055639|40383750|FG001|Overall Study|Protocol Violation|5|||
16523360|NCT01055639|40383749|FG000|Overall Study|Withdrawal by Subject|8|||
16396937|NCT00313144|39935320|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
16523361|NCT01055639|40383750|FG001|Overall Study|Withdrawal by Subject|11|||
16523362|NCT01962974|40383751|FG000|Overall Study|Study termination|7|||
16095262|NCT01277302|38839381|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
16095263|NCT01277302|38839379|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
16095264|NCT01277302|38839380|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
16326317|NCT03483961|39681532|FG003|Overall Study|Withdrawal by Subject|3|||
16326318|NCT03483961|39681533|FG004|Overall Study|Withdrawal by Subject|4|||
16326319|NCT03483961|39681534|FG005|Overall Study|Withdrawal by Subject|2|||
16523363|NCT00406029|40383762|FG000|Overall Study|Adverse Event|12|||
16523364|NCT00406029|40383763|FG001|Overall Study|Adverse Event|2|||
16523365|NCT00406029|40383764|FG002|Overall Study|Adverse Event|5|||
16523366|NCT00406029|40383765|FG003|Overall Study|Adverse Event|10|||
16523367|NCT00406029|40383766|FG004|Overall Study|Adverse Event|7|||
16523368|NCT00406029|40383762|FG000|Overall Study|Withdrawal by Subject|3|||
16523369|NCT00406029|40383763|FG001|Overall Study|Withdrawal by Subject|4|||
16523370|NCT00406029|40383764|FG002|Overall Study|Withdrawal by Subject|2|||
16523371|NCT00406029|40383765|FG003|Overall Study|Withdrawal by Subject|2|||
16523372|NCT00406029|40383766|FG004|Overall Study|Withdrawal by Subject|0|||
16523373|NCT00406029|40383762|FG000|Overall Study|Protocol Violation|1|||
16523374|NCT00406029|40383763|FG001|Overall Study|Protocol Violation|2|||
16523375|NCT00406029|40383764|FG002|Overall Study|Protocol Violation|0|||
16523376|NCT00406029|40383765|FG003|Overall Study|Protocol Violation|2|||
16523377|NCT00406029|40383766|FG004|Overall Study|Protocol Violation|0|||
16523378|NCT00406029|40383762|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
16326320|NCT03483961|39681535|FG006|Overall Study|Withdrawal by Subject|1|||
16326321|NCT03483961|39681536|FG007|Overall Study|Withdrawal by Subject|2|||
16326322|NCT03483961|39681537|FG008|Overall Study|Withdrawal by Subject|1|||
16326323|NCT03483961|39681538|FG009|Overall Study|Withdrawal by Subject|0|||
16326324|NCT03483961|39681529|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
16326325|NCT03483961|39681530|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
16326326|NCT03483961|39681531|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
16326327|NCT03483961|39681532|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
16326328|NCT03483961|39681533|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
16346366|NCT02367040|39753294|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
16346367|NCT02367040|39753293|FG000|Overall Study|Death|2|||
16523379|NCT00406029|40383763|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
16523380|NCT00406029|40383764|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
16523381|NCT00406029|40383765|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
16523382|NCT00406029|40383766|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
16523383|NCT00406029|40383762|FG000|Overall Study|Randomized in Error|0|||
16523384|NCT00406029|40383763|FG001|Overall Study|Randomized in Error|0|||
16523385|NCT00406029|40383764|FG002|Overall Study|Randomized in Error|2|||
16523386|NCT00406029|40383765|FG003|Overall Study|Randomized in Error|3|||
16523387|NCT00406029|40383766|FG004|Overall Study|Randomized in Error|1|||
16523388|NCT01669343|40383769|FG000|Part A: All Patients|Withdrawal by Subject|7|||
16523389|NCT01669343|40383769|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
16523390|NCT01669343|40383769|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
16346368|NCT02367040|39753294|FG001|Overall Study|Death|0|||
16346369|NCT05404711|39753296|FG000|Completed Study Visit|Withdrawal by Subject|1|||
16346370|NCT05404711|39753296|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
16346371|NCT05404711|39753296|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
16346372|NCT05404711|39753296|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
16346373|NCT05404711|39753296|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
16346374|NCT05404711|39753296|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
16346375|NCT01210482|39753301|FG000|Overall Study|Protocol Violation|1|||
16346376|NCT01210482|39753301|FG000|Overall Study|Case Report Forms were not collected|18|||
16346377|NCT01210482|39753301|FG000|Overall Study|Duplicated|2|||
16346378|NCT01210482|39753301|FG000|Overall Study|No Drug Administration|28|||
16346379|NCT04739800|39753302|FG000|Overall Study|Adverse Event|2|||
16346380|NCT04739800|39753303|FG001|Overall Study|Adverse Event|1|||
16346381|NCT04739800|39753304|FG002|Overall Study|Adverse Event|4|||
16346382|NCT04739800|39753305|FG003|Overall Study|Adverse Event|5|||
16523391|NCT01669343|40383769|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
16523392|NCT01669343|40383769|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
16523393|NCT04193202|40383771|FG000|Overall Study|Adverse Event|2|||
16523394|NCT04193202|40383772|FG001|Overall Study|Adverse Event|1|||
16523395|NCT04193202|40383771|FG000|Overall Study|Death|0|||
16523396|NCT04193202|40383772|FG001|Overall Study|Death|1|||
16523397|NCT04193202|40383771|FG000|Overall Study|Physician Decision|1|||
16207855|NCT01457924|39239969|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
16207856|NCT01457924|39239970|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
16207857|NCT01457924|39239971|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
16207858|NCT01457924|39239972|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
16207859|NCT01457924|39239973|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
16207860|NCT01457924|39239969|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
16207861|NCT01457924|39239970|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
16207862|NCT01457924|39239971|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
16207863|NCT01457924|39239972|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
16207864|NCT01457924|39239973|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
16207865|NCT01457924|39239969|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
16207866|NCT01457924|39239970|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
16207867|NCT01457924|39239971|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
16207868|NCT01457924|39239972|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
16326329|NCT03483961|39681534|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
16326330|NCT03483961|39681535|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
16326331|NCT03483961|39681536|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
16326332|NCT03483961|39681537|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
16326333|NCT03483961|39681538|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
16326334|NCT03483961|39681529|FG000|Overall Study|Adverse Event|0|||
16523398|NCT04193202|40383772|FG001|Overall Study|Physician Decision|1|||
16095265|NCT01277302|38839381|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
16095266|NCT01277302|38839379|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
16326335|NCT03483961|39681530|FG001|Overall Study|Adverse Event|0|||
16326336|NCT03483961|39681531|FG002|Overall Study|Adverse Event|1|||
16523399|NCT04193202|40383771|FG000|Overall Study|Protocol Violation|2|||
16523400|NCT04193202|40383772|FG001|Overall Study|Protocol Violation|2|||
16523401|NCT04193202|40383771|FG000|Overall Study|Withdrawal by Subject|11|||
16523402|NCT04193202|40383772|FG001|Overall Study|Withdrawal by Subject|5|||
16523403|NCT00803023|40383773|FG000|Overall Study|Adverse Event|5|||
16523404|NCT00803023|40383774|FG001|Overall Study|Adverse Event|4|||
16523405|NCT00803023|40383775|FG002|Overall Study|Adverse Event|8|||
16523406|NCT00803023|40383776|FG003|Overall Study|Adverse Event|6|||
16523407|NCT00803023|40383773|FG000|Overall Study|Withdrawal by Subject|0|||
16523408|NCT00803023|40383774|FG001|Overall Study|Withdrawal by Subject|2|||
16523409|NCT00803023|40383775|FG002|Overall Study|Withdrawal by Subject|0|||
16523410|NCT00803023|40383776|FG003|Overall Study|Withdrawal by Subject|0|||
16523411|NCT00803023|40383773|FG000|Overall Study|Lost to Follow-up|0|||
16523412|NCT00803023|40383774|FG001|Overall Study|Lost to Follow-up|1|||
16523413|NCT00803023|40383775|FG002|Overall Study|Lost to Follow-up|2|||
16523414|NCT00803023|40383776|FG003|Overall Study|Lost to Follow-up|1|||
16523415|NCT00803023|40383773|FG000|Overall Study|Lack of Efficacy|0|||
16523416|NCT00803023|40383774|FG001|Overall Study|Lack of Efficacy|1|||
16523417|NCT00803023|40383775|FG002|Overall Study|Lack of Efficacy|1|||
16523418|NCT00803023|40383776|FG003|Overall Study|Lack of Efficacy|1|||
16523419|NCT01033747|40383778|FG000|Overall Study|Adverse Event|9|||
16523420|NCT01033747|40383779|FG001|Overall Study|Adverse Event|4|||
16523421|NCT01033747|40383778|FG000|Overall Study|Abnormal Laboratory Value|1|||
16523422|NCT01033747|40383779|FG001|Overall Study|Abnormal Laboratory Value|0|||
16523423|NCT01033747|40383778|FG000|Overall Study|Abnormal test procedure|0|||
16523424|NCT01033747|40383779|FG001|Overall Study|Abnormal test procedure|1|||
16095267|NCT01277302|38839380|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
16326337|NCT03483961|39681532|FG003|Overall Study|Adverse Event|0|||
16326338|NCT03483961|39681533|FG004|Overall Study|Adverse Event|0|||
16326339|NCT03483961|39681534|FG005|Overall Study|Adverse Event|0|||
16326340|NCT03483961|39681535|FG006|Overall Study|Adverse Event|0|||
16523425|NCT01033747|40383778|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
16523426|NCT01033747|40383779|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
16523427|NCT01033747|40383778|FG000|Overall Study|Protocol Violation|1|||
16523428|NCT01033747|40383779|FG001|Overall Study|Protocol Violation|0|||
16523429|NCT01033747|40383778|FG000|Overall Study|Withdrawal by Subject|9|||
16523430|NCT01033747|40383779|FG001|Overall Study|Withdrawal by Subject|6|||
16523431|NCT01033747|40383778|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
16523432|NCT01033747|40383779|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
16326341|NCT03483961|39681536|FG007|Overall Study|Adverse Event|0|||
16523433|NCT01033747|40383778|FG000|Overall Study|Stopped at end of Extension 1|2|||
16523434|NCT01033747|40383779|FG001|Overall Study|Stopped at end of Extension 1|0|||
16523435|NCT03483623|40383780|FG000|Overall Study|43 complete sets achieved|1|||
16523436|NCT01931839|40383781|FG000|Overall Study|Death|0|||
16523437|NCT01931839|40383782|FG001|Overall Study|Death|1|||
16523438|NCT01931839|40383783|FG002|Overall Study|Death|2|||
16523439|NCT01931839|40383784|FG003|Overall Study|Death|0|||
16523440|NCT01931839|40383785|FG004|Overall Study|Death|0|||
16523441|NCT01931839|40383786|FG005|Overall Study|Death|0|||
16523442|NCT01931839|40383787|FG006|Overall Study|Death|0|||
16523443|NCT01931839|40383781|FG000|Overall Study|Physician Decision|1|||
16523444|NCT01931839|40383782|FG001|Overall Study|Physician Decision|0|||
16523445|NCT01931839|40383783|FG002|Overall Study|Physician Decision|1|||
16523446|NCT01931839|40383784|FG003|Overall Study|Physician Decision|0|||
16523447|NCT01931839|40383785|FG004|Overall Study|Physician Decision|0|||
16523448|NCT01931839|40383786|FG005|Overall Study|Physician Decision|0|||
16523449|NCT01931839|40383787|FG006|Overall Study|Physician Decision|1|||
16207869|NCT01457924|39239973|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
16207870|NCT01457924|39239969|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
16207871|NCT01457924|39239970|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
16207872|NCT01457924|39239971|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
16207873|NCT01457924|39239972|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
16207874|NCT01457924|39239973|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
16207875|NCT01457924|39239969|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
16207876|NCT01457924|39239970|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
16207877|NCT01457924|39239971|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
16207878|NCT01457924|39239972|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
16207879|NCT01457924|39239973|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
16207880|NCT01457924|39239969|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
16207881|NCT01457924|39239970|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
16207882|NCT01457924|39239971|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
16207883|NCT01457924|39239972|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
16207884|NCT01457924|39239973|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
16207885|NCT01457924|39239969|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
16207886|NCT01457924|39239970|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
16207887|NCT01457924|39239971|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
16207888|NCT01457924|39239972|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
16207889|NCT01457924|39239973|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
16207890|NCT01457924|39239969|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
16207891|NCT01457924|39239970|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
16207892|NCT01457924|39239971|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
16207893|NCT01457924|39239972|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
16207894|NCT01457924|39239973|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
16207895|NCT01457924|39239969|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
16326342|NCT03483961|39681537|FG008|Overall Study|Adverse Event|0|||
16326343|NCT03483961|39681538|FG009|Overall Study|Adverse Event|0|||
16326344|NCT03634033|39681539|FG000|Overall Study|Did not have a post-assessment|384|||
16326345|NCT03634033|39681540|FG001|Overall Study|Did not have a post-assessment|291|||
16326346|NCT03634033|39681541|FG002|Overall Study|Did not have a post-assessment|114|||
16326347|NCT03634033|39681542|FG003|Overall Study|Did not have a post-assessment|161|||
16326348|NCT03634033|39681543|FG004|Overall Study|Did not have a post-assessment|5|||
16326349|NCT03634033|39681544|FG005|Overall Study|Did not have a post-assessment|0|||
16326350|NCT03634033|39681545|FG006|Overall Study|Did not have a post-assessment|0|||
16523450|NCT01931839|40383781|FG000|Overall Study|Withdrawal of consent|0|||
16207896|NCT01457924|39239970|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
16207897|NCT01457924|39239971|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
16523451|NCT01931839|40383782|FG001|Overall Study|Withdrawal of consent|0|||
16523452|NCT01931839|40383783|FG002|Overall Study|Withdrawal of consent|0|||
16523453|NCT01931839|40383784|FG003|Overall Study|Withdrawal of consent|0|||
16207898|NCT01457924|39239972|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
16207899|NCT01457924|39239973|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
16207900|NCT01457924|39239969|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
16207901|NCT01457924|39239970|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
16207902|NCT01457924|39239971|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
16207903|NCT01457924|39239972|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
16207904|NCT01457924|39239973|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
16207905|NCT01457924|39239969|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
16207906|NCT01457924|39239970|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
16207907|NCT01457924|39239971|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
16207908|NCT01457924|39239972|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
16207909|NCT01457924|39239973|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
16207910|NCT01457924|39239969|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
16207911|NCT01457924|39239970|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
16207912|NCT01457924|39239971|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
16207913|NCT01457924|39239972|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
16207914|NCT01457924|39239973|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
16207915|NCT01457924|39239969|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
16207916|NCT01457924|39239970|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
16207917|NCT01457924|39239971|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
16207918|NCT01457924|39239972|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
16207919|NCT01457924|39239973|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
16207920|NCT00640146|39239978|FG000|Overall Study|Adverse Event|2|||
16207921|NCT00640146|39239979|FG001|Overall Study|Adverse Event|0|||
16207922|NCT00640146|39239978|FG000|Overall Study|Lost to Follow-up|0|||
16207923|NCT00640146|39239979|FG001|Overall Study|Lost to Follow-up|1|||
16207924|NCT00640146|39239978|FG000|Overall Study|Lack of Efficacy|0|||
16207925|NCT00640146|39239979|FG001|Overall Study|Lack of Efficacy|1|||
16207926|NCT00640146|39239978|FG000|Overall Study|Withdrawal by Subject|1|||
16207927|NCT00640146|39239979|FG001|Overall Study|Withdrawal by Subject|1|||
16207928|NCT00640146|39239978|FG000|Overall Study|Randomized but not treated|1|||
16207929|NCT00640146|39239979|FG001|Overall Study|Randomized but not treated|3|||
16207930|NCT00608842|39239980|FG000|Overall Study|Participant's Request|0|||
16207931|NCT00608842|39239981|FG001|Overall Study|Participant's Request|1|||
16207932|NCT00608842|39239982|FG002|Overall Study|Participant's Request|2|||
16207933|NCT00608842|39239983|FG003|Overall Study|Participant's Request|1|||
16207934|NCT00608842|39239980|FG000|Overall Study|Lost to Follow-up|1|||
16207935|NCT00608842|39239981|FG001|Overall Study|Lost to Follow-up|0|||
16207936|NCT00608842|39239982|FG002|Overall Study|Lost to Follow-up|0|||
16207937|NCT00608842|39239983|FG003|Overall Study|Lost to Follow-up|0|||
16207938|NCT01001234|39239987|FG000|Overall Study|Withdrawal by Subject|2|||
16207939|NCT01001234|39239988|FG001|Overall Study|Withdrawal by Subject|0|||
16207940|NCT01001234|39239989|FG002|Overall Study|Withdrawal by Subject|3|||
16207941|NCT01001234|39239990|FG003|Overall Study|Withdrawal by Subject|0|||
16207942|NCT01001234|39239991|FG004|Overall Study|Withdrawal by Subject|0|||
16207943|NCT01001234|39239987|FG000|Overall Study|Protocol Violation|34|||
16207944|NCT01001234|39239988|FG001|Overall Study|Protocol Violation|3|||
16207945|NCT01001234|39239989|FG002|Overall Study|Protocol Violation|19|||
16207946|NCT01001234|39239990|FG003|Overall Study|Protocol Violation|18|||
16207947|NCT01001234|39239991|FG004|Overall Study|Protocol Violation|0|||
16207948|NCT01001234|39239987|FG000|Overall Study|Lost to Follow-up|0|||
16207949|NCT01001234|39239988|FG001|Overall Study|Lost to Follow-up|0|||
16207950|NCT01001234|39239989|FG002|Overall Study|Lost to Follow-up|1|||
16207951|NCT01001234|39239990|FG003|Overall Study|Lost to Follow-up|2|||
16207952|NCT01001234|39239991|FG004|Overall Study|Lost to Follow-up|0|||
16207953|NCT01001234|39239987|FG000|Overall Study|Physician Decision|1|||
16523454|NCT01931839|40383785|FG004|Overall Study|Withdrawal of consent|1|||
16523455|NCT01931839|40383786|FG005|Overall Study|Withdrawal of consent|0|||
16523456|NCT01931839|40383787|FG006|Overall Study|Withdrawal of consent|0|||
16207954|NCT01001234|39239988|FG001|Overall Study|Physician Decision|0|||
16207955|NCT01001234|39239989|FG002|Overall Study|Physician Decision|0|||
16207956|NCT01001234|39239990|FG003|Overall Study|Physician Decision|0|||
16207957|NCT01001234|39239991|FG004|Overall Study|Physician Decision|0|||
16207958|NCT01001234|39239987|FG000|Overall Study|Not Treated: Adverse Event|1|||
16207959|NCT01001234|39239988|FG001|Overall Study|Not Treated: Adverse Event|0|||
16207960|NCT01001234|39239989|FG002|Overall Study|Not Treated: Adverse Event|0|||
16207961|NCT01001234|39239990|FG003|Overall Study|Not Treated: Adverse Event|0|||
16207962|NCT01001234|39239991|FG004|Overall Study|Not Treated: Adverse Event|0|||
16207963|NCT01001234|39239987|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
16207964|NCT01001234|39239988|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
16326351|NCT03634033|39681539|FG000|Overall Study|Death|0|||
16523457|NCT01931839|40383781|FG000|Overall Study|Adverse Event|9|||
16523458|NCT01931839|40383782|FG001|Overall Study|Adverse Event|4|||
16523459|NCT01931839|40383783|FG002|Overall Study|Adverse Event|1|||
16523460|NCT01931839|40383784|FG003|Overall Study|Adverse Event|3|||
16207965|NCT01001234|39239989|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
16207966|NCT01001234|39239990|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
16207967|NCT01001234|39239991|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
16207968|NCT01001234|39239987|FG000|Overall Study|Not Treated: Protocol Violation|3|||
16207969|NCT01001234|39239988|FG001|Overall Study|Not Treated: Protocol Violation|0|||
16207970|NCT01001234|39239989|FG002|Overall Study|Not Treated: Protocol Violation|0|||
16207971|NCT01001234|39239990|FG003|Overall Study|Not Treated: Protocol Violation|0|||
16207972|NCT01001234|39239991|FG004|Overall Study|Not Treated: Protocol Violation|0|||
16207973|NCT01001234|39239987|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
16207974|NCT01001234|39239988|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
16207975|NCT01001234|39239989|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
16207976|NCT01001234|39239990|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
16207977|NCT01001234|39239991|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
16207978|NCT01001234|39239987|FG000|Overall Study|Not Treated: Pregnancy|3|||
16207979|NCT01001234|39239988|FG001|Overall Study|Not Treated: Pregnancy|0|||
16207980|NCT01001234|39239989|FG002|Overall Study|Not Treated: Pregnancy|0|||
16207981|NCT01001234|39239990|FG003|Overall Study|Not Treated: Pregnancy|0|||
16207982|NCT01001234|39239991|FG004|Overall Study|Not Treated: Pregnancy|0|||
16207983|NCT01001234|39239987|FG000|Overall Study|Not Treated: Physician Decision|37|||
16207984|NCT01001234|39239988|FG001|Overall Study|Not Treated: Physician Decision|4|||
16207985|NCT01001234|39239989|FG002|Overall Study|Not Treated: Physician Decision|0|||
16207986|NCT01001234|39239990|FG003|Overall Study|Not Treated: Physician Decision|0|||
16207987|NCT01001234|39239991|FG004|Overall Study|Not Treated: Physician Decision|0|||
16207988|NCT01001234|39239987|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
16207989|NCT01001234|39239988|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
16207990|NCT01001234|39239989|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
16207991|NCT01001234|39239990|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
16207992|NCT01001234|39239991|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
16207993|NCT00701441|39239993|FG000|Overall Study|failure in cpap compliance|0|||
16207994|NCT00701441|39239994|FG001|Overall Study|failure in cpap compliance|4|||
16207995|NCT01849562|39239995|FG000|Overall Study|Lost to Follow-up|1|||
16207996|NCT01849562|39239996|FG001|Overall Study|Lost to Follow-up|0|||
16207997|NCT01849562|39239997|FG002|Overall Study|Lost to Follow-up|0|||
16207998|NCT01849562|39239995|FG000|Overall Study|Non-compliance with Study Drug|1|||
16207999|NCT01849562|39239996|FG001|Overall Study|Non-compliance with Study Drug|0|||
16208000|NCT01849562|39239997|FG002|Overall Study|Non-compliance with Study Drug|0|||
16208001|NCT00044213|39239998|FG000|Overall Study|Withdrawal by Subject|50|||
16208002|NCT00044213|39239999|FG001|Overall Study|Withdrawal by Subject|65|||
16208003|NCT00044213|39240000|FG002|Overall Study|Withdrawal by Subject|91|||
16208004|NCT00044213|39240001|FG003|Overall Study|Withdrawal by Subject|83|||
16208005|NCT00044213|39239998|FG000|Overall Study|Death|42|||
16208006|NCT00044213|39239999|FG001|Overall Study|Death|42|||
16208007|NCT00044213|39240000|FG002|Overall Study|Death|42|||
16208008|NCT00044213|39240001|FG003|Overall Study|Death|49|||
16208009|NCT00044213|39239998|FG000|Overall Study|Lost to Follow-up|8|||
16208010|NCT00044213|39239999|FG001|Overall Study|Lost to Follow-up|5|||
16208011|NCT00044213|39240000|FG002|Overall Study|Lost to Follow-up|5|||
16208012|NCT00044213|39240001|FG003|Overall Study|Lost to Follow-up|4|||
16208013|NCT00361218|39240002|FG000|Overall Study|Lost to Follow-up|11|||
16208014|NCT00361218|39240002|FG000|Overall Study|Personal Reasons|7|||
16208015|NCT00361218|39240002|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
16208016|NCT01522443|39240009|FG000|Overall Study|No longer receiving clinical benefit|36|||
16208017|NCT01522443|39240010|FG001|Overall Study|No longer receiving clinical benefit|28|||
16208018|NCT01522443|39240009|FG000|Overall Study|Adverse Event|10|||
16208019|NCT01522443|39240010|FG001|Overall Study|Adverse Event|15|||
16208020|NCT01522443|39240009|FG000|Overall Study|Withdrawal by Subject|5|||
16208021|NCT01522443|39240010|FG001|Overall Study|Withdrawal by Subject|8|||
16208022|NCT01522443|39240009|FG000|Overall Study|No study treatment given|1|||
16208023|NCT01522443|39240010|FG001|Overall Study|No study treatment given|1|||
16208024|NCT01522443|39240009|FG000|Overall Study|Other|1|||
16208025|NCT01522443|39240010|FG001|Overall Study|Other|3|||
16208026|NCT01001572|39240011|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
16208027|NCT01001572|39240012|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
16326352|NCT03634033|39681540|FG001|Overall Study|Death|0|||
16208028|NCT01001572|39240013|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
16208029|NCT01001572|39240011|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
16208030|NCT01001572|39240012|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
16208031|NCT01001572|39240013|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
16208032|NCT01001572|39240011|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
16208033|NCT01001572|39240012|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
16208034|NCT01001572|39240013|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
16208035|NCT01001572|39240011|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
16208036|NCT01001572|39240012|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
16208037|NCT01001572|39240013|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
16208038|NCT01001572|39240011|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
16208039|NCT01001572|39240012|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
16208040|NCT01001572|39240013|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
16208041|NCT01001572|39240011|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
16208042|NCT01001572|39240012|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
16523461|NCT01931839|40383785|FG004|Overall Study|Adverse Event|0|||
16208043|NCT01001572|39240013|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
16208044|NCT01001572|39240011|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
16208045|NCT01001572|39240012|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
16208046|NCT01001572|39240013|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
16208047|NCT01001572|39240011|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
16208048|NCT01001572|39240012|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
16208049|NCT01001572|39240013|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
16208050|NCT01001572|39240011|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
16208051|NCT01001572|39240012|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
16208052|NCT01001572|39240013|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
16208053|NCT01001572|39240011|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16208054|NCT01001572|39240012|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
16208055|NCT01001572|39240013|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
16326353|NCT03634033|39681541|FG002|Overall Study|Death|0|||
16326354|NCT03634033|39681542|FG003|Overall Study|Death|0|||
16208056|NCT01001572|39240011|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
16208057|NCT01001572|39240012|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
16208058|NCT01001572|39240013|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
16326355|NCT03634033|39681543|FG004|Overall Study|Death|0|||
16326356|NCT03634033|39681544|FG005|Overall Study|Death|7|||
16326357|NCT03634033|39681545|FG006|Overall Study|Death|7|||
16326358|NCT03634033|39681539|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
16326359|NCT03634033|39681540|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
16326360|NCT03634033|39681541|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
16326361|NCT03634033|39681542|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
16326362|NCT03634033|39681543|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
16326363|NCT03634033|39681544|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
16326364|NCT03634033|39681545|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
16326365|NCT03634033|39681539|FG000|Overall Study|Lost to Follow-up|0|||
16326366|NCT03634033|39681540|FG001|Overall Study|Lost to Follow-up|0|||
16326367|NCT03634033|39681541|FG002|Overall Study|Lost to Follow-up|0|||
16326368|NCT03634033|39681542|FG003|Overall Study|Lost to Follow-up|0|||
16326369|NCT03634033|39681543|FG004|Overall Study|Lost to Follow-up|0|||
16326370|NCT03634033|39681544|FG005|Overall Study|Lost to Follow-up|1|||
16326371|NCT03634033|39681545|FG006|Overall Study|Lost to Follow-up|2|||
16326372|NCT03634033|39681539|FG000|Overall Study|Withdrawal by Subject|0|||
16326373|NCT03634033|39681540|FG001|Overall Study|Withdrawal by Subject|0|||
16326374|NCT03634033|39681541|FG002|Overall Study|Withdrawal by Subject|0|||
16326375|NCT03634033|39681542|FG003|Overall Study|Withdrawal by Subject|0|||
16326376|NCT03634033|39681543|FG004|Overall Study|Withdrawal by Subject|0|||
16326377|NCT03634033|39681544|FG005|Overall Study|Withdrawal by Subject|0|||
16326378|NCT03634033|39681545|FG006|Overall Study|Withdrawal by Subject|1|||
16326379|NCT03843632|39681546|FG000|Overall Study|Withdrawal by Subject|1|||
16326380|NCT03843632|39681547|FG001|Overall Study|Withdrawal by Subject|0|||
16326381|NCT03843632|39681548|FG002|Overall Study|Withdrawal by Subject|0|||
16326382|NCT03843632|39681549|FG003|Overall Study|Withdrawal by Subject|0|||
16326383|NCT00956592|39681550|FG000|Overall Study|Protocol Violation|1|||
16326384|NCT00956592|39681551|FG001|Overall Study|Protocol Violation|3|||
16326385|NCT01095978|39681556|FG000|Overall Study|Did not take Klacid SR|2|||
16326386|NCT01095978|39681556|FG000|Overall Study|Adverse Event|1|||
16326387|NCT05845567|39681557|FG000|Overall Study|Withdrawal by Subject|1|||
16523462|NCT01931839|40383786|FG005|Overall Study|Adverse Event|0|||
16523463|NCT01931839|40383787|FG006|Overall Study|Adverse Event|1|||
16326388|NCT04439123|39681558|FG000|Overall Study|Adverse Event|11|||
16326389|NCT04439123|39681558|FG000|Overall Study|Death|1|||
16396938|NCT00313144|39935320|FG000|Overall Study|Death|7|||
16396939|NCT00313144|39935320|FG000|Overall Study|Lost to Follow-up|5|||
16396940|NCT00313144|39935320|FG000|Overall Study|Withdrawal by Subject|4|||
16396941|NCT00313144|39935320|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
16396942|NCT00313144|39935320|FG000|Overall Study|Physician Decision|4|||
16396943|NCT00313144|39935320|FG000|Overall Study|Adverse event - transient|5|||
16396944|NCT00313144|39935320|FG000|Overall Study|Liver transplant|1|||
16396945|NCT00313144|39935320|FG000|Overall Study|Insurance (homecare provider) change|1|||
16396946|NCT00313144|39935320|FG000|Overall Study|Change to different product|1|||
16396947|NCT00313144|39935320|FG000|Overall Study|Due to termination of the study|66|||
16396948|NCT01831466|39935324|FG000|Overall Study|Protocol Violation|1|||
16396949|NCT01831466|39935325|FG001|Overall Study|Protocol Violation|1|||
16396950|NCT01831466|39935326|FG002|Overall Study|Protocol Violation|2|||
16396951|NCT01831466|39935327|FG003|Overall Study|Protocol Violation|0|||
16396952|NCT01831466|39935328|FG004|Overall Study|Protocol Violation|0|||
16396953|NCT01831466|39935329|FG005|Overall Study|Protocol Violation|1|||
16396954|NCT01831466|39935330|FG006|Overall Study|Protocol Violation|0|||
16396955|NCT01831466|39935331|FG007|Overall Study|Protocol Violation|0|||
16326390|NCT04439123|39681558|FG000|Overall Study|Disease progression|19|||
16326391|NCT04439123|39681558|FG000|Overall Study|Withdrawal by Subject|2|||
16326392|NCT04439123|39681558|FG000|Overall Study|Still on treatment|2|||
16326393|NCT00002931|39681561|FG000|Overall Study|rapidly progressing disease during|2|||
16326394|NCT02279745|39681567|FG000|Overall Study|Adverse Event|7|||
16326395|NCT02279745|39681567|FG000|Overall Study|Death|6|||
16326396|NCT02279745|39681567|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
16326397|NCT02279745|39681567|FG000|Overall Study|Withdrawal by Subject|2|||
16326398|NCT02279745|39681567|FG000|Overall Study|Pregnancy|1|||
16326399|NCT02279745|39681567|FG000|Overall Study|Study Non-compliance|1|||
16326400|NCT02279745|39681567|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
16326401|NCT01282372|39681570|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
16396956|NCT01831466|39935332|FG008|Overall Study|Protocol Violation|0|||
16326402|NCT01282372|39681570|FG000|Overall Study|Lost to Follow-up|23|||
16326403|NCT01282372|39681570|FG000|Overall Study|Withdrawal by Subject|11|||
16326404|NCT01282372|39681570|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
16326405|NCT01282372|39681570|FG000|Overall Study|Death|1|||
16326406|NCT01282372|39681570|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
16326407|NCT01282372|39681570|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
16326408|NCT01282372|39681570|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
16326409|NCT01282372|39681570|FG000|Overall Study|Adverse Event|12|||
16326410|NCT02537431|39681571|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
16326411|NCT02320058|39681572|FG000|Overall Study|Death|25|||
16326412|NCT02320058|39681573|FG001|Overall Study|Death|10|||
16326413|NCT02320058|39681572|FG000|Overall Study|Lost to Follow-up|4|||
16326414|NCT02320058|39681573|FG001|Overall Study|Lost to Follow-up|0|||
16326415|NCT02320058|39681572|FG000|Overall Study|Other reasons|4|||
16326416|NCT02320058|39681573|FG001|Overall Study|Other reasons|1|||
16326417|NCT02320058|39681572|FG000|Overall Study|Withdrawal by Subject|8|||
16326418|NCT02320058|39681573|FG001|Overall Study|Withdrawal by Subject|2|||
16326419|NCT02320058|39681572|FG000|Overall Study|Not reported|1|||
16326420|NCT02320058|39681573|FG001|Overall Study|Not reported|0|||
16326421|NCT01698879|39681574|FG000|Overall Study|Withdrawal by Subject|1|||
16326422|NCT01698879|39681575|FG001|Overall Study|Withdrawal by Subject|0|||
16326423|NCT01698879|39681576|FG002|Overall Study|Withdrawal by Subject|0|||
16326424|NCT00656851|39681580|FG000|Overall Study|Withdrawal by Subject|0|||
16326425|NCT00656851|39681581|FG001|Overall Study|Withdrawal by Subject|4|||
16326426|NCT00546117|39681582|FG000|Overall Study|Withdrawal by Subject|3|||
16326427|NCT00546117|39681583|FG001|Overall Study|Withdrawal by Subject|0|||
16326428|NCT00546117|39681582|FG000|Overall Study|Inability to schedule follow-up visit|1|||
16326429|NCT00546117|39681583|FG001|Overall Study|Inability to schedule follow-up visit|0|||
16396957|NCT01831466|39935333|FG009|Overall Study|Protocol Violation|0|||
16396958|NCT01831466|39935334|FG010|Overall Study|Protocol Violation|0|||
16396959|NCT01831466|39935335|FG011|Overall Study|Protocol Violation|0|||
16326430|NCT00256854|39681584|FG000|Overall Study|Withdrawal by Subject|2|||
16326431|NCT00256854|39681585|FG001|Overall Study|Withdrawal by Subject|3|||
16326432|NCT00256854|39681586|FG002|Overall Study|Withdrawal by Subject|0|||
16326433|NCT00256854|39681587|FG003|Overall Study|Withdrawal by Subject|0|||
16326434|NCT00256854|39681588|FG004|Overall Study|Withdrawal by Subject|0|||
16326435|NCT00256854|39681589|FG005|Overall Study|Withdrawal by Subject|0|||
16396960|NCT01831466|39935324|FG000|Overall Study|Other|2|||
16396961|NCT01831466|39935325|FG001|Overall Study|Other|3|||
16396962|NCT01831466|39935326|FG002|Overall Study|Other|2|||
16326436|NCT00256854|39681584|FG000|Overall Study|Lack of Efficacy|1|||
16326437|NCT00256854|39681585|FG001|Overall Study|Lack of Efficacy|0|||
16326438|NCT00256854|39681586|FG002|Overall Study|Lack of Efficacy|0|||
16396963|NCT01831466|39935327|FG003|Overall Study|Other|2|||
16396964|NCT01831466|39935328|FG004|Overall Study|Other|2|||
16396965|NCT01831466|39935329|FG005|Overall Study|Other|1|||
16326439|NCT00256854|39681587|FG003|Overall Study|Lack of Efficacy|0|||
16326440|NCT00256854|39681588|FG004|Overall Study|Lack of Efficacy|0|||
16326441|NCT00256854|39681589|FG005|Overall Study|Lack of Efficacy|0|||
16326442|NCT00256854|39681584|FG000|Overall Study|Protocol Violation|0|||
16326443|NCT00256854|39681585|FG001|Overall Study|Protocol Violation|1|||
16326444|NCT00256854|39681586|FG002|Overall Study|Protocol Violation|1|||
16326445|NCT00256854|39681587|FG003|Overall Study|Protocol Violation|1|||
16326446|NCT00256854|39681588|FG004|Overall Study|Protocol Violation|0|||
16326447|NCT00256854|39681589|FG005|Overall Study|Protocol Violation|0|||
16326448|NCT00256854|39681584|FG000|Overall Study|Adverse Event|0|||
16326449|NCT00256854|39681585|FG001|Overall Study|Adverse Event|0|||
16326450|NCT00256854|39681586|FG002|Overall Study|Adverse Event|2|||
16326451|NCT00256854|39681587|FG003|Overall Study|Adverse Event|2|||
16326452|NCT00256854|39681588|FG004|Overall Study|Adverse Event|0|||
16326453|NCT00256854|39681589|FG005|Overall Study|Adverse Event|1|||
16326454|NCT00256854|39681584|FG000|Overall Study|Not compliant with the study drug|0|||
16326455|NCT00256854|39681585|FG001|Overall Study|Not compliant with the study drug|0|||
16326456|NCT00256854|39681586|FG002|Overall Study|Not compliant with the study drug|0|||
16326457|NCT00256854|39681587|FG003|Overall Study|Not compliant with the study drug|0|||
16326458|NCT00256854|39681588|FG004|Overall Study|Not compliant with the study drug|1|||
16326459|NCT00256854|39681589|FG005|Overall Study|Not compliant with the study drug|0|||
16326460|NCT02496091|39681599|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16326461|NCT02989649|39681601|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
16326462|NCT02989649|39681601|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
16326463|NCT02989649|39681601|FG000|Overall Study|Lost For Observation During Study|3|||
16326464|NCT02989649|39681601|FG000|Overall Study|Reason Not Specified|13|||
16326465|NCT00824382|39681604|FG000|Overall Study|Adverse Event|4|||
16326466|NCT00824382|39681605|FG001|Overall Study|Adverse Event|1|||
16326467|NCT00824382|39681606|FG002|Overall Study|Adverse Event|1|||
16326468|NCT00824382|39681607|FG003|Overall Study|Adverse Event|4|||
16326469|NCT00824382|39681604|FG000|Overall Study|Protocol Violation|1|||
16396966|NCT01831466|39935330|FG006|Overall Study|Other|0|||
16396967|NCT01831466|39935331|FG007|Overall Study|Other|0|||
16396968|NCT01831466|39935332|FG008|Overall Study|Other|0|||
16396969|NCT01831466|39935333|FG009|Overall Study|Other|0|||
16326470|NCT00824382|39681605|FG001|Overall Study|Protocol Violation|0|||
16326471|NCT00824382|39681606|FG002|Overall Study|Protocol Violation|0|||
16326472|NCT00824382|39681607|FG003|Overall Study|Protocol Violation|1|||
16326473|NCT00824382|39681604|FG000|Overall Study|Investigator's decision|0|||
16326474|NCT00824382|39681605|FG001|Overall Study|Investigator's decision|1|||
16326475|NCT00824382|39681606|FG002|Overall Study|Investigator's decision|2|||
16326476|NCT00824382|39681607|FG003|Overall Study|Investigator's decision|0|||
16326477|NCT02656290|39681608|FG000|Overall Study|Lost to Follow-up|1|||
16326478|NCT02656290|39681608|FG000|Overall Study|Reintervention|3|||
16326479|NCT01437995|39681609|FG000|Overall Study|Lost to Follow-up|11|||
16326480|NCT01437995|39681610|FG001|Overall Study|Lost to Follow-up|18|||
16326481|NCT01437995|39681611|FG002|Overall Study|Lost to Follow-up|20|||
16326482|NCT02682823|39681612|FG000|Overall Study|Withdrawal by Subject|0|||
16326483|NCT02682823|39681613|FG001|Overall Study|Withdrawal by Subject|0|||
16326484|NCT02682823|39681614|FG002|Overall Study|Withdrawal by Subject|1|||
16326485|NCT02682823|39681615|FG003|Overall Study|Withdrawal by Subject|0|||
16326486|NCT02682823|39681616|FG004|Overall Study|Withdrawal by Subject|1|||
16326487|NCT02682823|39681612|FG000|Overall Study|Protocol Deviation|0|||
16326488|NCT02682823|39681613|FG001|Overall Study|Protocol Deviation|1|||
16326489|NCT02682823|39681614|FG002|Overall Study|Protocol Deviation|0|||
16326490|NCT02682823|39681615|FG003|Overall Study|Protocol Deviation|0|||
16326491|NCT02682823|39681616|FG004|Overall Study|Protocol Deviation|0|||
16326492|NCT02682823|39681612|FG000|Overall Study|Adverse Event|0|||
16326493|NCT02682823|39681613|FG001|Overall Study|Adverse Event|0|||
16326494|NCT02682823|39681614|FG002|Overall Study|Adverse Event|0|||
16326495|NCT02682823|39681615|FG003|Overall Study|Adverse Event|1|||
16326496|NCT02682823|39681616|FG004|Overall Study|Adverse Event|0|||
16326497|NCT03521115|39681618|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
16326498|NCT03521115|39681619|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
16326499|NCT03521115|39681618|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
16326500|NCT03521115|39681619|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
16326501|NCT02247440|39681620|FG000|Overall Study|Withdrawal by Subject|1|||
16326502|NCT02247440|39681620|FG000|Overall Study|Lack of Efficacy|3|||
16326503|NCT01123941|39681621|FG000|Overall Study|Lost to Follow-up|2|||
16326504|NCT01123941|39681622|FG001|Overall Study|Lost to Follow-up|1|||
16326505|NCT04725812|39681623|FG000|Overall Study|Withdrawal by Subject|1|||
16326506|NCT00381043|39681624|FG000|Overall Study|Lost to Follow-up|8|||
16326507|NCT00381043|39681625|FG001|Overall Study|Lost to Follow-up|6|||
16326508|NCT00381043|39681624|FG000|Overall Study|Withdrawal by Subject|3|||
16396970|NCT01831466|39935334|FG010|Overall Study|Other|0|||
16396971|NCT01831466|39935335|FG011|Overall Study|Other|0|||
16396972|NCT01831466|39935324|FG000|Overall Study|Non-compliance with study treatment|2|||
16396973|NCT01831466|39935325|FG001|Overall Study|Non-compliance with study treatment|1|||
16523464|NCT01931839|40383781|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
16523465|NCT01931839|40383782|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
16523466|NCT01931839|40383783|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
16523467|NCT01931839|40383784|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
16523468|NCT01931839|40383785|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
16523469|NCT01931839|40383786|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
16523470|NCT01931839|40383787|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
16523471|NCT01931839|40383781|FG000|Overall Study|Other non-compliance|15|||
16523472|NCT01931839|40383782|FG001|Overall Study|Other non-compliance|9|||
16523473|NCT01931839|40383783|FG002|Overall Study|Other non-compliance|12|||
16523474|NCT01931839|40383784|FG003|Overall Study|Other non-compliance|3|||
16523475|NCT01931839|40383785|FG004|Overall Study|Other non-compliance|0|||
16523476|NCT01931839|40383786|FG005|Overall Study|Other non-compliance|3|||
16523477|NCT01931839|40383787|FG006|Overall Study|Other non-compliance|0|||
16523478|NCT01931839|40383781|FG000|Overall Study|Lost to Follow-up|1|||
16523479|NCT01931839|40383782|FG001|Overall Study|Lost to Follow-up|2|||
16523480|NCT01931839|40383783|FG002|Overall Study|Lost to Follow-up|4|||
16523481|NCT01931839|40383784|FG003|Overall Study|Lost to Follow-up|5|||
16523482|NCT01931839|40383785|FG004|Overall Study|Lost to Follow-up|0|||
16523483|NCT01931839|40383786|FG005|Overall Study|Lost to Follow-up|0|||
16523484|NCT01931839|40383787|FG006|Overall Study|Lost to Follow-up|0|||
16523485|NCT01931839|40383781|FG000|Overall Study|Other|4|||
16523486|NCT01931839|40383782|FG001|Overall Study|Other|2|||
16523487|NCT01931839|40383783|FG002|Overall Study|Other|6|||
16523488|NCT01931839|40383784|FG003|Overall Study|Other|0|||
16523489|NCT01931839|40383785|FG004|Overall Study|Other|0|||
16523490|NCT01931839|40383786|FG005|Overall Study|Other|0|||
16523491|NCT01931839|40383787|FG006|Overall Study|Other|0|||
16523492|NCT04027686|40383793|FG000|Overall Study|Lost to Follow-up|2|||
16523493|NCT04027686|40383794|FG001|Overall Study|Lost to Follow-up|0|||
16523494|NCT04027686|40383793|FG000|Overall Study|Withdrawal by Subject|0|||
16523495|NCT04027686|40383794|FG001|Overall Study|Withdrawal by Subject|1|||
16523496|NCT01896895|40383795|FG000|Double-blind MP|Physician Decision|0|||
16523497|NCT01896895|40383796|FG001|Double-blind MP|Physician Decision|0|||
16523498|NCT01896895|40383797|FG002|Double-blind MP|Physician Decision|1|||
16523499|NCT01896895|40383798|FG003|Double-blind MP|Physician Decision|0|||
16523500|NCT01896895|40383795|FG000|Double-blind MP|Withdrawal by Subject|0|||
16523501|NCT01896895|40383796|FG001|Double-blind MP|Withdrawal by Subject|2|||
16523502|NCT01896895|40383797|FG002|Double-blind MP|Withdrawal by Subject|1|||
16523503|NCT01896895|40383798|FG003|Double-blind MP|Withdrawal by Subject|0|||
16523504|NCT01896895|40383795|FG000|Double-blind MP|Lost to Follow-up|1|||
16523505|NCT01896895|40383796|FG001|Double-blind MP|Lost to Follow-up|0|||
16095268|NCT01277302|38839381|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
16095269|NCT01277302|38839379|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
16095270|NCT01277302|38839380|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
16095271|NCT01277302|38839381|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
16095272|NCT01277302|38839379|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
16095273|NCT01277302|38839380|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
16095274|NCT01277302|38839381|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
16095275|NCT02097420|38839382|FG000|Overall Study|Death|6|||
16095276|NCT02097420|38839382|FG000|Overall Study|Valve explanted|13|||
16095277|NCT02097420|38839382|FG000|Overall Study|Other Reason|1|||
16095278|NCT02964234|38839383|FG000|Overall Study|Lost to Follow-up|22|||
16095279|NCT02964234|38839384|FG001|Overall Study|Lost to Follow-up|13|||
16095280|NCT02014402|38839385|FG000|Overall Study|Adverse Event|1|||
16095281|NCT02014402|38839386|FG001|Overall Study|Adverse Event|0|||
16095282|NCT02014402|38839387|FG002|Overall Study|Adverse Event|0|||
16095283|NCT02014402|38839388|FG003|Overall Study|Adverse Event|0|||
16095284|NCT02014402|38839385|FG000|Overall Study|Withdrawal by Subject|1|||
16095285|NCT02014402|38839386|FG001|Overall Study|Withdrawal by Subject|2|||
16326509|NCT00381043|39681625|FG001|Overall Study|Withdrawal by Subject|1|||
16523506|NCT01896895|40383797|FG002|Double-blind MP|Lost to Follow-up|1|||
16523507|NCT01896895|40383798|FG003|Double-blind MP|Lost to Follow-up|0|||
16523508|NCT03295201|40383799|FG000|Overall Study|Lost to Follow-up|1|||
16523509|NCT03295201|40383800|FG001|Overall Study|Lost to Follow-up|1|||
16523510|NCT03295201|40383799|FG000|Overall Study|Hospital admission|0|||
16095286|NCT02014402|38839387|FG002|Overall Study|Withdrawal by Subject|2|||
16095287|NCT02014402|38839388|FG003|Overall Study|Withdrawal by Subject|1|||
16095288|NCT02014402|38839385|FG000|Overall Study|Subject did not have transportation|0|||
16095289|NCT02014402|38839386|FG001|Overall Study|Subject did not have transportation|1|||
16523511|NCT03295201|40383800|FG001|Overall Study|Hospital admission|1|||
16523512|NCT02417246|40383806|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
16523513|NCT02417246|40383807|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
16523514|NCT02417246|40383806|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
16326510|NCT00381043|39681624|FG000|Overall Study|wanted more care|0|||
16326511|NCT00381043|39681625|FG001|Overall Study|wanted more care|1|||
16326512|NCT00381043|39681624|FG000|Overall Study|incarcerated|1|||
16326513|NCT00381043|39681625|FG001|Overall Study|incarcerated|0|||
16326514|NCT01676896|39681626|FG000|Overall Study|Withdrawal by Subject|12|||
16326515|NCT01676896|39681627|FG001|Overall Study|Withdrawal by Subject|7|||
16326516|NCT01676896|39681628|FG002|Overall Study|Withdrawal by Subject|19|||
16326517|NCT04161079|39681629|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
16326518|NCT02448537|39681638|FG000|Overall Study|Withdrawal by Subject|1|||
16326519|NCT02448537|39681639|FG001|Overall Study|Withdrawal by Subject|1|||
16326520|NCT02448537|39681640|FG002|Overall Study|Withdrawal by Subject|1|||
16326521|NCT03687372|39681641|FG000|Overall Study|Lost to Follow-up|12|||
16326522|NCT03687372|39681642|FG001|Overall Study|Lost to Follow-up|21|||
16326523|NCT03687372|39681641|FG000|Overall Study|Withdrawal by Subject|4|||
16326524|NCT03687372|39681642|FG001|Overall Study|Withdrawal by Subject|17|||
16326525|NCT03687372|39681641|FG000|Overall Study|Investigator Decision|1|||
16326526|NCT03687372|39681642|FG001|Overall Study|Investigator Decision|1|||
16396974|NCT01831466|39935326|FG002|Overall Study|Non-compliance with study treatment|1|||
16396975|NCT01831466|39935327|FG003|Overall Study|Non-compliance with study treatment|0|||
16396976|NCT01831466|39935328|FG004|Overall Study|Non-compliance with study treatment|0|||
16396977|NCT01831466|39935329|FG005|Overall Study|Non-compliance with study treatment|1|||
16396978|NCT01831466|39935330|FG006|Overall Study|Non-compliance with study treatment|0|||
16396979|NCT01831466|39935331|FG007|Overall Study|Non-compliance with study treatment|0|||
16396980|NCT01831466|39935332|FG008|Overall Study|Non-compliance with study treatment|0|||
16396981|NCT01831466|39935333|FG009|Overall Study|Non-compliance with study treatment|0|||
16396982|NCT01831466|39935334|FG010|Overall Study|Non-compliance with study treatment|0|||
16326527|NCT00601172|39681643|FG000|Overall Study|Adverse Event|43|||
16326528|NCT00601172|39681644|FG001|Overall Study|Adverse Event|32|||
16326529|NCT00601172|39681643|FG000|Overall Study|Lack of Efficacy|11|||
16326530|NCT00601172|39681644|FG001|Overall Study|Lack of Efficacy|12|||
16326531|NCT00601172|39681643|FG000|Overall Study|Protocol Violation|2|||
16326532|NCT00601172|39681644|FG001|Overall Study|Protocol Violation|5|||
16326533|NCT00601172|39681643|FG000|Overall Study|Lost to Follow-up|4|||
16326534|NCT00601172|39681644|FG001|Overall Study|Lost to Follow-up|3|||
16396983|NCT01831466|39935335|FG011|Overall Study|Non-compliance with study treatment|0|||
16396984|NCT01831466|39935324|FG000|Overall Study|Death|0|||
16396985|NCT01831466|39935325|FG001|Overall Study|Death|1|||
16396986|NCT01831466|39935326|FG002|Overall Study|Death|0|||
16396987|NCT01831466|39935327|FG003|Overall Study|Death|0|||
16396988|NCT01831466|39935328|FG004|Overall Study|Death|0|||
16396989|NCT01831466|39935329|FG005|Overall Study|Death|0|||
16396990|NCT01831466|39935330|FG006|Overall Study|Death|0|||
16396991|NCT01831466|39935331|FG007|Overall Study|Death|0|||
16396992|NCT01831466|39935332|FG008|Overall Study|Death|0|||
16396993|NCT01831466|39935333|FG009|Overall Study|Death|0|||
16523515|NCT02417246|40383807|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
16326535|NCT00601172|39681643|FG000|Overall Study|Physician Decision|27|||
16326536|NCT00601172|39681644|FG001|Overall Study|Physician Decision|28|||
16326537|NCT00601172|39681643|FG000|Overall Study|Withdrawal by Subject|35|||
16326538|NCT00601172|39681644|FG001|Overall Study|Withdrawal by Subject|27|||
16396994|NCT01831466|39935334|FG010|Overall Study|Death|0|||
16396995|NCT01831466|39935335|FG011|Overall Study|Death|0|||
16523516|NCT02417246|40383806|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
16523517|NCT02417246|40383807|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
16523518|NCT02417246|40383806|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
16523519|NCT02417246|40383807|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
16523520|NCT00153101|40383809|FG000|Overall Study|Lost to Follow-up|14|||
16523521|NCT00153101|40383810|FG001|Overall Study|Lost to Follow-up|14|||
16523522|NCT00153101|40383811|FG002|Overall Study|Lost to Follow-up|12|||
16523523|NCT00153101|40383812|FG003|Overall Study|Lost to Follow-up|5|||
16523524|NCT00153101|40383813|FG004|Overall Study|Lost to Follow-up|5|||
16523525|NCT00153101|40383809|FG000|Overall Study|Withdrawal by Subject|3|||
16523526|NCT00153101|40383810|FG001|Overall Study|Withdrawal by Subject|4|||
16523527|NCT00153101|40383811|FG002|Overall Study|Withdrawal by Subject|3|||
16523528|NCT00153101|40383812|FG003|Overall Study|Withdrawal by Subject|3|||
16523529|NCT00153101|40383813|FG004|Overall Study|Withdrawal by Subject|5|||
16523530|NCT01003249|40383826|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
16523531|NCT01003249|40383827|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
16396996|NCT01831466|39935324|FG000|Overall Study|Withdrawal by Subject|6|||
16396997|NCT01831466|39935325|FG001|Overall Study|Withdrawal by Subject|3|||
16396998|NCT01831466|39935326|FG002|Overall Study|Withdrawal by Subject|3|||
16326539|NCT00601172|39681643|FG000|Overall Study|Did not meet continuation criteria|19|||
16396999|NCT01831466|39935327|FG003|Overall Study|Withdrawal by Subject|3|||
16397000|NCT01831466|39935328|FG004|Overall Study|Withdrawal by Subject|3|||
16397001|NCT01831466|39935329|FG005|Overall Study|Withdrawal by Subject|5|||
16397002|NCT01831466|39935330|FG006|Overall Study|Withdrawal by Subject|0|||
16523532|NCT01003249|40383826|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
16523533|NCT01003249|40383827|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
16523534|NCT01003249|40383826|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
16208059|NCT01001572|39240011|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
16208060|NCT01001572|39240012|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
16397003|NCT01831466|39935331|FG007|Overall Study|Withdrawal by Subject|0|||
16326540|NCT00601172|39681644|FG001|Overall Study|Did not meet continuation criteria|20|||
16326541|NCT02549287|39681645|FG000|Overall Study|Lost to Follow-up|65|||
16326542|NCT02549287|39681646|FG001|Overall Study|Lost to Follow-up|26|||
16326543|NCT02549287|39681645|FG000|Overall Study|Withdrawal by Subject|15|||
16326544|NCT02549287|39681646|FG001|Overall Study|Withdrawal by Subject|6|||
16326545|NCT01944839|39681649|FG000|Overall Study|Physician Decision|2|||
16326546|NCT01944839|39681650|FG001|Overall Study|Physician Decision|2|||
16326547|NCT01944839|39681649|FG000|Overall Study|Protocol Violation|0|||
16326548|NCT01944839|39681650|FG001|Overall Study|Protocol Violation|1|||
16326549|NCT01944839|39681649|FG000|Overall Study|Adverse Event|10|||
16326550|NCT01944839|39681650|FG001|Overall Study|Adverse Event|5|||
16326551|NCT01944839|39681649|FG000|Overall Study|Withdrawal by Subject|9|||
16326552|NCT01944839|39681650|FG001|Overall Study|Withdrawal by Subject|17|||
16326553|NCT01944839|39681649|FG000|Overall Study|Lost to Follow-up|1|||
16326554|NCT01944839|39681650|FG001|Overall Study|Lost to Follow-up|0|||
16326555|NCT01944839|39681649|FG000|Overall Study|Subject non-compliance|0|||
16326556|NCT01944839|39681650|FG001|Overall Study|Subject non-compliance|3|||
16326557|NCT03315286|39681652|FG000|Overall Study|Lost to Follow-up|0|||
16326558|NCT03315286|39681653|FG001|Overall Study|Lost to Follow-up|3|||
16326559|NCT03315286|39681652|FG000|Overall Study|Withdrawal by Subject|1|||
16326560|NCT03315286|39681653|FG001|Overall Study|Withdrawal by Subject|0|||
16326561|NCT03315286|39681652|FG000|Overall Study|Protocol Violation|0|||
16326562|NCT03315286|39681653|FG001|Overall Study|Protocol Violation|1|||
16326563|NCT00747474|39681654|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16326564|NCT00747474|39681655|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16326565|NCT00747474|39681656|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16326566|NCT00747474|39681657|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16326567|NCT00747474|39681658|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16326568|NCT00747474|39681659|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16326569|NCT00747474|39681660|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16326570|NCT00747474|39681661|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
16326571|NCT00747474|39681662|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16326572|NCT00747474|39681663|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16326573|NCT00747474|39681664|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16397004|NCT01831466|39935332|FG008|Overall Study|Withdrawal by Subject|0|||
16397005|NCT01831466|39935333|FG009|Overall Study|Withdrawal by Subject|1|||
16397006|NCT01831466|39935334|FG010|Overall Study|Withdrawal by Subject|0|||
16397007|NCT01831466|39935335|FG011|Overall Study|Withdrawal by Subject|1|||
16397008|NCT01831466|39935324|FG000|Overall Study|Lost to Follow-up|0|||
16397009|NCT01831466|39935325|FG001|Overall Study|Lost to Follow-up|1|||
16397010|NCT01831466|39935326|FG002|Overall Study|Lost to Follow-up|4|||
16397011|NCT01831466|39935327|FG003|Overall Study|Lost to Follow-up|2|||
16397012|NCT01831466|39935328|FG004|Overall Study|Lost to Follow-up|0|||
16397013|NCT01831466|39935329|FG005|Overall Study|Lost to Follow-up|3|||
16397014|NCT01831466|39935330|FG006|Overall Study|Lost to Follow-up|0|||
16397015|NCT01831466|39935331|FG007|Overall Study|Lost to Follow-up|0|||
16397016|NCT01831466|39935332|FG008|Overall Study|Lost to Follow-up|0|||
16397017|NCT01831466|39935333|FG009|Overall Study|Lost to Follow-up|1|||
16397018|NCT01831466|39935334|FG010|Overall Study|Lost to Follow-up|0|||
16397019|NCT01831466|39935335|FG011|Overall Study|Lost to Follow-up|1|||
16397020|NCT01831466|39935324|FG000|Overall Study|Lack of Efficacy|5|||
16397021|NCT01831466|39935325|FG001|Overall Study|Lack of Efficacy|8|||
16397022|NCT01831466|39935326|FG002|Overall Study|Lack of Efficacy|7|||
16397023|NCT01831466|39935327|FG003|Overall Study|Lack of Efficacy|6|||
16397024|NCT01831466|39935328|FG004|Overall Study|Lack of Efficacy|9|||
16397025|NCT01831466|39935329|FG005|Overall Study|Lack of Efficacy|8|||
16397026|NCT01831466|39935330|FG006|Overall Study|Lack of Efficacy|1|||
16397027|NCT01831466|39935331|FG007|Overall Study|Lack of Efficacy|1|||
16397028|NCT01831466|39935332|FG008|Overall Study|Lack of Efficacy|2|||
16397029|NCT01831466|39935333|FG009|Overall Study|Lack of Efficacy|2|||
16523535|NCT01003249|40383827|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16326574|NCT00747474|39681665|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
16326575|NCT02231879|39681667|FG000|Overall Study|Adverse Event|2|||
16397030|NCT01831466|39935334|FG010|Overall Study|Lack of Efficacy|2|||
16397031|NCT01831466|39935335|FG011|Overall Study|Lack of Efficacy|0|||
16397032|NCT01831466|39935324|FG000|Overall Study|Adverse Event|0|||
16397033|NCT01831466|39935325|FG001|Overall Study|Adverse Event|0|||
16397034|NCT01831466|39935326|FG002|Overall Study|Adverse Event|4|||
16397035|NCT01831466|39935327|FG003|Overall Study|Adverse Event|6|||
16397036|NCT01831466|39935328|FG004|Overall Study|Adverse Event|3|||
16397037|NCT01831466|39935329|FG005|Overall Study|Adverse Event|7|||
16397038|NCT01831466|39935330|FG006|Overall Study|Adverse Event|0|||
16397039|NCT01831466|39935331|FG007|Overall Study|Adverse Event|1|||
16397040|NCT01831466|39935332|FG008|Overall Study|Adverse Event|1|||
16397041|NCT01831466|39935333|FG009|Overall Study|Adverse Event|1|||
16397042|NCT01831466|39935334|FG010|Overall Study|Adverse Event|0|||
16397043|NCT01831466|39935335|FG011|Overall Study|Adverse Event|2|||
16397044|NCT05479097|39935344|FG000|Overall Study|Withdrawal by Subject|2|||
16397045|NCT01188551|39935345|FG000|Overall Study|Pharmacy issues|1|||
16397046|NCT01188551|39935346|FG001|Overall Study|Pharmacy issues|0|||
16397047|NCT01188551|39935347|FG002|Overall Study|Pharmacy issues|0|||
16397048|NCT01188551|39935348|FG003|Overall Study|Pharmacy issues|0|||
16397049|NCT00861692|39935349|FG000|Overall Study|Death|6|||
16397050|NCT02920528|39935350|FG000|Overall Study|Incomplete Data|1|||
16397051|NCT02920528|39935351|FG001|Overall Study|Incomplete Data|1|||
16397052|NCT02920528|39935352|FG002|Overall Study|Incomplete Data|1|||
16397053|NCT02920528|39935350|FG000|Overall Study|Adverse Event|0|||
16397054|NCT02920528|39935351|FG001|Overall Study|Adverse Event|0|||
16397055|NCT02920528|39935352|FG002|Overall Study|Adverse Event|3|||
16397056|NCT02920528|39935350|FG000|Overall Study|Did not meet inclusion criteria|2|||
16397057|NCT02920528|39935351|FG001|Overall Study|Did not meet inclusion criteria|0|||
16397058|NCT02920528|39935352|FG002|Overall Study|Did not meet inclusion criteria|1|||
16326576|NCT02231879|39681668|FG001|Overall Study|Adverse Event|1|||
16326577|NCT02231879|39681667|FG000|Overall Study|Lack of Efficacy|0|||
16326578|NCT02231879|39681668|FG001|Overall Study|Lack of Efficacy|1|||
16326579|NCT03430895|39681673|FG000|Overall Study|Not Treated|2|||
16326580|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
16326581|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
16326582|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
16326583|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
16326584|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
16326585|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
16326586|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
16326587|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
16326588|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
16326589|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
16397059|NCT00576628|39935354|FG000|Overall Study|Adverse Event|11|||
16397060|NCT00576628|39935354|FG000|Overall Study|Death|2|||
16397061|NCT00576628|39935354|FG000|Overall Study|Failure to return|1|||
16397062|NCT00576628|39935354|FG000|Overall Study|Refused Treatment|8|||
16397063|NCT00576628|39935354|FG000|Overall Study|Pregnancy|1|||
16397064|NCT00576628|39935354|FG000|Overall Study|RBC transfusion|1|||
16397065|NCT00576628|39935354|FG000|Overall Study|Progression of Kidney Disease|1|||
16397066|NCT00576628|39935354|FG000|Overall Study|Progression of Renal Failure|1|||
16397067|NCT00576628|39935354|FG000|Overall Study|The patient move into other town|1|||
16397068|NCT00576628|39935354|FG000|Overall Study|Transplantation|1|||
16397069|NCT00576628|39935354|FG000|Overall Study|Dialysis|15|||
16397070|NCT00810277|39935357|FG000|Overall Study|Adverse Event|1|||
16397071|NCT04908384|39935360|FG000|Overall Study|Lost to Follow-up|4|||
16397072|NCT04908384|39935361|FG001|Overall Study|Lost to Follow-up|4|||
16397073|NCT04908384|39935362|FG002|Overall Study|Lost to Follow-up|0|||
16397074|NCT04908384|39935363|FG003|Overall Study|Lost to Follow-up|0|||
16397075|NCT04493424|39935366|FG000|Overall Study|Termination of the trial by the sponsor|89|||
16208061|NCT01001572|39240013|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
16326590|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
16346383|NCT04739800|39753302|FG000|Overall Study|Never Treated|2|||
16346384|NCT04739800|39753303|FG001|Overall Study|Never Treated|0|||
16346385|NCT04739800|39753304|FG002|Overall Study|Never Treated|1|||
16346386|NCT04739800|39753305|FG003|Overall Study|Never Treated|1|||
16346387|NCT04739800|39753302|FG000|Overall Study|On Treatment|5|||
16346388|NCT04739800|39753303|FG001|Overall Study|On Treatment|9|||
16346389|NCT04739800|39753304|FG002|Overall Study|On Treatment|9|||
16346390|NCT04739800|39753305|FG003|Overall Study|On Treatment|9|||
16346391|NCT04739800|39753302|FG000|Overall Study|Symptomatic Deterioration|1|||
16346392|NCT04739800|39753303|FG001|Overall Study|Symptomatic Deterioration|1|||
16346393|NCT04739800|39753304|FG002|Overall Study|Symptomatic Deterioration|3|||
16346394|NCT04739800|39753305|FG003|Overall Study|Symptomatic Deterioration|0|||
16346395|NCT04739800|39753302|FG000|Overall Study|Withdrawal by Subject|1|||
16346396|NCT04739800|39753303|FG001|Overall Study|Withdrawal by Subject|2|||
16346397|NCT04739800|39753304|FG002|Overall Study|Withdrawal by Subject|1|||
16346398|NCT04739800|39753305|FG003|Overall Study|Withdrawal by Subject|3|||
16346399|NCT04739800|39753302|FG000|Overall Study|Other Reason|1|||
16346400|NCT04739800|39753303|FG001|Overall Study|Other Reason|3|||
16346401|NCT04739800|39753304|FG002|Overall Study|Other Reason|5|||
16346402|NCT04739800|39753305|FG003|Overall Study|Other Reason|4|||
16523536|NCT01003249|40383826|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
16095290|NCT02014402|38839387|FG002|Overall Study|Subject did not have transportation|0|||
16095291|NCT02014402|38839388|FG003|Overall Study|Subject did not have transportation|0|||
16095292|NCT02014402|38839385|FG000|Overall Study|Lost to Follow-up|0|||
16095293|NCT02014402|38839386|FG001|Overall Study|Lost to Follow-up|0|||
16095294|NCT02014402|38839387|FG002|Overall Study|Lost to Follow-up|1|||
16095295|NCT02014402|38839388|FG003|Overall Study|Lost to Follow-up|2|||
16095296|NCT01919489|38839391|FG000|Overall Study|Rejected the need of injections|4|||
16523537|NCT01003249|40383827|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
16523538|NCT00793910|40383832|FG000|Overall Study|discarded study pills|0|||
16523539|NCT00793910|40383833|FG001|Overall Study|discarded study pills|1|||
16523540|NCT00793910|40383832|FG000|Overall Study|did not pick up medications|1|||
16523541|NCT00793910|40383833|FG001|Overall Study|did not pick up medications|1|||
16523542|NCT00793910|40383832|FG000|Overall Study|ineligible based on entry criteria|2|||
16523543|NCT00793910|40383833|FG001|Overall Study|ineligible based on entry criteria|3|||
16523544|NCT00793910|40383832|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
16523545|NCT00793910|40383833|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
16523546|NCT00793910|40383832|FG000|Overall Study|Withdrawal by Subject|0|||
16523547|NCT00793910|40383833|FG001|Overall Study|Withdrawal by Subject|1|||
16523548|NCT01332305|40383834|FG000|Overall Study|Adverse Event|1|||
16523549|NCT01332305|40383835|FG001|Overall Study|Adverse Event|4|||
16523550|NCT01332305|40383836|FG002|Overall Study|Adverse Event|6|||
16523551|NCT01332305|40383837|FG003|Overall Study|Adverse Event|3|||
16523552|NCT01332305|40383838|FG004|Overall Study|Adverse Event|5|||
16523553|NCT01332305|40383834|FG000|Overall Study|Withdrawal by Subject|6|||
16523554|NCT01332305|40383835|FG001|Overall Study|Withdrawal by Subject|5|||
16523555|NCT01332305|40383836|FG002|Overall Study|Withdrawal by Subject|4|||
16095297|NCT01919489|38839392|FG001|Overall Study|Rejected the need of injections|7|||
16095298|NCT01919489|38839391|FG000|Overall Study|Adverse Event|10|||
16326591|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
16326592|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
16326593|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
16326594|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
16326595|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
16326596|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
16326597|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
16326598|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
16326599|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
16326600|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
16326601|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
16326602|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
16326603|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
16326604|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
16326605|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
16326606|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
16326607|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
16326608|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
16326609|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
16326610|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
16326611|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
16326612|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
16326613|NCT00839527|39681675|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
16326614|NCT00839527|39681676|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
16326615|NCT00839527|39681677|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
16326616|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
16326617|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
16326618|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
16326619|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
16326620|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
16326621|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
16326622|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
16326623|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
16326624|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
16326625|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
16326626|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
16326627|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
16326628|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
16326629|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
16523556|NCT01332305|40383837|FG003|Overall Study|Withdrawal by Subject|1|||
16523557|NCT01332305|40383838|FG004|Overall Study|Withdrawal by Subject|0|||
16397076|NCT04493424|39935366|FG000|Overall Study|Withdrawal by Subject|9|||
16208062|NCT01001572|39240011|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
16208063|NCT01001572|39240012|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
16208064|NCT01001572|39240013|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
16208065|NCT01001572|39240011|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16208066|NCT01001572|39240012|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16208067|NCT01001572|39240013|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
16326630|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
16326631|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
16095299|NCT01919489|38839392|FG001|Overall Study|Adverse Event|0|||
16397077|NCT04493424|39935366|FG000|Overall Study|Lost to Follow-up|2|||
16397078|NCT04493424|39935366|FG000|Overall Study|Lack of Efficacy|3|||
16523558|NCT01332305|40383834|FG000|Overall Study|Lost to Follow-up|0|||
16523559|NCT01332305|40383835|FG001|Overall Study|Lost to Follow-up|2|||
16095300|NCT01919489|38839391|FG000|Overall Study|Hospital readmission|2|||
16095301|NCT01919489|38839392|FG001|Overall Study|Hospital readmission|9|||
16095302|NCT01919489|38839391|FG000|Overall Study|Death|2|||
16095303|NCT01919489|38839392|FG001|Overall Study|Death|1|||
16095304|NCT01919489|38839391|FG000|Overall Study|Lost to Follow-up|38|||
16095305|NCT01919489|38839392|FG001|Overall Study|Lost to Follow-up|27|||
16095306|NCT01714947|38839393|FG000|Part B|Progressive Disease|3|||
16326632|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
16326633|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
16326634|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
16326635|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
16326636|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
16326637|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
16326638|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
16326639|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
16326640|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
16326641|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
16326642|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
16326643|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
16326644|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
16326645|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
16326646|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
16326647|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
16326648|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
16326649|NCT00839527|39681675|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
16326650|NCT00839527|39681676|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
16326651|NCT00839527|39681677|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
16326652|NCT01190410|39681678|FG000|Overall Study|Adverse Event|0|||
16326653|NCT01190410|39681679|FG001|Overall Study|Adverse Event|3|||
16326654|NCT01190410|39681678|FG000|Overall Study|Lack of Efficacy|0|||
16326655|NCT01190410|39681679|FG001|Overall Study|Lack of Efficacy|2|||
16326656|NCT01190410|39681678|FG000|Overall Study|Withdrawal by Subject|0|||
16326657|NCT01190410|39681679|FG001|Overall Study|Withdrawal by Subject|2|||
16326658|NCT01190410|39681678|FG000|Overall Study|Administrative decision|1|||
16326659|NCT01190410|39681679|FG001|Overall Study|Administrative decision|0|||
16326660|NCT01190410|39681678|FG000|Overall Study|PI discretion|0|||
16326661|NCT01190410|39681679|FG001|Overall Study|PI discretion|2|||
16326662|NCT02738879|39681685|FG000|Overall Study|Adverse Event|1|||
16326663|NCT02738879|39681686|FG001|Overall Study|Adverse Event|1|||
16326664|NCT02738879|39681685|FG000|Overall Study|Death|0|||
16326665|NCT02738879|39681686|FG001|Overall Study|Death|2|||
16326666|NCT02738879|39681685|FG000|Overall Study|Lost to Follow-up|1|||
16523560|NCT01332305|40383836|FG002|Overall Study|Lost to Follow-up|3|||
16523561|NCT01332305|40383837|FG003|Overall Study|Lost to Follow-up|2|||
16523562|NCT01332305|40383838|FG004|Overall Study|Lost to Follow-up|3|||
16523563|NCT01332305|40383834|FG000|Overall Study|Protocol Violation|1|||
16523564|NCT01332305|40383835|FG001|Overall Study|Protocol Violation|2|||
16095307|NCT02991456|38839394|FG000|Overall Study|Adverse Event|2|||
16208068|NCT02254551|39240014|FG000|Dose Escalation|Physician Decision|1|||
16326667|NCT02738879|39681686|FG001|Overall Study|Lost to Follow-up|5|||
16326668|NCT02738879|39681685|FG000|Overall Study|Protocol Violation|1|||
16326669|NCT02738879|39681686|FG001|Overall Study|Protocol Violation|3|||
16326670|NCT02738879|39681685|FG000|Overall Study|Physician Decision|3|||
16326671|NCT02738879|39681686|FG001|Overall Study|Physician Decision|4|||
16326672|NCT02738879|39681685|FG000|Overall Study|Pregnancy|0|||
16397079|NCT04493424|39935366|FG000|Overall Study|Adverse Event|5|||
16523565|NCT01332305|40383836|FG002|Overall Study|Protocol Violation|1|||
16095308|NCT02991456|38839395|FG001|Overall Study|Adverse Event|0|||
16095309|NCT02991456|38839394|FG000|Overall Study|Lost to Follow-up|0|||
16523566|NCT01332305|40383837|FG003|Overall Study|Protocol Violation|0|||
16326673|NCT02738879|39681686|FG001|Overall Study|Pregnancy|1|||
16326674|NCT02738879|39681685|FG000|Overall Study|Screen Failure|1|||
16326675|NCT02738879|39681686|FG001|Overall Study|Screen Failure|2|||
16326676|NCT02738879|39681685|FG000|Overall Study|Site Discontinued Study Participation|1|||
16326677|NCT02738879|39681686|FG001|Overall Study|Site Discontinued Study Participation|0|||
16326678|NCT02738879|39681685|FG000|Overall Study|Withdrawal by Subject|5|||
16326679|NCT02738879|39681686|FG001|Overall Study|Withdrawal by Subject|7|||
16326680|NCT02751450|39681687|FG000|Overall Study|Adverse Event|1|||
16326681|NCT02751450|39681688|FG001|Overall Study|Adverse Event|0|||
16326682|NCT03033602|39681689|FG000|Overall Study|Withdrawal by Subject|11|||
16326683|NCT03033602|39681690|FG001|Overall Study|Withdrawal by Subject|21|||
16326684|NCT03033602|39681689|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
16326685|NCT03033602|39681690|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
16326686|NCT01447446|39681693|FG000|Overall Study|Death|6|||
16326687|NCT01447446|39681694|FG001|Overall Study|Death|3|||
16326688|NCT01447446|39681695|FG002|Overall Study|Death|2|||
16326689|NCT01447446|39681696|FG003|Overall Study|Death|1|||
16326690|NCT01447446|39681697|FG004|Overall Study|Death|7|||
16326691|NCT01447446|39681698|FG005|Overall Study|Death|0|||
16326692|NCT01447446|39681693|FG000|Overall Study|Adverse Event|3|||
16326693|NCT01447446|39681694|FG001|Overall Study|Adverse Event|0|||
16326694|NCT01447446|39681695|FG002|Overall Study|Adverse Event|1|||
16326695|NCT01447446|39681696|FG003|Overall Study|Adverse Event|0|||
16326696|NCT01447446|39681697|FG004|Overall Study|Adverse Event|2|||
16326697|NCT01447446|39681698|FG005|Overall Study|Adverse Event|0|||
16326698|NCT01447446|39681693|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
16326699|NCT01447446|39681694|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
16326700|NCT01447446|39681695|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
16326701|NCT01447446|39681696|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
16326702|NCT01447446|39681697|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
16326703|NCT01447446|39681698|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
16326704|NCT01447446|39681693|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
16326705|NCT01447446|39681694|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
16326706|NCT01447446|39681695|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
16326707|NCT01447446|39681696|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
16326708|NCT01447446|39681697|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
16326709|NCT01447446|39681698|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
16326710|NCT01447446|39681693|FG000|Overall Study|Administrative/Other|34|||
16326711|NCT01447446|39681694|FG001|Overall Study|Administrative/Other|9|||
16326712|NCT01447446|39681695|FG002|Overall Study|Administrative/Other|10|||
16326713|NCT01447446|39681696|FG003|Overall Study|Administrative/Other|2|||
16326714|NCT01447446|39681697|FG004|Overall Study|Administrative/Other|33|||
16326715|NCT01447446|39681698|FG005|Overall Study|Administrative/Other|4|||
16326716|NCT01447446|39681693|FG000|Overall Study|SVR12 Assessment|13|||
16326717|NCT01447446|39681694|FG001|Overall Study|SVR12 Assessment|1|||
16326718|NCT01447446|39681695|FG002|Overall Study|SVR12 Assessment|2|||
16326719|NCT01447446|39681696|FG003|Overall Study|SVR12 Assessment|1|||
16326720|NCT01447446|39681697|FG004|Overall Study|SVR12 Assessment|5|||
16326721|NCT01447446|39681698|FG005|Overall Study|SVR12 Assessment|5|||
16326722|NCT01447446|39681693|FG000|Overall Study|New Treatment Started|8|||
16326723|NCT01447446|39681694|FG001|Overall Study|New Treatment Started|2|||
16326724|NCT01447446|39681695|FG002|Overall Study|New Treatment Started|1|||
16326725|NCT01447446|39681696|FG003|Overall Study|New Treatment Started|0|||
16326726|NCT01447446|39681697|FG004|Overall Study|New Treatment Started|2|||
16326727|NCT01447446|39681698|FG005|Overall Study|New Treatment Started|0|||
16326728|NCT01447446|39681693|FG000|Overall Study|Reason not Specified|1|||
16326729|NCT01447446|39681694|FG001|Overall Study|Reason not Specified|1|||
16326730|NCT01447446|39681695|FG002|Overall Study|Reason not Specified|1|||
16326731|NCT01447446|39681696|FG003|Overall Study|Reason not Specified|1|||
16326732|NCT01447446|39681697|FG004|Overall Study|Reason not Specified|1|||
16326733|NCT01447446|39681698|FG005|Overall Study|Reason not Specified|0|||
16326734|NCT01032239|39681700|FG000|Overall Study|Lost to Follow-up|3|||
16326735|NCT01032239|39681701|FG001|Overall Study|Lost to Follow-up|2|||
16326736|NCT01032239|39681700|FG000|Overall Study|Withdrawal by Subject|2|||
16326737|NCT01032239|39681701|FG001|Overall Study|Withdrawal by Subject|3|||
16326738|NCT01032239|39681700|FG000|Overall Study|Death|1|||
16523567|NCT01332305|40383838|FG004|Overall Study|Protocol Violation|3|||
16523568|NCT01332305|40383834|FG000|Overall Study|Withdrawal by Sponsor|1|||
16326739|NCT01032239|39681701|FG001|Overall Study|Death|0|||
16326740|NCT01032239|39681700|FG000|Overall Study|Protocol Violation|1|||
16326741|NCT01032239|39681701|FG001|Overall Study|Protocol Violation|0|||
16326742|NCT01637922|39681702|FG000|Overall Study|Adverse Event|0|||
16326743|NCT01637922|39681703|FG001|Overall Study|Adverse Event|1|||
16326744|NCT01637922|39681702|FG000|Overall Study|Protocol Violation|0|||
16326745|NCT01637922|39681703|FG001|Overall Study|Protocol Violation|1|||
16326746|NCT01637922|39681702|FG000|Overall Study|Withdrawal by Subject|0|||
16326747|NCT01637922|39681703|FG001|Overall Study|Withdrawal by Subject|3|||
16326748|NCT01637922|39681702|FG000|Overall Study|Lost to Follow-up|2|||
16326749|NCT01637922|39681703|FG001|Overall Study|Lost to Follow-up|0|||
16326750|NCT03200704|39681705|FG000|Overall Study|Withdrawal by Subject|1|||
16326751|NCT01758731|39681706|FG000|Overall Study|Physician Decision|1|||
16523569|NCT01332305|40383835|FG001|Overall Study|Withdrawal by Sponsor|0|||
16523570|NCT01332305|40383836|FG002|Overall Study|Withdrawal by Sponsor|0|||
16523571|NCT01332305|40383837|FG003|Overall Study|Withdrawal by Sponsor|1|||
16523572|NCT01332305|40383838|FG004|Overall Study|Withdrawal by Sponsor|1|||
16523573|NCT01332305|40383834|FG000|Overall Study|Treatment Failure|1|||
16523574|NCT01332305|40383835|FG001|Overall Study|Treatment Failure|1|||
16523575|NCT01332305|40383836|FG002|Overall Study|Treatment Failure|0|||
16523576|NCT01332305|40383837|FG003|Overall Study|Treatment Failure|0|||
16523577|NCT01332305|40383838|FG004|Overall Study|Treatment Failure|0|||
16523578|NCT01332305|40383834|FG000|Overall Study|Physician Decision|0|||
16523579|NCT01332305|40383835|FG001|Overall Study|Physician Decision|0|||
16523580|NCT01332305|40383836|FG002|Overall Study|Physician Decision|0|||
16523581|NCT01332305|40383837|FG003|Overall Study|Physician Decision|1|||
16523582|NCT01332305|40383838|FG004|Overall Study|Physician Decision|0|||
16523583|NCT01677195|40383839|FG000|Overall Study|Lost to Follow-up|14|||
16523584|NCT01677195|40383840|FG001|Overall Study|Lost to Follow-up|22|||
16523585|NCT01677195|40383841|FG002|Overall Study|Lost to Follow-up|22|||
16523586|NCT01677195|40383839|FG000|Overall Study|Withdrawal by Subject|1|||
16523587|NCT01677195|40383840|FG001|Overall Study|Withdrawal by Subject|0|||
16523588|NCT01677195|40383841|FG002|Overall Study|Withdrawal by Subject|1|||
16523589|NCT01677195|40383839|FG000|Overall Study|Adverse Event|6|||
16523590|NCT01677195|40383840|FG001|Overall Study|Adverse Event|4|||
16523591|NCT01677195|40383841|FG002|Overall Study|Adverse Event|1|||
16523592|NCT01677195|40383839|FG000|Overall Study|Physician Decision|1|||
16523593|NCT01677195|40383840|FG001|Overall Study|Physician Decision|2|||
16523594|NCT01677195|40383841|FG002|Overall Study|Physician Decision|2|||
16523595|NCT01677195|40383839|FG000|Overall Study|Pregnancy|0|||
16523596|NCT01677195|40383840|FG001|Overall Study|Pregnancy|1|||
16523597|NCT01677195|40383841|FG002|Overall Study|Pregnancy|0|||
16523598|NCT01677195|40383839|FG000|Overall Study|Protocol Violation|7|||
16523599|NCT01677195|40383840|FG001|Overall Study|Protocol Violation|3|||
16095310|NCT02991456|38839395|FG001|Overall Study|Lost to Follow-up|2|||
16095311|NCT02991456|38839394|FG000|Overall Study|Withdrawal by Subject|1|||
16523600|NCT01677195|40383841|FG002|Overall Study|Protocol Violation|4|||
16523601|NCT04260191|40383842|FG000|Overall Study|Decision by Sponsor|0|||
16523602|NCT04260191|40383843|FG001|Overall Study|Decision by Sponsor|1|||
16523603|NCT04260191|40383844|FG002|Overall Study|Decision by Sponsor|0|||
16523604|NCT04260191|40383842|FG000|Overall Study|Withdrawal by Subject|1|||
16523605|NCT04260191|40383843|FG001|Overall Study|Withdrawal by Subject|0|||
16523606|NCT04260191|40383844|FG002|Overall Study|Withdrawal by Subject|3|||
16523607|NCT04260191|40383842|FG000|Overall Study|Death|4|||
16523608|NCT04260191|40383843|FG001|Overall Study|Death|3|||
16523609|NCT04260191|40383844|FG002|Overall Study|Death|2|||
16523610|NCT03169153|40383845|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
16523611|NCT03169153|40383846|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
16523612|NCT03169153|40383845|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
16523613|NCT03169153|40383846|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
16523614|NCT03169153|40383845|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
16523615|NCT03169153|40383846|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
16326752|NCT03937908|39681707|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
16326753|NCT03937908|39681708|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
16326754|NCT00749684|39681709|FG000|Overall Study|Death|1|||
16326755|NCT00749684|39681709|FG000|Overall Study|Adverse Event|27|||
16326756|NCT00749684|39681709|FG000|Overall Study|Participant's Wish|10|||
16326757|NCT00749684|39681709|FG000|Overall Study|Not Documented|1|||
16326758|NCT00749684|39681709|FG000|Overall Study|Progressive Desease|31|||
16326759|NCT00749684|39681709|FG000|Overall Study|Therapy according to protocol + AE|2|||
16326760|NCT00749684|39681709|FG000|Overall Study|AE+discontinuation on participants wish|1|||
16326761|NCT00749684|39681709|FG000|Overall Study|Missing|9|||
16326762|NCT02714595|39681712|FG000|Overall Study|Lost to Follow-up|1|||
16326763|NCT02714595|39681713|FG001|Overall Study|Lost to Follow-up|0|||
16326764|NCT02714595|39681712|FG000|Overall Study|Withdrawal by Subject|1|||
16326765|NCT02714595|39681713|FG001|Overall Study|Withdrawal by Subject|2|||
16523616|NCT03169153|40383845|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
16523617|NCT03169153|40383846|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
16523618|NCT01607905|40383847|FG000|Overall Study|Withdrawal by participant|7|||
16523619|NCT01607905|40383848|FG001|Overall Study|Withdrawal by participant|2|||
16095312|NCT02991456|38839395|FG001|Overall Study|Withdrawal by Subject|0|||
16095313|NCT03976102|38839396|FG000|Overall Study|Withdrawal by Subject|4|||
16326766|NCT02714595|39681712|FG000|Overall Study|Lack of Efficacy|0|||
16523620|NCT01607905|40383849|FG002|Overall Study|Withdrawal by participant|4|||
16523621|NCT01607905|40383850|FG003|Overall Study|Withdrawal by participant|6|||
16523622|NCT01607905|40383851|FG004|Overall Study|Withdrawal by participant|0|||
16523623|NCT01607905|40383852|FG005|Overall Study|Withdrawal by participant|4|||
16523624|NCT01607905|40383853|FG006|Overall Study|Withdrawal by participant|12|||
16523625|NCT01607905|40383847|FG000|Overall Study|Incidence or severity of AEs|5|||
16523626|NCT01607905|40383848|FG001|Overall Study|Incidence or severity of AEs|1|||
16523627|NCT01607905|40383849|FG002|Overall Study|Incidence or severity of AEs|1|||
16326767|NCT02714595|39681713|FG001|Overall Study|Lack of Efficacy|1|||
16326768|NCT02714595|39681712|FG000|Overall Study|Death|30|||
16326769|NCT02714595|39681713|FG001|Overall Study|Death|9|||
16326770|NCT02714595|39681712|FG000|Overall Study|Other-Miscellaneous|0|||
16326771|NCT02714595|39681713|FG001|Overall Study|Other-Miscellaneous|1|||
16326772|NCT01163318|39681714|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
16326773|NCT01163318|39681714|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
16326774|NCT01163318|39681714|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
16326775|NCT01163318|39681714|FG000|Overall Study|Participants Without Case Report Form|7|||
16326776|NCT01163318|39681714|FG000|Overall Study|Multiple Reasons Per Participant|224|||
16326777|NCT02353442|39681717|FG000|Overall Study|Withdrawal by Subject|3|||
16326778|NCT02353442|39681718|FG001|Overall Study|Withdrawal by Subject|4|||
16326779|NCT00507728|39681721|FG000|Randomization to Month 3|Lost to Follow-up|15|||
16326780|NCT00507728|39681722|FG001|Randomization to Month 3|Lost to Follow-up|14|||
16326781|NCT00507728|39681723|FG002|Randomization to Month 3|Lost to Follow-up|20|||
16326782|NCT00507728|39681721|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
16326783|NCT00507728|39681722|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
16326784|NCT00507728|39681723|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
16326785|NCT01053962|39681724|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
16326786|NCT01053962|39681725|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
16326787|NCT01053962|39681726|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
16326788|NCT01053962|39681727|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
16326789|NCT01053962|39681728|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
16326790|NCT01053962|39681724|FG000|Pretreatment Period|Venipuncture Failure|0|||
16326791|NCT01053962|39681725|FG001|Pretreatment Period|Venipuncture Failure|0|||
16326792|NCT01053962|39681726|FG002|Pretreatment Period|Venipuncture Failure|1|||
16326793|NCT01053962|39681727|FG003|Pretreatment Period|Venipuncture Failure|0|||
16326794|NCT01053962|39681728|FG004|Pretreatment Period|Venipuncture Failure|0|||
16326795|NCT01053962|39681724|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
16326796|NCT01053962|39681725|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
16326797|NCT01053962|39681726|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
16326798|NCT01053962|39681727|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
16326799|NCT01053962|39681728|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
16326800|NCT01053962|39681724|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
16326801|NCT01053962|39681725|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
16326802|NCT01053962|39681726|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
16326803|NCT01053962|39681727|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
16326804|NCT01053962|39681728|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
16326805|NCT01053962|39681724|FG000|Treatment Period|Lack of Efficacy|0|||
16326806|NCT01053962|39681725|FG001|Treatment Period|Lack of Efficacy|0|||
16326807|NCT01053962|39681726|FG002|Treatment Period|Lack of Efficacy|0|||
16326808|NCT01053962|39681727|FG003|Treatment Period|Lack of Efficacy|0|||
16326809|NCT01053962|39681728|FG004|Treatment Period|Lack of Efficacy|1|||
16326810|NCT01053962|39681724|FG000|Treatment Period|Adverse Event|0|||
16326811|NCT01053962|39681725|FG001|Treatment Period|Adverse Event|0|||
16326812|NCT01053962|39681726|FG002|Treatment Period|Adverse Event|0|||
16326813|NCT01053962|39681727|FG003|Treatment Period|Adverse Event|0|||
16326814|NCT01053962|39681728|FG004|Treatment Period|Adverse Event|1|||
16326815|NCT01053962|39681724|FG000|Treatment Period|Withdrawal by Subject|0|||
16326816|NCT01053962|39681725|FG001|Treatment Period|Withdrawal by Subject|0|||
16326817|NCT01053962|39681726|FG002|Treatment Period|Withdrawal by Subject|0|||
16326818|NCT01053962|39681727|FG003|Treatment Period|Withdrawal by Subject|0|||
16326819|NCT01053962|39681728|FG004|Treatment Period|Withdrawal by Subject|1|||
16326820|NCT01053962|39681724|FG000|Treatment Period|Noncompliance with protocol|1|||
16326821|NCT01053962|39681725|FG001|Treatment Period|Noncompliance with protocol|0|||
16326822|NCT01053962|39681726|FG002|Treatment Period|Noncompliance with protocol|0|||
16326823|NCT01053962|39681727|FG003|Treatment Period|Noncompliance with protocol|0|||
16326824|NCT01053962|39681728|FG004|Treatment Period|Noncompliance with protocol|0|||
16326825|NCT03089697|39681734|FG000|Overall Study|Adverse Event|1|||
16326826|NCT03089697|39681735|FG001|Overall Study|Adverse Event|2|||
16326827|NCT03089697|39681734|FG000|Overall Study|Withdrawal by Subject|1|||
16326828|NCT03089697|39681735|FG001|Overall Study|Withdrawal by Subject|0|||
16523628|NCT01607905|40383850|FG003|Overall Study|Incidence or severity of AEs|3|||
16326829|NCT01855243|39681736|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
16326830|NCT01855243|39681737|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
16326831|NCT01855243|39681738|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
16326832|NCT01475851|39681739|FG000|Overall Study|Protocol defined stopping criteria|1|||
16326833|NCT01475851|39681740|FG001|Overall Study|Protocol defined stopping criteria|0|||
16326834|NCT00076752|39681741|FG000|Overall Study|Death|2|||
16326835|NCT00076752|39681741|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
16326836|NCT01254318|39681743|FG000|Overall Study|Lost to Follow-up|5|||
16326837|NCT01254318|39681743|FG000|Overall Study|Death|47|||
16326838|NCT03875482|39681746|FG000|Overall Study|Adverse Event|0|||
16326839|NCT03875482|39681747|FG001|Overall Study|Adverse Event|1|||
16326840|NCT03875482|39681746|FG000|Overall Study|Withdrew consent|5|||
16326841|NCT03875482|39681747|FG001|Overall Study|Withdrew consent|6|||
16326842|NCT03875482|39681746|FG000|Overall Study|Lost to Follow-up|8|||
16326843|NCT03875482|39681747|FG001|Overall Study|Lost to Follow-up|2|||
16326844|NCT03875482|39681746|FG000|Overall Study|Lack of Efficacy|0|||
16326845|NCT03875482|39681747|FG001|Overall Study|Lack of Efficacy|11|||
16326846|NCT04505722|39681752|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
16326847|NCT04505722|39681753|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
16326848|NCT04505722|39681754|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
16326849|NCT04505722|39681752|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
16326850|NCT04505722|39681753|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
16326851|NCT04505722|39681754|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
16326852|NCT04505722|39681752|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
16326853|NCT04505722|39681753|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
16326854|NCT04505722|39681754|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
16095314|NCT03976102|38839397|FG001|Overall Study|Withdrawal by Subject|4|||
16095315|NCT03976102|38839396|FG000|Overall Study|Adverse Event|2|||
16326855|NCT04505722|39681752|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
16326856|NCT04505722|39681753|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
16095316|NCT03976102|38839397|FG001|Overall Study|Adverse Event|4|||
16095317|NCT03976102|38839396|FG000|Overall Study|Not related to Covid-19|9|||
16095318|NCT03976102|38839397|FG001|Overall Study|Not related to Covid-19|13|||
16095319|NCT03976102|38839396|FG000|Overall Study|Lost to Follow-up|0|||
16095320|NCT03976102|38839397|FG001|Overall Study|Lost to Follow-up|2|||
16095321|NCT03976102|38839396|FG000|Overall Study|Death|3|||
16095322|NCT03976102|38839397|FG001|Overall Study|Death|2|||
16095323|NCT03976102|38839396|FG000|Overall Study|Physician Decision|1|||
16095324|NCT03976102|38839397|FG001|Overall Study|Physician Decision|1|||
16095325|NCT02205476|38839398|FG000|Overall Study|Study termination by Sponsor|7|||
16326857|NCT04505722|39681754|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
16326858|NCT04505722|39681752|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
16326859|NCT04505722|39681753|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
16326860|NCT04505722|39681754|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
16326861|NCT04505722|39681752|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
16397080|NCT00988052|39935367|FG000|Overall Study|Missing|1|||
16397081|NCT00988052|39935368|FG001|Overall Study|Missing|0|||
16095326|NCT02205476|38839399|FG001|Overall Study|Study termination by Sponsor|3|||
16095327|NCT01280656|38839400|FG000|Overall Study|Adverse Event|1|||
16095328|NCT01280656|38839401|FG001|Overall Study|Adverse Event|14|||
16095329|NCT01280656|38839402|FG002|Overall Study|Adverse Event|13|||
16095330|NCT01280656|38839400|FG000|Overall Study|Lack of Efficacy|1|||
16095331|NCT01280656|38839401|FG001|Overall Study|Lack of Efficacy|22|||
16095332|NCT01280656|38839402|FG002|Overall Study|Lack of Efficacy|38|||
16095333|NCT01280656|38839400|FG000|Overall Study|Treatment shortening (RGT)|0|||
16095334|NCT01280656|38839401|FG001|Overall Study|Treatment shortening (RGT)|4|||
16095335|NCT01280656|38839402|FG002|Overall Study|Treatment shortening (RGT)|5|||
16095336|NCT01280656|38839400|FG000|Overall Study|Other|1|||
16095337|NCT01280656|38839401|FG001|Overall Study|Other|7|||
16095338|NCT01280656|38839402|FG002|Overall Study|Other|7|||
16095339|NCT04839289|38839403|FG000|Overall Study|Withdrawal by Subject|1|||
16095340|NCT04839289|38839404|FG001|Overall Study|Withdrawal by Subject|0|||
16095341|NCT01863368|38839415|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
16326862|NCT04505722|39681753|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
16326863|NCT04505722|39681754|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
16326864|NCT04505722|39681752|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
16326865|NCT04505722|39681753|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
16326866|NCT04505722|39681754|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
16326867|NCT04505722|39681752|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
16095342|NCT01863368|38839416|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
16095343|NCT01863368|38839415|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
16397082|NCT00988052|39935367|FG000|Overall Study|Teva requested subject withdrawal|3|||
16095344|NCT01863368|38839416|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
16095345|NCT01863368|38839415|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
16095346|NCT01863368|38839416|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
16326868|NCT04505722|39681753|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
16326869|NCT04505722|39681754|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
16326870|NCT04505722|39681752|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
16326871|NCT04505722|39681753|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
16326872|NCT04505722|39681754|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
16326873|NCT04505722|39681752|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
16326874|NCT04505722|39681753|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
16326875|NCT04505722|39681754|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
16326876|NCT04505722|39681752|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
16326877|NCT04505722|39681753|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
16326878|NCT04505722|39681754|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
16326879|NCT04505722|39681752|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
16326880|NCT04505722|39681753|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
16326881|NCT04505722|39681754|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
16095347|NCT01863368|38839415|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
16326882|NCT04505722|39681752|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
16326883|NCT04505722|39681753|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
16326884|NCT04505722|39681754|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
16326885|NCT04505722|39681752|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
16326886|NCT04505722|39681753|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
16326887|NCT04505722|39681754|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
16326888|NCT04505722|39681752|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
16326889|NCT04505722|39681753|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
16095348|NCT01863368|38839416|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
16095349|NCT01863368|38839415|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
16095350|NCT01863368|38839416|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
16095351|NCT01863368|38839415|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
16095352|NCT01863368|38839416|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
16095353|NCT01825785|38839418|FG000|Overall Study|Adverse Event|0|||
16095354|NCT01825785|38839419|FG001|Overall Study|Adverse Event|0|||
16095355|NCT01825785|38839420|FG002|Overall Study|Adverse Event|0|||
16095356|NCT01825785|38839421|FG003|Overall Study|Adverse Event|0|||
16095357|NCT01825785|38839422|FG004|Overall Study|Adverse Event|1|||
16095358|NCT01825785|38839423|FG005|Overall Study|Adverse Event|0|||
16095359|NCT01825785|38839424|FG006|Overall Study|Adverse Event|0|||
16095360|NCT01825785|38839418|FG000|Overall Study|Withdrawal by Subject|0|||
16095361|NCT01825785|38839419|FG001|Overall Study|Withdrawal by Subject|0|||
16095362|NCT01825785|38839420|FG002|Overall Study|Withdrawal by Subject|0|||
16095363|NCT01825785|38839421|FG003|Overall Study|Withdrawal by Subject|0|||
16095364|NCT01825785|38839422|FG004|Overall Study|Withdrawal by Subject|1|||
16095365|NCT01825785|38839423|FG005|Overall Study|Withdrawal by Subject|1|||
16095366|NCT01825785|38839424|FG006|Overall Study|Withdrawal by Subject|0|||
16095367|NCT00396409|38839425|FG000|Period 1 - 2007|Adverse Event|0|||
16095368|NCT00396409|38839426|FG001|Period 1 - 2007|Adverse Event|1|||
16095369|NCT00396409|38839425|FG000|Period 1 - 2007|Lack of Efficacy|0|||
16095370|NCT00396409|38839426|FG001|Period 1 - 2007|Lack of Efficacy|1|||
16095371|NCT00396409|38839425|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
16095372|NCT00396409|38839426|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
16095373|NCT00396409|38839425|FG000|Period 1 - 2007|Lost to Follow-up|2|||
16095374|NCT00396409|38839426|FG001|Period 1 - 2007|Lost to Follow-up|3|||
16326890|NCT04505722|39681754|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
16326891|NCT01597375|39681755|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
16326892|NCT01597375|39681756|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
16095375|NCT00396409|38839425|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
16095376|NCT00396409|38839426|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
16095377|NCT00396409|38839425|FG000|Period 2 - 2008|Protocol Violation|1|||
16095378|NCT00396409|38839426|FG001|Period 2 - 2008|Protocol Violation|0|||
16095379|NCT00396409|38839425|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
16095380|NCT00396409|38839426|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
16095381|NCT00396409|38839425|FG000|Period 2 - 2008|Lost to Follow-up|3|||
16095382|NCT00396409|38839426|FG001|Period 2 - 2008|Lost to Follow-up|1|||
16095383|NCT03508830|38839427|FG000|Overall Study|Withdrawal by Subject|3|||
16095384|NCT03508830|38839428|FG001|Overall Study|Withdrawal by Subject|4|||
16095385|NCT03508830|38839427|FG000|Overall Study|Physician Decision|2|||
16095386|NCT03508830|38839428|FG001|Overall Study|Physician Decision|2|||
16095387|NCT00321555|38839429|FG000|Overall Study|Developed antibodies|1|||
16095388|NCT00321555|38839429|FG000|Overall Study|Switched to alternative treatment|3|||
16095389|NCT00321555|38839429|FG000|Overall Study|Physician Decision|1|||
16095390|NCT00321555|38839429|FG000|Overall Study|Disease progression on study|1|||
16095391|NCT00839306|38839435|FG000|Overall Study|Adverse Event|3|||
16095392|NCT00839306|38839436|FG001|Overall Study|Adverse Event|5|||
16095393|NCT00839306|38839435|FG000|Overall Study|Lost to Follow-up|6|||
16095394|NCT00839306|38839436|FG001|Overall Study|Lost to Follow-up|9|||
16095395|NCT00839306|38839435|FG000|Overall Study|Withdrawal by Subject|5|||
16095396|NCT00839306|38839436|FG001|Overall Study|Withdrawal by Subject|7|||
16095397|NCT00839306|38839435|FG000|Overall Study|Lack of Efficacy|5|||
16095398|NCT00839306|38839436|FG001|Overall Study|Lack of Efficacy|4|||
16095399|NCT00839306|38839435|FG000|Overall Study|Other|6|||
16095400|NCT00839306|38839436|FG001|Overall Study|Other|18|||
16095401|NCT01922102|38839437|FG000|Overall Study|Withdrawal by Subject|7|||
16095402|NCT01922102|38839438|FG001|Overall Study|Withdrawal by Subject|3|||
16095403|NCT01922102|38839439|FG002|Overall Study|Withdrawal by Subject|7|||
16095404|NCT01922102|38839437|FG000|Overall Study|Physician Decision|0|||
16095405|NCT01922102|38839438|FG001|Overall Study|Physician Decision|2|||
16095406|NCT01922102|38839439|FG002|Overall Study|Physician Decision|1|||
16095407|NCT01922102|38839437|FG000|Overall Study|Adverse Event|1|||
16095408|NCT01922102|38839438|FG001|Overall Study|Adverse Event|2|||
16095409|NCT01922102|38839439|FG002|Overall Study|Adverse Event|0|||
16095410|NCT01922102|38839437|FG000|Overall Study|Lost to Follow-up|1|||
16095411|NCT01922102|38839438|FG001|Overall Study|Lost to Follow-up|0|||
16095412|NCT01922102|38839439|FG002|Overall Study|Lost to Follow-up|0|||
16095413|NCT01922102|38839437|FG000|Overall Study|Administrative problems|0|||
16208069|NCT02254551|39240014|FG000|Dose Escalation|Dose-limiting toxicity|2|||
16208070|NCT00728936|39240016|FG000|Overall Study|Withdrawal by Subject|0|||
16095414|NCT01922102|38839438|FG001|Overall Study|Administrative problems|2|||
16095415|NCT01922102|38839439|FG002|Overall Study|Administrative problems|0|||
16095416|NCT01697956|38839440|FG000|Overall Study|Protocol Violation|1|||
16095417|NCT01697956|38839441|FG001|Overall Study|Protocol Violation|1|||
16095418|NCT02332889|38839442|FG000|Overall Study|Physician Decision|1|||
16095419|NCT03436797|38839443|FG000|Main Study|Withdrawal by Subject|2|||
16095420|NCT03436797|38839443|FG000|Main Study|Adverse Event|4|||
16095421|NCT03436797|38839443|FG000|Main Study|Lost to Follow-up|1|||
16095422|NCT03436797|38839443|FG000|Main Study|Death|1|||
16095423|NCT03436797|38839443|FG000|Main Study|Non-Specific|2|||
16095424|NCT03436797|38839443|FG000|Extended Dosing|Patient decision|1|||
16095425|NCT00383500|38839444|FG000|Overall Study|Withdrawal by Subject|8|||
16095426|NCT00383500|38839445|FG001|Overall Study|Withdrawal by Subject|3|||
16095427|NCT00383500|38839446|FG002|Overall Study|Withdrawal by Subject|0|||
16095428|NCT00383500|38839444|FG000|Overall Study|Lost to Follow-up|0|||
16095429|NCT00383500|38839445|FG001|Overall Study|Lost to Follow-up|0|||
16095430|NCT00383500|38839446|FG002|Overall Study|Lost to Follow-up|2|||
16095431|NCT02727998|38839447|FG000|Overall Study|Lost to Follow-up|3|||
16095432|NCT02727998|38839448|FG001|Overall Study|Lost to Follow-up|3|||
16095433|NCT02727998|38839447|FG000|Overall Study|Withdrawal by Subject|0|||
16095434|NCT02727998|38839448|FG001|Overall Study|Withdrawal by Subject|1|||
16095435|NCT00390806|38839449|FG000|Overall Study|Lost to Follow-up|7|||
16095436|NCT00390806|38839450|FG001|Overall Study|Lost to Follow-up|6|||
16095437|NCT00390806|38839449|FG000|Overall Study|Protocol Violation|2|||
16095438|NCT00390806|38839450|FG001|Overall Study|Protocol Violation|2|||
16095439|NCT00390806|38839449|FG000|Overall Study|Withdrawal by Subject|12|||
16095440|NCT00390806|38839450|FG001|Overall Study|Withdrawal by Subject|15|||
16095441|NCT00390806|38839449|FG000|Overall Study|Investigator Decision|4|||
16095442|NCT00390806|38839450|FG001|Overall Study|Investigator Decision|6|||
16095443|NCT00390806|38839449|FG000|Overall Study|Death|1|||
16095444|NCT00390806|38839450|FG001|Overall Study|Death|0|||
16208071|NCT00728936|39240017|FG001|Overall Study|Withdrawal by Subject|0|||
16208072|NCT00728936|39240018|FG002|Overall Study|Withdrawal by Subject|0|||
16326893|NCT01597375|39681755|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
16326894|NCT01597375|39681756|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
16326895|NCT01597375|39681755|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
16326896|NCT01597375|39681756|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
16326897|NCT01597375|39681755|FG000|Washout (2 Weeks)|Adverse Event|1|||
16326898|NCT01597375|39681756|FG001|Washout (2 Weeks)|Adverse Event|0|||
16326899|NCT01597375|39681755|FG000|Second Intervention|Failed to react at both Aspirin|1|||
16326900|NCT01597375|39681756|FG001|Second Intervention|Failed to react at both Aspirin|1|||
16326901|NCT00073983|39681760|FG000|Overall Study|not evaluable|1|||
16326902|NCT04439214|39681761|FG000|Overall Study|Adverse Event|13|||
16326903|NCT04439214|39681761|FG000|Overall Study|Disease progression|16|||
16326904|NCT04439214|39681761|FG000|Overall Study|Death|1|||
16326905|NCT04439214|39681761|FG000|Overall Study|Withdrawal by Subject|2|||
16326906|NCT04439214|39681761|FG000|Overall Study|Declining health|1|||
16326907|NCT04439214|39681761|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
16326908|NCT04439214|39681761|FG000|Overall Study|Ineligible|5|||
16326909|NCT02960763|39681762|FG000|Step 1|Withdrawal by Subject|10|||
16326910|NCT02960763|39681763|FG001|Step 1|Withdrawal by Subject|8|||
16095445|NCT00390806|38839449|FG000|Overall Study|Physician Decision|0|||
16208073|NCT00728936|39240019|FG003|Overall Study|Withdrawal by Subject|0|||
16208074|NCT00728936|39240020|FG004|Overall Study|Withdrawal by Subject|0|||
16208075|NCT00728936|39240021|FG005|Overall Study|Withdrawal by Subject|1|||
16326911|NCT02960763|39681764|FG002|Step 1|Withdrawal by Subject|13|||
16397083|NCT00988052|39935368|FG001|Overall Study|Teva requested subject withdrawal|1|||
16397084|NCT00988052|39935367|FG000|Overall Study|Death|1|||
16397085|NCT00988052|39935368|FG001|Overall Study|Death|3|||
16397086|NCT00988052|39935367|FG000|Overall Study|Protocol Violation|6|||
16397087|NCT00988052|39935368|FG001|Overall Study|Protocol Violation|5|||
16326912|NCT02960763|39681765|FG003|Step 1|Withdrawal by Subject|0|||
16326913|NCT02960763|39681766|FG004|Step 1|Withdrawal by Subject|0|||
16326914|NCT02960763|39681762|FG000|Step 1|Lost to Follow-up|7|||
16326915|NCT02960763|39681763|FG001|Step 1|Lost to Follow-up|9|||
16326916|NCT02960763|39681764|FG002|Step 1|Lost to Follow-up|12|||
16326917|NCT02960763|39681765|FG003|Step 1|Lost to Follow-up|0|||
16326918|NCT02960763|39681766|FG004|Step 1|Lost to Follow-up|0|||
16326919|NCT02960763|39681762|FG000|Step 1|Death|1|||
16326920|NCT02960763|39681763|FG001|Step 1|Death|1|||
16326921|NCT02960763|39681764|FG002|Step 1|Death|1|||
16397088|NCT00988052|39935367|FG000|Overall Study|Pregnancy|6|||
16326922|NCT02960763|39681765|FG003|Step 1|Death|0|||
16397089|NCT00988052|39935368|FG001|Overall Study|Pregnancy|6|||
16397090|NCT00988052|39935367|FG000|Overall Study|Lack of Efficacy|8|||
16397091|NCT00988052|39935368|FG001|Overall Study|Lack of Efficacy|7|||
16095446|NCT00390806|38839450|FG001|Overall Study|Physician Decision|1|||
16095447|NCT00390806|38839449|FG000|Overall Study|Ongoing|4|||
16095448|NCT00390806|38839450|FG001|Overall Study|Ongoing|2|||
16208076|NCT00728936|39240022|FG006|Overall Study|Withdrawal by Subject|0|||
16326923|NCT02960763|39681766|FG004|Step 1|Death|0|||
16326924|NCT02960763|39681762|FG000|Step 1|Investigator discretion|1|||
16326925|NCT02960763|39681763|FG001|Step 1|Investigator discretion|0|||
16095449|NCT03823703|38839451|FG000|Overall Study|Sponsor request|0|||
16095450|NCT03823703|38839452|FG001|Overall Study|Sponsor request|3|||
16208077|NCT02693691|39240023|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
16326926|NCT02960763|39681764|FG002|Step 1|Investigator discretion|1|||
16326927|NCT02960763|39681765|FG003|Step 1|Investigator discretion|0|||
16326928|NCT02960763|39681766|FG004|Step 1|Investigator discretion|0|||
16397092|NCT00988052|39935367|FG000|Overall Study|Lost to Follow-up|6|||
16208078|NCT02693691|39240023|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
16208079|NCT02693691|39240023|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
16208080|NCT02693691|39240023|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
16208081|NCT02693691|39240023|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
16208082|NCT02693691|39240023|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
16208083|NCT02693691|39240023|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
16208084|NCT02096042|39240026|FG000|Overall Study|Disease Progression|1|||
16208085|NCT02096042|39240027|FG001|Overall Study|Disease Progression|0|||
16208086|NCT02096042|39240028|FG002|Overall Study|Disease Progression|0|||
16208087|NCT03039569|39240032|FG000|Overall Study|Lost to Follow-up|5|||
16208088|NCT03039569|39240033|FG001|Overall Study|Lost to Follow-up|4|||
16208089|NCT00291187|39240039|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
16208090|NCT00291187|39240040|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
16208091|NCT00291187|39240041|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
16208092|NCT00291187|39240042|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
16208093|NCT00439725|39240043|FG000|Treatment Period|Withdrawal by Subject|22|||
16208094|NCT00439725|39240044|FG001|Treatment Period|Withdrawal by Subject|19|||
16208095|NCT00439725|39240043|FG000|Treatment Period|Study terminated by sponsor|156|||
16208096|NCT00439725|39240044|FG001|Treatment Period|Study terminated by sponsor|148|||
16208097|NCT00439725|39240043|FG000|Treatment Period|Site closed by investigator|1|||
16208098|NCT00439725|39240044|FG001|Treatment Period|Site closed by investigator|2|||
16208099|NCT00439725|39240043|FG000|Treatment Period|Adverse Event|39|||
16208100|NCT00439725|39240044|FG001|Treatment Period|Adverse Event|18|||
16208101|NCT00439725|39240043|FG000|Treatment Period|Physician Decision|1|||
16208102|NCT00439725|39240044|FG001|Treatment Period|Physician Decision|1|||
16208103|NCT00439725|39240043|FG000|Treatment Period|Protocol Violation|2|||
16208104|NCT00439725|39240044|FG001|Treatment Period|Protocol Violation|1|||
16208105|NCT00439725|39240043|FG000|Treatment Period|Clinical endpoint reached|6|||
16208106|NCT00439725|39240044|FG001|Treatment Period|Clinical endpoint reached|50|||
16208107|NCT00439725|39240043|FG000|Treatment Period|Technical problems|1|||
16208108|NCT00439725|39240044|FG001|Treatment Period|Technical problems|0|||
16208109|NCT00439725|39240043|FG000|Treatment Period|Lost to Follow-up|1|||
16208110|NCT00439725|39240044|FG001|Treatment Period|Lost to Follow-up|1|||
16208111|NCT00439725|39240043|FG000|Treatment Period|Participant convenience|1|||
16208112|NCT00439725|39240044|FG001|Treatment Period|Participant convenience|0|||
16208113|NCT00439725|39240043|FG000|Treatment Period|Protocol driven decision point|1|||
16208114|NCT00439725|39240044|FG001|Treatment Period|Protocol driven decision point|1|||
16208115|NCT00439725|39240043|FG000|Treatment Period|Death|1|||
16208116|NCT00439725|39240044|FG001|Treatment Period|Death|1|||
16208117|NCT00439725|39240043|FG000|Treatment Period|Participant did not receive treatment|4|||
16208118|NCT00439725|39240044|FG001|Treatment Period|Participant did not receive treatment|4|||
16208119|NCT00439725|39240043|FG000|Observational Period|Withdrawal by Subject|2|||
16208120|NCT00439725|39240044|FG001|Observational Period|Withdrawal by Subject|2|||
16208121|NCT00439725|39240043|FG000|Observational Period|Lost to Follow-up|0|||
16208122|NCT00439725|39240044|FG001|Observational Period|Lost to Follow-up|1|||
16208123|NCT00439725|39240043|FG000|Observational Period|Death|0|||
16208124|NCT00439725|39240044|FG001|Observational Period|Death|2|||
16208125|NCT00439725|39240043|FG000|Observational Period|Study termination by sponsor|1|||
16208126|NCT00439725|39240044|FG001|Observational Period|Study termination by sponsor|1|||
16208127|NCT00439725|39240043|FG000|Observational Period|Clinical endpoint reached|3|||
16208128|NCT00439725|39240044|FG001|Observational Period|Clinical endpoint reached|1|||
16208129|NCT00439725|39240043|FG000|Observational Period|Technical problems|1|||
16208130|NCT00439725|39240044|FG001|Observational Period|Technical problems|0|||
16208131|NCT00439725|39240043|FG000|Observational Period|Participant convenience|1|||
16208132|NCT00439725|39240044|FG001|Observational Period|Participant convenience|0|||
16208133|NCT00105183|39240045|FG000|Overall Study|Death|19|||
16208134|NCT00105183|39240046|FG001|Overall Study|Death|13|||
16397093|NCT00988052|39935368|FG001|Overall Study|Lost to Follow-up|11|||
16397094|NCT00988052|39935367|FG000|Overall Study|Physician Decision|27|||
16397095|NCT00988052|39935368|FG001|Overall Study|Physician Decision|28|||
16397096|NCT00988052|39935367|FG000|Overall Study|Adverse Event|35|||
16397097|NCT00988052|39935368|FG001|Overall Study|Adverse Event|28|||
16397098|NCT00988052|39935367|FG000|Overall Study|Withdrawal by Subject|90|||
16397099|NCT00988052|39935368|FG001|Overall Study|Withdrawal by Subject|91|||
16397100|NCT00988052|39935367|FG000|Overall Study|Study terminated by sponsor|240|||
16397101|NCT00988052|39935368|FG001|Overall Study|Study terminated by sponsor|236|||
16397102|NCT01001767|39935369|FG000|Overall Study|no baseline study performed|1|||
16397103|NCT01001767|39935370|FG001|Overall Study|no baseline study performed|0|||
16397104|NCT01001767|39935369|FG000|Overall Study|Protocol Violation|1|||
16208135|NCT00105183|39240047|FG002|Overall Study|Death|15|||
16208136|NCT00105183|39240045|FG000|Overall Study|Withdrawal by Subject|1|||
16397105|NCT01001767|39935370|FG001|Overall Study|Protocol Violation|0|||
16397106|NCT01001767|39935369|FG000|Overall Study|Lost to Follow-up|1|||
16397107|NCT01001767|39935370|FG001|Overall Study|Lost to Follow-up|0|||
16208137|NCT00105183|39240046|FG001|Overall Study|Withdrawal by Subject|1|||
16397108|NCT01001767|39935369|FG000|Overall Study|Physician Decision|1|||
16397109|NCT01001767|39935370|FG001|Overall Study|Physician Decision|0|||
16397110|NCT03832322|39935371|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
16397111|NCT03832322|39935372|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
16397112|NCT01406938|39935373|FG000|Induction Period|Subject/guardian decision|6|||
16397113|NCT01406938|39935374|FG001|Induction Period|Subject/guardian decision|8|||
16208138|NCT00105183|39240047|FG002|Overall Study|Withdrawal by Subject|4|||
16208139|NCT00105183|39240045|FG000|Overall Study|Physician Decision|1|||
16208140|NCT00105183|39240046|FG001|Overall Study|Physician Decision|2|||
16208141|NCT00105183|39240047|FG002|Overall Study|Physician Decision|3|||
16208142|NCT00105183|39240045|FG000|Overall Study|Lost to Follow-up|0|||
16208143|NCT00105183|39240046|FG001|Overall Study|Lost to Follow-up|1|||
16208144|NCT00105183|39240047|FG002|Overall Study|Lost to Follow-up|1|||
16208145|NCT00105183|39240045|FG000|Overall Study|Other reason|1|||
16208146|NCT00105183|39240046|FG001|Overall Study|Other reason|2|||
16208147|NCT00105183|39240047|FG002|Overall Study|Other reason|0|||
16208148|NCT03934203|39240048|FG000|Overall Study|Adverse Event|0|||
16208149|NCT03934203|39240049|FG001|Overall Study|Adverse Event|0|||
16208150|NCT03934203|39240050|FG002|Overall Study|Adverse Event|1|||
16208151|NCT03934203|39240051|FG003|Overall Study|Adverse Event|0|||
16208152|NCT03934203|39240052|FG004|Overall Study|Adverse Event|1|||
16208153|NCT03934203|39240053|FG005|Overall Study|Adverse Event|0|||
16208154|NCT03934203|39240054|FG006|Overall Study|Adverse Event|2|||
16208155|NCT03934203|39240055|FG007|Overall Study|Adverse Event|0|||
16208156|NCT03934203|39240056|FG008|Overall Study|Adverse Event|0|||
16208157|NCT03934203|39240057|FG009|Overall Study|Adverse Event|0|||
16208158|NCT03934203|39240058|FG010|Overall Study|Adverse Event|0|||
16208159|NCT03934203|39240059|FG011|Overall Study|Adverse Event|0|||
16208160|NCT03934203|39240060|FG012|Overall Study|Adverse Event|0|||
16208161|NCT03934203|39240061|FG013|Overall Study|Adverse Event|1|||
16208162|NCT03934203|39240062|FG014|Overall Study|Adverse Event|0|||
16208163|NCT00291499|39240066|FG000|Overall Study|Adverse Event|3|||
16208164|NCT00291499|39240067|FG001|Overall Study|Adverse Event|8|||
16208165|NCT00291499|39240066|FG000|Overall Study|Change to other therapy|2|||
16208166|NCT00291499|39240067|FG001|Overall Study|Change to other therapy|1|||
16208167|NCT00291499|39240066|FG000|Overall Study|Intercurrent illness|1|||
16208168|NCT00291499|39240067|FG001|Overall Study|Intercurrent illness|0|||
16208169|NCT00291499|39240066|FG000|Overall Study|Protocol Violation|2|||
16208170|NCT00291499|39240067|FG001|Overall Study|Protocol Violation|2|||
16208171|NCT00291499|39240066|FG000|Overall Study|Other reasons|1|||
16208172|NCT00291499|39240067|FG001|Overall Study|Other reasons|4|||
16208173|NCT01313078|39240068|FG000|Overall Study|Death|1|||
16208174|NCT01313078|39240068|FG000|Overall Study|Discontinued study drug|1|||
16208175|NCT01313078|39240068|FG000|Overall Study|Withdrawal by Subject|1|||
16208176|NCT00712933|39240069|FG000|Overall Study|Adverse Event|69|||
16208177|NCT00712933|39240069|FG000|Overall Study|Lack of Efficacy|6|||
16208178|NCT00712933|39240069|FG000|Overall Study|Lost to Follow-up|22|||
16208179|NCT00712933|39240069|FG000|Overall Study|Non-compliance with study drug|13|||
16208180|NCT00712933|39240069|FG000|Overall Study|Other Pregnancy|37|||
16208181|NCT00712933|39240069|FG000|Overall Study|Sponsor decision|14|||
16208182|NCT00712933|39240069|FG000|Overall Study|Withdrew consent|4|||
16208183|NCT00712933|39240069|FG000|Overall Study|Hip replacement surgery|1|||
16208184|NCT00712933|39240069|FG000|Overall Study|Involved in Clinical research|3|||
16208185|NCT00712933|39240069|FG000|Overall Study|Participant hospitalized|1|||
16208186|NCT00712933|39240069|FG000|Overall Study|Participant travelled overseas|2|||
16208187|NCT00712933|39240069|FG000|Overall Study|Death of patient|1|||
16208188|NCT00712933|39240069|FG000|Overall Study|Other Physician decision|1|||
16208189|NCT00712933|39240069|FG000|Overall Study|Not committed to contraception|1|||
16208190|NCT00712933|39240069|FG000|Overall Study|Participant received medication|1|||
16208191|NCT00712933|39240069|FG000|Overall Study|Physician Decision|36|||
16208192|NCT00712933|39240069|FG000|Overall Study|Protocol Violation|4|||
16397114|NCT01406938|39935375|FG002|Induction Period|Subject/guardian decision|0|||
16397115|NCT01406938|39935376|FG003|Induction Period|Subject/guardian decision|0|||
16397116|NCT01406938|39935377|FG004|Induction Period|Subject/guardian decision|0|||
16397117|NCT01406938|39935378|FG005|Induction Period|Subject/guardian decision|0|||
16208193|NCT00712933|39240069|FG000|Overall Study|Withdrawal by Subject|151|||
16208194|NCT01080625|39240070|FG000|Overall Study|Physician Decision|0|||
16208195|NCT01080625|39240071|FG001|Overall Study|Physician Decision|2|||
16208196|NCT01080625|39240072|FG002|Overall Study|Physician Decision|1|||
16208197|NCT01192204|39240079|FG000|Overall Study|could not keep recall appointments|1|||
16208198|NCT01192204|39240080|FG001|Overall Study|could not keep recall appointments|0|||
16208199|NCT01142193|39240081|FG000|Overall Study|Adverse Event|12|||
16208200|NCT01142193|39240082|FG001|Overall Study|Adverse Event|4|||
16208201|NCT01142193|39240081|FG000|Overall Study|Lack of Efficacy|2|||
16397118|NCT01406938|39935373|FG000|Induction Period|Protocol deviation|1|||
16397119|NCT01406938|39935374|FG001|Induction Period|Protocol deviation|0|||
16208202|NCT01142193|39240082|FG001|Overall Study|Lack of Efficacy|1|||
16208203|NCT01142193|39240081|FG000|Overall Study|Physician Decision|1|||
16208204|NCT01142193|39240082|FG001|Overall Study|Physician Decision|1|||
16208205|NCT01142193|39240081|FG000|Overall Study|Withdrawal by Subject|4|||
16208206|NCT01142193|39240082|FG001|Overall Study|Withdrawal by Subject|3|||
16208207|NCT01142193|39240081|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
16208208|NCT01142193|39240082|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
16208209|NCT01142193|39240081|FG000|Overall Study|Other|1|||
16208210|NCT01142193|39240082|FG001|Overall Study|Other|2|||
16208211|NCT00937326|39240083|FG000|Overall Study|Adverse Event|0|||
16208212|NCT00937326|39240084|FG001|Overall Study|Adverse Event|3|||
16208213|NCT00937326|39240085|FG002|Overall Study|Adverse Event|1|||
16208214|NCT00937326|39240086|FG003|Overall Study|Adverse Event|1|||
16208215|NCT00937326|39240087|FG004|Overall Study|Adverse Event|2|||
16208216|NCT00937326|39240083|FG000|Overall Study|Death|0|||
16208217|NCT00937326|39240084|FG001|Overall Study|Death|0|||
16208218|NCT00937326|39240085|FG002|Overall Study|Death|1|||
16208219|NCT00937326|39240086|FG003|Overall Study|Death|0|||
16208220|NCT00937326|39240087|FG004|Overall Study|Death|0|||
16208221|NCT00937326|39240083|FG000|Overall Study|Withdrawal by Subject|3|||
16208222|NCT00937326|39240084|FG001|Overall Study|Withdrawal by Subject|4|||
16208223|NCT00937326|39240085|FG002|Overall Study|Withdrawal by Subject|1|||
16208224|NCT00937326|39240086|FG003|Overall Study|Withdrawal by Subject|4|||
16208225|NCT00937326|39240087|FG004|Overall Study|Withdrawal by Subject|3|||
16208226|NCT00937326|39240083|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
16208227|NCT00937326|39240084|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
16208228|NCT00937326|39240085|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
16208229|NCT00937326|39240086|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
16208230|NCT00937326|39240087|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
16208231|NCT00557323|39240091|FG000|Overall Study|Death|3|||
16208232|NCT00557323|39240091|FG000|Overall Study|Withdrawal by Subject|2|||
16208233|NCT00557323|39240091|FG000|Overall Study|Administrative change|2|||
16208234|NCT01709708|39240092|FG000|Overall Study|Protocol Violation|1|||
16208235|NCT01709708|39240093|FG001|Overall Study|Protocol Violation|2|||
16208236|NCT03407170|39240095|FG000|Overall Study|Adverse Event|1|||
16208237|NCT01390038|39240096|FG000|Overall Study|Death|1|||
16208238|NCT01390038|39240096|FG000|Overall Study|Lost to Follow-up|1|||
16208239|NCT01390038|39240096|FG000|Overall Study|Withdrawal by Subject|4|||
16208240|NCT01390038|39240096|FG000|Overall Study|Simpliciti System Removal|2|||
16208241|NCT00425100|39240101|FG000|Overall Study|Adverse Event|36|||
16208242|NCT00425100|39240101|FG000|Overall Study|Lack of Efficacy|4|||
16208243|NCT00425100|39240101|FG000|Overall Study|Lost to Follow-up|2|||
16208244|NCT00425100|39240101|FG000|Overall Study|Protocol Violation|4|||
16208245|NCT00425100|39240101|FG000|Overall Study|Withdrawal by Subject|7|||
16208246|NCT03363165|39240107|FG000|3-month Follow-up|Death|0|||
16397120|NCT01406938|39935375|FG002|Induction Period|Protocol deviation|0|||
16397121|NCT01406938|39935376|FG003|Induction Period|Protocol deviation|0|||
16397122|NCT01406938|39935377|FG004|Induction Period|Protocol deviation|0|||
16397123|NCT01406938|39935378|FG005|Induction Period|Protocol deviation|0|||
16397124|NCT01406938|39935373|FG000|Induction Period|Adverse Event|8|||
16397125|NCT01406938|39935374|FG001|Induction Period|Adverse Event|9|||
16397126|NCT01406938|39935375|FG002|Induction Period|Adverse Event|0|||
16208247|NCT03363165|39240108|FG001|3-month Follow-up|Death|1|||
16208248|NCT03363165|39240107|FG000|6-month Follow-up|Death|0|||
16208249|NCT03363165|39240108|FG001|6-month Follow-up|Death|1|||
16208250|NCT03363165|39240107|FG000|6-month Follow-up|Withdrawal by Subject|1|||
16208251|NCT03363165|39240108|FG001|6-month Follow-up|Withdrawal by Subject|1|||
16208252|NCT03363165|39240107|FG000|12-month Follow-up|Death|1|||
16208253|NCT03363165|39240108|FG001|12-month Follow-up|Death|1|||
16208254|NCT03363165|39240107|FG000|12-month Follow-up|Withdrawal by Subject|1|||
16208255|NCT03363165|39240108|FG001|12-month Follow-up|Withdrawal by Subject|1|||
16208256|NCT03630016|39240109|FG000|Overall Study|Poor Sensor Placement|1|||
16208257|NCT01250756|39240110|FG000|Infant Series|Withdrawal by Subject|4|||
16208258|NCT01250756|39240111|FG001|Infant Series|Withdrawal by Subject|5|||
16208259|NCT01250756|39240110|FG000|Infant Series|Randomized, Not Vaccinated|2|||
16208260|NCT01250756|39240111|FG001|Infant Series|Randomized, Not Vaccinated|2|||
16208261|NCT01250756|39240110|FG000|Infant Series|Other|22|||
16397127|NCT01406938|39935376|FG003|Induction Period|Adverse Event|0|||
16397128|NCT01406938|39935377|FG004|Induction Period|Adverse Event|0|||
16208262|NCT01250756|39240111|FG001|Infant Series|Other|0|||
16208263|NCT01250756|39240110|FG000|After Infant Series|Adverse Event|5|||
16208264|NCT01250756|39240111|FG001|After Infant Series|Adverse Event|2|||
16208265|NCT01250756|39240110|FG000|After Infant Series|Withdrawal by Subject|4|||
16208266|NCT01250756|39240111|FG001|After Infant Series|Withdrawal by Subject|1|||
16397129|NCT01406938|39935378|FG005|Induction Period|Adverse Event|0|||
16208267|NCT01250756|39240110|FG000|After Infant Series|Other|2|||
16208268|NCT01250756|39240111|FG001|After Infant Series|Other|1|||
16208269|NCT01250756|39240110|FG000|Toddler Dose|Adverse Event|0|||
16208270|NCT01250756|39240111|FG001|Toddler Dose|Adverse Event|1|||
16397130|NCT01406938|39935373|FG000|Induction Period|Lack of Efficacy|1|||
16397131|NCT01406938|39935374|FG001|Induction Period|Lack of Efficacy|0|||
16397132|NCT01406938|39935375|FG002|Induction Period|Lack of Efficacy|0|||
16397133|NCT01406938|39935376|FG003|Induction Period|Lack of Efficacy|0|||
16397134|NCT01406938|39935377|FG004|Induction Period|Lack of Efficacy|0|||
16397135|NCT01406938|39935378|FG005|Induction Period|Lack of Efficacy|0|||
16208271|NCT01250756|39240110|FG000|After Toddler Dose|Adverse Event|0|||
16208272|NCT01250756|39240111|FG001|After Toddler Dose|Adverse Event|1|||
16208273|NCT01400139|39240116|FG000|HYD Core Study|Adverse Event|210|||
16208274|NCT01400139|39240116|FG000|HYD Core Study|Lack of Efficacy|59|||
16397136|NCT01406938|39935373|FG000|Induction Period|Lost to Follow-up|2|||
16397137|NCT01406938|39935374|FG001|Induction Period|Lost to Follow-up|3|||
16397138|NCT01406938|39935375|FG002|Induction Period|Lost to Follow-up|0|||
16397139|NCT01406938|39935376|FG003|Induction Period|Lost to Follow-up|0|||
16397140|NCT01406938|39935377|FG004|Induction Period|Lost to Follow-up|0|||
16397141|NCT01406938|39935378|FG005|Induction Period|Lost to Follow-up|0|||
16326929|NCT02960763|39681762|FG000|Step 1|Other|0|||
16326930|NCT02960763|39681763|FG001|Step 1|Other|0|||
16326931|NCT02960763|39681764|FG002|Step 1|Other|1|||
16326932|NCT02960763|39681765|FG003|Step 1|Other|0|||
16326933|NCT02960763|39681766|FG004|Step 1|Other|0|||
16326934|NCT02960763|39681762|FG000|Step 2|Withdrawal by Subject|0|||
16326935|NCT02960763|39681763|FG001|Step 2|Withdrawal by Subject|0|||
16326936|NCT02960763|39681764|FG002|Step 2|Withdrawal by Subject|0|||
16326937|NCT02960763|39681765|FG003|Step 2|Withdrawal by Subject|7|||
16326938|NCT02960763|39681766|FG004|Step 2|Withdrawal by Subject|3|||
16326939|NCT02960763|39681762|FG000|Step 2|Lost to Follow-up|0|||
16326940|NCT02960763|39681763|FG001|Step 2|Lost to Follow-up|0|||
16326941|NCT02960763|39681764|FG002|Step 2|Lost to Follow-up|0|||
16326942|NCT02960763|39681765|FG003|Step 2|Lost to Follow-up|4|||
16326943|NCT02960763|39681766|FG004|Step 2|Lost to Follow-up|1|||
16326944|NCT02960763|39681762|FG000|Step 2|Investigator discretion|0|||
16326945|NCT02960763|39681763|FG001|Step 2|Investigator discretion|0|||
16326946|NCT02960763|39681764|FG002|Step 2|Investigator discretion|0|||
16326947|NCT02960763|39681765|FG003|Step 2|Investigator discretion|0|||
16326948|NCT02960763|39681766|FG004|Step 2|Investigator discretion|1|||
16326949|NCT02949843|39681767|FG000|Overall Study|Withdrawal by Subject|0|||
16326950|NCT02949843|39681768|FG001|Overall Study|Withdrawal by Subject|1|||
16326951|NCT02949843|39681769|FG002|Overall Study|Withdrawal by Subject|1|||
16326952|NCT00957268|39681776|FG000|Overall Study|Voluntary Withdrawal|0|||
16326953|NCT00957268|39681777|FG001|Overall Study|Voluntary Withdrawal|0|||
16326954|NCT00957268|39681778|FG002|Overall Study|Voluntary Withdrawal|1|||
16326955|NCT00957268|39681779|FG003|Overall Study|Voluntary Withdrawal|0|||
16326956|NCT00957268|39681780|FG004|Overall Study|Voluntary Withdrawal|0|||
16326957|NCT02887248|39681781|FG000|Overall Study|Withdrawal by Subject|1|||
16326958|NCT02887248|39681781|FG000|Overall Study|Adverse Event|1|||
16326959|NCT02887248|39681781|FG000|Overall Study|Progressive Disease|1|||
16326960|NCT01704651|39681782|FG000|Overall Study|Pre-op withdrawal by subject|1|||
16326961|NCT01704651|39681783|FG001|Overall Study|Pre-op withdrawal by subject|1|||
16326962|NCT01704651|39681782|FG000|Overall Study|Pre-op change in treatment plan|1|||
16326963|NCT01704651|39681783|FG001|Overall Study|Pre-op change in treatment plan|4|||
16326964|NCT01704651|39681782|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
16326965|NCT01704651|39681783|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
16326966|NCT01704651|39681782|FG000|Overall Study|Post-op did not have laparotomy|2|||
16326967|NCT01704651|39681783|FG001|Overall Study|Post-op did not have laparotomy|1|||
16326968|NCT01646021|39681784|FG000|Overall Study|Death|77|||
16326969|NCT01646021|39681785|FG001|Overall Study|Death|83|||
16326970|NCT01646021|39681784|FG000|Overall Study|Study Terminated by Sponsor|50|||
16326971|NCT01646021|39681785|FG001|Overall Study|Study Terminated by Sponsor|41|||
16326972|NCT01646021|39681784|FG000|Overall Study|Lost to Follow-up|2|||
16326973|NCT01646021|39681785|FG001|Overall Study|Lost to Follow-up|2|||
16397142|NCT01406938|39935373|FG000|Maintenance Period|Adverse Event|0|||
16397143|NCT01406938|39935374|FG001|Maintenance Period|Adverse Event|0|||
16397144|NCT01406938|39935375|FG002|Maintenance Period|Adverse Event|2|||
16208275|NCT01400139|39240116|FG000|HYD Core Study|Withdrawal by Subject|114|||
16326974|NCT01646021|39681784|FG000|Overall Study|Withdrawal by Subject|10|||
16326975|NCT01646021|39681785|FG001|Overall Study|Withdrawal by Subject|15|||
16326976|NCT00661609|39681786|FG000|Overall Study|Adverse Event|4|||
16326977|NCT00661609|39681786|FG000|Overall Study|Death|20|||
16326978|NCT00661609|39681786|FG000|Overall Study|Withdrawal by Subject|2|||
16326979|NCT00661609|39681786|FG000|Overall Study|PI Decision|1|||
16326980|NCT00661609|39681786|FG000|Overall Study|Survival follow up stage discontinued|11|||
16397145|NCT01406938|39935376|FG003|Maintenance Period|Adverse Event|8|||
16397146|NCT01406938|39935377|FG004|Maintenance Period|Adverse Event|4|||
16397147|NCT01406938|39935378|FG005|Maintenance Period|Adverse Event|2|||
16208276|NCT01400139|39240116|FG000|HYD Core Study|Lost to Follow-up|39|||
16326981|NCT00661609|39681786|FG000|Overall Study|Disease progression|3|||
16326982|NCT01820572|39681790|FG000|Randomization|Not Treated|2|||
16326983|NCT01820572|39681791|FG001|Randomization|Not Treated|1|||
16397148|NCT01406938|39935373|FG000|Maintenance Period|Death|0|||
16397149|NCT01406938|39935374|FG001|Maintenance Period|Death|0|||
16326984|NCT01820572|39681790|FG000|Treatment Period|Adverse Event|12|||
16326985|NCT01820572|39681791|FG001|Treatment Period|Adverse Event|7|||
16326986|NCT01820572|39681790|FG000|Treatment Period|Death|3|||
16326987|NCT01820572|39681791|FG001|Treatment Period|Death|3|||
16326988|NCT01820572|39681790|FG000|Treatment Period|Lack of Efficacy|1|||
16326989|NCT01820572|39681791|FG001|Treatment Period|Lack of Efficacy|0|||
16326990|NCT01820572|39681790|FG000|Treatment Period|poor/non compliance|0|||
16326991|NCT01820572|39681791|FG001|Treatment Period|poor/non compliance|3|||
16326992|NCT01820572|39681790|FG000|Treatment Period|request to discontinue|6|||
16326993|NCT01820572|39681791|FG001|Treatment Period|request to discontinue|11|||
16326994|NCT01820572|39681790|FG000|Treatment Period|No longer meets study criteria|3|||
16326995|NCT01820572|39681791|FG001|Treatment Period|No longer meets study criteria|10|||
16523629|NCT01607905|40383851|FG004|Overall Study|Incidence or severity of AEs|0|||
16523630|NCT01607905|40383852|FG005|Overall Study|Incidence or severity of AEs|2|||
16326996|NCT01820572|39681790|FG000|Treatment Period|withdrew consent|1|||
16326997|NCT01820572|39681791|FG001|Treatment Period|withdrew consent|2|||
16397150|NCT01406938|39935375|FG002|Maintenance Period|Death|0|||
16095451|NCT03823703|38839453|FG002|Overall Study|Sponsor request|4|||
16095452|NCT03823703|38839451|FG000|Overall Study|Adverse Event|3|||
16095453|NCT03823703|38839452|FG001|Overall Study|Adverse Event|1|||
16095454|NCT03823703|38839453|FG002|Overall Study|Adverse Event|0|||
16095455|NCT03823703|38839451|FG000|Overall Study|Withdrawal by Subject|0|||
16095456|NCT03823703|38839452|FG001|Overall Study|Withdrawal by Subject|1|||
16095457|NCT03823703|38839453|FG002|Overall Study|Withdrawal by Subject|0|||
16095458|NCT02481934|38839454|FG000|Overall Study|Death|2|||
16095459|NCT02062827|38839455|FG000|Overall Study|Death|1|||
16095460|NCT02062827|38839456|FG001|Overall Study|Death|0|||
16095461|NCT02062827|38839457|FG002|Overall Study|Death|0|||
16095462|NCT02062827|38839458|FG003|Overall Study|Death|0|||
16095463|NCT02062827|38839459|FG004|Overall Study|Death|0|||
16095464|NCT02062827|38839460|FG005|Overall Study|Death|0|||
16095465|NCT02062827|38839461|FG006|Overall Study|Death|0|||
16095466|NCT02062827|38839462|FG007|Overall Study|Death|0|||
16095467|NCT02062827|38839455|FG000|Overall Study|Withdrawal by Subject|3|||
16095468|NCT02062827|38839456|FG001|Overall Study|Withdrawal by Subject|1|||
16095469|NCT02062827|38839457|FG002|Overall Study|Withdrawal by Subject|1|||
16095470|NCT02062827|38839458|FG003|Overall Study|Withdrawal by Subject|2|||
16095471|NCT02062827|38839459|FG004|Overall Study|Withdrawal by Subject|6|||
16095472|NCT02062827|38839460|FG005|Overall Study|Withdrawal by Subject|0|||
16095473|NCT02062827|38839461|FG006|Overall Study|Withdrawal by Subject|5|||
16095474|NCT02062827|38839462|FG007|Overall Study|Withdrawal by Subject|0|||
16095475|NCT02062827|38839455|FG000|Overall Study|Screen Fail|0|||
16095476|NCT02062827|38839456|FG001|Overall Study|Screen Fail|0|||
16095477|NCT02062827|38839457|FG002|Overall Study|Screen Fail|0|||
16095478|NCT02062827|38839458|FG003|Overall Study|Screen Fail|0|||
16208277|NCT01400139|39240116|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
16208278|NCT01400139|39240116|FG000|HYD Core Study|Administrative|56|||
16208279|NCT01400139|39240116|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
16208280|NCT01400139|39240116|FG000|HYD Extension Period|Adverse Event|8|||
16208281|NCT01400139|39240116|FG000|HYD Extension Period|Withdrawal by Subject|5|||
16208282|NCT01400139|39240116|FG000|HYD Extension Period|Administrative|10|||
16208283|NCT01484561|39240119|FG000|Overall Study|Lack of Efficacy|3|||
16208284|NCT01484561|39240120|FG001|Overall Study|Lack of Efficacy|1|||
16208285|NCT01484561|39240119|FG000|Overall Study|Lost to Follow-up|1|||
16208286|NCT01484561|39240120|FG001|Overall Study|Lost to Follow-up|0|||
16208287|NCT01484561|39240119|FG000|Overall Study|Withdrawal by Subject|3|||
16208288|NCT01484561|39240120|FG001|Overall Study|Withdrawal by Subject|0|||
16208289|NCT01484561|39240119|FG000|Overall Study|Other|1|||
16208290|NCT01484561|39240120|FG001|Overall Study|Other|1|||
16208291|NCT01484561|39240119|FG000|Overall Study|Adverse Event|1|||
16208292|NCT01484561|39240120|FG001|Overall Study|Adverse Event|4|||
16208293|NCT03457636|39240121|FG000|Overall Study|Lost to Follow-up|2|||
16208294|NCT01156532|39240122|FG000|Overall Study|Family Reasons|1|||
16208295|NCT01156532|39240122|FG000|Overall Study|Lost to Follow-up|1|||
16208296|NCT00481988|39240128|FG000|Overall Study|Withdrawal by Subject|1|||
16326998|NCT02828124|39681792|FG000|Overall Study|Disease Progression|1|||
16523631|NCT01607905|40383853|FG006|Overall Study|Incidence or severity of AEs|8|||
16095479|NCT02062827|38839459|FG004|Overall Study|Screen Fail|0|||
16095480|NCT02062827|38839460|FG005|Overall Study|Screen Fail|0|||
16095481|NCT02062827|38839461|FG006|Overall Study|Screen Fail|0|||
16208297|NCT00481988|39240129|FG001|Overall Study|Withdrawal by Subject|1|||
16095482|NCT02062827|38839462|FG007|Overall Study|Screen Fail|8|||
16095483|NCT01699178|38839465|FG000|Overall Study|Adverse Event|1|||
16208298|NCT00880607|39240130|FG000|Overall Study|Physician Decision|2|||
16326999|NCT02828124|39681793|FG001|Overall Study|Disease Progression|2|||
16095484|NCT01699178|38839466|FG001|Overall Study|Adverse Event|5|||
16327000|NCT02828124|39681794|FG002|Overall Study|Disease Progression|1|||
16523632|NCT01607905|40383847|FG000|Overall Study|Disease progression|44|||
16208299|NCT00880607|39240131|FG001|Overall Study|Physician Decision|2|||
16095485|NCT01699178|38839465|FG000|Overall Study|Lost to Follow-up|1|||
16095486|NCT01699178|38839466|FG001|Overall Study|Lost to Follow-up|6|||
16095487|NCT01699178|38839465|FG000|Overall Study|Non-compliance with Study Drug|3|||
16095488|NCT01699178|38839466|FG001|Overall Study|Non-compliance with Study Drug|1|||
16095489|NCT01699178|38839465|FG000|Overall Study|Physician Decision|1|||
16095490|NCT01699178|38839466|FG001|Overall Study|Physician Decision|0|||
16095491|NCT01699178|38839465|FG000|Overall Study|Withdrawal by Subject|4|||
16095492|NCT01699178|38839466|FG001|Overall Study|Withdrawal by Subject|12|||
16095493|NCT01699178|38839465|FG000|Overall Study|Hematocrit >54%|1|||
16095494|NCT01699178|38839466|FG001|Overall Study|Hematocrit >54%|1|||
16095495|NCT01699178|38839465|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
16095496|NCT01699178|38839466|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
16095497|NCT01699178|38839465|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
16095498|NCT01699178|38839466|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
16095499|NCT00889863|38839472|FG000|Part I: Open Label|Death|1|||
16095500|NCT00889863|38839473|FG001|Part I: Open Label|Death|0|||
16095501|NCT00889863|38839472|FG000|Part I: Open Label|Adverse Event|4|||
16095502|NCT00889863|38839473|FG001|Part I: Open Label|Adverse Event|0|||
16095503|NCT00889863|38839472|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
16095504|NCT00889863|38839473|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
16095505|NCT00889863|38839472|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
16095506|NCT00889863|38839473|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
16095507|NCT00889863|38839472|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
16095508|NCT00889863|38839473|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
16095509|NCT00889863|38839472|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
16095510|NCT00889863|38839473|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
16095511|NCT00889863|38839472|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
16095512|NCT00889863|38839473|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
16095513|NCT00409747|38839475|FG000|Overall Study|Withdrawal by Subject|1|||
16095514|NCT01912599|38839477|FG000|Overall Study|Withdrawal by Subject|0|||
16095515|NCT01912599|38839478|FG001|Overall Study|Withdrawal by Subject|1|||
16095516|NCT00440037|38839479|FG000|Overall Study|Withdrawal by Subject|6|||
16095517|NCT00440037|38839479|FG000|Overall Study|Administrative decision|3|||
16095518|NCT02335242|38839482|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
16095519|NCT02335242|38839483|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
16095520|NCT02335242|38839482|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
16095521|NCT02335242|38839483|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
16095522|NCT02335242|38839482|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
16095523|NCT02335242|38839483|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
16095524|NCT00848198|38839487|FG000|Overall Study|Incomplete Case Report Forms|15|||
16095525|NCT00525915|38839488|FG000|Overall Study|Non-Compliance|0|||
16095526|NCT00525915|38839489|FG001|Overall Study|Non-Compliance|1|||
16095527|NCT00525915|38839488|FG000|Overall Study|Disease Progression|5|||
16095528|NCT00525915|38839489|FG001|Overall Study|Disease Progression|6|||
16095529|NCT00525915|38839488|FG000|Overall Study|Withdrawal by Subject|1|||
16095530|NCT00525915|38839489|FG001|Overall Study|Withdrawal by Subject|0|||
16095531|NCT00525915|38839488|FG000|Overall Study|Refused Surgery|1|||
16095532|NCT00525915|38839489|FG001|Overall Study|Refused Surgery|2|||
16095533|NCT00525915|38839488|FG000|Overall Study|Unrelated illness|1|||
16095534|NCT00525915|38839489|FG001|Overall Study|Unrelated illness|0|||
16095535|NCT04050722|38839502|FG000|Overall Study|Withdrawal by Subject|1|||
16095536|NCT04050722|38839503|FG001|Overall Study|Withdrawal by Subject|0|||
16095537|NCT03394508|38839504|FG000|Overall Study|Protocol Violation|0|||
16095538|NCT03394508|38839505|FG001|Overall Study|Protocol Violation|3|||
16095539|NCT03394508|38839504|FG000|Overall Study|Lost to Follow-up|1|||
16095540|NCT03394508|38839505|FG001|Overall Study|Lost to Follow-up|0|||
16523633|NCT01607905|40383848|FG001|Overall Study|Disease progression|16|||
16523634|NCT01607905|40383849|FG002|Overall Study|Disease progression|15|||
16523635|NCT01607905|40383850|FG003|Overall Study|Disease progression|11|||
16523636|NCT01607905|40383851|FG004|Overall Study|Disease progression|6|||
16523637|NCT01607905|40383852|FG005|Overall Study|Disease progression|7|||
16523638|NCT01607905|40383853|FG006|Overall Study|Disease progression|21|||
16523639|NCT01607905|40383847|FG000|Overall Study|Non-compliance with study procedures|0|||
16523640|NCT01607905|40383848|FG001|Overall Study|Non-compliance with study procedures|0|||
16523641|NCT01607905|40383849|FG002|Overall Study|Non-compliance with study procedures|0|||
16523642|NCT01607905|40383850|FG003|Overall Study|Non-compliance with study procedures|0|||
16095541|NCT02069379|38839506|FG000|Baseline Measurements|Lost to Follow-up|1|||
16095542|NCT02069379|38839507|FG001|Baseline Measurements|Lost to Follow-up|0|||
16095543|NCT02069379|38839508|FG002|Baseline Measurements|Lost to Follow-up|0|||
16095544|NCT02069379|38839509|FG003|Baseline Measurements|Lost to Follow-up|0|||
16095545|NCT02069379|38839506|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
16095546|NCT02069379|38839507|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
16523643|NCT01607905|40383851|FG004|Overall Study|Non-compliance with study procedures|0|||
16095547|NCT02069379|38839508|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
16095548|NCT02069379|38839509|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
16095549|NCT02069379|38839506|FG000|First Treatment Arm|Lost to Follow-up|0|||
16095550|NCT02069379|38839507|FG001|First Treatment Arm|Lost to Follow-up|1|||
16095551|NCT02069379|38839508|FG002|First Treatment Arm|Lost to Follow-up|1|||
16095552|NCT02069379|38839509|FG003|First Treatment Arm|Lost to Follow-up|0|||
16095553|NCT02069379|38839506|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
16095554|NCT02069379|38839507|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
16095555|NCT02069379|38839508|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
16095556|NCT02069379|38839509|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
16095557|NCT02069379|38839506|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
16095558|NCT02069379|38839507|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
16095559|NCT02069379|38839508|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
16095560|NCT02069379|38839509|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
16095561|NCT02069379|38839506|FG000|Second Treatment Arm|Lost to Follow-up|0|||
16095562|NCT02069379|38839507|FG001|Second Treatment Arm|Lost to Follow-up|0|||
16095563|NCT02069379|38839508|FG002|Second Treatment Arm|Lost to Follow-up|1|||
16095564|NCT02069379|38839509|FG003|Second Treatment Arm|Lost to Follow-up|0|||
16095565|NCT01115309|38839510|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
16095566|NCT01115309|38839510|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
16095567|NCT01115309|38839510|FG000|Long-term Follow-up|Lost to Follow-up|6|||
16095568|NCT01864200|38839511|FG000|Overall Study|Lost to Follow-up|1|||
16095569|NCT01864200|38839512|FG001|Overall Study|Lost to Follow-up|3|||
16095570|NCT01864200|38839511|FG000|Overall Study|Protocol Violation|1|||
16095571|NCT01864200|38839512|FG001|Overall Study|Protocol Violation|0|||
16095572|NCT04410445|38839513|FG000|Overall Study|Lost to Follow-up|3|||
16095573|NCT04410445|38839514|FG001|Overall Study|Lost to Follow-up|9|||
16095574|NCT04410445|38839513|FG000|Overall Study|Withdrawal by Subject|27|||
16095575|NCT04410445|38839514|FG001|Overall Study|Withdrawal by Subject|15|||
16095576|NCT01975701|38839515|FG000|Overall Study|Lost to Follow-up|1|||
16095577|NCT01975701|38839515|FG000|Overall Study|Death|23|||
16095578|NCT01975701|38839515|FG000|Overall Study|Physician Decision|1|||
16095579|NCT02632747|38839516|FG000|Wash-out Period|Adverse Event|1|||
16095580|NCT02632747|38839517|FG001|Wash-out Period|Adverse Event|0|||
16095581|NCT03906240|38839521|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
16095582|NCT03906240|38839522|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
16095583|NCT03906240|38839521|FG000|Overall Study|Lost to Follow-up|1|||
16095584|NCT03906240|38839522|FG001|Overall Study|Lost to Follow-up|0|||
16095585|NCT03906240|38839521|FG000|Overall Study|Withdrawal by Subject|0|||
16095586|NCT03906240|38839522|FG001|Overall Study|Withdrawal by Subject|1|||
16095587|NCT03349476|38839523|FG000|Overall Study|Physician Decision|3|||
16095588|NCT00203502|38839528|FG000|Overall Study|Death|1|||
16095589|NCT00379210|38839529|FG000|Overall Study|Withdrawal by Subject|10|||
16095590|NCT00379210|38839530|FG001|Overall Study|Withdrawal by Subject|7|||
16095591|NCT04879823|38839544|FG000|Overall Study|Physician Decision|3|||
16095592|NCT04879823|38839545|FG001|Overall Study|Physician Decision|1|||
16095593|NCT04879823|38839544|FG000|Overall Study|Protocol Violation|2|||
16095594|NCT04879823|38839545|FG001|Overall Study|Protocol Violation|3|||
16095595|NCT04879823|38839544|FG000|Overall Study|Lost to Follow-up|43|||
16095596|NCT04879823|38839545|FG001|Overall Study|Lost to Follow-up|35|||
16095597|NCT01077284|38839546|FG000|Overall Study|Adverse Event|2|||
16095598|NCT01077284|38839547|FG001|Overall Study|Adverse Event|0|||
16095599|NCT01077284|38839548|FG002|Overall Study|Adverse Event|1|||
16095600|NCT01077284|38839546|FG000|Overall Study|Lost to Follow-up|1|||
16095601|NCT01077284|38839547|FG001|Overall Study|Lost to Follow-up|2|||
16095602|NCT01077284|38839548|FG002|Overall Study|Lost to Follow-up|0|||
16095603|NCT01077284|38839546|FG000|Overall Study|Withdrawal by Subject|2|||
16208300|NCT00880607|39240130|FG000|Overall Study|Protocol Violation|2|||
16208301|NCT00880607|39240131|FG001|Overall Study|Protocol Violation|1|||
16095604|NCT01077284|38839547|FG001|Overall Study|Withdrawal by Subject|3|||
16095605|NCT01077284|38839548|FG002|Overall Study|Withdrawal by Subject|1|||
16095606|NCT01077284|38839546|FG000|Overall Study|Other|0|||
16095607|NCT01077284|38839547|FG001|Overall Study|Other|0|||
16095608|NCT01077284|38839548|FG002|Overall Study|Other|1|||
16095609|NCT02418819|38839553|FG000|Overall Study|Adverse Event|0|||
16095610|NCT02418819|38839554|FG001|Overall Study|Adverse Event|0|||
16095611|NCT02418819|38839555|FG002|Overall Study|Adverse Event|1|||
16095612|NCT02418819|38839556|FG003|Overall Study|Adverse Event|0|||
16095613|NCT02418819|38839553|FG000|Overall Study|Lost to Follow-up|1|||
16095614|NCT02418819|38839554|FG001|Overall Study|Lost to Follow-up|0|||
16095615|NCT02418819|38839555|FG002|Overall Study|Lost to Follow-up|0|||
16208302|NCT00880607|39240130|FG000|Overall Study|surgery did not extend past L1 level|3|||
16095616|NCT02418819|38839556|FG003|Overall Study|Lost to Follow-up|0|||
16095617|NCT02418819|38839553|FG000|Overall Study|No longer meets eligibility criteria|0|||
16095618|NCT02418819|38839554|FG001|Overall Study|No longer meets eligibility criteria|0|||
16095619|NCT02418819|38839555|FG002|Overall Study|No longer meets eligibility criteria|1|||
16327001|NCT02828124|39681795|FG003|Overall Study|Disease Progression|4|||
16327002|NCT02828124|39681792|FG000|Overall Study|AE Unrelated to Study Drug|0|||
16327003|NCT02828124|39681793|FG001|Overall Study|AE Unrelated to Study Drug|0|||
16327004|NCT02828124|39681794|FG002|Overall Study|AE Unrelated to Study Drug|0|||
16327005|NCT02828124|39681795|FG003|Overall Study|AE Unrelated to Study Drug|1|||
16327006|NCT02828124|39681792|FG000|Overall Study|Subject Withdrew Consent|0|||
16327007|NCT02828124|39681793|FG001|Overall Study|Subject Withdrew Consent|0|||
16327008|NCT02828124|39681794|FG002|Overall Study|Subject Withdrew Consent|0|||
16327009|NCT02828124|39681795|FG003|Overall Study|Subject Withdrew Consent|1|||
16327010|NCT04713592|39681798|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
16327011|NCT04713592|39681799|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
16327012|NCT04713592|39681800|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
16327013|NCT04713592|39681801|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
16327014|NCT04713592|39681798|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
16327015|NCT04713592|39681799|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
16327016|NCT04713592|39681800|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
16327017|NCT04713592|39681801|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
16327018|NCT04713592|39681798|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
16327019|NCT04713592|39681799|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
16327020|NCT04713592|39681800|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
16327021|NCT04713592|39681801|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
16327022|NCT04713592|39681798|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16327023|NCT04713592|39681799|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16327024|NCT04713592|39681800|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
16327025|NCT04713592|39681801|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
16327026|NCT04713592|39681798|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
16327027|NCT04713592|39681799|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
16327028|NCT04713592|39681800|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
16327029|NCT04713592|39681801|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
16327030|NCT04713592|39681798|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16327031|NCT04713592|39681799|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16327032|NCT04713592|39681800|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
16327033|NCT04713592|39681801|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
16327034|NCT04713592|39681798|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
16327035|NCT04713592|39681799|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
16327036|NCT04713592|39681800|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
16327037|NCT04713592|39681801|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
16327038|NCT03361865|39685178|FG000|Overall Study|Death|17|||
16327039|NCT03361865|39685179|FG001|Overall Study|Death|18|||
16327040|NCT03361865|39685178|FG000|Overall Study|Physician Decision|1|||
16327041|NCT03361865|39685179|FG001|Overall Study|Physician Decision|9|||
16327042|NCT03361865|39685178|FG000|Overall Study|Withdrawal by Subject|1|||
16327043|NCT03361865|39685179|FG001|Overall Study|Withdrawal by Subject|0|||
16327044|NCT02659514|39685185|FG000|Overall Study|Adverse Event|3|||
16327045|NCT02659514|39685186|FG001|Overall Study|Adverse Event|12|||
16327046|NCT02659514|39685185|FG000|Overall Study|Disease Progression|23|||
16327047|NCT02659514|39685186|FG001|Overall Study|Disease Progression|13|||
16327048|NCT02659514|39685185|FG000|Overall Study|Withdrawal by Subject|0|||
16327049|NCT02659514|39685186|FG001|Overall Study|Withdrawal by Subject|4|||
16327050|NCT02659514|39685185|FG000|Overall Study|Lost to Follow-up|0|||
16327051|NCT02659514|39685186|FG001|Overall Study|Lost to Follow-up|1|||
16327052|NCT02659514|39685185|FG000|Overall Study|Death|6|||
16327053|NCT02659514|39685186|FG001|Overall Study|Death|1|||
16327054|NCT02659514|39685185|FG000|Overall Study|Reason Unspecified|0|||
16327055|NCT02659514|39685186|FG001|Overall Study|Reason Unspecified|3|||
16327056|NCT00191282|39685189|FG000|Overall Study|Adverse Event|5|||
16327057|NCT00191282|39685190|FG001|Overall Study|Adverse Event|6|||
16327058|NCT00191282|39685189|FG000|Overall Study|Death|51|||
16523644|NCT01607905|40383852|FG005|Overall Study|Non-compliance with study procedures|0|||
16523645|NCT01607905|40383853|FG006|Overall Study|Non-compliance with study procedures|1|||
16523646|NCT01607905|40383847|FG000|Overall Study|Death|1|||
16523647|NCT01607905|40383848|FG001|Overall Study|Death|1|||
16523648|NCT01607905|40383849|FG002|Overall Study|Death|1|||
16523649|NCT01607905|40383850|FG003|Overall Study|Death|1|||
16523650|NCT01607905|40383851|FG004|Overall Study|Death|0|||
16523651|NCT01607905|40383852|FG005|Overall Study|Death|0|||
16523652|NCT01607905|40383853|FG006|Overall Study|Death|3|||
16523653|NCT01607905|40383847|FG000|Overall Study|Other treatments become available|1|||
16523654|NCT01607905|40383848|FG001|Overall Study|Other treatments become available|0|||
16523655|NCT01607905|40383849|FG002|Overall Study|Other treatments become available|0|||
16523656|NCT01607905|40383850|FG003|Overall Study|Other treatments become available|0|||
16523657|NCT01607905|40383851|FG004|Overall Study|Other treatments become available|0|||
16397151|NCT01406938|39935376|FG003|Maintenance Period|Death|0|||
16397152|NCT01406938|39935377|FG004|Maintenance Period|Death|1|||
16397153|NCT01406938|39935378|FG005|Maintenance Period|Death|0|||
16397154|NCT01406938|39935373|FG000|Maintenance Period|Subject/guardian decision|0|||
16397155|NCT01406938|39935374|FG001|Maintenance Period|Subject/guardian decision|0|||
16397156|NCT01406938|39935375|FG002|Maintenance Period|Subject/guardian decision|11|||
16397157|NCT01406938|39935376|FG003|Maintenance Period|Subject/guardian decision|7|||
16397158|NCT01406938|39935377|FG004|Maintenance Period|Subject/guardian decision|10|||
16397159|NCT01406938|39935378|FG005|Maintenance Period|Subject/guardian decision|7|||
16397160|NCT01406938|39935373|FG000|Maintenance Period|Protocol Violation|0|||
16397161|NCT01406938|39935374|FG001|Maintenance Period|Protocol Violation|0|||
16397162|NCT01406938|39935375|FG002|Maintenance Period|Protocol Violation|2|||
16397163|NCT01406938|39935376|FG003|Maintenance Period|Protocol Violation|2|||
16397164|NCT01406938|39935377|FG004|Maintenance Period|Protocol Violation|2|||
16397165|NCT01406938|39935378|FG005|Maintenance Period|Protocol Violation|2|||
16397166|NCT01406938|39935373|FG000|Maintenance Period|Pregnancy|0|||
16397167|NCT01406938|39935374|FG001|Maintenance Period|Pregnancy|0|||
16397168|NCT01406938|39935375|FG002|Maintenance Period|Pregnancy|0|||
16397169|NCT01406938|39935376|FG003|Maintenance Period|Pregnancy|0|||
16397170|NCT01406938|39935377|FG004|Maintenance Period|Pregnancy|1|||
16397171|NCT01406938|39935378|FG005|Maintenance Period|Pregnancy|0|||
16397172|NCT01406938|39935373|FG000|Maintenance Period|Lost to Follow-up|0|||
16397173|NCT01406938|39935374|FG001|Maintenance Period|Lost to Follow-up|0|||
16397174|NCT01406938|39935375|FG002|Maintenance Period|Lost to Follow-up|0|||
16397175|NCT01406938|39935376|FG003|Maintenance Period|Lost to Follow-up|0|||
16397176|NCT01406938|39935377|FG004|Maintenance Period|Lost to Follow-up|4|||
16397177|NCT01406938|39935378|FG005|Maintenance Period|Lost to Follow-up|0|||
16397178|NCT01406938|39935373|FG000|Maintenance Period|Lack of Efficacy|0|||
16397179|NCT01406938|39935374|FG001|Maintenance Period|Lack of Efficacy|0|||
16397180|NCT01406938|39935375|FG002|Maintenance Period|Lack of Efficacy|2|||
16397181|NCT01406938|39935376|FG003|Maintenance Period|Lack of Efficacy|1|||
16397182|NCT01406938|39935377|FG004|Maintenance Period|Lack of Efficacy|3|||
16095620|NCT02418819|38839556|FG003|Overall Study|No longer meets eligibility criteria|0|||
16095621|NCT02418819|38839553|FG000|Overall Study|No longer willing to participate|0|||
16095622|NCT02418819|38839554|FG001|Overall Study|No longer willing to participate|0|||
16095623|NCT02418819|38839555|FG002|Overall Study|No longer willing to participate|2|||
16095624|NCT02418819|38839556|FG003|Overall Study|No longer willing to participate|1|||
16095625|NCT02577315|38839561|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16095626|NCT02577315|38839562|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
16095627|NCT00555620|38839563|FG000|Overall Study|Death|0|||
16095628|NCT00555620|38839564|FG001|Overall Study|Death|1|||
16095629|NCT00555620|38839565|FG002|Overall Study|Death|0|||
16095630|NCT00555620|38839566|FG003|Overall Study|Death|0|||
16095631|NCT00555620|38839567|FG004|Overall Study|Death|0|||
16397183|NCT01406938|39935378|FG005|Maintenance Period|Lack of Efficacy|5|||
16095632|NCT00555620|38839568|FG005|Overall Study|Death|1|||
16095633|NCT00555620|38839563|FG000|Overall Study|Study terminated by sponsor|0|||
16095634|NCT00555620|38839564|FG001|Overall Study|Study terminated by sponsor|0|||
16095635|NCT00555620|38839565|FG002|Overall Study|Study terminated by sponsor|1|||
16397184|NCT01406938|39935373|FG000|Follow up|Lack of Efficacy|3|||
16327059|NCT00191282|39685190|FG001|Overall Study|Death|51|||
16327060|NCT00191282|39685189|FG000|Overall Study|Lack of Efficacy|11|||
16327061|NCT00191282|39685190|FG001|Overall Study|Lack of Efficacy|6|||
16327062|NCT00191282|39685189|FG000|Overall Study|Noncompliance|14|||
16327063|NCT00191282|39685190|FG001|Overall Study|Noncompliance|17|||
16327064|NCT00191282|39685189|FG000|Overall Study|Patient moved|11|||
16327065|NCT00191282|39685190|FG001|Overall Study|Patient moved|14|||
16327066|NCT00191282|39685189|FG000|Overall Study|Withdrawal by Subject|59|||
16327067|NCT00191282|39685190|FG001|Overall Study|Withdrawal by Subject|44|||
16327068|NCT00191282|39685189|FG000|Overall Study|Physician Decision|18|||
16327069|NCT00191282|39685190|FG001|Overall Study|Physician Decision|15|||
16327070|NCT00191282|39685189|FG000|Overall Study|Protocol entry criteria not met|14|||
16327071|NCT00191282|39685190|FG001|Overall Study|Protocol entry criteria not met|9|||
16327072|NCT00191282|39685189|FG000|Overall Study|Protocol Violation|9|||
16327073|NCT00191282|39685190|FG001|Overall Study|Protocol Violation|12|||
16327074|NCT00191282|39685189|FG000|Overall Study|Severity of outcome|2|||
16327075|NCT00191282|39685190|FG001|Overall Study|Severity of outcome|5|||
16327076|NCT00191282|39685189|FG000|Overall Study|Sponsor's decision|2|||
16327077|NCT00191282|39685190|FG001|Overall Study|Sponsor's decision|2|||
16327078|NCT00191282|39685189|FG000|Overall Study|Lost to Follow-up|24|||
16327079|NCT00191282|39685190|FG001|Overall Study|Lost to Follow-up|31|||
16327080|NCT00638443|39685191|FG000|First Intervention|Adverse Event|2|||
16327081|NCT00638443|39685192|FG001|First Intervention|Adverse Event|1|||
16327082|NCT03605862|39685193|FG000|Overall Study|Withdrawal by Subject|12|||
16523658|NCT01607905|40383852|FG005|Overall Study|Other treatments become available|0|||
16523659|NCT01607905|40383853|FG006|Overall Study|Other treatments become available|1|||
16327083|NCT03605862|39685194|FG001|Overall Study|Withdrawal by Subject|9|||
16327084|NCT03605862|39685193|FG000|Overall Study|Adverse Event|2|||
16327085|NCT03605862|39685194|FG001|Overall Study|Adverse Event|1|||
16327086|NCT03605862|39685193|FG000|Overall Study|Physician Decision|3|||
16327087|NCT03605862|39685194|FG001|Overall Study|Physician Decision|1|||
16327088|NCT03605862|39685193|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
16327089|NCT03605862|39685194|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
16327090|NCT02234596|39685197|FG000|Overall Study|Participant not treated|2|||
16327091|NCT03403751|39685198|FG000|Overall Study|Death|5|||
16327092|NCT03403751|39685199|FG001|Overall Study|Death|6|||
16327093|NCT03403751|39685198|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
16327094|NCT03403751|39685199|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
16327095|NCT01984892|39685202|FG000|Overall Study|Progressive disease|7|||
16327096|NCT00727844|39685211|FG000|Initial Randomization|Physician Decision|2|||
16327097|NCT00727844|39685212|FG001|Initial Randomization|Physician Decision|0|||
16327098|NCT00727844|39685213|FG002|Initial Randomization|Physician Decision|0|||
16523660|NCT01607905|40383847|FG000|Overall Study|Investigator discretion|0|||
16523661|NCT01607905|40383848|FG001|Overall Study|Investigator discretion|0|||
16523662|NCT01607905|40383849|FG002|Overall Study|Investigator discretion|0|||
16523663|NCT01607905|40383850|FG003|Overall Study|Investigator discretion|0|||
16523664|NCT01607905|40383851|FG004|Overall Study|Investigator discretion|0|||
16523665|NCT01607905|40383852|FG005|Overall Study|Investigator discretion|1|||
16523666|NCT01607905|40383853|FG006|Overall Study|Investigator discretion|0|||
16523667|NCT01607905|40383847|FG000|Overall Study|Other|1|||
16523668|NCT01607905|40383848|FG001|Overall Study|Other|0|||
16208303|NCT00880607|39240131|FG001|Overall Study|surgery did not extend past L1 level|0|||
16327099|NCT00727844|39685214|FG003|Initial Randomization|Physician Decision|0|||
16327100|NCT00725608|39685219|FG000|Overall Study|Lost to Follow-up|60|||
16327101|NCT00725608|39685219|FG000|Overall Study|Adverse Event|14|||
16327102|NCT00725608|39685219|FG000|Overall Study|Individual reasons|86|||
16327103|NCT00725608|39685219|FG000|Overall Study|Other|7|||
16327104|NCT01154296|39685223|FG000|Randomization and Intervention|Decided to decline|1|||
16327105|NCT01154296|39685224|FG001|Randomization and Intervention|Decided to decline|1|||
16327106|NCT01154296|39685223|FG000|Randomization and Intervention|Declined by staff|1|||
16327107|NCT01154296|39685224|FG001|Randomization and Intervention|Declined by staff|0|||
16208304|NCT01855425|39240132|FG000|Overall Study|Physician Decision|20|||
16208305|NCT00928512|39240134|FG000|Overall Study|Adverse Event|4|||
16327108|NCT01154296|39685223|FG000|Randomization and Intervention|Did not return|1|||
16523669|NCT01607905|40383849|FG002|Overall Study|Other|0|||
16523670|NCT01607905|40383850|FG003|Overall Study|Other|0|||
16523671|NCT01607905|40383851|FG004|Overall Study|Other|0|||
16523672|NCT01607905|40383852|FG005|Overall Study|Other|0|||
16523673|NCT01607905|40383853|FG006|Overall Study|Other|1|||
16327109|NCT01154296|39685224|FG001|Randomization and Intervention|Did not return|0|||
16327110|NCT01154296|39685223|FG000|Randomization and Intervention|Left before test|0|||
16327111|NCT01154296|39685224|FG001|Randomization and Intervention|Left before test|1|||
16327112|NCT01154296|39685223|FG000|Randomization and Intervention|Left clinic early|2|||
16327113|NCT01154296|39685224|FG001|Randomization and Intervention|Left clinic early|0|||
16327114|NCT01154296|39685223|FG000|6-month Follow-up|Lost contact|269|||
16523674|NCT01607905|40383847|FG000|Overall Study|Randomized but not treated|1|||
16208306|NCT00928512|39240135|FG001|Overall Study|Adverse Event|3|||
16208307|NCT00928512|39240136|FG002|Overall Study|Adverse Event|2|||
16208308|NCT00928512|39240137|FG003|Overall Study|Adverse Event|8|||
16208309|NCT00928512|39240138|FG004|Overall Study|Adverse Event|6|||
16327115|NCT01154296|39685224|FG001|6-month Follow-up|Lost contact|275|||
16327116|NCT01154296|39685223|FG000|6-month Follow-up|Incarcerated|37|||
16327117|NCT01154296|39685224|FG001|6-month Follow-up|Incarcerated|32|||
16327118|NCT01154296|39685223|FG000|6-month Follow-up|Withdrew consent|14|||
16327119|NCT01154296|39685224|FG001|6-month Follow-up|Withdrew consent|15|||
16327120|NCT01154296|39685223|FG000|6-month Follow-up|Death|3|||
16327121|NCT01154296|39685224|FG001|6-month Follow-up|Death|2|||
16327122|NCT01154296|39685223|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
16327123|NCT01154296|39685224|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
16327124|NCT01970475|39685227|FG000|Overall Study|Withdrawal by Subject|11|||
16327125|NCT01970475|39685228|FG001|Overall Study|Withdrawal by Subject|6|||
16523675|NCT01607905|40383848|FG001|Overall Study|Randomized but not treated|0|||
16523676|NCT01607905|40383849|FG002|Overall Study|Randomized but not treated|0|||
16523677|NCT01607905|40383850|FG003|Overall Study|Randomized but not treated|0|||
16523678|NCT01607905|40383851|FG004|Overall Study|Randomized but not treated|1|||
16523679|NCT01607905|40383852|FG005|Overall Study|Randomized but not treated|1|||
16523680|NCT01607905|40383853|FG006|Overall Study|Randomized but not treated|0|||
16523681|NCT03285477|40383856|FG000|Treatment and Response Assessment Period|Death|1|||
16523682|NCT03285477|40383857|FG001|Treatment and Response Assessment Period|Death|0|||
16523683|NCT03285477|40383856|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
16523684|NCT03285477|40383857|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
16523685|NCT03285477|40383856|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
16523686|NCT03285477|40383857|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
16523687|NCT03285477|40383856|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
16523688|NCT03285477|40383857|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
16523689|NCT03285477|40383856|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
16523690|NCT03285477|40383857|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
16523691|NCT00384085|40383858|FG000|Overall Study|Adverse Event|5|||
16523692|NCT00384085|40383859|FG001|Overall Study|Adverse Event|5|||
16523693|NCT00384085|40383860|FG002|Overall Study|Adverse Event|4|||
16523694|NCT00384085|40383858|FG000|Overall Study|Lack of Efficacy|0|||
16523695|NCT00384085|40383859|FG001|Overall Study|Lack of Efficacy|3|||
16523696|NCT00384085|40383860|FG002|Overall Study|Lack of Efficacy|2|||
16523697|NCT00384085|40383858|FG000|Overall Study|No longer Requires Study Treatment|1|||
16523698|NCT00384085|40383859|FG001|Overall Study|No longer Requires Study Treatment|0|||
16208310|NCT00928512|39240134|FG000|Overall Study|Lack of Efficacy|2|||
16208311|NCT00928512|39240135|FG001|Overall Study|Lack of Efficacy|0|||
16208312|NCT00928512|39240136|FG002|Overall Study|Lack of Efficacy|4|||
16208313|NCT00928512|39240137|FG003|Overall Study|Lack of Efficacy|7|||
16208314|NCT00928512|39240138|FG004|Overall Study|Lack of Efficacy|3|||
16208315|NCT00928512|39240134|FG000|Overall Study|Protocol Violation|0|||
16208316|NCT00928512|39240135|FG001|Overall Study|Protocol Violation|1|||
16208317|NCT00928512|39240136|FG002|Overall Study|Protocol Violation|0|||
16208318|NCT00928512|39240137|FG003|Overall Study|Protocol Violation|1|||
16208319|NCT00928512|39240138|FG004|Overall Study|Protocol Violation|3|||
16208320|NCT00928512|39240134|FG000|Overall Study|Withdrawal by Subject|3|||
16208321|NCT00928512|39240135|FG001|Overall Study|Withdrawal by Subject|0|||
16327126|NCT01970475|39685227|FG000|Overall Study|Adverse Event|7|||
16523699|NCT00384085|40383860|FG002|Overall Study|No longer Requires Study Treatment|1|||
16208322|NCT00928512|39240136|FG002|Overall Study|Withdrawal by Subject|3|||
16208323|NCT00928512|39240137|FG003|Overall Study|Withdrawal by Subject|4|||
16327127|NCT01970475|39685228|FG001|Overall Study|Adverse Event|3|||
16327128|NCT01970475|39685227|FG000|Overall Study|Lost to Follow-up|2|||
16327129|NCT01970475|39685228|FG001|Overall Study|Lost to Follow-up|2|||
16327130|NCT01970475|39685227|FG000|Overall Study|Protocol Violation|1|||
16208324|NCT00928512|39240138|FG004|Overall Study|Withdrawal by Subject|0|||
16208325|NCT00928512|39240134|FG000|Overall Study|Lost to Follow-up|1|||
16208326|NCT00928512|39240135|FG001|Overall Study|Lost to Follow-up|1|||
16208327|NCT00928512|39240136|FG002|Overall Study|Lost to Follow-up|2|||
16208328|NCT00928512|39240137|FG003|Overall Study|Lost to Follow-up|1|||
16208329|NCT00928512|39240138|FG004|Overall Study|Lost to Follow-up|3|||
16208330|NCT00928512|39240134|FG000|Overall Study|Administrative Problems|0|||
16208331|NCT00928512|39240135|FG001|Overall Study|Administrative Problems|1|||
16208332|NCT00928512|39240136|FG002|Overall Study|Administrative Problems|0|||
16208333|NCT00928512|39240137|FG003|Overall Study|Administrative Problems|0|||
16208334|NCT00928512|39240138|FG004|Overall Study|Administrative Problems|0|||
16208335|NCT04702984|39240139|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
16208336|NCT01170221|39240143|FG000|Overall Study|Lost to Follow-up|22|||
16208337|NCT01170221|39240144|FG001|Overall Study|Lost to Follow-up|21|||
16208338|NCT01170221|39240143|FG000|Overall Study|Withdrawal by Subject|9|||
16208339|NCT01170221|39240144|FG001|Overall Study|Withdrawal by Subject|7|||
16208340|NCT01170221|39240143|FG000|Overall Study|Subject completed only screening and LFU|1|||
16208341|NCT01170221|39240144|FG001|Overall Study|Subject completed only screening and LFU|0|||
16208342|NCT01170221|39240143|FG000|Overall Study|Randomized but not treated|1|||
16208343|NCT01170221|39240144|FG001|Overall Study|Randomized but not treated|0|||
16208344|NCT02394808|39240145|FG000|Period 1|Unsatisfactory lens fitting|0|||
16208345|NCT02394808|39240146|FG001|Period 1|Unsatisfactory lens fitting|1|||
16208346|NCT02394808|39240145|FG000|Period 2|Lost to Follow-up|1|||
16208347|NCT02394808|39240146|FG001|Period 2|Lost to Follow-up|0|||
16208348|NCT02670928|39240147|FG000|Overall Study|Adverse Event|3|||
16208349|NCT02670928|39240148|FG001|Overall Study|Adverse Event|1|||
16208350|NCT02670928|39240147|FG000|Overall Study|Withdrawal by Subject|4|||
16208351|NCT02670928|39240148|FG001|Overall Study|Withdrawal by Subject|0|||
16208352|NCT02670928|39240147|FG000|Overall Study|Lost to Follow-up|1|||
16208353|NCT02670928|39240148|FG001|Overall Study|Lost to Follow-up|0|||
16208354|NCT02670928|39240147|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
16208355|NCT02670928|39240148|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
16208356|NCT01293084|39240149|FG000|Overall Study|Physician Decision|3|||
16208357|NCT01293084|39240149|FG000|Overall Study|Withdrawal by Subject|2|||
16208358|NCT03927911|39240152|FG000|Overall Study|problems with eDiary|0|||
16208359|NCT03927911|39240153|FG001|Overall Study|problems with eDiary|1|||
16208360|NCT03927911|39240154|FG002|Overall Study|problems with eDiary|0|||
16208361|NCT03927911|39240155|FG003|Overall Study|problems with eDiary|1|||
16208362|NCT03927911|39240156|FG004|Overall Study|problems with eDiary|0|||
16208363|NCT03927911|39240157|FG005|Overall Study|problems with eDiary|4|||
16208364|NCT03927911|39240152|FG000|Overall Study|Adverse Event|0|||
16208365|NCT03927911|39240153|FG001|Overall Study|Adverse Event|0|||
16208366|NCT03927911|39240154|FG002|Overall Study|Adverse Event|0|||
16523700|NCT00384085|40383858|FG000|Overall Study|Protocol Violation|2|||
16523701|NCT00384085|40383859|FG001|Overall Study|Protocol Violation|2|||
16327131|NCT01970475|39685228|FG001|Overall Study|Protocol Violation|0|||
16327132|NCT03555565|39685230|FG000|Overall Study|Case Report Forms Uncollected|2|||
16327133|NCT03555565|39685230|FG000|Overall Study|Protocol Deviation|13|||
16523702|NCT00384085|40383860|FG002|Overall Study|Protocol Violation|2|||
16523703|NCT00384085|40383858|FG000|Overall Study|Lost to Follow-up|9|||
16523704|NCT00384085|40383859|FG001|Overall Study|Lost to Follow-up|9|||
16208367|NCT03927911|39240155|FG003|Overall Study|Adverse Event|0|||
16208368|NCT03927911|39240156|FG004|Overall Study|Adverse Event|0|||
16208369|NCT03927911|39240157|FG005|Overall Study|Adverse Event|1|||
16208370|NCT03927911|39240152|FG000|Overall Study|not treated -study terminated by sponsor|0|||
16208371|NCT03927911|39240153|FG001|Overall Study|not treated -study terminated by sponsor|1|||
16208372|NCT03927911|39240154|FG002|Overall Study|not treated -study terminated by sponsor|0|||
16208373|NCT03927911|39240155|FG003|Overall Study|not treated -study terminated by sponsor|0|||
16208374|NCT03927911|39240156|FG004|Overall Study|not treated -study terminated by sponsor|0|||
16208375|NCT03927911|39240157|FG005|Overall Study|not treated -study terminated by sponsor|0|||
16208376|NCT03927911|39240152|FG000|Overall Study|Surgery cancelled|0|||
16523705|NCT00384085|40383860|FG002|Overall Study|Lost to Follow-up|10|||
16523706|NCT00384085|40383858|FG000|Overall Study|Progressive Disease|0|||
16523707|NCT00384085|40383859|FG001|Overall Study|Progressive Disease|1|||
16523708|NCT00384085|40383860|FG002|Overall Study|Progressive Disease|0|||
16523709|NCT00384085|40383858|FG000|Overall Study|Withdrawal by Subject|14|||
16523710|NCT00384085|40383859|FG001|Overall Study|Withdrawal by Subject|19|||
16523711|NCT00384085|40383860|FG002|Overall Study|Withdrawal by Subject|29|||
16523712|NCT00384085|40383858|FG000|Overall Study|Patient non-compliant|4|||
16208377|NCT03927911|39240153|FG001|Overall Study|Surgery cancelled|0|||
16523713|NCT00384085|40383859|FG001|Overall Study|Patient non-compliant|4|||
16523714|NCT00384085|40383860|FG002|Overall Study|Patient non-compliant|5|||
16523715|NCT00384085|40383858|FG000|Overall Study|Physician Decision|1|||
16208378|NCT03927911|39240154|FG002|Overall Study|Surgery cancelled|0|||
16208379|NCT03927911|39240155|FG003|Overall Study|Surgery cancelled|1|||
16208380|NCT03927911|39240156|FG004|Overall Study|Surgery cancelled|0|||
16095636|NCT00555620|38839566|FG003|Overall Study|Study terminated by sponsor|0|||
16095637|NCT00555620|38839567|FG004|Overall Study|Study terminated by sponsor|0|||
16523716|NCT00384085|40383859|FG001|Overall Study|Physician Decision|0|||
16523717|NCT00384085|40383860|FG002|Overall Study|Physician Decision|0|||
16327134|NCT00174967|39685233|FG000|Overall Study|Adverse Event|1|||
16327135|NCT00174967|39685234|FG001|Overall Study|Adverse Event|2|||
16327136|NCT00174967|39685235|FG002|Overall Study|Adverse Event|2|||
16327137|NCT00174967|39685236|FG003|Overall Study|Adverse Event|1|||
16327138|NCT00174967|39685233|FG000|Overall Study|Gout Flare|0|||
16327139|NCT00174967|39685234|FG001|Overall Study|Gout Flare|0|||
16523718|NCT00384085|40383858|FG000|Overall Study|Loss of site personnel|1|||
16095638|NCT00555620|38839568|FG005|Overall Study|Study terminated by sponsor|0|||
16095639|NCT00555620|38839563|FG000|Overall Study|Adverse Event|0|||
16095640|NCT00555620|38839564|FG001|Overall Study|Adverse Event|0|||
16208381|NCT03927911|39240157|FG005|Overall Study|Surgery cancelled|1|||
16523719|NCT00384085|40383859|FG001|Overall Study|Loss of site personnel|0|||
16523720|NCT00384085|40383860|FG002|Overall Study|Loss of site personnel|1|||
16208382|NCT03927911|39240152|FG000|Overall Study|Protocol Violation|0|||
16327140|NCT00174967|39685235|FG002|Overall Study|Gout Flare|0|||
16327141|NCT00174967|39685236|FG003|Overall Study|Gout Flare|1|||
16327142|NCT00174967|39685233|FG000|Overall Study|Other|0|||
16327143|NCT00174967|39685234|FG001|Overall Study|Other|1|||
16327144|NCT00174967|39685235|FG002|Overall Study|Other|0|||
16327145|NCT00174967|39685236|FG003|Overall Study|Other|0|||
16327146|NCT00679289|39685237|FG000|Overall Study|Progressive disease|4|||
16327147|NCT00679289|39685238|FG001|Overall Study|Progressive disease|5|||
16327148|NCT00679289|39685239|FG002|Overall Study|Progressive disease|18|||
16327149|NCT00679289|39685237|FG000|Overall Study|Withdrawal by Subject|0|||
16327150|NCT00679289|39685238|FG001|Overall Study|Withdrawal by Subject|1|||
16327151|NCT00679289|39685239|FG002|Overall Study|Withdrawal by Subject|1|||
16327152|NCT00679289|39685237|FG000|Overall Study|Adverse Event|0|||
16327153|NCT00679289|39685238|FG001|Overall Study|Adverse Event|0|||
16327154|NCT00679289|39685239|FG002|Overall Study|Adverse Event|3|||
16327155|NCT00679289|39685237|FG000|Overall Study|Physician Decision|1|||
16327156|NCT00679289|39685238|FG001|Overall Study|Physician Decision|0|||
16523721|NCT00384085|40383858|FG000|Overall Study|Sponsor decision|1|||
16523722|NCT00384085|40383859|FG001|Overall Study|Sponsor decision|2|||
16095641|NCT00555620|38839565|FG002|Overall Study|Adverse Event|1|||
16208383|NCT03927911|39240153|FG001|Overall Study|Protocol Violation|0|||
16208384|NCT03927911|39240154|FG002|Overall Study|Protocol Violation|0|||
16208385|NCT03927911|39240155|FG003|Overall Study|Protocol Violation|0|||
16208386|NCT03927911|39240156|FG004|Overall Study|Protocol Violation|0|||
16208387|NCT03927911|39240157|FG005|Overall Study|Protocol Violation|1|||
16208388|NCT03168555|39240162|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
16208389|NCT03168555|39240162|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
16208390|NCT03168555|39240162|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
16208391|NCT03168555|39240162|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
16208392|NCT03725293|39240163|FG000|Overall Study|Physician Decision|9|||
16208393|NCT03725293|39240164|FG001|Overall Study|Physician Decision|6|||
16208394|NCT03725293|39240163|FG000|Overall Study|alternative vascular access needs|1|||
16208395|NCT03725293|39240164|FG001|Overall Study|alternative vascular access needs|2|||
16208396|NCT03725293|39240163|FG000|Overall Study|venous anatomy screen failures|2|||
16208397|NCT03725293|39240164|FG001|Overall Study|venous anatomy screen failures|1|||
16208398|NCT01570309|39240165|FG000|Overall Study|Withdrawal by Subject|3|||
16208399|NCT01570309|39240166|FG001|Overall Study|Withdrawal by Subject|3|||
16208400|NCT00830804|39240167|FG000|Overall Study|Lost to Follow-up|4|||
16208401|NCT00830804|39240167|FG000|Overall Study|Death|1|||
16208402|NCT00830804|39240167|FG000|Overall Study|Unable to get to clinic|7|||
16208403|NCT00830804|39240167|FG000|Overall Study|Consent withdrawn|2|||
16208404|NCT00830804|39240167|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
16208405|NCT00407550|39243966|FG000|Overall Study|Adverse Event|0|||
16208406|NCT00407550|39243967|FG001|Overall Study|Adverse Event|1|||
16208407|NCT00407550|39243966|FG000|Overall Study|Withdrawal by Subject|0|||
16208408|NCT00407550|39243967|FG001|Overall Study|Withdrawal by Subject|2|||
16208409|NCT00407550|39243966|FG000|Overall Study|Death|1|||
16208410|NCT00407550|39243967|FG001|Overall Study|Death|0|||
16208411|NCT00407550|39243966|FG000|Overall Study|Insurance or Other medical condition|2|||
16208412|NCT00407550|39243967|FG001|Overall Study|Insurance or Other medical condition|1|||
16208413|NCT04268303|39243968|FG000|Overall Study|Lost to Follow-up|1|||
16327157|NCT00679289|39685239|FG002|Overall Study|Physician Decision|1|||
16327158|NCT01137110|39685242|FG000|Overall Study|Protocol Violation|1|||
16327159|NCT01137110|39685243|FG001|Overall Study|Protocol Violation|0|||
16327160|NCT00748189|39685244|FG000|Overall Study|Death|99|||
16397185|NCT01406938|39935374|FG001|Follow up|Lack of Efficacy|2|||
16208414|NCT04268303|39243969|FG001|Overall Study|Lost to Follow-up|1|||
16327161|NCT00748189|39685245|FG001|Overall Study|Death|84|||
16327162|NCT00748189|39685244|FG000|Overall Study|Withdrawal by Subject|23|||
16327163|NCT00748189|39685245|FG001|Overall Study|Withdrawal by Subject|29|||
16327164|NCT00748189|39685244|FG000|Overall Study|Physician Decision|16|||
16208415|NCT04268303|39243970|FG002|Overall Study|Lost to Follow-up|2|||
16208416|NCT04268303|39243968|FG000|Overall Study|Withdrawal by Subject|0|||
16208417|NCT04268303|39243969|FG001|Overall Study|Withdrawal by Subject|1|||
16208418|NCT04268303|39243970|FG002|Overall Study|Withdrawal by Subject|1|||
16208419|NCT04268303|39243968|FG000|Overall Study|Adverse Event|2|||
16208420|NCT04268303|39243969|FG001|Overall Study|Adverse Event|0|||
16208421|NCT04268303|39243970|FG002|Overall Study|Adverse Event|0|||
16208422|NCT01248364|39243971|FG000|Overall Study|Adverse Event|0|||
16208423|NCT01248364|39243972|FG001|Overall Study|Adverse Event|1|||
16208424|NCT01248364|39243973|FG002|Overall Study|Adverse Event|0|||
16208425|NCT01248364|39243974|FG003|Overall Study|Adverse Event|0|||
16208426|NCT03597503|39243977|FG000|Overall Study|Withdrawal by Subject|0|||
16208427|NCT03597503|39243978|FG001|Overall Study|Withdrawal by Subject|2|||
16208428|NCT03597503|39243977|FG000|Overall Study|Lost to Follow-up|1|||
16208429|NCT03597503|39243978|FG001|Overall Study|Lost to Follow-up|2|||
16208430|NCT03597503|39243977|FG000|Overall Study|Protocol Violation|1|||
16208431|NCT03597503|39243978|FG001|Overall Study|Protocol Violation|0|||
16208432|NCT02925312|39243979|FG000|Overall Study|Lost to Follow-up|25|||
16208433|NCT02925312|39243980|FG001|Overall Study|Lost to Follow-up|0|||
16208434|NCT02925312|39243979|FG000|Overall Study|Adverse Event|2|||
16208435|NCT02925312|39243980|FG001|Overall Study|Adverse Event|0|||
16208436|NCT01822223|39243981|FG000|Overall Study|Death|0|||
16208437|NCT01822223|39243982|FG001|Overall Study|Death|1|||
16208438|NCT01680991|39243985|FG000|Overall Study|Adverse Event|1|||
16208439|NCT01680991|39243986|FG001|Overall Study|Adverse Event|0|||
16208440|NCT01680991|39243987|FG002|Overall Study|Adverse Event|0|||
16208441|NCT01680991|39243985|FG000|Overall Study|Death|1|||
16208442|NCT01680991|39243986|FG001|Overall Study|Death|0|||
16208443|NCT01680991|39243987|FG002|Overall Study|Death|1|||
16208444|NCT01680991|39243985|FG000|Overall Study|Protocol Violation|0|||
16208445|NCT01680991|39243986|FG001|Overall Study|Protocol Violation|1|||
16208446|NCT01680991|39243987|FG002|Overall Study|Protocol Violation|0|||
16208447|NCT01680991|39243985|FG000|Overall Study|Withdrawal by Subject|5|||
16208448|NCT01680991|39243986|FG001|Overall Study|Withdrawal by Subject|1|||
16208449|NCT01680991|39243987|FG002|Overall Study|Withdrawal by Subject|0|||
16208450|NCT01680991|39243985|FG000|Overall Study|Progressive disease (PD)|0|||
16208451|NCT01680991|39243986|FG001|Overall Study|Progressive disease (PD)|10|||
16208452|NCT01680991|39243987|FG002|Overall Study|Progressive disease (PD)|0|||
16208453|NCT01680991|39243985|FG000|Overall Study|Physician Decision|0|||
16208454|NCT01680991|39243986|FG001|Overall Study|Physician Decision|7|||
16208455|NCT01680991|39243987|FG002|Overall Study|Physician Decision|2|||
16208456|NCT01680991|39243985|FG000|Overall Study|Bad physical condition|0|||
16208457|NCT01680991|39243986|FG001|Overall Study|Bad physical condition|0|||
16208458|NCT01680991|39243987|FG002|Overall Study|Bad physical condition|1|||
16208459|NCT01680991|39243985|FG000|Overall Study|PD confirmed in other hospital|1|||
16208460|NCT01680991|39243986|FG001|Overall Study|PD confirmed in other hospital|0|||
16208461|NCT01680991|39243987|FG002|Overall Study|PD confirmed in other hospital|0|||
16208462|NCT01376388|39243992|FG000|Overall Study|Adverse Event|13|||
16208463|NCT01376388|39243992|FG000|Overall Study|Lack of Efficacy|2|||
16208464|NCT01376388|39243992|FG000|Overall Study|Withdrawal by Subject|3|||
16208465|NCT01105936|39243999|FG000|Period 1|Adverse Event|0|||
16208466|NCT01105936|39244000|FG001|Period 1|Adverse Event|0|||
16208467|NCT01105936|39244001|FG002|Period 1|Adverse Event|0|||
16208468|NCT01105936|39244002|FG003|Period 1|Adverse Event|1|||
16208469|NCT01105936|39243999|FG000|Period 2|Adverse Event|1|||
16208470|NCT01105936|39244000|FG001|Period 2|Adverse Event|0|||
16208471|NCT01105936|39244001|FG002|Period 2|Adverse Event|0|||
16208472|NCT01105936|39244002|FG003|Period 2|Adverse Event|0|||
16208473|NCT01105936|39243999|FG000|Period 3|Protocol Violation|0|||
16208474|NCT01105936|39244000|FG001|Period 3|Protocol Violation|2|||
16208475|NCT01105936|39244001|FG002|Period 3|Protocol Violation|0|||
16208476|NCT01105936|39244002|FG003|Period 3|Protocol Violation|0|||
16208477|NCT02017704|39244004|FG000|Overall Study|Withdrawal by Subject|2|||
16208478|NCT02017704|39244005|FG001|Overall Study|Withdrawal by Subject|0|||
16208479|NCT00959894|39244008|FG000|Overall Study|Lost to Follow-up|10|||
16208480|NCT00959894|39244008|FG000|Overall Study|Adverse Event|3|||
16208481|NCT00959894|39244008|FG000|Overall Study|Withdrawal by Subject|1|||
16208482|NCT00959894|39244008|FG000|Overall Study|Need for contraindicated medication|1|||
16208483|NCT00959894|39244008|FG000|Overall Study|Subject moved out of town|1|||
16208484|NCT00255034|39244009|FG000|Overall Study|Withdrawal by Subject|15|||
16208485|NCT00255034|39244010|FG001|Overall Study|Withdrawal by Subject|38|||
16208486|NCT00841672|39244015|FG000|Overall Study|Adverse Event|7|||
16208487|NCT00841672|39244016|FG001|Overall Study|Adverse Event|16|||
16208488|NCT00841672|39244015|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16208489|NCT00841672|39244016|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16208490|NCT00841672|39244015|FG000|Overall Study|Subject withdrew consent|2|||
16208491|NCT00841672|39244016|FG001|Overall Study|Subject withdrew consent|4|||
16208492|NCT00841672|39244015|FG000|Overall Study|Lost to Follow-up|1|||
16208493|NCT00841672|39244016|FG001|Overall Study|Lost to Follow-up|1|||
16208494|NCT00841672|39244015|FG000|Overall Study|Administrative problems|9|||
16208495|NCT00841672|39244016|FG001|Overall Study|Administrative problems|9|||
16208496|NCT00841672|39244015|FG000|Overall Study|Misrandomized|1|||
16327165|NCT00748189|39685245|FG001|Overall Study|Physician Decision|5|||
16327166|NCT00748189|39685244|FG000|Overall Study|Lost to Follow-up|8|||
16327167|NCT00748189|39685245|FG001|Overall Study|Lost to Follow-up|15|||
16327168|NCT00748189|39685244|FG000|Overall Study|Study terminated by Sponsor|70|||
16208497|NCT00841672|39244016|FG001|Overall Study|Misrandomized|0|||
16208498|NCT00841672|39244015|FG000|Overall Study|Protocol Deviation|0|||
16208499|NCT00841672|39244016|FG001|Overall Study|Protocol Deviation|1|||
16208500|NCT01024920|39244033|FG000|Overall Study|Progressive disease|47|||
16208501|NCT01024920|39244034|FG001|Overall Study|Progressive disease|25|||
16208502|NCT01024920|39244033|FG000|Overall Study|Adverse Event|8|||
16208503|NCT01024920|39244034|FG001|Overall Study|Adverse Event|4|||
16208504|NCT01024920|39244033|FG000|Overall Study|Lost to Follow-up|0|||
16208505|NCT01024920|39244034|FG001|Overall Study|Lost to Follow-up|1|||
16208506|NCT01024920|39244033|FG000|Overall Study|Patient refusal to continue|4|||
16208507|NCT01024920|39244034|FG001|Overall Study|Patient refusal to continue|0|||
16208508|NCT01024920|39244033|FG000|Overall Study|Other than listed|5|||
16208509|NCT01024920|39244034|FG001|Overall Study|Other than listed|1|||
16208510|NCT01024920|39244033|FG000|Overall Study|Not treated|3|||
16208511|NCT01024920|39244034|FG001|Overall Study|Not treated|0|||
16208512|NCT01024920|39244033|FG000|Overall Study|Protocol Violation|0|||
16208513|NCT01024920|39244034|FG001|Overall Study|Protocol Violation|1|||
16208514|NCT01131078|39244037|FG000|Overall Study|Adverse Event|22|||
16208515|NCT01131078|39244038|FG001|Overall Study|Adverse Event|12|||
16208516|NCT01131078|39244039|FG002|Overall Study|Adverse Event|17|||
16208517|NCT01131078|39244037|FG000|Overall Study|Progressive Disease|58|||
16208518|NCT01131078|39244038|FG001|Overall Study|Progressive Disease|77|||
16208519|NCT01131078|39244039|FG002|Overall Study|Progressive Disease|71|||
16208520|NCT01131078|39244037|FG000|Overall Study|Protocol Violation|1|||
16208521|NCT01131078|39244038|FG001|Overall Study|Protocol Violation|0|||
16208522|NCT01131078|39244039|FG002|Overall Study|Protocol Violation|0|||
16208523|NCT01131078|39244037|FG000|Overall Study|Lost to Follow-up|1|||
16208524|NCT01131078|39244038|FG001|Overall Study|Lost to Follow-up|1|||
16208525|NCT01131078|39244039|FG002|Overall Study|Lost to Follow-up|1|||
16208526|NCT01131078|39244037|FG000|Overall Study|Withdrawal by Subject|2|||
16208527|NCT01131078|39244038|FG001|Overall Study|Withdrawal by Subject|4|||
16208528|NCT01131078|39244039|FG002|Overall Study|Withdrawal by Subject|3|||
16208529|NCT01131078|39244037|FG000|Overall Study|Non-compliance|3|||
16327169|NCT00748189|39685245|FG001|Overall Study|Study terminated by Sponsor|79|||
16327170|NCT04531462|39685246|FG000|Overall Study|Withdrawal by Subject|3|||
16327171|NCT04531462|39685247|FG001|Overall Study|Withdrawal by Subject|1|||
16327172|NCT04531462|39685246|FG000|Overall Study|Adverse Event|3|||
16327173|NCT04531462|39685247|FG001|Overall Study|Adverse Event|3|||
16327174|NCT03852628|39685251|FG000|Overall Study|Lost to Follow-up|7|||
16327175|NCT03852628|39685252|FG001|Overall Study|Lost to Follow-up|6|||
16327176|NCT03852628|39685251|FG000|Overall Study|Lack of Efficacy|6|||
16327177|NCT03852628|39685252|FG001|Overall Study|Lack of Efficacy|6|||
16327178|NCT03891862|39685253|FG000|Open-label Period|Adverse Event|2|||
16327179|NCT03891862|39685254|FG001|Open-label Period|Adverse Event|0|||
16327180|NCT03891862|39685255|FG002|Open-label Period|Adverse Event|0|||
16327181|NCT03891862|39685253|FG000|Open-label Period|Protocol Violation|5|||
16327182|NCT03891862|39685254|FG001|Open-label Period|Protocol Violation|0|||
16327183|NCT03891862|39685255|FG002|Open-label Period|Protocol Violation|0|||
16327184|NCT03891862|39685253|FG000|Open-label Period|Withdrawal by Subject|6|||
16208530|NCT01131078|39244038|FG001|Overall Study|Non-compliance|0|||
16208531|NCT01131078|39244039|FG002|Overall Study|Non-compliance|0|||
16208532|NCT01131078|39244037|FG000|Overall Study|Physician Decision|10|||
16208533|NCT01131078|39244038|FG001|Overall Study|Physician Decision|6|||
16208534|NCT01131078|39244039|FG002|Overall Study|Physician Decision|8|||
16208535|NCT01131078|39244037|FG000|Overall Study|Death|4|||
16327185|NCT03891862|39685254|FG001|Open-label Period|Withdrawal by Subject|0|||
16327186|NCT03891862|39685255|FG002|Open-label Period|Withdrawal by Subject|0|||
16208536|NCT01131078|39244038|FG001|Overall Study|Death|0|||
16208537|NCT01131078|39244039|FG002|Overall Study|Death|2|||
16208538|NCT01131078|39244037|FG000|Overall Study|Other|0|||
16208539|NCT01131078|39244038|FG001|Overall Study|Other|1|||
16208540|NCT01131078|39244039|FG002|Overall Study|Other|0|||
16208541|NCT04847141|39244043|FG000|Overall Study|Adverse Event|1|||
16208542|NCT04847141|39244044|FG001|Overall Study|Adverse Event|0|||
16208543|NCT04847141|39244045|FG002|Overall Study|Adverse Event|1|||
16208544|NCT04847141|39244043|FG000|Overall Study|Withdrawal by Subject|2|||
16208545|NCT04847141|39244044|FG001|Overall Study|Withdrawal by Subject|4|||
16208546|NCT04847141|39244045|FG002|Overall Study|Withdrawal by Subject|3|||
16208547|NCT04847141|39244043|FG000|Overall Study|Lost to Follow-up|7|||
16208548|NCT04847141|39244044|FG001|Overall Study|Lost to Follow-up|5|||
16208549|NCT04847141|39244045|FG002|Overall Study|Lost to Follow-up|7|||
16208550|NCT04847141|39244043|FG000|Overall Study|Reason not Specified|0|||
16208551|NCT04847141|39244044|FG001|Overall Study|Reason not Specified|1|||
16208552|NCT04847141|39244045|FG002|Overall Study|Reason not Specified|0|||
16208553|NCT00150345|39244047|FG000|Overall Study|Death|5|||
16208554|NCT00150345|39244048|FG001|Overall Study|Death|2|||
16208555|NCT00150345|39244047|FG000|Overall Study|Adverse Event|8|||
16208556|NCT00150345|39244048|FG001|Overall Study|Adverse Event|6|||
16208557|NCT00150345|39244047|FG000|Overall Study|Lack of Efficacy|5|||
16208558|NCT00150345|39244048|FG001|Overall Study|Lack of Efficacy|4|||
16208559|NCT00150345|39244047|FG000|Overall Study|Withdrawal by Subject|3|||
16397186|NCT01406938|39935375|FG002|Follow up|Lack of Efficacy|1|||
16397187|NCT01406938|39935376|FG003|Follow up|Lack of Efficacy|0|||
16397188|NCT01406938|39935377|FG004|Follow up|Lack of Efficacy|0|||
16397189|NCT01406938|39935378|FG005|Follow up|Lack of Efficacy|0|||
16397190|NCT01406938|39935373|FG000|Follow up|Patient/guardian decision|4|||
16397191|NCT01406938|39935374|FG001|Follow up|Patient/guardian decision|2|||
16397192|NCT01406938|39935375|FG002|Follow up|Patient/guardian decision|4|||
16397193|NCT01406938|39935376|FG003|Follow up|Patient/guardian decision|2|||
16397194|NCT01406938|39935377|FG004|Follow up|Patient/guardian decision|4|||
16397195|NCT01406938|39935378|FG005|Follow up|Patient/guardian decision|1|||
16397196|NCT01406938|39935373|FG000|Follow up|Protocol Violation|0|||
16397197|NCT01406938|39935374|FG001|Follow up|Protocol Violation|0|||
16397198|NCT01406938|39935375|FG002|Follow up|Protocol Violation|1|||
16397199|NCT01406938|39935376|FG003|Follow up|Protocol Violation|0|||
16397200|NCT01406938|39935377|FG004|Follow up|Protocol Violation|0|||
16397201|NCT01406938|39935378|FG005|Follow up|Protocol Violation|0|||
16397202|NCT01406938|39935373|FG000|Follow up|Physician Decision|0|||
16397203|NCT01406938|39935374|FG001|Follow up|Physician Decision|0|||
16397204|NCT01406938|39935375|FG002|Follow up|Physician Decision|2|||
16397205|NCT01406938|39935376|FG003|Follow up|Physician Decision|0|||
16397206|NCT01406938|39935377|FG004|Follow up|Physician Decision|3|||
16397207|NCT01406938|39935378|FG005|Follow up|Physician Decision|1|||
16397208|NCT01406938|39935373|FG000|Follow up|Lost to Follow-up|1|||
16397209|NCT01406938|39935374|FG001|Follow up|Lost to Follow-up|1|||
16397210|NCT01406938|39935375|FG002|Follow up|Lost to Follow-up|0|||
16397211|NCT01406938|39935376|FG003|Follow up|Lost to Follow-up|1|||
16397212|NCT01406938|39935377|FG004|Follow up|Lost to Follow-up|2|||
16397213|NCT01406938|39935378|FG005|Follow up|Lost to Follow-up|1|||
16397214|NCT01500252|39935380|FG000|Overall Study|Death|4|||
16397215|NCT01500252|39935381|FG001|Overall Study|Death|2|||
16397216|NCT01500252|39935380|FG000|Overall Study|Lost to Follow-up|5|||
16397217|NCT01500252|39935381|FG001|Overall Study|Lost to Follow-up|4|||
16397218|NCT00191945|39935383|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
16397219|NCT00191945|39935384|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
16397220|NCT00191945|39935383|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
16397221|NCT00191945|39935384|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
16397222|NCT00191945|39935383|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
16397223|NCT00191945|39935384|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
16397224|NCT00191945|39935383|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
16397225|NCT00191945|39935384|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
16208560|NCT00150345|39244048|FG001|Overall Study|Withdrawal by Subject|4|||
16397226|NCT01562314|39935385|FG000|Overall Study|Adverse Event|10|||
16397227|NCT01562314|39935386|FG001|Overall Study|Adverse Event|5|||
16397228|NCT01562314|39935385|FG000|Overall Study|Met Withdrawal Criteria|3|||
16397229|NCT01562314|39935386|FG001|Overall Study|Met Withdrawal Criteria|2|||
16397230|NCT01562314|39935385|FG000|Overall Study|Withdrawal by Subject|0|||
16397231|NCT01562314|39935386|FG001|Overall Study|Withdrawal by Subject|1|||
16397232|NCT04188834|39935387|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
16397233|NCT03726658|39935388|FG000|Overall Study|Lost to Follow-up|0|||
16208561|NCT00150345|39244047|FG000|Overall Study|Laboratory abnormality|1|||
16208562|NCT00150345|39244048|FG001|Overall Study|Laboratory abnormality|2|||
16208563|NCT00150345|39244047|FG000|Overall Study|Other|12|||
16208564|NCT00150345|39244048|FG001|Overall Study|Other|14|||
16208565|NCT00416312|39244049|FG000|Overall Study|tumors not visible on imaging|2|||
16208566|NCT03984812|39244050|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
16208567|NCT03984812|39244051|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
16208568|NCT03984812|39244052|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
16208569|NCT03984812|39244053|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
16208570|NCT03984812|39244054|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
16208571|NCT03984812|39244055|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
16208572|NCT03984812|39244056|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
16208573|NCT03984812|39244057|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
16208574|NCT03984812|39244058|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
16208575|NCT03984812|39244059|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
16208576|NCT03984812|39244060|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
16208577|NCT00610207|39244061|FG000|Overall Study|Lost to Follow-up|3|||
16208578|NCT00294684|39244066|FG000|Overall Study|Lost to Follow-up|5|||
16208579|NCT00294684|39244067|FG001|Overall Study|Lost to Follow-up|8|||
16208580|NCT00437203|39244068|FG000|Overall Study|Death|0|||
16208581|NCT00437203|39244069|FG001|Overall Study|Death|0|||
16208582|NCT00437203|39244070|FG002|Overall Study|Death|1|||
16208583|NCT00437203|39244071|FG003|Overall Study|Death|0|||
16208584|NCT00437203|39244072|FG004|Overall Study|Death|0|||
16208585|NCT00437203|39244073|FG005|Overall Study|Death|0|||
16208586|NCT00437203|39244074|FG006|Overall Study|Death|0|||
16208587|NCT00437203|39244075|FG007|Overall Study|Death|1|||
16208588|NCT00437203|39244076|FG008|Overall Study|Death|0|||
16208589|NCT00437203|39244077|FG009|Overall Study|Death|1|||
16208590|NCT00437203|39244068|FG000|Overall Study|Adverse Event|1|||
16208591|NCT00437203|39244069|FG001|Overall Study|Adverse Event|1|||
16208592|NCT00437203|39244070|FG002|Overall Study|Adverse Event|0|||
16208593|NCT00437203|39244071|FG003|Overall Study|Adverse Event|0|||
16208594|NCT00437203|39244072|FG004|Overall Study|Adverse Event|0|||
16208595|NCT00437203|39244073|FG005|Overall Study|Adverse Event|0|||
16208596|NCT00437203|39244074|FG006|Overall Study|Adverse Event|0|||
16208597|NCT00437203|39244075|FG007|Overall Study|Adverse Event|1|||
16208598|NCT00437203|39244076|FG008|Overall Study|Adverse Event|0|||
16208599|NCT00437203|39244077|FG009|Overall Study|Adverse Event|1|||
16208600|NCT00437203|39244068|FG000|Overall Study|Study terminated by sponsor|0|||
16208601|NCT00437203|39244069|FG001|Overall Study|Study terminated by sponsor|0|||
16208602|NCT00437203|39244070|FG002|Overall Study|Study terminated by sponsor|0|||
16208603|NCT00437203|39244071|FG003|Overall Study|Study terminated by sponsor|0|||
16208604|NCT00437203|39244072|FG004|Overall Study|Study terminated by sponsor|0|||
16208605|NCT00437203|39244073|FG005|Overall Study|Study terminated by sponsor|0|||
16208606|NCT00437203|39244074|FG006|Overall Study|Study terminated by sponsor|0|||
16208607|NCT00437203|39244075|FG007|Overall Study|Study terminated by sponsor|0|||
16208608|NCT00437203|39244076|FG008|Overall Study|Study terminated by sponsor|1|||
16208609|NCT00437203|39244077|FG009|Overall Study|Study terminated by sponsor|0|||
16208610|NCT00437203|39244068|FG000|Overall Study|Objective progression or relapse|5|||
16208611|NCT00437203|39244069|FG001|Overall Study|Objective progression or relapse|6|||
16208612|NCT00437203|39244070|FG002|Overall Study|Objective progression or relapse|2|||
16208613|NCT00437203|39244071|FG003|Overall Study|Objective progression or relapse|3|||
16208614|NCT00437203|39244072|FG004|Overall Study|Objective progression or relapse|3|||
16208615|NCT00437203|39244073|FG005|Overall Study|Objective progression or relapse|3|||
16208616|NCT00437203|39244074|FG006|Overall Study|Objective progression or relapse|6|||
16208617|NCT00437203|39244075|FG007|Overall Study|Objective progression or relapse|1|||
16208618|NCT00437203|39244076|FG008|Overall Study|Objective progression or relapse|2|||
16208619|NCT00437203|39244077|FG009|Overall Study|Objective progression or relapse|2|||
16208620|NCT00437203|39244068|FG000|Overall Study|Other|0|||
16208621|NCT00437203|39244069|FG001|Overall Study|Other|1|||
16208622|NCT00437203|39244070|FG002|Overall Study|Other|0|||
16208623|NCT00437203|39244071|FG003|Overall Study|Other|0|||
16208624|NCT00437203|39244072|FG004|Overall Study|Other|0|||
16208625|NCT00437203|39244073|FG005|Overall Study|Other|0|||
16208626|NCT00437203|39244074|FG006|Overall Study|Other|1|||
16208627|NCT00437203|39244075|FG007|Overall Study|Other|0|||
16397234|NCT03726658|39935389|FG001|Overall Study|Lost to Follow-up|0|||
16208628|NCT00437203|39244076|FG008|Overall Study|Other|0|||
16208629|NCT00437203|39244077|FG009|Overall Study|Other|0|||
16208630|NCT00254163|39244086|FG000|Overall Study|Adverse Event|29|||
16208631|NCT00254163|39244087|FG001|Overall Study|Adverse Event|26|||
16208632|NCT00254163|39244086|FG000|Overall Study|Patient request/withdrew consent|6|||
16208633|NCT00254163|39244087|FG001|Overall Study|Patient request/withdrew consent|4|||
16208634|NCT00254163|39244086|FG000|Overall Study|Investigator request|1|||
16208635|NCT00254163|39244087|FG001|Overall Study|Investigator request|3|||
16208636|NCT00254163|39244086|FG000|Overall Study|Failed entry|1|||
16208637|NCT00254163|39244087|FG001|Overall Study|Failed entry|3|||
16208638|NCT00254163|39244086|FG000|Overall Study|Progressive disease|0|||
16208639|NCT00254163|39244087|FG001|Overall Study|Progressive disease|1|||
16208640|NCT00254163|39244086|FG000|Overall Study|Death|0|||
16208641|NCT00254163|39244087|FG001|Overall Study|Death|1|||
16208642|NCT00254163|39244086|FG000|Overall Study|Other|8|||
16208643|NCT00254163|39244087|FG001|Overall Study|Other|8|||
16208644|NCT04914819|39244088|FG000|Overall Study|Pregnancy|3|||
16208645|NCT04914819|39244089|FG001|Overall Study|Pregnancy|1|||
16208646|NCT04914819|39244088|FG000|Overall Study|Discontinued study|4|||
16208647|NCT04914819|39244089|FG001|Overall Study|Discontinued study|1|||
16208648|NCT04914819|39244088|FG000|Overall Study|Lost to Follow-up|7|||
16208649|NCT04914819|39244089|FG001|Overall Study|Lost to Follow-up|0|||
16208650|NCT04423757|39244090|FG000|Overall Study|Adverse Event|2|||
16208651|NCT04423757|39244091|FG001|Overall Study|Adverse Event|0|||
16208652|NCT04423757|39244090|FG000|Overall Study|Not treated|1|||
16208653|NCT04423757|39244091|FG001|Overall Study|Not treated|1|||
16208654|NCT01176240|39244094|FG000|Study 306A|Lack of Efficacy|2|||
16208655|NCT01176240|39244095|FG001|Study 306A|Lack of Efficacy|1|||
16208656|NCT01176240|39244094|FG000|Study 306A|Protocol Violation|0|||
16208657|NCT01176240|39244095|FG001|Study 306A|Protocol Violation|1|||
16208658|NCT01176240|39244094|FG000|Study 306A|Withdrawal by Subject|0|||
16208659|NCT01176240|39244095|FG001|Study 306A|Withdrawal by Subject|1|||
16208660|NCT01176240|39244094|FG000|Study 306A|Stop due to diverse problems|1|||
16208661|NCT01176240|39244095|FG001|Study 306A|Stop due to diverse problems|0|||
16208662|NCT01176240|39244094|FG000|Study 306B|Lack of Efficacy|5|||
16208663|NCT01176240|39244095|FG001|Study 306B|Lack of Efficacy|3|||
16208664|NCT01176240|39244094|FG000|Study 306B|Adverse Event|10|||
16208665|NCT01176240|39244095|FG001|Study 306B|Adverse Event|5|||
16208666|NCT01176240|39244094|FG000|Study 306B|Protocol Violation|2|||
16208667|NCT01176240|39244095|FG001|Study 306B|Protocol Violation|3|||
16208668|NCT01176240|39244094|FG000|Study 306B|Withdrawal by Subject|4|||
16208669|NCT01176240|39244095|FG001|Study 306B|Withdrawal by Subject|1|||
16208670|NCT01176240|39244094|FG000|Study 306B|Physician Decision|2|||
16208671|NCT01176240|39244095|FG001|Study 306B|Physician Decision|1|||
16208672|NCT01176240|39244094|FG000|Study 306B|Supine Hypertension|1|||
16208673|NCT01176240|39244095|FG001|Study 306B|Supine Hypertension|2|||
16208674|NCT01176240|39244094|FG000|Study 306B|Lost to Follow-up|0|||
16208675|NCT01176240|39244095|FG001|Study 306B|Lost to Follow-up|1|||
16208676|NCT01176240|39244094|FG000|Study 306B|withdrew prior to dosing|2|||
16208677|NCT01176240|39244095|FG001|Study 306B|withdrew prior to dosing|1|||
16208678|NCT03210220|39244096|FG000|Overall Study|Physician Decision|1|||
16208679|NCT03210220|39244097|FG001|Overall Study|Physician Decision|0|||
16208680|NCT02000219|39244099|FG000|14-Week Study Period|Physician Decision|1|||
16208681|NCT02000219|39244099|FG000|14-Week Study Period|Adverse Event|1|||
16208682|NCT02000219|39244099|FG000|14-Week Study Period|Underwent transplantation|1|||
16208683|NCT02000219|39244099|FG000|Continuation Period|Withdrawal by Subject|1|||
16208684|NCT02000219|39244099|FG000|Continuation Period|Had liver transplant|2|||
16208685|NCT02000219|39244099|FG000|Continuation Period|Non-compliance with study drug|2|||
16208686|NCT02177812|39244104|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16208687|NCT02177812|39244105|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16208688|NCT02177812|39244106|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16208689|NCT02177812|39244107|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16208690|NCT02177812|39244108|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16208691|NCT02177812|39244109|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
16208692|NCT02177812|39244110|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
16208693|NCT02177812|39244111|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
16208694|NCT02177812|39244112|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
16208695|NCT02177812|39244104|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16523723|NCT00384085|40383860|FG002|Overall Study|Sponsor decision|1|||
16523724|NCT00384085|40383858|FG000|Overall Study|Patient moved|1|||
16523725|NCT00384085|40383859|FG001|Overall Study|Patient moved|0|||
16208696|NCT02177812|39244105|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16208697|NCT02177812|39244106|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16208698|NCT02177812|39244107|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16208699|NCT02177812|39244108|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16208700|NCT02177812|39244109|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
16208701|NCT02177812|39244110|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
16208702|NCT02177812|39244111|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16208703|NCT02177812|39244112|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
16208704|NCT02177812|39244104|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
16523726|NCT00384085|40383860|FG002|Overall Study|Patient moved|1|||
16208705|NCT02177812|39244105|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
16397235|NCT03726658|39935390|FG002|Overall Study|Lost to Follow-up|2|||
16397236|NCT03726658|39935391|FG003|Overall Study|Lost to Follow-up|0|||
16397237|NCT03726658|39935392|FG004|Overall Study|Lost to Follow-up|0|||
16397238|NCT03726658|39935393|FG005|Overall Study|Lost to Follow-up|1|||
16397239|NCT03726658|39935394|FG006|Overall Study|Lost to Follow-up|1|||
16208706|NCT02177812|39244106|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
16208707|NCT02177812|39244107|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
16327187|NCT03891862|39685253|FG000|Open-label Period|Death|1|||
16327188|NCT03891862|39685254|FG001|Open-label Period|Death|0|||
16327189|NCT03891862|39685255|FG002|Open-label Period|Death|0|||
16327190|NCT03891862|39685253|FG000|Open-label Period|Lost to Follow-up|2|||
16327191|NCT03891862|39685254|FG001|Open-label Period|Lost to Follow-up|0|||
16327192|NCT03891862|39685255|FG002|Open-label Period|Lost to Follow-up|0|||
16327193|NCT03891862|39685253|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
16208708|NCT02177812|39244108|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
16208709|NCT02177812|39244109|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
16208710|NCT02177812|39244110|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
16327194|NCT03891862|39685254|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
16327195|NCT03891862|39685255|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
16327196|NCT03891862|39685253|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
16327197|NCT03891862|39685254|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
16327198|NCT03891862|39685255|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
16327199|NCT03891862|39685253|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
16327200|NCT03891862|39685254|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
16327201|NCT03891862|39685255|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
16327202|NCT03891862|39685253|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
16327203|NCT03891862|39685254|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
16327204|NCT03891862|39685255|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
16327205|NCT00425061|39685256|FG000|Overall Study|Adverse Event|1|||
16327206|NCT00425061|39685257|FG001|Overall Study|Adverse Event|0|||
16327207|NCT00425061|39685258|FG002|Overall Study|Adverse Event|0|||
16327208|NCT00425061|39685259|FG003|Overall Study|Adverse Event|2|||
16327209|NCT00425061|39685260|FG004|Overall Study|Adverse Event|2|||
16327210|NCT00425061|39685261|FG005|Overall Study|Adverse Event|0|||
16327211|NCT00425061|39685262|FG006|Overall Study|Adverse Event|0|||
16327212|NCT00425061|39685256|FG000|Overall Study|Lost to Follow-up|0|||
16327213|NCT00425061|39685257|FG001|Overall Study|Lost to Follow-up|1|||
16327214|NCT00425061|39685258|FG002|Overall Study|Lost to Follow-up|0|||
16327215|NCT00425061|39685259|FG003|Overall Study|Lost to Follow-up|0|||
16327216|NCT00425061|39685260|FG004|Overall Study|Lost to Follow-up|0|||
16327217|NCT00425061|39685261|FG005|Overall Study|Lost to Follow-up|0|||
16327218|NCT00425061|39685262|FG006|Overall Study|Lost to Follow-up|0|||
16327219|NCT00425061|39685256|FG000|Overall Study|Protocol Violation|1|||
16327220|NCT00425061|39685257|FG001|Overall Study|Protocol Violation|0|||
16327221|NCT00425061|39685258|FG002|Overall Study|Protocol Violation|0|||
16327222|NCT00425061|39685259|FG003|Overall Study|Protocol Violation|0|||
16327223|NCT00425061|39685260|FG004|Overall Study|Protocol Violation|0|||
16327224|NCT00425061|39685261|FG005|Overall Study|Protocol Violation|0|||
16327225|NCT00425061|39685262|FG006|Overall Study|Protocol Violation|0|||
16327226|NCT00425061|39685256|FG000|Overall Study|Withdrawal by Subject|0|||
16327227|NCT00425061|39685257|FG001|Overall Study|Withdrawal by Subject|1|||
16327228|NCT00425061|39685258|FG002|Overall Study|Withdrawal by Subject|0|||
16327229|NCT00425061|39685259|FG003|Overall Study|Withdrawal by Subject|0|||
16327230|NCT00425061|39685260|FG004|Overall Study|Withdrawal by Subject|1|||
16327231|NCT00425061|39685261|FG005|Overall Study|Withdrawal by Subject|0|||
16327232|NCT00425061|39685262|FG006|Overall Study|Withdrawal by Subject|3|||
16327233|NCT00425061|39685256|FG000|Overall Study|Sponsor's request|0|||
16327234|NCT00425061|39685257|FG001|Overall Study|Sponsor's request|0|||
16327235|NCT00425061|39685258|FG002|Overall Study|Sponsor's request|0|||
16327236|NCT00425061|39685259|FG003|Overall Study|Sponsor's request|0|||
16327237|NCT00425061|39685260|FG004|Overall Study|Sponsor's request|19|||
16327238|NCT00425061|39685261|FG005|Overall Study|Sponsor's request|4|||
16327239|NCT00425061|39685262|FG006|Overall Study|Sponsor's request|15|||
16327240|NCT00425061|39685256|FG000|Overall Study|Physician Decision|0|||
16327241|NCT00425061|39685257|FG001|Overall Study|Physician Decision|0|||
16208711|NCT02177812|39244111|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
16327242|NCT00425061|39685258|FG002|Overall Study|Physician Decision|0|||
16327243|NCT00425061|39685259|FG003|Overall Study|Physician Decision|0|||
16327244|NCT00425061|39685260|FG004|Overall Study|Physician Decision|1|||
16327245|NCT00425061|39685261|FG005|Overall Study|Physician Decision|0|||
16327246|NCT00425061|39685262|FG006|Overall Study|Physician Decision|0|||
16327247|NCT00425061|39685256|FG000|Overall Study|Other|0|||
16208712|NCT02177812|39244112|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
16208713|NCT00571519|39244113|FG000|Overall Study|Subject withdrew consent|0|||
16208714|NCT00571519|39244114|FG001|Overall Study|Subject withdrew consent|1|||
16208715|NCT00571519|39244115|FG002|Overall Study|Subject withdrew consent|0|||
16208716|NCT00571519|39244116|FG003|Overall Study|Subject withdrew consent|2|||
16208717|NCT00571519|39244117|FG004|Overall Study|Subject withdrew consent|1|||
16208718|NCT00571519|39244118|FG005|Overall Study|Subject withdrew consent|1|||
16208719|NCT00571519|39244119|FG006|Overall Study|Subject withdrew consent|2|||
16208720|NCT00571519|39244113|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
16208721|NCT00571519|39244114|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
16208722|NCT00571519|39244115|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
16208723|NCT00571519|39244116|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
16208724|NCT00571519|39244117|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
16208725|NCT00571519|39244118|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
16208726|NCT00571519|39244119|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
16208727|NCT00571519|39244113|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
16208728|NCT00571519|39244114|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
16208729|NCT00571519|39244115|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
16208730|NCT00571519|39244116|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
16208731|NCT00571519|39244117|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
16208732|NCT00571519|39244118|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
16208733|NCT00571519|39244119|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
16208734|NCT00571519|39244113|FG000|Overall Study|Termination of study by Sponsor|2|||
16208735|NCT00571519|39244114|FG001|Overall Study|Termination of study by Sponsor|7|||
16208736|NCT00571519|39244115|FG002|Overall Study|Termination of study by Sponsor|10|||
16208737|NCT00571519|39244116|FG003|Overall Study|Termination of study by Sponsor|24|||
16208738|NCT00571519|39244117|FG004|Overall Study|Termination of study by Sponsor|8|||
16208739|NCT00571519|39244118|FG005|Overall Study|Termination of study by Sponsor|9|||
16208740|NCT00571519|39244119|FG006|Overall Study|Termination of study by Sponsor|22|||
16208741|NCT00571519|39244113|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16208742|NCT00571519|39244114|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16208743|NCT00571519|39244115|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
16208744|NCT00571519|39244116|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16208745|NCT00571519|39244117|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16208746|NCT00571519|39244118|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16208747|NCT00571519|39244119|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
16208748|NCT01802515|39244126|FG000|Overall Study|Withdrawal by Subject|3|||
16208749|NCT01802515|39244127|FG001|Overall Study|Withdrawal by Subject|0|||
16208750|NCT01802515|39244128|FG002|Overall Study|Withdrawal by Subject|0|||
16208751|NCT02142504|39244131|FG000|Overall Study|Protocol Violation|2|||
16208752|NCT02142504|39244132|FG001|Overall Study|Protocol Violation|1|||
16208753|NCT02142504|39244133|FG002|Overall Study|Protocol Violation|2|||
16208754|NCT02142504|39244131|FG000|Overall Study|Adverse Event|2|||
16208755|NCT02142504|39244132|FG001|Overall Study|Adverse Event|3|||
16208756|NCT02142504|39244133|FG002|Overall Study|Adverse Event|4|||
16208757|NCT02142504|39244131|FG000|Overall Study|Lost to Follow-up|12|||
16208758|NCT02142504|39244132|FG001|Overall Study|Lost to Follow-up|19|||
16208759|NCT02142504|39244133|FG002|Overall Study|Lost to Follow-up|17|||
16208760|NCT02142504|39244131|FG000|Overall Study|Withdrawal by Subject|7|||
16208761|NCT02142504|39244132|FG001|Overall Study|Withdrawal by Subject|9|||
16208762|NCT02142504|39244133|FG002|Overall Study|Withdrawal by Subject|11|||
16208763|NCT02142504|39244131|FG000|Overall Study|Pregnancy|4|||
16208764|NCT02142504|39244132|FG001|Overall Study|Pregnancy|4|||
16208765|NCT02142504|39244133|FG002|Overall Study|Pregnancy|2|||
16208766|NCT02142504|39244131|FG000|Overall Study|Physician Decision|0|||
16208767|NCT02142504|39244132|FG001|Overall Study|Physician Decision|1|||
16208768|NCT02142504|39244133|FG002|Overall Study|Physician Decision|3|||
16208769|NCT02142504|39244131|FG000|Overall Study|Reason Not Specified|4|||
16208770|NCT02142504|39244132|FG001|Overall Study|Reason Not Specified|5|||
16208771|NCT02142504|39244133|FG002|Overall Study|Reason Not Specified|4|||
16327248|NCT00425061|39685257|FG001|Overall Study|Other|0|||
16095642|NCT00555620|38839566|FG003|Overall Study|Adverse Event|5|||
16095643|NCT00555620|38839567|FG004|Overall Study|Adverse Event|0|||
16208772|NCT02578992|39244134|FG000|Overall Study|equipment not available or malfunction|3|||
16208773|NCT02578992|39244135|FG001|Overall Study|equipment not available or malfunction|3|||
16208774|NCT04731922|39244141|FG000|Overall Study|Adverse Event|0|||
16208775|NCT04731922|39244142|FG001|Overall Study|Adverse Event|0|||
16208776|NCT04731922|39244143|FG002|Overall Study|Adverse Event|0|||
16208777|NCT04731922|39244144|FG003|Overall Study|Adverse Event|0|||
16208778|NCT04731922|39244145|FG004|Overall Study|Adverse Event|0|||
16327249|NCT00425061|39685258|FG002|Overall Study|Other|0|||
16327250|NCT00425061|39685259|FG003|Overall Study|Other|0|||
16397240|NCT03726658|39935388|FG000|Overall Study|Withdrawal by Subject|1|||
16397241|NCT03726658|39935389|FG001|Overall Study|Withdrawal by Subject|0|||
16208779|NCT04731922|39244146|FG005|Overall Study|Adverse Event|0|||
16208780|NCT04731922|39244147|FG006|Overall Study|Adverse Event|0|||
16208781|NCT04731922|39244148|FG007|Overall Study|Adverse Event|0|||
16208782|NCT04731922|39244149|FG008|Overall Study|Adverse Event|0|||
16208783|NCT04731922|39244150|FG009|Overall Study|Adverse Event|0|||
16208784|NCT04731922|39244151|FG010|Overall Study|Adverse Event|1|||
16208785|NCT04731922|39244152|FG011|Overall Study|Adverse Event|0|||
16208786|NCT04731922|39244153|FG012|Overall Study|Adverse Event|0|||
16208787|NCT04731922|39244154|FG013|Overall Study|Adverse Event|0|||
16208788|NCT04731922|39244155|FG014|Overall Study|Adverse Event|0|||
16208789|NCT04731922|39244156|FG015|Overall Study|Adverse Event|0|||
16208790|NCT04731922|39244157|FG016|Overall Study|Adverse Event|0|||
16327251|NCT00425061|39685260|FG004|Overall Study|Other|3|||
16397242|NCT03726658|39935390|FG002|Overall Study|Withdrawal by Subject|0|||
16397243|NCT03726658|39935391|FG003|Overall Study|Withdrawal by Subject|0|||
16397244|NCT03726658|39935392|FG004|Overall Study|Withdrawal by Subject|6|||
16397245|NCT03726658|39935393|FG005|Overall Study|Withdrawal by Subject|4|||
16397246|NCT03726658|39935394|FG006|Overall Study|Withdrawal by Subject|2|||
16397247|NCT03726658|39935388|FG000|Overall Study|Pregnancy|0|||
16397248|NCT03726658|39935389|FG001|Overall Study|Pregnancy|0|||
16397249|NCT03726658|39935390|FG002|Overall Study|Pregnancy|0|||
16397250|NCT03726658|39935391|FG003|Overall Study|Pregnancy|0|||
16095644|NCT00555620|38839568|FG005|Overall Study|Adverse Event|1|||
16327252|NCT00425061|39685261|FG005|Overall Study|Other|0|||
16327253|NCT00425061|39685262|FG006|Overall Study|Other|1|||
16327254|NCT02272842|39685263|FG000|Overall Study|Lost to Follow-up|8|||
16327255|NCT02272842|39685264|FG001|Overall Study|Lost to Follow-up|8|||
16327256|NCT02272842|39685263|FG000|Overall Study|Withdrawal by Subject|8|||
16327257|NCT02272842|39685264|FG001|Overall Study|Withdrawal by Subject|2|||
16397251|NCT03726658|39935392|FG004|Overall Study|Pregnancy|0|||
16095645|NCT00555620|38839563|FG000|Overall Study|Objective progression or relapse|6|||
16095646|NCT00555620|38839564|FG001|Overall Study|Objective progression or relapse|5|||
16095647|NCT00555620|38839565|FG002|Overall Study|Objective progression or relapse|12|||
16095648|NCT00555620|38839566|FG003|Overall Study|Objective progression or relapse|17|||
16095649|NCT00555620|38839567|FG004|Overall Study|Objective progression or relapse|3|||
16095650|NCT00555620|38839568|FG005|Overall Study|Objective progression or relapse|16|||
16095651|NCT00555620|38839563|FG000|Overall Study|Participant refused treatment|0|||
16095652|NCT00555620|38839564|FG001|Overall Study|Participant refused treatment|1|||
16095653|NCT00555620|38839565|FG002|Overall Study|Participant refused treatment|1|||
16095654|NCT00555620|38839566|FG003|Overall Study|Participant refused treatment|0|||
16095655|NCT00555620|38839567|FG004|Overall Study|Participant refused treatment|0|||
16095656|NCT00555620|38839568|FG005|Overall Study|Participant refused treatment|1|||
16095657|NCT00555620|38839563|FG000|Overall Study|Other|0|||
16095658|NCT00555620|38839564|FG001|Overall Study|Other|0|||
16095659|NCT00555620|38839565|FG002|Overall Study|Other|0|||
16095660|NCT00555620|38839566|FG003|Overall Study|Other|1|||
16095661|NCT00555620|38839567|FG004|Overall Study|Other|0|||
16095662|NCT00555620|38839568|FG005|Overall Study|Other|3|||
16095663|NCT03332589|38839569|FG000|Overall Study|Lack of Efficacy|2|||
16095664|NCT03332589|38839570|FG001|Overall Study|Lack of Efficacy|0|||
16095665|NCT03332589|38839571|FG002|Overall Study|Lack of Efficacy|0|||
16095666|NCT03332589|38839569|FG000|Overall Study|Adverse Event|1|||
16095667|NCT03332589|38839570|FG001|Overall Study|Adverse Event|0|||
16095668|NCT03332589|38839571|FG002|Overall Study|Adverse Event|0|||
16095669|NCT03332589|38839569|FG000|Overall Study|Death|1|||
16095670|NCT03332589|38839570|FG001|Overall Study|Death|0|||
16095671|NCT03332589|38839571|FG002|Overall Study|Death|0|||
16095672|NCT03344458|38839575|FG000|Overall Study|Physician Decision|1|||
16095673|NCT03344458|38839575|FG000|Overall Study|Withdrawal by Subject|16|||
16095674|NCT03344458|38839575|FG000|Overall Study|Other reasons|10|||
16095675|NCT03344458|38839575|FG000|Overall Study|Lost to Follow-up|9|||
16095676|NCT03344458|38839575|FG000|Overall Study|Protocol Violation|3|||
16095677|NCT01207453|38839576|FG000|First Intervention|Adverse Event|2|||
16095678|NCT01207453|38839577|FG001|First Intervention|Adverse Event|1|||
16208791|NCT04731922|39244141|FG000|Overall Study|Lost to Follow-up|0|||
16208792|NCT04731922|39244142|FG001|Overall Study|Lost to Follow-up|0|||
16208793|NCT04731922|39244143|FG002|Overall Study|Lost to Follow-up|0|||
16095679|NCT01207453|38839576|FG000|Washout|Adverse Event|1|||
16095680|NCT01207453|38839577|FG001|Washout|Adverse Event|0|||
16327258|NCT00890084|39685265|FG000|Overall Study|Adverse Event|16|||
16327259|NCT00890084|39685265|FG000|Overall Study|Lost to Follow-up|126|||
16397252|NCT03726658|39935393|FG005|Overall Study|Pregnancy|0|||
16095681|NCT01207453|38839576|FG000|Washout|Lost to Follow-up|1|||
16095682|NCT01207453|38839577|FG001|Washout|Lost to Follow-up|0|||
16208794|NCT04731922|39244144|FG003|Overall Study|Lost to Follow-up|1|||
16208795|NCT04731922|39244145|FG004|Overall Study|Lost to Follow-up|0|||
16208796|NCT04731922|39244146|FG005|Overall Study|Lost to Follow-up|1|||
16095683|NCT01207453|38839576|FG000|2nd Intervention|Adverse Event|1|||
16095684|NCT01207453|38839577|FG001|2nd Intervention|Adverse Event|2|||
16095685|NCT01207453|38839576|FG000|2nd Intervention|Lost to Follow-up|1|||
16095686|NCT01207453|38839577|FG001|2nd Intervention|Lost to Follow-up|0|||
16095687|NCT01074229|38839578|FG000|Overall Study|Lost to Follow-up|1|||
16095688|NCT01074229|38839579|FG001|Overall Study|Lost to Follow-up|0|||
16095689|NCT01074229|38839580|FG002|Overall Study|Lost to Follow-up|0|||
16095690|NCT01074229|38839578|FG000|Overall Study|Change to open surgical procedure|1|||
16095691|NCT01074229|38839579|FG001|Overall Study|Change to open surgical procedure|3|||
16095692|NCT01074229|38839580|FG002|Overall Study|Change to open surgical procedure|4|||
16095693|NCT03214198|38839581|FG000|Overall Study|Case Report Forms Uncollected|18|||
16095694|NCT03214198|38839581|FG000|Overall Study|Protocol Deviation|18|||
16095695|NCT03562117|38839582|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
16095696|NCT03562117|38839583|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
16095697|NCT03562117|38839584|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
16095698|NCT03060525|38839586|FG000|Overall Study|moved out of state|1|||
16095699|NCT03060525|38839587|FG001|Overall Study|moved out of state|1|||
16095700|NCT03060525|38839588|FG002|Overall Study|moved out of state|1|||
16095701|NCT03060525|38839589|FG003|Overall Study|moved out of state|1|||
16095702|NCT03060525|38839586|FG000|Overall Study|unable to meet time commitment required of study|2|||
16095703|NCT03060525|38839587|FG001|Overall Study|unable to meet time commitment required of study|3|||
16095704|NCT03060525|38839588|FG002|Overall Study|unable to meet time commitment required of study|3|||
16095705|NCT03060525|38839589|FG003|Overall Study|unable to meet time commitment required of study|1|||
16095706|NCT03060525|38839586|FG000|Overall Study|no longer interested in doing intervention|0|||
16095707|NCT03060525|38839587|FG001|Overall Study|no longer interested in doing intervention|0|||
16095708|NCT03060525|38839588|FG002|Overall Study|no longer interested in doing intervention|0|||
16095709|NCT03060525|38839589|FG003|Overall Study|no longer interested in doing intervention|1|||
16095710|NCT04421456|38839592|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
16095711|NCT04421456|38839593|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
16095712|NCT04421456|38839594|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
16095713|NCT04421456|38839592|FG000|Randomized Treatment Period|Adverse Event|0|||
16095714|NCT04421456|38839593|FG001|Randomized Treatment Period|Adverse Event|1|||
16095715|NCT04421456|38839594|FG002|Randomized Treatment Period|Adverse Event|0|||
16095716|NCT04421456|38839592|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
16095717|NCT04421456|38839593|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
16095718|NCT04421456|38839594|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
16095719|NCT04421456|38839592|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
16095720|NCT04421456|38839593|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
16095721|NCT04421456|38839594|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
16095722|NCT04421456|38839592|FG000|Randomized Treatment Period|Participant non-compliance|1|||
16095723|NCT04421456|38839593|FG001|Randomized Treatment Period|Participant non-compliance|1|||
16095724|NCT04421456|38839594|FG002|Randomized Treatment Period|Participant non-compliance|2|||
16095725|NCT04421456|38839592|FG000|Randomized Treatment Period|Other|0|||
16095726|NCT04421456|38839593|FG001|Randomized Treatment Period|Other|1|||
16095727|NCT04421456|38839594|FG002|Randomized Treatment Period|Other|3|||
16095728|NCT01405508|38839595|FG000|Overall Study|AE, non-serious non-fatal|1|||
16095729|NCT01405508|38839596|FG001|Overall Study|AE, non-serious non-fatal|1|||
16095730|NCT01405508|38839597|FG002|Overall Study|AE, non-serious non-fatal|0|||
16095731|NCT01405508|38839598|FG003|Overall Study|AE, non-serious non-fatal|0|||
16095732|NCT00818519|38839604|FG000|Overall Study|Adverse Event|2|||
16095733|NCT00818519|38839605|FG001|Overall Study|Adverse Event|2|||
16095734|NCT00818519|38839604|FG000|Overall Study|Lost to Follow-up|4|||
16095735|NCT00818519|38839605|FG001|Overall Study|Lost to Follow-up|6|||
16095736|NCT00818519|38839604|FG000|Overall Study|Protocol Violation|2|||
16095737|NCT00818519|38839605|FG001|Overall Study|Protocol Violation|1|||
16095738|NCT00818519|38839604|FG000|Overall Study|Pregnancy|0|||
16095739|NCT00818519|38839605|FG001|Overall Study|Pregnancy|1|||
16095740|NCT00818519|38839604|FG000|Overall Study|Withdrawal by Subject|4|||
16095741|NCT00818519|38839605|FG001|Overall Study|Withdrawal by Subject|9|||
16095742|NCT00818519|38839604|FG000|Overall Study|participant recovered completely|1|||
16095743|NCT00818519|38839605|FG001|Overall Study|participant recovered completely|0|||
16095744|NCT00818519|38839604|FG000|Overall Study|participant will leave for long tme|1|||
16095745|NCT00818519|38839605|FG001|Overall Study|participant will leave for long tme|0|||
16095746|NCT02213094|38842576|FG000|Overall Study|Adverse Event|1|||
16095747|NCT02213094|38842577|FG001|Overall Study|Adverse Event|0|||
16095748|NCT01655498|38842578|FG000|Overall Study|Unrelated health issue|2|||
16397253|NCT03726658|39935394|FG006|Overall Study|Pregnancy|1|||
16095749|NCT01655498|38842578|FG000|Overall Study|Protocol Violation|2|||
16095750|NCT01655498|38842578|FG000|Overall Study|Withdrawal by Subject|1|||
16095751|NCT03672188|38842582|FG000|Overall Study|Withdrawal by Subject|0|||
16397254|NCT03726658|39935388|FG000|Overall Study|Not Reported|0|||
16095752|NCT03672188|38842583|FG001|Overall Study|Withdrawal by Subject|0|||
16095753|NCT03672188|38842584|FG002|Overall Study|Withdrawal by Subject|0|||
16095754|NCT03672188|38842585|FG003|Overall Study|Withdrawal by Subject|3|||
16095755|NCT03672188|38842586|FG004|Overall Study|Withdrawal by Subject|0|||
16095756|NCT03672188|38842587|FG005|Overall Study|Withdrawal by Subject|0|||
16095757|NCT03672188|38842588|FG006|Overall Study|Withdrawal by Subject|0|||
16397255|NCT03726658|39935389|FG001|Overall Study|Not Reported|0|||
16397256|NCT03726658|39935390|FG002|Overall Study|Not Reported|0|||
16397257|NCT03726658|39935391|FG003|Overall Study|Not Reported|0|||
16397258|NCT03726658|39935392|FG004|Overall Study|Not Reported|0|||
16095758|NCT03672188|38842589|FG007|Overall Study|Withdrawal by Subject|0|||
16397259|NCT03726658|39935393|FG005|Overall Study|Not Reported|0|||
16397260|NCT03726658|39935394|FG006|Overall Study|Not Reported|1|||
16397261|NCT04470050|39935396|FG000|Double-blind Treatment Phase|Adverse Event|0|||
16397262|NCT04470050|39935397|FG001|Double-blind Treatment Phase|Adverse Event|0|||
16397263|NCT04470050|39935398|FG002|Double-blind Treatment Phase|Adverse Event|0|||
16523727|NCT00384085|40383858|FG000|Overall Study|Patient required surgery|0|||
16523728|NCT00384085|40383859|FG001|Overall Study|Patient required surgery|1|||
16523729|NCT00384085|40383860|FG002|Overall Study|Patient required surgery|0|||
16523730|NCT03283670|40383861|FG000|Placebo Gas|Withdrawal by Subject|2|||
16523731|NCT03283670|40383861|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
16523732|NCT03283670|40383861|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
16523733|NCT01458171|40383862|FG000|Overall Study|Adverse Event|1|||
16523734|NCT02715765|40383865|FG000|Overall Study|Study Termination|3|||
16523735|NCT02715765|40383866|FG001|Overall Study|Study Termination|0|||
16523736|NCT02715765|40383867|FG002|Overall Study|Study Termination|0|||
16523737|NCT03579459|40383868|FG000|Overall Study|Adverse Event|7|||
16523738|NCT03579459|40383869|FG001|Overall Study|Adverse Event|6|||
16523739|NCT03579459|40383870|FG002|Overall Study|Adverse Event|2|||
16523740|NCT03579459|40383871|FG003|Overall Study|Adverse Event|6|||
16523741|NCT03579459|40383868|FG000|Overall Study|Death|1|||
16523742|NCT03579459|40383869|FG001|Overall Study|Death|0|||
16523743|NCT03579459|40383870|FG002|Overall Study|Death|1|||
16523744|NCT03579459|40383871|FG003|Overall Study|Death|2|||
16523745|NCT03579459|40383868|FG000|Overall Study|Lost to Follow-up|6|||
16523746|NCT03579459|40383869|FG001|Overall Study|Lost to Follow-up|2|||
16523747|NCT03579459|40383870|FG002|Overall Study|Lost to Follow-up|4|||
16523748|NCT03579459|40383871|FG003|Overall Study|Lost to Follow-up|1|||
16523749|NCT03579459|40383868|FG000|Overall Study|Physician Decision|0|||
16523750|NCT03579459|40383869|FG001|Overall Study|Physician Decision|1|||
16523751|NCT03579459|40383870|FG002|Overall Study|Physician Decision|0|||
16523752|NCT03579459|40383871|FG003|Overall Study|Physician Decision|1|||
16523753|NCT03579459|40383868|FG000|Overall Study|Protocol Violation|1|||
16523754|NCT03579459|40383869|FG001|Overall Study|Protocol Violation|2|||
16523755|NCT03579459|40383870|FG002|Overall Study|Protocol Violation|3|||
16523756|NCT03579459|40383871|FG003|Overall Study|Protocol Violation|5|||
16523757|NCT03579459|40383868|FG000|Overall Study|Withdrawal by Subject|12|||
16523758|NCT03579459|40383869|FG001|Overall Study|Withdrawal by Subject|8|||
16523759|NCT03579459|40383870|FG002|Overall Study|Withdrawal by Subject|11|||
16523760|NCT03579459|40383871|FG003|Overall Study|Withdrawal by Subject|8|||
16523761|NCT03579459|40383868|FG000|Overall Study|Medication error without associated adverse event|2|||
16523762|NCT03579459|40383869|FG001|Overall Study|Medication error without associated adverse event|1|||
16523763|NCT03579459|40383870|FG002|Overall Study|Medication error without associated adverse event|1|||
16523764|NCT03579459|40383871|FG003|Overall Study|Medication error without associated adverse event|0|||
16523765|NCT03579459|40383868|FG000|Overall Study|Other|0|||
16523766|NCT03579459|40383869|FG001|Overall Study|Other|1|||
16523767|NCT03579459|40383870|FG002|Overall Study|Other|1|||
16523768|NCT03579459|40383871|FG003|Overall Study|Other|0|||
16523769|NCT03579459|40383868|FG000|Overall Study|Randomized not vaccinated|0|||
16523770|NCT03579459|40383869|FG001|Overall Study|Randomized not vaccinated|2|||
16523771|NCT03579459|40383870|FG002|Overall Study|Randomized not vaccinated|0|||
16523772|NCT03579459|40383871|FG003|Overall Study|Randomized not vaccinated|1|||
16523773|NCT03238001|40383872|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
16523774|NCT03238001|40383872|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
16523775|NCT03238001|40383872|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
16523776|NCT03238001|40383872|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
16523777|NCT03238001|40383872|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
16523778|NCT03238001|40383872|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
16523779|NCT03238001|40383872|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
16523780|NCT03238001|40383872|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
16523781|NCT01059617|40383873|FG000|Overall Study|Other|7|||
16523782|NCT01059617|40383874|FG001|Overall Study|Other|1|||
16523783|NCT01059617|40383875|FG002|Overall Study|Other|8|||
16523784|NCT01059617|40383876|FG003|Overall Study|Other|6|||
16523785|NCT03217136|40383877|FG000|Overall Study|Lost to Follow-up|2|||
16523786|NCT03217136|40383878|FG001|Overall Study|Lost to Follow-up|1|||
16523787|NCT03217136|40383877|FG000|Overall Study|Site Randomized Participant in Error|0|||
16523788|NCT03217136|40383878|FG001|Overall Study|Site Randomized Participant in Error|1|||
16523789|NCT03217136|40383877|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
16523790|NCT03217136|40383878|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
16523791|NCT03217136|40383877|FG000|Overall Study|Dispensing Error|1|||
16523792|NCT03217136|40383878|FG001|Overall Study|Dispensing Error|0|||
16523793|NCT03217136|40383877|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
16523794|NCT03217136|40383878|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16523795|NCT01617629|40383894|FG000|Overall Study|Death|2|||
16523796|NCT01617629|40383894|FG000|Overall Study|Investigator's Clinical Judgement|1|||
16523797|NCT01617629|40383894|FG000|Overall Study|Reason Not Specified|1|||
16523798|NCT01617629|40383894|FG000|Overall Study|Participant Withdrew Consent|2|||
16397264|NCT04470050|39935399|FG003|Double-blind Treatment Phase|Adverse Event|1|||
16397265|NCT04470050|39935400|FG004|Double-blind Treatment Phase|Adverse Event|0|||
16397266|NCT04470050|39935401|FG005|Double-blind Treatment Phase|Adverse Event|0|||
16397267|NCT04470050|39935402|FG006|Double-blind Treatment Phase|Adverse Event|0|||
16397268|NCT04470050|39935396|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
16397269|NCT04470050|39935397|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
16397270|NCT04470050|39935398|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
16397271|NCT04470050|39935399|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
16397272|NCT04470050|39935400|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
16397273|NCT04470050|39935401|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
16397274|NCT04470050|39935402|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
16397275|NCT04470050|39935396|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
16397276|NCT04470050|39935397|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
16397277|NCT04470050|39935398|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
16397278|NCT04470050|39935399|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
16397279|NCT04470050|39935400|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
16397280|NCT04470050|39935401|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
16523799|NCT01870843|40383905|FG000|Overall Study|Adverse Event|10|||
16523800|NCT01870843|40383905|FG000|Overall Study|Lost to Follow-up|24|||
16523801|NCT01870843|40383905|FG000|Overall Study|Death|1|||
16523802|NCT01870843|40383905|FG000|Overall Study|Withdrawal by Subject|18|||
16523803|NCT02647658|40387576|FG000|Overall Study|Consent refusal|15|||
16523804|NCT02647658|40387577|FG001|Overall Study|Consent refusal|24|||
16523805|NCT02200042|40387579|FG000|Overall Study|Withdrawal by Subject|0|||
16523806|NCT02200042|40387580|FG001|Overall Study|Withdrawal by Subject|1|||
16523807|NCT00709722|40387583|FG000|Overall Study|Adverse Event|1|||
16523808|NCT01252251|40387584|FG000|Overall Study|Withdrawal by Subject|1|||
16523809|NCT01993719|40387588|FG000|First Drug Administration|Not treated|1|||
16523810|NCT01993719|40387589|FG001|First Drug Administration|Not treated|0|||
16523811|NCT01993719|40387590|FG002|First Drug Administration|Not treated|0|||
16523812|NCT01993719|40387591|FG003|First Drug Administration|Not treated|0|||
16523813|NCT01993719|40387592|FG004|First Drug Administration|Not treated|0|||
16523814|NCT05282004|40387593|FG000|Overall Study|Adverse Event|2|||
16523815|NCT00612066|40387597|FG000|Overall Study|Adverse Event|1|||
16523816|NCT03943095|40387600|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
16523817|NCT03943095|40387601|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
16523818|NCT03943095|40387600|FG000|Overall Study|Withdrawal by Subject|1|||
16523819|NCT03943095|40387601|FG001|Overall Study|Withdrawal by Subject|0|||
16523820|NCT02293005|40387602|FG000|Overall Study|Adverse Event|2|||
16523821|NCT02293005|40387602|FG000|Overall Study|Death|4|||
16523822|NCT02293005|40387602|FG000|Overall Study|Lost to Follow-up|1|||
16523823|NCT02293005|40387602|FG000|Overall Study|Withdrawal by Subject|2|||
16523824|NCT02293005|40387602|FG000|Overall Study|Progression|17|||
16523825|NCT03394924|40387604|FG000|Overall Study|Adverse Event|0|||
16523826|NCT03394924|40387605|FG001|Overall Study|Adverse Event|5|||
16523827|NCT03394924|40387606|FG002|Overall Study|Adverse Event|0|||
16523828|NCT03394924|40387604|FG000|Overall Study|Withdrawal by Subject|2|||
16523829|NCT03394924|40387605|FG001|Overall Study|Withdrawal by Subject|0|||
16523830|NCT03394924|40387606|FG002|Overall Study|Withdrawal by Subject|0|||
16523831|NCT03394924|40387604|FG000|Overall Study|Lost to Follow-up|0|||
16523832|NCT03394924|40387605|FG001|Overall Study|Lost to Follow-up|1|||
16523833|NCT03394924|40387606|FG002|Overall Study|Lost to Follow-up|0|||
16523834|NCT03394924|40387604|FG000|Overall Study|Did not meet all inclusion criteria|1|||
16523835|NCT03394924|40387605|FG001|Overall Study|Did not meet all inclusion criteria|0|||
16523836|NCT03394924|40387606|FG002|Overall Study|Did not meet all inclusion criteria|0|||
16523837|NCT02565381|40387607|FG000|Overall Study|Lost to Follow-up|1|||
16523838|NCT02565381|40387608|FG001|Overall Study|Lost to Follow-up|0|||
16523839|NCT02565381|40387609|FG002|Overall Study|Lost to Follow-up|1|||
16523840|NCT01539291|40387610|FG000|Study GS-US-312-0116|Adverse Event|9|||
16523841|NCT01539291|40387611|FG001|Study GS-US-312-0116|Adverse Event|0|||
16523842|NCT01539291|40387612|FG002|Study GS-US-312-0116|Adverse Event|0|||
16523843|NCT01539291|40387613|FG003|Study GS-US-312-0116|Adverse Event|0|||
16523844|NCT01539291|40387610|FG000|Study GS-US-312-0116|Physician Decision|1|||
16523845|NCT01539291|40387611|FG001|Study GS-US-312-0116|Physician Decision|0|||
16523846|NCT01539291|40387612|FG002|Study GS-US-312-0116|Physician Decision|0|||
16523847|NCT01539291|40387613|FG003|Study GS-US-312-0116|Physician Decision|0|||
16523848|NCT01539291|40387610|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
16523849|NCT01539291|40387611|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
16523850|NCT01539291|40387612|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
16523851|NCT01539291|40387613|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
16523852|NCT01539291|40387610|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
16523853|NCT01539291|40387611|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
16523854|NCT01539291|40387612|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
16523855|NCT01539291|40387613|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
16397281|NCT04470050|39935402|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
16397282|NCT02584452|39935403|FG000|Overall Study|Physician Decision|1|||
16397283|NCT02584452|39935404|FG001|Overall Study|Physician Decision|1|||
16397284|NCT02584452|39935403|FG000|Overall Study|Lost to Follow-up|1|||
16397285|NCT02584452|39935404|FG001|Overall Study|Lost to Follow-up|1|||
16397286|NCT02323126|39935405|FG000|Overall Study|Patient / guardian decision|0|||
16397287|NCT02323126|39935406|FG001|Overall Study|Patient / guardian decision|1|||
16397288|NCT02323126|39935407|FG002|Overall Study|Patient / guardian decision|2|||
16397289|NCT02323126|39935405|FG000|Overall Study|Progressive disease|14|||
16397290|NCT02323126|39935406|FG001|Overall Study|Progressive disease|8|||
16397291|NCT02323126|39935407|FG002|Overall Study|Progressive disease|14|||
16397292|NCT02323126|39935405|FG000|Overall Study|Physician Decision|0|||
16397293|NCT02323126|39935406|FG001|Overall Study|Physician Decision|1|||
16397294|NCT02323126|39935407|FG002|Overall Study|Physician Decision|3|||
16397295|NCT02323126|39935405|FG000|Overall Study|Death|1|||
16397296|NCT02323126|39935406|FG001|Overall Study|Death|1|||
16397297|NCT02323126|39935407|FG002|Overall Study|Death|4|||
16397298|NCT02323126|39935405|FG000|Overall Study|Adverse Event|3|||
16397299|NCT02323126|39935406|FG001|Overall Study|Adverse Event|5|||
16397300|NCT02323126|39935407|FG002|Overall Study|Adverse Event|7|||
16397301|NCT02231892|39935408|FG000|Overall Study|Lost to Follow-up|1|||
16397302|NCT02231892|39935409|FG001|Overall Study|Lost to Follow-up|0|||
16397303|NCT02231892|39935410|FG002|Overall Study|Lost to Follow-up|3|||
16397304|NCT02231892|39935408|FG000|Overall Study|Withdrawal by Subject|4|||
16397305|NCT02231892|39935409|FG001|Overall Study|Withdrawal by Subject|3|||
16397306|NCT02231892|39935410|FG002|Overall Study|Withdrawal by Subject|15|||
16397307|NCT02231892|39935408|FG000|Overall Study|Physician Decision|0|||
16397308|NCT02231892|39935409|FG001|Overall Study|Physician Decision|2|||
16397309|NCT02231892|39935410|FG002|Overall Study|Physician Decision|4|||
16397310|NCT02231892|39935408|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
16397311|NCT02231892|39935409|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
16397312|NCT02231892|39935410|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
16397313|NCT02231892|39935408|FG000|Overall Study|Participant motor threshold was >83%|0|||
16397314|NCT02231892|39935409|FG001|Overall Study|Participant motor threshold was >83%|0|||
16397315|NCT02231892|39935410|FG002|Overall Study|Participant motor threshold was >83%|9|||
16397316|NCT02231892|39935408|FG000|Overall Study|Could not find motor threshold|2|||
16397317|NCT02231892|39935409|FG001|Overall Study|Could not find motor threshold|0|||
16397318|NCT02231892|39935410|FG002|Overall Study|Could not find motor threshold|1|||
16397319|NCT02231892|39935408|FG000|Overall Study|Could not find reliable motor hotspot|0|||
16397320|NCT02231892|39935409|FG001|Overall Study|Could not find reliable motor hotspot|0|||
16397321|NCT02231892|39935410|FG002|Overall Study|Could not find reliable motor hotspot|1|||
16397322|NCT00606411|39935411|FG000|Overall Study|Adverse Event|1|||
16397323|NCT00606411|39935412|FG001|Overall Study|Adverse Event|2|||
16397324|NCT00606411|39935411|FG000|Overall Study|Lack of Adherence|1|||
16397325|NCT00606411|39935412|FG001|Overall Study|Lack of Adherence|1|||
16397326|NCT00606411|39935411|FG000|Overall Study|Lack of Efficacy|1|||
16397327|NCT00606411|39935412|FG001|Overall Study|Lack of Efficacy|1|||
16397328|NCT00606411|39935411|FG000|Overall Study|Withdrawal by Subject|2|||
16397329|NCT00606411|39935412|FG001|Overall Study|Withdrawal by Subject|0|||
16397330|NCT00606411|39935411|FG000|Overall Study|Lost to Follow-up|1|||
16397331|NCT00606411|39935412|FG001|Overall Study|Lost to Follow-up|2|||
16397332|NCT00606411|39935411|FG000|Overall Study|Move out of state|0|||
16397333|NCT00606411|39935412|FG001|Overall Study|Move out of state|1|||
16397334|NCT00292045|39935415|FG000|Core Study (Through Week 13)|Adverse Event|1|||
16397335|NCT00292045|39935415|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
16397336|NCT00617084|39935416|FG000|Overall Study|Withdrawal by Subject|5|||
16397337|NCT00617084|39935417|FG001|Overall Study|Withdrawal by Subject|7|||
16397338|NCT00617084|39935416|FG000|Overall Study|Missed 12 Months visit|16|||
16397339|NCT00617084|39935417|FG001|Overall Study|Missed 12 Months visit|19|||
16397340|NCT00301262|39935418|FG000|Double Blind Phase (DB)|Adverse Event|1|||
16397341|NCT00301262|39935419|FG001|Double Blind Phase (DB)|Adverse Event|0|||
16397342|NCT00301262|39935418|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
16397343|NCT00301262|39935419|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
16397344|NCT00301262|39935418|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
16397345|NCT00301262|39935419|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
16397346|NCT00301262|39935418|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
16397347|NCT00301262|39935419|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
16397348|NCT00301262|39935418|FG000|Double Blind Phase (DB)|Other|1|||
16397349|NCT00301262|39935419|FG001|Double Blind Phase (DB)|Other|4|||
16397350|NCT00301262|39935418|FG000|Open Label Phase (OL)|Adverse Event|1|||
16397351|NCT00301262|39935419|FG001|Open Label Phase (OL)|Adverse Event|0|||
16397352|NCT00301262|39935418|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
16397353|NCT00301262|39935419|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
16397354|NCT00301262|39935418|FG000|Open Label Phase (OL)|Other|2|||
16397355|NCT00301262|39935419|FG001|Open Label Phase (OL)|Other|0|||
16397356|NCT00688467|39935420|FG000|Treatment Period 1|Adverse Event|2|||
16397357|NCT00688467|39935421|FG001|Treatment Period 1|Adverse Event|1|||
16397358|NCT00688467|39935420|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
16397359|NCT00688467|39935421|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
16397360|NCT00688467|39935420|FG000|Treatment Period 2|Protocol Violation|0|||
16397361|NCT00688467|39935421|FG001|Treatment Period 2|Protocol Violation|1|||
16397362|NCT00688467|39935420|FG000|Treatment Period 2|Adverse Event|0|||
16397363|NCT00688467|39935421|FG001|Treatment Period 2|Adverse Event|1|||
16397364|NCT03162796|39935432|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
16397365|NCT03162796|39935433|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
16397366|NCT03162796|39935434|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
16397367|NCT03162796|39935432|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
16397368|NCT03162796|39935433|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
16397369|NCT03162796|39935434|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
16397370|NCT03162796|39935432|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
16397371|NCT03162796|39935433|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
16397372|NCT03162796|39935434|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
16397373|NCT03162796|39935432|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
16397374|NCT03162796|39935433|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
16397375|NCT03162796|39935434|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
16397376|NCT03162796|39935432|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
16397377|NCT03162796|39935433|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
16397378|NCT03162796|39935434|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
16397379|NCT03162796|39935432|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
16397380|NCT03162796|39935433|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
16397381|NCT03162796|39935434|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
16397382|NCT03162796|39935432|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
16523856|NCT01539291|40387610|FG000|Study GS-US-312-0116|Other|1|||
16523857|NCT01539291|40387611|FG001|Study GS-US-312-0116|Other|0|||
16523858|NCT01539291|40387612|FG002|Study GS-US-312-0116|Other|0|||
16523859|NCT01539291|40387613|FG003|Study GS-US-312-0116|Other|0|||
16523860|NCT01539291|40387610|FG000|Study GS-US-312-0117|Adverse Event|22|||
16523861|NCT01539291|40387611|FG001|Study GS-US-312-0117|Adverse Event|1|||
16523862|NCT01539291|40387612|FG002|Study GS-US-312-0117|Adverse Event|9|||
16523863|NCT01539291|40387613|FG003|Study GS-US-312-0117|Adverse Event|12|||
16523864|NCT01539291|40387610|FG000|Study GS-US-312-0117|Physician Decision|9|||
16523865|NCT01539291|40387611|FG001|Study GS-US-312-0117|Physician Decision|0|||
16523866|NCT01539291|40387612|FG002|Study GS-US-312-0117|Physician Decision|6|||
16523867|NCT01539291|40387613|FG003|Study GS-US-312-0117|Physician Decision|4|||
16523868|NCT01539291|40387610|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
16523869|NCT01539291|40387611|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
16523870|NCT01539291|40387612|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
16523871|NCT01539291|40387613|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
16523872|NCT01539291|40387610|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
16523873|NCT01539291|40387611|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
16523874|NCT01539291|40387612|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
16397383|NCT03162796|39935433|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
16327260|NCT00729157|39685266|FG000|Overall Study|Withdrawal by Subject|1|||
16327261|NCT01489254|39685267|FG000|Double-blind Part|Adverse Event|7|||
16327262|NCT01489254|39685268|FG001|Double-blind Part|Adverse Event|2|||
16327263|NCT01489254|39685269|FG002|Double-blind Part|Adverse Event|2|||
16327264|NCT01489254|39685270|FG003|Double-blind Part|Adverse Event|0|||
16327265|NCT01489254|39685267|FG000|Double-blind Part|Pregnancy|1|||
16327266|NCT01489254|39685268|FG001|Double-blind Part|Pregnancy|3|||
16327267|NCT01489254|39685269|FG002|Double-blind Part|Pregnancy|0|||
16327268|NCT01489254|39685270|FG003|Double-blind Part|Pregnancy|0|||
16327269|NCT01489254|39685267|FG000|Double-blind Part|Withdrawal by Subject|12|||
16327270|NCT01489254|39685268|FG001|Double-blind Part|Withdrawal by Subject|20|||
16327271|NCT01489254|39685269|FG002|Double-blind Part|Withdrawal by Subject|1|||
16327272|NCT01489254|39685270|FG003|Double-blind Part|Withdrawal by Subject|0|||
16327273|NCT01489254|39685267|FG000|Double-blind Part|Lost to Follow-up|1|||
16327274|NCT01489254|39685268|FG001|Double-blind Part|Lost to Follow-up|2|||
16327275|NCT01489254|39685269|FG002|Double-blind Part|Lost to Follow-up|0|||
16327276|NCT01489254|39685270|FG003|Double-blind Part|Lost to Follow-up|0|||
16327277|NCT01489254|39685267|FG000|Double-blind Part|Other reasons for not completing study|4|||
16327278|NCT01489254|39685268|FG001|Double-blind Part|Other reasons for not completing study|6|||
16327279|NCT01489254|39685269|FG002|Double-blind Part|Other reasons for not completing study|0|||
16327280|NCT01489254|39685270|FG003|Double-blind Part|Other reasons for not completing study|0|||
16327281|NCT01489254|39685267|FG000|Open-label Extension Part|Adverse Event|0|||
16327282|NCT01489254|39685268|FG001|Open-label Extension Part|Adverse Event|0|||
16327283|NCT01489254|39685269|FG002|Open-label Extension Part|Adverse Event|0|||
16327284|NCT01489254|39685270|FG003|Open-label Extension Part|Adverse Event|10|||
16327285|NCT01489254|39685267|FG000|Open-label Extension Part|Pregnancy|0|||
16327286|NCT01489254|39685268|FG001|Open-label Extension Part|Pregnancy|0|||
16327287|NCT01489254|39685269|FG002|Open-label Extension Part|Pregnancy|0|||
16327288|NCT01489254|39685270|FG003|Open-label Extension Part|Pregnancy|3|||
16327289|NCT01489254|39685267|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
16327290|NCT01489254|39685268|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
16327291|NCT01489254|39685269|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
16327292|NCT01489254|39685270|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
16327293|NCT01489254|39685267|FG000|Open-label Extension Part|Protocol Violation|0|||
16327294|NCT01489254|39685268|FG001|Open-label Extension Part|Protocol Violation|0|||
16327295|NCT01489254|39685269|FG002|Open-label Extension Part|Protocol Violation|0|||
16327296|NCT01489254|39685270|FG003|Open-label Extension Part|Protocol Violation|1|||
16327297|NCT01489254|39685267|FG000|Open-label Extension Part|Lost to Follow-up|0|||
16327298|NCT01489254|39685268|FG001|Open-label Extension Part|Lost to Follow-up|0|||
16327299|NCT01489254|39685269|FG002|Open-label Extension Part|Lost to Follow-up|0|||
16327300|NCT01489254|39685270|FG003|Open-label Extension Part|Lost to Follow-up|9|||
16327301|NCT01489254|39685267|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
16327302|NCT01489254|39685268|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
16327303|NCT01489254|39685269|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
16327304|NCT01489254|39685270|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
16327305|NCT03417024|39685271|FG000|Overall Study|Study Termination prior to follow-up|11|||
16327306|NCT03417024|39685271|FG000|Overall Study|Physician Decision|2|||
16327307|NCT00281632|39685272|FG000|Overall Study|Adverse Event|7|||
16327308|NCT00281632|39685272|FG000|Overall Study|Withdrawal by Subject|2|||
16327309|NCT00281632|39685272|FG000|Overall Study|Disease Progression|22|||
16327310|NCT00281632|39685272|FG000|Overall Study|Death|1|||
16327311|NCT00281632|39685272|FG000|Overall Study|Physician Decision|1|||
16327312|NCT00281632|39685272|FG000|Overall Study|Ongoing|3|||
16327313|NCT01967706|39685275|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
16397384|NCT03162796|39935434|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
16327314|NCT01967706|39685276|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
16327315|NCT01967706|39685277|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
16327316|NCT01967706|39685278|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
16327317|NCT02847494|39685279|FG000|Overall Study|Lost to Follow-up|8|||
16327318|NCT02847494|39685280|FG001|Overall Study|Lost to Follow-up|5|||
16327319|NCT00348790|39685281|FG000|Completed Treatment|Withdrawal by Subject|4|||
16327320|NCT00348790|39685281|FG000|Completed Treatment|Disease progression|14|||
16327321|NCT00348790|39685281|FG000|Completed Treatment|Adverse Event|4|||
16327322|NCT00348790|39685281|FG000|Completed Treatment|Required surgery|2|||
16327323|NCT00348790|39685281|FG000|Completed Treatment|Unable to travel to study site|1|||
16327324|NCT00138073|39685282|FG000|Overall Study|lack of resources|55|||
16327325|NCT03814720|39685283|FG000|Overall Study|Lost to Follow-up|0|||
16327326|NCT03814720|39685284|FG001|Overall Study|Lost to Follow-up|1|||
16327327|NCT03814720|39685285|FG002|Overall Study|Lost to Follow-up|0|||
16327328|NCT03814720|39685286|FG003|Overall Study|Lost to Follow-up|0|||
16327329|NCT03814720|39685287|FG004|Overall Study|Lost to Follow-up|0|||
16327330|NCT03503370|39685288|FG000|Overall Study|Death|3|||
16327331|NCT03503370|39685289|FG001|Overall Study|Death|1|||
16327332|NCT01290679|39685290|FG000|Overall Study|Adverse Event|2|||
16523875|NCT01539291|40387613|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
16523876|NCT01539291|40387610|FG000|Study GS-US-312-0117|Other|2|||
16523877|NCT01539291|40387611|FG001|Study GS-US-312-0117|Other|1|||
16523878|NCT01539291|40387612|FG002|Study GS-US-312-0117|Other|1|||
16523879|NCT01539291|40387613|FG003|Study GS-US-312-0117|Other|1|||
16523880|NCT00254982|40387614|FG000|Overall Study|Other|2|||
16523881|NCT00254982|40387615|FG001|Overall Study|Other|1|||
16523882|NCT00254982|40387614|FG000|Overall Study|Lack of Efficacy|5|||
16523883|NCT00254982|40387615|FG001|Overall Study|Lack of Efficacy|3|||
16095759|NCT03672188|38842590|FG008|Overall Study|Withdrawal by Subject|0|||
16095760|NCT03672188|38842591|FG009|Overall Study|Withdrawal by Subject|0|||
16095761|NCT03672188|38842592|FG010|Overall Study|Withdrawal by Subject|0|||
16095762|NCT03672188|38842593|FG011|Overall Study|Withdrawal by Subject|0|||
16095763|NCT03672188|38842594|FG012|Overall Study|Withdrawal by Subject|0|||
16095764|NCT03672188|38842595|FG013|Overall Study|Withdrawal by Subject|0|||
16095765|NCT03672188|38842596|FG014|Overall Study|Withdrawal by Subject|0|||
16095766|NCT03672188|38842582|FG000|Overall Study|Death|0|||
16095767|NCT03672188|38842583|FG001|Overall Study|Death|0|||
16523884|NCT00254982|40387614|FG000|Overall Study|Lost to Follow-up|5|||
16095768|NCT03672188|38842584|FG002|Overall Study|Death|0|||
16095769|NCT03672188|38842585|FG003|Overall Study|Death|0|||
16095770|NCT03672188|38842586|FG004|Overall Study|Death|0|||
16095771|NCT03672188|38842587|FG005|Overall Study|Death|0|||
16095772|NCT03672188|38842588|FG006|Overall Study|Death|0|||
16095773|NCT03672188|38842589|FG007|Overall Study|Death|0|||
16095774|NCT03672188|38842590|FG008|Overall Study|Death|0|||
16095775|NCT03672188|38842591|FG009|Overall Study|Death|0|||
16327333|NCT01290679|39685291|FG001|Overall Study|Adverse Event|0|||
16327334|NCT01290679|39685290|FG000|Overall Study|Lost to Follow-up|8|||
16327335|NCT01290679|39685291|FG001|Overall Study|Lost to Follow-up|10|||
16327336|NCT01290679|39685290|FG000|Overall Study|Protocol Violation|0|||
16327337|NCT01290679|39685291|FG001|Overall Study|Protocol Violation|1|||
16327338|NCT01290679|39685290|FG000|Overall Study|Withdrawal by Subject|6|||
16327339|NCT01290679|39685291|FG001|Overall Study|Withdrawal by Subject|5|||
16327340|NCT01290679|39685290|FG000|Overall Study|Subject Entered Another Trial|0|||
16327341|NCT01290679|39685291|FG001|Overall Study|Subject Entered Another Trial|5|||
16327342|NCT01438294|39685292|FG000|Overall Study|Lost to Follow-up|3|||
16327343|NCT01438294|39685293|FG001|Overall Study|Lost to Follow-up|7|||
16095776|NCT03672188|38842592|FG010|Overall Study|Death|0|||
16095777|NCT03672188|38842593|FG011|Overall Study|Death|0|||
16095778|NCT03672188|38842594|FG012|Overall Study|Death|1|||
16095779|NCT03672188|38842595|FG013|Overall Study|Death|0|||
16095780|NCT03672188|38842596|FG014|Overall Study|Death|0|||
16095781|NCT03672188|38842582|FG000|Overall Study|Lost to Follow-up|0|||
16095782|NCT03672188|38842583|FG001|Overall Study|Lost to Follow-up|0|||
16095783|NCT03672188|38842584|FG002|Overall Study|Lost to Follow-up|1|||
16095784|NCT03672188|38842585|FG003|Overall Study|Lost to Follow-up|0|||
16095785|NCT03672188|38842586|FG004|Overall Study|Lost to Follow-up|0|||
16327344|NCT00877071|39685298|FG000|Overall Study|disease progression|2|||
16397385|NCT03162796|39935432|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
16095786|NCT03672188|38842587|FG005|Overall Study|Lost to Follow-up|0|||
16208797|NCT04731922|39244147|FG006|Overall Study|Lost to Follow-up|0|||
16208798|NCT04731922|39244148|FG007|Overall Study|Lost to Follow-up|0|||
16208799|NCT04731922|39244149|FG008|Overall Study|Lost to Follow-up|0|||
16208800|NCT04731922|39244150|FG009|Overall Study|Lost to Follow-up|0|||
16208801|NCT04731922|39244151|FG010|Overall Study|Lost to Follow-up|0|||
16208802|NCT04731922|39244152|FG011|Overall Study|Lost to Follow-up|0|||
16208803|NCT04731922|39244153|FG012|Overall Study|Lost to Follow-up|0|||
16208804|NCT04731922|39244154|FG013|Overall Study|Lost to Follow-up|0|||
16208805|NCT04731922|39244155|FG014|Overall Study|Lost to Follow-up|0|||
16208806|NCT04731922|39244156|FG015|Overall Study|Lost to Follow-up|0|||
16208807|NCT04731922|39244157|FG016|Overall Study|Lost to Follow-up|0|||
16208808|NCT04731922|39244141|FG000|Overall Study|Withdrawal by Subject|1|||
16208809|NCT04731922|39244142|FG001|Overall Study|Withdrawal by Subject|0|||
16208810|NCT04731922|39244143|FG002|Overall Study|Withdrawal by Subject|0|||
16208811|NCT04731922|39244144|FG003|Overall Study|Withdrawal by Subject|0|||
16208812|NCT04731922|39244145|FG004|Overall Study|Withdrawal by Subject|1|||
16208813|NCT04731922|39244146|FG005|Overall Study|Withdrawal by Subject|0|||
16208814|NCT04731922|39244147|FG006|Overall Study|Withdrawal by Subject|1|||
16208815|NCT04731922|39244148|FG007|Overall Study|Withdrawal by Subject|0|||
16208816|NCT04731922|39244149|FG008|Overall Study|Withdrawal by Subject|0|||
16208817|NCT04731922|39244150|FG009|Overall Study|Withdrawal by Subject|0|||
16208818|NCT04731922|39244151|FG010|Overall Study|Withdrawal by Subject|0|||
16208819|NCT04731922|39244152|FG011|Overall Study|Withdrawal by Subject|0|||
16208820|NCT04731922|39244153|FG012|Overall Study|Withdrawal by Subject|0|||
16208821|NCT04731922|39244154|FG013|Overall Study|Withdrawal by Subject|1|||
16208822|NCT04731922|39244155|FG014|Overall Study|Withdrawal by Subject|0|||
16208823|NCT04731922|39244156|FG015|Overall Study|Withdrawal by Subject|0|||
16208824|NCT04731922|39244157|FG016|Overall Study|Withdrawal by Subject|0|||
16208825|NCT04731922|39244141|FG000|Overall Study|Other|0|||
16208826|NCT04731922|39244142|FG001|Overall Study|Other|0|||
16208827|NCT04731922|39244143|FG002|Overall Study|Other|0|||
16208828|NCT04731922|39244144|FG003|Overall Study|Other|0|||
16208829|NCT04731922|39244145|FG004|Overall Study|Other|0|||
16208830|NCT04731922|39244146|FG005|Overall Study|Other|0|||
16208831|NCT04731922|39244147|FG006|Overall Study|Other|1|||
16208832|NCT04731922|39244148|FG007|Overall Study|Other|0|||
16208833|NCT04731922|39244149|FG008|Overall Study|Other|0|||
16208834|NCT04731922|39244150|FG009|Overall Study|Other|0|||
16208835|NCT04731922|39244151|FG010|Overall Study|Other|0|||
16208836|NCT04731922|39244152|FG011|Overall Study|Other|0|||
16208837|NCT04731922|39244153|FG012|Overall Study|Other|0|||
16208838|NCT04731922|39244154|FG013|Overall Study|Other|0|||
16208839|NCT04731922|39244155|FG014|Overall Study|Other|0|||
16208840|NCT04731922|39244156|FG015|Overall Study|Other|0|||
16208841|NCT04731922|39244157|FG016|Overall Study|Other|0|||
16208842|NCT03693404|39244164|FG000|Overall Study|Withdrawal by Subject|1|||
16208843|NCT03693404|39244165|FG001|Overall Study|Withdrawal by Subject|0|||
16208844|NCT03693404|39244164|FG000|Overall Study|Lost to Follow-up|0|||
16208845|NCT03693404|39244165|FG001|Overall Study|Lost to Follow-up|5|||
16208846|NCT03693404|39244164|FG000|Overall Study|Excluded from Analysis|0|||
16327345|NCT03614078|39685301|FG000|Overall Study|Withdrawal by Subject|2|||
16327346|NCT03614078|39685302|FG001|Overall Study|Withdrawal by Subject|2|||
16327347|NCT03614078|39685303|FG002|Overall Study|Withdrawal by Subject|3|||
16327348|NCT03614078|39685301|FG000|Overall Study|Participant Did Not Return for Visit|0|||
16327349|NCT03614078|39685302|FG001|Overall Study|Participant Did Not Return for Visit|1|||
16327350|NCT03614078|39685303|FG002|Overall Study|Participant Did Not Return for Visit|0|||
16327351|NCT03614078|39685301|FG000|Overall Study|High Neutrophils|0|||
16327352|NCT03614078|39685302|FG001|Overall Study|High Neutrophils|0|||
16327353|NCT03614078|39685303|FG002|Overall Study|High Neutrophils|2|||
16327354|NCT03614078|39685301|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
16327355|NCT03614078|39685302|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
16327356|NCT03614078|39685303|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
16327357|NCT03614078|39685301|FG000|Overall Study|Exacerbation of Psoriasis|0|||
16208847|NCT03693404|39244165|FG001|Overall Study|Excluded from Analysis|1|||
16208848|NCT01376245|39244166|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
16208849|NCT01376245|39244167|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
16208850|NCT01376245|39244168|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
16208851|NCT01376245|39244169|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
16208852|NCT01376245|39244170|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
16208853|NCT01376245|39244166|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
16208854|NCT01376245|39244167|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
16208855|NCT01376245|39244168|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
16523885|NCT00254982|40387615|FG001|Overall Study|Lost to Follow-up|3|||
16523886|NCT00254982|40387614|FG000|Overall Study|Adverse Event|18|||
16327358|NCT03614078|39685302|FG001|Overall Study|Exacerbation of Psoriasis|1|||
16327359|NCT03614078|39685303|FG002|Overall Study|Exacerbation of Psoriasis|0|||
16208856|NCT01376245|39244169|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
16208857|NCT01376245|39244170|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
16208858|NCT01376245|39244166|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
16208859|NCT01376245|39244167|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
16208860|NCT01376245|39244168|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
16208861|NCT01376245|39244169|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
16208862|NCT01376245|39244170|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
16208863|NCT01376245|39244166|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
16208864|NCT01376245|39244167|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
16208865|NCT01376245|39244168|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
16208866|NCT01376245|39244169|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
16208867|NCT01376245|39244170|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
16208868|NCT01376245|39244166|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
16208869|NCT01376245|39244167|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
16208870|NCT01376245|39244168|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
16208871|NCT01376245|39244169|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
16208872|NCT01376245|39244170|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
16208873|NCT01376245|39244166|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
16208874|NCT01376245|39244167|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
16208875|NCT01376245|39244168|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
16208876|NCT01376245|39244169|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
16208877|NCT01376245|39244170|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
16208878|NCT01376245|39244166|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
16208879|NCT01376245|39244167|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
16208880|NCT01376245|39244168|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
16208881|NCT01376245|39244169|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
16208882|NCT01376245|39244170|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
16208883|NCT01376245|39244166|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
16208884|NCT01376245|39244167|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
16208885|NCT01376245|39244168|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
16208886|NCT01376245|39244169|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
16208887|NCT01376245|39244170|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
16208888|NCT01376245|39244166|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
16208889|NCT01376245|39244167|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
16208890|NCT01376245|39244168|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
16208891|NCT01376245|39244169|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
16208892|NCT01376245|39244170|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
16208893|NCT01376245|39244166|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16208894|NCT01376245|39244167|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
16208895|NCT01376245|39244168|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16208896|NCT01376245|39244169|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
16208897|NCT01376245|39244170|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
16327360|NCT03614078|39685301|FG000|Overall Study|Adverse Event|0|||
16327361|NCT03614078|39685302|FG001|Overall Study|Adverse Event|2|||
16327362|NCT03614078|39685303|FG002|Overall Study|Adverse Event|0|||
16327363|NCT03614078|39685301|FG000|Overall Study|Dizziness and Rash|0|||
16327364|NCT03614078|39685302|FG001|Overall Study|Dizziness and Rash|1|||
16327365|NCT03614078|39685303|FG002|Overall Study|Dizziness and Rash|0|||
16327366|NCT01944670|39685304|FG000|Overall Study|Lost to Follow-up|2|||
16327367|NCT00330343|39685307|FG000|Overall Study|Lost to Follow-up|5|||
16327368|NCT00658775|39685310|FG000|Overall Study|Adverse Event|4|||
16327369|NCT00658775|39685311|FG001|Overall Study|Adverse Event|6|||
16327370|NCT00658775|39685310|FG000|Overall Study|Lost to Follow-up|17|||
16327371|NCT00658775|39685311|FG001|Overall Study|Lost to Follow-up|18|||
16327372|NCT00658775|39685310|FG000|Overall Study|Withdrawal by Subject|6|||
16327373|NCT00658775|39685311|FG001|Overall Study|Withdrawal by Subject|4|||
16327374|NCT00658775|39685310|FG000|Overall Study|Withdrawal of consent|8|||
16327375|NCT00658775|39685311|FG001|Overall Study|Withdrawal of consent|7|||
16327376|NCT00658775|39685310|FG000|Overall Study|Other|7|||
16327377|NCT00658775|39685311|FG001|Overall Study|Other|8|||
16327378|NCT03962790|39685312|FG000|Period 1|Adverse Event|0|||
16327379|NCT03962790|39685313|FG001|Period 1|Adverse Event|1|||
16327380|NCT03962790|39685312|FG000|Period 1|Failed to meet all eligibility criteria|1|||
16327381|NCT03962790|39685313|FG001|Period 1|Failed to meet all eligibility criteria|1|||
16397386|NCT03162796|39935433|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
16327382|NCT03962790|39685312|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
16327383|NCT03962790|39685313|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
16327384|NCT03962790|39685312|FG000|Period 1|Withdrawal by Subject|1|||
16208898|NCT01376245|39244166|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
16208899|NCT01376245|39244167|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
16208900|NCT01376245|39244168|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
16208901|NCT01376245|39244169|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
16208902|NCT01376245|39244170|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
16208903|NCT01376245|39244166|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16208904|NCT01376245|39244167|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
16208905|NCT01376245|39244168|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
16208906|NCT01376245|39244169|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
16208907|NCT01376245|39244170|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
16208908|NCT00114218|39244176|FG000|Overall Study|Wrong Cell Type|2|||
16208909|NCT00114218|39244176|FG000|Overall Study|Wrong Primary|1|||
16208910|NCT00114218|39244176|FG000|Overall Study|Never Treated|1|||
16208911|NCT00423592|39244177|FG000|Overall Study|Adverse Event (through Week 12)|2|||
16208912|NCT00423592|39244177|FG000|Overall Study|Adverse Event (post Week 12)|5|||
16327385|NCT03962790|39685313|FG001|Period 1|Withdrawal by Subject|0|||
16327386|NCT01901653|39685314|FG000|Overall Study|Death|2|||
16327387|NCT01901653|39685315|FG001|Overall Study|Death|1|||
16327388|NCT01901653|39685316|FG002|Overall Study|Death|8|||
16327389|NCT01901653|39685317|FG003|Overall Study|Death|3|||
16327390|NCT01901653|39685318|FG004|Overall Study|Death|2|||
16208913|NCT01931150|39244178|FG000|Overall Study|Withdrawal by Subject|1|||
16208914|NCT01931150|39244179|FG001|Overall Study|Withdrawal by Subject|2|||
16208915|NCT01855945|39244180|FG000|Overall Study|Adverse Event|0|||
16208916|NCT01855945|39244181|FG001|Overall Study|Adverse Event|0|||
16208917|NCT01855945|39244182|FG002|Overall Study|Adverse Event|0|||
16208918|NCT01855945|39244183|FG003|Overall Study|Adverse Event|0|||
16208919|NCT01855945|39244184|FG004|Overall Study|Adverse Event|0|||
16208920|NCT01855945|39244185|FG005|Overall Study|Adverse Event|0|||
16208921|NCT01855945|39244186|FG006|Overall Study|Adverse Event|1|||
16208922|NCT01855945|39244187|FG007|Overall Study|Adverse Event|0|||
16208923|NCT01855945|39244188|FG008|Overall Study|Adverse Event|0|||
16208924|NCT01855945|39244189|FG009|Overall Study|Adverse Event|0|||
16208925|NCT01855945|39244190|FG010|Overall Study|Adverse Event|0|||
16208926|NCT01855945|39244191|FG011|Overall Study|Adverse Event|0|||
16208927|NCT01855945|39244180|FG000|Overall Study|Death|0|||
16208928|NCT01855945|39244181|FG001|Overall Study|Death|0|||
16208929|NCT01855945|39244182|FG002|Overall Study|Death|0|||
16208930|NCT01855945|39244183|FG003|Overall Study|Death|0|||
16208931|NCT01855945|39244184|FG004|Overall Study|Death|0|||
16208932|NCT01855945|39244185|FG005|Overall Study|Death|0|||
16208933|NCT01855945|39244186|FG006|Overall Study|Death|2|||
16208934|NCT01855945|39244187|FG007|Overall Study|Death|0|||
16208935|NCT01855945|39244188|FG008|Overall Study|Death|0|||
16208936|NCT01855945|39244189|FG009|Overall Study|Death|0|||
16208937|NCT01855945|39244190|FG010|Overall Study|Death|0|||
16208938|NCT01855945|39244191|FG011|Overall Study|Death|0|||
16208939|NCT01855945|39244180|FG000|Overall Study|Lost to Follow-up|11|||
16208940|NCT01855945|39244181|FG001|Overall Study|Lost to Follow-up|10|||
16208941|NCT01855945|39244182|FG002|Overall Study|Lost to Follow-up|7|||
16208942|NCT01855945|39244183|FG003|Overall Study|Lost to Follow-up|3|||
16208943|NCT01855945|39244184|FG004|Overall Study|Lost to Follow-up|0|||
16208944|NCT01855945|39244185|FG005|Overall Study|Lost to Follow-up|3|||
16327391|NCT01901653|39685319|FG005|Overall Study|Death|2|||
16327392|NCT01901653|39685320|FG006|Overall Study|Death|6|||
16095787|NCT03672188|38842588|FG006|Overall Study|Lost to Follow-up|0|||
16208945|NCT01855945|39244186|FG006|Overall Study|Lost to Follow-up|4|||
16208946|NCT01855945|39244187|FG007|Overall Study|Lost to Follow-up|7|||
16208947|NCT01855945|39244188|FG008|Overall Study|Lost to Follow-up|2|||
16208948|NCT01855945|39244189|FG009|Overall Study|Lost to Follow-up|0|||
16208949|NCT01855945|39244190|FG010|Overall Study|Lost to Follow-up|0|||
16208950|NCT01855945|39244191|FG011|Overall Study|Lost to Follow-up|2|||
16208951|NCT01855945|39244180|FG000|Overall Study|Other - Unclassified|1|||
16208952|NCT01855945|39244181|FG001|Overall Study|Other - Unclassified|1|||
16327393|NCT01901653|39685321|FG007|Overall Study|Death|9|||
16327394|NCT01901653|39685322|FG008|Overall Study|Death|1|||
16327395|NCT01901653|39685323|FG009|Overall Study|Death|16|||
16208953|NCT01855945|39244182|FG002|Overall Study|Other - Unclassified|1|||
16208954|NCT01855945|39244183|FG003|Overall Study|Other - Unclassified|0|||
16208955|NCT01855945|39244184|FG004|Overall Study|Other - Unclassified|0|||
16208956|NCT01855945|39244185|FG005|Overall Study|Other - Unclassified|0|||
16208957|NCT01855945|39244186|FG006|Overall Study|Other - Unclassified|2|||
16208958|NCT01855945|39244187|FG007|Overall Study|Other - Unclassified|1|||
16208959|NCT01855945|39244188|FG008|Overall Study|Other - Unclassified|0|||
16208960|NCT01855945|39244189|FG009|Overall Study|Other - Unclassified|0|||
16208961|NCT01855945|39244190|FG010|Overall Study|Other - Unclassified|1|||
16208962|NCT01855945|39244191|FG011|Overall Study|Other - Unclassified|0|||
16208963|NCT01855945|39244180|FG000|Overall Study|Withdrawal by Subject|4|||
16208964|NCT01855945|39244181|FG001|Overall Study|Withdrawal by Subject|0|||
16208965|NCT01855945|39244182|FG002|Overall Study|Withdrawal by Subject|4|||
16208966|NCT01855945|39244183|FG003|Overall Study|Withdrawal by Subject|1|||
16208967|NCT01855945|39244184|FG004|Overall Study|Withdrawal by Subject|1|||
16208968|NCT01855945|39244185|FG005|Overall Study|Withdrawal by Subject|0|||
16208969|NCT01855945|39244186|FG006|Overall Study|Withdrawal by Subject|1|||
16208970|NCT01855945|39244187|FG007|Overall Study|Withdrawal by Subject|0|||
16208971|NCT01855945|39244188|FG008|Overall Study|Withdrawal by Subject|0|||
16208972|NCT01855945|39244189|FG009|Overall Study|Withdrawal by Subject|2|||
16208973|NCT01855945|39244190|FG010|Overall Study|Withdrawal by Subject|4|||
16208974|NCT01855945|39244191|FG011|Overall Study|Withdrawal by Subject|1|||
16208975|NCT00562640|39244192|FG000|Overall Study|Death|0|||
16208976|NCT00562640|39244193|FG001|Overall Study|Death|1|||
16208977|NCT00562640|39244194|FG002|Overall Study|Death|1|||
16208978|NCT00562640|39244195|FG003|Overall Study|Death|0|||
16208979|NCT04018612|39244202|FG000|Overall Study|Withdrawal by Subject|1|||
16208980|NCT04018612|39244203|FG001|Overall Study|Withdrawal by Subject|0|||
16208981|NCT04018612|39244204|FG002|Overall Study|Withdrawal by Subject|1|||
16327396|NCT01901653|39685324|FG010|Overall Study|Death|2|||
16327397|NCT01901653|39685325|FG011|Overall Study|Death|15|||
16327398|NCT01901653|39685326|FG012|Overall Study|Death|4|||
16327399|NCT01901653|39685314|FG000|Overall Study|Lost to Follow-up|1|||
16327400|NCT01901653|39685315|FG001|Overall Study|Lost to Follow-up|0|||
16327401|NCT01901653|39685316|FG002|Overall Study|Lost to Follow-up|2|||
16327402|NCT01901653|39685317|FG003|Overall Study|Lost to Follow-up|0|||
16327403|NCT01901653|39685318|FG004|Overall Study|Lost to Follow-up|0|||
16327404|NCT01901653|39685319|FG005|Overall Study|Lost to Follow-up|1|||
16327405|NCT01901653|39685320|FG006|Overall Study|Lost to Follow-up|0|||
16327406|NCT01901653|39685321|FG007|Overall Study|Lost to Follow-up|1|||
16327407|NCT01901653|39685322|FG008|Overall Study|Lost to Follow-up|0|||
16327408|NCT01901653|39685323|FG009|Overall Study|Lost to Follow-up|0|||
16327409|NCT01901653|39685324|FG010|Overall Study|Lost to Follow-up|0|||
16327410|NCT01901653|39685325|FG011|Overall Study|Lost to Follow-up|0|||
16327411|NCT01901653|39685326|FG012|Overall Study|Lost to Follow-up|0|||
16327412|NCT01901653|39685314|FG000|Overall Study|Withdrawal by Subject|0|||
16327413|NCT01901653|39685315|FG001|Overall Study|Withdrawal by Subject|0|||
16327414|NCT01901653|39685316|FG002|Overall Study|Withdrawal by Subject|0|||
16327415|NCT01901653|39685317|FG003|Overall Study|Withdrawal by Subject|0|||
16327416|NCT01901653|39685318|FG004|Overall Study|Withdrawal by Subject|0|||
16327417|NCT01901653|39685319|FG005|Overall Study|Withdrawal by Subject|0|||
16327418|NCT01901653|39685320|FG006|Overall Study|Withdrawal by Subject|1|||
16327419|NCT01901653|39685321|FG007|Overall Study|Withdrawal by Subject|0|||
16327420|NCT01901653|39685322|FG008|Overall Study|Withdrawal by Subject|0|||
16327421|NCT01901653|39685323|FG009|Overall Study|Withdrawal by Subject|0|||
16327422|NCT01901653|39685324|FG010|Overall Study|Withdrawal by Subject|0|||
16327423|NCT01901653|39685325|FG011|Overall Study|Withdrawal by Subject|0|||
16327424|NCT01901653|39685326|FG012|Overall Study|Withdrawal by Subject|0|||
16327425|NCT01901653|39685314|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
16327426|NCT01901653|39685315|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
16327427|NCT01901653|39685316|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
16327428|NCT01901653|39685317|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
16327429|NCT01901653|39685318|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
16327430|NCT01901653|39685319|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
16327431|NCT01901653|39685320|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
16208982|NCT00804986|39244205|FG000|Overall Study|Adverse Event|0|||
16208983|NCT00804986|39244206|FG001|Overall Study|Adverse Event|1|||
16208984|NCT00804986|39244207|FG002|Overall Study|Adverse Event|2|||
16327432|NCT01901653|39685321|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
16327433|NCT01901653|39685322|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
16327434|NCT01901653|39685323|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
16327435|NCT01901653|39685324|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
16327436|NCT01901653|39685325|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
16327437|NCT01901653|39685326|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
16327438|NCT01054300|39685327|FG000|Period 1|Adverse Event|1|||
16327439|NCT01054300|39685328|FG001|Period 1|Adverse Event|0|||
16327440|NCT01054300|39685329|FG002|Period 1|Adverse Event|0|||
16327441|NCT01054300|39685330|FG003|Period 1|Adverse Event|0|||
16327442|NCT01054300|39685327|FG000|Period 2|Withdrawal by Subject|0|||
16327443|NCT01054300|39685328|FG001|Period 2|Withdrawal by Subject|0|||
16327444|NCT01054300|39685329|FG002|Period 2|Withdrawal by Subject|1|||
16327445|NCT01054300|39685330|FG003|Period 2|Withdrawal by Subject|0|||
16327446|NCT02968433|39685332|FG000|Overall Study|Withdrawal by Subject|1|||
16327447|NCT00954512|39685343|FG000|Overall Study|Withdrawal by Subject|0|||
16327448|NCT00954512|39685344|FG001|Overall Study|Withdrawal by Subject|0|||
16327449|NCT00954512|39685345|FG002|Overall Study|Withdrawal by Subject|0|||
16327450|NCT00954512|39685346|FG003|Overall Study|Withdrawal by Subject|0|||
16327451|NCT00954512|39685347|FG004|Overall Study|Withdrawal by Subject|0|||
16327452|NCT00954512|39685348|FG005|Overall Study|Withdrawal by Subject|1|||
16327453|NCT00954512|39685343|FG000|Overall Study|Adverse Event|0|||
16327454|NCT00954512|39685344|FG001|Overall Study|Adverse Event|0|||
16327455|NCT00954512|39685345|FG002|Overall Study|Adverse Event|0|||
16327456|NCT00954512|39685346|FG003|Overall Study|Adverse Event|0|||
16327457|NCT00954512|39685347|FG004|Overall Study|Adverse Event|1|||
16327458|NCT00954512|39685348|FG005|Overall Study|Adverse Event|2|||
16327459|NCT00954512|39685343|FG000|Overall Study|Physician Decision|0|||
16327460|NCT00954512|39685344|FG001|Overall Study|Physician Decision|1|||
16327461|NCT00954512|39685345|FG002|Overall Study|Physician Decision|0|||
16327462|NCT00954512|39685346|FG003|Overall Study|Physician Decision|1|||
16208985|NCT00804986|39244208|FG003|Overall Study|Adverse Event|1|||
16208986|NCT00804986|39244209|FG004|Overall Study|Adverse Event|3|||
16208987|NCT00804986|39244210|FG005|Overall Study|Adverse Event|0|||
16208988|NCT00804986|39244205|FG000|Overall Study|Lack of Efficacy|0|||
16208989|NCT00804986|39244206|FG001|Overall Study|Lack of Efficacy|0|||
16208990|NCT00804986|39244207|FG002|Overall Study|Lack of Efficacy|0|||
16327463|NCT00954512|39685347|FG004|Overall Study|Physician Decision|0|||
16327464|NCT00954512|39685348|FG005|Overall Study|Physician Decision|0|||
16327465|NCT00954512|39685343|FG000|Overall Study|Symptomatic Deterioration|0|||
16327466|NCT00954512|39685344|FG001|Overall Study|Symptomatic Deterioration|1|||
16327467|NCT00954512|39685345|FG002|Overall Study|Symptomatic Deterioration|0|||
16327468|NCT00954512|39685346|FG003|Overall Study|Symptomatic Deterioration|0|||
16327469|NCT00954512|39685347|FG004|Overall Study|Symptomatic Deterioration|2|||
16327470|NCT00954512|39685348|FG005|Overall Study|Symptomatic Deterioration|0|||
16327471|NCT00954512|39685343|FG000|Overall Study|Progression of Disease|2|||
16327472|NCT00954512|39685344|FG001|Overall Study|Progression of Disease|1|||
16327473|NCT00954512|39685345|FG002|Overall Study|Progression of Disease|0|||
16327474|NCT00954512|39685346|FG003|Overall Study|Progression of Disease|1|||
16327475|NCT00954512|39685347|FG004|Overall Study|Progression of Disease|1|||
16327476|NCT00954512|39685348|FG005|Overall Study|Progression of Disease|1|||
16327477|NCT00782184|39685350|FG000|Overall Study|Adverse Event|1|||
16327478|NCT00782184|39685351|FG001|Overall Study|Adverse Event|2|||
16327479|NCT00782184|39685350|FG000|Overall Study|Protocol Violation|0|||
16327480|NCT00782184|39685351|FG001|Overall Study|Protocol Violation|1|||
16327481|NCT00782184|39685350|FG000|Overall Study|Withdrawal by Subject|3|||
16327482|NCT00782184|39685351|FG001|Overall Study|Withdrawal by Subject|2|||
16327483|NCT03721835|39685352|FG000|Overall Study|Participant not able to return|1|||
16327484|NCT03721835|39685352|FG000|Overall Study|Lost to Follow-up|1|||
16327485|NCT03721835|39685352|FG000|Overall Study|Revision of the components of the study device|2|||
16327486|NCT03721835|39685352|FG000|Overall Study|Sponsor terminated study|6|||
16327487|NCT03721835|39685352|FG000|Overall Study|Death|1|||
16327488|NCT03721835|39685352|FG000|Overall Study|Sponsor decision|1|||
16327489|NCT00631410|39685353|FG000|Overall Study|Adverse Event|1|||
16327490|NCT00631410|39685354|FG001|Overall Study|Adverse Event|3|||
16327491|NCT00631410|39685353|FG000|Overall Study|Objective Progression or Relapse|4|||
16327492|NCT00631410|39685354|FG001|Overall Study|Objective Progression or Relapse|3|||
16327493|NCT00631410|39685353|FG000|Overall Study|Surgery|1|||
16095788|NCT03672188|38842589|FG007|Overall Study|Lost to Follow-up|0|||
16327494|NCT00631410|39685354|FG001|Overall Study|Surgery|0|||
16327495|NCT00380081|39685357|FG000|Overall Study|Withdrawal by Subject|0|||
16095789|NCT03672188|38842590|FG008|Overall Study|Lost to Follow-up|0|||
16095790|NCT03672188|38842591|FG009|Overall Study|Lost to Follow-up|0|||
16327496|NCT00380081|39685358|FG001|Overall Study|Withdrawal by Subject|0|||
16327497|NCT00380081|39685359|FG002|Overall Study|Withdrawal by Subject|0|||
16327498|NCT00380081|39685360|FG003|Overall Study|Withdrawal by Subject|0|||
16327499|NCT00380081|39685361|FG004|Overall Study|Withdrawal by Subject|1|||
16327500|NCT00380081|39685362|FG005|Overall Study|Withdrawal by Subject|0|||
16327501|NCT00380081|39685357|FG000|Overall Study|Family Emergency|0|||
16327502|NCT00380081|39685358|FG001|Overall Study|Family Emergency|0|||
16327503|NCT00380081|39685359|FG002|Overall Study|Family Emergency|0|||
16208991|NCT00804986|39244208|FG003|Overall Study|Lack of Efficacy|1|||
16327504|NCT00380081|39685360|FG003|Overall Study|Family Emergency|0|||
16327505|NCT00380081|39685361|FG004|Overall Study|Family Emergency|0|||
16327506|NCT00380081|39685362|FG005|Overall Study|Family Emergency|1|||
16327507|NCT02693171|39685365|FG000|Overall Study|Adverse Event|1|||
16327508|NCT02693171|39685365|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
16327509|NCT04590586|39685366|FG000|Overall Study|Death|7|||
16327510|NCT04590586|39685367|FG001|Overall Study|Death|1|||
16327511|NCT04590586|39685368|FG002|Overall Study|Death|37|||
16327512|NCT04590586|39685369|FG003|Overall Study|Death|34|||
16327513|NCT04590586|39685370|FG004|Overall Study|Death|19|||
16327514|NCT04590586|39685371|FG005|Overall Study|Death|3|||
16327515|NCT04590586|39685366|FG000|Overall Study|Lost to Follow-up|3|||
16327516|NCT04590586|39685367|FG001|Overall Study|Lost to Follow-up|0|||
16327517|NCT04590586|39685368|FG002|Overall Study|Lost to Follow-up|11|||
16327518|NCT04590586|39685369|FG003|Overall Study|Lost to Follow-up|11|||
16327519|NCT04590586|39685370|FG004|Overall Study|Lost to Follow-up|6|||
16327520|NCT04590586|39685371|FG005|Overall Study|Lost to Follow-up|0|||
16327521|NCT04590586|39685366|FG000|Overall Study|Withdrawal by Subject|0|||
16327522|NCT04590586|39685367|FG001|Overall Study|Withdrawal by Subject|0|||
16327523|NCT04590586|39685368|FG002|Overall Study|Withdrawal by Subject|6|||
16327524|NCT04590586|39685369|FG003|Overall Study|Withdrawal by Subject|0|||
16327525|NCT04590586|39685370|FG004|Overall Study|Withdrawal by Subject|3|||
16327526|NCT04590586|39685371|FG005|Overall Study|Withdrawal by Subject|0|||
16327527|NCT04590586|39685366|FG000|Overall Study|Other|3|||
16327528|NCT04590586|39685367|FG001|Overall Study|Other|0|||
16327529|NCT04590586|39685368|FG002|Overall Study|Other|1|||
16327530|NCT04590586|39685369|FG003|Overall Study|Other|1|||
16327531|NCT04590586|39685370|FG004|Overall Study|Other|2|||
16327532|NCT04590586|39685371|FG005|Overall Study|Other|1|||
16327533|NCT01936181|39685372|FG000|Randomised, Double-blind|Adverse Event|27|||
16327534|NCT01936181|39685373|FG001|Randomised, Double-blind|Adverse Event|21|||
16327535|NCT01936181|39685374|FG002|Randomised, Double-blind|Adverse Event|0|||
16327536|NCT01936181|39685375|FG003|Randomised, Double-blind|Adverse Event|0|||
16095791|NCT03672188|38842592|FG010|Overall Study|Lost to Follow-up|0|||
16095792|NCT03672188|38842593|FG011|Overall Study|Lost to Follow-up|0|||
16095793|NCT03672188|38842594|FG012|Overall Study|Lost to Follow-up|0|||
16095794|NCT03672188|38842595|FG013|Overall Study|Lost to Follow-up|0|||
16095795|NCT03672188|38842596|FG014|Overall Study|Lost to Follow-up|0|||
16095796|NCT02812706|38842597|FG000|Phase 1|Adverse Event|0|||
16208992|NCT00804986|39244209|FG004|Overall Study|Lack of Efficacy|0|||
16327537|NCT01936181|39685372|FG000|Randomised, Double-blind|Protocol Violation|1|||
16327538|NCT01936181|39685373|FG001|Randomised, Double-blind|Protocol Violation|5|||
16327539|NCT01936181|39685374|FG002|Randomised, Double-blind|Protocol Violation|0|||
16327540|NCT01936181|39685375|FG003|Randomised, Double-blind|Protocol Violation|0|||
16327541|NCT01936181|39685372|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
16327542|NCT01936181|39685373|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
16327543|NCT01936181|39685374|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
16327544|NCT01936181|39685375|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
16327545|NCT01936181|39685372|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
16327546|NCT01936181|39685373|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
16327547|NCT01936181|39685374|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
16327548|NCT01936181|39685375|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
16327549|NCT01936181|39685372|FG000|Randomised, Double-blind|Pregnancy|0|||
16327550|NCT01936181|39685373|FG001|Randomised, Double-blind|Pregnancy|1|||
16327551|NCT01936181|39685374|FG002|Randomised, Double-blind|Pregnancy|0|||
16327552|NCT01936181|39685375|FG003|Randomised, Double-blind|Pregnancy|0|||
16327553|NCT01936181|39685372|FG000|Randomised, Double-blind|Physician Decision|4|||
16327554|NCT01936181|39685373|FG001|Randomised, Double-blind|Physician Decision|4|||
16327555|NCT01936181|39685374|FG002|Randomised, Double-blind|Physician Decision|0|||
16327556|NCT01936181|39685375|FG003|Randomised, Double-blind|Physician Decision|0|||
16327557|NCT01936181|39685372|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
16327558|NCT01936181|39685373|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
16327559|NCT01936181|39685374|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
16327560|NCT01936181|39685375|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
16327561|NCT01936181|39685372|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
16327562|NCT01936181|39685373|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
16327563|NCT01936181|39685374|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
16327564|NCT01936181|39685375|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
16327565|NCT01936181|39685372|FG000|Transition-extension|Adverse Event|3|||
16327566|NCT01936181|39685373|FG001|Transition-extension|Adverse Event|0|||
16327567|NCT01936181|39685374|FG002|Transition-extension|Adverse Event|3|||
16327568|NCT01936181|39685375|FG003|Transition-extension|Adverse Event|1|||
16327569|NCT01936181|39685372|FG000|Transition-extension|Lost to Follow-up|3|||
16327570|NCT01936181|39685373|FG001|Transition-extension|Lost to Follow-up|0|||
16397387|NCT03162796|39935434|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
16095797|NCT02812706|38842598|FG001|Phase 1|Adverse Event|2|||
16327571|NCT01936181|39685374|FG002|Transition-extension|Lost to Follow-up|1|||
16327572|NCT01936181|39685375|FG003|Transition-extension|Lost to Follow-up|2|||
16327573|NCT01936181|39685372|FG000|Transition-extension|Physician Decision|2|||
16208993|NCT00804986|39244210|FG005|Overall Study|Lack of Efficacy|3|||
16208994|NCT00804986|39244205|FG000|Overall Study|Lost to Follow-up|0|||
16208995|NCT00804986|39244206|FG001|Overall Study|Lost to Follow-up|0|||
16208996|NCT00804986|39244207|FG002|Overall Study|Lost to Follow-up|0|||
16208997|NCT00804986|39244208|FG003|Overall Study|Lost to Follow-up|1|||
16208998|NCT00804986|39244209|FG004|Overall Study|Lost to Follow-up|1|||
16208999|NCT00804986|39244210|FG005|Overall Study|Lost to Follow-up|3|||
16209000|NCT00804986|39244205|FG000|Overall Study|Protocol Violation|0|||
16209001|NCT00804986|39244206|FG001|Overall Study|Protocol Violation|1|||
16209002|NCT00804986|39244207|FG002|Overall Study|Protocol Violation|0|||
16209003|NCT00804986|39244208|FG003|Overall Study|Protocol Violation|1|||
16209004|NCT00804986|39244209|FG004|Overall Study|Protocol Violation|0|||
16209005|NCT00804986|39244210|FG005|Overall Study|Protocol Violation|0|||
16209006|NCT00804986|39244205|FG000|Overall Study|Withdrawal by Subject|0|||
16209007|NCT00804986|39244206|FG001|Overall Study|Withdrawal by Subject|3|||
16209008|NCT00804986|39244207|FG002|Overall Study|Withdrawal by Subject|0|||
16209009|NCT00804986|39244208|FG003|Overall Study|Withdrawal by Subject|3|||
16209010|NCT00804986|39244209|FG004|Overall Study|Withdrawal by Subject|5|||
16209011|NCT00804986|39244210|FG005|Overall Study|Withdrawal by Subject|3|||
16209012|NCT00804986|39244205|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
16209013|NCT00804986|39244206|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
16209014|NCT00804986|39244207|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
16209015|NCT00804986|39244208|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
16209016|NCT00804986|39244209|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
16209017|NCT00804986|39244210|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
16209018|NCT00804986|39244205|FG000|Overall Study|Sponsor Decision|0|||
16209019|NCT00804986|39244206|FG001|Overall Study|Sponsor Decision|1|||
16209020|NCT00804986|39244207|FG002|Overall Study|Sponsor Decision|0|||
16209021|NCT00804986|39244208|FG003|Overall Study|Sponsor Decision|0|||
16209022|NCT00804986|39244209|FG004|Overall Study|Sponsor Decision|0|||
16209023|NCT00804986|39244210|FG005|Overall Study|Sponsor Decision|0|||
16209024|NCT00804986|39244205|FG000|Overall Study|Physician Decision|1|||
16209025|NCT00804986|39244206|FG001|Overall Study|Physician Decision|0|||
16209026|NCT00804986|39244207|FG002|Overall Study|Physician Decision|0|||
16209027|NCT00804986|39244208|FG003|Overall Study|Physician Decision|0|||
16209028|NCT00804986|39244209|FG004|Overall Study|Physician Decision|0|||
16209029|NCT00804986|39244210|FG005|Overall Study|Physician Decision|0|||
16209030|NCT02033850|39244211|FG000|Overall Study|Death|1|||
16209031|NCT02033850|39244212|FG001|Overall Study|Death|0|||
16209032|NCT02033850|39244211|FG000|Overall Study|unrelated medical reason|1|||
16209033|NCT02033850|39244212|FG001|Overall Study|unrelated medical reason|1|||
16209034|NCT00880100|39244213|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
16209035|NCT00880100|39244213|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
16209036|NCT00880100|39244213|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
16209037|NCT01055457|39244218|FG000|Overall Study|Lost to Follow-up|0|||
16209038|NCT01055457|39244219|FG001|Overall Study|Lost to Follow-up|1|||
16209039|NCT01055457|39244220|FG002|Overall Study|Lost to Follow-up|0|||
16209040|NCT01055457|39244221|FG003|Overall Study|Lost to Follow-up|0|||
16209041|NCT01055457|39244222|FG004|Overall Study|Lost to Follow-up|0|||
16209042|NCT01055457|39244223|FG005|Overall Study|Lost to Follow-up|1|||
16209043|NCT01055457|39244224|FG006|Overall Study|Lost to Follow-up|0|||
16209044|NCT01055457|39244225|FG007|Overall Study|Lost to Follow-up|0|||
16209045|NCT01055457|39244226|FG008|Overall Study|Lost to Follow-up|0|||
16209046|NCT01055457|39244227|FG009|Overall Study|Lost to Follow-up|0|||
16209047|NCT01055457|39244218|FG000|Overall Study|Protocol Violation|0|||
16209048|NCT01055457|39244219|FG001|Overall Study|Protocol Violation|0|||
16209049|NCT01055457|39244220|FG002|Overall Study|Protocol Violation|1|||
16209050|NCT01055457|39244221|FG003|Overall Study|Protocol Violation|1|||
16209051|NCT01055457|39244222|FG004|Overall Study|Protocol Violation|1|||
16209052|NCT01055457|39244223|FG005|Overall Study|Protocol Violation|2|||
16209053|NCT01055457|39244224|FG006|Overall Study|Protocol Violation|1|||
16209054|NCT01055457|39244225|FG007|Overall Study|Protocol Violation|0|||
16209055|NCT01055457|39244226|FG008|Overall Study|Protocol Violation|0|||
16209056|NCT01055457|39244227|FG009|Overall Study|Protocol Violation|1|||
16209057|NCT01055457|39244218|FG000|Overall Study|Subject Disinterest|0|||
16209058|NCT01055457|39244219|FG001|Overall Study|Subject Disinterest|0|||
16327574|NCT01936181|39685373|FG001|Transition-extension|Physician Decision|0|||
16327575|NCT01936181|39685374|FG002|Transition-extension|Physician Decision|0|||
16327576|NCT01936181|39685375|FG003|Transition-extension|Physician Decision|1|||
16095798|NCT02812706|38842599|FG002|Phase 1|Adverse Event|0|||
16095799|NCT02812706|38842597|FG000|Phase 1|Progressive disease|3|||
16209059|NCT01055457|39244220|FG002|Overall Study|Subject Disinterest|0|||
16209060|NCT01055457|39244221|FG003|Overall Study|Subject Disinterest|0|||
16095800|NCT02812706|38842598|FG001|Phase 1|Progressive disease|3|||
16095801|NCT02812706|38842599|FG002|Phase 1|Progressive disease|0|||
16095802|NCT02812706|38842597|FG000|Phase 2|Adverse Event|0|||
16095803|NCT02812706|38842598|FG001|Phase 2|Adverse Event|0|||
16095804|NCT02812706|38842599|FG002|Phase 2|Adverse Event|2|||
16095805|NCT02812706|38842597|FG000|Phase 2|Progressive disease|0|||
16095806|NCT02812706|38842598|FG001|Phase 2|Progressive disease|0|||
16095807|NCT02812706|38842599|FG002|Phase 2|Progressive disease|22|||
16327577|NCT01936181|39685372|FG000|Transition-extension|Withdrawal by Subject|7|||
16327578|NCT01936181|39685373|FG001|Transition-extension|Withdrawal by Subject|0|||
16327579|NCT01936181|39685374|FG002|Transition-extension|Withdrawal by Subject|2|||
16327580|NCT01936181|39685375|FG003|Transition-extension|Withdrawal by Subject|1|||
16327581|NCT00723255|39685376|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
16327582|NCT00723255|39685376|FG000|Overall Study|Ineligible: Second primary|1|||
16327583|NCT00723255|39685376|FG000|Overall Study|Ineligible: Wrong Primary|2|||
16327584|NCT03467763|39685379|FG000|Overall Study|Lost to Follow-up|1|||
16327585|NCT03467763|39685379|FG000|Overall Study|Protocol Violation|2|||
16327586|NCT01806961|39685397|FG000|Overall Study|sponsor decision|16|||
16327587|NCT03533114|39685398|FG000|Overall|Adverse Event|16|||
16327588|NCT03533114|39685399|FG001|Overall|Adverse Event|11|||
16327589|NCT03533114|39685398|FG000|Overall|Consent Withdrawal by Participant|7|||
16327590|NCT03533114|39685399|FG001|Overall|Consent Withdrawal by Participant|6|||
16327591|NCT03533114|39685398|FG000|Overall|Lack of Efficacy|5|||
16327592|NCT03533114|39685399|FG001|Overall|Lack of Efficacy|3|||
16327593|NCT03533114|39685398|FG000|Overall|Lost to Follow-up|1|||
16327594|NCT03533114|39685399|FG001|Overall|Lost to Follow-up|1|||
16327595|NCT03533114|39685398|FG000|Overall|Physician Decision|0|||
16327596|NCT03533114|39685399|FG001|Overall|Physician Decision|2|||
16327597|NCT03533114|39685398|FG000|Overall|Protocol deviation|1|||
16327598|NCT03533114|39685399|FG001|Overall|Protocol deviation|1|||
16327599|NCT03533114|39685398|FG000|Overall|Failure to meet randomization criteria|1|||
16327600|NCT03533114|39685399|FG001|Overall|Failure to meet randomization criteria|2|||
16327601|NCT03533114|39685398|FG000|Overall|Non-Compliance with study drug|0|||
16327602|NCT03533114|39685399|FG001|Overall|Non-Compliance with study drug|1|||
16327603|NCT03533114|39685398|FG000|Overall|Other|0|||
16327604|NCT03533114|39685399|FG001|Overall|Other|1|||
16327605|NCT03533114|39685398|FG000|Open Label Titration and Optimization|Adverse Event|11|||
16523887|NCT00254982|40387615|FG001|Overall Study|Adverse Event|16|||
16523888|NCT00254982|40387614|FG000|Overall Study|Withdrawal by Subject|1|||
16523889|NCT00254982|40387615|FG001|Overall Study|Withdrawal by Subject|1|||
16523890|NCT00254982|40387614|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
16523891|NCT00254982|40387615|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
16095808|NCT02812706|38842597|FG000|Phase 2|Other-Unspecified|0|||
16523892|NCT00254982|40387614|FG000|Overall Study|Protocol deviation|1|||
16523893|NCT00254982|40387615|FG001|Overall Study|Protocol deviation|1|||
16095809|NCT02812706|38842598|FG001|Phase 2|Other-Unspecified|0|||
16327606|NCT03533114|39685399|FG001|Open Label Titration and Optimization|Adverse Event|8|||
16327607|NCT03533114|39685398|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
16327608|NCT03533114|39685399|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
16327609|NCT03533114|39685398|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
16327610|NCT03533114|39685399|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
16327611|NCT03533114|39685398|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
16327612|NCT03533114|39685399|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
16327613|NCT03533114|39685398|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
16327614|NCT03533114|39685399|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
16327615|NCT03533114|39685398|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
16327616|NCT03533114|39685399|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
16327617|NCT03533114|39685398|FG000|Stable Dose|Adverse Event|0|||
16327618|NCT03533114|39685399|FG001|Stable Dose|Adverse Event|2|||
16327619|NCT03533114|39685398|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
16327620|NCT03533114|39685399|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
16327621|NCT03533114|39685398|FG000|Stable Dose|Lack of Efficacy|1|||
16327622|NCT03533114|39685399|FG001|Stable Dose|Lack of Efficacy|0|||
16327623|NCT03533114|39685398|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
16327624|NCT03533114|39685399|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
16327625|NCT03533114|39685398|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
16327626|NCT03533114|39685399|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
16327627|NCT03533114|39685398|FG000|Open-Label Safety Extension|Adverse Event|3|||
16327628|NCT03533114|39685399|FG001|Open-Label Safety Extension|Adverse Event|0|||
16327629|NCT03533114|39685398|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
16327630|NCT03533114|39685399|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
16523894|NCT00254982|40387614|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
16095810|NCT02812706|38842599|FG002|Phase 2|Other-Unspecified|4|||
16095811|NCT00441168|38842600|FG000|Treatment Period|Death|3|||
16327631|NCT03533114|39685398|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
16327632|NCT03533114|39685399|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
16327633|NCT03533114|39685398|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
16327634|NCT03533114|39685399|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
16327635|NCT03533114|39685398|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
16327636|NCT03533114|39685399|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
16095812|NCT00441168|38842601|FG001|Treatment Period|Death|0|||
16095813|NCT00441168|38842600|FG000|Treatment Period|Adverse Event|1|||
16523895|NCT00254982|40387615|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
16523896|NCT00254982|40387614|FG000|Overall Study|Malignancy|0|||
16523897|NCT00254982|40387615|FG001|Overall Study|Malignancy|2|||
16523898|NCT00254982|40387614|FG000|Overall Study|Opportunistic infection|1|||
16523899|NCT00254982|40387615|FG001|Overall Study|Opportunistic infection|0|||
16523900|NCT00254982|40387614|FG000|Overall Study|Abnormal liver function tests|2|||
16523901|NCT00254982|40387615|FG001|Overall Study|Abnormal liver function tests|1|||
16523902|NCT00047463|40387616|FG000|Overall Study|Withdrawal by Subject|0|||
16523903|NCT00047463|40387617|FG001|Overall Study|Withdrawal by Subject|3|||
16523904|NCT00113516|40387622|FG000|Part 1|Adverse Event|6|||
16523905|NCT00113516|40387623|FG001|Part 1|Adverse Event|0|||
16523906|NCT00113516|40387622|FG000|Part 1|Death|3|||
16523907|NCT00113516|40387623|FG001|Part 1|Death|0|||
16523908|NCT00113516|40387622|FG000|Part 1|Other|3|||
16523909|NCT00113516|40387623|FG001|Part 1|Other|0|||
16523910|NCT00113516|40387622|FG000|Part 1|Withdrawal by Subject|2|||
16523911|NCT00113516|40387623|FG001|Part 1|Withdrawal by Subject|0|||
16523912|NCT00113516|40387622|FG000|Part 1|Lack of Efficacy|2|||
16523913|NCT00113516|40387623|FG001|Part 1|Lack of Efficacy|0|||
16523914|NCT00113516|40387622|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
16523915|NCT00113516|40387623|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
16523916|NCT00113516|40387622|FG000|Part 1|Laboratory Abnormality|1|||
16523917|NCT00113516|40387623|FG001|Part 1|Laboratory Abnormality|0|||
16523918|NCT00113516|40387622|FG000|Part 1|Ongoing|1|||
16523919|NCT00113516|40387623|FG001|Part 1|Ongoing|0|||
16523920|NCT00113516|40387622|FG000|Part 1|Missing|65|||
16523921|NCT00113516|40387623|FG001|Part 1|Missing|0|||
16523922|NCT00113516|40387622|FG000|Part 2|Adverse Event|0|||
16523923|NCT00113516|40387623|FG001|Part 2|Adverse Event|16|||
16523924|NCT00113516|40387622|FG000|Part 2|Death|0|||
16523925|NCT00113516|40387623|FG001|Part 2|Death|5|||
16327637|NCT00537316|39685400|FG000|Part 1|Adverse Event|7|||
16327638|NCT00537316|39685401|FG001|Part 1|Adverse Event|11|||
16327639|NCT00537316|39685402|FG002|Part 1|Adverse Event|8|||
16327640|NCT00537316|39685403|FG003|Part 1|Adverse Event|0|||
16095814|NCT00441168|38842601|FG001|Treatment Period|Adverse Event|2|||
16327641|NCT00537316|39685404|FG004|Part 1|Adverse Event|0|||
16327642|NCT00537316|39685405|FG005|Part 1|Adverse Event|0|||
16327643|NCT00537316|39685406|FG006|Part 1|Adverse Event|0|||
16327644|NCT00537316|39685400|FG000|Part 1|Protocol defined clinical event|1|||
16327645|NCT00537316|39685401|FG001|Part 1|Protocol defined clinical event|0|||
16327646|NCT00537316|39685402|FG002|Part 1|Protocol defined clinical event|0|||
16327647|NCT00537316|39685403|FG003|Part 1|Protocol defined clinical event|0|||
16327648|NCT00537316|39685404|FG004|Part 1|Protocol defined clinical event|0|||
16209061|NCT01055457|39244222|FG004|Overall Study|Subject Disinterest|0|||
16327649|NCT00537316|39685405|FG005|Part 1|Protocol defined clinical event|0|||
16327650|NCT00537316|39685406|FG006|Part 1|Protocol defined clinical event|0|||
16327651|NCT00537316|39685400|FG000|Part 1|Lost to Follow-up|1|||
16327652|NCT00537316|39685401|FG001|Part 1|Lost to Follow-up|0|||
16523926|NCT00113516|40387622|FG000|Part 2|Lack of Efficacy|0|||
16523927|NCT00113516|40387623|FG001|Part 2|Lack of Efficacy|37|||
16523928|NCT00113516|40387622|FG000|Part 2|Withdrawal by Subject|0|||
16523929|NCT00113516|40387623|FG001|Part 2|Withdrawal by Subject|3|||
16523930|NCT00113516|40387622|FG000|Part 2|Other|0|||
16523931|NCT00113516|40387623|FG001|Part 2|Other|3|||
16523932|NCT00113516|40387622|FG000|Part 2|Laboratory Abnormality|0|||
16523933|NCT00113516|40387623|FG001|Part 2|Laboratory Abnormality|1|||
16523934|NCT00113516|40387622|FG000|Part 2|Ongoing|0|||
16523935|NCT00113516|40387623|FG001|Part 2|Ongoing|1|||
16523936|NCT01193556|40387626|FG000|Overall Study|Study termination|26|||
16523937|NCT01193556|40387627|FG001|Overall Study|Study termination|25|||
16523938|NCT02080091|40387630|FG000|Overall Study|Study Terminated|22|||
16523939|NCT02080091|40387630|FG000|Overall Study|Death|1|||
16523940|NCT02080091|40387630|FG000|Overall Study|Withdrawal by Subject|1|||
16523941|NCT02080091|40387630|FG000|Overall Study|Other|1|||
16523942|NCT03095417|40387634|FG000|Overall Study|missed|1|||
16523943|NCT03095417|40387635|FG001|Overall Study|missed|2|||
16523944|NCT03095417|40387636|FG002|Overall Study|missed|0|||
16523945|NCT03095417|40387637|FG003|Overall Study|missed|1|||
16523946|NCT03095417|40387634|FG000|Overall Study|Lost to Follow-up|2|||
16523947|NCT03095417|40387635|FG001|Overall Study|Lost to Follow-up|2|||
16523948|NCT03095417|40387636|FG002|Overall Study|Lost to Follow-up|1|||
16523949|NCT03095417|40387637|FG003|Overall Study|Lost to Follow-up|0|||
16327653|NCT00537316|39685402|FG002|Part 1|Lost to Follow-up|0|||
16523950|NCT03095417|40387634|FG000|Overall Study|refusal|0|||
16523951|NCT03095417|40387635|FG001|Overall Study|refusal|1|||
16523952|NCT03095417|40387636|FG002|Overall Study|refusal|0|||
16523953|NCT03095417|40387637|FG003|Overall Study|refusal|1|||
16523954|NCT03095417|40387634|FG000|Overall Study|Withdrawal by Subject|8|||
16523955|NCT03095417|40387635|FG001|Overall Study|Withdrawal by Subject|2|||
16095815|NCT00441168|38842600|FG000|Treatment Period|Progressive Disease|0|||
16327654|NCT00537316|39685403|FG003|Part 1|Lost to Follow-up|0|||
16327655|NCT00537316|39685404|FG004|Part 1|Lost to Follow-up|0|||
16327656|NCT00537316|39685405|FG005|Part 1|Lost to Follow-up|0|||
16327657|NCT00537316|39685406|FG006|Part 1|Lost to Follow-up|0|||
16327658|NCT00537316|39685400|FG000|Part 1|Withdrawal by Subject|3|||
16327659|NCT00537316|39685401|FG001|Part 1|Withdrawal by Subject|8|||
16327660|NCT00537316|39685402|FG002|Part 1|Withdrawal by Subject|4|||
16327661|NCT00537316|39685403|FG003|Part 1|Withdrawal by Subject|0|||
16327662|NCT00537316|39685404|FG004|Part 1|Withdrawal by Subject|0|||
16327663|NCT00537316|39685405|FG005|Part 1|Withdrawal by Subject|0|||
16327664|NCT00537316|39685406|FG006|Part 1|Withdrawal by Subject|0|||
16327665|NCT00537316|39685400|FG000|Part 1|Protocol Violation|1|||
16327666|NCT00537316|39685401|FG001|Part 1|Protocol Violation|5|||
16327667|NCT00537316|39685402|FG002|Part 1|Protocol Violation|1|||
16327668|NCT00537316|39685403|FG003|Part 1|Protocol Violation|0|||
16327669|NCT00537316|39685404|FG004|Part 1|Protocol Violation|0|||
16327670|NCT00537316|39685405|FG005|Part 1|Protocol Violation|0|||
16327671|NCT00537316|39685406|FG006|Part 1|Protocol Violation|0|||
16327672|NCT00537316|39685400|FG000|Part 1|Did not meet protocol eligibility|1|||
16327673|NCT00537316|39685401|FG001|Part 1|Did not meet protocol eligibility|3|||
16327674|NCT00537316|39685402|FG002|Part 1|Did not meet protocol eligibility|2|||
16327675|NCT00537316|39685403|FG003|Part 1|Did not meet protocol eligibility|0|||
16327676|NCT00537316|39685404|FG004|Part 1|Did not meet protocol eligibility|0|||
16327677|NCT00537316|39685405|FG005|Part 1|Did not meet protocol eligibility|0|||
16327678|NCT00537316|39685406|FG006|Part 1|Did not meet protocol eligibility|0|||
16327679|NCT00537316|39685400|FG000|Part 1|Administrative|0|||
16327680|NCT00537316|39685401|FG001|Part 1|Administrative|0|||
16327681|NCT00537316|39685402|FG002|Part 1|Administrative|2|||
16327682|NCT00537316|39685403|FG003|Part 1|Administrative|0|||
16327683|NCT00537316|39685404|FG004|Part 1|Administrative|0|||
16327684|NCT00537316|39685405|FG005|Part 1|Administrative|0|||
16327685|NCT00537316|39685406|FG006|Part 1|Administrative|0|||
16327686|NCT00537316|39685400|FG000|Part 2|Never entered follow-up|0|||
16327687|NCT00537316|39685401|FG001|Part 2|Never entered follow-up|0|||
16327688|NCT00537316|39685402|FG002|Part 2|Never entered follow-up|0|||
16327689|NCT00537316|39685403|FG003|Part 2|Never entered follow-up|0|||
16327690|NCT00537316|39685404|FG004|Part 2|Never entered follow-up|0|||
16327691|NCT00537316|39685405|FG005|Part 2|Never entered follow-up|0|||
16327692|NCT00537316|39685406|FG006|Part 2|Never entered follow-up|1|||
16327693|NCT00537316|39685400|FG000|Part 2|Adverse Event|4|||
16327694|NCT00537316|39685401|FG001|Part 2|Adverse Event|0|||
16327695|NCT00537316|39685402|FG002|Part 2|Adverse Event|2|||
16327696|NCT00537316|39685403|FG003|Part 2|Adverse Event|0|||
16327697|NCT00537316|39685404|FG004|Part 2|Adverse Event|0|||
16327698|NCT00537316|39685405|FG005|Part 2|Adverse Event|0|||
16327699|NCT00537316|39685406|FG006|Part 2|Adverse Event|0|||
16523956|NCT03095417|40387636|FG002|Overall Study|Withdrawal by Subject|5|||
16327700|NCT00537316|39685400|FG000|Part 2|Lost to Follow-up|1|||
16327701|NCT00537316|39685401|FG001|Part 2|Lost to Follow-up|0|||
16327702|NCT00537316|39685402|FG002|Part 2|Lost to Follow-up|2|||
16327703|NCT00537316|39685403|FG003|Part 2|Lost to Follow-up|0|||
16327704|NCT00537316|39685404|FG004|Part 2|Lost to Follow-up|0|||
16327705|NCT00537316|39685405|FG005|Part 2|Lost to Follow-up|0|||
16327706|NCT00537316|39685406|FG006|Part 2|Lost to Follow-up|0|||
16523957|NCT03095417|40387637|FG003|Overall Study|Withdrawal by Subject|4|||
16523958|NCT03095417|40387634|FG000|Overall Study|Physician Decision|1|||
16523959|NCT03095417|40387635|FG001|Overall Study|Physician Decision|2|||
16523960|NCT03095417|40387636|FG002|Overall Study|Physician Decision|2|||
16523961|NCT03095417|40387637|FG003|Overall Study|Physician Decision|2|||
16523962|NCT03095417|40387634|FG000|Overall Study|Death|1|||
16523963|NCT03095417|40387635|FG001|Overall Study|Death|2|||
16523964|NCT03095417|40387636|FG002|Overall Study|Death|1|||
16523965|NCT03095417|40387637|FG003|Overall Study|Death|3|||
16523966|NCT01040130|40387638|FG000|Overall Study|Adverse Event|1|||
16523967|NCT01040130|40387639|FG001|Overall Study|Adverse Event|1|||
16523968|NCT01040130|40387640|FG002|Overall Study|Adverse Event|0|||
16523969|NCT01040130|40387641|FG003|Overall Study|Adverse Event|5|||
16523970|NCT01040130|40387642|FG004|Overall Study|Adverse Event|0|||
16523971|NCT01040130|40387643|FG005|Overall Study|Adverse Event|3|||
16523972|NCT01040130|40387638|FG000|Overall Study|Protocol Violation|0|||
16523973|NCT01040130|40387639|FG001|Overall Study|Protocol Violation|0|||
16523974|NCT01040130|40387640|FG002|Overall Study|Protocol Violation|2|||
16523975|NCT01040130|40387641|FG003|Overall Study|Protocol Violation|0|||
16523976|NCT01040130|40387642|FG004|Overall Study|Protocol Violation|0|||
16523977|NCT01040130|40387643|FG005|Overall Study|Protocol Violation|0|||
16523978|NCT01040130|40387638|FG000|Overall Study|Withdrawal by Subject|0|||
16523979|NCT01040130|40387639|FG001|Overall Study|Withdrawal by Subject|2|||
16523980|NCT01040130|40387640|FG002|Overall Study|Withdrawal by Subject|0|||
16523981|NCT01040130|40387641|FG003|Overall Study|Withdrawal by Subject|0|||
16523982|NCT01040130|40387642|FG004|Overall Study|Withdrawal by Subject|0|||
16523983|NCT01040130|40387643|FG005|Overall Study|Withdrawal by Subject|1|||
16523984|NCT01040130|40387638|FG000|Overall Study|Other reasons not listed above|2|||
16523985|NCT01040130|40387639|FG001|Overall Study|Other reasons not listed above|0|||
16523986|NCT01040130|40387640|FG002|Overall Study|Other reasons not listed above|0|||
16523987|NCT01040130|40387641|FG003|Overall Study|Other reasons not listed above|0|||
16523988|NCT01040130|40387642|FG004|Overall Study|Other reasons not listed above|0|||
16523989|NCT01040130|40387643|FG005|Overall Study|Other reasons not listed above|0|||
16523990|NCT02318329|40387644|FG000|Overall Study|Progressive Disease|2|||
16523991|NCT02318329|40387645|FG001|Overall Study|Progressive Disease|3|||
16523992|NCT02318329|40387646|FG002|Overall Study|Progressive Disease|2|||
16523993|NCT02318329|40387647|FG003|Overall Study|Progressive Disease|3|||
16523994|NCT02318329|40387648|FG004|Overall Study|Progressive Disease|3|||
16327707|NCT00537316|39685400|FG000|Part 2|Withdrawal by Subject|5|||
16327708|NCT00537316|39685401|FG001|Part 2|Withdrawal by Subject|1|||
16327709|NCT00537316|39685402|FG002|Part 2|Withdrawal by Subject|4|||
16327710|NCT00537316|39685403|FG003|Part 2|Withdrawal by Subject|0|||
16523995|NCT02318329|40387649|FG005|Overall Study|Progressive Disease|3|||
16523996|NCT02318329|40387650|FG006|Overall Study|Progressive Disease|1|||
16523997|NCT02318329|40387651|FG007|Overall Study|Progressive Disease|1|||
16523998|NCT02318329|40387652|FG008|Overall Study|Progressive Disease|5|||
16523999|NCT02318329|40387653|FG009|Overall Study|Progressive Disease|39|||
16524000|NCT02318329|40387644|FG000|Overall Study|Death|0|||
16524001|NCT02318329|40387645|FG001|Overall Study|Death|0|||
16524002|NCT02318329|40387646|FG002|Overall Study|Death|0|||
16524003|NCT02318329|40387647|FG003|Overall Study|Death|0|||
16524004|NCT02318329|40387648|FG004|Overall Study|Death|0|||
16524005|NCT02318329|40387649|FG005|Overall Study|Death|0|||
16524006|NCT02318329|40387650|FG006|Overall Study|Death|0|||
16524007|NCT02318329|40387651|FG007|Overall Study|Death|0|||
16524008|NCT02318329|40387652|FG008|Overall Study|Death|0|||
16524009|NCT02318329|40387653|FG009|Overall Study|Death|5|||
16524010|NCT02318329|40387644|FG000|Overall Study|Lost to Follow-up|0|||
16524011|NCT02318329|40387645|FG001|Overall Study|Lost to Follow-up|0|||
16524012|NCT02318329|40387646|FG002|Overall Study|Lost to Follow-up|0|||
16524013|NCT02318329|40387647|FG003|Overall Study|Lost to Follow-up|0|||
16524014|NCT02318329|40387648|FG004|Overall Study|Lost to Follow-up|0|||
16524015|NCT02318329|40387649|FG005|Overall Study|Lost to Follow-up|0|||
16524016|NCT02318329|40387650|FG006|Overall Study|Lost to Follow-up|0|||
16327711|NCT00537316|39685404|FG004|Part 2|Withdrawal by Subject|0|||
16327712|NCT00537316|39685405|FG005|Part 2|Withdrawal by Subject|0|||
16327713|NCT00537316|39685406|FG006|Part 2|Withdrawal by Subject|0|||
16327714|NCT00537316|39685400|FG000|Part 2|Administrative|16|||
16327715|NCT00537316|39685401|FG001|Part 2|Administrative|8|||
16524017|NCT02318329|40387651|FG007|Overall Study|Lost to Follow-up|0|||
16524018|NCT02318329|40387652|FG008|Overall Study|Lost to Follow-up|0|||
16524019|NCT02318329|40387653|FG009|Overall Study|Lost to Follow-up|1|||
16524020|NCT02318329|40387644|FG000|Overall Study|Withdrawal by Subject|0|||
16524021|NCT02318329|40387645|FG001|Overall Study|Withdrawal by Subject|0|||
16524022|NCT02318329|40387646|FG002|Overall Study|Withdrawal by Subject|0|||
16327716|NCT00537316|39685402|FG002|Part 2|Administrative|24|||
16524023|NCT02318329|40387647|FG003|Overall Study|Withdrawal by Subject|0|||
16524024|NCT02318329|40387648|FG004|Overall Study|Withdrawal by Subject|0|||
16524025|NCT02318329|40387649|FG005|Overall Study|Withdrawal by Subject|0|||
16524026|NCT02318329|40387650|FG006|Overall Study|Withdrawal by Subject|0|||
16524027|NCT02318329|40387651|FG007|Overall Study|Withdrawal by Subject|0|||
16524028|NCT02318329|40387652|FG008|Overall Study|Withdrawal by Subject|0|||
16327717|NCT00537316|39685403|FG003|Part 2|Administrative|3|||
16327718|NCT00537316|39685404|FG004|Part 2|Administrative|1|||
16524029|NCT02318329|40387653|FG009|Overall Study|Withdrawal by Subject|6|||
16524030|NCT02318329|40387644|FG000|Overall Study|Other|1|||
16524031|NCT02318329|40387645|FG001|Overall Study|Other|1|||
16327719|NCT00537316|39685405|FG005|Part 2|Administrative|4|||
16327720|NCT00537316|39685406|FG006|Part 2|Administrative|1|||
16327721|NCT00474786|39685407|FG000|Overall Study|Not Meeting Study Criteria|0|||
16327722|NCT00474786|39685408|FG001|Overall Study|Not Meeting Study Criteria|1|||
16327723|NCT00474786|39685407|FG000|Overall Study|Investigator Request|2|||
16327724|NCT00474786|39685408|FG001|Overall Study|Investigator Request|1|||
16524032|NCT02318329|40387646|FG002|Overall Study|Other|1|||
16524033|NCT02318329|40387647|FG003|Overall Study|Other|0|||
16524034|NCT02318329|40387648|FG004|Overall Study|Other|0|||
16524035|NCT02318329|40387649|FG005|Overall Study|Other|0|||
16524036|NCT02318329|40387650|FG006|Overall Study|Other|0|||
16524037|NCT02318329|40387651|FG007|Overall Study|Other|0|||
16524038|NCT02318329|40387652|FG008|Overall Study|Other|1|||
16524039|NCT02318329|40387653|FG009|Overall Study|Other|1|||
16524040|NCT01731171|40387654|FG000|Overall Study|Withdrawal by Subject|4|||
16209062|NCT01055457|39244223|FG005|Overall Study|Subject Disinterest|0|||
16209063|NCT01055457|39244224|FG006|Overall Study|Subject Disinterest|0|||
16209064|NCT01055457|39244225|FG007|Overall Study|Subject Disinterest|1|||
16209065|NCT01055457|39244226|FG008|Overall Study|Subject Disinterest|0|||
16209066|NCT01055457|39244227|FG009|Overall Study|Subject Disinterest|0|||
16209067|NCT01055457|39244218|FG000|Overall Study|Subject Ineligible|1|||
16209068|NCT01055457|39244219|FG001|Overall Study|Subject Ineligible|0|||
16209069|NCT01055457|39244220|FG002|Overall Study|Subject Ineligible|1|||
16209070|NCT01055457|39244221|FG003|Overall Study|Subject Ineligible|0|||
16209071|NCT01055457|39244222|FG004|Overall Study|Subject Ineligible|1|||
16524041|NCT01731171|40387655|FG001|Overall Study|Withdrawal by Subject|1|||
16524042|NCT01731171|40387654|FG000|Overall Study|Lost to Follow-up|3|||
16095816|NCT00441168|38842601|FG001|Treatment Period|Progressive Disease|2|||
16095817|NCT00441168|38842600|FG000|Treatment Period|Protocol Violation|0|||
16209072|NCT01055457|39244223|FG005|Overall Study|Subject Ineligible|0|||
16209073|NCT01055457|39244224|FG006|Overall Study|Subject Ineligible|0|||
16209074|NCT01055457|39244225|FG007|Overall Study|Subject Ineligible|0|||
16209075|NCT01055457|39244226|FG008|Overall Study|Subject Ineligible|0|||
16209076|NCT01055457|39244227|FG009|Overall Study|Subject Ineligible|0|||
16209077|NCT01055457|39244218|FG000|Overall Study|Discomfort|0|||
16209078|NCT01055457|39244219|FG001|Overall Study|Discomfort|0|||
16209079|NCT01055457|39244220|FG002|Overall Study|Discomfort|0|||
16209080|NCT01055457|39244221|FG003|Overall Study|Discomfort|0|||
16209081|NCT01055457|39244222|FG004|Overall Study|Discomfort|1|||
16209082|NCT01055457|39244223|FG005|Overall Study|Discomfort|0|||
16209083|NCT01055457|39244224|FG006|Overall Study|Discomfort|0|||
16209084|NCT01055457|39244225|FG007|Overall Study|Discomfort|0|||
16209085|NCT01055457|39244226|FG008|Overall Study|Discomfort|0|||
16209086|NCT01055457|39244227|FG009|Overall Study|Discomfort|0|||
16209087|NCT01055457|39244218|FG000|Overall Study|Pregnancy|0|||
16209088|NCT01055457|39244219|FG001|Overall Study|Pregnancy|0|||
16209089|NCT01055457|39244220|FG002|Overall Study|Pregnancy|0|||
16209090|NCT01055457|39244221|FG003|Overall Study|Pregnancy|1|||
16209091|NCT01055457|39244222|FG004|Overall Study|Pregnancy|0|||
16209092|NCT01055457|39244223|FG005|Overall Study|Pregnancy|0|||
16209093|NCT01055457|39244224|FG006|Overall Study|Pregnancy|0|||
16209094|NCT01055457|39244225|FG007|Overall Study|Pregnancy|0|||
16209095|NCT01055457|39244226|FG008|Overall Study|Pregnancy|0|||
16209096|NCT01055457|39244227|FG009|Overall Study|Pregnancy|0|||
16209097|NCT01055457|39244218|FG000|Overall Study|Adverse Event|0|||
16209098|NCT01055457|39244219|FG001|Overall Study|Adverse Event|0|||
16209099|NCT01055457|39244220|FG002|Overall Study|Adverse Event|0|||
16209100|NCT01055457|39244221|FG003|Overall Study|Adverse Event|1|||
16209101|NCT01055457|39244222|FG004|Overall Study|Adverse Event|0|||
16209102|NCT01055457|39244223|FG005|Overall Study|Adverse Event|0|||
16209103|NCT01055457|39244224|FG006|Overall Study|Adverse Event|0|||
16209104|NCT01055457|39244225|FG007|Overall Study|Adverse Event|0|||
16209105|NCT01055457|39244226|FG008|Overall Study|Adverse Event|0|||
16209106|NCT01055457|39244227|FG009|Overall Study|Adverse Event|0|||
16209107|NCT01112982|39244228|FG000|Overall Study|Withdrawal by Subject|1|||
16327725|NCT00474786|39685407|FG000|Overall Study|Death|189|||
16327726|NCT00474786|39685408|FG001|Overall Study|Death|170|||
16524043|NCT01731171|40387655|FG001|Overall Study|Lost to Follow-up|2|||
16209108|NCT01112982|39244228|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
16327727|NCT00474786|39685407|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
16524044|NCT01731171|40387654|FG000|Overall Study|Moved out of Area|0|||
16524045|NCT01731171|40387655|FG001|Overall Study|Moved out of Area|2|||
16524046|NCT01731171|40387654|FG000|Overall Study|Terminated for Lack of Adherence|0|||
16524047|NCT01731171|40387655|FG001|Overall Study|Terminated for Lack of Adherence|1|||
16209109|NCT01993667|39244229|FG000|Overall Study|Insufficient data to analyze|16|||
16209110|NCT01993667|39244230|FG001|Overall Study|Insufficient data to analyze|16|||
16209111|NCT01993667|39244229|FG000|Overall Study|Insufficient altitude reached|3|||
16209112|NCT01993667|39244230|FG001|Overall Study|Insufficient altitude reached|1|||
16209113|NCT01993667|39244229|FG000|Overall Study|Lost to Follow-up|2|||
16209114|NCT01993667|39244230|FG001|Overall Study|Lost to Follow-up|2|||
16209115|NCT01878097|39244231|FG000|Baseline|Surveys not fully completed|2497|||
16209116|NCT01878097|39244232|FG001|Baseline|Surveys not fully completed|1800|||
16209117|NCT01878097|39244231|FG000|Implementation Year 1|Surveys not fully completed|3202|||
16209118|NCT01878097|39244232|FG001|Implementation Year 1|Surveys not fully completed|2549|||
16209119|NCT01878097|39244231|FG000|Implementation Year 2|Surveys not fully completed|3281|||
16209120|NCT01878097|39244232|FG001|Implementation Year 2|Surveys not fully completed|2841|||
16209121|NCT01878097|39244231|FG000|Implementation Year 3|Surveys not fully completed|3494|||
16209122|NCT01878097|39244232|FG001|Implementation Year 3|Surveys not fully completed|2980|||
16209123|NCT01878097|39244231|FG000|Implementation Year 4|Surveys not fully completed|3604|||
16327728|NCT00474786|39685408|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
16327729|NCT00474786|39685407|FG000|Overall Study|Lost to Follow-up|4|||
16327730|NCT00474786|39685408|FG001|Overall Study|Lost to Follow-up|7|||
16327731|NCT00474786|39685407|FG000|Overall Study|Protocol Violation|2|||
16327732|NCT00474786|39685408|FG001|Overall Study|Protocol Violation|0|||
16327733|NCT00474786|39685407|FG000|Overall Study|Withdrawal by Subject|15|||
16327734|NCT00474786|39685408|FG001|Overall Study|Withdrawal by Subject|15|||
16327735|NCT00474786|39685407|FG000|Overall Study|Other|5|||
16327736|NCT00474786|39685408|FG001|Overall Study|Other|0|||
16327737|NCT01075646|39685409|FG000|Overall Study|Lost to Follow-up|4|||
16327738|NCT01075646|39685410|FG001|Overall Study|Lost to Follow-up|3|||
16327739|NCT01075646|39685411|FG002|Overall Study|Lost to Follow-up|1|||
16327740|NCT01075646|39685412|FG003|Overall Study|Lost to Follow-up|2|||
16327741|NCT01582178|39685414|FG000|Overall Study|Physician Decision|6|||
16327742|NCT01582178|39685415|FG001|Overall Study|Physician Decision|5|||
16327743|NCT00754234|39685420|FG000|Overall Study|Withdrawal by Subject|3|||
16327744|NCT00412217|39685421|FG000|Overall Study|Insufficient Data Available|8|||
16327745|NCT00412217|39685422|FG001|Overall Study|Insufficient Data Available|3|||
16524048|NCT01731171|40387654|FG000|Overall Study|Terminated for Safety Reasons|0|||
16524049|NCT01731171|40387655|FG001|Overall Study|Terminated for Safety Reasons|1|||
16524050|NCT00829621|40387657|FG000|Overall Study|Death|1|||
16524051|NCT00829621|40387658|FG001|Overall Study|Death|0|||
16327746|NCT00412217|39685421|FG000|Overall Study|Death|5|||
16327747|NCT00412217|39685422|FG001|Overall Study|Death|4|||
16327748|NCT00412217|39685421|FG000|Overall Study|Disease Progression|2|||
16327749|NCT00412217|39685422|FG001|Overall Study|Disease Progression|3|||
16327750|NCT00412217|39685421|FG000|Overall Study|Investigator Decision|1|||
16327751|NCT00412217|39685422|FG001|Overall Study|Investigator Decision|0|||
16327752|NCT00412217|39685421|FG000|Overall Study|Withdrawal by Subject|2|||
16327753|NCT00412217|39685422|FG001|Overall Study|Withdrawal by Subject|0|||
16327754|NCT00412217|39685421|FG000|Overall Study|Lost to Follow-up|1|||
16327755|NCT00412217|39685422|FG001|Overall Study|Lost to Follow-up|4|||
16327756|NCT00412217|39685421|FG000|Overall Study|Study Terminated by Sponsor|26|||
16524052|NCT00829621|40387657|FG000|Overall Study|Lost to Follow-up|3|||
16209124|NCT01878097|39244232|FG001|Implementation Year 4|Surveys not fully completed|3007|||
16209125|NCT02427100|39244233|FG000|Overall Study|Lost to Follow-up|0|||
16209126|NCT02427100|39244234|FG001|Overall Study|Lost to Follow-up|2|||
16209127|NCT01181141|39244235|FG000|Overall Study|Adverse Event|2|||
16209128|NCT01181141|39244236|FG001|Overall Study|Adverse Event|1|||
16209129|NCT01181141|39244235|FG000|Overall Study|Lack of Efficacy|1|||
16209130|NCT01181141|39244236|FG001|Overall Study|Lack of Efficacy|0|||
16209131|NCT01181141|39244235|FG000|Overall Study|Lost to Follow-up|1|||
16209132|NCT01181141|39244236|FG001|Overall Study|Lost to Follow-up|1|||
16209133|NCT01181141|39244235|FG000|Overall Study|Physician Decision|2|||
16209134|NCT01181141|39244236|FG001|Overall Study|Physician Decision|0|||
16209135|NCT01181141|39244235|FG000|Overall Study|Protocol Violation|3|||
16209136|NCT01181141|39244236|FG001|Overall Study|Protocol Violation|1|||
16209137|NCT01181141|39244235|FG000|Overall Study|Withdrawal by Subject|3|||
16209138|NCT01181141|39244236|FG001|Overall Study|Withdrawal by Subject|1|||
16209139|NCT03383614|39244237|FG000|Overall Study|Withdrawal by Subject|0|||
16209140|NCT03383614|39244238|FG001|Overall Study|Withdrawal by Subject|1|||
16209141|NCT03383614|39244239|FG002|Overall Study|Withdrawal by Subject|0|||
16209142|NCT03383614|39244240|FG003|Overall Study|Withdrawal by Subject|0|||
16209143|NCT00527072|39244241|FG000|Overall Study|Adverse Event|13|||
16209144|NCT00527072|39244241|FG000|Overall Study|Lack of Efficacy|11|||
16209145|NCT00527072|39244241|FG000|Overall Study|Lost to Follow-up|3|||
16327757|NCT00412217|39685422|FG001|Overall Study|Study Terminated by Sponsor|33|||
16524053|NCT00829621|40387658|FG001|Overall Study|Lost to Follow-up|4|||
16524054|NCT02536508|40387662|FG000|Overall Study|Withdrawal by Subject|18|||
16209146|NCT00527072|39244241|FG000|Overall Study|Protocol Violation|2|||
16327758|NCT00412217|39685421|FG000|Overall Study|Other|1|||
16524055|NCT02536508|40387663|FG001|Overall Study|Withdrawal by Subject|13|||
16524056|NCT02536508|40387664|FG002|Overall Study|Withdrawal by Subject|7|||
16524057|NCT02536508|40387662|FG000|Overall Study|Adverse Event|14|||
16209147|NCT00527072|39244241|FG000|Overall Study|Withdrawal by Subject|7|||
16209148|NCT01749800|39244242|FG000|Overall Study|not meeting inclusion criteria|3|||
16327759|NCT00412217|39685422|FG001|Overall Study|Other|1|||
16327760|NCT01608087|39685424|FG000|Overall Study|Lost to Follow-up|0|||
16327761|NCT01608087|39685425|FG001|Overall Study|Lost to Follow-up|1|||
16209149|NCT01749800|39244243|FG001|Overall Study|not meeting inclusion criteria|0|||
16209150|NCT01749800|39244244|FG002|Overall Study|not meeting inclusion criteria|0|||
16209151|NCT01749800|39244242|FG000|Overall Study|Withdrawal by Subject|0|||
16209152|NCT01749800|39244243|FG001|Overall Study|Withdrawal by Subject|1|||
16209153|NCT01749800|39244244|FG002|Overall Study|Withdrawal by Subject|0|||
16209154|NCT00607919|39244245|FG000|Acute Phase|Adverse Event|9|||
16209155|NCT00607919|39244246|FG001|Acute Phase|Adverse Event|2|||
16209156|NCT00607919|39244245|FG000|Acute Phase|Entry Criteria Not Met|1|||
16209157|NCT00607919|39244246|FG001|Acute Phase|Entry Criteria Not Met|1|||
16209158|NCT00607919|39244245|FG000|Acute Phase|Lack of Efficacy|1|||
16209159|NCT00607919|39244246|FG001|Acute Phase|Lack of Efficacy|2|||
16209160|NCT00607919|39244245|FG000|Acute Phase|Lost to Follow-up|9|||
16209161|NCT00607919|39244246|FG001|Acute Phase|Lost to Follow-up|3|||
16209162|NCT00607919|39244245|FG000|Acute Phase|Parent/Caregiver Decision|6|||
16327762|NCT01608087|39685426|FG002|Overall Study|Lost to Follow-up|0|||
16524058|NCT02536508|40387663|FG001|Overall Study|Adverse Event|13|||
16524059|NCT02536508|40387664|FG002|Overall Study|Adverse Event|6|||
16524060|NCT02536508|40387662|FG000|Overall Study|Lost to Follow-up|12|||
16524061|NCT02536508|40387663|FG001|Overall Study|Lost to Follow-up|4|||
16524062|NCT02536508|40387664|FG002|Overall Study|Lost to Follow-up|0|||
16524063|NCT02536508|40387662|FG000|Overall Study|Lack of Efficacy|3|||
16524064|NCT02536508|40387663|FG001|Overall Study|Lack of Efficacy|5|||
16524065|NCT02536508|40387664|FG002|Overall Study|Lack of Efficacy|4|||
16327763|NCT01608087|39685424|FG000|Overall Study|Other Reason|0|||
16327764|NCT01608087|39685425|FG001|Overall Study|Other Reason|1|||
16327765|NCT01608087|39685426|FG002|Overall Study|Other Reason|0|||
16327766|NCT00654875|39685427|FG000|Overall Study|Adverse Event|5|||
16327767|NCT00654875|39685428|FG001|Overall Study|Adverse Event|5|||
16327768|NCT00654875|39685427|FG000|Overall Study|Withdrawal by Subject|4|||
16327769|NCT00654875|39685428|FG001|Overall Study|Withdrawal by Subject|4|||
16327770|NCT00654875|39685427|FG000|Overall Study|Protocol Violation|3|||
16327771|NCT00654875|39685428|FG001|Overall Study|Protocol Violation|3|||
16327772|NCT00654875|39685427|FG000|Overall Study|Lack of Efficacy|2|||
16327773|NCT00654875|39685428|FG001|Overall Study|Lack of Efficacy|2|||
16327774|NCT00654875|39685427|FG000|Overall Study|Lost to Follow-up|1|||
16209163|NCT00607919|39244246|FG001|Acute Phase|Parent/Caregiver Decision|4|||
16209164|NCT00607919|39244245|FG000|Acute Phase|Protocol Violation|5|||
16209165|NCT00607919|39244246|FG001|Acute Phase|Protocol Violation|1|||
16209166|NCT00607919|39244245|FG000|Acute Phase|Withdrawal by Subject|3|||
16209167|NCT00607919|39244246|FG001|Acute Phase|Withdrawal by Subject|3|||
16209168|NCT00607919|39244245|FG000|Open-Label Phase|Adverse Event|1|||
16209169|NCT00607919|39244246|FG001|Open-Label Phase|Adverse Event|5|||
16209170|NCT00607919|39244245|FG000|Open-Label Phase|Lost to Follow-up|4|||
16327775|NCT00654875|39685428|FG001|Overall Study|Lost to Follow-up|3|||
16327776|NCT00654875|39685427|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
16327777|NCT00654875|39685428|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
16327778|NCT00654875|39685427|FG000|Overall Study|Administrative Problems|1|||
16327779|NCT00654875|39685428|FG001|Overall Study|Administrative Problems|0|||
16327780|NCT00471718|39685429|FG000|Overall Study|Adverse Event|3|||
16327781|NCT00471718|39685429|FG000|Overall Study|other complicating disease|1|||
16327782|NCT00471718|39685429|FG000|Overall Study|disease progression|22|||
16209171|NCT00607919|39244246|FG001|Open-Label Phase|Lost to Follow-up|1|||
16209172|NCT00607919|39244245|FG000|Open-Label Phase|Protocol Violation|2|||
16209173|NCT00607919|39244246|FG001|Open-Label Phase|Protocol Violation|2|||
16209174|NCT00607919|39244245|FG000|Open-Label Phase|Withdrawal by Subject|2|||
16209175|NCT00607919|39244246|FG001|Open-Label Phase|Withdrawal by Subject|2|||
16209176|NCT00607919|39244245|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
16209177|NCT00607919|39244246|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
16327783|NCT00471718|39685429|FG000|Overall Study|Withdrawal by Subject|1|||
16327784|NCT02662764|39685430|FG000|Overall Study|Adverse Event|6|||
16327785|NCT02662764|39685430|FG000|Overall Study|Lack of Efficacy|8|||
16327786|NCT02662764|39685430|FG000|Overall Study|Protocol Violation|1|||
16327787|NCT02662764|39685430|FG000|Overall Study|Withdrawal by Subject|5|||
16327788|NCT02662764|39685430|FG000|Overall Study|Device failure|4|||
16327789|NCT02662764|39685430|FG000|Overall Study|Patient changed treatment|1|||
16327790|NCT02662764|39685430|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
16327791|NCT02892422|39685432|FG000|Overall Study|Enrolled not treated|4|||
16327792|NCT02892422|39685432|FG000|Overall Study|Adverse Event|38|||
16327793|NCT02892422|39685432|FG000|Overall Study|Lack of Efficacy|32|||
16327794|NCT02892422|39685432|FG000|Overall Study|Non-compliance with study drug|11|||
16327795|NCT02892422|39685432|FG000|Overall Study|Protocol Violation|4|||
16524066|NCT02536508|40387662|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
16524067|NCT02536508|40387663|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
16209178|NCT04685538|39244247|FG000|Overall Study|Adverse Event|0|||
16327796|NCT02892422|39685432|FG000|Overall Study|Withdrawal by Subject|56|||
16209179|NCT04685538|39244248|FG001|Overall Study|Adverse Event|1|||
16209180|NCT04685538|39244247|FG000|Overall Study|Lost to Follow-up|0|||
16327797|NCT02892422|39685432|FG000|Overall Study|Lost to Follow-up|5|||
16327798|NCT02892422|39685432|FG000|Overall Study|sponsor information 16159A results|21|||
16327799|NCT02892422|39685432|FG000|Overall Study|withdrawal of consent|13|||
16327800|NCT02892422|39685432|FG000|Overall Study|exclusion criteria met|3|||
16327801|NCT02892422|39685432|FG000|Overall Study|moving elsewhere|4|||
16327802|NCT02892422|39685432|FG000|Overall Study|non-compliance|10|||
16327803|NCT02892422|39685432|FG000|Overall Study|patient legally incapable|1|||
16327804|NCT02892422|39685432|FG000|Overall Study|patient decision|7|||
16327805|NCT02892422|39685432|FG000|Overall Study|Investigator decision|1|||
16327806|NCT01263782|39685435|FG000|Overall Study|Death|0|||
16327807|NCT01263782|39685436|FG001|Overall Study|Death|0|||
16327808|NCT01263782|39685437|FG002|Overall Study|Death|1|||
16327809|NCT01263782|39685438|FG003|Overall Study|Death|0|||
16327810|NCT01263782|39685435|FG000|Overall Study|Progressive disease|0|||
16327811|NCT01263782|39685436|FG001|Overall Study|Progressive disease|0|||
16327812|NCT01263782|39685437|FG002|Overall Study|Progressive disease|0|||
16327813|NCT01263782|39685438|FG003|Overall Study|Progressive disease|1|||
16327814|NCT01263782|39685435|FG000|Overall Study|Too early|0|||
16327815|NCT01263782|39685436|FG001|Overall Study|Too early|0|||
16327816|NCT01263782|39685437|FG002|Overall Study|Too early|1|||
16327817|NCT01263782|39685438|FG003|Overall Study|Too early|0|||
16327818|NCT01263782|39685435|FG000|Overall Study|Inevaluable|0|||
16327819|NCT01263782|39685436|FG001|Overall Study|Inevaluable|0|||
16327820|NCT01263782|39685437|FG002|Overall Study|Inevaluable|1|||
16327821|NCT01263782|39685438|FG003|Overall Study|Inevaluable|0|||
16327822|NCT01275755|39685441|FG000|Double-blind Treatment Period|Adverse Event|0|||
16327823|NCT01275755|39685442|FG001|Double-blind Treatment Period|Adverse Event|2|||
16327824|NCT01275755|39685441|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
16327825|NCT01275755|39685442|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
16327826|NCT01275755|39685441|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
16327827|NCT01275755|39685442|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
16327828|NCT01275755|39685441|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
16327829|NCT01275755|39685442|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
16327830|NCT04934189|39685443|FG000|Overall Study|Lost to Follow-up|4|||
16327831|NCT04934189|39685443|FG000|Overall Study|Withdrawal by Subject|17|||
16327832|NCT01084668|39685444|FG000|Overall Study|Lack of Efficacy|5|||
16327833|NCT01084668|39685444|FG000|Overall Study|Withdrawal by Subject|2|||
16327834|NCT01084668|39685444|FG000|Overall Study|Pregnancy|1|||
16327835|NCT01084668|39685444|FG000|Overall Study|Non-compliance|1|||
16327836|NCT05318092|39685445|FG000|Overall Study|Lost to Follow-up|3|||
16327837|NCT05318092|39685445|FG000|Overall Study|Withdrawal by Subject|1|||
16327838|NCT03613649|39685451|FG000|Second Treatment|Lost to Follow-up|0|||
16327839|NCT03613649|39685452|FG001|Second Treatment|Lost to Follow-up|0|||
16327840|NCT03613649|39685453|FG002|Second Treatment|Lost to Follow-up|1|||
16327841|NCT03613649|39685454|FG003|Second Treatment|Lost to Follow-up|0|||
16327842|NCT03613649|39685455|FG004|Second Treatment|Lost to Follow-up|0|||
16327843|NCT03613649|39685456|FG005|Second Treatment|Lost to Follow-up|0|||
16327844|NCT03613649|39685457|FG006|Second Treatment|Lost to Follow-up|0|||
16327845|NCT03613649|39685458|FG007|Second Treatment|Lost to Follow-up|0|||
16327846|NCT03613649|39685459|FG008|Second Treatment|Lost to Follow-up|0|||
16327847|NCT03613649|39685460|FG009|Second Treatment|Lost to Follow-up|0|||
16327848|NCT03613649|39685461|FG010|Second Treatment|Lost to Follow-up|0|||
16327849|NCT03613649|39685462|FG011|Second Treatment|Lost to Follow-up|0|||
16327850|NCT03613649|39685451|FG000|Second Treatment|Withdrawal by Subject|0|||
16327851|NCT03613649|39685452|FG001|Second Treatment|Withdrawal by Subject|0|||
16209181|NCT04685538|39244248|FG001|Overall Study|Lost to Follow-up|2|||
16209182|NCT03947255|39244249|FG000|Overall Study|Study Closure by Sponsor|2|||
16209183|NCT03947255|39244250|FG001|Overall Study|Study Closure by Sponsor|2|||
16209184|NCT03947255|39244249|FG000|Overall Study|Withdrawal by Subject|2|||
16209185|NCT03947255|39244250|FG001|Overall Study|Withdrawal by Subject|2|||
16209186|NCT03947255|39244249|FG000|Overall Study|Lost to Follow-up|2|||
16209187|NCT03947255|39244250|FG001|Overall Study|Lost to Follow-up|0|||
16327852|NCT03613649|39685453|FG002|Second Treatment|Withdrawal by Subject|0|||
16327853|NCT03613649|39685454|FG003|Second Treatment|Withdrawal by Subject|0|||
16327854|NCT03613649|39685455|FG004|Second Treatment|Withdrawal by Subject|1|||
16327855|NCT03613649|39685456|FG005|Second Treatment|Withdrawal by Subject|0|||
16327856|NCT03613649|39685457|FG006|Second Treatment|Withdrawal by Subject|0|||
16327857|NCT03613649|39685458|FG007|Second Treatment|Withdrawal by Subject|0|||
16327858|NCT03613649|39685459|FG008|Second Treatment|Withdrawal by Subject|0|||
16209188|NCT03947255|39244249|FG000|Overall Study|Death|0|||
16209189|NCT03947255|39244250|FG001|Overall Study|Death|2|||
16327859|NCT03613649|39685460|FG009|Second Treatment|Withdrawal by Subject|0|||
16209190|NCT01527110|39244255|FG000|Overall Study|Adverse Event|1|||
16209191|NCT02999191|39244256|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
16327860|NCT03613649|39685461|FG010|Second Treatment|Withdrawal by Subject|0|||
16327861|NCT03613649|39685462|FG011|Second Treatment|Withdrawal by Subject|0|||
16327862|NCT03613649|39685451|FG000|Third Treatment|Lost to Follow-up|0|||
16327863|NCT03613649|39685452|FG001|Third Treatment|Lost to Follow-up|0|||
16327864|NCT03613649|39685453|FG002|Third Treatment|Lost to Follow-up|0|||
16327865|NCT03613649|39685454|FG003|Third Treatment|Lost to Follow-up|0|||
16327866|NCT03613649|39685455|FG004|Third Treatment|Lost to Follow-up|1|||
16327867|NCT03613649|39685456|FG005|Third Treatment|Lost to Follow-up|0|||
16327868|NCT03613649|39685457|FG006|Third Treatment|Lost to Follow-up|0|||
16327869|NCT03613649|39685458|FG007|Third Treatment|Lost to Follow-up|0|||
16327870|NCT03613649|39685459|FG008|Third Treatment|Lost to Follow-up|0|||
16327871|NCT03613649|39685460|FG009|Third Treatment|Lost to Follow-up|0|||
16327872|NCT03613649|39685461|FG010|Third Treatment|Lost to Follow-up|0|||
16327873|NCT03613649|39685462|FG011|Third Treatment|Lost to Follow-up|1|||
16327874|NCT03613649|39685451|FG000|Third Treatment|Protocol Violation|0|||
16327875|NCT03613649|39685452|FG001|Third Treatment|Protocol Violation|0|||
16327876|NCT03613649|39685453|FG002|Third Treatment|Protocol Violation|0|||
16327877|NCT03613649|39685454|FG003|Third Treatment|Protocol Violation|0|||
16327878|NCT03613649|39685455|FG004|Third Treatment|Protocol Violation|0|||
16327879|NCT03613649|39685456|FG005|Third Treatment|Protocol Violation|0|||
16524068|NCT02536508|40387664|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
16524069|NCT02536508|40387662|FG000|Overall Study|Physician Decision|0|||
16524070|NCT02536508|40387663|FG001|Overall Study|Physician Decision|4|||
16524071|NCT02536508|40387664|FG002|Overall Study|Physician Decision|2|||
16524072|NCT02536508|40387662|FG000|Overall Study|Major Protocol Deviation|2|||
16524073|NCT02536508|40387663|FG001|Overall Study|Major Protocol Deviation|2|||
16209192|NCT02999191|39244257|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
16209193|NCT02999191|39244258|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
16209194|NCT03148795|39244261|FG000|Overall Study|Progressive Disease|1|||
16209195|NCT04322682|39244277|FG000|Overall Study|Withdrawal by Subject|33|||
16209196|NCT04322682|39244278|FG001|Overall Study|Withdrawal by Subject|47|||
16209197|NCT04322682|39244277|FG000|Overall Study|Death|5|||
16209198|NCT04322682|39244278|FG001|Overall Study|Death|9|||
16209199|NCT04322682|39244277|FG000|Overall Study|Lost to Follow-up|4|||
16209200|NCT04322682|39244278|FG001|Overall Study|Lost to Follow-up|8|||
16327880|NCT03613649|39685457|FG006|Third Treatment|Protocol Violation|1|||
16327881|NCT03613649|39685458|FG007|Third Treatment|Protocol Violation|0|||
16327882|NCT03613649|39685459|FG008|Third Treatment|Protocol Violation|0|||
16327883|NCT03613649|39685460|FG009|Third Treatment|Protocol Violation|0|||
16327884|NCT03613649|39685461|FG010|Third Treatment|Protocol Violation|0|||
16327885|NCT03613649|39685462|FG011|Third Treatment|Protocol Violation|1|||
16327886|NCT03613649|39685451|FG000|Fourth Treatment|Protocol Violation|1|||
16327887|NCT03613649|39685452|FG001|Fourth Treatment|Protocol Violation|0|||
16327888|NCT03613649|39685453|FG002|Fourth Treatment|Protocol Violation|0|||
16327889|NCT03613649|39685454|FG003|Fourth Treatment|Protocol Violation|0|||
16327890|NCT03613649|39685455|FG004|Fourth Treatment|Protocol Violation|1|||
16327891|NCT03613649|39685456|FG005|Fourth Treatment|Protocol Violation|0|||
16209201|NCT04322682|39244277|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
16327892|NCT03613649|39685457|FG006|Fourth Treatment|Protocol Violation|0|||
16327893|NCT03613649|39685458|FG007|Fourth Treatment|Protocol Violation|0|||
16327894|NCT03613649|39685459|FG008|Fourth Treatment|Protocol Violation|0|||
16327895|NCT03613649|39685460|FG009|Fourth Treatment|Protocol Violation|0|||
16327896|NCT03613649|39685461|FG010|Fourth Treatment|Protocol Violation|0|||
16327897|NCT03613649|39685462|FG011|Fourth Treatment|Protocol Violation|0|||
16327898|NCT03613649|39685451|FG000|Fourth Treatment|Physician Decision|0|||
16327899|NCT03613649|39685452|FG001|Fourth Treatment|Physician Decision|0|||
16327900|NCT03613649|39685453|FG002|Fourth Treatment|Physician Decision|0|||
16327901|NCT03613649|39685454|FG003|Fourth Treatment|Physician Decision|0|||
16327902|NCT03613649|39685455|FG004|Fourth Treatment|Physician Decision|0|||
16327903|NCT03613649|39685456|FG005|Fourth Treatment|Physician Decision|0|||
16327904|NCT03613649|39685457|FG006|Fourth Treatment|Physician Decision|1|||
16327905|NCT03613649|39685458|FG007|Fourth Treatment|Physician Decision|0|||
16327906|NCT03613649|39685459|FG008|Fourth Treatment|Physician Decision|0|||
16327907|NCT03613649|39685460|FG009|Fourth Treatment|Physician Decision|0|||
16327908|NCT03613649|39685461|FG010|Fourth Treatment|Physician Decision|0|||
16327909|NCT03613649|39685462|FG011|Fourth Treatment|Physician Decision|0|||
16327910|NCT02453334|39685463|FG000|Overall Study|Death|15|||
16327911|NCT02453334|39685464|FG001|Overall Study|Death|13|||
16327912|NCT02453334|39685463|FG000|Overall Study|Adverse Event|2|||
16327913|NCT02453334|39685464|FG001|Overall Study|Adverse Event|1|||
16327914|NCT02453334|39685463|FG000|Overall Study|Lost to Follow-up|5|||
16327915|NCT02453334|39685464|FG001|Overall Study|Lost to Follow-up|9|||
16327916|NCT02453334|39685463|FG000|Overall Study|Physician Decision|1|||
16327917|NCT02453334|39685464|FG001|Overall Study|Physician Decision|0|||
16327918|NCT02453334|39685463|FG000|Overall Study|Withdrawal by Subject|17|||
16327919|NCT02453334|39685464|FG001|Overall Study|Withdrawal by Subject|13|||
16524074|NCT02536508|40387664|FG002|Overall Study|Major Protocol Deviation|2|||
16327920|NCT02453334|39685463|FG000|Overall Study|Other reason|1|||
16327921|NCT02453334|39685464|FG001|Overall Study|Other reason|4|||
16327922|NCT00978250|39685465|FG000|Overall Study|Late determination of ineligibility|0|||
16327923|NCT00978250|39685466|FG001|Overall Study|Late determination of ineligibility|1|||
16209202|NCT04322682|39244278|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
16327924|NCT00978250|39685467|FG002|Overall Study|Late determination of ineligibility|0|||
16327925|NCT00978250|39685468|FG003|Overall Study|Late determination of ineligibility|1|||
16327926|NCT00308087|39685471|FG000|Overall Study|Progressive Disease|19|||
16327927|NCT00308087|39685472|FG001|Overall Study|Progressive Disease|21|||
16327928|NCT00308087|39685471|FG000|Overall Study|Study Closure|11|||
16327929|NCT00308087|39685472|FG001|Overall Study|Study Closure|12|||
16327930|NCT00308087|39685471|FG000|Overall Study|Withdrawal by Subject|2|||
16209203|NCT01281189|39244279|FG000|Overall Study|Adverse Event|7|||
16327931|NCT00308087|39685472|FG001|Overall Study|Withdrawal by Subject|1|||
16327932|NCT00308087|39685471|FG000|Overall Study|Other|4|||
16327933|NCT00308087|39685472|FG001|Overall Study|Other|3|||
16327934|NCT00637000|39685473|FG000|Overall Study|Withdrawal by Subject|4|||
16327935|NCT00637000|39685474|FG001|Overall Study|Withdrawal by Subject|3|||
16327936|NCT00526669|39685479|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
16327937|NCT00526669|39685480|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
16327938|NCT00526669|39685479|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
16327939|NCT00526669|39685480|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
16327940|NCT00526669|39685479|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
16327941|NCT00526669|39685480|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
16327942|NCT00526669|39685479|FG000|Combined Treatment Phase|Death|0|||
16327943|NCT00526669|39685480|FG001|Combined Treatment Phase|Death|2|||
16209204|NCT01281189|39244280|FG001|Overall Study|Adverse Event|9|||
16209205|NCT01281189|39244279|FG000|Overall Study|Lost to Follow-up|6|||
16209206|NCT01281189|39244280|FG001|Overall Study|Lost to Follow-up|4|||
16209207|NCT01281189|39244279|FG000|Overall Study|Withdrawal by Subject|21|||
16209208|NCT01281189|39244280|FG001|Overall Study|Withdrawal by Subject|24|||
16209209|NCT01281189|39244279|FG000|Overall Study|Physician Decision|2|||
16209210|NCT01281189|39244280|FG001|Overall Study|Physician Decision|3|||
16209211|NCT01281189|39244279|FG000|Overall Study|Death|103|||
16209212|NCT01281189|39244280|FG001|Overall Study|Death|91|||
16209213|NCT01281189|39244279|FG000|Overall Study|Other|8|||
16209214|NCT01281189|39244280|FG001|Overall Study|Other|12|||
16209215|NCT03004976|39244291|FG000|Overall Study|Lost to Follow-up|7|||
16209216|NCT03004976|39244292|FG001|Overall Study|Lost to Follow-up|5|||
16209217|NCT03004976|39244291|FG000|Overall Study|Physician Decision|1|||
16209218|NCT03004976|39244292|FG001|Overall Study|Physician Decision|0|||
16209219|NCT03004976|39244291|FG000|Overall Study|Withdrawal by Subject|1|||
16209220|NCT03004976|39244292|FG001|Overall Study|Withdrawal by Subject|0|||
16209221|NCT03004976|39244291|FG000|Overall Study|Death|4|||
16209222|NCT03004976|39244292|FG001|Overall Study|Death|1|||
16209223|NCT00753623|39244293|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
16209224|NCT00753623|39244294|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
16209225|NCT00753623|39244293|FG000|Phase I (14 Days)|Physician Decision|1|||
16209226|NCT00753623|39244294|FG001|Phase I (14 Days)|Physician Decision|2|||
16209227|NCT00753623|39244293|FG000|Phase I (14 Days)|Adverse Event|0|||
16209228|NCT00753623|39244294|FG001|Phase I (14 Days)|Adverse Event|1|||
16209229|NCT00753623|39244293|FG000|Washout (7 Days)|Physician Decision|1|||
16209230|NCT00753623|39244294|FG001|Washout (7 Days)|Physician Decision|0|||
16209231|NCT00753623|39244293|FG000|Phase II (14 Days)|Physician Decision|0|||
16209232|NCT00753623|39244294|FG001|Phase II (14 Days)|Physician Decision|1|||
16209233|NCT01922739|39244295|FG000|Titration/Adjustment Period|Adverse Event|3|||
16209234|NCT01922739|39244295|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
16209235|NCT01922739|39244295|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
16209236|NCT01922739|39244295|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
16209237|NCT01922739|39244295|FG000|Open-label Treatment Period|Adverse Event|6|||
16209238|NCT01922739|39244295|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
16209239|NCT01922739|39244295|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
16209240|NCT01922739|39244295|FG000|Open-label Treatment Period|Protocol Violation|5|||
16209241|NCT01922739|39244295|FG000|Open-label Treatment Period|Pregnancy|1|||
16327944|NCT02582242|39685483|FG000|Overall Study|Adverse Event|4|||
16209242|NCT01922739|39244295|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
16209243|NCT01922739|39244295|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
16327945|NCT02582242|39685484|FG001|Overall Study|Adverse Event|3|||
16327946|NCT02582242|39685483|FG000|Overall Study|Protocol Violation|3|||
16327947|NCT02582242|39685484|FG001|Overall Study|Protocol Violation|1|||
16209244|NCT01922739|39244295|FG000|Open-label Treatment Period|Physician Decision|1|||
16209245|NCT01922739|39244295|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
16209246|NCT02773368|39244296|FG000|Overall Study|Lost to Follow-up|4|||
16209247|NCT02773368|39244297|FG001|Overall Study|Lost to Follow-up|1|||
16209248|NCT02773368|39244296|FG000|Overall Study|Withdrawal by Subject|5|||
16209249|NCT02773368|39244297|FG001|Overall Study|Withdrawal by Subject|1|||
16327948|NCT02582242|39685483|FG000|Overall Study|Lost to Follow-up|0|||
16327949|NCT02582242|39685484|FG001|Overall Study|Lost to Follow-up|1|||
16327950|NCT02582242|39685483|FG000|Overall Study|Withdrawal by Subject|11|||
16209250|NCT02773368|39244296|FG000|Overall Study|Unclassified|1|||
16209251|NCT02773368|39244297|FG001|Overall Study|Unclassified|1|||
16327951|NCT02582242|39685484|FG001|Overall Study|Withdrawal by Subject|11|||
16327952|NCT02582242|39685483|FG000|Overall Study|Unclassified|2|||
16209252|NCT02773368|39244296|FG000|Overall Study|Missing|0|||
16209253|NCT02773368|39244297|FG001|Overall Study|Missing|1|||
16209254|NCT01963780|39244298|FG000|Overall Study|Death|7|||
16209255|NCT01587274|39244299|FG000|Overall Study|Lost to Follow-up|4|||
16209256|NCT01587274|39244300|FG001|Overall Study|Lost to Follow-up|5|||
16209257|NCT01587274|39244301|FG002|Overall Study|Lost to Follow-up|3|||
16209258|NCT00429572|39244302|FG000|Overall Study|Disease progression|1|||
16209259|NCT04964557|39244303|FG000|Overall Study|Withdrawal by Subject|3|||
16209260|NCT04964557|39244304|FG001|Overall Study|Withdrawal by Subject|2|||
16209261|NCT04964557|39244303|FG000|Overall Study|Lost to Follow-up|1|||
16209262|NCT04964557|39244304|FG001|Overall Study|Lost to Follow-up|2|||
16209263|NCT04964557|39244303|FG000|Overall Study|Physician Decision|2|||
16209264|NCT04964557|39244304|FG001|Overall Study|Physician Decision|0|||
16209265|NCT04964557|39244303|FG000|Overall Study|Death|3|||
16209266|NCT04964557|39244304|FG001|Overall Study|Death|0|||
16209267|NCT04964557|39244303|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
16209268|NCT04964557|39244304|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
16209269|NCT01517412|39244321|FG000|Overall Study|Adverse Event|10|||
16327953|NCT02582242|39685484|FG001|Overall Study|Unclassified|1|||
16327954|NCT05174949|39685485|FG000|Overall Study|Physician Decision|1|||
16327955|NCT05174949|39685486|FG001|Overall Study|Physician Decision|2|||
16327956|NCT05174949|39685487|FG002|Overall Study|Physician Decision|0|||
16327957|NCT05174949|39685488|FG003|Overall Study|Physician Decision|1|||
16327958|NCT05174949|39685489|FG004|Overall Study|Physician Decision|0|||
16327959|NCT05174949|39685490|FG005|Overall Study|Physician Decision|0|||
16327960|NCT05174949|39685485|FG000|Overall Study|Withdrawal by Subject|0|||
16327961|NCT05174949|39685486|FG001|Overall Study|Withdrawal by Subject|1|||
16327962|NCT05174949|39685487|FG002|Overall Study|Withdrawal by Subject|0|||
16327963|NCT05174949|39685488|FG003|Overall Study|Withdrawal by Subject|0|||
16327964|NCT05174949|39685489|FG004|Overall Study|Withdrawal by Subject|0|||
16327965|NCT05174949|39685490|FG005|Overall Study|Withdrawal by Subject|0|||
16327966|NCT05174949|39685485|FG000|Overall Study|Lost to Follow-up|0|||
16327967|NCT05174949|39685486|FG001|Overall Study|Lost to Follow-up|0|||
16327968|NCT05174949|39685487|FG002|Overall Study|Lost to Follow-up|0|||
16327969|NCT05174949|39685488|FG003|Overall Study|Lost to Follow-up|1|||
16327970|NCT05174949|39685489|FG004|Overall Study|Lost to Follow-up|0|||
16327971|NCT05174949|39685490|FG005|Overall Study|Lost to Follow-up|0|||
16327972|NCT01895608|39685491|FG000|Overall Study|change in health status|0|||
16327973|NCT01895608|39685492|FG001|Overall Study|change in health status|1|||
16327974|NCT01895608|39685493|FG002|Overall Study|change in health status|1|||
16327975|NCT01895608|39685494|FG003|Overall Study|change in health status|0|||
16327976|NCT01895608|39685491|FG000|Overall Study|Withdrawal by Subject|0|||
16327977|NCT01895608|39685492|FG001|Overall Study|Withdrawal by Subject|0|||
16327978|NCT01895608|39685493|FG002|Overall Study|Withdrawal by Subject|2|||
16327979|NCT01895608|39685494|FG003|Overall Study|Withdrawal by Subject|0|||
16327980|NCT02100670|39685495|FG000|Overall Study|Adverse Event|10|||
16327981|NCT02100670|39685496|FG001|Overall Study|Adverse Event|3|||
16327982|NCT02100670|39685497|FG002|Overall Study|Adverse Event|3|||
16209270|NCT01517412|39244322|FG001|Overall Study|Adverse Event|11|||
16209271|NCT01517412|39244321|FG000|Overall Study|Lack of Efficacy|10|||
16327983|NCT02100670|39685498|FG003|Overall Study|Adverse Event|0|||
16327984|NCT02100670|39685495|FG000|Overall Study|Lost to Follow-up|1|||
16327985|NCT02100670|39685496|FG001|Overall Study|Lost to Follow-up|0|||
16327986|NCT02100670|39685497|FG002|Overall Study|Lost to Follow-up|0|||
16327987|NCT02100670|39685498|FG003|Overall Study|Lost to Follow-up|0|||
16327988|NCT02100670|39685495|FG000|Overall Study|Protocol Violation|0|||
16327989|NCT02100670|39685496|FG001|Overall Study|Protocol Violation|1|||
16327990|NCT02100670|39685497|FG002|Overall Study|Protocol Violation|0|||
16327991|NCT02100670|39685498|FG003|Overall Study|Protocol Violation|1|||
16327992|NCT02100670|39685495|FG000|Overall Study|Withdrawal of Consent|0|||
16327993|NCT02100670|39685496|FG001|Overall Study|Withdrawal of Consent|1|||
16327994|NCT02100670|39685497|FG002|Overall Study|Withdrawal of Consent|1|||
16327995|NCT02100670|39685498|FG003|Overall Study|Withdrawal of Consent|0|||
16327996|NCT02100670|39685495|FG000|Overall Study|No swelling no pain|1|||
16327997|NCT02100670|39685496|FG001|Overall Study|No swelling no pain|0|||
16524075|NCT02536508|40387662|FG000|Overall Study|Administrative Reasons|0|||
16524076|NCT02536508|40387663|FG001|Overall Study|Administrative Reasons|1|||
16524077|NCT02536508|40387664|FG002|Overall Study|Administrative Reasons|0|||
16524078|NCT02401672|40387665|FG000|Overall Study|Withdrawal by Subject|1|||
16524079|NCT02401672|40387666|FG001|Overall Study|Withdrawal by Subject|3|||
16524080|NCT00975975|40387669|FG000|Overall Study|Death|6|||
16524081|NCT01954017|40387670|FG000|Overall Study|Adverse Event|0|||
16524082|NCT01954017|40387671|FG001|Overall Study|Adverse Event|0|||
16524083|NCT01954017|40387672|FG002|Overall Study|Adverse Event|1|||
16524084|NCT01954017|40387670|FG000|Overall Study|Death|2|||
16524085|NCT01954017|40387671|FG001|Overall Study|Death|1|||
16524086|NCT01954017|40387672|FG002|Overall Study|Death|1|||
16327998|NCT02100670|39685497|FG002|Overall Study|No swelling no pain|0|||
16327999|NCT02100670|39685498|FG003|Overall Study|No swelling no pain|0|||
16328000|NCT02100670|39685495|FG000|Overall Study|Poor Efficacy|0|||
16328001|NCT02100670|39685496|FG001|Overall Study|Poor Efficacy|1|||
16328002|NCT02100670|39685497|FG002|Overall Study|Poor Efficacy|0|||
16524087|NCT01954017|40387670|FG000|Overall Study|Withdrawal by Subject|0|||
16524088|NCT01954017|40387671|FG001|Overall Study|Withdrawal by Subject|1|||
16524089|NCT01954017|40387672|FG002|Overall Study|Withdrawal by Subject|0|||
16524090|NCT01954017|40387670|FG000|Overall Study|Protocol Violation|0|||
16524091|NCT01954017|40387671|FG001|Overall Study|Protocol Violation|3|||
16524092|NCT01954017|40387672|FG002|Overall Study|Protocol Violation|2|||
16524093|NCT01954017|40387670|FG000|Overall Study|Necrotizing enterocolitis|1|||
16524094|NCT01954017|40387671|FG001|Overall Study|Necrotizing enterocolitis|0|||
16524095|NCT01954017|40387672|FG002|Overall Study|Necrotizing enterocolitis|1|||
16524096|NCT01954017|40387670|FG000|Overall Study|Enteral intake stopped >7 days|0|||
16524097|NCT01954017|40387671|FG001|Overall Study|Enteral intake stopped >7 days|1|||
16524098|NCT01954017|40387672|FG002|Overall Study|Enteral intake stopped >7 days|1|||
16524099|NCT01954017|40387670|FG000|Overall Study|All other reasons|2|||
16524100|NCT01954017|40387671|FG001|Overall Study|All other reasons|2|||
16524101|NCT01954017|40387672|FG002|Overall Study|All other reasons|7|||
16524102|NCT04808609|40387673|FG000|Overall Study|Lost to Follow-up|0|||
16524103|NCT04808609|40387674|FG001|Overall Study|Lost to Follow-up|2|||
16524104|NCT04808609|40387673|FG000|Overall Study|Administrative Withdrawal|0|||
16524105|NCT04808609|40387674|FG001|Overall Study|Administrative Withdrawal|1|||
16524106|NCT03346759|40387681|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
16524107|NCT03346759|40387682|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
16524108|NCT03346759|40387681|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
16524109|NCT03346759|40387682|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
16524110|NCT03346759|40387681|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
16524111|NCT03346759|40387682|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
16524112|NCT01465334|40387685|FG000|Overall Study|Disease Progression|1|||
16524113|NCT01465334|40387686|FG001|Overall Study|Disease Progression|0|||
16524114|NCT01465334|40387685|FG000|Overall Study|Adverse Event|1|||
16524115|NCT01465334|40387686|FG001|Overall Study|Adverse Event|0|||
16209272|NCT01517412|39244322|FG001|Overall Study|Lack of Efficacy|5|||
16209273|NCT01517412|39244321|FG000|Overall Study|Poor compliance to protocol|8|||
16209274|NCT01517412|39244322|FG001|Overall Study|Poor compliance to protocol|3|||
16209275|NCT01517412|39244321|FG000|Overall Study|Other than specified above|8|||
16209276|NCT01517412|39244322|FG001|Overall Study|Other than specified above|5|||
16209277|NCT00425945|39244324|FG000|Overall Study|Concern about Supplement|2|||
16209278|NCT00425945|39244325|FG001|Overall Study|Concern about Supplement|0|||
16209279|NCT00425945|39244324|FG000|Overall Study|Inconvenience|0|||
16209280|NCT00425945|39244325|FG001|Overall Study|Inconvenience|2|||
16209281|NCT00425945|39244324|FG000|Overall Study|Lost to Follow-up|0|||
16209282|NCT00425945|39244325|FG001|Overall Study|Lost to Follow-up|2|||
16209283|NCT00425945|39244324|FG000|Overall Study|Began hypertension medication|1|||
16209284|NCT00425945|39244325|FG001|Overall Study|Began hypertension medication|0|||
16209285|NCT00425945|39244324|FG000|Overall Study|Began cancer treatments|1|||
16209286|NCT00425945|39244325|FG001|Overall Study|Began cancer treatments|0|||
16209287|NCT00425945|39244324|FG000|Overall Study|Moved from area|0|||
16209288|NCT00425945|39244325|FG001|Overall Study|Moved from area|1|||
16209289|NCT00251589|39244326|FG000|Overall Study|Adverse Event|5|||
16209290|NCT00251589|39244327|FG001|Overall Study|Adverse Event|1|||
16209291|NCT00251589|39244328|FG002|Overall Study|Adverse Event|2|||
16209292|NCT00251589|39244329|FG003|Overall Study|Adverse Event|1|||
16209293|NCT00251589|39244326|FG000|Overall Study|Withdrawal by Subject|1|||
16209294|NCT00251589|39244327|FG001|Overall Study|Withdrawal by Subject|1|||
16209295|NCT00251589|39244328|FG002|Overall Study|Withdrawal by Subject|0|||
16209296|NCT00251589|39244329|FG003|Overall Study|Withdrawal by Subject|0|||
16209297|NCT00251589|39244326|FG000|Overall Study|Discontinued due to progressive disease|9|||
16209298|NCT00251589|39244327|FG001|Overall Study|Discontinued due to progressive disease|1|||
16209299|NCT00251589|39244328|FG002|Overall Study|Discontinued due to progressive disease|0|||
16209300|NCT00251589|39244329|FG003|Overall Study|Discontinued due to progressive disease|1|||
16328003|NCT02100670|39685498|FG003|Overall Study|Poor Efficacy|0|||
16328004|NCT02100670|39685495|FG000|Overall Study|Physician Decision|0|||
16328005|NCT02100670|39685496|FG001|Overall Study|Physician Decision|1|||
16328006|NCT02100670|39685497|FG002|Overall Study|Physician Decision|0|||
16397388|NCT03162796|39935432|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
16524116|NCT01465334|40387685|FG000|Overall Study|Richter's transformation|0|||
16209301|NCT01041404|39244331|FG000|Overall Study|Adverse Event|45|||
16209302|NCT01041404|39244332|FG001|Overall Study|Adverse Event|35|||
16209303|NCT01041404|39244331|FG000|Overall Study|Lack of Efficacy|200|||
16209304|NCT01041404|39244332|FG001|Overall Study|Lack of Efficacy|210|||
16328007|NCT02100670|39685498|FG003|Overall Study|Physician Decision|0|||
16328008|NCT02100670|39685495|FG000|Overall Study|Withdrawal by Subject|1|||
16328009|NCT02100670|39685496|FG001|Overall Study|Withdrawal by Subject|0|||
16328010|NCT02100670|39685497|FG002|Overall Study|Withdrawal by Subject|0|||
16328011|NCT02100670|39685498|FG003|Overall Study|Withdrawal by Subject|0|||
16328012|NCT02783729|39685499|FG000|Overall Study|Lack of Efficacy|1|||
16328013|NCT02783729|39685500|FG001|Overall Study|Lack of Efficacy|0|||
16328014|NCT02783729|39685501|FG002|Overall Study|Lack of Efficacy|0|||
16328015|NCT02783729|39685502|FG003|Overall Study|Lack of Efficacy|0|||
16209305|NCT01041404|39244331|FG000|Overall Study|Violation of Selection Criteria|0|||
16209306|NCT01041404|39244332|FG001|Overall Study|Violation of Selection Criteria|1|||
16209307|NCT01041404|39244331|FG000|Overall Study|Protocol Violation|4|||
16209308|NCT01041404|39244332|FG001|Overall Study|Protocol Violation|0|||
16209309|NCT01041404|39244331|FG000|Overall Study|Withdrawal by Subject|29|||
16209310|NCT01041404|39244332|FG001|Overall Study|Withdrawal by Subject|23|||
16328016|NCT02783729|39685499|FG000|Overall Study|Adverse Event|2|||
16328017|NCT02783729|39685500|FG001|Overall Study|Adverse Event|6|||
16328018|NCT02783729|39685501|FG002|Overall Study|Adverse Event|2|||
16328019|NCT02783729|39685502|FG003|Overall Study|Adverse Event|3|||
16328020|NCT02783729|39685499|FG000|Overall Study|Other|1|||
16328021|NCT02783729|39685500|FG001|Overall Study|Other|6|||
16328022|NCT02783729|39685501|FG002|Overall Study|Other|2|||
16328023|NCT02783729|39685502|FG003|Overall Study|Other|3|||
16328024|NCT02783729|39685499|FG000|Overall Study|Withdrawal by Subject|2|||
16328025|NCT02783729|39685500|FG001|Overall Study|Withdrawal by Subject|3|||
16328026|NCT02783729|39685501|FG002|Overall Study|Withdrawal by Subject|1|||
16328027|NCT02783729|39685502|FG003|Overall Study|Withdrawal by Subject|2|||
16328028|NCT02783729|39685499|FG000|Overall Study|Participant's choice|2|||
16328029|NCT02783729|39685500|FG001|Overall Study|Participant's choice|1|||
16328030|NCT02783729|39685501|FG002|Overall Study|Participant's choice|2|||
16209311|NCT01041404|39244331|FG000|Overall Study|Failure to Return|1|||
16209312|NCT01041404|39244332|FG001|Overall Study|Failure to Return|2|||
16209313|NCT01041404|39244331|FG000|Overall Study|Other|11|||
16209314|NCT01041404|39244332|FG001|Overall Study|Other|23|||
16209315|NCT03077711|39244333|FG000|Overall Study|Lost to Follow-up|2|||
16328031|NCT02783729|39685502|FG003|Overall Study|Participant's choice|1|||
16328032|NCT02783729|39685499|FG000|Overall Study|Lost to Follow-up|2|||
16328033|NCT02783729|39685500|FG001|Overall Study|Lost to Follow-up|1|||
16328034|NCT02783729|39685501|FG002|Overall Study|Lost to Follow-up|1|||
16328035|NCT02783729|39685502|FG003|Overall Study|Lost to Follow-up|0|||
16328036|NCT02017912|39685503|FG000|Overall Study|Withdrawal by Subject|2|||
16328037|NCT02017912|39685504|FG001|Overall Study|Withdrawal by Subject|1|||
16328038|NCT02017912|39685503|FG000|Overall Study|miscellaneous|1|||
16328039|NCT02017912|39685504|FG001|Overall Study|miscellaneous|1|||
16328040|NCT02345889|39685505|FG000|Overall Study|Inadequate Bowel Prep|17|||
16328041|NCT02345889|39685506|FG001|Overall Study|Inadequate Bowel Prep|16|||
16524117|NCT01465334|40387686|FG001|Overall Study|Richter's transformation|3|||
16524118|NCT01465334|40387685|FG000|Overall Study|Refractory Disease|0|||
16524119|NCT01465334|40387686|FG001|Overall Study|Refractory Disease|3|||
16209316|NCT03077711|39244334|FG001|Overall Study|Lost to Follow-up|2|||
16209317|NCT03077711|39244333|FG000|Overall Study|noncompliant taking medication|2|||
16209318|NCT03077711|39244334|FG001|Overall Study|noncompliant taking medication|0|||
16209319|NCT01496274|39247900|FG000|Overall Study|Protocol Violation|0|||
16209320|NCT01496274|39247901|FG001|Overall Study|Protocol Violation|1|||
16209321|NCT01496274|39247900|FG000|Overall Study|Adverse Event|1|||
16209322|NCT01496274|39247901|FG001|Overall Study|Adverse Event|1|||
16209323|NCT01496274|39247900|FG000|Overall Study|Withdrawal by Subject|2|||
16209324|NCT01496274|39247901|FG001|Overall Study|Withdrawal by Subject|0|||
16209325|NCT01496274|39247900|FG000|Overall Study|Lost to Follow-up|0|||
16209326|NCT01496274|39247901|FG001|Overall Study|Lost to Follow-up|3|||
16209327|NCT02533401|39247903|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
16209328|NCT02533401|39247903|FG000|Overall Study|Death|5|||
16209329|NCT02533401|39247903|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
16209330|NCT02533401|39247903|FG000|Overall Study|Lost to Follow-up|1|||
16209331|NCT02533401|39247903|FG000|Overall Study|Violation of Selection Criteria|1|||
16209332|NCT04445688|39247904|FG000|Washout (One Week)|Adverse Event|2|||
16209333|NCT04445688|39247904|FG000|Washout (One Week)|Withdrawal by Subject|1|||
16209334|NCT00479167|39247905|FG000|Overall Study|Withdrawal by Subject|1|||
16209335|NCT00633893|39247906|FG000|Overall Study|Death|1|||
16328042|NCT02345889|39685507|FG002|Overall Study|Inadequate Bowel Prep|18|||
16328043|NCT02345889|39685508|FG003|Overall Study|Inadequate Bowel Prep|14|||
16524120|NCT00512135|40387687|FG000|Overall Study|Not Treated|5|||
16209336|NCT00633893|39247907|FG001|Overall Study|Death|3|||
16209337|NCT00633893|39247908|FG002|Overall Study|Death|9|||
16524121|NCT00512135|40387687|FG000|Overall Study|Lack of Efficacy|2|||
16209338|NCT00633893|39247906|FG000|Overall Study|Adverse Event|65|||
16209339|NCT00633893|39247907|FG001|Overall Study|Adverse Event|58|||
16209340|NCT00633893|39247908|FG002|Overall Study|Adverse Event|126|||
16209341|NCT00633893|39247906|FG000|Overall Study|Withdrawal by Subject|7|||
16209342|NCT00633893|39247907|FG001|Overall Study|Withdrawal by Subject|12|||
16524122|NCT00512135|40387687|FG000|Overall Study|Adverse Event|6|||
16209343|NCT00633893|39247908|FG002|Overall Study|Withdrawal by Subject|6|||
16209344|NCT00633893|39247906|FG000|Overall Study|Lost to Follow-up|2|||
16209345|NCT00633893|39247907|FG001|Overall Study|Lost to Follow-up|4|||
16209346|NCT00633893|39247908|FG002|Overall Study|Lost to Follow-up|8|||
16209347|NCT00633893|39247906|FG000|Overall Study|Poor/non-compliance|5|||
16209348|NCT00633893|39247907|FG001|Overall Study|Poor/non-compliance|12|||
16209349|NCT00633893|39247908|FG002|Overall Study|Poor/non-compliance|3|||
16209350|NCT00633893|39247906|FG000|Overall Study|Pregnancy|2|||
16209351|NCT00633893|39247907|FG001|Overall Study|Pregnancy|1|||
16209352|NCT00633893|39247908|FG002|Overall Study|Pregnancy|1|||
16209353|NCT00633893|39247906|FG000|Overall Study|Not meet/no longer meets criteria|4|||
16209354|NCT00633893|39247907|FG001|Overall Study|Not meet/no longer meets criteria|6|||
16209355|NCT00633893|39247908|FG002|Overall Study|Not meet/no longer meets criteria|4|||
16328044|NCT02345889|39685505|FG000|Overall Study|Polyposis identified during procedure|1|||
16328045|NCT02345889|39685506|FG001|Overall Study|Polyposis identified during procedure|1|||
16328046|NCT02345889|39685507|FG002|Overall Study|Polyposis identified during procedure|0|||
16328047|NCT02345889|39685508|FG003|Overall Study|Polyposis identified during procedure|1|||
16328048|NCT02345889|39685505|FG000|Overall Study|Recognized ineligible post-randomization|1|||
16328049|NCT02345889|39685506|FG001|Overall Study|Recognized ineligible post-randomization|0|||
16328050|NCT02345889|39685507|FG002|Overall Study|Recognized ineligible post-randomization|2|||
16328051|NCT02345889|39685508|FG003|Overall Study|Recognized ineligible post-randomization|1|||
16209356|NCT00633893|39247906|FG000|Overall Study|Other|28|||
16209357|NCT00633893|39247907|FG001|Overall Study|Other|33|||
16209358|NCT00633893|39247908|FG002|Overall Study|Other|31|||
16209359|NCT00498368|39247909|FG000|Overall Study|Withdrawal by Subject|3|||
16209360|NCT00498368|39247910|FG001|Overall Study|Withdrawal by Subject|2|||
16209361|NCT02580591|39247911|FG000|Overall Study|Adverse Event|0|||
16209362|NCT02580591|39247912|FG001|Overall Study|Adverse Event|1|||
16328052|NCT02345889|39685505|FG000|Overall Study|Ulcerative Colitis identified|1|||
16328053|NCT02345889|39685506|FG001|Overall Study|Ulcerative Colitis identified|0|||
16328054|NCT02345889|39685507|FG002|Overall Study|Ulcerative Colitis identified|0|||
16328055|NCT02345889|39685508|FG003|Overall Study|Ulcerative Colitis identified|0|||
16328056|NCT02345889|39685505|FG000|Overall Study|Cecum not intubated|1|||
16328057|NCT02345889|39685506|FG001|Overall Study|Cecum not intubated|0|||
16328058|NCT02345889|39685507|FG002|Overall Study|Cecum not intubated|0|||
16328059|NCT02345889|39685508|FG003|Overall Study|Cecum not intubated|0|||
16328060|NCT01565668|39685509|FG000|Overall Study|Death|2|||
16328061|NCT01565668|39685510|FG001|Overall Study|Death|1|||
16328062|NCT01565668|39685509|FG000|Overall Study|Lack of Efficacy|4|||
16328063|NCT01565668|39685510|FG001|Overall Study|Lack of Efficacy|2|||
16328064|NCT01565668|39685509|FG000|Overall Study|Participant went on Hospice Care|1|||
16328065|NCT01565668|39685510|FG001|Overall Study|Participant went on Hospice Care|0|||
16328066|NCT01565668|39685509|FG000|Overall Study|Adverse Event|6|||
16328067|NCT01565668|39685510|FG001|Overall Study|Adverse Event|1|||
16328068|NCT01565668|39685509|FG000|Overall Study|Randomized, but never received drug|0|||
16328069|NCT01565668|39685510|FG001|Overall Study|Randomized, but never received drug|2|||
16328070|NCT01565668|39685509|FG000|Overall Study|Progressive disease|13|||
16328071|NCT01565668|39685510|FG001|Overall Study|Progressive disease|14|||
16328072|NCT01565668|39685509|FG000|Overall Study|Withdrawal by Subject|1|||
16328073|NCT01565668|39685510|FG001|Overall Study|Withdrawal by Subject|3|||
16328074|NCT01565668|39685509|FG000|Overall Study|HSCT Transplant|11|||
16328075|NCT01565668|39685510|FG001|Overall Study|HSCT Transplant|15|||
16328076|NCT00968981|39685513|FG000|Overall Study|Adverse Event|2|||
16328077|NCT00968981|39685514|FG001|Overall Study|Adverse Event|0|||
16328078|NCT00968981|39685515|FG002|Overall Study|Adverse Event|0|||
16328079|NCT00968981|39685513|FG000|Overall Study|Disease Progression|14|||
16328080|NCT00968981|39685514|FG001|Overall Study|Disease Progression|16|||
16328081|NCT00968981|39685515|FG002|Overall Study|Disease Progression|13|||
16328082|NCT00968981|39685513|FG000|Overall Study|Lost to Follow-up|0|||
16328083|NCT00968981|39685514|FG001|Overall Study|Lost to Follow-up|0|||
16328084|NCT00968981|39685515|FG002|Overall Study|Lost to Follow-up|1|||
16328085|NCT00968981|39685513|FG000|Overall Study|Physician Decision|5|||
16328086|NCT00968981|39685514|FG001|Overall Study|Physician Decision|3|||
16328087|NCT00968981|39685515|FG002|Overall Study|Physician Decision|5|||
16328088|NCT00968981|39685513|FG000|Overall Study|Withdrawal by Subject|1|||
16328089|NCT00968981|39685514|FG001|Overall Study|Withdrawal by Subject|3|||
16328090|NCT00968981|39685515|FG002|Overall Study|Withdrawal by Subject|3|||
16328091|NCT01925131|39685516|FG000|Overall Study|Death|0|||
16328092|NCT01925131|39685517|FG001|Overall Study|Death|0|||
16095818|NCT00441168|38842601|FG001|Treatment Period|Protocol Violation|1|||
16209363|NCT02580591|39247913|FG002|Overall Study|Adverse Event|2|||
16328093|NCT01925131|39685518|FG002|Overall Study|Death|1|||
16209364|NCT02580591|39247914|FG003|Overall Study|Adverse Event|5|||
16209365|NCT02580591|39247911|FG000|Overall Study|Protocol Violation|3|||
16209366|NCT02580591|39247912|FG001|Overall Study|Protocol Violation|2|||
16209367|NCT02580591|39247913|FG002|Overall Study|Protocol Violation|1|||
16209368|NCT02580591|39247914|FG003|Overall Study|Protocol Violation|1|||
16328094|NCT01925131|39685519|FG003|Overall Study|Death|0|||
16328095|NCT01925131|39685520|FG004|Overall Study|Death|0|||
16328096|NCT01925131|39685521|FG005|Overall Study|Death|0|||
16328097|NCT01925131|39685516|FG000|Overall Study|Progression/Relapse|1|||
16328098|NCT01925131|39685517|FG001|Overall Study|Progression/Relapse|1|||
16328099|NCT01925131|39685518|FG002|Overall Study|Progression/Relapse|4|||
16328100|NCT01925131|39685519|FG003|Overall Study|Progression/Relapse|0|||
16328101|NCT01925131|39685520|FG004|Overall Study|Progression/Relapse|0|||
16328102|NCT01925131|39685521|FG005|Overall Study|Progression/Relapse|1|||
16328103|NCT01925131|39685516|FG000|Overall Study|Patient Refusal|1|||
16328104|NCT01925131|39685517|FG001|Overall Study|Patient Refusal|0|||
16328105|NCT01925131|39685518|FG002|Overall Study|Patient Refusal|0|||
16328106|NCT01925131|39685519|FG003|Overall Study|Patient Refusal|0|||
16209369|NCT02580591|39247911|FG000|Overall Study|Lost to Follow-up|5|||
16209370|NCT02580591|39247912|FG001|Overall Study|Lost to Follow-up|3|||
16209371|NCT02580591|39247913|FG002|Overall Study|Lost to Follow-up|3|||
16209372|NCT02580591|39247914|FG003|Overall Study|Lost to Follow-up|1|||
16209373|NCT02580591|39247911|FG000|Overall Study|Withdrawal by Subject|6|||
16328107|NCT01925131|39685520|FG004|Overall Study|Patient Refusal|0|||
16328108|NCT01925131|39685521|FG005|Overall Study|Patient Refusal|0|||
16328109|NCT01925131|39685516|FG000|Overall Study|Adverse Event|0|||
16328110|NCT01925131|39685517|FG001|Overall Study|Adverse Event|0|||
16328111|NCT01925131|39685518|FG002|Overall Study|Adverse Event|2|||
16328112|NCT01925131|39685519|FG003|Overall Study|Adverse Event|0|||
16328113|NCT01925131|39685520|FG004|Overall Study|Adverse Event|1|||
16328114|NCT01925131|39685521|FG005|Overall Study|Adverse Event|3|||
16328115|NCT01925131|39685516|FG000|Overall Study|Other - Not Protocol Specified|3|||
16328116|NCT01925131|39685517|FG001|Overall Study|Other - Not Protocol Specified|1|||
16328117|NCT01925131|39685518|FG002|Overall Study|Other - Not Protocol Specified|2|||
16328118|NCT01925131|39685519|FG003|Overall Study|Other - Not Protocol Specified|5|||
16328119|NCT01925131|39685520|FG004|Overall Study|Other - Not Protocol Specified|10|||
16328120|NCT01925131|39685521|FG005|Overall Study|Other - Not Protocol Specified|6|||
16328121|NCT03589976|39685522|FG000|Overall Study|Death|5|||
16328122|NCT03589976|39685523|FG001|Overall Study|Death|1|||
16328123|NCT03589976|39685522|FG000|Overall Study|Adverse Event|5|||
16328124|NCT03589976|39685523|FG001|Overall Study|Adverse Event|1|||
16209374|NCT02580591|39247912|FG001|Overall Study|Withdrawal by Subject|1|||
16209375|NCT02580591|39247913|FG002|Overall Study|Withdrawal by Subject|2|||
16209376|NCT02580591|39247914|FG003|Overall Study|Withdrawal by Subject|3|||
16209377|NCT02580591|39247911|FG000|Overall Study|Not treated|1|||
16328125|NCT03589976|39685522|FG000|Overall Study|Withdrawal by Subject|4|||
16328126|NCT03589976|39685523|FG001|Overall Study|Withdrawal by Subject|1|||
16328127|NCT03589976|39685522|FG000|Overall Study|Lost to Follow-up|1|||
16328128|NCT03589976|39685523|FG001|Overall Study|Lost to Follow-up|0|||
16328129|NCT03589976|39685522|FG000|Overall Study|Other|4|||
16328130|NCT03589976|39685523|FG001|Overall Study|Other|3|||
16328131|NCT02832375|39685524|FG000|Overall Study|Lost to Follow-up|1|||
16328132|NCT02832375|39685525|FG001|Overall Study|Lost to Follow-up|0|||
16209378|NCT02580591|39247912|FG001|Overall Study|Not treated|1|||
16209379|NCT02580591|39247913|FG002|Overall Study|Not treated|0|||
16524123|NCT00512135|40387687|FG000|Overall Study|Withdrawal by Subject|22|||
16524124|NCT00512135|40387687|FG000|Overall Study|Lost to Follow-up|27|||
16209380|NCT02580591|39247914|FG003|Overall Study|Not treated|0|||
16209381|NCT02580591|39247911|FG000|Overall Study|Other than specified|3|||
16209382|NCT02580591|39247912|FG001|Overall Study|Other than specified|2|||
16209383|NCT02580591|39247913|FG002|Overall Study|Other than specified|5|||
16209384|NCT02580591|39247914|FG003|Overall Study|Other than specified|2|||
16209385|NCT01929707|39247915|FG000|Intervention Period 1|Lost to Follow-up|0|||
16209386|NCT01929707|39247916|FG001|Intervention Period 1|Lost to Follow-up|0|||
16209387|NCT01929707|39247917|FG002|Intervention Period 1|Lost to Follow-up|0|||
16209388|NCT01929707|39247918|FG003|Intervention Period 1|Lost to Follow-up|1|||
16209389|NCT01929707|39247919|FG004|Intervention Period 1|Lost to Follow-up|0|||
16209390|NCT01929707|39247920|FG005|Intervention Period 1|Lost to Follow-up|0|||
16209391|NCT01929707|39247921|FG006|Intervention Period 1|Lost to Follow-up|0|||
16209392|NCT01929707|39247922|FG007|Intervention Period 1|Lost to Follow-up|0|||
16328133|NCT02832375|39685524|FG000|Overall Study|Withdrawal of Consent|1|||
16328134|NCT02832375|39685525|FG001|Overall Study|Withdrawal of Consent|0|||
16328135|NCT00459706|39685533|FG000|Overall Study|Adverse Event|19|||
16328136|NCT00459706|39685534|FG001|Overall Study|Adverse Event|13|||
16328137|NCT00459706|39685533|FG000|Overall Study|Withdrawal by Subject|1|||
16328138|NCT00459706|39685534|FG001|Overall Study|Withdrawal by Subject|6|||
16524125|NCT00512135|40387687|FG000|Overall Study|Other|22|||
16524126|NCT02770391|40387690|FG000|Overall Study|Lost to Follow-up|2|||
16209393|NCT01929707|39247915|FG000|Intervention Period 1|Withdrawal by Subject|0|||
16209394|NCT01929707|39247916|FG001|Intervention Period 1|Withdrawal by Subject|0|||
16209395|NCT01929707|39247917|FG002|Intervention Period 1|Withdrawal by Subject|0|||
16328139|NCT00459706|39685533|FG000|Overall Study|Physician Decision|2|||
16328140|NCT00459706|39685534|FG001|Overall Study|Physician Decision|0|||
16524127|NCT02770391|40387690|FG000|Overall Study|Withdrawal by Subject|1|||
16209396|NCT01929707|39247918|FG003|Intervention Period 1|Withdrawal by Subject|2|||
16209397|NCT01929707|39247919|FG004|Intervention Period 1|Withdrawal by Subject|0|||
16209398|NCT01929707|39247920|FG005|Intervention Period 1|Withdrawal by Subject|0|||
16209399|NCT01929707|39247921|FG006|Intervention Period 1|Withdrawal by Subject|0|||
16209400|NCT01929707|39247922|FG007|Intervention Period 1|Withdrawal by Subject|0|||
16209401|NCT01929707|39247915|FG000|Intervention Period 2|Withdrawal by Subject|0|||
16209402|NCT01929707|39247916|FG001|Intervention Period 2|Withdrawal by Subject|0|||
16209403|NCT01929707|39247917|FG002|Intervention Period 2|Withdrawal by Subject|0|||
16209404|NCT01929707|39247918|FG003|Intervention Period 2|Withdrawal by Subject|0|||
16209405|NCT01929707|39247919|FG004|Intervention Period 2|Withdrawal by Subject|0|||
16209406|NCT01929707|39247920|FG005|Intervention Period 2|Withdrawal by Subject|2|||
16209407|NCT01929707|39247921|FG006|Intervention Period 2|Withdrawal by Subject|0|||
16209408|NCT01929707|39247922|FG007|Intervention Period 2|Withdrawal by Subject|0|||
16209409|NCT01302691|39247927|FG000|Overall Study|Adverse Event|2|||
16209410|NCT01302691|39247928|FG001|Overall Study|Adverse Event|0|||
16209411|NCT01302691|39247927|FG000|Overall Study|Death|0|||
16209412|NCT01302691|39247928|FG001|Overall Study|Death|1|||
16209413|NCT01302691|39247927|FG000|Overall Study|Lost to Follow-up|1|||
16209414|NCT01302691|39247928|FG001|Overall Study|Lost to Follow-up|0|||
16209415|NCT01302691|39247927|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
16209416|NCT01302691|39247928|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
16209417|NCT01302691|39247927|FG000|Overall Study|Physician Decision|0|||
16209418|NCT01302691|39247928|FG001|Overall Study|Physician Decision|1|||
16209419|NCT01302691|39247927|FG000|Overall Study|Protocol Violation|1|||
16209420|NCT01302691|39247928|FG001|Overall Study|Protocol Violation|0|||
16209421|NCT02007252|39247929|FG000|Overall Study|Administrative problems|3|||
16209422|NCT02007252|39247930|FG001|Overall Study|Administrative problems|7|||
16328141|NCT00459706|39685533|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
16328142|NCT00459706|39685534|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
16328143|NCT00459706|39685533|FG000|Overall Study|Protocol Violation|2|||
16328144|NCT00459706|39685534|FG001|Overall Study|Protocol Violation|1|||
16328145|NCT00459706|39685533|FG000|Overall Study|Failed to Return|1|||
16328146|NCT00459706|39685534|FG001|Overall Study|Failed to Return|0|||
16328147|NCT00459706|39685533|FG000|Overall Study|Other|0|||
16328148|NCT00459706|39685534|FG001|Overall Study|Other|1|||
16328149|NCT04484142|39687686|FG000|Overall Study|Adverse Event|13|||
16328150|NCT04484142|39687686|FG000|Overall Study|Progressive Disease|87|||
16328151|NCT04484142|39687686|FG000|Overall Study|Clinical Progression|10|||
16328152|NCT04484142|39687686|FG000|Overall Study|Withdrawal by Subject|6|||
16328153|NCT04484142|39687686|FG000|Overall Study|Physician Decision|1|||
16328154|NCT00834639|39687690|FG000|Second Intervention|Physician Decision|0|||
16328155|NCT00834639|39687691|FG001|Second Intervention|Physician Decision|2|||
16328156|NCT02031640|39687695|FG000|Screening Period|Adverse Event|1|||
16328157|NCT02031640|39687696|FG001|Screening Period|Adverse Event|0|||
16328158|NCT02031640|39687697|FG002|Screening Period|Adverse Event|0|||
16524128|NCT02770391|40387690|FG000|Overall Study|Surgery delayed unevaluable|2|||
16524129|NCT02770391|40387690|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
16524130|NCT03574389|40387691|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
16524131|NCT03574389|40387692|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
16524132|NCT03574389|40387693|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
16524133|NCT03574389|40387694|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
16524134|NCT03574389|40387695|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
16524135|NCT03574389|40387696|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
16524136|NCT03574389|40387697|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
16524137|NCT03574389|40387691|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
16524138|NCT03574389|40387692|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
16524139|NCT03574389|40387693|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
16524140|NCT03574389|40387694|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
16524141|NCT03574389|40387695|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
16524142|NCT03574389|40387696|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
16524143|NCT03574389|40387697|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
16524144|NCT03574389|40387691|FG000|Vaccination Period|Other|6|||
16524145|NCT03574389|40387692|FG001|Vaccination Period|Other|0|||
16524146|NCT03574389|40387693|FG002|Vaccination Period|Other|0|||
16524147|NCT03574389|40387694|FG003|Vaccination Period|Other|0|||
16524148|NCT03574389|40387695|FG004|Vaccination Period|Other|0|||
16328159|NCT02031640|39687698|FG003|Screening Period|Adverse Event|0|||
16328160|NCT02031640|39687699|FG004|Screening Period|Adverse Event|0|||
16328161|NCT02031640|39687700|FG005|Screening Period|Adverse Event|0|||
16328162|NCT02031640|39687695|FG000|Screening Period|Withdrawal by Subject|29|||
16524149|NCT03574389|40387696|FG005|Vaccination Period|Other|0|||
16524150|NCT03574389|40387697|FG006|Vaccination Period|Other|0|||
16524151|NCT03574389|40387691|FG000|Vaccination Period|Adverse Event|0|||
16524152|NCT03574389|40387692|FG001|Vaccination Period|Adverse Event|1|||
16209423|NCT02007252|39247929|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16209424|NCT02007252|39247930|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16209425|NCT02007252|39247929|FG000|Overall Study|Adverse Event|7|||
16209426|NCT02007252|39247930|FG001|Overall Study|Adverse Event|4|||
16209427|NCT02911519|39247931|FG000|Overall Study|Lost to Follow-up|2|||
16209428|NCT02911519|39247932|FG001|Overall Study|Lost to Follow-up|2|||
16209429|NCT02911519|39247931|FG000|Overall Study|Death|0|||
16095819|NCT00441168|38842600|FG000|Treatment Period|Lost to Follow-up|0|||
16095820|NCT00441168|38842601|FG001|Treatment Period|Lost to Follow-up|1|||
16095821|NCT00441168|38842600|FG000|Treatment Period|Withdrawal by Subject|3|||
16095822|NCT00441168|38842601|FG001|Treatment Period|Withdrawal by Subject|0|||
16209430|NCT02911519|39247932|FG001|Overall Study|Death|2|||
16209431|NCT03124407|39247933|FG000|Overall Study|Lost to Follow-up|1|||
16209432|NCT03124407|39247934|FG001|Overall Study|Lost to Follow-up|0|||
16209433|NCT03124407|39247935|FG002|Overall Study|Lost to Follow-up|0|||
16095823|NCT00441168|38842600|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
16095824|NCT00441168|38842601|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
16095825|NCT00441168|38842600|FG000|Treatment Period|refractory disease|1|||
16095826|NCT00441168|38842601|FG001|Treatment Period|refractory disease|0|||
16095827|NCT00441168|38842600|FG000|Follow-up Period|Death|3|||
16095828|NCT00441168|38842601|FG001|Follow-up Period|Death|0|||
16095829|NCT00441168|38842600|FG000|Follow-up Period|Lost to Follow-up|5|||
16095830|NCT00441168|38842601|FG001|Follow-up Period|Lost to Follow-up|6|||
16095831|NCT00441168|38842600|FG000|Follow-up Period|Withdrawal by Subject|3|||
16095832|NCT00441168|38842601|FG001|Follow-up Period|Withdrawal by Subject|0|||
16095833|NCT00441168|38842600|FG000|Follow-up Period|Other|1|||
16095834|NCT00441168|38842601|FG001|Follow-up Period|Other|3|||
16095835|NCT02722278|38842606|FG000|Overall Study|Withdrawal by Subject|5|||
16095836|NCT02722278|38842607|FG001|Overall Study|Withdrawal by Subject|3|||
16095837|NCT02722278|38842606|FG000|Overall Study|Adverse Event|4|||
16095838|NCT02722278|38842607|FG001|Overall Study|Adverse Event|1|||
16095839|NCT02722278|38842606|FG000|Overall Study|Lost to Follow-up|2|||
16095840|NCT02722278|38842607|FG001|Overall Study|Lost to Follow-up|0|||
16209434|NCT03124407|39247936|FG003|Overall Study|Lost to Follow-up|0|||
16397389|NCT03162796|39935433|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
16397390|NCT03162796|39935434|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
16397391|NCT03162796|39935432|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
16397392|NCT03162796|39935433|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
16397393|NCT03162796|39935434|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
16397394|NCT03162796|39935432|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
16397395|NCT03162796|39935433|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
16397396|NCT03162796|39935434|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
16397397|NCT03370419|39935445|FG000|Overall Study|Lost to Follow-up|16|||
16397398|NCT02725476|39935450|FG000|Overall Study|Physician Decision|2|||
16397399|NCT02725476|39935451|FG001|Overall Study|Physician Decision|0|||
16397400|NCT02725476|39935450|FG000|Overall Study|Adverse Event|1|||
16397401|NCT02725476|39935451|FG001|Overall Study|Adverse Event|1|||
16397402|NCT00005947|39935452|FG000|Overall Study|Death|54|||
16397403|NCT00005947|39935453|FG001|Overall Study|Death|40|||
16397404|NCT00005947|39935452|FG000|Overall Study|Patient Refused to Continue|2|||
16397405|NCT00005947|39935453|FG001|Overall Study|Patient Refused to Continue|1|||
16397406|NCT00005947|39935452|FG000|Overall Study|Site Closure|1|||
16397407|NCT00005947|39935453|FG001|Overall Study|Site Closure|0|||
16397408|NCT00182078|39935454|FG000|Overall Study|Withdrawal by Subject|1|||
16397409|NCT00182078|39935455|FG001|Overall Study|Withdrawal by Subject|0|||
16397410|NCT01916824|39935463|FG000|Overall Study|Lost to Follow-up|3|||
16397411|NCT01916824|39935464|FG001|Overall Study|Lost to Follow-up|6|||
16524153|NCT03574389|40387693|FG002|Vaccination Period|Adverse Event|0|||
16524154|NCT03574389|40387694|FG003|Vaccination Period|Adverse Event|0|||
16524155|NCT03574389|40387695|FG004|Vaccination Period|Adverse Event|0|||
16524156|NCT03574389|40387696|FG005|Vaccination Period|Adverse Event|0|||
16524157|NCT03574389|40387697|FG006|Vaccination Period|Adverse Event|0|||
16524158|NCT03574389|40387691|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
16524159|NCT03574389|40387692|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
16524160|NCT03574389|40387693|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
16524161|NCT03574389|40387694|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
16524162|NCT03574389|40387695|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
16524163|NCT03574389|40387696|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
16524164|NCT03574389|40387697|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
16524165|NCT01181921|40387702|FG000|Overall Study|Lost to Follow-up|1|||
16095841|NCT02722278|38842606|FG000|Overall Study|Protocol Violation|1|||
16095842|NCT02722278|38842607|FG001|Overall Study|Protocol Violation|0|||
16095843|NCT02722278|38842606|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
16095844|NCT02722278|38842607|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
16209435|NCT03124407|39247933|FG000|Overall Study|Adverse Event|0|||
16209436|NCT03124407|39247934|FG001|Overall Study|Adverse Event|0|||
16209437|NCT03124407|39247935|FG002|Overall Study|Adverse Event|1|||
16095845|NCT02722278|38842606|FG000|Overall Study|Subject declined after tx assignment|0|||
16095846|NCT02722278|38842607|FG001|Overall Study|Subject declined after tx assignment|1|||
16095847|NCT02722278|38842606|FG000|Overall Study|Site closure not study related|0|||
16328163|NCT02031640|39687696|FG001|Screening Period|Withdrawal by Subject|0|||
16328164|NCT02031640|39687697|FG002|Screening Period|Withdrawal by Subject|0|||
16328165|NCT02031640|39687698|FG003|Screening Period|Withdrawal by Subject|0|||
16328166|NCT02031640|39687699|FG004|Screening Period|Withdrawal by Subject|0|||
16328167|NCT02031640|39687700|FG005|Screening Period|Withdrawal by Subject|0|||
16328168|NCT02031640|39687695|FG000|Screening Period|Inclusion criteria not met|312|||
16328169|NCT02031640|39687696|FG001|Screening Period|Inclusion criteria not met|0|||
16328170|NCT02031640|39687697|FG002|Screening Period|Inclusion criteria not met|0|||
16328171|NCT02031640|39687698|FG003|Screening Period|Inclusion criteria not met|0|||
16328172|NCT02031640|39687699|FG004|Screening Period|Inclusion criteria not met|0|||
16328173|NCT02031640|39687700|FG005|Screening Period|Inclusion criteria not met|0|||
16524166|NCT00852397|40387711|FG000|Overall Study|Adverse Event|4|||
16524167|NCT00852397|40387712|FG001|Overall Study|Adverse Event|6|||
16524168|NCT00852397|40387713|FG002|Overall Study|Adverse Event|4|||
16524169|NCT00852397|40387711|FG000|Overall Study|Death|0|||
16524170|NCT00852397|40387712|FG001|Overall Study|Death|0|||
16524171|NCT00852397|40387713|FG002|Overall Study|Death|1|||
16524172|NCT00852397|40387711|FG000|Overall Study|Withdrawal by Subject|4|||
16524173|NCT00852397|40387712|FG001|Overall Study|Withdrawal by Subject|1|||
16524174|NCT00852397|40387713|FG002|Overall Study|Withdrawal by Subject|2|||
16328174|NCT02031640|39687695|FG000|Screening Period|Exclusion criteria met|30|||
16328175|NCT02031640|39687696|FG001|Screening Period|Exclusion criteria met|0|||
16328176|NCT02031640|39687697|FG002|Screening Period|Exclusion criteria met|0|||
16328177|NCT02031640|39687698|FG003|Screening Period|Exclusion criteria met|0|||
16328178|NCT02031640|39687699|FG004|Screening Period|Exclusion criteria met|0|||
16328179|NCT02031640|39687700|FG005|Screening Period|Exclusion criteria met|0|||
16328180|NCT02031640|39687695|FG000|Screening Period|Lost to Follow-up|14|||
16328181|NCT02031640|39687696|FG001|Screening Period|Lost to Follow-up|0|||
16328182|NCT02031640|39687697|FG002|Screening Period|Lost to Follow-up|0|||
16328183|NCT02031640|39687698|FG003|Screening Period|Lost to Follow-up|0|||
16328184|NCT02031640|39687699|FG004|Screening Period|Lost to Follow-up|0|||
16328185|NCT02031640|39687700|FG005|Screening Period|Lost to Follow-up|0|||
16328186|NCT02031640|39687695|FG000|Screening Period|Enrollment closed|26|||
16328187|NCT02031640|39687696|FG001|Screening Period|Enrollment closed|0|||
16328188|NCT02031640|39687697|FG002|Screening Period|Enrollment closed|0|||
16328189|NCT02031640|39687698|FG003|Screening Period|Enrollment closed|0|||
16328190|NCT02031640|39687699|FG004|Screening Period|Enrollment closed|0|||
16328191|NCT02031640|39687700|FG005|Screening Period|Enrollment closed|0|||
16328192|NCT02031640|39687695|FG000|Run-In Period|Adverse Event|4|||
16328193|NCT02031640|39687696|FG001|Run-In Period|Adverse Event|0|||
16328194|NCT02031640|39687697|FG002|Run-In Period|Adverse Event|0|||
16328195|NCT02031640|39687698|FG003|Run-In Period|Adverse Event|0|||
16328196|NCT02031640|39687699|FG004|Run-In Period|Adverse Event|0|||
16328197|NCT02031640|39687700|FG005|Run-In Period|Adverse Event|0|||
16328198|NCT02031640|39687695|FG000|Run-In Period|Withdrawal by Subject|17|||
16328199|NCT02031640|39687696|FG001|Run-In Period|Withdrawal by Subject|0|||
16328200|NCT02031640|39687697|FG002|Run-In Period|Withdrawal by Subject|0|||
16328201|NCT02031640|39687698|FG003|Run-In Period|Withdrawal by Subject|0|||
16328202|NCT02031640|39687699|FG004|Run-In Period|Withdrawal by Subject|0|||
16328203|NCT02031640|39687700|FG005|Run-In Period|Withdrawal by Subject|0|||
16328204|NCT02031640|39687695|FG000|Run-In Period|Inclusion criteria not met|38|||
16328205|NCT02031640|39687696|FG001|Run-In Period|Inclusion criteria not met|0|||
16328206|NCT02031640|39687697|FG002|Run-In Period|Inclusion criteria not met|0|||
16328207|NCT02031640|39687698|FG003|Run-In Period|Inclusion criteria not met|0|||
16328208|NCT02031640|39687699|FG004|Run-In Period|Inclusion criteria not met|0|||
16328209|NCT02031640|39687700|FG005|Run-In Period|Inclusion criteria not met|0|||
16328210|NCT02031640|39687695|FG000|Run-In Period|Exclusion criteria met|8|||
16328211|NCT02031640|39687696|FG001|Run-In Period|Exclusion criteria met|0|||
16328212|NCT02031640|39687697|FG002|Run-In Period|Exclusion criteria met|0|||
16328213|NCT02031640|39687698|FG003|Run-In Period|Exclusion criteria met|0|||
16328214|NCT02031640|39687699|FG004|Run-In Period|Exclusion criteria met|0|||
16328215|NCT02031640|39687700|FG005|Run-In Period|Exclusion criteria met|0|||
16328216|NCT02031640|39687695|FG000|Run-In Period|Randomization criteria not met|85|||
16328217|NCT02031640|39687696|FG001|Run-In Period|Randomization criteria not met|0|||
16328218|NCT02031640|39687697|FG002|Run-In Period|Randomization criteria not met|0|||
16328219|NCT02031640|39687698|FG003|Run-In Period|Randomization criteria not met|0|||
16524175|NCT00852397|40387711|FG000|Overall Study|Study terminated by sponsor|2|||
16328220|NCT02031640|39687699|FG004|Run-In Period|Randomization criteria not met|0|||
16328221|NCT02031640|39687700|FG005|Run-In Period|Randomization criteria not met|0|||
16328222|NCT02031640|39687695|FG000|Run-In Period|Various administrative reasons|17|||
16524176|NCT00852397|40387712|FG001|Overall Study|Study terminated by sponsor|1|||
16524177|NCT00852397|40387713|FG002|Overall Study|Study terminated by sponsor|6|||
16524178|NCT00852397|40387711|FG000|Overall Study|Difficulty in study site visit|1|||
16524179|NCT00852397|40387712|FG001|Overall Study|Difficulty in study site visit|0|||
16095848|NCT02722278|38842607|FG001|Overall Study|Site closure not study related|1|||
16095849|NCT00942188|38842608|FG000|Overall Study|Adverse Event|0|||
16095850|NCT00942188|38842609|FG001|Overall Study|Adverse Event|3|||
16095851|NCT00942188|38842610|FG002|Overall Study|Adverse Event|2|||
16095852|NCT00942188|38842611|FG003|Overall Study|Adverse Event|0|||
16095853|NCT00942188|38842608|FG000|Overall Study|Lack of Efficacy|0|||
16095854|NCT00942188|38842609|FG001|Overall Study|Lack of Efficacy|0|||
16095855|NCT00942188|38842610|FG002|Overall Study|Lack of Efficacy|0|||
16095856|NCT00942188|38842611|FG003|Overall Study|Lack of Efficacy|1|||
16095857|NCT00942188|38842608|FG000|Overall Study|Protocol Violation|1|||
16095858|NCT00942188|38842609|FG001|Overall Study|Protocol Violation|1|||
16095859|NCT00942188|38842610|FG002|Overall Study|Protocol Violation|0|||
16397412|NCT01916824|39935463|FG000|Overall Study|Physician Decision|2|||
16397413|NCT01916824|39935464|FG001|Overall Study|Physician Decision|0|||
16397414|NCT01916824|39935463|FG000|Overall Study|Withdrawal by Subject|2|||
16397415|NCT01916824|39935464|FG001|Overall Study|Withdrawal by Subject|3|||
16397416|NCT02263326|39935465|FG000|Overall Study|Lost to Follow-up|1|||
16397417|NCT02263326|39935466|FG001|Overall Study|Lost to Follow-up|1|||
16397418|NCT01606176|39935473|FG000|Overall Study|Adverse Event|2|||
16397419|NCT01606176|39935474|FG001|Overall Study|Adverse Event|3|||
16095860|NCT00942188|38842611|FG003|Overall Study|Protocol Violation|0|||
16095861|NCT00942188|38842608|FG000|Overall Study|Lost to Follow-up|2|||
16095862|NCT00942188|38842609|FG001|Overall Study|Lost to Follow-up|1|||
16095863|NCT00942188|38842610|FG002|Overall Study|Lost to Follow-up|2|||
16095864|NCT00942188|38842611|FG003|Overall Study|Lost to Follow-up|0|||
16095865|NCT00942188|38842608|FG000|Overall Study|Withdrawal by Subject|1|||
16095866|NCT00942188|38842609|FG001|Overall Study|Withdrawal by Subject|3|||
16095867|NCT00942188|38842610|FG002|Overall Study|Withdrawal by Subject|4|||
16095868|NCT00942188|38842611|FG003|Overall Study|Withdrawal by Subject|2|||
16095869|NCT00942188|38842608|FG000|Overall Study|Physician Decision|0|||
16095870|NCT00942188|38842609|FG001|Overall Study|Physician Decision|0|||
16095871|NCT00942188|38842610|FG002|Overall Study|Physician Decision|1|||
16095872|NCT00942188|38842611|FG003|Overall Study|Physician Decision|0|||
16095873|NCT00942188|38842608|FG000|Overall Study|Sponsor Decision|0|||
16095874|NCT00942188|38842609|FG001|Overall Study|Sponsor Decision|2|||
16095875|NCT00942188|38842610|FG002|Overall Study|Sponsor Decision|0|||
16095876|NCT00942188|38842611|FG003|Overall Study|Sponsor Decision|1|||
16095877|NCT00609245|38842612|FG000|Overall Study|Adverse Event|1|||
16397420|NCT01606176|39935473|FG000|Overall Study|Disease progression|1|||
16397421|NCT01606176|39935474|FG001|Overall Study|Disease progression|0|||
16524180|NCT00852397|40387713|FG002|Overall Study|Difficulty in study site visit|0|||
16524181|NCT00852397|40387711|FG000|Overall Study|Protocol Violation|0|||
16524182|NCT00852397|40387712|FG001|Overall Study|Protocol Violation|0|||
16524183|NCT00852397|40387713|FG002|Overall Study|Protocol Violation|1|||
16524184|NCT02032901|40387714|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
16524185|NCT02032901|40387715|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
16524186|NCT02032901|40387714|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
16095878|NCT03696342|38842613|FG000|Overall Study|Lost to Follow-up|1|||
16095879|NCT03696342|38842614|FG001|Overall Study|Lost to Follow-up|0|||
16095880|NCT03686176|38842615|FG000|Overall Study|Procedure cancelled|1|||
16095881|NCT03686176|38842616|FG001|Overall Study|Procedure cancelled|0|||
16524187|NCT02032901|40387715|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
16524188|NCT01324024|40387718|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
16524189|NCT01324024|40387719|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16524190|NCT00835406|40387720|FG000|Period: First Intervention|Adverse Event|0|||
16524191|NCT00835406|40387721|FG001|Period: First Intervention|Adverse Event|1|||
16524192|NCT00835406|40387720|FG000|Period: First Intervention|Withdrawal by Subject|2|||
16524193|NCT00835406|40387721|FG001|Period: First Intervention|Withdrawal by Subject|0|||
16524194|NCT00835406|40387720|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
16524195|NCT00835406|40387721|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
16524196|NCT02348216|40387724|FG000|Overall Study|Death|5|||
16524197|NCT02348216|40387725|FG001|Overall Study|Death|53|||
16524198|NCT02348216|40387726|FG002|Overall Study|Death|11|||
16524199|NCT02348216|40387727|FG003|Overall Study|Death|20|||
16524200|NCT02348216|40387728|FG004|Overall Study|Death|16|||
16524201|NCT02348216|40387729|FG005|Overall Study|Death|32|||
16524202|NCT02348216|40387730|FG006|Overall Study|Death|17|||
16524203|NCT02348216|40387724|FG000|Overall Study|Full consent withdrawal|0|||
16524204|NCT02348216|40387725|FG001|Overall Study|Full consent withdrawal|0|||
16524205|NCT02348216|40387726|FG002|Overall Study|Full consent withdrawal|0|||
16524206|NCT02348216|40387727|FG003|Overall Study|Full consent withdrawal|1|||
16524207|NCT02348216|40387728|FG004|Overall Study|Full consent withdrawal|3|||
16524208|NCT02348216|40387729|FG005|Overall Study|Full consent withdrawal|0|||
16524209|NCT02348216|40387730|FG006|Overall Study|Full consent withdrawal|3|||
16524210|NCT02348216|40387724|FG000|Overall Study|Lost to Follow-up|0|||
16524211|NCT02348216|40387725|FG001|Overall Study|Lost to Follow-up|5|||
16524212|NCT02348216|40387726|FG002|Overall Study|Lost to Follow-up|2|||
16524213|NCT02348216|40387727|FG003|Overall Study|Lost to Follow-up|0|||
16524214|NCT02348216|40387728|FG004|Overall Study|Lost to Follow-up|1|||
16524215|NCT02348216|40387729|FG005|Overall Study|Lost to Follow-up|1|||
16524216|NCT02348216|40387730|FG006|Overall Study|Lost to Follow-up|1|||
16524217|NCT02348216|40387724|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
16524218|NCT02348216|40387725|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
16524219|NCT02348216|40387726|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
16524220|NCT02348216|40387727|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
16524221|NCT02348216|40387728|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
16524222|NCT02348216|40387729|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
16524223|NCT02348216|40387730|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
16524224|NCT02348216|40387724|FG000|Overall Study|Reason not specified|2|||
16524225|NCT02348216|40387725|FG001|Overall Study|Reason not specified|19|||
16524226|NCT02348216|40387726|FG002|Overall Study|Reason not specified|11|||
16524227|NCT02348216|40387727|FG003|Overall Study|Reason not specified|17|||
16524228|NCT02348216|40387728|FG004|Overall Study|Reason not specified|21|||
16524229|NCT02348216|40387729|FG005|Overall Study|Reason not specified|17|||
16524230|NCT02348216|40387730|FG006|Overall Study|Reason not specified|19|||
16524231|NCT03224468|40387731|FG000|Overall Study|Did not obtain MM card|53|||
16524232|NCT03224468|40387732|FG001|Overall Study|Did not obtain MM card|0|||
16524233|NCT03224468|40387731|FG000|Overall Study|Lost to Follow-up|4|||
16524234|NCT03224468|40387732|FG001|Overall Study|Lost to Follow-up|11|||
16524235|NCT03224468|40387731|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
16524236|NCT03224468|40387732|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
16524237|NCT00982020|40387733|FG000|Overall Study|Adverse Event|19|||
16524238|NCT00982020|40387734|FG001|Overall Study|Adverse Event|15|||
16524239|NCT00982020|40387733|FG000|Overall Study|Withdrawal by Subject|11|||
16524240|NCT00982020|40387734|FG001|Overall Study|Withdrawal by Subject|14|||
16524241|NCT00982020|40387733|FG000|Overall Study|Lost to Follow-up|5|||
16524242|NCT00982020|40387734|FG001|Overall Study|Lost to Follow-up|11|||
16524243|NCT00982020|40387733|FG000|Overall Study|Lack of Efficacy|10|||
16524244|NCT00982020|40387734|FG001|Overall Study|Lack of Efficacy|4|||
16524245|NCT00982020|40387733|FG000|Overall Study|Parent/Caregiver Decision|5|||
16524246|NCT00982020|40387734|FG001|Overall Study|Parent/Caregiver Decision|5|||
16524247|NCT00982020|40387733|FG000|Overall Study|Treatment Non-compliance|3|||
16524248|NCT00982020|40387734|FG001|Overall Study|Treatment Non-compliance|6|||
16524249|NCT00982020|40387733|FG000|Overall Study|Physician Decision|2|||
16524250|NCT00982020|40387734|FG001|Overall Study|Physician Decision|5|||
16524251|NCT00982020|40387733|FG000|Overall Study|Entry Criteria Not Met|2|||
16524252|NCT00982020|40387734|FG001|Overall Study|Entry Criteria Not Met|1|||
16524253|NCT00982020|40387733|FG000|Overall Study|Protocol Violation|0|||
16524254|NCT00982020|40387734|FG001|Overall Study|Protocol Violation|2|||
16524255|NCT00982020|40387733|FG000|Overall Study|Clinical Relapse|0|||
16524256|NCT00982020|40387734|FG001|Overall Study|Clinical Relapse|1|||
16524257|NCT02461589|40387738|FG000|Overall Study|Withdrawal by Subject|5|||
16524258|NCT02461589|40387739|FG001|Overall Study|Withdrawal by Subject|1|||
16524259|NCT02461589|40387740|FG002|Overall Study|Withdrawal by Subject|3|||
16524260|NCT02461589|40387741|FG003|Overall Study|Withdrawal by Subject|2|||
16524261|NCT02461589|40387742|FG004|Overall Study|Withdrawal by Subject|1|||
16095882|NCT03686176|38842617|FG002|Overall Study|Procedure cancelled|0|||
16095883|NCT03686176|38842615|FG000|Overall Study|VR Malfunction|1|||
16095884|NCT03686176|38842616|FG001|Overall Study|VR Malfunction|0|||
16095885|NCT03686176|38842617|FG002|Overall Study|VR Malfunction|0|||
16095886|NCT01540474|38842618|FG000|Vaccination Period|Lost to Follow-up|0|||
16095887|NCT01540474|38842619|FG001|Vaccination Period|Lost to Follow-up|1|||
16095888|NCT01540474|38842620|FG002|Vaccination Period|Lost to Follow-up|0|||
16095889|NCT01540474|38842621|FG003|Vaccination Period|Lost to Follow-up|0|||
16095890|NCT01964547|38842625|FG000|Overall Study|Adverse Event|8|||
16095891|NCT01964547|38842626|FG001|Overall Study|Adverse Event|2|||
16095892|NCT01964547|38842625|FG000|Overall Study|Withdrawal by Subject|4|||
16095893|NCT01964547|38842626|FG001|Overall Study|Withdrawal by Subject|7|||
16095894|NCT01964547|38842625|FG000|Overall Study|Lost to Follow-up|0|||
16095895|NCT01964547|38842626|FG001|Overall Study|Lost to Follow-up|1|||
16095896|NCT01964547|38842625|FG000|Overall Study|Withdrawal by Investigator|0|||
16095897|NCT01964547|38842626|FG001|Overall Study|Withdrawal by Investigator|1|||
16095898|NCT00742560|38842627|FG000|Overall Study|Adverse Event|0|||
16095899|NCT00742560|38842628|FG001|Overall Study|Adverse Event|0|||
16095900|NCT00742560|38842629|FG002|Overall Study|Adverse Event|1|||
16095901|NCT00742560|38842630|FG003|Overall Study|Adverse Event|1|||
16095902|NCT00742560|38842631|FG004|Overall Study|Adverse Event|1|||
16095903|NCT00742560|38842627|FG000|Overall Study|Death|0|||
16095904|NCT00742560|38842628|FG001|Overall Study|Death|2|||
16095905|NCT00742560|38842629|FG002|Overall Study|Death|0|||
16095906|NCT00742560|38842630|FG003|Overall Study|Death|2|||
16095907|NCT00742560|38842631|FG004|Overall Study|Death|3|||
16095908|NCT00742560|38842627|FG000|Overall Study|Subject's Decision|1|||
16095909|NCT00742560|38842628|FG001|Overall Study|Subject's Decision|0|||
16095910|NCT00742560|38842629|FG002|Overall Study|Subject's Decision|2|||
16095911|NCT00742560|38842630|FG003|Overall Study|Subject's Decision|3|||
16095912|NCT00742560|38842631|FG004|Overall Study|Subject's Decision|3|||
16095913|NCT00742560|38842627|FG000|Overall Study|Investigator's Decision|0|||
16095914|NCT00742560|38842628|FG001|Overall Study|Investigator's Decision|0|||
16095915|NCT00742560|38842629|FG002|Overall Study|Investigator's Decision|4|||
16095916|NCT00742560|38842630|FG003|Overall Study|Investigator's Decision|1|||
16095917|NCT00742560|38842631|FG004|Overall Study|Investigator's Decision|0|||
16095918|NCT00742560|38842627|FG000|Overall Study|Disease Progression|1|||
16095919|NCT00742560|38842628|FG001|Overall Study|Disease Progression|0|||
16095920|NCT00742560|38842629|FG002|Overall Study|Disease Progression|5|||
16095921|NCT00742560|38842630|FG003|Overall Study|Disease Progression|17|||
16095922|NCT00742560|38842631|FG004|Overall Study|Disease Progression|16|||
16095923|NCT00742560|38842627|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
16095924|NCT00742560|38842628|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
16095925|NCT00742560|38842629|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
16095926|NCT00742560|38842630|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
16095927|NCT00742560|38842631|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
16095928|NCT00742560|38842627|FG000|Overall Study|Other|0|||
16095929|NCT00742560|38842628|FG001|Overall Study|Other|1|||
16095930|NCT00742560|38842629|FG002|Overall Study|Other|8|||
16095931|NCT00742560|38842630|FG003|Overall Study|Other|9|||
16095932|NCT00742560|38842631|FG004|Overall Study|Other|9|||
16095933|NCT00742560|38842627|FG000|Overall Study|MIssing|0|||
16095934|NCT00742560|38842628|FG001|Overall Study|MIssing|0|||
16095935|NCT00742560|38842629|FG002|Overall Study|MIssing|0|||
16095936|NCT00742560|38842630|FG003|Overall Study|MIssing|0|||
16095937|NCT00742560|38842631|FG004|Overall Study|MIssing|1|||
16095938|NCT02092285|38842640|FG000|Induction Phase|Adverse Event|7|||
16095939|NCT02092285|38842640|FG000|Induction Phase|Physician Decision|4|||
16095940|NCT02092285|38842640|FG000|Induction Phase|Pregnancy|1|||
16095941|NCT02092285|38842640|FG000|Induction Phase|Relapse/Recurrence|7|||
16095942|NCT02092285|38842640|FG000|Induction Phase|Withdrawal by Subject|2|||
16095943|NCT02092285|38842640|FG000|Induction Phase|Lack of Efficacy|14|||
16095944|NCT02092285|38842640|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
16095945|NCT02092285|38842640|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
16095946|NCT02092285|38842640|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
16095947|NCT02092285|38842640|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
16095948|NCT02092285|38842640|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
16209438|NCT03124407|39247936|FG003|Overall Study|Adverse Event|0|||
16095949|NCT02092285|38842640|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
16095950|NCT02092285|38842640|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
16095951|NCT02092285|38842640|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
16095952|NCT02092285|38842640|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
16095953|NCT03449979|38842643|FG000|Overall Study|Technical difficulty|0|||
16095954|NCT03449979|38842644|FG001|Overall Study|Technical difficulty|0|||
16095955|NCT03449979|38842645|FG002|Overall Study|Technical difficulty|0|||
16095956|NCT03449979|38842646|FG003|Overall Study|Technical difficulty|1|||
16095957|NCT03386344|38842647|FG000|Overall Study|Adverse Event|6|||
16095958|NCT03386344|38842648|FG001|Overall Study|Adverse Event|3|||
16095959|NCT03386344|38842649|FG002|Overall Study|Adverse Event|1|||
16095960|NCT03386344|38842647|FG000|Overall Study|Poor Compliance to Protocol|0|||
16095961|NCT03386344|38842648|FG001|Overall Study|Poor Compliance to Protocol|1|||
16095962|NCT03386344|38842649|FG002|Overall Study|Poor Compliance to Protocol|0|||
16095963|NCT03386344|38842647|FG000|Overall Study|Study Terminated by Sponsor|101|||
16095964|NCT03386344|38842648|FG001|Overall Study|Study Terminated by Sponsor|102|||
16095965|NCT03386344|38842649|FG002|Overall Study|Study Terminated by Sponsor|106|||
16095966|NCT03386344|38842647|FG000|Overall Study|Lost to Follow-up|3|||
16095967|NCT03386344|38842648|FG001|Overall Study|Lost to Follow-up|2|||
16095968|NCT03386344|38842649|FG002|Overall Study|Lost to Follow-up|1|||
16095969|NCT03386344|38842647|FG000|Overall Study|At the Participant's own Request|7|||
16095970|NCT03386344|38842648|FG001|Overall Study|At the Participant's own Request|7|||
16095971|NCT03386344|38842649|FG002|Overall Study|At the Participant's own Request|8|||
16095972|NCT03386344|38842647|FG000|Overall Study|Reason not Specified|0|||
16095973|NCT03386344|38842648|FG001|Overall Study|Reason not Specified|1|||
16095974|NCT03386344|38842649|FG002|Overall Study|Reason not Specified|0|||
16095975|NCT00832650|38842651|FG000|Overall Study|Randomized but not treated|0|||
16095976|NCT00832650|38842652|FG001|Overall Study|Randomized but not treated|0|||
16095977|NCT00832650|38842653|FG002|Overall Study|Randomized but not treated|1|||
16095978|NCT00443820|38842654|FG000|Overall Study|Adverse Event|1|||
16095979|NCT00443820|38842655|FG001|Overall Study|Adverse Event|1|||
16095980|NCT00443820|38842656|FG002|Overall Study|Adverse Event|0|||
16095981|NCT00443820|38842657|FG003|Overall Study|Adverse Event|0|||
16524262|NCT02461589|40387743|FG005|Overall Study|Withdrawal by Subject|2|||
16524263|NCT02461589|40387744|FG006|Overall Study|Withdrawal by Subject|1|||
16524264|NCT02461589|40387745|FG007|Overall Study|Withdrawal by Subject|3|||
16524265|NCT02461589|40387746|FG008|Overall Study|Withdrawal by Subject|3|||
16524266|NCT02461589|40387747|FG009|Overall Study|Withdrawal by Subject|1|||
16524267|NCT02461589|40387738|FG000|Overall Study|Lost to Follow-up|0|||
16524268|NCT02461589|40387739|FG001|Overall Study|Lost to Follow-up|0|||
16524269|NCT02461589|40387740|FG002|Overall Study|Lost to Follow-up|2|||
16524270|NCT02461589|40387741|FG003|Overall Study|Lost to Follow-up|3|||
16524271|NCT02461589|40387742|FG004|Overall Study|Lost to Follow-up|1|||
16524272|NCT02461589|40387743|FG005|Overall Study|Lost to Follow-up|1|||
16524273|NCT02461589|40387744|FG006|Overall Study|Lost to Follow-up|3|||
16524274|NCT02461589|40387745|FG007|Overall Study|Lost to Follow-up|1|||
16524275|NCT02461589|40387746|FG008|Overall Study|Lost to Follow-up|3|||
16524276|NCT02461589|40387747|FG009|Overall Study|Lost to Follow-up|1|||
16524277|NCT02461589|40387738|FG000|Overall Study|Death|0|||
16524278|NCT02461589|40387739|FG001|Overall Study|Death|0|||
16524279|NCT02461589|40387740|FG002|Overall Study|Death|0|||
16524280|NCT02461589|40387741|FG003|Overall Study|Death|0|||
16524281|NCT02461589|40387742|FG004|Overall Study|Death|0|||
16524282|NCT02461589|40387743|FG005|Overall Study|Death|0|||
16524283|NCT02461589|40387744|FG006|Overall Study|Death|0|||
16524284|NCT02461589|40387745|FG007|Overall Study|Death|1|||
16524285|NCT02461589|40387746|FG008|Overall Study|Death|0|||
16524286|NCT02461589|40387747|FG009|Overall Study|Death|0|||
16524287|NCT02461589|40387738|FG000|Overall Study|Unclassified|0|||
16524288|NCT02461589|40387739|FG001|Overall Study|Unclassified|0|||
16524289|NCT02461589|40387740|FG002|Overall Study|Unclassified|0|||
16524290|NCT02461589|40387741|FG003|Overall Study|Unclassified|0|||
16524291|NCT02461589|40387742|FG004|Overall Study|Unclassified|0|||
16524292|NCT02461589|40387743|FG005|Overall Study|Unclassified|0|||
16524293|NCT02461589|40387744|FG006|Overall Study|Unclassified|1|||
16524294|NCT02461589|40387745|FG007|Overall Study|Unclassified|0|||
16524295|NCT02461589|40387746|FG008|Overall Study|Unclassified|0|||
16524296|NCT02461589|40387747|FG009|Overall Study|Unclassified|2|||
16524297|NCT02461589|40387738|FG000|Overall Study|Missing follow-up information|1|||
16524298|NCT02461589|40387739|FG001|Overall Study|Missing follow-up information|1|||
16524299|NCT02461589|40387740|FG002|Overall Study|Missing follow-up information|0|||
16524300|NCT02461589|40387741|FG003|Overall Study|Missing follow-up information|0|||
16524301|NCT02461589|40387742|FG004|Overall Study|Missing follow-up information|0|||
16524302|NCT02461589|40387743|FG005|Overall Study|Missing follow-up information|0|||
16095982|NCT00443820|38842654|FG000|Overall Study|Lack of Efficacy|3|||
16095983|NCT00443820|38842655|FG001|Overall Study|Lack of Efficacy|2|||
16095984|NCT00443820|38842656|FG002|Overall Study|Lack of Efficacy|1|||
16095985|NCT00443820|38842657|FG003|Overall Study|Lack of Efficacy|1|||
16095986|NCT00443820|38842654|FG000|Overall Study|Protocol Violation|2|||
16095987|NCT00443820|38842655|FG001|Overall Study|Protocol Violation|1|||
16095988|NCT00443820|38842656|FG002|Overall Study|Protocol Violation|2|||
16095989|NCT00443820|38842657|FG003|Overall Study|Protocol Violation|1|||
16095990|NCT00443820|38842654|FG000|Overall Study|Withdrawal by Subject|6|||
16524303|NCT02461589|40387744|FG006|Overall Study|Missing follow-up information|1|||
16524304|NCT02461589|40387745|FG007|Overall Study|Missing follow-up information|0|||
16524305|NCT02461589|40387746|FG008|Overall Study|Missing follow-up information|0|||
16524306|NCT02461589|40387747|FG009|Overall Study|Missing follow-up information|0|||
16524307|NCT02461589|40387738|FG000|Overall Study|Withdrawal from trial before exposure|0|||
16095991|NCT00443820|38842655|FG001|Overall Study|Withdrawal by Subject|7|||
16095992|NCT00443820|38842656|FG002|Overall Study|Withdrawal by Subject|8|||
16095993|NCT00443820|38842657|FG003|Overall Study|Withdrawal by Subject|9|||
16095994|NCT00443820|38842654|FG000|Overall Study|Lost to Follow-up|9|||
16095995|NCT00443820|38842655|FG001|Overall Study|Lost to Follow-up|8|||
16095996|NCT00443820|38842656|FG002|Overall Study|Lost to Follow-up|6|||
16095997|NCT00443820|38842657|FG003|Overall Study|Lost to Follow-up|5|||
16095998|NCT00443820|38842654|FG000|Overall Study|Administrative problems|0|||
16095999|NCT00443820|38842655|FG001|Overall Study|Administrative problems|0|||
16096000|NCT00443820|38842656|FG002|Overall Study|Administrative problems|0|||
16096001|NCT00443820|38842657|FG003|Overall Study|Administrative problems|1|||
16096002|NCT00443820|38842654|FG000|Overall Study|Death|0|||
16096003|NCT00443820|38842655|FG001|Overall Study|Death|0|||
16096004|NCT00443820|38842656|FG002|Overall Study|Death|1|||
16096005|NCT00443820|38842657|FG003|Overall Study|Death|0|||
16096006|NCT00529529|38842658|FG000|Overall Study|Adverse Event|12|||
16096007|NCT00529529|38842659|FG001|Overall Study|Adverse Event|17|||
16096008|NCT00529529|38842660|FG002|Overall Study|Adverse Event|8|||
16096009|NCT00529529|38842658|FG000|Overall Study|Subject withdrew consent|12|||
16096010|NCT00529529|38842659|FG001|Overall Study|Subject withdrew consent|9|||
16096011|NCT00529529|38842660|FG002|Overall Study|Subject withdrew consent|12|||
16096012|NCT00529529|38842658|FG000|Overall Study|Protocol deviation|8|||
16096013|NCT00529529|38842659|FG001|Overall Study|Protocol deviation|12|||
16096014|NCT00529529|38842660|FG002|Overall Study|Protocol deviation|5|||
16096015|NCT00529529|38842658|FG000|Overall Study|Lost to Follow-up|5|||
16096016|NCT00529529|38842659|FG001|Overall Study|Lost to Follow-up|3|||
16096017|NCT00529529|38842660|FG002|Overall Study|Lost to Follow-up|1|||
16096018|NCT00529529|38842658|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16096019|NCT00529529|38842659|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16096020|NCT00529529|38842660|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
16096021|NCT00529529|38842658|FG000|Overall Study|Death|2|||
16096022|NCT00529529|38842659|FG001|Overall Study|Death|0|||
16096023|NCT00529529|38842660|FG002|Overall Study|Death|0|||
16096024|NCT00529529|38842658|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16096025|NCT00529529|38842659|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16096026|NCT00529529|38842660|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16096027|NCT00529529|38842658|FG000|Overall Study|Administrative problems|1|||
16096028|NCT00529529|38842659|FG001|Overall Study|Administrative problems|0|||
16209439|NCT03796195|39247937|FG000|Overall Study|Study closed early|1|||
16209440|NCT01688999|39247940|FG000|Overall Study|Withdrawal by Subject|5|||
16209441|NCT01688999|39247941|FG001|Overall Study|Withdrawal by Subject|1|||
16209442|NCT01688999|39247942|FG002|Overall Study|Withdrawal by Subject|1|||
16209443|NCT01688999|39247940|FG000|Overall Study|Adverse Event|2|||
16209444|NCT01688999|39247941|FG001|Overall Study|Adverse Event|0|||
16096029|NCT00529529|38842660|FG002|Overall Study|Administrative problems|3|||
16209445|NCT01688999|39247942|FG002|Overall Study|Adverse Event|2|||
16096030|NCT01446042|38842661|FG000|Overall Study|Withdrawal by Subject|12|||
16096031|NCT01446042|38842662|FG001|Overall Study|Withdrawal by Subject|2|||
16096032|NCT01446042|38842663|FG002|Overall Study|Withdrawal by Subject|4|||
16209446|NCT01688999|39247940|FG000|Overall Study|Ineligible/Not treated|1|||
16096033|NCT01446042|38842661|FG000|Overall Study|Adverse Event|1|||
16096034|NCT01446042|38842662|FG001|Overall Study|Adverse Event|0|||
16328223|NCT02031640|39687696|FG001|Run-In Period|Various administrative reasons|0|||
16524308|NCT02461589|40387739|FG001|Overall Study|Withdrawal from trial before exposure|0|||
16524309|NCT02461589|40387740|FG002|Overall Study|Withdrawal from trial before exposure|0|||
16524310|NCT02461589|40387741|FG003|Overall Study|Withdrawal from trial before exposure|0|||
16524311|NCT02461589|40387742|FG004|Overall Study|Withdrawal from trial before exposure|0|||
16524312|NCT02461589|40387743|FG005|Overall Study|Withdrawal from trial before exposure|0|||
16524313|NCT02461589|40387744|FG006|Overall Study|Withdrawal from trial before exposure|0|||
16524314|NCT02461589|40387745|FG007|Overall Study|Withdrawal from trial before exposure|0|||
16524315|NCT02461589|40387746|FG008|Overall Study|Withdrawal from trial before exposure|0|||
16524316|NCT02461589|40387747|FG009|Overall Study|Withdrawal from trial before exposure|1|||
16328224|NCT02031640|39687697|FG002|Run-In Period|Various administrative reasons|0|||
16328225|NCT02031640|39687698|FG003|Run-In Period|Various administrative reasons|0|||
16328226|NCT02031640|39687699|FG004|Run-In Period|Various administrative reasons|0|||
16328227|NCT02031640|39687700|FG005|Run-In Period|Various administrative reasons|0|||
16328228|NCT02031640|39687695|FG000|Double-blind Treatment Period|Protocol deviation|0|||
16328229|NCT02031640|39687696|FG001|Double-blind Treatment Period|Protocol deviation|2|||
16328230|NCT02031640|39687697|FG002|Double-blind Treatment Period|Protocol deviation|0|||
16328231|NCT02031640|39687698|FG003|Double-blind Treatment Period|Protocol deviation|1|||
16328232|NCT02031640|39687699|FG004|Double-blind Treatment Period|Protocol deviation|3|||
16328233|NCT02031640|39687700|FG005|Double-blind Treatment Period|Protocol deviation|1|||
16328234|NCT02031640|39687695|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
16328235|NCT02031640|39687696|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
16328236|NCT02031640|39687697|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
16328237|NCT02031640|39687698|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
16328238|NCT02031640|39687699|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
16328239|NCT02031640|39687700|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
16328240|NCT02031640|39687695|FG000|Double-blind Treatment Period|Non-compliance|0|||
16328241|NCT02031640|39687696|FG001|Double-blind Treatment Period|Non-compliance|1|||
16328242|NCT02031640|39687697|FG002|Double-blind Treatment Period|Non-compliance|0|||
16328243|NCT02031640|39687698|FG003|Double-blind Treatment Period|Non-compliance|1|||
16328244|NCT02031640|39687699|FG004|Double-blind Treatment Period|Non-compliance|1|||
16328245|NCT02031640|39687700|FG005|Double-blind Treatment Period|Non-compliance|0|||
16328246|NCT02031640|39687695|FG000|Double-blind Treatment Period|Adverse Event|0|||
16328247|NCT02031640|39687696|FG001|Double-blind Treatment Period|Adverse Event|0|||
16328248|NCT02031640|39687697|FG002|Double-blind Treatment Period|Adverse Event|0|||
16328249|NCT02031640|39687698|FG003|Double-blind Treatment Period|Adverse Event|2|||
16328250|NCT02031640|39687699|FG004|Double-blind Treatment Period|Adverse Event|0|||
16328251|NCT02031640|39687700|FG005|Double-blind Treatment Period|Adverse Event|0|||
16328252|NCT02031640|39687695|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
16328253|NCT02031640|39687696|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
16328254|NCT02031640|39687697|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
16328255|NCT02031640|39687698|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
16328256|NCT02031640|39687699|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
16328257|NCT02031640|39687700|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
16328258|NCT02031640|39687695|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16328259|NCT02031640|39687696|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
16328260|NCT02031640|39687697|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
16328261|NCT02031640|39687698|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
16328262|NCT02031640|39687699|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
16328263|NCT02031640|39687700|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
16328264|NCT03197324|39687701|FG000|Overall Study|Adverse Event|0|||
16328265|NCT03197324|39687702|FG001|Overall Study|Adverse Event|1|||
16328266|NCT03843541|39687703|FG000|Overall Study|Adverse Event|4|||
16328267|NCT03843541|39687704|FG001|Overall Study|Adverse Event|2|||
16328268|NCT03843541|39687705|FG002|Overall Study|Adverse Event|3|||
16328269|NCT03843541|39687703|FG000|Overall Study|Death|1|||
16328270|NCT03843541|39687704|FG001|Overall Study|Death|0|||
16328271|NCT03843541|39687705|FG002|Overall Study|Death|0|||
16328272|NCT03843541|39687703|FG000|Overall Study|Lack of adherence to study medication|0|||
16328273|NCT03843541|39687704|FG001|Overall Study|Lack of adherence to study medication|0|||
16328274|NCT03843541|39687705|FG002|Overall Study|Lack of adherence to study medication|1|||
16328275|NCT03843541|39687703|FG000|Overall Study|Physician Decision|1|||
16328276|NCT03843541|39687704|FG001|Overall Study|Physician Decision|2|||
16328277|NCT03843541|39687705|FG002|Overall Study|Physician Decision|2|||
16328278|NCT03843541|39687703|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
16328279|NCT03843541|39687704|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
16397422|NCT01606176|39935473|FG000|Overall Study|Withdrawal by Subject|1|||
16096035|NCT01446042|38842663|FG002|Overall Study|Adverse Event|4|||
16397423|NCT01606176|39935474|FG001|Overall Study|Withdrawal by Subject|0|||
16524317|NCT00655980|40387748|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
16524318|NCT00655980|40387749|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
16524319|NCT00655980|40387750|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
16524320|NCT03029208|40387751|FG000|Overall Study|Withdrawal by Subject|2|||
16524321|NCT03029208|40387752|FG001|Overall Study|Withdrawal by Subject|3|||
16524322|NCT03029208|40387751|FG000|Overall Study|Lost to Follow-up|0|||
16524323|NCT03029208|40387752|FG001|Overall Study|Lost to Follow-up|1|||
16524324|NCT03728582|40387753|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
16524325|NCT03728582|40387754|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
16524326|NCT03728582|40387753|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
16524327|NCT03728582|40387754|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
16524328|NCT03965052|40387757|FG000|Overall Study|Protocol Violation|1|||
16524329|NCT03965052|40387758|FG001|Overall Study|Protocol Violation|0|||
16524330|NCT03669081|40387759|FG000|Overall Study|Data could not be validated|1|||
16524331|NCT03669081|40387760|FG001|Overall Study|Data could not be validated|1|||
16524332|NCT00504829|40387761|FG000|Overall Study|Protocol Violation|6|||
16524333|NCT00504829|40387762|FG001|Overall Study|Protocol Violation|4|||
16524334|NCT00504829|40387763|FG002|Overall Study|Protocol Violation|10|||
16524335|NCT02104557|40387764|FG000|Overall Study|Adverse Event|24|||
16524336|NCT02104557|40387764|FG000|Overall Study|Lost to Follow-up|34|||
16524337|NCT02104557|40387764|FG000|Overall Study|Violated the usage and dosage|14|||
16524338|NCT02104557|40387764|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
16524339|NCT02104557|40387764|FG000|Overall Study|Administered Sayana prior to the contract|1|||
16524340|NCT02104557|40387764|FG000|Overall Study|Other|17|||
16524341|NCT02104557|40387764|FG000|Overall Study|Change to other contraception methods|5|||
16524342|NCT02104557|40387764|FG000|Overall Study|Discontinuation due to no pain|1|||
16524343|NCT02104557|40387764|FG000|Overall Study|Withdrawal consent|2|||
16524344|NCT02104557|40387764|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
16524345|NCT02104557|40387764|FG000|Overall Study|Discontinuation of contraception|9|||
16524346|NCT00961259|40387765|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
16524347|NCT00961259|40387766|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
16524348|NCT00961259|40387767|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
16524349|NCT00345579|40387770|FG000|Overall Study|Adverse Event|9|||
16524350|NCT00345579|40387771|FG001|Overall Study|Adverse Event|6|||
16524351|NCT00345579|40387770|FG000|Overall Study|Protocol Violation|14|||
16524352|NCT00345579|40387771|FG001|Overall Study|Protocol Violation|5|||
16524353|NCT00345579|40387770|FG000|Overall Study|Withdrawal by Subject|50|||
16524354|NCT00345579|40387771|FG001|Overall Study|Withdrawal by Subject|17|||
16524355|NCT00345579|40387770|FG000|Overall Study|Lost to Follow-up|82|||
16524356|NCT00345579|40387771|FG001|Overall Study|Lost to Follow-up|36|||
16524357|NCT00345579|40387770|FG000|Overall Study|Other|9|||
16524358|NCT00345579|40387771|FG001|Overall Study|Other|1|||
16524359|NCT00765245|40387775|FG000|Overall Study|disease progression|3|||
16524360|NCT00765245|40387776|FG001|Overall Study|disease progression|2|||
16524361|NCT00765245|40387775|FG000|Overall Study|Withdrawal by Subject|3|||
16524362|NCT00765245|40387776|FG001|Overall Study|Withdrawal by Subject|0|||
16524363|NCT00765245|40387775|FG000|Overall Study|Adverse Event|5|||
16524364|NCT00765245|40387776|FG001|Overall Study|Adverse Event|0|||
16524365|NCT00765245|40387775|FG000|Overall Study|Physician Decision|1|||
16524366|NCT00765245|40387776|FG001|Overall Study|Physician Decision|0|||
16524367|NCT00765245|40387775|FG000|Overall Study|Death|1|||
16524368|NCT00765245|40387776|FG001|Overall Study|Death|0|||
16524369|NCT01172938|40387777|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
16524370|NCT01172938|40387778|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
16524371|NCT01172938|40387779|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
16524372|NCT01172938|40387780|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16524373|NCT01172938|40387781|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16524374|NCT01172938|40387782|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16524375|NCT01172938|40387783|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16524376|NCT01172938|40387784|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16524377|NCT01172938|40387785|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16524378|NCT01172938|40387777|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
16524379|NCT01172938|40387778|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
16524380|NCT01172938|40387779|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
16524381|NCT01172938|40387780|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16524382|NCT01172938|40387781|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16524383|NCT01172938|40387782|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16524384|NCT01172938|40387783|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16524385|NCT01172938|40387784|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16328280|NCT03843541|39687705|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
16524386|NCT01172938|40387785|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16524387|NCT01172938|40387777|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16524388|NCT01172938|40387778|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
16524389|NCT01172938|40387779|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
16524390|NCT01172938|40387780|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16524391|NCT01172938|40387781|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16524392|NCT01172938|40387782|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16524393|NCT01172938|40387783|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16524394|NCT01172938|40387784|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16524395|NCT01172938|40387785|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16524396|NCT01172938|40387777|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
16524397|NCT01172938|40387778|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
16524398|NCT01172938|40387779|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
16524399|NCT01172938|40387780|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16524400|NCT01172938|40387781|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16524401|NCT01172938|40387782|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16524402|NCT01172938|40387783|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16524403|NCT01172938|40387784|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16524404|NCT01172938|40387785|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16524405|NCT01172938|40387777|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
16524406|NCT01172938|40387778|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
16524407|NCT01172938|40387779|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
16524408|NCT01172938|40387780|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
16524409|NCT01172938|40387781|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
16524410|NCT01172938|40387782|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
16524411|NCT01172938|40387783|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
16524412|NCT01172938|40387784|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
16524413|NCT01172938|40387785|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
16524414|NCT01172938|40387777|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
16524415|NCT01172938|40387778|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16524416|NCT01172938|40387779|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16524417|NCT01172938|40387780|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16524418|NCT01172938|40387781|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16524419|NCT01172938|40387782|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16524420|NCT01172938|40387783|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16524421|NCT01172938|40387784|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16524422|NCT01172938|40387785|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16524423|NCT01172938|40387777|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
16524424|NCT01172938|40387778|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
16524425|NCT01172938|40387779|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
16524426|NCT01172938|40387780|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
16328281|NCT03843541|39687703|FG000|Overall Study|Withdrawal by Subject|6|||
16328282|NCT03843541|39687704|FG001|Overall Study|Withdrawal by Subject|9|||
16328283|NCT03843541|39687705|FG002|Overall Study|Withdrawal by Subject|7|||
16328284|NCT03843541|39687703|FG000|Overall Study|Administration of rescue mucolytic|0|||
16524427|NCT01172938|40387781|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
16524428|NCT01172938|40387782|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
16524429|NCT01172938|40387783|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
16524430|NCT01172938|40387784|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
16524431|NCT01172938|40387785|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
16524432|NCT01172938|40387777|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
16524433|NCT01172938|40387778|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
16524434|NCT01172938|40387779|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
16524435|NCT01172938|40387780|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
16524436|NCT01172938|40387781|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
16524437|NCT01172938|40387782|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
16524438|NCT01172938|40387783|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
16524439|NCT01172938|40387784|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
16524440|NCT01172938|40387785|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
16328285|NCT03843541|39687704|FG001|Overall Study|Administration of rescue mucolytic|0|||
16328286|NCT03843541|39687705|FG002|Overall Study|Administration of rescue mucolytic|1|||
16328287|NCT03843541|39687703|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
16328288|NCT03843541|39687704|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
16328289|NCT03843541|39687705|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
16524441|NCT01172938|40387777|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
16524442|NCT01172938|40387778|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
16524443|NCT01172938|40387779|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
16524444|NCT01172938|40387780|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
16524445|NCT01172938|40387781|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
16524446|NCT01172938|40387782|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
16524447|NCT01172938|40387783|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
16524448|NCT01172938|40387784|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
16524449|NCT01172938|40387785|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
16524450|NCT01172938|40387777|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16524451|NCT01172938|40387778|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16524452|NCT01172938|40387779|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
16524453|NCT01172938|40387780|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16524454|NCT01172938|40387781|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16524455|NCT01172938|40387782|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16524456|NCT01172938|40387783|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16524457|NCT01172938|40387784|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16524458|NCT01172938|40387785|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
16524459|NCT01172938|40387777|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
16524460|NCT01172938|40387778|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
16524461|NCT01172938|40387779|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
16524462|NCT01172938|40387780|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
16524463|NCT01172938|40387781|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
16524464|NCT01172938|40387782|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
16524465|NCT01172938|40387783|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
16524466|NCT01172938|40387784|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
16524467|NCT01172938|40387785|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
16524468|NCT01172938|40387777|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16524469|NCT01172938|40387778|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
16524470|NCT01172938|40387779|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
16524471|NCT01172938|40387780|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
16524472|NCT01172938|40387781|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16524473|NCT01172938|40387782|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16524474|NCT01172938|40387783|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16524475|NCT01172938|40387784|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16524476|NCT01172938|40387785|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
16524477|NCT01172938|40387777|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
16524478|NCT01172938|40387778|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
16524479|NCT01172938|40387779|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
16524480|NCT01172938|40387780|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
16524481|NCT01172938|40387781|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
16524482|NCT01172938|40387782|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
16524483|NCT01172938|40387783|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
16524484|NCT01172938|40387784|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
16524485|NCT01172938|40387785|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
16524486|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
16524487|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
16524488|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
16096036|NCT01446042|38842661|FG000|Overall Study|Lost to Follow-up|5|||
16096037|NCT01446042|38842662|FG001|Overall Study|Lost to Follow-up|0|||
16096038|NCT01446042|38842663|FG002|Overall Study|Lost to Follow-up|0|||
16096039|NCT01446042|38842661|FG000|Overall Study|Other reasons|2|||
16096040|NCT01446042|38842662|FG001|Overall Study|Other reasons|1|||
16096041|NCT01446042|38842663|FG002|Overall Study|Other reasons|1|||
16096042|NCT00157209|38842664|FG000|Overall Study|Ongoing at data cut-off|10|||
16096043|NCT00157209|38842665|FG001|Overall Study|Ongoing at data cut-off|0|||
16096044|NCT02522299|38842668|FG000|Overall Study|Adverse Event|2|||
16096045|NCT02522299|38842669|FG001|Overall Study|Adverse Event|0|||
16096046|NCT02522299|38842668|FG000|Overall Study|Physician Decision|0|||
16096047|NCT02522299|38842669|FG001|Overall Study|Physician Decision|1|||
16096048|NCT02522299|38842668|FG000|Overall Study|Withdrawal by Subject|2|||
16096049|NCT02522299|38842669|FG001|Overall Study|Withdrawal by Subject|0|||
16096050|NCT00476957|38842672|FG000|Overall Study|Lost to Follow-up|176|||
16096051|NCT00476957|38842673|FG001|Overall Study|Lost to Follow-up|193|||
16096052|NCT02516202|38842674|FG000|Overall Study|Withdrawal by Subject|1|||
16524489|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
16096053|NCT02516202|38842675|FG001|Overall Study|Withdrawal by Subject|0|||
16524490|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
16524491|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
16524492|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
16524493|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
16524494|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
16524495|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16524496|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
16524497|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
16524498|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16209447|NCT01688999|39247941|FG001|Overall Study|Ineligible/Not treated|0|||
16209448|NCT01688999|39247942|FG002|Overall Study|Ineligible/Not treated|0|||
16209449|NCT01316380|39247946|FG000|Overall Study|Adverse Event|0|||
16209450|NCT01316380|39247947|FG001|Overall Study|Adverse Event|2|||
16209451|NCT01316380|39247948|FG002|Overall Study|Adverse Event|1|||
16209452|NCT01316380|39247946|FG000|Overall Study|Protocol Violation|0|||
16209453|NCT01316380|39247947|FG001|Overall Study|Protocol Violation|0|||
16209454|NCT01316380|39247948|FG002|Overall Study|Protocol Violation|1|||
16209455|NCT01316380|39247946|FG000|Overall Study|Withdrawal by Subject|1|||
16209456|NCT01316380|39247947|FG001|Overall Study|Withdrawal by Subject|2|||
16209457|NCT01316380|39247948|FG002|Overall Study|Withdrawal by Subject|0|||
16209458|NCT01316380|39247946|FG000|Overall Study|Other|0|||
16209459|NCT01316380|39247947|FG001|Overall Study|Other|1|||
16209460|NCT01316380|39247948|FG002|Overall Study|Other|1|||
16209461|NCT01316380|39247946|FG000|Overall Study|Not treated|1|||
16209462|NCT01316380|39247947|FG001|Overall Study|Not treated|0|||
16209463|NCT01316380|39247948|FG002|Overall Study|Not treated|0|||
16209464|NCT02971007|39247949|FG000|Overall Study|Adverse Event|1|||
16209465|NCT02971007|39247950|FG001|Overall Study|Adverse Event|0|||
16209466|NCT02971007|39247951|FG002|Overall Study|Adverse Event|0|||
16209467|NCT02971007|39247949|FG000|Overall Study|Lost to Follow-up|0|||
16209468|NCT02971007|39247950|FG001|Overall Study|Lost to Follow-up|1|||
16209469|NCT02971007|39247951|FG002|Overall Study|Lost to Follow-up|1|||
16209470|NCT02971007|39247949|FG000|Overall Study|Withdrawal by Subject|0|||
16209471|NCT02971007|39247950|FG001|Overall Study|Withdrawal by Subject|1|||
16209472|NCT02971007|39247951|FG002|Overall Study|Withdrawal by Subject|0|||
16209473|NCT02971007|39247949|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
16209474|NCT02971007|39247950|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
16209475|NCT02971007|39247951|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
16209476|NCT02971007|39247949|FG000|Overall Study|Patient discontinued study drug|0|||
16209477|NCT02971007|39247950|FG001|Overall Study|Patient discontinued study drug|1|||
16209478|NCT02971007|39247951|FG002|Overall Study|Patient discontinued study drug|0|||
16209479|NCT00422669|39247952|FG000|Overall Study|The study was terminated early.|98|||
16209480|NCT00422669|39247953|FG001|Overall Study|The study was terminated early.|100|||
16209481|NCT00422669|39247954|FG002|Overall Study|The study was terminated early.|7|||
16209482|NCT00633360|39247957|FG000|Overall Study|Lost to Follow-up|1|||
16209483|NCT00633360|39247958|FG001|Overall Study|Lost to Follow-up|1|||
16209484|NCT00633360|39247957|FG000|Overall Study|Adverse Event|3|||
16328290|NCT00131365|39687708|FG000|Overall Study|Withdrawal by Subject|1|||
16328291|NCT00131365|39687708|FG000|Overall Study|Alternative treatment|3|||
16328292|NCT03917472|39687710|FG000|Overall Study|Physician Decision|4|||
16328293|NCT03917472|39687711|FG001|Overall Study|Physician Decision|0|||
16328294|NCT03917472|39687710|FG000|Overall Study|Adverse Event|3|||
16328295|NCT03917472|39687711|FG001|Overall Study|Adverse Event|1|||
16328296|NCT03917472|39687710|FG000|Overall Study|Death|7|||
16328297|NCT03917472|39687711|FG001|Overall Study|Death|5|||
16328298|NCT03917472|39687710|FG000|Overall Study|Withdrawal by Subject|11|||
16328299|NCT03917472|39687711|FG001|Overall Study|Withdrawal by Subject|4|||
16209485|NCT00633360|39247958|FG001|Overall Study|Adverse Event|1|||
16209486|NCT00633360|39247957|FG000|Overall Study|Protocol Violation|0|||
16209487|NCT00633360|39247958|FG001|Overall Study|Protocol Violation|1|||
16209488|NCT01628393|39247963|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
16328300|NCT03917472|39687710|FG000|Overall Study|Lost to Follow-up|10|||
16328301|NCT03917472|39687711|FG001|Overall Study|Lost to Follow-up|5|||
16328302|NCT00769067|39687712|FG000|Overall Study|Death|89|||
16209489|NCT01628393|39247964|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16209490|NCT01628393|39247965|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16209491|NCT01628393|39247966|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16209492|NCT01628393|39247967|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16209493|NCT01628393|39247963|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
16209494|NCT01628393|39247964|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
16209495|NCT01628393|39247965|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
16209496|NCT01628393|39247966|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
16209497|NCT01628393|39247967|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
16209498|NCT01628393|39247963|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
16209499|NCT01628393|39247964|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
16209500|NCT01628393|39247965|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
16209501|NCT01628393|39247966|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
16209502|NCT01628393|39247967|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
16209503|NCT01628393|39247963|FG000|Blinded Active Extension Period|Adverse Event|0|||
16209504|NCT01628393|39247964|FG001|Blinded Active Extension Period|Adverse Event|1|||
16209505|NCT01628393|39247965|FG002|Blinded Active Extension Period|Adverse Event|0|||
16209506|NCT01628393|39247966|FG003|Blinded Active Extension Period|Adverse Event|2|||
16209507|NCT01628393|39247967|FG004|Blinded Active Extension Period|Adverse Event|2|||
16209508|NCT01628393|39247963|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
16209509|NCT01628393|39247964|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
16209510|NCT01628393|39247965|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
16209511|NCT01628393|39247966|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
16209512|NCT01628393|39247967|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
16209513|NCT01628393|39247963|FG000|Blinded Active Extension Period|Physician Decision|0|||
16209514|NCT01628393|39247964|FG001|Blinded Active Extension Period|Physician Decision|3|||
16209515|NCT01628393|39247965|FG002|Blinded Active Extension Period|Physician Decision|0|||
16209516|NCT01628393|39247966|FG003|Blinded Active Extension Period|Physician Decision|1|||
16209517|NCT01628393|39247967|FG004|Blinded Active Extension Period|Physician Decision|0|||
16209518|NCT01628393|39247963|FG000|Blinded Active Extension Period|Protocol Violation|0|||
16209519|NCT01628393|39247964|FG001|Blinded Active Extension Period|Protocol Violation|0|||
16209520|NCT01628393|39247965|FG002|Blinded Active Extension Period|Protocol Violation|2|||
16209521|NCT01628393|39247966|FG003|Blinded Active Extension Period|Protocol Violation|1|||
16209522|NCT01628393|39247967|FG004|Blinded Active Extension Period|Protocol Violation|0|||
16209523|NCT01628393|39247963|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
16209524|NCT01628393|39247964|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
16209525|NCT01628393|39247965|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
16209526|NCT01628393|39247966|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
16209527|NCT01628393|39247967|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
16209528|NCT00588523|39247969|FG000|Overall Study|Not treated|3|||
16209529|NCT01392742|39247972|FG000|Overall Study|Premature study termination|42|||
16209530|NCT01392742|39247972|FG000|Overall Study|Failure to return|35|||
16209531|NCT01392742|39247972|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
16209532|NCT01392742|39247972|FG000|Overall Study|Lost to Follow-up|34|||
16209533|NCT01392742|39247972|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
16209534|NCT01392742|39247972|FG000|Overall Study|ITR and Protocol deviation|1|||
16209535|NCT01392742|39247972|FG000|Overall Study|Adverse event/intercurrent illness|17|||
16209536|NCT01392742|39247972|FG000|Overall Study|Protocol Violation|14|||
16209537|NCT01392742|39247972|FG000|Overall Study|Other|3|||
16209538|NCT01392742|39247972|FG000|Overall Study|Missing information|13|||
16209539|NCT00329784|39247973|FG000|Overall Study|Lost to Follow-up|0|||
16524499|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16209540|NCT00329784|39247974|FG001|Overall Study|Lost to Follow-up|1|||
16209541|NCT00329784|39247975|FG002|Overall Study|Lost to Follow-up|0|||
16209542|NCT00329784|39247976|FG003|Overall Study|Lost to Follow-up|0|||
16209543|NCT00329784|39247973|FG000|Overall Study|Withdrawal by Subject|4|||
16209544|NCT00329784|39247974|FG001|Overall Study|Withdrawal by Subject|2|||
16209545|NCT00329784|39247975|FG002|Overall Study|Withdrawal by Subject|0|||
16209546|NCT00329784|39247976|FG003|Overall Study|Withdrawal by Subject|0|||
16209547|NCT00329784|39247973|FG000|Overall Study|Other|1|||
16209548|NCT00329784|39247974|FG001|Overall Study|Other|2|||
16209549|NCT00329784|39247975|FG002|Overall Study|Other|0|||
16209550|NCT00329784|39247976|FG003|Overall Study|Other|0|||
16209551|NCT02688153|39247988|FG000|Overall Study|Death|7|||
16209552|NCT02688153|39247989|FG001|Overall Study|Death|5|||
16209553|NCT02688153|39247988|FG000|Overall Study|Withdrawal by Subject|4|||
16209554|NCT02688153|39247989|FG001|Overall Study|Withdrawal by Subject|2|||
16209555|NCT02688153|39247988|FG000|Overall Study|Valve Explant|1|||
16209556|NCT02688153|39247989|FG001|Overall Study|Valve Explant|0|||
16397424|NCT02993822|39935475|FG000|Overall Study|Lack of Efficacy|1|||
16397425|NCT02993822|39935476|FG001|Overall Study|Lack of Efficacy|1|||
16328303|NCT00769067|39687713|FG001|Overall Study|Death|86|||
16328304|NCT00769067|39687712|FG000|Overall Study|Lost to Follow-up|3|||
16209557|NCT02688153|39247988|FG000|Overall Study|Conversion to Commercial Valve|3|||
16209558|NCT02688153|39247989|FG001|Overall Study|Conversion to Commercial Valve|0|||
16209559|NCT02768103|39247990|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
16209560|NCT02332798|39247991|FG000|Overall Study|Unwilling to Participate in Study|0|||
16209561|NCT02332798|39247992|FG001|Overall Study|Unwilling to Participate in Study|1|||
16209562|NCT02332798|39247993|FG002|Overall Study|Unwilling to Participate in Study|1|||
16209563|NCT02332798|39247991|FG000|Overall Study|Positive Urine Drug Test|0|||
16209564|NCT02332798|39247992|FG001|Overall Study|Positive Urine Drug Test|1|||
16209565|NCT02332798|39247993|FG002|Overall Study|Positive Urine Drug Test|0|||
16209566|NCT02332798|39247991|FG000|Overall Study|Abnormal Laboratory Findings|1|||
16209567|NCT02332798|39247992|FG001|Overall Study|Abnormal Laboratory Findings|0|||
16209568|NCT02332798|39247993|FG002|Overall Study|Abnormal Laboratory Findings|0|||
16209569|NCT01929018|39248000|FG000|Overall Study|Lost to Follow-up|1|||
16209570|NCT01929018|39248001|FG001|Overall Study|Lost to Follow-up|0|||
16209571|NCT01929018|39248000|FG000|Overall Study|Hospitalization|0|||
16209572|NCT01929018|39248001|FG001|Overall Study|Hospitalization|1|||
16209573|NCT00643448|39248002|FG000|Overall Study|Lack of Efficacy|2|||
16209574|NCT00643448|39248003|FG001|Overall Study|Lack of Efficacy|0|||
16209575|NCT00643448|39248004|FG002|Overall Study|Lack of Efficacy|4|||
16209576|NCT00643448|39248002|FG000|Overall Study|Adverse Event|2|||
16209577|NCT00643448|39248003|FG001|Overall Study|Adverse Event|2|||
16209578|NCT00643448|39248004|FG002|Overall Study|Adverse Event|2|||
16209579|NCT00643448|39248002|FG000|Overall Study|QTcF>550 ms|0|||
16209580|NCT00643448|39248003|FG001|Overall Study|QTcF>550 ms|3|||
16397426|NCT02993822|39935477|FG002|Overall Study|Lack of Efficacy|0|||
16397427|NCT02993822|39935478|FG003|Overall Study|Lack of Efficacy|0|||
16397428|NCT02993822|39935475|FG000|Overall Study|Protocol Violation|1|||
16397429|NCT02993822|39935476|FG001|Overall Study|Protocol Violation|0|||
16209581|NCT00643448|39248004|FG002|Overall Study|QTcF>550 ms|0|||
16328305|NCT00769067|39687713|FG001|Overall Study|Lost to Follow-up|1|||
16328306|NCT00769067|39687712|FG000|Overall Study|Study terminated by sponsor|1|||
16524500|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16524501|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16524502|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
16524503|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
16524504|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16524505|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16328307|NCT00769067|39687713|FG001|Overall Study|Study terminated by sponsor|3|||
16328308|NCT00769067|39687712|FG000|Overall Study|Other|1|||
16328309|NCT00769067|39687713|FG001|Overall Study|Other|3|||
16328310|NCT00769067|39687712|FG000|Overall Study|Withdrawal by Subject|0|||
16328311|NCT00769067|39687713|FG001|Overall Study|Withdrawal by Subject|1|||
16328312|NCT02052596|39687714|FG000|Active Phase|Adverse Event|3|||
16328313|NCT02052596|39687715|FG001|Active Phase|Adverse Event|2|||
16524506|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
16524507|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16524508|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16524509|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16524510|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16524511|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16328314|NCT02052596|39687714|FG000|Active Phase|Lost to Follow-up|8|||
16328315|NCT02052596|39687715|FG001|Active Phase|Lost to Follow-up|11|||
16328316|NCT02052596|39687714|FG000|Active Phase|Protocol Violation|1|||
16328317|NCT02052596|39687715|FG001|Active Phase|Protocol Violation|2|||
16328318|NCT02052596|39687714|FG000|Active Phase|Withdrawal by Subject|3|||
16328319|NCT02052596|39687715|FG001|Active Phase|Withdrawal by Subject|4|||
16328320|NCT02052596|39687714|FG000|Active Phase|Enrolled in error|1|||
16397430|NCT02993822|39935477|FG002|Overall Study|Protocol Violation|0|||
16209582|NCT03654560|39248005|FG000|Overall Study|Death|3|||
16209583|NCT03654560|39248006|FG001|Overall Study|Death|1|||
16209584|NCT03654560|39248005|FG000|Overall Study|Lost to Follow-up|1|||
16209585|NCT03654560|39248006|FG001|Overall Study|Lost to Follow-up|0|||
16209586|NCT01352845|39248007|FG000|Overall Study|Lost to Follow-up|313|||
16209587|NCT01352845|39248008|FG001|Overall Study|Lost to Follow-up|92|||
16328321|NCT02052596|39687715|FG001|Active Phase|Enrolled in error|0|||
16328322|NCT02052596|39687714|FG000|Active Phase|Lost due to Crohn's disease|0|||
16328323|NCT02052596|39687715|FG001|Active Phase|Lost due to Crohn's disease|1|||
16328324|NCT02052596|39687714|FG000|Safety Phase|Adverse Event|6|||
16328325|NCT02052596|39687715|FG001|Safety Phase|Adverse Event|3|||
16524512|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
16524513|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
16209588|NCT01352845|39248007|FG000|Overall Study|No Longer Willing to Participate|205|||
16209589|NCT01352845|39248008|FG001|Overall Study|No Longer Willing to Participate|58|||
16209590|NCT01352845|39248007|FG000|Overall Study|Withdrawal by Subject|48|||
16209591|NCT01352845|39248008|FG001|Overall Study|Withdrawal by Subject|16|||
16209592|NCT01352845|39248007|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
16209593|NCT01352845|39248008|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
16209594|NCT01352845|39248007|FG000|Overall Study|Pregnancy|27|||
16209595|NCT01352845|39248008|FG001|Overall Study|Pregnancy|7|||
16209596|NCT01352845|39248007|FG000|Overall Study|Adverse Event|22|||
16209597|NCT01352845|39248008|FG001|Overall Study|Adverse Event|6|||
16209598|NCT01352845|39248007|FG000|Overall Study|Other|17|||
16209599|NCT01352845|39248008|FG001|Overall Study|Other|7|||
16209600|NCT01352845|39248007|FG000|Overall Study|Protocol Violation|12|||
16209601|NCT01352845|39248008|FG001|Overall Study|Protocol Violation|6|||
16209602|NCT01352845|39248007|FG000|Overall Study|Death|3|||
16209603|NCT01352845|39248008|FG001|Overall Study|Death|0|||
16209604|NCT00383708|39248009|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
16209605|NCT00383708|39248009|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
16209606|NCT00383708|39248009|FG000|Run-in Period|Protocol Violation|4|||
16209607|NCT00383708|39248009|FG000|Run-in Period|Adverse Event|2|||
16209608|NCT00383708|39248009|FG000|Run-in Period|Claustrophobia|1|||
16209609|NCT00383708|39248009|FG000|Co-administration Period|Adverse Event|5|||
16209610|NCT04153929|39248010|FG000|Overall Study|Other than listed|2|||
16209611|NCT04153929|39248011|FG001|Overall Study|Other than listed|2|||
16209612|NCT04153929|39248012|FG002|Overall Study|Other than listed|0|||
16524514|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
16209613|NCT04153929|39248013|FG003|Overall Study|Other than listed|1|||
16209614|NCT04153929|39248014|FG004|Overall Study|Other than listed|0|||
16209615|NCT04153929|39248015|FG005|Overall Study|Other than listed|2|||
16209616|NCT04153929|39248016|FG006|Overall Study|Other than listed|2|||
16209617|NCT04153929|39248017|FG007|Overall Study|Other than listed|1|||
16209618|NCT04153929|39248010|FG000|Overall Study|Lost to Follow-up|2|||
16209619|NCT04153929|39248011|FG001|Overall Study|Lost to Follow-up|1|||
16209620|NCT04153929|39248012|FG002|Overall Study|Lost to Follow-up|0|||
16209621|NCT04153929|39248013|FG003|Overall Study|Lost to Follow-up|1|||
16209622|NCT04153929|39248014|FG004|Overall Study|Lost to Follow-up|1|||
16209623|NCT04153929|39248015|FG005|Overall Study|Lost to Follow-up|0|||
16209624|NCT04153929|39248016|FG006|Overall Study|Lost to Follow-up|0|||
16209625|NCT04153929|39248017|FG007|Overall Study|Lost to Follow-up|0|||
16209626|NCT04153929|39248010|FG000|Overall Study|Withdrawal by Subject|3|||
16209627|NCT04153929|39248011|FG001|Overall Study|Withdrawal by Subject|1|||
16209628|NCT04153929|39248012|FG002|Overall Study|Withdrawal by Subject|0|||
16209629|NCT04153929|39248013|FG003|Overall Study|Withdrawal by Subject|3|||
16209630|NCT04153929|39248014|FG004|Overall Study|Withdrawal by Subject|1|||
16524515|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
16524516|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
16524517|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
16524518|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
16524519|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
16524520|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
16524521|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
16524522|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16524523|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16524524|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
16524525|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16209631|NCT04153929|39248015|FG005|Overall Study|Withdrawal by Subject|0|||
16209632|NCT04153929|39248016|FG006|Overall Study|Withdrawal by Subject|1|||
16209633|NCT04153929|39248017|FG007|Overall Study|Withdrawal by Subject|0|||
16209634|NCT04153929|39248010|FG000|Overall Study|Protocol Violation|0|||
16209635|NCT04153929|39248011|FG001|Overall Study|Protocol Violation|0|||
16209636|NCT04153929|39248012|FG002|Overall Study|Protocol Violation|0|||
16209637|NCT04153929|39248013|FG003|Overall Study|Protocol Violation|0|||
16209638|NCT04153929|39248014|FG004|Overall Study|Protocol Violation|0|||
16209639|NCT04153929|39248015|FG005|Overall Study|Protocol Violation|0|||
16209640|NCT04153929|39248016|FG006|Overall Study|Protocol Violation|1|||
16209641|NCT04153929|39248017|FG007|Overall Study|Protocol Violation|2|||
16524526|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16524527|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16209642|NCT04153929|39248010|FG000|Overall Study|Adverse Event|3|||
16209643|NCT04153929|39248011|FG001|Overall Study|Adverse Event|5|||
16209644|NCT04153929|39248012|FG002|Overall Study|Adverse Event|5|||
16209645|NCT04153929|39248013|FG003|Overall Study|Adverse Event|11|||
16209646|NCT04153929|39248014|FG004|Overall Study|Adverse Event|15|||
16209647|NCT04153929|39248015|FG005|Overall Study|Adverse Event|4|||
16209648|NCT04153929|39248016|FG006|Overall Study|Adverse Event|8|||
16209649|NCT04153929|39248017|FG007|Overall Study|Adverse Event|2|||
16209650|NCT04153929|39248010|FG000|Overall Study|Not treated|1|||
16209651|NCT04153929|39248011|FG001|Overall Study|Not treated|0|||
16209652|NCT04153929|39248012|FG002|Overall Study|Not treated|0|||
16209653|NCT04153929|39248013|FG003|Overall Study|Not treated|0|||
16209654|NCT04153929|39248014|FG004|Overall Study|Not treated|0|||
16209655|NCT04153929|39248015|FG005|Overall Study|Not treated|0|||
16209656|NCT04153929|39248016|FG006|Overall Study|Not treated|1|||
16209657|NCT04153929|39248017|FG007|Overall Study|Not treated|0|||
16209658|NCT03619837|39248018|FG000|Screening|received organs from HCV-negative donors|47|||
16209659|NCT03619837|39248018|FG000|Screening|died on the wait-list|2|||
16209660|NCT03619837|39248018|FG000|Screening|remained on the wait list|40|||
16209661|NCT03619837|39248018|FG000|Screening|didn't meet eligibility criteria|3|||
16209662|NCT03619837|39248018|FG000|Screening|withdrew consent|2|||
16209663|NCT03619837|39248018|FG000|Screening|never listed for HCV-viremic donor|1|||
16209664|NCT03619837|39248018|FG000|Screening|developed exclusion criteria|2|||
16209665|NCT03619837|39248018|FG000|Screening|excluded by the investigator due to non-compliance|1|||
16209666|NCT01235507|39248019|FG000|Overall Study|Adverse Event|1|||
16209667|NCT01235507|39248019|FG000|Overall Study|Withdrawal by Subject|1|||
16209668|NCT01915095|39248020|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
16209669|NCT01915095|39248021|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
16209670|NCT01915095|39248022|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
16209671|NCT01915095|39248023|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
16209672|NCT01915095|39248024|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
16209673|NCT05083949|39248031|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
16209674|NCT05083949|39248032|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
16209675|NCT05083949|39248031|FG000|Period 1|Adverse Event|1|||
16209676|NCT05083949|39248032|FG001|Period 1|Adverse Event|1|||
16209677|NCT05083949|39248031|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
16209678|NCT05083949|39248032|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
16209679|NCT05083949|39248031|FG000|Period 2|Adverse Event|0|||
16209680|NCT05083949|39248032|FG001|Period 2|Adverse Event|2|||
16209681|NCT01563107|39248035|FG000|Overall Study|Physician Decision|0|||
16209682|NCT01563107|39248036|FG001|Overall Study|Physician Decision|1|||
16209683|NCT01563107|39248037|FG002|Overall Study|Physician Decision|1|||
16209684|NCT01563107|39248038|FG003|Overall Study|Physician Decision|3|||
16209685|NCT01563107|39248035|FG000|Overall Study|Withdrawal by Subject|1|||
16209686|NCT01563107|39248036|FG001|Overall Study|Withdrawal by Subject|2|||
16209687|NCT01563107|39248037|FG002|Overall Study|Withdrawal by Subject|1|||
16209688|NCT01563107|39248038|FG003|Overall Study|Withdrawal by Subject|2|||
16209689|NCT00614991|39248040|FG000|Overall Study|Adverse Event|3|||
16209690|NCT00614991|39248041|FG001|Overall Study|Adverse Event|3|||
16209691|NCT00614991|39248042|FG002|Overall Study|Adverse Event|0|||
16209692|NCT00614991|39248043|FG003|Overall Study|Adverse Event|0|||
16209693|NCT00614991|39248044|FG004|Overall Study|Adverse Event|1|||
16209694|NCT00614991|39248045|FG005|Overall Study|Adverse Event|0|||
16209695|NCT03039790|39248046|FG000|Overall Study|Lost to Follow-up|2|||
16209696|NCT03039790|39248047|FG001|Overall Study|Lost to Follow-up|0|||
16328326|NCT02052596|39687714|FG000|Safety Phase|Lost to Follow-up|11|||
16328327|NCT02052596|39687715|FG001|Safety Phase|Lost to Follow-up|18|||
16209697|NCT03039790|39248048|FG002|Overall Study|Lost to Follow-up|1|||
16209698|NCT03039790|39248049|FG003|Overall Study|Lost to Follow-up|1|||
16209699|NCT03039790|39248050|FG004|Overall Study|Lost to Follow-up|0|||
16209700|NCT03039790|39248051|FG005|Overall Study|Lost to Follow-up|1|||
16209701|NCT03039790|39248052|FG006|Overall Study|Lost to Follow-up|1|||
16209702|NCT03039790|39248053|FG007|Overall Study|Lost to Follow-up|1|||
16209703|NCT03039790|39248054|FG008|Overall Study|Lost to Follow-up|0|||
16209704|NCT03039790|39248055|FG009|Overall Study|Lost to Follow-up|1|||
16209705|NCT03039790|39248056|FG010|Overall Study|Lost to Follow-up|1|||
16209706|NCT03039790|39248057|FG011|Overall Study|Lost to Follow-up|0|||
16209707|NCT03039790|39248058|FG012|Overall Study|Lost to Follow-up|1|||
16209708|NCT03039790|39248059|FG013|Overall Study|Lost to Follow-up|0|||
16209709|NCT03039790|39248060|FG014|Overall Study|Lost to Follow-up|3|||
16209710|NCT03039790|39248061|FG015|Overall Study|Lost to Follow-up|1|||
16209711|NCT03039790|39248062|FG016|Overall Study|Lost to Follow-up|2|||
16209712|NCT03039790|39248063|FG017|Overall Study|Lost to Follow-up|2|||
16209713|NCT03039790|39248064|FG018|Overall Study|Lost to Follow-up|1|||
16209714|NCT03039790|39248065|FG019|Overall Study|Lost to Follow-up|3|||
16209715|NCT03039790|39248046|FG000|Overall Study|Withdrawal of Consent|1|||
16209716|NCT03039790|39248047|FG001|Overall Study|Withdrawal of Consent|0|||
16209717|NCT03039790|39248048|FG002|Overall Study|Withdrawal of Consent|0|||
16209718|NCT03039790|39248049|FG003|Overall Study|Withdrawal of Consent|1|||
16209719|NCT03039790|39248050|FG004|Overall Study|Withdrawal of Consent|0|||
16209720|NCT03039790|39248051|FG005|Overall Study|Withdrawal of Consent|0|||
16328328|NCT02052596|39687714|FG000|Safety Phase|Protocol Violation|1|||
16209721|NCT03039790|39248052|FG006|Overall Study|Withdrawal of Consent|0|||
16209722|NCT03039790|39248053|FG007|Overall Study|Withdrawal of Consent|0|||
16209723|NCT03039790|39248054|FG008|Overall Study|Withdrawal of Consent|0|||
16209724|NCT03039790|39248055|FG009|Overall Study|Withdrawal of Consent|1|||
16209725|NCT03039790|39248056|FG010|Overall Study|Withdrawal of Consent|0|||
16209726|NCT03039790|39248057|FG011|Overall Study|Withdrawal of Consent|0|||
16209727|NCT03039790|39248058|FG012|Overall Study|Withdrawal of Consent|2|||
16209728|NCT03039790|39248059|FG013|Overall Study|Withdrawal of Consent|0|||
16209729|NCT03039790|39248060|FG014|Overall Study|Withdrawal of Consent|1|||
16209730|NCT03039790|39248061|FG015|Overall Study|Withdrawal of Consent|5|||
16209731|NCT03039790|39248062|FG016|Overall Study|Withdrawal of Consent|3|||
16209732|NCT03039790|39248063|FG017|Overall Study|Withdrawal of Consent|0|||
16209733|NCT03039790|39248064|FG018|Overall Study|Withdrawal of Consent|2|||
16209734|NCT03039790|39248065|FG019|Overall Study|Withdrawal of Consent|5|||
16209735|NCT03039790|39248046|FG000|Overall Study|Death|0|||
16209736|NCT03039790|39248047|FG001|Overall Study|Death|0|||
16209737|NCT03039790|39248048|FG002|Overall Study|Death|0|||
16209738|NCT03039790|39248049|FG003|Overall Study|Death|0|||
16209739|NCT03039790|39248050|FG004|Overall Study|Death|0|||
16209740|NCT03039790|39248051|FG005|Overall Study|Death|0|||
16209741|NCT03039790|39248052|FG006|Overall Study|Death|0|||
16209742|NCT03039790|39248053|FG007|Overall Study|Death|0|||
16328329|NCT02052596|39687715|FG001|Safety Phase|Protocol Violation|2|||
16328330|NCT02052596|39687714|FG000|Safety Phase|Withdrawal by Subject|8|||
16328331|NCT02052596|39687715|FG001|Safety Phase|Withdrawal by Subject|11|||
16328332|NCT02052596|39687714|FG000|Safety Phase|Enrolled in error|1|||
16328333|NCT02052596|39687715|FG001|Safety Phase|Enrolled in error|0|||
16328334|NCT02052596|39687714|FG000|Safety Phase|Lost due to Crohn's disease|0|||
16524528|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16328335|NCT02052596|39687715|FG001|Safety Phase|Lost due to Crohn's disease|1|||
16328336|NCT01044290|39687716|FG000|Follow-up 1|Death|3|||
16328337|NCT01044290|39687717|FG001|Follow-up 1|Death|3|||
16328338|NCT01044290|39687718|FG002|Follow-up 1|Death|1|||
16328339|NCT01044290|39687716|FG000|Follow-up 1|Withdrawal by Subject|2|||
16328340|NCT01044290|39687717|FG001|Follow-up 1|Withdrawal by Subject|2|||
16328341|NCT01044290|39687718|FG002|Follow-up 1|Withdrawal by Subject|0|||
16328342|NCT01044290|39687716|FG000|Follow-Up 2|Death|0|||
16328343|NCT01044290|39687717|FG001|Follow-Up 2|Death|1|||
16328344|NCT01044290|39687718|FG002|Follow-Up 2|Death|1|||
16328345|NCT01044290|39687716|FG000|Follow-Up 2|Withdrawal by Subject|0|||
16328346|NCT01044290|39687717|FG001|Follow-Up 2|Withdrawal by Subject|1|||
16328347|NCT01044290|39687718|FG002|Follow-Up 2|Withdrawal by Subject|1|||
16328348|NCT00784550|39687723|FG000|Overall Study|Adverse Event|12|||
16328349|NCT00784550|39687724|FG001|Overall Study|Adverse Event|10|||
16328350|NCT00784550|39687723|FG000|Overall Study|Lack of Efficacy|0|||
16328351|NCT00784550|39687724|FG001|Overall Study|Lack of Efficacy|1|||
16328352|NCT00784550|39687723|FG000|Overall Study|Protocol Violation|10|||
16328353|NCT00784550|39687724|FG001|Overall Study|Protocol Violation|10|||
16328354|NCT00784550|39687723|FG000|Overall Study|Lost to Follow-up|8|||
16328355|NCT00784550|39687724|FG001|Overall Study|Lost to Follow-up|5|||
16328356|NCT00784550|39687723|FG000|Overall Study|Physician Decision|2|||
16328357|NCT00784550|39687724|FG001|Overall Study|Physician Decision|3|||
16328358|NCT00784550|39687723|FG000|Overall Study|Withdrawal by Subject|4|||
16328359|NCT00784550|39687724|FG001|Overall Study|Withdrawal by Subject|13|||
16328360|NCT01446237|39687729|FG000|Overall Study|Adverse Event|1|||
16328361|NCT01446237|39687729|FG000|Overall Study|Lost to Follow-up|2|||
16328362|NCT01446237|39687729|FG000|Overall Study|Withdrawal by Subject|7|||
16328363|NCT04258254|39687730|FG000|Overall Study|Withdrawal by Subject|0|||
16328364|NCT04258254|39687731|FG001|Overall Study|Withdrawal by Subject|1|||
16328365|NCT04258254|39687732|FG002|Overall Study|Withdrawal by Subject|0|||
16524529|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16328366|NCT02062944|39687733|FG000|Overall Study|Lost to Follow-up|1|||
16328367|NCT02062944|39687733|FG000|Overall Study|New hemotological disorder identified|1|||
16328368|NCT02062944|39687733|FG000|Overall Study|Uncontrolled Hypertension|1|||
16328369|NCT02062944|39687733|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
16328370|NCT01661933|39687734|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
16397431|NCT02993822|39935478|FG003|Overall Study|Protocol Violation|0|||
16209743|NCT03039790|39248054|FG008|Overall Study|Death|0|||
16209744|NCT03039790|39248055|FG009|Overall Study|Death|0|||
16209745|NCT03039790|39248056|FG010|Overall Study|Death|0|||
16209746|NCT03039790|39248057|FG011|Overall Study|Death|0|||
16209747|NCT03039790|39248058|FG012|Overall Study|Death|0|||
16524530|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
16209748|NCT03039790|39248059|FG013|Overall Study|Death|0|||
16209749|NCT03039790|39248060|FG014|Overall Study|Death|0|||
16209750|NCT03039790|39248061|FG015|Overall Study|Death|1|||
16328371|NCT01661933|39687734|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
16328372|NCT01625689|39687735|FG000|Overall Study|Migration|2|||
16328373|NCT01625689|39687736|FG001|Overall Study|Migration|1|||
16328374|NCT00916344|39687737|FG000|Overall Study|Death|2|||
16328375|NCT00916344|39687737|FG000|Overall Study|ICD upgrade|1|||
16328376|NCT00916344|39687737|FG000|Overall Study|Drop-out|5|||
16328377|NCT02089334|39687738|FG000|Overall Study|Withdrawal by Subject|0|||
16328378|NCT02089334|39687739|FG001|Overall Study|Withdrawal by Subject|0|||
16328379|NCT02089334|39687740|FG002|Overall Study|Withdrawal by Subject|0|||
16328380|NCT02089334|39687741|FG003|Overall Study|Withdrawal by Subject|2|||
16328381|NCT02089334|39687738|FG000|Overall Study|Adverse Event|0|||
16328382|NCT02089334|39687739|FG001|Overall Study|Adverse Event|0|||
16328383|NCT02089334|39687740|FG002|Overall Study|Adverse Event|0|||
16328384|NCT02089334|39687741|FG003|Overall Study|Adverse Event|2|||
16328385|NCT02089334|39687738|FG000|Overall Study|Progressive disease|0|||
16328386|NCT02089334|39687739|FG001|Overall Study|Progressive disease|0|||
16328387|NCT02089334|39687740|FG002|Overall Study|Progressive disease|0|||
16328388|NCT02089334|39687741|FG003|Overall Study|Progressive disease|2|||
16328389|NCT02089334|39687738|FG000|Overall Study|Physician Decision|0|||
16328390|NCT02089334|39687739|FG001|Overall Study|Physician Decision|0|||
16328391|NCT02089334|39687740|FG002|Overall Study|Physician Decision|1|||
16328392|NCT02089334|39687741|FG003|Overall Study|Physician Decision|1|||
16328393|NCT02777970|39687742|FG000|Overall Study|Lost to Follow-up|0|||
16328394|NCT02777970|39687743|FG001|Overall Study|Lost to Follow-up|1|||
16328395|NCT02777970|39687744|FG002|Overall Study|Lost to Follow-up|0|||
16328396|NCT02777970|39687742|FG000|Overall Study|Protocol Violation|1|||
16328397|NCT02777970|39687743|FG001|Overall Study|Protocol Violation|0|||
16328398|NCT02777970|39687744|FG002|Overall Study|Protocol Violation|0|||
16328399|NCT03244618|39687745|FG000|Overall Study|Lost to Follow-up|3|||
16328400|NCT03244618|39687746|FG001|Overall Study|Lost to Follow-up|4|||
16328401|NCT03244618|39687745|FG000|Overall Study|Protocol Violation|4|||
16328402|NCT03244618|39687746|FG001|Overall Study|Protocol Violation|3|||
16328403|NCT03244618|39687745|FG000|Overall Study|Withdrawal by Subject|0|||
16328404|NCT03244618|39687746|FG001|Overall Study|Withdrawal by Subject|2|||
16328405|NCT00176644|39687747|FG000|Overall Study|Withdrawal by Subject|1|||
16328406|NCT01424514|39687748|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
16328407|NCT01424514|39687749|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
16328408|NCT01424514|39687748|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
16328409|NCT01424514|39687749|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
16328410|NCT01472965|39687750|FG000|Overall Study|Withdrawal by Subject|1|||
16096054|NCT02516202|38842676|FG002|Overall Study|Withdrawal by Subject|1|||
16096055|NCT02516202|38842674|FG000|Overall Study|Lost to Follow-up|1|||
16096056|NCT02516202|38842675|FG001|Overall Study|Lost to Follow-up|1|||
16096057|NCT02516202|38842676|FG002|Overall Study|Lost to Follow-up|1|||
16096058|NCT02516202|38842674|FG000|Overall Study|Stopped Follow-up|0|||
16096059|NCT02516202|38842675|FG001|Overall Study|Stopped Follow-up|0|||
16096060|NCT02516202|38842676|FG002|Overall Study|Stopped Follow-up|1|||
16096061|NCT00248794|38842677|FG000|Overall Study|Lost to Follow-up|6|||
16096062|NCT00248794|38842678|FG001|Overall Study|Lost to Follow-up|8|||
16096063|NCT00248794|38842679|FG002|Overall Study|Lost to Follow-up|3|||
16096064|NCT04454125|38842685|FG000|Overall Study|Lost to Follow-up|0|||
16096065|NCT04454125|38842686|FG001|Overall Study|Lost to Follow-up|1|||
16096066|NCT00988429|38842687|FG000|Overall Study|Adverse Event|9|||
16096067|NCT00988429|38842688|FG001|Overall Study|Adverse Event|21|||
16096068|NCT00988429|38842689|FG002|Overall Study|Adverse Event|45|||
16096069|NCT00988429|38842687|FG000|Overall Study|Lack of Efficacy|0|||
16096070|NCT00988429|38842688|FG001|Overall Study|Lack of Efficacy|0|||
16096071|NCT00988429|38842689|FG002|Overall Study|Lack of Efficacy|1|||
16096072|NCT00988429|38842687|FG000|Overall Study|Non-Compliance with Study Drug|5|||
16096073|NCT00988429|38842688|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16096074|NCT00988429|38842689|FG002|Overall Study|Non-Compliance with Study Drug|3|||
16096075|NCT00988429|38842687|FG000|Overall Study|Physician Decision|1|||
16096076|NCT00988429|38842688|FG001|Overall Study|Physician Decision|0|||
16096077|NCT00988429|38842689|FG002|Overall Study|Physician Decision|3|||
16096078|NCT00988429|38842687|FG000|Overall Study|Pregnancy|2|||
16096079|NCT00988429|38842688|FG001|Overall Study|Pregnancy|1|||
16096080|NCT00988429|38842689|FG002|Overall Study|Pregnancy|0|||
16096081|NCT00988429|38842687|FG000|Overall Study|Protocol Violation|4|||
16328411|NCT01472965|39687751|FG001|Overall Study|Withdrawal by Subject|0|||
16328412|NCT01869699|39687760|FG000|Overall Study|Withdrawal by Subject|1|||
16328413|NCT01869699|39687761|FG001|Overall Study|Withdrawal by Subject|0|||
16328414|NCT00150800|39687762|FG000|Overall Study|Adverse Event|89|||
16328415|NCT00150800|39687762|FG000|Overall Study|Death|18|||
16328416|NCT00150800|39687762|FG000|Overall Study|Lack of Efficacy|166|||
16328417|NCT00150800|39687762|FG000|Overall Study|Lost to Follow-up|58|||
16328418|NCT00150800|39687762|FG000|Overall Study|Subject's choice|90|||
16328419|NCT00150800|39687762|FG000|Overall Study|No compliance|18|||
16328420|NCT00150800|39687762|FG000|Overall Study|IP misshandling|1|||
16328421|NCT00150800|39687762|FG000|Overall Study|Site closure|24|||
16328422|NCT00150800|39687762|FG000|Overall Study|Protocol non-adherence|2|||
16328423|NCT00150800|39687762|FG000|Overall Study|Nobody to accompany patient|1|||
16096082|NCT00988429|38842688|FG001|Overall Study|Protocol Violation|3|||
16096083|NCT00988429|38842689|FG002|Overall Study|Protocol Violation|3|||
16096084|NCT00988429|38842687|FG000|Overall Study|Withdrawal by Subject|7|||
16096085|NCT00988429|38842688|FG001|Overall Study|Withdrawal by Subject|7|||
16096086|NCT00988429|38842689|FG002|Overall Study|Withdrawal by Subject|12|||
16096087|NCT00988429|38842687|FG000|Overall Study|Administrative Reasons|1|||
16096088|NCT00988429|38842688|FG001|Overall Study|Administrative Reasons|2|||
16096089|NCT00988429|38842689|FG002|Overall Study|Administrative Reasons|1|||
16096090|NCT00988429|38842687|FG000|Overall Study|other reasons|8|||
16096091|NCT00988429|38842688|FG001|Overall Study|other reasons|8|||
16096092|NCT00988429|38842689|FG002|Overall Study|other reasons|1|||
16096093|NCT01131325|38842690|FG000|Overall Study|Adverse Event|1|||
16096094|NCT01131325|38842690|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
16096095|NCT01695993|38842691|FG000|Overall Study|Lost to Follow-up|2|||
16096096|NCT01695993|38842692|FG001|Overall Study|Lost to Follow-up|1|||
16096097|NCT01695993|38842693|FG002|Overall Study|Lost to Follow-up|3|||
16096098|NCT01695993|38842691|FG000|Overall Study|Withdrawal by Subject|2|||
16096099|NCT01695993|38842692|FG001|Overall Study|Withdrawal by Subject|2|||
16096100|NCT01695993|38842693|FG002|Overall Study|Withdrawal by Subject|2|||
16096101|NCT01695993|38842691|FG000|Overall Study|To ill to continue|1|||
16096102|NCT01695993|38842692|FG001|Overall Study|To ill to continue|2|||
16096103|NCT01695993|38842693|FG002|Overall Study|To ill to continue|0|||
16096104|NCT01695993|38842691|FG000|Overall Study|Changed Medical Facility|0|||
16096105|NCT01695993|38842692|FG001|Overall Study|Changed Medical Facility|0|||
16096106|NCT01695993|38842693|FG002|Overall Study|Changed Medical Facility|1|||
16096107|NCT05265247|38842694|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
16096108|NCT05265247|38842695|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
16096109|NCT05265247|38842694|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
16096110|NCT05265247|38842695|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
16096111|NCT05265247|38842694|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
16096112|NCT05265247|38842695|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
16096113|NCT00472082|38842696|FG000|Overall Study|Study prematurely terminated|5|||
16096114|NCT02465866|38842697|FG000|Period 3|Withdrawal by Subject|0|||
16096115|NCT02465866|38842698|FG001|Period 3|Withdrawal by Subject|1|||
16096116|NCT02465866|38842699|FG002|Period 3|Withdrawal by Subject|0|||
16096117|NCT02465866|38842700|FG003|Period 3|Withdrawal by Subject|0|||
16096118|NCT01697592|38842701|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
16096119|NCT01697592|38842702|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16096120|NCT01697592|38842703|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16096121|NCT01697592|38842704|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16096122|NCT01697592|38842705|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16096123|NCT01697592|38842706|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16096124|NCT01697592|38842707|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16096125|NCT01697592|38842708|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16096126|NCT01697592|38842709|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16096127|NCT01697592|38842710|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
16096128|NCT01697592|38842701|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16096129|NCT01697592|38842702|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16096130|NCT01697592|38842703|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16096131|NCT01697592|38842704|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16096132|NCT01697592|38842705|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16096133|NCT01697592|38842706|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
16096134|NCT01697592|38842707|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16096135|NCT01697592|38842708|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16096136|NCT01697592|38842709|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16096137|NCT01697592|38842710|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16096138|NCT01697592|38842701|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
16096139|NCT01697592|38842702|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16096140|NCT01697592|38842703|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16096141|NCT01697592|38842704|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16096142|NCT01697592|38842705|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16096143|NCT01697592|38842706|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16096144|NCT01697592|38842707|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16096145|NCT01697592|38842708|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16096146|NCT01697592|38842709|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16096147|NCT01697592|38842710|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16209751|NCT03039790|39248062|FG016|Overall Study|Death|3|||
16096148|NCT01697592|38842701|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
16096149|NCT01697592|38842702|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
16096150|NCT01697592|38842703|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16096151|NCT01697592|38842704|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16096152|NCT01697592|38842705|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16096153|NCT01697592|38842706|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16096154|NCT01697592|38842707|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
16096155|NCT01697592|38842708|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16096156|NCT01697592|38842709|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16096157|NCT01697592|38842710|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
16096158|NCT01697592|38842701|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16096159|NCT01697592|38842702|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
16096160|NCT01697592|38842703|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
16096161|NCT01697592|38842704|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
16096162|NCT01697592|38842705|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16096163|NCT01697592|38842706|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16096164|NCT01697592|38842707|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
16096165|NCT01697592|38842708|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16096166|NCT01697592|38842709|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16096167|NCT01697592|38842710|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
16096168|NCT01697592|38842701|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
16096169|NCT01697592|38842702|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16096170|NCT01697592|38842703|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16096171|NCT01697592|38842704|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
16096172|NCT01697592|38842705|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16096173|NCT01697592|38842706|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16328424|NCT00150800|39687762|FG000|Overall Study|Distance too long for patient|1|||
16328425|NCT00150800|39687762|FG000|Overall Study|Neurosurgery|2|||
16328426|NCT00150800|39687762|FG000|Overall Study|BRV monotherapy|1|||
16397432|NCT02993822|39935475|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
16397433|NCT02993822|39935476|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
16397434|NCT02993822|39935477|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
16397435|NCT02993822|39935478|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
16397436|NCT02993822|39935475|FG000|Overall Study|Adverse Event|3|||
16397437|NCT02993822|39935476|FG001|Overall Study|Adverse Event|1|||
16397438|NCT02993822|39935477|FG002|Overall Study|Adverse Event|7|||
16397439|NCT02993822|39935478|FG003|Overall Study|Adverse Event|0|||
16397440|NCT02993822|39935475|FG000|Overall Study|Withdrawal by Subject|4|||
16397441|NCT02993822|39935476|FG001|Overall Study|Withdrawal by Subject|2|||
16397442|NCT02993822|39935477|FG002|Overall Study|Withdrawal by Subject|2|||
16397443|NCT02993822|39935478|FG003|Overall Study|Withdrawal by Subject|3|||
16397444|NCT02993822|39935475|FG000|Overall Study|Lost to Follow-up|1|||
16524531|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16524532|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
16524533|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
16524534|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16524535|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16524536|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16524537|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16524538|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
16524539|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
16524540|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16524541|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
16524542|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16524543|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16524544|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16524545|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16524546|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16524547|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
16524548|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
16524549|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16524550|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
16209752|NCT03039790|39248063|FG017|Overall Study|Death|0|||
16328427|NCT00150800|39687762|FG000|Overall Study|Visit refusal|3|||
16328428|NCT00150800|39687762|FG000|Overall Study|Sponsor's request|2|||
16328429|NCT00150800|39687762|FG000|Overall Study|Generalized Epilepsy|1|||
16328430|NCT00150800|39687762|FG000|Overall Study|Moved from area/country|8|||
16328431|NCT00150800|39687762|FG000|Overall Study|PI retiring|2|||
16328432|NCT00150800|39687762|FG000|Overall Study|PI leaving site|2|||
16328433|NCT00150800|39687762|FG000|Overall Study|Patient insurance|1|||
16328434|NCT00150800|39687762|FG000|Overall Study|Surgical intervention|4|||
16328435|NCT00150800|39687762|FG000|Overall Study|Pregnancy planned|1|||
16524551|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16524552|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16524553|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16096174|NCT01697592|38842707|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16397445|NCT02993822|39935476|FG001|Overall Study|Lost to Follow-up|0|||
16397446|NCT02993822|39935477|FG002|Overall Study|Lost to Follow-up|1|||
16397447|NCT02993822|39935478|FG003|Overall Study|Lost to Follow-up|0|||
16328436|NCT00150800|39687762|FG000|Overall Study|PI discontinuation request|1|||
16328437|NCT04050124|39687765|FG000|Overall Study|Death|1|||
16328438|NCT04050124|39687766|FG001|Overall Study|Death|0|||
16328439|NCT00809471|39687773|FG000|Overall Study|Protocol non-compliance|15|||
16328440|NCT00809471|39687774|FG001|Overall Study|Protocol non-compliance|15|||
16328441|NCT00809471|39687775|FG002|Overall Study|Protocol non-compliance|6|||
16328442|NCT00809471|39687773|FG000|Overall Study|Lost to Follow-up|4|||
16328443|NCT00809471|39687774|FG001|Overall Study|Lost to Follow-up|2|||
16328444|NCT00809471|39687775|FG002|Overall Study|Lost to Follow-up|9|||
16524554|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16524555|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16524556|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16524557|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
16524558|NCT01172938|40387777|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16524559|NCT01172938|40387778|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16524560|NCT01172938|40387779|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16524561|NCT01172938|40387780|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16524562|NCT01172938|40387781|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16524563|NCT01172938|40387782|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16524564|NCT01172938|40387783|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16524565|NCT01172938|40387784|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
16524566|NCT01172938|40387785|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
16524567|NCT01172938|40387777|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
16524568|NCT01172938|40387778|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
16524569|NCT01172938|40387779|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
16524570|NCT01172938|40387780|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
16524571|NCT01172938|40387781|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
16524572|NCT01172938|40387782|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
16524573|NCT01172938|40387783|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
16524574|NCT01172938|40387784|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
16524575|NCT01172938|40387785|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
16524576|NCT01172938|40387777|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
16524577|NCT01172938|40387778|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
16524578|NCT01172938|40387779|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
16524579|NCT01172938|40387780|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
16524580|NCT01172938|40387781|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
16524581|NCT01172938|40387782|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
16524582|NCT01172938|40387783|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
16524583|NCT01172938|40387784|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
16524584|NCT01172938|40387785|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
16524585|NCT01172938|40387777|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
16524586|NCT01172938|40387778|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
16524587|NCT01172938|40387779|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
16524588|NCT01172938|40387780|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
16524589|NCT01172938|40387781|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
16397448|NCT04153981|39935481|FG000|Overall Study|Death|1|||
16397449|NCT04153981|39935481|FG000|Overall Study|Withdrawal by Subject|24|||
16397450|NCT04153981|39935481|FG000|Overall Study|Lost to Follow-up|1|||
16397451|NCT04153981|39935481|FG000|Overall Study|Physician Decision|1|||
16397452|NCT04153981|39935481|FG000|Overall Study|Due to Unavailable Glucometer|1|||
16397453|NCT04153981|39935481|FG000|Overall Study|Covid 19|52|||
16397454|NCT04153981|39935481|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
16397455|NCT04153981|39935481|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
16397456|NCT02222688|39935482|FG000|Overall Study|Withdrawal by Subject|0|||
16397457|NCT02222688|39935483|FG001|Overall Study|Withdrawal by Subject|0|||
16397458|NCT02222688|39935484|FG002|Overall Study|Withdrawal by Subject|0|||
16397459|NCT02222688|39935485|FG003|Overall Study|Withdrawal by Subject|2|||
16397460|NCT02222688|39935486|FG004|Overall Study|Withdrawal by Subject|1|||
16524590|NCT01172938|40387782|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
16524591|NCT01172938|40387783|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
16328445|NCT00809471|39687773|FG000|Overall Study|Adverse Event|0|||
16328446|NCT00809471|39687774|FG001|Overall Study|Adverse Event|2|||
16397461|NCT02222688|39935487|FG005|Overall Study|Withdrawal by Subject|0|||
16397462|NCT02222688|39935488|FG006|Overall Study|Withdrawal by Subject|1|||
16397463|NCT02222688|39935482|FG000|Overall Study|Disease progression|1|||
16328447|NCT00809471|39687775|FG002|Overall Study|Adverse Event|2|||
16209753|NCT03039790|39248064|FG018|Overall Study|Death|2|||
16209754|NCT03039790|39248065|FG019|Overall Study|Death|0|||
16209755|NCT03039790|39248046|FG000|Overall Study|Reason, not Specified|1|||
16209756|NCT03039790|39248047|FG001|Overall Study|Reason, not Specified|0|||
16209757|NCT03039790|39248048|FG002|Overall Study|Reason, not Specified|0|||
16209758|NCT03039790|39248049|FG003|Overall Study|Reason, not Specified|0|||
16209759|NCT03039790|39248050|FG004|Overall Study|Reason, not Specified|0|||
16209760|NCT03039790|39248051|FG005|Overall Study|Reason, not Specified|0|||
16209761|NCT03039790|39248052|FG006|Overall Study|Reason, not Specified|0|||
16209762|NCT03039790|39248053|FG007|Overall Study|Reason, not Specified|0|||
16209763|NCT03039790|39248054|FG008|Overall Study|Reason, not Specified|0|||
16209764|NCT03039790|39248055|FG009|Overall Study|Reason, not Specified|0|||
16209765|NCT03039790|39248056|FG010|Overall Study|Reason, not Specified|0|||
16209766|NCT03039790|39248057|FG011|Overall Study|Reason, not Specified|0|||
16209767|NCT03039790|39248058|FG012|Overall Study|Reason, not Specified|0|||
16209768|NCT03039790|39248059|FG013|Overall Study|Reason, not Specified|0|||
16209769|NCT03039790|39248060|FG014|Overall Study|Reason, not Specified|0|||
16209770|NCT03039790|39248061|FG015|Overall Study|Reason, not Specified|0|||
16209771|NCT03039790|39248062|FG016|Overall Study|Reason, not Specified|2|||
16209772|NCT03039790|39248063|FG017|Overall Study|Reason, not Specified|0|||
16209773|NCT03039790|39248064|FG018|Overall Study|Reason, not Specified|1|||
16209774|NCT03039790|39248065|FG019|Overall Study|Reason, not Specified|0|||
16209775|NCT02266004|39248066|FG000|Overall Study|unrelated adverse event|1|||
16209776|NCT02266004|39248066|FG000|Overall Study|Physician Decision|1|||
16209777|NCT00887068|39248067|FG000|Overall Study|Withdrawal by Subject|2|||
16209778|NCT00887068|39248068|FG001|Overall Study|Withdrawal by Subject|0|||
16209779|NCT00887068|39248067|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
16209780|NCT00887068|39248068|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
16209781|NCT00293241|39248069|FG000|Overall Study|Lost to Follow-up|9|||
16209782|NCT00293241|39248070|FG001|Overall Study|Lost to Follow-up|16|||
16209783|NCT00293241|39248069|FG000|Overall Study|Physician Decision|23|||
16209784|NCT00293241|39248070|FG001|Overall Study|Physician Decision|17|||
16209785|NCT00293241|39248069|FG000|Overall Study|Withdrawal by Subject|4|||
16209786|NCT00293241|39248070|FG001|Overall Study|Withdrawal by Subject|8|||
16209787|NCT03370913|39248074|FG000|Overall Study|Death|1|||
16209788|NCT03370913|39248074|FG000|Overall Study|Lost to Follow-up|1|||
16209789|NCT01432457|39248078|FG000|Overall Study|Adverse Event|7|||
16209790|NCT01432457|39248079|FG001|Overall Study|Adverse Event|10|||
16209791|NCT01432457|39248080|FG002|Overall Study|Adverse Event|16|||
16209792|NCT01432457|39248078|FG000|Overall Study|Lack of Efficacy|2|||
16209793|NCT01432457|39248079|FG001|Overall Study|Lack of Efficacy|1|||
16209794|NCT01432457|39248080|FG002|Overall Study|Lack of Efficacy|1|||
16209795|NCT01432457|39248078|FG000|Overall Study|Lost to Follow-up|11|||
16209796|NCT01432457|39248079|FG001|Overall Study|Lost to Follow-up|15|||
16209797|NCT01432457|39248080|FG002|Overall Study|Lost to Follow-up|20|||
16209798|NCT01432457|39248078|FG000|Overall Study|Protocol Violation|3|||
16209799|NCT01432457|39248079|FG001|Overall Study|Protocol Violation|2|||
16209800|NCT01432457|39248080|FG002|Overall Study|Protocol Violation|6|||
16209801|NCT01432457|39248078|FG000|Overall Study|Withdrawal by Subject|6|||
16209802|NCT01432457|39248079|FG001|Overall Study|Withdrawal by Subject|11|||
16209803|NCT01432457|39248080|FG002|Overall Study|Withdrawal by Subject|9|||
16209804|NCT01432457|39248078|FG000|Overall Study|Reasons not defined|2|||
16209805|NCT01432457|39248079|FG001|Overall Study|Reasons not defined|3|||
16209806|NCT01432457|39248080|FG002|Overall Study|Reasons not defined|4|||
16209807|NCT01432457|39248078|FG000|Overall Study|Did not take study drug|6|||
16209808|NCT01432457|39248079|FG001|Overall Study|Did not take study drug|6|||
16209809|NCT01432457|39248080|FG002|Overall Study|Did not take study drug|3|||
16209810|NCT00412113|39248081|FG000|Overall Study|Adverse Event|11|||
16209811|NCT00412113|39248082|FG001|Overall Study|Adverse Event|15|||
16209812|NCT00412113|39248081|FG000|Overall Study|did not receive treatment|1|||
16209813|NCT00412113|39248082|FG001|Overall Study|did not receive treatment|0|||
16209814|NCT01106391|39248083|FG000|Overall Study|Death|12|||
16209815|NCT01106391|39248083|FG000|Overall Study|Withdrawal by Subject|7|||
16209816|NCT00712270|39248085|FG000|Overall Study|Withdrawal by Subject|11|||
16209817|NCT00712270|39248085|FG000|Overall Study|Screen Failure|3|||
16524592|NCT01172938|40387784|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
16209818|NCT02738580|39248086|FG000|Overall Study|Adverse Event|1|||
16209819|NCT02738580|39248087|FG001|Overall Study|Adverse Event|0|||
16209820|NCT02738580|39248086|FG000|Overall Study|Lack of Efficacy|3|||
16209821|NCT02738580|39248087|FG001|Overall Study|Lack of Efficacy|2|||
16209822|NCT02738580|39248086|FG000|Overall Study|Withdrawal by Subject|0|||
16209823|NCT02738580|39248087|FG001|Overall Study|Withdrawal by Subject|1|||
16209824|NCT02738580|39248086|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
16209825|NCT02738580|39248087|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
16209826|NCT02707601|39248090|FG000|Overall Study|Death|0|||
16209827|NCT02707601|39248091|FG001|Overall Study|Death|1|||
16209828|NCT02707601|39248090|FG000|Overall Study|Lack of Efficacy|0|||
16209829|NCT02707601|39248091|FG001|Overall Study|Lack of Efficacy|1|||
16096175|NCT01697592|38842708|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16096176|NCT01697592|38842709|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16096177|NCT01697592|38842710|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
16096178|NCT01697592|38842701|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
16096179|NCT01697592|38842702|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16096180|NCT01697592|38842703|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16096181|NCT01697592|38842704|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16096182|NCT01697592|38842705|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16096183|NCT01697592|38842706|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
16096184|NCT01697592|38842707|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16096185|NCT01697592|38842708|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
16096186|NCT01697592|38842709|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16096187|NCT01697592|38842710|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
16096188|NCT01697592|38842701|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
16096189|NCT01697592|38842702|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
16096190|NCT01697592|38842703|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
16096191|NCT01697592|38842704|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
16096192|NCT01697592|38842705|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
16096193|NCT01697592|38842706|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
16096194|NCT01697592|38842707|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
16096195|NCT01697592|38842708|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
16096196|NCT01697592|38842709|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
16096197|NCT01697592|38842710|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
16096198|NCT00670449|38842712|FG000|Overall Study|Adverse Event|6|||
16096199|NCT00670449|38842713|FG001|Overall Study|Adverse Event|2|||
16096200|NCT00670449|38842714|FG002|Overall Study|Adverse Event|8|||
16096201|NCT00670449|38842715|FG003|Overall Study|Adverse Event|5|||
16096202|NCT00670449|38842712|FG000|Overall Study|Protocol Deviation|1|||
16096203|NCT00670449|38842713|FG001|Overall Study|Protocol Deviation|2|||
16096204|NCT00670449|38842714|FG002|Overall Study|Protocol Deviation|0|||
16096205|NCT00670449|38842715|FG003|Overall Study|Protocol Deviation|1|||
16096206|NCT00670449|38842712|FG000|Overall Study|Administrative Problems|0|||
16096207|NCT00670449|38842713|FG001|Overall Study|Administrative Problems|2|||
16096208|NCT00670449|38842714|FG002|Overall Study|Administrative Problems|0|||
16096209|NCT00670449|38842715|FG003|Overall Study|Administrative Problems|1|||
16096210|NCT00670449|38842712|FG000|Overall Study|Subject Withdrew Consent|0|||
16096211|NCT00670449|38842713|FG001|Overall Study|Subject Withdrew Consent|2|||
16096212|NCT00670449|38842714|FG002|Overall Study|Subject Withdrew Consent|0|||
16096213|NCT00670449|38842715|FG003|Overall Study|Subject Withdrew Consent|1|||
16096214|NCT00670449|38842712|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
16096215|NCT00670449|38842713|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16096216|NCT00670449|38842714|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
16096217|NCT00670449|38842715|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16096218|NCT00670449|38842712|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
16096219|NCT00670449|38842713|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
16096220|NCT00670449|38842714|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
16096221|NCT00670449|38842715|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
16096222|NCT02762500|38842719|FG000|Overall Study|Lack of Efficacy|1|||
16096223|NCT02762500|38842720|FG001|Overall Study|Lack of Efficacy|0|||
16096224|NCT02762500|38842719|FG000|Overall Study|Withdrawal by Subject|1|||
16096225|NCT02762500|38842720|FG001|Overall Study|Withdrawal by Subject|1|||
16096226|NCT02762500|38842719|FG000|Overall Study|Adverse Event|0|||
16096227|NCT02762500|38842720|FG001|Overall Study|Adverse Event|2|||
16096228|NCT03209492|38842721|FG000|Overall Study|Case Report Forms Uncollected|5|||
16096229|NCT00316589|38842722|FG000|Overall Study|Withdrawal by Subject|0|||
16096230|NCT00316589|38842723|FG001|Overall Study|Withdrawal by Subject|5|||
16096231|NCT00316589|38842724|FG002|Overall Study|Withdrawal by Subject|0|||
16096232|NCT00316589|38842725|FG003|Overall Study|Withdrawal by Subject|1|||
16096233|NCT00316589|38842722|FG000|Overall Study|Subject unwilling/unable to comply|0|||
16328448|NCT00809471|39687773|FG000|Overall Study|Requirement for restricted medication|1|||
16328449|NCT00809471|39687774|FG001|Overall Study|Requirement for restricted medication|1|||
16328450|NCT00809471|39687775|FG002|Overall Study|Requirement for restricted medication|0|||
16096234|NCT00316589|38842723|FG001|Overall Study|Subject unwilling/unable to comply|6|||
16096235|NCT00316589|38842724|FG002|Overall Study|Subject unwilling/unable to comply|0|||
16096236|NCT00316589|38842725|FG003|Overall Study|Subject unwilling/unable to comply|2|||
16096237|NCT00316589|38842722|FG000|Overall Study|Adverse Event|1|||
16096238|NCT00316589|38842723|FG001|Overall Study|Adverse Event|0|||
16096239|NCT00316589|38842724|FG002|Overall Study|Adverse Event|0|||
16096240|NCT00316589|38842725|FG003|Overall Study|Adverse Event|1|||
16328451|NCT00750139|39687779|FG000|Overall Study|Adverse Event|1|||
16096241|NCT00316589|38842722|FG000|Overall Study|Physician Decision|0|||
16096242|NCT00316589|38842723|FG001|Overall Study|Physician Decision|1|||
16096243|NCT00316589|38842724|FG002|Overall Study|Physician Decision|0|||
16209830|NCT02707601|39248090|FG000|Overall Study|Investigator's Discretion|1|||
16209831|NCT02707601|39248091|FG001|Overall Study|Investigator's Discretion|0|||
16209832|NCT02707601|39248090|FG000|Overall Study|Withdrew Consent|0|||
16209833|NCT02707601|39248091|FG001|Overall Study|Withdrew Consent|1|||
16209834|NCT02707601|39248090|FG000|Overall Study|Lost to Follow-up|1|||
16209835|NCT02707601|39248091|FG001|Overall Study|Lost to Follow-up|1|||
16209836|NCT02707601|39248090|FG000|Overall Study|Participants Randomized but Not Treated|2|||
16209837|NCT02707601|39248091|FG001|Overall Study|Participants Randomized but Not Treated|0|||
16209838|NCT01770145|39248092|FG000|Baseline|Adverse Event|20|||
16209839|NCT01770145|39248092|FG000|Baseline|Withdrawal by Subject|1|||
16209840|NCT01770145|39248092|FG000|Baseline|Lost to Follow-up|1|||
16209841|NCT01770145|39248092|FG000|Baseline|Unable to define optimal dose|4|||
16209842|NCT01770145|39248092|FG000|Treatment|Adverse Event|3|||
16209843|NCT01770145|39248092|FG000|Treatment|Withdrawal by Subject|1|||
16209844|NCT00432562|39248093|FG000|Overall Study|Death|3|||
16209845|NCT00432562|39248094|FG001|Overall Study|Death|0|||
16209846|NCT04757376|39248097|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
16209847|NCT04757376|39248098|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
16209848|NCT04757376|39248099|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
16209849|NCT04757376|39248100|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
16209850|NCT04757376|39248101|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
16209851|NCT04757376|39248097|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
16209852|NCT04757376|39248098|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
16209853|NCT04757376|39248099|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
16209854|NCT04757376|39248100|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
16209855|NCT04757376|39248101|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
16209856|NCT04757376|39248097|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
16209857|NCT04757376|39248098|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
16209858|NCT04757376|39248099|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
16209859|NCT04757376|39248100|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
16209860|NCT04757376|39248101|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
16209861|NCT04757376|39248097|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
16209862|NCT04757376|39248098|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
16209863|NCT04757376|39248099|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
16209864|NCT04757376|39248100|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
16209865|NCT04757376|39248101|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
16209866|NCT04757376|39248097|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
16209867|NCT04757376|39248098|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
16209868|NCT04757376|39248099|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
16209869|NCT04757376|39248100|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
16209870|NCT04757376|39248101|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
16209871|NCT04757376|39248097|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
16209872|NCT04757376|39248098|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
16209873|NCT04757376|39248099|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
16209874|NCT04757376|39248100|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
16209875|NCT04757376|39248101|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
16209876|NCT04757376|39248097|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
16209877|NCT04757376|39248098|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
16209878|NCT04757376|39248099|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
16209879|NCT04757376|39248100|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
16209880|NCT04757376|39248101|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
16209881|NCT04757376|39248097|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
16209882|NCT04757376|39248098|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
16209883|NCT04757376|39248099|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
16209884|NCT04757376|39248100|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
16209885|NCT04757376|39248101|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
16209886|NCT00953225|39248102|FG000|Overall Study|Withdrawal by Subject|2|||
16328452|NCT00750139|39687780|FG001|Overall Study|Adverse Event|2|||
16328453|NCT00750139|39687781|FG002|Overall Study|Adverse Event|0|||
16328454|NCT00750139|39687782|FG003|Overall Study|Adverse Event|1|||
16328455|NCT00750139|39687779|FG000|Overall Study|Lost to Follow-up|17|||
16328456|NCT00750139|39687780|FG001|Overall Study|Lost to Follow-up|12|||
16524593|NCT01172938|40387785|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
16328457|NCT00750139|39687781|FG002|Overall Study|Lost to Follow-up|15|||
16328458|NCT00750139|39687782|FG003|Overall Study|Lost to Follow-up|6|||
16328459|NCT00750139|39687779|FG000|Overall Study|Withdrawal by Subject|3|||
16328460|NCT00750139|39687780|FG001|Overall Study|Withdrawal by Subject|2|||
16328461|NCT00750139|39687781|FG002|Overall Study|Withdrawal by Subject|6|||
16328462|NCT00750139|39687782|FG003|Overall Study|Withdrawal by Subject|2|||
16328463|NCT00750139|39687779|FG000|Overall Study|Physician Decision|1|||
16328464|NCT00750139|39687780|FG001|Overall Study|Physician Decision|1|||
16328465|NCT00750139|39687781|FG002|Overall Study|Physician Decision|0|||
16328466|NCT00750139|39687782|FG003|Overall Study|Physician Decision|0|||
16328467|NCT00750139|39687779|FG000|Overall Study|Non-compliance|1|||
16328468|NCT00750139|39687780|FG001|Overall Study|Non-compliance|0|||
16328469|NCT00750139|39687781|FG002|Overall Study|Non-compliance|1|||
16328470|NCT00750139|39687782|FG003|Overall Study|Non-compliance|3|||
16328471|NCT00750139|39687779|FG000|Overall Study|Termination by sponsor|4|||
16328472|NCT00750139|39687780|FG001|Overall Study|Termination by sponsor|0|||
16328473|NCT00750139|39687781|FG002|Overall Study|Termination by sponsor|0|||
16328474|NCT00750139|39687782|FG003|Overall Study|Termination by sponsor|1|||
16328475|NCT00750139|39687779|FG000|Overall Study|Non-specific|62|||
16397464|NCT02222688|39935483|FG001|Overall Study|Disease progression|0|||
16397465|NCT02222688|39935484|FG002|Overall Study|Disease progression|0|||
16397466|NCT02222688|39935485|FG003|Overall Study|Disease progression|0|||
16397467|NCT02222688|39935486|FG004|Overall Study|Disease progression|0|||
16397468|NCT02222688|39935487|FG005|Overall Study|Disease progression|0|||
16397469|NCT02222688|39935488|FG006|Overall Study|Disease progression|0|||
16397470|NCT02798315|39935489|FG000|Overall Study|Failure to return|1|||
16397471|NCT03098433|39935491|FG000|Overall Study|Withdrawal by Subject|10|||
16397472|NCT01054560|39935493|FG000|Overall Study|Death|10|||
16397473|NCT01054560|39935494|FG001|Overall Study|Death|21|||
16397474|NCT01054560|39935493|FG000|Overall Study|Lost to Follow-up|2|||
16397475|NCT01054560|39935494|FG001|Overall Study|Lost to Follow-up|5|||
16397476|NCT01054560|39935493|FG000|Overall Study|Withdrawal by Subject|0|||
16397477|NCT01054560|39935494|FG001|Overall Study|Withdrawal by Subject|2|||
16328476|NCT00750139|39687780|FG001|Overall Study|Non-specific|42|||
16328477|NCT00750139|39687781|FG002|Overall Study|Non-specific|79|||
16096244|NCT00316589|38842725|FG003|Overall Study|Physician Decision|0|||
16096245|NCT00316589|38842722|FG000|Overall Study|Other reason|0|||
16096246|NCT00316589|38842723|FG001|Overall Study|Other reason|12|||
16096247|NCT00316589|38842724|FG002|Overall Study|Other reason|1|||
16096248|NCT00316589|38842725|FG003|Overall Study|Other reason|1|||
16096249|NCT00087516|38842726|FG000|Overall Study|Adverse Event|10|||
16096250|NCT00087516|38842727|FG001|Overall Study|Adverse Event|10|||
16096251|NCT00087516|38842728|FG002|Overall Study|Adverse Event|3|||
16096252|NCT00087516|38842729|FG003|Overall Study|Adverse Event|6|||
16096253|NCT00087516|38842726|FG000|Overall Study|Lack of Efficacy|82|||
16096254|NCT00087516|38842727|FG001|Overall Study|Lack of Efficacy|80|||
16096255|NCT00087516|38842728|FG002|Overall Study|Lack of Efficacy|39|||
16096256|NCT00087516|38842729|FG003|Overall Study|Lack of Efficacy|29|||
16096257|NCT00087516|38842726|FG000|Overall Study|Lost to Follow-up|8|||
16096258|NCT00087516|38842727|FG001|Overall Study|Lost to Follow-up|6|||
16096259|NCT00087516|38842728|FG002|Overall Study|Lost to Follow-up|5|||
16096260|NCT00087516|38842729|FG003|Overall Study|Lost to Follow-up|5|||
16096261|NCT00087516|38842726|FG000|Overall Study|Protocol Violation|4|||
16096262|NCT00087516|38842727|FG001|Overall Study|Protocol Violation|8|||
16096263|NCT00087516|38842728|FG002|Overall Study|Protocol Violation|3|||
16096264|NCT00087516|38842729|FG003|Overall Study|Protocol Violation|6|||
16328478|NCT00750139|39687782|FG003|Overall Study|Non-specific|33|||
16328479|NCT02278367|39687786|FG000|Overall Study|Physician Decision|5|||
16096265|NCT00087516|38842726|FG000|Overall Study|Withdrawal by Subject|16|||
16096266|NCT00087516|38842727|FG001|Overall Study|Withdrawal by Subject|27|||
16096267|NCT00087516|38842728|FG002|Overall Study|Withdrawal by Subject|11|||
16096268|NCT00087516|38842729|FG003|Overall Study|Withdrawal by Subject|12|||
16096269|NCT00087516|38842726|FG000|Overall Study|Site terminated|0|||
16328480|NCT02278367|39687787|FG001|Overall Study|Physician Decision|0|||
16328481|NCT02278367|39687786|FG000|Overall Study|Withdrawal by Subject|5|||
16328482|NCT02278367|39687787|FG001|Overall Study|Withdrawal by Subject|0|||
16397478|NCT01054560|39935493|FG000|Overall Study|Physician Decision|1|||
16397479|NCT01054560|39935494|FG001|Overall Study|Physician Decision|0|||
16397480|NCT03818607|39935499|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
16096270|NCT00087516|38842727|FG001|Overall Study|Site terminated|2|||
16096271|NCT00087516|38842728|FG002|Overall Study|Site terminated|1|||
16096272|NCT00087516|38842729|FG003|Overall Study|Site terminated|0|||
16096273|NCT00087516|38842726|FG000|Overall Study|Protocol specified discontinuation|35|||
16096274|NCT00087516|38842727|FG001|Overall Study|Protocol specified discontinuation|33|||
16096275|NCT00087516|38842728|FG002|Overall Study|Protocol specified discontinuation|33|||
16328483|NCT04085523|39687793|FG000|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
16397481|NCT03818607|39935500|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
16397482|NCT03818607|39935499|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
16397483|NCT03818607|39935500|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
16397484|NCT03818607|39935499|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
16397485|NCT03818607|39935500|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
16397486|NCT01450696|39935518|FG000|Overall Study|Never Treated|1|||
16397487|NCT01450696|39935519|FG001|Overall Study|Never Treated|1|||
16397488|NCT01450696|39935518|FG000|Overall Study|Death|77|||
16397489|NCT01450696|39935519|FG001|Overall Study|Death|84|||
16397490|NCT01450696|39935518|FG000|Overall Study|Lost to Follow-up|3|||
16397491|NCT01450696|39935519|FG001|Overall Study|Lost to Follow-up|3|||
16397492|NCT01450696|39935518|FG000|Overall Study|Non-Compliance|1|||
16397493|NCT01450696|39935519|FG001|Overall Study|Non-Compliance|0|||
16397494|NCT01450696|39935518|FG000|Overall Study|Withdrawal by Subject|13|||
16397495|NCT01450696|39935519|FG001|Overall Study|Withdrawal by Subject|2|||
16397496|NCT01450696|39935518|FG000|Overall Study|Study Terminated by Sponsor|53|||
16397497|NCT01450696|39935519|FG001|Overall Study|Study Terminated by Sponsor|58|||
16397498|NCT03265145|39935523|FG000|Overall Study|Protocol Violation|2|||
16209887|NCT00953225|39248103|FG001|Overall Study|Withdrawal by Subject|0|||
16397499|NCT03265145|39935524|FG001|Overall Study|Protocol Violation|0|||
16397500|NCT03265145|39935523|FG000|Overall Study|Adverse Event|1|||
16397501|NCT03265145|39935524|FG001|Overall Study|Adverse Event|0|||
16397502|NCT03265145|39935523|FG000|Overall Study|Withdrawal by Subject|23|||
16328484|NCT04085523|39687794|FG001|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
16328485|NCT04085523|39687795|FG002|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
16328486|NCT04085523|39687796|FG003|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
16328487|NCT04085523|39687797|FG004|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
16328488|NCT04085523|39687798|FG005|Open-Label Period (Weeks 52 to 156)|Study Ongoing|57|||
16328489|NCT00759785|39687799|FG000|Overall Study|Participant sample not evaluable|11|||
16328490|NCT00759785|39687800|FG001|Overall Study|Participant sample not evaluable|2|||
16397503|NCT03265145|39935524|FG001|Overall Study|Withdrawal by Subject|19|||
16209888|NCT01194869|39248104|FG000|Overall Study|Disease Progression|2|||
16209889|NCT01194869|39248104|FG000|Overall Study|Toxicity|2|||
16209890|NCT01415908|39248105|FG000|Overall Study|Withdrawal by Subject|1|||
16209891|NCT01415908|39248106|FG001|Overall Study|Withdrawal by Subject|0|||
16209892|NCT02977507|39248107|FG000|Overall Study|Protocol Deviation|1|||
16209893|NCT02977507|39248108|FG001|Overall Study|Protocol Deviation|0|||
16209894|NCT02977507|39248107|FG000|Overall Study|Lost to Follow-up|1|||
16209895|NCT02977507|39248108|FG001|Overall Study|Lost to Follow-up|0|||
16209896|NCT02116361|39248119|FG000|Overall Study|Pregnancy|0|||
16397504|NCT03265145|39935523|FG000|Overall Study|Death|12|||
16397505|NCT03265145|39935524|FG001|Overall Study|Death|12|||
16397506|NCT03265145|39935523|FG000|Overall Study|Lost to Follow-up|13|||
16397507|NCT03265145|39935524|FG001|Overall Study|Lost to Follow-up|9|||
16209897|NCT02116361|39248120|FG001|Overall Study|Pregnancy|0|||
16209898|NCT02116361|39248121|FG002|Overall Study|Pregnancy|0|||
16209899|NCT02116361|39248122|FG003|Overall Study|Pregnancy|1|||
16209900|NCT02116361|39248119|FG000|Overall Study|Protocol Violation|1|||
16209901|NCT02116361|39248120|FG001|Overall Study|Protocol Violation|0|||
16209902|NCT02116361|39248121|FG002|Overall Study|Protocol Violation|0|||
16397508|NCT03265145|39935523|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
16397509|NCT03265145|39935524|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
16397510|NCT03265145|39935523|FG000|Overall Study|Switched back to previous medication|1|||
16397511|NCT03265145|39935524|FG001|Overall Study|Switched back to previous medication|0|||
16209903|NCT02116361|39248122|FG003|Overall Study|Protocol Violation|2|||
16397512|NCT03265145|39935523|FG000|Overall Study|Did not want to take medication|1|||
16397513|NCT03265145|39935524|FG001|Overall Study|Did not want to take medication|0|||
16397514|NCT03265145|39935523|FG000|Overall Study|Subject could not afford medication|0|||
16397515|NCT03265145|39935524|FG001|Overall Study|Subject could not afford medication|1|||
16397516|NCT03265145|39935523|FG000|Overall Study|Site closed|2|||
16397517|NCT03265145|39935524|FG001|Overall Study|Site closed|3|||
16397518|NCT03265145|39935523|FG000|Overall Study|Incorrectly randomized|16|||
16397519|NCT03265145|39935524|FG001|Overall Study|Incorrectly randomized|6|||
16397520|NCT03265145|39935523|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
16397521|NCT03265145|39935524|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
16397522|NCT03265145|39935523|FG000|Overall Study|Physician Decision|0|||
16397523|NCT03265145|39935524|FG001|Overall Study|Physician Decision|3|||
16397524|NCT03265145|39935523|FG000|Overall Study|Subject transferred to another facility|0|||
16397525|NCT03265145|39935524|FG001|Overall Study|Subject transferred to another facility|1|||
16397526|NCT00711594|39935525|FG000|Overall Study|Progressive disease|2|||
16397527|NCT00711594|39935526|FG001|Overall Study|Progressive disease|2|||
16397528|NCT00711594|39935527|FG002|Overall Study|Progressive disease|6|||
16397529|NCT00711594|39935528|FG003|Overall Study|Progressive disease|44|||
16397530|NCT00711594|39935525|FG000|Overall Study|Other Adverse Event|1|||
16397531|NCT00711594|39935526|FG001|Overall Study|Other Adverse Event|0|||
16397532|NCT00711594|39935527|FG002|Overall Study|Other Adverse Event|0|||
16397533|NCT00711594|39935528|FG003|Overall Study|Other Adverse Event|16|||
16397534|NCT00711594|39935525|FG000|Overall Study|Withdrawal by Subject|0|||
16397535|NCT00711594|39935526|FG001|Overall Study|Withdrawal by Subject|1|||
16397536|NCT00711594|39935527|FG002|Overall Study|Withdrawal by Subject|0|||
16397537|NCT00711594|39935528|FG003|Overall Study|Withdrawal by Subject|2|||
16397538|NCT01445613|39935529|FG000|30-day Follow-up|Withdrawal by Subject|6|||
16397539|NCT01445613|39935529|FG000|30-day Follow-up|Physician Decision|3|||
16397540|NCT01445613|39935529|FG000|30-day Follow-up|Missed visit|23|||
16397541|NCT01445613|39935529|FG000|30-day Follow-up|Death|3|||
16397542|NCT01445613|39935529|FG000|1-year Follow-up|Withdrawal by Subject|12|||
16397543|NCT01445613|39935529|FG000|1-year Follow-up|Missed visit|29|||
16397544|NCT01445613|39935529|FG000|1-year Follow-up|Lost to Follow-up|2|||
16397545|NCT01445613|39935529|FG000|1-year Follow-up|Death|30|||
16397546|NCT01445613|39935529|FG000|1-year Follow-up|Physician Decision|2|||
16397547|NCT01445613|39935529|FG000|1-year Follow-up|Received a non-study stent|2|||
16397548|NCT00967694|39935530|FG000|Overall Study|Withdrawal by Subject|6|||
16397549|NCT02667886|39935531|FG000|Dose Escalation (Part A)|Adverse Event|1|||
16397550|NCT02667886|39935532|FG001|Dose Escalation (Part A)|Adverse Event|3|||
16397551|NCT02667886|39935533|FG002|Dose Escalation (Part A)|Adverse Event|1|||
16397552|NCT02667886|39935534|FG003|Dose Escalation (Part A)|Adverse Event|0|||
16397553|NCT02667886|39935535|FG004|Dose Escalation (Part A)|Adverse Event|0|||
16397554|NCT02667886|39935531|FG000|Dose Escalation (Part A)|Disease Progression|1|||
16397555|NCT02667886|39935532|FG001|Dose Escalation (Part A)|Disease Progression|4|||
16397556|NCT02667886|39935533|FG002|Dose Escalation (Part A)|Disease Progression|3|||
16397557|NCT02667886|39935534|FG003|Dose Escalation (Part A)|Disease Progression|0|||
16397558|NCT02667886|39935535|FG004|Dose Escalation (Part A)|Disease Progression|0|||
16397559|NCT02667886|39935531|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
16397560|NCT02667886|39935532|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
16209904|NCT02116361|39248119|FG000|Overall Study|Physician Decision|2|||
16209905|NCT02116361|39248120|FG001|Overall Study|Physician Decision|3|||
16209906|NCT02116361|39248121|FG002|Overall Study|Physician Decision|0|||
16209907|NCT02116361|39248122|FG003|Overall Study|Physician Decision|0|||
16209908|NCT02116361|39248119|FG000|Overall Study|Adverse Event|1|||
16209909|NCT02116361|39248120|FG001|Overall Study|Adverse Event|0|||
16209910|NCT02116361|39248121|FG002|Overall Study|Adverse Event|0|||
16209911|NCT02116361|39248122|FG003|Overall Study|Adverse Event|3|||
16209912|NCT02116361|39248119|FG000|Overall Study|Other Reasons|3|||
16209913|NCT02116361|39248120|FG001|Overall Study|Other Reasons|3|||
16209914|NCT02116361|39248121|FG002|Overall Study|Other Reasons|3|||
16209915|NCT02116361|39248122|FG003|Overall Study|Other Reasons|3|||
16209916|NCT02116361|39248119|FG000|Overall Study|Lack of Efficacy|5|||
16209917|NCT02116361|39248120|FG001|Overall Study|Lack of Efficacy|7|||
16209918|NCT02116361|39248121|FG002|Overall Study|Lack of Efficacy|4|||
16209919|NCT02116361|39248122|FG003|Overall Study|Lack of Efficacy|3|||
16209920|NCT02116361|39248119|FG000|Overall Study|Lost to Follow-up|4|||
16209921|NCT02116361|39248120|FG001|Overall Study|Lost to Follow-up|5|||
16397561|NCT02667886|39935533|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
16209922|NCT02116361|39248121|FG002|Overall Study|Lost to Follow-up|7|||
16209923|NCT02116361|39248122|FG003|Overall Study|Lost to Follow-up|5|||
16209924|NCT02116361|39248119|FG000|Overall Study|Personal Reasons|6|||
16209925|NCT02116361|39248120|FG001|Overall Study|Personal Reasons|6|||
16209926|NCT02116361|39248121|FG002|Overall Study|Personal Reasons|4|||
16209927|NCT02116361|39248122|FG003|Overall Study|Personal Reasons|9|||
16209928|NCT02116361|39248119|FG000|Overall Study|Investigator Decision - Relapse|9|||
16209929|NCT02116361|39248120|FG001|Overall Study|Investigator Decision - Relapse|7|||
16397562|NCT02667886|39935534|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
16397563|NCT02667886|39935535|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
16328491|NCT00759785|39687799|FG000|Overall Study|Participant sample lost|0|||
16328492|NCT00759785|39687800|FG001|Overall Study|Participant sample lost|1|||
16328493|NCT00759785|39687799|FG000|Overall Study|Protocol Violation|1|||
16328494|NCT00759785|39687800|FG001|Overall Study|Protocol Violation|0|||
16328495|NCT00759785|39687799|FG000|Overall Study|Physician Decision|0|||
16328496|NCT00759785|39687800|FG001|Overall Study|Physician Decision|1|||
16328497|NCT00759785|39687799|FG000|Overall Study|Withdrawal by Subject|0|||
16328498|NCT00759785|39687800|FG001|Overall Study|Withdrawal by Subject|1|||
16328499|NCT04351373|39687801|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
16328500|NCT00519428|39687804|FG000|Overall Study|Adverse Event|5|||
16328501|NCT00519428|39687805|FG001|Overall Study|Adverse Event|2|||
16328502|NCT00519428|39687806|FG002|Overall Study|Adverse Event|10|||
16328503|NCT00519428|39687804|FG000|Overall Study|Lost to Follow-up|7|||
16328504|NCT00519428|39687805|FG001|Overall Study|Lost to Follow-up|7|||
16328505|NCT00519428|39687806|FG002|Overall Study|Lost to Follow-up|6|||
16328506|NCT00519428|39687804|FG000|Overall Study|Withdrawal by Subject|8|||
16328507|NCT00519428|39687805|FG001|Overall Study|Withdrawal by Subject|3|||
16328508|NCT00519428|39687806|FG002|Overall Study|Withdrawal by Subject|7|||
16328509|NCT00519428|39687804|FG000|Overall Study|unstated|1|||
16328510|NCT00519428|39687805|FG001|Overall Study|unstated|3|||
16328511|NCT00519428|39687806|FG002|Overall Study|unstated|2|||
16328512|NCT03505593|39687807|FG000|Overall Study|Withdrawal by Subject|1|||
16328513|NCT03505593|39687807|FG000|Overall Study|Died before procedure|1|||
16328514|NCT03505593|39687807|FG000|Overall Study|Anatomical abnormality|1|||
16328515|NCT03505593|39687807|FG000|Overall Study|Unable to pass through esophagus|1|||
16328516|NCT03505593|39687807|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
16328517|NCT02225366|39687808|FG000|Overall Study|Lack of Efficacy|1|||
16397564|NCT02667886|39935531|FG000|Dose Expansion (Part B)|Adverse Event|0|||
16397565|NCT02667886|39935532|FG001|Dose Expansion (Part B)|Adverse Event|0|||
16397566|NCT02667886|39935533|FG002|Dose Expansion (Part B)|Adverse Event|0|||
16397567|NCT02667886|39935534|FG003|Dose Expansion (Part B)|Adverse Event|9|||
16328518|NCT02225366|39687809|FG001|Overall Study|Lack of Efficacy|0|||
16328519|NCT01909934|39687810|FG000|Overall Study|Ongoing|23|||
16397568|NCT02667886|39935535|FG004|Dose Expansion (Part B)|Adverse Event|0|||
16397569|NCT02667886|39935531|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
16397570|NCT02667886|39935532|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
16397571|NCT02667886|39935533|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
16524594|NCT01172938|40387777|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16524595|NCT01172938|40387778|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
16524596|NCT01172938|40387779|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16524597|NCT01172938|40387780|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16524598|NCT01172938|40387781|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16524599|NCT01172938|40387782|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16524600|NCT01172938|40387783|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16524601|NCT01172938|40387784|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16524602|NCT01172938|40387785|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
16524603|NCT01172938|40387777|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16524604|NCT01172938|40387778|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16524605|NCT01172938|40387779|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
16524606|NCT01172938|40387780|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16524607|NCT01172938|40387781|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16524608|NCT01172938|40387782|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16524609|NCT01172938|40387783|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16524610|NCT01172938|40387784|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16524611|NCT01172938|40387785|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
16524612|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16524613|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
16524614|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
16524615|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16524616|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16524617|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16524618|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16524619|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
16524620|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
16524621|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
16524622|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
16524623|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
16328520|NCT01909934|39687810|FG000|Overall Study|Withdrawal by Subject|3|||
16328521|NCT01909934|39687810|FG000|Overall Study|Lost to Follow-up|1|||
16328522|NCT01909934|39687810|FG000|Overall Study|Withdrawal of Informed Consent|1|||
16328523|NCT01909934|39687810|FG000|Overall Study|Death|22|||
16328524|NCT02162719|39687815|FG000|Overall Study|Death|41|||
16328525|NCT02162719|39687816|FG001|Overall Study|Death|46|||
16328526|NCT02162719|39687815|FG000|Overall Study|Lost to Follow-up|1|||
16328527|NCT02162719|39687816|FG001|Overall Study|Lost to Follow-up|3|||
16328528|NCT02162719|39687815|FG000|Overall Study|Disease Progression|2|||
16328529|NCT02162719|39687816|FG001|Overall Study|Disease Progression|1|||
16328530|NCT02162719|39687815|FG000|Overall Study|Withdrawal by Subject|8|||
16328531|NCT02162719|39687816|FG001|Overall Study|Withdrawal by Subject|2|||
16328532|NCT02162719|39687815|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
16328533|NCT02162719|39687816|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
16328534|NCT01194531|39687817|FG000|Overall Study|Withdrawal by Subject|1|||
16328535|NCT01194531|39687818|FG001|Overall Study|Withdrawal by Subject|0|||
16328536|NCT01194531|39687817|FG000|Overall Study|Protocol Violation|4|||
16328537|NCT01194531|39687818|FG001|Overall Study|Protocol Violation|1|||
16328538|NCT01194531|39687817|FG000|Overall Study|Physician Decision|0|||
16328539|NCT01194531|39687818|FG001|Overall Study|Physician Decision|2|||
16328540|NCT01493284|39687821|FG000|Overall Study|Death|29|||
16397572|NCT02667886|39935534|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
16397573|NCT02667886|39935535|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
16397574|NCT02667886|39935531|FG000|Dose Expansion (Part B)|Disease Progression|0|||
16397575|NCT02667886|39935532|FG001|Dose Expansion (Part B)|Disease Progression|0|||
16397576|NCT02667886|39935533|FG002|Dose Expansion (Part B)|Disease Progression|0|||
16397577|NCT02667886|39935534|FG003|Dose Expansion (Part B)|Disease Progression|38|||
16397578|NCT02667886|39935535|FG004|Dose Expansion (Part B)|Disease Progression|0|||
16397579|NCT02667886|39935531|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
16397580|NCT02667886|39935532|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
16397581|NCT02667886|39935533|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
16397582|NCT02667886|39935534|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
16397583|NCT02667886|39935535|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
16397584|NCT02667886|39935531|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
16397585|NCT02667886|39935532|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
16397586|NCT02667886|39935533|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
16397587|NCT02667886|39935534|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
16397588|NCT02667886|39935535|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
16397589|NCT02667886|39935531|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
16397590|NCT02667886|39935532|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
16397591|NCT02667886|39935533|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
16397592|NCT02667886|39935534|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
16397593|NCT02667886|39935535|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
16397594|NCT01355679|39935536|FG000|Overall Study|benign tumor types found at biopsy|2|||
16397595|NCT02016716|39935541|FG000|Overall Study|Withdrawal by Subject|5|||
16397596|NCT02016716|39935542|FG001|Overall Study|Withdrawal by Subject|5|||
16397597|NCT02016716|39935543|FG002|Overall Study|Withdrawal by Subject|5|||
16397598|NCT02016716|39935541|FG000|Overall Study|Protocol-specified Criteria|0|||
16397599|NCT02016716|39935542|FG001|Overall Study|Protocol-specified Criteria|1|||
16397600|NCT02016716|39935543|FG002|Overall Study|Protocol-specified Criteria|0|||
16397601|NCT02016716|39935541|FG000|Overall Study|Lost to Follow-up|1|||
16397602|NCT02016716|39935542|FG001|Overall Study|Lost to Follow-up|2|||
16397603|NCT02016716|39935543|FG002|Overall Study|Lost to Follow-up|1|||
16397604|NCT00861757|39935545|FG000|Overall Study|Adverse Event|1|||
16397605|NCT00861757|39935546|FG001|Overall Study|Adverse Event|5|||
16397606|NCT00861757|39935547|FG002|Overall Study|Adverse Event|7|||
16397607|NCT00861757|39935548|FG003|Overall Study|Adverse Event|2|||
16397608|NCT00861757|39935545|FG000|Overall Study|Entry Criteria Not Met|1|||
16397609|NCT00861757|39935546|FG001|Overall Study|Entry Criteria Not Met|2|||
16397610|NCT00861757|39935547|FG002|Overall Study|Entry Criteria Not Met|1|||
16397611|NCT00861757|39935548|FG003|Overall Study|Entry Criteria Not Met|1|||
16397612|NCT00861757|39935545|FG000|Overall Study|Lack of Efficacy|3|||
16397613|NCT00861757|39935546|FG001|Overall Study|Lack of Efficacy|1|||
16397614|NCT00861757|39935547|FG002|Overall Study|Lack of Efficacy|0|||
16328541|NCT01493284|39687821|FG000|Overall Study|Withdrawal by Subject|32|||
16328542|NCT01966068|39687822|FG000|Overall Study|Withdrawal by Subject|57|||
16328543|NCT01966068|39687822|FG000|Overall Study|Lost to Follow-up|81|||
16397615|NCT00861757|39935548|FG003|Overall Study|Lack of Efficacy|1|||
16397616|NCT00861757|39935545|FG000|Overall Study|Lost to Follow-up|1|||
16397617|NCT00861757|39935546|FG001|Overall Study|Lost to Follow-up|0|||
16397618|NCT00861757|39935547|FG002|Overall Study|Lost to Follow-up|1|||
16397619|NCT00861757|39935548|FG003|Overall Study|Lost to Follow-up|1|||
16397620|NCT00861757|39935545|FG000|Overall Study|Physician Decision|0|||
16328544|NCT00636194|39687827|FG000|Overall Study|Study related symptoms and complaints|1|||
16328545|NCT00636194|39687828|FG001|Overall Study|Study related symptoms and complaints|0|||
16328546|NCT00636194|39687827|FG000|Overall Study|Protocol Violation|2|||
16096276|NCT00087516|38842729|FG003|Overall Study|Protocol specified discontinuation|26|||
16096277|NCT00087516|38842726|FG000|Overall Study|Patient moved|3|||
16096278|NCT00087516|38842727|FG001|Overall Study|Patient moved|2|||
16096279|NCT00087516|38842728|FG002|Overall Study|Patient moved|1|||
16096280|NCT00087516|38842729|FG003|Overall Study|Patient moved|0|||
16096281|NCT00087516|38842726|FG000|Overall Study|Patient was non-compliant|3|||
16096282|NCT00087516|38842727|FG001|Overall Study|Patient was non-compliant|1|||
16096283|NCT00087516|38842728|FG002|Overall Study|Patient was non-compliant|0|||
16096284|NCT00087516|38842729|FG003|Overall Study|Patient was non-compliant|0|||
16096285|NCT00087516|38842726|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
16096286|NCT00087516|38842727|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
16096287|NCT00087516|38842728|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
16096288|NCT00087516|38842729|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
16096289|NCT00087516|38842726|FG000|Overall Study|Other|0|||
16096290|NCT00087516|38842727|FG001|Overall Study|Other|0|||
16096291|NCT00087516|38842728|FG002|Overall Study|Other|1|||
16096292|NCT00087516|38842729|FG003|Overall Study|Other|0|||
16096293|NCT04930263|38842730|FG000|Overall Study|Withdrawal by Subject|3|||
16096294|NCT04930263|38842731|FG001|Overall Study|Withdrawal by Subject|5|||
16096295|NCT00422162|38842732|FG000|Overall Study|Adverse Event|11|||
16096296|NCT00422162|38842733|FG001|Overall Study|Adverse Event|9|||
16096297|NCT00422162|38842732|FG000|Overall Study|Lack of Efficacy|4|||
16096298|NCT00422162|38842733|FG001|Overall Study|Lack of Efficacy|10|||
16096299|NCT00422162|38842732|FG000|Overall Study|Withdrawal by Subject|7|||
16096300|NCT00422162|38842733|FG001|Overall Study|Withdrawal by Subject|6|||
16096301|NCT00422162|38842732|FG000|Overall Study|Lost to Follow-up|1|||
16096302|NCT00422162|38842733|FG001|Overall Study|Lost to Follow-up|2|||
16096303|NCT00422162|38842732|FG000|Overall Study|Non-Compliant with Protocol|1|||
16096304|NCT00422162|38842733|FG001|Overall Study|Non-Compliant with Protocol|1|||
16096305|NCT00422162|38842732|FG000|Overall Study|Other|0|||
16096306|NCT00422162|38842733|FG001|Overall Study|Other|1|||
16096307|NCT00422162|38842732|FG000|Overall Study|Didn't Receive Treatment|0|||
16096308|NCT00422162|38842733|FG001|Overall Study|Didn't Receive Treatment|1|||
16096309|NCT01469819|38842734|FG000|Overall Study|Withdrawal by Subject|1|||
16096310|NCT01469819|38842734|FG000|Overall Study|Did not meet inclusionary criteria|2|||
16096311|NCT01469819|38842734|FG000|Overall Study|Could not swallow SmartPill|2|||
16096312|NCT01469819|38842734|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
16096313|NCT04585815|38842735|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
16096314|NCT04585815|38842736|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
16096315|NCT04585815|38842737|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
16096316|NCT04585815|38842738|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
16096317|NCT04585815|38842739|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
16096318|NCT04585815|38842740|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
16096319|NCT04585815|38842741|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
16096320|NCT04585815|38842735|FG000|Sub-study A- Treatment Phase|Death|0|||
16096321|NCT04585815|38842736|FG001|Sub-study A- Treatment Phase|Death|1|||
16096322|NCT04585815|38842737|FG002|Sub-study A- Treatment Phase|Death|0|||
16096323|NCT04585815|38842738|FG003|Sub-study A- Treatment Phase|Death|0|||
16096324|NCT04585815|38842739|FG004|Sub-study A- Treatment Phase|Death|0|||
16096325|NCT04585815|38842740|FG005|Sub-study A- Treatment Phase|Death|0|||
16096326|NCT04585815|38842741|FG006|Sub-study A- Treatment Phase|Death|0|||
16096327|NCT04585815|38842735|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
16096328|NCT04585815|38842736|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
16096329|NCT04585815|38842737|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
16096330|NCT04585815|38842738|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
16096331|NCT04585815|38842739|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
16096332|NCT04585815|38842740|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
16096333|NCT04585815|38842741|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
16096334|NCT04585815|38842735|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
16096335|NCT04585815|38842736|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
16096336|NCT04585815|38842737|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
16096337|NCT04585815|38842738|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
16096338|NCT04585815|38842739|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
16096339|NCT04585815|38842740|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
16209930|NCT02116361|39248121|FG002|Overall Study|Investigator Decision - Relapse|8|||
16096340|NCT04585815|38842741|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
16096341|NCT04585815|38842735|FG000|Sub-study A- Treatment Phase|Other|1|||
16096342|NCT04585815|38842736|FG001|Sub-study A- Treatment Phase|Other|0|||
16096343|NCT04585815|38842737|FG002|Sub-study A- Treatment Phase|Other|0|||
16096344|NCT04585815|38842738|FG003|Sub-study A- Treatment Phase|Other|0|||
16096345|NCT04585815|38842739|FG004|Sub-study A- Treatment Phase|Other|0|||
16096346|NCT04585815|38842740|FG005|Sub-study A- Treatment Phase|Other|0|||
16096347|NCT04585815|38842741|FG006|Sub-study A- Treatment Phase|Other|0|||
16096348|NCT04585815|38842735|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
16096349|NCT04585815|38842736|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
16096350|NCT04585815|38842737|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
16096351|NCT04585815|38842738|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
16096352|NCT04585815|38842739|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
16096353|NCT04585815|38842740|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
16096354|NCT04585815|38842741|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
16209931|NCT02116361|39248122|FG003|Overall Study|Investigator Decision - Relapse|5|||
16209932|NCT03997760|39248123|FG000|Overall Study|Protocol Deviation|0|||
16209933|NCT03997760|39248124|FG001|Overall Study|Protocol Deviation|1|||
16209934|NCT03997760|39248125|FG002|Overall Study|Protocol Deviation|0|||
16209935|NCT03997760|39248126|FG003|Overall Study|Protocol Deviation|0|||
16209936|NCT00441480|39248128|FG000|Overall Study|Protocol Violation|1|||
16209937|NCT00441480|39248129|FG001|Overall Study|Protocol Violation|1|||
16209938|NCT00441480|39248128|FG000|Overall Study|Withdrawal by Subject|2|||
16209939|NCT00441480|39248129|FG001|Overall Study|Withdrawal by Subject|3|||
16209940|NCT00318370|39248138|FG000|Period 1|Lack of Efficacy|5|||
16209941|NCT00318370|39248139|FG001|Period 1|Lack of Efficacy|0|||
16209942|NCT00318370|39248140|FG002|Period 1|Lack of Efficacy|0|||
16209943|NCT00318370|39248138|FG000|Period 1|Physician Decision|1|||
16209944|NCT00318370|39248139|FG001|Period 1|Physician Decision|0|||
16209945|NCT00318370|39248140|FG002|Period 1|Physician Decision|0|||
16209946|NCT00318370|39248138|FG000|Period 1|Withdrawal by Subject|1|||
16209947|NCT00318370|39248139|FG001|Period 1|Withdrawal by Subject|0|||
16209948|NCT00318370|39248140|FG002|Period 1|Withdrawal by Subject|0|||
16209949|NCT00318370|39248138|FG000|Period 2|Adverse Event|0|||
16209950|NCT00318370|39248139|FG001|Period 2|Adverse Event|3|||
16209951|NCT00318370|39248140|FG002|Period 2|Adverse Event|0|||
16209952|NCT00318370|39248138|FG000|Period 2|Lack of Efficacy|0|||
16209953|NCT00318370|39248139|FG001|Period 2|Lack of Efficacy|5|||
16209954|NCT00318370|39248140|FG002|Period 2|Lack of Efficacy|0|||
16209955|NCT00318370|39248138|FG000|Period 2|Physician Decision|0|||
16209956|NCT00318370|39248139|FG001|Period 2|Physician Decision|1|||
16209957|NCT00318370|39248140|FG002|Period 2|Physician Decision|0|||
16209958|NCT00318370|39248138|FG000|Period 2|Withdrawal by Subject|0|||
16209959|NCT00318370|39248139|FG001|Period 2|Withdrawal by Subject|1|||
16209960|NCT00318370|39248140|FG002|Period 2|Withdrawal by Subject|0|||
16209961|NCT00318370|39248138|FG000|Period 2|Other|0|||
16209962|NCT00318370|39248139|FG001|Period 2|Other|1|||
16209963|NCT00318370|39248140|FG002|Period 2|Other|0|||
16209964|NCT00318370|39248138|FG000|Period 3|Adverse Event|0|||
16209965|NCT00318370|39248139|FG001|Period 3|Adverse Event|0|||
16209966|NCT00318370|39248140|FG002|Period 3|Adverse Event|1|||
16209967|NCT00318370|39248138|FG000|Period 3|Lack of Efficacy|0|||
16209968|NCT00318370|39248139|FG001|Period 3|Lack of Efficacy|0|||
16209969|NCT00318370|39248140|FG002|Period 3|Lack of Efficacy|24|||
16209970|NCT00318370|39248138|FG000|Period 3|Death|0|||
16209971|NCT00318370|39248139|FG001|Period 3|Death|0|||
16209972|NCT00318370|39248140|FG002|Period 3|Death|1|||
16209973|NCT00318370|39248138|FG000|Period 3|Physician Decision|0|||
16209974|NCT00318370|39248139|FG001|Period 3|Physician Decision|0|||
16328547|NCT00636194|39687828|FG001|Overall Study|Protocol Violation|0|||
16328548|NCT00452673|39687830|FG000|Dose Escalation Period|Disease Progression|6|||
16209975|NCT00318370|39248140|FG002|Period 3|Physician Decision|1|||
16209976|NCT00318370|39248138|FG000|Period 3|Withdrawal by Subject|0|||
16209977|NCT00318370|39248139|FG001|Period 3|Withdrawal by Subject|0|||
16209978|NCT00318370|39248140|FG002|Period 3|Withdrawal by Subject|3|||
16209979|NCT00318370|39248138|FG000|Period 3|Other|0|||
16209980|NCT00318370|39248139|FG001|Period 3|Other|0|||
16209981|NCT00318370|39248140|FG002|Period 3|Other|3|||
16209982|NCT02215616|39248141|FG000|Overall Study|Sponsor requested to stop study drug|0|||
16209983|NCT02215616|39248142|FG001|Overall Study|Sponsor requested to stop study drug|0|||
16209984|NCT02215616|39248143|FG002|Overall Study|Sponsor requested to stop study drug|1|||
16209985|NCT02215616|39248144|FG003|Overall Study|Sponsor requested to stop study drug|4|||
16209986|NCT02215616|39248141|FG000|Overall Study|Death|1|||
16209987|NCT02215616|39248142|FG001|Overall Study|Death|0|||
16209988|NCT02215616|39248143|FG002|Overall Study|Death|0|||
16209989|NCT02215616|39248144|FG003|Overall Study|Death|0|||
16209990|NCT02215616|39248141|FG000|Overall Study|Adverse Event|7|||
16328549|NCT00452673|39687831|FG001|Dose Escalation Period|Disease Progression|6|||
16328550|NCT00452673|39687832|FG002|Dose Escalation Period|Disease Progression|2|||
16096355|NCT04585815|38842735|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
16209991|NCT02215616|39248142|FG001|Overall Study|Adverse Event|4|||
16209992|NCT02215616|39248143|FG002|Overall Study|Adverse Event|9|||
16209993|NCT02215616|39248144|FG003|Overall Study|Adverse Event|2|||
16209994|NCT02215616|39248141|FG000|Overall Study|Withdrawal by Subject|1|||
16209995|NCT02215616|39248142|FG001|Overall Study|Withdrawal by Subject|8|||
16209996|NCT02215616|39248143|FG002|Overall Study|Withdrawal by Subject|2|||
16209997|NCT02215616|39248144|FG003|Overall Study|Withdrawal by Subject|5|||
16209998|NCT02215616|39248141|FG000|Overall Study|Non-compliance|0|||
16397621|NCT00861757|39935546|FG001|Overall Study|Physician Decision|0|||
16397622|NCT00861757|39935547|FG002|Overall Study|Physician Decision|0|||
16397623|NCT00861757|39935548|FG003|Overall Study|Physician Decision|1|||
16397624|NCT00861757|39935545|FG000|Overall Study|Protocol Violation|2|||
16524624|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
16524625|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
16524626|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
16524627|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
16524628|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
16096356|NCT04585815|38842736|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
16096357|NCT04585815|38842737|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
16096358|NCT04585815|38842738|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
16096359|NCT04585815|38842739|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
16096360|NCT04585815|38842740|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
16096361|NCT04585815|38842741|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
16096362|NCT04585815|38842735|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
16096363|NCT04585815|38842736|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
16096364|NCT04585815|38842737|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
16096365|NCT04585815|38842738|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
16096366|NCT04585815|38842739|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
16524629|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
16524630|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
16524631|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
16524632|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
16524633|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
16524634|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
16524635|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
16524636|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
16524637|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
16524638|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
16524639|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16524640|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16524641|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
16524642|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16524643|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16524644|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16524645|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16524646|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
16524647|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
16524648|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16524649|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16524650|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16397625|NCT00861757|39935546|FG001|Overall Study|Protocol Violation|2|||
16096367|NCT04585815|38842740|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
16524651|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16524652|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16524653|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16524654|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16524655|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
16524656|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
16524657|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16524658|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16524659|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
16524660|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16524661|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16524662|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16524663|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
16524664|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
16524665|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
16524666|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16524667|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16096368|NCT04585815|38842741|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
16096369|NCT04585815|38842735|FG000|Sub-study B- Treatment Phase|Death|0|||
16096370|NCT04585815|38842736|FG001|Sub-study B- Treatment Phase|Death|0|||
16096371|NCT04585815|38842737|FG002|Sub-study B- Treatment Phase|Death|0|||
16096372|NCT04585815|38842738|FG003|Sub-study B- Treatment Phase|Death|1|||
16096373|NCT04585815|38842739|FG004|Sub-study B- Treatment Phase|Death|0|||
16096374|NCT04585815|38842740|FG005|Sub-study B- Treatment Phase|Death|0|||
16096375|NCT04585815|38842741|FG006|Sub-study B- Treatment Phase|Death|0|||
16096376|NCT04585815|38842735|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
16096377|NCT04585815|38842736|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
16096378|NCT04585815|38842737|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
16096379|NCT04585815|38842738|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
16096380|NCT04585815|38842739|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
16096381|NCT04585815|38842740|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
16096382|NCT04585815|38842741|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
16096383|NCT04585815|38842735|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
16096384|NCT04585815|38842736|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
16096385|NCT04585815|38842737|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
16096386|NCT04585815|38842738|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
16096387|NCT04585815|38842739|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
16524668|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
16524669|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16524670|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16524671|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16524672|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16524673|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16524674|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
16524675|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16524676|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
16524677|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16524678|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16524679|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16524680|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16524681|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16524682|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
16524683|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
16524684|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16524685|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
16524686|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
16524687|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16524688|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16524689|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16524690|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16524691|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
16524692|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
16524693|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16524694|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16524695|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
16524696|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16524697|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16524698|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16524699|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16096388|NCT04585815|38842740|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
16096389|NCT04585815|38842741|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
16209999|NCT02215616|39248142|FG001|Overall Study|Non-compliance|2|||
16397626|NCT00861757|39935547|FG002|Overall Study|Protocol Violation|4|||
16397627|NCT00861757|39935548|FG003|Overall Study|Protocol Violation|1|||
16397628|NCT00861757|39935545|FG000|Overall Study|Withdrawal by Subject|1|||
16397629|NCT00861757|39935546|FG001|Overall Study|Withdrawal by Subject|5|||
16397630|NCT00861757|39935547|FG002|Overall Study|Withdrawal by Subject|5|||
16397631|NCT00861757|39935548|FG003|Overall Study|Withdrawal by Subject|2|||
16397632|NCT03292640|39935549|FG000|Overall Study|Withdrawal by Subject|17|||
16397633|NCT03292640|39935550|FG001|Overall Study|Withdrawal by Subject|16|||
16397634|NCT03292640|39935549|FG000|Overall Study|Adverse Event|20|||
16397635|NCT03292640|39935550|FG001|Overall Study|Adverse Event|2|||
16397636|NCT03292640|39935549|FG000|Overall Study|Lost to Follow-up|24|||
16397637|NCT03292640|39935550|FG001|Overall Study|Lost to Follow-up|24|||
16096390|NCT04585815|38842735|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
16096391|NCT04585815|38842736|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
16096392|NCT04585815|38842737|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
16096393|NCT04585815|38842738|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
16096394|NCT04585815|38842739|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
16210000|NCT02215616|39248143|FG002|Overall Study|Non-compliance|1|||
16210001|NCT02215616|39248144|FG003|Overall Study|Non-compliance|0|||
16210002|NCT02215616|39248141|FG000|Overall Study|Protocol Violation|0|||
16210003|NCT02215616|39248142|FG001|Overall Study|Protocol Violation|2|||
16210004|NCT02215616|39248143|FG002|Overall Study|Protocol Violation|0|||
16210005|NCT02215616|39248144|FG003|Overall Study|Protocol Violation|0|||
16210006|NCT02215616|39248141|FG000|Overall Study|Lost to Follow-up|1|||
16210007|NCT02215616|39248142|FG001|Overall Study|Lost to Follow-up|1|||
16210008|NCT02215616|39248143|FG002|Overall Study|Lost to Follow-up|0|||
16210009|NCT02215616|39248144|FG003|Overall Study|Lost to Follow-up|1|||
16210010|NCT02215616|39248141|FG000|Overall Study|Other than specified|1|||
16210011|NCT02215616|39248142|FG001|Overall Study|Other than specified|0|||
16210012|NCT02215616|39248143|FG002|Overall Study|Other than specified|1|||
16210013|NCT02215616|39248144|FG003|Overall Study|Other than specified|1|||
16210014|NCT03991936|39248147|FG000|Overall Study|Lost to Follow-up|1|||
16210015|NCT03991936|39248148|FG001|Overall Study|Lost to Follow-up|1|||
16210016|NCT03991936|39248149|FG002|Overall Study|Lost to Follow-up|1|||
16210017|NCT03991936|39248150|FG003|Overall Study|Lost to Follow-up|1|||
16210018|NCT03991936|39248151|FG004|Overall Study|Lost to Follow-up|1|||
16210019|NCT01102140|39248152|FG000|Overall Study|Lost to Follow-up|1|||
16210020|NCT01102140|39248153|FG001|Overall Study|Lost to Follow-up|0|||
16210021|NCT01102140|39248152|FG000|Overall Study|Investigator terminated study|2|||
16210022|NCT01102140|39248153|FG001|Overall Study|Investigator terminated study|2|||
16210023|NCT00499460|39248155|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
16210024|NCT00499460|39248156|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
16210025|NCT00499460|39248155|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
16210026|NCT00499460|39248156|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
16210027|NCT00499460|39248155|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
16210028|NCT00499460|39248156|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
16210029|NCT02996500|39248157|FG000|Overall Study|Adverse Event|1|||
16210030|NCT02996500|39248158|FG001|Overall Study|Adverse Event|1|||
16210031|NCT02996500|39248159|FG002|Overall Study|Adverse Event|4|||
16210032|NCT02996500|39248160|FG003|Overall Study|Adverse Event|3|||
16210033|NCT02996500|39248161|FG004|Overall Study|Adverse Event|1|||
16210034|NCT02996500|39248162|FG005|Overall Study|Adverse Event|2|||
16210035|NCT02996500|39248157|FG000|Overall Study|Lack of Efficacy|0|||
16210036|NCT02996500|39248158|FG001|Overall Study|Lack of Efficacy|0|||
16210037|NCT02996500|39248159|FG002|Overall Study|Lack of Efficacy|0|||
16210038|NCT02996500|39248160|FG003|Overall Study|Lack of Efficacy|0|||
16210039|NCT02996500|39248161|FG004|Overall Study|Lack of Efficacy|2|||
16210040|NCT02996500|39248162|FG005|Overall Study|Lack of Efficacy|0|||
16210041|NCT02996500|39248157|FG000|Overall Study|Lost to Follow-up|1|||
16210042|NCT02996500|39248158|FG001|Overall Study|Lost to Follow-up|0|||
16210043|NCT02996500|39248159|FG002|Overall Study|Lost to Follow-up|0|||
16210044|NCT02996500|39248160|FG003|Overall Study|Lost to Follow-up|0|||
16210045|NCT02996500|39248161|FG004|Overall Study|Lost to Follow-up|0|||
16210046|NCT02996500|39248162|FG005|Overall Study|Lost to Follow-up|1|||
16210047|NCT02996500|39248157|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16210048|NCT02996500|39248158|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16210049|NCT02996500|39248159|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
16210050|NCT02996500|39248160|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
16210051|NCT02996500|39248161|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
16397638|NCT02243371|39935551|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
16397639|NCT02243371|39935552|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
16397640|NCT02243371|39935551|FG000|Overall Study|Death (unrelated)|2|||
16210052|NCT02996500|39248162|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
16210053|NCT02996500|39248157|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16210054|NCT02996500|39248158|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16210055|NCT02996500|39248159|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16210056|NCT02996500|39248160|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16397641|NCT02243371|39935552|FG001|Overall Study|Death (unrelated)|4|||
16397642|NCT02243371|39935551|FG000|Overall Study|Adverse Event (unrelated)|0|||
16210057|NCT02996500|39248161|FG004|Overall Study|Non-Compliance With Study Drug|0|||
16210058|NCT02996500|39248162|FG005|Overall Study|Non-Compliance With Study Drug|1|||
16210059|NCT02996500|39248157|FG000|Overall Study|Progressive Disease|1|||
16210060|NCT02996500|39248158|FG001|Overall Study|Progressive Disease|0|||
16210061|NCT02996500|39248159|FG002|Overall Study|Progressive Disease|0|||
16210062|NCT02996500|39248160|FG003|Overall Study|Progressive Disease|0|||
16397643|NCT02243371|39935552|FG001|Overall Study|Adverse Event (unrelated)|1|||
16096395|NCT04585815|38842740|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
16397644|NCT02243371|39935551|FG000|Overall Study|Lack of Clinical Benefit|0|||
16328551|NCT00452673|39687833|FG003|Dose Escalation Period|Disease Progression|6|||
16328552|NCT00452673|39687834|FG004|Dose Escalation Period|Disease Progression|0|||
16328553|NCT00452673|39687830|FG000|Dose Escalation Period|study drug toxicity|1|||
16328554|NCT00452673|39687831|FG001|Dose Escalation Period|study drug toxicity|3|||
16328555|NCT00452673|39687832|FG002|Dose Escalation Period|study drug toxicity|3|||
16328556|NCT00452673|39687833|FG003|Dose Escalation Period|study drug toxicity|1|||
16328557|NCT00452673|39687834|FG004|Dose Escalation Period|study drug toxicity|0|||
16328558|NCT00452673|39687830|FG000|Dose Escalation Period|Other|0|||
16328559|NCT00452673|39687831|FG001|Dose Escalation Period|Other|0|||
16328560|NCT00452673|39687832|FG002|Dose Escalation Period|Other|1|||
16328561|NCT00452673|39687833|FG003|Dose Escalation Period|Other|0|||
16328562|NCT00452673|39687834|FG004|Dose Escalation Period|Other|0|||
16328563|NCT00452673|39687830|FG000|Dose Escalation Period|Adverse Event|0|||
16328564|NCT00452673|39687831|FG001|Dose Escalation Period|Adverse Event|0|||
16328565|NCT00452673|39687832|FG002|Dose Escalation Period|Adverse Event|0|||
16328566|NCT00452673|39687833|FG003|Dose Escalation Period|Adverse Event|1|||
16328567|NCT00452673|39687834|FG004|Dose Escalation Period|Adverse Event|0|||
16328568|NCT00452673|39687830|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
16328569|NCT00452673|39687831|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
16328570|NCT00452673|39687832|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
16328571|NCT00452673|39687833|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
16328572|NCT00452673|39687834|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
16328573|NCT00452673|39687830|FG000|Dose Expansion Period|Disease Progression|0|||
16328574|NCT00452673|39687831|FG001|Dose Expansion Period|Disease Progression|0|||
16328575|NCT00452673|39687832|FG002|Dose Expansion Period|Disease Progression|0|||
16328576|NCT00452673|39687833|FG003|Dose Expansion Period|Disease Progression|0|||
16328577|NCT00452673|39687834|FG004|Dose Expansion Period|Disease Progression|19|||
16328578|NCT00452673|39687830|FG000|Dose Expansion Period|Other|0|||
16328579|NCT00452673|39687831|FG001|Dose Expansion Period|Other|0|||
16328580|NCT00452673|39687832|FG002|Dose Expansion Period|Other|0|||
16524700|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16524701|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
16524702|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16524703|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16524704|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
16524705|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16328581|NCT00452673|39687833|FG003|Dose Expansion Period|Other|0|||
16328582|NCT00452673|39687834|FG004|Dose Expansion Period|Other|2|||
16328583|NCT05343364|39687835|FG000|Overall Study|Miscellaneous|0|||
16328584|NCT05343364|39687836|FG001|Overall Study|Miscellaneous|1|||
16328585|NCT04505540|39687837|FG000|Baseline|Protocol Violation|10|||
16328586|NCT04505540|39687837|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
16328587|NCT04505540|39687837|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
16328588|NCT04505540|39687837|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
16397645|NCT02243371|39935552|FG001|Overall Study|Lack of Clinical Benefit|1|||
16397646|NCT02243371|39935551|FG000|Overall Study|Withdrawal by Subject|0|||
16397647|NCT02243371|39935552|FG001|Overall Study|Withdrawal by Subject|2|||
16397648|NCT00395486|39935553|FG000|Overall Study|Adverse Event|1|||
16397649|NCT00395486|39935554|FG001|Overall Study|Adverse Event|2|||
16397650|NCT00395486|39935553|FG000|Overall Study|Withdrawal by Subject|5|||
16397651|NCT00395486|39935554|FG001|Overall Study|Withdrawal by Subject|2|||
16397652|NCT00395486|39935553|FG000|Overall Study|Lost to Follow-up|0|||
16397653|NCT00395486|39935554|FG001|Overall Study|Lost to Follow-up|1|||
16328589|NCT04505540|39687837|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
16328590|NCT04505540|39687837|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
16328591|NCT04505540|39687837|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
16328592|NCT04505540|39687837|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
16328593|NCT04505540|39687837|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
16328594|NCT04505540|39687837|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
16328595|NCT04505540|39687837|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
16328596|NCT04505540|39687837|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
16328597|NCT04505540|39687837|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
16328598|NCT03385304|39687841|FG000|Overall Study|Death|19|||
16328599|NCT03385304|39687842|FG001|Overall Study|Death|7|||
16328600|NCT03385304|39687841|FG000|Overall Study|Lost to Follow-up|17|||
16328601|NCT03385304|39687842|FG001|Overall Study|Lost to Follow-up|14|||
16328602|NCT03385304|39687841|FG000|Overall Study|Withdrawal by Subject|3|||
16328603|NCT03385304|39687842|FG001|Overall Study|Withdrawal by Subject|2|||
16397654|NCT02954887|39935555|FG000|Overall Study|Withdrawal by Subject|3|||
16397655|NCT02954887|39935555|FG000|Overall Study|Lack of Efficacy|3|||
16397656|NCT02954887|39935555|FG000|Overall Study|Other|1|||
16397657|NCT00588237|39935560|FG000|Overall Study|Evaluable for toxicity only|3|||
16328604|NCT03385304|39687841|FG000|Overall Study|Incarceration|2|||
16328605|NCT03385304|39687842|FG001|Overall Study|Incarceration|3|||
16328606|NCT01740128|39687843|FG000|Overall Study|Pregnancy|0|||
16328607|NCT01740128|39687844|FG001|Overall Study|Pregnancy|1|||
16328608|NCT01740128|39687843|FG000|Overall Study|Protocol Violation|1|||
16328609|NCT01740128|39687844|FG001|Overall Study|Protocol Violation|2|||
16328610|NCT01740128|39687843|FG000|Overall Study|Lost to Follow-up|2|||
16397658|NCT00588237|39935560|FG000|Overall Study|Patien not treated|1|||
16397659|NCT02957747|39935564|FG000|Overall Study|Withdrawal by Subject|0|||
16397660|NCT02957747|39935565|FG001|Overall Study|Withdrawal by Subject|3|||
16397661|NCT02957747|39935564|FG000|Overall Study|Lost to Follow-up|10|||
16397662|NCT02957747|39935565|FG001|Overall Study|Lost to Follow-up|5|||
16328611|NCT01740128|39687844|FG001|Overall Study|Lost to Follow-up|2|||
16328612|NCT01740128|39687843|FG000|Overall Study|Withdrawal by Subject|1|||
16328613|NCT01740128|39687844|FG001|Overall Study|Withdrawal by Subject|0|||
16328614|NCT01740128|39687843|FG000|Overall Study|Insufficient protocol compliance|2|||
16328615|NCT01740128|39687844|FG001|Overall Study|Insufficient protocol compliance|2|||
16328616|NCT05148234|39687848|FG000|Phase I|Ineligible|0|||
16328617|NCT05148234|39687849|FG001|Phase I|Ineligible|0|||
16328618|NCT05148234|39687850|FG002|Phase I|Ineligible|0|||
16328619|NCT05148234|39687851|FG003|Phase I|Ineligible|0|||
16328620|NCT05148234|39687852|FG004|Phase I|Ineligible|0|||
16328621|NCT05148234|39687853|FG005|Phase I|Ineligible|0|||
16328622|NCT05148234|39687854|FG006|Phase I|Ineligible|0|||
16328623|NCT05148234|39687855|FG007|Phase I|Ineligible|1|||
16328624|NCT05148234|39687848|FG000|Phase I|Company closed the trial.|0|||
16328625|NCT05148234|39687849|FG001|Phase I|Company closed the trial.|1|||
16328626|NCT05148234|39687850|FG002|Phase I|Company closed the trial.|0|||
16328627|NCT05148234|39687851|FG003|Phase I|Company closed the trial.|0|||
16328628|NCT05148234|39687852|FG004|Phase I|Company closed the trial.|0|||
16328629|NCT05148234|39687853|FG005|Phase I|Company closed the trial.|0|||
16328630|NCT05148234|39687854|FG006|Phase I|Company closed the trial.|0|||
16328631|NCT05148234|39687855|FG007|Phase I|Company closed the trial.|0|||
16328632|NCT00614523|39687856|FG000|Overall Study|Adverse Event|4|||
16328633|NCT00614523|39687857|FG001|Overall Study|Adverse Event|20|||
16328634|NCT00614523|39687856|FG000|Overall Study|Death|5|||
16328635|NCT00614523|39687857|FG001|Overall Study|Death|8|||
16328636|NCT00614523|39687856|FG000|Overall Study|Lack of Efficacy|9|||
16328637|NCT00614523|39687857|FG001|Overall Study|Lack of Efficacy|11|||
16328638|NCT00614523|39687856|FG000|Overall Study|Lost to Follow-up|0|||
16328639|NCT00614523|39687857|FG001|Overall Study|Lost to Follow-up|1|||
16328640|NCT00614523|39687856|FG000|Overall Study|Protocol Violation|3|||
16328641|NCT00614523|39687857|FG001|Overall Study|Protocol Violation|2|||
16328642|NCT00614523|39687856|FG000|Overall Study|Withdrawal by Subject|12|||
16328643|NCT00614523|39687857|FG001|Overall Study|Withdrawal by Subject|22|||
16328644|NCT00614523|39687856|FG000|Overall Study|Other|6|||
16328645|NCT00614523|39687857|FG001|Overall Study|Other|11|||
16328646|NCT00614523|39687856|FG000|Overall Study|Ineligibility Determined|1|||
16328647|NCT00614523|39687857|FG001|Overall Study|Ineligibility Determined|2|||
16328648|NCT00614523|39687856|FG000|Overall Study|Disease Progression|0|||
16328649|NCT00614523|39687857|FG001|Overall Study|Disease Progression|8|||
16328650|NCT00614523|39687856|FG000|Overall Study|Administrative Decision|23|||
16328651|NCT00614523|39687857|FG001|Overall Study|Administrative Decision|46|||
16328652|NCT04778059|39687863|FG000|Overall Study|Death|2|||
16328653|NCT04778059|39687864|FG001|Overall Study|Death|2|||
16397695|NCT01832493|39938526|FG000|Overall Study|Physician Decision|2|||
16397696|NCT01832493|39938526|FG000|Overall Study|Protocol Violation|4|||
16397697|NCT01832493|39938526|FG000|Overall Study|Unable to place LV lead|2|||
16397698|NCT01318135|39938529|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
16397699|NCT01318135|39938530|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16397700|NCT01318135|39938531|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16397701|NCT01318135|39938532|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16397702|NCT01318135|39938533|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16397703|NCT01318135|39938534|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16397704|NCT01318135|39938535|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16397705|NCT01318135|39938536|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16397706|NCT01318135|39938529|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
16397707|NCT01318135|39938530|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
16397708|NCT01318135|39938531|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
16397709|NCT01318135|39938532|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
16397710|NCT01318135|39938533|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
16397711|NCT01318135|39938534|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
16397712|NCT01318135|39938535|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
16397713|NCT01318135|39938536|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
16397714|NCT01318135|39938529|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
16397715|NCT01318135|39938530|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
16397716|NCT01318135|39938531|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
16397717|NCT01318135|39938532|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
16397718|NCT01318135|39938533|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
16397719|NCT01318135|39938534|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
16397720|NCT01318135|39938535|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
16397721|NCT01318135|39938536|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
16397722|NCT01318135|39938529|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
16397723|NCT01318135|39938530|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
16397724|NCT01318135|39938531|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
16397725|NCT01318135|39938532|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
16397726|NCT01318135|39938533|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
16397727|NCT01318135|39938534|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
16397728|NCT01318135|39938535|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
16397729|NCT01318135|39938536|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
16397730|NCT01318135|39938529|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16397731|NCT01318135|39938530|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16397732|NCT01318135|39938531|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16397733|NCT01318135|39938532|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16397734|NCT01318135|39938533|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16397735|NCT01318135|39938534|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
16397736|NCT01318135|39938535|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
16397737|NCT01318135|39938536|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16397738|NCT01318135|39938529|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
16397739|NCT01318135|39938530|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
16397740|NCT01318135|39938531|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
16397741|NCT01318135|39938532|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
16397742|NCT01318135|39938533|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
16397743|NCT01318135|39938534|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
16397744|NCT01318135|39938535|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
16397745|NCT01318135|39938536|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
16397746|NCT01318135|39938529|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
16397747|NCT01318135|39938530|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
16397748|NCT01318135|39938531|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
16397749|NCT01318135|39938532|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
16397750|NCT01318135|39938533|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
16397751|NCT01318135|39938534|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
16397752|NCT01318135|39938535|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
16397753|NCT01318135|39938536|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
16397754|NCT01390298|39938537|FG000|Overall Study|Death|1|||
16397755|NCT01390298|39938537|FG000|Overall Study|long term ICU admission|1|||
16397756|NCT01390298|39938537|FG000|Overall Study|Withdrawal by Subject|14|||
16096396|NCT04585815|38842741|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
16096397|NCT04585815|38842735|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
16096398|NCT04585815|38842736|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
16096399|NCT04585815|38842737|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
16096400|NCT04585815|38842738|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
16096401|NCT04585815|38842739|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
16096402|NCT04585815|38842740|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
16096403|NCT04585815|38842741|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
16096404|NCT04585815|38842735|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
16096405|NCT04585815|38842736|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
16096406|NCT04585815|38842737|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
16096407|NCT04585815|38842738|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
16096408|NCT04585815|38842739|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
16096409|NCT04585815|38842740|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
16096410|NCT04585815|38842741|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
16096411|NCT04585815|38842735|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
16096412|NCT04585815|38842736|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
16096413|NCT04585815|38842737|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
16096414|NCT04585815|38842738|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
16096415|NCT04585815|38842739|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
16096416|NCT04585815|38842740|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
16096417|NCT04585815|38842741|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
16096418|NCT04585815|38842735|FG000|Sub-study B- Follow-up Phase|Death|0|||
16096419|NCT04585815|38842736|FG001|Sub-study B- Follow-up Phase|Death|0|||
16096420|NCT04585815|38842737|FG002|Sub-study B- Follow-up Phase|Death|1|||
16096421|NCT04585815|38842738|FG003|Sub-study B- Follow-up Phase|Death|3|||
16328654|NCT04778059|39687865|FG002|Overall Study|Death|1|||
16328655|NCT04778059|39687866|FG003|Overall Study|Death|1|||
16328656|NCT04778059|39687867|FG004|Overall Study|Death|1|||
16328657|NCT04778059|39687863|FG000|Overall Study|Lost to Follow-up|0|||
16328658|NCT04778059|39687864|FG001|Overall Study|Lost to Follow-up|0|||
16328659|NCT04778059|39687865|FG002|Overall Study|Lost to Follow-up|0|||
16328660|NCT04778059|39687866|FG003|Overall Study|Lost to Follow-up|0|||
16328661|NCT04778059|39687867|FG004|Overall Study|Lost to Follow-up|1|||
16328662|NCT04778059|39687863|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
16328663|NCT04778059|39687864|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
16328664|NCT04778059|39687865|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
16328665|NCT04778059|39687866|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
16328666|NCT04778059|39687867|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
16328667|NCT02855359|39687871|FG000|Overall Study|Death|2|||
16328668|NCT02855359|39687872|FG001|Overall Study|Death|2|||
16328669|NCT02855359|39687873|FG002|Overall Study|Death|0|||
16328670|NCT02855359|39687874|FG003|Overall Study|Death|0|||
16328671|NCT02855359|39687871|FG000|Overall Study|Study Termination by Sponsor|9|||
16328672|NCT02855359|39687872|FG001|Overall Study|Study Termination by Sponsor|11|||
16328673|NCT02855359|39687873|FG002|Overall Study|Study Termination by Sponsor|0|||
16328674|NCT02855359|39687874|FG003|Overall Study|Study Termination by Sponsor|0|||
16328675|NCT02520427|39687877|FG000|Overall Study|Decision by sponsor|0|||
16328676|NCT02520427|39687878|FG001|Overall Study|Decision by sponsor|0|||
16328677|NCT02520427|39687879|FG002|Overall Study|Decision by sponsor|0|||
16328678|NCT02520427|39687880|FG003|Overall Study|Decision by sponsor|0|||
16328679|NCT02520427|39687881|FG004|Overall Study|Decision by sponsor|0|||
16328680|NCT02520427|39687882|FG005|Overall Study|Decision by sponsor|0|||
16328681|NCT02520427|39687883|FG006|Overall Study|Decision by sponsor|0|||
16328682|NCT02520427|39687884|FG007|Overall Study|Decision by sponsor|0|||
16328683|NCT02520427|39687885|FG008|Overall Study|Decision by sponsor|1|||
16328684|NCT02520427|39687886|FG009|Overall Study|Decision by sponsor|1|||
16328685|NCT02520427|39687887|FG010|Overall Study|Decision by sponsor|0|||
16328686|NCT02520427|39687888|FG011|Overall Study|Decision by sponsor|0|||
16328687|NCT02520427|39687889|FG012|Overall Study|Decision by sponsor|0|||
16328688|NCT02520427|39687890|FG013|Overall Study|Decision by sponsor|0|||
16328689|NCT02520427|39687891|FG014|Overall Study|Decision by sponsor|0|||
16096422|NCT04585815|38842739|FG004|Sub-study B- Follow-up Phase|Death|0|||
16096423|NCT04585815|38842740|FG005|Sub-study B- Follow-up Phase|Death|0|||
16096424|NCT04585815|38842741|FG006|Sub-study B- Follow-up Phase|Death|1|||
16096425|NCT03747575|38842742|FG000|Overall Study|Withdrawal by Subject|6|||
16328690|NCT02520427|39687892|FG015|Overall Study|Decision by sponsor|0|||
16096426|NCT03747575|38842743|FG001|Overall Study|Withdrawal by Subject|3|||
16096427|NCT03747575|38842742|FG000|Overall Study|Lost to Follow-up|3|||
16096428|NCT03747575|38842743|FG001|Overall Study|Lost to Follow-up|3|||
16096429|NCT03747575|38842742|FG000|Overall Study|Adverse Event|0|||
16096430|NCT03747575|38842743|FG001|Overall Study|Adverse Event|1|||
16096431|NCT01770509|38842744|FG000|Overall Study|Injury|0|||
16096432|NCT01770509|38842745|FG001|Overall Study|Injury|1|||
16096433|NCT01770509|38842744|FG000|Overall Study|Lost to Follow-up|1|||
16096434|NCT01770509|38842745|FG001|Overall Study|Lost to Follow-up|2|||
16096435|NCT01180400|38842746|FG000|Overall Study|Withdrawal by Subject|5|||
16096436|NCT01180400|38842747|FG001|Overall Study|Withdrawal by Subject|6|||
16096437|NCT01180400|38842746|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16096438|NCT01180400|38842747|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
16096439|NCT01180400|38842746|FG000|Overall Study|Adverse Event|12|||
16096440|NCT01180400|38842747|FG001|Overall Study|Adverse Event|10|||
16096441|NCT01180400|38842746|FG000|Overall Study|Severe non-compliance to protocol|1|||
16096442|NCT01180400|38842747|FG001|Overall Study|Severe non-compliance to protocol|2|||
16096443|NCT01180400|38842746|FG000|Overall Study|Condition under investigation worsened|2|||
16096444|NCT01180400|38842747|FG001|Overall Study|Condition under investigation worsened|1|||
16096445|NCT01180400|38842746|FG000|Overall Study|Lack of Efficacy|2|||
16096446|NCT01180400|38842747|FG001|Overall Study|Lack of Efficacy|0|||
16096447|NCT01180400|38842746|FG000|Overall Study|Study-specific withdrawal criteria|1|||
16096448|NCT01180400|38842747|FG001|Overall Study|Study-specific withdrawal criteria|2|||
16096449|NCT01180400|38842746|FG000|Overall Study|Lost to Follow-up|2|||
16096450|NCT01180400|38842747|FG001|Overall Study|Lost to Follow-up|3|||
16096451|NCT01180400|38842746|FG000|Overall Study|Other|0|||
16096452|NCT01180400|38842747|FG001|Overall Study|Other|1|||
16096453|NCT02543294|38842750|FG000|Overall Study|Lost to Follow-up|3|||
16096454|NCT02543294|38842750|FG000|Overall Study|Physician Decision|2|||
16096455|NCT02543294|38842750|FG000|Overall Study|Withdrawal by Subject|7|||
16096456|NCT02389894|38842752|FG000|Overall Study|Death|4|||
16524706|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16524707|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16524708|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16524709|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16524710|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
16524711|NCT01172938|40387777|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16524712|NCT01172938|40387778|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16524713|NCT01172938|40387779|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16524714|NCT01172938|40387780|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16524715|NCT01172938|40387781|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16524716|NCT01172938|40387782|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16524717|NCT01172938|40387783|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16524718|NCT01172938|40387784|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
16524719|NCT01172938|40387785|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
16524720|NCT02564198|40387788|FG000|Overall Study|Withdrawal by Subject|2|||
16524721|NCT02564198|40387789|FG001|Overall Study|Withdrawal by Subject|4|||
16524722|NCT02564198|40387790|FG002|Overall Study|Withdrawal by Subject|0|||
16524723|NCT02564198|40387788|FG000|Overall Study|Adverse Event|0|||
16524724|NCT02564198|40387789|FG001|Overall Study|Adverse Event|1|||
16524725|NCT02564198|40387790|FG002|Overall Study|Adverse Event|0|||
16524726|NCT00262834|40387791|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
16524727|NCT00262834|40387792|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
16524728|NCT03892889|40387795|FG000|Overall Study|Adverse Event|17|||
16524729|NCT03892889|40387795|FG000|Overall Study|Lack of Efficacy|1|||
16524730|NCT03892889|40387795|FG000|Overall Study|Lost to Follow-up|46|||
16524731|NCT03892889|40387795|FG000|Overall Study|Non-compliance with study drug|22|||
16524732|NCT03892889|40387795|FG000|Overall Study|Pregnancy|1|||
16524733|NCT03892889|40387795|FG000|Overall Study|Protocol Deviation|3|||
16524734|NCT03892889|40387795|FG000|Overall Study|Withdrawal by Subject|50|||
16524735|NCT03892889|40387795|FG000|Overall Study|Withdrawal by Caregiver|1|||
16524736|NCT03892889|40387795|FG000|Overall Study|Study Terminated by Sponsor|50|||
16524737|NCT03892889|40387795|FG000|Overall Study|Physician Decision|8|||
16524738|NCT03892889|40387795|FG000|Overall Study|Reason not Specified|5|||
16524739|NCT01978119|40387797|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
16524740|NCT01978119|40387798|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
16096457|NCT02389894|38842753|FG001|Overall Study|Death|5|||
16096458|NCT02389894|38842754|FG002|Overall Study|Death|3|||
16096459|NCT02389894|38842752|FG000|Overall Study|Withdrawal by Subject|2|||
16096460|NCT02389894|38842753|FG001|Overall Study|Withdrawal by Subject|4|||
16096461|NCT02389894|38842754|FG002|Overall Study|Withdrawal by Subject|5|||
16096462|NCT02389894|38842752|FG000|Overall Study|Lost to Follow-up|2|||
16096463|NCT02389894|38842753|FG001|Overall Study|Lost to Follow-up|1|||
16096464|NCT02389894|38842754|FG002|Overall Study|Lost to Follow-up|1|||
16524741|NCT01978119|40387797|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
16524742|NCT01978119|40387798|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16397757|NCT01390298|39938537|FG000|Overall Study|Lost to Follow-up|7|||
16397758|NCT01390298|39938537|FG000|Overall Study|Surgery cancelled|1|||
16397759|NCT01939977|39938538|FG000|Overall Study|Adverse Event|4|||
16397760|NCT01939977|39938539|FG001|Overall Study|Adverse Event|3|||
16397761|NCT01939977|39938538|FG000|Overall Study|Lack of Efficacy|3|||
16397762|NCT01939977|39938539|FG001|Overall Study|Lack of Efficacy|0|||
16397763|NCT01939977|39938538|FG000|Overall Study|Physician Decision|1|||
16397764|NCT01939977|39938539|FG001|Overall Study|Physician Decision|1|||
16397765|NCT01939977|39938538|FG000|Overall Study|Withdrawal by Subject|0|||
16397766|NCT01939977|39938539|FG001|Overall Study|Withdrawal by Subject|2|||
16397767|NCT01939977|39938538|FG000|Overall Study|Did not meet inclusion criteria|1|||
16397768|NCT01939977|39938539|FG001|Overall Study|Did not meet inclusion criteria|0|||
16397769|NCT01939977|39938538|FG000|Overall Study|Did not receive study medication|0|||
16397770|NCT01939977|39938539|FG001|Overall Study|Did not receive study medication|1|||
16397771|NCT01694121|39938545|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
16397772|NCT01694121|39938546|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
16397773|NCT02290691|39938547|FG000|Overall Study|Noncompliance|0|||
16397774|NCT02290691|39938548|FG001|Overall Study|Noncompliance|1|||
16397775|NCT02290691|39938547|FG000|Overall Study|Withdrawal by Subject|1|||
16397776|NCT02290691|39938548|FG001|Overall Study|Withdrawal by Subject|1|||
16397777|NCT02290691|39938547|FG000|Overall Study|Lost to Follow-up|7|||
16397778|NCT02290691|39938548|FG001|Overall Study|Lost to Follow-up|7|||
16397779|NCT01700959|39938561|FG000|Overall Study|Adverse Event|0|||
16397780|NCT01700959|39938562|FG001|Overall Study|Adverse Event|1|||
16397781|NCT01700959|39938563|FG002|Overall Study|Adverse Event|1|||
16397782|NCT01700959|39938564|FG003|Overall Study|Adverse Event|2|||
16397783|NCT01700959|39938565|FG004|Overall Study|Adverse Event|0|||
16397784|NCT01700959|39938566|FG005|Overall Study|Adverse Event|2|||
16397785|NCT01700959|39938561|FG000|Overall Study|Withdrawal by Subject|15|||
16397786|NCT01700959|39938562|FG001|Overall Study|Withdrawal by Subject|9|||
16397787|NCT01700959|39938563|FG002|Overall Study|Withdrawal by Subject|12|||
16397788|NCT01700959|39938564|FG003|Overall Study|Withdrawal by Subject|11|||
16397789|NCT01700959|39938565|FG004|Overall Study|Withdrawal by Subject|8|||
16397790|NCT01700959|39938566|FG005|Overall Study|Withdrawal by Subject|12|||
16397791|NCT01700959|39938561|FG000|Overall Study|Ineligible|2|||
16397792|NCT01700959|39938562|FG001|Overall Study|Ineligible|1|||
16397793|NCT01700959|39938563|FG002|Overall Study|Ineligible|2|||
16397794|NCT01700959|39938564|FG003|Overall Study|Ineligible|0|||
16397795|NCT01700959|39938565|FG004|Overall Study|Ineligible|0|||
16397796|NCT01700959|39938566|FG005|Overall Study|Ineligible|1|||
16397797|NCT01700959|39938561|FG000|Overall Study|Noncompliant|9|||
16397798|NCT01700959|39938562|FG001|Overall Study|Noncompliant|9|||
16397799|NCT01700959|39938563|FG002|Overall Study|Noncompliant|17|||
16397800|NCT01700959|39938564|FG003|Overall Study|Noncompliant|18|||
16397801|NCT01700959|39938565|FG004|Overall Study|Noncompliant|15|||
16397802|NCT01700959|39938566|FG005|Overall Study|Noncompliant|9|||
16397803|NCT01700959|39938561|FG000|Overall Study|Side effects|1|||
16397804|NCT01700959|39938562|FG001|Overall Study|Side effects|4|||
16397805|NCT01700959|39938563|FG002|Overall Study|Side effects|8|||
16397806|NCT01700959|39938564|FG003|Overall Study|Side effects|4|||
16397807|NCT01700959|39938565|FG004|Overall Study|Side effects|4|||
16397808|NCT01700959|39938566|FG005|Overall Study|Side effects|1|||
16397809|NCT01893411|39938567|FG000|Overall Study|Protocol Violation|1|||
16397810|NCT01893411|39938568|FG001|Overall Study|Protocol Violation|0|||
16397811|NCT01893411|39938569|FG002|Overall Study|Protocol Violation|0|||
16397812|NCT01893411|39938567|FG000|Overall Study|Physician Decision|1|||
16397813|NCT01893411|39938568|FG001|Overall Study|Physician Decision|1|||
16397814|NCT01893411|39938569|FG002|Overall Study|Physician Decision|2|||
16397815|NCT01893411|39938567|FG000|Overall Study|Lack of Efficacy|2|||
16397816|NCT01893411|39938568|FG001|Overall Study|Lack of Efficacy|1|||
16397817|NCT01893411|39938569|FG002|Overall Study|Lack of Efficacy|0|||
16397818|NCT01893411|39938567|FG000|Overall Study|Other|3|||
16524743|NCT01978119|40387797|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16524744|NCT01978119|40387798|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
16524745|NCT04095858|40387799|FG000|Overall Study|Death|1|||
16524746|NCT04095858|40387800|FG001|Overall Study|Death|0|||
16397819|NCT01893411|39938568|FG001|Overall Study|Other|1|||
16397820|NCT01893411|39938569|FG002|Overall Study|Other|3|||
16397821|NCT01893411|39938567|FG000|Overall Study|Adverse Event|1|||
16397822|NCT01893411|39938568|FG001|Overall Study|Adverse Event|0|||
16397823|NCT01893411|39938569|FG002|Overall Study|Adverse Event|0|||
16397824|NCT01893411|39938567|FG000|Overall Study|Withdrawal by Subject|7|||
16397825|NCT01893411|39938568|FG001|Overall Study|Withdrawal by Subject|4|||
16397826|NCT01893411|39938569|FG002|Overall Study|Withdrawal by Subject|3|||
16397827|NCT01893411|39938567|FG000|Overall Study|Lost to Follow-up|2|||
16397828|NCT01893411|39938568|FG001|Overall Study|Lost to Follow-up|0|||
16397829|NCT01893411|39938569|FG002|Overall Study|Lost to Follow-up|1|||
16096465|NCT01304940|38842762|FG000|Overall Study|not meet symptom severity requirement|3|||
16096466|NCT01304940|38842763|FG001|Overall Study|not meet symptom severity requirement|0|||
16096467|NCT01123356|38842773|FG000|Overall Study|Adverse Event|2|||
16096468|NCT01123356|38842773|FG000|Overall Study|Lack of Efficacy|4|||
16096469|NCT01123356|38842773|FG000|Overall Study|Withdrawal by Subject|1|||
16096470|NCT00700999|38842774|FG000|Overall Study|Lost to Follow-up|7|||
16096471|NCT00700999|38842775|FG001|Overall Study|Lost to Follow-up|7|||
16096472|NCT00700999|38842774|FG000|Overall Study|Excluded - did not meet study criteria|0|||
16096473|NCT00700999|38842775|FG001|Overall Study|Excluded - did not meet study criteria|1|||
16096474|NCT00700999|38842774|FG000|Overall Study|Withdrawal by Subject|8|||
16096475|NCT00700999|38842775|FG001|Overall Study|Withdrawal by Subject|1|||
16096476|NCT00730925|38842776|FG000|Overall Study|Progressive Disease|21|||
16096477|NCT00730925|38842776|FG000|Overall Study|Dose reducing Event|2|||
16096478|NCT00730925|38842776|FG000|Overall Study|Other Averse Event|7|||
16096479|NCT00730925|38842776|FG000|Overall Study|Protocol Violation|1|||
16096480|NCT00730925|38842776|FG000|Overall Study|Withdrawal by Subject|1|||
16096481|NCT00730925|38842776|FG000|Overall Study|Switch to combination therapy|8|||
16096482|NCT00730925|38842776|FG000|Overall Study|Other|1|||
16096483|NCT01021683|38842777|FG000|Overall Study|Lack of Efficacy|12|||
16096484|NCT01021683|38842777|FG000|Overall Study|Recovery of neutrophil count|51|||
16096485|NCT01021683|38842777|FG000|Overall Study|Other|8|||
16096486|NCT01348763|38842778|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
16096487|NCT01348763|38842778|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
16096488|NCT04783389|38842779|FG000|Overall Study|Withdrawal by Subject|2|||
16096489|NCT04783389|38842780|FG001|Overall Study|Withdrawal by Subject|0|||
16096490|NCT04783389|38842781|FG002|Overall Study|Withdrawal by Subject|0|||
16096491|NCT04783389|38842779|FG000|Overall Study|Termination of Study by Sponsor|10|||
16096492|NCT04783389|38842780|FG001|Overall Study|Termination of Study by Sponsor|12|||
16096493|NCT04783389|38842781|FG002|Overall Study|Termination of Study by Sponsor|14|||
16096494|NCT04908800|38842782|FG000|Overall Study|Adverse Event|0|||
16096495|NCT04908800|38842783|FG001|Overall Study|Adverse Event|0|||
16096496|NCT04908800|38842784|FG002|Overall Study|Adverse Event|0|||
16096497|NCT04908800|38842785|FG003|Overall Study|Adverse Event|0|||
16096498|NCT04908800|38842786|FG004|Overall Study|Adverse Event|0|||
16096499|NCT04908800|38842787|FG005|Overall Study|Adverse Event|0|||
16096500|NCT04908800|38842788|FG006|Overall Study|Adverse Event|0|||
16096501|NCT04908800|38842789|FG007|Overall Study|Adverse Event|0|||
16096502|NCT04908800|38842790|FG008|Overall Study|Adverse Event|0|||
16096503|NCT04908800|38842791|FG009|Overall Study|Adverse Event|0|||
16096504|NCT04908800|38842792|FG010|Overall Study|Adverse Event|1|||
16096505|NCT04908800|38842793|FG011|Overall Study|Adverse Event|0|||
16096506|NCT04908800|38842794|FG012|Overall Study|Adverse Event|0|||
16096507|NCT00447499|38842795|FG000|Overall Study|Adverse Event|1|||
16096508|NCT00447499|38842795|FG000|Overall Study|Patient Decision|4|||
16096509|NCT00447499|38842795|FG000|Overall Study|Sponsor Decision|1|||
16096510|NCT00447499|38842795|FG000|Overall Study|Physician Decision|1|||
16096511|NCT04271254|38842800|FG000|Overall Study|Withdrawal by Subject|3|||
16096512|NCT00828139|38842805|FG000|Overall Study|Adverse Event|8|||
16096513|NCT00828139|38842806|FG001|Overall Study|Adverse Event|1|||
16096514|NCT00828139|38842807|FG002|Overall Study|Adverse Event|10|||
16096515|NCT00828139|38842808|FG003|Overall Study|Adverse Event|5|||
16096516|NCT00828139|38842805|FG000|Overall Study|Death|2|||
16096517|NCT00828139|38842806|FG001|Overall Study|Death|1|||
16096518|NCT00828139|38842807|FG002|Overall Study|Death|0|||
16096519|NCT00828139|38842808|FG003|Overall Study|Death|2|||
16096520|NCT00828139|38842805|FG000|Overall Study|Refusal unrelated to toxicity|3|||
16096521|NCT00828139|38842806|FG001|Overall Study|Refusal unrelated to toxicity|4|||
16096522|NCT00828139|38842807|FG002|Overall Study|Refusal unrelated to toxicity|5|||
16096523|NCT00828139|38842808|FG003|Overall Study|Refusal unrelated to toxicity|3|||
16096524|NCT00828139|38842805|FG000|Overall Study|Disease Progression|24|||
16096525|NCT00828139|38842806|FG001|Overall Study|Disease Progression|33|||
16096526|NCT00828139|38842807|FG002|Overall Study|Disease Progression|35|||
16096527|NCT00828139|38842808|FG003|Overall Study|Disease Progression|39|||
16096528|NCT00828139|38842805|FG000|Overall Study|Other|4|||
16096529|NCT00828139|38842806|FG001|Overall Study|Other|2|||
16096530|NCT00828139|38842807|FG002|Overall Study|Other|5|||
16096531|NCT00828139|38842808|FG003|Overall Study|Other|2|||
16096532|NCT00621842|38842809|FG000|Overall Study|Adverse Event|6|||
16096533|NCT00621842|38842809|FG000|Overall Study|Withdrawal by Subject|7|||
16096534|NCT00621842|38842809|FG000|Overall Study|Protocol Violation|4|||
16096535|NCT00621842|38842809|FG000|Overall Study|Lack of Efficacy|2|||
16096536|NCT00476151|38842812|FG000|Overall Study|Adverse Event|0|||
16096537|NCT00476151|38842813|FG001|Overall Study|Adverse Event|2|||
16096538|NCT00476151|38842812|FG000|Overall Study|Protocol Violation|1|||
16096539|NCT00476151|38842813|FG001|Overall Study|Protocol Violation|3|||
16096540|NCT00476151|38842812|FG000|Overall Study|Withdrawal by Subject|2|||
16096541|NCT00476151|38842813|FG001|Overall Study|Withdrawal by Subject|0|||
16096542|NCT00476151|38842812|FG000|Overall Study|Physician Decision|0|||
16096543|NCT00476151|38842813|FG001|Overall Study|Physician Decision|2|||
16096544|NCT02879448|38842814|FG000|Overall Study|No implant attempt|17|||
16096545|NCT02879448|38842815|FG001|Overall Study|No implant attempt|28|||
16096546|NCT02879448|38842814|FG000|Overall Study|Withdrawal by Subject|20|||
16096547|NCT02879448|38842815|FG001|Overall Study|Withdrawal by Subject|46|||
16096548|NCT02879448|38842814|FG000|Overall Study|Death|63|||
16096549|NCT02879448|38842815|FG001|Overall Study|Death|85|||
16096550|NCT02879448|38842814|FG000|Overall Study|Lost to Follow-up|3|||
16096551|NCT02879448|38842815|FG001|Overall Study|Lost to Follow-up|4|||
16096552|NCT02879448|38842814|FG000|Overall Study|Missing visit|34|||
16096553|NCT02879448|38842815|FG001|Overall Study|Missing visit|39|||
16096554|NCT02879448|38842814|FG000|Overall Study|Pending evaluation|1|||
16096555|NCT02879448|38842815|FG001|Overall Study|Pending evaluation|0|||
16096556|NCT00472199|38842816|FG000|Overall Study|Adverse Event|19|||
16096557|NCT00472199|38842817|FG001|Overall Study|Adverse Event|23|||
16096558|NCT00472199|38842816|FG000|Overall Study|Lack of Efficacy|4|||
16096559|NCT00472199|38842817|FG001|Overall Study|Lack of Efficacy|25|||
16096560|NCT00472199|38842816|FG000|Overall Study|Lost to Follow-up|2|||
16096561|NCT00472199|38842817|FG001|Overall Study|Lost to Follow-up|4|||
16096562|NCT00472199|38842816|FG000|Overall Study|Protocol Violation|3|||
16096563|NCT00472199|38842817|FG001|Overall Study|Protocol Violation|2|||
16210063|NCT02996500|39248161|FG004|Overall Study|Progressive Disease|0|||
16397830|NCT00361231|39938570|FG000|Overall Study|Physician Decision|3|||
16397831|NCT00361231|39938570|FG000|Overall Study|Symptomatic deterioration|5|||
16397832|NCT00361231|39938570|FG000|Overall Study|Radiographic disease progression|16|||
16397833|NCT00361231|39938570|FG000|Overall Study|Withdrawal by Subject|4|||
16397834|NCT00361231|39938570|FG000|Overall Study|Adverse Event|6|||
16397835|NCT02443337|39938571|FG000|Overall Study|Adverse Event|0|||
16397836|NCT02443337|39938572|FG001|Overall Study|Adverse Event|1|||
16397837|NCT02443337|39938571|FG000|Overall Study|Clinical Progressive Disease|3|||
16397838|NCT02443337|39938572|FG001|Overall Study|Clinical Progressive Disease|0|||
16397839|NCT02443337|39938571|FG000|Overall Study|Withdrawal by Subject|2|||
16397840|NCT02443337|39938572|FG001|Overall Study|Withdrawal by Subject|1|||
16397841|NCT00624468|39938574|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
16397842|NCT00624468|39938575|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
16397843|NCT00624468|39938576|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
16397844|NCT00624468|39938577|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
16397845|NCT00624468|39938574|FG000|Double-blind Period|Withdrew Prematurely|1|||
16397846|NCT00624468|39938575|FG001|Double-blind Period|Withdrew Prematurely|1|||
16397847|NCT00624468|39938576|FG002|Double-blind Period|Withdrew Prematurely|0|||
16397848|NCT00624468|39938577|FG003|Double-blind Period|Withdrew Prematurely|0|||
16397849|NCT00624468|39938574|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
16397850|NCT00624468|39938575|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
16397851|NCT00624468|39938576|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
16397852|NCT00624468|39938577|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
16397853|NCT00624468|39938574|FG000|Safety Follow-up (SFU) Period|Other|0|||
16397854|NCT00624468|39938575|FG001|Safety Follow-up (SFU) Period|Other|0|||
16397855|NCT00624468|39938576|FG002|Safety Follow-up (SFU) Period|Other|1|||
16397856|NCT00624468|39938577|FG003|Safety Follow-up (SFU) Period|Other|1|||
16397857|NCT01843673|39938578|FG000|Overall Study|Lack of Efficacy|2|||
16397858|NCT01843673|39938578|FG000|Overall Study|Withdrawal by Subject|4|||
16397859|NCT02705105|39938580|FG000|Treatment|Objective Disease Progression|1|||
16096564|NCT00472199|38842816|FG000|Overall Study|Withdrawal by Subject|6|||
16210064|NCT02996500|39248162|FG005|Overall Study|Progressive Disease|0|||
16210065|NCT02996500|39248157|FG000|Overall Study|Other|2|||
16397860|NCT02705105|39938581|FG001|Treatment|Objective Disease Progression|50|||
16397861|NCT02705105|39938580|FG000|Treatment|Withdrawal by Subject|3|||
16397862|NCT02705105|39938581|FG001|Treatment|Withdrawal by Subject|5|||
16397863|NCT02705105|39938580|FG000|Treatment|Adverse Event|0|||
16096565|NCT00472199|38842817|FG001|Overall Study|Withdrawal by Subject|5|||
16096566|NCT00472199|38842816|FG000|Overall Study|personal reason|0|||
16096567|NCT00472199|38842817|FG001|Overall Study|personal reason|1|||
16096568|NCT00472199|38842816|FG000|Overall Study|patient was asymptomatic|1|||
16096569|NCT00472199|38842817|FG001|Overall Study|patient was asymptomatic|0|||
16096570|NCT00755716|38842818|FG000|Overall Study|Adverse Event|1|||
16096571|NCT00755716|38842819|FG001|Overall Study|Adverse Event|4|||
16096572|NCT00755716|38842820|FG002|Overall Study|Adverse Event|1|||
16096573|NCT00755716|38842818|FG000|Overall Study|Lack of Efficacy|2|||
16096574|NCT00755716|38842819|FG001|Overall Study|Lack of Efficacy|0|||
16328691|NCT02520427|39687893|FG016|Overall Study|Decision by sponsor|0|||
16328692|NCT02520427|39687894|FG017|Overall Study|Decision by sponsor|0|||
16096575|NCT00755716|38842820|FG002|Overall Study|Lack of Efficacy|0|||
16096576|NCT00755716|38842818|FG000|Overall Study|Lost to Follow-up|5|||
16096577|NCT00755716|38842819|FG001|Overall Study|Lost to Follow-up|3|||
16096578|NCT00755716|38842820|FG002|Overall Study|Lost to Follow-up|1|||
16096579|NCT00755716|38842818|FG000|Overall Study|work schedule issues|0|||
16096580|NCT00755716|38842819|FG001|Overall Study|work schedule issues|1|||
16096581|NCT00755716|38842820|FG002|Overall Study|work schedule issues|1|||
16096582|NCT00607789|38842821|FG000|Overall Study|Adverse Event|3|||
16524747|NCT04095858|40387799|FG000|Overall Study|Study terminated by Sponsor|2|||
16328693|NCT02520427|39687895|FG018|Overall Study|Decision by sponsor|0|||
16328694|NCT02520427|39687896|FG019|Overall Study|Decision by sponsor|0|||
16328695|NCT02520427|39687897|FG020|Overall Study|Decision by sponsor|0|||
16328696|NCT02520427|39687898|FG021|Overall Study|Decision by sponsor|0|||
16328697|NCT02520427|39687899|FG022|Overall Study|Decision by sponsor|0|||
16328698|NCT02520427|39687900|FG023|Overall Study|Decision by sponsor|0|||
16328699|NCT02520427|39687901|FG024|Overall Study|Decision by sponsor|0|||
16328700|NCT02520427|39687902|FG025|Overall Study|Decision by sponsor|0|||
16328701|NCT02520427|39687877|FG000|Overall Study|Withdrawal by Subject|0|||
16328702|NCT02520427|39687878|FG001|Overall Study|Withdrawal by Subject|0|||
16328703|NCT02520427|39687879|FG002|Overall Study|Withdrawal by Subject|1|||
16524748|NCT04095858|40387800|FG001|Overall Study|Study terminated by Sponsor|4|||
16524749|NCT03156023|40387802|FG000|Overall Study|Withdrawal by Subject|1|||
16524750|NCT03156023|40387803|FG001|Overall Study|Withdrawal by Subject|0|||
16524751|NCT03156023|40387804|FG002|Overall Study|Withdrawal by Subject|2|||
16096583|NCT00607789|38842822|FG001|Overall Study|Adverse Event|0|||
16096584|NCT00607789|38842821|FG000|Overall Study|Lack of Efficacy|0|||
16096585|NCT00607789|38842822|FG001|Overall Study|Lack of Efficacy|1|||
16096586|NCT00607789|38842821|FG000|Overall Study|Inadequate adherence|3|||
16096587|NCT00607789|38842822|FG001|Overall Study|Inadequate adherence|0|||
16096588|NCT00607789|38842821|FG000|Overall Study|Lost to Follow-up|0|||
16096589|NCT00607789|38842822|FG001|Overall Study|Lost to Follow-up|5|||
16096590|NCT00607789|38842821|FG000|Overall Study|Withdrawal by Subject|1|||
16096591|NCT00607789|38842822|FG001|Overall Study|Withdrawal by Subject|0|||
16096592|NCT00080119|38842823|FG000|Overall Study|Discontinued because of study closure|0|||
16096593|NCT00080119|38842824|FG001|Overall Study|Discontinued because of study closure|0|||
16096594|NCT00080119|38842825|FG002|Overall Study|Discontinued because of study closure|130|||
16328704|NCT02520427|39687880|FG003|Overall Study|Withdrawal by Subject|0|||
16328705|NCT02520427|39687881|FG004|Overall Study|Withdrawal by Subject|0|||
16524752|NCT03156023|40387805|FG003|Overall Study|Withdrawal by Subject|1|||
16524753|NCT03156023|40387806|FG004|Overall Study|Withdrawal by Subject|1|||
16524754|NCT03156023|40387802|FG000|Overall Study|Lost to Follow-up|0|||
16524755|NCT03156023|40387803|FG001|Overall Study|Lost to Follow-up|0|||
16524756|NCT03156023|40387804|FG002|Overall Study|Lost to Follow-up|0|||
16524757|NCT03156023|40387805|FG003|Overall Study|Lost to Follow-up|0|||
16524758|NCT03156023|40387806|FG004|Overall Study|Lost to Follow-up|1|||
16524759|NCT01762761|40387807|FG000|Overall Study|Adverse Event|15|||
16524760|NCT01762761|40387808|FG001|Overall Study|Adverse Event|17|||
16096595|NCT00080119|38842826|FG003|Overall Study|Discontinued because of study closure|141|||
16096596|NCT00080119|38842823|FG000|Overall Study|Unable to get to clinic|24|||
16096597|NCT00080119|38842824|FG001|Overall Study|Unable to get to clinic|24|||
16096598|NCT00080119|38842825|FG002|Overall Study|Unable to get to clinic|7|||
16328706|NCT02520427|39687882|FG005|Overall Study|Withdrawal by Subject|0|||
16328707|NCT02520427|39687883|FG006|Overall Study|Withdrawal by Subject|0|||
16328708|NCT02520427|39687884|FG007|Overall Study|Withdrawal by Subject|0|||
16328709|NCT02520427|39687885|FG008|Overall Study|Withdrawal by Subject|0|||
16328710|NCT02520427|39687886|FG009|Overall Study|Withdrawal by Subject|0|||
16328711|NCT02520427|39687887|FG010|Overall Study|Withdrawal by Subject|0|||
16328712|NCT02520427|39687888|FG011|Overall Study|Withdrawal by Subject|0|||
16328713|NCT02520427|39687889|FG012|Overall Study|Withdrawal by Subject|1|||
16328714|NCT02520427|39687890|FG013|Overall Study|Withdrawal by Subject|1|||
16328715|NCT02520427|39687891|FG014|Overall Study|Withdrawal by Subject|1|||
16328716|NCT02520427|39687892|FG015|Overall Study|Withdrawal by Subject|0|||
16328717|NCT02520427|39687893|FG016|Overall Study|Withdrawal by Subject|1|||
16328718|NCT02520427|39687894|FG017|Overall Study|Withdrawal by Subject|0|||
16328719|NCT02520427|39687895|FG018|Overall Study|Withdrawal by Subject|0|||
16328720|NCT02520427|39687896|FG019|Overall Study|Withdrawal by Subject|3|||
16328721|NCT02520427|39687897|FG020|Overall Study|Withdrawal by Subject|2|||
16328722|NCT02520427|39687898|FG021|Overall Study|Withdrawal by Subject|0|||
16328723|NCT02520427|39687899|FG022|Overall Study|Withdrawal by Subject|0|||
16328724|NCT02520427|39687900|FG023|Overall Study|Withdrawal by Subject|0|||
16397864|NCT02705105|39938581|FG001|Treatment|Adverse Event|17|||
16397865|NCT02705105|39938580|FG000|Treatment|Clinical Disease Progression|0|||
16397866|NCT02705105|39938581|FG001|Treatment|Clinical Disease Progression|32|||
16524761|NCT01762761|40387807|FG000|Overall Study|Lack of Efficacy|9|||
16524762|NCT01762761|40387808|FG001|Overall Study|Lack of Efficacy|25|||
16524763|NCT01762761|40387807|FG000|Overall Study|Protocol Violation|1|||
16524764|NCT01762761|40387808|FG001|Overall Study|Protocol Violation|1|||
16096599|NCT00080119|38842826|FG003|Overall Study|Unable to get to clinic|1|||
16524765|NCT01762761|40387807|FG000|Overall Study|Study closed/terminated|0|||
16524766|NCT01762761|40387808|FG001|Overall Study|Study closed/terminated|2|||
16524767|NCT01762761|40387807|FG000|Overall Study|Lost to Follow-up|3|||
16524768|NCT01762761|40387808|FG001|Overall Study|Lost to Follow-up|6|||
16096600|NCT00080119|38842823|FG000|Overall Study|Consent withdrawn|13|||
16096601|NCT00080119|38842824|FG001|Overall Study|Consent withdrawn|17|||
16096602|NCT00080119|38842825|FG002|Overall Study|Consent withdrawn|4|||
16096603|NCT00080119|38842826|FG003|Overall Study|Consent withdrawn|6|||
16096604|NCT00080119|38842823|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
16397867|NCT02705105|39938580|FG000|Treatment|Physician Decision|0|||
16397868|NCT02705105|39938581|FG001|Treatment|Physician Decision|3|||
16397869|NCT02705105|39938580|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
16397870|NCT02705105|39938581|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
16397871|NCT02705105|39938580|FG000|Follow-Up|Death|3|||
16397872|NCT02705105|39938581|FG001|Follow-Up|Death|68|||
16397873|NCT02705105|39938580|FG000|Follow-Up|Withdrawal by Subject|1|||
16397874|NCT02705105|39938581|FG001|Follow-Up|Withdrawal by Subject|14|||
16397875|NCT02705105|39938580|FG000|Follow-Up|Study Terminated|0|||
16397876|NCT02705105|39938581|FG001|Follow-Up|Study Terminated|26|||
16397877|NCT02705105|39938580|FG000|Follow-Up|Discontinued per Amendment 3|0|||
16397878|NCT02705105|39938581|FG001|Follow-Up|Discontinued per Amendment 3|2|||
16397879|NCT03941964|39938582|FG000|Overall Study|Adverse Event|1|||
16397880|NCT03941964|39938583|FG001|Overall Study|Adverse Event|8|||
16397881|NCT03941964|39938582|FG000|Overall Study|Progressive disease|7|||
16096605|NCT00080119|38842824|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
16397882|NCT03941964|39938583|FG001|Overall Study|Progressive disease|3|||
16397883|NCT03941964|39938582|FG000|Overall Study|Lack of Efficacy|0|||
16397884|NCT03941964|39938583|FG001|Overall Study|Lack of Efficacy|1|||
16397885|NCT03941964|39938582|FG000|Overall Study|Death|3|||
16328725|NCT02520427|39687901|FG024|Overall Study|Withdrawal by Subject|0|||
16328726|NCT02520427|39687902|FG025|Overall Study|Withdrawal by Subject|0|||
16328727|NCT02520427|39687877|FG000|Overall Study|Death|1|||
16397886|NCT03941964|39938583|FG001|Overall Study|Death|1|||
16524769|NCT01762761|40387807|FG000|Overall Study|Physician Decision|4|||
16328728|NCT02520427|39687878|FG001|Overall Study|Death|0|||
16328729|NCT02520427|39687879|FG002|Overall Study|Death|0|||
16524770|NCT01762761|40387808|FG001|Overall Study|Physician Decision|6|||
16096606|NCT00080119|38842825|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
16096607|NCT00080119|38842826|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
16096608|NCT00080119|38842823|FG000|Overall Study|Lost to Follow-up|16|||
16096609|NCT00080119|38842824|FG001|Overall Study|Lost to Follow-up|19|||
16096610|NCT00080119|38842825|FG002|Overall Study|Lost to Follow-up|19|||
16096611|NCT00080119|38842826|FG003|Overall Study|Lost to Follow-up|14|||
16096612|NCT04626128|38842829|FG000|Overall Study|Withdrawal by Subject|0|||
16096613|NCT04626128|38842830|FG001|Overall Study|Withdrawal by Subject|1|||
16096614|NCT04626128|38842831|FG002|Overall Study|Withdrawal by Subject|0|||
16096615|NCT04626128|38842832|FG003|Overall Study|Withdrawal by Subject|0|||
16096616|NCT05287178|38842834|FG000|Overall Study|Lost to Follow-up|2|||
16096617|NCT01426217|38842835|FG000|Overall Study|lost sample|8|||
16096618|NCT01426217|38842836|FG001|Overall Study|lost sample|14|||
16096619|NCT00788671|38842837|FG000|Overall Study|Death|2|||
16096620|NCT00788671|38842837|FG000|Overall Study|Unable to biopsy|1|||
16096621|NCT00788671|38842837|FG000|Overall Study|Withdrawal by Subject|4|||
16096622|NCT00788671|38842837|FG000|Overall Study|IUD expulsed|1|||
16096623|NCT00788671|38842837|FG000|Overall Study|Lost to follow up|2|||
16096624|NCT00731692|38842838|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
16096625|NCT00731692|38842839|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
16096626|NCT00731692|38842840|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
16096627|NCT00731692|38842838|FG000|Core Study (36 Months)|Physician Decision|1|||
16096628|NCT00731692|38842839|FG001|Core Study (36 Months)|Physician Decision|0|||
16096629|NCT00731692|38842840|FG002|Core Study (36 Months)|Physician Decision|2|||
16096630|NCT00731692|38842838|FG000|Core Study (36 Months)|Death|2|||
16096631|NCT00731692|38842839|FG001|Core Study (36 Months)|Death|1|||
16096632|NCT00731692|38842840|FG002|Core Study (36 Months)|Death|2|||
16096633|NCT00731692|38842838|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
16096634|NCT00731692|38842839|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
16096635|NCT00731692|38842840|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
16096636|NCT00731692|38842838|FG000|Core Study (36 Months)|Administrative|2|||
16096637|NCT00731692|38842839|FG001|Core Study (36 Months)|Administrative|2|||
16096638|NCT00731692|38842840|FG002|Core Study (36 Months)|Administrative|6|||
16096639|NCT00731692|38842838|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
16096640|NCT00731692|38842839|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
16096641|NCT00731692|38842840|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
16096642|NCT00731692|38842838|FG000|Core Study (36 Months)|Protocol Violation|4|||
16096643|NCT00731692|38842839|FG001|Core Study (36 Months)|Protocol Violation|5|||
16096644|NCT00731692|38842840|FG002|Core Study (36 Months)|Protocol Violation|8|||
16210066|NCT02996500|39248158|FG001|Overall Study|Other|0|||
16397887|NCT03941964|39938582|FG000|Overall Study|Withdrew consent|1|||
16397888|NCT03941964|39938583|FG001|Overall Study|Withdrew consent|3|||
16397889|NCT03941964|39938582|FG000|Overall Study|Physician Decision|9|||
16397890|NCT03941964|39938583|FG001|Overall Study|Physician Decision|2|||
16397891|NCT03941964|39938582|FG000|Overall Study|Other, not specified|2|||
16397892|NCT03941964|39938583|FG001|Overall Study|Other, not specified|1|||
16397893|NCT03198767|39938585|FG000|Overall Study|Protocol Violation|0|||
16397894|NCT03198767|39938586|FG001|Overall Study|Protocol Violation|0|||
16397895|NCT03198767|39938587|FG002|Overall Study|Protocol Violation|0|||
16397896|NCT03198767|39938588|FG003|Overall Study|Protocol Violation|6|||
16397897|NCT03198767|39938589|FG004|Overall Study|Protocol Violation|0|||
16397898|NCT03198767|39938590|FG005|Overall Study|Protocol Violation|0|||
16397899|NCT03198767|39938591|FG006|Overall Study|Protocol Violation|0|||
16397900|NCT03275246|39938592|FG000|Overall Study|Protocol Violation|5|||
16397901|NCT03275246|39938592|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
16397902|NCT00040742|39938593|FG000|Overall Study|Death|0|||
16397903|NCT00040742|39938594|FG001|Overall Study|Death|0|||
16397904|NCT00040742|39938595|FG002|Overall Study|Death|1|||
16397905|NCT00040742|39938596|FG003|Overall Study|Death|0|||
16397906|NCT00040742|39938593|FG000|Overall Study|Adverse Event|15|||
16397907|NCT00040742|39938594|FG001|Overall Study|Adverse Event|16|||
16397908|NCT00040742|39938595|FG002|Overall Study|Adverse Event|21|||
16397909|NCT00040742|39938596|FG003|Overall Study|Adverse Event|9|||
16397910|NCT00040742|39938593|FG000|Overall Study|Withdrawal by Subject|7|||
16397911|NCT00040742|39938594|FG001|Overall Study|Withdrawal by Subject|15|||
16397912|NCT00040742|39938595|FG002|Overall Study|Withdrawal by Subject|10|||
16397913|NCT00040742|39938596|FG003|Overall Study|Withdrawal by Subject|13|||
16397914|NCT00040742|39938593|FG000|Overall Study|Chemotoxicity|4|||
16397915|NCT00040742|39938594|FG001|Overall Study|Chemotoxicity|3|||
16397916|NCT00040742|39938595|FG002|Overall Study|Chemotoxicity|5|||
16096645|NCT00731692|38842838|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
16096646|NCT00731692|38842839|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
16096647|NCT00731692|38842840|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
16096648|NCT00731692|38842838|FG000|Core Study (36 Months)|Adverse Event|25|||
16096649|NCT00731692|38842839|FG001|Core Study (36 Months)|Adverse Event|28|||
16096650|NCT00731692|38842840|FG002|Core Study (36 Months)|Adverse Event|29|||
16096651|NCT00731692|38842838|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
16524771|NCT01762761|40387807|FG000|Overall Study|Withdrawal by Subject|7|||
16524772|NCT01762761|40387808|FG001|Overall Study|Withdrawal by Subject|8|||
16524773|NCT01513317|40387810|FG000|Overall Study|Withdrawal by Subject|15|||
16524774|NCT01513317|40387811|FG001|Overall Study|Withdrawal by Subject|4|||
16524775|NCT01513317|40387810|FG000|Overall Study|Death|1|||
16524776|NCT01513317|40387811|FG001|Overall Study|Death|1|||
16524777|NCT01513317|40387810|FG000|Overall Study|Study terminated by sponsor|18|||
16524778|NCT01513317|40387811|FG001|Overall Study|Study terminated by sponsor|18|||
16524779|NCT01513317|40387810|FG000|Overall Study|Other|0|||
16524780|NCT01513317|40387811|FG001|Overall Study|Other|1|||
16524781|NCT01709227|40387815|FG000|Overall Study|Physician Decision|1|||
16524782|NCT01709227|40387816|FG001|Overall Study|Physician Decision|0|||
16524783|NCT01709227|40387815|FG000|Overall Study|Pleural Peritoneal communication|0|||
16524784|NCT01709227|40387816|FG001|Overall Study|Pleural Peritoneal communication|9|||
16524785|NCT00840970|40387817|FG000|Overall Study|Adverse Event|0|||
16524786|NCT00840970|40387818|FG001|Overall Study|Adverse Event|0|||
16524787|NCT00840970|40387819|FG002|Overall Study|Adverse Event|1|||
16524788|NCT01038921|40387823|FG000|Overall Study|Withdrawal by Subject|1|||
16524789|NCT01038921|40387824|FG001|Overall Study|Withdrawal by Subject|0|||
16524790|NCT01038921|40387823|FG000|Overall Study|Physician Decision|1|||
16524791|NCT01038921|40387824|FG001|Overall Study|Physician Decision|0|||
16524792|NCT01312909|40387825|FG000|Overall Study|Randomized but not treated|1|||
16524793|NCT01312909|40387826|FG001|Overall Study|Randomized but not treated|3|||
16524794|NCT01312909|40387827|FG002|Overall Study|Randomized but not treated|1|||
16524795|NCT01312909|40387825|FG000|Overall Study|Adverse Event|1|||
16524796|NCT01312909|40387826|FG001|Overall Study|Adverse Event|0|||
16524797|NCT01312909|40387827|FG002|Overall Study|Adverse Event|3|||
16524798|NCT01312909|40387825|FG000|Overall Study|Protocol Violation|2|||
16524799|NCT01312909|40387826|FG001|Overall Study|Protocol Violation|0|||
16524800|NCT01312909|40387827|FG002|Overall Study|Protocol Violation|2|||
16524801|NCT01312909|40387825|FG000|Overall Study|Other|9|||
16524802|NCT01312909|40387826|FG001|Overall Study|Other|6|||
16524803|NCT01312909|40387827|FG002|Overall Study|Other|11|||
16524804|NCT01312909|40387825|FG000|Overall Study|Withdrawal by Subject|8|||
16524805|NCT01312909|40387826|FG001|Overall Study|Withdrawal by Subject|10|||
16524806|NCT01312909|40387827|FG002|Overall Study|Withdrawal by Subject|7|||
16524807|NCT01312909|40387825|FG000|Overall Study|Lost to Follow-up|21|||
16524808|NCT01312909|40387826|FG001|Overall Study|Lost to Follow-up|17|||
16524809|NCT01312909|40387827|FG002|Overall Study|Lost to Follow-up|20|||
16524810|NCT01312909|40387825|FG000|Overall Study|Insufficient clinical response|0|||
16524811|NCT01312909|40387826|FG001|Overall Study|Insufficient clinical response|0|||
16524812|NCT01312909|40387827|FG002|Overall Study|Insufficient clinical response|1|||
16524813|NCT01312909|40387825|FG000|Overall Study|Entrance criteria not met|0|||
16524814|NCT01312909|40387826|FG001|Overall Study|Entrance criteria not met|0|||
16524815|NCT01312909|40387827|FG002|Overall Study|Entrance criteria not met|2|||
16524816|NCT00462384|40387828|FG000|Overall Study|Adverse Event|2|||
16524817|NCT00462384|40387828|FG000|Overall Study|Death|2|||
16524818|NCT00462384|40387828|FG000|Overall Study|Withdrawal by Subject|1|||
16524819|NCT00462384|40387828|FG000|Overall Study|Other|4|||
16524820|NCT01921348|40387829|FG000|Overall Study|Withdrawal by Subject|1|||
16524821|NCT01921348|40387830|FG001|Overall Study|Withdrawal by Subject|0|||
16524822|NCT01921348|40387829|FG000|Overall Study|Lost to Follow-up|0|||
16524823|NCT01921348|40387830|FG001|Overall Study|Lost to Follow-up|2|||
16524824|NCT01071395|40387836|FG000|Overall Study|Withdrawal by Subject|2|||
16524825|NCT01071395|40387837|FG001|Overall Study|Withdrawal by Subject|1|||
16524826|NCT01071395|40387836|FG000|Overall Study|Adverse Event|3|||
16096652|NCT00731692|38842839|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
16328730|NCT02520427|39687880|FG003|Overall Study|Death|0|||
16096653|NCT00731692|38842840|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
16328731|NCT02520427|39687881|FG004|Overall Study|Death|0|||
16328732|NCT02520427|39687882|FG005|Overall Study|Death|0|||
16328733|NCT02520427|39687883|FG006|Overall Study|Death|0|||
16328734|NCT02520427|39687884|FG007|Overall Study|Death|0|||
16328735|NCT02520427|39687885|FG008|Overall Study|Death|0|||
16328736|NCT02520427|39687886|FG009|Overall Study|Death|0|||
16397917|NCT00040742|39938596|FG003|Overall Study|Chemotoxicity|2|||
16524827|NCT01071395|40387837|FG001|Overall Study|Adverse Event|1|||
16524828|NCT01557946|40387839|FG000|Overall Study|Adverse Event|3|||
16524829|NCT01557946|40387840|FG001|Overall Study|Adverse Event|0|||
16524830|NCT01722331|40387841|FG000|Part 1|Adverse Event|5|||
16524831|NCT01722331|40387842|FG001|Part 1|Adverse Event|0|||
16524832|NCT01722331|40387843|FG002|Part 1|Adverse Event|0|||
16096654|NCT00731692|38842838|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
16328737|NCT02520427|39687887|FG010|Overall Study|Death|0|||
16328738|NCT02520427|39687888|FG011|Overall Study|Death|0|||
16524833|NCT01722331|40387844|FG003|Part 1|Adverse Event|0|||
16524834|NCT01722331|40387845|FG004|Part 1|Adverse Event|0|||
16524835|NCT01722331|40387846|FG005|Part 1|Adverse Event|0|||
16524836|NCT01722331|40387847|FG006|Part 1|Adverse Event|0|||
16524837|NCT01722331|40387841|FG000|Part 1|Lack of Efficacy|0|||
16328739|NCT02520427|39687889|FG012|Overall Study|Death|0|||
16328740|NCT02520427|39687890|FG013|Overall Study|Death|0|||
16328741|NCT02520427|39687891|FG014|Overall Study|Death|0|||
16328742|NCT02520427|39687892|FG015|Overall Study|Death|0|||
16328743|NCT02520427|39687893|FG016|Overall Study|Death|2|||
16328744|NCT02520427|39687894|FG017|Overall Study|Death|1|||
16328745|NCT02520427|39687895|FG018|Overall Study|Death|3|||
16328746|NCT02520427|39687896|FG019|Overall Study|Death|2|||
16328747|NCT02520427|39687897|FG020|Overall Study|Death|0|||
16328748|NCT02520427|39687898|FG021|Overall Study|Death|0|||
16328749|NCT02520427|39687899|FG022|Overall Study|Death|1|||
16328750|NCT02520427|39687900|FG023|Overall Study|Death|0|||
16328751|NCT02520427|39687901|FG024|Overall Study|Death|1|||
16328752|NCT02520427|39687902|FG025|Overall Study|Death|0|||
16328753|NCT05723328|39687903|FG000|Overall Study|Investigator's Decision|5|||
16328754|NCT05723328|39687904|FG001|Overall Study|Investigator's Decision|2|||
16328755|NCT00614120|39687905|FG000|Overall Study|Adverse Event|9|||
16328756|NCT00614120|39687906|FG001|Overall Study|Adverse Event|22|||
16328757|NCT00614120|39687907|FG002|Overall Study|Adverse Event|30|||
16328758|NCT00614120|39687908|FG003|Overall Study|Adverse Event|3|||
16328759|NCT00614120|39687905|FG000|Overall Study|Lack of Efficacy|3|||
16328760|NCT00614120|39687906|FG001|Overall Study|Lack of Efficacy|3|||
16328761|NCT00614120|39687907|FG002|Overall Study|Lack of Efficacy|2|||
16328762|NCT00614120|39687908|FG003|Overall Study|Lack of Efficacy|2|||
16328763|NCT00614120|39687905|FG000|Overall Study|Protocol Violation|2|||
16328764|NCT00614120|39687906|FG001|Overall Study|Protocol Violation|5|||
16328765|NCT00614120|39687907|FG002|Overall Study|Protocol Violation|3|||
16328766|NCT00614120|39687908|FG003|Overall Study|Protocol Violation|1|||
16328767|NCT00614120|39687905|FG000|Overall Study|Withdrawal criteria|1|||
16328768|NCT00614120|39687906|FG001|Overall Study|Withdrawal criteria|0|||
16328769|NCT00614120|39687907|FG002|Overall Study|Withdrawal criteria|0|||
16328770|NCT00614120|39687908|FG003|Overall Study|Withdrawal criteria|0|||
16328771|NCT00614120|39687905|FG000|Overall Study|Withdrawal by Subject|9|||
16328772|NCT00614120|39687906|FG001|Overall Study|Withdrawal by Subject|10|||
16328773|NCT00614120|39687907|FG002|Overall Study|Withdrawal by Subject|16|||
16328774|NCT00614120|39687908|FG003|Overall Study|Withdrawal by Subject|3|||
16328775|NCT00614120|39687905|FG000|Overall Study|Did not meet trial criteria|0|||
16210067|NCT02996500|39248159|FG002|Overall Study|Other|2|||
16210068|NCT02996500|39248160|FG003|Overall Study|Other|0|||
16210069|NCT02996500|39248161|FG004|Overall Study|Other|0|||
16210070|NCT02996500|39248162|FG005|Overall Study|Other|0|||
16210071|NCT02996500|39248157|FG000|Overall Study|Protocol Violation|0|||
16210072|NCT02996500|39248158|FG001|Overall Study|Protocol Violation|0|||
16210073|NCT02996500|39248159|FG002|Overall Study|Protocol Violation|0|||
16210074|NCT02996500|39248160|FG003|Overall Study|Protocol Violation|1|||
16210075|NCT02996500|39248161|FG004|Overall Study|Protocol Violation|0|||
16210076|NCT02996500|39248162|FG005|Overall Study|Protocol Violation|0|||
16210077|NCT02996500|39248157|FG000|Overall Study|Withdrawal by Subject|3|||
16210078|NCT02996500|39248158|FG001|Overall Study|Withdrawal by Subject|0|||
16210079|NCT02996500|39248159|FG002|Overall Study|Withdrawal by Subject|3|||
16210080|NCT02996500|39248160|FG003|Overall Study|Withdrawal by Subject|0|||
16210081|NCT02996500|39248161|FG004|Overall Study|Withdrawal by Subject|2|||
16210082|NCT02996500|39248162|FG005|Overall Study|Withdrawal by Subject|0|||
16210083|NCT01143714|39248163|FG000|Overall Study|Adverse Event|4|||
16210084|NCT01143714|39248164|FG001|Overall Study|Adverse Event|2|||
16210085|NCT01143714|39248163|FG000|Overall Study|Withdrawal by Subject|1|||
16210086|NCT01143714|39248164|FG001|Overall Study|Withdrawal by Subject|0|||
16210087|NCT01143714|39248163|FG000|Overall Study|Subject non-compliance|0|||
16210088|NCT01143714|39248164|FG001|Overall Study|Subject non-compliance|1|||
16210089|NCT01143714|39248163|FG000|Overall Study|wound closed = deemed healed|1|||
16210090|NCT01143714|39248164|FG001|Overall Study|wound closed = deemed healed|0|||
16210091|NCT01143714|39248163|FG000|Overall Study|wound size increased|1|||
16210092|NCT01143714|39248164|FG001|Overall Study|wound size increased|0|||
16210093|NCT00927758|39248171|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
16328776|NCT00614120|39687906|FG001|Overall Study|Did not meet trial criteria|1|||
16328777|NCT00614120|39687907|FG002|Overall Study|Did not meet trial criteria|1|||
16210094|NCT00927758|39248172|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
16328778|NCT00614120|39687908|FG003|Overall Study|Did not meet trial criteria|1|||
16328779|NCT00614120|39687905|FG000|Overall Study|hCG positive (not pregnant)|0|||
16328780|NCT00614120|39687906|FG001|Overall Study|hCG positive (not pregnant)|0|||
16328781|NCT00614120|39687907|FG002|Overall Study|hCG positive (not pregnant)|1|||
16328782|NCT00614120|39687908|FG003|Overall Study|hCG positive (not pregnant)|0|||
16328783|NCT00614120|39687905|FG000|Overall Study|Hypoglycaemia|0|||
16210095|NCT00927758|39248173|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
16210096|NCT00927758|39248174|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
16328784|NCT00614120|39687906|FG001|Overall Study|Hypoglycaemia|0|||
16328785|NCT00614120|39687907|FG002|Overall Study|Hypoglycaemia|0|||
16328786|NCT00614120|39687908|FG003|Overall Study|Hypoglycaemia|1|||
16328787|NCT00614120|39687905|FG000|Overall Study|Lack of trial product|3|||
16328788|NCT00614120|39687906|FG001|Overall Study|Lack of trial product|3|||
16328789|NCT00614120|39687907|FG002|Overall Study|Lack of trial product|2|||
16328790|NCT00614120|39687908|FG003|Overall Study|Lack of trial product|0|||
16328791|NCT00614120|39687905|FG000|Overall Study|Late syphilis, latent|1|||
16328792|NCT00614120|39687906|FG001|Overall Study|Late syphilis, latent|0|||
16328793|NCT00614120|39687907|FG002|Overall Study|Late syphilis, latent|0|||
16328794|NCT00614120|39687908|FG003|Overall Study|Late syphilis, latent|0|||
16328795|NCT00614120|39687905|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
16328796|NCT00614120|39687906|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
16328797|NCT00614120|39687907|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
16328798|NCT00614120|39687908|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
16328799|NCT00614120|39687905|FG000|Overall Study|Lost to Follow-up|1|||
16328800|NCT00614120|39687906|FG001|Overall Study|Lost to Follow-up|2|||
16328801|NCT00614120|39687907|FG002|Overall Study|Lost to Follow-up|3|||
16328802|NCT00614120|39687908|FG003|Overall Study|Lost to Follow-up|4|||
16328803|NCT02850016|39687909|FG000|Overall Study|Withdrawal by Subject|1|||
16328804|NCT02850016|39687910|FG001|Overall Study|Withdrawal by Subject|2|||
16328805|NCT01905553|39687913|FG000|Period 2|Adverse Event|1|||
16328806|NCT01905553|39687914|FG001|Period 2|Adverse Event|0|||
16328807|NCT01346189|39687915|FG000|Overall Study|Withdrawal by Subject|7|||
16328808|NCT01346189|39687916|FG001|Overall Study|Withdrawal by Subject|5|||
16328809|NCT01346189|39687917|FG002|Overall Study|Withdrawal by Subject|3|||
16328810|NCT01346189|39687918|FG003|Overall Study|Withdrawal by Subject|5|||
16328811|NCT01346189|39687915|FG000|Overall Study|Physician Decision|4|||
16328812|NCT01346189|39687916|FG001|Overall Study|Physician Decision|0|||
16328813|NCT01346189|39687917|FG002|Overall Study|Physician Decision|0|||
16328814|NCT01346189|39687918|FG003|Overall Study|Physician Decision|0|||
16328815|NCT01346189|39687915|FG000|Overall Study|Moved|3|||
16328816|NCT01346189|39687916|FG001|Overall Study|Moved|0|||
16328817|NCT01346189|39687917|FG002|Overall Study|Moved|4|||
16328818|NCT01346189|39687918|FG003|Overall Study|Moved|0|||
16328819|NCT01346189|39687915|FG000|Overall Study|Other|2|||
16328820|NCT01346189|39687916|FG001|Overall Study|Other|4|||
16328821|NCT01346189|39687917|FG002|Overall Study|Other|7|||
16328822|NCT01346189|39687918|FG003|Overall Study|Other|3|||
16328823|NCT01346189|39687915|FG000|Overall Study|Death|0|||
16328824|NCT01346189|39687916|FG001|Overall Study|Death|3|||
16328825|NCT01346189|39687917|FG002|Overall Study|Death|0|||
16328826|NCT01346189|39687918|FG003|Overall Study|Death|0|||
16328827|NCT01346189|39687915|FG000|Overall Study|Non-health system primary care physician|0|||
16328828|NCT01346189|39687916|FG001|Overall Study|Non-health system primary care physician|5|||
16328829|NCT01346189|39687917|FG002|Overall Study|Non-health system primary care physician|0|||
16328830|NCT01346189|39687918|FG003|Overall Study|Non-health system primary care physician|0|||
16328831|NCT01346189|39687915|FG000|Overall Study|Travel|0|||
16328832|NCT01346189|39687916|FG001|Overall Study|Travel|0|||
16328833|NCT01346189|39687917|FG002|Overall Study|Travel|0|||
16328834|NCT01346189|39687918|FG003|Overall Study|Travel|3|||
16328835|NCT02637895|39687920|FG000|Overall Study|Lost to Follow-up|4|||
16328836|NCT02637895|39687921|FG001|Overall Study|Lost to Follow-up|0|||
16328837|NCT02637895|39687920|FG000|Overall Study|Protocol Violation|0|||
16328838|NCT02637895|39687921|FG001|Overall Study|Protocol Violation|1|||
16328839|NCT02637895|39687920|FG000|Overall Study|Lack of Efficacy|1|||
16328840|NCT02637895|39687921|FG001|Overall Study|Lack of Efficacy|0|||
16328841|NCT02637895|39687920|FG000|Overall Study|Withdrawal by Subject|1|||
16328842|NCT02637895|39687921|FG001|Overall Study|Withdrawal by Subject|1|||
16328843|NCT02637895|39687920|FG000|Overall Study|Abnormal baseline lab|0|||
16328844|NCT02637895|39687921|FG001|Overall Study|Abnormal baseline lab|1|||
16328845|NCT00970632|39687922|FG000|Overall Study|Adverse Event|2|||
16328846|NCT00970632|39687923|FG001|Overall Study|Adverse Event|2|||
16328847|NCT00970632|39687924|FG002|Overall Study|Adverse Event|1|||
16328848|NCT00970632|39687922|FG000|Overall Study|Lack of Efficacy|3|||
16328849|NCT00970632|39687923|FG001|Overall Study|Lack of Efficacy|0|||
16328850|NCT00970632|39687924|FG002|Overall Study|Lack of Efficacy|0|||
16328851|NCT00970632|39687922|FG000|Overall Study|Lost to Follow-up|3|||
16328852|NCT00970632|39687923|FG001|Overall Study|Lost to Follow-up|0|||
16328853|NCT00970632|39687924|FG002|Overall Study|Lost to Follow-up|2|||
16328854|NCT00970632|39687922|FG000|Overall Study|Protocol Violation|8|||
16328855|NCT00970632|39687923|FG001|Overall Study|Protocol Violation|5|||
16328856|NCT00970632|39687924|FG002|Overall Study|Protocol Violation|8|||
16328857|NCT00970632|39687922|FG000|Overall Study|Withdrawal by Subject|7|||
16328858|NCT00970632|39687923|FG001|Overall Study|Withdrawal by Subject|6|||
16397918|NCT00040742|39938593|FG000|Overall Study|Incomplete Forms|6|||
16397919|NCT00040742|39938594|FG001|Overall Study|Incomplete Forms|10|||
16328859|NCT00970632|39687924|FG002|Overall Study|Withdrawal by Subject|4|||
16328860|NCT00970632|39687922|FG000|Overall Study|Entry criteria not met|0|||
16328861|NCT00970632|39687923|FG001|Overall Study|Entry criteria not met|2|||
16328862|NCT00970632|39687924|FG002|Overall Study|Entry criteria not met|2|||
16328863|NCT00970632|39687922|FG000|Overall Study|Sponsor decision|1|||
16328864|NCT00970632|39687923|FG001|Overall Study|Sponsor decision|0|||
16328865|NCT00970632|39687924|FG002|Overall Study|Sponsor decision|1|||
16328866|NCT01083186|39687925|FG000|Overall Study|Lost to Follow-up|48|||
16328867|NCT01083186|39687925|FG000|Overall Study|Consent Withdrawal|7|||
16328868|NCT01083186|39687925|FG000|Overall Study|Death|3|||
16328869|NCT01083186|39687925|FG000|Overall Study|Adverse Event|3|||
16328870|NCT01083186|39687925|FG000|Overall Study|Lack of Efficacy|2|||
16328871|NCT01083186|39687925|FG000|Overall Study|Hemodialysis Initiation|28|||
16328872|NCT01083186|39687925|FG000|Overall Study|Administrative Reasons|2|||
16328873|NCT01083186|39687925|FG000|Overall Study|Non-compliance to Study Treatment|1|||
16096655|NCT00731692|38842839|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
16096656|NCT00731692|38842840|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
16096657|NCT00731692|38842838|FG000|Extension Phase|Abnormal test procedure|0|||
16096658|NCT00731692|38842839|FG001|Extension Phase|Abnormal test procedure|0|||
16096659|NCT00731692|38842840|FG002|Extension Phase|Abnormal test procedure|1|||
16096660|NCT00731692|38842838|FG000|Extension Phase|Abnormal lab values|0|||
16096661|NCT00731692|38842839|FG001|Extension Phase|Abnormal lab values|0|||
16096662|NCT00731692|38842840|FG002|Extension Phase|Abnormal lab values|1|||
16096663|NCT00731692|38842838|FG000|Extension Phase|Lost to Follow-up|0|||
16096664|NCT00731692|38842839|FG001|Extension Phase|Lost to Follow-up|1|||
16096665|NCT00731692|38842840|FG002|Extension Phase|Lost to Follow-up|4|||
16096666|NCT00731692|38842838|FG000|Extension Phase|Withdrawal by Subject|4|||
16096667|NCT00731692|38842839|FG001|Extension Phase|Withdrawal by Subject|5|||
16096668|NCT00731692|38842840|FG002|Extension Phase|Withdrawal by Subject|3|||
16096669|NCT00731692|38842838|FG000|Extension Phase|Adverse Event|1|||
16096670|NCT00731692|38842839|FG001|Extension Phase|Adverse Event|1|||
16328874|NCT00567489|39687938|FG000|Overall Study|Adverse Event|6|||
16328875|NCT00567489|39687939|FG001|Overall Study|Adverse Event|14|||
16328876|NCT00567489|39687938|FG000|Overall Study|Physician Decision|0|||
16328877|NCT00567489|39687939|FG001|Overall Study|Physician Decision|4|||
16328878|NCT00567489|39687938|FG000|Overall Study|Withdrawal by Subject|0|||
16328879|NCT00567489|39687939|FG001|Overall Study|Withdrawal by Subject|2|||
16328880|NCT00567489|39687938|FG000|Overall Study|Renal Transplantation|0|||
16328881|NCT00567489|39687939|FG001|Overall Study|Renal Transplantation|3|||
16328882|NCT00567489|39687938|FG000|Overall Study|Other|1|||
16328883|NCT00567489|39687939|FG001|Overall Study|Other|0|||
16328884|NCT01190267|39687940|FG000|Overall Study|Adverse Event|10|||
16328885|NCT01190267|39687941|FG001|Overall Study|Adverse Event|0|||
16328886|NCT01190267|39687940|FG000|Overall Study|Treatment Failure|8|||
16328887|NCT01190267|39687941|FG001|Overall Study|Treatment Failure|2|||
16328888|NCT01190267|39687940|FG000|Overall Study|Lost to Follow-up|2|||
16328889|NCT01190267|39687941|FG001|Overall Study|Lost to Follow-up|0|||
16328890|NCT01190267|39687940|FG000|Overall Study|Withdrawal by Subject|13|||
16328891|NCT01190267|39687941|FG001|Overall Study|Withdrawal by Subject|1|||
16328892|NCT01190267|39687940|FG000|Overall Study|Protocol Violation|8|||
16328893|NCT01190267|39687941|FG001|Overall Study|Protocol Violation|1|||
16328894|NCT00791661|39687942|FG000|7 Day Wash-out|Adverse Event|0|||
16328895|NCT00791661|39687943|FG001|7 Day Wash-out|Adverse Event|0|||
16328896|NCT00791661|39687944|FG002|7 Day Wash-out|Adverse Event|1|||
16328897|NCT00791661|39687942|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
16328898|NCT00791661|39687943|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
16328899|NCT00791661|39687944|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
16328900|NCT02680834|39692346|FG000|Overall Study|Physician Decision|5|||
16328901|NCT02680834|39692347|FG001|Overall Study|Physician Decision|2|||
16328902|NCT02680834|39692346|FG000|Overall Study|Withdrawal by Subject|6|||
16328903|NCT02680834|39692347|FG001|Overall Study|Withdrawal by Subject|0|||
16328904|NCT02680834|39692346|FG000|Overall Study|Lost to Follow-up|0|||
16328905|NCT02680834|39692347|FG001|Overall Study|Lost to Follow-up|1|||
16328906|NCT00976209|39692348|FG000|Treatment Period 1|Protocol Violation|1|||
16328907|NCT00976209|39692349|FG001|Treatment Period 1|Protocol Violation|0|||
16328908|NCT00976209|39692348|FG000|Treatment Period 1|Lost to Follow-up|2|||
16328909|NCT00976209|39692349|FG001|Treatment Period 1|Lost to Follow-up|0|||
16328910|NCT00976209|39692348|FG000|Treatment Period 1|Other|0|||
16328911|NCT00976209|39692349|FG001|Treatment Period 1|Other|1|||
16397920|NCT00040742|39938595|FG002|Overall Study|Incomplete Forms|4|||
16096671|NCT00731692|38842840|FG002|Extension Phase|Adverse Event|15|||
16096672|NCT03018288|38842841|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
16328912|NCT00976209|39692348|FG000|Wash-out Period|Adverse Event|1|||
16328913|NCT00976209|39692349|FG001|Wash-out Period|Adverse Event|2|||
16328914|NCT00976209|39692348|FG000|Wash-out Period|Lost to Follow-up|1|||
16328915|NCT00976209|39692349|FG001|Wash-out Period|Lost to Follow-up|0|||
16328916|NCT00976209|39692348|FG000|Wash-out Period|Protocol Violation|1|||
16328917|NCT00976209|39692349|FG001|Wash-out Period|Protocol Violation|0|||
16328918|NCT00976209|39692348|FG000|Wash-out Period|Other|1|||
16096673|NCT03018288|38842842|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
16328919|NCT00976209|39692349|FG001|Wash-out Period|Other|0|||
16328920|NCT00976209|39692348|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16328921|NCT00976209|39692349|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16328922|NCT00976209|39692348|FG000|Treatment Period 2|Lost to Follow-up|0|||
16328923|NCT00976209|39692349|FG001|Treatment Period 2|Lost to Follow-up|1|||
16328924|NCT02203851|39692352|FG000|Overall Study|Lost to Follow-up|4|||
16328925|NCT02203851|39692352|FG000|Overall Study|Withdrawal by Subject|6|||
16328926|NCT02203851|39692352|FG000|Overall Study|Other|1|||
16328927|NCT00878969|39692354|FG000|Overall Study|Physician Decision|5|||
16328928|NCT00878969|39692355|FG001|Overall Study|Physician Decision|3|||
16328929|NCT00878969|39692356|FG002|Overall Study|Physician Decision|2|||
16328930|NCT00878969|39692354|FG000|Overall Study|Withdrawal by Subject|1|||
16328931|NCT00878969|39692355|FG001|Overall Study|Withdrawal by Subject|6|||
16328932|NCT00878969|39692356|FG002|Overall Study|Withdrawal by Subject|3|||
16328933|NCT00878969|39692354|FG000|Overall Study|kidney transplant|2|||
16328934|NCT00878969|39692355|FG001|Overall Study|kidney transplant|3|||
16328935|NCT00878969|39692356|FG002|Overall Study|kidney transplant|2|||
16328936|NCT00878969|39692354|FG000|Overall Study|Adverse Event|3|||
16328937|NCT00878969|39692355|FG001|Overall Study|Adverse Event|1|||
16328938|NCT00878969|39692356|FG002|Overall Study|Adverse Event|2|||
16328939|NCT00878969|39692354|FG000|Overall Study|Lost to Follow-up|2|||
16328940|NCT00878969|39692355|FG001|Overall Study|Lost to Follow-up|1|||
16328941|NCT00878969|39692356|FG002|Overall Study|Lost to Follow-up|0|||
16328942|NCT00878969|39692354|FG000|Overall Study|Protocol Violation|2|||
16328943|NCT00878969|39692355|FG001|Overall Study|Protocol Violation|0|||
16328944|NCT00878969|39692356|FG002|Overall Study|Protocol Violation|0|||
16328945|NCT00878969|39692354|FG000|Overall Study|Death|0|||
16328946|NCT00878969|39692355|FG001|Overall Study|Death|0|||
16328947|NCT00878969|39692356|FG002|Overall Study|Death|2|||
16328948|NCT00878969|39692354|FG000|Overall Study|Pregnancy|0|||
16328949|NCT00878969|39692355|FG001|Overall Study|Pregnancy|1|||
16328950|NCT00878969|39692356|FG002|Overall Study|Pregnancy|0|||
16328951|NCT03409107|39692357|FG000|Overall Study|Withdrawal by Subject|4|||
16328952|NCT03409107|39692358|FG001|Overall Study|Withdrawal by Subject|2|||
16328953|NCT03409107|39692357|FG000|Overall Study|Physician Decision|1|||
16328954|NCT03409107|39692358|FG001|Overall Study|Physician Decision|0|||
16328955|NCT03409107|39692357|FG000|Overall Study|Lost to Follow-up|7|||
16328956|NCT03409107|39692358|FG001|Overall Study|Lost to Follow-up|2|||
16328957|NCT03409107|39692357|FG000|Overall Study|Adverse Event|5|||
16210097|NCT00927758|39248175|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
16210098|NCT00927758|39248176|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
16210099|NCT00927758|39248171|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
16210100|NCT00927758|39248172|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
16210101|NCT00927758|39248173|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
16210102|NCT00927758|39248174|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
16210103|NCT00927758|39248175|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
16328958|NCT03409107|39692358|FG001|Overall Study|Adverse Event|3|||
16328959|NCT01471340|39692359|FG000|Overall Study|Death|5|||
16328960|NCT01471340|39692360|FG001|Overall Study|Death|4|||
16328961|NCT01471340|39692359|FG000|Overall Study|Lost to Follow-up|0|||
16328962|NCT01471340|39692360|FG001|Overall Study|Lost to Follow-up|1|||
16524838|NCT01722331|40387842|FG001|Part 1|Lack of Efficacy|0|||
16210104|NCT00927758|39248176|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
16210105|NCT01201967|39248177|FG000|Overall Study|Lost to Follow-up|6|||
16210106|NCT01201967|39248178|FG001|Overall Study|Lost to Follow-up|5|||
16210107|NCT01843205|39248179|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
16210108|NCT01843205|39248180|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
16210109|NCT05166603|39248181|FG000|Overall Study|Withdrawal by Subject|68|||
16210110|NCT05166603|39248182|FG001|Overall Study|Withdrawal by Subject|0|||
16210111|NCT03037307|39248187|FG000|Period 1|Did Not Meet Study Criteria|0|||
16210112|NCT03037307|39248188|FG001|Period 1|Did Not Meet Study Criteria|0|||
16210113|NCT03037307|39248189|FG002|Period 1|Did Not Meet Study Criteria|0|||
16210114|NCT03037307|39248190|FG003|Period 1|Did Not Meet Study Criteria|1|||
16210115|NCT03037307|39248191|FG004|Period 1|Did Not Meet Study Criteria|0|||
16210116|NCT03037307|39248192|FG005|Period 1|Did Not Meet Study Criteria|0|||
16210117|NCT01119963|39248195|FG000|Overall Study|Lost to Follow-up|1|||
16210118|NCT01119963|39248196|FG001|Overall Study|Lost to Follow-up|1|||
16210119|NCT03807778|39248203|FG000|Overall Study|Adverse Event|0|||
16210120|NCT03807778|39248204|FG001|Overall Study|Adverse Event|0|||
16524839|NCT01722331|40387843|FG002|Part 1|Lack of Efficacy|1|||
16328963|NCT01471340|39692359|FG000|Overall Study|Investigational site closure|0|||
16328964|NCT01471340|39692360|FG001|Overall Study|Investigational site closure|1|||
16328965|NCT01471340|39692359|FG000|Overall Study|Invalid informed consent|1|||
16328966|NCT01471340|39692360|FG001|Overall Study|Invalid informed consent|0|||
16328967|NCT03769675|39692369|FG000|Overall Study|Lost to Follow-up|1|||
16328968|NCT00977574|39692370|FG000|Overall Study|Never Treated|4|||
16328969|NCT00977574|39692371|FG001|Overall Study|Never Treated|2|||
16328970|NCT00977574|39692372|FG002|Overall Study|Never Treated|4|||
16397921|NCT00040742|39938596|FG003|Overall Study|Incomplete Forms|5|||
16397922|NCT00040742|39938593|FG000|Overall Study|Other medical|7|||
16397923|NCT00040742|39938594|FG001|Overall Study|Other medical|5|||
16524840|NCT01722331|40387844|FG003|Part 1|Lack of Efficacy|0|||
16210121|NCT03807778|39248205|FG002|Overall Study|Adverse Event|3|||
16210122|NCT03807778|39248206|FG003|Overall Study|Adverse Event|5|||
16210123|NCT03807778|39248203|FG000|Overall Study|Progressive Disease|4|||
16210124|NCT03807778|39248204|FG001|Overall Study|Progressive Disease|2|||
16210125|NCT03807778|39248205|FG002|Overall Study|Progressive Disease|8|||
16210126|NCT03807778|39248206|FG003|Overall Study|Progressive Disease|15|||
16210127|NCT03807778|39248203|FG000|Overall Study|Symptomatic Deterioration|0|||
16210128|NCT03807778|39248204|FG001|Overall Study|Symptomatic Deterioration|1|||
16210129|NCT03807778|39248205|FG002|Overall Study|Symptomatic Deterioration|0|||
16210130|NCT03807778|39248206|FG003|Overall Study|Symptomatic Deterioration|1|||
16210131|NCT03807778|39248203|FG000|Overall Study|Withdrawal by Subject|0|||
16210132|NCT03807778|39248204|FG001|Overall Study|Withdrawal by Subject|1|||
16210133|NCT03807778|39248205|FG002|Overall Study|Withdrawal by Subject|0|||
16210134|NCT03807778|39248206|FG003|Overall Study|Withdrawal by Subject|1|||
16210135|NCT03807778|39248203|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
16210136|NCT03807778|39248204|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
16210137|NCT03807778|39248205|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
16210138|NCT03807778|39248206|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
16210139|NCT01997281|39248207|FG000|Overall Study|Withdrawal by Subject|1|||
16210140|NCT01997281|39248208|FG001|Overall Study|Withdrawal by Subject|0|||
16210141|NCT00515099|39248209|FG000|Overall Study|Lost to Follow-up|0|||
16210142|NCT00515099|39248210|FG001|Overall Study|Lost to Follow-up|4|||
16210143|NCT00515099|39248209|FG000|Overall Study|Withdrawal by Subject|2|||
16210144|NCT00515099|39248210|FG001|Overall Study|Withdrawal by Subject|0|||
16096674|NCT03018288|38842843|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
16096675|NCT03018288|38842844|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
16210145|NCT00515099|39248209|FG000|Overall Study|IRB Recommendation|1|||
16210146|NCT00515099|39248210|FG001|Overall Study|IRB Recommendation|0|||
16210147|NCT03235726|39248218|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
16210148|NCT03235726|39248219|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
16210149|NCT03235726|39248220|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
16210150|NCT03235726|39248221|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
16210151|NCT03235726|39248222|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
16210152|NCT03235726|39248223|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
16210153|NCT03235726|39248224|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
16210154|NCT03235726|39248225|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
16210155|NCT03235726|39248226|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
16210156|NCT03235726|39248227|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
16210157|NCT03235726|39248218|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
16210158|NCT03235726|39248219|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
16210159|NCT03235726|39248220|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
16210160|NCT03235726|39248221|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
16210161|NCT03235726|39248222|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
16210162|NCT03235726|39248223|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
16210163|NCT03235726|39248224|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
16210164|NCT03235726|39248225|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
16210165|NCT03235726|39248226|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
16210166|NCT03235726|39248227|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
16210167|NCT04058158|39248228|FG000|Period 1|Death|1|||
16210168|NCT04058158|39248229|FG001|Period 1|Death|0|||
16210169|NCT04058158|39248228|FG000|Period 1|Adverse Event|1|||
16210170|NCT04058158|39248229|FG001|Period 1|Adverse Event|1|||
16096676|NCT03018288|38842841|FG000|Overall Study|Participant withdrew consent.|0|||
16096677|NCT03018288|38842842|FG001|Overall Study|Participant withdrew consent.|0|||
16096678|NCT03018288|38842843|FG002|Overall Study|Participant withdrew consent.|1|||
16096679|NCT03018288|38842844|FG003|Overall Study|Participant withdrew consent.|0|||
16096680|NCT03018288|38842841|FG000|Overall Study|Switched to alternative treatment.|0|||
16096681|NCT03018288|38842842|FG001|Overall Study|Switched to alternative treatment.|0|||
16096682|NCT03018288|38842843|FG002|Overall Study|Switched to alternative treatment.|1|||
16096683|NCT03018288|38842844|FG003|Overall Study|Switched to alternative treatment.|0|||
16096684|NCT03018288|38842841|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
16096685|NCT03018288|38842842|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
16096686|NCT03018288|38842843|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
16096687|NCT03018288|38842844|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
16096688|NCT03018288|38842841|FG000|Overall Study|Screen failures|0|||
16096689|NCT03018288|38842842|FG001|Overall Study|Screen failures|0|||
16096690|NCT03018288|38842843|FG002|Overall Study|Screen failures|0|||
16096691|NCT03018288|38842844|FG003|Overall Study|Screen failures|51|||
16096692|NCT03018288|38842841|FG000|Overall Study|Chose treatment outside of UNC|0|||
16210171|NCT04058158|39248228|FG000|Period 1|Pregnancy|0|||
16210172|NCT04058158|39248229|FG001|Period 1|Pregnancy|1|||
16210173|NCT04134728|39248231|FG000|Overall Study|Adverse Event|3|||
16210174|NCT04134728|39248232|FG001|Overall Study|Adverse Event|2|||
16210175|NCT04134728|39248233|FG002|Overall Study|Adverse Event|9|||
16210176|NCT04134728|39248234|FG003|Overall Study|Adverse Event|0|||
16210177|NCT04134728|39248235|FG004|Overall Study|Adverse Event|0|||
16210178|NCT04134728|39248236|FG005|Overall Study|Adverse Event|0|||
16210179|NCT04134728|39248231|FG000|Overall Study|Lack of Efficacy|3|||
16210180|NCT04134728|39248232|FG001|Overall Study|Lack of Efficacy|3|||
16210181|NCT04134728|39248233|FG002|Overall Study|Lack of Efficacy|1|||
16210182|NCT04134728|39248234|FG003|Overall Study|Lack of Efficacy|2|||
16210183|NCT04134728|39248235|FG004|Overall Study|Lack of Efficacy|0|||
16210184|NCT04134728|39248236|FG005|Overall Study|Lack of Efficacy|0|||
16210185|NCT04134728|39248231|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
16210186|NCT04134728|39248232|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
16210187|NCT04134728|39248233|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
16210188|NCT04134728|39248234|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
16210189|NCT04134728|39248235|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
16397924|NCT00040742|39938595|FG002|Overall Study|Other medical|5|||
16210190|NCT04134728|39248236|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
16210191|NCT04134728|39248231|FG000|Overall Study|Protocol Deviation|0|||
16210192|NCT04134728|39248232|FG001|Overall Study|Protocol Deviation|0|||
16210193|NCT04134728|39248233|FG002|Overall Study|Protocol Deviation|1|||
16210194|NCT04134728|39248234|FG003|Overall Study|Protocol Deviation|0|||
16210195|NCT04134728|39248235|FG004|Overall Study|Protocol Deviation|0|||
16210196|NCT04134728|39248236|FG005|Overall Study|Protocol Deviation|0|||
16210197|NCT04134728|39248231|FG000|Overall Study|Informed Consent Withdrawn|3|||
16210198|NCT04134728|39248232|FG001|Overall Study|Informed Consent Withdrawn|6|||
16210199|NCT04134728|39248233|FG002|Overall Study|Informed Consent Withdrawn|8|||
16210200|NCT04134728|39248234|FG003|Overall Study|Informed Consent Withdrawn|1|||
16210201|NCT04134728|39248235|FG004|Overall Study|Informed Consent Withdrawn|1|||
16210202|NCT04134728|39248236|FG005|Overall Study|Informed Consent Withdrawn|0|||
16210203|NCT04134728|39248231|FG000|Overall Study|Physician Decision|2|||
16210204|NCT04134728|39248232|FG001|Overall Study|Physician Decision|0|||
16210205|NCT04134728|39248233|FG002|Overall Study|Physician Decision|0|||
16210206|NCT04134728|39248234|FG003|Overall Study|Physician Decision|0|||
16210207|NCT04134728|39248235|FG004|Overall Study|Physician Decision|0|||
16210208|NCT04134728|39248236|FG005|Overall Study|Physician Decision|0|||
16210209|NCT04134728|39248231|FG000|Overall Study|Lost to Follow-up|1|||
16210210|NCT04134728|39248232|FG001|Overall Study|Lost to Follow-up|2|||
16210211|NCT04134728|39248233|FG002|Overall Study|Lost to Follow-up|1|||
16210212|NCT04134728|39248234|FG003|Overall Study|Lost to Follow-up|0|||
16210213|NCT04134728|39248235|FG004|Overall Study|Lost to Follow-up|0|||
16210214|NCT04134728|39248236|FG005|Overall Study|Lost to Follow-up|1|||
16210215|NCT04134728|39248231|FG000|Overall Study|Investigator Site Closed|0|||
16397925|NCT00040742|39938596|FG003|Overall Study|Other medical|5|||
16210216|NCT04134728|39248232|FG001|Overall Study|Investigator Site Closed|1|||
16210217|NCT04134728|39248233|FG002|Overall Study|Investigator Site Closed|1|||
16210218|NCT04134728|39248234|FG003|Overall Study|Investigator Site Closed|0|||
16210219|NCT04134728|39248235|FG004|Overall Study|Investigator Site Closed|0|||
16210220|NCT04134728|39248236|FG005|Overall Study|Investigator Site Closed|0|||
16210221|NCT02023268|39248238|FG000|Overall Study|Lack of Efficacy|0|||
16210222|NCT02023268|39248239|FG001|Overall Study|Lack of Efficacy|1|||
16210223|NCT02023268|39248238|FG000|Overall Study|Adverse Event|0|||
16210224|NCT02023268|39248239|FG001|Overall Study|Adverse Event|2|||
16210225|NCT02023268|39248238|FG000|Overall Study|Withdrawal by Subject|0|||
16210226|NCT02023268|39248239|FG001|Overall Study|Withdrawal by Subject|1|||
16210227|NCT00968708|39248242|FG000|Overall Study|Adverse Event|169|||
16210228|NCT00968708|39248243|FG001|Overall Study|Adverse Event|150|||
16210229|NCT00968708|39248242|FG000|Overall Study|Major Protocol Deviation|0|||
16210230|NCT00968708|39248243|FG001|Overall Study|Major Protocol Deviation|1|||
16210231|NCT00968708|39248242|FG000|Overall Study|Lost to Follow-up|19|||
16210232|NCT00968708|39248243|FG001|Overall Study|Lost to Follow-up|11|||
16210233|NCT00968708|39248242|FG000|Overall Study|Voluntary Withdrawal|104|||
16210234|NCT00968708|39248243|FG001|Overall Study|Voluntary Withdrawal|101|||
16210235|NCT00968708|39248242|FG000|Overall Study|Investigator Discretion|0|||
16210236|NCT00968708|39248243|FG001|Overall Study|Investigator Discretion|1|||
16210237|NCT00968708|39248242|FG000|Overall Study|Other|26|||
16210238|NCT00968708|39248243|FG001|Overall Study|Other|34|||
16210239|NCT02244619|39251248|FG000|Overall Study|Did not receive study intervention|8|||
16210240|NCT02244619|39251249|FG001|Overall Study|Did not receive study intervention|21|||
16210241|NCT00520299|39251250|FG000|Overall Study|Withdrawal by Subject|0|||
16210242|NCT00520299|39251251|FG001|Overall Study|Withdrawal by Subject|0|||
16210243|NCT00520299|39251252|FG002|Overall Study|Withdrawal by Subject|2|||
16210244|NCT00520299|39251250|FG000|Overall Study|Progressive disease|0|||
16210245|NCT00520299|39251251|FG001|Overall Study|Progressive disease|3|||
16210246|NCT00520299|39251252|FG002|Overall Study|Progressive disease|4|||
16210247|NCT03379376|39251253|FG000|Overall Study|Lost to Follow-up|2|||
16210248|NCT03379376|39251253|FG000|Overall Study|Did not wish to complete follow up|1|||
16210249|NCT03379376|39251253|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
16397926|NCT01709110|39938599|FG000|Overall Study|Adverse Event|56|||
16397927|NCT01709110|39938600|FG001|Overall Study|Adverse Event|48|||
16397928|NCT01709110|39938599|FG000|Overall Study|Death|14|||
16397929|NCT01709110|39938600|FG001|Overall Study|Death|6|||
16397930|NCT01709110|39938599|FG000|Overall Study|Lost to Follow-up|7|||
16397931|NCT01709110|39938600|FG001|Overall Study|Lost to Follow-up|5|||
16397932|NCT01709110|39938599|FG000|Overall Study|Protocol Violation|4|||
16397933|NCT01709110|39938600|FG001|Overall Study|Protocol Violation|6|||
16397934|NCT01709110|39938599|FG000|Overall Study|Withdrawal by Subject|96|||
16397935|NCT01709110|39938600|FG001|Overall Study|Withdrawal by Subject|89|||
16397936|NCT01709110|39938599|FG000|Overall Study|Physician Decision|4|||
16397937|NCT01709110|39938600|FG001|Overall Study|Physician Decision|10|||
16397938|NCT01709110|39938599|FG000|Overall Study|Sponsor Decision|2|||
16397939|NCT01709110|39938600|FG001|Overall Study|Sponsor Decision|2|||
16397940|NCT01709110|39938599|FG000|Overall Study|Lack of Efficacy|1|||
16397941|NCT01709110|39938600|FG001|Overall Study|Lack of Efficacy|1|||
16397942|NCT01709110|39938599|FG000|Overall Study|Caregiver Decision|1|||
16397943|NCT01709110|39938600|FG001|Overall Study|Caregiver Decision|1|||
16397944|NCT01732510|39938601|FG000|Overall Study|Adverse Event|0|||
16397945|NCT01732510|39938602|FG001|Overall Study|Adverse Event|1|||
16397946|NCT01732510|39938603|FG002|Overall Study|Adverse Event|1|||
16397947|NCT01732510|39938604|FG003|Overall Study|Adverse Event|0|||
16397948|NCT01732510|39938605|FG004|Overall Study|Adverse Event|0|||
16397949|NCT01732510|39938606|FG005|Overall Study|Adverse Event|0|||
16397950|NCT01732510|39938607|FG006|Overall Study|Adverse Event|1|||
16397951|NCT01732510|39938601|FG000|Overall Study|Protocol Violation|0|||
16397952|NCT01732510|39938602|FG001|Overall Study|Protocol Violation|0|||
16397953|NCT01732510|39938603|FG002|Overall Study|Protocol Violation|0|||
16397954|NCT01732510|39938604|FG003|Overall Study|Protocol Violation|1|||
16397955|NCT01732510|39938605|FG004|Overall Study|Protocol Violation|0|||
16210250|NCT03379376|39251253|FG000|Overall Study|Death|1|||
16210251|NCT00322387|39251254|FG000|Treatment Period|Adverse Event|0|||
16210252|NCT00322387|39251255|FG001|Treatment Period|Adverse Event|1|||
16210253|NCT00322387|39251254|FG000|Follow-up Period|Final assessment not done|1|||
16210254|NCT00322387|39251255|FG001|Follow-up Period|Final assessment not done|3|||
16210255|NCT00322387|39251254|FG000|Follow-up Period|Death|1|||
16210256|NCT00322387|39251255|FG001|Follow-up Period|Death|0|||
16210257|NCT02723019|39251257|FG000|Overall Study|Death|17|||
16210258|NCT02723019|39251258|FG001|Overall Study|Death|13|||
16210259|NCT02723019|39251257|FG000|Overall Study|Withdrawal by Subject|11|||
16210260|NCT02723019|39251258|FG001|Overall Study|Withdrawal by Subject|7|||
16210261|NCT02723019|39251257|FG000|Overall Study|Lost to Follow-up|57|||
16210262|NCT02723019|39251258|FG001|Overall Study|Lost to Follow-up|70|||
16397956|NCT01732510|39938606|FG005|Overall Study|Protocol Violation|0|||
16397957|NCT01732510|39938607|FG006|Overall Study|Protocol Violation|0|||
16397958|NCT01732510|39938601|FG000|Overall Study|Withdrawal by Subject|1|||
16397959|NCT01732510|39938602|FG001|Overall Study|Withdrawal by Subject|3|||
16397960|NCT01732510|39938603|FG002|Overall Study|Withdrawal by Subject|2|||
16397961|NCT01732510|39938604|FG003|Overall Study|Withdrawal by Subject|1|||
16397962|NCT01732510|39938605|FG004|Overall Study|Withdrawal by Subject|5|||
16397963|NCT01732510|39938606|FG005|Overall Study|Withdrawal by Subject|0|||
16397964|NCT01732510|39938607|FG006|Overall Study|Withdrawal by Subject|1|||
16397965|NCT01732510|39938601|FG000|Overall Study|Lost to Follow-up|0|||
16397966|NCT01732510|39938602|FG001|Overall Study|Lost to Follow-up|0|||
16397967|NCT01732510|39938603|FG002|Overall Study|Lost to Follow-up|1|||
16524841|NCT01722331|40387845|FG004|Part 1|Lack of Efficacy|2|||
16524842|NCT01722331|40387846|FG005|Part 1|Lack of Efficacy|0|||
16096693|NCT03018288|38842842|FG001|Overall Study|Chose treatment outside of UNC|0|||
16096694|NCT03018288|38842843|FG002|Overall Study|Chose treatment outside of UNC|0|||
16096695|NCT03018288|38842844|FG003|Overall Study|Chose treatment outside of UNC|1|||
16096696|NCT03018288|38842841|FG000|Overall Study|Unable to comply with protocol requirements|1|||
16096697|NCT03018288|38842842|FG001|Overall Study|Unable to comply with protocol requirements|1|||
16096698|NCT03018288|38842843|FG002|Overall Study|Unable to comply with protocol requirements|0|||
16096699|NCT03018288|38842844|FG003|Overall Study|Unable to comply with protocol requirements|1|||
16096700|NCT03018288|38842841|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
16096701|NCT03018288|38842842|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
16210263|NCT01902173|39251260|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
16210264|NCT01902173|39251261|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
16397968|NCT01732510|39938604|FG003|Overall Study|Lost to Follow-up|1|||
16397969|NCT01732510|39938605|FG004|Overall Study|Lost to Follow-up|0|||
16397970|NCT01732510|39938606|FG005|Overall Study|Lost to Follow-up|1|||
16397971|NCT01732510|39938607|FG006|Overall Study|Lost to Follow-up|0|||
16397972|NCT01732510|39938601|FG000|Overall Study|Physician Decision|0|||
16397973|NCT01732510|39938602|FG001|Overall Study|Physician Decision|1|||
16524843|NCT01722331|40387847|FG006|Part 1|Lack of Efficacy|0|||
16524844|NCT01722331|40387841|FG000|Part 1|Lost to Follow-up|1|||
16524845|NCT01722331|40387842|FG001|Part 1|Lost to Follow-up|0|||
16524846|NCT01722331|40387843|FG002|Part 1|Lost to Follow-up|2|||
16524847|NCT01722331|40387844|FG003|Part 1|Lost to Follow-up|0|||
16524848|NCT01722331|40387845|FG004|Part 1|Lost to Follow-up|1|||
16524849|NCT01722331|40387846|FG005|Part 1|Lost to Follow-up|0|||
16524850|NCT01722331|40387847|FG006|Part 1|Lost to Follow-up|0|||
16524851|NCT01722331|40387841|FG000|Part 1|Physician Decision|0|||
16524852|NCT01722331|40387842|FG001|Part 1|Physician Decision|0|||
16524853|NCT01722331|40387843|FG002|Part 1|Physician Decision|3|||
16524854|NCT01722331|40387844|FG003|Part 1|Physician Decision|0|||
16524855|NCT01722331|40387845|FG004|Part 1|Physician Decision|1|||
16524856|NCT01722331|40387846|FG005|Part 1|Physician Decision|0|||
16524857|NCT01722331|40387847|FG006|Part 1|Physician Decision|0|||
16524858|NCT01722331|40387841|FG000|Part 1|Pregnancy|1|||
16524859|NCT01722331|40387842|FG001|Part 1|Pregnancy|0|||
16524860|NCT01722331|40387843|FG002|Part 1|Pregnancy|0|||
16524861|NCT01722331|40387844|FG003|Part 1|Pregnancy|0|||
16524862|NCT01722331|40387845|FG004|Part 1|Pregnancy|0|||
16524863|NCT01722331|40387846|FG005|Part 1|Pregnancy|0|||
16524864|NCT01722331|40387847|FG006|Part 1|Pregnancy|0|||
16524865|NCT01722331|40387841|FG000|Part 1|Progressive Disease|0|||
16524866|NCT01722331|40387842|FG001|Part 1|Progressive Disease|0|||
16524867|NCT01722331|40387843|FG002|Part 1|Progressive Disease|0|||
16524868|NCT01722331|40387844|FG003|Part 1|Progressive Disease|0|||
16524869|NCT01722331|40387845|FG004|Part 1|Progressive Disease|1|||
16524870|NCT01722331|40387846|FG005|Part 1|Progressive Disease|0|||
16524871|NCT01722331|40387847|FG006|Part 1|Progressive Disease|0|||
16524872|NCT01722331|40387841|FG000|Part 1|Protocol Violation|1|||
16524873|NCT01722331|40387842|FG001|Part 1|Protocol Violation|0|||
16524874|NCT01722331|40387843|FG002|Part 1|Protocol Violation|0|||
16524875|NCT01722331|40387844|FG003|Part 1|Protocol Violation|0|||
16524876|NCT01722331|40387845|FG004|Part 1|Protocol Violation|1|||
16524877|NCT01722331|40387846|FG005|Part 1|Protocol Violation|0|||
16524878|NCT01722331|40387847|FG006|Part 1|Protocol Violation|0|||
16524879|NCT01722331|40387841|FG000|Part 1|Withdrawal by Subject|2|||
16524880|NCT01722331|40387842|FG001|Part 1|Withdrawal by Subject|0|||
16524881|NCT01722331|40387843|FG002|Part 1|Withdrawal by Subject|3|||
16524882|NCT01722331|40387844|FG003|Part 1|Withdrawal by Subject|0|||
16524883|NCT01722331|40387845|FG004|Part 1|Withdrawal by Subject|3|||
16524884|NCT01722331|40387846|FG005|Part 1|Withdrawal by Subject|0|||
16524885|NCT01722331|40387847|FG006|Part 1|Withdrawal by Subject|0|||
16524886|NCT01722331|40387841|FG000|Part 2|Adverse Event|3|||
16524887|NCT01722331|40387842|FG001|Part 2|Adverse Event|0|||
16524888|NCT01722331|40387843|FG002|Part 2|Adverse Event|0|||
16524889|NCT01722331|40387844|FG003|Part 2|Adverse Event|0|||
16524890|NCT01722331|40387845|FG004|Part 2|Adverse Event|0|||
16524891|NCT01722331|40387846|FG005|Part 2|Adverse Event|1|||
16524892|NCT01722331|40387847|FG006|Part 2|Adverse Event|0|||
16524893|NCT01722331|40387841|FG000|Part 2|Lack of Efficacy|3|||
16524894|NCT01722331|40387842|FG001|Part 2|Lack of Efficacy|0|||
16524895|NCT01722331|40387843|FG002|Part 2|Lack of Efficacy|11|||
16524896|NCT01722331|40387844|FG003|Part 2|Lack of Efficacy|0|||
16524897|NCT01722331|40387845|FG004|Part 2|Lack of Efficacy|0|||
16524898|NCT01722331|40387846|FG005|Part 2|Lack of Efficacy|3|||
16524899|NCT01722331|40387847|FG006|Part 2|Lack of Efficacy|3|||
16524900|NCT01722331|40387841|FG000|Part 2|Lost to Follow-up|0|||
16524901|NCT01722331|40387842|FG001|Part 2|Lost to Follow-up|0|||
16524902|NCT01722331|40387843|FG002|Part 2|Lost to Follow-up|3|||
16524903|NCT01722331|40387844|FG003|Part 2|Lost to Follow-up|0|||
16524904|NCT01722331|40387845|FG004|Part 2|Lost to Follow-up|0|||
16524905|NCT01722331|40387846|FG005|Part 2|Lost to Follow-up|1|||
16524906|NCT01722331|40387847|FG006|Part 2|Lost to Follow-up|1|||
16524907|NCT01722331|40387841|FG000|Part 2|Non-Compliance with Study Drug|1|||
16524908|NCT01722331|40387842|FG001|Part 2|Non-Compliance with Study Drug|0|||
16524909|NCT01722331|40387843|FG002|Part 2|Non-Compliance with Study Drug|1|||
16524910|NCT01722331|40387844|FG003|Part 2|Non-Compliance with Study Drug|0|||
16524911|NCT01722331|40387845|FG004|Part 2|Non-Compliance with Study Drug|0|||
16524912|NCT01722331|40387846|FG005|Part 2|Non-Compliance with Study Drug|0|||
16524913|NCT01722331|40387847|FG006|Part 2|Non-Compliance with Study Drug|0|||
16524914|NCT01722331|40387841|FG000|Part 2|Physician Decision|0|||
16524915|NCT01722331|40387842|FG001|Part 2|Physician Decision|0|||
16524916|NCT01722331|40387843|FG002|Part 2|Physician Decision|2|||
16524917|NCT01722331|40387844|FG003|Part 2|Physician Decision|0|||
16524918|NCT01722331|40387845|FG004|Part 2|Physician Decision|0|||
16524919|NCT01722331|40387846|FG005|Part 2|Physician Decision|0|||
16524920|NCT01722331|40387847|FG006|Part 2|Physician Decision|0|||
16524921|NCT01722331|40387841|FG000|Part 2|Pregnancy|0|||
16524922|NCT01722331|40387842|FG001|Part 2|Pregnancy|0|||
16524923|NCT01722331|40387843|FG002|Part 2|Pregnancy|0|||
16524924|NCT01722331|40387844|FG003|Part 2|Pregnancy|0|||
16524925|NCT01722331|40387845|FG004|Part 2|Pregnancy|0|||
16524926|NCT01722331|40387846|FG005|Part 2|Pregnancy|1|||
16524927|NCT01722331|40387847|FG006|Part 2|Pregnancy|0|||
16524928|NCT01722331|40387841|FG000|Part 2|Progressive Disease|0|||
16524929|NCT01722331|40387842|FG001|Part 2|Progressive Disease|0|||
16524930|NCT01722331|40387843|FG002|Part 2|Progressive Disease|1|||
16397974|NCT01732510|39938603|FG002|Overall Study|Physician Decision|0|||
16397975|NCT01732510|39938604|FG003|Overall Study|Physician Decision|0|||
16397976|NCT01732510|39938605|FG004|Overall Study|Physician Decision|0|||
16397977|NCT01732510|39938606|FG005|Overall Study|Physician Decision|0|||
16397978|NCT01732510|39938607|FG006|Overall Study|Physician Decision|0|||
16397979|NCT01732510|39938601|FG000|Overall Study|Pregnancy|0|||
16397980|NCT01732510|39938602|FG001|Overall Study|Pregnancy|0|||
16397981|NCT01732510|39938603|FG002|Overall Study|Pregnancy|0|||
16397982|NCT01732510|39938604|FG003|Overall Study|Pregnancy|1|||
16397983|NCT01732510|39938605|FG004|Overall Study|Pregnancy|0|||
16397984|NCT01732510|39938606|FG005|Overall Study|Pregnancy|0|||
16397985|NCT01732510|39938607|FG006|Overall Study|Pregnancy|0|||
16397986|NCT01732510|39938601|FG000|Overall Study|Study Terminated By Sponsor|0|||
16397987|NCT01732510|39938602|FG001|Overall Study|Study Terminated By Sponsor|0|||
16397988|NCT01732510|39938603|FG002|Overall Study|Study Terminated By Sponsor|0|||
16397989|NCT01732510|39938604|FG003|Overall Study|Study Terminated By Sponsor|1|||
16397990|NCT01732510|39938605|FG004|Overall Study|Study Terminated By Sponsor|0|||
16397991|NCT01732510|39938606|FG005|Overall Study|Study Terminated By Sponsor|12|||
16397992|NCT01732510|39938607|FG006|Overall Study|Study Terminated By Sponsor|6|||
16397993|NCT01014767|39938608|FG000|Overall Study|PI left institution, data unavailable|12|||
16397994|NCT01014767|39938609|FG001|Overall Study|PI left institution, data unavailable|1|||
16397995|NCT01014767|39938610|FG002|Overall Study|PI left institution, data unavailable|4|||
16397996|NCT01014767|39938611|FG003|Overall Study|PI left institution, data unavailable|1|||
16397997|NCT00615719|39938612|FG000|Overall Study|Physician Decision|5|||
16397998|NCT00610857|39938613|FG000|Overall Study|Not evaluable for response|2|||
16397999|NCT01703091|39938614|FG000|Overall Study|Adverse Event|5|||
16398000|NCT01703091|39938615|FG001|Overall Study|Adverse Event|3|||
16096702|NCT03018288|38842843|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
16096703|NCT03018288|38842844|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
16096704|NCT03018288|38842841|FG000|Overall Study|Physician Decision|0|||
16096705|NCT03018288|38842842|FG001|Overall Study|Physician Decision|0|||
16096706|NCT03018288|38842843|FG002|Overall Study|Physician Decision|0|||
16096707|NCT03018288|38842844|FG003|Overall Study|Physician Decision|1|||
16398001|NCT01703091|39938614|FG000|Overall Study|Physician Decision|2|||
16398002|NCT01703091|39938615|FG001|Overall Study|Physician Decision|1|||
16398003|NCT01703091|39938614|FG000|Overall Study|Withdrawal by Subject|1|||
16398004|NCT01703091|39938615|FG001|Overall Study|Withdrawal by Subject|0|||
16210265|NCT01902173|39251262|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
16398005|NCT01703091|39938614|FG000|Overall Study|Sponsor Decision|1|||
16398006|NCT01703091|39938615|FG001|Overall Study|Sponsor Decision|0|||
16398007|NCT00412958|39938616|FG000|Overall Study|Withdrawal by Subject|3|||
16398008|NCT00412958|39938617|FG001|Overall Study|Withdrawal by Subject|0|||
16398009|NCT00412958|39938618|FG002|Overall Study|Withdrawal by Subject|0|||
16398010|NCT00412958|39938619|FG003|Overall Study|Withdrawal by Subject|1|||
16398011|NCT00412958|39938616|FG000|Overall Study|Adverse Event|0|||
16398012|NCT00412958|39938617|FG001|Overall Study|Adverse Event|1|||
16398013|NCT00412958|39938618|FG002|Overall Study|Adverse Event|0|||
16398014|NCT00412958|39938619|FG003|Overall Study|Adverse Event|0|||
16398015|NCT00412958|39938616|FG000|Overall Study|Lost to Follow-up|0|||
16398016|NCT00412958|39938617|FG001|Overall Study|Lost to Follow-up|1|||
16398017|NCT00412958|39938618|FG002|Overall Study|Lost to Follow-up|0|||
16398018|NCT00412958|39938619|FG003|Overall Study|Lost to Follow-up|0|||
16398019|NCT00412958|39938616|FG000|Overall Study|Death|0|||
16398020|NCT00412958|39938617|FG001|Overall Study|Death|1|||
16398021|NCT00412958|39938618|FG002|Overall Study|Death|0|||
16398022|NCT00412958|39938619|FG003|Overall Study|Death|0|||
16398023|NCT00412958|39938616|FG000|Overall Study|Transport issue|0|||
16398024|NCT00412958|39938617|FG001|Overall Study|Transport issue|1|||
16398025|NCT00412958|39938618|FG002|Overall Study|Transport issue|0|||
16398026|NCT00412958|39938619|FG003|Overall Study|Transport issue|0|||
16398027|NCT03028415|39938623|FG000|Overall Study|Lost to Follow-up|6|||
16524931|NCT01722331|40387844|FG003|Part 2|Progressive Disease|0|||
16524932|NCT01722331|40387845|FG004|Part 2|Progressive Disease|0|||
16524933|NCT01722331|40387846|FG005|Part 2|Progressive Disease|0|||
16096708|NCT02350127|38842845|FG000|4-Month Assessment|Withdrawal by Subject|10|||
16524934|NCT01722331|40387847|FG006|Part 2|Progressive Disease|0|||
16096709|NCT02350127|38842846|FG001|4-Month Assessment|Withdrawal by Subject|9|||
16210266|NCT01902173|39251263|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
16524935|NCT01722331|40387841|FG000|Part 2|Protocol Violation|1|||
16524936|NCT01722331|40387842|FG001|Part 2|Protocol Violation|0|||
16096710|NCT02350127|38842845|FG000|4-Month Assessment|Death|1|||
16398028|NCT03028415|39938624|FG001|Overall Study|Lost to Follow-up|3|||
16524937|NCT01722331|40387843|FG002|Part 2|Protocol Violation|0|||
16398029|NCT03028415|39938623|FG000|Overall Study|Withdrawal by Subject|1|||
16398030|NCT03028415|39938624|FG001|Overall Study|Withdrawal by Subject|0|||
16398031|NCT03028415|39938623|FG000|Overall Study|Discontinued due to COVID-19|1|||
16398032|NCT03028415|39938624|FG001|Overall Study|Discontinued due to COVID-19|0|||
16398033|NCT00161616|39938625|FG000|Overall Study|Withdrawal by Subject|6|||
16398034|NCT00161616|39938626|FG001|Overall Study|Withdrawal by Subject|5|||
16398035|NCT00161616|39938625|FG000|Overall Study|Physician Decision|1|||
16398036|NCT00161616|39938626|FG001|Overall Study|Physician Decision|0|||
16398037|NCT00161616|39938625|FG000|Overall Study|Death|1|||
16398038|NCT00161616|39938626|FG001|Overall Study|Death|1|||
16398039|NCT00161616|39938625|FG000|Overall Study|Lost to Follow-up|17|||
16398040|NCT00161616|39938626|FG001|Overall Study|Lost to Follow-up|13|||
16398041|NCT00161616|39938625|FG000|Overall Study|Protocol deviation|1|||
16398042|NCT00161616|39938626|FG001|Overall Study|Protocol deviation|0|||
16398043|NCT03530995|39938627|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
16398044|NCT03530995|39938628|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
16096711|NCT02350127|38842846|FG001|4-Month Assessment|Death|0|||
16096712|NCT02350127|38842845|FG000|8-Month Assessment|Death|1|||
16096713|NCT02350127|38842846|FG001|8-Month Assessment|Death|1|||
16096714|NCT02350127|38842845|FG000|8-Month Assessment|Withdrawal by Subject|5|||
16096715|NCT02350127|38842846|FG001|8-Month Assessment|Withdrawal by Subject|8|||
16096716|NCT04543942|38842847|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
16096717|NCT04543942|38842848|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
16096718|NCT04543942|38842847|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
16096719|NCT04543942|38842848|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
16096720|NCT02854436|38842850|FG000|Overall Study|Adverse Event|1|||
16096721|NCT02854436|38842850|FG000|Overall Study|Death|208|||
16096722|NCT02854436|38842850|FG000|Overall Study|Lost to Follow-up|5|||
16096723|NCT02854436|38842850|FG000|Overall Study|Withdrawal by Subject|24|||
16096724|NCT02854436|38842850|FG000|Overall Study|Other|45|||
16096725|NCT02854436|38842850|FG000|Overall Study|Physician Decision|6|||
16096726|NCT02525744|38842851|FG000|Period 1|Physician Decision|0|||
16096727|NCT02525744|38842852|FG001|Period 1|Physician Decision|0|||
16096728|NCT02525744|38842853|FG002|Period 1|Physician Decision|1|||
16096729|NCT02525744|38842854|FG003|Period 1|Physician Decision|0|||
16096730|NCT02525744|38842851|FG000|Period 3|Adverse Event|0|||
16096731|NCT02525744|38842852|FG001|Period 3|Adverse Event|1|||
16096732|NCT02525744|38842853|FG002|Period 3|Adverse Event|0|||
16096733|NCT02525744|38842854|FG003|Period 3|Adverse Event|0|||
16096734|NCT02525744|38842851|FG000|Period 4|Withdrawal by Subject|1|||
16096735|NCT02525744|38842852|FG001|Period 4|Withdrawal by Subject|0|||
16096736|NCT02525744|38842853|FG002|Period 4|Withdrawal by Subject|0|||
16398045|NCT03530995|39938627|FG000|Part 1 Period 3|Protocol Violation|1|||
16398046|NCT03530995|39938628|FG001|Part 1 Period 3|Protocol Violation|0|||
16398047|NCT03530995|39938627|FG000|Part 1 Period 4|Physician Decision|1|||
16398048|NCT03530995|39938628|FG001|Part 1 Period 4|Physician Decision|0|||
16398049|NCT03530995|39938627|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
16398050|NCT03530995|39938628|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
16398051|NCT00809835|39938629|FG000|Overall Study|Lost to Follow-up|7|||
16398052|NCT00809835|39938630|FG001|Overall Study|Lost to Follow-up|6|||
16398053|NCT00809835|39938631|FG002|Overall Study|Lost to Follow-up|10|||
16398054|NCT00809835|39938632|FG003|Overall Study|Lost to Follow-up|2|||
16398055|NCT00809835|39938629|FG000|Overall Study|Withdrawal by Subject|1|||
16398056|NCT00809835|39938630|FG001|Overall Study|Withdrawal by Subject|1|||
16524938|NCT01722331|40387844|FG003|Part 2|Protocol Violation|0|||
16524939|NCT01722331|40387845|FG004|Part 2|Protocol Violation|0|||
16524940|NCT01722331|40387846|FG005|Part 2|Protocol Violation|0|||
16524941|NCT01722331|40387847|FG006|Part 2|Protocol Violation|0|||
16524942|NCT01722331|40387841|FG000|Part 2|Withdrawal by Subject|5|||
16524943|NCT01722331|40387842|FG001|Part 2|Withdrawal by Subject|0|||
16096737|NCT02525744|38842854|FG003|Period 4|Withdrawal by Subject|0|||
16096738|NCT02525744|38842851|FG000|Period 5|Physician Decision|1|||
16398057|NCT00809835|39938631|FG002|Overall Study|Withdrawal by Subject|1|||
16398058|NCT00809835|39938632|FG003|Overall Study|Withdrawal by Subject|0|||
16398059|NCT00070109|39938633|FG000|Overall Study|Death|1|||
16398060|NCT00070109|39938634|FG001|Overall Study|Death|1|||
16398061|NCT00070109|39938635|FG002|Overall Study|Death|0|||
16398062|NCT00070109|39938636|FG003|Overall Study|Death|0|||
16398063|NCT00070109|39938637|FG004|Overall Study|Death|1|||
16096739|NCT02525744|38842852|FG001|Period 5|Physician Decision|0|||
16096740|NCT02525744|38842853|FG002|Period 5|Physician Decision|0|||
16096741|NCT02525744|38842854|FG003|Period 5|Physician Decision|0|||
16398064|NCT00070109|39938633|FG000|Overall Study|Lack of Efficacy|6|||
16398065|NCT00070109|39938634|FG001|Overall Study|Lack of Efficacy|4|||
16398066|NCT00070109|39938635|FG002|Overall Study|Lack of Efficacy|5|||
16398067|NCT00070109|39938636|FG003|Overall Study|Lack of Efficacy|15|||
16398068|NCT00070109|39938637|FG004|Overall Study|Lack of Efficacy|5|||
16398069|NCT00070109|39938633|FG000|Overall Study|Physician Decision|1|||
16398070|NCT00070109|39938634|FG001|Overall Study|Physician Decision|0|||
16398071|NCT00070109|39938635|FG002|Overall Study|Physician Decision|0|||
16096742|NCT01350102|38842855|FG000|Overall Study|Adverse Event|0|||
16096743|NCT01350102|38842856|FG001|Overall Study|Adverse Event|0|||
16096744|NCT01350102|38842857|FG002|Overall Study|Adverse Event|1|||
16096745|NCT01350102|38842858|FG003|Overall Study|Adverse Event|0|||
16398072|NCT00070109|39938636|FG003|Overall Study|Physician Decision|0|||
16524944|NCT01722331|40387843|FG002|Part 2|Withdrawal by Subject|3|||
16328971|NCT00189306|39692373|FG000|Treatment Period|Withdrawal by Subject|2|||
16328972|NCT00189306|39692373|FG000|Treatment Period|Adverse Event|2|||
16328973|NCT00189306|39692373|FG000|Treatment Period|Protocol Violation|1|||
16328974|NCT00189306|39692373|FG000|Posttreatment Period|Death|1|||
16328975|NCT00189306|39692373|FG000|Posttreatment Period|Withdrawal by Subject|2|||
16328976|NCT00189306|39692373|FG000|Posttreatment Period|Noncompliance|1|||
16328977|NCT00189306|39692373|FG000|Posttreatment Period|Target lesion excised|1|||
16328978|NCT00189306|39692373|FG000|Posttreatment Period|Protocol Violation|1|||
16328979|NCT00189306|39692373|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
16328980|NCT00189306|39692373|FG000|Posttreatment Period|Local skin reaction/sign|1|||
16328981|NCT00189306|39692373|FG000|Long-Term Follow-up|Adverse Event|2|||
16328982|NCT00189306|39692373|FG000|Long-Term Follow-up|Death|4|||
16328983|NCT00189306|39692373|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
16328984|NCT00189306|39692373|FG000|Long-Term Follow-up|Intercurrent disease|2|||
16328985|NCT00189306|39692373|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
16328986|NCT00189306|39692373|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
16328987|NCT00115037|39692374|FG000|Phase1|Lost to Follow-up|16|||
16328988|NCT00115037|39692375|FG001|Phase1|Lost to Follow-up|23|||
16524945|NCT01722331|40387844|FG003|Part 2|Withdrawal by Subject|0|||
16524946|NCT01722331|40387845|FG004|Part 2|Withdrawal by Subject|0|||
16328989|NCT00115037|39692376|FG002|Phase1|Lost to Follow-up|0|||
16328990|NCT00115037|39692377|FG003|Phase1|Lost to Follow-up|0|||
16328991|NCT00115037|39692378|FG004|Phase1|Lost to Follow-up|0|||
16328992|NCT00115037|39692379|FG005|Phase1|Lost to Follow-up|0|||
16328993|NCT00115037|39692374|FG000|Phase1|Withdrawal by Subject|9|||
16328994|NCT00115037|39692375|FG001|Phase1|Withdrawal by Subject|4|||
16328995|NCT00115037|39692376|FG002|Phase1|Withdrawal by Subject|0|||
16328996|NCT00115037|39692377|FG003|Phase1|Withdrawal by Subject|0|||
16328997|NCT00115037|39692378|FG004|Phase1|Withdrawal by Subject|0|||
16328998|NCT00115037|39692379|FG005|Phase1|Withdrawal by Subject|0|||
16328999|NCT00115037|39692374|FG000|Phase2|Death|0|||
16524947|NCT01722331|40387846|FG005|Part 2|Withdrawal by Subject|2|||
16524948|NCT01722331|40387847|FG006|Part 2|Withdrawal by Subject|2|||
16524949|NCT01722331|40387841|FG000|Part 2|Other Protocol Specified Criteria|6|||
16329000|NCT00115037|39692375|FG001|Phase2|Death|0|||
16329001|NCT00115037|39692376|FG002|Phase2|Death|1|||
16329002|NCT00115037|39692377|FG003|Phase2|Death|0|||
16524950|NCT01722331|40387842|FG001|Part 2|Other Protocol Specified Criteria|0|||
16524951|NCT01722331|40387843|FG002|Part 2|Other Protocol Specified Criteria|10|||
16524952|NCT01722331|40387844|FG003|Part 2|Other Protocol Specified Criteria|0|||
16524953|NCT01722331|40387845|FG004|Part 2|Other Protocol Specified Criteria|0|||
16524954|NCT01722331|40387846|FG005|Part 2|Other Protocol Specified Criteria|2|||
16524955|NCT01722331|40387847|FG006|Part 2|Other Protocol Specified Criteria|1|||
16524956|NCT01722331|40387841|FG000|Part 3|Adverse Event|2|||
16524957|NCT01722331|40387842|FG001|Part 3|Adverse Event|2|||
16524958|NCT01722331|40387843|FG002|Part 3|Adverse Event|0|||
16524959|NCT01722331|40387844|FG003|Part 3|Adverse Event|1|||
16524960|NCT01722331|40387845|FG004|Part 3|Adverse Event|0|||
16524961|NCT01722331|40387846|FG005|Part 3|Adverse Event|0|||
16524962|NCT01722331|40387847|FG006|Part 3|Adverse Event|0|||
16524963|NCT01722331|40387841|FG000|Part 3|Death|1|||
16524964|NCT01722331|40387842|FG001|Part 3|Death|0|||
16524965|NCT01722331|40387843|FG002|Part 3|Death|0|||
16524966|NCT01722331|40387844|FG003|Part 3|Death|0|||
16524967|NCT01722331|40387845|FG004|Part 3|Death|0|||
16524968|NCT01722331|40387846|FG005|Part 3|Death|0|||
16524969|NCT01722331|40387847|FG006|Part 3|Death|0|||
16524970|NCT01722331|40387841|FG000|Part 3|Lack of Efficacy|1|||
16524971|NCT01722331|40387842|FG001|Part 3|Lack of Efficacy|0|||
16524972|NCT01722331|40387843|FG002|Part 3|Lack of Efficacy|0|||
16524973|NCT01722331|40387844|FG003|Part 3|Lack of Efficacy|0|||
16524974|NCT01722331|40387845|FG004|Part 3|Lack of Efficacy|0|||
16524975|NCT01722331|40387846|FG005|Part 3|Lack of Efficacy|0|||
16524976|NCT01722331|40387847|FG006|Part 3|Lack of Efficacy|0|||
16524977|NCT01722331|40387841|FG000|Part 3|Lost to Follow-up|3|||
16524978|NCT01722331|40387842|FG001|Part 3|Lost to Follow-up|4|||
16329003|NCT00115037|39692378|FG004|Phase2|Death|0|||
16329004|NCT00115037|39692379|FG005|Phase2|Death|1|||
16329005|NCT00115037|39692374|FG000|Phase2|Withdrawal by Subject|0|||
16329006|NCT00115037|39692375|FG001|Phase2|Withdrawal by Subject|0|||
16329007|NCT00115037|39692376|FG002|Phase2|Withdrawal by Subject|2|||
16524979|NCT01722331|40387843|FG002|Part 3|Lost to Follow-up|0|||
16524980|NCT01722331|40387844|FG003|Part 3|Lost to Follow-up|0|||
16524981|NCT01722331|40387845|FG004|Part 3|Lost to Follow-up|0|||
16524982|NCT01722331|40387846|FG005|Part 3|Lost to Follow-up|1|||
16329008|NCT00115037|39692377|FG003|Phase2|Withdrawal by Subject|1|||
16329009|NCT00115037|39692378|FG004|Phase2|Withdrawal by Subject|2|||
16329010|NCT00115037|39692379|FG005|Phase2|Withdrawal by Subject|1|||
16329011|NCT00115037|39692374|FG000|Phase2|Lost to Follow-up|0|||
16329012|NCT00115037|39692375|FG001|Phase2|Lost to Follow-up|0|||
16329013|NCT00115037|39692376|FG002|Phase2|Lost to Follow-up|12|||
16524983|NCT01722331|40387847|FG006|Part 3|Lost to Follow-up|0|||
16524984|NCT01722331|40387841|FG000|Part 3|Non-Compliance with Study Drug|0|||
16524985|NCT01722331|40387842|FG001|Part 3|Non-Compliance with Study Drug|1|||
16329014|NCT00115037|39692377|FG003|Phase2|Lost to Follow-up|14|||
16329015|NCT00115037|39692378|FG004|Phase2|Lost to Follow-up|4|||
16329016|NCT00115037|39692379|FG005|Phase2|Lost to Follow-up|10|||
16329017|NCT00090584|39692380|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
16329018|NCT00090584|39692381|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
16329019|NCT00090584|39692380|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
16329020|NCT00090584|39692381|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
16329021|NCT02653170|39692382|FG000|Overall Study|Withdrawal by Subject|3|||
16329022|NCT02653170|39692383|FG001|Overall Study|Withdrawal by Subject|8|||
16329023|NCT02653170|39692384|FG002|Overall Study|Withdrawal by Subject|3|||
16329024|NCT02653170|39692382|FG000|Overall Study|withdrawn by study team|2|||
16329025|NCT02653170|39692383|FG001|Overall Study|withdrawn by study team|4|||
16329026|NCT02653170|39692384|FG002|Overall Study|withdrawn by study team|5|||
16329027|NCT02653170|39692382|FG000|Overall Study|Lost to Follow-up|12|||
16329028|NCT02653170|39692383|FG001|Overall Study|Lost to Follow-up|4|||
16329029|NCT02653170|39692384|FG002|Overall Study|Lost to Follow-up|10|||
16524986|NCT01722331|40387843|FG002|Part 3|Non-Compliance with Study Drug|0|||
16524987|NCT01722331|40387844|FG003|Part 3|Non-Compliance with Study Drug|0|||
16524988|NCT01722331|40387845|FG004|Part 3|Non-Compliance with Study Drug|0|||
16524989|NCT01722331|40387846|FG005|Part 3|Non-Compliance with Study Drug|0|||
16524990|NCT01722331|40387847|FG006|Part 3|Non-Compliance with Study Drug|0|||
16524991|NCT01722331|40387841|FG000|Part 3|Physician Decision|1|||
16524992|NCT01722331|40387842|FG001|Part 3|Physician Decision|1|||
16524993|NCT01722331|40387843|FG002|Part 3|Physician Decision|0|||
16524994|NCT01722331|40387844|FG003|Part 3|Physician Decision|0|||
16524995|NCT01722331|40387845|FG004|Part 3|Physician Decision|0|||
16524996|NCT01722331|40387846|FG005|Part 3|Physician Decision|0|||
16524997|NCT01722331|40387847|FG006|Part 3|Physician Decision|1|||
16329030|NCT01104246|39692385|FG000|Overall Study|Withdrawal by Subject|1|||
16329031|NCT01104246|39692385|FG000|Overall Study|did not meet inclusion criteria|4|||
16329032|NCT02603562|39692390|FG000|Overall Study|Lost to Follow-up|1|||
16329033|NCT03191864|39692395|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
16329034|NCT03191864|39692396|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
16329035|NCT03191864|39692397|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
16329036|NCT03191864|39692398|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
16329037|NCT03191864|39692399|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
16329038|NCT03191864|39692400|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
16329039|NCT03191864|39692395|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
16329040|NCT03191864|39692396|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
16329041|NCT03191864|39692397|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
16329042|NCT03191864|39692398|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
16329043|NCT03191864|39692399|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
16329044|NCT03191864|39692400|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
16329045|NCT03191864|39692395|FG000|Baseline Symptom Assessment|Adverse Event|0|||
16329046|NCT03191864|39692396|FG001|Baseline Symptom Assessment|Adverse Event|0|||
16329047|NCT03191864|39692397|FG002|Baseline Symptom Assessment|Adverse Event|0|||
16329048|NCT03191864|39692398|FG003|Baseline Symptom Assessment|Adverse Event|0|||
16329049|NCT03191864|39692399|FG004|Baseline Symptom Assessment|Adverse Event|0|||
16329050|NCT03191864|39692400|FG005|Baseline Symptom Assessment|Adverse Event|2|||
16329051|NCT03191864|39692395|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
16329052|NCT03191864|39692396|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
16329053|NCT03191864|39692397|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
16329054|NCT03191864|39692398|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
16329055|NCT03191864|39692399|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
16329056|NCT03191864|39692400|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
16329057|NCT03191864|39692395|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
16329058|NCT03191864|39692396|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
16329059|NCT03191864|39692397|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
16329060|NCT03191864|39692398|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
16329061|NCT03191864|39692399|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
16329062|NCT03191864|39692400|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
16524998|NCT01722331|40387841|FG000|Part 3|Protocol Violation|2|||
16524999|NCT01722331|40387842|FG001|Part 3|Protocol Violation|1|||
16096746|NCT03602391|38842859|FG000|Overall Study|COVID-19|7|||
16329063|NCT03191864|39692395|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
16329064|NCT03191864|39692396|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
16329065|NCT03191864|39692397|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
16329066|NCT03191864|39692398|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
16329067|NCT03191864|39692399|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
16398073|NCT00070109|39938637|FG004|Overall Study|Physician Decision|0|||
16525000|NCT01722331|40387843|FG002|Part 3|Protocol Violation|0|||
16525001|NCT01722331|40387844|FG003|Part 3|Protocol Violation|0|||
16329068|NCT03191864|39692400|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
16329069|NCT03191864|39692395|FG000|Part 1 - Induction|Adverse Event|0|||
16329070|NCT03191864|39692396|FG001|Part 1 - Induction|Adverse Event|2|||
16329071|NCT03191864|39692397|FG002|Part 1 - Induction|Adverse Event|0|||
16329072|NCT03191864|39692398|FG003|Part 1 - Induction|Adverse Event|1|||
16329073|NCT03191864|39692399|FG004|Part 1 - Induction|Adverse Event|0|||
16329074|NCT03191864|39692400|FG005|Part 1 - Induction|Adverse Event|2|||
16329075|NCT03191864|39692395|FG000|Part 1 - Induction|Randomized but never dosed|0|||
16329076|NCT03191864|39692396|FG001|Part 1 - Induction|Randomized but never dosed|0|||
16329077|NCT03191864|39692397|FG002|Part 1 - Induction|Randomized but never dosed|1|||
16329078|NCT03191864|39692398|FG003|Part 1 - Induction|Randomized but never dosed|0|||
16329079|NCT03191864|39692399|FG004|Part 1 - Induction|Randomized but never dosed|0|||
16329080|NCT03191864|39692400|FG005|Part 1 - Induction|Randomized but never dosed|0|||
16329081|NCT03191864|39692395|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
16329082|NCT03191864|39692396|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
16329083|NCT03191864|39692397|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
16329084|NCT03191864|39692398|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
16329085|NCT03191864|39692399|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
16329086|NCT03191864|39692400|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
16329087|NCT03191864|39692395|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
16525002|NCT01722331|40387845|FG004|Part 3|Protocol Violation|0|||
16525003|NCT01722331|40387846|FG005|Part 3|Protocol Violation|0|||
16525004|NCT01722331|40387847|FG006|Part 3|Protocol Violation|0|||
16525005|NCT01722331|40387841|FG000|Part 3|Withdrawal by Subject|4|||
16525006|NCT01722331|40387842|FG001|Part 3|Withdrawal by Subject|7|||
16525007|NCT01722331|40387843|FG002|Part 3|Withdrawal by Subject|0|||
16525008|NCT01722331|40387844|FG003|Part 3|Withdrawal by Subject|0|||
16525009|NCT01722331|40387845|FG004|Part 3|Withdrawal by Subject|0|||
16525010|NCT01722331|40387846|FG005|Part 3|Withdrawal by Subject|2|||
16525011|NCT01722331|40387847|FG006|Part 3|Withdrawal by Subject|1|||
16525012|NCT01722331|40387841|FG000|Part 3|Other Protocol Specified Criteria|1|||
16525013|NCT01722331|40387842|FG001|Part 3|Other Protocol Specified Criteria|1|||
16525014|NCT01722331|40387843|FG002|Part 3|Other Protocol Specified Criteria|0|||
16525015|NCT01722331|40387844|FG003|Part 3|Other Protocol Specified Criteria|0|||
16525016|NCT01722331|40387845|FG004|Part 3|Other Protocol Specified Criteria|0|||
16525017|NCT01722331|40387846|FG005|Part 3|Other Protocol Specified Criteria|0|||
16525018|NCT01722331|40387847|FG006|Part 3|Other Protocol Specified Criteria|0|||
16525019|NCT02613481|40387850|FG000|Overall Study|Lost to Follow-up|7|||
16525020|NCT02613481|40387850|FG000|Overall Study|Withdrawal by Subject|2|||
16525021|NCT01968434|40387851|FG000|Overall Study|Lost to Follow-up|3|||
16525022|NCT01968434|40387852|FG001|Overall Study|Lost to Follow-up|6|||
16525023|NCT00434057|40387853|FG000|Overall Study|Withdrawal by Subject|1|||
16525024|NCT04640311|40387856|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
16525025|NCT04640311|40387857|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525026|NCT04640311|40387858|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525027|NCT04640311|40387859|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525028|NCT04640311|40387860|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525029|NCT04640311|40387861|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525030|NCT04640311|40387862|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525031|NCT04640311|40387863|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525032|NCT04640311|40387864|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16096747|NCT03602391|38842860|FG001|Overall Study|COVID-19|6|||
16096748|NCT01345253|38842861|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
16525033|NCT04640311|40387865|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525034|NCT04640311|40387866|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525035|NCT04640311|40387867|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525036|NCT04640311|40387868|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525037|NCT04640311|40387856|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525038|NCT04640311|40387857|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
16525039|NCT04640311|40387858|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525040|NCT04640311|40387859|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525041|NCT04640311|40387860|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525042|NCT04640311|40387861|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525043|NCT04640311|40387862|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525044|NCT04640311|40387863|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16329088|NCT03191864|39692396|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
16329089|NCT03191864|39692397|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
16329090|NCT03191864|39692398|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
16329091|NCT03191864|39692399|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
16329092|NCT03191864|39692400|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
16346403|NCT01971567|39757131|FG000|Overall Study|Withdrawal by Subject|3|||
16398074|NCT00070109|39938633|FG000|Overall Study|Withdrawal by Subject|0|||
16398075|NCT00070109|39938634|FG001|Overall Study|Withdrawal by Subject|1|||
16398076|NCT00070109|39938635|FG002|Overall Study|Withdrawal by Subject|1|||
16398077|NCT00070109|39938636|FG003|Overall Study|Withdrawal by Subject|0|||
16398078|NCT00070109|39938637|FG004|Overall Study|Withdrawal by Subject|0|||
16398079|NCT00070109|39938633|FG000|Overall Study|Adverse Event|0|||
16398080|NCT00070109|39938634|FG001|Overall Study|Adverse Event|0|||
16398081|NCT00070109|39938635|FG002|Overall Study|Adverse Event|2|||
16398082|NCT00070109|39938636|FG003|Overall Study|Adverse Event|4|||
16398083|NCT00070109|39938637|FG004|Overall Study|Adverse Event|2|||
16398084|NCT00070109|39938633|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
16398085|NCT00070109|39938634|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
16398086|NCT00070109|39938635|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
16398087|NCT00070109|39938636|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
16398088|NCT00070109|39938637|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
16398089|NCT01202188|39938638|FG000|Overall Study|Protocol deviation|14|||
16398090|NCT01202188|39938639|FG001|Overall Study|Protocol deviation|8|||
16096749|NCT01345253|38842862|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
16096750|NCT01345253|38842861|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
16096751|NCT01345253|38842862|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
16096752|NCT01345253|38842861|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
16096753|NCT01345253|38842862|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
16096754|NCT01345253|38842861|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
16096755|NCT01345253|38842862|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
16096756|NCT01345253|38842861|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
16096757|NCT01345253|38842862|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
16398091|NCT01202188|39938640|FG002|Overall Study|Protocol deviation|12|||
16398092|NCT01202188|39938641|FG003|Overall Study|Protocol deviation|10|||
16398093|NCT01202188|39938642|FG004|Overall Study|Protocol deviation|11|||
16398094|NCT01202188|39938638|FG000|Overall Study|Subject withdrew consent|12|||
16525045|NCT04640311|40387864|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525046|NCT04640311|40387865|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525047|NCT04640311|40387866|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525048|NCT04640311|40387867|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525049|NCT04640311|40387868|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
16525050|NCT04640311|40387856|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525051|NCT04640311|40387857|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
16525052|NCT04640311|40387858|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525053|NCT04640311|40387859|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525054|NCT04640311|40387860|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525055|NCT04640311|40387861|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525056|NCT04640311|40387862|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525057|NCT04640311|40387863|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525058|NCT04640311|40387864|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525059|NCT04640311|40387865|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16546372|NCT01662063|40464798|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
16210267|NCT01902173|39251264|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
16210268|NCT01902173|39251265|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
16210269|NCT01902173|39251260|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
16210270|NCT01902173|39251261|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
16210271|NCT01902173|39251262|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
16210272|NCT01902173|39251263|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
16329093|NCT03191864|39692395|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
16329094|NCT03191864|39692396|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
16329095|NCT03191864|39692397|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
16329096|NCT03191864|39692398|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
16329097|NCT03191864|39692399|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
16329098|NCT03191864|39692400|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
16329099|NCT03191864|39692395|FG000|Part 2 - Maintenance|Physician Decision|1|||
16329100|NCT03191864|39692396|FG001|Part 2 - Maintenance|Physician Decision|0|||
16525060|NCT04640311|40387866|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525061|NCT04640311|40387867|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16210273|NCT01902173|39251264|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
16210274|NCT01902173|39251265|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
16210275|NCT01902173|39251260|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
16210276|NCT01902173|39251261|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
16210277|NCT01902173|39251262|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
16210278|NCT01902173|39251263|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
16210279|NCT01902173|39251264|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
16210280|NCT01902173|39251265|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
16210281|NCT01902173|39251260|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
16210282|NCT01902173|39251261|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
16210283|NCT01902173|39251262|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
16210284|NCT01902173|39251263|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
16210285|NCT01902173|39251264|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
16210286|NCT01902173|39251265|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
16210287|NCT01902173|39251260|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
16210288|NCT01902173|39251261|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
16210289|NCT01902173|39251262|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
16210290|NCT01902173|39251263|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
16210291|NCT01902173|39251264|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
16210292|NCT01902173|39251265|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
16210293|NCT01902173|39251260|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
16210294|NCT01902173|39251261|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
16210295|NCT01902173|39251262|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
16210296|NCT01902173|39251263|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
16210297|NCT01902173|39251264|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
16210298|NCT01902173|39251265|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
16210299|NCT01902173|39251260|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
16210300|NCT01902173|39251261|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
16210301|NCT01902173|39251262|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
16210302|NCT01902173|39251263|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
16210303|NCT01902173|39251264|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
16210304|NCT01902173|39251265|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
16525062|NCT04640311|40387868|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16210305|NCT01902173|39251260|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
16210306|NCT01902173|39251261|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
16210307|NCT01902173|39251262|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
16210308|NCT01902173|39251263|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
16210309|NCT01902173|39251264|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
16210310|NCT01902173|39251265|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
16525063|NCT04640311|40387856|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
16525064|NCT04640311|40387857|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
16525065|NCT04640311|40387858|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
16525066|NCT04640311|40387859|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525067|NCT04640311|40387860|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525068|NCT04640311|40387861|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16546373|NCT01662063|40464796|FG000|Overall Study|Lack of Efficacy|1|||
16329101|NCT03191864|39692397|FG002|Part 2 - Maintenance|Physician Decision|0|||
16329102|NCT03191864|39692398|FG003|Part 2 - Maintenance|Physician Decision|0|||
16525069|NCT04640311|40387862|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525070|NCT04640311|40387863|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525071|NCT04640311|40387864|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525072|NCT04640311|40387865|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525073|NCT04640311|40387866|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525074|NCT04640311|40387867|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525075|NCT04640311|40387868|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
16525076|NCT04640311|40387856|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525077|NCT04640311|40387857|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525078|NCT04640311|40387858|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
16525079|NCT04640311|40387859|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525080|NCT04640311|40387860|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525081|NCT04640311|40387861|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525082|NCT04640311|40387862|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525083|NCT04640311|40387863|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525084|NCT04640311|40387864|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525085|NCT04640311|40387865|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525086|NCT04640311|40387866|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525087|NCT04640311|40387867|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525088|NCT04640311|40387868|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
16525089|NCT04640311|40387856|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525090|NCT04640311|40387857|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525091|NCT04640311|40387858|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525092|NCT04640311|40387859|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
16525093|NCT04640311|40387860|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525094|NCT04640311|40387861|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525095|NCT04640311|40387862|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
16525096|NCT04640311|40387863|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525097|NCT04640311|40387864|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525098|NCT04640311|40387865|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525099|NCT04640311|40387866|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525100|NCT04640311|40387867|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525101|NCT04640311|40387868|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
16525102|NCT04640311|40387856|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525103|NCT04640311|40387857|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525104|NCT04640311|40387858|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525105|NCT04640311|40387859|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525106|NCT04640311|40387860|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525107|NCT04640311|40387861|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
16525108|NCT04640311|40387862|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525109|NCT04640311|40387863|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525110|NCT04640311|40387864|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
16525111|NCT04640311|40387865|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525112|NCT04640311|40387866|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525113|NCT04640311|40387867|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525114|NCT04640311|40387868|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
16525115|NCT04640311|40387856|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16525116|NCT04640311|40387857|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16525117|NCT04640311|40387858|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16525118|NCT04640311|40387859|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16525119|NCT04640311|40387860|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16329103|NCT03191864|39692399|FG004|Part 2 - Maintenance|Physician Decision|0|||
16329104|NCT03191864|39692400|FG005|Part 2 - Maintenance|Physician Decision|0|||
16329105|NCT03191864|39692395|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
16329106|NCT03191864|39692396|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
16329107|NCT03191864|39692397|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
16096758|NCT01345253|38842861|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
16525120|NCT04640311|40387861|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16525121|NCT04640311|40387862|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
16525122|NCT04640311|40387863|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16525123|NCT04640311|40387864|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16525124|NCT04640311|40387865|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16525125|NCT04640311|40387866|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
16525126|NCT04640311|40387867|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16525127|NCT04640311|40387868|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
16525128|NCT04640311|40387856|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525129|NCT04640311|40387857|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525130|NCT04640311|40387858|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525131|NCT04640311|40387859|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525132|NCT04640311|40387860|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16210311|NCT01902173|39251260|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
16210312|NCT01902173|39251261|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
16210313|NCT01902173|39251262|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
16329108|NCT03191864|39692398|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
16096759|NCT01345253|38842862|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
16096760|NCT01345253|38842861|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
16096761|NCT01345253|38842862|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
16096762|NCT01345253|38842861|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
16096763|NCT01345253|38842862|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
16096764|NCT01345253|38842861|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
16096765|NCT01345253|38842862|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
16096766|NCT01345253|38842861|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
16096767|NCT01345253|38842862|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
16096768|NCT01345253|38842861|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
16096769|NCT01345253|38842862|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
16096770|NCT01345253|38842861|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
16096771|NCT01345253|38842862|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
16096772|NCT01345253|38842861|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
16096773|NCT01345253|38842862|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
16096774|NCT01345253|38842861|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
16096775|NCT01345253|38842862|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
16096776|NCT01345253|38842861|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
16096777|NCT01345253|38842862|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
16096778|NCT00871494|38842870|FG000|Overall Study|Protocol Violation|5|||
16096779|NCT00871494|38842870|FG000|Overall Study|Lack of Efficacy|4|||
16096780|NCT00871494|38842870|FG000|Overall Study|Adverse Event|4|||
16096781|NCT00871494|38842870|FG000|Overall Study|Lost to Follow-up|1|||
16096782|NCT02066389|38842871|FG000|Overall Study|Adverse Event|1|||
16096783|NCT02066389|38842872|FG001|Overall Study|Adverse Event|1|||
16096784|NCT02066389|38842873|FG002|Overall Study|Adverse Event|1|||
16096785|NCT02066389|38842874|FG003|Overall Study|Adverse Event|1|||
16096786|NCT02066389|38842875|FG004|Overall Study|Adverse Event|5|||
16096787|NCT02066389|38842876|FG005|Overall Study|Adverse Event|1|||
16096788|NCT02066389|38842871|FG000|Overall Study|Withdrawal by Subject|4|||
16096789|NCT02066389|38842872|FG001|Overall Study|Withdrawal by Subject|0|||
16096790|NCT02066389|38842873|FG002|Overall Study|Withdrawal by Subject|5|||
16096791|NCT02066389|38842874|FG003|Overall Study|Withdrawal by Subject|1|||
16096792|NCT02066389|38842875|FG004|Overall Study|Withdrawal by Subject|1|||
16096793|NCT02066389|38842876|FG005|Overall Study|Withdrawal by Subject|2|||
16096794|NCT02066389|38842871|FG000|Overall Study|Lost to Follow-up|0|||
16096795|NCT02066389|38842872|FG001|Overall Study|Lost to Follow-up|0|||
16096796|NCT02066389|38842873|FG002|Overall Study|Lost to Follow-up|0|||
16096797|NCT02066389|38842874|FG003|Overall Study|Lost to Follow-up|1|||
16096798|NCT02066389|38842875|FG004|Overall Study|Lost to Follow-up|1|||
16096799|NCT02066389|38842876|FG005|Overall Study|Lost to Follow-up|1|||
16096800|NCT02066389|38842871|FG000|Overall Study|Randomized in Error|0|||
16096801|NCT02066389|38842872|FG001|Overall Study|Randomized in Error|0|||
16096802|NCT02066389|38842873|FG002|Overall Study|Randomized in Error|0|||
16096803|NCT02066389|38842874|FG003|Overall Study|Randomized in Error|0|||
16096804|NCT02066389|38842875|FG004|Overall Study|Randomized in Error|0|||
16096805|NCT02066389|38842876|FG005|Overall Study|Randomized in Error|1|||
16096806|NCT03928821|38842877|FG000|Overall Study|Death|0|||
16096807|NCT03928821|38842878|FG001|Overall Study|Death|1|||
16096808|NCT03928821|38842879|FG002|Overall Study|Death|0|||
16096809|NCT03928821|38842880|FG003|Overall Study|Death|0|||
16096810|NCT03928821|38842877|FG000|Overall Study|Lost to Follow-up|0|||
16096811|NCT03928821|38842878|FG001|Overall Study|Lost to Follow-up|2|||
16096812|NCT03928821|38842879|FG002|Overall Study|Lost to Follow-up|3|||
16096813|NCT03928821|38842880|FG003|Overall Study|Lost to Follow-up|0|||
16096814|NCT03928821|38842877|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
16096815|NCT03928821|38842878|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
16096816|NCT03928821|38842879|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
16096817|NCT03928821|38842880|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
16096818|NCT00857311|38842881|FG000|Overall Study|Lost to Follow-up|1|||
16096819|NCT00857311|38842882|FG001|Overall Study|Lost to Follow-up|0|||
16096820|NCT00857311|38842883|FG002|Overall Study|Lost to Follow-up|0|||
16096821|NCT00857311|38842884|FG003|Overall Study|Lost to Follow-up|0|||
16096822|NCT00451906|38842885|FG000|Overall Study|Adverse Event|515|||
16096823|NCT00451906|38842885|FG000|Overall Study|Lost to Follow-up|31|||
16096824|NCT00451906|38842885|FG000|Overall Study|Withdrawal by Subject|111|||
16096825|NCT00451906|38842885|FG000|Overall Study|Protocol Violation|21|||
16096826|NCT00451906|38842885|FG000|Overall Study|Progressive disease|1328|||
16096827|NCT00451906|38842885|FG000|Overall Study|Termination of the study|108|||
16096828|NCT00451906|38842885|FG000|Overall Study|Other Reasons|121|||
16096829|NCT00451906|38842885|FG000|Overall Study|Did not complete final visit|4|||
16096830|NCT00276016|38842886|FG000|Intervention 1|Withdrawal by Subject|0|||
16096831|NCT00276016|38842887|FG001|Intervention 1|Withdrawal by Subject|1|||
16096832|NCT00276016|38842888|FG002|Intervention 1|Withdrawal by Subject|0|||
16096833|NCT00276016|38842889|FG003|Intervention 1|Withdrawal by Subject|0|||
16096834|NCT00276016|38842890|FG004|Intervention 1|Withdrawal by Subject|0|||
16096835|NCT00276016|38842891|FG005|Intervention 1|Withdrawal by Subject|0|||
16096836|NCT02023099|38846751|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
16096837|NCT02023099|38846752|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
16096838|NCT02023099|38846753|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
16096839|NCT02023099|38846751|FG000|Overall Study|Withdrawn Consent|3|||
16096840|NCT02023099|38846752|FG001|Overall Study|Withdrawn Consent|0|||
16096841|NCT02023099|38846753|FG002|Overall Study|Withdrawn Consent|1|||
16096842|NCT02023099|38846751|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
16096843|NCT02023099|38846752|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
16096844|NCT02023099|38846753|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
16096845|NCT01951105|38846754|FG000|Overall Study|Adverse Event|0|||
16096846|NCT01951105|38846755|FG001|Overall Study|Adverse Event|5|||
16096847|NCT01951105|38846756|FG002|Overall Study|Adverse Event|0|||
16096848|NCT01951105|38846754|FG000|Overall Study|Lost to Follow-up|0|||
16096849|NCT01951105|38846755|FG001|Overall Study|Lost to Follow-up|1|||
16096850|NCT01951105|38846756|FG002|Overall Study|Lost to Follow-up|0|||
16096851|NCT01951105|38846754|FG000|Overall Study|Protocol Violation|1|||
16096852|NCT01951105|38846755|FG001|Overall Study|Protocol Violation|1|||
16096853|NCT01951105|38846756|FG002|Overall Study|Protocol Violation|1|||
16096854|NCT01951105|38846754|FG000|Overall Study|Withdrawal by Subject|0|||
16096855|NCT01951105|38846755|FG001|Overall Study|Withdrawal by Subject|3|||
16096856|NCT01951105|38846756|FG002|Overall Study|Withdrawal by Subject|1|||
16096857|NCT01038128|38846757|FG000|Overall Study|Lack of Efficacy|1|||
16096858|NCT01038128|38846757|FG000|Overall Study|Lost to Follow-up|1|||
16096859|NCT01038128|38846757|FG000|Overall Study|Withdrawal by Subject|2|||
16096860|NCT00938041|38846758|FG000|Overall Study|Lost to Follow-up|6|||
16096861|NCT00938041|38846758|FG000|Overall Study|Received Alternative Therapy|1|||
16096862|NCT00938041|38846758|FG000|Overall Study|Progressive Disease|5|||
16096863|NCT00938041|38846758|FG000|Overall Study|Death|12|||
16525133|NCT04640311|40387861|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525134|NCT04640311|40387862|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525135|NCT04640311|40387863|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525136|NCT04640311|40387864|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525137|NCT04640311|40387865|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525138|NCT04640311|40387866|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525139|NCT04640311|40387867|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
16525140|NCT04640311|40387868|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
16525141|NCT03891524|40387869|FG000|Overall Study|Death|0|||
16525142|NCT03891524|40387870|FG001|Overall Study|Death|0|||
16525143|NCT03891524|40387871|FG002|Overall Study|Death|0|||
16096864|NCT00938041|38846758|FG000|Overall Study|Adrenal Insufficiency|3|||
16525144|NCT03891524|40387872|FG003|Overall Study|Death|0|||
16096865|NCT01804140|38846759|FG000|Overall Study|No sampling or biopsy procedures done|114|||
16096866|NCT01199302|38846766|FG000|Overall Study|Adverse Event|1|||
16096867|NCT01199302|38846767|FG001|Overall Study|Adverse Event|1|||
16096868|NCT01199302|38846768|FG002|Overall Study|Adverse Event|2|||
16096869|NCT01199302|38846769|FG003|Overall Study|Adverse Event|0|||
16096870|NCT01199302|38846766|FG000|Overall Study|Withdrawal by Subject|2|||
16096871|NCT01199302|38846767|FG001|Overall Study|Withdrawal by Subject|2|||
16096872|NCT01199302|38846768|FG002|Overall Study|Withdrawal by Subject|3|||
16096873|NCT01199302|38846769|FG003|Overall Study|Withdrawal by Subject|0|||
16096874|NCT01199302|38846766|FG000|Overall Study|Disease Progression|3|||
16096875|NCT01199302|38846767|FG001|Overall Study|Disease Progression|4|||
16525145|NCT03891524|40387873|FG004|Overall Study|Death|0|||
16525146|NCT03891524|40387874|FG005|Overall Study|Death|0|||
16525147|NCT03891524|40387875|FG006|Overall Study|Death|0|||
16525148|NCT03891524|40387876|FG007|Overall Study|Death|1|||
16525149|NCT03891524|40387869|FG000|Overall Study|Withdrawal by Subject|0|||
16525150|NCT03891524|40387870|FG001|Overall Study|Withdrawal by Subject|1|||
16525151|NCT03891524|40387871|FG002|Overall Study|Withdrawal by Subject|2|||
16525152|NCT03891524|40387872|FG003|Overall Study|Withdrawal by Subject|1|||
16525153|NCT03891524|40387873|FG004|Overall Study|Withdrawal by Subject|2|||
16525154|NCT03891524|40387874|FG005|Overall Study|Withdrawal by Subject|2|||
16525155|NCT03891524|40387875|FG006|Overall Study|Withdrawal by Subject|2|||
16525156|NCT03891524|40387876|FG007|Overall Study|Withdrawal by Subject|1|||
16525157|NCT01401530|40387880|FG000|Overall Study|Disease Progression|1|||
16525158|NCT01401530|40387881|FG001|Overall Study|Disease Progression|2|||
16525159|NCT01401530|40387882|FG002|Overall Study|Disease Progression|1|||
16525160|NCT01401530|40387880|FG000|Overall Study|Adverse Event|1|||
16525161|NCT01401530|40387881|FG001|Overall Study|Adverse Event|1|||
16525162|NCT01401530|40387882|FG002|Overall Study|Adverse Event|1|||
16525163|NCT01401530|40387880|FG000|Overall Study|Participant Choice|1|||
16525164|NCT01401530|40387881|FG001|Overall Study|Participant Choice|2|||
16525165|NCT01401530|40387882|FG002|Overall Study|Participant Choice|1|||
16525166|NCT01401530|40387880|FG000|Overall Study|Physician Decision|0|||
16525167|NCT01401530|40387881|FG001|Overall Study|Physician Decision|1|||
16525168|NCT01401530|40387882|FG002|Overall Study|Physician Decision|0|||
16525169|NCT02956629|40387883|FG000|Overall Study|Adverse Event|0|||
16525170|NCT02956629|40387884|FG001|Overall Study|Adverse Event|0|||
16525171|NCT02956629|40387885|FG002|Overall Study|Adverse Event|1|||
16525172|NCT02956629|40387886|FG003|Overall Study|Adverse Event|0|||
16525173|NCT02956629|40387887|FG004|Overall Study|Adverse Event|0|||
16525174|NCT02956629|40387888|FG005|Overall Study|Adverse Event|0|||
16096876|NCT01199302|38846768|FG002|Overall Study|Disease Progression|4|||
16096877|NCT01199302|38846769|FG003|Overall Study|Disease Progression|2|||
16096878|NCT01199302|38846766|FG000|Overall Study|Study Termination|13|||
16096879|NCT01199302|38846767|FG001|Overall Study|Study Termination|8|||
16525175|NCT02956629|40387883|FG000|Overall Study|Lost to Follow-up|2|||
16096880|NCT01199302|38846768|FG002|Overall Study|Study Termination|11|||
16096881|NCT01199302|38846769|FG003|Overall Study|Study Termination|9|||
16096882|NCT01199302|38846766|FG000|Overall Study|Lost to Follow-up|0|||
16096883|NCT01199302|38846767|FG001|Overall Study|Lost to Follow-up|1|||
16096884|NCT01199302|38846768|FG002|Overall Study|Lost to Follow-up|0|||
16096885|NCT01199302|38846769|FG003|Overall Study|Lost to Follow-up|0|||
16096886|NCT01199302|38846766|FG000|Overall Study|Other|1|||
16096887|NCT01199302|38846767|FG001|Overall Study|Other|0|||
16096888|NCT01199302|38846768|FG002|Overall Study|Other|0|||
16096889|NCT01199302|38846769|FG003|Overall Study|Other|0|||
16096890|NCT02161185|38846770|FG000|Treatment Phase|Administrative/Other|7|||
16096891|NCT04620733|38846775|FG000|Overall Study|Adverse Event|4|||
16096892|NCT04620733|38846776|FG001|Overall Study|Adverse Event|3|||
16096893|NCT04620733|38846775|FG000|Overall Study|Withdrawal by Subject|2|||
16096894|NCT04620733|38846776|FG001|Overall Study|Withdrawal by Subject|5|||
16096895|NCT04620733|38846775|FG000|Overall Study|Lost to Follow-up|1|||
16096896|NCT04620733|38846776|FG001|Overall Study|Lost to Follow-up|1|||
16096897|NCT04620733|38846775|FG000|Overall Study|Protocol Deviation|1|||
16096898|NCT04620733|38846776|FG001|Overall Study|Protocol Deviation|1|||
16096899|NCT04620733|38846775|FG000|Overall Study|Reason Not Specified|0|||
16096900|NCT04620733|38846776|FG001|Overall Study|Reason Not Specified|1|||
16096901|NCT02316171|38846777|FG000|Overall Study|difficulties with urinary catheter|1|||
16096902|NCT02316171|38846778|FG001|Overall Study|difficulties with urinary catheter|0|||
16096903|NCT02316171|38846779|FG002|Overall Study|difficulties with urinary catheter|0|||
16096904|NCT02316171|38846780|FG003|Overall Study|difficulties with urinary catheter|0|||
16096905|NCT02246647|38846781|FG000|Overall Study|Withdrawal by Subject|1|||
16096906|NCT02246647|38846782|FG001|Overall Study|Withdrawal by Subject|1|||
16096907|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
16096908|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
16525176|NCT02956629|40387884|FG001|Overall Study|Lost to Follow-up|5|||
16525177|NCT02956629|40387885|FG002|Overall Study|Lost to Follow-up|3|||
16525178|NCT02956629|40387886|FG003|Overall Study|Lost to Follow-up|1|||
16525179|NCT02956629|40387887|FG004|Overall Study|Lost to Follow-up|0|||
16525180|NCT02956629|40387888|FG005|Overall Study|Lost to Follow-up|1|||
16525181|NCT02956629|40387883|FG000|Overall Study|Withdrawal by Subject|3|||
16096909|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
16525182|NCT02956629|40387884|FG001|Overall Study|Withdrawal by Subject|1|||
16096910|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
16096911|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
16096912|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
16096913|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
16096914|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
16096915|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
16096916|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
16096917|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
16096918|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
16096919|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
16096920|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
16096921|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
16096922|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
16096923|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
16096924|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
16096925|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
16096926|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
16096927|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
16210314|NCT01902173|39251263|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
16210315|NCT01902173|39251264|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
16210316|NCT01902173|39251265|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
16210317|NCT01902173|39251260|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
16210318|NCT01902173|39251261|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
16210319|NCT01902173|39251262|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
16210320|NCT01902173|39251263|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
16210321|NCT01902173|39251264|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
16210322|NCT01902173|39251265|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
16210323|NCT01902173|39251260|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
16210324|NCT01902173|39251261|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
16210325|NCT01902173|39251262|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
16210326|NCT01902173|39251263|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
16210327|NCT01902173|39251264|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
16210328|NCT01902173|39251265|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
16210329|NCT01902173|39251260|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
16210330|NCT01902173|39251261|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
16210331|NCT01902173|39251262|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
16210332|NCT01902173|39251263|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
16210333|NCT01902173|39251264|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
16210334|NCT01902173|39251265|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
16210335|NCT01902173|39251260|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
16210336|NCT01902173|39251261|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
16210337|NCT01902173|39251262|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
16210338|NCT01902173|39251263|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
16210339|NCT01902173|39251264|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
16210340|NCT01902173|39251265|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
16210341|NCT01902173|39251260|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
16210342|NCT01902173|39251261|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
16210343|NCT01902173|39251262|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
16210344|NCT01902173|39251263|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
16210345|NCT01902173|39251264|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
16210346|NCT01902173|39251265|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
16210347|NCT02443805|39251266|FG000|Overall Study|Adverse Event|100|||
16210348|NCT02443805|39251267|FG001|Overall Study|Adverse Event|18|||
16210349|NCT02443805|39251266|FG000|Overall Study|Withdrawal by Subject|73|||
16210350|NCT02443805|39251267|FG001|Overall Study|Withdrawal by Subject|74|||
16210351|NCT02443805|39251266|FG000|Overall Study|Lost to Follow-up|19|||
16210352|NCT02443805|39251267|FG001|Overall Study|Lost to Follow-up|14|||
16210353|NCT02443805|39251266|FG000|Overall Study|Pregnancy|6|||
16210354|NCT02443805|39251267|FG001|Overall Study|Pregnancy|5|||
16210355|NCT02443805|39251266|FG000|Overall Study|Protocol Violation|2|||
16210356|NCT02443805|39251267|FG001|Overall Study|Protocol Violation|4|||
16210357|NCT02443805|39251266|FG000|Overall Study|Lack of Efficacy|1|||
16210358|NCT02443805|39251267|FG001|Overall Study|Lack of Efficacy|1|||
16210359|NCT02443805|39251266|FG000|Overall Study|Non-compliance with study drug|6|||
16210360|NCT02443805|39251267|FG001|Overall Study|Non-compliance with study drug|4|||
16210361|NCT02443805|39251266|FG000|Overall Study|Withdrawal by parent/guardian|3|||
16210362|NCT02443805|39251267|FG001|Overall Study|Withdrawal by parent/guardian|5|||
16210363|NCT02443805|39251266|FG000|Overall Study|Any other reason not above-mentioned|3|||
16210364|NCT02443805|39251267|FG001|Overall Study|Any other reason not above-mentioned|2|||
16210365|NCT03417505|39251268|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
16210366|NCT03417505|39251269|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
16210367|NCT00608881|39251270|FG000|Overall Study|Death|22|||
16525183|NCT02956629|40387885|FG002|Overall Study|Withdrawal by Subject|0|||
16329109|NCT03191864|39692399|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
16329110|NCT03191864|39692400|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
16329111|NCT03191864|39692395|FG000|Part 2 - Maintenance|Adverse Event|0|||
16329112|NCT03191864|39692396|FG001|Part 2 - Maintenance|Adverse Event|0|||
16329113|NCT03191864|39692397|FG002|Part 2 - Maintenance|Adverse Event|0|||
16329114|NCT03191864|39692398|FG003|Part 2 - Maintenance|Adverse Event|0|||
16329115|NCT03191864|39692399|FG004|Part 2 - Maintenance|Adverse Event|1|||
16329116|NCT03191864|39692400|FG005|Part 2 - Maintenance|Adverse Event|0|||
16329117|NCT03191864|39692395|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
16096928|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
16096929|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
16096930|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
16096931|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
16096932|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
16096933|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
16096934|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
16096935|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
16096936|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
16096937|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
16096938|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
16096939|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
16096940|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
16096941|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
16096942|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
16329118|NCT03191864|39692396|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
16329119|NCT03191864|39692397|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
16329120|NCT03191864|39692398|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
16329121|NCT03191864|39692399|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
16329122|NCT03191864|39692400|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
16329123|NCT03191864|39692395|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
16329124|NCT03191864|39692396|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
16329125|NCT03191864|39692397|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
16329126|NCT03191864|39692398|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
16329127|NCT03191864|39692399|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
16329128|NCT03191864|39692400|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
16329129|NCT01149421|39692413|FG000|Overall Study|Adverse Event|22|||
16329130|NCT01149421|39692414|FG001|Overall Study|Adverse Event|6|||
16329131|NCT01149421|39692415|FG002|Overall Study|Adverse Event|11|||
16329132|NCT01149421|39692413|FG000|Overall Study|Withdrawal by Subject|20|||
16329133|NCT01149421|39692414|FG001|Overall Study|Withdrawal by Subject|12|||
16329134|NCT01149421|39692415|FG002|Overall Study|Withdrawal by Subject|13|||
16329135|NCT01149421|39692413|FG000|Overall Study|Sponsor Decision|0|||
16329136|NCT01149421|39692414|FG001|Overall Study|Sponsor Decision|1|||
16329137|NCT01149421|39692415|FG002|Overall Study|Sponsor Decision|1|||
16329138|NCT01149421|39692413|FG000|Overall Study|Lost to Follow-up|2|||
16329139|NCT01149421|39692414|FG001|Overall Study|Lost to Follow-up|4|||
16329140|NCT01149421|39692415|FG002|Overall Study|Lost to Follow-up|5|||
16329141|NCT01149421|39692413|FG000|Overall Study|Physician Decision|5|||
16329142|NCT01149421|39692414|FG001|Overall Study|Physician Decision|3|||
16525184|NCT02956629|40387886|FG003|Overall Study|Withdrawal by Subject|0|||
16525185|NCT02956629|40387887|FG004|Overall Study|Withdrawal by Subject|0|||
16525186|NCT02956629|40387888|FG005|Overall Study|Withdrawal by Subject|0|||
16525187|NCT02239510|40387889|FG000|Overall Study|Lost to Follow-up|2|||
16525188|NCT02239510|40387890|FG001|Overall Study|Lost to Follow-up|1|||
16525189|NCT02343458|40387893|FG000|Overall Study|Adverse Event|15|||
16525190|NCT02343458|40387894|FG001|Overall Study|Adverse Event|14|||
16096943|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
16096944|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
16096945|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
16210368|NCT00608881|39251271|FG001|Overall Study|Death|13|||
16329143|NCT01149421|39692415|FG002|Overall Study|Physician Decision|6|||
16329144|NCT01149421|39692413|FG000|Overall Study|Entry Criteria Not Met|1|||
16329145|NCT01149421|39692414|FG001|Overall Study|Entry Criteria Not Met|1|||
16329146|NCT01149421|39692415|FG002|Overall Study|Entry Criteria Not Met|2|||
16329147|NCT01149421|39692413|FG000|Overall Study|Protocol Violation|2|||
16329148|NCT01149421|39692414|FG001|Overall Study|Protocol Violation|2|||
16329149|NCT01149421|39692415|FG002|Overall Study|Protocol Violation|6|||
16525191|NCT02343458|40387895|FG002|Overall Study|Adverse Event|15|||
16525192|NCT02343458|40387896|FG003|Overall Study|Adverse Event|3|||
16525193|NCT02343458|40387893|FG000|Overall Study|Lack of Efficacy|3|||
16329150|NCT02487771|39692416|FG000|Overall Study|Lost to Follow-up|2|||
16525194|NCT02343458|40387894|FG001|Overall Study|Lack of Efficacy|8|||
16525195|NCT02343458|40387895|FG002|Overall Study|Lack of Efficacy|4|||
16525196|NCT02343458|40387896|FG003|Overall Study|Lack of Efficacy|8|||
16525197|NCT02343458|40387893|FG000|Overall Study|Withdrawal by Subject|18|||
16525198|NCT02343458|40387894|FG001|Overall Study|Withdrawal by Subject|17|||
16525199|NCT02343458|40387895|FG002|Overall Study|Withdrawal by Subject|23|||
16525200|NCT02343458|40387896|FG003|Overall Study|Withdrawal by Subject|14|||
16525201|NCT02343458|40387893|FG000|Overall Study|Physician Decision|1|||
16525202|NCT02343458|40387894|FG001|Overall Study|Physician Decision|4|||
16525203|NCT02343458|40387895|FG002|Overall Study|Physician Decision|2|||
16525204|NCT02343458|40387896|FG003|Overall Study|Physician Decision|2|||
16525205|NCT02343458|40387893|FG000|Overall Study|Lost to Follow-up|5|||
16525206|NCT02343458|40387894|FG001|Overall Study|Lost to Follow-up|5|||
16525207|NCT02343458|40387895|FG002|Overall Study|Lost to Follow-up|3|||
16210369|NCT00608881|39251270|FG000|Overall Study|Adverse Event|5|||
16210370|NCT00608881|39251271|FG001|Overall Study|Adverse Event|3|||
16210371|NCT00608881|39251270|FG000|Overall Study|Lost to Follow-up|28|||
16210372|NCT00608881|39251271|FG001|Overall Study|Lost to Follow-up|14|||
16210373|NCT00608881|39251270|FG000|Overall Study|Withdrawal by Subject|18|||
16210374|NCT00608881|39251271|FG001|Overall Study|Withdrawal by Subject|29|||
16210375|NCT00608881|39251270|FG000|Overall Study|Physician Decision|5|||
16210376|NCT00608881|39251271|FG001|Overall Study|Physician Decision|5|||
16210377|NCT00608881|39251270|FG000|Overall Study|Institutionalized|1|||
16210378|NCT00608881|39251271|FG001|Overall Study|Institutionalized|2|||
16210379|NCT00572728|39251276|FG000|Overall Study|Withdrawal by Subject|10|||
16210380|NCT00572728|39251276|FG000|Overall Study|Ineligible|3|||
16210381|NCT00572728|39251276|FG000|Overall Study|Enrolled under Amendment 4|5|||
16210382|NCT00572728|39251276|FG000|Overall Study|Offstudy due to complicating disease|1|||
16210383|NCT00572728|39251276|FG000|Overall Study|FLT1 not completed|4|||
16210384|NCT00572728|39251276|FG000|Overall Study|First Chemotherapy not initiated|2|||
16210385|NCT00572728|39251276|FG000|Overall Study|FLT2 not completed|5|||
16210386|NCT00572728|39251276|FG000|Overall Study|Second chemotherapy not initiated|1|||
16210387|NCT00572728|39251276|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
16210388|NCT00572728|39251276|FG000|Overall Study|Pathology missing|1|||
16210389|NCT02563925|39251277|FG000|Overall Study|Withdrawal by Subject|2|||
16210390|NCT00865046|39251278|FG000|Overall Study|Lost to Follow-up|1|||
16210391|NCT00865046|39251279|FG001|Overall Study|Lost to Follow-up|4|||
16210392|NCT00865046|39251280|FG002|Overall Study|Lost to Follow-up|0|||
16210393|NCT00865046|39251278|FG000|Overall Study|Death|0|||
16210394|NCT00865046|39251279|FG001|Overall Study|Death|1|||
16210395|NCT00865046|39251280|FG002|Overall Study|Death|1|||
16210396|NCT00865046|39251278|FG000|Overall Study|Withdrawal by Subject|5|||
16210397|NCT00865046|39251279|FG001|Overall Study|Withdrawal by Subject|0|||
16210398|NCT00865046|39251280|FG002|Overall Study|Withdrawal by Subject|0|||
16210399|NCT05263921|39251281|FG000|Overall Study|Other: family emergency.|0|||
16210400|NCT05263921|39251282|FG001|Overall Study|Other: family emergency.|0|||
16210401|NCT05263921|39251283|FG002|Overall Study|Other: family emergency.|1|||
16210402|NCT05263921|39251284|FG003|Overall Study|Other: family emergency.|0|||
16210403|NCT02255760|39251285|FG000|Overall Study|Lost to Follow-up|0|||
16210404|NCT02255760|39251286|FG001|Overall Study|Lost to Follow-up|1|||
16210405|NCT02255760|39251287|FG002|Overall Study|Lost to Follow-up|0|||
16210406|NCT02255760|39251288|FG003|Overall Study|Lost to Follow-up|0|||
16210407|NCT02255760|39251289|FG004|Overall Study|Lost to Follow-up|0|||
16210408|NCT02076334|39251290|FG000|Overall Study|Protocol Violation|1|||
16210409|NCT02076334|39251291|FG001|Overall Study|Protocol Violation|0|||
16210410|NCT02076334|39251292|FG002|Overall Study|Protocol Violation|0|||
16210411|NCT02076334|39251293|FG003|Overall Study|Protocol Violation|0|||
16210412|NCT02076334|39251290|FG000|Overall Study|Lost to Follow-up|0|||
16210413|NCT02076334|39251291|FG001|Overall Study|Lost to Follow-up|1|||
16210414|NCT02076334|39251292|FG002|Overall Study|Lost to Follow-up|1|||
16210415|NCT02076334|39251293|FG003|Overall Study|Lost to Follow-up|0|||
16210416|NCT02076334|39251290|FG000|Overall Study|muscle soreness|0|||
16210417|NCT02076334|39251291|FG001|Overall Study|muscle soreness|0|||
16210418|NCT02076334|39251292|FG002|Overall Study|muscle soreness|0|||
16210419|NCT02076334|39251293|FG003|Overall Study|muscle soreness|1|||
16210420|NCT02848313|39251296|FG000|Overall Study|Adverse Event|1|||
16210421|NCT02848313|39251297|FG001|Overall Study|Adverse Event|2|||
16210422|NCT02848313|39251296|FG000|Overall Study|Lack of Efficacy|0|||
16525208|NCT02343458|40387896|FG003|Overall Study|Lost to Follow-up|1|||
16525209|NCT02343458|40387893|FG000|Overall Study|Protocol Violation|2|||
16210423|NCT02848313|39251297|FG001|Overall Study|Lack of Efficacy|1|||
16210424|NCT02848313|39251296|FG000|Overall Study|Withdrawal by Subject|1|||
16210425|NCT02848313|39251297|FG001|Overall Study|Withdrawal by Subject|1|||
16525210|NCT02343458|40387894|FG001|Overall Study|Protocol Violation|5|||
16525211|NCT02343458|40387895|FG002|Overall Study|Protocol Violation|2|||
16210426|NCT02848313|39251296|FG000|Overall Study|Lost to follow up|1|||
16210427|NCT02848313|39251297|FG001|Overall Study|Lost to follow up|0|||
16525212|NCT02343458|40387896|FG003|Overall Study|Protocol Violation|2|||
16210428|NCT00368472|39251298|FG000|Overall Study|Adverse Event|22|||
16525213|NCT02343458|40387893|FG000|Overall Study|Protocol Specified Criteria|17|||
16398095|NCT01202188|39938639|FG001|Overall Study|Subject withdrew consent|13|||
16398096|NCT01202188|39938640|FG002|Overall Study|Subject withdrew consent|22|||
16398097|NCT01202188|39938641|FG003|Overall Study|Subject withdrew consent|11|||
16398098|NCT01202188|39938642|FG004|Overall Study|Subject withdrew consent|13|||
16398099|NCT01202188|39938638|FG000|Overall Study|Adverse Event|5|||
16398100|NCT01202188|39938639|FG001|Overall Study|Adverse Event|23|||
16398101|NCT01202188|39938640|FG002|Overall Study|Adverse Event|13|||
16398102|NCT01202188|39938641|FG003|Overall Study|Adverse Event|10|||
16398103|NCT01202188|39938642|FG004|Overall Study|Adverse Event|10|||
16398104|NCT01202188|39938638|FG000|Overall Study|Administrative problems|3|||
16398105|NCT01202188|39938639|FG001|Overall Study|Administrative problems|2|||
16398106|NCT01202188|39938640|FG002|Overall Study|Administrative problems|1|||
16398107|NCT01202188|39938641|FG003|Overall Study|Administrative problems|1|||
16398108|NCT01202188|39938642|FG004|Overall Study|Administrative problems|2|||
16398109|NCT01202188|39938638|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16398110|NCT01202188|39938639|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
16398111|NCT01202188|39938640|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
16398112|NCT01202188|39938641|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
16398113|NCT01202188|39938642|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
16398114|NCT01202188|39938638|FG000|Overall Study|Lost to Follow-up|1|||
16398115|NCT01202188|39938639|FG001|Overall Study|Lost to Follow-up|1|||
16398116|NCT01202188|39938640|FG002|Overall Study|Lost to Follow-up|0|||
16398117|NCT01202188|39938641|FG003|Overall Study|Lost to Follow-up|4|||
16398118|NCT01202188|39938642|FG004|Overall Study|Lost to Follow-up|1|||
16398119|NCT01202188|39938638|FG000|Overall Study|Death|1|||
16398120|NCT01202188|39938639|FG001|Overall Study|Death|1|||
16398121|NCT01202188|39938640|FG002|Overall Study|Death|1|||
16210429|NCT00368472|39251298|FG000|Overall Study|Medication non-compliance|4|||
16398122|NCT01202188|39938641|FG003|Overall Study|Death|1|||
16398123|NCT01202188|39938642|FG004|Overall Study|Death|0|||
16398124|NCT01202188|39938638|FG000|Overall Study|Abnormal test procedure result (s)|0|||
16398125|NCT01202188|39938639|FG001|Overall Study|Abnormal test procedure result (s)|0|||
16398126|NCT01202188|39938640|FG002|Overall Study|Abnormal test procedure result (s)|2|||
16398127|NCT01202188|39938641|FG003|Overall Study|Abnormal test procedure result (s)|0|||
16398128|NCT01202188|39938642|FG004|Overall Study|Abnormal test procedure result (s)|0|||
16398129|NCT00675441|39938643|FG000|Overall Study|Withdrawal by Subject|2|||
16398130|NCT00675441|39938643|FG000|Overall Study|Death|1|||
16525214|NCT02343458|40387894|FG001|Overall Study|Protocol Specified Criteria|13|||
16525215|NCT02343458|40387895|FG002|Overall Study|Protocol Specified Criteria|14|||
16525216|NCT02343458|40387896|FG003|Overall Study|Protocol Specified Criteria|8|||
16525217|NCT02352493|40387899|FG000|Overall Study|Pregnancy|0|||
16525218|NCT02352493|40387900|FG001|Overall Study|Pregnancy|0|||
16525219|NCT02352493|40387901|FG002|Overall Study|Pregnancy|0|||
16525220|NCT02352493|40387902|FG003|Overall Study|Pregnancy|0|||
16525221|NCT02352493|40387903|FG004|Overall Study|Pregnancy|0|||
16525222|NCT02352493|40387904|FG005|Overall Study|Pregnancy|0|||
16525223|NCT02352493|40387905|FG006|Overall Study|Pregnancy|1|||
16525224|NCT02352493|40387906|FG007|Overall Study|Pregnancy|0|||
16525225|NCT02352493|40387907|FG008|Overall Study|Pregnancy|1|||
16525226|NCT02352493|40387908|FG009|Overall Study|Pregnancy|0|||
16525227|NCT02352493|40387909|FG010|Overall Study|Pregnancy|0|||
16525228|NCT02352493|40387910|FG011|Overall Study|Pregnancy|0|||
16525229|NCT02352493|40387911|FG012|Overall Study|Pregnancy|0|||
16525230|NCT02352493|40387912|FG013|Overall Study|Pregnancy|0|||
16525231|NCT02352493|40387913|FG014|Overall Study|Pregnancy|0|||
16525232|NCT02352493|40387914|FG015|Overall Study|Pregnancy|0|||
16525233|NCT02352493|40387915|FG016|Overall Study|Pregnancy|0|||
16525234|NCT02352493|40387916|FG017|Overall Study|Pregnancy|0|||
16525235|NCT02352493|40387899|FG000|Overall Study|Withdrawal by Subject|0|||
16525236|NCT02352493|40387900|FG001|Overall Study|Withdrawal by Subject|0|||
16525237|NCT02352493|40387901|FG002|Overall Study|Withdrawal by Subject|0|||
16525238|NCT02352493|40387902|FG003|Overall Study|Withdrawal by Subject|0|||
16525239|NCT02352493|40387903|FG004|Overall Study|Withdrawal by Subject|0|||
16525240|NCT02352493|40387904|FG005|Overall Study|Withdrawal by Subject|0|||
16525241|NCT02352493|40387905|FG006|Overall Study|Withdrawal by Subject|0|||
16525242|NCT02352493|40387906|FG007|Overall Study|Withdrawal by Subject|0|||
16525243|NCT02352493|40387907|FG008|Overall Study|Withdrawal by Subject|1|||
16525244|NCT02352493|40387908|FG009|Overall Study|Withdrawal by Subject|0|||
16210430|NCT00368472|39251298|FG000|Overall Study|Protocol Violation|2|||
16210431|NCT00368472|39251298|FG000|Overall Study|Request of Investigator or Sponsor|3|||
16398131|NCT00709319|39938646|FG000|Overall Study|Death|4|||
16398132|NCT00709319|39938646|FG000|Overall Study|Withdrawal by Subject|2|||
16398133|NCT00425698|39938649|FG000|Overall Study|Adverse Event|3|||
16398134|NCT00425698|39938650|FG001|Overall Study|Adverse Event|1|||
16398135|NCT00425698|39938649|FG000|Overall Study|Withdrawal by Subject|0|||
16525245|NCT02352493|40387909|FG010|Overall Study|Withdrawal by Subject|0|||
16525246|NCT02352493|40387910|FG011|Overall Study|Withdrawal by Subject|0|||
16525247|NCT02352493|40387911|FG012|Overall Study|Withdrawal by Subject|0|||
16398136|NCT00425698|39938650|FG001|Overall Study|Withdrawal by Subject|1|||
16398137|NCT02752633|39938653|FG000|Overall Study|Withdrawal by Subject|1|||
16398138|NCT03308968|39938659|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
16398139|NCT03308968|39938660|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
16398140|NCT03308968|39938661|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
16398141|NCT03308968|39938659|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
16398142|NCT03308968|39938660|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
16398143|NCT03308968|39938661|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
16398144|NCT03308968|39938659|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
16398145|NCT03308968|39938660|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
16398146|NCT03308968|39938661|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
16398147|NCT03308968|39938659|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
16398148|NCT03308968|39938660|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
16398149|NCT03308968|39938661|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
16398150|NCT03308968|39938659|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
16398151|NCT03308968|39938660|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
16398152|NCT03308968|39938661|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
16398153|NCT03308968|39938659|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
16398154|NCT03308968|39938660|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
16398155|NCT03308968|39938661|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
16398156|NCT03308968|39938659|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
16398157|NCT03308968|39938660|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
16398158|NCT03308968|39938661|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
16398159|NCT03308968|39938659|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
16398160|NCT03308968|39938660|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
16398161|NCT03308968|39938661|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
16398162|NCT03308968|39938659|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
16398163|NCT03308968|39938660|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
16398164|NCT03308968|39938661|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
16398165|NCT03308968|39938659|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
16398166|NCT03308968|39938660|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
16398167|NCT03308968|39938661|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
16398168|NCT03308968|39938659|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
16398169|NCT03308968|39938660|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
16398170|NCT03308968|39938661|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
16398171|NCT03308968|39938659|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
16398172|NCT03308968|39938660|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
16398173|NCT03308968|39938661|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
16398174|NCT03308968|39938659|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
16398175|NCT03308968|39938660|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
16398176|NCT03308968|39938661|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
16398177|NCT03308968|39938659|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
16398178|NCT03308968|39938660|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
16398179|NCT03308968|39938661|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
16398180|NCT01672879|39938662|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
16398181|NCT01672879|39938663|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
16398182|NCT01672879|39938664|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
16398183|NCT01672879|39938662|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
16398184|NCT01672879|39938663|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
16398185|NCT01672879|39938664|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
16398186|NCT01672879|39938662|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
16398187|NCT01672879|39938663|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
16398188|NCT01672879|39938664|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
16398189|NCT01672879|39938662|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
16398190|NCT01672879|39938663|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
16398191|NCT01672879|39938664|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
16398192|NCT01672879|39938662|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
16398193|NCT01672879|39938663|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
16210432|NCT00368472|39251298|FG000|Overall Study|Withdrawal by Subject|40|||
16210433|NCT00368472|39251298|FG000|Overall Study|Diary non-compliance|1|||
16398194|NCT01672879|39938664|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
16398195|NCT01672879|39938662|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
16398196|NCT01672879|39938663|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
16398197|NCT01672879|39938664|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
16398198|NCT01672879|39938662|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
16398199|NCT01672879|39938663|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
16546374|NCT01662063|40464797|FG001|Overall Study|Lack of Efficacy|6|||
16210434|NCT00368472|39251298|FG000|Overall Study|Other|32|||
16210435|NCT00368472|39251298|FG000|Overall Study|Missing Final Disposition Date|1|||
16398200|NCT01672879|39938664|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
16398201|NCT01672879|39938662|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
16398202|NCT01672879|39938663|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
16398203|NCT01672879|39938664|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
16398204|NCT01672879|39938662|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
16398205|NCT01672879|39938663|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
16398206|NCT01672879|39938664|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
16398207|NCT01672879|39938662|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
16398208|NCT01672879|39938663|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
16096946|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
16096947|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
16096948|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
16096949|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
16096950|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
16096951|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
16096952|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
16398209|NCT01672879|39938664|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
16398210|NCT01672879|39938662|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
16398211|NCT01672879|39938663|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
16398212|NCT01672879|39938664|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
16398213|NCT01672879|39938662|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
16398214|NCT01672879|39938663|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
16398215|NCT01672879|39938664|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
16398216|NCT01672879|39938662|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
16398217|NCT01672879|39938663|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
16525248|NCT02352493|40387912|FG013|Overall Study|Withdrawal by Subject|0|||
16525249|NCT02352493|40387913|FG014|Overall Study|Withdrawal by Subject|1|||
16525250|NCT02352493|40387914|FG015|Overall Study|Withdrawal by Subject|0|||
16525251|NCT02352493|40387915|FG016|Overall Study|Withdrawal by Subject|0|||
16525252|NCT02352493|40387916|FG017|Overall Study|Withdrawal by Subject|0|||
16525253|NCT02352493|40387899|FG000|Overall Study|Lost to Follow-up|0|||
16525254|NCT02352493|40387900|FG001|Overall Study|Lost to Follow-up|0|||
16525255|NCT02352493|40387901|FG002|Overall Study|Lost to Follow-up|0|||
16525256|NCT02352493|40387902|FG003|Overall Study|Lost to Follow-up|0|||
16525257|NCT02352493|40387903|FG004|Overall Study|Lost to Follow-up|0|||
16525258|NCT02352493|40387904|FG005|Overall Study|Lost to Follow-up|0|||
16525259|NCT02352493|40387905|FG006|Overall Study|Lost to Follow-up|0|||
16525260|NCT02352493|40387906|FG007|Overall Study|Lost to Follow-up|0|||
16525261|NCT02352493|40387907|FG008|Overall Study|Lost to Follow-up|0|||
16525262|NCT02352493|40387908|FG009|Overall Study|Lost to Follow-up|1|||
16525263|NCT02352493|40387909|FG010|Overall Study|Lost to Follow-up|0|||
16525264|NCT02352493|40387910|FG011|Overall Study|Lost to Follow-up|0|||
16525265|NCT02352493|40387911|FG012|Overall Study|Lost to Follow-up|1|||
16525266|NCT02352493|40387912|FG013|Overall Study|Lost to Follow-up|2|||
16525267|NCT02352493|40387913|FG014|Overall Study|Lost to Follow-up|0|||
16096953|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
16096954|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
16096955|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
16096956|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
16096957|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
16096958|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
16096959|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
16096960|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
16096961|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
16096962|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
16096963|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
16096964|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
16096965|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
16096966|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
16096967|NCT03395197|38846783|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
16525268|NCT02352493|40387914|FG015|Overall Study|Lost to Follow-up|0|||
16525269|NCT02352493|40387915|FG016|Overall Study|Lost to Follow-up|0|||
16525270|NCT02352493|40387916|FG017|Overall Study|Lost to Follow-up|0|||
16525271|NCT01913041|40387917|FG000|Overall Study|Protocol Violation|35|||
16096968|NCT03395197|38846784|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
16096969|NCT03395197|38846785|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
16096970|NCT03395197|38846786|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
16096971|NCT03395197|38846787|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
16096972|NCT03395197|38846788|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
16210436|NCT01094808|39251301|FG000|Overall Study|Withdrawal by Subject|1|||
16210437|NCT01094808|39251302|FG001|Overall Study|Withdrawal by Subject|1|||
16329151|NCT02487771|39692417|FG001|Overall Study|Lost to Follow-up|3|||
16329152|NCT02487771|39692416|FG000|Overall Study|Moved out of area|5|||
16329153|NCT02487771|39692417|FG001|Overall Study|Moved out of area|6|||
16329154|NCT02487771|39692416|FG000|Overall Study|Withdrawal by Subject|3|||
16329155|NCT02487771|39692417|FG001|Overall Study|Withdrawal by Subject|5|||
16329156|NCT00550862|39692419|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
16329157|NCT00550862|39692420|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
16329158|NCT00550862|39692421|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
16329159|NCT00550862|39692422|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
16329160|NCT00550862|39692423|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
16329161|NCT00550862|39692419|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
16329162|NCT00550862|39692420|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
16329163|NCT00550862|39692421|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
16329164|NCT00550862|39692422|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
16329165|NCT00550862|39692423|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
16329166|NCT00550862|39692419|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
16329167|NCT00550862|39692420|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
16329168|NCT00550862|39692421|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
16329169|NCT00550862|39692422|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
16329170|NCT00550862|39692423|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
16525272|NCT01913041|40387917|FG000|Overall Study|Withdrawal by Subject|3|||
16525273|NCT01913041|40387917|FG000|Overall Study|Physician Decision|1|||
16525274|NCT02029443|40387918|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
16525275|NCT02029443|40387919|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
16525276|NCT02029443|40387920|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
16525277|NCT02029443|40387921|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
16525278|NCT02029443|40387922|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
16525279|NCT02029443|40387918|FG000|Overall Study|Death|13|||
16525280|NCT02029443|40387919|FG001|Overall Study|Death|2|||
16525281|NCT02029443|40387920|FG002|Overall Study|Death|2|||
16525282|NCT02029443|40387921|FG003|Overall Study|Death|11|||
16329171|NCT00550862|39692419|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
16329172|NCT00550862|39692420|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
16329173|NCT00550862|39692421|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
16525283|NCT02029443|40387922|FG004|Overall Study|Death|2|||
16525284|NCT02029443|40387918|FG000|Overall Study|Lost to Follow-up|1|||
16525285|NCT02029443|40387919|FG001|Overall Study|Lost to Follow-up|0|||
16525286|NCT02029443|40387920|FG002|Overall Study|Lost to Follow-up|1|||
16525287|NCT02029443|40387921|FG003|Overall Study|Lost to Follow-up|1|||
16525288|NCT02029443|40387922|FG004|Overall Study|Lost to Follow-up|0|||
16525289|NCT02029443|40387918|FG000|Overall Study|Started other anti-cancer therapy|17|||
16525290|NCT02029443|40387919|FG001|Overall Study|Started other anti-cancer therapy|4|||
16525291|NCT02029443|40387920|FG002|Overall Study|Started other anti-cancer therapy|7|||
16525292|NCT02029443|40387921|FG003|Overall Study|Started other anti-cancer therapy|9|||
16525293|NCT02029443|40387922|FG004|Overall Study|Started other anti-cancer therapy|3|||
16525294|NCT02029443|40387918|FG000|Overall Study|Withdrawal by Subject|3|||
16525295|NCT02029443|40387919|FG001|Overall Study|Withdrawal by Subject|1|||
16525296|NCT02029443|40387920|FG002|Overall Study|Withdrawal by Subject|1|||
16525297|NCT02029443|40387921|FG003|Overall Study|Withdrawal by Subject|1|||
16525298|NCT02029443|40387922|FG004|Overall Study|Withdrawal by Subject|0|||
16525299|NCT02029443|40387918|FG000|Overall Study|Other|6|||
16525300|NCT02029443|40387919|FG001|Overall Study|Other|6|||
16525301|NCT02029443|40387920|FG002|Overall Study|Other|4|||
16525302|NCT02029443|40387921|FG003|Overall Study|Other|2|||
16525303|NCT02029443|40387922|FG004|Overall Study|Other|0|||
16525304|NCT01969838|40387923|FG000|Double-blind Phase|Adverse Event|10|||
16525305|NCT01969838|40387924|FG001|Double-blind Phase|Adverse Event|4|||
16525306|NCT01969838|40387925|FG002|Double-blind Phase|Adverse Event|0|||
16525307|NCT01969838|40387926|FG003|Double-blind Phase|Adverse Event|0|||
16525308|NCT01969838|40387923|FG000|Double-blind Phase|Death|5|||
16525309|NCT01969838|40387924|FG001|Double-blind Phase|Death|2|||
16525310|NCT01969838|40387925|FG002|Double-blind Phase|Death|0|||
16525311|NCT01969838|40387926|FG003|Double-blind Phase|Death|0|||
16525312|NCT01969838|40387923|FG000|Double-blind Phase|Physician Decision|5|||
16525313|NCT01969838|40387924|FG001|Double-blind Phase|Physician Decision|1|||
16525314|NCT01969838|40387925|FG002|Double-blind Phase|Physician Decision|0|||
16525315|NCT01969838|40387926|FG003|Double-blind Phase|Physician Decision|0|||
16525316|NCT01969838|40387923|FG000|Double-blind Phase|Subject Decision|4|||
16525317|NCT01969838|40387924|FG001|Double-blind Phase|Subject Decision|2|||
16525318|NCT01969838|40387925|FG002|Double-blind Phase|Subject Decision|0|||
16525319|NCT01969838|40387926|FG003|Double-blind Phase|Subject Decision|0|||
16525320|NCT01969838|40387923|FG000|Double-blind Phase|Disease Progression|2|||
16525321|NCT01969838|40387924|FG001|Double-blind Phase|Disease Progression|0|||
16525322|NCT01969838|40387925|FG002|Double-blind Phase|Disease Progression|0|||
16525323|NCT01969838|40387926|FG003|Double-blind Phase|Disease Progression|0|||
16525324|NCT01969838|40387923|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
16525325|NCT01969838|40387924|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
16525326|NCT01969838|40387925|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
16329174|NCT00550862|39692422|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
16525327|NCT01969838|40387926|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
16525328|NCT01969838|40387923|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
16525329|NCT01969838|40387924|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
16525330|NCT01969838|40387925|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
16525331|NCT01969838|40387926|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
16525332|NCT01969838|40387923|FG000|Open-label Phase|Adverse Event|0|||
16525333|NCT01969838|40387924|FG001|Open-label Phase|Adverse Event|0|||
16525334|NCT01969838|40387925|FG002|Open-label Phase|Adverse Event|37|||
16525335|NCT01969838|40387926|FG003|Open-label Phase|Adverse Event|49|||
16525336|NCT01969838|40387923|FG000|Open-label Phase|Disease Progression|0|||
16525337|NCT01969838|40387924|FG001|Open-label Phase|Disease Progression|0|||
16525338|NCT01969838|40387925|FG002|Open-label Phase|Disease Progression|26|||
16525339|NCT01969838|40387926|FG003|Open-label Phase|Disease Progression|27|||
16525340|NCT01969838|40387923|FG000|Open-label Phase|Lack of Efficacy|0|||
16525341|NCT01969838|40387924|FG001|Open-label Phase|Lack of Efficacy|0|||
16525342|NCT01969838|40387925|FG002|Open-label Phase|Lack of Efficacy|17|||
16329175|NCT00550862|39692423|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
16525343|NCT01969838|40387926|FG003|Open-label Phase|Lack of Efficacy|19|||
16525344|NCT01969838|40387923|FG000|Open-label Phase|Subject Decision|0|||
16525345|NCT01969838|40387924|FG001|Open-label Phase|Subject Decision|0|||
16525346|NCT01969838|40387925|FG002|Open-label Phase|Subject Decision|14|||
16525347|NCT01969838|40387926|FG003|Open-label Phase|Subject Decision|15|||
16525348|NCT01969838|40387923|FG000|Open-label Phase|Death|0|||
16525349|NCT01969838|40387924|FG001|Open-label Phase|Death|0|||
16525350|NCT01969838|40387925|FG002|Open-label Phase|Death|13|||
16525351|NCT01969838|40387926|FG003|Open-label Phase|Death|11|||
16525352|NCT01969838|40387923|FG000|Open-label Phase|Physician Decision|0|||
16525353|NCT01969838|40387924|FG001|Open-label Phase|Physician Decision|0|||
16525354|NCT01969838|40387925|FG002|Open-label Phase|Physician Decision|9|||
16525355|NCT01969838|40387926|FG003|Open-label Phase|Physician Decision|14|||
16525356|NCT01969838|40387923|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
16525357|NCT01969838|40387924|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
16525358|NCT01969838|40387925|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
16525359|NCT01969838|40387926|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
16525360|NCT00572572|40387927|FG000|Overall Study|Withdrawal by Subject|3|||
16525361|NCT00572572|40387928|FG001|Overall Study|Withdrawal by Subject|6|||
16096973|NCT03395197|38846783|FG000|Analysis for DDR-Deficient Participants|Death|0|||
16096974|NCT03395197|38846784|FG001|Analysis for DDR-Deficient Participants|Death|0|||
16096975|NCT03395197|38846785|FG002|Analysis for DDR-Deficient Participants|Death|0|||
16096976|NCT03395197|38846786|FG003|Analysis for DDR-Deficient Participants|Death|0|||
16096977|NCT03395197|38846787|FG004|Analysis for DDR-Deficient Participants|Death|1|||
16096978|NCT03395197|38846788|FG005|Analysis for DDR-Deficient Participants|Death|4|||
16096979|NCT03395197|38846783|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
16096980|NCT03395197|38846784|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
16096981|NCT03395197|38846785|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
16525362|NCT04755595|40387931|FG000|Overall Study|Lost to Follow-up|1|||
16525363|NCT01076400|40390965|FG000|Overall Study|Adverse Event|2|||
16525364|NCT01076400|40390966|FG001|Overall Study|Adverse Event|0|||
16525365|NCT01076400|40390967|FG002|Overall Study|Adverse Event|0|||
16525366|NCT01076400|40390965|FG000|Overall Study|Progressive Disease|5|||
16096982|NCT03395197|38846786|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
16096983|NCT03395197|38846787|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
16096984|NCT03395197|38846788|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
16096985|NCT03395197|38846783|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
16096986|NCT03395197|38846784|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
16096987|NCT03395197|38846785|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
16096988|NCT03395197|38846786|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
16096989|NCT03395197|38846787|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
16096990|NCT03395197|38846788|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
16096991|NCT03395197|38846783|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
16096992|NCT03395197|38846784|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
16096993|NCT03395197|38846785|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
16096994|NCT03395197|38846786|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
16096995|NCT03395197|38846787|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
16096996|NCT03395197|38846788|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
16096997|NCT03395197|38846783|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
16096998|NCT03395197|38846784|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
16096999|NCT03395197|38846785|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
16097000|NCT03395197|38846786|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
16097001|NCT03395197|38846787|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
16097002|NCT03395197|38846788|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
16097003|NCT03395197|38846783|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
16097004|NCT03395197|38846784|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
16097005|NCT03395197|38846785|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
16097006|NCT03395197|38846786|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
16097007|NCT03395197|38846787|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
16097008|NCT03395197|38846788|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
16097009|NCT03395197|38846783|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
16097010|NCT03395197|38846784|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
16525367|NCT01076400|40390966|FG001|Overall Study|Progressive Disease|0|||
16525368|NCT01076400|40390967|FG002|Overall Study|Progressive Disease|0|||
16525369|NCT01940900|40390970|FG000|Overall Study|Physician Decision|4|||
16525370|NCT01940900|40390971|FG001|Overall Study|Physician Decision|0|||
16525371|NCT01940900|40390970|FG000|Overall Study|Adverse Event|10|||
16525372|NCT01940900|40390971|FG001|Overall Study|Adverse Event|15|||
16097011|NCT03395197|38846785|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
16097012|NCT03395197|38846786|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
16097013|NCT03395197|38846787|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
16097014|NCT03395197|38846788|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
16097015|NCT03395197|38846783|FG000|Analysis for DDR-Deficient Participants|Other|0|||
16097016|NCT03395197|38846784|FG001|Analysis for DDR-Deficient Participants|Other|0|||
16097017|NCT03395197|38846785|FG002|Analysis for DDR-Deficient Participants|Other|0|||
16097018|NCT03395197|38846786|FG003|Analysis for DDR-Deficient Participants|Other|0|||
16097019|NCT03395197|38846787|FG004|Analysis for DDR-Deficient Participants|Other|3|||
16097020|NCT03395197|38846788|FG005|Analysis for DDR-Deficient Participants|Other|3|||
16097021|NCT03395197|38846783|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
16097022|NCT03395197|38846784|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
16097023|NCT03395197|38846785|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
16097024|NCT03395197|38846786|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
16097025|NCT03395197|38846787|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
16097026|NCT03395197|38846788|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
16097027|NCT02188784|38846792|FG000|Overall Study|Death|3|||
16097028|NCT02188784|38846793|FG001|Overall Study|Death|1|||
16097029|NCT02188784|38846792|FG000|Overall Study|Lost to Follow-up|1|||
16097030|NCT02188784|38846793|FG001|Overall Study|Lost to Follow-up|0|||
16097031|NCT02188784|38846792|FG000|Overall Study|Withdrawal by Subject|3|||
16097032|NCT02188784|38846793|FG001|Overall Study|Withdrawal by Subject|9|||
16097033|NCT02188784|38846792|FG000|Overall Study|Physician Decision|2|||
16097034|NCT02188784|38846793|FG001|Overall Study|Physician Decision|3|||
16097035|NCT00561678|38846794|FG000|Overall Study|Withdrawal by Subject|4|||
16097036|NCT00561678|38846795|FG001|Overall Study|Withdrawal by Subject|3|||
16097037|NCT00561678|38846794|FG000|Overall Study|surgery cancelled|1|||
16097038|NCT00561678|38846795|FG001|Overall Study|surgery cancelled|1|||
16097039|NCT00561678|38846794|FG000|Overall Study|surgery rescheduled to different site|2|||
16097040|NCT00561678|38846795|FG001|Overall Study|surgery rescheduled to different site|2|||
16097041|NCT00561678|38846794|FG000|Overall Study|anesthesia provider refusal|1|||
16097042|NCT00561678|38846795|FG001|Overall Study|anesthesia provider refusal|0|||
16097043|NCT01572493|38846797|FG000|Overall Study|Physician Decision|1|||
16097044|NCT01572493|38846798|FG001|Overall Study|Physician Decision|0|||
16097045|NCT01572493|38846799|FG002|Overall Study|Physician Decision|0|||
16097046|NCT01572493|38846800|FG003|Overall Study|Physician Decision|0|||
16097047|NCT01572493|38846801|FG004|Overall Study|Physician Decision|0|||
16097048|NCT01572493|38846802|FG005|Overall Study|Physician Decision|0|||
16097049|NCT01572493|38846803|FG006|Overall Study|Physician Decision|0|||
16097050|NCT01572493|38846804|FG007|Overall Study|Physician Decision|0|||
16097051|NCT01572493|38846805|FG008|Overall Study|Physician Decision|0|||
16097052|NCT01572493|38846797|FG000|Overall Study|Switched to alternative treatment|0|||
16097053|NCT01572493|38846798|FG001|Overall Study|Switched to alternative treatment|1|||
16097054|NCT01572493|38846799|FG002|Overall Study|Switched to alternative treatment|2|||
16097055|NCT01572493|38846800|FG003|Overall Study|Switched to alternative treatment|1|||
16097056|NCT01572493|38846801|FG004|Overall Study|Switched to alternative treatment|2|||
16097057|NCT01572493|38846802|FG005|Overall Study|Switched to alternative treatment|0|||
16097058|NCT01572493|38846803|FG006|Overall Study|Switched to alternative treatment|2|||
16097059|NCT01572493|38846804|FG007|Overall Study|Switched to alternative treatment|0|||
16097060|NCT01572493|38846805|FG008|Overall Study|Switched to alternative treatment|2|||
16097061|NCT01572493|38846797|FG000|Overall Study|Death|0|||
16097062|NCT01572493|38846798|FG001|Overall Study|Death|0|||
16097063|NCT01572493|38846799|FG002|Overall Study|Death|0|||
16097064|NCT01572493|38846800|FG003|Overall Study|Death|1|||
16097065|NCT01572493|38846801|FG004|Overall Study|Death|0|||
16097066|NCT01572493|38846802|FG005|Overall Study|Death|1|||
16097067|NCT01572493|38846803|FG006|Overall Study|Death|0|||
16097068|NCT01572493|38846804|FG007|Overall Study|Death|0|||
16097069|NCT01572493|38846805|FG008|Overall Study|Death|0|||
16097070|NCT01572493|38846797|FG000|Overall Study|Adverse Event|0|||
16097071|NCT01572493|38846798|FG001|Overall Study|Adverse Event|0|||
16097072|NCT01572493|38846799|FG002|Overall Study|Adverse Event|0|||
16097073|NCT01572493|38846800|FG003|Overall Study|Adverse Event|0|||
16097074|NCT01572493|38846801|FG004|Overall Study|Adverse Event|0|||
16210438|NCT01094808|39251303|FG002|Overall Study|Withdrawal by Subject|0|||
16210439|NCT02667236|39251304|FG000|Overall Study|Adverse Event|1|||
16097075|NCT01572493|38846802|FG005|Overall Study|Adverse Event|0|||
16097076|NCT01572493|38846803|FG006|Overall Study|Adverse Event|1|||
16097077|NCT01572493|38846804|FG007|Overall Study|Adverse Event|0|||
16097078|NCT01572493|38846805|FG008|Overall Study|Adverse Event|0|||
16210440|NCT02667236|39251305|FG001|Overall Study|Adverse Event|1|||
16210441|NCT02667236|39251304|FG000|Overall Study|Withdrawal by Subject|2|||
16097079|NCT00841321|38846808|FG000|Overall Study|Lost to Follow-up|1|||
16097080|NCT00841321|38846809|FG001|Overall Study|Lost to Follow-up|1|||
16097081|NCT00841321|38846808|FG000|Overall Study|Adverse Event|0|||
16210442|NCT02667236|39251305|FG001|Overall Study|Withdrawal by Subject|0|||
16097082|NCT00841321|38846809|FG001|Overall Study|Adverse Event|2|||
16097083|NCT01280721|38846814|FG000|Overall Study|Adverse Event|4|||
16097084|NCT01280721|38846814|FG000|Overall Study|Physician Decision|3|||
16097085|NCT01280721|38846814|FG000|Overall Study|Withdrawal by Subject|6|||
16097086|NCT01280721|38846814|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
16097087|NCT01280721|38846814|FG000|Overall Study|No tolerability for the lowest dose|2|||
16097088|NCT03740919|38846815|FG000|Lead-in Period|Lost to Follow-up|1|||
16097089|NCT03740919|38846816|FG001|Lead-in Period|Lost to Follow-up|0|||
16097090|NCT03740919|38846817|FG002|Lead-in Period|Lost to Follow-up|0|||
16097091|NCT03740919|38846818|FG003|Lead-in Period|Lost to Follow-up|0|||
16097092|NCT03740919|38846815|FG000|Lead-in Period|Physician Decision|2|||
16097093|NCT03740919|38846816|FG001|Lead-in Period|Physician Decision|0|||
16097094|NCT03740919|38846817|FG002|Lead-in Period|Physician Decision|0|||
16097095|NCT03740919|38846818|FG003|Lead-in Period|Physician Decision|0|||
16097096|NCT03740919|38846815|FG000|Lead-in Period|Protocol Violation|1|||
16097097|NCT03740919|38846816|FG001|Lead-in Period|Protocol Violation|0|||
16097098|NCT03740919|38846817|FG002|Lead-in Period|Protocol Violation|0|||
16097099|NCT03740919|38846818|FG003|Lead-in Period|Protocol Violation|0|||
16525373|NCT01940900|40390970|FG000|Overall Study|Withdrawal by Subject|11|||
16525374|NCT01940900|40390971|FG001|Overall Study|Withdrawal by Subject|15|||
16525375|NCT01940900|40390970|FG000|Overall Study|Lost to Follow-up|1|||
16525376|NCT01940900|40390971|FG001|Overall Study|Lost to Follow-up|0|||
16525377|NCT01940900|40390970|FG000|Overall Study|Sponsor Decision|1|||
16525378|NCT01940900|40390971|FG001|Overall Study|Sponsor Decision|0|||
16525379|NCT01940900|40390970|FG000|Overall Study|subject non-compliance|1|||
16525380|NCT01940900|40390971|FG001|Overall Study|subject non-compliance|1|||
16525381|NCT01940900|40390970|FG000|Overall Study|other|1|||
16525382|NCT01940900|40390971|FG001|Overall Study|other|0|||
16525383|NCT02391948|40390972|FG000|6-month Assessment|Death|0|||
16525384|NCT02391948|40390973|FG001|6-month Assessment|Death|0|||
16525385|NCT02391948|40390974|FG002|6-month Assessment|Death|0|||
16525386|NCT02391948|40390975|FG003|6-month Assessment|Death|0|||
16525387|NCT02391948|40390976|FG004|6-month Assessment|Death|1|||
16525388|NCT02391948|40390972|FG000|6-month Assessment|Withdrawal by Subject|0|||
16525389|NCT02391948|40390973|FG001|6-month Assessment|Withdrawal by Subject|0|||
16097100|NCT03740919|38846815|FG000|Lead-in Period|Withdrawal by Subject|10|||
16097101|NCT03740919|38846816|FG001|Lead-in Period|Withdrawal by Subject|0|||
16097102|NCT03740919|38846817|FG002|Lead-in Period|Withdrawal by Subject|0|||
16097103|NCT03740919|38846818|FG003|Lead-in Period|Withdrawal by Subject|0|||
16097104|NCT03740919|38846815|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
16525390|NCT02391948|40390974|FG002|6-month Assessment|Withdrawal by Subject|1|||
16525391|NCT02391948|40390975|FG003|6-month Assessment|Withdrawal by Subject|2|||
16525392|NCT02391948|40390976|FG004|6-month Assessment|Withdrawal by Subject|0|||
16525393|NCT02391948|40390972|FG000|6-month Assessment|Lost to Follow-up|4|||
16525394|NCT02391948|40390973|FG001|6-month Assessment|Lost to Follow-up|5|||
16525395|NCT02391948|40390974|FG002|6-month Assessment|Lost to Follow-up|2|||
16525396|NCT02391948|40390975|FG003|6-month Assessment|Lost to Follow-up|3|||
16525397|NCT02391948|40390976|FG004|6-month Assessment|Lost to Follow-up|1|||
16525398|NCT02391948|40390972|FG000|6-month Assessment|Medical issue/illness|1|||
16329176|NCT00550862|39692419|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
16329177|NCT00550862|39692420|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
16329178|NCT00550862|39692421|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
16525399|NCT02391948|40390973|FG001|6-month Assessment|Medical issue/illness|1|||
16525400|NCT02391948|40390974|FG002|6-month Assessment|Medical issue/illness|0|||
16525401|NCT02391948|40390975|FG003|6-month Assessment|Medical issue/illness|0|||
16525402|NCT02391948|40390976|FG004|6-month Assessment|Medical issue/illness|0|||
16525403|NCT02391948|40390972|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
16525404|NCT02391948|40390973|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
16525405|NCT02391948|40390974|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
16525406|NCT02391948|40390975|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
16525407|NCT02391948|40390976|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
16525408|NCT02391948|40390972|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
16525409|NCT02391948|40390973|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
16525410|NCT02391948|40390974|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
16525411|NCT02391948|40390975|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
16525412|NCT02391948|40390976|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
16525413|NCT02391948|40390972|FG000|12-month Assessment|Death|0|||
16525414|NCT02391948|40390973|FG001|12-month Assessment|Death|0|||
16097105|NCT03740919|38846816|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
16097106|NCT03740919|38846817|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
16210443|NCT00595868|39251306|FG000|Overall Study|Lost to Follow-up|45|||
16525415|NCT02391948|40390974|FG002|12-month Assessment|Death|0|||
16525416|NCT02391948|40390975|FG003|12-month Assessment|Death|1|||
16525417|NCT02391948|40390976|FG004|12-month Assessment|Death|0|||
16525418|NCT02391948|40390972|FG000|12-month Assessment|Withdrawal by Subject|1|||
16525419|NCT02391948|40390973|FG001|12-month Assessment|Withdrawal by Subject|0|||
16329179|NCT00550862|39692422|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
16329180|NCT00550862|39692423|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
16329181|NCT00550862|39692419|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
16329182|NCT00550862|39692420|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
16329183|NCT00550862|39692421|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
16525420|NCT02391948|40390974|FG002|12-month Assessment|Withdrawal by Subject|0|||
16525421|NCT02391948|40390975|FG003|12-month Assessment|Withdrawal by Subject|1|||
16525422|NCT02391948|40390976|FG004|12-month Assessment|Withdrawal by Subject|0|||
16525423|NCT02391948|40390972|FG000|12-month Assessment|Lost to Follow-up|5|||
16525424|NCT02391948|40390973|FG001|12-month Assessment|Lost to Follow-up|4|||
16525425|NCT02391948|40390974|FG002|12-month Assessment|Lost to Follow-up|4|||
16525426|NCT02391948|40390975|FG003|12-month Assessment|Lost to Follow-up|4|||
16525427|NCT02391948|40390976|FG004|12-month Assessment|Lost to Follow-up|5|||
16525428|NCT02391948|40390972|FG000|12-month Assessment|Medical issue/illness|0|||
16525429|NCT02391948|40390973|FG001|12-month Assessment|Medical issue/illness|1|||
16525430|NCT02391948|40390974|FG002|12-month Assessment|Medical issue/illness|0|||
16525431|NCT02391948|40390975|FG003|12-month Assessment|Medical issue/illness|1|||
16525432|NCT02391948|40390976|FG004|12-month Assessment|Medical issue/illness|0|||
16525433|NCT02391948|40390972|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
16525434|NCT02391948|40390973|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
16525435|NCT02391948|40390974|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
16525436|NCT02391948|40390975|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
16525437|NCT02391948|40390976|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
16525438|NCT02391948|40390972|FG000|18-month Assessment|Death|0|||
16525439|NCT02391948|40390973|FG001|18-month Assessment|Death|0|||
16525440|NCT02391948|40390974|FG002|18-month Assessment|Death|0|||
16525441|NCT02391948|40390975|FG003|18-month Assessment|Death|1|||
16525442|NCT02391948|40390976|FG004|18-month Assessment|Death|1|||
16525443|NCT02391948|40390972|FG000|18-month Assessment|Withdrawal by Subject|1|||
16525444|NCT02391948|40390973|FG001|18-month Assessment|Withdrawal by Subject|0|||
16525445|NCT02391948|40390974|FG002|18-month Assessment|Withdrawal by Subject|0|||
16525446|NCT02391948|40390975|FG003|18-month Assessment|Withdrawal by Subject|1|||
16525447|NCT02391948|40390976|FG004|18-month Assessment|Withdrawal by Subject|0|||
16525448|NCT02391948|40390972|FG000|18-month Assessment|Lost to Follow-up|2|||
16525449|NCT02391948|40390973|FG001|18-month Assessment|Lost to Follow-up|6|||
16525450|NCT02391948|40390974|FG002|18-month Assessment|Lost to Follow-up|2|||
16525451|NCT02391948|40390975|FG003|18-month Assessment|Lost to Follow-up|2|||
16525452|NCT02391948|40390976|FG004|18-month Assessment|Lost to Follow-up|3|||
16525453|NCT02391948|40390972|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
16525454|NCT02391948|40390973|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
16525455|NCT02391948|40390974|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
16525456|NCT02391948|40390975|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
16525457|NCT02391948|40390976|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
16525458|NCT02391948|40390972|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
16525459|NCT02391948|40390973|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
16525460|NCT02391948|40390974|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
16525461|NCT02391948|40390975|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
16525462|NCT02391948|40390976|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
16525463|NCT02391948|40390972|FG000|24-month Assessment|Death|0|||
16525464|NCT02391948|40390973|FG001|24-month Assessment|Death|0|||
16525465|NCT02391948|40390974|FG002|24-month Assessment|Death|0|||
16525466|NCT02391948|40390975|FG003|24-month Assessment|Death|0|||
16525467|NCT02391948|40390976|FG004|24-month Assessment|Death|1|||
16525468|NCT02391948|40390972|FG000|24-month Assessment|Withdrawal by Subject|1|||
16525469|NCT02391948|40390973|FG001|24-month Assessment|Withdrawal by Subject|1|||
16525470|NCT02391948|40390974|FG002|24-month Assessment|Withdrawal by Subject|0|||
16525471|NCT02391948|40390975|FG003|24-month Assessment|Withdrawal by Subject|0|||
16525472|NCT02391948|40390976|FG004|24-month Assessment|Withdrawal by Subject|1|||
16525473|NCT02391948|40390972|FG000|24-month Assessment|Lost to Follow-up|5|||
16525474|NCT02391948|40390973|FG001|24-month Assessment|Lost to Follow-up|4|||
16525475|NCT02391948|40390974|FG002|24-month Assessment|Lost to Follow-up|0|||
16525476|NCT02391948|40390975|FG003|24-month Assessment|Lost to Follow-up|0|||
16525477|NCT02391948|40390976|FG004|24-month Assessment|Lost to Follow-up|0|||
16525478|NCT02391948|40390972|FG000|24-month Assessment|Medical issue/illness|0|||
16525479|NCT02391948|40390973|FG001|24-month Assessment|Medical issue/illness|0|||
16329184|NCT00550862|39692422|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
16329185|NCT00550862|39692423|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
16329186|NCT00550862|39692419|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
16329187|NCT00550862|39692420|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
16329188|NCT00550862|39692421|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
16525480|NCT02391948|40390974|FG002|24-month Assessment|Medical issue/illness|1|||
16525481|NCT02391948|40390975|FG003|24-month Assessment|Medical issue/illness|0|||
16525482|NCT02391948|40390976|FG004|24-month Assessment|Medical issue/illness|0|||
16525483|NCT02391948|40390972|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
16525484|NCT02391948|40390973|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
16525485|NCT02391948|40390974|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
16525486|NCT02391948|40390975|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
16525487|NCT02391948|40390976|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
16525488|NCT01105533|40390977|FG000|Overall Study|Death|0|||
16525489|NCT01105533|40390978|FG001|Overall Study|Death|0|||
16525490|NCT01105533|40390979|FG002|Overall Study|Death|0|||
16525491|NCT01105533|40390980|FG003|Overall Study|Death|0|||
16525492|NCT01105533|40390981|FG004|Overall Study|Death|1|||
16525493|NCT01105533|40390982|FG005|Overall Study|Death|0|||
16525494|NCT01105533|40390983|FG006|Overall Study|Death|0|||
16525495|NCT01105533|40390984|FG007|Overall Study|Death|0|||
16525496|NCT01105533|40390985|FG008|Overall Study|Death|0|||
16525497|NCT01105533|40390977|FG000|Overall Study|Lack of Efficacy|1|||
16525498|NCT01105533|40390978|FG001|Overall Study|Lack of Efficacy|1|||
16525499|NCT01105533|40390979|FG002|Overall Study|Lack of Efficacy|3|||
16525500|NCT01105533|40390980|FG003|Overall Study|Lack of Efficacy|3|||
16525501|NCT01105533|40390981|FG004|Overall Study|Lack of Efficacy|4|||
16525502|NCT01105533|40390982|FG005|Overall Study|Lack of Efficacy|5|||
16525503|NCT01105533|40390983|FG006|Overall Study|Lack of Efficacy|3|||
16525504|NCT01105533|40390984|FG007|Overall Study|Lack of Efficacy|2|||
16525505|NCT01105533|40390985|FG008|Overall Study|Lack of Efficacy|9|||
16525506|NCT01105533|40390977|FG000|Overall Study|Adverse Event|0|||
16525507|NCT01105533|40390978|FG001|Overall Study|Adverse Event|0|||
16525508|NCT01105533|40390979|FG002|Overall Study|Adverse Event|0|||
16525509|NCT01105533|40390980|FG003|Overall Study|Adverse Event|0|||
16525510|NCT01105533|40390981|FG004|Overall Study|Adverse Event|1|||
16097107|NCT03740919|38846818|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
16097108|NCT03740919|38846815|FG000|Lead-in Period|Study Task Too Burdensome|1|||
16097109|NCT03740919|38846816|FG001|Lead-in Period|Study Task Too Burdensome|0|||
16097110|NCT03740919|38846817|FG002|Lead-in Period|Study Task Too Burdensome|0|||
16097111|NCT03740919|38846818|FG003|Lead-in Period|Study Task Too Burdensome|0|||
16097112|NCT03740919|38846815|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
16097113|NCT03740919|38846816|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
16097114|NCT03740919|38846817|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
16097115|NCT03740919|38846818|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
16097116|NCT03740919|38846815|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
16097117|NCT03740919|38846816|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
16097118|NCT03740919|38846817|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
16097119|NCT03740919|38846818|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
16097120|NCT03740919|38846815|FG000|Treatment Period|Adverse Event|0|||
16097121|NCT03740919|38846816|FG001|Treatment Period|Adverse Event|0|||
16097122|NCT03740919|38846817|FG002|Treatment Period|Adverse Event|2|||
16097123|NCT03740919|38846818|FG003|Treatment Period|Adverse Event|0|||
16097124|NCT03740919|38846815|FG000|Treatment Period|Protocol Violation|0|||
16097125|NCT03740919|38846816|FG001|Treatment Period|Protocol Violation|1|||
16097126|NCT03740919|38846817|FG002|Treatment Period|Protocol Violation|0|||
16210444|NCT00595868|39251307|FG001|Overall Study|Lost to Follow-up|50|||
16210445|NCT03128307|39251308|FG000|Overall Study|Lost to Follow-up|29|||
16210446|NCT03128307|39251308|FG000|Overall Study|Withdrawal by Subject|5|||
16210447|NCT00777257|39251322|FG000|Overall Study|Adverse Event|3|||
16210448|NCT00777257|39251323|FG001|Overall Study|Adverse Event|1|||
16210449|NCT00777257|39251324|FG002|Overall Study|Adverse Event|0|||
16210450|NCT00777257|39251322|FG000|Overall Study|Lost to Follow-up|3|||
16210451|NCT00777257|39251323|FG001|Overall Study|Lost to Follow-up|3|||
16210452|NCT00777257|39251324|FG002|Overall Study|Lost to Follow-up|2|||
16210453|NCT00777257|39251322|FG000|Overall Study|Protocol Violation|2|||
16210454|NCT00777257|39251323|FG001|Overall Study|Protocol Violation|2|||
16525511|NCT01105533|40390982|FG005|Overall Study|Adverse Event|2|||
16525512|NCT01105533|40390983|FG006|Overall Study|Adverse Event|2|||
16525513|NCT01105533|40390984|FG007|Overall Study|Adverse Event|0|||
16525514|NCT01105533|40390985|FG008|Overall Study|Adverse Event|1|||
16210455|NCT00777257|39251324|FG002|Overall Study|Protocol Violation|2|||
16210456|NCT00777257|39251322|FG000|Overall Study|Withdrawal by Subject|3|||
16525515|NCT01105533|40390977|FG000|Overall Study|Other|0|||
16525516|NCT01105533|40390978|FG001|Overall Study|Other|0|||
16525517|NCT01105533|40390979|FG002|Overall Study|Other|0|||
16210457|NCT00777257|39251323|FG001|Overall Study|Withdrawal by Subject|6|||
16210458|NCT00777257|39251324|FG002|Overall Study|Withdrawal by Subject|5|||
16210459|NCT03447769|39251332|FG000|Overall Study|Progressive disease|138|||
16210460|NCT03447769|39251333|FG001|Overall Study|Progressive disease|148|||
16210461|NCT03447769|39251332|FG000|Overall Study|Study terminated by Sponsor|60|||
16210462|NCT03447769|39251333|FG001|Overall Study|Study terminated by Sponsor|44|||
16210463|NCT03447769|39251332|FG000|Overall Study|Adverse Event|34|||
16210464|NCT03447769|39251333|FG001|Overall Study|Adverse Event|31|||
16210465|NCT03447769|39251332|FG000|Overall Study|Patient decision|27|||
16210466|NCT03447769|39251333|FG001|Overall Study|Patient decision|27|||
16210467|NCT03447769|39251332|FG000|Overall Study|Protocol deviation|4|||
16210468|NCT03447769|39251333|FG001|Overall Study|Protocol deviation|6|||
16210469|NCT03447769|39251332|FG000|Overall Study|Death|2|||
16210470|NCT03447769|39251333|FG001|Overall Study|Death|7|||
16210471|NCT03447769|39251332|FG000|Overall Study|Technical problems|1|||
16210472|NCT03447769|39251333|FG001|Overall Study|Technical problems|0|||
16210473|NCT03447769|39251332|FG000|Overall Study|Lost to Follow-up|0|||
16210474|NCT03447769|39251333|FG001|Overall Study|Lost to Follow-up|1|||
16210475|NCT03447769|39251332|FG000|Overall Study|Physician Decision|13|||
16210476|NCT03447769|39251333|FG001|Overall Study|Physician Decision|5|||
16210477|NCT01263444|39251334|FG000|Overall Study|Adverse Event|8|||
16210478|NCT01263444|39251334|FG000|Overall Study|Withdrawal by Subject|1|||
16210479|NCT01263444|39251334|FG000|Overall Study|Protocol Violation|1|||
16210480|NCT02786836|39251335|FG000|Overall Study|Death|1|||
16210481|NCT02786836|39251335|FG000|Overall Study|Lack of Efficacy|2|||
16210482|NCT02786836|39251335|FG000|Overall Study|Protocol Violation|3|||
16210483|NCT02786836|39251335|FG000|Overall Study|Withdrawal by Subject|3|||
16210484|NCT02786836|39251335|FG000|Overall Study|Liver Transplantation|2|||
16210485|NCT02786836|39251335|FG000|Overall Study|Device or Pharmacy Issues|3|||
16210486|NCT04599972|39251343|FG000|Overall Study|Withdrawal by Subject|6|||
16210487|NCT04599972|39251344|FG001|Overall Study|Withdrawal by Subject|1|||
16210488|NCT04599972|39251343|FG000|Overall Study|Adverse Event|1|||
16210489|NCT04599972|39251344|FG001|Overall Study|Adverse Event|1|||
16210490|NCT04599972|39251343|FG000|Overall Study|Lost to Follow-up|1|||
16210491|NCT04599972|39251344|FG001|Overall Study|Lost to Follow-up|6|||
16210492|NCT04599972|39251343|FG000|Overall Study|Protocol Violation|1|||
16210493|NCT04599972|39251344|FG001|Overall Study|Protocol Violation|0|||
16210494|NCT04599972|39251343|FG000|Overall Study|Other reason|1|||
16210495|NCT04599972|39251344|FG001|Overall Study|Other reason|0|||
16210496|NCT02143141|39251345|FG000|Overall Study|pain scores at 24 hours not collected|1|||
16210497|NCT02143141|39251346|FG001|Overall Study|pain scores at 24 hours not collected|0|||
16210498|NCT01117181|39251348|FG000|Overall Study|Lost to Follow-up|1|||
16210499|NCT01117181|39251349|FG001|Overall Study|Lost to Follow-up|0|||
16210500|NCT01117181|39251348|FG000|Overall Study|Withdrawal by Subject|0|||
16210501|NCT01117181|39251349|FG001|Overall Study|Withdrawal by Subject|2|||
16210502|NCT00431496|39251350|FG000|Overall Study|Adverse Event|3|||
16210503|NCT00431496|39251350|FG000|Overall Study|Lost to Follow-up|1|||
16210504|NCT00431496|39251350|FG000|Overall Study|Withdrawal by Subject|2|||
16210505|NCT00431496|39251350|FG000|Overall Study|Protocol-specified criteria|5|||
16210506|NCT01673490|39251351|FG000|Overall Study|Lost to Follow-up|1|||
16210507|NCT01673490|39251351|FG000|Overall Study|Adverse Event|3|||
16210508|NCT01673490|39251351|FG000|Overall Study|Withdrawal by Subject|3|||
16210509|NCT03510910|39251352|FG000|Overall Study|Incomplete Survey|2|||
16210510|NCT03510910|39251353|FG001|Overall Study|Incomplete Survey|3|||
16210511|NCT04063865|39251354|FG000|Overall Study|Physician Decision|1|||
16398218|NCT01672879|39938664|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
16398219|NCT02467192|39938665|FG000|Overall Study|Death|1|||
16398220|NCT02467192|39938665|FG000|Overall Study|revealed to have pneumonia before|2|||
16398221|NCT04776161|39938670|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
16210512|NCT04063865|39251355|FG001|Overall Study|Physician Decision|3|||
16210513|NCT04063865|39251354|FG000|Overall Study|Study Closed Prior to Completion|4|||
16210514|NCT04063865|39251355|FG001|Overall Study|Study Closed Prior to Completion|4|||
16210515|NCT04063865|39251354|FG000|Overall Study|Withdrawal by Subject|1|||
16210516|NCT04063865|39251355|FG001|Overall Study|Withdrawal by Subject|1|||
16210517|NCT03518034|39251356|FG000|Overall Study|Not Treated|5|||
16210518|NCT03518034|39251357|FG001|Overall Study|Not Treated|1|||
16210519|NCT03518034|39251356|FG000|Overall Study|Withdrawal by Subject|309|||
16210520|NCT03518034|39251357|FG001|Overall Study|Withdrawal by Subject|351|||
16210521|NCT03518034|39251356|FG000|Overall Study|Lost to Follow-up|446|||
16398222|NCT04776161|39938671|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
16210522|NCT03518034|39251357|FG001|Overall Study|Lost to Follow-up|458|||
16210523|NCT03518034|39251356|FG000|Overall Study|Adverse Event|138|||
16210524|NCT03518034|39251357|FG001|Overall Study|Adverse Event|130|||
16210525|NCT03518034|39251356|FG000|Overall Study|Lack of Efficacy|11|||
16210526|NCT03518034|39251357|FG001|Overall Study|Lack of Efficacy|23|||
16210527|NCT03518034|39251356|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
16210528|NCT03518034|39251357|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
16210529|NCT03518034|39251356|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
16210530|NCT03518034|39251357|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
16210531|NCT03518034|39251356|FG000|Overall Study|Other, Not Specified|84|||
16210532|NCT03518034|39251357|FG001|Overall Study|Other, Not Specified|53|||
16210533|NCT03518034|39251356|FG000|Overall Study|Reason Missing|2|||
16210534|NCT03518034|39251357|FG001|Overall Study|Reason Missing|3|||
16210535|NCT04095793|39251362|FG000|Overall Study|Adverse Event|3|||
16210536|NCT04095793|39251362|FG000|Overall Study|Study Terminated by Sponsor|103|||
16210537|NCT04095793|39251362|FG000|Overall Study|Withdrawal by Subject|4|||
16210538|NCT01098032|39251363|FG000|Overall Study|Withdrawal by Subject|1|||
16210539|NCT01098032|39251364|FG001|Overall Study|Withdrawal by Subject|1|||
16210540|NCT04228445|39251365|FG000|Overall Study|Lost to Follow-up|1|||
16210541|NCT04228445|39251366|FG001|Overall Study|Lost to Follow-up|1|||
16210542|NCT04228445|39251365|FG000|Overall Study|Physician Decision|1|||
16210543|NCT04228445|39251366|FG001|Overall Study|Physician Decision|2|||
16210544|NCT04228445|39251365|FG000|Overall Study|Withdrawal by Subject|0|||
16210545|NCT04228445|39251366|FG001|Overall Study|Withdrawal by Subject|1|||
16210546|NCT04228445|39251365|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
16210547|NCT04228445|39251366|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
16210548|NCT01412151|39251367|FG000|Week 0 - 306 - Treatment Period|Death|1|||
16210549|NCT01412151|39251367|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
16210550|NCT01412151|39251367|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
16210551|NCT01412151|39251367|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
16210552|NCT02327078|39251369|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
16210553|NCT02327078|39251370|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
16210554|NCT02327078|39251371|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
16210555|NCT02327078|39251372|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
16329189|NCT00550862|39692422|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
16329190|NCT00550862|39692423|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
16329191|NCT00550862|39692419|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
16329192|NCT00550862|39692420|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
16329193|NCT00550862|39692421|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
16329194|NCT00550862|39692422|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
16329195|NCT00550862|39692423|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
16329196|NCT00550862|39692419|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
16329197|NCT00550862|39692420|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
16329198|NCT00550862|39692421|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
16329199|NCT00550862|39692422|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
16329200|NCT00550862|39692423|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
16329201|NCT00550862|39692419|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
16329202|NCT00550862|39692420|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
16329203|NCT00550862|39692421|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
16329204|NCT00550862|39692422|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
16329205|NCT00550862|39692423|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
16329206|NCT00504725|39692425|FG000|Overall Study|Protocol Violation|1|||
16329207|NCT00504725|39692426|FG001|Overall Study|Protocol Violation|0|||
16329208|NCT01732471|39692433|FG000|Overall Study|Withdrawal by Subject|1|||
16329209|NCT01874353|39692434|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
16329210|NCT01874353|39692435|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
16329211|NCT01874353|39692436|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
16329212|NCT01874353|39692437|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
16329213|NCT01874353|39692434|FG000|Overall Study|Lost to Follow-up|2|||
16329214|NCT01874353|39692435|FG001|Overall Study|Lost to Follow-up|2|||
16329215|NCT01874353|39692436|FG002|Overall Study|Lost to Follow-up|2|||
16329216|NCT01874353|39692437|FG003|Overall Study|Lost to Follow-up|0|||
16329217|NCT01874353|39692434|FG000|Overall Study|Death|110|||
16329218|NCT01874353|39692435|FG001|Overall Study|Death|60|||
16329219|NCT01874353|39692436|FG002|Overall Study|Death|13|||
16329220|NCT01874353|39692437|FG003|Overall Study|Death|7|||
16329221|NCT01874353|39692434|FG000|Overall Study|Withdrawal by Subject|13|||
16329222|NCT01874353|39692435|FG001|Overall Study|Withdrawal by Subject|11|||
16097127|NCT03740919|38846818|FG003|Treatment Period|Protocol Violation|0|||
16329223|NCT01874353|39692436|FG002|Overall Study|Withdrawal by Subject|0|||
16329224|NCT01874353|39692437|FG003|Overall Study|Withdrawal by Subject|0|||
16398223|NCT04776161|39938672|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
16398224|NCT04776161|39938670|FG000|Overall Study|Withdrawal by Subject|1|||
16398225|NCT04776161|39938671|FG001|Overall Study|Withdrawal by Subject|0|||
16398226|NCT04776161|39938672|FG002|Overall Study|Withdrawal by Subject|1|||
16398227|NCT04776161|39938670|FG000|Overall Study|Adverse Event|0|||
16398228|NCT04776161|39938671|FG001|Overall Study|Adverse Event|1|||
16398229|NCT04776161|39938672|FG002|Overall Study|Adverse Event|1|||
16398230|NCT00306293|39938673|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
16398231|NCT00306293|39938674|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
16398232|NCT00306293|39938673|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
16398233|NCT00306293|39938674|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
16398234|NCT00306293|39938673|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
16398235|NCT00306293|39938674|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
16398236|NCT00306293|39938673|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
16398237|NCT00306293|39938674|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
16398238|NCT00306293|39938673|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
16525518|NCT01105533|40390980|FG003|Overall Study|Other|0|||
16525519|NCT01105533|40390981|FG004|Overall Study|Other|1|||
16525520|NCT01105533|40390982|FG005|Overall Study|Other|0|||
16525521|NCT01105533|40390983|FG006|Overall Study|Other|3|||
16525522|NCT01105533|40390984|FG007|Overall Study|Other|1|||
16525523|NCT01105533|40390985|FG008|Overall Study|Other|2|||
16525524|NCT01105533|40390977|FG000|Overall Study|Physician Decision|0|||
16525525|NCT01105533|40390978|FG001|Overall Study|Physician Decision|0|||
16525526|NCT01105533|40390979|FG002|Overall Study|Physician Decision|0|||
16525527|NCT01105533|40390980|FG003|Overall Study|Physician Decision|0|||
16525528|NCT01105533|40390981|FG004|Overall Study|Physician Decision|0|||
16525529|NCT01105533|40390982|FG005|Overall Study|Physician Decision|0|||
16525530|NCT01105533|40390983|FG006|Overall Study|Physician Decision|0|||
16525531|NCT01105533|40390984|FG007|Overall Study|Physician Decision|1|||
16525532|NCT01105533|40390985|FG008|Overall Study|Physician Decision|0|||
16525533|NCT00659646|40390986|FG000|Overall Study|Protocol Violation|12|||
16525534|NCT00659646|40390987|FG001|Overall Study|Protocol Violation|8|||
16525535|NCT00659646|40390986|FG000|Overall Study|Adverse Event|1|||
16525536|NCT00659646|40390987|FG001|Overall Study|Adverse Event|0|||
16525537|NCT00659646|40390986|FG000|Overall Study|Lost to Follow-up|1|||
16525538|NCT00659646|40390987|FG001|Overall Study|Lost to Follow-up|0|||
16525539|NCT00659646|40390986|FG000|Overall Study|protocol noncompliance after randomized|1|||
16525540|NCT00659646|40390987|FG001|Overall Study|protocol noncompliance after randomized|0|||
16525541|NCT00617240|40390995|FG000|Overall Study|Lack of Efficacy|1|||
16525542|NCT00617240|40390996|FG001|Overall Study|Lack of Efficacy|0|||
16525543|NCT02519504|40390999|FG000|Overall Study|Protocol Violation|6|||
16329225|NCT00574795|39692438|FG000|Infant Series|Withdrawal by Subject|2|||
16329226|NCT00574795|39692438|FG000|Infant Series|Protocol Violation|2|||
16329227|NCT00574795|39692438|FG000|Infant Series|Adverse Event|1|||
16329228|NCT00574795|39692438|FG000|After Infant Series|Withdrawal by Subject|1|||
16525544|NCT02519504|40391000|FG001|Overall Study|Protocol Violation|5|||
16525545|NCT02519504|40390999|FG000|Overall Study|Ineligible for direct testing|12|||
16525546|NCT02519504|40391000|FG001|Overall Study|Ineligible for direct testing|12|||
16525547|NCT02519504|40390999|FG000|Overall Study|Did not participate in direct testing|95|||
16525548|NCT02519504|40391000|FG001|Overall Study|Did not participate in direct testing|86|||
16525549|NCT01165281|40391001|FG000|Overall Study|Adverse Event|12|||
16525550|NCT01165281|40391002|FG001|Overall Study|Adverse Event|14|||
16525551|NCT01165281|40391001|FG000|Overall Study|Death|3|||
16329229|NCT00574795|39692438|FG000|After Infant Series|Adverse Event|2|||
16329230|NCT00574795|39692438|FG000|Toddler Dose|Withdrawal by Subject|1|||
16329231|NCT02396420|39692444|FG000|Overall Study|Death|1|||
16329232|NCT05108922|39692445|FG000|Overall Study|Adverse Event|0|||
16329233|NCT05108922|39692446|FG001|Overall Study|Adverse Event|1|||
16329234|NCT05108922|39692445|FG000|Overall Study|Physician Decision|1|||
16329235|NCT05108922|39692446|FG001|Overall Study|Physician Decision|1|||
16329236|NCT05108922|39692445|FG000|Overall Study|Screen Failure|1|||
16329237|NCT05108922|39692446|FG001|Overall Study|Screen Failure|1|||
16329238|NCT05108922|39692445|FG000|Overall Study|Withdrawal by Subject|7|||
16329239|NCT05108922|39692446|FG001|Overall Study|Withdrawal by Subject|4|||
16329240|NCT00094536|39692457|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
16329241|NCT00094536|39692457|FG000|Treatment and Follow-up|Adverse Event|4|||
16329242|NCT00094536|39692457|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
16329243|NCT00094536|39692457|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
16329244|NCT00094536|39692457|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
16329245|NCT00094536|39692457|FG000|Treatment and Follow-up|Subject non-compliance|9|||
16329246|NCT00094536|39692457|FG000|Treatment and Follow-up|Unable to attend visits|1|||
16329247|NCT02284568|39692459|FG000|Overall Study|Adverse Event|2|||
16329248|NCT02284568|39692460|FG001|Overall Study|Adverse Event|9|||
16329249|NCT02284568|39692461|FG002|Overall Study|Adverse Event|4|||
16329250|NCT02284568|39692459|FG000|Overall Study|Withdrawal by Subject|22|||
16329251|NCT02284568|39692460|FG001|Overall Study|Withdrawal by Subject|21|||
16329252|NCT02284568|39692461|FG002|Overall Study|Withdrawal by Subject|1|||
16329253|NCT02284568|39692459|FG000|Overall Study|Noncompliance with study drug admin|1|||
16329254|NCT02284568|39692460|FG001|Overall Study|Noncompliance with study drug admin|2|||
16329255|NCT02284568|39692461|FG002|Overall Study|Noncompliance with study drug admin|0|||
16525552|NCT01165281|40391002|FG001|Overall Study|Death|4|||
16525553|NCT01165281|40391001|FG000|Overall Study|Lack of Efficacy|4|||
16525554|NCT01165281|40391002|FG001|Overall Study|Lack of Efficacy|1|||
16525555|NCT01165281|40391001|FG000|Overall Study|Lost to Follow-up|0|||
16525556|NCT01165281|40391002|FG001|Overall Study|Lost to Follow-up|1|||
16525557|NCT01165281|40391001|FG000|Overall Study|Physician Decision|8|||
16525558|NCT01165281|40391002|FG001|Overall Study|Physician Decision|1|||
16525559|NCT01165281|40391001|FG000|Overall Study|Protocol Violation|6|||
16329256|NCT02284568|39692459|FG000|Overall Study|Noncompliance|1|||
16329257|NCT02284568|39692460|FG001|Overall Study|Noncompliance|0|||
16329258|NCT02284568|39692461|FG002|Overall Study|Noncompliance|0|||
16329259|NCT02284568|39692459|FG000|Overall Study|Protocol Violation|0|||
16329260|NCT02284568|39692460|FG001|Overall Study|Protocol Violation|1|||
16398239|NCT00306293|39938674|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
16398240|NCT00306293|39938673|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
16398241|NCT00306293|39938674|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
16398242|NCT00306293|39938673|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
16398243|NCT00306293|39938674|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
16398244|NCT00306293|39938673|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
16398245|NCT00306293|39938674|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
16398246|NCT00152477|39938675|FG000|Chemotherapy Period|Adverse Event|9|||
16398247|NCT00152477|39938676|FG001|Chemotherapy Period|Adverse Event|4|||
16398248|NCT00152477|39938677|FG002|Chemotherapy Period|Adverse Event|5|||
16398249|NCT00152477|39938675|FG000|Chemotherapy Period|Death|1|||
16398250|NCT00152477|39938676|FG001|Chemotherapy Period|Death|3|||
16398251|NCT00152477|39938677|FG002|Chemotherapy Period|Death|3|||
16329261|NCT02284568|39692461|FG002|Overall Study|Protocol Violation|0|||
16398252|NCT00152477|39938675|FG000|Chemotherapy Period|Lack of Efficacy|4|||
16398253|NCT00152477|39938676|FG001|Chemotherapy Period|Lack of Efficacy|5|||
16398254|NCT00152477|39938677|FG002|Chemotherapy Period|Lack of Efficacy|6|||
16398255|NCT00152477|39938675|FG000|Chemotherapy Period|Lost to Follow-up|1|||
16398256|NCT00152477|39938676|FG001|Chemotherapy Period|Lost to Follow-up|0|||
16398257|NCT00152477|39938677|FG002|Chemotherapy Period|Lost to Follow-up|1|||
16398258|NCT00152477|39938675|FG000|Chemotherapy Period|Protocol Violation|1|||
16398259|NCT00152477|39938676|FG001|Chemotherapy Period|Protocol Violation|1|||
16398260|NCT00152477|39938677|FG002|Chemotherapy Period|Protocol Violation|0|||
16398261|NCT00152477|39938675|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
16398262|NCT00152477|39938676|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
16398263|NCT00152477|39938677|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
16398264|NCT00152477|39938675|FG000|Chemotherapy Period|Progression of Disease|6|||
16398265|NCT00152477|39938676|FG001|Chemotherapy Period|Progression of Disease|8|||
16398266|NCT00152477|39938677|FG002|Chemotherapy Period|Progression of Disease|4|||
16398267|NCT00152477|39938675|FG000|Chemotherapy Period|Investigator decision|0|||
16398268|NCT00152477|39938676|FG001|Chemotherapy Period|Investigator decision|0|||
16398269|NCT00152477|39938677|FG002|Chemotherapy Period|Investigator decision|1|||
16398270|NCT00152477|39938675|FG000|Chemotherapy Period|Patient condition worsened|1|||
16398271|NCT00152477|39938676|FG001|Chemotherapy Period|Patient condition worsened|0|||
16398272|NCT00152477|39938677|FG002|Chemotherapy Period|Patient condition worsened|0|||
16398273|NCT00152477|39938675|FG000|Monotherapy Period|Adverse Event|1|||
16398274|NCT00152477|39938676|FG001|Monotherapy Period|Adverse Event|0|||
16398275|NCT00152477|39938677|FG002|Monotherapy Period|Adverse Event|5|||
16398276|NCT00152477|39938675|FG000|Monotherapy Period|Death|2|||
16398277|NCT00152477|39938676|FG001|Monotherapy Period|Death|0|||
16398278|NCT00152477|39938677|FG002|Monotherapy Period|Death|1|||
16398279|NCT00152477|39938675|FG000|Monotherapy Period|Lack of Efficacy|7|||
16398280|NCT00152477|39938676|FG001|Monotherapy Period|Lack of Efficacy|16|||
16398281|NCT00152477|39938677|FG002|Monotherapy Period|Lack of Efficacy|10|||
16398282|NCT00152477|39938675|FG000|Monotherapy Period|Protocol Violation|0|||
16398283|NCT00152477|39938676|FG001|Monotherapy Period|Protocol Violation|1|||
16398284|NCT00152477|39938677|FG002|Monotherapy Period|Protocol Violation|0|||
16398285|NCT00152477|39938675|FG000|Monotherapy Period|Withdrawal by Subject|0|||
16398286|NCT00152477|39938676|FG001|Monotherapy Period|Withdrawal by Subject|0|||
16398287|NCT00152477|39938677|FG002|Monotherapy Period|Withdrawal by Subject|4|||
16398288|NCT00152477|39938675|FG000|Monotherapy Period|Progression of Disease|5|||
16398289|NCT00152477|39938676|FG001|Monotherapy Period|Progression of Disease|11|||
16398290|NCT00152477|39938677|FG002|Monotherapy Period|Progression of Disease|12|||
16398291|NCT00152477|39938675|FG000|Monotherapy Period|Patient decision|0|||
16398292|NCT00152477|39938676|FG001|Monotherapy Period|Patient decision|1|||
16398293|NCT00152477|39938677|FG002|Monotherapy Period|Patient decision|1|||
16398294|NCT00152477|39938675|FG000|Monotherapy Period|Study personel decision|0|||
16398295|NCT00152477|39938676|FG001|Monotherapy Period|Study personel decision|0|||
16398296|NCT00152477|39938677|FG002|Monotherapy Period|Study personel decision|1|||
16398297|NCT01208961|39938681|FG000|High-Fat Period III|Protocol Violation|1|||
16398298|NCT01208961|39938682|FG001|High-Fat Period III|Protocol Violation|0|||
16398299|NCT01229254|39938684|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
16398300|NCT01229254|39938685|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
16398301|NCT01229254|39938686|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
16398302|NCT01229254|39938684|FG000|Overall Study|Adverse Event|4|||
16398303|NCT01229254|39938685|FG001|Overall Study|Adverse Event|5|||
16398304|NCT01229254|39938686|FG002|Overall Study|Adverse Event|3|||
16398305|NCT01229254|39938684|FG000|Overall Study|Lost to Follow-up|3|||
16398306|NCT01229254|39938685|FG001|Overall Study|Lost to Follow-up|0|||
16398307|NCT01229254|39938686|FG002|Overall Study|Lost to Follow-up|1|||
16398308|NCT01229254|39938684|FG000|Overall Study|Physician Decision|0|||
16398309|NCT01229254|39938685|FG001|Overall Study|Physician Decision|3|||
16398310|NCT01229254|39938686|FG002|Overall Study|Physician Decision|0|||
16398311|NCT01229254|39938684|FG000|Overall Study|Protocol Violation|4|||
16398312|NCT01229254|39938685|FG001|Overall Study|Protocol Violation|6|||
16398313|NCT01229254|39938686|FG002|Overall Study|Protocol Violation|5|||
16398314|NCT01229254|39938684|FG000|Overall Study|Withdrawal by Subject|1|||
16398315|NCT01229254|39938685|FG001|Overall Study|Withdrawal by Subject|0|||
16398316|NCT01229254|39938686|FG002|Overall Study|Withdrawal by Subject|1|||
16398317|NCT01229254|39938684|FG000|Overall Study|Non-compliance with Study Drug|0|||
16398318|NCT01229254|39938685|FG001|Overall Study|Non-compliance with Study Drug|1|||
16398319|NCT01229254|39938686|FG002|Overall Study|Non-compliance with Study Drug|1|||
16398320|NCT01108731|39938694|FG000|Overall Study|Withdrawal by Subject|1|||
16398321|NCT01108731|39938695|FG001|Overall Study|Withdrawal by Subject|1|||
16398322|NCT01108731|39938694|FG000|Overall Study|Adverse Event|3|||
16398323|NCT01108731|39938695|FG001|Overall Study|Adverse Event|3|||
16398324|NCT00054327|39938696|FG000|Overall Study|Engraftment failure|1|||
16398325|NCT00054327|39938697|FG001|Overall Study|Engraftment failure|0|||
16398326|NCT00054327|39938698|FG002|Overall Study|Engraftment failure|0|||
16398327|NCT00054327|39938699|FG003|Overall Study|Engraftment failure|0|||
16398328|NCT00054327|39938700|FG004|Overall Study|Engraftment failure|0|||
16398329|NCT00054327|39938701|FG005|Overall Study|Engraftment failure|0|||
16097128|NCT03740919|38846815|FG000|Treatment Period|Withdrawal by Subject|0|||
16097129|NCT03740919|38846816|FG001|Treatment Period|Withdrawal by Subject|7|||
16097130|NCT03740919|38846817|FG002|Treatment Period|Withdrawal by Subject|6|||
16097131|NCT03740919|38846818|FG003|Treatment Period|Withdrawal by Subject|2|||
16097132|NCT03740919|38846815|FG000|Treatment Period|Terminated by Sponsor|0|||
16097133|NCT03740919|38846816|FG001|Treatment Period|Terminated by Sponsor|1|||
16097134|NCT03740919|38846817|FG002|Treatment Period|Terminated by Sponsor|0|||
16097135|NCT03740919|38846818|FG003|Treatment Period|Terminated by Sponsor|0|||
16097136|NCT03740919|38846815|FG000|Treatment Period|Issue with Insulin Pump|0|||
16097137|NCT03740919|38846816|FG001|Treatment Period|Issue with Insulin Pump|1|||
16097138|NCT03740919|38846817|FG002|Treatment Period|Issue with Insulin Pump|0|||
16097139|NCT03740919|38846818|FG003|Treatment Period|Issue with Insulin Pump|0|||
16097140|NCT03740919|38846815|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
16097141|NCT03740919|38846816|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
16097142|NCT03740919|38846817|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
16097143|NCT03740919|38846818|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
16097144|NCT03740919|38846815|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
16097145|NCT03740919|38846816|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
16097146|NCT03740919|38846817|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
16097147|NCT03740919|38846818|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
16097148|NCT03740919|38846815|FG000|Treatment Period|Not Completing Diary|0|||
16097149|NCT03740919|38846816|FG001|Treatment Period|Not Completing Diary|0|||
16097150|NCT03740919|38846817|FG002|Treatment Period|Not Completing Diary|1|||
16097151|NCT03740919|38846818|FG003|Treatment Period|Not Completing Diary|0|||
16097152|NCT03740919|38846815|FG000|Treatment Period|Insulin Painful to Participant|0|||
16097153|NCT03740919|38846816|FG001|Treatment Period|Insulin Painful to Participant|0|||
16097154|NCT03740919|38846817|FG002|Treatment Period|Insulin Painful to Participant|1|||
16097155|NCT03740919|38846818|FG003|Treatment Period|Insulin Painful to Participant|0|||
16097156|NCT01636778|38846819|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
16097157|NCT01636778|38846820|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
16097158|NCT01636778|38846821|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
16097159|NCT01636778|38846819|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
16097160|NCT01636778|38846820|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
16097161|NCT01636778|38846821|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
16097162|NCT01636778|38846819|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
16097163|NCT01636778|38846820|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
16097164|NCT01636778|38846821|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
16097165|NCT01636778|38846819|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
16097166|NCT01636778|38846820|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
16097167|NCT01636778|38846821|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
16097168|NCT01636778|38846819|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
16097169|NCT01636778|38846820|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
16097170|NCT01636778|38846821|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
16097171|NCT01636778|38846819|FG000|Follow-up Period After Part 2|Other|0|||
16097172|NCT01636778|38846820|FG001|Follow-up Period After Part 2|Other|0|||
16097173|NCT01636778|38846821|FG002|Follow-up Period After Part 2|Other|1|||
16210556|NCT02327078|39251373|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
16097174|NCT01636778|38846819|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
16097175|NCT01636778|38846820|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
16111463|NCT00760747|38897275|FG001|Study Period II|Withdrawal by Subject|0|||
16210557|NCT02327078|39251374|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
16097176|NCT01636778|38846821|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
16097177|NCT01636778|38846819|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
16097178|NCT01636778|38846820|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
16097179|NCT01636778|38846821|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
16097180|NCT00409006|38846825|FG000|Overall Study|Death|15|||
16097181|NCT00409006|38846826|FG001|Overall Study|Death|6|||
16097182|NCT00409006|38846825|FG000|Overall Study|Lost to Follow-up|1|||
16097183|NCT00409006|38846826|FG001|Overall Study|Lost to Follow-up|2|||
16097184|NCT00409006|38846825|FG000|Overall Study|Withdrawal by Subject|3|||
16097185|NCT00409006|38846826|FG001|Overall Study|Withdrawal by Subject|2|||
16097186|NCT00409006|38846825|FG000|Overall Study|Physician Decision|1|||
16097187|NCT00409006|38846826|FG001|Overall Study|Physician Decision|2|||
16097188|NCT01182285|38846827|FG000|First Intervention Week 1-10|Disease progression|1|||
16097189|NCT01182285|38846828|FG001|First Intervention Week 1-10|Disease progression|0|||
16097190|NCT01182285|38846829|FG002|First Intervention Week 1-10|Disease progression|0|||
16097191|NCT01182285|38846827|FG000|First Intervention Week 1-10|Adverse Event|1|||
16097192|NCT01182285|38846828|FG001|First Intervention Week 1-10|Adverse Event|0|||
16097193|NCT01182285|38846829|FG002|First Intervention Week 1-10|Adverse Event|0|||
16398330|NCT02851797|39938714|FG000|Overall Study|Withdrawal by Subject|4|||
16398331|NCT02851797|39938715|FG001|Overall Study|Withdrawal by Subject|2|||
16398332|NCT02851797|39938714|FG000|Overall Study|Adverse Event|3|||
16398333|NCT02851797|39938715|FG001|Overall Study|Adverse Event|0|||
16398334|NCT01147250|39938729|FG000|Overall Study|Lost to Follow-up|14|||
16398335|NCT01147250|39938730|FG001|Overall Study|Lost to Follow-up|11|||
16398336|NCT01147250|39938729|FG000|Overall Study|Withdrawal by Subject|83|||
16398337|NCT01147250|39938730|FG001|Overall Study|Withdrawal by Subject|88|||
16398338|NCT01147250|39938729|FG000|Overall Study|Site termination by sponsor|13|||
16398339|NCT01147250|39938730|FG001|Overall Study|Site termination by sponsor|5|||
16398340|NCT01147250|39938729|FG000|Overall Study|Other than specified|0|||
16398341|NCT01147250|39938730|FG001|Overall Study|Other than specified|1|||
16398342|NCT02013778|39938731|FG000|Overall Study|Death|4|||
16398343|NCT02013778|39938731|FG000|Overall Study|Withdrawal by Subject|1|||
16398344|NCT02013778|39938731|FG000|Overall Study|Physician Decision|1|||
16525560|NCT01165281|40391002|FG001|Overall Study|Protocol Violation|5|||
16525561|NCT01165281|40391001|FG000|Overall Study|Withdrawal by Subject|8|||
16525562|NCT01165281|40391002|FG001|Overall Study|Withdrawal by Subject|7|||
16525563|NCT01165281|40391001|FG000|Overall Study|Noncompliance with Study Drug|1|||
16398345|NCT02013778|39938731|FG000|Overall Study|Adverse Event|1|||
16398346|NCT03299244|39938732|FG000|Overall Study|Withdrawal by Subject|34|||
16398347|NCT03299244|39938733|FG001|Overall Study|Withdrawal by Subject|29|||
16398348|NCT03299244|39938732|FG000|Overall Study|Decision by Sponsor|4|||
16398349|NCT03299244|39938733|FG001|Overall Study|Decision by Sponsor|5|||
16398350|NCT03299244|39938732|FG000|Overall Study|Death|9|||
16398351|NCT03299244|39938733|FG001|Overall Study|Death|4|||
16398352|NCT03006458|39938736|FG000|First Intervention|Unsatisfied Vision|0|||
16398353|NCT03006458|39938737|FG001|First Intervention|Unsatisfied Vision|3|||
16398354|NCT03655054|39938738|FG000|Overall Study|Lost to Follow-up|1|||
16398355|NCT03286543|39938742|FG000|Consented|Screen failure before randomization|2|||
16398356|NCT03286543|39938743|FG001|Consented|Screen failure before randomization|0|||
16398357|NCT03286543|39938744|FG002|Consented|Screen failure before randomization|0|||
16398358|NCT03286543|39938742|FG000|Consented|Screen failure before enrollment|4|||
16398359|NCT03286543|39938743|FG001|Consented|Screen failure before enrollment|0|||
16398360|NCT03286543|39938744|FG002|Consented|Screen failure before enrollment|0|||
16398361|NCT03286543|39938742|FG000|Consented|TKA cancelled after enrollment|1|||
16398362|NCT03286543|39938743|FG001|Consented|TKA cancelled after enrollment|0|||
16398363|NCT03286543|39938744|FG002|Consented|TKA cancelled after enrollment|0|||
16398364|NCT03286543|39938742|FG000|Consented|Withdrawn from study|12|||
16398365|NCT03286543|39938743|FG001|Consented|Withdrawn from study|0|||
16398366|NCT03286543|39938744|FG002|Consented|Withdrawn from study|0|||
16398367|NCT03286543|39938742|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
16398368|NCT03286543|39938743|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
16398369|NCT03286543|39938744|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
16398370|NCT03286543|39938742|FG000|Study Enrollment|Withdrawn from study|0|||
16398371|NCT03286543|39938743|FG001|Study Enrollment|Withdrawn from study|6|||
16398372|NCT03286543|39938744|FG002|Study Enrollment|Withdrawn from study|6|||
16398373|NCT03219034|39938745|FG000|Overall Study|Lost to Follow-up|9|||
16398374|NCT03219034|39938746|FG001|Overall Study|Lost to Follow-up|13|||
16398375|NCT03219034|39938745|FG000|Overall Study|Additional dental work needed|1|||
16398376|NCT03219034|39938746|FG001|Overall Study|Additional dental work needed|0|||
16097194|NCT01182285|38846827|FG000|First Intervention Week 1-10|Non-compliance|1|||
16097195|NCT01182285|38846828|FG001|First Intervention Week 1-10|Non-compliance|0|||
16398377|NCT03219034|39938745|FG000|Overall Study|UPPP Surgery|1|||
16398378|NCT03219034|39938746|FG001|Overall Study|UPPP Surgery|0|||
16398379|NCT03219034|39938745|FG000|Overall Study|Dental sensitivity|0|||
16398380|NCT03219034|39938746|FG001|Overall Study|Dental sensitivity|1|||
16398381|NCT03219034|39938745|FG000|Overall Study|Death in family|0|||
16398382|NCT03219034|39938746|FG001|Overall Study|Death in family|1|||
16398383|NCT01496287|39938747|FG000|Overall Study|Lost to Follow-up|1|||
16398384|NCT01496287|39938747|FG000|Overall Study|Incomplete anesthesia|5|||
16398385|NCT03015363|39938748|FG000|Overall Study|Physician Decision|14|||
16398386|NCT03015363|39938748|FG000|Overall Study|Withdrawal by Subject|3|||
16398387|NCT03226249|39938749|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
16398388|NCT03226249|39938749|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
16398389|NCT03226249|39938749|FG000|Survival Follow-up|Patients still in follow-up.|30|||
16398390|NCT05059301|39938756|FG000|Overall Study|Adverse Event|0|||
16398391|NCT05059301|39938757|FG001|Overall Study|Adverse Event|2|||
16398392|NCT05059301|39938758|FG002|Overall Study|Adverse Event|2|||
16398393|NCT05059301|39938756|FG000|Overall Study|Lost to Follow-up|2|||
16398394|NCT05059301|39938757|FG001|Overall Study|Lost to Follow-up|3|||
16398395|NCT05059301|39938758|FG002|Overall Study|Lost to Follow-up|3|||
16398396|NCT02574078|39938759|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16398397|NCT02574078|39938760|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16398398|NCT02574078|39938761|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16398399|NCT02574078|39938762|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16398400|NCT02574078|39938763|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16097196|NCT01182285|38846829|FG002|First Intervention Week 1-10|Non-compliance|0|||
16097197|NCT01182285|38846827|FG000|Third Intervention Week 11-52|Disease Progression|0|||
16097198|NCT01182285|38846828|FG001|Third Intervention Week 11-52|Disease Progression|0|||
16097199|NCT01182285|38846829|FG002|Third Intervention Week 11-52|Disease Progression|6|||
16097200|NCT01182285|38846827|FG000|Third Intervention Week 11-52|Other|0|||
16097201|NCT01182285|38846828|FG001|Third Intervention Week 11-52|Other|0|||
16097202|NCT01182285|38846829|FG002|Third Intervention Week 11-52|Other|2|||
16097203|NCT01234675|38846830|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
16097204|NCT01234675|38846831|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
16097205|NCT01234675|38846830|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
16097206|NCT01234675|38846831|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
16097207|NCT00402298|38846832|FG000|Overall Study|Withdrawal by Subject|1|||
16398401|NCT02574078|39938764|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16398402|NCT02574078|39938765|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
16398403|NCT02574078|39938766|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16398404|NCT02574078|39938767|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16398405|NCT02574078|39938768|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16398406|NCT02574078|39938769|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16398407|NCT02574078|39938770|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16398408|NCT02574078|39938771|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16398409|NCT02574078|39938759|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
16398410|NCT02574078|39938760|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
16398411|NCT02574078|39938761|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
16398412|NCT02574078|39938762|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
16398413|NCT02574078|39938763|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
16398414|NCT02574078|39938764|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
16398415|NCT02574078|39938765|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
16398416|NCT02574078|39938766|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
16398417|NCT02574078|39938767|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
16398418|NCT02574078|39938768|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
16398419|NCT02574078|39938769|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
16398420|NCT02574078|39938770|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
16398421|NCT02574078|39938771|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
16398422|NCT02574078|39938759|FG000|Pre-Treatment Period|Other reasons|0|||
16398423|NCT02574078|39938760|FG001|Pre-Treatment Period|Other reasons|0|||
16398424|NCT02574078|39938761|FG002|Pre-Treatment Period|Other reasons|0|||
16398425|NCT02574078|39938762|FG003|Pre-Treatment Period|Other reasons|0|||
16398426|NCT02574078|39938763|FG004|Pre-Treatment Period|Other reasons|0|||
16398427|NCT02574078|39938764|FG005|Pre-Treatment Period|Other reasons|0|||
16398428|NCT02574078|39938765|FG006|Pre-Treatment Period|Other reasons|2|||
16398429|NCT02574078|39938766|FG007|Pre-Treatment Period|Other reasons|0|||
16398430|NCT02574078|39938767|FG008|Pre-Treatment Period|Other reasons|0|||
16398431|NCT02574078|39938768|FG009|Pre-Treatment Period|Other reasons|0|||
16398432|NCT02574078|39938769|FG010|Pre-Treatment Period|Other reasons|2|||
16398433|NCT02574078|39938770|FG011|Pre-Treatment Period|Other reasons|0|||
16398434|NCT02574078|39938771|FG012|Pre-Treatment Period|Other reasons|0|||
16398435|NCT02574078|39938759|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
16398436|NCT02574078|39938760|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
16398437|NCT02574078|39938761|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
16398438|NCT02574078|39938762|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
16398439|NCT02574078|39938763|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
16097208|NCT00402298|38846833|FG001|Overall Study|Withdrawal by Subject|0|||
16097209|NCT02176018|38846834|FG000|Overall Study|Adverse Event|0|||
16097210|NCT02176018|38846835|FG001|Overall Study|Adverse Event|2|||
16398440|NCT02574078|39938764|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
16398441|NCT02574078|39938765|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
16097211|NCT02176018|38846834|FG000|Overall Study|Lost to Follow-up|3|||
16097212|NCT02176018|38846835|FG001|Overall Study|Lost to Follow-up|1|||
16097213|NCT02176018|38846834|FG000|Overall Study|Protocol Violation|1|||
16097214|NCT02176018|38846835|FG001|Overall Study|Protocol Violation|1|||
16097215|NCT02176018|38846834|FG000|Overall Study|Withdrawal by Subject|1|||
16097216|NCT02176018|38846835|FG001|Overall Study|Withdrawal by Subject|2|||
16097217|NCT00111839|38846836|FG000|Overall Study|Disease Progression|30|||
16097218|NCT00111839|38846837|FG001|Overall Study|Disease Progression|33|||
16097219|NCT00111839|38846838|FG002|Overall Study|Disease Progression|33|||
16097220|NCT00111839|38846836|FG000|Overall Study|Adverse Event|5|||
16097221|NCT00111839|38846837|FG001|Overall Study|Adverse Event|3|||
16097222|NCT00111839|38846838|FG002|Overall Study|Adverse Event|1|||
16398442|NCT02574078|39938766|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
16398443|NCT02574078|39938767|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
16398444|NCT02574078|39938768|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
16398445|NCT02574078|39938769|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
16398446|NCT02574078|39938770|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
16398447|NCT02574078|39938771|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
16398448|NCT02574078|39938759|FG000|Treatment Period|Disease progression|6|||
16398449|NCT02574078|39938760|FG001|Treatment Period|Disease progression|4|||
16398450|NCT02574078|39938761|FG002|Treatment Period|Disease progression|7|||
16398451|NCT02574078|39938762|FG003|Treatment Period|Disease progression|18|||
16398452|NCT02574078|39938763|FG004|Treatment Period|Disease progression|16|||
16398453|NCT02574078|39938764|FG005|Treatment Period|Disease progression|26|||
16398454|NCT02574078|39938765|FG006|Treatment Period|Disease progression|5|||
16398455|NCT02574078|39938766|FG007|Treatment Period|Disease progression|9|||
16398456|NCT02574078|39938767|FG008|Treatment Period|Disease progression|8|||
16398457|NCT02574078|39938768|FG009|Treatment Period|Disease progression|5|||
16398458|NCT02574078|39938769|FG010|Treatment Period|Disease progression|20|||
16398459|NCT02574078|39938770|FG011|Treatment Period|Disease progression|29|||
16398460|NCT02574078|39938771|FG012|Treatment Period|Disease progression|2|||
16398461|NCT02574078|39938759|FG000|Treatment Period|Study drug toxicity|1|||
16398462|NCT02574078|39938760|FG001|Treatment Period|Study drug toxicity|1|||
16398463|NCT02574078|39938761|FG002|Treatment Period|Study drug toxicity|0|||
16398464|NCT02574078|39938762|FG003|Treatment Period|Study drug toxicity|5|||
16398465|NCT02574078|39938763|FG004|Treatment Period|Study drug toxicity|3|||
16398466|NCT02574078|39938764|FG005|Treatment Period|Study drug toxicity|1|||
16398467|NCT02574078|39938765|FG006|Treatment Period|Study drug toxicity|2|||
16398468|NCT02574078|39938766|FG007|Treatment Period|Study drug toxicity|0|||
16398469|NCT02574078|39938767|FG008|Treatment Period|Study drug toxicity|2|||
16398470|NCT02574078|39938768|FG009|Treatment Period|Study drug toxicity|1|||
16398471|NCT02574078|39938769|FG010|Treatment Period|Study drug toxicity|16|||
16398472|NCT02574078|39938770|FG011|Treatment Period|Study drug toxicity|2|||
16525564|NCT01165281|40391002|FG001|Overall Study|Noncompliance with Study Drug|4|||
16525565|NCT01165281|40391001|FG000|Overall Study|Progressive Disease|10|||
16525566|NCT01165281|40391002|FG001|Overall Study|Progressive Disease|14|||
16525567|NCT01165281|40391001|FG000|Overall Study|Other|6|||
16525568|NCT01165281|40391002|FG001|Overall Study|Other|0|||
16525569|NCT01274637|40391003|FG000|Overall Study|Withdrawal by Subject|0|||
16525570|NCT01274637|40391004|FG001|Overall Study|Withdrawal by Subject|1|||
16525571|NCT01274637|40391003|FG000|Overall Study|Lost to Follow-up|0|||
16525572|NCT01274637|40391004|FG001|Overall Study|Lost to Follow-up|1|||
16525573|NCT01923181|40391007|FG000|Overall Study|Protocol Violation|2|||
16525574|NCT01923181|40391008|FG001|Overall Study|Protocol Violation|2|||
16525575|NCT01923181|40391009|FG002|Overall Study|Protocol Violation|0|||
16525576|NCT01923181|40391010|FG003|Overall Study|Protocol Violation|2|||
16525577|NCT01923181|40391011|FG004|Overall Study|Protocol Violation|2|||
16525578|NCT01923181|40391012|FG005|Overall Study|Protocol Violation|1|||
16525579|NCT01923181|40391013|FG006|Overall Study|Protocol Violation|1|||
16525580|NCT01923181|40391014|FG007|Overall Study|Protocol Violation|2|||
16525581|NCT01923181|40391015|FG008|Overall Study|Protocol Violation|1|||
16097223|NCT00111839|38846836|FG000|Overall Study|Protocol Violation|2|||
16097224|NCT00111839|38846837|FG001|Overall Study|Protocol Violation|4|||
16525582|NCT01923181|40391007|FG000|Overall Study|Withdrawal by Subject|0|||
16525583|NCT01923181|40391008|FG001|Overall Study|Withdrawal by Subject|1|||
16525584|NCT01923181|40391009|FG002|Overall Study|Withdrawal by Subject|0|||
16097225|NCT00111839|38846838|FG002|Overall Study|Protocol Violation|2|||
16097226|NCT00111839|38846836|FG000|Overall Study|Death|1|||
16525585|NCT01923181|40391010|FG003|Overall Study|Withdrawal by Subject|1|||
16097227|NCT00111839|38846837|FG001|Overall Study|Death|1|||
16097228|NCT00111839|38846838|FG002|Overall Study|Death|6|||
16097229|NCT00111839|38846836|FG000|Overall Study|Withdrawal by Subject|2|||
16097230|NCT00111839|38846837|FG001|Overall Study|Withdrawal by Subject|2|||
16097231|NCT00111839|38846838|FG002|Overall Study|Withdrawal by Subject|2|||
16097232|NCT00111839|38846836|FG000|Overall Study|Lost to Follow-up|1|||
16097233|NCT00111839|38846837|FG001|Overall Study|Lost to Follow-up|0|||
16097234|NCT00111839|38846838|FG002|Overall Study|Lost to Follow-up|0|||
16097235|NCT00111839|38846836|FG000|Overall Study|Logistical Constraint|1|||
16097236|NCT00111839|38846837|FG001|Overall Study|Logistical Constraint|0|||
16097237|NCT00111839|38846838|FG002|Overall Study|Logistical Constraint|0|||
16097238|NCT00111839|38846836|FG000|Overall Study|Other|6|||
16097239|NCT00111839|38846837|FG001|Overall Study|Other|3|||
16097240|NCT00111839|38846838|FG002|Overall Study|Other|3|||
16097241|NCT00111839|38846836|FG000|Overall Study|Randomized but Not Treated|0|||
16525586|NCT01923181|40391011|FG004|Overall Study|Withdrawal by Subject|4|||
16525587|NCT01923181|40391012|FG005|Overall Study|Withdrawal by Subject|2|||
16525588|NCT01923181|40391013|FG006|Overall Study|Withdrawal by Subject|4|||
16525589|NCT01923181|40391014|FG007|Overall Study|Withdrawal by Subject|3|||
16525590|NCT01923181|40391015|FG008|Overall Study|Withdrawal by Subject|1|||
16525591|NCT01923181|40391007|FG000|Overall Study|Other|1|||
16097242|NCT00111839|38846837|FG001|Overall Study|Randomized but Not Treated|0|||
16097243|NCT00111839|38846838|FG002|Overall Study|Randomized but Not Treated|2|||
16097244|NCT03484819|38846847|FG000|Overall Study|Death|2|||
16097245|NCT03484819|38846847|FG000|Overall Study|Adverse Event|2|||
16097246|NCT03484819|38846847|FG000|Overall Study|Physician Decision|1|||
16097247|NCT03484819|38846847|FG000|Overall Study|Withdrawal by Subject|2|||
16097248|NCT03484819|38846847|FG000|Overall Study|Disease Progression|4|||
16097249|NCT03484819|38846847|FG000|Overall Study|Complicating Condition|1|||
16097250|NCT01544153|38846848|FG000|Overall Study|Under 18|0|||
16097251|NCT01544153|38846849|FG001|Overall Study|Under 18|1|||
16097252|NCT01544153|38846850|FG002|Overall Study|Under 18|0|||
16097253|NCT01544153|38846851|FG003|Overall Study|Under 18|0|||
16097254|NCT01544153|38846848|FG000|Overall Study|Non-smoker|0|||
16097255|NCT01544153|38846849|FG001|Overall Study|Non-smoker|0|||
16097256|NCT01544153|38846850|FG002|Overall Study|Non-smoker|1|||
16097257|NCT01544153|38846851|FG003|Overall Study|Non-smoker|0|||
16097258|NCT01587703|38846853|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
16097259|NCT01587703|38846854|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097260|NCT01587703|38846855|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097261|NCT01587703|38846856|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097262|NCT01587703|38846857|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097263|NCT01587703|38846858|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097264|NCT01587703|38846859|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097265|NCT01587703|38846860|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097266|NCT01587703|38846861|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097267|NCT01587703|38846862|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097268|NCT01587703|38846863|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16525592|NCT01923181|40391008|FG001|Overall Study|Other|0|||
16525593|NCT01923181|40391009|FG002|Overall Study|Other|0|||
16525594|NCT01923181|40391010|FG003|Overall Study|Other|1|||
16525595|NCT01923181|40391011|FG004|Overall Study|Other|0|||
16525596|NCT01923181|40391012|FG005|Overall Study|Other|0|||
16097269|NCT01587703|38846864|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097270|NCT01587703|38846865|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097271|NCT01587703|38846866|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097272|NCT01587703|38846867|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097273|NCT01587703|38846868|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097274|NCT01587703|38846869|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097275|NCT01587703|38846870|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16097276|NCT01587703|38846871|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
16329262|NCT02284568|39692459|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
16329263|NCT02284568|39692460|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
16329264|NCT02284568|39692461|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
16329265|NCT02284568|39692459|FG000|Overall Study|Lost to Follow-up|0|||
16329266|NCT02284568|39692460|FG001|Overall Study|Lost to Follow-up|3|||
16329267|NCT02284568|39692461|FG002|Overall Study|Lost to Follow-up|0|||
16329268|NCT02284568|39692459|FG000|Overall Study|Lack of Efficacy|4|||
16329269|NCT02284568|39692460|FG001|Overall Study|Lack of Efficacy|7|||
16329270|NCT02284568|39692461|FG002|Overall Study|Lack of Efficacy|0|||
16329271|NCT02284568|39692459|FG000|Overall Study|Other|1|||
16329272|NCT02284568|39692460|FG001|Overall Study|Other|2|||
16329273|NCT02284568|39692461|FG002|Overall Study|Other|0|||
16329274|NCT02284568|39692459|FG000|Overall Study|Withdrew before taking study drug|0|||
16525597|NCT01923181|40391013|FG006|Overall Study|Other|0|||
16210558|NCT02327078|39251375|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
16210559|NCT02327078|39251376|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
16210560|NCT02327078|39251377|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
16210561|NCT02327078|39251369|FG000|Overall Study|Death|2|||
16210562|NCT02327078|39251370|FG001|Overall Study|Death|4|||
16210563|NCT02327078|39251371|FG002|Overall Study|Death|10|||
16210564|NCT02327078|39251372|FG003|Overall Study|Death|6|||
16210565|NCT02327078|39251373|FG004|Overall Study|Death|4|||
16210566|NCT02327078|39251374|FG005|Overall Study|Death|3|||
16210567|NCT02327078|39251375|FG006|Overall Study|Death|2|||
16210568|NCT02327078|39251376|FG007|Overall Study|Death|51|||
16210569|NCT02327078|39251377|FG008|Overall Study|Death|97|||
16210570|NCT02327078|39251369|FG000|Overall Study|Lost to Follow-up|0|||
16210571|NCT02327078|39251370|FG001|Overall Study|Lost to Follow-up|1|||
16210572|NCT02327078|39251371|FG002|Overall Study|Lost to Follow-up|1|||
16210573|NCT02327078|39251372|FG003|Overall Study|Lost to Follow-up|0|||
16210574|NCT02327078|39251373|FG004|Overall Study|Lost to Follow-up|0|||
16210575|NCT02327078|39251374|FG005|Overall Study|Lost to Follow-up|0|||
16210576|NCT02327078|39251375|FG006|Overall Study|Lost to Follow-up|0|||
16210577|NCT02327078|39251376|FG007|Overall Study|Lost to Follow-up|2|||
16210578|NCT02327078|39251377|FG008|Overall Study|Lost to Follow-up|5|||
16210579|NCT02327078|39251369|FG000|Overall Study|Site Terminated by Sponsor|1|||
16525598|NCT01923181|40391014|FG007|Overall Study|Other|0|||
16210580|NCT02327078|39251370|FG001|Overall Study|Site Terminated by Sponsor|0|||
16210581|NCT02327078|39251371|FG002|Overall Study|Site Terminated by Sponsor|1|||
16210582|NCT02327078|39251372|FG003|Overall Study|Site Terminated by Sponsor|4|||
16329275|NCT02284568|39692460|FG001|Overall Study|Withdrew before taking study drug|1|||
16329276|NCT02284568|39692461|FG002|Overall Study|Withdrew before taking study drug|0|||
16329277|NCT01085136|39692473|FG000|Part A|Other Adverse event|223|||
16329278|NCT01085136|39692474|FG001|Part A|Other Adverse event|0|||
16329279|NCT01085136|39692475|FG002|Part A|Other Adverse event|0|||
16329280|NCT01085136|39692473|FG000|Part A|Protocol Violation|3|||
16329281|NCT01085136|39692474|FG001|Part A|Protocol Violation|0|||
16329282|NCT01085136|39692475|FG002|Part A|Protocol Violation|0|||
16329283|NCT01085136|39692473|FG000|Part A|Lost to Follow-up|3|||
16329284|NCT01085136|39692474|FG001|Part A|Lost to Follow-up|0|||
16329285|NCT01085136|39692475|FG002|Part A|Lost to Follow-up|0|||
16329286|NCT01085136|39692473|FG000|Part A|Refusal to continue trial medication|64|||
16329287|NCT01085136|39692474|FG001|Part A|Refusal to continue trial medication|0|||
16329288|NCT01085136|39692475|FG002|Part A|Refusal to continue trial medication|0|||
16329289|NCT01085136|39692473|FG000|Part A|Other reason not defined above|30|||
16329290|NCT01085136|39692474|FG001|Part A|Other reason not defined above|0|||
16329291|NCT01085136|39692475|FG002|Part A|Other reason not defined above|0|||
16329292|NCT01085136|39692473|FG000|Part B|Other AE|0|||
16398473|NCT02574078|39938771|FG012|Treatment Period|Study drug toxicity|4|||
16398474|NCT02574078|39938759|FG000|Treatment Period|Death|2|||
16398475|NCT02574078|39938760|FG001|Treatment Period|Death|0|||
16210583|NCT02327078|39251373|FG004|Overall Study|Site Terminated by Sponsor|0|||
16210584|NCT02327078|39251374|FG005|Overall Study|Site Terminated by Sponsor|0|||
16398476|NCT02574078|39938761|FG002|Treatment Period|Death|0|||
16210585|NCT02327078|39251375|FG006|Overall Study|Site Terminated by Sponsor|0|||
16210586|NCT02327078|39251376|FG007|Overall Study|Site Terminated by Sponsor|11|||
16210587|NCT02327078|39251377|FG008|Overall Study|Site Terminated by Sponsor|25|||
16210588|NCT02327078|39251369|FG000|Overall Study|Physician Decision|0|||
16210589|NCT02327078|39251370|FG001|Overall Study|Physician Decision|0|||
16210590|NCT02327078|39251371|FG002|Overall Study|Physician Decision|0|||
16398477|NCT02574078|39938762|FG003|Treatment Period|Death|0|||
16398478|NCT02574078|39938763|FG004|Treatment Period|Death|1|||
16398479|NCT02574078|39938764|FG005|Treatment Period|Death|1|||
16398480|NCT02574078|39938765|FG006|Treatment Period|Death|1|||
16398481|NCT02574078|39938766|FG007|Treatment Period|Death|1|||
16398482|NCT02574078|39938767|FG008|Treatment Period|Death|7|||
16398483|NCT02574078|39938768|FG009|Treatment Period|Death|1|||
16398484|NCT02574078|39938769|FG010|Treatment Period|Death|0|||
16398485|NCT02574078|39938770|FG011|Treatment Period|Death|2|||
16398486|NCT02574078|39938771|FG012|Treatment Period|Death|1|||
16210591|NCT02327078|39251372|FG003|Overall Study|Physician Decision|1|||
16210592|NCT02327078|39251373|FG004|Overall Study|Physician Decision|0|||
16210593|NCT02327078|39251374|FG005|Overall Study|Physician Decision|0|||
16329293|NCT01085136|39692474|FG001|Part B|Other AE|29|||
16525599|NCT01923181|40391015|FG008|Overall Study|Other|0|||
16210594|NCT02327078|39251375|FG006|Overall Study|Physician Decision|0|||
16329294|NCT01085136|39692475|FG002|Part B|Other AE|8|||
16329295|NCT01085136|39692473|FG000|Part B|Refusal to continue trial medication|0|||
16329296|NCT01085136|39692474|FG001|Part B|Refusal to continue trial medication|12|||
16329297|NCT01085136|39692475|FG002|Part B|Refusal to continue trial medication|7|||
16329298|NCT01085136|39692473|FG000|Part B|Not treated|0|||
16329299|NCT01085136|39692474|FG001|Part B|Not treated|4|||
16398487|NCT02574078|39938759|FG000|Treatment Period|Adverse event unrelated to drug|0|||
16398488|NCT02574078|39938760|FG001|Treatment Period|Adverse event unrelated to drug|0|||
16210595|NCT02327078|39251376|FG007|Overall Study|Physician Decision|0|||
16210596|NCT02327078|39251377|FG008|Overall Study|Physician Decision|1|||
16210597|NCT02327078|39251369|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
16210598|NCT02327078|39251370|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
16210599|NCT02327078|39251371|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
16210600|NCT02327078|39251372|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
16210601|NCT02327078|39251373|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
16210602|NCT02327078|39251374|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
16210603|NCT02327078|39251375|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
16210604|NCT02327078|39251376|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
16210605|NCT02327078|39251377|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
16210606|NCT02327078|39251369|FG000|Overall Study|Reason not Specified|0|||
16210607|NCT02327078|39251370|FG001|Overall Study|Reason not Specified|0|||
16210608|NCT02327078|39251371|FG002|Overall Study|Reason not Specified|0|||
16210609|NCT02327078|39251372|FG003|Overall Study|Reason not Specified|0|||
16210610|NCT02327078|39251373|FG004|Overall Study|Reason not Specified|0|||
16210611|NCT02327078|39251374|FG005|Overall Study|Reason not Specified|0|||
16210612|NCT02327078|39251375|FG006|Overall Study|Reason not Specified|0|||
16210613|NCT02327078|39251376|FG007|Overall Study|Reason not Specified|5|||
16210614|NCT02327078|39251377|FG008|Overall Study|Reason not Specified|12|||
16210615|NCT00107172|39251378|FG000|Overall Study|Withdrawal by Subject|1|||
16210616|NCT00107172|39251379|FG001|Overall Study|Withdrawal by Subject|0|||
16210617|NCT00107172|39251378|FG000|Overall Study|Death|0|||
16210618|NCT00107172|39251379|FG001|Overall Study|Death|2|||
16210619|NCT00107172|39251378|FG000|Overall Study|Other Reason|4|||
16210620|NCT00107172|39251379|FG001|Overall Study|Other Reason|3|||
16210621|NCT00618813|39251381|FG000|Overall Study|Lack of Efficacy|1|||
16210622|NCT00618813|39251381|FG000|Overall Study|Physician Decision|2|||
16210623|NCT00618813|39251381|FG000|Overall Study|Withdrawal by Subject|1|||
16210624|NCT01136746|39251383|FG000|Overall Study|Lost to Follow-up|0|||
16210625|NCT01136746|39251384|FG001|Overall Study|Lost to Follow-up|2|||
16210626|NCT01136746|39251383|FG000|Overall Study|Protocol Violation|2|||
16210627|NCT01136746|39251384|FG001|Overall Study|Protocol Violation|1|||
16210628|NCT01136746|39251383|FG000|Overall Study|Death|1|||
16210629|NCT01136746|39251384|FG001|Overall Study|Death|0|||
16210630|NCT01665768|39251385|FG000|Overall Study|Adverse Event|3|||
16210631|NCT01665768|39251385|FG000|Overall Study|Lack of Efficacy|19|||
16210632|NCT01665768|39251385|FG000|Overall Study|Withdrawal by Subject|1|||
16210633|NCT00367341|39251388|FG000|Overall Study|Physician Decision|1|||
16210634|NCT00367341|39251389|FG001|Overall Study|Physician Decision|0|||
16210635|NCT00367341|39251388|FG000|Overall Study|Protocol Violation|1|||
16210636|NCT00367341|39251389|FG001|Overall Study|Protocol Violation|0|||
16210637|NCT00688623|39251390|FG000|Overall Study|Adverse Event|22|||
16210638|NCT00688623|39251390|FG000|Overall Study|abnormal lab value|1|||
16210639|NCT00688623|39251390|FG000|Overall Study|Withdrawal by Subject|4|||
16210640|NCT00688623|39251390|FG000|Overall Study|Death|3|||
16329300|NCT01085136|39692475|FG002|Part B|Not treated|8|||
16329301|NCT01085136|39692473|FG000|Part B|Other reason not defined above|0|||
16329302|NCT01085136|39692474|FG001|Part B|Other reason not defined above|6|||
16329303|NCT01085136|39692475|FG002|Part B|Other reason not defined above|3|||
16329304|NCT02928770|39692477|FG000|Overall Study|Withdrawal by Subject|2|||
16329305|NCT00784238|39692478|FG000|Overall Study|Adverse Event|14|||
16329306|NCT00784238|39692478|FG000|Overall Study|Death|2|||
16329307|NCT00784238|39692478|FG000|Overall Study|Lack of Efficacy|33|||
16329308|NCT00784238|39692478|FG000|Overall Study|Lost to Follow-up|29|||
16329309|NCT00784238|39692478|FG000|Overall Study|Pregnancy|1|||
16329310|NCT00784238|39692478|FG000|Overall Study|Withdrawal by Subject|26|||
16329311|NCT00784238|39692478|FG000|Overall Study|Other|14|||
16329312|NCT02604550|39692479|FG000|Overall Study|Lost to Follow-up|7|||
16329313|NCT02604550|39692480|FG001|Overall Study|Lost to Follow-up|6|||
16329314|NCT02604550|39692479|FG000|Overall Study|Withdrawal by Subject|0|||
16329315|NCT02604550|39692480|FG001|Overall Study|Withdrawal by Subject|1|||
16329316|NCT02604550|39692479|FG000|Overall Study|Incomplete data using paper journal|18|||
16210641|NCT00688623|39251390|FG000|Overall Study|disease progression|23|||
16210642|NCT00688623|39251390|FG000|Overall Study|Protocol Violation|2|||
16329317|NCT02604550|39692480|FG001|Overall Study|Incomplete data using paper journal|19|||
16329318|NCT04450407|39692481|FG000|Overall Study|Withdrawal by Subject|10|||
16329319|NCT04450407|39692482|FG001|Overall Study|Withdrawal by Subject|1|||
16329320|NCT04450407|39692483|FG002|Overall Study|Withdrawal by Subject|4|||
16329321|NCT04450407|39692481|FG000|Overall Study|Adverse Event|0|||
16329322|NCT04450407|39692482|FG001|Overall Study|Adverse Event|0|||
16329323|NCT04450407|39692483|FG002|Overall Study|Adverse Event|1|||
16329324|NCT04450407|39692481|FG000|Overall Study|Lost to Follow-up|1|||
16210643|NCT01976624|39251393|FG000|Overall Study|Participants contraindicated|2|||
16210644|NCT01976624|39251393|FG000|Overall Study|Participants age less than 19 years|12|||
16329325|NCT04450407|39692482|FG001|Overall Study|Lost to Follow-up|0|||
16329326|NCT04450407|39692483|FG002|Overall Study|Lost to Follow-up|0|||
16329327|NCT04450407|39692481|FG000|Overall Study|Physician Decision|0|||
16329328|NCT04450407|39692482|FG001|Overall Study|Physician Decision|0|||
16329329|NCT04450407|39692483|FG002|Overall Study|Physician Decision|1|||
16329330|NCT04450407|39692481|FG000|Overall Study|Pregnancy|1|||
16329331|NCT04450407|39692482|FG001|Overall Study|Pregnancy|0|||
16329332|NCT04450407|39692483|FG002|Overall Study|Pregnancy|0|||
16329333|NCT04450407|39692481|FG000|Overall Study|Protocol Violation|2|||
16329334|NCT04450407|39692482|FG001|Overall Study|Protocol Violation|0|||
16329335|NCT04450407|39692483|FG002|Overall Study|Protocol Violation|0|||
16329336|NCT04450407|39692481|FG000|Overall Study|Investigational site terminated by sponsor|3|||
16329337|NCT04450407|39692482|FG001|Overall Study|Investigational site terminated by sponsor|0|||
16329338|NCT04450407|39692483|FG002|Overall Study|Investigational site terminated by sponsor|2|||
16329339|NCT00732758|39692484|FG000|Overall Study|Lost to Follow-up|8|||
16329340|NCT00732758|39692485|FG001|Overall Study|Lost to Follow-up|16|||
16329341|NCT02002533|39692487|FG000|Overall Study|Withdrawal by Subject|6|||
16329342|NCT02002533|39692488|FG001|Overall Study|Withdrawal by Subject|13|||
16329343|NCT02002533|39692487|FG000|Overall Study|Protocol Violation|0|||
16329344|NCT02002533|39692488|FG001|Overall Study|Protocol Violation|1|||
16329345|NCT02002533|39692487|FG000|Overall Study|Adverse Event|0|||
16329346|NCT02002533|39692488|FG001|Overall Study|Adverse Event|3|||
16398489|NCT02574078|39938761|FG002|Treatment Period|Adverse event unrelated to drug|1|||
16398490|NCT02574078|39938762|FG003|Treatment Period|Adverse event unrelated to drug|0|||
16398491|NCT02574078|39938763|FG004|Treatment Period|Adverse event unrelated to drug|2|||
16398492|NCT02574078|39938764|FG005|Treatment Period|Adverse event unrelated to drug|3|||
16398493|NCT02574078|39938765|FG006|Treatment Period|Adverse event unrelated to drug|0|||
16398494|NCT02574078|39938766|FG007|Treatment Period|Adverse event unrelated to drug|0|||
16097277|NCT01587703|38846853|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097278|NCT01587703|38846854|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097279|NCT01587703|38846855|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097280|NCT01587703|38846856|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097281|NCT01587703|38846857|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16329347|NCT02002533|39692487|FG000|Overall Study|Lost to Follow-up|0|||
16329348|NCT02002533|39692488|FG001|Overall Study|Lost to Follow-up|1|||
16097282|NCT01587703|38846858|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
16097283|NCT01587703|38846859|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097284|NCT01587703|38846860|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
16097285|NCT01587703|38846861|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097286|NCT01587703|38846862|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097287|NCT01587703|38846863|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097288|NCT01587703|38846864|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097289|NCT01587703|38846865|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097290|NCT01587703|38846866|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097291|NCT01587703|38846867|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097292|NCT01587703|38846868|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097293|NCT01587703|38846869|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097294|NCT01587703|38846870|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097295|NCT01587703|38846871|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
16097296|NCT01587703|38846853|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097297|NCT01587703|38846854|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097298|NCT01587703|38846855|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097299|NCT01587703|38846856|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097300|NCT01587703|38846857|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097301|NCT01587703|38846858|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097302|NCT01587703|38846859|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
16097303|NCT01587703|38846860|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097304|NCT01587703|38846861|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097305|NCT01587703|38846862|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097306|NCT01587703|38846863|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097307|NCT01587703|38846864|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16329349|NCT03488225|39692489|FG000|Overall Study|Off Protocol Therapy|2|||
16329350|NCT03488225|39692489|FG000|Overall Study|Stem Cell Transplant|2|||
16329351|NCT01892085|39692490|FG000|Overall Study|Death|4|||
16329352|NCT01892085|39692491|FG001|Overall Study|Death|1|||
16329353|NCT01892085|39692492|FG002|Overall Study|Death|3|||
16398495|NCT02574078|39938767|FG008|Treatment Period|Adverse event unrelated to drug|1|||
16329354|NCT01892085|39692490|FG000|Overall Study|Withdrawal by Subject|2|||
16398496|NCT02574078|39938768|FG009|Treatment Period|Adverse event unrelated to drug|2|||
16097308|NCT01587703|38846865|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16210645|NCT05179057|39251396|FG000|Overall Study|Adverse Event|3|||
16329355|NCT01892085|39692491|FG001|Overall Study|Withdrawal by Subject|0|||
16329356|NCT01892085|39692492|FG002|Overall Study|Withdrawal by Subject|2|||
16097309|NCT01587703|38846866|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097310|NCT01587703|38846867|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097311|NCT01587703|38846868|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097312|NCT01587703|38846869|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097313|NCT01587703|38846870|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097314|NCT01587703|38846871|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
16097315|NCT01587703|38846853|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
16097316|NCT01587703|38846854|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
16097317|NCT01587703|38846855|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
16097318|NCT01587703|38846856|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
16097319|NCT01587703|38846857|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
16097320|NCT01587703|38846858|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
16097321|NCT01587703|38846859|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
16097322|NCT01587703|38846860|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
16097323|NCT01587703|38846861|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16097324|NCT01587703|38846862|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16097325|NCT01587703|38846863|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16097326|NCT01587703|38846864|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16097327|NCT01587703|38846865|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16097328|NCT01587703|38846866|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16097329|NCT01587703|38846867|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16097330|NCT01587703|38846868|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16097331|NCT01587703|38846869|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16329357|NCT00514904|39692498|FG000|Overall Study|Withdrawal by Subject|3|||
16329358|NCT00514904|39692499|FG001|Overall Study|Withdrawal by Subject|2|||
16329359|NCT00514904|39692498|FG000|Overall Study|Lost to Follow-up|21|||
16398497|NCT02574078|39938769|FG010|Treatment Period|Adverse event unrelated to drug|4|||
16398498|NCT02574078|39938770|FG011|Treatment Period|Adverse event unrelated to drug|1|||
16398499|NCT02574078|39938771|FG012|Treatment Period|Adverse event unrelated to drug|0|||
16398500|NCT02574078|39938759|FG000|Treatment Period|Administrative reason by Sponsor|0|||
16398501|NCT02574078|39938760|FG001|Treatment Period|Administrative reason by Sponsor|1|||
16398502|NCT02574078|39938761|FG002|Treatment Period|Administrative reason by Sponsor|0|||
16398503|NCT02574078|39938762|FG003|Treatment Period|Administrative reason by Sponsor|0|||
16398504|NCT02574078|39938763|FG004|Treatment Period|Administrative reason by Sponsor|0|||
16398505|NCT02574078|39938764|FG005|Treatment Period|Administrative reason by Sponsor|0|||
16097332|NCT01587703|38846870|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16210646|NCT05179057|39251397|FG001|Overall Study|Adverse Event|2|||
16329360|NCT00514904|39692499|FG001|Overall Study|Lost to Follow-up|3|||
16329361|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
16329362|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
16329363|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
16329364|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
16329365|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
16329366|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
16329367|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
16329368|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
16329369|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Death|0|||
16329370|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Death|1|||
16329371|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
16329372|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
16329373|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
16329374|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
16329375|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
16329376|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
16329377|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
16329378|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
16329379|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
16329380|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
16097333|NCT01587703|38846871|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
16097334|NCT01587703|38846853|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097335|NCT01587703|38846854|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097336|NCT01587703|38846855|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097337|NCT01587703|38846856|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097338|NCT01587703|38846857|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097339|NCT01587703|38846858|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097340|NCT01587703|38846859|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097341|NCT01587703|38846860|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097342|NCT01587703|38846861|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
16097343|NCT01587703|38846862|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
16097344|NCT01587703|38846863|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
16097345|NCT01587703|38846864|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097346|NCT01587703|38846865|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097347|NCT01587703|38846866|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097348|NCT01587703|38846867|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097349|NCT01587703|38846868|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097350|NCT01587703|38846869|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097351|NCT01587703|38846870|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097352|NCT01587703|38846871|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
16097353|NCT01587703|38846853|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097354|NCT01587703|38846854|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16329381|NCT00394836|39692500|FG000|Teatment or Follow-up Phase|Non compliance|0|||
16329382|NCT00394836|39692501|FG001|Teatment or Follow-up Phase|Non compliance|1|||
16329383|NCT00394836|39692500|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
16329384|NCT00394836|39692501|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
16329385|NCT00394836|39692500|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
16329386|NCT00394836|39692501|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
16329387|NCT00394836|39692500|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
16329388|NCT00394836|39692501|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
16329389|NCT00394836|39692500|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
16329390|NCT00394836|39692501|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
16329391|NCT00199797|39692502|FG000|Overall Study|Progressive Disease|1|||
16329392|NCT00199797|39692502|FG000|Overall Study|Adverse Event|1|||
16329393|NCT00199797|39692502|FG000|Overall Study|Physician Decision|1|||
16329394|NCT03671564|39692503|FG000|Overall Study|Progressive Disease|3|||
16329395|NCT03671564|39692504|FG001|Overall Study|Progressive Disease|5|||
16329396|NCT03671564|39692505|FG002|Overall Study|Progressive Disease|3|||
16398506|NCT02574078|39938765|FG006|Treatment Period|Administrative reason by Sponsor|1|||
16398507|NCT02574078|39938766|FG007|Treatment Period|Administrative reason by Sponsor|0|||
16398508|NCT02574078|39938767|FG008|Treatment Period|Administrative reason by Sponsor|0|||
16398509|NCT02574078|39938768|FG009|Treatment Period|Administrative reason by Sponsor|0|||
16398510|NCT02574078|39938769|FG010|Treatment Period|Administrative reason by Sponsor|0|||
16398511|NCT02574078|39938770|FG011|Treatment Period|Administrative reason by Sponsor|0|||
16398512|NCT02574078|39938771|FG012|Treatment Period|Administrative reason by Sponsor|3|||
16398513|NCT02574078|39938759|FG000|Treatment Period|Other reasons|1|||
16398514|NCT02574078|39938760|FG001|Treatment Period|Other reasons|0|||
16398515|NCT02574078|39938761|FG002|Treatment Period|Other reasons|1|||
16398516|NCT02574078|39938762|FG003|Treatment Period|Other reasons|3|||
16525600|NCT01923181|40391007|FG000|Overall Study|Lost to Follow-up|0|||
16525601|NCT01923181|40391008|FG001|Overall Study|Lost to Follow-up|3|||
16525602|NCT01923181|40391009|FG002|Overall Study|Lost to Follow-up|2|||
16525603|NCT01923181|40391010|FG003|Overall Study|Lost to Follow-up|1|||
16525604|NCT01923181|40391011|FG004|Overall Study|Lost to Follow-up|2|||
16525605|NCT01923181|40391012|FG005|Overall Study|Lost to Follow-up|1|||
16525606|NCT01923181|40391013|FG006|Overall Study|Lost to Follow-up|3|||
16097355|NCT01587703|38846855|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097356|NCT01587703|38846856|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097357|NCT01587703|38846857|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097358|NCT01587703|38846858|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097359|NCT01587703|38846859|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097360|NCT01587703|38846860|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097361|NCT01587703|38846861|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
16097362|NCT01587703|38846862|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16329397|NCT03671564|39692503|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
16525607|NCT01923181|40391014|FG007|Overall Study|Lost to Follow-up|3|||
16525608|NCT01923181|40391015|FG008|Overall Study|Lost to Follow-up|1|||
16525609|NCT03036566|40391016|FG000|Overall Study|Lost to Follow-up|3|||
16398517|NCT02574078|39938763|FG004|Treatment Period|Other reasons|3|||
16398518|NCT02574078|39938764|FG005|Treatment Period|Other reasons|1|||
16329398|NCT03671564|39692504|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
16329399|NCT03671564|39692505|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
16329400|NCT03671564|39692503|FG000|Overall Study|Withdrawal by Subject|1|||
16525610|NCT01542528|40391017|FG000|Overall Study|Lost to Follow-up|2|||
16525611|NCT01542528|40391018|FG001|Overall Study|Lost to Follow-up|1|||
16525612|NCT01542528|40391017|FG000|Overall Study|Physician Decision|1|||
16525613|NCT01542528|40391018|FG001|Overall Study|Physician Decision|0|||
16525614|NCT01542528|40391017|FG000|Overall Study|Withdrawal by Subject|9|||
16525615|NCT01542528|40391018|FG001|Overall Study|Withdrawal by Subject|6|||
16329401|NCT03671564|39692504|FG001|Overall Study|Withdrawal by Subject|1|||
16329402|NCT03671564|39692505|FG002|Overall Study|Withdrawal by Subject|0|||
16329403|NCT02703272|39692519|FG000|Overall Study|Death|4|||
16329404|NCT02703272|39692520|FG001|Overall Study|Death|9|||
16329405|NCT02703272|39692521|FG002|Overall Study|Death|19|||
16329406|NCT02703272|39692522|FG003|Overall Study|Death|10|||
16329407|NCT02703272|39692519|FG000|Overall Study|Withdrawal by Subject|0|||
16329408|NCT02703272|39692520|FG001|Overall Study|Withdrawal by Subject|0|||
16329409|NCT02703272|39692521|FG002|Overall Study|Withdrawal by Subject|4|||
16525616|NCT01308749|40391019|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
16525617|NCT01308749|40391020|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
16525618|NCT01308749|40391019|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
16525619|NCT01308749|40391020|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
16525620|NCT01308749|40391019|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
16525621|NCT01308749|40391020|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
16525622|NCT00345397|40391027|FG000|Overall Study|Death|1|||
16525623|NCT02646423|40391031|FG000|Overall Study|Adverse Event|5|||
16525624|NCT02646423|40391032|FG001|Overall Study|Adverse Event|7|||
16329410|NCT02703272|39692522|FG003|Overall Study|Withdrawal by Subject|2|||
16398519|NCT02574078|39938765|FG006|Treatment Period|Other reasons|2|||
16398520|NCT02574078|39938766|FG007|Treatment Period|Other reasons|1|||
16398521|NCT02574078|39938767|FG008|Treatment Period|Other reasons|3|||
16525625|NCT02646423|40391031|FG000|Overall Study|Ineligible|2|||
16525626|NCT02646423|40391032|FG001|Overall Study|Ineligible|1|||
16525627|NCT00003457|40391033|FG000|Overall Study|Not evaluable|9|||
16525628|NCT00182689|40391034|FG000|Overall Study|Adverse Event|8|||
16525629|NCT00182689|40391035|FG001|Overall Study|Adverse Event|11|||
16525630|NCT00182689|40391034|FG000|Overall Study|Withdrawal by Subject|2|||
16525631|NCT00182689|40391035|FG001|Overall Study|Withdrawal by Subject|2|||
16525632|NCT00182689|40391034|FG000|Overall Study|Progression|27|||
16398522|NCT02574078|39938768|FG009|Treatment Period|Other reasons|1|||
16398523|NCT02574078|39938769|FG010|Treatment Period|Other reasons|1|||
16398524|NCT02574078|39938770|FG011|Treatment Period|Other reasons|3|||
16398525|NCT02574078|39938771|FG012|Treatment Period|Other reasons|1|||
16398526|NCT02574078|39938759|FG000|Treatment Period|Participant request to stop drug|0|||
16398527|NCT02574078|39938760|FG001|Treatment Period|Participant request to stop drug|0|||
16398528|NCT02574078|39938761|FG002|Treatment Period|Participant request to stop drug|0|||
16398529|NCT02574078|39938762|FG003|Treatment Period|Participant request to stop drug|2|||
16398530|NCT02574078|39938763|FG004|Treatment Period|Participant request to stop drug|4|||
16398531|NCT02574078|39938764|FG005|Treatment Period|Participant request to stop drug|0|||
16398532|NCT02574078|39938765|FG006|Treatment Period|Participant request to stop drug|1|||
16398533|NCT02574078|39938766|FG007|Treatment Period|Participant request to stop drug|0|||
16398534|NCT02574078|39938767|FG008|Treatment Period|Participant request to stop drug|3|||
16398535|NCT02574078|39938768|FG009|Treatment Period|Participant request to stop drug|2|||
16398536|NCT02574078|39938769|FG010|Treatment Period|Participant request to stop drug|2|||
16398537|NCT02574078|39938770|FG011|Treatment Period|Participant request to stop drug|4|||
16398538|NCT02574078|39938771|FG012|Treatment Period|Participant request to stop drug|1|||
16398539|NCT02574078|39938759|FG000|Treatment Period|Participant withdrew consent|0|||
16398540|NCT02574078|39938760|FG001|Treatment Period|Participant withdrew consent|0|||
16525633|NCT00182689|40391035|FG001|Overall Study|Progression|29|||
16525634|NCT00182689|40391034|FG000|Overall Study|Death|1|||
16525635|NCT00182689|40391035|FG001|Overall Study|Death|0|||
16525636|NCT00182689|40391034|FG000|Overall Study|not protocol specified|0|||
16525637|NCT00182689|40391035|FG001|Overall Study|not protocol specified|3|||
16329411|NCT02703272|39692519|FG000|Overall Study|Study Terminated by Sponsor|6|||
16329412|NCT02703272|39692520|FG001|Overall Study|Study Terminated by Sponsor|1|||
16398541|NCT02574078|39938761|FG002|Treatment Period|Participant withdrew consent|0|||
16398542|NCT02574078|39938762|FG003|Treatment Period|Participant withdrew consent|0|||
16525638|NCT00182689|40391034|FG000|Overall Study|Ineligible|1|||
16525639|NCT00182689|40391035|FG001|Overall Study|Ineligible|4|||
16525640|NCT00182689|40391034|FG000|Overall Study|Never received treatment|1|||
16525641|NCT00182689|40391035|FG001|Overall Study|Never received treatment|0|||
16525642|NCT02162810|40391036|FG000|Overall Study|Protocol Violation|1|||
16525643|NCT02162810|40391037|FG001|Overall Study|Protocol Violation|0|||
16525644|NCT02162810|40391036|FG000|Overall Study|patients did not report compliance|4|||
16525645|NCT02162810|40391037|FG001|Overall Study|patients did not report compliance|1|||
16525646|NCT02546544|40391038|FG000|Overall Study|Disease Progression|14|||
16525647|NCT02546544|40391038|FG000|Overall Study|Adverse Event|1|||
16525648|NCT02546544|40391038|FG000|Overall Study|Withdrawal by Subject|1|||
16525649|NCT01643473|40391039|FG000|Overall Study|Lost to Follow-up|1|||
16525650|NCT01643473|40391040|FG001|Overall Study|Lost to Follow-up|0|||
16525651|NCT00560833|40391047|FG000|Overall Study|Adverse Event|16|||
16525652|NCT00560833|40391048|FG001|Overall Study|Adverse Event|10|||
16525653|NCT00560833|40391049|FG002|Overall Study|Adverse Event|25|||
16525654|NCT00560833|40391050|FG003|Overall Study|Adverse Event|23|||
16525655|NCT00560833|40391051|FG004|Overall Study|Adverse Event|35|||
16525656|NCT00560833|40391047|FG000|Overall Study|Lost to Follow-up|0|||
16525657|NCT00560833|40391048|FG001|Overall Study|Lost to Follow-up|0|||
16525658|NCT00560833|40391049|FG002|Overall Study|Lost to Follow-up|1|||
16525659|NCT00560833|40391050|FG003|Overall Study|Lost to Follow-up|0|||
16525660|NCT00560833|40391051|FG004|Overall Study|Lost to Follow-up|0|||
16525661|NCT00560833|40391047|FG000|Overall Study|Lack of Efficacy|22|||
16525662|NCT00560833|40391048|FG001|Overall Study|Lack of Efficacy|9|||
16525663|NCT00560833|40391049|FG002|Overall Study|Lack of Efficacy|6|||
16210647|NCT05179057|39251396|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
16210648|NCT05179057|39251397|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
16210649|NCT05179057|39251396|FG000|Overall Study|Study terminated|13|||
16210650|NCT05179057|39251397|FG001|Overall Study|Study terminated|7|||
16210651|NCT05179057|39251396|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
16210652|NCT05179057|39251397|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
16210653|NCT05179057|39251396|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
16210654|NCT05179057|39251397|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
16210655|NCT04363944|39251398|FG000|Overall Study|Withdrawal by Subject|2|||
16210656|NCT04363944|39251399|FG001|Overall Study|Withdrawal by Subject|0|||
16210657|NCT02009930|39251400|FG000|Overall Study|withdrawn|5|||
16210658|NCT03682055|39251401|FG000|Overall Study|Lack of Efficacy|1|||
16210659|NCT03682055|39251402|FG001|Overall Study|Lack of Efficacy|2|||
16210660|NCT03682055|39251403|FG002|Overall Study|Lack of Efficacy|1|||
16210661|NCT03682055|39251404|FG003|Overall Study|Lack of Efficacy|2|||
16210662|NCT03682055|39251405|FG004|Overall Study|Lack of Efficacy|1|||
16210663|NCT03682055|39251406|FG005|Overall Study|Lack of Efficacy|3|||
16210664|NCT03682055|39251401|FG000|Overall Study|Withdrawal by Subject|0|||
16210665|NCT03682055|39251402|FG001|Overall Study|Withdrawal by Subject|0|||
16210666|NCT03682055|39251403|FG002|Overall Study|Withdrawal by Subject|0|||
16210667|NCT03682055|39251404|FG003|Overall Study|Withdrawal by Subject|0|||
16210668|NCT03682055|39251405|FG004|Overall Study|Withdrawal by Subject|0|||
16210669|NCT03682055|39251406|FG005|Overall Study|Withdrawal by Subject|1|||
16210670|NCT03682055|39251401|FG000|Overall Study|Termination of Study by Sponsor|0|||
16210671|NCT03682055|39251402|FG001|Overall Study|Termination of Study by Sponsor|0|||
16525664|NCT00560833|40391050|FG003|Overall Study|Lack of Efficacy|4|||
16525665|NCT00560833|40391051|FG004|Overall Study|Lack of Efficacy|4|||
16525666|NCT00560833|40391047|FG000|Overall Study|Participant uncooperative|5|||
16525667|NCT00560833|40391048|FG001|Overall Study|Participant uncooperative|5|||
16525668|NCT00560833|40391049|FG002|Overall Study|Participant uncooperative|4|||
16525669|NCT00560833|40391050|FG003|Overall Study|Participant uncooperative|4|||
16525670|NCT00560833|40391051|FG004|Overall Study|Participant uncooperative|2|||
16525671|NCT00560833|40391047|FG000|Overall Study|Other|1|||
16525672|NCT00560833|40391048|FG001|Overall Study|Other|1|||
16525673|NCT00560833|40391049|FG002|Overall Study|Other|3|||
16525674|NCT00560833|40391050|FG003|Overall Study|Other|0|||
16525675|NCT00560833|40391051|FG004|Overall Study|Other|0|||
16525676|NCT00560833|40391047|FG000|Overall Study|Never received drug|0|||
16525677|NCT00560833|40391048|FG001|Overall Study|Never received drug|1|||
16525678|NCT00560833|40391049|FG002|Overall Study|Never received drug|0|||
16210672|NCT03682055|39251403|FG002|Overall Study|Termination of Study by Sponsor|0|||
16210673|NCT03682055|39251404|FG003|Overall Study|Termination of Study by Sponsor|0|||
16210674|NCT03682055|39251405|FG004|Overall Study|Termination of Study by Sponsor|0|||
16525679|NCT00560833|40391050|FG003|Overall Study|Never received drug|0|||
16210675|NCT03682055|39251406|FG005|Overall Study|Termination of Study by Sponsor|3|||
16210676|NCT00918346|39251407|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
16525680|NCT00560833|40391051|FG004|Overall Study|Never received drug|1|||
16525681|NCT02371369|40391052|FG000|Part 1|Physician Decision|0|||
16525682|NCT02371369|40391053|FG001|Part 1|Physician Decision|3|||
16525683|NCT02371369|40391052|FG000|Part 1|Adverse Event|8|||
16525684|NCT02371369|40391053|FG001|Part 1|Adverse Event|0|||
16210677|NCT00918346|39251408|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
16210678|NCT01249157|39251409|FG000|Overall Study|Withdrawal by Subject|1|||
16210679|NCT01804842|39251410|FG000|Overall Study|Adverse Event|1|||
16329413|NCT02703272|39692521|FG002|Overall Study|Study Terminated by Sponsor|12|||
16329414|NCT02703272|39692522|FG003|Overall Study|Study Terminated by Sponsor|4|||
16329415|NCT02703272|39692519|FG000|Overall Study|Other|1|||
16329416|NCT02703272|39692520|FG001|Overall Study|Other|0|||
16329417|NCT02703272|39692521|FG002|Overall Study|Other|0|||
16329418|NCT02703272|39692522|FG003|Overall Study|Other|0|||
16329419|NCT01258075|39692527|FG000|Overall Study|Adverse Event|8|||
16329420|NCT01258075|39692528|FG001|Overall Study|Adverse Event|3|||
16329421|NCT01258075|39692527|FG000|Overall Study|Lost to Follow-up|11|||
16329422|NCT01258075|39692528|FG001|Overall Study|Lost to Follow-up|6|||
16329423|NCT01258075|39692527|FG000|Overall Study|Withdrawal by Subject|10|||
16329424|NCT01258075|39692528|FG001|Overall Study|Withdrawal by Subject|7|||
16329425|NCT01258075|39692527|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
16329426|NCT01258075|39692528|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
16329427|NCT01258075|39692527|FG000|Overall Study|Other|12|||
16329428|NCT01258075|39692528|FG001|Overall Study|Other|5|||
16329429|NCT03806231|39692529|FG000|Overall Study|Physician Decision|1|||
16329430|NCT03806231|39692530|FG001|Overall Study|Physician Decision|0|||
16329431|NCT03806231|39692529|FG000|Overall Study|Withdrawal by Subject|1|||
16329432|NCT03806231|39692530|FG001|Overall Study|Withdrawal by Subject|0|||
16329433|NCT02276053|39692531|FG000|Overall Study|Death|2|||
16329434|NCT02276053|39692531|FG000|Overall Study|Adverse Event|5|||
16329435|NCT02276053|39692531|FG000|Overall Study|Lack of Efficacy|2|||
16329436|NCT02276053|39692531|FG000|Overall Study|Withdrawal by Subject|1|||
16329437|NCT02276053|39692531|FG000|Overall Study|Patient does not meet selection criteria|3|||
16525685|NCT02371369|40391052|FG000|Part 1|Withdrawal by Subject|1|||
16525686|NCT02371369|40391053|FG001|Part 1|Withdrawal by Subject|6|||
16525687|NCT02371369|40391052|FG000|Part 1|Disease progression|0|||
16525688|NCT02371369|40391053|FG001|Part 1|Disease progression|1|||
16525689|NCT02371369|40391052|FG000|Part 1|Protocol Violation|0|||
16525690|NCT02371369|40391053|FG001|Part 1|Protocol Violation|1|||
16097363|NCT01587703|38846863|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
16097364|NCT01587703|38846864|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097365|NCT01587703|38846865|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097366|NCT01587703|38846866|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097367|NCT01587703|38846867|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097368|NCT01587703|38846868|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097369|NCT01587703|38846869|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097370|NCT01587703|38846870|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097371|NCT01587703|38846871|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
16097372|NCT01587703|38846853|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16525691|NCT02371369|40391052|FG000|Part 2|Adverse Event|6|||
16525692|NCT02371369|40391053|FG001|Part 2|Adverse Event|5|||
16525693|NCT02371369|40391052|FG000|Part 2|Withdrawal by Subject|16|||
16525694|NCT02371369|40391053|FG001|Part 2|Withdrawal by Subject|6|||
16525695|NCT02371369|40391052|FG000|Part 2|Investigator decision|1|||
16525696|NCT02371369|40391053|FG001|Part 2|Investigator decision|2|||
16525697|NCT02371369|40391052|FG000|Part 2|Death|0|||
16525698|NCT02371369|40391053|FG001|Part 2|Death|1|||
16525699|NCT02371369|40391052|FG000|Part 2|Disease progression|1|||
16525700|NCT02371369|40391053|FG001|Part 2|Disease progression|0|||
16525701|NCT02371369|40391052|FG000|Part 2|Subject Noncompliance|1|||
16525702|NCT02371369|40391053|FG001|Part 2|Subject Noncompliance|0|||
16525703|NCT02371369|40391052|FG000|Part 2|Lost to Follow-up|1|||
16525704|NCT02371369|40391053|FG001|Part 2|Lost to Follow-up|1|||
16525705|NCT02371369|40391052|FG000|Part 2|Subject transitioned to commercial supply|6|||
16525706|NCT02371369|40391053|FG001|Part 2|Subject transitioned to commercial supply|4|||
16525707|NCT02371369|40391052|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
16525708|NCT02371369|40391053|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
16525709|NCT02371369|40391052|FG000|Part 2|Surgical resection of tumor|1|||
16525710|NCT02371369|40391053|FG001|Part 2|Surgical resection of tumor|1|||
16525711|NCT02371369|40391052|FG000|Part 2|Other|0|||
16097373|NCT01587703|38846854|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16329438|NCT02276053|39692531|FG000|Overall Study|Patient needs to increase baseline AED|1|||
16329439|NCT00520481|39692532|FG000|Overall Study|Adverse Event|4|||
16329440|NCT00520481|39692533|FG001|Overall Study|Adverse Event|1|||
16329441|NCT00520481|39692532|FG000|Overall Study|Withdrawal by Subject|3|||
16525712|NCT02371369|40391053|FG001|Part 2|Other|1|||
16525713|NCT00360308|40391057|FG000|Overall Study|Adverse Event|15|||
16525714|NCT00360308|40391058|FG001|Overall Study|Adverse Event|14|||
16525715|NCT00360308|40391059|FG002|Overall Study|Adverse Event|25|||
16097374|NCT01587703|38846855|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097375|NCT01587703|38846856|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16210680|NCT01804842|39251411|FG001|Overall Study|Adverse Event|1|||
16210681|NCT01804842|39251412|FG002|Overall Study|Adverse Event|0|||
16210682|NCT01804842|39251410|FG000|Overall Study|Lost to Follow-up|1|||
16210683|NCT01804842|39251411|FG001|Overall Study|Lost to Follow-up|0|||
16210684|NCT01804842|39251412|FG002|Overall Study|Lost to Follow-up|0|||
16210685|NCT01804842|39251410|FG000|Overall Study|Non-Compliance|1|||
16210686|NCT01804842|39251411|FG001|Overall Study|Non-Compliance|1|||
16210687|NCT01804842|39251412|FG002|Overall Study|Non-Compliance|0|||
16210688|NCT01804842|39251410|FG000|Overall Study|Personal Reason|0|||
16210689|NCT01804842|39251411|FG001|Overall Study|Personal Reason|0|||
16210690|NCT01804842|39251412|FG002|Overall Study|Personal Reason|1|||
16210691|NCT01750840|39251413|FG000|Overall Study|Lost to Follow-up|4|||
16210692|NCT00225212|39251414|FG000|Overall Study|Disease progression|2|||
16210693|NCT00225212|39251414|FG000|Overall Study|Death|1|||
16210694|NCT00225212|39251414|FG000|Overall Study|Adverse Event|2|||
16210695|NCT00225212|39251414|FG000|Overall Study|Intercurrent illness|1|||
16210696|NCT04498468|39251415|FG000|Overall Study|Lost to Follow-up|3|||
16210697|NCT02715804|39251416|FG000|Overall Study|Death|222|||
16210698|NCT02715804|39251417|FG001|Overall Study|Death|106|||
16210699|NCT02715804|39251416|FG000|Overall Study|Withdrawal by Subject|5|||
16210700|NCT02715804|39251417|FG001|Overall Study|Withdrawal by Subject|4|||
16210701|NCT02715804|39251416|FG000|Overall Study|Other than specified|2|||
16210702|NCT02715804|39251417|FG001|Overall Study|Other than specified|3|||
16210703|NCT00136357|39251419|FG000|Overall Study|Withdrawal by Subject|3|||
16210704|NCT00136357|39251420|FG001|Overall Study|Withdrawal by Subject|2|||
16210705|NCT04362189|39251421|FG000|Overall Study|Lost to Follow-up|0|||
16210706|NCT04362189|39251422|FG001|Overall Study|Lost to Follow-up|1|||
16210707|NCT04362189|39251421|FG000|Overall Study|Withdrawal by Subject|1|||
16210708|NCT04362189|39251422|FG001|Overall Study|Withdrawal by Subject|0|||
16210709|NCT04362189|39251421|FG000|Overall Study|FDA Clinical Hold|7|||
16210710|NCT04362189|39251422|FG001|Overall Study|FDA Clinical Hold|2|||
16210711|NCT04362189|39251421|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
16210712|NCT04362189|39251422|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
16210713|NCT04362189|39251421|FG000|Overall Study|Adverse Event|0|||
16210714|NCT04362189|39251422|FG001|Overall Study|Adverse Event|2|||
16210715|NCT04362189|39251421|FG000|Overall Study|Death|4|||
16210716|NCT04362189|39251422|FG001|Overall Study|Death|1|||
16210717|NCT03924427|39251425|FG000|Overall Study|Adverse Event|4|||
16210718|NCT03924427|39251425|FG000|Overall Study|Lack of Efficacy|1|||
16210719|NCT03924427|39251425|FG000|Overall Study|Withdrawal by Subject|1|||
16210720|NCT02001688|39251430|FG000|Overall Study|Withdrawal by Subject|0|||
16210721|NCT02001688|39251431|FG001|Overall Study|Withdrawal by Subject|0|||
16210722|NCT02001688|39251432|FG002|Overall Study|Withdrawal by Subject|1|||
16210723|NCT02001688|39251430|FG000|Overall Study|Adverse Event|0|||
16210724|NCT02001688|39251431|FG001|Overall Study|Adverse Event|1|||
16210725|NCT02001688|39251432|FG002|Overall Study|Adverse Event|0|||
16329442|NCT00520481|39692533|FG001|Overall Study|Withdrawal by Subject|0|||
16329443|NCT00628095|39692535|FG000|Overall Study|Adverse Event|5|||
16329444|NCT00628095|39692536|FG001|Overall Study|Adverse Event|3|||
16329445|NCT00628095|39692535|FG000|Overall Study|Lack of Efficacy|0|||
16329446|NCT00628095|39692536|FG001|Overall Study|Lack of Efficacy|3|||
16329447|NCT00628095|39692535|FG000|Overall Study|Withdrawal by Subject|2|||
16210726|NCT02910089|39251437|FG000|Overall Study|Lost insurance eligibility|22|||
16210727|NCT02910089|39251438|FG001|Overall Study|Lost insurance eligibility|16|||
16210728|NCT02392468|39251441|FG000|Overall Study|Adverse Event|0|||
16210729|NCT02392468|39251442|FG001|Overall Study|Adverse Event|1|||
16210730|NCT02392468|39251443|FG002|Overall Study|Adverse Event|0|||
16210731|NCT02392468|39251444|FG003|Overall Study|Adverse Event|0|||
16329448|NCT00628095|39692536|FG001|Overall Study|Withdrawal by Subject|0|||
16329449|NCT00628095|39692535|FG000|Overall Study|Other|0|||
16329450|NCT00628095|39692536|FG001|Overall Study|Other|1|||
16329451|NCT02829723|39692537|FG000|Overall Study|Adverse Event|0|||
16329452|NCT02829723|39692538|FG001|Overall Study|Adverse Event|0|||
16329453|NCT02829723|39692539|FG002|Overall Study|Adverse Event|1|||
16329454|NCT02829723|39692540|FG003|Overall Study|Adverse Event|1|||
16329455|NCT02829723|39692541|FG004|Overall Study|Adverse Event|0|||
16329456|NCT02829723|39692542|FG005|Overall Study|Adverse Event|0|||
16210732|NCT02392468|39251445|FG004|Overall Study|Adverse Event|0|||
16210733|NCT02392468|39251446|FG005|Overall Study|Adverse Event|1|||
16398543|NCT02574078|39938763|FG004|Treatment Period|Participant withdrew consent|1|||
16210734|NCT03706040|39251447|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
16210735|NCT03706040|39251448|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
16329457|NCT02829723|39692543|FG006|Overall Study|Adverse Event|0|||
16329458|NCT02829723|39692544|FG007|Overall Study|Adverse Event|1|||
16329459|NCT02829723|39692545|FG008|Overall Study|Adverse Event|0|||
16329460|NCT02829723|39692546|FG009|Overall Study|Adverse Event|0|||
16329461|NCT02829723|39692547|FG010|Overall Study|Adverse Event|0|||
16210736|NCT03706040|39251449|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
16210737|NCT03706040|39251450|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
16210738|NCT03706040|39251451|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
16210739|NCT03706040|39251452|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
16210740|NCT03706040|39251453|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
16210741|NCT03706040|39251447|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
16210742|NCT03706040|39251448|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
16210743|NCT03706040|39251449|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
16210744|NCT03706040|39251450|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
16210745|NCT03706040|39251451|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
16210746|NCT03706040|39251452|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
16210747|NCT03706040|39251453|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
16210748|NCT03706040|39251447|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
16210749|NCT03706040|39251448|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
16210750|NCT03706040|39251449|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
16210751|NCT03706040|39251450|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
16210752|NCT03706040|39251451|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
16210753|NCT03706040|39251452|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
16210754|NCT03706040|39251453|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
16210755|NCT03706040|39251447|FG000|Period A (Week 0 to Week 16)|Other|2|||
16210756|NCT03706040|39251448|FG001|Period A (Week 0 to Week 16)|Other|0|||
16210757|NCT03706040|39251449|FG002|Period A (Week 0 to Week 16)|Other|2|||
16210758|NCT03706040|39251450|FG003|Period A (Week 0 to Week 16)|Other|0|||
16210759|NCT03706040|39251451|FG004|Period A (Week 0 to Week 16)|Other|0|||
16210760|NCT03706040|39251452|FG005|Period A (Week 0 to Week 16)|Other|0|||
16210761|NCT03706040|39251453|FG006|Period A (Week 0 to Week 16)|Other|0|||
16210762|NCT03706040|39251447|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
16210763|NCT03706040|39251448|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
16210764|NCT03706040|39251449|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
16210765|NCT03706040|39251450|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
16210766|NCT03706040|39251451|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
16210767|NCT03706040|39251452|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
16210768|NCT03706040|39251453|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
16210769|NCT03706040|39251447|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
16210770|NCT03706040|39251448|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
16210771|NCT03706040|39251449|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
16210772|NCT03706040|39251450|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
16398544|NCT02574078|39938764|FG005|Treatment Period|Participant withdrew consent|1|||
16210773|NCT03706040|39251451|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
16210774|NCT03706040|39251452|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
16210775|NCT03706040|39251453|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
16210776|NCT03706040|39251447|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
16210777|NCT03706040|39251448|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
16210778|NCT03706040|39251449|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
16210779|NCT03706040|39251450|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
16210780|NCT03706040|39251451|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
16210781|NCT03706040|39251452|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
16210782|NCT03706040|39251453|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
16210783|NCT03706040|39251447|FG000|Period B (Week 16 to Week 52)|Other|0|||
16210784|NCT03706040|39251448|FG001|Period B (Week 16 to Week 52)|Other|0|||
16210785|NCT03706040|39251449|FG002|Period B (Week 16 to Week 52)|Other|0|||
16210786|NCT03706040|39251450|FG003|Period B (Week 16 to Week 52)|Other|4|||
16210787|NCT03706040|39251451|FG004|Period B (Week 16 to Week 52)|Other|5|||
16210788|NCT03706040|39251452|FG005|Period B (Week 16 to Week 52)|Other|23|||
16210789|NCT03706040|39251453|FG006|Period B (Week 16 to Week 52)|Other|17|||
16210790|NCT02705755|39251454|FG000|Part A (6 Days)|Adverse Event|1|||
16210791|NCT02705755|39251455|FG001|Part A (6 Days)|Adverse Event|0|||
16210792|NCT02705755|39251456|FG002|Part A (6 Days)|Adverse Event|0|||
16210793|NCT02705755|39251457|FG003|Part A (6 Days)|Adverse Event|0|||
16210794|NCT02705755|39251454|FG000|Part A (6 Days)|Physician Decision|3|||
16210795|NCT02705755|39251455|FG001|Part A (6 Days)|Physician Decision|0|||
16210796|NCT02705755|39251456|FG002|Part A (6 Days)|Physician Decision|0|||
16210797|NCT02705755|39251457|FG003|Part A (6 Days)|Physician Decision|0|||
16210798|NCT02705755|39251454|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
16210799|NCT02705755|39251455|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
16210800|NCT02705755|39251456|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
16210801|NCT02705755|39251457|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
16210802|NCT02705755|39251454|FG000|Part C (20 Weeks)|Physician Decision|0|||
16210803|NCT02705755|39251455|FG001|Part C (20 Weeks)|Physician Decision|0|||
16210804|NCT02705755|39251456|FG002|Part C (20 Weeks)|Physician Decision|0|||
16210805|NCT02705755|39251457|FG003|Part C (20 Weeks)|Physician Decision|2|||
16210806|NCT02705755|39251454|FG000|Part C (20 Weeks)|Adverse Event|0|||
16210807|NCT02705755|39251455|FG001|Part C (20 Weeks)|Adverse Event|0|||
16210808|NCT02705755|39251456|FG002|Part C (20 Weeks)|Adverse Event|0|||
16210809|NCT02705755|39251457|FG003|Part C (20 Weeks)|Adverse Event|6|||
16210810|NCT02705755|39251454|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
16210811|NCT02705755|39251455|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
16210812|NCT02705755|39251456|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
16210813|NCT02705755|39251457|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
16210814|NCT00741260|39251458|FG000|Overall Study|Disease Progression|3|||
16210815|NCT00741260|39251459|FG001|Overall Study|Disease Progression|5|||
16210816|NCT00741260|39251460|FG002|Overall Study|Disease Progression|3|||
16210817|NCT00741260|39251461|FG003|Overall Study|Disease Progression|3|||
16210818|NCT00741260|39251462|FG004|Overall Study|Disease Progression|5|||
16210819|NCT00741260|39251463|FG005|Overall Study|Disease Progression|37|||
16210820|NCT00741260|39251464|FG006|Overall Study|Disease Progression|4|||
16210821|NCT00741260|39251458|FG000|Overall Study|Death|0|||
16210822|NCT00741260|39251459|FG001|Overall Study|Death|1|||
16210823|NCT00741260|39251460|FG002|Overall Study|Death|0|||
16210824|NCT00741260|39251461|FG003|Overall Study|Death|1|||
16210825|NCT00741260|39251462|FG004|Overall Study|Death|2|||
16210826|NCT00741260|39251463|FG005|Overall Study|Death|2|||
16210827|NCT00741260|39251464|FG006|Overall Study|Death|1|||
16210828|NCT00741260|39251458|FG000|Overall Study|Withdrawal by Subject|0|||
16210829|NCT00741260|39251459|FG001|Overall Study|Withdrawal by Subject|0|||
16210830|NCT00741260|39251460|FG002|Overall Study|Withdrawal by Subject|0|||
16329462|NCT02829723|39692548|FG011|Overall Study|Adverse Event|0|||
16329463|NCT02829723|39692549|FG012|Overall Study|Adverse Event|0|||
16329464|NCT02829723|39692550|FG013|Overall Study|Adverse Event|0|||
16329465|NCT02829723|39692551|FG014|Overall Study|Adverse Event|1|||
16329466|NCT02829723|39692552|FG015|Overall Study|Adverse Event|1|||
16329467|NCT02829723|39692553|FG016|Overall Study|Adverse Event|1|||
16329468|NCT02829723|39692554|FG017|Overall Study|Adverse Event|2|||
16329469|NCT02829723|39692555|FG018|Overall Study|Adverse Event|1|||
16329470|NCT02829723|39692556|FG019|Overall Study|Adverse Event|1|||
16329471|NCT02829723|39692557|FG020|Overall Study|Adverse Event|3|||
16329472|NCT02829723|39692558|FG021|Overall Study|Adverse Event|0|||
16329473|NCT02829723|39692559|FG022|Overall Study|Adverse Event|0|||
16329474|NCT02829723|39692560|FG023|Overall Study|Adverse Event|1|||
16210831|NCT00741260|39251461|FG003|Overall Study|Withdrawal by Subject|0|||
16210832|NCT00741260|39251462|FG004|Overall Study|Withdrawal by Subject|1|||
16329475|NCT02829723|39692561|FG024|Overall Study|Adverse Event|1|||
16329476|NCT02829723|39692562|FG025|Overall Study|Adverse Event|3|||
16329477|NCT02829723|39692563|FG026|Overall Study|Adverse Event|5|||
16329478|NCT02829723|39692537|FG000|Overall Study|Death|1|||
16329479|NCT02829723|39692538|FG001|Overall Study|Death|0|||
16329480|NCT02829723|39692539|FG002|Overall Study|Death|1|||
16329481|NCT02829723|39692540|FG003|Overall Study|Death|1|||
16329482|NCT02829723|39692541|FG004|Overall Study|Death|0|||
16329483|NCT02829723|39692542|FG005|Overall Study|Death|0|||
16329484|NCT02829723|39692543|FG006|Overall Study|Death|2|||
16329485|NCT02829723|39692544|FG007|Overall Study|Death|0|||
16329486|NCT02829723|39692545|FG008|Overall Study|Death|1|||
16329487|NCT02829723|39692546|FG009|Overall Study|Death|0|||
16329488|NCT02829723|39692547|FG010|Overall Study|Death|0|||
16329489|NCT02829723|39692548|FG011|Overall Study|Death|0|||
16329490|NCT02829723|39692549|FG012|Overall Study|Death|2|||
16329491|NCT02829723|39692550|FG013|Overall Study|Death|1|||
16329492|NCT02829723|39692551|FG014|Overall Study|Death|0|||
16329493|NCT02829723|39692552|FG015|Overall Study|Death|0|||
16329494|NCT02829723|39692553|FG016|Overall Study|Death|0|||
16329495|NCT02829723|39692554|FG017|Overall Study|Death|0|||
16329496|NCT02829723|39692555|FG018|Overall Study|Death|0|||
16329497|NCT02829723|39692556|FG019|Overall Study|Death|0|||
16329498|NCT02829723|39692557|FG020|Overall Study|Death|0|||
16329499|NCT02829723|39692558|FG021|Overall Study|Death|2|||
16329500|NCT02829723|39692559|FG022|Overall Study|Death|0|||
16329501|NCT02829723|39692560|FG023|Overall Study|Death|0|||
16329502|NCT02829723|39692561|FG024|Overall Study|Death|0|||
16329503|NCT02829723|39692562|FG025|Overall Study|Death|1|||
16329504|NCT02829723|39692563|FG026|Overall Study|Death|2|||
16329505|NCT02829723|39692537|FG000|Overall Study|Physician Decision|0|||
16329506|NCT02829723|39692538|FG001|Overall Study|Physician Decision|0|||
16329507|NCT02829723|39692539|FG002|Overall Study|Physician Decision|0|||
16329508|NCT02829723|39692540|FG003|Overall Study|Physician Decision|0|||
16329509|NCT02829723|39692541|FG004|Overall Study|Physician Decision|0|||
16329510|NCT02829723|39692542|FG005|Overall Study|Physician Decision|0|||
16329511|NCT02829723|39692543|FG006|Overall Study|Physician Decision|0|||
16329512|NCT02829723|39692544|FG007|Overall Study|Physician Decision|0|||
16329513|NCT02829723|39692545|FG008|Overall Study|Physician Decision|0|||
16329514|NCT02829723|39692546|FG009|Overall Study|Physician Decision|1|||
16329515|NCT02829723|39692547|FG010|Overall Study|Physician Decision|1|||
16329516|NCT02829723|39692548|FG011|Overall Study|Physician Decision|0|||
16329517|NCT02829723|39692549|FG012|Overall Study|Physician Decision|0|||
16329518|NCT02829723|39692550|FG013|Overall Study|Physician Decision|1|||
16329519|NCT02829723|39692551|FG014|Overall Study|Physician Decision|0|||
16329520|NCT02829723|39692552|FG015|Overall Study|Physician Decision|0|||
16329521|NCT02829723|39692553|FG016|Overall Study|Physician Decision|2|||
16329522|NCT02829723|39692554|FG017|Overall Study|Physician Decision|0|||
16329523|NCT02829723|39692555|FG018|Overall Study|Physician Decision|0|||
16329524|NCT02829723|39692556|FG019|Overall Study|Physician Decision|0|||
16329525|NCT02829723|39692557|FG020|Overall Study|Physician Decision|0|||
16329526|NCT02829723|39692558|FG021|Overall Study|Physician Decision|0|||
16329527|NCT02829723|39692559|FG022|Overall Study|Physician Decision|1|||
16329528|NCT02829723|39692560|FG023|Overall Study|Physician Decision|1|||
16329529|NCT02829723|39692561|FG024|Overall Study|Physician Decision|1|||
16329530|NCT02829723|39692562|FG025|Overall Study|Physician Decision|1|||
16329531|NCT02829723|39692563|FG026|Overall Study|Physician Decision|3|||
16329532|NCT02829723|39692537|FG000|Overall Study|Progressive disease|4|||
16329533|NCT02829723|39692538|FG001|Overall Study|Progressive disease|6|||
16329534|NCT02829723|39692539|FG002|Overall Study|Progressive disease|3|||
16329535|NCT02829723|39692540|FG003|Overall Study|Progressive disease|3|||
16329536|NCT02829723|39692541|FG004|Overall Study|Progressive disease|3|||
16329537|NCT02829723|39692542|FG005|Overall Study|Progressive disease|5|||
16329538|NCT02829723|39692543|FG006|Overall Study|Progressive disease|4|||
16329539|NCT02829723|39692544|FG007|Overall Study|Progressive disease|6|||
16329540|NCT02829723|39692545|FG008|Overall Study|Progressive disease|8|||
16329541|NCT02829723|39692546|FG009|Overall Study|Progressive disease|4|||
16329542|NCT02829723|39692547|FG010|Overall Study|Progressive disease|9|||
16329543|NCT02829723|39692548|FG011|Overall Study|Progressive disease|0|||
16329544|NCT02829723|39692549|FG012|Overall Study|Progressive disease|3|||
16329545|NCT02829723|39692550|FG013|Overall Study|Progressive disease|4|||
16329546|NCT02829723|39692551|FG014|Overall Study|Progressive disease|2|||
16329547|NCT02829723|39692552|FG015|Overall Study|Progressive disease|4|||
16329548|NCT02829723|39692553|FG016|Overall Study|Progressive disease|5|||
16097376|NCT01587703|38846857|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097377|NCT01587703|38846858|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097378|NCT01587703|38846859|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097379|NCT01587703|38846860|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16398545|NCT02574078|39938765|FG006|Treatment Period|Participant withdrew consent|0|||
16398546|NCT02574078|39938766|FG007|Treatment Period|Participant withdrew consent|1|||
16398547|NCT02574078|39938767|FG008|Treatment Period|Participant withdrew consent|0|||
16398548|NCT02574078|39938768|FG009|Treatment Period|Participant withdrew consent|2|||
16398549|NCT02574078|39938769|FG010|Treatment Period|Participant withdrew consent|1|||
16398550|NCT02574078|39938770|FG011|Treatment Period|Participant withdrew consent|4|||
16398551|NCT02574078|39938771|FG012|Treatment Period|Participant withdrew consent|1|||
16398552|NCT02574078|39938759|FG000|Treatment Period|Participant no longer meets criteria|0|||
16398553|NCT02574078|39938760|FG001|Treatment Period|Participant no longer meets criteria|0|||
16398554|NCT02574078|39938761|FG002|Treatment Period|Participant no longer meets criteria|0|||
16398555|NCT02574078|39938762|FG003|Treatment Period|Participant no longer meets criteria|0|||
16398556|NCT02574078|39938763|FG004|Treatment Period|Participant no longer meets criteria|1|||
16398557|NCT02574078|39938764|FG005|Treatment Period|Participant no longer meets criteria|0|||
16398558|NCT02574078|39938765|FG006|Treatment Period|Participant no longer meets criteria|0|||
16398559|NCT02574078|39938766|FG007|Treatment Period|Participant no longer meets criteria|0|||
16398560|NCT02574078|39938767|FG008|Treatment Period|Participant no longer meets criteria|0|||
16398561|NCT02574078|39938768|FG009|Treatment Period|Participant no longer meets criteria|1|||
16398562|NCT02574078|39938769|FG010|Treatment Period|Participant no longer meets criteria|1|||
16398563|NCT02574078|39938770|FG011|Treatment Period|Participant no longer meets criteria|1|||
16398564|NCT02574078|39938771|FG012|Treatment Period|Participant no longer meets criteria|0|||
16398565|NCT02574078|39938759|FG000|Treatment Period|Lost to Follow-up|0|||
16398566|NCT02574078|39938760|FG001|Treatment Period|Lost to Follow-up|0|||
16398567|NCT02574078|39938761|FG002|Treatment Period|Lost to Follow-up|0|||
16398568|NCT02574078|39938762|FG003|Treatment Period|Lost to Follow-up|0|||
16398569|NCT02574078|39938763|FG004|Treatment Period|Lost to Follow-up|0|||
16398570|NCT02574078|39938764|FG005|Treatment Period|Lost to Follow-up|0|||
16398571|NCT02574078|39938765|FG006|Treatment Period|Lost to Follow-up|0|||
16398572|NCT02574078|39938766|FG007|Treatment Period|Lost to Follow-up|0|||
16398573|NCT02574078|39938767|FG008|Treatment Period|Lost to Follow-up|0|||
16398574|NCT02574078|39938768|FG009|Treatment Period|Lost to Follow-up|1|||
16398575|NCT02574078|39938769|FG010|Treatment Period|Lost to Follow-up|0|||
16398576|NCT02574078|39938770|FG011|Treatment Period|Lost to Follow-up|1|||
16097380|NCT01587703|38846861|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097381|NCT01587703|38846862|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
16097382|NCT01587703|38846863|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
16097383|NCT01587703|38846864|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097384|NCT01587703|38846865|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097385|NCT01587703|38846866|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097386|NCT01587703|38846867|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097387|NCT01587703|38846868|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097388|NCT01587703|38846869|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097389|NCT01587703|38846870|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097390|NCT01587703|38846871|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
16097391|NCT01587703|38846853|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097392|NCT01587703|38846854|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097393|NCT01587703|38846855|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097394|NCT01587703|38846856|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097395|NCT01587703|38846857|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097396|NCT01587703|38846858|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097397|NCT01587703|38846859|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097398|NCT01587703|38846860|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097399|NCT01587703|38846861|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
16097400|NCT01587703|38846862|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097401|NCT01587703|38846863|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16525716|NCT00360308|40391057|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
16525717|NCT00360308|40391058|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
16525718|NCT00360308|40391059|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
16525719|NCT00360308|40391057|FG000|Overall Study|Protocol Violation|2|||
16525720|NCT00360308|40391058|FG001|Overall Study|Protocol Violation|1|||
16398577|NCT02574078|39938771|FG012|Treatment Period|Lost to Follow-up|0|||
16398578|NCT02574078|39938759|FG000|Treatment Period|Maximum clinical benefit|0|||
16398579|NCT02574078|39938760|FG001|Treatment Period|Maximum clinical benefit|0|||
16398580|NCT02574078|39938761|FG002|Treatment Period|Maximum clinical benefit|0|||
16525721|NCT00360308|40391059|FG002|Overall Study|Protocol Violation|2|||
16097402|NCT01587703|38846864|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097403|NCT01587703|38846865|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097404|NCT01587703|38846866|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097405|NCT01587703|38846867|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097406|NCT01587703|38846868|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097407|NCT01587703|38846869|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097408|NCT01587703|38846870|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097409|NCT01587703|38846871|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
16097410|NCT01587703|38846853|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097411|NCT01587703|38846854|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097412|NCT01587703|38846855|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097413|NCT01587703|38846856|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097414|NCT01587703|38846857|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097415|NCT01587703|38846858|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097416|NCT01587703|38846859|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097417|NCT01587703|38846860|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097418|NCT01587703|38846861|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097419|NCT01587703|38846862|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097420|NCT01587703|38846863|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097421|NCT01587703|38846864|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097422|NCT01587703|38846865|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097423|NCT01587703|38846866|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097424|NCT01587703|38846867|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097425|NCT01587703|38846868|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097426|NCT01587703|38846869|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16097427|NCT01587703|38846870|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
16525722|NCT00360308|40391057|FG000|Overall Study|Withdrawal by Subject|11|||
16525723|NCT00360308|40391058|FG001|Overall Study|Withdrawal by Subject|7|||
16525724|NCT00360308|40391059|FG002|Overall Study|Withdrawal by Subject|14|||
16525725|NCT00360308|40391057|FG000|Overall Study|Lack of Efficacy|3|||
16525726|NCT00360308|40391058|FG001|Overall Study|Lack of Efficacy|0|||
16097428|NCT01587703|38846871|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
16398581|NCT02574078|39938762|FG003|Treatment Period|Maximum clinical benefit|0|||
16398582|NCT02574078|39938763|FG004|Treatment Period|Maximum clinical benefit|0|||
16398583|NCT02574078|39938764|FG005|Treatment Period|Maximum clinical benefit|0|||
16398584|NCT02574078|39938765|FG006|Treatment Period|Maximum clinical benefit|0|||
16398585|NCT02574078|39938766|FG007|Treatment Period|Maximum clinical benefit|0|||
16398586|NCT02574078|39938767|FG008|Treatment Period|Maximum clinical benefit|0|||
16398587|NCT02574078|39938768|FG009|Treatment Period|Maximum clinical benefit|1|||
16398588|NCT02574078|39938769|FG010|Treatment Period|Maximum clinical benefit|0|||
16398589|NCT02574078|39938770|FG011|Treatment Period|Maximum clinical benefit|0|||
16398590|NCT02574078|39938771|FG012|Treatment Period|Maximum clinical benefit|0|||
16398591|NCT01951586|39938775|FG000|Overall Study|Death|61|||
16398592|NCT01951586|39938776|FG001|Overall Study|Death|120|||
16398593|NCT01951586|39938775|FG000|Overall Study|Withdrawal by Subject|8|||
16398594|NCT01951586|39938776|FG001|Overall Study|Withdrawal by Subject|17|||
16398595|NCT01951586|39938775|FG000|Overall Study|Lost to Follow-up|0|||
16398596|NCT01951586|39938776|FG001|Overall Study|Lost to Follow-up|1|||
16398597|NCT01951586|39938775|FG000|Overall Study|Sponsor Decision|9|||
16398598|NCT01951586|39938776|FG001|Overall Study|Sponsor Decision|10|||
16398599|NCT00269087|39938777|FG000|Overall Study|Adverse Event|20|||
16398600|NCT00269087|39938777|FG000|Overall Study|Withdrawal by Subject|1|||
16398601|NCT00269087|39938777|FG000|Overall Study|Exacerbation of COPD|13|||
16398602|NCT00413894|39938778|FG000|Overall Study|Withdrawal by Subject|10|||
16398603|NCT00413894|39938778|FG000|Overall Study|Administrative Reasons|1|||
16398604|NCT00413894|39938778|FG000|Overall Study|Hb <10 grams/deciliter|12|||
16398605|NCT00413894|39938778|FG000|Overall Study|Adverse Event|28|||
16398606|NCT00413894|39938778|FG000|Overall Study|Protocol Violation|11|||
16398607|NCT00413894|39938778|FG000|Overall Study|Other|18|||
16398608|NCT02038777|39938779|FG000|Overall Study|Death|0|||
16398609|NCT02038777|39938780|FG001|Overall Study|Death|2|||
16398610|NCT02038777|39938781|FG002|Overall Study|Death|0|||
16398611|NCT02038777|39938782|FG003|Overall Study|Death|1|||
16398612|NCT02038777|39938783|FG004|Overall Study|Death|2|||
16398613|NCT02038777|39938784|FG005|Overall Study|Death|4|||
16398614|NCT02038777|39938785|FG006|Overall Study|Death|0|||
16398615|NCT02038777|39938786|FG007|Overall Study|Death|10|||
16398616|NCT02038777|39938779|FG000|Overall Study|Lost to Follow-up|0|||
16398617|NCT02038777|39938780|FG001|Overall Study|Lost to Follow-up|0|||
16525727|NCT00360308|40391059|FG002|Overall Study|Lack of Efficacy|2|||
16525728|NCT00360308|40391057|FG000|Overall Study|Other|2|||
16525729|NCT00360308|40391058|FG001|Overall Study|Other|1|||
16398618|NCT02038777|39938781|FG002|Overall Study|Lost to Follow-up|0|||
16398619|NCT02038777|39938782|FG003|Overall Study|Lost to Follow-up|1|||
16398620|NCT02038777|39938783|FG004|Overall Study|Lost to Follow-up|0|||
16398621|NCT02038777|39938784|FG005|Overall Study|Lost to Follow-up|0|||
16398622|NCT02038777|39938785|FG006|Overall Study|Lost to Follow-up|0|||
16398623|NCT02038777|39938786|FG007|Overall Study|Lost to Follow-up|0|||
16398624|NCT02038777|39938779|FG000|Overall Study|Other|0|||
16398625|NCT02038777|39938780|FG001|Overall Study|Other|1|||
16398626|NCT02038777|39938781|FG002|Overall Study|Other|0|||
16398627|NCT02038777|39938782|FG003|Overall Study|Other|2|||
16398628|NCT02038777|39938783|FG004|Overall Study|Other|1|||
16398629|NCT02038777|39938784|FG005|Overall Study|Other|0|||
16398630|NCT02038777|39938785|FG006|Overall Study|Other|0|||
16398631|NCT02038777|39938786|FG007|Overall Study|Other|0|||
16398632|NCT02038777|39938779|FG000|Overall Study|Randomized but not treated|0|||
16398633|NCT02038777|39938780|FG001|Overall Study|Randomized but not treated|1|||
16398634|NCT02038777|39938781|FG002|Overall Study|Randomized but not treated|0|||
16398635|NCT02038777|39938782|FG003|Overall Study|Randomized but not treated|0|||
16398636|NCT02038777|39938783|FG004|Overall Study|Randomized but not treated|0|||
16398637|NCT02038777|39938784|FG005|Overall Study|Randomized but not treated|0|||
16398638|NCT02038777|39938785|FG006|Overall Study|Randomized but not treated|0|||
16398639|NCT02038777|39938786|FG007|Overall Study|Randomized but not treated|0|||
16398640|NCT02038777|39938779|FG000|Overall Study|Started Chemotherapy|1|||
16398641|NCT02038777|39938780|FG001|Overall Study|Started Chemotherapy|0|||
16398642|NCT02038777|39938781|FG002|Overall Study|Started Chemotherapy|3|||
16398643|NCT02038777|39938782|FG003|Overall Study|Started Chemotherapy|0|||
16398644|NCT02038777|39938783|FG004|Overall Study|Started Chemotherapy|0|||
16398645|NCT02038777|39938784|FG005|Overall Study|Started Chemotherapy|0|||
16398646|NCT02038777|39938785|FG006|Overall Study|Started Chemotherapy|0|||
16398647|NCT02038777|39938786|FG007|Overall Study|Started Chemotherapy|0|||
16398648|NCT02684058|39938793|FG000|Treatment Period|Progressive disease|4|||
16398649|NCT02684058|39938794|FG001|Treatment Period|Progressive disease|10|||
16398650|NCT02684058|39938795|FG002|Treatment Period|Progressive disease|19|||
16398651|NCT02684058|39938793|FG000|Treatment Period|Adverse Event|3|||
16398652|NCT02684058|39938794|FG001|Treatment Period|Adverse Event|8|||
16398653|NCT02684058|39938795|FG002|Treatment Period|Adverse Event|1|||
16398654|NCT02684058|39938793|FG000|Treatment Period|Physician Decision|5|||
16398655|NCT02684058|39938794|FG001|Treatment Period|Physician Decision|1|||
16398656|NCT02684058|39938795|FG002|Treatment Period|Physician Decision|2|||
16398657|NCT02684058|39938793|FG000|Treatment Period|New therapy for study indication|1|||
16398658|NCT02684058|39938794|FG001|Treatment Period|New therapy for study indication|0|||
16398659|NCT02684058|39938795|FG002|Treatment Period|New therapy for study indication|0|||
16398660|NCT02684058|39938793|FG000|Treatment Period|Protocol deviation|0|||
16398661|NCT02684058|39938794|FG001|Treatment Period|Protocol deviation|1|||
16398662|NCT02684058|39938795|FG002|Treatment Period|Protocol deviation|0|||
16398663|NCT02684058|39938793|FG000|Treatment Period|Subject/guardian decision|4|||
16398664|NCT02684058|39938794|FG001|Treatment Period|Subject/guardian decision|3|||
16398665|NCT02684058|39938795|FG002|Treatment Period|Subject/guardian decision|0|||
16398666|NCT02684058|39938793|FG000|Treatment Period|Death|0|||
16398667|NCT02684058|39938794|FG001|Treatment Period|Death|0|||
16398668|NCT02684058|39938795|FG002|Treatment Period|Death|2|||
16398669|NCT02684058|39938793|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
16398670|NCT02684058|39938794|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
16398671|NCT02684058|39938795|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
16398672|NCT02684058|39938793|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
16398673|NCT02684058|39938794|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
16398674|NCT02684058|39938795|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
16398675|NCT02684058|39938793|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
16398676|NCT02684058|39938794|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
16398677|NCT02684058|39938795|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
16398678|NCT02684058|39938793|FG000|Post-treatment Efficacy Follow-up|Death|0|||
16398679|NCT02684058|39938794|FG001|Post-treatment Efficacy Follow-up|Death|0|||
16398680|NCT02684058|39938795|FG002|Post-treatment Efficacy Follow-up|Death|3|||
16398681|NCT02684058|39938793|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
16398682|NCT02684058|39938794|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
16398683|NCT02684058|39938795|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
16398684|NCT02684058|39938793|FG000|Post-treatment Survival Follow-up|Death|0|||
16398685|NCT02684058|39938794|FG001|Post-treatment Survival Follow-up|Death|0|||
16398686|NCT02684058|39938795|FG002|Post-treatment Survival Follow-up|Death|7|||
16398687|NCT02684058|39938793|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
16398688|NCT02684058|39938794|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
16398689|NCT02684058|39938795|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
16398690|NCT02684058|39938793|FG000|Crossover Treatment Period|Progressive disease|0|||
16398691|NCT02684058|39938794|FG001|Crossover Treatment Period|Progressive disease|1|||
16398692|NCT02684058|39938795|FG002|Crossover Treatment Period|Progressive disease|0|||
16398693|NCT02907216|39938796|FG000|Overall Study|No benefit to be obtained by continuing|0|||
16398694|NCT02907216|39938797|FG001|Overall Study|No benefit to be obtained by continuing|1|||
16398695|NCT02907216|39938796|FG000|Overall Study|Withdrawal by Subject|1|||
16398696|NCT02907216|39938797|FG001|Overall Study|Withdrawal by Subject|0|||
16398697|NCT01814397|39938800|FG000|Overall Study|Adverse Event|7|||
16398698|NCT01814397|39938800|FG000|Overall Study|Withdrawal by Subject|7|||
16398699|NCT04245449|39938802|FG000|Overall Study|COVID shutdown|7|||
16398700|NCT01059864|39938807|FG000|Open-Label Run-In Phase|Adverse Event|7|||
16398701|NCT01059864|39938808|FG001|Open-Label Run-In Phase|Adverse Event|0|||
16398702|NCT01059864|39938809|FG002|Open-Label Run-In Phase|Adverse Event|0|||
16525730|NCT00360308|40391059|FG002|Overall Study|Other|1|||
16525731|NCT00360308|40391057|FG000|Overall Study|Study termination by sponsor|43|||
16329549|NCT02829723|39692554|FG017|Overall Study|Progressive disease|3|||
16329550|NCT02829723|39692555|FG018|Overall Study|Progressive disease|4|||
16329551|NCT02829723|39692556|FG019|Overall Study|Progressive disease|4|||
16329552|NCT02829723|39692557|FG020|Overall Study|Progressive disease|7|||
16329553|NCT02829723|39692558|FG021|Overall Study|Progressive disease|6|||
16329554|NCT02829723|39692559|FG022|Overall Study|Progressive disease|3|||
16329555|NCT02829723|39692560|FG023|Overall Study|Progressive disease|3|||
16329556|NCT02829723|39692561|FG024|Overall Study|Progressive disease|3|||
16329557|NCT02829723|39692562|FG025|Overall Study|Progressive disease|16|||
16329558|NCT02829723|39692563|FG026|Overall Study|Progressive disease|10|||
16329559|NCT02829723|39692537|FG000|Overall Study|Subject/guardian decision|0|||
16329560|NCT02829723|39692538|FG001|Overall Study|Subject/guardian decision|1|||
16329561|NCT02829723|39692539|FG002|Overall Study|Subject/guardian decision|0|||
16329562|NCT02829723|39692540|FG003|Overall Study|Subject/guardian decision|1|||
16329563|NCT02829723|39692541|FG004|Overall Study|Subject/guardian decision|0|||
16329564|NCT02829723|39692542|FG005|Overall Study|Subject/guardian decision|0|||
16329565|NCT02829723|39692543|FG006|Overall Study|Subject/guardian decision|0|||
16329566|NCT02829723|39692544|FG007|Overall Study|Subject/guardian decision|1|||
16329567|NCT02829723|39692545|FG008|Overall Study|Subject/guardian decision|0|||
16329568|NCT02829723|39692546|FG009|Overall Study|Subject/guardian decision|0|||
16329569|NCT02829723|39692547|FG010|Overall Study|Subject/guardian decision|0|||
16329570|NCT02829723|39692548|FG011|Overall Study|Subject/guardian decision|0|||
16329571|NCT02829723|39692549|FG012|Overall Study|Subject/guardian decision|0|||
16329572|NCT02829723|39692550|FG013|Overall Study|Subject/guardian decision|0|||
16329573|NCT02829723|39692551|FG014|Overall Study|Subject/guardian decision|1|||
16329574|NCT02829723|39692552|FG015|Overall Study|Subject/guardian decision|0|||
16329575|NCT02829723|39692553|FG016|Overall Study|Subject/guardian decision|1|||
16329576|NCT02829723|39692554|FG017|Overall Study|Subject/guardian decision|0|||
16329577|NCT02829723|39692555|FG018|Overall Study|Subject/guardian decision|1|||
16329578|NCT02829723|39692556|FG019|Overall Study|Subject/guardian decision|0|||
16329579|NCT02829723|39692557|FG020|Overall Study|Subject/guardian decision|1|||
16329580|NCT02829723|39692558|FG021|Overall Study|Subject/guardian decision|0|||
16329581|NCT02829723|39692559|FG022|Overall Study|Subject/guardian decision|0|||
16329582|NCT02829723|39692560|FG023|Overall Study|Subject/guardian decision|1|||
16329583|NCT02829723|39692561|FG024|Overall Study|Subject/guardian decision|0|||
16329584|NCT02829723|39692562|FG025|Overall Study|Subject/guardian decision|1|||
16329585|NCT02829723|39692563|FG026|Overall Study|Subject/guardian decision|1|||
16329586|NCT02829723|39692537|FG000|Overall Study|Study terminated by sponsor|0|||
16329587|NCT02829723|39692538|FG001|Overall Study|Study terminated by sponsor|0|||
16329588|NCT02829723|39692539|FG002|Overall Study|Study terminated by sponsor|0|||
16329589|NCT02829723|39692540|FG003|Overall Study|Study terminated by sponsor|0|||
16329590|NCT02829723|39692541|FG004|Overall Study|Study terminated by sponsor|0|||
16329591|NCT02829723|39692542|FG005|Overall Study|Study terminated by sponsor|0|||
16329592|NCT02829723|39692543|FG006|Overall Study|Study terminated by sponsor|0|||
16329593|NCT02829723|39692544|FG007|Overall Study|Study terminated by sponsor|0|||
16329594|NCT02829723|39692545|FG008|Overall Study|Study terminated by sponsor|0|||
16329595|NCT02829723|39692546|FG009|Overall Study|Study terminated by sponsor|0|||
16329596|NCT02829723|39692547|FG010|Overall Study|Study terminated by sponsor|0|||
16329597|NCT02829723|39692548|FG011|Overall Study|Study terminated by sponsor|0|||
16329598|NCT02829723|39692549|FG012|Overall Study|Study terminated by sponsor|0|||
16329599|NCT02829723|39692550|FG013|Overall Study|Study terminated by sponsor|0|||
16329600|NCT02829723|39692551|FG014|Overall Study|Study terminated by sponsor|0|||
16329601|NCT02829723|39692552|FG015|Overall Study|Study terminated by sponsor|0|||
16329602|NCT02829723|39692553|FG016|Overall Study|Study terminated by sponsor|0|||
16329603|NCT02829723|39692554|FG017|Overall Study|Study terminated by sponsor|0|||
16329604|NCT02829723|39692555|FG018|Overall Study|Study terminated by sponsor|0|||
16329605|NCT02829723|39692556|FG019|Overall Study|Study terminated by sponsor|0|||
16329606|NCT02829723|39692557|FG020|Overall Study|Study terminated by sponsor|0|||
16329607|NCT02829723|39692558|FG021|Overall Study|Study terminated by sponsor|1|||
16329608|NCT02829723|39692559|FG022|Overall Study|Study terminated by sponsor|0|||
16329609|NCT02829723|39692560|FG023|Overall Study|Study terminated by sponsor|0|||
16329610|NCT02829723|39692561|FG024|Overall Study|Study terminated by sponsor|0|||
16329611|NCT02829723|39692562|FG025|Overall Study|Study terminated by sponsor|0|||
16329612|NCT02829723|39692563|FG026|Overall Study|Study terminated by sponsor|0|||
16329613|NCT03646305|39692565|FG000|Overall Study|Lost to Follow-up|4|||
16329614|NCT03646305|39692566|FG001|Overall Study|Lost to Follow-up|2|||
16329615|NCT03646305|39692567|FG002|Overall Study|Lost to Follow-up|2|||
16329616|NCT03646305|39692568|FG003|Overall Study|Lost to Follow-up|1|||
16329617|NCT03646305|39692565|FG000|Overall Study|Withdrawal by Subject|1|||
16329618|NCT03646305|39692566|FG001|Overall Study|Withdrawal by Subject|0|||
16329619|NCT03646305|39692567|FG002|Overall Study|Withdrawal by Subject|0|||
16329620|NCT03646305|39692568|FG003|Overall Study|Withdrawal by Subject|1|||
16329621|NCT02091375|39692569|FG000|Overall Study|Adverse Event|8|||
16329622|NCT02091375|39692570|FG001|Overall Study|Adverse Event|1|||
16329623|NCT02091375|39692569|FG000|Overall Study|Lost to Follow-up|0|||
16329624|NCT02091375|39692570|FG001|Overall Study|Lost to Follow-up|1|||
16329625|NCT02091375|39692569|FG000|Overall Study|Withdrawal by Subject|0|||
16329626|NCT02091375|39692570|FG001|Overall Study|Withdrawal by Subject|1|||
16329627|NCT02091375|39692569|FG000|Overall Study|Withdrawn by the investigator|1|||
16329628|NCT02091375|39692570|FG001|Overall Study|Withdrawn by the investigator|0|||
16329629|NCT02954653|39692571|FG000|Overall Study|Death|3|||
16329630|NCT02954653|39692572|FG001|Overall Study|Death|1|||
16097429|NCT01587703|38846853|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097430|NCT01587703|38846854|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097431|NCT01587703|38846855|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097432|NCT01587703|38846856|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097433|NCT01587703|38846857|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097434|NCT01587703|38846858|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097435|NCT01587703|38846859|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097436|NCT01587703|38846860|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097437|NCT01587703|38846861|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097438|NCT01587703|38846862|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16398703|NCT01059864|39938807|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
16398704|NCT01059864|39938808|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
16398705|NCT01059864|39938809|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
16398706|NCT01059864|39938807|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
16398707|NCT01059864|39938808|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
16398708|NCT01059864|39938809|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
16398709|NCT01059864|39938807|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
16398710|NCT01059864|39938808|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
16398711|NCT01059864|39938809|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
16398712|NCT01059864|39938807|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
16398713|NCT01059864|39938808|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
16398714|NCT01059864|39938809|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
16398715|NCT01059864|39938807|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
16398716|NCT01059864|39938808|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
16398717|NCT01059864|39938809|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
16398718|NCT00635349|39938810|FG000|Overall Study|Other|8|||
16398719|NCT00635349|39938811|FG001|Overall Study|Other|6|||
16398720|NCT00635349|39938810|FG000|Overall Study|Protocol Violation|18|||
16398721|NCT00635349|39938811|FG001|Overall Study|Protocol Violation|22|||
16398722|NCT00635349|39938810|FG000|Overall Study|Withdrawal by Subject|3|||
16398723|NCT00635349|39938811|FG001|Overall Study|Withdrawal by Subject|8|||
16398724|NCT00635349|39938810|FG000|Overall Study|Lost to Follow-up|4|||
16398725|NCT00635349|39938811|FG001|Overall Study|Lost to Follow-up|3|||
16398726|NCT00635349|39938810|FG000|Overall Study|Adverse Event|11|||
16398727|NCT00635349|39938811|FG001|Overall Study|Adverse Event|9|||
16398728|NCT02597452|39938812|FG000|Overall Study|testing incomplete|30|||
16398729|NCT00245050|39938818|FG000|Overall Study|Adverse Event|3|||
16398730|NCT00245050|39938819|FG001|Overall Study|Adverse Event|2|||
16398731|NCT01923363|39938820|FG000|Overall Study|Protocol Violation|1|||
16398732|NCT02455336|39938826|FG000|Overall Study|Withdrawal by Subject|0|||
16398733|NCT02455336|39938827|FG001|Overall Study|Withdrawal by Subject|2|||
16398734|NCT02455336|39938826|FG000|Overall Study|Adverse Event|3|||
16398735|NCT02455336|39938827|FG001|Overall Study|Adverse Event|0|||
16398736|NCT02455336|39938826|FG000|Overall Study|Non-responder to treatment|2|||
16398737|NCT02455336|39938827|FG001|Overall Study|Non-responder to treatment|0|||
16398738|NCT04097028|39938830|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
16398739|NCT04097028|39938830|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
16398740|NCT04097028|39938830|FG000|Overall Study|Disease Progression prior to Surgery|2|||
16398741|NCT04097028|39938830|FG000|Overall Study|Adverse Event prior to Surgery|1|||
16398742|NCT02684617|39938831|FG000|Overall Study|Adverse Event|1|||
16398743|NCT02684617|39938832|FG001|Overall Study|Adverse Event|0|||
16398744|NCT02684617|39938833|FG002|Overall Study|Adverse Event|1|||
16398745|NCT02684617|39938831|FG000|Overall Study|Death|8|||
16398746|NCT02684617|39938832|FG001|Overall Study|Death|16|||
16398747|NCT02684617|39938833|FG002|Overall Study|Death|28|||
16398748|NCT02684617|39938831|FG000|Overall Study|Withdrawal by Subject|2|||
16398749|NCT02684617|39938832|FG001|Overall Study|Withdrawal by Subject|0|||
16398750|NCT02684617|39938833|FG002|Overall Study|Withdrawal by Subject|4|||
16398751|NCT02684617|39938831|FG000|Overall Study|Screen Failure|1|||
16097439|NCT01587703|38846863|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16329631|NCT02954653|39692573|FG002|Overall Study|Death|0|||
16398752|NCT02684617|39938832|FG001|Overall Study|Screen Failure|0|||
16398753|NCT02684617|39938833|FG002|Overall Study|Screen Failure|2|||
16398754|NCT02684617|39938831|FG000|Overall Study|Study Terminated by Sponsor|6|||
16398755|NCT02684617|39938832|FG001|Overall Study|Study Terminated by Sponsor|1|||
16546375|NCT01662063|40464798|FG002|Overall Study|Lack of Efficacy|0|||
16097440|NCT01587703|38846864|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097441|NCT01587703|38846865|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097442|NCT01587703|38846866|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097443|NCT01587703|38846867|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097444|NCT01587703|38846868|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16097445|NCT01587703|38846869|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
16398756|NCT02684617|39938833|FG002|Overall Study|Study Terminated by Sponsor|5|||
16398757|NCT01301066|39938837|FG000|Overall Study|Lost to Follow-up|5|||
16398758|NCT01301066|39938838|FG001|Overall Study|Lost to Follow-up|11|||
16398759|NCT01301066|39938837|FG000|Overall Study|Protocol Violation|8|||
16398760|NCT01301066|39938838|FG001|Overall Study|Protocol Violation|7|||
16398761|NCT01301066|39938837|FG000|Overall Study|Withdrawal by Subject|4|||
16398762|NCT01301066|39938838|FG001|Overall Study|Withdrawal by Subject|9|||
16398763|NCT01301066|39938837|FG000|Overall Study|Adverse Event|6|||
16398764|NCT01301066|39938838|FG001|Overall Study|Adverse Event|6|||
16398765|NCT01301066|39938837|FG000|Overall Study|Sponsor Decision|2|||
16398766|NCT01301066|39938838|FG001|Overall Study|Sponsor Decision|1|||
16398767|NCT01301066|39938837|FG000|Overall Study|Physician Decision|0|||
16398768|NCT01301066|39938838|FG001|Overall Study|Physician Decision|1|||
16398769|NCT01301066|39938837|FG000|Overall Study|Other|2|||
16398770|NCT01301066|39938838|FG001|Overall Study|Other|0|||
16398771|NCT00656058|39938841|FG000|Overall Study|Withdrawal by Subject|2|||
16097446|NCT01587703|38846870|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
16398772|NCT00656058|39938841|FG000|Overall Study|Withdrawal by Subject|4|||
16398773|NCT02379988|39938850|FG000|Overall Study|Not eligible|1|||
16398774|NCT03985943|39938854|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
16398775|NCT03985943|39938855|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
16398776|NCT03985943|39938856|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
16398777|NCT03985943|39938857|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
16398778|NCT03985943|39938858|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
16525732|NCT00360308|40391058|FG001|Overall Study|Study termination by sponsor|55|||
16525733|NCT00360308|40391059|FG002|Overall Study|Study termination by sponsor|44|||
16525734|NCT00439777|40391060|FG000|Treatment Period|Death|29|||
16525735|NCT00439777|40391061|FG001|Treatment Period|Death|21|||
16525736|NCT00439777|40391060|FG000|Treatment Period|Study terminated by sponsor|125|||
16525737|NCT00439777|40391061|FG001|Treatment Period|Study terminated by sponsor|132|||
16525738|NCT00439777|40391060|FG000|Treatment Period|Site closed by investigator|0|||
16525739|NCT00439777|40391061|FG001|Treatment Period|Site closed by investigator|1|||
16525740|NCT00439777|40391060|FG000|Treatment Period|Did not take study treatment|7|||
16525741|NCT00439777|40391061|FG001|Treatment Period|Did not take study treatment|8|||
16525742|NCT00439777|40391060|FG000|Treatment Period|Adverse Event|111|||
16525743|NCT00439777|40391061|FG001|Treatment Period|Adverse Event|92|||
16525744|NCT00439777|40391060|FG000|Treatment Period|Protocol Violation|23|||
16525745|NCT00439777|40391061|FG001|Treatment Period|Protocol Violation|30|||
16525746|NCT00439777|40391060|FG000|Treatment Period|Withdrawal by Subject|66|||
16525747|NCT00439777|40391061|FG001|Treatment Period|Withdrawal by Subject|118|||
16525748|NCT00439777|40391060|FG000|Treatment Period|Lack of Efficacy|1|||
16525749|NCT00439777|40391061|FG001|Treatment Period|Lack of Efficacy|4|||
16525750|NCT00439777|40391060|FG000|Treatment Period|Lost to Follow-up|8|||
16525751|NCT00439777|40391061|FG001|Treatment Period|Lost to Follow-up|10|||
16525752|NCT00439777|40391060|FG000|Treatment Period|Protocol driven decision point|1|||
16525753|NCT00439777|40391061|FG001|Treatment Period|Protocol driven decision point|3|||
16525754|NCT00439777|40391060|FG000|Treatment Period|Physician Decision|7|||
16525755|NCT00439777|40391061|FG001|Treatment Period|Physician Decision|18|||
16525756|NCT00439777|40391060|FG000|Treatment Period|Clinical endpoint reached|26|||
16525757|NCT00439777|40391061|FG001|Treatment Period|Clinical endpoint reached|13|||
16525758|NCT00439777|40391060|FG000|Treatment Period|Technical problems|3|||
16525759|NCT00439777|40391061|FG001|Treatment Period|Technical problems|1|||
16525760|NCT00439777|40391060|FG000|Treatment Period|Participant convenience|12|||
16525761|NCT00439777|40391061|FG001|Treatment Period|Participant convenience|8|||
16525762|NCT00439777|40391060|FG000|Observational Period|Protocol Violation|0|||
16525763|NCT00439777|40391061|FG001|Observational Period|Protocol Violation|2|||
16525764|NCT00439777|40391060|FG000|Observational Period|Withdrawal by Subject|9|||
16525765|NCT00439777|40391061|FG001|Observational Period|Withdrawal by Subject|5|||
16525766|NCT00439777|40391060|FG000|Observational Period|Lost to Follow-up|1|||
16525767|NCT00439777|40391061|FG001|Observational Period|Lost to Follow-up|11|||
16525768|NCT00439777|40391060|FG000|Observational Period|Death|27|||
16525769|NCT00439777|40391061|FG001|Observational Period|Death|20|||
16525770|NCT00439777|40391060|FG000|Observational Period|Study terminated by sponsor|3|||
16525771|NCT00439777|40391061|FG001|Observational Period|Study terminated by sponsor|1|||
16525772|NCT00439777|40391060|FG000|Observational Period|Protocol driven decision point|0|||
16525773|NCT00439777|40391061|FG001|Observational Period|Protocol driven decision point|1|||
16525774|NCT00439777|40391060|FG000|Observational Period|Lack of Efficacy|1|||
16525775|NCT00439777|40391061|FG001|Observational Period|Lack of Efficacy|0|||
16525776|NCT00439777|40391060|FG000|Observational Period|Technical problems|0|||
16525777|NCT00439777|40391061|FG001|Observational Period|Technical problems|1|||
16525778|NCT03755765|40391062|FG000|Overall Study|Withdrawal by Subject|2|||
16525779|NCT03755765|40391063|FG001|Overall Study|Withdrawal by Subject|4|||
16525780|NCT03755765|40391064|FG002|Overall Study|Withdrawal by Subject|4|||
16525781|NCT03221257|40391076|FG000|Overall Study|Lost to Follow-up|0|||
16525782|NCT03221257|40391077|FG001|Overall Study|Lost to Follow-up|1|||
16525783|NCT03221257|40391076|FG000|Overall Study|Withdrawal by Subject|1|||
16398779|NCT03985943|39938859|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
16525784|NCT03221257|40391077|FG001|Overall Study|Withdrawal by Subject|1|||
16210833|NCT00741260|39251463|FG005|Overall Study|Withdrawal by Subject|3|||
16210834|NCT00741260|39251464|FG006|Overall Study|Withdrawal by Subject|1|||
16210835|NCT00741260|39251458|FG000|Overall Study|Physician Decision|1|||
16210836|NCT00741260|39251459|FG001|Overall Study|Physician Decision|1|||
16210837|NCT00741260|39251460|FG002|Overall Study|Physician Decision|0|||
16210838|NCT00741260|39251461|FG003|Overall Study|Physician Decision|0|||
16097447|NCT01587703|38846871|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
16097448|NCT01587703|38846853|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097449|NCT01587703|38846854|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097450|NCT01587703|38846855|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097451|NCT01587703|38846856|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097452|NCT01587703|38846857|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097453|NCT01587703|38846858|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097454|NCT01587703|38846859|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097455|NCT01587703|38846860|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097456|NCT01587703|38846861|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097457|NCT01587703|38846862|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097458|NCT01587703|38846863|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097459|NCT01587703|38846864|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097460|NCT01587703|38846865|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097461|NCT01587703|38846866|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097462|NCT01587703|38846867|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16210839|NCT00741260|39251462|FG004|Overall Study|Physician Decision|0|||
16210840|NCT00741260|39251463|FG005|Overall Study|Physician Decision|0|||
16210841|NCT00741260|39251464|FG006|Overall Study|Physician Decision|0|||
16210842|NCT00741260|39251458|FG000|Overall Study|Other|2|||
16210843|NCT00741260|39251459|FG001|Overall Study|Other|1|||
16210844|NCT00741260|39251460|FG002|Overall Study|Other|1|||
16210845|NCT00741260|39251461|FG003|Overall Study|Other|2|||
16210846|NCT00741260|39251462|FG004|Overall Study|Other|1|||
16210847|NCT00741260|39251463|FG005|Overall Study|Other|3|||
16210848|NCT00741260|39251464|FG006|Overall Study|Other|1|||
16210849|NCT00899678|39251466|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
16210850|NCT00899678|39251467|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
16210851|NCT00899678|39251468|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
16210852|NCT00899678|39251466|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
16210853|NCT00899678|39251467|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
16210854|NCT00899678|39251468|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
16210855|NCT00899678|39251466|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
16210856|NCT00899678|39251467|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
16210857|NCT00899678|39251468|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
16210858|NCT00899678|39251466|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
16210859|NCT00899678|39251467|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
16210860|NCT00899678|39251468|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
16210861|NCT00899678|39251466|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
16210862|NCT00899678|39251467|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
16210863|NCT00899678|39251468|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
16210864|NCT00899678|39251466|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
16210865|NCT00899678|39251467|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
16210866|NCT00899678|39251468|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
16210867|NCT00899678|39251466|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
16329632|NCT02954653|39692574|FG003|Overall Study|Death|0|||
16398780|NCT03985943|39938854|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
16097463|NCT01587703|38846868|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
16097464|NCT01587703|38846869|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097465|NCT01587703|38846870|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097466|NCT01587703|38846871|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
16097467|NCT01587703|38846853|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097468|NCT01587703|38846854|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097469|NCT01587703|38846855|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097470|NCT01587703|38846856|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097471|NCT01587703|38846857|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097472|NCT01587703|38846858|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097473|NCT01587703|38846859|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097474|NCT01587703|38846860|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16398781|NCT03985943|39938855|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
16329633|NCT02954653|39692575|FG004|Overall Study|Death|0|||
16329634|NCT02954653|39692576|FG005|Overall Study|Death|0|||
16329635|NCT02954653|39692577|FG006|Overall Study|Death|0|||
16329636|NCT02954653|39692578|FG007|Overall Study|Death|0|||
16329637|NCT02954653|39692579|FG008|Overall Study|Death|0|||
16329638|NCT02954653|39692571|FG000|Overall Study|Randomized but did not receive treatment|1|||
16329639|NCT02954653|39692572|FG001|Overall Study|Randomized but did not receive treatment|0|||
16398782|NCT03985943|39938856|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
16398783|NCT03985943|39938857|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
16398784|NCT03985943|39938858|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
16329640|NCT02954653|39692573|FG002|Overall Study|Randomized but did not receive treatment|0|||
16329641|NCT02954653|39692574|FG003|Overall Study|Randomized but did not receive treatment|0|||
16097475|NCT01587703|38846861|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097476|NCT01587703|38846862|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097477|NCT01587703|38846863|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097478|NCT01587703|38846864|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
16097479|NCT01587703|38846865|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097480|NCT01587703|38846866|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097481|NCT01587703|38846867|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
16097482|NCT01587703|38846868|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097483|NCT01587703|38846869|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097484|NCT01587703|38846870|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097485|NCT01587703|38846871|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
16097486|NCT01587703|38846853|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097487|NCT01587703|38846854|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097488|NCT01587703|38846855|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097489|NCT01587703|38846856|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097490|NCT01587703|38846857|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097491|NCT01587703|38846858|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097492|NCT01587703|38846859|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097493|NCT01587703|38846860|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097494|NCT01587703|38846861|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097495|NCT01587703|38846862|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097496|NCT01587703|38846863|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097497|NCT01587703|38846864|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
16097498|NCT01587703|38846865|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
16097499|NCT01587703|38846866|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
16097500|NCT01587703|38846867|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
16097501|NCT01587703|38846868|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
16097502|NCT01587703|38846869|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
16097503|NCT01587703|38846870|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097504|NCT01587703|38846871|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
16097505|NCT01587703|38846853|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097506|NCT01587703|38846854|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097507|NCT01587703|38846855|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097508|NCT01587703|38846856|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097509|NCT01587703|38846857|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097510|NCT01587703|38846858|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097511|NCT01587703|38846859|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
16329642|NCT02954653|39692575|FG004|Overall Study|Randomized but did not receive treatment|0|||
16329643|NCT02954653|39692576|FG005|Overall Study|Randomized but did not receive treatment|0|||
16329644|NCT02954653|39692577|FG006|Overall Study|Randomized but did not receive treatment|0|||
16329645|NCT02954653|39692578|FG007|Overall Study|Randomized but did not receive treatment|0|||
16329646|NCT02954653|39692579|FG008|Overall Study|Randomized but did not receive treatment|0|||
16329647|NCT02954653|39692571|FG000|Overall Study|Started another anti-cancer therapy|0|||
16329648|NCT02954653|39692572|FG001|Overall Study|Started another anti-cancer therapy|1|||
16329649|NCT02954653|39692573|FG002|Overall Study|Started another anti-cancer therapy|0|||
16329650|NCT02954653|39692574|FG003|Overall Study|Started another anti-cancer therapy|0|||
16329651|NCT02954653|39692575|FG004|Overall Study|Started another anti-cancer therapy|0|||
16329652|NCT02954653|39692576|FG005|Overall Study|Started another anti-cancer therapy|0|||
16329653|NCT02954653|39692577|FG006|Overall Study|Started another anti-cancer therapy|0|||
16329654|NCT02954653|39692578|FG007|Overall Study|Started another anti-cancer therapy|0|||
16329655|NCT02954653|39692579|FG008|Overall Study|Started another anti-cancer therapy|0|||
16329656|NCT02954653|39692571|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
16329657|NCT02954653|39692572|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
16329658|NCT02954653|39692573|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
16329659|NCT02954653|39692574|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
16329660|NCT02954653|39692575|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
16329661|NCT02954653|39692576|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
16329662|NCT02954653|39692577|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
16329663|NCT02954653|39692578|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
16329664|NCT02954653|39692579|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
16329665|NCT00477607|39692585|FG000|Overall Study|Lost to Follow-up|7|||
16329666|NCT00477607|39692586|FG001|Overall Study|Lost to Follow-up|7|||
16329667|NCT04068688|39692587|FG000|Overall Study|Lost to Follow-up|1|||
16398785|NCT03985943|39938859|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
16398786|NCT03985943|39938854|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
16097512|NCT01587703|38846860|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097513|NCT01587703|38846861|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097514|NCT01587703|38846862|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
16329668|NCT04068688|39692588|FG001|Overall Study|Lost to Follow-up|1|||
16329669|NCT04068688|39692589|FG002|Overall Study|Lost to Follow-up|0|||
16329670|NCT04068688|39692590|FG003|Overall Study|Lost to Follow-up|0|||
16329671|NCT04068688|39692591|FG004|Overall Study|Lost to Follow-up|5|||
16329672|NCT04068688|39692592|FG005|Overall Study|Lost to Follow-up|5|||
16329673|NCT04068688|39692593|FG006|Overall Study|Lost to Follow-up|0|||
16329674|NCT04068688|39692594|FG007|Overall Study|Lost to Follow-up|0|||
16329675|NCT04068688|39692595|FG008|Overall Study|Lost to Follow-up|1|||
16329676|NCT04068688|39692596|FG009|Overall Study|Lost to Follow-up|0|||
16329677|NCT04068688|39692587|FG000|Overall Study|Withdrawal by Subject|1|||
16329678|NCT04068688|39692588|FG001|Overall Study|Withdrawal by Subject|1|||
16329679|NCT04068688|39692589|FG002|Overall Study|Withdrawal by Subject|0|||
16329680|NCT04068688|39692590|FG003|Overall Study|Withdrawal by Subject|0|||
16329681|NCT04068688|39692591|FG004|Overall Study|Withdrawal by Subject|0|||
16329682|NCT04068688|39692592|FG005|Overall Study|Withdrawal by Subject|0|||
16329683|NCT04068688|39692593|FG006|Overall Study|Withdrawal by Subject|0|||
16329684|NCT04068688|39692594|FG007|Overall Study|Withdrawal by Subject|0|||
16329685|NCT04068688|39692595|FG008|Overall Study|Withdrawal by Subject|0|||
16329686|NCT04068688|39692596|FG009|Overall Study|Withdrawal by Subject|0|||
16329687|NCT04068688|39692587|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
16329688|NCT04068688|39692588|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
16329689|NCT04068688|39692589|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
16329690|NCT04068688|39692590|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
16329691|NCT04068688|39692591|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
16329692|NCT04068688|39692592|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
16329693|NCT04068688|39692593|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
16329694|NCT04068688|39692594|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
16329695|NCT04068688|39692595|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
16329696|NCT04068688|39692596|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
16329697|NCT02912455|39692597|FG000|Overall Study|Withdrawal by Subject|0|||
16329698|NCT02912455|39692598|FG001|Overall Study|Withdrawal by Subject|1|||
16329699|NCT02912455|39692597|FG000|Overall Study|Lack of Efficacy|0|||
16329700|NCT02912455|39692598|FG001|Overall Study|Lack of Efficacy|1|||
16329701|NCT02912455|39692597|FG000|Overall Study|Lost to Follow-up|2|||
16329702|NCT02912455|39692598|FG001|Overall Study|Lost to Follow-up|1|||
16329703|NCT01992653|39692605|FG000|Overall Study|Death|0|||
16329704|NCT01992653|39692606|FG001|Overall Study|Death|0|||
16329705|NCT01992653|39692607|FG002|Overall Study|Death|1|||
16329706|NCT01992653|39692608|FG003|Overall Study|Death|0|||
16329707|NCT01992653|39692609|FG004|Overall Study|Death|1|||
16329708|NCT01992653|39692610|FG005|Overall Study|Death|0|||
16329709|NCT01992653|39692611|FG006|Overall Study|Death|4|||
16329710|NCT01992653|39692612|FG007|Overall Study|Death|2|||
16329711|NCT01992653|39692605|FG000|Overall Study|Lost to Follow-up|0|||
16329712|NCT01992653|39692606|FG001|Overall Study|Lost to Follow-up|0|||
16329713|NCT01992653|39692607|FG002|Overall Study|Lost to Follow-up|0|||
16329714|NCT01992653|39692608|FG003|Overall Study|Lost to Follow-up|0|||
16329715|NCT01992653|39692609|FG004|Overall Study|Lost to Follow-up|0|||
16329716|NCT01992653|39692610|FG005|Overall Study|Lost to Follow-up|0|||
16329717|NCT01992653|39692611|FG006|Overall Study|Lost to Follow-up|0|||
16329718|NCT01992653|39692612|FG007|Overall Study|Lost to Follow-up|1|||
16329719|NCT01992653|39692605|FG000|Overall Study|Study Completed|0|||
16329720|NCT01992653|39692606|FG001|Overall Study|Study Completed|0|||
16329721|NCT01992653|39692607|FG002|Overall Study|Study Completed|0|||
16329722|NCT01992653|39692608|FG003|Overall Study|Study Completed|0|||
16329723|NCT01992653|39692609|FG004|Overall Study|Study Completed|0|||
16329724|NCT01992653|39692610|FG005|Overall Study|Study Completed|0|||
16329725|NCT01992653|39692611|FG006|Overall Study|Study Completed|0|||
16329726|NCT01992653|39692612|FG007|Overall Study|Study Completed|1|||
16329727|NCT01992653|39692605|FG000|Overall Study|Disease Progression|0|||
16329728|NCT01992653|39692606|FG001|Overall Study|Disease Progression|0|||
16329729|NCT01992653|39692607|FG002|Overall Study|Disease Progression|0|||
16329730|NCT01992653|39692608|FG003|Overall Study|Disease Progression|0|||
16329731|NCT01992653|39692609|FG004|Overall Study|Disease Progression|0|||
16329732|NCT01992653|39692610|FG005|Overall Study|Disease Progression|0|||
16329733|NCT01992653|39692611|FG006|Overall Study|Disease Progression|4|||
16329734|NCT01992653|39692612|FG007|Overall Study|Disease Progression|0|||
16329735|NCT03320850|39692613|FG000|Overall Study|Lost to Follow-up|0|||
16329736|NCT03320850|39692614|FG001|Overall Study|Lost to Follow-up|0|||
16329737|NCT03320850|39692615|FG002|Overall Study|Lost to Follow-up|0|||
16329738|NCT03320850|39692616|FG003|Overall Study|Lost to Follow-up|0|||
16329739|NCT03320850|39692617|FG004|Overall Study|Lost to Follow-up|1|||
16329740|NCT03320850|39692618|FG005|Overall Study|Lost to Follow-up|2|||
16329741|NCT03320850|39692619|FG006|Overall Study|Lost to Follow-up|2|||
16329742|NCT03320850|39692620|FG007|Overall Study|Lost to Follow-up|0|||
16329743|NCT03320850|39692621|FG008|Overall Study|Lost to Follow-up|6|||
16329744|NCT03320850|39692622|FG009|Overall Study|Lost to Follow-up|4|||
16525785|NCT02086591|40391081|FG000|Overall Study|Adverse Event|1|||
16398787|NCT03985943|39938855|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
16398788|NCT03985943|39938856|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
16398789|NCT03985943|39938857|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
16398790|NCT03985943|39938858|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
16398791|NCT03985943|39938859|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
16398792|NCT03985943|39938854|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
16398793|NCT03985943|39938855|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
16398794|NCT03985943|39938856|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
16398795|NCT03985943|39938857|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
16398796|NCT03985943|39938858|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
16398797|NCT03985943|39938859|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
16398798|NCT03985943|39938854|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
16398799|NCT03985943|39938855|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
16398800|NCT03985943|39938856|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
16398801|NCT03985943|39938857|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
16398802|NCT03985943|39938858|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
16329745|NCT03320850|39692613|FG000|Overall Study|Withdrawal by Subject|0|||
16329746|NCT03320850|39692614|FG001|Overall Study|Withdrawal by Subject|0|||
16329747|NCT03320850|39692615|FG002|Overall Study|Withdrawal by Subject|0|||
16329748|NCT03320850|39692616|FG003|Overall Study|Withdrawal by Subject|0|||
16329749|NCT03320850|39692617|FG004|Overall Study|Withdrawal by Subject|1|||
16329750|NCT03320850|39692618|FG005|Overall Study|Withdrawal by Subject|2|||
16329751|NCT03320850|39692619|FG006|Overall Study|Withdrawal by Subject|4|||
16329752|NCT03320850|39692620|FG007|Overall Study|Withdrawal by Subject|5|||
16329753|NCT03320850|39692621|FG008|Overall Study|Withdrawal by Subject|2|||
16329754|NCT03320850|39692622|FG009|Overall Study|Withdrawal by Subject|1|||
16329755|NCT03320850|39692613|FG000|Overall Study|Lack of Efficacy|0|||
16398803|NCT03985943|39938859|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
16398804|NCT03985943|39938854|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
16398805|NCT03985943|39938855|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
16398806|NCT03985943|39938856|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
16398807|NCT03985943|39938857|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
16525786|NCT02086591|40391081|FG000|Overall Study|Withdrawal by Subject|1|||
16525787|NCT02086591|40391081|FG000|Overall Study|protocol terminated|3|||
16525788|NCT01313559|40391082|FG000|Overall Study|Withdrawal by Subject|1|||
16525789|NCT01313559|40391083|FG001|Overall Study|Withdrawal by Subject|2|||
16525790|NCT01313559|40391082|FG000|Overall Study|Disease progression|1|||
16525791|NCT01313559|40391083|FG001|Overall Study|Disease progression|0|||
16525792|NCT01313559|40391082|FG000|Overall Study|Rising PSA|2|||
16329756|NCT03320850|39692614|FG001|Overall Study|Lack of Efficacy|0|||
16329757|NCT03320850|39692615|FG002|Overall Study|Lack of Efficacy|0|||
16329758|NCT03320850|39692616|FG003|Overall Study|Lack of Efficacy|1|||
16329759|NCT03320850|39692617|FG004|Overall Study|Lack of Efficacy|0|||
16329760|NCT03320850|39692618|FG005|Overall Study|Lack of Efficacy|1|||
16329761|NCT03320850|39692619|FG006|Overall Study|Lack of Efficacy|0|||
16329762|NCT03320850|39692620|FG007|Overall Study|Lack of Efficacy|2|||
16329763|NCT03320850|39692621|FG008|Overall Study|Lack of Efficacy|0|||
16525793|NCT01313559|40391083|FG001|Overall Study|Rising PSA|0|||
16525794|NCT04419493|40391084|FG000|Wash-out After Period 1|Adverse Event|1|||
16525795|NCT04419493|40391085|FG001|Wash-out After Period 1|Adverse Event|2|||
16525796|NCT04419493|40391086|FG002|Wash-out After Period 1|Adverse Event|1|||
16525797|NCT04419493|40391087|FG003|Wash-out After Period 1|Adverse Event|0|||
16525798|NCT00856856|40391100|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
16525799|NCT00856856|40391100|FG000|4-year Clinical Follow-up|Missed visit|1|||
16525800|NCT01525082|40391101|FG000|Overall Study|Death|1|||
16525801|NCT00782340|40391102|FG000|Open Label Titration|Adverse Event|12|||
16525802|NCT00782340|40391103|FG001|Open Label Titration|Adverse Event|0|||
16525803|NCT00782340|40391104|FG002|Open Label Titration|Adverse Event|0|||
16525804|NCT00782340|40391102|FG000|Open Label Titration|Treatment failure|50|||
16525805|NCT00782340|40391103|FG001|Open Label Titration|Treatment failure|0|||
16525806|NCT00782340|40391104|FG002|Open Label Titration|Treatment failure|0|||
16525807|NCT00782340|40391102|FG000|Open Label Titration|Protocol Violation|5|||
16525808|NCT00782340|40391103|FG001|Open Label Titration|Protocol Violation|0|||
16525809|NCT00782340|40391104|FG002|Open Label Titration|Protocol Violation|0|||
16329764|NCT03320850|39692622|FG009|Overall Study|Lack of Efficacy|3|||
16398808|NCT03985943|39938858|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
16525810|NCT00782340|40391102|FG000|Open Label Titration|Withdrawal by Subject|5|||
16525811|NCT00782340|40391103|FG001|Open Label Titration|Withdrawal by Subject|0|||
16329765|NCT03320850|39692613|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
16329766|NCT03320850|39692614|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
16329767|NCT03320850|39692615|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
16097515|NCT01587703|38846863|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097516|NCT01587703|38846864|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
16097517|NCT01587703|38846865|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
16097518|NCT01587703|38846866|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
16097519|NCT01587703|38846867|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
16097520|NCT01587703|38846868|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
16097521|NCT01587703|38846869|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
16097522|NCT01587703|38846870|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097523|NCT01587703|38846871|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
16097524|NCT01587703|38846853|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097525|NCT01587703|38846854|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097526|NCT01587703|38846855|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097527|NCT01587703|38846856|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097528|NCT01587703|38846857|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097529|NCT01587703|38846858|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097530|NCT01587703|38846859|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16210868|NCT00899678|39251467|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
16329768|NCT03320850|39692616|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
16329769|NCT03320850|39692617|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
16329770|NCT03320850|39692618|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
16329771|NCT03320850|39692619|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
16329772|NCT03320850|39692620|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
16525812|NCT00782340|40391104|FG002|Open Label Titration|Withdrawal by Subject|0|||
16525813|NCT00782340|40391102|FG000|Open Label Titration|Enrollment capped|16|||
16525814|NCT00782340|40391103|FG001|Open Label Titration|Enrollment capped|0|||
16525815|NCT00782340|40391104|FG002|Open Label Titration|Enrollment capped|0|||
16525816|NCT00782340|40391102|FG000|Open Label Titration|Did not meet responder criteria|2|||
16525817|NCT00782340|40391103|FG001|Open Label Titration|Did not meet responder criteria|0|||
16525818|NCT00782340|40391104|FG002|Open Label Titration|Did not meet responder criteria|0|||
16525819|NCT00782340|40391102|FG000|Open Label Titration|Lost to Follow-up|5|||
16525820|NCT00782340|40391103|FG001|Open Label Titration|Lost to Follow-up|0|||
16525821|NCT00782340|40391104|FG002|Open Label Titration|Lost to Follow-up|0|||
16525822|NCT00782340|40391102|FG000|Open Label Titration|Randomized in error|6|||
16525823|NCT00782340|40391103|FG001|Open Label Titration|Randomized in error|0|||
16525824|NCT00782340|40391104|FG002|Open Label Titration|Randomized in error|0|||
16329773|NCT03320850|39692621|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
16329774|NCT03320850|39692622|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
16329775|NCT03320850|39692613|FG000|Overall Study|Adverse Event|0|||
16329776|NCT03320850|39692614|FG001|Overall Study|Adverse Event|0|||
16329777|NCT03320850|39692615|FG002|Overall Study|Adverse Event|0|||
16329778|NCT03320850|39692616|FG003|Overall Study|Adverse Event|0|||
16329779|NCT03320850|39692617|FG004|Overall Study|Adverse Event|0|||
16329780|NCT03320850|39692618|FG005|Overall Study|Adverse Event|2|||
16329781|NCT03320850|39692619|FG006|Overall Study|Adverse Event|1|||
16329782|NCT03320850|39692620|FG007|Overall Study|Adverse Event|0|||
16329783|NCT03320850|39692621|FG008|Overall Study|Adverse Event|2|||
16329784|NCT03320850|39692622|FG009|Overall Study|Adverse Event|0|||
16329785|NCT03320850|39692613|FG000|Overall Study|Reason Not Specified|0|||
16329786|NCT03320850|39692614|FG001|Overall Study|Reason Not Specified|0|||
16329787|NCT03320850|39692615|FG002|Overall Study|Reason Not Specified|0|||
16329788|NCT03320850|39692616|FG003|Overall Study|Reason Not Specified|0|||
16329789|NCT03320850|39692617|FG004|Overall Study|Reason Not Specified|0|||
16329790|NCT03320850|39692618|FG005|Overall Study|Reason Not Specified|1|||
16329791|NCT03320850|39692619|FG006|Overall Study|Reason Not Specified|0|||
16329792|NCT03320850|39692620|FG007|Overall Study|Reason Not Specified|0|||
16329793|NCT03320850|39692621|FG008|Overall Study|Reason Not Specified|0|||
16329794|NCT03320850|39692622|FG009|Overall Study|Reason Not Specified|1|||
16329795|NCT01801358|39692627|FG000|Overall Study|Adverse Event|0|||
16329796|NCT01801358|39692628|FG001|Overall Study|Adverse Event|2|||
16329797|NCT01801358|39692629|FG002|Overall Study|Adverse Event|1|||
16329798|NCT01801358|39692630|FG003|Overall Study|Adverse Event|0|||
16329799|NCT01801358|39692631|FG004|Overall Study|Adverse Event|0|||
16329800|NCT01801358|39692632|FG005|Overall Study|Adverse Event|1|||
16097531|NCT01587703|38846860|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097532|NCT01587703|38846861|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097533|NCT01587703|38846862|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16329801|NCT01801358|39692627|FG000|Overall Study|Physician Decision|0|||
16329802|NCT01801358|39692628|FG001|Overall Study|Physician Decision|0|||
16329803|NCT01801358|39692629|FG002|Overall Study|Physician Decision|1|||
16329804|NCT01801358|39692630|FG003|Overall Study|Physician Decision|0|||
16329805|NCT01801358|39692631|FG004|Overall Study|Physician Decision|0|||
16329806|NCT01801358|39692632|FG005|Overall Study|Physician Decision|0|||
16329807|NCT01801358|39692627|FG000|Overall Study|Progressive Disease|6|||
16329808|NCT01801358|39692628|FG001|Overall Study|Progressive Disease|4|||
16329809|NCT01801358|39692629|FG002|Overall Study|Progressive Disease|4|||
16329810|NCT01801358|39692630|FG003|Overall Study|Progressive Disease|5|||
16329811|NCT01801358|39692631|FG004|Overall Study|Progressive Disease|6|||
16329812|NCT01801358|39692632|FG005|Overall Study|Progressive Disease|5|||
16329813|NCT01801358|39692627|FG000|Overall Study|Withdrawal by Subject|0|||
16329814|NCT01801358|39692628|FG001|Overall Study|Withdrawal by Subject|0|||
16329815|NCT01801358|39692629|FG002|Overall Study|Withdrawal by Subject|0|||
16329816|NCT01801358|39692630|FG003|Overall Study|Withdrawal by Subject|1|||
16329817|NCT01801358|39692631|FG004|Overall Study|Withdrawal by Subject|0|||
16329818|NCT01801358|39692632|FG005|Overall Study|Withdrawal by Subject|2|||
16329819|NCT02347891|39692633|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
16329820|NCT02347891|39692634|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
16329821|NCT02347891|39692633|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
16329822|NCT02347891|39692634|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
16329823|NCT01647516|39692635|FG000|Induction Period (IP)|Physician Decision|2|||
16329824|NCT01647516|39692636|FG001|Induction Period (IP)|Physician Decision|0|||
16329825|NCT01647516|39692637|FG002|Induction Period (IP)|Physician Decision|0|||
16329826|NCT01647516|39692638|FG003|Induction Period (IP)|Physician Decision|0|||
16329827|NCT01647516|39692639|FG004|Induction Period (IP)|Physician Decision|0|||
16329828|NCT01647516|39692640|FG005|Induction Period (IP)|Physician Decision|0|||
16329829|NCT01647516|39692635|FG000|Induction Period (IP)|Adverse Event|1|||
16329830|NCT01647516|39692636|FG001|Induction Period (IP)|Adverse Event|2|||
16329831|NCT01647516|39692637|FG002|Induction Period (IP)|Adverse Event|0|||
16329832|NCT01647516|39692638|FG003|Induction Period (IP)|Adverse Event|0|||
16329833|NCT01647516|39692639|FG004|Induction Period (IP)|Adverse Event|0|||
16329834|NCT01647516|39692640|FG005|Induction Period (IP)|Adverse Event|0|||
16329835|NCT01647516|39692635|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
16329836|NCT01647516|39692636|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
16329837|NCT01647516|39692637|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
16329838|NCT01647516|39692638|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
16329839|NCT01647516|39692639|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
16329840|NCT01647516|39692640|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
16329841|NCT01647516|39692635|FG000|Induction Period (IP)|Participant Choice|0|||
16329842|NCT01647516|39692636|FG001|Induction Period (IP)|Participant Choice|0|||
16329843|NCT01647516|39692637|FG002|Induction Period (IP)|Participant Choice|1|||
16329844|NCT01647516|39692638|FG003|Induction Period (IP)|Participant Choice|0|||
16329845|NCT01647516|39692639|FG004|Induction Period (IP)|Participant Choice|0|||
16329846|NCT01647516|39692640|FG005|Induction Period (IP)|Participant Choice|0|||
16329847|NCT01647516|39692635|FG000|Induction Period (IP)|Lack of Efficacy|1|||
16329848|NCT01647516|39692636|FG001|Induction Period (IP)|Lack of Efficacy|0|||
16329849|NCT01647516|39692637|FG002|Induction Period (IP)|Lack of Efficacy|0|||
16329850|NCT01647516|39692638|FG003|Induction Period (IP)|Lack of Efficacy|0|||
16329851|NCT01647516|39692639|FG004|Induction Period (IP)|Lack of Efficacy|0|||
16329852|NCT01647516|39692640|FG005|Induction Period (IP)|Lack of Efficacy|0|||
16329853|NCT01647516|39692635|FG000|Induction Period (IP)|No study drug received|1|||
16329854|NCT01647516|39692636|FG001|Induction Period (IP)|No study drug received|1|||
16329855|NCT01647516|39692637|FG002|Induction Period (IP)|No study drug received|0|||
16329856|NCT01647516|39692638|FG003|Induction Period (IP)|No study drug received|0|||
16329857|NCT01647516|39692639|FG004|Induction Period (IP)|No study drug received|0|||
16329858|NCT01647516|39692640|FG005|Induction Period (IP)|No study drug received|0|||
16329859|NCT01647516|39692635|FG000|Maintenance Period (MP)|Adverse Event|2|||
16329860|NCT01647516|39692636|FG001|Maintenance Period (MP)|Adverse Event|1|||
16329861|NCT01647516|39692637|FG002|Maintenance Period (MP)|Adverse Event|0|||
16329862|NCT01647516|39692638|FG003|Maintenance Period (MP)|Adverse Event|0|||
16329863|NCT01647516|39692639|FG004|Maintenance Period (MP)|Adverse Event|0|||
16097534|NCT01587703|38846863|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16210869|NCT00899678|39251468|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
16210870|NCT00899678|39251466|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
16210871|NCT00899678|39251467|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
16210872|NCT00899678|39251468|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
16210873|NCT00899678|39251466|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
16329864|NCT01647516|39692640|FG005|Maintenance Period (MP)|Adverse Event|0|||
16329865|NCT01647516|39692635|FG000|Maintenance Period (MP)|Non-compliance|1|||
16329866|NCT01647516|39692636|FG001|Maintenance Period (MP)|Non-compliance|0|||
16329867|NCT01647516|39692637|FG002|Maintenance Period (MP)|Non-compliance|0|||
16329868|NCT01647516|39692638|FG003|Maintenance Period (MP)|Non-compliance|0|||
16329869|NCT01647516|39692639|FG004|Maintenance Period (MP)|Non-compliance|0|||
16329870|NCT01647516|39692640|FG005|Maintenance Period (MP)|Non-compliance|0|||
16329871|NCT01647516|39692635|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
16329872|NCT01647516|39692636|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
16329873|NCT01647516|39692637|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
16525825|NCT01307501|40391105|FG000|Overall Study|Treatment Failure|1|||
16525826|NCT01307501|40391105|FG000|Overall Study|Death|20|||
16525827|NCT01307501|40391105|FG000|Overall Study|Lost to Follow-up|1|||
16525828|NCT01307501|40391105|FG000|Overall Study|Starting Hospice|1|||
16525829|NCT00630877|40391113|FG000|Overall Study|Adverse Event|11|||
16525830|NCT00630877|40391114|FG001|Overall Study|Adverse Event|8|||
16525831|NCT00630877|40391115|FG002|Overall Study|Adverse Event|7|||
16525832|NCT00630877|40391113|FG000|Overall Study|Withdrawal by Subject|3|||
16525833|NCT00630877|40391114|FG001|Overall Study|Withdrawal by Subject|4|||
16525834|NCT00630877|40391115|FG002|Overall Study|Withdrawal by Subject|0|||
16525835|NCT00630877|40391113|FG000|Overall Study|Lost to Follow-up|2|||
16525836|NCT00630877|40391114|FG001|Overall Study|Lost to Follow-up|0|||
16525837|NCT00630877|40391115|FG002|Overall Study|Lost to Follow-up|0|||
16525838|NCT00630877|40391113|FG000|Overall Study|Noncompliance|2|||
16525839|NCT00630877|40391114|FG001|Overall Study|Noncompliance|3|||
16525840|NCT00630877|40391115|FG002|Overall Study|Noncompliance|1|||
16525841|NCT00630877|40391113|FG000|Overall Study|Protocol violation|1|||
16525842|NCT00630877|40391114|FG001|Overall Study|Protocol violation|0|||
16097535|NCT01587703|38846864|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
16210874|NCT00899678|39251467|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
16210875|NCT00899678|39251468|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
16210876|NCT00126425|39251470|FG000|Overall Study|Withdrawal by Subject|17|||
16210877|NCT00126425|39251471|FG001|Overall Study|Withdrawal by Subject|1|||
16210878|NCT00126425|39251470|FG000|Overall Study|Lost to Follow-up|8|||
16210879|NCT00126425|39251471|FG001|Overall Study|Lost to Follow-up|4|||
16210880|NCT00126425|39251470|FG000|Overall Study|Protocol Violation|9|||
16210881|NCT00126425|39251471|FG001|Overall Study|Protocol Violation|6|||
16210882|NCT00126425|39251470|FG000|Overall Study|Adverse Event|1|||
16210883|NCT00126425|39251471|FG001|Overall Study|Adverse Event|0|||
16329874|NCT01647516|39692638|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
16329875|NCT01647516|39692639|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
16329876|NCT01647516|39692640|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
16329877|NCT01647516|39692635|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
16329878|NCT01647516|39692636|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
16329879|NCT01647516|39692637|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
16329880|NCT01647516|39692638|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
16329881|NCT01647516|39692639|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
16329882|NCT01647516|39692640|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
16329883|NCT01647516|39692635|FG000|Open-Label Period|Adverse Event|0|||
16329884|NCT01647516|39692636|FG001|Open-Label Period|Adverse Event|0|||
16329885|NCT01647516|39692637|FG002|Open-Label Period|Adverse Event|0|||
16329886|NCT01647516|39692638|FG003|Open-Label Period|Adverse Event|5|||
16329887|NCT01647516|39692639|FG004|Open-Label Period|Adverse Event|6|||
16329888|NCT01647516|39692640|FG005|Open-Label Period|Adverse Event|3|||
16329889|NCT01647516|39692635|FG000|Open-Label Period|Pregnancy|0|||
16329890|NCT01647516|39692636|FG001|Open-Label Period|Pregnancy|0|||
16329891|NCT01647516|39692637|FG002|Open-Label Period|Pregnancy|0|||
16329892|NCT01647516|39692638|FG003|Open-Label Period|Pregnancy|0|||
16329893|NCT01647516|39692639|FG004|Open-Label Period|Pregnancy|0|||
16329894|NCT01647516|39692640|FG005|Open-Label Period|Pregnancy|1|||
16329895|NCT01647516|39692635|FG000|Open-Label Period|Non-compliance|0|||
16329896|NCT01647516|39692636|FG001|Open-Label Period|Non-compliance|0|||
16329897|NCT01647516|39692637|FG002|Open-Label Period|Non-compliance|0|||
16329898|NCT01647516|39692638|FG003|Open-Label Period|Non-compliance|1|||
16329899|NCT01647516|39692639|FG004|Open-Label Period|Non-compliance|0|||
16329900|NCT01647516|39692640|FG005|Open-Label Period|Non-compliance|1|||
16329901|NCT01647516|39692635|FG000|Open-Label Period|Physician Decision|0|||
16329902|NCT01647516|39692636|FG001|Open-Label Period|Physician Decision|0|||
16329903|NCT01647516|39692637|FG002|Open-Label Period|Physician Decision|0|||
16329904|NCT01647516|39692638|FG003|Open-Label Period|Physician Decision|1|||
16329905|NCT01647516|39692639|FG004|Open-Label Period|Physician Decision|1|||
16329906|NCT01647516|39692640|FG005|Open-Label Period|Physician Decision|0|||
16329907|NCT01647516|39692635|FG000|Open-Label Period|Withdrawal by Subject|0|||
16329908|NCT01647516|39692636|FG001|Open-Label Period|Withdrawal by Subject|0|||
16329909|NCT01647516|39692637|FG002|Open-Label Period|Withdrawal by Subject|0|||
16329910|NCT01647516|39692638|FG003|Open-Label Period|Withdrawal by Subject|9|||
16398809|NCT03985943|39938859|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
16097536|NCT01587703|38846865|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097537|NCT01587703|38846866|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16210884|NCT00126425|39251470|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
16210885|NCT00126425|39251471|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
16210886|NCT00126425|39251470|FG000|Overall Study|Other|5|||
16329911|NCT01647516|39692639|FG004|Open-Label Period|Withdrawal by Subject|11|||
16329912|NCT01647516|39692640|FG005|Open-Label Period|Withdrawal by Subject|6|||
16329913|NCT01647516|39692635|FG000|Open-Label Period|Lost to Follow-up|0|||
16525843|NCT00630877|40391115|FG002|Overall Study|Protocol violation|1|||
16525844|NCT00630877|40391113|FG000|Overall Study|Personal reasons|0|||
16210887|NCT00126425|39251471|FG001|Overall Study|Other|0|||
16210888|NCT02985684|39251472|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
16210889|NCT02985684|39251472|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
16210890|NCT02985684|39251472|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
16210891|NCT01025232|39251475|FG000|Overall Study|Study drug no longer available|3|||
16210892|NCT01025232|39251476|FG001|Overall Study|Study drug no longer available|6|||
16210893|NCT01838213|39251479|FG000|Overall Study|Ineligible|166|||
16210894|NCT01838213|39251480|FG001|Overall Study|Ineligible|191|||
16210895|NCT02671760|39251481|FG000|Overall Study|Lost to Follow-up|0|||
16210896|NCT02671760|39251482|FG001|Overall Study|Lost to Follow-up|1|||
16210897|NCT02671760|39251483|FG002|Overall Study|Lost to Follow-up|0|||
16210898|NCT01624467|39251484|FG000|Overall Study|Withdrawal by Subject|2|||
16210899|NCT01624467|39251484|FG000|Overall Study|Lost to Follow-up|1|||
16210900|NCT01624467|39251484|FG000|Overall Study|Adverse Event|7|||
16210901|NCT01624467|39251484|FG000|Overall Study|Progressive Disease|19|||
16210902|NCT01624467|39251484|FG000|Overall Study|Per Sponsor Requirement|1|||
16210903|NCT01624467|39251484|FG000|Overall Study|Subject Withdrew from Treatment|1|||
16210904|NCT01505114|39251487|FG000|Overall Study|Withdrawal by Subject|5|||
16210905|NCT01505114|39251488|FG001|Overall Study|Withdrawal by Subject|4|||
16210906|NCT01505114|39251489|FG002|Overall Study|Withdrawal by Subject|4|||
16210907|NCT01505114|39251490|FG003|Overall Study|Withdrawal by Subject|7|||
16210908|NCT01505114|39251487|FG000|Overall Study|Death|1|||
16210909|NCT01505114|39251488|FG001|Overall Study|Death|0|||
16210910|NCT01505114|39251489|FG002|Overall Study|Death|0|||
16210911|NCT01505114|39251490|FG003|Overall Study|Death|1|||
16210912|NCT01505114|39251487|FG000|Overall Study|unable to adhere to visit schedule|3|||
16210913|NCT01505114|39251488|FG001|Overall Study|unable to adhere to visit schedule|2|||
16210914|NCT01505114|39251489|FG002|Overall Study|unable to adhere to visit schedule|3|||
16210915|NCT01505114|39251490|FG003|Overall Study|unable to adhere to visit schedule|3|||
16210916|NCT01505114|39251487|FG000|Overall Study|Lost to Follow-up|11|||
16210917|NCT01505114|39251488|FG001|Overall Study|Lost to Follow-up|5|||
16210918|NCT01505114|39251489|FG002|Overall Study|Lost to Follow-up|8|||
16210919|NCT01505114|39251490|FG003|Overall Study|Lost to Follow-up|7|||
16210920|NCT01505114|39251487|FG000|Overall Study|relocated|4|||
16210921|NCT01505114|39251488|FG001|Overall Study|relocated|2|||
16210922|NCT01505114|39251489|FG002|Overall Study|relocated|2|||
16210923|NCT01505114|39251490|FG003|Overall Study|relocated|3|||
16210924|NCT01505114|39251487|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
16210925|NCT01505114|39251488|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
16210926|NCT01505114|39251489|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
16210927|NCT01505114|39251490|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
16210928|NCT01505114|39251487|FG000|Overall Study|staff safety concerns|0|||
16210929|NCT01505114|39251488|FG001|Overall Study|staff safety concerns|0|||
16210930|NCT01505114|39251489|FG002|Overall Study|staff safety concerns|0|||
16210931|NCT01505114|39251490|FG003|Overall Study|staff safety concerns|1|||
16210932|NCT01505114|39251487|FG000|Overall Study|investigator decision|1|||
16210933|NCT01505114|39251488|FG001|Overall Study|investigator decision|0|||
16210934|NCT01505114|39251489|FG002|Overall Study|investigator decision|1|||
16210935|NCT01505114|39251490|FG003|Overall Study|investigator decision|0|||
16210936|NCT03418376|39251491|FG000|Overall Study|Musculoskeletal injury|1|||
16210937|NCT03418376|39251492|FG001|Overall Study|Musculoskeletal injury|2|||
16210938|NCT03418376|39251493|FG002|Overall Study|Musculoskeletal injury|1|||
16210939|NCT03418376|39251494|FG003|Overall Study|Musculoskeletal injury|0|||
16210940|NCT03418376|39251491|FG000|Overall Study|Personal reasons|0|||
16210941|NCT03418376|39251492|FG001|Overall Study|Personal reasons|2|||
16210942|NCT03418376|39251493|FG002|Overall Study|Personal reasons|2|||
16210943|NCT03418376|39251494|FG003|Overall Study|Personal reasons|1|||
16210944|NCT03418376|39251491|FG000|Overall Study|Exacerbation|0|||
16210945|NCT03418376|39251492|FG001|Overall Study|Exacerbation|1|||
16210946|NCT03418376|39251493|FG002|Overall Study|Exacerbation|0|||
16210947|NCT03418376|39251494|FG003|Overall Study|Exacerbation|0|||
16210948|NCT01833806|39251499|FG000|Overall Study|Alternative treatment|2|||
16210949|NCT01833806|39251499|FG000|Overall Study|Death|5|||
16210950|NCT01833806|39251499|FG000|Overall Study|Physician Decision|1|||
16210951|NCT01833806|39251499|FG000|Overall Study|Lost to Follow-up|1|||
16210952|NCT01226472|39251500|FG000|Overall Study|Progressive Disease|1|||
16210953|NCT03748420|39251509|FG000|Overall Study|No 12 month medication adherence data available|0|||
16210954|NCT03748420|39251510|FG001|Overall Study|No 12 month medication adherence data available|1|||
16210955|NCT03748420|39251509|FG000|Overall Study|Death|24|||
16210956|NCT03748420|39251510|FG001|Overall Study|Death|28|||
16210957|NCT03748420|39251509|FG000|Overall Study|Lost to Follow-up|231|||
16210958|NCT03748420|39251510|FG001|Overall Study|Lost to Follow-up|230|||
16409981|NCT02536300|39981854|FG000|Overall Study|Study Terminated by Sponsor|6|||
16210959|NCT03839940|39251511|FG000|Overall Study|Withdrawal by Subject|3|||
16210960|NCT03839940|39251512|FG001|Overall Study|Withdrawal by Subject|0|||
16210961|NCT03839940|39251511|FG000|Overall Study|Protocol Violation|0|||
16210962|NCT03839940|39251512|FG001|Overall Study|Protocol Violation|1|||
16210963|NCT03839940|39251511|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
16210964|NCT03839940|39251512|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
16210965|NCT01518309|39251513|FG000|Overall Study|Adverse Event|6|||
16210966|NCT01518309|39251513|FG000|Overall Study|Death|6|||
16210967|NCT01518309|39251513|FG000|Overall Study|Lack of Efficacy|7|||
16210968|NCT01518309|39251513|FG000|Overall Study|Withdrawal by Subject|6|||
16210969|NCT01518309|39251513|FG000|Overall Study|Physician Decision|3|||
16210970|NCT01518309|39251513|FG000|Overall Study|Sponsor Decision|2|||
16210971|NCT01518309|39251513|FG000|Overall Study|Not in Predefined Categories|9|||
16210972|NCT03799627|39251514|FG000|Overall Study|Adverse Event|1|||
16210973|NCT03799627|39251515|FG001|Overall Study|Adverse Event|2|||
16210974|NCT03799627|39251516|FG002|Overall Study|Adverse Event|0|||
16210975|NCT03799627|39251517|FG003|Overall Study|Adverse Event|0|||
16210976|NCT03799627|39251518|FG004|Overall Study|Adverse Event|2|||
16210977|NCT03799627|39251519|FG005|Overall Study|Adverse Event|5|||
16210978|NCT03799627|39251520|FG006|Overall Study|Adverse Event|0|||
16210979|NCT03799627|39251521|FG007|Overall Study|Adverse Event|2|||
16210980|NCT03799627|39251522|FG008|Overall Study|Adverse Event|0|||
16210981|NCT03799627|39251514|FG000|Overall Study|Physician Decision|2|||
16210982|NCT03799627|39251515|FG001|Overall Study|Physician Decision|2|||
16210983|NCT03799627|39251516|FG002|Overall Study|Physician Decision|0|||
16210984|NCT03799627|39251517|FG003|Overall Study|Physician Decision|0|||
16210985|NCT03799627|39251518|FG004|Overall Study|Physician Decision|2|||
16210986|NCT03799627|39251519|FG005|Overall Study|Physician Decision|2|||
16210987|NCT03799627|39251520|FG006|Overall Study|Physician Decision|0|||
16210988|NCT03799627|39251521|FG007|Overall Study|Physician Decision|0|||
16210989|NCT03799627|39251522|FG008|Overall Study|Physician Decision|0|||
16210990|NCT03799627|39251514|FG000|Overall Study|Withdrawal by Subject|1|||
16210991|NCT03799627|39251515|FG001|Overall Study|Withdrawal by Subject|1|||
16210992|NCT03799627|39251516|FG002|Overall Study|Withdrawal by Subject|0|||
16210993|NCT03799627|39251517|FG003|Overall Study|Withdrawal by Subject|2|||
16210994|NCT03799627|39251518|FG004|Overall Study|Withdrawal by Subject|0|||
16210995|NCT03799627|39251519|FG005|Overall Study|Withdrawal by Subject|3|||
16210996|NCT03799627|39251520|FG006|Overall Study|Withdrawal by Subject|0|||
16210997|NCT03799627|39251521|FG007|Overall Study|Withdrawal by Subject|0|||
16210998|NCT03799627|39251522|FG008|Overall Study|Withdrawal by Subject|0|||
16210999|NCT03799627|39251514|FG000|Overall Study|Lack of Efficacy|0|||
16211000|NCT03799627|39251515|FG001|Overall Study|Lack of Efficacy|0|||
16211001|NCT03799627|39251516|FG002|Overall Study|Lack of Efficacy|0|||
16211002|NCT03799627|39251517|FG003|Overall Study|Lack of Efficacy|1|||
16211003|NCT03799627|39251518|FG004|Overall Study|Lack of Efficacy|0|||
16211004|NCT03799627|39251519|FG005|Overall Study|Lack of Efficacy|0|||
16211005|NCT03799627|39251520|FG006|Overall Study|Lack of Efficacy|0|||
16211006|NCT03799627|39251521|FG007|Overall Study|Lack of Efficacy|0|||
16211007|NCT03799627|39251522|FG008|Overall Study|Lack of Efficacy|0|||
16211008|NCT03799627|39251514|FG000|Overall Study|Lost to Follow-up|0|||
16211009|NCT03799627|39251515|FG001|Overall Study|Lost to Follow-up|0|||
16211010|NCT03799627|39251516|FG002|Overall Study|Lost to Follow-up|0|||
16211011|NCT03799627|39251517|FG003|Overall Study|Lost to Follow-up|0|||
16211012|NCT03799627|39251518|FG004|Overall Study|Lost to Follow-up|0|||
16211013|NCT03799627|39251519|FG005|Overall Study|Lost to Follow-up|0|||
16211014|NCT03799627|39251520|FG006|Overall Study|Lost to Follow-up|1|||
16211015|NCT03799627|39251521|FG007|Overall Study|Lost to Follow-up|0|||
16211016|NCT03799627|39251522|FG008|Overall Study|Lost to Follow-up|1|||
16211017|NCT03799627|39251514|FG000|Overall Study|Death|0|||
16211018|NCT03799627|39251515|FG001|Overall Study|Death|0|||
16211019|NCT03799627|39251516|FG002|Overall Study|Death|0|||
16211020|NCT03799627|39251517|FG003|Overall Study|Death|1|||
16211021|NCT03799627|39251518|FG004|Overall Study|Death|0|||
16211022|NCT03799627|39251519|FG005|Overall Study|Death|0|||
16211023|NCT03799627|39251520|FG006|Overall Study|Death|0|||
16211024|NCT03799627|39251521|FG007|Overall Study|Death|0|||
16211025|NCT03799627|39251522|FG008|Overall Study|Death|0|||
16211026|NCT03799627|39251514|FG000|Overall Study|Study Drug Put on Hold|1|||
16211027|NCT03799627|39251515|FG001|Overall Study|Study Drug Put on Hold|0|||
16211028|NCT03799627|39251516|FG002|Overall Study|Study Drug Put on Hold|0|||
16211029|NCT03799627|39251517|FG003|Overall Study|Study Drug Put on Hold|0|||
16329914|NCT01647516|39692636|FG001|Open-Label Period|Lost to Follow-up|0|||
16211030|NCT03799627|39251518|FG004|Overall Study|Study Drug Put on Hold|0|||
16211031|NCT03799627|39251519|FG005|Overall Study|Study Drug Put on Hold|0|||
16211032|NCT03799627|39251520|FG006|Overall Study|Study Drug Put on Hold|0|||
16211033|NCT03799627|39251521|FG007|Overall Study|Study Drug Put on Hold|0|||
16211034|NCT03799627|39251522|FG008|Overall Study|Study Drug Put on Hold|0|||
16211035|NCT03799627|39251514|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
16211036|NCT03799627|39251515|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
16329915|NCT01647516|39692637|FG002|Open-Label Period|Lost to Follow-up|0|||
16329916|NCT01647516|39692638|FG003|Open-Label Period|Lost to Follow-up|1|||
16329917|NCT01647516|39692639|FG004|Open-Label Period|Lost to Follow-up|0|||
16329918|NCT01647516|39692640|FG005|Open-Label Period|Lost to Follow-up|1|||
16211037|NCT03799627|39251516|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
16211038|NCT03799627|39251517|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
16211039|NCT03799627|39251518|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
16211040|NCT03799627|39251519|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
16211041|NCT03799627|39251520|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
16211042|NCT03799627|39251521|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
16211043|NCT03799627|39251522|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
16211044|NCT03799627|39251514|FG000|Overall Study|Kidney Transplantation|1|||
16211045|NCT03799627|39251515|FG001|Overall Study|Kidney Transplantation|0|||
16211046|NCT03799627|39251516|FG002|Overall Study|Kidney Transplantation|0|||
16211047|NCT03799627|39251517|FG003|Overall Study|Kidney Transplantation|1|||
16525845|NCT00630877|40391114|FG001|Overall Study|Personal reasons|0|||
16525846|NCT00630877|40391115|FG002|Overall Study|Personal reasons|1|||
16525847|NCT03646513|40391116|FG000|Overall Study|Premature study termination|4|||
16525848|NCT01992536|40391117|FG000|Overall Study|Administrative Reason|0|||
16525849|NCT01992536|40391118|FG001|Overall Study|Administrative Reason|0|||
16525850|NCT01992536|40391119|FG002|Overall Study|Administrative Reason|0|||
16525851|NCT01992536|40391120|FG003|Overall Study|Administrative Reason|0|||
16525852|NCT01992536|40391121|FG004|Overall Study|Administrative Reason|0|||
16525853|NCT01992536|40391122|FG005|Overall Study|Administrative Reason|0|||
16525854|NCT01992536|40391123|FG006|Overall Study|Administrative Reason|7|||
16525855|NCT01992536|40391124|FG007|Overall Study|Administrative Reason|0|||
16525856|NCT01992536|40391125|FG008|Overall Study|Administrative Reason|0|||
16525857|NCT01992536|40391126|FG009|Overall Study|Administrative Reason|0|||
16525858|NCT01992536|40391117|FG000|Overall Study|Lost to Follow-up|4|||
16525859|NCT01992536|40391118|FG001|Overall Study|Lost to Follow-up|2|||
16525860|NCT01992536|40391119|FG002|Overall Study|Lost to Follow-up|1|||
16525861|NCT01992536|40391120|FG003|Overall Study|Lost to Follow-up|0|||
16525862|NCT01992536|40391121|FG004|Overall Study|Lost to Follow-up|0|||
16525863|NCT01992536|40391122|FG005|Overall Study|Lost to Follow-up|1|||
16525864|NCT01992536|40391123|FG006|Overall Study|Lost to Follow-up|0|||
16525865|NCT01992536|40391124|FG007|Overall Study|Lost to Follow-up|0|||
16525866|NCT01992536|40391125|FG008|Overall Study|Lost to Follow-up|1|||
16525867|NCT01992536|40391126|FG009|Overall Study|Lost to Follow-up|1|||
16525868|NCT01992536|40391117|FG000|Overall Study|Withdrawal by Subject|0|||
16525869|NCT01992536|40391118|FG001|Overall Study|Withdrawal by Subject|1|||
16525870|NCT01992536|40391119|FG002|Overall Study|Withdrawal by Subject|0|||
16525871|NCT01992536|40391120|FG003|Overall Study|Withdrawal by Subject|2|||
16525872|NCT01992536|40391121|FG004|Overall Study|Withdrawal by Subject|0|||
16525873|NCT01992536|40391122|FG005|Overall Study|Withdrawal by Subject|0|||
16525874|NCT01992536|40391123|FG006|Overall Study|Withdrawal by Subject|0|||
16525875|NCT01992536|40391124|FG007|Overall Study|Withdrawal by Subject|0|||
16525876|NCT01992536|40391125|FG008|Overall Study|Withdrawal by Subject|0|||
16525877|NCT01992536|40391126|FG009|Overall Study|Withdrawal by Subject|0|||
16525878|NCT00466193|40391127|FG000|Overall Study|Adverse Event|0|||
16525879|NCT00466193|40391128|FG001|Overall Study|Adverse Event|1|||
16525880|NCT00466193|40391127|FG000|Overall Study|Lost to Follow-up|2|||
16525881|NCT00466193|40391128|FG001|Overall Study|Lost to Follow-up|4|||
16525882|NCT00466193|40391127|FG000|Overall Study|Physician Decision|1|||
16525883|NCT00466193|40391128|FG001|Overall Study|Physician Decision|0|||
16211048|NCT03799627|39251518|FG004|Overall Study|Kidney Transplantation|1|||
16211049|NCT03799627|39251519|FG005|Overall Study|Kidney Transplantation|0|||
16211050|NCT03799627|39251520|FG006|Overall Study|Kidney Transplantation|0|||
16211051|NCT03799627|39251521|FG007|Overall Study|Kidney Transplantation|0|||
16211052|NCT03799627|39251522|FG008|Overall Study|Kidney Transplantation|0|||
16211053|NCT03799627|39251514|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
16211054|NCT03799627|39251515|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
16211055|NCT03799627|39251516|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
16211056|NCT03799627|39251517|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
16211057|NCT03799627|39251518|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
16211058|NCT03799627|39251519|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
16211059|NCT03799627|39251520|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
16211060|NCT03799627|39251521|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
16525884|NCT00466193|40391127|FG000|Overall Study|Protocol Violation|1|||
16525885|NCT00466193|40391128|FG001|Overall Study|Protocol Violation|1|||
16525886|NCT00466193|40391127|FG000|Overall Study|Withdrawal by Subject|7|||
16398810|NCT03985943|39938854|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
16398811|NCT03985943|39938855|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
16398812|NCT03985943|39938856|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
16398813|NCT03985943|39938857|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
16398814|NCT03985943|39938858|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
16398815|NCT03985943|39938859|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
16398816|NCT03985943|39938854|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
16398817|NCT03985943|39938855|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
16398818|NCT03985943|39938856|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
16398819|NCT03985943|39938857|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
16525887|NCT00466193|40391128|FG001|Overall Study|Withdrawal by Subject|2|||
16525888|NCT00466193|40391127|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
16525889|NCT00466193|40391128|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
16525890|NCT02806986|40391129|FG000|Treatment Stage 1|Adverse Event|1|||
16525891|NCT02806986|40391129|FG000|Treatment Stage 2|Adverse Event|3|||
16525892|NCT02806986|40391129|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
16525893|NCT04408469|40391130|FG000|Overall Study|Lost to Follow-up|6|||
16525894|NCT04408469|40391131|FG001|Overall Study|Lost to Follow-up|9|||
16525895|NCT04408469|40391130|FG000|Overall Study|Withdrawal by Subject|6|||
16525896|NCT04408469|40391131|FG001|Overall Study|Withdrawal by Subject|1|||
16525897|NCT04408469|40391130|FG000|Overall Study|Dismissal due to ineligibility|0|||
16525898|NCT04408469|40391131|FG001|Overall Study|Dismissal due to ineligibility|1|||
16525899|NCT02480621|40391132|FG000|Randomization|Withdrawal by Subject|1|||
16525900|NCT02480621|40391133|FG001|Randomization|Withdrawal by Subject|0|||
16525901|NCT02480621|40391132|FG000|Randomization|Surgeon did not give intervention|0|||
16525902|NCT02480621|40391133|FG001|Randomization|Surgeon did not give intervention|1|||
16525903|NCT02480621|40391132|FG000|Follow Up|Lost to Follow-up|4|||
16525904|NCT02480621|40391133|FG001|Follow Up|Lost to Follow-up|2|||
16525905|NCT01958918|40391134|FG000|Overall Study|Death|1|||
16525906|NCT01958918|40391135|FG001|Overall Study|Death|3|||
16525907|NCT01958918|40391134|FG000|Overall Study|Lost to Follow-up|4|||
16525908|NCT01958918|40391135|FG001|Overall Study|Lost to Follow-up|7|||
16525909|NCT01958918|40391134|FG000|Overall Study|Withdrawal by Subject|13|||
16525910|NCT01958918|40391135|FG001|Overall Study|Withdrawal by Subject|8|||
16525911|NCT01958918|40391134|FG000|Overall Study|Lack of Efficacy|13|||
16525912|NCT01958918|40391135|FG001|Overall Study|Lack of Efficacy|10|||
16525913|NCT01958918|40391134|FG000|Overall Study|Adverse Event|12|||
16525914|NCT01958918|40391135|FG001|Overall Study|Adverse Event|12|||
16525915|NCT01958918|40391134|FG000|Overall Study|administrative problems|0|||
16525916|NCT01958918|40391135|FG001|Overall Study|administrative problems|2|||
16525917|NCT03783923|40391136|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
16525918|NCT03783923|40391137|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
16525919|NCT03783923|40391136|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
16525920|NCT03783923|40391137|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
16525921|NCT03783923|40391136|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
16525922|NCT03783923|40391137|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
16525923|NCT03783923|40391136|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
16525924|NCT03783923|40391137|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
16525925|NCT03783923|40391136|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
16525926|NCT03783923|40391137|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
16525927|NCT02075593|40391142|FG000|Overall Study|Withdrawal by Subject|1|||
16525928|NCT00524134|40391143|FG000|Overall Study|Withdrawal by Subject|1|||
16525929|NCT00524134|40391143|FG000|Overall Study|Physician Decision|1|||
16525930|NCT00642304|40391144|FG000|Overall Study|Adverse Event|1|||
16525931|NCT00642304|40391144|FG000|Overall Study|Death|1|||
16525932|NCT00642304|40391144|FG000|Overall Study|Blood transfusion|2|||
16525933|NCT00642304|40391144|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
16525934|NCT00642304|40391144|FG000|Overall Study|Transplantation|1|||
16525935|NCT00736996|40391149|FG000|Overall Study|Lost to Follow-up|1|||
16525936|NCT00736996|40391150|FG001|Overall Study|Lost to Follow-up|9|||
16525937|NCT00736996|40391151|FG002|Overall Study|Lost to Follow-up|2|||
16525938|NCT02276482|40391152|FG000|Overall Study|Adverse Event|1|||
16525939|NCT02276482|40391153|FG001|Overall Study|Adverse Event|0|||
16525940|NCT02276482|40391152|FG000|Overall Study|Withdrawal by Subject|1|||
16525941|NCT02276482|40391153|FG001|Overall Study|Withdrawal by Subject|0|||
16525942|NCT02276482|40391152|FG000|Overall Study|Gram-negative infection|1|||
16525943|NCT02276482|40391153|FG001|Overall Study|Gram-negative infection|0|||
16525944|NCT02276482|40391152|FG000|Overall Study|Reason not specified|0|||
16525945|NCT02276482|40391153|FG001|Overall Study|Reason not specified|1|||
16525946|NCT02331134|40391156|FG000|Overall Study|Withdrawal by Subject|1|||
16525947|NCT00932893|40391157|FG000|Overall Study|Death|115|||
16525948|NCT00932893|40391158|FG001|Overall Study|Death|24|||
16398820|NCT03985943|39938858|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
16398821|NCT03985943|39938859|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
16398822|NCT03985943|39938854|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
16398823|NCT03985943|39938855|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
16398824|NCT03985943|39938856|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
16398825|NCT03985943|39938857|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
16398826|NCT03985943|39938858|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
16398827|NCT03985943|39938859|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
16398828|NCT03985943|39938854|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
16398829|NCT03985943|39938855|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
16398830|NCT03985943|39938856|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
16398831|NCT03985943|39938857|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
16398832|NCT03985943|39938858|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
16398833|NCT03985943|39938859|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
16398834|NCT03985943|39938854|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
16398835|NCT03985943|39938855|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
16398836|NCT03985943|39938856|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
16398837|NCT03985943|39938857|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
16398838|NCT03985943|39938858|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
16398839|NCT03985943|39938859|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
16398840|NCT03985943|39938854|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16398841|NCT03985943|39938855|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16398842|NCT03985943|39938856|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16097538|NCT01587703|38846867|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097539|NCT01587703|38846868|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097540|NCT01587703|38846869|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097541|NCT01587703|38846870|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16525949|NCT00932893|40391157|FG000|Overall Study|Lost to Follow-up|8|||
16329919|NCT01647516|39692635|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
16329920|NCT01647516|39692636|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
16329921|NCT01647516|39692637|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
16329922|NCT01647516|39692638|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
16329923|NCT01647516|39692639|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
16329924|NCT01647516|39692640|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
16329925|NCT01647516|39692635|FG000|Open-Label Period|Lack of Efficacy|0|||
16329926|NCT01647516|39692636|FG001|Open-Label Period|Lack of Efficacy|0|||
16329927|NCT01647516|39692637|FG002|Open-Label Period|Lack of Efficacy|0|||
16329928|NCT01647516|39692638|FG003|Open-Label Period|Lack of Efficacy|7|||
16329929|NCT01647516|39692639|FG004|Open-Label Period|Lack of Efficacy|9|||
16329930|NCT01647516|39692640|FG005|Open-Label Period|Lack of Efficacy|10|||
16329931|NCT01647516|39692635|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
16097542|NCT01587703|38846871|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
16097543|NCT04380688|38846872|FG000|Overall Study|Death|2|||
16097544|NCT04380688|38846873|FG001|Overall Study|Death|2|||
16097545|NCT04380688|38846872|FG000|Overall Study|Lost to Follow-up|2|||
16097546|NCT04380688|38846873|FG001|Overall Study|Lost to Follow-up|4|||
16097547|NCT04380688|38846872|FG000|Overall Study|Withdrawal by Subject|3|||
16097548|NCT04380688|38846873|FG001|Overall Study|Withdrawal by Subject|3|||
16329932|NCT01647516|39692636|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
16525950|NCT00932893|40391158|FG001|Overall Study|Lost to Follow-up|0|||
16525951|NCT00932893|40391157|FG000|Overall Study|Withdrawal by Subject|5|||
16525952|NCT00932893|40391158|FG001|Overall Study|Withdrawal by Subject|2|||
16525953|NCT00932893|40391157|FG000|Overall Study|Other|5|||
16525954|NCT00932893|40391158|FG001|Overall Study|Other|144|||
16525955|NCT03936244|40391160|FG000|Overall Study|Lost to Follow-up|5|||
16525956|NCT03936244|40391161|FG001|Overall Study|Lost to Follow-up|1|||
16525957|NCT03936244|40391160|FG000|Overall Study|Physician Decision|7|||
16525958|NCT03936244|40391161|FG001|Overall Study|Physician Decision|3|||
16525959|NCT01965834|40391162|FG000|Overall Study|Lack of Efficacy|4|||
16525960|NCT04818346|40391163|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
16525961|NCT04818346|40391164|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
16525962|NCT04818346|40391165|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
16525963|NCT04818346|40391166|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
16525964|NCT04818346|40391163|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
16525965|NCT04818346|40391164|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
16525966|NCT04818346|40391165|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
16525967|NCT04818346|40391166|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
16525968|NCT04818346|40391163|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
16525969|NCT04818346|40391164|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
16097549|NCT01066897|38846874|FG000|Overall Study|Withdrawal by Subject|1|||
16097550|NCT01066897|38846875|FG001|Overall Study|Withdrawal by Subject|0|||
16097551|NCT01066897|38846874|FG000|Overall Study|stopped study after developing the flu.|1|||
16525970|NCT04818346|40391165|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
16525971|NCT04818346|40391166|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
16525972|NCT04818346|40391163|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
16525973|NCT04818346|40391164|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
16525974|NCT04818346|40391165|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
16525975|NCT04818346|40391166|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
16525976|NCT04818346|40391163|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
16525977|NCT04818346|40391164|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
16525978|NCT04818346|40391165|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
16525979|NCT04818346|40391166|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
16525980|NCT04818346|40391163|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
16525981|NCT04818346|40391164|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
16525982|NCT04818346|40391165|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
16525983|NCT04818346|40391166|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
16525984|NCT04818346|40391163|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
16525985|NCT04818346|40391164|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
16525986|NCT04818346|40391165|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
16525987|NCT04818346|40391166|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
16525988|NCT04818346|40391163|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
16525989|NCT04818346|40391164|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
16398843|NCT03985943|39938857|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
16398844|NCT03985943|39938858|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
16398845|NCT03985943|39938859|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
16398846|NCT03985943|39938854|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
16398847|NCT03985943|39938855|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
16398848|NCT03985943|39938856|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
16398849|NCT03985943|39938857|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
16398850|NCT03985943|39938858|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
16398851|NCT03985943|39938859|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
16398852|NCT03985943|39938854|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
16398853|NCT03985943|39938855|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
16398854|NCT03985943|39938856|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
16398855|NCT03985943|39938857|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
16398856|NCT03985943|39938858|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
16398857|NCT03985943|39938859|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
16398858|NCT03985943|39938854|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
16398859|NCT03985943|39938855|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
16398860|NCT03985943|39938856|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
16398861|NCT03985943|39938857|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
16398862|NCT03985943|39938858|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
16398863|NCT03985943|39938859|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
16398864|NCT01352221|39941416|FG000|Double-blind Phase|Adverse Event|6|||
16398865|NCT01352221|39941417|FG001|Double-blind Phase|Adverse Event|4|||
16398866|NCT01352221|39941418|FG002|Double-blind Phase|Adverse Event|0|||
16398867|NCT01352221|39941419|FG003|Double-blind Phase|Adverse Event|0|||
16398868|NCT01352221|39941416|FG000|Double-blind Phase|Withdrawal by Subject|3|||
16398869|NCT01352221|39941417|FG001|Double-blind Phase|Withdrawal by Subject|5|||
16398870|NCT01352221|39941418|FG002|Double-blind Phase|Withdrawal by Subject|0|||
16398871|NCT01352221|39941419|FG003|Double-blind Phase|Withdrawal by Subject|0|||
16398872|NCT01352221|39941416|FG000|Double-blind Phase|Lost to Follow-up|0|||
16398873|NCT01352221|39941417|FG001|Double-blind Phase|Lost to Follow-up|1|||
16398874|NCT01352221|39941418|FG002|Double-blind Phase|Lost to Follow-up|0|||
16398875|NCT01352221|39941419|FG003|Double-blind Phase|Lost to Follow-up|0|||
16398876|NCT01352221|39941416|FG000|Double-blind Phase|Protocol Violation|0|||
16398877|NCT01352221|39941417|FG001|Double-blind Phase|Protocol Violation|1|||
16398878|NCT01352221|39941418|FG002|Double-blind Phase|Protocol Violation|0|||
16398879|NCT01352221|39941419|FG003|Double-blind Phase|Protocol Violation|0|||
16398880|NCT01352221|39941416|FG000|Open-label Phase|Physician Decision|0|||
16398881|NCT01352221|39941417|FG001|Open-label Phase|Physician Decision|0|||
16398882|NCT01352221|39941418|FG002|Open-label Phase|Physician Decision|2|||
16398883|NCT01352221|39941419|FG003|Open-label Phase|Physician Decision|1|||
16398884|NCT01352221|39941416|FG000|Open-label Phase|Pregnancy|0|||
16398885|NCT01352221|39941417|FG001|Open-label Phase|Pregnancy|0|||
16398886|NCT01352221|39941418|FG002|Open-label Phase|Pregnancy|1|||
16398887|NCT01352221|39941419|FG003|Open-label Phase|Pregnancy|0|||
16398888|NCT01352221|39941416|FG000|Open-label Phase|Adverse Event|0|||
16398889|NCT01352221|39941417|FG001|Open-label Phase|Adverse Event|0|||
16525990|NCT04818346|40391165|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
16525991|NCT04818346|40391166|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
16329933|NCT01647516|39692637|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
16329934|NCT01647516|39692638|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
16329935|NCT01647516|39692639|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
16329936|NCT01647516|39692640|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
16329937|NCT01647516|39692635|FG000|Open-Label Period|No completion / discontinuation visit|0|||
16329938|NCT01647516|39692636|FG001|Open-Label Period|No completion / discontinuation visit|0|||
16329939|NCT01647516|39692637|FG002|Open-Label Period|No completion / discontinuation visit|0|||
16329940|NCT01647516|39692638|FG003|Open-Label Period|No completion / discontinuation visit|0|||
16329941|NCT01647516|39692639|FG004|Open-Label Period|No completion / discontinuation visit|2|||
16329942|NCT01647516|39692640|FG005|Open-Label Period|No completion / discontinuation visit|1|||
16329943|NCT02892513|39692641|FG000|Overall Study|Withdrawal by Subject|0|||
16329944|NCT02892513|39692642|FG001|Overall Study|Withdrawal by Subject|1|||
16329945|NCT02255552|39692643|FG000|Overall Study|Participants enrolled into another study|0|||
16329946|NCT02255552|39692644|FG001|Overall Study|Participants enrolled into another study|11|||
16329947|NCT02255552|39692643|FG000|Overall Study|Withdrawal by Subject|1|||
16329948|NCT02255552|39692644|FG001|Overall Study|Withdrawal by Subject|4|||
16329949|NCT02867592|39692649|FG000|Overall Study|Adverse Event|3|||
16329950|NCT02867592|39692650|FG001|Overall Study|Adverse Event|0|||
16329951|NCT02867592|39692651|FG002|Overall Study|Adverse Event|2|||
16329952|NCT02867592|39692652|FG003|Overall Study|Adverse Event|1|||
16329953|NCT02867592|39692653|FG004|Overall Study|Adverse Event|1|||
16329954|NCT02867592|39692654|FG005|Overall Study|Adverse Event|5|||
16329955|NCT02867592|39692649|FG000|Overall Study|Death|0|||
16329956|NCT02867592|39692650|FG001|Overall Study|Death|0|||
16329957|NCT02867592|39692651|FG002|Overall Study|Death|0|||
16329958|NCT02867592|39692652|FG003|Overall Study|Death|1|||
16329959|NCT02867592|39692653|FG004|Overall Study|Death|0|||
16329960|NCT02867592|39692654|FG005|Overall Study|Death|1|||
16329961|NCT02867592|39692649|FG000|Overall Study|Lack of Efficacy|8|||
16329962|NCT02867592|39692650|FG001|Overall Study|Lack of Efficacy|10|||
16329963|NCT02867592|39692651|FG002|Overall Study|Lack of Efficacy|8|||
16329964|NCT02867592|39692652|FG003|Overall Study|Lack of Efficacy|8|||
16329965|NCT02867592|39692653|FG004|Overall Study|Lack of Efficacy|12|||
16329966|NCT02867592|39692654|FG005|Overall Study|Lack of Efficacy|17|||
16329967|NCT02867592|39692649|FG000|Overall Study|Physician Decision|1|||
16329968|NCT02867592|39692650|FG001|Overall Study|Physician Decision|2|||
16329969|NCT02867592|39692651|FG002|Overall Study|Physician Decision|2|||
16329970|NCT02867592|39692652|FG003|Overall Study|Physician Decision|0|||
16525992|NCT04818346|40391163|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
16525993|NCT04818346|40391164|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
16525994|NCT04818346|40391165|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
16525995|NCT04818346|40391166|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
16525996|NCT04818346|40391163|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
16525997|NCT04818346|40391164|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
16525998|NCT04818346|40391165|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
16525999|NCT04818346|40391166|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
16526000|NCT04818346|40391163|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
16526001|NCT04818346|40391164|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
16526002|NCT04818346|40391165|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
16329971|NCT02867592|39692653|FG004|Overall Study|Physician Decision|5|||
16329972|NCT02867592|39692654|FG005|Overall Study|Physician Decision|1|||
16329973|NCT02867592|39692649|FG000|Overall Study|Protocol Violation|0|||
16329974|NCT02867592|39692650|FG001|Overall Study|Protocol Violation|0|||
16329975|NCT02867592|39692651|FG002|Overall Study|Protocol Violation|0|||
16329976|NCT02867592|39692652|FG003|Overall Study|Protocol Violation|0|||
16398890|NCT01352221|39941418|FG002|Open-label Phase|Adverse Event|8|||
16398891|NCT01352221|39941419|FG003|Open-label Phase|Adverse Event|4|||
16398892|NCT01352221|39941416|FG000|Open-label Phase|Withdrawal by Subject|0|||
16329977|NCT02867592|39692653|FG004|Overall Study|Protocol Violation|1|||
16329978|NCT02867592|39692654|FG005|Overall Study|Protocol Violation|1|||
16329979|NCT02867592|39692649|FG000|Overall Study|Withdrawal by Subject|0|||
16329980|NCT02867592|39692650|FG001|Overall Study|Withdrawal by Subject|1|||
16329981|NCT02867592|39692651|FG002|Overall Study|Withdrawal by Subject|0|||
16329982|NCT02867592|39692652|FG003|Overall Study|Withdrawal by Subject|1|||
16329983|NCT02867592|39692653|FG004|Overall Study|Withdrawal by Subject|3|||
16329984|NCT02867592|39692654|FG005|Overall Study|Withdrawal by Subject|3|||
16329985|NCT02867592|39692649|FG000|Overall Study|Ineligible|1|||
16329986|NCT02867592|39692650|FG001|Overall Study|Ineligible|1|||
16329987|NCT02867592|39692651|FG002|Overall Study|Ineligible|0|||
16329988|NCT02867592|39692652|FG003|Overall Study|Ineligible|0|||
16329989|NCT02867592|39692653|FG004|Overall Study|Ineligible|2|||
16329990|NCT02867592|39692654|FG005|Overall Study|Ineligible|0|||
16329991|NCT02867592|39692649|FG000|Overall Study|No Treatment|1|||
16329992|NCT02867592|39692650|FG001|Overall Study|No Treatment|0|||
16329993|NCT02867592|39692651|FG002|Overall Study|No Treatment|0|||
16329994|NCT02867592|39692652|FG003|Overall Study|No Treatment|0|||
16329995|NCT02867592|39692653|FG004|Overall Study|No Treatment|0|||
16329996|NCT02867592|39692654|FG005|Overall Study|No Treatment|0|||
16329997|NCT02867592|39692649|FG000|Overall Study|Still on Therapy|0|||
16329998|NCT02867592|39692650|FG001|Overall Study|Still on Therapy|0|||
16329999|NCT02867592|39692651|FG002|Overall Study|Still on Therapy|0|||
16330000|NCT02867592|39692652|FG003|Overall Study|Still on Therapy|0|||
16330001|NCT02867592|39692653|FG004|Overall Study|Still on Therapy|1|||
16330002|NCT02867592|39692654|FG005|Overall Study|Still on Therapy|0|||
16330003|NCT02867592|39692649|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
16330004|NCT02867592|39692650|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
16330005|NCT02867592|39692651|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
16330006|NCT02867592|39692652|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
16330007|NCT02867592|39692653|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
16330008|NCT02867592|39692654|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
16330009|NCT02867592|39692649|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
16330010|NCT02867592|39692650|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
16330011|NCT02867592|39692651|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
16330012|NCT02867592|39692652|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
16330013|NCT02867592|39692653|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
16330014|NCT02867592|39692654|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
16330015|NCT04299048|39692655|FG000|Overall Study|Death|1|||
16330016|NCT04299048|39692655|FG000|Overall Study|Global deterioration of health status|2|||
16330017|NCT04299048|39692655|FG000|Overall Study|Enrolled and not treated|1|||
16330018|NCT02059434|39692658|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
16330019|NCT02059434|39692659|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
16330020|NCT02059434|39692660|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
16330021|NCT02059434|39692661|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
16330022|NCT02059434|39692662|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
16330023|NCT02059434|39692663|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
16330024|NCT02059434|39692664|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
16330025|NCT02059434|39692665|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
16330026|NCT02059434|39692666|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
16330027|NCT02059434|39692658|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
16330028|NCT02059434|39692659|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
16330029|NCT02059434|39692660|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
16330030|NCT02059434|39692661|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
16330031|NCT02059434|39692662|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
16330032|NCT02059434|39692663|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
16330033|NCT02059434|39692664|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
16330034|NCT02059434|39692665|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
16330035|NCT02059434|39692666|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
16330036|NCT02059434|39692658|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
16097552|NCT01066897|38846875|FG001|Overall Study|stopped study after developing the flu.|0|||
16330037|NCT02059434|39692659|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
16330038|NCT02059434|39692660|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
16526003|NCT04818346|40391166|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
16526004|NCT04818346|40391163|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
16526005|NCT04818346|40391164|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
16526006|NCT04818346|40391165|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
16546376|NCT01662063|40464796|FG000|Overall Study|Lost to Follow-up|0|||
16330039|NCT02059434|39692661|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
16330040|NCT02059434|39692662|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
16330041|NCT02059434|39692663|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
16330042|NCT02059434|39692664|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
16330043|NCT02059434|39692665|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
16398893|NCT01352221|39941417|FG001|Open-label Phase|Withdrawal by Subject|0|||
16398894|NCT01352221|39941418|FG002|Open-label Phase|Withdrawal by Subject|1|||
16398895|NCT01352221|39941419|FG003|Open-label Phase|Withdrawal by Subject|6|||
16398896|NCT01352221|39941416|FG000|Open-label Phase|Worsening of IBD|0|||
16398897|NCT01352221|39941417|FG001|Open-label Phase|Worsening of IBD|0|||
16398898|NCT01352221|39941418|FG002|Open-label Phase|Worsening of IBD|1|||
16398899|NCT01352221|39941419|FG003|Open-label Phase|Worsening of IBD|0|||
16398900|NCT00079391|39941425|FG000|Overall Study|Withdrawal by Subject|1|||
16398901|NCT00830375|39941426|FG000|Overall Study|Lost to Follow-up|1|||
16398902|NCT00841776|39941427|FG000|Overall Study|Lack of Efficacy|0|||
16398903|NCT00841776|39941428|FG001|Overall Study|Lack of Efficacy|1|||
16398904|NCT00841776|39941427|FG000|Overall Study|Lost to Follow-up|2|||
16398905|NCT00841776|39941428|FG001|Overall Study|Lost to Follow-up|1|||
16398906|NCT00841776|39941427|FG000|Overall Study|Withdrawal by Subject|0|||
16398907|NCT00841776|39941428|FG001|Overall Study|Withdrawal by Subject|1|||
16398908|NCT00730041|39941435|FG000|Overall Study|Lost to Follow-up|0|||
16398909|NCT00730041|39941436|FG001|Overall Study|Lost to Follow-up|2|||
16398910|NCT01576146|39941437|FG000|Extension Period 1|Adverse Event|2|||
16398911|NCT01576146|39941437|FG000|Extension Period 1|Death|2|||
16398912|NCT01576146|39941437|FG000|Extension Period 1|Physician Decision|2|||
16398913|NCT01576146|39941437|FG000|Extension Period 1|Withdrawal by Subject|1|||
16398914|NCT01576146|39941437|FG000|Extension Period 1|Lost to Follow-up|1|||
16398915|NCT01576146|39941437|FG000|Extension Period 1|Parathyroidectomy|1|||
16330044|NCT02059434|39692666|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
16330045|NCT02059434|39692658|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
16330046|NCT02059434|39692659|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
16330047|NCT02059434|39692660|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
16398916|NCT01576146|39941437|FG000|Extension Period 1|Renal Transplant|1|||
16398917|NCT01576146|39941437|FG000|Extension Period 2|Sponsor Decision|13|||
16398918|NCT01576146|39941437|FG000|Extension Period 2|Death|1|||
16398919|NCT01576146|39941437|FG000|Extension Period 2|Adverse Event|1|||
16398920|NCT01576146|39941437|FG000|Extension Period 2|Renal Transplant|1|||
16398921|NCT01576146|39941437|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
16398922|NCT02952313|39941438|FG000|Primary Endpoint|Lost to Follow-up|4|||
16398923|NCT02952313|39941438|FG000|Primary Endpoint|Withdrawal by Subject|1|||
16398924|NCT02952313|39941438|FG000|Primary Endpoint|Lack of Efficacy|1|||
16398925|NCT02952313|39941438|FG000|Primary Endpoint|Missed visit|1|||
16398926|NCT02952313|39941438|FG000|Long-term Follow-up|Lost to Follow-up|12|||
16398927|NCT02952313|39941438|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
16398928|NCT02952313|39941438|FG000|Long-term Follow-up|Lack of Efficacy|6|||
16398929|NCT02952313|39941438|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
16398930|NCT02952313|39941438|FG000|Long-term Follow-up|Physician Decision|1|||
16398931|NCT02952313|39941438|FG000|Long-term Follow-up|Death|1|||
16398932|NCT05243745|39941439|FG000|Overall Study|Withdrawal by Subject|0|||
16398933|NCT05243745|39941440|FG001|Overall Study|Withdrawal by Subject|0|||
16398934|NCT05243745|39941441|FG002|Overall Study|Withdrawal by Subject|0|||
16398935|NCT05243745|39941442|FG003|Overall Study|Withdrawal by Subject|1|||
16398936|NCT05243745|39941439|FG000|Overall Study|Unable to Attend Visit 6|0|||
16398937|NCT05243745|39941440|FG001|Overall Study|Unable to Attend Visit 6|0|||
16398938|NCT05243745|39941441|FG002|Overall Study|Unable to Attend Visit 6|1|||
16398939|NCT05243745|39941442|FG003|Overall Study|Unable to Attend Visit 6|0|||
16398940|NCT02218697|39941443|FG000|Overall Study|Adverse Event|0|||
16398941|NCT02218697|39941444|FG001|Overall Study|Adverse Event|2|||
16398942|NCT02218697|39941443|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
16398943|NCT02218697|39941444|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
16398944|NCT02218697|39941443|FG000|Overall Study|Withdrawal by Subject|2|||
16398945|NCT02218697|39941444|FG001|Overall Study|Withdrawal by Subject|3|||
16398946|NCT02027311|39941445|FG000|Overall Study|Protocol Violation|3|||
16398947|NCT02027311|39941446|FG001|Overall Study|Protocol Violation|2|||
16398948|NCT01814046|39941449|FG000|Drug Administration|Death due to complications of RSV|1|||
16398949|NCT01814046|39941450|FG001|Drug Administration|Death due to complications of RSV|0|||
16398950|NCT01814046|39941451|FG002|Drug Administration|Death due to complications of RSV|0|||
16330048|NCT02059434|39692661|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
16330049|NCT02059434|39692662|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
16330050|NCT02059434|39692663|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
16330051|NCT02059434|39692664|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
16330052|NCT02059434|39692665|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
16330053|NCT02059434|39692666|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
16330054|NCT02059434|39692658|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16330055|NCT02059434|39692659|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16330056|NCT02059434|39692660|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16330057|NCT02059434|39692661|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16330058|NCT02059434|39692662|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16330059|NCT02059434|39692663|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16330060|NCT02059434|39692664|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16330061|NCT02059434|39692665|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
16330062|NCT02059434|39692666|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
16330063|NCT01482962|39692669|FG000|Overall Study|Progressive Disease|65|||
16330064|NCT01482962|39692670|FG001|Overall Study|Progressive Disease|53|||
16330065|NCT01482962|39692669|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
16330066|NCT01482962|39692670|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
16330067|NCT01482962|39692669|FG000|Overall Study|Adverse Event|18|||
16330068|NCT01482962|39692670|FG001|Overall Study|Adverse Event|22|||
16330069|NCT01482962|39692669|FG000|Overall Study|Withdrawal by Participant|8|||
16330070|NCT01482962|39692670|FG001|Overall Study|Withdrawal by Participant|13|||
16330071|NCT01482962|39692669|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
16330072|NCT01482962|39692670|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
16330073|NCT01482962|39692669|FG000|Overall Study|Other Reason|1|||
16330074|NCT01482962|39692670|FG001|Overall Study|Other Reason|5|||
16398951|NCT02248649|39941452|FG000|Overall Study|Death|7|||
16398952|NCT02248649|39941453|FG001|Overall Study|Death|11|||
16398953|NCT02248649|39941452|FG000|Overall Study|Lost to Follow-up|14|||
16398954|NCT02248649|39941453|FG001|Overall Study|Lost to Follow-up|10|||
16398955|NCT02516982|39941454|FG000|Overall Study|Called in to antenatal appointment|32|||
16398956|NCT02516982|39941455|FG001|Overall Study|Called in to antenatal appointment|35|||
16398957|NCT02516982|39941456|FG002|Overall Study|Called in to antenatal appointment|0|||
16398958|NCT02516982|39941457|FG003|Overall Study|Called in to antenatal appointment|0|||
16398959|NCT02516982|39941454|FG000|Overall Study|Withdrawal by Subject|0|||
16398960|NCT02516982|39941455|FG001|Overall Study|Withdrawal by Subject|0|||
16398961|NCT02516982|39941456|FG002|Overall Study|Withdrawal by Subject|1|||
16398962|NCT02516982|39941457|FG003|Overall Study|Withdrawal by Subject|2|||
16398963|NCT02516982|39941454|FG000|Overall Study|Protocol Violation|0|||
16398964|NCT02516982|39941455|FG001|Overall Study|Protocol Violation|0|||
16398965|NCT02516982|39941456|FG002|Overall Study|Protocol Violation|1|||
16398966|NCT02516982|39941457|FG003|Overall Study|Protocol Violation|1|||
16398967|NCT02516982|39941454|FG000|Overall Study|Did not install the app|0|||
16398968|NCT02516982|39941455|FG001|Overall Study|Did not install the app|0|||
16398969|NCT02516982|39941456|FG002|Overall Study|Did not install the app|46|||
16398970|NCT02516982|39941457|FG003|Overall Study|Did not install the app|47|||
16398971|NCT02120781|39941463|FG000|Overall Study|Physician Decision|2|||
16398972|NCT02120781|39941464|FG001|Overall Study|Physician Decision|0|||
16526007|NCT04818346|40391166|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
16526008|NCT04818346|40391163|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
16526009|NCT04818346|40391164|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
16526010|NCT04818346|40391165|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
16526011|NCT04818346|40391166|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
16526012|NCT04818346|40391163|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
16330075|NCT01482962|39692669|FG000|Overall Study|Study Terminated by Sponsor|5|||
16330076|NCT01482962|39692670|FG001|Overall Study|Study Terminated by Sponsor|2|||
16398973|NCT02120781|39941463|FG000|Overall Study|Completion not documented|2|||
16398974|NCT02120781|39941464|FG001|Overall Study|Completion not documented|1|||
16398975|NCT02096952|39941465|FG000|Overall Study|Adverse Event|1|||
16398976|NCT00372619|39941468|FG000|Overall Study|Ineligible|0|||
16398977|NCT00372619|39941469|FG001|Overall Study|Ineligible|0|||
16398978|NCT00372619|39941470|FG002|Overall Study|Ineligible|0|||
16398979|NCT00372619|39941471|FG003|Overall Study|Ineligible|0|||
16398980|NCT00372619|39941472|FG004|Overall Study|Ineligible|0|||
16398981|NCT00372619|39941473|FG005|Overall Study|Ineligible|2|||
16398982|NCT00372619|39941474|FG006|Overall Study|Ineligible|0|||
16398983|NCT00372619|39941468|FG000|Overall Study|Inevaluable|0|||
16398984|NCT00372619|39941469|FG001|Overall Study|Inevaluable|0|||
16398985|NCT00372619|39941470|FG002|Overall Study|Inevaluable|0|||
16398986|NCT00372619|39941471|FG003|Overall Study|Inevaluable|0|||
16398987|NCT00372619|39941472|FG004|Overall Study|Inevaluable|0|||
16398988|NCT00372619|39941473|FG005|Overall Study|Inevaluable|1|||
16398989|NCT00372619|39941474|FG006|Overall Study|Inevaluable|0|||
16398990|NCT00951080|39941475|FG000|Overall Study|Adverse Event|3|||
16398991|NCT00951080|39941476|FG001|Overall Study|Adverse Event|3|||
16398992|NCT00951080|39941475|FG000|Overall Study|Lost to Follow-up|0|||
16398993|NCT00951080|39941476|FG001|Overall Study|Lost to Follow-up|1|||
16398994|NCT00951080|39941475|FG000|Overall Study|Physician Decision|4|||
16398995|NCT00951080|39941476|FG001|Overall Study|Physician Decision|1|||
16398996|NCT00951080|39941475|FG000|Overall Study|Other|19|||
16398997|NCT00951080|39941476|FG001|Overall Study|Other|22|||
16398998|NCT00316706|39941478|FG000|Overall Study|Lost to Follow-up|38|||
16398999|NCT00316706|39941479|FG001|Overall Study|Lost to Follow-up|48|||
16399000|NCT03650413|39941483|FG000|Overall Study|Adverse Event|1|||
16399001|NCT03650413|39941483|FG000|Overall Study|Lack of Efficacy|17|||
16399002|NCT03650413|39941483|FG000|Overall Study|Other|9|||
16399003|NCT03650413|39941483|FG000|Overall Study|Physician Decision|2|||
16399004|NCT03650413|39941483|FG000|Overall Study|Study Terminated By Sponsor|16|||
16399005|NCT03650413|39941483|FG000|Overall Study|Withdrawal by Subject|16|||
16399006|NCT03249909|39941484|FG000|Overall Study|Withdrawal by Subject|3|||
16399007|NCT03249909|39941485|FG001|Overall Study|Withdrawal by Subject|0|||
16399008|NCT03249909|39941486|FG002|Overall Study|Withdrawal by Subject|0|||
16399009|NCT03249909|39941484|FG000|Overall Study|Adverse Event|3|||
16399010|NCT03249909|39941485|FG001|Overall Study|Adverse Event|0|||
16399011|NCT03249909|39941486|FG002|Overall Study|Adverse Event|0|||
16399012|NCT03249909|39941484|FG000|Overall Study|Lost to Follow-up|0|||
16399013|NCT03249909|39941485|FG001|Overall Study|Lost to Follow-up|1|||
16399014|NCT03249909|39941486|FG002|Overall Study|Lost to Follow-up|0|||
16399015|NCT02675751|39941489|FG000|Overall Study|Lost to Follow-up|16|||
16399016|NCT03842969|39941492|FG000|Overall Study|Participant declined follow-up visit|0|||
16399017|NCT03842969|39941493|FG001|Overall Study|Participant declined follow-up visit|1|||
16399018|NCT03842969|39941494|FG002|Overall Study|Participant declined follow-up visit|0|||
16399019|NCT03842969|39941492|FG000|Overall Study|Sponsor's decision|12|||
16399020|NCT03842969|39941493|FG001|Overall Study|Sponsor's decision|99|||
16399021|NCT03842969|39941494|FG002|Overall Study|Sponsor's decision|61|||
16399022|NCT03842969|39941492|FG000|Overall Study|Pregnancy|0|||
16399023|NCT03842969|39941493|FG001|Overall Study|Pregnancy|0|||
16399024|NCT03842969|39941494|FG002|Overall Study|Pregnancy|1|||
16399025|NCT03842969|39941492|FG000|Overall Study|Death|1|||
16399026|NCT03842969|39941493|FG001|Overall Study|Death|0|||
16399027|NCT03842969|39941494|FG002|Overall Study|Death|1|||
16399028|NCT03842969|39941492|FG000|Overall Study|Withdrawal by Subject|3|||
16399029|NCT03842969|39941493|FG001|Overall Study|Withdrawal by Subject|30|||
16399030|NCT03842969|39941494|FG002|Overall Study|Withdrawal by Subject|18|||
16399031|NCT03842969|39941492|FG000|Overall Study|Protocol Violation|1|||
16399032|NCT03842969|39941493|FG001|Overall Study|Protocol Violation|1|||
16399033|NCT03842969|39941494|FG002|Overall Study|Protocol Violation|0|||
16399034|NCT03842969|39941492|FG000|Overall Study|Physician Decision|0|||
16399035|NCT03842969|39941493|FG001|Overall Study|Physician Decision|3|||
16399036|NCT03842969|39941494|FG002|Overall Study|Physician Decision|0|||
16399037|NCT03842969|39941492|FG000|Overall Study|Lost to Follow-up|0|||
16399038|NCT03842969|39941493|FG001|Overall Study|Lost to Follow-up|2|||
16399039|NCT03842969|39941494|FG002|Overall Study|Lost to Follow-up|0|||
16399040|NCT03842969|39941492|FG000|Overall Study|Adverse Event|0|||
16399041|NCT03842969|39941493|FG001|Overall Study|Adverse Event|2|||
16399042|NCT03842969|39941494|FG002|Overall Study|Adverse Event|0|||
16399043|NCT00920218|39941495|FG000|Overall Study|Serious Adverse Event|2|||
16399044|NCT00920218|39941496|FG001|Overall Study|Serious Adverse Event|0|||
16399045|NCT00920218|39941497|FG002|Overall Study|Serious Adverse Event|2|||
16399046|NCT00920218|39941498|FG003|Overall Study|Serious Adverse Event|1|||
16399047|NCT00920218|39941495|FG000|Overall Study|Withdrawal by Subject|0|||
16399048|NCT00920218|39941496|FG001|Overall Study|Withdrawal by Subject|3|||
16399049|NCT00920218|39941497|FG002|Overall Study|Withdrawal by Subject|2|||
16399050|NCT00920218|39941498|FG003|Overall Study|Withdrawal by Subject|0|||
16399051|NCT00920218|39941495|FG000|Overall Study|Migrated/moved from study area|0|||
16399052|NCT00920218|39941496|FG001|Overall Study|Migrated/moved from study area|0|||
16399053|NCT00920218|39941497|FG002|Overall Study|Migrated/moved from study area|1|||
16399054|NCT00920218|39941498|FG003|Overall Study|Migrated/moved from study area|0|||
16399055|NCT00920218|39941495|FG000|Overall Study|Lost to Follow-up|0|||
16399056|NCT00920218|39941496|FG001|Overall Study|Lost to Follow-up|1|||
16399057|NCT00920218|39941497|FG002|Overall Study|Lost to Follow-up|0|||
16399058|NCT00920218|39941498|FG003|Overall Study|Lost to Follow-up|3|||
16399059|NCT00920218|39941495|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
16546377|NCT01662063|40464797|FG001|Overall Study|Lost to Follow-up|4|||
16399060|NCT00920218|39941496|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
16399061|NCT00920218|39941497|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
16399062|NCT00920218|39941498|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
16526013|NCT04818346|40391164|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
16330077|NCT01482962|39692669|FG000|Overall Study|Did not Receive Study Drug|1|||
16330078|NCT01482962|39692670|FG001|Overall Study|Did not Receive Study Drug|6|||
16330079|NCT01097421|39692671|FG000|Overall Study|Adverse Event|8|||
16330080|NCT01097421|39692671|FG000|Overall Study|Protocol Violation|2|||
16330081|NCT01097421|39692671|FG000|Overall Study|Lost to Follow-up|1|||
16330082|NCT01097421|39692671|FG000|Overall Study|Withdrawal by Subject|3|||
16330083|NCT02122770|39692672|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
16330084|NCT02122770|39692673|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
16330085|NCT02122770|39692674|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
16330086|NCT02122770|39692675|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
16330087|NCT02122770|39692676|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
16330088|NCT02122770|39692677|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
16330089|NCT02122770|39692672|FG000|Part A: Drug-drug Interaction 2|Other|0|||
16330090|NCT02122770|39692673|FG001|Part A: Drug-drug Interaction 2|Other|0|||
16330091|NCT02122770|39692674|FG002|Part A: Drug-drug Interaction 2|Other|1|||
16330092|NCT02122770|39692675|FG003|Part A: Drug-drug Interaction 2|Other|0|||
16330093|NCT02122770|39692676|FG004|Part A: Drug-drug Interaction 2|Other|0|||
16330094|NCT02122770|39692677|FG005|Part A: Drug-drug Interaction 2|Other|0|||
16330095|NCT02122770|39692672|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
16330096|NCT02122770|39692673|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
16330097|NCT02122770|39692674|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
16330098|NCT02122770|39692675|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
16330099|NCT02122770|39692676|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
16399063|NCT00920218|39941495|FG000|Overall Study|Other|0|||
16526014|NCT04818346|40391165|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
16526015|NCT04818346|40391166|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
16526016|NCT04818346|40391163|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
16526017|NCT04818346|40391164|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
16526018|NCT04818346|40391165|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
16526019|NCT04818346|40391166|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
16526020|NCT05348681|40391167|FG000|Overall Study|Study terminated by Sponsor|8|||
16526021|NCT05348681|40391168|FG001|Overall Study|Study terminated by Sponsor|3|||
16526022|NCT05348681|40391167|FG000|Overall Study|Withdrawal by Subject|1|||
16526023|NCT05348681|40391168|FG001|Overall Study|Withdrawal by Subject|1|||
16526024|NCT05348681|40391167|FG000|Overall Study|Lost to Follow-up|1|||
16526025|NCT05348681|40391168|FG001|Overall Study|Lost to Follow-up|1|||
16526026|NCT05348681|40391167|FG000|Overall Study|Adverse Event|1|||
16526027|NCT05348681|40391168|FG001|Overall Study|Adverse Event|0|||
16526028|NCT05348681|40391167|FG000|Overall Study|Other|2|||
16526029|NCT05348681|40391168|FG001|Overall Study|Other|1|||
16526030|NCT00634647|40391170|FG000|Overall Study|death on study|3|||
16526031|NCT00634647|40391170|FG000|Overall Study|refused further treatment|3|||
16526032|NCT00634647|40391170|FG000|Overall Study|declined to participate before treatment|1|||
16526033|NCT01043874|40391173|FG000|Overall Study|Adverse Event|3|||
16526034|NCT01043874|40391173|FG000|Overall Study|Withdrawal by Subject|1|||
16526035|NCT01043874|40391173|FG000|Overall Study|Lack of Efficacy|1|||
16526036|NCT01043874|40391173|FG000|Overall Study|Administrative Problems|1|||
16526037|NCT00759109|40391174|FG000|Overall Study|Adverse Event|17|||
16526038|NCT00759109|40391175|FG001|Overall Study|Adverse Event|12|||
16526039|NCT00759109|40391174|FG000|Overall Study|Inability to comply|1|||
16526040|NCT00759109|40391175|FG001|Overall Study|Inability to comply|1|||
16526041|NCT00759109|40391174|FG000|Overall Study|Withdrawal by Subject|9|||
16526042|NCT00759109|40391175|FG001|Overall Study|Withdrawal by Subject|5|||
16526043|NCT00759109|40391174|FG000|Overall Study|Death|4|||
16526044|NCT00759109|40391175|FG001|Overall Study|Death|3|||
16526045|NCT00759109|40391174|FG000|Overall Study|Lost to Follow-up|4|||
16526046|NCT00759109|40391175|FG001|Overall Study|Lost to Follow-up|6|||
16526047|NCT00759109|40391174|FG000|Overall Study|Started new therapy|2|||
16526048|NCT00759109|40391175|FG001|Overall Study|Started new therapy|6|||
16526049|NCT00759109|40391174|FG000|Overall Study|HCV RNA negative|1|||
16526050|NCT00759109|40391175|FG001|Overall Study|HCV RNA negative|0|||
16526051|NCT00759109|40391174|FG000|Overall Study|Participant moved to a different city|0|||
16097553|NCT02473913|38846876|FG000|Overall Study|Lost to Follow-up|3|||
16097554|NCT02473913|38846877|FG001|Overall Study|Lost to Follow-up|3|||
16211061|NCT03799627|39251522|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
16330100|NCT02122770|39692677|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
16399064|NCT00920218|39941496|FG001|Overall Study|Other|0|||
16399065|NCT00920218|39941497|FG002|Overall Study|Other|1|||
16399066|NCT00920218|39941498|FG003|Overall Study|Other|0|||
16526052|NCT00759109|40391175|FG001|Overall Study|Participant moved to a different city|1|||
16526053|NCT00759109|40391174|FG000|Overall Study|Participant had a liver transplant|0|||
16526054|NCT00759109|40391175|FG001|Overall Study|Participant had a liver transplant|1|||
16526055|NCT00759109|40391174|FG000|Overall Study|Lost during study|1|||
16330101|NCT02122770|39692672|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
16330102|NCT02122770|39692673|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
16330103|NCT02122770|39692674|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
16330104|NCT02122770|39692675|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
16330105|NCT02122770|39692676|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
16330106|NCT02122770|39692677|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
16330107|NCT02122770|39692672|FG000|Part B: Standard of Care|Adverse Event|0|||
16330108|NCT02122770|39692673|FG001|Part B: Standard of Care|Adverse Event|0|||
16330109|NCT02122770|39692674|FG002|Part B: Standard of Care|Adverse Event|0|||
16330110|NCT02122770|39692675|FG003|Part B: Standard of Care|Adverse Event|0|||
16330111|NCT02122770|39692676|FG004|Part B: Standard of Care|Adverse Event|4|||
16330112|NCT02122770|39692677|FG005|Part B: Standard of Care|Adverse Event|1|||
16330113|NCT02122770|39692672|FG000|Part B: Standard of Care|Other|0|||
16330114|NCT02122770|39692673|FG001|Part B: Standard of Care|Other|0|||
16330115|NCT02122770|39692674|FG002|Part B: Standard of Care|Other|0|||
16399067|NCT00405392|39941507|FG000|Overall Study|Adverse Event|15|||
16399068|NCT00405392|39941508|FG001|Overall Study|Adverse Event|14|||
16399069|NCT00405392|39941507|FG000|Overall Study|Did not meet Eligibility criteria|7|||
16399070|NCT00405392|39941508|FG001|Overall Study|Did not meet Eligibility criteria|2|||
16399071|NCT00405392|39941507|FG000|Overall Study|Withdrawal by Subject|4|||
16399072|NCT00405392|39941508|FG001|Overall Study|Withdrawal by Subject|3|||
16399073|NCT00405392|39941507|FG000|Overall Study|Lost to Follow-up|1|||
16399074|NCT00405392|39941508|FG001|Overall Study|Lost to Follow-up|2|||
16399075|NCT00405392|39941507|FG000|Overall Study|Data missing|2|||
16399076|NCT00405392|39941508|FG001|Overall Study|Data missing|0|||
16399077|NCT00405392|39941507|FG000|Overall Study|Non-compliance|0|||
16399078|NCT00405392|39941508|FG001|Overall Study|Non-compliance|1|||
16399079|NCT00405392|39941507|FG000|Overall Study|Other|1|||
16399080|NCT00405392|39941508|FG001|Overall Study|Other|5|||
16399081|NCT02482298|39941510|FG000|Overall Study|Withdrawal by Subject|2|||
16399082|NCT02482298|39941511|FG001|Overall Study|Withdrawal by Subject|1|||
16399083|NCT02482298|39941512|FG002|Overall Study|Withdrawal by Subject|2|||
16399084|NCT02482298|39941510|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
16399085|NCT02482298|39941511|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
16399086|NCT02482298|39941512|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
16399087|NCT02482298|39941510|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
16399088|NCT02482298|39941511|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
16399089|NCT02482298|39941512|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
16399090|NCT02482298|39941510|FG000|Overall Study|Lost to Follow-up|0|||
16399091|NCT02482298|39941511|FG001|Overall Study|Lost to Follow-up|1|||
16399092|NCT02482298|39941512|FG002|Overall Study|Lost to Follow-up|0|||
16526056|NCT00759109|40391175|FG001|Overall Study|Lost during study|0|||
16526057|NCT01808313|40391176|FG000|Overall Study|Adverse Event|5|||
16526058|NCT01808313|40391176|FG000|Overall Study|Protocol Violation|2|||
16526059|NCT01808313|40391176|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16526060|NCT01808313|40391176|FG000|Overall Study|Lost to Follow-up|1|||
16526061|NCT01808313|40391176|FG000|Overall Study|Physician Decision|1|||
16526062|NCT03791398|40391178|FG000|Overall Study|Progression of Disease Under Study|2|||
16526063|NCT03791398|40391179|FG001|Overall Study|Progression of Disease Under Study|0|||
16526064|NCT03791398|40391180|FG002|Overall Study|Progression of Disease Under Study|0|||
16526065|NCT02823145|40391181|FG000|Enrollment|Other|1|||
16526066|NCT02823145|40391182|FG001|Enrollment|Other|0|||
16526067|NCT02823145|40391181|FG000|Treatment|Adverse Event|0|||
16526068|NCT02823145|40391182|FG001|Treatment|Adverse Event|11|||
16526069|NCT02823145|40391181|FG000|Treatment|Death|0|||
16526070|NCT02823145|40391182|FG001|Treatment|Death|3|||
16526071|NCT02823145|40391181|FG000|Treatment|Family Decision|0|||
16526072|NCT02823145|40391182|FG001|Treatment|Family Decision|1|||
16526073|NCT02823145|40391181|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
16526074|NCT02823145|40391182|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
16330116|NCT02122770|39692675|FG003|Part B: Standard of Care|Other|0|||
16330117|NCT02122770|39692676|FG004|Part B: Standard of Care|Other|0|||
16330118|NCT02122770|39692677|FG005|Part B: Standard of Care|Other|2|||
16330119|NCT02122770|39692672|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
16399093|NCT00443053|39941513|FG000|Overall Study|Adverse Event|2|||
16399094|NCT00443053|39941514|FG001|Overall Study|Adverse Event|1|||
16399095|NCT00443053|39941513|FG000|Overall Study|Withdrawal by Subject|9|||
16526075|NCT02823145|40391181|FG000|Treatment|Lack of Efficacy|0|||
16526076|NCT02823145|40391182|FG001|Treatment|Lack of Efficacy|48|||
16526077|NCT02823145|40391181|FG000|Treatment|Non-Compliance With E-Diary|0|||
16526078|NCT02823145|40391182|FG001|Treatment|Non-Compliance With E-Diary|1|||
16399096|NCT00443053|39941514|FG001|Overall Study|Withdrawal by Subject|18|||
16526079|NCT02823145|40391181|FG000|Treatment|Physician Decision|0|||
16526080|NCT02823145|40391182|FG001|Treatment|Physician Decision|2|||
16526081|NCT02823145|40391181|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
16526082|NCT02823145|40391182|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
16097555|NCT04676763|38846878|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
16211062|NCT03799627|39251514|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
16526083|NCT02823145|40391181|FG000|Treatment|Subject needed to take prohibited medication|0|||
16526084|NCT02823145|40391182|FG001|Treatment|Subject needed to take prohibited medication|1|||
16526085|NCT02823145|40391181|FG000|Treatment|Subject transferred to direct access programme|0|||
16526086|NCT02823145|40391182|FG001|Treatment|Subject transferred to direct access programme|1|||
16526087|NCT02823145|40391181|FG000|Treatment|Switching to commercially available drug|0|||
16526088|NCT02823145|40391182|FG001|Treatment|Switching to commercially available drug|11|||
16526089|NCT02823145|40391181|FG000|Treatment|Transitioned to commercial supply of medication|0|||
16526090|NCT02823145|40391182|FG001|Treatment|Transitioned to commercial supply of medication|1|||
16526091|NCT02823145|40391181|FG000|Treatment|Withdrawal By Caregiver|0|||
16526092|NCT02823145|40391182|FG001|Treatment|Withdrawal By Caregiver|1|||
16526093|NCT02823145|40391181|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
16526094|NCT02823145|40391182|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
16526095|NCT02823145|40391181|FG000|Treatment|Withdrawal by Subject|0|||
16526096|NCT02823145|40391182|FG001|Treatment|Withdrawal by Subject|16|||
16526097|NCT02823145|40391181|FG000|Treatment|Reason unknown|0|||
16526098|NCT02823145|40391182|FG001|Treatment|Reason unknown|1|||
16330120|NCT02122770|39692673|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
16330121|NCT02122770|39692674|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
16330122|NCT02122770|39692675|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
16330123|NCT02122770|39692676|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
16330124|NCT02122770|39692677|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
16526099|NCT00887341|40391185|FG000|Overall Study|Refused treatment|1|||
16526100|NCT00887341|40391186|FG001|Overall Study|Refused treatment|0|||
16526101|NCT00887341|40391185|FG000|Overall Study|Withdrawal by Subject|1|||
16526102|NCT00887341|40391186|FG001|Overall Study|Withdrawal by Subject|1|||
16526103|NCT00887341|40391185|FG000|Overall Study|Adverse Event|0|||
16526104|NCT00887341|40391186|FG001|Overall Study|Adverse Event|1|||
16526105|NCT00887341|40391185|FG000|Overall Study|Lost to Follow-up|0|||
16526106|NCT00887341|40391186|FG001|Overall Study|Lost to Follow-up|1|||
16526107|NCT01272934|40391187|FG000|Overall Study|Adverse Event|0|||
16526108|NCT01272934|40391188|FG001|Overall Study|Adverse Event|1|||
16526109|NCT01272934|40391187|FG000|Overall Study|Abnormal Laboratory Value|0|||
16526110|NCT01272934|40391188|FG001|Overall Study|Abnormal Laboratory Value|1|||
16526111|NCT03864900|40391195|FG000|Overall Study|Withdrawal by Subject|1|||
16526112|NCT03864900|40391196|FG001|Overall Study|Withdrawal by Subject|1|||
16526113|NCT03864900|40391195|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
16526114|NCT03864900|40391196|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
16526115|NCT01265953|40391199|FG000|Overall Study|Non compliance|5|||
16526116|NCT01265953|40391200|FG001|Overall Study|Non compliance|3|||
16526117|NCT01831089|40391201|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
16526118|NCT01831089|40391202|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
16526119|NCT01831089|40391203|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
16526120|NCT01831089|40391204|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
16526121|NCT01831089|40391205|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
16526122|NCT01831089|40391206|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
16526123|NCT01831089|40391201|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
16526124|NCT01831089|40391202|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
16526125|NCT01831089|40391203|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
16526126|NCT01831089|40391204|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
16526127|NCT01831089|40391205|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
16526128|NCT01831089|40391206|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
16526129|NCT01831089|40391201|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
16526130|NCT01831089|40391202|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
16526131|NCT01831089|40391203|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
16526132|NCT01831089|40391204|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
16526133|NCT01831089|40391205|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
16526134|NCT01831089|40391206|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
16526135|NCT01831089|40391201|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
16330125|NCT02122770|39692672|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
16330126|NCT02122770|39692673|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
16526136|NCT01831089|40391202|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
16526137|NCT01831089|40391203|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
16526138|NCT01831089|40391204|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
16526139|NCT01831089|40391205|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
16526140|NCT01831089|40391206|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
16526141|NCT01831089|40391201|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
16526142|NCT01831089|40391202|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
16526143|NCT01831089|40391203|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
16526144|NCT01831089|40391204|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
16526145|NCT01831089|40391205|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
16526146|NCT01831089|40391206|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
16526147|NCT01831089|40391201|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
16526148|NCT01831089|40391202|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
16526149|NCT01831089|40391203|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
16526150|NCT01831089|40391204|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
16526151|NCT01831089|40391205|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
16526152|NCT01831089|40391206|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
16526153|NCT01831089|40391201|FG000|Cohort III: Dose Level 3|Global end of study|0|||
16526154|NCT01831089|40391202|FG001|Cohort III: Dose Level 3|Global end of study|0|||
16526155|NCT01831089|40391203|FG002|Cohort III: Dose Level 3|Global end of study|1|||
16211063|NCT03799627|39251515|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
16211064|NCT03799627|39251516|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
16211065|NCT03799627|39251517|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
16211066|NCT03799627|39251518|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
16399097|NCT00443053|39941513|FG000|Overall Study|Lost to Follow-up|4|||
16399098|NCT00443053|39941514|FG001|Overall Study|Lost to Follow-up|5|||
16399099|NCT00443053|39941513|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
16399100|NCT00443053|39941514|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
16399101|NCT00443053|39941513|FG000|Overall Study|Noncompliance|2|||
16399102|NCT00443053|39941514|FG001|Overall Study|Noncompliance|1|||
16399103|NCT00443053|39941513|FG000|Overall Study|Other|3|||
16399104|NCT00443053|39941514|FG001|Overall Study|Other|4|||
16399105|NCT00443053|39941513|FG000|Overall Study|Physician Decision|0|||
16399106|NCT00443053|39941514|FG001|Overall Study|Physician Decision|4|||
16399107|NCT01645735|39941515|FG000|Overall Study|Physician Decision|2|||
16399108|NCT01645735|39941516|FG001|Overall Study|Physician Decision|0|||
16399109|NCT01645735|39941515|FG000|Overall Study|Withdrawal by Subject|1|||
16399110|NCT01645735|39941516|FG001|Overall Study|Withdrawal by Subject|0|||
16399111|NCT01645735|39941515|FG000|Overall Study|Protocol Violation|1|||
16399112|NCT01645735|39941516|FG001|Overall Study|Protocol Violation|0|||
16211067|NCT03799627|39251519|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
16211068|NCT03799627|39251520|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
16211069|NCT03799627|39251521|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
16211070|NCT03799627|39251522|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
16211071|NCT03799627|39251514|FG000|Overall Study|Met Exclusion Criteria|0|||
16211072|NCT03799627|39251515|FG001|Overall Study|Met Exclusion Criteria|0|||
16211073|NCT03799627|39251516|FG002|Overall Study|Met Exclusion Criteria|0|||
16211074|NCT03799627|39251517|FG003|Overall Study|Met Exclusion Criteria|1|||
16211075|NCT03799627|39251518|FG004|Overall Study|Met Exclusion Criteria|0|||
16211076|NCT03799627|39251519|FG005|Overall Study|Met Exclusion Criteria|0|||
16211077|NCT03799627|39251520|FG006|Overall Study|Met Exclusion Criteria|0|||
16211078|NCT03799627|39251521|FG007|Overall Study|Met Exclusion Criteria|0|||
16211079|NCT03799627|39251522|FG008|Overall Study|Met Exclusion Criteria|0|||
16211080|NCT03799627|39251514|FG000|Overall Study|Investigational Product Noncompliance|0|||
16211081|NCT03799627|39251515|FG001|Overall Study|Investigational Product Noncompliance|0|||
16211082|NCT03799627|39251516|FG002|Overall Study|Investigational Product Noncompliance|0|||
16211083|NCT03799627|39251517|FG003|Overall Study|Investigational Product Noncompliance|1|||
16399113|NCT01645735|39941515|FG000|Overall Study|Adverse Event|0|||
16399114|NCT01645735|39941516|FG001|Overall Study|Adverse Event|1|||
16399115|NCT00322452|39941517|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16526156|NCT01831089|40391204|FG003|Cohort III: Dose Level 3|Global end of study|0|||
16211084|NCT03799627|39251518|FG004|Overall Study|Investigational Product Noncompliance|0|||
16399116|NCT00322452|39941518|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16526157|NCT01831089|40391205|FG004|Cohort III: Dose Level 3|Global end of study|0|||
16399117|NCT00322452|39941517|FG000|Overall Study|Lost to Follow-up|5|||
16399118|NCT00322452|39941518|FG001|Overall Study|Lost to Follow-up|2|||
16399119|NCT00322452|39941517|FG000|Overall Study|Withdrawal by Subject|19|||
16399120|NCT00322452|39941518|FG001|Overall Study|Withdrawal by Subject|46|||
16399121|NCT00322452|39941517|FG000|Overall Study|Death|223|||
16399122|NCT00322452|39941518|FG001|Overall Study|Death|227|||
16399123|NCT04209634|39941522|FG000|Overall Study|Ongoing|10|||
16330127|NCT02122770|39692674|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
16330128|NCT02122770|39692675|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
16330129|NCT02122770|39692676|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
16330130|NCT02122770|39692677|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
16330131|NCT02122770|39692672|FG000|Part B: Standard of Care|Progressive Disease|0|||
16330132|NCT02122770|39692673|FG001|Part B: Standard of Care|Progressive Disease|0|||
16399124|NCT04308239|39941524|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
16399125|NCT04308239|39941525|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
16399126|NCT04308239|39941524|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
16399127|NCT04308239|39941525|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
16399128|NCT04308239|39941524|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
16399129|NCT04308239|39941525|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
16399130|NCT04308239|39941524|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
16399131|NCT04308239|39941525|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
16399132|NCT00956007|39941530|FG000|Overall Study|Protocol Violation|27|||
16399133|NCT00956007|39941531|FG001|Overall Study|Protocol Violation|23|||
16399134|NCT00443872|39941532|FG000|Overall Study|Protocol Violation|7|||
16399135|NCT00443872|39941532|FG000|Overall Study|Lost to Follow-up|2|||
16399136|NCT00443872|39941532|FG000|Overall Study|Adverse Event|8|||
16399137|NCT02241733|39941533|FG000|Overall Study|Lost to Follow-up|9|||
16399138|NCT02241733|39941534|FG001|Overall Study|Lost to Follow-up|4|||
16399139|NCT02241733|39941533|FG000|Overall Study|Physician Decision|6|||
16399140|NCT02241733|39941534|FG001|Overall Study|Physician Decision|2|||
16399141|NCT02241733|39941533|FG000|Overall Study|Withdrawal by Subject|0|||
16399142|NCT02241733|39941534|FG001|Overall Study|Withdrawal by Subject|2|||
16399143|NCT02241733|39941533|FG000|Overall Study|Death|0|||
16399144|NCT02241733|39941534|FG001|Overall Study|Death|2|||
16399145|NCT01610557|39941535|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
16399146|NCT01610557|39941536|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
16399147|NCT01610557|39941537|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
16399148|NCT01610557|39941538|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
16399149|NCT01610557|39941539|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
16399150|NCT01610557|39941535|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
16399151|NCT01610557|39941536|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
16399152|NCT01610557|39941537|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
16330133|NCT02122770|39692674|FG002|Part B: Standard of Care|Progressive Disease|0|||
16330134|NCT02122770|39692675|FG003|Part B: Standard of Care|Progressive Disease|0|||
16330135|NCT02122770|39692676|FG004|Part B: Standard of Care|Progressive Disease|10|||
16330136|NCT02122770|39692677|FG005|Part B: Standard of Care|Progressive Disease|8|||
16399153|NCT01610557|39941538|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
16399154|NCT01610557|39941539|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
16097556|NCT04676763|38846879|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
16399155|NCT00962741|39941540|FG000|Overall Study|Failed to return|3|||
16399156|NCT00962741|39941540|FG000|Overall Study|Lost to Follow-up|2|||
16399157|NCT00962741|39941540|FG000|Overall Study|Withdrawal by Subject|1|||
16399158|NCT00962741|39941540|FG000|Overall Study|Lack of Efficacy|1|||
16399159|NCT00962741|39941540|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
16399160|NCT02791516|39941541|FG000|Overall Study|Withdrawal by Subject|1|||
16399161|NCT02791516|39941542|FG001|Overall Study|Withdrawal by Subject|1|||
16399162|NCT01066104|39941543|FG000|Overall Study|Adverse Event|1|||
16399163|NCT01066104|39941544|FG001|Overall Study|Adverse Event|1|||
16399164|NCT01066104|39941543|FG000|Overall Study|Protocol Violation|1|||
16399165|NCT01066104|39941544|FG001|Overall Study|Protocol Violation|0|||
16399166|NCT01521923|39941545|FG000|Overall Study|AE, serious fatal|1|||
16399167|NCT01521923|39941546|FG001|Overall Study|AE, serious fatal|0|||
16399168|NCT01521923|39941547|FG002|Overall Study|AE, serious fatal|0|||
16399169|NCT01521923|39941548|FG003|Overall Study|AE, serious fatal|0|||
16399170|NCT01521923|39941545|FG000|Overall Study|SAE, non-fatal|0|||
16399171|NCT01521923|39941546|FG001|Overall Study|SAE, non-fatal|2|||
16399172|NCT01521923|39941547|FG002|Overall Study|SAE, non-fatal|2|||
16399173|NCT01521923|39941548|FG003|Overall Study|SAE, non-fatal|0|||
16399174|NCT01521923|39941545|FG000|Overall Study|AE, non-serious, non-fatal|1|||
16399175|NCT01521923|39941546|FG001|Overall Study|AE, non-serious, non-fatal|3|||
16399176|NCT01521923|39941547|FG002|Overall Study|AE, non-serious, non-fatal|6|||
16399177|NCT01521923|39941548|FG003|Overall Study|AE, non-serious, non-fatal|2|||
16399178|NCT01521923|39941545|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
16399179|NCT01521923|39941546|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
16399180|NCT01521923|39941547|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
16399181|NCT01521923|39941548|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
16399182|NCT01521923|39941545|FG000|Overall Study|Lack of Efficacy|1|||
16399183|NCT01521923|39941546|FG001|Overall Study|Lack of Efficacy|1|||
16399184|NCT01521923|39941547|FG002|Overall Study|Lack of Efficacy|0|||
16399185|NCT01521923|39941548|FG003|Overall Study|Lack of Efficacy|0|||
16399186|NCT01521923|39941545|FG000|Overall Study|Protocol Violation|0|||
16399187|NCT01521923|39941546|FG001|Overall Study|Protocol Violation|0|||
16399188|NCT01521923|39941547|FG002|Overall Study|Protocol Violation|1|||
16399189|NCT01521923|39941548|FG003|Overall Study|Protocol Violation|0|||
16399190|NCT01521923|39941545|FG000|Overall Study|Lost to Follow-up|1|||
16399191|NCT01521923|39941546|FG001|Overall Study|Lost to Follow-up|0|||
16399192|NCT01521923|39941547|FG002|Overall Study|Lost to Follow-up|2|||
16399193|NCT01521923|39941548|FG003|Overall Study|Lost to Follow-up|1|||
16399194|NCT01521923|39941545|FG000|Overall Study|Withdrawal by Subject|1|||
16399195|NCT01521923|39941546|FG001|Overall Study|Withdrawal by Subject|1|||
16399196|NCT01521923|39941547|FG002|Overall Study|Withdrawal by Subject|1|||
16399197|NCT01521923|39941548|FG003|Overall Study|Withdrawal by Subject|2|||
16399198|NCT01521923|39941545|FG000|Overall Study|Other|2|||
16399199|NCT01521923|39941546|FG001|Overall Study|Other|1|||
16399200|NCT01521923|39941547|FG002|Overall Study|Other|3|||
16399201|NCT01521923|39941548|FG003|Overall Study|Other|6|||
16399202|NCT01521923|39941545|FG000|Overall Study|AE, captured in Period 1|0|||
16399203|NCT01521923|39941546|FG001|Overall Study|AE, captured in Period 1|1|||
16399204|NCT01521923|39941547|FG002|Overall Study|AE, captured in Period 1|0|||
16399205|NCT01521923|39941548|FG003|Overall Study|AE, captured in Period 1|1|||
16399206|NCT01468233|39941549|FG000|Treatment Period 1|Adverse Event|5|||
16399207|NCT01468233|39941550|FG001|Treatment Period 1|Adverse Event|3|||
16399208|NCT01468233|39941551|FG002|Treatment Period 1|Adverse Event|0|||
16399209|NCT01468233|39941552|FG003|Treatment Period 1|Adverse Event|0|||
16399210|NCT01468233|39941553|FG004|Treatment Period 1|Adverse Event|0|||
16399211|NCT01468233|39941554|FG005|Treatment Period 1|Adverse Event|0|||
16399212|NCT01468233|39941549|FG000|Treatment Period 1|Withdrawal by Subject|3|||
16399213|NCT01468233|39941550|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16399214|NCT01468233|39941551|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16399215|NCT01468233|39941552|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16399216|NCT01468233|39941553|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16399217|NCT01468233|39941554|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16399218|NCT01468233|39941549|FG000|Treatment Period 1|Lost to Follow-up|3|||
16399219|NCT01468233|39941550|FG001|Treatment Period 1|Lost to Follow-up|0|||
16399220|NCT01468233|39941551|FG002|Treatment Period 1|Lost to Follow-up|0|||
16399221|NCT01468233|39941552|FG003|Treatment Period 1|Lost to Follow-up|0|||
16399222|NCT01468233|39941553|FG004|Treatment Period 1|Lost to Follow-up|0|||
16399223|NCT01468233|39941554|FG005|Treatment Period 1|Lost to Follow-up|0|||
16399224|NCT01468233|39941549|FG000|Treatment Period 1|Other|1|||
16399225|NCT01468233|39941550|FG001|Treatment Period 1|Other|1|||
16399226|NCT01468233|39941551|FG002|Treatment Period 1|Other|0|||
16399227|NCT01468233|39941552|FG003|Treatment Period 1|Other|0|||
16399228|NCT01468233|39941553|FG004|Treatment Period 1|Other|0|||
16399229|NCT01468233|39941554|FG005|Treatment Period 1|Other|0|||
16330137|NCT03696108|39692678|FG000|Overall Study|Physician Decision|1|||
16330138|NCT03696108|39692679|FG001|Overall Study|Physician Decision|0|||
16330139|NCT03696108|39692678|FG000|Overall Study|Withdrawal by Subject|3|||
16330140|NCT03696108|39692679|FG001|Overall Study|Withdrawal by Subject|6|||
16330141|NCT00595517|39692682|FG000|Overall Study|Adverse Event|6|||
16399230|NCT01468233|39941549|FG000|Treatment Period 2|Adverse Event|0|||
16526158|NCT01831089|40391206|FG005|Cohort III: Dose Level 3|Global end of study|0|||
16526159|NCT01831089|40391201|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
16526160|NCT01831089|40391202|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
16526161|NCT01831089|40391203|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
16526162|NCT01831089|40391204|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
16526163|NCT01831089|40391205|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
16526164|NCT01831089|40391206|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
16526165|NCT01831089|40391201|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
16097557|NCT04676763|38846880|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
16526166|NCT01831089|40391202|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
16526167|NCT01831089|40391203|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
16097558|NCT04676763|38846878|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
16526168|NCT01831089|40391204|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
16526169|NCT01831089|40391205|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
16097559|NCT04676763|38846879|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
16097560|NCT04676763|38846880|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
16097561|NCT04676763|38846878|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
16330142|NCT00595517|39692682|FG000|Overall Study|Withdrawal by Subject|4|||
16330143|NCT00595517|39692682|FG000|Overall Study|Protocol Violation|2|||
16330144|NCT00595517|39692682|FG000|Overall Study|Recurrence of ulcer|5|||
16330145|NCT00595517|39692682|FG000|Overall Study|usage of prohibited treatment|1|||
16097562|NCT04676763|38846879|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
16097563|NCT04676763|38846880|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
16330146|NCT00595517|39692682|FG000|Overall Study|No intention to attend regularly|1|||
16330147|NCT03045276|39692683|FG000|Intervention Phase|Withdrawal by Subject|7|||
16330148|NCT03045276|39692684|FG001|Intervention Phase|Withdrawal by Subject|2|||
16330149|NCT03045276|39692685|FG002|Intervention Phase|Withdrawal by Subject|3|||
16330150|NCT03045276|39692686|FG003|Intervention Phase|Withdrawal by Subject|7|||
16330151|NCT03045276|39692683|FG000|Intervention Phase|Developed exclusionary criteria|3|||
16399231|NCT01468233|39941550|FG001|Treatment Period 2|Adverse Event|0|||
16399232|NCT01468233|39941551|FG002|Treatment Period 2|Adverse Event|3|||
16399233|NCT01468233|39941552|FG003|Treatment Period 2|Adverse Event|0|||
16399234|NCT01468233|39941553|FG004|Treatment Period 2|Adverse Event|2|||
16399235|NCT01468233|39941554|FG005|Treatment Period 2|Adverse Event|1|||
16399236|NCT01468233|39941549|FG000|Treatment Period 2|Lack of Efficacy|0|||
16399237|NCT01468233|39941550|FG001|Treatment Period 2|Lack of Efficacy|0|||
16526170|NCT01831089|40391206|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
16526171|NCT01831089|40391201|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
16526172|NCT01831089|40391202|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
16526173|NCT01831089|40391203|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
16526174|NCT01831089|40391204|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
16526175|NCT01831089|40391205|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
16526176|NCT01831089|40391206|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
16526177|NCT01831089|40391201|FG000|Cohort V: Dose Level 5|Death|0|||
16526178|NCT01831089|40391202|FG001|Cohort V: Dose Level 5|Death|0|||
16526179|NCT01831089|40391203|FG002|Cohort V: Dose Level 5|Death|0|||
16097564|NCT03997409|38846883|FG000|Overall Study|Protocol Violation|1|||
16097565|NCT03997409|38846884|FG001|Overall Study|Protocol Violation|1|||
16097566|NCT03997409|38846885|FG002|Overall Study|Protocol Violation|0|||
16097567|NCT03997409|38846883|FG000|Overall Study|Withdrawal by Subject|3|||
16097568|NCT03997409|38846884|FG001|Overall Study|Withdrawal by Subject|0|||
16097569|NCT03997409|38846885|FG002|Overall Study|Withdrawal by Subject|0|||
16097570|NCT03997409|38846883|FG000|Overall Study|Lost to Follow-up|0|||
16097571|NCT03997409|38846884|FG001|Overall Study|Lost to Follow-up|0|||
16097572|NCT03997409|38846885|FG002|Overall Study|Lost to Follow-up|1|||
16097573|NCT04203199|38846886|FG000|First Intervention Period|Lost to Follow-up|0|||
16097574|NCT04203199|38846887|FG001|First Intervention Period|Lost to Follow-up|1|||
16097575|NCT04203199|38846886|FG000|Second Intervention Period|Medication change|1|||
16097576|NCT04203199|38846887|FG001|Second Intervention Period|Medication change|0|||
16399238|NCT01468233|39941551|FG002|Treatment Period 2|Lack of Efficacy|9|||
16399239|NCT01468233|39941552|FG003|Treatment Period 2|Lack of Efficacy|2|||
16399240|NCT01468233|39941553|FG004|Treatment Period 2|Lack of Efficacy|0|||
16399241|NCT01468233|39941554|FG005|Treatment Period 2|Lack of Efficacy|1|||
16399242|NCT01468233|39941549|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16399243|NCT01468233|39941550|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16097583|NCT02339506|38846892|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
16097584|NCT02339506|38846893|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
16097585|NCT02339506|38846892|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
16097586|NCT02339506|38846893|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
16097587|NCT01586910|38846894|FG000|Overall Study|Death|4|||
16097588|NCT01586910|38846895|FG001|Overall Study|Death|4|||
16097589|NCT01586910|38846894|FG000|Overall Study|Withdrawal by Subject|6|||
16097590|NCT01586910|38846895|FG001|Overall Study|Withdrawal by Subject|43|||
16097591|NCT01586910|38846894|FG000|Overall Study|Physician withdrew Subject|5|||
16097592|NCT01586910|38846895|FG001|Overall Study|Physician withdrew Subject|24|||
16097593|NCT01332318|38846897|FG000|Overall Study|Adverse Event|0|||
16097594|NCT01332318|38846898|FG001|Overall Study|Adverse Event|3|||
16211085|NCT03799627|39251519|FG005|Overall Study|Investigational Product Noncompliance|0|||
16330152|NCT03045276|39692684|FG001|Intervention Phase|Developed exclusionary criteria|3|||
16097595|NCT01332318|38846899|FG002|Overall Study|Adverse Event|0|||
16097596|NCT01332318|38846900|FG003|Overall Study|Adverse Event|0|||
16097597|NCT01332318|38846897|FG000|Overall Study|Withdrawal by Subject|1|||
16330153|NCT03045276|39692685|FG002|Intervention Phase|Developed exclusionary criteria|0|||
16330154|NCT03045276|39692686|FG003|Intervention Phase|Developed exclusionary criteria|0|||
16330155|NCT03045276|39692683|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
16330156|NCT03045276|39692684|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
16330157|NCT03045276|39692685|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
16330158|NCT03045276|39692686|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
16330159|NCT03045276|39692683|FG000|Follow-Up Phase|Lost to Follow-up|0|||
16330160|NCT03045276|39692684|FG001|Follow-Up Phase|Lost to Follow-up|1|||
16330161|NCT03045276|39692685|FG002|Follow-Up Phase|Lost to Follow-up|0|||
16330162|NCT03045276|39692686|FG003|Follow-Up Phase|Lost to Follow-up|1|||
16330163|NCT03045276|39692683|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
16330164|NCT03045276|39692684|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
16330165|NCT03045276|39692685|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
16330166|NCT03045276|39692686|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
16330167|NCT02054910|39692689|FG000|Overall Study|Lost to Follow-up|4|||
16097598|NCT01332318|38846898|FG001|Overall Study|Withdrawal by Subject|1|||
16330168|NCT02054910|39692690|FG001|Overall Study|Lost to Follow-up|1|||
16330169|NCT00270231|39692692|FG000|First Intervention|Lost to Follow-up|1|||
16330170|NCT00270231|39692693|FG001|First Intervention|Lost to Follow-up|1|||
16330171|NCT00270231|39692692|FG000|Washout Period|Lost to Follow-up|1|||
16330172|NCT00270231|39692693|FG001|Washout Period|Lost to Follow-up|0|||
16330173|NCT00270231|39692692|FG000|Second Intervention|Lost to Follow-up|0|||
16330174|NCT00270231|39692693|FG001|Second Intervention|Lost to Follow-up|1|||
16330175|NCT01546168|39692694|FG000|Overall Study|Lost to Follow-up|1|||
16097599|NCT01332318|38846899|FG002|Overall Study|Withdrawal by Subject|0|||
16097600|NCT01332318|38846900|FG003|Overall Study|Withdrawal by Subject|1|||
16097601|NCT01332318|38846897|FG000|Overall Study|Protocol Violation|1|||
16097602|NCT01332318|38846898|FG001|Overall Study|Protocol Violation|0|||
16097603|NCT01332318|38846899|FG002|Overall Study|Protocol Violation|1|||
16097604|NCT01332318|38846900|FG003|Overall Study|Protocol Violation|1|||
16097605|NCT02164578|38846901|FG000|Treatment Period|Withdrawal by Subject|3|||
16097606|NCT02164578|38846902|FG001|Treatment Period|Withdrawal by Subject|3|||
16097607|NCT02164578|38846901|FG000|Treatment Period|Adverse Event|13|||
16097608|NCT02164578|38846902|FG001|Treatment Period|Adverse Event|6|||
16097609|NCT02164578|38846901|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
16097610|NCT02164578|38846902|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
16097611|NCT02164578|38846901|FG000|Treatment Period|Protocol Violation|0|||
16097612|NCT02164578|38846902|FG001|Treatment Period|Protocol Violation|2|||
16330176|NCT01546168|39692695|FG001|Overall Study|Lost to Follow-up|0|||
16330177|NCT01546168|39692694|FG000|Overall Study|Withdrawal by Subject|1|||
16330178|NCT01546168|39692695|FG001|Overall Study|Withdrawal by Subject|0|||
16330179|NCT01546168|39692694|FG000|Overall Study|ineligible after signing consent|2|||
16330180|NCT01546168|39692695|FG001|Overall Study|ineligible after signing consent|0|||
16097613|NCT02164578|38846901|FG000|Extension Period|Withdrawal by Subject|2|||
16097614|NCT02164578|38846902|FG001|Extension Period|Withdrawal by Subject|0|||
16097615|NCT02164578|38846901|FG000|Extension Period|Adverse Event|4|||
16097616|NCT02164578|38846902|FG001|Extension Period|Adverse Event|0|||
16097617|NCT02164578|38846901|FG000|Extension Period|Expiry of study medication|1|||
16097618|NCT02164578|38846902|FG001|Extension Period|Expiry of study medication|0|||
16097619|NCT02164578|38846901|FG000|Extension Period|Protocol Violation|0|||
16097620|NCT02164578|38846902|FG001|Extension Period|Protocol Violation|1|||
16097621|NCT01498445|38846903|FG000|Overall Study|Lack of Efficacy|0|||
16097622|NCT01498445|38846904|FG001|Overall Study|Lack of Efficacy|0|||
16097623|NCT01498445|38846905|FG002|Overall Study|Lack of Efficacy|1|||
16097624|NCT01498445|38846906|FG003|Overall Study|Lack of Efficacy|2|||
16097625|NCT01498445|38846907|FG004|Overall Study|Lack of Efficacy|0|||
16097626|NCT01498445|38846908|FG005|Overall Study|Lack of Efficacy|0|||
16097627|NCT01498445|38846903|FG000|Overall Study|Screen Failure|0|||
16097628|NCT01498445|38846904|FG001|Overall Study|Screen Failure|0|||
16097629|NCT01498445|38846905|FG002|Overall Study|Screen Failure|0|||
16097630|NCT01498445|38846906|FG003|Overall Study|Screen Failure|0|||
16097631|NCT01498445|38846907|FG004|Overall Study|Screen Failure|1|||
16097632|NCT01498445|38846908|FG005|Overall Study|Screen Failure|1|||
16097633|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16097634|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16097635|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16097636|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
16097637|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
16097638|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16097639|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16097640|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16097641|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16097642|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
16097643|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16097644|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16097645|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
16097646|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
16097647|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
16097648|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
16097649|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
16097650|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
16097651|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
16097652|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
16097653|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
16097654|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16097655|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16097656|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
16097657|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
16097658|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16097659|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
16097660|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16097661|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
16097662|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16097663|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16211086|NCT03799627|39251520|FG006|Overall Study|Investigational Product Noncompliance|0|||
16399244|NCT01468233|39941551|FG002|Treatment Period 2|Withdrawal by Subject|9|||
16211087|NCT03799627|39251521|FG007|Overall Study|Investigational Product Noncompliance|0|||
16097664|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
16097665|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
16097666|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
16097667|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
16097668|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
16097669|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
16097670|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
16097671|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
16097672|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
16097673|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
16399245|NCT01468233|39941552|FG003|Treatment Period 2|Withdrawal by Subject|1|||
16399246|NCT01468233|39941553|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16399247|NCT01468233|39941554|FG005|Treatment Period 2|Withdrawal by Subject|1|||
16399248|NCT01468233|39941549|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
16399249|NCT01468233|39941550|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
16399250|NCT01468233|39941551|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
16399251|NCT01468233|39941552|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
16399252|NCT01468233|39941553|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
16097674|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
16097675|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
16097676|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
16097677|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
16097678|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
16097679|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
16097680|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
16097681|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
16097682|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
16097683|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
16097684|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
16097685|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
16097686|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
16097687|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
16097688|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
16097689|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
16097690|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097691|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097692|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097693|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097694|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097695|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16330181|NCT00972816|39692696|FG000|Overall Study|Adverse Event|0|||
16330182|NCT00972816|39692697|FG001|Overall Study|Adverse Event|0|||
16330183|NCT00972816|39692698|FG002|Overall Study|Adverse Event|1|||
16330184|NCT00972816|39692699|FG003|Overall Study|Adverse Event|0|||
16097696|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097697|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097698|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097699|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16330185|NCT00972816|39692700|FG004|Overall Study|Adverse Event|0|||
16330186|NCT00972816|39692701|FG005|Overall Study|Adverse Event|0|||
16330187|NCT00972816|39692702|FG006|Overall Study|Adverse Event|0|||
16330188|NCT00972816|39692703|FG007|Overall Study|Adverse Event|0|||
16330189|NCT00972816|39692696|FG000|Overall Study|Withdrawal by Subject|4|||
16330190|NCT00972816|39692697|FG001|Overall Study|Withdrawal by Subject|2|||
16330191|NCT00972816|39692698|FG002|Overall Study|Withdrawal by Subject|1|||
16330192|NCT00972816|39692699|FG003|Overall Study|Withdrawal by Subject|3|||
16330193|NCT00972816|39692700|FG004|Overall Study|Withdrawal by Subject|0|||
16330194|NCT00972816|39692701|FG005|Overall Study|Withdrawal by Subject|1|||
16330195|NCT00972816|39692702|FG006|Overall Study|Withdrawal by Subject|1|||
16330196|NCT00972816|39692703|FG007|Overall Study|Withdrawal by Subject|2|||
16330197|NCT00972816|39692696|FG000|Overall Study|Lost to Follow-up|11|||
16330198|NCT00972816|39692697|FG001|Overall Study|Lost to Follow-up|9|||
16330199|NCT00972816|39692698|FG002|Overall Study|Lost to Follow-up|7|||
16330200|NCT00972816|39692699|FG003|Overall Study|Lost to Follow-up|5|||
16330201|NCT00972816|39692700|FG004|Overall Study|Lost to Follow-up|11|||
16330202|NCT00972816|39692701|FG005|Overall Study|Lost to Follow-up|10|||
16330203|NCT00972816|39692702|FG006|Overall Study|Lost to Follow-up|7|||
16330204|NCT00972816|39692703|FG007|Overall Study|Lost to Follow-up|7|||
16399253|NCT01468233|39941554|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
16399254|NCT01468233|39941549|FG000|Treatment Period 2|Lost to Follow-up|0|||
16097700|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
16097701|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16526180|NCT01831089|40391204|FG003|Cohort V: Dose Level 5|Death|0|||
16330205|NCT00972816|39692696|FG000|Overall Study|Inappropriate enrolment|0|||
16330206|NCT00972816|39692697|FG001|Overall Study|Inappropriate enrolment|0|||
16330207|NCT00972816|39692698|FG002|Overall Study|Inappropriate enrolment|0|||
16330208|NCT00972816|39692699|FG003|Overall Study|Inappropriate enrolment|0|||
16330209|NCT00972816|39692700|FG004|Overall Study|Inappropriate enrolment|0|||
16330210|NCT00972816|39692701|FG005|Overall Study|Inappropriate enrolment|0|||
16526181|NCT01831089|40391205|FG004|Cohort V: Dose Level 5|Death|1|||
16526182|NCT01831089|40391206|FG005|Cohort V: Dose Level 5|Death|0|||
16526183|NCT01831089|40391201|FG000|Cohort V: Dose Level 5|Global end of study|0|||
16526184|NCT01831089|40391202|FG001|Cohort V: Dose Level 5|Global end of study|0|||
16526185|NCT01831089|40391203|FG002|Cohort V: Dose Level 5|Global end of study|0|||
16526186|NCT01831089|40391204|FG003|Cohort V: Dose Level 5|Global end of study|0|||
16526187|NCT01831089|40391205|FG004|Cohort V: Dose Level 5|Global end of study|2|||
16526188|NCT01831089|40391206|FG005|Cohort V: Dose Level 5|Global end of study|0|||
16526189|NCT01831089|40391201|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
16526190|NCT01831089|40391202|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
16526191|NCT01831089|40391203|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
16526192|NCT01831089|40391204|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
16526193|NCT01831089|40391205|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
16526194|NCT01831089|40391206|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
16526195|NCT01831089|40391201|FG000|Cohort B: Arm B|Progressive disease|0|||
16526196|NCT01831089|40391202|FG001|Cohort B: Arm B|Progressive disease|0|||
16526197|NCT01831089|40391203|FG002|Cohort B: Arm B|Progressive disease|0|||
16526198|NCT01831089|40391204|FG003|Cohort B: Arm B|Progressive disease|0|||
16526199|NCT01831089|40391205|FG004|Cohort B: Arm B|Progressive disease|0|||
16526200|NCT01831089|40391206|FG005|Cohort B: Arm B|Progressive disease|8|||
16526201|NCT01831089|40391201|FG000|Cohort B: Arm B|Physician Decision|0|||
16526202|NCT01831089|40391202|FG001|Cohort B: Arm B|Physician Decision|0|||
16526203|NCT01831089|40391203|FG002|Cohort B: Arm B|Physician Decision|0|||
16526204|NCT01831089|40391204|FG003|Cohort B: Arm B|Physician Decision|0|||
16526205|NCT01831089|40391205|FG004|Cohort B: Arm B|Physician Decision|0|||
16526206|NCT01831089|40391206|FG005|Cohort B: Arm B|Physician Decision|2|||
16526207|NCT01831089|40391201|FG000|Cohort B: Arm B|Never treated|0|||
16526208|NCT01831089|40391202|FG001|Cohort B: Arm B|Never treated|0|||
16526209|NCT01831089|40391203|FG002|Cohort B: Arm B|Never treated|0|||
16526210|NCT01831089|40391204|FG003|Cohort B: Arm B|Never treated|0|||
16526211|NCT01831089|40391205|FG004|Cohort B: Arm B|Never treated|0|||
16526212|NCT01831089|40391206|FG005|Cohort B: Arm B|Never treated|2|||
16526213|NCT01831089|40391201|FG000|Cohort B: Arm B|Adverse Event|0|||
16526214|NCT01831089|40391202|FG001|Cohort B: Arm B|Adverse Event|0|||
16526215|NCT01831089|40391203|FG002|Cohort B: Arm B|Adverse Event|0|||
16526216|NCT01831089|40391204|FG003|Cohort B: Arm B|Adverse Event|0|||
16526217|NCT01831089|40391205|FG004|Cohort B: Arm B|Adverse Event|0|||
16526218|NCT01831089|40391206|FG005|Cohort B: Arm B|Adverse Event|1|||
16526219|NCT01831089|40391201|FG000|Cohort B: Arm B|Global end of study|0|||
16526220|NCT01831089|40391202|FG001|Cohort B: Arm B|Global end of study|0|||
16526221|NCT01831089|40391203|FG002|Cohort B: Arm B|Global end of study|0|||
16526222|NCT01831089|40391204|FG003|Cohort B: Arm B|Global end of study|0|||
16526223|NCT01831089|40391205|FG004|Cohort B: Arm B|Global end of study|0|||
16330211|NCT00972816|39692702|FG006|Overall Study|Inappropriate enrolment|2|||
16330212|NCT00972816|39692703|FG007|Overall Study|Inappropriate enrolment|0|||
16330213|NCT00972816|39692696|FG000|Overall Study|Unable to classify|2|||
16330214|NCT00972816|39692697|FG001|Overall Study|Unable to classify|0|||
16526224|NCT01831089|40391206|FG005|Cohort B: Arm B|Global end of study|1|||
16526225|NCT02799082|40391209|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
16526226|NCT02799082|40391210|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
16526227|NCT02799082|40391209|FG000|Overall Study|Protocol Violation|0|||
16526228|NCT02799082|40391210|FG001|Overall Study|Protocol Violation|1|||
16330215|NCT00972816|39692698|FG002|Overall Study|Unable to classify|0|||
16526229|NCT00889421|40391213|FG000|Overall Study|Lack of Efficacy|3|||
16526230|NCT00363766|40391215|FG000|Overall Study|Progressive Disease|15|||
16526231|NCT00363766|40391216|FG001|Overall Study|Progressive Disease|9|||
16526232|NCT00363766|40391215|FG000|Overall Study|Adverse Event|10|||
16526233|NCT00363766|40391216|FG001|Overall Study|Adverse Event|2|||
16526234|NCT00363766|40391215|FG000|Overall Study|Disease Related Death|1|||
16526235|NCT00363766|40391216|FG001|Overall Study|Disease Related Death|3|||
16526236|NCT00363766|40391215|FG000|Overall Study|Not Disease Related Death|3|||
16526237|NCT00363766|40391216|FG001|Overall Study|Not Disease Related Death|4|||
16526238|NCT00363766|40391215|FG000|Overall Study|Withdrawal by Subject|2|||
16526239|NCT00363766|40391216|FG001|Overall Study|Withdrawal by Subject|0|||
16526240|NCT00363766|40391215|FG000|Overall Study|Physician Decision|1|||
16526241|NCT00363766|40391216|FG001|Overall Study|Physician Decision|2|||
16526242|NCT02766608|40391219|FG000|Overall Study|Adverse Event|27|||
16526243|NCT02766608|40391220|FG001|Overall Study|Adverse Event|22|||
16526244|NCT02766608|40391221|FG002|Overall Study|Adverse Event|17|||
16526245|NCT02766608|40391222|FG003|Overall Study|Adverse Event|13|||
16526246|NCT02766608|40391223|FG004|Overall Study|Adverse Event|12|||
16526247|NCT02766608|40391219|FG000|Overall Study|Withdrawal by Subject|21|||
16526248|NCT02766608|40391220|FG001|Overall Study|Withdrawal by Subject|20|||
16526249|NCT02766608|40391221|FG002|Overall Study|Withdrawal by Subject|24|||
16526250|NCT02766608|40391222|FG003|Overall Study|Withdrawal by Subject|13|||
16526251|NCT02766608|40391223|FG004|Overall Study|Withdrawal by Subject|10|||
16526252|NCT02766608|40391219|FG000|Overall Study|Lack of Efficacy|16|||
16526253|NCT02766608|40391220|FG001|Overall Study|Lack of Efficacy|15|||
16526254|NCT02766608|40391221|FG002|Overall Study|Lack of Efficacy|32|||
16526255|NCT02766608|40391222|FG003|Overall Study|Lack of Efficacy|8|||
16526256|NCT02766608|40391223|FG004|Overall Study|Lack of Efficacy|2|||
16526257|NCT02766608|40391219|FG000|Overall Study|Lost to Follow-up|6|||
16526258|NCT02766608|40391220|FG001|Overall Study|Lost to Follow-up|3|||
16526259|NCT02766608|40391221|FG002|Overall Study|Lost to Follow-up|5|||
16526260|NCT02766608|40391222|FG003|Overall Study|Lost to Follow-up|2|||
16526261|NCT02766608|40391223|FG004|Overall Study|Lost to Follow-up|2|||
16526262|NCT02766608|40391219|FG000|Overall Study|Physician Decision|3|||
16526263|NCT02766608|40391220|FG001|Overall Study|Physician Decision|2|||
16526264|NCT02766608|40391221|FG002|Overall Study|Physician Decision|3|||
16526265|NCT02766608|40391222|FG003|Overall Study|Physician Decision|1|||
16526266|NCT02766608|40391223|FG004|Overall Study|Physician Decision|2|||
16526267|NCT02766608|40391219|FG000|Overall Study|Protocol disc criteria|3|||
16526268|NCT02766608|40391220|FG001|Overall Study|Protocol disc criteria|3|||
16526269|NCT02766608|40391221|FG002|Overall Study|Protocol disc criteria|4|||
16526270|NCT02766608|40391222|FG003|Overall Study|Protocol disc criteria|0|||
16526271|NCT02766608|40391223|FG004|Overall Study|Protocol disc criteria|0|||
16526272|NCT02766608|40391219|FG000|Overall Study|Protocol Violation|0|||
16526273|NCT02766608|40391220|FG001|Overall Study|Protocol Violation|4|||
16526274|NCT02766608|40391221|FG002|Overall Study|Protocol Violation|4|||
16526275|NCT02766608|40391222|FG003|Overall Study|Protocol Violation|0|||
16526276|NCT02766608|40391223|FG004|Overall Study|Protocol Violation|1|||
16526277|NCT02766608|40391219|FG000|Overall Study|Administrative Reasons|3|||
16526278|NCT02766608|40391220|FG001|Overall Study|Administrative Reasons|1|||
16526279|NCT02766608|40391221|FG002|Overall Study|Administrative Reasons|1|||
16526280|NCT02766608|40391222|FG003|Overall Study|Administrative Reasons|0|||
16211088|NCT03799627|39251522|FG008|Overall Study|Investigational Product Noncompliance|0|||
16211089|NCT03799627|39251514|FG000|Overall Study|Participant Relocation|0|||
16526281|NCT02766608|40391223|FG004|Overall Study|Administrative Reasons|0|||
16526282|NCT03086447|40391226|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16526283|NCT03086447|40391227|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
16526284|NCT03086447|40391226|FG000|Overall Study|Lost Lens|2|||
16526285|NCT03086447|40391227|FG001|Overall Study|Lost Lens|5|||
16526286|NCT03086447|40391226|FG000|Overall Study|Product quality complaint|0|||
16526287|NCT03086447|40391227|FG001|Overall Study|Product quality complaint|1|||
16526288|NCT03086447|40391226|FG000|Overall Study|Lens Damage|1|||
16097702|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097703|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097704|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097705|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097706|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16330216|NCT00972816|39692699|FG003|Overall Study|Unable to classify|0|||
16526289|NCT03086447|40391227|FG001|Overall Study|Lens Damage|6|||
16526290|NCT03086447|40391226|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
16526291|NCT03086447|40391227|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
16526292|NCT03086447|40391226|FG000|Overall Study|Test Article No Longer Available|1|||
16526293|NCT03086447|40391227|FG001|Overall Study|Test Article No Longer Available|0|||
16526294|NCT03086447|40391226|FG000|Overall Study|Protocol Violation|2|||
16526295|NCT03086447|40391227|FG001|Overall Study|Protocol Violation|4|||
16526296|NCT03086447|40391226|FG000|Overall Study|Lost to Follow-up|0|||
16526297|NCT03086447|40391227|FG001|Overall Study|Lost to Follow-up|1|||
16097707|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16211090|NCT03799627|39251515|FG001|Overall Study|Participant Relocation|0|||
16526298|NCT03086447|40391226|FG000|Overall Study|Adverse Event|3|||
16097708|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
16097709|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
16097710|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16526299|NCT03086447|40391227|FG001|Overall Study|Adverse Event|0|||
16526300|NCT03086447|40391226|FG000|Overall Study|Lens Discomfort|2|||
16526301|NCT03086447|40391227|FG001|Overall Study|Lens Discomfort|1|||
16526302|NCT01602315|40394471|FG000|Overall Study|Protocol Violation|0|||
16526303|NCT01602315|40394472|FG001|Overall Study|Protocol Violation|0|||
16526304|NCT01602315|40394473|FG002|Overall Study|Protocol Violation|0|||
16526305|NCT01602315|40394474|FG003|Overall Study|Protocol Violation|0|||
16526306|NCT01602315|40394475|FG004|Overall Study|Protocol Violation|0|||
16526307|NCT01602315|40394476|FG005|Overall Study|Protocol Violation|1|||
16526308|NCT01602315|40394477|FG006|Overall Study|Protocol Violation|0|||
16526309|NCT01602315|40394471|FG000|Overall Study|Physician Decision|2|||
16526310|NCT01602315|40394472|FG001|Overall Study|Physician Decision|0|||
16526311|NCT01602315|40394473|FG002|Overall Study|Physician Decision|0|||
16526312|NCT01602315|40394474|FG003|Overall Study|Physician Decision|0|||
16526313|NCT01602315|40394475|FG004|Overall Study|Physician Decision|2|||
16526314|NCT01602315|40394476|FG005|Overall Study|Physician Decision|1|||
16526315|NCT01602315|40394477|FG006|Overall Study|Physician Decision|1|||
16526316|NCT01602315|40394471|FG000|Overall Study|Disease progression|6|||
16526317|NCT01602315|40394472|FG001|Overall Study|Disease progression|3|||
16526318|NCT01602315|40394473|FG002|Overall Study|Disease progression|10|||
16526319|NCT01602315|40394474|FG003|Overall Study|Disease progression|1|||
16526320|NCT01602315|40394475|FG004|Overall Study|Disease progression|41|||
16526321|NCT01602315|40394476|FG005|Overall Study|Disease progression|12|||
16526322|NCT01602315|40394477|FG006|Overall Study|Disease progression|15|||
16097711|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16097712|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16097713|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16097714|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
16097715|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16097716|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16097717|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16097718|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16211091|NCT03799627|39251516|FG002|Overall Study|Participant Relocation|0|||
16526323|NCT01602315|40394471|FG000|Overall Study|Death|1|||
16526324|NCT01602315|40394472|FG001|Overall Study|Death|1|||
16526325|NCT01602315|40394473|FG002|Overall Study|Death|1|||
16526326|NCT01602315|40394474|FG003|Overall Study|Death|1|||
16526327|NCT01602315|40394475|FG004|Overall Study|Death|7|||
16526328|NCT01602315|40394476|FG005|Overall Study|Death|2|||
16211092|NCT03799627|39251517|FG003|Overall Study|Participant Relocation|1|||
16211093|NCT03799627|39251518|FG004|Overall Study|Participant Relocation|0|||
16211094|NCT03799627|39251519|FG005|Overall Study|Participant Relocation|1|||
16211095|NCT03799627|39251520|FG006|Overall Study|Participant Relocation|0|||
16211096|NCT03799627|39251521|FG007|Overall Study|Participant Relocation|0|||
16211097|NCT03799627|39251522|FG008|Overall Study|Participant Relocation|0|||
16211098|NCT03799627|39251514|FG000|Overall Study|Eurofin Issue|0|||
16211099|NCT03799627|39251515|FG001|Overall Study|Eurofin Issue|0|||
16211100|NCT03799627|39251516|FG002|Overall Study|Eurofin Issue|0|||
16211101|NCT03799627|39251517|FG003|Overall Study|Eurofin Issue|0|||
16211102|NCT03799627|39251518|FG004|Overall Study|Eurofin Issue|1|||
16211103|NCT03799627|39251519|FG005|Overall Study|Eurofin Issue|0|||
16211104|NCT03799627|39251520|FG006|Overall Study|Eurofin Issue|0|||
16211105|NCT03799627|39251521|FG007|Overall Study|Eurofin Issue|0|||
16211106|NCT03799627|39251522|FG008|Overall Study|Eurofin Issue|0|||
16211107|NCT03799627|39251514|FG000|Overall Study|Noncompliance with Site Instructions|0|||
16211108|NCT03799627|39251515|FG001|Overall Study|Noncompliance with Site Instructions|0|||
16211109|NCT03799627|39251516|FG002|Overall Study|Noncompliance with Site Instructions|0|||
16211110|NCT03799627|39251517|FG003|Overall Study|Noncompliance with Site Instructions|0|||
16211111|NCT03799627|39251518|FG004|Overall Study|Noncompliance with Site Instructions|1|||
16211112|NCT03799627|39251519|FG005|Overall Study|Noncompliance with Site Instructions|0|||
16211113|NCT03799627|39251520|FG006|Overall Study|Noncompliance with Site Instructions|0|||
16211114|NCT03799627|39251521|FG007|Overall Study|Noncompliance with Site Instructions|0|||
16526329|NCT01602315|40394477|FG006|Overall Study|Death|2|||
16526330|NCT01602315|40394471|FG000|Overall Study|Withdrawal by Subject|2|||
16211115|NCT03799627|39251522|FG008|Overall Study|Noncompliance with Site Instructions|0|||
16526331|NCT01602315|40394472|FG001|Overall Study|Withdrawal by Subject|0|||
16526332|NCT01602315|40394473|FG002|Overall Study|Withdrawal by Subject|2|||
16526333|NCT01602315|40394474|FG003|Overall Study|Withdrawal by Subject|0|||
16097719|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
16526334|NCT01602315|40394475|FG004|Overall Study|Withdrawal by Subject|6|||
16526335|NCT01602315|40394476|FG005|Overall Study|Withdrawal by Subject|0|||
16526336|NCT01602315|40394477|FG006|Overall Study|Withdrawal by Subject|1|||
16526337|NCT01602315|40394471|FG000|Overall Study|Adverse Event|5|||
16526338|NCT01602315|40394472|FG001|Overall Study|Adverse Event|1|||
16526339|NCT01602315|40394473|FG002|Overall Study|Adverse Event|5|||
16526340|NCT01602315|40394474|FG003|Overall Study|Adverse Event|4|||
16526341|NCT01602315|40394475|FG004|Overall Study|Adverse Event|15|||
16526342|NCT01602315|40394476|FG005|Overall Study|Adverse Event|3|||
16526343|NCT01602315|40394477|FG006|Overall Study|Adverse Event|9|||
16526344|NCT01602315|40394471|FG000|Overall Study|Subject/guardian decision|0|||
16526345|NCT01602315|40394472|FG001|Overall Study|Subject/guardian decision|0|||
16526346|NCT01602315|40394473|FG002|Overall Study|Subject/guardian decision|0|||
16526347|NCT01602315|40394474|FG003|Overall Study|Subject/guardian decision|0|||
16526348|NCT01602315|40394475|FG004|Overall Study|Subject/guardian decision|0|||
16211116|NCT03799627|39251514|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
16211117|NCT03799627|39251515|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
16211118|NCT03799627|39251516|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
16211119|NCT03799627|39251517|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
16211120|NCT03799627|39251518|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
16211121|NCT03799627|39251519|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
16211122|NCT03799627|39251520|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
16211123|NCT03799627|39251521|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
16211124|NCT03799627|39251522|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
16211125|NCT03799627|39251514|FG000|Overall Study|Changes In Hemoglobin Values|1|||
16526349|NCT01602315|40394476|FG005|Overall Study|Subject/guardian decision|0|||
16526350|NCT01602315|40394477|FG006|Overall Study|Subject/guardian decision|1|||
16211126|NCT03799627|39251515|FG001|Overall Study|Changes In Hemoglobin Values|2|||
16211127|NCT03799627|39251516|FG002|Overall Study|Changes In Hemoglobin Values|1|||
16211128|NCT03799627|39251517|FG003|Overall Study|Changes In Hemoglobin Values|0|||
16211129|NCT03799627|39251518|FG004|Overall Study|Changes In Hemoglobin Values|0|||
16211130|NCT03799627|39251519|FG005|Overall Study|Changes In Hemoglobin Values|2|||
16211131|NCT03799627|39251520|FG006|Overall Study|Changes In Hemoglobin Values|1|||
16211132|NCT03799627|39251521|FG007|Overall Study|Changes In Hemoglobin Values|0|||
16211133|NCT03799627|39251522|FG008|Overall Study|Changes In Hemoglobin Values|1|||
16211134|NCT05041062|39251523|FG000|Overall Study|Adverse Event|2|||
16211135|NCT03073213|39251525|FG000|Multiple Dose Period|Protocol Violation|0|||
16211136|NCT03073213|39251526|FG001|Multiple Dose Period|Protocol Violation|0|||
16211137|NCT03073213|39251527|FG002|Multiple Dose Period|Protocol Violation|1|||
16211138|NCT01039428|39251528|FG000|Overall Study|Protocol Violation|1|||
16211139|NCT01039428|39251529|FG001|Overall Study|Protocol Violation|0|||
16211140|NCT01039428|39251528|FG000|Overall Study|Withdrawal by Subject|1|||
16211141|NCT01039428|39251529|FG001|Overall Study|Withdrawal by Subject|0|||
16211142|NCT02943668|39251530|FG000|Overall Study|Disease Progression|1|||
16211143|NCT02959190|39251531|FG000|Open Label|Adverse Event|5|||
16211144|NCT02959190|39251532|FG001|Open Label|Adverse Event|7|||
16211145|NCT02959190|39251533|FG002|Open Label|Adverse Event|3|||
16211146|NCT02959190|39251534|FG003|Open Label|Adverse Event|4|||
16211147|NCT02959190|39251531|FG000|Open Label|Pregnancy|0|||
16211148|NCT02959190|39251532|FG001|Open Label|Pregnancy|1|||
16211149|NCT02959190|39251533|FG002|Open Label|Pregnancy|0|||
16211150|NCT02959190|39251534|FG003|Open Label|Pregnancy|0|||
16211151|NCT02959190|39251531|FG000|Open Label|Withdrawal by Subject|2|||
16211152|NCT02959190|39251532|FG001|Open Label|Withdrawal by Subject|8|||
16211153|NCT02959190|39251533|FG002|Open Label|Withdrawal by Subject|0|||
16211154|NCT02959190|39251534|FG003|Open Label|Withdrawal by Subject|0|||
16211155|NCT02959190|39251531|FG000|Open Label|Physician Decision|0|||
16211156|NCT02959190|39251532|FG001|Open Label|Physician Decision|0|||
16211157|NCT02959190|39251533|FG002|Open Label|Physician Decision|1|||
16211158|NCT02959190|39251534|FG003|Open Label|Physician Decision|0|||
16211159|NCT02959190|39251531|FG000|Open Label|Protocol Violation|0|||
16211160|NCT02959190|39251532|FG001|Open Label|Protocol Violation|0|||
16211161|NCT02959190|39251533|FG002|Open Label|Protocol Violation|0|||
16211162|NCT02959190|39251534|FG003|Open Label|Protocol Violation|2|||
16211163|NCT02959190|39251531|FG000|Post Treatment Follow Up|Adverse Event|1|||
16211164|NCT02959190|39251532|FG001|Post Treatment Follow Up|Adverse Event|1|||
16211165|NCT02959190|39251533|FG002|Post Treatment Follow Up|Adverse Event|0|||
16211166|NCT02959190|39251534|FG003|Post Treatment Follow Up|Adverse Event|0|||
16211167|NCT02959190|39251531|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
16211168|NCT02959190|39251532|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
16211169|NCT02959190|39251533|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
16211170|NCT02959190|39251534|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
16526351|NCT01602315|40394471|FG000|Overall Study|Cross-over patients to combo treatment|0|||
16211171|NCT03892707|39251535|FG000|Overall Study|Screen failure|6|||
16211172|NCT03892707|39251536|FG001|Overall Study|Screen failure|0|||
16330217|NCT00972816|39692700|FG004|Overall Study|Unable to classify|1|||
16526352|NCT01602315|40394472|FG001|Overall Study|Cross-over patients to combo treatment|0|||
16211173|NCT03892707|39251535|FG000|Overall Study|Pain resolution|0|||
16526353|NCT01602315|40394473|FG002|Overall Study|Cross-over patients to combo treatment|0|||
16211174|NCT03892707|39251536|FG001|Overall Study|Pain resolution|4|||
16211175|NCT03892707|39251535|FG000|Overall Study|Withdrawal by Subject|0|||
16211176|NCT03892707|39251536|FG001|Overall Study|Withdrawal by Subject|1|||
16211177|NCT03892707|39251535|FG000|Overall Study|Other (long business trip)|0|||
16211178|NCT03892707|39251536|FG001|Overall Study|Other (long business trip)|1|||
16211179|NCT02579863|39251537|FG000|Overall Study|Final Disposition Unknown|2|||
16211180|NCT02579863|39251538|FG001|Overall Study|Final Disposition Unknown|1|||
16211181|NCT02579863|39251537|FG000|Overall Study|Adverse Event|18|||
16211182|NCT02579863|39251538|FG001|Overall Study|Adverse Event|11|||
16211183|NCT02579863|39251537|FG000|Overall Study|Death|31|||
16211184|NCT02579863|39251538|FG001|Overall Study|Death|29|||
16211185|NCT02579863|39251537|FG000|Overall Study|Lost to Follow-up|2|||
16211186|NCT02579863|39251538|FG001|Overall Study|Lost to Follow-up|1|||
16211187|NCT02579863|39251537|FG000|Overall Study|Physician Decision|1|||
16211188|NCT02579863|39251538|FG001|Overall Study|Physician Decision|2|||
16211189|NCT02579863|39251537|FG000|Overall Study|Screen Failure|0|||
16526354|NCT01602315|40394474|FG003|Overall Study|Cross-over patients to combo treatment|0|||
16526355|NCT01602315|40394475|FG004|Overall Study|Cross-over patients to combo treatment|0|||
16526356|NCT01602315|40394476|FG005|Overall Study|Cross-over patients to combo treatment|16|||
16526357|NCT01602315|40394477|FG006|Overall Study|Cross-over patients to combo treatment|0|||
16097720|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16097721|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16097722|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
16526358|NCT01143259|40394478|FG000|Overall Study|Withdrawal by Subject|3|||
16526359|NCT01143259|40394479|FG001|Overall Study|Withdrawal by Subject|2|||
16526360|NCT01143259|40394478|FG000|Overall Study|Protocol Violation|13|||
16097723|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
16097724|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
16097725|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
16097726|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
16097727|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
16097728|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097729|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097730|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097731|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097732|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
16097733|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097734|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097735|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097736|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097737|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
16097738|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097739|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097740|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097741|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097742|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097743|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097744|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097745|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097746|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
16097747|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16211190|NCT02579863|39251538|FG001|Overall Study|Screen Failure|2|||
16211191|NCT02579863|39251537|FG000|Overall Study|Study Terminated at Selected Sites|82|||
16211192|NCT02579863|39251538|FG001|Overall Study|Study Terminated at Selected Sites|88|||
16211193|NCT02579863|39251537|FG000|Overall Study|Withdrawal by Subject|20|||
16526361|NCT01143259|40394479|FG001|Overall Study|Protocol Violation|9|||
16526362|NCT01143259|40394478|FG000|Overall Study|Screen Failure|7|||
16526363|NCT01143259|40394479|FG001|Overall Study|Screen Failure|9|||
16526364|NCT02528214|40394490|FG000|Overall Study|Protocol Violation|0|||
16526365|NCT02528214|40394491|FG001|Overall Study|Protocol Violation|1|||
16526366|NCT02528214|40394490|FG000|Overall Study|Adverse Event|0|||
16526367|NCT02528214|40394491|FG001|Overall Study|Adverse Event|1|||
16526368|NCT02528214|40394490|FG000|Overall Study|Other than specified above|0|||
16211194|NCT02579863|39251538|FG001|Overall Study|Withdrawal by Subject|20|||
16526369|NCT02528214|40394491|FG001|Overall Study|Other than specified above|1|||
16097748|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16097749|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
16097750|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16211195|NCT01607073|39251541|FG000|Overall Study|Adverse Event|1|||
16526370|NCT03912259|40394492|FG000|Overall Study|Adverse Event (AE)|2|||
16526371|NCT03912259|40394493|FG001|Overall Study|Adverse Event (AE)|4|||
16526372|NCT03912259|40394492|FG000|Overall Study|Lack of Efficacy|4|||
16211196|NCT00420342|39251542|FG000|Overall Study|Lost to Follow-up|1|||
16211197|NCT00420342|39251543|FG001|Overall Study|Lost to Follow-up|0|||
16211198|NCT00420342|39251544|FG002|Overall Study|Lost to Follow-up|1|||
16211199|NCT00420342|39251542|FG000|Overall Study|Withdrawal by Subject|0|||
16211200|NCT00420342|39251543|FG001|Overall Study|Withdrawal by Subject|2|||
16211201|NCT00420342|39251544|FG002|Overall Study|Withdrawal by Subject|0|||
16211202|NCT01678313|39255510|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
16211203|NCT01678313|39255511|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
16211204|NCT01678313|39255510|FG000|Completed the 3-month Therapy|Physician Decision|3|||
16211205|NCT01678313|39255511|FG001|Completed the 3-month Therapy|Physician Decision|4|||
16211206|NCT01678313|39255510|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
16211207|NCT01678313|39255511|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
16211208|NCT01678313|39255510|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
16211209|NCT01678313|39255511|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
16211210|NCT04737759|39255512|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
16211211|NCT04737759|39255513|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
16211212|NCT04737759|39255512|FG000|Overall Study|Death|2|||
16211213|NCT04737759|39255513|FG001|Overall Study|Death|0|||
16211214|NCT04737759|39255512|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
16097751|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16097752|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16097753|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16097754|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16097755|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16097756|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16211215|NCT04737759|39255513|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
16211216|NCT04737759|39255512|FG000|Overall Study|Lost to Follow-up|4|||
16211217|NCT04737759|39255513|FG001|Overall Study|Lost to Follow-up|12|||
16211218|NCT03565991|39255529|FG000|Overall Study|Other|11|||
16211219|NCT03565991|39255530|FG001|Overall Study|Other|0|||
16211220|NCT03565991|39255529|FG000|Overall Study|Global deterioration of health status|14|||
16211221|NCT03565991|39255530|FG001|Overall Study|Global deterioration of health status|4|||
16211222|NCT03565991|39255529|FG000|Overall Study|Withdrawal by Subject|2|||
16211223|NCT03565991|39255530|FG001|Overall Study|Withdrawal by Subject|6|||
16211224|NCT03565991|39255529|FG000|Overall Study|Progressive disease|121|||
16211225|NCT03565991|39255530|FG001|Overall Study|Progressive disease|29|||
16211226|NCT03565991|39255529|FG000|Overall Study|Death|3|||
16211227|NCT03565991|39255530|FG001|Overall Study|Death|0|||
16211228|NCT03565991|39255529|FG000|Overall Study|Adverse Event|7|||
16211229|NCT03565991|39255530|FG001|Overall Study|Adverse Event|2|||
16211230|NCT03922711|39255533|FG000|Overall Study|Adverse Event|3|||
16211231|NCT03922711|39255534|FG001|Overall Study|Adverse Event|2|||
16211232|NCT03922711|39255535|FG002|Overall Study|Adverse Event|2|||
16211233|NCT03922711|39255533|FG000|Overall Study|Protocol Violation|1|||
16211234|NCT03922711|39255534|FG001|Overall Study|Protocol Violation|0|||
16211235|NCT03922711|39255535|FG002|Overall Study|Protocol Violation|0|||
16211236|NCT03922711|39255533|FG000|Overall Study|Withdrawal by Subject|0|||
16211237|NCT03922711|39255534|FG001|Overall Study|Withdrawal by Subject|3|||
16211238|NCT03922711|39255535|FG002|Overall Study|Withdrawal by Subject|1|||
16211239|NCT03922711|39255533|FG000|Overall Study|Not further specified|0|||
16211240|NCT03922711|39255534|FG001|Overall Study|Not further specified|0|||
16211241|NCT03922711|39255535|FG002|Overall Study|Not further specified|1|||
16526373|NCT03912259|40394493|FG001|Overall Study|Lack of Efficacy|1|||
16097757|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16097758|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16097759|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16097760|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16211242|NCT02972593|39255538|FG000|Overall Study|Lost to Follow-up|19|||
16211243|NCT02972593|39255539|FG001|Overall Study|Lost to Follow-up|15|||
16211244|NCT02972593|39255538|FG000|Overall Study|Protocol Violation|1|||
16211245|NCT02972593|39255539|FG001|Overall Study|Protocol Violation|0|||
16211246|NCT00654420|39255540|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
16211247|NCT00654420|39255541|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
16211248|NCT00654420|39255542|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
16211249|NCT00654420|39255543|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
16330218|NCT00972816|39692701|FG005|Overall Study|Unable to classify|0|||
16526374|NCT03912259|40394492|FG000|Overall Study|Withdrawal by Subject|11|||
16526375|NCT03912259|40394493|FG001|Overall Study|Withdrawal by Subject|1|||
16526376|NCT01432366|40394494|FG000|Overall Study|Non-Responder|7|||
16526377|NCT01432366|40394494|FG000|Overall Study|Adverse Event|8|||
16526378|NCT01432366|40394494|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
16526379|NCT01432366|40394494|FG000|Overall Study|Pregnancy|1|||
16526380|NCT01432366|40394494|FG000|Overall Study|Lost to Follow-up|13|||
16526381|NCT01432366|40394494|FG000|Overall Study|Lack of Efficacy|1|||
16211250|NCT00654420|39255540|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
16211251|NCT00654420|39255541|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
16211252|NCT00654420|39255542|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
16211253|NCT00654420|39255543|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
16211254|NCT00654420|39255540|FG000|Phase II|Adverse Event|0|||
16211255|NCT00654420|39255541|FG001|Phase II|Adverse Event|0|||
16211256|NCT00654420|39255542|FG002|Phase II|Adverse Event|3|||
16211257|NCT00654420|39255543|FG003|Phase II|Adverse Event|3|||
16211258|NCT00654420|39255540|FG000|Phase II|Lost to Follow-up|0|||
16211259|NCT00654420|39255541|FG001|Phase II|Lost to Follow-up|0|||
16211260|NCT00654420|39255542|FG002|Phase II|Lost to Follow-up|0|||
16211261|NCT00654420|39255543|FG003|Phase II|Lost to Follow-up|1|||
16211262|NCT00654420|39255540|FG000|Phase II|Physician Decision|0|||
16211263|NCT00654420|39255541|FG001|Phase II|Physician Decision|0|||
16211264|NCT00654420|39255542|FG002|Phase II|Physician Decision|0|||
16211265|NCT00654420|39255543|FG003|Phase II|Physician Decision|4|||
16211266|NCT00654420|39255540|FG000|Phase II|Progressive Disease|0|||
16211267|NCT00654420|39255541|FG001|Phase II|Progressive Disease|0|||
16211268|NCT00654420|39255542|FG002|Phase II|Progressive Disease|29|||
16211269|NCT00654420|39255543|FG003|Phase II|Progressive Disease|29|||
16211270|NCT00654420|39255540|FG000|Phase II|Withdrawal by Subject|0|||
16211271|NCT00654420|39255541|FG001|Phase II|Withdrawal by Subject|0|||
16211272|NCT00654420|39255542|FG002|Phase II|Withdrawal by Subject|4|||
16211273|NCT00654420|39255543|FG003|Phase II|Withdrawal by Subject|1|||
16211274|NCT00654420|39255540|FG000|Phase II|Missing Disposition Record|0|||
16211275|NCT00654420|39255541|FG001|Phase II|Missing Disposition Record|0|||
16211276|NCT00654420|39255542|FG002|Phase II|Missing Disposition Record|1|||
16211277|NCT00654420|39255543|FG003|Phase II|Missing Disposition Record|0|||
16211278|NCT02120469|39255549|FG000|Overall Study|HER-2/neu-amplified|1|||
16211279|NCT02120469|39255550|FG001|Overall Study|HER-2/neu-amplified|0|||
16211280|NCT02120469|39255551|FG002|Overall Study|HER-2/neu-amplified|1|||
16211281|NCT01681836|39255552|FG000|Second Intervention|Withdrawal by Subject|0|||
16211282|NCT01681836|39255553|FG001|Second Intervention|Withdrawal by Subject|1|||
16211283|NCT00102804|39255556|FG000|Overall Study|Progressive Disease (PD)|307|||
16211284|NCT00102804|39255557|FG001|Overall Study|Progressive Disease (PD)|196|||
16211285|NCT00102804|39255556|FG000|Overall Study|Withdrawal by Subject|46|||
16211286|NCT00102804|39255557|FG001|Overall Study|Withdrawal by Subject|7|||
16211287|NCT00102804|39255556|FG000|Overall Study|Adverse Event|37|||
16211288|NCT00102804|39255557|FG001|Overall Study|Adverse Event|3|||
16330219|NCT00972816|39692702|FG006|Overall Study|Unable to classify|0|||
16330220|NCT00972816|39692703|FG007|Overall Study|Unable to classify|0|||
16211289|NCT00102804|39255556|FG000|Overall Study|Physician Decision|24|||
16211290|NCT00102804|39255557|FG001|Overall Study|Physician Decision|6|||
16211291|NCT00102804|39255556|FG000|Overall Study|Death|5|||
16211292|NCT00102804|39255557|FG001|Overall Study|Death|6|||
16211293|NCT00102804|39255556|FG000|Overall Study|Enrollment Criteria Not Met|6|||
16211294|NCT00102804|39255557|FG001|Overall Study|Enrollment Criteria Not Met|0|||
16211295|NCT00102804|39255556|FG000|Overall Study|Lost to Follow-up|4|||
16211296|NCT00102804|39255557|FG001|Overall Study|Lost to Follow-up|1|||
16211297|NCT00102804|39255556|FG000|Overall Study|Protocol Violation|2|||
16211298|NCT00102804|39255557|FG001|Overall Study|Protocol Violation|1|||
16211299|NCT00102804|39255556|FG000|Overall Study|Satisfactory Response|2|||
16211300|NCT00102804|39255557|FG001|Overall Study|Satisfactory Response|0|||
16211301|NCT00102804|39255556|FG000|Overall Study|Sponsor Decision|1|||
16211302|NCT00102804|39255557|FG001|Overall Study|Sponsor Decision|0|||
16211303|NCT00102804|39255556|FG000|Overall Study|Alive, Receiving Treatment|7|||
16211304|NCT00102804|39255557|FG001|Overall Study|Alive, Receiving Treatment|2|||
16211305|NCT03127852|39255560|FG000|Overall Study|Withdrawal by Subject|4|||
16211306|NCT03127852|39255561|FG001|Overall Study|Withdrawal by Subject|1|||
16211307|NCT03127852|39255560|FG000|Overall Study|Death|1|||
16211308|NCT03127852|39255561|FG001|Overall Study|Death|1|||
16211309|NCT02762708|39255562|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
16211310|NCT02762708|39255563|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
16211311|NCT02762708|39255564|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
16211312|NCT02762708|39255565|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
16211313|NCT02724111|39255566|FG000|Overall Study|Protocol Violation|2|||
16211314|NCT02724111|39255567|FG001|Overall Study|Protocol Violation|5|||
16211315|NCT02443155|39255568|FG000|Overall Study|Adverse Event|3|||
16211316|NCT02443155|39255569|FG001|Overall Study|Adverse Event|4|||
16211317|NCT02443155|39255570|FG002|Overall Study|Adverse Event|1|||
16211318|NCT02443155|39255571|FG003|Overall Study|Adverse Event|2|||
16211319|NCT02443155|39255568|FG000|Overall Study|Unclassified|0|||
16211320|NCT02443155|39255569|FG001|Overall Study|Unclassified|0|||
16211321|NCT02443155|39255570|FG002|Overall Study|Unclassified|2|||
16211322|NCT02443155|39255571|FG003|Overall Study|Unclassified|1|||
16211323|NCT02443155|39255568|FG000|Overall Study|Withdrawal by Subject|4|||
16211324|NCT02443155|39255569|FG001|Overall Study|Withdrawal by Subject|7|||
16211325|NCT02443155|39255570|FG002|Overall Study|Withdrawal by Subject|3|||
16211326|NCT02443155|39255571|FG003|Overall Study|Withdrawal by Subject|9|||
16211327|NCT02443155|39255568|FG000|Overall Study|Pregnancy|3|||
16211328|NCT02443155|39255569|FG001|Overall Study|Pregnancy|1|||
16211329|NCT02443155|39255570|FG002|Overall Study|Pregnancy|1|||
16211330|NCT02443155|39255571|FG003|Overall Study|Pregnancy|2|||
16211331|NCT02443155|39255568|FG000|Overall Study|Lost to Follow-up|1|||
16211332|NCT02443155|39255569|FG001|Overall Study|Lost to Follow-up|2|||
16211333|NCT02443155|39255570|FG002|Overall Study|Lost to Follow-up|0|||
16211334|NCT02443155|39255571|FG003|Overall Study|Lost to Follow-up|1|||
16211335|NCT02443155|39255568|FG000|Overall Study|Protocol Violation|1|||
16211336|NCT02443155|39255569|FG001|Overall Study|Protocol Violation|0|||
16211337|NCT02443155|39255570|FG002|Overall Study|Protocol Violation|1|||
16211338|NCT02443155|39255571|FG003|Overall Study|Protocol Violation|1|||
16211339|NCT02443155|39255568|FG000|Overall Study|Death|0|||
16097761|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16097762|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
16097763|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
16097764|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
16097765|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
16211340|NCT02443155|39255569|FG001|Overall Study|Death|0|||
16211341|NCT02443155|39255570|FG002|Overall Study|Death|1|||
16526382|NCT01432366|40394494|FG000|Overall Study|Site Closed|20|||
16526383|NCT01432366|40394494|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
16526384|NCT01432366|40394494|FG000|Overall Study|Other|14|||
16526385|NCT03701555|40394495|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
16526386|NCT03701555|40394496|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
16526387|NCT03701555|40394497|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
16526388|NCT03701555|40394498|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
16526389|NCT03701555|40394499|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
16526390|NCT03701555|40394500|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
16211342|NCT02443155|39255571|FG003|Overall Study|Death|0|||
16211343|NCT01712490|39255572|FG000|Overall Study|Ongoing|601|||
16211344|NCT01712490|39255573|FG001|Overall Study|Ongoing|586|||
16211345|NCT01712490|39255572|FG000|Overall Study|Other|11|||
16211346|NCT01712490|39255573|FG001|Overall Study|Other|11|||
16211347|NCT01712490|39255572|FG000|Overall Study|Withdrawal by Subject|36|||
16211348|NCT01712490|39255573|FG001|Overall Study|Withdrawal by Subject|44|||
16211349|NCT01712490|39255572|FG000|Overall Study|Lost to Follow-up|16|||
16211350|NCT01712490|39255573|FG001|Overall Study|Lost to Follow-up|29|||
16211351|NCT01828567|39255574|FG000|Overall Study|Lost to Follow-up|27|||
16211352|NCT01828567|39255575|FG001|Overall Study|Lost to Follow-up|9|||
16211353|NCT01828567|39255574|FG000|Overall Study|Excluded - did not meet criteria|4|||
16399255|NCT01468233|39941550|FG001|Treatment Period 2|Lost to Follow-up|0|||
16399256|NCT01468233|39941551|FG002|Treatment Period 2|Lost to Follow-up|3|||
16399257|NCT01468233|39941552|FG003|Treatment Period 2|Lost to Follow-up|0|||
16399258|NCT01468233|39941553|FG004|Treatment Period 2|Lost to Follow-up|2|||
16399259|NCT01468233|39941554|FG005|Treatment Period 2|Lost to Follow-up|0|||
16399260|NCT01468233|39941549|FG000|Treatment Period 2|Other|0|||
16399261|NCT01468233|39941550|FG001|Treatment Period 2|Other|0|||
16399262|NCT01468233|39941551|FG002|Treatment Period 2|Other|3|||
16399263|NCT01468233|39941552|FG003|Treatment Period 2|Other|0|||
16526391|NCT03701555|40394501|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
16526392|NCT03701555|40394502|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
16526393|NCT03701555|40394503|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
16211354|NCT01828567|39255575|FG001|Overall Study|Excluded - did not meet criteria|1|||
16211355|NCT03342404|39255576|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
16399264|NCT01468233|39941553|FG004|Treatment Period 2|Other|1|||
16399265|NCT01468233|39941554|FG005|Treatment Period 2|Other|0|||
16399266|NCT00580034|39941559|FG000|Overall Study|Toxicity|10|||
16399267|NCT00580034|39941560|FG001|Overall Study|Toxicity|0|||
16399268|NCT01535599|39941561|FG000|Overall Study|Adverse Event|6|||
16526394|NCT03701555|40394504|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
16526395|NCT03701555|40394505|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
16399269|NCT01535599|39941562|FG001|Overall Study|Adverse Event|15|||
16399270|NCT01535599|39941561|FG000|Overall Study|Lost to Follow-up|3|||
16097766|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
16097767|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
16097768|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16097769|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
16097770|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16097771|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16097772|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
16097773|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16097774|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16097775|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16097776|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
16097777|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16097778|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
16097779|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
16097780|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
16097781|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
16097782|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
16097783|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
16097784|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
16097785|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097786|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097787|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097788|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097789|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097790|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097791|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097792|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097793|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16211356|NCT03342404|39255577|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
16399271|NCT01535599|39941562|FG001|Overall Study|Lost to Follow-up|4|||
16399272|NCT01535599|39941561|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
16399273|NCT01535599|39941562|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
16399274|NCT01535599|39941561|FG000|Overall Study|Treatment Failure|33|||
16399275|NCT01535599|39941562|FG001|Overall Study|Treatment Failure|66|||
16399276|NCT01535599|39941561|FG000|Overall Study|BL Culture + for Group A Strep|0|||
16399277|NCT01535599|39941562|FG001|Overall Study|BL Culture + for Group A Strep|1|||
16399278|NCT01535599|39941561|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
16399279|NCT01535599|39941562|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
16399280|NCT01535599|39941561|FG000|Overall Study|Randomized in Error|2|||
16526396|NCT03701555|40394506|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
16526397|NCT03701555|40394507|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
16526398|NCT03701555|40394508|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
16526399|NCT03701555|40394509|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
16526400|NCT03701555|40394510|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
16526401|NCT03701555|40394511|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
16526402|NCT03701555|40394512|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
16526403|NCT03701555|40394513|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
16526404|NCT03701555|40394514|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
16526405|NCT03701555|40394515|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
16526406|NCT03701555|40394516|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
16526407|NCT03701555|40394517|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
16526408|NCT03701555|40394518|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
16526409|NCT03701555|40394519|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
16211357|NCT03342404|39255576|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
16211358|NCT03342404|39255577|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
16211359|NCT03342404|39255576|FG000|Blinded Treatment Phase|Adverse Event|5|||
16211360|NCT03342404|39255577|FG001|Blinded Treatment Phase|Adverse Event|4|||
16211361|NCT03342404|39255576|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
16211362|NCT03342404|39255577|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
16211363|NCT03342404|39255576|FG000|Blinded Treatment Phase|Other reasons|1|||
16097794|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097795|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
16097796|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097797|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097798|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
16097799|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097800|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097801|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
16097802|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
16097803|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
16097804|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
16097805|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097806|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097807|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097808|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097809|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
16097810|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097811|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097812|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097813|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097814|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097815|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097816|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097817|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16211364|NCT03342404|39255577|FG001|Blinded Treatment Phase|Other reasons|0|||
16211365|NCT03342404|39255576|FG000|Blinded Treatment Phase|Physician Decision|1|||
16330221|NCT01088243|39692704|FG000|Overall Study|Adverse Event|1|||
16330222|NCT01088243|39692705|FG001|Overall Study|Adverse Event|0|||
16330223|NCT01459718|39692708|FG000|Overall Study|Physician Decision|1|||
16399281|NCT01535599|39941562|FG001|Overall Study|Randomized in Error|4|||
16399282|NCT01535599|39941561|FG000|Overall Study|Did not use product|1|||
16399283|NCT01535599|39941562|FG001|Overall Study|Did not use product|0|||
16399284|NCT01535599|39941561|FG000|Overall Study|Other|1|||
16399285|NCT01535599|39941562|FG001|Overall Study|Other|0|||
16399286|NCT01535599|39941561|FG000|Overall Study|Stopped medication|0|||
16330224|NCT01459718|39692708|FG000|Overall Study|Lost to Follow-up|1|||
16330225|NCT01459718|39692708|FG000|Overall Study|Adverse Event|1|||
16330226|NCT01527487|39692709|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
16330227|NCT01527487|39692710|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
16330228|NCT01527487|39692709|FG000|Overall Study|Disease Progression|4|||
16330229|NCT01527487|39692710|FG001|Overall Study|Disease Progression|1|||
16330230|NCT01527487|39692709|FG000|Overall Study|Adverse Event|1|||
16330231|NCT01527487|39692710|FG001|Overall Study|Adverse Event|1|||
16399287|NCT01535599|39941562|FG001|Overall Study|Stopped medication|1|||
16399288|NCT01535599|39941561|FG000|Overall Study|Noncompliance|0|||
16399289|NCT01535599|39941562|FG001|Overall Study|Noncompliance|1|||
16399290|NCT00090779|39941563|FG000|Step 1|Withdrawal by Subject|4|||
16399291|NCT00090779|39941564|FG001|Step 1|Withdrawal by Subject|2|||
16399292|NCT00090779|39941563|FG000|Step 1|Lost to Follow-up|3|||
16399293|NCT00090779|39941564|FG001|Step 1|Lost to Follow-up|2|||
16399294|NCT00090779|39941563|FG000|Step 1|Death|0|||
16211366|NCT03342404|39255577|FG001|Blinded Treatment Phase|Physician Decision|0|||
16211367|NCT03342404|39255576|FG000|Blinded Treatment Phase|Death|1|||
16211368|NCT03342404|39255577|FG001|Blinded Treatment Phase|Death|0|||
16211369|NCT03342404|39255576|FG000|Open-Label Phase|Lost to Follow-up|0|||
16330232|NCT01527487|39692709|FG000|Overall Study|Death|0|||
16330233|NCT01527487|39692710|FG001|Overall Study|Death|1|||
16330234|NCT02461524|39692715|FG000|Overall Study|Death|16|||
16399295|NCT00090779|39941564|FG001|Step 1|Death|2|||
16399296|NCT00090779|39941563|FG000|Step 1|Physician Decision|1|||
16399297|NCT00090779|39941564|FG001|Step 1|Physician Decision|0|||
16399298|NCT00090779|39941563|FG000|Step 1|Pregnancy|1|||
16399299|NCT00090779|39941564|FG001|Step 1|Pregnancy|0|||
16399300|NCT00090779|39941563|FG000|Step 1|Non-compliance to study requirements|0|||
16399301|NCT00090779|39941564|FG001|Step 1|Non-compliance to study requirements|1|||
16399302|NCT00090779|39941563|FG000|Step 1|Subject relocated|2|||
16399303|NCT00090779|39941564|FG001|Step 1|Subject relocated|8|||
16399304|NCT00090779|39941563|FG000|Step 2|Off study per study closure|6|||
16399305|NCT00090779|39941564|FG001|Step 2|Off study per study closure|16|||
16399306|NCT00090779|39941563|FG000|Step 2|Subject relocated|0|||
16399307|NCT00090779|39941564|FG001|Step 2|Subject relocated|1|||
16399308|NCT00090779|39941563|FG000|Step 2|Non-compliance to study requirements|0|||
16399309|NCT00090779|39941564|FG001|Step 2|Non-compliance to study requirements|1|||
16399310|NCT00090779|39941563|FG000|Step 3|Initiation of ART and off extended study|3|||
16399311|NCT00090779|39941564|FG001|Step 3|Initiation of ART and off extended study|2|||
16399312|NCT00090779|39941563|FG000|Step 3|Off extended study due to study closure|4|||
16399313|NCT00090779|39941564|FG001|Step 3|Off extended study due to study closure|3|||
16399314|NCT02301546|39941567|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
16399315|NCT02301546|39941568|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
16399316|NCT02301546|39941567|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
16399317|NCT02301546|39941568|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
16399318|NCT02301546|39941567|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
16399319|NCT02301546|39941568|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
16399320|NCT02301546|39941567|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
16399321|NCT02301546|39941568|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
16399322|NCT02301546|39941567|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
16399323|NCT02301546|39941568|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
16399324|NCT02301546|39941567|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
16399325|NCT02301546|39941568|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
16399326|NCT02301546|39941567|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
16399327|NCT02301546|39941568|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
16399328|NCT00791479|39941572|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
16399329|NCT00791479|39941573|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
16399330|NCT00791479|39941574|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
16399331|NCT00791479|39941575|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
16399332|NCT00791479|39941576|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
16399333|NCT00791479|39941577|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
16399334|NCT00791479|39941572|FG000|Overall Study|Adverse Event|0|||
16399335|NCT00791479|39941573|FG001|Overall Study|Adverse Event|1|||
16399336|NCT00791479|39941574|FG002|Overall Study|Adverse Event|0|||
16399337|NCT00791479|39941575|FG003|Overall Study|Adverse Event|2|||
16399338|NCT00791479|39941576|FG004|Overall Study|Adverse Event|0|||
16399339|NCT00791479|39941577|FG005|Overall Study|Adverse Event|1|||
16399340|NCT00791479|39941572|FG000|Overall Study|Lost to Follow-up|0|||
16399341|NCT00791479|39941573|FG001|Overall Study|Lost to Follow-up|1|||
16399342|NCT00791479|39941574|FG002|Overall Study|Lost to Follow-up|0|||
16399343|NCT00791479|39941575|FG003|Overall Study|Lost to Follow-up|0|||
16399344|NCT00791479|39941576|FG004|Overall Study|Lost to Follow-up|0|||
16399345|NCT00791479|39941577|FG005|Overall Study|Lost to Follow-up|1|||
16399346|NCT00791479|39941572|FG000|Overall Study|Protocol Violation|2|||
16399347|NCT00791479|39941573|FG001|Overall Study|Protocol Violation|1|||
16399348|NCT00791479|39941574|FG002|Overall Study|Protocol Violation|0|||
16399349|NCT00791479|39941575|FG003|Overall Study|Protocol Violation|1|||
16399350|NCT00791479|39941576|FG004|Overall Study|Protocol Violation|0|||
16399351|NCT00791479|39941577|FG005|Overall Study|Protocol Violation|0|||
16399352|NCT00791479|39941572|FG000|Overall Study|Withdrawal by Subject|0|||
16399353|NCT00791479|39941573|FG001|Overall Study|Withdrawal by Subject|0|||
16399354|NCT00791479|39941574|FG002|Overall Study|Withdrawal by Subject|0|||
16399355|NCT00791479|39941575|FG003|Overall Study|Withdrawal by Subject|1|||
16399356|NCT00791479|39941576|FG004|Overall Study|Withdrawal by Subject|0|||
16399357|NCT00791479|39941577|FG005|Overall Study|Withdrawal by Subject|1|||
16399358|NCT00396136|39941579|FG000|Overall Study|Death|43|||
16399359|NCT00396136|39941579|FG000|Overall Study|Withdrawal by Subject|59|||
16399360|NCT00396136|39941579|FG000|Overall Study|Lost to Follow-up|15|||
16399361|NCT00396136|39941579|FG000|Overall Study|Study device explanted|8|||
16399362|NCT00185380|39941580|FG000|Overall Study|Adverse Event|41|||
16399363|NCT00185380|39941581|FG001|Overall Study|Adverse Event|43|||
16399364|NCT00185380|39941582|FG002|Overall Study|Adverse Event|48|||
16097818|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
16097819|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097820|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097821|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
16097822|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
16097823|NCT01915498|38846912|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16097824|NCT01915498|38846913|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16399365|NCT00185380|39941580|FG000|Overall Study|Lost to Follow-up|0|||
16399366|NCT00185380|39941581|FG001|Overall Study|Lost to Follow-up|4|||
16399367|NCT00185380|39941582|FG002|Overall Study|Lost to Follow-up|3|||
16399368|NCT00185380|39941580|FG000|Overall Study|Pregnancy|1|||
16399369|NCT00185380|39941581|FG001|Overall Study|Pregnancy|4|||
16399370|NCT00185380|39941582|FG002|Overall Study|Pregnancy|0|||
16399371|NCT00185380|39941580|FG000|Overall Study|Protocol Violation|2|||
16399372|NCT00185380|39941581|FG001|Overall Study|Protocol Violation|2|||
16399373|NCT00185380|39941582|FG002|Overall Study|Protocol Violation|1|||
16399374|NCT00185380|39941580|FG000|Overall Study|Withdrawal by Subject|1|||
16399375|NCT00185380|39941581|FG001|Overall Study|Withdrawal by Subject|2|||
16399376|NCT00185380|39941582|FG002|Overall Study|Withdrawal by Subject|0|||
16399377|NCT00185380|39941580|FG000|Overall Study|Failed insertion|1|||
16399378|NCT00185380|39941581|FG001|Overall Study|Failed insertion|1|||
16399379|NCT00185380|39941582|FG002|Overall Study|Failed insertion|2|||
16399380|NCT00185380|39941580|FG000|Overall Study|Planned pregnancy|9|||
16399381|NCT00185380|39941581|FG001|Overall Study|Planned pregnancy|12|||
16399382|NCT00185380|39941582|FG002|Overall Study|Planned pregnancy|12|||
16399383|NCT00185380|39941580|FG000|Overall Study|No need for contraception|3|||
16399384|NCT00185380|39941581|FG001|Overall Study|No need for contraception|3|||
16399385|NCT00185380|39941582|FG002|Overall Study|No need for contraception|3|||
16399386|NCT00185380|39941580|FG000|Overall Study|Could not attend visits|2|||
16399387|NCT00185380|39941581|FG001|Overall Study|Could not attend visits|0|||
16399388|NCT00185380|39941582|FG002|Overall Study|Could not attend visits|4|||
16399389|NCT00185380|39941580|FG000|Overall Study|personal reason|6|||
16399390|NCT00185380|39941581|FG001|Overall Study|personal reason|1|||
16399391|NCT00185380|39941582|FG002|Overall Study|personal reason|1|||
16399392|NCT03490292|39941583|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
16399393|NCT03490292|39941584|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
16399394|NCT03490292|39941583|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
16399395|NCT03490292|39941584|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
16399396|NCT03490292|39941583|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
16399397|NCT03490292|39941584|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
16399398|NCT03490292|39941583|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
16399399|NCT03490292|39941584|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
16399400|NCT03490292|39941583|FG000|1 Year Follow Up Post Last Dose|Death|1|||
16399401|NCT03490292|39941584|FG001|1 Year Follow Up Post Last Dose|Death|1|||
16399402|NCT02249091|39941587|FG000|Overall Study|Lack of Efficacy|8|||
16399403|NCT02249091|39941588|FG001|Overall Study|Lack of Efficacy|3|||
16399404|NCT02249091|39941587|FG000|Overall Study|Physician Decision|4|||
16399405|NCT02249091|39941588|FG001|Overall Study|Physician Decision|1|||
16399406|NCT02249091|39941587|FG000|Overall Study|Withdrawal by Subject|2|||
16526410|NCT03701555|40394520|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
16526411|NCT03701555|40394521|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
16526412|NCT03701555|40394522|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
16097825|NCT01915498|38846914|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16097826|NCT01915498|38846915|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16097827|NCT01915498|38846916|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16097828|NCT01915498|38846917|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
16097829|NCT01915498|38846918|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16097830|NCT01915498|38846919|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16097831|NCT01915498|38846920|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16097832|NCT01915498|38846921|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
16399407|NCT02249091|39941588|FG001|Overall Study|Withdrawal by Subject|2|||
16526413|NCT03701555|40394523|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
16526414|NCT03701555|40394524|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
16526415|NCT03701555|40394525|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
16526416|NCT03701555|40394526|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
16399408|NCT02249091|39941587|FG000|Overall Study|Death|3|||
16399409|NCT02249091|39941588|FG001|Overall Study|Death|4|||
16399410|NCT02249091|39941587|FG000|Overall Study|Adverse Event|1|||
16399411|NCT02249091|39941588|FG001|Overall Study|Adverse Event|0|||
16399412|NCT02249091|39941587|FG000|Overall Study|Stable disease with following SCT|0|||
16399413|NCT02249091|39941588|FG001|Overall Study|Stable disease with following SCT|1|||
16399414|NCT02249091|39941587|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
16526417|NCT03701555|40394527|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
16526418|NCT03701555|40394528|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
16399415|NCT02249091|39941588|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
16399416|NCT02249091|39941587|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
16399417|NCT02249091|39941588|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
16399418|NCT02249091|39941587|FG000|Overall Study|Refractory AML|1|||
16399419|NCT02249091|39941588|FG001|Overall Study|Refractory AML|1|||
16399420|NCT03292874|39941589|FG000|Overall Study|Due to pandemic|5|||
16399421|NCT02397915|39941590|FG000|Period 1|Protocol Violation|0|||
16399422|NCT02397915|39941591|FG001|Period 1|Protocol Violation|1|||
16399423|NCT02397915|39941592|FG002|Period 1|Protocol Violation|0|||
16399424|NCT02397915|39941593|FG003|Period 1|Protocol Violation|0|||
16399425|NCT02397915|39941590|FG000|Period 1|Physician Decision|1|||
16399426|NCT02397915|39941591|FG001|Period 1|Physician Decision|0|||
16399427|NCT02397915|39941592|FG002|Period 1|Physician Decision|0|||
16399428|NCT02397915|39941593|FG003|Period 1|Physician Decision|0|||
16399429|NCT00218634|39941597|FG000|Overall Study|Lost to Follow-up|8|||
16399430|NCT00218634|39941598|FG001|Overall Study|Lost to Follow-up|15|||
16399431|NCT01802580|39941599|FG000|Overall Study|Physician Decision|1|||
16399432|NCT01802580|39941600|FG001|Overall Study|Physician Decision|0|||
16399433|NCT01802580|39941599|FG000|Overall Study|Protocol Violation|2|||
16399434|NCT01802580|39941600|FG001|Overall Study|Protocol Violation|0|||
16399435|NCT01802580|39941599|FG000|Overall Study|Withdrawal by Subject|5|||
16399436|NCT01802580|39941600|FG001|Overall Study|Withdrawal by Subject|6|||
16399437|NCT01802580|39941599|FG000|Overall Study|Other|1|||
16399438|NCT01802580|39941600|FG001|Overall Study|Other|3|||
16097833|NCT01915498|38846922|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16399439|NCT01802580|39941599|FG000|Overall Study|Lack of Efficacy|0|||
16399440|NCT01802580|39941600|FG001|Overall Study|Lack of Efficacy|2|||
16399441|NCT02570152|39941603|FG000|Overall Study|Protocol Violation|2|||
16399442|NCT02570152|39941603|FG000|Overall Study|Migrated/moved from study area|13|||
16399443|NCT01221753|39941604|FG000|Overall Study|Adverse Event|1|||
16399444|NCT00433966|39941610|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
16399445|NCT00433966|39941611|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
16399446|NCT00433966|39941612|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
16399447|NCT00433966|39941613|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
16399448|NCT00433966|39941610|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
16399449|NCT00433966|39941611|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
16399450|NCT00433966|39941612|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
16399451|NCT00433966|39941613|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
16399452|NCT00433966|39941610|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
16399453|NCT00433966|39941611|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
16399454|NCT00433966|39941612|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
16399455|NCT00433966|39941613|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
16399456|NCT00433966|39941610|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
16399457|NCT00433966|39941611|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
16399458|NCT00433966|39941612|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
16097834|NCT01915498|38846923|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16097835|NCT01915498|38846924|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16097836|NCT01915498|38846925|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
16097837|NCT01915498|38846926|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
16097838|NCT01915498|38846927|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
16097839|NCT01915498|38846928|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
16097840|NCT01915498|38846929|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
16097841|NCT01915498|38846930|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
16097842|NCT01915498|38846912|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097843|NCT01915498|38846913|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097844|NCT01915498|38846914|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097845|NCT01915498|38846915|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16399459|NCT00433966|39941613|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
16399460|NCT00433966|39941610|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
16399461|NCT00433966|39941611|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
16399462|NCT00433966|39941612|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
16399463|NCT00433966|39941613|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
16399464|NCT00566982|39941616|FG000|Overall Study|Adverse Event|6|||
16399465|NCT00566982|39941617|FG001|Overall Study|Adverse Event|48|||
16399466|NCT00566982|39941616|FG000|Overall Study|Withdrawal by Subject|1|||
16399467|NCT00566982|39941617|FG001|Overall Study|Withdrawal by Subject|14|||
16399468|NCT00566982|39941616|FG000|Overall Study|Protocol Violation|1|||
16399469|NCT00566982|39941617|FG001|Overall Study|Protocol Violation|4|||
16399470|NCT00566982|39941616|FG000|Overall Study|Lost to Follow-up|0|||
16399471|NCT00566982|39941617|FG001|Overall Study|Lost to Follow-up|1|||
16399472|NCT00566982|39941616|FG000|Overall Study|Other-family problems & doctor's request|0|||
16399473|NCT00566982|39941617|FG001|Overall Study|Other-family problems & doctor's request|2|||
16399474|NCT02566785|39941618|FG000|Overall Study|Lost to Follow-up|0|||
16399475|NCT02566785|39941619|FG001|Overall Study|Lost to Follow-up|2|||
16399476|NCT02566785|39941618|FG000|Overall Study|Worsening condition|1|||
16399477|NCT02566785|39941619|FG001|Overall Study|Worsening condition|1|||
16399478|NCT01581021|39941620|FG000|Overall Study|Lost to Follow-up|4|||
16399479|NCT01581021|39941621|FG001|Overall Study|Lost to Follow-up|6|||
16399480|NCT01581021|39941620|FG000|Overall Study|More than 2 hooks in thoracic|3|||
16526419|NCT03701555|40394529|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
16526420|NCT03701555|40394530|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
16097846|NCT01915498|38846916|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097847|NCT01915498|38846917|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097848|NCT01915498|38846918|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097849|NCT01915498|38846919|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097850|NCT01915498|38846920|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097851|NCT01915498|38846921|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097852|NCT01915498|38846922|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097853|NCT01915498|38846923|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097854|NCT01915498|38846924|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097855|NCT01915498|38846925|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097856|NCT01915498|38846926|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097857|NCT01915498|38846927|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097858|NCT01915498|38846928|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097859|NCT01915498|38846929|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
16097860|NCT01915498|38846930|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
16097861|NCT01654289|38846931|FG000|Overall Study|Withdrawal by Subject|10|||
16097862|NCT01654289|38846932|FG001|Overall Study|Withdrawal by Subject|8|||
16097863|NCT01654289|38846933|FG002|Overall Study|Withdrawal by Subject|5|||
16097864|NCT01654289|38846931|FG000|Overall Study|Withdrew from intervention only|17|||
16097865|NCT01654289|38846932|FG001|Overall Study|Withdrew from intervention only|20|||
16097866|NCT01654289|38846933|FG002|Overall Study|Withdrew from intervention only|0|||
16097867|NCT00784277|38846934|FG000|IR Treatment|Adverse Event|4|||
16097868|NCT00784277|38846935|FG001|IR Treatment|Adverse Event|8|||
16097869|NCT00784277|38846936|FG002|IR Treatment|Adverse Event|19|||
16097870|NCT00784277|38846937|FG003|IR Treatment|Adverse Event|35|||
16526421|NCT03701555|40394495|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
16526422|NCT03701555|40394496|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
16526423|NCT03701555|40394497|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
16526424|NCT03701555|40394498|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
16526425|NCT03701555|40394499|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
16097871|NCT00784277|38846938|FG004|IR Treatment|Adverse Event|0|||
16097872|NCT00784277|38846939|FG005|IR Treatment|Adverse Event|0|||
16211370|NCT03342404|39255577|FG001|Open-Label Phase|Lost to Follow-up|1|||
16097873|NCT00784277|38846940|FG006|IR Treatment|Adverse Event|0|||
16097874|NCT00784277|38846934|FG000|IR Treatment|Lack of Efficacy|4|||
16097875|NCT00784277|38846935|FG001|IR Treatment|Lack of Efficacy|4|||
16097876|NCT00784277|38846936|FG002|IR Treatment|Lack of Efficacy|1|||
16097877|NCT00784277|38846937|FG003|IR Treatment|Lack of Efficacy|0|||
16211371|NCT03342404|39255576|FG000|Open-Label Phase|Other reasons|0|||
16211372|NCT03342404|39255577|FG001|Open-Label Phase|Other reasons|1|||
16399481|NCT01581021|39941621|FG001|Overall Study|More than 2 hooks in thoracic|0|||
16097878|NCT00784277|38846938|FG004|IR Treatment|Lack of Efficacy|0|||
16097879|NCT00784277|38846939|FG005|IR Treatment|Lack of Efficacy|0|||
16097880|NCT00784277|38846940|FG006|IR Treatment|Lack of Efficacy|0|||
16097881|NCT00784277|38846934|FG000|IR Treatment|Lost to Follow-up|1|||
16526426|NCT03701555|40394500|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
16526427|NCT03701555|40394501|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
16097882|NCT00784277|38846935|FG001|IR Treatment|Lost to Follow-up|0|||
16211373|NCT03342404|39255576|FG000|Open-Label Phase|Adverse Event|0|||
16399482|NCT01581021|39941620|FG000|Overall Study|Neuromuscular|2|||
16526428|NCT03701555|40394502|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
16526429|NCT03701555|40394503|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
16526430|NCT03701555|40394504|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
16526431|NCT03701555|40394505|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
16526432|NCT03701555|40394506|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
16526433|NCT03701555|40394507|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
16399483|NCT01581021|39941621|FG001|Overall Study|Neuromuscular|1|||
16399484|NCT01581021|39941620|FG000|Overall Study|Not Randomized|1|||
16399485|NCT01581021|39941621|FG001|Overall Study|Not Randomized|2|||
16526434|NCT03701555|40394508|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
16526435|NCT03701555|40394509|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
16526436|NCT03701555|40394510|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
16211374|NCT03342404|39255577|FG001|Open-Label Phase|Adverse Event|3|||
16399486|NCT01581021|39941620|FG000|Overall Study|Lenke 6 Classification|0|||
16526437|NCT03701555|40394511|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
16526438|NCT03701555|40394512|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
16526439|NCT03701555|40394513|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
16526440|NCT03701555|40394514|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
16526441|NCT03701555|40394515|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
16526442|NCT03701555|40394516|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
16526443|NCT03701555|40394517|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
16526444|NCT03701555|40394518|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
16526445|NCT03701555|40394519|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
16526446|NCT03701555|40394520|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
16526447|NCT03701555|40394521|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
16526448|NCT03701555|40394522|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
16526449|NCT03701555|40394523|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
16526450|NCT03701555|40394524|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
16526451|NCT03701555|40394525|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
16526452|NCT03701555|40394526|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
16526453|NCT03701555|40394527|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
16526454|NCT03701555|40394528|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
16526455|NCT03701555|40394529|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
16526456|NCT03701555|40394530|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
16526457|NCT03701555|40394495|FG000|Part 2 (Day 1)|Other|0|||
16526458|NCT03701555|40394496|FG001|Part 2 (Day 1)|Other|0|||
16526459|NCT03701555|40394497|FG002|Part 2 (Day 1)|Other|0|||
16526460|NCT03701555|40394498|FG003|Part 2 (Day 1)|Other|0|||
16399487|NCT01581021|39941621|FG001|Overall Study|Lenke 6 Classification|1|||
16526461|NCT03701555|40394499|FG004|Part 2 (Day 1)|Other|0|||
16526462|NCT03701555|40394500|FG005|Part 2 (Day 1)|Other|0|||
16526463|NCT03701555|40394501|FG006|Part 2 (Day 1)|Other|0|||
16526464|NCT03701555|40394502|FG007|Part 2 (Day 1)|Other|0|||
16526465|NCT03701555|40394503|FG008|Part 2 (Day 1)|Other|0|||
16526466|NCT03701555|40394504|FG009|Part 2 (Day 1)|Other|0|||
16526467|NCT03701555|40394505|FG010|Part 2 (Day 1)|Other|3|||
16526468|NCT03701555|40394506|FG011|Part 2 (Day 1)|Other|1|||
16526469|NCT03701555|40394507|FG012|Part 2 (Day 1)|Other|0|||
16526470|NCT03701555|40394508|FG013|Part 2 (Day 1)|Other|1|||
16526471|NCT03701555|40394509|FG014|Part 2 (Day 1)|Other|0|||
16526472|NCT03701555|40394510|FG015|Part 2 (Day 1)|Other|2|||
16526473|NCT03701555|40394511|FG016|Part 2 (Day 1)|Other|2|||
16526474|NCT03701555|40394512|FG017|Part 2 (Day 1)|Other|0|||
16526475|NCT03701555|40394513|FG018|Part 2 (Day 1)|Other|0|||
16526476|NCT03701555|40394514|FG019|Part 2 (Day 1)|Other|0|||
16526477|NCT03701555|40394515|FG020|Part 2 (Day 1)|Other|0|||
16526478|NCT03701555|40394516|FG021|Part 2 (Day 1)|Other|0|||
16526479|NCT03701555|40394517|FG022|Part 2 (Day 1)|Other|0|||
16526480|NCT03701555|40394518|FG023|Part 2 (Day 1)|Other|0|||
16526481|NCT03701555|40394519|FG024|Part 2 (Day 1)|Other|0|||
16526482|NCT03701555|40394520|FG025|Part 2 (Day 1)|Other|0|||
16526483|NCT03701555|40394521|FG026|Part 2 (Day 1)|Other|0|||
16526484|NCT03701555|40394522|FG027|Part 2 (Day 1)|Other|0|||
16526485|NCT03701555|40394523|FG028|Part 2 (Day 1)|Other|0|||
16526486|NCT03701555|40394524|FG029|Part 2 (Day 1)|Other|0|||
16526487|NCT03701555|40394525|FG030|Part 2 (Day 1)|Other|0|||
16526488|NCT03701555|40394526|FG031|Part 2 (Day 1)|Other|0|||
16526489|NCT03701555|40394527|FG032|Part 2 (Day 1)|Other|0|||
16526490|NCT03701555|40394528|FG033|Part 2 (Day 1)|Other|0|||
16526491|NCT03701555|40394529|FG034|Part 2 (Day 1)|Other|0|||
16526492|NCT03701555|40394530|FG035|Part 2 (Day 1)|Other|0|||
16526493|NCT03701555|40394495|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
16526494|NCT03701555|40394496|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
16526495|NCT03701555|40394497|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
16526496|NCT03701555|40394498|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
16526497|NCT03701555|40394499|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
16526498|NCT03701555|40394500|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
16526499|NCT03701555|40394501|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
16526500|NCT03701555|40394502|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
16526501|NCT03701555|40394503|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
16526502|NCT03701555|40394504|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
16526503|NCT03701555|40394505|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
16526504|NCT03701555|40394506|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
16526505|NCT03701555|40394507|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
16526506|NCT03701555|40394508|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
16526507|NCT03701555|40394509|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
16526508|NCT03701555|40394510|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
16526509|NCT03701555|40394511|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
16526510|NCT03701555|40394512|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
16526511|NCT03701555|40394513|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
16526512|NCT03701555|40394514|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
16526513|NCT03701555|40394515|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
16526514|NCT03701555|40394516|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
16526515|NCT03701555|40394517|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
16526516|NCT03701555|40394518|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
16526517|NCT03701555|40394519|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
16526518|NCT03701555|40394520|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
16526519|NCT03701555|40394521|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
16526520|NCT03701555|40394522|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
16526521|NCT03701555|40394523|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
16211375|NCT03342404|39255576|FG000|Open-Label Phase|Withdrawal by Subject|0|||
16526522|NCT03701555|40394524|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
16526523|NCT03701555|40394525|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
16097883|NCT00784277|38846936|FG002|IR Treatment|Lost to Follow-up|1|||
16211376|NCT03342404|39255577|FG001|Open-Label Phase|Withdrawal by Subject|6|||
16211377|NCT02657434|39255579|FG000|Overall Study|Study Terminated By Sponsor|64|||
16211378|NCT02657434|39255580|FG001|Overall Study|Study Terminated By Sponsor|82|||
16211379|NCT02657434|39255579|FG000|Overall Study|Death|189|||
16526524|NCT03701555|40394526|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
16526525|NCT03701555|40394527|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
16526526|NCT03701555|40394528|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
16526527|NCT03701555|40394529|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
16526528|NCT03701555|40394530|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
16526529|NCT03701555|40394495|FG000|Part 3 (Day 1)|Subject Decision|0|||
16526530|NCT03701555|40394496|FG001|Part 3 (Day 1)|Subject Decision|0|||
16526531|NCT03701555|40394497|FG002|Part 3 (Day 1)|Subject Decision|0|||
16526532|NCT03701555|40394498|FG003|Part 3 (Day 1)|Subject Decision|0|||
16526533|NCT03701555|40394499|FG004|Part 3 (Day 1)|Subject Decision|0|||
16526534|NCT03701555|40394500|FG005|Part 3 (Day 1)|Subject Decision|0|||
16526535|NCT03701555|40394501|FG006|Part 3 (Day 1)|Subject Decision|0|||
16526536|NCT03701555|40394502|FG007|Part 3 (Day 1)|Subject Decision|0|||
16526537|NCT03701555|40394503|FG008|Part 3 (Day 1)|Subject Decision|0|||
16526538|NCT03701555|40394504|FG009|Part 3 (Day 1)|Subject Decision|0|||
16526539|NCT03701555|40394505|FG010|Part 3 (Day 1)|Subject Decision|0|||
16526540|NCT03701555|40394506|FG011|Part 3 (Day 1)|Subject Decision|0|||
16526541|NCT03701555|40394507|FG012|Part 3 (Day 1)|Subject Decision|0|||
16526542|NCT03701555|40394508|FG013|Part 3 (Day 1)|Subject Decision|0|||
16526543|NCT03701555|40394509|FG014|Part 3 (Day 1)|Subject Decision|0|||
16526544|NCT03701555|40394510|FG015|Part 3 (Day 1)|Subject Decision|0|||
16526545|NCT03701555|40394511|FG016|Part 3 (Day 1)|Subject Decision|0|||
16526546|NCT03701555|40394512|FG017|Part 3 (Day 1)|Subject Decision|0|||
16526547|NCT03701555|40394513|FG018|Part 3 (Day 1)|Subject Decision|0|||
16526548|NCT03701555|40394514|FG019|Part 3 (Day 1)|Subject Decision|0|||
16526549|NCT03701555|40394515|FG020|Part 3 (Day 1)|Subject Decision|0|||
16526550|NCT03701555|40394516|FG021|Part 3 (Day 1)|Subject Decision|0|||
16526551|NCT03701555|40394517|FG022|Part 3 (Day 1)|Subject Decision|0|||
16526552|NCT03701555|40394518|FG023|Part 3 (Day 1)|Subject Decision|0|||
16526553|NCT03701555|40394519|FG024|Part 3 (Day 1)|Subject Decision|0|||
16526554|NCT03701555|40394520|FG025|Part 3 (Day 1)|Subject Decision|0|||
16526555|NCT03701555|40394521|FG026|Part 3 (Day 1)|Subject Decision|1|||
16526556|NCT03701555|40394522|FG027|Part 3 (Day 1)|Subject Decision|0|||
16526557|NCT03701555|40394523|FG028|Part 3 (Day 1)|Subject Decision|0|||
16526558|NCT03701555|40394524|FG029|Part 3 (Day 1)|Subject Decision|0|||
16526559|NCT03701555|40394525|FG030|Part 3 (Day 1)|Subject Decision|0|||
16526560|NCT03701555|40394526|FG031|Part 3 (Day 1)|Subject Decision|2|||
16526561|NCT03701555|40394527|FG032|Part 3 (Day 1)|Subject Decision|1|||
16526562|NCT03701555|40394528|FG033|Part 3 (Day 1)|Subject Decision|1|||
16526563|NCT03701555|40394529|FG034|Part 3 (Day 1)|Subject Decision|0|||
16526564|NCT03701555|40394530|FG035|Part 3 (Day 1)|Subject Decision|0|||
16526565|NCT03701555|40394495|FG000|Part 3 (Day 1)|Other|0|||
16526566|NCT03701555|40394496|FG001|Part 3 (Day 1)|Other|0|||
16526567|NCT03701555|40394497|FG002|Part 3 (Day 1)|Other|0|||
16526568|NCT03701555|40394498|FG003|Part 3 (Day 1)|Other|0|||
16526569|NCT03701555|40394499|FG004|Part 3 (Day 1)|Other|0|||
16526570|NCT03701555|40394500|FG005|Part 3 (Day 1)|Other|0|||
16526571|NCT03701555|40394501|FG006|Part 3 (Day 1)|Other|0|||
16526572|NCT03701555|40394502|FG007|Part 3 (Day 1)|Other|0|||
16526573|NCT03701555|40394503|FG008|Part 3 (Day 1)|Other|0|||
16526574|NCT03701555|40394504|FG009|Part 3 (Day 1)|Other|0|||
16526575|NCT03701555|40394505|FG010|Part 3 (Day 1)|Other|0|||
16526576|NCT03701555|40394506|FG011|Part 3 (Day 1)|Other|0|||
16526577|NCT03701555|40394507|FG012|Part 3 (Day 1)|Other|0|||
16526578|NCT03701555|40394508|FG013|Part 3 (Day 1)|Other|0|||
16526579|NCT03701555|40394509|FG014|Part 3 (Day 1)|Other|0|||
16526580|NCT03701555|40394510|FG015|Part 3 (Day 1)|Other|0|||
16526581|NCT03701555|40394511|FG016|Part 3 (Day 1)|Other|0|||
16526582|NCT03701555|40394512|FG017|Part 3 (Day 1)|Other|0|||
16526583|NCT03701555|40394513|FG018|Part 3 (Day 1)|Other|0|||
16526584|NCT03701555|40394514|FG019|Part 3 (Day 1)|Other|0|||
16526585|NCT03701555|40394515|FG020|Part 3 (Day 1)|Other|0|||
16526586|NCT03701555|40394516|FG021|Part 3 (Day 1)|Other|0|||
16526587|NCT03701555|40394517|FG022|Part 3 (Day 1)|Other|0|||
16526588|NCT03701555|40394518|FG023|Part 3 (Day 1)|Other|0|||
16526589|NCT03701555|40394519|FG024|Part 3 (Day 1)|Other|1|||
16526590|NCT03701555|40394520|FG025|Part 3 (Day 1)|Other|1|||
16526591|NCT03701555|40394521|FG026|Part 3 (Day 1)|Other|0|||
16526592|NCT03701555|40394522|FG027|Part 3 (Day 1)|Other|0|||
16526593|NCT03701555|40394523|FG028|Part 3 (Day 1)|Other|0|||
16526594|NCT03701555|40394524|FG029|Part 3 (Day 1)|Other|1|||
16526595|NCT03701555|40394525|FG030|Part 3 (Day 1)|Other|1|||
16526596|NCT03701555|40394526|FG031|Part 3 (Day 1)|Other|0|||
16526597|NCT03701555|40394527|FG032|Part 3 (Day 1)|Other|1|||
16526598|NCT03701555|40394528|FG033|Part 3 (Day 1)|Other|1|||
16526599|NCT03701555|40394529|FG034|Part 3 (Day 1)|Other|0|||
16526600|NCT03701555|40394530|FG035|Part 3 (Day 1)|Other|0|||
16526601|NCT01944046|40394531|FG000|Randomized to DB|Adverse Event|5|||
16526602|NCT01944046|40394532|FG001|Randomized to DB|Adverse Event|2|||
16526603|NCT01944046|40394531|FG000|Randomized to DB|Clinical Worsening|3|||
16526604|NCT01944046|40394532|FG001|Randomized to DB|Clinical Worsening|2|||
16526605|NCT01944046|40394531|FG000|Randomized to DB|Lost to Follow-up|3|||
16526606|NCT01944046|40394532|FG001|Randomized to DB|Lost to Follow-up|3|||
16526607|NCT01944046|40394531|FG000|Randomized to DB|Withdrawal by Subject|2|||
16526608|NCT01944046|40394532|FG001|Randomized to DB|Withdrawal by Subject|4|||
16526609|NCT01944046|40394531|FG000|Randomized to DB|Physician Decision|1|||
16526610|NCT01944046|40394532|FG001|Randomized to DB|Physician Decision|2|||
16526611|NCT01944046|40394531|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
16526612|NCT01944046|40394532|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
16526613|NCT01944046|40394531|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
16526614|NCT01944046|40394532|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
16526615|NCT01944046|40394531|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
16526616|NCT01944046|40394532|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
16526617|NCT01944046|40394531|FG000|Open Label Eligible and Consented|Adverse Event|6|||
16526618|NCT01944046|40394532|FG001|Open Label Eligible and Consented|Adverse Event|1|||
16526619|NCT01944046|40394531|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
16526620|NCT01944046|40394532|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
16526621|NCT01944046|40394531|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
16526622|NCT01944046|40394532|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
16526623|NCT00627705|40394537|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
16526624|NCT00627705|40394538|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
16526625|NCT00627705|40394537|FG000|Overall Study|Adverse Event|1|||
16526626|NCT00627705|40394538|FG001|Overall Study|Adverse Event|0|||
16526627|NCT00627705|40394537|FG000|Overall Study|Withdrawal by Subject|0|||
16526628|NCT00627705|40394538|FG001|Overall Study|Withdrawal by Subject|2|||
16526629|NCT00627705|40394537|FG000|Overall Study|Lost to Follow-up|0|||
16526630|NCT00627705|40394538|FG001|Overall Study|Lost to Follow-up|1|||
16526631|NCT04598152|40394539|FG000|Overall Study|Lost to Follow-up|0|||
16526632|NCT04598152|40394540|FG001|Overall Study|Lost to Follow-up|1|||
16526633|NCT01197950|40394541|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
16526634|NCT01197950|40394542|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
16526635|NCT01197950|40394543|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
16526636|NCT03165045|40394544|FG000|Visit 1|No registration after visit 1|9|||
16526637|NCT03165045|40394544|FG000|Visit 1|No treatment documented|10|||
16526638|NCT03165045|40394544|FG000|Visit 1|No visit 1|10|||
16526639|NCT03165045|40394544|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
16526640|NCT03165045|40394544|FG000|Visit 2|No available total CCQ score at all|29|||
16526641|NCT03165045|40394544|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
16526642|NCT00581945|40394545|FG000|Overall Study|Adverse Event|4|||
16526643|NCT00581945|40394546|FG001|Overall Study|Adverse Event|4|||
16097884|NCT00784277|38846937|FG003|IR Treatment|Lost to Follow-up|0|||
16097885|NCT00784277|38846938|FG004|IR Treatment|Lost to Follow-up|0|||
16097886|NCT00784277|38846939|FG005|IR Treatment|Lost to Follow-up|0|||
16097887|NCT00784277|38846940|FG006|IR Treatment|Lost to Follow-up|0|||
16097888|NCT00784277|38846934|FG000|IR Treatment|Withdrawal by Subject|5|||
16097889|NCT00784277|38846935|FG001|IR Treatment|Withdrawal by Subject|1|||
16526644|NCT00581945|40394545|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16526645|NCT00581945|40394546|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16526646|NCT00581945|40394545|FG000|Overall Study|Withdrawal by Subject|2|||
16526647|NCT00581945|40394546|FG001|Overall Study|Withdrawal by Subject|6|||
16526648|NCT00581945|40394545|FG000|Overall Study|Death|1|||
16526649|NCT00581945|40394546|FG001|Overall Study|Death|0|||
16526650|NCT02317575|40394547|FG000|Period 1|Difficulty with venous cannulation|0|||
16526651|NCT02317575|40394548|FG001|Period 1|Difficulty with venous cannulation|1|||
16526652|NCT02317575|40394549|FG002|Period 1|Difficulty with venous cannulation|0|||
16526653|NCT02317575|40394550|FG003|Period 1|Difficulty with venous cannulation|0|||
16526654|NCT02317575|40394551|FG004|Period 1|Difficulty with venous cannulation|0|||
16526655|NCT02317575|40394547|FG000|Period 1|Withdrawal by Subject|1|||
16526656|NCT02317575|40394548|FG001|Period 1|Withdrawal by Subject|0|||
16526657|NCT02317575|40394549|FG002|Period 1|Withdrawal by Subject|0|||
16526658|NCT02317575|40394550|FG003|Period 1|Withdrawal by Subject|0|||
16526659|NCT02317575|40394551|FG004|Period 1|Withdrawal by Subject|0|||
16526660|NCT02571452|40394556|FG000|Overall Study Treatment|Protocol Violation|0|||
16526661|NCT02571452|40394557|FG001|Overall Study Treatment|Protocol Violation|1|||
16526662|NCT02571452|40394556|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
16526663|NCT02571452|40394557|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
16526664|NCT02571452|40394556|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
16526665|NCT02571452|40394557|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
16526666|NCT01793792|40394561|FG000|Overall Study|Death|5|||
16526667|NCT01793792|40394561|FG000|Overall Study|Lost to Follow-up|5|||
16526668|NCT01793792|40394561|FG000|Overall Study|Withdrawal by Subject|1|||
16526669|NCT01793792|40394561|FG000|Overall Study|Device Not Implanted|1|||
16526670|NCT02696850|40394562|FG000|Overall Study|Withdrawal by Subject|3|||
16526671|NCT02696850|40394563|FG001|Overall Study|Withdrawal by Subject|3|||
16526672|NCT02696850|40394562|FG000|Overall Study|Lost to Follow-up|8|||
16526673|NCT02696850|40394563|FG001|Overall Study|Lost to Follow-up|5|||
16526674|NCT04266028|40394564|FG000|Overall Study|Adverse Event|0|||
16526675|NCT04266028|40394565|FG001|Overall Study|Adverse Event|0|||
16526676|NCT04266028|40394566|FG002|Overall Study|Adverse Event|1|||
16526677|NCT04266028|40394567|FG003|Overall Study|Adverse Event|0|||
16526678|NCT04266028|40394568|FG004|Overall Study|Adverse Event|1|||
16526679|NCT04266028|40394569|FG005|Overall Study|Adverse Event|0|||
16097890|NCT00784277|38846936|FG002|IR Treatment|Withdrawal by Subject|4|||
16097891|NCT00784277|38846937|FG003|IR Treatment|Withdrawal by Subject|6|||
16097892|NCT00784277|38846938|FG004|IR Treatment|Withdrawal by Subject|0|||
16330235|NCT02461524|39692715|FG000|Overall Study|Withdrawal by Subject|4|||
16526680|NCT04266028|40394570|FG006|Overall Study|Adverse Event|2|||
16526681|NCT04266028|40394571|FG007|Overall Study|Adverse Event|0|||
16526682|NCT04266028|40394564|FG000|Overall Study|temporary halt of the study|0|||
16526683|NCT04266028|40394565|FG001|Overall Study|temporary halt of the study|0|||
16526684|NCT04266028|40394566|FG002|Overall Study|temporary halt of the study|0|||
16526685|NCT04266028|40394567|FG003|Overall Study|temporary halt of the study|0|||
16526686|NCT04266028|40394568|FG004|Overall Study|temporary halt of the study|0|||
16526687|NCT04266028|40394569|FG005|Overall Study|temporary halt of the study|0|||
16526688|NCT04266028|40394570|FG006|Overall Study|temporary halt of the study|2|||
16526689|NCT04266028|40394571|FG007|Overall Study|temporary halt of the study|1|||
16526690|NCT04266028|40394564|FG000|Overall Study|Onset of birch pollen season|0|||
16526691|NCT04266028|40394565|FG001|Overall Study|Onset of birch pollen season|0|||
16526692|NCT04266028|40394566|FG002|Overall Study|Onset of birch pollen season|0|||
16526693|NCT04266028|40394567|FG003|Overall Study|Onset of birch pollen season|0|||
16526694|NCT04266028|40394568|FG004|Overall Study|Onset of birch pollen season|1|||
16526695|NCT04266028|40394569|FG005|Overall Study|Onset of birch pollen season|0|||
16526696|NCT04266028|40394570|FG006|Overall Study|Onset of birch pollen season|0|||
16097893|NCT00784277|38846939|FG005|IR Treatment|Withdrawal by Subject|0|||
16097894|NCT00784277|38846940|FG006|IR Treatment|Withdrawal by Subject|0|||
16097895|NCT00784277|38846934|FG000|IR Treatment|Resolution Of Pain|0|||
16097896|NCT00784277|38846935|FG001|IR Treatment|Resolution Of Pain|1|||
16097897|NCT00784277|38846936|FG002|IR Treatment|Resolution Of Pain|0|||
16097898|NCT00784277|38846937|FG003|IR Treatment|Resolution Of Pain|0|||
16097899|NCT00784277|38846938|FG004|IR Treatment|Resolution Of Pain|0|||
16097900|NCT00784277|38846939|FG005|IR Treatment|Resolution Of Pain|0|||
16097901|NCT00784277|38846940|FG006|IR Treatment|Resolution Of Pain|0|||
16097902|NCT00784277|38846934|FG000|IR Treatment|Other|2|||
16097903|NCT00784277|38846935|FG001|IR Treatment|Other|3|||
16097904|NCT00784277|38846936|FG002|IR Treatment|Other|3|||
16097905|NCT00784277|38846937|FG003|IR Treatment|Other|2|||
16097906|NCT00784277|38846938|FG004|IR Treatment|Other|0|||
16526697|NCT04266028|40394571|FG007|Overall Study|Onset of birch pollen season|0|||
16526698|NCT00714168|40394576|FG000|Overall Study|Pregnancy|5|||
16526699|NCT00714168|40394577|FG001|Overall Study|Pregnancy|4|||
16526700|NCT00714168|40394576|FG000|Overall Study|Lost to Follow-up|32|||
16526701|NCT00714168|40394577|FG001|Overall Study|Lost to Follow-up|50|||
16526702|NCT00714168|40394576|FG000|Overall Study|Relocation|4|||
16526703|NCT00714168|40394577|FG001|Overall Study|Relocation|3|||
16526704|NCT00714168|40394576|FG000|Overall Study|Non-study medical condition|3|||
16526705|NCT00714168|40394577|FG001|Overall Study|Non-study medical condition|2|||
16526706|NCT01404312|40394578|FG000|Overall Study|Death|21|||
16526707|NCT01404312|40394579|FG001|Overall Study|Death|27|||
16526708|NCT01404312|40394578|FG000|Overall Study|Withdrawal by Subject|15|||
16526709|NCT01404312|40394579|FG001|Overall Study|Withdrawal by Subject|18|||
16526710|NCT01404312|40394578|FG000|Overall Study|Participant Unable to get to clinic|93|||
16526711|NCT01404312|40394579|FG001|Overall Study|Participant Unable to get to clinic|103|||
16526712|NCT01404312|40394578|FG000|Overall Study|Lost to Follow-up|115|||
16526713|NCT01404312|40394579|FG001|Overall Study|Lost to Follow-up|111|||
16526714|NCT01404312|40394578|FG000|Overall Study|Site closed|22|||
16526715|NCT01404312|40394579|FG001|Overall Study|Site closed|21|||
16526716|NCT01404312|40394578|FG000|Overall Study|Participant not willing to adhere to req|31|||
16526717|NCT01404312|40394579|FG001|Overall Study|Participant not willing to adhere to req|29|||
16330236|NCT02461524|39692715|FG000|Overall Study|Device Explanted|5|||
16330237|NCT02461524|39692715|FG000|Overall Study|Missed Visit|6|||
16526718|NCT01404312|40394578|FG000|Overall Study|Severe debilitation, unable to continue|1|||
16526719|NCT01404312|40394579|FG001|Overall Study|Severe debilitation, unable to continue|2|||
16526720|NCT01925183|40394583|FG000|Overall Study|Adverse Event|1|||
16526721|NCT01925183|40394584|FG001|Overall Study|Adverse Event|0|||
16526722|NCT01296568|40394586|FG000|Continued Access Phase|Lost to Follow-up|1|||
16526723|NCT01296568|40394586|FG000|Continued Access Phase|Withdrawal by Subject|1|||
16526724|NCT01296568|40394586|FG000|Continued Access Phase|Disease Progression|1|||
16526725|NCT01259713|40394587|FG000|Overall Study|Adverse Event|54|||
16526726|NCT01259713|40394588|FG001|Overall Study|Adverse Event|23|||
16526727|NCT01259713|40394587|FG000|Overall Study|Death Not Related to IFI|8|||
16526728|NCT01259713|40394588|FG001|Overall Study|Death Not Related to IFI|1|||
16526729|NCT01259713|40394587|FG000|Overall Study|Investigators Discretion|14|||
16526730|NCT01259713|40394588|FG001|Overall Study|Investigators Discretion|6|||
16097907|NCT00784277|38846939|FG005|IR Treatment|Other|0|||
16097908|NCT00784277|38846940|FG006|IR Treatment|Other|0|||
16330238|NCT00793546|39692716|FG000|Overall Study|Death|3|||
16097909|NCT00784277|38846934|FG000|ER Treatment|Adverse Event|0|||
16330239|NCT00793546|39692717|FG001|Overall Study|Death|0|||
16526731|NCT01259713|40394587|FG000|Overall Study|Lack of Efficacy|2|||
16526732|NCT01259713|40394588|FG001|Overall Study|Lack of Efficacy|0|||
16097910|NCT00784277|38846935|FG001|ER Treatment|Adverse Event|0|||
16097911|NCT00784277|38846936|FG002|ER Treatment|Adverse Event|0|||
16097912|NCT00784277|38846937|FG003|ER Treatment|Adverse Event|0|||
16097913|NCT00784277|38846938|FG004|ER Treatment|Adverse Event|1|||
16097914|NCT00784277|38846939|FG005|ER Treatment|Adverse Event|7|||
16097915|NCT00784277|38846940|FG006|ER Treatment|Adverse Event|7|||
16097916|NCT00784277|38846934|FG000|ER Treatment|Lack of Efficacy|0|||
16097917|NCT00784277|38846935|FG001|ER Treatment|Lack of Efficacy|0|||
16097918|NCT00784277|38846936|FG002|ER Treatment|Lack of Efficacy|0|||
16097919|NCT00784277|38846937|FG003|ER Treatment|Lack of Efficacy|0|||
16097920|NCT00784277|38846938|FG004|ER Treatment|Lack of Efficacy|3|||
16097921|NCT00784277|38846939|FG005|ER Treatment|Lack of Efficacy|4|||
16097922|NCT00784277|38846940|FG006|ER Treatment|Lack of Efficacy|0|||
16097923|NCT00784277|38846934|FG000|ER Treatment|Lost to Follow-up|0|||
16097924|NCT00784277|38846935|FG001|ER Treatment|Lost to Follow-up|0|||
16097925|NCT00784277|38846936|FG002|ER Treatment|Lost to Follow-up|0|||
16097926|NCT00784277|38846937|FG003|ER Treatment|Lost to Follow-up|0|||
16097927|NCT00784277|38846938|FG004|ER Treatment|Lost to Follow-up|0|||
16097928|NCT00784277|38846939|FG005|ER Treatment|Lost to Follow-up|2|||
16097929|NCT00784277|38846940|FG006|ER Treatment|Lost to Follow-up|0|||
16097930|NCT00784277|38846934|FG000|ER Treatment|Withdrawal by Subject|0|||
16097931|NCT00784277|38846935|FG001|ER Treatment|Withdrawal by Subject|0|||
16097932|NCT00784277|38846936|FG002|ER Treatment|Withdrawal by Subject|0|||
16097933|NCT00784277|38846937|FG003|ER Treatment|Withdrawal by Subject|0|||
16097934|NCT00784277|38846938|FG004|ER Treatment|Withdrawal by Subject|2|||
16097935|NCT00784277|38846939|FG005|ER Treatment|Withdrawal by Subject|5|||
16097936|NCT00784277|38846940|FG006|ER Treatment|Withdrawal by Subject|3|||
16097937|NCT00784277|38846934|FG000|ER Treatment|Study Medication Non-Compliant|0|||
16097938|NCT00784277|38846935|FG001|ER Treatment|Study Medication Non-Compliant|0|||
16097939|NCT00784277|38846936|FG002|ER Treatment|Study Medication Non-Compliant|0|||
16097940|NCT00784277|38846937|FG003|ER Treatment|Study Medication Non-Compliant|0|||
16097941|NCT00784277|38846938|FG004|ER Treatment|Study Medication Non-Compliant|2|||
16097942|NCT00784277|38846939|FG005|ER Treatment|Study Medication Non-Compliant|3|||
16097943|NCT00784277|38846940|FG006|ER Treatment|Study Medication Non-Compliant|3|||
16097944|NCT00784277|38846934|FG000|ER Treatment|Other|0|||
16526733|NCT01259713|40394587|FG000|Overall Study|Protocol Violation|5|||
16526734|NCT01259713|40394588|FG001|Overall Study|Protocol Violation|4|||
16526735|NCT01259713|40394587|FG000|Overall Study|Subject Withdrew Consent|12|||
16526736|NCT01259713|40394588|FG001|Overall Study|Subject Withdrew Consent|7|||
16526737|NCT00586105|40394591|FG000|Overall Study|Adverse Event|4|||
16526738|NCT00586105|40394591|FG000|Overall Study|Death|2|||
16526739|NCT00586105|40394591|FG000|Overall Study|Protocol Violation|1|||
16526740|NCT00586105|40394591|FG000|Overall Study|Withdrawal by Subject|3|||
16526741|NCT00586105|40394591|FG000|Overall Study|Disease progression|19|||
16526742|NCT00586105|40394591|FG000|Overall Study|Switched to commercial drug|9|||
16526743|NCT00586105|40394591|FG000|Overall Study|Reason not reported|1|||
16526744|NCT02763384|40394594|FG000|Overall Study|Physician Decision|1|||
16526745|NCT02763384|40394594|FG000|Overall Study|Rapid decline - went on hospice|1|||
16526746|NCT03985423|40394595|FG000|Overall Study|Adverse Event|1|||
16526747|NCT03985423|40394595|FG000|Overall Study|Death|2|||
16526748|NCT03985423|40394595|FG000|Overall Study|Physician Decision|1|||
16526749|NCT03985423|40394595|FG000|Overall Study|Withdrawal by Subject|2|||
16526750|NCT03985423|40394595|FG000|Overall Study|Lack of insurance and citizenship|1|||
16526751|NCT02091726|40394596|FG000|Overall Study|Lost to Follow-up|6|||
16526752|NCT02696317|40394597|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
16097945|NCT00784277|38846935|FG001|ER Treatment|Other|0|||
16097946|NCT00784277|38846936|FG002|ER Treatment|Other|0|||
16097947|NCT00784277|38846937|FG003|ER Treatment|Other|0|||
16097948|NCT00784277|38846938|FG004|ER Treatment|Other|1|||
16097949|NCT00784277|38846939|FG005|ER Treatment|Other|3|||
16097950|NCT00784277|38846940|FG006|ER Treatment|Other|2|||
16211380|NCT02657434|39255580|FG001|Overall Study|Death|190|||
16211381|NCT02657434|39255579|FG000|Overall Study|Lost to Follow-up|2|||
16211382|NCT02657434|39255580|FG001|Overall Study|Lost to Follow-up|2|||
16211383|NCT02657434|39255579|FG000|Overall Study|Randomization by Error|2|||
16211384|NCT02657434|39255580|FG001|Overall Study|Randomization by Error|0|||
16211385|NCT02657434|39255579|FG000|Overall Study|Withdrawal by Subject|28|||
16211386|NCT02657434|39255580|FG001|Overall Study|Withdrawal by Subject|17|||
16211387|NCT02657434|39255579|FG000|Overall Study|Protocol Violation|1|||
16211388|NCT02657434|39255580|FG001|Overall Study|Protocol Violation|0|||
16211389|NCT02657434|39255579|FG000|Overall Study|Physician Decision|0|||
16211390|NCT02657434|39255580|FG001|Overall Study|Physician Decision|1|||
16211391|NCT00959699|39255587|FG000|Treatment Period|Adverse Event|3|||
16526753|NCT02696317|40394598|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
16526754|NCT02696317|40394597|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
16097951|NCT01799993|38846944|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
16097952|NCT01799993|38846945|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
16097953|NCT01799993|38846944|FG000|Overall Study|Death|61|||
16097954|NCT01799993|38846945|FG001|Overall Study|Death|45|||
16097955|NCT01799993|38846944|FG000|Overall Study|Withdrawal by Subject|23|||
16097956|NCT01799993|38846945|FG001|Overall Study|Withdrawal by Subject|24|||
16526755|NCT02696317|40394598|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
16526756|NCT01659021|40394599|FG000|Main Study|Adverse Event|2|||
16526757|NCT01659021|40394600|FG001|Main Study|Adverse Event|3|||
16526758|NCT01659021|40394599|FG000|Main Study|Lost to Follow-up|1|||
16526759|NCT01659021|40394600|FG001|Main Study|Lost to Follow-up|0|||
16526760|NCT01659021|40394599|FG000|Main Study|Unknown Reasons|2|||
16526761|NCT01659021|40394600|FG001|Main Study|Unknown Reasons|1|||
16526762|NCT01659021|40394599|FG000|Main Study|Physician Decision|34|||
16526763|NCT01659021|40394600|FG001|Main Study|Physician Decision|16|||
16526764|NCT01659021|40394599|FG000|Main Study|Withdrawal by Subject|19|||
16526765|NCT01659021|40394600|FG001|Main Study|Withdrawal by Subject|16|||
16526766|NCT01659021|40394599|FG000|Main Study|Study Terminated by Sponsor|16|||
16526767|NCT01659021|40394600|FG001|Main Study|Study Terminated by Sponsor|1|||
16526768|NCT01659021|40394599|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
16526769|NCT01659021|40394600|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
16526770|NCT01659021|40394599|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
16526771|NCT01659021|40394600|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
16526772|NCT02802345|40394601|FG000|Overall Study|Not Treated|0|||
16526773|NCT02802345|40394602|FG001|Overall Study|Not Treated|1|||
16526774|NCT02802345|40394601|FG000|Overall Study|Adverse Event|28|||
16526775|NCT02802345|40394602|FG001|Overall Study|Adverse Event|20|||
16526776|NCT02802345|40394601|FG000|Overall Study|Withdrawal by Subject|3|||
16526777|NCT02802345|40394602|FG001|Overall Study|Withdrawal by Subject|3|||
16526778|NCT02802345|40394601|FG000|Overall Study|Protocol Violation|0|||
16526779|NCT02802345|40394602|FG001|Overall Study|Protocol Violation|1|||
16526780|NCT02802345|40394601|FG000|Overall Study|Other than listed|1|||
16526781|NCT02802345|40394602|FG001|Overall Study|Other than listed|5|||
16526782|NCT01337089|40394606|FG000|Overall Study|Adverse Event|237|||
16526783|NCT01337089|40394606|FG000|Overall Study|Withdrawal by Subject|129|||
16211392|NCT00959699|39255588|FG001|Treatment Period|Adverse Event|13|||
16211393|NCT00959699|39255587|FG000|Treatment Period|Lack of Efficacy|15|||
16211394|NCT00959699|39255588|FG001|Treatment Period|Lack of Efficacy|6|||
16211395|NCT00959699|39255587|FG000|Treatment Period|Lost to Follow-up|0|||
16211396|NCT00959699|39255588|FG001|Treatment Period|Lost to Follow-up|1|||
16211397|NCT00959699|39255587|FG000|Treatment Period|Withdrawal by Subject|1|||
16211398|NCT00959699|39255588|FG001|Treatment Period|Withdrawal by Subject|3|||
16211399|NCT00959699|39255587|FG000|Treatment Period|Non-Compliance with Protocol|0|||
16211400|NCT00959699|39255588|FG001|Treatment Period|Non-Compliance with Protocol|1|||
16211401|NCT00959699|39255587|FG000|Treatment Period|Did not receive treatment|0|||
16211402|NCT00959699|39255588|FG001|Treatment Period|Did not receive treatment|1|||
16211403|NCT00959699|39255587|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
16211404|NCT00959699|39255588|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
16211405|NCT00959699|39255587|FG000|Follow-up Period|Lost to Follow-up|3|||
16211406|NCT00959699|39255588|FG001|Follow-up Period|Lost to Follow-up|2|||
16211407|NCT00959699|39255587|FG000|Follow-up Period|Withdrawal by Subject|3|||
16211408|NCT00959699|39255588|FG001|Follow-up Period|Withdrawal by Subject|4|||
16211409|NCT00693693|39255589|FG000|Overall Study|Lost to Follow-up|1|||
16211410|NCT00693693|39255590|FG001|Overall Study|Lost to Follow-up|1|||
16211411|NCT00693693|39255591|FG002|Overall Study|Lost to Follow-up|2|||
16211412|NCT02470429|39255592|FG000|Overall Study|Adverse Event|1|||
16211413|NCT02470429|39255593|FG001|Overall Study|Adverse Event|0|||
16211414|NCT02470429|39255592|FG000|Overall Study|Withdrawal by Subject|1|||
16211415|NCT02470429|39255593|FG001|Overall Study|Withdrawal by Subject|0|||
16211416|NCT00224003|39255594|FG000|Overall Study|Adverse Event|1|||
16211417|NCT00224003|39255594|FG000|Overall Study|Protocol Violation|2|||
16211418|NCT00224003|39255594|FG000|Overall Study|Withdrawal by Subject|1|||
16526784|NCT01337089|40394606|FG000|Overall Study|Withdrawal by Investigator|33|||
16526785|NCT01337089|40394606|FG000|Overall Study|Met Withdrawal Criteria|3|||
16526786|NCT01337089|40394606|FG000|Overall Study|Lost to Follow-up|2|||
16526787|NCT03299049|40394609|FG000|Overall Study|On-going|486|||
16526788|NCT03299049|40394610|FG001|Overall Study|On-going|481|||
16526789|NCT03299049|40394609|FG000|Overall Study|Withdrawal by Subject|6|||
16211419|NCT00224003|39255594|FG000|Overall Study|unk|3|||
16211420|NCT00493467|39255597|FG000|Overall Study|Death|1|||
16211421|NCT01175590|39255602|FG000|Overall Study|Lost to Follow-up|1|||
16526790|NCT03299049|40394610|FG001|Overall Study|Withdrawal by Subject|21|||
16526791|NCT03299049|40394609|FG000|Overall Study|Physician Decision|5|||
16526792|NCT03299049|40394610|FG001|Overall Study|Physician Decision|1|||
16399488|NCT01581021|39941620|FG000|Overall Study|Lack of Efficacy|0|||
16399489|NCT01581021|39941621|FG001|Overall Study|Lack of Efficacy|1|||
16399490|NCT01691105|39941627|FG000|1 Month Follow-up|Lost to Follow-up|41|||
16399491|NCT01691105|39941628|FG001|1 Month Follow-up|Lost to Follow-up|38|||
16399492|NCT01691105|39941627|FG000|1 Month Follow-up|Death|2|||
16399493|NCT01691105|39941628|FG001|1 Month Follow-up|Death|3|||
16399494|NCT01691105|39941627|FG000|6 Month Follow-up|Lost to Follow-up|39|||
16399495|NCT01691105|39941628|FG001|6 Month Follow-up|Lost to Follow-up|58|||
16399496|NCT01691105|39941627|FG000|6 Month Follow-up|Death|13|||
16399497|NCT01691105|39941628|FG001|6 Month Follow-up|Death|13|||
16399498|NCT01691105|39941627|FG000|12 Month Follow-up|Lost to Follow-up|50|||
16399499|NCT01691105|39941628|FG001|12 Month Follow-up|Lost to Follow-up|71|||
16399500|NCT01691105|39941627|FG000|12 Month Follow-up|Death|22|||
16399501|NCT01691105|39941628|FG001|12 Month Follow-up|Death|30|||
16399502|NCT01691105|39941627|FG000|12 Month Biochemical Verification|Death|22|||
16399503|NCT01691105|39941628|FG001|12 Month Biochemical Verification|Death|30|||
16399504|NCT01691105|39941627|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
16399505|NCT01691105|39941628|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
16399506|NCT01691105|39941627|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
16399507|NCT01691105|39941628|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
16399508|NCT01169701|39941629|FG000|Overall Study|Lost to Follow-up|1|||
16211422|NCT01175590|39255603|FG001|Overall Study|Lost to Follow-up|0|||
16211423|NCT01175590|39255602|FG000|Overall Study|Withdrawal by Subject|0|||
16211424|NCT01175590|39255603|FG001|Overall Study|Withdrawal by Subject|2|||
16211425|NCT01175590|39255602|FG000|Overall Study|Adverse Event|4|||
16399509|NCT01169701|39941630|FG001|Overall Study|Lost to Follow-up|1|||
16399510|NCT01169701|39941629|FG000|Overall Study|Withdrawal by Subject|1|||
16399511|NCT01169701|39941630|FG001|Overall Study|Withdrawal by Subject|3|||
16399512|NCT01169701|39941629|FG000|Overall Study|Adverse Event|1|||
16399513|NCT01169701|39941630|FG001|Overall Study|Adverse Event|2|||
16399514|NCT01169701|39941629|FG000|Overall Study|Exclusion criteria|2|||
16211426|NCT01175590|39255603|FG001|Overall Study|Adverse Event|0|||
16399515|NCT01169701|39941630|FG001|Overall Study|Exclusion criteria|0|||
16399516|NCT01169701|39941629|FG000|Overall Study|Death|0|||
16399517|NCT01169701|39941630|FG001|Overall Study|Death|1|||
16399518|NCT01169701|39941629|FG000|Overall Study|Administrative problems|0|||
16399519|NCT01169701|39941630|FG001|Overall Study|Administrative problems|1|||
16399520|NCT01169701|39941629|FG000|Overall Study|Serious adverse event|0|||
16399521|NCT01169701|39941630|FG001|Overall Study|Serious adverse event|1|||
16399522|NCT01169701|39941629|FG000|Overall Study|Sponsor decision|0|||
16399523|NCT01169701|39941630|FG001|Overall Study|Sponsor decision|1|||
16526793|NCT03299049|40394609|FG000|Overall Study|Lost to Follow-up|2|||
16526794|NCT03299049|40394610|FG001|Overall Study|Lost to Follow-up|0|||
16526795|NCT03299049|40394609|FG000|Overall Study|Pregnancy|1|||
16526796|NCT03299049|40394610|FG001|Overall Study|Pregnancy|3|||
16526797|NCT03299049|40394609|FG000|Overall Study|Protocol Violation|1|||
16526798|NCT03299049|40394610|FG001|Overall Study|Protocol Violation|1|||
16526799|NCT03299049|40394609|FG000|Overall Study|Lack of Efficacy|9|||
16526800|NCT03299049|40394610|FG001|Overall Study|Lack of Efficacy|3|||
16526801|NCT03299049|40394609|FG000|Overall Study|Adverse Event|12|||
16526802|NCT03299049|40394610|FG001|Overall Study|Adverse Event|13|||
16526803|NCT02117570|40394611|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
16526804|NCT02117570|40394612|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
16526805|NCT02117570|40394613|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
16526806|NCT02117570|40394611|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
16526807|NCT02117570|40394612|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
16526808|NCT02117570|40394613|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
16526809|NCT02117570|40394611|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
16526810|NCT02117570|40394612|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
16526811|NCT02117570|40394613|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
16526812|NCT02117570|40394611|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
16526813|NCT02117570|40394612|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
16526814|NCT02117570|40394613|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
16399524|NCT03403361|39941631|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
16097957|NCT01799993|38846944|FG000|Overall Study|Lost to Follow-up|5|||
16399525|NCT01071252|39941632|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
16399526|NCT01071252|39941633|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
16399527|NCT01071252|39941634|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
16399528|NCT01071252|39941635|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
16399529|NCT01071252|39941636|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
16526815|NCT02117570|40394611|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
16097958|NCT01799993|38846945|FG001|Overall Study|Lost to Follow-up|8|||
16399530|NCT01071252|39941632|FG000|Overall Study|Withdrawal by Subject|8|||
16399531|NCT01071252|39941633|FG001|Overall Study|Withdrawal by Subject|2|||
16399532|NCT01071252|39941634|FG002|Overall Study|Withdrawal by Subject|1|||
16399533|NCT01071252|39941635|FG003|Overall Study|Withdrawal by Subject|2|||
16526816|NCT02117570|40394612|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
16526817|NCT02117570|40394613|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
16526818|NCT02117570|40394611|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
16526819|NCT02117570|40394612|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
16526820|NCT02117570|40394613|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
16526821|NCT02117570|40394611|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
16526822|NCT02117570|40394612|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
16526823|NCT02117570|40394613|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
16526824|NCT00127608|40394614|FG000|Overall Study|VZV DNA negative|1|||
16526825|NCT03738865|40394615|FG000|Overall Study|Withdrawal by Subject|3|||
16526826|NCT03738865|40394616|FG001|Overall Study|Withdrawal by Subject|3|||
16526827|NCT03738865|40394615|FG000|Overall Study|Adverse Event|2|||
16526828|NCT03738865|40394616|FG001|Overall Study|Adverse Event|0|||
16526829|NCT03738865|40394615|FG000|Overall Study|Physician Decision|0|||
16526830|NCT03738865|40394616|FG001|Overall Study|Physician Decision|1|||
16526831|NCT00086346|40394617|FG000|Randomization|Did not receive test article|4|||
16526832|NCT00086346|40394618|FG001|Randomization|Did not receive test article|4|||
16526833|NCT00086346|40394617|FG000|Patients Dosed With Test Article|Adverse Event|94|||
16211427|NCT01175590|39255602|FG000|Overall Study|Physician Decision|1|||
16211428|NCT01175590|39255603|FG001|Overall Study|Physician Decision|4|||
16211429|NCT01175590|39255602|FG000|Overall Study|Lack of Efficacy|1|||
16211430|NCT01175590|39255603|FG001|Overall Study|Lack of Efficacy|1|||
16211431|NCT01175590|39255602|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
16211432|NCT01175590|39255603|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
16330240|NCT00793546|39692716|FG000|Overall Study|Lost to Follow-up|1|||
16330241|NCT00793546|39692717|FG001|Overall Study|Lost to Follow-up|0|||
16330242|NCT00793546|39692716|FG000|Overall Study|Withdrawal by Subject|1|||
16330243|NCT00793546|39692717|FG001|Overall Study|Withdrawal by Subject|1|||
16330244|NCT00793546|39692716|FG000|Overall Study|Study Terminated by Sponsor|8|||
16330245|NCT00793546|39692717|FG001|Overall Study|Study Terminated by Sponsor|27|||
16330246|NCT00793546|39692716|FG000|Overall Study|Other|1|||
16330247|NCT00793546|39692717|FG001|Overall Study|Other|0|||
16330248|NCT02939716|39696160|FG000|Overall Study|scanner failure|0|||
16330249|NCT02939716|39696161|FG001|Overall Study|scanner failure|0|||
16330250|NCT02939716|39696162|FG002|Overall Study|scanner failure|0|||
16330251|NCT02939716|39696163|FG003|Overall Study|scanner failure|1|||
16330252|NCT02939716|39696164|FG004|Overall Study|scanner failure|1|||
16330253|NCT02939716|39696165|FG005|Overall Study|scanner failure|1|||
16330254|NCT02822573|39696166|FG000|Overall Study|Lost to Follow-up|5|||
16330255|NCT02822573|39696167|FG001|Overall Study|Lost to Follow-up|3|||
16330256|NCT02822573|39696166|FG000|Overall Study|Physician Decision|1|||
16330257|NCT02822573|39696167|FG001|Overall Study|Physician Decision|1|||
16330258|NCT02822573|39696166|FG000|Overall Study|Withdrawal by Subject|9|||
16330259|NCT02822573|39696167|FG001|Overall Study|Withdrawal by Subject|5|||
16330260|NCT02822573|39696166|FG000|Overall Study|Protocol Violation|6|||
16330261|NCT02822573|39696167|FG001|Overall Study|Protocol Violation|4|||
16330262|NCT02822573|39696166|FG000|Overall Study|Too sick or ill|2|||
16330263|NCT02822573|39696167|FG001|Overall Study|Too sick or ill|1|||
16330264|NCT02822573|39696166|FG000|Overall Study|Disease Progression|1|||
16330265|NCT02822573|39696167|FG001|Overall Study|Disease Progression|1|||
16330266|NCT02822573|39696166|FG000|Overall Study|No reason given|6|||
16330267|NCT02822573|39696167|FG001|Overall Study|No reason given|4|||
16526834|NCT00086346|40394618|FG001|Patients Dosed With Test Article|Adverse Event|11|||
16526835|NCT00086346|40394617|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
16526836|NCT00086346|40394618|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
16526837|NCT00086346|40394617|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
16526838|NCT00086346|40394618|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
16526839|NCT00086346|40394617|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
16526840|NCT00086346|40394618|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
16526841|NCT00086346|40394617|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
16526842|NCT00086346|40394618|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
16526843|NCT00086346|40394617|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
16330268|NCT01668966|39696168|FG000|Overall Study|Withdrawal by Subject|1|||
16330269|NCT01668966|39696168|FG000|Overall Study|Death|1|||
16330270|NCT01668966|39696168|FG000|Overall Study|Not treated|2|||
16330271|NCT02847182|39696169|FG000|Overall Study|Withdrawal by Subject|0|||
16330272|NCT02847182|39696170|FG001|Overall Study|Withdrawal by Subject|1|||
16330273|NCT02691936|39696176|FG000|Overall Study|Withdrawal by Subject|2|||
16330274|NCT02691936|39696177|FG001|Overall Study|Withdrawal by Subject|5|||
16330275|NCT04245202|39696187|FG000|Overall Study|Lack of Efficacy|10|||
16330276|NCT04245202|39696188|FG001|Overall Study|Lack of Efficacy|1|||
16526844|NCT00086346|40394618|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
16211433|NCT01175590|39255602|FG000|Overall Study|Treated not as randomized|3|||
16211434|NCT01175590|39255603|FG001|Overall Study|Treated not as randomized|2|||
16211435|NCT01175590|39255602|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
16330277|NCT00712881|39696194|FG000|Overall Study|Adverse Event|3|||
16399534|NCT01071252|39941636|FG004|Overall Study|Withdrawal by Subject|3|||
16399535|NCT01071252|39941632|FG000|Overall Study|administrative problems|1|||
16399536|NCT01071252|39941633|FG001|Overall Study|administrative problems|1|||
16399537|NCT01071252|39941634|FG002|Overall Study|administrative problems|0|||
16399538|NCT01071252|39941635|FG003|Overall Study|administrative problems|2|||
16399539|NCT01071252|39941636|FG004|Overall Study|administrative problems|1|||
16399540|NCT01071252|39941632|FG000|Overall Study|Lost to Follow-up|1|||
16399541|NCT01071252|39941633|FG001|Overall Study|Lost to Follow-up|0|||
16399542|NCT01071252|39941634|FG002|Overall Study|Lost to Follow-up|1|||
16399543|NCT01071252|39941635|FG003|Overall Study|Lost to Follow-up|2|||
16399544|NCT01071252|39941636|FG004|Overall Study|Lost to Follow-up|0|||
16399545|NCT01071252|39941632|FG000|Overall Study|Adverse Event|1|||
16399546|NCT01071252|39941633|FG001|Overall Study|Adverse Event|1|||
16399547|NCT01071252|39941634|FG002|Overall Study|Adverse Event|0|||
16399548|NCT01071252|39941635|FG003|Overall Study|Adverse Event|1|||
16399549|NCT01071252|39941636|FG004|Overall Study|Adverse Event|0|||
16399550|NCT01071252|39941632|FG000|Overall Study|Death|0|||
16399551|NCT01071252|39941633|FG001|Overall Study|Death|0|||
16399552|NCT01071252|39941634|FG002|Overall Study|Death|0|||
16399553|NCT01071252|39941635|FG003|Overall Study|Death|0|||
16399554|NCT01071252|39941636|FG004|Overall Study|Death|1|||
16399555|NCT00853242|39941637|FG000|Overall Study|Adverse Event|0|||
16399556|NCT00853242|39941638|FG001|Overall Study|Adverse Event|1|||
16399557|NCT00853242|39941639|FG002|Overall Study|Adverse Event|1|||
16399558|NCT00853242|39941640|FG003|Overall Study|Adverse Event|0|||
16399559|NCT00853242|39941641|FG004|Overall Study|Adverse Event|3|||
16399560|NCT00853242|39941642|FG005|Overall Study|Adverse Event|1|||
16399561|NCT00853242|39941643|FG006|Overall Study|Adverse Event|1|||
16399562|NCT00853242|39941637|FG000|Overall Study|Noncompliant|0|||
16399563|NCT00853242|39941638|FG001|Overall Study|Noncompliant|0|||
16399564|NCT00853242|39941639|FG002|Overall Study|Noncompliant|0|||
16399565|NCT00853242|39941640|FG003|Overall Study|Noncompliant|0|||
16399566|NCT00853242|39941641|FG004|Overall Study|Noncompliant|1|||
16399567|NCT00853242|39941642|FG005|Overall Study|Noncompliant|0|||
16399568|NCT00853242|39941643|FG006|Overall Study|Noncompliant|0|||
16399569|NCT00853242|39941637|FG000|Overall Study|Withdrawal by Subject|1|||
16399570|NCT00853242|39941638|FG001|Overall Study|Withdrawal by Subject|2|||
16399571|NCT00853242|39941639|FG002|Overall Study|Withdrawal by Subject|0|||
16399572|NCT00853242|39941640|FG003|Overall Study|Withdrawal by Subject|4|||
16399573|NCT00853242|39941641|FG004|Overall Study|Withdrawal by Subject|0|||
16399574|NCT00853242|39941642|FG005|Overall Study|Withdrawal by Subject|0|||
16399575|NCT00853242|39941643|FG006|Overall Study|Withdrawal by Subject|2|||
16399576|NCT00853242|39941637|FG000|Overall Study|Other|2|||
16399577|NCT00853242|39941638|FG001|Overall Study|Other|0|||
16399578|NCT00853242|39941639|FG002|Overall Study|Other|2|||
16399579|NCT00853242|39941640|FG003|Overall Study|Other|0|||
16526845|NCT03376321|40394620|FG000|Overall Study|Other|5|||
16526846|NCT03376321|40394621|FG001|Overall Study|Other|1|||
16526847|NCT03376321|40394620|FG000|Overall Study|Withdrawal by Subject|8|||
16526848|NCT03376321|40394621|FG001|Overall Study|Withdrawal by Subject|14|||
16526849|NCT03376321|40394620|FG000|Overall Study|Lost to Follow-up|1|||
16526850|NCT03376321|40394621|FG001|Overall Study|Lost to Follow-up|7|||
16526851|NCT03376321|40394620|FG000|Overall Study|Death|4|||
16526852|NCT03376321|40394621|FG001|Overall Study|Death|0|||
16526853|NCT03376321|40394620|FG000|Overall Study|Randomized, not treated|5|||
16526854|NCT03376321|40394621|FG001|Overall Study|Randomized, not treated|3|||
16526855|NCT00214136|40394622|FG000|Overall Study|Death|5|||
16526856|NCT00346034|40394625|FG000|Overall Study|Adverse Event|34|||
16526857|NCT00346034|40394625|FG000|Overall Study|Lack of Efficacy|8|||
16526858|NCT00346034|40394625|FG000|Overall Study|Withdrawal by Subject|13|||
16526859|NCT00346034|40394625|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
16526860|NCT00346034|40394625|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
16526861|NCT01114646|40394626|FG000|Overall Study|Withdrawal by Subject|3|||
16526862|NCT01114646|40394627|FG001|Overall Study|Withdrawal by Subject|2|||
16526863|NCT02553330|40394628|FG000|Overall Study|Study Terminated by Sponsor|2|||
16399580|NCT00853242|39941641|FG004|Overall Study|Other|0|||
16399581|NCT00853242|39941642|FG005|Overall Study|Other|1|||
16399582|NCT00853242|39941643|FG006|Overall Study|Other|2|||
16399583|NCT02778555|39941644|FG000|Overall Study|Withdrawal by Subject|55|||
16399584|NCT02778555|39941645|FG001|Overall Study|Withdrawal by Subject|32|||
16399585|NCT02778555|39941646|FG002|Overall Study|Withdrawal by Subject|107|||
16399586|NCT01811485|39941650|FG000|Overall Study|Adverse Event|1|||
16399587|NCT01811485|39941651|FG001|Overall Study|Adverse Event|3|||
16399588|NCT01811485|39941652|FG002|Overall Study|Adverse Event|2|||
16399589|NCT01811485|39941650|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16399590|NCT01811485|39941651|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16399591|NCT01811485|39941652|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
16399592|NCT01811485|39941650|FG000|Overall Study|Administrative problems|1|||
16399593|NCT01811485|39941651|FG001|Overall Study|Administrative problems|0|||
16399594|NCT01811485|39941652|FG002|Overall Study|Administrative problems|0|||
16399595|NCT01811485|39941650|FG000|Overall Study|Protocol Deviation|0|||
16399596|NCT01811485|39941651|FG001|Overall Study|Protocol Deviation|1|||
16399597|NCT01811485|39941652|FG002|Overall Study|Protocol Deviation|0|||
16399598|NCT00579553|39941655|FG000|Overall Study|Lost to Follow-up|16|||
16399599|NCT00579553|39941656|FG001|Overall Study|Lost to Follow-up|13|||
16399600|NCT00441142|39941660|FG000|Overall Study|Adverse Event|2|||
16399601|NCT00441142|39941661|FG001|Overall Study|Adverse Event|3|||
16399602|NCT00441142|39941662|FG002|Overall Study|Adverse Event|3|||
16399603|NCT00441142|39941663|FG003|Overall Study|Adverse Event|22|||
16399604|NCT00441142|39941660|FG000|Overall Study|Lack of Efficacy|3|||
16399605|NCT00441142|39941661|FG001|Overall Study|Lack of Efficacy|3|||
16399606|NCT00441142|39941662|FG002|Overall Study|Lack of Efficacy|17|||
16399607|NCT00441142|39941663|FG003|Overall Study|Lack of Efficacy|32|||
16399608|NCT00441142|39941660|FG000|Overall Study|Withdrawal by Subject|0|||
16399609|NCT00441142|39941661|FG001|Overall Study|Withdrawal by Subject|0|||
16399610|NCT00441142|39941662|FG002|Overall Study|Withdrawal by Subject|2|||
16399611|NCT00441142|39941663|FG003|Overall Study|Withdrawal by Subject|10|||
16399612|NCT00441142|39941660|FG000|Overall Study|Patient still receiving active study tx|1|||
16399613|NCT00441142|39941661|FG001|Overall Study|Patient still receiving active study tx|0|||
16399614|NCT00441142|39941662|FG002|Overall Study|Patient still receiving active study tx|0|||
16399615|NCT00441142|39941663|FG003|Overall Study|Patient still receiving active study tx|2|||
16399616|NCT00441142|39941660|FG000|Overall Study|Physician Decision|0|||
16399617|NCT00441142|39941661|FG001|Overall Study|Physician Decision|1|||
16399618|NCT00441142|39941662|FG002|Overall Study|Physician Decision|0|||
16399619|NCT00441142|39941663|FG003|Overall Study|Physician Decision|1|||
16399620|NCT00441142|39941660|FG000|Overall Study|Death|0|||
16399621|NCT00441142|39941661|FG001|Overall Study|Death|0|||
16399622|NCT00441142|39941662|FG002|Overall Study|Death|0|||
16399623|NCT00441142|39941663|FG003|Overall Study|Death|1|||
16399624|NCT01891396|39941664|FG000|Overall Study|Withdrawal by Subject|4|||
16399625|NCT01891396|39941665|FG001|Overall Study|Withdrawal by Subject|4|||
16399626|NCT01891396|39941666|FG002|Overall Study|Withdrawal by Subject|3|||
16399627|NCT01891396|39941664|FG000|Overall Study|Lost to Follow-up|0|||
16399628|NCT01891396|39941665|FG001|Overall Study|Lost to Follow-up|1|||
16399629|NCT01891396|39941666|FG002|Overall Study|Lost to Follow-up|0|||
16399630|NCT03248531|39941667|FG000|Overall Study|Adverse Event|0|||
16399631|NCT03248531|39941668|FG001|Overall Study|Adverse Event|0|||
16399632|NCT03248531|39941669|FG002|Overall Study|Adverse Event|1|||
16399633|NCT03248531|39941667|FG000|Overall Study|Lost to Follow-up|1|||
16399634|NCT03248531|39941668|FG001|Overall Study|Lost to Follow-up|0|||
16399635|NCT03248531|39941669|FG002|Overall Study|Lost to Follow-up|5|||
16399636|NCT03248531|39941667|FG000|Overall Study|Withdrawal by Subject|3|||
16399637|NCT03248531|39941668|FG001|Overall Study|Withdrawal by Subject|3|||
16399638|NCT03248531|39941669|FG002|Overall Study|Withdrawal by Subject|2|||
16399639|NCT03248531|39941667|FG000|Overall Study|Sponsor Request|0|||
16399640|NCT03248531|39941668|FG001|Overall Study|Sponsor Request|2|||
16399641|NCT03248531|39941669|FG002|Overall Study|Sponsor Request|0|||
16399642|NCT03350035|39941670|FG000|Overall Study|Lack of Efficacy|2|||
16399643|NCT03350035|39941671|FG001|Overall Study|Lack of Efficacy|0|||
16399644|NCT03350035|39941672|FG002|Overall Study|Lack of Efficacy|0|||
16399645|NCT03350035|39941670|FG000|Overall Study|Subject discharged to hospice|0|||
16399646|NCT03350035|39941671|FG001|Overall Study|Subject discharged to hospice|0|||
16399647|NCT03350035|39941672|FG002|Overall Study|Subject discharged to hospice|1|||
16097959|NCT01799993|38846944|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
16399648|NCT02543281|39941673|FG000|Overall Study|Lost to Follow-up|0|||
16399649|NCT02543281|39941674|FG001|Overall Study|Lost to Follow-up|0|||
16399650|NCT02543281|39941675|FG002|Overall Study|Lost to Follow-up|1|||
16399651|NCT02091362|39944796|FG000|Period 1|Protocol Violation|1|||
16399652|NCT02091362|39944797|FG001|Period 1|Protocol Violation|0|||
16399653|NCT02091362|39944796|FG000|Period 1|Withdrawal by Subject|2|||
16399654|NCT02091362|39944797|FG001|Period 1|Withdrawal by Subject|3|||
16399655|NCT02091362|39944796|FG000|Period 1|Lost to Follow-up|0|||
16399656|NCT02091362|39944797|FG001|Period 1|Lost to Follow-up|1|||
16399657|NCT02091362|39944796|FG000|Period 1|Adverse Event|2|||
16399658|NCT02091362|39944797|FG001|Period 1|Adverse Event|0|||
16399659|NCT02091362|39944796|FG000|Wash-out|Lost to Follow-up|1|||
16399660|NCT02091362|39944797|FG001|Wash-out|Lost to Follow-up|1|||
16399661|NCT02091362|39944796|FG000|Wash-out|Withdrawal by Subject|0|||
16399662|NCT02091362|39944797|FG001|Wash-out|Withdrawal by Subject|2|||
16399663|NCT02091362|39944796|FG000|Period 2|Adverse Event|1|||
16399664|NCT02091362|39944797|FG001|Period 2|Adverse Event|0|||
16399665|NCT02091362|39944796|FG000|Period 2|Lost to Follow-up|0|||
16399666|NCT02091362|39944797|FG001|Period 2|Lost to Follow-up|1|||
16399667|NCT02091362|39944796|FG000|Period 2|Withdrawal by Subject|1|||
16399668|NCT02091362|39944797|FG001|Period 2|Withdrawal by Subject|1|||
16399669|NCT03718884|39944799|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
16399670|NCT03718884|39944800|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
16399671|NCT03718884|39944799|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
16399672|NCT03718884|39944800|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
16399673|NCT00541866|39944803|FG000|Overall Study|Adverse Event|3|||
16399674|NCT00541866|39944804|FG001|Overall Study|Adverse Event|0|||
16399675|NCT00541866|39944805|FG002|Overall Study|Adverse Event|0|||
16399676|NCT00541866|39944806|FG003|Overall Study|Adverse Event|0|||
16399677|NCT00541866|39944807|FG004|Overall Study|Adverse Event|0|||
16399678|NCT00541866|39944803|FG000|Overall Study|Death|1|||
16399679|NCT00541866|39944804|FG001|Overall Study|Death|0|||
16399680|NCT00541866|39944805|FG002|Overall Study|Death|0|||
16399681|NCT00541866|39944806|FG003|Overall Study|Death|0|||
16399682|NCT00541866|39944807|FG004|Overall Study|Death|0|||
16399683|NCT00541866|39944803|FG000|Overall Study|Lack of Efficacy|19|||
16097960|NCT01799993|38846945|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
16097961|NCT01799993|38846944|FG000|Overall Study|Protocol driven decision point|0|||
16097962|NCT01799993|38846945|FG001|Overall Study|Protocol driven decision point|3|||
16097963|NCT01799993|38846944|FG000|Overall Study|Protocol Violation|1|||
16097964|NCT01799993|38846945|FG001|Overall Study|Protocol Violation|1|||
16097965|NCT01799993|38846944|FG000|Overall Study|Deterioration of general conditions|2|||
16097966|NCT01799993|38846945|FG001|Overall Study|Deterioration of general conditions|0|||
16097967|NCT01799993|38846944|FG000|Overall Study|Screen failure|0|||
16399684|NCT00541866|39944804|FG001|Overall Study|Lack of Efficacy|15|||
16399685|NCT00541866|39944805|FG002|Overall Study|Lack of Efficacy|10|||
16399686|NCT00541866|39944806|FG003|Overall Study|Lack of Efficacy|12|||
16399687|NCT00541866|39944807|FG004|Overall Study|Lack of Efficacy|14|||
16399688|NCT00541866|39944803|FG000|Overall Study|Not Reported or Other|11|||
16399689|NCT00541866|39944804|FG001|Overall Study|Not Reported or Other|3|||
16399690|NCT00541866|39944805|FG002|Overall Study|Not Reported or Other|3|||
16399691|NCT00541866|39944806|FG003|Overall Study|Not Reported or Other|3|||
16097968|NCT01799993|38846945|FG001|Overall Study|Screen failure|1|||
16399692|NCT00541866|39944807|FG004|Overall Study|Not Reported or Other|1|||
16399693|NCT00541866|39944803|FG000|Overall Study|Physician Decision|0|||
16330278|NCT00712881|39696195|FG001|Overall Study|Adverse Event|3|||
16330279|NCT00712881|39696194|FG000|Overall Study|Withdrawal by Subject|1|||
16330280|NCT00712881|39696195|FG001|Overall Study|Withdrawal by Subject|1|||
16330281|NCT00712881|39696194|FG000|Overall Study|Disease Progression|2|||
16399694|NCT00541866|39944804|FG001|Overall Study|Physician Decision|0|||
16399695|NCT00541866|39944805|FG002|Overall Study|Physician Decision|2|||
16399696|NCT00541866|39944806|FG003|Overall Study|Physician Decision|1|||
16399697|NCT00541866|39944807|FG004|Overall Study|Physician Decision|0|||
16399698|NCT03300024|39944810|FG000|Overall Study|Physician Decision|4|||
16399699|NCT03300024|39944811|FG001|Overall Study|Physician Decision|6|||
16399700|NCT00113399|39944814|FG000|Overall Study|Death|1|||
16399701|NCT00113399|39944815|FG001|Overall Study|Death|1|||
16399702|NCT00113399|39944814|FG000|Overall Study|Withdrawal by Subject|1|||
16399703|NCT00113399|39944815|FG001|Overall Study|Withdrawal by Subject|2|||
16399704|NCT00113399|39944814|FG000|Overall Study|Complete Response|0|||
16399705|NCT00113399|39944815|FG001|Overall Study|Complete Response|1|||
16399706|NCT00113399|39944814|FG000|Overall Study|Other|0|||
16526864|NCT02553330|40394629|FG001|Overall Study|Study Terminated by Sponsor|13|||
16526865|NCT02553330|40394630|FG002|Overall Study|Study Terminated by Sponsor|12|||
16526866|NCT02553330|40394628|FG000|Overall Study|Withdrawal by Subject|3|||
16330282|NCT00712881|39696195|FG001|Overall Study|Disease Progression|1|||
16330283|NCT00712881|39696194|FG000|Overall Study|Lost to Follow-up|1|||
16330284|NCT00712881|39696195|FG001|Overall Study|Lost to Follow-up|1|||
16330285|NCT00712881|39696194|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
16330286|NCT00712881|39696195|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
16330287|NCT00712881|39696194|FG000|Overall Study|Protocol Violation|1|||
16330288|NCT00712881|39696195|FG001|Overall Study|Protocol Violation|1|||
16330289|NCT00712881|39696194|FG000|Overall Study|Randomized but not treated|1|||
16330290|NCT00712881|39696195|FG001|Overall Study|Randomized but not treated|0|||
16330291|NCT00558896|39696198|FG000|Overall Study|Adverse Event|1|||
16330292|NCT00558896|39696199|FG001|Overall Study|Adverse Event|1|||
16330293|NCT00558896|39696200|FG002|Overall Study|Adverse Event|1|||
16330294|NCT00558896|39696201|FG003|Overall Study|Adverse Event|3|||
16330295|NCT00558896|39696202|FG004|Overall Study|Adverse Event|4|||
16330296|NCT00558896|39696203|FG005|Overall Study|Adverse Event|10|||
16330297|NCT00558896|39696204|FG006|Overall Study|Adverse Event|3|||
16330298|NCT00558896|39696198|FG000|Overall Study|Death|3|||
16526867|NCT02553330|40394629|FG001|Overall Study|Withdrawal by Subject|19|||
16526868|NCT02553330|40394630|FG002|Overall Study|Withdrawal by Subject|21|||
16526869|NCT02553330|40394628|FG000|Overall Study|Other|0|||
16526870|NCT02553330|40394629|FG001|Overall Study|Other|1|||
16526871|NCT02553330|40394630|FG002|Overall Study|Other|0|||
16526872|NCT02553330|40394628|FG000|Overall Study|Non compliance to study treatment|0|||
16526873|NCT02553330|40394629|FG001|Overall Study|Non compliance to study treatment|1|||
16526874|NCT02553330|40394630|FG002|Overall Study|Non compliance to study treatment|0|||
16526875|NCT02553330|40394628|FG000|Overall Study|Adverse Event|0|||
16526876|NCT02553330|40394629|FG001|Overall Study|Adverse Event|1|||
16526877|NCT02553330|40394630|FG002|Overall Study|Adverse Event|0|||
16526878|NCT02553330|40394628|FG000|Overall Study|Lost to Follow-up|0|||
16526879|NCT02553330|40394629|FG001|Overall Study|Lost to Follow-up|4|||
16526880|NCT02553330|40394630|FG002|Overall Study|Lost to Follow-up|4|||
16526881|NCT01205685|40394633|FG000|Overall Study|Disease Progression|10|||
16526882|NCT01205685|40394633|FG000|Overall Study|Withdrawal by Subject|1|||
16526883|NCT01610700|40394654|FG000|Overall Study|Adverse Event|3|||
16526884|NCT01610700|40394655|FG001|Overall Study|Adverse Event|1|||
16526885|NCT01610700|40394654|FG000|Overall Study|Withdrawal by Subject|0|||
16526886|NCT01610700|40394655|FG001|Overall Study|Withdrawal by Subject|1|||
16526887|NCT01610700|40394654|FG000|Overall Study|subject took one dose of street cannabis|0|||
16526888|NCT01610700|40394655|FG001|Overall Study|subject took one dose of street cannabis|1|||
16526889|NCT01024387|40394656|FG000|Overall Study|Radiographic Progression|29|||
16526890|NCT01024387|40394656|FG000|Overall Study|Symptomatic Progression|10|||
16526891|NCT01024387|40394656|FG000|Overall Study|Physician Decision|5|||
16526892|NCT01024387|40394656|FG000|Overall Study|Withdrawal by Subject|5|||
16330299|NCT00558896|39696199|FG001|Overall Study|Death|0|||
16330300|NCT00558896|39696200|FG002|Overall Study|Death|2|||
16330301|NCT00558896|39696201|FG003|Overall Study|Death|3|||
16330302|NCT00558896|39696202|FG004|Overall Study|Death|2|||
16330303|NCT00558896|39696203|FG005|Overall Study|Death|2|||
16330304|NCT00558896|39696204|FG006|Overall Study|Death|6|||
16399707|NCT00113399|39944815|FG001|Overall Study|Other|1|||
16399708|NCT00606034|39944816|FG000|Overall Study|incarceration|1|||
16330305|NCT00558896|39696198|FG000|Overall Study|Withdrawal by Subject|2|||
16330306|NCT00558896|39696199|FG001|Overall Study|Withdrawal by Subject|1|||
16399709|NCT03077438|39944817|FG000|Overall Study|Protocol Violation|3|||
16330307|NCT00558896|39696200|FG002|Overall Study|Withdrawal by Subject|1|||
16330308|NCT00558896|39696201|FG003|Overall Study|Withdrawal by Subject|1|||
16330309|NCT00558896|39696202|FG004|Overall Study|Withdrawal by Subject|1|||
16330310|NCT00558896|39696203|FG005|Overall Study|Withdrawal by Subject|5|||
16399710|NCT03077438|39944818|FG001|Overall Study|Protocol Violation|5|||
16330311|NCT00558896|39696204|FG006|Overall Study|Withdrawal by Subject|5|||
16330312|NCT00558896|39696198|FG000|Overall Study|Alternative Treatment|2|||
16330313|NCT00558896|39696199|FG001|Overall Study|Alternative Treatment|2|||
16330314|NCT00558896|39696200|FG002|Overall Study|Alternative Treatment|0|||
16330315|NCT00558896|39696201|FG003|Overall Study|Alternative Treatment|2|||
16330316|NCT00558896|39696202|FG004|Overall Study|Alternative Treatment|6|||
16330317|NCT00558896|39696203|FG005|Overall Study|Alternative Treatment|7|||
16330318|NCT00558896|39696204|FG006|Overall Study|Alternative Treatment|1|||
16330319|NCT00558896|39696198|FG000|Overall Study|Physician discretion|3|||
16330320|NCT00558896|39696199|FG001|Overall Study|Physician discretion|2|||
16526893|NCT01024387|40394656|FG000|Overall Study|Death|2|||
16526894|NCT01024387|40394656|FG000|Overall Study|Prolonged Treatment Delay|1|||
16526895|NCT01024387|40394656|FG000|Overall Study|Adverse Event|3|||
16526896|NCT01024387|40394656|FG000|Overall Study|Other|5|||
16526897|NCT02194621|40394659|FG000|Overall Study|6 withdrew prior to randomization|2|||
16526898|NCT02194621|40394660|FG001|Overall Study|6 withdrew prior to randomization|2|||
16526899|NCT02194621|40394661|FG002|Overall Study|6 withdrew prior to randomization|2|||
16526900|NCT02194621|40394659|FG000|Overall Study|Withdrawal by Subject|4|||
16526901|NCT02194621|40394660|FG001|Overall Study|Withdrawal by Subject|4|||
16526902|NCT02194621|40394661|FG002|Overall Study|Withdrawal by Subject|7|||
16526903|NCT02667912|40394662|FG000|Overall Study|Death|3|||
16526904|NCT02667912|40394663|FG001|Overall Study|Death|1|||
16526905|NCT02667912|40394662|FG000|Overall Study|Withdrawal by Subject|1|||
16526906|NCT02667912|40394663|FG001|Overall Study|Withdrawal by Subject|2|||
16526907|NCT02667912|40394662|FG000|Overall Study|Withdrawal by Subject|1|||
16330321|NCT00558896|39696200|FG002|Overall Study|Physician discretion|1|||
16330322|NCT00558896|39696201|FG003|Overall Study|Physician discretion|2|||
16330323|NCT00558896|39696202|FG004|Overall Study|Physician discretion|1|||
16526908|NCT02667912|40394663|FG001|Overall Study|Withdrawal by Subject|0|||
16526909|NCT03328897|40394666|FG000|Randomized-treatment Epoch|Adverse Event|4|||
16526910|NCT03328897|40394667|FG001|Randomized-treatment Epoch|Adverse Event|1|||
16526911|NCT03328897|40394668|FG002|Randomized-treatment Epoch|Adverse Event|1|||
16330324|NCT00558896|39696203|FG005|Overall Study|Physician discretion|3|||
16330325|NCT00558896|39696204|FG006|Overall Study|Physician discretion|3|||
16330326|NCT00558896|39696198|FG000|Overall Study|Continues on treatment|10|||
16330327|NCT00558896|39696199|FG001|Overall Study|Continues on treatment|1|||
16330328|NCT00558896|39696200|FG002|Overall Study|Continues on treatment|0|||
16330329|NCT00558896|39696201|FG003|Overall Study|Continues on treatment|1|||
16330330|NCT00558896|39696202|FG004|Overall Study|Continues on treatment|9|||
16330331|NCT00558896|39696203|FG005|Overall Study|Continues on treatment|25|||
16330332|NCT00558896|39696204|FG006|Overall Study|Continues on treatment|6|||
16330333|NCT02073565|39696212|FG000|Cohort A|Withdrawal by Subject|1|||
16330334|NCT02073565|39696213|FG001|Cohort A|Withdrawal by Subject|0|||
16330335|NCT02073565|39696212|FG000|Cohort B|Withdrawal by Subject|1|||
16330336|NCT02073565|39696213|FG001|Cohort B|Withdrawal by Subject|2|||
16330337|NCT02073565|39696212|FG000|Cohort C|Withdrawal by Subject|0|||
16330338|NCT02073565|39696213|FG001|Cohort C|Withdrawal by Subject|2|||
16330339|NCT02073565|39696212|FG000|Cohort C|Lost to Follow-up|0|||
16330340|NCT02073565|39696213|FG001|Cohort C|Lost to Follow-up|2|||
16330341|NCT01664949|39696214|FG000|Overall Study|Adverse Event|11|||
16330342|NCT01664949|39696215|FG001|Overall Study|Adverse Event|12|||
16330343|NCT01664949|39696214|FG000|Overall Study|Lack of Efficacy|1|||
16330344|NCT01664949|39696215|FG001|Overall Study|Lack of Efficacy|1|||
16330345|NCT01664949|39696214|FG000|Overall Study|Lost to Follow-up|1|||
16330346|NCT01664949|39696215|FG001|Overall Study|Lost to Follow-up|2|||
16330347|NCT01664949|39696214|FG000|Overall Study|Personal Reasons|3|||
16330348|NCT01664949|39696215|FG001|Overall Study|Personal Reasons|4|||
16330349|NCT01664949|39696214|FG000|Overall Study|Protocol Violation|5|||
16330350|NCT01664949|39696215|FG001|Overall Study|Protocol Violation|5|||
16330351|NCT01664949|39696214|FG000|Overall Study|Other Miscellaneous Reasons|3|||
16330352|NCT01664949|39696215|FG001|Overall Study|Other Miscellaneous Reasons|1|||
16330353|NCT03802565|39696216|FG000|Overall Study|Adverse Event|0|||
16330354|NCT03802565|39696217|FG001|Overall Study|Adverse Event|1|||
16330355|NCT03802565|39696218|FG002|Overall Study|Adverse Event|2|||
16330356|NCT03802565|39696219|FG003|Overall Study|Adverse Event|1|||
16330357|NCT03802565|39696220|FG004|Overall Study|Adverse Event|1|||
16546378|NCT01662063|40464798|FG002|Overall Study|Lost to Follow-up|0|||
16330358|NCT03802565|39696216|FG000|Overall Study|Withdrawal by Subject|2|||
16330359|NCT03802565|39696217|FG001|Overall Study|Withdrawal by Subject|2|||
16330360|NCT03802565|39696218|FG002|Overall Study|Withdrawal by Subject|2|||
16330361|NCT03802565|39696219|FG003|Overall Study|Withdrawal by Subject|0|||
16330362|NCT03802565|39696220|FG004|Overall Study|Withdrawal by Subject|1|||
16330363|NCT03802565|39696216|FG000|Overall Study|Protocol Violation|2|||
16330364|NCT03802565|39696217|FG001|Overall Study|Protocol Violation|1|||
16330365|NCT03802565|39696218|FG002|Overall Study|Protocol Violation|4|||
16330366|NCT03802565|39696219|FG003|Overall Study|Protocol Violation|5|||
16330367|NCT03802565|39696220|FG004|Overall Study|Protocol Violation|1|||
16330368|NCT03802565|39696216|FG000|Overall Study|Lost to Follow-up|0|||
16330369|NCT03802565|39696217|FG001|Overall Study|Lost to Follow-up|0|||
16330370|NCT03802565|39696218|FG002|Overall Study|Lost to Follow-up|1|||
16330371|NCT03802565|39696219|FG003|Overall Study|Lost to Follow-up|0|||
16330372|NCT03802565|39696220|FG004|Overall Study|Lost to Follow-up|0|||
16330373|NCT03802565|39696216|FG000|Overall Study|Subjects Related to Each Other|1|||
16330374|NCT03802565|39696217|FG001|Overall Study|Subjects Related to Each Other|0|||
16330375|NCT03802565|39696218|FG002|Overall Study|Subjects Related to Each Other|0|||
16330376|NCT03802565|39696219|FG003|Overall Study|Subjects Related to Each Other|2|||
16330377|NCT03802565|39696220|FG004|Overall Study|Subjects Related to Each Other|1|||
16330378|NCT03802565|39696216|FG000|Overall Study|Elevated Enzymes|0|||
16526912|NCT03328897|40394666|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
16526913|NCT03328897|40394667|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
16526914|NCT03328897|40394668|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
16526915|NCT03328897|40394666|FG000|Randomized-treatment Epoch|Pregnancy|3|||
16526916|NCT03328897|40394667|FG001|Randomized-treatment Epoch|Pregnancy|0|||
16526917|NCT03328897|40394668|FG002|Randomized-treatment Epoch|Pregnancy|0|||
16526918|NCT03328897|40394666|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
16526919|NCT03328897|40394667|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
16526920|NCT03328897|40394668|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
16526921|NCT03328897|40394666|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
16526922|NCT03328897|40394667|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
16526923|NCT03328897|40394668|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
16526924|NCT03328897|40394666|FG000|Follow-up Epoch|Adverse Event|4|||
16526925|NCT03328897|40394667|FG001|Follow-up Epoch|Adverse Event|0|||
16526926|NCT03328897|40394668|FG002|Follow-up Epoch|Adverse Event|1|||
16526927|NCT03328897|40394666|FG000|Follow-up Epoch|Lack of Efficacy|1|||
16526928|NCT03328897|40394667|FG001|Follow-up Epoch|Lack of Efficacy|1|||
16526929|NCT03328897|40394668|FG002|Follow-up Epoch|Lack of Efficacy|1|||
16526930|NCT03328897|40394666|FG000|Follow-up Epoch|Lost to Follow-up|0|||
16330379|NCT03802565|39696217|FG001|Overall Study|Elevated Enzymes|0|||
16211436|NCT01175590|39255603|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
16211437|NCT01175590|39255602|FG000|Overall Study|Protocol Violation|0|||
16330380|NCT03802565|39696218|FG002|Overall Study|Elevated Enzymes|0|||
16330381|NCT03802565|39696219|FG003|Overall Study|Elevated Enzymes|0|||
16330382|NCT03802565|39696220|FG004|Overall Study|Elevated Enzymes|2|||
16330383|NCT00432276|39696222|FG000|Overall Study|Hyperglycemic Rescue|44|||
16330384|NCT00432276|39696223|FG001|Overall Study|Hyperglycemic Rescue|87|||
16330385|NCT00432276|39696222|FG000|Overall Study|Adverse Event|13|||
16330386|NCT00432276|39696223|FG001|Overall Study|Adverse Event|16|||
16330387|NCT00432276|39696222|FG000|Overall Study|Protocol Violation|25|||
16330388|NCT00432276|39696223|FG001|Overall Study|Protocol Violation|20|||
16330389|NCT00432276|39696222|FG000|Overall Study|Lost to Follow-up|6|||
16330390|NCT00432276|39696223|FG001|Overall Study|Lost to Follow-up|2|||
16330391|NCT00432276|39696222|FG000|Overall Study|Withdrawal by Subject|25|||
16330392|NCT00432276|39696223|FG001|Overall Study|Withdrawal by Subject|20|||
16330393|NCT00432276|39696222|FG000|Overall Study|Physician Decision|6|||
16330394|NCT00432276|39696223|FG001|Overall Study|Physician Decision|8|||
16330395|NCT00432276|39696222|FG000|Overall Study|Other|2|||
16330396|NCT00432276|39696223|FG001|Overall Study|Other|3|||
16330397|NCT02483572|39696224|FG000|Overall Study|Withdrawal by Subject|1|||
16330398|NCT02483572|39696225|FG001|Overall Study|Withdrawal by Subject|0|||
16330399|NCT02483572|39696224|FG000|Overall Study|Lost to Follow-up|1|||
16330400|NCT02483572|39696225|FG001|Overall Study|Lost to Follow-up|0|||
16330401|NCT02483572|39696224|FG000|Overall Study|Physician Decision|0|||
16330402|NCT02483572|39696225|FG001|Overall Study|Physician Decision|1|||
16330403|NCT02791438|39696231|FG000|Treatment Period|Adverse Event|1|||
16330404|NCT02791438|39696232|FG001|Treatment Period|Adverse Event|0|||
16330405|NCT02791438|39696231|FG000|Treatment Period|Withdrawal by Subject|0|||
16330406|NCT02791438|39696232|FG001|Treatment Period|Withdrawal by Subject|1|||
16330407|NCT02791438|39696231|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
16330408|NCT02791438|39696232|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
16330409|NCT02998476|39696238|FG000|Overall Study|Lost to Follow-up|1|||
16330410|NCT02998476|39696239|FG001|Overall Study|Lost to Follow-up|0|||
16330411|NCT02998476|39696238|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
16330412|NCT02998476|39696239|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
16330413|NCT02998476|39696238|FG000|Overall Study|Withdrawal by Subject|1|||
16330414|NCT02998476|39696239|FG001|Overall Study|Withdrawal by Subject|2|||
16330415|NCT02998476|39696238|FG000|Overall Study|Death|45|||
16330416|NCT02998476|39696239|FG001|Overall Study|Death|2|||
16330417|NCT02998476|39696238|FG000|Overall Study|Other|6|||
16330418|NCT02998476|39696239|FG001|Overall Study|Other|1|||
16330419|NCT01001598|39696242|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
16330420|NCT01001598|39696242|FG000|Overall Study|Adverse Event|1|||
16330421|NCT00373958|39696243|FG000|Infant Series|Withdrawal by Subject|13|||
16330422|NCT00373958|39696244|FG001|Infant Series|Withdrawal by Subject|15|||
16399711|NCT03077438|39944817|FG000|Overall Study|Withdrawal by Subject|3|||
16097969|NCT01799993|38846944|FG000|Overall Study|Adverse Event|1|||
16211438|NCT01175590|39255603|FG001|Overall Study|Protocol Violation|1|||
16330423|NCT00373958|39696243|FG000|Infant Series|Failed to return|8|||
16330424|NCT00373958|39696244|FG001|Infant Series|Failed to return|13|||
16526931|NCT03328897|40394667|FG001|Follow-up Epoch|Lost to Follow-up|1|||
16526932|NCT03328897|40394668|FG002|Follow-up Epoch|Lost to Follow-up|0|||
16526933|NCT03328897|40394666|FG000|Follow-up Epoch|Pregnancy|1|||
16526934|NCT03328897|40394667|FG001|Follow-up Epoch|Pregnancy|0|||
16526935|NCT03328897|40394668|FG002|Follow-up Epoch|Pregnancy|0|||
16526936|NCT03328897|40394666|FG000|Follow-up Epoch|Patient/guardian decision|2|||
16526937|NCT03328897|40394667|FG001|Follow-up Epoch|Patient/guardian decision|1|||
16526938|NCT03328897|40394668|FG002|Follow-up Epoch|Patient/guardian decision|0|||
16526939|NCT03811912|40394669|FG000|Overall Study|Withdrew Consent|4|||
16526940|NCT03811912|40394670|FG001|Overall Study|Withdrew Consent|2|||
16526941|NCT01910519|40394671|FG000|Overall Study|Withdrawal by Subject|2|||
16526942|NCT01910519|40394672|FG001|Overall Study|Withdrawal by Subject|0|||
16526943|NCT01910519|40394671|FG000|Overall Study|Adverse Event|2|||
16526944|NCT01910519|40394672|FG001|Overall Study|Adverse Event|0|||
16526945|NCT00435370|40394673|FG000|Overall Study|Adverse Event|8|||
16526946|NCT00435370|40394674|FG001|Overall Study|Adverse Event|8|||
16526947|NCT00435370|40394673|FG000|Overall Study|Withdrawal by Subject|10|||
16526948|NCT00435370|40394674|FG001|Overall Study|Withdrawal by Subject|10|||
16526949|NCT00435370|40394673|FG000|Overall Study|Antipsychotic medication changed|4|||
16526950|NCT00435370|40394674|FG001|Overall Study|Antipsychotic medication changed|2|||
16526951|NCT00352534|40394677|FG000|Initial Staging|Ineligible|8|||
16526952|NCT00352534|40394678|FG001|Initial Staging|Ineligible|9|||
16526953|NCT00352534|40394679|FG002|Initial Staging|Ineligible|0|||
16097970|NCT01799993|38846945|FG001|Overall Study|Adverse Event|0|||
16526954|NCT00352534|40394680|FG003|Initial Staging|Ineligible|0|||
16526955|NCT00352534|40394681|FG004|Initial Staging|Ineligible|0|||
16526956|NCT00352534|40394682|FG005|Initial Staging|Ineligible|0|||
16526957|NCT00352534|40394683|FG006|Initial Staging|Ineligible|0|||
16526958|NCT00352534|40394677|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
16526959|NCT00352534|40394678|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
16526960|NCT00352534|40394679|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
16526961|NCT00352534|40394680|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
16526962|NCT00352534|40394681|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
16526963|NCT00352534|40394682|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
16526964|NCT00352534|40394683|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
16526965|NCT00352534|40394677|FG000|Final Risk Group Assignment|Physician Decision|0|||
16526966|NCT00352534|40394678|FG001|Final Risk Group Assignment|Physician Decision|0|||
16526967|NCT00352534|40394679|FG002|Final Risk Group Assignment|Physician Decision|0|||
16526968|NCT00352534|40394680|FG003|Final Risk Group Assignment|Physician Decision|0|||
16526969|NCT00352534|40394681|FG004|Final Risk Group Assignment|Physician Decision|0|||
16526970|NCT00352534|40394682|FG005|Final Risk Group Assignment|Physician Decision|8|||
16526971|NCT00352534|40394683|FG006|Final Risk Group Assignment|Physician Decision|0|||
16526972|NCT00352534|40394677|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
16526973|NCT00352534|40394678|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
16526974|NCT00352534|40394679|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
16526975|NCT00352534|40394680|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
16526976|NCT00352534|40394681|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
16526977|NCT00352534|40394682|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
16526978|NCT00352534|40394683|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
16526979|NCT00352534|40394677|FG000|Final Risk Group Assignment|Ineligible|0|||
16526980|NCT00352534|40394678|FG001|Final Risk Group Assignment|Ineligible|0|||
16526981|NCT00352534|40394679|FG002|Final Risk Group Assignment|Ineligible|3|||
16526982|NCT00352534|40394680|FG003|Final Risk Group Assignment|Ineligible|1|||
16526983|NCT00352534|40394681|FG004|Final Risk Group Assignment|Ineligible|0|||
16526984|NCT00352534|40394682|FG005|Final Risk Group Assignment|Ineligible|13|||
16526985|NCT00352534|40394683|FG006|Final Risk Group Assignment|Ineligible|0|||
16526986|NCT00352534|40394677|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
16526987|NCT00352534|40394678|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
16526988|NCT00352534|40394679|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
16526989|NCT00352534|40394680|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
16526990|NCT00352534|40394681|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
16526991|NCT00352534|40394682|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
16526992|NCT00352534|40394683|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
16526993|NCT00352534|40394677|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
16526994|NCT00352534|40394678|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
16526995|NCT00352534|40394679|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
16097971|NCT01799993|38846944|FG000|Overall Study|Lack of Efficacy|1|||
16526996|NCT00352534|40394680|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
16097972|NCT01799993|38846945|FG001|Overall Study|Lack of Efficacy|0|||
16526997|NCT00352534|40394681|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
16526998|NCT00352534|40394682|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
16526999|NCT00352534|40394683|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
16527000|NCT00352534|40394677|FG000|Final Risk Group Assignment|Death|0|||
16527001|NCT00352534|40394678|FG001|Final Risk Group Assignment|Death|0|||
16527002|NCT00352534|40394679|FG002|Final Risk Group Assignment|Death|0|||
16527003|NCT00352534|40394680|FG003|Final Risk Group Assignment|Death|0|||
16527004|NCT00352534|40394681|FG004|Final Risk Group Assignment|Death|0|||
16527005|NCT00352534|40394682|FG005|Final Risk Group Assignment|Death|2|||
16527006|NCT00352534|40394683|FG006|Final Risk Group Assignment|Death|0|||
16527007|NCT01490060|40394685|FG000|Cycle 1|Change of Treatment|0|||
16527008|NCT01490060|40394686|FG001|Cycle 1|Change of Treatment|1|||
16527009|NCT01490060|40394687|FG002|Cycle 1|Change of Treatment|1|||
16527010|NCT01490060|40394688|FG003|Cycle 1|Change of Treatment|1|||
16527011|NCT01490060|40394685|FG000|Cycle 1|Insurance Denied|0|||
16527012|NCT01490060|40394686|FG001|Cycle 1|Insurance Denied|0|||
16527013|NCT01490060|40394687|FG002|Cycle 1|Insurance Denied|2|||
16527014|NCT01490060|40394688|FG003|Cycle 1|Insurance Denied|0|||
16527015|NCT01490060|40394685|FG000|Cycle 1|Withdrawal by Subject|0|||
16527016|NCT01490060|40394686|FG001|Cycle 1|Withdrawal by Subject|0|||
16527017|NCT01490060|40394687|FG002|Cycle 1|Withdrawal by Subject|0|||
16527018|NCT01490060|40394688|FG003|Cycle 1|Withdrawal by Subject|1|||
16527019|NCT01490060|40394685|FG000|Cycle 1|Treatment at Another Facility|0|||
16527020|NCT01490060|40394686|FG001|Cycle 1|Treatment at Another Facility|0|||
16527021|NCT01490060|40394687|FG002|Cycle 1|Treatment at Another Facility|0|||
16527022|NCT01490060|40394688|FG003|Cycle 1|Treatment at Another Facility|1|||
16527023|NCT01490060|40394685|FG000|Cycle 2|Change of Treatment|1|||
16527024|NCT01490060|40394686|FG001|Cycle 2|Change of Treatment|1|||
16527025|NCT01490060|40394687|FG002|Cycle 2|Change of Treatment|0|||
16527026|NCT01490060|40394688|FG003|Cycle 2|Change of Treatment|0|||
16527027|NCT01490060|40394685|FG000|Cycle 2|Non-Compliance|0|||
16330425|NCT00373958|39696243|FG000|Infant Series|Lost to Follow-up|6|||
16330426|NCT00373958|39696244|FG001|Infant Series|Lost to Follow-up|5|||
16330427|NCT00373958|39696243|FG000|Infant Series|Protocol Violation|3|||
16330428|NCT00373958|39696244|FG001|Infant Series|Protocol Violation|7|||
16330429|NCT00373958|39696243|FG000|Infant Series|Lost Kaiser coverage|4|||
16330430|NCT00373958|39696244|FG001|Infant Series|Lost Kaiser coverage|0|||
16330431|NCT00373958|39696243|FG000|Infant Series|Child relocated|1|||
16330432|NCT00373958|39696244|FG001|Infant Series|Child relocated|0|||
16330433|NCT00373958|39696243|FG000|Infant Series|Consent was not received|1|||
16330434|NCT00373958|39696244|FG001|Infant Series|Consent was not received|0|||
16330435|NCT00373958|39696243|FG000|Infant Series|Adverse Event|3|||
16330436|NCT00373958|39696244|FG001|Infant Series|Adverse Event|1|||
16330437|NCT00373958|39696243|FG000|Infant Series|Physician Decision|1|||
16330438|NCT00373958|39696244|FG001|Infant Series|Physician Decision|1|||
16330439|NCT00373958|39696243|FG000|Toddler Dose|Lost to Follow-up|5|||
16330440|NCT00373958|39696244|FG001|Toddler Dose|Lost to Follow-up|8|||
16330441|NCT00373958|39696243|FG000|Toddler Dose|Withdrawal by Subject|2|||
16330442|NCT00373958|39696244|FG001|Toddler Dose|Withdrawal by Subject|2|||
16330443|NCT00373958|39696243|FG000|Toddler Dose|Failed to return|1|||
16330444|NCT00373958|39696244|FG001|Toddler Dose|Failed to return|2|||
16330445|NCT00373958|39696243|FG000|Toddler Dose|Protocol Violation|0|||
16330446|NCT00373958|39696244|FG001|Toddler Dose|Protocol Violation|1|||
16330447|NCT00373958|39696243|FG000|Toddler Dose|Withdrawn after infant series|22|||
16330448|NCT00373958|39696244|FG001|Toddler Dose|Withdrawn after infant series|25|||
16097973|NCT01799993|38846944|FG000|Overall Study|Recovery|0|||
16330449|NCT03199612|39696248|FG000|Overall Study|Adverse Event|1|||
16330450|NCT03199612|39696249|FG001|Overall Study|Adverse Event|0|||
16527028|NCT01490060|40394686|FG001|Cycle 2|Non-Compliance|0|||
16330451|NCT02195427|39696252|FG000|Overall Study|Did not consent to study extension|13|||
16330452|NCT02195427|39696253|FG001|Overall Study|Did not consent to study extension|9|||
16330453|NCT02195427|39696252|FG000|Overall Study|Withdrawal by Subject|4|||
16330454|NCT02195427|39696253|FG001|Overall Study|Withdrawal by Subject|2|||
16330455|NCT02195427|39696252|FG000|Overall Study|Lost to Follow-up|0|||
16330456|NCT02195427|39696253|FG001|Overall Study|Lost to Follow-up|1|||
16330457|NCT02195427|39696252|FG000|Overall Study|Protocol Violation|7|||
16330458|NCT02195427|39696253|FG001|Overall Study|Protocol Violation|14|||
16330459|NCT02195427|39696252|FG000|Overall Study|Conditional re-treatment at W52|2|||
16330460|NCT02195427|39696253|FG001|Overall Study|Conditional re-treatment at W52|1|||
16330461|NCT04599933|39696254|FG000|Overall Study|Adverse Event|4|||
16330462|NCT04599933|39696255|FG001|Overall Study|Adverse Event|1|||
16330463|NCT04599933|39696254|FG000|Overall Study|Withdrawal by Subject|4|||
16330464|NCT04599933|39696255|FG001|Overall Study|Withdrawal by Subject|2|||
16527029|NCT01490060|40394687|FG002|Cycle 2|Non-Compliance|1|||
16527030|NCT01490060|40394688|FG003|Cycle 2|Non-Compliance|0|||
16330465|NCT04599933|39696254|FG000|Overall Study|Lost to Follow-up|0|||
16527031|NCT01490060|40394685|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
16527032|NCT01490060|40394686|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
16330466|NCT04599933|39696255|FG001|Overall Study|Lost to Follow-up|1|||
16527033|NCT01490060|40394687|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
16527034|NCT01490060|40394688|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
16527035|NCT03855189|40394692|FG000|Overall Study|Adverse Event|5|||
16211439|NCT01095666|39255606|FG000|Overall Study|Lack of Efficacy|0|||
16211440|NCT01095666|39255607|FG001|Overall Study|Lack of Efficacy|0|||
16211441|NCT01095666|39255608|FG002|Overall Study|Lack of Efficacy|1|||
16211442|NCT01095666|39255606|FG000|Overall Study|Adverse Event|2|||
16211443|NCT01095666|39255607|FG001|Overall Study|Adverse Event|1|||
16211444|NCT01095666|39255608|FG002|Overall Study|Adverse Event|3|||
16211445|NCT01095666|39255606|FG000|Overall Study|Lost to Follow-up|2|||
16211446|NCT01095666|39255607|FG001|Overall Study|Lost to Follow-up|2|||
16211447|NCT01095666|39255608|FG002|Overall Study|Lost to Follow-up|0|||
16211448|NCT01095666|39255606|FG000|Overall Study|Withdrawal by Subject|6|||
16330467|NCT04599933|39696254|FG000|Overall Study|Physician Decision|0|||
16330468|NCT04599933|39696255|FG001|Overall Study|Physician Decision|1|||
16330469|NCT04599933|39696254|FG000|Overall Study|Screen Failure|1|||
16330470|NCT04599933|39696255|FG001|Overall Study|Screen Failure|2|||
16330471|NCT03722485|39696256|FG000|Overall Study|Withdrawal by Subject|1|||
16330472|NCT03722485|39696257|FG001|Overall Study|Withdrawal by Subject|0|||
16330473|NCT03722485|39696256|FG000|Overall Study|Adverse Event|0|||
16211449|NCT01095666|39255607|FG001|Overall Study|Withdrawal by Subject|6|||
16211450|NCT01095666|39255608|FG002|Overall Study|Withdrawal by Subject|1|||
16211451|NCT01095666|39255606|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
16211452|NCT01095666|39255607|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
16211453|NCT01095666|39255608|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
16211454|NCT02658968|39255611|FG000|Received Rituximab|Adverse Event|0|||
16211455|NCT02658968|39255612|FG001|Received Rituximab|Adverse Event|0|||
16211456|NCT02658968|39255613|FG002|Received Rituximab|Adverse Event|0|||
16211457|NCT02658968|39255614|FG003|Received Rituximab|Adverse Event|0|||
16211458|NCT02658968|39255615|FG004|Received Rituximab|Adverse Event|1|||
16211459|NCT02658968|39255611|FG000|Received Rituximab|Progressive disease|0|||
16211460|NCT02658968|39255612|FG001|Received Rituximab|Progressive disease|0|||
16211461|NCT02658968|39255613|FG002|Received Rituximab|Progressive disease|0|||
16211462|NCT02658968|39255614|FG003|Received Rituximab|Progressive disease|0|||
16211463|NCT02658968|39255615|FG004|Received Rituximab|Progressive disease|1|||
16211464|NCT02658968|39255611|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
16211465|NCT02658968|39255612|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
16211466|NCT02658968|39255613|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
16211467|NCT02658968|39255614|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
16211468|NCT02658968|39255615|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
16211469|NCT02658968|39255611|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
16211470|NCT02658968|39255612|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
16211471|NCT02658968|39255613|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
16211472|NCT02658968|39255614|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
16211473|NCT02658968|39255615|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
16211474|NCT02658968|39255611|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
16211475|NCT02658968|39255612|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
16211476|NCT02658968|39255613|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
16211477|NCT02658968|39255614|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
16211478|NCT02658968|39255615|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
16211479|NCT02658968|39255611|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
16211480|NCT02658968|39255612|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
16211481|NCT02658968|39255613|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
16211482|NCT02658968|39255614|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
16211483|NCT02658968|39255615|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
16211484|NCT02658968|39255611|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
16211485|NCT02658968|39255612|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
16211486|NCT02658968|39255613|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
16211487|NCT02658968|39255614|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
16399712|NCT03077438|39944818|FG001|Overall Study|Withdrawal by Subject|6|||
16211488|NCT02658968|39255615|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
16211489|NCT01826448|39255617|FG000|Overall Study|Adverse Event|1|||
16211490|NCT01826448|39255618|FG001|Overall Study|Adverse Event|3|||
16399713|NCT03077438|39944817|FG000|Overall Study|Lost to Follow-up|6|||
16330474|NCT03722485|39696257|FG001|Overall Study|Adverse Event|2|||
16527036|NCT03855189|40394693|FG001|Overall Study|Adverse Event|2|||
16399714|NCT03077438|39944818|FG001|Overall Study|Lost to Follow-up|3|||
16399715|NCT02998203|39944820|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
16399716|NCT02998203|39944821|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
16527037|NCT03855189|40394694|FG002|Overall Study|Adverse Event|4|||
16527038|NCT03855189|40394692|FG000|Overall Study|Treatment Failure|1|||
16527039|NCT03855189|40394693|FG001|Overall Study|Treatment Failure|1|||
16527040|NCT03855189|40394694|FG002|Overall Study|Treatment Failure|2|||
16527041|NCT03855189|40394692|FG000|Overall Study|Noncompliance with Protocol|0|||
16527042|NCT03855189|40394693|FG001|Overall Study|Noncompliance with Protocol|1|||
16527043|NCT03855189|40394694|FG002|Overall Study|Noncompliance with Protocol|0|||
16527044|NCT03855189|40394692|FG000|Overall Study|Did Not Return|4|||
16527045|NCT03855189|40394693|FG001|Overall Study|Did Not Return|3|||
16527046|NCT03855189|40394694|FG002|Overall Study|Did Not Return|0|||
16527047|NCT00672477|40394695|FG000|Overall Study|Adverse Event|10|||
16527048|NCT00672477|40394696|FG001|Overall Study|Adverse Event|7|||
16527049|NCT00672477|40394695|FG000|Overall Study|Death|7|||
16330475|NCT03722485|39696256|FG000|Overall Study|subject discharged prior to study completion|1|||
16330476|NCT03722485|39696257|FG001|Overall Study|subject discharged prior to study completion|5|||
16330477|NCT03722485|39696256|FG000|Overall Study|eligibility criteria not met|2|||
16330478|NCT03722485|39696257|FG001|Overall Study|eligibility criteria not met|0|||
16330479|NCT05153148|39696259|FG000|Overall Study|Adverse Event|1|||
16330480|NCT05153148|39696260|FG001|Overall Study|Adverse Event|0|||
16330481|NCT05153148|39696261|FG002|Overall Study|Adverse Event|3|||
16330482|NCT05153148|39696262|FG003|Overall Study|Adverse Event|5|||
16330483|NCT05153148|39696259|FG000|Overall Study|Lost to Follow-up|1|||
16330484|NCT05153148|39696260|FG001|Overall Study|Lost to Follow-up|1|||
16330485|NCT05153148|39696261|FG002|Overall Study|Lost to Follow-up|2|||
16330486|NCT05153148|39696262|FG003|Overall Study|Lost to Follow-up|0|||
16330487|NCT05153148|39696259|FG000|Overall Study|Withdrawal by Subject|6|||
16330488|NCT05153148|39696260|FG001|Overall Study|Withdrawal by Subject|8|||
16330489|NCT05153148|39696261|FG002|Overall Study|Withdrawal by Subject|6|||
16330490|NCT05153148|39696262|FG003|Overall Study|Withdrawal by Subject|8|||
16330491|NCT05153148|39696259|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
16330492|NCT05153148|39696260|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
16330493|NCT05153148|39696261|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
16330494|NCT05153148|39696262|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
16330495|NCT05153148|39696259|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
16330496|NCT05153148|39696260|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
16330497|NCT05153148|39696261|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
16330498|NCT05153148|39696262|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
16527050|NCT00672477|40394696|FG001|Overall Study|Death|11|||
16527051|NCT00672477|40394695|FG000|Overall Study|Physician Decision|2|||
16527052|NCT00672477|40394696|FG001|Overall Study|Physician Decision|0|||
16527053|NCT00672477|40394695|FG000|Overall Study|Protocol Violation|1|||
16330499|NCT05153148|39696259|FG000|Overall Study|Reason not Specified|1|||
16330500|NCT05153148|39696260|FG001|Overall Study|Reason not Specified|1|||
16330501|NCT05153148|39696261|FG002|Overall Study|Reason not Specified|1|||
16330502|NCT05153148|39696262|FG003|Overall Study|Reason not Specified|1|||
16330503|NCT04608344|39696273|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
16211491|NCT01826448|39255617|FG000|Overall Study|Disease progression|2|||
16211492|NCT01826448|39255618|FG001|Overall Study|Disease progression|4|||
16211493|NCT01826448|39255617|FG000|Overall Study|Withdrawal by Subject|1|||
16211494|NCT01826448|39255618|FG001|Overall Study|Withdrawal by Subject|0|||
16211495|NCT01826448|39255617|FG000|Overall Study|Physician Decision|0|||
16211496|NCT01826448|39255618|FG001|Overall Study|Physician Decision|1|||
16211497|NCT01826448|39255617|FG000|Overall Study|2 active cancers|0|||
16211498|NCT01826448|39255618|FG001|Overall Study|2 active cancers|1|||
16211499|NCT01366534|39255619|FG000|Overall Study|Lost to Follow-up|1|||
16211500|NCT01366534|39255620|FG001|Overall Study|Lost to Follow-up|0|||
16211501|NCT01366534|39255621|FG002|Overall Study|Lost to Follow-up|0|||
16211502|NCT01366534|39255619|FG000|Overall Study|Migrated|1|||
16211503|NCT01366534|39255620|FG001|Overall Study|Migrated|1|||
16211504|NCT01366534|39255621|FG002|Overall Study|Migrated|0|||
16211505|NCT01366534|39255619|FG000|Overall Study|Declined challenged|0|||
16211506|NCT01366534|39255620|FG001|Overall Study|Declined challenged|1|||
16211507|NCT01366534|39255621|FG002|Overall Study|Declined challenged|0|||
16211508|NCT02465489|39255627|FG000|Overall Study|Adverse Event|5|||
16330504|NCT04608344|39696274|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
16330505|NCT04608344|39696273|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
16330506|NCT04608344|39696274|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
16330507|NCT02370667|39696275|FG000|Overall Study|Lost to Follow-up|0|||
16330508|NCT02370667|39696276|FG001|Overall Study|Lost to Follow-up|1|||
16330509|NCT02370667|39696277|FG002|Overall Study|Lost to Follow-up|0|||
16330510|NCT00623597|39696279|FG000|Overall Study|Failed to return|1|||
16330511|NCT00623597|39696280|FG001|Overall Study|Failed to return|0|||
16527054|NCT00672477|40394696|FG001|Overall Study|Protocol Violation|1|||
16527055|NCT00672477|40394695|FG000|Overall Study|Withdrawal by Subject|5|||
16527056|NCT00672477|40394696|FG001|Overall Study|Withdrawal by Subject|3|||
16527057|NCT00672477|40394695|FG000|Overall Study|Lack of Efficacy|1|||
16527058|NCT00672477|40394696|FG001|Overall Study|Lack of Efficacy|1|||
16527059|NCT00672477|40394695|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
16527060|NCT00672477|40394696|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
16527061|NCT00099983|40394697|FG000|Overall Study|Lost to Follow-up|2|||
16527062|NCT00099983|40394698|FG001|Overall Study|Lost to Follow-up|3|||
16527063|NCT00099983|40394697|FG000|Overall Study|Missing Source Documents|14|||
16527064|NCT00099983|40394698|FG001|Overall Study|Missing Source Documents|15|||
16527065|NCT00099983|40394697|FG000|Overall Study|Withdrawal by Subject|3|||
16527066|NCT00099983|40394698|FG001|Overall Study|Withdrawal by Subject|2|||
16527067|NCT00099983|40394697|FG000|Overall Study|Adverse Event|1|||
16527068|NCT00099983|40394698|FG001|Overall Study|Adverse Event|1|||
16527069|NCT00099983|40394697|FG000|Overall Study|Lack of Efficacy|0|||
16527070|NCT00099983|40394698|FG001|Overall Study|Lack of Efficacy|1|||
16527071|NCT00099983|40394697|FG000|Overall Study|Unable to return for appointments|1|||
16527072|NCT00099983|40394698|FG001|Overall Study|Unable to return for appointments|1|||
16527073|NCT00099983|40394697|FG000|Overall Study|Moved|1|||
16527074|NCT00099983|40394698|FG001|Overall Study|Moved|0|||
16527075|NCT00099983|40394697|FG000|Overall Study|Other psychiatric problem|1|||
16527076|NCT00099983|40394698|FG001|Overall Study|Other psychiatric problem|0|||
16527077|NCT00099983|40394697|FG000|Overall Study|Incarcerated|0|||
16211509|NCT00092677|39255628|FG000|Overall Study|Lost to Follow-up|0|||
16211510|NCT00092677|39255629|FG001|Overall Study|Lost to Follow-up|2|||
16211511|NCT00092677|39255628|FG000|Overall Study|Adminstrative|5|||
16211512|NCT00092677|39255629|FG001|Overall Study|Adminstrative|9|||
16211513|NCT04897594|39255630|FG000|Overall Study|Lost to Follow-up|0|||
16211514|NCT04897594|39255631|FG001|Overall Study|Lost to Follow-up|1|||
16211515|NCT04897594|39255632|FG002|Overall Study|Lost to Follow-up|1|||
16527078|NCT00099983|40394698|FG001|Overall Study|Incarcerated|1|||
16527079|NCT00099983|40394697|FG000|Overall Study|Intolerant of burden of visits|0|||
16527080|NCT00099983|40394698|FG001|Overall Study|Intolerant of burden of visits|1|||
16527081|NCT00099983|40394697|FG000|Overall Study|Other issue|1|||
16527082|NCT00099983|40394698|FG001|Overall Study|Other issue|0|||
16527083|NCT03867734|40394699|FG000|Overall Study|Lost to Follow-up|2|||
16527084|NCT02132611|40394700|FG000|Overall Study|Death|2|||
16527085|NCT01773226|40394701|FG000|Overall Study|Withdrawal by Subject|1|||
16527086|NCT02159482|40394702|FG000|Overall Study|Withdrawal by Subject|2|||
16211516|NCT04897594|39255630|FG000|Overall Study|Sponsor Decision|0|||
16211517|NCT04897594|39255631|FG001|Overall Study|Sponsor Decision|0|||
16211518|NCT04897594|39255632|FG002|Overall Study|Sponsor Decision|1|||
16211519|NCT04897594|39255630|FG000|Overall Study|Withdrawal by Subject|1|||
16211520|NCT04897594|39255631|FG001|Overall Study|Withdrawal by Subject|0|||
16211521|NCT04897594|39255632|FG002|Overall Study|Withdrawal by Subject|1|||
16211522|NCT00839436|39255639|FG000|Overall Study|Developed exclusionary condition|1|||
16527087|NCT02159482|40394702|FG000|Overall Study|Physician Decision|3|||
16527088|NCT02161718|40394704|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
16527089|NCT02161718|40394705|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
16527090|NCT02161718|40394706|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
16527091|NCT02161718|40394704|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
16527092|NCT02161718|40394705|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
16527093|NCT02161718|40394706|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
16527094|NCT02161718|40394704|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
16527095|NCT02161718|40394705|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
16527096|NCT02161718|40394706|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
16527097|NCT02161718|40394704|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
16527098|NCT02161718|40394705|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
16527099|NCT02161718|40394706|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
16527100|NCT02161718|40394704|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
16527101|NCT02161718|40394705|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
16527102|NCT02161718|40394706|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
16527103|NCT02161718|40394704|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
16527104|NCT02161718|40394705|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
16527105|NCT02161718|40394706|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
16527106|NCT02161718|40394704|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
16527107|NCT02161718|40394705|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
16527108|NCT02161718|40394706|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
16527109|NCT02161718|40394704|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
16527110|NCT02161718|40394705|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
16527111|NCT02161718|40394706|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
16527112|NCT02161718|40394704|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
16527113|NCT02161718|40394705|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
16527114|NCT02161718|40394706|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
16527115|NCT02161718|40394704|FG000|Post- Randomization Period|Lost to Follow-up|0|||
16527116|NCT02161718|40394705|FG001|Post- Randomization Period|Lost to Follow-up|9|||
16527117|NCT02161718|40394706|FG002|Post- Randomization Period|Lost to Follow-up|15|||
16527118|NCT02161718|40394704|FG000|Post- Randomization Period|Adverse Event|0|||
16527119|NCT02161718|40394705|FG001|Post- Randomization Period|Adverse Event|9|||
16527120|NCT02161718|40394706|FG002|Post- Randomization Period|Adverse Event|10|||
16527121|NCT02161718|40394704|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
16527122|NCT02161718|40394705|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
16527123|NCT02161718|40394706|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
16527124|NCT02161718|40394704|FG000|Post- Randomization Period|Physician Decision|0|||
16527125|NCT02161718|40394705|FG001|Post- Randomization Period|Physician Decision|2|||
16527126|NCT02161718|40394706|FG002|Post- Randomization Period|Physician Decision|4|||
16527127|NCT02161718|40394704|FG000|Post- Randomization Period|Protocol Violation|0|||
16527128|NCT02161718|40394705|FG001|Post- Randomization Period|Protocol Violation|2|||
16527129|NCT02161718|40394706|FG002|Post- Randomization Period|Protocol Violation|3|||
16527130|NCT02161718|40394704|FG000|Post- Randomization Period|Lack of Efficacy|0|||
16527131|NCT02161718|40394705|FG001|Post- Randomization Period|Lack of Efficacy|0|||
16527132|NCT02161718|40394706|FG002|Post- Randomization Period|Lack of Efficacy|1|||
16527133|NCT02161718|40394704|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
16527134|NCT02161718|40394705|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
16527135|NCT02161718|40394706|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
16527136|NCT02161718|40394704|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
16527137|NCT02161718|40394705|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
16527138|NCT02161718|40394706|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
16527139|NCT02161718|40394704|FG000|Post- Randomization Period|Relocation|0|||
16527140|NCT02161718|40394705|FG001|Post- Randomization Period|Relocation|3|||
16527141|NCT02161718|40394706|FG002|Post- Randomization Period|Relocation|0|||
16527142|NCT00817089|40394707|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
16527143|NCT00817089|40394708|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
16527144|NCT00817089|40394709|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
16527145|NCT00817089|40394710|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
16527146|NCT00817089|40394707|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
16527147|NCT00817089|40394708|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
16527148|NCT00817089|40394709|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
16527149|NCT00817089|40394710|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
16527150|NCT01073618|40394712|FG000|Overall Study|Death|208|||
16527151|NCT01073618|40394712|FG000|Overall Study|Adverse Event|19|||
16527152|NCT01073618|40394712|FG000|Overall Study|Other|80|||
16527153|NCT04287920|40394713|FG000|Overall Study|Lost to Follow-up|1|||
16527154|NCT04287920|40394714|FG001|Overall Study|Lost to Follow-up|1|||
16527155|NCT04287920|40394713|FG000|Overall Study|Withdrawal by Subject|0|||
16527156|NCT04287920|40394714|FG001|Overall Study|Withdrawal by Subject|3|||
16527157|NCT03870763|40394722|FG000|Overall Study|Study terminated by sponsor|0|||
16527158|NCT03870763|40394723|FG001|Overall Study|Study terminated by sponsor|2|||
16527159|NCT03870763|40394724|FG002|Overall Study|Study terminated by sponsor|0|||
16527160|NCT03870763|40394722|FG000|Overall Study|Withdrawal by Subject|0|||
16527161|NCT03870763|40394723|FG001|Overall Study|Withdrawal by Subject|1|||
16527162|NCT03870763|40394724|FG002|Overall Study|Withdrawal by Subject|0|||
16527163|NCT03870763|40394722|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
16527164|NCT03870763|40394723|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
16527165|NCT03870763|40394724|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
16527166|NCT01286779|40394727|FG000|Overall Study|Withdrawal by Subject|9|||
16527167|NCT01286779|40394727|FG000|Overall Study|Protocol Violation|5|||
16527168|NCT01286779|40394727|FG000|Overall Study|Physician Decision|2|||
16527169|NCT01286779|40394727|FG000|Overall Study|Participant had scheduled surgery|1|||
16527170|NCT01286779|40394727|FG000|Overall Study|Participant moved to another country|1|||
16527171|NCT01286779|40394727|FG000|Overall Study|Discontinued by sponsor|1|||
16527172|NCT02663817|40394728|FG000|Overall Study|Screen failure|2|||
16527173|NCT00661492|40394733|FG000|Overall Study|Adverse Event|16|||
16527174|NCT00661492|40394734|FG001|Overall Study|Adverse Event|13|||
16527175|NCT00661492|40394733|FG000|Overall Study|Disease Progression|44|||
16527176|NCT00661492|40394734|FG001|Overall Study|Disease Progression|14|||
16527177|NCT00661492|40394733|FG000|Overall Study|Patient Request|6|||
16527178|NCT00661492|40394734|FG001|Overall Study|Patient Request|1|||
16527179|NCT00661492|40394733|FG000|Overall Study|Investigator Request|1|||
16330512|NCT02505334|39696281|FG000|Main Treatment Period|Adverse Event|3|||
16330513|NCT02505334|39696282|FG001|Main Treatment Period|Adverse Event|3|||
16330514|NCT02505334|39696281|FG000|Main Treatment Period|Lack of Efficacy|7|||
16330515|NCT02505334|39696282|FG001|Main Treatment Period|Lack of Efficacy|17|||
16330516|NCT02505334|39696281|FG000|Main Treatment Period|Protocol Violation|0|||
16330517|NCT02505334|39696282|FG001|Main Treatment Period|Protocol Violation|1|||
16330518|NCT02505334|39696281|FG000|Main Treatment Period|Withdrawal by Subject|1|||
16330519|NCT02505334|39696282|FG001|Main Treatment Period|Withdrawal by Subject|8|||
16330520|NCT02505334|39696281|FG000|Main Treatment Period|Unclassified|4|||
16330521|NCT02505334|39696282|FG001|Main Treatment Period|Unclassified|10|||
16330522|NCT02505334|39696281|FG000|Extension Treatment Period|Adverse Event|5|||
16330523|NCT02505334|39696282|FG001|Extension Treatment Period|Adverse Event|0|||
16330524|NCT02505334|39696281|FG000|Extension Treatment Period|Lack of Efficacy|4|||
16330525|NCT02505334|39696282|FG001|Extension Treatment Period|Lack of Efficacy|0|||
16330526|NCT02505334|39696281|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
16330527|NCT02505334|39696282|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
16330528|NCT02505334|39696281|FG000|Extension Treatment Period|Unclassified|3|||
16330529|NCT02505334|39696282|FG001|Extension Treatment Period|Unclassified|0|||
16330530|NCT00980174|39696283|FG000|Overall Study|Withdrawal by Subject|1|||
16527180|NCT00661492|40394734|FG001|Overall Study|Investigator Request|0|||
16527181|NCT00661492|40394733|FG000|Overall Study|Lost to Follow-up|0|||
16527182|NCT00661492|40394734|FG001|Overall Study|Lost to Follow-up|1|||
16527183|NCT00661492|40394733|FG000|Overall Study|Other|1|||
16527184|NCT00661492|40394734|FG001|Overall Study|Other|0|||
16527185|NCT02473952|40394735|FG000|Overall Study|Adverse Event|2|||
16527186|NCT02473952|40394736|FG001|Overall Study|Adverse Event|2|||
16527187|NCT02473952|40394735|FG000|Overall Study|Withdrawal by Subject|0|||
16527188|NCT02473952|40394736|FG001|Overall Study|Withdrawal by Subject|6|||
16527189|NCT01877421|40394739|FG000|Phase 2|Lost to Follow-up|0|||
16527190|NCT01877421|40394740|FG001|Phase 2|Lost to Follow-up|0|||
16527191|NCT01877421|40394741|FG002|Phase 2|Lost to Follow-up|0|||
16527192|NCT01877421|40394742|FG003|Phase 2|Lost to Follow-up|0|||
16527193|NCT01877421|40394743|FG004|Phase 2|Lost to Follow-up|0|||
16527194|NCT01877421|40394744|FG005|Phase 2|Lost to Follow-up|0|||
16527195|NCT01877421|40394745|FG006|Phase 2|Lost to Follow-up|1|||
16527196|NCT01877421|40394746|FG007|Phase 2|Lost to Follow-up|0|||
16527197|NCT01877421|40394747|FG008|Phase 2|Lost to Follow-up|0|||
16527198|NCT01877421|40394748|FG009|Phase 2|Lost to Follow-up|0|||
16527199|NCT01877421|40394749|FG010|Phase 2|Lost to Follow-up|0|||
16527200|NCT01877421|40394750|FG011|Phase 2|Lost to Follow-up|0|||
16527201|NCT01877421|40394751|FG012|Phase 2|Lost to Follow-up|0|||
16527202|NCT01877421|40394752|FG013|Phase 2|Lost to Follow-up|0|||
16527203|NCT01877421|40394753|FG014|Phase 2|Lost to Follow-up|0|||
16527204|NCT01877421|40394754|FG015|Phase 2|Lost to Follow-up|0|||
16527205|NCT01877421|40394755|FG016|Phase 2|Lost to Follow-up|0|||
16330531|NCT00980174|39696284|FG001|Overall Study|Withdrawal by Subject|4|||
16330532|NCT00980174|39696283|FG000|Overall Study|Adverse Event|0|||
16527206|NCT01877421|40394756|FG017|Phase 2|Lost to Follow-up|0|||
16527207|NCT01877421|40394739|FG000|Phase 2|Withdrawal by Subject|0|||
16527208|NCT01877421|40394740|FG001|Phase 2|Withdrawal by Subject|0|||
16527209|NCT01877421|40394741|FG002|Phase 2|Withdrawal by Subject|0|||
16527210|NCT01877421|40394742|FG003|Phase 2|Withdrawal by Subject|0|||
16527211|NCT01877421|40394743|FG004|Phase 2|Withdrawal by Subject|0|||
16527212|NCT01877421|40394744|FG005|Phase 2|Withdrawal by Subject|0|||
16527213|NCT01877421|40394745|FG006|Phase 2|Withdrawal by Subject|0|||
16527214|NCT01877421|40394746|FG007|Phase 2|Withdrawal by Subject|0|||
16527215|NCT01877421|40394747|FG008|Phase 2|Withdrawal by Subject|1|||
16527216|NCT01877421|40394748|FG009|Phase 2|Withdrawal by Subject|0|||
16527217|NCT01877421|40394749|FG010|Phase 2|Withdrawal by Subject|1|||
16527218|NCT01877421|40394750|FG011|Phase 2|Withdrawal by Subject|0|||
16527219|NCT01877421|40394751|FG012|Phase 2|Withdrawal by Subject|1|||
16527220|NCT01877421|40394752|FG013|Phase 2|Withdrawal by Subject|0|||
16527221|NCT01877421|40394753|FG014|Phase 2|Withdrawal by Subject|0|||
16527222|NCT01877421|40394754|FG015|Phase 2|Withdrawal by Subject|1|||
16527223|NCT01877421|40394755|FG016|Phase 2|Withdrawal by Subject|0|||
16527224|NCT01877421|40394756|FG017|Phase 2|Withdrawal by Subject|0|||
16527225|NCT01877421|40394739|FG000|Phase 2|Protocol Violation|0|||
16527226|NCT01877421|40394740|FG001|Phase 2|Protocol Violation|0|||
16527227|NCT01877421|40394741|FG002|Phase 2|Protocol Violation|0|||
16527228|NCT01877421|40394742|FG003|Phase 2|Protocol Violation|0|||
16527229|NCT01877421|40394743|FG004|Phase 2|Protocol Violation|0|||
16527230|NCT01877421|40394744|FG005|Phase 2|Protocol Violation|0|||
16527231|NCT01877421|40394745|FG006|Phase 2|Protocol Violation|0|||
16527232|NCT01877421|40394746|FG007|Phase 2|Protocol Violation|0|||
16527233|NCT01877421|40394747|FG008|Phase 2|Protocol Violation|0|||
16527234|NCT01877421|40394748|FG009|Phase 2|Protocol Violation|0|||
16527235|NCT01877421|40394749|FG010|Phase 2|Protocol Violation|1|||
16527236|NCT01877421|40394750|FG011|Phase 2|Protocol Violation|0|||
16527237|NCT01877421|40394751|FG012|Phase 2|Protocol Violation|0|||
16527238|NCT01877421|40394752|FG013|Phase 2|Protocol Violation|0|||
16527239|NCT01877421|40394753|FG014|Phase 2|Protocol Violation|0|||
16527240|NCT01877421|40394754|FG015|Phase 2|Protocol Violation|0|||
16527241|NCT01877421|40394755|FG016|Phase 2|Protocol Violation|0|||
16527242|NCT01877421|40394756|FG017|Phase 2|Protocol Violation|0|||
16527243|NCT03359096|40394766|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
16527244|NCT03359096|40394767|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
16527245|NCT03359096|40394766|FG000|First Intervention (4 Weeks)|Death|1|||
16527246|NCT03359096|40394767|FG001|First Intervention (4 Weeks)|Death|0|||
16527247|NCT03359096|40394766|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
16527248|NCT03359096|40394767|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
16527249|NCT00408993|40394768|FG000|Overall Study|Adverse Event|15|||
16527250|NCT00408993|40394769|FG001|Overall Study|Adverse Event|4|||
16527251|NCT00408993|40394768|FG000|Overall Study|Protocol Violation|1|||
16527252|NCT00408993|40394769|FG001|Overall Study|Protocol Violation|6|||
16527253|NCT00408993|40394768|FG000|Overall Study|Lack of Efficacy|1|||
16527254|NCT00408993|40394769|FG001|Overall Study|Lack of Efficacy|4|||
16527255|NCT00408993|40394768|FG000|Overall Study|Withdrawal by Subject|2|||
16527256|NCT00408993|40394769|FG001|Overall Study|Withdrawal by Subject|3|||
16527257|NCT04757649|40394770|FG000|Overall Study|Withdrawal by Subject|1|||
16527258|NCT04757649|40394770|FG000|Overall Study|Adverse Event|1|||
16527259|NCT04443218|40394771|FG000|Overall Study|Exited study for other reasons|9|||
16527260|NCT04443218|40394771|FG000|Overall Study|Withdrawal by Subject|1|||
16527261|NCT04443218|40394771|FG000|Overall Study|Lost to Follow-up|4|||
16527262|NCT04443218|40394771|FG000|Overall Study|Death|19|||
16527263|NCT04000165|40394772|FG000|Overall Study|Physician Decision|1|||
16527264|NCT04000165|40394772|FG000|Overall Study|Withdrawal by Subject|1|||
16527265|NCT00922428|40394778|FG000|Overall Study|retrospective/extremely implausible data|2|||
16527266|NCT00922428|40394778|FG000|Overall Study|no medication use or questionable use|13|||
16527267|NCT00319098|40394779|FG000|Overall Study|Serious adverse event|3|||
16527268|NCT00319098|40394780|FG001|Overall Study|Serious adverse event|0|||
16527269|NCT00319098|40394779|FG000|Overall Study|Adverse Event|20|||
16527270|NCT00319098|40394780|FG001|Overall Study|Adverse Event|1|||
16527271|NCT00319098|40394779|FG000|Overall Study|Withdrawal by Subject|37|||
16527272|NCT00319098|40394780|FG001|Overall Study|Withdrawal by Subject|8|||
16527273|NCT00319098|40394779|FG000|Overall Study|Migrated/moved from study area|2|||
16211523|NCT00839436|39255640|FG001|Overall Study|Developed exclusionary condition|0|||
16211524|NCT00839436|39255641|FG002|Overall Study|Developed exclusionary condition|0|||
16527274|NCT00319098|40394780|FG001|Overall Study|Migrated/moved from study area|1|||
16527275|NCT00319098|40394779|FG000|Overall Study|Lost to Follow-up|37|||
16527276|NCT00319098|40394780|FG001|Overall Study|Lost to Follow-up|13|||
16527277|NCT00319098|40394779|FG000|Overall Study|Others|33|||
16527278|NCT00319098|40394780|FG001|Overall Study|Others|8|||
16527279|NCT00319098|40394779|FG000|Overall Study|Protocol Violation|3|||
16527280|NCT00319098|40394780|FG001|Overall Study|Protocol Violation|1|||
16527281|NCT03073603|40394781|FG000|Overall Study|Noncompliance|3|||
16527282|NCT03073603|40394782|FG001|Overall Study|Noncompliance|1|||
16527283|NCT03073603|40394781|FG000|Overall Study|Adverse Event|5|||
16527284|NCT03073603|40394782|FG001|Overall Study|Adverse Event|3|||
16527285|NCT03073603|40394781|FG000|Overall Study|Physician Decision|1|||
16527286|NCT03073603|40394782|FG001|Overall Study|Physician Decision|2|||
16527287|NCT03073603|40394781|FG000|Overall Study|Required treatment not allowed by protocol|1|||
16330533|NCT00980174|39696284|FG001|Overall Study|Adverse Event|3|||
16527288|NCT03073603|40394782|FG001|Overall Study|Required treatment not allowed by protocol|0|||
16527289|NCT03073603|40394781|FG000|Overall Study|Financial or insurance-related|8|||
16211525|NCT00839436|39255639|FG000|Overall Study|Withdrawal by Subject|0|||
16211526|NCT00839436|39255640|FG001|Overall Study|Withdrawal by Subject|1|||
16211527|NCT00839436|39255641|FG002|Overall Study|Withdrawal by Subject|0|||
16211528|NCT00839436|39255639|FG000|Overall Study|Study drug no longer available|0|||
16211529|NCT00839436|39255640|FG001|Overall Study|Study drug no longer available|0|||
16211530|NCT00839436|39255641|FG002|Overall Study|Study drug no longer available|1|||
16211531|NCT00638690|39255642|FG000|Overall Study|Death|655|||
16211532|NCT00638690|39255643|FG001|Overall Study|Death|335|||
16211533|NCT00638690|39255642|FG000|Overall Study|Withdrawal by Subject|22|||
16211534|NCT00638690|39255643|FG001|Overall Study|Withdrawal by Subject|5|||
16211535|NCT00638690|39255642|FG000|Overall Study|Lost to Follow-up|4|||
16211536|NCT00638690|39255643|FG001|Overall Study|Lost to Follow-up|2|||
16330534|NCT00980174|39696283|FG000|Overall Study|Ineligibility determined|2|||
16330535|NCT00980174|39696284|FG001|Overall Study|Ineligibility determined|1|||
16330536|NCT00980174|39696283|FG000|Overall Study|Death|1|||
16330537|NCT00980174|39696284|FG001|Overall Study|Death|1|||
16330538|NCT00980174|39696283|FG000|Overall Study|Other|0|||
16330539|NCT00980174|39696284|FG001|Overall Study|Other|1|||
16330540|NCT03760458|39696285|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
16330541|NCT03760458|39696286|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
16330542|NCT03760458|39696287|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
16330543|NCT03760458|39696288|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
16330544|NCT03760458|39696289|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
16330545|NCT01573767|39696290|FG000|Overall Study|Adverse Event|0|||
16330546|NCT01573767|39696291|FG001|Overall Study|Adverse Event|1|||
16330547|NCT01573767|39696292|FG002|Overall Study|Adverse Event|0|||
16330548|NCT01573767|39696293|FG003|Overall Study|Adverse Event|1|||
16330549|NCT01573767|39696290|FG000|Overall Study|Lack of Efficacy|18|||
16330550|NCT01573767|39696291|FG001|Overall Study|Lack of Efficacy|15|||
16330551|NCT01573767|39696292|FG002|Overall Study|Lack of Efficacy|12|||
16330552|NCT01573767|39696293|FG003|Overall Study|Lack of Efficacy|17|||
16330553|NCT01573767|39696290|FG000|Overall Study|Protocol Violation|3|||
16330554|NCT01573767|39696291|FG001|Overall Study|Protocol Violation|1|||
16330555|NCT01573767|39696292|FG002|Overall Study|Protocol Violation|1|||
16330556|NCT01573767|39696293|FG003|Overall Study|Protocol Violation|3|||
16330557|NCT01573767|39696290|FG000|Overall Study|Lost to Follow-up|0|||
16097974|NCT01799993|38846945|FG001|Overall Study|Recovery|1|||
16097975|NCT01799993|38846944|FG000|Overall Study|Logistical difficulties|1|||
16097976|NCT01799993|38846945|FG001|Overall Study|Logistical difficulties|0|||
16097977|NCT01799993|38846944|FG000|Overall Study|Protocol deviation|1|||
16097978|NCT01799993|38846945|FG001|Overall Study|Protocol deviation|0|||
16097979|NCT01799993|38846944|FG000|Overall Study|Non-compliance with medical device|1|||
16097980|NCT01799993|38846945|FG001|Overall Study|Non-compliance with medical device|0|||
16097981|NCT01799993|38846944|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16330558|NCT01573767|39696291|FG001|Overall Study|Lost to Follow-up|1|||
16399717|NCT02998203|39944820|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
16399718|NCT02998203|39944821|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
16399719|NCT01801436|39944822|FG000|Overall Study|Withdrawal by Subject|3|||
16399720|NCT01801436|39944822|FG000|Overall Study|Adverse Event|2|||
16399721|NCT01801436|39944822|FG000|Overall Study|Progressive disease|4|||
16399722|NCT02547038|39944828|FG000|Overall Study|Lost to Follow-up|3|||
16399723|NCT02547038|39944829|FG001|Overall Study|Lost to Follow-up|2|||
16211537|NCT02015104|39255644|FG000|Overall Study|Withdrew consent after first dose drug|1|||
16330559|NCT01573767|39696292|FG002|Overall Study|Lost to Follow-up|1|||
16399724|NCT01265563|39944831|FG000|Overall Study|Withdrawal by Subject|0|||
16097982|NCT01799993|38846945|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16211538|NCT02015104|39255645|FG001|Overall Study|Withdrew consent after first dose drug|0|||
16330560|NCT01573767|39696293|FG003|Overall Study|Lost to Follow-up|1|||
16330561|NCT01573767|39696290|FG000|Overall Study|Physician Decision|1|||
16399725|NCT01265563|39944832|FG001|Overall Study|Withdrawal by Subject|1|||
16097983|NCT01799993|38846944|FG000|Overall Study|Other|1|||
16211539|NCT02015104|39255644|FG000|Overall Study|Withdrew consent prior to treatment|0|||
16211540|NCT02015104|39255645|FG001|Overall Study|Withdrew consent prior to treatment|1|||
16211541|NCT00422240|39255646|FG000|Overall Study|Lack of Efficacy|1|||
16211542|NCT00422240|39255647|FG001|Overall Study|Lack of Efficacy|2|||
16211543|NCT00422240|39255648|FG002|Overall Study|Lack of Efficacy|0|||
16211544|NCT00422240|39255649|FG003|Overall Study|Lack of Efficacy|1|||
16211545|NCT00422240|39255646|FG000|Overall Study|Adverse Event|11|||
16211546|NCT00422240|39255647|FG001|Overall Study|Adverse Event|4|||
16211547|NCT00422240|39255648|FG002|Overall Study|Adverse Event|5|||
16211548|NCT00422240|39255649|FG003|Overall Study|Adverse Event|2|||
16211549|NCT00422240|39255646|FG000|Overall Study|Subject request|21|||
16211550|NCT00422240|39255647|FG001|Overall Study|Subject request|17|||
16211551|NCT00422240|39255648|FG002|Overall Study|Subject request|18|||
16211552|NCT00422240|39255649|FG003|Overall Study|Subject request|30|||
16211553|NCT00422240|39255646|FG000|Overall Study|Protocol Violation|0|||
16211554|NCT00422240|39255647|FG001|Overall Study|Protocol Violation|1|||
16211555|NCT00422240|39255648|FG002|Overall Study|Protocol Violation|0|||
16211556|NCT00422240|39255649|FG003|Overall Study|Protocol Violation|1|||
16211557|NCT00422240|39255646|FG000|Overall Study|Lost to Follow-up|31|||
16211558|NCT00422240|39255647|FG001|Overall Study|Lost to Follow-up|32|||
16211559|NCT00422240|39255648|FG002|Overall Study|Lost to Follow-up|19|||
16211560|NCT00422240|39255649|FG003|Overall Study|Lost to Follow-up|34|||
16211561|NCT00422240|39255646|FG000|Overall Study|Other|1|||
16211562|NCT00422240|39255647|FG001|Overall Study|Other|0|||
16211563|NCT00422240|39255648|FG002|Overall Study|Other|0|||
16211564|NCT00422240|39255649|FG003|Overall Study|Other|1|||
16211565|NCT00422240|39255646|FG000|Overall Study|Pregnancy|3|||
16211566|NCT00422240|39255647|FG001|Overall Study|Pregnancy|1|||
16211567|NCT00422240|39255648|FG002|Overall Study|Pregnancy|1|||
16211568|NCT00422240|39255649|FG003|Overall Study|Pregnancy|2|||
16211569|NCT00010803|39255650|FG000|Overall Study|Withdrawal by Subject|97|||
16211570|NCT00010803|39255651|FG001|Overall Study|Withdrawal by Subject|98|||
16211571|NCT02603172|39255652|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16211572|NCT02603172|39255653|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16211573|NCT02603172|39255654|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
16330562|NCT01573767|39696291|FG001|Overall Study|Physician Decision|2|||
16211574|NCT02603172|39255655|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16211575|NCT02603172|39255656|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16211576|NCT02603172|39255657|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16211577|NCT02603172|39255658|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16211578|NCT02603172|39255659|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
16211579|NCT00688545|39255660|FG000|Overall Study|Lost to Follow-up|1|||
16211580|NCT00688545|39255661|FG001|Overall Study|Lost to Follow-up|4|||
16211581|NCT00688545|39255660|FG000|Overall Study|Insurance/cost of drug|0|||
16527290|NCT03073603|40394782|FG001|Overall Study|Financial or insurance-related|0|||
16527291|NCT03073603|40394781|FG000|Overall Study|Withdrawal by Subject|0|||
16527292|NCT03073603|40394782|FG001|Overall Study|Withdrawal by Subject|1|||
16527293|NCT03073603|40394781|FG000|Overall Study|Discontinued DMT|4|||
16527294|NCT03073603|40394782|FG001|Overall Study|Discontinued DMT|0|||
16527295|NCT03073603|40394781|FG000|Overall Study|Restarted DMT|0|||
16527296|NCT03073603|40394782|FG001|Overall Study|Restarted DMT|1|||
16527297|NCT02617589|40394785|FG000|Randomization|Request to Discontinue Study Treatment|1|||
16527298|NCT02617589|40394786|FG001|Randomization|Request to Discontinue Study Treatment|3|||
16527299|NCT02617589|40394785|FG000|Randomization|Participant Withdrew Consent|1|||
16527300|NCT02617589|40394786|FG001|Randomization|Participant Withdrew Consent|2|||
16527301|NCT02617589|40394785|FG000|Treatment|Other Reasons|3|||
16527302|NCT02617589|40394786|FG001|Treatment|Other Reasons|3|||
16527303|NCT02617589|40394785|FG000|Treatment|Poor/Non Compliance|1|||
16527304|NCT02617589|40394786|FG001|Treatment|Poor/Non Compliance|1|||
16527305|NCT02617589|40394785|FG000|Treatment|Maximum Clinical Benefit|0|||
16527306|NCT02617589|40394786|FG001|Treatment|Maximum Clinical Benefit|2|||
16527307|NCT02617589|40394785|FG000|Treatment|Participant Withdrew Consent|2|||
16527308|NCT02617589|40394786|FG001|Treatment|Participant Withdrew Consent|6|||
16527309|NCT02617589|40394785|FG000|Treatment|Participant Request to Discontinue|12|||
16527310|NCT02617589|40394786|FG001|Treatment|Participant Request to Discontinue|21|||
16527311|NCT02617589|40394785|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
16527312|NCT02617589|40394786|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
16527313|NCT02617589|40394785|FG000|Treatment|Death|1|||
16527314|NCT02617589|40394786|FG001|Treatment|Death|1|||
16527315|NCT02617589|40394785|FG000|Treatment|Study Drug Toxicity|27|||
16527316|NCT02617589|40394786|FG001|Treatment|Study Drug Toxicity|20|||
16527317|NCT02617589|40394785|FG000|Treatment|Disease Progression|216|||
16527318|NCT02617589|40394786|FG001|Treatment|Disease Progression|136|||
16527319|NCT02043782|40394788|FG000|Period 1|Adverse Event|0|||
16527320|NCT02043782|40394789|FG001|Period 1|Adverse Event|0|||
16527321|NCT02043782|40394790|FG002|Period 1|Adverse Event|1|||
16527322|NCT02043782|40394791|FG003|Period 1|Adverse Event|0|||
16527323|NCT02043782|40394792|FG004|Period 1|Adverse Event|0|||
16527324|NCT02043782|40394793|FG005|Period 1|Adverse Event|0|||
16527325|NCT00364858|40394794|FG000|Overall Study|Adverse Event|1|||
16527326|NCT00364858|40394795|FG001|Overall Study|Adverse Event|5|||
16527327|NCT00364858|40394794|FG000|Overall Study|Withdrawal by Subject|1|||
16527328|NCT00364858|40394795|FG001|Overall Study|Withdrawal by Subject|1|||
16527329|NCT00364858|40394794|FG000|Overall Study|Pregnancy|1|||
16527330|NCT00364858|40394795|FG001|Overall Study|Pregnancy|1|||
16527331|NCT00364858|40394794|FG000|Overall Study|Clinical failure|2|||
16527332|NCT00364858|40394795|FG001|Overall Study|Clinical failure|13|||
16527333|NCT00364858|40394794|FG000|Overall Study|Discontinuation at baseline|1|||
16527334|NCT00364858|40394795|FG001|Overall Study|Discontinuation at baseline|0|||
16527335|NCT00364858|40394794|FG000|Overall Study|Non-compliant|1|||
16527336|NCT00364858|40394795|FG001|Overall Study|Non-compliant|0|||
16527337|NCT00364858|40394794|FG000|Overall Study|Return to Q2 regimen|0|||
16211582|NCT00688545|39255661|FG001|Overall Study|Insurance/cost of drug|1|||
16211583|NCT00688545|39255660|FG000|Overall Study|Withdrawal by Subject|2|||
16211584|NCT00688545|39255661|FG001|Overall Study|Withdrawal by Subject|3|||
16211585|NCT00688545|39255660|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
16211586|NCT00688545|39255661|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
16211587|NCT00611767|39255666|FG000|Overall Study|Withdrawal by Subject|4|||
16211588|NCT00611767|39255667|FG001|Overall Study|Withdrawal by Subject|1|||
16211589|NCT00611767|39255666|FG000|Overall Study|Thiopental not available|3|||
16527338|NCT00364858|40394795|FG001|Overall Study|Return to Q2 regimen|1|||
16527339|NCT00364858|40394794|FG000|Overall Study|Clinical baseline issue|0|||
16527340|NCT00364858|40394795|FG001|Overall Study|Clinical baseline issue|1|||
16527341|NCT03647501|40394809|FG000|Overall Study|Lost to Follow-up|1|||
16527342|NCT03647501|40394810|FG001|Overall Study|Lost to Follow-up|1|||
16527343|NCT03647501|40394809|FG000|Overall Study|Withdrawal by Subject|0|||
16211590|NCT00611767|39255667|FG001|Overall Study|Thiopental not available|0|||
16527344|NCT03647501|40394810|FG001|Overall Study|Withdrawal by Subject|1|||
16527345|NCT01592708|40394812|FG000|Overall Study|Protocol Violation|3|||
16527346|NCT01592708|40394813|FG001|Overall Study|Protocol Violation|0|||
16527347|NCT01682837|40394814|FG000|Baseline|Withdrawal by Subject|5|||
16211591|NCT00611767|39255666|FG000|Overall Study|didn't like the medication|1|||
16211592|NCT00611767|39255667|FG001|Overall Study|didn't like the medication|1|||
16211593|NCT00611767|39255666|FG000|Overall Study|Physician Decision|1|||
16211594|NCT00611767|39255667|FG001|Overall Study|Physician Decision|0|||
16211595|NCT04728815|39255668|FG000|Overall Study|Lost to Follow-up|3|||
16211596|NCT04728815|39255669|FG001|Overall Study|Lost to Follow-up|0|||
16211597|NCT04728815|39255670|FG002|Overall Study|Lost to Follow-up|0|||
16211598|NCT04728815|39255671|FG003|Overall Study|Lost to Follow-up|1|||
16211599|NCT04728815|39255672|FG004|Overall Study|Lost to Follow-up|1|||
16211600|NCT04728815|39255673|FG005|Overall Study|Lost to Follow-up|0|||
16211601|NCT04728815|39255674|FG006|Overall Study|Lost to Follow-up|2|||
16211602|NCT04728815|39255675|FG007|Overall Study|Lost to Follow-up|0|||
16211603|NCT04728815|39255668|FG000|Overall Study|Physician Decision|0|||
16211604|NCT04728815|39255669|FG001|Overall Study|Physician Decision|0|||
16211605|NCT04728815|39255670|FG002|Overall Study|Physician Decision|1|||
16211606|NCT04728815|39255671|FG003|Overall Study|Physician Decision|0|||
16211607|NCT04728815|39255672|FG004|Overall Study|Physician Decision|0|||
16211608|NCT04728815|39255673|FG005|Overall Study|Physician Decision|0|||
16211609|NCT04728815|39255674|FG006|Overall Study|Physician Decision|0|||
16211610|NCT04728815|39255675|FG007|Overall Study|Physician Decision|0|||
16211611|NCT04728815|39255668|FG000|Overall Study|Treatment drop|0|||
16211612|NCT04728815|39255669|FG001|Overall Study|Treatment drop|2|||
16211613|NCT04728815|39255670|FG002|Overall Study|Treatment drop|1|||
16211614|NCT04728815|39255671|FG003|Overall Study|Treatment drop|0|||
16211615|NCT04728815|39255672|FG004|Overall Study|Treatment drop|3|||
16211616|NCT04728815|39255673|FG005|Overall Study|Treatment drop|1|||
16211617|NCT04728815|39255674|FG006|Overall Study|Treatment drop|3|||
16211618|NCT04728815|39255675|FG007|Overall Study|Treatment drop|0|||
16211619|NCT04728815|39255668|FG000|Overall Study|Study drop|0|||
16211620|NCT04728815|39255669|FG001|Overall Study|Study drop|3|||
16211621|NCT04728815|39255670|FG002|Overall Study|Study drop|3|||
16211622|NCT04728815|39255671|FG003|Overall Study|Study drop|0|||
16211623|NCT04728815|39255672|FG004|Overall Study|Study drop|0|||
16211624|NCT04728815|39255673|FG005|Overall Study|Study drop|0|||
16211625|NCT04728815|39255674|FG006|Overall Study|Study drop|7|||
16211626|NCT04728815|39255675|FG007|Overall Study|Study drop|0|||
16211627|NCT00285649|39255676|FG000|Overall Study|Lost to Follow-up|6|||
16211628|NCT00285649|39255677|FG001|Overall Study|Lost to Follow-up|4|||
16211629|NCT00285649|39255678|FG002|Overall Study|Lost to Follow-up|4|||
16211630|NCT00285649|39255676|FG000|Overall Study|Withdrawal by Subject|3|||
16211631|NCT00285649|39255677|FG001|Overall Study|Withdrawal by Subject|2|||
16211632|NCT00285649|39255678|FG002|Overall Study|Withdrawal by Subject|2|||
16211633|NCT06048705|39255681|FG000|Overall Study|Physician Decision|1|||
16211634|NCT06048705|39255682|FG001|Overall Study|Physician Decision|0|||
16211635|NCT06048705|39255683|FG002|Overall Study|Physician Decision|0|||
16211636|NCT06048705|39255681|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
16211637|NCT06048705|39255682|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
16527348|NCT03321981|40394815|FG000|Overall Study|Progressive Disease (PD)|15|||
16211638|NCT06048705|39255683|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
16211639|NCT06048705|39255681|FG000|Overall Study|Death prior to lymphodepletion|0|||
16211640|NCT06048705|39255682|FG001|Overall Study|Death prior to lymphodepletion|0|||
16211641|NCT06048705|39255683|FG002|Overall Study|Death prior to lymphodepletion|1|||
16211642|NCT05116683|39255684|FG000|Overall Study|Physician Decision|4|||
16211643|NCT03250624|39255685|FG000|Overall Study|Lack of Efficacy|1|||
16211644|NCT03250624|39255686|FG001|Overall Study|Lack of Efficacy|4|||
16211645|NCT03250624|39255685|FG000|Overall Study|Adverse Event|0|||
16211646|NCT03250624|39255686|FG001|Overall Study|Adverse Event|1|||
16527349|NCT03321981|40394816|FG001|Overall Study|Progressive Disease (PD)|30|||
16527350|NCT03321981|40394817|FG002|Overall Study|Progressive Disease (PD)|47|||
16527351|NCT03321981|40394815|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
16211647|NCT03250624|39255685|FG000|Overall Study|Other|1|||
16211648|NCT03250624|39255686|FG001|Overall Study|Other|2|||
16211649|NCT00003838|39255689|FG000|Overall Study|Death|0|||
16211650|NCT00003838|39255690|FG001|Overall Study|Death|12|||
16211651|NCT00003838|39255691|FG002|Overall Study|Death|7|||
16211652|NCT00003838|39255689|FG000|Overall Study|Lost to Follow-up|0|||
16211653|NCT00003838|39255690|FG001|Overall Study|Lost to Follow-up|1|||
16211654|NCT00003838|39255691|FG002|Overall Study|Lost to Follow-up|1|||
16211655|NCT00003838|39255689|FG000|Overall Study|Disease Progression|0|||
16211656|NCT00003838|39255690|FG001|Overall Study|Disease Progression|12|||
16211657|NCT00003838|39255691|FG002|Overall Study|Disease Progression|0|||
16211658|NCT00415623|39255694|FG000|Overall Study|Adverse Event|3|||
16211659|NCT00415623|39255695|FG001|Overall Study|Adverse Event|4|||
16211660|NCT00415623|39255694|FG000|Overall Study|Death|1|||
16211661|NCT00415623|39255695|FG001|Overall Study|Death|0|||
16211662|NCT00415623|39255694|FG000|Overall Study|Withdrawal by Subject|1|||
16211663|NCT00415623|39255695|FG001|Overall Study|Withdrawal by Subject|1|||
16211664|NCT03192176|39255702|FG000|Overall Study|Adverse Event|1|||
16211665|NCT03192176|39255703|FG001|Overall Study|Adverse Event|0|||
16211666|NCT03192176|39255704|FG002|Overall Study|Adverse Event|4|||
16527352|NCT03321981|40394816|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
16527353|NCT03321981|40394817|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
16211667|NCT03192176|39255705|FG003|Overall Study|Adverse Event|5|||
16211668|NCT03192176|39255706|FG004|Overall Study|Adverse Event|3|||
16211669|NCT03192176|39255707|FG005|Overall Study|Adverse Event|2|||
16211670|NCT03192176|39255708|FG006|Overall Study|Adverse Event|3|||
16211671|NCT03192176|39255709|FG007|Overall Study|Adverse Event|3|||
16211672|NCT03192176|39255702|FG000|Overall Study|Lost to Follow-up|0|||
16211673|NCT03192176|39255703|FG001|Overall Study|Lost to Follow-up|0|||
16211674|NCT03192176|39255704|FG002|Overall Study|Lost to Follow-up|1|||
16211675|NCT03192176|39255705|FG003|Overall Study|Lost to Follow-up|2|||
16211676|NCT03192176|39255706|FG004|Overall Study|Lost to Follow-up|3|||
16211677|NCT03192176|39255707|FG005|Overall Study|Lost to Follow-up|1|||
16211678|NCT03192176|39255708|FG006|Overall Study|Lost to Follow-up|1|||
16211679|NCT03192176|39255709|FG007|Overall Study|Lost to Follow-up|1|||
16211680|NCT03192176|39255702|FG000|Overall Study|Physician Decision|1|||
16211681|NCT03192176|39255703|FG001|Overall Study|Physician Decision|0|||
16211682|NCT03192176|39255704|FG002|Overall Study|Physician Decision|0|||
16211683|NCT03192176|39255705|FG003|Overall Study|Physician Decision|0|||
16211684|NCT03192176|39255706|FG004|Overall Study|Physician Decision|0|||
16211685|NCT03192176|39255707|FG005|Overall Study|Physician Decision|2|||
16211686|NCT03192176|39255708|FG006|Overall Study|Physician Decision|1|||
16211687|NCT03192176|39255709|FG007|Overall Study|Physician Decision|0|||
16211688|NCT03192176|39255702|FG000|Overall Study|Protocol Deviation|1|||
16211689|NCT03192176|39255703|FG001|Overall Study|Protocol Deviation|1|||
16211690|NCT03192176|39255704|FG002|Overall Study|Protocol Deviation|0|||
16211691|NCT03192176|39255705|FG003|Overall Study|Protocol Deviation|0|||
16211692|NCT03192176|39255706|FG004|Overall Study|Protocol Deviation|2|||
16211693|NCT03192176|39255707|FG005|Overall Study|Protocol Deviation|0|||
16211694|NCT03192176|39255708|FG006|Overall Study|Protocol Deviation|0|||
16211695|NCT03192176|39255709|FG007|Overall Study|Protocol Deviation|0|||
16211696|NCT03192176|39255702|FG000|Overall Study|Withdrawal by Subject|3|||
16211697|NCT03192176|39255703|FG001|Overall Study|Withdrawal by Subject|4|||
16211698|NCT03192176|39255704|FG002|Overall Study|Withdrawal by Subject|0|||
16211699|NCT03192176|39255705|FG003|Overall Study|Withdrawal by Subject|4|||
16211700|NCT03192176|39255706|FG004|Overall Study|Withdrawal by Subject|3|||
16211701|NCT03192176|39255707|FG005|Overall Study|Withdrawal by Subject|4|||
16211702|NCT03192176|39255708|FG006|Overall Study|Withdrawal by Subject|4|||
16399726|NCT01265563|39944833|FG002|Overall Study|Withdrawal by Subject|1|||
16399727|NCT01265563|39944834|FG003|Overall Study|Withdrawal by Subject|0|||
16399728|NCT01265563|39944835|FG004|Overall Study|Withdrawal by Subject|2|||
16211703|NCT03192176|39255709|FG007|Overall Study|Withdrawal by Subject|2|||
16211704|NCT03192176|39255702|FG000|Overall Study|Miscellaneous|1|||
16399729|NCT01779856|39944836|FG000|Overall Study|Withdrawal by Subject|15|||
16399730|NCT01779856|39944836|FG000|Overall Study|Death|3|||
16399731|NCT01779856|39944836|FG000|Overall Study|Physician Decision|1|||
16399732|NCT01779856|39944836|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
16399733|NCT01779856|39944836|FG000|Overall Study|Delays in scheduling implant|1|||
16399734|NCT01779856|39944836|FG000|Overall Study|Subject ineligible for Implant|2|||
16399735|NCT04005352|39944837|FG000|Overall Study|Adverse Event|4|||
16399736|NCT04005352|39944838|FG001|Overall Study|Adverse Event|5|||
16399737|NCT04005352|39944837|FG000|Overall Study|Death|4|||
16399738|NCT04005352|39944838|FG001|Overall Study|Death|2|||
16399739|NCT04005352|39944837|FG000|Overall Study|Lost to Follow-up|6|||
16399740|NCT04005352|39944838|FG001|Overall Study|Lost to Follow-up|2|||
16399741|NCT04005352|39944837|FG000|Overall Study|Physician Decision|7|||
16527354|NCT03321981|40394815|FG000|Overall Study|Adverse Event|0|||
16527355|NCT03321981|40394816|FG001|Overall Study|Adverse Event|0|||
16211705|NCT03192176|39255703|FG001|Overall Study|Miscellaneous|0|||
16211706|NCT03192176|39255704|FG002|Overall Study|Miscellaneous|1|||
16211707|NCT03192176|39255705|FG003|Overall Study|Miscellaneous|1|||
16527356|NCT03321981|40394817|FG002|Overall Study|Adverse Event|2|||
16527357|NCT03321981|40394815|FG000|Overall Study|symptomatic deterioration|0|||
16527358|NCT03321981|40394816|FG001|Overall Study|symptomatic deterioration|1|||
16527359|NCT03321981|40394817|FG002|Overall Study|symptomatic deterioration|1|||
16211708|NCT03192176|39255706|FG004|Overall Study|Miscellaneous|1|||
16211709|NCT03192176|39255707|FG005|Overall Study|Miscellaneous|2|||
16211710|NCT03192176|39255708|FG006|Overall Study|Miscellaneous|0|||
16211711|NCT03192176|39255709|FG007|Overall Study|Miscellaneous|1|||
16399742|NCT04005352|39944838|FG001|Overall Study|Physician Decision|13|||
16399743|NCT04005352|39944837|FG000|Overall Study|Protocol Violation|0|||
16211712|NCT01421069|39255710|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
16211713|NCT01421069|39255710|FG000|Parent Study|Failed to return|3|||
16399744|NCT04005352|39944838|FG001|Overall Study|Protocol Violation|1|||
16399745|NCT04005352|39944837|FG000|Overall Study|Withdrawal by Subject|28|||
16399746|NCT04005352|39944838|FG001|Overall Study|Withdrawal by Subject|38|||
16399747|NCT00066222|39944839|FG000|Overall Study|No protocol treatment received|1|||
16211714|NCT01421069|39255710|FG000|Parent Study|Withdrawal by Subject|1|||
16211715|NCT01421069|39255710|FG000|Parent Study|Lost to Follow-up|2|||
16211716|NCT01421069|39255710|FG000|Parent Study|Lack of Efficacy|1|||
16211717|NCT01421069|39255710|FG000|Overall Period for Extension Study|Other|2|||
16211718|NCT01421069|39255710|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
16211719|NCT01421069|39255710|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
16211720|NCT01421069|39255710|FG000|Overall Period for Extension Study|Pregnancy|1|||
16211721|NCT01421069|39255710|FG000|Overall Period for Extension Study|Adverse Event|1|||
16211722|NCT01421069|39255710|FG000|Overall Period for Extension Study|Protocol Violation|1|||
16211723|NCT01421069|39255710|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
16211724|NCT01421069|39255710|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
16211725|NCT01421069|39255710|FG000|Active Treatment Period|Other|1|||
16211726|NCT01421069|39255710|FG000|Active Treatment Period|No longer willing to participate in study|8|||
16211727|NCT01421069|39255710|FG000|Active Treatment Period|Insufficient clinical response|1|||
16211728|NCT01421069|39255710|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
16211729|NCT01421069|39255710|FG000|Active Treatment Period|Pregnancy|1|||
16211730|NCT01421069|39255710|FG000|Active Treatment Period|Adverse Event|1|||
16211731|NCT01421069|39255710|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
16211732|NCT01421069|39255710|FG000|Active Treatment Period|Enrolled in observational period|29|||
16211733|NCT01421069|39255710|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
16211734|NCT01421069|39255710|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
16399748|NCT02550288|39944842|FG000|Overall Study|Adverse Event|0|||
16399749|NCT02550288|39944843|FG001|Overall Study|Adverse Event|1|||
16399750|NCT02550288|39944844|FG002|Overall Study|Adverse Event|0|||
16399751|NCT02550288|39944845|FG003|Overall Study|Adverse Event|0|||
16399752|NCT02550288|39944846|FG004|Overall Study|Adverse Event|0|||
16399753|NCT02550288|39944842|FG000|Overall Study|Physician Decision|0|||
16399754|NCT02550288|39944843|FG001|Overall Study|Physician Decision|0|||
16399755|NCT02550288|39944844|FG002|Overall Study|Physician Decision|0|||
16399756|NCT02550288|39944845|FG003|Overall Study|Physician Decision|1|||
16399757|NCT02550288|39944846|FG004|Overall Study|Physician Decision|0|||
16399758|NCT02550288|39944842|FG000|Overall Study|Protocol Violation|2|||
16399759|NCT02550288|39944843|FG001|Overall Study|Protocol Violation|2|||
16399760|NCT02550288|39944844|FG002|Overall Study|Protocol Violation|1|||
16399761|NCT02550288|39944845|FG003|Overall Study|Protocol Violation|0|||
16399762|NCT02550288|39944846|FG004|Overall Study|Protocol Violation|3|||
16399763|NCT02550288|39944842|FG000|Overall Study|Participant moved|0|||
16399764|NCT02550288|39944843|FG001|Overall Study|Participant moved|0|||
16527360|NCT03321981|40394815|FG000|Overall Study|Lack of compliance|0|||
16527361|NCT03321981|40394816|FG001|Overall Study|Lack of compliance|1|||
16527362|NCT03321981|40394817|FG002|Overall Study|Lack of compliance|0|||
16527363|NCT03321981|40394815|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
16527364|NCT03321981|40394816|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
16527365|NCT03321981|40394817|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
16527366|NCT03321981|40394815|FG000|Overall Study|Death|0|||
16527367|NCT03321981|40394816|FG001|Overall Study|Death|1|||
16527368|NCT03321981|40394817|FG002|Overall Study|Death|0|||
16527369|NCT03321981|40394815|FG000|Overall Study|Subject withdrawal of investigational product|0|||
16527370|NCT03321981|40394816|FG001|Overall Study|Subject withdrawal of investigational product|1|||
16527371|NCT03321981|40394817|FG002|Overall Study|Subject withdrawal of investigational product|0|||
16527372|NCT03321981|40394815|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
16527373|NCT03321981|40394816|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
16527374|NCT03321981|40394817|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
16527375|NCT03321981|40394815|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
16527376|NCT03321981|40394816|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
16527377|NCT03321981|40394817|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
16527378|NCT01343368|40394818|FG000|Overall Study|Death|1|||
16527379|NCT01343368|40394819|FG001|Overall Study|Death|0|||
16527380|NCT01343368|40394818|FG000|Overall Study|Lost to Follow-up|1|||
16527381|NCT01343368|40394819|FG001|Overall Study|Lost to Follow-up|0|||
16527382|NCT02056301|40394820|FG000|Overall Study|Protocol Violation|1|||
16527383|NCT02056301|40394821|FG001|Overall Study|Protocol Violation|2|||
16399765|NCT02550288|39944844|FG002|Overall Study|Participant moved|0|||
16399766|NCT02550288|39944845|FG003|Overall Study|Participant moved|1|||
16399767|NCT02550288|39944846|FG004|Overall Study|Participant moved|0|||
16399768|NCT02550288|39944842|FG000|Overall Study|Withdrawal by Subject|0|||
16399769|NCT02550288|39944843|FG001|Overall Study|Withdrawal by Subject|0|||
16527384|NCT02056301|40394820|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
16527385|NCT02056301|40394821|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
16527386|NCT02056301|40394820|FG000|Overall Study|Withdrawal by Subject|0|||
16527387|NCT02056301|40394821|FG001|Overall Study|Withdrawal by Subject|1|||
16527388|NCT02056301|40394820|FG000|Overall Study|Issues with epidural|0|||
16527389|NCT02056301|40394821|FG001|Overall Study|Issues with epidural|3|||
16527390|NCT00464542|40394822|FG000|Pre-treatment|Withdrawal by Subject|2|||
16527391|NCT00448539|40394823|FG000|Overall Study|Medication non-compliance|4|||
16527392|NCT00448539|40394824|FG001|Overall Study|Medication non-compliance|1|||
16527393|NCT00448539|40394823|FG000|Overall Study|Protocol Violation|1|||
16527394|NCT00448539|40394824|FG001|Overall Study|Protocol Violation|0|||
16097984|NCT01799993|38846945|FG001|Overall Study|Other|0|||
16097985|NCT01799993|38846944|FG000|Overall Study|Subject didn't return for follow-up|0|||
16097986|NCT01799993|38846945|FG001|Overall Study|Subject didn't return for follow-up|1|||
16097987|NCT01894620|38846950|FG000|Overall Study|Withdrawal by Subject|0|||
16097988|NCT01894620|38846951|FG001|Overall Study|Withdrawal by Subject|1|||
16097989|NCT05203822|38846952|FG000|Overall Study|Adverse Event|1|||
16097990|NCT05203822|38846952|FG000|Overall Study|Withdrawal by Subject|1|||
16097991|NCT00215943|38846953|FG000|Overall Study|Disease Progression|3|||
16097992|NCT00215943|38846954|FG001|Overall Study|Disease Progression|5|||
16097993|NCT00215943|38846953|FG000|Overall Study|Alternate therapy|0|||
16097994|NCT00215943|38846954|FG001|Overall Study|Alternate therapy|1|||
16097995|NCT00215943|38846953|FG000|Overall Study|Adverse Event|3|||
16097996|NCT00215943|38846954|FG001|Overall Study|Adverse Event|6|||
16097997|NCT00215943|38846953|FG000|Overall Study|Other disease|0|||
16097998|NCT00215943|38846954|FG001|Overall Study|Other disease|1|||
16097999|NCT00215943|38846953|FG000|Overall Study|Other complications|3|||
16098000|NCT00215943|38846954|FG001|Overall Study|Other complications|1|||
16098001|NCT04088136|38846955|FG000|Overall Study|Withdrawal by Subject|5|||
16098002|NCT04088136|38846956|FG001|Overall Study|Withdrawal by Subject|0|||
16098003|NCT04088136|38846955|FG000|Overall Study|Lack of Efficacy|0|||
16098004|NCT04088136|38846956|FG001|Overall Study|Lack of Efficacy|1|||
16098005|NCT00191984|38846958|FG000|Overall Study|Disease Progression|21|||
16098006|NCT00191984|38846958|FG000|Overall Study|Adverse Event|4|||
16098007|NCT00191984|38846958|FG000|Overall Study|Death|2|||
16098008|NCT00191984|38846958|FG000|Overall Study|Entry Criteria Exclusion|1|||
16098009|NCT00191984|38846958|FG000|Overall Study|Withdrawal by Subject|7|||
16098010|NCT00191984|38846958|FG000|Overall Study|Physician Decision|4|||
16098011|NCT02105688|38846959|FG000|Part A: Double-Blind|Adverse Event|1|||
16098012|NCT02105688|38846960|FG001|Part A: Double-Blind|Adverse Event|0|||
16098013|NCT02105688|38846959|FG000|Part A: Double-Blind|Death|0|||
16211735|NCT01421069|39255710|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
16211736|NCT01421069|39255710|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
16211737|NCT01421069|39255710|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
16211738|NCT01421069|39255710|FG000|2b. Retreatment Period|Protocol Violation|1|||
16211739|NCT01421069|39255710|FG000|Observational Period|Other|1|||
16211740|NCT01421069|39255710|FG000|Observational Period|No longer willing to participate in study|4|||
16211741|NCT01421069|39255710|FG000|Observational Period|Lost to Follow-up|3|||
16211742|NCT03689972|39255711|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
16211743|NCT03689972|39255712|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
16211744|NCT03689972|39255713|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
16211745|NCT03689972|39255714|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
16211746|NCT03689972|39255715|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
16211747|NCT03689972|39255711|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
16211748|NCT03689972|39255712|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
16527395|NCT00448539|40394823|FG000|Overall Study|Request of the investigator or sponsor|67|||
16527396|NCT00448539|40394824|FG001|Overall Study|Request of the investigator or sponsor|54|||
16527397|NCT00448539|40394823|FG000|Overall Study|Withdrawal by Subject|20|||
16098014|NCT02105688|38846960|FG001|Part A: Double-Blind|Death|1|||
16098015|NCT02105688|38846959|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
16098016|NCT02105688|38846960|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
16098017|NCT02105688|38846959|FG000|Part A: Double-Blind|Physician Decision|0|||
16098018|NCT02105688|38846960|FG001|Part A: Double-Blind|Physician Decision|1|||
16098019|NCT02105688|38846959|FG000|Part A: Double-Blind|Status Unknown|0|||
16211749|NCT03689972|39255713|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
16211750|NCT03689972|39255714|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
16211751|NCT03689972|39255715|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
16211752|NCT03689972|39255711|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
16098020|NCT02105688|38846960|FG001|Part A: Double-Blind|Status Unknown|2|||
16098021|NCT02105688|38846959|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
16098022|NCT02105688|38846960|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
16098023|NCT02105688|38846959|FG000|Part B: Observational Follow-up|Death|2|||
16098024|NCT02105688|38846960|FG001|Part B: Observational Follow-up|Death|1|||
16098025|NCT02105688|38846959|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
16098026|NCT02105688|38846960|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
16098027|NCT02105688|38846959|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
16211753|NCT03689972|39255712|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
16211754|NCT03689972|39255713|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
16211755|NCT03689972|39255714|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
16211756|NCT03689972|39255715|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
16211757|NCT03689972|39255711|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
16211758|NCT03689972|39255712|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
16211759|NCT03689972|39255713|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
16211760|NCT03689972|39255714|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
16211761|NCT03689972|39255715|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
16211762|NCT03689972|39255711|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
16211763|NCT03689972|39255712|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
16211764|NCT03689972|39255713|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
16098028|NCT02105688|38846960|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
16098029|NCT02105688|38846959|FG000|Part B: Observational Follow-up|Physician Decision|3|||
16399770|NCT02550288|39944844|FG002|Overall Study|Withdrawal by Subject|0|||
16399771|NCT02550288|39944845|FG003|Overall Study|Withdrawal by Subject|1|||
16399772|NCT02550288|39944846|FG004|Overall Study|Withdrawal by Subject|0|||
16399773|NCT04848220|39944849|FG000|Overall Study|Unable to proceed to study procedure|0|||
16399774|NCT04848220|39944850|FG001|Overall Study|Unable to proceed to study procedure|1|||
16399775|NCT04848220|39944851|FG002|Overall Study|Unable to proceed to study procedure|0|||
16399776|NCT04848220|39944849|FG000|Overall Study|Fractional flow not significant|0|||
16399777|NCT04848220|39944850|FG001|Overall Study|Fractional flow not significant|1|||
16399778|NCT04848220|39944851|FG002|Overall Study|Fractional flow not significant|0|||
16399779|NCT00431444|39944853|FG000|Overall Study|Protocol Violation|1|||
16399780|NCT00431444|39944854|FG001|Overall Study|Protocol Violation|4|||
16399781|NCT00431444|39944853|FG000|Overall Study|Adverse Event|2|||
16399782|NCT00431444|39944854|FG001|Overall Study|Adverse Event|1|||
16399783|NCT00431444|39944853|FG000|Overall Study|Withdrawal by Subject|1|||
16399784|NCT00431444|39944854|FG001|Overall Study|Withdrawal by Subject|1|||
16399785|NCT00431444|39944853|FG000|Overall Study|Lost to Follow-up|1|||
16399786|NCT00431444|39944854|FG001|Overall Study|Lost to Follow-up|0|||
16399787|NCT00431444|39944853|FG000|Overall Study|Administrative Problems|0|||
16399788|NCT00431444|39944854|FG001|Overall Study|Administrative Problems|1|||
16399789|NCT01132651|39944855|FG000|Overall Study|Lost to Follow-up|1|||
16399790|NCT01132651|39944856|FG001|Overall Study|Lost to Follow-up|1|||
16399791|NCT03255967|39944858|FG000|Overall Study|Adverse Event|26|||
16399792|NCT03255967|39944859|FG001|Overall Study|Adverse Event|30|||
16399793|NCT03255967|39944858|FG000|Overall Study|Withdrawal by Subject|6|||
16399794|NCT03255967|39944859|FG001|Overall Study|Withdrawal by Subject|6|||
16399795|NCT03255967|39944858|FG000|Overall Study|Schedule conflict|6|||
16399796|NCT03255967|39944859|FG001|Overall Study|Schedule conflict|4|||
16399797|NCT03255967|39944858|FG000|Overall Study|POA did not sign consent form|2|||
16399798|NCT03255967|39944859|FG001|Overall Study|POA did not sign consent form|0|||
16399799|NCT03748706|39944860|FG000|Overall Study|Lost to Follow-up|1|||
16399800|NCT00577707|39944861|FG000|Overall Study|Withdrawal by Subject|3|||
16399801|NCT03333252|39944862|FG000|Overall Study|Adverse Event|10|||
16399802|NCT03333252|39944863|FG001|Overall Study|Adverse Event|6|||
16399803|NCT03333252|39944864|FG002|Overall Study|Adverse Event|5|||
16399804|NCT03333252|39944865|FG003|Overall Study|Adverse Event|2|||
16399805|NCT03333252|39944862|FG000|Overall Study|Death|1|||
16399806|NCT03333252|39944863|FG001|Overall Study|Death|3|||
16399807|NCT03333252|39944864|FG002|Overall Study|Death|0|||
16399808|NCT03333252|39944865|FG003|Overall Study|Death|0|||
16399809|NCT03333252|39944862|FG000|Overall Study|Lack of Efficacy|8|||
16527398|NCT00448539|40394824|FG001|Overall Study|Withdrawal by Subject|24|||
16527399|NCT00448539|40394823|FG000|Overall Study|Diary non-compliance|1|||
16527400|NCT00448539|40394824|FG001|Overall Study|Diary non-compliance|0|||
16527401|NCT00448539|40394823|FG000|Overall Study|Adverse Event|9|||
16527402|NCT00448539|40394824|FG001|Overall Study|Adverse Event|26|||
16527403|NCT00448539|40394823|FG000|Overall Study|Lack of Efficacy|27|||
16527404|NCT00448539|40394824|FG001|Overall Study|Lack of Efficacy|40|||
16527405|NCT00448539|40394823|FG000|Overall Study|Miscellaneous|2|||
16527406|NCT00448539|40394824|FG001|Overall Study|Miscellaneous|1|||
16527407|NCT00448539|40394823|FG000|Overall Study|Change of meds|2|||
16527408|NCT00448539|40394824|FG001|Overall Study|Change of meds|3|||
16527409|NCT00448539|40394823|FG000|Overall Study|Lost to Follow-up|1|||
16527410|NCT00448539|40394824|FG001|Overall Study|Lost to Follow-up|3|||
16527411|NCT03062891|40394825|FG000|Overall Study|Withdrawal by Subject|2|||
16527412|NCT03062891|40394826|FG001|Overall Study|Withdrawal by Subject|0|||
16527413|NCT03062891|40394825|FG000|Overall Study|Lost to Follow-up|50|||
16527414|NCT03062891|40394826|FG001|Overall Study|Lost to Follow-up|38|||
16527415|NCT01136291|40394827|FG000|Overall Study|Lost to Follow-up|1|||
16527416|NCT01136291|40394828|FG001|Overall Study|Lost to Follow-up|1|||
16527417|NCT02641080|40394833|FG000|Overall Study|Physician Decision|2|||
16527418|NCT02641080|40394834|FG001|Overall Study|Physician Decision|0|||
16527419|NCT02641080|40394833|FG000|Overall Study|Withdrawal by Subject|0|||
16527420|NCT02641080|40394834|FG001|Overall Study|Withdrawal by Subject|1|||
16527421|NCT02641080|40394833|FG000|Overall Study|Rehab Center denied use of pumps|0|||
16527422|NCT02641080|40394834|FG001|Overall Study|Rehab Center denied use of pumps|3|||
16527423|NCT02641080|40394833|FG000|Overall Study|Lost to Follow-up|0|||
16527424|NCT02641080|40394834|FG001|Overall Study|Lost to Follow-up|3|||
16527425|NCT01175668|40398045|FG000|Overall Study|Withdrawal by Subject|2|||
16527426|NCT01175668|40398046|FG001|Overall Study|Withdrawal by Subject|0|||
16527427|NCT00823719|40398047|FG000|Overall Study|Adverse Event|1|||
16527428|NCT00823719|40398048|FG001|Overall Study|Adverse Event|2|||
16527429|NCT00823719|40398047|FG000|Overall Study|Physician Decision|1|||
16399810|NCT03333252|39944863|FG001|Overall Study|Lack of Efficacy|4|||
16399811|NCT03333252|39944864|FG002|Overall Study|Lack of Efficacy|0|||
16399812|NCT03333252|39944865|FG003|Overall Study|Lack of Efficacy|7|||
16527430|NCT00823719|40398048|FG001|Overall Study|Physician Decision|4|||
16098030|NCT02105688|38846960|FG001|Part B: Observational Follow-up|Physician Decision|1|||
16098031|NCT02592434|38846961|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
16098032|NCT02592434|38846962|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
16098033|NCT02592434|38846963|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
16527431|NCT00823719|40398047|FG000|Overall Study|Withdrawal by Subject|0|||
16527432|NCT00823719|40398048|FG001|Overall Study|Withdrawal by Subject|1|||
16527433|NCT00823719|40398047|FG000|Overall Study|Disease Progression|4|||
16098034|NCT02592434|38846961|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
16098035|NCT02592434|38846962|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
16211765|NCT03689972|39255714|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
16211766|NCT03689972|39255715|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
16211767|NCT03689972|39255711|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
16211768|NCT03689972|39255712|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
16211769|NCT03689972|39255713|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
16211770|NCT03689972|39255714|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
16211771|NCT03689972|39255715|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
16211772|NCT03689972|39255711|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
16211773|NCT03689972|39255712|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
16211774|NCT03689972|39255713|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
16211775|NCT03689972|39255714|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
16211776|NCT03689972|39255715|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
16211777|NCT03689972|39255711|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
16211778|NCT03689972|39255712|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
16211779|NCT03689972|39255713|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
16211780|NCT03689972|39255714|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
16211781|NCT03689972|39255715|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
16211782|NCT03689972|39255711|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
16211783|NCT03689972|39255712|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
16211784|NCT03689972|39255713|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
16211785|NCT03689972|39255714|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
16211786|NCT03689972|39255715|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
16211787|NCT03689972|39255711|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
16211788|NCT03689972|39255712|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
16211789|NCT03689972|39255713|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
16211790|NCT03689972|39255714|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
16527434|NCT00823719|40398048|FG001|Overall Study|Disease Progression|4|||
16527435|NCT03859323|40398049|FG000|Overall Study|Lost to Follow-up|0|||
16527436|NCT03859323|40398050|FG001|Overall Study|Lost to Follow-up|0|||
16211791|NCT03689972|39255715|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
16211792|NCT03689972|39255711|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
16211793|NCT03689972|39255712|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
16330563|NCT01573767|39696292|FG002|Overall Study|Physician Decision|0|||
16527437|NCT03859323|40398051|FG002|Overall Study|Lost to Follow-up|0|||
16527438|NCT03859323|40398052|FG003|Overall Study|Lost to Follow-up|0|||
16527439|NCT03859323|40398053|FG004|Overall Study|Lost to Follow-up|0|||
16527440|NCT03859323|40398054|FG005|Overall Study|Lost to Follow-up|0|||
16527441|NCT03859323|40398055|FG006|Overall Study|Lost to Follow-up|1|||
16527442|NCT03859323|40398056|FG007|Overall Study|Lost to Follow-up|0|||
16098036|NCT02592434|38846963|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
16527443|NCT03859323|40398057|FG008|Overall Study|Lost to Follow-up|0|||
16527444|NCT03859323|40398058|FG009|Overall Study|Lost to Follow-up|0|||
16527445|NCT03859323|40398059|FG010|Overall Study|Lost to Follow-up|0|||
16527446|NCT03859323|40398060|FG011|Overall Study|Lost to Follow-up|0|||
16527447|NCT03859323|40398061|FG012|Overall Study|Lost to Follow-up|0|||
16527448|NCT03859323|40398049|FG000|Overall Study|Withdrawal by Subject|0|||
16527449|NCT03859323|40398050|FG001|Overall Study|Withdrawal by Subject|0|||
16527450|NCT03859323|40398051|FG002|Overall Study|Withdrawal by Subject|1|||
16527451|NCT03859323|40398052|FG003|Overall Study|Withdrawal by Subject|0|||
16527452|NCT03859323|40398053|FG004|Overall Study|Withdrawal by Subject|0|||
16527453|NCT03859323|40398054|FG005|Overall Study|Withdrawal by Subject|1|||
16527454|NCT03859323|40398055|FG006|Overall Study|Withdrawal by Subject|0|||
16527455|NCT03859323|40398056|FG007|Overall Study|Withdrawal by Subject|0|||
16527456|NCT03859323|40398057|FG008|Overall Study|Withdrawal by Subject|0|||
16527457|NCT03859323|40398058|FG009|Overall Study|Withdrawal by Subject|1|||
16527458|NCT03859323|40398059|FG010|Overall Study|Withdrawal by Subject|1|||
16527459|NCT03859323|40398060|FG011|Overall Study|Withdrawal by Subject|2|||
16098037|NCT02592434|38846961|FG000|Open-Label Phase (18 Weeks)|Other|3|||
16211794|NCT03689972|39255713|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
16211795|NCT03689972|39255714|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
16211796|NCT03689972|39255715|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
16211797|NCT03689972|39255711|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
16211798|NCT03689972|39255712|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
16211799|NCT03689972|39255713|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
16211800|NCT03689972|39255714|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
16211801|NCT03689972|39255715|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
16211802|NCT03689972|39255711|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
16330564|NCT01573767|39696293|FG003|Overall Study|Physician Decision|2|||
16330565|NCT01573767|39696290|FG000|Overall Study|Withdrawal by Subject|0|||
16330566|NCT01573767|39696291|FG001|Overall Study|Withdrawal by Subject|1|||
16330567|NCT01573767|39696292|FG002|Overall Study|Withdrawal by Subject|0|||
16330568|NCT01573767|39696293|FG003|Overall Study|Withdrawal by Subject|0|||
16330569|NCT00937040|39696294|FG000|Overall Study|Adverse Event|5|||
16330570|NCT00937040|39696295|FG001|Overall Study|Adverse Event|8|||
16330571|NCT00937040|39696294|FG000|Overall Study|Lost to Follow-up|12|||
16330572|NCT00937040|39696295|FG001|Overall Study|Lost to Follow-up|12|||
16330573|NCT00937040|39696294|FG000|Overall Study|Protocol Violation|3|||
16330574|NCT00937040|39696295|FG001|Overall Study|Protocol Violation|0|||
16330575|NCT00937040|39696294|FG000|Overall Study|Withdrawal by Subject|13|||
16330576|NCT00937040|39696295|FG001|Overall Study|Withdrawal by Subject|7|||
16330577|NCT00937040|39696294|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
16330578|NCT00937040|39696295|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
16330579|NCT00937040|39696294|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
16330580|NCT00937040|39696295|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
16330581|NCT01328548|39696296|FG000|Overall Study|Death|3|||
16330582|NCT01328548|39696297|FG001|Overall Study|Death|0|||
16330583|NCT01328548|39696296|FG000|Overall Study|Protocol Violation|1|||
16330584|NCT01328548|39696297|FG001|Overall Study|Protocol Violation|0|||
16330585|NCT01294371|39696300|FG000|Overall Study|Adverse Event|1|||
16330586|NCT01294371|39696300|FG000|Overall Study|Withdrawal by Subject|12|||
16330587|NCT01294371|39696300|FG000|Overall Study|Lost to Follow-up|6|||
16527460|NCT03859323|40398061|FG012|Overall Study|Withdrawal by Subject|1|||
16527461|NCT03859323|40398049|FG000|Overall Study|Pregnancy|0|||
16330588|NCT01294371|39696300|FG000|Overall Study|Administrative Reason|1|||
16330589|NCT01294371|39696300|FG000|Overall Study|Other|14|||
16330590|NCT00819780|39696304|FG000|Overall Study|Did not receive study drug|3|||
16330591|NCT00819780|39696305|FG001|Overall Study|Did not receive study drug|4|||
16330592|NCT00819780|39696304|FG000|Overall Study|Still in treatment|25|||
16330593|NCT00819780|39696305|FG001|Overall Study|Still in treatment|17|||
16330594|NCT02658734|39696306|FG000|Overall Study|Adverse Event|2|||
16330595|NCT02658734|39696306|FG000|Overall Study|Death|4|||
16330596|NCT02658734|39696306|FG000|Overall Study|Lost to Follow-up|7|||
16330597|NCT02658734|39696306|FG000|Overall Study|Withdrawal of Consent|16|||
16330598|NCT02658734|39696306|FG000|Overall Study|Disease Progression|28|||
16330599|NCT00090987|39696307|FG000|Overall Study|Adverse Event|5|||
16330600|NCT00090987|39696307|FG000|Overall Study|Lack of Efficacy|7|||
16330601|NCT00090987|39696307|FG000|Overall Study|Withdrawal by Subject|3|||
16330602|NCT00090987|39696307|FG000|Overall Study|alternative therapy|1|||
16330603|NCT00090987|39696307|FG000|Overall Study|Non-compliance|4|||
16330604|NCT00090987|39696307|FG000|Overall Study|Incarcerated|1|||
16330605|NCT01237327|39696308|FG000|Overall Study|Protocol Violation: Core Study|1|||
16330606|NCT01237327|39696309|FG001|Overall Study|Protocol Violation: Core Study|0|||
16330607|NCT01237327|39696308|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
16330608|NCT01237327|39696309|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
16330609|NCT01237327|39696308|FG000|Overall Study|Progression of Disease: Core Study|18|||
16330610|NCT01237327|39696309|FG001|Overall Study|Progression of Disease: Core Study|22|||
16330611|NCT01237327|39696308|FG000|Overall Study|Progression of Disease: Extension Study|15|||
16330612|NCT01237327|39696309|FG001|Overall Study|Progression of Disease: Extension Study|13|||
16330613|NCT01237327|39696308|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
16330614|NCT01237327|39696309|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
16330615|NCT01237327|39696308|FG000|Overall Study|Withdrawal by Subject|1|||
16330616|NCT01237327|39696309|FG001|Overall Study|Withdrawal by Subject|3|||
16330617|NCT01237327|39696308|FG000|Overall Study|Lost to Follow-up|3|||
16330618|NCT01237327|39696309|FG001|Overall Study|Lost to Follow-up|0|||
16330619|NCT01179737|39696310|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
16098038|NCT02592434|38846962|FG001|Open-Label Phase (18 Weeks)|Other|0|||
16330620|NCT01179737|39696311|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
16330621|NCT01179737|39696312|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
16330622|NCT01179737|39696313|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
16330623|NCT01179737|39696310|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
16330624|NCT01179737|39696311|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
16330625|NCT01179737|39696312|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
16098039|NCT02592434|38846963|FG002|Open-Label Phase (18 Weeks)|Other|0|||
16399813|NCT03333252|39944862|FG000|Overall Study|Lost to Follow-up|0|||
16399814|NCT03333252|39944863|FG001|Overall Study|Lost to Follow-up|5|||
16399815|NCT03333252|39944864|FG002|Overall Study|Lost to Follow-up|9|||
16399816|NCT03333252|39944865|FG003|Overall Study|Lost to Follow-up|3|||
16399817|NCT03333252|39944862|FG000|Overall Study|Withdrawal by Subject|14|||
16399818|NCT03333252|39944863|FG001|Overall Study|Withdrawal by Subject|24|||
16399819|NCT03333252|39944864|FG002|Overall Study|Withdrawal by Subject|11|||
16399820|NCT03333252|39944865|FG003|Overall Study|Withdrawal by Subject|17|||
16399821|NCT00294645|39944872|FG000|Overall Study|Death|10|||
16399822|NCT00294645|39944873|FG001|Overall Study|Death|18|||
16399823|NCT00294645|39944872|FG000|Overall Study|Lost to Follow-up|1|||
16399824|NCT00294645|39944873|FG001|Overall Study|Lost to Follow-up|10|||
16399825|NCT00294645|39944872|FG000|Overall Study|Withdrawal by Subject|18|||
16399826|NCT00294645|39944873|FG001|Overall Study|Withdrawal by Subject|34|||
16399827|NCT00294645|39944872|FG000|Overall Study|Physician Decision|15|||
16399828|NCT00294645|39944873|FG001|Overall Study|Physician Decision|20|||
16399829|NCT00294645|39944872|FG000|Overall Study|Other|4|||
16399830|NCT00294645|39944873|FG001|Overall Study|Other|10|||
16399831|NCT00368745|39944874|FG000|Double-blind Treatment Period|Adverse Event|6|||
16399832|NCT00368745|39944875|FG001|Double-blind Treatment Period|Adverse Event|6|||
16399833|NCT00368745|39944874|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
16399834|NCT00368745|39944875|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
16399835|NCT00368745|39944874|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
16399836|NCT00368745|39944875|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
16399837|NCT00368745|39944874|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
16399838|NCT00368745|39944875|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
16399839|NCT00368745|39944874|FG000|Double-blind Treatment Period|Other|7|||
16399840|NCT00368745|39944875|FG001|Double-blind Treatment Period|Other|6|||
16399841|NCT00978380|39944876|FG000|Overall Study|Protocol Violation|2|||
16399842|NCT00978380|39944876|FG000|Overall Study|Withdrawal criteria|9|||
16399843|NCT00978380|39944876|FG000|Overall Study|Unclassified|8|||
16399844|NCT04075513|39944877|FG000|Overall Study|Withdrawal by Subject|2|||
16399845|NCT04075513|39944878|FG001|Overall Study|Withdrawal by Subject|2|||
16399846|NCT04075513|39944877|FG000|Overall Study|Lack of Efficacy|1|||
16399847|NCT04075513|39944878|FG001|Overall Study|Lack of Efficacy|0|||
16399848|NCT04075513|39944877|FG000|Overall Study|Lost to Follow-up|4|||
16399849|NCT04075513|39944878|FG001|Overall Study|Lost to Follow-up|2|||
16399850|NCT04075513|39944877|FG000|Overall Study|Switch to insulin pump|1|||
16399851|NCT04075513|39944878|FG001|Overall Study|Switch to insulin pump|0|||
16399852|NCT00487942|39944881|FG000|Overall Study|Adverse Event|1|||
16399853|NCT00487942|39944882|FG001|Overall Study|Adverse Event|1|||
16399854|NCT00487942|39944883|FG002|Overall Study|Adverse Event|1|||
16399855|NCT00487942|39944884|FG003|Overall Study|Adverse Event|1|||
16399856|NCT00487942|39944881|FG000|Overall Study|Lost to Follow-up|1|||
16399857|NCT00487942|39944882|FG001|Overall Study|Lost to Follow-up|0|||
16399858|NCT00487942|39944883|FG002|Overall Study|Lost to Follow-up|0|||
16399859|NCT00487942|39944884|FG003|Overall Study|Lost to Follow-up|1|||
16399860|NCT00487942|39944881|FG000|Overall Study|Protocol Violation|1|||
16399861|NCT00487942|39944882|FG001|Overall Study|Protocol Violation|1|||
16399862|NCT00487942|39944883|FG002|Overall Study|Protocol Violation|0|||
16399863|NCT00487942|39944884|FG003|Overall Study|Protocol Violation|0|||
16399864|NCT00487942|39944881|FG000|Overall Study|Withdrawal by Subject|0|||
16399865|NCT00487942|39944882|FG001|Overall Study|Withdrawal by Subject|1|||
16399866|NCT00487942|39944883|FG002|Overall Study|Withdrawal by Subject|2|||
16399867|NCT00487942|39944884|FG003|Overall Study|Withdrawal by Subject|0|||
16399868|NCT01685801|39944893|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
16399869|NCT01685801|39944894|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
16399870|NCT01685801|39944895|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
16399871|NCT01685801|39944896|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
16399872|NCT01685801|39944893|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
16399873|NCT01685801|39944894|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
16399874|NCT01685801|39944895|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
16399875|NCT01685801|39944896|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
16399876|NCT00557310|39944901|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
16098040|NCT02592434|38846961|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
16399877|NCT00557310|39944901|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
16399878|NCT00557310|39944901|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
16399879|NCT00557310|39944901|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
16399880|NCT00557310|39944901|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
16399881|NCT00557310|39944901|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
16399882|NCT01164891|39944913|FG000|Overall Study|Disease Progression|5|||
16399883|NCT01164891|39944913|FG000|Overall Study|Adverse Event|1|||
16399884|NCT03143153|39944914|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
16399885|NCT03143153|39944915|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
16399886|NCT03143153|39944916|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
16399887|NCT03143153|39944914|FG000|Pre-Treatment|Participant withdrew consent|0|||
16399888|NCT03143153|39944915|FG001|Pre-Treatment|Participant withdrew consent|1|||
16211803|NCT03689972|39255712|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
16211804|NCT03689972|39255713|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
16211805|NCT03689972|39255714|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
16211806|NCT03689972|39255715|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
16211807|NCT03689972|39255711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
16211808|NCT03689972|39255712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
16211809|NCT03689972|39255713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
16211810|NCT03689972|39255714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
16211811|NCT03689972|39255715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
16211812|NCT03689972|39255711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
16211813|NCT03689972|39255712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
16399889|NCT03143153|39944916|FG002|Pre-Treatment|Participant withdrew consent|12|||
16399890|NCT03143153|39944914|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
16399891|NCT03143153|39944915|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
16399892|NCT03143153|39944916|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
16399893|NCT03143153|39944914|FG000|Pre-Treatment|Other Reasons|1|||
16399894|NCT03143153|39944915|FG001|Pre-Treatment|Other Reasons|2|||
16399895|NCT03143153|39944916|FG002|Pre-Treatment|Other Reasons|1|||
16399896|NCT03143153|39944914|FG000|Pre-Treatment|Disease Progression|1|||
16399897|NCT03143153|39944915|FG001|Pre-Treatment|Disease Progression|1|||
16399898|NCT03143153|39944916|FG002|Pre-Treatment|Disease Progression|2|||
16399899|NCT03143153|39944914|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
16399900|NCT03143153|39944915|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
16399901|NCT03143153|39944916|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
16399902|NCT03143153|39944914|FG000|Treatment|Disease progression|174|||
16399903|NCT03143153|39944915|FG001|Treatment|Disease progression|184|||
16527462|NCT03859323|40398050|FG001|Overall Study|Pregnancy|0|||
16527463|NCT03859323|40398051|FG002|Overall Study|Pregnancy|0|||
16527464|NCT03859323|40398052|FG003|Overall Study|Pregnancy|0|||
16527465|NCT03859323|40398053|FG004|Overall Study|Pregnancy|0|||
16527466|NCT03859323|40398054|FG005|Overall Study|Pregnancy|0|||
16527467|NCT03859323|40398055|FG006|Overall Study|Pregnancy|0|||
16527468|NCT03859323|40398056|FG007|Overall Study|Pregnancy|0|||
16527469|NCT03859323|40398057|FG008|Overall Study|Pregnancy|0|||
16527470|NCT03859323|40398058|FG009|Overall Study|Pregnancy|1|||
16527471|NCT03859323|40398059|FG010|Overall Study|Pregnancy|0|||
16527472|NCT03859323|40398060|FG011|Overall Study|Pregnancy|0|||
16527473|NCT03859323|40398061|FG012|Overall Study|Pregnancy|0|||
16527474|NCT02564523|40398062|FG000|Overall Study|Withdrawal by Subject|3|||
16527475|NCT02564523|40398063|FG001|Overall Study|Withdrawal by Subject|0|||
16527476|NCT02564523|40398064|FG002|Overall Study|Withdrawal by Subject|1|||
16527477|NCT02564523|40398065|FG003|Overall Study|Withdrawal by Subject|0|||
16527478|NCT02564523|40398066|FG004|Overall Study|Withdrawal by Subject|1|||
16527479|NCT02564523|40398067|FG005|Overall Study|Withdrawal by Subject|0|||
16527480|NCT02564523|40398068|FG006|Overall Study|Withdrawal by Subject|1|||
16527481|NCT02564523|40398069|FG007|Overall Study|Withdrawal by Subject|0|||
16527482|NCT02564523|40398070|FG008|Overall Study|Withdrawal by Subject|0|||
16527483|NCT02564523|40398071|FG009|Overall Study|Withdrawal by Subject|0|||
16527484|NCT02564523|40398072|FG010|Overall Study|Withdrawal by Subject|1|||
16527485|NCT02564523|40398073|FG011|Overall Study|Withdrawal by Subject|0|||
16527486|NCT02564523|40398074|FG012|Overall Study|Withdrawal by Subject|1|||
16527487|NCT02564523|40398075|FG013|Overall Study|Withdrawal by Subject|0|||
16527488|NCT02564523|40398076|FG014|Overall Study|Withdrawal by Subject|0|||
16527489|NCT02564523|40398077|FG015|Overall Study|Withdrawal by Subject|0|||
16527490|NCT02564523|40398078|FG016|Overall Study|Withdrawal by Subject|0|||
16527491|NCT02564523|40398079|FG017|Overall Study|Withdrawal by Subject|0|||
16527492|NCT02564523|40398062|FG000|Overall Study|Adverse Event|0|||
16527493|NCT02564523|40398063|FG001|Overall Study|Adverse Event|0|||
16527494|NCT02564523|40398064|FG002|Overall Study|Adverse Event|0|||
16527495|NCT02564523|40398065|FG003|Overall Study|Adverse Event|0|||
16527496|NCT02564523|40398066|FG004|Overall Study|Adverse Event|0|||
16527497|NCT02564523|40398067|FG005|Overall Study|Adverse Event|0|||
16527498|NCT02564523|40398068|FG006|Overall Study|Adverse Event|0|||
16527499|NCT02564523|40398069|FG007|Overall Study|Adverse Event|0|||
16527500|NCT02564523|40398070|FG008|Overall Study|Adverse Event|0|||
16527501|NCT02564523|40398071|FG009|Overall Study|Adverse Event|0|||
16527502|NCT02564523|40398072|FG010|Overall Study|Adverse Event|0|||
16527503|NCT02564523|40398073|FG011|Overall Study|Adverse Event|0|||
16527504|NCT02564523|40398074|FG012|Overall Study|Adverse Event|0|||
16527505|NCT02564523|40398075|FG013|Overall Study|Adverse Event|0|||
16527506|NCT02564523|40398076|FG014|Overall Study|Adverse Event|0|||
16527507|NCT02564523|40398077|FG015|Overall Study|Adverse Event|0|||
16527508|NCT02564523|40398078|FG016|Overall Study|Adverse Event|0|||
16527509|NCT02564523|40398079|FG017|Overall Study|Adverse Event|1|||
16399904|NCT03143153|39944916|FG002|Treatment|Disease progression|193|||
16399905|NCT03143153|39944914|FG000|Treatment|Study drug toxicity|59|||
16399906|NCT03143153|39944915|FG001|Treatment|Study drug toxicity|33|||
16399907|NCT03143153|39944916|FG002|Treatment|Study drug toxicity|40|||
16399908|NCT03143153|39944914|FG000|Treatment|Death|5|||
16399909|NCT03143153|39944915|FG001|Treatment|Death|3|||
16399910|NCT03143153|39944916|FG002|Treatment|Death|4|||
16399911|NCT03143153|39944914|FG000|Treatment|Adverse event unrelated to study drug|19|||
16399912|NCT03143153|39944915|FG001|Treatment|Adverse event unrelated to study drug|28|||
16399913|NCT03143153|39944916|FG002|Treatment|Adverse event unrelated to study drug|12|||
16399914|NCT03143153|39944914|FG000|Treatment|Participant request to discontinue study treatment|13|||
16399915|NCT03143153|39944915|FG001|Treatment|Participant request to discontinue study treatment|15|||
16399916|NCT03143153|39944916|FG002|Treatment|Participant request to discontinue study treatment|20|||
16399917|NCT03143153|39944914|FG000|Treatment|Participant withdrew consent|3|||
16098041|NCT02592434|38846962|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
16098042|NCT02592434|38846963|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
16098043|NCT02592434|38846961|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
16098044|NCT02592434|38846962|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
16098045|NCT02592434|38846963|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
16098046|NCT02592434|38846961|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
16098047|NCT02592434|38846962|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
16098048|NCT02592434|38846963|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
16098049|NCT02592434|38846961|FG000|Double Blind Phase (26 Weeks)|Other|0|||
16098050|NCT02592434|38846962|FG001|Double Blind Phase (26 Weeks)|Other|1|||
16098051|NCT02592434|38846963|FG002|Double Blind Phase (26 Weeks)|Other|0|||
16098052|NCT02592434|38846961|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
16098053|NCT02592434|38846962|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
16098054|NCT02592434|38846963|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
16098055|NCT02592434|38846961|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
16098056|NCT02592434|38846962|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
16098057|NCT02592434|38846963|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
16098058|NCT02592434|38846961|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
16098059|NCT02592434|38846962|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
16098060|NCT02592434|38846963|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
16098061|NCT00331799|38846966|FG000|Overall Study|Withdrawal by Subject|2|||
16098062|NCT00331799|38846966|FG000|Overall Study|Sedation|1|||
16098063|NCT00417989|38846967|FG000|Overall Study|Withdrawal by Subject|13|||
16098064|NCT00417989|38846968|FG001|Overall Study|Withdrawal by Subject|13|||
16098065|NCT00417989|38846967|FG000|Overall Study|Lost to Follow-up|1|||
16098066|NCT00417989|38846968|FG001|Overall Study|Lost to Follow-up|6|||
16098067|NCT00417989|38846967|FG000|Overall Study|Protocol Violation|1|||
16098068|NCT00417989|38846968|FG001|Overall Study|Protocol Violation|0|||
16098069|NCT00417989|38846967|FG000|Overall Study|Death|0|||
16211814|NCT03689972|39255713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
16211815|NCT03689972|39255714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
16211816|NCT03689972|39255715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
16211817|NCT03689972|39255711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
16211818|NCT03689972|39255712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
16211819|NCT03689972|39255713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
16211820|NCT03689972|39255714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
16211821|NCT03689972|39255715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
16211822|NCT03689972|39255711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
16211823|NCT03689972|39255712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
16211824|NCT03689972|39255713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
16211825|NCT03689972|39255714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
16211826|NCT03689972|39255715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
16399918|NCT03143153|39944915|FG001|Treatment|Participant withdrew consent|4|||
16399919|NCT03143153|39944916|FG002|Treatment|Participant withdrew consent|12|||
16399920|NCT03143153|39944914|FG000|Treatment|Pregnancy|1|||
16399921|NCT03143153|39944915|FG001|Treatment|Pregnancy|0|||
16098070|NCT00417989|38846968|FG001|Overall Study|Death|1|||
16098071|NCT00417989|38846967|FG000|Overall Study|Physician Decision|5|||
16098072|NCT00417989|38846968|FG001|Overall Study|Physician Decision|2|||
16211827|NCT03689972|39255711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
16098073|NCT03320941|38846969|FG000|Overall Study|subject/guardian decision|0|||
16098074|NCT03320941|38846970|FG001|Overall Study|subject/guardian decision|0|||
16098075|NCT03320941|38846971|FG002|Overall Study|subject/guardian decision|0|||
16098076|NCT03320941|38846972|FG003|Overall Study|subject/guardian decision|1|||
16098077|NCT03320941|38846973|FG004|Overall Study|subject/guardian decision|0|||
16098078|NCT03694210|38846979|FG000|Overall Study|Death|1|||
16098079|NCT03694210|38846979|FG000|Overall Study|Screen Failure|7|||
16098080|NCT01524887|38846980|FG000|Overall Study|Withdrawal by Subject|6|||
16098081|NCT01524887|38846981|FG001|Overall Study|Withdrawal by Subject|2|||
16098082|NCT01524887|38846982|FG002|Overall Study|Withdrawal by Subject|3|||
16098083|NCT01524887|38846980|FG000|Overall Study|Adverse Event|5|||
16098084|NCT01524887|38846981|FG001|Overall Study|Adverse Event|1|||
16098085|NCT01524887|38846982|FG002|Overall Study|Adverse Event|1|||
16098086|NCT01524887|38846980|FG000|Overall Study|Protocol Violation|0|||
16098087|NCT01524887|38846981|FG001|Overall Study|Protocol Violation|0|||
16211828|NCT03689972|39255712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
16211829|NCT03689972|39255713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
16211830|NCT03689972|39255714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
16211831|NCT03689972|39255715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
16211832|NCT03689972|39255711|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
16211833|NCT03689972|39255712|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
16330626|NCT01179737|39696313|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
16330627|NCT01179737|39696310|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
16330628|NCT01179737|39696311|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
16330629|NCT01179737|39696312|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
16330630|NCT01179737|39696313|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
16330631|NCT01179737|39696310|FG000|Cohort 1 & Cohort 2|Death|0|||
16330632|NCT01179737|39696311|FG001|Cohort 1 & Cohort 2|Death|0|||
16330633|NCT01179737|39696312|FG002|Cohort 1 & Cohort 2|Death|1|||
16330634|NCT01179737|39696313|FG003|Cohort 1 & Cohort 2|Death|0|||
16330635|NCT01179737|39696310|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
16399922|NCT03143153|39944916|FG002|Treatment|Pregnancy|0|||
16527510|NCT02564523|40398062|FG000|Overall Study|Death|0|||
16527511|NCT02564523|40398063|FG001|Overall Study|Death|0|||
16399923|NCT03143153|39944914|FG000|Treatment|Maximum clinical benefit|1|||
16399924|NCT03143153|39944915|FG001|Treatment|Maximum clinical benefit|3|||
16399925|NCT03143153|39944916|FG002|Treatment|Maximum clinical benefit|4|||
16399926|NCT03143153|39944914|FG000|Treatment|Completed treatment as per Protocol|13|||
16527512|NCT02564523|40398064|FG002|Overall Study|Death|0|||
16527513|NCT02564523|40398065|FG003|Overall Study|Death|0|||
16527514|NCT02564523|40398066|FG004|Overall Study|Death|0|||
16527515|NCT02564523|40398067|FG005|Overall Study|Death|0|||
16527516|NCT02564523|40398068|FG006|Overall Study|Death|1|||
16527517|NCT02564523|40398069|FG007|Overall Study|Death|0|||
16527518|NCT02564523|40398070|FG008|Overall Study|Death|0|||
16527519|NCT02564523|40398071|FG009|Overall Study|Death|0|||
16527520|NCT02564523|40398072|FG010|Overall Study|Death|1|||
16527521|NCT02564523|40398073|FG011|Overall Study|Death|0|||
16527522|NCT02564523|40398074|FG012|Overall Study|Death|0|||
16527523|NCT02564523|40398075|FG013|Overall Study|Death|0|||
16527524|NCT02564523|40398076|FG014|Overall Study|Death|0|||
16527525|NCT02564523|40398077|FG015|Overall Study|Death|0|||
16527526|NCT02564523|40398078|FG016|Overall Study|Death|0|||
16527527|NCT02564523|40398079|FG017|Overall Study|Death|0|||
16527528|NCT02564523|40398062|FG000|Overall Study|Lost to Follow-up|2|||
16527529|NCT02564523|40398063|FG001|Overall Study|Lost to Follow-up|1|||
16527530|NCT02564523|40398064|FG002|Overall Study|Lost to Follow-up|4|||
16527531|NCT02564523|40398065|FG003|Overall Study|Lost to Follow-up|0|||
16527532|NCT02564523|40398066|FG004|Overall Study|Lost to Follow-up|1|||
16527533|NCT02564523|40398067|FG005|Overall Study|Lost to Follow-up|0|||
16527534|NCT02564523|40398068|FG006|Overall Study|Lost to Follow-up|1|||
16527535|NCT02564523|40398069|FG007|Overall Study|Lost to Follow-up|0|||
16527536|NCT02564523|40398070|FG008|Overall Study|Lost to Follow-up|0|||
16527537|NCT02564523|40398071|FG009|Overall Study|Lost to Follow-up|0|||
16527538|NCT02564523|40398072|FG010|Overall Study|Lost to Follow-up|0|||
16527539|NCT02564523|40398073|FG011|Overall Study|Lost to Follow-up|1|||
16527540|NCT02564523|40398074|FG012|Overall Study|Lost to Follow-up|1|||
16527541|NCT02564523|40398075|FG013|Overall Study|Lost to Follow-up|0|||
16527542|NCT02564523|40398076|FG014|Overall Study|Lost to Follow-up|0|||
16527543|NCT02564523|40398077|FG015|Overall Study|Lost to Follow-up|0|||
16527544|NCT02564523|40398078|FG016|Overall Study|Lost to Follow-up|0|||
16527545|NCT02564523|40398079|FG017|Overall Study|Lost to Follow-up|0|||
16098088|NCT01524887|38846982|FG002|Overall Study|Protocol Violation|1|||
16098089|NCT01524887|38846980|FG000|Overall Study|Study termination|73|||
16527546|NCT02564523|40398062|FG000|Overall Study|Physician Decision|0|||
16527547|NCT02564523|40398063|FG001|Overall Study|Physician Decision|0|||
16527548|NCT02564523|40398064|FG002|Overall Study|Physician Decision|0|||
16527549|NCT02564523|40398065|FG003|Overall Study|Physician Decision|0|||
16527550|NCT02564523|40398066|FG004|Overall Study|Physician Decision|1|||
16330636|NCT01179737|39696311|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
16211834|NCT03689972|39255713|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
16211835|NCT03689972|39255714|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
16211836|NCT03689972|39255715|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
16211837|NCT00149890|39255716|FG000|Overall Study|Adverse Event|1|||
16211838|NCT00149890|39255717|FG001|Overall Study|Adverse Event|8|||
16211839|NCT00149890|39255716|FG000|Overall Study|Lack of Efficacy|8|||
16211840|NCT00149890|39255717|FG001|Overall Study|Lack of Efficacy|9|||
16211841|NCT00149890|39255716|FG000|Overall Study|Protocol Violation|1|||
16211842|NCT00149890|39255717|FG001|Overall Study|Protocol Violation|0|||
16211843|NCT00149890|39255716|FG000|Overall Study|Lost to Follow-up|1|||
16211844|NCT00149890|39255717|FG001|Overall Study|Lost to Follow-up|0|||
16211845|NCT00149890|39255716|FG000|Overall Study|Graft Loss|2|||
16330637|NCT01179737|39696312|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
16330638|NCT01179737|39696313|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
16330639|NCT01179737|39696310|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
16330640|NCT01179737|39696311|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
16330641|NCT01179737|39696312|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
16330642|NCT01179737|39696313|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
16330643|NCT01179737|39696310|FG000|Extension|The study was terminated|3|||
16330644|NCT01179737|39696311|FG001|Extension|The study was terminated|0|||
16399927|NCT03143153|39944915|FG001|Treatment|Completed treatment as per Protocol|8|||
16399928|NCT03143153|39944916|FG002|Treatment|Completed treatment as per Protocol|0|||
16399929|NCT03143153|39944914|FG000|Treatment|Other reasons|12|||
16399930|NCT03143153|39944915|FG001|Treatment|Other reasons|7|||
16399931|NCT03143153|39944916|FG002|Treatment|Other reasons|15|||
16399932|NCT03143153|39944914|FG000|Treatment|Not reported|1|||
16399933|NCT03143153|39944915|FG001|Treatment|Not reported|0|||
16211846|NCT00149890|39255717|FG001|Overall Study|Graft Loss|1|||
16211847|NCT02687711|39255718|FG000|Overall Study|Adverse Event|89|||
16211848|NCT02687711|39255718|FG000|Overall Study|Lack of Efficacy|70|||
16211849|NCT02687711|39255718|FG000|Overall Study|Lost to Follow-up|20|||
16211850|NCT02687711|39255718|FG000|Overall Study|Consent withdrawn|15|||
16211851|NCT02687711|39255718|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
16211852|NCT02687711|39255718|FG000|Overall Study|Too expensive|4|||
16211853|NCT02687711|39255718|FG000|Overall Study|Participant moved abroad|1|||
16211854|NCT02687711|39255718|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
16211855|NCT02687711|39255718|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
16211856|NCT02687711|39255718|FG000|Overall Study|Disliked taste|1|||
16211857|NCT02687711|39255718|FG000|Overall Study|Low mood|1|||
16399934|NCT03143153|39944916|FG002|Treatment|Not reported|0|||
16399935|NCT03650803|39944917|FG000|Overall Study|Lost to Follow-up|6|||
16399936|NCT00716482|39944918|FG000|Overall Study|Lost to Follow-up|6|||
16399937|NCT00716482|39944918|FG000|Overall Study|Inadequate acquisition or analysis|50|||
16399938|NCT00716482|39944918|FG000|Overall Study|no pathology obtained|10|||
16399939|NCT00716482|39944918|FG000|Overall Study|technical/machine error|28|||
16399940|NCT00716482|39944918|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
16399941|NCT00958347|39944919|FG000|Overall Study|Death|43|||
16399942|NCT00958347|39944919|FG000|Overall Study|Withdrawal by Subject|23|||
16399943|NCT00958347|39944919|FG000|Overall Study|Lost to Follow-up|15|||
16399944|NCT00958347|39944919|FG000|Overall Study|revision/removal|10|||
16399945|NCT00958347|39944919|FG000|Overall Study|study termination|135|||
16399946|NCT00623233|39944920|FG000|Overall Study|Adverse Event|10|||
16399947|NCT00623233|39944920|FG000|Overall Study|Physician Decision|10|||
16330645|NCT01179737|39696312|FG002|Extension|The study was terminated|0|||
16330646|NCT01179737|39696313|FG003|Extension|The study was terminated|0|||
16330647|NCT02951533|39696314|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
16399948|NCT00623233|39944920|FG000|Overall Study|Lost to Follow-up|1|||
16211858|NCT02687711|39255718|FG000|Overall Study|Side effects|1|||
16211859|NCT02687711|39255718|FG000|Overall Study|Change of Hospital|1|||
16399949|NCT00623233|39944920|FG000|Overall Study|Withdrawal by Subject|3|||
16399950|NCT01106651|39944923|FG000|Overall Study|Adverse Event|17|||
16399951|NCT01106651|39944924|FG001|Overall Study|Adverse Event|9|||
16399952|NCT01106651|39944925|FG002|Overall Study|Adverse Event|23|||
16399953|NCT01106651|39944923|FG000|Overall Study|Lost to Follow-up|8|||
16399954|NCT01106651|39944924|FG001|Overall Study|Lost to Follow-up|2|||
16399955|NCT01106651|39944925|FG002|Overall Study|Lost to Follow-up|6|||
16399956|NCT01106651|39944923|FG000|Overall Study|Physician Decision|4|||
16330648|NCT02951533|39696315|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
16399957|NCT01106651|39944924|FG001|Overall Study|Physician Decision|3|||
16399958|NCT01106651|39944925|FG002|Overall Study|Physician Decision|1|||
16399959|NCT01106651|39944923|FG000|Overall Study|Protocol Violation|1|||
16399960|NCT01106651|39944924|FG001|Overall Study|Protocol Violation|2|||
16399961|NCT01106651|39944925|FG002|Overall Study|Protocol Violation|1|||
16399962|NCT01106651|39944923|FG000|Overall Study|Withdrawal by Subject|14|||
16399963|NCT01106651|39944924|FG001|Overall Study|Withdrawal by Subject|7|||
16399964|NCT01106651|39944925|FG002|Overall Study|Withdrawal by Subject|4|||
16399965|NCT01106651|39944923|FG000|Overall Study|Noncompliance with study drug|1|||
16399966|NCT01106651|39944924|FG001|Overall Study|Noncompliance with study drug|0|||
16399967|NCT01106651|39944925|FG002|Overall Study|Noncompliance with study drug|2|||
16399968|NCT01106651|39944923|FG000|Overall Study|Other|34|||
16399969|NCT01106651|39944924|FG001|Overall Study|Other|31|||
16330649|NCT02951533|39696316|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
16330650|NCT02951533|39696314|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
16330651|NCT02951533|39696315|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
16330652|NCT02951533|39696316|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
16399970|NCT01106651|39944925|FG002|Overall Study|Other|21|||
16399971|NCT01106651|39944923|FG000|Overall Study|Death|0|||
16527551|NCT02564523|40398067|FG005|Overall Study|Physician Decision|0|||
16527552|NCT02564523|40398068|FG006|Overall Study|Physician Decision|0|||
16527553|NCT02564523|40398069|FG007|Overall Study|Physician Decision|0|||
16527554|NCT02564523|40398070|FG008|Overall Study|Physician Decision|0|||
16527555|NCT02564523|40398071|FG009|Overall Study|Physician Decision|0|||
16098090|NCT01524887|38846981|FG001|Overall Study|Study termination|87|||
16527556|NCT02564523|40398072|FG010|Overall Study|Physician Decision|1|||
16527557|NCT02564523|40398073|FG011|Overall Study|Physician Decision|0|||
16527558|NCT02564523|40398074|FG012|Overall Study|Physician Decision|0|||
16527559|NCT02564523|40398075|FG013|Overall Study|Physician Decision|0|||
16527560|NCT02564523|40398076|FG014|Overall Study|Physician Decision|0|||
16527561|NCT02564523|40398077|FG015|Overall Study|Physician Decision|0|||
16098091|NCT01524887|38846982|FG002|Overall Study|Study termination|79|||
16098092|NCT01524887|38846980|FG000|Overall Study|Withdrawal by Caregiver|0|||
16098093|NCT01524887|38846981|FG001|Overall Study|Withdrawal by Caregiver|0|||
16098094|NCT01524887|38846982|FG002|Overall Study|Withdrawal by Caregiver|2|||
16330653|NCT02951533|39696314|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
16330654|NCT02951533|39696315|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
16098095|NCT01524887|38846980|FG000|Overall Study|Use of prohibited medication|1|||
16098096|NCT01524887|38846981|FG001|Overall Study|Use of prohibited medication|0|||
16330655|NCT02951533|39696316|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
16330656|NCT02951533|39696314|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
16330657|NCT02951533|39696315|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
16330658|NCT02951533|39696316|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
16330659|NCT02951533|39696314|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
16330660|NCT02951533|39696315|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
16330661|NCT02951533|39696316|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
16330662|NCT02951533|39696314|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
16330663|NCT02951533|39696315|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
16330664|NCT02951533|39696316|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
16330665|NCT02951533|39696314|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
16399972|NCT01106651|39944924|FG001|Overall Study|Death|3|||
16399973|NCT01106651|39944925|FG002|Overall Study|Death|0|||
16399974|NCT00964002|39944926|FG000|Overall Study|Protocol Violation|8|||
16399975|NCT03199053|39944932|FG000|ST Period|Withdrawal by Subject|2|||
16399976|NCT03199053|39944933|FG001|ST Period|Withdrawal by Subject|4|||
16399977|NCT03199053|39944934|FG002|ST Period|Withdrawal by Subject|6|||
16527562|NCT02564523|40398078|FG016|Overall Study|Physician Decision|0|||
16527563|NCT02564523|40398079|FG017|Overall Study|Physician Decision|0|||
16527564|NCT02564523|40398062|FG000|Overall Study|Protocol Violation|2|||
16527565|NCT02564523|40398063|FG001|Overall Study|Protocol Violation|2|||
16527566|NCT02564523|40398064|FG002|Overall Study|Protocol Violation|5|||
16527567|NCT02564523|40398065|FG003|Overall Study|Protocol Violation|0|||
16527568|NCT02564523|40398066|FG004|Overall Study|Protocol Violation|1|||
16527569|NCT02564523|40398067|FG005|Overall Study|Protocol Violation|0|||
16527570|NCT02564523|40398068|FG006|Overall Study|Protocol Violation|0|||
16527571|NCT02564523|40398069|FG007|Overall Study|Protocol Violation|0|||
16527572|NCT02564523|40398070|FG008|Overall Study|Protocol Violation|0|||
16527573|NCT02564523|40398071|FG009|Overall Study|Protocol Violation|0|||
16527574|NCT02564523|40398072|FG010|Overall Study|Protocol Violation|0|||
16527575|NCT02564523|40398073|FG011|Overall Study|Protocol Violation|0|||
16527576|NCT02564523|40398074|FG012|Overall Study|Protocol Violation|0|||
16527577|NCT02564523|40398075|FG013|Overall Study|Protocol Violation|0|||
16527578|NCT02564523|40398076|FG014|Overall Study|Protocol Violation|0|||
16527579|NCT02564523|40398077|FG015|Overall Study|Protocol Violation|0|||
16527580|NCT02564523|40398078|FG016|Overall Study|Protocol Violation|0|||
16527581|NCT02564523|40398079|FG017|Overall Study|Protocol Violation|0|||
16527582|NCT02564523|40398062|FG000|Overall Study|Other|3|||
16527583|NCT02564523|40398063|FG001|Overall Study|Other|0|||
16527584|NCT02564523|40398064|FG002|Overall Study|Other|0|||
16527585|NCT02564523|40398065|FG003|Overall Study|Other|1|||
16527586|NCT02564523|40398066|FG004|Overall Study|Other|0|||
16527587|NCT02564523|40398067|FG005|Overall Study|Other|0|||
16527588|NCT02564523|40398068|FG006|Overall Study|Other|0|||
16527589|NCT02564523|40398069|FG007|Overall Study|Other|0|||
16527590|NCT02564523|40398070|FG008|Overall Study|Other|0|||
16527591|NCT02564523|40398071|FG009|Overall Study|Other|0|||
16527592|NCT02564523|40398072|FG010|Overall Study|Other|0|||
16527593|NCT02564523|40398073|FG011|Overall Study|Other|0|||
16527594|NCT02564523|40398074|FG012|Overall Study|Other|0|||
16527595|NCT02564523|40398075|FG013|Overall Study|Other|0|||
16527596|NCT02564523|40398076|FG014|Overall Study|Other|0|||
16527597|NCT02564523|40398077|FG015|Overall Study|Other|0|||
16527598|NCT02564523|40398078|FG016|Overall Study|Other|0|||
16527599|NCT02564523|40398079|FG017|Overall Study|Other|0|||
16527600|NCT01660763|40398083|FG000|Overall Study|Lack of Efficacy|45|||
16527601|NCT01660763|40398084|FG001|Overall Study|Lack of Efficacy|50|||
16527602|NCT01660763|40398083|FG000|Overall Study|Adverse Event|22|||
16527603|NCT01660763|40398084|FG001|Overall Study|Adverse Event|7|||
16527604|NCT01660763|40398083|FG000|Overall Study|Protocol Violation|1|||
16527605|NCT01660763|40398084|FG001|Overall Study|Protocol Violation|0|||
16527606|NCT01660763|40398083|FG000|Overall Study|Withdrawal by Subject|4|||
16527607|NCT01660763|40398084|FG001|Overall Study|Withdrawal by Subject|0|||
16527608|NCT01660763|40398083|FG000|Overall Study|Patient ready for early discharge|28|||
16527609|NCT01660763|40398084|FG001|Overall Study|Patient ready for early discharge|4|||
16527610|NCT02493361|40398090|FG000|Overall Study|Withdrawal by Subject|3|||
16527611|NCT02039505|40398091|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
16527612|NCT02039505|40398092|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
16527613|NCT02039505|40398093|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
16527614|NCT02039505|40398094|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
16527615|NCT02039505|40398095|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
16527616|NCT02039505|40398096|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
16527617|NCT02039505|40398097|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
16527618|NCT02039505|40398091|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
16527619|NCT02039505|40398092|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
16527620|NCT02039505|40398093|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
16527621|NCT02039505|40398094|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
16527622|NCT02039505|40398095|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
16527623|NCT02039505|40398096|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
16527624|NCT02039505|40398097|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
16527625|NCT02039505|40398091|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
16527626|NCT02039505|40398092|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16527627|NCT02039505|40398093|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16527628|NCT02039505|40398094|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16527629|NCT02039505|40398095|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16527630|NCT02039505|40398096|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16527631|NCT02039505|40398097|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
16527632|NCT02039505|40398091|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
16527633|NCT02039505|40398092|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
16546379|NCT01662063|40464796|FG000|Overall Study|Protocol Violation|1|||
16527634|NCT02039505|40398093|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
16211860|NCT02687711|39255718|FG000|Overall Study|Liver Encephalopathy|1|||
16211861|NCT02687711|39255718|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
16211862|NCT02687711|39255718|FG000|Overall Study|Withdrawn due to intake interruption|1|||
16527635|NCT02039505|40398094|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
16527636|NCT02039505|40398095|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
16527637|NCT02039505|40398096|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
16527638|NCT02039505|40398097|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
16527639|NCT02039505|40398091|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
16527640|NCT02039505|40398092|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
16527641|NCT02039505|40398093|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
16527642|NCT02039505|40398094|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
16527643|NCT02039505|40398095|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
16527644|NCT02039505|40398096|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
16527645|NCT02039505|40398097|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
16527646|NCT02039505|40398091|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
16527647|NCT02039505|40398092|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
16527648|NCT02039505|40398093|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
16527649|NCT02039505|40398094|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
16527650|NCT02039505|40398095|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
16527651|NCT02039505|40398096|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
16527652|NCT02039505|40398097|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
16527653|NCT02039505|40398091|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16527654|NCT02039505|40398092|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16527655|NCT02039505|40398093|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16527656|NCT02039505|40398094|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
16527657|NCT02039505|40398095|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16527658|NCT02039505|40398096|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16527659|NCT02039505|40398097|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
16527660|NCT02039505|40398091|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16527661|NCT02039505|40398092|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16527662|NCT02039505|40398093|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16527663|NCT02039505|40398094|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16527664|NCT02039505|40398095|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16527665|NCT02039505|40398096|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
16527666|NCT02039505|40398097|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
16527667|NCT02039505|40398091|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16527668|NCT02039505|40398092|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16527669|NCT02039505|40398093|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16527670|NCT02039505|40398094|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16527671|NCT02039505|40398095|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16527672|NCT02039505|40398096|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
16527673|NCT02039505|40398097|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
16527674|NCT02039505|40398091|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16527675|NCT02039505|40398092|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16527676|NCT02039505|40398093|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16527677|NCT02039505|40398094|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16527678|NCT02039505|40398095|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16527679|NCT02039505|40398096|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
16527680|NCT02039505|40398097|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
16527681|NCT02039505|40398091|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16527682|NCT02039505|40398092|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16527683|NCT02039505|40398093|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16527684|NCT02039505|40398094|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16527685|NCT02039505|40398095|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16527686|NCT02039505|40398096|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
16527687|NCT02039505|40398097|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
16527688|NCT00920426|40398098|FG000|ITZ111451|Adverse Event|1|||
16527689|NCT00920426|40398099|FG001|ITZ111451|Adverse Event|0|||
16527690|NCT00920426|40398100|FG002|ITZ111451|Adverse Event|0|||
16527691|NCT00920426|40398101|FG003|ITZ111451|Adverse Event|0|||
16527692|NCT00389324|40398102|FG000|Run-In Phase|Adverse Event|1|||
16527693|NCT00389324|40398102|FG000|Run-In Phase|Lost to Follow-up|1|||
16527694|NCT00389324|40398102|FG000|Run-In Phase|Withdrawal by Subject|1|||
16527695|NCT00389324|40398102|FG000|Subcutaneous Phase|Adverse Event|2|||
16527696|NCT00389324|40398102|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
16527697|NCT00389324|40398102|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
16527698|NCT00389324|40398102|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
16527699|NCT00613951|40398111|FG000|Overall Study|Adverse Event|1|||
16527700|NCT00613951|40398112|FG001|Overall Study|Adverse Event|0|||
16527701|NCT00613951|40398113|FG002|Overall Study|Adverse Event|1|||
16527702|NCT00613951|40398111|FG000|Overall Study|Lack of Efficacy|0|||
16527703|NCT00613951|40398112|FG001|Overall Study|Lack of Efficacy|1|||
16330666|NCT02951533|39696315|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
16527704|NCT00613951|40398113|FG002|Overall Study|Lack of Efficacy|1|||
16527705|NCT00613951|40398111|FG000|Overall Study|Protocol Violation|1|||
16527706|NCT00613951|40398112|FG001|Overall Study|Protocol Violation|1|||
16527707|NCT00613951|40398113|FG002|Overall Study|Protocol Violation|1|||
16527708|NCT00613951|40398111|FG000|Overall Study|Unclassified|5|||
16527709|NCT00613951|40398112|FG001|Overall Study|Unclassified|3|||
16527710|NCT00613951|40398113|FG002|Overall Study|Unclassified|2|||
16527711|NCT01774903|40398114|FG000|Overall Study|Adverse Event|7|||
16527712|NCT01774903|40398114|FG000|Overall Study|Withdrawal by Subject|2|||
16527713|NCT01774903|40398114|FG000|Overall Study|Lack of Efficacy|1|||
16527714|NCT01774903|40398114|FG000|Overall Study|Ineligible to continue the trial|1|||
16527715|NCT02138214|40398117|FG000|Overall Study|Withdrawal by Subject|0|||
16527716|NCT02138214|40398118|FG001|Overall Study|Withdrawal by Subject|1|||
16527717|NCT02138214|40398119|FG002|Overall Study|Withdrawal by Subject|0|||
16527718|NCT02138214|40398117|FG000|Overall Study|Lost to Follow-up|0|||
16527719|NCT02138214|40398118|FG001|Overall Study|Lost to Follow-up|2|||
16527720|NCT02138214|40398119|FG002|Overall Study|Lost to Follow-up|4|||
16527721|NCT02138214|40398117|FG000|Overall Study|Screen Failure|0|||
16527722|NCT02138214|40398118|FG001|Overall Study|Screen Failure|1|||
16527723|NCT02138214|40398119|FG002|Overall Study|Screen Failure|0|||
16527724|NCT03674177|40398121|FG000|Overall Study|Lost to Follow-up|2|||
16211863|NCT02687711|39255718|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
16211864|NCT02687711|39255718|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
16211865|NCT02687711|39255718|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
16211866|NCT02640755|39255721|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
16211867|NCT02640755|39255722|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
16211868|NCT02640755|39255721|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
16211869|NCT02640755|39255722|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
16211870|NCT02640755|39255721|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
16211871|NCT02640755|39255722|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
16211872|NCT02109744|39255723|FG000|Overall Study|Death|1|||
16211873|NCT02109744|39255724|FG001|Overall Study|Death|1|||
16211874|NCT02109744|39255723|FG000|Overall Study|no marrow exam|1|||
16211875|NCT02109744|39255724|FG001|Overall Study|no marrow exam|0|||
16211876|NCT00247273|39255725|FG000|Overall Study|Adverse Event|85|||
16330667|NCT02951533|39696316|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
16527725|NCT03674177|40398122|FG001|Overall Study|Lost to Follow-up|1|||
16527726|NCT03674177|40398123|FG002|Overall Study|Lost to Follow-up|0|||
16098097|NCT01524887|38846982|FG002|Overall Study|Use of prohibited medication|0|||
16098098|NCT02291861|38846985|FG000|Overall Study|Adverse Event|2|||
16527727|NCT03674177|40398124|FG003|Overall Study|Lost to Follow-up|2|||
16527728|NCT03349710|40398125|FG000|Treatment Period|Death|0|||
16211877|NCT00247273|39255726|FG001|Overall Study|Adverse Event|80|||
16211878|NCT00247273|39255725|FG000|Overall Study|Physician Decision|6|||
16211879|NCT00247273|39255726|FG001|Overall Study|Physician Decision|3|||
16211880|NCT00247273|39255725|FG000|Overall Study|Lost to Follow-up|7|||
16211881|NCT00247273|39255726|FG001|Overall Study|Lost to Follow-up|7|||
16211882|NCT00247273|39255725|FG000|Overall Study|Withdrawal by Subject|46|||
16211883|NCT00247273|39255726|FG001|Overall Study|Withdrawal by Subject|47|||
16211884|NCT00247273|39255725|FG000|Overall Study|Did not take any study drug|2|||
16211885|NCT00247273|39255726|FG001|Overall Study|Did not take any study drug|0|||
16211886|NCT03369704|39255727|FG000|Treatment Epoch|technical problems|1|||
16211887|NCT03369704|39255728|FG001|Treatment Epoch|technical problems|0|||
16211888|NCT03369704|39255727|FG000|Treatment Epoch|Protocol Violation|1|||
16211889|NCT03369704|39255728|FG001|Treatment Epoch|Protocol Violation|0|||
16211890|NCT03369704|39255727|FG000|Treatment Epoch|Lost to Follow-up|0|||
16211891|NCT03369704|39255728|FG001|Treatment Epoch|Lost to Follow-up|1|||
16211892|NCT03369704|39255727|FG000|Treatment Epoch|Lack of Efficacy|0|||
16211893|NCT03369704|39255728|FG001|Treatment Epoch|Lack of Efficacy|2|||
16211894|NCT03369704|39255727|FG000|Treatment Epoch|Adverse Event|2|||
16211895|NCT03369704|39255728|FG001|Treatment Epoch|Adverse Event|0|||
16211896|NCT03369704|39255727|FG000|Follow-up Epoch|Lost to Follow-up|1|||
16211897|NCT03369704|39255728|FG001|Follow-up Epoch|Lost to Follow-up|0|||
16211898|NCT02475629|39255729|FG000|Overall Study|Adverse Event|1|||
16211899|NCT02475629|39255729|FG000|Overall Study|Death|4|||
16211900|NCT02475629|39255729|FG000|Overall Study|Physician Decision|1|||
16211901|NCT02475629|39255729|FG000|Overall Study|Withdrawal by Subject|1|||
16211902|NCT02475629|39255729|FG000|Overall Study|Lost to Follow-up|1|||
16527729|NCT03349710|40398126|FG001|Treatment Period|Death|0|||
16527730|NCT03349710|40398127|FG002|Treatment Period|Death|1|||
16527731|NCT03349710|40398128|FG003|Treatment Period|Death|0|||
16527732|NCT03349710|40398125|FG000|Treatment Period|Disease Progression|0|||
16527733|NCT03349710|40398126|FG001|Treatment Period|Disease Progression|2|||
16527734|NCT03349710|40398127|FG002|Treatment Period|Disease Progression|0|||
16211903|NCT02475629|39255729|FG000|Overall Study|Subject non-compliance|1|||
16211904|NCT00093470|39255736|FG000|Overall Study|Disease progression|39|||
16211905|NCT00093470|39255737|FG001|Overall Study|Disease progression|0|||
16211906|NCT00093470|39255736|FG000|Overall Study|Adverse Event|15|||
16211907|NCT00093470|39255737|FG001|Overall Study|Adverse Event|0|||
16211908|NCT00093470|39255736|FG000|Overall Study|Death|2|||
16211909|NCT00093470|39255737|FG001|Overall Study|Death|0|||
16211910|NCT00093470|39255736|FG000|Overall Study|Withdrawal by Subject|8|||
16211911|NCT00093470|39255737|FG001|Overall Study|Withdrawal by Subject|0|||
16211912|NCT00093470|39255736|FG000|Overall Study|Alternative therapy|2|||
16211913|NCT00093470|39255737|FG001|Overall Study|Alternative therapy|0|||
16211914|NCT00093470|39255736|FG000|Overall Study|Other complicating disease|3|||
16211915|NCT00093470|39255737|FG001|Overall Study|Other complicating disease|0|||
16211916|NCT00093470|39255736|FG000|Overall Study|Physician Decision|2|||
16211917|NCT00093470|39255737|FG001|Overall Study|Physician Decision|0|||
16211918|NCT00093470|39255736|FG000|Overall Study|Never started treatment|1|||
16211919|NCT00093470|39255737|FG001|Overall Study|Never started treatment|0|||
16211920|NCT00093470|39255736|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
16211921|NCT00093470|39255737|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
16211922|NCT01197794|39255739|FG000|Overall Study|Adverse Event|3|||
16211923|NCT01197794|39255740|FG001|Overall Study|Adverse Event|2|||
16211924|NCT01197794|39255741|FG002|Overall Study|Adverse Event|4|||
16211925|NCT01197794|39255742|FG003|Overall Study|Adverse Event|4|||
16211926|NCT01197794|39255743|FG004|Overall Study|Adverse Event|4|||
16211927|NCT01197794|39255744|FG005|Overall Study|Adverse Event|2|||
16211928|NCT01197794|39255745|FG006|Overall Study|Adverse Event|3|||
16211929|NCT01197794|39255739|FG000|Overall Study|Protocol Violation|0|||
16211930|NCT01197794|39255740|FG001|Overall Study|Protocol Violation|0|||
16211931|NCT01197794|39255741|FG002|Overall Study|Protocol Violation|0|||
16211932|NCT01197794|39255742|FG003|Overall Study|Protocol Violation|0|||
16211933|NCT01197794|39255743|FG004|Overall Study|Protocol Violation|2|||
16211934|NCT01197794|39255744|FG005|Overall Study|Protocol Violation|0|||
16211935|NCT01197794|39255745|FG006|Overall Study|Protocol Violation|1|||
16399978|NCT03199053|39944932|FG000|ST Period|Withdrawal by parent/guardian|1|||
16399979|NCT03199053|39944933|FG001|ST Period|Withdrawal by parent/guardian|1|||
16527735|NCT03349710|40398128|FG003|Treatment Period|Disease Progression|1|||
16527736|NCT03349710|40398125|FG000|Treatment Period|Study Drug Toxicity|1|||
16527737|NCT03349710|40398126|FG001|Treatment Period|Study Drug Toxicity|0|||
16211936|NCT01197794|39255739|FG000|Overall Study|Development of study withdrawal criteria|3|||
16211937|NCT01197794|39255740|FG001|Overall Study|Development of study withdrawal criteria|0|||
16211938|NCT01197794|39255741|FG002|Overall Study|Development of study withdrawal criteria|0|||
16527738|NCT03349710|40398127|FG002|Treatment Period|Study Drug Toxicity|1|||
16527739|NCT03349710|40398128|FG003|Treatment Period|Study Drug Toxicity|1|||
16211939|NCT01197794|39255742|FG003|Overall Study|Development of study withdrawal criteria|1|||
16211940|NCT01197794|39255743|FG004|Overall Study|Development of study withdrawal criteria|0|||
16211941|NCT01197794|39255744|FG005|Overall Study|Development of study withdrawal criteria|0|||
16211942|NCT01197794|39255745|FG006|Overall Study|Development of study withdrawal criteria|1|||
16211943|NCT01197794|39255739|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
16211944|NCT01197794|39255740|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
16211945|NCT01197794|39255741|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
16211946|NCT01197794|39255742|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
16211947|NCT01197794|39255743|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
16211948|NCT01197794|39255744|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
16211949|NCT01197794|39255745|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
16211950|NCT01197794|39255739|FG000|Overall Study|Withdrawal by Subject|3|||
16211951|NCT01197794|39255740|FG001|Overall Study|Withdrawal by Subject|3|||
16527740|NCT03349710|40398125|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
16527741|NCT03349710|40398126|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
16527742|NCT03349710|40398127|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
16527743|NCT03349710|40398128|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
16527744|NCT03349710|40398125|FG000|Treatment Period|admin reason by sponsor|0|||
16527745|NCT03349710|40398126|FG001|Treatment Period|admin reason by sponsor|7|||
16527746|NCT03349710|40398127|FG002|Treatment Period|admin reason by sponsor|0|||
16527747|NCT03349710|40398128|FG003|Treatment Period|admin reason by sponsor|19|||
16527748|NCT03349710|40398125|FG000|Treatment Period|Other Reason|2|||
16211952|NCT01197794|39255741|FG002|Overall Study|Withdrawal by Subject|4|||
16211953|NCT01197794|39255742|FG003|Overall Study|Withdrawal by Subject|1|||
16211954|NCT01197794|39255743|FG004|Overall Study|Withdrawal by Subject|1|||
16211955|NCT01197794|39255744|FG005|Overall Study|Withdrawal by Subject|5|||
16211956|NCT01197794|39255745|FG006|Overall Study|Withdrawal by Subject|6|||
16211957|NCT01197794|39255739|FG000|Overall Study|Lost to Follow-up|1|||
16211958|NCT01197794|39255740|FG001|Overall Study|Lost to Follow-up|1|||
16211959|NCT01197794|39255741|FG002|Overall Study|Lost to Follow-up|0|||
16211960|NCT01197794|39255742|FG003|Overall Study|Lost to Follow-up|1|||
16211961|NCT01197794|39255743|FG004|Overall Study|Lost to Follow-up|0|||
16211962|NCT01197794|39255744|FG005|Overall Study|Lost to Follow-up|1|||
16211963|NCT01197794|39255745|FG006|Overall Study|Lost to Follow-up|0|||
16211964|NCT01197794|39255739|FG000|Overall Study|Other|1|||
16211965|NCT01197794|39255740|FG001|Overall Study|Other|1|||
16211966|NCT01197794|39255741|FG002|Overall Study|Other|3|||
16211967|NCT01197794|39255742|FG003|Overall Study|Other|0|||
16211968|NCT01197794|39255743|FG004|Overall Study|Other|2|||
16211969|NCT01197794|39255744|FG005|Overall Study|Other|2|||
16211970|NCT01197794|39255745|FG006|Overall Study|Other|4|||
16211971|NCT03099304|39255746|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
16211972|NCT03099304|39255747|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
16211973|NCT03099304|39255748|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
16211974|NCT03099304|39255749|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
16211975|NCT03099304|39255750|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
16211976|NCT03099304|39255751|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
16211977|NCT03099304|39255746|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
16211978|NCT03099304|39255747|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
16211979|NCT03099304|39255748|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
16211980|NCT03099304|39255749|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
16211981|NCT03099304|39255750|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
16211982|NCT03099304|39255751|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
16211983|NCT03099304|39255746|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
16527749|NCT03349710|40398126|FG001|Treatment Period|Other Reason|0|||
16527750|NCT03349710|40398127|FG002|Treatment Period|Other Reason|2|||
16211984|NCT03099304|39255747|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
16211985|NCT03099304|39255748|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
16399980|NCT03199053|39944934|FG002|ST Period|Withdrawal by parent/guardian|1|||
16399981|NCT03199053|39944932|FG000|ST Period|Lost to Follow-up|2|||
16330668|NCT02951533|39696314|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
16330669|NCT02951533|39696315|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
16330670|NCT02951533|39696316|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
16330671|NCT02951533|39696314|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
16330672|NCT02951533|39696315|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
16330673|NCT02951533|39696316|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
16330674|NCT02951533|39696314|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
16330675|NCT02951533|39696315|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
16330676|NCT02951533|39696316|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
16330677|NCT02951533|39696314|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
16330678|NCT02951533|39696315|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
16330679|NCT02951533|39696316|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
16330680|NCT03422159|39696323|FG000|Overall Study|Exclusion due to terminal disease|2|||
16330681|NCT03422159|39696324|FG001|Overall Study|Exclusion due to terminal disease|1|||
16330682|NCT04063657|39696328|FG000|Overall Study|Lost to Follow-up|1|||
16330683|NCT04063657|39696329|FG001|Overall Study|Lost to Follow-up|0|||
16330684|NCT04420585|39696330|FG000|Overall Study|Adverse Event|1|||
16330685|NCT04420585|39696330|FG000|Overall Study|Never initiated medication|2|||
16330686|NCT02091986|39696331|FG000|Overall Study|7 rand in error 1 patient decision|2|||
16330687|NCT02091986|39696332|FG001|Overall Study|7 rand in error 1 patient decision|3|||
16330688|NCT02091986|39696333|FG002|Overall Study|7 rand in error 1 patient decision|3|||
16330689|NCT02091986|39696331|FG000|Overall Study|Lost to Follow-up|1|||
16330690|NCT02091986|39696332|FG001|Overall Study|Lost to Follow-up|0|||
16330691|NCT02091986|39696333|FG002|Overall Study|Lost to Follow-up|0|||
16330692|NCT02091986|39696331|FG000|Overall Study|Withdrawal by Subject|4|||
16330693|NCT02091986|39696332|FG001|Overall Study|Withdrawal by Subject|8|||
16330694|NCT02091986|39696333|FG002|Overall Study|Withdrawal by Subject|3|||
16330695|NCT02091986|39696331|FG000|Overall Study|Adverse Event|0|||
16330696|NCT02091986|39696332|FG001|Overall Study|Adverse Event|0|||
16330697|NCT02091986|39696333|FG002|Overall Study|Adverse Event|2|||
16330698|NCT00616603|39696334|FG000|Overall Study|Physician Decision|2|||
16330699|NCT00616603|39696335|FG001|Overall Study|Physician Decision|0|||
16330700|NCT00616603|39696336|FG002|Overall Study|Physician Decision|2|||
16330701|NCT02071706|39696337|FG000|Overall Study|Adverse Event|1|||
16330702|NCT02071706|39696337|FG000|Overall Study|Withdrawal by Subject|2|||
16330703|NCT04326439|39696338|FG000|Overall Study|Withdrawal by Subject|1|||
16330704|NCT04326439|39696339|FG001|Overall Study|Withdrawal by Subject|0|||
16330705|NCT04326439|39696338|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
16330706|NCT04326439|39696339|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
16330707|NCT04326439|39696338|FG000|Overall Study|Relapse after Induction 2|0|||
16330708|NCT04326439|39696339|FG001|Overall Study|Relapse after Induction 2|1|||
16330709|NCT04326439|39696338|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
16330710|NCT04326439|39696339|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
16330711|NCT02670382|39696340|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
16330712|NCT02670382|39696341|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
16330713|NCT00866333|39696342|FG000|Overall Study|Withdrawal of consent|0|||
16330714|NCT00866333|39696343|FG001|Overall Study|Withdrawal of consent|1|||
16330715|NCT00866333|39696344|FG002|Overall Study|Withdrawal of consent|2|||
16330716|NCT00866333|39696342|FG000|Overall Study|Reason not Specified|3|||
16330717|NCT00866333|39696343|FG001|Overall Study|Reason not Specified|1|||
16330718|NCT00866333|39696344|FG002|Overall Study|Reason not Specified|1|||
16330719|NCT00866333|39696342|FG000|Overall Study|Study Terminated by Sponsor|2|||
16330720|NCT00866333|39696343|FG001|Overall Study|Study Terminated by Sponsor|5|||
16330721|NCT00866333|39696344|FG002|Overall Study|Study Terminated by Sponsor|9|||
16330722|NCT01382225|39696345|FG000|Overall Study|Adverse Event|3|||
16330723|NCT01382225|39696346|FG001|Overall Study|Adverse Event|2|||
16330724|NCT01382225|39696345|FG000|Overall Study|Protocol Violation|2|||
16330725|NCT01382225|39696346|FG001|Overall Study|Protocol Violation|1|||
16330726|NCT01382225|39696345|FG000|Overall Study|Subject Withdrew Consent|5|||
16399982|NCT03199053|39944933|FG001|ST Period|Lost to Follow-up|0|||
16399983|NCT03199053|39944934|FG002|ST Period|Lost to Follow-up|1|||
16399984|NCT03199053|39944932|FG000|LT Period|Withdrawal by Subject|1|||
16211986|NCT03099304|39255749|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
16211987|NCT03099304|39255750|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
16211988|NCT03099304|39255751|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
16211989|NCT03099304|39255746|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
16211990|NCT03099304|39255747|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
16211991|NCT03099304|39255748|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
16211992|NCT03099304|39255749|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
16211993|NCT03099304|39255750|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
16211994|NCT03099304|39255751|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
16399985|NCT03199053|39944933|FG001|LT Period|Withdrawal by Subject|3|||
16399986|NCT03199053|39944934|FG002|LT Period|Withdrawal by Subject|3|||
16399987|NCT03199053|39944932|FG000|LT Period|Withdrawal by parent/guardian|0|||
16399988|NCT03199053|39944933|FG001|LT Period|Withdrawal by parent/guardian|0|||
16399989|NCT03199053|39944934|FG002|LT Period|Withdrawal by parent/guardian|1|||
16211995|NCT03099304|39255746|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
16211996|NCT03099304|39255747|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
16211997|NCT03099304|39255748|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
16211998|NCT03099304|39255749|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
16211999|NCT03099304|39255750|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
16212000|NCT03099304|39255751|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
16212001|NCT03099304|39255746|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
16212002|NCT03099304|39255747|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
16212003|NCT03099304|39255748|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
16212004|NCT03099304|39255749|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
16212005|NCT03099304|39255750|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
16212006|NCT03099304|39255751|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
16212007|NCT03099304|39255746|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
16212008|NCT03099304|39255747|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
16212009|NCT03099304|39255748|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
16212010|NCT03099304|39255749|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
16212011|NCT03099304|39255750|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
16212012|NCT03099304|39255751|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
16212013|NCT03099304|39255746|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
16212014|NCT03099304|39255747|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
16212015|NCT03099304|39255748|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
16212016|NCT03099304|39255749|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
16212017|NCT03099304|39255750|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
16212018|NCT03099304|39255751|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
16212019|NCT03099304|39255746|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
16212020|NCT03099304|39255747|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
16212021|NCT03099304|39255748|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
16212022|NCT03099304|39255749|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
16527751|NCT03349710|40398128|FG003|Treatment Period|Other Reason|1|||
16527752|NCT03349710|40398125|FG000|Treatment Period|completed|6|||
16527753|NCT03349710|40398126|FG001|Treatment Period|completed|0|||
16527754|NCT03349710|40398127|FG002|Treatment Period|completed|18|||
16527755|NCT03349710|40398128|FG003|Treatment Period|completed|1|||
16527756|NCT03349710|40398125|FG000|Treatment Period|participant request to discontinue|0|||
16527757|NCT03349710|40398126|FG001|Treatment Period|participant request to discontinue|0|||
16527758|NCT03349710|40398127|FG002|Treatment Period|participant request to discontinue|4|||
16212023|NCT03099304|39255750|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
16212024|NCT03099304|39255751|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
16212025|NCT03099304|39255746|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
16399990|NCT03199053|39944932|FG000|LT Period|Lost to Follow-up|0|||
16399991|NCT03199053|39944933|FG001|LT Period|Lost to Follow-up|1|||
16399992|NCT03199053|39944934|FG002|LT Period|Lost to Follow-up|1|||
16399993|NCT03199053|39944932|FG000|LT Period|Miscellaneous|0|||
16399994|NCT03199053|39944933|FG001|LT Period|Miscellaneous|0|||
16399995|NCT03199053|39944934|FG002|LT Period|Miscellaneous|2|||
16399996|NCT03199053|39944932|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
16399997|NCT03199053|39944933|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
16527759|NCT03349710|40398128|FG003|Treatment Period|participant request to discontinue|0|||
16212026|NCT03099304|39255747|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
16212027|NCT03099304|39255748|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
16212028|NCT03099304|39255749|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
16212029|NCT03099304|39255750|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
16399998|NCT03199053|39944934|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
16399999|NCT03199053|39944932|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
16400000|NCT03199053|39944933|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
16400001|NCT03199053|39944934|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
16400002|NCT03199053|39944932|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
16400003|NCT03199053|39944933|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
16400004|NCT03199053|39944934|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
16400005|NCT03199053|39944932|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
16400006|NCT03199053|39944933|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
16400007|NCT03199053|39944934|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
16400008|NCT01133756|39944938|FG000|Overall Study|Adverse Event|1|||
16400009|NCT01133756|39944939|FG001|Overall Study|Adverse Event|2|||
16400010|NCT01133756|39944940|FG002|Overall Study|Adverse Event|1|||
16400011|NCT01133756|39944938|FG000|Overall Study|Investigator Decision|1|||
16400012|NCT01133756|39944939|FG001|Overall Study|Investigator Decision|0|||
16400013|NCT01133756|39944940|FG002|Overall Study|Investigator Decision|0|||
16400014|NCT01133756|39944938|FG000|Overall Study|Withdrawal by Subject|0|||
16400015|NCT01133756|39944939|FG001|Overall Study|Withdrawal by Subject|1|||
16400016|NCT01133756|39944940|FG002|Overall Study|Withdrawal by Subject|0|||
16400017|NCT01133756|39944938|FG000|Overall Study|Progression of Disease|0|||
16400018|NCT01133756|39944939|FG001|Overall Study|Progression of Disease|0|||
16400019|NCT01133756|39944940|FG002|Overall Study|Progression of Disease|1|||
16400020|NCT00939029|39944941|FG000|Overall Study|Withdrawal by Subject|3|||
16400021|NCT00939029|39944942|FG001|Overall Study|Withdrawal by Subject|7|||
16400022|NCT00939029|39944941|FG000|Overall Study|Lost to Follow-up|3|||
16400023|NCT00939029|39944942|FG001|Overall Study|Lost to Follow-up|4|||
16400024|NCT00939029|39944941|FG000|Overall Study|Adverse Event|0|||
16400025|NCT00939029|39944942|FG001|Overall Study|Adverse Event|1|||
16400026|NCT01453205|39944943|FG000|Overall Study|Lost to Follow-up|3|||
16400027|NCT01453205|39944944|FG001|Overall Study|Lost to Follow-up|0|||
16400028|NCT01453205|39944945|FG002|Overall Study|Lost to Follow-up|1|||
16400029|NCT01453205|39944943|FG000|Overall Study|Withdrawal by Subject|8|||
16400030|NCT01453205|39944944|FG001|Overall Study|Withdrawal by Subject|3|||
16400031|NCT01453205|39944945|FG002|Overall Study|Withdrawal by Subject|0|||
16400032|NCT01453205|39944943|FG000|Overall Study|Death|24|||
16400033|NCT01453205|39944944|FG001|Overall Study|Death|22|||
16400034|NCT01453205|39944945|FG002|Overall Study|Death|18|||
16400035|NCT01453205|39944943|FG000|Overall Study|Other|45|||
16400036|NCT01453205|39944944|FG001|Overall Study|Other|27|||
16400037|NCT01453205|39944945|FG002|Overall Study|Other|35|||
16400038|NCT01092780|39944947|FG000|Washout Period 1|Adverse Event|0|||
16400039|NCT01092780|39944948|FG001|Washout Period 1|Adverse Event|1|||
16400040|NCT01092780|39944949|FG002|Washout Period 1|Adverse Event|0|||
16400041|NCT01092780|39944950|FG003|Washout Period 1|Adverse Event|0|||
16400042|NCT01092780|39944947|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
16400043|NCT01092780|39944948|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
16400044|NCT01092780|39944949|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
16400045|NCT01092780|39944950|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
16400046|NCT01092780|39944947|FG000|Washout Period 2|Adverse Event|0|||
16400047|NCT01092780|39944948|FG001|Washout Period 2|Adverse Event|1|||
16400048|NCT01092780|39944949|FG002|Washout Period 2|Adverse Event|1|||
16400049|NCT01092780|39944950|FG003|Washout Period 2|Adverse Event|0|||
16400050|NCT02321319|39944951|FG000|Overall Study|Product discontinued|5|||
16400051|NCT00342628|39944952|FG000|Overall Study|Withdrawal by Subject|19|||
16400052|NCT00342628|39944953|FG001|Overall Study|Withdrawal by Subject|19|||
16400053|NCT00342628|39944954|FG002|Overall Study|Withdrawal by Subject|18|||
16400054|NCT00342628|39944952|FG000|Overall Study|Death|1|||
16400055|NCT00342628|39944953|FG001|Overall Study|Death|1|||
16400056|NCT00342628|39944954|FG002|Overall Study|Death|0|||
16400057|NCT00342628|39944952|FG000|Overall Study|moved residence|0|||
16400058|NCT00342628|39944953|FG001|Overall Study|moved residence|1|||
16400059|NCT00342628|39944954|FG002|Overall Study|moved residence|1|||
16400060|NCT03116828|39944955|FG000|Overall Study|Adverse Event|1|||
16400061|NCT03116828|39944956|FG001|Overall Study|Adverse Event|10|||
16400062|NCT03116828|39944955|FG000|Overall Study|Withdrawal by Subject|4|||
16400063|NCT03116828|39944956|FG001|Overall Study|Withdrawal by Subject|8|||
16400064|NCT03116828|39944955|FG000|Overall Study|OTHER|3|||
16400065|NCT03116828|39944956|FG001|Overall Study|OTHER|3|||
16400066|NCT00813865|39944957|FG000|Overall Study|Failure to Respond|3|||
16527760|NCT03349710|40398125|FG000|Treatment Period|participant withdrew consent|1|||
16527761|NCT03349710|40398126|FG001|Treatment Period|participant withdrew consent|0|||
16527762|NCT03349710|40398127|FG002|Treatment Period|participant withdrew consent|0|||
16527763|NCT03349710|40398128|FG003|Treatment Period|participant withdrew consent|0|||
16527764|NCT04401579|40398129|FG000|Overall Study|Death|23|||
16400067|NCT00813865|39944957|FG000|Overall Study|Lost to Follow-up|3|||
16400068|NCT00813865|39944957|FG000|Overall Study|Withdrawal by Subject|1|||
16400069|NCT02545517|39944958|FG000|Overall Study|Death|2|||
16400070|NCT02545517|39944959|FG001|Overall Study|Death|2|||
16527765|NCT04401579|40398130|FG001|Overall Study|Death|36|||
16400071|NCT02545517|39944960|FG002|Overall Study|Death|1|||
16400072|NCT02545517|39944958|FG000|Overall Study|Lost to Follow-up|14|||
16527766|NCT04401579|40398129|FG000|Overall Study|Lost to Follow-up|40|||
16527767|NCT04401579|40398130|FG001|Overall Study|Lost to Follow-up|41|||
16527768|NCT04401579|40398129|FG000|Overall Study|Withdrawal by Subject|8|||
16527769|NCT04401579|40398130|FG001|Overall Study|Withdrawal by Subject|16|||
16527770|NCT04401579|40398129|FG000|Overall Study|Physician Decision|1|||
16527771|NCT04401579|40398130|FG001|Overall Study|Physician Decision|2|||
16527772|NCT04401579|40398129|FG000|Overall Study|Became ineligible after enrollment|1|||
16527773|NCT04401579|40398130|FG001|Overall Study|Became ineligible after enrollment|1|||
16527774|NCT04401579|40398129|FG000|Overall Study|Enrolled but treatment not administered|7|||
16527775|NCT04401579|40398130|FG001|Overall Study|Enrolled but treatment not administered|9|||
16527776|NCT04401579|40398129|FG000|Overall Study|Adverse Event|2|||
16527777|NCT04401579|40398130|FG001|Overall Study|Adverse Event|1|||
16527778|NCT04401579|40398129|FG000|Overall Study|Scheduling error|1|||
16527779|NCT04401579|40398130|FG001|Overall Study|Scheduling error|2|||
16527780|NCT04401579|40398129|FG000|Overall Study|Transferred to another hospital|1|||
16527781|NCT04401579|40398130|FG001|Overall Study|Transferred to another hospital|2|||
16527782|NCT04313634|40398131|FG000|Overall Study|Adverse Event|2|||
16527783|NCT04313634|40398132|FG001|Overall Study|Adverse Event|2|||
16527784|NCT04313634|40398133|FG002|Overall Study|Adverse Event|0|||
16098099|NCT02291861|38846986|FG001|Overall Study|Adverse Event|4|||
16400073|NCT02545517|39944959|FG001|Overall Study|Lost to Follow-up|13|||
16400074|NCT02545517|39944960|FG002|Overall Study|Lost to Follow-up|17|||
16400075|NCT02545517|39944958|FG000|Overall Study|Protocol Violation|0|||
16400076|NCT02545517|39944959|FG001|Overall Study|Protocol Violation|1|||
16400077|NCT02545517|39944960|FG002|Overall Study|Protocol Violation|1|||
16400078|NCT02545517|39944958|FG000|Overall Study|Withdrawal by Subject|5|||
16400079|NCT02545517|39944959|FG001|Overall Study|Withdrawal by Subject|8|||
16400080|NCT02545517|39944960|FG002|Overall Study|Withdrawal by Subject|9|||
16400081|NCT02545517|39944958|FG000|Overall Study|Administrative reason|5|||
16400082|NCT02545517|39944959|FG001|Overall Study|Administrative reason|6|||
16400083|NCT02545517|39944960|FG002|Overall Study|Administrative reason|10|||
16400084|NCT02545517|39944958|FG000|Overall Study|Other|2|||
16400085|NCT02545517|39944959|FG001|Overall Study|Other|4|||
16400086|NCT02545517|39944960|FG002|Overall Study|Other|3|||
16400087|NCT01795495|39944961|FG000|Overall Study|Protocol Violation|1|||
16400088|NCT01795495|39944962|FG001|Overall Study|Protocol Violation|0|||
16400089|NCT01795495|39944963|FG002|Overall Study|Protocol Violation|1|||
16400090|NCT01795495|39944961|FG000|Overall Study|Physician Decision|0|||
16400091|NCT01795495|39944962|FG001|Overall Study|Physician Decision|0|||
16400092|NCT01795495|39944963|FG002|Overall Study|Physician Decision|1|||
16400093|NCT04085458|39944964|FG000|Overall Study|Other|1|||
16400094|NCT04085458|39944964|FG000|Overall Study|Withdrawal by Subject|2|||
16400095|NCT04085458|39944964|FG000|Overall Study|Adverse Event|2|||
16400096|NCT01221623|39944968|FG000|Overall Study|Withdrawal by Subject|19|||
16400097|NCT01221623|39944969|FG001|Overall Study|Withdrawal by Subject|8|||
16400098|NCT01221623|39944968|FG000|Overall Study|Lost to Follow-up|7|||
16400099|NCT01221623|39944969|FG001|Overall Study|Lost to Follow-up|1|||
16400100|NCT01221623|39944968|FG000|Overall Study|Adverse Event|6|||
16400101|NCT01221623|39944969|FG001|Overall Study|Adverse Event|3|||
16400102|NCT01221623|39944968|FG000|Overall Study|Death|1|||
16400103|NCT01221623|39944969|FG001|Overall Study|Death|0|||
16400104|NCT01221623|39944968|FG000|Overall Study|Other|5|||
16400105|NCT01221623|39944969|FG001|Overall Study|Other|2|||
16400106|NCT02910401|39944972|FG000|Overall Study|Study closure Study closure|0|||
16400107|NCT02910401|39944973|FG001|Overall Study|Study closure Study closure|0|||
16400108|NCT02910401|39944974|FG002|Overall Study|Study closure Study closure|2|||
16098100|NCT02291861|38846987|FG002|Overall Study|Adverse Event|1|||
16400109|NCT02910401|39944972|FG000|Overall Study|Physician Decision|1|||
16400110|NCT02910401|39944973|FG001|Overall Study|Physician Decision|0|||
16400111|NCT02910401|39944974|FG002|Overall Study|Physician Decision|0|||
16400112|NCT00734604|39944975|FG000|Overall Study|Adverse Event|0|||
16527785|NCT04313634|40398131|FG000|Overall Study|Withdrawal by Subject|1|||
16527786|NCT04313634|40398132|FG001|Overall Study|Withdrawal by Subject|0|||
16527787|NCT04313634|40398133|FG002|Overall Study|Withdrawal by Subject|1|||
16400113|NCT00734604|39944976|FG001|Overall Study|Adverse Event|2|||
16400114|NCT00734604|39944977|FG002|Overall Study|Adverse Event|0|||
16400115|NCT00734604|39944978|FG003|Overall Study|Adverse Event|2|||
16400116|NCT00734604|39944979|FG004|Overall Study|Adverse Event|1|||
16400117|NCT00734604|39944980|FG005|Overall Study|Adverse Event|1|||
16400118|NCT00734604|39944975|FG000|Overall Study|Serious Adverse Event|1|||
16330727|NCT01382225|39696346|FG001|Overall Study|Subject Withdrew Consent|2|||
16330728|NCT01382225|39696345|FG000|Overall Study|Other|4|||
16330729|NCT01382225|39696346|FG001|Overall Study|Other|2|||
16330730|NCT02333383|39696353|FG000|Overall Study|Adalimumab discontinuation|21|||
16330731|NCT02333383|39696353|FG000|Overall Study|Lost to Follow-up|15|||
16330732|NCT02333383|39696353|FG000|Overall Study|Withdrawal by Subject|3|||
16330733|NCT02333383|39696353|FG000|Overall Study|Transfer to another hospital|2|||
16330734|NCT01871402|39696354|FG000|Overall Study|Lost to Follow-up|1|||
16330735|NCT01871402|39696355|FG001|Overall Study|Lost to Follow-up|0|||
16330736|NCT01871402|39696354|FG000|Overall Study|Withdrawal by Subject|0|||
16330737|NCT01871402|39696355|FG001|Overall Study|Withdrawal by Subject|2|||
16330738|NCT01871402|39696354|FG000|Overall Study|Non-compliance|0|||
16330739|NCT01871402|39696355|FG001|Overall Study|Non-compliance|1|||
16330740|NCT00984061|39696359|FG000|Clarithromycin Alone|Protocol Violation|1|||
16330741|NCT02484651|39696361|FG000|Overall Study|Patients' data files were corrupted.|1|||
16330742|NCT02484651|39696362|FG001|Overall Study|Patients' data files were corrupted.|1|||
16330743|NCT02484651|39696361|FG000|Overall Study|BIS monitoring failed.|1|||
16330744|NCT02484651|39696362|FG001|Overall Study|BIS monitoring failed.|1|||
16330745|NCT02484651|39696361|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
16330746|NCT02484651|39696362|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
16330747|NCT02339155|39696368|FG000|Overall Study|Adverse Event|0|||
16330748|NCT02339155|39696369|FG001|Overall Study|Adverse Event|6|||
16330749|NCT02339155|39696368|FG000|Overall Study|Death|1|||
16330750|NCT02339155|39696369|FG001|Overall Study|Death|1|||
16330751|NCT02339155|39696368|FG000|Overall Study|Lost to Follow-up|8|||
16330752|NCT02339155|39696369|FG001|Overall Study|Lost to Follow-up|9|||
16330753|NCT02339155|39696368|FG000|Overall Study|Physician Decision|2|||
16330754|NCT02339155|39696369|FG001|Overall Study|Physician Decision|1|||
16330755|NCT02339155|39696368|FG000|Overall Study|Withdrawal by Subject|4|||
16330756|NCT02339155|39696369|FG001|Overall Study|Withdrawal by Subject|4|||
16330757|NCT01047332|39696370|FG000|Overall Study|SEMS Obstruction|11|||
16330758|NCT01047332|39696371|FG001|Overall Study|SEMS Obstruction|20|||
16400119|NCT00734604|39944976|FG001|Overall Study|Serious Adverse Event|0|||
16098101|NCT02291861|38846988|FG003|Overall Study|Adverse Event|2|||
16400120|NCT00734604|39944977|FG002|Overall Study|Serious Adverse Event|1|||
16098102|NCT02291861|38846985|FG000|Overall Study|Death|0|||
16330759|NCT01047332|39696370|FG000|Overall Study|Died Unobstructed|38|||
16330760|NCT01047332|39696371|FG001|Overall Study|Died Unobstructed|41|||
16330761|NCT01047332|39696370|FG000|Overall Study|Lost to Follow-up|8|||
16330762|NCT01047332|39696371|FG001|Overall Study|Lost to Follow-up|3|||
16330763|NCT00622336|39696372|FG000|Treatment Phase|Progression of Disease|181|||
16330764|NCT00622336|39696372|FG000|Treatment Phase|Adverse Event|46|||
16212030|NCT03099304|39255751|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
16400121|NCT00734604|39944978|FG003|Overall Study|Serious Adverse Event|2|||
16400122|NCT00734604|39944979|FG004|Overall Study|Serious Adverse Event|0|||
16400123|NCT00734604|39944980|FG005|Overall Study|Serious Adverse Event|1|||
16400124|NCT00734604|39944975|FG000|Overall Study|Lost to Follow-up|1|||
16400125|NCT00734604|39944976|FG001|Overall Study|Lost to Follow-up|2|||
16400126|NCT00734604|39944977|FG002|Overall Study|Lost to Follow-up|2|||
16527788|NCT04313634|40398131|FG000|Overall Study|Protocol Violation|0|||
16527789|NCT04313634|40398132|FG001|Overall Study|Protocol Violation|0|||
16527790|NCT04313634|40398133|FG002|Overall Study|Protocol Violation|1|||
16527791|NCT04862143|40398134|FG000|Overall Study|Adverse Event|1|||
16527792|NCT04862143|40398134|FG000|Overall Study|Study terminated by sponsor|1|||
16527793|NCT00673049|40398143|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
16527794|NCT00673049|40398144|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
16527795|NCT00673049|40398145|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
16527796|NCT00673049|40398146|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
16527797|NCT00673049|40398143|FG000|Before Progression on Erlotinib|Death|235|||
16527798|NCT00673049|40398144|FG001|Before Progression on Erlotinib|Death|167|||
16527799|NCT00673049|40398145|FG002|Before Progression on Erlotinib|Death|1|||
16527800|NCT00673049|40398146|FG003|Before Progression on Erlotinib|Death|0|||
16527801|NCT00673049|40398143|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
16527802|NCT00673049|40398144|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
16527803|NCT00673049|40398145|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
16527804|NCT00673049|40398146|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
16527805|NCT00673049|40398143|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
16527806|NCT00673049|40398144|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
16527807|NCT00673049|40398145|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
16527808|NCT00673049|40398146|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
16527809|NCT00673049|40398143|FG000|Before Progression on Erlotinib|Other|1|||
16527810|NCT00673049|40398144|FG001|Before Progression on Erlotinib|Other|2|||
16527811|NCT00673049|40398145|FG002|Before Progression on Erlotinib|Other|0|||
16527812|NCT00673049|40398146|FG003|Before Progression on Erlotinib|Other|0|||
16527813|NCT00673049|40398143|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
16527814|NCT00673049|40398144|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
16527815|NCT00673049|40398145|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
16527816|NCT00673049|40398146|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
16527817|NCT00673049|40398143|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
16527818|NCT00673049|40398144|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
16527819|NCT00673049|40398145|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
16527820|NCT00673049|40398146|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
16527821|NCT00673049|40398143|FG000|After Progression on Erlotinib|Death|0|||
16527822|NCT00673049|40398144|FG001|After Progression on Erlotinib|Death|0|||
16527823|NCT00673049|40398145|FG002|After Progression on Erlotinib|Death|0|||
16527824|NCT00673049|40398146|FG003|After Progression on Erlotinib|Death|71|||
16527825|NCT00673049|40398143|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
16527826|NCT00673049|40398144|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
16527827|NCT00673049|40398145|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
16527828|NCT00673049|40398146|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
16527829|NCT00673049|40398143|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
16527830|NCT00673049|40398144|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
16527831|NCT00673049|40398145|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
16527832|NCT00673049|40398146|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
16527833|NCT00673049|40398143|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
16527834|NCT00673049|40398144|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
16527835|NCT00673049|40398145|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
16527836|NCT00673049|40398146|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
16527837|NCT00874029|40398147|FG000|Overall Study|Withdrawal by Subject|10|||
16527838|NCT00874029|40398147|FG000|Overall Study|Pregnancy|4|||
16527839|NCT00874029|40398147|FG000|Overall Study|Physician Decision|1|||
16527840|NCT00874029|40398147|FG000|Overall Study|Adverse Event|1|||
16527841|NCT00874029|40398147|FG000|Overall Study|Lost to Follow-up|5|||
16527842|NCT01046110|40398148|FG000|Overall Study|Adverse Event|9|||
16527843|NCT01046110|40398149|FG001|Overall Study|Adverse Event|2|||
16527844|NCT01046110|40398148|FG000|Overall Study|Lack of Efficacy|0|||
16527845|NCT01046110|40398149|FG001|Overall Study|Lack of Efficacy|1|||
16400127|NCT00734604|39944978|FG003|Overall Study|Lost to Follow-up|4|||
16527846|NCT01046110|40398148|FG000|Overall Study|Protocol Violation|7|||
16527847|NCT01046110|40398149|FG001|Overall Study|Protocol Violation|12|||
16527848|NCT01046110|40398148|FG000|Overall Study|Withdrawal Criteria|3|||
16527849|NCT01046110|40398149|FG001|Overall Study|Withdrawal Criteria|5|||
16527850|NCT01046110|40398148|FG000|Overall Study|Unclassified|36|||
16527851|NCT01046110|40398149|FG001|Overall Study|Unclassified|35|||
16527852|NCT03387852|40398150|FG000|Overall Study|Adverse event (AE)|3|||
16527853|NCT03387852|40398151|FG001|Overall Study|Adverse event (AE)|0|||
16527854|NCT03387852|40398152|FG002|Overall Study|Adverse event (AE)|2|||
16527855|NCT03387852|40398153|FG003|Overall Study|Adverse event (AE)|0|||
16527856|NCT03387852|40398150|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
16527857|NCT03387852|40398151|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
16527858|NCT03387852|40398152|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
16527859|NCT03387852|40398153|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
16527860|NCT03387852|40398150|FG000|Overall Study|Withdrawal by participant|1|||
16527861|NCT03387852|40398151|FG001|Overall Study|Withdrawal by participant|1|||
16527862|NCT03387852|40398152|FG002|Overall Study|Withdrawal by participant|3|||
16527863|NCT03387852|40398153|FG003|Overall Study|Withdrawal by participant|2|||
16527864|NCT03387852|40398150|FG000|Overall Study|Other- Unspecified|1|||
16527865|NCT03387852|40398151|FG001|Overall Study|Other- Unspecified|1|||
16527866|NCT03387852|40398152|FG002|Overall Study|Other- Unspecified|2|||
16527867|NCT03387852|40398153|FG003|Overall Study|Other- Unspecified|1|||
16527868|NCT03387852|40398150|FG000|Overall Study|Poor compliance to protocol|0|||
16527869|NCT03387852|40398151|FG001|Overall Study|Poor compliance to protocol|0|||
16527870|NCT03387852|40398152|FG002|Overall Study|Poor compliance to protocol|0|||
16527871|NCT03387852|40398153|FG003|Overall Study|Poor compliance to protocol|1|||
16527872|NCT03387852|40398150|FG000|Overall Study|Randomized and not treated|0|||
16527873|NCT03387852|40398151|FG001|Overall Study|Randomized and not treated|0|||
16527874|NCT03387852|40398152|FG002|Overall Study|Randomized and not treated|0|||
16527875|NCT03387852|40398153|FG003|Overall Study|Randomized and not treated|1|||
16527876|NCT01233817|40398156|FG000|Overall Study|Lost to Follow-up|1|||
16527877|NCT01233817|40398156|FG000|Overall Study|Withdrawal by Subject|2|||
16527878|NCT01365494|40398157|FG000|Overall Study|Adverse Event|1|||
16527879|NCT01365494|40398158|FG001|Overall Study|Adverse Event|0|||
16527880|NCT01365494|40398157|FG000|Overall Study|Withdrawal by Subject|0|||
16527881|NCT01365494|40398158|FG001|Overall Study|Withdrawal by Subject|1|||
16527882|NCT01365494|40398157|FG000|Overall Study|Lost to Follow-up|1|||
16527883|NCT01365494|40398158|FG001|Overall Study|Lost to Follow-up|2|||
16527884|NCT02055352|40398162|FG000|Overall Study|Adverse Event|0|||
16527885|NCT02055352|40398163|FG001|Overall Study|Adverse Event|1|||
16527886|NCT02055352|40398162|FG000|Overall Study|Non-eligible|0|||
16527887|NCT02055352|40398163|FG001|Overall Study|Non-eligible|1|||
16527888|NCT02055352|40398162|FG000|Overall Study|Poor compliance|1|||
16527889|NCT02055352|40398163|FG001|Overall Study|Poor compliance|1|||
16527890|NCT02055352|40398162|FG000|Overall Study|Death|1|||
16527891|NCT02055352|40398163|FG001|Overall Study|Death|2|||
16527892|NCT02055352|40398162|FG000|Overall Study|Patient decision|1|||
16527893|NCT02055352|40398163|FG001|Overall Study|Patient decision|1|||
16527894|NCT02055352|40398162|FG000|Overall Study|Use of prohibited treatment|0|||
16527895|NCT02055352|40398163|FG001|Overall Study|Use of prohibited treatment|3|||
16527896|NCT02055352|40398162|FG000|Overall Study|AE, study drug would be detrimental|1|||
16527897|NCT02055352|40398163|FG001|Overall Study|AE, study drug would be detrimental|3|||
16527898|NCT02055352|40398162|FG000|Overall Study|Withdrawal of informed consent|1|||
16527899|NCT02055352|40398163|FG001|Overall Study|Withdrawal of informed consent|0|||
16527900|NCT02055352|40398162|FG000|Overall Study|Reason unknown|1|||
16527901|NCT02055352|40398163|FG001|Overall Study|Reason unknown|5|||
16527902|NCT04001829|40398169|FG000|Overall Study|Never start protocol therapy|5|||
16527903|NCT04001829|40398170|FG001|Overall Study|Never start protocol therapy|5|||
16527904|NCT04001829|40398169|FG000|Overall Study|Adverse Event|11|||
16527905|NCT04001829|40398170|FG001|Overall Study|Adverse Event|7|||
16527906|NCT04001829|40398169|FG000|Overall Study|Alternative therapy|1|||
16527907|NCT04001829|40398170|FG001|Overall Study|Alternative therapy|2|||
16527908|NCT04001829|40398169|FG000|Overall Study|Disease progression/relapse|2|||
16098103|NCT02291861|38846986|FG001|Overall Study|Death|0|||
16527909|NCT04001829|40398170|FG001|Overall Study|Disease progression/relapse|1|||
16527910|NCT04001829|40398169|FG000|Overall Study|Other complicating disease|1|||
16527911|NCT04001829|40398170|FG001|Overall Study|Other complicating disease|0|||
16527912|NCT04001829|40398169|FG000|Overall Study|Withdrawal by Subject|1|||
16527913|NCT04001829|40398170|FG001|Overall Study|Withdrawal by Subject|4|||
16098104|NCT02291861|38846987|FG002|Overall Study|Death|1|||
16527914|NCT04001829|40398169|FG000|Overall Study|Ineligible|2|||
16527915|NCT04001829|40398170|FG001|Overall Study|Ineligible|2|||
16527916|NCT04001829|40398169|FG000|Overall Study|Reason missing due to delinquent data|1|||
16527917|NCT04001829|40398170|FG001|Overall Study|Reason missing due to delinquent data|0|||
16098105|NCT02291861|38846988|FG003|Overall Study|Death|1|||
16527918|NCT00898677|40398171|FG000|Overall Study|Adverse Event|0|||
16527919|NCT00898677|40398172|FG001|Overall Study|Adverse Event|0|||
16527920|NCT00898677|40398173|FG002|Overall Study|Adverse Event|1|||
16212031|NCT03099304|39255746|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
16527921|NCT00898677|40398174|FG003|Overall Study|Adverse Event|0|||
16527922|NCT00898677|40398171|FG000|Overall Study|Lost to Follow-up|0|||
16527923|NCT00898677|40398172|FG001|Overall Study|Lost to Follow-up|0|||
16527924|NCT00898677|40398173|FG002|Overall Study|Lost to Follow-up|2|||
16527925|NCT00898677|40398174|FG003|Overall Study|Lost to Follow-up|0|||
16527926|NCT00898677|40398171|FG000|Overall Study|Protocol Violation|1|||
16098106|NCT02291861|38846985|FG000|Overall Study|Protocol Violation|1|||
16098107|NCT02291861|38846986|FG001|Overall Study|Protocol Violation|0|||
16098108|NCT02291861|38846987|FG002|Overall Study|Protocol Violation|0|||
16098109|NCT02291861|38846988|FG003|Overall Study|Protocol Violation|1|||
16098110|NCT02291861|38846985|FG000|Overall Study|Withdrawal by Subject|1|||
16098111|NCT02291861|38846986|FG001|Overall Study|Withdrawal by Subject|2|||
16212032|NCT03099304|39255747|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
16212033|NCT03099304|39255748|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
16400128|NCT00734604|39944979|FG004|Overall Study|Lost to Follow-up|2|||
16212034|NCT03099304|39255749|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
16212035|NCT03099304|39255750|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
16212036|NCT03099304|39255751|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
16212037|NCT03099304|39255746|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
16212038|NCT03099304|39255747|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
16212039|NCT03099304|39255748|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
16212040|NCT03099304|39255749|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
16212041|NCT03099304|39255750|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
16212042|NCT03099304|39255751|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
16212043|NCT03099304|39255746|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
16212044|NCT03099304|39255747|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
16212045|NCT03099304|39255748|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
16212046|NCT03099304|39255749|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
16212047|NCT03099304|39255750|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
16212048|NCT03099304|39255751|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
16212049|NCT03099304|39255746|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
16212050|NCT03099304|39255747|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
16212051|NCT03099304|39255748|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
16212052|NCT03099304|39255749|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
16212053|NCT03099304|39255750|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
16212054|NCT03099304|39255751|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
16212055|NCT03099304|39255746|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
16212056|NCT03099304|39255747|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
16212057|NCT03099304|39255748|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
16212058|NCT03099304|39255749|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
16212059|NCT03099304|39255750|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
16212060|NCT03099304|39255751|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
16212061|NCT03099304|39255746|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
16212062|NCT03099304|39255747|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
16212063|NCT03099304|39255748|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
16212064|NCT03099304|39255749|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
16212065|NCT03099304|39255750|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
16212066|NCT03099304|39255751|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
16212067|NCT03099304|39255746|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
16212068|NCT03099304|39255747|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
16212069|NCT03099304|39255748|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
16212070|NCT03099304|39255749|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
16212071|NCT03099304|39255750|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
16212072|NCT03099304|39255751|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
16212073|NCT00445341|39255752|FG000|Overall Study|refused further treatment|1|||
16212074|NCT00445341|39255752|FG000|Overall Study|taken off treatment too early|1|||
16212075|NCT02741310|39255755|FG000|Overall Study|Sponsor Decision|2|||
16212076|NCT02741310|39255756|FG001|Overall Study|Sponsor Decision|2|||
16212077|NCT03864627|39255759|FG000|Overall Study|Adverse Event|0|||
16212078|NCT03864627|39255760|FG001|Overall Study|Adverse Event|1|||
16212079|NCT03864627|39255759|FG000|Overall Study|Lack of Efficacy|0|||
16212080|NCT03864627|39255760|FG001|Overall Study|Lack of Efficacy|1|||
16212081|NCT03864627|39255759|FG000|Overall Study|Lost to Follow-up|0|||
16400129|NCT00734604|39944980|FG005|Overall Study|Lost to Follow-up|3|||
16400130|NCT00734604|39944975|FG000|Overall Study|Physician Decision|0|||
16527927|NCT00898677|40398172|FG001|Overall Study|Protocol Violation|1|||
16527928|NCT00898677|40398173|FG002|Overall Study|Protocol Violation|2|||
16527929|NCT00898677|40398174|FG003|Overall Study|Protocol Violation|0|||
16098112|NCT02291861|38846987|FG002|Overall Study|Withdrawal by Subject|1|||
16527930|NCT00898677|40398171|FG000|Overall Study|Withdrawal by Subject|0|||
16527931|NCT00898677|40398172|FG001|Overall Study|Withdrawal by Subject|0|||
16527932|NCT00898677|40398173|FG002|Overall Study|Withdrawal by Subject|0|||
16527933|NCT00898677|40398174|FG003|Overall Study|Withdrawal by Subject|1|||
16527934|NCT00898677|40398171|FG000|Overall Study|Not Treated: Adverse Event|0|||
16527935|NCT00898677|40398172|FG001|Overall Study|Not Treated: Adverse Event|2|||
16527936|NCT00898677|40398173|FG002|Overall Study|Not Treated: Adverse Event|1|||
16527937|NCT00898677|40398174|FG003|Overall Study|Not Treated: Adverse Event|0|||
16527938|NCT00898677|40398171|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
16527939|NCT00898677|40398172|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
16527940|NCT00898677|40398173|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
16527941|NCT00898677|40398174|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
16527942|NCT00898677|40398171|FG000|Overall Study|Not Treated: Pregnancy|0|||
16527943|NCT00898677|40398172|FG001|Overall Study|Not Treated: Pregnancy|0|||
16527944|NCT00898677|40398173|FG002|Overall Study|Not Treated: Pregnancy|1|||
16527945|NCT00898677|40398174|FG003|Overall Study|Not Treated: Pregnancy|0|||
16527946|NCT00898677|40398171|FG000|Overall Study|Not Treated: Protocol Violation|2|||
16527947|NCT00898677|40398172|FG001|Overall Study|Not Treated: Protocol Violation|0|||
16400131|NCT00734604|39944976|FG001|Overall Study|Physician Decision|1|||
16400132|NCT00734604|39944977|FG002|Overall Study|Physician Decision|1|||
16400133|NCT00734604|39944978|FG003|Overall Study|Physician Decision|0|||
16400134|NCT00734604|39944979|FG004|Overall Study|Physician Decision|0|||
16400135|NCT00734604|39944980|FG005|Overall Study|Physician Decision|0|||
16400136|NCT00734604|39944975|FG000|Overall Study|Protocol Violation|0|||
16400137|NCT00734604|39944976|FG001|Overall Study|Protocol Violation|2|||
16400138|NCT00734604|39944977|FG002|Overall Study|Protocol Violation|0|||
16400139|NCT00734604|39944978|FG003|Overall Study|Protocol Violation|0|||
16400140|NCT00734604|39944979|FG004|Overall Study|Protocol Violation|1|||
16400141|NCT00734604|39944980|FG005|Overall Study|Protocol Violation|0|||
16400142|NCT00734604|39944975|FG000|Overall Study|Sponsor Decision|1|||
16400143|NCT00734604|39944976|FG001|Overall Study|Sponsor Decision|2|||
16212082|NCT03864627|39255760|FG001|Overall Study|Lost to Follow-up|1|||
16400144|NCT00734604|39944977|FG002|Overall Study|Sponsor Decision|1|||
16400145|NCT00734604|39944978|FG003|Overall Study|Sponsor Decision|0|||
16400146|NCT00734604|39944979|FG004|Overall Study|Sponsor Decision|2|||
16400147|NCT00734604|39944980|FG005|Overall Study|Sponsor Decision|0|||
16400148|NCT00734604|39944975|FG000|Overall Study|Withdrawal by Subject|0|||
16400149|NCT00734604|39944976|FG001|Overall Study|Withdrawal by Subject|2|||
16400150|NCT00734604|39944977|FG002|Overall Study|Withdrawal by Subject|0|||
16400151|NCT00734604|39944978|FG003|Overall Study|Withdrawal by Subject|1|||
16400152|NCT00734604|39944979|FG004|Overall Study|Withdrawal by Subject|2|||
16400153|NCT00734604|39944980|FG005|Overall Study|Withdrawal by Subject|1|||
16400154|NCT00734604|39944975|FG000|Overall Study|Lack of Efficacy|0|||
16400155|NCT00734604|39944976|FG001|Overall Study|Lack of Efficacy|1|||
16400156|NCT00734604|39944977|FG002|Overall Study|Lack of Efficacy|1|||
16400157|NCT00734604|39944978|FG003|Overall Study|Lack of Efficacy|0|||
16400158|NCT00734604|39944979|FG004|Overall Study|Lack of Efficacy|0|||
16400159|NCT00734604|39944980|FG005|Overall Study|Lack of Efficacy|0|||
16400160|NCT00281099|39944981|FG000|Overall Study|Death|46|||
16400161|NCT00281099|39944982|FG001|Overall Study|Death|57|||
16400162|NCT00281099|39944981|FG000|Overall Study|Lost to Follow-up|10|||
16400163|NCT00281099|39944982|FG001|Overall Study|Lost to Follow-up|19|||
16400164|NCT00281099|39944981|FG000|Overall Study|Withdrawal by Subject|65|||
16400165|NCT00281099|39944982|FG001|Overall Study|Withdrawal by Subject|70|||
16400166|NCT00281099|39944981|FG000|Overall Study|Physician Decision|79|||
16400167|NCT00281099|39944982|FG001|Overall Study|Physician Decision|72|||
16400168|NCT00281099|39944981|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
16400169|NCT00281099|39944982|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
16400170|NCT00904670|39944986|FG000|Open Label Phase|Withdrawal by Subject|2|||
16400171|NCT00904670|39944987|FG001|Open Label Phase|Withdrawal by Subject|0|||
16400172|NCT00904670|39944986|FG000|Open Label Phase|Adverse Event|2|||
16400173|NCT00904670|39944987|FG001|Open Label Phase|Adverse Event|0|||
16400174|NCT00904670|39944986|FG000|Open Label Phase|Lack of Efficacy|1|||
16400175|NCT00904670|39944987|FG001|Open Label Phase|Lack of Efficacy|0|||
16400176|NCT00904670|39944986|FG000|Open Label Phase|Lost to Follow-up|1|||
16400177|NCT00904670|39944987|FG001|Open Label Phase|Lost to Follow-up|0|||
16400178|NCT00118846|39944988|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
16527948|NCT00898677|40398173|FG002|Overall Study|Not Treated: Protocol Violation|2|||
16527949|NCT00898677|40398174|FG003|Overall Study|Not Treated: Protocol Violation|0|||
16400179|NCT00118846|39944989|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
16409982|NCT02536300|39981855|FG001|Overall Study|Study Terminated by Sponsor|4|||
16527950|NCT00898677|40398171|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
16527951|NCT00898677|40398172|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
16527952|NCT00898677|40398173|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
16527953|NCT00898677|40398174|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
16527954|NCT00898677|40398171|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
16527955|NCT00898677|40398172|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
16527956|NCT00898677|40398173|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
16527957|NCT00898677|40398174|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
16527958|NCT00898677|40398171|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
16527959|NCT00898677|40398172|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
16527960|NCT00898677|40398173|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
16527961|NCT00898677|40398174|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
16527962|NCT00898677|40398171|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
16527963|NCT00898677|40398172|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
16527964|NCT00898677|40398173|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
16527965|NCT00898677|40398174|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
16527966|NCT00898677|40398171|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
16527967|NCT00898677|40398172|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
16527968|NCT00898677|40398173|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
16527969|NCT00898677|40398174|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
16527970|NCT00898677|40398171|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
16527971|NCT00898677|40398172|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
16527972|NCT00898677|40398173|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
16527973|NCT00898677|40398174|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
16527974|NCT00898677|40398171|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
16527975|NCT00898677|40398172|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
16527976|NCT00898677|40398173|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
16527977|NCT00898677|40398174|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
16527978|NCT03478891|40398176|FG000|Overall Study|Enrolled, but product never administered|0|||
16527979|NCT03478891|40398177|FG001|Overall Study|Enrolled, but product never administered|0|||
16527980|NCT03478891|40398178|FG002|Overall Study|Enrolled, but product never administered|1|||
16527981|NCT03478891|40398176|FG000|Overall Study|Moved from area|0|||
16330765|NCT00622336|39696372|FG000|Treatment Phase|Other|40|||
16330766|NCT00622336|39696372|FG000|Treatment Phase|Death|14|||
16330767|NCT00622336|39696372|FG000|Treatment Phase|Lack of therapeutic effect|13|||
16330768|NCT00622336|39696372|FG000|Treatment Phase|Withdrawal by Subject|13|||
16330769|NCT00622336|39696372|FG000|Treatment Phase|Lost to Follow-up|2|||
16330770|NCT00622336|39696372|FG000|Extension Phase|Adverse Event|2|||
16330771|NCT00622336|39696372|FG000|Extension Phase|Progressive Disease|6|||
16330772|NCT00622336|39696372|FG000|Extension Phase|Lack of therapeutic effect|2|||
16330773|NCT00622336|39696372|FG000|Extension Phase|Withdrawal by Subject|1|||
16330774|NCT00622336|39696372|FG000|Extension Phase|Lost to Follow-up|1|||
16330775|NCT00622336|39696372|FG000|Extension Phase|Other|9|||
16330776|NCT01286168|39696373|FG000|Overall Study|Withdrawal by Subject|1|||
16330777|NCT01286168|39696373|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
16330778|NCT03408444|39696376|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
16330779|NCT03408444|39696377|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
16330780|NCT03408444|39696378|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
16330781|NCT03408444|39696379|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
16330782|NCT03408444|39696376|FG000|Overall Study|Lens Discomfort|0|||
16330783|NCT03408444|39696377|FG001|Overall Study|Lens Discomfort|1|||
16330784|NCT03408444|39696378|FG002|Overall Study|Lens Discomfort|0|||
16330785|NCT03408444|39696379|FG003|Overall Study|Lens Discomfort|0|||
16330786|NCT03408444|39696376|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
16330787|NCT03408444|39696377|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
16330788|NCT03408444|39696378|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
16527982|NCT03478891|40398177|FG001|Overall Study|Moved from area|0|||
16527983|NCT03478891|40398178|FG002|Overall Study|Moved from area|1|||
16527984|NCT03478891|40398176|FG000|Overall Study|Lost to Follow-up|1|||
16527985|NCT03478891|40398177|FG001|Overall Study|Lost to Follow-up|0|||
16527986|NCT03478891|40398178|FG002|Overall Study|Lost to Follow-up|1|||
16527987|NCT03794089|40398179|FG000|Overall Study|Lost to Follow-up|4|||
16527988|NCT03794089|40398180|FG001|Overall Study|Lost to Follow-up|1|||
16527989|NCT03794089|40398179|FG000|Overall Study|Withdrawal by Subject|2|||
16527990|NCT03794089|40398180|FG001|Overall Study|Withdrawal by Subject|0|||
16527991|NCT01226745|40398186|FG000|Overall Study|Did not complete schedule of assessments|8|||
16527992|NCT01226745|40398187|FG001|Overall Study|Did not complete schedule of assessments|3|||
16330789|NCT03408444|39696379|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
16527993|NCT01226745|40398188|FG002|Overall Study|Did not complete schedule of assessments|6|||
16527994|NCT01226745|40398189|FG003|Overall Study|Did not complete schedule of assessments|0|||
16527995|NCT01226745|40398190|FG004|Overall Study|Did not complete schedule of assessments|0|||
16527996|NCT01226745|40398191|FG005|Overall Study|Did not complete schedule of assessments|1|||
16330790|NCT03408444|39696376|FG000|Overall Study|Withdrawal by Subject|0|||
16527997|NCT01226745|40398186|FG000|Overall Study|Lost to Follow-up|2|||
16527998|NCT01226745|40398187|FG001|Overall Study|Lost to Follow-up|6|||
16527999|NCT01226745|40398188|FG002|Overall Study|Lost to Follow-up|6|||
16528000|NCT01226745|40398189|FG003|Overall Study|Lost to Follow-up|1|||
16528001|NCT01226745|40398190|FG004|Overall Study|Lost to Follow-up|1|||
16528002|NCT01226745|40398191|FG005|Overall Study|Lost to Follow-up|2|||
16528003|NCT01226745|40398186|FG000|Overall Study|Death|1|||
16528004|NCT01226745|40398187|FG001|Overall Study|Death|0|||
16528005|NCT01226745|40398188|FG002|Overall Study|Death|0|||
16528006|NCT01226745|40398189|FG003|Overall Study|Death|0|||
16528007|NCT01226745|40398190|FG004|Overall Study|Death|0|||
16528008|NCT01226745|40398191|FG005|Overall Study|Death|1|||
16528009|NCT01226745|40398186|FG000|Overall Study|Other|6|||
16528010|NCT01226745|40398187|FG001|Overall Study|Other|7|||
16528011|NCT01226745|40398188|FG002|Overall Study|Other|8|||
16528012|NCT01226745|40398189|FG003|Overall Study|Other|4|||
16528013|NCT01226745|40398190|FG004|Overall Study|Other|3|||
16330791|NCT03408444|39696377|FG001|Overall Study|Withdrawal by Subject|2|||
16528014|NCT01226745|40398191|FG005|Overall Study|Other|1|||
16528015|NCT01178853|40398193|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
16528016|NCT01178853|40398194|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
16528017|NCT01178853|40398193|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
16528018|NCT01178853|40398194|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
16528019|NCT01178853|40398193|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
16528020|NCT01178853|40398194|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
16528021|NCT01178853|40398193|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
16528022|NCT01178853|40398194|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
16528023|NCT01178853|40398193|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
16528024|NCT01178853|40398194|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
16528025|NCT02896855|40398197|FG000|Overall Study|Death|50|||
16528026|NCT02896855|40398198|FG001|Overall Study|Death|40|||
16528027|NCT02896855|40398197|FG000|Overall Study|Lost to Follow-up|15|||
16528028|NCT02896855|40398198|FG001|Overall Study|Lost to Follow-up|9|||
16528029|NCT02896855|40398197|FG000|Overall Study|Withdrawal by Subject|7|||
16528030|NCT02896855|40398198|FG001|Overall Study|Withdrawal by Subject|4|||
16528031|NCT02308033|40398199|FG000|Overall Study|Normal Gram stain at Baseline|13|||
16528032|NCT02308033|40398200|FG001|Overall Study|Normal Gram stain at Baseline|10|||
16528033|NCT02308033|40398199|FG000|Overall Study|Positive for STD at Baseline|7|||
16528034|NCT02308033|40398200|FG001|Overall Study|Positive for STD at Baseline|4|||
16528035|NCT02308033|40398199|FG000|Overall Study|Lost to Follow-up|6|||
16528036|NCT02308033|40398200|FG001|Overall Study|Lost to Follow-up|5|||
16528037|NCT00237744|40398201|FG000|Overall Study|Withdrawal by Subject|3|||
16528038|NCT00237744|40398202|FG001|Overall Study|Withdrawal by Subject|1|||
16528039|NCT00237744|40398203|FG002|Overall Study|Withdrawal by Subject|0|||
16528040|NCT01438411|40398206|FG000|Overall Study|Adverse Event|8|||
16528041|NCT01438411|40398206|FG000|Overall Study|Lost to Follow-up|1|||
16528042|NCT01438411|40398206|FG000|Overall Study|Lack of Efficacy|1|||
16528043|NCT01438411|40398206|FG000|Overall Study|Withdrawal by Subject|3|||
16528044|NCT00833989|40398207|FG000|Overall Study|Physician Decision|0|||
16528045|NCT00833989|40398208|FG001|Overall Study|Physician Decision|0|||
16528046|NCT00833989|40398209|FG002|Overall Study|Physician Decision|0|||
16528047|NCT00833989|40398210|FG003|Overall Study|Physician Decision|1|||
16528048|NCT00833989|40398207|FG000|Overall Study|Withdrawal by Subject|3|||
16528049|NCT00833989|40398208|FG001|Overall Study|Withdrawal by Subject|0|||
16528050|NCT00833989|40398209|FG002|Overall Study|Withdrawal by Subject|1|||
16528051|NCT00833989|40398210|FG003|Overall Study|Withdrawal by Subject|1|||
16528052|NCT02121847|40398212|FG000|Overall Study|Administrative Reasons|1|||
16528053|NCT02121847|40398212|FG000|Overall Study|Adverse Event|2|||
16528054|NCT01196975|40398213|FG000|Overall Study|Adverse Event|2|||
16528055|NCT01196975|40398214|FG001|Overall Study|Adverse Event|2|||
16528056|NCT01196975|40398215|FG002|Overall Study|Adverse Event|0|||
16528057|NCT01196975|40398216|FG003|Overall Study|Adverse Event|0|||
16528058|NCT01196975|40398217|FG004|Overall Study|Adverse Event|2|||
16528059|NCT01196975|40398213|FG000|Overall Study|Withdrawal by Subject|2|||
16528060|NCT01196975|40398214|FG001|Overall Study|Withdrawal by Subject|1|||
16528061|NCT01196975|40398215|FG002|Overall Study|Withdrawal by Subject|0|||
16528062|NCT01196975|40398216|FG003|Overall Study|Withdrawal by Subject|1|||
16528063|NCT01196975|40398217|FG004|Overall Study|Withdrawal by Subject|0|||
16528064|NCT01196975|40398213|FG000|Overall Study|Lost to Follow-up|11|||
16528065|NCT01196975|40398214|FG001|Overall Study|Lost to Follow-up|6|||
16528066|NCT01196975|40398215|FG002|Overall Study|Lost to Follow-up|5|||
16528067|NCT01196975|40398216|FG003|Overall Study|Lost to Follow-up|5|||
16528068|NCT01196975|40398217|FG004|Overall Study|Lost to Follow-up|11|||
16528069|NCT02648698|40398218|FG000|Overall Study|Protocol Violation|1|||
16528070|NCT02648698|40398219|FG001|Overall Study|Protocol Violation|5|||
16528071|NCT04177758|40398220|FG000|Overall Study|Lost to Follow-up|19|||
16528072|NCT04177758|40398221|FG001|Overall Study|Lost to Follow-up|11|||
16528073|NCT02114892|40398222|FG000|Overall Study|Lost to Follow-up|1|||
16528074|NCT02114892|40398223|FG001|Overall Study|Lost to Follow-up|2|||
16528075|NCT00710424|40398224|FG000|Overall Study|Adverse Event|30|||
16528076|NCT00710424|40398225|FG001|Overall Study|Adverse Event|12|||
16528077|NCT00710424|40398224|FG000|Overall Study|Lack of Efficacy|4|||
16330792|NCT03408444|39696378|FG002|Overall Study|Withdrawal by Subject|3|||
16330793|NCT03408444|39696379|FG003|Overall Study|Withdrawal by Subject|0|||
16330794|NCT03408444|39696376|FG000|Overall Study|Lost to Follow-up|0|||
16212083|NCT03864627|39255759|FG000|Overall Study|Withdrawal by Subject|4|||
16212084|NCT03864627|39255760|FG001|Overall Study|Withdrawal by Subject|8|||
16212085|NCT03864627|39255759|FG000|Overall Study|Study terminated by sponsor|0|||
16212086|NCT03864627|39255760|FG001|Overall Study|Study terminated by sponsor|1|||
16528078|NCT00710424|40398225|FG001|Overall Study|Lack of Efficacy|5|||
16330795|NCT03408444|39696377|FG001|Overall Study|Lost to Follow-up|0|||
16330796|NCT03408444|39696378|FG002|Overall Study|Lost to Follow-up|1|||
16330797|NCT03408444|39696379|FG003|Overall Study|Lost to Follow-up|0|||
16330798|NCT03408444|39696376|FG000|Overall Study|Adverse Event|0|||
16330799|NCT03408444|39696377|FG001|Overall Study|Adverse Event|0|||
16528079|NCT00710424|40398224|FG000|Overall Study|Withdrawal by Subject|5|||
16528080|NCT00710424|40398225|FG001|Overall Study|Withdrawal by Subject|3|||
16212087|NCT02940860|39255761|FG000|Overall Study|Non-serious AE|1|||
16212088|NCT02940860|39255762|FG001|Overall Study|Non-serious AE|2|||
16212089|NCT02940860|39255761|FG000|Overall Study|Serious AE|7|||
16212090|NCT02940860|39255762|FG001|Overall Study|Serious AE|3|||
16212091|NCT02940860|39255761|FG000|Overall Study|Withdrawal by Subject|19|||
16212092|NCT02940860|39255762|FG001|Overall Study|Withdrawal by Subject|9|||
16212093|NCT02940860|39255761|FG000|Overall Study|Lost to Follow-up|13|||
16212094|NCT02940860|39255762|FG001|Overall Study|Lost to Follow-up|7|||
16212095|NCT02940860|39255761|FG000|Overall Study|Physician Decision|5|||
16212096|NCT02940860|39255762|FG001|Overall Study|Physician Decision|3|||
16212097|NCT02940860|39255761|FG000|Overall Study|Sponsor Decision|0|||
16212098|NCT02940860|39255762|FG001|Overall Study|Sponsor Decision|1|||
16212099|NCT02940860|39255761|FG000|Overall Study|Protocol Violation|0|||
16212100|NCT02940860|39255762|FG001|Overall Study|Protocol Violation|2|||
16212101|NCT02940860|39255761|FG000|Overall Study|Death|3|||
16212102|NCT02940860|39255762|FG001|Overall Study|Death|2|||
16212103|NCT02940860|39255761|FG000|Overall Study|Moved, poor venous access, transport|6|||
16212104|NCT02940860|39255762|FG001|Overall Study|Moved, poor venous access, transport|4|||
16212105|NCT02940860|39255761|FG000|Overall Study|Not treated|2|||
16212106|NCT02940860|39255762|FG001|Overall Study|Not treated|2|||
16212107|NCT02975349|39255767|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16212108|NCT02975349|39255768|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16212109|NCT02975349|39255769|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
16212110|NCT02975349|39255770|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
16212111|NCT02975349|39255771|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16212112|NCT02975349|39255772|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16212113|NCT02975349|39255767|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
16212114|NCT02975349|39255768|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16212115|NCT02975349|39255769|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16212116|NCT02975349|39255770|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16212117|NCT02975349|39255771|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16212118|NCT02975349|39255772|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16212119|NCT02975349|39255767|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
16212120|NCT02975349|39255768|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
16212121|NCT02975349|39255769|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
16212122|NCT02975349|39255770|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
16330800|NCT03408444|39696378|FG002|Overall Study|Adverse Event|0|||
16330801|NCT03408444|39696379|FG003|Overall Study|Adverse Event|1|||
16330802|NCT03408444|39696376|FG000|Overall Study|Lens Handling Difficulties|0|||
16330803|NCT03408444|39696377|FG001|Overall Study|Lens Handling Difficulties|0|||
16528081|NCT00710424|40398224|FG000|Overall Study|Lost to Follow-up|0|||
16528082|NCT00710424|40398225|FG001|Overall Study|Lost to Follow-up|1|||
16528083|NCT00710424|40398224|FG000|Overall Study|Refused medication, no side effects|1|||
16528084|NCT00710424|40398225|FG001|Overall Study|Refused medication, no side effects|0|||
16212123|NCT02975349|39255771|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
16212124|NCT02975349|39255772|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
16212125|NCT02975349|39255767|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
16212126|NCT02975349|39255768|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
16212127|NCT02975349|39255769|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
16212128|NCT02975349|39255770|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
16528085|NCT00710424|40398224|FG000|Overall Study|Non-compliance with stable analgesia|1|||
16528086|NCT00710424|40398225|FG001|Overall Study|Non-compliance with stable analgesia|0|||
16528087|NCT00710424|40398224|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
16212129|NCT02975349|39255771|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
16212130|NCT02975349|39255772|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
16212131|NCT02975349|39255767|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
16212132|NCT02975349|39255768|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
16212133|NCT02975349|39255769|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
16212134|NCT02975349|39255770|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
16212135|NCT02975349|39255771|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
16212136|NCT02975349|39255772|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
16212137|NCT02975349|39255767|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
16212138|NCT02975349|39255768|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
16212139|NCT02975349|39255769|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
16212140|NCT02975349|39255770|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
16212141|NCT02975349|39255771|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
16212142|NCT02975349|39255772|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
16212143|NCT02975349|39255767|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
16212144|NCT02975349|39255768|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
16212145|NCT02975349|39255769|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
16212146|NCT02975349|39255770|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
16212147|NCT02975349|39255771|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
16212148|NCT02975349|39255772|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
16212149|NCT02975349|39255767|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
16212150|NCT02975349|39255768|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
16212151|NCT02975349|39255769|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
16212152|NCT02975349|39255770|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
16212153|NCT02975349|39255771|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
16212154|NCT02975349|39255772|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
16528088|NCT00710424|40398225|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
16528089|NCT00710424|40398224|FG000|Overall Study|Subject thought medication changed|1|||
16528090|NCT00710424|40398225|FG001|Overall Study|Subject thought medication changed|0|||
16528091|NCT00710424|40398224|FG000|Overall Study|Ceased treatment due to travel|1|||
16528092|NCT00710424|40398225|FG001|Overall Study|Ceased treatment due to travel|0|||
16528093|NCT00710424|40398224|FG000|Overall Study|Subject preferred paracetamol|0|||
16528094|NCT00710424|40398225|FG001|Overall Study|Subject preferred paracetamol|1|||
16528095|NCT00710424|40398224|FG000|Overall Study|Felt good so stopped treatment|0|||
16528096|NCT00710424|40398225|FG001|Overall Study|Felt good so stopped treatment|1|||
16528097|NCT01389973|40398230|FG000|Overall Study|Lost to Follow-up|1|||
16528098|NCT01389973|40398230|FG000|Overall Study|Trial Stopped by Sponsor|9|||
16528099|NCT01389973|40398230|FG000|Overall Study|Other|10|||
16528100|NCT03152552|40398231|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
16528101|NCT03152552|40398232|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
16528102|NCT03152552|40398233|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
16528103|NCT03152552|40398234|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
16528104|NCT03152552|40398235|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
16528105|NCT03152552|40398231|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
16528106|NCT03152552|40398232|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
16528107|NCT03152552|40398233|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
16528108|NCT03152552|40398234|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
16528109|NCT03152552|40398235|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
16528110|NCT03152552|40398231|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
16528111|NCT03152552|40398232|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
16528112|NCT03152552|40398233|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
16528113|NCT03152552|40398234|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
16528114|NCT03152552|40398235|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
16528115|NCT03152552|40398231|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16528116|NCT03152552|40398232|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16528117|NCT03152552|40398233|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
16528118|NCT03152552|40398234|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16528119|NCT03152552|40398235|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16528120|NCT03152552|40398231|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
16528121|NCT03152552|40398232|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
16528122|NCT03152552|40398233|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
16528123|NCT03152552|40398234|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
16528124|NCT03152552|40398235|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
16528125|NCT03152552|40398231|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
16528126|NCT03152552|40398232|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
16528127|NCT03152552|40398233|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
16212155|NCT02975349|39255767|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
16212156|NCT02975349|39255768|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
16212157|NCT02975349|39255769|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
16212158|NCT02975349|39255770|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
16212159|NCT02975349|39255771|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
16212160|NCT02975349|39255772|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
16212161|NCT00324740|39255773|FG000|Overall Study|Withdrawal by Subject|1|||
16212162|NCT00324740|39255774|FG001|Overall Study|Withdrawal by Subject|0|||
16212163|NCT00324740|39255775|FG002|Overall Study|Withdrawal by Subject|1|||
16212164|NCT02829775|39255776|FG000|Overall Study|Death|1|||
16212165|NCT02829775|39255776|FG000|Overall Study|Withdrawal by Subject|3|||
16212166|NCT02829775|39255776|FG000|Overall Study|Disease remission|1|||
16212167|NCT04624672|39255777|FG000|Overall Study|Early Study Closure|2|||
16212168|NCT04624672|39255778|FG001|Overall Study|Early Study Closure|1|||
16212169|NCT02348840|39255779|FG000|Overall Study|Withdrawal by Subject|2|||
16212170|NCT02348840|39255780|FG001|Overall Study|Withdrawal by Subject|1|||
16212171|NCT02348840|39255781|FG002|Overall Study|Withdrawal by Subject|0|||
16212172|NCT02348840|39255782|FG003|Overall Study|Withdrawal by Subject|0|||
16212173|NCT02903368|39255783|FG000|Part 1|Adverse Event|3|||
16212174|NCT02903368|39255784|FG001|Part 1|Adverse Event|0|||
16212175|NCT02903368|39255785|FG002|Part 1|Adverse Event|0|||
16212176|NCT02903368|39255786|FG003|Part 1|Adverse Event|0|||
16212177|NCT02903368|39255783|FG000|Part 1|Withdrawal by Subject|1|||
16212178|NCT02903368|39255784|FG001|Part 1|Withdrawal by Subject|0|||
16212179|NCT02903368|39255785|FG002|Part 1|Withdrawal by Subject|0|||
16212180|NCT02903368|39255786|FG003|Part 1|Withdrawal by Subject|0|||
16212181|NCT02903368|39255783|FG000|Part 2|Adverse Event|0|||
16212182|NCT02903368|39255784|FG001|Part 2|Adverse Event|0|||
16212183|NCT02903368|39255785|FG002|Part 2|Adverse Event|5|||
16212184|NCT02903368|39255786|FG003|Part 2|Adverse Event|0|||
16212185|NCT02903368|39255783|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
16212186|NCT02903368|39255784|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
16212187|NCT02903368|39255785|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
16212188|NCT02903368|39255786|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
16212189|NCT02903368|39255783|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
16212190|NCT02903368|39255784|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
16212191|NCT02903368|39255785|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
16212192|NCT02903368|39255786|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
16212193|NCT02903368|39255783|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
16212194|NCT02903368|39255784|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
16212195|NCT02903368|39255785|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
16212196|NCT02903368|39255786|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
16212197|NCT02187224|39255787|FG000|Overall Study|Did not show up for test day|1|||
16212198|NCT02187224|39255788|FG001|Overall Study|Did not show up for test day|0|||
16212199|NCT02025530|39255789|FG000|Overall Study|No longer met elligibility criteria|5|||
16212200|NCT02025530|39255790|FG001|Overall Study|No longer met elligibility criteria|1|||
16212201|NCT02959970|39255793|FG000|Overall Study|Adverse Event|1|||
16212202|NCT02959970|39255794|FG001|Overall Study|Adverse Event|0|||
16212203|NCT02959970|39255793|FG000|Overall Study|Withdrawal by Subject|0|||
16212204|NCT02959970|39255794|FG001|Overall Study|Withdrawal by Subject|2|||
16212205|NCT02959970|39255793|FG000|Overall Study|Lost to Follow-up|1|||
16212206|NCT02959970|39255794|FG001|Overall Study|Lost to Follow-up|5|||
16212207|NCT00106249|39255795|FG000|Overall Study|Lost to Follow-up|3|||
16212208|NCT00106249|39255796|FG001|Overall Study|Lost to Follow-up|2|||
16212209|NCT03887052|39255799|FG000|Overall Study|Adverse Event|2|||
16400180|NCT00118846|39944988|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
16400181|NCT00118846|39944989|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
16400182|NCT00118846|39944988|FG000|Overall Study|Physician Decision|1|||
16212210|NCT03887052|39255799|FG000|Overall Study|Physician Decision|2|||
16212211|NCT03887052|39255799|FG000|Overall Study|Withdrawal by Subject|3|||
16212212|NCT03887052|39255799|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
16212213|NCT03887052|39255799|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
16212214|NCT02100813|39258601|FG000|Overall Study|Adverse Event|0|||
16400183|NCT00118846|39944989|FG001|Overall Study|Physician Decision|0|||
16400184|NCT00118846|39944988|FG000|Overall Study|Medical condition|2|||
16400185|NCT00118846|39944989|FG001|Overall Study|Medical condition|2|||
16400186|NCT00118846|39944988|FG000|Overall Study|Lost to Follow-up|0|||
16400187|NCT00118846|39944989|FG001|Overall Study|Lost to Follow-up|2|||
16400188|NCT00118846|39944988|FG000|Overall Study|Personal reason|4|||
16400189|NCT00118846|39944989|FG001|Overall Study|Personal reason|5|||
16400190|NCT03928418|39944990|FG000|Overall Study|Lost to Follow-up|5|||
16400191|NCT03928418|39944991|FG001|Overall Study|Lost to Follow-up|3|||
16400192|NCT03928418|39944992|FG002|Overall Study|Lost to Follow-up|5|||
16400193|NCT03928418|39944990|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
16400194|NCT03928418|39944991|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
16400195|NCT03928418|39944992|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
16400196|NCT00316225|39944993|FG000|Overall Study|Adverse Event|2|||
16400197|NCT00316225|39944993|FG000|Overall Study|Physician Decision|3|||
16400198|NCT00316225|39944993|FG000|Overall Study|Progressive Disease|15|||
16212215|NCT02100813|39258602|FG001|Overall Study|Adverse Event|0|||
16212216|NCT02100813|39258603|FG002|Overall Study|Adverse Event|0|||
16212217|NCT02100813|39258604|FG003|Overall Study|Adverse Event|0|||
16212218|NCT02100813|39258605|FG004|Overall Study|Adverse Event|0|||
16212219|NCT02100813|39258606|FG005|Overall Study|Adverse Event|0|||
16212220|NCT02100813|39258607|FG006|Overall Study|Adverse Event|0|||
16400199|NCT00316225|39944993|FG000|Overall Study|Withdrawal by Subject|3|||
16400200|NCT00316225|39944993|FG000|Overall Study|Death|2|||
16528128|NCT03152552|40398234|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
16528129|NCT03152552|40398235|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
16528130|NCT03152552|40398231|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
16528131|NCT03152552|40398232|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
16528132|NCT03152552|40398233|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
16528133|NCT03152552|40398234|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
16528134|NCT03152552|40398235|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
16528135|NCT01985126|40398236|FG000|Overall Study|Death|15|||
16528136|NCT01985126|40398237|FG001|Overall Study|Death|69|||
16528137|NCT01985126|40398236|FG000|Overall Study|Lost to Follow-up|0|||
16528138|NCT01985126|40398237|FG001|Overall Study|Lost to Follow-up|8|||
16098113|NCT02291861|38846988|FG003|Overall Study|Withdrawal by Subject|4|||
16400201|NCT00549900|39944994|FG000|Overall Study|Adverse Event|1|||
16400202|NCT05286658|39944997|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
16400203|NCT05286658|39944997|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
16400204|NCT00721578|39944998|FG000|Overall Study|Death|1|||
16400205|NCT00721578|39944999|FG001|Overall Study|Death|1|||
16400206|NCT00721578|39944998|FG000|Overall Study|Withdrawal by Subject|1|||
16400207|NCT00721578|39944999|FG001|Overall Study|Withdrawal by Subject|1|||
16400208|NCT01885208|39945004|FG000|Overall Study|Unclassified|32|||
16400209|NCT01885208|39945005|FG001|Overall Study|Unclassified|38|||
16400210|NCT03215758|39945006|FG000|Overall Study|Technical Problems|1|||
16400211|NCT03215758|39945007|FG001|Overall Study|Technical Problems|0|||
16400212|NCT03215758|39945006|FG000|Overall Study|Protocol deviation|0|||
16400213|NCT03215758|39945007|FG001|Overall Study|Protocol deviation|1|||
16400214|NCT03215758|39945006|FG000|Overall Study|Physician Decision|0|||
16400215|NCT03215758|39945007|FG001|Overall Study|Physician Decision|1|||
16400216|NCT03215758|39945006|FG000|Overall Study|Death|0|||
16400217|NCT03215758|39945007|FG001|Overall Study|Death|1|||
16400218|NCT03215758|39945006|FG000|Overall Study|Adverse Event|1|||
16400219|NCT03215758|39945007|FG001|Overall Study|Adverse Event|2|||
16400220|NCT03215758|39945006|FG000|Overall Study|Subject/Guardian Decision|3|||
16400221|NCT03215758|39945007|FG001|Overall Study|Subject/Guardian Decision|3|||
16400222|NCT01667224|39945015|FG000|Overall Study|Withdrawal by Subject|3|||
16400223|NCT01667224|39945016|FG001|Overall Study|Withdrawal by Subject|1|||
16400224|NCT01667224|39945015|FG000|Overall Study|Protocol Violation|1|||
16400225|NCT01667224|39945016|FG001|Overall Study|Protocol Violation|1|||
16400226|NCT02266147|39945017|FG000|PART 1: Dose Escalation|Physician Decision|0|||
16400227|NCT02266147|39945018|FG001|PART 1: Dose Escalation|Physician Decision|0|||
16400228|NCT02266147|39945019|FG002|PART 1: Dose Escalation|Physician Decision|1|||
16400229|NCT02266147|39945020|FG003|PART 1: Dose Escalation|Physician Decision|0|||
16400230|NCT02266147|39945017|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
16400231|NCT02266147|39945018|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
16400232|NCT02266147|39945019|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
16528139|NCT01985126|40398236|FG000|Overall Study|Study Terminated By Sponsor|1|||
16528140|NCT01985126|40398237|FG001|Overall Study|Study Terminated By Sponsor|22|||
16098114|NCT02291861|38846985|FG000|Overall Study|Noncompliance|1|||
16212221|NCT02100813|39258608|FG007|Overall Study|Adverse Event|1|||
16400233|NCT02266147|39945020|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
16212222|NCT03050307|39258609|FG000|Overall Study|Adverse Event|4|||
16400234|NCT02266147|39945017|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
16400235|NCT02266147|39945018|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
16400236|NCT02266147|39945019|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
16400237|NCT02266147|39945020|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
16528141|NCT01985126|40398236|FG000|Overall Study|Withdrawal by Subject|2|||
16528142|NCT01985126|40398237|FG001|Overall Study|Withdrawal by Subject|7|||
16528143|NCT00856583|40398238|FG000|Overall Study|Lack of Efficacy|389|||
16528144|NCT00856583|40398239|FG001|Overall Study|Lack of Efficacy|377|||
16528145|NCT00856583|40398238|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
16528146|NCT00856583|40398239|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
16528147|NCT00856583|40398238|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
16528148|NCT00856583|40398239|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
16528149|NCT00856583|40398238|FG000|Overall Study|Non-compliance|305|||
16528150|NCT00856583|40398239|FG001|Overall Study|Non-compliance|262|||
16528151|NCT00856583|40398238|FG000|Overall Study|Withdrawal by Subject|1092|||
16528152|NCT00856583|40398239|FG001|Overall Study|Withdrawal by Subject|919|||
16528153|NCT00856583|40398238|FG000|Overall Study|Physician Decision|59|||
16528154|NCT00856583|40398239|FG001|Overall Study|Physician Decision|82|||
16528155|NCT00856583|40398238|FG000|Overall Study|Pregnancy|14|||
16528156|NCT00856583|40398239|FG001|Overall Study|Pregnancy|5|||
16528157|NCT00856583|40398238|FG000|Overall Study|Other|92|||
16528158|NCT00856583|40398239|FG001|Overall Study|Other|104|||
16528159|NCT00856583|40398238|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
16528160|NCT00856583|40398239|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
16400238|NCT02266147|39945017|FG000|PART 1: Dose Escalation|Other|1|||
16400239|NCT02266147|39945018|FG001|PART 1: Dose Escalation|Other|1|||
16400240|NCT02266147|39945019|FG002|PART 1: Dose Escalation|Other|0|||
16400241|NCT02266147|39945020|FG003|PART 1: Dose Escalation|Other|0|||
16400242|NCT02266147|39945017|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
16400243|NCT02266147|39945018|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
16400244|NCT02266147|39945019|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
16400245|NCT02266147|39945020|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
16400246|NCT02266147|39945017|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
16400247|NCT02266147|39945018|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
16400248|NCT02266147|39945019|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
16400249|NCT02266147|39945020|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
16400250|NCT00271856|39945025|FG000|Overall Study|Withdrawal by Subject|1|||
16400251|NCT00271856|39945026|FG001|Overall Study|Withdrawal by Subject|7|||
16400252|NCT00271856|39945025|FG000|Overall Study|Lost to Follow-up|10|||
16400253|NCT00271856|39945026|FG001|Overall Study|Lost to Follow-up|11|||
16400254|NCT02680041|39945029|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
16400255|NCT02680041|39945029|FG000|Overall Study|Lost to Follow-up|2|||
16400256|NCT00227344|39945038|FG000|Overall Study|study terminated early|12|||
16400257|NCT00227344|39945039|FG001|Overall Study|study terminated early|5|||
16400258|NCT01814878|39945040|FG000|Overall Study|Adverse Event|16|||
16400259|NCT01814878|39945041|FG001|Overall Study|Adverse Event|5|||
16400260|NCT01814878|39945040|FG000|Overall Study|Withdrawal by Subject|20|||
16400261|NCT01814878|39945041|FG001|Overall Study|Withdrawal by Subject|16|||
16400262|NCT01814878|39945040|FG000|Overall Study|Protocol Violation|5|||
16400263|NCT01814878|39945041|FG001|Overall Study|Protocol Violation|5|||
16400264|NCT01814878|39945040|FG000|Overall Study|Physician Decision|3|||
16400265|NCT01814878|39945041|FG001|Overall Study|Physician Decision|1|||
16400266|NCT01814878|39945040|FG000|Overall Study|Screening failure (drop-out)|0|||
16400267|NCT01814878|39945041|FG001|Overall Study|Screening failure (drop-out)|3|||
16400268|NCT01814878|39945040|FG000|Overall Study|Other|2|||
16400269|NCT01814878|39945041|FG001|Overall Study|Other|0|||
16400270|NCT01529515|39945042|FG000|TRANSITION PHASE|Adverse Event|16|||
16400271|NCT01529515|39945043|FG001|TRANSITION PHASE|Adverse Event|0|||
16400272|NCT01529515|39945044|FG002|TRANSITION PHASE|Adverse Event|0|||
16400273|NCT01529515|39945045|FG003|TRANSITION PHASE|Adverse Event|0|||
16400274|NCT01529515|39945042|FG000|TRANSITION PHASE|Death|1|||
16400275|NCT01529515|39945043|FG001|TRANSITION PHASE|Death|0|||
16400276|NCT01529515|39945044|FG002|TRANSITION PHASE|Death|0|||
16400277|NCT01529515|39945045|FG003|TRANSITION PHASE|Death|0|||
16400278|NCT01529515|39945042|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
16400279|NCT01529515|39945043|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
16528161|NCT00355082|40398240|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
16528162|NCT00355082|40398241|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
16528163|NCT00355082|40398242|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
16400280|NCT01529515|39945044|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
16400281|NCT01529515|39945045|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
16400282|NCT01529515|39945042|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
16400283|NCT01529515|39945043|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
16400284|NCT01529515|39945044|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
16400285|NCT01529515|39945045|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
16400286|NCT01529515|39945042|FG000|TRANSITION PHASE|Protocol Violation|4|||
16400287|NCT01529515|39945043|FG001|TRANSITION PHASE|Protocol Violation|0|||
16400288|NCT01529515|39945044|FG002|TRANSITION PHASE|Protocol Violation|0|||
16400289|NCT01529515|39945045|FG003|TRANSITION PHASE|Protocol Violation|0|||
16400290|NCT01529515|39945042|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
16400291|NCT01529515|39945043|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
16330804|NCT03408444|39696378|FG002|Overall Study|Lens Handling Difficulties|1|||
16330805|NCT03408444|39696379|FG003|Overall Study|Lens Handling Difficulties|0|||
16330806|NCT03408444|39696376|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
16330807|NCT03408444|39696377|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
16330808|NCT03408444|39696378|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
16330809|NCT03408444|39696379|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
16330810|NCT03673345|39696380|FG000|Overall Study|Lost to Follow-up|1|||
16330811|NCT03673345|39696381|FG001|Overall Study|Lost to Follow-up|0|||
16330812|NCT03673345|39696382|FG002|Overall Study|Lost to Follow-up|3|||
16330813|NCT03673345|39696383|FG003|Overall Study|Lost to Follow-up|3|||
16330814|NCT03673345|39696384|FG004|Overall Study|Lost to Follow-up|2|||
16330815|NCT03673345|39696385|FG005|Overall Study|Lost to Follow-up|1|||
16330816|NCT03673345|39696386|FG006|Overall Study|Lost to Follow-up|0|||
16330817|NCT03673345|39696387|FG007|Overall Study|Lost to Follow-up|0|||
16330818|NCT03673345|39696380|FG000|Overall Study|Withdrawal by Subject|1|||
16330819|NCT03673345|39696381|FG001|Overall Study|Withdrawal by Subject|0|||
16330820|NCT03673345|39696382|FG002|Overall Study|Withdrawal by Subject|4|||
16330821|NCT03673345|39696383|FG003|Overall Study|Withdrawal by Subject|2|||
16330822|NCT03673345|39696384|FG004|Overall Study|Withdrawal by Subject|0|||
16330823|NCT03673345|39696385|FG005|Overall Study|Withdrawal by Subject|0|||
16330824|NCT03673345|39696386|FG006|Overall Study|Withdrawal by Subject|0|||
16330825|NCT03673345|39696387|FG007|Overall Study|Withdrawal by Subject|0|||
16330826|NCT03673345|39696380|FG000|Overall Study|Physician Decision|0|||
16330827|NCT03673345|39696381|FG001|Overall Study|Physician Decision|0|||
16330828|NCT03673345|39696382|FG002|Overall Study|Physician Decision|2|||
16330829|NCT03673345|39696383|FG003|Overall Study|Physician Decision|0|||
16330830|NCT03673345|39696384|FG004|Overall Study|Physician Decision|0|||
16330831|NCT03673345|39696385|FG005|Overall Study|Physician Decision|0|||
16330832|NCT03673345|39696386|FG006|Overall Study|Physician Decision|0|||
16330833|NCT03673345|39696387|FG007|Overall Study|Physician Decision|0|||
16330834|NCT00477750|39696388|FG000|Overall Study|Currently Receiving Treatment|11|||
16330835|NCT02600845|39696392|FG000|Overall Study|Reason Not Specified|3|||
16330836|NCT02600845|39696392|FG000|Overall Study|Non-compliance with Study Procedures|10|||
16330837|NCT02600845|39696392|FG000|Overall Study|Consent Withdrawal|5|||
16330838|NCT01384019|39696393|FG000|Overall Study|Withdrawal by Subject|3|||
16330839|NCT01384019|39696394|FG001|Overall Study|Withdrawal by Subject|0|||
16330840|NCT01384019|39696393|FG000|Overall Study|Death|1|||
16330841|NCT01384019|39696394|FG001|Overall Study|Death|0|||
16330842|NCT01384019|39696393|FG000|Overall Study|MRI refusal|6|||
16330843|NCT01384019|39696394|FG001|Overall Study|MRI refusal|6|||
16330844|NCT00435019|39696399|FG000|Overall Study|Adverse Event|1|||
16330845|NCT00435019|39696400|FG001|Overall Study|Adverse Event|0|||
16330846|NCT00435019|39696399|FG000|Overall Study|Lack of Efficacy|1|||
16330847|NCT00435019|39696400|FG001|Overall Study|Lack of Efficacy|2|||
16330848|NCT00435019|39696399|FG000|Overall Study|Protocol Violation|3|||
16330849|NCT00435019|39696400|FG001|Overall Study|Protocol Violation|1|||
16330850|NCT00435019|39696399|FG000|Overall Study|Personal reasons for withdrawal|8|||
16330851|NCT00435019|39696400|FG001|Overall Study|Personal reasons for withdrawal|7|||
16330852|NCT01764997|39696401|FG000|Run-in Period|Adverse Event|15|||
16330853|NCT01764997|39696402|FG001|Run-in Period|Adverse Event|0|||
16330854|NCT01764997|39696403|FG002|Run-in Period|Adverse Event|0|||
16330855|NCT01764997|39696404|FG003|Run-in Period|Adverse Event|0|||
16330856|NCT01764997|39696405|FG004|Run-in Period|Adverse Event|0|||
16400292|NCT01529515|39945044|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
16400293|NCT01529515|39945045|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
16400294|NCT01529515|39945042|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
16400295|NCT01529515|39945043|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
16400296|NCT01529515|39945044|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
16400297|NCT01529515|39945045|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
16098115|NCT02291861|38846986|FG001|Overall Study|Noncompliance|1|||
16098116|NCT02291861|38846987|FG002|Overall Study|Noncompliance|2|||
16330857|NCT01764997|39696401|FG000|Run-in Period|Lack of Efficacy|5|||
16330858|NCT01764997|39696402|FG001|Run-in Period|Lack of Efficacy|0|||
16330859|NCT01764997|39696403|FG002|Run-in Period|Lack of Efficacy|0|||
16330860|NCT01764997|39696404|FG003|Run-in Period|Lack of Efficacy|0|||
16400298|NCT01529515|39945042|FG000|TRANSITION PHASE|Other|9|||
16400299|NCT01529515|39945043|FG001|TRANSITION PHASE|Other|0|||
16400300|NCT01529515|39945044|FG002|TRANSITION PHASE|Other|0|||
16400301|NCT01529515|39945045|FG003|TRANSITION PHASE|Other|0|||
16400302|NCT01529515|39945042|FG000|MAINTENANCE PHASE|Adverse Event|0|||
16400303|NCT01529515|39945043|FG001|MAINTENANCE PHASE|Adverse Event|10|||
16400304|NCT01529515|39945044|FG002|MAINTENANCE PHASE|Adverse Event|0|||
16400305|NCT01529515|39945045|FG003|MAINTENANCE PHASE|Adverse Event|0|||
16400306|NCT01529515|39945042|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
16400307|NCT01529515|39945043|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
16400308|NCT01529515|39945044|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
16400309|NCT01529515|39945045|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
16400310|NCT01529515|39945042|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
16400311|NCT01529515|39945043|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
16400312|NCT01529515|39945044|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
16400313|NCT01529515|39945045|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
16400314|NCT01529515|39945042|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
16400315|NCT01529515|39945043|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
16400316|NCT01529515|39945044|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
16400317|NCT01529515|39945045|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
16400318|NCT01529515|39945042|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
16400319|NCT01529515|39945043|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
16400320|NCT01529515|39945044|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
16400321|NCT01529515|39945045|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
16400322|NCT01529515|39945042|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
16400323|NCT01529515|39945043|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
16400324|NCT01529515|39945044|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
16400325|NCT01529515|39945045|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
16400326|NCT01529515|39945042|FG000|MAINTENANCE PHASE|Other|0|||
16400327|NCT01529515|39945043|FG001|MAINTENANCE PHASE|Other|10|||
16400328|NCT01529515|39945044|FG002|MAINTENANCE PHASE|Other|0|||
16400329|NCT01529515|39945045|FG003|MAINTENANCE PHASE|Other|0|||
16400330|NCT01529515|39945042|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
16400331|NCT01529515|39945043|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
16400332|NCT01529515|39945044|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
16400333|NCT01529515|39945045|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
16400334|NCT01529515|39945042|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
16400335|NCT01529515|39945043|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
16400336|NCT01529515|39945044|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
16400337|NCT01529515|39945045|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
16400338|NCT01529515|39945042|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
16400339|NCT01529515|39945043|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
16400340|NCT01529515|39945044|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
16400341|NCT01529515|39945045|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
16400342|NCT01529515|39945042|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
16400343|NCT01529515|39945043|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
16400344|NCT01529515|39945044|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
16400345|NCT01529515|39945045|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
16400346|NCT01529515|39945042|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
16400347|NCT01529515|39945043|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
16400348|NCT01529515|39945044|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
16400349|NCT01529515|39945045|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
16400350|NCT01529515|39945042|FG000|DOUBLE BLIND PHASE|Other|0|||
16400351|NCT01529515|39945043|FG001|DOUBLE BLIND PHASE|Other|0|||
16400352|NCT01529515|39945044|FG002|DOUBLE BLIND PHASE|Other|9|||
16400353|NCT01529515|39945045|FG003|DOUBLE BLIND PHASE|Other|2|||
16400354|NCT01818258|39945052|FG000|Overall Study|Death|3|||
16400355|NCT01818258|39945053|FG001|Overall Study|Death|0|||
16400356|NCT01818258|39945052|FG000|Overall Study|Withdrawal by Subject|0|||
16400357|NCT01818258|39945053|FG001|Overall Study|Withdrawal by Subject|1|||
16400358|NCT01818258|39945052|FG000|Overall Study|Lost to Follow-up|0|||
16400359|NCT01818258|39945053|FG001|Overall Study|Lost to Follow-up|1|||
16400360|NCT01818258|39945052|FG000|Overall Study|Unable to Travel to Clinic|0|||
16400361|NCT01818258|39945053|FG001|Overall Study|Unable to Travel to Clinic|1|||
16400362|NCT04599803|39945054|FG000|Overall Study|Withdrawal by Subject|5|||
16400363|NCT04599803|39945054|FG000|Overall Study|Lost to Follow-up|26|||
16400364|NCT00875485|39945055|FG000|Challenge Dose Epoch|Pregnancy|1|||
16400365|NCT00875485|39945056|FG001|Challenge Dose Epoch|Pregnancy|0|||
16400366|NCT00485758|39945062|FG000|Overall Study|Adverse Event|102|||
16400367|NCT00485758|39945063|FG001|Overall Study|Adverse Event|31|||
16400368|NCT00485758|39945062|FG000|Overall Study|Death|0|||
16400369|NCT00485758|39945063|FG001|Overall Study|Death|1|||
16400370|NCT00485758|39945062|FG000|Overall Study|Lost to Follow-up|5|||
16400371|NCT00485758|39945063|FG001|Overall Study|Lost to Follow-up|1|||
16400372|NCT00485758|39945062|FG000|Overall Study|Physician Decision|3|||
16400373|NCT00485758|39945063|FG001|Overall Study|Physician Decision|3|||
16400374|NCT00485758|39945062|FG000|Overall Study|Protocol Violation|11|||
16400375|NCT00485758|39945063|FG001|Overall Study|Protocol Violation|2|||
16400376|NCT00485758|39945062|FG000|Overall Study|Withdrawal by Subject|32|||
16400377|NCT00485758|39945063|FG001|Overall Study|Withdrawal by Subject|27|||
16400378|NCT00485758|39945062|FG000|Overall Study|Study Terminated by Sponsor|3|||
16400379|NCT00485758|39945063|FG001|Overall Study|Study Terminated by Sponsor|0|||
16400380|NCT01443364|39948247|FG000|Overall Study|Lack of Efficacy|14|||
16400381|NCT01443364|39948247|FG000|Overall Study|Lost to Follow-up|3|||
16400382|NCT01443364|39948247|FG000|Overall Study|Withdrawal by Subject|5|||
16400383|NCT01443364|39948247|FG000|Overall Study|Other Reason|4|||
16400384|NCT01443364|39948247|FG000|Overall Study|SAE, non-fatal|6|||
16400385|NCT01443364|39948247|FG000|Overall Study|AE, non-serious non-fatal|8|||
16400386|NCT01443364|39948247|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16400387|NCT03905265|39948249|FG000|Overall Study|Withdrawal by Subject|1|||
16400388|NCT03905265|39948250|FG001|Overall Study|Withdrawal by Subject|1|||
16400389|NCT03905265|39948251|FG002|Overall Study|Withdrawal by Subject|0|||
16400390|NCT03905265|39948252|FG003|Overall Study|Withdrawal by Subject|0|||
16400391|NCT01545934|39948253|FG000|Overall Study|Withdrawal by Subject|4|||
16528164|NCT00355082|40398240|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
16528165|NCT00355082|40398241|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
16528166|NCT00355082|40398242|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
16528167|NCT00355082|40398240|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
16528168|NCT00355082|40398241|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
16528169|NCT00355082|40398242|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
16528170|NCT00355082|40398240|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
16528171|NCT00355082|40398241|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
16528172|NCT00355082|40398242|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
16528173|NCT00355082|40398240|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
16528174|NCT00355082|40398241|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
16528175|NCT00355082|40398242|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
16528176|NCT00355082|40398240|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
16528177|NCT00355082|40398241|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
16528178|NCT00355082|40398242|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
16528179|NCT00355082|40398240|FG000|Continuation Phase|Adverse Event|2|||
16528180|NCT00355082|40398241|FG001|Continuation Phase|Adverse Event|0|||
16528181|NCT00355082|40398242|FG002|Continuation Phase|Adverse Event|1|||
16528182|NCT00355082|40398240|FG000|Continuation Phase|Lost to Follow-up|2|||
16528183|NCT00355082|40398241|FG001|Continuation Phase|Lost to Follow-up|0|||
16528184|NCT00355082|40398242|FG002|Continuation Phase|Lost to Follow-up|1|||
16528185|NCT00355082|40398240|FG000|Continuation Phase|Protocol Violation|1|||
16528186|NCT00355082|40398241|FG001|Continuation Phase|Protocol Violation|0|||
16528187|NCT00355082|40398242|FG002|Continuation Phase|Protocol Violation|1|||
16528188|NCT00355082|40398240|FG000|Continuation Phase|Withdrawal by Subject|4|||
16528189|NCT00355082|40398241|FG001|Continuation Phase|Withdrawal by Subject|0|||
16528190|NCT00355082|40398242|FG002|Continuation Phase|Withdrawal by Subject|0|||
16528191|NCT00355082|40398240|FG000|Continuation Phase|Lack of Efficacy|5|||
16528192|NCT00355082|40398241|FG001|Continuation Phase|Lack of Efficacy|0|||
16528193|NCT00355082|40398242|FG002|Continuation Phase|Lack of Efficacy|0|||
16528194|NCT00355082|40398240|FG000|Continuation Phase|Site Closed by Sponsor|8|||
16528195|NCT00355082|40398241|FG001|Continuation Phase|Site Closed by Sponsor|0|||
16528196|NCT00355082|40398242|FG002|Continuation Phase|Site Closed by Sponsor|0|||
16528197|NCT00355082|40398240|FG000|Continuation Phase|Scheduling Error|1|||
16528198|NCT00355082|40398241|FG001|Continuation Phase|Scheduling Error|0|||
16528199|NCT00355082|40398242|FG002|Continuation Phase|Scheduling Error|0|||
16528200|NCT00355082|40398240|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
16528201|NCT00355082|40398241|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
16528202|NCT00355082|40398242|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
16528203|NCT03277313|40398245|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
16528204|NCT03277313|40398246|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
16098117|NCT02291861|38846988|FG003|Overall Study|Noncompliance|1|||
16400392|NCT01545934|39948254|FG001|Overall Study|Withdrawal by Subject|3|||
16400393|NCT01545934|39948253|FG000|Overall Study|Lost to Follow-up|1|||
16400394|NCT01545934|39948254|FG001|Overall Study|Lost to Follow-up|0|||
16098118|NCT02291861|38846985|FG000|Overall Study|Lost to Follow-up|2|||
16400395|NCT02743949|39948255|FG000|Overall Study|Adverse Event|0|||
16400396|NCT02743949|39948256|FG001|Overall Study|Adverse Event|0|||
16400397|NCT02743949|39948257|FG002|Overall Study|Adverse Event|2|||
16400398|NCT02743949|39948255|FG000|Overall Study|Significant Protocol Deviation|2|||
16400399|NCT02743949|39948256|FG001|Overall Study|Significant Protocol Deviation|0|||
16400400|NCT02743949|39948257|FG002|Overall Study|Significant Protocol Deviation|1|||
16400401|NCT02743949|39948255|FG000|Overall Study|Voluntary Withdrawal|2|||
16400402|NCT02743949|39948256|FG001|Overall Study|Voluntary Withdrawal|1|||
16400403|NCT02743949|39948257|FG002|Overall Study|Voluntary Withdrawal|0|||
16400404|NCT03350256|39948258|FG000|Overall Study|Inclusion/exclusion violation|4|||
16400405|NCT03350256|39948258|FG000|Overall Study|Recommended for other therapies|2|||
16400406|NCT03350256|39948258|FG000|Overall Study|Protocol Violation|3|||
16400407|NCT03350256|39948258|FG000|Overall Study|Non compliance|2|||
16400408|NCT03350256|39948258|FG000|Overall Study|Denial by insurance|1|||
16400409|NCT03350256|39948258|FG000|Overall Study|Adverse Event|2|||
16400410|NCT03350256|39948258|FG000|Overall Study|Trial failure|12|||
16400411|NCT03350256|39948258|FG000|Overall Study|Did not proceed to permanent implant|3|||
16400412|NCT03350256|39948258|FG000|Overall Study|Withdrawal by Subject|3|||
16400413|NCT03350256|39948258|FG000|Overall Study|Subject moving out of state|1|||
16400414|NCT03350256|39948258|FG000|Overall Study|Lost to Follow-up|1|||
16400415|NCT03350256|39948258|FG000|Overall Study|Lack of Efficacy|2|||
16400416|NCT05289271|39948259|FG000|Overall Study|Mistakenly allocated, untreated|1|||
16400417|NCT05289271|39948260|FG001|Overall Study|Mistakenly allocated, untreated|0|||
16098119|NCT02291861|38846986|FG001|Overall Study|Lost to Follow-up|1|||
16098120|NCT02291861|38846987|FG002|Overall Study|Lost to Follow-up|4|||
16098121|NCT02291861|38846988|FG003|Overall Study|Lost to Follow-up|0|||
16098122|NCT02291861|38846985|FG000|Overall Study|Other|0|||
16098123|NCT02291861|38846986|FG001|Overall Study|Other|0|||
16098124|NCT02291861|38846987|FG002|Overall Study|Other|0|||
16098125|NCT02291861|38846988|FG003|Overall Study|Other|1|||
16098126|NCT04468633|38846989|FG000|Overall Study|Withdrawal by Subject|4|||
16098127|NCT04468633|38846990|FG001|Overall Study|Withdrawal by Subject|0|||
16098128|NCT01876823|38846991|FG000|Overall Study|Withdrawal by Subject|5|||
16098129|NCT01876823|38846991|FG000|Overall Study|Physician Decision|2|||
16098130|NCT01876823|38846991|FG000|Overall Study|Patients moved|2|||
16400418|NCT00347438|39948261|FG000|Overall Study|Withdrawal by Subject|1|||
16400419|NCT00347438|39948261|FG000|Overall Study|Physician Decision|1|||
16400420|NCT00960011|39948262|FG000|Overall Study|Death|5|||
16400421|NCT00960011|39948263|FG001|Overall Study|Death|0|||
16400422|NCT00960011|39948262|FG000|Overall Study|Lost to Follow-up|6|||
16400423|NCT00960011|39948263|FG001|Overall Study|Lost to Follow-up|2|||
16528205|NCT03277313|40398245|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
16528206|NCT03277313|40398246|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
16528207|NCT03277313|40398245|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
16528208|NCT03277313|40398246|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
16528209|NCT03277313|40398245|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
16528210|NCT03277313|40398246|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
16528211|NCT03277313|40398245|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
16528212|NCT03277313|40398246|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
16528213|NCT00784043|40398249|FG000|Overall Study|Withdrawal by Subject|8|||
16528214|NCT00784043|40398250|FG001|Overall Study|Withdrawal by Subject|5|||
16528215|NCT00784043|40398249|FG000|Overall Study|Protocol Terminated|23|||
16098131|NCT04908488|38846992|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
16400424|NCT01257230|39948264|FG000|Overall Study|Not Treated|0|||
16400425|NCT01257230|39948265|FG001|Overall Study|Not Treated|0|||
16400426|NCT01257230|39948266|FG002|Overall Study|Not Treated|1|||
16400427|NCT01257230|39948264|FG000|Overall Study|Adverse Event|2|||
16400428|NCT01257230|39948265|FG001|Overall Study|Adverse Event|0|||
16400429|NCT01257230|39948266|FG002|Overall Study|Adverse Event|0|||
16400430|NCT01257230|39948264|FG000|Overall Study|Lack of Efficacy|0|||
16400431|NCT01257230|39948265|FG001|Overall Study|Lack of Efficacy|1|||
16400432|NCT01257230|39948266|FG002|Overall Study|Lack of Efficacy|0|||
16400433|NCT01257230|39948264|FG000|Overall Study|Protocol Violation|3|||
16528216|NCT00784043|40398250|FG001|Overall Study|Protocol Terminated|1|||
16528217|NCT00924950|40398251|FG000|Overall Study|Lost to Follow-up|2|||
16528218|NCT01045447|40398256|FG000|Overall Study|Adverse Event|0|||
16528219|NCT01045447|40398257|FG001|Overall Study|Adverse Event|1|||
16528220|NCT01045447|40398256|FG000|Overall Study|Lack of Efficacy|3|||
16528221|NCT01045447|40398257|FG001|Overall Study|Lack of Efficacy|1|||
16528222|NCT01045447|40398256|FG000|Overall Study|Protocol Violation|6|||
16528223|NCT01045447|40398257|FG001|Overall Study|Protocol Violation|3|||
16528224|NCT01045447|40398256|FG000|Overall Study|Withdrawal Criteria|10|||
16528225|NCT01045447|40398257|FG001|Overall Study|Withdrawal Criteria|10|||
16528226|NCT01045447|40398256|FG000|Overall Study|Unclassified|17|||
16528227|NCT01045447|40398257|FG001|Overall Study|Unclassified|13|||
16528228|NCT03143829|40398261|FG000|Overall Study|Withdrawal by Subject|2|||
16528229|NCT03143829|40398262|FG001|Overall Study|Withdrawal by Subject|5|||
16528230|NCT03143829|40398261|FG000|Overall Study|Lost to Follow-up|0|||
16528231|NCT03143829|40398262|FG001|Overall Study|Lost to Follow-up|2|||
16528232|NCT03143829|40398261|FG000|Overall Study|Death|1|||
16528233|NCT03143829|40398262|FG001|Overall Study|Death|1|||
16528234|NCT03143829|40398261|FG000|Overall Study|changed treatment, no longer eligible|2|||
16528235|NCT03143829|40398262|FG001|Overall Study|changed treatment, no longer eligible|2|||
16528236|NCT03778294|40398263|FG000|Overall Study|Death|1|||
16528237|NCT03778294|40398263|FG000|Overall Study|Issues with insurance|1|||
16528238|NCT03778294|40398263|FG000|Overall Study|disease progression before treatment|2|||
16528239|NCT02863991|40398266|FG000|Overall Study|Death|0|||
16330861|NCT01764997|39696405|FG004|Run-in Period|Lack of Efficacy|0|||
16528240|NCT02863991|40398267|FG001|Overall Study|Death|3|||
16528241|NCT02863991|40398266|FG000|Overall Study|Lack of Efficacy|0|||
16528242|NCT02863991|40398267|FG001|Overall Study|Lack of Efficacy|1|||
16528243|NCT02863991|40398266|FG000|Overall Study|Study Terminated|2|||
16528244|NCT02863991|40398267|FG001|Overall Study|Study Terminated|8|||
16528245|NCT00795600|40398268|FG000|Overall Study|Adverse Event|1|||
16528246|NCT00795600|40398269|FG001|Overall Study|Adverse Event|1|||
16528247|NCT00795600|40398268|FG000|Overall Study|Protocol Violation|1|||
16528248|NCT00795600|40398269|FG001|Overall Study|Protocol Violation|2|||
16528249|NCT00795600|40398268|FG000|Overall Study|Withdrawal by Subject|1|||
16528250|NCT00795600|40398269|FG001|Overall Study|Withdrawal by Subject|0|||
16528251|NCT00795600|40398268|FG000|Overall Study|Unclassified|1|||
16528252|NCT00795600|40398269|FG001|Overall Study|Unclassified|1|||
16528253|NCT00096135|40398272|FG000|Overall Study|Physician Decision|20|||
16528254|NCT00096135|40398273|FG001|Overall Study|Physician Decision|4|||
16528255|NCT00096135|40398272|FG000|Overall Study|Refusal of further protocol therapy|4|||
16528256|NCT00096135|40398273|FG001|Overall Study|Refusal of further protocol therapy|1|||
16528257|NCT00096135|40398272|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
16528258|NCT00096135|40398273|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
16330862|NCT01764997|39696401|FG000|Run-in Period|Poor compliance to protocol|1|||
16330863|NCT01764997|39696402|FG001|Run-in Period|Poor compliance to protocol|0|||
16330864|NCT01764997|39696403|FG002|Run-in Period|Poor compliance to protocol|0|||
16330865|NCT01764997|39696404|FG003|Run-in Period|Poor compliance to protocol|0|||
16330866|NCT01764997|39696405|FG004|Run-in Period|Poor compliance to protocol|0|||
16330867|NCT01764997|39696401|FG000|Run-in Period|Other than specified above|17|||
16330868|NCT01764997|39696402|FG001|Run-in Period|Other than specified above|0|||
16330869|NCT01764997|39696403|FG002|Run-in Period|Other than specified above|0|||
16330870|NCT01764997|39696404|FG003|Run-in Period|Other than specified above|0|||
16528259|NCT00096135|40398272|FG000|Overall Study|Other, specify|15|||
16528260|NCT00096135|40398273|FG001|Overall Study|Other, specify|3|||
16528261|NCT00096135|40398272|FG000|Overall Study|Ineligible|2|||
16528262|NCT00096135|40398273|FG001|Overall Study|Ineligible|0|||
16528263|NCT00622167|40398275|FG000|Overall Study|Did not meet angiographic criteria|20|||
16528264|NCT02007577|40398278|FG000|Overall Study|Adverse Event|1|||
16528265|NCT02007577|40398279|FG001|Overall Study|Adverse Event|0|||
16528266|NCT02007577|40398278|FG000|Overall Study|Withdrawal by Subject|0|||
16528267|NCT02007577|40398279|FG001|Overall Study|Withdrawal by Subject|1|||
16528268|NCT03220035|40398282|FG000|Overall Study|Adverse Event|1|||
16330871|NCT01764997|39696405|FG004|Run-in Period|Other than specified above|0|||
16528269|NCT03220035|40398282|FG000|Overall Study|Protocol Violation|1|||
16528270|NCT03220035|40398282|FG000|Overall Study|Progressive Disease|2|||
16528271|NCT00724282|40398283|FG000|Overall Study|Withdrawal by Subject|3|||
16528272|NCT00724282|40398283|FG000|Overall Study|Physician Decision|1|||
16528273|NCT03551938|40398284|FG000|3-Month Follow Up|Lost to Follow-up|39|||
16528274|NCT03551938|40398285|FG001|3-Month Follow Up|Lost to Follow-up|38|||
16528275|NCT03551938|40398284|FG000|6-Month Follow Up|Lost to Follow-up|46|||
16528276|NCT03551938|40398285|FG001|6-Month Follow Up|Lost to Follow-up|42|||
16528277|NCT03551938|40398284|FG000|9-Month Follow Up|Lost to Follow-up|44|||
16528278|NCT03551938|40398285|FG001|9-Month Follow Up|Lost to Follow-up|43|||
16330872|NCT01764997|39696401|FG000|Study Drug Treatment Period|Adverse Event|0|||
16330873|NCT01764997|39696402|FG001|Study Drug Treatment Period|Adverse Event|1|||
16330874|NCT01764997|39696403|FG002|Study Drug Treatment Period|Adverse Event|0|||
16528279|NCT03329092|40398290|FG000|Overall Study|Other|2|||
16528280|NCT03329092|40398291|FG001|Overall Study|Other|2|||
16528281|NCT03329092|40398290|FG000|Overall Study|Withdrawal by Subject|16|||
16528282|NCT03329092|40398291|FG001|Overall Study|Withdrawal by Subject|3|||
16528283|NCT03329092|40398290|FG000|Overall Study|Physician Decision|1|||
16528284|NCT03329092|40398291|FG001|Overall Study|Physician Decision|0|||
16528285|NCT03329092|40398290|FG000|Overall Study|Death|17|||
16528286|NCT03329092|40398291|FG001|Overall Study|Death|11|||
16528287|NCT03329092|40398290|FG000|Overall Study|Adverse Event|3|||
16528288|NCT03329092|40398291|FG001|Overall Study|Adverse Event|1|||
16528289|NCT03329092|40398290|FG000|Overall Study|Lost to Follow-up|1|||
16528290|NCT03329092|40398291|FG001|Overall Study|Lost to Follow-up|1|||
16528291|NCT01343082|40398292|FG000|The run-in Period|Not meeting criteria|3|||
16528292|NCT01343082|40398293|FG001|The run-in Period|Not meeting criteria|4|||
16528293|NCT01343082|40398294|FG002|The run-in Period|Not meeting criteria|5|||
16528294|NCT01343082|40398292|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
16528295|NCT01343082|40398293|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
16528296|NCT01343082|40398294|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
16528297|NCT01343082|40398292|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
16528298|NCT01343082|40398293|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
16528299|NCT01343082|40398294|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
16528300|NCT01343082|40398292|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
16528301|NCT01343082|40398293|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
16528302|NCT01343082|40398294|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
16528303|NCT01343082|40398292|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
16528304|NCT01343082|40398293|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
16528305|NCT01343082|40398294|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
16528306|NCT02576574|40398295|FG000|Overall Study|still ongoing|65|||
16528307|NCT02576574|40398296|FG001|Overall Study|still ongoing|66|||
16528308|NCT02576574|40398297|FG002|Overall Study|still ongoing|73|||
16528309|NCT02576574|40398295|FG000|Overall Study|Randomized, not treated|5|||
16528310|NCT02576574|40398296|FG001|Overall Study|Randomized, not treated|4|||
16528311|NCT02576574|40398297|FG002|Overall Study|Randomized, not treated|26|||
16528312|NCT02148250|40401328|FG000|Screening|Withdrawal by Subject|5|||
16528313|NCT02148250|40401329|FG001|Screening|Withdrawal by Subject|0|||
16528314|NCT03067441|40401332|FG000|Overall Study|Withdrawal by Subject|16|||
16528315|NCT03067441|40401333|FG001|Overall Study|Withdrawal by Subject|34|||
16528316|NCT03067441|40401332|FG000|Overall Study|Lost to Follow-up|7|||
16528317|NCT03067441|40401333|FG001|Overall Study|Lost to Follow-up|5|||
16528318|NCT03067441|40401332|FG000|Overall Study|Adverse Event|7|||
16528319|NCT03067441|40401333|FG001|Overall Study|Adverse Event|14|||
16528320|NCT03067441|40401332|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
16528321|NCT03067441|40401333|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
16528322|NCT03067441|40401332|FG000|Overall Study|Physician Decision|1|||
16528323|NCT03067441|40401333|FG001|Overall Study|Physician Decision|3|||
16528324|NCT03067441|40401332|FG000|Overall Study|Other|1|||
16528325|NCT03067441|40401333|FG001|Overall Study|Other|1|||
16528326|NCT02548962|40401334|FG000|Overall Study|Withdrawal by Subject|1|||
16528327|NCT02548962|40401335|FG001|Overall Study|Withdrawal by Subject|0|||
16528328|NCT03314987|40401343|FG000|Overall Study|Lost to Follow-up|13|||
16528329|NCT03314987|40401344|FG001|Overall Study|Lost to Follow-up|13|||
16528330|NCT04831736|40401345|FG000|Overall Study|Withdrawal by Subject|0|||
16330875|NCT01764997|39696404|FG003|Study Drug Treatment Period|Adverse Event|0|||
16330876|NCT01764997|39696405|FG004|Study Drug Treatment Period|Adverse Event|24|||
16330877|NCT01764997|39696401|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
16330878|NCT01764997|39696402|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
16330879|NCT01764997|39696403|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
16330880|NCT01764997|39696404|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
16330881|NCT01764997|39696405|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
16330882|NCT01764997|39696401|FG000|Study Drug Treatment Period|Other than specified above|0|||
16400434|NCT01257230|39948265|FG001|Overall Study|Protocol Violation|0|||
16400435|NCT01257230|39948266|FG002|Overall Study|Protocol Violation|1|||
16528331|NCT04831736|40401346|FG001|Overall Study|Withdrawal by Subject|1|||
16528332|NCT02270450|40401350|FG000|Overall Study|Refusal unrelated to adverse event|3|||
16528333|NCT02270450|40401351|FG001|Overall Study|Refusal unrelated to adverse event|1|||
16528334|NCT02270450|40401352|FG002|Overall Study|Refusal unrelated to adverse event|5|||
16528335|NCT02270450|40401353|FG003|Overall Study|Refusal unrelated to adverse event|14|||
16528336|NCT02270450|40401350|FG000|Overall Study|Progression/relapse|1|||
16528337|NCT02270450|40401351|FG001|Overall Study|Progression/relapse|2|||
16528338|NCT02270450|40401352|FG002|Overall Study|Progression/relapse|4|||
16528339|NCT02270450|40401353|FG003|Overall Study|Progression/relapse|9|||
16528340|NCT02270450|40401350|FG000|Overall Study|Death|19|||
16528341|NCT02270450|40401351|FG001|Overall Study|Death|19|||
16528342|NCT02270450|40401352|FG002|Overall Study|Death|31|||
16528343|NCT02270450|40401353|FG003|Overall Study|Death|59|||
16528344|NCT01990950|40401354|FG000|Overall Study|Death|3|||
16528345|NCT01990950|40401354|FG000|Overall Study|Lost to Follow-up|2|||
16212223|NCT03050307|39258610|FG001|Overall Study|Adverse Event|2|||
16212224|NCT03050307|39258609|FG000|Overall Study|Significant Protocol Deviation|0|||
16212225|NCT03050307|39258610|FG001|Overall Study|Significant Protocol Deviation|1|||
16212226|NCT03050307|39258609|FG000|Overall Study|Lost to Follow-up|0|||
16400436|NCT01257230|39948264|FG000|Overall Study|Withdrawal by Subject|0|||
16400437|NCT01257230|39948265|FG001|Overall Study|Withdrawal by Subject|4|||
16400438|NCT01257230|39948266|FG002|Overall Study|Withdrawal by Subject|1|||
16400439|NCT01257230|39948264|FG000|Overall Study|Other reason not defined above|1|||
16400440|NCT01257230|39948265|FG001|Overall Study|Other reason not defined above|5|||
16400441|NCT01257230|39948266|FG002|Overall Study|Other reason not defined above|3|||
16400442|NCT00666588|39948267|FG000|Overall Study|ineligible|2|||
16400443|NCT00666588|39948268|FG001|Overall Study|ineligible|0|||
16400444|NCT00666588|39948269|FG002|Overall Study|ineligible|0|||
16400445|NCT00666588|39948270|FG003|Overall Study|ineligible|2|||
16400446|NCT00666588|39948267|FG000|Overall Study|inevaluable|2|||
16400447|NCT00666588|39948268|FG001|Overall Study|inevaluable|0|||
16400448|NCT00666588|39948269|FG002|Overall Study|inevaluable|0|||
16528346|NCT01990950|40401354|FG000|Overall Study|Withdrawal by Subject|6|||
16330883|NCT01764997|39696402|FG001|Study Drug Treatment Period|Other than specified above|0|||
16330884|NCT01764997|39696403|FG002|Study Drug Treatment Period|Other than specified above|0|||
16528347|NCT00353704|40401355|FG000|Overall Study|Protocol Violation|3|||
16528348|NCT00353704|40401356|FG001|Overall Study|Protocol Violation|1|||
16528349|NCT02508311|40401357|FG000|Overall Study|Withdrawal by Subject|1|||
16528350|NCT02508311|40401358|FG001|Overall Study|Withdrawal by Subject|0|||
16528351|NCT00023673|40401359|FG000|Overall Study|Ineligible / no protocol treatment|0|||
16528352|NCT00023673|40401360|FG001|Overall Study|Ineligible / no protocol treatment|0|||
16528353|NCT00023673|40401361|FG002|Overall Study|Ineligible / no protocol treatment|0|||
16528354|NCT00023673|40401362|FG003|Overall Study|Ineligible / no protocol treatment|1|||
16212227|NCT03050307|39258610|FG001|Overall Study|Lost to Follow-up|1|||
16212228|NCT03050307|39258609|FG000|Overall Study|Voluntary Withdrawal|3|||
16212229|NCT03050307|39258610|FG001|Overall Study|Voluntary Withdrawal|4|||
16212230|NCT03050307|39258609|FG000|Overall Study|Reason not Specified|1|||
16212231|NCT03050307|39258610|FG001|Overall Study|Reason not Specified|1|||
16330885|NCT01764997|39696404|FG003|Study Drug Treatment Period|Other than specified above|0|||
16528355|NCT00023673|40401359|FG000|Overall Study|Patient withdrew consent|0|||
16528356|NCT00023673|40401360|FG001|Overall Study|Patient withdrew consent|0|||
16528357|NCT00023673|40401361|FG002|Overall Study|Patient withdrew consent|0|||
16528358|NCT00023673|40401362|FG003|Overall Study|Patient withdrew consent|1|||
16528359|NCT02415400|40401368|FG000|Overall Study|Adverse Event|0|||
16528360|NCT02415400|40401369|FG001|Overall Study|Adverse Event|1|||
16528361|NCT02415400|40401370|FG002|Overall Study|Adverse Event|1|||
16528362|NCT02415400|40401371|FG003|Overall Study|Adverse Event|2|||
16528363|NCT02415400|40401368|FG000|Overall Study|Participant request to stop therapy|4|||
16528364|NCT02415400|40401369|FG001|Overall Study|Participant request to stop therapy|3|||
16528365|NCT02415400|40401370|FG002|Overall Study|Participant request to stop therapy|8|||
16528366|NCT02415400|40401371|FG003|Overall Study|Participant request to stop therapy|6|||
16528367|NCT02415400|40401368|FG000|Overall Study|Participant withdrew consent|14|||
16528368|NCT02415400|40401369|FG001|Overall Study|Participant withdrew consent|12|||
16098132|NCT04908488|38846993|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
16330886|NCT01764997|39696405|FG004|Study Drug Treatment Period|Other than specified above|10|||
16528369|NCT02415400|40401370|FG002|Overall Study|Participant withdrew consent|30|||
16528370|NCT02415400|40401371|FG003|Overall Study|Participant withdrew consent|21|||
16400449|NCT00666588|39948270|FG003|Overall Study|inevaluable|0|||
16528371|NCT02415400|40401368|FG000|Overall Study|Death|39|||
16528372|NCT02415400|40401369|FG001|Overall Study|Death|41|||
16528373|NCT02415400|40401370|FG002|Overall Study|Death|35|||
16528374|NCT02415400|40401371|FG003|Overall Study|Death|42|||
16528375|NCT02415400|40401368|FG000|Overall Study|Lost to Follow-up|3|||
16528376|NCT02415400|40401369|FG001|Overall Study|Lost to Follow-up|3|||
16528377|NCT02415400|40401370|FG002|Overall Study|Lost to Follow-up|2|||
16528378|NCT02415400|40401371|FG003|Overall Study|Lost to Follow-up|5|||
16528379|NCT02415400|40401368|FG000|Overall Study|Poor/Non-Compliance|0|||
16528380|NCT02415400|40401369|FG001|Overall Study|Poor/Non-Compliance|1|||
16528381|NCT02415400|40401370|FG002|Overall Study|Poor/Non-Compliance|3|||
16528382|NCT02415400|40401371|FG003|Overall Study|Poor/Non-Compliance|4|||
16528383|NCT02415400|40401368|FG000|Overall Study|Participant no longer meets criteria|2|||
16528384|NCT02415400|40401369|FG001|Overall Study|Participant no longer meets criteria|0|||
16528385|NCT02415400|40401370|FG002|Overall Study|Participant no longer meets criteria|0|||
16528386|NCT02415400|40401371|FG003|Overall Study|Participant no longer meets criteria|1|||
16528387|NCT02415400|40401368|FG000|Overall Study|Participant doesn't answer phone|1|||
16528388|NCT02415400|40401369|FG001|Overall Study|Participant doesn't answer phone|0|||
16528389|NCT02415400|40401370|FG002|Overall Study|Participant doesn't answer phone|0|||
16528390|NCT02415400|40401371|FG003|Overall Study|Participant doesn't answer phone|0|||
16528391|NCT02415400|40401368|FG000|Overall Study|Participant wanted home visits|1|||
16528392|NCT02415400|40401369|FG001|Overall Study|Participant wanted home visits|0|||
16528393|NCT02415400|40401370|FG002|Overall Study|Participant wanted home visits|0|||
16528394|NCT02415400|40401371|FG003|Overall Study|Participant wanted home visits|0|||
16528395|NCT02415400|40401368|FG000|Overall Study|Randomized in error|2|||
16528396|NCT02415400|40401369|FG001|Overall Study|Randomized in error|0|||
16528397|NCT02415400|40401370|FG002|Overall Study|Randomized in error|0|||
16528398|NCT02415400|40401371|FG003|Overall Study|Randomized in error|0|||
16528399|NCT02415400|40401368|FG000|Overall Study|No study drug on site|0|||
16528400|NCT02415400|40401369|FG001|Overall Study|No study drug on site|1|||
16528401|NCT02415400|40401370|FG002|Overall Study|No study drug on site|0|||
16528402|NCT02415400|40401371|FG003|Overall Study|No study drug on site|0|||
16528403|NCT02415400|40401368|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
16528404|NCT02415400|40401369|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
16528405|NCT02415400|40401370|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
16528406|NCT02415400|40401371|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
16528407|NCT02415400|40401368|FG000|Overall Study|Coagulation values cannot be set|0|||
16528408|NCT02415400|40401369|FG001|Overall Study|Coagulation values cannot be set|0|||
16528409|NCT02415400|40401370|FG002|Overall Study|Coagulation values cannot be set|1|||
16528410|NCT02415400|40401371|FG003|Overall Study|Coagulation values cannot be set|0|||
16528411|NCT02415400|40401368|FG000|Overall Study|State regulations prevent participation|0|||
16528412|NCT02415400|40401369|FG001|Overall Study|State regulations prevent participation|0|||
16528413|NCT02415400|40401370|FG002|Overall Study|State regulations prevent participation|1|||
16528414|NCT02415400|40401371|FG003|Overall Study|State regulations prevent participation|0|||
16528415|NCT02415400|40401368|FG000|Overall Study|Poor treatment monitoring|0|||
16528416|NCT02415400|40401369|FG001|Overall Study|Poor treatment monitoring|0|||
16528417|NCT02415400|40401370|FG002|Overall Study|Poor treatment monitoring|1|||
16528418|NCT02415400|40401371|FG003|Overall Study|Poor treatment monitoring|0|||
16098133|NCT04908488|38846992|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
16528419|NCT02415400|40401368|FG000|Overall Study|Participant in jail|0|||
16528420|NCT02415400|40401369|FG001|Overall Study|Participant in jail|0|||
16528421|NCT02415400|40401370|FG002|Overall Study|Participant in jail|1|||
16528422|NCT02415400|40401371|FG003|Overall Study|Participant in jail|0|||
16528423|NCT02415400|40401368|FG000|Overall Study|Investigator decision|0|||
16528424|NCT02415400|40401369|FG001|Overall Study|Investigator decision|0|||
16528425|NCT02415400|40401370|FG002|Overall Study|Investigator decision|1|||
16528426|NCT02415400|40401371|FG003|Overall Study|Investigator decision|1|||
16528427|NCT02415400|40401368|FG000|Overall Study|Site closure; participant won't transfer|0|||
16528428|NCT02415400|40401369|FG001|Overall Study|Site closure; participant won't transfer|0|||
16528429|NCT02415400|40401370|FG002|Overall Study|Site closure; participant won't transfer|0|||
16330887|NCT01214252|39696406|FG000|Overall Study|Not eligible per protocol|82|||
16330888|NCT02706886|39696411|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
16330889|NCT02706886|39696412|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
16330890|NCT02706886|39696413|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
16330891|NCT02706886|39696414|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
16330892|NCT02706886|39696415|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
16330893|NCT02706886|39696416|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
16330894|NCT02706886|39696417|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
16330895|NCT02706886|39696418|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
16330896|NCT02706886|39696419|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
16330897|NCT01195844|39696423|FG000|Overall Study|Fecal sample not collected|40|||
16330898|NCT04392167|39696424|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
16330899|NCT03787303|39696425|FG000|Overall Study|Death|1|||
16330900|NCT03787303|39696425|FG000|Overall Study|Premature Termination of Study|1|||
16330901|NCT01793688|39696430|FG000|Overall Study|Protocol Violation|2|||
16330902|NCT04329091|39696434|FG000|Overall Study|Physician Decision|5|||
16330903|NCT00965341|39696435|FG000|Overall Study|Withdrew consent|1|||
16330904|NCT00965341|39696436|FG001|Overall Study|Withdrew consent|5|||
16330905|NCT00965341|39696435|FG000|Overall Study|Lost to Follow-up|1|||
16330906|NCT00965341|39696436|FG001|Overall Study|Lost to Follow-up|0|||
16330907|NCT00965341|39696435|FG000|Overall Study|Transportation issues|4|||
16330908|NCT00965341|39696436|FG001|Overall Study|Transportation issues|3|||
16330909|NCT04331067|39696437|FG000|Overall Study|Adverse Event|1|||
16330910|NCT04331067|39696438|FG001|Overall Study|Adverse Event|3|||
16330911|NCT04331067|39696439|FG002|Overall Study|Adverse Event|1|||
16330912|NCT04331067|39696437|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
16330913|NCT04331067|39696438|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
16330914|NCT04331067|39696439|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
16330915|NCT03379792|39696440|FG000|Overall Study|Physician Decision|0|||
16330916|NCT03379792|39696441|FG001|Overall Study|Physician Decision|0|||
16528430|NCT02415400|40401371|FG003|Overall Study|Site closure; participant won't transfer|1|||
16528431|NCT00558285|40401374|FG000|Overall Study|Adverse Event|1|||
16528432|NCT00558285|40401375|FG001|Overall Study|Adverse Event|1|||
16528433|NCT00558285|40401376|FG002|Overall Study|Adverse Event|4|||
16528434|NCT00558285|40401377|FG003|Overall Study|Adverse Event|1|||
16528435|NCT00558285|40401378|FG004|Overall Study|Adverse Event|2|||
16528436|NCT00558285|40401374|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16528437|NCT00558285|40401375|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16528438|NCT00558285|40401376|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16528439|NCT00558285|40401377|FG003|Overall Study|Abnormal test procedure result(s)|0|||
16528440|NCT00558285|40401378|FG004|Overall Study|Abnormal test procedure result(s)|0|||
16528441|NCT00558285|40401374|FG000|Overall Study|Subject withdrew consent|2|||
16528442|NCT00558285|40401375|FG001|Overall Study|Subject withdrew consent|0|||
16528443|NCT00558285|40401376|FG002|Overall Study|Subject withdrew consent|1|||
16528444|NCT00558285|40401377|FG003|Overall Study|Subject withdrew consent|1|||
16528445|NCT00558285|40401378|FG004|Overall Study|Subject withdrew consent|1|||
16528446|NCT00558285|40401374|FG000|Overall Study|Lost to Follow-up|1|||
16528447|NCT00558285|40401375|FG001|Overall Study|Lost to Follow-up|1|||
16330917|NCT03379792|39696442|FG002|Overall Study|Physician Decision|0|||
16330918|NCT03379792|39696443|FG003|Overall Study|Physician Decision|1|||
16330919|NCT03379792|39696444|FG004|Overall Study|Physician Decision|0|||
16330920|NCT03379792|39696445|FG005|Overall Study|Physician Decision|0|||
16330921|NCT03379792|39696440|FG000|Overall Study|Withdrawal by Subject|0|||
16330922|NCT03379792|39696441|FG001|Overall Study|Withdrawal by Subject|0|||
16330923|NCT03379792|39696442|FG002|Overall Study|Withdrawal by Subject|0|||
16528448|NCT00558285|40401376|FG002|Overall Study|Lost to Follow-up|0|||
16528449|NCT00558285|40401377|FG003|Overall Study|Lost to Follow-up|0|||
16528450|NCT00558285|40401378|FG004|Overall Study|Lost to Follow-up|0|||
16330924|NCT03379792|39696443|FG003|Overall Study|Withdrawal by Subject|0|||
16528451|NCT00558285|40401374|FG000|Overall Study|Administrative problems|0|||
16546380|NCT01662063|40464797|FG001|Overall Study|Protocol Violation|0|||
16330925|NCT03379792|39696444|FG004|Overall Study|Withdrawal by Subject|1|||
16330926|NCT03379792|39696445|FG005|Overall Study|Withdrawal by Subject|1|||
16330927|NCT03954041|39696446|FG000|Overall Study|Lost to Follow-up|3|||
16330928|NCT03954041|39696447|FG001|Overall Study|Lost to Follow-up|3|||
16330929|NCT03954041|39696448|FG002|Overall Study|Lost to Follow-up|6|||
16330930|NCT03954041|39696446|FG000|Overall Study|Death|4|||
16330931|NCT03954041|39696447|FG001|Overall Study|Death|0|||
16528452|NCT00558285|40401375|FG001|Overall Study|Administrative problems|0|||
16528453|NCT00558285|40401376|FG002|Overall Study|Administrative problems|0|||
16528454|NCT00558285|40401377|FG003|Overall Study|Administrative problems|1|||
16528455|NCT00558285|40401378|FG004|Overall Study|Administrative problems|1|||
16528456|NCT00558285|40401374|FG000|Overall Study|Protocol deviation|1|||
16212232|NCT02614261|39258615|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
16330932|NCT03954041|39696448|FG002|Overall Study|Death|1|||
16330933|NCT03954041|39696446|FG000|Overall Study|Death by neurologic criteria|0|||
16330934|NCT03954041|39696447|FG001|Overall Study|Death by neurologic criteria|0|||
16330935|NCT03954041|39696448|FG002|Overall Study|Death by neurologic criteria|1|||
16330936|NCT03954041|39696446|FG000|Overall Study|Reason not specified|7|||
16330937|NCT03954041|39696447|FG001|Overall Study|Reason not specified|4|||
16330938|NCT03954041|39696448|FG002|Overall Study|Reason not specified|2|||
16330939|NCT03954041|39696446|FG000|Overall Study|Withdrew prior to dosing|4|||
16330940|NCT03954041|39696447|FG001|Overall Study|Withdrew prior to dosing|2|||
16330941|NCT03954041|39696448|FG002|Overall Study|Withdrew prior to dosing|0|||
16330942|NCT00358956|39696449|FG000|Overall Study|Adverse Event|3|||
16330943|NCT00358956|39696449|FG000|Overall Study|condition under investigation worsened|4|||
16330944|NCT00358956|39696449|FG000|Overall Study|Withdrawal by Subject|1|||
16330945|NCT02956057|39696454|FG000|Overall Study|Discontinued intervention|14|||
16330946|NCT02956057|39696455|FG001|Overall Study|Discontinued intervention|10|||
16330947|NCT02956057|39696456|FG002|Overall Study|Discontinued intervention|7|||
16330948|NCT02956057|39696457|FG003|Overall Study|Discontinued intervention|14|||
16330949|NCT02956057|39696458|FG004|Overall Study|Discontinued intervention|4|||
16330950|NCT02956057|39696459|FG005|Overall Study|Discontinued intervention|17|||
16330951|NCT02956057|39696454|FG000|Overall Study|Lost to Follow-up|0|||
16330952|NCT02956057|39696455|FG001|Overall Study|Lost to Follow-up|2|||
16330953|NCT02956057|39696456|FG002|Overall Study|Lost to Follow-up|1|||
16330954|NCT02956057|39696457|FG003|Overall Study|Lost to Follow-up|1|||
16330955|NCT02956057|39696458|FG004|Overall Study|Lost to Follow-up|1|||
16330956|NCT02956057|39696459|FG005|Overall Study|Lost to Follow-up|0|||
16330957|NCT02240069|39696460|FG000|Overall Study|Withdrawal by Subject|5|||
16330958|NCT02240069|39696461|FG001|Overall Study|Withdrawal by Subject|5|||
16330959|NCT02240069|39696462|FG002|Overall Study|Withdrawal by Subject|2|||
16330960|NCT01542034|39696463|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
16330961|NCT01542034|39696464|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
16330962|NCT01542034|39696463|FG000|Overall Study|Administrative decision|0|||
16330963|NCT01542034|39696464|FG001|Overall Study|Administrative decision|3|||
16330964|NCT01542034|39696463|FG000|Overall Study|Subject Noncompliance|1|||
16330965|NCT01542034|39696464|FG001|Overall Study|Subject Noncompliance|0|||
16330966|NCT01542034|39696463|FG000|Overall Study|Adverse Event|2|||
16330967|NCT01542034|39696464|FG001|Overall Study|Adverse Event|2|||
16330968|NCT01542034|39696463|FG000|Overall Study|Lost to Follow-up|7|||
16330969|NCT01542034|39696464|FG001|Overall Study|Lost to Follow-up|6|||
16330970|NCT01300338|39696470|FG000|Overall Study|Lost to Follow-up|5|||
16212233|NCT02614261|39258616|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
16212234|NCT02614261|39258617|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
16212235|NCT02614261|39258618|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
16212236|NCT02614261|39258615|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
16212237|NCT02614261|39258616|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16330971|NCT01300338|39696471|FG001|Overall Study|Lost to Follow-up|0|||
16330972|NCT03782974|39696472|FG000|Overall Study|Withdrawal by Subject|7|||
16212238|NCT02614261|39258617|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16212239|NCT02614261|39258618|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16212240|NCT02614261|39258615|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
16212241|NCT02614261|39258616|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
16212242|NCT02614261|39258617|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
16330973|NCT03782974|39696473|FG001|Overall Study|Withdrawal by Subject|7|||
16400450|NCT03299881|39948271|FG000|Overall Study|Study Termination|17|||
16400451|NCT03299881|39948272|FG001|Overall Study|Study Termination|13|||
16400452|NCT00338286|39948277|FG000|Overall Study|Withdrawal by Subject|50|||
16400453|NCT00338286|39948278|FG001|Overall Study|Withdrawal by Subject|54|||
16400454|NCT00338286|39948277|FG000|Overall Study|Lost to Follow-up|80|||
16400455|NCT00338286|39948278|FG001|Overall Study|Lost to Follow-up|66|||
16400456|NCT00338286|39948277|FG000|Overall Study|Other|103|||
16528457|NCT00558285|40401375|FG001|Overall Study|Protocol deviation|1|||
16212243|NCT02614261|39258618|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16330974|NCT03782974|39696472|FG000|Overall Study|Pregnancy|1|||
16330975|NCT03782974|39696473|FG001|Overall Study|Pregnancy|0|||
16330976|NCT01298141|39696474|FG000|Overall Study|Adverse Event|3|||
16330977|NCT01298141|39696474|FG000|Overall Study|Refusal of Required Study Procedures|1|||
16330978|NCT01298141|39696474|FG000|Overall Study|Withdrawal by Subject|6|||
16400457|NCT00338286|39948278|FG001|Overall Study|Other|93|||
16400458|NCT01534260|39948279|FG000|Overall Study|Adverse Event|1|||
16400459|NCT01534260|39948280|FG001|Overall Study|Adverse Event|8|||
16400460|NCT01534260|39948279|FG000|Overall Study|Death|2|||
16400461|NCT01534260|39948280|FG001|Overall Study|Death|0|||
16400462|NCT01534260|39948279|FG000|Overall Study|Lack of Efficacy|1|||
16400463|NCT01534260|39948280|FG001|Overall Study|Lack of Efficacy|1|||
16400464|NCT01534260|39948279|FG000|Overall Study|Withdrawal by Subject|1|||
16400465|NCT01534260|39948280|FG001|Overall Study|Withdrawal by Subject|3|||
16400466|NCT01534260|39948279|FG000|Overall Study|Disease Progression|8|||
16400467|NCT01534260|39948280|FG001|Overall Study|Disease Progression|6|||
16400468|NCT01534260|39948279|FG000|Overall Study|Physician Decision|3|||
16400469|NCT01534260|39948280|FG001|Overall Study|Physician Decision|1|||
16400470|NCT01534260|39948279|FG000|Overall Study|No treatment, per protocol|0|||
16400471|NCT01534260|39948280|FG001|Overall Study|No treatment, per protocol|1|||
16400472|NCT01425359|39948281|FG000|Overall Study|Randomized but Not Treated|2|||
16400473|NCT01425359|39948282|FG001|Overall Study|Randomized but Not Treated|3|||
16400474|NCT01425359|39948281|FG000|Overall Study|Adverse Event|9|||
16400475|NCT01425359|39948282|FG001|Overall Study|Adverse Event|8|||
16400476|NCT01425359|39948281|FG000|Overall Study|Revascularization|0|||
16400477|NCT01425359|39948282|FG001|Overall Study|Revascularization|1|||
16400478|NCT01425359|39948281|FG000|Overall Study|Death|0|||
16400479|NCT01425359|39948282|FG001|Overall Study|Death|1|||
16400480|NCT01425359|39948281|FG000|Overall Study|Unsatisfactory Response|1|||
16400481|NCT01425359|39948282|FG001|Overall Study|Unsatisfactory Response|0|||
16400482|NCT01425359|39948281|FG000|Overall Study|Protocol Violation|1|||
16400483|NCT01425359|39948282|FG001|Overall Study|Protocol Violation|2|||
16400484|NCT01425359|39948281|FG000|Overall Study|Subject Withdrew Consent|1|||
16400485|NCT01425359|39948282|FG001|Overall Study|Subject Withdrew Consent|2|||
16400486|NCT01425359|39948281|FG000|Overall Study|Investigator's Discretion|2|||
16400487|NCT01425359|39948282|FG001|Overall Study|Investigator's Discretion|0|||
16098134|NCT04908488|38846993|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
16098135|NCT00748098|38846994|FG000|First Treatment Intervention Period|Adverse Event|1|||
16098136|NCT00748098|38846995|FG001|First Treatment Intervention Period|Adverse Event|1|||
16098137|NCT00748098|38846994|FG000|First Treatment Intervention Period|Protocol Violation|1|||
16098138|NCT00748098|38846995|FG001|First Treatment Intervention Period|Protocol Violation|0|||
16098139|NCT00748098|38846994|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
16098140|NCT00748098|38846995|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
16098141|NCT00748098|38846994|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
16400488|NCT01425359|39948281|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
16400489|NCT01425359|39948282|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
16400490|NCT00778375|39948283|FG000|Overall Study|Ineligible|3|||
16400491|NCT01421303|39948286|FG000|Overall Study|Lost to Follow-up|13|||
16400492|NCT01421303|39948286|FG000|Overall Study|Non compliance with study procedure|1|||
16400493|NCT01421303|39948286|FG000|Overall Study|Other|7|||
16400494|NCT01421303|39948286|FG000|Overall Study|Withdrawal by Subject|1|||
16400495|NCT03276026|39948288|FG000|Overall Study|Protocol Violation|1|||
16400496|NCT03276026|39948289|FG001|Overall Study|Protocol Violation|0|||
16400497|NCT00022763|39948290|FG000|Overall Study|Adverse Event|1|||
16400498|NCT00022763|39948291|FG001|Overall Study|Adverse Event|2|||
16400499|NCT00022763|39948290|FG000|Overall Study|Injection Site Reactions|0|||
16400500|NCT00022763|39948291|FG001|Overall Study|Injection Site Reactions|2|||
16400501|NCT00022763|39948290|FG000|Overall Study|Death|0|||
16400502|NCT00022763|39948291|FG001|Overall Study|Death|1|||
16400503|NCT00022763|39948290|FG000|Overall Study|Lost to Follow-up|0|||
16400504|NCT00022763|39948291|FG001|Overall Study|Lost to Follow-up|3|||
16400505|NCT00022763|39948290|FG000|Overall Study|Withdrawal by Subject|4|||
16400506|NCT00022763|39948291|FG001|Overall Study|Withdrawal by Subject|7|||
16400507|NCT00022763|39948290|FG000|Overall Study|Insufficient Therapy|1|||
16400508|NCT00022763|39948291|FG001|Overall Study|Insufficient Therapy|0|||
16400509|NCT00022763|39948290|FG000|Overall Study|Admin|3|||
16400510|NCT00022763|39948291|FG001|Overall Study|Admin|2|||
16400511|NCT00336284|39948292|FG000|Overall Study|Death|52|||
16400512|NCT00336284|39948293|FG001|Overall Study|Death|26|||
16400513|NCT00336284|39948292|FG000|Overall Study|Lost to Follow-up|82|||
16400514|NCT00336284|39948293|FG001|Overall Study|Lost to Follow-up|61|||
16098142|NCT00748098|38846995|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
16098143|NCT00748098|38846994|FG000|First Taper Period|Protocol Violation|1|||
16400515|NCT00336284|39948292|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
16400516|NCT00336284|39948293|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
16400517|NCT00759356|39948294|FG000|Overall Study|Adverse Event|0|||
16400518|NCT00759356|39948295|FG001|Overall Study|Adverse Event|1|||
16400519|NCT00759356|39948294|FG000|Overall Study|Withdrawal by Subject|0|||
16400520|NCT00759356|39948295|FG001|Overall Study|Withdrawal by Subject|2|||
16400521|NCT00759356|39948294|FG000|Overall Study|Subject was unable to return|1|||
16400522|NCT00759356|39948295|FG001|Overall Study|Subject was unable to return|0|||
16400523|NCT01519791|39948300|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
16400524|NCT01519791|39948301|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
16400525|NCT01519791|39948300|FG000|Overall Study|Protocol Violation|6|||
16400526|NCT01519791|39948301|FG001|Overall Study|Protocol Violation|19|||
16400527|NCT01519791|39948300|FG000|Overall Study|Other Reason|87|||
16400528|NCT01519791|39948301|FG001|Overall Study|Other Reason|222|||
16400529|NCT01519791|39948300|FG000|Overall Study|subjects randomized in error|2|||
16400530|NCT01519791|39948301|FG001|Overall Study|subjects randomized in error|0|||
16400531|NCT01519791|39948300|FG000|Overall Study|Lack of Efficacy|16|||
16400532|NCT01519791|39948301|FG001|Overall Study|Lack of Efficacy|20|||
16400533|NCT01519791|39948300|FG000|Overall Study|SAE, non-fatal|6|||
16400534|NCT01519791|39948301|FG001|Overall Study|SAE, non-fatal|22|||
16528458|NCT00558285|40401376|FG002|Overall Study|Protocol deviation|0|||
16528459|NCT00558285|40401377|FG003|Overall Study|Protocol deviation|1|||
16528460|NCT00558285|40401378|FG004|Overall Study|Protocol deviation|0|||
16528461|NCT01568047|40401379|FG000|Overall Study|Ineligibility|1|||
16528462|NCT01568047|40401380|FG001|Overall Study|Ineligibility|0|||
16098144|NCT00748098|38846995|FG001|First Taper Period|Protocol Violation|0|||
16098145|NCT00748098|38846994|FG000|First Taper Period|Withdrawal by Subject|2|||
16098146|NCT00748098|38846995|FG001|First Taper Period|Withdrawal by Subject|0|||
16098147|NCT00748098|38846994|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
16098148|NCT00748098|38846995|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
16098149|NCT00748098|38846994|FG000|1-Week Washout Period|Adverse Event|0|||
16098150|NCT00748098|38846995|FG001|1-Week Washout Period|Adverse Event|1|||
16098151|NCT00748098|38846994|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
16098152|NCT00748098|38846995|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
16098153|NCT00748098|38846994|FG000|Second Treatment Intervention Period|Adverse Event|4|||
16098154|NCT00748098|38846995|FG001|Second Treatment Intervention Period|Adverse Event|1|||
16098155|NCT00748098|38846994|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
16212244|NCT02614261|39258615|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
16212245|NCT02614261|39258616|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
16212246|NCT02614261|39258617|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
16400535|NCT01519791|39948300|FG000|Overall Study|AE, serious fatal|0|||
16400536|NCT01519791|39948301|FG001|Overall Study|AE, serious fatal|1|||
16528463|NCT01568047|40401381|FG002|Overall Study|Ineligibility|0|||
16528464|NCT01568047|40401382|FG003|Overall Study|Ineligibility|0|||
16528465|NCT01568047|40401379|FG000|Overall Study|Withdrawal by Subject|0|||
16528466|NCT01568047|40401380|FG001|Overall Study|Withdrawal by Subject|1|||
16528467|NCT01568047|40401381|FG002|Overall Study|Withdrawal by Subject|0|||
16528468|NCT01568047|40401382|FG003|Overall Study|Withdrawal by Subject|0|||
16528469|NCT01568047|40401379|FG000|Overall Study|Adverse Event|0|||
16528470|NCT01568047|40401380|FG001|Overall Study|Adverse Event|0|||
16528471|NCT01568047|40401381|FG002|Overall Study|Adverse Event|1|||
16528472|NCT01568047|40401382|FG003|Overall Study|Adverse Event|1|||
16528473|NCT03725982|40401385|FG000|First Intervention|Withdrawal by Subject|0|||
16528474|NCT03725982|40401386|FG001|First Intervention|Withdrawal by Subject|1|||
16528475|NCT03725982|40401385|FG000|First Intervention|Physician Decision|1|||
16528476|NCT03725982|40401386|FG001|First Intervention|Physician Decision|1|||
16528477|NCT01292603|40401387|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
16546381|NCT01662063|40464798|FG002|Overall Study|Protocol Violation|0|||
16098156|NCT00748098|38846995|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
16400537|NCT01519791|39948300|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
16330979|NCT01298141|39696474|FG000|Overall Study|Termination of Study by the Investigator|5|||
16330980|NCT01298141|39696474|FG000|Overall Study|Other|5|||
16330981|NCT01298141|39696474|FG000|Overall Study|Lost to Follow-up|1|||
16330982|NCT01298141|39696474|FG000|Overall Study|Death|6|||
16330983|NCT01298141|39696474|FG000|Overall Study|Not treated|4|||
16330984|NCT03181503|39696475|FG000|Overall Study|Adverse Event|2|||
16098157|NCT00748098|38846994|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
16330985|NCT03181503|39696476|FG001|Overall Study|Adverse Event|2|||
16528478|NCT01292603|40401388|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
16528479|NCT01292603|40401389|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
16528480|NCT01292603|40401390|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
16528481|NCT01292603|40401391|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
16528482|NCT01292603|40401392|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
16528483|NCT01292603|40401387|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
16400538|NCT01519791|39948301|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
16098158|NCT00748098|38846995|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
16098159|NCT05274906|38846998|FG000|Overall Study|Withdrawal by Subject|2|||
16528484|NCT01292603|40401388|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
16098160|NCT05274906|38846999|FG001|Overall Study|Withdrawal by Subject|1|||
16098161|NCT01807234|38847000|FG000|Overall Study|Lost to Follow-up|2|||
16098162|NCT01807234|38847001|FG001|Overall Study|Lost to Follow-up|5|||
16098163|NCT01807234|38847002|FG002|Overall Study|Lost to Follow-up|1|||
16098164|NCT01807234|38847003|FG003|Overall Study|Lost to Follow-up|1|||
16098165|NCT01807234|38847004|FG004|Overall Study|Lost to Follow-up|1|||
16098166|NCT01807234|38847005|FG005|Overall Study|Lost to Follow-up|2|||
16098167|NCT01807234|38847000|FG000|Overall Study|Withdrawal by Subject|3|||
16098168|NCT01807234|38847001|FG001|Overall Study|Withdrawal by Subject|1|||
16400539|NCT01519791|39948300|FG000|Overall Study|AE, non-serious non-fatal|12|||
16400540|NCT01519791|39948301|FG001|Overall Study|AE, non-serious non-fatal|31|||
16400541|NCT01519791|39948300|FG000|Overall Study|Withdrawal by Subject|15|||
16400542|NCT01519791|39948301|FG001|Overall Study|Withdrawal by Subject|37|||
16400543|NCT01519791|39948300|FG000|Overall Study|Lost to Follow-up|6|||
16400544|NCT01519791|39948301|FG001|Overall Study|Lost to Follow-up|14|||
16400545|NCT00522418|39948302|FG000|Overall Study|Local IRB Consent Violation|5|||
16400546|NCT00522418|39948303|FG001|Overall Study|Local IRB Consent Violation|5|||
16400547|NCT00522418|39948302|FG000|Overall Study|Early Study Termination|46|||
16400548|NCT00522418|39948303|FG001|Overall Study|Early Study Termination|47|||
16400549|NCT00522418|39948302|FG000|Overall Study|Noncompliance|2|||
16400550|NCT00522418|39948303|FG001|Overall Study|Noncompliance|2|||
16400551|NCT00522418|39948302|FG000|Overall Study|Reason Not Specified|3|||
16400552|NCT00522418|39948303|FG001|Overall Study|Reason Not Specified|1|||
16400553|NCT00522418|39948302|FG000|Overall Study|Consent Withdraw|1|||
16400554|NCT00522418|39948303|FG001|Overall Study|Consent Withdraw|2|||
16400555|NCT00522418|39948302|FG000|Overall Study|Lack of Efficacy|0|||
16400556|NCT00522418|39948303|FG001|Overall Study|Lack of Efficacy|1|||
16400557|NCT01944098|39948312|FG000|Overall Study|Physician Decision|1|||
16400558|NCT01944098|39948313|FG001|Overall Study|Physician Decision|0|||
16400559|NCT00290771|39948314|FG000|Overall Study|Disease progression|95|||
16400560|NCT00290771|39948315|FG001|Overall Study|Disease progression|73|||
16400561|NCT00290771|39948314|FG000|Overall Study|Death|11|||
16400562|NCT00290771|39948315|FG001|Overall Study|Death|10|||
16400563|NCT00290771|39948314|FG000|Overall Study|Adverse Event|12|||
16400564|NCT00290771|39948315|FG001|Overall Study|Adverse Event|6|||
16400565|NCT00290771|39948314|FG000|Overall Study|Withdrawal by Subject|5|||
16400566|NCT00290771|39948315|FG001|Overall Study|Withdrawal by Subject|6|||
16400567|NCT00290771|39948314|FG000|Overall Study|Administrative problems|2|||
16400568|NCT00290771|39948315|FG001|Overall Study|Administrative problems|1|||
16400569|NCT00290771|39948314|FG000|Overall Study|Protocol Violation|2|||
16400570|NCT00290771|39948315|FG001|Overall Study|Protocol Violation|0|||
16400571|NCT00290771|39948314|FG000|Overall Study|Lost to Follow-up|0|||
16400572|NCT00290771|39948315|FG001|Overall Study|Lost to Follow-up|1|||
16400573|NCT00855933|39948316|FG000|Overall Study|Withdrawal by Subject|0|||
16400574|NCT00855933|39948317|FG001|Overall Study|Withdrawal by Subject|1|||
16528485|NCT01292603|40401389|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
16528486|NCT01292603|40401390|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
16098169|NCT01807234|38847002|FG002|Overall Study|Withdrawal by Subject|1|||
16330986|NCT03181503|39696475|FG000|Overall Study|Protocol Violation|1|||
16330987|NCT03181503|39696476|FG001|Overall Study|Protocol Violation|0|||
16330988|NCT03181503|39696475|FG000|Overall Study|Withdrawal by Subject|3|||
16400575|NCT04123093|39948320|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
16400576|NCT04123093|39948321|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
16400577|NCT04123093|39948320|FG000|Phase 2|Physician Decision|0|||
16400578|NCT04123093|39948321|FG001|Phase 2|Physician Decision|1|||
16400579|NCT04123093|39948320|FG000|Phase 2|Withdrawal by Subject|0|||
16098170|NCT01807234|38847003|FG003|Overall Study|Withdrawal by Subject|1|||
16098171|NCT01807234|38847004|FG004|Overall Study|Withdrawal by Subject|2|||
16400580|NCT04123093|39948321|FG001|Phase 2|Withdrawal by Subject|1|||
16330989|NCT03181503|39696476|FG001|Overall Study|Withdrawal by Subject|0|||
16330990|NCT03181503|39696475|FG000|Overall Study|Lost to Follow-up|1|||
16330991|NCT03181503|39696476|FG001|Overall Study|Lost to Follow-up|1|||
16330992|NCT01077739|39696481|FG000|Overall Study|Premature withdrawal|1|||
16330993|NCT01077739|39696482|FG001|Overall Study|Premature withdrawal|3|||
16330994|NCT01077739|39696481|FG000|Overall Study|Withdrawal by Subject|1|||
16330995|NCT01077739|39696482|FG001|Overall Study|Withdrawal by Subject|0|||
16330996|NCT01077739|39696481|FG000|Overall Study|Death|0|||
16330997|NCT01077739|39696482|FG001|Overall Study|Death|3|||
16330998|NCT01077739|39696481|FG000|Overall Study|Unacceptable toxicity|1|||
16400581|NCT03037476|39948323|FG000|Overall Study|Lost to Follow-up|63|||
16400582|NCT03037476|39948324|FG001|Overall Study|Lost to Follow-up|46|||
16400583|NCT01471028|39948326|FG000|VTI-208|Adverse Event|39|||
16400584|NCT01471028|39948327|FG001|VTI-208|Adverse Event|41|||
16400585|NCT01471028|39948326|FG000|VTI-208|Withdrawal by Subject|0|||
16400586|NCT01471028|39948327|FG001|VTI-208|Withdrawal by Subject|2|||
16400587|NCT01471028|39948326|FG000|VTI-208|Lost to Follow-up|1|||
16400588|NCT01471028|39948327|FG001|VTI-208|Lost to Follow-up|1|||
16400589|NCT01471028|39948326|FG000|VTI-208E|Death|7|||
16400590|NCT01471028|39948327|FG001|VTI-208E|Death|10|||
16400591|NCT01471028|39948326|FG000|VTI-208E|Withdrawal by Subject|1|||
16400592|NCT01471028|39948327|FG001|VTI-208E|Withdrawal by Subject|0|||
16400593|NCT01471028|39948326|FG000|VTI-208E|Lost to Follow-up|0|||
16400594|NCT01471028|39948327|FG001|VTI-208E|Lost to Follow-up|2|||
16400595|NCT02516098|39948330|FG000|Period 1|Protocol Violation|1|||
16400596|NCT02516098|39948331|FG001|Period 1|Protocol Violation|0|||
16400597|NCT02516098|39948330|FG000|Washout After Period 1|Adverse Event|0|||
16400598|NCT02516098|39948331|FG001|Washout After Period 1|Adverse Event|1|||
16400599|NCT02516098|39948330|FG000|Period 2|Withdrawal by Subject|0|||
16400600|NCT02516098|39948331|FG001|Period 2|Withdrawal by Subject|1|||
16400601|NCT01631747|39948332|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
16528487|NCT01292603|40401391|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
16528488|NCT01292603|40401392|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
16528489|NCT01292603|40401387|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
16400602|NCT01631747|39948333|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
16400603|NCT01631747|39948332|FG000|Live Birth|Pregnancy Termination|1|||
16400604|NCT01631747|39948333|FG001|Live Birth|Pregnancy Termination|0|||
16400605|NCT01631747|39948332|FG000|Live Birth|MIscarriage|2|||
16400606|NCT01631747|39948333|FG001|Live Birth|MIscarriage|0|||
16400607|NCT01631747|39948332|FG000|Live Birth|Stillbirth|1|||
16528490|NCT01292603|40401388|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
16528491|NCT01292603|40401389|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
16528492|NCT01292603|40401390|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
16528493|NCT01292603|40401391|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
16528494|NCT01292603|40401392|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
16528495|NCT01292603|40401387|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
16528496|NCT01292603|40401388|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
16528497|NCT01292603|40401389|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
16528498|NCT01292603|40401390|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
16528499|NCT01292603|40401391|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
16528500|NCT01292603|40401392|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
16528501|NCT01292603|40401387|FG000|Part 1: Regular Follow-Up Period|Death|3|||
16528502|NCT01292603|40401388|FG001|Part 1: Regular Follow-Up Period|Death|1|||
16528503|NCT01292603|40401389|FG002|Part 1: Regular Follow-Up Period|Death|3|||
16528504|NCT01292603|40401390|FG003|Part 1: Regular Follow-Up Period|Death|1|||
16528505|NCT01292603|40401391|FG004|Part 1: Regular Follow-Up Period|Death|0|||
16528506|NCT01292603|40401392|FG005|Part 1: Regular Follow-Up Period|Death|0|||
16528507|NCT01292603|40401387|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
16528508|NCT01292603|40401388|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
16528509|NCT01292603|40401389|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
16528510|NCT01292603|40401390|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
16528511|NCT01292603|40401391|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
16528512|NCT01292603|40401392|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
16528513|NCT01292603|40401387|FG000|Part 2: Dose Confirmation Period|Death|0|||
16528514|NCT01292603|40401388|FG001|Part 2: Dose Confirmation Period|Death|0|||
16400608|NCT01631747|39948333|FG001|Live Birth|Stillbirth|1|||
16400609|NCT01631747|39948332|FG000|One Year Infant Outcomes|Patient Refused|13|||
16400610|NCT01631747|39948333|FG001|One Year Infant Outcomes|Patient Refused|9|||
16400611|NCT03327220|39948334|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
16400612|NCT03327220|39948335|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
16400613|NCT03327220|39948334|FG000|Overall Study|Investigator Decision|2|||
16400614|NCT03327220|39948335|FG001|Overall Study|Investigator Decision|0|||
16330999|NCT01077739|39696482|FG001|Overall Study|Unacceptable toxicity|2|||
16331000|NCT01077739|39696481|FG000|Overall Study|Other|2|||
16400615|NCT03327220|39948334|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
16400616|NCT03327220|39948335|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
16400617|NCT03327220|39948334|FG000|Overall Study|Fungal infection|1|||
16400618|NCT03327220|39948335|FG001|Overall Study|Fungal infection|0|||
16400619|NCT03327220|39948334|FG000|Overall Study|Discharged to Rehabilitation|0|||
16400620|NCT03327220|39948335|FG001|Overall Study|Discharged to Rehabilitation|1|||
16400621|NCT03327220|39948334|FG000|Overall Study|Missing|1|||
16400622|NCT03327220|39948335|FG001|Overall Study|Missing|0|||
16400623|NCT02901054|39948341|FG000|Overall Study|Physician Decision|1|||
16331001|NCT01077739|39696482|FG001|Overall Study|Other|2|||
16331002|NCT01447927|39699807|FG000|Overall Study|Adverse Event|4|||
16331003|NCT01447927|39699808|FG001|Overall Study|Adverse Event|3|||
16331004|NCT01447927|39699807|FG000|Overall Study|Withdrawal by Subject|1|||
16331005|NCT01447927|39699808|FG001|Overall Study|Withdrawal by Subject|0|||
16331006|NCT02607306|39699809|FG000|Overall Study|Adverse Event|8|||
16400624|NCT02901054|39948341|FG000|Overall Study|Withdrawal by Subject|3|||
16400625|NCT01005316|39948342|FG000|Overall Study|Adverse Event|0|||
16400626|NCT01005316|39948343|FG001|Overall Study|Adverse Event|0|||
16400627|NCT01005316|39948344|FG002|Overall Study|Adverse Event|0|||
16400628|NCT01005316|39948345|FG003|Overall Study|Adverse Event|1|||
16400629|NCT01005316|39948342|FG000|Overall Study|Death|20|||
16400630|NCT01005316|39948343|FG001|Overall Study|Death|5|||
16400631|NCT01005316|39948344|FG002|Overall Study|Death|1|||
16400632|NCT01005316|39948345|FG003|Overall Study|Death|15|||
16400633|NCT01005316|39948342|FG000|Overall Study|Study Termination|5|||
16400634|NCT01005316|39948343|FG001|Overall Study|Study Termination|63|||
16400635|NCT01005316|39948344|FG002|Overall Study|Study Termination|9|||
16400636|NCT01005316|39948345|FG003|Overall Study|Study Termination|85|||
16400637|NCT01005316|39948342|FG000|Overall Study|Lost to Follow-up|1|||
16400638|NCT01005316|39948343|FG001|Overall Study|Lost to Follow-up|3|||
16400639|NCT01005316|39948344|FG002|Overall Study|Lost to Follow-up|0|||
16400640|NCT01005316|39948345|FG003|Overall Study|Lost to Follow-up|2|||
16400641|NCT01005316|39948342|FG000|Overall Study|Physician Decision|6|||
16400642|NCT01005316|39948343|FG001|Overall Study|Physician Decision|0|||
16400643|NCT01005316|39948344|FG002|Overall Study|Physician Decision|0|||
16400644|NCT01005316|39948345|FG003|Overall Study|Physician Decision|0|||
16400645|NCT01005316|39948342|FG000|Overall Study|Sponsor Decision|6|||
16400646|NCT01005316|39948343|FG001|Overall Study|Sponsor Decision|3|||
16400647|NCT01005316|39948344|FG002|Overall Study|Sponsor Decision|0|||
16400648|NCT01005316|39948345|FG003|Overall Study|Sponsor Decision|0|||
16400649|NCT01005316|39948342|FG000|Overall Study|Withdrawal by Subject|1|||
16400650|NCT01005316|39948343|FG001|Overall Study|Withdrawal by Subject|1|||
16400651|NCT01005316|39948344|FG002|Overall Study|Withdrawal by Subject|0|||
16400652|NCT01005316|39948345|FG003|Overall Study|Withdrawal by Subject|2|||
16400653|NCT01005316|39948342|FG000|Overall Study|Consented to Another Study|2|||
16400654|NCT01005316|39948343|FG001|Overall Study|Consented to Another Study|0|||
16400655|NCT01005316|39948344|FG002|Overall Study|Consented to Another Study|0|||
16331007|NCT02607306|39699810|FG001|Overall Study|Adverse Event|6|||
16331008|NCT02607306|39699811|FG002|Overall Study|Adverse Event|6|||
16331009|NCT02607306|39699809|FG000|Overall Study|Unclassified|1|||
16331010|NCT02607306|39699810|FG001|Overall Study|Unclassified|4|||
16331011|NCT02607306|39699811|FG002|Overall Study|Unclassified|0|||
16331012|NCT02607306|39699809|FG000|Overall Study|Withdrawal by Subject|8|||
16331013|NCT02607306|39699810|FG001|Overall Study|Withdrawal by Subject|10|||
16331014|NCT02607306|39699811|FG002|Overall Study|Withdrawal by Subject|2|||
16331015|NCT02607306|39699809|FG000|Overall Study|Lack of Efficacy|0|||
16331016|NCT02607306|39699810|FG001|Overall Study|Lack of Efficacy|1|||
16331017|NCT02607306|39699811|FG002|Overall Study|Lack of Efficacy|1|||
16331018|NCT02607306|39699809|FG000|Overall Study|Protocol Violation|4|||
16331019|NCT02607306|39699810|FG001|Overall Study|Protocol Violation|2|||
16400656|NCT01005316|39948345|FG003|Overall Study|Consented to Another Study|0|||
16400657|NCT01005316|39948342|FG000|Overall Study|Delisted|8|||
16331020|NCT02607306|39699811|FG002|Overall Study|Protocol Violation|1|||
16331021|NCT00415597|39699813|FG000|Enrollment|Withdrawal by Subject|1|||
16331022|NCT00415597|39699813|FG000|Enrollment|Protocol Violation|1|||
16400658|NCT01005316|39948343|FG001|Overall Study|Delisted|0|||
16400659|NCT01005316|39948344|FG002|Overall Study|Delisted|0|||
16331023|NCT00415597|39699813|FG000|Treatment|Adverse Event|110|||
16331024|NCT00415597|39699813|FG000|Treatment|Lack of Efficacy|39|||
16331025|NCT00415597|39699813|FG000|Treatment|Protocol Violation|67|||
16331026|NCT00415597|39699813|FG000|Treatment|Physician Decision|3|||
16400660|NCT01005316|39948345|FG003|Overall Study|Delisted|0|||
16400661|NCT01005316|39948342|FG000|Overall Study|Transferred Care|1|||
16400662|NCT01005316|39948343|FG001|Overall Study|Transferred Care|0|||
16400663|NCT01005316|39948344|FG002|Overall Study|Transferred Care|1|||
16400664|NCT01005316|39948345|FG003|Overall Study|Transferred Care|3|||
16400665|NCT01005316|39948342|FG000|Overall Study|Retransplanted|0|||
16331027|NCT00415597|39699813|FG000|Treatment|Withdrawal by Subject|51|||
16331028|NCT00415597|39699813|FG000|Treatment|Lost to Follow-up|28|||
16331029|NCT00415597|39699813|FG000|Treatment|Drug Screen|2|||
16400666|NCT01005316|39948343|FG001|Overall Study|Retransplanted|1|||
16400667|NCT01005316|39948344|FG002|Overall Study|Retransplanted|0|||
16400668|NCT01005316|39948345|FG003|Overall Study|Retransplanted|0|||
16400669|NCT00391430|39948346|FG000|Overall Study|Withdrawal by Subject|3|||
16400670|NCT00391430|39948347|FG001|Overall Study|Withdrawal by Subject|0|||
16400671|NCT00391430|39948348|FG002|Overall Study|Withdrawal by Subject|12|||
16400672|NCT01942161|39948351|FG000|Overall Study|Adverse Event|1|||
16400673|NCT01942161|39948352|FG001|Overall Study|Adverse Event|2|||
16400674|NCT01942161|39948353|FG002|Overall Study|Adverse Event|5|||
16400675|NCT01942161|39948351|FG000|Overall Study|Physician Decision|3|||
16400676|NCT01942161|39948352|FG001|Overall Study|Physician Decision|1|||
16400677|NCT01942161|39948353|FG002|Overall Study|Physician Decision|0|||
16400678|NCT01942161|39948351|FG000|Overall Study|Protocol Violation|1|||
16400679|NCT01942161|39948352|FG001|Overall Study|Protocol Violation|0|||
16400680|NCT01942161|39948353|FG002|Overall Study|Protocol Violation|0|||
16400681|NCT01942161|39948351|FG000|Overall Study|Withdrawal by Subject|3|||
16400682|NCT01942161|39948352|FG001|Overall Study|Withdrawal by Subject|3|||
16400683|NCT01942161|39948353|FG002|Overall Study|Withdrawal by Subject|1|||
16400684|NCT02141399|39948359|FG000|Overall Study|Adverse Event|158|||
16400685|NCT02141399|39948359|FG000|Overall Study|Lack of Efficacy|62|||
16400686|NCT02141399|39948359|FG000|Overall Study|Lost to Follow-up|151|||
16400687|NCT02141399|39948359|FG000|Overall Study|Non-compliance with study drug|18|||
16400688|NCT02141399|39948359|FG000|Overall Study|Other|45|||
16400689|NCT02141399|39948359|FG000|Overall Study|Physician Decision|17|||
16400690|NCT02141399|39948359|FG000|Overall Study|Pregnancy|3|||
16400691|NCT02141399|39948359|FG000|Overall Study|Protocol Violation|38|||
16400692|NCT02141399|39948359|FG000|Overall Study|Withdrawal by Subject|238|||
16400693|NCT02141399|39948359|FG000|Overall Study|Failure to meet eligibility criteria|14|||
16400694|NCT00873041|39948363|FG000|Core Study|Adverse Event|2|||
16400695|NCT00873041|39948364|FG001|Core Study|Adverse Event|3|||
16400696|NCT00873041|39948365|FG002|Core Study|Adverse Event|1|||
16400697|NCT00873041|39948363|FG000|Core Study|Withdrawal by Subject|1|||
16400698|NCT00873041|39948364|FG001|Core Study|Withdrawal by Subject|2|||
16400699|NCT00873041|39948365|FG002|Core Study|Withdrawal by Subject|2|||
16400700|NCT00873041|39948363|FG000|Core Study|Lost to Follow-up|3|||
16400701|NCT00873041|39948364|FG001|Core Study|Lost to Follow-up|1|||
16400702|NCT00873041|39948365|FG002|Core Study|Lost to Follow-up|0|||
16400703|NCT00873041|39948363|FG000|Core Study|Abnormal laboratory value|0|||
16400704|NCT00873041|39948364|FG001|Core Study|Abnormal laboratory value|0|||
16400705|NCT00873041|39948365|FG002|Core Study|Abnormal laboratory value|1|||
16400706|NCT00873041|39948363|FG000|Core Study|Protocol deviation|1|||
16400707|NCT00873041|39948364|FG001|Core Study|Protocol deviation|0|||
16400708|NCT00873041|39948365|FG002|Core Study|Protocol deviation|1|||
16400709|NCT00873041|39948363|FG000|Extension Study|Adverse Event|1|||
16400710|NCT00873041|39948364|FG001|Extension Study|Adverse Event|0|||
16400711|NCT00873041|39948365|FG002|Extension Study|Adverse Event|1|||
16400712|NCT00873041|39948363|FG000|Extension Study|Administrative reasons|0|||
16400713|NCT00873041|39948364|FG001|Extension Study|Administrative reasons|0|||
16400714|NCT00873041|39948365|FG002|Extension Study|Administrative reasons|1|||
16400715|NCT02247011|39948369|FG000|Overall Study|Poor quality of radiological results|125|||
16400716|NCT01439971|39948370|FG000|Overall Study|Required number in cohort dosed|0|||
16400717|NCT01439971|39948371|FG001|Overall Study|Required number in cohort dosed|1|||
16400718|NCT01439971|39948372|FG002|Overall Study|Required number in cohort dosed|2|||
16400719|NCT01439971|39948373|FG003|Overall Study|Required number in cohort dosed|0|||
16400720|NCT01439971|39948374|FG004|Overall Study|Required number in cohort dosed|1|||
16400721|NCT01921218|39948376|FG000|Overall Study|Death|2|||
16400722|NCT01921218|39948377|FG001|Overall Study|Death|1|||
16400723|NCT01921218|39948376|FG000|Overall Study|Withdrawal by Subject|0|||
16400724|NCT01921218|39948377|FG001|Overall Study|Withdrawal by Subject|2|||
16331030|NCT00415597|39699813|FG000|Treatment|Administrative|3|||
16331031|NCT00415597|39699813|FG000|Treatment|Sponsor Decision|1|||
16331032|NCT00415597|39699813|FG000|Treatment|Multiple Reasons|1|||
16331033|NCT01430624|39699814|FG000|Overall Study|Lost to Follow-up|23|||
16331034|NCT01430624|39699815|FG001|Overall Study|Lost to Follow-up|29|||
16331035|NCT01430624|39699816|FG002|Overall Study|Lost to Follow-up|27|||
16331036|NCT01430624|39699814|FG000|Overall Study|technical or eligibility|5|||
16331037|NCT01430624|39699815|FG001|Overall Study|technical or eligibility|5|||
16331038|NCT01430624|39699816|FG002|Overall Study|technical or eligibility|2|||
16331039|NCT01706575|39699817|FG000|Overall Study|Participant Withdrew Consent|4|||
16400725|NCT01921218|39948376|FG000|Overall Study|Kidney transplant|1|||
16400726|NCT01921218|39948377|FG001|Overall Study|Kidney transplant|1|||
16400727|NCT01920568|39948378|FG000|Overall Study|Adverse Event|27|||
16400728|NCT01920568|39948379|FG001|Overall Study|Adverse Event|8|||
16400729|NCT01920568|39948378|FG000|Overall Study|Protocol Violation|5|||
16400730|NCT01920568|39948379|FG001|Overall Study|Protocol Violation|3|||
16400731|NCT01920568|39948378|FG000|Overall Study|Lost to Follow-up|2|||
16400732|NCT01920568|39948379|FG001|Overall Study|Lost to Follow-up|2|||
16400733|NCT01920568|39948378|FG000|Overall Study|Physician Decision|13|||
16400734|NCT01920568|39948379|FG001|Overall Study|Physician Decision|4|||
16528515|NCT01292603|40401389|FG002|Part 2: Dose Confirmation Period|Death|0|||
16528516|NCT01292603|40401390|FG003|Part 2: Dose Confirmation Period|Death|0|||
16528517|NCT01292603|40401391|FG004|Part 2: Dose Confirmation Period|Death|1|||
16528518|NCT01292603|40401392|FG005|Part 2: Dose Confirmation Period|Death|0|||
16528519|NCT01292603|40401387|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
16528520|NCT01292603|40401388|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
16528521|NCT01292603|40401389|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
16528522|NCT01292603|40401390|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
16528523|NCT01292603|40401391|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
16528524|NCT01292603|40401392|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
16528525|NCT01292603|40401387|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
16331040|NCT01706575|39699817|FG000|Overall Study|Lost to Follow-up|2|||
16331041|NCT01706575|39699817|FG000|Overall Study|Started but not Treated|6|||
16331042|NCT03627416|39699818|FG000|Overall Study|Adverse Event|0|||
16331043|NCT03627416|39699819|FG001|Overall Study|Adverse Event|1|||
16331044|NCT02450552|39699820|FG000|Overall Study|Withdrawal by Subject|4|||
16331045|NCT02450552|39699821|FG001|Overall Study|Withdrawal by Subject|0|||
16331046|NCT02450552|39699822|FG002|Overall Study|Withdrawal by Subject|4|||
16331047|NCT02450552|39699820|FG000|Overall Study|Physician Decision|1|||
16331048|NCT02450552|39699821|FG001|Overall Study|Physician Decision|0|||
16331049|NCT02450552|39699822|FG002|Overall Study|Physician Decision|1|||
16331050|NCT02243046|39699823|FG000|Overall Study|Lost to Follow-up|1|||
16331051|NCT02243046|39699824|FG001|Overall Study|Lost to Follow-up|1|||
16331052|NCT02243046|39699825|FG002|Overall Study|Lost to Follow-up|4|||
16331053|NCT02553499|39699826|FG000|Overall Study|Adverse Event|0|||
16331054|NCT02553499|39699827|FG001|Overall Study|Adverse Event|0|||
16331055|NCT02553499|39699828|FG002|Overall Study|Adverse Event|0|||
16528526|NCT01292603|40401388|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
16528527|NCT01292603|40401389|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
16528528|NCT01292603|40401390|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
16528529|NCT01292603|40401391|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
16528530|NCT01292603|40401392|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
16528531|NCT01292603|40401387|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
16528532|NCT01292603|40401388|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
16528533|NCT01292603|40401389|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
16528534|NCT01292603|40401390|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
16528535|NCT01292603|40401391|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
16528536|NCT01292603|40401392|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
16528537|NCT01292603|40401387|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
16528538|NCT01292603|40401388|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
16528539|NCT01292603|40401389|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
16528540|NCT01292603|40401390|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
16528541|NCT01292603|40401391|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
16528542|NCT01292603|40401392|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
16528543|NCT01292603|40401387|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
16528544|NCT01292603|40401388|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
16528545|NCT01292603|40401389|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
16528546|NCT01292603|40401390|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
16528547|NCT01292603|40401391|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
16528548|NCT01292603|40401392|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
16528549|NCT01292603|40401387|FG000|Part 2: Regular Follow-Up|Death|0|||
16528550|NCT01292603|40401388|FG001|Part 2: Regular Follow-Up|Death|0|||
16528551|NCT01292603|40401389|FG002|Part 2: Regular Follow-Up|Death|0|||
16528552|NCT01292603|40401390|FG003|Part 2: Regular Follow-Up|Death|0|||
16528553|NCT01292603|40401391|FG004|Part 2: Regular Follow-Up|Death|6|||
16528554|NCT01292603|40401392|FG005|Part 2: Regular Follow-Up|Death|3|||
16528555|NCT01292603|40401387|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
16528556|NCT01292603|40401388|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
16528557|NCT01292603|40401389|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
16528558|NCT01292603|40401390|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
16528559|NCT01292603|40401391|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
16528560|NCT01292603|40401392|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
16528561|NCT01292603|40401387|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
16528562|NCT01292603|40401388|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
16331056|NCT02553499|39699829|FG003|Overall Study|Adverse Event|0|||
16528563|NCT01292603|40401389|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
16528564|NCT01292603|40401390|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
16528565|NCT01292603|40401391|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
16331057|NCT02553499|39699830|FG004|Overall Study|Adverse Event|0|||
16331058|NCT02553499|39699831|FG005|Overall Study|Adverse Event|0|||
16331059|NCT02553499|39699832|FG006|Overall Study|Adverse Event|1|||
16331060|NCT02553499|39699833|FG007|Overall Study|Adverse Event|1|||
16528566|NCT01292603|40401392|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
16528567|NCT01292603|40401387|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
16528568|NCT01292603|40401388|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
16528569|NCT01292603|40401389|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
16528570|NCT01292603|40401390|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
16528571|NCT01292603|40401391|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
16528572|NCT01292603|40401392|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
16528573|NCT01292603|40401387|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
16528574|NCT01292603|40401388|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
16528575|NCT01292603|40401389|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
16528576|NCT01292603|40401390|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
16528577|NCT01292603|40401391|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
16528578|NCT01292603|40401392|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
16528579|NCT01292603|40401387|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
16528580|NCT01292603|40401388|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
16528581|NCT01292603|40401389|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
16528582|NCT01292603|40401390|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
16528583|NCT01292603|40401391|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
16528584|NCT01292603|40401392|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
16528585|NCT01292603|40401387|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
16528586|NCT01292603|40401388|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
16528587|NCT01292603|40401389|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
16528588|NCT01292603|40401390|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
16528589|NCT01292603|40401391|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
16528590|NCT01292603|40401392|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
16528591|NCT01292603|40401387|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
16528592|NCT01292603|40401388|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
16528593|NCT01292603|40401389|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
16528594|NCT01292603|40401390|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
16528595|NCT01292603|40401391|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
16528596|NCT01292603|40401392|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
16528597|NCT01292603|40401387|FG000|Overall Survival Status|Death|3|||
16528598|NCT01292603|40401388|FG001|Overall Survival Status|Death|1|||
16528599|NCT01292603|40401389|FG002|Overall Survival Status|Death|3|||
16528600|NCT01292603|40401390|FG003|Overall Survival Status|Death|1|||
16528601|NCT01292603|40401391|FG004|Overall Survival Status|Death|16|||
16528602|NCT01292603|40401392|FG005|Overall Survival Status|Death|10|||
16528603|NCT01672801|40401394|FG000|Overall Study|Screen Failure|0|||
16528604|NCT01672801|40401395|FG001|Overall Study|Screen Failure|1|||
16528605|NCT01682460|40401401|FG000|Overall Study|Withdrawal by Subject|2|||
16528606|NCT01682460|40401401|FG000|Overall Study|Did not meet inclusion criteria|2|||
16528607|NCT01639001|40401410|FG000|Overall Study|Refused further follow-up|9|||
16528608|NCT01639001|40401411|FG001|Overall Study|Refused further follow-up|12|||
16528609|NCT01639001|40401410|FG000|Overall Study|Lost to Follow-up|3|||
16528610|NCT01639001|40401411|FG001|Overall Study|Lost to Follow-up|0|||
16528611|NCT01639001|40401410|FG000|Overall Study|Death|62|||
16528612|NCT01639001|40401411|FG001|Overall Study|Death|61|||
16528613|NCT01639001|40401410|FG000|Overall Study|Randomized but not treated|0|||
16528614|NCT01639001|40401411|FG001|Overall Study|Randomized but not treated|2|||
16528615|NCT01639001|40401410|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
16528616|NCT01639001|40401411|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
16528617|NCT01605617|40401412|FG000|First Intervention|Adverse Event|0|||
16528618|NCT01605617|40401413|FG001|First Intervention|Adverse Event|1|||
16528619|NCT01605617|40401412|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
16528620|NCT01605617|40401413|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
16528621|NCT00467870|40401414|FG000|Overall Study|Adverse Event|13|||
16528622|NCT00467870|40401415|FG001|Overall Study|Adverse Event|9|||
16528623|NCT00467870|40401416|FG002|Overall Study|Adverse Event|1|||
16528624|NCT00467870|40401417|FG003|Overall Study|Adverse Event|15|||
16528625|NCT00467870|40401418|FG004|Overall Study|Adverse Event|15|||
16212247|NCT02614261|39258618|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
16212248|NCT02614261|39258615|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
16528626|NCT00467870|40401419|FG005|Overall Study|Adverse Event|1|||
16528627|NCT00467870|40401414|FG000|Overall Study|Protocol Violation|2|||
16528628|NCT00467870|40401415|FG001|Overall Study|Protocol Violation|1|||
16528629|NCT00467870|40401416|FG002|Overall Study|Protocol Violation|1|||
16528630|NCT00467870|40401417|FG003|Overall Study|Protocol Violation|2|||
16528631|NCT00467870|40401418|FG004|Overall Study|Protocol Violation|0|||
16528632|NCT00467870|40401419|FG005|Overall Study|Protocol Violation|0|||
16528633|NCT00467870|40401414|FG000|Overall Study|Withdrawal by Subject|14|||
16528634|NCT00467870|40401415|FG001|Overall Study|Withdrawal by Subject|21|||
16528635|NCT00467870|40401416|FG002|Overall Study|Withdrawal by Subject|0|||
16528636|NCT00467870|40401417|FG003|Overall Study|Withdrawal by Subject|9|||
16528637|NCT00467870|40401418|FG004|Overall Study|Withdrawal by Subject|10|||
16528638|NCT00467870|40401419|FG005|Overall Study|Withdrawal by Subject|1|||
16528639|NCT00467870|40401414|FG000|Overall Study|Lost to Follow-up|5|||
16528640|NCT00467870|40401415|FG001|Overall Study|Lost to Follow-up|3|||
16528641|NCT00467870|40401416|FG002|Overall Study|Lost to Follow-up|1|||
16528642|NCT00467870|40401417|FG003|Overall Study|Lost to Follow-up|1|||
16528643|NCT00467870|40401418|FG004|Overall Study|Lost to Follow-up|3|||
16528644|NCT00467870|40401419|FG005|Overall Study|Lost to Follow-up|0|||
16528645|NCT00467870|40401414|FG000|Overall Study|Subject Non-compliance|3|||
16528646|NCT00467870|40401415|FG001|Overall Study|Subject Non-compliance|4|||
16528647|NCT00467870|40401416|FG002|Overall Study|Subject Non-compliance|0|||
16528648|NCT00467870|40401417|FG003|Overall Study|Subject Non-compliance|1|||
16528649|NCT00467870|40401418|FG004|Overall Study|Subject Non-compliance|5|||
16528650|NCT00467870|40401419|FG005|Overall Study|Subject Non-compliance|0|||
16528651|NCT00467870|40401414|FG000|Overall Study|Other/Unknown|8|||
16528652|NCT00467870|40401415|FG001|Overall Study|Other/Unknown|5|||
16528653|NCT00467870|40401416|FG002|Overall Study|Other/Unknown|1|||
16528654|NCT00467870|40401417|FG003|Overall Study|Other/Unknown|5|||
16528655|NCT00467870|40401418|FG004|Overall Study|Other/Unknown|4|||
16528656|NCT00467870|40401419|FG005|Overall Study|Other/Unknown|0|||
16528657|NCT01808690|40401420|FG000|Overall Study|Withdrawal by Subject|1|||
16528658|NCT01808690|40401421|FG001|Overall Study|Withdrawal by Subject|2|||
16528659|NCT00413153|40401423|FG000|Overall Study|Withdrawal by Subject|1|||
16528660|NCT00413153|40401424|FG001|Overall Study|Withdrawal by Subject|1|||
16528661|NCT00413153|40401423|FG000|Overall Study|Adverse Event|1|||
16528662|NCT00413153|40401424|FG001|Overall Study|Adverse Event|0|||
16528663|NCT04495374|40401425|FG000|Overall Study|Protocol Violation|2|||
16528664|NCT04495374|40401426|FG001|Overall Study|Protocol Violation|1|||
16528665|NCT03836053|40401430|FG000|Overall Study|Protocol-specified criteria|0|||
16528666|NCT03836053|40401431|FG001|Overall Study|Protocol-specified criteria|2|||
16528667|NCT03836053|40401432|FG002|Overall Study|Protocol-specified criteria|1|||
16528668|NCT03836053|40401430|FG000|Overall Study|Death|1|||
16528669|NCT03836053|40401431|FG001|Overall Study|Death|6|||
16528670|NCT03836053|40401432|FG002|Overall Study|Death|4|||
16528671|NCT03836053|40401430|FG000|Overall Study|Withdrawal of consent from study|0|||
16528672|NCT03836053|40401431|FG001|Overall Study|Withdrawal of consent from study|0|||
16528673|NCT03836053|40401432|FG002|Overall Study|Withdrawal of consent from study|1|||
16528674|NCT03836053|40401430|FG000|Overall Study|Decision by sponsor|0|||
16528675|NCT03836053|40401431|FG001|Overall Study|Decision by sponsor|2|||
16528676|NCT03836053|40401432|FG002|Overall Study|Decision by sponsor|4|||
16528677|NCT02079805|40401433|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16528678|NCT02079805|40401434|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
16528679|NCT02079805|40401433|FG000|Overall Study|Voluntary Withdrawal|0|||
16528680|NCT02079805|40401434|FG001|Overall Study|Voluntary Withdrawal|1|||
16528681|NCT01748994|40401435|FG000|Overall Study|Lost to Follow-up|8|||
16528682|NCT01748994|40401436|FG001|Overall Study|Lost to Follow-up|6|||
16528683|NCT02169674|40401437|FG000|Overall Study|Withdrawal by Subject|2|||
16528684|NCT02169674|40401438|FG001|Overall Study|Withdrawal by Subject|1|||
16528685|NCT02169674|40401437|FG000|Overall Study|Seroprotected|30|||
16528686|NCT02169674|40401438|FG001|Overall Study|Seroprotected|76|||
16528687|NCT02169674|40401437|FG000|Overall Study|Lost to Follow-up|0|||
16528688|NCT02169674|40401438|FG001|Overall Study|Lost to Follow-up|1|||
16528689|NCT02345512|40401439|FG000|Overall Study|Adverse Event|1|||
16528690|NCT02345512|40401439|FG000|Overall Study|Withdrawal by Subject|1|||
16528691|NCT00796718|40401440|FG000|Overall Study|Adverse Event|2|||
16528692|NCT00796718|40401440|FG000|Overall Study|Exclusion Criteria|1|||
16528693|NCT00796718|40401440|FG000|Overall Study|Lost to Follow-up|5|||
16528694|NCT00796718|40401440|FG000|Overall Study|Withdrawal by Informed Consent|1|||
16528695|NCT00511004|40401441|FG000|Overall Study|Lost to Follow-up|0|||
16528696|NCT00511004|40401442|FG001|Overall Study|Lost to Follow-up|0|||
16528697|NCT00511004|40401443|FG002|Overall Study|Lost to Follow-up|4|||
16528698|NCT03034577|40401444|FG000|Overall Study|Withdrawal by Subject|6|||
16528699|NCT03034577|40401445|FG001|Overall Study|Withdrawal by Subject|9|||
16528700|NCT03034577|40401444|FG000|Overall Study|Lost to Follow-up|25|||
16528701|NCT03034577|40401445|FG001|Overall Study|Lost to Follow-up|26|||
16528702|NCT00970502|40401446|FG000|Overall Study|Withdrawal by Subject|1|||
16528703|NCT04307186|40401454|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
16528704|NCT04307186|40401454|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
16528705|NCT04307186|40401454|FG000|Washout 3-14 Days|Progressive disease|1|||
16528706|NCT04307186|40401454|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
16528707|NCT04307186|40401454|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
16528708|NCT02730819|40401462|FG000|Overall Study|Lost to Follow-up|9|||
16528709|NCT02866682|40401463|FG000|Overall Study|Death|0|||
16528710|NCT02866682|40401464|FG001|Overall Study|Death|1|||
16528711|NCT02866682|40401463|FG000|Overall Study|Lost to Follow-up|0|||
16528712|NCT02866682|40401464|FG001|Overall Study|Lost to Follow-up|4|||
16528713|NCT02866682|40401463|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
16528714|NCT02866682|40401464|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
16528715|NCT02866682|40401463|FG000|Overall Study|Other|0|||
16400735|NCT01920568|39948378|FG000|Overall Study|Withdrawal by Subject|79|||
16400736|NCT01920568|39948379|FG001|Overall Study|Withdrawal by Subject|55|||
16400737|NCT01920568|39948378|FG000|Overall Study|Death due to disease progression|25|||
16400738|NCT01920568|39948379|FG001|Overall Study|Death due to disease progression|12|||
16400739|NCT01252186|39948380|FG000|Overall Study|Adverse Event|9|||
16400740|NCT01252186|39948381|FG001|Overall Study|Adverse Event|6|||
16400741|NCT01252186|39948382|FG002|Overall Study|Adverse Event|8|||
16400742|NCT01252186|39948380|FG000|Overall Study|Withdrawal by Subject|2|||
16400743|NCT01252186|39948381|FG001|Overall Study|Withdrawal by Subject|5|||
16400744|NCT01252186|39948382|FG002|Overall Study|Withdrawal by Subject|2|||
16400745|NCT01252186|39948380|FG000|Overall Study|Physician Decision|0|||
16400746|NCT01252186|39948381|FG001|Overall Study|Physician Decision|0|||
16528716|NCT02866682|40401464|FG001|Overall Study|Other|1|||
16528717|NCT05553808|40401467|FG000|Overall Study|Death|25|||
16528718|NCT05553808|40401468|FG001|Overall Study|Death|62|||
16528719|NCT05553808|40401467|FG000|Overall Study|Site Closed|6|||
16528720|NCT05553808|40401468|FG001|Overall Study|Site Closed|6|||
16528721|NCT05553808|40401467|FG000|Overall Study|Lost to Follow-up|1|||
16528722|NCT05553808|40401468|FG001|Overall Study|Lost to Follow-up|0|||
16528723|NCT05553808|40401467|FG000|Overall Study|Withdrawal by Subject|3|||
16528724|NCT05553808|40401468|FG001|Overall Study|Withdrawal by Subject|2|||
16528725|NCT02525133|40401469|FG000|Overall Study|Adverse Event|0|||
16528726|NCT02525133|40401470|FG001|Overall Study|Adverse Event|1|||
16528727|NCT02525133|40401469|FG000|Overall Study|Death|0|||
16528728|NCT02525133|40401470|FG001|Overall Study|Death|1|||
16528729|NCT02525133|40401469|FG000|Overall Study|did not meet randomization criteria|1|||
16528730|NCT02525133|40401470|FG001|Overall Study|did not meet randomization criteria|0|||
16528731|NCT02525133|40401469|FG000|Overall Study|Lost to Follow-up|5|||
16528732|NCT02525133|40401470|FG001|Overall Study|Lost to Follow-up|1|||
16528733|NCT02525133|40401469|FG000|Overall Study|randomized not enrolled|3|||
16528734|NCT02525133|40401470|FG001|Overall Study|randomized not enrolled|0|||
16528735|NCT02525133|40401469|FG000|Overall Study|Withdrawal by Subject|1|||
16528736|NCT02525133|40401470|FG001|Overall Study|Withdrawal by Subject|0|||
16528737|NCT00993447|40401471|FG000|Overall Study|Withdrawal by Subject|23|||
16528738|NCT00993447|40401472|FG001|Overall Study|Withdrawal by Subject|8|||
16528739|NCT00993447|40401471|FG000|Overall Study|Protocol Violation|12|||
16528740|NCT00993447|40401472|FG001|Overall Study|Protocol Violation|8|||
16528741|NCT00993447|40401471|FG000|Overall Study|Lost to Follow-up|1|||
16528742|NCT00993447|40401472|FG001|Overall Study|Lost to Follow-up|3|||
16528743|NCT00993447|40401471|FG000|Overall Study|Adverse Event|1|||
16528744|NCT00993447|40401472|FG001|Overall Study|Adverse Event|0|||
16528745|NCT00766376|40401473|FG000|Overall Study|Withdrawal by Subject|27|||
16528746|NCT02416791|40401475|FG000|6 Months|Lost to Follow-up|0|||
16528747|NCT02416791|40401476|FG001|6 Months|Lost to Follow-up|0|||
16528748|NCT02416791|40401477|FG002|6 Months|Lost to Follow-up|1|||
16528749|NCT01556438|40401478|FG000|Overall Study|Adverse Event|4|||
16528750|NCT01556438|40401479|FG001|Overall Study|Adverse Event|2|||
16528751|NCT01556438|40401478|FG000|Overall Study|Sponsor Decision|0|||
16528752|NCT01556438|40401479|FG001|Overall Study|Sponsor Decision|2|||
16528753|NCT01556438|40401478|FG000|Overall Study|Progressive Disease|0|||
16528754|NCT01556438|40401479|FG001|Overall Study|Progressive Disease|6|||
16528755|NCT01556438|40401478|FG000|Overall Study|Death|0|||
16528756|NCT01556438|40401479|FG001|Overall Study|Death|1|||
16528757|NCT01306162|40401480|FG000|Period 1|Adverse Event|0|||
16528758|NCT01306162|40401481|FG001|Period 1|Adverse Event|0|||
16528759|NCT01306162|40401482|FG002|Period 1|Adverse Event|0|||
16528760|NCT01306162|40401483|FG003|Period 1|Adverse Event|1|||
16528761|NCT01306162|40401480|FG000|Washout 1|Non-compliance to protocol|0|||
16528762|NCT01306162|40401481|FG001|Washout 1|Non-compliance to protocol|1|||
16528763|NCT01306162|40401482|FG002|Washout 1|Non-compliance to protocol|0|||
16528764|NCT01306162|40401483|FG003|Washout 1|Non-compliance to protocol|0|||
16528765|NCT02328326|40401484|FG000|Overall Study|Withdrawal by Subject|10|||
16528766|NCT02328326|40401485|FG001|Overall Study|Withdrawal by Subject|3|||
16528767|NCT02328326|40401484|FG000|Overall Study|Death|2|||
16528768|NCT02328326|40401485|FG001|Overall Study|Death|1|||
16528769|NCT02328326|40401484|FG000|Overall Study|Lost to Follow-up|10|||
16528770|NCT02328326|40401485|FG001|Overall Study|Lost to Follow-up|4|||
16528771|NCT00965523|40401488|FG000|Study 221|Progressive Disease|4|||
16528772|NCT00965523|40401488|FG000|Study 221|Physician Decision|3|||
16528773|NCT00965523|40401488|FG000|Study 224|Progressive Disease|5|||
16528774|NCT00965523|40401488|FG000|Study 224|Physician Decision|1|||
16528775|NCT04447404|40401493|FG000|Overall Study|Death|2|||
16528776|NCT04447404|40401494|FG001|Overall Study|Death|0|||
16400747|NCT01252186|39948382|FG002|Overall Study|Physician Decision|1|||
16528777|NCT01519206|40401500|FG000|Overall Study|Lost to Follow-up|3|||
16528778|NCT01519206|40401500|FG000|Overall Study|Missed Visit|2|||
16528779|NCT00987467|40401501|FG000|Overall Study|Lost to Follow-up|2|||
16528780|NCT02566031|40401504|FG000|Overall Study|Patient/guardian decision|14|||
16528781|NCT02566031|40401505|FG001|Overall Study|Patient/guardian decision|7|||
16528782|NCT02566031|40401504|FG000|Overall Study|Protocol deviation|2|||
16528783|NCT02566031|40401505|FG001|Overall Study|Protocol deviation|3|||
16528784|NCT02566031|40401504|FG000|Overall Study|Adverse Event|3|||
16528785|NCT02566031|40401505|FG001|Overall Study|Adverse Event|1|||
16528786|NCT02566031|40401504|FG000|Overall Study|Lost to Follow-up|1|||
16528787|NCT02566031|40401505|FG001|Overall Study|Lost to Follow-up|1|||
16528788|NCT02005471|40401508|FG000|Main Study|Adverse Event|0|||
16528789|NCT02005471|40401509|FG001|Main Study|Adverse Event|1|||
16528790|NCT02005471|40401510|FG002|Main Study|Adverse Event|0|||
16528791|NCT02005471|40401511|FG003|Main Study|Adverse Event|0|||
16528792|NCT02005471|40401508|FG000|Main Study|Death|83|||
16528793|NCT02005471|40401509|FG001|Main Study|Death|52|||
16528794|NCT02005471|40401510|FG002|Main Study|Death|0|||
16528795|NCT02005471|40401511|FG003|Main Study|Death|0|||
16528796|NCT02005471|40401508|FG000|Main Study|Lost to Follow-up|4|||
16528797|NCT02005471|40401509|FG001|Main Study|Lost to Follow-up|5|||
16528798|NCT02005471|40401510|FG002|Main Study|Lost to Follow-up|0|||
16528799|NCT02005471|40401511|FG003|Main Study|Lost to Follow-up|0|||
16528800|NCT02005471|40401508|FG000|Main Study|Physician Decision|3|||
16528801|NCT02005471|40401509|FG001|Main Study|Physician Decision|1|||
16528802|NCT02005471|40401510|FG002|Main Study|Physician Decision|0|||
16528803|NCT02005471|40401511|FG003|Main Study|Physician Decision|0|||
16528804|NCT02005471|40401508|FG000|Main Study|Withdrawal by Subject|26|||
16528805|NCT02005471|40401509|FG001|Main Study|Withdrawal by Subject|11|||
16528806|NCT02005471|40401510|FG002|Main Study|Withdrawal by Subject|0|||
16528807|NCT02005471|40401511|FG003|Main Study|Withdrawal by Subject|0|||
16528808|NCT02005471|40401508|FG000|Main Study|Reason not Specified|0|||
16528809|NCT02005471|40401509|FG001|Main Study|Reason not Specified|6|||
16528810|NCT02005471|40401510|FG002|Main Study|Reason not Specified|0|||
16528811|NCT02005471|40401511|FG003|Main Study|Reason not Specified|0|||
16528812|NCT02005471|40401508|FG000|Main Study|Randomized but not Dosed|8|||
16528813|NCT02005471|40401509|FG001|Main Study|Randomized but not Dosed|0|||
16528814|NCT02005471|40401510|FG002|Main Study|Randomized but not Dosed|0|||
16528815|NCT02005471|40401511|FG003|Main Study|Randomized but not Dosed|0|||
16528816|NCT02005471|40401508|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
16528817|NCT02005471|40401509|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
16528818|NCT02005471|40401510|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
16528819|NCT02005471|40401511|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
16528820|NCT02005471|40401508|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
16528821|NCT02005471|40401509|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
16528822|NCT02005471|40401510|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
16528823|NCT02005471|40401511|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
16528824|NCT02005471|40401508|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
16528825|NCT02005471|40401509|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
16528826|NCT02005471|40401510|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
16528827|NCT02005471|40401511|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
16528828|NCT02493127|40401514|FG000|Overall Study|Lost to Follow-up|1|||
16528829|NCT02493127|40401515|FG001|Overall Study|Lost to Follow-up|1|||
16528830|NCT02979535|40401516|FG000|Overall Study|Non compliance with the protocol|78|||
16528831|NCT02979535|40401517|FG001|Overall Study|Non compliance with the protocol|82|||
16528832|NCT02979535|40401516|FG000|Overall Study|Consent withdrawn by participant|11|||
16528833|NCT02979535|40401517|FG001|Overall Study|Consent withdrawn by participant|18|||
16528834|NCT02979535|40401516|FG000|Overall Study|Lost to Follow-up|6|||
16528835|NCT02979535|40401517|FG001|Overall Study|Lost to Follow-up|1|||
16528836|NCT01435577|40401520|FG000|Overall Study|Adverse Event|10|||
16528837|NCT01435577|40401521|FG001|Overall Study|Adverse Event|0|||
16528838|NCT01435577|40401520|FG000|Overall Study|Lack of Efficacy|7|||
16528839|NCT01435577|40401521|FG001|Overall Study|Lack of Efficacy|51|||
16528840|NCT01435577|40401520|FG000|Overall Study|Alternative treatment started|0|||
16528841|NCT01435577|40401521|FG001|Overall Study|Alternative treatment started|1|||
16528842|NCT02207829|40401527|FG000|Overall Study|Adverse Event|10|||
16528843|NCT02207829|40401528|FG001|Overall Study|Adverse Event|9|||
16528844|NCT02207829|40401527|FG000|Overall Study|Lack of Efficacy|7|||
16528845|NCT02207829|40401528|FG001|Overall Study|Lack of Efficacy|5|||
16528846|NCT02207829|40401527|FG000|Overall Study|Lost to Follow-up|2|||
16528847|NCT02207829|40401528|FG001|Overall Study|Lost to Follow-up|2|||
16528848|NCT02207829|40401527|FG000|Overall Study|Protocol deviation|5|||
16528849|NCT02207829|40401528|FG001|Overall Study|Protocol deviation|4|||
16528850|NCT02207829|40401527|FG000|Overall Study|Withdrew consent|18|||
16528851|NCT02207829|40401528|FG001|Overall Study|Withdrew consent|14|||
16528852|NCT02807948|40401529|FG000|Overall Study|Physician Decision|1|||
16528853|NCT02807948|40401530|FG001|Overall Study|Physician Decision|0|||
16528854|NCT01054820|40401531|FG000|Overall Study|Withdrawal by Subject|2|||
16528855|NCT02013765|40401532|FG000|Overall Study|Trial was terminated by sponsor|1|||
16528856|NCT00407537|40401534|FG000|Overall Study|Death|5|||
16528857|NCT00407537|40401535|FG001|Overall Study|Death|2|||
16528858|NCT00407537|40401534|FG000|Overall Study|Adverse Event|36|||
16528859|NCT00407537|40401535|FG001|Overall Study|Adverse Event|0|||
16528860|NCT00407537|40401534|FG000|Overall Study|Lost to Follow-up|12|||
16528861|NCT00407537|40401535|FG001|Overall Study|Lost to Follow-up|19|||
16528862|NCT00407537|40401534|FG000|Overall Study|Other|6|||
16528863|NCT00407537|40401535|FG001|Overall Study|Other|7|||
16528864|NCT00407537|40401534|FG000|Overall Study|Withdrawal by Subject|34|||
16528865|NCT00407537|40401535|FG001|Overall Study|Withdrawal by Subject|16|||
16528866|NCT00744653|40401536|FG000|Overall Study|antineoplastic treatment|11|||
16528867|NCT00744653|40401536|FG000|Overall Study|Death|1|||
16528868|NCT00744653|40401536|FG000|Overall Study|Lost to Follow-up|1|||
16528869|NCT00744653|40401536|FG000|Overall Study|Physician Decision|3|||
16528870|NCT01782131|40401537|FG000|Overall Study|Death|93|||
16528871|NCT01782131|40401538|FG001|Overall Study|Death|96|||
16528872|NCT01782131|40401537|FG000|Overall Study|Lost to Follow-up|1|||
16528873|NCT01782131|40401538|FG001|Overall Study|Lost to Follow-up|3|||
16528874|NCT01782131|40401537|FG000|Overall Study|Withdrawal by Subject|10|||
16528875|NCT01782131|40401538|FG001|Overall Study|Withdrawal by Subject|10|||
16528876|NCT01782131|40401537|FG000|Overall Study|Randomized but not treated|5|||
16528877|NCT01782131|40401538|FG001|Overall Study|Randomized but not treated|5|||
16528878|NCT01782131|40401537|FG000|Overall Study|Reason not provided|0|||
16528879|NCT01782131|40401538|FG001|Overall Study|Reason not provided|1|||
16528880|NCT02246998|40401539|FG000|Overall Study|Adverse Event|0|||
16528881|NCT02246998|40401540|FG001|Overall Study|Adverse Event|1|||
16528882|NCT02246998|40401541|FG002|Overall Study|Adverse Event|1|||
16528883|NCT02246998|40401542|FG003|Overall Study|Adverse Event|0|||
16528884|NCT02246998|40401539|FG000|Overall Study|Lost to Follow-up|1|||
16528885|NCT02246998|40401540|FG001|Overall Study|Lost to Follow-up|0|||
16528886|NCT02246998|40401541|FG002|Overall Study|Lost to Follow-up|0|||
16528887|NCT02246998|40401542|FG003|Overall Study|Lost to Follow-up|1|||
16528888|NCT02246998|40401539|FG000|Overall Study|Randomized but Never Dosed|1|||
16528889|NCT02246998|40401540|FG001|Overall Study|Randomized but Never Dosed|2|||
16528890|NCT02246998|40401541|FG002|Overall Study|Randomized but Never Dosed|2|||
16528891|NCT02246998|40401542|FG003|Overall Study|Randomized but Never Dosed|1|||
16528892|NCT01760954|40401543|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
16528893|NCT01760954|40401544|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
16528894|NCT01760954|40401545|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
16528895|NCT01760954|40401546|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
16528896|NCT01760954|40401543|FG000|Treatment Period (6 Months)|Adverse Event|5|||
16528897|NCT01760954|40401544|FG001|Treatment Period (6 Months)|Adverse Event|3|||
16528898|NCT01760954|40401545|FG002|Treatment Period (6 Months)|Adverse Event|4|||
16528899|NCT01760954|40401546|FG003|Treatment Period (6 Months)|Adverse Event|10|||
16528900|NCT01760954|40401543|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
16528901|NCT01760954|40401544|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
16528902|NCT01760954|40401545|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
16528903|NCT01760954|40401546|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
16528904|NCT01760954|40401543|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
16528905|NCT01760954|40401544|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
16528906|NCT01760954|40401545|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
16528907|NCT01760954|40401546|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
16528908|NCT01760954|40401543|FG000|Treatment Period (6 Months)|Pregnancy|5|||
16528909|NCT01760954|40401544|FG001|Treatment Period (6 Months)|Pregnancy|0|||
16528910|NCT01760954|40401545|FG002|Treatment Period (6 Months)|Pregnancy|3|||
16528911|NCT01760954|40401546|FG003|Treatment Period (6 Months)|Pregnancy|2|||
16528912|NCT01760954|40401543|FG000|Treatment Period (6 Months)|Non-compliance|1|||
16528913|NCT01760954|40401544|FG001|Treatment Period (6 Months)|Non-compliance|4|||
16528914|NCT01760954|40401545|FG002|Treatment Period (6 Months)|Non-compliance|0|||
16528915|NCT01760954|40401546|FG003|Treatment Period (6 Months)|Non-compliance|3|||
16528916|NCT01760954|40401543|FG000|Treatment Period (6 Months)|Other|0|||
16528917|NCT01760954|40401544|FG001|Treatment Period (6 Months)|Other|3|||
16528918|NCT01760954|40401545|FG002|Treatment Period (6 Months)|Other|3|||
16528919|NCT01760954|40401546|FG003|Treatment Period (6 Months)|Other|1|||
16528920|NCT01760954|40401543|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
16528921|NCT01760954|40401544|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
16528922|NCT01760954|40401545|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
16528923|NCT01760954|40401546|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
16528924|NCT01760954|40401543|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
16528925|NCT01760954|40401544|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
16528926|NCT01760954|40401545|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
16528927|NCT01760954|40401546|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
16528928|NCT01760954|40401543|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
16528929|NCT01760954|40401544|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
16528930|NCT01760954|40401545|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
16528931|NCT01760954|40401546|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
16098172|NCT01807234|38847005|FG005|Overall Study|Withdrawal by Subject|1|||
16098173|NCT01807234|38847000|FG000|Overall Study|Lack of Efficacy|0|||
16098174|NCT01807234|38847001|FG001|Overall Study|Lack of Efficacy|0|||
16098175|NCT01807234|38847002|FG002|Overall Study|Lack of Efficacy|0|||
16098176|NCT01807234|38847003|FG003|Overall Study|Lack of Efficacy|0|||
16098177|NCT01807234|38847004|FG004|Overall Study|Lack of Efficacy|1|||
16098178|NCT01807234|38847005|FG005|Overall Study|Lack of Efficacy|1|||
16098179|NCT01753323|38847006|FG000|Overall Study|Lack of Efficacy|0|||
16098180|NCT01753323|38847007|FG001|Overall Study|Lack of Efficacy|0|||
16098181|NCT01753323|38847008|FG002|Overall Study|Lack of Efficacy|8|||
16098182|NCT01753323|38847006|FG000|Overall Study|Protocol deviation|1|||
16098183|NCT01753323|38847007|FG001|Overall Study|Protocol deviation|0|||
16098184|NCT01753323|38847008|FG002|Overall Study|Protocol deviation|0|||
16098185|NCT01753323|38847006|FG000|Overall Study|Adverse Event|0|||
16098186|NCT01753323|38847007|FG001|Overall Study|Adverse Event|0|||
16098187|NCT01753323|38847008|FG002|Overall Study|Adverse Event|1|||
16528932|NCT01760954|40401543|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
16528933|NCT01760954|40401544|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
16528934|NCT01760954|40401545|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
16528935|NCT01760954|40401546|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
16528936|NCT01760954|40401543|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
16528937|NCT01760954|40401544|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
16528938|NCT01760954|40401545|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
16528939|NCT01760954|40401546|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
16528940|NCT01760954|40401543|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
16528941|NCT01760954|40401544|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
16528942|NCT01760954|40401545|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
16528943|NCT01760954|40401546|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
16528944|NCT01760954|40401543|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
16528945|NCT01760954|40401544|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
16528946|NCT01760954|40401545|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
16528947|NCT01760954|40401546|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
16528948|NCT01760954|40401543|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
16528949|NCT01760954|40401544|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
16528950|NCT01760954|40401545|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
16528951|NCT01760954|40401546|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
16528952|NCT02660944|40401547|FG000|Overall Study|Adverse Event|3|||
16528953|NCT02660944|40401548|FG001|Overall Study|Adverse Event|4|||
16528954|NCT02660944|40401547|FG000|Overall Study|Physician Decision|3|||
16528955|NCT02660944|40401548|FG001|Overall Study|Physician Decision|1|||
16528956|NCT02660944|40401547|FG000|Overall Study|Withdrawal by Subject|5|||
16528957|NCT02660944|40401548|FG001|Overall Study|Withdrawal by Subject|3|||
16528958|NCT02660944|40401547|FG000|Overall Study|Lost to Follow-up|4|||
16528959|NCT02660944|40401548|FG001|Overall Study|Lost to Follow-up|1|||
16528960|NCT02660944|40401547|FG000|Overall Study|Subject schedule|0|||
16528961|NCT02660944|40401548|FG001|Overall Study|Subject schedule|1|||
16528962|NCT02660944|40401547|FG000|Overall Study|Exclusion criteria met|2|||
16528963|NCT02660944|40401548|FG001|Overall Study|Exclusion criteria met|0|||
16528964|NCT00968669|40401549|FG000|Overall Study|Lost to Follow-up|5|||
16528965|NCT00968669|40401550|FG001|Overall Study|Lost to Follow-up|2|||
16528966|NCT00968669|40401551|FG002|Overall Study|Lost to Follow-up|1|||
16528967|NCT00968669|40401552|FG003|Overall Study|Lost to Follow-up|4|||
16528968|NCT00968669|40401549|FG000|Overall Study|Withdrawal by Subject|9|||
16528969|NCT00968669|40401550|FG001|Overall Study|Withdrawal by Subject|7|||
16528970|NCT00968669|40401551|FG002|Overall Study|Withdrawal by Subject|5|||
16098188|NCT00587171|38847009|FG000|Overall Study|Lost to Follow-up|1|||
16098189|NCT00587171|38847010|FG001|Overall Study|Lost to Follow-up|1|||
16098190|NCT02542293|38847011|FG000|Overall Study|Death|367|||
16098191|NCT02542293|38847012|FG001|Overall Study|Death|377|||
16528971|NCT00968669|40401552|FG003|Overall Study|Withdrawal by Subject|3|||
16528972|NCT00968669|40401549|FG000|Overall Study|Pregnancy|0|||
16528973|NCT00968669|40401550|FG001|Overall Study|Pregnancy|0|||
16528974|NCT00968669|40401551|FG002|Overall Study|Pregnancy|2|||
16528975|NCT00968669|40401552|FG003|Overall Study|Pregnancy|0|||
16528976|NCT00968669|40401549|FG000|Overall Study|AE|1|||
16528977|NCT00968669|40401550|FG001|Overall Study|AE|0|||
16528978|NCT00968669|40401551|FG002|Overall Study|AE|0|||
16528979|NCT00968669|40401552|FG003|Overall Study|AE|0|||
16528980|NCT00968669|40401549|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
16528981|NCT00968669|40401550|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
16528982|NCT00968669|40401551|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
16528983|NCT00968669|40401552|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
16528984|NCT00968669|40401549|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
16528985|NCT00968669|40401550|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
16528986|NCT00968669|40401551|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
16528987|NCT00968669|40401552|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
16528988|NCT00968669|40401549|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
16528989|NCT00968669|40401550|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
16528990|NCT00968669|40401551|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
16528991|NCT00968669|40401552|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
16528992|NCT00968669|40401549|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
16528993|NCT00968669|40401550|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
16528994|NCT00968669|40401551|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
16528995|NCT00968669|40401552|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
16528996|NCT00968669|40401549|FG000|Overall Study|EARLY WITHDRAWAL|0|||
16528997|NCT00968669|40401550|FG001|Overall Study|EARLY WITHDRAWAL|1|||
16528998|NCT00968669|40401551|FG002|Overall Study|EARLY WITHDRAWAL|0|||
16098192|NCT02542293|38847011|FG000|Overall Study|Withdrawal by Subject|8|||
16098193|NCT02542293|38847012|FG001|Overall Study|Withdrawal by Subject|19|||
16098194|NCT01755598|38847014|FG000|Overall Study|Other|109|||
16212249|NCT02614261|39258616|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
16212250|NCT02614261|39258617|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
16212251|NCT02614261|39258618|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
16212252|NCT02614261|39258615|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
16212253|NCT02614261|39258616|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
16212254|NCT02614261|39258617|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
16212255|NCT02614261|39258618|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
16212256|NCT02614261|39258615|FG000|Double-Blind Treatment Phase|Screen failure|0|||
16212257|NCT02614261|39258616|FG001|Double-Blind Treatment Phase|Screen failure|1|||
16528999|NCT00968669|40401552|FG003|Overall Study|EARLY WITHDRAWAL|0|||
16529000|NCT00968669|40401549|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
16529001|NCT00968669|40401550|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
16529002|NCT00968669|40401551|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
16529003|NCT00968669|40401552|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
16529004|NCT00968669|40401549|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
16529005|NCT00968669|40401550|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
16529006|NCT00968669|40401551|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
16529007|NCT00968669|40401552|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
16529008|NCT00968669|40401549|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
16529009|NCT00968669|40401550|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
16212258|NCT02614261|39258617|FG002|Double-Blind Treatment Phase|Screen failure|2|||
16212259|NCT02614261|39258618|FG003|Double-Blind Treatment Phase|Screen failure|0|||
16212260|NCT02614261|39258615|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
16212261|NCT02614261|39258616|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
16212262|NCT02614261|39258617|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
16212263|NCT02614261|39258618|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16212264|NCT02614261|39258615|FG000|Open-Label Extension Phase|Adverse Event|23|||
16212265|NCT02614261|39258616|FG001|Open-Label Extension Phase|Adverse Event|12|||
16212266|NCT02614261|39258617|FG002|Open-Label Extension Phase|Adverse Event|11|||
16212267|NCT02614261|39258618|FG003|Open-Label Extension Phase|Adverse Event|0|||
16212268|NCT02614261|39258615|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
16212269|NCT02614261|39258616|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
16212270|NCT02614261|39258617|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
16212271|NCT02614261|39258618|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
16212272|NCT02614261|39258615|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
16212273|NCT02614261|39258616|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
16212274|NCT02614261|39258617|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
16212275|NCT02614261|39258618|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
16212276|NCT02614261|39258615|FG000|Open-Label Extension Phase|Physician Decision|2|||
16212277|NCT02614261|39258616|FG001|Open-Label Extension Phase|Physician Decision|0|||
16212278|NCT02614261|39258617|FG002|Open-Label Extension Phase|Physician Decision|0|||
16212279|NCT02614261|39258618|FG003|Open-Label Extension Phase|Physician Decision|0|||
16212280|NCT02614261|39258615|FG000|Open-Label Extension Phase|Pregnancy|1|||
16212281|NCT02614261|39258616|FG001|Open-Label Extension Phase|Pregnancy|2|||
16212282|NCT02614261|39258617|FG002|Open-Label Extension Phase|Pregnancy|1|||
16212283|NCT02614261|39258618|FG003|Open-Label Extension Phase|Pregnancy|0|||
16212284|NCT02614261|39258615|FG000|Open-Label Extension Phase|Protocol Violation|3|||
16212285|NCT02614261|39258616|FG001|Open-Label Extension Phase|Protocol Violation|4|||
16212286|NCT02614261|39258617|FG002|Open-Label Extension Phase|Protocol Violation|1|||
16212287|NCT02614261|39258618|FG003|Open-Label Extension Phase|Protocol Violation|0|||
16212288|NCT02614261|39258615|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
16212289|NCT02614261|39258616|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
16212290|NCT02614261|39258617|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
16212291|NCT02614261|39258618|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
16212292|NCT02614261|39258615|FG000|Follow-up Phase|Adverse Event|2|||
16212293|NCT02614261|39258616|FG001|Follow-up Phase|Adverse Event|0|||
16212294|NCT02614261|39258617|FG002|Follow-up Phase|Adverse Event|1|||
16212295|NCT02614261|39258618|FG003|Follow-up Phase|Adverse Event|0|||
16212296|NCT02614261|39258615|FG000|Follow-up Phase|Lost to Follow-up|12|||
16212297|NCT02614261|39258616|FG001|Follow-up Phase|Lost to Follow-up|5|||
16212298|NCT02614261|39258617|FG002|Follow-up Phase|Lost to Follow-up|2|||
16212299|NCT02614261|39258618|FG003|Follow-up Phase|Lost to Follow-up|0|||
16212300|NCT02614261|39258615|FG000|Follow-up Phase|Physician Decision|5|||
16212301|NCT02614261|39258616|FG001|Follow-up Phase|Physician Decision|1|||
16212302|NCT02614261|39258617|FG002|Follow-up Phase|Physician Decision|0|||
16212303|NCT02614261|39258618|FG003|Follow-up Phase|Physician Decision|0|||
16212304|NCT02614261|39258615|FG000|Follow-up Phase|Pregnancy|0|||
16212305|NCT02614261|39258616|FG001|Follow-up Phase|Pregnancy|1|||
16212306|NCT02614261|39258617|FG002|Follow-up Phase|Pregnancy|0|||
16212307|NCT02614261|39258618|FG003|Follow-up Phase|Pregnancy|0|||
16212308|NCT02614261|39258615|FG000|Follow-up Phase|Protocol Violation|1|||
16212309|NCT02614261|39258616|FG001|Follow-up Phase|Protocol Violation|0|||
16212310|NCT02614261|39258617|FG002|Follow-up Phase|Protocol Violation|0|||
16212311|NCT02614261|39258618|FG003|Follow-up Phase|Protocol Violation|0|||
16212312|NCT02614261|39258615|FG000|Follow-up Phase|Withdrawal by Subject|12|||
16212313|NCT02614261|39258616|FG001|Follow-up Phase|Withdrawal by Subject|4|||
16212314|NCT02614261|39258617|FG002|Follow-up Phase|Withdrawal by Subject|11|||
16212315|NCT02614261|39258618|FG003|Follow-up Phase|Withdrawal by Subject|0|||
16212316|NCT02614261|39258615|FG000|Israel Addendum|Withdrawal by Subject|0|||
16212317|NCT02614261|39258616|FG001|Israel Addendum|Withdrawal by Subject|0|||
16212318|NCT02614261|39258617|FG002|Israel Addendum|Withdrawal by Subject|0|||
16212319|NCT02614261|39258618|FG003|Israel Addendum|Withdrawal by Subject|4|||
16212320|NCT03512275|39258619|FG000|Overall Study|Withdrawal by Subject|1|||
16212321|NCT03512275|39258620|FG001|Overall Study|Withdrawal by Subject|3|||
16212322|NCT03512275|39258619|FG000|Overall Study|Physician Decision|0|||
16212323|NCT03512275|39258620|FG001|Overall Study|Physician Decision|1|||
16212324|NCT03512275|39258619|FG000|Overall Study|Lost to Follow-up|0|||
16212325|NCT03512275|39258620|FG001|Overall Study|Lost to Follow-up|3|||
16212326|NCT03512275|39258619|FG000|Overall Study|Other|1|||
16212327|NCT03512275|39258620|FG001|Overall Study|Other|0|||
16212328|NCT03954704|39258621|FG000|Overall Study|Death|1|||
16212329|NCT03954704|39258622|FG001|Overall Study|Death|1|||
16212330|NCT03954704|39258623|FG002|Overall Study|Death|1|||
16212331|NCT03954704|39258624|FG003|Overall Study|Death|3|||
16212332|NCT03954704|39258625|FG004|Overall Study|Death|2|||
16212333|NCT03954704|39258626|FG005|Overall Study|Death|2|||
16212334|NCT03954704|39258627|FG006|Overall Study|Death|0|||
16212335|NCT03954704|39258621|FG000|Overall Study|Withdrew Consent|0|||
16212336|NCT03954704|39258622|FG001|Overall Study|Withdrew Consent|0|||
16212337|NCT03954704|39258623|FG002|Overall Study|Withdrew Consent|1|||
16212338|NCT03954704|39258624|FG003|Overall Study|Withdrew Consent|0|||
16212339|NCT03954704|39258625|FG004|Overall Study|Withdrew Consent|0|||
16212340|NCT03954704|39258626|FG005|Overall Study|Withdrew Consent|1|||
16212341|NCT03954704|39258627|FG006|Overall Study|Withdrew Consent|0|||
16212342|NCT03954704|39258621|FG000|Overall Study|Lost to Follow-up|0|||
16212343|NCT03954704|39258622|FG001|Overall Study|Lost to Follow-up|0|||
16212344|NCT03954704|39258623|FG002|Overall Study|Lost to Follow-up|0|||
16529010|NCT00968669|40401551|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
16212345|NCT03954704|39258624|FG003|Overall Study|Lost to Follow-up|0|||
16212346|NCT03954704|39258625|FG004|Overall Study|Lost to Follow-up|0|||
16212347|NCT03954704|39258626|FG005|Overall Study|Lost to Follow-up|0|||
16212348|NCT03954704|39258627|FG006|Overall Study|Lost to Follow-up|1|||
16212349|NCT03954704|39258621|FG000|Overall Study|Study Terminated by Sponsor|0|||
16212350|NCT03954704|39258622|FG001|Overall Study|Study Terminated by Sponsor|0|||
16212351|NCT03954704|39258623|FG002|Overall Study|Study Terminated by Sponsor|1|||
16212352|NCT03954704|39258624|FG003|Overall Study|Study Terminated by Sponsor|0|||
16212353|NCT03954704|39258625|FG004|Overall Study|Study Terminated by Sponsor|1|||
16212354|NCT03954704|39258626|FG005|Overall Study|Study Terminated by Sponsor|4|||
16212355|NCT03954704|39258627|FG006|Overall Study|Study Terminated by Sponsor|2|||
16212356|NCT03954704|39258621|FG000|Overall Study|Enrolled but not Treated|0|||
16212357|NCT03954704|39258622|FG001|Overall Study|Enrolled but not Treated|0|||
16212358|NCT03954704|39258623|FG002|Overall Study|Enrolled but not Treated|0|||
16212359|NCT03954704|39258624|FG003|Overall Study|Enrolled but not Treated|0|||
16098195|NCT01755598|38847015|FG001|Overall Study|Other|109|||
16098196|NCT01755598|38847014|FG000|Overall Study|Lost to Follow-up|32|||
16098197|NCT01755598|38847015|FG001|Overall Study|Lost to Follow-up|43|||
16098198|NCT01755598|38847014|FG000|Overall Study|Migrated/moved from study area|76|||
16098199|NCT01755598|38847015|FG001|Overall Study|Migrated/moved from study area|65|||
16098200|NCT01755598|38847014|FG000|Overall Study|Withdrawal by Subject|22|||
16098201|NCT01755598|38847015|FG001|Overall Study|Withdrawal by Subject|31|||
16098202|NCT01755598|38847014|FG000|Overall Study|Protocol Violation|7|||
16098203|NCT01755598|38847015|FG001|Overall Study|Protocol Violation|7|||
16098204|NCT01755598|38847014|FG000|Overall Study|Adverse Event|19|||
16098205|NCT01755598|38847015|FG001|Overall Study|Adverse Event|28|||
16098206|NCT01816165|38847019|FG000|Overall Study|Adverse Event|1|||
16212360|NCT03954704|39258625|FG004|Overall Study|Enrolled but not Treated|0|||
16098207|NCT01816165|38847020|FG001|Overall Study|Adverse Event|0|||
16098208|NCT01816165|38847021|FG002|Overall Study|Adverse Event|0|||
16098209|NCT01816165|38847022|FG003|Overall Study|Adverse Event|0|||
16212361|NCT03954704|39258626|FG005|Overall Study|Enrolled but not Treated|1|||
16212362|NCT03954704|39258627|FG006|Overall Study|Enrolled but not Treated|0|||
16212363|NCT01473355|39258632|FG000|Overall Study|Protocol Violation|2|||
16212364|NCT01473355|39258632|FG000|Overall Study|Adverse Event|2|||
16212365|NCT01473355|39258632|FG000|Overall Study|Lost to Follow-up|2|||
16212366|NCT01023516|39258639|FG000|Overall Study|Voluntary discontinuation|7|||
16212367|NCT01023516|39258640|FG001|Overall Study|Voluntary discontinuation|5|||
16529011|NCT00968669|40401552|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
16529012|NCT00968669|40401549|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
16529013|NCT00968669|40401550|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
16529014|NCT00968669|40401551|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
16529015|NCT00968669|40401552|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
16529016|NCT00968669|40401549|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
16529017|NCT00968669|40401550|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
16529018|NCT00968669|40401551|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
16098210|NCT04049578|38847023|FG000|Overall Study|Physician Decision|1|||
16212368|NCT01023516|39258639|FG000|Overall Study|Adverse Event|9|||
16212369|NCT01023516|39258640|FG001|Overall Study|Adverse Event|6|||
16212370|NCT01023516|39258639|FG000|Overall Study|Safety reason|0|||
16212371|NCT01023516|39258640|FG001|Overall Study|Safety reason|3|||
16212372|NCT01023516|39258639|FG000|Overall Study|Study-specific criteria|4|||
16212373|NCT01023516|39258640|FG001|Overall Study|Study-specific criteria|2|||
16212374|NCT01023516|39258639|FG000|Overall Study|Incorrect enrolment|4|||
16212375|NCT01023516|39258640|FG001|Overall Study|Incorrect enrolment|2|||
16212376|NCT02809118|39258641|FG000|Overall Study|Withdrawal by Subject|0|||
16212377|NCT02809118|39258642|FG001|Overall Study|Withdrawal by Subject|1|||
16212378|NCT02809118|39258643|FG002|Overall Study|Withdrawal by Subject|1|||
16212379|NCT00002981|39258645|FG000|Overall Study|Inevaluable|6|||
16212380|NCT01199198|39258646|FG000|Overall Study|Adverse Event|3|||
16212381|NCT01199198|39258647|FG001|Overall Study|Adverse Event|0|||
16212382|NCT01199198|39258646|FG000|Overall Study|Lost to Follow-up|1|||
16212383|NCT01199198|39258647|FG001|Overall Study|Lost to Follow-up|5|||
16212384|NCT01199198|39258646|FG000|Overall Study|Withdrawal by Subject|1|||
16212385|NCT01199198|39258647|FG001|Overall Study|Withdrawal by Subject|2|||
16212386|NCT01199198|39258646|FG000|Overall Study|ICU Transfer|1|||
16212387|NCT01199198|39258647|FG001|Overall Study|ICU Transfer|2|||
16212388|NCT01199198|39258646|FG000|Overall Study|Hospice-care transfer|1|||
16212389|NCT01199198|39258647|FG001|Overall Study|Hospice-care transfer|2|||
16212390|NCT03878160|39258649|FG000|Overall Study|Lost to Follow-up|1|||
16212391|NCT03878160|39258650|FG001|Overall Study|Lost to Follow-up|1|||
16212392|NCT03878160|39258651|FG002|Overall Study|Lost to Follow-up|1|||
16212393|NCT03878160|39258649|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
16212394|NCT03878160|39258650|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
16212395|NCT03878160|39258651|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
16212396|NCT04402385|39258652|FG000|Overall Study|Withdrawal by Subject|4|||
16212397|NCT04402385|39258653|FG001|Overall Study|Withdrawal by Subject|4|||
16212398|NCT04402385|39258652|FG000|Overall Study|Lost to Follow-up|1|||
16212399|NCT04402385|39258653|FG001|Overall Study|Lost to Follow-up|1|||
16212400|NCT04402385|39258652|FG000|Overall Study|Physician Decision|0|||
16212401|NCT04402385|39258653|FG001|Overall Study|Physician Decision|1|||
16212402|NCT02280096|39258660|FG000|Overall Study|Pregnancy|1|||
16212403|NCT02280096|39258661|FG001|Overall Study|Pregnancy|0|||
16212404|NCT02280096|39258660|FG000|Overall Study|Functional neurological disorder|1|||
16212405|NCT02280096|39258661|FG001|Overall Study|Functional neurological disorder|0|||
16212406|NCT02280096|39258660|FG000|Overall Study|Lack of attachment|0|||
16212407|NCT02280096|39258661|FG001|Overall Study|Lack of attachment|1|||
16529019|NCT00968669|40401552|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
16529020|NCT00968669|40401549|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
16212408|NCT00320190|39258667|FG000|First 12 Months|Completed but did not enter extension|5|||
16212409|NCT00320190|39258668|FG001|First 12 Months|Completed but did not enter extension|3|||
16212410|NCT00320190|39258667|FG000|First 12 Months|Sponsor terminated study|2|||
16212411|NCT00320190|39258668|FG001|First 12 Months|Sponsor terminated study|2|||
16212412|NCT00320190|39258667|FG000|First 12 Months|Lost to Follow-up|0|||
16212413|NCT00320190|39258668|FG001|First 12 Months|Lost to Follow-up|1|||
16212414|NCT00320190|39258667|FG000|First 12 Months|Enrollment failure|0|||
16212415|NCT00320190|39258668|FG001|First 12 Months|Enrollment failure|1|||
16212416|NCT00320190|39258667|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
16212417|NCT00320190|39258668|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
16212418|NCT00320190|39258667|FG000|First 12 Months|Investigator request|0|||
16212419|NCT00320190|39258668|FG001|First 12 Months|Investigator request|1|||
16212420|NCT00320190|39258667|FG000|First 12 Months|Study drug toxicity|0|||
16212421|NCT00320190|39258668|FG001|First 12 Months|Study drug toxicity|1|||
16212422|NCT00320190|39258667|FG000|First 12 Months|Withdrawal by Subject|0|||
16212423|NCT00320190|39258668|FG001|First 12 Months|Withdrawal by Subject|1|||
16212424|NCT00320190|39258667|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
16212425|NCT00320190|39258668|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
16212426|NCT00320190|39258667|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
16212427|NCT00320190|39258668|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
16212428|NCT00320190|39258667|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
16212429|NCT00320190|39258668|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
16212430|NCT00732238|39258673|FG000|Overall Study|Bacteremia|4|||
16212431|NCT00732238|39258674|FG001|Overall Study|Bacteremia|1|||
16212432|NCT00732238|39258673|FG000|Overall Study|Asymptomatic bacteriuria|1|||
16212433|NCT00732238|39258674|FG001|Overall Study|Asymptomatic bacteriuria|0|||
16212434|NCT02499575|39258675|FG000|Overall Study|Protocol Violation|0|||
16212435|NCT02499575|39258676|FG001|Overall Study|Protocol Violation|1|||
16212436|NCT02201472|39258677|FG000|Overall Study|Lack of Efficacy|2|||
16212437|NCT03051217|39258680|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
16212438|NCT03051217|39258681|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16212439|NCT03051217|39258682|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
16529021|NCT00968669|40401550|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
16529022|NCT00968669|40401551|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
16529023|NCT00968669|40401552|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
16529024|NCT00968669|40401549|FG000|Overall Study|SPONSOR DECISION|0|||
16529025|NCT00968669|40401550|FG001|Overall Study|SPONSOR DECISION|1|||
16529026|NCT00968669|40401551|FG002|Overall Study|SPONSOR DECISION|0|||
16529027|NCT00968669|40401552|FG003|Overall Study|SPONSOR DECISION|0|||
16529028|NCT00968669|40401549|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
16529029|NCT00968669|40401550|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
16529030|NCT00968669|40401551|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
16529031|NCT00968669|40401552|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
16529032|NCT00968669|40401549|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
16529033|NCT00968669|40401550|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
16529034|NCT00968669|40401551|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
16529035|NCT00968669|40401552|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
16529036|NCT00968669|40401549|FG000|Overall Study|SUBJECT INCARCERATED|0|||
16529037|NCT00968669|40401550|FG001|Overall Study|SUBJECT INCARCERATED|1|||
16529038|NCT00968669|40401551|FG002|Overall Study|SUBJECT INCARCERATED|0|||
16529039|NCT00968669|40401552|FG003|Overall Study|SUBJECT INCARCERATED|0|||
16529040|NCT00968669|40401549|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
16529041|NCT00968669|40401550|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
16529042|NCT00968669|40401551|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
16529043|NCT00968669|40401552|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
16529044|NCT00968669|40401549|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
16529045|NCT00968669|40401550|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
16529046|NCT00968669|40401551|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
16529047|NCT00968669|40401552|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
16529048|NCT01753193|40401556|FG000|Overall Study|Withdrawal by Subject|23|||
16529049|NCT01753193|40401556|FG000|Overall Study|Lost to Follow-up|6|||
16529050|NCT01753193|40401556|FG000|Overall Study|Death|1|||
16529051|NCT01753193|40401556|FG000|Overall Study|Other|16|||
16529052|NCT00129987|40401557|FG000|1st Educational Session|Withdrawal by Subject|141|||
16212440|NCT03051217|39258683|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16212441|NCT03051217|39258684|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16212442|NCT03051217|39258685|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16212443|NCT03051217|39258686|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16529053|NCT00129987|40401558|FG001|1st Educational Session|Withdrawal by Subject|109|||
16529054|NCT00129987|40401557|FG000|1 Year|Withdrawal by Subject|32|||
16529055|NCT00129987|40401558|FG001|1 Year|Withdrawal by Subject|21|||
16529056|NCT01302119|40401566|FG000|Overall Study|Withdrawal by Subject|30|||
16529057|NCT01302119|40401567|FG001|Overall Study|Withdrawal by Subject|20|||
16529058|NCT01302119|40401566|FG000|Overall Study|Lost to Follow-up|10|||
16529059|NCT01302119|40401567|FG001|Overall Study|Lost to Follow-up|4|||
16529060|NCT01302119|40401566|FG000|Overall Study|Adverse Event|2|||
16529061|NCT01302119|40401567|FG001|Overall Study|Adverse Event|1|||
16529062|NCT01302119|40401566|FG000|Overall Study|Non-compliance|4|||
16529063|NCT01302119|40401567|FG001|Overall Study|Non-compliance|2|||
16529064|NCT01302119|40401566|FG000|Overall Study|Non-specific|4|||
16529065|NCT01302119|40401567|FG001|Overall Study|Non-specific|1|||
16529066|NCT02477618|40401568|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
16529067|NCT02477618|40401569|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
16529068|NCT02477618|40401568|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
16529069|NCT02477618|40401569|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
16529070|NCT02477618|40401568|FG000|Overall Study|Adverse Event|1|||
16529071|NCT02477618|40401569|FG001|Overall Study|Adverse Event|1|||
16529072|NCT02477618|40401568|FG000|Overall Study|Transferred Away from Study Site|1|||
16529073|NCT02477618|40401569|FG001|Overall Study|Transferred Away from Study Site|0|||
16529074|NCT02477618|40401568|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
16529075|NCT02477618|40401569|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
16529076|NCT00990652|40401570|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
16529077|NCT00990652|40401570|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
16529078|NCT02504294|40401572|FG000|Overall Study|Adverse Event|15|||
16529079|NCT02504294|40401573|FG001|Overall Study|Adverse Event|12|||
16529080|NCT02504294|40401572|FG000|Overall Study|Withdrawal by Subject|7|||
16529081|NCT02504294|40401573|FG001|Overall Study|Withdrawal by Subject|1|||
16529082|NCT02504294|40401572|FG000|Overall Study|Protocol Violation|27|||
16212444|NCT03051217|39258680|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
16212445|NCT03051217|39258681|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
16212446|NCT03051217|39258682|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
16212447|NCT03051217|39258683|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
16212448|NCT03051217|39258684|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
16212449|NCT03051217|39258685|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
16212450|NCT03051217|39258686|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
16212451|NCT03051217|39258680|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
16212452|NCT03051217|39258681|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
16212453|NCT03051217|39258682|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
16212454|NCT03051217|39258683|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16212455|NCT03051217|39258684|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16212456|NCT03051217|39258685|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16212457|NCT03051217|39258686|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16212458|NCT03051217|39258680|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
16331061|NCT02553499|39699834|FG008|Overall Study|Adverse Event|0|||
16331062|NCT02553499|39699835|FG009|Overall Study|Adverse Event|0|||
16331063|NCT02553499|39699836|FG010|Overall Study|Adverse Event|0|||
16331064|NCT02553499|39699837|FG011|Overall Study|Adverse Event|0|||
16529083|NCT02504294|40401573|FG001|Overall Study|Protocol Violation|26|||
16529084|NCT02504294|40401572|FG000|Overall Study|Physician Decision|1|||
16529085|NCT02504294|40401573|FG001|Overall Study|Physician Decision|2|||
16529086|NCT02504294|40401572|FG000|Overall Study|Lost to Follow-up|6|||
16529087|NCT02504294|40401573|FG001|Overall Study|Lost to Follow-up|7|||
16529088|NCT00803634|40401581|FG000|Overall Study|Withdrew Consent|1|||
16529089|NCT00803634|40401582|FG001|Overall Study|Withdrew Consent|0|||
16529090|NCT00803634|40401581|FG000|Overall Study|Lost to Follow-up|2|||
16331065|NCT02553499|39699838|FG012|Overall Study|Adverse Event|0|||
16331066|NCT02553499|39699839|FG013|Overall Study|Adverse Event|1|||
16331067|NCT02553499|39699826|FG000|Overall Study|Death|0|||
16331068|NCT02553499|39699827|FG001|Overall Study|Death|1|||
16331069|NCT02553499|39699828|FG002|Overall Study|Death|1|||
16529091|NCT00803634|40401582|FG001|Overall Study|Lost to Follow-up|3|||
16529092|NCT00803634|40401581|FG000|Overall Study|Death|3|||
16529093|NCT00803634|40401582|FG001|Overall Study|Death|2|||
16529094|NCT02097472|40401583|FG000|Received Vaccination 2|Adverse Event|0|||
16529095|NCT02097472|40401584|FG001|Received Vaccination 2|Adverse Event|0|||
16529096|NCT02097472|40401585|FG002|Received Vaccination 2|Adverse Event|0|||
16529097|NCT02097472|40401586|FG003|Received Vaccination 2|Adverse Event|0|||
16529098|NCT02097472|40401587|FG004|Received Vaccination 2|Adverse Event|0|||
16529099|NCT02097472|40401588|FG005|Received Vaccination 2|Adverse Event|0|||
16529100|NCT02097472|40401589|FG006|Received Vaccination 2|Adverse Event|1|||
16529101|NCT02097472|40401590|FG007|Received Vaccination 2|Adverse Event|0|||
16529102|NCT02473614|40401591|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
16529103|NCT02473614|40401592|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
16212459|NCT03051217|39258681|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
16331070|NCT02553499|39699829|FG003|Overall Study|Death|0|||
16529104|NCT02388724|40401599|FG000|Overall Study|Reason not Specified|0|||
16529105|NCT02388724|40401600|FG001|Overall Study|Reason not Specified|1|||
16212460|NCT03051217|39258682|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
16212461|NCT03051217|39258683|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
16212462|NCT03051217|39258684|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
16212463|NCT03051217|39258685|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
16212464|NCT03051217|39258686|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
16212465|NCT03051217|39258680|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
16212466|NCT03051217|39258681|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
16212467|NCT03051217|39258682|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
16212468|NCT03051217|39258683|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
16212469|NCT03051217|39258684|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
16212470|NCT03051217|39258685|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
16212471|NCT03051217|39258686|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
16212472|NCT03051217|39258680|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
16212473|NCT03051217|39258681|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
16212474|NCT03051217|39258682|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
16212475|NCT03051217|39258683|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
16212476|NCT03051217|39258684|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
16212477|NCT03051217|39258685|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
16212478|NCT03051217|39258686|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
16212479|NCT03051217|39258680|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
16212480|NCT03051217|39258681|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
16212481|NCT03051217|39258682|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
16212482|NCT03051217|39258683|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
16212483|NCT03051217|39258684|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
16212484|NCT03051217|39258685|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
16212485|NCT03051217|39258686|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
16212486|NCT03051217|39258680|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
16212487|NCT03051217|39258681|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
16212488|NCT03051217|39258682|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
16212489|NCT03051217|39258683|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
16212490|NCT03051217|39258684|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
16212491|NCT03051217|39258685|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
16212492|NCT03051217|39258686|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
16212493|NCT01190020|39258690|FG000|Overall Study|Adverse Event|2|||
16400748|NCT01252186|39948380|FG000|Overall Study|Non-compliance|0|||
16400749|NCT01252186|39948381|FG001|Overall Study|Non-compliance|3|||
16400750|NCT01252186|39948382|FG002|Overall Study|Non-compliance|4|||
16400751|NCT01252186|39948380|FG000|Overall Study|Protocol Violation|0|||
16400752|NCT01252186|39948381|FG001|Overall Study|Protocol Violation|0|||
16400753|NCT01252186|39948382|FG002|Overall Study|Protocol Violation|1|||
16400754|NCT01252186|39948380|FG000|Overall Study|Pregnancy|2|||
16400755|NCT01252186|39948381|FG001|Overall Study|Pregnancy|2|||
16400756|NCT01252186|39948382|FG002|Overall Study|Pregnancy|0|||
16400757|NCT01252186|39948380|FG000|Overall Study|Sponsor Request|2|||
16400758|NCT01252186|39948381|FG001|Overall Study|Sponsor Request|1|||
16400759|NCT01252186|39948382|FG002|Overall Study|Sponsor Request|0|||
16400760|NCT01252186|39948380|FG000|Overall Study|Lost to Follow-up|10|||
16400761|NCT01252186|39948381|FG001|Overall Study|Lost to Follow-up|10|||
16400762|NCT01252186|39948382|FG002|Overall Study|Lost to Follow-up|11|||
16400763|NCT01252186|39948380|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
16400764|NCT01252186|39948381|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
16400765|NCT01252186|39948382|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
16212494|NCT01190020|39258691|FG001|Overall Study|Adverse Event|0|||
16212495|NCT01190020|39258690|FG000|Overall Study|Lost to Follow-up|2|||
16212496|NCT01190020|39258691|FG001|Overall Study|Lost to Follow-up|0|||
16212497|NCT01190020|39258690|FG000|Overall Study|Withdrawal by Subject|3|||
16212498|NCT01190020|39258691|FG001|Overall Study|Withdrawal by Subject|0|||
16212499|NCT00373880|39258693|FG000|Overall Study|Physician Decision|3|||
16400766|NCT03632993|39948383|FG000|Overall Study|Withdrawal by Subject|1|||
16400767|NCT03632993|39948384|FG001|Overall Study|Withdrawal by Subject|0|||
16400768|NCT03632993|39948385|FG002|Overall Study|Withdrawal by Subject|0|||
16400769|NCT03632993|39948386|FG003|Overall Study|Withdrawal by Subject|0|||
16400770|NCT03632993|39948387|FG004|Overall Study|Withdrawal by Subject|0|||
16529106|NCT02388724|40401599|FG000|Overall Study|Major Protocol Deviation|3|||
16529107|NCT02388724|40401600|FG001|Overall Study|Major Protocol Deviation|3|||
16529108|NCT02388724|40401599|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
16529109|NCT02388724|40401600|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
16529110|NCT02388724|40401599|FG000|Overall Study|Voluntary Withdrawal|6|||
16212500|NCT00373880|39258693|FG000|Overall Study|Arrested|1|||
16212501|NCT00373880|39258693|FG000|Overall Study|Protocol Violation|14|||
16212502|NCT01156363|39258695|FG000|Overall Study|Adverse Event|6|||
16212503|NCT01156363|39258695|FG000|Overall Study|Insufficient Therapeutic Response|5|||
16212504|NCT01156363|39258695|FG000|Overall Study|Failure to Return|1|||
16212505|NCT01156363|39258695|FG000|Overall Study|Refused Treatment|4|||
16212506|NCT01156363|39258695|FG000|Overall Study|Other|6|||
16212507|NCT03907969|39258699|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
16400771|NCT03632993|39948388|FG005|Overall Study|Withdrawal by Subject|0|||
16400772|NCT03632993|39948389|FG006|Overall Study|Withdrawal by Subject|0|||
16400773|NCT03632993|39948390|FG007|Overall Study|Withdrawal by Subject|0|||
16400774|NCT03632993|39948391|FG008|Overall Study|Withdrawal by Subject|0|||
16400775|NCT03632993|39948392|FG009|Overall Study|Withdrawal by Subject|1|||
16400776|NCT03632993|39948383|FG000|Overall Study|Protocol Non-compliance|0|||
16400777|NCT03632993|39948384|FG001|Overall Study|Protocol Non-compliance|1|||
16400778|NCT03632993|39948385|FG002|Overall Study|Protocol Non-compliance|0|||
16400779|NCT03632993|39948386|FG003|Overall Study|Protocol Non-compliance|0|||
16400780|NCT03632993|39948387|FG004|Overall Study|Protocol Non-compliance|0|||
16400781|NCT03632993|39948388|FG005|Overall Study|Protocol Non-compliance|0|||
16400782|NCT03632993|39948389|FG006|Overall Study|Protocol Non-compliance|0|||
16529111|NCT02388724|40401600|FG001|Overall Study|Voluntary Withdrawal|5|||
16529112|NCT02388724|40401599|FG000|Overall Study|Randomized but not Treated|0|||
16212508|NCT03907969|39258700|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
16212509|NCT03907969|39258701|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
16529113|NCT02388724|40401600|FG001|Overall Study|Randomized but not Treated|2|||
16529114|NCT00695903|40401603|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
16529115|NCT00695903|40401604|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
16529116|NCT00695903|40401603|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
16529117|NCT00695903|40401604|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
16529118|NCT00695903|40401603|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
16529119|NCT00695903|40401604|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
16529120|NCT00695903|40401603|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
16529121|NCT00695903|40401604|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
16529122|NCT00695903|40401603|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
16529123|NCT00695903|40401604|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
16529124|NCT00695903|40401603|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
16529125|NCT00695903|40401604|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
16529126|NCT00695903|40401603|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
16529127|NCT00695903|40401604|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
16529128|NCT00695903|40401603|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
16529129|NCT00695903|40401604|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
16212510|NCT03907969|39258702|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
16529130|NCT00695903|40401603|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
16529131|NCT00695903|40401604|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
16098211|NCT02374476|38847024|FG000|VT Induced Ablation|Screening Failures|36|||
16098212|NCT02374476|38847025|FG001|VT Induced Ablation|Screening Failures|0|||
16098213|NCT02374476|38847026|FG002|VT Induced Ablation|Screening Failures|0|||
16098214|NCT02374476|38847024|FG000|Arm Assignment|Withdrawal by Subject|0|||
16529132|NCT02103439|40401607|FG000|Overall Study|Adverse Event|0|||
16529133|NCT02103439|40401608|FG001|Overall Study|Adverse Event|2|||
16529134|NCT02103439|40401607|FG000|Overall Study|Withdrawal by Subject|3|||
16529135|NCT02103439|40401608|FG001|Overall Study|Withdrawal by Subject|1|||
16529136|NCT03727750|40405927|FG000|Overall Study|Death|45|||
16529137|NCT03727750|40405927|FG000|Overall Study|Withdrawal by Subject|2|||
16098215|NCT02374476|38847025|FG001|Arm Assignment|Withdrawal by Subject|0|||
16098216|NCT02374476|38847026|FG002|Arm Assignment|Withdrawal by Subject|1|||
16098217|NCT02446912|38847027|FG000|Overall Study|Adverse Event|3|||
16331071|NCT02553499|39699830|FG004|Overall Study|Death|1|||
16331072|NCT02553499|39699831|FG005|Overall Study|Death|2|||
16331073|NCT02553499|39699832|FG006|Overall Study|Death|0|||
16331074|NCT02553499|39699833|FG007|Overall Study|Death|0|||
16331075|NCT02553499|39699834|FG008|Overall Study|Death|0|||
16331076|NCT02553499|39699835|FG009|Overall Study|Death|0|||
16331077|NCT02553499|39699836|FG010|Overall Study|Death|1|||
16331078|NCT02553499|39699837|FG011|Overall Study|Death|0|||
16331079|NCT02553499|39699838|FG012|Overall Study|Death|0|||
16331080|NCT02553499|39699839|FG013|Overall Study|Death|0|||
16331081|NCT02553499|39699826|FG000|Overall Study|Lost to Follow-up|0|||
16331082|NCT02553499|39699827|FG001|Overall Study|Lost to Follow-up|0|||
16331083|NCT02553499|39699828|FG002|Overall Study|Lost to Follow-up|0|||
16331084|NCT02553499|39699829|FG003|Overall Study|Lost to Follow-up|0|||
16331085|NCT02553499|39699830|FG004|Overall Study|Lost to Follow-up|0|||
16331086|NCT02553499|39699831|FG005|Overall Study|Lost to Follow-up|0|||
16331087|NCT02553499|39699832|FG006|Overall Study|Lost to Follow-up|1|||
16331088|NCT02553499|39699833|FG007|Overall Study|Lost to Follow-up|0|||
16331089|NCT02553499|39699834|FG008|Overall Study|Lost to Follow-up|0|||
16331090|NCT02553499|39699835|FG009|Overall Study|Lost to Follow-up|0|||
16529138|NCT03727750|40405927|FG000|Overall Study|Lost to Follow-up|1|||
16529139|NCT03727750|40405927|FG000|Overall Study|Other|1|||
16098218|NCT02446912|38847028|FG001|Overall Study|Adverse Event|13|||
16331091|NCT02553499|39699836|FG010|Overall Study|Lost to Follow-up|0|||
16331092|NCT02553499|39699837|FG011|Overall Study|Lost to Follow-up|0|||
16529140|NCT04302350|40405931|FG000|Overall Study|Physician Decision|1|||
16529141|NCT04302350|40405932|FG001|Overall Study|Physician Decision|1|||
16529142|NCT04302350|40405933|FG002|Overall Study|Physician Decision|2|||
16098219|NCT02446912|38847029|FG002|Overall Study|Adverse Event|5|||
16098220|NCT02446912|38847027|FG000|Overall Study|Condition under investigation worsened|0|||
16331093|NCT02553499|39699838|FG012|Overall Study|Lost to Follow-up|0|||
16331094|NCT02553499|39699839|FG013|Overall Study|Lost to Follow-up|0|||
16331095|NCT02553499|39699826|FG000|Overall Study|Physician Decision|0|||
16331096|NCT02553499|39699827|FG001|Overall Study|Physician Decision|1|||
16331097|NCT02553499|39699828|FG002|Overall Study|Physician Decision|1|||
16331098|NCT02553499|39699829|FG003|Overall Study|Physician Decision|0|||
16331099|NCT02553499|39699830|FG004|Overall Study|Physician Decision|1|||
16331100|NCT02553499|39699831|FG005|Overall Study|Physician Decision|0|||
16331101|NCT02553499|39699832|FG006|Overall Study|Physician Decision|0|||
16331102|NCT02553499|39699833|FG007|Overall Study|Physician Decision|1|||
16331103|NCT02553499|39699834|FG008|Overall Study|Physician Decision|1|||
16331104|NCT02553499|39699835|FG009|Overall Study|Physician Decision|2|||
16331105|NCT02553499|39699836|FG010|Overall Study|Physician Decision|1|||
16331106|NCT02553499|39699837|FG011|Overall Study|Physician Decision|3|||
16331107|NCT02553499|39699838|FG012|Overall Study|Physician Decision|1|||
16331108|NCT02553499|39699839|FG013|Overall Study|Physician Decision|0|||
16331109|NCT02553499|39699826|FG000|Overall Study|Progressive Disease|0|||
16331110|NCT02553499|39699827|FG001|Overall Study|Progressive Disease|0|||
16331111|NCT02553499|39699828|FG002|Overall Study|Progressive Disease|0|||
16331112|NCT02553499|39699829|FG003|Overall Study|Progressive Disease|2|||
16331113|NCT02553499|39699830|FG004|Overall Study|Progressive Disease|1|||
16331114|NCT02553499|39699831|FG005|Overall Study|Progressive Disease|1|||
16331115|NCT02553499|39699832|FG006|Overall Study|Progressive Disease|1|||
16529143|NCT04302350|40405931|FG000|Overall Study|Lack of Efficacy|1|||
16529144|NCT04302350|40405932|FG001|Overall Study|Lack of Efficacy|1|||
16529145|NCT04302350|40405933|FG002|Overall Study|Lack of Efficacy|4|||
16098221|NCT02446912|38847028|FG001|Overall Study|Condition under investigation worsened|1|||
16098222|NCT02446912|38847029|FG002|Overall Study|Condition under investigation worsened|1|||
16098223|NCT02446912|38847027|FG000|Overall Study|Study-specific withdrawal criteria|1|||
16098224|NCT02446912|38847028|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16098225|NCT02446912|38847029|FG002|Overall Study|Study-specific withdrawal criteria|0|||
16529146|NCT04302350|40405931|FG000|Overall Study|Adverse Event|0|||
16529147|NCT04302350|40405932|FG001|Overall Study|Adverse Event|1|||
16529148|NCT04302350|40405933|FG002|Overall Study|Adverse Event|2|||
16529149|NCT02370602|40405936|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16529150|NCT02370602|40405937|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
16529151|NCT02370602|40405938|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16529152|NCT02370602|40405939|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
16529153|NCT02370602|40405940|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
16529154|NCT02370602|40405941|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
16529155|NCT00618514|40405954|FG000|Overall Study|Lost to Follow-up|11|||
16529156|NCT00618514|40405955|FG001|Overall Study|Lost to Follow-up|12|||
16529157|NCT00618514|40405956|FG002|Overall Study|Lost to Follow-up|4|||
16529158|NCT00506493|40405958|FG000|Overall Study|Death|6|||
16529159|NCT00506493|40405958|FG000|Overall Study|Withdrawal by Subject|5|||
16529160|NCT03021187|40405959|FG000|Overall Study|Death|0|||
16529161|NCT03021187|40405960|FG001|Overall Study|Death|0|||
16529162|NCT03021187|40405961|FG002|Overall Study|Death|3|||
16529163|NCT03021187|40405962|FG003|Overall Study|Death|0|||
16529164|NCT03021187|40405959|FG000|Overall Study|Withdrawal by Subject|0|||
16212511|NCT03907969|39258703|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
16331116|NCT02553499|39699833|FG007|Overall Study|Progressive Disease|0|||
16098226|NCT02446912|38847027|FG000|Overall Study|Lack of Efficacy|1|||
16098227|NCT02446912|38847028|FG001|Overall Study|Lack of Efficacy|4|||
16098228|NCT02446912|38847029|FG002|Overall Study|Lack of Efficacy|7|||
16098229|NCT02446912|38847027|FG000|Overall Study|Lost to Follow-up|0|||
16098230|NCT02446912|38847028|FG001|Overall Study|Lost to Follow-up|0|||
16098231|NCT02446912|38847029|FG002|Overall Study|Lost to Follow-up|2|||
16529165|NCT03021187|40405960|FG001|Overall Study|Withdrawal by Subject|6|||
16529166|NCT03021187|40405961|FG002|Overall Study|Withdrawal by Subject|2|||
16212512|NCT03907969|39258704|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
16212513|NCT03907969|39258705|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
16529167|NCT03021187|40405962|FG003|Overall Study|Withdrawal by Subject|5|||
16331117|NCT02553499|39699834|FG008|Overall Study|Progressive Disease|0|||
16529168|NCT03021187|40405959|FG000|Overall Study|Lost to Follow-up|10|||
16529169|NCT03021187|40405960|FG001|Overall Study|Lost to Follow-up|3|||
16529170|NCT03021187|40405961|FG002|Overall Study|Lost to Follow-up|1|||
16529171|NCT03021187|40405962|FG003|Overall Study|Lost to Follow-up|4|||
16529172|NCT03131648|40405963|FG000|Initial Treatment Period|Not dosed|2|||
16529173|NCT03131648|40405964|FG001|Initial Treatment Period|Not dosed|2|||
16529174|NCT03131648|40405965|FG002|Initial Treatment Period|Not dosed|0|||
16529175|NCT03131648|40405966|FG003|Initial Treatment Period|Not dosed|0|||
16529176|NCT03131648|40405967|FG004|Initial Treatment Period|Not dosed|0|||
16529177|NCT03131648|40405968|FG005|Initial Treatment Period|Not dosed|0|||
16529178|NCT03131648|40405969|FG006|Initial Treatment Period|Not dosed|0|||
16529179|NCT03131648|40405970|FG007|Initial Treatment Period|Not dosed|0|||
16529180|NCT03131648|40405963|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
16529181|NCT03131648|40405964|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
16529182|NCT03131648|40405965|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16529183|NCT03131648|40405966|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16331118|NCT02553499|39699835|FG009|Overall Study|Progressive Disease|1|||
16331119|NCT02553499|39699836|FG010|Overall Study|Progressive Disease|0|||
16331120|NCT02553499|39699837|FG011|Overall Study|Progressive Disease|0|||
16331121|NCT02553499|39699838|FG012|Overall Study|Progressive Disease|2|||
16331122|NCT02553499|39699839|FG013|Overall Study|Progressive Disease|1|||
16331123|NCT02553499|39699826|FG000|Overall Study|Study Terminated by Sponsor|0|||
16331124|NCT02553499|39699827|FG001|Overall Study|Study Terminated by Sponsor|0|||
16331125|NCT02553499|39699828|FG002|Overall Study|Study Terminated by Sponsor|0|||
16331126|NCT02553499|39699829|FG003|Overall Study|Study Terminated by Sponsor|0|||
16331127|NCT02553499|39699830|FG004|Overall Study|Study Terminated by Sponsor|0|||
16331128|NCT02553499|39699831|FG005|Overall Study|Study Terminated by Sponsor|0|||
16331129|NCT02553499|39699832|FG006|Overall Study|Study Terminated by Sponsor|0|||
16331130|NCT02553499|39699833|FG007|Overall Study|Study Terminated by Sponsor|0|||
16331131|NCT02553499|39699834|FG008|Overall Study|Study Terminated by Sponsor|1|||
16331132|NCT02553499|39699835|FG009|Overall Study|Study Terminated by Sponsor|0|||
16331133|NCT02553499|39699836|FG010|Overall Study|Study Terminated by Sponsor|0|||
16331134|NCT02553499|39699837|FG011|Overall Study|Study Terminated by Sponsor|0|||
16331135|NCT02553499|39699838|FG012|Overall Study|Study Terminated by Sponsor|0|||
16331136|NCT02553499|39699839|FG013|Overall Study|Study Terminated by Sponsor|0|||
16331137|NCT02553499|39699826|FG000|Overall Study|Withdrawal by Subject|2|||
16331138|NCT02553499|39699827|FG001|Overall Study|Withdrawal by Subject|0|||
16331139|NCT02553499|39699828|FG002|Overall Study|Withdrawal by Subject|0|||
16331140|NCT02553499|39699829|FG003|Overall Study|Withdrawal by Subject|0|||
16331141|NCT02553499|39699830|FG004|Overall Study|Withdrawal by Subject|0|||
16331142|NCT02553499|39699831|FG005|Overall Study|Withdrawal by Subject|0|||
16331143|NCT02553499|39699832|FG006|Overall Study|Withdrawal by Subject|0|||
16331144|NCT02553499|39699833|FG007|Overall Study|Withdrawal by Subject|1|||
16331145|NCT02553499|39699834|FG008|Overall Study|Withdrawal by Subject|1|||
16331146|NCT02553499|39699835|FG009|Overall Study|Withdrawal by Subject|0|||
16331147|NCT02553499|39699836|FG010|Overall Study|Withdrawal by Subject|1|||
16331148|NCT02553499|39699837|FG011|Overall Study|Withdrawal by Subject|0|||
16331149|NCT02553499|39699838|FG012|Overall Study|Withdrawal by Subject|0|||
16331150|NCT02553499|39699839|FG013|Overall Study|Withdrawal by Subject|0|||
16331151|NCT01777295|39699840|FG000|Overall Study|Withdrawal by Subject|2|||
16331152|NCT01777295|39699841|FG001|Overall Study|Withdrawal by Subject|2|||
16331153|NCT01777295|39699840|FG000|Overall Study|Pregnancy|0|||
16331154|NCT01777295|39699841|FG001|Overall Study|Pregnancy|1|||
16331155|NCT01777295|39699840|FG000|Overall Study|Personal problem|1|||
16331156|NCT01777295|39699841|FG001|Overall Study|Personal problem|0|||
16331157|NCT01777295|39699840|FG000|Overall Study|Investigator call for AEs check|1|||
16331158|NCT01777295|39699841|FG001|Overall Study|Investigator call for AEs check|0|||
16331159|NCT03168919|39699847|FG000|Overall Study|Withdrawal by Subject|2|||
16331160|NCT00766467|39699848|FG000|Overall Study|Withdrawal by Subject|7|||
16331161|NCT00766467|39699849|FG001|Overall Study|Withdrawal by Subject|2|||
16331162|NCT00766467|39699848|FG000|Overall Study|Adverse Event|1|||
16331163|NCT00766467|39699849|FG001|Overall Study|Adverse Event|1|||
16331164|NCT00766467|39699848|FG000|Overall Study|Protocol Violation|2|||
16331165|NCT00766467|39699849|FG001|Overall Study|Protocol Violation|4|||
16331166|NCT00766467|39699848|FG000|Overall Study|Tumor Progression on Study|0|||
16331167|NCT00766467|39699849|FG001|Overall Study|Tumor Progression on Study|1|||
16331168|NCT00766467|39699848|FG000|Overall Study|Physician Decision|1|||
16529184|NCT03131648|40405967|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16331169|NCT00766467|39699849|FG001|Overall Study|Physician Decision|0|||
16331170|NCT01717391|39699850|FG000|Overall Study|Withdrawal by Subject|5|||
16331171|NCT01717391|39699850|FG000|Overall Study|Physician Decision|1|||
16331172|NCT01717391|39699850|FG000|Overall Study|FLT technical failure|3|||
16331173|NCT02921750|39699851|FG000|Overall Study|Adverse Event|1|||
16331174|NCT02921750|39699852|FG001|Overall Study|Adverse Event|2|||
16331175|NCT02921750|39699851|FG000|Overall Study|Withdrawal by Subject|1|||
16529185|NCT03131648|40405968|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16529186|NCT03131648|40405969|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16331176|NCT02921750|39699852|FG001|Overall Study|Withdrawal by Subject|1|||
16529187|NCT03131648|40405970|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16529188|NCT03131648|40405963|FG000|Open-label Treatment|Discontinued IMP|0|||
16529189|NCT03131648|40405964|FG001|Open-label Treatment|Discontinued IMP|0|||
16529190|NCT03131648|40405965|FG002|Open-label Treatment|Discontinued IMP|0|||
16529191|NCT03131648|40405966|FG003|Open-label Treatment|Discontinued IMP|0|||
16529192|NCT03131648|40405967|FG004|Open-label Treatment|Discontinued IMP|0|||
16529193|NCT03131648|40405968|FG005|Open-label Treatment|Discontinued IMP|0|||
16529194|NCT03131648|40405969|FG006|Open-label Treatment|Discontinued IMP|112|||
16529195|NCT03131648|40405970|FG007|Open-label Treatment|Discontinued IMP|0|||
16529196|NCT03131648|40405963|FG000|Open-label Treatment|Completed Week 50|0|||
16529197|NCT03131648|40405964|FG001|Open-label Treatment|Completed Week 50|0|||
16529198|NCT03131648|40405965|FG002|Open-label Treatment|Completed Week 50|0|||
16529199|NCT03131648|40405966|FG003|Open-label Treatment|Completed Week 50|0|||
16529200|NCT03131648|40405967|FG004|Open-label Treatment|Completed Week 50|0|||
16529201|NCT03131648|40405968|FG005|Open-label Treatment|Completed Week 50|0|||
16529202|NCT03131648|40405969|FG006|Open-label Treatment|Completed Week 50|6|||
16529203|NCT03131648|40405970|FG007|Open-label Treatment|Completed Week 50|0|||
16529204|NCT03131648|40405963|FG000|Maintenance Treatment Period|Not dosed|0|||
16529205|NCT03131648|40405964|FG001|Maintenance Treatment Period|Not dosed|0|||
16529206|NCT03131648|40405965|FG002|Maintenance Treatment Period|Not dosed|3|||
16529207|NCT03131648|40405966|FG003|Maintenance Treatment Period|Not dosed|2|||
16529208|NCT03131648|40405967|FG004|Maintenance Treatment Period|Not dosed|1|||
16529209|NCT03131648|40405968|FG005|Maintenance Treatment Period|Not dosed|0|||
16529210|NCT03131648|40405969|FG006|Maintenance Treatment Period|Not dosed|0|||
16529211|NCT03131648|40405970|FG007|Maintenance Treatment Period|Not dosed|0|||
16529212|NCT03131648|40405963|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
16529213|NCT03131648|40405964|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
16529214|NCT03131648|40405965|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
16529215|NCT03131648|40405966|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
16529216|NCT03131648|40405967|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
16529217|NCT03131648|40405968|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
16529218|NCT03131648|40405969|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
16529219|NCT03131648|40405970|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
16529220|NCT03131648|40405963|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
16529221|NCT03131648|40405964|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
16529222|NCT03131648|40405965|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
16529223|NCT03131648|40405966|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
16212514|NCT03907969|39258706|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
16212515|NCT03907969|39258707|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
16212516|NCT03907969|39258708|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
16212517|NCT03907969|39258709|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
16212518|NCT03907969|39258699|FG000|Monotherapy Part A|Progressive Disease|0|||
16212519|NCT03907969|39258700|FG001|Monotherapy Part A|Progressive Disease|1|||
16212520|NCT03907969|39258701|FG002|Monotherapy Part A|Progressive Disease|0|||
16212521|NCT03907969|39258702|FG003|Monotherapy Part A|Progressive Disease|0|||
16212522|NCT03907969|39258703|FG004|Monotherapy Part A|Progressive Disease|0|||
16212523|NCT03907969|39258704|FG005|Monotherapy Part A|Progressive Disease|1|||
16212524|NCT03907969|39258705|FG006|Monotherapy Part A|Progressive Disease|2|||
16212525|NCT03907969|39258706|FG007|Monotherapy Part A|Progressive Disease|0|||
16212526|NCT03907969|39258707|FG008|Monotherapy Part A|Progressive Disease|0|||
16212527|NCT03907969|39258708|FG009|Monotherapy Part A|Progressive Disease|0|||
16212528|NCT03907969|39258709|FG010|Monotherapy Part A|Progressive Disease|0|||
16212529|NCT03907969|39258699|FG000|Monotherapy Part A|Death|0|||
16212530|NCT03907969|39258700|FG001|Monotherapy Part A|Death|0|||
16212531|NCT03907969|39258701|FG002|Monotherapy Part A|Death|1|||
16529224|NCT03131648|40405967|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
16529225|NCT03131648|40405968|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
16529226|NCT03131648|40405969|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
16529227|NCT03131648|40405970|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
16529228|NCT03131648|40405963|FG000|Maintenance Treatment Period|Completed Week 50|0|||
16529229|NCT03131648|40405964|FG001|Maintenance Treatment Period|Completed Week 50|0|||
16529230|NCT03131648|40405965|FG002|Maintenance Treatment Period|Completed Week 50|0|||
16529231|NCT03131648|40405966|FG003|Maintenance Treatment Period|Completed Week 50|0|||
16529232|NCT03131648|40405967|FG004|Maintenance Treatment Period|Completed Week 50|1|||
16098232|NCT02446912|38847027|FG000|Overall Study|Severe non-compliance to protocol|1|||
16212532|NCT03907969|39258702|FG003|Monotherapy Part A|Death|1|||
16212533|NCT03907969|39258703|FG004|Monotherapy Part A|Death|0|||
16529233|NCT03131648|40405968|FG005|Maintenance Treatment Period|Completed Week 50|0|||
16529234|NCT03131648|40405969|FG006|Maintenance Treatment Period|Completed Week 50|0|||
16212534|NCT03907969|39258704|FG005|Monotherapy Part A|Death|1|||
16529235|NCT03131648|40405970|FG007|Maintenance Treatment Period|Completed Week 50|0|||
16529236|NCT03131648|40405963|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
16529237|NCT03131648|40405964|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
16529238|NCT03131648|40405965|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
16529239|NCT03131648|40405966|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
16529240|NCT03131648|40405967|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
16529241|NCT03131648|40405968|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
16529242|NCT03131648|40405969|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
16529243|NCT03131648|40405970|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
16529244|NCT01775904|40405972|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
16529245|NCT01775904|40405972|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
16529246|NCT02621606|40405978|FG000|Overall Study|Withdrawal by Subject|0|||
16529247|NCT02621606|40405979|FG001|Overall Study|Withdrawal by Subject|1|||
16529248|NCT02621606|40405980|FG002|Overall Study|Withdrawal by Subject|0|||
16529249|NCT01640808|40405981|FG000|Overall Study|Unable to continue dynamic CT|14|||
16529250|NCT01640808|40405982|FG001|Overall Study|Unable to continue dynamic CT|4|||
16529251|NCT01640808|40405981|FG000|Overall Study|Withdrawal by Subject|12|||
16529252|NCT01640808|40405982|FG001|Overall Study|Withdrawal by Subject|4|||
16529253|NCT01640808|40405981|FG000|Overall Study|Lost to Follow-up|4|||
16529254|NCT01640808|40405982|FG001|Overall Study|Lost to Follow-up|0|||
16529255|NCT01640808|40405981|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
16529256|NCT01640808|40405982|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
16529257|NCT01640808|40405981|FG000|Overall Study|Administration of anticancer drugs|2|||
16331177|NCT02921750|39699851|FG000|Overall Study|Lost to Follow-up|3|||
16331178|NCT02921750|39699852|FG001|Overall Study|Lost to Follow-up|3|||
16331179|NCT02921750|39699851|FG000|Overall Study|Wound healed|3|||
16529258|NCT01640808|40405982|FG001|Overall Study|Administration of anticancer drugs|1|||
16529259|NCT01640808|40405981|FG000|Overall Study|Physician Decision|19|||
16529260|NCT01640808|40405982|FG001|Overall Study|Physician Decision|5|||
16529261|NCT01640808|40405981|FG000|Overall Study|Randomized but not treated|4|||
16529262|NCT01640808|40405982|FG001|Overall Study|Randomized but not treated|2|||
16529263|NCT00288587|40405983|FG000|Overall Study|Death|4|||
16529264|NCT00288587|40405984|FG001|Overall Study|Death|4|||
16529265|NCT00288587|40405983|FG000|Overall Study|Transplant|0|||
16529266|NCT00288587|40405984|FG001|Overall Study|Transplant|3|||
16529267|NCT00288587|40405983|FG000|Overall Study|Adverse Event|0|||
16529268|NCT00288587|40405984|FG001|Overall Study|Adverse Event|1|||
16529269|NCT00288587|40405983|FG000|Overall Study|Physician Decision|0|||
16529270|NCT00288587|40405984|FG001|Overall Study|Physician Decision|2|||
16529271|NCT00288587|40405983|FG000|Overall Study|Severe Aortic Stenosis|1|||
16331180|NCT02921750|39699852|FG001|Overall Study|Wound healed|3|||
16331181|NCT02921750|39699851|FG000|Overall Study|Serious Adverse Event|1|||
16331182|NCT02921750|39699852|FG001|Overall Study|Serious Adverse Event|2|||
16331183|NCT01210495|39699862|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
16331184|NCT01210495|39699863|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
16331185|NCT01210495|39699864|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
16331186|NCT01210495|39699865|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
16331187|NCT01210495|39699862|FG000|Overall Study|Death|14|||
16331188|NCT01210495|39699863|FG001|Overall Study|Death|7|||
16331189|NCT01210495|39699864|FG002|Overall Study|Death|112|||
16331190|NCT01210495|39699865|FG003|Overall Study|Death|54|||
16331191|NCT01210495|39699862|FG000|Overall Study|Study Terminated by Sponsor|0|||
16400783|NCT03632993|39948390|FG007|Overall Study|Protocol Non-compliance|0|||
16400784|NCT03632993|39948391|FG008|Overall Study|Protocol Non-compliance|0|||
16400785|NCT03632993|39948392|FG009|Overall Study|Protocol Non-compliance|0|||
16400786|NCT03632993|39948383|FG000|Overall Study|Lost to Follow-up|0|||
16400787|NCT03632993|39948384|FG001|Overall Study|Lost to Follow-up|0|||
16400788|NCT03632993|39948385|FG002|Overall Study|Lost to Follow-up|0|||
16529272|NCT00288587|40405984|FG001|Overall Study|Severe Aortic Stenosis|0|||
16529273|NCT02352948|40405985|FG000|Overall Study|Death|47|||
16098233|NCT02446912|38847028|FG001|Overall Study|Severe non-compliance to protocol|0|||
16529274|NCT02352948|40405986|FG001|Overall Study|Death|48|||
16529275|NCT02352948|40405987|FG002|Overall Study|Death|114|||
16529276|NCT02352948|40405988|FG003|Overall Study|Death|74|||
16529277|NCT02352948|40405989|FG004|Overall Study|Death|77|||
16529278|NCT02352948|40405990|FG005|Overall Study|Death|44|||
16529279|NCT02352948|40405985|FG000|Overall Study|Lost to Follow-up|1|||
16529280|NCT02352948|40405986|FG001|Overall Study|Lost to Follow-up|0|||
16529281|NCT02352948|40405987|FG002|Overall Study|Lost to Follow-up|2|||
16529282|NCT02352948|40405988|FG003|Overall Study|Lost to Follow-up|1|||
16529283|NCT02352948|40405989|FG004|Overall Study|Lost to Follow-up|2|||
16529284|NCT02352948|40405990|FG005|Overall Study|Lost to Follow-up|1|||
16529285|NCT02352948|40405985|FG000|Overall Study|Withdrawal by Subject|1|||
16529286|NCT02352948|40405986|FG001|Overall Study|Withdrawal by Subject|10|||
16212535|NCT03907969|39258705|FG006|Monotherapy Part A|Death|0|||
16212536|NCT03907969|39258706|FG007|Monotherapy Part A|Death|0|||
16212537|NCT03907969|39258707|FG008|Monotherapy Part A|Death|0|||
16212538|NCT03907969|39258708|FG009|Monotherapy Part A|Death|0|||
16212539|NCT03907969|39258709|FG010|Monotherapy Part A|Death|0|||
16212540|NCT03907969|39258699|FG000|Combination Therapy Part A|Adverse Event|0|||
16212541|NCT03907969|39258700|FG001|Combination Therapy Part A|Adverse Event|0|||
16212542|NCT03907969|39258701|FG002|Combination Therapy Part A|Adverse Event|0|||
16212543|NCT03907969|39258702|FG003|Combination Therapy Part A|Adverse Event|0|||
16212544|NCT03907969|39258703|FG004|Combination Therapy Part A|Adverse Event|0|||
16212545|NCT03907969|39258704|FG005|Combination Therapy Part A|Adverse Event|0|||
16212546|NCT03907969|39258705|FG006|Combination Therapy Part A|Adverse Event|0|||
16212547|NCT03907969|39258706|FG007|Combination Therapy Part A|Adverse Event|0|||
16212548|NCT03907969|39258707|FG008|Combination Therapy Part A|Adverse Event|0|||
16212549|NCT03907969|39258708|FG009|Combination Therapy Part A|Adverse Event|1|||
16212550|NCT03907969|39258709|FG010|Combination Therapy Part A|Adverse Event|1|||
16212551|NCT03907969|39258699|FG000|Combination Therapy Part A|Progressive disease|0|||
16212552|NCT03907969|39258700|FG001|Combination Therapy Part A|Progressive disease|0|||
16212553|NCT03907969|39258701|FG002|Combination Therapy Part A|Progressive disease|0|||
16212554|NCT03907969|39258702|FG003|Combination Therapy Part A|Progressive disease|0|||
16212555|NCT03907969|39258703|FG004|Combination Therapy Part A|Progressive disease|0|||
16212556|NCT03907969|39258704|FG005|Combination Therapy Part A|Progressive disease|0|||
16212557|NCT03907969|39258705|FG006|Combination Therapy Part A|Progressive disease|0|||
16212558|NCT03907969|39258706|FG007|Combination Therapy Part A|Progressive disease|1|||
16212559|NCT03907969|39258707|FG008|Combination Therapy Part A|Progressive disease|0|||
16212560|NCT03907969|39258708|FG009|Combination Therapy Part A|Progressive disease|2|||
16212561|NCT03907969|39258709|FG010|Combination Therapy Part A|Progressive disease|3|||
16212562|NCT03907969|39258699|FG000|Combination Therapy Part A|Death|0|||
16212563|NCT03907969|39258700|FG001|Combination Therapy Part A|Death|0|||
16212564|NCT03907969|39258701|FG002|Combination Therapy Part A|Death|0|||
16212565|NCT03907969|39258702|FG003|Combination Therapy Part A|Death|0|||
16212566|NCT03907969|39258703|FG004|Combination Therapy Part A|Death|0|||
16212567|NCT03907969|39258704|FG005|Combination Therapy Part A|Death|0|||
16212568|NCT03907969|39258705|FG006|Combination Therapy Part A|Death|0|||
16212569|NCT03907969|39258706|FG007|Combination Therapy Part A|Death|0|||
16212570|NCT03907969|39258707|FG008|Combination Therapy Part A|Death|1|||
16212571|NCT03907969|39258708|FG009|Combination Therapy Part A|Death|0|||
16212572|NCT03907969|39258709|FG010|Combination Therapy Part A|Death|1|||
16212573|NCT03907969|39258699|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
16212574|NCT03907969|39258700|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
16212575|NCT03907969|39258701|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
16212576|NCT03907969|39258702|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
16212577|NCT03907969|39258703|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
16212578|NCT03907969|39258704|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
16212579|NCT03907969|39258705|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
16212580|NCT03907969|39258706|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
16212581|NCT03907969|39258707|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
16212582|NCT03907969|39258708|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
16212583|NCT03907969|39258709|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
16212584|NCT03907969|39258699|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
16212585|NCT03907969|39258700|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
16212586|NCT03907969|39258701|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
16212587|NCT03907969|39258702|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
16212588|NCT03907969|39258703|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
16212589|NCT03907969|39258704|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
16212590|NCT03907969|39258705|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
16212591|NCT03907969|39258706|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
16212592|NCT03907969|39258707|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
16212593|NCT03907969|39258708|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
16212594|NCT03907969|39258709|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
16212595|NCT03907969|39258699|FG000|Combination Therapy Part A|Physician Decision|0|||
16212596|NCT03907969|39258700|FG001|Combination Therapy Part A|Physician Decision|0|||
16212597|NCT03907969|39258701|FG002|Combination Therapy Part A|Physician Decision|0|||
16212598|NCT03907969|39258702|FG003|Combination Therapy Part A|Physician Decision|0|||
16331192|NCT01210495|39699863|FG001|Overall Study|Study Terminated by Sponsor|0|||
16331193|NCT01210495|39699864|FG002|Overall Study|Study Terminated by Sponsor|4|||
16529287|NCT02352948|40405987|FG002|Overall Study|Withdrawal by Subject|11|||
16529288|NCT02352948|40405988|FG003|Overall Study|Withdrawal by Subject|23|||
16212599|NCT03907969|39258703|FG004|Combination Therapy Part A|Physician Decision|0|||
16529289|NCT02352948|40405989|FG004|Overall Study|Withdrawal by Subject|9|||
16529290|NCT02352948|40405990|FG005|Overall Study|Withdrawal by Subject|4|||
16529291|NCT02352948|40405985|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16529292|NCT02352948|40405986|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16098234|NCT02446912|38847029|FG002|Overall Study|Severe non-compliance to protocol|1|||
16098235|NCT02446912|38847027|FG000|Overall Study|Withdrawal by Subject|10|||
16098236|NCT02446912|38847028|FG001|Overall Study|Withdrawal by Subject|15|||
16098237|NCT02446912|38847029|FG002|Overall Study|Withdrawal by Subject|15|||
16098238|NCT02446912|38847027|FG000|Overall Study|Miscellaneous|2|||
16098239|NCT02446912|38847028|FG001|Overall Study|Miscellaneous|2|||
16529293|NCT02352948|40405987|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
16529294|NCT02352948|40405988|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
16529295|NCT02352948|40405989|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
16529296|NCT02352948|40405990|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
16529297|NCT02352948|40405985|FG000|Overall Study|Other|0|||
16529298|NCT02352948|40405986|FG001|Overall Study|Other|0|||
16529299|NCT02352948|40405987|FG002|Overall Study|Other|2|||
16529300|NCT02352948|40405988|FG003|Overall Study|Other|0|||
16529301|NCT02352948|40405989|FG004|Overall Study|Other|0|||
16529302|NCT02352948|40405990|FG005|Overall Study|Other|0|||
16098240|NCT02446912|38847029|FG002|Overall Study|Miscellaneous|4|||
16212600|NCT03907969|39258704|FG005|Combination Therapy Part A|Physician Decision|0|||
16212601|NCT03907969|39258705|FG006|Combination Therapy Part A|Physician Decision|0|||
16212602|NCT03907969|39258706|FG007|Combination Therapy Part A|Physician Decision|1|||
16212603|NCT03907969|39258707|FG008|Combination Therapy Part A|Physician Decision|0|||
16212604|NCT03907969|39258708|FG009|Combination Therapy Part A|Physician Decision|0|||
16212605|NCT03907969|39258709|FG010|Combination Therapy Part A|Physician Decision|1|||
16212606|NCT00998985|39258713|FG000|Overall Study|Withdrawal by Subject|0|||
16212607|NCT00998985|39258714|FG001|Overall Study|Withdrawal by Subject|0|||
16212608|NCT00998985|39258715|FG002|Overall Study|Withdrawal by Subject|0|||
16212609|NCT00998985|39258716|FG003|Overall Study|Withdrawal by Subject|0|||
16212610|NCT00998985|39258717|FG004|Overall Study|Withdrawal by Subject|0|||
16212611|NCT00998985|39258718|FG005|Overall Study|Withdrawal by Subject|0|||
16212612|NCT00998985|39258719|FG006|Overall Study|Withdrawal by Subject|0|||
16212613|NCT00998985|39258720|FG007|Overall Study|Withdrawal by Subject|0|||
16212614|NCT00998985|39258721|FG008|Overall Study|Withdrawal by Subject|1|||
16212615|NCT00998985|39258722|FG009|Overall Study|Withdrawal by Subject|0|||
16212616|NCT00998985|39258723|FG010|Overall Study|Withdrawal by Subject|0|||
16212617|NCT00998985|39258724|FG011|Overall Study|Withdrawal by Subject|0|||
16212618|NCT00998985|39258725|FG012|Overall Study|Withdrawal by Subject|0|||
16212619|NCT00998985|39258726|FG013|Overall Study|Withdrawal by Subject|0|||
16212620|NCT00998985|39258713|FG000|Overall Study|Protocol Violation|0|||
16212621|NCT00998985|39258714|FG001|Overall Study|Protocol Violation|0|||
16212622|NCT00998985|39258715|FG002|Overall Study|Protocol Violation|0|||
16212623|NCT00998985|39258716|FG003|Overall Study|Protocol Violation|0|||
16212624|NCT00998985|39258717|FG004|Overall Study|Protocol Violation|0|||
16212625|NCT00998985|39258718|FG005|Overall Study|Protocol Violation|1|||
16212626|NCT00998985|39258719|FG006|Overall Study|Protocol Violation|0|||
16212627|NCT00998985|39258720|FG007|Overall Study|Protocol Violation|0|||
16212628|NCT00998985|39258721|FG008|Overall Study|Protocol Violation|0|||
16212629|NCT00998985|39258722|FG009|Overall Study|Protocol Violation|0|||
16212630|NCT00998985|39258723|FG010|Overall Study|Protocol Violation|0|||
16212631|NCT00998985|39258724|FG011|Overall Study|Protocol Violation|0|||
16331194|NCT01210495|39699865|FG003|Overall Study|Study Terminated by Sponsor|11|||
16331195|NCT01210495|39699862|FG000|Overall Study|Lost to Follow-up|0|||
16331196|NCT01210495|39699863|FG001|Overall Study|Lost to Follow-up|0|||
16331197|NCT01210495|39699864|FG002|Overall Study|Lost to Follow-up|1|||
16331198|NCT01210495|39699865|FG003|Overall Study|Lost to Follow-up|1|||
16331199|NCT01210495|39699862|FG000|Overall Study|Other unspecified|0|||
16331200|NCT01210495|39699863|FG001|Overall Study|Other unspecified|0|||
16331201|NCT01210495|39699864|FG002|Overall Study|Other unspecified|6|||
16331202|NCT01210495|39699865|FG003|Overall Study|Other unspecified|0|||
16331203|NCT03026530|39699866|FG000|Overall Study|Lost to Follow-up|19|||
16331204|NCT03026530|39699867|FG001|Overall Study|Lost to Follow-up|24|||
16331205|NCT03026530|39699866|FG000|Overall Study|Protocol Violation|2|||
16331206|NCT03026530|39699867|FG001|Overall Study|Protocol Violation|5|||
16331207|NCT01322035|39699875|FG000|Overall Study|Lost to Follow-up|8|||
16331208|NCT01322035|39699876|FG001|Overall Study|Lost to Follow-up|3|||
16331209|NCT02342548|39699877|FG000|Overall Study|Adverse Event|12|||
16331210|NCT02342548|39699878|FG001|Overall Study|Adverse Event|17|||
16331211|NCT02342548|39699879|FG002|Overall Study|Adverse Event|13|||
16331212|NCT02342548|39699877|FG000|Overall Study|Lost to Follow-up|0|||
16331213|NCT02342548|39699878|FG001|Overall Study|Lost to Follow-up|1|||
16331214|NCT02342548|39699879|FG002|Overall Study|Lost to Follow-up|0|||
16331215|NCT02342548|39699877|FG000|Overall Study|Study terminated by sponsor|20|||
16331216|NCT02342548|39699878|FG001|Overall Study|Study terminated by sponsor|39|||
16331217|NCT02342548|39699879|FG002|Overall Study|Study terminated by sponsor|25|||
16212632|NCT00998985|39258725|FG012|Overall Study|Protocol Violation|0|||
16212633|NCT00998985|39258726|FG013|Overall Study|Protocol Violation|0|||
16212634|NCT00641706|39258728|FG000|Overall Study|Adverse Event|2|||
16212635|NCT00641706|39258729|FG001|Overall Study|Adverse Event|1|||
16212636|NCT00641706|39258728|FG000|Overall Study|Withdrawal by Subject|6|||
16212637|NCT00641706|39258729|FG001|Overall Study|Withdrawal by Subject|1|||
16529303|NCT04258020|40405996|FG000|Overall Study|Withdrawal by Subject|1|||
16529304|NCT04258020|40405997|FG001|Overall Study|Withdrawal by Subject|0|||
16212638|NCT00641706|39258728|FG000|Overall Study|Clinical Decline|1|||
16331218|NCT02342548|39699877|FG000|Overall Study|Protocol Violation|0|||
16529305|NCT01627249|40405998|FG000|Overall Study|Death|3|||
16529306|NCT01627249|40405999|FG001|Overall Study|Death|5|||
16529307|NCT01627249|40406000|FG002|Overall Study|Death|3|||
16212639|NCT00641706|39258729|FG001|Overall Study|Clinical Decline|0|||
16331219|NCT02342548|39699878|FG001|Overall Study|Protocol Violation|1|||
16331220|NCT02342548|39699879|FG002|Overall Study|Protocol Violation|0|||
16331221|NCT02342548|39699877|FG000|Overall Study|Withdrawal by Subject|1|||
16331222|NCT02342548|39699878|FG001|Overall Study|Withdrawal by Subject|3|||
16331223|NCT02342548|39699879|FG002|Overall Study|Withdrawal by Subject|4|||
16331224|NCT02342548|39699877|FG000|Overall Study|Other|1|||
16331225|NCT02342548|39699878|FG001|Overall Study|Other|1|||
16331226|NCT02342548|39699879|FG002|Overall Study|Other|1|||
16331227|NCT02858180|39699880|FG000|Overall Study|Lost to Follow-up|0|||
16529308|NCT01627249|40405998|FG000|Overall Study|Withdrawal by Subject|12|||
16529309|NCT01627249|40405999|FG001|Overall Study|Withdrawal by Subject|6|||
16529310|NCT01627249|40406000|FG002|Overall Study|Withdrawal by Subject|9|||
16529311|NCT01627249|40405998|FG000|Overall Study|Missed Visit|1|||
16529312|NCT01627249|40405999|FG001|Overall Study|Missed Visit|1|||
16529313|NCT01627249|40406000|FG002|Overall Study|Missed Visit|0|||
16529314|NCT02462876|40406001|FG000|Overall Study|Death|3|||
16529315|NCT02462876|40406001|FG000|Overall Study|Lost to Follow-up|7|||
16529316|NCT02462876|40406001|FG000|Overall Study|Surgical Bypass|9|||
16529317|NCT02462876|40406001|FG000|Overall Study|Amputation Above the Metatarsals|1|||
16529318|NCT02462876|40406001|FG000|Overall Study|36 months follow-up visit missed|1|||
16529319|NCT02462876|40406001|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
16529320|NCT02462876|40406001|FG000|Overall Study|Patient did not come back to the vascular department|1|||
16529321|NCT02462876|40406001|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
16529322|NCT02462876|40406001|FG000|Overall Study|Patient refused to come back|1|||
16529323|NCT02462876|40406001|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
16529324|NCT02462876|40406001|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
16529325|NCT03538626|40406002|FG000|Overall Study|Withdrawal by Subject|0|||
16529326|NCT03538626|40406003|FG001|Overall Study|Withdrawal by Subject|1|||
16529327|NCT03538626|40406004|FG002|Overall Study|Withdrawal by Subject|0|||
16331228|NCT02858180|39699881|FG001|Overall Study|Lost to Follow-up|2|||
16212640|NCT00641706|39258728|FG000|Overall Study|Lead Investigator Decision|0|||
16212641|NCT00641706|39258729|FG001|Overall Study|Lead Investigator Decision|1|||
16331229|NCT02817516|39699887|FG000|Overall Study|Other|0|||
16331230|NCT02817516|39699888|FG001|Overall Study|Other|0|||
16331231|NCT02817516|39699889|FG002|Overall Study|Other|1|||
16529328|NCT03538626|40406005|FG003|Overall Study|Withdrawal by Subject|0|||
16212642|NCT04083794|39258746|FG000|Overall Study|Lost to Follow-up|9|||
16212643|NCT00369278|39258747|FG000|Overall Study|Adverse Event|14|||
16212644|NCT00369278|39258748|FG001|Overall Study|Adverse Event|11|||
16212645|NCT00369278|39258747|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16212646|NCT00369278|39258748|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
16212647|NCT00369278|39258747|FG000|Overall Study|Protocol Violation|2|||
16212648|NCT00369278|39258748|FG001|Overall Study|Protocol Violation|1|||
16212649|NCT00369278|39258747|FG000|Overall Study|Withdrawal by Subject|2|||
16212650|NCT00369278|39258748|FG001|Overall Study|Withdrawal by Subject|2|||
16212651|NCT00369278|39258747|FG000|Overall Study|Lost to Follow-up|1|||
16212652|NCT00369278|39258748|FG001|Overall Study|Lost to Follow-up|0|||
16212653|NCT00369278|39258747|FG000|Overall Study|Graft loss|1|||
16212654|NCT00369278|39258748|FG001|Overall Study|Graft loss|2|||
16212655|NCT00552344|39258753|FG000|Overall Study|Lack of Efficacy|55|||
16212656|NCT00552344|39258753|FG000|Overall Study|Loss of efficacy|75|||
16212657|NCT00552344|39258753|FG000|Overall Study|Lost to Follow-up|8|||
16212658|NCT00552344|39258753|FG000|Overall Study|Withdrawal by Subject|48|||
16212659|NCT00552344|39258753|FG000|Overall Study|SAE, non-fatal|6|||
16212660|NCT00552344|39258753|FG000|Overall Study|AE, non-serious non-fatal|38|||
16212661|NCT00552344|39258753|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
16212662|NCT00552344|39258753|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
16212663|NCT00552344|39258753|FG000|Overall Study|Other Reason|22|||
16212664|NCT03472040|39258757|FG000|Overall Study|Physician Decision|0|||
16212665|NCT03472040|39258758|FG001|Overall Study|Physician Decision|3|||
16212666|NCT03472040|39258757|FG000|Overall Study|Withdrawal by Subject|10|||
16212667|NCT03472040|39258758|FG001|Overall Study|Withdrawal by Subject|23|||
16212668|NCT03472040|39258757|FG000|Overall Study|Perceived Lack of Efficacy|29|||
16212669|NCT03472040|39258758|FG001|Overall Study|Perceived Lack of Efficacy|30|||
16212670|NCT03472040|39258757|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
16212671|NCT03472040|39258758|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
16212672|NCT03472040|39258757|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
16212673|NCT03472040|39258758|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
16212674|NCT03472040|39258757|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
16212675|NCT03472040|39258758|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
16212676|NCT03472040|39258757|FG000|Overall Study|Subject Non-compliance|2|||
16212677|NCT03472040|39258758|FG001|Overall Study|Subject Non-compliance|5|||
16212678|NCT03472040|39258757|FG000|Overall Study|Discontinuation due to Rash|0|||
16212679|NCT03472040|39258758|FG001|Overall Study|Discontinuation due to Rash|1|||
16212680|NCT03472040|39258757|FG000|Overall Study|Subsequent Ineligibility|0|||
16212681|NCT03472040|39258758|FG001|Overall Study|Subsequent Ineligibility|2|||
16212682|NCT03472040|39258757|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
16212683|NCT03472040|39258758|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
16212684|NCT03135262|39258763|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
16212685|NCT03135262|39258764|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
16212686|NCT03135262|39258765|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
16212687|NCT03135262|39258766|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
16212688|NCT03135262|39258767|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
16212689|NCT03135262|39258763|FG000|Overall Study|Progression of disease|0|||
16212690|NCT03135262|39258764|FG001|Overall Study|Progression of disease|0|||
16212691|NCT03135262|39258765|FG002|Overall Study|Progression of disease|0|||
16212692|NCT03135262|39258766|FG003|Overall Study|Progression of disease|1|||
16212693|NCT03135262|39258767|FG004|Overall Study|Progression of disease|0|||
16212694|NCT03135262|39258763|FG000|Overall Study|Death|6|||
16212695|NCT03135262|39258764|FG001|Overall Study|Death|2|||
16212696|NCT03135262|39258765|FG002|Overall Study|Death|2|||
16212697|NCT03135262|39258766|FG003|Overall Study|Death|2|||
16212698|NCT03135262|39258767|FG004|Overall Study|Death|0|||
16212699|NCT03135262|39258763|FG000|Overall Study|Withdrawal by Subject|0|||
16212700|NCT03135262|39258764|FG001|Overall Study|Withdrawal by Subject|0|||
16212701|NCT03135262|39258765|FG002|Overall Study|Withdrawal by Subject|1|||
16212702|NCT03135262|39258766|FG003|Overall Study|Withdrawal by Subject|0|||
16098241|NCT00274287|38847032|FG000|Overall Study|Withdrawal by Subject|1|||
16212703|NCT03135262|39258767|FG004|Overall Study|Withdrawal by Subject|1|||
16212704|NCT03135262|39258763|FG000|Overall Study|Study terminated by sponsor|2|||
16212705|NCT03135262|39258764|FG001|Overall Study|Study terminated by sponsor|4|||
16212706|NCT03135262|39258765|FG002|Overall Study|Study terminated by sponsor|4|||
16212707|NCT03135262|39258766|FG003|Overall Study|Study terminated by sponsor|3|||
16212708|NCT03135262|39258767|FG004|Overall Study|Study terminated by sponsor|0|||
16212709|NCT01831804|39258770|FG000|Overall Study|Adverse Event|0|||
16212710|NCT01831804|39258771|FG001|Overall Study|Adverse Event|0|||
16400789|NCT03632993|39948386|FG003|Overall Study|Lost to Follow-up|0|||
16400790|NCT03632993|39948387|FG004|Overall Study|Lost to Follow-up|0|||
16400791|NCT03632993|39948388|FG005|Overall Study|Lost to Follow-up|1|||
16400792|NCT03632993|39948389|FG006|Overall Study|Lost to Follow-up|0|||
16400793|NCT03632993|39948390|FG007|Overall Study|Lost to Follow-up|1|||
16400794|NCT03632993|39948391|FG008|Overall Study|Lost to Follow-up|0|||
16331232|NCT02817516|39699890|FG003|Overall Study|Other|0|||
16400795|NCT03632993|39948392|FG009|Overall Study|Lost to Follow-up|0|||
16529329|NCT03538626|40406006|FG004|Overall Study|Withdrawal by Subject|0|||
16529330|NCT03538626|40406007|FG005|Overall Study|Withdrawal by Subject|0|||
16529331|NCT03538626|40406008|FG006|Overall Study|Withdrawal by Subject|0|||
16529332|NCT03538626|40406009|FG007|Overall Study|Withdrawal by Subject|0|||
16529333|NCT03538626|40406002|FG000|Overall Study|Lost to Follow-up|0|||
16331233|NCT00990665|39699891|FG000|Overall Study|Unsuccessful Implant|8|||
16331234|NCT00990665|39699891|FG000|Overall Study|Death|29|||
16331235|NCT00990665|39699891|FG000|Overall Study|Heart Transplant|1|||
16331236|NCT00990665|39699891|FG000|Overall Study|Withdrawal by Subject|6|||
16331237|NCT00990665|39699891|FG000|Overall Study|Lost to Follow-up|1|||
16331238|NCT00990665|39699891|FG000|Overall Study|System Explant|3|||
16331239|NCT02620384|39699892|FG000|Overall Study|Adverse Event|2|||
16331240|NCT02620384|39699893|FG001|Overall Study|Adverse Event|1|||
16331241|NCT02620384|39699892|FG000|Overall Study|Discharged prior to 2nd dose|2|||
16331242|NCT02620384|39699893|FG001|Overall Study|Discharged prior to 2nd dose|5|||
16331243|NCT02620384|39699892|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
16331244|NCT02620384|39699893|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
16331245|NCT01041976|39699894|FG000|Overall Study|Withdrawal by Subject|3|||
16331246|NCT01041976|39699895|FG001|Overall Study|Withdrawal by Subject|0|||
16331247|NCT01041976|39699894|FG000|Overall Study|Incarceration|2|||
16331248|NCT01041976|39699895|FG001|Overall Study|Incarceration|0|||
16331249|NCT01041976|39699894|FG000|Overall Study|Death|0|||
16400796|NCT03632993|39948383|FG000|Overall Study|Adverse Event|0|||
16400797|NCT03632993|39948384|FG001|Overall Study|Adverse Event|0|||
16400798|NCT03632993|39948385|FG002|Overall Study|Adverse Event|0|||
16400799|NCT03632993|39948386|FG003|Overall Study|Adverse Event|0|||
16400800|NCT03632993|39948387|FG004|Overall Study|Adverse Event|0|||
16529334|NCT03538626|40406003|FG001|Overall Study|Lost to Follow-up|0|||
16400801|NCT03632993|39948388|FG005|Overall Study|Adverse Event|1|||
16529335|NCT03538626|40406004|FG002|Overall Study|Lost to Follow-up|0|||
16529336|NCT03538626|40406005|FG003|Overall Study|Lost to Follow-up|0|||
16529337|NCT03538626|40406006|FG004|Overall Study|Lost to Follow-up|0|||
16529338|NCT03538626|40406007|FG005|Overall Study|Lost to Follow-up|0|||
16529339|NCT03538626|40406008|FG006|Overall Study|Lost to Follow-up|1|||
16529340|NCT03538626|40406009|FG007|Overall Study|Lost to Follow-up|0|||
16529341|NCT02105948|40406013|FG000|Overall Study|Adverse Event|10|||
16529342|NCT02105948|40406014|FG001|Overall Study|Adverse Event|7|||
16529343|NCT02105948|40406015|FG002|Overall Study|Adverse Event|11|||
16529344|NCT02105948|40406016|FG003|Overall Study|Adverse Event|11|||
16529345|NCT02105948|40406013|FG000|Overall Study|Lack of Efficacy|0|||
16529346|NCT02105948|40406014|FG001|Overall Study|Lack of Efficacy|1|||
16529347|NCT02105948|40406015|FG002|Overall Study|Lack of Efficacy|3|||
16529348|NCT02105948|40406016|FG003|Overall Study|Lack of Efficacy|2|||
16529349|NCT02105948|40406013|FG000|Overall Study|Lost to Follow-up|0|||
16529350|NCT02105948|40406014|FG001|Overall Study|Lost to Follow-up|0|||
16529351|NCT02105948|40406015|FG002|Overall Study|Lost to Follow-up|2|||
16529352|NCT02105948|40406016|FG003|Overall Study|Lost to Follow-up|1|||
16529353|NCT02105948|40406013|FG000|Overall Study|Physician Decision|2|||
16529354|NCT02105948|40406014|FG001|Overall Study|Physician Decision|2|||
16529355|NCT02105948|40406015|FG002|Overall Study|Physician Decision|2|||
16529356|NCT02105948|40406016|FG003|Overall Study|Physician Decision|2|||
16529357|NCT02105948|40406013|FG000|Overall Study|Withdrawal by Subject|15|||
16529358|NCT02105948|40406014|FG001|Overall Study|Withdrawal by Subject|10|||
16529359|NCT02105948|40406015|FG002|Overall Study|Withdrawal by Subject|10|||
16529360|NCT02105948|40406016|FG003|Overall Study|Withdrawal by Subject|11|||
16529361|NCT04955639|40406017|FG000|Overall Study|Withdrawal by Subject|2|||
16400802|NCT03632993|39948389|FG006|Overall Study|Adverse Event|0|||
16400803|NCT03632993|39948390|FG007|Overall Study|Adverse Event|1|||
16400804|NCT03632993|39948391|FG008|Overall Study|Adverse Event|0|||
16529362|NCT04955639|40406018|FG001|Overall Study|Withdrawal by Subject|2|||
16529363|NCT04955639|40406017|FG000|Overall Study|Week 26 survey not completed|2|||
16529364|NCT04955639|40406018|FG001|Overall Study|Week 26 survey not completed|2|||
16529365|NCT01054729|40406019|FG000|Overall Study|Randomized but Not Treated|0|||
16529366|NCT01054729|40406020|FG001|Overall Study|Randomized but Not Treated|1|||
16331250|NCT01041976|39699895|FG001|Overall Study|Death|4|||
16331251|NCT01037127|39699896|FG000|Overall Study|Lost to Follow-up|2|||
16529367|NCT01054729|40406021|FG002|Overall Study|Randomized but Not Treated|0|||
16529368|NCT01054729|40406022|FG003|Overall Study|Randomized but Not Treated|0|||
16529369|NCT01054729|40406019|FG000|Overall Study|Adverse Event|1|||
16331252|NCT01037127|39699897|FG001|Overall Study|Lost to Follow-up|4|||
16331253|NCT01037127|39699896|FG000|Overall Study|Physician Decision|1|||
16529370|NCT01054729|40406020|FG001|Overall Study|Adverse Event|1|||
16529371|NCT01054729|40406021|FG002|Overall Study|Adverse Event|2|||
16529372|NCT01054729|40406022|FG003|Overall Study|Adverse Event|1|||
16529373|NCT01054729|40406019|FG000|Overall Study|Withdrawal by Subject|1|||
16529374|NCT01054729|40406020|FG001|Overall Study|Withdrawal by Subject|0|||
16529375|NCT01054729|40406021|FG002|Overall Study|Withdrawal by Subject|1|||
16529376|NCT01054729|40406022|FG003|Overall Study|Withdrawal by Subject|0|||
16529377|NCT01054729|40406019|FG000|Overall Study|Lost to Follow-up|0|||
16529378|NCT01054729|40406020|FG001|Overall Study|Lost to Follow-up|1|||
16529379|NCT01054729|40406021|FG002|Overall Study|Lost to Follow-up|0|||
16529380|NCT01054729|40406022|FG003|Overall Study|Lost to Follow-up|0|||
16529381|NCT01054729|40406019|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
16529382|NCT01054729|40406020|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
16529383|NCT01054729|40406021|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
16098242|NCT00274287|38847032|FG000|Overall Study|subject non-compliance|1|||
16098243|NCT04523571|38847033|FG000|Received 2 Doses|Withdrawal by Subject|0|||
16098244|NCT04523571|38847034|FG001|Received 2 Doses|Withdrawal by Subject|0|||
16098245|NCT04523571|38847035|FG002|Received 2 Doses|Withdrawal by Subject|0|||
16098246|NCT04523571|38847036|FG003|Received 2 Doses|Withdrawal by Subject|1|||
16098247|NCT04523571|38847037|FG004|Received 2 Doses|Withdrawal by Subject|1|||
16098248|NCT04523571|38847038|FG005|Received 2 Doses|Withdrawal by Subject|0|||
16529384|NCT01054729|40406022|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
16529385|NCT01054729|40406019|FG000|Overall Study|Non-responder|1|||
16529386|NCT01054729|40406020|FG001|Overall Study|Non-responder|0|||
16098249|NCT04523571|38847033|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
16098250|NCT04523571|38847034|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
16098251|NCT04523571|38847035|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
16098252|NCT04523571|38847036|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
16098253|NCT04523571|38847037|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
16098254|NCT04523571|38847038|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
16098255|NCT04523571|38847033|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
16098256|NCT04523571|38847034|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
16098257|NCT04523571|38847035|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
16098258|NCT04523571|38847036|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
16098259|NCT04523571|38847037|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
16098260|NCT04523571|38847038|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
16098261|NCT04523571|38847033|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
16098262|NCT04523571|38847034|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
16098263|NCT04523571|38847035|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
16098264|NCT04523571|38847036|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
16098265|NCT04523571|38847037|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
16098266|NCT04523571|38847038|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
16098267|NCT00647699|38847039|FG000|Overall Study|Lost to Follow-up|5|||
16098268|NCT00647699|38847040|FG001|Overall Study|Lost to Follow-up|4|||
16098269|NCT00647699|38847039|FG000|Overall Study|Withdrawal by Subject|3|||
16098270|NCT00647699|38847040|FG001|Overall Study|Withdrawal by Subject|8|||
16098271|NCT03524092|38847041|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
16098272|NCT03524092|38847042|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
16098273|NCT03524092|38847043|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
16098274|NCT03524092|38847044|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
16098275|NCT03524092|38847045|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
16098276|NCT03524092|38847046|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
16098277|NCT03524092|38847041|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
16098278|NCT03524092|38847042|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
16098279|NCT03524092|38847043|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
16098280|NCT03524092|38847044|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
16098281|NCT03524092|38847045|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
16098282|NCT03524092|38847046|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
16098283|NCT03524092|38847041|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
16098284|NCT03524092|38847042|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
16098285|NCT03524092|38847043|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
16098286|NCT03524092|38847044|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
16098287|NCT03524092|38847045|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
16098288|NCT03524092|38847046|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
16098289|NCT03524092|38847041|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
16098290|NCT03524092|38847042|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
16529387|NCT01054729|40406021|FG002|Overall Study|Non-responder|1|||
16529388|NCT01054729|40406022|FG003|Overall Study|Non-responder|1|||
16331254|NCT01037127|39699897|FG001|Overall Study|Physician Decision|0|||
16529389|NCT01054729|40406019|FG000|Overall Study|PEG/RBV Non-responder|1|||
16529390|NCT01054729|40406020|FG001|Overall Study|PEG/RBV Non-responder|0|||
16529391|NCT01054729|40406021|FG002|Overall Study|PEG/RBV Non-responder|1|||
16529392|NCT01054729|40406022|FG003|Overall Study|PEG/RBV Non-responder|0|||
16529393|NCT01054729|40406019|FG000|Overall Study|Personal/Obligations|0|||
16529394|NCT01054729|40406020|FG001|Overall Study|Personal/Obligations|1|||
16529395|NCT01054729|40406021|FG002|Overall Study|Personal/Obligations|0|||
16529396|NCT01054729|40406022|FG003|Overall Study|Personal/Obligations|0|||
16529397|NCT01054729|40406019|FG000|Overall Study|Subject moved|0|||
16529398|NCT01054729|40406020|FG001|Overall Study|Subject moved|0|||
16529399|NCT01054729|40406021|FG002|Overall Study|Subject moved|1|||
16529400|NCT01054729|40406022|FG003|Overall Study|Subject moved|0|||
16529401|NCT01054729|40406019|FG000|Overall Study|Lack of Efficacy|0|||
16529402|NCT01054729|40406020|FG001|Overall Study|Lack of Efficacy|0|||
16529403|NCT01054729|40406021|FG002|Overall Study|Lack of Efficacy|0|||
16529404|NCT01054729|40406022|FG003|Overall Study|Lack of Efficacy|1|||
16529405|NCT02265237|40406023|FG000|As Treated (Overall Study)|Adverse Event|1|||
16529406|NCT02265237|40406024|FG001|As Treated (Overall Study)|Adverse Event|1|||
16529407|NCT02265237|40406025|FG002|As Treated (Overall Study)|Adverse Event|0|||
16529408|NCT02265237|40406026|FG003|As Treated (Overall Study)|Adverse Event|0|||
16529409|NCT02265237|40406023|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
16529410|NCT02265237|40406024|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
16529411|NCT02265237|40406025|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
16529412|NCT02265237|40406026|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
16529413|NCT02265237|40406023|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
16529414|NCT02265237|40406024|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
16529415|NCT02265237|40406025|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
16529416|NCT02265237|40406026|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
16529417|NCT02265237|40406023|FG000|As Treated (Overall Study)|Other|2|||
16529418|NCT02265237|40406024|FG001|As Treated (Overall Study)|Other|0|||
16529419|NCT02265237|40406025|FG002|As Treated (Overall Study)|Other|3|||
16529420|NCT02265237|40406026|FG003|As Treated (Overall Study)|Other|1|||
16529421|NCT00659334|40406027|FG000|Overall Study|Screen Failure|8|||
16529422|NCT00659334|40406028|FG001|Overall Study|Screen Failure|5|||
16529423|NCT00659334|40406029|FG002|Overall Study|Screen Failure|0|||
16529424|NCT00659334|40406030|FG003|Overall Study|Screen Failure|0|||
16529425|NCT00659334|40406031|FG004|Overall Study|Screen Failure|0|||
16529426|NCT00659334|40406032|FG005|Overall Study|Screen Failure|0|||
16529427|NCT00659334|40406033|FG006|Overall Study|Screen Failure|1|||
16529428|NCT01613248|40406034|FG000|Overall Study|Adverse Event|0|||
16529429|NCT01613248|40406035|FG001|Overall Study|Adverse Event|0|||
16529430|NCT01613248|40406036|FG002|Overall Study|Adverse Event|0|||
16529431|NCT01613248|40406037|FG003|Overall Study|Adverse Event|1|||
16529432|NCT01613248|40406038|FG004|Overall Study|Adverse Event|0|||
16529433|NCT01613248|40406039|FG005|Overall Study|Adverse Event|0|||
16529434|NCT01613248|40406034|FG000|Overall Study|Withdrawal by Subject|3|||
16529435|NCT01613248|40406035|FG001|Overall Study|Withdrawal by Subject|2|||
16529436|NCT01613248|40406036|FG002|Overall Study|Withdrawal by Subject|2|||
16529437|NCT01613248|40406037|FG003|Overall Study|Withdrawal by Subject|5|||
16529438|NCT01613248|40406038|FG004|Overall Study|Withdrawal by Subject|0|||
16529439|NCT01613248|40406039|FG005|Overall Study|Withdrawal by Subject|1|||
16529440|NCT01613248|40406034|FG000|Overall Study|Lost to Follow-up|5|||
16529441|NCT01613248|40406035|FG001|Overall Study|Lost to Follow-up|7|||
16529442|NCT01613248|40406036|FG002|Overall Study|Lost to Follow-up|4|||
16529443|NCT01613248|40406037|FG003|Overall Study|Lost to Follow-up|8|||
16529444|NCT01613248|40406038|FG004|Overall Study|Lost to Follow-up|4|||
16529445|NCT01613248|40406039|FG005|Overall Study|Lost to Follow-up|2|||
16529446|NCT01613248|40406034|FG000|Overall Study|Study Terminated by Sponsor|4|||
16529447|NCT01613248|40406035|FG001|Overall Study|Study Terminated by Sponsor|6|||
16529448|NCT01613248|40406036|FG002|Overall Study|Study Terminated by Sponsor|8|||
16529449|NCT01613248|40406037|FG003|Overall Study|Study Terminated by Sponsor|8|||
16529450|NCT01613248|40406038|FG004|Overall Study|Study Terminated by Sponsor|9|||
16212711|NCT01831804|39258772|FG002|Overall Study|Adverse Event|0|||
16529451|NCT01613248|40406039|FG005|Overall Study|Study Terminated by Sponsor|11|||
16529452|NCT01613248|40406034|FG000|Overall Study|Physician Decision|8|||
16212712|NCT01831804|39258773|FG003|Overall Study|Adverse Event|0|||
16331255|NCT01037127|39699896|FG000|Overall Study|Study Closed Terminated|2|||
16529453|NCT01613248|40406035|FG001|Overall Study|Physician Decision|8|||
16529454|NCT01613248|40406036|FG002|Overall Study|Physician Decision|9|||
16529455|NCT01613248|40406037|FG003|Overall Study|Physician Decision|4|||
16529456|NCT01613248|40406038|FG004|Overall Study|Physician Decision|7|||
16529457|NCT01613248|40406039|FG005|Overall Study|Physician Decision|6|||
16529458|NCT01613248|40406034|FG000|Overall Study|Lack of Qualifying Event|9|||
16529459|NCT01613248|40406035|FG001|Overall Study|Lack of Qualifying Event|11|||
16529460|NCT01613248|40406036|FG002|Overall Study|Lack of Qualifying Event|10|||
16529461|NCT01613248|40406037|FG003|Overall Study|Lack of Qualifying Event|11|||
16529462|NCT01613248|40406038|FG004|Overall Study|Lack of Qualifying Event|15|||
16098291|NCT03524092|38847043|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
16098292|NCT03524092|38847044|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
16098293|NCT03524092|38847045|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
16098294|NCT03524092|38847046|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
16098295|NCT03524092|38847041|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
16098296|NCT03524092|38847042|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
16098297|NCT03524092|38847043|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
16098298|NCT03524092|38847044|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
16098299|NCT03524092|38847045|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
16098300|NCT03524092|38847046|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
16098301|NCT03524092|38847041|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
16098302|NCT03524092|38847042|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
16098303|NCT03524092|38847043|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
16098304|NCT03524092|38847044|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
16098305|NCT03524092|38847045|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
16098306|NCT03524092|38847046|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
16098307|NCT03524092|38847041|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
16098308|NCT03524092|38847042|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
16098309|NCT03524092|38847043|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
16098310|NCT03524092|38847044|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
16098311|NCT03524092|38847045|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
16098312|NCT03524092|38847046|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
16098313|NCT03524092|38847041|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
16098314|NCT03524092|38847042|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
16098315|NCT03524092|38847043|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
16098316|NCT03524092|38847044|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
16098317|NCT03524092|38847045|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
16098318|NCT03524092|38847046|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
16098319|NCT03524092|38847041|FG000|Loss of Response Rescue Period|Adverse Event|0|||
16098320|NCT03524092|38847042|FG001|Loss of Response Rescue Period|Adverse Event|0|||
16098321|NCT03524092|38847043|FG002|Loss of Response Rescue Period|Adverse Event|0|||
16098322|NCT03524092|38847044|FG003|Loss of Response Rescue Period|Adverse Event|2|||
16098323|NCT03524092|38847045|FG004|Loss of Response Rescue Period|Adverse Event|0|||
16098324|NCT03524092|38847046|FG005|Loss of Response Rescue Period|Adverse Event|0|||
16098325|NCT03524092|38847041|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
16098326|NCT03524092|38847042|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
16098327|NCT03524092|38847043|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
16098328|NCT03524092|38847044|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
16212713|NCT01831804|39258774|FG004|Overall Study|Adverse Event|0|||
16212714|NCT01831804|39258775|FG005|Overall Study|Adverse Event|0|||
16331256|NCT01037127|39699897|FG001|Overall Study|Study Closed Terminated|17|||
16331257|NCT00778102|39699898|FG000|Overall Study|Adverse Event|8|||
16331258|NCT00778102|39699899|FG001|Overall Study|Adverse Event|5|||
16331259|NCT00778102|39699898|FG000|Overall Study|Death|1|||
16331260|NCT00778102|39699899|FG001|Overall Study|Death|1|||
16331261|NCT00778102|39699898|FG000|Overall Study|Lost to Follow-up|1|||
16331262|NCT00778102|39699899|FG001|Overall Study|Lost to Follow-up|0|||
16331263|NCT00778102|39699898|FG000|Overall Study|Violation of Selection Criteria|1|||
16331264|NCT00778102|39699899|FG001|Overall Study|Violation of Selection Criteria|1|||
16331265|NCT00778102|39699898|FG000|Overall Study|Protocol Violation|0|||
16331266|NCT00778102|39699899|FG001|Overall Study|Protocol Violation|1|||
16331267|NCT00778102|39699898|FG000|Overall Study|Refused Treatment|2|||
16400805|NCT03632993|39948392|FG009|Overall Study|Adverse Event|0|||
16400806|NCT01126268|39948393|FG000|Overall Study|Adverse Event|1|||
16400807|NCT00516893|39948394|FG000|Overall Study|Lost to Follow-up|4|||
16400808|NCT00516893|39948394|FG000|Overall Study|Adverse Event|3|||
16400809|NCT00516893|39948394|FG000|Overall Study|Withdrawal by Subject|2|||
16400810|NCT00516893|39948394|FG000|Overall Study|Noncompliance|2|||
16400811|NCT00516893|39948394|FG000|Overall Study|Death|1|||
16400812|NCT00516893|39948394|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
16400813|NCT00516893|39948394|FG000|Overall Study|Relocated|1|||
16331268|NCT00778102|39699899|FG001|Overall Study|Refused Treatment|3|||
16331269|NCT00778102|39699898|FG000|Overall Study|Withdrawal by Subject|1|||
16331270|NCT00778102|39699899|FG001|Overall Study|Withdrawal by Subject|1|||
16331271|NCT00778102|39699898|FG000|Overall Study|Administrative Reason|7|||
16400814|NCT00516893|39948394|FG000|Overall Study|Pregnancy|1|||
16400815|NCT00516893|39948394|FG000|Overall Study|Received Medication From Another Study|1|||
16400816|NCT00733291|39948395|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
16400817|NCT00733291|39948396|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
16331272|NCT00778102|39699899|FG001|Overall Study|Administrative Reason|10|||
16400818|NCT00733291|39948397|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
16400819|NCT00733291|39948398|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
16400820|NCT03764631|39948399|FG000|Overall Study|Personal Reasons|3|||
16400821|NCT03764631|39948400|FG001|Overall Study|Personal Reasons|2|||
16400822|NCT03764631|39948399|FG000|Overall Study|Switching Therapy|3|||
16400823|NCT03764631|39948400|FG001|Overall Study|Switching Therapy|3|||
16400824|NCT03764631|39948399|FG000|Overall Study|Adverse Event|0|||
16400825|NCT03764631|39948400|FG001|Overall Study|Adverse Event|1|||
16400826|NCT03764631|39948399|FG000|Overall Study|Lost to Follow-up|33|||
16400827|NCT03764631|39948400|FG001|Overall Study|Lost to Follow-up|41|||
16400828|NCT03764631|39948399|FG000|Overall Study|No data as study site was closed|2|||
16400829|NCT03764631|39948400|FG001|Overall Study|No data as study site was closed|6|||
16400830|NCT00642174|39948403|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
16400831|NCT00642174|39948404|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
16400832|NCT00632827|39948407|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
16400833|NCT00632827|39948407|FG000|Overall Study|Death|2|||
16400834|NCT00632827|39948407|FG000|Overall Study|Adverse Event|5|||
16400835|NCT00632827|39948407|FG000|Overall Study|Lost to Follow-up|1|||
16400836|NCT03654404|39948415|FG000|Overall Study|Death|1|||
16400837|NCT03654404|39948415|FG000|Overall Study|Lost to Follow-up|2|||
16400838|NCT03654404|39948415|FG000|Overall Study|Withdrawal by Subject|5|||
16400839|NCT00327015|39948416|FG000|Overall Study|Lack of Efficacy|18|||
16400840|NCT00327015|39948417|FG001|Overall Study|Lack of Efficacy|18|||
16400841|NCT00327015|39948418|FG002|Overall Study|Lack of Efficacy|35|||
16400842|NCT00327015|39948419|FG003|Overall Study|Lack of Efficacy|29|||
16400843|NCT00327015|39948416|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
16400844|NCT00327015|39948417|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
16400845|NCT00327015|39948418|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
16400846|NCT00327015|39948419|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
16400847|NCT00327015|39948416|FG000|Overall Study|Lost to Follow-up|22|||
16400848|NCT00327015|39948417|FG001|Overall Study|Lost to Follow-up|23|||
16400849|NCT00327015|39948418|FG002|Overall Study|Lost to Follow-up|29|||
16400850|NCT00327015|39948419|FG003|Overall Study|Lost to Follow-up|22|||
16400851|NCT00327015|39948416|FG000|Overall Study|Adverse Event|14|||
16400852|NCT00327015|39948417|FG001|Overall Study|Adverse Event|10|||
16331273|NCT01867294|39699903|FG000|Overall Study|Withdrawal by Subject|1|||
16331274|NCT01867294|39699904|FG001|Overall Study|Withdrawal by Subject|1|||
16331275|NCT01867294|39699905|FG002|Overall Study|Withdrawal by Subject|0|||
16331276|NCT01867294|39699906|FG003|Overall Study|Withdrawal by Subject|0|||
16331277|NCT01524783|39699907|FG000|Blinded Period|Adverse Event|64|||
16331278|NCT01524783|39699908|FG001|Blinded Period|Adverse Event|7|||
16331279|NCT01524783|39699909|FG002|Blinded Period|Adverse Event|0|||
16400853|NCT00327015|39948418|FG002|Overall Study|Adverse Event|14|||
16400854|NCT00327015|39948419|FG003|Overall Study|Adverse Event|14|||
16400855|NCT00327015|39948416|FG000|Overall Study|Subject no longer meets study criteria|4|||
16331280|NCT01524783|39699907|FG000|Blinded Period|Disease Progression|89|||
16400856|NCT00327015|39948417|FG001|Overall Study|Subject no longer meets study criteria|2|||
16400857|NCT00327015|39948418|FG002|Overall Study|Subject no longer meets study criteria|8|||
16529463|NCT01613248|40406039|FG005|Overall Study|Lack of Qualifying Event|18|||
16529464|NCT01613248|40406034|FG000|Overall Study|Pregnancy|0|||
16529465|NCT01613248|40406035|FG001|Overall Study|Pregnancy|0|||
16529466|NCT01613248|40406036|FG002|Overall Study|Pregnancy|0|||
16529467|NCT01613248|40406037|FG003|Overall Study|Pregnancy|1|||
16529468|NCT01613248|40406038|FG004|Overall Study|Pregnancy|0|||
16529469|NCT01613248|40406039|FG005|Overall Study|Pregnancy|0|||
16529470|NCT00116805|40406040|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
16529471|NCT00116805|40406041|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
16529472|NCT00116805|40406040|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
16529473|NCT00116805|40406041|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
16529474|NCT00116805|40406040|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
16529475|NCT00116805|40406041|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
16529476|NCT00116805|40406040|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
16529477|NCT00116805|40406041|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
16529478|NCT00116805|40406040|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
16529479|NCT00116805|40406041|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
16529480|NCT00116805|40406040|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
16529481|NCT00116805|40406041|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
16529482|NCT00116805|40406040|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
16529483|NCT00116805|40406041|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
16529484|NCT00116805|40406040|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
16529485|NCT00116805|40406041|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
16529486|NCT00116805|40406040|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
16529487|NCT00116805|40406041|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
16529488|NCT00116805|40406040|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
16529489|NCT00116805|40406041|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
16529490|NCT00116805|40406040|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
16529491|NCT00116805|40406041|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
16331281|NCT01524783|39699908|FG001|Blinded Period|Disease Progression|75|||
16331282|NCT01524783|39699909|FG002|Blinded Period|Disease Progression|0|||
16331283|NCT01524783|39699907|FG000|Blinded Period|Withdrawal by Subject|19|||
16098329|NCT03524092|38847045|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
16098330|NCT03524092|38847046|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
16098331|NCT03524092|38847041|FG000|Loss of Response Rescue Period|Pregnancy|0|||
16098332|NCT03524092|38847042|FG001|Loss of Response Rescue Period|Pregnancy|0|||
16212715|NCT01831804|39258776|FG006|Overall Study|Adverse Event|1|||
16331284|NCT01524783|39699908|FG001|Blinded Period|Withdrawal by Subject|6|||
16331285|NCT01524783|39699909|FG002|Blinded Period|Withdrawal by Subject|0|||
16331286|NCT01524783|39699907|FG000|Blinded Period|Protocol deviation|2|||
16331287|NCT01524783|39699908|FG001|Blinded Period|Protocol deviation|1|||
16331288|NCT01524783|39699909|FG002|Blinded Period|Protocol deviation|0|||
16331289|NCT01524783|39699907|FG000|Blinded Period|Death|5|||
16331290|NCT01524783|39699908|FG001|Blinded Period|Death|2|||
16331291|NCT01524783|39699909|FG002|Blinded Period|Death|0|||
16331292|NCT01524783|39699907|FG000|Open-label Period|Disease progression|13|||
16331293|NCT01524783|39699908|FG001|Open-label Period|Disease progression|0|||
16331294|NCT01524783|39699909|FG002|Open-label Period|Disease progression|2|||
16331295|NCT01524783|39699907|FG000|Open-label Period|Administrative problems|5|||
16331296|NCT01524783|39699908|FG001|Open-label Period|Administrative problems|0|||
16331297|NCT01524783|39699909|FG002|Open-label Period|Administrative problems|2|||
16331298|NCT01524783|39699907|FG000|Open-label Period|Adverse Event|5|||
16331299|NCT01524783|39699908|FG001|Open-label Period|Adverse Event|0|||
16331300|NCT01524783|39699909|FG002|Open-label Period|Adverse Event|1|||
16331301|NCT01524783|39699907|FG000|Open-label Period|Withdrawal by Subject|2|||
16331302|NCT01524783|39699908|FG001|Open-label Period|Withdrawal by Subject|0|||
16331303|NCT01524783|39699909|FG002|Open-label Period|Withdrawal by Subject|1|||
16331304|NCT01524783|39699907|FG000|Open-label Period|Protocol deviation|1|||
16331305|NCT01524783|39699908|FG001|Open-label Period|Protocol deviation|0|||
16331306|NCT01524783|39699909|FG002|Open-label Period|Protocol deviation|0|||
16331307|NCT01500213|39699910|FG000|Overall Study|Adverse Event|35|||
16529492|NCT00116805|40406040|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
16529493|NCT00116805|40406041|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
16529494|NCT00116805|40406040|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
16529495|NCT00116805|40406041|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
16529496|NCT00116805|40406040|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
16529497|NCT00116805|40406041|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
16331308|NCT01500213|39699911|FG001|Overall Study|Adverse Event|35|||
16529498|NCT00116805|40406040|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
16529499|NCT00116805|40406041|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
16098333|NCT03524092|38847043|FG002|Loss of Response Rescue Period|Pregnancy|0|||
16331309|NCT01500213|39699910|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
16331310|NCT01500213|39699911|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
16098334|NCT03524092|38847044|FG003|Loss of Response Rescue Period|Pregnancy|1|||
16098335|NCT03524092|38847045|FG004|Loss of Response Rescue Period|Pregnancy|0|||
16098336|NCT03524092|38847046|FG005|Loss of Response Rescue Period|Pregnancy|0|||
16098337|NCT03524092|38847041|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
16098338|NCT03524092|38847042|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
16098339|NCT03524092|38847043|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
16098340|NCT03524092|38847044|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
16098341|NCT03524092|38847045|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
16098342|NCT03524092|38847046|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
16098343|NCT03524092|38847041|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
16098344|NCT03524092|38847042|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
16529500|NCT00116805|40406040|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
16529501|NCT00116805|40406041|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
16529502|NCT00116805|40406040|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
16529503|NCT00116805|40406041|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
16529504|NCT00116805|40406040|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
16529505|NCT00116805|40406041|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
16529506|NCT00116805|40406040|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
16529507|NCT00116805|40406041|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
16529508|NCT00116805|40406040|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
16529509|NCT00116805|40406041|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
16098345|NCT03524092|38847043|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
16098346|NCT03524092|38847044|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
16098347|NCT03524092|38847045|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
16098348|NCT03524092|38847046|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
16098349|NCT03524092|38847041|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
16098350|NCT03524092|38847042|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
16098351|NCT03524092|38847043|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
16098352|NCT03524092|38847044|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
16098353|NCT03524092|38847045|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
16098354|NCT03524092|38847046|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
16098355|NCT03524092|38847041|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
16098356|NCT03524092|38847042|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
16098357|NCT03524092|38847043|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
16098358|NCT03524092|38847044|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
16098359|NCT03524092|38847045|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
16098360|NCT03524092|38847046|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
16098361|NCT03524092|38847041|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
16098362|NCT03524092|38847042|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
16098363|NCT03524092|38847043|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
16098364|NCT03524092|38847044|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
16098365|NCT03524092|38847045|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
16098366|NCT03524092|38847046|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
16098367|NCT03524092|38847041|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
16098368|NCT03524092|38847042|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
16098369|NCT03524092|38847043|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
16098370|NCT03524092|38847044|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
16098371|NCT03524092|38847045|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
16098372|NCT03524092|38847046|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
16098373|NCT03524092|38847041|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
16212716|NCT01831804|39258777|FG007|Overall Study|Adverse Event|0|||
16212717|NCT01831804|39258778|FG008|Overall Study|Adverse Event|1|||
16331311|NCT01500213|39699910|FG000|Overall Study|Withdrawal by Subject|28|||
16331312|NCT01500213|39699911|FG001|Overall Study|Withdrawal by Subject|37|||
16331313|NCT01500213|39699910|FG000|Overall Study|Death|7|||
16331314|NCT01500213|39699911|FG001|Overall Study|Death|3|||
16331315|NCT01500213|39699910|FG000|Overall Study|Disease Progression|13|||
16331316|NCT01500213|39699911|FG001|Overall Study|Disease Progression|21|||
16331317|NCT01500213|39699910|FG000|Overall Study|Protocol Violation|19|||
16331318|NCT01500213|39699911|FG001|Overall Study|Protocol Violation|19|||
16529510|NCT00116805|40406040|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
16529511|NCT00116805|40406041|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
16529512|NCT00116805|40406040|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
16331319|NCT01500213|39699910|FG000|Overall Study|Physician Decision|12|||
16331320|NCT01500213|39699911|FG001|Overall Study|Physician Decision|10|||
16331321|NCT01500213|39699910|FG000|Overall Study|Lack of Efficacy|9|||
16529513|NCT00116805|40406041|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
16529514|NCT00116805|40406040|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
16529515|NCT00116805|40406041|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
16529516|NCT00116805|40406040|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
16529517|NCT00116805|40406041|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
16400858|NCT00327015|39948419|FG003|Overall Study|Subject no longer meets study criteria|7|||
16400859|NCT00327015|39948416|FG000|Overall Study|Poor/Noncompliance|11|||
16529518|NCT00116805|40406040|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
16400860|NCT00327015|39948417|FG001|Overall Study|Poor/Noncompliance|8|||
16529519|NCT00116805|40406041|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
16529520|NCT00116805|40406040|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
16529521|NCT00116805|40406041|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
16098374|NCT03524092|38847042|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
16098375|NCT03524092|38847043|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
16098376|NCT03524092|38847044|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
16098377|NCT03524092|38847045|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
16098378|NCT03524092|38847046|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
16098379|NCT03524092|38847041|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
16098380|NCT03524092|38847042|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
16331322|NCT01500213|39699911|FG001|Overall Study|Lack of Efficacy|7|||
16331323|NCT01500213|39699910|FG000|Overall Study|Lost to Follow-up|3|||
16529522|NCT00116805|40406040|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
16529523|NCT00116805|40406041|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
16529524|NCT00116805|40406040|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
16529525|NCT00116805|40406041|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
16529526|NCT00116805|40406040|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
16529527|NCT00116805|40406041|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
16529528|NCT00116805|40406040|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
16529529|NCT00116805|40406041|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
16529530|NCT00116805|40406040|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
16331324|NCT01500213|39699911|FG001|Overall Study|Lost to Follow-up|6|||
16331325|NCT01500213|39699910|FG000|Overall Study|Other Reasons|7|||
16331326|NCT01500213|39699911|FG001|Overall Study|Other Reasons|5|||
16331327|NCT01279070|39699912|FG000|Overall Study|Withdrawal by Subject|2|||
16331328|NCT01279070|39699913|FG001|Overall Study|Withdrawal by Subject|3|||
16331329|NCT01279070|39699912|FG000|Overall Study|Acute exacerbation|3|||
16331330|NCT01279070|39699913|FG001|Overall Study|Acute exacerbation|1|||
16331331|NCT01378975|39699914|FG000|Overall Study|Death|77|||
16331332|NCT01378975|39699915|FG001|Overall Study|Death|46|||
16331333|NCT01378975|39699914|FG000|Overall Study|Investigator Request|1|||
16331334|NCT01378975|39699915|FG001|Overall Study|Investigator Request|0|||
16400861|NCT00327015|39948418|FG002|Overall Study|Poor/Noncompliance|4|||
16529531|NCT00116805|40406041|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
16529532|NCT00116805|40406040|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
16529533|NCT00116805|40406041|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
16529534|NCT00116805|40406040|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
16529535|NCT00116805|40406041|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
16529536|NCT00116805|40406040|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
16529537|NCT00116805|40406041|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
16529538|NCT00116805|40406040|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
16529539|NCT00116805|40406041|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
16529540|NCT00116805|40406040|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
16529541|NCT00116805|40406041|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
16529542|NCT00116805|40406040|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
16529543|NCT00116805|40406041|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
16529544|NCT00116805|40406040|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
16529545|NCT00116805|40406041|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
16529546|NCT00116805|40406040|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
16529547|NCT00116805|40406041|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
16529548|NCT00116805|40406040|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
16529549|NCT00116805|40406041|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
16529550|NCT00116805|40406040|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
16529551|NCT00116805|40406041|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
16529552|NCT00116805|40406040|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
16529553|NCT00116805|40406041|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
16529554|NCT00116805|40406040|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
16529555|NCT00116805|40406041|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
16529556|NCT00116805|40406040|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
16529557|NCT00116805|40406041|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
16529558|NCT00116805|40406040|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
16529559|NCT00116805|40406041|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
16529560|NCT01412944|40406046|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
16529561|NCT01412944|40406047|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
16529562|NCT01412944|40406048|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
16529563|NCT01412944|40406049|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
16529564|NCT01412944|40406050|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
16529565|NCT01412944|40406051|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
16529566|NCT01412944|40406046|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
16529567|NCT01412944|40406047|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
16529568|NCT01412944|40406048|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
16529569|NCT01412944|40406049|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
16529570|NCT01412944|40406050|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
16529571|NCT01412944|40406051|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
16529572|NCT01412944|40406046|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
16529573|NCT01412944|40406047|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
16529574|NCT01412944|40406048|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
16529575|NCT01412944|40406049|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
16529576|NCT01412944|40406050|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
16529577|NCT01412944|40406051|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
16529578|NCT01412944|40406046|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
16529579|NCT01412944|40406047|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
16529580|NCT01412944|40406048|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
16529581|NCT01412944|40406049|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
16529582|NCT01412944|40406050|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
16529583|NCT01412944|40406051|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
16529584|NCT01412944|40406046|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
16529585|NCT01412944|40406047|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
16529586|NCT01412944|40406048|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
16331335|NCT01378975|39699914|FG000|Overall Study|Lost to Follow-up|4|||
16331336|NCT01378975|39699915|FG001|Overall Study|Lost to Follow-up|1|||
16331337|NCT01378975|39699914|FG000|Overall Study|Withdrew Consent|4|||
16331338|NCT01378975|39699915|FG001|Overall Study|Withdrew Consent|3|||
16331339|NCT00501059|39699917|FG000|Overall Study|Protocol Violation|80|||
16331340|NCT00501059|39699918|FG001|Overall Study|Protocol Violation|69|||
16331341|NCT00501059|39699917|FG000|Overall Study|Death|140|||
16331342|NCT00501059|39699918|FG001|Overall Study|Death|137|||
16331343|NCT00501059|39699917|FG000|Overall Study|Other|236|||
16331344|NCT00501059|39699918|FG001|Overall Study|Other|239|||
16331345|NCT00501059|39699917|FG000|Overall Study|Missing end-of-study page|91|||
16529587|NCT01412944|40406049|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
16529588|NCT01412944|40406050|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
16529589|NCT01412944|40406051|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
16529590|NCT01412944|40406046|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
16529591|NCT01412944|40406047|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
16529592|NCT01412944|40406048|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
16529593|NCT01412944|40406049|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
16529594|NCT01412944|40406050|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
16529595|NCT01412944|40406051|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
16529596|NCT01412944|40406046|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16529597|NCT01412944|40406047|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16529598|NCT01412944|40406048|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
16529599|NCT01412944|40406049|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
16529600|NCT01412944|40406050|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
16529601|NCT01412944|40406051|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16529602|NCT01412944|40406046|FG000|Entire: IV + Maintenance|Adverse Event|0|||
16529603|NCT01412944|40406047|FG001|Entire: IV + Maintenance|Adverse Event|0|||
16529604|NCT01412944|40406048|FG002|Entire: IV + Maintenance|Adverse Event|0|||
16529605|NCT01412944|40406049|FG003|Entire: IV + Maintenance|Adverse Event|0|||
16529606|NCT01412944|40406050|FG004|Entire: IV + Maintenance|Adverse Event|1|||
16529607|NCT01412944|40406051|FG005|Entire: IV + Maintenance|Adverse Event|0|||
16529608|NCT01412944|40406046|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
16529609|NCT01412944|40406047|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
16529610|NCT01412944|40406048|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
16529611|NCT01412944|40406049|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
16529612|NCT01412944|40406050|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
16529613|NCT01412944|40406051|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
16529614|NCT01412944|40406046|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
16529615|NCT01412944|40406047|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
16529616|NCT01412944|40406048|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
16529617|NCT01412944|40406049|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
16529618|NCT01412944|40406050|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
16529619|NCT01412944|40406051|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
16529620|NCT01412944|40406046|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
16529621|NCT01412944|40406047|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
16529622|NCT01412944|40406048|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
16529623|NCT01412944|40406049|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
16529624|NCT01412944|40406050|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
16529625|NCT01412944|40406051|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
16529626|NCT01412944|40406046|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
16529627|NCT01412944|40406047|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
16529628|NCT01412944|40406048|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16529629|NCT01412944|40406049|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16529630|NCT01412944|40406050|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16529631|NCT01412944|40406051|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
16529632|NCT01412944|40406046|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
16529633|NCT01412944|40406047|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
16529634|NCT01412944|40406048|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
16529635|NCT01412944|40406049|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
16529636|NCT01412944|40406050|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
16529637|NCT01412944|40406051|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
16529638|NCT01412944|40406046|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
16529639|NCT01412944|40406047|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
16529640|NCT01412944|40406048|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
16529641|NCT01412944|40406049|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
16529642|NCT01412944|40406050|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
16529643|NCT01412944|40406051|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
16529644|NCT01412944|40406046|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
16529645|NCT01412944|40406047|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
16529646|NCT01412944|40406048|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
16529647|NCT01412944|40406049|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
16529648|NCT01412944|40406050|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
16331346|NCT00501059|39699918|FG001|Overall Study|Missing end-of-study page|92|||
16331347|NCT00501059|39699917|FG000|Overall Study|Clinical endpoint reached|110|||
16331348|NCT00501059|39699918|FG001|Overall Study|Clinical endpoint reached|123|||
16331349|NCT00501059|39699917|FG000|Overall Study|Insufficient therapeutic effect|4|||
16331350|NCT00501059|39699918|FG001|Overall Study|Insufficient therapeutic effect|5|||
16331351|NCT00501059|39699917|FG000|Overall Study|Consent withdrawn by subject|817|||
16331352|NCT00501059|39699918|FG001|Overall Study|Consent withdrawn by subject|873|||
16331353|NCT00501059|39699917|FG000|Overall Study|Non-compliant with study treatment|23|||
16331354|NCT00501059|39699918|FG001|Overall Study|Non-compliant with study treatment|16|||
16331355|NCT00501059|39699917|FG000|Overall Study|Reason not given|3|||
16331356|NCT00501059|39699918|FG001|Overall Study|Reason not given|1|||
16212718|NCT01831804|39258770|FG000|Overall Study|Protocol Violation|0|||
16212719|NCT01831804|39258771|FG001|Overall Study|Protocol Violation|0|||
16212720|NCT01831804|39258772|FG002|Overall Study|Protocol Violation|2|||
16212721|NCT01831804|39258773|FG003|Overall Study|Protocol Violation|0|||
16212722|NCT01831804|39258774|FG004|Overall Study|Protocol Violation|0|||
16212723|NCT01831804|39258775|FG005|Overall Study|Protocol Violation|0|||
16331357|NCT00501059|39699917|FG000|Overall Study|Adverse Event|129|||
16331358|NCT00501059|39699918|FG001|Overall Study|Adverse Event|122|||
16331359|NCT00501059|39699917|FG000|Overall Study|Lost to Follow-up|210|||
16331360|NCT00501059|39699918|FG001|Overall Study|Lost to Follow-up|198|||
16331361|NCT00501059|39699917|FG000|Overall Study|Not treated|25|||
16331362|NCT00501059|39699918|FG001|Overall Study|Not treated|17|||
16331363|NCT01959698|39699921|FG000|Overall Study|Adverse Event|0|||
16331364|NCT01959698|39699922|FG001|Overall Study|Adverse Event|0|||
16331365|NCT01959698|39699923|FG002|Overall Study|Adverse Event|0|||
16331366|NCT01959698|39699924|FG003|Overall Study|Adverse Event|0|||
16331367|NCT01959698|39699925|FG004|Overall Study|Adverse Event|0|||
16331368|NCT01959698|39699926|FG005|Overall Study|Adverse Event|0|||
16331369|NCT01959698|39699927|FG006|Overall Study|Adverse Event|1|||
16331370|NCT01959698|39699921|FG000|Overall Study|Physician Decision|1|||
16331371|NCT01959698|39699922|FG001|Overall Study|Physician Decision|0|||
16331372|NCT01959698|39699923|FG002|Overall Study|Physician Decision|1|||
16331373|NCT01959698|39699924|FG003|Overall Study|Physician Decision|2|||
16331374|NCT01959698|39699925|FG004|Overall Study|Physician Decision|0|||
16331375|NCT01959698|39699926|FG005|Overall Study|Physician Decision|3|||
16331376|NCT01959698|39699927|FG006|Overall Study|Physician Decision|3|||
16331377|NCT02134353|39699932|FG000|Overall Study|Adverse Event|10|||
16331378|NCT02134353|39699933|FG001|Overall Study|Adverse Event|6|||
16331379|NCT02134353|39699932|FG000|Overall Study|Lost to Follow-up|1|||
16331380|NCT02134353|39699933|FG001|Overall Study|Lost to Follow-up|1|||
16331381|NCT02134353|39699932|FG000|Overall Study|Lack of Efficacy|2|||
16331382|NCT02134353|39699933|FG001|Overall Study|Lack of Efficacy|1|||
16331383|NCT02134353|39699932|FG000|Overall Study|Withdrawal by Subject|12|||
16212724|NCT01831804|39258776|FG006|Overall Study|Protocol Violation|0|||
16212725|NCT01831804|39258777|FG007|Overall Study|Protocol Violation|0|||
16212726|NCT01831804|39258778|FG008|Overall Study|Protocol Violation|0|||
16212727|NCT01831804|39258770|FG000|Overall Study|Protocol defined stopping criteria|1|||
16212728|NCT01831804|39258771|FG001|Overall Study|Protocol defined stopping criteria|1|||
16331384|NCT02134353|39699933|FG001|Overall Study|Withdrawal by Subject|13|||
16331385|NCT02134353|39699932|FG000|Overall Study|Death|0|||
16331386|NCT02134353|39699933|FG001|Overall Study|Death|1|||
16331387|NCT02134353|39699932|FG000|Overall Study|Pregnancy|0|||
16331388|NCT02134353|39699933|FG001|Overall Study|Pregnancy|1|||
16331389|NCT02134353|39699932|FG000|Overall Study|Relocation|1|||
16331390|NCT02134353|39699933|FG001|Overall Study|Relocation|0|||
16212729|NCT01831804|39258772|FG002|Overall Study|Protocol defined stopping criteria|3|||
16331391|NCT02134353|39699932|FG000|Overall Study|Other - Patient's Choice|0|||
16331392|NCT02134353|39699933|FG001|Overall Study|Other - Patient's Choice|1|||
16331393|NCT04250350|39699934|FG000|Overall Study|Withdrawal by Subject|13|||
16212730|NCT01831804|39258773|FG003|Overall Study|Protocol defined stopping criteria|0|||
16212731|NCT01831804|39258774|FG004|Overall Study|Protocol defined stopping criteria|1|||
16212732|NCT01831804|39258775|FG005|Overall Study|Protocol defined stopping criteria|0|||
16212733|NCT01831804|39258776|FG006|Overall Study|Protocol defined stopping criteria|0|||
16212734|NCT01831804|39258777|FG007|Overall Study|Protocol defined stopping criteria|0|||
16212735|NCT01831804|39258778|FG008|Overall Study|Protocol defined stopping criteria|0|||
16212736|NCT01831804|39258770|FG000|Overall Study|Lost to Follow-up|0|||
16212737|NCT01831804|39258771|FG001|Overall Study|Lost to Follow-up|0|||
16212738|NCT01831804|39258772|FG002|Overall Study|Lost to Follow-up|1|||
16212739|NCT01831804|39258773|FG003|Overall Study|Lost to Follow-up|0|||
16212740|NCT01831804|39258774|FG004|Overall Study|Lost to Follow-up|0|||
16212741|NCT01831804|39258775|FG005|Overall Study|Lost to Follow-up|0|||
16212742|NCT01831804|39258776|FG006|Overall Study|Lost to Follow-up|0|||
16212743|NCT01831804|39258777|FG007|Overall Study|Lost to Follow-up|0|||
16212744|NCT01831804|39258778|FG008|Overall Study|Lost to Follow-up|1|||
16212745|NCT01831804|39258770|FG000|Overall Study|Investigator discretion|0|||
16212746|NCT01831804|39258771|FG001|Overall Study|Investigator discretion|0|||
16212747|NCT01831804|39258772|FG002|Overall Study|Investigator discretion|0|||
16212748|NCT01831804|39258773|FG003|Overall Study|Investigator discretion|0|||
16212749|NCT01831804|39258774|FG004|Overall Study|Investigator discretion|1|||
16212750|NCT01831804|39258775|FG005|Overall Study|Investigator discretion|0|||
16212751|NCT01831804|39258776|FG006|Overall Study|Investigator discretion|0|||
16212752|NCT01831804|39258777|FG007|Overall Study|Investigator discretion|1|||
16212753|NCT01831804|39258778|FG008|Overall Study|Investigator discretion|0|||
16212754|NCT01831804|39258770|FG000|Overall Study|Withdrew Consent|0|||
16212755|NCT01831804|39258771|FG001|Overall Study|Withdrew Consent|1|||
16212756|NCT01831804|39258772|FG002|Overall Study|Withdrew Consent|0|||
16212757|NCT01831804|39258773|FG003|Overall Study|Withdrew Consent|0|||
16212758|NCT01831804|39258774|FG004|Overall Study|Withdrew Consent|0|||
16212759|NCT01831804|39258775|FG005|Overall Study|Withdrew Consent|0|||
16212760|NCT01831804|39258776|FG006|Overall Study|Withdrew Consent|0|||
16212761|NCT01831804|39258777|FG007|Overall Study|Withdrew Consent|2|||
16212762|NCT01831804|39258778|FG008|Overall Study|Withdrew Consent|0|||
16212763|NCT02756845|39258779|FG000|Overall Study|Death|12|||
16212764|NCT02756845|39258780|FG001|Overall Study|Death|2|||
16212765|NCT02756845|39258779|FG000|Overall Study|Withdrawal by Subject|1|||
16212766|NCT02756845|39258780|FG001|Overall Study|Withdrawal by Subject|0|||
16212767|NCT00810043|39258782|FG000|Overall Study|Withdrawal by Subject|1|||
16212768|NCT00810043|39258783|FG001|Overall Study|Withdrawal by Subject|0|||
16212769|NCT00810043|39258784|FG002|Overall Study|Withdrawal by Subject|2|||
16212770|NCT00810043|39258782|FG000|Overall Study|Lost to Follow-up|1|||
16212771|NCT00810043|39258783|FG001|Overall Study|Lost to Follow-up|0|||
16212772|NCT00810043|39258784|FG002|Overall Study|Lost to Follow-up|0|||
16212773|NCT00810043|39258782|FG000|Overall Study|Physician Decision|0|||
16212774|NCT00810043|39258783|FG001|Overall Study|Physician Decision|0|||
16212775|NCT00810043|39258784|FG002|Overall Study|Physician Decision|2|||
16212776|NCT00810043|39258782|FG000|Overall Study|Death|2|||
16212777|NCT00810043|39258783|FG001|Overall Study|Death|0|||
16212778|NCT00810043|39258784|FG002|Overall Study|Death|0|||
16212779|NCT00810043|39258782|FG000|Overall Study|Unrelated medical problem|0|||
16212780|NCT00810043|39258783|FG001|Overall Study|Unrelated medical problem|1|||
16212781|NCT00810043|39258784|FG002|Overall Study|Unrelated medical problem|0|||
16212782|NCT00810043|39258782|FG000|Overall Study|Non-medical problem|0|||
16212783|NCT00810043|39258783|FG001|Overall Study|Non-medical problem|0|||
16212784|NCT00810043|39258784|FG002|Overall Study|Non-medical problem|1|||
16400862|NCT00327015|39948419|FG003|Overall Study|Poor/Noncompliance|5|||
16400863|NCT00327015|39948416|FG000|Overall Study|Physician Decision|0|||
16529649|NCT01412944|40406051|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
16529650|NCT01412944|40406046|FG000|Entire: IV + Maintenance|Adverse Event|0|||
16529651|NCT01412944|40406047|FG001|Entire: IV + Maintenance|Adverse Event|1|||
16529652|NCT01412944|40406048|FG002|Entire: IV + Maintenance|Adverse Event|0|||
16529653|NCT01412944|40406049|FG003|Entire: IV + Maintenance|Adverse Event|0|||
16529654|NCT01412944|40406050|FG004|Entire: IV + Maintenance|Adverse Event|0|||
16529655|NCT01412944|40406051|FG005|Entire: IV + Maintenance|Adverse Event|0|||
16212785|NCT00810043|39258782|FG000|Overall Study|No longer met enrollment criteria|0|||
16212786|NCT00810043|39258783|FG001|Overall Study|No longer met enrollment criteria|0|||
16212787|NCT00810043|39258784|FG002|Overall Study|No longer met enrollment criteria|3|||
16212788|NCT01268514|39258789|FG000|Overall Study|Adverse Event|20|||
16212789|NCT01268514|39258789|FG000|Overall Study|Death|8|||
16212790|NCT01268514|39258789|FG000|Overall Study|Lost to Follow-up|5|||
16212791|NCT01268514|39258789|FG000|Overall Study|Withdrawal by Subject|3|||
16212792|NCT01268514|39258789|FG000|Overall Study|Withdrawal by Surgeon|5|||
16212793|NCT01819194|39258790|FG000|Overall Study|Loss of study articles|2|||
16212794|NCT04055844|39258791|FG000|Overall Study|Adverse Event|12|||
16212795|NCT04055844|39258791|FG000|Overall Study|Poor Performance|1|||
16212796|NCT04055844|39258791|FG000|Overall Study|Death|1|||
16212797|NCT00528840|39258795|FG000|Overall Study|Lost to Follow-up|10|||
16400864|NCT00327015|39948417|FG001|Overall Study|Physician Decision|1|||
16212798|NCT00528840|39258795|FG000|Overall Study|Adverse Event|1|||
16212799|NCT00528840|39258795|FG000|Overall Study|Withdrawal by Subject|17|||
16212800|NCT00528840|39258795|FG000|Overall Study|Death|2|||
16212801|NCT00528840|39258795|FG000|Overall Study|Administrative Reasons|1|||
16212802|NCT00528840|39258795|FG000|Overall Study|Other|2|||
16212803|NCT03238352|39258798|FG000|Overall Study|Lost to Follow-up|0|||
16212804|NCT03238352|39258799|FG001|Overall Study|Lost to Follow-up|2|||
16212805|NCT03238352|39258800|FG002|Overall Study|Lost to Follow-up|1|||
16212806|NCT03238352|39258798|FG000|Overall Study|Withdrawal by Subject|0|||
16212807|NCT03238352|39258799|FG001|Overall Study|Withdrawal by Subject|1|||
16212808|NCT03238352|39258800|FG002|Overall Study|Withdrawal by Subject|0|||
16212809|NCT02679781|39258807|FG000|Overall Study|Lost to Follow-up|1|||
16212810|NCT02679781|39258808|FG001|Overall Study|Lost to Follow-up|2|||
16212811|NCT02679781|39258807|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
16212812|NCT02679781|39258808|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
16212813|NCT00981682|39258809|FG000|Overall Study|Adverse Event|48|||
16212814|NCT00981682|39258809|FG000|Overall Study|Withdrawal by Subject|52|||
16212815|NCT00981682|39258809|FG000|Overall Study|Lost to Follow-up|14|||
16212816|NCT00981682|39258809|FG000|Overall Study|Lack of Efficacy|13|||
16212817|NCT00981682|39258809|FG000|Overall Study|Protocol Violation|6|||
16212818|NCT00981682|39258809|FG000|Overall Study|administrative|9|||
16212819|NCT01047436|39258814|FG000|Overall Study|Protocol Violation|1|||
16212820|NCT01047436|39258815|FG001|Overall Study|Protocol Violation|0|||
16212821|NCT02963766|39258816|FG000|Double-Blind Period|Adverse Event|1|||
16212822|NCT02963766|39258817|FG001|Double-Blind Period|Adverse Event|0|||
16212823|NCT02963766|39258818|FG002|Double-Blind Period|Adverse Event|1|||
16212824|NCT02963766|39258816|FG000|Double-Blind Period|Physician Decision|1|||
16212825|NCT02963766|39258817|FG001|Double-Blind Period|Physician Decision|0|||
16529656|NCT04433767|40406055|FG000|Overall Study|Adverse Event|1|||
16529657|NCT01962493|40406056|FG000|Overall Study|Adverse Event|1|||
16529658|NCT01962493|40406057|FG001|Overall Study|Adverse Event|2|||
16529659|NCT01962493|40406056|FG000|Overall Study|Protocol Violation|0|||
16098381|NCT03524092|38847043|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
16098382|NCT03524092|38847044|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
16098383|NCT03524092|38847045|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
16098384|NCT03524092|38847046|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
16098385|NCT03524092|38847041|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
16098386|NCT03524092|38847042|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
16098387|NCT03524092|38847043|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
16098388|NCT03524092|38847044|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
16098389|NCT03524092|38847045|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
16098390|NCT03524092|38847046|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
16098391|NCT03524092|38847041|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
16098392|NCT03524092|38847042|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
16098393|NCT03524092|38847043|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
16098394|NCT03524092|38847044|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
16098395|NCT03524092|38847045|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
16098396|NCT03524092|38847046|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
16098397|NCT03524092|38847041|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
16098398|NCT03524092|38847042|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
16098399|NCT03524092|38847043|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
16098400|NCT03524092|38847044|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
16098401|NCT03524092|38847045|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
16098402|NCT03524092|38847046|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
16098403|NCT03524092|38847041|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
16098404|NCT03524092|38847042|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
16098405|NCT03524092|38847043|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
16098406|NCT03524092|38847044|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
16098407|NCT03524092|38847045|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
16098408|NCT03524092|38847046|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
16212826|NCT02963766|39258818|FG002|Double-Blind Period|Physician Decision|0|||
16212827|NCT02963766|39258816|FG000|Double-Blind Period|Withdrawal by Subject|1|||
16212828|NCT02963766|39258817|FG001|Double-Blind Period|Withdrawal by Subject|1|||
16212829|NCT02963766|39258818|FG002|Double-Blind Period|Withdrawal by Subject|0|||
16212830|NCT02963766|39258816|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
16212831|NCT02963766|39258817|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
16212832|NCT02963766|39258818|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
16212833|NCT02963766|39258816|FG000|Double-Blind Period|Protocol Violation|1|||
16529660|NCT01962493|40406057|FG001|Overall Study|Protocol Violation|1|||
16098409|NCT01320683|38847047|FG000|Overall Study|Positive antibody response|1|||
16098410|NCT01393964|38847048|FG000|Overall Study|Disease Progression|4|||
16098411|NCT01393964|38847049|FG001|Overall Study|Disease Progression|3|||
16098412|NCT01393964|38847050|FG002|Overall Study|Disease Progression|5|||
16098413|NCT01393964|38847048|FG000|Overall Study|Study drug toxicity|1|||
16098414|NCT01393964|38847049|FG001|Overall Study|Study drug toxicity|0|||
16098415|NCT01393964|38847050|FG002|Overall Study|Study drug toxicity|0|||
16098416|NCT01393964|38847048|FG000|Overall Study|Withdrawal by Subject|0|||
16098417|NCT01393964|38847049|FG001|Overall Study|Withdrawal by Subject|0|||
16098418|NCT01393964|38847050|FG002|Overall Study|Withdrawal by Subject|1|||
16098419|NCT01393964|38847048|FG000|Overall Study|Adverse event unrelated to study drug|0|||
16098420|NCT01393964|38847049|FG001|Overall Study|Adverse event unrelated to study drug|3|||
16098421|NCT01393964|38847050|FG002|Overall Study|Adverse event unrelated to study drug|0|||
16098422|NCT01393964|38847048|FG000|Overall Study|Subject request stop study treatment|0|||
16098423|NCT01393964|38847049|FG001|Overall Study|Subject request stop study treatment|1|||
16098424|NCT01393964|38847050|FG002|Overall Study|Subject request stop study treatment|0|||
16098425|NCT01393964|38847048|FG000|Overall Study|Subject decided to move to transplant|1|||
16098426|NCT01393964|38847049|FG001|Overall Study|Subject decided to move to transplant|0|||
16098427|NCT01393964|38847050|FG002|Overall Study|Subject decided to move to transplant|0|||
16098428|NCT01393964|38847048|FG000|Overall Study|Subject switched to commercial supply|1|||
16098429|NCT01393964|38847049|FG001|Overall Study|Subject switched to commercial supply|0|||
16098430|NCT01393964|38847050|FG002|Overall Study|Subject switched to commercial supply|2|||
16098431|NCT01393964|38847048|FG000|Overall Study|Subject plateaued in terms of effect|1|||
16098432|NCT01393964|38847049|FG001|Overall Study|Subject plateaued in terms of effect|0|||
16098433|NCT01393964|38847050|FG002|Overall Study|Subject plateaued in terms of effect|0|||
16098434|NCT01393964|38847048|FG000|Overall Study|Investigator removed subject from study|0|||
16098435|NCT01393964|38847049|FG001|Overall Study|Investigator removed subject from study|1|||
16098436|NCT01393964|38847050|FG002|Overall Study|Investigator removed subject from study|0|||
16098437|NCT01393964|38847048|FG000|Overall Study|Subject converted to roll-over study|0|||
16098438|NCT01393964|38847049|FG001|Overall Study|Subject converted to roll-over study|1|||
16098439|NCT01393964|38847050|FG002|Overall Study|Subject converted to roll-over study|0|||
16098440|NCT01393964|38847048|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
16098441|NCT01393964|38847049|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
16098442|NCT01393964|38847050|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
16098443|NCT02379078|38847051|FG000|Overall Study|Lost to Follow-up|33|||
16098444|NCT02379078|38847052|FG001|Overall Study|Lost to Follow-up|30|||
16098445|NCT02379078|38847051|FG000|Overall Study|Withdrawal by Subject|6|||
16098446|NCT02379078|38847052|FG001|Overall Study|Withdrawal by Subject|5|||
16098447|NCT03169530|38847053|FG000|Overall Study|Study ended by NIH|15|||
16098448|NCT03169530|38847054|FG001|Overall Study|Study ended by NIH|17|||
16098449|NCT03647709|38847055|FG000|Overall Study|Lost to Follow-up|5|||
16098450|NCT03647709|38847055|FG000|Overall Study|Physician Decision|6|||
16098451|NCT03647709|38847055|FG000|Overall Study|Withdrawal by Subject|3|||
16098452|NCT03481725|38847056|FG000|Overall Study|Withdrawal by Subject|1|||
16098453|NCT03481725|38847057|FG001|Overall Study|Withdrawal by Subject|0|||
16098454|NCT01090076|38847062|FG000|Overall Study|Death|1|||
16098455|NCT01090076|38847063|FG001|Overall Study|Death|1|||
16098456|NCT01090076|38847062|FG000|Overall Study|Withdrawal by Subject|0|||
16098457|NCT01090076|38847063|FG001|Overall Study|Withdrawal by Subject|1|||
16098458|NCT00910871|38847064|FG000|Overall Study|Adverse Event|5|||
16098459|NCT00910871|38847064|FG000|Overall Study|Death|12|||
16098460|NCT00910871|38847064|FG000|Overall Study|Lost to Follow-up|8|||
16098461|NCT00910871|38847064|FG000|Overall Study|Protocol Violation|11|||
16098462|NCT00910871|38847064|FG000|Overall Study|Withdrawal by Subject|12|||
16098463|NCT00910871|38847064|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
16098464|NCT00910871|38847064|FG000|Overall Study|Undefined|1|||
16098465|NCT00130728|38849764|FG000|Overall Study|Death|258|||
16098466|NCT00130728|38849765|FG001|Overall Study|Death|258|||
16098467|NCT00130728|38849764|FG000|Overall Study|Lost to Follow-up|4|||
16098468|NCT00130728|38849765|FG001|Overall Study|Lost to Follow-up|0|||
16331394|NCT04250350|39699934|FG000|Overall Study|Lost to Follow-up|8|||
16529661|NCT01962493|40406056|FG000|Overall Study|Withdrawal by Subject|4|||
16529662|NCT01962493|40406057|FG001|Overall Study|Withdrawal by Subject|2|||
16098469|NCT00130728|38849764|FG000|Overall Study|Withdrawal by Subject|0|||
16098470|NCT00130728|38849765|FG001|Overall Study|Withdrawal by Subject|2|||
16098471|NCT01064856|38849766|FG000|Double-blind (DB) Period|Adverse Event|1|||
16098472|NCT01064856|38849767|FG001|Double-blind (DB) Period|Adverse Event|0|||
16098473|NCT01064856|38849768|FG002|Double-blind (DB) Period|Adverse Event|0|||
16098474|NCT01064856|38849769|FG003|Double-blind (DB) Period|Adverse Event|0|||
16098475|NCT01064856|38849766|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
16098476|NCT01064856|38849767|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
16331395|NCT04250350|39699934|FG000|Overall Study|Adverse Event|5|||
16331396|NCT04250350|39699934|FG000|Overall Study|Lack of Efficacy|4|||
16529663|NCT01248884|40406058|FG000|Overall Study|Withdrawal by Subject|1|||
16400865|NCT00327015|39948418|FG002|Overall Study|Physician Decision|3|||
16400866|NCT00327015|39948419|FG003|Overall Study|Physician Decision|2|||
16400867|NCT00327015|39948416|FG000|Overall Study|Death|1|||
16400868|NCT00327015|39948417|FG001|Overall Study|Death|2|||
16400869|NCT00327015|39948418|FG002|Overall Study|Death|2|||
16400870|NCT00327015|39948419|FG003|Overall Study|Death|3|||
16400871|NCT00327015|39948416|FG000|Overall Study|Pregnancy|0|||
16400872|NCT00327015|39948417|FG001|Overall Study|Pregnancy|2|||
16400873|NCT00327015|39948418|FG002|Overall Study|Pregnancy|1|||
16400874|NCT00327015|39948419|FG003|Overall Study|Pregnancy|1|||
16529664|NCT01248884|40406059|FG001|Overall Study|Withdrawal by Subject|3|||
16529665|NCT01248884|40406060|FG002|Overall Study|Withdrawal by Subject|1|||
16529666|NCT01248884|40406058|FG000|Overall Study|Adverse Event|1|||
16529667|NCT01248884|40406059|FG001|Overall Study|Adverse Event|0|||
16529668|NCT01248884|40406060|FG002|Overall Study|Adverse Event|0|||
16529669|NCT00680407|40406061|FG000|Overall Study|Lost to Follow-up|3|||
16529670|NCT00680407|40406062|FG001|Overall Study|Lost to Follow-up|3|||
16529671|NCT00680407|40406063|FG002|Overall Study|Lost to Follow-up|1|||
16529672|NCT00680407|40406061|FG000|Overall Study|Withdrawal by Subject|5|||
16529673|NCT00680407|40406062|FG001|Overall Study|Withdrawal by Subject|2|||
16529674|NCT00680407|40406063|FG002|Overall Study|Withdrawal by Subject|2|||
16529675|NCT00377819|40406064|FG000|Overall Study|Adverse Event|2|||
16529676|NCT00377819|40406065|FG001|Overall Study|Adverse Event|3|||
16529677|NCT00377819|40406064|FG000|Overall Study|Withdrawal by Subject|10|||
16529678|NCT00377819|40406065|FG001|Overall Study|Withdrawal by Subject|4|||
16529679|NCT00377819|40406064|FG000|Overall Study|Death|0|||
16529680|NCT00377819|40406065|FG001|Overall Study|Death|1|||
16529681|NCT00377819|40406064|FG000|Overall Study|Lost to Follow-up|0|||
16529682|NCT00377819|40406065|FG001|Overall Study|Lost to Follow-up|1|||
16529683|NCT00377819|40406064|FG000|Overall Study|Protocol Violation|1|||
16529684|NCT00377819|40406065|FG001|Overall Study|Protocol Violation|1|||
16529685|NCT01767116|40406066|FG000|Overall Study|Lost to Follow-up|2|||
16529686|NCT01767116|40406067|FG001|Overall Study|Lost to Follow-up|2|||
16529687|NCT02244944|40406068|FG000|Overall Study|Withdrawal by Subject|1|||
16529688|NCT02244944|40406068|FG000|Overall Study|Study Terminated|1|||
16529689|NCT00071487|40406069|FG000|52-Week Double-Blind Period|Adverse Event|5|||
16529690|NCT00071487|40406070|FG001|52-Week Double-Blind Period|Adverse Event|8|||
16529691|NCT00071487|40406071|FG002|52-Week Double-Blind Period|Adverse Event|4|||
16529692|NCT00071487|40406072|FG003|52-Week Double-Blind Period|Adverse Event|8|||
16529693|NCT00071487|40406069|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
16529694|NCT00071487|40406070|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
16529695|NCT00071487|40406071|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
16529696|NCT00071487|40406072|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
16529697|NCT00071487|40406069|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
16529698|NCT00071487|40406070|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
16529699|NCT00071487|40406071|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
16529700|NCT00071487|40406072|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
16529701|NCT00071487|40406069|FG000|52-Week Double-Blind Period|Physician Decision|1|||
16529702|NCT00071487|40406070|FG001|52-Week Double-Blind Period|Physician Decision|0|||
16529703|NCT00071487|40406071|FG002|52-Week Double-Blind Period|Physician Decision|0|||
16529704|NCT00071487|40406072|FG003|52-Week Double-Blind Period|Physician Decision|0|||
16529705|NCT00071487|40406069|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
16400875|NCT00327015|39948416|FG000|Overall Study|Administrative Reason by Sponsor|1|||
16400876|NCT00327015|39948417|FG001|Overall Study|Administrative Reason by Sponsor|2|||
16529706|NCT00071487|40406070|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
16529707|NCT00071487|40406071|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
16529708|NCT00071487|40406072|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
16529709|NCT00071487|40406069|FG000|52-Week Double-Blind Period|Pregnancy|0|||
16529710|NCT00071487|40406070|FG001|52-Week Double-Blind Period|Pregnancy|1|||
16529711|NCT00071487|40406071|FG002|52-Week Double-Blind Period|Pregnancy|0|||
16400877|NCT00327015|39948418|FG002|Overall Study|Administrative Reason by Sponsor|2|||
16400878|NCT00327015|39948419|FG003|Overall Study|Administrative Reason by Sponsor|1|||
16400879|NCT02954406|39948420|FG000|Overall Study|Adverse Event|0|||
16400880|NCT02954406|39948421|FG001|Overall Study|Adverse Event|1|||
16400881|NCT02954406|39948422|FG002|Overall Study|Adverse Event|0|||
16400882|NCT02954406|39948423|FG003|Overall Study|Adverse Event|0|||
16212834|NCT02963766|39258817|FG001|Double-Blind Period|Protocol Violation|0|||
16212835|NCT02963766|39258818|FG002|Double-Blind Period|Protocol Violation|0|||
16212836|NCT02963766|39258816|FG000|Double-Blind Period|Lost to Follow-up|0|||
16212837|NCT02963766|39258817|FG001|Double-Blind Period|Lost to Follow-up|1|||
16212838|NCT02963766|39258818|FG002|Double-Blind Period|Lost to Follow-up|0|||
16212839|NCT02963766|39258816|FG000|Open Label Extension (OLE)|Physician Decision|1|||
16212840|NCT02963766|39258817|FG001|Open Label Extension (OLE)|Physician Decision|2|||
16212841|NCT02963766|39258818|FG002|Open Label Extension (OLE)|Physician Decision|2|||
16212842|NCT02963766|39258816|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
16212843|NCT02963766|39258817|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
16212844|NCT02963766|39258818|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
16212845|NCT00537771|39258819|FG000|Overall Study|Withdrawal by Subject|6|||
16212846|NCT00537771|39258820|FG001|Overall Study|Withdrawal by Subject|23|||
16212847|NCT00537771|39258819|FG000|Overall Study|Adverse Event|8|||
16212848|NCT00537771|39258820|FG001|Overall Study|Adverse Event|15|||
16212849|NCT00537771|39258819|FG000|Overall Study|Lost to Follow-up|9|||
16212850|NCT00537771|39258820|FG001|Overall Study|Lost to Follow-up|15|||
16212851|NCT00537771|39258819|FG000|Overall Study|Protocol Violation|2|||
16400883|NCT02954406|39948424|FG004|Overall Study|Adverse Event|1|||
16400884|NCT02954406|39948425|FG005|Overall Study|Adverse Event|0|||
16529712|NCT00071487|40406072|FG003|52-Week Double-Blind Period|Pregnancy|0|||
16529713|NCT00071487|40406069|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
16400885|NCT02954406|39948426|FG006|Overall Study|Adverse Event|0|||
16400886|NCT02954406|39948427|FG007|Overall Study|Adverse Event|0|||
16400887|NCT02954406|39948428|FG008|Overall Study|Adverse Event|1|||
16529714|NCT00071487|40406070|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
16529715|NCT00071487|40406071|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
16529716|NCT00071487|40406072|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
16529717|NCT00071487|40406069|FG000|52-Week Double-Blind Period|Death|0|||
16529718|NCT00071487|40406070|FG001|52-Week Double-Blind Period|Death|1|||
16529719|NCT00071487|40406071|FG002|52-Week Double-Blind Period|Death|0|||
16529720|NCT00071487|40406072|FG003|52-Week Double-Blind Period|Death|0|||
16529721|NCT00071487|40406069|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
16529722|NCT00071487|40406070|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
16529723|NCT00071487|40406071|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
16529724|NCT00071487|40406072|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
16529725|NCT00071487|40406069|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
16529726|NCT00071487|40406070|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
16529727|NCT00071487|40406071|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
16529728|NCT00071487|40406072|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
16529729|NCT00071487|40406069|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
16529730|NCT00071487|40406070|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
16529731|NCT00071487|40406071|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
16529732|NCT00071487|40406072|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
16529733|NCT00071487|40406069|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
16529734|NCT00071487|40406070|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
16529735|NCT00071487|40406071|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
16529736|NCT00071487|40406072|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
16529737|NCT00071487|40406069|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
16529738|NCT00071487|40406070|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
16529739|NCT00071487|40406071|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
16529740|NCT00071487|40406072|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
16529741|NCT00071487|40406069|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
16529742|NCT00071487|40406070|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
16529743|NCT00071487|40406071|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
16529744|NCT00071487|40406072|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
16529745|NCT00071487|40406069|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
16529746|NCT00071487|40406070|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
16529747|NCT00071487|40406071|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
16529748|NCT00071487|40406072|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
16529749|NCT03896035|40406075|FG000|Overall Study|Lost to Follow-up|2|||
16212852|NCT00537771|39258820|FG001|Overall Study|Protocol Violation|6|||
16212853|NCT00537771|39258819|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
16212854|NCT00537771|39258820|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
16400888|NCT02954406|39948429|FG009|Overall Study|Adverse Event|1|||
16400889|NCT02954406|39948430|FG010|Overall Study|Adverse Event|0|||
16098477|NCT01064856|38849768|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
16098478|NCT01064856|38849769|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
16098479|NCT01064856|38849766|FG000|Open-label (OL) Period|Adverse Event|0|||
16098480|NCT01064856|38849767|FG001|Open-label (OL) Period|Adverse Event|0|||
16098481|NCT01064856|38849768|FG002|Open-label (OL) Period|Adverse Event|12|||
16098482|NCT01064856|38849769|FG003|Open-label (OL) Period|Adverse Event|6|||
16098483|NCT01064856|38849766|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
16098484|NCT01064856|38849767|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
16098485|NCT01064856|38849768|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
16098486|NCT01064856|38849769|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
16098487|NCT01064856|38849766|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
16400890|NCT02954406|39948420|FG000|Overall Study|Progressive Disease|3|||
16400891|NCT02954406|39948421|FG001|Overall Study|Progressive Disease|4|||
16400892|NCT02954406|39948422|FG002|Overall Study|Progressive Disease|3|||
16400893|NCT02954406|39948423|FG003|Overall Study|Progressive Disease|4|||
16400894|NCT02954406|39948424|FG004|Overall Study|Progressive Disease|3|||
16400895|NCT02954406|39948425|FG005|Overall Study|Progressive Disease|3|||
16400896|NCT02954406|39948426|FG006|Overall Study|Progressive Disease|2|||
16400897|NCT02954406|39948427|FG007|Overall Study|Progressive Disease|2|||
16400898|NCT02954406|39948428|FG008|Overall Study|Progressive Disease|1|||
16400899|NCT02954406|39948429|FG009|Overall Study|Progressive Disease|1|||
16400900|NCT02954406|39948430|FG010|Overall Study|Progressive Disease|0|||
16400901|NCT02954406|39948420|FG000|Overall Study|Symptomatic Deterioration|0|||
16400902|NCT02954406|39948421|FG001|Overall Study|Symptomatic Deterioration|1|||
16400903|NCT02954406|39948422|FG002|Overall Study|Symptomatic Deterioration|0|||
16400904|NCT02954406|39948423|FG003|Overall Study|Symptomatic Deterioration|0|||
16400905|NCT02954406|39948424|FG004|Overall Study|Symptomatic Deterioration|0|||
16400906|NCT02954406|39948425|FG005|Overall Study|Symptomatic Deterioration|0|||
16400907|NCT02954406|39948426|FG006|Overall Study|Symptomatic Deterioration|0|||
16400908|NCT02954406|39948427|FG007|Overall Study|Symptomatic Deterioration|0|||
16400909|NCT02954406|39948428|FG008|Overall Study|Symptomatic Deterioration|0|||
16400910|NCT02954406|39948429|FG009|Overall Study|Symptomatic Deterioration|0|||
16400911|NCT02954406|39948430|FG010|Overall Study|Symptomatic Deterioration|0|||
16400912|NCT02954406|39948420|FG000|Overall Study|Death|0|||
16400913|NCT02954406|39948421|FG001|Overall Study|Death|0|||
16400914|NCT02954406|39948422|FG002|Overall Study|Death|0|||
16400915|NCT02954406|39948423|FG003|Overall Study|Death|0|||
16400916|NCT02954406|39948424|FG004|Overall Study|Death|1|||
16098488|NCT01064856|38849767|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
16098489|NCT01064856|38849768|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
16098490|NCT01064856|38849769|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
16098491|NCT01064856|38849766|FG000|Open-label (OL) Period|Other|0|||
16098492|NCT01064856|38849767|FG001|Open-label (OL) Period|Other|0|||
16098493|NCT01064856|38849768|FG002|Open-label (OL) Period|Other|7|||
16098494|NCT01064856|38849769|FG003|Open-label (OL) Period|Other|7|||
16098495|NCT01358175|38849770|FG000|Overall Study|Death|1|||
16098496|NCT01358175|38849771|FG001|Overall Study|Death|0|||
16098497|NCT01358175|38849772|FG002|Overall Study|Death|1|||
16098498|NCT01358175|38849770|FG000|Overall Study|Withdrawal by Subject|9|||
16098499|NCT01358175|38849771|FG001|Overall Study|Withdrawal by Subject|5|||
16098500|NCT01358175|38849772|FG002|Overall Study|Withdrawal by Subject|10|||
16098501|NCT01358175|38849770|FG000|Overall Study|Technical issues|0|||
16098502|NCT01358175|38849771|FG001|Overall Study|Technical issues|1|||
16400917|NCT02954406|39948425|FG005|Overall Study|Death|0|||
16400918|NCT02954406|39948426|FG006|Overall Study|Death|0|||
16400919|NCT02954406|39948427|FG007|Overall Study|Death|0|||
16400920|NCT02954406|39948428|FG008|Overall Study|Death|1|||
16400921|NCT02954406|39948429|FG009|Overall Study|Death|1|||
16400922|NCT02954406|39948430|FG010|Overall Study|Death|0|||
16400923|NCT02954406|39948420|FG000|Overall Study|Reason Not Specified|0|||
16400924|NCT02954406|39948421|FG001|Overall Study|Reason Not Specified|0|||
16400925|NCT02954406|39948422|FG002|Overall Study|Reason Not Specified|3|||
16400926|NCT02954406|39948423|FG003|Overall Study|Reason Not Specified|2|||
16400927|NCT02954406|39948424|FG004|Overall Study|Reason Not Specified|2|||
16400928|NCT02954406|39948425|FG005|Overall Study|Reason Not Specified|0|||
16098503|NCT01358175|38849772|FG002|Overall Study|Technical issues|0|||
16098504|NCT01358175|38849770|FG000|Overall Study|Pregnancy|0|||
16098505|NCT01358175|38849771|FG001|Overall Study|Pregnancy|1|||
16098506|NCT01358175|38849772|FG002|Overall Study|Pregnancy|0|||
16400929|NCT02954406|39948426|FG006|Overall Study|Reason Not Specified|1|||
16400930|NCT02954406|39948427|FG007|Overall Study|Reason Not Specified|0|||
16400931|NCT02954406|39948428|FG008|Overall Study|Reason Not Specified|1|||
16400932|NCT02954406|39948429|FG009|Overall Study|Reason Not Specified|0|||
16400933|NCT02954406|39948430|FG010|Overall Study|Reason Not Specified|0|||
16400934|NCT04115748|39948433|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
16400935|NCT04115748|39948434|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
16400936|NCT04115748|39948435|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
16400937|NCT04115748|39948436|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
16098507|NCT01358175|38849770|FG000|Overall Study|Physician Decision|1|||
16098508|NCT01358175|38849771|FG001|Overall Study|Physician Decision|0|||
16400938|NCT04115748|39948437|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16400939|NCT04115748|39948438|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16400940|NCT04115748|39948439|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16400941|NCT04115748|39948440|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16400942|NCT04115748|39948441|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16400943|NCT04115748|39948442|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
16400944|NCT04115748|39948433|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16400945|NCT04115748|39948434|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16400946|NCT04115748|39948435|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16400947|NCT04115748|39948436|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
16400948|NCT04115748|39948437|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16400949|NCT04115748|39948438|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16400950|NCT04115748|39948439|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16400951|NCT04115748|39948440|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16400952|NCT04115748|39948441|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16400953|NCT04115748|39948442|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
16331397|NCT04250350|39699934|FG000|Overall Study|Physician Decision|1|||
16212855|NCT01782885|39258823|FG000|Overall Study|Lost to Follow-up|4|||
16212856|NCT01782885|39258824|FG001|Overall Study|Lost to Follow-up|6|||
16212857|NCT04445051|39258825|FG000|Overall Study|Adverse Event|0|||
16212858|NCT04445051|39258826|FG001|Overall Study|Adverse Event|0|||
16212859|NCT04445051|39258827|FG002|Overall Study|Adverse Event|1|||
16212860|NCT04445051|39258828|FG003|Overall Study|Adverse Event|0|||
16212861|NCT04445051|39258829|FG004|Overall Study|Adverse Event|0|||
16331398|NCT04250350|39699934|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
16331399|NCT01173055|39699935|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
16331400|NCT01173055|39699936|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
16331401|NCT01173055|39699935|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
16331402|NCT01173055|39699936|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
16331403|NCT00177307|39699938|FG000|Overall Study|Withdrawal by Subject|1|||
16331404|NCT01854879|39699943|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
16331405|NCT01854879|39699943|FG000|Overall Study|screen fail|3|||
16331406|NCT01854879|39699943|FG000|Overall Study|incomplete data set|1|||
16331407|NCT02429310|39699944|FG000|Overall Study|Lost to Follow-up|1|||
16331408|NCT02429310|39699945|FG001|Overall Study|Lost to Follow-up|2|||
16331409|NCT02429310|39699944|FG000|Overall Study|Protocol Violation|1|||
16331410|NCT02429310|39699945|FG001|Overall Study|Protocol Violation|1|||
16331411|NCT01935700|39699946|FG000|Overall Study|Withdrawal by Subject|1|||
16331412|NCT01935700|39699947|FG001|Overall Study|Withdrawal by Subject|0|||
16331413|NCT01935700|39699946|FG000|Overall Study|Physician Decision|4|||
16331414|NCT01935700|39699947|FG001|Overall Study|Physician Decision|0|||
16331415|NCT02612610|39699948|FG000|Overall Study|Withdrawal by Subject|1|||
16331416|NCT02612610|39699949|FG001|Overall Study|Withdrawal by Subject|1|||
16331417|NCT02612610|39699950|FG002|Overall Study|Withdrawal by Subject|0|||
16331418|NCT02612610|39699951|FG003|Overall Study|Withdrawal by Subject|2|||
16400954|NCT04115748|39948433|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
16400955|NCT04115748|39948434|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
16400956|NCT04115748|39948435|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
16400957|NCT04115748|39948436|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
16400958|NCT04115748|39948437|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
16400959|NCT04115748|39948438|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
16400960|NCT04115748|39948439|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
16400961|NCT04115748|39948440|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
16400962|NCT04115748|39948441|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
16400963|NCT04115748|39948442|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
16400964|NCT04115748|39948433|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16400965|NCT04115748|39948434|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16212862|NCT04445051|39258830|FG005|Overall Study|Adverse Event|0|||
16212863|NCT01436357|39258833|FG000|Overall Study|Death|5|||
16331419|NCT02612610|39699948|FG000|Overall Study|Adverse Event|2|||
16331420|NCT02612610|39699949|FG001|Overall Study|Adverse Event|2|||
16331421|NCT02612610|39699950|FG002|Overall Study|Adverse Event|3|||
16331422|NCT02612610|39699951|FG003|Overall Study|Adverse Event|10|||
16331423|NCT02612610|39699948|FG000|Overall Study|Lost to Follow-up|0|||
16331424|NCT02612610|39699949|FG001|Overall Study|Lost to Follow-up|1|||
16331425|NCT02612610|39699950|FG002|Overall Study|Lost to Follow-up|0|||
16331426|NCT02612610|39699951|FG003|Overall Study|Lost to Follow-up|0|||
16212864|NCT01436357|39258834|FG001|Overall Study|Death|1|||
16212865|NCT01436357|39258833|FG000|Overall Study|Enrolled but not vaccinated|1|||
16212866|NCT01436357|39258834|FG001|Overall Study|Enrolled but not vaccinated|1|||
16212867|NCT01436357|39258833|FG000|Overall Study|Incarceration|18|||
16331427|NCT02612610|39699948|FG000|Overall Study|Protocol Violation|0|||
16331428|NCT02612610|39699949|FG001|Overall Study|Protocol Violation|1|||
16331429|NCT02612610|39699950|FG002|Overall Study|Protocol Violation|1|||
16331430|NCT02612610|39699951|FG003|Overall Study|Protocol Violation|0|||
16331431|NCT02612610|39699948|FG000|Overall Study|Lack of Efficacy|1|||
16331432|NCT02612610|39699949|FG001|Overall Study|Lack of Efficacy|2|||
16331433|NCT02612610|39699950|FG002|Overall Study|Lack of Efficacy|0|||
16331434|NCT02612610|39699951|FG003|Overall Study|Lack of Efficacy|1|||
16331435|NCT02612610|39699948|FG000|Overall Study|Physician Decision|0|||
16331436|NCT02612610|39699949|FG001|Overall Study|Physician Decision|1|||
16331437|NCT02612610|39699950|FG002|Overall Study|Physician Decision|0|||
16331438|NCT02612610|39699951|FG003|Overall Study|Physician Decision|0|||
16331439|NCT02612610|39699948|FG000|Overall Study|Noncompliance|1|||
16331440|NCT02612610|39699949|FG001|Overall Study|Noncompliance|0|||
16331441|NCT02612610|39699950|FG002|Overall Study|Noncompliance|0|||
16331442|NCT02612610|39699951|FG003|Overall Study|Noncompliance|0|||
16331443|NCT02612610|39699948|FG000|Overall Study|Cough Improvement|0|||
16212868|NCT01436357|39258834|FG001|Overall Study|Incarceration|20|||
16212869|NCT01436357|39258833|FG000|Overall Study|Lost to Follow-up|67|||
16212870|NCT01436357|39258834|FG001|Overall Study|Lost to Follow-up|61|||
16212871|NCT01436357|39258833|FG000|Overall Study|Protocol Violation|1|||
16212872|NCT01436357|39258834|FG001|Overall Study|Protocol Violation|0|||
16212873|NCT01436357|39258833|FG000|Overall Study|Withdrawal by Subject|26|||
16212874|NCT01436357|39258834|FG001|Overall Study|Withdrawal by Subject|38|||
16212875|NCT01436357|39258833|FG000|Overall Study|Physician Decision|3|||
16212876|NCT01436357|39258834|FG001|Overall Study|Physician Decision|4|||
16212877|NCT01436357|39258833|FG000|Overall Study|Moved out of area|1|||
16331444|NCT02612610|39699949|FG001|Overall Study|Cough Improvement|0|||
16331445|NCT02612610|39699950|FG002|Overall Study|Cough Improvement|1|||
16331446|NCT02612610|39699951|FG003|Overall Study|Cough Improvement|0|||
16331447|NCT01404208|39699957|FG000|Overall Study|Discontinued|3|||
16331448|NCT01404208|39699958|FG001|Overall Study|Discontinued|0|||
16331449|NCT02306694|39699959|FG000|Overall Study|Withdrawal by Subject|3|||
16331450|NCT02306694|39699959|FG000|Overall Study|Lost to Follow-up|1|||
16331451|NCT01078298|39699960|FG000|Overall Study|Lost to Follow-up|12|||
16331452|NCT01078298|39699961|FG001|Overall Study|Lost to Follow-up|13|||
16331453|NCT01078298|39699960|FG000|Overall Study|Withdrawal by Subject|31|||
16331454|NCT01078298|39699961|FG001|Overall Study|Withdrawal by Subject|33|||
16400966|NCT04115748|39948435|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16400967|NCT04115748|39948436|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16400968|NCT04115748|39948437|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16400969|NCT04115748|39948438|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16400970|NCT04115748|39948439|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16400971|NCT04115748|39948440|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16331455|NCT01078298|39699960|FG000|Overall Study|Protocol Violation|6|||
16331456|NCT01078298|39699961|FG001|Overall Study|Protocol Violation|6|||
16331457|NCT01078298|39699960|FG000|Overall Study|Adverse Event|6|||
16331458|NCT01078298|39699961|FG001|Overall Study|Adverse Event|5|||
16331459|NCT01078298|39699960|FG000|Overall Study|Death|2|||
16331460|NCT01078298|39699961|FG001|Overall Study|Death|0|||
16331461|NCT01078298|39699960|FG000|Overall Study|Did not meet entrance criteria|0|||
16331462|NCT01078298|39699961|FG001|Overall Study|Did not meet entrance criteria|1|||
16331463|NCT01078298|39699960|FG000|Overall Study|Other|24|||
16331464|NCT01078298|39699961|FG001|Overall Study|Other|32|||
16331465|NCT00503997|39699962|FG000|Overall Study|disease progression|1|||
16331466|NCT00503997|39699962|FG000|Overall Study|Adverse Event|5|||
16331467|NCT00503997|39699962|FG000|Overall Study|Death|1|||
16331468|NCT00503997|39699962|FG000|Overall Study|Withdrawal by Subject|1|||
16331469|NCT00664859|39699963|FG000|Overall Study|Adverse Event|2|||
16331470|NCT00664859|39699964|FG001|Overall Study|Adverse Event|1|||
16331471|NCT00664859|39699965|FG002|Overall Study|Adverse Event|3|||
16331472|NCT00664859|39699963|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
16331473|NCT00664859|39699964|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
16331474|NCT00664859|39699965|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
16331475|NCT00664859|39699963|FG000|Overall Study|Noncompliance with protocol|1|||
16331476|NCT00664859|39699964|FG001|Overall Study|Noncompliance with protocol|0|||
16331477|NCT00664859|39699965|FG002|Overall Study|Noncompliance with protocol|4|||
16331478|NCT00664859|39699963|FG000|Overall Study|Laboratory abnormality|2|||
16331479|NCT00664859|39699964|FG001|Overall Study|Laboratory abnormality|1|||
16212878|NCT01436357|39258834|FG001|Overall Study|Moved out of area|2|||
16212879|NCT01436357|39258833|FG000|Overall Study|Subject in rehab|0|||
16212880|NCT01436357|39258834|FG001|Overall Study|Subject in rehab|1|||
16212881|NCT01642004|39258835|FG000|Randomization|Adverse Event unrelated to study drug|1|||
16331480|NCT00664859|39699965|FG002|Overall Study|Laboratory abnormality|4|||
16331481|NCT00664859|39699963|FG000|Overall Study|Withdrawal by Subject|4|||
16331482|NCT00664859|39699964|FG001|Overall Study|Withdrawal by Subject|1|||
16331483|NCT00664859|39699965|FG002|Overall Study|Withdrawal by Subject|3|||
16529750|NCT03896035|40406076|FG001|Overall Study|Lost to Follow-up|6|||
16529751|NCT03896035|40406075|FG000|Overall Study|Withdrawal by Subject|0|||
16331484|NCT00664859|39699963|FG000|Overall Study|Lost to Follow-up|2|||
16331485|NCT00664859|39699964|FG001|Overall Study|Lost to Follow-up|2|||
16529752|NCT03896035|40406076|FG001|Overall Study|Withdrawal by Subject|1|||
16529753|NCT03896035|40406075|FG000|Overall Study|Health/family health issues during COVID|0|||
16098509|NCT01358175|38849772|FG002|Overall Study|Physician Decision|0|||
16098510|NCT01358175|38849770|FG000|Overall Study|Non Compliance with Study Treatment|0|||
16098511|NCT01358175|38849771|FG001|Overall Study|Non Compliance with Study Treatment|1|||
16098512|NCT01358175|38849772|FG002|Overall Study|Non Compliance with Study Treatment|1|||
16331486|NCT00664859|39699965|FG002|Overall Study|Lost to Follow-up|1|||
16331487|NCT00664859|39699963|FG000|Overall Study|Other|0|||
16331488|NCT00664859|39699964|FG001|Overall Study|Other|1|||
16331489|NCT00664859|39699965|FG002|Overall Study|Other|2|||
16331490|NCT00334802|39699967|FG000|Overall Study|Progressive Disease|2|||
16331491|NCT00334802|39699968|FG001|Overall Study|Progressive Disease|24|||
16331492|NCT00334802|39699967|FG000|Overall Study|Toxicity|1|||
16331493|NCT00334802|39699968|FG001|Overall Study|Toxicity|5|||
16331494|NCT00334802|39699967|FG000|Overall Study|Lack of Efficacy|1|||
16331495|NCT00334802|39699968|FG001|Overall Study|Lack of Efficacy|3|||
16331496|NCT00334802|39699967|FG000|Overall Study|Patient Condition Aggrevated|1|||
16331497|NCT00334802|39699968|FG001|Overall Study|Patient Condition Aggrevated|0|||
16331498|NCT00334802|39699967|FG000|Overall Study|Physician Decision|1|||
16331499|NCT00334802|39699968|FG001|Overall Study|Physician Decision|0|||
16331500|NCT00334802|39699967|FG000|Overall Study|Withdrawal by Subject|0|||
16331501|NCT00334802|39699968|FG001|Overall Study|Withdrawal by Subject|4|||
16331502|NCT00334802|39699967|FG000|Overall Study|Adverse Event|0|||
16331503|NCT00334802|39699968|FG001|Overall Study|Adverse Event|3|||
16331504|NCT00334802|39699967|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
16331505|NCT00334802|39699968|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
16331506|NCT01249833|39699974|FG000|Overall Study|Lost to Follow-up|0|||
16331507|NCT01249833|39699975|FG001|Overall Study|Lost to Follow-up|1|||
16331508|NCT02179749|39699976|FG000|Overall Study|Adverse Event|0|||
16331509|NCT02179749|39699977|FG001|Overall Study|Adverse Event|0|||
16331510|NCT02179749|39699978|FG002|Overall Study|Adverse Event|1|||
16331511|NCT02179749|39699976|FG000|Overall Study|Withdrawal by Subject|0|||
16331512|NCT02179749|39699977|FG001|Overall Study|Withdrawal by Subject|0|||
16331513|NCT02179749|39699978|FG002|Overall Study|Withdrawal by Subject|1|||
16331514|NCT00278148|39699979|FG000|Phase II - Expansion Phase|Disease progression|0|||
16331515|NCT00278148|39699980|FG001|Phase II - Expansion Phase|Disease progression|0|||
16331516|NCT00278148|39699981|FG002|Phase II - Expansion Phase|Disease progression|4|||
16331517|NCT00278148|39699979|FG000|Phase II - Expansion Phase|Adverse Event|0|||
16331518|NCT00278148|39699980|FG001|Phase II - Expansion Phase|Adverse Event|0|||
16331519|NCT00278148|39699981|FG002|Phase II - Expansion Phase|Adverse Event|2|||
16331520|NCT00742508|39699982|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
16331521|NCT00742508|39699983|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
16331522|NCT00742508|39699982|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
16331523|NCT00742508|39699983|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
16331524|NCT00742508|39699982|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
16331525|NCT00742508|39699983|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
16331526|NCT00742508|39699982|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
16331527|NCT00742508|39699983|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
16331528|NCT00742508|39699982|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
16331529|NCT00742508|39699983|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
16331530|NCT00705718|39699987|FG000|Overall Study|Death|6|||
16331531|NCT00705718|39699988|FG001|Overall Study|Death|6|||
16331532|NCT00705718|39699987|FG000|Overall Study|Not due for Visit|0|||
16331533|NCT00705718|39699988|FG001|Overall Study|Not due for Visit|12|||
16331534|NCT00705718|39699987|FG000|Overall Study|Follow up not done|1|||
16331535|NCT00705718|39699988|FG001|Overall Study|Follow up not done|4|||
16331536|NCT02267135|39699989|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
16331537|NCT02267135|39699990|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
16331538|NCT02267135|39699989|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
16331539|NCT02267135|39699990|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
16331540|NCT02267135|39699989|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
16331541|NCT02267135|39699990|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
16331542|NCT02267135|39699989|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
16331543|NCT02267135|39699990|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
16400972|NCT04115748|39948441|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
16529754|NCT03896035|40406076|FG001|Overall Study|Health/family health issues during COVID|4|||
16331544|NCT02267135|39699989|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
16331545|NCT02267135|39699990|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
16331546|NCT00108485|39699991|FG000|Overall Study|Withdrawal by Subject|3|||
16529755|NCT01369342|40406078|FG000|Overall Study|Withdrawal by Subject|7|||
16331547|NCT00108485|39699992|FG001|Overall Study|Withdrawal by Subject|0|||
16331548|NCT00108485|39699991|FG000|Overall Study|Lost to Follow-up|0|||
16331549|NCT00108485|39699992|FG001|Overall Study|Lost to Follow-up|2|||
16400973|NCT04115748|39948442|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
16400974|NCT04187144|39948445|FG000|Overall Study|Lost to Follow-up|12|||
16400975|NCT04187144|39948446|FG001|Overall Study|Lost to Follow-up|11|||
16400976|NCT04187144|39948445|FG000|Overall Study|Withdrawal by Subject|20|||
16331550|NCT02637713|39699993|FG000|Overall Study|Screen Failure|2|||
16331551|NCT01730534|39700004|FG000|Overall Study|Withdrawal by Subject|97|||
16331552|NCT01730534|39700005|FG001|Overall Study|Withdrawal by Subject|127|||
16331553|NCT01730534|39700004|FG000|Overall Study|Lost to Follow-up|12|||
16331554|NCT01730534|39700005|FG001|Overall Study|Lost to Follow-up|18|||
16331555|NCT02474355|39700011|FG000|Overall Study|Other|43|||
16331556|NCT02474355|39700011|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
16331557|NCT02474355|39700011|FG000|Overall Study|Lost to Follow-up|98|||
16331558|NCT02474355|39700011|FG000|Overall Study|Withdrawal by Subject|124|||
16331559|NCT02474355|39700011|FG000|Overall Study|Death|1361|||
16331560|NCT00835679|39700012|FG000|Overall Study|Withdrawal by Subject|1|||
16331561|NCT00835679|39700013|FG001|Overall Study|Withdrawal by Subject|0|||
16529756|NCT01369342|40406079|FG001|Overall Study|Withdrawal by Subject|7|||
16529757|NCT01369342|40406080|FG002|Overall Study|Withdrawal by Subject|2|||
16529758|NCT01369342|40406078|FG000|Overall Study|Lost to Follow-up|5|||
16529759|NCT01369342|40406079|FG001|Overall Study|Lost to Follow-up|2|||
16529760|NCT01369342|40406080|FG002|Overall Study|Lost to Follow-up|1|||
16529761|NCT01369342|40406078|FG000|Overall Study|Not Treated|1|||
16529762|NCT01369342|40406079|FG001|Overall Study|Not Treated|0|||
16529763|NCT01369342|40406080|FG002|Overall Study|Not Treated|0|||
16529764|NCT01202773|40406081|FG000|Overall Study|Adverse Event|4|||
16529765|NCT01202773|40406082|FG001|Overall Study|Adverse Event|5|||
16529766|NCT01202773|40406083|FG002|Overall Study|Adverse Event|5|||
16529767|NCT01202773|40406081|FG000|Overall Study|Lack of Efficacy|5|||
16529768|NCT01202773|40406082|FG001|Overall Study|Lack of Efficacy|4|||
16529769|NCT01202773|40406083|FG002|Overall Study|Lack of Efficacy|9|||
16529770|NCT01202773|40406081|FG000|Overall Study|Entry Criteria Not Met|2|||
16529771|NCT01202773|40406082|FG001|Overall Study|Entry Criteria Not Met|0|||
16331562|NCT00835679|39700014|FG002|Overall Study|Withdrawal by Subject|0|||
16331563|NCT00835679|39700015|FG003|Overall Study|Withdrawal by Subject|0|||
16331564|NCT03436199|39700016|FG000|Overall Study|Adverse Event|15|||
16331565|NCT03436199|39700017|FG001|Overall Study|Adverse Event|40|||
16331566|NCT03436199|39700018|FG002|Overall Study|Adverse Event|7|||
16331567|NCT03436199|39700016|FG000|Overall Study|Withdrawal by Subject|4|||
16331568|NCT03436199|39700017|FG001|Overall Study|Withdrawal by Subject|10|||
16331569|NCT03436199|39700018|FG002|Overall Study|Withdrawal by Subject|3|||
16331570|NCT03436199|39700016|FG000|Overall Study|Lost to Follow-up|1|||
16529772|NCT01202773|40406083|FG002|Overall Study|Entry Criteria Not Met|1|||
16529773|NCT01202773|40406081|FG000|Overall Study|Lost to Follow-up|1|||
16529774|NCT01202773|40406082|FG001|Overall Study|Lost to Follow-up|2|||
16529775|NCT01202773|40406083|FG002|Overall Study|Lost to Follow-up|2|||
16400977|NCT04187144|39948446|FG001|Overall Study|Withdrawal by Subject|18|||
16331571|NCT03436199|39700017|FG001|Overall Study|Lost to Follow-up|0|||
16529776|NCT01202773|40406081|FG000|Overall Study|Withdrawal by Subject|13|||
16529777|NCT01202773|40406082|FG001|Overall Study|Withdrawal by Subject|6|||
16529778|NCT01202773|40406083|FG002|Overall Study|Withdrawal by Subject|5|||
16529779|NCT01202773|40406081|FG000|Overall Study|Physician Decision|2|||
16529780|NCT01202773|40406082|FG001|Overall Study|Physician Decision|0|||
16529781|NCT01202773|40406083|FG002|Overall Study|Physician Decision|0|||
16529782|NCT01202773|40406081|FG000|Overall Study|Protocol Violation|11|||
16529783|NCT01202773|40406082|FG001|Overall Study|Protocol Violation|6|||
16331572|NCT03436199|39700018|FG002|Overall Study|Lost to Follow-up|2|||
16331573|NCT03436199|39700016|FG000|Overall Study|Protocol Violation|1|||
16529784|NCT01202773|40406083|FG002|Overall Study|Protocol Violation|10|||
16529785|NCT01202773|40406081|FG000|Overall Study|Sponsor Decision|19|||
16529786|NCT01202773|40406082|FG001|Overall Study|Sponsor Decision|20|||
16529787|NCT01202773|40406083|FG002|Overall Study|Sponsor Decision|23|||
16529788|NCT02627677|40406084|FG000|Overall Study|Adverse event (not progressive disease)|1|||
16529789|NCT02627677|40406085|FG001|Overall Study|Adverse event (not progressive disease)|4|||
16529790|NCT02627677|40406086|FG002|Overall Study|Adverse event (not progressive disease)|1|||
16529791|NCT02627677|40406084|FG000|Overall Study|Progressive disease|1|||
16529792|NCT02627677|40406085|FG001|Overall Study|Progressive disease|3|||
16529793|NCT02627677|40406086|FG002|Overall Study|Progressive disease|0|||
16529794|NCT02627677|40406084|FG000|Overall Study|Lack of Efficacy|1|||
16529795|NCT02627677|40406085|FG001|Overall Study|Lack of Efficacy|2|||
16529796|NCT02627677|40406086|FG002|Overall Study|Lack of Efficacy|0|||
16529797|NCT02627677|40406084|FG000|Overall Study|Lost to Follow-up|0|||
16529798|NCT02627677|40406085|FG001|Overall Study|Lost to Follow-up|0|||
16529799|NCT02627677|40406086|FG002|Overall Study|Lost to Follow-up|1|||
16529800|NCT02627677|40406084|FG000|Overall Study|Pregnancy|0|||
16529801|NCT02627677|40406085|FG001|Overall Study|Pregnancy|1|||
16529802|NCT02627677|40406086|FG002|Overall Study|Pregnancy|0|||
16529803|NCT02627677|40406084|FG000|Overall Study|Study Terminated by Sponsor|5|||
16529804|NCT02627677|40406085|FG001|Overall Study|Study Terminated by Sponsor|10|||
16529805|NCT02627677|40406086|FG002|Overall Study|Study Terminated by Sponsor|6|||
16529806|NCT02627677|40406084|FG000|Overall Study|Physician Decision|0|||
16529807|NCT02627677|40406085|FG001|Overall Study|Physician Decision|0|||
16529808|NCT02627677|40406086|FG002|Overall Study|Physician Decision|2|||
16529809|NCT02627677|40406084|FG000|Overall Study|Withdrawal by Subject|2|||
16529810|NCT02627677|40406085|FG001|Overall Study|Withdrawal by Subject|1|||
16529811|NCT02627677|40406086|FG002|Overall Study|Withdrawal by Subject|1|||
16529812|NCT02627677|40406084|FG000|Overall Study|Reason not Specified|0|||
16529813|NCT02627677|40406085|FG001|Overall Study|Reason not Specified|0|||
16529814|NCT02627677|40406086|FG002|Overall Study|Reason not Specified|1|||
16529815|NCT02627677|40406084|FG000|Overall Study|Randomized but not Treated|1|||
16529816|NCT02627677|40406085|FG001|Overall Study|Randomized but not Treated|0|||
16529817|NCT02627677|40406086|FG002|Overall Study|Randomized but not Treated|0|||
16529818|NCT00659269|40406088|FG000|Overall Study|Physician Decision|1|||
16400978|NCT04187144|39948445|FG000|Overall Study|Adverse Event|19|||
16400979|NCT04187144|39948446|FG001|Overall Study|Adverse Event|4|||
16529819|NCT00659269|40406089|FG001|Overall Study|Physician Decision|1|||
16529820|NCT02959437|40406090|FG000|Overall Study|Death|33|||
16529821|NCT02959437|40406091|FG001|Overall Study|Death|3|||
16529822|NCT02959437|40406092|FG002|Overall Study|Death|0|||
16400980|NCT04187144|39948445|FG000|Overall Study|Physician Decision|5|||
16400981|NCT04187144|39948446|FG001|Overall Study|Physician Decision|3|||
16400982|NCT04187144|39948445|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
16400983|NCT04187144|39948446|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
16400984|NCT04187144|39948445|FG000|Overall Study|Protocol Deviation|1|||
16400985|NCT04187144|39948446|FG001|Overall Study|Protocol Deviation|4|||
16400986|NCT04225676|39948449|FG000|Overall Study|Physician Decision|1|||
16400987|NCT04225676|39948449|FG000|Overall Study|Lack of Efficacy|1|||
16400988|NCT04225676|39948449|FG000|Overall Study|Study terminated by sponsor|3|||
16400989|NCT04776720|39948450|FG000|Overall Study|COVID Related|4|||
16400990|NCT04776720|39948451|FG001|Overall Study|COVID Related|2|||
16400991|NCT04776720|39948450|FG000|Overall Study|Adverse Event|2|||
16400992|NCT04776720|39948451|FG001|Overall Study|Adverse Event|0|||
16400993|NCT04776720|39948450|FG000|Overall Study|Serious Adverse Event|0|||
16400994|NCT04776720|39948451|FG001|Overall Study|Serious Adverse Event|1|||
16400995|NCT04776720|39948450|FG000|Overall Study|Too Busy|3|||
16400996|NCT04776720|39948451|FG001|Overall Study|Too Busy|1|||
16529823|NCT02959437|40406093|FG003|Overall Study|Death|0|||
16529824|NCT02959437|40406090|FG000|Overall Study|Lost to Follow-up|3|||
16529825|NCT02959437|40406091|FG001|Overall Study|Lost to Follow-up|1|||
16529826|NCT02959437|40406092|FG002|Overall Study|Lost to Follow-up|0|||
16529827|NCT02959437|40406093|FG003|Overall Study|Lost to Follow-up|0|||
16529828|NCT02959437|40406090|FG000|Overall Study|Withdrawal by Subject|11|||
16529829|NCT02959437|40406091|FG001|Overall Study|Withdrawal by Subject|3|||
16529830|NCT02959437|40406092|FG002|Overall Study|Withdrawal by Subject|0|||
16529831|NCT02959437|40406093|FG003|Overall Study|Withdrawal by Subject|0|||
16529832|NCT02959437|40406090|FG000|Overall Study|Progressive Disease|9|||
16098513|NCT01358175|38849770|FG000|Overall Study|Lost to Follow-up|1|||
16529833|NCT02959437|40406091|FG001|Overall Study|Progressive Disease|1|||
16529834|NCT02959437|40406092|FG002|Overall Study|Progressive Disease|0|||
16529835|NCT02959437|40406093|FG003|Overall Study|Progressive Disease|0|||
16529836|NCT02959437|40406090|FG000|Overall Study|Study Terminated by Sponsor|4|||
16529837|NCT02959437|40406091|FG001|Overall Study|Study Terminated by Sponsor|0|||
16529838|NCT02959437|40406092|FG002|Overall Study|Study Terminated by Sponsor|0|||
16529839|NCT02959437|40406093|FG003|Overall Study|Study Terminated by Sponsor|0|||
16529840|NCT02959437|40406090|FG000|Overall Study|Other Unspecified|2|||
16529841|NCT02959437|40406091|FG001|Overall Study|Other Unspecified|0|||
16529842|NCT02959437|40406092|FG002|Overall Study|Other Unspecified|0|||
16529843|NCT02959437|40406093|FG003|Overall Study|Other Unspecified|0|||
16529844|NCT03449030|40406098|FG000|Overall Study|Withdrawal by Subject|0|||
16529845|NCT03449030|40406099|FG001|Overall Study|Withdrawal by Subject|0|||
16529846|NCT03449030|40406100|FG002|Overall Study|Withdrawal by Subject|0|||
16529847|NCT03449030|40406101|FG003|Overall Study|Withdrawal by Subject|1|||
16529848|NCT03449030|40406102|FG004|Overall Study|Withdrawal by Subject|1|||
16529849|NCT03449030|40406103|FG005|Overall Study|Withdrawal by Subject|1|||
16529850|NCT03449030|40406104|FG006|Overall Study|Withdrawal by Subject|1|||
16529851|NCT03449030|40406105|FG007|Overall Study|Withdrawal by Subject|2|||
16529852|NCT03449030|40406106|FG008|Overall Study|Withdrawal by Subject|0|||
16529853|NCT03449030|40406107|FG009|Overall Study|Withdrawal by Subject|0|||
16529854|NCT03449030|40406098|FG000|Overall Study|Symptomatic Deterioration|0|||
16529855|NCT03449030|40406099|FG001|Overall Study|Symptomatic Deterioration|1|||
16529856|NCT03449030|40406100|FG002|Overall Study|Symptomatic Deterioration|0|||
16098514|NCT01358175|38849771|FG001|Overall Study|Lost to Follow-up|1|||
16098515|NCT01358175|38849772|FG002|Overall Study|Lost to Follow-up|3|||
16098516|NCT01358175|38849770|FG000|Overall Study|Lack of Efficacy|3|||
16098517|NCT01358175|38849771|FG001|Overall Study|Lack of Efficacy|8|||
16098518|NCT01358175|38849772|FG002|Overall Study|Lack of Efficacy|6|||
16098519|NCT01358175|38849770|FG000|Overall Study|Adverse Event|6|||
16098520|NCT01358175|38849771|FG001|Overall Study|Adverse Event|11|||
16098521|NCT01358175|38849772|FG002|Overall Study|Adverse Event|11|||
16098522|NCT03030599|38849773|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
16098523|NCT03030599|38849774|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
16098524|NCT03030599|38849775|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
16098525|NCT03030599|38849773|FG000|Open Label Treatment and Titration|Other|1|||
16098526|NCT03030599|38849774|FG001|Open Label Treatment and Titration|Other|0|||
16098527|NCT03030599|38849775|FG002|Open Label Treatment and Titration|Other|0|||
16098528|NCT03030599|38849773|FG000|Open Label Treatment and Titration|Physician Decision|3|||
16098529|NCT03030599|38849774|FG001|Open Label Treatment and Titration|Physician Decision|0|||
16212882|NCT01642004|39258836|FG001|Randomization|Adverse Event unrelated to study drug|0|||
16212883|NCT01642004|39258835|FG000|Randomization|Participant withdrew consent|1|||
16212884|NCT01642004|39258836|FG001|Randomization|Participant withdrew consent|6|||
16212885|NCT01642004|39258835|FG000|Randomization|No longer meets study criteria|2|||
16331574|NCT03436199|39700017|FG001|Overall Study|Protocol Violation|1|||
16331575|NCT03436199|39700018|FG002|Overall Study|Protocol Violation|0|||
16331576|NCT03436199|39700016|FG000|Overall Study|Physician Decision|0|||
16331577|NCT03436199|39700017|FG001|Overall Study|Physician Decision|1|||
16331578|NCT03436199|39700018|FG002|Overall Study|Physician Decision|0|||
16331579|NCT03436199|39700016|FG000|Overall Study|Could not return to clinic|1|||
16331580|NCT03436199|39700017|FG001|Overall Study|Could not return to clinic|0|||
16331581|NCT03436199|39700018|FG002|Overall Study|Could not return to clinic|0|||
16331582|NCT03436199|39700016|FG000|Overall Study|Withdrawn per physician|0|||
16331583|NCT03436199|39700017|FG001|Overall Study|Withdrawn per physician|1|||
16529857|NCT03449030|40406101|FG003|Overall Study|Symptomatic Deterioration|0|||
16529858|NCT03449030|40406102|FG004|Overall Study|Symptomatic Deterioration|0|||
16529859|NCT03449030|40406103|FG005|Overall Study|Symptomatic Deterioration|1|||
16529860|NCT03449030|40406104|FG006|Overall Study|Symptomatic Deterioration|1|||
16529861|NCT03449030|40406105|FG007|Overall Study|Symptomatic Deterioration|0|||
16529862|NCT03449030|40406106|FG008|Overall Study|Symptomatic Deterioration|2|||
16529863|NCT03449030|40406107|FG009|Overall Study|Symptomatic Deterioration|0|||
16529864|NCT03449030|40406098|FG000|Overall Study|Progressive Disease|1|||
16529865|NCT03449030|40406099|FG001|Overall Study|Progressive Disease|0|||
16529866|NCT03449030|40406100|FG002|Overall Study|Progressive Disease|1|||
16098530|NCT03030599|38849775|FG002|Open Label Treatment and Titration|Physician Decision|0|||
16098531|NCT03030599|38849773|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
16212886|NCT01642004|39258836|FG001|Randomization|No longer meets study criteria|2|||
16212887|NCT01642004|39258835|FG000|Treatment|Disease progression|95|||
16212888|NCT01642004|39258836|FG001|Treatment|Disease progression|79|||
16212889|NCT01642004|39258835|FG000|Treatment|Study drug toxicity|10|||
16212890|NCT01642004|39258836|FG001|Treatment|Study drug toxicity|13|||
16212891|NCT01642004|39258835|FG000|Treatment|Death|1|||
16212892|NCT01642004|39258836|FG001|Treatment|Death|1|||
16212893|NCT01642004|39258835|FG000|Treatment|Adverse event unrelated to study drug|9|||
16212894|NCT01642004|39258836|FG001|Treatment|Adverse event unrelated to study drug|13|||
16212895|NCT01642004|39258835|FG000|Treatment|Maximum clinical benefit|1|||
16212896|NCT01642004|39258836|FG001|Treatment|Maximum clinical benefit|9|||
16212897|NCT01642004|39258835|FG000|Treatment|Poor/non-compliance|1|||
16212898|NCT01642004|39258836|FG001|Treatment|Poor/non-compliance|0|||
16212899|NCT01642004|39258835|FG000|Treatment|No longer meets study criteria|1|||
16212900|NCT01642004|39258836|FG001|Treatment|No longer meets study criteria|2|||
16212901|NCT01642004|39258835|FG000|Treatment|Other reasons|2|||
16212902|NCT01642004|39258836|FG001|Treatment|Other reasons|0|||
16212903|NCT01642004|39258835|FG000|Treatment|Not reported|0|||
16212904|NCT01642004|39258836|FG001|Treatment|Not reported|3|||
16212905|NCT01642004|39258835|FG000|Treatment|Participant request to discontinue study treatment|6|||
16212906|NCT01642004|39258836|FG001|Treatment|Participant request to discontinue study treatment|4|||
16212907|NCT01642004|39258835|FG000|Treatment|Participant withdrew consent|5|||
16212908|NCT01642004|39258836|FG001|Treatment|Participant withdrew consent|5|||
16212909|NCT00796224|39258839|FG000|Overall Study|Adverse Event|1|||
16212910|NCT00796224|39258840|FG001|Overall Study|Adverse Event|0|||
16212911|NCT00796224|39258839|FG000|Overall Study|Protocol Violation|0|||
16212912|NCT00796224|39258840|FG001|Overall Study|Protocol Violation|1|||
16212913|NCT03344562|39258842|FG000|Overall Study|Withdrawal by Subject|2|||
16212914|NCT03344562|39258843|FG001|Overall Study|Withdrawal by Subject|0|||
16212915|NCT01347840|39258846|FG000|Overall Study|Withdrawal by Subject|1|||
16212916|NCT03325010|39258847|FG000|Overall Study|Adverse Event|3|||
16212917|NCT03325010|39258848|FG001|Overall Study|Adverse Event|8|||
16212918|NCT03325010|39258847|FG000|Overall Study|Protocol Violation|1|||
16212919|NCT03325010|39258848|FG001|Overall Study|Protocol Violation|8|||
16212920|NCT03325010|39258847|FG000|Overall Study|Withdrawal by Subject|1|||
16212921|NCT03325010|39258848|FG001|Overall Study|Withdrawal by Subject|3|||
16212922|NCT03325010|39258847|FG000|Overall Study|Lost to Follow-up|1|||
16212923|NCT03325010|39258848|FG001|Overall Study|Lost to Follow-up|0|||
16331584|NCT03436199|39700018|FG002|Overall Study|Withdrawn per physician|0|||
16331585|NCT00387010|39700019|FG000|Dose Titration Period|Adverse Event|12|||
16331586|NCT00387010|39700019|FG000|Dose Titration Period|Lack of Efficacy|5|||
16331587|NCT00387010|39700019|FG000|Dose Titration Period|Withdrawal by Subject|3|||
16529867|NCT03449030|40406101|FG003|Overall Study|Progressive Disease|4|||
16529868|NCT03449030|40406102|FG004|Overall Study|Progressive Disease|5|||
16529869|NCT03449030|40406103|FG005|Overall Study|Progressive Disease|3|||
16529870|NCT03449030|40406104|FG006|Overall Study|Progressive Disease|0|||
16529871|NCT03449030|40406105|FG007|Overall Study|Progressive Disease|1|||
16529872|NCT03449030|40406106|FG008|Overall Study|Progressive Disease|1|||
16529873|NCT03449030|40406107|FG009|Overall Study|Progressive Disease|1|||
16529874|NCT03449030|40406098|FG000|Overall Study|Adverse Event|0|||
16529875|NCT03449030|40406099|FG001|Overall Study|Adverse Event|0|||
16529876|NCT03449030|40406100|FG002|Overall Study|Adverse Event|0|||
16212924|NCT03325010|39258847|FG000|Overall Study|Physician Decision|1|||
16529877|NCT03449030|40406101|FG003|Overall Study|Adverse Event|0|||
16529878|NCT03449030|40406102|FG004|Overall Study|Adverse Event|0|||
16529879|NCT03449030|40406103|FG005|Overall Study|Adverse Event|2|||
16529880|NCT03449030|40406104|FG006|Overall Study|Adverse Event|0|||
16529881|NCT03449030|40406105|FG007|Overall Study|Adverse Event|0|||
16529882|NCT03449030|40406106|FG008|Overall Study|Adverse Event|0|||
16529883|NCT03449030|40406107|FG009|Overall Study|Adverse Event|0|||
16529884|NCT03449030|40406098|FG000|Overall Study|Death|0|||
16529885|NCT03449030|40406099|FG001|Overall Study|Death|0|||
16529886|NCT03449030|40406100|FG002|Overall Study|Death|0|||
16212925|NCT03325010|39258848|FG001|Overall Study|Physician Decision|1|||
16212926|NCT03325010|39258847|FG000|Overall Study|Lack of Efficacy|2|||
16212927|NCT03325010|39258848|FG001|Overall Study|Lack of Efficacy|0|||
16212928|NCT00126672|39258849|FG000|Overall Study|Adverse Event|4|||
16212929|NCT00126672|39258849|FG000|Overall Study|Lost to Follow-up|4|||
16212930|NCT01611298|39258853|FG000|Overall Study|Relapsed|2|||
16212931|NCT00592072|39258854|FG000|Wash Out Period|Lost to Follow-up|1|||
16212932|NCT00592072|39258855|FG001|Wash Out Period|Lost to Follow-up|1|||
16212933|NCT01305941|39258857|FG000|Overall Study|Adverse Event|6|||
16212934|NCT01305941|39258857|FG000|Overall Study|Clinical decline|2|||
16212935|NCT01305941|39258857|FG000|Overall Study|Withdrawal by Subject|1|||
16529887|NCT03449030|40406101|FG003|Overall Study|Death|0|||
16212936|NCT01305941|39258857|FG000|Overall Study|Death|1|||
16212937|NCT02691468|39258858|FG000|Overall Study|Bronchial blocker use|2|||
16212938|NCT02691468|39258859|FG001|Overall Study|Bronchial blocker use|1|||
16212939|NCT02691468|39258858|FG000|Overall Study|Lost to Follow-up|2|||
16212940|NCT02691468|39258859|FG001|Overall Study|Lost to Follow-up|1|||
16212941|NCT02691468|39258858|FG000|Overall Study|Failure to advance FOB|2|||
16212942|NCT02691468|39258859|FG001|Overall Study|Failure to advance FOB|0|||
16212943|NCT01474889|39258861|FG000|Overall Study|Physician Decision|1|||
16212944|NCT01474889|39258862|FG001|Overall Study|Physician Decision|0|||
16212945|NCT01474889|39258863|FG002|Overall Study|Physician Decision|0|||
16212946|NCT01474889|39258861|FG000|Overall Study|Did not meet inclusion|1|||
16212947|NCT01474889|39258862|FG001|Overall Study|Did not meet inclusion|0|||
16212948|NCT01474889|39258863|FG002|Overall Study|Did not meet inclusion|0|||
16212949|NCT01474889|39258861|FG000|Overall Study|Withdrawal by Subject|0|||
16212950|NCT01474889|39258862|FG001|Overall Study|Withdrawal by Subject|1|||
16212951|NCT01474889|39258863|FG002|Overall Study|Withdrawal by Subject|0|||
16212952|NCT01974440|39258864|FG000|Overall Study|Lost to Follow-up|7|||
16212953|NCT01974440|39258865|FG001|Overall Study|Lost to Follow-up|7|||
16098532|NCT03030599|38849774|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
16098533|NCT03030599|38849775|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
16098534|NCT03030599|38849773|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
16098535|NCT03030599|38849774|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
16098536|NCT03030599|38849775|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
16098537|NCT03030599|38849773|FG000|Open Label Treatment and Titration|Adverse Event|18|||
16098538|NCT03030599|38849774|FG001|Open Label Treatment and Titration|Adverse Event|0|||
16098539|NCT03030599|38849775|FG002|Open Label Treatment and Titration|Adverse Event|0|||
16098540|NCT03030599|38849773|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
16098541|NCT03030599|38849774|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
16098542|NCT03030599|38849775|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
16098543|NCT03030599|38849773|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
16098544|NCT03030599|38849774|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
16098545|NCT03030599|38849775|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
16098546|NCT03030599|38849773|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
16098547|NCT03030599|38849774|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
16098548|NCT03030599|38849775|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
16098549|NCT03030599|38849773|FG000|Stable Dose|Protocol deviation|3|||
16098550|NCT03030599|38849774|FG001|Stable Dose|Protocol deviation|0|||
16098551|NCT03030599|38849775|FG002|Stable Dose|Protocol deviation|0|||
16098552|NCT03030599|38849773|FG000|Stable Dose|Adverse Event|1|||
16098553|NCT03030599|38849774|FG001|Stable Dose|Adverse Event|0|||
16098554|NCT03030599|38849775|FG002|Stable Dose|Adverse Event|0|||
16098555|NCT03030599|38849773|FG000|Stable Dose|Lost to Follow-up|1|||
16212954|NCT01974440|39258864|FG000|Overall Study|Withdrawal by Subject|24|||
16212955|NCT01974440|39258865|FG001|Overall Study|Withdrawal by Subject|20|||
16212956|NCT01974440|39258864|FG000|Overall Study|Sponsor decision|109|||
16212957|NCT01974440|39258865|FG001|Overall Study|Sponsor decision|110|||
16212958|NCT01600105|39258866|FG000|Total Participants|Withdrawal by Subject|1|||
16529888|NCT03449030|40406102|FG004|Overall Study|Death|1|||
16529889|NCT03449030|40406103|FG005|Overall Study|Death|0|||
16529890|NCT03449030|40406104|FG006|Overall Study|Death|0|||
16529891|NCT03449030|40406105|FG007|Overall Study|Death|0|||
16529892|NCT03449030|40406106|FG008|Overall Study|Death|0|||
16529893|NCT03449030|40406107|FG009|Overall Study|Death|0|||
16529894|NCT02707055|40406110|FG000|Phase 1|Withdrawal by Subject|1|||
16529895|NCT02707055|40406111|FG001|Phase 1|Withdrawal by Subject|2|||
16529896|NCT02707055|40406110|FG000|Phase 1|Physician Decision|0|||
16529897|NCT02707055|40406111|FG001|Phase 1|Physician Decision|1|||
16529898|NCT02707055|40406110|FG000|Phase 2|Adverse Event|1|||
16529899|NCT02707055|40406111|FG001|Phase 2|Adverse Event|2|||
16529900|NCT01221597|40406112|FG000|Overall Study|Adverse Event|4|||
16529901|NCT01221597|40406113|FG001|Overall Study|Adverse Event|1|||
16529902|NCT01221597|40406112|FG000|Overall Study|Withdrawal by Subject|20|||
16098556|NCT03030599|38849774|FG001|Stable Dose|Lost to Follow-up|0|||
16098557|NCT03030599|38849775|FG002|Stable Dose|Lost to Follow-up|0|||
16098558|NCT03030599|38849773|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
16098559|NCT03030599|38849774|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
16212959|NCT01600105|39258867|FG001|Total Participants|Withdrawal by Subject|0|||
16212960|NCT01600105|39258866|FG000|Total Participants|No images in PACS|10|||
16212961|NCT01600105|39258867|FG001|Total Participants|No images in PACS|0|||
16212962|NCT01600105|39258866|FG000|Total Participants|Insufficient image quality|30|||
16212963|NCT01600105|39258867|FG001|Total Participants|Insufficient image quality|10|||
16212964|NCT01600105|39258866|FG000|Sub Study I|Insufficient image quality|0|||
16212965|NCT01600105|39258867|FG001|Sub Study I|Insufficient image quality|10|||
16212966|NCT01600105|39258866|FG000|Sub Study II|Withdrawal by Subject|1|||
16529903|NCT01221597|40406113|FG001|Overall Study|Withdrawal by Subject|6|||
16529904|NCT01221597|40406112|FG000|Overall Study|Lost to Follow-up|6|||
16529905|NCT01221597|40406113|FG001|Overall Study|Lost to Follow-up|5|||
16212967|NCT01600105|39258867|FG001|Sub Study II|Withdrawal by Subject|0|||
16212968|NCT01600105|39258866|FG000|Sub Study II|No images in PACS|1|||
16212969|NCT01600105|39258867|FG001|Sub Study II|No images in PACS|0|||
16212970|NCT01600105|39258866|FG000|Sub Study II|Insufficient image quality|3|||
16212971|NCT01600105|39258867|FG001|Sub Study II|Insufficient image quality|0|||
16212972|NCT01600105|39258866|FG000|Sub Study III|Insufficient image quality|5|||
16212973|NCT01600105|39258867|FG001|Sub Study III|Insufficient image quality|0|||
16212974|NCT01600105|39258866|FG000|Sub Study V|Poor Image Quality|2|||
16212975|NCT01600105|39258867|FG001|Sub Study V|Poor Image Quality|0|||
16212976|NCT00636155|39258873|FG000|Overall Study|Adverse Event|8|||
16212977|NCT00636155|39258873|FG000|Overall Study|Lack of Efficacy|1|||
16212978|NCT00636155|39258873|FG000|Overall Study|Withdrawal by Subject|3|||
16212979|NCT00636155|39258873|FG000|Overall Study|Stem cell transplant|1|||
16212980|NCT00636155|39258873|FG000|Overall Study|Physician Decision|5|||
16212981|NCT01387074|39258879|FG000|Overall Study|Lost to Follow-up|7|||
16212982|NCT01387074|39258879|FG000|Overall Study|Lack of Efficacy|1|||
16212983|NCT00246376|39258881|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
16212984|NCT00246376|39258882|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
16212985|NCT00246376|39258883|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
16212986|NCT00246376|39258884|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
16212987|NCT00246376|39258885|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
16212988|NCT00246376|39258881|FG000|Overall Study|Adverse Event|2|||
16529906|NCT01221597|40406112|FG000|Overall Study|Protocol Violation|1|||
16529907|NCT01221597|40406113|FG001|Overall Study|Protocol Violation|0|||
16529908|NCT01221597|40406112|FG000|Overall Study|Other|3|||
16529909|NCT01221597|40406113|FG001|Overall Study|Other|4|||
16529910|NCT01221597|40406112|FG000|Overall Study|Death|2|||
16529911|NCT01221597|40406113|FG001|Overall Study|Death|0|||
16529912|NCT04988308|40406114|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
16529913|NCT04988308|40406115|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
16212989|NCT00246376|39258882|FG001|Overall Study|Adverse Event|3|||
16212990|NCT00246376|39258883|FG002|Overall Study|Adverse Event|1|||
16212991|NCT00246376|39258884|FG003|Overall Study|Adverse Event|3|||
16212992|NCT00246376|39258885|FG004|Overall Study|Adverse Event|1|||
16212993|NCT00246376|39258881|FG000|Overall Study|Lost to Follow-up|2|||
16212994|NCT00246376|39258882|FG001|Overall Study|Lost to Follow-up|11|||
16212995|NCT00246376|39258883|FG002|Overall Study|Lost to Follow-up|11|||
16212996|NCT00246376|39258884|FG003|Overall Study|Lost to Follow-up|16|||
16212997|NCT00246376|39258885|FG004|Overall Study|Lost to Follow-up|13|||
16212998|NCT02865928|39258887|FG000|Overall Study|Withdrawal by Subject|1|||
16212999|NCT02865928|39258888|FG001|Overall Study|Withdrawal by Subject|0|||
16213000|NCT02865928|39258887|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
16213001|NCT02865928|39258888|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
16213002|NCT02865928|39258887|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
16213003|NCT02865928|39258888|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
16213004|NCT00402285|39258889|FG000|Overall Study|insufficient RNA quality|7|||
16213005|NCT00402285|39258890|FG001|Overall Study|insufficient RNA quality|6|||
16213006|NCT00402285|39258891|FG002|Overall Study|insufficient RNA quality|2|||
16213007|NCT01641081|39258892|FG000|Period 1|Sponsor request (potential unblinding)|0|||
16213008|NCT01641081|39258893|FG001|Period 1|Sponsor request (potential unblinding)|0|||
16331588|NCT00387010|39700019|FG000|Dose Titration Period|Protocol Violation|1|||
16331589|NCT00387010|39700019|FG000|Dose Titration Period|Lost to Follow-up|2|||
16331590|NCT00387010|39700019|FG000|Dose Titration Period|Noncompliance with study medication|8|||
16331591|NCT00387010|39700019|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
16331592|NCT00387010|39700019|FG000|Treatment Period|Adverse Event|4|||
16331593|NCT00387010|39700019|FG000|Treatment Period|Withdrawal by Subject|1|||
16331594|NCT00387010|39700019|FG000|Treatment Period|Noncompliance with study medication|2|||
16331595|NCT00387010|39700019|FG000|Treatment Period|Noncompliance with study procedures|3|||
16331596|NCT00387010|39700019|FG000|Treatment Period|Participant reported study drug stolen|1|||
16331597|NCT01844505|39700020|FG000|Overall Study|Disease progression|170|||
16331598|NCT01844505|39700021|FG001|Overall Study|Disease progression|88|||
16331599|NCT01844505|39700022|FG002|Overall Study|Disease progression|224|||
16331600|NCT01844505|39700020|FG000|Overall Study|Study drug toxicity|40|||
16331601|NCT01844505|39700021|FG001|Overall Study|Study drug toxicity|131|||
16331602|NCT01844505|39700022|FG002|Overall Study|Study drug toxicity|50|||
16331603|NCT01844505|39700020|FG000|Overall Study|Death|1|||
16331604|NCT01844505|39700021|FG001|Overall Study|Death|3|||
16331605|NCT01844505|39700022|FG002|Overall Study|Death|1|||
16331606|NCT01844505|39700020|FG000|Overall Study|Adverse event unrelated to study drug|7|||
16331607|NCT01844505|39700021|FG001|Overall Study|Adverse event unrelated to study drug|15|||
16331608|NCT01844505|39700022|FG002|Overall Study|Adverse event unrelated to study drug|6|||
16331609|NCT01844505|39700020|FG000|Overall Study|Subject request discontinue treatment|17|||
16213009|NCT01641081|39258894|FG002|Period 1|Sponsor request (potential unblinding)|0|||
16213010|NCT01641081|39258895|FG003|Period 1|Sponsor request (potential unblinding)|0|||
16213011|NCT01641081|39258896|FG004|Period 1|Sponsor request (potential unblinding)|0|||
16400997|NCT04776720|39948450|FG000|Overall Study|Lost to Follow-up|1|||
16400998|NCT04776720|39948451|FG001|Overall Study|Lost to Follow-up|2|||
16213012|NCT01641081|39258897|FG005|Period 1|Sponsor request (potential unblinding)|0|||
16213013|NCT01641081|39258898|FG006|Period 1|Sponsor request (potential unblinding)|1|||
16331610|NCT01844505|39700021|FG001|Overall Study|Subject request discontinue treatment|14|||
16331611|NCT01844505|39700022|FG002|Overall Study|Subject request discontinue treatment|8|||
16331612|NCT01844505|39700020|FG000|Overall Study|Withdrawal by Subject|0|||
16331613|NCT01844505|39700021|FG001|Overall Study|Withdrawal by Subject|3|||
16331614|NCT01844505|39700022|FG002|Overall Study|Withdrawal by Subject|0|||
16331615|NCT01844505|39700020|FG000|Overall Study|Lost to Follow-up|1|||
16331616|NCT01844505|39700021|FG001|Overall Study|Lost to Follow-up|0|||
16331617|NCT01844505|39700022|FG002|Overall Study|Lost to Follow-up|0|||
16331618|NCT01844505|39700020|FG000|Overall Study|Maximum clinical benefit|8|||
16331619|NCT01844505|39700021|FG001|Overall Study|Maximum clinical benefit|11|||
16331620|NCT01844505|39700022|FG002|Overall Study|Maximum clinical benefit|2|||
16331621|NCT01844505|39700020|FG000|Overall Study|Poor/non-compliance|1|||
16331622|NCT01844505|39700021|FG001|Overall Study|Poor/non-compliance|1|||
16331623|NCT01844505|39700022|FG002|Overall Study|Poor/non-compliance|1|||
16331624|NCT01844505|39700020|FG000|Overall Study|Subject no longer meets criteria|0|||
16331625|NCT01844505|39700021|FG001|Overall Study|Subject no longer meets criteria|1|||
16331626|NCT01844505|39700022|FG002|Overall Study|Subject no longer meets criteria|0|||
16331627|NCT01844505|39700020|FG000|Overall Study|Other Reasons|4|||
16331628|NCT01844505|39700021|FG001|Overall Study|Other Reasons|2|||
16331629|NCT01844505|39700022|FG002|Overall Study|Other Reasons|2|||
16331630|NCT01844505|39700020|FG000|Overall Study|Not Reported|0|||
16331631|NCT01844505|39700021|FG001|Overall Study|Not Reported|0|||
16331632|NCT01844505|39700022|FG002|Overall Study|Not Reported|1|||
16331633|NCT02143791|39700024|FG000|Enrolled|Withdrawal by Subject|4|||
16331634|NCT02143791|39700024|FG000|Trial Stimulation|Lack of Efficacy|21|||
16331635|NCT02143791|39700024|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
16331636|NCT02143791|39700024|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
16331637|NCT02143791|39700024|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
16331638|NCT02143791|39700024|FG000|Any Programming (3-6 Months)|Missing Data|1|||
16331639|NCT02143791|39700024|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
16331640|NCT04829331|39700025|FG000|Overall Study|Lost to Follow-up|1|||
16331641|NCT04829331|39700026|FG001|Overall Study|Lost to Follow-up|0|||
16331642|NCT00932698|39700027|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
16331643|NCT00932698|39700028|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
16331644|NCT00932698|39700029|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
16331645|NCT00932698|39700030|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
16331646|NCT00932698|39700031|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
16331647|NCT00932698|39700032|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
16331648|NCT00932698|39700033|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
16331649|NCT00932698|39700034|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
16331650|NCT00932698|39700035|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
16331651|NCT00932698|39700036|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
16331652|NCT00932698|39700037|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
16331653|NCT00932698|39700027|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16331654|NCT00932698|39700028|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
16331655|NCT00932698|39700029|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16331656|NCT00932698|39700030|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
16331657|NCT00932698|39700031|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16331658|NCT00932698|39700032|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
16331659|NCT00932698|39700033|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
16331660|NCT00932698|39700034|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16331661|NCT00932698|39700035|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16331662|NCT00932698|39700036|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16098560|NCT03030599|38849775|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
16098561|NCT03030599|38849773|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
16098562|NCT03030599|38849774|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
16098563|NCT03030599|38849775|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
16098564|NCT03030599|38849773|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
16098565|NCT03030599|38849774|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
16098566|NCT03030599|38849775|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
16098567|NCT03030599|38849773|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
16098568|NCT03030599|38849774|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
16098569|NCT03030599|38849775|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
16098570|NCT03030599|38849773|FG000|Open-label Extension|Adverse Event|3|||
16098571|NCT03030599|38849774|FG001|Open-label Extension|Adverse Event|0|||
16098572|NCT03030599|38849775|FG002|Open-label Extension|Adverse Event|0|||
16098573|NCT03030599|38849773|FG000|Open-label Extension|Lost to Follow-up|2|||
16331663|NCT00932698|39700037|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
16098574|NCT03030599|38849774|FG001|Open-label Extension|Lost to Follow-up|0|||
16098575|NCT03030599|38849775|FG002|Open-label Extension|Lost to Follow-up|0|||
16098576|NCT03030599|38849773|FG000|Open-label Extension|Lack of Efficacy|1|||
16098577|NCT03030599|38849774|FG001|Open-label Extension|Lack of Efficacy|0|||
16098578|NCT03030599|38849775|FG002|Open-label Extension|Lack of Efficacy|0|||
16098579|NCT03030599|38849773|FG000|Open-label Extension|Other Reason|1|||
16098580|NCT03030599|38849774|FG001|Open-label Extension|Other Reason|0|||
16098581|NCT03030599|38849775|FG002|Open-label Extension|Other Reason|0|||
16098582|NCT04295499|38849776|FG000|Overall Study|moving out of state|1|||
16098583|NCT04295499|38849777|FG001|Overall Study|moving out of state|0|||
16098584|NCT04295499|38849776|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
16098585|NCT04295499|38849777|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
16098586|NCT00914732|38849778|FG000|Overall Study|Lost to Follow-up|6|||
16098587|NCT00914732|38849779|FG001|Overall Study|Lost to Follow-up|7|||
16098588|NCT00914732|38849780|FG002|Overall Study|Lost to Follow-up|9|||
16098589|NCT00914732|38849778|FG000|Overall Study|Withdrawal by Subject|3|||
16098590|NCT00914732|38849779|FG001|Overall Study|Withdrawal by Subject|0|||
16098591|NCT00914732|38849780|FG002|Overall Study|Withdrawal by Subject|2|||
16098592|NCT00914732|38849778|FG000|Overall Study|Adverse Event|1|||
16098593|NCT00914732|38849779|FG001|Overall Study|Adverse Event|0|||
16098594|NCT00914732|38849780|FG002|Overall Study|Adverse Event|0|||
16098595|NCT01018992|38849785|FG000|Overall Study|Adverse Event|8|||
16098596|NCT01018992|38849786|FG001|Overall Study|Adverse Event|3|||
16098597|NCT01018992|38849785|FG000|Overall Study|Withdrawal by Subject|3|||
16098598|NCT01018992|38849786|FG001|Overall Study|Withdrawal by Subject|8|||
16098599|NCT01018992|38849785|FG000|Overall Study|Protocol Violation|0|||
16098600|NCT01018992|38849786|FG001|Overall Study|Protocol Violation|4|||
16098601|NCT01018992|38849785|FG000|Overall Study|Lost to Follow-up|5|||
16098602|NCT01018992|38849786|FG001|Overall Study|Lost to Follow-up|1|||
16098603|NCT04617847|38849793|FG000|Overall Study|Withdrawal by Subject|1|||
16098604|NCT04617847|38849794|FG001|Overall Study|Withdrawal by Subject|0|||
16098605|NCT04617847|38849793|FG000|Overall Study|Adverse Event|0|||
16098606|NCT04617847|38849794|FG001|Overall Study|Adverse Event|2|||
16098607|NCT04617847|38849793|FG000|Overall Study|Death|0|||
16098608|NCT04617847|38849794|FG001|Overall Study|Death|1|||
16331664|NCT00932698|39700027|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
16331665|NCT00932698|39700028|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
16331666|NCT00932698|39700029|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
16331667|NCT00932698|39700030|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
16331668|NCT00932698|39700031|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
16331669|NCT00932698|39700032|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
16331670|NCT00932698|39700033|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
16331671|NCT00932698|39700034|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
16331672|NCT00932698|39700035|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
16331673|NCT00932698|39700036|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
16331674|NCT00932698|39700037|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
16331675|NCT00932698|39700027|FG000|Part 1 (Dose Escalation)|Other|0|||
16331676|NCT00932698|39700028|FG001|Part 1 (Dose Escalation)|Other|0|||
16331677|NCT00932698|39700029|FG002|Part 1 (Dose Escalation)|Other|1|||
16331678|NCT00932698|39700030|FG003|Part 1 (Dose Escalation)|Other|0|||
16331679|NCT00932698|39700031|FG004|Part 1 (Dose Escalation)|Other|0|||
16098609|NCT04617847|38849793|FG000|Overall Study|Termination of Study by Sponsor|2|||
16098610|NCT04617847|38849794|FG001|Overall Study|Termination of Study by Sponsor|21|||
16098611|NCT04267393|38849795|FG000|Randomization|Adverse Event|1|||
16098612|NCT04267393|38849796|FG001|Randomization|Adverse Event|0|||
16098613|NCT04267393|38849797|FG002|Randomization|Adverse Event|0|||
16098614|NCT04267393|38849795|FG000|Randomization|Administrative Reasons by Sponsor|0|||
16098615|NCT04267393|38849796|FG001|Randomization|Administrative Reasons by Sponsor|1|||
16098616|NCT04267393|38849797|FG002|Randomization|Administrative Reasons by Sponsor|0|||
16098617|NCT04267393|38849795|FG000|Treatment Period|Adverse Event|0|||
16098618|NCT04267393|38849796|FG001|Treatment Period|Adverse Event|2|||
16098619|NCT04267393|38849797|FG002|Treatment Period|Adverse Event|3|||
16098620|NCT04267393|38849795|FG000|Treatment Period|Participant Withdrew Consent|0|||
16098621|NCT04267393|38849796|FG001|Treatment Period|Participant Withdrew Consent|0|||
16098622|NCT04267393|38849797|FG002|Treatment Period|Participant Withdrew Consent|1|||
16098623|NCT04267393|38849795|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
16098624|NCT04267393|38849796|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
16098625|NCT04267393|38849797|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
16098626|NCT01678898|38849803|FG000|PB-102-F01|Adverse Event|0|||
16098627|NCT01678898|38849804|FG001|PB-102-F01|Adverse Event|1|||
16098628|NCT01678898|38849805|FG002|PB-102-F01|Adverse Event|0|||
16098629|NCT01678898|38849803|FG000|PB-102-F01|Physician Decision|0|||
16098630|NCT01678898|38849804|FG001|PB-102-F01|Physician Decision|1|||
16098631|NCT01678898|38849805|FG002|PB-102-F01|Physician Decision|0|||
16098632|NCT03613454|38849807|FG000|Overall Study|Protocol Violation|1|||
16098633|NCT03613454|38849808|FG001|Overall Study|Protocol Violation|0|||
16098634|NCT03613454|38849807|FG000|Overall Study|Protocol Violation|0|||
16098635|NCT03613454|38849808|FG001|Overall Study|Protocol Violation|1|||
16098636|NCT00774306|38849809|FG000|Overall Study|Adverse Event|3|||
16098637|NCT00774306|38849810|FG001|Overall Study|Adverse Event|0|||
16098638|NCT00774306|38849811|FG002|Overall Study|Adverse Event|0|||
16098639|NCT00774306|38849812|FG003|Overall Study|Adverse Event|0|||
16098640|NCT00774306|38849809|FG000|Overall Study|Protocol Violation|2|||
16098641|NCT00774306|38849810|FG001|Overall Study|Protocol Violation|0|||
16098642|NCT00774306|38849811|FG002|Overall Study|Protocol Violation|3|||
16098643|NCT00774306|38849812|FG003|Overall Study|Protocol Violation|0|||
16098644|NCT00774306|38849809|FG000|Overall Study|Withdrawal by Subject|6|||
16098645|NCT00774306|38849810|FG001|Overall Study|Withdrawal by Subject|1|||
16098646|NCT00774306|38849811|FG002|Overall Study|Withdrawal by Subject|1|||
16098647|NCT00774306|38849812|FG003|Overall Study|Withdrawal by Subject|0|||
16098648|NCT00774306|38849809|FG000|Overall Study|Lost to Follow-up|6|||
16098649|NCT00774306|38849810|FG001|Overall Study|Lost to Follow-up|0|||
16098650|NCT00774306|38849811|FG002|Overall Study|Lost to Follow-up|4|||
16098651|NCT00774306|38849812|FG003|Overall Study|Lost to Follow-up|5|||
16098652|NCT00774306|38849809|FG000|Overall Study|Death|1|||
16098653|NCT00774306|38849810|FG001|Overall Study|Death|1|||
16098654|NCT00774306|38849811|FG002|Overall Study|Death|0|||
16098655|NCT00774306|38849812|FG003|Overall Study|Death|0|||
16098656|NCT02056873|38849813|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
16098657|NCT03575572|38849821|FG000|Overall Study|Withdrawal by Subject|2|||
16098658|NCT03575572|38849821|FG000|Overall Study|Physician Decision|2|||
16098659|NCT00170950|38849822|FG000|Overall Study|Death|236|||
16098660|NCT00170950|38849823|FG001|Overall Study|Death|274|||
16098661|NCT00170950|38849822|FG000|Overall Study|Withdrawal by Subject|496|||
16098662|NCT00170950|38849823|FG001|Overall Study|Withdrawal by Subject|498|||
16098663|NCT00170950|38849822|FG000|Overall Study|Lost to Follow-up|134|||
16098664|NCT00170950|38849823|FG001|Overall Study|Lost to Follow-up|115|||
16098665|NCT00170950|38849822|FG000|Overall Study|Missing|2|||
16098666|NCT00170950|38849823|FG001|Overall Study|Missing|1|||
16098667|NCT00170950|38849822|FG000|Overall Study|Termination Data Not Recorded|17|||
16098668|NCT00170950|38849823|FG001|Overall Study|Termination Data Not Recorded|22|||
16098669|NCT00070707|38849824|FG000|Overall Study|Adverse Event|1|||
16098670|NCT00070707|38849825|FG001|Overall Study|Adverse Event|2|||
16098671|NCT00070707|38849824|FG000|Overall Study|Lack of Efficacy|4|||
16098672|NCT00070707|38849825|FG001|Overall Study|Lack of Efficacy|1|||
16098673|NCT00070707|38849824|FG000|Overall Study|Protocol Violation|8|||
16098674|NCT00070707|38849825|FG001|Overall Study|Protocol Violation|4|||
16098675|NCT00070707|38849824|FG000|Overall Study|Unrelated to Study Medication|1|||
16098676|NCT00070707|38849825|FG001|Overall Study|Unrelated to Study Medication|0|||
16098677|NCT03557307|38849826|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
16098678|NCT03557307|38849826|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
16098679|NCT03557307|38849826|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
16098680|NCT03557307|38849826|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
16098681|NCT03557307|38849826|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
16098682|NCT03557307|38849826|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
16098683|NCT03557307|38849826|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
16098684|NCT03557307|38849826|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
16331680|NCT00932698|39700032|FG005|Part 1 (Dose Escalation)|Other|0|||
16098685|NCT03557307|38849826|FG000|Period 2: Maintenance Phase|Death|3|||
16098686|NCT03557307|38849826|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
16098687|NCT03557307|38849826|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
16098688|NCT03557307|38849826|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
16098689|NCT03557307|38849826|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
16098690|NCT03557307|38849826|FG000|Period 2: Maintenance Phase|other|3|||
16098691|NCT04474691|38849829|FG000|Overall Study|Withdrawal by Subject|9|||
16098692|NCT02489799|38849830|FG000|Overall Study|Lost to Follow-up|4|||
16098693|NCT02489799|38849831|FG001|Overall Study|Lost to Follow-up|1|||
16098694|NCT02489799|38849830|FG000|Overall Study|Failure to Maintain Eligibility|4|||
16098695|NCT02489799|38849831|FG001|Overall Study|Failure to Maintain Eligibility|6|||
16098696|NCT02489799|38849830|FG000|Overall Study|Withdrawal by Subject|1|||
16098697|NCT02489799|38849831|FG001|Overall Study|Withdrawal by Subject|1|||
16098698|NCT02489799|38849830|FG000|Overall Study|Death|0|||
16098699|NCT02489799|38849831|FG001|Overall Study|Death|1|||
16098700|NCT00376259|38849834|FG000|Overall Study|Sponsor request - study termination|21|||
16098701|NCT00376259|38849835|FG001|Overall Study|Sponsor request - study termination|21|||
16098702|NCT00376259|38849834|FG000|Overall Study|Patient request|1|||
16098703|NCT00376259|38849835|FG001|Overall Study|Patient request|0|||
16098704|NCT01877720|38849836|FG000|Overall Study|Adverse Event|1|||
16098705|NCT01877720|38849837|FG001|Overall Study|Adverse Event|0|||
16098706|NCT04564027|38849838|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
16098707|NCT04564027|38849839|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
16098708|NCT04564027|38849840|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
16098709|NCT04564027|38849841|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
16098710|NCT04372186|38849844|FG000|Overall Study|Death|24|||
16098711|NCT04372186|38849845|FG001|Overall Study|Death|11|||
16098712|NCT04372186|38849844|FG000|Overall Study|Transferred to a different facility for care|0|||
16098713|NCT04372186|38849845|FG001|Overall Study|Transferred to a different facility for care|2|||
16098714|NCT00580047|38849851|FG000|Overall Study|Lost to Follow-up|1|||
16529914|NCT04988308|40406116|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
16529915|NCT04988308|40406117|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
16529916|NCT04988308|40406118|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
16529917|NCT04988308|40406119|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
16098715|NCT00580047|38849852|FG001|Overall Study|Lost to Follow-up|1|||
16098716|NCT00580047|38849853|FG002|Overall Study|Lost to Follow-up|0|||
16098717|NCT00580047|38849851|FG000|Overall Study|Withdrawal by Subject|1|||
16331681|NCT00932698|39700033|FG006|Part 1 (Dose Escalation)|Other|1|||
16331682|NCT00932698|39700034|FG007|Part 1 (Dose Escalation)|Other|0|||
16331683|NCT00932698|39700035|FG008|Part 1 (Dose Escalation)|Other|0|||
16331684|NCT00932698|39700036|FG009|Part 1 (Dose Escalation)|Other|0|||
16529918|NCT04988308|40406114|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
16529919|NCT04988308|40406115|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
16529920|NCT04988308|40406116|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
16529921|NCT04988308|40406117|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
16529922|NCT04988308|40406118|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
16529923|NCT04988308|40406119|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
16529924|NCT04988308|40406114|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
16331685|NCT00932698|39700037|FG010|Part 1 (Dose Escalation)|Other|0|||
16098718|NCT00580047|38849852|FG001|Overall Study|Withdrawal by Subject|1|||
16098719|NCT00580047|38849853|FG002|Overall Study|Withdrawal by Subject|2|||
16098720|NCT00580047|38849851|FG000|Overall Study|Withdrawal by Subject|1|||
16400999|NCT04776720|39948450|FG000|Overall Study|Family|2|||
16401000|NCT04776720|39948451|FG001|Overall Study|Family|2|||
16401001|NCT04776720|39948450|FG000|Overall Study|No remote technology access|0|||
16401002|NCT04776720|39948451|FG001|Overall Study|No remote technology access|1|||
16401003|NCT04776720|39948450|FG000|Overall Study|Withdrawal by Subject|1|||
16401004|NCT04776720|39948451|FG001|Overall Study|Withdrawal by Subject|0|||
16401005|NCT04776720|39948450|FG000|Overall Study|Cannot tolerate intervention|1|||
16401006|NCT04776720|39948451|FG001|Overall Study|Cannot tolerate intervention|0|||
16401007|NCT04776720|39948450|FG000|Overall Study|Incomplete outcome data|6|||
16401008|NCT04776720|39948451|FG001|Overall Study|Incomplete outcome data|1|||
16401009|NCT02438384|39948452|FG000|Overall Study|Lost to Follow-up|8|||
16401010|NCT02438384|39948453|FG001|Overall Study|Lost to Follow-up|6|||
16401011|NCT02438384|39948454|FG002|Overall Study|Lost to Follow-up|4|||
16401012|NCT01082874|39948455|FG000|Overall Study|Lost to Follow-up|10|||
16401013|NCT01082874|39948456|FG001|Overall Study|Lost to Follow-up|10|||
16401014|NCT01082874|39948457|FG002|Overall Study|Lost to Follow-up|6|||
16401015|NCT01082874|39948458|FG003|Overall Study|Lost to Follow-up|10|||
16401016|NCT01082874|39948455|FG000|Overall Study|Withdrawal by Subject|1|||
16401017|NCT01082874|39948456|FG001|Overall Study|Withdrawal by Subject|2|||
16401018|NCT01082874|39948457|FG002|Overall Study|Withdrawal by Subject|5|||
16401019|NCT01082874|39948458|FG003|Overall Study|Withdrawal by Subject|3|||
16401020|NCT02447250|39948459|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
16401021|NCT02447250|39948459|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
16401022|NCT02447250|39948459|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
16401023|NCT00737568|39948461|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
16401024|NCT00737568|39948462|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
16401025|NCT00737568|39948461|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
16401026|NCT00737568|39948462|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
16401027|NCT00737568|39948461|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
16401028|NCT00737568|39948462|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
16401029|NCT00737568|39948461|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
16401030|NCT00737568|39948462|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
16401031|NCT00737568|39948461|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
16401032|NCT00737568|39948462|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
16401033|NCT00737568|39948461|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
16401034|NCT00737568|39948462|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
16401035|NCT00737568|39948461|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
16401036|NCT00737568|39948462|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
16401037|NCT00737568|39948461|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
16401038|NCT00737568|39948462|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
16401039|NCT00737568|39948461|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
16401040|NCT00737568|39948462|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
16401041|NCT00176488|39948465|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
16401042|NCT00090233|39948468|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
16401043|NCT00090233|39948469|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
16401044|NCT00090233|39948468|FG000|Overall Study|Adverse Event|214|||
16401045|NCT00090233|39948469|FG001|Overall Study|Adverse Event|198|||
16401046|NCT00090233|39948468|FG000|Overall Study|Lost to Follow-up|68|||
16401047|NCT00090233|39948469|FG001|Overall Study|Lost to Follow-up|95|||
16401048|NCT00090233|39948468|FG000|Overall Study|Protocol Violation|960|||
16401049|NCT00090233|39948469|FG001|Overall Study|Protocol Violation|1022|||
16401050|NCT00090233|39948468|FG000|Overall Study|Withdrawal by Subject|182|||
16401051|NCT00090233|39948469|FG001|Overall Study|Withdrawal by Subject|211|||
16401052|NCT00090233|39948468|FG000|Overall Study|Moved|203|||
16401053|NCT00090233|39948469|FG001|Overall Study|Moved|189|||
16401054|NCT00090233|39948468|FG000|Overall Study|Other|1211|||
16401055|NCT00090233|39948469|FG001|Overall Study|Other|1160|||
16401056|NCT00090233|39948468|FG000|Overall Study|Data not available at data cut-off point|1552|||
16401057|NCT00090233|39948469|FG001|Overall Study|Data not available at data cut-off point|1563|||
16401058|NCT02003638|39948470|FG000|Overall Study|Withdrawal by Subject|1|||
16401059|NCT02003638|39948471|FG001|Overall Study|Withdrawal by Subject|0|||
16401060|NCT00564902|39948472|FG000|Overall Study|Withdrawal by Subject|0|||
16401061|NCT00564902|39948473|FG001|Overall Study|Withdrawal by Subject|3|||
16401062|NCT00564902|39948474|FG002|Overall Study|Withdrawal by Subject|4|||
16401063|NCT00564902|39948472|FG000|Overall Study|Death|1|||
16401064|NCT00564902|39948473|FG001|Overall Study|Death|1|||
16401065|NCT00564902|39948474|FG002|Overall Study|Death|0|||
16401066|NCT00882583|39948477|FG000|Overall Study|Physician Decision|1|||
16401067|NCT00882583|39948478|FG001|Overall Study|Physician Decision|0|||
16401068|NCT00882583|39948477|FG000|Overall Study|Adverse Event|0|||
16401069|NCT00882583|39948478|FG001|Overall Study|Adverse Event|1|||
16401070|NCT02379221|39948481|FG000|Overall Study|Lost to Follow-up|1|||
16401071|NCT01007435|39948486|FG000|Overall Study|Adverse Event|16|||
16401072|NCT01007435|39948487|FG001|Overall Study|Adverse Event|25|||
16401073|NCT01007435|39948488|FG002|Overall Study|Adverse Event|47|||
16401074|NCT01007435|39948489|FG003|Overall Study|Adverse Event|31|||
16401075|NCT01007435|39948486|FG000|Overall Study|Death|2|||
16401076|NCT01007435|39948487|FG001|Overall Study|Death|4|||
16401077|NCT01007435|39948488|FG002|Overall Study|Death|2|||
16401078|NCT01007435|39948489|FG003|Overall Study|Death|1|||
16401079|NCT01007435|39948486|FG000|Overall Study|Insufficient Therapeutic Response|21|||
16401080|NCT01007435|39948487|FG001|Overall Study|Insufficient Therapeutic Response|7|||
16401081|NCT01007435|39948488|FG002|Overall Study|Insufficient Therapeutic Response|2|||
16401082|NCT01007435|39948489|FG003|Overall Study|Insufficient Therapeutic Response|9|||
16401083|NCT01007435|39948486|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
16401084|NCT01007435|39948487|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
16401085|NCT01007435|39948488|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
16401086|NCT01007435|39948489|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
16401087|NCT01007435|39948486|FG000|Overall Study|Other Protocol Violation|2|||
16401088|NCT01007435|39948487|FG001|Overall Study|Other Protocol Violation|0|||
16401089|NCT01007435|39948488|FG002|Overall Study|Other Protocol Violation|1|||
16401090|NCT01007435|39948489|FG003|Overall Study|Other Protocol Violation|0|||
16401091|NCT01007435|39948486|FG000|Overall Study|Refused Treatment|13|||
16401092|NCT01007435|39948487|FG001|Overall Study|Refused Treatment|13|||
16401093|NCT01007435|39948488|FG002|Overall Study|Refused Treatment|5|||
16401094|NCT01007435|39948489|FG003|Overall Study|Refused Treatment|8|||
16401095|NCT01007435|39948486|FG000|Overall Study|Failure to Return|5|||
16401096|NCT01007435|39948487|FG001|Overall Study|Failure to Return|4|||
16401097|NCT01007435|39948488|FG002|Overall Study|Failure to Return|3|||
16401098|NCT01007435|39948489|FG003|Overall Study|Failure to Return|6|||
16401099|NCT01007435|39948486|FG000|Overall Study|Reason not Specified|1|||
16401100|NCT01007435|39948487|FG001|Overall Study|Reason not Specified|1|||
16401101|NCT01007435|39948488|FG002|Overall Study|Reason not Specified|2|||
16401102|NCT01007435|39948489|FG003|Overall Study|Reason not Specified|1|||
16401103|NCT02141633|39948490|FG000|Overall Study|Physician Decision|1|||
16401104|NCT02141633|39948491|FG001|Overall Study|Physician Decision|0|||
16401105|NCT02135029|39948492|FG000|Overall Study|Adverse Event|2|||
16401106|NCT02135029|39948493|FG001|Overall Study|Adverse Event|2|||
16401107|NCT02135029|39948494|FG002|Overall Study|Adverse Event|2|||
16401108|NCT02135029|39948492|FG000|Overall Study|Lost to Follow-up|0|||
16401109|NCT02135029|39948493|FG001|Overall Study|Lost to Follow-up|1|||
16401110|NCT02135029|39948494|FG002|Overall Study|Lost to Follow-up|0|||
16401111|NCT02135029|39948492|FG000|Overall Study|Withdrawal by Subject|2|||
16401112|NCT02135029|39948493|FG001|Overall Study|Withdrawal by Subject|0|||
16401113|NCT02135029|39948494|FG002|Overall Study|Withdrawal by Subject|1|||
16529925|NCT04988308|40406115|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
16213014|NCT01641081|39258899|FG007|Period 1|Sponsor request (potential unblinding)|0|||
16401114|NCT02135029|39948492|FG000|Overall Study|Other|0|||
16401115|NCT02135029|39948493|FG001|Overall Study|Other|1|||
16401116|NCT02135029|39948494|FG002|Overall Study|Other|0|||
16401117|NCT02135029|39948492|FG000|Overall Study|Death|0|||
16401118|NCT02135029|39948493|FG001|Overall Study|Death|1|||
16401119|NCT02135029|39948494|FG002|Overall Study|Death|0|||
16401120|NCT04049266|39948495|FG000|Overall Study|Adverse Event|16|||
16401121|NCT04049266|39948496|FG001|Overall Study|Adverse Event|9|||
16401122|NCT04049266|39948495|FG000|Overall Study|Non-compliance with study drug|0|||
16401123|NCT04049266|39948496|FG001|Overall Study|Non-compliance with study drug|3|||
16401124|NCT04049266|39948495|FG000|Overall Study|Withdrawal by Subject|6|||
16401125|NCT04049266|39948496|FG001|Overall Study|Withdrawal by Subject|10|||
16401126|NCT04049266|39948495|FG000|Overall Study|Lost to Follow-up|2|||
16529926|NCT04988308|40406116|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
16401127|NCT04049266|39948496|FG001|Overall Study|Lost to Follow-up|2|||
16401128|NCT04049266|39948495|FG000|Overall Study|Progressive disease|11|||
16401129|NCT04049266|39948496|FG001|Overall Study|Progressive disease|2|||
16401130|NCT04049266|39948495|FG000|Overall Study|Physician Decision|1|||
16401131|NCT04049266|39948496|FG001|Overall Study|Physician Decision|0|||
16098721|NCT00580047|38849852|FG001|Overall Study|Withdrawal by Subject|0|||
16098722|NCT00580047|38849853|FG002|Overall Study|Withdrawal by Subject|0|||
16098723|NCT00919061|38849855|FG000|Overall Study|Adverse Event|1|||
16331686|NCT00932698|39700027|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
16331687|NCT00932698|39700028|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
16331688|NCT00932698|39700029|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
16331689|NCT00932698|39700030|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
16331690|NCT00932698|39700031|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
16331691|NCT00932698|39700032|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
16331692|NCT00932698|39700033|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
16331693|NCT00932698|39700034|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
16331694|NCT00932698|39700035|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
16331695|NCT00932698|39700036|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
16331696|NCT00932698|39700037|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
16331697|NCT00932698|39700027|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16331698|NCT00932698|39700028|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16331699|NCT00932698|39700029|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16331700|NCT00932698|39700030|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16331701|NCT00932698|39700031|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16331702|NCT00932698|39700032|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16331703|NCT00932698|39700033|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16331704|NCT00932698|39700034|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
16331705|NCT00932698|39700035|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
16331706|NCT00932698|39700036|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
16331707|NCT00932698|39700037|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
16331708|NCT00932698|39700027|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
16331709|NCT00932698|39700028|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
16331710|NCT00932698|39700029|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
16331711|NCT00932698|39700030|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
16331712|NCT00932698|39700031|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
16331713|NCT00932698|39700032|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
16331714|NCT00932698|39700033|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
16331715|NCT00932698|39700034|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
16331716|NCT00932698|39700035|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
16331717|NCT00932698|39700036|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
16331718|NCT00932698|39700037|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
16331719|NCT00157820|39700038|FG000|Randomized|Physician Decision|4|||
16331720|NCT00157820|39700039|FG001|Randomized|Physician Decision|2|||
16331721|NCT00157820|39700040|FG002|Randomized|Physician Decision|3|||
16331722|NCT00157820|39700038|FG000|Randomized|Withdrawal by Subject|1|||
16331723|NCT00157820|39700039|FG001|Randomized|Withdrawal by Subject|2|||
16331724|NCT00157820|39700040|FG002|Randomized|Withdrawal by Subject|3|||
16331725|NCT00157820|39700038|FG000|Randomized|Protocol Violation|2|||
16098724|NCT00919061|38849855|FG000|Overall Study|Withdrawal by Subject|1|||
16111464|NCT00760747|38897274|FG000|Study Period II|No drug administered|0|||
16401132|NCT04049266|39948495|FG000|Overall Study|Patient moved out of state|1|||
16529927|NCT04988308|40406117|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
16529928|NCT04988308|40406118|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
16529929|NCT04988308|40406119|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
16529930|NCT04988308|40406114|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
16529931|NCT04988308|40406115|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
16529932|NCT04988308|40406116|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
16529933|NCT04988308|40406117|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
16529934|NCT04988308|40406118|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
16529935|NCT04988308|40406119|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
16529936|NCT04988308|40406114|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
16529937|NCT04988308|40406115|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
16529938|NCT04988308|40406116|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
16529939|NCT04988308|40406117|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
16529940|NCT04988308|40406118|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
16529941|NCT04988308|40406119|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
16529942|NCT04988308|40406114|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
16529943|NCT04988308|40406115|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
16529944|NCT04988308|40406116|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
16529945|NCT04988308|40406117|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
16529946|NCT04988308|40406118|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
16529947|NCT04988308|40406119|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
16529948|NCT04988308|40406114|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
16529949|NCT04988308|40406115|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
16529950|NCT04988308|40406116|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
16529951|NCT04988308|40406117|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
16529952|NCT04988308|40406118|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
16529953|NCT04988308|40406119|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
16529954|NCT04988308|40406114|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
16529955|NCT04988308|40406115|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
16529956|NCT04988308|40406116|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
16529957|NCT04988308|40406117|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
16529958|NCT04988308|40406118|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
16529959|NCT04988308|40406119|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
16529960|NCT04988308|40406114|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
16331726|NCT00157820|39700039|FG001|Randomized|Protocol Violation|1|||
16529961|NCT04988308|40406115|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
16529962|NCT04988308|40406116|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
16529963|NCT04988308|40406117|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
16529964|NCT04988308|40406118|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
16529965|NCT04988308|40406119|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
16529966|NCT02014116|40406120|FG000|Overall Study|Progressive Disease|3|||
16529967|NCT02014116|40406121|FG001|Overall Study|Progressive Disease|4|||
16529968|NCT02014116|40406122|FG002|Overall Study|Progressive Disease|2|||
16529969|NCT02014116|40406123|FG003|Overall Study|Progressive Disease|6|||
16529970|NCT02014116|40406124|FG004|Overall Study|Progressive Disease|1|||
16529971|NCT02014116|40406125|FG005|Overall Study|Progressive Disease|13|||
16529972|NCT02014116|40406126|FG006|Overall Study|Progressive Disease|1|||
16331727|NCT00157820|39700040|FG002|Randomized|Protocol Violation|2|||
16331728|NCT00157820|39700038|FG000|1st 8 Month|Death|7|||
16331729|NCT00157820|39700039|FG001|1st 8 Month|Death|8|||
16331730|NCT00157820|39700040|FG002|1st 8 Month|Death|3|||
16331731|NCT00157820|39700038|FG000|1st 8 Month|Lost to Follow-up|1|||
16331732|NCT00157820|39700039|FG001|1st 8 Month|Lost to Follow-up|2|||
16331733|NCT00157820|39700040|FG002|1st 8 Month|Lost to Follow-up|1|||
16331734|NCT00157820|39700038|FG000|1st 8 Month|Premature cross-over|0|||
16331735|NCT00157820|39700039|FG001|1st 8 Month|Premature cross-over|2|||
16331736|NCT00157820|39700040|FG002|1st 8 Month|Premature cross-over|2|||
16331737|NCT00157820|39700038|FG000|2nd 8 Months|Death|3|||
16331738|NCT00157820|39700039|FG001|2nd 8 Months|Death|1|||
16331739|NCT00157820|39700040|FG002|2nd 8 Months|Death|3|||
16331740|NCT00157820|39700038|FG000|2nd 8 Months|Lost to Follow-up|1|||
16331741|NCT00157820|39700039|FG001|2nd 8 Months|Lost to Follow-up|5|||
16331742|NCT00157820|39700040|FG002|2nd 8 Months|Lost to Follow-up|2|||
16331743|NCT00157820|39700038|FG000|2nd 8 Months|Premature cross-over|1|||
16331744|NCT00157820|39700039|FG001|2nd 8 Months|Premature cross-over|7|||
16331745|NCT00157820|39700040|FG002|2nd 8 Months|Premature cross-over|9|||
16331746|NCT02609724|39700041|FG000|Overall Study|Death|2|||
16331747|NCT02609724|39700042|FG001|Overall Study|Death|0|||
16331748|NCT02609724|39700043|FG002|Overall Study|Death|1|||
16331749|NCT02609724|39700041|FG000|Overall Study|Withdrawal by Subject|1|||
16529973|NCT02014116|40406127|FG007|Overall Study|Progressive Disease|3|||
16529974|NCT02014116|40406128|FG008|Overall Study|Progressive Disease|7|||
16529975|NCT02014116|40406120|FG000|Overall Study|Adverse Event|0|||
16529976|NCT02014116|40406121|FG001|Overall Study|Adverse Event|0|||
16529977|NCT02014116|40406122|FG002|Overall Study|Adverse Event|0|||
16529978|NCT02014116|40406123|FG003|Overall Study|Adverse Event|0|||
16529979|NCT02014116|40406124|FG004|Overall Study|Adverse Event|1|||
16529980|NCT02014116|40406125|FG005|Overall Study|Adverse Event|0|||
16529981|NCT02014116|40406126|FG006|Overall Study|Adverse Event|0|||
16529982|NCT02014116|40406127|FG007|Overall Study|Adverse Event|1|||
16529983|NCT02014116|40406128|FG008|Overall Study|Adverse Event|0|||
16529984|NCT02014116|40406120|FG000|Overall Study|Lost to Follow-up|0|||
16529985|NCT02014116|40406121|FG001|Overall Study|Lost to Follow-up|0|||
16529986|NCT02014116|40406122|FG002|Overall Study|Lost to Follow-up|0|||
16529987|NCT02014116|40406123|FG003|Overall Study|Lost to Follow-up|0|||
16529988|NCT02014116|40406124|FG004|Overall Study|Lost to Follow-up|0|||
16529989|NCT02014116|40406125|FG005|Overall Study|Lost to Follow-up|1|||
16529990|NCT02014116|40406126|FG006|Overall Study|Lost to Follow-up|0|||
16529991|NCT02014116|40406127|FG007|Overall Study|Lost to Follow-up|0|||
16529992|NCT02014116|40406128|FG008|Overall Study|Lost to Follow-up|1|||
16529993|NCT02014116|40406120|FG000|Overall Study|Death|0|||
16529994|NCT02014116|40406121|FG001|Overall Study|Death|0|||
16529995|NCT02014116|40406122|FG002|Overall Study|Death|0|||
16529996|NCT02014116|40406123|FG003|Overall Study|Death|0|||
16529997|NCT02014116|40406124|FG004|Overall Study|Death|0|||
16529998|NCT02014116|40406125|FG005|Overall Study|Death|0|||
16529999|NCT02014116|40406126|FG006|Overall Study|Death|0|||
16530000|NCT02014116|40406127|FG007|Overall Study|Death|1|||
16530001|NCT02014116|40406128|FG008|Overall Study|Death|1|||
16530002|NCT02014116|40406120|FG000|Overall Study|Withdrawal by Subject|0|||
16530003|NCT02014116|40406121|FG001|Overall Study|Withdrawal by Subject|0|||
16530004|NCT02014116|40406122|FG002|Overall Study|Withdrawal by Subject|1|||
16530005|NCT02014116|40406123|FG003|Overall Study|Withdrawal by Subject|1|||
16530006|NCT02014116|40406124|FG004|Overall Study|Withdrawal by Subject|0|||
16530007|NCT02014116|40406125|FG005|Overall Study|Withdrawal by Subject|1|||
16530008|NCT02014116|40406126|FG006|Overall Study|Withdrawal by Subject|0|||
16530009|NCT02014116|40406127|FG007|Overall Study|Withdrawal by Subject|0|||
16530010|NCT02014116|40406128|FG008|Overall Study|Withdrawal by Subject|0|||
16530011|NCT02014116|40406120|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
16530012|NCT02014116|40406121|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
16530013|NCT02014116|40406122|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
16530014|NCT02014116|40406123|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
16530015|NCT02014116|40406124|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
16530016|NCT02014116|40406125|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
16530017|NCT02014116|40406126|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
16530018|NCT02014116|40406127|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
16530019|NCT02014116|40406128|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
16530020|NCT02014116|40406120|FG000|Overall Study|Physician Decision|0|||
16530021|NCT02014116|40406121|FG001|Overall Study|Physician Decision|0|||
16530022|NCT02014116|40406122|FG002|Overall Study|Physician Decision|0|||
16530023|NCT02014116|40406123|FG003|Overall Study|Physician Decision|0|||
16530024|NCT02014116|40406124|FG004|Overall Study|Physician Decision|0|||
16530025|NCT02014116|40406125|FG005|Overall Study|Physician Decision|0|||
16530026|NCT02014116|40406126|FG006|Overall Study|Physician Decision|0|||
16530027|NCT02014116|40406127|FG007|Overall Study|Physician Decision|0|||
16530028|NCT02014116|40406128|FG008|Overall Study|Physician Decision|1|||
16530029|NCT00727272|40406129|FG000|Washout Period A|Adverse Event|0|||
16530030|NCT00727272|40406130|FG001|Washout Period A|Adverse Event|0|||
16530031|NCT00727272|40406131|FG002|Washout Period A|Adverse Event|1|||
16530032|NCT00727272|40406129|FG000|Washout Period B|Withdrawal by Subject|0|||
16530033|NCT00727272|40406130|FG001|Washout Period B|Withdrawal by Subject|0|||
16331750|NCT02609724|39700042|FG001|Overall Study|Withdrawal by Subject|2|||
16530034|NCT00727272|40406131|FG002|Washout Period B|Withdrawal by Subject|1|||
16530035|NCT04575467|40406132|FG000|Overall Study|Adverse Event|0|||
16530036|NCT04575467|40406133|FG001|Overall Study|Adverse Event|1|||
16530037|NCT04575467|40406134|FG002|Overall Study|Adverse Event|0|||
16530038|NCT04575467|40406135|FG003|Overall Study|Adverse Event|0|||
16530039|NCT01329029|40406136|FG000|Overall Study|Withdrawal by Subject|117|||
16530040|NCT01329029|40406137|FG001|Overall Study|Withdrawal by Subject|87|||
16530041|NCT01329029|40406136|FG000|Overall Study|Adverse Event|82|||
16530042|NCT01329029|40406137|FG001|Overall Study|Adverse Event|29|||
16530043|NCT01329029|40406136|FG000|Overall Study|Death|16|||
16530044|NCT01329029|40406137|FG001|Overall Study|Death|19|||
16530045|NCT01329029|40406136|FG000|Overall Study|Other|14|||
16530046|NCT01329029|40406137|FG001|Overall Study|Other|20|||
16530047|NCT01329029|40406136|FG000|Overall Study|COPD Exacerbation|11|||
16530048|NCT01329029|40406137|FG001|Overall Study|COPD Exacerbation|18|||
16530049|NCT01329029|40406136|FG000|Overall Study|Physician Decision|16|||
16530050|NCT01329029|40406137|FG001|Overall Study|Physician Decision|13|||
16530051|NCT01329029|40406136|FG000|Overall Study|Lost to Follow-up|8|||
16530052|NCT01329029|40406137|FG001|Overall Study|Lost to Follow-up|5|||
16530053|NCT01329029|40406136|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
16530054|NCT01329029|40406137|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
16530055|NCT02363738|40406140|FG000|Overall Study|Adverse Event|5|||
16530056|NCT02363738|40406141|FG001|Overall Study|Adverse Event|2|||
16530057|NCT02363738|40406140|FG000|Overall Study|Lack of Efficacy|1|||
16530058|NCT02363738|40406141|FG001|Overall Study|Lack of Efficacy|2|||
16530059|NCT02363738|40406140|FG000|Overall Study|Lost to Follow-up|2|||
16530060|NCT02363738|40406141|FG001|Overall Study|Lost to Follow-up|1|||
16530061|NCT02691455|40406146|FG000|Overall Study|Withdrawal by Subject|1|||
16530062|NCT02691455|40406147|FG001|Overall Study|Withdrawal by Subject|2|||
16530063|NCT02691455|40406146|FG000|Overall Study|Lost to Follow-up|15|||
16530064|NCT02691455|40406147|FG001|Overall Study|Lost to Follow-up|15|||
16530065|NCT02015676|40406149|FG000|Overall Study|Adverse Event|2|||
16530066|NCT02015676|40406150|FG001|Overall Study|Adverse Event|18|||
16530067|NCT02015676|40406151|FG002|Overall Study|Adverse Event|0|||
16530068|NCT02015676|40406149|FG000|Overall Study|Lack of Efficacy|2|||
16530069|NCT02015676|40406150|FG001|Overall Study|Lack of Efficacy|4|||
16530070|NCT02015676|40406151|FG002|Overall Study|Lack of Efficacy|0|||
16530071|NCT02015676|40406149|FG000|Overall Study|Protocol Violation|1|||
16530072|NCT02015676|40406150|FG001|Overall Study|Protocol Violation|0|||
16530073|NCT02015676|40406151|FG002|Overall Study|Protocol Violation|0|||
16530074|NCT02015676|40406149|FG000|Overall Study|Withdrawal by Subject|1|||
16530075|NCT02015676|40406150|FG001|Overall Study|Withdrawal by Subject|7|||
16530076|NCT02015676|40406151|FG002|Overall Study|Withdrawal by Subject|1|||
16530077|NCT02015676|40406149|FG000|Overall Study|Administrative reasons|0|||
16530078|NCT02015676|40406150|FG001|Overall Study|Administrative reasons|3|||
16530079|NCT02015676|40406151|FG002|Overall Study|Administrative reasons|1|||
16530080|NCT02015676|40406149|FG000|Overall Study|Death|0|||
16530081|NCT02015676|40406150|FG001|Overall Study|Death|1|||
16530082|NCT02015676|40406151|FG002|Overall Study|Death|0|||
16530083|NCT02015676|40406149|FG000|Overall Study|Disease progression|3|||
16530084|NCT02015676|40406150|FG001|Overall Study|Disease progression|1|||
16530085|NCT02015676|40406151|FG002|Overall Study|Disease progression|1|||
16530086|NCT03586648|40406152|FG000|Period 1|Withdrawal by Subject|0|||
16530087|NCT03586648|40406153|FG001|Period 1|Withdrawal by Subject|1|||
16530088|NCT03586648|40406152|FG000|Period 1|Lost to Follow-up|1|||
16530089|NCT03586648|40406153|FG001|Period 1|Lost to Follow-up|1|||
16530090|NCT03586648|40406152|FG000|Period 1|Adverse Event|1|||
16530091|NCT03586648|40406153|FG001|Period 1|Adverse Event|0|||
16530092|NCT03586648|40406152|FG000|Period 1|Study related symptoms or complaints|2|||
16530093|NCT03586648|40406153|FG001|Period 1|Study related symptoms or complaints|1|||
16530094|NCT03586648|40406152|FG000|Period 1|Physician Decision|0|||
16530095|NCT03586648|40406153|FG001|Period 1|Physician Decision|1|||
16530096|NCT03586648|40406152|FG000|Period 2|Adverse Event|1|||
16530097|NCT03586648|40406153|FG001|Period 2|Adverse Event|0|||
16530098|NCT02625623|40406157|FG000|Overall Study|Participants randomized but not treated|9|||
16530099|NCT02625623|40406158|FG001|Overall Study|Participants randomized but not treated|1|||
16530100|NCT00144339|40406159|FG000|Overall Study|Adverse Event|746|||
16530101|NCT00144339|40406160|FG001|Overall Study|Adverse Event|627|||
16530102|NCT00144339|40406159|FG000|Overall Study|Protocol Violation|75|||
16530103|NCT00144339|40406160|FG001|Overall Study|Protocol Violation|48|||
16530104|NCT00144339|40406159|FG000|Overall Study|Withdrawal by Subject|403|||
16530105|NCT00144339|40406160|FG001|Overall Study|Withdrawal by Subject|300|||
16530106|NCT00144339|40406159|FG000|Overall Study|Lost to Follow-up|76|||
16530107|NCT00144339|40406160|FG001|Overall Study|Lost to Follow-up|64|||
16530108|NCT00144339|40406159|FG000|Overall Study|Other|58|||
16098725|NCT03873714|38849859|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
16331751|NCT02609724|39700043|FG002|Overall Study|Withdrawal by Subject|3|||
16530109|NCT00144339|40406160|FG001|Overall Study|Other|60|||
16530110|NCT01308580|40406161|FG000|Overall Study|Lost to Follow-up|12|||
16530111|NCT01308580|40406162|FG001|Overall Study|Lost to Follow-up|7|||
16530112|NCT00121238|40406176|FG000|Overall Study|disease progression before intervention|1|||
16530113|NCT00121238|40406176|FG000|Overall Study|Protocol Violation|2|||
16530114|NCT04265755|40406179|FG000|Overall Study|Withdrawal by Subject|39|||
16098726|NCT03219216|38849860|FG000|Overall Study|Lost to Follow-up|0|||
16530115|NCT04265755|40406179|FG000|Overall Study|Decision by sponsor|2|||
16530116|NCT04265755|40406179|FG000|Overall Study|Lost to Follow-up|11|||
16530117|NCT04265755|40406179|FG000|Overall Study|Death|1|||
16530118|NCT00941603|40406180|FG000|Overall Study|Adverse Event|10|||
16530119|NCT00941603|40406181|FG001|Overall Study|Adverse Event|15|||
16530120|NCT00941603|40406182|FG002|Overall Study|Adverse Event|5|||
16530121|NCT00941603|40406183|FG003|Overall Study|Adverse Event|1|||
16530122|NCT00941603|40406184|FG004|Overall Study|Adverse Event|4|||
16098727|NCT03219216|38849861|FG001|Overall Study|Lost to Follow-up|1|||
16530123|NCT00941603|40406185|FG005|Overall Study|Adverse Event|0|||
16530124|NCT00941603|40406180|FG000|Overall Study|Lost to Follow-up|0|||
16530125|NCT00941603|40406181|FG001|Overall Study|Lost to Follow-up|0|||
16530126|NCT00941603|40406182|FG002|Overall Study|Lost to Follow-up|0|||
16213015|NCT01641081|39258900|FG008|Period 1|Sponsor request (potential unblinding)|0|||
16213016|NCT01641081|39258901|FG009|Period 1|Sponsor request (potential unblinding)|0|||
16213017|NCT01641081|39258892|FG000|Period 1|Protocol Violation|0|||
16213018|NCT01641081|39258893|FG001|Period 1|Protocol Violation|0|||
16213019|NCT01641081|39258894|FG002|Period 1|Protocol Violation|0|||
16213020|NCT01641081|39258895|FG003|Period 1|Protocol Violation|0|||
16213021|NCT01641081|39258896|FG004|Period 1|Protocol Violation|1|||
16213022|NCT01641081|39258897|FG005|Period 1|Protocol Violation|0|||
16213023|NCT01641081|39258898|FG006|Period 1|Protocol Violation|0|||
16213024|NCT01641081|39258899|FG007|Period 1|Protocol Violation|1|||
16213025|NCT01641081|39258900|FG008|Period 1|Protocol Violation|0|||
16213026|NCT01641081|39258901|FG009|Period 1|Protocol Violation|0|||
16213027|NCT01641081|39258892|FG000|Period 1|Adverse Event|1|||
16213028|NCT01641081|39258893|FG001|Period 1|Adverse Event|0|||
16213029|NCT01641081|39258894|FG002|Period 1|Adverse Event|0|||
16213030|NCT01641081|39258895|FG003|Period 1|Adverse Event|0|||
16213031|NCT01641081|39258896|FG004|Period 1|Adverse Event|0|||
16213032|NCT01641081|39258897|FG005|Period 1|Adverse Event|0|||
16213033|NCT01641081|39258898|FG006|Period 1|Adverse Event|0|||
16213034|NCT01641081|39258899|FG007|Period 1|Adverse Event|2|||
16213035|NCT01641081|39258900|FG008|Period 1|Adverse Event|0|||
16213036|NCT01641081|39258901|FG009|Period 1|Adverse Event|0|||
16213037|NCT01641081|39258892|FG000|Period 2|Adverse Event|0|||
16213038|NCT01641081|39258893|FG001|Period 2|Adverse Event|0|||
16213039|NCT01641081|39258894|FG002|Period 2|Adverse Event|0|||
16213040|NCT01641081|39258895|FG003|Period 2|Adverse Event|0|||
16213041|NCT01641081|39258896|FG004|Period 2|Adverse Event|0|||
16213042|NCT01641081|39258897|FG005|Period 2|Adverse Event|1|||
16213043|NCT01641081|39258898|FG006|Period 2|Adverse Event|0|||
16213044|NCT01641081|39258899|FG007|Period 2|Adverse Event|0|||
16213045|NCT01641081|39258900|FG008|Period 2|Adverse Event|0|||
16213046|NCT01641081|39258901|FG009|Period 2|Adverse Event|0|||
16213047|NCT01641081|39258892|FG000|Period 2|Withdrawal by Subject|0|||
16213048|NCT01641081|39258893|FG001|Period 2|Withdrawal by Subject|0|||
16213049|NCT01641081|39258894|FG002|Period 2|Withdrawal by Subject|0|||
16213050|NCT01641081|39258895|FG003|Period 2|Withdrawal by Subject|1|||
16213051|NCT01641081|39258896|FG004|Period 2|Withdrawal by Subject|0|||
16213052|NCT01641081|39258897|FG005|Period 2|Withdrawal by Subject|0|||
16213053|NCT01641081|39258898|FG006|Period 2|Withdrawal by Subject|2|||
16213054|NCT01641081|39258899|FG007|Period 2|Withdrawal by Subject|0|||
16213055|NCT01641081|39258900|FG008|Period 2|Withdrawal by Subject|0|||
16213056|NCT01641081|39258901|FG009|Period 2|Withdrawal by Subject|0|||
16213057|NCT01641081|39258892|FG000|Period 2|Protocol Violation|1|||
16213058|NCT01641081|39258893|FG001|Period 2|Protocol Violation|0|||
16213059|NCT01641081|39258894|FG002|Period 2|Protocol Violation|0|||
16213060|NCT01641081|39258895|FG003|Period 2|Protocol Violation|0|||
16213061|NCT01641081|39258896|FG004|Period 2|Protocol Violation|0|||
16213062|NCT01641081|39258897|FG005|Period 2|Protocol Violation|0|||
16213063|NCT01641081|39258898|FG006|Period 2|Protocol Violation|0|||
16213064|NCT01641081|39258899|FG007|Period 2|Protocol Violation|0|||
16331752|NCT02609724|39700041|FG000|Overall Study|Illness|2|||
16331753|NCT02609724|39700042|FG001|Overall Study|Illness|1|||
16331754|NCT02609724|39700043|FG002|Overall Study|Illness|0|||
16213065|NCT01641081|39258900|FG008|Period 2|Protocol Violation|0|||
16213066|NCT01641081|39258901|FG009|Period 2|Protocol Violation|0|||
16213067|NCT01641081|39258892|FG000|Period 3|Adverse Event|0|||
16213068|NCT01641081|39258893|FG001|Period 3|Adverse Event|0|||
16213069|NCT01641081|39258894|FG002|Period 3|Adverse Event|1|||
16213070|NCT01641081|39258895|FG003|Period 3|Adverse Event|0|||
16213071|NCT01641081|39258896|FG004|Period 3|Adverse Event|0|||
16213072|NCT01641081|39258897|FG005|Period 3|Adverse Event|0|||
16213073|NCT01641081|39258898|FG006|Period 3|Adverse Event|0|||
16213074|NCT01641081|39258899|FG007|Period 3|Adverse Event|0|||
16213075|NCT01641081|39258900|FG008|Period 3|Adverse Event|0|||
16213076|NCT01641081|39258901|FG009|Period 3|Adverse Event|0|||
16213077|NCT01641081|39258892|FG000|Period 3|Withdrawal by Subject|0|||
16213078|NCT01641081|39258893|FG001|Period 3|Withdrawal by Subject|0|||
16213079|NCT01641081|39258894|FG002|Period 3|Withdrawal by Subject|0|||
16213080|NCT01641081|39258895|FG003|Period 3|Withdrawal by Subject|0|||
16213081|NCT01641081|39258896|FG004|Period 3|Withdrawal by Subject|0|||
16213082|NCT01641081|39258897|FG005|Period 3|Withdrawal by Subject|0|||
16213083|NCT01641081|39258898|FG006|Period 3|Withdrawal by Subject|0|||
16213084|NCT01641081|39258899|FG007|Period 3|Withdrawal by Subject|0|||
16213085|NCT01641081|39258900|FG008|Period 3|Withdrawal by Subject|1|||
16213086|NCT01641081|39258901|FG009|Period 3|Withdrawal by Subject|0|||
16213087|NCT01641081|39258892|FG000|Period 4|Adverse Event|0|||
16213088|NCT01641081|39258893|FG001|Period 4|Adverse Event|1|||
16213089|NCT01641081|39258894|FG002|Period 4|Adverse Event|0|||
16213090|NCT01641081|39258895|FG003|Period 4|Adverse Event|1|||
16530127|NCT00941603|40406183|FG003|Overall Study|Lost to Follow-up|1|||
16530128|NCT00941603|40406184|FG004|Overall Study|Lost to Follow-up|0|||
16530129|NCT00941603|40406185|FG005|Overall Study|Lost to Follow-up|2|||
16530130|NCT00941603|40406180|FG000|Overall Study|Withdrawal by Subject|0|||
16530131|NCT00941603|40406181|FG001|Overall Study|Withdrawal by Subject|0|||
16530132|NCT00941603|40406182|FG002|Overall Study|Withdrawal by Subject|0|||
16530133|NCT00941603|40406183|FG003|Overall Study|Withdrawal by Subject|2|||
16530134|NCT00941603|40406184|FG004|Overall Study|Withdrawal by Subject|0|||
16530135|NCT00941603|40406185|FG005|Overall Study|Withdrawal by Subject|1|||
16530136|NCT00941603|40406180|FG000|Overall Study|Protocol Violation|0|||
16530137|NCT00941603|40406181|FG001|Overall Study|Protocol Violation|1|||
16530138|NCT00941603|40406182|FG002|Overall Study|Protocol Violation|0|||
16530139|NCT00941603|40406183|FG003|Overall Study|Protocol Violation|0|||
16530140|NCT00941603|40406184|FG004|Overall Study|Protocol Violation|0|||
16530141|NCT00941603|40406185|FG005|Overall Study|Protocol Violation|0|||
16530142|NCT00941603|40406180|FG000|Overall Study|Did not meet protocol eligibility|1|||
16530143|NCT00941603|40406181|FG001|Overall Study|Did not meet protocol eligibility|0|||
16530144|NCT00941603|40406182|FG002|Overall Study|Did not meet protocol eligibility|0|||
16530145|NCT00941603|40406183|FG003|Overall Study|Did not meet protocol eligibility|0|||
16530146|NCT00941603|40406184|FG004|Overall Study|Did not meet protocol eligibility|0|||
16530147|NCT00941603|40406185|FG005|Overall Study|Did not meet protocol eligibility|0|||
16530148|NCT04313881|40406186|FG000|Overall Study|Death|138|||
16530149|NCT04313881|40406187|FG001|Overall Study|Death|126|||
16530150|NCT04313881|40406186|FG000|Overall Study|Study terminated by sponsor|108|||
16213091|NCT01641081|39258896|FG004|Period 4|Adverse Event|0|||
16331755|NCT00401960|39700047|FG000|Overall Study|Lost to Follow-up|3|||
16331756|NCT00401960|39700048|FG001|Overall Study|Lost to Follow-up|0|||
16530151|NCT04313881|40406187|FG001|Overall Study|Study terminated by sponsor|129|||
16530152|NCT04313881|40406186|FG000|Overall Study|Consent withdrawn|19|||
16530153|NCT04313881|40406187|FG001|Overall Study|Consent withdrawn|15|||
16530154|NCT04313881|40406186|FG000|Overall Study|Reason not Specified|3|||
16530155|NCT04313881|40406187|FG001|Overall Study|Reason not Specified|1|||
16530156|NCT01328574|40406188|FG000|Overall Study|Refused further treatment|1|||
16530157|NCT03832010|40406189|FG000|Overall Study|Withdrawal by Subject|2|||
16530158|NCT03832010|40406190|FG001|Overall Study|Withdrawal by Subject|1|||
16530159|NCT03832010|40406191|FG002|Overall Study|Withdrawal by Subject|0|||
16530160|NCT03832010|40406189|FG000|Overall Study|Lost to Follow-up|2|||
16530161|NCT03832010|40406190|FG001|Overall Study|Lost to Follow-up|1|||
16530162|NCT03832010|40406191|FG002|Overall Study|Lost to Follow-up|1|||
16530163|NCT01458574|40406194|FG000|Overall Study|Adverse Event|5|||
16530164|NCT01458574|40406195|FG001|Overall Study|Adverse Event|9|||
16530165|NCT01458574|40406196|FG002|Overall Study|Adverse Event|7|||
16530166|NCT01458574|40406194|FG000|Overall Study|Lack of Efficacy|70|||
16530167|NCT01458574|40406195|FG001|Overall Study|Lack of Efficacy|53|||
16530168|NCT01458574|40406196|FG002|Overall Study|Lack of Efficacy|132|||
16530169|NCT01458574|40406194|FG000|Overall Study|Lost to Follow-up|3|||
16530170|NCT01458574|40406195|FG001|Overall Study|Lost to Follow-up|2|||
16530171|NCT01458574|40406196|FG002|Overall Study|Lost to Follow-up|1|||
16098728|NCT00460577|38849862|FG000|Overall Study|Protocol Violation|2|||
16098729|NCT00460577|38849863|FG001|Overall Study|Protocol Violation|6|||
16098730|NCT03640754|38849864|FG000|Overall Study|Withdrawal by Subject|1|||
16530172|NCT01458574|40406194|FG000|Overall Study|Pregnancy|1|||
16530173|NCT01458574|40406195|FG001|Overall Study|Pregnancy|1|||
16530174|NCT01458574|40406196|FG002|Overall Study|Pregnancy|0|||
16530175|NCT01458574|40406194|FG000|Overall Study|Protocol Violation|0|||
16530176|NCT01458574|40406195|FG001|Overall Study|Protocol Violation|1|||
16530177|NCT01458574|40406196|FG002|Overall Study|Protocol Violation|0|||
16530178|NCT01458574|40406194|FG000|Overall Study|Withdrawal by Subject|6|||
16530179|NCT01458574|40406195|FG001|Overall Study|Withdrawal by Subject|3|||
16530180|NCT01458574|40406196|FG002|Overall Study|Withdrawal by Subject|5|||
16530181|NCT01458574|40406194|FG000|Overall Study|Other|2|||
16530182|NCT01458574|40406195|FG001|Overall Study|Other|1|||
16530183|NCT01458574|40406196|FG002|Overall Study|Other|0|||
16530184|NCT01458574|40406194|FG000|Overall Study|Randomized but not treated|0|||
16530185|NCT01458574|40406195|FG001|Overall Study|Randomized but not treated|1|||
16530186|NCT01458574|40406196|FG002|Overall Study|Randomized but not treated|0|||
16530187|NCT01666002|40406199|FG000|Overall Study|Lost to Follow-up|5|||
16530188|NCT01666002|40406200|FG001|Overall Study|Lost to Follow-up|0|||
16530189|NCT00583557|40406202|FG000|Overall Study|Withdrawal by Subject|18|||
16530190|NCT00583557|40406202|FG000|Overall Study|Adverse Event|9|||
16530191|NCT00583557|40406202|FG000|Overall Study|Lack of Efficacy|31|||
16530192|NCT00583557|40406202|FG000|Overall Study|Lack of Compliance|5|||
16530193|NCT00583557|40406202|FG000|Overall Study|Other|5|||
16530194|NCT00583557|40406202|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
16530195|NCT01310036|40406203|FG000|Overall Study|Administrative/other|10|||
16530196|NCT01310036|40406203|FG000|Overall Study|Withdrew Consent|11|||
16098731|NCT03640754|38849865|FG001|Overall Study|Withdrawal by Subject|0|||
16098732|NCT03640754|38849864|FG000|Overall Study|Lost to Follow-up|0|||
16098733|NCT03640754|38849865|FG001|Overall Study|Lost to Follow-up|1|||
16530197|NCT01310036|40406203|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
16530198|NCT01310036|40406203|FG000|Overall Study|Progression of Disease|164|||
16530199|NCT01310036|40406203|FG000|Overall Study|Death|1|||
16530200|NCT01310036|40406203|FG000|Overall Study|Adverse event or intercurrent illness|12|||
16530201|NCT00253864|40406209|FG000|Overall Study|Lost to Follow-up|5|||
16530202|NCT00253864|40406210|FG001|Overall Study|Lost to Follow-up|8|||
16530203|NCT01983293|40406211|FG000|Overall Study|Withdrawal by Subject|29|||
16098734|NCT03023878|38849866|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
16098735|NCT03023878|38849866|FG000|Pre-Study Run-In Period|Death|1|||
16098736|NCT03023878|38849866|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
16098737|NCT03023878|38849866|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
16098738|NCT03023878|38849866|FG000|Treatment Period|Disease Progression|1|||
16098739|NCT03023878|38849866|FG000|Treatment Period|Withdrawal by Subject|1|||
16098740|NCT03023878|38849866|FG000|Treatment Period|Adverse Event|1|||
16530204|NCT01983293|40406212|FG001|Overall Study|Withdrawal by Subject|15|||
16530205|NCT01983293|40406211|FG000|Overall Study|Missing 12-month visit|3|||
16530206|NCT01983293|40406212|FG001|Overall Study|Missing 12-month visit|3|||
16530207|NCT01983293|40406211|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
16530208|NCT01983293|40406212|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
16530209|NCT01934218|40406213|FG000|Double-blind Phase|Adverse Event|8|||
16530210|NCT01934218|40406214|FG001|Double-blind Phase|Adverse Event|8|||
16530211|NCT01934218|40406213|FG000|Double-blind Phase|Lack of Efficacy|6|||
16530212|NCT01934218|40406214|FG001|Double-blind Phase|Lack of Efficacy|7|||
16530213|NCT01934218|40406213|FG000|Double-blind Phase|Lost to Follow-up|7|||
16530214|NCT01934218|40406214|FG001|Double-blind Phase|Lost to Follow-up|14|||
16098741|NCT03023878|38849866|FG000|Long Term Follow-Up Period|Death|2|||
16530215|NCT01934218|40406213|FG000|Double-blind Phase|Physician Decision|1|||
16530216|NCT01934218|40406214|FG001|Double-blind Phase|Physician Decision|2|||
16098742|NCT00884793|38849867|FG000|Overall Study|Withdrawal by Subject|1|||
16530217|NCT01934218|40406213|FG000|Double-blind Phase|Protocol Violation|4|||
16530218|NCT01934218|40406214|FG001|Double-blind Phase|Protocol Violation|0|||
16530219|NCT01934218|40406213|FG000|Double-blind Phase|Withdrawal by Subject|16|||
16530220|NCT01934218|40406214|FG001|Double-blind Phase|Withdrawal by Subject|13|||
16530221|NCT01934218|40406213|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
16530222|NCT01934218|40406214|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
16530223|NCT01934218|40406213|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
16530224|NCT01934218|40406214|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
16530225|NCT01934218|40406213|FG000|Open-Label Phase|Adverse Event|2|||
16530226|NCT01934218|40406214|FG001|Open-Label Phase|Adverse Event|4|||
16530227|NCT01934218|40406213|FG000|Open-Label Phase|Lack of Efficacy|1|||
16530228|NCT01934218|40406214|FG001|Open-Label Phase|Lack of Efficacy|4|||
16530229|NCT01934218|40406213|FG000|Open-Label Phase|Lost to Follow-up|4|||
16530230|NCT01934218|40406214|FG001|Open-Label Phase|Lost to Follow-up|2|||
16530231|NCT01934218|40406213|FG000|Open-Label Phase|Physician Decision|1|||
16530232|NCT01934218|40406214|FG001|Open-Label Phase|Physician Decision|0|||
16530233|NCT01934218|40406213|FG000|Open-Label Phase|Protocol Violation|1|||
16530234|NCT01934218|40406214|FG001|Open-Label Phase|Protocol Violation|0|||
16530235|NCT01934218|40406213|FG000|Open-Label Phase|Withdrawal by Subject|13|||
16530236|NCT01934218|40406214|FG001|Open-Label Phase|Withdrawal by Subject|11|||
16530237|NCT01934218|40406213|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
16213092|NCT01641081|39258897|FG005|Period 4|Adverse Event|0|||
16213093|NCT01641081|39258898|FG006|Period 4|Adverse Event|0|||
16213094|NCT01641081|39258899|FG007|Period 4|Adverse Event|0|||
16213095|NCT01641081|39258900|FG008|Period 4|Adverse Event|0|||
16213096|NCT01641081|39258901|FG009|Period 4|Adverse Event|0|||
16213097|NCT01641081|39258892|FG000|Period 5|Adverse Event|0|||
16213098|NCT01641081|39258893|FG001|Period 5|Adverse Event|0|||
16213099|NCT01641081|39258894|FG002|Period 5|Adverse Event|2|||
16213100|NCT01641081|39258895|FG003|Period 5|Adverse Event|0|||
16213101|NCT01641081|39258896|FG004|Period 5|Adverse Event|0|||
16213102|NCT01641081|39258897|FG005|Period 5|Adverse Event|0|||
16530238|NCT01934218|40406214|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
16213103|NCT01641081|39258898|FG006|Period 5|Adverse Event|0|||
16213104|NCT01641081|39258899|FG007|Period 5|Adverse Event|0|||
16213105|NCT01641081|39258900|FG008|Period 5|Adverse Event|0|||
16530239|NCT01934218|40406213|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
16213106|NCT01641081|39258901|FG009|Period 5|Adverse Event|0|||
16213107|NCT01329341|39258902|FG000|Overall Study|Withdrawal by Subject|44|||
16213108|NCT03458234|39258908|FG000|Overall Study|Withdrawal by Subject|1|||
16213109|NCT02967562|39258909|FG000|Overall Study|Consent not obtained|1|||
16213110|NCT02967562|39258910|FG001|Overall Study|Consent not obtained|0|||
16213111|NCT02967562|39258909|FG000|Overall Study|High leak precluding analysis|1|||
16213112|NCT02967562|39258910|FG001|Overall Study|High leak precluding analysis|1|||
16213113|NCT03938636|39258918|FG000|Overall Study|Protocol Violation|0|||
16213114|NCT03938636|39258919|FG001|Overall Study|Protocol Violation|1|||
16213115|NCT03938636|39258920|FG002|Overall Study|Protocol Violation|1|||
16213116|NCT03938636|39258918|FG000|Overall Study|Subject withdrew due to death in family|0|||
16213117|NCT03938636|39258919|FG001|Overall Study|Subject withdrew due to death in family|1|||
16213118|NCT03938636|39258920|FG002|Overall Study|Subject withdrew due to death in family|0|||
16213119|NCT03938636|39258918|FG000|Overall Study|Missed visit|0|||
16213120|NCT03938636|39258919|FG001|Overall Study|Missed visit|1|||
16213121|NCT03938636|39258920|FG002|Overall Study|Missed visit|0|||
16213122|NCT03938636|39258918|FG000|Overall Study|Adverse Event|0|||
16213123|NCT03938636|39258919|FG001|Overall Study|Adverse Event|0|||
16213124|NCT03938636|39258920|FG002|Overall Study|Adverse Event|1|||
16213125|NCT03938636|39258918|FG000|Overall Study|Lost to Follow-up|0|||
16213126|NCT03938636|39258919|FG001|Overall Study|Lost to Follow-up|0|||
16213127|NCT03938636|39258920|FG002|Overall Study|Lost to Follow-up|1|||
16213128|NCT02224274|39258923|FG000|Overall Study|Death|1|||
16213129|NCT02224274|39258924|FG001|Overall Study|Death|0|||
16213130|NCT01585168|39258925|FG000|Overall Study|Lost to Follow-up|3|||
16213131|NCT01585168|39258926|FG001|Overall Study|Lost to Follow-up|1|||
16213132|NCT01585168|39258927|FG002|Overall Study|Lost to Follow-up|1|||
16213133|NCT01585168|39258928|FG003|Overall Study|Lost to Follow-up|1|||
16213134|NCT02096471|39258934|FG000|Overall Study|Adverse Event|1|||
16213135|NCT02096471|39258934|FG000|Overall Study|Lack of Efficacy|7|||
16213136|NCT02096471|39258934|FG000|Overall Study|Withdrawal by Subject|3|||
16213137|NCT02096471|39258934|FG000|Overall Study|Non-Compliant|2|||
16213138|NCT00560794|39261771|FG000|Overall Study|Adverse Event|2|||
16213139|NCT00560794|39261771|FG000|Overall Study|Patient was not Compliant|1|||
16213140|NCT00560794|39261771|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
16213141|NCT00560794|39261771|FG000|Overall Study|Hematological Relapse|1|||
16213142|NCT00560794|39261771|FG000|Overall Study|Received Bone Marrow Transplant|6|||
16213143|NCT01100658|39261772|FG000|Overall Study|Withdrawal by Subject|1|||
16213144|NCT01468701|39261773|FG000|Overall Study|Not eligible|91|||
16213145|NCT01468701|39261774|FG001|Overall Study|Not eligible|140|||
16213146|NCT01468701|39261775|FG002|Overall Study|Not eligible|29|||
16213147|NCT01468701|39261776|FG003|Overall Study|Not eligible|12|||
16213148|NCT01468701|39261777|FG004|Overall Study|Not eligible|22|||
16213149|NCT01468701|39261778|FG005|Overall Study|Not eligible|2|||
16213150|NCT01468701|39261779|FG006|Overall Study|Not eligible|39|||
16213151|NCT01468701|39261780|FG007|Overall Study|Not eligible|1|||
16213152|NCT01468701|39261781|FG008|Overall Study|Not eligible|40|||
16213153|NCT01468701|39261782|FG009|Overall Study|Not eligible|126|||
16213154|NCT01468701|39261783|FG010|Overall Study|Not eligible|39|||
16213155|NCT01468701|39261784|FG011|Overall Study|Not eligible|33|||
16213156|NCT01468701|39261785|FG012|Overall Study|Not eligible|1|||
16213157|NCT01468701|39261786|FG013|Overall Study|Not eligible|19|||
16213158|NCT01468701|39261787|FG014|Overall Study|Not eligible|1|||
16213159|NCT01468701|39261788|FG015|Overall Study|Not eligible|32|||
16213160|NCT01468701|39261789|FG016|Overall Study|Not eligible|0|||
16213161|NCT01468701|39261773|FG000|Overall Study|Lost to Follow-up|306|||
16213162|NCT01468701|39261774|FG001|Overall Study|Lost to Follow-up|0|||
16213163|NCT01468701|39261775|FG002|Overall Study|Lost to Follow-up|0|||
16213164|NCT01468701|39261776|FG003|Overall Study|Lost to Follow-up|0|||
16213165|NCT01468701|39261777|FG004|Overall Study|Lost to Follow-up|0|||
16213166|NCT01468701|39261778|FG005|Overall Study|Lost to Follow-up|0|||
16213167|NCT01468701|39261779|FG006|Overall Study|Lost to Follow-up|0|||
16213168|NCT01468701|39261780|FG007|Overall Study|Lost to Follow-up|0|||
16213169|NCT01468701|39261781|FG008|Overall Study|Lost to Follow-up|215|||
16213170|NCT01468701|39261782|FG009|Overall Study|Lost to Follow-up|309|||
16213171|NCT01468701|39261783|FG010|Overall Study|Lost to Follow-up|224|||
16213172|NCT01468701|39261784|FG011|Overall Study|Lost to Follow-up|212|||
16213173|NCT01468701|39261785|FG012|Overall Study|Lost to Follow-up|11|||
16213174|NCT01468701|39261786|FG013|Overall Study|Lost to Follow-up|164|||
16213175|NCT01468701|39261787|FG014|Overall Study|Lost to Follow-up|17|||
16213176|NCT01468701|39261788|FG015|Overall Study|Lost to Follow-up|127|||
16213177|NCT01468701|39261789|FG016|Overall Study|Lost to Follow-up|1|||
16213178|NCT01468701|39261773|FG000|Overall Study|Withdrawal by Subject|165|||
16213179|NCT01468701|39261774|FG001|Overall Study|Withdrawal by Subject|0|||
16213180|NCT01468701|39261775|FG002|Overall Study|Withdrawal by Subject|0|||
16213181|NCT01468701|39261776|FG003|Overall Study|Withdrawal by Subject|0|||
16213182|NCT01468701|39261777|FG004|Overall Study|Withdrawal by Subject|0|||
16213183|NCT01468701|39261778|FG005|Overall Study|Withdrawal by Subject|0|||
16213184|NCT01468701|39261779|FG006|Overall Study|Withdrawal by Subject|0|||
16213185|NCT01468701|39261780|FG007|Overall Study|Withdrawal by Subject|0|||
16213186|NCT01468701|39261781|FG008|Overall Study|Withdrawal by Subject|83|||
16213187|NCT01468701|39261782|FG009|Overall Study|Withdrawal by Subject|88|||
16213188|NCT01468701|39261783|FG010|Overall Study|Withdrawal by Subject|100|||
16213189|NCT01468701|39261784|FG011|Overall Study|Withdrawal by Subject|114|||
16213190|NCT01468701|39261785|FG012|Overall Study|Withdrawal by Subject|9|||
16213191|NCT01468701|39261786|FG013|Overall Study|Withdrawal by Subject|47|||
16213192|NCT01468701|39261787|FG014|Overall Study|Withdrawal by Subject|6|||
16213193|NCT01468701|39261788|FG015|Overall Study|Withdrawal by Subject|31|||
16213194|NCT01468701|39261789|FG016|Overall Study|Withdrawal by Subject|0|||
16213195|NCT01468701|39261773|FG000|Overall Study|Other reasons than listed|437|||
16213196|NCT01468701|39261774|FG001|Overall Study|Other reasons than listed|0|||
16213197|NCT01468701|39261775|FG002|Overall Study|Other reasons than listed|0|||
16213198|NCT01468701|39261776|FG003|Overall Study|Other reasons than listed|0|||
16213199|NCT01468701|39261777|FG004|Overall Study|Other reasons than listed|0|||
16213200|NCT01468701|39261778|FG005|Overall Study|Other reasons than listed|0|||
16213201|NCT01468701|39261779|FG006|Overall Study|Other reasons than listed|0|||
16213202|NCT01468701|39261780|FG007|Overall Study|Other reasons than listed|0|||
16213203|NCT01468701|39261781|FG008|Overall Study|Other reasons than listed|318|||
16213204|NCT01468701|39261782|FG009|Overall Study|Other reasons than listed|658|||
16213205|NCT01468701|39261783|FG010|Overall Study|Other reasons than listed|433|||
16213206|NCT01468701|39261784|FG011|Overall Study|Other reasons than listed|504|||
16213207|NCT01468701|39261785|FG012|Overall Study|Other reasons than listed|28|||
16213208|NCT01468701|39261786|FG013|Overall Study|Other reasons than listed|239|||
16213209|NCT01468701|39261787|FG014|Overall Study|Other reasons than listed|39|||
16213210|NCT01468701|39261788|FG015|Overall Study|Other reasons than listed|172|||
16213211|NCT01468701|39261789|FG016|Overall Study|Other reasons than listed|0|||
16213212|NCT01468701|39261773|FG000|Overall Study|No end of study case report form|0|||
16213213|NCT01468701|39261774|FG001|Overall Study|No end of study case report form|0|||
16213214|NCT01468701|39261775|FG002|Overall Study|No end of study case report form|0|||
16213215|NCT01468701|39261776|FG003|Overall Study|No end of study case report form|0|||
16213216|NCT01468701|39261777|FG004|Overall Study|No end of study case report form|0|||
16530240|NCT01934218|40406214|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
16530241|NCT01953926|40406217|FG000|Overall Study|Withdrawal by Subject|23|||
16530242|NCT01953926|40406218|FG001|Overall Study|Withdrawal by Subject|3|||
16530243|NCT01953926|40406219|FG002|Overall Study|Withdrawal by Subject|3|||
16530244|NCT01953926|40406220|FG003|Overall Study|Withdrawal by Subject|5|||
16530245|NCT01953926|40406221|FG004|Overall Study|Withdrawal by Subject|6|||
16530246|NCT01953926|40406222|FG005|Overall Study|Withdrawal by Subject|0|||
16530247|NCT01953926|40406223|FG006|Overall Study|Withdrawal by Subject|1|||
16530248|NCT01953926|40406217|FG000|Overall Study|Physician Decision|1|||
16530249|NCT01953926|40406218|FG001|Overall Study|Physician Decision|0|||
16530250|NCT01953926|40406219|FG002|Overall Study|Physician Decision|0|||
16530251|NCT01953926|40406220|FG003|Overall Study|Physician Decision|0|||
16530252|NCT01953926|40406221|FG004|Overall Study|Physician Decision|2|||
16530253|NCT01953926|40406222|FG005|Overall Study|Physician Decision|0|||
16530254|NCT01953926|40406223|FG006|Overall Study|Physician Decision|0|||
16530255|NCT01953926|40406217|FG000|Overall Study|Lost to Follow-up|18|||
16530256|NCT01953926|40406218|FG001|Overall Study|Lost to Follow-up|3|||
16530257|NCT01953926|40406219|FG002|Overall Study|Lost to Follow-up|0|||
16530258|NCT01953926|40406220|FG003|Overall Study|Lost to Follow-up|5|||
16098743|NCT00547300|38849868|FG000|Overall Study|Study was Administratively Terminated|25|||
16213217|NCT01468701|39261778|FG005|Overall Study|No end of study case report form|0|||
16213218|NCT01468701|39261779|FG006|Overall Study|No end of study case report form|0|||
16213219|NCT01468701|39261780|FG007|Overall Study|No end of study case report form|0|||
16213220|NCT01468701|39261781|FG008|Overall Study|No end of study case report form|4|||
16213221|NCT01468701|39261782|FG009|Overall Study|No end of study case report form|1|||
16098744|NCT00547300|38849869|FG001|Overall Study|Study was Administratively Terminated|24|||
16098745|NCT00547300|38849868|FG000|Overall Study|Did not Meet Entry Criteria|0|||
16213222|NCT01468701|39261783|FG010|Overall Study|No end of study case report form|2|||
16213223|NCT01468701|39261784|FG011|Overall Study|No end of study case report form|3|||
16213224|NCT01468701|39261785|FG012|Overall Study|No end of study case report form|0|||
16213225|NCT01468701|39261786|FG013|Overall Study|No end of study case report form|1|||
16213226|NCT01468701|39261787|FG014|Overall Study|No end of study case report form|0|||
16213227|NCT01468701|39261788|FG015|Overall Study|No end of study case report form|0|||
16213228|NCT01468701|39261789|FG016|Overall Study|No end of study case report form|0|||
16213229|NCT01468701|39261773|FG000|Overall Study|Not being followed up|0|||
16213230|NCT01468701|39261774|FG001|Overall Study|Not being followed up|4963|||
16213231|NCT01468701|39261775|FG002|Overall Study|Not being followed up|1755|||
16213232|NCT01468701|39261776|FG003|Overall Study|Not being followed up|703|||
16213233|NCT01468701|39261777|FG004|Overall Study|Not being followed up|1714|||
16530259|NCT01953926|40406221|FG004|Overall Study|Lost to Follow-up|3|||
16530260|NCT01953926|40406222|FG005|Overall Study|Lost to Follow-up|0|||
16530261|NCT01953926|40406223|FG006|Overall Study|Lost to Follow-up|0|||
16530262|NCT01953926|40406217|FG000|Overall Study|Protocol Violation|1|||
16213234|NCT01468701|39261778|FG005|Overall Study|Not being followed up|126|||
16213235|NCT01468701|39261779|FG006|Overall Study|Not being followed up|1170|||
16213236|NCT01468701|39261780|FG007|Overall Study|Not being followed up|4|||
16213237|NCT01468701|39261781|FG008|Overall Study|Not being followed up|0|||
16213238|NCT01468701|39261782|FG009|Overall Study|Not being followed up|0|||
16213239|NCT01468701|39261783|FG010|Overall Study|Not being followed up|0|||
16213240|NCT01468701|39261784|FG011|Overall Study|Not being followed up|0|||
16213241|NCT01468701|39261785|FG012|Overall Study|Not being followed up|0|||
16213242|NCT01468701|39261786|FG013|Overall Study|Not being followed up|0|||
16213243|NCT01468701|39261787|FG014|Overall Study|Not being followed up|0|||
16213244|NCT01468701|39261788|FG015|Overall Study|Not being followed up|0|||
16213245|NCT01468701|39261789|FG016|Overall Study|Not being followed up|0|||
16213246|NCT00666536|39261790|FG000|Overall Study|Adverse Event|9|||
16213247|NCT00666536|39261791|FG001|Overall Study|Adverse Event|19|||
16213248|NCT00666536|39261790|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16213249|NCT00666536|39261791|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16213250|NCT00666536|39261790|FG000|Overall Study|Protocol deviation(s)|8|||
16213251|NCT00666536|39261791|FG001|Overall Study|Protocol deviation(s)|6|||
16213252|NCT00666536|39261790|FG000|Overall Study|Withdrawal by Subject|10|||
16213253|NCT00666536|39261791|FG001|Overall Study|Withdrawal by Subject|9|||
16213254|NCT00666536|39261790|FG000|Overall Study|Lost to Follow-up|4|||
16213255|NCT00666536|39261791|FG001|Overall Study|Lost to Follow-up|3|||
16213256|NCT03074318|39261792|FG000|Overall Study|Adverse Event|0|||
16213257|NCT03074318|39261793|FG001|Overall Study|Adverse Event|1|||
16213258|NCT03074318|39261794|FG002|Overall Study|Adverse Event|1|||
16213259|NCT03074318|39261795|FG003|Overall Study|Adverse Event|1|||
16213260|NCT03074318|39261792|FG000|Overall Study|Death|1|||
16331757|NCT00401960|39700047|FG000|Overall Study|Death|2|||
16331758|NCT00401960|39700048|FG001|Overall Study|Death|0|||
16331759|NCT00467961|39700049|FG000|Overall Study|Technical Failures|5|||
16331760|NCT00467961|39700049|FG000|Overall Study|Disease Progression|2|||
16331761|NCT02124759|39700050|FG000|Overall Study|Withdrawal by Subject|3|||
16331762|NCT02124759|39700051|FG001|Overall Study|Withdrawal by Subject|1|||
16098746|NCT00547300|38849869|FG001|Overall Study|Did not Meet Entry Criteria|2|||
16098747|NCT01648699|38849875|FG000|Overall Study|Death|1|||
16098748|NCT01648699|38849875|FG000|Overall Study|Lost to Follow-up|2|||
16213261|NCT03074318|39261793|FG001|Overall Study|Death|0|||
16213262|NCT03074318|39261794|FG002|Overall Study|Death|0|||
16331763|NCT02124759|39700052|FG002|Overall Study|Withdrawal by Subject|1|||
16331764|NCT02124759|39700050|FG000|Overall Study|Screen Fail|2|||
16331765|NCT02124759|39700051|FG001|Overall Study|Screen Fail|2|||
16331766|NCT02124759|39700052|FG002|Overall Study|Screen Fail|3|||
16331767|NCT00430352|39700053|FG000|Overall Study|Disease progression|58|||
16331768|NCT00430352|39700053|FG000|Overall Study|Withdrawal by Subject|11|||
16331769|NCT00430352|39700053|FG000|Overall Study|Adverse Event|16|||
16331770|NCT00430352|39700053|FG000|Overall Study|Death|5|||
16331771|NCT00430352|39700053|FG000|Overall Study|Other|48|||
16331772|NCT03956615|39700054|FG000|Overall Study|No multiple myeloma confirmed|2|||
16331773|NCT03956615|39700054|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
16331774|NCT03956615|39700054|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
16331775|NCT03956615|39700054|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
16331776|NCT02474589|39700055|FG000|Overall Study|Adverse Event|6|||
16098749|NCT01648699|38849875|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
16213263|NCT03074318|39261795|FG003|Overall Study|Death|0|||
16213264|NCT03074318|39261792|FG000|Overall Study|Withdrawal by Subject|1|||
16213265|NCT03074318|39261793|FG001|Overall Study|Withdrawal by Subject|2|||
16213266|NCT03074318|39261794|FG002|Overall Study|Withdrawal by Subject|2|||
16213267|NCT03074318|39261795|FG003|Overall Study|Withdrawal by Subject|4|||
16213268|NCT03074318|39261792|FG000|Overall Study|Trial Closure|2|||
16331777|NCT02474589|39700056|FG001|Overall Study|Adverse Event|2|||
16331778|NCT02474589|39700055|FG000|Overall Study|Lost to Follow-up|6|||
16213269|NCT03074318|39261793|FG001|Overall Study|Trial Closure|2|||
16213270|NCT03074318|39261794|FG002|Overall Study|Trial Closure|3|||
16213271|NCT03074318|39261795|FG003|Overall Study|Trial Closure|11|||
16213272|NCT01060124|39261796|FG000|Overall Study|Other|16|||
16213273|NCT01060124|39261796|FG000|Overall Study|Adverse Event|14|||
16213274|NCT01060124|39261796|FG000|Overall Study|Withdrawal by Subject|7|||
16213275|NCT00952419|39261797|FG000|Overall Study|Adverse Event|2|||
16213276|NCT00952419|39261798|FG001|Overall Study|Adverse Event|0|||
16213277|NCT00952419|39261799|FG002|Overall Study|Adverse Event|0|||
16213278|NCT00952419|39261797|FG000|Overall Study|Protocol Violation|3|||
16213279|NCT00952419|39261798|FG001|Overall Study|Protocol Violation|7|||
16213280|NCT00952419|39261799|FG002|Overall Study|Protocol Violation|0|||
16213281|NCT00952419|39261797|FG000|Overall Study|Withdrawal by Subject|1|||
16213282|NCT00952419|39261798|FG001|Overall Study|Withdrawal by Subject|3|||
16213283|NCT00952419|39261799|FG002|Overall Study|Withdrawal by Subject|0|||
16213284|NCT00615459|39261802|FG000|Period I|Adverse Event|2|||
16213285|NCT00615459|39261803|FG001|Period I|Adverse Event|0|||
16213286|NCT00615459|39261804|FG002|Period I|Adverse Event|1|||
16213287|NCT00615459|39261805|FG003|Period I|Adverse Event|0|||
16213288|NCT00615459|39261802|FG000|Period I|Subject withdrew consent|1|||
16213289|NCT00615459|39261803|FG001|Period I|Subject withdrew consent|0|||
16213290|NCT00615459|39261804|FG002|Period I|Subject withdrew consent|0|||
16213291|NCT00615459|39261805|FG003|Period I|Subject withdrew consent|1|||
16213292|NCT00615459|39261802|FG000|Period I|Abnormal test procedure results|1|||
16213293|NCT00615459|39261803|FG001|Period I|Abnormal test procedure results|1|||
16213294|NCT00615459|39261804|FG002|Period I|Abnormal test procedure results|1|||
16213295|NCT00615459|39261805|FG003|Period I|Abnormal test procedure results|0|||
16213296|NCT00615459|39261802|FG000|Period II|Adverse Event|1|||
16213297|NCT00615459|39261803|FG001|Period II|Adverse Event|0|||
16213298|NCT00615459|39261804|FG002|Period II|Adverse Event|0|||
16213299|NCT00615459|39261805|FG003|Period II|Adverse Event|0|||
16213300|NCT00615459|39261802|FG000|Period II|Lost to Follow-up|0|||
16213301|NCT00615459|39261803|FG001|Period II|Lost to Follow-up|0|||
16213302|NCT00615459|39261804|FG002|Period II|Lost to Follow-up|0|||
16213303|NCT00615459|39261805|FG003|Period II|Lost to Follow-up|1|||
16213304|NCT00615459|39261802|FG000|Period III|Adverse Event|0|||
16213305|NCT00615459|39261803|FG001|Period III|Adverse Event|1|||
16530263|NCT01953926|40406218|FG001|Overall Study|Protocol Violation|0|||
16530264|NCT01953926|40406219|FG002|Overall Study|Protocol Violation|0|||
16530265|NCT01953926|40406220|FG003|Overall Study|Protocol Violation|0|||
16530266|NCT01953926|40406221|FG004|Overall Study|Protocol Violation|0|||
16530267|NCT01953926|40406222|FG005|Overall Study|Protocol Violation|0|||
16530268|NCT01953926|40406223|FG006|Overall Study|Protocol Violation|0|||
16213306|NCT00615459|39261804|FG002|Period III|Adverse Event|0|||
16213307|NCT00615459|39261805|FG003|Period III|Adverse Event|0|||
16213308|NCT00615459|39261802|FG000|Period III|Administrative problems|0|||
16213309|NCT00615459|39261803|FG001|Period III|Administrative problems|1|||
16213310|NCT00615459|39261804|FG002|Period III|Administrative problems|1|||
16213311|NCT00615459|39261805|FG003|Period III|Administrative problems|0|||
16213312|NCT00615459|39261802|FG000|Period III|Unsatisfactory therapeutic effect|0|||
16213313|NCT00615459|39261803|FG001|Period III|Unsatisfactory therapeutic effect|1|||
16213314|NCT00615459|39261804|FG002|Period III|Unsatisfactory therapeutic effect|0|||
16213315|NCT00615459|39261805|FG003|Period III|Unsatisfactory therapeutic effect|0|||
16530269|NCT01953926|40406217|FG000|Overall Study|Other, Disease progression|2|||
16530270|NCT01953926|40406218|FG001|Overall Study|Other, Disease progression|1|||
16530271|NCT01953926|40406219|FG002|Overall Study|Other, Disease progression|0|||
16401133|NCT04049266|39948496|FG001|Overall Study|Patient moved out of state|0|||
16331779|NCT02474589|39700056|FG001|Overall Study|Lost to Follow-up|1|||
16331780|NCT02474589|39700055|FG000|Overall Study|Protocol Violation|4|||
16331781|NCT02474589|39700056|FG001|Overall Study|Protocol Violation|1|||
16331782|NCT02474589|39700055|FG000|Overall Study|Withdrawal by Subject|4|||
16331783|NCT02474589|39700056|FG001|Overall Study|Withdrawal by Subject|0|||
16331784|NCT02474589|39700055|FG000|Overall Study|Inability to complete study procedures|5|||
16331785|NCT02474589|39700056|FG001|Overall Study|Inability to complete study procedures|1|||
16098750|NCT01190228|38849876|FG000|Overall Study|Protocol Violation|4|||
16098751|NCT01190228|38849877|FG001|Overall Study|Protocol Violation|0|||
16098752|NCT01190228|38849878|FG002|Overall Study|Protocol Violation|0|||
16331786|NCT01282164|39700058|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
16213316|NCT01235338|39261808|FG000|Overall Study|Adverse Event|3|||
16213317|NCT01235338|39261809|FG001|Overall Study|Adverse Event|2|||
16213318|NCT01235338|39261808|FG000|Overall Study|Protocol Violation|1|||
16213319|NCT01235338|39261809|FG001|Overall Study|Protocol Violation|1|||
16213320|NCT01235338|39261808|FG000|Overall Study|Withdrawal by Subject|5|||
16213321|NCT01235338|39261809|FG001|Overall Study|Withdrawal by Subject|0|||
16213322|NCT01235338|39261808|FG000|Overall Study|Exclusion criteria violations|1|||
16213323|NCT01235338|39261809|FG001|Overall Study|Exclusion criteria violations|1|||
16213324|NCT01235338|39261808|FG000|Overall Study|Positive drug screen|0|||
16213325|NCT01235338|39261809|FG001|Overall Study|Positive drug screen|1|||
16213326|NCT01235338|39261808|FG000|Overall Study|Prohibited meds|1|||
16213327|NCT01235338|39261809|FG001|Overall Study|Prohibited meds|0|||
16331787|NCT01282164|39700059|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
16331788|NCT00454818|39700061|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
16098753|NCT01190228|38849876|FG000|Overall Study|Withdrawal by Subject|1|||
16098754|NCT01190228|38849877|FG001|Overall Study|Withdrawal by Subject|0|||
16098755|NCT01190228|38849878|FG002|Overall Study|Withdrawal by Subject|0|||
16213328|NCT02774291|39261818|FG000|Overall Study|Lost to Follow-up|1|||
16213329|NCT01899768|39261822|FG000|Part A|Adverse Event|2|||
16213330|NCT01899768|39261822|FG000|Part A|Withdrawal by Subject|1|||
16213331|NCT01899768|39261822|FG000|Part B|Adverse Event|1|||
16213332|NCT01899768|39261822|FG000|Part B|Withdrawal by Subject|1|||
16213333|NCT02635867|39261823|FG000|Overall Study|Lost to Follow-up|4|||
16213334|NCT02635867|39261824|FG001|Overall Study|Lost to Follow-up|3|||
16213335|NCT02635867|39261825|FG002|Overall Study|Lost to Follow-up|3|||
16098756|NCT04288778|38849879|FG000|Overall Study|Withdrawal by Subject|2|||
16098757|NCT04288778|38849879|FG000|Overall Study|Adverse Event|5|||
16098758|NCT04288778|38849879|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16098759|NCT04288778|38849879|FG000|Overall Study|Other|1|||
16098760|NCT04288778|38849879|FG000|Overall Study|Started but not treated|2|||
16098761|NCT03614923|38849885|FG000|Overall Study|Withdrawal by Subject|2|||
16098762|NCT03614923|38849886|FG001|Overall Study|Withdrawal by Subject|1|||
16098763|NCT03614923|38849887|FG002|Overall Study|Withdrawal by Subject|1|||
16098764|NCT03614923|38849885|FG000|Overall Study|Adverse Event|0|||
16098765|NCT03614923|38849886|FG001|Overall Study|Adverse Event|2|||
16098766|NCT03614923|38849887|FG002|Overall Study|Adverse Event|1|||
16098767|NCT03614923|38849885|FG000|Overall Study|Lost to Follow-up|1|||
16098768|NCT03614923|38849886|FG001|Overall Study|Lost to Follow-up|0|||
16098769|NCT03614923|38849887|FG002|Overall Study|Lost to Follow-up|1|||
16098770|NCT03614923|38849885|FG000|Overall Study|Lack of Efficacy|2|||
16098771|NCT03614923|38849886|FG001|Overall Study|Lack of Efficacy|0|||
16098772|NCT03614923|38849887|FG002|Overall Study|Lack of Efficacy|1|||
16098773|NCT03614923|38849885|FG000|Overall Study|Non-compliance|0|||
16098774|NCT03614923|38849886|FG001|Overall Study|Non-compliance|1|||
16530272|NCT01953926|40406220|FG003|Overall Study|Other, Disease progression|0|||
16530273|NCT01953926|40406221|FG004|Overall Study|Other, Disease progression|1|||
16530274|NCT01953926|40406222|FG005|Overall Study|Other, Disease progression|0|||
16530275|NCT01953926|40406223|FG006|Overall Study|Other, Disease progression|0|||
16530276|NCT01953926|40406217|FG000|Overall Study|Discontinuation of study by sponsor|41|||
16530277|NCT01953926|40406218|FG001|Overall Study|Discontinuation of study by sponsor|7|||
16098775|NCT03614923|38849887|FG002|Overall Study|Non-compliance|0|||
16098776|NCT03614923|38849885|FG000|Overall Study|Other|0|||
16098777|NCT03614923|38849886|FG001|Overall Study|Other|1|||
16098778|NCT03614923|38849887|FG002|Overall Study|Other|1|||
16098779|NCT00930644|38849889|FG000|Overall Study|Withdrawal by Subject|4|||
16098780|NCT00930644|38849889|FG000|Overall Study|Physician Decision|2|||
16098781|NCT00930644|38849889|FG000|Overall Study|Death|1|||
16098782|NCT00930644|38849889|FG000|Overall Study|Adverse Event|16|||
16098783|NCT03512288|38849890|FG000|Overall Study|Adverse Event|1|||
16098784|NCT03512288|38849891|FG001|Overall Study|Adverse Event|0|||
16098785|NCT03512288|38849890|FG000|Overall Study|Lost to Follow-up|12|||
16098786|NCT03512288|38849891|FG001|Overall Study|Lost to Follow-up|15|||
16098787|NCT03512288|38849890|FG000|Overall Study|Physician Decision|0|||
16098788|NCT03512288|38849891|FG001|Overall Study|Physician Decision|2|||
16098789|NCT03512288|38849890|FG000|Overall Study|Protocol Violation|6|||
16098790|NCT03512288|38849891|FG001|Overall Study|Protocol Violation|4|||
16098791|NCT03512288|38849890|FG000|Overall Study|Medication error without associated adverse event|1|||
16098792|NCT03512288|38849891|FG001|Overall Study|Medication error without associated adverse event|0|||
16098793|NCT03512288|38849890|FG000|Overall Study|No longer met eligibility criteria|5|||
16098794|NCT03512288|38849891|FG001|Overall Study|No longer met eligibility criteria|2|||
16098795|NCT03512288|38849890|FG000|Overall Study|Withdrawal by parent/guardian|14|||
16098796|NCT03512288|38849891|FG001|Overall Study|Withdrawal by parent/guardian|18|||
16098797|NCT03512288|38849890|FG000|Overall Study|Other|1|||
16098798|NCT03512288|38849891|FG001|Overall Study|Other|1|||
16098799|NCT03512288|38849890|FG000|Overall Study|Randomized but not treated|1|||
16098800|NCT03512288|38849891|FG001|Overall Study|Randomized but not treated|1|||
16098801|NCT00139659|38849892|FG000|Overall Study|Adverse Event|12|||
16098802|NCT00139659|38849893|FG001|Overall Study|Adverse Event|1|||
16098803|NCT00139659|38849892|FG000|Overall Study|Lack of Efficacy|1|||
16098804|NCT00139659|38849893|FG001|Overall Study|Lack of Efficacy|1|||
16098805|NCT00139659|38849892|FG000|Overall Study|Lost to Follow-up|7|||
16098806|NCT00139659|38849893|FG001|Overall Study|Lost to Follow-up|3|||
16098807|NCT00139659|38849892|FG000|Overall Study|Reason not Specified|6|||
16098808|NCT00139659|38849893|FG001|Overall Study|Reason not Specified|3|||
16098809|NCT00139659|38849892|FG000|Overall Study|Withdrawal by Subject|14|||
16098810|NCT00139659|38849893|FG001|Overall Study|Withdrawal by Subject|10|||
16098811|NCT00821093|38849894|FG000|Overall Study|Adverse Event|20|||
16098812|NCT00821093|38849895|FG001|Overall Study|Adverse Event|12|||
16098813|NCT00821093|38849894|FG000|Overall Study|Withdrawal by Subject|9|||
16098814|NCT00821093|38849895|FG001|Overall Study|Withdrawal by Subject|13|||
16098815|NCT00821093|38849894|FG000|Overall Study|Lost to Follow-up|9|||
16098816|NCT00821093|38849895|FG001|Overall Study|Lost to Follow-up|3|||
16098817|NCT00821093|38849894|FG000|Overall Study|Protocol deviation|3|||
16098818|NCT00821093|38849895|FG001|Overall Study|Protocol deviation|6|||
16098819|NCT00821093|38849894|FG000|Overall Study|Abnormal laboratory value(s)|2|||
16098820|NCT00821093|38849895|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16098821|NCT00821093|38849894|FG000|Overall Study|Lack of Efficacy|2|||
16098822|NCT00821093|38849895|FG001|Overall Study|Lack of Efficacy|2|||
16098823|NCT00821093|38849894|FG000|Overall Study|Death|2|||
16098824|NCT00821093|38849895|FG001|Overall Study|Death|1|||
16098825|NCT00821093|38849894|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16530278|NCT01953926|40406219|FG002|Overall Study|Discontinuation of study by sponsor|5|||
16530279|NCT01953926|40406220|FG003|Overall Study|Discontinuation of study by sponsor|12|||
16530280|NCT01953926|40406221|FG004|Overall Study|Discontinuation of study by sponsor|46|||
16530281|NCT01953926|40406222|FG005|Overall Study|Discontinuation of study by sponsor|5|||
16530282|NCT01953926|40406223|FG006|Overall Study|Discontinuation of study by sponsor|6|||
16530283|NCT01953926|40406217|FG000|Overall Study|Not Treated|1|||
16530284|NCT01953926|40406218|FG001|Overall Study|Not Treated|0|||
16530285|NCT01953926|40406219|FG002|Overall Study|Not Treated|1|||
16530286|NCT01953926|40406220|FG003|Overall Study|Not Treated|0|||
16530287|NCT01953926|40406221|FG004|Overall Study|Not Treated|0|||
16530288|NCT01953926|40406222|FG005|Overall Study|Not Treated|0|||
16530289|NCT01953926|40406223|FG006|Overall Study|Not Treated|0|||
16530290|NCT00305058|40406227|FG000|Overall Study|Participant too young|1|||
16530291|NCT00305058|40406228|FG001|Overall Study|Participant too young|0|||
16530292|NCT00305058|40406227|FG000|Overall Study|Missing data collection instrument|3|||
16530293|NCT00305058|40406228|FG001|Overall Study|Missing data collection instrument|2|||
16530294|NCT00305058|40406227|FG000|Overall Study|Missing outcome data|3|||
16530295|NCT00305058|40406228|FG001|Overall Study|Missing outcome data|2|||
16530296|NCT01572727|40406229|FG000|Overall Study|Adverse Event|43|||
16530297|NCT01572727|40406230|FG001|Overall Study|Adverse Event|15|||
16530298|NCT01572727|40406229|FG000|Overall Study|Lost to Follow-up|1|||
16530299|NCT01572727|40406230|FG001|Overall Study|Lost to Follow-up|1|||
16530300|NCT01572727|40406229|FG000|Overall Study|Physician Decision|23|||
16530301|NCT01572727|40406230|FG001|Overall Study|Physician Decision|9|||
16530302|NCT01572727|40406229|FG000|Overall Study|Progressive disease|59|||
16530303|NCT01572727|40406230|FG001|Overall Study|Progressive disease|82|||
16530304|NCT01572727|40406229|FG000|Overall Study|Protocol Violation|0|||
16530305|NCT01572727|40406230|FG001|Overall Study|Protocol Violation|1|||
16530306|NCT01572727|40406229|FG000|Overall Study|Study terminated by sponsor|61|||
16530307|NCT01572727|40406230|FG001|Overall Study|Study terminated by sponsor|83|||
16530308|NCT01572727|40406229|FG000|Overall Study|Parent/guardian decision|14|||
16530309|NCT01572727|40406230|FG001|Overall Study|Parent/guardian decision|9|||
16530310|NCT01572727|40406229|FG000|Overall Study|Death|2|||
16530311|NCT01572727|40406230|FG001|Overall Study|Death|2|||
16530312|NCT01572727|40406229|FG000|Overall Study|Untreated|4|||
16530313|NCT01572727|40406230|FG001|Overall Study|Untreated|7|||
16530314|NCT01410448|40406232|FG000|Overall Study|No conversion to everolimus|0|||
16530315|NCT01410448|40406233|FG001|Overall Study|No conversion to everolimus|24|||
16530316|NCT01410448|40406232|FG000|Overall Study|Graft loss|4|||
16530317|NCT01410448|40406233|FG001|Overall Study|Graft loss|1|||
16530318|NCT01410448|40406232|FG000|Overall Study|Administrative issues|2|||
16331789|NCT00454818|39700062|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
16331790|NCT00454818|39700063|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
16331791|NCT00454818|39700064|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
16331792|NCT00454818|39700065|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
16331793|NCT00454818|39700061|FG000|Phase I: Open-label Dose-escalation|Death|0|||
16331794|NCT00454818|39700062|FG001|Phase I: Open-label Dose-escalation|Death|1|||
16331795|NCT00454818|39700063|FG002|Phase I: Open-label Dose-escalation|Death|0|||
16331796|NCT00454818|39700064|FG003|Phase I: Open-label Dose-escalation|Death|0|||
16331797|NCT00454818|39700065|FG004|Phase I: Open-label Dose-escalation|Death|0|||
16331798|NCT00454818|39700061|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
16331799|NCT00454818|39700062|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
16331800|NCT00454818|39700063|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
16331801|NCT00454818|39700064|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
16331802|NCT00454818|39700065|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
16530319|NCT01410448|40406233|FG001|Overall Study|Administrative issues|1|||
16530320|NCT01410448|40406232|FG000|Overall Study|Lost to Follow-up|1|||
16530321|NCT01410448|40406233|FG001|Overall Study|Lost to Follow-up|0|||
16530322|NCT01410448|40406232|FG000|Overall Study|Withdrawal by Subject|3|||
16530323|NCT01410448|40406233|FG001|Overall Study|Withdrawal by Subject|2|||
16530324|NCT01410448|40406232|FG000|Overall Study|Protocol Violation|0|||
16530325|NCT01410448|40406233|FG001|Overall Study|Protocol Violation|4|||
16530326|NCT01410448|40406232|FG000|Overall Study|Death|2|||
16530327|NCT01410448|40406233|FG001|Overall Study|Death|3|||
16530328|NCT02044510|40406234|FG000|Overall Study|Adverse Event|1|||
16530329|NCT02044510|40406235|FG001|Overall Study|Adverse Event|2|||
16530330|NCT01303627|40406238|FG000|Overall Study|the failure while performing URS|0|||
16530331|NCT01303627|40406239|FG001|Overall Study|the failure while performing URS|1|||
16530332|NCT01174342|40406241|FG000|Overall Study|Conversion to cesarean section|4|||
16530333|NCT00566228|40406243|FG000|Overall Study|Withdrawal by Subject|1|||
16530334|NCT00566228|40406244|FG001|Overall Study|Withdrawal by Subject|0|||
16530335|NCT00566228|40406243|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
16530336|NCT00566228|40406244|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
16530337|NCT00566228|40406243|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
16530338|NCT00566228|40406244|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
16530339|NCT00566228|40406243|FG000|Overall Study|progressed before infusion could occur|0|||
16530340|NCT00566228|40406244|FG001|Overall Study|progressed before infusion could occur|1|||
16530341|NCT04642638|40406245|FG000|Overall Study|Withdrawal by Subject|23|||
16530342|NCT04642638|40406246|FG001|Overall Study|Withdrawal by Subject|29|||
16530343|NCT04642638|40406247|FG002|Overall Study|Withdrawal by Subject|9|||
16530344|NCT04642638|40406248|FG003|Overall Study|Withdrawal by Subject|7|||
16530345|NCT04642638|40406249|FG004|Overall Study|Withdrawal by Subject|61|||
16530346|NCT04642638|40406250|FG005|Overall Study|Withdrawal by Subject|27|||
16530347|NCT04642638|40406245|FG000|Overall Study|Lost to Follow-up|17|||
16530348|NCT04642638|40406246|FG001|Overall Study|Lost to Follow-up|18|||
16530349|NCT04642638|40406247|FG002|Overall Study|Lost to Follow-up|5|||
16530350|NCT04642638|40406248|FG003|Overall Study|Lost to Follow-up|5|||
16530351|NCT04642638|40406249|FG004|Overall Study|Lost to Follow-up|6|||
16331803|NCT00454818|39700061|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
16530352|NCT04642638|40406250|FG005|Overall Study|Lost to Follow-up|3|||
16530353|NCT04642638|40406245|FG000|Overall Study|Adverse Event|0|||
16530354|NCT04642638|40406246|FG001|Overall Study|Adverse Event|0|||
16530355|NCT04642638|40406247|FG002|Overall Study|Adverse Event|1|||
16530356|NCT04642638|40406248|FG003|Overall Study|Adverse Event|0|||
16530357|NCT04642638|40406249|FG004|Overall Study|Adverse Event|10|||
16530358|NCT04642638|40406250|FG005|Overall Study|Adverse Event|3|||
16530359|NCT04642638|40406245|FG000|Overall Study|Reason Not Specified|1|||
16331804|NCT00454818|39700062|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
16530360|NCT04642638|40406246|FG001|Overall Study|Reason Not Specified|4|||
16530361|NCT04642638|40406247|FG002|Overall Study|Reason Not Specified|0|||
16530362|NCT04642638|40406248|FG003|Overall Study|Reason Not Specified|0|||
16530363|NCT04642638|40406249|FG004|Overall Study|Reason Not Specified|38|||
16530364|NCT04642638|40406250|FG005|Overall Study|Reason Not Specified|16|||
16530365|NCT04642638|40406245|FG000|Overall Study|Physician Decision|0|||
16530366|NCT04642638|40406246|FG001|Overall Study|Physician Decision|0|||
16530367|NCT04642638|40406247|FG002|Overall Study|Physician Decision|0|||
16530368|NCT04642638|40406248|FG003|Overall Study|Physician Decision|0|||
16331805|NCT00454818|39700063|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
16331806|NCT00454818|39700064|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
16331807|NCT00454818|39700065|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
16331808|NCT00454818|39700061|FG000|Phase 2: Randomized Double-blind|Death|0|||
16530369|NCT04642638|40406249|FG004|Overall Study|Physician Decision|2|||
16530370|NCT04642638|40406250|FG005|Overall Study|Physician Decision|1|||
16530371|NCT04642638|40406245|FG000|Overall Study|Protocol Deviation|0|||
16331809|NCT00454818|39700062|FG001|Phase 2: Randomized Double-blind|Death|1|||
16331810|NCT00454818|39700063|FG002|Phase 2: Randomized Double-blind|Death|0|||
16331811|NCT00454818|39700064|FG003|Phase 2: Randomized Double-blind|Death|0|||
16331812|NCT00454818|39700065|FG004|Phase 2: Randomized Double-blind|Death|1|||
16331813|NCT00454818|39700061|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
16331814|NCT00454818|39700062|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
16331815|NCT00454818|39700063|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
16331816|NCT00454818|39700064|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
16331817|NCT00454818|39700065|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
16331818|NCT00454818|39700061|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
16331819|NCT00454818|39700062|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
16530372|NCT04642638|40406246|FG001|Overall Study|Protocol Deviation|0|||
16530373|NCT04642638|40406247|FG002|Overall Study|Protocol Deviation|0|||
16530374|NCT04642638|40406248|FG003|Overall Study|Protocol Deviation|0|||
16530375|NCT04642638|40406249|FG004|Overall Study|Protocol Deviation|1|||
16530376|NCT04642638|40406250|FG005|Overall Study|Protocol Deviation|3|||
16530377|NCT04642638|40406245|FG000|Overall Study|Study Terminated|0|||
16530378|NCT04642638|40406246|FG001|Overall Study|Study Terminated|0|||
16530379|NCT04642638|40406247|FG002|Overall Study|Study Terminated|0|||
16530380|NCT04642638|40406248|FG003|Overall Study|Study Terminated|0|||
16530381|NCT04642638|40406249|FG004|Overall Study|Study Terminated|484|||
16098826|NCT00821093|38849895|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16098827|NCT00821093|38849894|FG000|Overall Study|Administrative problems|1|||
16098828|NCT00821093|38849895|FG001|Overall Study|Administrative problems|2|||
16401134|NCT01597908|39948501|FG000|Randomized Phase|Death|217|||
16331820|NCT00454818|39700063|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
16530382|NCT04642638|40406250|FG005|Overall Study|Study Terminated|250|||
16530383|NCT04642638|40406245|FG000|Overall Study|Pregnancy|0|||
16530384|NCT04642638|40406246|FG001|Overall Study|Pregnancy|0|||
16530385|NCT04642638|40406247|FG002|Overall Study|Pregnancy|0|||
16530386|NCT04642638|40406248|FG003|Overall Study|Pregnancy|0|||
16530387|NCT04642638|40406249|FG004|Overall Study|Pregnancy|1|||
16530388|NCT04642638|40406250|FG005|Overall Study|Pregnancy|0|||
16530389|NCT01660906|40406251|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
16530390|NCT01198600|40406252|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
16530391|NCT01198600|40406253|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
16530392|NCT01198600|40406254|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
16530393|NCT01198600|40406255|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
16530394|NCT01198600|40406252|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
16530395|NCT01198600|40406253|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
16530396|NCT01198600|40406254|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
16530397|NCT01198600|40406255|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
16530398|NCT01198600|40406252|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
16530399|NCT01198600|40406253|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
16530400|NCT01198600|40406254|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
16530401|NCT01198600|40406255|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
16530402|NCT01198600|40406252|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
16098829|NCT00702520|38849896|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
16213336|NCT02635867|39261826|FG003|Overall Study|Lost to Follow-up|4|||
16331821|NCT00454818|39700064|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
16331822|NCT00454818|39700065|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
16331823|NCT00783224|39700066|FG000|Overall Study|Adverse Event|0|||
16331824|NCT00783224|39700067|FG001|Overall Study|Adverse Event|0|||
16213337|NCT02635867|39261827|FG004|Overall Study|Lost to Follow-up|1|||
16331825|NCT00783224|39700068|FG002|Overall Study|Adverse Event|1|||
16331826|NCT00783224|39700069|FG003|Overall Study|Adverse Event|0|||
16331827|NCT00783224|39700066|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
16331828|NCT00783224|39700067|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
16401135|NCT01597908|39948502|FG001|Randomized Phase|Death|238|||
16401136|NCT01597908|39948503|FG002|Randomized Phase|Death|0|||
16401137|NCT01597908|39948501|FG000|Randomized Phase|Sponsor Decision|93|||
16331829|NCT00783224|39700068|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
16331830|NCT00783224|39700069|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
16331831|NCT00783224|39700066|FG000|Overall Study|Inappropriate as a study subject|0|||
16331832|NCT00783224|39700067|FG001|Overall Study|Inappropriate as a study subject|0|||
16331833|NCT00783224|39700068|FG002|Overall Study|Inappropriate as a study subject|0|||
16331834|NCT00783224|39700069|FG003|Overall Study|Inappropriate as a study subject|1|||
16331835|NCT00290693|39700070|FG000|Overall Study|Withdrawal by Subject|2|||
16331836|NCT00232596|39700071|FG000|6-Week Titration Phase|Adverse Event|6|||
16331837|NCT00232596|39700072|FG001|6-Week Titration Phase|Adverse Event|19|||
16331838|NCT00232596|39700071|FG000|6-Week Titration Phase|Failed to Return|2|||
16331839|NCT00232596|39700072|FG001|6-Week Titration Phase|Failed to Return|1|||
16331840|NCT00232596|39700071|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
16331841|NCT00232596|39700072|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
16331842|NCT00232596|39700071|FG000|6-Week Titration Phase|Protocol Violation|1|||
16331843|NCT00232596|39700072|FG001|6-Week Titration Phase|Protocol Violation|3|||
16401138|NCT01597908|39948502|FG001|Randomized Phase|Sponsor Decision|39|||
16401139|NCT01597908|39948503|FG002|Randomized Phase|Sponsor Decision|0|||
16530403|NCT01198600|40406253|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
16098830|NCT00702520|38849897|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
16331844|NCT00232596|39700071|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
16401140|NCT01597908|39948501|FG000|Randomized Phase|Lost to Follow-up|9|||
16401141|NCT01597908|39948502|FG001|Randomized Phase|Lost to Follow-up|16|||
16401142|NCT01597908|39948503|FG002|Randomized Phase|Lost to Follow-up|0|||
16401143|NCT01597908|39948501|FG000|Randomized Phase|Physician Decision|6|||
16401144|NCT01597908|39948502|FG001|Randomized Phase|Physician Decision|3|||
16401145|NCT01597908|39948503|FG002|Randomized Phase|Physician Decision|0|||
16401146|NCT01597908|39948501|FG000|Randomized Phase|Withdrawal by Subject|26|||
16401147|NCT01597908|39948502|FG001|Randomized Phase|Withdrawal by Subject|22|||
16530404|NCT01198600|40406254|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
16530405|NCT01198600|40406255|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
16530406|NCT01198600|40406252|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
16530407|NCT01198600|40406253|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
16530408|NCT01198600|40406254|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
16530409|NCT01198600|40406255|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
16530410|NCT01198600|40406252|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
16530411|NCT01198600|40406253|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
16530412|NCT01198600|40406254|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
16530413|NCT01198600|40406255|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
16530414|NCT01198600|40406252|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
16530415|NCT01198600|40406253|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
16530416|NCT01198600|40406254|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
16530417|NCT01198600|40406255|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
16530418|NCT00383435|40406256|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
16530419|NCT00383435|40406257|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
16331845|NCT00232596|39700072|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
16331846|NCT00232596|39700071|FG000|6-Week Titration Phase|Other|3|||
16331847|NCT00232596|39700072|FG001|6-Week Titration Phase|Other|3|||
16331848|NCT00232596|39700071|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
16331849|NCT00232596|39700072|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
16331850|NCT00232596|39700071|FG000|12-Week Maintenance Phase|Adverse Event|7|||
16331851|NCT00232596|39700072|FG001|12-Week Maintenance Phase|Adverse Event|22|||
16331852|NCT00232596|39700071|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
16331853|NCT00232596|39700072|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
16331854|NCT00232596|39700071|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
16331855|NCT00232596|39700072|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
16331856|NCT00232596|39700071|FG000|12-Week Maintenance Phase|Other|1|||
16331857|NCT00232596|39700072|FG001|12-Week Maintenance Phase|Other|3|||
16331858|NCT02552888|39700073|FG000|Overall Study|Lost to Follow-up|1|||
16331859|NCT02552888|39700074|FG001|Overall Study|Lost to Follow-up|1|||
16331860|NCT00386425|39700075|FG000|Overall Study|Physician Decision|3|||
16331861|NCT00386425|39700076|FG001|Overall Study|Physician Decision|0|||
16331862|NCT00386425|39700077|FG002|Overall Study|Physician Decision|0|||
16331863|NCT00386425|39700075|FG000|Overall Study|Withdrawal by Subject|0|||
16331864|NCT00386425|39700076|FG001|Overall Study|Withdrawal by Subject|1|||
16331865|NCT00386425|39700077|FG002|Overall Study|Withdrawal by Subject|0|||
16331866|NCT04481191|39700078|FG000|Overall Study|Withdrawn by parent/guardian|15|||
16331867|NCT04481191|39700079|FG001|Overall Study|Withdrawn by parent/guardian|10|||
16331868|NCT00348595|39700080|FG000|Overall Study|Adverse Event|5|||
16331869|NCT00348595|39700081|FG001|Overall Study|Adverse Event|8|||
16331870|NCT01552915|39700086|FG000|Overall Study|Adverse Event|3|||
16331871|NCT01552915|39700087|FG001|Overall Study|Adverse Event|14|||
16331872|NCT01552915|39700088|FG002|Overall Study|Adverse Event|3|||
16331873|NCT01552915|39700086|FG000|Overall Study|Lost to Follow-up|4|||
16331874|NCT01552915|39700087|FG001|Overall Study|Lost to Follow-up|6|||
16331875|NCT01552915|39700088|FG002|Overall Study|Lost to Follow-up|5|||
16331876|NCT01552915|39700086|FG000|Overall Study|Withdrawal by Subject|6|||
16331877|NCT01552915|39700087|FG001|Overall Study|Withdrawal by Subject|4|||
16331878|NCT01552915|39700088|FG002|Overall Study|Withdrawal by Subject|5|||
16331879|NCT01552915|39700086|FG000|Overall Study|Protocol Violation|0|||
16331880|NCT01552915|39700087|FG001|Overall Study|Protocol Violation|4|||
16331881|NCT01552915|39700088|FG002|Overall Study|Protocol Violation|4|||
16331882|NCT01552915|39700086|FG000|Overall Study|Lack of Efficacy|8|||
16331883|NCT01552915|39700087|FG001|Overall Study|Lack of Efficacy|1|||
16331884|NCT01552915|39700088|FG002|Overall Study|Lack of Efficacy|4|||
16331885|NCT01552915|39700086|FG000|Overall Study|Other|2|||
16331886|NCT01552915|39700087|FG001|Overall Study|Other|0|||
16331887|NCT01552915|39700088|FG002|Overall Study|Other|6|||
16331888|NCT00197002|39700089|FG000|Overall Study|Adverse Event|0|||
16331889|NCT00197002|39700090|FG001|Overall Study|Adverse Event|1|||
16331890|NCT00197002|39700091|FG002|Overall Study|Adverse Event|0|||
16401148|NCT01597908|39948503|FG002|Randomized Phase|Withdrawal by Subject|0|||
16401149|NCT01597908|39948501|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
16331891|NCT00197002|39700089|FG000|Overall Study|Protocol Violation|1|||
16331892|NCT00197002|39700090|FG001|Overall Study|Protocol Violation|0|||
16331893|NCT00197002|39700091|FG002|Overall Study|Protocol Violation|2|||
16530420|NCT00383435|40406258|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
16530421|NCT00383435|40406259|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
16530422|NCT00383435|40406260|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
16530423|NCT00383435|40406256|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
16530424|NCT00383435|40406257|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
16530425|NCT00383435|40406258|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
16530426|NCT00383435|40406259|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
16530427|NCT00383435|40406260|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
16530428|NCT00383435|40406256|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
16530429|NCT00383435|40406257|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
16530430|NCT00383435|40406258|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
16530431|NCT00383435|40406259|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
16530432|NCT00383435|40406260|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
16530433|NCT00383435|40406256|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
16530434|NCT00383435|40406257|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
16530435|NCT00383435|40406258|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
16530436|NCT00383435|40406259|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
16530437|NCT00383435|40406260|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
16530438|NCT00383435|40406256|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
16530439|NCT00383435|40406257|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
16530440|NCT00383435|40406258|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
16530441|NCT00383435|40406259|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
16530442|NCT00383435|40406260|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
16530443|NCT00383435|40406256|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
16530444|NCT00383435|40406257|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
16530445|NCT00383435|40406258|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
16530446|NCT00383435|40406259|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
16213338|NCT04007367|39261828|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
16213339|NCT04007367|39261829|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
16213340|NCT04007367|39261830|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
16213341|NCT04007367|39261828|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
16213342|NCT04007367|39261829|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
16213343|NCT04007367|39261830|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
16213344|NCT04007367|39261828|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
16213345|NCT04007367|39261829|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
16331894|NCT00197002|39700089|FG000|Overall Study|Withdrawal by Subject|9|||
16331895|NCT00197002|39700090|FG001|Overall Study|Withdrawal by Subject|5|||
16331896|NCT00197002|39700091|FG002|Overall Study|Withdrawal by Subject|7|||
16331897|NCT00197002|39700089|FG000|Overall Study|Migrated/moved from study area|3|||
16213346|NCT04007367|39261830|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
16331898|NCT00197002|39700090|FG001|Overall Study|Migrated/moved from study area|5|||
16331899|NCT00197002|39700091|FG002|Overall Study|Migrated/moved from study area|1|||
16331900|NCT00197002|39700089|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
16331901|NCT00197002|39700090|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
16331902|NCT00197002|39700091|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
16331903|NCT00197002|39700089|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
16331904|NCT00197002|39700090|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
16331905|NCT00197002|39700091|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
16331906|NCT00197002|39700089|FG000|Overall Study|Others|3|||
16331907|NCT00197002|39700090|FG001|Overall Study|Others|1|||
16331908|NCT00197002|39700091|FG002|Overall Study|Others|1|||
16331909|NCT01904903|39700094|FG000|Overall Study|Withdrawal by Subject|1|||
16331910|NCT01371877|39700096|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
16331911|NCT01371877|39700097|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
16331912|NCT00394771|39700099|FG000|Overall Study|Did not meet protocol requirements|1|||
16331913|NCT00394771|39700100|FG001|Overall Study|Did not meet protocol requirements|0|||
16331914|NCT00394771|39700101|FG002|Overall Study|Did not meet protocol requirements|2|||
16331915|NCT00394771|39700102|FG003|Overall Study|Did not meet protocol requirements|0|||
16331916|NCT00394771|39700099|FG000|Overall Study|Protocol Violation|2|||
16331917|NCT00394771|39700100|FG001|Overall Study|Protocol Violation|4|||
16331918|NCT00394771|39700101|FG002|Overall Study|Protocol Violation|9|||
16331919|NCT00394771|39700102|FG003|Overall Study|Protocol Violation|7|||
16331920|NCT00394771|39700099|FG000|Overall Study|Withdrawal by Subject|10|||
16401150|NCT01597908|39948502|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
16401151|NCT01597908|39948503|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
16401152|NCT01597908|39948501|FG000|Crossover Phase|Death|0|||
16401153|NCT01597908|39948502|FG001|Crossover Phase|Death|0|||
16530447|NCT00383435|40406260|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
16530448|NCT00383435|40406256|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
16530449|NCT00383435|40406257|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
16530450|NCT00383435|40406258|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
16530451|NCT00383435|40406259|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
16530452|NCT00383435|40406260|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
16530453|NCT00383435|40406256|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
16530454|NCT00383435|40406257|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
16530455|NCT00383435|40406258|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
16530456|NCT00383435|40406259|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
16530457|NCT00383435|40406260|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
16530458|NCT00383435|40406256|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
16530459|NCT00383435|40406257|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
16530460|NCT00383435|40406258|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
16530461|NCT00383435|40406259|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
16530462|NCT00383435|40406260|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
16530463|NCT00383435|40406256|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
16530464|NCT00383435|40406257|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
16530465|NCT00383435|40406258|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
16530466|NCT00383435|40406259|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
16530467|NCT00383435|40406260|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
16530468|NCT00383435|40406256|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
16530469|NCT00383435|40406257|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
16530470|NCT00383435|40406258|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
16530471|NCT00383435|40406259|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
16530472|NCT00383435|40406260|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
16530473|NCT00383435|40406256|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
16530474|NCT00383435|40406257|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
16530475|NCT00383435|40406258|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
16530476|NCT00383435|40406259|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
16530477|NCT00383435|40406260|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
16530478|NCT00383435|40406256|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
16530479|NCT00383435|40406257|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
16530480|NCT00383435|40406258|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
16530481|NCT00383435|40406259|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
16530482|NCT00383435|40406260|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
16530483|NCT00383435|40406256|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
16530484|NCT00383435|40406257|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
16530485|NCT00383435|40406258|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
16530486|NCT00383435|40406259|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
16530487|NCT00383435|40406260|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
16530488|NCT00383435|40406256|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
16530489|NCT00383435|40406257|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
16530490|NCT00383435|40406258|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
16530491|NCT00383435|40406259|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
16530492|NCT00383435|40406260|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
16530493|NCT00383435|40406256|FG000|26-Week Treatment Safety Extension|Administrative|1|||
16530494|NCT00383435|40406257|FG001|26-Week Treatment Safety Extension|Administrative|1|||
16530495|NCT00383435|40406258|FG002|26-Week Treatment Safety Extension|Administrative|0|||
16530496|NCT00383435|40406259|FG003|26-Week Treatment Safety Extension|Administrative|1|||
16530497|NCT00383435|40406260|FG004|26-Week Treatment Safety Extension|Administrative|0|||
16530498|NCT04329104|40406261|FG000|Efficacy Study|Withdrawal by Subject|0|||
16530499|NCT04329104|40406262|FG001|Efficacy Study|Withdrawal by Subject|0|||
16530500|NCT04329104|40406263|FG002|Efficacy Study|Withdrawal by Subject|0|||
16530501|NCT04329104|40406264|FG003|Efficacy Study|Withdrawal by Subject|5|||
16530502|NCT04329104|40406265|FG004|Efficacy Study|Withdrawal by Subject|6|||
16530503|NCT04329104|40406266|FG005|Efficacy Study|Withdrawal by Subject|8|||
16530504|NCT01863680|40406272|FG000|Overall Study|Adverse Event|17|||
16530505|NCT01863680|40406272|FG000|Overall Study|Risk of OHSS|17|||
16530506|NCT01863680|40406272|FG000|Overall Study|Spontaneous pregnancy|2|||
16530507|NCT01863680|40406272|FG000|Overall Study|Withdrawal by Subject|1|||
16530508|NCT01863680|40406272|FG000|Overall Study|Did not undergo IVF/ET|14|||
16530509|NCT01863680|40406272|FG000|Overall Study|Other|6|||
16530510|NCT00574080|40406276|FG000|Overall Study|Death|10|||
16530511|NCT00574080|40406277|FG001|Overall Study|Death|10|||
16530512|NCT00263666|40406278|FG000|Overall Study|Adverse Event|6|||
16530513|NCT00263666|40406279|FG001|Overall Study|Adverse Event|8|||
16530514|NCT00263666|40406278|FG000|Overall Study|Lost to Follow-up|1|||
16530515|NCT00263666|40406279|FG001|Overall Study|Lost to Follow-up|2|||
16530516|NCT00263666|40406278|FG000|Overall Study|Withdrawal by Subject|0|||
16530517|NCT00263666|40406279|FG001|Overall Study|Withdrawal by Subject|1|||
16530518|NCT00380068|40406280|FG000|Overall Study|Adverse Event|40|||
16530519|NCT00380068|40406280|FG000|Overall Study|Withdrawal by Subject|10|||
16530520|NCT00380068|40406280|FG000|Overall Study|Not compliant|6|||
16530521|NCT00380068|40406280|FG000|Overall Study|Lost to Follow-up|1|||
16530522|NCT00380068|40406280|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
16530523|NCT00380068|40406280|FG000|Overall Study|Lung transplant|3|||
16530524|NCT00380068|40406280|FG000|Overall Study|Physician Decision|2|||
16530525|NCT00380068|40406280|FG000|Overall Study|Partipant moved away|1|||
16530526|NCT00380068|40406280|FG000|Overall Study|Lack of Efficacy|5|||
16530527|NCT02734212|40406281|FG000|Overall Study|Lost to Follow-up|5|||
16530528|NCT02734212|40406282|FG001|Overall Study|Lost to Follow-up|10|||
16530529|NCT02277106|40406283|FG000|Stage 2|Adverse Event|0|||
16530530|NCT02277106|40406284|FG001|Stage 2|Adverse Event|0|||
16530531|NCT02277106|40406285|FG002|Stage 2|Adverse Event|1|||
16530532|NCT00839072|40406286|FG000|First Intervention Period|Withdrawal by Subject|1|||
16530533|NCT00839072|40406287|FG001|First Intervention Period|Withdrawal by Subject|0|||
16530534|NCT00839072|40406286|FG000|First Intervention Period|Adverse Event|1|||
16530535|NCT00839072|40406287|FG001|First Intervention Period|Adverse Event|1|||
16530536|NCT00839072|40406286|FG000|Second Intervention Period|Withdrawal by Subject|1|||
16098831|NCT00702520|38849898|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
16098832|NCT00702520|38849899|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
16098833|NCT00702520|38849896|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
16098834|NCT00702520|38849897|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
16098835|NCT00702520|38849898|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
16098836|NCT00702520|38849899|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
16098837|NCT00702520|38849896|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
16098838|NCT00702520|38849897|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
16098839|NCT00702520|38849898|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
16098840|NCT00702520|38849899|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
16530537|NCT00839072|40406287|FG001|Second Intervention Period|Withdrawal by Subject|0|||
16530538|NCT00833638|40406288|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
16530539|NCT00833638|40406289|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
16530540|NCT00833638|40406290|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
16530541|NCT00833638|40406288|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
16530542|NCT00833638|40406289|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
16098841|NCT04361617|38849903|FG000|Overall Study|Withdrawal by Subject|0|||
16098842|NCT04361617|38849904|FG001|Overall Study|Withdrawal by Subject|1|||
16098843|NCT03749616|38849905|FG000|Overall Study|Lost to Follow-up|4|||
16098844|NCT03749616|38849906|FG001|Overall Study|Lost to Follow-up|7|||
16098845|NCT03749616|38849905|FG000|Overall Study|Screen Failure|1|||
16098846|NCT03749616|38849906|FG001|Overall Study|Screen Failure|1|||
16098847|NCT03749616|38849905|FG000|Overall Study|Withdrawal by Subject|2|||
16098848|NCT03749616|38849906|FG001|Overall Study|Withdrawal by Subject|0|||
16098849|NCT01177228|38849907|FG000|Overall Study|Positive tuberculosis test|0|||
16098850|NCT01177228|38849908|FG001|Overall Study|Positive tuberculosis test|1|||
16098851|NCT01177228|38849909|FG002|Overall Study|Positive tuberculosis test|0|||
16098852|NCT01177228|38849910|FG003|Overall Study|Positive tuberculosis test|0|||
16098853|NCT01177228|38849907|FG000|Overall Study|Worsening disease activity|1|||
16098854|NCT01177228|38849908|FG001|Overall Study|Worsening disease activity|0|||
16098855|NCT01177228|38849909|FG002|Overall Study|Worsening disease activity|0|||
16098856|NCT01177228|38849910|FG003|Overall Study|Worsening disease activity|0|||
16098857|NCT01177228|38849907|FG000|Overall Study|Withdrawal by Subject|0|||
16098858|NCT01177228|38849908|FG001|Overall Study|Withdrawal by Subject|1|||
16098859|NCT01177228|38849909|FG002|Overall Study|Withdrawal by Subject|0|||
16098860|NCT01177228|38849910|FG003|Overall Study|Withdrawal by Subject|0|||
16098861|NCT03151551|38849911|FG000|Open-Label Treatment Period|Adverse Event|0|||
16331921|NCT00394771|39700100|FG001|Overall Study|Withdrawal by Subject|6|||
16530543|NCT00833638|40406290|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
16530544|NCT00833638|40406288|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
16530545|NCT00833638|40406289|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
16098862|NCT03151551|38849912|FG001|Open-Label Treatment Period|Adverse Event|2|||
16098863|NCT03151551|38849911|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
16098864|NCT03151551|38849912|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
16098865|NCT03151551|38849911|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
16098866|NCT03151551|38849912|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
16331922|NCT00394771|39700101|FG002|Overall Study|Withdrawal by Subject|8|||
16530546|NCT00833638|40406290|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
16331923|NCT00394771|39700102|FG003|Overall Study|Withdrawal by Subject|12|||
16331924|NCT00394771|39700099|FG000|Overall Study|Adverse Event|10|||
16331925|NCT00394771|39700100|FG001|Overall Study|Adverse Event|5|||
16331926|NCT00394771|39700101|FG002|Overall Study|Adverse Event|12|||
16331927|NCT00394771|39700102|FG003|Overall Study|Adverse Event|8|||
16331928|NCT00394771|39700099|FG000|Overall Study|Participant pregnant|0|||
16331929|NCT00394771|39700100|FG001|Overall Study|Participant pregnant|1|||
16331930|NCT00394771|39700101|FG002|Overall Study|Participant pregnant|2|||
16331931|NCT00394771|39700102|FG003|Overall Study|Participant pregnant|2|||
16331932|NCT00394771|39700099|FG000|Overall Study|Lost to Follow-up|15|||
16331933|NCT00394771|39700100|FG001|Overall Study|Lost to Follow-up|15|||
16331934|NCT00394771|39700101|FG002|Overall Study|Lost to Follow-up|13|||
16331935|NCT00394771|39700102|FG003|Overall Study|Lost to Follow-up|10|||
16331936|NCT00394771|39700099|FG000|Overall Study|Other|3|||
16331937|NCT00394771|39700100|FG001|Overall Study|Other|3|||
16331938|NCT00394771|39700101|FG002|Overall Study|Other|1|||
16331939|NCT00394771|39700102|FG003|Overall Study|Other|0|||
16331940|NCT00401544|39700107|FG000|Overall Study|Adverse Event|5|||
16331941|NCT00401544|39700108|FG001|Overall Study|Adverse Event|1|||
16331942|NCT00401544|39700109|FG002|Overall Study|Adverse Event|1|||
16331943|NCT00401544|39700110|FG003|Overall Study|Adverse Event|1|||
16331944|NCT00401544|39700107|FG000|Overall Study|Death|3|||
16331945|NCT00401544|39700108|FG001|Overall Study|Death|6|||
16331946|NCT00401544|39700109|FG002|Overall Study|Death|2|||
16331947|NCT00401544|39700110|FG003|Overall Study|Death|5|||
16331948|NCT00401544|39700107|FG000|Overall Study|Lost to Follow-up|2|||
16331949|NCT00401544|39700108|FG001|Overall Study|Lost to Follow-up|0|||
16331950|NCT00401544|39700109|FG002|Overall Study|Lost to Follow-up|1|||
16331951|NCT00401544|39700110|FG003|Overall Study|Lost to Follow-up|1|||
16331952|NCT00401544|39700107|FG000|Overall Study|Withdrawal by Subject|7|||
16331953|NCT00401544|39700108|FG001|Overall Study|Withdrawal by Subject|6|||
16331954|NCT00401544|39700109|FG002|Overall Study|Withdrawal by Subject|6|||
16331955|NCT00401544|39700110|FG003|Overall Study|Withdrawal by Subject|5|||
16331956|NCT00401544|39700107|FG000|Overall Study|Physician Decision|1|||
16331957|NCT00401544|39700108|FG001|Overall Study|Physician Decision|3|||
16331958|NCT00401544|39700109|FG002|Overall Study|Physician Decision|0|||
16331959|NCT00401544|39700110|FG003|Overall Study|Physician Decision|0|||
16331960|NCT00401544|39700107|FG000|Overall Study|Ineligibility determined|0|||
16331961|NCT00401544|39700108|FG001|Overall Study|Ineligibility determined|1|||
16331962|NCT00401544|39700109|FG002|Overall Study|Ineligibility determined|0|||
16331963|NCT00401544|39700110|FG003|Overall Study|Ineligibility determined|2|||
16331964|NCT00401544|39700107|FG000|Overall Study|Disease progression|0|||
16331965|NCT00401544|39700108|FG001|Overall Study|Disease progression|1|||
16331966|NCT00401544|39700109|FG002|Overall Study|Disease progression|0|||
16331967|NCT00401544|39700110|FG003|Overall Study|Disease progression|0|||
16331968|NCT00401544|39700107|FG000|Overall Study|Other|0|||
16331969|NCT00401544|39700108|FG001|Overall Study|Other|0|||
16331970|NCT00401544|39700109|FG002|Overall Study|Other|2|||
16331971|NCT00401544|39700110|FG003|Overall Study|Other|2|||
16331972|NCT04500769|39700111|FG000|Overall Study|Withdrawal by Subject|5|||
16331973|NCT00630747|39703246|FG000|Overall Study|Death|1|||
16331974|NCT00630747|39703246|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
16331975|NCT00630747|39703246|FG000|Overall Study|Returned to country of origin|1|||
16331976|NCT02638129|39703247|FG000|Overall Study|Study terminated|28|||
16331977|NCT02638129|39703248|FG001|Overall Study|Study terminated|30|||
16331978|NCT01952080|39703249|FG000|Overall Study|Withdrawal by Subject|0|||
16331979|NCT01952080|39703250|FG001|Overall Study|Withdrawal by Subject|0|||
16331980|NCT01952080|39703251|FG002|Overall Study|Withdrawal by Subject|0|||
16331981|NCT01952080|39703252|FG003|Overall Study|Withdrawal by Subject|1|||
16331982|NCT01952080|39703249|FG000|Overall Study|Protocol Non-compliance|0|||
16331983|NCT01952080|39703250|FG001|Overall Study|Protocol Non-compliance|1|||
16331984|NCT01952080|39703251|FG002|Overall Study|Protocol Non-compliance|0|||
16331985|NCT01952080|39703252|FG003|Overall Study|Protocol Non-compliance|0|||
16331986|NCT04495816|39703253|FG000|Overall Study|Lost to Follow-up|10|||
16331987|NCT04495816|39703254|FG001|Overall Study|Lost to Follow-up|4|||
16331988|NCT04495816|39703253|FG000|Overall Study|Withdrawal by Subject|3|||
16331989|NCT04495816|39703254|FG001|Overall Study|Withdrawal by Subject|5|||
16331990|NCT03536949|39703259|FG000|Overall Study|Adverse Event|4|||
16331991|NCT03536949|39703260|FG001|Overall Study|Adverse Event|0|||
16331992|NCT03536949|39703259|FG000|Overall Study|Lost to Follow-up|2|||
16331993|NCT03536949|39703260|FG001|Overall Study|Lost to Follow-up|1|||
16331994|NCT03536949|39703259|FG000|Overall Study|Withdrawal by Subject|6|||
16331995|NCT03536949|39703260|FG001|Overall Study|Withdrawal by Subject|0|||
16331996|NCT03536949|39703259|FG000|Overall Study|Non-compliance|2|||
16331997|NCT03536949|39703260|FG001|Overall Study|Non-compliance|1|||
16331998|NCT01632904|39703261|FG000|Overall Study|Adverse Event|4|||
16331999|NCT01632904|39703262|FG001|Overall Study|Adverse Event|1|||
16332000|NCT01632904|39703261|FG000|Overall Study|Physician Decision|0|||
16332001|NCT01632904|39703262|FG001|Overall Study|Physician Decision|1|||
16332002|NCT01632904|39703261|FG000|Overall Study|Subject decision|3|||
16332003|NCT01632904|39703262|FG001|Overall Study|Subject decision|2|||
16332004|NCT01632904|39703261|FG000|Overall Study|Disease Progression|0|||
16332005|NCT01632904|39703262|FG001|Overall Study|Disease Progression|1|||
16332006|NCT01632904|39703261|FG000|Overall Study|Reason for discontinuation not available|0|||
16332007|NCT01632904|39703262|FG001|Overall Study|Reason for discontinuation not available|1|||
16332008|NCT03047720|39703264|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
16332009|NCT03047720|39703265|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
16332010|NCT02631070|39703267|FG000|Overall Study|Withdrawal by Subject|35|||
16332011|NCT02631070|39703268|FG001|Overall Study|Withdrawal by Subject|13|||
16332012|NCT02631070|39703267|FG000|Overall Study|Death|45|||
16332013|NCT02631070|39703268|FG001|Overall Study|Death|24|||
16332014|NCT02631070|39703267|FG000|Overall Study|Lost to Follow-up|5|||
16332015|NCT02631070|39703268|FG001|Overall Study|Lost to Follow-up|1|||
16332016|NCT02631070|39703267|FG000|Overall Study|Transition to rollover protocol|52|||
16332017|NCT02631070|39703268|FG001|Overall Study|Transition to rollover protocol|21|||
16332018|NCT02631070|39703267|FG000|Overall Study|Other reasons|12|||
16332019|NCT02631070|39703268|FG001|Overall Study|Other reasons|5|||
16332020|NCT02386345|39703269|FG000|Overall Study|Not treated|14|||
16332021|NCT02386345|39703269|FG000|Overall Study|Lost to Follow-up|1|||
16332022|NCT02386345|39703269|FG000|Overall Study|Adverse Event|5|||
16332023|NCT02386345|39703269|FG000|Overall Study|Repeat Procedure|10|||
16332024|NCT02386345|39703269|FG000|Overall Study|Did not complete 12-month follow-up|72|||
16332025|NCT01764659|39703270|FG000|Overall Study|Death|1|||
16332026|NCT01764659|39703270|FG000|Overall Study|Physician Decision|1|||
16332027|NCT02407054|39703271|FG000|Overall Study|Adverse Event|1|||
16332028|NCT02407054|39703272|FG001|Overall Study|Adverse Event|4|||
16332029|NCT02407054|39703273|FG002|Overall Study|Adverse Event|1|||
16332030|NCT02407054|39703271|FG000|Overall Study|Non-compliance with Study|0|||
16332031|NCT02407054|39703272|FG001|Overall Study|Non-compliance with Study|2|||
16332032|NCT02407054|39703273|FG002|Overall Study|Non-compliance with Study|1|||
16332033|NCT02407054|39703271|FG000|Overall Study|Physician Decision|1|||
16332034|NCT02407054|39703272|FG001|Overall Study|Physician Decision|3|||
16332035|NCT02407054|39703273|FG002|Overall Study|Physician Decision|3|||
16332036|NCT02407054|39703271|FG000|Overall Study|Withdrawal by Subject|5|||
16332037|NCT02407054|39703272|FG001|Overall Study|Withdrawal by Subject|9|||
16332038|NCT02407054|39703273|FG002|Overall Study|Withdrawal by Subject|2|||
16332039|NCT00586898|39703274|FG000|Overall Study|Adverse Event|1|||
16332040|NCT00586898|39703274|FG000|Overall Study|Patiemt Non-compliance|1|||
16332041|NCT00586898|39703274|FG000|Overall Study|Evaluable for Toxicity Only|5|||
16332042|NCT01785849|39703275|FG000|Overall Study|Death|7|||
16332043|NCT01785849|39703276|FG001|Overall Study|Death|9|||
16332044|NCT01785849|39703275|FG000|Overall Study|Protocol Specified Criteria|29|||
16332045|NCT01785849|39703276|FG001|Overall Study|Protocol Specified Criteria|1|||
16332046|NCT01785849|39703275|FG000|Overall Study|Withdrawal by Subject|15|||
16332047|NCT01785849|39703276|FG001|Overall Study|Withdrawal by Subject|12|||
16332048|NCT01785849|39703275|FG000|Overall Study|Sponsor Decision|0|||
16332049|NCT01785849|39703276|FG001|Overall Study|Sponsor Decision|1|||
16332050|NCT01785849|39703275|FG000|Overall Study|Lost to Follow-up|10|||
16332051|NCT01785849|39703276|FG001|Overall Study|Lost to Follow-up|11|||
16332052|NCT01398410|39703277|FG000|Overall Study|Adverse Event|12|||
16332053|NCT01398410|39703278|FG001|Overall Study|Adverse Event|16|||
16332054|NCT01398410|39703277|FG000|Overall Study|Participants Choice|8|||
16332055|NCT01398410|39703278|FG001|Overall Study|Participants Choice|11|||
16332056|NCT01398410|39703277|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
16332057|NCT01398410|39703278|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
16332058|NCT01398410|39703277|FG000|Overall Study|Other|36|||
16332059|NCT01398410|39703278|FG001|Overall Study|Other|29|||
16332060|NCT02945254|39703279|FG000|Overall Study|Lost to Follow-up|1|||
16332061|NCT02945254|39703280|FG001|Overall Study|Lost to Follow-up|0|||
16530547|NCT00833638|40406288|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
16530548|NCT00833638|40406289|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
16530549|NCT00833638|40406290|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
16530550|NCT00833638|40406288|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
16530551|NCT00833638|40406289|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
16530552|NCT00833638|40406290|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
16332062|NCT02945254|39703279|FG000|Overall Study|Withdrawal by Subject|1|||
16332063|NCT02945254|39703280|FG001|Overall Study|Withdrawal by Subject|0|||
16332064|NCT02273908|39703281|FG000|Overall Study|Adverse Event|16|||
16332065|NCT02273908|39703282|FG001|Overall Study|Adverse Event|0|||
16332066|NCT02273908|39703281|FG000|Overall Study|Lost to Follow-up|10|||
16332067|NCT02273908|39703282|FG001|Overall Study|Lost to Follow-up|1|||
16332068|NCT02273908|39703281|FG000|Overall Study|Did not meet entrance criteria|3|||
16332069|NCT02273908|39703282|FG001|Overall Study|Did not meet entrance criteria|2|||
16332070|NCT02273908|39703281|FG000|Overall Study|Withdrawal by Subject|4|||
16332071|NCT02273908|39703282|FG001|Overall Study|Withdrawal by Subject|2|||
16332072|NCT00655681|39703284|FG000|Overall Study|Lost to Follow-up|1|||
16332073|NCT00655681|39703285|FG001|Overall Study|Lost to Follow-up|1|||
16332074|NCT00081731|39703288|FG000|Overall Study|scientific integrity issue|8|||
16332075|NCT00081731|39703289|FG001|Overall Study|scientific integrity issue|8|||
16332076|NCT01783821|39703290|FG000|Overall Study|Screen Failure|1|||
16332077|NCT01783821|39703291|FG001|Overall Study|Screen Failure|1|||
16332078|NCT02388906|39703292|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
16332079|NCT02388906|39703293|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
16332080|NCT02388906|39703292|FG000|Treatment Period|Disease progression|121|||
16332081|NCT02388906|39703293|FG001|Treatment Period|Disease progression|101|||
16332082|NCT02388906|39703292|FG000|Treatment Period|Study drug toxicity|41|||
16530553|NCT00833638|40406288|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
16530554|NCT00833638|40406289|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
16530555|NCT00833638|40406290|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
16530556|NCT00833638|40406288|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
16530557|NCT00833638|40406289|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
16530558|NCT00833638|40406290|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
16530559|NCT00833638|40406288|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
16530560|NCT00833638|40406289|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
16530561|NCT00833638|40406290|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
16530562|NCT00833638|40406288|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
16530563|NCT00833638|40406289|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
16332083|NCT02388906|39703293|FG001|Treatment Period|Study drug toxicity|208|||
16530564|NCT00833638|40406290|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
16530565|NCT02543346|40406291|FG000|Second Priming Visit|Withdrawal by Subject|0|||
16530566|NCT02543346|40406292|FG001|Second Priming Visit|Withdrawal by Subject|2|||
16530567|NCT02543346|40406293|FG002|Second Priming Visit|Withdrawal by Subject|2|||
16530568|NCT02543346|40406294|FG003|Second Priming Visit|Withdrawal by Subject|2|||
16530569|NCT02543346|40406291|FG000|Second Priming Visit|Adverse Event|1|||
16530570|NCT02543346|40406292|FG001|Second Priming Visit|Adverse Event|0|||
16530571|NCT02543346|40406293|FG002|Second Priming Visit|Adverse Event|0|||
16530572|NCT02543346|40406294|FG003|Second Priming Visit|Adverse Event|0|||
16530573|NCT00809757|40406295|FG000|Overall Study|Adverse Event|2|||
16530574|NCT00809757|40406296|FG001|Overall Study|Adverse Event|3|||
16530575|NCT00809757|40406297|FG002|Overall Study|Adverse Event|3|||
16530576|NCT00809757|40406295|FG000|Overall Study|Lost to Follow-up|0|||
16530577|NCT00809757|40406296|FG001|Overall Study|Lost to Follow-up|0|||
16530578|NCT00809757|40406297|FG002|Overall Study|Lost to Follow-up|1|||
16530579|NCT00809757|40406295|FG000|Overall Study|Protocol Violation|1|||
16530580|NCT00809757|40406296|FG001|Overall Study|Protocol Violation|1|||
16530581|NCT00809757|40406297|FG002|Overall Study|Protocol Violation|1|||
16530582|NCT00809757|40406295|FG000|Overall Study|Withdrawal by Subject|2|||
16530583|NCT00809757|40406296|FG001|Overall Study|Withdrawal by Subject|1|||
16530584|NCT00809757|40406297|FG002|Overall Study|Withdrawal by Subject|3|||
16530585|NCT00809757|40406295|FG000|Overall Study|Subject Uncooperative|1|||
16530586|NCT00809757|40406296|FG001|Overall Study|Subject Uncooperative|0|||
16530587|NCT00809757|40406297|FG002|Overall Study|Subject Uncooperative|2|||
16530588|NCT00809757|40406295|FG000|Overall Study|Noncompliance with Medication|0|||
16530589|NCT00809757|40406296|FG001|Overall Study|Noncompliance with Medication|0|||
16530590|NCT00809757|40406297|FG002|Overall Study|Noncompliance with Medication|1|||
16530591|NCT02511431|40406298|FG000|Treatment|Lost to Follow-up|0|||
16213347|NCT04007367|39261828|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
16213348|NCT04007367|39261829|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
16213349|NCT04007367|39261830|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
16213350|NCT04007367|39261828|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
16213351|NCT04007367|39261829|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
16213352|NCT04007367|39261830|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
16213353|NCT01975675|39261836|FG000|Overall Study|Death|0|||
16213354|NCT01975675|39261837|FG001|Overall Study|Death|1|||
16213355|NCT01975675|39261838|FG002|Overall Study|Death|0|||
16213356|NCT01975675|39261839|FG003|Overall Study|Death|0|||
16213357|NCT01998906|39261840|FG000|Overall Study|Participants ongoing in follow-up|77|||
16332084|NCT02388906|39703292|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
16332085|NCT02388906|39703293|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
16332086|NCT02388906|39703292|FG000|Treatment Period|Participant request to stop treatment|5|||
16530592|NCT02511431|40406299|FG001|Treatment|Lost to Follow-up|0|||
16530593|NCT02511431|40406300|FG002|Treatment|Lost to Follow-up|1|||
16530594|NCT02511431|40406301|FG003|Treatment|Lost to Follow-up|0|||
16530595|NCT02511431|40406302|FG004|Treatment|Lost to Follow-up|0|||
16530596|NCT02511431|40406303|FG005|Treatment|Lost to Follow-up|1|||
16530597|NCT01064739|40406304|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
16213358|NCT01998906|39261841|FG001|Overall Study|Participants ongoing in follow-up|60|||
16213359|NCT01998906|39261842|FG002|Overall Study|Participants ongoing in follow-up|58|||
16213360|NCT01998906|39261840|FG000|Overall Study|Death|21|||
16332087|NCT02388906|39703293|FG001|Treatment Period|Participant request to stop treatment|9|||
16530598|NCT00455195|40406305|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
16530599|NCT00455195|40406306|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
16530600|NCT00455195|40406305|FG000|Double-blind Study AGLU02704|Death|1|||
16530601|NCT00455195|40406306|FG001|Double-blind Study AGLU02704|Death|0|||
16530602|NCT00455195|40406305|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
16213361|NCT01998906|39261841|FG001|Overall Study|Death|30|||
16213362|NCT01998906|39261842|FG002|Overall Study|Death|17|||
16213363|NCT01998906|39261840|FG000|Overall Study|Lack of Efficacy|10|||
16213364|NCT01998906|39261841|FG001|Overall Study|Lack of Efficacy|9|||
16530603|NCT00455195|40406306|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
16530604|NCT00455195|40406305|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
16530605|NCT00455195|40406306|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
16530606|NCT03058679|40406307|FG000|Baseline to Week 6|Lost to Follow-up|3|||
16530607|NCT03058679|40406308|FG001|Baseline to Week 6|Lost to Follow-up|2|||
16530608|NCT03058679|40406307|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
16530609|NCT03058679|40406308|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
16530610|NCT03058679|40406307|FG000|Baseline to Week 6|Adverse Event|6|||
16530611|NCT03058679|40406308|FG001|Baseline to Week 6|Adverse Event|6|||
16530612|NCT03058679|40406307|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
16530613|NCT03058679|40406308|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
16530614|NCT03058679|40406307|FG000|Baseline to Week 6|Difficulty following the diet|0|||
16530615|NCT03058679|40406308|FG001|Baseline to Week 6|Difficulty following the diet|2|||
16530616|NCT03058679|40406307|FG000|Baseline to Week 6|Physician Decision|1|||
16530617|NCT03058679|40406308|FG001|Baseline to Week 6|Physician Decision|0|||
16530618|NCT03058679|40406307|FG000|Week 6 to Week 12|Change in medication|5|||
16530619|NCT03058679|40406308|FG001|Week 6 to Week 12|Change in medication|7|||
16213365|NCT01998906|39261842|FG002|Overall Study|Lack of Efficacy|8|||
16213366|NCT01998906|39261840|FG000|Overall Study|Failure to return|0|||
16213367|NCT01998906|39261841|FG001|Overall Study|Failure to return|2|||
16213368|NCT01998906|39261842|FG002|Overall Study|Failure to return|4|||
16213369|NCT01998906|39261840|FG000|Overall Study|Violation of Selection Criteria|0|||
16213370|NCT01998906|39261841|FG001|Overall Study|Violation of Selection Criteria|0|||
16213371|NCT01998906|39261842|FG002|Overall Study|Violation of Selection Criteria|1|||
16213372|NCT01998906|39261840|FG000|Overall Study|Withdrawal by Subject|1|||
16213373|NCT01998906|39261841|FG001|Overall Study|Withdrawal by Subject|4|||
16213374|NCT01998906|39261842|FG002|Overall Study|Withdrawal by Subject|3|||
16213375|NCT01998906|39261840|FG000|Overall Study|Administrative/Other|2|||
16213376|NCT01998906|39261841|FG001|Overall Study|Administrative/Other|1|||
16213377|NCT01998906|39261842|FG002|Overall Study|Administrative/Other|3|||
16213378|NCT01998906|39261840|FG000|Overall Study|Other|3|||
16213379|NCT01998906|39261841|FG001|Overall Study|Other|8|||
16213380|NCT01998906|39261842|FG002|Overall Study|Other|4|||
16213381|NCT00859573|39261844|FG000|Overall Study|Withdrawal by Subject|4|||
16213382|NCT00859573|39261845|FG001|Overall Study|Withdrawal by Subject|1|||
16213383|NCT00859573|39261844|FG000|Overall Study|Physician Decision|1|||
16213384|NCT00859573|39261845|FG001|Overall Study|Physician Decision|1|||
16213385|NCT00653068|39261847|FG000|Overall Study|Death|9|||
16213386|NCT00653068|39261847|FG000|Overall Study|Lack of Efficacy|34|||
16213387|NCT00653068|39261847|FG000|Overall Study|Physician Decision|4|||
16213388|NCT00653068|39261847|FG000|Overall Study|Withdrawal by Subject|1|||
16213389|NCT00653068|39261847|FG000|Overall Study|Ineligible|2|||
16213390|NCT00939055|39261850|FG000|Overall Study|Discontinuation prior to procedure|4|||
16213391|NCT00939055|39261851|FG001|Overall Study|Discontinuation prior to procedure|0|||
16213392|NCT01678560|39261857|FG000|Overall Study|Physician Decision|4|||
16213393|NCT01678560|39261858|FG001|Overall Study|Physician Decision|4|||
16213394|NCT01678560|39261857|FG000|Overall Study|Death|0|||
16530620|NCT03058679|40406307|FG000|Week 6 to Week 12|Adverse Event|4|||
16530621|NCT03058679|40406308|FG001|Week 6 to Week 12|Adverse Event|3|||
16530622|NCT03058679|40406307|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
16530623|NCT03058679|40406308|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
16213395|NCT01678560|39261858|FG001|Overall Study|Death|1|||
16213396|NCT01678560|39261857|FG000|Overall Study|Withdrawal by Subject|0|||
16213397|NCT01678560|39261858|FG001|Overall Study|Withdrawal by Subject|1|||
16213398|NCT00707486|39261860|FG000|Overall Study|Withdrawal by Subject|1|||
16213399|NCT04412668|39261861|FG000|Overall Study|Death - multiple comorbidities|2|||
16213400|NCT04412668|39261862|FG001|Overall Study|Death - multiple comorbidities|0|||
16213401|NCT04412668|39261863|FG002|Overall Study|Death - multiple comorbidities|0|||
16213402|NCT04412668|39261861|FG000|Overall Study|Withdrawal by Subject|3|||
16213403|NCT04412668|39261862|FG001|Overall Study|Withdrawal by Subject|0|||
16213404|NCT04412668|39261863|FG002|Overall Study|Withdrawal by Subject|0|||
16213405|NCT04412668|39261861|FG000|Overall Study|Other than Specified|2|||
16213406|NCT04412668|39261862|FG001|Overall Study|Other than Specified|0|||
16213407|NCT04412668|39261863|FG002|Overall Study|Other than Specified|0|||
16213408|NCT00976963|39261864|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
16401154|NCT01597908|39948503|FG002|Crossover Phase|Death|11|||
16213409|NCT00976963|39261865|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
16213410|NCT00976963|39261864|FG000|Overall Study|administrative error|1|||
16213411|NCT00976963|39261865|FG001|Overall Study|administrative error|0|||
16213412|NCT00976963|39261864|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
16213413|NCT00976963|39261865|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
16213414|NCT02886338|39261866|FG000|Overall Study|Withdrawal by Subject|1|||
16401155|NCT01597908|39948501|FG000|Crossover Phase|Withdrawal by Subject|0|||
16401156|NCT01597908|39948502|FG001|Crossover Phase|Withdrawal by Subject|0|||
16401157|NCT01597908|39948503|FG002|Crossover Phase|Withdrawal by Subject|3|||
16401158|NCT01597908|39948501|FG000|Crossover Phase|Sponsor Decision|0|||
16401159|NCT01597908|39948502|FG001|Crossover Phase|Sponsor Decision|0|||
16401160|NCT01597908|39948503|FG002|Crossover Phase|Sponsor Decision|20|||
16401161|NCT00526656|39948504|FG000|Overall Study|Death|1|||
16401162|NCT00526656|39948504|FG000|Overall Study|Refused surgery|1|||
16401163|NCT00713349|39948505|FG000|Overall Study|Protocol Violation|1|||
16401164|NCT03654040|39948506|FG000|Overall Study|Death|1|||
16401165|NCT03654040|39948507|FG001|Overall Study|Death|0|||
16213415|NCT00446641|39261867|FG000|Overall Study|Withdrawal by Subject|8|||
16213416|NCT00446641|39261868|FG001|Overall Study|Withdrawal by Subject|3|||
16213417|NCT00446641|39261867|FG000|Overall Study|poor compliance|8|||
16213418|NCT00446641|39261868|FG001|Overall Study|poor compliance|6|||
16401166|NCT03654040|39948506|FG000|Overall Study|Withdrawal by Subject|1|||
16401167|NCT03654040|39948507|FG001|Overall Study|Withdrawal by Subject|0|||
16401168|NCT03654040|39948506|FG000|Overall Study|Study terminated by sponsor|8|||
16098867|NCT03151551|38849911|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
16098868|NCT03151551|38849912|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
16098869|NCT03151551|38849911|FG000|Open-Label Treatment Period|Physician Decision|3|||
16098870|NCT03151551|38849912|FG001|Open-Label Treatment Period|Physician Decision|0|||
16098871|NCT03151551|38849911|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
16098872|NCT03151551|38849912|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
16098873|NCT03151551|38849911|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
16098874|NCT03151551|38849912|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
16098875|NCT03151551|38849911|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
16098876|NCT03151551|38849912|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
16098877|NCT03151551|38849911|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
16098878|NCT03151551|38849912|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
16098879|NCT03151551|38849911|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
16098880|NCT03151551|38849912|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
16098881|NCT03050372|38849914|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
16098882|NCT03050372|38849915|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
16098883|NCT03050372|38849914|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
16098884|NCT03050372|38849915|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
16098885|NCT05066230|38849916|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
16098886|NCT05066230|38849917|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
16098887|NCT05066230|38849916|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
16098888|NCT05066230|38849917|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
16098889|NCT05066230|38849916|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
16098890|NCT05066230|38849917|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
16098891|NCT05066230|38849916|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
16098892|NCT05066230|38849917|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
16098893|NCT05066230|38849916|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
16098894|NCT05066230|38849917|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
16098895|NCT05066230|38849916|FG000|After Week 48|Adverse Event|1|||
16098896|NCT05066230|38849917|FG001|After Week 48|Adverse Event|0|||
16098897|NCT05066230|38849916|FG000|After Week 48|Non-compliance with study schedule|1|||
16098898|NCT05066230|38849917|FG001|After Week 48|Non-compliance with study schedule|0|||
16098899|NCT05066230|38849916|FG000|After Week 48|Withdrawal by Subject|0|||
16098900|NCT05066230|38849917|FG001|After Week 48|Withdrawal by Subject|1|||
16098901|NCT05066230|38849916|FG000|After Week 48|Lost to Follow-up|3|||
16098902|NCT05066230|38849917|FG001|After Week 48|Lost to Follow-up|3|||
16098903|NCT05066230|38849916|FG000|After Week 48|Sponsor Request|115|||
16098904|NCT05066230|38849917|FG001|After Week 48|Sponsor Request|111|||
16098905|NCT01951261|38849918|FG000|Overall Study|Death|1|||
16098906|NCT01951261|38849919|FG001|Overall Study|Death|0|||
16098907|NCT01951261|38849918|FG000|Overall Study|Lost to Follow-up|4|||
16098908|NCT01951261|38849919|FG001|Overall Study|Lost to Follow-up|3|||
16213419|NCT00446641|39261867|FG000|Overall Study|Lost to Follow-up|1|||
16213420|NCT00446641|39261868|FG001|Overall Study|Lost to Follow-up|1|||
16213421|NCT00038142|39261869|FG000|Overall Study|Ineligible|1|||
16530624|NCT03058679|40406307|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
16530625|NCT03058679|40406308|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
16530626|NCT00726752|40409927|FG000|Overall Study|Lack of Efficacy|6|||
16530627|NCT00251745|40409929|FG000|Overall Study|Adverse Event|7|||
16530628|NCT00251745|40409930|FG001|Overall Study|Adverse Event|9|||
16530629|NCT00251745|40409931|FG002|Overall Study|Adverse Event|11|||
16530630|NCT00251745|40409929|FG000|Overall Study|Lost to Follow-up|4|||
16530631|NCT00251745|40409930|FG001|Overall Study|Lost to Follow-up|2|||
16530632|NCT00251745|40409931|FG002|Overall Study|Lost to Follow-up|5|||
16530633|NCT00251745|40409929|FG000|Overall Study|Withdrawal by Subject|13|||
16530634|NCT00251745|40409930|FG001|Overall Study|Withdrawal by Subject|7|||
16530635|NCT00251745|40409931|FG002|Overall Study|Withdrawal by Subject|3|||
16213422|NCT00038142|39261870|FG001|Overall Study|Ineligible|0|||
16530636|NCT00251745|40409929|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
16530637|NCT00251745|40409930|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
16530638|NCT00251745|40409931|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
16213423|NCT00038142|39261869|FG000|Overall Study|Progressive Disease|11|||
16213424|NCT00038142|39261870|FG001|Overall Study|Progressive Disease|7|||
16213425|NCT00038142|39261869|FG000|Overall Study|Death|1|||
16213426|NCT00038142|39261870|FG001|Overall Study|Death|0|||
16332088|NCT02388906|39703292|FG000|Treatment Period|Participant withdrew consent|2|||
16332089|NCT02388906|39703293|FG001|Treatment Period|Participant withdrew consent|3|||
16332090|NCT02388906|39703292|FG000|Treatment Period|Poor/non-compliance|0|||
16332091|NCT02388906|39703293|FG001|Treatment Period|Poor/non-compliance|1|||
16332092|NCT02388906|39703292|FG000|Treatment Period|Participant no longer meets study criteria|0|||
16332093|NCT02388906|39703293|FG001|Treatment Period|Participant no longer meets study criteria|1|||
16332094|NCT02388906|39703292|FG000|Treatment Period|Other reasons|3|||
16332095|NCT02388906|39703293|FG001|Treatment Period|Other reasons|3|||
16332096|NCT02515994|39703294|FG000|Overall Study|Protocol Violation|3|||
16332097|NCT02515994|39703295|FG001|Overall Study|Protocol Violation|5|||
16332098|NCT02515994|39703294|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
16332099|NCT02515994|39703295|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
16332100|NCT02515994|39703294|FG000|Overall Study|Adverse Event|3|||
16332101|NCT02515994|39703295|FG001|Overall Study|Adverse Event|1|||
16332102|NCT02515994|39703294|FG000|Overall Study|Withdrawal by Subject|2|||
16332103|NCT02515994|39703295|FG001|Overall Study|Withdrawal by Subject|0|||
16332104|NCT00987402|39703296|FG000|Overall Study|Insufficient data entry|86|||
16401169|NCT03654040|39948507|FG001|Overall Study|Study terminated by sponsor|2|||
16401170|NCT03654040|39948506|FG000|Overall Study|Failure to initiate study therapy|2|||
16213427|NCT00038142|39261869|FG000|Overall Study|Adverse Event|1|||
16332105|NCT00987402|39703297|FG001|Overall Study|Insufficient data entry|98|||
16332106|NCT02669082|39703298|FG000|Overall Study|Adverse Event|1|||
16332107|NCT02258334|39703302|FG000|Overall Study|Adverse Event|1|||
16098909|NCT01951261|38849918|FG000|Overall Study|Protocol Violation|4|||
16098910|NCT01951261|38849919|FG001|Overall Study|Protocol Violation|3|||
16098911|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
16098912|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
16098913|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
16098914|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
16098915|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Death|0|||
16098916|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Death|0|||
16098917|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Death|1|||
16098918|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Death|0|||
16098919|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
16098920|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
16098921|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
16098922|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
16098923|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
16098924|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
16098925|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
16098926|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
16098927|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
16098928|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
16098929|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
16098930|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
16098931|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
16098932|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
16098933|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
16098934|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
16098935|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
16098936|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
16098937|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
16098938|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
16098939|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Other|2|||
16098940|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Other|0|||
16098941|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Other|0|||
16098942|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Other|0|||
16098943|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
16098944|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
16098945|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
16098946|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
16098947|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
16098948|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
16098949|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
16098950|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
16098951|NCT03845517|38849932|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
16098952|NCT03845517|38849933|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
16098953|NCT03845517|38849934|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
16401171|NCT03654040|39948507|FG001|Overall Study|Failure to initiate study therapy|0|||
16401172|NCT03654040|39948506|FG000|Overall Study|Transplanted at another center|2|||
16098954|NCT03845517|38849935|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
16098955|NCT03845517|38849932|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
16098956|NCT03845517|38849933|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
16098957|NCT03845517|38849934|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
16098958|NCT03845517|38849935|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
16098959|NCT03845517|38849932|FG000|Follow-up Period (4 Weeks)|Death|0|||
16098960|NCT03845517|38849933|FG001|Follow-up Period (4 Weeks)|Death|0|||
16098961|NCT03845517|38849934|FG002|Follow-up Period (4 Weeks)|Death|1|||
16098962|NCT03845517|38849935|FG003|Follow-up Period (4 Weeks)|Death|1|||
16098963|NCT03845517|38849932|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
16098964|NCT03845517|38849933|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
16401173|NCT03654040|39948507|FG001|Overall Study|Transplanted at another center|0|||
16530639|NCT00251745|40409929|FG000|Overall Study|Lack of Efficacy|3|||
16098965|NCT03845517|38849934|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
16401174|NCT03654040|39948506|FG000|Overall Study|Failure to meet eligibility criteria|14|||
16530640|NCT00251745|40409930|FG001|Overall Study|Lack of Efficacy|0|||
16530641|NCT00251745|40409931|FG002|Overall Study|Lack of Efficacy|0|||
16530642|NCT00251745|40409929|FG000|Overall Study|Noncompliant|0|||
16530643|NCT00251745|40409930|FG001|Overall Study|Noncompliant|2|||
16530644|NCT00251745|40409931|FG002|Overall Study|Noncompliant|2|||
16530645|NCT00251745|40409929|FG000|Overall Study|Pregnancy|0|||
16530646|NCT00251745|40409930|FG001|Overall Study|Pregnancy|1|||
16530647|NCT00251745|40409931|FG002|Overall Study|Pregnancy|0|||
16530648|NCT00251745|40409929|FG000|Overall Study|Per Subject Request|0|||
16530649|NCT00251745|40409930|FG001|Overall Study|Per Subject Request|0|||
16530650|NCT00251745|40409931|FG002|Overall Study|Per Subject Request|1|||
16530651|NCT00251745|40409929|FG000|Overall Study|Per Investigator Request|1|||
16401175|NCT03654040|39948507|FG001|Overall Study|Failure to meet eligibility criteria|2|||
16401176|NCT03654040|39948506|FG000|Overall Study|No longer transplant candidate|1|||
16401177|NCT03654040|39948507|FG001|Overall Study|No longer transplant candidate|0|||
16401178|NCT03654040|39948506|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
16401179|NCT03654040|39948507|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
16401180|NCT03654040|39948506|FG000|Overall Study|Recipient ineligible|0|||
16401181|NCT03654040|39948507|FG001|Overall Study|Recipient ineligible|2|||
16401182|NCT03654040|39948506|FG000|Overall Study|Received deceased liver|0|||
16401183|NCT03654040|39948507|FG001|Overall Study|Received deceased liver|1|||
16098966|NCT03845517|38849935|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
16098967|NCT03845517|38849932|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
16098968|NCT03845517|38849933|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
16401184|NCT00098748|39948513|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
16530652|NCT00251745|40409930|FG001|Overall Study|Per Investigator Request|0|||
16530653|NCT00251745|40409931|FG002|Overall Study|Per Investigator Request|0|||
16530654|NCT01075074|40409934|FG000|Overall Study|Surgeon changed to open incisional case|1|||
16530655|NCT01075074|40409935|FG001|Overall Study|Surgeon changed to open incisional case|2|||
16530656|NCT01075074|40409936|FG002|Overall Study|Surgeon changed to open incisional case|2|||
16530657|NCT00599326|40409942|FG000|Overall Study|Lost to Follow-up|1|||
16213428|NCT00038142|39261870|FG001|Overall Study|Adverse Event|0|||
16213429|NCT00038142|39261869|FG000|Overall Study|Unknown Reason|8|||
16213430|NCT00038142|39261870|FG001|Overall Study|Unknown Reason|0|||
16530658|NCT00599326|40409942|FG000|Overall Study|Noncompliant|1|||
16530659|NCT03325712|40409943|FG000|Overall Study|Protocol Violation|0|||
16530660|NCT03325712|40409944|FG001|Overall Study|Protocol Violation|0|||
16530661|NCT03325712|40409945|FG002|Overall Study|Protocol Violation|0|||
16530662|NCT03325712|40409946|FG003|Overall Study|Protocol Violation|0|||
16530663|NCT03325712|40409947|FG004|Overall Study|Protocol Violation|1|||
16098969|NCT03845517|38849934|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
16098970|NCT03845517|38849935|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
16530664|NCT03325712|40409948|FG005|Overall Study|Protocol Violation|0|||
16530665|NCT03325712|40409949|FG006|Overall Study|Protocol Violation|0|||
16530666|NCT03325712|40409950|FG007|Overall Study|Protocol Violation|0|||
16530667|NCT03325712|40409943|FG000|Overall Study|Adverse Event|0|||
16530668|NCT03325712|40409944|FG001|Overall Study|Adverse Event|0|||
16530669|NCT03325712|40409945|FG002|Overall Study|Adverse Event|0|||
16530670|NCT03325712|40409946|FG003|Overall Study|Adverse Event|0|||
16530671|NCT03325712|40409947|FG004|Overall Study|Adverse Event|1|||
16213431|NCT02177786|39261871|FG000|Overall Study|Withdrew Consent|2|||
16213432|NCT02177786|39261872|FG001|Overall Study|Withdrew Consent|6|||
16213433|NCT02177786|39261873|FG002|Overall Study|Withdrew Consent|9|||
16098971|NCT03845517|38849932|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
16401185|NCT00098748|39948514|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
16401186|NCT00098748|39948515|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
16401187|NCT00098748|39948513|FG000|Received Study Treatment|Death|2|||
16401188|NCT00098748|39948514|FG001|Received Study Treatment|Death|1|||
16401189|NCT00098748|39948515|FG002|Received Study Treatment|Death|2|||
16530672|NCT03325712|40409948|FG005|Overall Study|Adverse Event|0|||
16530673|NCT03325712|40409949|FG006|Overall Study|Adverse Event|0|||
16530674|NCT03325712|40409950|FG007|Overall Study|Adverse Event|0|||
16098972|NCT03845517|38849933|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
16098973|NCT03845517|38849934|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
16098974|NCT03845517|38849935|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
16098975|NCT03845517|38849932|FG000|Follow-up Period (4 Weeks)|Other|1|||
16098976|NCT03845517|38849933|FG001|Follow-up Period (4 Weeks)|Other|0|||
16098977|NCT03845517|38849934|FG002|Follow-up Period (4 Weeks)|Other|1|||
16213434|NCT02177786|39261874|FG003|Overall Study|Withdrew Consent|5|||
16530675|NCT01159938|40409957|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
16530676|NCT01159938|40409958|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
16530677|NCT01159938|40409959|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
16098978|NCT03845517|38849935|FG003|Follow-up Period (4 Weeks)|Other|0|||
16213435|NCT02177786|39261871|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
16530678|NCT01159938|40409960|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
16530679|NCT01159938|40409961|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
16530680|NCT02252211|40409962|FG000|Overall Study|Adverse Event|0|||
16530681|NCT02252211|40409963|FG001|Overall Study|Adverse Event|1|||
16098979|NCT03845517|38849932|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
16401190|NCT00098748|39948513|FG000|Received Study Treatment|Adverse Event|1|||
16098980|NCT03845517|38849933|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
16332108|NCT02258334|39703303|FG001|Overall Study|Adverse Event|0|||
16332109|NCT02258334|39703304|FG002|Overall Study|Adverse Event|0|||
16530682|NCT02252211|40409964|FG002|Overall Study|Adverse Event|0|||
16530683|NCT02252211|40409962|FG000|Overall Study|Progressive disease|3|||
16530684|NCT02252211|40409963|FG001|Overall Study|Progressive disease|2|||
16530685|NCT02252211|40409964|FG002|Overall Study|Progressive disease|0|||
16530686|NCT02252211|40409962|FG000|Overall Study|Withdrawal by Subject|1|||
16530687|NCT02252211|40409963|FG001|Overall Study|Withdrawal by Subject|0|||
16530688|NCT02252211|40409964|FG002|Overall Study|Withdrawal by Subject|0|||
16530689|NCT02252211|40409962|FG000|Overall Study|Serious Adverse Event During Screening|1|||
16530690|NCT02252211|40409963|FG001|Overall Study|Serious Adverse Event During Screening|0|||
16530691|NCT02252211|40409964|FG002|Overall Study|Serious Adverse Event During Screening|1|||
16332110|NCT02258334|39703305|FG003|Overall Study|Adverse Event|0|||
16332111|NCT00932451|39703306|FG000|Overall Study|Withdrawal by Subject|69|||
16332112|NCT00932451|39703306|FG000|Overall Study|Lost to Follow-up|22|||
16530692|NCT00492284|40409968|FG000|Overall Study|Adverse Event|0|||
16530693|NCT00492284|40409969|FG001|Overall Study|Adverse Event|1|||
16530694|NCT00492284|40409970|FG002|Overall Study|Adverse Event|1|||
16530695|NCT00492284|40409971|FG003|Overall Study|Adverse Event|2|||
16530696|NCT00492284|40409968|FG000|Overall Study|Lost to Follow-up|0|||
16530697|NCT00492284|40409969|FG001|Overall Study|Lost to Follow-up|0|||
16530698|NCT00492284|40409970|FG002|Overall Study|Lost to Follow-up|3|||
16530699|NCT00492284|40409971|FG003|Overall Study|Lost to Follow-up|1|||
16332113|NCT00932451|39703306|FG000|Overall Study|Death|726|||
16530700|NCT00492284|40409968|FG000|Overall Study|Death|0|||
16530701|NCT00492284|40409969|FG001|Overall Study|Death|3|||
16530702|NCT00492284|40409970|FG002|Overall Study|Death|2|||
16530703|NCT00492284|40409971|FG003|Overall Study|Death|5|||
16530704|NCT00492284|40409968|FG000|Overall Study|Withdrawal by Subject|1|||
16530705|NCT00492284|40409969|FG001|Overall Study|Withdrawal by Subject|0|||
16530706|NCT00492284|40409970|FG002|Overall Study|Withdrawal by Subject|0|||
16530707|NCT00492284|40409971|FG003|Overall Study|Withdrawal by Subject|2|||
16530708|NCT01747772|40409972|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
16530709|NCT00773968|40409973|FG000|Overall Study|Adverse Event|2|||
16530710|NCT00773968|40409973|FG000|Overall Study|Death|1|||
16530711|NCT00773968|40409973|FG000|Overall Study|Failure to Return|2|||
16530712|NCT00773968|40409973|FG000|Overall Study|Lack of Efficacy|3|||
16530713|NCT00773968|40409973|FG000|Overall Study|Protocol Violation|1|||
16530714|NCT00773968|40409973|FG000|Overall Study|Withdrawal by Subject|11|||
16530715|NCT00773968|40409973|FG000|Overall Study|Screen Failure|17|||
16530716|NCT00773968|40409973|FG000|Overall Study|Other|8|||
16530717|NCT02862457|40409980|FG000|Overall Study|Death|1|||
16530718|NCT02862457|40409981|FG001|Overall Study|Death|3|||
16530719|NCT02862457|40409982|FG002|Overall Study|Death|2|||
16530720|NCT02862457|40409983|FG003|Overall Study|Death|3|||
16530721|NCT02862457|40409984|FG004|Overall Study|Death|0|||
16530722|NCT02862457|40409985|FG005|Overall Study|Death|2|||
16530723|NCT02862457|40409986|FG006|Overall Study|Death|1|||
16530724|NCT02862457|40409980|FG000|Overall Study|Lost to Follow-up|1|||
16530725|NCT02862457|40409981|FG001|Overall Study|Lost to Follow-up|0|||
16530726|NCT02862457|40409982|FG002|Overall Study|Lost to Follow-up|0|||
16332114|NCT00932451|39703306|FG000|Overall Study|Other reasons|5|||
16332115|NCT00710684|39703307|FG000|Overall Study|Adverse Event|11|||
16332116|NCT00710684|39703308|FG001|Overall Study|Adverse Event|19|||
16332117|NCT00710684|39703309|FG002|Overall Study|Adverse Event|16|||
16332118|NCT00710684|39703307|FG000|Overall Study|Lack of Efficacy|4|||
16332119|NCT00710684|39703308|FG001|Overall Study|Lack of Efficacy|3|||
16332120|NCT00710684|39703309|FG002|Overall Study|Lack of Efficacy|5|||
16332121|NCT00710684|39703307|FG000|Overall Study|Protocol Violation|5|||
16332122|NCT00710684|39703308|FG001|Overall Study|Protocol Violation|5|||
16332123|NCT00710684|39703309|FG002|Overall Study|Protocol Violation|5|||
16332124|NCT00710684|39703307|FG000|Overall Study|Lost to Follow-up|4|||
16401191|NCT00098748|39948514|FG001|Received Study Treatment|Adverse Event|2|||
16401192|NCT00098748|39948515|FG002|Received Study Treatment|Adverse Event|5|||
16530727|NCT02862457|40409983|FG003|Overall Study|Lost to Follow-up|1|||
16530728|NCT02862457|40409984|FG004|Overall Study|Lost to Follow-up|0|||
16530729|NCT02862457|40409985|FG005|Overall Study|Lost to Follow-up|0|||
16530730|NCT02862457|40409986|FG006|Overall Study|Lost to Follow-up|0|||
16530731|NCT02862457|40409980|FG000|Overall Study|Withdrawal by Subject|0|||
16530732|NCT02862457|40409981|FG001|Overall Study|Withdrawal by Subject|0|||
16530733|NCT02862457|40409982|FG002|Overall Study|Withdrawal by Subject|1|||
16098981|NCT03845517|38849934|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
16332125|NCT00710684|39703308|FG001|Overall Study|Lost to Follow-up|6|||
16332126|NCT00710684|39703309|FG002|Overall Study|Lost to Follow-up|7|||
16332127|NCT00710684|39703307|FG000|Overall Study|Physician Decision|0|||
16530734|NCT02862457|40409983|FG003|Overall Study|Withdrawal by Subject|0|||
16530735|NCT02862457|40409984|FG004|Overall Study|Withdrawal by Subject|0|||
16530736|NCT02862457|40409985|FG005|Overall Study|Withdrawal by Subject|1|||
16530737|NCT02862457|40409986|FG006|Overall Study|Withdrawal by Subject|0|||
16213436|NCT02177786|39261872|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
16213437|NCT02177786|39261873|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
16213438|NCT02177786|39261874|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
16213439|NCT02177786|39261871|FG000|Overall Study|Adverse Event|1|||
16213440|NCT02177786|39261872|FG001|Overall Study|Adverse Event|1|||
16213441|NCT02177786|39261873|FG002|Overall Study|Adverse Event|2|||
16213442|NCT02177786|39261874|FG003|Overall Study|Adverse Event|3|||
16213443|NCT02177786|39261871|FG000|Overall Study|Death|1|||
16213444|NCT02177786|39261872|FG001|Overall Study|Death|1|||
16213445|NCT02177786|39261873|FG002|Overall Study|Death|1|||
16213446|NCT02177786|39261874|FG003|Overall Study|Death|1|||
16213447|NCT02177786|39261871|FG000|Overall Study|Lost to Follow-up|0|||
16213448|NCT02177786|39261872|FG001|Overall Study|Lost to Follow-up|0|||
16213449|NCT02177786|39261873|FG002|Overall Study|Lost to Follow-up|2|||
16213450|NCT02177786|39261874|FG003|Overall Study|Lost to Follow-up|2|||
16213451|NCT02177786|39261871|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16213452|NCT02177786|39261872|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16213453|NCT02177786|39261873|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16213454|NCT02177786|39261874|FG003|Overall Study|Non-Compliance with Study Drug|1|||
16213455|NCT02177786|39261871|FG000|Overall Study|Protocol Violation|0|||
16213456|NCT02177786|39261872|FG001|Overall Study|Protocol Violation|0|||
16213457|NCT02177786|39261873|FG002|Overall Study|Protocol Violation|2|||
16213458|NCT02177786|39261874|FG003|Overall Study|Protocol Violation|0|||
16213459|NCT02177786|39261871|FG000|Overall Study|Progressive Disease|0|||
16213460|NCT02177786|39261872|FG001|Overall Study|Progressive Disease|1|||
16213461|NCT02177786|39261873|FG002|Overall Study|Progressive Disease|0|||
16213462|NCT02177786|39261874|FG003|Overall Study|Progressive Disease|0|||
16213463|NCT02177786|39261871|FG000|Overall Study|Missing study completion status|0|||
16213464|NCT02177786|39261872|FG001|Overall Study|Missing study completion status|1|||
16213465|NCT02177786|39261873|FG002|Overall Study|Missing study completion status|0|||
16213466|NCT02177786|39261874|FG003|Overall Study|Missing study completion status|0|||
16213467|NCT00832091|39261876|FG000|Overall Study|Adverse Event|1|||
16213468|NCT00832091|39261877|FG001|Overall Study|Adverse Event|1|||
16213469|NCT00832091|39261876|FG000|Overall Study|Protocol Violation|1|||
16213470|NCT00832091|39261877|FG001|Overall Study|Protocol Violation|0|||
16213471|NCT00832091|39261876|FG000|Overall Study|Withdrawal by Subject|2|||
16213472|NCT00832091|39261877|FG001|Overall Study|Withdrawal by Subject|1|||
16213473|NCT00832091|39261876|FG000|Overall Study|Prohibited Medication|1|||
16213474|NCT00832091|39261877|FG001|Overall Study|Prohibited Medication|0|||
16213475|NCT00063986|39261878|FG000|Overall Study|Withdrawal by Subject|1|||
16213476|NCT00063986|39261878|FG000|Overall Study|Ineligible|1|||
16213477|NCT00063986|39261878|FG000|Overall Study|Intra-operatively ineligible|4|||
16213478|NCT01764022|39261879|FG000|Overall Study|Death|3|||
16213479|NCT01764022|39261880|FG001|Overall Study|Death|5|||
16213480|NCT01764022|39261879|FG000|Overall Study|Withdrawal by Subject|2|||
16213481|NCT01764022|39261880|FG001|Overall Study|Withdrawal by Subject|6|||
16213482|NCT01764022|39261879|FG000|Overall Study|Lack of Efficacy|0|||
16213483|NCT01764022|39261880|FG001|Overall Study|Lack of Efficacy|1|||
16213484|NCT01764022|39261879|FG000|Overall Study|Physician Decision|0|||
16213485|NCT01764022|39261880|FG001|Overall Study|Physician Decision|2|||
16401193|NCT00098748|39948513|FG000|Received Study Treatment|Lack of Efficacy|40|||
16401194|NCT00098748|39948514|FG001|Received Study Treatment|Lack of Efficacy|27|||
16401195|NCT00098748|39948515|FG002|Received Study Treatment|Lack of Efficacy|27|||
16401196|NCT00098748|39948513|FG000|Received Study Treatment|Other|2|||
16401197|NCT00098748|39948514|FG001|Received Study Treatment|Other|2|||
16401198|NCT00098748|39948515|FG002|Received Study Treatment|Other|6|||
16401199|NCT00098748|39948513|FG000|Received Study Treatment|Subject defaulted|3|||
16401200|NCT00098748|39948514|FG001|Received Study Treatment|Subject defaulted|4|||
16401201|NCT00098748|39948515|FG002|Received Study Treatment|Subject defaulted|4|||
16401202|NCT00098748|39948513|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
16401203|NCT00098748|39948514|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
16530738|NCT01750268|40409987|FG000|Overall Study|Lost to Follow-up|0|||
16530739|NCT01750268|40409988|FG001|Overall Study|Lost to Follow-up|2|||
16213486|NCT01764022|39261879|FG000|Overall Study|Lost to Follow-up|2|||
16213487|NCT01764022|39261880|FG001|Overall Study|Lost to Follow-up|0|||
16213488|NCT01764022|39261879|FG000|Overall Study|Protocol Violation|1|||
16213489|NCT01764022|39261880|FG001|Overall Study|Protocol Violation|0|||
16213490|NCT02148952|39261885|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
16213491|NCT02148952|39261886|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
16213492|NCT02148952|39261885|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
16213493|NCT02148952|39261886|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
16213494|NCT02148952|39261885|FG000|Follow-Up|Lost to Follow-up|219|||
16213495|NCT02148952|39261886|FG001|Follow-Up|Lost to Follow-up|231|||
16213496|NCT02148952|39261885|FG000|Follow-Up|Withdrawal by Subject|46|||
16213497|NCT02148952|39261886|FG001|Follow-Up|Withdrawal by Subject|48|||
16401204|NCT00098748|39948515|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
16213498|NCT03607994|39261887|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
16213499|NCT03607994|39261888|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
16213500|NCT04159701|39261889|FG000|Period 1: Treatment Period|Pregnancy|1|||
16213501|NCT04159701|39261890|FG001|Period 1: Treatment Period|Pregnancy|0|||
16213502|NCT04159701|39261889|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
16213503|NCT04159701|39261890|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
16213504|NCT04159701|39261889|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
16213505|NCT04159701|39261890|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
16213506|NCT04159701|39261889|FG000|Washout Period|site terminated by sponsor|0|||
16213507|NCT04159701|39261890|FG001|Washout Period|site terminated by sponsor|1|||
16213508|NCT04159701|39261889|FG000|Washout Period|study terminated by sponsor|10|||
16213509|NCT04159701|39261890|FG001|Washout Period|study terminated by sponsor|3|||
16213510|NCT04159701|39261889|FG000|Washout Period|Withdrawal by Subject|1|||
16213511|NCT04159701|39261890|FG001|Washout Period|Withdrawal by Subject|0|||
16213512|NCT04159701|39261889|FG000|Washout Period|Inadvertent Enrollment|1|||
16213513|NCT04159701|39261890|FG001|Washout Period|Inadvertent Enrollment|0|||
16213514|NCT04159701|39261889|FG000|Washout Period|Miscellaneous|1|||
16213515|NCT04159701|39261890|FG001|Washout Period|Miscellaneous|0|||
16213516|NCT04159701|39261889|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
16213517|NCT04159701|39261890|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
16213518|NCT04159701|39261889|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
16213519|NCT04159701|39261890|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
16213520|NCT04159701|39261889|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
16213521|NCT04159701|39261890|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
16213522|NCT04159701|39261889|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
16213523|NCT04159701|39261890|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
16213524|NCT04159701|39261889|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
16213525|NCT04159701|39261890|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
16213526|NCT03442595|39261891|FG000|Overall Study|Lost to Follow-up|94|||
16213527|NCT03442595|39261892|FG001|Overall Study|Lost to Follow-up|0|||
16213528|NCT02623699|39261893|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213529|NCT02623699|39261894|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
16213530|NCT02623699|39261895|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213531|NCT02623699|39261896|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213532|NCT02623699|39261897|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213533|NCT02623699|39261898|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213534|NCT02623699|39261899|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213535|NCT02623699|39261900|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213536|NCT02623699|39261901|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213537|NCT02623699|39261902|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213538|NCT02623699|39261903|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213539|NCT02623699|39261904|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
16213540|NCT02623699|39261893|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213541|NCT02623699|39261894|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213542|NCT02623699|39261895|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213543|NCT02623699|39261896|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213544|NCT02623699|39261897|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213545|NCT02623699|39261898|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213546|NCT02623699|39261899|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
16213547|NCT02623699|39261900|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213548|NCT02623699|39261901|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213549|NCT02623699|39261902|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213550|NCT02623699|39261903|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213551|NCT02623699|39261904|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
16213552|NCT02623699|39261893|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16213553|NCT02623699|39261894|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16213554|NCT02623699|39261895|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16213555|NCT02623699|39261896|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16213556|NCT02623699|39261897|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16530740|NCT01750268|40409987|FG000|Overall Study|Physician Decision|0|||
16530741|NCT01750268|40409988|FG001|Overall Study|Physician Decision|3|||
16530742|NCT01750268|40409987|FG000|Overall Study|Withdrawal by Subject|2|||
16530743|NCT01750268|40409988|FG001|Overall Study|Withdrawal by Subject|0|||
16213557|NCT02623699|39261898|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
16213558|NCT02623699|39261899|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16213559|NCT02623699|39261900|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16213560|NCT02623699|39261901|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16213561|NCT02623699|39261902|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16213562|NCT02623699|39261903|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16213563|NCT02623699|39261904|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
16530744|NCT00553267|40409989|FG000|Overall Study|Adverse Event|8|||
16213564|NCT02623699|39261893|FG000|Part B (Up to 289 Days)|Death|0|||
16213565|NCT02623699|39261894|FG001|Part B (Up to 289 Days)|Death|0|||
16213566|NCT02623699|39261895|FG002|Part B (Up to 289 Days)|Death|0|||
16213567|NCT02623699|39261896|FG003|Part B (Up to 289 Days)|Death|0|||
16213568|NCT02623699|39261897|FG004|Part B (Up to 289 Days)|Death|0|||
16213569|NCT02623699|39261898|FG005|Part B (Up to 289 Days)|Death|1|||
16213570|NCT02623699|39261899|FG006|Part B (Up to 289 Days)|Death|1|||
16213571|NCT02623699|39261900|FG007|Part B (Up to 289 Days)|Death|0|||
16213572|NCT02623699|39261901|FG008|Part B (Up to 289 Days)|Death|1|||
16213573|NCT02623699|39261902|FG009|Part B (Up to 289 Days)|Death|0|||
16213574|NCT02623699|39261903|FG010|Part B (Up to 289 Days)|Death|0|||
16213575|NCT02623699|39261904|FG011|Part B (Up to 289 Days)|Death|0|||
16213576|NCT02623699|39261893|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
16213577|NCT02623699|39261894|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
16213578|NCT02623699|39261895|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
16213579|NCT02623699|39261896|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
16213580|NCT02623699|39261897|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
16213581|NCT02623699|39261898|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
16213582|NCT02623699|39261899|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
16213583|NCT02623699|39261900|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
16213584|NCT02623699|39261901|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
16213585|NCT02623699|39261902|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
16213586|NCT02623699|39261903|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
16213587|NCT02623699|39261904|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
16213588|NCT02623699|39261893|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
16213589|NCT02623699|39261894|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
16213590|NCT02623699|39261895|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
16213591|NCT02623699|39261896|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
16213592|NCT02623699|39261897|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
16213593|NCT02623699|39261898|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
16213594|NCT02623699|39261899|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
16213595|NCT02623699|39261900|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
16213596|NCT02623699|39261901|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
16213597|NCT02623699|39261902|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
16213598|NCT02623699|39261903|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
16213599|NCT02623699|39261904|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
16213600|NCT02623699|39261893|FG000|Part C (Up to 236 Days)|Death|0|||
16213601|NCT02623699|39261894|FG001|Part C (Up to 236 Days)|Death|0|||
16213602|NCT02623699|39261895|FG002|Part C (Up to 236 Days)|Death|0|||
16213603|NCT02623699|39261896|FG003|Part C (Up to 236 Days)|Death|0|||
16213604|NCT02623699|39261897|FG004|Part C (Up to 236 Days)|Death|0|||
16213605|NCT02623699|39261898|FG005|Part C (Up to 236 Days)|Death|0|||
16213606|NCT02623699|39261899|FG006|Part C (Up to 236 Days)|Death|0|||
16213607|NCT02623699|39261900|FG007|Part C (Up to 236 Days)|Death|0|||
16213608|NCT02623699|39261901|FG008|Part C (Up to 236 Days)|Death|0|||
16213609|NCT02623699|39261902|FG009|Part C (Up to 236 Days)|Death|0|||
16213610|NCT02623699|39261903|FG010|Part C (Up to 236 Days)|Death|0|||
16213611|NCT02623699|39261904|FG011|Part C (Up to 236 Days)|Death|1|||
16213612|NCT02623699|39261893|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
16213613|NCT02623699|39261894|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
16213614|NCT02623699|39261895|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
16213615|NCT02623699|39261896|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
16213616|NCT02623699|39261897|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
16213617|NCT02623699|39261898|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
16213618|NCT02623699|39261899|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
16213619|NCT02623699|39261900|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
16213620|NCT02623699|39261901|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
16401205|NCT00098748|39948513|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
16530745|NCT00553267|40409990|FG001|Overall Study|Adverse Event|10|||
16530746|NCT00553267|40409991|FG002|Overall Study|Adverse Event|5|||
16530747|NCT00553267|40409989|FG000|Overall Study|Non compliant with protocol|3|||
16530748|NCT00553267|40409990|FG001|Overall Study|Non compliant with protocol|3|||
16213621|NCT02623699|39261902|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
16213622|NCT02623699|39261903|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
16213623|NCT02623699|39261904|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
16213624|NCT00290355|39261905|FG000|Overall Study|Serious adverse event|7|||
16213625|NCT00290355|39261906|FG001|Overall Study|Serious adverse event|4|||
16213626|NCT00290355|39261905|FG000|Overall Study|Study product reactogenicity|1|||
16213627|NCT00290355|39261906|FG001|Overall Study|Study product reactogenicity|0|||
16213628|NCT00290355|39261905|FG000|Overall Study|Protocol Violation|1|||
16213629|NCT00290355|39261906|FG001|Overall Study|Protocol Violation|0|||
16213630|NCT00290355|39261905|FG000|Overall Study|Withdrawal by Subject|2|||
16213631|NCT00290355|39261906|FG001|Overall Study|Withdrawal by Subject|0|||
16213632|NCT00290355|39261905|FG000|Overall Study|Migrated / moved from the study area|1|||
16213633|NCT00290355|39261906|FG001|Overall Study|Migrated / moved from the study area|0|||
16530749|NCT00553267|40409991|FG002|Overall Study|Non compliant with protocol|2|||
16213634|NCT00290355|39261905|FG000|Overall Study|Lost to Follow-up|3|||
16213635|NCT00290355|39261906|FG001|Overall Study|Lost to Follow-up|1|||
16213636|NCT00290355|39261905|FG000|Overall Study|Other|2|||
16213637|NCT00290355|39261906|FG001|Overall Study|Other|0|||
16213638|NCT02853123|39261908|FG000|Treatment Period 1|Adverse Event|0|||
16213639|NCT02853123|39261909|FG001|Treatment Period 1|Adverse Event|3|||
16213640|NCT02853123|39261908|FG000|Washout Period|Worsening of COPD|0|||
16213641|NCT02853123|39261909|FG001|Washout Period|Worsening of COPD|3|||
16213642|NCT02853123|39261908|FG000|Washout Period|Adverse Event|1|||
16213643|NCT02853123|39261909|FG001|Washout Period|Adverse Event|0|||
16213644|NCT00809614|39261910|FG000|Overall Study|Lack of Efficacy|2|||
16213645|NCT00809614|39261911|FG001|Overall Study|Lack of Efficacy|3|||
16213646|NCT00809614|39261910|FG000|Overall Study|Withdrawal by Subject|1|||
16213647|NCT00809614|39261911|FG001|Overall Study|Withdrawal by Subject|1|||
16213648|NCT02332876|39261912|FG000|Overall Study|Lost to Follow-up|1|||
16213649|NCT02332876|39261913|FG001|Overall Study|Lost to Follow-up|1|||
16213650|NCT00441012|39261914|FG000|Overall Study|Adverse Event|0|||
16213651|NCT00441012|39261915|FG001|Overall Study|Adverse Event|1|||
16213652|NCT00441012|39261914|FG000|Overall Study|Lost to Follow-up|3|||
16213653|NCT00441012|39261915|FG001|Overall Study|Lost to Follow-up|3|||
16213654|NCT00441012|39261914|FG000|Overall Study|Protocol Violation|10|||
16213655|NCT00441012|39261915|FG001|Overall Study|Protocol Violation|9|||
16213656|NCT00441012|39261914|FG000|Overall Study|Withdrawal by Subject|4|||
16213657|NCT00441012|39261915|FG001|Overall Study|Withdrawal by Subject|0|||
16213658|NCT00441012|39261914|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
16213659|NCT00441012|39261915|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
16213660|NCT02736929|39261917|FG000|Main Study|Lost to Follow-up|7|||
16213661|NCT02736929|39261918|FG001|Main Study|Lost to Follow-up|1|||
16213662|NCT02736929|39261919|FG002|Main Study|Lost to Follow-up|0|||
16213663|NCT02736929|39261917|FG000|Main Study|Withdrawal by Subject|1|||
16213664|NCT02736929|39261918|FG001|Main Study|Withdrawal by Subject|1|||
16213665|NCT02736929|39261919|FG002|Main Study|Withdrawal by Subject|0|||
16213666|NCT02736929|39261917|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
16213667|NCT02736929|39261918|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
16213668|NCT02736929|39261919|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
16213669|NCT01010776|39261922|FG000|Main Phase|Withdrawal by Subject|14|||
16213670|NCT01010776|39261922|FG000|Main Phase|Lack of Efficacy|8|||
16213671|NCT01010776|39261922|FG000|Main Phase|Adverse Event|7|||
16213672|NCT01010776|39261922|FG000|Main Phase|Lost to Follow-up|6|||
16213673|NCT01010776|39261922|FG000|Main Phase|Non-compliance to study medication|5|||
16213674|NCT01010776|39261922|FG000|Main Phase|Selection failure|2|||
16213675|NCT01010776|39261922|FG000|Main Phase|Inform consent withdrawal|1|||
16213676|NCT01010776|39261922|FG000|Main Phase|Other|1|||
16213677|NCT01010776|39261922|FG000|Main Phase|Did not received study medication|5|||
16213678|NCT01010776|39261922|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
16530750|NCT00553267|40409989|FG000|Overall Study|Lost to Follow-up|0|||
16530751|NCT00553267|40409990|FG001|Overall Study|Lost to Follow-up|0|||
16530752|NCT00553267|40409991|FG002|Overall Study|Lost to Follow-up|1|||
16530753|NCT00553267|40409989|FG000|Overall Study|Consent withdrawn|2|||
16530754|NCT00553267|40409990|FG001|Overall Study|Consent withdrawn|3|||
16530755|NCT00553267|40409991|FG002|Overall Study|Consent withdrawn|1|||
16530756|NCT00553267|40409989|FG000|Overall Study|Specified category|1|||
16530757|NCT00553267|40409990|FG001|Overall Study|Specified category|2|||
16530758|NCT00553267|40409991|FG002|Overall Study|Specified category|1|||
16530759|NCT00374322|40409992|FG000|Overall Study|Lost to Follow-up|92|||
16530760|NCT00374322|40409993|FG001|Overall Study|Lost to Follow-up|90|||
16530761|NCT00374322|40409992|FG000|Overall Study|Protocol Violation|8|||
16530762|NCT00374322|40409993|FG001|Overall Study|Protocol Violation|3|||
16530763|NCT00374322|40409992|FG000|Overall Study|Withdrawal by Subject|235|||
16530764|NCT00374322|40409993|FG001|Overall Study|Withdrawal by Subject|167|||
16530765|NCT00374322|40409992|FG000|Overall Study|Sponsor Terminated Study|866|||
16530766|NCT00374322|40409993|FG001|Overall Study|Sponsor Terminated Study|990|||
16530767|NCT00374322|40409992|FG000|Overall Study|Physician Decision|36|||
16530768|NCT00374322|40409993|FG001|Overall Study|Physician Decision|32|||
16213679|NCT01010776|39261922|FG000|Extension Phase|Other|3|||
16530769|NCT00374322|40409992|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
16530770|NCT00374322|40409993|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
16530771|NCT00374322|40409992|FG000|Overall Study|Sponsor Decision|2|||
16530772|NCT00374322|40409993|FG001|Overall Study|Sponsor Decision|3|||
16530773|NCT00374322|40409992|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
16213680|NCT01431521|39261923|FG000|Overall Study|Withdrawal by Subject|0|||
16213681|NCT01431521|39261924|FG001|Overall Study|Withdrawal by Subject|0|||
16213682|NCT01431521|39261925|FG002|Overall Study|Withdrawal by Subject|1|||
16213683|NCT01431521|39261926|FG003|Overall Study|Withdrawal by Subject|0|||
16213684|NCT00333970|39261930|FG000|Overall Study|Withdrawal by Subject|13|||
16213685|NCT00333970|39261931|FG001|Overall Study|Withdrawal by Subject|7|||
16213686|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
16213687|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
16213688|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
16213689|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
16213690|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
16213691|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
16213692|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
16213693|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
16213694|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
16213695|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
16213696|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
16213697|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
16213698|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
16213699|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
16213700|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
16213701|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
16213702|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
16213703|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
16213704|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
16213705|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
16213706|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
16213707|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
16213708|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
16213709|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
16530774|NCT00374322|40409993|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
16530775|NCT00374322|40409992|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
16530776|NCT00374322|40409993|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
16530777|NCT00374322|40409992|FG000|Overall Study|Severe Toxicity|1|||
16530778|NCT00374322|40409993|FG001|Overall Study|Severe Toxicity|0|||
16530779|NCT00374322|40409992|FG000|Overall Study|Site Closed|2|||
16530780|NCT00374322|40409993|FG001|Overall Study|Site Closed|2|||
16530781|NCT00374322|40409992|FG000|Overall Study|Participant Changed Physician|1|||
16530782|NCT00374322|40409993|FG001|Overall Study|Participant Changed Physician|0|||
16530783|NCT00374322|40409992|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
16213710|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
16213711|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
16213712|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
16213713|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
16213714|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
16213715|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
16213716|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
16213717|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
16213718|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
16213719|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
16213720|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
16213721|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
16530784|NCT00374322|40409993|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
16530785|NCT00374322|40409992|FG000|Overall Study|Noncompliance with Study Requirements|0|||
16530786|NCT00374322|40409993|FG001|Overall Study|Noncompliance with Study Requirements|1|||
16530787|NCT00374322|40409992|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
16530788|NCT00374322|40409993|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
16530789|NCT00374322|40409992|FG000|Overall Study|Did Not Receive Study Medication|8|||
16530790|NCT00374322|40409993|FG001|Overall Study|Did Not Receive Study Medication|6|||
16530791|NCT02827877|40410000|FG000|Overall Study|Withdrawal by Subject|1|||
16530792|NCT00688636|40410001|FG000|Overall Study|Adverse Event|2|||
16530793|NCT00688636|40410002|FG001|Overall Study|Adverse Event|1|||
16213722|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
16213723|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
16530794|NCT03043664|40410004|FG000|Overall Study|Lost to Follow-up|1|||
16530795|NCT01816594|40410005|FG000|Overall Study|Local Progress|0|||
16530796|NCT01816594|40410006|FG001|Overall Study|Local Progress|2|||
16213724|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
16332128|NCT00710684|39703308|FG001|Overall Study|Physician Decision|2|||
16332129|NCT00710684|39703309|FG002|Overall Study|Physician Decision|4|||
16332130|NCT00710684|39703307|FG000|Overall Study|Withdrawal by Subject|24|||
16332131|NCT00710684|39703308|FG001|Overall Study|Withdrawal by Subject|18|||
16332132|NCT00710684|39703309|FG002|Overall Study|Withdrawal by Subject|11|||
16332133|NCT00710684|39703307|FG000|Overall Study|Missing|1|||
16332134|NCT00710684|39703308|FG001|Overall Study|Missing|0|||
16530797|NCT01816594|40410005|FG000|Overall Study|Adverse Event|9|||
16530798|NCT01816594|40410006|FG001|Overall Study|Adverse Event|0|||
16332135|NCT00710684|39703309|FG002|Overall Study|Missing|0|||
16401206|NCT00098748|39948514|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
16401207|NCT00098748|39948515|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
16401208|NCT00098748|39948513|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
16401209|NCT00098748|39948514|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
16401210|NCT00098748|39948515|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
16401211|NCT00098748|39948513|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
16401212|NCT00098748|39948514|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
16401213|NCT00098748|39948515|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
16401214|NCT00098748|39948513|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
16401215|NCT00098748|39948514|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
16401216|NCT00098748|39948515|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
16401217|NCT02152371|39948516|FG000|Overall Study|Adverse Event|6|||
16401218|NCT02152371|39948517|FG001|Overall Study|Adverse Event|2|||
16401219|NCT02152371|39948516|FG000|Overall Study|Withdrawal by Subject|3|||
16401220|NCT02152371|39948517|FG001|Overall Study|Withdrawal by Subject|7|||
16401221|NCT02152371|39948516|FG000|Overall Study|Protocol Violation|2|||
16401222|NCT02152371|39948517|FG001|Overall Study|Protocol Violation|3|||
16098982|NCT03845517|38849935|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
16213725|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
16213726|NCT03605836|39261933|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
16213727|NCT03605836|39261934|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
16213728|NCT03605836|39261935|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
16213729|NCT03605836|39261936|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
16213730|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
16213731|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
16213732|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
16213733|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
16213734|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
16213735|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
16213736|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
16213737|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
16213738|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
16213739|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
16213740|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
16213741|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
16213742|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
16213743|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
16213744|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
16213745|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
16213746|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
16213747|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
16213748|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
16213749|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
16213750|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
16213751|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
16213752|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
16213753|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
16213754|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
16213755|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
16213756|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
16213757|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
16213758|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
16213759|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
16213760|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
16213761|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
16213762|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
16213763|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
16213764|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
16213765|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
16213766|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
16401223|NCT02152371|39948516|FG000|Overall Study|Lost to Follow-up|1|||
16530799|NCT01816594|40410005|FG000|Overall Study|Withdrawal by Subject|1|||
16401224|NCT02152371|39948517|FG001|Overall Study|Lost to Follow-up|0|||
16213767|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
16213768|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
16213769|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
16213770|NCT03605836|39261933|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
16213771|NCT03605836|39261934|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
16213772|NCT03605836|39261935|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
16213773|NCT03605836|39261936|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
16213774|NCT00623766|39261937|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
16213775|NCT00623766|39261938|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
16213776|NCT00623766|39261937|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
16213777|NCT00623766|39261938|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
16213778|NCT00623766|39261937|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
16213779|NCT00623766|39261938|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
16213780|NCT00623766|39261937|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
16213781|NCT00623766|39261938|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
16213782|NCT00623766|39261937|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
16213783|NCT00623766|39261938|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
16213784|NCT03639987|39261939|FG000|Overall Study|Study terminated by sponsor|26|||
16213785|NCT03639987|39261940|FG001|Overall Study|Study terminated by sponsor|25|||
16213786|NCT03639987|39261939|FG000|Overall Study|Lost to Follow-up|0|||
16213787|NCT03639987|39261940|FG001|Overall Study|Lost to Follow-up|1|||
16213788|NCT04259346|39261941|FG000|Overall Study|Lost to Follow-up|1|||
16213789|NCT04259346|39261942|FG001|Overall Study|Lost to Follow-up|3|||
16213790|NCT04259346|39261941|FG000|Overall Study|Protocol Violation|1|||
16213791|NCT04259346|39261942|FG001|Overall Study|Protocol Violation|0|||
16213792|NCT04259346|39261941|FG000|Overall Study|Withdrawal by Subject|1|||
16213793|NCT04259346|39261942|FG001|Overall Study|Withdrawal by Subject|0|||
16213794|NCT04259346|39261941|FG000|Overall Study|Adverse Event|1|||
16213795|NCT04259346|39261942|FG001|Overall Study|Adverse Event|1|||
16213796|NCT04899349|39261943|FG000|Overall Study|Study terminated by Sponsor|2|||
16213797|NCT04899349|39261944|FG001|Overall Study|Study terminated by Sponsor|0|||
16213798|NCT03137173|39261954|FG000|Overall Study|Withdrawal by Subject|8|||
16213799|NCT03137173|39261955|FG001|Overall Study|Withdrawal by Subject|13|||
16213800|NCT03137173|39261954|FG000|Overall Study|Death|1|||
16213801|NCT03137173|39261955|FG001|Overall Study|Death|3|||
16213802|NCT03137173|39261954|FG000|Overall Study|Physician Decision|1|||
16213803|NCT03137173|39261955|FG001|Overall Study|Physician Decision|0|||
16213804|NCT03137173|39261954|FG000|Overall Study|Lost to Follow-up|13|||
16213805|NCT03137173|39261955|FG001|Overall Study|Lost to Follow-up|18|||
16213806|NCT03137173|39261954|FG000|Overall Study|Other reasons|3|||
16213807|NCT03137173|39261955|FG001|Overall Study|Other reasons|2|||
16213808|NCT01237223|39261957|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
16213809|NCT01237223|39261958|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
16213810|NCT01237223|39261959|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
16213811|NCT01237223|39261960|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
16213812|NCT01237223|39261961|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
16213813|NCT01237223|39261962|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
16530800|NCT01816594|40410006|FG001|Overall Study|Withdrawal by Subject|0|||
16530801|NCT01816594|40410005|FG000|Overall Study|Physician Decision|1|||
16530802|NCT01816594|40410006|FG001|Overall Study|Physician Decision|0|||
16530803|NCT03492281|40410010|FG000|Overall Study|Withdrawal by Subject|21|||
16530804|NCT03492281|40410011|FG001|Overall Study|Withdrawal by Subject|14|||
16530805|NCT03492281|40410012|FG002|Overall Study|Withdrawal by Subject|13|||
16530806|NCT03492281|40410010|FG000|Overall Study|Lost to Follow-up|14|||
16530807|NCT03492281|40410011|FG001|Overall Study|Lost to Follow-up|15|||
16530808|NCT03492281|40410012|FG002|Overall Study|Lost to Follow-up|10|||
16530809|NCT03492281|40410010|FG000|Overall Study|Adverse Event|6|||
16530810|NCT03492281|40410011|FG001|Overall Study|Adverse Event|8|||
16530811|NCT03492281|40410012|FG002|Overall Study|Adverse Event|13|||
16530812|NCT03492281|40410010|FG000|Overall Study|Lack of Efficacy|3|||
16530813|NCT03492281|40410011|FG001|Overall Study|Lack of Efficacy|0|||
16530814|NCT03492281|40410012|FG002|Overall Study|Lack of Efficacy|1|||
16213814|NCT01237223|39261957|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
16213815|NCT01237223|39261958|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
16213816|NCT01237223|39261959|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
16213817|NCT01237223|39261960|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
16213818|NCT01237223|39261961|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
16213819|NCT01237223|39261962|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
16530815|NCT03492281|40410010|FG000|Overall Study|Physician Decision|1|||
16530816|NCT03492281|40410011|FG001|Overall Study|Physician Decision|0|||
16530817|NCT03492281|40410012|FG002|Overall Study|Physician Decision|3|||
16213820|NCT01237223|39261957|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
16213821|NCT01237223|39261958|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
16213822|NCT01237223|39261959|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
16213823|NCT01237223|39261960|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
16213824|NCT01237223|39261961|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
16213825|NCT01237223|39261962|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
16213826|NCT01237223|39261957|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
16213827|NCT01237223|39261958|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
16213828|NCT01237223|39261959|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
16213829|NCT01237223|39261960|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
16213830|NCT01237223|39261961|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
16213831|NCT01237223|39261962|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
16213832|NCT01237223|39261957|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
16213833|NCT01237223|39261958|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
16213834|NCT01237223|39261959|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
16213835|NCT01237223|39261960|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
16213836|NCT01237223|39261961|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
16213837|NCT01237223|39261962|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
16213838|NCT01237223|39261957|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
16213839|NCT01237223|39261958|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
16213840|NCT01237223|39261959|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
16213841|NCT01237223|39261960|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
16213842|NCT01237223|39261961|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
16213843|NCT01237223|39261962|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
16213844|NCT01237223|39261957|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
16213845|NCT01237223|39261958|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
16213846|NCT01237223|39261959|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
16213847|NCT01237223|39261960|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
16213848|NCT01237223|39261961|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
16213849|NCT01237223|39261962|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
16213850|NCT01237223|39261957|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
16213851|NCT01237223|39261958|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
16213852|NCT01237223|39261959|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
16213853|NCT01237223|39261960|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
16213854|NCT01237223|39261961|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
16213855|NCT01237223|39261962|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
16213856|NCT01237223|39261957|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
16213857|NCT01237223|39261958|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
16213858|NCT01237223|39261959|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
16213859|NCT01237223|39261960|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
16213860|NCT01237223|39261961|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
16213861|NCT01237223|39261962|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
16213862|NCT01237223|39261957|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
16213863|NCT01237223|39261958|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
16213864|NCT01237223|39261959|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
16213865|NCT01237223|39261960|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
16213866|NCT01237223|39261961|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
16213867|NCT01237223|39261962|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
16213868|NCT00948428|39261963|FG000|Overall Study|Withdrawal by Subject|6|||
16213869|NCT00948428|39261964|FG001|Overall Study|Withdrawal by Subject|12|||
16213870|NCT00948428|39261965|FG002|Overall Study|Withdrawal by Subject|7|||
16213871|NCT00948428|39261963|FG000|Overall Study|Adverse Event|6|||
16213872|NCT00948428|39261964|FG001|Overall Study|Adverse Event|3|||
16213873|NCT00948428|39261965|FG002|Overall Study|Adverse Event|0|||
16213874|NCT00948428|39261963|FG000|Overall Study|Lost to Follow-up|2|||
16213875|NCT00948428|39261964|FG001|Overall Study|Lost to Follow-up|1|||
16213876|NCT00948428|39261965|FG002|Overall Study|Lost to Follow-up|1|||
16213877|NCT00948428|39261963|FG000|Overall Study|Death|2|||
16213878|NCT00948428|39261964|FG001|Overall Study|Death|0|||
16213879|NCT00948428|39261965|FG002|Overall Study|Death|0|||
16213880|NCT00948428|39261963|FG000|Overall Study|Intercurrent Illness|1|||
16213881|NCT00948428|39261964|FG001|Overall Study|Intercurrent Illness|0|||
16213882|NCT00948428|39261965|FG002|Overall Study|Intercurrent Illness|0|||
16213883|NCT00948428|39261963|FG000|Overall Study|Non-compliance|1|||
16213884|NCT00948428|39261964|FG001|Overall Study|Non-compliance|2|||
16213885|NCT00948428|39261965|FG002|Overall Study|Non-compliance|0|||
16213886|NCT02252588|39261966|FG000|Overall Study|Withdrawal by Subject|4|||
16213887|NCT02252588|39261967|FG001|Overall Study|Withdrawal by Subject|0|||
16213888|NCT01462045|39261971|FG000|Overall Study|Family matter|0|||
16213889|NCT01462045|39261972|FG001|Overall Study|Family matter|1|||
16213890|NCT01462045|39261973|FG002|Overall Study|Family matter|0|||
16213891|NCT00957723|39261976|FG000|Overall Study|Death|3|||
16213892|NCT00957723|39261976|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
16213893|NCT00957723|39261976|FG000|Overall Study|Lost to Follow-up|8|||
16213894|NCT00957723|39261976|FG000|Overall Study|Withdrawal by Subject|24|||
16213895|NCT00957723|39261976|FG000|Overall Study|Investigative Site Terminated|61|||
16213896|NCT00957723|39261976|FG000|Overall Study|Intercurrent Illness|2|||
16213897|NCT00957723|39261976|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
16213898|NCT04921969|39261977|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
16213899|NCT04921969|39261978|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
16213900|NCT04921969|39261979|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
16213901|NCT04921969|39261980|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
16213902|NCT04921969|39261981|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
16213903|NCT04921969|39261982|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
16213904|NCT04921969|39261983|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
16213905|NCT04921969|39261977|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
16213906|NCT04921969|39261978|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16213907|NCT04921969|39261979|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16213908|NCT04921969|39261980|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16213909|NCT04921969|39261981|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16213910|NCT04921969|39261982|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16213911|NCT04921969|39261983|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
16213912|NCT04921969|39261977|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
16213913|NCT04921969|39261978|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
16213914|NCT04921969|39261979|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
16213915|NCT04921969|39261980|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16213916|NCT04921969|39261981|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16213917|NCT04921969|39261982|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16530818|NCT03492281|40410010|FG000|Overall Study|Protocol Violation|0|||
16530819|NCT03492281|40410011|FG001|Overall Study|Protocol Violation|2|||
16530820|NCT03492281|40410012|FG002|Overall Study|Protocol Violation|1|||
16213918|NCT04921969|39261983|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16213919|NCT04921969|39261977|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
16213920|NCT04921969|39261978|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
16213921|NCT04921969|39261979|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
16213922|NCT04921969|39261980|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
16213923|NCT04921969|39261981|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
16213924|NCT04921969|39261982|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
16213925|NCT04921969|39261983|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
16213926|NCT04921969|39261977|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
16213927|NCT04921969|39261978|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
16213928|NCT04921969|39261979|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
16213929|NCT04921969|39261980|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
16213930|NCT04921969|39261981|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
16213931|NCT04921969|39261982|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
16213932|NCT04921969|39261983|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
16213933|NCT04921969|39261977|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
16213934|NCT04921969|39261978|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
16213935|NCT04921969|39261979|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
16213936|NCT04921969|39261980|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16213937|NCT04921969|39261981|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16213938|NCT04921969|39261982|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16213939|NCT04921969|39261983|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16213940|NCT04921969|39261977|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
16213941|NCT04921969|39261978|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
16530821|NCT03492281|40410010|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
16213942|NCT04921969|39261979|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
16213943|NCT04921969|39261980|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
16213944|NCT04921969|39261981|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
16213945|NCT04921969|39261982|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
16213946|NCT04921969|39261983|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
16213947|NCT04921969|39261977|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
16213948|NCT04921969|39261978|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
16530822|NCT03492281|40410011|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
16530823|NCT03492281|40410012|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
16401225|NCT02152371|39948516|FG000|Overall Study|Lack of Efficacy|0|||
16401226|NCT02152371|39948517|FG001|Overall Study|Lack of Efficacy|1|||
16401227|NCT02152371|39948516|FG000|Overall Study|Physician Decision|0|||
16401228|NCT02152371|39948517|FG001|Overall Study|Physician Decision|2|||
16401229|NCT02152371|39948516|FG000|Overall Study|Reason Not Given|0|||
16401230|NCT02152371|39948517|FG001|Overall Study|Reason Not Given|1|||
16401231|NCT02923830|39948518|FG000|Overall Study|Physician Decision|13|||
16401232|NCT02923830|39948519|FG001|Overall Study|Physician Decision|15|||
16401233|NCT00616018|39948522|FG000|Overall Study|Protocol Violation|3|||
16401234|NCT00157196|39948532|FG000|Overall Study|Ongoing at data cut-off|9|||
16401235|NCT01159171|39948533|FG000|Overall Study|Adverse Event|11|||
16401236|NCT01159171|39948533|FG000|Overall Study|Progression of Disease|28|||
16401237|NCT01159171|39948533|FG000|Overall Study|Protocol Violation|1|||
16401238|NCT01159171|39948533|FG000|Overall Study|Need for Surgery|5|||
16401239|NCT01159171|39948533|FG000|Overall Study|Medical Decision|4|||
16401240|NCT01159171|39948533|FG000|Overall Study|Death|1|||
16401241|NCT00519376|39953493|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401242|NCT00519376|39953494|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401243|NCT00519376|39953495|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401244|NCT00519376|39953496|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401245|NCT00519376|39953497|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401246|NCT00519376|39953498|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401247|NCT00519376|39953499|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401248|NCT00519376|39953500|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401249|NCT00519376|39953501|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401250|NCT00519376|39953502|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401251|NCT00519376|39953503|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401252|NCT00519376|39953504|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401253|NCT00519376|39953505|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
16401254|NCT00519376|39953506|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401255|NCT00519376|39953507|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401256|NCT00519376|39953508|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
16401257|NCT00519376|39953493|FG000|Treatment Period 4|Lost to Follow-up|0|||
16401258|NCT00519376|39953494|FG001|Treatment Period 4|Lost to Follow-up|0|||
16401259|NCT00519376|39953495|FG002|Treatment Period 4|Lost to Follow-up|1|||
16401260|NCT00519376|39953496|FG003|Treatment Period 4|Lost to Follow-up|0|||
16401261|NCT00519376|39953497|FG004|Treatment Period 4|Lost to Follow-up|0|||
16401262|NCT00519376|39953498|FG005|Treatment Period 4|Lost to Follow-up|0|||
16401263|NCT00519376|39953499|FG006|Treatment Period 4|Lost to Follow-up|0|||
16401264|NCT00519376|39953500|FG007|Treatment Period 4|Lost to Follow-up|0|||
16401265|NCT00519376|39953501|FG008|Treatment Period 4|Lost to Follow-up|0|||
16401266|NCT00519376|39953502|FG009|Treatment Period 4|Lost to Follow-up|0|||
16401267|NCT00519376|39953503|FG010|Treatment Period 4|Lost to Follow-up|0|||
16401268|NCT00519376|39953504|FG011|Treatment Period 4|Lost to Follow-up|0|||
16401269|NCT00519376|39953505|FG012|Treatment Period 4|Lost to Follow-up|0|||
16401270|NCT00519376|39953506|FG013|Treatment Period 4|Lost to Follow-up|0|||
16098983|NCT03845517|38849932|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
16213949|NCT04921969|39261979|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
16213950|NCT04921969|39261980|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
16213951|NCT04921969|39261981|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
16213952|NCT04921969|39261982|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
16213953|NCT04921969|39261983|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
16213954|NCT04921969|39261977|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16213955|NCT04921969|39261978|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16213956|NCT04921969|39261979|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16213957|NCT04921969|39261980|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
16213958|NCT04921969|39261981|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16213959|NCT04921969|39261982|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
16213960|NCT04921969|39261983|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
16098984|NCT03845517|38849933|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
16098985|NCT03845517|38849934|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
16098986|NCT03845517|38849935|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
16098987|NCT03845517|38849932|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
16098988|NCT03845517|38849933|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
16098989|NCT03845517|38849934|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
16401271|NCT00519376|39953507|FG014|Treatment Period 4|Lost to Follow-up|0|||
16401272|NCT00519376|39953508|FG015|Treatment Period 4|Lost to Follow-up|0|||
16401273|NCT00984165|39953510|FG000|Overall Study|Death on study|2|||
16401274|NCT00984165|39953511|FG001|Overall Study|Death on study|0|||
16401275|NCT00984165|39953512|FG002|Overall Study|Death on study|0|||
16401276|NCT00984165|39953513|FG003|Overall Study|Death on study|0|||
16401277|NCT00984165|39953510|FG000|Overall Study|Disease progression on study|5|||
16098990|NCT03845517|38849935|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
16098991|NCT04088500|38849936|FG000|Overall Study|Reason unknown|1|||
16098992|NCT04088500|38849936|FG000|Overall Study|Participant withdrew consent|1|||
16213961|NCT04921969|39261977|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16213962|NCT04921969|39261978|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16213963|NCT04921969|39261979|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16213964|NCT04921969|39261980|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
16213965|NCT04921969|39261981|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|3|||
16213966|NCT04921969|39261982|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|13|||
16213967|NCT04921969|39261983|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
16213968|NCT04921969|39261977|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
16213969|NCT04921969|39261978|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
16213970|NCT04921969|39261979|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
16213971|NCT04921969|39261980|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
16213972|NCT04921969|39261981|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
16213973|NCT04921969|39261982|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
16213974|NCT04921969|39261983|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
16213975|NCT04921969|39261977|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16213976|NCT04921969|39261978|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16213977|NCT04921969|39261979|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16213978|NCT04921969|39261980|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
16213979|NCT04921969|39261981|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
16213980|NCT04921969|39261982|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
16213981|NCT04921969|39261983|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|13|||
16213982|NCT04921969|39261977|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
16213983|NCT04921969|39261978|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
16213984|NCT04921969|39261979|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
16213985|NCT04921969|39261980|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
16213986|NCT04921969|39261981|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
16213987|NCT04921969|39261982|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
16213988|NCT04921969|39261983|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
16213989|NCT04921969|39261977|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
16213990|NCT04921969|39261978|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
16213991|NCT04921969|39261979|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
16213992|NCT04921969|39261980|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
16213993|NCT04921969|39261981|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
16213994|NCT04921969|39261982|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
16213995|NCT04921969|39261983|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
16213996|NCT04921969|39261977|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
16213997|NCT04921969|39261978|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
16213998|NCT04921969|39261979|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
16213999|NCT04921969|39261980|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
16214000|NCT04921969|39261981|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
16214001|NCT04921969|39261982|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|1|||
16214002|NCT04921969|39261983|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|2|||
16214003|NCT04921969|39261977|FG000|LTS Period (Weeks 8 to 52)|Ongoing|0|||
16214004|NCT04921969|39261978|FG001|LTS Period (Weeks 8 to 52)|Ongoing|0|||
16214005|NCT04921969|39261979|FG002|LTS Period (Weeks 8 to 52)|Ongoing|0|||
16214006|NCT04921969|39261980|FG003|LTS Period (Weeks 8 to 52)|Ongoing|14|||
16214007|NCT04921969|39261981|FG004|LTS Period (Weeks 8 to 52)|Ongoing|12|||
16214008|NCT04921969|39261982|FG005|LTS Period (Weeks 8 to 52)|Ongoing|55|||
16214009|NCT04921969|39261983|FG006|LTS Period (Weeks 8 to 52)|Ongoing|54|||
16214010|NCT02590406|39261984|FG000|Overall Study|Adverse Event|1|||
16214011|NCT02590406|39261985|FG001|Overall Study|Adverse Event|0|||
16214012|NCT02590406|39261984|FG000|Overall Study|Saturometer malfunction|0|||
16214013|NCT02590406|39261985|FG001|Overall Study|Saturometer malfunction|1|||
16214014|NCT03573804|39261986|FG000|Overall Study|claustrophobia or MRI table problems|10|||
16214015|NCT02718625|39261989|FG000|Overall Study|Adverse Event|0|||
16214016|NCT02718625|39261990|FG001|Overall Study|Adverse Event|1|||
16214017|NCT02718625|39261989|FG000|Overall Study|Termination of Study by Sponsor|0|||
16214018|NCT02718625|39261990|FG001|Overall Study|Termination of Study by Sponsor|1|||
16214019|NCT00863317|39261992|FG000|Overall Study|Lost to Follow-up|8|||
16214020|NCT00863317|39261993|FG001|Overall Study|Lost to Follow-up|9|||
16214021|NCT05104749|39261994|FG000|Overall Study|Lost to Follow-up|2|||
16214022|NCT05104749|39261995|FG001|Overall Study|Lost to Follow-up|3|||
16214023|NCT01432938|39261998|FG000|First Intervention|Protocol Violation|1|||
16214024|NCT01432938|39261999|FG001|First Intervention|Protocol Violation|0|||
16214025|NCT01432938|39261998|FG000|First Intervention|Physician Decision|1|||
16214026|NCT01432938|39261999|FG001|First Intervention|Physician Decision|0|||
16214027|NCT01432938|39261998|FG000|Second Intervention|Adverse Event|1|||
16214028|NCT01432938|39261999|FG001|Second Intervention|Adverse Event|0|||
16214029|NCT01424306|39262000|FG000|Overall Study|Protocol Violation|0|||
16214030|NCT01424306|39262001|FG001|Overall Study|Protocol Violation|0|||
16214031|NCT01424306|39262002|FG002|Overall Study|Protocol Violation|0|||
16214032|NCT01424306|39262003|FG003|Overall Study|Protocol Violation|0|||
16214033|NCT01424306|39262004|FG004|Overall Study|Protocol Violation|1|||
16214034|NCT01424306|39262005|FG005|Overall Study|Protocol Violation|0|||
16214035|NCT00486889|39262007|FG000|Overall Study|Death|3|||
16214036|NCT00486889|39262007|FG000|Overall Study|Non-compliant|2|||
16214037|NCT00486889|39262007|FG000|Overall Study|Withdrawal by Subject|6|||
16214038|NCT03745989|39262008|FG000|Overall Study|Death|3|||
16214039|NCT03745989|39262009|FG001|Overall Study|Death|7|||
16214040|NCT03745989|39262010|FG002|Overall Study|Death|4|||
16214041|NCT03745989|39262008|FG000|Overall Study|Lost to Follow-up|0|||
16214042|NCT03745989|39262009|FG001|Overall Study|Lost to Follow-up|2|||
16214043|NCT03745989|39262010|FG002|Overall Study|Lost to Follow-up|0|||
16214044|NCT03745989|39262008|FG000|Overall Study|Sponsor Decision|0|||
16214045|NCT03745989|39262009|FG001|Overall Study|Sponsor Decision|2|||
16214046|NCT03745989|39262010|FG002|Overall Study|Sponsor Decision|8|||
16214047|NCT03745989|39262008|FG000|Overall Study|Withdrawal by Subject|0|||
16214048|NCT03745989|39262009|FG001|Overall Study|Withdrawal by Subject|1|||
16214049|NCT03745989|39262010|FG002|Overall Study|Withdrawal by Subject|3|||
16214050|NCT00608244|39262012|FG000|Overall Study|Adverse Event|1|||
16214051|NCT00608244|39262012|FG000|Overall Study|Low trough levels|1|||
16214052|NCT02182999|39262015|FG000|Overall Study|Adverse Event|4|||
16214053|NCT02182999|39262016|FG001|Overall Study|Adverse Event|3|||
16214054|NCT02182999|39262015|FG000|Overall Study|Physician Decision|1|||
16214055|NCT02182999|39262016|FG001|Overall Study|Physician Decision|0|||
16214056|NCT03685643|39262017|FG000|Overall Study|Lost to Follow-up|14|||
16214057|NCT03685643|39262018|FG001|Overall Study|Lost to Follow-up|22|||
16214058|NCT04539262|39262019|FG000|Overall Study|Adverse Event|0|||
16214059|NCT04539262|39262020|FG001|Overall Study|Adverse Event|0|||
16214060|NCT04539262|39262021|FG002|Overall Study|Adverse Event|1|||
16214061|NCT04539262|39262022|FG003|Overall Study|Adverse Event|0|||
16214062|NCT04539262|39262023|FG004|Overall Study|Adverse Event|0|||
16214063|NCT04539262|39262024|FG005|Overall Study|Adverse Event|0|||
16214064|NCT04539262|39262025|FG006|Overall Study|Adverse Event|0|||
16214065|NCT04539262|39262026|FG007|Overall Study|Adverse Event|0|||
16214066|NCT04539262|39262019|FG000|Overall Study|Withdrew Consent|0|||
16214067|NCT04539262|39262020|FG001|Overall Study|Withdrew Consent|0|||
16214068|NCT04539262|39262021|FG002|Overall Study|Withdrew Consent|0|||
16098993|NCT04088500|38849936|FG000|Overall Study|Disease progression|3|||
16098994|NCT05153499|38849939|FG000|Overall Study|Withdrawal by Subject|1|||
16098995|NCT05153499|38849940|FG001|Overall Study|Withdrawal by Subject|0|||
16098996|NCT05153499|38849939|FG000|Overall Study|Clinical Hold|1|||
16098997|NCT05153499|38849940|FG001|Overall Study|Clinical Hold|0|||
16098998|NCT05153499|38849939|FG000|Overall Study|Study Termination|6|||
16098999|NCT05153499|38849940|FG001|Overall Study|Study Termination|5|||
16401278|NCT00984165|39953511|FG001|Overall Study|Disease progression on study|1|||
16401279|NCT00984165|39953512|FG002|Overall Study|Disease progression on study|0|||
16401280|NCT00984165|39953513|FG003|Overall Study|Disease progression on study|0|||
16401281|NCT00984165|39953510|FG000|Overall Study|Death of recipient|0|||
16401282|NCT00984165|39953511|FG001|Overall Study|Death of recipient|0|||
16401283|NCT00984165|39953512|FG002|Overall Study|Death of recipient|0|||
16401284|NCT00984165|39953513|FG003|Overall Study|Death of recipient|1|||
16401285|NCT00984165|39953510|FG000|Overall Study|New protocol|0|||
16401286|NCT00984165|39953511|FG001|Overall Study|New protocol|0|||
16401287|NCT00984165|39953512|FG002|Overall Study|New protocol|0|||
16401288|NCT00984165|39953513|FG003|Overall Study|New protocol|1|||
16401289|NCT00984165|39953510|FG000|Overall Study|P+/donor pair removed from protocol|0|||
16401290|NCT00984165|39953511|FG001|Overall Study|P+/donor pair removed from protocol|0|||
16401291|NCT00984165|39953512|FG002|Overall Study|P+/donor pair removed from protocol|0|||
16401292|NCT00984165|39953513|FG003|Overall Study|P+/donor pair removed from protocol|1|||
16401293|NCT00984165|39953510|FG000|Overall Study|removed with a pair recipient|0|||
16401294|NCT00984165|39953511|FG001|Overall Study|removed with a pair recipient|0|||
16401295|NCT00984165|39953512|FG002|Overall Study|removed with a pair recipient|0|||
16401296|NCT00984165|39953513|FG003|Overall Study|removed with a pair recipient|1|||
16401297|NCT02199314|39953518|FG000|Overall Study|Withdrawal by Subject|6|||
16401298|NCT02199314|39953518|FG000|Overall Study|Physician Decision|10|||
16401299|NCT01524224|39953520|FG000|Overall Study|Progressive Disease|1|||
16401300|NCT01524224|39953521|FG001|Overall Study|Progressive Disease|0|||
16401301|NCT01524224|39953522|FG002|Overall Study|Progressive Disease|2|||
16401302|NCT01524224|39953523|FG003|Overall Study|Progressive Disease|1|||
16401303|NCT01524224|39953524|FG004|Overall Study|Progressive Disease|2|||
16401304|NCT01524224|39953525|FG005|Overall Study|Progressive Disease|1|||
16401305|NCT01524224|39953526|FG006|Overall Study|Progressive Disease|1|||
16401306|NCT01524224|39953527|FG007|Overall Study|Progressive Disease|5|||
16401307|NCT01524224|39953520|FG000|Overall Study|Withdrawal by Subject|2|||
16401308|NCT01524224|39953521|FG001|Overall Study|Withdrawal by Subject|0|||
16401309|NCT01524224|39953522|FG002|Overall Study|Withdrawal by Subject|0|||
16401310|NCT01524224|39953523|FG003|Overall Study|Withdrawal by Subject|0|||
16099000|NCT04385849|38849941|FG000|Overall Study|Lost to Follow-up|1|||
16099001|NCT04385849|38849942|FG001|Overall Study|Lost to Follow-up|0|||
16099002|NCT00640042|38849943|FG000|Enrollment|Did not receive study drug|83|||
16099003|NCT03861078|38849944|FG000|Overall Study|COVID-19 shut down|4|||
16099004|NCT03861078|38849944|FG000|Overall Study|Lost to Follow-up|1|||
16099005|NCT03861078|38849944|FG000|Overall Study|Protocol Violation|2|||
16099006|NCT03861078|38849944|FG000|Overall Study|lack of venous access|1|||
16099007|NCT00443599|38849945|FG000|Overall Study|Physician Decision|2|||
16099008|NCT00443599|38849946|FG001|Overall Study|Physician Decision|1|||
16099009|NCT00443599|38849945|FG000|Overall Study|Death|1|||
16099010|NCT00443599|38849946|FG001|Overall Study|Death|1|||
16099011|NCT00443599|38849945|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
16099012|NCT00443599|38849946|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
16214069|NCT04539262|39262022|FG003|Overall Study|Withdrew Consent|1|||
16214070|NCT04539262|39262023|FG004|Overall Study|Withdrew Consent|0|||
16401311|NCT01524224|39953524|FG004|Overall Study|Withdrawal by Subject|0|||
16401312|NCT01524224|39953525|FG005|Overall Study|Withdrawal by Subject|0|||
16401313|NCT01524224|39953526|FG006|Overall Study|Withdrawal by Subject|2|||
16401314|NCT01524224|39953527|FG007|Overall Study|Withdrawal by Subject|0|||
16401315|NCT01524224|39953520|FG000|Overall Study|Adverse Event|0|||
16401316|NCT01524224|39953521|FG001|Overall Study|Adverse Event|1|||
16401317|NCT01524224|39953522|FG002|Overall Study|Adverse Event|0|||
16401318|NCT01524224|39953523|FG003|Overall Study|Adverse Event|0|||
16401319|NCT01524224|39953524|FG004|Overall Study|Adverse Event|0|||
16530824|NCT03492281|40410010|FG000|Overall Study|Death|0|||
16530825|NCT03492281|40410011|FG001|Overall Study|Death|0|||
16530826|NCT03492281|40410012|FG002|Overall Study|Death|1|||
16530827|NCT03492281|40410010|FG000|Overall Study|Captured as Other in Database|8|||
16530828|NCT03492281|40410011|FG001|Overall Study|Captured as Other in Database|6|||
16530829|NCT03492281|40410012|FG002|Overall Study|Captured as Other in Database|3|||
16530830|NCT00868439|40410017|FG000|Overall Study|Adverse Event|4|||
16099013|NCT04150250|38849951|FG000|Overall Study|Lost to Follow-up|0|||
16099014|NCT04150250|38849952|FG001|Overall Study|Lost to Follow-up|2|||
16401320|NCT01524224|39953525|FG005|Overall Study|Adverse Event|1|||
16401321|NCT01524224|39953526|FG006|Overall Study|Adverse Event|0|||
16401322|NCT01524224|39953527|FG007|Overall Study|Adverse Event|0|||
16530831|NCT00868439|40410018|FG001|Overall Study|Adverse Event|3|||
16214071|NCT04539262|39262024|FG005|Overall Study|Withdrew Consent|0|||
16214072|NCT04539262|39262025|FG006|Overall Study|Withdrew Consent|0|||
16214073|NCT04539262|39262026|FG007|Overall Study|Withdrew Consent|0|||
16214074|NCT04539262|39262019|FG000|Overall Study|Randomized, Not treated|0|||
16214075|NCT04539262|39262020|FG001|Overall Study|Randomized, Not treated|1|||
16214076|NCT04539262|39262021|FG002|Overall Study|Randomized, Not treated|0|||
16214077|NCT04539262|39262022|FG003|Overall Study|Randomized, Not treated|0|||
16214078|NCT04539262|39262023|FG004|Overall Study|Randomized, Not treated|0|||
16214079|NCT04539262|39262024|FG005|Overall Study|Randomized, Not treated|0|||
16214080|NCT04539262|39262025|FG006|Overall Study|Randomized, Not treated|1|||
16214081|NCT04539262|39262026|FG007|Overall Study|Randomized, Not treated|0|||
16214082|NCT01040728|39262027|FG000|Overall Study|Adverse Event|4|||
16214083|NCT01040728|39262028|FG001|Overall Study|Adverse Event|8|||
16214084|NCT01040728|39262029|FG002|Overall Study|Adverse Event|0|||
16214085|NCT01040728|39262030|FG003|Overall Study|Adverse Event|4|||
16214086|NCT01040728|39262027|FG000|Overall Study|Withdrawal by Subject|0|||
16214087|NCT01040728|39262028|FG001|Overall Study|Withdrawal by Subject|1|||
16214088|NCT01040728|39262029|FG002|Overall Study|Withdrawal by Subject|1|||
16214089|NCT01040728|39262030|FG003|Overall Study|Withdrawal by Subject|0|||
16214090|NCT01040728|39262027|FG000|Overall Study|Protocol Violation|0|||
16214091|NCT01040728|39262028|FG001|Overall Study|Protocol Violation|0|||
16214092|NCT01040728|39262029|FG002|Overall Study|Protocol Violation|0|||
16401323|NCT01524224|39953520|FG000|Overall Study|Physician Decision|0|||
16401324|NCT01524224|39953521|FG001|Overall Study|Physician Decision|0|||
16401325|NCT01524224|39953522|FG002|Overall Study|Physician Decision|0|||
16401326|NCT01524224|39953523|FG003|Overall Study|Physician Decision|1|||
16401327|NCT01524224|39953524|FG004|Overall Study|Physician Decision|1|||
16401328|NCT01524224|39953525|FG005|Overall Study|Physician Decision|0|||
16401329|NCT01524224|39953526|FG006|Overall Study|Physician Decision|0|||
16401330|NCT01524224|39953527|FG007|Overall Study|Physician Decision|1|||
16401331|NCT01524224|39953520|FG000|Overall Study|Sponsor Decision|0|||
16401332|NCT01524224|39953521|FG001|Overall Study|Sponsor Decision|0|||
16401333|NCT01524224|39953522|FG002|Overall Study|Sponsor Decision|0|||
16401334|NCT01524224|39953523|FG003|Overall Study|Sponsor Decision|0|||
16401335|NCT01524224|39953524|FG004|Overall Study|Sponsor Decision|1|||
16401336|NCT01524224|39953525|FG005|Overall Study|Sponsor Decision|0|||
16530832|NCT00868439|40410017|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
16530833|NCT00868439|40410018|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
16530834|NCT00868439|40410017|FG000|Overall Study|Death|0|||
16530835|NCT00868439|40410018|FG001|Overall Study|Death|1|||
16530836|NCT00868439|40410017|FG000|Overall Study|Protocol Violation|1|||
16214093|NCT01040728|39262030|FG003|Overall Study|Protocol Violation|1|||
16214094|NCT01040728|39262027|FG000|Overall Study|Lack of Efficacy|0|||
16214095|NCT01040728|39262028|FG001|Overall Study|Lack of Efficacy|1|||
16530837|NCT00868439|40410018|FG001|Overall Study|Protocol Violation|1|||
16530838|NCT00868439|40410017|FG000|Overall Study|Physician Decision|1|||
16530839|NCT00868439|40410018|FG001|Overall Study|Physician Decision|0|||
16530840|NCT00868439|40410017|FG000|Overall Study|Withdrawal by Subject|0|||
16530841|NCT00868439|40410018|FG001|Overall Study|Withdrawal by Subject|1|||
16530842|NCT01596582|40410025|FG000|Overall Study|Deemed ineligible after study visit|3|||
16530843|NCT01596582|40410026|FG001|Overall Study|Deemed ineligible after study visit|6|||
16530844|NCT01596582|40410025|FG000|Overall Study|Missing all outcome data|1|||
16530845|NCT01596582|40410026|FG001|Overall Study|Missing all outcome data|1|||
16530846|NCT00715429|40410031|FG000|Overall Study|Did not complete the study diary|0|||
16530847|NCT00715429|40410032|FG001|Overall Study|Did not complete the study diary|1|||
16530848|NCT01218438|40410033|FG000|Epoch 1|Physician Decision|2|||
16530849|NCT01218438|40410033|FG000|Epoch 1|Adverse Event|1|||
16530850|NCT01218438|40410033|FG000|Epoch 3|Withdrawal by Subject|3|||
16530851|NCT01218438|40410033|FG000|Epoch 3|Adverse Event|1|||
16530852|NCT01218438|40410033|FG000|Epoch 4|Physician Decision|1|||
16530853|NCT01218438|40410033|FG000|Epoch 4|Withdrawal by Subject|2|||
16530854|NCT01131312|40410036|FG000|Overall Study|Lost to Follow-up|425|||
16530855|NCT01131312|40410037|FG001|Overall Study|Lost to Follow-up|229|||
16530856|NCT01131312|40410038|FG002|Overall Study|Lost to Follow-up|351|||
16530857|NCT01664078|40410040|FG000|Overall Study|Death|9|||
16530858|NCT01664078|40410040|FG000|Overall Study|Withdrawal by Subject|4|||
16530859|NCT01664078|40410040|FG000|Overall Study|Lost to Follow-up|2|||
16214096|NCT01040728|39262029|FG002|Overall Study|Lack of Efficacy|0|||
16214097|NCT01040728|39262030|FG003|Overall Study|Lack of Efficacy|1|||
16530860|NCT01664078|40410040|FG000|Overall Study|missed 5 year visit|1|||
16530861|NCT01664078|40410040|FG000|Overall Study|Other|53|||
16530862|NCT02232893|40410044|FG000|Overall Study|Withdrawal by Subject|4|||
16530863|NCT02232893|40410045|FG001|Overall Study|Withdrawal by Subject|1|||
16530864|NCT02232893|40410044|FG000|Overall Study|Adverse Event|0|||
16530865|NCT02232893|40410045|FG001|Overall Study|Adverse Event|1|||
16530866|NCT02232893|40410044|FG000|Overall Study|Sponsor request early termination|0|||
16214098|NCT01040728|39262027|FG000|Overall Study|Other reasons not listed above|0|||
16401337|NCT01524224|39953526|FG006|Overall Study|Sponsor Decision|0|||
16401338|NCT01524224|39953527|FG007|Overall Study|Sponsor Decision|0|||
16214099|NCT01040728|39262028|FG001|Overall Study|Other reasons not listed above|1|||
16214100|NCT01040728|39262029|FG002|Overall Study|Other reasons not listed above|0|||
16214101|NCT01040728|39262030|FG003|Overall Study|Other reasons not listed above|0|||
16214102|NCT00209092|39262031|FG000|Overall Study|Progression of disease|7|||
16214103|NCT00209092|39262032|FG001|Overall Study|Progression of disease|1|||
16214104|NCT00209092|39262031|FG000|Overall Study|Adverse Event|0|||
16214105|NCT00209092|39262032|FG001|Overall Study|Adverse Event|1|||
16214106|NCT00209092|39262031|FG000|Overall Study|Withdrawal by Subject|1|||
16214107|NCT00209092|39262032|FG001|Overall Study|Withdrawal by Subject|0|||
16214108|NCT01405027|39262033|FG000|Overall Study|Withdrawn consent|3|||
16214109|NCT01405027|39262034|FG001|Overall Study|Withdrawn consent|0|||
16214110|NCT01405027|39262033|FG000|Overall Study|Lost to Follow-up|16|||
16214111|NCT01405027|39262034|FG001|Overall Study|Lost to Follow-up|24|||
16214112|NCT01405027|39262033|FG000|Overall Study|Investigator judgement|0|||
16332136|NCT00710684|39703307|FG000|Overall Study|Did not continue after week 24|25|||
16530867|NCT02232893|40410045|FG001|Overall Study|Sponsor request early termination|1|||
16530868|NCT02232893|40410044|FG000|Overall Study|Developed exclusion criteria|0|||
16401339|NCT02359045|39953528|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
16401340|NCT02359045|39953529|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16401341|NCT02359045|39953528|FG000|Overall Study|Lost to Follow-up|1|||
16401342|NCT02359045|39953529|FG001|Overall Study|Lost to Follow-up|1|||
16401343|NCT02359045|39953528|FG000|Overall Study|Adverse Event|0|||
16401344|NCT02359045|39953529|FG001|Overall Study|Adverse Event|1|||
16401345|NCT01205061|39953530|FG000|Overall Study|Adverse Event|4|||
16401346|NCT01205061|39953530|FG000|Overall Study|Withdrawal by Subject|11|||
16401347|NCT01205061|39953530|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
16401348|NCT01205061|39953530|FG000|Overall Study|Lost to Follow-up|9|||
16332137|NCT00710684|39703308|FG001|Overall Study|Did not continue after week 24|21|||
16401349|NCT01205061|39953530|FG000|Overall Study|Other|1|||
16401350|NCT04098367|39953534|FG000|Overall Study|Adverse Event|0|||
16401351|NCT04098367|39953535|FG001|Overall Study|Adverse Event|0|||
16401352|NCT04098367|39953536|FG002|Overall Study|Adverse Event|1|||
16401353|NCT04098367|39953534|FG000|Overall Study|Lost to Follow-up|1|||
16401354|NCT04098367|39953535|FG001|Overall Study|Lost to Follow-up|5|||
16401355|NCT04098367|39953536|FG002|Overall Study|Lost to Follow-up|2|||
16401356|NCT04098367|39953534|FG000|Overall Study|Withdrawal by Subject|0|||
16401357|NCT04098367|39953535|FG001|Overall Study|Withdrawal by Subject|0|||
16401358|NCT04098367|39953536|FG002|Overall Study|Withdrawal by Subject|1|||
16401359|NCT04098367|39953534|FG000|Overall Study|Sick . Could not attend visit|1|||
16401360|NCT04098367|39953535|FG001|Overall Study|Sick . Could not attend visit|0|||
16401361|NCT04098367|39953536|FG002|Overall Study|Sick . Could not attend visit|0|||
16401362|NCT02759107|39953537|FG000|Overall Study|Adverse Event|0|||
16401363|NCT02759107|39953538|FG001|Overall Study|Adverse Event|0|||
16401364|NCT02759107|39953539|FG002|Overall Study|Adverse Event|0|||
16332138|NCT00710684|39703309|FG002|Overall Study|Did not continue after week 24|16|||
16332139|NCT01362244|39703312|FG000|Overall Study|Adverse Event|3|||
16332140|NCT01362244|39703313|FG001|Overall Study|Adverse Event|5|||
16332141|NCT01362244|39703312|FG000|Overall Study|Lack of Efficacy|5|||
16332142|NCT01362244|39703313|FG001|Overall Study|Lack of Efficacy|11|||
16332143|NCT01362244|39703312|FG000|Overall Study|Lost to Follow-up|0|||
16332144|NCT01362244|39703313|FG001|Overall Study|Lost to Follow-up|2|||
16332145|NCT01362244|39703312|FG000|Overall Study|Protocol Violation|5|||
16332146|NCT01362244|39703313|FG001|Overall Study|Protocol Violation|1|||
16332147|NCT01362244|39703312|FG000|Overall Study|Withdrawal by Subject|2|||
16332148|NCT01362244|39703313|FG001|Overall Study|Withdrawal by Subject|1|||
16332149|NCT01362244|39703312|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
16401365|NCT02759107|39953540|FG003|Overall Study|Adverse Event|0|||
16401366|NCT02759107|39953541|FG004|Overall Study|Adverse Event|0|||
16401367|NCT02759107|39953542|FG005|Overall Study|Adverse Event|0|||
16401368|NCT02759107|39953543|FG006|Overall Study|Adverse Event|0|||
16401369|NCT02759107|39953544|FG007|Overall Study|Adverse Event|0|||
16401370|NCT02759107|39953545|FG008|Overall Study|Adverse Event|0|||
16214113|NCT01405027|39262034|FG001|Overall Study|Investigator judgement|2|||
16214114|NCT01405027|39262033|FG000|Overall Study|Death|1|||
16214115|NCT01405027|39262034|FG001|Overall Study|Death|0|||
16214116|NCT01405027|39262033|FG000|Overall Study|Other or Unknown|12|||
16332150|NCT01362244|39703313|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
16332151|NCT01362244|39703312|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
16214117|NCT01405027|39262034|FG001|Overall Study|Other or Unknown|25|||
16214118|NCT04973085|39262035|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
16401371|NCT02759107|39953546|FG009|Overall Study|Adverse Event|0|||
16401372|NCT02759107|39953547|FG010|Overall Study|Adverse Event|0|||
16401373|NCT02759107|39953548|FG011|Overall Study|Adverse Event|0|||
16401374|NCT02759107|39953549|FG012|Overall Study|Adverse Event|2|||
16401375|NCT02759107|39953550|FG013|Overall Study|Adverse Event|0|||
16401376|NCT02759107|39953551|FG014|Overall Study|Adverse Event|0|||
16530869|NCT02232893|40410045|FG001|Overall Study|Developed exclusion criteria|1|||
16530870|NCT02232893|40410044|FG000|Overall Study|Other|0|||
16530871|NCT02232893|40410045|FG001|Overall Study|Other|3|||
16530872|NCT01910129|40410051|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
16530873|NCT01910129|40410052|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
16530874|NCT01910129|40410053|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
16530875|NCT01910129|40410051|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
16530876|NCT01910129|40410052|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
16332152|NCT01362244|39703313|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
16332153|NCT00603382|39703317|FG000|Overall Study|Adverse Event|0|||
16332154|NCT00603382|39703318|FG001|Overall Study|Adverse Event|1|||
16332155|NCT00603382|39703319|FG002|Overall Study|Adverse Event|1|||
16332156|NCT00603382|39703320|FG003|Overall Study|Adverse Event|2|||
16332157|NCT00603382|39703321|FG004|Overall Study|Adverse Event|1|||
16332158|NCT00603382|39703322|FG005|Overall Study|Adverse Event|2|||
16332159|NCT00603382|39703317|FG000|Overall Study|Lack of Efficacy|14|||
16530877|NCT01910129|40410053|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
16530878|NCT02239679|40410058|FG000|Overall Study|Lost to Follow-up|1|||
16530879|NCT02239679|40410059|FG001|Overall Study|Lost to Follow-up|0|||
16530880|NCT02239679|40410060|FG002|Overall Study|Lost to Follow-up|0|||
16530881|NCT02239679|40410058|FG000|Overall Study|Withdrawal by Subject|2|||
16530882|NCT02239679|40410059|FG001|Overall Study|Withdrawal by Subject|3|||
16530883|NCT02239679|40410060|FG002|Overall Study|Withdrawal by Subject|1|||
16530884|NCT01914926|40410061|FG000|Overall Study|Adverse Event|1|||
16530885|NCT01914926|40410062|FG001|Overall Study|Adverse Event|0|||
16530886|NCT01914926|40410061|FG000|Overall Study|uncooperative, agitated and removed|0|||
16530887|NCT01914926|40410062|FG001|Overall Study|uncooperative, agitated and removed|1|||
16530888|NCT00617344|40410063|FG000|Overall Study|Serious adverse event|1|||
16530889|NCT00617344|40410064|FG001|Overall Study|Serious adverse event|0|||
16530890|NCT00617344|40410065|FG002|Overall Study|Serious adverse event|0|||
16530891|NCT00617344|40410063|FG000|Overall Study|Other Adverse Event|1|||
16530892|NCT00617344|40410064|FG001|Overall Study|Other Adverse Event|1|||
16530893|NCT00617344|40410065|FG002|Overall Study|Other Adverse Event|0|||
16530894|NCT00617344|40410063|FG000|Overall Study|Protocol Violation|10|||
16530895|NCT00617344|40410064|FG001|Overall Study|Protocol Violation|8|||
16530896|NCT00617344|40410065|FG002|Overall Study|Protocol Violation|5|||
16530897|NCT00617344|40410063|FG000|Overall Study|Lost to Follow-up|5|||
16530898|NCT00617344|40410064|FG001|Overall Study|Lost to Follow-up|4|||
16530899|NCT00617344|40410065|FG002|Overall Study|Lost to Follow-up|1|||
16530900|NCT00617344|40410063|FG000|Overall Study|Withdrawal by Subject|8|||
16530901|NCT00617344|40410064|FG001|Overall Study|Withdrawal by Subject|9|||
16530902|NCT00617344|40410065|FG002|Overall Study|Withdrawal by Subject|2|||
16530903|NCT00450411|40410066|FG000|Overall Study|Protocol Violation|6|||
16530904|NCT00450411|40410066|FG000|Overall Study|No protocol treatment|2|||
16530905|NCT02096900|40410067|FG000|Overall Study|Did not receive medication|3|||
16530906|NCT02096900|40410068|FG001|Overall Study|Did not receive medication|1|||
16530907|NCT02096900|40410067|FG000|Overall Study|Surgery cancelled- medication received|1|||
16530908|NCT02096900|40410068|FG001|Overall Study|Surgery cancelled- medication received|1|||
16530909|NCT02535065|40410069|FG000|Overall Study|Death|13|||
16530910|NCT02535065|40410069|FG000|Overall Study|Lost to Follow-up|1|||
16530911|NCT02535065|40410069|FG000|Overall Study|Withdrawal by Subject|6|||
16530912|NCT01159691|40410070|FG000|Overall Study|Lost to Follow-up|2|||
16530913|NCT01159691|40410070|FG000|Overall Study|Unknown reasons|1|||
16530914|NCT01159691|40410070|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
16530915|NCT01159691|40410070|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
16530916|NCT01159691|40410070|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
16530917|NCT01159691|40410070|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
16530918|NCT01159691|40410070|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
16530919|NCT01159691|40410070|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
16530920|NCT03550313|40410071|FG000|Overall Study|Adverse Event|0|||
16530921|NCT03550313|40410072|FG001|Overall Study|Adverse Event|1|||
16530922|NCT03550313|40410073|FG002|Overall Study|Adverse Event|0|||
16099015|NCT02820298|38849960|FG000|Overall Study|Withdrawal by Subject|0|||
16530923|NCT03550313|40410071|FG000|Overall Study|Lost to Follow-up|5|||
16530924|NCT03550313|40410072|FG001|Overall Study|Lost to Follow-up|7|||
16530925|NCT03550313|40410073|FG002|Overall Study|Lost to Follow-up|12|||
16530926|NCT03550313|40410071|FG000|Overall Study|Study terminated by sponsor|44|||
16099016|NCT02820298|38849961|FG001|Overall Study|Withdrawal by Subject|1|||
16332160|NCT00603382|39703318|FG001|Overall Study|Lack of Efficacy|9|||
16332161|NCT00603382|39703319|FG002|Overall Study|Lack of Efficacy|3|||
16332162|NCT00603382|39703320|FG003|Overall Study|Lack of Efficacy|6|||
16332163|NCT00603382|39703321|FG004|Overall Study|Lack of Efficacy|6|||
16530927|NCT03550313|40410072|FG001|Overall Study|Study terminated by sponsor|37|||
16530928|NCT03550313|40410073|FG002|Overall Study|Study terminated by sponsor|48|||
16530929|NCT03550313|40410071|FG000|Overall Study|No longer met eligibility criteria|3|||
16530930|NCT03550313|40410072|FG001|Overall Study|No longer met eligibility criteria|5|||
16099017|NCT02820298|38849960|FG000|Overall Study|Physician Decision|1|||
16099018|NCT02820298|38849961|FG001|Overall Study|Physician Decision|0|||
16530931|NCT03550313|40410073|FG002|Overall Study|No longer met eligibility criteria|6|||
16530932|NCT03550313|40410071|FG000|Overall Study|Withdrawal by parent/guardian|20|||
16530933|NCT03550313|40410072|FG001|Overall Study|Withdrawal by parent/guardian|18|||
16530934|NCT03550313|40410073|FG002|Overall Study|Withdrawal by parent/guardian|26|||
16530935|NCT03550313|40410071|FG000|Overall Study|Other|4|||
16530936|NCT03550313|40410072|FG001|Overall Study|Other|2|||
16530937|NCT03550313|40410073|FG002|Overall Study|Other|2|||
16530938|NCT03550313|40410071|FG000|Overall Study|Randomized but not vaccinated|3|||
16530939|NCT03550313|40410072|FG001|Overall Study|Randomized but not vaccinated|23|||
16530940|NCT03550313|40410073|FG002|Overall Study|Randomized but not vaccinated|2|||
16530941|NCT03550313|40410071|FG000|Overall Study|Sites terminated due to quality issues|18|||
16530942|NCT03550313|40410072|FG001|Overall Study|Sites terminated due to quality issues|17|||
16530943|NCT03550313|40410073|FG002|Overall Study|Sites terminated due to quality issues|18|||
16530944|NCT01571362|40410075|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
16530945|NCT01571362|40410076|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
16530946|NCT01571362|40410077|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
16530947|NCT01571362|40410075|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
16530948|NCT01571362|40410076|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
16530949|NCT01571362|40410077|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
16530950|NCT01571362|40410075|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
16530951|NCT01571362|40410076|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
16530952|NCT01571362|40410077|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
16530953|NCT01571362|40410075|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
16530954|NCT01571362|40410076|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
16530955|NCT01571362|40410077|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
16530956|NCT01571362|40410075|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
16530957|NCT01571362|40410076|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
16530958|NCT01571362|40410077|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
16530959|NCT01571362|40410075|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
16530960|NCT01571362|40410076|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
16530961|NCT01571362|40410077|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
16530962|NCT01571362|40410075|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16530963|NCT01571362|40410076|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
16530964|NCT01571362|40410077|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
16530965|NCT01571362|40410075|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
16530966|NCT01571362|40410076|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
16530967|NCT01571362|40410077|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
16530968|NCT01571362|40410075|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16530969|NCT01571362|40410076|FG001|Double-Blind Treatment Period|Adverse Event|9|||
16530970|NCT01571362|40410077|FG002|Double-Blind Treatment Period|Adverse Event|14|||
16530971|NCT01571362|40410075|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16530972|NCT01571362|40410076|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
16530973|NCT01571362|40410077|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
16530974|NCT01571362|40410075|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
16530975|NCT01571362|40410076|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
16530976|NCT01571362|40410077|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
16530977|NCT01571362|40410075|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
16530978|NCT01571362|40410076|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
16530979|NCT01571362|40410077|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
16530980|NCT02367911|40410080|FG000|Overall Study|Withdrawal by Subject|3|||
16530981|NCT02367911|40410081|FG001|Overall Study|Withdrawal by Subject|2|||
16530982|NCT02367911|40410080|FG000|Overall Study|Lost to Follow-up|2|||
16530983|NCT02367911|40410081|FG001|Overall Study|Lost to Follow-up|2|||
16530984|NCT02012491|40410082|FG000|Overall Study|Lost to Follow-up|1|||
16530985|NCT02012491|40410083|FG001|Overall Study|Lost to Follow-up|0|||
16530986|NCT02012491|40410082|FG000|Overall Study|Protocol Violation|0|||
16530987|NCT02012491|40410083|FG001|Overall Study|Protocol Violation|1|||
16530988|NCT02012491|40410082|FG000|Overall Study|Withdrawal by Subject|1|||
16099019|NCT02820298|38849960|FG000|Overall Study|Protocol Violation|0|||
16099020|NCT02820298|38849961|FG001|Overall Study|Protocol Violation|1|||
16099021|NCT01631825|38849962|FG000|Overall Study|Adverse Event|42|||
16099022|NCT01631825|38849962|FG000|Overall Study|Lack of Efficacy|7|||
16099023|NCT01631825|38849962|FG000|Overall Study|Withdrawal by Subject|9|||
16214119|NCT04973085|39262036|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
16099024|NCT01631825|38849962|FG000|Overall Study|Protocol Violation|4|||
16214120|NCT02736474|39262037|FG000|Overall Study|Lost to Follow-up|0|||
16214121|NCT02736474|39262038|FG001|Overall Study|Lost to Follow-up|1|||
16099025|NCT01631825|38849962|FG000|Overall Study|Discontinuation criteria|1|||
16099026|NCT01631825|38849962|FG000|Overall Study|Physician Decision|2|||
16099027|NCT03282799|38849963|FG000|Overall Study|Pregnancy|1|||
16099028|NCT03282799|38849964|FG001|Overall Study|Pregnancy|0|||
16099029|NCT03282799|38849963|FG000|Overall Study|Physician Decision|1|||
16099030|NCT03282799|38849964|FG001|Overall Study|Physician Decision|0|||
16099031|NCT03960437|38849965|FG000|Overall Study|Removed by PI|4|||
16099032|NCT03960437|38849965|FG000|Overall Study|Lost to Follow-up|2|||
16099033|NCT03960437|38849965|FG000|Overall Study|Withdrawal by Subject|1|||
16099034|NCT03960437|38849965|FG000|Overall Study|Death|2|||
16099035|NCT04526665|38849969|FG000|Overall Study|Withdrawal by Subject|6|||
16099036|NCT04526665|38849970|FG001|Overall Study|Withdrawal by Subject|3|||
16099037|NCT04526665|38849969|FG000|Overall Study|Adverse Event|4|||
16099038|NCT04526665|38849970|FG001|Overall Study|Adverse Event|1|||
16099039|NCT04526665|38849969|FG000|Overall Study|Physician Decision|2|||
16099040|NCT04526665|38849970|FG001|Overall Study|Physician Decision|2|||
16099041|NCT04526665|38849969|FG000|Overall Study|Death|2|||
16099042|NCT04526665|38849970|FG001|Overall Study|Death|0|||
16099043|NCT04526665|38849969|FG000|Overall Study|Other|0|||
16099044|NCT04526665|38849970|FG001|Overall Study|Other|1|||
16099045|NCT02963922|38849971|FG000|Overall Study|Adverse Event|15|||
16099046|NCT02963922|38849972|FG001|Overall Study|Adverse Event|6|||
16099047|NCT02963922|38849971|FG000|Overall Study|Protocol deviation|6|||
16099048|NCT02963922|38849972|FG001|Overall Study|Protocol deviation|6|||
16099049|NCT02963922|38849971|FG000|Overall Study|Lack of Efficacy|1|||
16099050|NCT02963922|38849972|FG001|Overall Study|Lack of Efficacy|1|||
16099051|NCT02963922|38849971|FG000|Overall Study|Lost to Follow-up|2|||
16099052|NCT02963922|38849972|FG001|Overall Study|Lost to Follow-up|3|||
16099053|NCT02963922|38849971|FG000|Overall Study|Other|8|||
16099054|NCT02963922|38849972|FG001|Overall Study|Other|14|||
16099055|NCT03213678|38849973|FG000|Overall Study|Death|1|||
16099056|NCT03213678|38849973|FG000|Overall Study|Physician Decision|1|||
16099057|NCT03213678|38849973|FG000|Overall Study|Progressive disease|16|||
16099058|NCT01263223|38849976|FG000|Period 2|Withdrawal by Subject|0|||
16099059|NCT01263223|38849977|FG001|Period 2|Withdrawal by Subject|1|||
16099060|NCT01263223|38849976|FG000|7-day Follow-up|Withdrawal by Subject|0|||
16099061|NCT01263223|38849977|FG001|7-day Follow-up|Withdrawal by Subject|1|||
16099062|NCT01263223|38849976|FG000|7-day Follow-up|Lost to Follow-up|1|||
16099063|NCT01263223|38849977|FG001|7-day Follow-up|Lost to Follow-up|0|||
16099064|NCT01767376|38849978|FG000|Overall Study|Lost to Follow-up|3|||
16099065|NCT01767376|38849979|FG001|Overall Study|Lost to Follow-up|2|||
16099066|NCT01767376|38849980|FG002|Overall Study|Lost to Follow-up|0|||
16099067|NCT01767376|38849978|FG000|Overall Study|Withdrawal by Subject|1|||
16099068|NCT01767376|38849979|FG001|Overall Study|Withdrawal by Subject|1|||
16099069|NCT01767376|38849980|FG002|Overall Study|Withdrawal by Subject|0|||
16099070|NCT03839355|38849981|FG000|Overall Study|Withdrawal by Subject|1|||
16099071|NCT03839355|38849982|FG001|Overall Study|Withdrawal by Subject|0|||
16099072|NCT00267956|38849983|FG000|Controlled Period|Adverse Event|4|||
16099073|NCT00267956|38849984|FG001|Controlled Period|Adverse Event|1|||
16099074|NCT00267956|38849985|FG002|Controlled Period|Adverse Event|0|||
16099075|NCT00267956|38849986|FG003|Controlled Period|Adverse Event|0|||
16099076|NCT00267956|38849983|FG000|Controlled Period|Lack of Efficacy|4|||
16099077|NCT00267956|38849984|FG001|Controlled Period|Lack of Efficacy|2|||
16099078|NCT00267956|38849985|FG002|Controlled Period|Lack of Efficacy|0|||
16099079|NCT00267956|38849986|FG003|Controlled Period|Lack of Efficacy|0|||
16099080|NCT00267956|38849983|FG000|Controlled Period|Lost to Follow-up|2|||
16099081|NCT00267956|38849984|FG001|Controlled Period|Lost to Follow-up|0|||
16099082|NCT00267956|38849985|FG002|Controlled Period|Lost to Follow-up|0|||
16099083|NCT00267956|38849986|FG003|Controlled Period|Lost to Follow-up|0|||
16099084|NCT00267956|38849983|FG000|Controlled Period|Withdrew consent|3|||
16099085|NCT00267956|38849984|FG001|Controlled Period|Withdrew consent|1|||
16099086|NCT00267956|38849985|FG002|Controlled Period|Withdrew consent|0|||
16099087|NCT00267956|38849986|FG003|Controlled Period|Withdrew consent|0|||
16099088|NCT00267956|38849983|FG000|After Controlled Period|Adverse Event|0|||
16099089|NCT00267956|38849984|FG001|After Controlled Period|Adverse Event|0|||
16214122|NCT01194414|39262046|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
16214123|NCT01194414|39262047|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
16099090|NCT00267956|38849985|FG002|After Controlled Period|Adverse Event|2|||
16099091|NCT00267956|38849986|FG003|After Controlled Period|Adverse Event|1|||
16099092|NCT00267956|38849983|FG000|After Controlled Period|Lack of Efficacy|0|||
16099093|NCT00267956|38849984|FG001|After Controlled Period|Lack of Efficacy|0|||
16099094|NCT00267956|38849985|FG002|After Controlled Period|Lack of Efficacy|1|||
16099095|NCT00267956|38849986|FG003|After Controlled Period|Lack of Efficacy|1|||
16099096|NCT00267956|38849983|FG000|After Controlled Period|Lost to Follow-up|0|||
16099097|NCT00267956|38849984|FG001|After Controlled Period|Lost to Follow-up|0|||
16099098|NCT00267956|38849985|FG002|After Controlled Period|Lost to Follow-up|1|||
16099099|NCT00267956|38849986|FG003|After Controlled Period|Lost to Follow-up|0|||
16099100|NCT00267956|38849983|FG000|After Controlled Period|Withdrew consent|0|||
16099101|NCT00267956|38849984|FG001|After Controlled Period|Withdrew consent|0|||
16099102|NCT00267956|38849985|FG002|After Controlled Period|Withdrew consent|1|||
16099103|NCT00267956|38849986|FG003|After Controlled Period|Withdrew consent|0|||
16099104|NCT03036124|38849989|FG000|Overall Study|Lost to Follow-up|0|||
16099105|NCT03036124|38849990|FG001|Overall Study|Lost to Follow-up|2|||
16099106|NCT03036124|38849989|FG000|Overall Study|Withdrawal by Subject|5|||
16099107|NCT03036124|38849990|FG001|Overall Study|Withdrawal by Subject|4|||
16099108|NCT01622088|38849991|FG000|Overall Study|Adverse Event|20|||
16099109|NCT01622088|38849991|FG000|Overall Study|Lost to Follow-up|1|||
16099110|NCT01622088|38849991|FG000|Overall Study|Withdrawal by Subject|20|||
16099111|NCT01622088|38849991|FG000|Overall Study|Investigator Decision|1|||
16099112|NCT01622088|38849991|FG000|Overall Study|Death|53|||
16099113|NCT01622088|38849991|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
16099114|NCT03441789|38849992|FG000|Overall Study|Withdrawal by Subject|1|||
16099115|NCT03441789|38849993|FG001|Overall Study|Withdrawal by Subject|1|||
16099116|NCT03441789|38849992|FG000|Overall Study|Adverse Event|0|||
16099117|NCT03441789|38849993|FG001|Overall Study|Adverse Event|1|||
16099118|NCT03441789|38849992|FG000|Overall Study|Protocol Violation|0|||
16099119|NCT03441789|38849993|FG001|Overall Study|Protocol Violation|1|||
16099120|NCT03441789|38849992|FG000|Overall Study|Lost to Follow-up|0|||
16099121|NCT03441789|38849993|FG001|Overall Study|Lost to Follow-up|1|||
16099122|NCT00278395|38849994|FG000|Overall Study|Adverse Event|2|||
16099123|NCT00278395|38849994|FG000|Overall Study|Nonevaluable|1|||
16099124|NCT00108355|38849995|FG000|Overall Study|Peritonitis at index paracentesis|1|||
16099125|NCT00108355|38849996|FG001|Overall Study|Peritonitis at index paracentesis|1|||
16099126|NCT00108355|38849995|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
16099127|NCT00108355|38849996|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
16099128|NCT03651271|38849997|FG000|Overall Study|Death|4|||
16099129|NCT03651271|38849998|FG001|Overall Study|Death|37|||
16099130|NCT03651271|38849999|FG002|Overall Study|Death|0|||
16099131|NCT03651271|38850000|FG003|Overall Study|Death|2|||
16099132|NCT03651271|38850001|FG004|Overall Study|Death|6|||
16214124|NCT01194414|39262048|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
16214125|NCT01194414|39262049|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
16214126|NCT01194414|39262046|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
16214127|NCT01194414|39262047|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
16214128|NCT01194414|39262048|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
16214129|NCT01194414|39262049|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
16214130|NCT01194414|39262046|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
16214131|NCT01194414|39262047|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
16214132|NCT01194414|39262048|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
16214133|NCT01194414|39262049|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
16214134|NCT01194414|39262046|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
16214135|NCT01194414|39262047|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
16214136|NCT01194414|39262048|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
16214137|NCT01194414|39262049|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
16214138|NCT01194414|39262046|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
16214139|NCT01194414|39262047|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
16214140|NCT01194414|39262048|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
16214141|NCT01194414|39262049|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
16214142|NCT01194414|39262046|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
16214143|NCT01194414|39262047|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
16214144|NCT01194414|39262048|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
16332164|NCT00603382|39703322|FG005|Overall Study|Lack of Efficacy|11|||
16332165|NCT00603382|39703317|FG000|Overall Study|Protocol Violation|1|||
16332166|NCT00603382|39703318|FG001|Overall Study|Protocol Violation|0|||
16332167|NCT00603382|39703319|FG002|Overall Study|Protocol Violation|1|||
16332168|NCT00603382|39703320|FG003|Overall Study|Protocol Violation|2|||
16332169|NCT00603382|39703321|FG004|Overall Study|Protocol Violation|1|||
16332170|NCT00603382|39703322|FG005|Overall Study|Protocol Violation|0|||
16332171|NCT00603382|39703317|FG000|Overall Study|Lost to Follow-up|0|||
16332172|NCT00603382|39703318|FG001|Overall Study|Lost to Follow-up|1|||
16332173|NCT00603382|39703319|FG002|Overall Study|Lost to Follow-up|1|||
16332174|NCT00603382|39703320|FG003|Overall Study|Lost to Follow-up|1|||
16332175|NCT00603382|39703321|FG004|Overall Study|Lost to Follow-up|0|||
16099133|NCT03651271|38849997|FG000|Overall Study|Lost to Follow-up|1|||
16332176|NCT00603382|39703322|FG005|Overall Study|Lost to Follow-up|1|||
16332177|NCT00603382|39703317|FG000|Overall Study|Physician Decision|0|||
16332178|NCT00603382|39703318|FG001|Overall Study|Physician Decision|0|||
16332179|NCT00603382|39703319|FG002|Overall Study|Physician Decision|2|||
16099134|NCT03651271|38849998|FG001|Overall Study|Lost to Follow-up|5|||
16332180|NCT00603382|39703320|FG003|Overall Study|Physician Decision|0|||
16099135|NCT03651271|38849999|FG002|Overall Study|Lost to Follow-up|0|||
16099136|NCT03651271|38850000|FG003|Overall Study|Lost to Follow-up|1|||
16099137|NCT03651271|38850001|FG004|Overall Study|Lost to Follow-up|0|||
16401377|NCT02759107|39953552|FG015|Overall Study|Adverse Event|1|||
16401378|NCT02759107|39953553|FG016|Overall Study|Adverse Event|0|||
16401379|NCT02759107|39953554|FG017|Overall Study|Adverse Event|2|||
16401380|NCT02759107|39953537|FG000|Overall Study|Scheduling Conflict|0|||
16401381|NCT02759107|39953538|FG001|Overall Study|Scheduling Conflict|0|||
16401382|NCT02759107|39953539|FG002|Overall Study|Scheduling Conflict|0|||
16401383|NCT02759107|39953540|FG003|Overall Study|Scheduling Conflict|0|||
16401384|NCT02759107|39953541|FG004|Overall Study|Scheduling Conflict|0|||
16401385|NCT02759107|39953542|FG005|Overall Study|Scheduling Conflict|0|||
16401386|NCT02759107|39953543|FG006|Overall Study|Scheduling Conflict|0|||
16401387|NCT02759107|39953544|FG007|Overall Study|Scheduling Conflict|0|||
16099138|NCT03651271|38849997|FG000|Overall Study|Physician Decision|0|||
16099139|NCT03651271|38849998|FG001|Overall Study|Physician Decision|2|||
16099140|NCT03651271|38849999|FG002|Overall Study|Physician Decision|0|||
16099141|NCT03651271|38850000|FG003|Overall Study|Physician Decision|0|||
16099142|NCT03651271|38850001|FG004|Overall Study|Physician Decision|0|||
16099143|NCT03651271|38849997|FG000|Overall Study|Withdrawal by Subject|1|||
16099144|NCT03651271|38849998|FG001|Overall Study|Withdrawal by Subject|15|||
16099145|NCT03651271|38849999|FG002|Overall Study|Withdrawal by Subject|0|||
16099146|NCT03651271|38850000|FG003|Overall Study|Withdrawal by Subject|0|||
16099147|NCT03651271|38850001|FG004|Overall Study|Withdrawal by Subject|1|||
16099148|NCT03651271|38849997|FG000|Overall Study|Patient medically unable to continue|0|||
16099149|NCT03651271|38849998|FG001|Overall Study|Patient medically unable to continue|0|||
16099150|NCT03651271|38849999|FG002|Overall Study|Patient medically unable to continue|0|||
16099151|NCT03651271|38850000|FG003|Overall Study|Patient medically unable to continue|1|||
16099152|NCT03651271|38850001|FG004|Overall Study|Patient medically unable to continue|0|||
16099153|NCT02121808|38850004|FG000|Overall Study|Technical problem|3|||
16099154|NCT01848483|38850005|FG000|Overall Study|Death|2|||
16099155|NCT01848483|38850006|FG001|Overall Study|Death|1|||
16099156|NCT01848483|38850005|FG000|Overall Study|Lost to Follow-up|6|||
16099157|NCT01848483|38850006|FG001|Overall Study|Lost to Follow-up|8|||
16401388|NCT02759107|39953545|FG008|Overall Study|Scheduling Conflict|0|||
16099158|NCT01848483|38850005|FG000|Overall Study|Withdrawal by Subject|1|||
16099159|NCT01848483|38850006|FG001|Overall Study|Withdrawal by Subject|0|||
16099160|NCT01848483|38850005|FG000|Overall Study|Incarceration|2|||
16099161|NCT01848483|38850006|FG001|Overall Study|Incarceration|2|||
16401389|NCT02759107|39953546|FG009|Overall Study|Scheduling Conflict|1|||
16401390|NCT02759107|39953547|FG010|Overall Study|Scheduling Conflict|0|||
16401391|NCT02759107|39953548|FG011|Overall Study|Scheduling Conflict|0|||
16401392|NCT02759107|39953549|FG012|Overall Study|Scheduling Conflict|0|||
16401393|NCT02759107|39953550|FG013|Overall Study|Scheduling Conflict|0|||
16401394|NCT02759107|39953551|FG014|Overall Study|Scheduling Conflict|0|||
16401395|NCT02759107|39953552|FG015|Overall Study|Scheduling Conflict|0|||
16401396|NCT02759107|39953553|FG016|Overall Study|Scheduling Conflict|0|||
16099162|NCT01636258|38850007|FG000|Overall Study|Lost to Follow-up|1|||
16099163|NCT01636258|38850008|FG001|Overall Study|Lost to Follow-up|0|||
16401397|NCT02759107|39953554|FG017|Overall Study|Scheduling Conflict|0|||
16401398|NCT01126437|39953555|FG000|Overall Study|Not treated|11|||
16401399|NCT01126437|39953556|FG001|Overall Study|Not treated|18|||
16401400|NCT01126437|39953557|FG002|Overall Study|Not treated|19|||
16401401|NCT01126437|39953555|FG000|Overall Study|Sites with data irregularities/fraud|6|||
16401402|NCT01126437|39953556|FG001|Overall Study|Sites with data irregularities/fraud|6|||
16401403|NCT01126437|39953557|FG002|Overall Study|Sites with data irregularities/fraud|7|||
16099164|NCT01190449|38850009|FG000|Overall Study|Ineligible|0|||
16099165|NCT01190449|38850010|FG001|Overall Study|Ineligible|4|||
16099166|NCT03087851|38850011|FG000|Overall Study|Withdraw on medical grounds|0|||
16401404|NCT01126437|39953555|FG000|Overall Study|Adverse Event|602|||
16401405|NCT01126437|39953556|FG001|Overall Study|Adverse Event|606|||
16099167|NCT03087851|38850012|FG001|Overall Study|Withdraw on medical grounds|1|||
16099168|NCT03087851|38850013|FG002|Overall Study|Withdraw on medical grounds|2|||
16099169|NCT01989156|38850014|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
16401406|NCT01126437|39953557|FG002|Overall Study|Adverse Event|635|||
16401407|NCT01126437|39953555|FG000|Overall Study|Lack of Efficacy|65|||
16401408|NCT01126437|39953556|FG001|Overall Study|Lack of Efficacy|60|||
16401409|NCT01126437|39953557|FG002|Overall Study|Lack of Efficacy|59|||
16401410|NCT01126437|39953555|FG000|Overall Study|Protocol Violation|64|||
16401411|NCT01126437|39953556|FG001|Overall Study|Protocol Violation|66|||
16401412|NCT01126437|39953557|FG002|Overall Study|Protocol Violation|41|||
16401413|NCT01126437|39953555|FG000|Overall Study|Lost to Follow-up|52|||
16401414|NCT01126437|39953556|FG001|Overall Study|Lost to Follow-up|63|||
16530989|NCT02012491|40410083|FG001|Overall Study|Withdrawal by Subject|0|||
16530990|NCT02273141|40410084|FG000|Overall Study|Adverse Event|0|||
16530991|NCT02273141|40410085|FG001|Overall Study|Adverse Event|1|||
16530992|NCT02273141|40410084|FG000|Overall Study|Lost to Follow-up|1|||
16530993|NCT02273141|40410085|FG001|Overall Study|Lost to Follow-up|3|||
16530994|NCT02273141|40410084|FG000|Overall Study|Withdrawal by Subject|10|||
16530995|NCT02273141|40410085|FG001|Overall Study|Withdrawal by Subject|15|||
16530996|NCT02273141|40410084|FG000|Overall Study|Various|6|||
16530997|NCT02273141|40410085|FG001|Overall Study|Various|6|||
16530998|NCT03305016|40410087|FG000|Overall Study|Withdrawal by Subject|2|||
16530999|NCT03564496|40410088|FG000|Overall Study|Withdrawal by Subject|1|||
16531000|NCT03564496|40410089|FG001|Overall Study|Withdrawal by Subject|1|||
16531001|NCT03564496|40410090|FG002|Overall Study|Withdrawal by Subject|0|||
16531002|NCT03564496|40410088|FG000|Overall Study|Screen failure|0|||
16531003|NCT03564496|40410089|FG001|Overall Study|Screen failure|3|||
16099170|NCT01989156|38850015|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
16099171|NCT01989156|38850016|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
16099172|NCT01989156|38850014|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
16099173|NCT01989156|38850015|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
16099174|NCT01989156|38850016|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
16099175|NCT01989156|38850014|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
16099176|NCT01989156|38850015|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
16099177|NCT01989156|38850016|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
16099178|NCT01989156|38850014|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
16099179|NCT01989156|38850015|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
16099180|NCT01989156|38850016|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
16099181|NCT01989156|38850014|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
16099182|NCT01989156|38850015|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
16099183|NCT01989156|38850016|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
16099184|NCT01989156|38850014|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
16099185|NCT01989156|38850015|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
16099186|NCT01989156|38850016|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
16099187|NCT01989156|38850014|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
16099188|NCT01989156|38850015|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
16099189|NCT01989156|38850016|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
16099190|NCT01989156|38850014|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
16099191|NCT01989156|38850015|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
16099192|NCT01989156|38850016|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
16099193|NCT01838499|38850019|FG000|Overall Study|Protocol Violation|0|||
16099194|NCT01838499|38850020|FG001|Overall Study|Protocol Violation|1|||
16099195|NCT01838499|38850019|FG000|Overall Study|Lost to Follow-up|2|||
16099196|NCT01838499|38850020|FG001|Overall Study|Lost to Follow-up|4|||
16099197|NCT01838499|38850019|FG000|Overall Study|Lack of Efficacy|1|||
16099198|NCT01838499|38850020|FG001|Overall Study|Lack of Efficacy|2|||
16099199|NCT01838499|38850019|FG000|Overall Study|Adverse Event|2|||
16099200|NCT01838499|38850020|FG001|Overall Study|Adverse Event|1|||
16099201|NCT01838499|38850019|FG000|Overall Study|Withdrawal by Subject|19|||
16099202|NCT01838499|38850020|FG001|Overall Study|Withdrawal by Subject|9|||
16099203|NCT02152995|38850021|FG000|Overall Study|Withdrawal by Subject|1|||
16099204|NCT02152995|38850022|FG001|Overall Study|Withdrawal by Subject|0|||
16099205|NCT04089332|38852813|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
16099206|NCT04089332|38852813|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
16099207|NCT04089332|38852813|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
16099208|NCT02005484|38852816|FG000|Overall Study|Death|1|||
16332181|NCT00603382|39703321|FG004|Overall Study|Physician Decision|1|||
16401415|NCT01126437|39953557|FG002|Overall Study|Lost to Follow-up|55|||
16401416|NCT01126437|39953555|FG000|Overall Study|Withdrawal by Subject|331|||
16531004|NCT03564496|40410090|FG002|Overall Study|Screen failure|0|||
16531005|NCT00127101|40410091|FG000|Base Protocol|Adverse Event|0|||
16531006|NCT00127101|40410092|FG001|Base Protocol|Adverse Event|2|||
16531007|NCT00127101|40410093|FG002|Base Protocol|Adverse Event|1|||
16531008|NCT00127101|40410094|FG003|Base Protocol|Adverse Event|0|||
16099209|NCT02005484|38852816|FG000|Overall Study|Disease progression|1|||
16099210|NCT02005484|38852816|FG000|Overall Study|Changed to a Different Study|1|||
16099211|NCT02005484|38852816|FG000|Overall Study|Sponsor decision|1|||
16099212|NCT04783519|38852817|FG000|Overall Study|Withdrawal by Subject|2|||
16099213|NCT04783519|38852818|FG001|Overall Study|Withdrawal by Subject|7|||
16099214|NCT04783519|38852819|FG002|Overall Study|Withdrawal by Subject|3|||
16099215|NCT04783519|38852817|FG000|Overall Study|Lost to Follow-up|9|||
16099216|NCT04783519|38852818|FG001|Overall Study|Lost to Follow-up|7|||
16099217|NCT04783519|38852819|FG002|Overall Study|Lost to Follow-up|6|||
16099218|NCT02965599|38852820|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
16099219|NCT02965599|38852821|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
16099220|NCT04736602|38852824|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
16099221|NCT04736602|38852824|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
16099222|NCT01113541|38852828|FG000|Overall Study|Withdrawal by Subject|1|||
16099223|NCT01113541|38852828|FG000|Overall Study|Protocol Violation|1|||
16099224|NCT01113541|38852828|FG000|Overall Study|Study Terminated by Sponsor|7|||
16099225|NCT01113541|38852828|FG000|Overall Study|Adverse Event|4|||
16099226|NCT00244751|38852829|FG000|Overall Study|Adverse Event|7|||
16099227|NCT00244751|38852830|FG001|Overall Study|Adverse Event|7|||
16099228|NCT00244751|38852831|FG002|Overall Study|Adverse Event|5|||
16099229|NCT00244751|38852829|FG000|Overall Study|Lost to Follow-up|0|||
16099230|NCT00244751|38852830|FG001|Overall Study|Lost to Follow-up|1|||
16099231|NCT00244751|38852831|FG002|Overall Study|Lost to Follow-up|0|||
16099232|NCT00244751|38852829|FG000|Overall Study|Protocol Violation|1|||
16099233|NCT00244751|38852830|FG001|Overall Study|Protocol Violation|0|||
16099234|NCT00244751|38852831|FG002|Overall Study|Protocol Violation|1|||
16099235|NCT00244751|38852829|FG000|Overall Study|Withdrawal by Subject|7|||
16099236|NCT00244751|38852830|FG001|Overall Study|Withdrawal by Subject|5|||
16099237|NCT00244751|38852831|FG002|Overall Study|Withdrawal by Subject|3|||
16099238|NCT00244751|38852829|FG000|Overall Study|Elevated liver enzymes|1|||
16099239|NCT00244751|38852830|FG001|Overall Study|Elevated liver enzymes|0|||
16099240|NCT00244751|38852831|FG002|Overall Study|Elevated liver enzymes|0|||
16099241|NCT00244751|38852829|FG000|Overall Study|Lack of compliance with protocol|0|||
16099242|NCT00244751|38852830|FG001|Overall Study|Lack of compliance with protocol|1|||
16099243|NCT00244751|38852831|FG002|Overall Study|Lack of compliance with protocol|0|||
16099244|NCT00244751|38852829|FG000|Overall Study|Safety reasons|0|||
16099245|NCT00244751|38852830|FG001|Overall Study|Safety reasons|1|||
16099246|NCT00244751|38852831|FG002|Overall Study|Safety reasons|0|||
16099247|NCT00244751|38852829|FG000|Overall Study|Participant randomized by mistake|0|||
16531009|NCT00127101|40410095|FG004|Base Protocol|Adverse Event|0|||
16531010|NCT00127101|40410096|FG005|Base Protocol|Adverse Event|0|||
16531011|NCT00127101|40410091|FG000|Base Protocol|Lack of Efficacy|1|||
16531012|NCT00127101|40410092|FG001|Base Protocol|Lack of Efficacy|0|||
16531013|NCT00127101|40410093|FG002|Base Protocol|Lack of Efficacy|0|||
16531014|NCT00127101|40410094|FG003|Base Protocol|Lack of Efficacy|0|||
16531015|NCT00127101|40410095|FG004|Base Protocol|Lack of Efficacy|2|||
16531016|NCT00127101|40410096|FG005|Base Protocol|Lack of Efficacy|0|||
16531017|NCT00127101|40410091|FG000|Base Protocol|Withdrawal by Subject|1|||
16531018|NCT00127101|40410092|FG001|Base Protocol|Withdrawal by Subject|2|||
16531019|NCT00127101|40410093|FG002|Base Protocol|Withdrawal by Subject|1|||
16531020|NCT00127101|40410094|FG003|Base Protocol|Withdrawal by Subject|0|||
16531021|NCT00127101|40410095|FG004|Base Protocol|Withdrawal by Subject|0|||
16531022|NCT00127101|40410096|FG005|Base Protocol|Withdrawal by Subject|1|||
16531023|NCT00127101|40410091|FG000|Continuation Phase|Adverse Event|0|||
16531024|NCT00127101|40410092|FG001|Continuation Phase|Adverse Event|0|||
16531025|NCT00127101|40410093|FG002|Continuation Phase|Adverse Event|0|||
16531026|NCT00127101|40410094|FG003|Continuation Phase|Adverse Event|0|||
16531027|NCT00127101|40410095|FG004|Continuation Phase|Adverse Event|1|||
16531028|NCT00127101|40410096|FG005|Continuation Phase|Adverse Event|1|||
16531029|NCT00127101|40410091|FG000|Continuation Phase|Lack of Efficacy|0|||
16531030|NCT00127101|40410092|FG001|Continuation Phase|Lack of Efficacy|0|||
16099248|NCT00244751|38852830|FG001|Overall Study|Participant randomized by mistake|0|||
16099249|NCT00244751|38852831|FG002|Overall Study|Participant randomized by mistake|1|||
16099250|NCT02101554|38852839|FG000|Overall Study|Protocol Violation|0|||
16531031|NCT00127101|40410093|FG002|Continuation Phase|Lack of Efficacy|0|||
16531032|NCT00127101|40410094|FG003|Continuation Phase|Lack of Efficacy|0|||
16531033|NCT00127101|40410095|FG004|Continuation Phase|Lack of Efficacy|0|||
16531034|NCT00127101|40410096|FG005|Continuation Phase|Lack of Efficacy|1|||
16531035|NCT00127101|40410091|FG000|Continuation Phase|Withdrawal by Subject|0|||
16531036|NCT00127101|40410092|FG001|Continuation Phase|Withdrawal by Subject|0|||
16099251|NCT02101554|38852840|FG001|Overall Study|Protocol Violation|1|||
16099252|NCT02101554|38852841|FG002|Overall Study|Protocol Violation|0|||
16099253|NCT02101554|38852839|FG000|Overall Study|Insufficient Clinical Response|0|||
16099254|NCT02101554|38852840|FG001|Overall Study|Insufficient Clinical Response|2|||
16531037|NCT00127101|40410093|FG002|Continuation Phase|Withdrawal by Subject|1|||
16531038|NCT00127101|40410094|FG003|Continuation Phase|Withdrawal by Subject|0|||
16531039|NCT00127101|40410095|FG004|Continuation Phase|Withdrawal by Subject|2|||
16531040|NCT00127101|40410096|FG005|Continuation Phase|Withdrawal by Subject|1|||
16531041|NCT01669122|40410103|FG000|Period I|Lost to Follow-up|1|||
16531042|NCT01669122|40410103|FG000|Washout Period II|Protocol Violation|2|||
16531043|NCT03565887|40410104|FG000|Overall Study|Adverse Event|1|||
16531044|NCT03565887|40410105|FG001|Overall Study|Adverse Event|0|||
16531045|NCT03565887|40410104|FG000|Overall Study|Withdrawal by Subject|0|||
16531046|NCT03565887|40410105|FG001|Overall Study|Withdrawal by Subject|2|||
16531047|NCT00317772|40410112|FG000|Overall Study|Adverse Event|0|||
16531048|NCT00317772|40410113|FG001|Overall Study|Adverse Event|0|||
16531049|NCT00317772|40410114|FG002|Overall Study|Adverse Event|0|||
16531050|NCT00317772|40410115|FG003|Overall Study|Adverse Event|2|||
16531051|NCT00317772|40410112|FG000|Overall Study|Disease Progression|2|||
16531052|NCT00317772|40410113|FG001|Overall Study|Disease Progression|2|||
16531053|NCT00317772|40410114|FG002|Overall Study|Disease Progression|1|||
16531054|NCT00317772|40410115|FG003|Overall Study|Disease Progression|7|||
16531055|NCT03105362|40410116|FG000|Overall Study|Withdrawal by Subject|1|||
16531056|NCT03105362|40410116|FG000|Overall Study|Lost to Follow-up|1|||
16531057|NCT02291614|40410117|FG000|Overall Study|Lost to Follow-up|0|||
16531058|NCT02291614|40410118|FG001|Overall Study|Lost to Follow-up|0|||
16531059|NCT02291614|40410119|FG002|Overall Study|Lost to Follow-up|0|||
16531060|NCT02291614|40410120|FG003|Overall Study|Lost to Follow-up|0|||
16531061|NCT02291614|40410121|FG004|Overall Study|Lost to Follow-up|0|||
16531062|NCT02291614|40410122|FG005|Overall Study|Lost to Follow-up|0|||
16531063|NCT02291614|40410123|FG006|Overall Study|Lost to Follow-up|0|||
16531064|NCT02291614|40410124|FG007|Overall Study|Lost to Follow-up|1|||
16531065|NCT02291614|40410125|FG008|Overall Study|Lost to Follow-up|0|||
16531066|NCT02291614|40410126|FG009|Overall Study|Lost to Follow-up|0|||
16531067|NCT02291614|40410127|FG010|Overall Study|Lost to Follow-up|0|||
16214145|NCT01194414|39262049|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
16214146|NCT01194414|39262046|FG000|24 Weeks Double Blind Period|Other|0|||
16214147|NCT01194414|39262047|FG001|24 Weeks Double Blind Period|Other|1|||
16214148|NCT01194414|39262048|FG002|24 Weeks Double Blind Period|Other|0|||
16214149|NCT01194414|39262049|FG003|24 Weeks Double Blind Period|Other|0|||
16214150|NCT01194414|39262046|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
16214151|NCT01194414|39262047|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
16214152|NCT01194414|39262048|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
16214153|NCT01194414|39262049|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
16214154|NCT01194414|39262046|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
16214155|NCT01194414|39262047|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
16214156|NCT01194414|39262048|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
16214157|NCT01194414|39262049|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
16214158|NCT01194414|39262046|FG000|24 Weeks Double Blind Period|Death|0|||
16214159|NCT01194414|39262047|FG001|24 Weeks Double Blind Period|Death|1|||
16214160|NCT01194414|39262048|FG002|24 Weeks Double Blind Period|Death|0|||
16214161|NCT01194414|39262049|FG003|24 Weeks Double Blind Period|Death|0|||
16214162|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
16332182|NCT00603382|39703322|FG005|Overall Study|Physician Decision|3|||
16332183|NCT00603382|39703317|FG000|Overall Study|Withdrawal by Subject|3|||
16332184|NCT00603382|39703318|FG001|Overall Study|Withdrawal by Subject|3|||
16332185|NCT00603382|39703319|FG002|Overall Study|Withdrawal by Subject|1|||
16332186|NCT00603382|39703320|FG003|Overall Study|Withdrawal by Subject|1|||
16332187|NCT00603382|39703321|FG004|Overall Study|Withdrawal by Subject|0|||
16332188|NCT00603382|39703322|FG005|Overall Study|Withdrawal by Subject|1|||
16214163|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
16214164|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
16214165|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
16214166|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
16332189|NCT03840148|39703323|FG000|Study Drug Disposition|Adverse Event|13|||
16332190|NCT03840148|39703324|FG001|Study Drug Disposition|Adverse Event|2|||
16332191|NCT03840148|39703323|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
16332192|NCT03840148|39703324|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
16401417|NCT01126437|39953556|FG001|Overall Study|Withdrawal by Subject|335|||
16531068|NCT02291614|40410117|FG000|Overall Study|Withdrawal by Subject|0|||
16531069|NCT02291614|40410118|FG001|Overall Study|Withdrawal by Subject|1|||
16531070|NCT02291614|40410119|FG002|Overall Study|Withdrawal by Subject|0|||
16531071|NCT02291614|40410120|FG003|Overall Study|Withdrawal by Subject|0|||
16531072|NCT02291614|40410121|FG004|Overall Study|Withdrawal by Subject|0|||
16531073|NCT02291614|40410122|FG005|Overall Study|Withdrawal by Subject|0|||
16531074|NCT02291614|40410123|FG006|Overall Study|Withdrawal by Subject|0|||
16531075|NCT02291614|40410124|FG007|Overall Study|Withdrawal by Subject|0|||
16531076|NCT02291614|40410125|FG008|Overall Study|Withdrawal by Subject|0|||
16531077|NCT02291614|40410126|FG009|Overall Study|Withdrawal by Subject|2|||
16531078|NCT02291614|40410127|FG010|Overall Study|Withdrawal by Subject|2|||
16099255|NCT02101554|38852841|FG002|Overall Study|Insufficient Clinical Response|0|||
16099256|NCT02101554|38852839|FG000|Overall Study|Adverse Event|2|||
16214167|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
16214168|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
16214169|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
16214170|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
16214171|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
16214172|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
16214173|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
16214174|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
16214175|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
16214176|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
16214177|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
16214178|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
16214179|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
16214180|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
16214181|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
16214182|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
16214183|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
16214184|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
16214185|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
16214186|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Other|2|||
16214187|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Other|1|||
16214188|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Other|0|||
16214189|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Other|0|||
16214190|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
16214191|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
16214192|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
16214193|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
16214194|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
16214195|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
16214196|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
16214197|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
16214198|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
16214199|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
16214200|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
16214201|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
16214202|NCT01194414|39262046|FG000|72 Weeks Open Label Extension|Death|1|||
16214203|NCT01194414|39262047|FG001|72 Weeks Open Label Extension|Death|2|||
16214204|NCT01194414|39262048|FG002|72 Weeks Open Label Extension|Death|0|||
16214205|NCT01194414|39262049|FG003|72 Weeks Open Label Extension|Death|2|||
16214206|NCT01685372|39262050|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
16214207|NCT01685372|39262051|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
16214208|NCT01983683|39262052|FG000|Overall Study|Withdrawal by Subject|14|||
16214209|NCT01983683|39262053|FG001|Overall Study|Withdrawal by Subject|18|||
16214210|NCT01983683|39262052|FG000|Overall Study|Death|11|||
16214211|NCT01983683|39262053|FG001|Overall Study|Death|15|||
16214212|NCT01983683|39262052|FG000|Overall Study|Physician Decision|8|||
16214213|NCT01983683|39262053|FG001|Overall Study|Physician Decision|9|||
16214214|NCT01983683|39262052|FG000|Overall Study|Lost to Follow-up|4|||
16214215|NCT01983683|39262053|FG001|Overall Study|Lost to Follow-up|8|||
16214216|NCT01983683|39262052|FG000|Overall Study|Sponsor Decision|1|||
16214217|NCT01983683|39262053|FG001|Overall Study|Sponsor Decision|1|||
16214218|NCT01057862|39262058|FG000|Overall Study|Withdrawal by Subject|1|||
16214219|NCT01057862|39262059|FG001|Overall Study|Withdrawal by Subject|2|||
16214220|NCT00085644|39262062|FG000|Double-Blind Period|Adverse Event|5|||
16214221|NCT00085644|39262063|FG001|Double-Blind Period|Adverse Event|2|||
16099257|NCT02101554|38852840|FG001|Overall Study|Adverse Event|1|||
16099258|NCT02101554|38852841|FG002|Overall Study|Adverse Event|1|||
16099259|NCT02101554|38852839|FG000|Overall Study|Lost to Follow-up|0|||
16214222|NCT00085644|39262064|FG002|Double-Blind Period|Adverse Event|0|||
16214223|NCT00085644|39262062|FG000|Double-Blind Period|Withdrawal by Subject|3|||
16214224|NCT00085644|39262063|FG001|Double-Blind Period|Withdrawal by Subject|0|||
16214225|NCT00085644|39262064|FG002|Double-Blind Period|Withdrawal by Subject|0|||
16214226|NCT00085644|39262062|FG000|Double-Blind Period|Lost to Follow-up|2|||
16214227|NCT00085644|39262063|FG001|Double-Blind Period|Lost to Follow-up|1|||
16214228|NCT00085644|39262064|FG002|Double-Blind Period|Lost to Follow-up|0|||
16531079|NCT02291614|40410117|FG000|Overall Study|Decision by sponsor|0|||
16531080|NCT02291614|40410118|FG001|Overall Study|Decision by sponsor|0|||
16531081|NCT02291614|40410119|FG002|Overall Study|Decision by sponsor|0|||
16099260|NCT02101554|38852840|FG001|Overall Study|Lost to Follow-up|1|||
16214229|NCT00085644|39262062|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
16214230|NCT00085644|39262063|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
16214231|NCT00085644|39262064|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
16214232|NCT00085644|39262062|FG000|Double-Blind Period|Contemplating pregnancy|1|||
16214233|NCT00085644|39262063|FG001|Double-Blind Period|Contemplating pregnancy|0|||
16214234|NCT00085644|39262064|FG002|Double-Blind Period|Contemplating pregnancy|0|||
16214235|NCT00085644|39262062|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
16214236|NCT00085644|39262063|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
16214237|NCT00085644|39262064|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
16214238|NCT00085644|39262062|FG000|Open-Label Period|Adverse Event|0|||
16214239|NCT00085644|39262063|FG001|Open-Label Period|Adverse Event|0|||
16214240|NCT00085644|39262064|FG002|Open-Label Period|Adverse Event|38|||
16214241|NCT00085644|39262062|FG000|Open-Label Period|Withdrawal by Subject|0|||
16214242|NCT00085644|39262063|FG001|Open-Label Period|Withdrawal by Subject|0|||
16214243|NCT00085644|39262064|FG002|Open-Label Period|Withdrawal by Subject|29|||
16214244|NCT00085644|39262062|FG000|Open-Label Period|Lost to Follow-up|0|||
16214245|NCT00085644|39262063|FG001|Open-Label Period|Lost to Follow-up|0|||
16214246|NCT00085644|39262064|FG002|Open-Label Period|Lost to Follow-up|13|||
16214247|NCT00085644|39262062|FG000|Open-Label Period|Lack of Efficacy|0|||
16214248|NCT00085644|39262063|FG001|Open-Label Period|Lack of Efficacy|0|||
16214249|NCT00085644|39262064|FG002|Open-Label Period|Lack of Efficacy|15|||
16214250|NCT00085644|39262062|FG000|Open-Label Period|Pregnancy|0|||
16214251|NCT00085644|39262063|FG001|Open-Label Period|Pregnancy|0|||
16214252|NCT00085644|39262064|FG002|Open-Label Period|Pregnancy|3|||
16214253|NCT00085644|39262062|FG000|Open-Label Period|Contemplating pregnancy|0|||
16214254|NCT00085644|39262063|FG001|Open-Label Period|Contemplating pregnancy|0|||
16214255|NCT00085644|39262064|FG002|Open-Label Period|Contemplating pregnancy|3|||
16214256|NCT00085644|39262062|FG000|Open-Label Period|Protocol Violation|0|||
16214257|NCT00085644|39262063|FG001|Open-Label Period|Protocol Violation|0|||
16214258|NCT00085644|39262064|FG002|Open-Label Period|Protocol Violation|4|||
16099261|NCT02101554|38852841|FG002|Overall Study|Lost to Follow-up|0|||
16099262|NCT02101554|38852839|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
16214259|NCT00085644|39262062|FG000|Open-Label Period|Personal reason|0|||
16214260|NCT00085644|39262063|FG001|Open-Label Period|Personal reason|0|||
16214261|NCT00085644|39262064|FG002|Open-Label Period|Personal reason|4|||
16214262|NCT01818765|39262065|FG000|Overall Study|Death|2|||
16214263|NCT03073200|39265433|FG000|Double Blind Treatment Period|Protocol Violation|1|||
16214264|NCT03073200|39265434|FG001|Double Blind Treatment Period|Protocol Violation|0|||
16214265|NCT03073200|39265435|FG002|Double Blind Treatment Period|Protocol Violation|0|||
16214266|NCT03073200|39265436|FG003|Double Blind Treatment Period|Protocol Violation|0|||
16214267|NCT03073200|39265437|FG004|Double Blind Treatment Period|Protocol Violation|0|||
16214268|NCT03073200|39265438|FG005|Double Blind Treatment Period|Protocol Violation|0|||
16214269|NCT03073200|39265439|FG006|Double Blind Treatment Period|Protocol Violation|0|||
16214270|NCT03073200|39265440|FG007|Double Blind Treatment Period|Protocol Violation|0|||
16214271|NCT03073200|39265441|FG008|Double Blind Treatment Period|Protocol Violation|0|||
16214272|NCT03073200|39265442|FG009|Double Blind Treatment Period|Protocol Violation|0|||
16214273|NCT03073200|39265443|FG010|Double Blind Treatment Period|Protocol Violation|0|||
16214274|NCT03073200|39265444|FG011|Double Blind Treatment Period|Protocol Violation|0|||
16214275|NCT03073200|39265445|FG012|Double Blind Treatment Period|Protocol Violation|0|||
16214276|NCT03073200|39265446|FG013|Double Blind Treatment Period|Protocol Violation|0|||
16332193|NCT03840148|39703323|FG000|Study Drug Disposition|Lack of Efficacy|3|||
16332194|NCT03840148|39703324|FG001|Study Drug Disposition|Lack of Efficacy|0|||
16332195|NCT03840148|39703323|FG000|Study Drug Disposition|Physician Decision|2|||
16332196|NCT03840148|39703324|FG001|Study Drug Disposition|Physician Decision|0|||
16332197|NCT03840148|39703323|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
16332198|NCT03840148|39703324|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
16332199|NCT03840148|39703323|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
16214277|NCT03073200|39265447|FG014|Double Blind Treatment Period|Protocol Violation|0|||
16214278|NCT03073200|39265433|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214279|NCT03073200|39265434|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
16214280|NCT03073200|39265435|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214281|NCT03073200|39265436|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214282|NCT03073200|39265437|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214283|NCT03073200|39265438|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214284|NCT03073200|39265439|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214285|NCT03073200|39265440|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214286|NCT03073200|39265441|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214287|NCT03073200|39265442|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214288|NCT03073200|39265443|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214289|NCT03073200|39265444|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214290|NCT03073200|39265445|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214291|NCT03073200|39265446|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214292|NCT03073200|39265447|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
16214293|NCT03073200|39265433|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
16214294|NCT03073200|39265434|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214295|NCT03073200|39265435|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214296|NCT03073200|39265436|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214297|NCT03073200|39265437|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214298|NCT03073200|39265438|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214299|NCT03073200|39265439|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214300|NCT03073200|39265440|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214301|NCT03073200|39265441|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214302|NCT03073200|39265442|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214303|NCT03073200|39265443|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214304|NCT03073200|39265444|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214305|NCT03073200|39265445|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214306|NCT03073200|39265446|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214307|NCT03073200|39265447|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
16214308|NCT03073200|39265433|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214309|NCT03073200|39265434|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214310|NCT03073200|39265435|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214311|NCT03073200|39265436|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
16214312|NCT03073200|39265437|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
16214313|NCT03073200|39265438|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214314|NCT03073200|39265439|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214315|NCT03073200|39265440|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214316|NCT03073200|39265441|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214317|NCT03073200|39265442|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214318|NCT03073200|39265443|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214319|NCT03073200|39265444|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214320|NCT03073200|39265445|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214321|NCT03073200|39265446|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214322|NCT03073200|39265447|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
16214323|NCT03073200|39265433|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
16332200|NCT03840148|39703324|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
16332201|NCT03840148|39703323|FG000|Study Completion Disposition|Physician Decision|2|||
16332202|NCT03840148|39703324|FG001|Study Completion Disposition|Physician Decision|0|||
16332203|NCT03840148|39703323|FG000|Study Completion Disposition|Covid-19 related|2|||
16332204|NCT03840148|39703324|FG001|Study Completion Disposition|Covid-19 related|0|||
16332205|NCT03840148|39703323|FG000|Study Completion Disposition|Lost to Follow-up|1|||
16332206|NCT03840148|39703324|FG001|Study Completion Disposition|Lost to Follow-up|1|||
16332207|NCT03840148|39703323|FG000|Study Completion Disposition|Death|1|||
16332208|NCT03840148|39703324|FG001|Study Completion Disposition|Death|0|||
16332209|NCT03840148|39703323|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
16332210|NCT03840148|39703324|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
16332211|NCT01432275|39703327|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
16332212|NCT01432275|39703328|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
16332213|NCT01432275|39703327|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
16332214|NCT01432275|39703328|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
16401418|NCT01126437|39953557|FG002|Overall Study|Withdrawal by Subject|319|||
16401419|NCT01126437|39953555|FG000|Overall Study|Other reason not specified|210|||
16214324|NCT03073200|39265434|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
16214325|NCT03073200|39265435|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
16214326|NCT03073200|39265436|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
16214327|NCT03073200|39265437|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
16214328|NCT03073200|39265438|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
16214329|NCT03073200|39265439|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
16214330|NCT03073200|39265440|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
16214331|NCT03073200|39265441|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
16214332|NCT03073200|39265442|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
16214333|NCT03073200|39265443|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
16214334|NCT03073200|39265444|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
16214335|NCT03073200|39265445|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
16214336|NCT03073200|39265446|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
16214337|NCT03073200|39265447|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
16214338|NCT03073200|39265433|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214339|NCT03073200|39265434|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214340|NCT03073200|39265435|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214341|NCT03073200|39265436|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214342|NCT03073200|39265437|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
16214343|NCT03073200|39265438|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214344|NCT03073200|39265439|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214345|NCT03073200|39265440|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214346|NCT03073200|39265441|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214347|NCT03073200|39265442|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214348|NCT03073200|39265443|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214349|NCT03073200|39265444|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214350|NCT03073200|39265445|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214351|NCT03073200|39265446|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214352|NCT03073200|39265447|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
16214353|NCT03073200|39265433|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214354|NCT03073200|39265434|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214355|NCT03073200|39265435|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214356|NCT03073200|39265436|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
16214357|NCT03073200|39265437|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
16214358|NCT03073200|39265438|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214359|NCT03073200|39265439|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214360|NCT03073200|39265440|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214361|NCT03073200|39265441|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214362|NCT03073200|39265442|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214363|NCT03073200|39265443|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214364|NCT03073200|39265444|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214365|NCT03073200|39265445|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214366|NCT03073200|39265446|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214367|NCT03073200|39265447|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
16214368|NCT03073200|39265433|FG000|Extension Period|Lost to Follow-up|0|||
16214369|NCT03073200|39265434|FG001|Extension Period|Lost to Follow-up|0|||
16214370|NCT03073200|39265435|FG002|Extension Period|Lost to Follow-up|0|||
16214371|NCT03073200|39265436|FG003|Extension Period|Lost to Follow-up|0|||
16214372|NCT03073200|39265437|FG004|Extension Period|Lost to Follow-up|0|||
16214373|NCT03073200|39265438|FG005|Extension Period|Lost to Follow-up|0|||
16214374|NCT03073200|39265439|FG006|Extension Period|Lost to Follow-up|1|||
16214375|NCT03073200|39265440|FG007|Extension Period|Lost to Follow-up|1|||
16214376|NCT03073200|39265441|FG008|Extension Period|Lost to Follow-up|0|||
16214377|NCT03073200|39265442|FG009|Extension Period|Lost to Follow-up|0|||
16214378|NCT03073200|39265443|FG010|Extension Period|Lost to Follow-up|0|||
16214379|NCT03073200|39265444|FG011|Extension Period|Lost to Follow-up|0|||
16401420|NCT01126437|39953556|FG001|Overall Study|Other reason not specified|176|||
16401421|NCT01126437|39953557|FG002|Overall Study|Other reason not specified|178|||
16401422|NCT01330628|39953567|FG000|Overall Study|Death|2|||
16401423|NCT01330628|39953568|FG001|Overall Study|Death|3|||
16401424|NCT01330628|39953567|FG000|Overall Study|Lost to Follow-up|5|||
16401425|NCT01330628|39953568|FG001|Overall Study|Lost to Follow-up|6|||
16401426|NCT01330628|39953567|FG000|Overall Study|Adverse Event|44|||
16401427|NCT01330628|39953568|FG001|Overall Study|Adverse Event|25|||
16401428|NCT01330628|39953567|FG000|Overall Study|Withdrawn|18|||
16401429|NCT01330628|39953568|FG001|Overall Study|Withdrawn|6|||
16401430|NCT01330628|39953567|FG000|Overall Study|Didn't receive study treatment|1|||
16401431|NCT01330628|39953568|FG001|Overall Study|Didn't receive study treatment|0|||
16099263|NCT02101554|38852840|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
16401432|NCT01610713|39953575|FG000|Overall Study|Adverse Event|3|||
16401433|NCT01610713|39953576|FG001|Overall Study|Adverse Event|0|||
16401434|NCT01610713|39953575|FG000|Overall Study|Lack of Efficacy|1|||
16401435|NCT01610713|39953576|FG001|Overall Study|Lack of Efficacy|0|||
16401436|NCT01610713|39953575|FG000|Overall Study|low mood and poor motivation|1|||
16401437|NCT01610713|39953576|FG001|Overall Study|low mood and poor motivation|0|||
16401438|NCT01610713|39953575|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
16401439|NCT01610713|39953576|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
16401440|NCT01610713|39953575|FG000|Overall Study|Lost to Follow-up|0|||
16401441|NCT01610713|39953576|FG001|Overall Study|Lost to Follow-up|1|||
16401442|NCT00957944|39953577|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
16401443|NCT00957944|39953578|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
16401444|NCT00244933|39953579|FG000|Overall Study|Not response evaluable|2|||
16401445|NCT00578877|39953582|FG000|Overall Study|Lost to Follow-up|8|||
16401446|NCT00578877|39953583|FG001|Overall Study|Lost to Follow-up|10|||
16401447|NCT00578877|39953582|FG000|Overall Study|early discontinue|61|||
16401448|NCT00578877|39953583|FG001|Overall Study|early discontinue|101|||
16401449|NCT00578877|39953582|FG000|Overall Study|did not provide follow-up data|12|||
16401450|NCT00578877|39953583|FG001|Overall Study|did not provide follow-up data|17|||
16401451|NCT02013206|39953584|FG000|Overall Study|Progressive disease (PD)|14|||
16401452|NCT02013206|39953585|FG001|Overall Study|Progressive disease (PD)|17|||
16401453|NCT02013206|39953584|FG000|Overall Study|Symptomatic deterioration|3|||
16401454|NCT02013206|39953585|FG001|Overall Study|Symptomatic deterioration|1|||
16401455|NCT02013206|39953584|FG000|Overall Study|Adverse Event|1|||
16401456|NCT02013206|39953585|FG001|Overall Study|Adverse Event|0|||
16401457|NCT02013206|39953584|FG000|Overall Study|Patient refusal|2|||
16401458|NCT02013206|39953585|FG001|Overall Study|Patient refusal|0|||
16401459|NCT02013206|39953584|FG000|Overall Study|Patient non-compliance|1|||
16401460|NCT02013206|39953585|FG001|Overall Study|Patient non-compliance|0|||
16401461|NCT02013206|39953584|FG000|Overall Study|Death|1|||
16401462|NCT02013206|39953585|FG001|Overall Study|Death|2|||
16401463|NCT02013206|39953584|FG000|Overall Study|Other reasons off treatment|5|||
16099264|NCT02101554|38852841|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
16401464|NCT02013206|39953585|FG001|Overall Study|Other reasons off treatment|2|||
16401465|NCT03457142|39953586|FG000|Overall Study|Death|1|||
16401466|NCT02589665|39953587|FG000|Induction Period|Did not receive drug|0|||
16401467|NCT02589665|39953588|FG001|Induction Period|Did not receive drug|0|||
16401468|NCT02589665|39953589|FG002|Induction Period|Did not receive drug|0|||
16401469|NCT02589665|39953590|FG003|Induction Period|Did not receive drug|1|||
16401470|NCT02589665|39953591|FG004|Induction Period|Did not receive drug|0|||
16401471|NCT02589665|39953592|FG005|Induction Period|Did not receive drug|0|||
16401472|NCT02589665|39953593|FG006|Induction Period|Did not receive drug|0|||
16401473|NCT02589665|39953594|FG007|Induction Period|Did not receive drug|0|||
16401474|NCT02589665|39953595|FG008|Induction Period|Did not receive drug|0|||
16401475|NCT02589665|39953596|FG009|Induction Period|Did not receive drug|0|||
16099265|NCT03972137|38852842|FG000|Overall Study|Lost to Follow-up|2|||
16099266|NCT03972137|38852842|FG000|Overall Study|Withdrawal by Subject|4|||
16099267|NCT01482819|38852843|FG000|Overall Study|Lost to Follow-up|2|||
16099268|NCT02409732|38852846|FG000|Overall Study|Withdrawal by Subject|4|||
16099269|NCT02409732|38852846|FG000|Overall Study|Lost to Follow-up|2|||
16099270|NCT05294328|38852847|FG000|Overall Study|Adverse Event|1|||
16099271|NCT05294328|38852848|FG001|Overall Study|Adverse Event|0|||
16099272|NCT05294328|38852849|FG002|Overall Study|Adverse Event|0|||
16099273|NCT05294328|38852847|FG000|Overall Study|Physician Decision|1|||
16099274|NCT05294328|38852848|FG001|Overall Study|Physician Decision|1|||
16099275|NCT05294328|38852849|FG002|Overall Study|Physician Decision|0|||
16099276|NCT05294328|38852847|FG000|Overall Study|Withdrawal by Subject|0|||
16099277|NCT05294328|38852848|FG001|Overall Study|Withdrawal by Subject|2|||
16099278|NCT05294328|38852849|FG002|Overall Study|Withdrawal by Subject|1|||
16099279|NCT05294328|38852847|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
16099280|NCT05294328|38852848|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
16099281|NCT05294328|38852849|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
16099282|NCT05431543|38852850|FG000|Overall Study|Medical History|1|||
16099283|NCT05431543|38852851|FG001|Overall Study|Medical History|0|||
16099284|NCT05431543|38852852|FG002|Overall Study|Medical History|0|||
16099285|NCT01023022|38852853|FG000|Overall Study|Death|5|||
16099286|NCT01023022|38852853|FG000|Overall Study|Lost to Follow-up|7|||
16099287|NCT01023022|38852853|FG000|Overall Study|due to technical issues|2|||
16099288|NCT01270347|38852854|FG000|Core Phase|Adverse Event|1|||
16099289|NCT01270347|38852855|FG001|Core Phase|Adverse Event|6|||
16099290|NCT01270347|38852854|FG000|Core Phase|Withdrawal by Subject|1|||
16099291|NCT01270347|38852855|FG001|Core Phase|Withdrawal by Subject|2|||
16099292|NCT01270347|38852854|FG000|Core Phase|Lost to Follow-up|0|||
16099293|NCT01270347|38852855|FG001|Core Phase|Lost to Follow-up|1|||
16099294|NCT01270347|38852854|FG000|Core Phase|Miscellaneous|8|||
16099295|NCT01270347|38852855|FG001|Core Phase|Miscellaneous|14|||
16099296|NCT01270347|38852854|FG000|Extension Phase|Adverse Event|1|||
16099297|NCT01270347|38852855|FG001|Extension Phase|Adverse Event|3|||
16099298|NCT01270347|38852854|FG000|Extension Phase|Withdrawal by Subject|3|||
16099299|NCT01270347|38852855|FG001|Extension Phase|Withdrawal by Subject|4|||
16099300|NCT01270347|38852854|FG000|Extension Phase|Miscellaneous|2|||
16099301|NCT01270347|38852855|FG001|Extension Phase|Miscellaneous|2|||
16099302|NCT02877680|38852858|FG000|Overall Study|Lost to Follow-up|1|||
16099303|NCT02877680|38852859|FG001|Overall Study|Lost to Follow-up|1|||
16099304|NCT02068352|38852860|FG000|Overall Study|Lost to Follow-up|0|||
16099305|NCT02068352|38852861|FG001|Overall Study|Lost to Follow-up|2|||
16099306|NCT02068352|38852862|FG002|Overall Study|Lost to Follow-up|0|||
16099307|NCT02068352|38852860|FG000|Overall Study|Adverse Event|4|||
16099308|NCT02068352|38852861|FG001|Overall Study|Adverse Event|2|||
16099309|NCT02068352|38852862|FG002|Overall Study|Adverse Event|7|||
16099310|NCT02068352|38852860|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
16099311|NCT02068352|38852861|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
16099312|NCT02068352|38852862|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
16099313|NCT02068352|38852860|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
16099314|NCT02068352|38852861|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
16099315|NCT02068352|38852862|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
16099316|NCT02068352|38852860|FG000|Overall Study|Protocol Deviation|0|||
16099317|NCT02068352|38852861|FG001|Overall Study|Protocol Deviation|0|||
16099318|NCT02068352|38852862|FG002|Overall Study|Protocol Deviation|1|||
16099319|NCT01072396|38852863|FG000|Period One|Adverse Event|1|||
16099320|NCT01072396|38852864|FG001|Period One|Adverse Event|1|||
16099321|NCT01072396|38852863|FG000|Period One|Protocol Violation|2|||
16401476|NCT02589665|39953587|FG000|Induction Period|Adverse Event|3|||
16099322|NCT01072396|38852864|FG001|Period One|Protocol Violation|1|||
16099323|NCT01072396|38852863|FG000|Period One|Withdrawal by Subject|2|||
16099324|NCT01072396|38852864|FG001|Period One|Withdrawal by Subject|0|||
16099325|NCT01072396|38852863|FG000|Washout Period|Missing termination information|0|||
16099326|NCT01072396|38852864|FG001|Washout Period|Missing termination information|1|||
16099327|NCT01072396|38852863|FG000|Period Two|Adverse Event|0|||
16099328|NCT01072396|38852864|FG001|Period Two|Adverse Event|3|||
16099329|NCT01072396|38852863|FG000|Period Two|Lost to Follow-up|1|||
16099330|NCT01072396|38852864|FG001|Period Two|Lost to Follow-up|0|||
16099331|NCT02294461|38852865|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
16099332|NCT02294461|38852866|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
16099333|NCT02294461|38852865|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
16099334|NCT02294461|38852866|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
16099335|NCT02294461|38852865|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
16099336|NCT02294461|38852866|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
16099337|NCT02294461|38852865|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
16099338|NCT02294461|38852866|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
16099339|NCT02294461|38852865|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
16099340|NCT02294461|38852866|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
16099341|NCT02294461|38852865|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
16099342|NCT02294461|38852866|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
16099343|NCT02294461|38852865|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
16099344|NCT02294461|38852866|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
16099345|NCT02294461|38852865|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
16099346|NCT02294461|38852866|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
16099347|NCT02294461|38852865|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
16099348|NCT02294461|38852866|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
16099349|NCT02294461|38852865|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
16099350|NCT02294461|38852866|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
16099351|NCT02294461|38852865|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
16099352|NCT02294461|38852866|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
16099353|NCT02294461|38852865|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
16099354|NCT02294461|38852866|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
16099355|NCT02294461|38852865|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
16099356|NCT02294461|38852866|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
16401477|NCT02589665|39953588|FG001|Induction Period|Adverse Event|0|||
16401478|NCT02589665|39953589|FG002|Induction Period|Adverse Event|2|||
16401479|NCT02589665|39953590|FG003|Induction Period|Adverse Event|2|||
16401480|NCT02589665|39953591|FG004|Induction Period|Adverse Event|0|||
16401481|NCT02589665|39953592|FG005|Induction Period|Adverse Event|0|||
16401482|NCT02589665|39953593|FG006|Induction Period|Adverse Event|0|||
16531082|NCT02291614|40410120|FG003|Overall Study|Decision by sponsor|1|||
16531083|NCT02291614|40410121|FG004|Overall Study|Decision by sponsor|0|||
16531084|NCT02291614|40410122|FG005|Overall Study|Decision by sponsor|0|||
16531085|NCT02291614|40410123|FG006|Overall Study|Decision by sponsor|0|||
16531086|NCT02291614|40410124|FG007|Overall Study|Decision by sponsor|0|||
16531087|NCT02291614|40410125|FG008|Overall Study|Decision by sponsor|0|||
16531088|NCT02291614|40410126|FG009|Overall Study|Decision by sponsor|0|||
16531089|NCT02291614|40410127|FG010|Overall Study|Decision by sponsor|0|||
16531090|NCT02291614|40410117|FG000|Overall Study|Death|0|||
16531091|NCT02291614|40410118|FG001|Overall Study|Death|0|||
16531092|NCT02291614|40410119|FG002|Overall Study|Death|1|||
16531093|NCT02291614|40410120|FG003|Overall Study|Death|0|||
16531094|NCT02291614|40410121|FG004|Overall Study|Death|1|||
16531095|NCT02291614|40410122|FG005|Overall Study|Death|1|||
16531096|NCT02291614|40410123|FG006|Overall Study|Death|1|||
16531097|NCT02291614|40410124|FG007|Overall Study|Death|0|||
16531098|NCT02291614|40410125|FG008|Overall Study|Death|0|||
16531099|NCT02291614|40410126|FG009|Overall Study|Death|0|||
16531100|NCT02291614|40410127|FG010|Overall Study|Death|0|||
16531101|NCT03178266|40410130|FG000|Overall Study|Death|0|||
16531102|NCT03178266|40410131|FG001|Overall Study|Death|1|||
16531103|NCT03178266|40410130|FG000|Overall Study|Disont. Early|0|||
16531104|NCT03178266|40410131|FG001|Overall Study|Disont. Early|1|||
16531105|NCT03178266|40410130|FG000|Overall Study|Withdrawal by Subject|0|||
16531106|NCT03178266|40410131|FG001|Overall Study|Withdrawal by Subject|2|||
16531107|NCT03694548|40410132|FG000|Part A Survey|Protocol Violation|3|||
16531108|NCT03694548|40410133|FG001|Part A Survey|Protocol Violation|3|||
16099357|NCT02294461|38852865|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
16099358|NCT02294461|38852866|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
16099359|NCT02294461|38852865|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
16099360|NCT02294461|38852866|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
16099361|NCT03751280|38852867|FG000|Overall Study|Adverse Event|0|||
16099362|NCT03751280|38852868|FG001|Overall Study|Adverse Event|1|||
16099363|NCT03751280|38852867|FG000|Overall Study|Lost to Follow-up|3|||
16099364|NCT03751280|38852868|FG001|Overall Study|Lost to Follow-up|5|||
16099365|NCT03751280|38852867|FG000|Overall Study|Physician Decision|0|||
16099366|NCT03751280|38852868|FG001|Overall Study|Physician Decision|2|||
16099367|NCT03751280|38852867|FG000|Overall Study|Protocol Violation|0|||
16099368|NCT03751280|38852868|FG001|Overall Study|Protocol Violation|2|||
16099369|NCT03751280|38852867|FG000|Overall Study|Withdrawal by Subject|5|||
16099370|NCT03751280|38852868|FG001|Overall Study|Withdrawal by Subject|2|||
16099371|NCT04175834|38852869|FG000|Overall Study|Withdrawal by Subject|1|||
16099372|NCT04175834|38852870|FG001|Overall Study|Withdrawal by Subject|0|||
16099373|NCT03323034|38852874|FG000|Overall Study|Lack of Efficacy|5|||
16099374|NCT03323034|38852875|FG001|Overall Study|Lack of Efficacy|5|||
16099375|NCT03323034|38852876|FG002|Overall Study|Lack of Efficacy|6|||
16099376|NCT03323034|38852877|FG003|Overall Study|Lack of Efficacy|5|||
16099377|NCT03323034|38852878|FG004|Overall Study|Lack of Efficacy|5|||
16099378|NCT03323034|38852874|FG000|Overall Study|Physician Decision|0|||
16099379|NCT03323034|38852875|FG001|Overall Study|Physician Decision|0|||
16099380|NCT03323034|38852876|FG002|Overall Study|Physician Decision|0|||
16099381|NCT03323034|38852877|FG003|Overall Study|Physician Decision|0|||
16099382|NCT03323034|38852878|FG004|Overall Study|Physician Decision|1|||
16099383|NCT03323034|38852874|FG000|Overall Study|Withdrawal by Subject|1|||
16099384|NCT03323034|38852875|FG001|Overall Study|Withdrawal by Subject|1|||
16099385|NCT03323034|38852876|FG002|Overall Study|Withdrawal by Subject|0|||
16099386|NCT03323034|38852877|FG003|Overall Study|Withdrawal by Subject|1|||
16099387|NCT03323034|38852878|FG004|Overall Study|Withdrawal by Subject|0|||
16099388|NCT03233204|38852881|FG000|Overall Study|Adverse Event|1|||
16099389|NCT03233204|38852881|FG000|Overall Study|Death|1|||
16099390|NCT03233204|38852881|FG000|Overall Study|Withdrawal by Subject|1|||
16099391|NCT03233204|38852881|FG000|Overall Study|Progressive Disease|3|||
16099392|NCT01502371|38852884|FG000|Overall Study|Withdrawal by Subject|1|||
16099393|NCT01502371|38852885|FG001|Overall Study|Withdrawal by Subject|2|||
16099394|NCT01502371|38852886|FG002|Overall Study|Withdrawal by Subject|1|||
16099395|NCT01502371|38852887|FG003|Overall Study|Withdrawal by Subject|1|||
16099396|NCT01502371|38852888|FG004|Overall Study|Withdrawal by Subject|1|||
16099397|NCT01502371|38852884|FG000|Overall Study|Adverse Event|2|||
16099398|NCT01502371|38852885|FG001|Overall Study|Adverse Event|1|||
16099399|NCT01502371|38852886|FG002|Overall Study|Adverse Event|0|||
16099400|NCT01502371|38852887|FG003|Overall Study|Adverse Event|4|||
16099401|NCT01502371|38852888|FG004|Overall Study|Adverse Event|3|||
16099402|NCT01502371|38852884|FG000|Overall Study|Treatment Failure|22|||
16099403|NCT01502371|38852885|FG001|Overall Study|Treatment Failure|20|||
16099404|NCT01502371|38852886|FG002|Overall Study|Treatment Failure|12|||
16099405|NCT01502371|38852887|FG003|Overall Study|Treatment Failure|19|||
16099406|NCT01502371|38852888|FG004|Overall Study|Treatment Failure|30|||
16099407|NCT01502371|38852884|FG000|Overall Study|Lack of Efficacy|3|||
16099408|NCT01502371|38852885|FG001|Overall Study|Lack of Efficacy|3|||
16099409|NCT01502371|38852886|FG002|Overall Study|Lack of Efficacy|2|||
16099410|NCT01502371|38852887|FG003|Overall Study|Lack of Efficacy|2|||
16099411|NCT01502371|38852888|FG004|Overall Study|Lack of Efficacy|4|||
16099412|NCT01502371|38852884|FG000|Overall Study|Physician Decision|3|||
16099413|NCT01502371|38852885|FG001|Overall Study|Physician Decision|0|||
16099414|NCT01502371|38852886|FG002|Overall Study|Physician Decision|0|||
16099415|NCT01502371|38852887|FG003|Overall Study|Physician Decision|0|||
16099416|NCT01502371|38852888|FG004|Overall Study|Physician Decision|1|||
16099417|NCT01502371|38852884|FG000|Overall Study|Noncompliance with Study Drug|0|||
16099418|NCT01502371|38852885|FG001|Overall Study|Noncompliance with Study Drug|0|||
16099419|NCT01502371|38852886|FG002|Overall Study|Noncompliance with Study Drug|1|||
16099420|NCT01502371|38852887|FG003|Overall Study|Noncompliance with Study Drug|2|||
16099421|NCT01502371|38852888|FG004|Overall Study|Noncompliance with Study Drug|1|||
16099422|NCT01502371|38852884|FG000|Overall Study|Technical Problems|1|||
16099423|NCT01502371|38852885|FG001|Overall Study|Technical Problems|0|||
16099424|NCT01502371|38852886|FG002|Overall Study|Technical Problems|2|||
16099425|NCT01502371|38852887|FG003|Overall Study|Technical Problems|4|||
16099426|NCT01502371|38852888|FG004|Overall Study|Technical Problems|1|||
16099427|NCT01502371|38852884|FG000|Overall Study|Protocol Violation|9|||
16099428|NCT01502371|38852885|FG001|Overall Study|Protocol Violation|5|||
16099429|NCT01502371|38852886|FG002|Overall Study|Protocol Violation|6|||
16099430|NCT01502371|38852887|FG003|Overall Study|Protocol Violation|5|||
16099431|NCT01502371|38852888|FG004|Overall Study|Protocol Violation|10|||
16099432|NCT01502371|38852884|FG000|Overall Study|Excluded Medication|0|||
16099433|NCT01502371|38852885|FG001|Overall Study|Excluded Medication|1|||
16099434|NCT01502371|38852886|FG002|Overall Study|Excluded Medication|1|||
16099435|NCT01502371|38852887|FG003|Overall Study|Excluded Medication|0|||
16099436|NCT01502371|38852888|FG004|Overall Study|Excluded Medication|1|||
16099437|NCT02679079|38852889|FG000|Overall Study|Adverse Event|2|||
16099438|NCT02679079|38852890|FG001|Overall Study|Adverse Event|0|||
16099439|NCT02679079|38852891|FG002|Overall Study|Adverse Event|2|||
16099440|NCT02679079|38852889|FG000|Overall Study|Protocol Violation|0|||
16099441|NCT02679079|38852890|FG001|Overall Study|Protocol Violation|1|||
16099442|NCT02679079|38852891|FG002|Overall Study|Protocol Violation|0|||
16099443|NCT02679079|38852889|FG000|Overall Study|Withdrawal by Subject|2|||
16099444|NCT02679079|38852890|FG001|Overall Study|Withdrawal by Subject|1|||
16099445|NCT02679079|38852891|FG002|Overall Study|Withdrawal by Subject|0|||
16099446|NCT02162771|38852899|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
16099447|NCT02162771|38852900|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
16099448|NCT02162771|38852899|FG000|Core Study Period (Part 2)|Adverse Event|4|||
16099449|NCT02162771|38852900|FG001|Core Study Period (Part 2)|Adverse Event|1|||
16099450|NCT02162771|38852899|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
16099451|NCT02162771|38852900|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
16099452|NCT02162771|38852899|FG000|Core Study Period (Part 2)|Physician Decision|0|||
16099453|NCT02162771|38852900|FG001|Core Study Period (Part 2)|Physician Decision|2|||
16531109|NCT03694548|40410134|FG002|Part A Survey|Protocol Violation|0|||
16531110|NCT03694548|40410132|FG000|Part B Yoga Program|Protocol Violation|0|||
16099454|NCT02162771|38852899|FG000|Core Study Period (Part 2)|Death|1|||
16099455|NCT02162771|38852900|FG001|Core Study Period (Part 2)|Death|0|||
16099456|NCT02162771|38852899|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
16531111|NCT03694548|40410133|FG001|Part B Yoga Program|Protocol Violation|0|||
16531112|NCT03694548|40410134|FG002|Part B Yoga Program|Protocol Violation|3|||
16531113|NCT03694548|40410132|FG000|Part B Yoga Program|Did not attend intervention|0|||
16531114|NCT03694548|40410133|FG001|Part B Yoga Program|Did not attend intervention|0|||
16531115|NCT03694548|40410134|FG002|Part B Yoga Program|Did not attend intervention|8|||
16531116|NCT02347761|40410137|FG000|All Collected|Death|1|||
16531117|NCT02347761|40410138|FG001|All Collected|Death|0|||
16531118|NCT02347761|40410139|FG002|All Collected|Death|0|||
16531119|NCT02347761|40410137|FG000|All Collected|Lost to Follow-up|3|||
16531120|NCT02347761|40410138|FG001|All Collected|Lost to Follow-up|2|||
16531121|NCT02347761|40410139|FG002|All Collected|Lost to Follow-up|3|||
16531122|NCT02347761|40410137|FG000|All Collected|Withdrawal by Subject|11|||
16531123|NCT02347761|40410138|FG001|All Collected|Withdrawal by Subject|11|||
16531124|NCT02347761|40410139|FG002|All Collected|Withdrawal by Subject|22|||
16531125|NCT02347761|40410137|FG000|All Collected|invetigator disretion|2|||
16531126|NCT02347761|40410138|FG001|All Collected|invetigator disretion|0|||
16531127|NCT02347761|40410139|FG002|All Collected|invetigator disretion|0|||
16531128|NCT02347761|40410137|FG000|All Collected|instillation site pain|0|||
16531129|NCT02347761|40410138|FG001|All Collected|instillation site pain|0|||
16531130|NCT02347761|40410139|FG002|All Collected|instillation site pain|1|||
16099457|NCT02162771|38852900|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
16099458|NCT02162771|38852899|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
16099459|NCT02162771|38852900|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
16099460|NCT02162771|38852899|FG000|Maintenance Study Period (Part 2)|Death|2|||
16099461|NCT02162771|38852900|FG001|Maintenance Study Period (Part 2)|Death|1|||
16099462|NCT02162771|38852899|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
16099463|NCT02162771|38852900|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
16099464|NCT02162771|38852899|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
16099465|NCT02162771|38852900|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
16099466|NCT02162771|38852899|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
16099467|NCT02162771|38852900|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
16099468|NCT00006436|38852901|FG000|Overall Study|Refused further treatment|2|||
16099469|NCT00006436|38852901|FG000|Overall Study|Declined to participate (before treatment started)|1|||
16099470|NCT03334695|38852904|FG000|Overall Study|Lost to Follow-up|3|||
16099471|NCT03334695|38852905|FG001|Overall Study|Lost to Follow-up|3|||
16099472|NCT03334695|38852904|FG000|Overall Study|Physician Decision|1|||
16099473|NCT03334695|38852905|FG001|Overall Study|Physician Decision|2|||
16099474|NCT03334695|38852904|FG000|Overall Study|Protocol Violation|0|||
16099475|NCT03334695|38852905|FG001|Overall Study|Protocol Violation|1|||
16099476|NCT01078571|38852906|FG000|Overall Study|Adverse Event|36|||
16099477|NCT01078571|38852906|FG000|Overall Study|Lack of effectiveness|36|||
16099478|NCT01078571|38852906|FG000|Overall Study|Reason not reported|21|||
16531131|NCT02347761|40410137|FG000|All Collected|exacerbation of COPD|0|||
16531132|NCT02347761|40410138|FG001|All Collected|exacerbation of COPD|0|||
16531133|NCT02347761|40410139|FG002|All Collected|exacerbation of COPD|1|||
16531134|NCT02347761|40410137|FG000|All Collected|moved/travel|0|||
16099479|NCT01078571|38852906|FG000|Overall Study|Withdrawal by Subject|12|||
16099480|NCT01078571|38852906|FG000|Overall Study|Lost to Follow-up|8|||
16099481|NCT01078571|38852906|FG000|Overall Study|Protocol Violation|2|||
16214380|NCT03073200|39265445|FG012|Extension Period|Lost to Follow-up|0|||
16531135|NCT02347761|40410138|FG001|All Collected|moved/travel|1|||
16531136|NCT02347761|40410139|FG002|All Collected|moved/travel|0|||
16099482|NCT01014013|38852911|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
16099483|NCT01014013|38852912|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
16099484|NCT01014013|38852911|FG000|Overall Study|Clinical adverse experience|4|||
16099485|NCT01014013|38852912|FG001|Overall Study|Clinical adverse experience|2|||
16099486|NCT01014013|38852911|FG000|Overall Study|Laboratory adverse experience|1|||
16099487|NCT01014013|38852912|FG001|Overall Study|Laboratory adverse experience|1|||
16099488|NCT01014013|38852911|FG000|Overall Study|Protocol Violation|1|||
16099489|NCT01014013|38852912|FG001|Overall Study|Protocol Violation|3|||
16099490|NCT01014013|38852911|FG000|Overall Study|Withdrawal by Subject|7|||
16099491|NCT01014013|38852912|FG001|Overall Study|Withdrawal by Subject|4|||
16099492|NCT01014013|38852911|FG000|Overall Study|Clinical/microbiologic failure|1|||
16099493|NCT01014013|38852912|FG001|Overall Study|Clinical/microbiologic failure|2|||
16401483|NCT02589665|39953594|FG007|Induction Period|Adverse Event|0|||
16401484|NCT02589665|39953595|FG008|Induction Period|Adverse Event|0|||
16531137|NCT02347761|40410137|FG000|On Study Treatment|Lack of Efficacy|2|||
16531138|NCT02347761|40410138|FG001|On Study Treatment|Lack of Efficacy|3|||
16531139|NCT02347761|40410139|FG002|On Study Treatment|Lack of Efficacy|4|||
16531140|NCT02347761|40410137|FG000|On Study Treatment|non-compliance with study medication|0|||
16531141|NCT02347761|40410138|FG001|On Study Treatment|non-compliance with study medication|0|||
16531142|NCT02347761|40410139|FG002|On Study Treatment|non-compliance with study medication|2|||
16531143|NCT02347761|40410137|FG000|On Study Treatment|Withdrawal by Subject|7|||
16531144|NCT02347761|40410138|FG001|On Study Treatment|Withdrawal by Subject|3|||
16531145|NCT02347761|40410139|FG002|On Study Treatment|Withdrawal by Subject|5|||
16531146|NCT02347761|40410137|FG000|On Study Treatment|move/travel|2|||
16099494|NCT01014013|38852911|FG000|Overall Study|Pathogen culture = no growth|26|||
16099495|NCT01014013|38852912|FG001|Overall Study|Pathogen culture = no growth|34|||
16099496|NCT01014013|38852911|FG000|Overall Study|Negative urine culture|2|||
16099497|NCT01014013|38852912|FG001|Overall Study|Negative urine culture|0|||
16099498|NCT01014013|38852911|FG000|Overall Study|Pathogen resistant|7|||
16332215|NCT01432275|39703327|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
16099499|NCT01014013|38852912|FG001|Overall Study|Pathogen resistant|4|||
16099500|NCT01014013|38852911|FG000|Overall Study|Physician Decision|0|||
16099501|NCT01014013|38852912|FG001|Overall Study|Physician Decision|1|||
16099502|NCT01014013|38852911|FG000|Overall Study|Another antibiotic therapy required|0|||
16099503|NCT01014013|38852912|FG001|Overall Study|Another antibiotic therapy required|1|||
16099504|NCT01014013|38852911|FG000|Overall Study|Appendectomy|1|||
16332216|NCT01432275|39703328|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
16332217|NCT01432275|39703327|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
16332218|NCT01432275|39703328|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
16332219|NCT01432275|39703327|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
16332220|NCT01432275|39703328|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
16332221|NCT01432275|39703327|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
16531147|NCT02347761|40410138|FG001|On Study Treatment|move/travel|6|||
16531148|NCT02347761|40410139|FG002|On Study Treatment|move/travel|5|||
16531149|NCT02347761|40410137|FG000|On Study Treatment|dissastisfaction with device|2|||
16531150|NCT02347761|40410138|FG001|On Study Treatment|dissastisfaction with device|1|||
16531151|NCT02347761|40410139|FG002|On Study Treatment|dissastisfaction with device|4|||
16531152|NCT02347761|40410137|FG000|On Study Treatment|Lost to Follow-up|2|||
16531153|NCT02347761|40410138|FG001|On Study Treatment|Lost to Follow-up|1|||
16531154|NCT02347761|40410139|FG002|On Study Treatment|Lost to Follow-up|1|||
16531155|NCT02347761|40410137|FG000|On Study Treatment|investigator discretion|2|||
16531156|NCT02347761|40410138|FG001|On Study Treatment|investigator discretion|0|||
16531157|NCT02347761|40410139|FG002|On Study Treatment|investigator discretion|0|||
16531158|NCT02347761|40410137|FG000|On Study Treatment|durg not working|0|||
16531159|NCT02347761|40410138|FG001|On Study Treatment|durg not working|1|||
16531160|NCT02347761|40410139|FG002|On Study Treatment|durg not working|1|||
16531161|NCT02347761|40410137|FG000|On Study Treatment|Adverse Event|10|||
16531162|NCT02347761|40410138|FG001|On Study Treatment|Adverse Event|8|||
16531163|NCT02347761|40410139|FG002|On Study Treatment|Adverse Event|20|||
16531164|NCT01549613|40410140|FG000|Overall Study|Lost to Follow-up|11|||
16531165|NCT01549613|40410141|FG001|Overall Study|Lost to Follow-up|11|||
16531166|NCT03147248|40410142|FG000|Overall Study|Adverse Event|0|||
16531167|NCT03147248|40410143|FG001|Overall Study|Adverse Event|2|||
16531168|NCT03147248|40410144|FG002|Overall Study|Adverse Event|2|||
16531169|NCT03147248|40410145|FG003|Overall Study|Adverse Event|2|||
16531170|NCT03147248|40410146|FG004|Overall Study|Adverse Event|6|||
16531171|NCT03147248|40410147|FG005|Overall Study|Adverse Event|11|||
16531172|NCT03147248|40410142|FG000|Overall Study|Disease progression|1|||
16099505|NCT01014013|38852912|FG001|Overall Study|Appendectomy|0|||
16099506|NCT01014013|38852911|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
16332222|NCT01432275|39703328|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
16332223|NCT01432275|39703327|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
16401485|NCT02589665|39953596|FG009|Induction Period|Adverse Event|0|||
16531173|NCT03147248|40410143|FG001|Overall Study|Disease progression|0|||
16332224|NCT01432275|39703328|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
16332225|NCT01432275|39703327|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
16332226|NCT01432275|39703328|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
16332227|NCT01432275|39703327|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
16332228|NCT01432275|39703328|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
16332229|NCT01333956|39703329|FG000|Overall Study|Lost to Follow-up|1|||
16332230|NCT01333956|39703330|FG001|Overall Study|Lost to Follow-up|2|||
16099507|NCT01014013|38852912|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
16099508|NCT01032200|38852913|FG000|Overall Study|Death|1|||
16099509|NCT01032200|38852914|FG001|Overall Study|Death|1|||
16099510|NCT01032200|38852913|FG000|Overall Study|Withdrawal by Subject|1|||
16099511|NCT01032200|38852914|FG001|Overall Study|Withdrawal by Subject|3|||
16099512|NCT01032200|38852913|FG000|Overall Study|Toxicity|0|||
16099513|NCT01032200|38852914|FG001|Overall Study|Toxicity|2|||
16099514|NCT01032200|38852913|FG000|Overall Study|Progression|1|||
16099515|NCT01032200|38852914|FG001|Overall Study|Progression|0|||
16099516|NCT01032200|38852913|FG000|Overall Study|Multiple|1|||
16099517|NCT01032200|38852914|FG001|Overall Study|Multiple|1|||
16099518|NCT01047306|38852915|FG000|Overall Study|Withdrawal by Subject|2|||
16099519|NCT01047306|38852916|FG001|Overall Study|Withdrawal by Subject|0|||
16099520|NCT01047306|38852915|FG000|Overall Study|Lost to Follow-up|1|||
16099521|NCT01047306|38852916|FG001|Overall Study|Lost to Follow-up|0|||
16099522|NCT01313299|38852919|FG000|Overall Study|Adverse Event|3|||
16531174|NCT03147248|40410144|FG002|Overall Study|Disease progression|0|||
16531175|NCT03147248|40410145|FG003|Overall Study|Disease progression|0|||
16531176|NCT03147248|40410146|FG004|Overall Study|Disease progression|0|||
16531177|NCT03147248|40410147|FG005|Overall Study|Disease progression|2|||
16531178|NCT03147248|40410142|FG000|Overall Study|Withdrawal by Subject|0|||
16531179|NCT03147248|40410143|FG001|Overall Study|Withdrawal by Subject|0|||
16531180|NCT03147248|40410144|FG002|Overall Study|Withdrawal by Subject|0|||
16531181|NCT03147248|40410145|FG003|Overall Study|Withdrawal by Subject|0|||
16099523|NCT01313299|38852920|FG001|Overall Study|Adverse Event|1|||
16099524|NCT01313299|38852921|FG002|Overall Study|Adverse Event|1|||
16099525|NCT01313299|38852919|FG000|Overall Study|Lost to Follow-up|1|||
16099526|NCT01313299|38852920|FG001|Overall Study|Lost to Follow-up|0|||
16099527|NCT01313299|38852921|FG002|Overall Study|Lost to Follow-up|0|||
16099528|NCT01313299|38852919|FG000|Overall Study|Protocol Violation|2|||
16099529|NCT01313299|38852920|FG001|Overall Study|Protocol Violation|0|||
16099530|NCT01313299|38852921|FG002|Overall Study|Protocol Violation|0|||
16531182|NCT03147248|40410146|FG004|Overall Study|Withdrawal by Subject|12|||
16531183|NCT03147248|40410147|FG005|Overall Study|Withdrawal by Subject|9|||
16531184|NCT03147248|40410142|FG000|Overall Study|Protocol Violation|0|||
16531185|NCT03147248|40410143|FG001|Overall Study|Protocol Violation|0|||
16531186|NCT03147248|40410144|FG002|Overall Study|Protocol Violation|0|||
16531187|NCT03147248|40410145|FG003|Overall Study|Protocol Violation|0|||
16099531|NCT01313299|38852919|FG000|Overall Study|Withdrawal by Subject|1|||
16099532|NCT01313299|38852920|FG001|Overall Study|Withdrawal by Subject|0|||
16099533|NCT01313299|38852921|FG002|Overall Study|Withdrawal by Subject|2|||
16332231|NCT01333956|39703331|FG002|Overall Study|Lost to Follow-up|0|||
16332232|NCT01333956|39703332|FG003|Overall Study|Lost to Follow-up|1|||
16332233|NCT01333956|39703329|FG000|Overall Study|Unable to complete study procedure|1|||
16531188|NCT03147248|40410146|FG004|Overall Study|Protocol Violation|2|||
16531189|NCT03147248|40410147|FG005|Overall Study|Protocol Violation|0|||
16531190|NCT03147248|40410142|FG000|Overall Study|Lost to Follow-up|0|||
16531191|NCT03147248|40410143|FG001|Overall Study|Lost to Follow-up|0|||
16531192|NCT03147248|40410144|FG002|Overall Study|Lost to Follow-up|0|||
16531193|NCT03147248|40410145|FG003|Overall Study|Lost to Follow-up|0|||
16531194|NCT03147248|40410146|FG004|Overall Study|Lost to Follow-up|2|||
16531195|NCT03147248|40410147|FG005|Overall Study|Lost to Follow-up|0|||
16531196|NCT03147248|40410142|FG000|Overall Study|Pregnancy|0|||
16531197|NCT03147248|40410143|FG001|Overall Study|Pregnancy|0|||
16531198|NCT03147248|40410144|FG002|Overall Study|Pregnancy|0|||
16332234|NCT01333956|39703330|FG001|Overall Study|Unable to complete study procedure|0|||
16332235|NCT01333956|39703331|FG002|Overall Study|Unable to complete study procedure|0|||
16332236|NCT01333956|39703332|FG003|Overall Study|Unable to complete study procedure|1|||
16332237|NCT01333956|39703329|FG000|Overall Study|Withdrawal by Subject|0|||
16332238|NCT01333956|39703330|FG001|Overall Study|Withdrawal by Subject|2|||
16332239|NCT01333956|39703331|FG002|Overall Study|Withdrawal by Subject|1|||
16332240|NCT01333956|39703332|FG003|Overall Study|Withdrawal by Subject|0|||
16401486|NCT02589665|39953587|FG000|Induction Period|Withdrawal by Subject|0|||
16401487|NCT02589665|39953588|FG001|Induction Period|Withdrawal by Subject|1|||
16401488|NCT02589665|39953589|FG002|Induction Period|Withdrawal by Subject|0|||
16531199|NCT03147248|40410145|FG003|Overall Study|Pregnancy|0|||
16531200|NCT03147248|40410146|FG004|Overall Study|Pregnancy|1|||
16531201|NCT03147248|40410147|FG005|Overall Study|Pregnancy|0|||
16531202|NCT03147248|40410142|FG000|Overall Study|Death|0|||
16099534|NCT01313299|38852919|FG000|Overall Study|Family reason and moved out of state|0|||
16531203|NCT03147248|40410143|FG001|Overall Study|Death|0|||
16099535|NCT01313299|38852920|FG001|Overall Study|Family reason and moved out of state|2|||
16099536|NCT01313299|38852921|FG002|Overall Study|Family reason and moved out of state|0|||
16099537|NCT01313299|38852919|FG000|Overall Study|Lack of subject compliance|0|||
16099538|NCT01313299|38852920|FG001|Overall Study|Lack of subject compliance|0|||
16531204|NCT03147248|40410144|FG002|Overall Study|Death|0|||
16531205|NCT03147248|40410145|FG003|Overall Study|Death|0|||
16531206|NCT03147248|40410146|FG004|Overall Study|Death|0|||
16531207|NCT03147248|40410147|FG005|Overall Study|Death|4|||
16531208|NCT03147248|40410142|FG000|Overall Study|Physician Decision|0|||
16531209|NCT03147248|40410143|FG001|Overall Study|Physician Decision|0|||
16531210|NCT03147248|40410144|FG002|Overall Study|Physician Decision|0|||
16531211|NCT03147248|40410145|FG003|Overall Study|Physician Decision|0|||
16531212|NCT03147248|40410146|FG004|Overall Study|Physician Decision|2|||
16531213|NCT03147248|40410147|FG005|Overall Study|Physician Decision|4|||
16531214|NCT03147248|40410142|FG000|Overall Study|Prolonged Dosing Interval|0|||
16531215|NCT03147248|40410143|FG001|Overall Study|Prolonged Dosing Interval|0|||
16214381|NCT03073200|39265446|FG013|Extension Period|Lost to Follow-up|0|||
16214382|NCT03073200|39265447|FG014|Extension Period|Lost to Follow-up|0|||
16214383|NCT03073200|39265433|FG000|Extension Period|Sponsor Decision|0|||
16214384|NCT03073200|39265434|FG001|Extension Period|Sponsor Decision|0|||
16214385|NCT03073200|39265435|FG002|Extension Period|Sponsor Decision|0|||
16214386|NCT03073200|39265436|FG003|Extension Period|Sponsor Decision|0|||
16214387|NCT03073200|39265437|FG004|Extension Period|Sponsor Decision|0|||
16214388|NCT03073200|39265438|FG005|Extension Period|Sponsor Decision|0|||
16214389|NCT03073200|39265439|FG006|Extension Period|Sponsor Decision|0|||
16214390|NCT03073200|39265440|FG007|Extension Period|Sponsor Decision|0|||
16214391|NCT03073200|39265441|FG008|Extension Period|Sponsor Decision|1|||
16214392|NCT03073200|39265442|FG009|Extension Period|Sponsor Decision|0|||
16214393|NCT03073200|39265443|FG010|Extension Period|Sponsor Decision|0|||
16214394|NCT03073200|39265444|FG011|Extension Period|Sponsor Decision|0|||
16214395|NCT03073200|39265445|FG012|Extension Period|Sponsor Decision|0|||
16214396|NCT03073200|39265446|FG013|Extension Period|Sponsor Decision|0|||
16214397|NCT03073200|39265447|FG014|Extension Period|Sponsor Decision|0|||
16214398|NCT03073200|39265433|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
16214399|NCT03073200|39265434|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
16214400|NCT03073200|39265435|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
16214401|NCT03073200|39265436|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
16214402|NCT03073200|39265437|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
16214403|NCT03073200|39265438|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
16214404|NCT03073200|39265439|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
16214405|NCT03073200|39265440|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
16214406|NCT03073200|39265441|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
16214407|NCT03073200|39265442|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
16214408|NCT03073200|39265443|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
16214409|NCT03073200|39265444|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
16214410|NCT03073200|39265445|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
16214411|NCT03073200|39265446|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
16214412|NCT03073200|39265447|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
16214413|NCT03073200|39265433|FG000|Extension Period|Withdrawal by Subject|0|||
16214414|NCT03073200|39265434|FG001|Extension Period|Withdrawal by Subject|0|||
16214415|NCT03073200|39265435|FG002|Extension Period|Withdrawal by Subject|0|||
16214416|NCT03073200|39265436|FG003|Extension Period|Withdrawal by Subject|0|||
16214417|NCT03073200|39265437|FG004|Extension Period|Withdrawal by Subject|0|||
16214418|NCT03073200|39265438|FG005|Extension Period|Withdrawal by Subject|0|||
16531216|NCT03147248|40410144|FG002|Overall Study|Prolonged Dosing Interval|0|||
16099539|NCT01313299|38852921|FG002|Overall Study|Lack of subject compliance|1|||
16214419|NCT03073200|39265439|FG006|Extension Period|Withdrawal by Subject|1|||
16214420|NCT03073200|39265440|FG007|Extension Period|Withdrawal by Subject|2|||
16214421|NCT03073200|39265441|FG008|Extension Period|Withdrawal by Subject|0|||
16214422|NCT03073200|39265442|FG009|Extension Period|Withdrawal by Subject|0|||
16531217|NCT03147248|40410145|FG003|Overall Study|Prolonged Dosing Interval|0|||
16214423|NCT03073200|39265443|FG010|Extension Period|Withdrawal by Subject|0|||
16214424|NCT03073200|39265444|FG011|Extension Period|Withdrawal by Subject|0|||
16531218|NCT03147248|40410146|FG004|Overall Study|Prolonged Dosing Interval|1|||
16531219|NCT03147248|40410147|FG005|Overall Study|Prolonged Dosing Interval|1|||
16214425|NCT03073200|39265445|FG012|Extension Period|Withdrawal by Subject|0|||
16214426|NCT03073200|39265446|FG013|Extension Period|Withdrawal by Subject|0|||
16214427|NCT03073200|39265447|FG014|Extension Period|Withdrawal by Subject|0|||
16214428|NCT03073200|39265433|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214429|NCT03073200|39265434|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214430|NCT03073200|39265435|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214431|NCT03073200|39265436|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214432|NCT03073200|39265437|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214433|NCT03073200|39265438|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214434|NCT03073200|39265439|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214435|NCT03073200|39265440|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214436|NCT03073200|39265441|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214437|NCT03073200|39265442|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214438|NCT03073200|39265443|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214439|NCT03073200|39265444|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
16214440|NCT03073200|39265445|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214441|NCT03073200|39265446|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214442|NCT03073200|39265447|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
16214443|NCT03073200|39265433|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214444|NCT03073200|39265434|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214445|NCT03073200|39265435|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214446|NCT03073200|39265436|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214447|NCT03073200|39265437|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214448|NCT03073200|39265438|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214449|NCT03073200|39265439|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214450|NCT03073200|39265440|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214451|NCT03073200|39265441|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214452|NCT03073200|39265442|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214453|NCT03073200|39265443|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214454|NCT03073200|39265444|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
16214455|NCT03073200|39265445|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214456|NCT03073200|39265446|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214457|NCT03073200|39265447|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
16214458|NCT03073200|39265433|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214459|NCT03073200|39265434|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214460|NCT03073200|39265435|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214461|NCT03073200|39265436|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214462|NCT03073200|39265437|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214463|NCT03073200|39265438|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214464|NCT03073200|39265439|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214465|NCT03073200|39265440|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214466|NCT03073200|39265441|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214467|NCT03073200|39265442|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214468|NCT03073200|39265443|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
16214469|NCT03073200|39265444|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
16214470|NCT03073200|39265445|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214471|NCT03073200|39265446|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214472|NCT03073200|39265447|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16214473|NCT03073200|39265433|FG000|Randomized Withdrawal Period|Adverse Event|0|||
16214474|NCT03073200|39265434|FG001|Randomized Withdrawal Period|Adverse Event|0|||
16214475|NCT03073200|39265435|FG002|Randomized Withdrawal Period|Adverse Event|0|||
16214476|NCT03073200|39265436|FG003|Randomized Withdrawal Period|Adverse Event|0|||
16214477|NCT03073200|39265437|FG004|Randomized Withdrawal Period|Adverse Event|0|||
16214478|NCT03073200|39265438|FG005|Randomized Withdrawal Period|Adverse Event|0|||
16214479|NCT03073200|39265439|FG006|Randomized Withdrawal Period|Adverse Event|0|||
16214480|NCT03073200|39265440|FG007|Randomized Withdrawal Period|Adverse Event|0|||
16214481|NCT03073200|39265441|FG008|Randomized Withdrawal Period|Adverse Event|0|||
16214482|NCT03073200|39265442|FG009|Randomized Withdrawal Period|Adverse Event|0|||
16214483|NCT03073200|39265443|FG010|Randomized Withdrawal Period|Adverse Event|1|||
16214484|NCT03073200|39265444|FG011|Randomized Withdrawal Period|Adverse Event|0|||
16214485|NCT03073200|39265445|FG012|Randomized Withdrawal Period|Adverse Event|0|||
16099540|NCT05270863|38852922|FG000|Visit 2 First Intervention|Randomization error|0|||
16214486|NCT03073200|39265446|FG013|Randomized Withdrawal Period|Adverse Event|0|||
16214487|NCT03073200|39265447|FG014|Randomized Withdrawal Period|Adverse Event|0|||
16332241|NCT03854370|39703343|FG000|Overall Study|samples not collected|1|||
16531220|NCT00605280|40410152|FG000|Year 1|Protocol Violation|0|||
16531221|NCT00605280|40410153|FG001|Year 1|Protocol Violation|0|||
16531222|NCT00605280|40410154|FG002|Year 1|Protocol Violation|0|||
16531223|NCT00605280|40410155|FG003|Year 1|Protocol Violation|1|||
16531224|NCT00605280|40410152|FG000|Year 1|Adverse Event|3|||
16531225|NCT00605280|40410153|FG001|Year 1|Adverse Event|1|||
16531226|NCT00605280|40410154|FG002|Year 1|Adverse Event|1|||
16531227|NCT00605280|40410155|FG003|Year 1|Adverse Event|5|||
16531228|NCT00605280|40410152|FG000|Year 1|Physician Decision|7|||
16531229|NCT00605280|40410153|FG001|Year 1|Physician Decision|4|||
16531230|NCT00605280|40410154|FG002|Year 1|Physician Decision|0|||
16531231|NCT00605280|40410155|FG003|Year 1|Physician Decision|6|||
16531232|NCT00605280|40410152|FG000|Year 1|Withdrawal by Subject|2|||
16531233|NCT00605280|40410153|FG001|Year 1|Withdrawal by Subject|4|||
16531234|NCT00605280|40410154|FG002|Year 1|Withdrawal by Subject|0|||
16531235|NCT00605280|40410155|FG003|Year 1|Withdrawal by Subject|4|||
16531236|NCT00605280|40410152|FG000|Year 1|Other|2|||
16531237|NCT00605280|40410153|FG001|Year 1|Other|1|||
16531238|NCT00605280|40410154|FG002|Year 1|Other|0|||
16531239|NCT00605280|40410155|FG003|Year 1|Other|1|||
16531240|NCT00605280|40410152|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
16531241|NCT00605280|40410153|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
16531242|NCT00605280|40410154|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
16531243|NCT00605280|40410155|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
16531244|NCT00605280|40410152|FG000|Year 2|Adverse Event|4|||
16531245|NCT00605280|40410153|FG001|Year 2|Adverse Event|0|||
16531246|NCT00605280|40410154|FG002|Year 2|Adverse Event|2|||
16531247|NCT00605280|40410155|FG003|Year 2|Adverse Event|4|||
16531248|NCT00605280|40410152|FG000|Year 2|Physician Decision|11|||
16531249|NCT00605280|40410153|FG001|Year 2|Physician Decision|6|||
16531250|NCT00605280|40410154|FG002|Year 2|Physician Decision|4|||
16531251|NCT00605280|40410155|FG003|Year 2|Physician Decision|11|||
16531252|NCT00605280|40410152|FG000|Year 2|Withdrawal by Subject|4|||
16531253|NCT00605280|40410153|FG001|Year 2|Withdrawal by Subject|0|||
16531254|NCT00605280|40410154|FG002|Year 2|Withdrawal by Subject|0|||
16531255|NCT00605280|40410155|FG003|Year 2|Withdrawal by Subject|4|||
16531256|NCT00605280|40410152|FG000|Year 2|Other|1|||
16531257|NCT00605280|40410153|FG001|Year 2|Other|0|||
16531258|NCT00605280|40410154|FG002|Year 2|Other|0|||
16531259|NCT00605280|40410155|FG003|Year 2|Other|1|||
16531260|NCT00605280|40410152|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
16531261|NCT00605280|40410153|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
16531262|NCT00605280|40410154|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
16531263|NCT00605280|40410155|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
16531264|NCT00605280|40410152|FG000|Year 3 Extension|Adverse Event|2|||
16531265|NCT00605280|40410153|FG001|Year 3 Extension|Adverse Event|0|||
16531266|NCT00605280|40410154|FG002|Year 3 Extension|Adverse Event|0|||
16531267|NCT00605280|40410155|FG003|Year 3 Extension|Adverse Event|2|||
16531268|NCT00605280|40410152|FG000|Year 3 Extension|Physician Decision|0|||
16531269|NCT00605280|40410153|FG001|Year 3 Extension|Physician Decision|0|||
16531270|NCT00605280|40410154|FG002|Year 3 Extension|Physician Decision|0|||
16531271|NCT00605280|40410155|FG003|Year 3 Extension|Physician Decision|2|||
16531272|NCT00605280|40410152|FG000|Year 3 Extension|Withdrawal by Subject|2|||
16531273|NCT00605280|40410153|FG001|Year 3 Extension|Withdrawal by Subject|0|||
16531274|NCT00605280|40410154|FG002|Year 3 Extension|Withdrawal by Subject|0|||
16531275|NCT00605280|40410155|FG003|Year 3 Extension|Withdrawal by Subject|5|||
16531276|NCT00605280|40410152|FG000|Year 3 Extension|Other|2|||
16531277|NCT00605280|40410153|FG001|Year 3 Extension|Other|0|||
16531278|NCT00605280|40410154|FG002|Year 3 Extension|Other|0|||
16531279|NCT00605280|40410155|FG003|Year 3 Extension|Other|0|||
16531280|NCT00605280|40410152|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
16531281|NCT00605280|40410153|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
16531282|NCT00605280|40410154|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
16531283|NCT00605280|40410155|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
16531284|NCT02937545|40410156|FG000|Overall Study|Withdrawal by Subject|1|||
16531285|NCT02937545|40410157|FG001|Overall Study|Withdrawal by Subject|2|||
16531286|NCT02937545|40410158|FG002|Overall Study|Withdrawal by Subject|6|||
16531287|NCT02937545|40410159|FG003|Overall Study|Withdrawal by Subject|7|||
16531288|NCT02937545|40410156|FG000|Overall Study|Lost to Follow-up|1|||
16531289|NCT02937545|40410157|FG001|Overall Study|Lost to Follow-up|0|||
16531290|NCT02937545|40410158|FG002|Overall Study|Lost to Follow-up|0|||
16531291|NCT02937545|40410159|FG003|Overall Study|Lost to Follow-up|0|||
16531292|NCT00201006|40410160|FG000|Overall Study|Withdrawal by Subject|7|||
16531293|NCT00201006|40410161|FG001|Overall Study|Withdrawal by Subject|2|||
16531294|NCT00201006|40410162|FG002|Overall Study|Withdrawal by Subject|3|||
16531295|NCT00201006|40410160|FG000|Overall Study|Adverse Event|1|||
16531296|NCT00201006|40410161|FG001|Overall Study|Adverse Event|0|||
16531297|NCT00201006|40410162|FG002|Overall Study|Adverse Event|1|||
16531298|NCT00563784|40410163|FG000|Overall Study|Withdrawal by Subject|2|||
16531299|NCT00563784|40410163|FG000|Overall Study|Screen Failures|20|||
16531300|NCT04479618|40410166|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
16531301|NCT04479618|40410167|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
16531302|NCT04479618|40410168|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
16531303|NCT04479618|40410166|FG000|Overall Study|Lack of Efficacy|1|||
16531304|NCT04479618|40410167|FG001|Overall Study|Lack of Efficacy|0|||
16531305|NCT04479618|40410168|FG002|Overall Study|Lack of Efficacy|0|||
16531306|NCT04479618|40410166|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
16531307|NCT04479618|40410167|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
16531308|NCT04479618|40410168|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
16531309|NCT04479618|40410166|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
16531310|NCT04479618|40410167|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
16531311|NCT04479618|40410168|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
16531312|NCT04479618|40410166|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
16531313|NCT04479618|40410167|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
16531314|NCT04479618|40410168|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
16531315|NCT04479618|40410166|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
16531316|NCT04479618|40410167|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
16531317|NCT04479618|40410168|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
16099541|NCT05270863|38852923|FG001|Visit 2 First Intervention|Randomization error|0|||
16214488|NCT03073200|39265433|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214489|NCT03073200|39265434|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214490|NCT03073200|39265435|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214491|NCT03073200|39265436|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214492|NCT03073200|39265437|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214493|NCT03073200|39265438|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214494|NCT03073200|39265439|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214495|NCT03073200|39265440|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214496|NCT03073200|39265441|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214497|NCT03073200|39265442|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214498|NCT03073200|39265443|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
16214499|NCT03073200|39265444|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
16332242|NCT03854370|39703344|FG001|Overall Study|samples not collected|1|||
16332243|NCT03854370|39703345|FG002|Overall Study|samples not collected|1|||
16332244|NCT03854370|39703346|FG003|Overall Study|samples not collected|1|||
16332245|NCT01490697|39703347|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
16332246|NCT01490697|39703348|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
16332247|NCT02908074|39703351|FG000|Overall Study|sponsor/ICON decision|0|||
16332248|NCT02908074|39703352|FG001|Overall Study|sponsor/ICON decision|0|||
16332249|NCT02908074|39703353|FG002|Overall Study|sponsor/ICON decision|1|||
16332250|NCT02908074|39703354|FG003|Overall Study|sponsor/ICON decision|0|||
16332251|NCT02908074|39703355|FG004|Overall Study|sponsor/ICON decision|0|||
16332252|NCT02908074|39703356|FG005|Overall Study|sponsor/ICON decision|0|||
16332253|NCT02908074|39703351|FG000|Overall Study|Protocol Violation|0|||
16332254|NCT02908074|39703352|FG001|Overall Study|Protocol Violation|1|||
16332255|NCT02908074|39703353|FG002|Overall Study|Protocol Violation|0|||
16332256|NCT02908074|39703354|FG003|Overall Study|Protocol Violation|0|||
16332257|NCT02908074|39703355|FG004|Overall Study|Protocol Violation|0|||
16332258|NCT02908074|39703356|FG005|Overall Study|Protocol Violation|0|||
16332259|NCT02908074|39703351|FG000|Overall Study|Adverse Event|5|||
16332260|NCT02908074|39703352|FG001|Overall Study|Adverse Event|2|||
16332261|NCT02908074|39703353|FG002|Overall Study|Adverse Event|0|||
16332262|NCT02908074|39703354|FG003|Overall Study|Adverse Event|0|||
16099542|NCT05270863|38852924|FG002|Visit 2 First Intervention|Randomization error|0|||
16099543|NCT05270863|38852925|FG003|Visit 2 First Intervention|Randomization error|1|||
16214500|NCT03073200|39265445|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
16332263|NCT02908074|39703355|FG004|Overall Study|Adverse Event|1|||
16332264|NCT02908074|39703356|FG005|Overall Study|Adverse Event|0|||
16332265|NCT02908074|39703351|FG000|Overall Study|AESI|1|||
16332266|NCT02908074|39703352|FG001|Overall Study|AESI|0|||
16401489|NCT02589665|39953590|FG003|Induction Period|Withdrawal by Subject|1|||
16401490|NCT02589665|39953591|FG004|Induction Period|Withdrawal by Subject|0|||
16401491|NCT02589665|39953592|FG005|Induction Period|Withdrawal by Subject|0|||
16401492|NCT02589665|39953593|FG006|Induction Period|Withdrawal by Subject|0|||
16401493|NCT02589665|39953594|FG007|Induction Period|Withdrawal by Subject|0|||
16401494|NCT02589665|39953595|FG008|Induction Period|Withdrawal by Subject|0|||
16401495|NCT02589665|39953596|FG009|Induction Period|Withdrawal by Subject|0|||
16401496|NCT02589665|39953587|FG000|Induction Period|Protocol Violation|0|||
16401497|NCT02589665|39953588|FG001|Induction Period|Protocol Violation|1|||
16401498|NCT02589665|39953589|FG002|Induction Period|Protocol Violation|0|||
16401499|NCT02589665|39953590|FG003|Induction Period|Protocol Violation|0|||
16401500|NCT02589665|39953591|FG004|Induction Period|Protocol Violation|0|||
16401501|NCT02589665|39953592|FG005|Induction Period|Protocol Violation|0|||
16401502|NCT02589665|39953593|FG006|Induction Period|Protocol Violation|0|||
16401503|NCT02589665|39953594|FG007|Induction Period|Protocol Violation|0|||
16401504|NCT02589665|39953595|FG008|Induction Period|Protocol Violation|0|||
16401505|NCT02589665|39953596|FG009|Induction Period|Protocol Violation|0|||
16401506|NCT02589665|39953587|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401507|NCT02589665|39953588|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401508|NCT02589665|39953589|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401509|NCT02589665|39953590|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401510|NCT02589665|39953591|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
16401511|NCT02589665|39953592|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
16401512|NCT02589665|39953593|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
16401513|NCT02589665|39953594|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401514|NCT02589665|39953595|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401515|NCT02589665|39953596|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401516|NCT02589665|39953587|FG000|Maintenance Period|Withdrawal by Subject|0|||
16401517|NCT02589665|39953588|FG001|Maintenance Period|Withdrawal by Subject|0|||
16401518|NCT02589665|39953589|FG002|Maintenance Period|Withdrawal by Subject|0|||
16401519|NCT02589665|39953590|FG003|Maintenance Period|Withdrawal by Subject|0|||
16401520|NCT02589665|39953591|FG004|Maintenance Period|Withdrawal by Subject|4|||
16401521|NCT02589665|39953592|FG005|Maintenance Period|Withdrawal by Subject|2|||
16401522|NCT02589665|39953593|FG006|Maintenance Period|Withdrawal by Subject|4|||
16401523|NCT02589665|39953594|FG007|Maintenance Period|Withdrawal by Subject|0|||
16401524|NCT02589665|39953595|FG008|Maintenance Period|Withdrawal by Subject|0|||
16401525|NCT02589665|39953596|FG009|Maintenance Period|Withdrawal by Subject|0|||
16401526|NCT02589665|39953587|FG000|Maintenance Period|Lack of Efficacy|0|||
16401527|NCT02589665|39953588|FG001|Maintenance Period|Lack of Efficacy|0|||
16401528|NCT02589665|39953589|FG002|Maintenance Period|Lack of Efficacy|0|||
16401529|NCT02589665|39953590|FG003|Maintenance Period|Lack of Efficacy|0|||
16401530|NCT02589665|39953591|FG004|Maintenance Period|Lack of Efficacy|2|||
16401531|NCT02589665|39953592|FG005|Maintenance Period|Lack of Efficacy|1|||
16401532|NCT02589665|39953593|FG006|Maintenance Period|Lack of Efficacy|0|||
16401533|NCT02589665|39953594|FG007|Maintenance Period|Lack of Efficacy|0|||
16401534|NCT02589665|39953595|FG008|Maintenance Period|Lack of Efficacy|0|||
16401535|NCT02589665|39953596|FG009|Maintenance Period|Lack of Efficacy|0|||
16401536|NCT02589665|39953587|FG000|Maintenance Period|Adverse Event|0|||
16401537|NCT02589665|39953588|FG001|Maintenance Period|Adverse Event|0|||
16401538|NCT02589665|39953589|FG002|Maintenance Period|Adverse Event|0|||
16531318|NCT02395120|40410175|FG000|Overall Study|Missed follow-up dental exam|57|||
16531319|NCT02395120|40410176|FG001|Overall Study|Missed follow-up dental exam|62|||
16531320|NCT02395120|40410177|FG002|Overall Study|Missed follow-up dental exam|6|||
16531321|NCT02395120|40410178|FG003|Overall Study|Missed follow-up dental exam|6|||
16531322|NCT02395120|40410179|FG004|Overall Study|Missed follow-up dental exam|51|||
16531323|NCT03266588|40410180|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
16531324|NCT03266588|40410181|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
16531325|NCT03266588|40410182|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
16531326|NCT03266588|40410180|FG000|Observational Period|Withdrawal by Subject|44|||
16531327|NCT03266588|40410181|FG001|Observational Period|Withdrawal by Subject|22|||
16531328|NCT03266588|40410182|FG002|Observational Period|Withdrawal by Subject|13|||
16531329|NCT03266588|40410180|FG000|Observational Period|Non-compliance|18|||
16531330|NCT03266588|40410181|FG001|Observational Period|Non-compliance|12|||
16531331|NCT03266588|40410182|FG002|Observational Period|Non-compliance|10|||
16531332|NCT03266588|40410180|FG000|Observational Period|Lost to Follow-up|8|||
16531333|NCT03266588|40410181|FG001|Observational Period|Lost to Follow-up|12|||
16531334|NCT03266588|40410182|FG002|Observational Period|Lost to Follow-up|4|||
16531335|NCT03266588|40410180|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
16401539|NCT02589665|39953590|FG003|Maintenance Period|Adverse Event|0|||
16401540|NCT02589665|39953591|FG004|Maintenance Period|Adverse Event|0|||
16401541|NCT02589665|39953592|FG005|Maintenance Period|Adverse Event|0|||
16531336|NCT03266588|40410181|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
16401542|NCT02589665|39953593|FG006|Maintenance Period|Adverse Event|2|||
16401543|NCT02589665|39953594|FG007|Maintenance Period|Adverse Event|0|||
16401544|NCT02589665|39953595|FG008|Maintenance Period|Adverse Event|0|||
16401545|NCT02589665|39953596|FG009|Maintenance Period|Adverse Event|0|||
16401546|NCT02589665|39953587|FG000|Maintenance Period|Lost to Follow-up|0|||
16401547|NCT02589665|39953588|FG001|Maintenance Period|Lost to Follow-up|0|||
16401548|NCT02589665|39953589|FG002|Maintenance Period|Lost to Follow-up|0|||
16401549|NCT02589665|39953590|FG003|Maintenance Period|Lost to Follow-up|0|||
16401550|NCT02589665|39953591|FG004|Maintenance Period|Lost to Follow-up|0|||
16401551|NCT02589665|39953592|FG005|Maintenance Period|Lost to Follow-up|1|||
16401552|NCT02589665|39953593|FG006|Maintenance Period|Lost to Follow-up|0|||
16401553|NCT02589665|39953594|FG007|Maintenance Period|Lost to Follow-up|0|||
16401554|NCT02589665|39953595|FG008|Maintenance Period|Lost to Follow-up|0|||
16401555|NCT02589665|39953596|FG009|Maintenance Period|Lost to Follow-up|0|||
16401556|NCT02589665|39953587|FG000|Maintenance Period|Physician Decision|0|||
16401557|NCT02589665|39953588|FG001|Maintenance Period|Physician Decision|0|||
16401558|NCT02589665|39953589|FG002|Maintenance Period|Physician Decision|0|||
16401559|NCT02589665|39953590|FG003|Maintenance Period|Physician Decision|0|||
16401560|NCT02589665|39953591|FG004|Maintenance Period|Physician Decision|0|||
16401561|NCT02589665|39953592|FG005|Maintenance Period|Physician Decision|1|||
16401562|NCT02589665|39953593|FG006|Maintenance Period|Physician Decision|0|||
16401563|NCT02589665|39953594|FG007|Maintenance Period|Physician Decision|0|||
16401564|NCT02589665|39953595|FG008|Maintenance Period|Physician Decision|0|||
16401565|NCT02589665|39953596|FG009|Maintenance Period|Physician Decision|0|||
16401566|NCT02589665|39953587|FG000|Maintenance Period|Reason Not Collected|0|||
16401567|NCT02589665|39953588|FG001|Maintenance Period|Reason Not Collected|0|||
16401568|NCT02589665|39953589|FG002|Maintenance Period|Reason Not Collected|0|||
16401569|NCT02589665|39953590|FG003|Maintenance Period|Reason Not Collected|0|||
16401570|NCT02589665|39953591|FG004|Maintenance Period|Reason Not Collected|0|||
16401571|NCT02589665|39953592|FG005|Maintenance Period|Reason Not Collected|1|||
16401572|NCT02589665|39953593|FG006|Maintenance Period|Reason Not Collected|1|||
16401573|NCT02589665|39953594|FG007|Maintenance Period|Reason Not Collected|0|||
16401574|NCT02589665|39953595|FG008|Maintenance Period|Reason Not Collected|0|||
16401575|NCT02589665|39953596|FG009|Maintenance Period|Reason Not Collected|0|||
16401576|NCT02589665|39953587|FG000|Induction Extension Period|Adverse Event|0|||
16401577|NCT02589665|39953588|FG001|Induction Extension Period|Adverse Event|0|||
16401578|NCT02589665|39953589|FG002|Induction Extension Period|Adverse Event|0|||
16401579|NCT02589665|39953590|FG003|Induction Extension Period|Adverse Event|0|||
16401580|NCT02589665|39953591|FG004|Induction Extension Period|Adverse Event|0|||
16401581|NCT02589665|39953592|FG005|Induction Extension Period|Adverse Event|0|||
16401582|NCT02589665|39953593|FG006|Induction Extension Period|Adverse Event|0|||
16401583|NCT02589665|39953594|FG007|Induction Extension Period|Adverse Event|0|||
16401584|NCT02589665|39953595|FG008|Induction Extension Period|Adverse Event|4|||
16401585|NCT02589665|39953596|FG009|Induction Extension Period|Adverse Event|0|||
16401586|NCT02589665|39953587|FG000|Induction Extension Period|Lack of Efficacy|0|||
16401587|NCT02589665|39953588|FG001|Induction Extension Period|Lack of Efficacy|0|||
16401588|NCT02589665|39953589|FG002|Induction Extension Period|Lack of Efficacy|0|||
16401589|NCT02589665|39953590|FG003|Induction Extension Period|Lack of Efficacy|0|||
16401590|NCT02589665|39953591|FG004|Induction Extension Period|Lack of Efficacy|0|||
16401591|NCT02589665|39953592|FG005|Induction Extension Period|Lack of Efficacy|0|||
16531337|NCT03266588|40410182|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
16531338|NCT03266588|40410180|FG000|Observational Period|Protocol Deviation|1|||
16531339|NCT03266588|40410181|FG001|Observational Period|Protocol Deviation|0|||
16531340|NCT03266588|40410182|FG002|Observational Period|Protocol Deviation|0|||
16531341|NCT03266588|40410180|FG000|Observational Period|Other Reasons|3|||
16531342|NCT03266588|40410181|FG001|Observational Period|Other Reasons|0|||
16099544|NCT05270863|38852926|FG004|Visit 2 First Intervention|Randomization error|0|||
16099545|NCT05270863|38852927|FG005|Visit 2 First Intervention|Randomization error|0|||
16099546|NCT05270863|38852922|FG000|First Washout|Withdrawal by Subject|0|||
16099547|NCT05270863|38852923|FG001|First Washout|Withdrawal by Subject|0|||
16531343|NCT03266588|40410182|FG002|Observational Period|Other Reasons|1|||
16531344|NCT03266588|40410180|FG000|Long-term Treatment Period|Adverse Event|33|||
16531345|NCT03266588|40410181|FG001|Long-term Treatment Period|Adverse Event|17|||
16531346|NCT03266588|40410182|FG002|Long-term Treatment Period|Adverse Event|8|||
16531347|NCT03266588|40410180|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
16531348|NCT03266588|40410181|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
16531349|NCT03266588|40410182|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
16531350|NCT03266588|40410180|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
16531351|NCT03266588|40410181|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
16531352|NCT03266588|40410182|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
16531353|NCT03266588|40410180|FG000|Long-term Treatment Period|Non-Compliance|126|||
16531354|NCT03266588|40410181|FG001|Long-term Treatment Period|Non-Compliance|57|||
16531355|NCT03266588|40410182|FG002|Long-term Treatment Period|Non-Compliance|7|||
16531356|NCT03266588|40410180|FG000|Long-term Treatment Period|Pregnancy|11|||
16531357|NCT03266588|40410181|FG001|Long-term Treatment Period|Pregnancy|5|||
16531358|NCT03266588|40410182|FG002|Long-term Treatment Period|Pregnancy|0|||
16531359|NCT03266588|40410180|FG000|Long-term Treatment Period|Protocol Deviation|17|||
16531360|NCT03266588|40410181|FG001|Long-term Treatment Period|Protocol Deviation|10|||
16531361|NCT03266588|40410182|FG002|Long-term Treatment Period|Protocol Deviation|4|||
16531362|NCT03266588|40410180|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
16531363|NCT03266588|40410181|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
16099548|NCT05270863|38852924|FG002|First Washout|Withdrawal by Subject|0|||
16099549|NCT05270863|38852925|FG003|First Washout|Withdrawal by Subject|0|||
16099550|NCT05270863|38852926|FG004|First Washout|Withdrawal by Subject|1|||
16099551|NCT05270863|38852927|FG005|First Washout|Withdrawal by Subject|1|||
16099552|NCT05270863|38852922|FG000|First Washout|Lost to Follow-up|0|||
16099553|NCT05270863|38852923|FG001|First Washout|Lost to Follow-up|0|||
16099554|NCT05270863|38852924|FG002|First Washout|Lost to Follow-up|0|||
16332267|NCT02908074|39703353|FG002|Overall Study|AESI|1|||
16332268|NCT02908074|39703354|FG003|Overall Study|AESI|0|||
16332269|NCT02908074|39703355|FG004|Overall Study|AESI|1|||
16332270|NCT02908074|39703356|FG005|Overall Study|AESI|0|||
16332271|NCT02908074|39703351|FG000|Overall Study|Discontinuation criteria per protocol|0|||
16332272|NCT02908074|39703352|FG001|Overall Study|Discontinuation criteria per protocol|0|||
16332273|NCT02908074|39703353|FG002|Overall Study|Discontinuation criteria per protocol|1|||
16332274|NCT02908074|39703354|FG003|Overall Study|Discontinuation criteria per protocol|0|||
16332275|NCT02908074|39703355|FG004|Overall Study|Discontinuation criteria per protocol|0|||
16401592|NCT02589665|39953593|FG006|Induction Extension Period|Lack of Efficacy|0|||
16401593|NCT02589665|39953594|FG007|Induction Extension Period|Lack of Efficacy|0|||
16401594|NCT02589665|39953595|FG008|Induction Extension Period|Lack of Efficacy|3|||
16531364|NCT03266588|40410182|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
16531365|NCT03266588|40410180|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
16531366|NCT03266588|40410181|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
16531367|NCT03266588|40410182|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
16531368|NCT03266588|40410180|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
16099555|NCT05270863|38852925|FG003|First Washout|Lost to Follow-up|0|||
16099556|NCT05270863|38852926|FG004|First Washout|Lost to Follow-up|0|||
16099557|NCT05270863|38852927|FG005|First Washout|Lost to Follow-up|1|||
16332276|NCT02908074|39703356|FG005|Overall Study|Discontinuation criteria per protocol|1|||
16332277|NCT02908074|39703351|FG000|Overall Study|Withdrawal by Subject|3|||
16332278|NCT02908074|39703352|FG001|Overall Study|Withdrawal by Subject|2|||
16332279|NCT02908074|39703353|FG002|Overall Study|Withdrawal by Subject|2|||
16332280|NCT02908074|39703354|FG003|Overall Study|Withdrawal by Subject|2|||
16332281|NCT02908074|39703355|FG004|Overall Study|Withdrawal by Subject|2|||
16332282|NCT02908074|39703356|FG005|Overall Study|Withdrawal by Subject|2|||
16332283|NCT02908074|39703351|FG000|Overall Study|Lost to Follow-up|0|||
16531369|NCT03266588|40410181|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
16531370|NCT03266588|40410182|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
16531371|NCT03266588|40410180|FG000|Long-term Treatment Period|Other Reasons|5|||
16531372|NCT03266588|40410181|FG001|Long-term Treatment Period|Other Reasons|0|||
16531373|NCT03266588|40410182|FG002|Long-term Treatment Period|Other Reasons|0|||
16531374|NCT03266588|40410180|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
16531375|NCT03266588|40410181|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
16531376|NCT03266588|40410182|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
16531377|NCT01585103|40410183|FG000|Overall Study|Unable to swallow Cytosponge|6|||
16531378|NCT01392560|40410186|FG000|Overall Study|Adverse Event|2|||
16531379|NCT01392560|40410186|FG000|Overall Study|not entered|8|||
16531380|NCT01392560|40410186|FG000|Overall Study|discontinued during placebo run-in|2|||
16531381|NCT01362140|40410189|FG000|Overall Study|Noncompliance|1|||
16531382|NCT01362140|40410190|FG001|Overall Study|Noncompliance|0|||
16531383|NCT01362140|40410189|FG000|Overall Study|Adverse Event|2|||
16332284|NCT02908074|39703352|FG001|Overall Study|Lost to Follow-up|1|||
16332285|NCT02908074|39703353|FG002|Overall Study|Lost to Follow-up|1|||
16332286|NCT02908074|39703354|FG003|Overall Study|Lost to Follow-up|1|||
16531384|NCT01362140|40410190|FG001|Overall Study|Adverse Event|2|||
16531385|NCT01362140|40410189|FG000|Overall Study|Withdrawal by Subject|3|||
16531386|NCT01362140|40410190|FG001|Overall Study|Withdrawal by Subject|3|||
16531387|NCT01362140|40410189|FG000|Overall Study|Administrative Decision|0|||
16531388|NCT01362140|40410190|FG001|Overall Study|Administrative Decision|1|||
16531389|NCT01362140|40410189|FG000|Overall Study|Death|2|||
16531390|NCT01362140|40410190|FG001|Overall Study|Death|1|||
16531391|NCT01362140|40410189|FG000|Overall Study|Other|1|||
16531392|NCT01362140|40410190|FG001|Overall Study|Other|1|||
16531393|NCT01362140|40410189|FG000|Overall Study|Protocol-specified Criteria|1|||
16531394|NCT01362140|40410190|FG001|Overall Study|Protocol-specified Criteria|2|||
16531395|NCT01362140|40410189|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
16531396|NCT01362140|40410190|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
16531397|NCT00476476|40410191|FG000|Overall Study|Adverse Event|2|||
16531398|NCT00476476|40410192|FG001|Overall Study|Adverse Event|7|||
16531399|NCT00476476|40410191|FG000|Overall Study|Progressive Disease|0|||
16531400|NCT00476476|40410192|FG001|Overall Study|Progressive Disease|17|||
16531401|NCT00717860|40410196|FG000|Overall Study|Clinical adverse experience|5|||
16531402|NCT00717860|40410197|FG001|Overall Study|Clinical adverse experience|9|||
16531403|NCT00717860|40410196|FG000|Overall Study|Laboratory adverse experience|2|||
16531404|NCT00717860|40410197|FG001|Overall Study|Laboratory adverse experience|2|||
16531405|NCT00717860|40410196|FG000|Overall Study|Lack of Efficacy|7|||
16531406|NCT00717860|40410197|FG001|Overall Study|Lack of Efficacy|13|||
16531407|NCT00717860|40410196|FG000|Overall Study|Discontinued for other reason|6|||
16531408|NCT00717860|40410197|FG001|Overall Study|Discontinued for other reason|1|||
16099558|NCT05270863|38852922|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
16099559|NCT05270863|38852923|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
16099560|NCT05270863|38852924|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
16099561|NCT05270863|38852925|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
16531409|NCT00717860|40410196|FG000|Overall Study|Withdrew consent|7|||
16099562|NCT05270863|38852926|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
16099563|NCT05270863|38852927|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
16531410|NCT00717860|40410197|FG001|Overall Study|Withdrew consent|3|||
16332287|NCT02908074|39703355|FG004|Overall Study|Lost to Follow-up|0|||
16332288|NCT02908074|39703356|FG005|Overall Study|Lost to Follow-up|1|||
16332289|NCT01877382|39703357|FG000|Dose Escalation|Progressive disease|2|||
16531411|NCT05054374|40410201|FG000|Overall Study|Withdrawal by Subject|1|||
16531412|NCT05054374|40410202|FG001|Overall Study|Withdrawal by Subject|0|||
16531413|NCT05054374|40410203|FG002|Overall Study|Withdrawal by Subject|0|||
16531414|NCT05054374|40410204|FG003|Overall Study|Withdrawal by Subject|0|||
16531415|NCT05054374|40410201|FG000|Overall Study|Progressive Disease|5|||
16531416|NCT05054374|40410202|FG001|Overall Study|Progressive Disease|0|||
16531417|NCT05054374|40410203|FG002|Overall Study|Progressive Disease|0|||
16531418|NCT05054374|40410204|FG003|Overall Study|Progressive Disease|0|||
16531419|NCT01491854|40410205|FG000|Overall Study|mainly due to premature termination|93|||
16531420|NCT01491854|40410205|FG000|Overall Study|Death|1|||
16099564|NCT05270863|38852922|FG000|Second Washout|Withdrawal by Subject|1|||
16099565|NCT05270863|38852923|FG001|Second Washout|Withdrawal by Subject|1|||
16099566|NCT05270863|38852924|FG002|Second Washout|Withdrawal by Subject|0|||
16099567|NCT05270863|38852925|FG003|Second Washout|Withdrawal by Subject|0|||
16099568|NCT05270863|38852926|FG004|Second Washout|Withdrawal by Subject|0|||
16099569|NCT05270863|38852927|FG005|Second Washout|Withdrawal by Subject|0|||
16099570|NCT05270863|38852922|FG000|Second Washout|Lost to Follow-up|0|||
16099571|NCT05270863|38852923|FG001|Second Washout|Lost to Follow-up|0|||
16099572|NCT05270863|38852924|FG002|Second Washout|Lost to Follow-up|0|||
16099573|NCT05270863|38852925|FG003|Second Washout|Lost to Follow-up|1|||
16099574|NCT05270863|38852926|FG004|Second Washout|Lost to Follow-up|0|||
16099575|NCT05270863|38852927|FG005|Second Washout|Lost to Follow-up|0|||
16099576|NCT00666835|38852933|FG000|Overall Study|Withdrawal by Subject|5|||
16099577|NCT00666835|38852934|FG001|Overall Study|Withdrawal by Subject|2|||
16099578|NCT00666835|38852933|FG000|Overall Study|Lack of Efficacy|0|||
16099579|NCT00666835|38852934|FG001|Overall Study|Lack of Efficacy|1|||
16099580|NCT00666835|38852933|FG000|Overall Study|Incl./excl. not fulfilled|7|||
16099581|NCT00666835|38852934|FG001|Overall Study|Incl./excl. not fulfilled|2|||
16099582|NCT00666835|38852933|FG000|Overall Study|Adverse Event|7|||
16099583|NCT00666835|38852934|FG001|Overall Study|Adverse Event|6|||
16099584|NCT00666835|38852933|FG000|Overall Study|Protocol Violation|2|||
16099585|NCT00666835|38852934|FG001|Overall Study|Protocol Violation|0|||
16099586|NCT00666835|38852933|FG000|Overall Study|Death|15|||
16099587|NCT00666835|38852934|FG001|Overall Study|Death|4|||
16099588|NCT00666835|38852933|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
16099589|NCT00666835|38852934|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
16332290|NCT01877382|39703358|FG001|Dose Escalation|Progressive disease|0|||
16332291|NCT01877382|39703359|FG002|Dose Escalation|Progressive disease|1|||
16332292|NCT01877382|39703360|FG003|Dose Escalation|Progressive disease|6|||
16332293|NCT01877382|39703361|FG004|Dose Escalation|Progressive disease|1|||
16332294|NCT01877382|39703362|FG005|Dose Escalation|Progressive disease|0|||
16332295|NCT01877382|39703363|FG006|Dose Escalation|Progressive disease|3|||
16531421|NCT01491854|40410205|FG000|Overall Study|Withdrawal by Subject|3|||
16531422|NCT01491854|40410205|FG000|Overall Study|Lost to Follow-up|33|||
16531423|NCT02053350|40410211|FG000|Overall Study|Withdrawal by Subject|1|||
16531424|NCT02053350|40410211|FG000|Overall Study|Adverse Event|4|||
16531425|NCT03336619|40410212|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
16531426|NCT03336619|40410213|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
16531427|NCT03336619|40410212|FG000|Overall Study|Withdrawal by Subject|17|||
16531428|NCT03336619|40410213|FG001|Overall Study|Withdrawal by Subject|16|||
16531429|NCT03336619|40410212|FG000|Overall Study|Adverse Event|2|||
16531430|NCT03336619|40410213|FG001|Overall Study|Adverse Event|5|||
16531431|NCT03336619|40410212|FG000|Overall Study|Physician Decision|3|||
16531432|NCT03336619|40410213|FG001|Overall Study|Physician Decision|0|||
16531433|NCT00518115|40410214|FG000|Overall Study|Adverse Event|6|||
16531434|NCT00518115|40410215|FG001|Overall Study|Adverse Event|1|||
16531435|NCT00518115|40410216|FG002|Overall Study|Adverse Event|5|||
16531436|NCT00518115|40410217|FG003|Overall Study|Adverse Event|6|||
16531437|NCT00518115|40410218|FG004|Overall Study|Adverse Event|5|||
16332296|NCT01877382|39703364|FG007|Dose Escalation|Progressive disease|10|||
16332297|NCT01877382|39703365|FG008|Dose Escalation|Progressive disease|4|||
16531438|NCT00518115|40410219|FG005|Overall Study|Adverse Event|5|||
16531439|NCT00518115|40410220|FG006|Overall Study|Adverse Event|5|||
16531440|NCT00518115|40410221|FG007|Overall Study|Adverse Event|10|||
16531441|NCT00518115|40410222|FG008|Overall Study|Adverse Event|2|||
16099590|NCT00666835|38852933|FG000|Overall Study|Hemoglobulin concentration|4|||
16099591|NCT00666835|38852934|FG001|Overall Study|Hemoglobulin concentration|3|||
16099592|NCT00666835|38852933|FG000|Overall Study|Planned operation|2|||
16099593|NCT00666835|38852934|FG001|Overall Study|Planned operation|0|||
16099594|NCT00666835|38852933|FG000|Overall Study|Physician Decision|1|||
16099595|NCT00666835|38852934|FG001|Overall Study|Physician Decision|2|||
16332298|NCT01877382|39703366|FG009|Dose Escalation|Progressive disease|2|||
16332299|NCT01877382|39703367|FG010|Dose Escalation|Progressive disease|3|||
16332300|NCT01877382|39703368|FG011|Dose Escalation|Progressive disease|3|||
16332301|NCT01877382|39703369|FG012|Dose Escalation|Progressive disease|13|||
16332302|NCT01877382|39703370|FG013|Dose Escalation|Progressive disease|1|||
16531442|NCT00518115|40410223|FG009|Overall Study|Adverse Event|9|||
16531443|NCT00518115|40410214|FG000|Overall Study|Lost to Follow-up|0|||
16531444|NCT00518115|40410215|FG001|Overall Study|Lost to Follow-up|0|||
16531445|NCT00518115|40410216|FG002|Overall Study|Lost to Follow-up|2|||
16531446|NCT00518115|40410217|FG003|Overall Study|Lost to Follow-up|3|||
16531447|NCT00518115|40410218|FG004|Overall Study|Lost to Follow-up|1|||
16531448|NCT00518115|40410219|FG005|Overall Study|Lost to Follow-up|3|||
16531449|NCT00518115|40410220|FG006|Overall Study|Lost to Follow-up|0|||
16531450|NCT00518115|40410221|FG007|Overall Study|Lost to Follow-up|1|||
16531451|NCT00518115|40410222|FG008|Overall Study|Lost to Follow-up|1|||
16531452|NCT00518115|40410223|FG009|Overall Study|Lost to Follow-up|1|||
16531453|NCT00518115|40410214|FG000|Overall Study|Protocol Violation|1|||
16531454|NCT00518115|40410215|FG001|Overall Study|Protocol Violation|3|||
16531455|NCT00518115|40410216|FG002|Overall Study|Protocol Violation|1|||
16531456|NCT00518115|40410217|FG003|Overall Study|Protocol Violation|0|||
16531457|NCT00518115|40410218|FG004|Overall Study|Protocol Violation|0|||
16531458|NCT00518115|40410219|FG005|Overall Study|Protocol Violation|0|||
16531459|NCT00518115|40410220|FG006|Overall Study|Protocol Violation|0|||
16531460|NCT00518115|40410221|FG007|Overall Study|Protocol Violation|0|||
16531461|NCT00518115|40410222|FG008|Overall Study|Protocol Violation|0|||
16531462|NCT00518115|40410223|FG009|Overall Study|Protocol Violation|0|||
16531463|NCT00518115|40410214|FG000|Overall Study|Withdrawal by Subject|1|||
16531464|NCT00518115|40410215|FG001|Overall Study|Withdrawal by Subject|1|||
16531465|NCT00518115|40410216|FG002|Overall Study|Withdrawal by Subject|5|||
16531466|NCT00518115|40410217|FG003|Overall Study|Withdrawal by Subject|0|||
16332303|NCT01877382|39703371|FG014|Dose Escalation|Progressive disease|0|||
16332304|NCT01877382|39703357|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
16332305|NCT01877382|39703358|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332306|NCT01877382|39703359|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332307|NCT01877382|39703360|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
16332308|NCT01877382|39703361|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332309|NCT01877382|39703362|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332310|NCT01877382|39703363|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
16332311|NCT01877382|39703364|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332312|NCT01877382|39703365|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332313|NCT01877382|39703366|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332314|NCT01877382|39703367|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332315|NCT01877382|39703368|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332316|NCT01877382|39703369|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332317|NCT01877382|39703370|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332318|NCT01877382|39703371|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332319|NCT01877382|39703357|FG000|Dose Escalation|Clinical progression|0|||
16332320|NCT01877382|39703358|FG001|Dose Escalation|Clinical progression|1|||
16332321|NCT01877382|39703359|FG002|Dose Escalation|Clinical progression|0|||
16332322|NCT01877382|39703360|FG003|Dose Escalation|Clinical progression|2|||
16332323|NCT01877382|39703361|FG004|Dose Escalation|Clinical progression|0|||
16332324|NCT01877382|39703362|FG005|Dose Escalation|Clinical progression|0|||
16332325|NCT01877382|39703363|FG006|Dose Escalation|Clinical progression|1|||
16332326|NCT01877382|39703364|FG007|Dose Escalation|Clinical progression|0|||
16332327|NCT01877382|39703365|FG008|Dose Escalation|Clinical progression|0|||
16332328|NCT01877382|39703366|FG009|Dose Escalation|Clinical progression|1|||
16332329|NCT01877382|39703367|FG010|Dose Escalation|Clinical progression|0|||
16332330|NCT01877382|39703368|FG011|Dose Escalation|Clinical progression|0|||
16332331|NCT01877382|39703369|FG012|Dose Escalation|Clinical progression|2|||
16332332|NCT01877382|39703370|FG013|Dose Escalation|Clinical progression|1|||
16332333|NCT01877382|39703371|FG014|Dose Escalation|Clinical progression|0|||
16332334|NCT01877382|39703357|FG000|Dose Escalation|Adverse Event|0|||
16332335|NCT01877382|39703358|FG001|Dose Escalation|Adverse Event|0|||
16332336|NCT01877382|39703359|FG002|Dose Escalation|Adverse Event|0|||
16332337|NCT01877382|39703360|FG003|Dose Escalation|Adverse Event|4|||
16531467|NCT00518115|40410218|FG004|Overall Study|Withdrawal by Subject|2|||
16531468|NCT00518115|40410219|FG005|Overall Study|Withdrawal by Subject|1|||
16531469|NCT00518115|40410220|FG006|Overall Study|Withdrawal by Subject|0|||
16531470|NCT00518115|40410221|FG007|Overall Study|Withdrawal by Subject|2|||
16531471|NCT00518115|40410222|FG008|Overall Study|Withdrawal by Subject|1|||
16531472|NCT00518115|40410223|FG009|Overall Study|Withdrawal by Subject|3|||
16531473|NCT00518115|40410214|FG000|Overall Study|Lack of Efficacy|1|||
16531474|NCT00518115|40410215|FG001|Overall Study|Lack of Efficacy|0|||
16531475|NCT00518115|40410216|FG002|Overall Study|Lack of Efficacy|1|||
16214501|NCT03073200|39265446|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
16531476|NCT00518115|40410217|FG003|Overall Study|Lack of Efficacy|1|||
16332338|NCT01877382|39703361|FG004|Dose Escalation|Adverse Event|1|||
16332339|NCT01877382|39703362|FG005|Dose Escalation|Adverse Event|2|||
16332340|NCT01877382|39703363|FG006|Dose Escalation|Adverse Event|1|||
16531477|NCT00518115|40410218|FG004|Overall Study|Lack of Efficacy|0|||
16531478|NCT00518115|40410219|FG005|Overall Study|Lack of Efficacy|0|||
16531479|NCT00518115|40410220|FG006|Overall Study|Lack of Efficacy|0|||
16531480|NCT00518115|40410221|FG007|Overall Study|Lack of Efficacy|1|||
16531481|NCT00518115|40410222|FG008|Overall Study|Lack of Efficacy|0|||
16531482|NCT00518115|40410223|FG009|Overall Study|Lack of Efficacy|0|||
16531483|NCT00518115|40410214|FG000|Overall Study|Non-Compliance|1|||
16531484|NCT00518115|40410215|FG001|Overall Study|Non-Compliance|0|||
16531485|NCT00518115|40410216|FG002|Overall Study|Non-Compliance|1|||
16531486|NCT00518115|40410217|FG003|Overall Study|Non-Compliance|0|||
16531487|NCT00518115|40410218|FG004|Overall Study|Non-Compliance|1|||
16531488|NCT00518115|40410219|FG005|Overall Study|Non-Compliance|1|||
16214502|NCT03073200|39265447|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
16099596|NCT05361304|38852935|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
16099597|NCT05361304|38852936|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
16099598|NCT05361304|38852935|FG000|Overall Study|COVID-19 Related|1|||
16099599|NCT05361304|38852936|FG001|Overall Study|COVID-19 Related|2|||
16099600|NCT05361304|38852935|FG000|Overall Study|Withdrawal by Subject|1|||
16099601|NCT05361304|38852936|FG001|Overall Study|Withdrawal by Subject|0|||
16099602|NCT00473512|38852937|FG000|Period 1 (Phase 1)|Adverse Event|0|||
16099603|NCT00473512|38852938|FG001|Period 1 (Phase 1)|Adverse Event|0|||
16099604|NCT00473512|38852939|FG002|Period 1 (Phase 1)|Adverse Event|0|||
16099605|NCT00473512|38852940|FG003|Period 1 (Phase 1)|Adverse Event|5|||
16099606|NCT00473512|38852941|FG004|Period 1 (Phase 1)|Adverse Event|0|||
16099607|NCT00473512|38852937|FG000|Period 1 (Phase 1)|Death|0|||
16099608|NCT00473512|38852938|FG001|Period 1 (Phase 1)|Death|0|||
16099609|NCT00473512|38852939|FG002|Period 1 (Phase 1)|Death|0|||
16099610|NCT00473512|38852940|FG003|Period 1 (Phase 1)|Death|1|||
16099611|NCT00473512|38852941|FG004|Period 1 (Phase 1)|Death|0|||
16099612|NCT00473512|38852937|FG000|Period 1 (Phase 1)|Disease Progression|1|||
16099613|NCT00473512|38852938|FG001|Period 1 (Phase 1)|Disease Progression|1|||
16099614|NCT00473512|38852939|FG002|Period 1 (Phase 1)|Disease Progression|0|||
16099615|NCT00473512|38852940|FG003|Period 1 (Phase 1)|Disease Progression|10|||
16099616|NCT00473512|38852941|FG004|Period 1 (Phase 1)|Disease Progression|1|||
16099617|NCT00473512|38852937|FG000|Period 1 (Phase 1)|Other|0|||
16099618|NCT00473512|38852938|FG001|Period 1 (Phase 1)|Other|0|||
16099619|NCT00473512|38852939|FG002|Period 1 (Phase 1)|Other|0|||
16099620|NCT00473512|38852940|FG003|Period 1 (Phase 1)|Other|1|||
16099621|NCT00473512|38852941|FG004|Period 1 (Phase 1)|Other|0|||
16099622|NCT00473512|38852937|FG000|Period 2 (Phase 2)|Adverse Event|0|||
16099623|NCT00473512|38852938|FG001|Period 2 (Phase 2)|Adverse Event|0|||
16099624|NCT00473512|38852939|FG002|Period 2 (Phase 2)|Adverse Event|0|||
16099625|NCT00473512|38852940|FG003|Period 2 (Phase 2)|Adverse Event|1|||
16099626|NCT00473512|38852941|FG004|Period 2 (Phase 2)|Adverse Event|0|||
16099627|NCT00473512|38852937|FG000|Period 2 (Phase 2)|Death|0|||
16099628|NCT00473512|38852938|FG001|Period 2 (Phase 2)|Death|0|||
16099629|NCT00473512|38852939|FG002|Period 2 (Phase 2)|Death|0|||
16099630|NCT00473512|38852940|FG003|Period 2 (Phase 2)|Death|1|||
16099631|NCT00473512|38852941|FG004|Period 2 (Phase 2)|Death|1|||
16099632|NCT00473512|38852937|FG000|Period 2 (Phase 2)|Disease Progression|0|||
16099633|NCT00473512|38852938|FG001|Period 2 (Phase 2)|Disease Progression|2|||
16099634|NCT00473512|38852939|FG002|Period 2 (Phase 2)|Disease Progression|2|||
16099635|NCT00473512|38852940|FG003|Period 2 (Phase 2)|Disease Progression|17|||
16099636|NCT00473512|38852941|FG004|Period 2 (Phase 2)|Disease Progression|1|||
16099637|NCT00473512|38852937|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
16099638|NCT00473512|38852938|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
16214503|NCT03073200|39265433|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16531489|NCT00518115|40410220|FG006|Overall Study|Non-Compliance|1|||
16531490|NCT00518115|40410221|FG007|Overall Study|Non-Compliance|1|||
16531491|NCT00518115|40410222|FG008|Overall Study|Non-Compliance|0|||
16531492|NCT00518115|40410223|FG009|Overall Study|Non-Compliance|1|||
16531493|NCT00518115|40410214|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
16531494|NCT00518115|40410215|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
16531495|NCT00518115|40410216|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
16531496|NCT00518115|40410217|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
16531497|NCT00518115|40410218|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
16531498|NCT00518115|40410219|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
16531499|NCT00518115|40410220|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
16099639|NCT00473512|38852939|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
16099640|NCT00473512|38852940|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
16099641|NCT00473512|38852941|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
16099642|NCT00473512|38852937|FG000|Period 2 (Phase 2)|Other|1|||
16099643|NCT00473512|38852938|FG001|Period 2 (Phase 2)|Other|0|||
16214504|NCT03073200|39265434|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16531500|NCT00518115|40410221|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
16099644|NCT00473512|38852939|FG002|Period 2 (Phase 2)|Other|0|||
16531501|NCT00518115|40410222|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
16531502|NCT00518115|40410223|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
16531503|NCT00518115|40410214|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
16531504|NCT00518115|40410215|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
16531505|NCT00518115|40410216|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
16531506|NCT00518115|40410217|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
16531507|NCT00518115|40410218|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
16531508|NCT00518115|40410219|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
16531509|NCT00518115|40410220|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
16531510|NCT00518115|40410221|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
16531511|NCT00518115|40410222|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
16531512|NCT00518115|40410223|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
16099645|NCT00473512|38852940|FG003|Period 2 (Phase 2)|Other|3|||
16099646|NCT00473512|38852941|FG004|Period 2 (Phase 2)|Other|0|||
16099647|NCT04374253|38852942|FG000|Overall Study|Adverse Event|0|||
16099648|NCT04374253|38852943|FG001|Overall Study|Adverse Event|26|||
16099649|NCT04374253|38852944|FG002|Overall Study|Adverse Event|2|||
16099650|NCT04374253|38852945|FG003|Overall Study|Adverse Event|12|||
16099651|NCT04374253|38852942|FG000|Overall Study|Study terminated by sponsor|13|||
16099652|NCT04374253|38852943|FG001|Overall Study|Study terminated by sponsor|593|||
16099653|NCT04374253|38852944|FG002|Overall Study|Study terminated by sponsor|21|||
16099654|NCT04374253|38852945|FG003|Overall Study|Study terminated by sponsor|567|||
16099655|NCT04374253|38852942|FG000|Overall Study|Withdrawal by Subject|0|||
16099656|NCT04374253|38852943|FG001|Overall Study|Withdrawal by Subject|55|||
16099657|NCT04374253|38852944|FG002|Overall Study|Withdrawal by Subject|3|||
16099658|NCT04374253|38852945|FG003|Overall Study|Withdrawal by Subject|40|||
16099659|NCT04374253|38852942|FG000|Overall Study|Physician Decision|1|||
16099660|NCT04374253|38852943|FG001|Overall Study|Physician Decision|10|||
16099661|NCT04374253|38852944|FG002|Overall Study|Physician Decision|1|||
16099662|NCT04374253|38852945|FG003|Overall Study|Physician Decision|10|||
16099663|NCT04374253|38852942|FG000|Overall Study|Protocol Violation|0|||
16099664|NCT04374253|38852943|FG001|Overall Study|Protocol Violation|0|||
16099665|NCT04374253|38852944|FG002|Overall Study|Protocol Violation|0|||
16099666|NCT04374253|38852945|FG003|Overall Study|Protocol Violation|2|||
16099667|NCT04374253|38852942|FG000|Overall Study|Death|0|||
16099668|NCT04374253|38852943|FG001|Overall Study|Death|3|||
16099669|NCT04374253|38852944|FG002|Overall Study|Death|1|||
16099670|NCT04374253|38852945|FG003|Overall Study|Death|1|||
16099671|NCT04374253|38852942|FG000|Overall Study|Lack of Efficacy|0|||
16099672|NCT04374253|38852943|FG001|Overall Study|Lack of Efficacy|0|||
16099673|NCT04374253|38852944|FG002|Overall Study|Lack of Efficacy|0|||
16099674|NCT04374253|38852945|FG003|Overall Study|Lack of Efficacy|1|||
16099675|NCT04374253|38852942|FG000|Overall Study|Lost to Follow-up|1|||
16099676|NCT04374253|38852943|FG001|Overall Study|Lost to Follow-up|1|||
16099677|NCT04374253|38852944|FG002|Overall Study|Lost to Follow-up|0|||
16099678|NCT04374253|38852945|FG003|Overall Study|Lost to Follow-up|2|||
16099679|NCT04374253|38852942|FG000|Overall Study|Reason Not Specified|0|||
16099680|NCT04374253|38852943|FG001|Overall Study|Reason Not Specified|8|||
16099681|NCT04374253|38852944|FG002|Overall Study|Reason Not Specified|0|||
16099682|NCT04374253|38852945|FG003|Overall Study|Reason Not Specified|8|||
16099683|NCT03326193|38852950|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
16099684|NCT03326193|38852950|FG000|Overall Study|Death|19|||
16099685|NCT03326193|38852950|FG000|Overall Study|Withdrawal by Subject|8|||
16099686|NCT00449033|38852956|FG000|Treatment Period|Adverse Event|117|||
16099687|NCT00449033|38852957|FG001|Treatment Period|Adverse Event|83|||
16099688|NCT00449033|38852956|FG000|Treatment Period|Death|21|||
16099689|NCT00449033|38852957|FG001|Treatment Period|Death|12|||
16099690|NCT00449033|38852956|FG000|Treatment Period|Lost to Follow-up|0|||
16099691|NCT00449033|38852957|FG001|Treatment Period|Lost to Follow-up|2|||
16099692|NCT00449033|38852956|FG000|Treatment Period|Physician Decision|4|||
16099693|NCT00449033|38852957|FG001|Treatment Period|Physician Decision|5|||
16099694|NCT00449033|38852956|FG000|Treatment Period|Protocol Violation|8|||
16099695|NCT00449033|38852957|FG001|Treatment Period|Protocol Violation|7|||
16099696|NCT00449033|38852956|FG000|Treatment Period|Disease Progression|231|||
16099697|NCT00449033|38852957|FG001|Treatment Period|Disease Progression|288|||
16099698|NCT00449033|38852956|FG000|Treatment Period|Consent Withdrawn|36|||
16099699|NCT00449033|38852957|FG001|Treatment Period|Consent Withdrawn|20|||
16099700|NCT00449033|38852956|FG000|Treatment Period|Amended Protocol Criteria|22|||
16099701|NCT00449033|38852957|FG001|Treatment Period|Amended Protocol Criteria|18|||
16099702|NCT00449033|38852956|FG000|Treatment Period|Non-compliance|7|||
16214505|NCT03073200|39265435|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16099703|NCT00449033|38852957|FG001|Treatment Period|Non-compliance|8|||
16099704|NCT00449033|38852956|FG000|Treatment Period|Second Malignancy|0|||
16099705|NCT00449033|38852957|FG001|Treatment Period|Second Malignancy|1|||
16099706|NCT00449033|38852956|FG000|Treatment Period|Reason Missing|0|||
16099707|NCT00449033|38852957|FG001|Treatment Period|Reason Missing|4|||
16099708|NCT00449033|38852956|FG000|Treatment Period|Treatment Ongoing|6|||
16099709|NCT00449033|38852957|FG001|Treatment Period|Treatment Ongoing|4|||
16099710|NCT00449033|38852956|FG000|Follow-up Period|Death|299|||
16099711|NCT00449033|38852957|FG001|Follow-up Period|Death|311|||
16099712|NCT00449033|38852956|FG000|Follow-up Period|Lost to Follow-up|6|||
16099713|NCT00449033|38852957|FG001|Follow-up Period|Lost to Follow-up|10|||
16099714|NCT00449033|38852956|FG000|Follow-up Period|Reason Missing|120|||
16099715|NCT00449033|38852957|FG001|Follow-up Period|Reason Missing|113|||
16099716|NCT02785900|38852958|FG000|Overall Study|Study Termination by Sponsor|64|||
16099717|NCT02785900|38852959|FG001|Overall Study|Study Termination by Sponsor|81|||
16099718|NCT02785900|38852958|FG000|Overall Study|Death|46|||
16099719|NCT02785900|38852959|FG001|Overall Study|Death|32|||
16099720|NCT02785900|38852958|FG000|Overall Study|Withdrawal by Subject|4|||
16099721|NCT02785900|38852959|FG001|Overall Study|Withdrawal by Subject|8|||
16099722|NCT02785900|38852958|FG000|Overall Study|Physician Decision|3|||
16099723|NCT02785900|38852959|FG001|Overall Study|Physician Decision|2|||
16214506|NCT03073200|39265436|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214507|NCT03073200|39265437|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214508|NCT03073200|39265438|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214509|NCT03073200|39265439|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214510|NCT03073200|39265440|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214511|NCT03073200|39265441|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214512|NCT03073200|39265442|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214513|NCT03073200|39265443|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214514|NCT03073200|39265444|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214515|NCT03073200|39265445|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214516|NCT03073200|39265446|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
16214517|NCT03073200|39265447|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16214518|NCT03073200|39265433|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214519|NCT03073200|39265434|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214520|NCT03073200|39265435|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214521|NCT03073200|39265436|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16099724|NCT03356145|38852966|FG000|Overall Study|Withdrawal by Subject|2|||
16099725|NCT03356145|38852967|FG001|Overall Study|Withdrawal by Subject|1|||
16099726|NCT03356145|38852966|FG000|Overall Study|Did not meet inclusion criteria|1|||
16099727|NCT03356145|38852967|FG001|Overall Study|Did not meet inclusion criteria|0|||
16099728|NCT03049306|38852968|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
16214522|NCT03073200|39265437|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214523|NCT03073200|39265438|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214524|NCT03073200|39265439|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214525|NCT03073200|39265440|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214526|NCT03073200|39265441|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214527|NCT03073200|39265442|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214528|NCT03073200|39265443|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214529|NCT03073200|39265444|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214530|NCT03073200|39265445|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214531|NCT03073200|39265446|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
16214532|NCT03073200|39265447|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
16214533|NCT03073200|39265433|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16332341|NCT01877382|39703364|FG007|Dose Escalation|Adverse Event|2|||
16332342|NCT01877382|39703365|FG008|Dose Escalation|Adverse Event|0|||
16332343|NCT01877382|39703366|FG009|Dose Escalation|Adverse Event|0|||
16332344|NCT01877382|39703367|FG010|Dose Escalation|Adverse Event|0|||
16332345|NCT01877382|39703368|FG011|Dose Escalation|Adverse Event|0|||
16332346|NCT01877382|39703369|FG012|Dose Escalation|Adverse Event|1|||
16332347|NCT01877382|39703370|FG013|Dose Escalation|Adverse Event|0|||
16332348|NCT01877382|39703371|FG014|Dose Escalation|Adverse Event|0|||
16332349|NCT01877382|39703357|FG000|Dose Escalation|Withdrawal by Subject|0|||
16332350|NCT01877382|39703358|FG001|Dose Escalation|Withdrawal by Subject|0|||
16332351|NCT01877382|39703359|FG002|Dose Escalation|Withdrawal by Subject|0|||
16332352|NCT01877382|39703360|FG003|Dose Escalation|Withdrawal by Subject|0|||
16332353|NCT01877382|39703361|FG004|Dose Escalation|Withdrawal by Subject|0|||
16332354|NCT01877382|39703362|FG005|Dose Escalation|Withdrawal by Subject|3|||
16332355|NCT01877382|39703363|FG006|Dose Escalation|Withdrawal by Subject|2|||
16332356|NCT01877382|39703364|FG007|Dose Escalation|Withdrawal by Subject|1|||
16332357|NCT01877382|39703365|FG008|Dose Escalation|Withdrawal by Subject|1|||
16332358|NCT01877382|39703366|FG009|Dose Escalation|Withdrawal by Subject|0|||
16332359|NCT01877382|39703367|FG010|Dose Escalation|Withdrawal by Subject|0|||
16332360|NCT01877382|39703368|FG011|Dose Escalation|Withdrawal by Subject|0|||
16099729|NCT03049306|38852969|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
16099730|NCT05109117|38852974|FG000|Overall Study|Lost to Follow-up|1|||
16332361|NCT01877382|39703369|FG012|Dose Escalation|Withdrawal by Subject|0|||
16332362|NCT01877382|39703370|FG013|Dose Escalation|Withdrawal by Subject|0|||
16332363|NCT01877382|39703371|FG014|Dose Escalation|Withdrawal by Subject|0|||
16214534|NCT03073200|39265434|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214535|NCT03073200|39265435|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214536|NCT03073200|39265436|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214537|NCT03073200|39265437|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214538|NCT03073200|39265438|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214539|NCT03073200|39265439|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214540|NCT03073200|39265440|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214541|NCT03073200|39265441|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214542|NCT03073200|39265442|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214543|NCT03073200|39265443|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214544|NCT03073200|39265444|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214545|NCT03073200|39265445|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214546|NCT03073200|39265446|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
16214547|NCT03073200|39265447|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16214548|NCT03073200|39265433|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16214549|NCT03073200|39265434|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16332364|NCT01877382|39703357|FG000|Dose Escalation|Protocol Violation|0|||
16332365|NCT01877382|39703358|FG001|Dose Escalation|Protocol Violation|0|||
16332366|NCT01877382|39703359|FG002|Dose Escalation|Protocol Violation|0|||
16214550|NCT03073200|39265435|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16332367|NCT01877382|39703360|FG003|Dose Escalation|Protocol Violation|0|||
16332368|NCT01877382|39703361|FG004|Dose Escalation|Protocol Violation|0|||
16332369|NCT01877382|39703362|FG005|Dose Escalation|Protocol Violation|0|||
16332370|NCT01877382|39703363|FG006|Dose Escalation|Protocol Violation|1|||
16332371|NCT01877382|39703364|FG007|Dose Escalation|Protocol Violation|0|||
16332372|NCT01877382|39703365|FG008|Dose Escalation|Protocol Violation|0|||
16332373|NCT01877382|39703366|FG009|Dose Escalation|Protocol Violation|0|||
16332374|NCT01877382|39703367|FG010|Dose Escalation|Protocol Violation|0|||
16332375|NCT01877382|39703368|FG011|Dose Escalation|Protocol Violation|0|||
16332376|NCT01877382|39703369|FG012|Dose Escalation|Protocol Violation|0|||
16332377|NCT01877382|39703370|FG013|Dose Escalation|Protocol Violation|0|||
16332378|NCT01877382|39703371|FG014|Dose Escalation|Protocol Violation|0|||
16332379|NCT01877382|39703357|FG000|Dose Escalation|Study terminated by sponsor|0|||
16332380|NCT01877382|39703358|FG001|Dose Escalation|Study terminated by sponsor|0|||
16332381|NCT01877382|39703359|FG002|Dose Escalation|Study terminated by sponsor|0|||
16332382|NCT01877382|39703360|FG003|Dose Escalation|Study terminated by sponsor|0|||
16332383|NCT01877382|39703361|FG004|Dose Escalation|Study terminated by sponsor|0|||
16332384|NCT01877382|39703362|FG005|Dose Escalation|Study terminated by sponsor|0|||
16332385|NCT01877382|39703363|FG006|Dose Escalation|Study terminated by sponsor|0|||
16332386|NCT01877382|39703364|FG007|Dose Escalation|Study terminated by sponsor|1|||
16332387|NCT01877382|39703365|FG008|Dose Escalation|Study terminated by sponsor|1|||
16332388|NCT01877382|39703366|FG009|Dose Escalation|Study terminated by sponsor|0|||
16332389|NCT01877382|39703367|FG010|Dose Escalation|Study terminated by sponsor|0|||
16332390|NCT01877382|39703368|FG011|Dose Escalation|Study terminated by sponsor|0|||
16332391|NCT01877382|39703369|FG012|Dose Escalation|Study terminated by sponsor|3|||
16332392|NCT01877382|39703370|FG013|Dose Escalation|Study terminated by sponsor|0|||
16332393|NCT01877382|39703371|FG014|Dose Escalation|Study terminated by sponsor|0|||
16332394|NCT01877382|39703357|FG000|Dose Escalation|Death|0|||
16332395|NCT01877382|39703358|FG001|Dose Escalation|Death|0|||
16332396|NCT01877382|39703359|FG002|Dose Escalation|Death|0|||
16332397|NCT01877382|39703360|FG003|Dose Escalation|Death|0|||
16332398|NCT01877382|39703361|FG004|Dose Escalation|Death|0|||
16332399|NCT01877382|39703362|FG005|Dose Escalation|Death|0|||
16332400|NCT01877382|39703363|FG006|Dose Escalation|Death|0|||
16332401|NCT01877382|39703364|FG007|Dose Escalation|Death|1|||
16332402|NCT01877382|39703365|FG008|Dose Escalation|Death|0|||
16332403|NCT01877382|39703366|FG009|Dose Escalation|Death|0|||
16332404|NCT01877382|39703367|FG010|Dose Escalation|Death|0|||
16332405|NCT01877382|39703368|FG011|Dose Escalation|Death|0|||
16332406|NCT01877382|39703369|FG012|Dose Escalation|Death|1|||
16332407|NCT01877382|39703370|FG013|Dose Escalation|Death|1|||
16332408|NCT01877382|39703371|FG014|Dose Escalation|Death|0|||
16332409|NCT01877382|39703357|FG000|Dose Expansion|Progressive disease|0|||
16332410|NCT01877382|39703358|FG001|Dose Expansion|Progressive disease|0|||
16332411|NCT01877382|39703359|FG002|Dose Expansion|Progressive disease|0|||
16332412|NCT01877382|39703360|FG003|Dose Expansion|Progressive disease|0|||
16332413|NCT01877382|39703361|FG004|Dose Expansion|Progressive disease|0|||
16332414|NCT01877382|39703362|FG005|Dose Expansion|Progressive disease|0|||
16332415|NCT01877382|39703363|FG006|Dose Expansion|Progressive disease|0|||
16332416|NCT01877382|39703364|FG007|Dose Expansion|Progressive disease|0|||
16332417|NCT01877382|39703365|FG008|Dose Expansion|Progressive disease|0|||
16332418|NCT01877382|39703366|FG009|Dose Expansion|Progressive disease|0|||
16332419|NCT01877382|39703367|FG010|Dose Expansion|Progressive disease|0|||
16332420|NCT01877382|39703368|FG011|Dose Expansion|Progressive disease|0|||
16099731|NCT05109117|38852974|FG000|Overall Study|Discontinued for non-compliance|1|||
16099732|NCT00296504|38852975|FG000|Interim Analysis|Withdrawal by Subject|8|||
16099733|NCT00296504|38852976|FG001|Interim Analysis|Withdrawal by Subject|0|||
16214551|NCT03073200|39265436|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16332421|NCT01877382|39703369|FG012|Dose Expansion|Progressive disease|0|||
16332422|NCT01877382|39703370|FG013|Dose Expansion|Progressive disease|0|||
16332423|NCT01877382|39703371|FG014|Dose Expansion|Progressive disease|11|||
16332424|NCT01877382|39703357|FG000|Dose Expansion|Clinical progression|0|||
16332425|NCT01877382|39703358|FG001|Dose Expansion|Clinical progression|0|||
16332426|NCT01877382|39703359|FG002|Dose Expansion|Clinical progression|0|||
16332427|NCT01877382|39703360|FG003|Dose Expansion|Clinical progression|0|||
16332428|NCT01877382|39703361|FG004|Dose Expansion|Clinical progression|0|||
16332429|NCT01877382|39703362|FG005|Dose Expansion|Clinical progression|0|||
16332430|NCT01877382|39703363|FG006|Dose Expansion|Clinical progression|0|||
16332431|NCT01877382|39703364|FG007|Dose Expansion|Clinical progression|0|||
16332432|NCT01877382|39703365|FG008|Dose Expansion|Clinical progression|0|||
16332433|NCT01877382|39703366|FG009|Dose Expansion|Clinical progression|0|||
16332434|NCT01877382|39703367|FG010|Dose Expansion|Clinical progression|0|||
16332435|NCT01877382|39703368|FG011|Dose Expansion|Clinical progression|0|||
16332436|NCT01877382|39703369|FG012|Dose Expansion|Clinical progression|0|||
16332437|NCT01877382|39703370|FG013|Dose Expansion|Clinical progression|0|||
16332438|NCT01877382|39703371|FG014|Dose Expansion|Clinical progression|6|||
16332439|NCT01877382|39703357|FG000|Dose Expansion|Adverse Event|0|||
16332440|NCT01877382|39703358|FG001|Dose Expansion|Adverse Event|0|||
16332441|NCT01877382|39703359|FG002|Dose Expansion|Adverse Event|0|||
16332442|NCT01877382|39703360|FG003|Dose Expansion|Adverse Event|0|||
16332443|NCT01877382|39703361|FG004|Dose Expansion|Adverse Event|0|||
16332444|NCT01877382|39703362|FG005|Dose Expansion|Adverse Event|0|||
16332445|NCT01877382|39703363|FG006|Dose Expansion|Adverse Event|0|||
16332446|NCT01877382|39703364|FG007|Dose Expansion|Adverse Event|0|||
16332447|NCT01877382|39703365|FG008|Dose Expansion|Adverse Event|0|||
16332448|NCT01877382|39703366|FG009|Dose Expansion|Adverse Event|0|||
16332449|NCT01877382|39703367|FG010|Dose Expansion|Adverse Event|0|||
16332450|NCT01877382|39703368|FG011|Dose Expansion|Adverse Event|0|||
16332451|NCT01877382|39703369|FG012|Dose Expansion|Adverse Event|0|||
16332452|NCT01877382|39703370|FG013|Dose Expansion|Adverse Event|0|||
16531513|NCT00518115|40410214|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
16531514|NCT00518115|40410215|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
16531515|NCT00518115|40410216|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
16531516|NCT00518115|40410217|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
16531517|NCT00518115|40410218|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
16531518|NCT00518115|40410219|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
16531519|NCT00518115|40410220|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
16531520|NCT00518115|40410221|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
16531521|NCT00518115|40410222|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
16531522|NCT00518115|40410223|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
16531523|NCT00518115|40410214|FG000|Overall Study|Wrong Monotherapy Administered|0|||
16531524|NCT00518115|40410215|FG001|Overall Study|Wrong Monotherapy Administered|0|||
16531525|NCT00518115|40410216|FG002|Overall Study|Wrong Monotherapy Administered|1|||
16531526|NCT00518115|40410217|FG003|Overall Study|Wrong Monotherapy Administered|0|||
16531527|NCT00518115|40410218|FG004|Overall Study|Wrong Monotherapy Administered|0|||
16531528|NCT00518115|40410219|FG005|Overall Study|Wrong Monotherapy Administered|0|||
16531529|NCT00518115|40410220|FG006|Overall Study|Wrong Monotherapy Administered|1|||
16531530|NCT00518115|40410221|FG007|Overall Study|Wrong Monotherapy Administered|0|||
16531531|NCT00518115|40410222|FG008|Overall Study|Wrong Monotherapy Administered|0|||
16531532|NCT00518115|40410223|FG009|Overall Study|Wrong Monotherapy Administered|0|||
16531533|NCT00518115|40410214|FG000|Overall Study|Violation of Exclusion Criteria|0|||
16531534|NCT00518115|40410215|FG001|Overall Study|Violation of Exclusion Criteria|0|||
16531535|NCT00518115|40410216|FG002|Overall Study|Violation of Exclusion Criteria|0|||
16531536|NCT00518115|40410217|FG003|Overall Study|Violation of Exclusion Criteria|1|||
16099734|NCT00296504|38852977|FG002|Interim Analysis|Withdrawal by Subject|12|||
16099735|NCT00296504|38852978|FG003|Interim Analysis|Withdrawal by Subject|0|||
16332453|NCT01877382|39703371|FG014|Dose Expansion|Adverse Event|1|||
16332454|NCT01877382|39703357|FG000|Dose Expansion|Death|0|||
16332455|NCT01877382|39703358|FG001|Dose Expansion|Death|0|||
16332456|NCT01877382|39703359|FG002|Dose Expansion|Death|0|||
16332457|NCT01877382|39703360|FG003|Dose Expansion|Death|0|||
16332458|NCT01877382|39703361|FG004|Dose Expansion|Death|0|||
16332459|NCT01877382|39703362|FG005|Dose Expansion|Death|0|||
16332460|NCT01877382|39703363|FG006|Dose Expansion|Death|0|||
16531537|NCT00518115|40410218|FG004|Overall Study|Violation of Exclusion Criteria|0|||
16531538|NCT00518115|40410219|FG005|Overall Study|Violation of Exclusion Criteria|0|||
16401595|NCT02589665|39953596|FG009|Induction Extension Period|Lack of Efficacy|0|||
16401596|NCT02589665|39953587|FG000|Induction Extension Period|Withdrawal by Subject|0|||
16401597|NCT02589665|39953588|FG001|Induction Extension Period|Withdrawal by Subject|0|||
16401598|NCT02589665|39953589|FG002|Induction Extension Period|Withdrawal by Subject|0|||
16401599|NCT02589665|39953590|FG003|Induction Extension Period|Withdrawal by Subject|0|||
16401600|NCT02589665|39953591|FG004|Induction Extension Period|Withdrawal by Subject|0|||
16099736|NCT00296504|38852979|FG004|Interim Analysis|Withdrawal by Subject|5|||
16401601|NCT02589665|39953592|FG005|Induction Extension Period|Withdrawal by Subject|0|||
16401602|NCT02589665|39953593|FG006|Induction Extension Period|Withdrawal by Subject|0|||
16214552|NCT03073200|39265437|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16332461|NCT01877382|39703364|FG007|Dose Expansion|Death|0|||
16332462|NCT01877382|39703365|FG008|Dose Expansion|Death|0|||
16332463|NCT01877382|39703366|FG009|Dose Expansion|Death|0|||
16332464|NCT01877382|39703367|FG010|Dose Expansion|Death|0|||
16332465|NCT01877382|39703368|FG011|Dose Expansion|Death|0|||
16332466|NCT01877382|39703369|FG012|Dose Expansion|Death|0|||
16332467|NCT01877382|39703370|FG013|Dose Expansion|Death|0|||
16332468|NCT01877382|39703371|FG014|Dose Expansion|Death|1|||
16332469|NCT01877382|39703357|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332470|NCT01877382|39703358|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332471|NCT01877382|39703359|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332472|NCT01877382|39703360|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332473|NCT01877382|39703361|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332474|NCT01877382|39703362|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332475|NCT01877382|39703363|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332476|NCT01877382|39703364|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16401603|NCT02589665|39953594|FG007|Induction Extension Period|Withdrawal by Subject|2|||
16401604|NCT02589665|39953595|FG008|Induction Extension Period|Withdrawal by Subject|3|||
16401605|NCT02589665|39953596|FG009|Induction Extension Period|Withdrawal by Subject|0|||
16401606|NCT02589665|39953587|FG000|Induction Extension Period|Physician Decision|0|||
16401607|NCT02589665|39953588|FG001|Induction Extension Period|Physician Decision|0|||
16401608|NCT02589665|39953589|FG002|Induction Extension Period|Physician Decision|0|||
16401609|NCT02589665|39953590|FG003|Induction Extension Period|Physician Decision|0|||
16401610|NCT02589665|39953591|FG004|Induction Extension Period|Physician Decision|0|||
16401611|NCT02589665|39953592|FG005|Induction Extension Period|Physician Decision|0|||
16401612|NCT02589665|39953593|FG006|Induction Extension Period|Physician Decision|0|||
16401613|NCT02589665|39953594|FG007|Induction Extension Period|Physician Decision|0|||
16401614|NCT02589665|39953595|FG008|Induction Extension Period|Physician Decision|1|||
16401615|NCT02589665|39953596|FG009|Induction Extension Period|Physician Decision|0|||
16401616|NCT02589665|39953587|FG000|Induction Extension Period|Reason Not Collected|0|||
16401617|NCT02589665|39953588|FG001|Induction Extension Period|Reason Not Collected|0|||
16401618|NCT02589665|39953589|FG002|Induction Extension Period|Reason Not Collected|0|||
16401619|NCT02589665|39953590|FG003|Induction Extension Period|Reason Not Collected|0|||
16531539|NCT00518115|40410220|FG006|Overall Study|Violation of Exclusion Criteria|1|||
16531540|NCT00518115|40410221|FG007|Overall Study|Violation of Exclusion Criteria|0|||
16531541|NCT00518115|40410222|FG008|Overall Study|Violation of Exclusion Criteria|0|||
16531542|NCT00518115|40410223|FG009|Overall Study|Violation of Exclusion Criteria|0|||
16531543|NCT00518115|40410214|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
16531544|NCT00518115|40410215|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
16531545|NCT00518115|40410216|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
16531546|NCT00518115|40410217|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
16531547|NCT00518115|40410218|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
16531548|NCT00518115|40410219|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
16531549|NCT00518115|40410220|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
16531550|NCT00518115|40410221|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
16531551|NCT00518115|40410222|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
16531552|NCT00518115|40410223|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
16531553|NCT00518115|40410214|FG000|Overall Study|Withdrew Consent|0|||
16531554|NCT00518115|40410215|FG001|Overall Study|Withdrew Consent|0|||
16531555|NCT00518115|40410216|FG002|Overall Study|Withdrew Consent|0|||
16531556|NCT00518115|40410217|FG003|Overall Study|Withdrew Consent|0|||
16531557|NCT00518115|40410218|FG004|Overall Study|Withdrew Consent|0|||
16531558|NCT00518115|40410219|FG005|Overall Study|Withdrew Consent|1|||
16531559|NCT00518115|40410220|FG006|Overall Study|Withdrew Consent|0|||
16531560|NCT00518115|40410221|FG007|Overall Study|Withdrew Consent|0|||
16531561|NCT00518115|40410222|FG008|Overall Study|Withdrew Consent|0|||
16531562|NCT00518115|40410223|FG009|Overall Study|Withdrew Consent|0|||
16531563|NCT00518115|40410214|FG000|Overall Study|Moved Out of State|0|||
16531564|NCT00518115|40410215|FG001|Overall Study|Moved Out of State|0|||
16531565|NCT00518115|40410216|FG002|Overall Study|Moved Out of State|0|||
16531566|NCT00518115|40410217|FG003|Overall Study|Moved Out of State|0|||
16531567|NCT00518115|40410218|FG004|Overall Study|Moved Out of State|0|||
16531568|NCT00518115|40410219|FG005|Overall Study|Moved Out of State|0|||
16531569|NCT00518115|40410220|FG006|Overall Study|Moved Out of State|0|||
16531570|NCT00518115|40410221|FG007|Overall Study|Moved Out of State|0|||
16531571|NCT00518115|40410222|FG008|Overall Study|Moved Out of State|0|||
16531572|NCT00518115|40410223|FG009|Overall Study|Moved Out of State|1|||
16531573|NCT02864082|40410224|FG000|Overall Study|Adverse Event|1|||
16531574|NCT02864082|40410225|FG001|Overall Study|Adverse Event|1|||
16531575|NCT02864082|40410224|FG000|Overall Study|Lost to Follow-up|0|||
16531576|NCT02864082|40410225|FG001|Overall Study|Lost to Follow-up|1|||
16531577|NCT02864082|40410224|FG000|Overall Study|Withdrawal by Subject|2|||
16531578|NCT02864082|40410225|FG001|Overall Study|Withdrawal by Subject|2|||
16531579|NCT02119416|40410232|FG000|Overall Study|Protocol Violation|1|||
16099737|NCT00296504|38852980|FG005|Interim Analysis|Withdrawal by Subject|5|||
16099738|NCT00296504|38852981|FG006|Interim Analysis|Withdrawal by Subject|9|||
16099739|NCT00296504|38852982|FG007|Interim Analysis|Withdrawal by Subject|3|||
16332477|NCT01877382|39703365|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332478|NCT01877382|39703366|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332479|NCT01877382|39703367|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332480|NCT01877382|39703368|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332481|NCT01877382|39703369|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332482|NCT01877382|39703370|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
16332483|NCT01877382|39703371|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
16332484|NCT02258542|39703374|FG000|Overall Study|eg. not made to the visit|7|||
16332485|NCT02258542|39703375|FG001|Overall Study|eg. not made to the visit|4|||
16332486|NCT02258542|39703376|FG002|Overall Study|eg. not made to the visit|0|||
16332487|NCT02258542|39703377|FG003|Overall Study|eg. not made to the visit|1|||
16332488|NCT02258542|39703374|FG000|Overall Study|study specific discount. criteria|1|||
16332489|NCT02258542|39703375|FG001|Overall Study|study specific discount. criteria|1|||
16332490|NCT02258542|39703376|FG002|Overall Study|study specific discount. criteria|0|||
16332491|NCT02258542|39703377|FG003|Overall Study|study specific discount. criteria|0|||
16531580|NCT02119416|40410233|FG001|Overall Study|Protocol Violation|1|||
16531581|NCT02119416|40410234|FG002|Overall Study|Protocol Violation|1|||
16531582|NCT02119416|40410232|FG000|Overall Study|wrong pubertal stage|1|||
16531583|NCT02119416|40410233|FG001|Overall Study|wrong pubertal stage|0|||
16531584|NCT02119416|40410234|FG002|Overall Study|wrong pubertal stage|1|||
16531585|NCT00626522|40410235|FG000|Overall Study|Protocol Violation|0|||
16531586|NCT00626522|40410236|FG001|Overall Study|Protocol Violation|0|||
16531587|NCT00626522|40410237|FG002|Overall Study|Protocol Violation|0|||
16531588|NCT00626522|40410238|FG003|Overall Study|Protocol Violation|0|||
16531589|NCT00626522|40410239|FG004|Overall Study|Protocol Violation|1|||
16531590|NCT00626522|40410240|FG005|Overall Study|Protocol Violation|0|||
16531591|NCT00626522|40410235|FG000|Overall Study|Adverse Event|2|||
16531592|NCT00626522|40410236|FG001|Overall Study|Adverse Event|1|||
16531593|NCT00626522|40410237|FG002|Overall Study|Adverse Event|2|||
16531594|NCT00626522|40410238|FG003|Overall Study|Adverse Event|0|||
16531595|NCT00626522|40410239|FG004|Overall Study|Adverse Event|1|||
16531596|NCT00626522|40410240|FG005|Overall Study|Adverse Event|1|||
16099740|NCT00296504|38852983|FG008|Interim Analysis|Withdrawal by Subject|0|||
16332492|NCT02258542|39703374|FG000|Overall Study|Withdrawal by Subject|20|||
16332493|NCT02258542|39703375|FG001|Overall Study|Withdrawal by Subject|20|||
16332494|NCT02258542|39703376|FG002|Overall Study|Withdrawal by Subject|7|||
16332495|NCT02258542|39703377|FG003|Overall Study|Withdrawal by Subject|1|||
16332496|NCT02258542|39703374|FG000|Overall Study|Lost to Follow-up|5|||
16332497|NCT02258542|39703375|FG001|Overall Study|Lost to Follow-up|12|||
16332498|NCT02258542|39703376|FG002|Overall Study|Lost to Follow-up|1|||
16332499|NCT02258542|39703377|FG003|Overall Study|Lost to Follow-up|2|||
16332500|NCT02258542|39703374|FG000|Overall Study|Death|5|||
16332501|NCT02258542|39703375|FG001|Overall Study|Death|4|||
16332502|NCT02258542|39703376|FG002|Overall Study|Death|0|||
16332503|NCT02258542|39703377|FG003|Overall Study|Death|1|||
16332504|NCT02258542|39703374|FG000|Overall Study|Adverse Event|3|||
16332505|NCT02258542|39703375|FG001|Overall Study|Adverse Event|4|||
16332506|NCT02258542|39703376|FG002|Overall Study|Adverse Event|0|||
16332507|NCT02258542|39703377|FG003|Overall Study|Adverse Event|0|||
16332508|NCT02258542|39703374|FG000|Overall Study|Protocol Violation|1|||
16531597|NCT00626522|40410235|FG000|Overall Study|Withdrawal by Subject|2|||
16531598|NCT00626522|40410236|FG001|Overall Study|Withdrawal by Subject|5|||
16531599|NCT00626522|40410237|FG002|Overall Study|Withdrawal by Subject|5|||
16531600|NCT00626522|40410238|FG003|Overall Study|Withdrawal by Subject|0|||
16531601|NCT00626522|40410239|FG004|Overall Study|Withdrawal by Subject|4|||
16531602|NCT00626522|40410240|FG005|Overall Study|Withdrawal by Subject|1|||
16099741|NCT00296504|38852975|FG000|Interim Analysis|Lost to Follow-up|13|||
16099742|NCT00296504|38852976|FG001|Interim Analysis|Lost to Follow-up|3|||
16099743|NCT00296504|38852977|FG002|Interim Analysis|Lost to Follow-up|26|||
16099744|NCT00296504|38852978|FG003|Interim Analysis|Lost to Follow-up|8|||
16099745|NCT00296504|38852979|FG004|Interim Analysis|Lost to Follow-up|14|||
16099746|NCT00296504|38852980|FG005|Interim Analysis|Lost to Follow-up|4|||
16099747|NCT00296504|38852981|FG006|Interim Analysis|Lost to Follow-up|11|||
16099748|NCT00296504|38852982|FG007|Interim Analysis|Lost to Follow-up|4|||
16099749|NCT00296504|38852983|FG008|Interim Analysis|Lost to Follow-up|0|||
16099750|NCT00296504|38852975|FG000|Interim Analysis|Clinical Progression|1|||
16099751|NCT00296504|38852976|FG001|Interim Analysis|Clinical Progression|0|||
16099752|NCT00296504|38852977|FG002|Interim Analysis|Clinical Progression|1|||
16099753|NCT00296504|38852978|FG003|Interim Analysis|Clinical Progression|1|||
16099754|NCT00296504|38852979|FG004|Interim Analysis|Clinical Progression|0|||
16099755|NCT00296504|38852980|FG005|Interim Analysis|Clinical Progression|2|||
16099756|NCT00296504|38852981|FG006|Interim Analysis|Clinical Progression|1|||
16099757|NCT00296504|38852982|FG007|Interim Analysis|Clinical Progression|2|||
16099758|NCT00296504|38852983|FG008|Interim Analysis|Clinical Progression|0|||
16099759|NCT00296504|38852975|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
16099760|NCT00296504|38852976|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
16099761|NCT00296504|38852977|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
16099762|NCT00296504|38852978|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
16099763|NCT00296504|38852979|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
16099764|NCT00296504|38852980|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
16099765|NCT00296504|38852981|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
16099766|NCT00296504|38852982|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
16099767|NCT00296504|38852983|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
16099768|NCT00296504|38852975|FG000|Interim Analysis|Adverse Event|0|||
16099769|NCT00296504|38852976|FG001|Interim Analysis|Adverse Event|0|||
16099770|NCT00296504|38852977|FG002|Interim Analysis|Adverse Event|13|||
16214553|NCT03073200|39265438|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16099771|NCT00296504|38852978|FG003|Interim Analysis|Adverse Event|4|||
16099772|NCT00296504|38852979|FG004|Interim Analysis|Adverse Event|6|||
16099773|NCT00296504|38852980|FG005|Interim Analysis|Adverse Event|3|||
16099774|NCT00296504|38852981|FG006|Interim Analysis|Adverse Event|4|||
16099775|NCT00296504|38852982|FG007|Interim Analysis|Adverse Event|5|||
16099776|NCT00296504|38852983|FG008|Interim Analysis|Adverse Event|0|||
16099777|NCT00296504|38852975|FG000|Interim Analysis|Protocol Violation|0|||
16531603|NCT00626522|40410235|FG000|Overall Study|COPD exacerbation|0|||
16531604|NCT00626522|40410236|FG001|Overall Study|COPD exacerbation|0|||
16531605|NCT00626522|40410237|FG002|Overall Study|COPD exacerbation|0|||
16531606|NCT00626522|40410238|FG003|Overall Study|COPD exacerbation|1|||
16531607|NCT00626522|40410239|FG004|Overall Study|COPD exacerbation|1|||
16531608|NCT00626522|40410240|FG005|Overall Study|COPD exacerbation|0|||
16531609|NCT00626522|40410235|FG000|Overall Study|Lost to Follow-up|0|||
16531610|NCT00626522|40410236|FG001|Overall Study|Lost to Follow-up|1|||
16531611|NCT00626522|40410237|FG002|Overall Study|Lost to Follow-up|0|||
16531612|NCT00626522|40410238|FG003|Overall Study|Lost to Follow-up|0|||
16531613|NCT00626522|40410239|FG004|Overall Study|Lost to Follow-up|0|||
16531614|NCT00626522|40410240|FG005|Overall Study|Lost to Follow-up|0|||
16531615|NCT00626522|40410235|FG000|Overall Study|Inconsistent reason reported|1|||
16531616|NCT00626522|40410236|FG001|Overall Study|Inconsistent reason reported|0|||
16531617|NCT00626522|40410237|FG002|Overall Study|Inconsistent reason reported|0|||
16531618|NCT00626522|40410238|FG003|Overall Study|Inconsistent reason reported|0|||
16531619|NCT00626522|40410239|FG004|Overall Study|Inconsistent reason reported|0|||
16531620|NCT00626522|40410240|FG005|Overall Study|Inconsistent reason reported|0|||
16531621|NCT00626522|40410235|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
16531622|NCT00626522|40410236|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
16531623|NCT00626522|40410237|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
16531624|NCT00626522|40410238|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
16531625|NCT00626522|40410239|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
16531626|NCT00626522|40410240|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
16531627|NCT04137380|40410241|FG000|Overall Study|Physician Decision|0|||
16531628|NCT04137380|40410242|FG001|Overall Study|Physician Decision|0|||
16531629|NCT04137380|40410243|FG002|Overall Study|Physician Decision|0|||
16531630|NCT04137380|40410244|FG003|Overall Study|Physician Decision|1|||
16531631|NCT04137380|40410245|FG004|Overall Study|Physician Decision|0|||
16531632|NCT04137380|40410246|FG005|Overall Study|Physician Decision|0|||
16531633|NCT04137380|40410247|FG006|Overall Study|Physician Decision|0|||
16531634|NCT04786444|40410248|FG000|Overall Study|Withdrawal by Subject|4|||
16332509|NCT02258542|39703375|FG001|Overall Study|Protocol Violation|2|||
16332510|NCT02258542|39703376|FG002|Overall Study|Protocol Violation|0|||
16332511|NCT02258542|39703377|FG003|Overall Study|Protocol Violation|0|||
16332512|NCT02258542|39703374|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16332513|NCT02258542|39703375|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
16332514|NCT02258542|39703376|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
16332515|NCT02258542|39703377|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
16332516|NCT00672841|39703378|FG000|Overall Study|Comfort care|1|||
16332517|NCT00672841|39703379|FG001|Overall Study|Comfort care|4|||
16332518|NCT00672841|39703378|FG000|Overall Study|icteric specimens|0|||
16332519|NCT00672841|39703379|FG001|Overall Study|icteric specimens|3|||
16332520|NCT00672841|39703378|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
16332521|NCT00672841|39703379|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
16332522|NCT00672841|39703378|FG000|Overall Study|Adverse Event|0|||
16332523|NCT00672841|39703379|FG001|Overall Study|Adverse Event|3|||
16332524|NCT00672841|39703378|FG000|Overall Study|Pregnancy|0|||
16332525|NCT00672841|39703379|FG001|Overall Study|Pregnancy|1|||
16332526|NCT00803205|39703380|FG000|Overall Study|Adverse Event|7|||
16332527|NCT00803205|39703381|FG001|Overall Study|Adverse Event|2|||
16332528|NCT00803205|39703380|FG000|Overall Study|Lost to Follow-up|1|||
16531635|NCT04786444|40410249|FG001|Overall Study|Withdrawal by Subject|7|||
16531636|NCT04786444|40410250|FG002|Overall Study|Withdrawal by Subject|2|||
16531637|NCT04786444|40410248|FG000|Overall Study|Lost to Follow-up|11|||
16531638|NCT04786444|40410249|FG001|Overall Study|Lost to Follow-up|9|||
16531639|NCT04786444|40410250|FG002|Overall Study|Lost to Follow-up|10|||
16531640|NCT04786444|40410248|FG000|Overall Study|Subject would like to become pregnant|0|||
16531641|NCT04786444|40410249|FG001|Overall Study|Subject would like to become pregnant|1|||
16531642|NCT04786444|40410250|FG002|Overall Study|Subject would like to become pregnant|0|||
16531643|NCT02682264|40410251|FG000|Overall Study|Withdrawal by Subject|56|||
16531644|NCT02682264|40410252|FG001|Overall Study|Withdrawal by Subject|45|||
16531645|NCT02682264|40410251|FG000|Overall Study|Lost to Follow-up|49|||
16531646|NCT02682264|40410252|FG001|Overall Study|Lost to Follow-up|41|||
16332529|NCT00803205|39703381|FG001|Overall Study|Lost to Follow-up|0|||
16332530|NCT00803205|39703380|FG000|Overall Study|Withdrawal by Subject|9|||
16332531|NCT00803205|39703381|FG001|Overall Study|Withdrawal by Subject|9|||
16332532|NCT00803205|39703380|FG000|Overall Study|Physician Decision|1|||
16332533|NCT00803205|39703381|FG001|Overall Study|Physician Decision|0|||
16332534|NCT00803205|39703380|FG000|Overall Study|Protocol Violation|1|||
16332535|NCT00803205|39703381|FG001|Overall Study|Protocol Violation|1|||
16332536|NCT00803205|39703380|FG000|Overall Study|Medical Monitor Decision|1|||
16332537|NCT00803205|39703381|FG001|Overall Study|Medical Monitor Decision|0|||
16332538|NCT00803205|39703380|FG000|Overall Study|Acquired a Lung Infection|0|||
16332539|NCT00803205|39703381|FG001|Overall Study|Acquired a Lung Infection|1|||
16332540|NCT00803205|39703380|FG000|Overall Study|Sponsor Decision|0|||
16531647|NCT02682264|40410251|FG000|Overall Study|Lack of Efficacy|14|||
16531648|NCT02682264|40410252|FG001|Overall Study|Lack of Efficacy|16|||
16531649|NCT02682264|40410251|FG000|Overall Study|Withdrawal by Parent|6|||
16531650|NCT02682264|40410252|FG001|Overall Study|Withdrawal by Parent|7|||
16531651|NCT02682264|40410251|FG000|Overall Study|Adverse Event|9|||
16531652|NCT02682264|40410252|FG001|Overall Study|Adverse Event|0|||
16531653|NCT02682264|40410251|FG000|Overall Study|Noncompliance with study drug|1|||
16531654|NCT02682264|40410252|FG001|Overall Study|Noncompliance with study drug|4|||
16531655|NCT02682264|40410251|FG000|Overall Study|Pregnancy|1|||
16531656|NCT02682264|40410252|FG001|Overall Study|Pregnancy|2|||
16531657|NCT02682264|40410251|FG000|Overall Study|Recovery|1|||
16531658|NCT02682264|40410252|FG001|Overall Study|Recovery|2|||
16531659|NCT02682264|40410251|FG000|Overall Study|Progressive Disease|1|||
16531660|NCT02682264|40410252|FG001|Overall Study|Progressive Disease|0|||
16531661|NCT02682264|40410251|FG000|Overall Study|Technical Problems|0|||
16531662|NCT02682264|40410252|FG001|Overall Study|Technical Problems|1|||
16531663|NCT02682264|40410251|FG000|Overall Study|Moved abroad and unable to continue|0|||
16531664|NCT02682264|40410252|FG001|Overall Study|Moved abroad and unable to continue|3|||
16531665|NCT02682264|40410251|FG000|Overall Study|Stopped test article application|0|||
16531666|NCT02682264|40410252|FG001|Overall Study|Stopped test article application|1|||
16531667|NCT00454051|40410253|FG000|Overall Study|Adverse Event|1|||
16332541|NCT00803205|39703381|FG001|Overall Study|Sponsor Decision|1|||
16531668|NCT00454051|40410254|FG001|Overall Study|Adverse Event|2|||
16531669|NCT00454051|40410253|FG000|Overall Study|Withdrawal by Subject|1|||
16332542|NCT03535194|39703382|FG000|Induction Period|Adverse Event|2|||
16332543|NCT03535194|39703383|FG001|Induction Period|Adverse Event|2|||
16332544|NCT03535194|39703384|FG002|Induction Period|Adverse Event|1|||
16531670|NCT00454051|40410254|FG001|Overall Study|Withdrawal by Subject|0|||
16531671|NCT00454051|40410253|FG000|Overall Study|Protocol Violation|1|||
16531672|NCT00454051|40410254|FG001|Overall Study|Protocol Violation|1|||
16531673|NCT00843167|40410255|FG000|Treatment Period|Adverse Event|1|||
16531674|NCT00843167|40410256|FG001|Treatment Period|Adverse Event|5|||
16531675|NCT00843167|40410255|FG000|Treatment Period|Withdrawal by Subject|2|||
16531676|NCT00843167|40410256|FG001|Treatment Period|Withdrawal by Subject|3|||
16531677|NCT03422250|40410261|FG000|Intervention|Adverse Event|0|||
16531678|NCT03422250|40410262|FG001|Intervention|Adverse Event|1|||
16531679|NCT03422250|40410263|FG002|Intervention|Adverse Event|0|||
16531680|NCT03422250|40410264|FG003|Intervention|Adverse Event|1|||
16531681|NCT03422250|40410261|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
16531682|NCT03422250|40410262|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
16531683|NCT03422250|40410263|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
16531684|NCT03422250|40410264|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
16531685|NCT03422250|40410261|FG000|Follow-up|Withdrawal by Subject|0|||
16332545|NCT03535194|39703385|FG003|Induction Period|Adverse Event|3|||
16332546|NCT03535194|39703386|FG004|Induction Period|Adverse Event|0|||
16332547|NCT03535194|39703382|FG000|Induction Period|Death|0|||
16332548|NCT03535194|39703383|FG001|Induction Period|Death|1|||
16332549|NCT03535194|39703384|FG002|Induction Period|Death|0|||
16332550|NCT03535194|39703385|FG003|Induction Period|Death|0|||
16332551|NCT03535194|39703386|FG004|Induction Period|Death|0|||
16332552|NCT03535194|39703382|FG000|Induction Period|Lack of Efficacy|1|||
16332553|NCT03535194|39703383|FG001|Induction Period|Lack of Efficacy|3|||
16332554|NCT03535194|39703384|FG002|Induction Period|Lack of Efficacy|2|||
16401620|NCT02589665|39953591|FG004|Induction Extension Period|Reason Not Collected|0|||
16401621|NCT02589665|39953592|FG005|Induction Extension Period|Reason Not Collected|0|||
16401622|NCT02589665|39953593|FG006|Induction Extension Period|Reason Not Collected|0|||
16401623|NCT02589665|39953594|FG007|Induction Extension Period|Reason Not Collected|0|||
16401624|NCT02589665|39953595|FG008|Induction Extension Period|Reason Not Collected|1|||
16531686|NCT03422250|40410262|FG001|Follow-up|Withdrawal by Subject|0|||
16531687|NCT03422250|40410263|FG002|Follow-up|Withdrawal by Subject|0|||
16531688|NCT03422250|40410264|FG003|Follow-up|Withdrawal by Subject|1|||
16531689|NCT03422250|40410261|FG000|Follow-up|Adverse Event|0|||
16531690|NCT03422250|40410262|FG001|Follow-up|Adverse Event|0|||
16531691|NCT03422250|40410263|FG002|Follow-up|Adverse Event|0|||
16531692|NCT03422250|40410264|FG003|Follow-up|Adverse Event|1|||
16531693|NCT02576067|40410265|FG000|Overall Study|Death|0|||
16531694|NCT02576067|40410266|FG001|Overall Study|Death|1|||
16531695|NCT02576067|40410265|FG000|Overall Study|Lack of Efficacy|1|||
16531696|NCT02576067|40410266|FG001|Overall Study|Lack of Efficacy|0|||
16531697|NCT02576067|40410265|FG000|Overall Study|Lost to Follow-up|11|||
16531698|NCT02576067|40410266|FG001|Overall Study|Lost to Follow-up|0|||
16531699|NCT02576067|40410265|FG000|Overall Study|Withdrawal by Subject|11|||
16531700|NCT02576067|40410266|FG001|Overall Study|Withdrawal by Subject|2|||
16531701|NCT02576067|40410265|FG000|Overall Study|study closure of main CIRT trial)|0|||
16531702|NCT02576067|40410266|FG001|Overall Study|study closure of main CIRT trial)|8|||
16531703|NCT02576067|40410265|FG000|Overall Study|not randomized, failed run-in|7|||
16531704|NCT02576067|40410266|FG001|Overall Study|not randomized, failed run-in|0|||
16531705|NCT02576067|40410265|FG000|Overall Study|screen failure/ re-enrolled|0|||
16531706|NCT02576067|40410266|FG001|Overall Study|screen failure/ re-enrolled|25|||
16332555|NCT03535194|39703385|FG003|Induction Period|Lack of Efficacy|2|||
16401625|NCT02589665|39953596|FG009|Induction Extension Period|Reason Not Collected|0|||
16401626|NCT02589665|39953587|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401627|NCT02589665|39953588|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401628|NCT02589665|39953589|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401629|NCT02589665|39953590|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401630|NCT02589665|39953591|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401631|NCT02589665|39953592|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401632|NCT02589665|39953593|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401633|NCT02589665|39953594|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401634|NCT02589665|39953595|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
16401635|NCT02589665|39953596|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
16332556|NCT03535194|39703386|FG004|Induction Period|Lack of Efficacy|0|||
16332557|NCT03535194|39703382|FG000|Induction Period|Lost to Follow-up|3|||
16332558|NCT03535194|39703383|FG001|Induction Period|Lost to Follow-up|5|||
16332559|NCT03535194|39703384|FG002|Induction Period|Lost to Follow-up|2|||
16332560|NCT03535194|39703385|FG003|Induction Period|Lost to Follow-up|3|||
16531707|NCT02576067|40410265|FG000|Overall Study|Physician Decision|4|||
16531708|NCT02576067|40410266|FG001|Overall Study|Physician Decision|0|||
16531709|NCT01154166|40413680|FG000|Overall Study|Adverse Event|14|||
16531710|NCT01154166|40413681|FG001|Overall Study|Adverse Event|9|||
16332561|NCT03535194|39703386|FG004|Induction Period|Lost to Follow-up|0|||
16531711|NCT01154166|40413680|FG000|Overall Study|Lost to Follow-up|1|||
16531712|NCT01154166|40413681|FG001|Overall Study|Lost to Follow-up|1|||
16531713|NCT01154166|40413680|FG000|Overall Study|Protocol Violation|4|||
16531714|NCT01154166|40413681|FG001|Overall Study|Protocol Violation|1|||
16531715|NCT01154166|40413680|FG000|Overall Study|Withdrawal by Subject|10|||
16531716|NCT01154166|40413681|FG001|Overall Study|Withdrawal by Subject|1|||
16531717|NCT01154166|40413680|FG000|Overall Study|Lack of Efficacy|3|||
16531718|NCT01154166|40413681|FG001|Overall Study|Lack of Efficacy|0|||
16531719|NCT01154166|40413680|FG000|Overall Study|Disease Progression|1|||
16531720|NCT01154166|40413681|FG001|Overall Study|Disease Progression|0|||
16531721|NCT01154166|40413680|FG000|Overall Study|Poor Compliance|1|||
16531722|NCT01154166|40413681|FG001|Overall Study|Poor Compliance|0|||
16531723|NCT01474681|40413682|FG000|Overall Study|Death|0|||
16531724|NCT01474681|40413683|FG001|Overall Study|Death|3|||
16531725|NCT01474681|40413684|FG002|Overall Study|Death|2|||
16531726|NCT01474681|40413685|FG003|Overall Study|Death|6|||
16531727|NCT00489970|40413689|FG000|Persistence Year 9|Lost to Follow-up|2|||
16531728|NCT00489970|40413690|FG001|Persistence Year 9|Lost to Follow-up|2|||
16531729|NCT00489970|40413691|FG002|Persistence Year 9|Lost to Follow-up|3|||
16531730|NCT00489970|40413689|FG000|Persistence Year 9|Other|1|||
16531731|NCT00489970|40413690|FG001|Persistence Year 9|Other|0|||
16531732|NCT00489970|40413691|FG002|Persistence Year 9|Other|2|||
16531733|NCT03031938|40413692|FG000|Overall Study|Death|1|||
16531734|NCT03031938|40413693|FG001|Overall Study|Death|0|||
16531735|NCT00896168|40413694|FG000|Overall Study|Adverse Event|4|||
16531736|NCT00896168|40413695|FG001|Overall Study|Adverse Event|7|||
16531737|NCT00896168|40413694|FG000|Overall Study|Treatment failure|8|||
16332562|NCT03535194|39703382|FG000|Induction Period|Physician Decision|1|||
16332563|NCT03535194|39703383|FG001|Induction Period|Physician Decision|1|||
16332564|NCT03535194|39703384|FG002|Induction Period|Physician Decision|0|||
16332565|NCT03535194|39703385|FG003|Induction Period|Physician Decision|0|||
16332566|NCT03535194|39703386|FG004|Induction Period|Physician Decision|0|||
16332567|NCT03535194|39703382|FG000|Induction Period|Protocol Violation|1|||
16332568|NCT03535194|39703383|FG001|Induction Period|Protocol Violation|0|||
16332569|NCT03535194|39703384|FG002|Induction Period|Protocol Violation|0|||
16332570|NCT03535194|39703385|FG003|Induction Period|Protocol Violation|1|||
16332571|NCT03535194|39703386|FG004|Induction Period|Protocol Violation|0|||
16332572|NCT03535194|39703382|FG000|Induction Period|Screen Failure|0|||
16332573|NCT03535194|39703383|FG001|Induction Period|Screen Failure|1|||
16332574|NCT03535194|39703384|FG002|Induction Period|Screen Failure|0|||
16332575|NCT03535194|39703385|FG003|Induction Period|Screen Failure|0|||
16401636|NCT02589665|39953587|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
16401637|NCT02589665|39953588|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
16214554|NCT03073200|39265439|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16401638|NCT02589665|39953589|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
16401639|NCT02589665|39953590|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
16401640|NCT02589665|39953591|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
16401641|NCT02589665|39953592|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
16401642|NCT02589665|39953593|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
16401643|NCT02589665|39953594|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
16401644|NCT02589665|39953595|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
16401645|NCT02589665|39953596|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
16401646|NCT02589665|39953587|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
16401647|NCT02589665|39953588|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
16401648|NCT02589665|39953589|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
16401649|NCT02589665|39953590|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
16401650|NCT02589665|39953591|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
16401651|NCT02589665|39953592|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
16401652|NCT02589665|39953593|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
16401653|NCT02589665|39953594|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
16401654|NCT02589665|39953595|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
16401655|NCT02589665|39953596|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
16332576|NCT03535194|39703386|FG004|Induction Period|Screen Failure|0|||
16531738|NCT00896168|40413695|FG001|Overall Study|Treatment failure|10|||
16401656|NCT02589665|39953587|FG000|Maintenance Extension Period|Adverse Event|0|||
16401657|NCT02589665|39953588|FG001|Maintenance Extension Period|Adverse Event|0|||
16401658|NCT02589665|39953589|FG002|Maintenance Extension Period|Adverse Event|0|||
16531739|NCT00896168|40413694|FG000|Overall Study|Lost to Follow-up|1|||
16531740|NCT00896168|40413695|FG001|Overall Study|Lost to Follow-up|1|||
16332577|NCT03535194|39703382|FG000|Induction Period|Withdrawal by Subject|3|||
16332578|NCT03535194|39703383|FG001|Induction Period|Withdrawal by Subject|4|||
16531741|NCT00896168|40413694|FG000|Overall Study|Other|1|||
16531742|NCT00896168|40413695|FG001|Overall Study|Other|1|||
16531743|NCT01026974|40413696|FG000|Overall Study|Withdrawal by Subject|0|||
16531744|NCT01026974|40413697|FG001|Overall Study|Withdrawal by Subject|1|||
16531745|NCT01026974|40413698|FG002|Overall Study|Withdrawal by Subject|7|||
16531746|NCT01026974|40413699|FG003|Overall Study|Withdrawal by Subject|2|||
16531747|NCT01026974|40413696|FG000|Overall Study|Lost to Follow-up|1|||
16531748|NCT01026974|40413697|FG001|Overall Study|Lost to Follow-up|1|||
16531749|NCT01026974|40413698|FG002|Overall Study|Lost to Follow-up|4|||
16531750|NCT01026974|40413699|FG003|Overall Study|Lost to Follow-up|0|||
16531751|NCT01026974|40413696|FG000|Overall Study|Adverse Event|0|||
16531752|NCT01026974|40413697|FG001|Overall Study|Adverse Event|0|||
16531753|NCT01026974|40413698|FG002|Overall Study|Adverse Event|0|||
16531754|NCT01026974|40413699|FG003|Overall Study|Adverse Event|1|||
16531755|NCT01026974|40413696|FG000|Overall Study|Inappropriate enrollment|0|||
16531756|NCT01026974|40413697|FG001|Overall Study|Inappropriate enrollment|0|||
16531757|NCT01026974|40413698|FG002|Overall Study|Inappropriate enrollment|1|||
16531758|NCT01026974|40413699|FG003|Overall Study|Inappropriate enrollment|0|||
16531759|NCT02601313|40413700|FG000|Overall Study|Death|2|||
16531760|NCT02601313|40413701|FG001|Overall Study|Death|16|||
16531761|NCT02601313|40413702|FG002|Overall Study|Death|4|||
16531762|NCT02601313|40413700|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
16531763|NCT02601313|40413701|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
16531764|NCT02601313|40413702|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
16531765|NCT02601313|40413700|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
16531766|NCT02601313|40413701|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
16531767|NCT02601313|40413702|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
16531768|NCT02601313|40413700|FG000|Overall Study|Still on study|0|||
16531769|NCT02601313|40413701|FG001|Overall Study|Still on study|52|||
16531770|NCT02601313|40413702|FG002|Overall Study|Still on study|10|||
16531771|NCT02601313|40413700|FG000|Overall Study|Enrolled, did not initiate AC|4|||
16531772|NCT02601313|40413701|FG001|Overall Study|Enrolled, did not initiate AC|0|||
16531773|NCT02601313|40413702|FG002|Overall Study|Enrolled, did not initiate AC|0|||
16531774|NCT04330638|40413706|FG000|Overall Study|Adverse Event|9|||
16531775|NCT04330638|40413707|FG001|Overall Study|Adverse Event|10|||
16531776|NCT04330638|40413708|FG002|Overall Study|Adverse Event|15|||
16531777|NCT04330638|40413709|FG003|Overall Study|Adverse Event|6|||
16531778|NCT04330638|40413710|FG004|Overall Study|Adverse Event|10|||
16531779|NCT04330638|40413711|FG005|Overall Study|Adverse Event|5|||
16531780|NCT04330638|40413706|FG000|Overall Study|Other|2|||
16531781|NCT04330638|40413707|FG001|Overall Study|Other|2|||
16531782|NCT04330638|40413708|FG002|Overall Study|Other|5|||
16531783|NCT04330638|40413709|FG003|Overall Study|Other|1|||
16531784|NCT04330638|40413710|FG004|Overall Study|Other|3|||
16531785|NCT04330638|40413711|FG005|Overall Study|Other|2|||
16531786|NCT04330638|40413706|FG000|Overall Study|Withdrawal by Subject|4|||
16531787|NCT04330638|40413707|FG001|Overall Study|Withdrawal by Subject|0|||
16531788|NCT04330638|40413708|FG002|Overall Study|Withdrawal by Subject|0|||
16531789|NCT04330638|40413709|FG003|Overall Study|Withdrawal by Subject|0|||
16531790|NCT04330638|40413710|FG004|Overall Study|Withdrawal by Subject|0|||
16531791|NCT04330638|40413711|FG005|Overall Study|Withdrawal by Subject|0|||
16531792|NCT04330638|40413706|FG000|Overall Study|Lost to Follow-up|3|||
16531793|NCT04330638|40413707|FG001|Overall Study|Lost to Follow-up|2|||
16531794|NCT04330638|40413708|FG002|Overall Study|Lost to Follow-up|3|||
16531795|NCT04330638|40413709|FG003|Overall Study|Lost to Follow-up|2|||
16531796|NCT04330638|40413710|FG004|Overall Study|Lost to Follow-up|3|||
16531797|NCT04330638|40413711|FG005|Overall Study|Lost to Follow-up|0|||
16531798|NCT02280044|40413713|FG000|Overall Study|Planned alternate|0|||
16531799|NCT02280044|40413714|FG001|Overall Study|Planned alternate|2|||
16531800|NCT03624504|40413715|FG000|Overall Study|Unsuccessful Implant|1|||
16531801|NCT03905655|40413716|FG000|Overall Study|Adverse Event|1|||
16531802|NCT03905655|40413717|FG001|Overall Study|Adverse Event|0|||
16531803|NCT03905655|40413718|FG002|Overall Study|Adverse Event|1|||
16531804|NCT03905655|40413719|FG003|Overall Study|Adverse Event|1|||
16531805|NCT00808808|40413721|FG000|Overall Study|Vaccinated; survey not completed|131|||
16531806|NCT00808808|40413722|FG001|Overall Study|Vaccinated; survey not completed|169|||
16531807|NCT00808808|40413723|FG002|Overall Study|Vaccinated; survey not completed|302|||
16531808|NCT00808808|40413721|FG000|Overall Study|Employee was not vaccinated.|2686|||
16531809|NCT00808808|40413722|FG001|Overall Study|Employee was not vaccinated.|2268|||
16531810|NCT00808808|40413723|FG002|Overall Study|Employee was not vaccinated.|2255|||
16531811|NCT04085328|40413726|FG000|Overall Study|Witihdrew Consent|16|||
16531812|NCT04085328|40413727|FG001|Overall Study|Witihdrew Consent|16|||
16531813|NCT04085328|40413726|FG000|Overall Study|Adverse Event|8|||
16531814|NCT04085328|40413727|FG001|Overall Study|Adverse Event|7|||
16531815|NCT04085328|40413726|FG000|Overall Study|Lost to Follow-up|7|||
16531816|NCT04085328|40413727|FG001|Overall Study|Lost to Follow-up|2|||
16531817|NCT04085328|40413726|FG000|Overall Study|Physician Decision|0|||
16531818|NCT04085328|40413727|FG001|Overall Study|Physician Decision|1|||
16531819|NCT04085328|40413726|FG000|Overall Study|Pregnancy|0|||
16531820|NCT04085328|40413727|FG001|Overall Study|Pregnancy|1|||
16531821|NCT04085328|40413726|FG000|Overall Study|Reasons Related to COVID-19|5|||
16531822|NCT04085328|40413727|FG001|Overall Study|Reasons Related to COVID-19|8|||
16531823|NCT04085328|40413726|FG000|Overall Study|Did not meet inclusion criteria|1|||
16531824|NCT04085328|40413727|FG001|Overall Study|Did not meet inclusion criteria|1|||
16531825|NCT04085328|40413726|FG000|Overall Study|Early termination|1|||
16531826|NCT04085328|40413727|FG001|Overall Study|Early termination|0|||
16531827|NCT01358968|40413732|FG000|Period 2|Adverse Event|0|||
16531828|NCT01358968|40413733|FG001|Period 2|Adverse Event|1|||
16531829|NCT01358968|40413734|FG002|Period 2|Adverse Event|0|||
16531830|NCT01358968|40413735|FG003|Period 2|Adverse Event|0|||
16531831|NCT01358968|40413732|FG000|Continued Access Phase|Progression of Disease|0|||
16531832|NCT01358968|40413733|FG001|Continued Access Phase|Progression of Disease|0|||
16531833|NCT01358968|40413734|FG002|Continued Access Phase|Progression of Disease|8|||
16531834|NCT01358968|40413735|FG003|Continued Access Phase|Progression of Disease|4|||
16531835|NCT01358968|40413732|FG000|Continued Access Phase|Protocol Violation|0|||
16531836|NCT01358968|40413733|FG001|Continued Access Phase|Protocol Violation|0|||
16531837|NCT01358968|40413734|FG002|Continued Access Phase|Protocol Violation|0|||
16531838|NCT01358968|40413735|FG003|Continued Access Phase|Protocol Violation|2|||
16531839|NCT01358968|40413732|FG000|Continued Access Phase|Withdrawal by Subject|0|||
16531840|NCT01358968|40413733|FG001|Continued Access Phase|Withdrawal by Subject|0|||
16531841|NCT01358968|40413734|FG002|Continued Access Phase|Withdrawal by Subject|3|||
16531842|NCT01358968|40413735|FG003|Continued Access Phase|Withdrawal by Subject|0|||
16531843|NCT01358968|40413732|FG000|Continued Access Phase|Death|0|||
16531844|NCT01358968|40413733|FG001|Continued Access Phase|Death|0|||
16531845|NCT01358968|40413734|FG002|Continued Access Phase|Death|1|||
16531846|NCT01358968|40413735|FG003|Continued Access Phase|Death|1|||
16531847|NCT03643952|40413736|FG000|Overall Study|Lack of Efficacy|1|||
16531848|NCT00558428|40413737|FG000|Overall Study|Adverse Event|6|||
16531849|NCT00558428|40413738|FG001|Overall Study|Adverse Event|22|||
16531850|NCT00558428|40413739|FG002|Overall Study|Adverse Event|3|||
16531851|NCT00558428|40413740|FG003|Overall Study|Adverse Event|4|||
16531852|NCT00558428|40413737|FG000|Overall Study|Lost to Follow-up|0|||
16531853|NCT00558428|40413738|FG001|Overall Study|Lost to Follow-up|1|||
16531854|NCT00558428|40413739|FG002|Overall Study|Lost to Follow-up|0|||
16531855|NCT00558428|40413740|FG003|Overall Study|Lost to Follow-up|0|||
16531856|NCT00558428|40413737|FG000|Overall Study|Lack of Efficacy|0|||
16531857|NCT00558428|40413738|FG001|Overall Study|Lack of Efficacy|0|||
16531858|NCT00558428|40413739|FG002|Overall Study|Lack of Efficacy|1|||
16531859|NCT00558428|40413740|FG003|Overall Study|Lack of Efficacy|2|||
16531860|NCT00558428|40413737|FG000|Overall Study|Non compliant with protocol|1|||
16531861|NCT00558428|40413738|FG001|Overall Study|Non compliant with protocol|0|||
16531862|NCT00558428|40413739|FG002|Overall Study|Non compliant with protocol|0|||
16214555|NCT03073200|39265440|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16401659|NCT02589665|39953590|FG003|Maintenance Extension Period|Adverse Event|0|||
16401660|NCT02589665|39953591|FG004|Maintenance Extension Period|Adverse Event|0|||
16401661|NCT02589665|39953592|FG005|Maintenance Extension Period|Adverse Event|0|||
16401662|NCT02589665|39953593|FG006|Maintenance Extension Period|Adverse Event|0|||
16401663|NCT02589665|39953594|FG007|Maintenance Extension Period|Adverse Event|0|||
16401664|NCT02589665|39953595|FG008|Maintenance Extension Period|Adverse Event|0|||
16401665|NCT02589665|39953596|FG009|Maintenance Extension Period|Adverse Event|2|||
16401666|NCT02589665|39953587|FG000|Maintenance Extension Period|Non-responder|0|||
16401667|NCT02589665|39953588|FG001|Maintenance Extension Period|Non-responder|0|||
16401668|NCT02589665|39953589|FG002|Maintenance Extension Period|Non-responder|0|||
16401669|NCT02589665|39953590|FG003|Maintenance Extension Period|Non-responder|0|||
16401670|NCT02589665|39953591|FG004|Maintenance Extension Period|Non-responder|0|||
16401671|NCT02589665|39953592|FG005|Maintenance Extension Period|Non-responder|0|||
16401672|NCT02589665|39953593|FG006|Maintenance Extension Period|Non-responder|0|||
16401673|NCT02589665|39953594|FG007|Maintenance Extension Period|Non-responder|0|||
16401674|NCT02589665|39953595|FG008|Maintenance Extension Period|Non-responder|0|||
16401675|NCT02589665|39953596|FG009|Maintenance Extension Period|Non-responder|1|||
16531863|NCT00558428|40413740|FG003|Overall Study|Non compliant with protocol|3|||
16531864|NCT00558428|40413737|FG000|Overall Study|Consent withdrawn|2|||
16531865|NCT00558428|40413738|FG001|Overall Study|Consent withdrawn|1|||
16531866|NCT00558428|40413739|FG002|Overall Study|Consent withdrawn|0|||
16531867|NCT00558428|40413740|FG003|Overall Study|Consent withdrawn|1|||
16531868|NCT00558428|40413737|FG000|Overall Study|Other|3|||
16531869|NCT00558428|40413738|FG001|Overall Study|Other|0|||
16531870|NCT00558428|40413739|FG002|Overall Study|Other|0|||
16401676|NCT02019108|39953597|FG000|Overall Study|Lost to Follow-up|5|||
16531871|NCT00558428|40413740|FG003|Overall Study|Other|1|||
16401677|NCT02019108|39953598|FG001|Overall Study|Lost to Follow-up|7|||
16401678|NCT04003207|39953599|FG000|Overall Study|Protocol Violation|1|||
16401679|NCT04606199|39953600|FG000|Overall Study|Withdrawal by Subject|2|||
16531872|NCT00487162|40413741|FG000|Overall Study|Adverse Event|0|||
16531873|NCT00487162|40413742|FG001|Overall Study|Adverse Event|1|||
16531874|NCT00487162|40413741|FG000|Overall Study|Physician Decision|0|||
16531875|NCT00487162|40413742|FG001|Overall Study|Physician Decision|1|||
16531876|NCT00487162|40413741|FG000|Overall Study|Withdrawal by Subject|2|||
16531877|NCT00487162|40413742|FG001|Overall Study|Withdrawal by Subject|3|||
16531878|NCT03581305|40413743|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
16531879|NCT03581305|40413744|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
16531880|NCT03581305|40413743|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
16531881|NCT03581305|40413744|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
16531882|NCT03581305|40413743|FG000|Serotonergic Study|Withdrawal by Subject|5|||
16531883|NCT03581305|40413744|FG001|Serotonergic Study|Withdrawal by Subject|1|||
16531884|NCT01764945|40413746|FG000|Overall Study|Adverse Event|0|||
16531885|NCT01764945|40413747|FG001|Overall Study|Adverse Event|1|||
16531886|NCT01764945|40413748|FG002|Overall Study|Adverse Event|0|||
16531887|NCT01764945|40413749|FG003|Overall Study|Adverse Event|0|||
16531888|NCT01764945|40413750|FG004|Overall Study|Adverse Event|0|||
16531889|NCT01764945|40413751|FG005|Overall Study|Adverse Event|0|||
16531890|NCT01764945|40413752|FG006|Overall Study|Adverse Event|1|||
16531891|NCT01764945|40413753|FG007|Overall Study|Adverse Event|0|||
16531892|NCT04201262|40413754|FG000|Overall Study|Adverse Event|1|||
16531893|NCT04201262|40413755|FG001|Overall Study|Adverse Event|2|||
16531894|NCT04201262|40413754|FG000|Overall Study|Continuing in the study|57|||
16531895|NCT04201262|40413755|FG001|Overall Study|Continuing in the study|0|||
16531896|NCT04201262|40413754|FG000|Overall Study|Withdrawal by Subject|0|||
16531897|NCT04201262|40413755|FG001|Overall Study|Withdrawal by Subject|1|||
16531898|NCT02653482|40413760|FG000|Overall Study|Death|1|||
16531899|NCT02653482|40413761|FG001|Overall Study|Death|1|||
16531900|NCT03434119|40413763|FG000|Overall Study|Randomized but not treated|1|||
16531901|NCT03434119|40413764|FG001|Overall Study|Randomized but not treated|0|||
16531902|NCT03434119|40413763|FG000|Overall Study|Adverse Event|1|||
16531903|NCT03434119|40413764|FG001|Overall Study|Adverse Event|0|||
16531904|NCT03434119|40413763|FG000|Overall Study|Poor Compliance to Protocol|0|||
16531905|NCT03434119|40413764|FG001|Overall Study|Poor Compliance to Protocol|1|||
16531906|NCT03434119|40413763|FG000|Overall Study|Study Terminated by Sponsor|91|||
16531907|NCT03434119|40413764|FG001|Overall Study|Study Terminated by Sponsor|102|||
16531908|NCT03434119|40413763|FG000|Overall Study|Withdrawal by Subject|7|||
16531909|NCT03434119|40413764|FG001|Overall Study|Withdrawal by Subject|5|||
16531910|NCT03434119|40413763|FG000|Overall Study|Other than specified|7|||
16531911|NCT03434119|40413764|FG001|Overall Study|Other than specified|5|||
16531912|NCT01109992|40413765|FG000|Overall Study|Withdrawal by Subject|0|||
16531913|NCT01109992|40413766|FG001|Overall Study|Withdrawal by Subject|1|||
16531914|NCT01109992|40413765|FG000|Overall Study|Movement during rest scan.|0|||
16531915|NCT01109992|40413766|FG001|Overall Study|Movement during rest scan.|1|||
16531916|NCT00818753|40413771|FG000|Overall Study|Protocol Violation|1|||
16531917|NCT00818753|40413772|FG001|Overall Study|Protocol Violation|0|||
16531918|NCT00818753|40413773|FG002|Overall Study|Protocol Violation|0|||
16531919|NCT00818753|40413771|FG000|Overall Study|Other reason (not specified)|0|||
16531920|NCT00818753|40413772|FG001|Overall Study|Other reason (not specified)|0|||
16531921|NCT00818753|40413773|FG002|Overall Study|Other reason (not specified)|1|||
16531922|NCT00818753|40413771|FG000|Overall Study|Randomised and not treated|2|||
16531923|NCT00818753|40413772|FG001|Overall Study|Randomised and not treated|0|||
16531924|NCT00818753|40413773|FG002|Overall Study|Randomised and not treated|0|||
16531925|NCT01434602|40413774|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
16531926|NCT01434602|40413775|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
16531927|NCT01434602|40413776|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
16531928|NCT01434602|40413777|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
16531929|NCT01434602|40413778|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
16531930|NCT01434602|40413774|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
16531931|NCT01434602|40413775|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
16531932|NCT01434602|40413776|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
16531933|NCT01434602|40413777|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
16531934|NCT01434602|40413778|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
16531935|NCT01434602|40413774|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
16531936|NCT01434602|40413775|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
16531937|NCT01434602|40413776|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
16546382|NCT01662063|40464796|FG000|Overall Study|Withdrawal by Subject|2|||
16214556|NCT03073200|39265441|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16214557|NCT03073200|39265442|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16214558|NCT03073200|39265443|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16214559|NCT03073200|39265444|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16214560|NCT03073200|39265445|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16214561|NCT03073200|39265446|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
16214562|NCT03073200|39265447|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
16214563|NCT03073200|39265433|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214564|NCT03073200|39265434|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214565|NCT03073200|39265435|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214566|NCT03073200|39265436|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214567|NCT03073200|39265437|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214568|NCT03073200|39265438|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214569|NCT03073200|39265439|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214570|NCT03073200|39265440|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214571|NCT03073200|39265441|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214572|NCT03073200|39265442|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214573|NCT03073200|39265443|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214574|NCT03073200|39265444|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214575|NCT03073200|39265445|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214576|NCT03073200|39265446|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
16214577|NCT03073200|39265447|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
16214578|NCT03073200|39265433|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214579|NCT03073200|39265434|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214580|NCT03073200|39265435|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214581|NCT03073200|39265436|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214582|NCT03073200|39265437|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214583|NCT03073200|39265438|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214584|NCT03073200|39265439|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214585|NCT03073200|39265440|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214586|NCT03073200|39265441|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214587|NCT03073200|39265442|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214588|NCT03073200|39265443|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214589|NCT03073200|39265444|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214590|NCT03073200|39265445|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214591|NCT03073200|39265446|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
16214592|NCT03073200|39265447|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16214593|NCT03073200|39265433|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214594|NCT03073200|39265434|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214595|NCT03073200|39265435|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214596|NCT03073200|39265436|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214597|NCT03073200|39265437|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214598|NCT03073200|39265438|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214599|NCT03073200|39265439|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214600|NCT03073200|39265440|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214601|NCT03073200|39265441|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214602|NCT03073200|39265442|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214603|NCT03073200|39265443|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214604|NCT03073200|39265444|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214605|NCT03073200|39265445|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16401680|NCT02534935|39953604|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
16401681|NCT02534935|39953605|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
16401682|NCT02534935|39953606|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
16401683|NCT02534935|39953604|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
16401684|NCT02534935|39953605|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
16401685|NCT02534935|39953606|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
16401686|NCT02534935|39953604|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
16401687|NCT02534935|39953605|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
16401688|NCT02534935|39953606|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
16401689|NCT02534935|39953604|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
16401690|NCT02534935|39953605|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
16214606|NCT03073200|39265446|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
16214607|NCT03073200|39265447|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
16214608|NCT00122317|39265448|FG000|Overall Study|Death|3|||
16214609|NCT00122317|39265448|FG000|Overall Study|Adverse Event|4|||
16214610|NCT00122317|39265448|FG000|Overall Study|Physician Decision|2|||
16214611|NCT00122317|39265448|FG000|Overall Study|patient non-compliance|1|||
16214612|NCT00122317|39265448|FG000|Overall Study|Withdrawal by Subject|1|||
16214613|NCT01553591|39265453|FG000|Overall Study|Voluntarily withdrew|94|||
16214614|NCT01553591|39265454|FG001|Overall Study|Voluntarily withdrew|79|||
16214615|NCT01553591|39265455|FG002|Overall Study|Voluntarily withdrew|96|||
16214616|NCT01553591|39265453|FG000|Overall Study|Adverse Event|36|||
16214617|NCT01553591|39265454|FG001|Overall Study|Adverse Event|45|||
16214618|NCT01553591|39265455|FG002|Overall Study|Adverse Event|16|||
16214619|NCT01553591|39265453|FG000|Overall Study|Lost to Follow-up|25|||
16214620|NCT01553591|39265454|FG001|Overall Study|Lost to Follow-up|23|||
16214621|NCT01553591|39265455|FG002|Overall Study|Lost to Follow-up|16|||
16214622|NCT01553591|39265453|FG000|Overall Study|Physician decision: other|11|||
16214623|NCT01553591|39265454|FG001|Overall Study|Physician decision: other|14|||
16214624|NCT01553591|39265455|FG002|Overall Study|Physician decision: other|16|||
16214625|NCT01553591|39265453|FG000|Overall Study|Physician decision: lack of efficacy|2|||
16214626|NCT01553591|39265454|FG001|Overall Study|Physician decision: lack of efficacy|3|||
16214627|NCT01553591|39265455|FG002|Overall Study|Physician decision: lack of efficacy|7|||
16214628|NCT01553591|39265453|FG000|Overall Study|Protocol Violation|3|||
16214629|NCT01553591|39265454|FG001|Overall Study|Protocol Violation|4|||
16214630|NCT01553591|39265455|FG002|Overall Study|Protocol Violation|4|||
16214631|NCT01553591|39265453|FG000|Overall Study|Sponsor decision|1|||
16214632|NCT01553591|39265454|FG001|Overall Study|Sponsor decision|0|||
16214633|NCT01553591|39265455|FG002|Overall Study|Sponsor decision|3|||
16214634|NCT01553591|39265453|FG000|Overall Study|Randomized and never dispensed drug|0|||
16214635|NCT01553591|39265454|FG001|Overall Study|Randomized and never dispensed drug|1|||
16214636|NCT01553591|39265455|FG002|Overall Study|Randomized and never dispensed drug|0|||
16214637|NCT01326910|39265457|FG000|Overall Study|Withdrawal by Subject|3|||
16214638|NCT01326910|39265458|FG001|Overall Study|Withdrawal by Subject|2|||
16214639|NCT01326910|39265457|FG000|Overall Study|Protocol Violation|1|||
16214640|NCT01326910|39265458|FG001|Overall Study|Protocol Violation|1|||
16214641|NCT00398138|39265459|FG000|Overall Study|Adverse Event|2|||
16214642|NCT02692560|39265460|FG000|Overall Study|Withdrawal by Subject|0|||
16214643|NCT02692560|39265461|FG001|Overall Study|Withdrawal by Subject|6|||
16214644|NCT03621189|39265462|FG000|Overall Study|Withdrawal by Subject|0|||
16214645|NCT03621189|39265463|FG001|Overall Study|Withdrawal by Subject|3|||
16214646|NCT03621189|39265462|FG000|Overall Study|Physician Decision|0|||
16214647|NCT03621189|39265463|FG001|Overall Study|Physician Decision|2|||
16214648|NCT01308853|39265464|FG000|Overall Study|Adverse Event|1|||
16214649|NCT01308853|39265464|FG000|Overall Study|Lost to Follow-up|2|||
16214650|NCT01308853|39265464|FG000|Overall Study|Insertion of permanent implants|1|||
16214651|NCT02565576|39265465|FG000|Overall Study|abnormal lab value|2|||
16214652|NCT02565576|39265466|FG001|Overall Study|abnormal lab value|0|||
16214653|NCT02565576|39265465|FG000|Overall Study|subject / guardian decision|1|||
16214654|NCT02565576|39265466|FG001|Overall Study|subject / guardian decision|3|||
16214655|NCT02565576|39265465|FG000|Overall Study|Lost to Follow-up|1|||
16214656|NCT02565576|39265466|FG001|Overall Study|Lost to Follow-up|0|||
16214657|NCT02565576|39265465|FG000|Overall Study|Death|0|||
16214658|NCT02565576|39265466|FG001|Overall Study|Death|2|||
16214659|NCT02565576|39265465|FG000|Overall Study|Adverse Event|1|||
16214660|NCT02565576|39265466|FG001|Overall Study|Adverse Event|0|||
16214661|NCT00517634|39265467|FG000|Second Treatment Period|Withdrawal by Subject|0|||
16214662|NCT00517634|39265468|FG001|Second Treatment Period|Withdrawal by Subject|0|||
16214663|NCT00517634|39265469|FG002|Second Treatment Period|Withdrawal by Subject|0|||
16214664|NCT00517634|39265470|FG003|Second Treatment Period|Withdrawal by Subject|0|||
16214665|NCT00517634|39265471|FG004|Second Treatment Period|Withdrawal by Subject|1|||
16214666|NCT00517634|39265472|FG005|Second Treatment Period|Withdrawal by Subject|0|||
16214667|NCT02447952|39265473|FG000|Overall Study|Adverse Event|2|||
16214668|NCT02447952|39265473|FG000|Overall Study|Physician Decision|1|||
16214669|NCT02447952|39265473|FG000|Overall Study|Withdrawal by Subject|4|||
16214670|NCT02343952|39265474|FG000|Study Treatment|Disease Progression|23|||
16214671|NCT02343952|39265474|FG000|Study Treatment|Death|3|||
16214672|NCT02343952|39265474|FG000|Study Treatment|Adverse Event|19|||
16099778|NCT00296504|38852976|FG001|Interim Analysis|Protocol Violation|0|||
16401691|NCT02534935|39953606|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
16214673|NCT02343952|39265474|FG000|Study Treatment|Withdrawal by Subject|7|||
16214674|NCT02343952|39265474|FG000|Study Treatment|other complicating Diseases|1|||
16214675|NCT02343952|39265474|FG000|Follow up|Withdrawal by Subject|3|||
16214676|NCT02343952|39265474|FG000|Follow up|Death|33|||
16214677|NCT02343952|39265474|FG000|Follow up|Patient does not meet eligibility for study.|1|||
16214678|NCT02343952|39265474|FG000|Follow up|Research department closed by the practice.|5|||
16214679|NCT02343952|39265474|FG000|Follow up|Patient went home to Russia|1|||
16214680|NCT02343952|39265474|FG000|Follow up|Disease Progression|1|||
16214681|NCT02343952|39265474|FG000|Follow up|study terminated|1|||
16214682|NCT00686699|39265475|FG000|Treatment Period 1|Adverse Event|0|||
16214683|NCT00686699|39265476|FG001|Treatment Period 1|Adverse Event|2|||
16214684|NCT00439309|39265477|FG000|Follow-Up|Death|1|||
16214685|NCT00439309|39265478|FG001|Follow-Up|Death|0|||
16214686|NCT00439309|39265477|FG000|Follow-Up|Lost to Follow-up|2|||
16214687|NCT00439309|39265478|FG001|Follow-Up|Lost to Follow-up|0|||
16214688|NCT00439309|39265477|FG000|Follow-Up|Withdrawal by Subject|0|||
16214689|NCT00439309|39265478|FG001|Follow-Up|Withdrawal by Subject|1|||
16214690|NCT00439309|39265477|FG000|Follow-Up|Late response by subject|0|||
16214691|NCT00439309|39265478|FG001|Follow-Up|Late response by subject|1|||
16214692|NCT00948194|39265479|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
16214693|NCT00948194|39265480|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
16214694|NCT04350372|39265481|FG000|Overall Study|Death|1|||
16214695|NCT01440972|39265482|FG000|Overall Study|Withdrawal by Subject|3|||
16214696|NCT01440972|39265483|FG001|Overall Study|Withdrawal by Subject|2|||
16214697|NCT01700140|39265484|FG000|Overall Study|Use of rescue drugs|3|||
16214698|NCT01700140|39265485|FG001|Overall Study|Use of rescue drugs|3|||
16214699|NCT01700140|39265486|FG002|Overall Study|Use of rescue drugs|1|||
16214700|NCT01700140|39265484|FG000|Overall Study|Discontinuation of radiotherapy|1|||
16214701|NCT01700140|39265485|FG001|Overall Study|Discontinuation of radiotherapy|0|||
16214702|NCT01700140|39265486|FG002|Overall Study|Discontinuation of radiotherapy|0|||
16214703|NCT01700140|39265484|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
16214704|NCT01700140|39265485|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
16214705|NCT01700140|39265486|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
16214706|NCT01700140|39265484|FG000|Overall Study|Aggravation of symptoms|1|||
16214707|NCT01700140|39265485|FG001|Overall Study|Aggravation of symptoms|0|||
16214708|NCT01700140|39265486|FG002|Overall Study|Aggravation of symptoms|0|||
16214709|NCT01700140|39265484|FG000|Overall Study|Adverse Event|0|||
16214710|NCT01700140|39265485|FG001|Overall Study|Adverse Event|1|||
16214711|NCT01700140|39265486|FG002|Overall Study|Adverse Event|0|||
16214712|NCT01700140|39265484|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
16214713|NCT01700140|39265485|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
16214714|NCT01700140|39265486|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
16214715|NCT00985738|39265488|FG000|Overall Study|Study closed prematurely|8|||
16214716|NCT00985738|39265489|FG001|Overall Study|Study closed prematurely|8|||
16214717|NCT01347073|39265490|FG000|Overall Study|Adverse Event|1|||
16214718|NCT01347073|39265490|FG000|Overall Study|Liver Transplant|1|||
16214719|NCT01332851|39265498|FG000|Overall Study|Withdrawal by Subject|4|||
16214720|NCT01332851|39265499|FG001|Overall Study|Withdrawal by Subject|2|||
16214721|NCT01332851|39265498|FG000|Overall Study|Lost to Follow-up|7|||
16214722|NCT01332851|39265499|FG001|Overall Study|Lost to Follow-up|11|||
16214723|NCT02043509|39265500|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
16531938|NCT01434602|40413777|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
16531939|NCT01434602|40413778|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
16531940|NCT01434602|40413774|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
16531941|NCT01434602|40413775|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
16531942|NCT01434602|40413776|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
16531943|NCT01434602|40413777|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
16531944|NCT01434602|40413778|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
16531945|NCT01434602|40413774|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
16531946|NCT01434602|40413775|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
16531947|NCT01434602|40413776|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
16531948|NCT01434602|40413777|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
16214724|NCT02043509|39265501|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
16214725|NCT02043509|39265500|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
16531949|NCT01434602|40413778|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
16531950|NCT01434602|40413774|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
16531951|NCT01434602|40413775|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
16531952|NCT01434602|40413776|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
16214726|NCT02043509|39265501|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
16214727|NCT02043509|39265500|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
16214728|NCT02043509|39265501|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
16214729|NCT02043509|39265500|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
16214730|NCT02043509|39265501|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
16214731|NCT00255008|39265504|FG000|Overall Study|Adverse Event|1|||
16214732|NCT00255008|39265505|FG001|Overall Study|Adverse Event|1|||
16214733|NCT00255008|39265506|FG002|Overall Study|Adverse Event|2|||
16214734|NCT00255008|39265507|FG003|Overall Study|Adverse Event|0|||
16214735|NCT00255008|39265504|FG000|Overall Study|Lost to Follow-up|1|||
16214736|NCT00255008|39265505|FG001|Overall Study|Lost to Follow-up|0|||
16401692|NCT02534935|39953604|FG000|Stage 1: 24 Months|Adverse Event|0|||
16401693|NCT02534935|39953605|FG001|Stage 1: 24 Months|Adverse Event|2|||
16401694|NCT02534935|39953606|FG002|Stage 1: 24 Months|Adverse Event|0|||
16401695|NCT02534935|39953604|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
16214737|NCT00255008|39265506|FG002|Overall Study|Lost to Follow-up|1|||
16214738|NCT00255008|39265507|FG003|Overall Study|Lost to Follow-up|2|||
16214739|NCT00255008|39265504|FG000|Overall Study|Did not meet viral reduction criteria|4|||
16214740|NCT00255008|39265505|FG001|Overall Study|Did not meet viral reduction criteria|5|||
16214741|NCT00255008|39265506|FG002|Overall Study|Did not meet viral reduction criteria|0|||
16214742|NCT00255008|39265507|FG003|Overall Study|Did not meet viral reduction criteria|1|||
16214743|NCT00255008|39265504|FG000|Overall Study|Withdrew consent|0|||
16214744|NCT00255008|39265505|FG001|Overall Study|Withdrew consent|0|||
16214745|NCT00255008|39265506|FG002|Overall Study|Withdrew consent|2|||
16214746|NCT00255008|39265507|FG003|Overall Study|Withdrew consent|0|||
16214747|NCT00255008|39265504|FG000|Overall Study|Sponsor request|18|||
16214748|NCT00255008|39265505|FG001|Overall Study|Sponsor request|3|||
16214749|NCT00255008|39265506|FG002|Overall Study|Sponsor request|8|||
16214750|NCT00255008|39265507|FG003|Overall Study|Sponsor request|17|||
16214751|NCT00255008|39265504|FG000|Overall Study|Adverse lab experience|1|||
16214752|NCT00255008|39265505|FG001|Overall Study|Adverse lab experience|0|||
16214753|NCT00255008|39265506|FG002|Overall Study|Adverse lab experience|0|||
16214754|NCT00255008|39265507|FG003|Overall Study|Adverse lab experience|0|||
16214755|NCT00255008|39265504|FG000|Overall Study|Other|7|||
16214756|NCT00255008|39265505|FG001|Overall Study|Other|0|||
16214757|NCT00255008|39265506|FG002|Overall Study|Other|3|||
16214758|NCT00255008|39265507|FG003|Overall Study|Other|2|||
16214759|NCT00808028|39265511|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
16214760|NCT00808028|39265512|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
16214761|NCT00808028|39265513|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
16214762|NCT00808028|39265514|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
16214763|NCT00808028|39265511|FG000|Stage 1 (6 Months)|Other|1|||
16214764|NCT00808028|39265512|FG001|Stage 1 (6 Months)|Other|0|||
16214765|NCT00808028|39265513|FG002|Stage 1 (6 Months)|Other|2|||
16214766|NCT00808028|39265514|FG003|Stage 1 (6 Months)|Other|4|||
16214767|NCT00808028|39265511|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
16214768|NCT00808028|39265512|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
16214769|NCT00808028|39265513|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
16214770|NCT00808028|39265514|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
16214771|NCT00808028|39265511|FG000|Stage 1 (6 Months)|Adverse Event|0|||
16214772|NCT00808028|39265512|FG001|Stage 1 (6 Months)|Adverse Event|0|||
16214773|NCT00808028|39265513|FG002|Stage 1 (6 Months)|Adverse Event|1|||
16214774|NCT00808028|39265514|FG003|Stage 1 (6 Months)|Adverse Event|2|||
16214775|NCT00808028|39265511|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
16214776|NCT00808028|39265512|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
16531953|NCT01434602|40413777|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
16531954|NCT01434602|40413778|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
16531955|NCT01434602|40413774|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
16531956|NCT01434602|40413775|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
16531957|NCT01434602|40413776|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
16531958|NCT01434602|40413777|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
16531959|NCT01434602|40413778|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
16401696|NCT02534935|39953605|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
16401697|NCT02534935|39953606|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
16409983|NCT02536300|39981856|FG002|Overall Study|Study Terminated by Sponsor|7|||
16214777|NCT00808028|39265513|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
16214778|NCT00808028|39265514|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
16214779|NCT00808028|39265511|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
16214780|NCT00808028|39265512|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
16214781|NCT00808028|39265513|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
16214782|NCT00808028|39265514|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
16214783|NCT00808028|39265511|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
16214784|NCT00808028|39265512|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
16214785|NCT00808028|39265513|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
16214786|NCT00808028|39265514|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
16214787|NCT00808028|39265511|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
16214788|NCT00808028|39265512|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
16214789|NCT00808028|39265513|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
16214790|NCT00808028|39265514|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
16214791|NCT00808028|39265511|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
16214792|NCT00808028|39265512|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
16214793|NCT00808028|39265513|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
16214794|NCT00808028|39265514|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
16214795|NCT00808028|39265511|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
16214796|NCT00808028|39265512|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
16214797|NCT00808028|39265513|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
16214798|NCT00808028|39265514|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
16214799|NCT00808028|39265511|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
16214800|NCT00808028|39265512|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
16214801|NCT00808028|39265513|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
16214802|NCT00808028|39265514|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
16214803|NCT00808028|39265511|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
16214804|NCT00808028|39265512|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
16214805|NCT00808028|39265513|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
16214806|NCT00808028|39265514|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
16214807|NCT00808028|39265511|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
16214808|NCT00808028|39265512|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
16214809|NCT00808028|39265513|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
16214810|NCT00808028|39265514|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
16214811|NCT00808028|39265511|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
16214812|NCT00808028|39265512|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
16214813|NCT00808028|39265513|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
16214814|NCT00808028|39265514|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
16214815|NCT00808028|39265511|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
16214816|NCT00808028|39265512|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
16214817|NCT00808028|39265513|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
16214818|NCT00808028|39265514|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
16214819|NCT02158728|39265515|FG000|Overall Study|no procedure according to CIP done|3|||
16214820|NCT02158728|39265515|FG000|Overall Study|no qualified dataset|24|||
16214821|NCT03032523|39265519|FG000|Overall Study|Withdrawal by Subject|2|||
16214822|NCT03032523|39265520|FG001|Overall Study|Withdrawal by Subject|2|||
16214823|NCT03032523|39265519|FG000|Overall Study|Physician Decision|1|||
16214824|NCT03032523|39265520|FG001|Overall Study|Physician Decision|0|||
16214825|NCT01572844|39265521|FG000|Overall Study|Physician Decision|1|||
16214826|NCT01572844|39265522|FG001|Overall Study|Physician Decision|1|||
16214827|NCT00090766|39265523|FG000|Overall Study|Nephrectomy Planned|0|||
16214828|NCT00090766|39265524|FG001|Overall Study|Nephrectomy Planned|0|||
16214829|NCT00090766|39265525|FG002|Overall Study|Nephrectomy Planned|1|||
16214830|NCT00090766|39265523|FG000|Overall Study|Death|1|||
16214831|NCT00090766|39265524|FG001|Overall Study|Death|0|||
16214832|NCT00090766|39265525|FG002|Overall Study|Death|0|||
16214833|NCT00090766|39265523|FG000|Overall Study|Admin|0|||
16214834|NCT00090766|39265524|FG001|Overall Study|Admin|2|||
16214835|NCT00090766|39265525|FG002|Overall Study|Admin|0|||
16214836|NCT00090766|39265523|FG000|Overall Study|Lost to Follow-up|2|||
16214837|NCT00090766|39265524|FG001|Overall Study|Lost to Follow-up|0|||
16214838|NCT00090766|39265525|FG002|Overall Study|Lost to Follow-up|2|||
16214839|NCT00654368|39265526|FG000|Overall Study|Ineligibility determined|6|||
16214840|NCT00654368|39265527|FG001|Overall Study|Ineligibility determined|0|||
16214841|NCT00654368|39265528|FG002|Overall Study|Ineligibility determined|0|||
16214842|NCT00654368|39265526|FG000|Overall Study|Protocol deviation|3|||
16214843|NCT00654368|39265527|FG001|Overall Study|Protocol deviation|2|||
16214844|NCT00654368|39265528|FG002|Overall Study|Protocol deviation|1|||
16214845|NCT00654368|39265526|FG000|Overall Study|Non-compliance|2|||
16214846|NCT00654368|39265527|FG001|Overall Study|Non-compliance|1|||
16099779|NCT00296504|38852977|FG002|Interim Analysis|Protocol Violation|2|||
16214847|NCT00654368|39265528|FG002|Overall Study|Non-compliance|2|||
16214848|NCT00654368|39265526|FG000|Overall Study|Withdrawal by Subject|5|||
16214849|NCT00654368|39265527|FG001|Overall Study|Withdrawal by Subject|2|||
16401698|NCT02534935|39953604|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
16099780|NCT00296504|38852978|FG003|Interim Analysis|Protocol Violation|0|||
16214850|NCT00654368|39265528|FG002|Overall Study|Withdrawal by Subject|2|||
16214851|NCT00654368|39265526|FG000|Overall Study|Disease progression|21|||
16214852|NCT00654368|39265527|FG001|Overall Study|Disease progression|31|||
16214853|NCT00654368|39265528|FG002|Overall Study|Disease progression|13|||
16214854|NCT00654368|39265526|FG000|Overall Study|Requirement for alternative therapy|1|||
16214855|NCT00654368|39265527|FG001|Overall Study|Requirement for alternative therapy|1|||
16214856|NCT00654368|39265528|FG002|Overall Study|Requirement for alternative therapy|1|||
16214857|NCT00654368|39265526|FG000|Overall Study|Physician Decision|0|||
16214858|NCT00654368|39265527|FG001|Overall Study|Physician Decision|0|||
16214859|NCT00654368|39265528|FG002|Overall Study|Physician Decision|2|||
16214860|NCT00654368|39265526|FG000|Overall Study|Death|1|||
16214861|NCT00654368|39265527|FG001|Overall Study|Death|0|||
16214862|NCT00654368|39265528|FG002|Overall Study|Death|0|||
16214863|NCT00654368|39265526|FG000|Overall Study|Pregnancy|0|||
16214864|NCT00654368|39265527|FG001|Overall Study|Pregnancy|0|||
16214865|NCT00654368|39265528|FG002|Overall Study|Pregnancy|2|||
16214866|NCT00654368|39265526|FG000|Overall Study|Other|0|||
16214867|NCT00654368|39265527|FG001|Overall Study|Other|2|||
16214868|NCT00654368|39265528|FG002|Overall Study|Other|3|||
16214869|NCT00654368|39265526|FG000|Overall Study|Adverse Event|14|||
16214870|NCT00654368|39265527|FG001|Overall Study|Adverse Event|9|||
16214871|NCT00654368|39265528|FG002|Overall Study|Adverse Event|6|||
16214872|NCT02286089|39265532|FG000|Overall Study|Ongoing in Study|1|||
16214873|NCT02286089|39265533|FG001|Overall Study|Ongoing in Study|1|||
16214874|NCT02286089|39265534|FG002|Overall Study|Ongoing in Study|4|||
16214875|NCT02286089|39265535|FG003|Overall Study|Ongoing in Study|10|||
16214876|NCT02286089|39265532|FG000|Overall Study|Withdrawal by Subject|0|||
16214877|NCT02286089|39265533|FG001|Overall Study|Withdrawal by Subject|0|||
16214878|NCT02286089|39265534|FG002|Overall Study|Withdrawal by Subject|2|||
16214879|NCT02286089|39265535|FG003|Overall Study|Withdrawal by Subject|2|||
16214880|NCT02993783|39265536|FG000|Overall Study|Reason not Specified|6|||
16214881|NCT02993783|39265537|FG001|Overall Study|Reason not Specified|9|||
16214882|NCT03277794|39265544|FG000|Overall Study|Lost to Follow-up|2|||
16214883|NCT03277794|39265545|FG001|Overall Study|Lost to Follow-up|4|||
16214884|NCT03277794|39265544|FG000|Overall Study|Withdrew due to high acuity|1|||
16214885|NCT03277794|39265545|FG001|Overall Study|Withdrew due to high acuity|0|||
16214886|NCT02000622|39265547|FG000|Overall Study|Withdrawal by Subject|5|||
16214887|NCT02000622|39265548|FG001|Overall Study|Withdrawal by Subject|7|||
16214888|NCT02000622|39265547|FG000|Overall Study|Lost to Follow-up|4|||
16214889|NCT02000622|39265548|FG001|Overall Study|Lost to Follow-up|0|||
16214890|NCT02000622|39265547|FG000|Overall Study|Death|159|||
16214891|NCT02000622|39265548|FG001|Overall Study|Death|73|||
16214892|NCT02000622|39265547|FG000|Overall Study|Withdrawn due to site closure|1|||
16214893|NCT02000622|39265548|FG001|Overall Study|Withdrawn due to site closure|0|||
16214894|NCT01354106|39265554|FG000|Overall Study|Withdrawal by Subject|2|||
16214895|NCT00518336|39265555|FG000|Year 7|Lost to Follow-up|2|||
16214896|NCT00518336|39265556|FG001|Year 7|Lost to Follow-up|0|||
16214897|NCT00518336|39265555|FG000|Year 7|Could not attend in time|0|||
16214898|NCT00518336|39265556|FG001|Year 7|Could not attend in time|3|||
16214899|NCT00518336|39265555|FG000|Year 8|Lost to Follow-up|1|||
16214900|NCT00518336|39265556|FG001|Year 8|Lost to Follow-up|1|||
16214901|NCT00518336|39265555|FG000|Year 8|Could not attend in time|0|||
16214902|NCT00518336|39265556|FG001|Year 8|Could not attend in time|1|||
16214903|NCT00518336|39265555|FG000|Year 9|Migrated/moved from study area|1|||
16214904|NCT00518336|39265556|FG001|Year 9|Migrated/moved from study area|1|||
16214905|NCT00518336|39265555|FG000|Year 9|Lost to Follow-up|3|||
16214906|NCT00518336|39265556|FG001|Year 9|Lost to Follow-up|0|||
16214907|NCT00518336|39265555|FG000|Year 9|Personal reasons|1|||
16214908|NCT00518336|39265556|FG001|Year 9|Personal reasons|0|||
16214909|NCT01624974|39265569|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
16214910|NCT01624974|39265570|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
16214911|NCT01624974|39265569|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
16214912|NCT01624974|39265570|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
16214913|NCT01624974|39265569|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
16214914|NCT01624974|39265570|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
16214915|NCT01624974|39265569|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
16214916|NCT01624974|39265570|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
16214917|NCT01624974|39265569|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
16214918|NCT01624974|39265570|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
16214919|NCT01624974|39265569|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
16214920|NCT01624974|39265570|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
16214921|NCT01624974|39265569|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
16214922|NCT01624974|39265570|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
16214923|NCT01624974|39265569|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
16214924|NCT01624974|39265570|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
16214925|NCT01624974|39265569|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
16214926|NCT01624974|39265570|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
16214927|NCT01624974|39265569|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
16214928|NCT01624974|39265570|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
16214929|NCT01624974|39265569|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
16214930|NCT01624974|39265570|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
16214931|NCT01624974|39265569|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
16214932|NCT01624974|39265570|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
16214933|NCT01662986|39265571|FG000|Overall Study|Adverse Event|5|||
16214934|NCT01662986|39265572|FG001|Overall Study|Adverse Event|4|||
16214935|NCT01662986|39265571|FG000|Overall Study|Protocol Violation|2|||
16214936|NCT01662986|39265572|FG001|Overall Study|Protocol Violation|3|||
16214937|NCT01662986|39265571|FG000|Overall Study|Lost to Follow-up|5|||
16214938|NCT01662986|39265572|FG001|Overall Study|Lost to Follow-up|4|||
16214939|NCT01662986|39265571|FG000|Overall Study|Withdrawal by Subject|2|||
16214940|NCT01662986|39265572|FG001|Overall Study|Withdrawal by Subject|2|||
16214941|NCT01662986|39265571|FG000|Overall Study|Not Treated|1|||
16214942|NCT01662986|39265572|FG001|Overall Study|Not Treated|0|||
16214943|NCT01662986|39265571|FG000|Overall Study|Other than stated above|3|||
16214944|NCT01662986|39265572|FG001|Overall Study|Other than stated above|0|||
16214945|NCT01997892|39265574|FG000|Overall Study|Physician Decision|2|||
16214946|NCT01997892|39265574|FG000|Overall Study|Lost to Follow-up|6|||
16214947|NCT01997892|39265574|FG000|Overall Study|Death|14|||
16214948|NCT01997892|39265574|FG000|Overall Study|Renal transplant|8|||
16214949|NCT01997892|39265574|FG000|Overall Study|Other|3|||
16214950|NCT01997892|39265574|FG000|Overall Study|Study completion data not recorded|35|||
16214951|NCT02355665|39265577|FG000|Overall Study|Adverse Event|16|||
16214952|NCT02355665|39265578|FG001|Overall Study|Adverse Event|24|||
16214953|NCT02355665|39265577|FG000|Overall Study|Protocol Violation|2|||
16214954|NCT02355665|39265578|FG001|Overall Study|Protocol Violation|0|||
16214955|NCT02355665|39265577|FG000|Overall Study|Withdrawal by Subject|90|||
16214956|NCT02355665|39265578|FG001|Overall Study|Withdrawal by Subject|100|||
16214957|NCT02355665|39265577|FG000|Overall Study|Lost to Follow-up|131|||
16214958|NCT02355665|39265578|FG001|Overall Study|Lost to Follow-up|103|||
16214959|NCT02355665|39265577|FG000|Overall Study|Death|4|||
16214960|NCT02355665|39265578|FG001|Overall Study|Death|2|||
16214961|NCT02355665|39265577|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
16214962|NCT02355665|39265578|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
16214963|NCT03898323|39265583|FG000|Overall Study|Physician Decision|1|||
16214964|NCT02954952|39265587|FG000|Overall Study|Withdrawal by Subject|1|||
16214965|NCT02954952|39265588|FG001|Overall Study|Withdrawal by Subject|0|||
16214966|NCT02954952|39265589|FG002|Overall Study|Withdrawal by Subject|0|||
16214967|NCT02954952|39265587|FG000|Overall Study|No data collected|0|||
16214968|NCT02954952|39265588|FG001|Overall Study|No data collected|1|||
16214969|NCT02954952|39265589|FG002|Overall Study|No data collected|0|||
16214970|NCT00242710|39265590|FG000|Core Study (up to Year 1)|Adverse Event|30|||
16214971|NCT00242710|39265591|FG001|Core Study (up to Year 1)|Adverse Event|25|||
16214972|NCT00242710|39265592|FG002|Core Study (up to Year 1)|Adverse Event|23|||
16214973|NCT00242710|39265593|FG003|Core Study (up to Year 1)|Adverse Event|14|||
16214974|NCT00242710|39265590|FG000|Core Study (up to Year 1)|Death|0|||
16214975|NCT00242710|39265591|FG001|Core Study (up to Year 1)|Death|0|||
16214976|NCT00242710|39265592|FG002|Core Study (up to Year 1)|Death|1|||
16214977|NCT00242710|39265593|FG003|Core Study (up to Year 1)|Death|0|||
16214978|NCT00242710|39265590|FG000|Core Study (up to Year 1)|Physician Decision|0|||
16214979|NCT00242710|39265591|FG001|Core Study (up to Year 1)|Physician Decision|1|||
16214980|NCT00242710|39265592|FG002|Core Study (up to Year 1)|Physician Decision|0|||
16214981|NCT00242710|39265593|FG003|Core Study (up to Year 1)|Physician Decision|1|||
16214982|NCT00242710|39265590|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
16214983|NCT00242710|39265591|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
16214984|NCT00242710|39265592|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
16214985|NCT00242710|39265593|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
16214986|NCT00242710|39265590|FG000|Core Study (up to Year 1)|Other|6|||
16214987|NCT00242710|39265591|FG001|Core Study (up to Year 1)|Other|1|||
16214988|NCT00242710|39265592|FG002|Core Study (up to Year 1)|Other|0|||
16214989|NCT00242710|39265593|FG003|Core Study (up to Year 1)|Other|2|||
16214990|NCT00242710|39265590|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
16214991|NCT00242710|39265591|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
16214992|NCT00242710|39265592|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
16214993|NCT00242710|39265593|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
16214994|NCT00242710|39265590|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
16214995|NCT00242710|39265591|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
16214996|NCT00242710|39265592|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
16214997|NCT00242710|39265593|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
16214998|NCT00242710|39265590|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
16214999|NCT00242710|39265591|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
16401699|NCT02534935|39953605|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
16215000|NCT00242710|39265592|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
16215001|NCT00242710|39265593|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
16215002|NCT00242710|39265590|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
16215003|NCT00242710|39265591|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
16215004|NCT00242710|39265592|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
16215005|NCT00242710|39265593|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
16215006|NCT00242710|39265590|FG000|Period Between Core Study and Extension|Adverse Event|2|||
16215007|NCT00242710|39265591|FG001|Period Between Core Study and Extension|Adverse Event|3|||
16215008|NCT00242710|39265592|FG002|Period Between Core Study and Extension|Adverse Event|5|||
16215009|NCT00242710|39265593|FG003|Period Between Core Study and Extension|Adverse Event|2|||
16215010|NCT00242710|39265590|FG000|Period Between Core Study and Extension|Physician Decision|1|||
16215011|NCT00242710|39265591|FG001|Period Between Core Study and Extension|Physician Decision|1|||
16215012|NCT00242710|39265592|FG002|Period Between Core Study and Extension|Physician Decision|0|||
16215013|NCT00242710|39265593|FG003|Period Between Core Study and Extension|Physician Decision|0|||
16215014|NCT00242710|39265590|FG000|Period Between Core Study and Extension|Other|24|||
16215015|NCT00242710|39265591|FG001|Period Between Core Study and Extension|Other|24|||
16215016|NCT00242710|39265592|FG002|Period Between Core Study and Extension|Other|9|||
16215017|NCT00242710|39265593|FG003|Period Between Core Study and Extension|Other|11|||
16215018|NCT00242710|39265590|FG000|Period Between Core Study and Extension|Extension not Available|17|||
16215019|NCT00242710|39265591|FG001|Period Between Core Study and Extension|Extension not Available|21|||
16215020|NCT00242710|39265592|FG002|Period Between Core Study and Extension|Extension not Available|8|||
16215021|NCT00242710|39265593|FG003|Period Between Core Study and Extension|Extension not Available|7|||
16215022|NCT00242710|39265590|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
16215023|NCT00242710|39265591|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
16215024|NCT00242710|39265592|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
16215025|NCT00242710|39265593|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
16215026|NCT00242710|39265590|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
16215027|NCT00242710|39265591|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
16215028|NCT00242710|39265592|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
16215029|NCT00242710|39265593|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
16215030|NCT00242710|39265590|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
16215031|NCT00242710|39265591|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
16215032|NCT00242710|39265592|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
16215033|NCT00242710|39265593|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
16215034|NCT00242710|39265590|FG000|Study Extension (up to Year 2)|Death|0|||
16215035|NCT00242710|39265591|FG001|Study Extension (up to Year 2)|Death|0|||
16215036|NCT00242710|39265592|FG002|Study Extension (up to Year 2)|Death|0|||
16215037|NCT00242710|39265593|FG003|Study Extension (up to Year 2)|Death|1|||
16215038|NCT00242710|39265590|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
16215039|NCT00242710|39265591|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
16215040|NCT00242710|39265592|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
16215041|NCT00242710|39265593|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
16215042|NCT00242710|39265590|FG000|Study Extension (up to Year 2)|Other|3|||
16215043|NCT00242710|39265591|FG001|Study Extension (up to Year 2)|Other|5|||
16215044|NCT00242710|39265592|FG002|Study Extension (up to Year 2)|Other|4|||
16215045|NCT00242710|39265593|FG003|Study Extension (up to Year 2)|Other|3|||
16215046|NCT00242710|39265590|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
16215047|NCT00242710|39265591|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
16215048|NCT00242710|39265592|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
16215049|NCT00242710|39265593|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
16215050|NCT00242710|39265590|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
16215051|NCT00242710|39265591|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
16215052|NCT00242710|39265592|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
16215053|NCT00242710|39265593|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
16215054|NCT02485860|39265594|FG000|Overall Study|Lost to Follow-up|4|||
16215055|NCT02485860|39265595|FG001|Overall Study|Lost to Follow-up|1|||
16215056|NCT02485860|39265594|FG000|Overall Study|Physician Decision|1|||
16215057|NCT02485860|39265595|FG001|Overall Study|Physician Decision|2|||
16215058|NCT02485860|39265594|FG000|Overall Study|Health context (COVID-19)|1|||
16215059|NCT02485860|39265595|FG001|Overall Study|Health context (COVID-19)|0|||
16215060|NCT04280081|39265596|FG000|Overall Study|Adverse Event|4|||
16215061|NCT04280081|39265596|FG000|Overall Study|Death|2|||
16215062|NCT04280081|39265596|FG000|Overall Study|Progressive Disease|6|||
16215063|NCT01369069|39265597|FG000|Overall Study|Lost to Follow-up|8|||
16215064|NCT01369069|39265598|FG001|Overall Study|Lost to Follow-up|9|||
16215065|NCT01369069|39265597|FG000|Overall Study|Withdrawal by Subject|9|||
16215066|NCT01369069|39265598|FG001|Overall Study|Withdrawal by Subject|7|||
16215067|NCT01166386|39265612|FG000|Overall Study|Withdrawal by Subject|3|||
16215068|NCT01166386|39265613|FG001|Overall Study|Withdrawal by Subject|5|||
16215069|NCT01365091|39265615|FG000|Period 1|Adverse Event|1|||
16531960|NCT01434602|40413774|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
16215070|NCT01365091|39265616|FG001|Period 1|Adverse Event|0|||
16215071|NCT01365091|39265617|FG002|Period 1|Adverse Event|2|||
16215072|NCT01365091|39265618|FG003|Period 1|Adverse Event|3|||
16215073|NCT01365091|39265615|FG000|Period 1|Positive test result for drugs of abuse|1|||
16215074|NCT01365091|39265616|FG001|Period 1|Positive test result for drugs of abuse|0|||
16215075|NCT01365091|39265617|FG002|Period 1|Positive test result for drugs of abuse|0|||
16215076|NCT01365091|39265618|FG003|Period 1|Positive test result for drugs of abuse|0|||
16215077|NCT01365091|39265615|FG000|Period 1|No longer met study criteria|0|||
16215078|NCT01365091|39265616|FG001|Period 1|No longer met study criteria|1|||
16215079|NCT01365091|39265617|FG002|Period 1|No longer met study criteria|0|||
16215080|NCT01365091|39265618|FG003|Period 1|No longer met study criteria|0|||
16215081|NCT01365091|39265615|FG000|Period 1|Withdrawal by Subject|0|||
16215082|NCT01365091|39265616|FG001|Period 1|Withdrawal by Subject|1|||
16215083|NCT01365091|39265617|FG002|Period 1|Withdrawal by Subject|0|||
16215084|NCT01365091|39265618|FG003|Period 1|Withdrawal by Subject|0|||
16215085|NCT01365091|39265615|FG000|Period 1|Personal reasons|0|||
16215086|NCT01365091|39265616|FG001|Period 1|Personal reasons|0|||
16215087|NCT01365091|39265617|FG002|Period 1|Personal reasons|1|||
16215088|NCT01365091|39265618|FG003|Period 1|Personal reasons|0|||
16215089|NCT01365091|39265615|FG000|Period 2|Withdrawal by Subject|1|||
16531961|NCT01434602|40413775|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
16531962|NCT01434602|40413776|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
16215090|NCT01365091|39265616|FG001|Period 2|Withdrawal by Subject|0|||
16215091|NCT01365091|39265617|FG002|Period 2|Withdrawal by Subject|0|||
16215092|NCT01365091|39265618|FG003|Period 2|Withdrawal by Subject|0|||
16215093|NCT01365091|39265615|FG000|Period 2|Adverse Event|0|||
16215094|NCT01365091|39265616|FG001|Period 2|Adverse Event|0|||
16215095|NCT01365091|39265617|FG002|Period 2|Adverse Event|1|||
16215096|NCT01365091|39265618|FG003|Period 2|Adverse Event|0|||
16215097|NCT01846208|39265621|FG000|Overall Study|Withdrew prior to treatment|1|||
16215098|NCT01846208|39265622|FG001|Overall Study|Withdrew prior to treatment|1|||
16215099|NCT01846208|39265623|FG002|Overall Study|Withdrew prior to treatment|1|||
16215100|NCT01846208|39265621|FG000|Overall Study|Dosing Symptoms|1|||
16215101|NCT01846208|39265622|FG001|Overall Study|Dosing Symptoms|2|||
16215102|NCT01846208|39265623|FG002|Overall Study|Dosing Symptoms|6|||
16215103|NCT01846208|39265621|FG000|Overall Study|Withdrawal by Subject|5|||
16215104|NCT01846208|39265622|FG001|Overall Study|Withdrawal by Subject|0|||
16215105|NCT01846208|39265623|FG002|Overall Study|Withdrawal by Subject|0|||
16215106|NCT01846208|39265621|FG000|Overall Study|Non-compliance|1|||
16215107|NCT01846208|39265622|FG001|Overall Study|Non-compliance|1|||
16215108|NCT01846208|39265623|FG002|Overall Study|Non-compliance|0|||
16215109|NCT01846208|39265621|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
16215110|NCT01846208|39265622|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
16215111|NCT01846208|39265623|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
16215112|NCT01846208|39265621|FG000|Overall Study|Refused SU OFC|0|||
16215113|NCT01846208|39265622|FG001|Overall Study|Refused SU OFC|0|||
16215114|NCT01846208|39265623|FG002|Overall Study|Refused SU OFC|1|||
16215115|NCT02608892|39265624|FG000|Overall Study|Lost to Follow-up|1|||
16215116|NCT02608892|39265625|FG001|Overall Study|Lost to Follow-up|0|||
16215117|NCT00783263|39265626|FG000|Overall Study|Adverse Event|3|||
16215118|NCT00783263|39265627|FG001|Overall Study|Adverse Event|0|||
16215119|NCT00783263|39265628|FG002|Overall Study|Adverse Event|2|||
16215120|NCT00783263|39265629|FG003|Overall Study|Adverse Event|1|||
16215121|NCT00783263|39265626|FG000|Overall Study|Lost to Follow-up|1|||
16215122|NCT00783263|39265627|FG001|Overall Study|Lost to Follow-up|1|||
16215123|NCT00783263|39265628|FG002|Overall Study|Lost to Follow-up|0|||
16215124|NCT00783263|39265629|FG003|Overall Study|Lost to Follow-up|0|||
16215125|NCT00783263|39265626|FG000|Overall Study|Withdrawal by Subject|0|||
16215126|NCT00783263|39265627|FG001|Overall Study|Withdrawal by Subject|1|||
16215127|NCT00783263|39265628|FG002|Overall Study|Withdrawal by Subject|1|||
16215128|NCT00783263|39265629|FG003|Overall Study|Withdrawal by Subject|2|||
16215129|NCT00117572|39265639|FG000|Overall Study|Site withdrew before starting treatment|2|||
16215130|NCT00117572|39265640|FG001|Overall Study|Site withdrew before starting treatment|3|||
16215131|NCT00117572|39265639|FG000|Overall Study|Withdrawal by Subject|3|||
16531963|NCT01434602|40413777|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
16215132|NCT00117572|39265640|FG001|Overall Study|Withdrawal by Subject|3|||
16215133|NCT00117572|39265639|FG000|Overall Study|Protocol Violation|1|||
16215134|NCT00117572|39265640|FG001|Overall Study|Protocol Violation|0|||
16531964|NCT01434602|40413778|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
16215135|NCT03964493|39265641|FG000|Overall Study|Withdrawal by Subject|4|||
16215136|NCT03964493|39265642|FG001|Overall Study|Withdrawal by Subject|1|||
16215137|NCT03964493|39265641|FG000|Overall Study|Lost to Follow-up|13|||
16215138|NCT03964493|39265642|FG001|Overall Study|Lost to Follow-up|4|||
16215139|NCT01894776|39265647|FG000|Overall Study|Withdrawal by Subject|1|||
16215140|NCT00430027|39265648|FG000|Overall Study|Study terminated|8|||
16215141|NCT01602744|39265649|FG000|Overall Study|Death|17|||
16215142|NCT01602744|39265650|FG001|Overall Study|Death|15|||
16215143|NCT01602744|39265649|FG000|Overall Study|Lost to Follow-up|13|||
16215144|NCT01602744|39265650|FG001|Overall Study|Lost to Follow-up|8|||
16215145|NCT03285490|39265651|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
16215146|NCT03285490|39265652|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
16215147|NCT03285490|39265651|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
16215148|NCT03285490|39265652|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
16215149|NCT03644173|39265653|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
16215150|NCT03644173|39265653|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
16215151|NCT03644173|39265653|FG000|Participants at the 1-month Follow up|Death|2|||
16215152|NCT03644173|39265653|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
16215153|NCT01012037|39265657|FG000|Overall Study|Adverse Event|0|||
16215154|NCT01012037|39265658|FG001|Overall Study|Adverse Event|8|||
16215155|NCT01012037|39265659|FG002|Overall Study|Adverse Event|3|||
16215156|NCT01012037|39265657|FG000|Overall Study|Protocol Violation|0|||
16215157|NCT01012037|39265658|FG001|Overall Study|Protocol Violation|3|||
16215158|NCT01012037|39265659|FG002|Overall Study|Protocol Violation|5|||
16215159|NCT01012037|39265657|FG000|Overall Study|Withdrawal by Subject|0|||
16215160|NCT01012037|39265658|FG001|Overall Study|Withdrawal by Subject|4|||
16215161|NCT01012037|39265659|FG002|Overall Study|Withdrawal by Subject|1|||
16215162|NCT01012037|39265657|FG000|Overall Study|Other reason (not specified)|1|||
16215163|NCT01012037|39265658|FG001|Overall Study|Other reason (not specified)|1|||
16215164|NCT01012037|39265659|FG002|Overall Study|Other reason (not specified)|1|||
16215165|NCT01135394|39265660|FG000|Screening|Lost to Follow-up|2|||
16215166|NCT01135394|39265660|FG000|Screening|Withdrawal by Subject|10|||
16215167|NCT01135394|39265660|FG000|Screening|Screening failure|16|||
16215168|NCT01135394|39265660|FG000|Screening|Physician Decision|5|||
16215169|NCT01135394|39265660|FG000|Baseline Assessment|Withdrawal by Subject|9|||
16215170|NCT01135394|39265660|FG000|Baseline Assessment|Physician Decision|3|||
16215171|NCT01135394|39265660|FG000|Baseline Assessment|Lost to Follow-up|2|||
16215172|NCT01135394|39265660|FG000|Baseline Assessment|Adverse Event|1|||
16215173|NCT01135394|39265660|FG000|Study Treatment|Withdrawal by Subject|1|||
16215174|NCT01135394|39265660|FG000|Study Treatment|Physician Decision|1|||
16215175|NCT01135394|39265660|FG000|Study Treatment|Adverse Event|2|||
16215176|NCT01192100|39265661|FG000|Overall Study|Withdrawal by Subject|0|||
16215177|NCT01192100|39265662|FG001|Overall Study|Withdrawal by Subject|0|||
16215178|NCT01192100|39265663|FG002|Overall Study|Withdrawal by Subject|0|||
16215179|NCT01192100|39265664|FG003|Overall Study|Withdrawal by Subject|0|||
16215180|NCT01192100|39265665|FG004|Overall Study|Withdrawal by Subject|1|||
16215181|NCT01192100|39265666|FG005|Overall Study|Withdrawal by Subject|0|||
16215182|NCT01192100|39265661|FG000|Overall Study|Protocol Violation|0|||
16215183|NCT01192100|39265662|FG001|Overall Study|Protocol Violation|0|||
16215184|NCT01192100|39265663|FG002|Overall Study|Protocol Violation|0|||
16215185|NCT01192100|39265664|FG003|Overall Study|Protocol Violation|1|||
16215186|NCT01192100|39265665|FG004|Overall Study|Protocol Violation|0|||
16401700|NCT02534935|39953606|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
16401701|NCT03960580|39953608|FG000|Overall Study|Adverse Event|2|||
16401702|NCT03960580|39953609|FG001|Overall Study|Adverse Event|1|||
16401703|NCT03960580|39953610|FG002|Overall Study|Adverse Event|1|||
16401704|NCT03960580|39953608|FG000|Overall Study|Lost to Follow-up|1|||
16401705|NCT03960580|39953609|FG001|Overall Study|Lost to Follow-up|0|||
16401706|NCT03960580|39953610|FG002|Overall Study|Lost to Follow-up|0|||
16401707|NCT03960580|39953608|FG000|Overall Study|Lack of Efficacy|2|||
16401708|NCT03960580|39953609|FG001|Overall Study|Lack of Efficacy|1|||
16401709|NCT03960580|39953610|FG002|Overall Study|Lack of Efficacy|0|||
16401710|NCT03960580|39953608|FG000|Overall Study|Protocol Violation|0|||
16401711|NCT03960580|39953609|FG001|Overall Study|Protocol Violation|0|||
16401712|NCT03960580|39953610|FG002|Overall Study|Protocol Violation|1|||
16401713|NCT03960580|39953608|FG000|Overall Study|Withdrawal by Subject|1|||
16401714|NCT03960580|39953609|FG001|Overall Study|Withdrawal by Subject|1|||
16401715|NCT03960580|39953610|FG002|Overall Study|Withdrawal by Subject|1|||
16401716|NCT03960580|39953608|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
16401717|NCT03960580|39953609|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
16401718|NCT03960580|39953610|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
16401719|NCT04114357|39953611|FG000|Baseline-Randomization|Adverse Event|2|||
16401720|NCT04114357|39953612|FG001|Baseline-Randomization|Adverse Event|1|||
16215187|NCT01192100|39265666|FG005|Overall Study|Protocol Violation|0|||
16215188|NCT02352090|39265673|FG000|Overall Study|general malaise|1|||
16215189|NCT02352090|39265674|FG001|Overall Study|general malaise|0|||
16215190|NCT02352090|39265675|FG002|Overall Study|general malaise|0|||
16401721|NCT04114357|39953611|FG000|Baseline-Randomization|Lost to Follow-up|1|||
16401722|NCT04114357|39953612|FG001|Baseline-Randomization|Lost to Follow-up|1|||
16401723|NCT04114357|39953611|FG000|Cross-over|Adverse Event|0|||
16401724|NCT04114357|39953612|FG001|Cross-over|Adverse Event|1|||
16215191|NCT02352090|39265673|FG000|Overall Study|non-specified mild side-effects|0|||
16215192|NCT02352090|39265674|FG001|Overall Study|non-specified mild side-effects|0|||
16401725|NCT01032291|39953613|FG000|Safety Lead-in|Adverse Event|1|||
16401726|NCT01032291|39953614|FG001|Safety Lead-in|Adverse Event|0|||
16401727|NCT01032291|39953615|FG002|Safety Lead-in|Adverse Event|0|||
16401728|NCT01032291|39953613|FG000|Safety Lead-in|Death|1|||
16401729|NCT01032291|39953614|FG001|Safety Lead-in|Death|0|||
16401730|NCT01032291|39953615|FG002|Safety Lead-in|Death|0|||
16401731|NCT01032291|39953613|FG000|Proof of Concept|Adverse Event|0|||
16401732|NCT01032291|39953614|FG001|Proof of Concept|Adverse Event|5|||
16401733|NCT01032291|39953615|FG002|Proof of Concept|Adverse Event|1|||
16401734|NCT01032291|39953613|FG000|Proof of Concept|Death|0|||
16401735|NCT01032291|39953614|FG001|Proof of Concept|Death|1|||
16401736|NCT01032291|39953615|FG002|Proof of Concept|Death|2|||
16401737|NCT01032291|39953613|FG000|Proof of Concept|Lack of Efficacy|0|||
16401738|NCT01032291|39953614|FG001|Proof of Concept|Lack of Efficacy|1|||
16401739|NCT01032291|39953615|FG002|Proof of Concept|Lack of Efficacy|0|||
16401740|NCT01032291|39953613|FG000|Proof of Concept|Never Received Study Drug|0|||
16401741|NCT01032291|39953614|FG001|Proof of Concept|Never Received Study Drug|1|||
16401742|NCT01032291|39953615|FG002|Proof of Concept|Never Received Study Drug|0|||
16401743|NCT01895543|39953616|FG000|Overall Study|Withdrawal by Subject|43|||
16215193|NCT02352090|39265675|FG002|Overall Study|non-specified mild side-effects|2|||
16215194|NCT00446797|39265676|FG000|Overall Study|Lack of Efficacy|0|||
16215195|NCT00446797|39265677|FG001|Overall Study|Lack of Efficacy|2|||
16401744|NCT01895543|39953616|FG000|Overall Study|Lost to Follow-up|25|||
16401745|NCT01895543|39953616|FG000|Overall Study|Adverse Event|28|||
16401746|NCT01895543|39953616|FG000|Overall Study|Subject's substantial non-compliance|6|||
16401747|NCT01895543|39953616|FG000|Overall Study|Protocol Violation|1|||
16401748|NCT01895543|39953616|FG000|Overall Study|Physician Decision|2|||
16401749|NCT01895543|39953616|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
16401750|NCT01177553|39953617|FG000|Overall Study|babies not yet 6 months of age|1|||
16401751|NCT01177553|39953618|FG001|Overall Study|babies not yet 6 months of age|0|||
16531965|NCT01434602|40413774|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
16531966|NCT01434602|40413775|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
16531967|NCT01434602|40413776|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
16531968|NCT01434602|40413777|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
16531969|NCT01434602|40413778|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
16531970|NCT01434602|40413774|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
16401752|NCT01340625|39953619|FG000|First Intervention|Adverse Event|1|||
16401753|NCT01340625|39953620|FG001|First Intervention|Adverse Event|0|||
16401754|NCT01340625|39953619|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
16332579|NCT03535194|39703384|FG002|Induction Period|Withdrawal by Subject|3|||
16332580|NCT03535194|39703385|FG003|Induction Period|Withdrawal by Subject|2|||
16332581|NCT03535194|39703386|FG004|Induction Period|Withdrawal by Subject|0|||
16332582|NCT03535194|39703382|FG000|Maintenance Period|Adverse Event|6|||
16332583|NCT03535194|39703383|FG001|Maintenance Period|Adverse Event|5|||
16332584|NCT03535194|39703384|FG002|Maintenance Period|Adverse Event|1|||
16332585|NCT03535194|39703385|FG003|Maintenance Period|Adverse Event|11|||
16332586|NCT03535194|39703386|FG004|Maintenance Period|Adverse Event|4|||
16332587|NCT03535194|39703382|FG000|Maintenance Period|Lack of Efficacy|3|||
16332588|NCT03535194|39703383|FG001|Maintenance Period|Lack of Efficacy|2|||
16332589|NCT03535194|39703384|FG002|Maintenance Period|Lack of Efficacy|5|||
16332590|NCT03535194|39703385|FG003|Maintenance Period|Lack of Efficacy|9|||
16332591|NCT03535194|39703386|FG004|Maintenance Period|Lack of Efficacy|0|||
16332592|NCT03535194|39703382|FG000|Maintenance Period|Lost to Follow-up|4|||
16332593|NCT03535194|39703383|FG001|Maintenance Period|Lost to Follow-up|2|||
16332594|NCT03535194|39703384|FG002|Maintenance Period|Lost to Follow-up|1|||
16332595|NCT03535194|39703385|FG003|Maintenance Period|Lost to Follow-up|5|||
16332596|NCT03535194|39703386|FG004|Maintenance Period|Lost to Follow-up|2|||
16332597|NCT03535194|39703382|FG000|Maintenance Period|Other|1|||
16332598|NCT03535194|39703383|FG001|Maintenance Period|Other|2|||
16332599|NCT03535194|39703384|FG002|Maintenance Period|Other|0|||
16332600|NCT03535194|39703385|FG003|Maintenance Period|Other|0|||
16332601|NCT03535194|39703386|FG004|Maintenance Period|Other|0|||
16332602|NCT03535194|39703382|FG000|Maintenance Period|Physician Decision|1|||
16332603|NCT03535194|39703383|FG001|Maintenance Period|Physician Decision|2|||
16332604|NCT03535194|39703384|FG002|Maintenance Period|Physician Decision|0|||
16332605|NCT03535194|39703385|FG003|Maintenance Period|Physician Decision|2|||
16332606|NCT03535194|39703386|FG004|Maintenance Period|Physician Decision|0|||
16332607|NCT03535194|39703382|FG000|Maintenance Period|Pregnancy|0|||
16409984|NCT02536300|39981854|FG000|Overall Study|Death|7|||
16401755|NCT01340625|39953620|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
16401756|NCT01239381|39953634|FG000|Overall Study|Protocol Violation|1|||
16401757|NCT01239381|39953634|FG000|Overall Study|Withdrawal by Subject|1|||
16401758|NCT02789345|39953635|FG000|Overall Study|Adverse Event|0|||
16401759|NCT02789345|39953636|FG001|Overall Study|Adverse Event|0|||
16401760|NCT02789345|39953637|FG002|Overall Study|Adverse Event|1|||
16401761|NCT02789345|39953635|FG000|Overall Study|Death|0|||
16401762|NCT02789345|39953636|FG001|Overall Study|Death|0|||
16401763|NCT02789345|39953637|FG002|Overall Study|Death|1|||
16401764|NCT02789345|39953635|FG000|Overall Study|Physician Decision|2|||
16401765|NCT02789345|39953636|FG001|Overall Study|Physician Decision|0|||
16401766|NCT02789345|39953637|FG002|Overall Study|Physician Decision|1|||
16401767|NCT02789345|39953635|FG000|Overall Study|Progressive Disease|1|||
16401768|NCT02789345|39953636|FG001|Overall Study|Progressive Disease|3|||
16401769|NCT02789345|39953637|FG002|Overall Study|Progressive Disease|14|||
16401770|NCT03389555|39953641|FG000|Overall Study|Protocol Violation|1|||
16401771|NCT03389555|39953642|FG001|Overall Study|Protocol Violation|3|||
16401772|NCT03389555|39953641|FG000|Overall Study|Death|1|||
16401773|NCT03389555|39953642|FG001|Overall Study|Death|0|||
16401774|NCT00654745|39953643|FG000|Overall Study|Adverse Event|12|||
16401775|NCT00654745|39953643|FG000|Overall Study|Lost to Follow-up|7|||
16401776|NCT00654745|39953643|FG000|Overall Study|Protocol Violation|11|||
16401777|NCT00654745|39953643|FG000|Overall Study|Withdrawal by Subject|10|||
16401778|NCT00654745|39953643|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
16401779|NCT03305081|39953644|FG000|Overall Study|Lost to Follow-up|10|||
16401780|NCT03305081|39953645|FG001|Overall Study|Lost to Follow-up|15|||
16401781|NCT02439450|39953648|FG000|Overall Study|Adverse Event|4|||
16401782|NCT02439450|39953649|FG001|Overall Study|Adverse Event|1|||
16401783|NCT02439450|39953650|FG002|Overall Study|Adverse Event|0|||
16401784|NCT02439450|39953651|FG003|Overall Study|Adverse Event|0|||
16401785|NCT02439450|39953648|FG000|Overall Study|Withdrawal by Subject|1|||
16401786|NCT02439450|39953649|FG001|Overall Study|Withdrawal by Subject|2|||
16401787|NCT02439450|39953650|FG002|Overall Study|Withdrawal by Subject|0|||
16401788|NCT02439450|39953651|FG003|Overall Study|Withdrawal by Subject|0|||
16401789|NCT02439450|39953648|FG000|Overall Study|Death|3|||
16401790|NCT02439450|39953649|FG001|Overall Study|Death|0|||
16401791|NCT02439450|39953650|FG002|Overall Study|Death|0|||
16401792|NCT02439450|39953651|FG003|Overall Study|Death|1|||
16215196|NCT00446797|39265676|FG000|Overall Study|Lost to Follow-up|5|||
16401793|NCT02439450|39953648|FG000|Overall Study|Progressive Disease|18|||
16401794|NCT02439450|39953649|FG001|Overall Study|Progressive Disease|41|||
16401795|NCT02439450|39953650|FG002|Overall Study|Progressive Disease|2|||
16401796|NCT02439450|39953651|FG003|Overall Study|Progressive Disease|3|||
16401797|NCT02442310|39953652|FG000|Overall Study|Adverse Event|2|||
16401798|NCT02442310|39953652|FG000|Overall Study|Withdrawal by Subject|1|||
16401799|NCT01345591|39953656|FG000|Overall Study|Lost to Follow-up|1|||
16401800|NCT01892436|39953659|FG000|Overall Study|Withdrawal by Subject|8|||
16401801|NCT01892436|39953660|FG001|Overall Study|Withdrawal by Subject|15|||
16401802|NCT01892436|39953661|FG002|Overall Study|Withdrawal by Subject|4|||
16401803|NCT01892436|39953662|FG003|Overall Study|Withdrawal by Subject|4|||
16215197|NCT00446797|39265677|FG001|Overall Study|Lost to Follow-up|3|||
16401804|NCT01892436|39953659|FG000|Overall Study|Death|1|||
16401805|NCT01892436|39953660|FG001|Overall Study|Death|1|||
16401806|NCT01892436|39953661|FG002|Overall Study|Death|0|||
16401807|NCT01892436|39953662|FG003|Overall Study|Death|0|||
16401808|NCT01892436|39953659|FG000|Overall Study|Physician Decision|2|||
16401809|NCT01892436|39953660|FG001|Overall Study|Physician Decision|1|||
16401810|NCT01892436|39953661|FG002|Overall Study|Physician Decision|0|||
16401811|NCT01892436|39953662|FG003|Overall Study|Physician Decision|1|||
16401812|NCT01892436|39953659|FG000|Overall Study|Pregnancy|0|||
16401813|NCT01892436|39953660|FG001|Overall Study|Pregnancy|2|||
16401814|NCT01892436|39953661|FG002|Overall Study|Pregnancy|1|||
16401815|NCT01892436|39953662|FG003|Overall Study|Pregnancy|0|||
16401816|NCT01892436|39953659|FG000|Overall Study|Technical problems|2|||
16401817|NCT01892436|39953660|FG001|Overall Study|Technical problems|1|||
16401818|NCT01892436|39953661|FG002|Overall Study|Technical problems|1|||
16401819|NCT01892436|39953662|FG003|Overall Study|Technical problems|1|||
16401820|NCT01892436|39953659|FG000|Overall Study|Lack of Efficacy|1|||
16401821|NCT01892436|39953660|FG001|Overall Study|Lack of Efficacy|2|||
16401822|NCT01892436|39953661|FG002|Overall Study|Lack of Efficacy|2|||
16401823|NCT01892436|39953662|FG003|Overall Study|Lack of Efficacy|2|||
16401824|NCT01892436|39953659|FG000|Overall Study|Lost to Follow-up|1|||
16401825|NCT01892436|39953660|FG001|Overall Study|Lost to Follow-up|1|||
16401826|NCT01892436|39953661|FG002|Overall Study|Lost to Follow-up|1|||
16401827|NCT01892436|39953662|FG003|Overall Study|Lost to Follow-up|3|||
16401828|NCT01892436|39953659|FG000|Overall Study|non-compliance with treatment|1|||
16401829|NCT01892436|39953660|FG001|Overall Study|non-compliance with treatment|0|||
16401830|NCT01892436|39953661|FG002|Overall Study|non-compliance with treatment|0|||
16401831|NCT01892436|39953662|FG003|Overall Study|non-compliance with treatment|0|||
16401832|NCT01892436|39953659|FG000|Overall Study|Adverse Event|7|||
16401833|NCT01892436|39953660|FG001|Overall Study|Adverse Event|6|||
16401834|NCT01892436|39953661|FG002|Overall Study|Adverse Event|2|||
16401835|NCT01892436|39953662|FG003|Overall Study|Adverse Event|3|||
16401836|NCT01730339|39953663|FG000|Overall Study|Withdrawal by Subject|3|||
16401837|NCT01730339|39953664|FG001|Overall Study|Withdrawal by Subject|2|||
16401838|NCT01730339|39953663|FG000|Overall Study|Lost to Follow-up|1|||
16401839|NCT01730339|39953664|FG001|Overall Study|Lost to Follow-up|1|||
16401840|NCT01730339|39953663|FG000|Overall Study|Un-specified|1|||
16401841|NCT01730339|39953664|FG001|Overall Study|Un-specified|0|||
16401842|NCT01482169|39953669|FG000|Overall Study|Physician Decision|2|||
16401843|NCT00510718|39953670|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
16401844|NCT00510718|39953671|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
16401845|NCT00510718|39953670|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
16401846|NCT00510718|39953671|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
16401847|NCT00510718|39953670|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
16401848|NCT00510718|39953671|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
16401849|NCT00510718|39953670|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
16401850|NCT00510718|39953671|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
16401851|NCT00510718|39953670|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
16401852|NCT00510718|39953671|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
16099781|NCT00296504|38852979|FG004|Interim Analysis|Protocol Violation|1|||
16401853|NCT00510718|39953670|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
16401854|NCT00510718|39953671|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
16401855|NCT01257568|39953672|FG000|Overall Study|Lost to Follow-up|2|||
16401856|NCT01257568|39953672|FG000|Overall Study|Withdrawal by Subject|6|||
16401857|NCT01257568|39953672|FG000|Overall Study|Terminated|1|||
16401858|NCT01257568|39953672|FG000|Overall Study|Component Revision|24|||
16401859|NCT04686084|39953675|FG000|Overall Study|Lost to Follow-up|1|||
16401860|NCT04537208|39953677|FG000|Overall Study|Adverse Event|0|||
16401861|NCT04537208|39953678|FG001|Overall Study|Adverse Event|0|||
16401862|NCT04537208|39953679|FG002|Overall Study|Adverse Event|0|||
16401863|NCT04537208|39953680|FG003|Overall Study|Adverse Event|0|||
16401864|NCT04537208|39953681|FG004|Overall Study|Adverse Event|0|||
16401865|NCT04537208|39953682|FG005|Overall Study|Adverse Event|0|||
16401866|NCT04537208|39953683|FG006|Overall Study|Adverse Event|0|||
16401867|NCT04537208|39953684|FG007|Overall Study|Adverse Event|0|||
16401868|NCT04537208|39953685|FG008|Overall Study|Adverse Event|1|||
16099782|NCT00296504|38852980|FG005|Interim Analysis|Protocol Violation|0|||
16401869|NCT04537208|39953686|FG009|Overall Study|Adverse Event|0|||
16401870|NCT04537208|39953687|FG010|Overall Study|Adverse Event|0|||
16401871|NCT04537208|39953677|FG000|Overall Study|Protocol deviation|0|||
16401872|NCT04537208|39953678|FG001|Overall Study|Protocol deviation|0|||
16401873|NCT04537208|39953679|FG002|Overall Study|Protocol deviation|2|||
16401874|NCT04537208|39953680|FG003|Overall Study|Protocol deviation|0|||
16401875|NCT04537208|39953681|FG004|Overall Study|Protocol deviation|0|||
16401876|NCT04537208|39953682|FG005|Overall Study|Protocol deviation|2|||
16401877|NCT04537208|39953683|FG006|Overall Study|Protocol deviation|4|||
16401878|NCT04537208|39953684|FG007|Overall Study|Protocol deviation|0|||
16401879|NCT04537208|39953685|FG008|Overall Study|Protocol deviation|1|||
16401880|NCT04537208|39953686|FG009|Overall Study|Protocol deviation|0|||
16401881|NCT04537208|39953687|FG010|Overall Study|Protocol deviation|2|||
16401882|NCT04537208|39953677|FG000|Overall Study|Withdrawal by Subject|4|||
16401883|NCT04537208|39953678|FG001|Overall Study|Withdrawal by Subject|2|||
16401884|NCT04537208|39953679|FG002|Overall Study|Withdrawal by Subject|1|||
16401885|NCT04537208|39953680|FG003|Overall Study|Withdrawal by Subject|3|||
16401886|NCT04537208|39953681|FG004|Overall Study|Withdrawal by Subject|5|||
16401887|NCT04537208|39953682|FG005|Overall Study|Withdrawal by Subject|1|||
16401888|NCT04537208|39953683|FG006|Overall Study|Withdrawal by Subject|6|||
16401889|NCT04537208|39953684|FG007|Overall Study|Withdrawal by Subject|1|||
16401890|NCT04537208|39953685|FG008|Overall Study|Withdrawal by Subject|7|||
16401891|NCT04537208|39953686|FG009|Overall Study|Withdrawal by Subject|2|||
16401892|NCT04537208|39953687|FG010|Overall Study|Withdrawal by Subject|4|||
16531971|NCT01434602|40413775|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
16332608|NCT03535194|39703383|FG001|Maintenance Period|Pregnancy|0|||
16332609|NCT03535194|39703384|FG002|Maintenance Period|Pregnancy|0|||
16332610|NCT03535194|39703385|FG003|Maintenance Period|Pregnancy|2|||
16332611|NCT03535194|39703386|FG004|Maintenance Period|Pregnancy|0|||
16332612|NCT03535194|39703382|FG000|Maintenance Period|Protocol Violation|0|||
16332613|NCT03535194|39703383|FG001|Maintenance Period|Protocol Violation|1|||
16332614|NCT03535194|39703384|FG002|Maintenance Period|Protocol Violation|0|||
16332615|NCT03535194|39703385|FG003|Maintenance Period|Protocol Violation|0|||
16332616|NCT03535194|39703386|FG004|Maintenance Period|Protocol Violation|0|||
16332617|NCT03535194|39703382|FG000|Maintenance Period|Withdrawal by Subject|7|||
16332618|NCT03535194|39703383|FG001|Maintenance Period|Withdrawal by Subject|2|||
16332619|NCT03535194|39703384|FG002|Maintenance Period|Withdrawal by Subject|1|||
16332620|NCT03535194|39703385|FG003|Maintenance Period|Withdrawal by Subject|8|||
16332621|NCT03535194|39703386|FG004|Maintenance Period|Withdrawal by Subject|0|||
16332622|NCT03535194|39703382|FG000|Post-Treatment Followup Period|Adverse Event|4|||
16332623|NCT03535194|39703383|FG001|Post-Treatment Followup Period|Adverse Event|5|||
16332624|NCT03535194|39703384|FG002|Post-Treatment Followup Period|Adverse Event|1|||
16332625|NCT03535194|39703385|FG003|Post-Treatment Followup Period|Adverse Event|8|||
16332626|NCT03535194|39703386|FG004|Post-Treatment Followup Period|Adverse Event|0|||
16332627|NCT03535194|39703382|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
16332628|NCT03535194|39703383|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
16332629|NCT03535194|39703384|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
16332630|NCT03535194|39703385|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
16332631|NCT03535194|39703386|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
16332632|NCT03535194|39703382|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
16332633|NCT03535194|39703383|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
16332634|NCT03535194|39703384|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
16332635|NCT03535194|39703385|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
16332636|NCT03535194|39703386|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
16332637|NCT03535194|39703382|FG000|Post-Treatment Followup Period|Other|1|||
16332638|NCT03535194|39703383|FG001|Post-Treatment Followup Period|Other|0|||
16332639|NCT03535194|39703384|FG002|Post-Treatment Followup Period|Other|0|||
16332640|NCT03535194|39703385|FG003|Post-Treatment Followup Period|Other|5|||
16332641|NCT03535194|39703386|FG004|Post-Treatment Followup Period|Other|0|||
16401893|NCT04537208|39953677|FG000|Overall Study|Lost to Follow-up|4|||
16401894|NCT04537208|39953678|FG001|Overall Study|Lost to Follow-up|1|||
16401895|NCT04537208|39953679|FG002|Overall Study|Lost to Follow-up|3|||
16401896|NCT04537208|39953680|FG003|Overall Study|Lost to Follow-up|4|||
16531972|NCT01434602|40413776|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
16531973|NCT01434602|40413777|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
16531974|NCT01434602|40413778|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
16531975|NCT01140880|40413780|FG000|Overall Study|Death|0|||
16531976|NCT01140880|40413781|FG001|Overall Study|Death|1|||
16531977|NCT01140880|40413780|FG000|Overall Study|Withdrawal by Subject|6|||
16531978|NCT01140880|40413781|FG001|Overall Study|Withdrawal by Subject|3|||
16531979|NCT01140880|40413780|FG000|Overall Study|Lost to Follow-up|8|||
16531980|NCT01140880|40413781|FG001|Overall Study|Lost to Follow-up|10|||
16531981|NCT01140880|40413780|FG000|Overall Study|Protocol Violation|0|||
16531982|NCT01140880|40413781|FG001|Overall Study|Protocol Violation|30|||
16401897|NCT04537208|39953681|FG004|Overall Study|Lost to Follow-up|3|||
16401898|NCT04537208|39953682|FG005|Overall Study|Lost to Follow-up|2|||
16099783|NCT00296504|38852981|FG006|Interim Analysis|Protocol Violation|0|||
16099784|NCT00296504|38852982|FG007|Interim Analysis|Protocol Violation|1|||
16215198|NCT00446797|39265676|FG000|Overall Study|Withdrawal by Subject|2|||
16215199|NCT00446797|39265677|FG001|Overall Study|Withdrawal by Subject|2|||
16401899|NCT04537208|39953683|FG006|Overall Study|Lost to Follow-up|3|||
16099785|NCT00296504|38852983|FG008|Interim Analysis|Protocol Violation|0|||
16401900|NCT04537208|39953684|FG007|Overall Study|Lost to Follow-up|2|||
16215200|NCT00446797|39265676|FG000|Overall Study|Protocol Violation|1|||
16215201|NCT00446797|39265677|FG001|Overall Study|Protocol Violation|3|||
16401901|NCT04537208|39953685|FG008|Overall Study|Lost to Follow-up|7|||
16401902|NCT04537208|39953686|FG009|Overall Study|Lost to Follow-up|2|||
16401903|NCT04537208|39953687|FG010|Overall Study|Lost to Follow-up|2|||
16401904|NCT03070171|39953688|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
16401905|NCT03070171|39953689|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
16401906|NCT03070171|39953688|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
16401907|NCT03070171|39953689|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
16401908|NCT00313313|39953690|FG000|Overall Study|Lack of Efficacy|14|||
16401909|NCT00313313|39953691|FG001|Overall Study|Lack of Efficacy|9|||
16401910|NCT00313313|39953692|FG002|Overall Study|Lack of Efficacy|20|||
16401911|NCT00313313|39953690|FG000|Overall Study|Withdrawal of consent by subject|18|||
16401912|NCT00313313|39953691|FG001|Overall Study|Withdrawal of consent by subject|17|||
16401913|NCT00313313|39953692|FG002|Overall Study|Withdrawal of consent by subject|31|||
16401914|NCT00313313|39953690|FG000|Overall Study|Lost to Follow-up|10|||
16401915|NCT00313313|39953691|FG001|Overall Study|Lost to Follow-up|7|||
16401916|NCT00313313|39953692|FG002|Overall Study|Lost to Follow-up|9|||
16401917|NCT00313313|39953690|FG000|Overall Study|Adverse Event|15|||
16401918|NCT00313313|39953691|FG001|Overall Study|Adverse Event|16|||
16401919|NCT00313313|39953692|FG002|Overall Study|Adverse Event|12|||
16401920|NCT00313313|39953690|FG000|Overall Study|Physician Decision|2|||
16401921|NCT00313313|39953691|FG001|Overall Study|Physician Decision|6|||
16401922|NCT00313313|39953692|FG002|Overall Study|Physician Decision|4|||
16401923|NCT00313313|39953690|FG000|Overall Study|Poor/Noncompliance|3|||
16401924|NCT00313313|39953691|FG001|Overall Study|Poor/Noncompliance|6|||
16401925|NCT00313313|39953692|FG002|Overall Study|Poor/Noncompliance|2|||
16401926|NCT00313313|39953690|FG000|Overall Study|Pregnancy|1|||
16401927|NCT00313313|39953691|FG001|Overall Study|Pregnancy|2|||
16401928|NCT00313313|39953692|FG002|Overall Study|Pregnancy|0|||
16401929|NCT00313313|39953690|FG000|Overall Study|Death|0|||
16401930|NCT00313313|39953691|FG001|Overall Study|Death|0|||
16401931|NCT00313313|39953692|FG002|Overall Study|Death|2|||
16401932|NCT00313313|39953690|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
16401933|NCT00313313|39953691|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
16401934|NCT00313313|39953692|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
16401935|NCT03359785|39953693|FG000|Overall Study|Protocol Violation|0|||
16401936|NCT03359785|39953694|FG001|Overall Study|Protocol Violation|1|||
16401937|NCT03359785|39953695|FG002|Overall Study|Protocol Violation|0|||
16401938|NCT03359785|39953696|FG003|Overall Study|Protocol Violation|0|||
16401939|NCT03359785|39953693|FG000|Overall Study|Early study termination due to study pause|0|||
16401940|NCT03359785|39953694|FG001|Overall Study|Early study termination due to study pause|0|||
16401941|NCT03359785|39953695|FG002|Overall Study|Early study termination due to study pause|2|||
16401942|NCT03359785|39953696|FG003|Overall Study|Early study termination due to study pause|0|||
16401943|NCT03359785|39953693|FG000|Overall Study|Withdrawal by Subject|2|||
16401944|NCT03359785|39953694|FG001|Overall Study|Withdrawal by Subject|2|||
16401945|NCT03359785|39953695|FG002|Overall Study|Withdrawal by Subject|0|||
16401946|NCT03359785|39953696|FG003|Overall Study|Withdrawal by Subject|0|||
16401947|NCT03213938|39953698|FG000|Overall Study|Lost to Follow-up|4|||
16401948|NCT03213938|39953699|FG001|Overall Study|Lost to Follow-up|3|||
16401949|NCT03213938|39953698|FG000|Overall Study|Lack of Efficacy|1|||
16401950|NCT03213938|39953699|FG001|Overall Study|Lack of Efficacy|0|||
16401951|NCT03213938|39953698|FG000|Overall Study|Decline to participate|5|||
16401952|NCT03213938|39953699|FG001|Overall Study|Decline to participate|4|||
16401953|NCT03213938|39953698|FG000|Overall Study|Without reason|4|||
16401954|NCT03213938|39953699|FG001|Overall Study|Without reason|5|||
16401955|NCT01939002|39953711|FG000|Overall Study|Adverse Event|13|||
16401956|NCT01939002|39953712|FG001|Overall Study|Adverse Event|13|||
16401957|NCT01939002|39953711|FG000|Overall Study|Withdrawal by Subject|5|||
16401958|NCT01939002|39953712|FG001|Overall Study|Withdrawal by Subject|3|||
16401959|NCT01939002|39953711|FG000|Overall Study|Other|1|||
16401960|NCT01939002|39953712|FG001|Overall Study|Other|2|||
16401961|NCT01190475|39953715|FG000|Overall Study|Withdrawal by Subject|0|||
16401962|NCT01190475|39953716|FG001|Overall Study|Withdrawal by Subject|0|||
16401963|NCT01190475|39953717|FG002|Overall Study|Withdrawal by Subject|1|||
16401964|NCT01296711|39953718|FG000|Overall Study|Adverse Event|3|||
16401965|NCT01296711|39953719|FG001|Overall Study|Adverse Event|1|||
16401966|NCT01296711|39953720|FG002|Overall Study|Adverse Event|4|||
16401967|NCT01296711|39953721|FG003|Overall Study|Adverse Event|3|||
16401968|NCT01296711|39953722|FG004|Overall Study|Adverse Event|1|||
16401969|NCT01296711|39953723|FG005|Overall Study|Adverse Event|6|||
16401970|NCT01296711|39953724|FG006|Overall Study|Adverse Event|11|||
16401971|NCT01296711|39953725|FG007|Overall Study|Adverse Event|3|||
16401972|NCT01296711|39953718|FG000|Overall Study|Lack of Efficacy|1|||
16401973|NCT01296711|39953719|FG001|Overall Study|Lack of Efficacy|4|||
16401974|NCT01296711|39953720|FG002|Overall Study|Lack of Efficacy|1|||
16401975|NCT01296711|39953721|FG003|Overall Study|Lack of Efficacy|1|||
16401976|NCT01296711|39953722|FG004|Overall Study|Lack of Efficacy|1|||
16401977|NCT01296711|39953723|FG005|Overall Study|Lack of Efficacy|0|||
16401978|NCT01296711|39953724|FG006|Overall Study|Lack of Efficacy|2|||
16401979|NCT01296711|39953725|FG007|Overall Study|Lack of Efficacy|3|||
16401980|NCT01296711|39953718|FG000|Overall Study|Lost to Follow-up|0|||
16401981|NCT01296711|39953719|FG001|Overall Study|Lost to Follow-up|0|||
16401982|NCT01296711|39953720|FG002|Overall Study|Lost to Follow-up|1|||
16401983|NCT01296711|39953721|FG003|Overall Study|Lost to Follow-up|1|||
16401984|NCT01296711|39953722|FG004|Overall Study|Lost to Follow-up|2|||
16401985|NCT01296711|39953723|FG005|Overall Study|Lost to Follow-up|0|||
16401986|NCT01296711|39953724|FG006|Overall Study|Lost to Follow-up|4|||
16401987|NCT01296711|39953725|FG007|Overall Study|Lost to Follow-up|2|||
16401988|NCT01296711|39953718|FG000|Overall Study|Protocol Violation|0|||
16401989|NCT01296711|39953719|FG001|Overall Study|Protocol Violation|0|||
16401990|NCT01296711|39953720|FG002|Overall Study|Protocol Violation|0|||
16401991|NCT01296711|39953721|FG003|Overall Study|Protocol Violation|1|||
16401992|NCT01296711|39953722|FG004|Overall Study|Protocol Violation|1|||
16401993|NCT01296711|39953723|FG005|Overall Study|Protocol Violation|0|||
16401994|NCT01296711|39953724|FG006|Overall Study|Protocol Violation|0|||
16401995|NCT01296711|39953725|FG007|Overall Study|Protocol Violation|0|||
16401996|NCT01296711|39953718|FG000|Overall Study|Withdrawal by Subject|4|||
16531983|NCT00490646|40413784|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
16401997|NCT01296711|39953719|FG001|Overall Study|Withdrawal by Subject|2|||
16401998|NCT01296711|39953720|FG002|Overall Study|Withdrawal by Subject|2|||
16401999|NCT01296711|39953721|FG003|Overall Study|Withdrawal by Subject|1|||
16402000|NCT01296711|39953722|FG004|Overall Study|Withdrawal by Subject|1|||
16402001|NCT01296711|39953723|FG005|Overall Study|Withdrawal by Subject|1|||
16402002|NCT01296711|39953724|FG006|Overall Study|Withdrawal by Subject|2|||
16402003|NCT01296711|39953725|FG007|Overall Study|Withdrawal by Subject|1|||
16402004|NCT01296711|39953718|FG000|Overall Study|Study termination|8|||
16402005|NCT01296711|39953719|FG001|Overall Study|Study termination|1|||
16402006|NCT01296711|39953720|FG002|Overall Study|Study termination|5|||
16402007|NCT01296711|39953721|FG003|Overall Study|Study termination|4|||
16402008|NCT01296711|39953722|FG004|Overall Study|Study termination|4|||
16402009|NCT01296711|39953723|FG005|Overall Study|Study termination|4|||
16402010|NCT01296711|39953724|FG006|Overall Study|Study termination|8|||
16402011|NCT01296711|39953725|FG007|Overall Study|Study termination|10|||
16402012|NCT01296711|39953718|FG000|Overall Study|Continued elevated liver enzymes|0|||
16402013|NCT01296711|39953719|FG001|Overall Study|Continued elevated liver enzymes|0|||
16402014|NCT01296711|39953720|FG002|Overall Study|Continued elevated liver enzymes|0|||
16402015|NCT01296711|39953721|FG003|Overall Study|Continued elevated liver enzymes|1|||
16402016|NCT01296711|39953722|FG004|Overall Study|Continued elevated liver enzymes|0|||
16402017|NCT01296711|39953723|FG005|Overall Study|Continued elevated liver enzymes|0|||
16402018|NCT01296711|39953724|FG006|Overall Study|Continued elevated liver enzymes|0|||
16402019|NCT01296711|39953725|FG007|Overall Study|Continued elevated liver enzymes|0|||
16402020|NCT01296711|39953718|FG000|Overall Study|Methotrexate discontinued|0|||
16402021|NCT01296711|39953719|FG001|Overall Study|Methotrexate discontinued|0|||
16402022|NCT01296711|39953720|FG002|Overall Study|Methotrexate discontinued|0|||
16402023|NCT01296711|39953721|FG003|Overall Study|Methotrexate discontinued|1|||
16402024|NCT01296711|39953722|FG004|Overall Study|Methotrexate discontinued|0|||
16402025|NCT01296711|39953723|FG005|Overall Study|Methotrexate discontinued|0|||
16402026|NCT01296711|39953724|FG006|Overall Study|Methotrexate discontinued|0|||
16402027|NCT01296711|39953725|FG007|Overall Study|Methotrexate discontinued|0|||
16402028|NCT01296711|39953718|FG000|Overall Study|Investigator discretion|0|||
16402029|NCT01296711|39953719|FG001|Overall Study|Investigator discretion|0|||
16402030|NCT01296711|39953720|FG002|Overall Study|Investigator discretion|0|||
16402031|NCT01296711|39953721|FG003|Overall Study|Investigator discretion|0|||
16402032|NCT01296711|39953722|FG004|Overall Study|Investigator discretion|0|||
16402033|NCT01296711|39953723|FG005|Overall Study|Investigator discretion|0|||
16402034|NCT01296711|39953724|FG006|Overall Study|Investigator discretion|1|||
16402035|NCT01296711|39953725|FG007|Overall Study|Investigator discretion|0|||
16402036|NCT01296711|39953718|FG000|Overall Study|Other|0|||
16402037|NCT01296711|39953719|FG001|Overall Study|Other|0|||
16402038|NCT01296711|39953720|FG002|Overall Study|Other|0|||
16402039|NCT01296711|39953721|FG003|Overall Study|Other|0|||
16402040|NCT01296711|39953722|FG004|Overall Study|Other|0|||
16402041|NCT01296711|39953723|FG005|Overall Study|Other|0|||
16402042|NCT01296711|39953724|FG006|Overall Study|Other|1|||
16402043|NCT01296711|39953725|FG007|Overall Study|Other|0|||
16402044|NCT01296711|39953718|FG000|Overall Study|Required restricted steroid injections|0|||
16402045|NCT01296711|39953719|FG001|Overall Study|Required restricted steroid injections|0|||
16402046|NCT01296711|39953720|FG002|Overall Study|Required restricted steroid injections|0|||
16402047|NCT01296711|39953721|FG003|Overall Study|Required restricted steroid injections|0|||
16402048|NCT01296711|39953722|FG004|Overall Study|Required restricted steroid injections|0|||
16402049|NCT01296711|39953723|FG005|Overall Study|Required restricted steroid injections|0|||
16402050|NCT01296711|39953724|FG006|Overall Study|Required restricted steroid injections|1|||
16402051|NCT01296711|39953725|FG007|Overall Study|Required restricted steroid injections|0|||
16402052|NCT01296711|39953718|FG000|Overall Study|Ongoing missed appointments|0|||
16402053|NCT01296711|39953719|FG001|Overall Study|Ongoing missed appointments|0|||
16402054|NCT01296711|39953720|FG002|Overall Study|Ongoing missed appointments|0|||
16402055|NCT01296711|39953721|FG003|Overall Study|Ongoing missed appointments|0|||
16402056|NCT01296711|39953722|FG004|Overall Study|Ongoing missed appointments|0|||
16402057|NCT01296711|39953723|FG005|Overall Study|Ongoing missed appointments|0|||
16402058|NCT01296711|39953724|FG006|Overall Study|Ongoing missed appointments|1|||
16402059|NCT01296711|39953725|FG007|Overall Study|Ongoing missed appointments|0|||
16402060|NCT01296711|39953718|FG000|Overall Study|Failure to comply with visits|0|||
16402061|NCT01296711|39953719|FG001|Overall Study|Failure to comply with visits|0|||
16402062|NCT01296711|39953720|FG002|Overall Study|Failure to comply with visits|0|||
16402063|NCT01296711|39953721|FG003|Overall Study|Failure to comply with visits|0|||
16402064|NCT01296711|39953722|FG004|Overall Study|Failure to comply with visits|0|||
16402065|NCT01296711|39953723|FG005|Overall Study|Failure to comply with visits|0|||
16402066|NCT01296711|39953724|FG006|Overall Study|Failure to comply with visits|0|||
16402067|NCT01296711|39953725|FG007|Overall Study|Failure to comply with visits|1|||
16402068|NCT01296711|39953718|FG000|Overall Study|Patient decision due to transport|0|||
16402069|NCT01296711|39953719|FG001|Overall Study|Patient decision due to transport|0|||
16402070|NCT01296711|39953720|FG002|Overall Study|Patient decision due to transport|0|||
16402071|NCT01296711|39953721|FG003|Overall Study|Patient decision due to transport|0|||
16402072|NCT01296711|39953722|FG004|Overall Study|Patient decision due to transport|0|||
16402073|NCT01296711|39953723|FG005|Overall Study|Patient decision due to transport|0|||
16402074|NCT01296711|39953724|FG006|Overall Study|Patient decision due to transport|0|||
16402075|NCT01296711|39953725|FG007|Overall Study|Patient decision due to transport|1|||
16402076|NCT02449889|39953726|FG000|Overall Study|Adverse Event|1|||
16402077|NCT02449889|39953727|FG001|Overall Study|Adverse Event|2|||
16402078|NCT02449889|39953728|FG002|Overall Study|Adverse Event|0|||
16402079|NCT02449889|39953726|FG000|Overall Study|Protocol Violation|0|||
16402080|NCT02449889|39953727|FG001|Overall Study|Protocol Violation|4|||
16402081|NCT02449889|39953728|FG002|Overall Study|Protocol Violation|1|||
16402082|NCT03781323|39953731|FG000|Overall Study|Withdrawal by Subject|1|||
16402083|NCT02461290|39953733|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
16402084|NCT02461290|39953733|FG000|Overall Study|Lost to Follow-up|3|||
16402085|NCT00064259|39953734|FG000|Overall Study|Adverse Event|1|||
16402086|NCT00064259|39953735|FG001|Overall Study|Adverse Event|0|||
16402087|NCT00064259|39953736|FG002|Overall Study|Adverse Event|0|||
16531984|NCT00490646|40413785|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
16531985|NCT00490646|40413784|FG000|Overall Study|Never Treated (had an adverse event)|1|||
16531986|NCT00490646|40413785|FG001|Overall Study|Never Treated (had an adverse event)|0|||
16531987|NCT00490646|40413784|FG000|Overall Study|Never Treated (withdrew consent)|0|||
16531988|NCT00490646|40413785|FG001|Overall Study|Never Treated (withdrew consent)|1|||
16531989|NCT00966940|40413786|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
16531990|NCT00966940|40413787|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
16531991|NCT00966940|40413786|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
16332642|NCT03535194|39703382|FG000|Post-Treatment Followup Period|Physician Decision|0|||
16531992|NCT00966940|40413787|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
16531993|NCT00674986|40413789|FG000|Overall Study|Adverse Event|2|||
16531994|NCT00674986|40413790|FG001|Overall Study|Adverse Event|1|||
16531995|NCT00674986|40413789|FG000|Overall Study|Subject withdrew consent|12|||
16531996|NCT00674986|40413790|FG001|Overall Study|Subject withdrew consent|19|||
16531997|NCT00674986|40413789|FG000|Overall Study|Lost to Follow-up|25|||
16531998|NCT00674986|40413790|FG001|Overall Study|Lost to Follow-up|53|||
16531999|NCT00674986|40413789|FG000|Overall Study|Other reasons|4|||
16532000|NCT00674986|40413790|FG001|Overall Study|Other reasons|8|||
16532001|NCT01786512|40413791|FG000|Overall Study|Lost to Follow-up|0|||
16532002|NCT01786512|40413792|FG001|Overall Study|Lost to Follow-up|0|||
16532003|NCT01786512|40413793|FG002|Overall Study|Lost to Follow-up|0|||
16532004|NCT01786512|40413794|FG003|Overall Study|Lost to Follow-up|0|||
16532005|NCT01786512|40413795|FG004|Overall Study|Lost to Follow-up|0|||
16532006|NCT01786512|40413796|FG005|Overall Study|Lost to Follow-up|0|||
16532007|NCT01786512|40413797|FG006|Overall Study|Lost to Follow-up|0|||
16532008|NCT01786512|40413798|FG007|Overall Study|Lost to Follow-up|0|||
16532009|NCT01786512|40413799|FG008|Overall Study|Lost to Follow-up|0|||
16532010|NCT01786512|40413800|FG009|Overall Study|Lost to Follow-up|1|||
16532011|NCT01786512|40413801|FG010|Overall Study|Lost to Follow-up|0|||
16532012|NCT01786512|40413791|FG000|Overall Study|Decision by sponsor|0|||
16532013|NCT01786512|40413792|FG001|Overall Study|Decision by sponsor|0|||
16532014|NCT01786512|40413793|FG002|Overall Study|Decision by sponsor|0|||
16532015|NCT01786512|40413794|FG003|Overall Study|Decision by sponsor|0|||
16532016|NCT01786512|40413795|FG004|Overall Study|Decision by sponsor|0|||
16532017|NCT01786512|40413796|FG005|Overall Study|Decision by sponsor|0|||
16532018|NCT01786512|40413797|FG006|Overall Study|Decision by sponsor|0|||
16532019|NCT01786512|40413798|FG007|Overall Study|Decision by sponsor|0|||
16532020|NCT01786512|40413799|FG008|Overall Study|Decision by sponsor|0|||
16532021|NCT01786512|40413800|FG009|Overall Study|Decision by sponsor|0|||
16532022|NCT01786512|40413801|FG010|Overall Study|Decision by sponsor|2|||
16532023|NCT01786512|40413791|FG000|Overall Study|Withdrawal by Subject|0|||
16532024|NCT01786512|40413792|FG001|Overall Study|Withdrawal by Subject|1|||
16532025|NCT01786512|40413793|FG002|Overall Study|Withdrawal by Subject|0|||
16532026|NCT01786512|40413794|FG003|Overall Study|Withdrawal by Subject|0|||
16332643|NCT03535194|39703383|FG001|Post-Treatment Followup Period|Physician Decision|2|||
16332644|NCT03535194|39703384|FG002|Post-Treatment Followup Period|Physician Decision|1|||
16332645|NCT03535194|39703385|FG003|Post-Treatment Followup Period|Physician Decision|1|||
16332646|NCT03535194|39703386|FG004|Post-Treatment Followup Period|Physician Decision|0|||
16332647|NCT03535194|39703382|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
16332648|NCT03535194|39703383|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
16332649|NCT03535194|39703384|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
16332650|NCT03535194|39703385|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
16402088|NCT00064259|39953737|FG003|Overall Study|Adverse Event|1|||
16402089|NCT01579565|39953741|FG000|Randomized|Adverse Event|1|||
16402090|NCT01579565|39953742|FG001|Randomized|Adverse Event|3|||
16402091|NCT01579565|39953741|FG000|Randomized|Withdrawal by Subject|3|||
16532027|NCT01786512|40413795|FG004|Overall Study|Withdrawal by Subject|0|||
16532028|NCT01786512|40413796|FG005|Overall Study|Withdrawal by Subject|0|||
16532029|NCT01786512|40413797|FG006|Overall Study|Withdrawal by Subject|1|||
16532030|NCT01786512|40413798|FG007|Overall Study|Withdrawal by Subject|0|||
16402092|NCT01579565|39953742|FG001|Randomized|Withdrawal by Subject|0|||
16402093|NCT01579565|39953741|FG000|Randomized|inadequate preoperative pupil dilation|0|||
16402094|NCT01579565|39953742|FG001|Randomized|inadequate preoperative pupil dilation|1|||
16402095|NCT01579565|39953741|FG000|Randomized|prohibited preoperative eating|1|||
16402096|NCT01579565|39953742|FG001|Randomized|prohibited preoperative eating|0|||
16402097|NCT01579565|39953741|FG000|Randomized|prohibited preoperative medication|0|||
16402098|NCT01579565|39953742|FG001|Randomized|prohibited preoperative medication|1|||
16402099|NCT01579565|39953741|FG000|Treated|Physician Decision|0|||
16402100|NCT01579565|39953742|FG001|Treated|Physician Decision|1|||
16402101|NCT01579565|39953741|FG000|Treated|Lost to Follow-up|2|||
16402102|NCT01579565|39953742|FG001|Treated|Lost to Follow-up|1|||
16402103|NCT01579565|39953741|FG000|Treated|declined to return for final visit|0|||
16402104|NCT01579565|39953742|FG001|Treated|declined to return for final visit|1|||
16402105|NCT00676520|39953743|FG000|Overall Study|Withdrawal by Subject|163|||
16402106|NCT00676520|39953743|FG000|Overall Study|Lost to Follow-up|162|||
16402107|NCT00676520|39953743|FG000|Overall Study|Death|159|||
16402108|NCT00676520|39953743|FG000|Overall Study|Physician Decision|20|||
16402109|NCT00676520|39953743|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
16402110|NCT00676520|39953743|FG000|Overall Study|Other Reason|18|||
16402111|NCT03245736|39953748|FG000|Overall Study|Adverse Event|1|||
16402112|NCT03245736|39953748|FG000|Overall Study|Progressive Disease|4|||
16402113|NCT02585830|39953749|FG000|Overall Study|Withdrawal by Subject|3|||
16402114|NCT01988662|39953752|FG000|Overall Study|Subject/guardian decision|1|||
16402115|NCT01988662|39953753|FG001|Overall Study|Subject/guardian decision|1|||
16402116|NCT01988662|39953752|FG000|Overall Study|Adverse Event|3|||
16402117|NCT01988662|39953753|FG001|Overall Study|Adverse Event|1|||
16402118|NCT02576535|39953754|FG000|Overall Study|Withdrawal by Subject|2|||
16402119|NCT01751906|39953755|FG000|Overall Study|Lost to Follow-up|151|||
16402120|NCT01751906|39953756|FG001|Overall Study|Lost to Follow-up|68|||
16402121|NCT01751906|39953755|FG000|Overall Study|Withdrawal by Subject|22|||
16402122|NCT01751906|39953756|FG001|Overall Study|Withdrawal by Subject|18|||
16402123|NCT01751906|39953755|FG000|Overall Study|Physician Decision|5|||
16402124|NCT01751906|39953756|FG001|Overall Study|Physician Decision|2|||
16402125|NCT01751906|39953755|FG000|Overall Study|Death|84|||
16402126|NCT01751906|39953756|FG001|Overall Study|Death|43|||
16402127|NCT01751906|39953755|FG000|Overall Study|Denied on premises for follow-up by law|1|||
16402128|NCT01751906|39953756|FG001|Overall Study|Denied on premises for follow-up by law|0|||
16402129|NCT04417218|39953757|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
16402130|NCT04417218|39953758|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
16402131|NCT00368836|39953759|FG000|Phase II|Screen Failure|1|||
16402132|NCT00368836|39953759|FG000|Phase II|Withdrawal by Subject|1|||
16402133|NCT00368836|39953759|FG000|Phase II|unable to collect blood and/or breath|17|||
16402134|NCT00368836|39953759|FG000|Phase II|Protocol Violation|2|||
16402135|NCT01639339|39953760|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
16402136|NCT01639339|39953761|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
16402137|NCT01639339|39953760|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
16402138|NCT01639339|39953761|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
16402139|NCT01639339|39953760|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
16402140|NCT01639339|39953761|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
16402141|NCT01639339|39953760|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
16402142|NCT01639339|39953761|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
16402143|NCT01639339|39953760|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
16402144|NCT01639339|39953761|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
16402145|NCT01639339|39953760|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
16402146|NCT01639339|39953761|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
16402147|NCT01639339|39953760|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
16402148|NCT01639339|39953761|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
16402149|NCT01639339|39953760|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
16402150|NCT01639339|39953761|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
16402151|NCT01639339|39953760|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
16402152|NCT01639339|39953761|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
16402153|NCT01639339|39953760|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
16402154|NCT01639339|39953761|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
16402155|NCT01961297|39953763|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
16402156|NCT01961297|39953764|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
16402157|NCT01549886|39953765|FG000|Overall Study|Sponsor's decision|2|||
16402158|NCT01549886|39953766|FG001|Overall Study|Sponsor's decision|3|||
16402159|NCT02256384|39953767|FG000|Overall Study|Withdrawal by Subject|12|||
16402160|NCT02256384|39953767|FG000|Overall Study|Equipment not capturing data|2|||
16402161|NCT03645421|39953768|FG000|Overall Study|Adverse Event|0|||
16402162|NCT03645421|39953769|FG001|Overall Study|Adverse Event|0|||
16402163|NCT03645421|39953770|FG002|Overall Study|Adverse Event|4|||
16402164|NCT03645421|39953771|FG003|Overall Study|Adverse Event|1|||
16402165|NCT03645421|39953768|FG000|Overall Study|Withdrawal by patient|0|||
16402166|NCT03645421|39953769|FG001|Overall Study|Withdrawal by patient|0|||
16402167|NCT03645421|39953770|FG002|Overall Study|Withdrawal by patient|0|||
16402168|NCT03645421|39953771|FG003|Overall Study|Withdrawal by patient|3|||
16402169|NCT03645421|39953768|FG000|Overall Study|Study specific withdrawal criteria|0|||
16402170|NCT03645421|39953769|FG001|Overall Study|Study specific withdrawal criteria|0|||
16402171|NCT03645421|39953770|FG002|Overall Study|Study specific withdrawal criteria|1|||
16402172|NCT03645421|39953771|FG003|Overall Study|Study specific withdrawal criteria|0|||
16402173|NCT01703208|39953774|FG000|Overall Study|Death|61|||
16402174|NCT01703208|39953775|FG001|Overall Study|Death|48|||
16402175|NCT01703208|39953774|FG000|Overall Study|Lack of Efficacy|1|||
16402176|NCT01703208|39953775|FG001|Overall Study|Lack of Efficacy|2|||
16402177|NCT01703208|39953774|FG000|Overall Study|Lost to Follow-up|68|||
16402178|NCT01703208|39953775|FG001|Overall Study|Lost to Follow-up|62|||
16402179|NCT01703208|39953774|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16402180|NCT01703208|39953775|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16402181|NCT01703208|39953774|FG000|Overall Study|Excluded Medication|1|||
16402182|NCT01703208|39953775|FG001|Overall Study|Excluded Medication|2|||
16402183|NCT01703208|39953774|FG000|Overall Study|Site Discontinued Study Participation|23|||
16402184|NCT01703208|39953775|FG001|Overall Study|Site Discontinued Study Participation|27|||
16402185|NCT01703208|39953774|FG000|Overall Study|Physician Decision|11|||
16402186|NCT01703208|39953775|FG001|Overall Study|Physician Decision|13|||
16402187|NCT01703208|39953774|FG000|Overall Study|Progressive disease|2|||
16402188|NCT01703208|39953775|FG001|Overall Study|Progressive disease|2|||
16402189|NCT01703208|39953774|FG000|Overall Study|Protocol Violation|1|||
16402190|NCT01703208|39953775|FG001|Overall Study|Protocol Violation|1|||
16402191|NCT01703208|39953774|FG000|Overall Study|Study Terminated by Sponsor|1710|||
16402192|NCT01703208|39953775|FG001|Overall Study|Study Terminated by Sponsor|1716|||
16402193|NCT01703208|39953774|FG000|Overall Study|Withdrawal by Subject|205|||
16402194|NCT01703208|39953775|FG001|Overall Study|Withdrawal by Subject|209|||
16402195|NCT01703208|39953774|FG000|Overall Study|Adverse Event|14|||
16402196|NCT01703208|39953775|FG001|Overall Study|Adverse Event|19|||
16402197|NCT01703208|39953774|FG000|Overall Study|Technical Problems|0|||
16402198|NCT01703208|39953775|FG001|Overall Study|Technical Problems|1|||
16402199|NCT01703208|39953774|FG000|Overall Study|Protocol Deviation|2|||
16402200|NCT01703208|39953775|FG001|Overall Study|Protocol Deviation|0|||
16402201|NCT04731298|39953776|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
16402202|NCT04731298|39953777|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
16402203|NCT01089413|39953779|FG000|Overall Study|Lost to Follow-up|1|||
16402204|NCT01089413|39953779|FG000|Overall Study|Progressive Disease|93|||
16402205|NCT01089413|39953779|FG000|Overall Study|Participant Withdrew Consent|1|||
16402206|NCT01089413|39953779|FG000|Overall Study|Unacceptable Toxicity|12|||
16402207|NCT01089413|39953779|FG000|Overall Study|Death|10|||
16402208|NCT01089413|39953779|FG000|Overall Study|Metastasectomy|13|||
16402209|NCT01089413|39953779|FG000|Overall Study|Other|71|||
16402210|NCT04043234|39953790|FG000|Overall Study|Lost to Follow-up|1|||
16402211|NCT04043234|39953790|FG000|Overall Study|Withdrawal by Subject|1|||
16402212|NCT03831191|39953796|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
16402213|NCT03831191|39953797|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
16402214|NCT03831191|39953798|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
16402215|NCT03831191|39953799|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
16402216|NCT03831191|39953800|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
16402217|NCT03831191|39953801|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
16402218|NCT03831191|39953802|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
16402219|NCT03831191|39953803|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
16402220|NCT03831191|39953804|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
16402221|NCT03831191|39953805|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
16402222|NCT03831191|39953806|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
16402223|NCT03831191|39953807|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
16402224|NCT03831191|39953808|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
16402225|NCT03831191|39953809|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
16402226|NCT03831191|39953810|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
16402227|NCT03831191|39953796|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
16402228|NCT03831191|39953797|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
16402229|NCT03831191|39953798|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402230|NCT03831191|39953799|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16215202|NCT00446797|39265676|FG000|Overall Study|subject entered at another site|0|||
16402231|NCT03831191|39953800|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402232|NCT03831191|39953801|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402233|NCT03831191|39953802|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402234|NCT03831191|39953803|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402235|NCT03831191|39953804|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402236|NCT03831191|39953805|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402237|NCT03831191|39953806|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16099786|NCT00296504|38852975|FG000|Interim Analysis|Insufficient CD4 Response|0|||
16099787|NCT00296504|38852976|FG001|Interim Analysis|Insufficient CD4 Response|0|||
16099788|NCT00296504|38852977|FG002|Interim Analysis|Insufficient CD4 Response|0|||
16099789|NCT00296504|38852978|FG003|Interim Analysis|Insufficient CD4 Response|0|||
16099790|NCT00296504|38852979|FG004|Interim Analysis|Insufficient CD4 Response|1|||
16099791|NCT00296504|38852980|FG005|Interim Analysis|Insufficient CD4 Response|1|||
16099792|NCT00296504|38852981|FG006|Interim Analysis|Insufficient CD4 Response|0|||
16099793|NCT00296504|38852982|FG007|Interim Analysis|Insufficient CD4 Response|0|||
16099794|NCT00296504|38852983|FG008|Interim Analysis|Insufficient CD4 Response|0|||
16099795|NCT00296504|38852975|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
16099796|NCT00296504|38852976|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
16099797|NCT00296504|38852977|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
16099798|NCT00296504|38852978|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
16099799|NCT00296504|38852979|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
16099800|NCT00296504|38852980|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
16099801|NCT00296504|38852981|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
16099802|NCT00296504|38852982|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
16402238|NCT03831191|39953807|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402239|NCT03831191|39953808|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402240|NCT03831191|39953809|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402241|NCT03831191|39953810|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
16402242|NCT03831191|39953796|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
16402243|NCT03831191|39953797|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
16402244|NCT03831191|39953798|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
16402245|NCT03831191|39953799|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
16402246|NCT03831191|39953800|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
16532031|NCT01786512|40413799|FG008|Overall Study|Withdrawal by Subject|0|||
16532032|NCT01786512|40413800|FG009|Overall Study|Withdrawal by Subject|3|||
16532033|NCT01786512|40413801|FG010|Overall Study|Withdrawal by Subject|7|||
16532034|NCT01786512|40413791|FG000|Overall Study|Death|0|||
16532035|NCT01786512|40413792|FG001|Overall Study|Death|0|||
16532036|NCT01786512|40413793|FG002|Overall Study|Death|0|||
16402247|NCT03831191|39953801|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
16402248|NCT03831191|39953802|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
16402249|NCT03831191|39953803|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
16402250|NCT03831191|39953804|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
16402251|NCT03831191|39953805|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
16402252|NCT03831191|39953806|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
16402253|NCT03831191|39953807|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
16402254|NCT03831191|39953808|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
16402255|NCT03831191|39953809|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
16402256|NCT03831191|39953810|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
16402257|NCT03831191|39953796|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
16402258|NCT03831191|39953797|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
16402259|NCT03831191|39953798|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
16402260|NCT03831191|39953799|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
16402261|NCT03831191|39953800|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
16402262|NCT03831191|39953801|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
16402263|NCT03831191|39953802|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
16402264|NCT03831191|39953803|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
16402265|NCT03831191|39953804|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
16402266|NCT03831191|39953805|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
16402267|NCT03831191|39953806|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
16402268|NCT03831191|39953807|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
16402269|NCT03831191|39953808|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
16402270|NCT03831191|39953809|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
16402271|NCT03831191|39953810|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
16402272|NCT03831191|39953796|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
16402273|NCT03831191|39953797|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
16402274|NCT03831191|39953798|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
16402275|NCT03831191|39953799|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
16402276|NCT03831191|39953800|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16532037|NCT01786512|40413794|FG003|Overall Study|Death|0|||
16532038|NCT01786512|40413795|FG004|Overall Study|Death|0|||
16532039|NCT01786512|40413796|FG005|Overall Study|Death|0|||
16532040|NCT01786512|40413797|FG006|Overall Study|Death|0|||
16532041|NCT01786512|40413798|FG007|Overall Study|Death|0|||
16532042|NCT01786512|40413799|FG008|Overall Study|Death|4|||
16099803|NCT00296504|38852983|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
16532043|NCT01786512|40413800|FG009|Overall Study|Death|1|||
16532044|NCT01786512|40413801|FG010|Overall Study|Death|3|||
16532045|NCT01949480|40413807|FG000|Overall Study|Physician Decision|5|||
16099804|NCT00296504|38852975|FG000|Interim Analysis|Pregnancy|4|||
16099805|NCT00296504|38852976|FG001|Interim Analysis|Pregnancy|1|||
16099806|NCT00296504|38852977|FG002|Interim Analysis|Pregnancy|4|||
16099807|NCT00296504|38852978|FG003|Interim Analysis|Pregnancy|2|||
16099808|NCT00296504|38852979|FG004|Interim Analysis|Pregnancy|0|||
16099809|NCT00296504|38852980|FG005|Interim Analysis|Pregnancy|1|||
16099810|NCT00296504|38852981|FG006|Interim Analysis|Pregnancy|1|||
16099811|NCT00296504|38852982|FG007|Interim Analysis|Pregnancy|1|||
16099812|NCT00296504|38852983|FG008|Interim Analysis|Pregnancy|0|||
16099813|NCT00296504|38852975|FG000|Interim Analysis|Death|1|||
16099814|NCT00296504|38852976|FG001|Interim Analysis|Death|0|||
16099815|NCT00296504|38852977|FG002|Interim Analysis|Death|3|||
16099816|NCT00296504|38852978|FG003|Interim Analysis|Death|0|||
16099817|NCT00296504|38852979|FG004|Interim Analysis|Death|0|||
16099818|NCT00296504|38852980|FG005|Interim Analysis|Death|0|||
16099819|NCT00296504|38852981|FG006|Interim Analysis|Death|0|||
16099820|NCT00296504|38852982|FG007|Interim Analysis|Death|0|||
16099821|NCT00296504|38852983|FG008|Interim Analysis|Death|0|||
16099822|NCT00296504|38852975|FG000|Interim Analysis|Participant Non-compliant|0|||
16099823|NCT00296504|38852976|FG001|Interim Analysis|Participant Non-compliant|1|||
16099824|NCT00296504|38852977|FG002|Interim Analysis|Participant Non-compliant|2|||
16099825|NCT00296504|38852978|FG003|Interim Analysis|Participant Non-compliant|1|||
16099826|NCT00296504|38852979|FG004|Interim Analysis|Participant Non-compliant|1|||
16099827|NCT00296504|38852980|FG005|Interim Analysis|Participant Non-compliant|3|||
16099828|NCT00296504|38852981|FG006|Interim Analysis|Participant Non-compliant|6|||
16099829|NCT00296504|38852982|FG007|Interim Analysis|Participant Non-compliant|2|||
16099830|NCT00296504|38852983|FG008|Interim Analysis|Participant Non-compliant|0|||
16099831|NCT00296504|38852975|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
16402277|NCT03831191|39953801|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16402278|NCT03831191|39953802|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16402279|NCT03831191|39953803|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16402280|NCT03831191|39953804|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16402281|NCT03831191|39953805|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16402282|NCT03831191|39953806|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16402283|NCT03831191|39953807|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16402284|NCT03831191|39953808|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16402285|NCT03831191|39953809|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16532046|NCT01949480|40413808|FG001|Overall Study|Physician Decision|8|||
16532047|NCT01939028|40413809|FG000|Overall Study|Withdrawal by Subject|5|||
16532048|NCT01939028|40413809|FG000|Overall Study|Physician Decision|7|||
16532049|NCT01597050|40413810|FG000|Overall Study|Withdrawal by Subject|1|||
16532050|NCT01597050|40413811|FG001|Overall Study|Withdrawal by Subject|0|||
16532051|NCT00983073|40413813|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
16532052|NCT00983073|40413813|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
16532053|NCT00983073|40413813|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
16532054|NCT00983073|40413813|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
16532055|NCT00983073|40413813|FG000|Titration and Optimal Dose Period|Other reason|4|||
16532056|NCT00983073|40413813|FG000|Maintenance Period|Adverse Event|5|||
16532057|NCT00983073|40413813|FG000|Maintenance Period|Withdrawal by Subject|2|||
16532058|NCT00983073|40413813|FG000|Maintenance Period|Lack of Efficacy|2|||
16532059|NCT00983073|40413813|FG000|Maintenance Period|Other Reason|7|||
16532060|NCT01349569|40413814|FG000|Overall Study|Lack of Efficacy|4|||
16532061|NCT03826667|40413815|FG000|Overall Study|Protocol deviation|21|||
16532062|NCT00771810|40413818|FG000|Overall Study|Adverse Event|3|||
16532063|NCT00771810|40413819|FG001|Overall Study|Adverse Event|0|||
16532064|NCT00771810|40413820|FG002|Overall Study|Adverse Event|2|||
16532065|NCT00771810|40413818|FG000|Overall Study|Lost to Follow-up|0|||
16532066|NCT00771810|40413819|FG001|Overall Study|Lost to Follow-up|0|||
16532067|NCT00771810|40413820|FG002|Overall Study|Lost to Follow-up|1|||
16532068|NCT00771810|40413818|FG000|Overall Study|Physician Decision|1|||
16532069|NCT00771810|40413819|FG001|Overall Study|Physician Decision|2|||
16532070|NCT00771810|40413820|FG002|Overall Study|Physician Decision|2|||
16532071|NCT00771810|40413818|FG000|Overall Study|Protocol Violation|0|||
16532072|NCT00771810|40413819|FG001|Overall Study|Protocol Violation|1|||
16532073|NCT00771810|40413820|FG002|Overall Study|Protocol Violation|1|||
16532074|NCT00771810|40413818|FG000|Overall Study|Withdrawal by Subject|1|||
16532075|NCT00771810|40413819|FG001|Overall Study|Withdrawal by Subject|2|||
16099832|NCT00296504|38852976|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
16099833|NCT00296504|38852977|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
16402286|NCT03831191|39953810|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16532076|NCT00771810|40413820|FG002|Overall Study|Withdrawal by Subject|0|||
16532077|NCT00771810|40413818|FG000|Overall Study|Other|0|||
16099834|NCT00296504|38852978|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
16099835|NCT00296504|38852979|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
16099836|NCT00296504|38852980|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
16532078|NCT00771810|40413819|FG001|Overall Study|Other|0|||
16532079|NCT00771810|40413820|FG002|Overall Study|Other|1|||
16532080|NCT03521635|40413827|FG000|Overall Study|Adverse Event|1|||
16532081|NCT03521635|40413828|FG001|Overall Study|Adverse Event|1|||
16099837|NCT00296504|38852981|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
16532082|NCT03521635|40413827|FG000|Overall Study|Refused to complete study visit|1|||
16532083|NCT03521635|40413828|FG001|Overall Study|Refused to complete study visit|0|||
16532084|NCT03521635|40413827|FG000|Overall Study|Refused to continue trial medication|2|||
16532085|NCT03521635|40413828|FG001|Overall Study|Refused to continue trial medication|2|||
16532086|NCT03521635|40413827|FG000|Overall Study|Lost to Follow-up|0|||
16532087|NCT03521635|40413828|FG001|Overall Study|Lost to Follow-up|1|||
16532088|NCT03521635|40413827|FG000|Overall Study|Meet exclusion criteria|0|||
16532089|NCT03521635|40413828|FG001|Overall Study|Meet exclusion criteria|1|||
16532090|NCT03521635|40413827|FG000|Overall Study|Patient not taken study medicine|0|||
16532091|NCT03521635|40413828|FG001|Overall Study|Patient not taken study medicine|1|||
16532092|NCT01830127|40413830|FG000|Overall Study|Adverse Event|1|||
16532093|NCT01830127|40413831|FG001|Overall Study|Adverse Event|6|||
16532094|NCT01830127|40413830|FG000|Overall Study|Lack of Efficacy|3|||
16532095|NCT01830127|40413831|FG001|Overall Study|Lack of Efficacy|0|||
16532096|NCT01830127|40413830|FG000|Overall Study|Withdrawal by Subject|1|||
16532097|NCT01830127|40413831|FG001|Overall Study|Withdrawal by Subject|1|||
16532098|NCT01830127|40413830|FG000|Overall Study|Other reason not defined above|0|||
16099838|NCT00296504|38852982|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
16099839|NCT00296504|38852983|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
16099840|NCT00296504|38852975|FG000|Interim Analysis|To Simplify Treatment|0|||
16099841|NCT00296504|38852976|FG001|Interim Analysis|To Simplify Treatment|0|||
16099842|NCT00296504|38852977|FG002|Interim Analysis|To Simplify Treatment|1|||
16332651|NCT03535194|39703386|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16332652|NCT01731470|39703387|FG000|Overall Study|Withdrawal by Subject|1|||
16332653|NCT01731470|39703387|FG000|Overall Study|Did not meet study criteria|1|||
16099843|NCT00296504|38852978|FG003|Interim Analysis|To Simplify Treatment|0|||
16332654|NCT05020366|39703388|FG000|Overall Study|Lost to Follow-up|2|||
16332655|NCT05020366|39703389|FG001|Overall Study|Lost to Follow-up|0|||
16332656|NCT05020366|39703388|FG000|Overall Study|Withdrawal by Subject|2|||
16332657|NCT05020366|39703389|FG001|Overall Study|Withdrawal by Subject|0|||
16332658|NCT03515629|39703400|FG000|Overall Study|Death|0|||
16332659|NCT03515629|39703401|FG001|Overall Study|Death|1|||
16332660|NCT03515629|39703402|FG002|Overall Study|Death|1|||
16332661|NCT03515629|39703400|FG000|Overall Study|Progressive disease|0|||
16332662|NCT03515629|39703401|FG001|Overall Study|Progressive disease|1|||
16332663|NCT03515629|39703402|FG002|Overall Study|Progressive disease|0|||
16332664|NCT00980018|39703404|FG000|Overall Study|Adverse Event|8|||
16332665|NCT00980018|39703404|FG000|Overall Study|Patient withdrew consent|3|||
16332666|NCT00980018|39703404|FG000|Overall Study|Lost to Follow-up|1|||
16332667|NCT00948506|39703407|FG000|Overall Study|Withdrawal by Subject|3|||
16332668|NCT00948506|39703408|FG001|Overall Study|Withdrawal by Subject|1|||
16332669|NCT00033657|39703409|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
16332670|NCT00033657|39703410|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
16332671|NCT00033657|39703409|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
16332672|NCT00033657|39703410|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
16332673|NCT00033657|39703409|FG000|Neoadjuvant Chemotherapy|Death|1|||
16332674|NCT00033657|39703410|FG001|Neoadjuvant Chemotherapy|Death|1|||
16332675|NCT00033657|39703409|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
16332676|NCT00033657|39703410|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
16332677|NCT00033657|39703409|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
16332678|NCT00033657|39703410|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
16332679|NCT00033657|39703409|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
16099844|NCT00296504|38852979|FG004|Interim Analysis|To Simplify Treatment|0|||
16099845|NCT00296504|38852980|FG005|Interim Analysis|To Simplify Treatment|0|||
16099846|NCT00296504|38852981|FG006|Interim Analysis|To Simplify Treatment|2|||
16099847|NCT00296504|38852982|FG007|Interim Analysis|To Simplify Treatment|0|||
16099848|NCT00296504|38852983|FG008|Interim Analysis|To Simplify Treatment|0|||
16099849|NCT00296504|38852975|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
16099850|NCT00296504|38852976|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
16099851|NCT00296504|38852977|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
16099852|NCT00296504|38852978|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
16099853|NCT00296504|38852979|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
16332680|NCT00033657|39703410|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
16332681|NCT00033657|39703409|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
16332682|NCT00033657|39703410|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
16532099|NCT01830127|40413831|FG001|Overall Study|Other reason not defined above|2|||
16099854|NCT00296504|38852980|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
16409985|NCT02536300|39981855|FG001|Overall Study|Death|0|||
16532100|NCT03273946|40413833|FG000|Overall Study|Withdrawal by Subject|5|||
16532101|NCT03273946|40413833|FG000|Overall Study|Unwillingness of the guardian|1|||
16099855|NCT00296504|38852981|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
16099856|NCT00296504|38852982|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
16099857|NCT00296504|38852983|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
16099858|NCT00296504|38852975|FG000|Interim Analysis|Participant Moved|1|||
16099859|NCT00296504|38852976|FG001|Interim Analysis|Participant Moved|0|||
16099860|NCT00296504|38852977|FG002|Interim Analysis|Participant Moved|1|||
16099861|NCT00296504|38852978|FG003|Interim Analysis|Participant Moved|0|||
16099862|NCT00296504|38852979|FG004|Interim Analysis|Participant Moved|0|||
16215203|NCT00446797|39265677|FG001|Overall Study|subject entered at another site|1|||
16215204|NCT00446797|39265676|FG000|Overall Study|did not meet entrance criteria|0|||
16215205|NCT00446797|39265677|FG001|Overall Study|did not meet entrance criteria|1|||
16215206|NCT03742271|39265682|FG000|Overall Study|Unsatisfactory Visual Response|1|||
16215207|NCT03742271|39265682|FG000|Overall Study|Withdrawal by Subject|3|||
16215208|NCT03742271|39265682|FG000|Overall Study|Lost to Follow-up|4|||
16215209|NCT03742271|39265682|FG000|Overall Study|Failed Insertion & removal|3|||
16215210|NCT03742271|39265682|FG000|Overall Study|Protocol Violation|1|||
16215211|NCT01307046|39265683|FG000|Overall Study|Adverse Event|3|||
16215212|NCT01307046|39265684|FG001|Overall Study|Adverse Event|3|||
16215213|NCT01307046|39265683|FG000|Overall Study|Lack of Efficacy|0|||
16215214|NCT01307046|39265684|FG001|Overall Study|Lack of Efficacy|2|||
16215215|NCT01307046|39265683|FG000|Overall Study|Physician Decision|2|||
16215216|NCT01307046|39265684|FG001|Overall Study|Physician Decision|0|||
16215217|NCT01307046|39265683|FG000|Overall Study|Withdrawal by Subject|1|||
16215218|NCT01307046|39265684|FG001|Overall Study|Withdrawal by Subject|1|||
16215219|NCT01307046|39265683|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
16215220|NCT01307046|39265684|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
16215221|NCT01307046|39265683|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
16215222|NCT01307046|39265684|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
16215223|NCT01867580|39265685|FG000|Overall Study|Withdrawal by Subject|2|||
16215224|NCT01867580|39265686|FG001|Overall Study|Withdrawal by Subject|3|||
16215225|NCT01867580|39265685|FG000|Overall Study|Physician Decision|17|||
16215226|NCT01867580|39265686|FG001|Overall Study|Physician Decision|12|||
16215227|NCT01867580|39265685|FG000|Overall Study|Lost to Follow-up|3|||
16215228|NCT01867580|39265686|FG001|Overall Study|Lost to Follow-up|5|||
16215229|NCT01867580|39265685|FG000|Overall Study|Sponsor terminated study|1|||
16215230|NCT01867580|39265686|FG001|Overall Study|Sponsor terminated study|0|||
16215231|NCT01867580|39265685|FG000|Overall Study|Missed follow-up assessment|2|||
16215232|NCT01867580|39265686|FG001|Overall Study|Missed follow-up assessment|1|||
16215233|NCT01867580|39265685|FG000|Overall Study|Interruption to therapy|3|||
16099863|NCT00296504|38852980|FG005|Interim Analysis|Participant Moved|1|||
16099864|NCT00296504|38852981|FG006|Interim Analysis|Participant Moved|1|||
16215234|NCT01867580|39265686|FG001|Overall Study|Interruption to therapy|0|||
16215235|NCT01867580|39265685|FG000|Overall Study|Osteomyelitis|0|||
16215236|NCT01867580|39265686|FG001|Overall Study|Osteomyelitis|1|||
16215237|NCT01867580|39265685|FG000|Overall Study|Continuation of therapy|0|||
16215238|NCT01867580|39265686|FG001|Overall Study|Continuation of therapy|1|||
16215239|NCT01867580|39265685|FG000|Overall Study|Wound recurrence|0|||
16215240|NCT01867580|39265686|FG001|Overall Study|Wound recurrence|1|||
16215241|NCT00472043|39265690|FG000|Overall Study|Withdrawal by Subject|1|||
16215242|NCT00472043|39265691|FG001|Overall Study|Withdrawal by Subject|0|||
16332683|NCT00033657|39703409|FG000|Surgical Resection|not complete resection|0|||
16332684|NCT00033657|39703410|FG001|Surgical Resection|not complete resection|3|||
16099865|NCT00296504|38852982|FG007|Interim Analysis|Participant Moved|0|||
16099866|NCT00296504|38852983|FG008|Interim Analysis|Participant Moved|0|||
16215243|NCT00472043|39265690|FG000|Overall Study|Death|1|||
16215244|NCT00472043|39265691|FG001|Overall Study|Death|0|||
16215245|NCT00693420|39265692|FG000|Overall Study|Adverse Event|4|||
16215246|NCT00693420|39265693|FG001|Overall Study|Adverse Event|4|||
16215247|NCT00693420|39265692|FG000|Overall Study|Lost to Follow-up|0|||
16215248|NCT00693420|39265693|FG001|Overall Study|Lost to Follow-up|3|||
16215249|NCT00693420|39265692|FG000|Overall Study|Withdrawal by Subject|1|||
16215250|NCT00693420|39265693|FG001|Overall Study|Withdrawal by Subject|0|||
16215251|NCT00693420|39265692|FG000|Overall Study|Protocol Violation|0|||
16402287|NCT03831191|39953796|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
16402288|NCT03831191|39953797|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
16402289|NCT03831191|39953798|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
16402290|NCT03831191|39953799|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
16402291|NCT03831191|39953800|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16402292|NCT03831191|39953801|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16402293|NCT03831191|39953802|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16402294|NCT03831191|39953803|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16215252|NCT00693420|39265693|FG001|Overall Study|Protocol Violation|2|||
16215253|NCT00693420|39265692|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
16409986|NCT02536300|39981856|FG002|Overall Study|Death|5|||
16215254|NCT00693420|39265693|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
16215255|NCT00693420|39265692|FG000|Overall Study|Personal Reasons|1|||
16215256|NCT00693420|39265693|FG001|Overall Study|Personal Reasons|4|||
16215257|NCT00893763|39265700|FG000|Overall Study|extubated|110|||
16215258|NCT00893763|39265701|FG001|Overall Study|extubated|110|||
16215259|NCT01355497|39265704|FG000|Overall Study|Death|19|||
16215260|NCT01355497|39265705|FG001|Overall Study|Death|18|||
16215261|NCT01355497|39265704|FG000|Overall Study|Lost to Follow-up|3|||
16215262|NCT01355497|39265705|FG001|Overall Study|Lost to Follow-up|0|||
16215263|NCT01355497|39265704|FG000|Overall Study|Protocol Violation|0|||
16215264|NCT01355497|39265705|FG001|Overall Study|Protocol Violation|1|||
16215265|NCT01355497|39265704|FG000|Overall Study|other-not provided|9|||
16215266|NCT01355497|39265705|FG001|Overall Study|other-not provided|4|||
16215267|NCT01355497|39265704|FG000|Overall Study|Withdrawal by Subject|12|||
16215268|NCT01355497|39265705|FG001|Overall Study|Withdrawal by Subject|20|||
16215269|NCT01355497|39265704|FG000|Overall Study|noncompliance|1|||
16215270|NCT01355497|39265705|FG001|Overall Study|noncompliance|2|||
16215271|NCT01355497|39265704|FG000|Overall Study|progressive disease|11|||
16215272|NCT01355497|39265705|FG001|Overall Study|progressive disease|8|||
16215273|NCT01355497|39265704|FG000|Overall Study|Adverse Event|11|||
16215274|NCT01355497|39265705|FG001|Overall Study|Adverse Event|10|||
16215275|NCT01572480|39265706|FG000|Participants Enrolled|Withdrawal by Subject|1|||
16215276|NCT01572480|39265706|FG000|Drug Administration|Discontinued drug/Off Study|1|||
16215277|NCT01572480|39265706|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
16215278|NCT01572480|39265706|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
16215279|NCT00233324|39265709|FG000|Main Study|Death|68|||
16215280|NCT00233324|39265710|FG001|Main Study|Death|60|||
16215281|NCT00233324|39265711|FG002|Main Study|Death|62|||
16215282|NCT00233324|39265712|FG003|Main Study|Death|47|||
16215283|NCT00233324|39265709|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
16215284|NCT00233324|39265710|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
16215285|NCT00233324|39265711|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
16215286|NCT00233324|39265712|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
16215287|NCT00233324|39265709|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
16215288|NCT00233324|39265710|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
16215289|NCT00233324|39265711|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
16215290|NCT00233324|39265712|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
16215291|NCT00866606|39265713|FG000|Overall Study|Lost to Follow-up|3|||
16215292|NCT00866606|39265713|FG000|Overall Study|Adverse Event|1|||
16215293|NCT00853112|39265725|FG000|Overall Study|Randomized but not treated|0|||
16215294|NCT00853112|39265726|FG001|Overall Study|Randomized but not treated|1|||
16215295|NCT00853112|39265727|FG002|Overall Study|Randomized but not treated|0|||
16215296|NCT00853112|39265728|FG003|Overall Study|Randomized but not treated|2|||
16215297|NCT00853112|39265729|FG004|Overall Study|Randomized but not treated|0|||
16215298|NCT00853112|39265730|FG005|Overall Study|Randomized but not treated|0|||
16215299|NCT00853112|39265731|FG006|Overall Study|Randomized but not treated|1|||
16215300|NCT00464620|39265735|FG000|Overall Study|Physician Decision|1|||
16215301|NCT00464620|39265736|FG001|Overall Study|Physician Decision|0|||
16215302|NCT00464620|39265737|FG002|Overall Study|Physician Decision|0|||
16215303|NCT00464620|39265735|FG000|Overall Study|Withdrawal by Subject|1|||
16215304|NCT00464620|39265736|FG001|Overall Study|Withdrawal by Subject|0|||
16215305|NCT00464620|39265737|FG002|Overall Study|Withdrawal by Subject|3|||
16215306|NCT00464620|39265735|FG000|Overall Study|Ineligible sarcoma subtype|0|||
16215307|NCT00464620|39265736|FG001|Overall Study|Ineligible sarcoma subtype|2|||
16215308|NCT00464620|39265737|FG002|Overall Study|Ineligible sarcoma subtype|2|||
16215309|NCT00464620|39265735|FG000|Overall Study|Use of prohibited concomitant medication|0|||
16215310|NCT00464620|39265736|FG001|Overall Study|Use of prohibited concomitant medication|0|||
16215311|NCT00464620|39265737|FG002|Overall Study|Use of prohibited concomitant medication|2|||
16215312|NCT01634100|39265739|FG000|Overall Study|Withdrawal by Subject|1|||
16215313|NCT01634100|39265740|FG001|Overall Study|Withdrawal by Subject|0|||
16215314|NCT01634100|39265741|FG002|Overall Study|Withdrawal by Subject|1|||
16215315|NCT01634100|39265742|FG003|Overall Study|Withdrawal by Subject|0|||
16215316|NCT01634100|39265743|FG004|Overall Study|Withdrawal by Subject|0|||
16215317|NCT01634100|39265744|FG005|Overall Study|Withdrawal by Subject|0|||
16215318|NCT02728206|39265745|FG000|Overall Study|Death|1|||
16215319|NCT00561340|39265749|FG000|Overall Study|refused to drink pediasure|6|||
16215320|NCT00561340|39265750|FG001|Overall Study|refused to drink pediasure|0|||
16215321|NCT00509028|39265751|FG000|Overall Study|Adverse Event|2|||
16215322|NCT00509028|39265752|FG001|Overall Study|Adverse Event|0|||
16215323|NCT00509028|39265751|FG000|Overall Study|Withdrawal by Subject|4|||
16215324|NCT00509028|39265752|FG001|Overall Study|Withdrawal by Subject|3|||
16215325|NCT00509028|39265751|FG000|Overall Study|Lost to Follow-up|0|||
16215326|NCT00509028|39265752|FG001|Overall Study|Lost to Follow-up|1|||
16215327|NCT00509028|39265751|FG000|Overall Study|Protocol Violation|4|||
16215328|NCT00509028|39265752|FG001|Overall Study|Protocol Violation|2|||
16215329|NCT00509028|39265751|FG000|Overall Study|Non-compliance|2|||
16215330|NCT00509028|39265752|FG001|Overall Study|Non-compliance|1|||
16215331|NCT02668692|39265753|FG000|Overall Study|Adverse Event|1|||
16215332|NCT02668692|39265754|FG001|Overall Study|Adverse Event|0|||
16215333|NCT02038790|39268650|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
16215334|NCT02038790|39268651|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
16215335|NCT01868594|39268652|FG000|Overall Study|Do not meet inclusion criteria|4|||
16215336|NCT01868594|39268653|FG001|Overall Study|Do not meet inclusion criteria|3|||
16215337|NCT03198728|39268655|FG000|Overall Study|Adverse Event|10|||
16215338|NCT03198728|39268656|FG001|Overall Study|Adverse Event|5|||
16215339|NCT03198728|39268655|FG000|Overall Study|Lost to Follow-up|21|||
16215340|NCT03198728|39268656|FG001|Overall Study|Lost to Follow-up|7|||
16215341|NCT03198728|39268655|FG000|Overall Study|Physician Decision|7|||
16215342|NCT03198728|39268656|FG001|Overall Study|Physician Decision|2|||
16215343|NCT03198728|39268655|FG000|Overall Study|Withdrawal by Subject|14|||
16215344|NCT03198728|39268656|FG001|Overall Study|Withdrawal by Subject|10|||
16215345|NCT03950440|39268657|FG000|Overall Study|Death|8|||
16215346|NCT03950440|39268658|FG001|Overall Study|Death|2|||
16215347|NCT03950440|39268659|FG002|Overall Study|Death|1|||
16215348|NCT01756833|39268660|FG000|Overall Study|Withdrawal by Subject|4|||
16215349|NCT01756833|39268661|FG001|Overall Study|Withdrawal by Subject|3|||
16215350|NCT01878175|39268663|FG000|Overall Study|Developed contraindicated health problem|2|||
16215351|NCT02415595|39268670|FG000|Overall Study|Administrative reason by sponsor|39|||
16215352|NCT02415595|39268671|FG001|Overall Study|Administrative reason by sponsor|40|||
16215353|NCT02415595|39268672|FG002|Overall Study|Administrative reason by sponsor|41|||
16215354|NCT02415595|39268673|FG003|Overall Study|Administrative reason by sponsor|39|||
16215355|NCT02415595|39268670|FG000|Overall Study|Adverse Event|1|||
16215356|NCT02415595|39268671|FG001|Overall Study|Adverse Event|3|||
16215357|NCT02415595|39268672|FG002|Overall Study|Adverse Event|5|||
16215358|NCT02415595|39268673|FG003|Overall Study|Adverse Event|10|||
16215359|NCT02415595|39268670|FG000|Overall Study|Lack of Efficacy|4|||
16215360|NCT02415595|39268671|FG001|Overall Study|Lack of Efficacy|4|||
16215361|NCT02415595|39268672|FG002|Overall Study|Lack of Efficacy|0|||
16215362|NCT02415595|39268673|FG003|Overall Study|Lack of Efficacy|0|||
16215363|NCT02415595|39268670|FG000|Overall Study|Lost to Follow-up|1|||
16215364|NCT02415595|39268671|FG001|Overall Study|Lost to Follow-up|3|||
16215365|NCT02415595|39268672|FG002|Overall Study|Lost to Follow-up|1|||
16215366|NCT02415595|39268673|FG003|Overall Study|Lost to Follow-up|1|||
16215367|NCT02415595|39268670|FG000|Overall Study|Poor/Non-compliance|1|||
16215368|NCT02415595|39268671|FG001|Overall Study|Poor/Non-compliance|0|||
16215369|NCT02415595|39268672|FG002|Overall Study|Poor/Non-compliance|1|||
16215370|NCT02415595|39268673|FG003|Overall Study|Poor/Non-compliance|0|||
16215371|NCT02415595|39268670|FG000|Overall Study|Reached stopping criteria|0|||
16215372|NCT02415595|39268671|FG001|Overall Study|Reached stopping criteria|1|||
16215373|NCT02415595|39268672|FG002|Overall Study|Reached stopping criteria|1|||
16215374|NCT02415595|39268673|FG003|Overall Study|Reached stopping criteria|0|||
16215375|NCT02415595|39268670|FG000|Overall Study|Withdrawal by Subject|4|||
16402295|NCT03831191|39953804|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16532102|NCT03273946|40413833|FG000|Overall Study|Participant refused to use the drug|2|||
16532103|NCT03273946|40413833|FG000|Overall Study|Participant relative refused to use drug|1|||
16215376|NCT02415595|39268671|FG001|Overall Study|Withdrawal by Subject|0|||
16215377|NCT02415595|39268672|FG002|Overall Study|Withdrawal by Subject|1|||
16215378|NCT02415595|39268673|FG003|Overall Study|Withdrawal by Subject|3|||
16215379|NCT02415595|39268670|FG000|Overall Study|Other|0|||
16215380|NCT02415595|39268671|FG001|Overall Study|Other|1|||
16215381|NCT02415595|39268672|FG002|Overall Study|Other|1|||
16215382|NCT02415595|39268673|FG003|Overall Study|Other|0|||
16215383|NCT00711412|39268674|FG000|Induction Treatment|Death|2|||
16215384|NCT00711412|39268674|FG000|Induction Treatment|Adverse Event|1|||
16215385|NCT00711412|39268674|FG000|Induction Treatment|Other|1|||
16215386|NCT00711412|39268674|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
16332685|NCT00033657|39703409|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
16332686|NCT00033657|39703410|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
16332687|NCT00033657|39703409|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
16332688|NCT00033657|39703410|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
16332689|NCT00033657|39703409|FG000|Adjuvant Chemotherapy|Death|2|||
16332690|NCT00033657|39703410|FG001|Adjuvant Chemotherapy|Death|1|||
16332691|NCT00033657|39703409|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
16332692|NCT00033657|39703410|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
16332693|NCT00033657|39703409|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
16332694|NCT00033657|39703410|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
16332695|NCT00033657|39703409|FG000|Adjuvant Chemotherapy|Other|0|||
16332696|NCT00033657|39703410|FG001|Adjuvant Chemotherapy|Other|2|||
16332697|NCT03738800|39703411|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
16332698|NCT03738800|39703412|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
16332699|NCT03738800|39703413|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16409987|NCT02536300|39981854|FG000|Overall Study|Withdrew Consent|4|||
16402296|NCT03831191|39953805|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16402297|NCT03831191|39953806|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16402298|NCT03831191|39953807|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16402299|NCT03831191|39953808|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16402300|NCT03831191|39953809|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16402301|NCT03831191|39953810|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
16402302|NCT03831191|39953796|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402303|NCT03831191|39953797|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402304|NCT03831191|39953798|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402305|NCT03831191|39953799|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
16402306|NCT03831191|39953800|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402307|NCT03831191|39953801|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402308|NCT03831191|39953802|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402309|NCT03831191|39953803|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402310|NCT03831191|39953804|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402311|NCT03831191|39953805|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402312|NCT03831191|39953806|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402313|NCT03831191|39953807|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402314|NCT03831191|39953808|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402315|NCT03831191|39953809|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402316|NCT03831191|39953810|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
16402317|NCT03831191|39953796|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
16402318|NCT03831191|39953797|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
16402319|NCT03831191|39953798|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
16402320|NCT03831191|39953799|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
16402321|NCT03831191|39953800|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
16402322|NCT03831191|39953801|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
16402323|NCT03831191|39953802|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
16402324|NCT03831191|39953803|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
16402325|NCT03831191|39953804|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
16402326|NCT03831191|39953805|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
16402327|NCT03831191|39953806|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
16402328|NCT03831191|39953807|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
16402329|NCT03831191|39953808|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
16402330|NCT03831191|39953809|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
16402331|NCT03831191|39953810|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
16402332|NCT03831191|39953796|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402333|NCT03831191|39953797|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402334|NCT03831191|39953798|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402335|NCT03831191|39953799|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402336|NCT03831191|39953800|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402337|NCT03831191|39953801|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402338|NCT03831191|39953802|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402339|NCT03831191|39953803|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402340|NCT03831191|39953804|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402341|NCT03831191|39953805|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402342|NCT03831191|39953806|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402343|NCT03831191|39953807|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402344|NCT03831191|39953808|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402345|NCT03831191|39953809|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
16402346|NCT03831191|39953810|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
16402347|NCT03831191|39953796|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402348|NCT03831191|39953797|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402349|NCT03831191|39953798|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402350|NCT03831191|39953799|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402351|NCT03831191|39953800|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402352|NCT03831191|39953801|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402353|NCT03831191|39953802|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402354|NCT03831191|39953803|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402355|NCT03831191|39953804|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402356|NCT03831191|39953805|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402357|NCT03831191|39953806|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402358|NCT03831191|39953807|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402359|NCT03831191|39953808|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402360|NCT03831191|39953809|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
16402361|NCT03831191|39953810|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
16402362|NCT00096226|39953811|FG000|Overall Study|Ineligible|2|||
16402363|NCT00096226|39953811|FG000|Overall Study|Protocol treatment not started|1|||
16402364|NCT01986231|39953816|FG000|Overall Study|Adverse Event|1|||
16402365|NCT02095873|39953822|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
16402366|NCT02095873|39953823|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
16402367|NCT02095873|39953822|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
16402368|NCT02095873|39953823|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
16402369|NCT02095873|39953822|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
16402370|NCT02095873|39953823|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
16402371|NCT02839720|39953828|FG000|Overall Study|Adverse Event|2|||
16402372|NCT02839720|39953828|FG000|Overall Study|Non-compliance|2|||
16402373|NCT02839720|39953828|FG000|Overall Study|Intercurrent Illness|1|||
16402374|NCT02839720|39953828|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
16402375|NCT01774097|39953829|FG000|Overall Study|Withdrawal by Subject|1|||
16402376|NCT01774097|39953830|FG001|Overall Study|Withdrawal by Subject|1|||
16402377|NCT01774097|39953829|FG000|Overall Study|Adverse Event|1|||
16402378|NCT01774097|39953830|FG001|Overall Study|Adverse Event|1|||
16402379|NCT04091581|39953831|FG000|Overall Study|Lost to Follow-up|0|||
16402380|NCT04091581|39953832|FG001|Overall Study|Lost to Follow-up|1|||
16402381|NCT00246025|39953833|FG000|Overall Study|Adverse Event|7|||
16402382|NCT00246025|39953834|FG001|Overall Study|Adverse Event|9|||
16402383|NCT00246025|39953835|FG002|Overall Study|Adverse Event|9|||
16402384|NCT00246025|39953836|FG003|Overall Study|Adverse Event|10|||
16402385|NCT00246025|39953833|FG000|Overall Study|Withdrawal by Subject|3|||
16402386|NCT00246025|39953834|FG001|Overall Study|Withdrawal by Subject|0|||
16402387|NCT00246025|39953835|FG002|Overall Study|Withdrawal by Subject|1|||
16402388|NCT00246025|39953836|FG003|Overall Study|Withdrawal by Subject|2|||
16402389|NCT00246025|39953833|FG000|Overall Study|unsuitable medical history was found|0|||
16402390|NCT00246025|39953834|FG001|Overall Study|unsuitable medical history was found|0|||
16402391|NCT00246025|39953835|FG002|Overall Study|unsuitable medical history was found|0|||
16402392|NCT00246025|39953836|FG003|Overall Study|unsuitable medical history was found|1|||
16402393|NCT02557100|39956715|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
16402394|NCT02557100|39956716|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
16402395|NCT02557100|39956717|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
16402396|NCT02557100|39956715|FG000|Single Blind Treatment Period|Death|0|||
16402397|NCT02557100|39956716|FG001|Single Blind Treatment Period|Death|1|||
16402398|NCT02557100|39956717|FG002|Single Blind Treatment Period|Death|0|||
16402399|NCT02557100|39956715|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
16402400|NCT02557100|39956716|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
16402401|NCT02557100|39956717|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
16402402|NCT02557100|39956715|FG000|Single Blind Treatment Period|Adverse Event|0|||
16402403|NCT02557100|39956716|FG001|Single Blind Treatment Period|Adverse Event|1|||
16402404|NCT02557100|39956717|FG002|Single Blind Treatment Period|Adverse Event|0|||
16402405|NCT02557100|39956715|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
16402406|NCT02557100|39956716|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
16402407|NCT02557100|39956717|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
16402408|NCT02557100|39956715|FG000|Cumulative Abatacept Period|Other Reasons|0|||
16402409|NCT02557100|39956716|FG001|Cumulative Abatacept Period|Other Reasons|0|||
16402410|NCT02557100|39956717|FG002|Cumulative Abatacept Period|Other Reasons|1|||
16402411|NCT02557100|39956715|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
16402412|NCT02557100|39956716|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
16402413|NCT02557100|39956717|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
16402414|NCT02557100|39956715|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
16402415|NCT02557100|39956716|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
16402416|NCT02557100|39956717|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
16402417|NCT00322023|39956718|FG000|Overall Study|various|0|||
16402418|NCT00322023|39956719|FG001|Overall Study|various|2|||
16402419|NCT00322023|39956720|FG002|Overall Study|various|6|||
16402420|NCT01734395|39956721|FG000|Overall Study|Other|65|||
16402421|NCT01734395|39956721|FG000|Overall Study|Lost to Follow-up|287|||
16402422|NCT01734395|39956721|FG000|Overall Study|Lack of Efficacy|5|||
16402423|NCT01734395|39956721|FG000|Overall Study|Adverse Event|40|||
16402424|NCT01734395|39956721|FG000|Overall Study|Withdrawal by Subject|10|||
16402425|NCT01734395|39956721|FG000|Overall Study|Missing the reasons for not completed|3|||
16402426|NCT04752566|39956722|FG000|Overall Study|Protocol Violation|0|||
16402427|NCT04752566|39956723|FG001|Overall Study|Protocol Violation|1|||
16402428|NCT04752566|39956722|FG000|Overall Study|Death|1|||
16402429|NCT04752566|39956723|FG001|Overall Study|Death|0|||
16402430|NCT04752566|39956722|FG000|Overall Study|Adverse Event|1|||
16402431|NCT04752566|39956723|FG001|Overall Study|Adverse Event|0|||
16402432|NCT04752566|39956722|FG000|Overall Study|Withdrawal by Subject|2|||
16402433|NCT04752566|39956723|FG001|Overall Study|Withdrawal by Subject|0|||
16402434|NCT04752566|39956722|FG000|Overall Study|Physician Decision|1|||
16402435|NCT04752566|39956723|FG001|Overall Study|Physician Decision|1|||
16402436|NCT02524275|39956724|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
16402437|NCT00404755|39956733|FG000|Phase I (Bupropion)|Adverse Event|3|||
16402438|NCT00404755|39956733|FG000|Phase I (Bupropion)|Other|1|||
16402439|NCT00404755|39956733|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
16402440|NCT00712725|39956736|FG000|Overall Study|Adverse Event|1|||
16402441|NCT00712725|39956737|FG001|Overall Study|Adverse Event|0|||
16402442|NCT00712725|39956738|FG002|Overall Study|Adverse Event|0|||
16402443|NCT00712725|39956739|FG003|Overall Study|Adverse Event|1|||
16402444|NCT00712725|39956740|FG004|Overall Study|Adverse Event|0|||
16402445|NCT00712725|39956741|FG005|Overall Study|Adverse Event|0|||
16402446|NCT00712725|39956742|FG006|Overall Study|Adverse Event|0|||
16402447|NCT00712725|39956743|FG007|Overall Study|Adverse Event|0|||
16402448|NCT00712725|39956736|FG000|Overall Study|Lost to Follow-up|3|||
16402449|NCT00712725|39956737|FG001|Overall Study|Lost to Follow-up|2|||
16402450|NCT00712725|39956738|FG002|Overall Study|Lost to Follow-up|1|||
16402451|NCT00712725|39956739|FG003|Overall Study|Lost to Follow-up|1|||
16402452|NCT00712725|39956740|FG004|Overall Study|Lost to Follow-up|2|||
16402453|NCT00712725|39956741|FG005|Overall Study|Lost to Follow-up|2|||
16402454|NCT00712725|39956742|FG006|Overall Study|Lost to Follow-up|3|||
16402455|NCT00712725|39956743|FG007|Overall Study|Lost to Follow-up|1|||
16402456|NCT00712725|39956736|FG000|Overall Study|Physician Decision|2|||
16402457|NCT00712725|39956737|FG001|Overall Study|Physician Decision|0|||
16402458|NCT00712725|39956738|FG002|Overall Study|Physician Decision|0|||
16402459|NCT00712725|39956739|FG003|Overall Study|Physician Decision|0|||
16402460|NCT00712725|39956740|FG004|Overall Study|Physician Decision|1|||
16402461|NCT00712725|39956741|FG005|Overall Study|Physician Decision|0|||
16402462|NCT00712725|39956742|FG006|Overall Study|Physician Decision|2|||
16402463|NCT00712725|39956743|FG007|Overall Study|Physician Decision|0|||
16402464|NCT00712725|39956736|FG000|Overall Study|Pregnancy|0|||
16532104|NCT03461003|40413834|FG000|Overall Study|Lost to Follow-up|2|||
16532105|NCT03461003|40413835|FG001|Overall Study|Lost to Follow-up|2|||
16532106|NCT03461003|40413834|FG000|Overall Study|Withdrawal by Subject|3|||
16532107|NCT03461003|40413835|FG001|Overall Study|Withdrawal by Subject|1|||
16532108|NCT01380327|40413836|FG000|Overall Study|Lost to Follow-up|0|||
16532109|NCT01380327|40413837|FG001|Overall Study|Lost to Follow-up|1|||
16532110|NCT01380327|40413838|FG002|Overall Study|Lost to Follow-up|1|||
16532111|NCT01380327|40413836|FG000|Overall Study|Protocol Violation|3|||
16532112|NCT01380327|40413837|FG001|Overall Study|Protocol Violation|2|||
16532113|NCT01380327|40413838|FG002|Overall Study|Protocol Violation|3|||
16532114|NCT01380327|40413836|FG000|Overall Study|Withdrawal by Subject|0|||
16532115|NCT01380327|40413837|FG001|Overall Study|Withdrawal by Subject|0|||
16532116|NCT01380327|40413838|FG002|Overall Study|Withdrawal by Subject|1|||
16532117|NCT01380327|40413836|FG000|Overall Study|Housing situation precluded ability to k|0|||
16532118|NCT01380327|40413837|FG001|Overall Study|Housing situation precluded ability to k|0|||
16532119|NCT01380327|40413838|FG002|Overall Study|Housing situation precluded ability to k|1|||
16532120|NCT01380327|40413836|FG000|Overall Study|Questionable onset of epilepsy|0|||
16532121|NCT01380327|40413837|FG001|Overall Study|Questionable onset of epilepsy|0|||
16532122|NCT01380327|40413838|FG002|Overall Study|Questionable onset of epilepsy|1|||
16532123|NCT00344461|40413839|FG000|Overall Study|Adverse Event|6|||
16532124|NCT00344461|40413839|FG000|Overall Study|Death|1|||
16532125|NCT00344461|40413839|FG000|Overall Study|Lack of Efficacy|2|||
16532126|NCT00344461|40413839|FG000|Overall Study|Lost to Follow-up|2|||
16532127|NCT00344461|40413839|FG000|Overall Study|Physician Decision|2|||
16532128|NCT00344461|40413839|FG000|Overall Study|Protocol Violation|6|||
16532129|NCT00344461|40413839|FG000|Overall Study|Withdrawal by Subject|2|||
16532130|NCT00743366|40413840|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
16532131|NCT00743366|40413841|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
16532132|NCT01618162|40413842|FG000|Overall Study|Protocol Violation|13|||
16532133|NCT01618162|40413843|FG001|Overall Study|Protocol Violation|10|||
16532134|NCT01618162|40413842|FG000|Overall Study|Adverse Event|9|||
16532135|NCT01618162|40413843|FG001|Overall Study|Adverse Event|2|||
16532136|NCT01618162|40413842|FG000|Overall Study|Withdrawal Criteria|2|||
16532137|NCT01618162|40413843|FG001|Overall Study|Withdrawal Criteria|10|||
16532138|NCT01618162|40413842|FG000|Overall Study|Unclassified|14|||
16532139|NCT01618162|40413843|FG001|Overall Study|Unclassified|13|||
16532140|NCT03743038|40413845|FG000|Overall Study|Physician Decision|1|||
16532141|NCT01022762|40413852|FG000|Overall Study|Adverse Event|3|||
16402465|NCT00712725|39956737|FG001|Overall Study|Pregnancy|1|||
16402466|NCT00712725|39956738|FG002|Overall Study|Pregnancy|0|||
16532142|NCT01022762|40413853|FG001|Overall Study|Adverse Event|1|||
16532143|NCT01022762|40413852|FG000|Overall Study|Lack of Efficacy|0|||
16532144|NCT01022762|40413853|FG001|Overall Study|Lack of Efficacy|1|||
16532145|NCT01022762|40413852|FG000|Overall Study|Protocol Violation|7|||
16532146|NCT01022762|40413853|FG001|Overall Study|Protocol Violation|6|||
16099867|NCT00296504|38852975|FG000|Interim Analysis|Participant Was Incarcerated|2|||
16099868|NCT00296504|38852976|FG001|Interim Analysis|Participant Was Incarcerated|0|||
16099869|NCT00296504|38852977|FG002|Interim Analysis|Participant Was Incarcerated|1|||
16099870|NCT00296504|38852978|FG003|Interim Analysis|Participant Was Incarcerated|0|||
16099871|NCT00296504|38852979|FG004|Interim Analysis|Participant Was Incarcerated|0|||
16099872|NCT00296504|38852980|FG005|Interim Analysis|Participant Was Incarcerated|0|||
16099873|NCT00296504|38852981|FG006|Interim Analysis|Participant Was Incarcerated|0|||
16099874|NCT00296504|38852982|FG007|Interim Analysis|Participant Was Incarcerated|0|||
16099875|NCT00296504|38852983|FG008|Interim Analysis|Participant Was Incarcerated|0|||
16099876|NCT00296504|38852975|FG000|Interim Analysis|Resistance to FPV|0|||
16099877|NCT00296504|38852976|FG001|Interim Analysis|Resistance to FPV|0|||
16099878|NCT00296504|38852977|FG002|Interim Analysis|Resistance to FPV|1|||
16099879|NCT00296504|38852978|FG003|Interim Analysis|Resistance to FPV|0|||
16099880|NCT00296504|38852979|FG004|Interim Analysis|Resistance to FPV|0|||
16332700|NCT03738800|39703411|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
16332701|NCT03738800|39703412|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
16332702|NCT03738800|39703413|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
16332703|NCT03738800|39703411|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
16332704|NCT03738800|39703412|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
16332705|NCT03738800|39703413|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
16332706|NCT02918552|39703418|FG000|Overall Study|Failed Pharmacokinetics|1|||
16332707|NCT02918552|39703419|FG001|Overall Study|Failed Pharmacokinetics|0|||
16332708|NCT02918552|39703418|FG000|Overall Study|Withdrawal by Subject|0|||
16332709|NCT02918552|39703419|FG001|Overall Study|Withdrawal by Subject|1|||
16332710|NCT02918552|39703418|FG000|Overall Study|Lost to Follow-up|0|||
16332711|NCT02918552|39703419|FG001|Overall Study|Lost to Follow-up|1|||
16332712|NCT00875433|39703420|FG000|Overall Study|Progressive disease|41|||
16332713|NCT00875433|39703420|FG000|Overall Study|Other Adverse Event|14|||
16332714|NCT00875433|39703420|FG000|Overall Study|Withdrawal by Subject|2|||
16332715|NCT00875433|39703420|FG000|Overall Study|Other|3|||
16332716|NCT00328094|39703421|FG000|Overall Study|Physician Decision|3|||
16332717|NCT00328094|39703422|FG001|Overall Study|Physician Decision|3|||
16332718|NCT00979420|39703423|FG000|Overall Study|Adverse Event|1|||
16332719|NCT00979420|39703424|FG001|Overall Study|Adverse Event|0|||
16532147|NCT01022762|40413852|FG000|Overall Study|Unclassified|12|||
16532148|NCT01022762|40413853|FG001|Overall Study|Unclassified|20|||
16532149|NCT02777593|40413854|FG000|Overall Study|Still in study|28|||
16532150|NCT02777593|40413855|FG001|Overall Study|Still in study|71|||
16532151|NCT02777593|40413856|FG002|Overall Study|Still in study|5|||
16532152|NCT02777593|40413857|FG003|Overall Study|Still in study|6|||
16532153|NCT02777593|40413858|FG004|Overall Study|Still in study|6|||
16532154|NCT02777593|40413854|FG000|Overall Study|Death|19|||
16532155|NCT02777593|40413855|FG001|Overall Study|Death|24|||
16532156|NCT02777593|40413856|FG002|Overall Study|Death|0|||
16532157|NCT02777593|40413857|FG003|Overall Study|Death|5|||
16532158|NCT02777593|40413858|FG004|Overall Study|Death|0|||
16402467|NCT00712725|39956739|FG003|Overall Study|Pregnancy|0|||
16402468|NCT00712725|39956740|FG004|Overall Study|Pregnancy|1|||
16402469|NCT00712725|39956741|FG005|Overall Study|Pregnancy|0|||
16402470|NCT00712725|39956742|FG006|Overall Study|Pregnancy|2|||
16402471|NCT00712725|39956743|FG007|Overall Study|Pregnancy|0|||
16402472|NCT00712725|39956736|FG000|Overall Study|Protocol Violation|2|||
16402473|NCT00712725|39956737|FG001|Overall Study|Protocol Violation|0|||
16402474|NCT00712725|39956738|FG002|Overall Study|Protocol Violation|1|||
16402475|NCT00712725|39956739|FG003|Overall Study|Protocol Violation|3|||
16402476|NCT00712725|39956740|FG004|Overall Study|Protocol Violation|2|||
16402477|NCT00712725|39956741|FG005|Overall Study|Protocol Violation|0|||
16402478|NCT00712725|39956742|FG006|Overall Study|Protocol Violation|1|||
16402479|NCT00712725|39956743|FG007|Overall Study|Protocol Violation|1|||
16402480|NCT00712725|39956736|FG000|Overall Study|Withdrawal by Subject|2|||
16402481|NCT00712725|39956737|FG001|Overall Study|Withdrawal by Subject|1|||
16402482|NCT00712725|39956738|FG002|Overall Study|Withdrawal by Subject|1|||
16402483|NCT00712725|39956739|FG003|Overall Study|Withdrawal by Subject|2|||
16402484|NCT00712725|39956740|FG004|Overall Study|Withdrawal by Subject|1|||
16402485|NCT00712725|39956741|FG005|Overall Study|Withdrawal by Subject|1|||
16402486|NCT00712725|39956742|FG006|Overall Study|Withdrawal by Subject|1|||
16402487|NCT00712725|39956743|FG007|Overall Study|Withdrawal by Subject|2|||
16402488|NCT00712725|39956736|FG000|Overall Study|Lack of Qualifying Event|16|||
16402489|NCT00712725|39956737|FG001|Overall Study|Lack of Qualifying Event|2|||
16402490|NCT00712725|39956738|FG002|Overall Study|Lack of Qualifying Event|6|||
16402491|NCT00712725|39956739|FG003|Overall Study|Lack of Qualifying Event|8|||
16402492|NCT00712725|39956740|FG004|Overall Study|Lack of Qualifying Event|11|||
16402493|NCT00712725|39956741|FG005|Overall Study|Lack of Qualifying Event|13|||
16402494|NCT00712725|39956742|FG006|Overall Study|Lack of Qualifying Event|11|||
16402495|NCT00712725|39956743|FG007|Overall Study|Lack of Qualifying Event|6|||
16402496|NCT00712725|39956736|FG000|Overall Study|Protocol Specified Criteria|3|||
16402497|NCT00712725|39956737|FG001|Overall Study|Protocol Specified Criteria|0|||
16402498|NCT00712725|39956738|FG002|Overall Study|Protocol Specified Criteria|1|||
16402499|NCT00712725|39956739|FG003|Overall Study|Protocol Specified Criteria|2|||
16402500|NCT00712725|39956740|FG004|Overall Study|Protocol Specified Criteria|1|||
16402501|NCT00712725|39956741|FG005|Overall Study|Protocol Specified Criteria|0|||
16402502|NCT00712725|39956742|FG006|Overall Study|Protocol Specified Criteria|2|||
16402503|NCT00712725|39956743|FG007|Overall Study|Protocol Specified Criteria|1|||
16402504|NCT02513485|39956744|FG000|Overall Study|Adverse Event|1|||
16402505|NCT02513485|39956745|FG001|Overall Study|Adverse Event|0|||
16402506|NCT02403817|39956746|FG000|Overall Study|Withdrawal by Subject|5|||
16402507|NCT02403817|39956747|FG001|Overall Study|Withdrawal by Subject|0|||
16402508|NCT04027049|39956749|FG000|Overall Study|Withdrawn by family|1|||
16402509|NCT04027049|39956750|FG001|Overall Study|Withdrawn by family|0|||
16402510|NCT04027049|39956749|FG000|Overall Study|Participant safety|1|||
16402511|NCT04027049|39956750|FG001|Overall Study|Participant safety|0|||
16402512|NCT00948857|39956751|FG000|Overall Study|Lost to Follow-up|1|||
16402513|NCT00948857|39956752|FG001|Overall Study|Lost to Follow-up|0|||
16402514|NCT00072293|39956760|FG000|Overall Study|Lost to Follow-up|1|||
16402515|NCT00072293|39956761|FG001|Overall Study|Lost to Follow-up|1|||
16402516|NCT00072293|39956760|FG000|Overall Study|Withdrawal by Subject|0|||
16402517|NCT00072293|39956761|FG001|Overall Study|Withdrawal by Subject|1|||
16402518|NCT01659996|39956766|FG000|Overall Study|Protocol Violation|3|||
16402519|NCT01659996|39956767|FG001|Overall Study|Protocol Violation|3|||
16402520|NCT01659996|39956768|FG002|Overall Study|Protocol Violation|3|||
16402521|NCT01659996|39956766|FG000|Overall Study|Lost to Follow-up|1|||
16532159|NCT02777593|40413854|FG000|Overall Study|Withdrawal by Subject|6|||
16532160|NCT02777593|40413855|FG001|Overall Study|Withdrawal by Subject|3|||
16402522|NCT01659996|39956767|FG001|Overall Study|Lost to Follow-up|3|||
16402523|NCT01659996|39956768|FG002|Overall Study|Lost to Follow-up|2|||
16402524|NCT01659996|39956766|FG000|Overall Study|Adverse Event|0|||
16402525|NCT01659996|39956767|FG001|Overall Study|Adverse Event|0|||
16402526|NCT01659996|39956768|FG002|Overall Study|Adverse Event|1|||
16402527|NCT01659996|39956766|FG000|Overall Study|Withdrawal by Subject|4|||
16402528|NCT01659996|39956767|FG001|Overall Study|Withdrawal by Subject|1|||
16402529|NCT01659996|39956768|FG002|Overall Study|Withdrawal by Subject|5|||
16402530|NCT02324205|39956769|FG000|Overall Study|Withdrawal by Subject|37|||
16402531|NCT04195438|39956772|FG000|Overall Study|Withdrawal by Subject|1|||
16402532|NCT00328562|39956773|FG000|Overall Study|Disease progression|1|||
16402533|NCT01331837|39956774|FG000|Overall Study|Death|30|||
16402534|NCT01331837|39956775|FG001|Overall Study|Death|34|||
16402535|NCT01331837|39956774|FG000|Overall Study|Lost to Follow-up|3|||
16402536|NCT01331837|39956775|FG001|Overall Study|Lost to Follow-up|1|||
16402537|NCT01331837|39956774|FG000|Overall Study|Info not recorded|10|||
16402538|NCT01331837|39956775|FG001|Overall Study|Info not recorded|16|||
16402539|NCT01331837|39956774|FG000|Overall Study|Withdrawal by Subject|13|||
16402540|NCT01331837|39956775|FG001|Overall Study|Withdrawal by Subject|16|||
16402541|NCT01062841|39956776|FG000|Overall Study|Indwelling Device Removed|41|||
16402542|NCT01062841|39956777|FG001|Overall Study|Indwelling Device Removed|48|||
16402543|NCT01062841|39956776|FG000|Overall Study|Death|3|||
16402544|NCT01062841|39956777|FG001|Overall Study|Death|5|||
16402545|NCT01062841|39956776|FG000|Overall Study|Withdrawal by Subject|2|||
16402546|NCT01062841|39956777|FG001|Overall Study|Withdrawal by Subject|0|||
16402547|NCT01062841|39956776|FG000|Overall Study|Withdrawal by Study|3|||
16402548|NCT01062841|39956777|FG001|Overall Study|Withdrawal by Study|0|||
16402549|NCT00724854|39956782|FG000|Overall Study|Lack of Efficacy|187|||
16402550|NCT00724854|39956783|FG001|Overall Study|Lack of Efficacy|13|||
16402551|NCT00724854|39956782|FG000|Overall Study|Lost to Follow-up|87|||
16402552|NCT00724854|39956783|FG001|Overall Study|Lost to Follow-up|10|||
16532161|NCT02777593|40413856|FG002|Overall Study|Withdrawal by Subject|1|||
16532162|NCT02777593|40413857|FG003|Overall Study|Withdrawal by Subject|1|||
16532163|NCT02777593|40413858|FG004|Overall Study|Withdrawal by Subject|0|||
16532164|NCT02777593|40413854|FG000|Overall Study|Lost to Follow-up|4|||
16532165|NCT02777593|40413855|FG001|Overall Study|Lost to Follow-up|12|||
16532166|NCT02777593|40413856|FG002|Overall Study|Lost to Follow-up|4|||
16532167|NCT02777593|40413857|FG003|Overall Study|Lost to Follow-up|0|||
16532168|NCT02777593|40413858|FG004|Overall Study|Lost to Follow-up|0|||
16532169|NCT02777593|40413854|FG000|Overall Study|Physician Decision|2|||
16532170|NCT02777593|40413855|FG001|Overall Study|Physician Decision|2|||
16532171|NCT02777593|40413856|FG002|Overall Study|Physician Decision|0|||
16532172|NCT02777593|40413857|FG003|Overall Study|Physician Decision|0|||
16532173|NCT02777593|40413858|FG004|Overall Study|Physician Decision|0|||
16532174|NCT02777593|40413854|FG000|Overall Study|Discontinued due to Other|3|||
16532175|NCT02777593|40413855|FG001|Overall Study|Discontinued due to Other|0|||
16532176|NCT02777593|40413856|FG002|Overall Study|Discontinued due to Other|0|||
16532177|NCT02777593|40413857|FG003|Overall Study|Discontinued due to Other|0|||
16532178|NCT02777593|40413858|FG004|Overall Study|Discontinued due to Other|0|||
16532179|NCT03568318|40413859|FG000|Overall Study|Adverse Event|3|||
16532180|NCT03568318|40413860|FG001|Overall Study|Adverse Event|1|||
16532181|NCT03568318|40413861|FG002|Overall Study|Adverse Event|1|||
16532182|NCT03568318|40413862|FG003|Overall Study|Adverse Event|0|||
16532183|NCT03568318|40413863|FG004|Overall Study|Adverse Event|1|||
16532184|NCT03568318|40413864|FG005|Overall Study|Adverse Event|0|||
16532185|NCT03568318|40413859|FG000|Overall Study|Withdrawal by Subject|6|||
16532186|NCT03568318|40413860|FG001|Overall Study|Withdrawal by Subject|5|||
16532187|NCT03568318|40413861|FG002|Overall Study|Withdrawal by Subject|2|||
16532188|NCT03568318|40413862|FG003|Overall Study|Withdrawal by Subject|1|||
16332720|NCT00979420|39703425|FG002|Overall Study|Adverse Event|0|||
16402553|NCT00724854|39956782|FG000|Overall Study|Adverse Event|62|||
16402554|NCT00724854|39956783|FG001|Overall Study|Adverse Event|4|||
16402555|NCT00724854|39956782|FG000|Overall Study|Other|42|||
16402556|NCT00724854|39956783|FG001|Overall Study|Other|3|||
16402557|NCT00724854|39956782|FG000|Overall Study|Death|11|||
16402558|NCT00724854|39956783|FG001|Overall Study|Death|0|||
16402559|NCT00724854|39956782|FG000|Overall Study|Change of treatment|7|||
16402560|NCT00724854|39956783|FG001|Overall Study|Change of treatment|0|||
16402561|NCT00724854|39956782|FG000|Overall Study|Withdrawal by Subject|5|||
16402562|NCT00724854|39956783|FG001|Overall Study|Withdrawal by Subject|0|||
16402563|NCT00724854|39956782|FG000|Overall Study|Adverse event + lack of efficacy|2|||
16402564|NCT00724854|39956783|FG001|Overall Study|Adverse event + lack of efficacy|1|||
16402565|NCT03172325|39956784|FG000|Overall Study|Adverse Event|2|||
16402566|NCT03172325|39956785|FG001|Overall Study|Adverse Event|3|||
16402567|NCT03172325|39956784|FG000|Overall Study|Positive PPD|1|||
16402568|NCT03172325|39956785|FG001|Overall Study|Positive PPD|0|||
16402569|NCT03172325|39956784|FG000|Overall Study|Poor Compliance|1|||
16402570|NCT03172325|39956785|FG001|Overall Study|Poor Compliance|1|||
16402571|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Adverse Event|76|||
16402572|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Adverse Event|0|||
16402573|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Adverse Event|0|||
16402574|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Death|3|||
16402575|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Death|0|||
16402576|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Death|0|||
16402577|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
16402578|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
16402579|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
16402580|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Physician Decision|9|||
16402581|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Physician Decision|0|||
16402582|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Physician Decision|0|||
16402583|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
16402584|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
16402585|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
16402586|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Disease progression|45|||
16402587|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Disease progression|0|||
16402588|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Disease progression|0|||
16402589|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
16402590|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
16402591|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
16402592|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
16402593|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
16402594|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
16402595|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
16402596|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
16402597|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
16402598|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
16402599|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
16402600|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
16402601|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
16402602|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
16402603|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
16402604|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
16402605|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
16402606|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
16402607|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
16402608|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
16402609|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
16402610|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
16402611|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
16402612|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
16402613|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
16402614|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
16402615|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
16402616|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Promotor request|1|||
16532189|NCT03568318|40413863|FG004|Overall Study|Withdrawal by Subject|0|||
16532190|NCT03568318|40413864|FG005|Overall Study|Withdrawal by Subject|0|||
16532191|NCT03568318|40413859|FG000|Overall Study|Lost to Follow-up|3|||
16532192|NCT03568318|40413860|FG001|Overall Study|Lost to Follow-up|2|||
16332721|NCT00979420|39703426|FG003|Overall Study|Adverse Event|0|||
16402617|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Promotor request|0|||
16402618|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Promotor request|0|||
16402619|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
16402620|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
16402621|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
16409988|NCT02536300|39981855|FG001|Overall Study|Withdrew Consent|2|||
16402622|NCT01461928|39956786|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
16402623|NCT01461928|39956787|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
16402624|NCT01461928|39956788|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
16402625|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Death|3|||
16402626|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Death|0|||
16402627|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Death|0|||
16402628|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
16402629|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
16402630|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
16402631|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
16402632|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
16402633|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
16402634|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Diseases progression|91|||
16402635|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Diseases progression|0|||
16402636|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Diseases progression|0|||
16402637|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Adverse Event|70|||
16402638|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Adverse Event|0|||
16402639|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Adverse Event|0|||
16402640|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Physician Decision|9|||
16402641|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Physician Decision|0|||
16402642|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Physician Decision|0|||
16402643|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
16402644|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
16402645|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
16402646|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
16402647|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
16402648|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
16402649|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
16532193|NCT03568318|40413861|FG002|Overall Study|Lost to Follow-up|2|||
16332722|NCT00979420|39703423|FG000|Overall Study|Lack of Efficacy|3|||
16332723|NCT00979420|39703424|FG001|Overall Study|Lack of Efficacy|0|||
16332724|NCT00979420|39703425|FG002|Overall Study|Lack of Efficacy|1|||
16332725|NCT00979420|39703426|FG003|Overall Study|Lack of Efficacy|1|||
16332726|NCT00979420|39703423|FG000|Overall Study|Other reasons not related to Viramune|3|||
16332727|NCT00979420|39703424|FG001|Overall Study|Other reasons not related to Viramune|0|||
16332728|NCT00979420|39703425|FG002|Overall Study|Other reasons not related to Viramune|0|||
16332729|NCT00979420|39703426|FG003|Overall Study|Other reasons not related to Viramune|1|||
16332730|NCT00934856|39703427|FG000|Feasibility Part|Progressive disease|4|||
16332731|NCT00934856|39703428|FG001|Feasibility Part|Progressive disease|4|||
16332732|NCT00934856|39703429|FG002|Feasibility Part|Progressive disease|2|||
16332733|NCT00934856|39703430|FG003|Feasibility Part|Progressive disease|3|||
16332734|NCT00934856|39703431|FG004|Feasibility Part|Progressive disease|0|||
16332735|NCT00934856|39703432|FG005|Feasibility Part|Progressive disease|0|||
16332736|NCT00934856|39703427|FG000|Feasibility Part|Physician Decision|0|||
16332737|NCT00934856|39703428|FG001|Feasibility Part|Physician Decision|0|||
16332738|NCT00934856|39703429|FG002|Feasibility Part|Physician Decision|1|||
16332739|NCT00934856|39703430|FG003|Feasibility Part|Physician Decision|0|||
16332740|NCT00934856|39703431|FG004|Feasibility Part|Physician Decision|0|||
16332741|NCT00934856|39703432|FG005|Feasibility Part|Physician Decision|0|||
16332742|NCT00934856|39703427|FG000|Feasibility Part|Adverse Event|1|||
16332743|NCT00934856|39703428|FG001|Feasibility Part|Adverse Event|1|||
16332744|NCT00934856|39703429|FG002|Feasibility Part|Adverse Event|0|||
16332745|NCT00934856|39703430|FG003|Feasibility Part|Adverse Event|1|||
16332746|NCT00934856|39703431|FG004|Feasibility Part|Adverse Event|0|||
16332747|NCT00934856|39703432|FG005|Feasibility Part|Adverse Event|2|||
16332748|NCT00934856|39703427|FG000|Feasibility Part|Withdrawal by Subject|0|||
16332749|NCT00934856|39703428|FG001|Feasibility Part|Withdrawal by Subject|0|||
16332750|NCT00934856|39703429|FG002|Feasibility Part|Withdrawal by Subject|0|||
16332751|NCT00934856|39703430|FG003|Feasibility Part|Withdrawal by Subject|1|||
16332752|NCT00934856|39703431|FG004|Feasibility Part|Withdrawal by Subject|0|||
16332753|NCT00934856|39703432|FG005|Feasibility Part|Withdrawal by Subject|1|||
16332754|NCT00934856|39703427|FG000|Extension Part|Adverse Event|0|||
16332755|NCT00934856|39703428|FG001|Extension Part|Adverse Event|0|||
16332756|NCT00934856|39703429|FG002|Extension Part|Adverse Event|0|||
16332757|NCT00934856|39703430|FG003|Extension Part|Adverse Event|1|||
16332758|NCT00934856|39703431|FG004|Extension Part|Adverse Event|4|||
16332759|NCT00934856|39703432|FG005|Extension Part|Adverse Event|4|||
16332760|NCT00934856|39703427|FG000|Extension Part|Progressive disease|0|||
16332761|NCT00934856|39703428|FG001|Extension Part|Progressive disease|0|||
16332762|NCT00934856|39703429|FG002|Extension Part|Progressive disease|0|||
16402650|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
16402651|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
16409989|NCT02536300|39981856|FG002|Overall Study|Withdrew Consent|0|||
16402652|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Not compliant|1|||
16402653|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Not compliant|0|||
16402654|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Not compliant|0|||
16402655|NCT01461928|39956786|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
16402656|NCT01461928|39956787|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
16402657|NCT01461928|39956788|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
16402658|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Adverse Event|0|||
16402659|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Adverse Event|2|||
16402660|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Adverse Event|0|||
16402661|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Death|0|||
16402662|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Death|10|||
16402663|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Death|8|||
16402664|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Physician Decision|0|||
16402665|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Physician Decision|0|||
16402666|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Physician Decision|4|||
16402667|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
16402668|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
16402669|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
16402670|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Moved to another town|0|||
16402671|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Moved to another town|1|||
16402672|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Moved to another town|0|||
16402673|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Disease progression|0|||
16402674|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Disease progression|0|||
16402675|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Disease progression|3|||
16402676|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
16402677|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
16402678|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
16402679|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
16402680|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
16402681|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
16402682|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
16402683|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
16402684|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
16402685|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
16402686|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
16532194|NCT03568318|40413862|FG003|Overall Study|Lost to Follow-up|2|||
16532195|NCT03568318|40413863|FG004|Overall Study|Lost to Follow-up|1|||
16532196|NCT03568318|40413864|FG005|Overall Study|Lost to Follow-up|0|||
16532197|NCT03568318|40413859|FG000|Overall Study|Other|3|||
16532198|NCT03568318|40413860|FG001|Overall Study|Other|1|||
16532199|NCT03568318|40413861|FG002|Overall Study|Other|3|||
16532200|NCT03568318|40413862|FG003|Overall Study|Other|0|||
16532201|NCT03568318|40413863|FG004|Overall Study|Other|0|||
16532202|NCT03568318|40413864|FG005|Overall Study|Other|0|||
16532203|NCT03568318|40413859|FG000|Overall Study|Ongoing at Time of Analysis|5|||
16532204|NCT03568318|40413860|FG001|Overall Study|Ongoing at Time of Analysis|3|||
16532205|NCT03568318|40413861|FG002|Overall Study|Ongoing at Time of Analysis|2|||
16532206|NCT03568318|40413862|FG003|Overall Study|Ongoing at Time of Analysis|1|||
16532207|NCT03568318|40413863|FG004|Overall Study|Ongoing at Time of Analysis|0|||
16532208|NCT03568318|40413864|FG005|Overall Study|Ongoing at Time of Analysis|0|||
16532209|NCT00110617|40413866|FG000|Overall Study|Adverse Event|2|||
16532210|NCT00110617|40413867|FG001|Overall Study|Adverse Event|4|||
16532211|NCT00110617|40413866|FG000|Overall Study|Abnormal Laboratory Value|4|||
16532212|NCT00110617|40413867|FG001|Overall Study|Abnormal Laboratory Value|2|||
16532213|NCT00110617|40413866|FG000|Overall Study|Lack of Efficacy|1|||
16532214|NCT00110617|40413867|FG001|Overall Study|Lack of Efficacy|0|||
16532215|NCT00110617|40413866|FG000|Overall Study|Patient no longer requires study drug|1|||
16532216|NCT00110617|40413867|FG001|Overall Study|Patient no longer requires study drug|0|||
16532217|NCT00110617|40413866|FG000|Overall Study|Protocol Violation|5|||
16532218|NCT00110617|40413867|FG001|Overall Study|Protocol Violation|0|||
16532219|NCT00110617|40413866|FG000|Overall Study|Withdrawal by Subject|10|||
16532220|NCT00110617|40413867|FG001|Overall Study|Withdrawal by Subject|4|||
16532221|NCT00110617|40413866|FG000|Overall Study|Lost to Follow-up|9|||
16532222|NCT00110617|40413867|FG001|Overall Study|Lost to Follow-up|1|||
16532223|NCT00110617|40413866|FG000|Overall Study|Administrative problems|6|||
16532224|NCT00110617|40413867|FG001|Overall Study|Administrative problems|5|||
16532225|NCT00110617|40413866|FG000|Overall Study|Death|1|||
16532226|NCT00110617|40413867|FG001|Overall Study|Death|1|||
16532227|NCT00110617|40413866|FG000|Overall Study|Did not receive study drug|0|||
16402687|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
16402688|NCT01461928|39956786|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
16402689|NCT01461928|39956787|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
16402690|NCT01461928|39956788|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
16402691|NCT04556591|39956789|FG000|Overall Study|Lost to Follow-up|1|||
16402692|NCT04556591|39956790|FG001|Overall Study|Lost to Follow-up|0|||
16402693|NCT04556591|39956789|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
16402694|NCT04556591|39956790|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
16402695|NCT01145352|39956791|FG000|Overall Study|Found to have been registered twice|6|||
16402696|NCT01145352|39956791|FG000|Overall Study|Treated before marketing approval|4|||
16402697|NCT01145352|39956791|FG000|Overall Study|Syringe formulation was used|1|||
16402698|NCT00503776|39956794|FG000|Overall Study|Withdrawal by Subject|1|||
16402699|NCT00503776|39956795|FG001|Overall Study|Withdrawal by Subject|0|||
16402700|NCT00503776|39956796|FG002|Overall Study|Withdrawal by Subject|1|||
16402701|NCT00503776|39956797|FG003|Overall Study|Withdrawal by Subject|1|||
16402702|NCT00503776|39956794|FG000|Overall Study|Physician Decision|0|||
16402703|NCT00503776|39956795|FG001|Overall Study|Physician Decision|0|||
16402704|NCT00503776|39956796|FG002|Overall Study|Physician Decision|1|||
16402705|NCT00503776|39956797|FG003|Overall Study|Physician Decision|1|||
16402706|NCT00778258|39956806|FG000|Overall Study|Adverse Event|1|||
16402707|NCT00778258|39956807|FG001|Overall Study|Adverse Event|0|||
16402708|NCT00778258|39956808|FG002|Overall Study|Adverse Event|0|||
16402709|NCT00778258|39956809|FG003|Overall Study|Adverse Event|0|||
16402710|NCT00778258|39956810|FG004|Overall Study|Adverse Event|0|||
16402711|NCT00778258|39956811|FG005|Overall Study|Adverse Event|1|||
16402712|NCT00778258|39956812|FG006|Overall Study|Adverse Event|0|||
16099881|NCT00296504|38852980|FG005|Interim Analysis|Resistance to FPV|0|||
16099882|NCT00296504|38852981|FG006|Interim Analysis|Resistance to FPV|0|||
16099883|NCT00296504|38852982|FG007|Interim Analysis|Resistance to FPV|0|||
16099884|NCT00296504|38852983|FG008|Interim Analysis|Resistance to FPV|0|||
16215387|NCT00711412|39268674|FG000|Evaluated for Combination Treatment|Death|1|||
16215388|NCT00711412|39268674|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
16215389|NCT00711412|39268674|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
16215390|NCT00711412|39268674|FG000|Combination Treatment|Progressive Disease|1|||
16215391|NCT00711412|39268674|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
16099885|NCT00296504|38852975|FG000|Interim Analysis|Physician Decision|0|||
16099886|NCT00296504|38852976|FG001|Interim Analysis|Physician Decision|0|||
16099887|NCT00296504|38852977|FG002|Interim Analysis|Physician Decision|1|||
16099888|NCT00296504|38852978|FG003|Interim Analysis|Physician Decision|0|||
16099889|NCT00296504|38852979|FG004|Interim Analysis|Physician Decision|0|||
16099890|NCT00296504|38852980|FG005|Interim Analysis|Physician Decision|0|||
16099891|NCT00296504|38852981|FG006|Interim Analysis|Physician Decision|0|||
16099892|NCT00296504|38852982|FG007|Interim Analysis|Physician Decision|0|||
16099893|NCT00296504|38852983|FG008|Interim Analysis|Physician Decision|0|||
16099894|NCT00296504|38852975|FG000|Interim Analysis|Principle Investigator Discretion|2|||
16099895|NCT00296504|38852976|FG001|Interim Analysis|Principle Investigator Discretion|0|||
16099896|NCT00296504|38852977|FG002|Interim Analysis|Principle Investigator Discretion|1|||
16099897|NCT00296504|38852978|FG003|Interim Analysis|Principle Investigator Discretion|1|||
16099898|NCT00296504|38852979|FG004|Interim Analysis|Principle Investigator Discretion|0|||
16099899|NCT00296504|38852980|FG005|Interim Analysis|Principle Investigator Discretion|0|||
16099900|NCT00296504|38852981|FG006|Interim Analysis|Principle Investigator Discretion|0|||
16215392|NCT00711412|39268674|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
16215393|NCT00711412|39268674|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
16215394|NCT00711412|39268674|FG000|Evaluation for Response and Surgery|Death|1|||
16402713|NCT00778258|39956813|FG007|Overall Study|Adverse Event|0|||
16402714|NCT00778258|39956814|FG008|Overall Study|Adverse Event|0|||
16402715|NCT00778258|39956806|FG000|Overall Study|Lost to Follow-up|0|||
16099901|NCT00296504|38852982|FG007|Interim Analysis|Principle Investigator Discretion|0|||
16402716|NCT00778258|39956807|FG001|Overall Study|Lost to Follow-up|0|||
16402717|NCT00778258|39956808|FG002|Overall Study|Lost to Follow-up|2|||
16099902|NCT00296504|38852983|FG008|Interim Analysis|Principle Investigator Discretion|0|||
16099903|NCT00296504|38852975|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
16099904|NCT00296504|38852976|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
16099905|NCT00296504|38852977|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
16099906|NCT00296504|38852978|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
16099907|NCT00296504|38852979|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
16099908|NCT00296504|38852980|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
16099909|NCT00296504|38852981|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
16099910|NCT00296504|38852982|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
16099911|NCT00296504|38852983|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
16099912|NCT00296504|38852975|FG000|Interim Analysis|Non-adherence|2|||
16099913|NCT00296504|38852976|FG001|Interim Analysis|Non-adherence|0|||
16099914|NCT00296504|38852977|FG002|Interim Analysis|Non-adherence|0|||
16099915|NCT00296504|38852978|FG003|Interim Analysis|Non-adherence|0|||
16099916|NCT00296504|38852979|FG004|Interim Analysis|Non-adherence|1|||
16099917|NCT00296504|38852980|FG005|Interim Analysis|Non-adherence|0|||
16099918|NCT00296504|38852981|FG006|Interim Analysis|Non-adherence|0|||
16099919|NCT00296504|38852982|FG007|Interim Analysis|Non-adherence|1|||
16099920|NCT00296504|38852983|FG008|Interim Analysis|Non-adherence|0|||
16099921|NCT00296504|38852975|FG000|Interim Analysis|Site Closing|1|||
16099922|NCT00296504|38852976|FG001|Interim Analysis|Site Closing|0|||
16099923|NCT00296504|38852977|FG002|Interim Analysis|Site Closing|0|||
16099924|NCT00296504|38852978|FG003|Interim Analysis|Site Closing|0|||
16099925|NCT00296504|38852979|FG004|Interim Analysis|Site Closing|0|||
16099926|NCT00296504|38852980|FG005|Interim Analysis|Site Closing|1|||
16099927|NCT00296504|38852981|FG006|Interim Analysis|Site Closing|2|||
16099928|NCT00296504|38852982|FG007|Interim Analysis|Site Closing|0|||
16099929|NCT00296504|38852983|FG008|Interim Analysis|Site Closing|0|||
16099930|NCT00296504|38852975|FG000|Interim Analysis|Lack of Personnel at Site|1|||
16099931|NCT00296504|38852976|FG001|Interim Analysis|Lack of Personnel at Site|0|||
16402718|NCT00778258|39956809|FG003|Overall Study|Lost to Follow-up|0|||
16402719|NCT00778258|39956810|FG004|Overall Study|Lost to Follow-up|0|||
16402720|NCT00778258|39956811|FG005|Overall Study|Lost to Follow-up|3|||
16099932|NCT00296504|38852977|FG002|Interim Analysis|Lack of Personnel at Site|0|||
16402721|NCT00778258|39956812|FG006|Overall Study|Lost to Follow-up|2|||
16402722|NCT00778258|39956813|FG007|Overall Study|Lost to Follow-up|2|||
16402723|NCT00778258|39956814|FG008|Overall Study|Lost to Follow-up|0|||
16402724|NCT00778258|39956806|FG000|Overall Study|Withdrawal by Subject|6|||
16532228|NCT00110617|40413867|FG001|Overall Study|Did not receive study drug|12|||
16099933|NCT00296504|38852978|FG003|Interim Analysis|Lack of Personnel at Site|0|||
16099934|NCT00296504|38852979|FG004|Interim Analysis|Lack of Personnel at Site|0|||
16099935|NCT00296504|38852980|FG005|Interim Analysis|Lack of Personnel at Site|0|||
16099936|NCT00296504|38852981|FG006|Interim Analysis|Lack of Personnel at Site|0|||
16099937|NCT00296504|38852982|FG007|Interim Analysis|Lack of Personnel at Site|0|||
16099938|NCT00296504|38852983|FG008|Interim Analysis|Lack of Personnel at Site|0|||
16099939|NCT00296504|38852975|FG000|Interim Analysis|Missed Schedule Date|1|||
16099940|NCT00296504|38852976|FG001|Interim Analysis|Missed Schedule Date|0|||
16099941|NCT00296504|38852977|FG002|Interim Analysis|Missed Schedule Date|0|||
16099942|NCT00296504|38852978|FG003|Interim Analysis|Missed Schedule Date|0|||
16099943|NCT00296504|38852979|FG004|Interim Analysis|Missed Schedule Date|0|||
16099944|NCT00296504|38852980|FG005|Interim Analysis|Missed Schedule Date|0|||
16099945|NCT00296504|38852981|FG006|Interim Analysis|Missed Schedule Date|0|||
16099946|NCT00296504|38852982|FG007|Interim Analysis|Missed Schedule Date|0|||
16099947|NCT00296504|38852983|FG008|Interim Analysis|Missed Schedule Date|0|||
16099948|NCT00296504|38852975|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
16099949|NCT00296504|38852976|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
16099950|NCT00296504|38852977|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
16099951|NCT00296504|38852978|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
16099952|NCT00296504|38852979|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
16099953|NCT00296504|38852980|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
16099954|NCT00296504|38852981|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
16099955|NCT00296504|38852982|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
16099956|NCT00296504|38852983|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
16099957|NCT00296504|38852975|FG000|Interim Analysis|Participant Stopped|0|||
16099958|NCT00296504|38852976|FG001|Interim Analysis|Participant Stopped|0|||
16099959|NCT00296504|38852977|FG002|Interim Analysis|Participant Stopped|0|||
16099960|NCT00296504|38852978|FG003|Interim Analysis|Participant Stopped|0|||
16402725|NCT00778258|39956807|FG001|Overall Study|Withdrawal by Subject|2|||
16402726|NCT00778258|39956808|FG002|Overall Study|Withdrawal by Subject|8|||
16402727|NCT00778258|39956809|FG003|Overall Study|Withdrawal by Subject|2|||
16532229|NCT01371851|40413868|FG000|Overall Study|Lost to Follow-up|5|||
16099961|NCT00296504|38852979|FG004|Interim Analysis|Participant Stopped|1|||
16099962|NCT00296504|38852980|FG005|Interim Analysis|Participant Stopped|0|||
16099963|NCT00296504|38852981|FG006|Interim Analysis|Participant Stopped|0|||
16099964|NCT00296504|38852982|FG007|Interim Analysis|Participant Stopped|0|||
16099965|NCT00296504|38852983|FG008|Interim Analysis|Participant Stopped|0|||
16099966|NCT00296504|38852975|FG000|Interim Analysis|Physician and Participant Decision|0|||
16099967|NCT00296504|38852976|FG001|Interim Analysis|Physician and Participant Decision|0|||
16099968|NCT00296504|38852977|FG002|Interim Analysis|Physician and Participant Decision|0|||
16099969|NCT00296504|38852978|FG003|Interim Analysis|Physician and Participant Decision|0|||
16099970|NCT00296504|38852979|FG004|Interim Analysis|Physician and Participant Decision|0|||
16099971|NCT00296504|38852980|FG005|Interim Analysis|Physician and Participant Decision|1|||
16099972|NCT00296504|38852981|FG006|Interim Analysis|Physician and Participant Decision|0|||
16099973|NCT00296504|38852982|FG007|Interim Analysis|Physician and Participant Decision|0|||
16099974|NCT00296504|38852983|FG008|Interim Analysis|Physician and Participant Decision|0|||
16099975|NCT00296504|38852975|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
16099976|NCT00296504|38852976|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
16099977|NCT00296504|38852977|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
16215395|NCT00711412|39268674|FG000|Survival Follow up Until Death|Other|12|||
16215396|NCT00621244|39268677|FG000|Overall Study|Withdrawal by Subject|7|||
16215397|NCT00621244|39268678|FG001|Overall Study|Withdrawal by Subject|3|||
16215398|NCT00621244|39268679|FG002|Overall Study|Withdrawal by Subject|3|||
16215399|NCT00621244|39268680|FG003|Overall Study|Withdrawal by Subject|3|||
16215400|NCT00621244|39268677|FG000|Overall Study|Disease progression|44|||
16215401|NCT00621244|39268678|FG001|Overall Study|Disease progression|20|||
16099978|NCT00296504|38852978|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
16099979|NCT00296504|38852979|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
16099980|NCT00296504|38852980|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
16099981|NCT00296504|38852981|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
16099982|NCT00296504|38852982|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
16099983|NCT00296504|38852983|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
16099984|NCT00296504|38852975|FG000|Interim Analysis|Study Ended|0|||
16099985|NCT00296504|38852976|FG001|Interim Analysis|Study Ended|0|||
16099986|NCT00296504|38852977|FG002|Interim Analysis|Study Ended|0|||
16099987|NCT00296504|38852978|FG003|Interim Analysis|Study Ended|0|||
16099988|NCT00296504|38852979|FG004|Interim Analysis|Study Ended|0|||
16099989|NCT00296504|38852980|FG005|Interim Analysis|Study Ended|0|||
16099990|NCT00296504|38852981|FG006|Interim Analysis|Study Ended|1|||
16099991|NCT00296504|38852982|FG007|Interim Analysis|Study Ended|0|||
16099992|NCT00296504|38852983|FG008|Interim Analysis|Study Ended|0|||
16532230|NCT01371851|40413869|FG001|Overall Study|Lost to Follow-up|8|||
16532231|NCT01371851|40413868|FG000|Overall Study|was arrested and put in jail|0|||
16532232|NCT01371851|40413869|FG001|Overall Study|was arrested and put in jail|1|||
16532233|NCT01371851|40413868|FG000|Overall Study|non study related adverse event|1|||
16532234|NCT01371851|40413869|FG001|Overall Study|non study related adverse event|0|||
16532235|NCT01371851|40413868|FG000|Overall Study|Blood Pressure outside study parameters|2|||
16532236|NCT01371851|40413869|FG001|Overall Study|Blood Pressure outside study parameters|0|||
16532237|NCT03204279|40413870|FG000|Overall Study|Withdrawal by Subject|0|||
16532238|NCT03204279|40413871|FG001|Overall Study|Withdrawal by Subject|1|||
16099993|NCT00296504|38852975|FG000|Interim Analysis|Participant Needed Interferon|0|||
16099994|NCT00296504|38852976|FG001|Interim Analysis|Participant Needed Interferon|0|||
16099995|NCT00296504|38852977|FG002|Interim Analysis|Participant Needed Interferon|0|||
16099996|NCT00296504|38852978|FG003|Interim Analysis|Participant Needed Interferon|0|||
16099997|NCT00296504|38852979|FG004|Interim Analysis|Participant Needed Interferon|0|||
16099998|NCT00296504|38852980|FG005|Interim Analysis|Participant Needed Interferon|0|||
16099999|NCT00296504|38852981|FG006|Interim Analysis|Participant Needed Interferon|0|||
16100000|NCT00296504|38852982|FG007|Interim Analysis|Participant Needed Interferon|1|||
16100001|NCT00296504|38852983|FG008|Interim Analysis|Participant Needed Interferon|0|||
16100002|NCT00296504|38852975|FG000|Interim Analysis|Ongoing|32|||
16100003|NCT00296504|38852976|FG001|Interim Analysis|Ongoing|12|||
16100004|NCT00296504|38852977|FG002|Interim Analysis|Ongoing|16|||
16100005|NCT00296504|38852978|FG003|Interim Analysis|Ongoing|22|||
16100006|NCT00296504|38852979|FG004|Interim Analysis|Ongoing|0|||
16100007|NCT00296504|38852980|FG005|Interim Analysis|Ongoing|0|||
16100008|NCT00296504|38852981|FG006|Interim Analysis|Ongoing|30|||
16100009|NCT00296504|38852982|FG007|Interim Analysis|Ongoing|1|||
16100010|NCT00296504|38852983|FG008|Interim Analysis|Ongoing|0|||
16100011|NCT00296504|38852975|FG000|Final Analysis|Withdrawal by Subject|0|||
16100012|NCT00296504|38852976|FG001|Final Analysis|Withdrawal by Subject|0|||
16100013|NCT00296504|38852977|FG002|Final Analysis|Withdrawal by Subject|0|||
16100014|NCT00296504|38852978|FG003|Final Analysis|Withdrawal by Subject|0|||
16100015|NCT00296504|38852979|FG004|Final Analysis|Withdrawal by Subject|0|||
16215402|NCT00621244|39268679|FG002|Overall Study|Disease progression|20|||
16215403|NCT00621244|39268680|FG003|Overall Study|Disease progression|15|||
16100016|NCT00296504|38852980|FG005|Final Analysis|Withdrawal by Subject|0|||
16100017|NCT00296504|38852981|FG006|Final Analysis|Withdrawal by Subject|0|||
16100018|NCT00296504|38852982|FG007|Final Analysis|Withdrawal by Subject|0|||
16100019|NCT00296504|38852983|FG008|Final Analysis|Withdrawal by Subject|1|||
16100020|NCT00296504|38852975|FG000|Final Analysis|Lost to Follow-up|0|||
16100021|NCT00296504|38852976|FG001|Final Analysis|Lost to Follow-up|0|||
16100022|NCT00296504|38852977|FG002|Final Analysis|Lost to Follow-up|0|||
16100023|NCT00296504|38852978|FG003|Final Analysis|Lost to Follow-up|0|||
16100024|NCT00296504|38852979|FG004|Final Analysis|Lost to Follow-up|0|||
16100025|NCT00296504|38852980|FG005|Final Analysis|Lost to Follow-up|0|||
16100026|NCT00296504|38852981|FG006|Final Analysis|Lost to Follow-up|0|||
16100027|NCT00296504|38852982|FG007|Final Analysis|Lost to Follow-up|0|||
16100028|NCT00296504|38852983|FG008|Final Analysis|Lost to Follow-up|5|||
16100029|NCT00296504|38852975|FG000|Final Analysis|Insufficient Viral Load Response|0|||
16100030|NCT00296504|38852976|FG001|Final Analysis|Insufficient Viral Load Response|0|||
16100031|NCT00296504|38852977|FG002|Final Analysis|Insufficient Viral Load Response|0|||
16100032|NCT00296504|38852978|FG003|Final Analysis|Insufficient Viral Load Response|0|||
16100033|NCT00296504|38852979|FG004|Final Analysis|Insufficient Viral Load Response|0|||
16100034|NCT00296504|38852980|FG005|Final Analysis|Insufficient Viral Load Response|0|||
16100035|NCT00296504|38852981|FG006|Final Analysis|Insufficient Viral Load Response|0|||
16532239|NCT01453595|40413872|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
16532240|NCT01453595|40413873|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
16532241|NCT01453595|40413874|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
16532242|NCT01178086|40413875|FG000|Overall Study|Participant refusal|7|||
16100036|NCT00296504|38852982|FG007|Final Analysis|Insufficient Viral Load Response|0|||
16100037|NCT00296504|38852983|FG008|Final Analysis|Insufficient Viral Load Response|6|||
16100038|NCT00296504|38852975|FG000|Final Analysis|Adverse Event|0|||
16100039|NCT00296504|38852976|FG001|Final Analysis|Adverse Event|0|||
16100040|NCT00296504|38852977|FG002|Final Analysis|Adverse Event|0|||
16100041|NCT00296504|38852978|FG003|Final Analysis|Adverse Event|0|||
16100042|NCT00296504|38852979|FG004|Final Analysis|Adverse Event|0|||
16100043|NCT00296504|38852980|FG005|Final Analysis|Adverse Event|0|||
16100044|NCT00296504|38852981|FG006|Final Analysis|Adverse Event|0|||
16100045|NCT00296504|38852982|FG007|Final Analysis|Adverse Event|0|||
16100046|NCT00296504|38852983|FG008|Final Analysis|Adverse Event|2|||
16100047|NCT00296504|38852975|FG000|Final Analysis|Pregnancy|0|||
16100048|NCT00296504|38852976|FG001|Final Analysis|Pregnancy|0|||
16532243|NCT01178086|40413875|FG000|Overall Study|Physician Decision|44|||
16532244|NCT01178086|40413875|FG000|Overall Study|Switch to other CLL therapy|113|||
16532245|NCT01178086|40413875|FG000|Overall Study|Death|59|||
16532246|NCT01178086|40413875|FG000|Overall Study|Other unspecified|89|||
16532247|NCT01178086|40413875|FG000|Overall Study|Excluded from EAS|20|||
16532248|NCT04794803|40413876|FG000|Overall Study|Death|1|||
16532249|NCT04794803|40413877|FG001|Overall Study|Death|3|||
16532250|NCT04794803|40413876|FG000|Overall Study|Lost to Follow-up|2|||
16532251|NCT04794803|40413877|FG001|Overall Study|Lost to Follow-up|2|||
16332763|NCT00934856|39703430|FG003|Extension Part|Progressive disease|1|||
16100049|NCT00296504|38852977|FG002|Final Analysis|Pregnancy|0|||
16100050|NCT00296504|38852978|FG003|Final Analysis|Pregnancy|0|||
16100051|NCT00296504|38852979|FG004|Final Analysis|Pregnancy|0|||
16532252|NCT04794803|40413876|FG000|Overall Study|Withdrawal by Subject|1|||
16532253|NCT04794803|40413877|FG001|Overall Study|Withdrawal by Subject|0|||
16532254|NCT04794803|40413876|FG000|Overall Study|Physician Decision|1|||
16532255|NCT04794803|40413877|FG001|Overall Study|Physician Decision|1|||
16532256|NCT04794803|40413876|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
16532257|NCT04794803|40413877|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
16532258|NCT04794803|40413876|FG000|Overall Study|Refused to continue the treatment|1|||
16532259|NCT04794803|40413877|FG001|Overall Study|Refused to continue the treatment|0|||
16332764|NCT00934856|39703431|FG004|Extension Part|Progressive disease|0|||
16332765|NCT00934856|39703432|FG005|Extension Part|Progressive disease|0|||
16332766|NCT00934856|39703427|FG000|Extension Part|Non-compliance with drug|0|||
16332767|NCT00934856|39703428|FG001|Extension Part|Non-compliance with drug|0|||
16332768|NCT00934856|39703429|FG002|Extension Part|Non-compliance with drug|0|||
16332769|NCT00934856|39703430|FG003|Extension Part|Non-compliance with drug|0|||
16332770|NCT00934856|39703431|FG004|Extension Part|Non-compliance with drug|0|||
16332771|NCT00934856|39703432|FG005|Extension Part|Non-compliance with drug|1|||
16332772|NCT00551161|39703435|FG000|Overall Study|Withdrawal by Subject|1|||
16532260|NCT04794803|40413876|FG000|Overall Study|Patient admitted to ICU|0|||
16100052|NCT00296504|38852980|FG005|Final Analysis|Pregnancy|0|||
16100053|NCT00296504|38852981|FG006|Final Analysis|Pregnancy|0|||
16100054|NCT00296504|38852982|FG007|Final Analysis|Pregnancy|0|||
16332773|NCT02614131|39703438|FG000|Overall Study|Withdrawal by Subject|1|||
16532261|NCT04794803|40413877|FG001|Overall Study|Patient admitted to ICU|1|||
16532262|NCT02363946|40413883|FG000|Overall Study|Lost to Follow-up|0|||
16532263|NCT02363946|40413884|FG001|Overall Study|Lost to Follow-up|0|||
16100055|NCT00296504|38852983|FG008|Final Analysis|Pregnancy|4|||
16100056|NCT00296504|38852975|FG000|Final Analysis|Tuberculosis|0|||
16100057|NCT00296504|38852976|FG001|Final Analysis|Tuberculosis|0|||
16100058|NCT00296504|38852977|FG002|Final Analysis|Tuberculosis|0|||
16100059|NCT00296504|38852978|FG003|Final Analysis|Tuberculosis|0|||
16100060|NCT00296504|38852979|FG004|Final Analysis|Tuberculosis|0|||
16532264|NCT02363946|40413885|FG002|Overall Study|Lost to Follow-up|0|||
16532265|NCT02363946|40413886|FG003|Overall Study|Lost to Follow-up|0|||
16532266|NCT02363946|40413887|FG004|Overall Study|Lost to Follow-up|0|||
16532267|NCT02363946|40413888|FG005|Overall Study|Lost to Follow-up|0|||
16532268|NCT02363946|40413889|FG006|Overall Study|Lost to Follow-up|0|||
16532269|NCT02363946|40413890|FG007|Overall Study|Lost to Follow-up|1|||
16532270|NCT02363946|40413891|FG008|Overall Study|Lost to Follow-up|0|||
16532271|NCT02363946|40413892|FG009|Overall Study|Lost to Follow-up|0|||
16532272|NCT02363946|40413893|FG010|Overall Study|Lost to Follow-up|0|||
16532273|NCT02363946|40413894|FG011|Overall Study|Lost to Follow-up|0|||
16532274|NCT02363946|40413895|FG012|Overall Study|Lost to Follow-up|0|||
16532275|NCT02261493|40413896|FG000|Overall Study|Noncompliance|0|||
16532276|NCT02261493|40413897|FG001|Overall Study|Noncompliance|0|||
16532277|NCT02261493|40413898|FG002|Overall Study|Noncompliance|2|||
16532278|NCT02261493|40413896|FG000|Overall Study|Physician Decision|0|||
16532279|NCT02261493|40413897|FG001|Overall Study|Physician Decision|1|||
16532280|NCT02261493|40413898|FG002|Overall Study|Physician Decision|0|||
16532281|NCT02261493|40413896|FG000|Overall Study|Undisclosed alcohol abuse|0|||
16332774|NCT02614131|39703439|FG001|Overall Study|Withdrawal by Subject|0|||
16332775|NCT02614131|39703440|FG002|Overall Study|Withdrawal by Subject|0|||
16532282|NCT02261493|40413897|FG001|Overall Study|Undisclosed alcohol abuse|1|||
16532283|NCT02261493|40413898|FG002|Overall Study|Undisclosed alcohol abuse|0|||
16532284|NCT02261493|40413896|FG000|Overall Study|Protocol Violation|1|||
16532285|NCT02261493|40413897|FG001|Overall Study|Protocol Violation|0|||
16532286|NCT02261493|40413898|FG002|Overall Study|Protocol Violation|0|||
16532287|NCT02261493|40413896|FG000|Overall Study|Personal Reasons|14|||
16532288|NCT02261493|40413897|FG001|Overall Study|Personal Reasons|14|||
16532289|NCT02261493|40413898|FG002|Overall Study|Personal Reasons|16|||
16532290|NCT02261493|40413896|FG000|Overall Study|Lost to Follow-up|14|||
16532291|NCT02261493|40413897|FG001|Overall Study|Lost to Follow-up|27|||
16532292|NCT02261493|40413898|FG002|Overall Study|Lost to Follow-up|8|||
16532293|NCT02261493|40413896|FG000|Overall Study|Pregnancy|1|||
16532294|NCT02261493|40413897|FG001|Overall Study|Pregnancy|2|||
16532295|NCT02261493|40413898|FG002|Overall Study|Pregnancy|0|||
16532296|NCT02261493|40413896|FG000|Overall Study|Lack of Efficacy|0|||
16532297|NCT02261493|40413897|FG001|Overall Study|Lack of Efficacy|1|||
16532298|NCT02261493|40413898|FG002|Overall Study|Lack of Efficacy|0|||
16532299|NCT02261493|40413896|FG000|Overall Study|Adverse Event|0|||
16532300|NCT02261493|40413897|FG001|Overall Study|Adverse Event|1|||
16532301|NCT02261493|40413898|FG002|Overall Study|Adverse Event|0|||
16532302|NCT01800968|40413899|FG000|Overall Study|Death|23|||
16532303|NCT01800968|40413900|FG001|Overall Study|Death|16|||
16532304|NCT01800968|40413899|FG000|Overall Study|Lost to Follow-up|5|||
16532305|NCT01800968|40413900|FG001|Overall Study|Lost to Follow-up|7|||
16532306|NCT01800968|40413899|FG000|Overall Study|Withdrawal by Subject|7|||
16532307|NCT01800968|40413900|FG001|Overall Study|Withdrawal by Subject|9|||
16532308|NCT01800968|40413899|FG000|Overall Study|Physician Decision|1|||
16532309|NCT01800968|40413900|FG001|Overall Study|Physician Decision|0|||
16532310|NCT03282227|40413903|FG000|Overall Study|Exposure Goals Achieved|60|||
16532311|NCT03282227|40413903|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
16532312|NCT03282227|40413903|FG000|Overall Study|Adverse Event|15|||
16532313|NCT03282227|40413903|FG000|Overall Study|Lost to Follow-up|21|||
16532314|NCT03282227|40413903|FG000|Overall Study|Withdrawal by Subject|20|||
16532315|NCT03282227|40413903|FG000|Overall Study|Lack of Efficacy|12|||
16532316|NCT03282227|40413903|FG000|Overall Study|Sponsor decision|3|||
16532317|NCT03282227|40413903|FG000|Overall Study|Physician Decision|2|||
16532318|NCT03282227|40413903|FG000|Overall Study|Pregnancy|2|||
16532319|NCT03282227|40413903|FG000|Overall Study|Other|1|||
16532320|NCT02492100|40413906|FG000|Overall Study|Death|1|||
16100061|NCT00296504|38852980|FG005|Final Analysis|Tuberculosis|0|||
16100062|NCT00296504|38852981|FG006|Final Analysis|Tuberculosis|0|||
16100063|NCT00296504|38852982|FG007|Final Analysis|Tuberculosis|0|||
16332776|NCT02614131|39703441|FG003|Overall Study|Withdrawal by Subject|0|||
16100064|NCT00296504|38852983|FG008|Final Analysis|Tuberculosis|1|||
16100065|NCT00296504|38852975|FG000|Final Analysis|Participant Moved to Another Country|0|||
16332777|NCT02614131|39703442|FG004|Overall Study|Withdrawal by Subject|0|||
16532321|NCT03019536|40413910|FG000|Overall Study|Withdrawal by Subject|1|||
16532322|NCT03019536|40413911|FG001|Overall Study|Withdrawal by Subject|1|||
16532323|NCT03019536|40413912|FG002|Overall Study|Withdrawal by Subject|0|||
16100066|NCT00296504|38852976|FG001|Final Analysis|Participant Moved to Another Country|0|||
16332778|NCT02614131|39703443|FG005|Overall Study|Withdrawal by Subject|0|||
16532324|NCT03019536|40413910|FG000|Overall Study|Adverse Event|0|||
16532325|NCT03019536|40413911|FG001|Overall Study|Adverse Event|0|||
16532326|NCT03019536|40413912|FG002|Overall Study|Adverse Event|2|||
16532327|NCT02293538|40413913|FG000|Overall Study|Adverse Event|0|||
16532328|NCT02293538|40413914|FG001|Overall Study|Adverse Event|1|||
16532329|NCT02293538|40413913|FG000|Overall Study|Lost to Follow-up|1|||
16532330|NCT02293538|40413914|FG001|Overall Study|Lost to Follow-up|0|||
16532331|NCT02293538|40413913|FG000|Overall Study|Withdrawal by Subject|0|||
16532332|NCT02293538|40413914|FG001|Overall Study|Withdrawal by Subject|1|||
16532333|NCT03489304|40413915|FG000|Overall Study|Lost to Follow-up|4|||
16532334|NCT03667053|40413919|FG000|Overall Study|Withdrawal by Subject|1|||
16532335|NCT03667053|40413920|FG001|Overall Study|Withdrawal by Subject|0|||
16532336|NCT03667053|40413921|FG002|Overall Study|Withdrawal by Subject|0|||
16532337|NCT04969250|40413925|FG000|Overall Study|Protocol Violation|0|||
16532338|NCT04969250|40413926|FG001|Overall Study|Protocol Violation|2|||
16532339|NCT04969250|40413927|FG002|Overall Study|Protocol Violation|3|||
16532340|NCT04969250|40413928|FG003|Overall Study|Protocol Violation|8|||
16532341|NCT04969250|40413925|FG000|Overall Study|Withdrawal by Subject|0|||
16532342|NCT04969250|40413926|FG001|Overall Study|Withdrawal by Subject|1|||
16532343|NCT04969250|40413927|FG002|Overall Study|Withdrawal by Subject|0|||
16532344|NCT04969250|40413928|FG003|Overall Study|Withdrawal by Subject|0|||
16532345|NCT01490632|40413934|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
16532346|NCT01490632|40413935|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
16532347|NCT01490632|40413936|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
16532348|NCT01490632|40413937|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
16532349|NCT01490632|40413938|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
16532350|NCT01490632|40413939|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
16532351|NCT01490632|40413940|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
16532352|NCT01490632|40413941|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
16532353|NCT01490632|40413942|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
16532354|NCT01490632|40413943|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
16532355|NCT01490632|40413944|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
16532356|NCT01490632|40413945|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
16532357|NCT01490632|40413946|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
16532358|NCT01490632|40413947|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
16532359|NCT01490632|40413948|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
16532360|NCT01490632|40413949|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
16532361|NCT01490632|40413950|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
16100067|NCT00296504|38852977|FG002|Final Analysis|Participant Moved to Another Country|0|||
16100068|NCT00296504|38852978|FG003|Final Analysis|Participant Moved to Another Country|0|||
16100069|NCT00296504|38852979|FG004|Final Analysis|Participant Moved to Another Country|0|||
16100070|NCT00296504|38852980|FG005|Final Analysis|Participant Moved to Another Country|0|||
16100071|NCT00296504|38852981|FG006|Final Analysis|Participant Moved to Another Country|0|||
16100072|NCT00296504|38852982|FG007|Final Analysis|Participant Moved to Another Country|0|||
16100073|NCT00296504|38852983|FG008|Final Analysis|Participant Moved to Another Country|1|||
16100074|NCT00296504|38852975|FG000|Final Analysis|Poor Adherence|0|||
16100075|NCT00296504|38852976|FG001|Final Analysis|Poor Adherence|0|||
16100076|NCT00296504|38852977|FG002|Final Analysis|Poor Adherence|0|||
16100077|NCT00296504|38852978|FG003|Final Analysis|Poor Adherence|0|||
16100078|NCT00296504|38852979|FG004|Final Analysis|Poor Adherence|0|||
16100079|NCT00296504|38852980|FG005|Final Analysis|Poor Adherence|0|||
16100080|NCT00296504|38852981|FG006|Final Analysis|Poor Adherence|0|||
16100081|NCT00296504|38852982|FG007|Final Analysis|Poor Adherence|0|||
16100082|NCT00296504|38852983|FG008|Final Analysis|Poor Adherence|1|||
16100083|NCT01294358|38852984|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
16100084|NCT01294358|38852985|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
16100085|NCT01294358|38852986|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
16100086|NCT01294358|38852987|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
16100087|NCT01294358|38852988|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
16100088|NCT01294358|38852984|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
16100089|NCT01294358|38852985|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
16100090|NCT01294358|38852986|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
16100091|NCT01294358|38852987|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
16100092|NCT01294358|38852988|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
16100093|NCT01294358|38852984|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
16100094|NCT01294358|38852985|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
16100095|NCT01294358|38852986|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
16100096|NCT01294358|38852987|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
16100097|NCT01294358|38852988|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
16100098|NCT01294358|38852984|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
16100099|NCT01294358|38852985|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
16100100|NCT01294358|38852986|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
16100101|NCT01294358|38852987|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
16532362|NCT01490632|40413951|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
16532363|NCT01490632|40413952|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
16532364|NCT01490632|40413953|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
16215404|NCT00621244|39268677|FG000|Overall Study|Death|3|||
16215405|NCT00621244|39268678|FG001|Overall Study|Death|3|||
16215406|NCT00621244|39268679|FG002|Overall Study|Death|1|||
16215407|NCT00621244|39268680|FG003|Overall Study|Death|1|||
16215408|NCT00621244|39268677|FG000|Overall Study|Adverse Event|27|||
16215409|NCT00621244|39268678|FG001|Overall Study|Adverse Event|7|||
16532365|NCT01490632|40413934|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
16532366|NCT01490632|40413935|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
16215410|NCT00621244|39268679|FG002|Overall Study|Adverse Event|9|||
16215411|NCT00621244|39268680|FG003|Overall Study|Adverse Event|2|||
16215412|NCT00621244|39268677|FG000|Overall Study|Administrative problems|5|||
16215413|NCT00621244|39268678|FG001|Overall Study|Administrative problems|1|||
16532367|NCT01490632|40413936|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
16532368|NCT01490632|40413937|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
16532369|NCT01490632|40413938|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532370|NCT01490632|40413939|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532371|NCT01490632|40413940|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532372|NCT01490632|40413941|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16215414|NCT00621244|39268679|FG002|Overall Study|Administrative problems|0|||
16215415|NCT00621244|39268680|FG003|Overall Study|Administrative problems|2|||
16215416|NCT02708966|39268681|FG000|Overall Study|Lost to Follow-up|2|||
16215417|NCT02708966|39268682|FG001|Overall Study|Lost to Follow-up|2|||
16215418|NCT00374127|39268683|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
16215419|NCT00374127|39268683|FG000|Overall Study|Blood could not be drawn.|2|||
16215420|NCT00374127|39268683|FG000|Overall Study|Protocol Violation|5|||
16215421|NCT00374127|39268683|FG000|Overall Study|Pregnancy|1|||
16215422|NCT01809691|39268684|FG000|Overall Study|Currently on Treatment|192|||
16215423|NCT01809691|39268685|FG001|Overall Study|Currently on Treatment|100|||
16215424|NCT01809691|39268684|FG000|Overall Study|No Protocol Treatment|10|||
16215425|NCT01809691|39268685|FG001|Overall Study|No Protocol Treatment|11|||
16215426|NCT01809691|39268684|FG000|Overall Study|Adverse Event|80|||
16215427|NCT01809691|39268685|FG001|Overall Study|Adverse Event|21|||
16215428|NCT01809691|39268684|FG000|Overall Study|Disease Progression|226|||
16215429|NCT01809691|39268685|FG001|Overall Study|Disease Progression|372|||
16215430|NCT01809691|39268684|FG000|Overall Study|Death|26|||
16215431|NCT01809691|39268685|FG001|Overall Study|Death|13|||
16215432|NCT01809691|39268684|FG000|Overall Study|Participant Refusal|70|||
16215433|NCT01809691|39268685|FG001|Overall Study|Participant Refusal|72|||
16215434|NCT01809691|39268684|FG000|Overall Study|Other, Not Specified|34|||
16215435|NCT01809691|39268685|FG001|Overall Study|Other, Not Specified|52|||
16215436|NCT00882362|39268686|FG000|Overall Study|Adverse Event|13|||
16215437|NCT00882362|39268687|FG001|Overall Study|Adverse Event|10|||
16215438|NCT00882362|39268686|FG000|Overall Study|Withdrawal by Subject|13|||
16215439|NCT00882362|39268687|FG001|Overall Study|Withdrawal by Subject|10|||
16215440|NCT00882362|39268686|FG000|Overall Study|Lack of Efficacy|3|||
16215441|NCT00882362|39268687|FG001|Overall Study|Lack of Efficacy|0|||
16215442|NCT00882362|39268686|FG000|Overall Study|Protocol Violation|7|||
16215443|NCT00882362|39268687|FG001|Overall Study|Protocol Violation|2|||
16215444|NCT00882362|39268686|FG000|Overall Study|Pregnancy|1|||
16215445|NCT00882362|39268687|FG001|Overall Study|Pregnancy|0|||
16215446|NCT00882362|39268686|FG000|Overall Study|Physician Decision|5|||
16215447|NCT00882362|39268687|FG001|Overall Study|Physician Decision|1|||
16215448|NCT00882362|39268686|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
16215449|NCT00882362|39268687|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
16215450|NCT00882362|39268686|FG000|Overall Study|change of residence or other commitments|5|||
16215451|NCT00882362|39268687|FG001|Overall Study|change of residence or other commitments|0|||
16215452|NCT01957215|39268690|FG000|Overall Study|Adverse Event|2|||
16215453|NCT01957215|39268691|FG001|Overall Study|Adverse Event|2|||
16332779|NCT02614131|39703444|FG006|Overall Study|Withdrawal by Subject|0|||
16532373|NCT01490632|40413942|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532374|NCT01490632|40413943|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532375|NCT01490632|40413944|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532376|NCT01490632|40413945|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532377|NCT01490632|40413946|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532378|NCT01490632|40413947|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532379|NCT01490632|40413948|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532380|NCT01490632|40413949|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16215454|NCT01957215|39268690|FG000|Overall Study|Lost to Follow-up|3|||
16215455|NCT01957215|39268691|FG001|Overall Study|Lost to Follow-up|3|||
16215456|NCT01957215|39268690|FG000|Overall Study|Protocol Violation|1|||
16215457|NCT01957215|39268691|FG001|Overall Study|Protocol Violation|2|||
16215458|NCT01957215|39268690|FG000|Overall Study|Withdrawal by Subject|7|||
16215459|NCT01957215|39268691|FG001|Overall Study|Withdrawal by Subject|5|||
16215460|NCT00958191|39268692|FG000|Overall Study|Death|4|||
16215461|NCT00958191|39268692|FG000|Overall Study|Lost to Follow-up|5|||
16215462|NCT00958191|39268692|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
16532381|NCT01490632|40413950|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16215463|NCT00958191|39268692|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
16215464|NCT00958191|39268692|FG000|Overall Study|Revision of study device|4|||
16215465|NCT00958191|39268692|FG000|Overall Study|Site termination|11|||
16215466|NCT00958191|39268692|FG000|Overall Study|No 5 yr x-rays|56|||
16215467|NCT02892734|39268693|FG000|Treatment on Study|Progressive Disease|2|||
16215468|NCT02892734|39268693|FG000|Follow up for 2 Years|Death|2|||
16215469|NCT02892734|39268693|FG000|Follow up for 2 Years|Study closed early|1|||
16215470|NCT00378534|39268694|FG000|Overall Study|Participants did not receive transplant|3|||
16215471|NCT00378534|39268695|FG001|Overall Study|Participants did not receive transplant|0|||
16215472|NCT01510028|39268696|FG000|Overall Study|Lack of Efficacy|1|||
16215473|NCT01510028|39268697|FG001|Overall Study|Lack of Efficacy|0|||
16215474|NCT01510028|39268698|FG002|Overall Study|Lack of Efficacy|0|||
16532382|NCT01490632|40413951|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532383|NCT01490632|40413952|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532384|NCT01490632|40413953|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
16532385|NCT01490632|40413934|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532386|NCT01490632|40413935|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532387|NCT01490632|40413936|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
16215475|NCT01510028|39268699|FG003|Overall Study|Lack of Efficacy|0|||
16215476|NCT00441727|39268700|FG000|Overall Study|Protocol Violation|19|||
16215477|NCT00441727|39268701|FG001|Overall Study|Protocol Violation|28|||
16215478|NCT00441727|39268702|FG002|Overall Study|Protocol Violation|32|||
16215479|NCT00441727|39268700|FG000|Overall Study|Adverse Event|26|||
16215480|NCT00441727|39268701|FG001|Overall Study|Adverse Event|33|||
16215481|NCT00441727|39268702|FG002|Overall Study|Adverse Event|28|||
16215482|NCT00441727|39268700|FG000|Overall Study|Lack of Efficacy|7|||
16215483|NCT00441727|39268701|FG001|Overall Study|Lack of Efficacy|8|||
16215484|NCT00441727|39268702|FG002|Overall Study|Lack of Efficacy|48|||
16215485|NCT00441727|39268700|FG000|Overall Study|Withdrawal by Subject|40|||
16215486|NCT00441727|39268701|FG001|Overall Study|Withdrawal by Subject|34|||
16215487|NCT00441727|39268702|FG002|Overall Study|Withdrawal by Subject|47|||
16215488|NCT00441727|39268700|FG000|Overall Study|Lost to Follow-up|5|||
16215489|NCT00441727|39268701|FG001|Overall Study|Lost to Follow-up|6|||
16215490|NCT00441727|39268702|FG002|Overall Study|Lost to Follow-up|5|||
16215491|NCT00441727|39268700|FG000|Overall Study|Safety Reasons|3|||
16215492|NCT00441727|39268701|FG001|Overall Study|Safety Reasons|1|||
16215493|NCT00441727|39268702|FG002|Overall Study|Safety Reasons|3|||
16215494|NCT00441727|39268700|FG000|Overall Study|Various reason specified|6|||
16215495|NCT00441727|39268701|FG001|Overall Study|Various reason specified|8|||
16215496|NCT00441727|39268702|FG002|Overall Study|Various reason specified|5|||
16215497|NCT00118040|39268703|FG000|Overall Study|Adverse Event|0|||
16215498|NCT00118040|39268704|FG001|Overall Study|Adverse Event|1|||
16215499|NCT00118040|39268705|FG002|Overall Study|Adverse Event|0|||
16215500|NCT00118040|39268703|FG000|Overall Study|Withdrawal by Subject|0|||
16215501|NCT00118040|39268704|FG001|Overall Study|Withdrawal by Subject|0|||
16215502|NCT00118040|39268705|FG002|Overall Study|Withdrawal by Subject|2|||
16215503|NCT00118040|39268703|FG000|Overall Study|Medical Contraindication|0|||
16215504|NCT00118040|39268704|FG001|Overall Study|Medical Contraindication|0|||
16215505|NCT00118040|39268705|FG002|Overall Study|Medical Contraindication|1|||
16215506|NCT00118040|39268703|FG000|Overall Study|Non-Compliant Participant|1|||
16215507|NCT00118040|39268704|FG001|Overall Study|Non-Compliant Participant|1|||
16215508|NCT00118040|39268705|FG002|Overall Study|Non-Compliant Participant|2|||
16215509|NCT00118040|39268703|FG000|Overall Study|Other|0|||
16215510|NCT00118040|39268704|FG001|Overall Study|Other|0|||
16215511|NCT00118040|39268705|FG002|Overall Study|Other|1|||
16215512|NCT02735044|39268706|FG000|Overall Study|Adverse Event|3|||
16402728|NCT00778258|39956810|FG004|Overall Study|Withdrawal by Subject|0|||
16402729|NCT00778258|39956811|FG005|Overall Study|Withdrawal by Subject|6|||
16402730|NCT00778258|39956812|FG006|Overall Study|Withdrawal by Subject|12|||
16402731|NCT00778258|39956813|FG007|Overall Study|Withdrawal by Subject|12|||
16402732|NCT00778258|39956814|FG008|Overall Study|Withdrawal by Subject|4|||
16402733|NCT00778258|39956806|FG000|Overall Study|New Contraindication|0|||
16402734|NCT00778258|39956807|FG001|Overall Study|New Contraindication|0|||
16532388|NCT01490632|40413937|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
16532389|NCT01490632|40413938|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
16532390|NCT01490632|40413939|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532391|NCT01490632|40413940|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16215513|NCT02735044|39268707|FG001|Overall Study|Adverse Event|3|||
16215514|NCT02735044|39268706|FG000|Overall Study|Lack of Efficacy|1|||
16215515|NCT02735044|39268707|FG001|Overall Study|Lack of Efficacy|0|||
16215516|NCT02735044|39268706|FG000|Overall Study|Poor compliance to protocol|7|||
16215517|NCT02735044|39268707|FG001|Overall Study|Poor compliance to protocol|7|||
16215518|NCT02735044|39268706|FG000|Overall Study|Randomized and not treated|0|||
16215519|NCT02735044|39268707|FG001|Overall Study|Randomized and not treated|2|||
16402735|NCT00778258|39956808|FG002|Overall Study|New Contraindication|0|||
16402736|NCT00778258|39956809|FG003|Overall Study|New Contraindication|0|||
16402737|NCT00778258|39956810|FG004|Overall Study|New Contraindication|0|||
16402738|NCT00778258|39956811|FG005|Overall Study|New Contraindication|0|||
16402739|NCT00778258|39956812|FG006|Overall Study|New Contraindication|0|||
16402740|NCT00778258|39956813|FG007|Overall Study|New Contraindication|1|||
16402741|NCT00778258|39956814|FG008|Overall Study|New Contraindication|0|||
16402742|NCT00778258|39956806|FG000|Overall Study|Non-compliance|0|||
16402743|NCT00778258|39956807|FG001|Overall Study|Non-compliance|0|||
16402744|NCT00778258|39956808|FG002|Overall Study|Non-compliance|0|||
16402745|NCT00778258|39956809|FG003|Overall Study|Non-compliance|1|||
16402746|NCT00778258|39956810|FG004|Overall Study|Non-compliance|0|||
16402747|NCT00778258|39956811|FG005|Overall Study|Non-compliance|0|||
16402748|NCT00778258|39956812|FG006|Overall Study|Non-compliance|0|||
16402749|NCT00778258|39956813|FG007|Overall Study|Non-compliance|0|||
16402750|NCT00778258|39956814|FG008|Overall Study|Non-compliance|0|||
16402751|NCT00778258|39956806|FG000|Overall Study|Other|0|||
16402752|NCT00778258|39956807|FG001|Overall Study|Other|0|||
16402753|NCT00778258|39956808|FG002|Overall Study|Other|0|||
16402754|NCT00778258|39956809|FG003|Overall Study|Other|0|||
16402755|NCT00778258|39956810|FG004|Overall Study|Other|0|||
16402756|NCT00778258|39956811|FG005|Overall Study|Other|0|||
16402757|NCT00778258|39956812|FG006|Overall Study|Other|1|||
16402758|NCT00778258|39956813|FG007|Overall Study|Other|0|||
16402759|NCT00778258|39956814|FG008|Overall Study|Other|0|||
16402760|NCT01778049|39956824|FG000|Open Label Treatment Period|Adverse Event|5|||
16402761|NCT01778049|39956825|FG001|Open Label Treatment Period|Adverse Event|15|||
16402762|NCT01778049|39956826|FG002|Open Label Treatment Period|Adverse Event|0|||
16402763|NCT01778049|39956827|FG003|Open Label Treatment Period|Adverse Event|0|||
16402764|NCT01778049|39956828|FG004|Open Label Treatment Period|Adverse Event|0|||
16402765|NCT01778049|39956829|FG005|Open Label Treatment Period|Adverse Event|0|||
16402766|NCT01778049|39956824|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
16402767|NCT01778049|39956825|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
16402768|NCT01778049|39956826|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
16402769|NCT01778049|39956827|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
16402770|NCT01778049|39956828|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
16402771|NCT01778049|39956829|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
16402772|NCT01778049|39956824|FG000|Open Label Treatment Period|Protocol Violation|5|||
16402773|NCT01778049|39956825|FG001|Open Label Treatment Period|Protocol Violation|5|||
16402774|NCT01778049|39956826|FG002|Open Label Treatment Period|Protocol Violation|0|||
16402775|NCT01778049|39956827|FG003|Open Label Treatment Period|Protocol Violation|0|||
16402776|NCT01778049|39956828|FG004|Open Label Treatment Period|Protocol Violation|0|||
16402777|NCT01778049|39956829|FG005|Open Label Treatment Period|Protocol Violation|0|||
16402778|NCT01778049|39956824|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
16402779|NCT01778049|39956825|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
16402780|NCT01778049|39956826|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
16402781|NCT01778049|39956827|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
16402782|NCT01778049|39956828|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
16402783|NCT01778049|39956829|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
16402784|NCT01778049|39956824|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
16402785|NCT01778049|39956825|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
16402786|NCT01778049|39956826|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
16402787|NCT01778049|39956827|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
16402788|NCT01778049|39956828|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
16402789|NCT01778049|39956829|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
16402790|NCT01778049|39956824|FG000|Open Label Treatment Period|Not treated|2|||
16402791|NCT01778049|39956825|FG001|Open Label Treatment Period|Not treated|1|||
16402792|NCT01778049|39956826|FG002|Open Label Treatment Period|Not treated|0|||
16402793|NCT01778049|39956827|FG003|Open Label Treatment Period|Not treated|0|||
16402794|NCT01778049|39956828|FG004|Open Label Treatment Period|Not treated|0|||
16402795|NCT01778049|39956829|FG005|Open Label Treatment Period|Not treated|0|||
16402796|NCT01778049|39956824|FG000|Open Label Treatment Period|Other reason not defined above|77|||
16402797|NCT01778049|39956825|FG001|Open Label Treatment Period|Other reason not defined above|94|||
16402798|NCT01778049|39956826|FG002|Open Label Treatment Period|Other reason not defined above|0|||
16402799|NCT01778049|39956827|FG003|Open Label Treatment Period|Other reason not defined above|0|||
16402800|NCT01778049|39956828|FG004|Open Label Treatment Period|Other reason not defined above|0|||
16402801|NCT01778049|39956829|FG005|Open Label Treatment Period|Other reason not defined above|0|||
16532392|NCT01490632|40413941|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532393|NCT01490632|40413942|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532394|NCT01490632|40413943|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532395|NCT01490632|40413944|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532396|NCT01490632|40413945|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532397|NCT01490632|40413946|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16402802|NCT01778049|39956824|FG000|Double Blind Treatment Period|Adverse Event|0|||
16402803|NCT01778049|39956825|FG001|Double Blind Treatment Period|Adverse Event|0|||
16402804|NCT01778049|39956826|FG002|Double Blind Treatment Period|Adverse Event|4|||
16402805|NCT01778049|39956827|FG003|Double Blind Treatment Period|Adverse Event|5|||
16402806|NCT01778049|39956828|FG004|Double Blind Treatment Period|Adverse Event|3|||
16402807|NCT01778049|39956829|FG005|Double Blind Treatment Period|Adverse Event|2|||
16402808|NCT01778049|39956824|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
16532398|NCT01490632|40413947|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532399|NCT01490632|40413948|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16100102|NCT01294358|38852988|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
16100103|NCT03048058|38852996|FG000|Overall Study|Lost to Follow-up|4|||
16100104|NCT03048058|38852997|FG001|Overall Study|Lost to Follow-up|0|||
16532400|NCT01490632|40413949|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532401|NCT01490632|40413950|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532402|NCT01490632|40413951|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532403|NCT01490632|40413952|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532404|NCT01490632|40413953|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
16532405|NCT01490632|40413934|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
16532406|NCT01490632|40413935|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
16532407|NCT01490632|40413936|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
16100105|NCT03048058|38852996|FG000|Overall Study|Withdrawal by Subject|0|||
16100106|NCT03048058|38852997|FG001|Overall Study|Withdrawal by Subject|4|||
16100107|NCT01133678|38852998|FG000|Overall Study|Death|1|||
16100108|NCT01133678|38852999|FG001|Overall Study|Death|1|||
16100109|NCT01374971|38853000|FG000|Overall Study|Withdrawal by Subject|1|||
16100110|NCT03334747|38853001|FG000|Treatment Phase|Technical problems|0|||
16100111|NCT03334747|38853002|FG001|Treatment Phase|Technical problems|0|||
16100112|NCT03334747|38853003|FG002|Treatment Phase|Technical problems|0|||
16100113|NCT03334747|38853004|FG003|Treatment Phase|Technical problems|0|||
16100114|NCT03334747|38853005|FG004|Treatment Phase|Technical problems|1|||
16100115|NCT03334747|38853006|FG005|Treatment Phase|Technical problems|0|||
16100116|NCT03334747|38853007|FG006|Treatment Phase|Technical problems|0|||
16532408|NCT01490632|40413937|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
16532409|NCT01490632|40413938|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
16100117|NCT03334747|38853008|FG007|Treatment Phase|Technical problems|0|||
16100118|NCT03334747|38853009|FG008|Treatment Phase|Technical problems|0|||
16100119|NCT03334747|38853001|FG000|Treatment Phase|Subject/guardian decision|1|||
16100120|NCT03334747|38853002|FG001|Treatment Phase|Subject/guardian decision|0|||
16100121|NCT03334747|38853003|FG002|Treatment Phase|Subject/guardian decision|0|||
16100122|NCT03334747|38853004|FG003|Treatment Phase|Subject/guardian decision|0|||
16100123|NCT03334747|38853005|FG004|Treatment Phase|Subject/guardian decision|0|||
16100124|NCT03334747|38853006|FG005|Treatment Phase|Subject/guardian decision|1|||
16100125|NCT03334747|38853007|FG006|Treatment Phase|Subject/guardian decision|0|||
16100126|NCT03334747|38853008|FG007|Treatment Phase|Subject/guardian decision|0|||
16402809|NCT01778049|39956825|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
16532410|NCT01490632|40413939|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
16532411|NCT01490632|40413940|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
16532412|NCT01490632|40413941|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
16532413|NCT01490632|40413942|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
16532414|NCT01490632|40413943|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
16532415|NCT01490632|40413944|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
16532416|NCT01490632|40413945|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
16532417|NCT01490632|40413946|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
16532418|NCT01490632|40413947|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
16532419|NCT01490632|40413948|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
16532420|NCT01490632|40413949|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
16532421|NCT01490632|40413950|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
16532422|NCT01490632|40413951|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
16532423|NCT01490632|40413952|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
16532424|NCT01490632|40413953|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
16532425|NCT01490632|40413934|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
16532426|NCT01490632|40413935|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532427|NCT01490632|40413936|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532428|NCT01490632|40413937|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532429|NCT01490632|40413938|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532430|NCT01490632|40413939|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532431|NCT01490632|40413940|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
16100127|NCT03334747|38853009|FG008|Treatment Phase|Subject/guardian decision|0|||
16100128|NCT03334747|38853001|FG000|Follow-Up Phase|Subject/guardian decision|0|||
16100129|NCT03334747|38853002|FG001|Follow-Up Phase|Subject/guardian decision|0|||
16100130|NCT03334747|38853003|FG002|Follow-Up Phase|Subject/guardian decision|0|||
16100131|NCT03334747|38853004|FG003|Follow-Up Phase|Subject/guardian decision|0|||
16532432|NCT01490632|40413941|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532433|NCT01490632|40413942|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
16402810|NCT01778049|39956826|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
16402811|NCT01778049|39956827|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
16402812|NCT01778049|39956828|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
16215520|NCT02735044|39268706|FG000|Overall Study|Other, not specified above|5|||
16332780|NCT02614131|39703438|FG000|Overall Study|Adverse Event|0|||
16402813|NCT01778049|39956829|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
16532434|NCT01490632|40413943|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532435|NCT01490632|40413944|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532436|NCT01490632|40413945|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532437|NCT01490632|40413946|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532438|NCT01490632|40413947|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532439|NCT01490632|40413948|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532440|NCT01490632|40413949|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
16332781|NCT02614131|39703439|FG001|Overall Study|Adverse Event|0|||
16532441|NCT01490632|40413950|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532442|NCT01490632|40413951|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532443|NCT01490632|40413952|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532444|NCT01490632|40413953|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
16532445|NCT01490632|40413934|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
16532446|NCT01490632|40413935|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
16532447|NCT01490632|40413936|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532448|NCT01490632|40413937|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
16532449|NCT01490632|40413938|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
16532450|NCT01490632|40413939|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532451|NCT01490632|40413940|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532452|NCT01490632|40413941|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532453|NCT01490632|40413942|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532454|NCT01490632|40413943|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532455|NCT01490632|40413944|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532456|NCT01490632|40413945|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532457|NCT01490632|40413946|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532458|NCT01490632|40413947|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532459|NCT01490632|40413948|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532460|NCT01490632|40413949|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532461|NCT01490632|40413950|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532462|NCT01490632|40413951|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532463|NCT01490632|40413952|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532464|NCT01490632|40413953|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
16532465|NCT01490632|40413934|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532466|NCT01490632|40413935|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532467|NCT01490632|40413936|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532468|NCT01490632|40413937|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532469|NCT01490632|40413938|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
16532470|NCT01490632|40413939|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532471|NCT01490632|40413940|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532472|NCT01490632|40413941|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532473|NCT01490632|40413942|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532474|NCT01490632|40413943|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532475|NCT01490632|40413944|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532476|NCT01490632|40413945|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532477|NCT01490632|40413946|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532478|NCT01490632|40413947|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16332782|NCT02614131|39703440|FG002|Overall Study|Adverse Event|0|||
16332783|NCT02614131|39703441|FG003|Overall Study|Adverse Event|0|||
16332784|NCT02614131|39703442|FG004|Overall Study|Adverse Event|0|||
16332785|NCT02614131|39703443|FG005|Overall Study|Adverse Event|0|||
16332786|NCT02614131|39703444|FG006|Overall Study|Adverse Event|1|||
16332787|NCT03126019|39703445|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
16332788|NCT03126019|39703446|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
16402814|NCT01778049|39956824|FG000|Double Blind Treatment Period|Protocol Violation|0|||
16215521|NCT02735044|39268707|FG001|Overall Study|Other, not specified above|11|||
16215522|NCT02881151|39268709|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
16332789|NCT03126019|39703445|FG000|Overall Study|Death|2|||
16332790|NCT03126019|39703446|FG001|Overall Study|Death|7|||
16332791|NCT03126019|39703445|FG000|Overall Study|Lost to Follow-up|2|||
16215523|NCT01836549|39268710|FG000|Overall Study|Did not receive study drug|0|||
16215524|NCT01836549|39268711|FG001|Overall Study|Did not receive study drug|0|||
16215525|NCT01836549|39268712|FG002|Overall Study|Did not receive study drug|1|||
16215526|NCT01836549|39268713|FG003|Overall Study|Did not receive study drug|0|||
16215527|NCT01836549|39268714|FG004|Overall Study|Did not receive study drug|0|||
16215528|NCT01836549|39268715|FG005|Overall Study|Did not receive study drug|0|||
16215529|NCT01836549|39268716|FG006|Overall Study|Did not receive study drug|0|||
16215530|NCT01836549|39268710|FG000|Overall Study|Patient declared ineligible|0|||
16215531|NCT01836549|39268711|FG001|Overall Study|Patient declared ineligible|0|||
16215532|NCT01836549|39268712|FG002|Overall Study|Patient declared ineligible|0|||
16215533|NCT01836549|39268713|FG003|Overall Study|Patient declared ineligible|1|||
16215534|NCT01836549|39268714|FG004|Overall Study|Patient declared ineligible|0|||
16215535|NCT01836549|39268715|FG005|Overall Study|Patient declared ineligible|0|||
16215536|NCT01836549|39268716|FG006|Overall Study|Patient declared ineligible|0|||
16215537|NCT01836549|39268710|FG000|Overall Study|Patient inevaluable to start therapy|0|||
16215538|NCT01836549|39268711|FG001|Overall Study|Patient inevaluable to start therapy|0|||
16215539|NCT01836549|39268712|FG002|Overall Study|Patient inevaluable to start therapy|0|||
16332792|NCT03126019|39703446|FG001|Overall Study|Lost to Follow-up|3|||
16332793|NCT03126019|39703445|FG000|Overall Study|Withdrawal by Participant|1|||
16332794|NCT03126019|39703446|FG001|Overall Study|Withdrawal by Participant|3|||
16332795|NCT03126019|39703445|FG000|Overall Study|Reason not Specified|1|||
16332796|NCT03126019|39703446|FG001|Overall Study|Reason not Specified|3|||
16332797|NCT00829829|39703450|FG000|Overall Study|Protocol Violation|0|||
16332798|NCT00829829|39703451|FG001|Overall Study|Protocol Violation|3|||
16332799|NCT00829829|39703452|FG002|Overall Study|Protocol Violation|0|||
16332800|NCT00829829|39703450|FG000|Overall Study|Adverse Event|4|||
16332801|NCT00829829|39703451|FG001|Overall Study|Adverse Event|4|||
16332802|NCT00829829|39703452|FG002|Overall Study|Adverse Event|3|||
16332803|NCT00829829|39703450|FG000|Overall Study|Withdrawal by Subject|8|||
16332804|NCT00829829|39703451|FG001|Overall Study|Withdrawal by Subject|4|||
16332805|NCT00829829|39703452|FG002|Overall Study|Withdrawal by Subject|2|||
16332806|NCT00829829|39703450|FG000|Overall Study|Decision by the Sponsor|1|||
16332807|NCT00829829|39703451|FG001|Overall Study|Decision by the Sponsor|0|||
16332808|NCT00829829|39703452|FG002|Overall Study|Decision by the Sponsor|2|||
16332809|NCT00829829|39703450|FG000|Overall Study|Lost to Follow-up|7|||
16402815|NCT01778049|39956825|FG001|Double Blind Treatment Period|Protocol Violation|0|||
16402816|NCT01778049|39956826|FG002|Double Blind Treatment Period|Protocol Violation|2|||
16402817|NCT01778049|39956827|FG003|Double Blind Treatment Period|Protocol Violation|0|||
16215540|NCT01836549|39268713|FG003|Overall Study|Patient inevaluable to start therapy|0|||
16215541|NCT01836549|39268714|FG004|Overall Study|Patient inevaluable to start therapy|0|||
16332810|NCT00829829|39703451|FG001|Overall Study|Lost to Follow-up|3|||
16332811|NCT00829829|39703452|FG002|Overall Study|Lost to Follow-up|3|||
16332812|NCT00829829|39703450|FG000|Overall Study|Other than specified above|2|||
16332813|NCT00829829|39703451|FG001|Overall Study|Other than specified above|2|||
16215542|NCT01836549|39268715|FG005|Overall Study|Patient inevaluable to start therapy|0|||
16332814|NCT00829829|39703452|FG002|Overall Study|Other than specified above|1|||
16402818|NCT01778049|39956828|FG004|Double Blind Treatment Period|Protocol Violation|0|||
16402819|NCT01778049|39956829|FG005|Double Blind Treatment Period|Protocol Violation|0|||
16402820|NCT01778049|39956824|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
16402821|NCT01778049|39956825|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
16402822|NCT01778049|39956826|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
16402823|NCT01778049|39956827|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
16402824|NCT01778049|39956828|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
16402825|NCT01778049|39956829|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
16402826|NCT01778049|39956824|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
16402827|NCT01778049|39956825|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
16402828|NCT01778049|39956826|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
16215543|NCT01836549|39268716|FG006|Overall Study|Patient inevaluable to start therapy|1|||
16215544|NCT00683774|39268717|FG000|Overall Study|Withdrawal by Subject|0|||
16215545|NCT00683774|39268718|FG001|Overall Study|Withdrawal by Subject|1|||
16215546|NCT00683774|39268717|FG000|Overall Study|Physician Decision|3|||
16215547|NCT00683774|39268718|FG001|Overall Study|Physician Decision|0|||
16215548|NCT01131130|39268719|FG000|Period 1 - Baseline|Pregnancy|1|||
16215549|NCT01131130|39268719|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
16215550|NCT01188811|39268723|FG000|Overall Study|Withdrawal by Subject|0|||
16215551|NCT01188811|39268724|FG001|Overall Study|Withdrawal by Subject|2|||
16215552|NCT01188811|39268723|FG000|Overall Study|Adverse Event|6|||
16215553|NCT01188811|39268724|FG001|Overall Study|Adverse Event|0|||
16532479|NCT01490632|40413948|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532480|NCT01490632|40413949|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532481|NCT01490632|40413950|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532482|NCT01490632|40413951|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532483|NCT01490632|40413952|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532484|NCT01490632|40413953|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
16532485|NCT01490632|40413934|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532486|NCT01490632|40413935|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532487|NCT01490632|40413936|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532488|NCT01490632|40413937|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532489|NCT01490632|40413938|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532490|NCT01490632|40413939|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
16532491|NCT01490632|40413940|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
16532492|NCT01490632|40413941|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532493|NCT01490632|40413942|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532494|NCT01490632|40413943|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
16532495|NCT01490632|40413944|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
16532496|NCT01490632|40413945|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
16532497|NCT01490632|40413946|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532498|NCT01490632|40413947|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532499|NCT01490632|40413948|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532500|NCT01490632|40413949|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
16215554|NCT04067011|39268725|FG000|Overall Study|Not Treated|8|||
16215555|NCT04067011|39268726|FG001|Overall Study|Not Treated|7|||
16332815|NCT01217385|39703453|FG000|Overall Study|Withdrawal by Subject|3|||
16332816|NCT01217385|39703453|FG000|Overall Study|DOSI not performed/not eval|12|||
16332817|NCT01217385|39703453|FG000|Overall Study|Central Path not Available|1|||
16332818|NCT01217385|39703453|FG000|Overall Study|Normal Breast TOI not available|10|||
16332819|NCT02543892|39703460|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
16332820|NCT02543892|39703461|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
16332821|NCT02543892|39703462|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
16332822|NCT02543892|39703463|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
16332823|NCT02543892|39703464|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
16332824|NCT02543892|39703465|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
16332825|NCT02543892|39703466|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
16332826|NCT02543892|39703467|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
16332827|NCT02543892|39703460|FG000|Received Vaccination 2|Physician Decision|0|||
16332828|NCT02543892|39703461|FG001|Received Vaccination 2|Physician Decision|0|||
16332829|NCT02543892|39703462|FG002|Received Vaccination 2|Physician Decision|0|||
16332830|NCT02543892|39703463|FG003|Received Vaccination 2|Physician Decision|0|||
16332831|NCT02543892|39703464|FG004|Received Vaccination 2|Physician Decision|0|||
16332832|NCT02543892|39703465|FG005|Received Vaccination 2|Physician Decision|1|||
16332833|NCT02543892|39703466|FG006|Received Vaccination 2|Physician Decision|0|||
16332834|NCT02543892|39703467|FG007|Received Vaccination 2|Physician Decision|0|||
16332835|NCT02543892|39703460|FG000|Received Vaccination 2|Adverse Event|0|||
16332836|NCT02543892|39703461|FG001|Received Vaccination 2|Adverse Event|1|||
16215556|NCT04067011|39268727|FG002|Overall Study|Not Treated|5|||
16332837|NCT02543892|39703462|FG002|Received Vaccination 2|Adverse Event|0|||
16332838|NCT02543892|39703463|FG003|Received Vaccination 2|Adverse Event|0|||
16532501|NCT01490632|40413950|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532502|NCT01490632|40413951|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532503|NCT01490632|40413952|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532504|NCT01490632|40413953|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
16532505|NCT01490632|40413934|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532506|NCT01490632|40413935|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532507|NCT01490632|40413936|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532508|NCT01490632|40413937|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532509|NCT01490632|40413938|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532510|NCT01490632|40413939|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16100132|NCT03334747|38853005|FG004|Follow-Up Phase|Subject/guardian decision|0|||
16100133|NCT03334747|38853006|FG005|Follow-Up Phase|Subject/guardian decision|0|||
16100134|NCT03334747|38853007|FG006|Follow-Up Phase|Subject/guardian decision|1|||
16100135|NCT03334747|38853008|FG007|Follow-Up Phase|Subject/guardian decision|0|||
16100136|NCT03334747|38853009|FG008|Follow-Up Phase|Subject/guardian decision|1|||
16100137|NCT01745380|38853010|FG000|Overall Study|Lost to Follow-up|1|||
16100138|NCT01745380|38853011|FG001|Overall Study|Lost to Follow-up|0|||
16100139|NCT01745380|38853010|FG000|Overall Study|Lack of Efficacy|0|||
16100140|NCT01745380|38853011|FG001|Overall Study|Lack of Efficacy|1|||
16100141|NCT01762345|38853016|FG000|Overall Study|Adverse Event|5|||
16100142|NCT01762345|38853016|FG000|Overall Study|Protocol Violation|2|||
16100143|NCT00443755|38853017|FG000|Overall Study|Withdrawal by Subject|2|||
16100144|NCT00443755|38853018|FG001|Overall Study|Withdrawal by Subject|1|||
16100145|NCT01679613|38853025|FG000|Overall Study|other than stated above|0|||
16100146|NCT01679613|38853026|FG001|Overall Study|other than stated above|1|||
16100147|NCT01679613|38853027|FG002|Overall Study|other than stated above|2|||
16100148|NCT01679613|38853028|FG003|Overall Study|other than stated above|2|||
16100149|NCT00005908|38853029|FG000|Overall Study|Withdrawal by Subject|1|||
16100150|NCT00005908|38853030|FG001|Overall Study|Withdrawal by Subject|0|||
16402829|NCT01778049|39956827|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
16100153|NCT01345188|38853033|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
16100154|NCT01345188|38853033|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
16100155|NCT02798861|38853034|FG000|Overall Study|Lost to Follow-up|22|||
16100156|NCT02798861|38853034|FG000|Overall Study|Withdrawal by Subject|1|||
16100157|NCT00676663|38853039|FG000|Overall Study|Death|43|||
16100158|NCT00676663|38853040|FG001|Overall Study|Death|27|||
16100159|NCT00676663|38853039|FG000|Overall Study|Withdrew Consent|1|||
16100160|NCT00676663|38853040|FG001|Overall Study|Withdrew Consent|8|||
16100161|NCT00676663|38853039|FG000|Overall Study|Lost to Follow-up|1|||
16100162|NCT00676663|38853040|FG001|Overall Study|Lost to Follow-up|3|||
16100163|NCT01808144|38853041|FG000|Overall Study|Death|1|||
16100164|NCT01808144|38853042|FG001|Overall Study|Death|0|||
16100165|NCT01808144|38853041|FG000|Overall Study|Withdrawal by Subject|16|||
16100166|NCT01808144|38853042|FG001|Overall Study|Withdrawal by Subject|23|||
16100167|NCT01808144|38853041|FG000|Overall Study|Lost to Follow-up|6|||
16100168|NCT01808144|38853042|FG001|Overall Study|Lost to Follow-up|3|||
16100169|NCT01808144|38853041|FG000|Overall Study|Protocol Violation|6|||
16100170|NCT01808144|38853042|FG001|Overall Study|Protocol Violation|6|||
16100171|NCT01808144|38853041|FG000|Overall Study|Gout flare|0|||
16100172|NCT01808144|38853042|FG001|Overall Study|Gout flare|1|||
16100173|NCT01808144|38853041|FG000|Overall Study|Adverse Event|11|||
16100174|NCT01808144|38853042|FG001|Overall Study|Adverse Event|15|||
16100175|NCT00509925|38853043|FG000|Overall Study|Personal reasons|0|||
16100176|NCT00509925|38853044|FG001|Overall Study|Personal reasons|1|||
16332839|NCT02543892|39703464|FG004|Received Vaccination 2|Adverse Event|0|||
16332840|NCT02543892|39703465|FG005|Received Vaccination 2|Adverse Event|0|||
16100177|NCT01323309|38853051|FG000|Overall Study|Death|9|||
16100178|NCT01323309|38853052|FG001|Overall Study|Death|15|||
16100179|NCT01323309|38853053|FG002|Overall Study|Death|5|||
16100180|NCT01323309|38853051|FG000|Overall Study|Lost to Follow-up|11|||
16332841|NCT02543892|39703466|FG006|Received Vaccination 2|Adverse Event|0|||
16100181|NCT01323309|38853052|FG001|Overall Study|Lost to Follow-up|14|||
16100182|NCT01323309|38853053|FG002|Overall Study|Lost to Follow-up|24|||
16100183|NCT01323309|38853051|FG000|Overall Study|Withdrawal by Subject|14|||
16100184|NCT01323309|38853052|FG001|Overall Study|Withdrawal by Subject|14|||
16100185|NCT01323309|38853053|FG002|Overall Study|Withdrawal by Subject|18|||
16100186|NCT01323309|38853051|FG000|Overall Study|Disease progression|5|||
16100187|NCT01323309|38853052|FG001|Overall Study|Disease progression|11|||
16100188|NCT01323309|38853053|FG002|Overall Study|Disease progression|4|||
16100189|NCT00562484|38853054|FG000|Overall Study|Adverse Event|6|||
16100190|NCT00562484|38853055|FG001|Overall Study|Adverse Event|1|||
16100191|NCT00562484|38853054|FG000|Overall Study|Protocol Violation|11|||
16100192|NCT00562484|38853055|FG001|Overall Study|Protocol Violation|2|||
16100193|NCT00562484|38853054|FG000|Overall Study|Withdrawal by Subject|12|||
16100194|NCT00562484|38853055|FG001|Overall Study|Withdrawal by Subject|9|||
16100195|NCT00562484|38853054|FG000|Overall Study|Moved away from the study area|20|||
16100196|NCT00562484|38853055|FG001|Overall Study|Moved away from the study area|9|||
16100197|NCT00562484|38853054|FG000|Overall Study|Lost to Follow-up|132|||
16100198|NCT00562484|38853055|FG001|Overall Study|Lost to Follow-up|71|||
16100199|NCT00562484|38853054|FG000|Overall Study|Reason not provided or not specified|25|||
16100200|NCT00562484|38853055|FG001|Overall Study|Reason not provided or not specified|12|||
16100201|NCT01322347|38853058|FG000|Overall Study|Adverse Event|7|||
16100202|NCT01322347|38853059|FG001|Overall Study|Adverse Event|2|||
16100203|NCT01322347|38853058|FG000|Overall Study|Death|5|||
16100204|NCT01322347|38853059|FG001|Overall Study|Death|3|||
16100205|NCT01322347|38853058|FG000|Overall Study|Physician Decision|2|||
16100206|NCT01322347|38853059|FG001|Overall Study|Physician Decision|1|||
16100207|NCT01322347|38853058|FG000|Overall Study|Protocol Violation|5|||
16100208|NCT01322347|38853059|FG001|Overall Study|Protocol Violation|2|||
16100209|NCT01322347|38853058|FG000|Overall Study|Withdrawal by Subject|1|||
16100210|NCT01322347|38853059|FG001|Overall Study|Withdrawal by Subject|4|||
16100211|NCT01322347|38853058|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
16100212|NCT01322347|38853059|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
16100213|NCT01322347|38853058|FG000|Overall Study|blood transfusion|5|||
16100214|NCT01322347|38853059|FG001|Overall Study|blood transfusion|5|||
16100215|NCT01322347|38853058|FG000|Overall Study|sponsor decision|1|||
16100216|NCT01322347|38853059|FG001|Overall Study|sponsor decision|3|||
16100217|NCT01322347|38853058|FG000|Overall Study|ineligible|6|||
16100218|NCT01322347|38853059|FG001|Overall Study|ineligible|3|||
16100219|NCT01322347|38853058|FG000|Overall Study|kidney transplant|3|||
16100220|NCT01322347|38853059|FG001|Overall Study|kidney transplant|1|||
16100221|NCT01322347|38853058|FG000|Overall Study|study drug withheld > 12 wks|0|||
16100222|NCT01322347|38853059|FG001|Overall Study|study drug withheld > 12 wks|1|||
16100223|NCT01322347|38853058|FG000|Overall Study|moved/changed dialysis|2|||
16100224|NCT01322347|38853059|FG001|Overall Study|moved/changed dialysis|4|||
16100225|NCT01283971|38853086|FG000|Overall Study|Adverse Event|3|||
16100226|NCT01283971|38853087|FG001|Overall Study|Adverse Event|5|||
16100227|NCT01283971|38853086|FG000|Overall Study|Insufficient therapeutic responses|3|||
16100228|NCT01283971|38853087|FG001|Overall Study|Insufficient therapeutic responses|3|||
16100229|NCT01283971|38853086|FG000|Overall Study|Protocol Violation|5|||
16100230|NCT01283971|38853087|FG001|Overall Study|Protocol Violation|1|||
16100231|NCT01283971|38853086|FG000|Overall Study|Refused treatment|3|||
16100232|NCT01283971|38853087|FG001|Overall Study|Refused treatment|1|||
16100233|NCT01283971|38853086|FG000|Overall Study|Failure to return|0|||
16100234|NCT01283971|38853087|FG001|Overall Study|Failure to return|1|||
16100235|NCT01283971|38853086|FG000|Overall Study|Administrative reasons|1|||
16100236|NCT01283971|38853087|FG001|Overall Study|Administrative reasons|1|||
16100237|NCT03530345|38853088|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
16100238|NCT03530345|38853089|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
16100239|NCT03530345|38853088|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
16100240|NCT03530345|38853089|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
16100241|NCT03530345|38853088|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
16100242|NCT03530345|38853089|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
16100243|NCT03530345|38853088|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
16100244|NCT03530345|38853089|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
16100245|NCT01780584|38853090|FG000|Overall Study|Death|1|||
16100246|NCT01780584|38853091|FG001|Overall Study|Death|0|||
16100247|NCT01780584|38853092|FG002|Overall Study|Death|1|||
16100248|NCT01780584|38853090|FG000|Overall Study|Adverse Event|0|||
16332842|NCT02543892|39703467|FG007|Received Vaccination 2|Adverse Event|0|||
16100249|NCT01780584|38853091|FG001|Overall Study|Adverse Event|1|||
16100250|NCT01780584|38853092|FG002|Overall Study|Adverse Event|0|||
16100251|NCT01780584|38853090|FG000|Overall Study|Protocol Violation|0|||
16100252|NCT01780584|38853091|FG001|Overall Study|Protocol Violation|0|||
16100253|NCT01780584|38853092|FG002|Overall Study|Protocol Violation|1|||
16100254|NCT02359552|38853093|FG000|Overall Study|Lost to Follow-up|3|||
16100255|NCT02359552|38853094|FG001|Overall Study|Lost to Follow-up|4|||
16332843|NCT02543892|39703460|FG000|Had Immunology Data|Withdrawal by Subject|0|||
16100256|NCT02849509|38853095|FG000|Overall Study|Worsening of disease under study|1|||
16100257|NCT02849509|38853096|FG001|Overall Study|Worsening of disease under study|1|||
16100258|NCT02849509|38853097|FG002|Overall Study|Worsening of disease under study|1|||
16100259|NCT02849509|38853095|FG000|Overall Study|Worsening of other pre-existing disease|0|||
16100260|NCT02849509|38853096|FG001|Overall Study|Worsening of other pre-existing disease|1|||
16100261|NCT02849509|38853097|FG002|Overall Study|Worsening of other pre-existing disease|2|||
16100262|NCT02849509|38853095|FG000|Overall Study|Other adverse event|36|||
16100263|NCT02849509|38853096|FG001|Overall Study|Other adverse event|41|||
16100264|NCT02849509|38853097|FG002|Overall Study|Other adverse event|8|||
16100265|NCT02849509|38853095|FG000|Overall Study|Withdrawal by Subject|6|||
16100266|NCT02849509|38853096|FG001|Overall Study|Withdrawal by Subject|17|||
16100267|NCT02849509|38853097|FG002|Overall Study|Withdrawal by Subject|12|||
16100268|NCT02849509|38853095|FG000|Overall Study|Lost to Follow-up|27|||
16100269|NCT02849509|38853096|FG001|Overall Study|Lost to Follow-up|67|||
16100270|NCT02849509|38853097|FG002|Overall Study|Lost to Follow-up|36|||
16100271|NCT02849509|38853095|FG000|Overall Study|Other, reason not specified|14|||
16100272|NCT02849509|38853096|FG001|Overall Study|Other, reason not specified|29|||
16100273|NCT02849509|38853097|FG002|Overall Study|Other, reason not specified|25|||
16100274|NCT02849509|38853095|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
16100275|NCT02849509|38853096|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
16100276|NCT02849509|38853097|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
16100277|NCT01870999|38853100|FG000|Overall Study|Adverse Event|0|||
16100278|NCT01870999|38853101|FG001|Overall Study|Adverse Event|4|||
16100279|NCT01870999|38853102|FG002|Overall Study|Adverse Event|1|||
16100280|NCT01870999|38853100|FG000|Overall Study|Subject met withdrawal criteria|3|||
16100281|NCT01870999|38853101|FG001|Overall Study|Subject met withdrawal criteria|2|||
16100282|NCT01870999|38853102|FG002|Overall Study|Subject met withdrawal criteria|0|||
16100283|NCT01870999|38853100|FG000|Overall Study|Subject withdrawn by Investigator|1|||
16100284|NCT01870999|38853101|FG001|Overall Study|Subject withdrawn by Investigator|0|||
16100285|NCT01870999|38853102|FG002|Overall Study|Subject withdrawn by Investigator|0|||
16100286|NCT01870999|38853100|FG000|Overall Study|Withdrawal by Subject|0|||
16100287|NCT01870999|38853101|FG001|Overall Study|Withdrawal by Subject|2|||
16100288|NCT01870999|38853102|FG002|Overall Study|Withdrawal by Subject|5|||
16100289|NCT01870999|38853100|FG000|Overall Study|Protocol Violation|0|||
16100290|NCT01870999|38853101|FG001|Overall Study|Protocol Violation|0|||
16100291|NCT01870999|38853102|FG002|Overall Study|Protocol Violation|1|||
16332844|NCT02543892|39703461|FG001|Had Immunology Data|Withdrawal by Subject|0|||
16332845|NCT02543892|39703462|FG002|Had Immunology Data|Withdrawal by Subject|0|||
16332846|NCT02543892|39703463|FG003|Had Immunology Data|Withdrawal by Subject|0|||
16332847|NCT02543892|39703464|FG004|Had Immunology Data|Withdrawal by Subject|0|||
16332848|NCT02543892|39703465|FG005|Had Immunology Data|Withdrawal by Subject|0|||
16332849|NCT02543892|39703466|FG006|Had Immunology Data|Withdrawal by Subject|1|||
16332850|NCT02543892|39703467|FG007|Had Immunology Data|Withdrawal by Subject|0|||
16332851|NCT00908076|39703468|FG000|Overall Study|Lack of Efficacy|1|||
16332852|NCT00908076|39703469|FG001|Overall Study|Lack of Efficacy|1|||
16332853|NCT01458951|39703476|FG000|Overall Study|Other|1|||
16332854|NCT01458951|39703477|FG001|Overall Study|Other|0|||
16332855|NCT01458951|39703478|FG002|Overall Study|Other|0|||
16332856|NCT01458951|39703476|FG000|Overall Study|Protocol Violation|5|||
16332857|NCT01458951|39703477|FG001|Overall Study|Protocol Violation|1|||
16332858|NCT01458951|39703478|FG002|Overall Study|Protocol Violation|0|||
16332859|NCT01458951|39703476|FG000|Overall Study|Withdrawal by Subject|2|||
16332860|NCT01458951|39703477|FG001|Overall Study|Withdrawal by Subject|0|||
16332861|NCT01458951|39703478|FG002|Overall Study|Withdrawal by Subject|2|||
16332862|NCT01458951|39703476|FG000|Overall Study|Adverse Event|7|||
16332863|NCT01458951|39703477|FG001|Overall Study|Adverse Event|0|||
16332864|NCT01458951|39703478|FG002|Overall Study|Adverse Event|2|||
16332865|NCT01458951|39703476|FG000|Overall Study|Insufficient Clinical Response|17|||
16332866|NCT01458951|39703477|FG001|Overall Study|Insufficient Clinical Response|0|||
16332867|NCT01458951|39703478|FG002|Overall Study|Insufficient Clinical Response|11|||
16332868|NCT01846221|39703479|FG000|Overall Study|Catheter Failure|2|||
16332869|NCT01846221|39703480|FG001|Overall Study|Catheter Failure|0|||
16332870|NCT01846221|39703479|FG000|Overall Study|Age Exclusion|1|||
16332871|NCT01846221|39703480|FG001|Overall Study|Age Exclusion|0|||
16332872|NCT00207727|39703481|FG000|Overall Study|Withdrawal by Subject|0|||
16332873|NCT00207727|39703482|FG001|Overall Study|Withdrawal by Subject|0|||
16332874|NCT00207727|39703483|FG002|Overall Study|Withdrawal by Subject|0|||
16332875|NCT00207727|39703484|FG003|Overall Study|Withdrawal by Subject|0|||
16332876|NCT00207727|39703485|FG004|Overall Study|Withdrawal by Subject|1|||
16332877|NCT00207727|39703481|FG000|Overall Study|Lost to Follow-up|0|||
16532511|NCT01490632|40413940|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
16332878|NCT00207727|39703482|FG001|Overall Study|Lost to Follow-up|1|||
16332879|NCT00207727|39703483|FG002|Overall Study|Lost to Follow-up|0|||
16332880|NCT00207727|39703484|FG003|Overall Study|Lost to Follow-up|0|||
16332881|NCT00207727|39703485|FG004|Overall Study|Lost to Follow-up|0|||
16532512|NCT01490632|40413941|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16332882|NCT00207727|39703481|FG000|Overall Study|Other|38|||
16332883|NCT00207727|39703482|FG001|Overall Study|Other|41|||
16332884|NCT00207727|39703483|FG002|Overall Study|Other|41|||
16332885|NCT00207727|39703484|FG003|Overall Study|Other|37|||
16332886|NCT00207727|39703485|FG004|Overall Study|Other|33|||
16332887|NCT02470403|39703489|FG000|Overall Study|Adverse Event|1|||
16332888|NCT02470403|39703490|FG001|Overall Study|Adverse Event|0|||
16332889|NCT02470403|39703491|FG002|Overall Study|Adverse Event|0|||
16332890|NCT02470403|39703492|FG003|Overall Study|Adverse Event|0|||
16332891|NCT02470403|39703493|FG004|Overall Study|Adverse Event|0|||
16332892|NCT02470403|39703489|FG000|Overall Study|Lost to Follow-up|0|||
16332893|NCT02470403|39703490|FG001|Overall Study|Lost to Follow-up|1|||
16332894|NCT02470403|39703491|FG002|Overall Study|Lost to Follow-up|0|||
16332895|NCT02470403|39703492|FG003|Overall Study|Lost to Follow-up|0|||
16332896|NCT02470403|39703493|FG004|Overall Study|Lost to Follow-up|0|||
16332897|NCT02470403|39703489|FG000|Overall Study|Subject/guardian decision|1|||
16332898|NCT02470403|39703490|FG001|Overall Study|Subject/guardian decision|0|||
16332899|NCT02470403|39703491|FG002|Overall Study|Subject/guardian decision|0|||
16332900|NCT02470403|39703492|FG003|Overall Study|Subject/guardian decision|4|||
16332901|NCT02470403|39703493|FG004|Overall Study|Subject/guardian decision|0|||
16332902|NCT02638259|39703498|FG000|Treatment Period 1|Adverse Event|1|||
16332903|NCT02638259|39703499|FG001|Treatment Period 1|Adverse Event|5|||
16332904|NCT02638259|39703498|FG000|Treatment Period 1|Death|0|||
16332905|NCT02638259|39703499|FG001|Treatment Period 1|Death|1|||
16402830|NCT01778049|39956828|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
16402831|NCT01778049|39956829|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
16402832|NCT01778049|39956824|FG000|Double Blind Treatment Period|Not treated|0|||
16402833|NCT01778049|39956825|FG001|Double Blind Treatment Period|Not treated|0|||
16402834|NCT01778049|39956826|FG002|Double Blind Treatment Period|Not treated|0|||
16402835|NCT01778049|39956827|FG003|Double Blind Treatment Period|Not treated|2|||
16402836|NCT01778049|39956828|FG004|Double Blind Treatment Period|Not treated|2|||
16402837|NCT01778049|39956829|FG005|Double Blind Treatment Period|Not treated|0|||
16402838|NCT01778049|39956824|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
16100292|NCT03034772|38853107|FG000|Overall Study|Adverse Event|0|||
16332906|NCT02638259|39703498|FG000|Treatment Period 1|Lack of Efficacy|0|||
16332907|NCT02638259|39703499|FG001|Treatment Period 1|Lack of Efficacy|1|||
16402839|NCT01778049|39956825|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
16332908|NCT02638259|39703498|FG000|Treatment Period 1|Protocol Violation|0|||
16332909|NCT02638259|39703499|FG001|Treatment Period 1|Protocol Violation|3|||
16332910|NCT02638259|39703498|FG000|Treatment Period 1|Withdrawal by Subject|4|||
16532513|NCT01490632|40413942|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
16532514|NCT01490632|40413943|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
16532515|NCT01490632|40413944|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
16532516|NCT01490632|40413945|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532517|NCT01490632|40413946|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532518|NCT01490632|40413947|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532519|NCT01490632|40413948|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532520|NCT01490632|40413949|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532521|NCT01490632|40413950|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532522|NCT01490632|40413951|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532523|NCT01490632|40413952|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532524|NCT01490632|40413953|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
16532525|NCT01490632|40413934|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532526|NCT01490632|40413935|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532527|NCT01490632|40413936|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532528|NCT01490632|40413937|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532529|NCT01490632|40413938|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532530|NCT01490632|40413939|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532531|NCT01490632|40413940|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
16532532|NCT01490632|40413941|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532533|NCT01490632|40413942|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532534|NCT01490632|40413943|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
16532535|NCT01490632|40413944|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532536|NCT01490632|40413945|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532537|NCT01490632|40413946|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532538|NCT01490632|40413947|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532539|NCT01490632|40413948|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532540|NCT01490632|40413949|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532541|NCT01490632|40413950|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532542|NCT01490632|40413951|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532543|NCT01490632|40413952|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16532544|NCT01490632|40413953|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
16332911|NCT02638259|39703499|FG001|Treatment Period 1|Withdrawal by Subject|6|||
16532545|NCT01490632|40413934|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532546|NCT01490632|40413935|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532547|NCT01490632|40413936|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532548|NCT01490632|40413937|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532549|NCT01490632|40413938|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532550|NCT01490632|40413939|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532551|NCT01490632|40413940|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
16532552|NCT01490632|40413941|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532553|NCT01490632|40413942|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532554|NCT01490632|40413943|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532555|NCT01490632|40413944|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532556|NCT01490632|40413945|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532557|NCT01490632|40413946|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532558|NCT01490632|40413947|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532559|NCT01490632|40413948|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532560|NCT01490632|40413949|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532561|NCT01490632|40413950|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532562|NCT01490632|40413951|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532563|NCT01490632|40413952|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532564|NCT01490632|40413953|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
16532565|NCT01490632|40413934|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532566|NCT01490632|40413935|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532567|NCT01490632|40413936|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532568|NCT01490632|40413937|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532569|NCT01490632|40413938|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532570|NCT01490632|40413939|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
16532571|NCT01490632|40413940|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532572|NCT01490632|40413941|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532573|NCT01490632|40413942|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532574|NCT01490632|40413943|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532575|NCT01490632|40413944|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532576|NCT01490632|40413945|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532577|NCT01490632|40413946|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532578|NCT01490632|40413947|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532579|NCT01490632|40413948|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532580|NCT01490632|40413949|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532581|NCT01490632|40413950|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532582|NCT01490632|40413951|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532583|NCT01490632|40413952|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532584|NCT01490632|40413953|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
16532585|NCT01490632|40413934|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532586|NCT01490632|40413935|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532587|NCT01490632|40413936|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532588|NCT01490632|40413937|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532589|NCT01490632|40413938|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532590|NCT01490632|40413939|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532591|NCT01490632|40413940|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
16532592|NCT01490632|40413941|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532593|NCT01490632|40413942|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
16532594|NCT01490632|40413943|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532595|NCT01490632|40413944|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
16532596|NCT01490632|40413945|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
16532597|NCT01490632|40413946|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532598|NCT01490632|40413947|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532599|NCT01490632|40413948|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532600|NCT01490632|40413949|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532601|NCT01490632|40413950|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532602|NCT01490632|40413951|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532603|NCT01490632|40413952|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532604|NCT01490632|40413953|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
16532605|NCT01490632|40413934|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532606|NCT01490632|40413935|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532607|NCT01490632|40413936|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532608|NCT01490632|40413937|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16100293|NCT03034772|38853108|FG001|Overall Study|Adverse Event|1|||
16532609|NCT01490632|40413938|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532610|NCT01490632|40413939|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
16532611|NCT01490632|40413940|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
16532612|NCT01490632|40413941|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
16532613|NCT01490632|40413942|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
16532614|NCT01490632|40413943|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
16532615|NCT01490632|40413944|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
16532616|NCT01490632|40413945|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
16532617|NCT01490632|40413946|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532618|NCT01490632|40413947|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532619|NCT01490632|40413948|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532620|NCT01490632|40413949|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532621|NCT01490632|40413950|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16332912|NCT02638259|39703498|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
16332913|NCT02638259|39703499|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
16332914|NCT02638259|39703498|FG000|Treatment Period 2|Adverse Event|5|||
16332915|NCT02638259|39703499|FG001|Treatment Period 2|Adverse Event|4|||
16100294|NCT03034772|38853107|FG000|Overall Study|Withdrawal by Subject|0|||
16100295|NCT03034772|38853108|FG001|Overall Study|Withdrawal by Subject|1|||
16332916|NCT02638259|39703498|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16332917|NCT02638259|39703499|FG001|Treatment Period 2|Withdrawal by Subject|7|||
16332918|NCT02678000|39703500|FG000|PART 2|Adverse Event|0|||
16332919|NCT02678000|39703501|FG001|PART 2|Adverse Event|0|||
16332920|NCT02678000|39703502|FG002|PART 2|Adverse Event|2|||
16332921|NCT02678000|39703503|FG003|PART 2|Adverse Event|1|||
16332922|NCT02678000|39703504|FG004|PART 2|Adverse Event|0|||
16332923|NCT02678000|39703500|FG000|PART 2|Withdrawal by Subject|0|||
16332924|NCT02678000|39703501|FG001|PART 2|Withdrawal by Subject|0|||
16332925|NCT02678000|39703502|FG002|PART 2|Withdrawal by Subject|1|||
16332926|NCT02678000|39703503|FG003|PART 2|Withdrawal by Subject|0|||
16332927|NCT02678000|39703504|FG004|PART 2|Withdrawal by Subject|0|||
16332928|NCT01069419|39703505|FG000|Overall Study|Adverse Event|233|||
16332929|NCT01069419|39703505|FG000|Overall Study|Lack of Efficacy|332|||
16332930|NCT01069419|39703505|FG000|Overall Study|Lost to Follow-up|49|||
16332931|NCT01069419|39703505|FG000|Overall Study|Remission of disease|11|||
16332932|NCT01069419|39703505|FG000|Overall Study|Withdrawal by Subject|34|||
16332933|NCT01069419|39703505|FG000|Overall Study|Other Reason|43|||
16332934|NCT01069419|39703505|FG000|Overall Study|Missing termination information|13|||
16332935|NCT00070018|39703506|FG000|Overall Study|Adverse Event|2|||
16332936|NCT00070018|39703506|FG000|Overall Study|Lack of Efficacy|1|||
16332937|NCT00070018|39703506|FG000|Overall Study|Withdrawal by Subject|1|||
16332938|NCT00380718|39703510|FG000|Overall Study|Adverse Event|1|||
16332939|NCT00380718|39703510|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
16332940|NCT02987972|39703511|FG000|Overall Study|Adverse Event|1|||
16332941|NCT02987972|39703512|FG001|Overall Study|Adverse Event|1|||
16332942|NCT02987972|39703513|FG002|Overall Study|Adverse Event|0|||
16332943|NCT02987972|39703511|FG000|Overall Study|Death|1|||
16332944|NCT02987972|39703512|FG001|Overall Study|Death|0|||
16332945|NCT02987972|39703513|FG002|Overall Study|Death|0|||
16100296|NCT02498418|38853109|FG000|Overall Study|Lack of Efficacy|0|||
16332946|NCT02987972|39703511|FG000|Overall Study|Lack of Efficacy|9|||
16332947|NCT02987972|39703512|FG001|Overall Study|Lack of Efficacy|12|||
16332948|NCT02987972|39703513|FG002|Overall Study|Lack of Efficacy|12|||
16100297|NCT02498418|38853110|FG001|Overall Study|Lack of Efficacy|0|||
16332949|NCT02987972|39703511|FG000|Overall Study|Lost to Follow-up|7|||
16332950|NCT02987972|39703512|FG001|Overall Study|Lost to Follow-up|8|||
16332951|NCT02987972|39703513|FG002|Overall Study|Lost to Follow-up|4|||
16332952|NCT02987972|39703511|FG000|Overall Study|Physician Decision|1|||
16332953|NCT02987972|39703512|FG001|Overall Study|Physician Decision|6|||
16332954|NCT02987972|39703513|FG002|Overall Study|Physician Decision|0|||
16332955|NCT02987972|39703511|FG000|Overall Study|Protocol Violation|2|||
16332956|NCT02987972|39703512|FG001|Overall Study|Protocol Violation|1|||
16332957|NCT02987972|39703513|FG002|Overall Study|Protocol Violation|5|||
16332958|NCT02987972|39703511|FG000|Overall Study|Withdrawal by Subject|22|||
16332959|NCT02987972|39703512|FG001|Overall Study|Withdrawal by Subject|17|||
16332960|NCT02987972|39703513|FG002|Overall Study|Withdrawal by Subject|21|||
16332961|NCT01074255|39703516|FG000|Overall Study|Did not receive EMEND|2|||
16332962|NCT01629823|39703527|FG000|Trial Period|Missed visit|11|||
16332963|NCT01629823|39703528|FG001|Trial Period|Missed visit|9|||
16332964|NCT01629823|39703529|FG002|Trial Period|Missed visit|8|||
16332965|NCT01629823|39703527|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
16332966|NCT01629823|39703528|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
16332967|NCT01629823|39703529|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
16332968|NCT01629823|39703527|FG000|Trial Period|Pregnancy|1|||
16332969|NCT01629823|39703528|FG001|Trial Period|Pregnancy|0|||
16402840|NCT01778049|39956826|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
16402841|NCT01778049|39956827|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
16100298|NCT02498418|38853111|FG002|Overall Study|Lack of Efficacy|1|||
16100299|NCT02498418|38853109|FG000|Overall Study|Withdrawal by Subject|2|||
16100300|NCT02498418|38853110|FG001|Overall Study|Withdrawal by Subject|0|||
16100301|NCT02498418|38853111|FG002|Overall Study|Withdrawal by Subject|3|||
16100302|NCT02498418|38853109|FG000|Overall Study|Lost to Follow-up|0|||
16100303|NCT02498418|38853110|FG001|Overall Study|Lost to Follow-up|1|||
16100304|NCT02498418|38853111|FG002|Overall Study|Lost to Follow-up|1|||
16100305|NCT02498418|38853109|FG000|Overall Study|Participant taken prohibited medication|0|||
16100306|NCT02498418|38853110|FG001|Overall Study|Participant taken prohibited medication|1|||
16100307|NCT02498418|38853111|FG002|Overall Study|Participant taken prohibited medication|1|||
16100308|NCT05072795|38853112|FG000|Overall Study|Lost to Follow-up|5|||
16100309|NCT02865135|38853116|FG000|Overall Study|Death|0|||
16100310|NCT02865135|38853117|FG001|Overall Study|Death|1|||
16100311|NCT02865135|38853118|FG002|Overall Study|Death|0|||
16100312|NCT02865135|38853116|FG000|Overall Study|Progression|6|||
16100313|NCT02865135|38853117|FG001|Overall Study|Progression|2|||
16100314|NCT02865135|38853118|FG002|Overall Study|Progression|2|||
16100315|NCT00050167|38856476|FG000|Overall Study|not eligible not invasive|1|||
16100316|NCT00050167|38856477|FG001|Overall Study|not eligible not invasive|1|||
16100317|NCT01012999|38856482|FG000|Overall Study|Protocol Violation|1|||
16100318|NCT02864342|38856483|FG000|Overall Study|Eligibility Criteria Deviation|2|||
16100319|NCT02864342|38856484|FG001|Overall Study|Eligibility Criteria Deviation|3|||
16100320|NCT02864342|38856483|FG000|Overall Study|Withdrawal by Subject|4|||
16100321|NCT02864342|38856484|FG001|Overall Study|Withdrawal by Subject|2|||
16100322|NCT02864342|38856483|FG000|Overall Study|Device Technology Issue|6|||
16100323|NCT02864342|38856484|FG001|Overall Study|Device Technology Issue|7|||
16100324|NCT02864342|38856483|FG000|Overall Study|Death|0|||
16100325|NCT02864342|38856484|FG001|Overall Study|Death|1|||
16100326|NCT02864342|38856483|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
16100327|NCT02864342|38856484|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
16100328|NCT02864342|38856483|FG000|Overall Study|Lost to Follow-up|1|||
16100329|NCT02864342|38856484|FG001|Overall Study|Lost to Follow-up|5|||
16100330|NCT02864342|38856483|FG000|Overall Study|Lost Device|1|||
16100331|NCT02864342|38856484|FG001|Overall Study|Lost Device|0|||
16100332|NCT02864342|38856483|FG000|Overall Study|Adverse Event|1|||
16100333|NCT02864342|38856484|FG001|Overall Study|Adverse Event|0|||
16100334|NCT03745651|38856485|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
16100335|NCT03745651|38856486|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
16100336|NCT03745651|38856487|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16215557|NCT04067011|39268725|FG000|Overall Study|Adverse Event|2|||
16332970|NCT01629823|39703529|FG002|Trial Period|Pregnancy|0|||
16332971|NCT01629823|39703527|FG000|Trial Period|Adverse Event|0|||
16402842|NCT01778049|39956828|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
16402843|NCT01778049|39956829|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
16402844|NCT01498575|39956830|FG000|Overall Sample|Withdrawal by Subject|60|||
16402845|NCT01498575|39956831|FG001|Overall Sample|Withdrawal by Subject|14|||
16402846|NCT01498575|39956830|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
16402847|NCT01498575|39956831|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
16402848|NCT01498575|39956830|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
16402849|NCT01498575|39956831|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
16100337|NCT03745651|38856488|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16100338|NCT03745651|38856489|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16100339|NCT03745651|38856490|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16100340|NCT03745651|38856491|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
16332972|NCT01629823|39703528|FG001|Trial Period|Adverse Event|1|||
16332973|NCT01629823|39703529|FG002|Trial Period|Adverse Event|0|||
16332974|NCT01629823|39703527|FG000|Trial Period|Out-of-window visit|0|||
16332975|NCT01629823|39703528|FG001|Trial Period|Out-of-window visit|2|||
16332976|NCT01629823|39703529|FG002|Trial Period|Out-of-window visit|0|||
16332977|NCT01629823|39703527|FG000|Trial Period|Failed to hold medication|0|||
16332978|NCT01629823|39703528|FG001|Trial Period|Failed to hold medication|0|||
16332979|NCT01629823|39703529|FG002|Trial Period|Failed to hold medication|1|||
16332980|NCT01629823|39703527|FG000|Washout Period|Safety|2|||
16332981|NCT01629823|39703528|FG001|Washout Period|Safety|5|||
16332982|NCT01629823|39703529|FG002|Washout Period|Safety|0|||
16332983|NCT01629823|39703527|FG000|Washout Period|Pregnancy|1|||
16332984|NCT01629823|39703528|FG001|Washout Period|Pregnancy|0|||
16332985|NCT01629823|39703529|FG002|Washout Period|Pregnancy|0|||
16332986|NCT01629823|39703527|FG000|Washout Period|Protocol Violation|0|||
16332987|NCT01629823|39703528|FG001|Washout Period|Protocol Violation|1|||
16332988|NCT01629823|39703529|FG002|Washout Period|Protocol Violation|0|||
16332989|NCT02035748|39703531|FG000|Overall Study|Adverse Event|5|||
16332990|NCT02035748|39703531|FG000|Overall Study|Death|3|||
16532622|NCT01490632|40413951|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532623|NCT01490632|40413952|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532624|NCT01490632|40413953|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
16532625|NCT01490632|40413934|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532626|NCT01490632|40413935|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532627|NCT01490632|40413936|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532628|NCT01490632|40413937|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532629|NCT01490632|40413938|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532630|NCT01490632|40413939|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532631|NCT01490632|40413940|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532632|NCT01490632|40413941|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532633|NCT01490632|40413942|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532634|NCT01490632|40413943|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532635|NCT01490632|40413944|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532636|NCT01490632|40413945|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532637|NCT01490632|40413946|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532638|NCT01490632|40413947|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532639|NCT01490632|40413948|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
16532640|NCT01490632|40413949|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
16532641|NCT01490632|40413950|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532642|NCT01490632|40413951|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532643|NCT01490632|40413952|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532644|NCT01490632|40413953|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
16532645|NCT01490632|40413934|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532646|NCT01490632|40413935|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532647|NCT01490632|40413936|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532648|NCT01490632|40413937|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532649|NCT01490632|40413938|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532650|NCT01490632|40413939|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532651|NCT01490632|40413940|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532652|NCT01490632|40413941|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532653|NCT01490632|40413942|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532654|NCT01490632|40413943|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532655|NCT01490632|40413944|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532656|NCT01490632|40413945|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532657|NCT01490632|40413946|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532658|NCT01490632|40413947|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
16532659|NCT01490632|40413948|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532660|NCT01490632|40413949|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532661|NCT01490632|40413950|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532662|NCT01490632|40413951|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532663|NCT01490632|40413952|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532664|NCT01490632|40413953|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
16532665|NCT01490632|40413934|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532666|NCT01490632|40413935|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532667|NCT01490632|40413936|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532668|NCT01490632|40413937|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16332991|NCT02035748|39703531|FG000|Overall Study|Lost to Follow-up|2|||
16332992|NCT02035748|39703531|FG000|Overall Study|Physician Decision|3|||
16332993|NCT02035748|39703531|FG000|Overall Study|Withdrawal by Subject|6|||
16332994|NCT02035748|39703531|FG000|Overall Study|Progressive Disease|1|||
16532669|NCT01490632|40413938|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532670|NCT01490632|40413939|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532671|NCT01490632|40413940|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532672|NCT01490632|40413941|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532673|NCT01490632|40413942|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532674|NCT01490632|40413943|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532675|NCT01490632|40413944|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532676|NCT01490632|40413945|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532677|NCT01490632|40413946|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532678|NCT01490632|40413947|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532679|NCT01490632|40413948|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
16532680|NCT01490632|40413949|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
16532681|NCT01490632|40413950|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532682|NCT01490632|40413951|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532683|NCT01490632|40413952|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532684|NCT01490632|40413953|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
16532685|NCT01490632|40413934|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532686|NCT01490632|40413935|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532687|NCT01490632|40413936|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532688|NCT01490632|40413937|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532689|NCT01490632|40413938|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532690|NCT01490632|40413939|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16332995|NCT02631746|39703532|FG000|Overall Study|Lack of Efficacy|3|||
16332996|NCT02083185|39703533|FG000|Overall Study|Lost to Follow-up|0|||
16332997|NCT02083185|39703534|FG001|Overall Study|Lost to Follow-up|3|||
16332998|NCT02083185|39703535|FG002|Overall Study|Lost to Follow-up|0|||
16332999|NCT02083185|39703533|FG000|Overall Study|Withdrawal by Subject|9|||
16333000|NCT02083185|39703534|FG001|Overall Study|Withdrawal by Subject|15|||
16333001|NCT02083185|39703535|FG002|Overall Study|Withdrawal by Subject|1|||
16333002|NCT02083185|39703533|FG000|Overall Study|Death|2|||
16333003|NCT02083185|39703534|FG001|Overall Study|Death|2|||
16333004|NCT02083185|39703535|FG002|Overall Study|Death|1|||
16333005|NCT02083185|39703533|FG000|Overall Study|Reason not Specified|9|||
16402850|NCT02109432|39956832|FG000|Overall Study|Withdrawal by Subject|1|||
16402851|NCT02499900|39956833|FG000|Core Study Period|Other|1|||
16402852|NCT02499900|39956834|FG001|Core Study Period|Other|4|||
16402853|NCT02499900|39956833|FG000|Core Study Period|Lost to Follow-up|1|||
16402854|NCT02499900|39956834|FG001|Core Study Period|Lost to Follow-up|2|||
16402855|NCT02499900|39956833|FG000|Core Study Period|Per sponsor request|0|||
16402856|NCT02499900|39956834|FG001|Core Study Period|Per sponsor request|1|||
16402857|NCT02499900|39956833|FG000|Core Study Period|Pregnancy|1|||
16402858|NCT02499900|39956834|FG001|Core Study Period|Pregnancy|0|||
16402859|NCT02499900|39956833|FG000|Core Study Period|Protocol Violation|3|||
16402860|NCT02499900|39956834|FG001|Core Study Period|Protocol Violation|0|||
16402861|NCT02499900|39956833|FG000|Core Study Period|Withdrawal by Subject|11|||
16402862|NCT02499900|39956834|FG001|Core Study Period|Withdrawal by Subject|10|||
16402863|NCT02499900|39956833|FG000|Core Study Period|Adverse Event|18|||
16402864|NCT02499900|39956834|FG001|Core Study Period|Adverse Event|14|||
16402865|NCT02499900|39956833|FG000|Core Study Period|Death|0|||
16402866|NCT02499900|39956834|FG001|Core Study Period|Death|1|||
16402867|NCT02499900|39956833|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
16402868|NCT02499900|39956834|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
16402869|NCT02499900|39956833|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
16402870|NCT02499900|39956834|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
16402871|NCT02499900|39956833|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
16402872|NCT02499900|39956834|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
16402873|NCT02499900|39956833|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
16402874|NCT02499900|39956834|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
16402875|NCT02499900|39956833|FG000|Extension Study Period|Adverse Event|2|||
16402876|NCT02499900|39956834|FG001|Extension Study Period|Adverse Event|4|||
16402877|NCT02499900|39956833|FG000|Extension Study Period|Withdrawal by Subject|5|||
16402878|NCT02499900|39956834|FG001|Extension Study Period|Withdrawal by Subject|2|||
16402879|NCT02499900|39956833|FG000|Extension Study Period|Physician Decision|2|||
16402880|NCT02499900|39956834|FG001|Extension Study Period|Physician Decision|5|||
16402881|NCT02499900|39956833|FG000|Extension Study Period|Pregnancy|1|||
16333006|NCT02083185|39703534|FG001|Overall Study|Reason not Specified|6|||
16333007|NCT02083185|39703535|FG002|Overall Study|Reason not Specified|5|||
16402882|NCT02499900|39956834|FG001|Extension Study Period|Pregnancy|2|||
16402883|NCT02499900|39956833|FG000|Extension Study Period|Lost to Follow-up|2|||
16333008|NCT02083185|39703533|FG000|Overall Study|Study Terminated by Sponsor|0|||
16333009|NCT02083185|39703534|FG001|Overall Study|Study Terminated by Sponsor|1|||
16532691|NCT01490632|40413940|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532692|NCT01490632|40413941|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532693|NCT01490632|40413942|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532694|NCT01490632|40413943|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532695|NCT01490632|40413944|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532696|NCT01490632|40413945|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532697|NCT01490632|40413946|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
16532698|NCT01490632|40413947|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
16532699|NCT01490632|40413948|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
16532700|NCT01490632|40413949|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
16532701|NCT01490632|40413950|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532702|NCT01490632|40413951|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532703|NCT01490632|40413952|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532704|NCT01490632|40413953|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
16532705|NCT01490632|40413934|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
16532706|NCT01490632|40413935|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
16532707|NCT01490632|40413936|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
16532708|NCT01490632|40413937|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
16532709|NCT01490632|40413938|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
16532710|NCT01490632|40413939|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
16532711|NCT01490632|40413940|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
16532712|NCT01490632|40413941|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
16532713|NCT01490632|40413942|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
16532714|NCT01490632|40413943|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
16532715|NCT01490632|40413944|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
16532716|NCT01490632|40413945|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
16532717|NCT01490632|40413946|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
16532718|NCT01490632|40413947|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
16532719|NCT01490632|40413948|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
16532720|NCT01490632|40413949|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
16532721|NCT01490632|40413950|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
16532722|NCT01490632|40413951|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
16532723|NCT01490632|40413952|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
16532724|NCT01490632|40413953|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
16532725|NCT01490632|40413934|FG000|Part D: Re-Treatment Period|Death|0|||
16532726|NCT01490632|40413935|FG001|Part D: Re-Treatment Period|Death|0|||
16532727|NCT01490632|40413936|FG002|Part D: Re-Treatment Period|Death|0|||
16532728|NCT01490632|40413937|FG003|Part D: Re-Treatment Period|Death|0|||
16532729|NCT01490632|40413938|FG004|Part D: Re-Treatment Period|Death|0|||
16532730|NCT01490632|40413939|FG005|Part D: Re-Treatment Period|Death|0|||
16532731|NCT01490632|40413940|FG006|Part D: Re-Treatment Period|Death|0|||
16532732|NCT01490632|40413941|FG007|Part D: Re-Treatment Period|Death|0|||
16532733|NCT01490632|40413942|FG008|Part D: Re-Treatment Period|Death|0|||
16532734|NCT01490632|40413943|FG009|Part D: Re-Treatment Period|Death|0|||
16532735|NCT01490632|40413944|FG010|Part D: Re-Treatment Period|Death|0|||
16215558|NCT04067011|39268726|FG001|Overall Study|Adverse Event|1|||
16215559|NCT04067011|39268727|FG002|Overall Study|Adverse Event|0|||
16532736|NCT01490632|40413945|FG011|Part D: Re-Treatment Period|Death|0|||
16532737|NCT01490632|40413946|FG012|Part D: Re-Treatment Period|Death|0|||
16532738|NCT01490632|40413947|FG013|Part D: Re-Treatment Period|Death|0|||
16532739|NCT01490632|40413948|FG014|Part D: Re-Treatment Period|Death|0|||
16532740|NCT01490632|40413949|FG015|Part D: Re-Treatment Period|Death|0|||
16532741|NCT01490632|40413950|FG016|Part D: Re-Treatment Period|Death|0|||
16532742|NCT01490632|40413951|FG017|Part D: Re-Treatment Period|Death|0|||
16532743|NCT01490632|40413952|FG018|Part D: Re-Treatment Period|Death|1|||
16532744|NCT01490632|40413953|FG019|Part D: Re-Treatment Period|Death|0|||
16532745|NCT01490632|40413934|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532746|NCT01490632|40413935|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16215560|NCT04067011|39268725|FG000|Overall Study|Withdrawal by Subject|6|||
16215561|NCT04067011|39268726|FG001|Overall Study|Withdrawal by Subject|2|||
16215562|NCT04067011|39268727|FG002|Overall Study|Withdrawal by Subject|1|||
16215563|NCT04067011|39268725|FG000|Overall Study|Lost to Follow-up|0|||
16215564|NCT04067011|39268726|FG001|Overall Study|Lost to Follow-up|0|||
16333010|NCT02083185|39703535|FG002|Overall Study|Study Terminated by Sponsor|0|||
16333011|NCT02083185|39703533|FG000|Overall Study|Did not Receive Study Drug|0|||
16532747|NCT01490632|40413936|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532748|NCT01490632|40413937|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16215565|NCT04067011|39268727|FG002|Overall Study|Lost to Follow-up|1|||
16215566|NCT04067011|39268725|FG000|Overall Study|Physician Decision|1|||
16215567|NCT04067011|39268726|FG001|Overall Study|Physician Decision|1|||
16215568|NCT04067011|39268727|FG002|Overall Study|Physician Decision|0|||
16215569|NCT04067011|39268725|FG000|Overall Study|Other Reasons|2|||
16215570|NCT04067011|39268726|FG001|Overall Study|Other Reasons|0|||
16215571|NCT04067011|39268727|FG002|Overall Study|Other Reasons|1|||
16215572|NCT04067011|39268725|FG000|Overall Study|Missing|0|||
16215573|NCT04067011|39268726|FG001|Overall Study|Missing|2|||
16215574|NCT04067011|39268727|FG002|Overall Study|Missing|0|||
16215575|NCT00511108|39268729|FG000|Overall Study|Adverse Event|2|||
16215576|NCT00511108|39268730|FG001|Overall Study|Adverse Event|0|||
16215577|NCT00511108|39268731|FG002|Overall Study|Adverse Event|1|||
16215578|NCT00511108|39268732|FG003|Overall Study|Adverse Event|2|||
16215579|NCT00511108|39268729|FG000|Overall Study|Lost to Follow-up|0|||
16215580|NCT00511108|39268730|FG001|Overall Study|Lost to Follow-up|2|||
16215581|NCT00511108|39268731|FG002|Overall Study|Lost to Follow-up|1|||
16215582|NCT00511108|39268732|FG003|Overall Study|Lost to Follow-up|0|||
16215583|NCT00511108|39268729|FG000|Overall Study|Physician Decision|0|||
16215584|NCT00511108|39268730|FG001|Overall Study|Physician Decision|0|||
16215585|NCT00511108|39268731|FG002|Overall Study|Physician Decision|0|||
16215586|NCT00511108|39268732|FG003|Overall Study|Physician Decision|1|||
16215587|NCT00511108|39268729|FG000|Overall Study|Withdrawal by Subject|4|||
16215588|NCT00511108|39268730|FG001|Overall Study|Withdrawal by Subject|0|||
16215589|NCT00511108|39268731|FG002|Overall Study|Withdrawal by Subject|3|||
16215590|NCT00511108|39268732|FG003|Overall Study|Withdrawal by Subject|2|||
16215591|NCT04785144|39268733|FG000|Overall Study|Withdrawal by Subject|4|||
16215592|NCT04785144|39268734|FG001|Overall Study|Withdrawal by Subject|1|||
16215593|NCT04785144|39268735|FG002|Overall Study|Withdrawal by Subject|0|||
16215594|NCT04785144|39268736|FG003|Overall Study|Withdrawal by Subject|0|||
16215595|NCT04785144|39268737|FG004|Overall Study|Withdrawal by Subject|0|||
16532749|NCT01490632|40413938|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16215596|NCT04785144|39268738|FG005|Overall Study|Withdrawal by Subject|2|||
16402884|NCT02499900|39956834|FG001|Extension Study Period|Lost to Follow-up|5|||
16402885|NCT02499900|39956833|FG000|Extension Study Period|Other|0|||
16215597|NCT04785144|39268739|FG006|Overall Study|Withdrawal by Subject|2|||
16215598|NCT04785144|39268740|FG007|Overall Study|Withdrawal by Subject|0|||
16215599|NCT04785144|39268741|FG008|Overall Study|Withdrawal by Subject|1|||
16215600|NCT04785144|39268742|FG009|Overall Study|Withdrawal by Subject|0|||
16215601|NCT04785144|39268733|FG000|Overall Study|Lost to Follow-up|1|||
16215602|NCT04785144|39268734|FG001|Overall Study|Lost to Follow-up|0|||
16215603|NCT04785144|39268735|FG002|Overall Study|Lost to Follow-up|0|||
16215604|NCT04785144|39268736|FG003|Overall Study|Lost to Follow-up|0|||
16215605|NCT04785144|39268737|FG004|Overall Study|Lost to Follow-up|1|||
16215606|NCT04785144|39268738|FG005|Overall Study|Lost to Follow-up|2|||
16215607|NCT04785144|39268739|FG006|Overall Study|Lost to Follow-up|1|||
16215608|NCT04785144|39268740|FG007|Overall Study|Lost to Follow-up|2|||
16215609|NCT04785144|39268741|FG008|Overall Study|Lost to Follow-up|4|||
16215610|NCT04785144|39268742|FG009|Overall Study|Lost to Follow-up|1|||
16215611|NCT04785144|39268733|FG000|Overall Study|Protocol Violation|0|||
16215612|NCT04785144|39268734|FG001|Overall Study|Protocol Violation|0|||
16215613|NCT04785144|39268735|FG002|Overall Study|Protocol Violation|0|||
16215614|NCT04785144|39268736|FG003|Overall Study|Protocol Violation|0|||
16215615|NCT04785144|39268737|FG004|Overall Study|Protocol Violation|0|||
16215616|NCT04785144|39268738|FG005|Overall Study|Protocol Violation|0|||
16215617|NCT04785144|39268739|FG006|Overall Study|Protocol Violation|1|||
16215618|NCT04785144|39268740|FG007|Overall Study|Protocol Violation|0|||
16215619|NCT04785144|39268741|FG008|Overall Study|Protocol Violation|0|||
16215620|NCT04785144|39268742|FG009|Overall Study|Protocol Violation|0|||
16215621|NCT04785144|39268733|FG000|Overall Study|Physician Decision|0|||
16215622|NCT04785144|39268734|FG001|Overall Study|Physician Decision|0|||
16215623|NCT04785144|39268735|FG002|Overall Study|Physician Decision|0|||
16215624|NCT04785144|39268736|FG003|Overall Study|Physician Decision|0|||
16215625|NCT04785144|39268737|FG004|Overall Study|Physician Decision|0|||
16215626|NCT04785144|39268738|FG005|Overall Study|Physician Decision|0|||
16215627|NCT04785144|39268739|FG006|Overall Study|Physician Decision|0|||
16215628|NCT04785144|39268740|FG007|Overall Study|Physician Decision|0|||
16215629|NCT04785144|39268741|FG008|Overall Study|Physician Decision|0|||
16215630|NCT04785144|39268742|FG009|Overall Study|Physician Decision|1|||
16215631|NCT04785144|39268733|FG000|Overall Study|Unable to continue due to work schedule|0|||
16402886|NCT02499900|39956834|FG001|Extension Study Period|Other|2|||
16215632|NCT04785144|39268734|FG001|Overall Study|Unable to continue due to work schedule|0|||
16215633|NCT04785144|39268735|FG002|Overall Study|Unable to continue due to work schedule|0|||
16215634|NCT04785144|39268736|FG003|Overall Study|Unable to continue due to work schedule|0|||
16215635|NCT04785144|39268737|FG004|Overall Study|Unable to continue due to work schedule|0|||
16215636|NCT04785144|39268738|FG005|Overall Study|Unable to continue due to work schedule|0|||
16215637|NCT04785144|39268739|FG006|Overall Study|Unable to continue due to work schedule|0|||
16215638|NCT04785144|39268740|FG007|Overall Study|Unable to continue due to work schedule|0|||
16215639|NCT04785144|39268741|FG008|Overall Study|Unable to continue due to work schedule|0|||
16402887|NCT02867813|39956835|FG000|Overall Study|Withdrawal by Subject|57|||
16215640|NCT04785144|39268742|FG009|Overall Study|Unable to continue due to work schedule|1|||
16215641|NCT05307523|39268747|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
16215642|NCT05307523|39268748|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
16215643|NCT05307523|39268747|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
16215644|NCT05307523|39268748|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
16215645|NCT02365506|39268749|FG000|Overall Study|Investigator's Discretion|0|||
16215646|NCT02365506|39268750|FG001|Overall Study|Investigator's Discretion|0|||
16215647|NCT02365506|39268751|FG002|Overall Study|Investigator's Discretion|1|||
16215648|NCT02933489|39268752|FG000|Overall Study|Ineligible|3|||
16215649|NCT02933489|39268753|FG001|Overall Study|Ineligible|3|||
16215650|NCT02933489|39268752|FG000|Overall Study|Withdrawal by Subject|27|||
16215651|NCT02933489|39268753|FG001|Overall Study|Withdrawal by Subject|18|||
16215652|NCT02933489|39268752|FG000|Overall Study|Unable to complete exams (other)|14|||
16215653|NCT02933489|39268753|FG001|Overall Study|Unable to complete exams (other)|7|||
16215654|NCT02253992|39268756|FG000|Overall Study|Study drug toxicity|1|||
16215655|NCT02253992|39268757|FG001|Overall Study|Study drug toxicity|0|||
16215656|NCT02253992|39268758|FG002|Overall Study|Study drug toxicity|10|||
16215657|NCT02253992|39268756|FG000|Overall Study|Disease progression|4|||
16215658|NCT02253992|39268757|FG001|Overall Study|Disease progression|3|||
16215659|NCT02253992|39268758|FG002|Overall Study|Disease progression|98|||
16215660|NCT02253992|39268756|FG000|Overall Study|Withdrawal by Subject|0|||
16215661|NCT02253992|39268757|FG001|Overall Study|Withdrawal by Subject|0|||
16215662|NCT02253992|39268758|FG002|Overall Study|Withdrawal by Subject|3|||
16215663|NCT02253992|39268756|FG000|Overall Study|Adverse Event|0|||
16215664|NCT02253992|39268757|FG001|Overall Study|Adverse Event|0|||
16215665|NCT02253992|39268758|FG002|Overall Study|Adverse Event|8|||
16215666|NCT02253992|39268756|FG000|Overall Study|Death|0|||
16215667|NCT02253992|39268757|FG001|Overall Study|Death|0|||
16215668|NCT02253992|39268758|FG002|Overall Study|Death|1|||
16215669|NCT02253992|39268756|FG000|Overall Study|Subject discontinued study drug|1|||
16215670|NCT02253992|39268757|FG001|Overall Study|Subject discontinued study drug|0|||
16215671|NCT02253992|39268758|FG002|Overall Study|Subject discontinued study drug|1|||
16215672|NCT02253992|39268756|FG000|Overall Study|Completed treatment as per protocol|0|||
16215673|NCT02253992|39268757|FG001|Overall Study|Completed treatment as per protocol|1|||
16215674|NCT02253992|39268758|FG002|Overall Study|Completed treatment as per protocol|22|||
16215675|NCT02253992|39268756|FG000|Overall Study|Other|0|||
16215676|NCT02253992|39268757|FG001|Overall Study|Other|0|||
16215677|NCT02253992|39268758|FG002|Overall Study|Other|1|||
16215678|NCT00403390|39268766|FG000|Overall Study|Withdrawal by Subject|1|||
16215679|NCT00403390|39268767|FG001|Overall Study|Withdrawal by Subject|0|||
16215680|NCT00403390|39268766|FG000|Overall Study|samples lost|1|||
16215681|NCT00403390|39268767|FG001|Overall Study|samples lost|0|||
16215682|NCT00403390|39268766|FG000|Overall Study|non-compliant|1|||
16215683|NCT00403390|39268767|FG001|Overall Study|non-compliant|0|||
16215684|NCT00989664|39268768|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
16215685|NCT00989664|39268768|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
16215686|NCT00989664|39268768|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
16215687|NCT00989664|39268768|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
16215688|NCT00989664|39268768|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
16215689|NCT00989664|39268768|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
16215690|NCT00989664|39268768|FG000|Long-Term Follow-Up|Death|3|||
16215691|NCT02289833|39268769|FG000|Overall Study|Study discontinuation|0|||
16215692|NCT02289833|39268770|FG001|Overall Study|Study discontinuation|1|||
16215693|NCT02289833|39268769|FG000|Overall Study|Lost to Follow-up|4|||
16215694|NCT02289833|39268770|FG001|Overall Study|Lost to Follow-up|0|||
16215695|NCT02289833|39268769|FG000|Overall Study|Death|23|||
16215696|NCT02289833|39268770|FG001|Overall Study|Death|16|||
16215697|NCT02573012|39268771|FG000|Overall Study|Adverse Event|5|||
16215698|NCT02573012|39268772|FG001|Overall Study|Adverse Event|5|||
16215699|NCT02573012|39268771|FG000|Overall Study|Lack of Efficacy|5|||
16215700|NCT02573012|39268772|FG001|Overall Study|Lack of Efficacy|4|||
16215701|NCT02573012|39268771|FG000|Overall Study|Non-compliance|1|||
16215702|NCT02573012|39268772|FG001|Overall Study|Non-compliance|2|||
16215703|NCT02573012|39268771|FG000|Overall Study|Withdrawal by Subject|2|||
16215704|NCT02573012|39268772|FG001|Overall Study|Withdrawal by Subject|2|||
16215705|NCT02573012|39268771|FG000|Overall Study|Study Ended per Protocol|1|||
16215706|NCT02573012|39268772|FG001|Overall Study|Study Ended per Protocol|0|||
16215707|NCT02573012|39268771|FG000|Overall Study|Physician Decision|1|||
16215708|NCT02573012|39268772|FG001|Overall Study|Physician Decision|2|||
16215709|NCT02750501|39268773|FG000|Overall Study|Adverse Event|4|||
16215710|NCT02750501|39268773|FG000|Overall Study|Physician Decision|1|||
16402888|NCT02867813|39956836|FG001|Overall Study|Withdrawal by Subject|56|||
16402889|NCT02867813|39956835|FG000|Overall Study|Decision by Sponsor|7|||
16215711|NCT02750501|39268773|FG000|Overall Study|Protocol Violation|1|||
16215712|NCT02750501|39268773|FG000|Overall Study|G-tube came out|1|||
16215713|NCT02750501|39268773|FG000|Overall Study|Non-compliant use of PERT|1|||
16215714|NCT01388491|39268776|FG000|Overall Study|Adverse Event|10|||
16215715|NCT01388491|39268777|FG001|Overall Study|Adverse Event|9|||
16215716|NCT01388491|39268776|FG000|Overall Study|Sponsor Request|9|||
16215717|NCT01388491|39268777|FG001|Overall Study|Sponsor Request|7|||
16215718|NCT01388491|39268776|FG000|Overall Study|Withdrawal by Subject|6|||
16215719|NCT01388491|39268777|FG001|Overall Study|Withdrawal by Subject|10|||
16215720|NCT01388491|39268776|FG000|Overall Study|Lost to Follow-up|4|||
16215721|NCT01388491|39268777|FG001|Overall Study|Lost to Follow-up|3|||
16215722|NCT01388491|39268776|FG000|Overall Study|Protocol Violation|2|||
16100341|NCT03745651|38856485|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
16100342|NCT03745651|38856486|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
16333012|NCT02083185|39703534|FG001|Overall Study|Did not Receive Study Drug|2|||
16333013|NCT02083185|39703535|FG002|Overall Study|Did not Receive Study Drug|0|||
16333014|NCT01317797|39703536|FG000|Overall Study|Other|0|||
16333015|NCT01317797|39703537|FG001|Overall Study|Other|1|||
16333016|NCT01317797|39703538|FG002|Overall Study|Other|0|||
16333017|NCT01317797|39703536|FG000|Overall Study|Withdrawal of Patient|0|||
16215723|NCT01388491|39268777|FG001|Overall Study|Protocol Violation|0|||
16215724|NCT01388491|39268776|FG000|Overall Study|Noncompliance|2|||
16215725|NCT01388491|39268777|FG001|Overall Study|Noncompliance|0|||
16215726|NCT01388491|39268776|FG000|Overall Study|Pregnancy|1|||
16215727|NCT01388491|39268777|FG001|Overall Study|Pregnancy|0|||
16215728|NCT02513394|39268780|FG000|Overall Study|Withdrawal by Subject|11|||
16215729|NCT02513394|39268781|FG001|Overall Study|Withdrawal by Subject|23|||
16215730|NCT02513394|39268780|FG000|Overall Study|Ineligible|1|||
16333018|NCT01317797|39703537|FG001|Overall Study|Withdrawal of Patient|0|||
16333019|NCT01317797|39703538|FG002|Overall Study|Withdrawal of Patient|1|||
16333020|NCT00900731|39703539|FG000|Overall Study|Adverse Event|31|||
16333021|NCT00900731|39703540|FG001|Overall Study|Adverse Event|27|||
16333022|NCT00900731|39703539|FG000|Overall Study|Withdrawal by Subject|8|||
16333023|NCT00900731|39703540|FG001|Overall Study|Withdrawal by Subject|7|||
16402890|NCT02867813|39956836|FG001|Overall Study|Decision by Sponsor|7|||
16402891|NCT02867813|39956835|FG000|Overall Study|Lost to Follow-up|91|||
16333024|NCT00900731|39703539|FG000|Overall Study|Protocol Deviation|8|||
16333025|NCT00900731|39703540|FG001|Overall Study|Protocol Deviation|11|||
16333026|NCT00900731|39703539|FG000|Overall Study|Administrative Problems|5|||
16333027|NCT00900731|39703540|FG001|Overall Study|Administrative Problems|4|||
16333028|NCT00900731|39703539|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
16333029|NCT00900731|39703540|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
16333030|NCT00900731|39703539|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
16333031|NCT00900731|39703540|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
16333032|NCT00900731|39703539|FG000|Overall Study|Lost to Follow-up|2|||
16333033|NCT00900731|39703540|FG001|Overall Study|Lost to Follow-up|3|||
16333034|NCT00900731|39703539|FG000|Overall Study|Lack of Efficacy|1|||
16333035|NCT00900731|39703540|FG001|Overall Study|Lack of Efficacy|3|||
16333036|NCT00900731|39703539|FG000|Overall Study|Death|0|||
16333037|NCT00900731|39703540|FG001|Overall Study|Death|2|||
16333038|NCT03521817|39703542|FG000|Overall Study|Protocol Violation|0|||
16333039|NCT03521817|39703543|FG001|Overall Study|Protocol Violation|1|||
16333040|NCT00844480|39703545|FG000|Overall Study|Withdrawal by Subject|2|||
16333041|NCT00844480|39703546|FG001|Overall Study|Withdrawal by Subject|3|||
16333042|NCT01876979|39706929|FG000|Overall Study|Physician Decision|2|||
16333043|NCT01876979|39706930|FG001|Overall Study|Physician Decision|3|||
16333044|NCT00561470|39706931|FG000|Overall Study|Adverse Event|74|||
16215731|NCT02513394|39268781|FG001|Overall Study|Ineligible|0|||
16215732|NCT04476108|39268782|FG000|Overall Study|Adverse Event|4|||
16333045|NCT00561470|39706932|FG001|Overall Study|Adverse Event|163|||
16333046|NCT00561470|39706931|FG000|Overall Study|Disease progression|437|||
16215733|NCT04476108|39268783|FG001|Overall Study|Adverse Event|1|||
16333047|NCT00561470|39706932|FG001|Overall Study|Disease progression|305|||
16333048|NCT00561470|39706931|FG000|Overall Study|poor compliance to protocol|4|||
16333049|NCT00561470|39706932|FG001|Overall Study|poor compliance to protocol|4|||
16333050|NCT00561470|39706931|FG000|Overall Study|Lost to Follow-up|2|||
16333051|NCT00561470|39706932|FG001|Overall Study|Lost to Follow-up|0|||
16333052|NCT00561470|39706931|FG000|Overall Study|Physician Decision|21|||
16333053|NCT00561470|39706932|FG001|Overall Study|Physician Decision|20|||
16333054|NCT00561470|39706931|FG000|Overall Study|Consent Withdrawn|2|||
16333055|NCT00561470|39706932|FG001|Overall Study|Consent Withdrawn|6|||
16333056|NCT00561470|39706931|FG000|Overall Study|Subject request|43|||
16333057|NCT00561470|39706932|FG001|Overall Study|Subject request|77|||
16333058|NCT00561470|39706931|FG000|Overall Study|Metastatic surgery|10|||
16333059|NCT00561470|39706932|FG001|Overall Study|Metastatic surgery|12|||
16333060|NCT00561470|39706931|FG000|Overall Study|Unauthorized procedure|3|||
16333061|NCT00561470|39706932|FG001|Overall Study|Unauthorized procedure|1|||
16333062|NCT00561470|39706931|FG000|Overall Study|Randomized but not treated|5|||
16402892|NCT02867813|39956836|FG001|Overall Study|Lost to Follow-up|78|||
16402893|NCT02867813|39956835|FG000|Overall Study|Missing|2|||
16402894|NCT02867813|39956836|FG001|Overall Study|Missing|1|||
16402895|NCT02867813|39956835|FG000|Overall Study|Death|294|||
16402896|NCT02867813|39956836|FG001|Overall Study|Death|268|||
16402897|NCT03640052|39956837|FG000|Overall Study|Lost to Follow-up|0|||
16402898|NCT03640052|39956838|FG001|Overall Study|Lost to Follow-up|1|||
16402899|NCT03640052|39956839|FG002|Overall Study|Lost to Follow-up|0|||
16402900|NCT03640052|39956840|FG003|Overall Study|Lost to Follow-up|0|||
16402901|NCT03640052|39956841|FG004|Overall Study|Lost to Follow-up|0|||
16402902|NCT03425006|39956843|FG000|Overall Study|Withdrawal by Subject|1|||
16402903|NCT03425006|39956843|FG000|Overall Study|Physician Decision|1|||
16402904|NCT03425006|39956843|FG000|Overall Study|Death|1|||
16402905|NCT00633074|39956844|FG000|Overall Study|Adverse Event|1|||
16402906|NCT00633074|39956845|FG001|Overall Study|Adverse Event|0|||
16402907|NCT01166373|39956848|FG000|Overall Study|Lost to Follow-up|3|||
16402908|NCT01166373|39956849|FG001|Overall Study|Lost to Follow-up|2|||
16402909|NCT01166373|39956850|FG002|Overall Study|Lost to Follow-up|2|||
16402910|NCT01166373|39956851|FG003|Overall Study|Lost to Follow-up|2|||
16402911|NCT01166373|39956848|FG000|Overall Study|Withdrawal by Subject|1|||
16402912|NCT01166373|39956849|FG001|Overall Study|Withdrawal by Subject|2|||
16402913|NCT01166373|39956850|FG002|Overall Study|Withdrawal by Subject|2|||
16402914|NCT01166373|39956851|FG003|Overall Study|Withdrawal by Subject|3|||
16402915|NCT01166373|39956848|FG000|Overall Study|Physician Decision|1|||
16402916|NCT01166373|39956849|FG001|Overall Study|Physician Decision|0|||
16402917|NCT01166373|39956850|FG002|Overall Study|Physician Decision|0|||
16402918|NCT01166373|39956851|FG003|Overall Study|Physician Decision|0|||
16402919|NCT00695955|39956853|FG000|Cohort 1|Adverse Event|26|||
16402920|NCT00695955|39956853|FG000|Cohort 1|Protocol Violation|2|||
16402921|NCT00695955|39956853|FG000|Cohort 1|Lost to Follow-up|30|||
16402922|NCT00695955|39956853|FG000|Cohort 1|Withdrawal by Subject|25|||
16402923|NCT00695955|39956853|FG000|Cohort 1|Lack of Efficacy|3|||
16402924|NCT00695955|39956853|FG000|Cohort 1|Other|16|||
16402925|NCT00695955|39956853|FG000|Cohort 2|Adverse Event|24|||
16402926|NCT00695955|39956853|FG000|Cohort 2|Protocol Violation|5|||
16402927|NCT00695955|39956853|FG000|Cohort 2|Lost to Follow-up|38|||
16402928|NCT00695955|39956853|FG000|Cohort 2|Withdrawal by Subject|28|||
16402929|NCT00695955|39956853|FG000|Cohort 2|Lack of Efficacy|4|||
16402930|NCT00695955|39956853|FG000|Cohort 2|Other|5|||
16402931|NCT00907803|39956854|FG000|Overall Study|Withdrawal of consent - long commute|1|||
16402932|NCT00907803|39956855|FG001|Overall Study|Withdrawal of consent - long commute|0|||
16402933|NCT00907803|39956856|FG002|Overall Study|Withdrawal of consent - long commute|0|||
16402934|NCT00907803|39956854|FG000|Overall Study|Adverse Event|2|||
16402935|NCT00907803|39956855|FG001|Overall Study|Adverse Event|0|||
16402936|NCT00907803|39956856|FG002|Overall Study|Adverse Event|0|||
16402937|NCT00907803|39956854|FG000|Overall Study|Withdrawal by Subject|0|||
16402938|NCT00907803|39956855|FG001|Overall Study|Withdrawal by Subject|1|||
16402939|NCT00907803|39956856|FG002|Overall Study|Withdrawal by Subject|0|||
16402940|NCT00907803|39956854|FG000|Overall Study|Lost to Follow-up|0|||
16402941|NCT00907803|39956855|FG001|Overall Study|Lost to Follow-up|1|||
16402942|NCT00907803|39956856|FG002|Overall Study|Lost to Follow-up|0|||
16402943|NCT00907803|39956854|FG000|Overall Study|Protocol Violation|0|||
16215734|NCT04476108|39268782|FG000|Overall Study|Lost to Follow-up|1|||
16333063|NCT00561470|39706932|FG001|Overall Study|Randomized but not treated|5|||
16333064|NCT00561470|39706931|FG000|Overall Study|Missed visit window|1|||
16402944|NCT00907803|39956855|FG001|Overall Study|Protocol Violation|1|||
16402945|NCT00907803|39956856|FG002|Overall Study|Protocol Violation|0|||
16402946|NCT01451931|39956857|FG000|Overall Study|Lost to Follow-up|17|||
16402947|NCT01451931|39956858|FG001|Overall Study|Lost to Follow-up|36|||
16402948|NCT01451931|39956859|FG002|Overall Study|Lost to Follow-up|21|||
16402949|NCT01451931|39956857|FG000|Overall Study|Withdrawal by Subject|16|||
16402950|NCT01451931|39956858|FG001|Overall Study|Withdrawal by Subject|22|||
16402951|NCT01451931|39956859|FG002|Overall Study|Withdrawal by Subject|22|||
16402952|NCT04743804|39956862|FG000|Overall Study|Other|1|||
16402953|NCT04743804|39956863|FG001|Overall Study|Other|0|||
16402954|NCT04743804|39956862|FG000|Overall Study|Withdrawal by Subject|0|||
16333065|NCT00561470|39706932|FG001|Overall Study|Missed visit window|4|||
16402955|NCT04743804|39956863|FG001|Overall Study|Withdrawal by Subject|1|||
16402956|NCT04743804|39956862|FG000|Overall Study|Study Terminated by Sponsor|1|||
16402957|NCT04743804|39956863|FG001|Overall Study|Study Terminated by Sponsor|4|||
16402958|NCT04743804|39956862|FG000|Overall Study|Physician Decision|0|||
16402959|NCT04743804|39956863|FG001|Overall Study|Physician Decision|1|||
16100343|NCT03745651|38856487|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
16100344|NCT03745651|38856488|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16333066|NCT00561470|39706931|FG000|Overall Study|Planning surgery|1|||
16333067|NCT00561470|39706932|FG001|Overall Study|Planning surgery|1|||
16333068|NCT00561470|39706931|FG000|Overall Study|Ongoing Treatment|11|||
16333069|NCT00561470|39706932|FG001|Overall Study|Ongoing Treatment|14|||
16333070|NCT03085238|39706933|FG000|Overall Study|Adverse Event|2|||
16333071|NCT03085238|39706933|FG000|Overall Study|Death|2|||
16333072|NCT03301831|39706939|FG000|Overall Study|Lost to Follow-up|5|||
16333073|NCT03301831|39706940|FG001|Overall Study|Lost to Follow-up|3|||
16333074|NCT03301831|39706939|FG000|Overall Study|Protocol Violation|4|||
16333075|NCT03301831|39706940|FG001|Overall Study|Protocol Violation|0|||
16333076|NCT03301831|39706939|FG000|Overall Study|Withdrawal by Subject|11|||
16402960|NCT04743804|39956862|FG000|Overall Study|Death|3|||
16402961|NCT04743804|39956863|FG001|Overall Study|Death|0|||
16100345|NCT03745651|38856489|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16100346|NCT03745651|38856490|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16100347|NCT03745651|38856491|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
16100348|NCT03745651|38856485|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
16100349|NCT03745651|38856486|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16100350|NCT03745651|38856487|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
16100351|NCT03745651|38856488|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16100352|NCT03745651|38856489|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16100353|NCT03745651|38856490|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16100354|NCT03745651|38856491|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
16100355|NCT03745651|38856485|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16100356|NCT03745651|38856486|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
16100357|NCT03745651|38856487|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16100358|NCT03745651|38856488|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16100359|NCT03745651|38856489|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16100360|NCT03745651|38856490|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16100361|NCT03745651|38856491|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
16100362|NCT03745651|38856485|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
16100363|NCT03745651|38856486|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
16100364|NCT03745651|38856487|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
16100365|NCT03745651|38856488|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16100366|NCT03745651|38856489|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16100367|NCT03745651|38856490|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16100368|NCT03745651|38856491|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
16100369|NCT03745651|38856485|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
16100370|NCT03745651|38856486|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
16100371|NCT03745651|38856487|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
16100372|NCT03745651|38856488|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
16100373|NCT03745651|38856489|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
16100374|NCT03745651|38856490|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
16100375|NCT03745651|38856491|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
16215735|NCT04476108|39268783|FG001|Overall Study|Lost to Follow-up|0|||
16333077|NCT03301831|39706940|FG001|Overall Study|Withdrawal by Subject|0|||
16333078|NCT01314105|39706941|FG000|Overall Study|Progressive Disease|6|||
16402962|NCT01035463|39956864|FG000|Overall Study|Adverse Event|0|||
16402963|NCT01035463|39956865|FG001|Overall Study|Adverse Event|0|||
16100376|NCT03745651|38856485|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16402964|NCT01035463|39956866|FG002|Overall Study|Adverse Event|4|||
16402965|NCT01035463|39956867|FG003|Overall Study|Adverse Event|1|||
16402966|NCT01035463|39956868|FG004|Overall Study|Adverse Event|5|||
16402967|NCT01035463|39956869|FG005|Overall Study|Adverse Event|7|||
16402968|NCT01035463|39956864|FG000|Overall Study|Withdrawal by Subject|0|||
16402969|NCT01035463|39956865|FG001|Overall Study|Withdrawal by Subject|2|||
16402970|NCT01035463|39956866|FG002|Overall Study|Withdrawal by Subject|1|||
16100377|NCT03745651|38856486|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16100378|NCT03745651|38856487|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16100379|NCT03745651|38856488|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16100380|NCT03745651|38856489|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16100381|NCT03745651|38856490|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
16100382|NCT03745651|38856491|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
16333079|NCT01314105|39706942|FG001|Overall Study|Progressive Disease|10|||
16402971|NCT01035463|39956867|FG003|Overall Study|Withdrawal by Subject|0|||
16402972|NCT01035463|39956868|FG004|Overall Study|Withdrawal by Subject|1|||
16402973|NCT01035463|39956869|FG005|Overall Study|Withdrawal by Subject|4|||
16402974|NCT01035463|39956864|FG000|Overall Study|Disease progression|0|||
16402975|NCT01035463|39956865|FG001|Overall Study|Disease progression|0|||
16402976|NCT01035463|39956866|FG002|Overall Study|Disease progression|0|||
16402977|NCT01035463|39956867|FG003|Overall Study|Disease progression|0|||
16402978|NCT01035463|39956868|FG004|Overall Study|Disease progression|0|||
16402979|NCT01035463|39956869|FG005|Overall Study|Disease progression|3|||
16402980|NCT01035463|39956864|FG000|Overall Study|Other Malignancy|0|||
16402981|NCT01035463|39956865|FG001|Overall Study|Other Malignancy|0|||
16402982|NCT01035463|39956866|FG002|Overall Study|Other Malignancy|0|||
16402983|NCT01035463|39956867|FG003|Overall Study|Other Malignancy|0|||
16402984|NCT01035463|39956868|FG004|Overall Study|Other Malignancy|0|||
16402985|NCT01035463|39956869|FG005|Overall Study|Other Malignancy|2|||
16402986|NCT01035463|39956864|FG000|Overall Study|Other|0|||
16402987|NCT01035463|39956865|FG001|Overall Study|Other|0|||
16402988|NCT01035463|39956866|FG002|Overall Study|Other|0|||
16402989|NCT01035463|39956867|FG003|Overall Study|Other|1|||
16402990|NCT01035463|39956868|FG004|Overall Study|Other|0|||
16402991|NCT01035463|39956869|FG005|Overall Study|Other|2|||
16402992|NCT01327053|39956872|FG000|Overall Study|Adverse Event|23|||
16402993|NCT01327053|39956873|FG001|Overall Study|Adverse Event|57|||
16402994|NCT01327053|39956872|FG000|Overall Study|Patient/guardian decision|11|||
16402995|NCT01327053|39956873|FG001|Overall Study|Patient/guardian decision|35|||
16402996|NCT01327053|39956872|FG000|Overall Study|Physician Decision|10|||
16402997|NCT01327053|39956873|FG001|Overall Study|Physician Decision|14|||
16402998|NCT01327053|39956872|FG000|Overall Study|Death|1|||
16402999|NCT01327053|39956873|FG001|Overall Study|Death|5|||
16403000|NCT01327053|39956872|FG000|Overall Study|Lost to Follow-up|2|||
16403001|NCT01327053|39956873|FG001|Overall Study|Lost to Follow-up|4|||
16403002|NCT01327053|39956872|FG000|Overall Study|Non-compliance with study treatment|0|||
16403003|NCT01327053|39956873|FG001|Overall Study|Non-compliance with study treatment|5|||
16403004|NCT01327053|39956872|FG000|Overall Study|Study terminated by Sponsor|1|||
16403005|NCT01327053|39956873|FG001|Overall Study|Study terminated by Sponsor|3|||
16532750|NCT01490632|40413939|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532751|NCT01490632|40413940|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532752|NCT01490632|40413941|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532753|NCT01490632|40413942|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532754|NCT01490632|40413943|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532755|NCT01490632|40413944|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532756|NCT01490632|40413945|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532757|NCT01490632|40413946|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532758|NCT01490632|40413947|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532759|NCT01490632|40413948|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532760|NCT01490632|40413949|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532761|NCT01490632|40413950|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
16532762|NCT01490632|40413951|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
16532763|NCT01490632|40413952|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
16532764|NCT01490632|40413953|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
16532765|NCT01490632|40413934|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532766|NCT01490632|40413935|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532767|NCT01490632|40413936|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532768|NCT01490632|40413937|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532769|NCT01490632|40413938|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532770|NCT01490632|40413939|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532771|NCT01490632|40413940|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532772|NCT01490632|40413941|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532773|NCT01490632|40413942|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532774|NCT01490632|40413943|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16403006|NCT01327053|39956872|FG000|Overall Study|Progressive disease|31|||
16403007|NCT01327053|39956873|FG001|Overall Study|Progressive disease|26|||
16403008|NCT01327053|39956872|FG000|Overall Study|Protocol Violation|0|||
16403009|NCT01327053|39956873|FG001|Overall Study|Protocol Violation|1|||
16403010|NCT01327053|39956872|FG000|Overall Study|Untreated|0|||
16403011|NCT01327053|39956873|FG001|Overall Study|Untreated|1|||
16403012|NCT03555981|39956874|FG000|Overall Study|Lost to Follow-up|0|||
16403013|NCT03555981|39956875|FG001|Overall Study|Lost to Follow-up|2|||
16403014|NCT00459875|39956876|FG000|Overall Study|Ineligible participant|1|||
16403015|NCT00459875|39956876|FG000|Overall Study|Adverse Event|2|||
16403016|NCT03315793|39956877|FG000|Overall Study|Adverse Event|4|||
16403017|NCT03315793|39956878|FG001|Overall Study|Adverse Event|2|||
16403018|NCT03315793|39956877|FG000|Overall Study|Protocol Deviation|1|||
16403019|NCT03315793|39956878|FG001|Overall Study|Protocol Deviation|0|||
16403020|NCT03315793|39956877|FG000|Overall Study|Difficult for regular visit|0|||
16403021|NCT03315793|39956878|FG001|Overall Study|Difficult for regular visit|1|||
16403022|NCT02039219|39956879|FG000|Treatment|Withdrawal by Subject|1|||
16403023|NCT02039219|39956880|FG001|Treatment|Withdrawal by Subject|0|||
16403024|NCT02039219|39956879|FG000|Treatment|Adverse Event|0|||
16403025|NCT02039219|39956880|FG001|Treatment|Adverse Event|1|||
16403026|NCT02039219|39956879|FG000|Treatment|Physician Decision|1|||
16403027|NCT02039219|39956880|FG001|Treatment|Physician Decision|0|||
16403028|NCT02039219|39956879|FG000|Treatment|Lost to Follow-up|0|||
16403029|NCT02039219|39956880|FG001|Treatment|Lost to Follow-up|1|||
16403030|NCT02039219|39956879|FG000|Treatment|Protocol Violation|1|||
16403031|NCT02039219|39956880|FG001|Treatment|Protocol Violation|0|||
16403032|NCT02039219|39956879|FG000|Treatment|Death|1|||
16403033|NCT02039219|39956880|FG001|Treatment|Death|0|||
16403034|NCT02039219|39956879|FG000|Follow up|Adverse Event|0|||
16403035|NCT02039219|39956880|FG001|Follow up|Adverse Event|1|||
16403036|NCT03224507|39956881|FG000|Overall Study|Death|3|||
16403037|NCT03224507|39956882|FG001|Overall Study|Death|0|||
16403038|NCT03224507|39956881|FG000|Overall Study|Lack of Efficacy|6|||
16403039|NCT03224507|39956882|FG001|Overall Study|Lack of Efficacy|0|||
16403040|NCT03224507|39956881|FG000|Overall Study|Withdrawal by Subject|6|||
16403041|NCT03224507|39956882|FG001|Overall Study|Withdrawal by Subject|0|||
16403042|NCT01271712|39956883|FG000|Double Blind Treatment|Death|2|||
16403043|NCT01271712|39956884|FG001|Double Blind Treatment|Death|0|||
16403044|NCT01271712|39956883|FG000|Double Blind Treatment|Lack of Efficacy|1|||
16403045|NCT01271712|39956884|FG001|Double Blind Treatment|Lack of Efficacy|0|||
16403046|NCT01271712|39956883|FG000|Double Blind Treatment|Adverse Event|9|||
16403047|NCT01271712|39956884|FG001|Double Blind Treatment|Adverse Event|4|||
16403048|NCT01271712|39956883|FG000|Double Blind Treatment|Progressive disease|23|||
16403049|NCT01271712|39956884|FG001|Double Blind Treatment|Progressive disease|3|||
16403050|NCT01271712|39956883|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
16100383|NCT03745651|38856485|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16100384|NCT03745651|38856486|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16100385|NCT03745651|38856487|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16100386|NCT03745651|38856488|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
16100387|NCT03745651|38856489|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
16100388|NCT03745651|38856490|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
16100389|NCT03745651|38856491|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
16100390|NCT03745651|38856485|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16100391|NCT03745651|38856486|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16100392|NCT03745651|38856487|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
16100393|NCT03745651|38856488|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
16100394|NCT03745651|38856489|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
16100395|NCT03745651|38856490|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
16100396|NCT03745651|38856491|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
16100397|NCT03745651|38856485|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16100398|NCT03745651|38856486|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16100399|NCT03745651|38856487|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16333080|NCT01314105|39706941|FG000|Overall Study|Refused to continue taking medication|0|||
16333081|NCT01314105|39706942|FG001|Overall Study|Refused to continue taking medication|1|||
16333082|NCT01314105|39706941|FG000|Overall Study|Other Adverse Event|1|||
16333083|NCT01314105|39706942|FG001|Overall Study|Other Adverse Event|1|||
16333084|NCT00717275|39706943|FG000|Overall Study|Premature study termination.|3|||
16333085|NCT01280682|39706944|FG000|Overall Study|Lost to Follow-up|0|||
16333086|NCT01280682|39706945|FG001|Overall Study|Lost to Follow-up|6|||
16333087|NCT01280682|39706944|FG000|Overall Study|Withdrawal by Subject|0|||
16333088|NCT01280682|39706945|FG001|Overall Study|Withdrawal by Subject|7|||
16333089|NCT04907227|39706946|FG000|Overall Study|Death|12|||
16333090|NCT04907227|39706947|FG001|Overall Study|Death|8|||
16333091|NCT04907227|39706946|FG000|Overall Study|Withdrawal by Subject|2|||
16333092|NCT04907227|39706947|FG001|Overall Study|Withdrawal by Subject|2|||
16333093|NCT04907227|39706946|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
16333094|NCT04907227|39706947|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
16333095|NCT04907227|39706946|FG000|Overall Study|Sponsor Decision|25|||
16333096|NCT04907227|39706947|FG001|Overall Study|Sponsor Decision|30|||
16333097|NCT04907227|39706946|FG000|Overall Study|Physician Decision|1|||
16333098|NCT04907227|39706947|FG001|Overall Study|Physician Decision|0|||
16403051|NCT01271712|39956884|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
16100400|NCT03745651|38856488|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
16100401|NCT03745651|38856489|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
16100402|NCT03745651|38856490|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
16333099|NCT01362517|39706948|FG000|Overall Study|Protocol Violation|1|||
16333100|NCT01362517|39706948|FG000|Overall Study|Lost to Follow-up|1|||
16333101|NCT02294175|39706949|FG000|Overall Study|Withdrawal by Subject|1|||
16333102|NCT02294175|39706950|FG001|Overall Study|Withdrawal by Subject|2|||
16333103|NCT02294175|39706949|FG000|Overall Study|pt taking excluded medication|3|||
16333104|NCT02294175|39706950|FG001|Overall Study|pt taking excluded medication|1|||
16333105|NCT02294175|39706949|FG000|Overall Study|Protocol Violation|1|||
16333106|NCT02294175|39706950|FG001|Overall Study|Protocol Violation|0|||
16333107|NCT02294175|39706949|FG000|Overall Study|Lost to Follow-up|0|||
16333108|NCT02294175|39706950|FG001|Overall Study|Lost to Follow-up|1|||
16333109|NCT02294175|39706949|FG000|Overall Study|wound healed|0|||
16333110|NCT02294175|39706950|FG001|Overall Study|wound healed|2|||
16333111|NCT04569968|39706951|FG000|Overall Study|Lost to Follow-up|2|||
16333112|NCT04569968|39706952|FG001|Overall Study|Lost to Follow-up|5|||
16333113|NCT04569968|39706951|FG000|Overall Study|Story of head and/or neck surgery|2|||
16333114|NCT04569968|39706952|FG001|Overall Study|Story of head and/or neck surgery|2|||
16333115|NCT04569968|39706951|FG000|Overall Study|Time of stroke onset|8|||
16333116|NCT04569968|39706952|FG001|Overall Study|Time of stroke onset|7|||
16333117|NCT04569968|39706951|FG000|Overall Study|Type of strokr|12|||
16333118|NCT04569968|39706952|FG001|Overall Study|Type of strokr|8|||
16333119|NCT04569968|39706951|FG000|Overall Study|Cooperation|8|||
16333120|NCT04569968|39706952|FG001|Overall Study|Cooperation|8|||
16333121|NCT04569968|39706951|FG000|Overall Study|Age interval|17|||
16333122|NCT04569968|39706952|FG001|Overall Study|Age interval|6|||
16333123|NCT04569968|39706951|FG000|Overall Study|Denial of participation to the study|0|||
16333124|NCT04569968|39706952|FG001|Overall Study|Denial of participation to the study|3|||
16532775|NCT01490632|40413944|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16100403|NCT03745651|38856491|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
16100404|NCT03745651|38856485|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
16100405|NCT03745651|38856486|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
16100406|NCT03745651|38856487|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
16100407|NCT03745651|38856488|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
16100408|NCT03745651|38856489|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
16100409|NCT03745651|38856490|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
16100410|NCT03745651|38856491|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
16100411|NCT03745651|38856485|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16100412|NCT03745651|38856486|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16100413|NCT03745651|38856487|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16100414|NCT03745651|38856488|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16532776|NCT01490632|40413945|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532777|NCT01490632|40413946|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532778|NCT01490632|40413947|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16333125|NCT04569968|39706951|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
16532779|NCT01490632|40413948|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532780|NCT01490632|40413949|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532781|NCT01490632|40413950|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532782|NCT01490632|40413951|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532783|NCT01490632|40413952|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
16532784|NCT01490632|40413953|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
16532785|NCT01490632|40413934|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
16532786|NCT01490632|40413935|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
16532787|NCT01490632|40413936|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
16532788|NCT01490632|40413937|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
16532789|NCT01490632|40413938|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
16532790|NCT01490632|40413939|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
16532791|NCT01490632|40413940|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
16532792|NCT01490632|40413941|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
16532793|NCT01490632|40413942|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
16532794|NCT01490632|40413943|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
16532795|NCT01490632|40413944|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
16532796|NCT01490632|40413945|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
16532797|NCT01490632|40413946|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
16532798|NCT01490632|40413947|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
16532799|NCT01490632|40413948|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
16532800|NCT01490632|40413949|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
16532801|NCT01490632|40413950|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
16333126|NCT04569968|39706952|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
16333127|NCT04569968|39706951|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
16100415|NCT03745651|38856489|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16100416|NCT03745651|38856490|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
16100417|NCT03745651|38856491|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
16100418|NCT03745651|38856485|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16100419|NCT03745651|38856486|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16100420|NCT03745651|38856487|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
16100421|NCT03745651|38856488|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
16100422|NCT03745651|38856489|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
16100423|NCT03745651|38856490|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
16100424|NCT03745651|38856491|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
16100425|NCT03745651|38856485|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
16100426|NCT03745651|38856486|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
16100427|NCT03745651|38856487|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
16100428|NCT03745651|38856488|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
16100429|NCT03745651|38856489|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
16532802|NCT01490632|40413951|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
16532803|NCT01490632|40413952|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
16532804|NCT01490632|40413953|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
16532805|NCT01490632|40413934|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
16532806|NCT01490632|40413935|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
16532807|NCT01490632|40413936|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
16532808|NCT01490632|40413937|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
16532809|NCT01490632|40413938|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
16532810|NCT01490632|40413939|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
16532811|NCT01490632|40413940|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
16532812|NCT01490632|40413941|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
16532813|NCT01490632|40413942|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
16532814|NCT01490632|40413943|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
16532815|NCT01490632|40413944|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
16532816|NCT01490632|40413945|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
16532817|NCT01490632|40413946|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
16532818|NCT01490632|40413947|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
16532819|NCT01490632|40413948|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
16532820|NCT01490632|40413949|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
16532821|NCT01490632|40413950|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
16532822|NCT01490632|40413951|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
16532823|NCT01490632|40413952|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
16532824|NCT01490632|40413953|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
16532825|NCT01490632|40413934|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532826|NCT01490632|40413935|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532827|NCT01490632|40413936|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532828|NCT01490632|40413937|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532829|NCT01490632|40413938|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532830|NCT01490632|40413939|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532831|NCT01490632|40413940|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532832|NCT01490632|40413941|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532833|NCT01490632|40413942|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532834|NCT01490632|40413943|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532835|NCT01490632|40413944|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532836|NCT01490632|40413945|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532837|NCT01490632|40413946|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532838|NCT01490632|40413947|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532839|NCT01490632|40413948|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532840|NCT01490632|40413949|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532841|NCT01490632|40413950|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
16532842|NCT01490632|40413951|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
16532843|NCT01490632|40413952|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
16532844|NCT01490632|40413953|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
16532845|NCT02308748|40413956|FG000|Period 1|Withdrawal by Subject|0|||
16532846|NCT02308748|40413957|FG001|Period 1|Withdrawal by Subject|0|||
16532847|NCT02308748|40413958|FG002|Period 1|Withdrawal by Subject|1|||
16532848|NCT02308748|40413959|FG003|Period 1|Withdrawal by Subject|0|||
16532849|NCT02308748|40413960|FG004|Period 1|Withdrawal by Subject|0|||
16532850|NCT02308748|40413961|FG005|Period 1|Withdrawal by Subject|0|||
16532851|NCT02308748|40413962|FG006|Period 1|Withdrawal by Subject|0|||
16532852|NCT02308748|40413963|FG007|Period 1|Withdrawal by Subject|0|||
16532853|NCT02308748|40413964|FG008|Period 1|Withdrawal by Subject|0|||
16532854|NCT02308748|40413965|FG009|Period 1|Withdrawal by Subject|0|||
16532855|NCT02308748|40413956|FG000|Period 2|Adverse Event|0|||
16532856|NCT02308748|40413957|FG001|Period 2|Adverse Event|0|||
16532857|NCT02308748|40413958|FG002|Period 2|Adverse Event|0|||
16532858|NCT02308748|40413959|FG003|Period 2|Adverse Event|0|||
16532859|NCT02308748|40413960|FG004|Period 2|Adverse Event|0|||
16532860|NCT02308748|40413961|FG005|Period 2|Adverse Event|0|||
16532861|NCT02308748|40413962|FG006|Period 2|Adverse Event|0|||
16532862|NCT02308748|40413963|FG007|Period 2|Adverse Event|1|||
16532863|NCT02308748|40413964|FG008|Period 2|Adverse Event|0|||
16532864|NCT02308748|40413965|FG009|Period 2|Adverse Event|0|||
16532865|NCT02308748|40413956|FG000|Period 3|Protocol Violation|0|||
16532866|NCT02308748|40413957|FG001|Period 3|Protocol Violation|0|||
16532867|NCT02308748|40413958|FG002|Period 3|Protocol Violation|0|||
16532868|NCT02308748|40413959|FG003|Period 3|Protocol Violation|0|||
16532869|NCT02308748|40413960|FG004|Period 3|Protocol Violation|0|||
16532870|NCT02308748|40413961|FG005|Period 3|Protocol Violation|0|||
16532871|NCT02308748|40413962|FG006|Period 3|Protocol Violation|0|||
16532872|NCT02308748|40413963|FG007|Period 3|Protocol Violation|0|||
16532873|NCT02308748|40413964|FG008|Period 3|Protocol Violation|0|||
16532874|NCT02308748|40413965|FG009|Period 3|Protocol Violation|1|||
16532875|NCT02308748|40413956|FG000|Period 5|Adverse Event|1|||
16532876|NCT02308748|40413957|FG001|Period 5|Adverse Event|0|||
16532877|NCT02308748|40413958|FG002|Period 5|Adverse Event|0|||
16532878|NCT02308748|40413959|FG003|Period 5|Adverse Event|0|||
16532879|NCT02308748|40413960|FG004|Period 5|Adverse Event|0|||
16532880|NCT02308748|40413961|FG005|Period 5|Adverse Event|0|||
16532881|NCT02308748|40413962|FG006|Period 5|Adverse Event|0|||
16532882|NCT02308748|40413963|FG007|Period 5|Adverse Event|0|||
16532883|NCT02308748|40413964|FG008|Period 5|Adverse Event|1|||
16532884|NCT02308748|40413965|FG009|Period 5|Adverse Event|0|||
16532885|NCT00698646|40413967|FG000|Overall Study|Adverse Event|8|||
16532886|NCT00698646|40413968|FG001|Overall Study|Adverse Event|7|||
16532887|NCT00698646|40413969|FG002|Overall Study|Adverse Event|8|||
16532888|NCT00698646|40413967|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
16532889|NCT00698646|40413968|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
16532890|NCT00698646|40413969|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
16532891|NCT00698646|40413967|FG000|Overall Study|Protocol Deviation|6|||
16532892|NCT00698646|40413968|FG001|Overall Study|Protocol Deviation|2|||
16532893|NCT00698646|40413969|FG002|Overall Study|Protocol Deviation|3|||
16532894|NCT00698646|40413967|FG000|Overall Study|Withdrawal by Subject|10|||
16532895|NCT00698646|40413968|FG001|Overall Study|Withdrawal by Subject|11|||
16532896|NCT00698646|40413969|FG002|Overall Study|Withdrawal by Subject|8|||
16532897|NCT00698646|40413967|FG000|Overall Study|Lost to Follow-up|0|||
16532898|NCT00698646|40413968|FG001|Overall Study|Lost to Follow-up|0|||
16532899|NCT00698646|40413969|FG002|Overall Study|Lost to Follow-up|2|||
16532900|NCT00698646|40413967|FG000|Overall Study|Administrative problems|1|||
16532901|NCT00698646|40413968|FG001|Overall Study|Administrative problems|0|||
16532902|NCT00698646|40413969|FG002|Overall Study|Administrative problems|1|||
16532903|NCT00175825|40413970|FG000|Overall Study|Adverse Event|3|||
16532904|NCT00175825|40413971|FG001|Overall Study|Adverse Event|2|||
16532905|NCT00175825|40413972|FG002|Overall Study|Adverse Event|1|||
16532906|NCT00175825|40413973|FG003|Overall Study|Adverse Event|1|||
16532907|NCT00175825|40413970|FG000|Overall Study|Lost to Follow-up|1|||
16532908|NCT00175825|40413971|FG001|Overall Study|Lost to Follow-up|2|||
16532909|NCT00175825|40413972|FG002|Overall Study|Lost to Follow-up|0|||
16532910|NCT00175825|40413973|FG003|Overall Study|Lost to Follow-up|0|||
16532911|NCT00175825|40413970|FG000|Overall Study|Withdrawal by Subject|1|||
16532912|NCT00175825|40413971|FG001|Overall Study|Withdrawal by Subject|0|||
16532913|NCT00175825|40413972|FG002|Overall Study|Withdrawal by Subject|0|||
16532914|NCT00175825|40413973|FG003|Overall Study|Withdrawal by Subject|0|||
16100430|NCT03745651|38856490|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
16100431|NCT03745651|38856491|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
16100432|NCT02391116|38856495|FG000|Treatment|Withdrawal by Subject|1|||
16532915|NCT00360529|40413974|FG000|Overall Study|Adverse Event|10|||
16532916|NCT00360529|40413975|FG001|Overall Study|Adverse Event|23|||
16532917|NCT00360529|40413976|FG002|Overall Study|Adverse Event|33|||
16532918|NCT00360529|40413974|FG000|Overall Study|Protocol Violation|3|||
16532919|NCT00360529|40413975|FG001|Overall Study|Protocol Violation|3|||
16532920|NCT00360529|40413976|FG002|Overall Study|Protocol Violation|11|||
16532921|NCT00360529|40413974|FG000|Overall Study|Lost to Follow-up|14|||
16333128|NCT04569968|39706952|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
16532922|NCT00360529|40413975|FG001|Overall Study|Lost to Follow-up|10|||
16532923|NCT00360529|40413976|FG002|Overall Study|Lost to Follow-up|13|||
16532924|NCT00360529|40413974|FG000|Overall Study|Withdrawal by Subject|22|||
16532925|NCT00360529|40413975|FG001|Overall Study|Withdrawal by Subject|14|||
16532926|NCT00360529|40413976|FG002|Overall Study|Withdrawal by Subject|18|||
16532927|NCT00360529|40413974|FG000|Overall Study|Lack of Efficacy|8|||
16532928|NCT00360529|40413975|FG001|Overall Study|Lack of Efficacy|6|||
16532929|NCT00360529|40413976|FG002|Overall Study|Lack of Efficacy|5|||
16532930|NCT00360529|40413974|FG000|Overall Study|Reason discontinued not explained above|4|||
16532931|NCT00360529|40413975|FG001|Overall Study|Reason discontinued not explained above|9|||
16532932|NCT00360529|40413976|FG002|Overall Study|Reason discontinued not explained above|11|||
16532933|NCT01627327|40413980|FG000|Overall Study|Adverse Event|6|||
16100433|NCT02391116|38856495|FG000|Treatment|Protocol Violation|1|||
16100434|NCT02391116|38856495|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
16100435|NCT02391116|38856495|FG000|Treatment|AE with Clinical PD|3|||
16100436|NCT02391116|38856495|FG000|Safety Follow-up|Adverse Event|1|||
16100437|NCT02391116|38856495|FG000|Safety Follow-up|Withdrawal by Subject|4|||
16100438|NCT02391116|38856495|FG000|Safety Follow-up|Switching to Other Therapy|4|||
16100439|NCT02391116|38856495|FG000|Safety Follow-up|No Follow Up|1|||
16100440|NCT02391116|38856495|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
16100441|NCT02391116|38856495|FG000|Active Follow-up|Withdrawal by Subject|1|||
16100442|NCT02391116|38856495|FG000|Active Follow-up|Switching to Other Therapy|2|||
16100443|NCT02391116|38856495|FG000|Survival Follow-up|Withdrawal by Subject|3|||
16100444|NCT02391116|38856495|FG000|Survival Follow-up|Switching to Other Therapy|1|||
16100445|NCT00274846|38856496|FG000|Overall Study|Did not receive adequate NK cells|1|||
16100446|NCT02706834|38856497|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16100447|NCT02706834|38856498|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
16100448|NCT02706834|38856499|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16100449|NCT02706834|38856500|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
16100450|NCT02706834|38856501|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
16100451|NCT02706834|38856502|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
16100452|NCT02706834|38856503|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
16100453|NCT02706834|38856504|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
16100454|NCT02706834|38856505|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
16100455|NCT02706834|38856506|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
16100456|NCT02706834|38856507|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
16100457|NCT02706834|38856497|FG000|Overall Study|Lost to Follow-up|0|||
16100458|NCT02706834|38856498|FG001|Overall Study|Lost to Follow-up|0|||
16100459|NCT02706834|38856499|FG002|Overall Study|Lost to Follow-up|1|||
16100460|NCT02706834|38856500|FG003|Overall Study|Lost to Follow-up|0|||
16100461|NCT02706834|38856501|FG004|Overall Study|Lost to Follow-up|0|||
16100462|NCT02706834|38856502|FG005|Overall Study|Lost to Follow-up|0|||
16100463|NCT02706834|38856503|FG006|Overall Study|Lost to Follow-up|0|||
16100464|NCT02706834|38856504|FG007|Overall Study|Lost to Follow-up|0|||
16100465|NCT02706834|38856505|FG008|Overall Study|Lost to Follow-up|0|||
16100466|NCT02706834|38856506|FG009|Overall Study|Lost to Follow-up|0|||
16100467|NCT02706834|38856507|FG010|Overall Study|Lost to Follow-up|0|||
16100468|NCT02706834|38856497|FG000|Overall Study|Voluntary Withdrawal|1|||
16100469|NCT02706834|38856498|FG001|Overall Study|Voluntary Withdrawal|0|||
16100470|NCT02706834|38856499|FG002|Overall Study|Voluntary Withdrawal|0|||
16100471|NCT02706834|38856500|FG003|Overall Study|Voluntary Withdrawal|0|||
16100472|NCT02706834|38856501|FG004|Overall Study|Voluntary Withdrawal|0|||
16100473|NCT02706834|38856502|FG005|Overall Study|Voluntary Withdrawal|0|||
16100474|NCT02706834|38856503|FG006|Overall Study|Voluntary Withdrawal|0|||
16100475|NCT02706834|38856504|FG007|Overall Study|Voluntary Withdrawal|0|||
16100476|NCT02706834|38856505|FG008|Overall Study|Voluntary Withdrawal|0|||
16100477|NCT02706834|38856506|FG009|Overall Study|Voluntary Withdrawal|1|||
16100478|NCT02706834|38856507|FG010|Overall Study|Voluntary Withdrawal|0|||
16100479|NCT02706834|38856497|FG000|Overall Study|Other Reason Not Specified|1|||
16100480|NCT02706834|38856498|FG001|Overall Study|Other Reason Not Specified|0|||
16100481|NCT02706834|38856499|FG002|Overall Study|Other Reason Not Specified|0|||
16100482|NCT02706834|38856500|FG003|Overall Study|Other Reason Not Specified|0|||
16100483|NCT02706834|38856501|FG004|Overall Study|Other Reason Not Specified|1|||
16100484|NCT02706834|38856502|FG005|Overall Study|Other Reason Not Specified|0|||
16100485|NCT02706834|38856503|FG006|Overall Study|Other Reason Not Specified|0|||
16100486|NCT02706834|38856504|FG007|Overall Study|Other Reason Not Specified|0|||
16100487|NCT02706834|38856505|FG008|Overall Study|Other Reason Not Specified|0|||
16532934|NCT01627327|40413981|FG001|Overall Study|Adverse Event|12|||
16532935|NCT01627327|40413980|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
16532936|NCT01627327|40413981|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
16532937|NCT01627327|40413980|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
16532938|NCT01627327|40413981|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
16532939|NCT01627327|40413980|FG000|Overall Study|Protocol Violation|4|||
16100488|NCT02706834|38856506|FG009|Overall Study|Other Reason Not Specified|0|||
16100489|NCT02706834|38856507|FG010|Overall Study|Other Reason Not Specified|0|||
16532940|NCT01627327|40413981|FG001|Overall Study|Protocol Violation|10|||
16532941|NCT01627327|40413980|FG000|Overall Study|Lost to Follow-up|1|||
16100490|NCT00228813|38856513|FG000|Overall Study|Death|4|||
16100491|NCT02499835|38856528|FG000|Overall Study|Withdrawal by Subject|1|||
16100492|NCT02499835|38856529|FG001|Overall Study|Withdrawal by Subject|0|||
16100493|NCT02499835|38856530|FG002|Overall Study|Withdrawal by Subject|0|||
16100494|NCT02499835|38856531|FG003|Overall Study|Withdrawal by Subject|1|||
16100495|NCT02499835|38856528|FG000|Overall Study|Physician Decision|0|||
16100496|NCT02499835|38856529|FG001|Overall Study|Physician Decision|3|||
16100497|NCT02499835|38856530|FG002|Overall Study|Physician Decision|18|||
16100498|NCT02499835|38856531|FG003|Overall Study|Physician Decision|7|||
16100499|NCT02499835|38856528|FG000|Overall Study|Adverse Event|0|||
16100500|NCT02499835|38856529|FG001|Overall Study|Adverse Event|0|||
16100501|NCT02499835|38856530|FG002|Overall Study|Adverse Event|0|||
16100502|NCT02499835|38856531|FG003|Overall Study|Adverse Event|1|||
16100503|NCT02499835|38856528|FG000|Overall Study|Disease progression|2|||
16100504|NCT02499835|38856529|FG001|Overall Study|Disease progression|1|||
16100505|NCT02499835|38856530|FG002|Overall Study|Disease progression|0|||
16100506|NCT02499835|38856531|FG003|Overall Study|Disease progression|7|||
16100507|NCT00899379|38856534|FG000|Overall Study|Adverse Event|2|||
16100508|NCT00899379|38856535|FG001|Overall Study|Adverse Event|2|||
16100509|NCT00899379|38856536|FG002|Overall Study|Adverse Event|1|||
16100510|NCT00899379|38856537|FG003|Overall Study|Adverse Event|1|||
16333129|NCT04569968|39706951|FG000|Overall Study|Quarantine|1|||
16333130|NCT04569968|39706952|FG001|Overall Study|Quarantine|0|||
16333131|NCT04569968|39706951|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
16333132|NCT04569968|39706952|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
16333133|NCT04569968|39706951|FG000|Overall Study|Repetitive stroke|8|||
16403052|NCT01271712|39956883|FG000|Double Blind Treatment|Non compliance with study drug|2|||
16403053|NCT01271712|39956884|FG001|Double Blind Treatment|Non compliance with study drug|0|||
16403054|NCT01271712|39956883|FG000|Double Blind Treatment|receive no study drug|1|||
16403055|NCT01271712|39956884|FG001|Double Blind Treatment|receive no study drug|0|||
16403056|NCT01271712|39956883|FG000|Open Label Treatment|Death|6|||
16403057|NCT01271712|39956884|FG001|Open Label Treatment|Death|5|||
16532942|NCT01627327|40413981|FG001|Overall Study|Lost to Follow-up|3|||
16532943|NCT01627327|40413980|FG000|Overall Study|Physician Decision|1|||
16532944|NCT01627327|40413981|FG001|Overall Study|Physician Decision|0|||
16532945|NCT01627327|40413980|FG000|Overall Study|Withdrawal by Subject|3|||
16532946|NCT01627327|40413981|FG001|Overall Study|Withdrawal by Subject|3|||
16532947|NCT04389840|40413987|FG000|Overall Study|Adverse Event|0|||
16532948|NCT04389840|40413988|FG001|Overall Study|Adverse Event|0|||
16532949|NCT04389840|40413989|FG002|Overall Study|Adverse Event|0|||
16532950|NCT04389840|40413990|FG003|Overall Study|Adverse Event|1|||
16532951|NCT04389840|40413991|FG004|Overall Study|Adverse Event|0|||
16532952|NCT04389840|40413992|FG005|Overall Study|Adverse Event|0|||
16532953|NCT04389840|40413987|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
16532954|NCT04389840|40413988|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
16532955|NCT04389840|40413989|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
16333134|NCT04569968|39706952|FG001|Overall Study|Repetitive stroke|0|||
16333135|NCT04569968|39706951|FG000|Overall Study|Insufficient mastication|1|||
16333136|NCT04569968|39706952|FG001|Overall Study|Insufficient mastication|0|||
16333137|NCT04569968|39706951|FG000|Overall Study|Infection|1|||
16333138|NCT04569968|39706952|FG001|Overall Study|Infection|0|||
16333139|NCT01995175|39706955|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
16333140|NCT01995175|39706955|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
16403058|NCT01271712|39956883|FG000|Open Label Treatment|Withdrawal by Subject|6|||
16403059|NCT01271712|39956884|FG001|Open Label Treatment|Withdrawal by Subject|11|||
16403060|NCT01271712|39956883|FG000|Open Label Treatment|Physician Decision|2|||
16532956|NCT04389840|40413990|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
16532957|NCT04389840|40413991|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
16532958|NCT04389840|40413992|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
16532959|NCT04389840|40413987|FG000|Overall Study|Death|0|||
16100511|NCT00899379|38856538|FG004|Overall Study|Adverse Event|2|||
16532960|NCT04389840|40413988|FG001|Overall Study|Death|1|||
16532961|NCT04389840|40413989|FG002|Overall Study|Death|0|||
16532962|NCT04389840|40413990|FG003|Overall Study|Death|0|||
16532963|NCT04389840|40413991|FG004|Overall Study|Death|0|||
16532964|NCT04389840|40413992|FG005|Overall Study|Death|0|||
16532965|NCT00838110|40413993|FG000|Overall Study|Death|0|||
16532966|NCT00838110|40413994|FG001|Overall Study|Death|0|||
16532967|NCT00838110|40413995|FG002|Overall Study|Death|1|||
16532968|NCT00838110|40413996|FG003|Overall Study|Death|2|||
16532969|NCT00838110|40413993|FG000|Overall Study|Adverse Event|11|||
16532970|NCT00838110|40413994|FG001|Overall Study|Adverse Event|10|||
16532971|NCT00838110|40413995|FG002|Overall Study|Adverse Event|8|||
16532972|NCT00838110|40413996|FG003|Overall Study|Adverse Event|7|||
16532973|NCT00838110|40413993|FG000|Overall Study|Withdrawal by Subject|5|||
16333141|NCT01995175|39706955|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
16333142|NCT01995175|39706955|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
16333143|NCT01995175|39706955|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
16333144|NCT01995175|39706955|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
16333145|NCT01995175|39706955|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
16333146|NCT01995175|39706955|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
16333147|NCT01995175|39706955|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
16333148|NCT00723190|39706958|FG000|Overall Study|Withdrawal by Subject|45|||
16333149|NCT00723190|39706958|FG000|Overall Study|Lost to Follow-up|37|||
16333150|NCT00723190|39706958|FG000|Overall Study|Adverse Event|18|||
16333151|NCT00723190|39706958|FG000|Overall Study|Lack of Efficacy|16|||
16333152|NCT00723190|39706958|FG000|Overall Study|Protocol Violation|15|||
16333153|NCT00723190|39706958|FG000|Overall Study|Other-Premature Discontinuation|9|||
16333154|NCT00723190|39706958|FG000|Overall Study|Other-Not included in safety population|2|||
16333155|NCT00367484|39706964|FG000|Overall Study|Adverse Event|7|||
16333156|NCT00367484|39706964|FG000|Overall Study|Withdrew informed consent|5|||
16333157|NCT00367484|39706964|FG000|Overall Study|Travel to USA|1|||
16403061|NCT01271712|39956884|FG001|Open Label Treatment|Physician Decision|0|||
16403062|NCT01271712|39956883|FG000|Open Label Treatment|Adverse Event|14|||
16403063|NCT01271712|39956884|FG001|Open Label Treatment|Adverse Event|8|||
16403064|NCT01271712|39956883|FG000|Open Label Treatment|Progressive disease|59|||
16403065|NCT01271712|39956884|FG001|Open Label Treatment|Progressive disease|32|||
16532974|NCT00838110|40413994|FG001|Overall Study|Withdrawal by Subject|6|||
16532975|NCT00838110|40413995|FG002|Overall Study|Withdrawal by Subject|3|||
16532976|NCT00838110|40413996|FG003|Overall Study|Withdrawal by Subject|4|||
16532977|NCT00838110|40413993|FG000|Overall Study|Other|3|||
16532978|NCT00838110|40413994|FG001|Overall Study|Other|3|||
16532979|NCT00838110|40413995|FG002|Overall Study|Other|3|||
16532980|NCT00838110|40413996|FG003|Overall Study|Other|2|||
16532981|NCT00838110|40413993|FG000|Overall Study|Protocol Violation|0|||
16532982|NCT00838110|40413994|FG001|Overall Study|Protocol Violation|2|||
16532983|NCT00838110|40413995|FG002|Overall Study|Protocol Violation|1|||
16532984|NCT00838110|40413996|FG003|Overall Study|Protocol Violation|1|||
16532985|NCT00838110|40413993|FG000|Overall Study|Lost to Follow-up|3|||
16532986|NCT00838110|40413994|FG001|Overall Study|Lost to Follow-up|0|||
16532987|NCT00838110|40413995|FG002|Overall Study|Lost to Follow-up|0|||
16532988|NCT00838110|40413996|FG003|Overall Study|Lost to Follow-up|0|||
16532989|NCT00838110|40413993|FG000|Overall Study|Did not meet eligibility criteria|0|||
16532990|NCT00838110|40413994|FG001|Overall Study|Did not meet eligibility criteria|0|||
16532991|NCT00838110|40413995|FG002|Overall Study|Did not meet eligibility criteria|1|||
16532992|NCT00838110|40413996|FG003|Overall Study|Did not meet eligibility criteria|2|||
16532993|NCT00838110|40413993|FG000|Overall Study|Randomized but not treated|0|||
16532994|NCT00838110|40413994|FG001|Overall Study|Randomized but not treated|1|||
16532995|NCT00838110|40413995|FG002|Overall Study|Randomized but not treated|0|||
16532996|NCT00838110|40413996|FG003|Overall Study|Randomized but not treated|0|||
16532997|NCT02384954|40414001|FG000|Phase 1|Progressive Disease|2|||
16532998|NCT02384954|40414002|FG001|Phase 1|Progressive Disease|0|||
16532999|NCT02384954|40414003|FG002|Phase 1|Progressive Disease|1|||
16215736|NCT04476108|39268782|FG000|Overall Study|Inadvertent Enrollment|1|||
16403066|NCT01271712|39956883|FG000|Open Label Treatment|transferred to rollover study|1|||
16403067|NCT01271712|39956884|FG001|Open Label Treatment|transferred to rollover study|0|||
16533000|NCT02384954|40414004|FG003|Phase 1|Progressive Disease|1|||
16533001|NCT02384954|40414005|FG004|Phase 1|Progressive Disease|0|||
16533002|NCT02384954|40414006|FG005|Phase 1|Progressive Disease|0|||
16533003|NCT02384954|40414007|FG006|Phase 1|Progressive Disease|0|||
16533004|NCT02384954|40414008|FG007|Phase 1|Progressive Disease|0|||
16403068|NCT01271712|39956883|FG000|Open Label Treatment|Non-compliance with study drug|1|||
16403069|NCT01271712|39956884|FG001|Open Label Treatment|Non-compliance with study drug|0|||
16533005|NCT02384954|40414009|FG008|Phase 1|Progressive Disease|0|||
16533006|NCT02384954|40414001|FG000|Phase 1|Adverse Event|0|||
16533007|NCT02384954|40414002|FG001|Phase 1|Adverse Event|0|||
16533008|NCT02384954|40414003|FG002|Phase 1|Adverse Event|1|||
16533009|NCT02384954|40414004|FG003|Phase 1|Adverse Event|0|||
16533010|NCT02384954|40414005|FG004|Phase 1|Adverse Event|0|||
16533011|NCT02384954|40414006|FG005|Phase 1|Adverse Event|0|||
16533012|NCT02384954|40414007|FG006|Phase 1|Adverse Event|0|||
16533013|NCT02384954|40414008|FG007|Phase 1|Adverse Event|0|||
16533014|NCT02384954|40414009|FG008|Phase 1|Adverse Event|0|||
16533015|NCT02384954|40414001|FG000|Phase 2|Progressive Disease|0|||
16533016|NCT02384954|40414002|FG001|Phase 2|Progressive Disease|0|||
16533017|NCT02384954|40414003|FG002|Phase 2|Progressive Disease|0|||
16533018|NCT02384954|40414004|FG003|Phase 2|Progressive Disease|0|||
16533019|NCT02384954|40414005|FG004|Phase 2|Progressive Disease|0|||
16533020|NCT02384954|40414006|FG005|Phase 2|Progressive Disease|0|||
16533021|NCT02384954|40414007|FG006|Phase 2|Progressive Disease|0|||
16533022|NCT02384954|40414008|FG007|Phase 2|Progressive Disease|1|||
16533023|NCT02384954|40414009|FG008|Phase 2|Progressive Disease|2|||
16533024|NCT02384954|40414001|FG000|Phase 2|Adverse Event|0|||
16533025|NCT02384954|40414002|FG001|Phase 2|Adverse Event|0|||
16533026|NCT02384954|40414003|FG002|Phase 2|Adverse Event|0|||
16533027|NCT02384954|40414004|FG003|Phase 2|Adverse Event|0|||
16533028|NCT02384954|40414005|FG004|Phase 2|Adverse Event|0|||
16533029|NCT02384954|40414006|FG005|Phase 2|Adverse Event|0|||
16533030|NCT02384954|40414007|FG006|Phase 2|Adverse Event|0|||
16533031|NCT02384954|40414008|FG007|Phase 2|Adverse Event|1|||
16533032|NCT02384954|40414009|FG008|Phase 2|Adverse Event|1|||
16533033|NCT02384954|40414001|FG000|Phase 2|Failure to meet continuation criteria|0|||
16533034|NCT02384954|40414002|FG001|Phase 2|Failure to meet continuation criteria|0|||
16533035|NCT02384954|40414003|FG002|Phase 2|Failure to meet continuation criteria|0|||
16533036|NCT02384954|40414004|FG003|Phase 2|Failure to meet continuation criteria|0|||
16533037|NCT02384954|40414005|FG004|Phase 2|Failure to meet continuation criteria|0|||
16533038|NCT02384954|40414006|FG005|Phase 2|Failure to meet continuation criteria|0|||
16533039|NCT02384954|40414007|FG006|Phase 2|Failure to meet continuation criteria|0|||
16533040|NCT02384954|40414008|FG007|Phase 2|Failure to meet continuation criteria|1|||
16533041|NCT02384954|40414009|FG008|Phase 2|Failure to meet continuation criteria|0|||
16533042|NCT00722761|40414010|FG000|Overall Study|Lost to Follow-up|1|||
16533043|NCT00722761|40414011|FG001|Overall Study|Lost to Follow-up|4|||
16533044|NCT00722761|40414010|FG000|Overall Study|Withdrawal by Subject|5|||
16533045|NCT00722761|40414011|FG001|Overall Study|Withdrawal by Subject|2|||
16533046|NCT02062632|40414012|FG000|Overall Study|No treatment data|1|||
16215737|NCT04476108|39268783|FG001|Overall Study|Inadvertent Enrollment|0|||
16215738|NCT04476108|39268782|FG000|Overall Study|Protocol Violation|1|||
16215739|NCT04476108|39268783|FG001|Overall Study|Protocol Violation|1|||
16215740|NCT04476108|39268782|FG000|Overall Study|Withdrawal by Subject|1|||
16215741|NCT04476108|39268783|FG001|Overall Study|Withdrawal by Subject|1|||
16403070|NCT01271712|39956883|FG000|Open Label Treatment|Protocol Violation|0|||
16403071|NCT01271712|39956884|FG001|Open Label Treatment|Protocol Violation|1|||
16403072|NCT01271712|39956883|FG000|Open Label Treatment|Switching to other therapy|2|||
16403073|NCT01271712|39956884|FG001|Open Label Treatment|Switching to other therapy|1|||
16403074|NCT01271712|39956883|FG000|Safety Follow-up|Death|11|||
16403075|NCT01271712|39956884|FG001|Safety Follow-up|Death|7|||
16403076|NCT01271712|39956883|FG000|Safety Follow-up|Withdrawal by Subject|4|||
16403077|NCT01271712|39956884|FG001|Safety Follow-up|Withdrawal by Subject|2|||
16403078|NCT01271712|39956883|FG000|Safety Follow-up|Protocol Violation|1|||
16403079|NCT01271712|39956884|FG001|Safety Follow-up|Protocol Violation|1|||
16403080|NCT01271712|39956883|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
16403081|NCT01271712|39956884|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
16215742|NCT00364832|39268784|FG000|Core Period|Early Withdrawals|2|||
16533047|NCT01881620|40414013|FG000|Overall Study|Protocol Violation|4|||
16215743|NCT00364832|39268785|FG001|Core Period|Early Withdrawals|2|||
16215744|NCT00364832|39268786|FG002|Core Period|Early Withdrawals|1|||
16215745|NCT00364832|39268787|FG003|Core Period|Early Withdrawals|1|||
16215746|NCT00364832|39268788|FG004|Core Period|Early Withdrawals|0|||
16215747|NCT00364832|39268789|FG005|Core Period|Early Withdrawals|0|||
16215748|NCT00364832|39268790|FG006|Core Period|Early Withdrawals|4|||
16215749|NCT00364832|39268791|FG007|Core Period|Early Withdrawals|1|||
16215750|NCT00364832|39268792|FG008|Core Period|Early Withdrawals|0|||
16533048|NCT01332227|40414014|FG000|Overall Study|Adverse Event|4|||
16533049|NCT01332227|40414015|FG001|Overall Study|Adverse Event|1|||
16215751|NCT00364832|39268793|FG009|Core Period|Early Withdrawals|0|||
16403082|NCT01271712|39956883|FG000|Safety Follow-up|No follow-up|1|||
16403083|NCT01271712|39956884|FG001|Safety Follow-up|No follow-up|1|||
16533050|NCT01332227|40414014|FG000|Overall Study|Withdrawal by Subject|5|||
16533051|NCT01332227|40414015|FG001|Overall Study|Withdrawal by Subject|1|||
16403084|NCT01271712|39956883|FG000|Safety Follow-up|Progressive disease|1|||
16533052|NCT01332227|40414014|FG000|Overall Study|Lost to Follow-up|2|||
16533053|NCT01332227|40414015|FG001|Overall Study|Lost to Follow-up|0|||
16533054|NCT01332227|40414014|FG000|Overall Study|Lack of Efficacy|3|||
16533055|NCT01332227|40414015|FG001|Overall Study|Lack of Efficacy|1|||
16215752|NCT00364832|39268794|FG010|Core Period|Early Withdrawals|0|||
16215753|NCT00364832|39268795|FG011|Core Period|Early Withdrawals|0|||
16215754|NCT00364832|39268784|FG000|Extension Year 1|Early Withdrawals|0|||
16215755|NCT00364832|39268785|FG001|Extension Year 1|Early Withdrawals|0|||
16533056|NCT01332227|40414014|FG000|Overall Study|Poor compliance/noncompliance|1|||
16533057|NCT01332227|40414015|FG001|Overall Study|Poor compliance/noncompliance|1|||
16533058|NCT01332227|40414014|FG000|Overall Study|Patient moved from area|1|||
16533059|NCT01332227|40414015|FG001|Overall Study|Patient moved from area|0|||
16533060|NCT01332227|40414014|FG000|Overall Study|Patient began prohibited medication|0|||
16533061|NCT01332227|40414015|FG001|Overall Study|Patient began prohibited medication|1|||
16533062|NCT02590354|40414016|FG000|Phase 1|Active hepatitis B or C infection|1|||
16533063|NCT02590354|40414016|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
16533064|NCT02590354|40414016|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
16100512|NCT00899379|38856534|FG000|Overall Study|Lack of Efficacy|0|||
16100513|NCT00899379|38856535|FG001|Overall Study|Lack of Efficacy|4|||
16533065|NCT02590354|40414016|FG000|Phase 1|Subject does not want to participate|20|||
16100514|NCT00899379|38856536|FG002|Overall Study|Lack of Efficacy|3|||
16100515|NCT00899379|38856537|FG003|Overall Study|Lack of Efficacy|0|||
16215756|NCT00364832|39268786|FG002|Extension Year 1|Early Withdrawals|0|||
16333158|NCT00367484|39706964|FG000|Overall Study|Lost to Follow-up|1|||
16333159|NCT00367484|39706964|FG000|Overall Study|Protocol Violation|1|||
16333160|NCT00367484|39706964|FG000|Overall Study|The choice of the patient|1|||
16333161|NCT00367484|39706964|FG000|Overall Study|Lack of Efficacy|1|||
16333162|NCT00785213|39706965|FG000|Quinine Sulfate Alone|Adverse Event|4|||
16333163|NCT00785213|39706965|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
16333164|NCT02305446|39706966|FG000|Overall Study|Adverse Event|1|||
16333165|NCT01472757|39706967|FG000|Overall Study|Withdrawal by Subject|1|||
16333166|NCT01472757|39706968|FG001|Overall Study|Withdrawal by Subject|2|||
16333167|NCT01472757|39706969|FG002|Overall Study|Withdrawal by Subject|2|||
16333168|NCT01472757|39706970|FG003|Overall Study|Withdrawal by Subject|0|||
16333169|NCT01472757|39706967|FG000|Overall Study|Asthma exacerbation|4|||
16333170|NCT01472757|39706968|FG001|Overall Study|Asthma exacerbation|1|||
16333171|NCT01472757|39706969|FG002|Overall Study|Asthma exacerbation|2|||
16333172|NCT01472757|39706970|FG003|Overall Study|Asthma exacerbation|1|||
16333173|NCT01472757|39706967|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
16333174|NCT01472757|39706968|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
16333175|NCT01472757|39706969|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
16333176|NCT01472757|39706970|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
16333177|NCT01472757|39706967|FG000|Overall Study|Protocol Violation|3|||
16333178|NCT01472757|39706968|FG001|Overall Study|Protocol Violation|2|||
16333179|NCT01472757|39706969|FG002|Overall Study|Protocol Violation|4|||
16333180|NCT01472757|39706970|FG003|Overall Study|Protocol Violation|4|||
16333181|NCT01472757|39706967|FG000|Overall Study|Other reasons|1|||
16333182|NCT01472757|39706968|FG001|Overall Study|Other reasons|0|||
16333183|NCT01472757|39706969|FG002|Overall Study|Other reasons|2|||
16333184|NCT01472757|39706970|FG003|Overall Study|Other reasons|2|||
16333185|NCT01267201|39706973|FG000|First Intervention Period|Withdrawal by Subject|1|||
16333186|NCT01267201|39706974|FG001|First Intervention Period|Withdrawal by Subject|0|||
16333187|NCT01267201|39706975|FG002|First Intervention Period|Withdrawal by Subject|0|||
16333188|NCT01267201|39706976|FG003|First Intervention Period|Withdrawal by Subject|0|||
16333189|NCT01267201|39706977|FG004|First Intervention Period|Withdrawal by Subject|0|||
16333190|NCT01267201|39706978|FG005|First Intervention Period|Withdrawal by Subject|0|||
16333191|NCT01267201|39706973|FG000|Second Intervention Period|Withdrawal by Subject|0|||
16333192|NCT01267201|39706974|FG001|Second Intervention Period|Withdrawal by Subject|1|||
16333193|NCT01267201|39706975|FG002|Second Intervention Period|Withdrawal by Subject|0|||
16333194|NCT01267201|39706976|FG003|Second Intervention Period|Withdrawal by Subject|0|||
16333195|NCT01267201|39706977|FG004|Second Intervention Period|Withdrawal by Subject|0|||
16333196|NCT01267201|39706978|FG005|Second Intervention Period|Withdrawal by Subject|0|||
16333197|NCT00314132|39706979|FG000|Overall Study|Lost to Follow-up|3|||
16333198|NCT00314132|39706980|FG001|Overall Study|Lost to Follow-up|13|||
16333199|NCT00314132|39706979|FG000|Overall Study|Withdrawal by Subject|3|||
16333200|NCT00314132|39706980|FG001|Overall Study|Withdrawal by Subject|5|||
16333201|NCT00314132|39706979|FG000|Overall Study|Adverse Event|1|||
16333202|NCT00314132|39706980|FG001|Overall Study|Adverse Event|0|||
16333203|NCT00314132|39706979|FG000|Overall Study|Physician Decision|1|||
16333204|NCT00314132|39706980|FG001|Overall Study|Physician Decision|0|||
16333205|NCT03077659|39706981|FG000|Overall Study|Withdrawal by Subject|0|||
16333206|NCT03077659|39706982|FG001|Overall Study|Withdrawal by Subject|0|||
16333207|NCT03077659|39706983|FG002|Overall Study|Withdrawal by Subject|1|||
16333208|NCT02044874|39706984|FG000|Overall Study|Adverse Event|5|||
16333209|NCT02044874|39706985|FG001|Overall Study|Adverse Event|6|||
16333210|NCT02044874|39706986|FG002|Overall Study|Adverse Event|6|||
16333211|NCT02044874|39706984|FG000|Overall Study|Withdrawal by Subject|8|||
16333212|NCT02044874|39706985|FG001|Overall Study|Withdrawal by Subject|16|||
16333213|NCT02044874|39706986|FG002|Overall Study|Withdrawal by Subject|23|||
16403085|NCT01271712|39956884|FG001|Safety Follow-up|Progressive disease|0|||
16403086|NCT01271712|39956883|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
16403087|NCT01271712|39956884|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
16403088|NCT00624585|39956885|FG000|Overall Study|Death|3|||
16403089|NCT00624585|39956885|FG000|Overall Study|Disease Progression|6|||
16403090|NCT00624585|39956885|FG000|Overall Study|Adverse Event|3|||
16403091|NCT00349921|39956886|FG000|First Spinal Injection|Physician Decision|1|||
16403092|NCT00349921|39956887|FG001|First Spinal Injection|Physician Decision|0|||
16403093|NCT00349921|39956888|FG002|First Spinal Injection|Physician Decision|0|||
16403094|NCT00349921|39956889|FG003|First Spinal Injection|Physician Decision|0|||
16403095|NCT00349921|39956886|FG000|First Spinal Injection|Adverse Event|0|||
16403096|NCT00349921|39956887|FG001|First Spinal Injection|Adverse Event|0|||
16403097|NCT00349921|39956888|FG002|First Spinal Injection|Adverse Event|1|||
16403098|NCT00349921|39956889|FG003|First Spinal Injection|Adverse Event|0|||
16403099|NCT03576066|39956890|FG000|Overall Study|Noncompliance with study drug|0|||
16403100|NCT03576066|39956891|FG001|Overall Study|Noncompliance with study drug|1|||
16403101|NCT02927925|39956892|FG000|Overall Study|Death|16|||
16403102|NCT02927925|39956892|FG000|Overall Study|Physician Decision|1|||
16403103|NCT02927925|39956892|FG000|Overall Study|Withdrawal by Subject|11|||
16403104|NCT02927925|39956892|FG000|Overall Study|Other|3|||
16403105|NCT02927925|39956892|FG000|Overall Study|Disease progression at clinical cutoff|1|||
16403106|NCT02120300|39956894|FG000|Overall Study|Enrolled but Never Treated|2|||
16403107|NCT02120300|39956895|FG001|Overall Study|Enrolled but Never Treated|0|||
16403108|NCT02120300|39956896|FG002|Overall Study|Enrolled but Never Treated|0|||
16403109|NCT02120300|39956897|FG003|Overall Study|Enrolled but Never Treated|0|||
16403110|NCT02120300|39956894|FG000|Overall Study|Lack of Efficacy|0|||
16403111|NCT02120300|39956895|FG001|Overall Study|Lack of Efficacy|0|||
16403112|NCT02120300|39956896|FG002|Overall Study|Lack of Efficacy|0|||
16403113|NCT02120300|39956897|FG003|Overall Study|Lack of Efficacy|1|||
16403114|NCT02120300|39956894|FG000|Overall Study|Lost to Follow-up|1|||
16403115|NCT02120300|39956895|FG001|Overall Study|Lost to Follow-up|0|||
16403116|NCT02120300|39956896|FG002|Overall Study|Lost to Follow-up|0|||
16403117|NCT02120300|39956897|FG003|Overall Study|Lost to Follow-up|0|||
16403118|NCT01560637|39956898|FG000|Overall Study|Adverse Event|63|||
16403119|NCT01560637|39956898|FG000|Overall Study|Death|69|||
16403120|NCT01560637|39956898|FG000|Overall Study|Lost to Follow-up|8|||
16403121|NCT01560637|39956898|FG000|Overall Study|Protocol Violation|8|||
16403122|NCT01560637|39956898|FG000|Overall Study|Withdrawal by Subject|24|||
16403123|NCT01560637|39956898|FG000|Overall Study|Progressive Disease|20|||
16403124|NCT01560637|39956898|FG000|Overall Study|Other Reason Not Specified|6|||
16403125|NCT01646645|39956899|FG000|Overall Study|No Treated|1|||
16403126|NCT01646645|39956899|FG000|Overall Study|Inevaluable Donor|29|||
16403127|NCT01044745|39956900|FG000|Overall Study|Ineiligible|2|||
16403128|NCT00027378|39956903|FG000|Overall Study|Physician Decision|0|||
16403129|NCT00027378|39956904|FG001|Overall Study|Physician Decision|3|||
16403130|NCT00223808|39956905|FG000|Overall Study|<5 hrs therapy before discharge|3|||
16403131|NCT00223808|39956906|FG001|Overall Study|<5 hrs therapy before discharge|5|||
16403132|NCT00223808|39956907|FG002|Overall Study|<5 hrs therapy before discharge|5|||
16403133|NCT00837265|39956910|FG000|Pilot Phase|Withdrawal by Subject|0|||
16403134|NCT00837265|39956911|FG001|Pilot Phase|Withdrawal by Subject|2|||
16403135|NCT00837265|39956912|FG002|Pilot Phase|Withdrawal by Subject|3|||
16403136|NCT00837265|39956913|FG003|Pilot Phase|Withdrawal by Subject|2|||
16403137|NCT00837265|39956914|FG004|Pilot Phase|Withdrawal by Subject|0|||
16403138|NCT00837265|39956915|FG005|Pilot Phase|Withdrawal by Subject|0|||
16403139|NCT00837265|39956916|FG006|Pilot Phase|Withdrawal by Subject|0|||
16403140|NCT00837265|39956910|FG000|Pilot Phase|Decision of the investigator|2|||
16403141|NCT00837265|39956911|FG001|Pilot Phase|Decision of the investigator|1|||
16403142|NCT00837265|39956912|FG002|Pilot Phase|Decision of the investigator|0|||
16403143|NCT00837265|39956913|FG003|Pilot Phase|Decision of the investigator|0|||
16403144|NCT00837265|39956914|FG004|Pilot Phase|Decision of the investigator|0|||
16403145|NCT00837265|39956915|FG005|Pilot Phase|Decision of the investigator|0|||
16403146|NCT00837265|39956916|FG006|Pilot Phase|Decision of the investigator|0|||
16403147|NCT00837265|39956910|FG000|Pilot Phase|Adverse Event|1|||
16403148|NCT00837265|39956911|FG001|Pilot Phase|Adverse Event|0|||
16403149|NCT00837265|39956912|FG002|Pilot Phase|Adverse Event|0|||
16403150|NCT00837265|39956913|FG003|Pilot Phase|Adverse Event|0|||
16403151|NCT00837265|39956914|FG004|Pilot Phase|Adverse Event|0|||
16403152|NCT00837265|39956915|FG005|Pilot Phase|Adverse Event|0|||
16403153|NCT00837265|39956916|FG006|Pilot Phase|Adverse Event|0|||
16403154|NCT00837265|39956910|FG000|Pilot Phase|Disease progression|0|||
16403155|NCT00837265|39956911|FG001|Pilot Phase|Disease progression|0|||
16403156|NCT00837265|39956912|FG002|Pilot Phase|Disease progression|0|||
16403157|NCT00837265|39956913|FG003|Pilot Phase|Disease progression|1|||
16403158|NCT00837265|39956914|FG004|Pilot Phase|Disease progression|0|||
16403159|NCT00837265|39956915|FG005|Pilot Phase|Disease progression|0|||
16403160|NCT00837265|39956916|FG006|Pilot Phase|Disease progression|0|||
16403161|NCT00837265|39956910|FG000|Pilot Phase|Participant left the city|0|||
16403162|NCT00837265|39956911|FG001|Pilot Phase|Participant left the city|0|||
16403163|NCT00837265|39956912|FG002|Pilot Phase|Participant left the city|0|||
16403164|NCT00837265|39956913|FG003|Pilot Phase|Participant left the city|1|||
16403165|NCT00837265|39956914|FG004|Pilot Phase|Participant left the city|0|||
16403166|NCT00837265|39956915|FG005|Pilot Phase|Participant left the city|0|||
16403167|NCT00837265|39956916|FG006|Pilot Phase|Participant left the city|0|||
16403168|NCT00837265|39956910|FG000|Main Phase|Withdrawal by Subject|0|||
16403169|NCT00837265|39956911|FG001|Main Phase|Withdrawal by Subject|0|||
16403170|NCT00837265|39956912|FG002|Main Phase|Withdrawal by Subject|0|||
16403171|NCT00837265|39956913|FG003|Main Phase|Withdrawal by Subject|0|||
16403172|NCT00837265|39956914|FG004|Main Phase|Withdrawal by Subject|4|||
16403173|NCT00837265|39956915|FG005|Main Phase|Withdrawal by Subject|2|||
16403174|NCT00837265|39956916|FG006|Main Phase|Withdrawal by Subject|1|||
16403175|NCT00837265|39956910|FG000|Main Phase|Decision of the investigator|0|||
16403176|NCT00837265|39956911|FG001|Main Phase|Decision of the investigator|0|||
16403177|NCT00837265|39956912|FG002|Main Phase|Decision of the investigator|0|||
16403178|NCT00837265|39956913|FG003|Main Phase|Decision of the investigator|0|||
16403179|NCT00837265|39956914|FG004|Main Phase|Decision of the investigator|0|||
16403180|NCT00837265|39956915|FG005|Main Phase|Decision of the investigator|2|||
16403181|NCT00837265|39956916|FG006|Main Phase|Decision of the investigator|1|||
16403182|NCT00837265|39956910|FG000|Main Phase|Adverse Event|0|||
16403183|NCT00837265|39956911|FG001|Main Phase|Adverse Event|0|||
16403184|NCT00837265|39956912|FG002|Main Phase|Adverse Event|0|||
16403185|NCT00837265|39956913|FG003|Main Phase|Adverse Event|0|||
16403186|NCT00837265|39956914|FG004|Main Phase|Adverse Event|0|||
16403187|NCT00837265|39956915|FG005|Main Phase|Adverse Event|1|||
16403188|NCT00837265|39956916|FG006|Main Phase|Adverse Event|0|||
16403189|NCT00837265|39956910|FG000|Main Phase|Death|0|||
16403190|NCT00837265|39956911|FG001|Main Phase|Death|0|||
16403191|NCT00837265|39956912|FG002|Main Phase|Death|0|||
16533066|NCT02590354|40414016|FG000|Phase 1|Lost to Follow-up|1|||
16533067|NCT02590354|40414016|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
16533068|NCT02041195|40414017|FG000|Overall Study|Adverse Event|1|||
16533069|NCT02041195|40414018|FG001|Overall Study|Adverse Event|2|||
16403192|NCT00837265|39956913|FG003|Main Phase|Death|0|||
16403193|NCT00837265|39956914|FG004|Main Phase|Death|2|||
16403194|NCT00837265|39956915|FG005|Main Phase|Death|0|||
16403195|NCT00837265|39956916|FG006|Main Phase|Death|1|||
16403196|NCT00837265|39956910|FG000|Main Phase|Lost to Follow-up|0|||
16403197|NCT00837265|39956911|FG001|Main Phase|Lost to Follow-up|0|||
16403198|NCT00837265|39956912|FG002|Main Phase|Lost to Follow-up|0|||
16403199|NCT00837265|39956913|FG003|Main Phase|Lost to Follow-up|0|||
16403200|NCT00837265|39956914|FG004|Main Phase|Lost to Follow-up|1|||
16403201|NCT00837265|39956915|FG005|Main Phase|Lost to Follow-up|0|||
16100516|NCT00899379|38856538|FG004|Overall Study|Lack of Efficacy|1|||
16100517|NCT00899379|38856534|FG000|Overall Study|Lost to Follow-up|9|||
16100518|NCT00899379|38856535|FG001|Overall Study|Lost to Follow-up|3|||
16100519|NCT00899379|38856536|FG002|Overall Study|Lost to Follow-up|0|||
16100520|NCT00899379|38856537|FG003|Overall Study|Lost to Follow-up|6|||
16100521|NCT00899379|38856538|FG004|Overall Study|Lost to Follow-up|2|||
16100522|NCT00899379|38856534|FG000|Overall Study|Protocol Violation|0|||
16100523|NCT00899379|38856535|FG001|Overall Study|Protocol Violation|0|||
16100524|NCT00899379|38856536|FG002|Overall Study|Protocol Violation|1|||
16100525|NCT00899379|38856537|FG003|Overall Study|Protocol Violation|1|||
16100526|NCT00899379|38856538|FG004|Overall Study|Protocol Violation|0|||
16100527|NCT00899379|38856534|FG000|Overall Study|Withdrawal by Subject|2|||
16100528|NCT00899379|38856535|FG001|Overall Study|Withdrawal by Subject|4|||
16100529|NCT00899379|38856536|FG002|Overall Study|Withdrawal by Subject|2|||
16100530|NCT00899379|38856537|FG003|Overall Study|Withdrawal by Subject|3|||
16100531|NCT00899379|38856538|FG004|Overall Study|Withdrawal by Subject|6|||
16100532|NCT00899379|38856534|FG000|Overall Study|Pregnancy|0|||
16100533|NCT00899379|38856535|FG001|Overall Study|Pregnancy|0|||
16100534|NCT00899379|38856536|FG002|Overall Study|Pregnancy|1|||
16100535|NCT00899379|38856537|FG003|Overall Study|Pregnancy|0|||
16100536|NCT00899379|38856538|FG004|Overall Study|Pregnancy|1|||
16215757|NCT00364832|39268787|FG003|Extension Year 1|Early Withdrawals|0|||
16215758|NCT00364832|39268788|FG004|Extension Year 1|Early Withdrawals|0|||
16215759|NCT00364832|39268789|FG005|Extension Year 1|Early Withdrawals|0|||
16215760|NCT00364832|39268790|FG006|Extension Year 1|Early Withdrawals|0|||
16215761|NCT00364832|39268791|FG007|Extension Year 1|Early Withdrawals|0|||
16215762|NCT00364832|39268792|FG008|Extension Year 1|Early Withdrawals|0|||
16215763|NCT00364832|39268793|FG009|Extension Year 1|Early Withdrawals|4|||
16215764|NCT00364832|39268794|FG010|Extension Year 1|Early Withdrawals|2|||
16215765|NCT00364832|39268795|FG011|Extension Year 1|Early Withdrawals|10|||
16215766|NCT00364832|39268784|FG000|Extension Year 2|Early Withdrawals|0|||
16215767|NCT00364832|39268785|FG001|Extension Year 2|Early Withdrawals|0|||
16215768|NCT00364832|39268786|FG002|Extension Year 2|Early Withdrawals|0|||
16215769|NCT00364832|39268787|FG003|Extension Year 2|Early Withdrawals|0|||
16215770|NCT00364832|39268788|FG004|Extension Year 2|Early Withdrawals|0|||
16215771|NCT00364832|39268789|FG005|Extension Year 2|Early Withdrawals|0|||
16215772|NCT00364832|39268790|FG006|Extension Year 2|Early Withdrawals|0|||
16215773|NCT00364832|39268791|FG007|Extension Year 2|Early Withdrawals|0|||
16215774|NCT00364832|39268792|FG008|Extension Year 2|Early Withdrawals|0|||
16215775|NCT00364832|39268793|FG009|Extension Year 2|Early Withdrawals|5|||
16215776|NCT00364832|39268794|FG010|Extension Year 2|Early Withdrawals|5|||
16533070|NCT02041195|40414019|FG002|Overall Study|Adverse Event|0|||
16533071|NCT02041195|40414020|FG003|Overall Study|Adverse Event|0|||
16533072|NCT02041195|40414021|FG004|Overall Study|Adverse Event|0|||
16533073|NCT02041195|40414022|FG005|Overall Study|Adverse Event|0|||
16215777|NCT00364832|39268795|FG011|Extension Year 2|Early Withdrawals|3|||
16215778|NCT01594411|39268796|FG000|Overall Study|Lost to Follow-up|2|||
16215779|NCT03152110|39268797|FG000|Overall Study|Withdrawal by Subject|3|||
16215780|NCT00691054|39268811|FG000|Overall Study|Withdrawal by Subject|1|||
16215781|NCT00796549|39268817|FG000|Overall Study|Adverse Event|11|||
16215782|NCT00796549|39268817|FG000|Overall Study|not entered|149|||
16215783|NCT00796549|39268817|FG000|Overall Study|Other|2|||
16215784|NCT00796549|39268817|FG000|Overall Study|Progressive disease|56|||
16215785|NCT00742391|39268818|FG000|Overall Study|Adverse Event|2|||
16215786|NCT00742391|39268819|FG001|Overall Study|Adverse Event|1|||
16215787|NCT00742391|39268818|FG000|Overall Study|Lost to Follow-up|1|||
16215788|NCT00742391|39268819|FG001|Overall Study|Lost to Follow-up|0|||
16215789|NCT00742391|39268818|FG000|Overall Study|Protocol Violation|1|||
16215790|NCT00742391|39268819|FG001|Overall Study|Protocol Violation|0|||
16215791|NCT01925014|39268820|FG000|Overall Study|Inappropriate enrollment|4|||
16215792|NCT01925014|39268821|FG001|Overall Study|Inappropriate enrollment|6|||
16215793|NCT01925014|39268820|FG000|Overall Study|Withdrawal by Subject|5|||
16215794|NCT01925014|39268821|FG001|Overall Study|Withdrawal by Subject|13|||
16533074|NCT02041195|40414023|FG006|Overall Study|Adverse Event|3|||
16533075|NCT02041195|40414024|FG007|Overall Study|Adverse Event|0|||
16533076|NCT02041195|40414017|FG000|Overall Study|Withdrawal by Subject|1|||
16533077|NCT02041195|40414018|FG001|Overall Study|Withdrawal by Subject|0|||
16533078|NCT02041195|40414019|FG002|Overall Study|Withdrawal by Subject|0|||
16100537|NCT00899379|38856534|FG000|Overall Study|Patient Uncooperative|0|||
16215795|NCT01058356|39268825|FG000|Overall Study|Adverse Event|5|||
16215796|NCT01058356|39268825|FG000|Overall Study|Administration of contraindicated drugs|12|||
16215797|NCT01058356|39268825|FG000|Overall Study|Withdrawal by Subject|21|||
16215798|NCT01058356|39268825|FG000|Overall Study|Lost to Follow-up|4|||
16215799|NCT02181504|39268831|FG000|Overall Study|Adverse Event|1|||
16100538|NCT00899379|38856535|FG001|Overall Study|Patient Uncooperative|1|||
16100539|NCT00899379|38856536|FG002|Overall Study|Patient Uncooperative|0|||
16215800|NCT02181504|39268832|FG001|Overall Study|Adverse Event|1|||
16533079|NCT02041195|40414020|FG003|Overall Study|Withdrawal by Subject|0|||
16533080|NCT02041195|40414021|FG004|Overall Study|Withdrawal by Subject|0|||
16403202|NCT00837265|39956916|FG006|Main Phase|Lost to Follow-up|0|||
16403203|NCT00837265|39956910|FG000|Main Phase|Principal investigator resignation|0|||
16403204|NCT00837265|39956911|FG001|Main Phase|Principal investigator resignation|0|||
16403205|NCT00837265|39956912|FG002|Main Phase|Principal investigator resignation|0|||
16403206|NCT00837265|39956913|FG003|Main Phase|Principal investigator resignation|0|||
16403207|NCT00837265|39956914|FG004|Main Phase|Principal investigator resignation|2|||
16403208|NCT00837265|39956915|FG005|Main Phase|Principal investigator resignation|0|||
16403209|NCT00837265|39956916|FG006|Main Phase|Principal investigator resignation|0|||
16403210|NCT00837265|39956910|FG000|Main Phase|Participant's personal reason|0|||
16403211|NCT00837265|39956911|FG001|Main Phase|Participant's personal reason|0|||
16403212|NCT00837265|39956912|FG002|Main Phase|Participant's personal reason|0|||
16403213|NCT00837265|39956913|FG003|Main Phase|Participant's personal reason|0|||
16403214|NCT00837265|39956914|FG004|Main Phase|Participant's personal reason|1|||
16533081|NCT02041195|40414022|FG005|Overall Study|Withdrawal by Subject|0|||
16533082|NCT02041195|40414023|FG006|Overall Study|Withdrawal by Subject|4|||
16403215|NCT00837265|39956915|FG005|Main Phase|Participant's personal reason|0|||
16533083|NCT02041195|40414024|FG007|Overall Study|Withdrawal by Subject|3|||
16533084|NCT02041195|40414017|FG000|Overall Study|Unable to comply with study visits|0|||
16215801|NCT02181504|39268833|FG002|Overall Study|Adverse Event|1|||
16215802|NCT02656173|39268834|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
16533085|NCT02041195|40414018|FG001|Overall Study|Unable to comply with study visits|1|||
16533086|NCT02041195|40414019|FG002|Overall Study|Unable to comply with study visits|0|||
16533087|NCT02041195|40414020|FG003|Overall Study|Unable to comply with study visits|0|||
16533088|NCT02041195|40414021|FG004|Overall Study|Unable to comply with study visits|1|||
16533089|NCT02041195|40414022|FG005|Overall Study|Unable to comply with study visits|0|||
16533090|NCT02041195|40414023|FG006|Overall Study|Unable to comply with study visits|0|||
16533091|NCT02041195|40414024|FG007|Overall Study|Unable to comply with study visits|0|||
16533092|NCT01475136|40414028|FG000|Overall Study|Sponsor Decision|0|||
16533093|NCT01475136|40414029|FG001|Overall Study|Sponsor Decision|1|||
16533094|NCT01475136|40414030|FG002|Overall Study|Sponsor Decision|0|||
16533095|NCT01475136|40414031|FG003|Overall Study|Sponsor Decision|0|||
16533096|NCT01475136|40414028|FG000|Overall Study|Entry Criteria Not Met|0|||
16533097|NCT01475136|40414029|FG001|Overall Study|Entry Criteria Not Met|2|||
16533098|NCT01475136|40414030|FG002|Overall Study|Entry Criteria Not Met|3|||
16533099|NCT01475136|40414031|FG003|Overall Study|Entry Criteria Not Met|1|||
16533100|NCT01475136|40414028|FG000|Overall Study|Withdrawal by Subject|0|||
16533101|NCT01475136|40414029|FG001|Overall Study|Withdrawal by Subject|0|||
16533102|NCT01475136|40414030|FG002|Overall Study|Withdrawal by Subject|0|||
16533103|NCT01475136|40414031|FG003|Overall Study|Withdrawal by Subject|2|||
16533104|NCT01475136|40414028|FG000|Overall Study|Adverse Event|1|||
16533105|NCT01475136|40414029|FG001|Overall Study|Adverse Event|0|||
16533106|NCT01475136|40414030|FG002|Overall Study|Adverse Event|0|||
16533107|NCT01475136|40414031|FG003|Overall Study|Adverse Event|1|||
16100540|NCT00899379|38856537|FG003|Overall Study|Patient Uncooperative|1|||
16100541|NCT00899379|38856538|FG004|Overall Study|Patient Uncooperative|2|||
16100542|NCT00899379|38856534|FG000|Overall Study|Abnormal Baseline ECG|0|||
16100543|NCT00899379|38856535|FG001|Overall Study|Abnormal Baseline ECG|0|||
16100544|NCT00899379|38856536|FG002|Overall Study|Abnormal Baseline ECG|0|||
16100545|NCT00899379|38856537|FG003|Overall Study|Abnormal Baseline ECG|1|||
16100546|NCT00899379|38856538|FG004|Overall Study|Abnormal Baseline ECG|0|||
16100547|NCT00899379|38856534|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
16100548|NCT00899379|38856535|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
16100549|NCT00899379|38856536|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
16100550|NCT00899379|38856537|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
16100551|NCT00899379|38856538|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
16100552|NCT00899379|38856534|FG000|Overall Study|Not Completed/Entered Extn|5|||
16100553|NCT00899379|38856535|FG001|Overall Study|Not Completed/Entered Extn|1|||
16100554|NCT00899379|38856536|FG002|Overall Study|Not Completed/Entered Extn|6|||
16100555|NCT00899379|38856537|FG003|Overall Study|Not Completed/Entered Extn|4|||
16100556|NCT00899379|38856538|FG004|Overall Study|Not Completed/Entered Extn|3|||
16100557|NCT00899379|38856534|FG000|Overall Study|Study Terminated|3|||
16100558|NCT00899379|38856535|FG001|Overall Study|Study Terminated|0|||
16100559|NCT00899379|38856536|FG002|Overall Study|Study Terminated|3|||
16100560|NCT00899379|38856537|FG003|Overall Study|Study Terminated|3|||
16100561|NCT00899379|38856538|FG004|Overall Study|Study Terminated|1|||
16215803|NCT02656173|39268835|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
16215804|NCT02656173|39268834|FG000|Overall Study|Adverse Event|7|||
16215805|NCT02656173|39268835|FG001|Overall Study|Adverse Event|5|||
16215806|NCT02656173|39268834|FG000|Overall Study|Withdrawal by Subject|1|||
16215807|NCT02656173|39268835|FG001|Overall Study|Withdrawal by Subject|3|||
16533108|NCT01475136|40414028|FG000|Overall Study|Death|0|||
16533109|NCT01475136|40414029|FG001|Overall Study|Death|0|||
16533110|NCT01475136|40414030|FG002|Overall Study|Death|0|||
16533111|NCT01475136|40414031|FG003|Overall Study|Death|1|||
16215808|NCT02656173|39268834|FG000|Overall Study|Protocol Violation|0|||
16215809|NCT02656173|39268835|FG001|Overall Study|Protocol Violation|1|||
16215810|NCT02656173|39268834|FG000|Overall Study|Miscellaneous|2|||
16215811|NCT02656173|39268835|FG001|Overall Study|Miscellaneous|0|||
16215812|NCT00952588|39268836|FG000|Overall Study|Death|28|||
16215813|NCT00952588|39268837|FG001|Overall Study|Death|13|||
16215814|NCT00952588|39268836|FG000|Overall Study|Withdrawal by Subject|2|||
16403216|NCT00837265|39956916|FG006|Main Phase|Participant's personal reason|0|||
16100562|NCT00899379|38856534|FG000|Overall Study|Lost to Follow-up|3|||
16100563|NCT00899379|38856535|FG001|Overall Study|Lost to Follow-up|1|||
16100564|NCT00899379|38856536|FG002|Overall Study|Lost to Follow-up|0|||
16100565|NCT00899379|38856537|FG003|Overall Study|Lost to Follow-up|2|||
16100566|NCT00899379|38856538|FG004|Overall Study|Lost to Follow-up|5|||
16100567|NCT00899379|38856534|FG000|Overall Study|Withdrawal by Subject|4|||
16100568|NCT00899379|38856535|FG001|Overall Study|Withdrawal by Subject|7|||
16100569|NCT00899379|38856536|FG002|Overall Study|Withdrawal by Subject|4|||
16100570|NCT00899379|38856537|FG003|Overall Study|Withdrawal by Subject|7|||
16100571|NCT00899379|38856538|FG004|Overall Study|Withdrawal by Subject|2|||
16100572|NCT00899379|38856534|FG000|Overall Study|Pregnancy|1|||
16100573|NCT00899379|38856535|FG001|Overall Study|Pregnancy|0|||
16100574|NCT00899379|38856536|FG002|Overall Study|Pregnancy|0|||
16100575|NCT00899379|38856537|FG003|Overall Study|Pregnancy|0|||
16100576|NCT00899379|38856538|FG004|Overall Study|Pregnancy|0|||
16100577|NCT00899379|38856534|FG000|Overall Study|Patient Uncooperative|0|||
16333214|NCT02044874|39706984|FG000|Overall Study|Physician Decision|0|||
16333215|NCT02044874|39706985|FG001|Overall Study|Physician Decision|2|||
16333216|NCT02044874|39706986|FG002|Overall Study|Physician Decision|1|||
16333217|NCT02044874|39706984|FG000|Overall Study|Lost to Follow-up|10|||
16533112|NCT01517802|40414032|FG000|Overall Study|Death|1|||
16533113|NCT03117738|40414033|FG000|Overall Study|Withdrawal by Subject|3|||
16533114|NCT03117738|40414034|FG001|Overall Study|Withdrawal by Subject|1|||
16533115|NCT03117738|40414033|FG000|Overall Study|Lost to Follow-up|1|||
16533116|NCT03117738|40414034|FG001|Overall Study|Lost to Follow-up|4|||
16533117|NCT00321854|40414040|FG000|Overall Study|Adverse Event|41|||
16533118|NCT00321854|40414041|FG001|Overall Study|Adverse Event|43|||
16533119|NCT00321854|40414040|FG000|Overall Study|Lack of Efficacy|9|||
16533120|NCT00321854|40414041|FG001|Overall Study|Lack of Efficacy|14|||
16533121|NCT00321854|40414040|FG000|Overall Study|Protocol Violation|6|||
16533122|NCT00321854|40414041|FG001|Overall Study|Protocol Violation|5|||
16403217|NCT01960998|39956917|FG000|Overall Study|Lost to Follow-up|3|||
16403218|NCT01960998|39956918|FG001|Overall Study|Lost to Follow-up|7|||
16403219|NCT01960998|39956917|FG000|Overall Study|Death|0|||
16403220|NCT01960998|39956918|FG001|Overall Study|Death|1|||
16533123|NCT00321854|40414040|FG000|Overall Study|Lost to Follow-up|0|||
16533124|NCT00321854|40414041|FG001|Overall Study|Lost to Follow-up|2|||
16533125|NCT00321854|40414040|FG000|Overall Study|Withdrawal by Subject|6|||
16533126|NCT00321854|40414041|FG001|Overall Study|Withdrawal by Subject|17|||
16533127|NCT00321854|40414040|FG000|Overall Study|Other|1|||
16533128|NCT00321854|40414041|FG001|Overall Study|Other|1|||
16533129|NCT04827212|40414044|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
16533130|NCT04827212|40414045|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
16333218|NCT02044874|39706985|FG001|Overall Study|Lost to Follow-up|27|||
16403221|NCT01960998|39956917|FG000|Overall Study|Withdrawal by Subject|8|||
16403222|NCT01960998|39956918|FG001|Overall Study|Withdrawal by Subject|2|||
16403223|NCT01960998|39956917|FG000|Overall Study|lost computer access|0|||
16403224|NCT01960998|39956918|FG001|Overall Study|lost computer access|1|||
16403225|NCT00075725|39956928|FG000|Overall Study|Adverse Event|6|||
16403226|NCT00075725|39956929|FG001|Overall Study|Adverse Event|6|||
16403227|NCT00075725|39956930|FG002|Overall Study|Adverse Event|20|||
16403228|NCT00075725|39956931|FG003|Overall Study|Adverse Event|8|||
16333219|NCT02044874|39706986|FG002|Overall Study|Lost to Follow-up|21|||
16333220|NCT02044874|39706984|FG000|Overall Study|Sponsor Decision|0|||
16333221|NCT02044874|39706985|FG001|Overall Study|Sponsor Decision|1|||
16333222|NCT02044874|39706986|FG002|Overall Study|Sponsor Decision|1|||
16333223|NCT02044874|39706984|FG000|Overall Study|Other|7|||
16333224|NCT02044874|39706985|FG001|Overall Study|Other|3|||
16533131|NCT04827212|40414044|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
16100578|NCT00899379|38856535|FG001|Overall Study|Patient Uncooperative|0|||
16100579|NCT00899379|38856536|FG002|Overall Study|Patient Uncooperative|0|||
16100580|NCT00899379|38856537|FG003|Overall Study|Patient Uncooperative|1|||
16100581|NCT00899379|38856538|FG004|Overall Study|Patient Uncooperative|0|||
16333225|NCT02044874|39706986|FG002|Overall Study|Other|8|||
16100582|NCT00899379|38856534|FG000|Overall Study|Abnormal Prestudy Labs|0|||
16100583|NCT00899379|38856535|FG001|Overall Study|Abnormal Prestudy Labs|0|||
16403229|NCT00075725|39956932|FG004|Overall Study|Adverse Event|4|||
16533132|NCT04827212|40414045|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
16533133|NCT01781572|40417947|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
16533134|NCT01781572|40417948|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
16215815|NCT00952588|39268837|FG001|Overall Study|Withdrawal by Subject|5|||
16333226|NCT01627782|39706987|FG000|Overall Study|Adverse Event|1|||
16100584|NCT00899379|38856536|FG002|Overall Study|Abnormal Prestudy Labs|0|||
16100585|NCT00899379|38856537|FG003|Overall Study|Abnormal Prestudy Labs|0|||
16100586|NCT00899379|38856538|FG004|Overall Study|Abnormal Prestudy Labs|2|||
16100587|NCT00899379|38856534|FG000|Overall Study|Abnormal Baseline ECG|0|||
16100588|NCT00899379|38856535|FG001|Overall Study|Abnormal Baseline ECG|0|||
16100589|NCT00899379|38856536|FG002|Overall Study|Abnormal Baseline ECG|1|||
16100590|NCT00899379|38856537|FG003|Overall Study|Abnormal Baseline ECG|1|||
16100591|NCT00899379|38856538|FG004|Overall Study|Abnormal Baseline ECG|0|||
16100592|NCT00899379|38856534|FG000|Overall Study|No Attack Pretreatment|3|||
16100593|NCT00899379|38856535|FG001|Overall Study|No Attack Pretreatment|5|||
16100594|NCT00899379|38856536|FG002|Overall Study|No Attack Pretreatment|5|||
16100595|NCT00899379|38856537|FG003|Overall Study|No Attack Pretreatment|6|||
16100596|NCT00899379|38856538|FG004|Overall Study|No Attack Pretreatment|4|||
16100597|NCT00899379|38856534|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
16100598|NCT00899379|38856535|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
16100599|NCT00899379|38856536|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
16100600|NCT00899379|38856537|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
16100601|NCT00899379|38856538|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
16100602|NCT00899379|38856534|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
16100603|NCT00899379|38856535|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
16100604|NCT00899379|38856536|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
16100605|NCT00899379|38856537|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
16100606|NCT00899379|38856538|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
16215816|NCT00952588|39268836|FG000|Overall Study|Adverse Event|2|||
16215817|NCT00952588|39268837|FG001|Overall Study|Adverse Event|3|||
16215818|NCT00952588|39268836|FG000|Overall Study|Lost to Follow-up|2|||
16215819|NCT00952588|39268837|FG001|Overall Study|Lost to Follow-up|0|||
16215820|NCT00952588|39268836|FG000|Overall Study|Physician Decision|0|||
16215821|NCT00952588|39268837|FG001|Overall Study|Physician Decision|1|||
16215822|NCT00952588|39268836|FG000|Overall Study|Lack of Efficacy|2|||
16403230|NCT00075725|39956933|FG005|Overall Study|Adverse Event|38|||
16403231|NCT00075725|39956934|FG006|Overall Study|Adverse Event|3|||
16215823|NCT00952588|39268837|FG001|Overall Study|Lack of Efficacy|2|||
16215824|NCT02574520|39268838|FG000|Overall Study|Not dosed|2|||
16215825|NCT02574520|39268839|FG001|Overall Study|Not dosed|0|||
16215826|NCT02574520|39268840|FG002|Overall Study|Not dosed|5|||
16215827|NCT02574520|39268841|FG003|Overall Study|Not dosed|4|||
16215828|NCT02574520|39268838|FG000|Overall Study|Adverse Event|0|||
16215829|NCT02574520|39268839|FG001|Overall Study|Adverse Event|0|||
16215830|NCT02574520|39268840|FG002|Overall Study|Adverse Event|0|||
16215831|NCT02574520|39268841|FG003|Overall Study|Adverse Event|1|||
16215832|NCT02574520|39268838|FG000|Overall Study|Withdrawal by Subject|0|||
16215833|NCT02574520|39268839|FG001|Overall Study|Withdrawal by Subject|0|||
16215834|NCT02574520|39268840|FG002|Overall Study|Withdrawal by Subject|0|||
16215835|NCT02574520|39268841|FG003|Overall Study|Withdrawal by Subject|1|||
16215836|NCT02574520|39268838|FG000|Overall Study|Other|0|||
16215837|NCT02574520|39268839|FG001|Overall Study|Other|0|||
16215838|NCT02574520|39268840|FG002|Overall Study|Other|0|||
16215839|NCT02574520|39268841|FG003|Overall Study|Other|2|||
16215840|NCT03858686|39268842|FG000|Period 1|Adverse Event|1|||
16215841|NCT03858686|39268843|FG001|Period 1|Adverse Event|1|||
16215842|NCT03858686|39268842|FG000|Period 1|Lack of compliance|0|||
16215843|NCT03858686|39268843|FG001|Period 1|Lack of compliance|1|||
16215844|NCT03858686|39268842|FG000|Period 1|Adverse Event|0|||
16215845|NCT03858686|39268843|FG001|Period 1|Adverse Event|1|||
16215846|NCT03858686|39268842|FG000|Period 2|Adverse Event|0|||
16215847|NCT03858686|39268843|FG001|Period 2|Adverse Event|1|||
16215848|NCT01614795|39268848|FG000|Overall Study|Adverse Event|0|||
16215849|NCT01614795|39268849|FG001|Overall Study|Adverse Event|0|||
16215850|NCT01614795|39268850|FG002|Overall Study|Adverse Event|1|||
16215851|NCT01614795|39268851|FG003|Overall Study|Adverse Event|1|||
16215852|NCT01614795|39268848|FG000|Overall Study|Lack of Efficacy|10|||
16215853|NCT01614795|39268849|FG001|Overall Study|Lack of Efficacy|10|||
16215854|NCT01614795|39268850|FG002|Overall Study|Lack of Efficacy|9|||
16215855|NCT01614795|39268851|FG003|Overall Study|Lack of Efficacy|8|||
16215856|NCT01614795|39268848|FG000|Overall Study|Physician Decision|1|||
16403232|NCT00075725|39956935|FG007|Overall Study|Adverse Event|51|||
16403233|NCT00075725|39956936|FG008|Overall Study|Adverse Event|15|||
16403234|NCT00075725|39956937|FG009|Overall Study|Adverse Event|4|||
16403235|NCT00075725|39956938|FG010|Overall Study|Adverse Event|2|||
16403236|NCT00075725|39956939|FG011|Overall Study|Adverse Event|2|||
16403237|NCT00075725|39956928|FG000|Overall Study|Death|3|||
16100607|NCT00464737|38856541|FG000|Overall Study|Adverse Event|12|||
16100608|NCT00464737|38856542|FG001|Overall Study|Adverse Event|17|||
16100609|NCT00464737|38856543|FG002|Overall Study|Adverse Event|33|||
16215857|NCT01614795|39268849|FG001|Overall Study|Physician Decision|0|||
16215858|NCT01614795|39268850|FG002|Overall Study|Physician Decision|1|||
16215859|NCT01614795|39268851|FG003|Overall Study|Physician Decision|1|||
16403238|NCT00075725|39956929|FG001|Overall Study|Death|5|||
16403239|NCT00075725|39956930|FG002|Overall Study|Death|10|||
16533135|NCT01781572|40417949|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
16533136|NCT01781572|40417947|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
16533137|NCT01781572|40417948|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
16533138|NCT01781572|40417949|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
16533139|NCT01781572|40417947|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
16533140|NCT01781572|40417948|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
16533141|NCT01781572|40417949|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
16533142|NCT01781572|40417947|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
16215860|NCT01614795|39268848|FG000|Overall Study|Withdrawal by Subject|0|||
16215861|NCT01614795|39268849|FG001|Overall Study|Withdrawal by Subject|1|||
16215862|NCT01614795|39268850|FG002|Overall Study|Withdrawal by Subject|0|||
16215863|NCT01614795|39268851|FG003|Overall Study|Withdrawal by Subject|2|||
16215864|NCT01614795|39268848|FG000|Overall Study|Ineligible|0|||
16215865|NCT01614795|39268849|FG001|Overall Study|Ineligible|1|||
16215866|NCT01614795|39268850|FG002|Overall Study|Ineligible|0|||
16215867|NCT01614795|39268851|FG003|Overall Study|Ineligible|0|||
16215868|NCT00772889|39268854|FG000|Overall Study|Adverse Event|7|||
16215869|NCT00772889|39268855|FG001|Overall Study|Adverse Event|4|||
16215870|NCT00772889|39268856|FG002|Overall Study|Adverse Event|0|||
16215871|NCT00772889|39268854|FG000|Overall Study|Withdrawal by Subject|9|||
16215872|NCT00772889|39268855|FG001|Overall Study|Withdrawal by Subject|8|||
16215873|NCT00772889|39268856|FG002|Overall Study|Withdrawal by Subject|9|||
16215874|NCT00772889|39268854|FG000|Overall Study|Lost to Follow-up|6|||
16215875|NCT00772889|39268855|FG001|Overall Study|Lost to Follow-up|6|||
16215876|NCT00772889|39268856|FG002|Overall Study|Lost to Follow-up|7|||
16215877|NCT01601873|39268858|FG000|Overall Study|Lost to Follow-up|2|||
16215878|NCT01601873|39268859|FG001|Overall Study|Lost to Follow-up|3|||
16215879|NCT00608894|39268862|FG000|Overall Study|Withdrawal by Subject|0|||
16215880|NCT00608894|39268863|FG001|Overall Study|Withdrawal by Subject|2|||
16215881|NCT00068822|39268864|FG000|First Randomized Intervention|Lost to Follow-up|1|||
16215882|NCT00068822|39268865|FG001|First Randomized Intervention|Lost to Follow-up|2|||
16215883|NCT01387594|39268866|FG000|Overall Study|Withdrawal by Subject|0|||
16215884|NCT01387594|39268867|FG001|Overall Study|Withdrawal by Subject|2|||
16215885|NCT01387594|39268866|FG000|Overall Study|Lost to Follow-up|0|||
16215886|NCT01387594|39268867|FG001|Overall Study|Lost to Follow-up|1|||
16215887|NCT03860844|39268868|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
16215888|NCT03860844|39268869|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
16215889|NCT03860844|39268870|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
16215890|NCT03860844|39268868|FG000|Overall Study|Progressive disease|5|||
16215891|NCT03860844|39268869|FG001|Overall Study|Progressive disease|3|||
16215892|NCT03860844|39268870|FG002|Overall Study|Progressive disease|4|||
16215893|NCT03860844|39268868|FG000|Overall Study|Other, Not related to COVID-19|0|||
16215894|NCT03860844|39268869|FG001|Overall Study|Other, Not related to COVID-19|1|||
16215895|NCT03860844|39268870|FG002|Overall Study|Other, Not related to COVID-19|0|||
16215896|NCT04247828|39268873|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
16215897|NCT00729560|39268878|FG000|Overall Study|Withdrawal by Subject|3|||
16215898|NCT02875366|39268880|FG000|Overall Study|Adverse Event|0|||
16215899|NCT02875366|39268881|FG001|Overall Study|Adverse Event|2|||
16215900|NCT02875366|39268880|FG000|Overall Study|Noncompliance|0|||
16215901|NCT02875366|39268881|FG001|Overall Study|Noncompliance|1|||
16215902|NCT04432376|39268883|FG000|Double-blind Treatment Period|Adverse Event|2|||
16333227|NCT01627782|39706988|FG001|Overall Study|Adverse Event|2|||
16333228|NCT01627782|39706989|FG002|Overall Study|Adverse Event|0|||
16533143|NCT01781572|40417948|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
16100610|NCT00464737|38856541|FG000|Overall Study|Lack of Efficacy|7|||
16100611|NCT00464737|38856542|FG001|Overall Study|Lack of Efficacy|7|||
16100612|NCT00464737|38856543|FG002|Overall Study|Lack of Efficacy|4|||
16100613|NCT00464737|38856541|FG000|Overall Study|Withdrawal by Subject|5|||
16100614|NCT00464737|38856542|FG001|Overall Study|Withdrawal by Subject|3|||
16100615|NCT00464737|38856543|FG002|Overall Study|Withdrawal by Subject|5|||
16100616|NCT00464737|38856541|FG000|Overall Study|Protocol Violation|1|||
16100617|NCT00464737|38856542|FG001|Overall Study|Protocol Violation|1|||
16100618|NCT00464737|38856543|FG002|Overall Study|Protocol Violation|5|||
16100619|NCT00464737|38856541|FG000|Overall Study|Non-compliance|0|||
16100620|NCT00464737|38856542|FG001|Overall Study|Non-compliance|1|||
16100621|NCT00464737|38856543|FG002|Overall Study|Non-compliance|1|||
16100622|NCT00464737|38856541|FG000|Overall Study|Lost to Follow-up|5|||
16100623|NCT00464737|38856542|FG001|Overall Study|Lost to Follow-up|2|||
16215903|NCT04432376|39268884|FG001|Double-blind Treatment Period|Adverse Event|6|||
16215904|NCT04432376|39268885|FG002|Double-blind Treatment Period|Adverse Event|0|||
16215905|NCT04432376|39268883|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
16215906|NCT04432376|39268884|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
16215907|NCT04432376|39268885|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
16215908|NCT04432376|39268883|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
16333229|NCT01627782|39706990|FG003|Overall Study|Adverse Event|1|||
16215909|NCT04432376|39268884|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
16215910|NCT04432376|39268885|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16215911|NCT04432376|39268883|FG000|Double-blind Treatment Period|Protocol Violation|0|||
16215912|NCT04432376|39268884|FG001|Double-blind Treatment Period|Protocol Violation|1|||
16215913|NCT04432376|39268885|FG002|Double-blind Treatment Period|Protocol Violation|0|||
16215914|NCT04432376|39268883|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
16215915|NCT04432376|39268884|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
16215916|NCT04432376|39268885|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
16215917|NCT01969565|39268890|FG000|Overall Study|Withdrawal by Subject|1|||
16215918|NCT03733249|39268895|FG000|Overall Study|Death|7|||
16215919|NCT03733249|39268895|FG000|Overall Study|Disease relapse|16|||
16215920|NCT03733249|39268895|FG000|Overall Study|Lost to Follow-up|4|||
16215921|NCT03733249|39268895|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
16215922|NCT03733249|39268895|FG000|Overall Study|Withdrawal by Subject|1|||
16215923|NCT02008396|39268896|FG000|Overall Study|Protocol Violation|0|||
16215924|NCT02008396|39268897|FG001|Overall Study|Protocol Violation|1|||
16215925|NCT00790218|39268904|FG000|Overall Study|Death|1|||
16215926|NCT00790218|39268905|FG001|Overall Study|Death|0|||
16215927|NCT00790218|39268906|FG002|Overall Study|Death|0|||
16215928|NCT00609167|39268909|FG000|Overall Study|Withdrawal by Subject|1|||
16215929|NCT00609167|39268910|FG001|Overall Study|Withdrawal by Subject|0|||
16215930|NCT00609167|39268909|FG000|Overall Study|Lack of Efficacy|1|||
16215931|NCT00609167|39268910|FG001|Overall Study|Lack of Efficacy|0|||
16215932|NCT00609167|39268909|FG000|Overall Study|Adverse Event|5|||
16215933|NCT00609167|39268910|FG001|Overall Study|Adverse Event|1|||
16215934|NCT00609167|39268909|FG000|Overall Study|Disease Progression|1|||
16215935|NCT00609167|39268910|FG001|Overall Study|Disease Progression|0|||
16215936|NCT00609167|39268909|FG000|Overall Study|Stem Cell Transplant|0|||
16215937|NCT00609167|39268910|FG001|Overall Study|Stem Cell Transplant|6|||
16215938|NCT01984294|39268917|FG000|Overall Study|Randomized but Never Treated|0|||
16215939|NCT01984294|39268918|FG001|Overall Study|Randomized but Never Treated|0|||
16215940|NCT01984294|39268919|FG002|Overall Study|Randomized but Never Treated|1|||
16215941|NCT01984294|39268917|FG000|Overall Study|Lack of Efficacy|4|||
16215942|NCT01984294|39268918|FG001|Overall Study|Lack of Efficacy|2|||
16215943|NCT01984294|39268919|FG002|Overall Study|Lack of Efficacy|6|||
16215944|NCT01984294|39268917|FG000|Overall Study|Adverse Event|0|||
16215945|NCT01984294|39268918|FG001|Overall Study|Adverse Event|1|||
16215946|NCT01984294|39268919|FG002|Overall Study|Adverse Event|0|||
16215947|NCT02274311|39268920|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
16215948|NCT02850276|39268921|FG000|Overall Study|screen failure|43|||
16215949|NCT02850276|39268921|FG000|Overall Study|Withdrawal by Subject|14|||
16215950|NCT02850276|39268921|FG000|Overall Study|Physician Decision|2|||
16215951|NCT02850276|39268921|FG000|Overall Study|Lost to Follow-up|2|||
16215952|NCT00744991|39268922|FG000|Overall Study|Progressive Disease|11|||
16215953|NCT00744991|39268922|FG000|Overall Study|Withdrawal by Subject|8|||
16215954|NCT00744991|39268922|FG000|Overall Study|Physician Decision|3|||
16215955|NCT00744991|39268922|FG000|Overall Study|Adverse Event|2|||
16215956|NCT00744991|39268922|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
16215957|NCT00410514|39268924|FG000|Overall Study|Adverse Event|2|||
16215958|NCT00410514|39268925|FG001|Overall Study|Adverse Event|2|||
16215959|NCT00410514|39268926|FG002|Overall Study|Adverse Event|2|||
16215960|NCT00410514|39268924|FG000|Overall Study|Protocol Violation|0|||
16215961|NCT00410514|39268925|FG001|Overall Study|Protocol Violation|1|||
16215962|NCT00410514|39268926|FG002|Overall Study|Protocol Violation|1|||
16215963|NCT00410514|39268924|FG000|Overall Study|Lost to Follow-up|0|||
16215964|NCT00410514|39268925|FG001|Overall Study|Lost to Follow-up|0|||
16215965|NCT00410514|39268926|FG002|Overall Study|Lost to Follow-up|2|||
16215966|NCT00410514|39268924|FG000|Overall Study|Non-compliant with study procedures|0|||
16215967|NCT00410514|39268925|FG001|Overall Study|Non-compliant with study procedures|0|||
16215968|NCT00410514|39268926|FG002|Overall Study|Non-compliant with study procedures|2|||
16215969|NCT01376908|39268927|FG000|Overall Study|Protocol Violation|1|||
16215970|NCT01376908|39268928|FG001|Overall Study|Protocol Violation|1|||
16215971|NCT01376908|39268927|FG000|Overall Study|Withdrawal by Subject|1|||
16215972|NCT01376908|39268928|FG001|Overall Study|Withdrawal by Subject|2|||
16215973|NCT00471315|39268930|FG000|Overall Study|Adverse Event|7|||
16215974|NCT00471315|39268930|FG000|Overall Study|Withdrawal by Subject|1|||
16215975|NCT00216086|39272217|FG000|Overall Study|Protocol Violation|1|||
16215976|NCT00216086|39272217|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
16215977|NCT00216086|39272217|FG000|Overall Study|Social Reasons|2|||
16215978|NCT01675141|39272218|FG000|Overall Study|Lenalidomide outside NIH|3|||
16215979|NCT01675141|39272218|FG000|Overall Study|Withdrawal by Subject|3|||
16215980|NCT01675141|39272218|FG000|Overall Study|Physician Decision|4|||
16215981|NCT01675141|39272218|FG000|Overall Study|No treatment, per protocol|1|||
16215982|NCT00081263|39272225|FG000|Overall Study|clerical error|1|||
16215983|NCT00081263|39272226|FG001|Overall Study|clerical error|0|||
16215984|NCT00081263|39272225|FG000|Overall Study|wrong cell type|7|||
16215985|NCT00081263|39272226|FG001|Overall Study|wrong cell type|5|||
16215986|NCT00081263|39272225|FG000|Overall Study|improper pre-protocol therapy|0|||
16215987|NCT00081263|39272226|FG001|Overall Study|improper pre-protocol therapy|1|||
16215988|NCT00081263|39272225|FG000|Overall Study|Inadequate pathology|0|||
16215989|NCT00081263|39272226|FG001|Overall Study|Inadequate pathology|1|||
16215990|NCT00081263|39272225|FG000|Overall Study|Never treated|4|||
16215991|NCT00081263|39272226|FG001|Overall Study|Never treated|5|||
16215992|NCT00081263|39272225|FG000|Overall Study|Inadequate data|5|||
16215993|NCT00081263|39272226|FG001|Overall Study|Inadequate data|10|||
16215994|NCT00982111|39272228|FG000|Overall Study|Adverse Event|1|||
16215995|NCT00982111|39272229|FG001|Overall Study|Adverse Event|1|||
16215996|NCT00982111|39272228|FG000|Overall Study|Progressive Disease|46|||
16215997|NCT00982111|39272229|FG001|Overall Study|Progressive Disease|39|||
16215998|NCT00982111|39272228|FG000|Overall Study|Lost to Follow-up|9|||
16215999|NCT00982111|39272229|FG001|Overall Study|Lost to Follow-up|6|||
16216000|NCT00982111|39272228|FG000|Overall Study|New Anti-Cancer Therapy|5|||
16216001|NCT00982111|39272229|FG001|Overall Study|New Anti-Cancer Therapy|5|||
16216002|NCT00982111|39272228|FG000|Overall Study|Medical Decision|1|||
16216003|NCT00982111|39272229|FG001|Overall Study|Medical Decision|0|||
16333230|NCT01627782|39706987|FG000|Overall Study|Lack of Efficacy|11|||
16333231|NCT01627782|39706988|FG001|Overall Study|Lack of Efficacy|1|||
16403240|NCT00075725|39956931|FG003|Overall Study|Death|2|||
16403241|NCT00075725|39956932|FG004|Overall Study|Death|3|||
16403242|NCT00075725|39956933|FG005|Overall Study|Death|25|||
16403243|NCT00075725|39956934|FG006|Overall Study|Death|4|||
16403244|NCT00075725|39956935|FG007|Overall Study|Death|22|||
16403245|NCT00075725|39956936|FG008|Overall Study|Death|14|||
16403246|NCT00075725|39956937|FG009|Overall Study|Death|4|||
16403247|NCT00075725|39956938|FG010|Overall Study|Death|3|||
16100624|NCT00464737|38856543|FG002|Overall Study|Lost to Follow-up|5|||
16333232|NCT01627782|39706989|FG002|Overall Study|Lack of Efficacy|15|||
16333233|NCT01627782|39706990|FG003|Overall Study|Lack of Efficacy|2|||
16333234|NCT01627782|39706987|FG000|Overall Study|Protocol Violation|1|||
16333235|NCT01627782|39706988|FG001|Overall Study|Protocol Violation|0|||
16333236|NCT01627782|39706989|FG002|Overall Study|Protocol Violation|0|||
16333237|NCT01627782|39706990|FG003|Overall Study|Protocol Violation|0|||
16333238|NCT01627782|39706987|FG000|Overall Study|Withdrawal by Subject|2|||
16333239|NCT01627782|39706988|FG001|Overall Study|Withdrawal by Subject|1|||
16333240|NCT01627782|39706989|FG002|Overall Study|Withdrawal by Subject|0|||
16333241|NCT01627782|39706990|FG003|Overall Study|Withdrawal by Subject|0|||
16333242|NCT01627782|39706987|FG000|Overall Study|Other|0|||
16333243|NCT01627782|39706988|FG001|Overall Study|Other|2|||
16333244|NCT01627782|39706989|FG002|Overall Study|Other|0|||
16333245|NCT01627782|39706990|FG003|Overall Study|Other|3|||
16333246|NCT01627782|39706987|FG000|Overall Study|Randomized But Not Treated|1|||
16333247|NCT01627782|39706988|FG001|Overall Study|Randomized But Not Treated|0|||
16333248|NCT01627782|39706989|FG002|Overall Study|Randomized But Not Treated|0|||
16333249|NCT01627782|39706990|FG003|Overall Study|Randomized But Not Treated|0|||
16333250|NCT01397786|39706991|FG000|Phase A|Lost to Follow-up|0|||
16333251|NCT01397786|39706992|FG001|Phase A|Lost to Follow-up|0|||
16333252|NCT01397786|39706993|FG002|Phase A|Lost to Follow-up|6|||
16333253|NCT01397786|39706991|FG000|Phase A|Adverse Event|0|||
16333254|NCT01397786|39706992|FG001|Phase A|Adverse Event|0|||
16333255|NCT01397786|39706993|FG002|Phase A|Adverse Event|8|||
16333256|NCT01397786|39706991|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
16333257|NCT01397786|39706992|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
16333258|NCT01397786|39706993|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
16403248|NCT00075725|39956939|FG011|Overall Study|Death|0|||
16216004|NCT00982111|39272228|FG000|Overall Study|Withdrawal by Subject|17|||
16216005|NCT00982111|39272229|FG001|Overall Study|Withdrawal by Subject|19|||
16333259|NCT01397786|39706991|FG000|Phase A|Physician Decision|0|||
16333260|NCT01397786|39706992|FG001|Phase A|Physician Decision|0|||
16333261|NCT01397786|39706993|FG002|Phase A|Physician Decision|1|||
16333262|NCT01397786|39706991|FG000|Phase A|Withdrawal by Subject|0|||
16216006|NCT00982111|39272228|FG000|Overall Study|Global Study End|0|||
16333263|NCT01397786|39706992|FG001|Phase A|Withdrawal by Subject|0|||
16216007|NCT00982111|39272229|FG001|Overall Study|Global Study End|1|||
16216008|NCT00982111|39272228|FG000|Overall Study|Sponsor's Decision|0|||
16216009|NCT00982111|39272229|FG001|Overall Study|Sponsor's Decision|1|||
16333264|NCT01397786|39706993|FG002|Phase A|Withdrawal by Subject|5|||
16333265|NCT01397786|39706991|FG000|Phase A|Lack of Efficacy|0|||
16333266|NCT01397786|39706992|FG001|Phase A|Lack of Efficacy|0|||
16333267|NCT01397786|39706993|FG002|Phase A|Lack of Efficacy|1|||
16403249|NCT00075725|39956928|FG000|Overall Study|Lost to Follow-up|1|||
16403250|NCT00075725|39956929|FG001|Overall Study|Lost to Follow-up|1|||
16403251|NCT00075725|39956930|FG002|Overall Study|Lost to Follow-up|4|||
16403252|NCT00075725|39956931|FG003|Overall Study|Lost to Follow-up|1|||
16403253|NCT00075725|39956932|FG004|Overall Study|Lost to Follow-up|0|||
16403254|NCT00075725|39956933|FG005|Overall Study|Lost to Follow-up|13|||
16403255|NCT00075725|39956934|FG006|Overall Study|Lost to Follow-up|2|||
16403256|NCT00075725|39956935|FG007|Overall Study|Lost to Follow-up|4|||
16403257|NCT00075725|39956936|FG008|Overall Study|Lost to Follow-up|1|||
16403258|NCT00075725|39956937|FG009|Overall Study|Lost to Follow-up|0|||
16403259|NCT00075725|39956938|FG010|Overall Study|Lost to Follow-up|0|||
16403260|NCT00075725|39956939|FG011|Overall Study|Lost to Follow-up|0|||
16403261|NCT00075725|39956928|FG000|Overall Study|Physician Decision|2|||
16403262|NCT00075725|39956929|FG001|Overall Study|Physician Decision|6|||
16216010|NCT00636506|39272235|FG000|Overall Study|Lost to Follow-up|8|||
16216011|NCT00636506|39272235|FG000|Overall Study|Explanted|1|||
16216012|NCT00636506|39272235|FG000|Overall Study|Withdrawal by Subject|6|||
16216013|NCT00636506|39272235|FG000|Overall Study|Procedure aborted|1|||
16216014|NCT02639182|39272236|FG000|Overall Study|Disease Progression|50|||
16216015|NCT02639182|39272237|FG001|Overall Study|Disease Progression|49|||
16216016|NCT02639182|39272236|FG000|Overall Study|Adverse Event|7|||
16216017|NCT02639182|39272237|FG001|Overall Study|Adverse Event|5|||
16216018|NCT02639182|39272236|FG000|Overall Study|Physician Decision|3|||
16216019|NCT02639182|39272237|FG001|Overall Study|Physician Decision|3|||
16216020|NCT02639182|39272236|FG000|Overall Study|Withdrew Consent|5|||
16216021|NCT02639182|39272237|FG001|Overall Study|Withdrew Consent|4|||
16216022|NCT02639182|39272236|FG000|Overall Study|Lost to Follow-up|0|||
16216023|NCT02639182|39272237|FG001|Overall Study|Lost to Follow-up|1|||
16216024|NCT02639182|39272236|FG000|Overall Study|Study Closure|1|||
16216025|NCT02639182|39272237|FG001|Overall Study|Study Closure|2|||
16216026|NCT02639182|39272236|FG000|Overall Study|Sponsor Ended Study|0|||
16216027|NCT02639182|39272237|FG001|Overall Study|Sponsor Ended Study|1|||
16216028|NCT02639182|39272236|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
16216029|NCT02639182|39272237|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
16216030|NCT05375838|39272238|FG000|Overall Study|Other|0|||
16216031|NCT05375838|39272239|FG001|Overall Study|Other|0|||
16216032|NCT05375838|39272240|FG002|Overall Study|Other|0|||
16216033|NCT05375838|39272241|FG003|Overall Study|Other|1|||
16216034|NCT05375838|39272242|FG004|Overall Study|Other|1|||
16216035|NCT05375838|39272243|FG005|Overall Study|Other|0|||
16216036|NCT05375838|39272238|FG000|Overall Study|Withdrawal by Subject|2|||
16216037|NCT05375838|39272239|FG001|Overall Study|Withdrawal by Subject|1|||
16216038|NCT05375838|39272240|FG002|Overall Study|Withdrawal by Subject|3|||
16216039|NCT05375838|39272241|FG003|Overall Study|Withdrawal by Subject|2|||
16216040|NCT05375838|39272242|FG004|Overall Study|Withdrawal by Subject|2|||
16216041|NCT05375838|39272243|FG005|Overall Study|Withdrawal by Subject|0|||
16216042|NCT05375838|39272238|FG000|Overall Study|Protocol Violation|0|||
16216043|NCT05375838|39272239|FG001|Overall Study|Protocol Violation|0|||
16216044|NCT05375838|39272240|FG002|Overall Study|Protocol Violation|0|||
16216045|NCT05375838|39272241|FG003|Overall Study|Protocol Violation|0|||
16216046|NCT05375838|39272242|FG004|Overall Study|Protocol Violation|1|||
16216047|NCT05375838|39272243|FG005|Overall Study|Protocol Violation|0|||
16216048|NCT05375838|39272238|FG000|Overall Study|Physician Decision|0|||
16216049|NCT05375838|39272239|FG001|Overall Study|Physician Decision|1|||
16216050|NCT05375838|39272240|FG002|Overall Study|Physician Decision|0|||
16216051|NCT05375838|39272241|FG003|Overall Study|Physician Decision|0|||
16216052|NCT05375838|39272242|FG004|Overall Study|Physician Decision|0|||
16216053|NCT05375838|39272243|FG005|Overall Study|Physician Decision|1|||
16216054|NCT05375838|39272238|FG000|Overall Study|Lost to Follow-up|2|||
16216055|NCT05375838|39272239|FG001|Overall Study|Lost to Follow-up|7|||
16216056|NCT05375838|39272240|FG002|Overall Study|Lost to Follow-up|0|||
16216057|NCT05375838|39272241|FG003|Overall Study|Lost to Follow-up|4|||
16216058|NCT05375838|39272242|FG004|Overall Study|Lost to Follow-up|2|||
16216059|NCT05375838|39272243|FG005|Overall Study|Lost to Follow-up|3|||
16216060|NCT03512028|39272244|FG000|Overall Study|Withdrawal by Subject|2|||
16216061|NCT03512028|39272245|FG001|Overall Study|Withdrawal by Subject|0|||
16216062|NCT03512028|39272244|FG000|Overall Study|Protocol Violation|2|||
16216063|NCT03512028|39272245|FG001|Overall Study|Protocol Violation|0|||
16216064|NCT01997333|39272247|FG000|Randomization and Treatment|Disease Progression|70|||
16216065|NCT01997333|39272248|FG001|Randomization and Treatment|Disease Progression|159|||
16216066|NCT01997333|39272247|FG000|Randomization and Treatment|Adverse Event|10|||
16216067|NCT01997333|39272248|FG001|Randomization and Treatment|Adverse Event|32|||
16403263|NCT00075725|39956930|FG002|Overall Study|Physician Decision|5|||
16403264|NCT00075725|39956931|FG003|Overall Study|Physician Decision|8|||
16216068|NCT01997333|39272247|FG000|Randomization and Treatment|Physician Decision|0|||
16216069|NCT01997333|39272248|FG001|Randomization and Treatment|Physician Decision|4|||
16216070|NCT01997333|39272247|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
16216071|NCT01997333|39272248|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
16216072|NCT01997333|39272247|FG000|Randomization and Treatment|Did not receive treatment|17|||
16216073|NCT01997333|39272248|FG001|Randomization and Treatment|Did not receive treatment|5|||
16403265|NCT00075725|39956932|FG004|Overall Study|Physician Decision|4|||
16333268|NCT01397786|39706991|FG000|Phase B|Lost to Follow-up|22|||
16333269|NCT01397786|39706992|FG001|Phase B|Lost to Follow-up|12|||
16333270|NCT01397786|39706993|FG002|Phase B|Lost to Follow-up|22|||
16333271|NCT01397786|39706991|FG000|Phase B|Adverse Event|109|||
16333272|NCT01397786|39706992|FG001|Phase B|Adverse Event|23|||
16333273|NCT01397786|39706993|FG002|Phase B|Adverse Event|27|||
16333274|NCT01397786|39706991|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
16333275|NCT01397786|39706992|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
16333276|NCT01397786|39706993|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
16216074|NCT01997333|39272247|FG000|Survival Follow up|Withdrawal by Subject|15|||
16216075|NCT01997333|39272248|FG001|Survival Follow up|Withdrawal by Subject|6|||
16403266|NCT00075725|39956933|FG005|Overall Study|Physician Decision|19|||
16216076|NCT01997333|39272247|FG000|Survival Follow up|Lost to Follow-up|0|||
16216077|NCT01997333|39272248|FG001|Survival Follow up|Lost to Follow-up|6|||
16333277|NCT01397786|39706991|FG000|Phase B|Physician Decision|9|||
16403267|NCT00075725|39956934|FG006|Overall Study|Physician Decision|3|||
16403268|NCT00075725|39956935|FG007|Overall Study|Physician Decision|17|||
16403269|NCT00075725|39956936|FG008|Overall Study|Physician Decision|5|||
16403270|NCT00075725|39956937|FG009|Overall Study|Physician Decision|0|||
16403271|NCT00075725|39956938|FG010|Overall Study|Physician Decision|1|||
16403272|NCT00075725|39956939|FG011|Overall Study|Physician Decision|0|||
16403273|NCT00075725|39956928|FG000|Overall Study|Pregnancy|0|||
16403274|NCT00075725|39956929|FG001|Overall Study|Pregnancy|0|||
16403275|NCT00075725|39956930|FG002|Overall Study|Pregnancy|0|||
16403276|NCT00075725|39956931|FG003|Overall Study|Pregnancy|0|||
16403277|NCT00075725|39956932|FG004|Overall Study|Pregnancy|0|||
16403278|NCT00075725|39956933|FG005|Overall Study|Pregnancy|1|||
16403279|NCT00075725|39956934|FG006|Overall Study|Pregnancy|0|||
16403280|NCT00075725|39956935|FG007|Overall Study|Pregnancy|1|||
16216078|NCT01997333|39272247|FG000|Survival Follow up|Various|1|||
16403281|NCT00075725|39956936|FG008|Overall Study|Pregnancy|0|||
16403282|NCT00075725|39956937|FG009|Overall Study|Pregnancy|0|||
16403283|NCT00075725|39956938|FG010|Overall Study|Pregnancy|0|||
16533144|NCT01781572|40417949|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
16533145|NCT01781572|40417947|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
16533146|NCT01781572|40417948|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
16533147|NCT01781572|40417949|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
16533148|NCT01781572|40417947|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
16533149|NCT01781572|40417948|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
16533150|NCT01781572|40417949|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
16533151|NCT01781572|40417947|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
16533152|NCT01781572|40417948|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
16533153|NCT01781572|40417949|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
16333278|NCT01397786|39706992|FG001|Phase B|Physician Decision|1|||
16333279|NCT01397786|39706993|FG002|Phase B|Physician Decision|3|||
16333280|NCT01397786|39706991|FG000|Phase B|Withdrawal by Subject|102|||
16333281|NCT01397786|39706992|FG001|Phase B|Withdrawal by Subject|45|||
16333282|NCT01397786|39706993|FG002|Phase B|Withdrawal by Subject|30|||
16333283|NCT01397786|39706991|FG000|Phase B|Protocol Deviation|1|||
16333284|NCT01397786|39706992|FG001|Phase B|Protocol Deviation|2|||
16333285|NCT01397786|39706993|FG002|Phase B|Protocol Deviation|4|||
16333286|NCT01397786|39706991|FG000|Phase B|Lack of Efficacy|22|||
16333287|NCT01397786|39706992|FG001|Phase B|Lack of Efficacy|7|||
16333288|NCT01397786|39706993|FG002|Phase B|Lack of Efficacy|14|||
16333289|NCT01440569|39706994|FG000|Main Study|Enrolled but not treated|1|||
16333290|NCT01440569|39706995|FG001|Main Study|Enrolled but not treated|0|||
16333291|NCT01440569|39706994|FG000|Main Study|Adverse Event|9|||
16333292|NCT01440569|39706995|FG001|Main Study|Adverse Event|0|||
16333293|NCT01440569|39706994|FG000|Main Study|Pregnancy|1|||
16333294|NCT01440569|39706995|FG001|Main Study|Pregnancy|0|||
16333295|NCT01440569|39706994|FG000|Main Study|Investigator's Discretion|1|||
16403284|NCT00075725|39956939|FG011|Overall Study|Pregnancy|0|||
16403285|NCT00075725|39956928|FG000|Overall Study|Protocol Violation|1|||
16403286|NCT00075725|39956929|FG001|Overall Study|Protocol Violation|1|||
16533154|NCT01781572|40417947|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
16533155|NCT01781572|40417948|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
16533156|NCT01781572|40417949|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
16533157|NCT01781572|40417947|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
16333296|NCT01440569|39706995|FG001|Main Study|Investigator's Discretion|1|||
16333297|NCT01440569|39706994|FG000|Main Study|Withdrew Consent|7|||
16333298|NCT01440569|39706995|FG001|Main Study|Withdrew Consent|1|||
16333299|NCT01440569|39706994|FG000|Main Study|Lost to Follow-up|13|||
16333300|NCT01440569|39706995|FG001|Main Study|Lost to Follow-up|2|||
16403287|NCT00075725|39956930|FG002|Overall Study|Protocol Violation|0|||
16403288|NCT00075725|39956931|FG003|Overall Study|Protocol Violation|3|||
16333301|NCT01440569|39706994|FG000|Main Study|Subject Non-Compliance|3|||
16333302|NCT01440569|39706995|FG001|Main Study|Subject Non-Compliance|0|||
16333303|NCT01440569|39706994|FG000|Main Study|Protocol Violation|1|||
16403289|NCT00075725|39956932|FG004|Overall Study|Protocol Violation|3|||
16216079|NCT01997333|39272248|FG001|Survival Follow up|Various|2|||
16216080|NCT01888965|39272249|FG000|Overall Study|Adverse Event|5|||
16216081|NCT01888965|39272249|FG000|Overall Study|Lack of Efficacy|4|||
16216082|NCT04735432|39272250|FG000|Overall Study|Other - due to personal reason|1|||
16216083|NCT04735432|39272251|FG001|Overall Study|Other - due to personal reason|0|||
16216084|NCT04735432|39272250|FG000|Overall Study|Adverse Event|2|||
16216085|NCT04735432|39272251|FG001|Overall Study|Adverse Event|0|||
16216086|NCT03323086|39272254|FG000|Overall Study|Lost to Follow-up|3|||
16216087|NCT03323086|39272255|FG001|Overall Study|Lost to Follow-up|2|||
16216088|NCT01738594|39272256|FG000|Registration and Treatment Start|Adverse Event|0|||
16216089|NCT01738594|39272257|FG001|Registration and Treatment Start|Adverse Event|1|||
16216090|NCT01738594|39272258|FG002|Registration and Treatment Start|Adverse Event|0|||
16216091|NCT01738594|39272259|FG003|Registration and Treatment Start|Adverse Event|0|||
16216092|NCT01738594|39272260|FG004|Registration and Treatment Start|Adverse Event|0|||
16216093|NCT01738594|39272261|FG005|Registration and Treatment Start|Adverse Event|0|||
16216094|NCT01738594|39272262|FG006|Registration and Treatment Start|Adverse Event|0|||
16216095|NCT01738594|39272263|FG007|Registration and Treatment Start|Adverse Event|0|||
16216096|NCT01738594|39272256|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16216097|NCT01738594|39272257|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16216098|NCT01738594|39272258|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16216099|NCT01738594|39272259|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16216100|NCT01738594|39272260|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16216101|NCT01738594|39272261|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
16216102|NCT01738594|39272262|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16216103|NCT01738594|39272263|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
16216104|NCT01738594|39272256|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
16216105|NCT01738594|39272257|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
16216106|NCT01738594|39272258|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
16216107|NCT01738594|39272259|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
16216108|NCT01738594|39272260|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
16216109|NCT01738594|39272261|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
16216110|NCT01738594|39272262|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
16216111|NCT01738594|39272263|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
16216112|NCT01738594|39272256|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16216113|NCT01738594|39272257|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16216114|NCT01738594|39272258|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16216115|NCT01738594|39272259|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16216116|NCT01738594|39272260|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16216117|NCT01738594|39272261|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
16216118|NCT01738594|39272262|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16216119|NCT01738594|39272263|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
16216120|NCT01738594|39272256|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16216121|NCT01738594|39272257|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16216122|NCT01738594|39272258|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16216123|NCT01738594|39272259|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16216124|NCT01738594|39272260|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16216125|NCT01738594|39272261|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
16216126|NCT01738594|39272262|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16216127|NCT01738594|39272263|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
16216128|NCT01738594|39272256|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16216129|NCT01738594|39272257|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16533158|NCT01781572|40417948|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
16533159|NCT01781572|40417949|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
16216130|NCT01738594|39272258|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16216131|NCT01738594|39272259|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16216132|NCT01738594|39272260|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
16216133|NCT01738594|39272261|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16216134|NCT01738594|39272262|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16216135|NCT01738594|39272263|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
16216136|NCT01738594|39272256|FG000|Follow up for 1 Year|Death|0|||
16216137|NCT01738594|39272257|FG001|Follow up for 1 Year|Death|0|||
16216138|NCT01738594|39272258|FG002|Follow up for 1 Year|Death|0|||
16216139|NCT01738594|39272259|FG003|Follow up for 1 Year|Death|0|||
16533160|NCT01781572|40417947|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
16533161|NCT01781572|40417948|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
16533162|NCT01781572|40417949|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
16216140|NCT01738594|39272260|FG004|Follow up for 1 Year|Death|0|||
16216141|NCT01738594|39272261|FG005|Follow up for 1 Year|Death|1|||
16533163|NCT01781572|40417947|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
16533164|NCT01781572|40417948|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
16533165|NCT01781572|40417949|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
16533166|NCT01781572|40417947|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
16533167|NCT01781572|40417948|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
16533168|NCT01781572|40417949|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
16533169|NCT01781572|40417947|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
16533170|NCT01781572|40417948|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
16216142|NCT01738594|39272262|FG006|Follow up for 1 Year|Death|0|||
16216143|NCT01738594|39272263|FG007|Follow up for 1 Year|Death|0|||
16216144|NCT01738594|39272256|FG000|Follow up for 1 Year|Other|0|||
16100625|NCT00464737|38856541|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
16100626|NCT00464737|38856542|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
16533171|NCT01781572|40417949|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
16533172|NCT01781572|40417947|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
16533173|NCT01781572|40417948|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
16533174|NCT01781572|40417949|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
16533175|NCT01781572|40417947|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
16533176|NCT01781572|40417948|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
16533177|NCT01781572|40417949|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
16533178|NCT01781572|40417947|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
16533179|NCT01781572|40417948|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
16533180|NCT01781572|40417949|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
16533181|NCT01781572|40417947|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
16533182|NCT01781572|40417948|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
16533183|NCT01781572|40417949|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
16100627|NCT00464737|38856543|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
16100628|NCT00464737|38856541|FG000|Overall Study|Other: Subject left town; family illness|1|||
16100629|NCT00464737|38856542|FG001|Overall Study|Other: Subject left town; family illness|0|||
16100630|NCT00464737|38856543|FG002|Overall Study|Other: Subject left town; family illness|0|||
16216145|NCT01738594|39272257|FG001|Follow up for 1 Year|Other|0|||
16216146|NCT01738594|39272258|FG002|Follow up for 1 Year|Other|0|||
16216147|NCT01738594|39272259|FG003|Follow up for 1 Year|Other|0|||
16216148|NCT01738594|39272260|FG004|Follow up for 1 Year|Other|0|||
16216149|NCT01738594|39272261|FG005|Follow up for 1 Year|Other|2|||
16216150|NCT01738594|39272262|FG006|Follow up for 1 Year|Other|0|||
16216151|NCT01738594|39272263|FG007|Follow up for 1 Year|Other|0|||
16216152|NCT02306148|39272266|FG000|Overall Study|Adverse Event|12|||
16216153|NCT02306148|39272267|FG001|Overall Study|Adverse Event|6|||
16216154|NCT02306148|39272266|FG000|Overall Study|Lost to Follow-up|1|||
16216155|NCT02306148|39272267|FG001|Overall Study|Lost to Follow-up|4|||
16216156|NCT00376675|39272268|FG000|Overall Study|Withdrawal by Subject|9|||
16100631|NCT00464737|38856541|FG000|Overall Study|Other: Study demands too great|0|||
16100632|NCT00464737|38856542|FG001|Overall Study|Other: Study demands too great|1|||
16100633|NCT00464737|38856543|FG002|Overall Study|Other: Study demands too great|0|||
16100634|NCT00464737|38856541|FG000|Overall Study|Other: Personal family reasons|0|||
16100635|NCT00464737|38856542|FG001|Overall Study|Other: Personal family reasons|0|||
16100636|NCT00464737|38856543|FG002|Overall Study|Other: Personal family reasons|1|||
16100637|NCT00464737|38856541|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
16100638|NCT00464737|38856542|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
16100639|NCT00464737|38856543|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
16100640|NCT04043806|38856544|FG000|Overall Study|Commercial drug is available for participants|13|||
16100641|NCT04043806|38856544|FG000|Overall Study|Physician Decision|2|||
16216157|NCT00376675|39272269|FG001|Overall Study|Withdrawal by Subject|2|||
16216158|NCT00376675|39272268|FG000|Overall Study|Adverse Event|10|||
16333304|NCT01440569|39706995|FG001|Main Study|Protocol Violation|0|||
16333305|NCT01440569|39706994|FG000|Open-Label Rollover Phase|Adverse Event|3|||
16216159|NCT00376675|39272269|FG001|Overall Study|Adverse Event|5|||
16216160|NCT00376675|39272268|FG000|Overall Study|Other Reason|1|||
16216161|NCT00376675|39272269|FG001|Overall Study|Other Reason|7|||
16333306|NCT01440569|39706995|FG001|Open-Label Rollover Phase|Adverse Event|0|||
16333307|NCT01440569|39706994|FG000|Open-Label Rollover Phase|Pregnancy|1|||
16333308|NCT01440569|39706995|FG001|Open-Label Rollover Phase|Pregnancy|0|||
16533184|NCT01781572|40417947|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
16216162|NCT03399786|39272272|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
16216163|NCT03399786|39272273|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
16216164|NCT03399786|39272274|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
16216165|NCT03399786|39272275|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
16333309|NCT01440569|39706994|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
16216166|NCT03399786|39272272|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
16216167|NCT03399786|39272273|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
16216168|NCT03399786|39272274|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
16216169|NCT03399786|39272275|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
16216170|NCT03399786|39272272|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
16216171|NCT03399786|39272273|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
16216172|NCT03399786|39272274|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
16216173|NCT03399786|39272275|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
16333310|NCT01440569|39706995|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
16333311|NCT01440569|39706994|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
16333312|NCT01440569|39706995|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
16333313|NCT01440569|39706994|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
16333314|NCT01440569|39706995|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
16333315|NCT01440569|39706994|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
16333316|NCT01440569|39706995|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
16333317|NCT01440569|39706994|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
16333318|NCT01440569|39706995|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
16333319|NCT03570554|39706997|FG000|Overall Study|Non-compliance with study drug|0|||
16333320|NCT03570554|39706998|FG001|Overall Study|Non-compliance with study drug|0|||
16333321|NCT03570554|39706999|FG002|Overall Study|Non-compliance with study drug|1|||
16333322|NCT03570554|39707000|FG003|Overall Study|Non-compliance with study drug|0|||
16333323|NCT03570554|39706997|FG000|Overall Study|Adverse Event|0|||
16333324|NCT03570554|39706998|FG001|Overall Study|Adverse Event|0|||
16333325|NCT03570554|39706999|FG002|Overall Study|Adverse Event|0|||
16333326|NCT03570554|39707000|FG003|Overall Study|Adverse Event|1|||
16333327|NCT02787083|39707004|FG000|Overall Study|Adverse Event|1|||
16333328|NCT02787083|39707005|FG001|Overall Study|Adverse Event|0|||
16333329|NCT02787083|39707004|FG000|Overall Study|Withdrawal by Subject|2|||
16333330|NCT02787083|39707005|FG001|Overall Study|Withdrawal by Subject|2|||
16333331|NCT00460265|39707007|FG000|Overall Study|Lost to Follow-up|14|||
16333332|NCT00460265|39707008|FG001|Overall Study|Lost to Follow-up|15|||
16333333|NCT00460265|39707007|FG000|Overall Study|Physician Decision|1|||
16333334|NCT00460265|39707008|FG001|Overall Study|Physician Decision|2|||
16333335|NCT00460265|39707007|FG000|Overall Study|Withdrawal by Subject|10|||
16333336|NCT00460265|39707008|FG001|Overall Study|Withdrawal by Subject|25|||
16333337|NCT00460265|39707007|FG000|Overall Study|Ongoing|60|||
16333338|NCT00460265|39707008|FG001|Overall Study|Ongoing|47|||
16333339|NCT03495154|39707009|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
16333340|NCT03495154|39707009|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
16333341|NCT03495154|39707009|FG000|Overall Study|Screen Failures During Surgery|6|||
16333342|NCT03495154|39707009|FG000|Overall Study|Death|2|||
16333343|NCT03495154|39707009|FG000|Overall Study|Lost to Follow-up|16|||
16333344|NCT03495154|39707009|FG000|Overall Study|Withdrawal by Subject|2|||
16333345|NCT03495154|39707009|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
16333346|NCT02083653|39707010|FG000|Overall Study|Randomized but not Treated|0|||
16333347|NCT02083653|39707011|FG001|Overall Study|Randomized but not Treated|2|||
16333348|NCT02083653|39707012|FG002|Overall Study|Randomized but not Treated|7|||
16333349|NCT02083653|39707010|FG000|Overall Study|Adverse Event|12|||
16333350|NCT02083653|39707011|FG001|Overall Study|Adverse Event|5|||
16333351|NCT02083653|39707012|FG002|Overall Study|Adverse Event|4|||
16333352|NCT02083653|39707010|FG000|Overall Study|Lost to Follow-up|1|||
16333353|NCT02083653|39707011|FG001|Overall Study|Lost to Follow-up|0|||
16333354|NCT02083653|39707012|FG002|Overall Study|Lost to Follow-up|0|||
16333355|NCT02083653|39707010|FG000|Overall Study|Death|2|||
16333356|NCT02083653|39707011|FG001|Overall Study|Death|2|||
16333357|NCT02083653|39707012|FG002|Overall Study|Death|2|||
16333358|NCT02083653|39707010|FG000|Overall Study|Progressive Disease|65|||
16333359|NCT02083653|39707011|FG001|Overall Study|Progressive Disease|73|||
16333360|NCT02083653|39707012|FG002|Overall Study|Progressive Disease|63|||
16333361|NCT02083653|39707010|FG000|Overall Study|Withdrawal by Subject|2|||
16333362|NCT02083653|39707011|FG001|Overall Study|Withdrawal by Subject|1|||
16333363|NCT02083653|39707012|FG002|Overall Study|Withdrawal by Subject|2|||
16333364|NCT02083653|39707010|FG000|Overall Study|Other Events|0|||
16333365|NCT02083653|39707011|FG001|Overall Study|Other Events|2|||
16333366|NCT02083653|39707012|FG002|Overall Study|Other Events|2|||
16333367|NCT02083653|39707010|FG000|Overall Study|Reason Missing|0|||
16403290|NCT00075725|39956933|FG005|Overall Study|Protocol Violation|2|||
16333368|NCT02083653|39707011|FG001|Overall Study|Reason Missing|0|||
16333369|NCT02083653|39707012|FG002|Overall Study|Reason Missing|4|||
16333370|NCT02919267|39707016|FG000|Overall Study|Protocol Violation|0|||
16333371|NCT02919267|39707017|FG001|Overall Study|Protocol Violation|3|||
16333372|NCT02919267|39707018|FG002|Overall Study|Protocol Violation|3|||
16333373|NCT02919267|39707019|FG003|Overall Study|Protocol Violation|4|||
16333374|NCT00985959|39707022|FG000|Overall Study|Adverse Event|0|||
16333375|NCT00985959|39707023|FG001|Overall Study|Adverse Event|0|||
16100642|NCT04043806|38856544|FG000|Overall Study|Other|12|||
16100643|NCT04043806|38856544|FG000|Overall Study|Adverse Event|2|||
16100644|NCT04043806|38856544|FG000|Overall Study|Lost to Follow-up|6|||
16100645|NCT04043806|38856544|FG000|Overall Study|Other non-compliance|2|||
16100646|NCT04043806|38856544|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
16100647|NCT04043806|38856544|FG000|Overall Study|Never Dosed|1|||
16100648|NCT02625922|38856545|FG000|Overall Study|Non-availability of IMP|1|||
16100649|NCT02625922|38856546|FG001|Overall Study|Non-availability of IMP|1|||
16100650|NCT02625922|38856545|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
16100651|NCT02625922|38856546|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
16100652|NCT00744796|38856547|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
16100653|NCT03568708|38856548|FG000|Overall Study|Withdrawal by Subject|1|||
16100654|NCT03568708|38856549|FG001|Overall Study|Withdrawal by Subject|1|||
16100655|NCT03568708|38856548|FG000|Overall Study|Lost to Follow-up|0|||
16100656|NCT03568708|38856549|FG001|Overall Study|Lost to Follow-up|1|||
16100657|NCT00372255|38856550|FG000|Overall Study|Withdrawn for other reasons|2|||
16100658|NCT00372255|38856551|FG001|Overall Study|Withdrawn for other reasons|1|||
16216174|NCT05333289|39272276|FG000|Overall Study|Other|1|||
16100659|NCT01536535|38856552|FG000|Overall Study|Withdrawal by Subject|10|||
16100660|NCT01536535|38856553|FG001|Overall Study|Withdrawal by Subject|5|||
16216175|NCT05333289|39272277|FG001|Overall Study|Other|0|||
16216176|NCT05333289|39272278|FG002|Overall Study|Other|0|||
16333376|NCT00985959|39707024|FG002|Overall Study|Adverse Event|19|||
16333377|NCT00985959|39707022|FG000|Overall Study|Withdrawal by Subject|0|||
16333378|NCT00985959|39707023|FG001|Overall Study|Withdrawal by Subject|0|||
16403291|NCT00075725|39956934|FG006|Overall Study|Protocol Violation|1|||
16403292|NCT00075725|39956935|FG007|Overall Study|Protocol Violation|2|||
16403293|NCT00075725|39956936|FG008|Overall Study|Protocol Violation|3|||
16403294|NCT00075725|39956937|FG009|Overall Study|Protocol Violation|0|||
16333379|NCT00985959|39707024|FG002|Overall Study|Withdrawal by Subject|8|||
16333380|NCT00985959|39707022|FG000|Overall Study|Progressive disease|1|||
16333381|NCT00985959|39707023|FG001|Overall Study|Progressive disease|2|||
16333382|NCT00985959|39707024|FG002|Overall Study|Progressive disease|8|||
16333383|NCT00985959|39707022|FG000|Overall Study|Unrecovered toxicity|0|||
16333384|NCT00985959|39707023|FG001|Overall Study|Unrecovered toxicity|0|||
16333385|NCT00985959|39707024|FG002|Overall Study|Unrecovered toxicity|7|||
16333386|NCT00985959|39707022|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
16333387|NCT00985959|39707023|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
16333388|NCT00985959|39707024|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
16333389|NCT00985959|39707022|FG000|Overall Study|Complete response observed over 2 cycles|0|||
16333390|NCT00985959|39707023|FG001|Overall Study|Complete response observed over 2 cycles|1|||
16333391|NCT00985959|39707024|FG002|Overall Study|Complete response observed over 2 cycles|4|||
16333392|NCT00985959|39707022|FG000|Overall Study|Other|0|||
16333393|NCT00985959|39707023|FG001|Overall Study|Other|0|||
16333394|NCT00985959|39707024|FG002|Overall Study|Other|11|||
16333395|NCT00505661|39707027|FG000|Overall Study|Not Eligible|4|||
16333396|NCT02906033|39707028|FG000|Baseline|Protocol Violation|37|||
16333397|NCT02906033|39707029|FG001|Baseline|Protocol Violation|33|||
16333398|NCT02906033|39707028|FG000|Follow-up|Lost to Follow-up|46|||
16333399|NCT02906033|39707029|FG001|Follow-up|Lost to Follow-up|62|||
16333400|NCT02839876|39707030|FG000|Overall Study|Protocol Violation|10|||
16333401|NCT02839876|39707031|FG001|Overall Study|Protocol Violation|11|||
16333402|NCT02536781|39707032|FG000|Overall Study|Lost to Follow-up|2|||
16333403|NCT02536781|39707033|FG001|Overall Study|Lost to Follow-up|0|||
16333404|NCT00938587|39707056|FG000|Overall Study|Adverse Event|2|||
16333405|NCT00938587|39707057|FG001|Overall Study|Adverse Event|0|||
16333406|NCT00938587|39707058|FG002|Overall Study|Adverse Event|0|||
16333407|NCT00938587|39707059|FG003|Overall Study|Adverse Event|2|||
16333408|NCT00938587|39707056|FG000|Overall Study|Did not meet entrance criteria|0|||
16333409|NCT00938587|39707057|FG001|Overall Study|Did not meet entrance criteria|0|||
16333410|NCT00938587|39707058|FG002|Overall Study|Did not meet entrance criteria|1|||
16333411|NCT00938587|39707059|FG003|Overall Study|Did not meet entrance criteria|0|||
16403295|NCT00075725|39956938|FG010|Overall Study|Protocol Violation|0|||
16403296|NCT00075725|39956939|FG011|Overall Study|Protocol Violation|1|||
16403297|NCT00075725|39956928|FG000|Overall Study|Withdrawal by Subject|12|||
16100661|NCT01536535|38856552|FG000|Overall Study|Lost to Follow-up|4|||
16100662|NCT01536535|38856553|FG001|Overall Study|Lost to Follow-up|6|||
16100663|NCT01536535|38856552|FG000|Overall Study|Physician Decision|1|||
16100664|NCT01536535|38856553|FG001|Overall Study|Physician Decision|1|||
16100665|NCT01536535|38856552|FG000|Overall Study|Participant moved|0|||
16100666|NCT01536535|38856553|FG001|Overall Study|Participant moved|1|||
16216177|NCT05333289|39272279|FG003|Overall Study|Other|1|||
16216178|NCT05333289|39272280|FG004|Overall Study|Other|1|||
16333412|NCT00938587|39707056|FG000|Overall Study|Withdrawal by Subject|1|||
16333413|NCT00938587|39707057|FG001|Overall Study|Withdrawal by Subject|1|||
16333414|NCT00938587|39707058|FG002|Overall Study|Withdrawal by Subject|0|||
16403298|NCT00075725|39956929|FG001|Overall Study|Withdrawal by Subject|3|||
16403299|NCT00075725|39956930|FG002|Overall Study|Withdrawal by Subject|6|||
16403300|NCT00075725|39956931|FG003|Overall Study|Withdrawal by Subject|10|||
16403301|NCT00075725|39956932|FG004|Overall Study|Withdrawal by Subject|6|||
16403302|NCT00075725|39956933|FG005|Overall Study|Withdrawal by Subject|27|||
16403303|NCT00075725|39956934|FG006|Overall Study|Withdrawal by Subject|7|||
16403304|NCT00075725|39956935|FG007|Overall Study|Withdrawal by Subject|31|||
16403305|NCT00075725|39956936|FG008|Overall Study|Withdrawal by Subject|10|||
16403306|NCT00075725|39956937|FG009|Overall Study|Withdrawal by Subject|2|||
16403307|NCT00075725|39956938|FG010|Overall Study|Withdrawal by Subject|0|||
16403308|NCT00075725|39956939|FG011|Overall Study|Withdrawal by Subject|0|||
16403309|NCT00075725|39956928|FG000|Overall Study|Disease Progression, all other reasons|17|||
16403310|NCT00075725|39956929|FG001|Overall Study|Disease Progression, all other reasons|5|||
16403311|NCT00075725|39956930|FG002|Overall Study|Disease Progression, all other reasons|33|||
16403312|NCT00075725|39956931|FG003|Overall Study|Disease Progression, all other reasons|6|||
16403313|NCT00075725|39956932|FG004|Overall Study|Disease Progression, all other reasons|21|||
16403314|NCT00075725|39956933|FG005|Overall Study|Disease Progression, all other reasons|59|||
16403315|NCT00075725|39956934|FG006|Overall Study|Disease Progression, all other reasons|20|||
16403316|NCT00075725|39956935|FG007|Overall Study|Disease Progression, all other reasons|46|||
16403317|NCT00075725|39956936|FG008|Overall Study|Disease Progression, all other reasons|21|||
16403318|NCT00075725|39956937|FG009|Overall Study|Disease Progression, all other reasons|4|||
16403319|NCT00075725|39956938|FG010|Overall Study|Disease Progression, all other reasons|0|||
16403320|NCT00075725|39956939|FG011|Overall Study|Disease Progression, all other reasons|5|||
16403321|NCT00075725|39956928|FG000|Overall Study|Patient off treatment|0|||
16403322|NCT00075725|39956929|FG001|Overall Study|Patient off treatment|0|||
16403323|NCT00075725|39956930|FG002|Overall Study|Patient off treatment|1|||
16403324|NCT00075725|39956931|FG003|Overall Study|Patient off treatment|2|||
16403325|NCT00075725|39956932|FG004|Overall Study|Patient off treatment|1|||
16403326|NCT00075725|39956933|FG005|Overall Study|Patient off treatment|0|||
16403327|NCT00075725|39956934|FG006|Overall Study|Patient off treatment|0|||
16403328|NCT00075725|39956935|FG007|Overall Study|Patient off treatment|2|||
16403329|NCT00075725|39956936|FG008|Overall Study|Patient off treatment|1|||
16403330|NCT00075725|39956937|FG009|Overall Study|Patient off treatment|0|||
16403331|NCT00075725|39956938|FG010|Overall Study|Patient off treatment|0|||
16403332|NCT00075725|39956939|FG011|Overall Study|Patient off treatment|0|||
16403333|NCT00075725|39956928|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
16403334|NCT00075725|39956929|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
16403335|NCT00075725|39956930|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
16403336|NCT00075725|39956931|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
16403337|NCT00075725|39956932|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
16403338|NCT00075725|39956933|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
16100667|NCT02029521|38856558|FG000|Overall Study|Protocol Violation|1|||
16100668|NCT02029521|38856559|FG001|Overall Study|Protocol Violation|0|||
16100669|NCT02029521|38856558|FG000|Overall Study|Withdrawal by Subject|1|||
16100670|NCT02029521|38856559|FG001|Overall Study|Withdrawal by Subject|1|||
16100671|NCT02282059|38856561|FG000|Overall Study|Other|15|||
16403339|NCT00075725|39956934|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
16403340|NCT00075725|39956935|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
16403341|NCT00075725|39956936|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
16403342|NCT00075725|39956937|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
16403343|NCT00075725|39956938|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
16403344|NCT00075725|39956939|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
16403345|NCT00075725|39956928|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
16403346|NCT00075725|39956929|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
16403347|NCT00075725|39956930|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
16403348|NCT00075725|39956931|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
16403349|NCT00075725|39956932|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
16403350|NCT00075725|39956933|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
16403351|NCT00075725|39956934|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
16100672|NCT02282059|38856562|FG001|Overall Study|Other|3|||
16100673|NCT02282059|38856561|FG000|Overall Study|Participant refused further follow-up|8|||
16100674|NCT02282059|38856562|FG001|Overall Study|Participant refused further follow-up|4|||
16100675|NCT02282059|38856561|FG000|Overall Study|Lost to Follow-up|19|||
16100676|NCT02282059|38856562|FG001|Overall Study|Lost to Follow-up|3|||
16100677|NCT02282059|38856561|FG000|Overall Study|Death|40|||
16100678|NCT02282059|38856562|FG001|Overall Study|Death|8|||
16100679|NCT01568112|38856563|FG000|Overall Study|Randomized But Not Treated|0|||
16403352|NCT00075725|39956935|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
16403353|NCT00075725|39956936|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
16403354|NCT00075725|39956937|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
16403355|NCT00075725|39956938|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
16403356|NCT00075725|39956939|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
16403357|NCT00075725|39956928|FG000|Overall Study|Pt non compliant with therapy|2|||
16403358|NCT00075725|39956929|FG001|Overall Study|Pt non compliant with therapy|1|||
16100680|NCT01568112|38856564|FG001|Overall Study|Randomized But Not Treated|1|||
16100681|NCT01568112|38856565|FG002|Overall Study|Randomized But Not Treated|0|||
16100682|NCT01568112|38856566|FG003|Overall Study|Randomized But Not Treated|0|||
16100683|NCT01568112|38856563|FG000|Overall Study|Withdrew due to Adverse Event|2|||
16100684|NCT01568112|38856564|FG001|Overall Study|Withdrew due to Adverse Event|4|||
16100685|NCT01568112|38856565|FG002|Overall Study|Withdrew due to Adverse Event|6|||
16100686|NCT01568112|38856566|FG003|Overall Study|Withdrew due to Adverse Event|3|||
16100687|NCT01568112|38856563|FG000|Overall Study|Lost to Follow-up|0|||
16100688|NCT01568112|38856564|FG001|Overall Study|Lost to Follow-up|0|||
16100689|NCT01568112|38856565|FG002|Overall Study|Lost to Follow-up|0|||
16100690|NCT01568112|38856566|FG003|Overall Study|Lost to Follow-up|1|||
16100691|NCT01568112|38856563|FG000|Overall Study|Withdrawal by Subject|2|||
16100692|NCT01568112|38856564|FG001|Overall Study|Withdrawal by Subject|3|||
16100693|NCT01568112|38856565|FG002|Overall Study|Withdrawal by Subject|0|||
16100694|NCT01568112|38856566|FG003|Overall Study|Withdrawal by Subject|7|||
16100695|NCT01568112|38856563|FG000|Overall Study|Withdrawal by Physician|1|||
16100696|NCT01568112|38856564|FG001|Overall Study|Withdrawal by Physician|0|||
16100697|NCT01568112|38856565|FG002|Overall Study|Withdrawal by Physician|1|||
16100698|NCT01568112|38856566|FG003|Overall Study|Withdrawal by Physician|1|||
16100699|NCT00092456|38856567|FG000|Overall Study|Adverse Event|0|||
16100700|NCT00092456|38856568|FG001|Overall Study|Adverse Event|0|||
16100701|NCT00092456|38856569|FG002|Overall Study|Adverse Event|1|||
16100702|NCT00092456|38856570|FG003|Overall Study|Adverse Event|1|||
16100703|NCT00092456|38856567|FG000|Overall Study|Lost to Follow-up|2|||
16100704|NCT00092456|38856568|FG001|Overall Study|Lost to Follow-up|2|||
16100705|NCT00092456|38856569|FG002|Overall Study|Lost to Follow-up|1|||
16100706|NCT00092456|38856570|FG003|Overall Study|Lost to Follow-up|2|||
16100707|NCT00092456|38856567|FG000|Overall Study|Protocol Violation|5|||
16100708|NCT00092456|38856568|FG001|Overall Study|Protocol Violation|7|||
16100709|NCT00092456|38856569|FG002|Overall Study|Protocol Violation|8|||
16100710|NCT00092456|38856570|FG003|Overall Study|Protocol Violation|6|||
16100711|NCT00092456|38856567|FG000|Overall Study|Withdrawal by Subject|13|||
16100712|NCT00092456|38856568|FG001|Overall Study|Withdrawal by Subject|5|||
16100713|NCT00092456|38856569|FG002|Overall Study|Withdrawal by Subject|16|||
16100714|NCT00092456|38856570|FG003|Overall Study|Withdrawal by Subject|6|||
16100715|NCT00092456|38856567|FG000|Overall Study|Moved|1|||
16100716|NCT00092456|38856568|FG001|Overall Study|Moved|1|||
16100717|NCT00092456|38856569|FG002|Overall Study|Moved|0|||
16100718|NCT00092456|38856570|FG003|Overall Study|Moved|1|||
16100719|NCT00092456|38856567|FG000|Overall Study|Other|4|||
16100720|NCT00092456|38856568|FG001|Overall Study|Other|2|||
16100721|NCT00092456|38856569|FG002|Overall Study|Other|3|||
16100722|NCT00092456|38856570|FG003|Overall Study|Other|0|||
16100723|NCT01924806|38856571|FG000|Overall Study|Physician Decision|2|||
16100724|NCT01924806|38856572|FG001|Overall Study|Physician Decision|1|||
16100725|NCT00230971|38856573|FG000|Randomization|No study drug administered|3|||
16100726|NCT00230971|38856574|FG001|Randomization|No study drug administered|3|||
16100727|NCT00230971|38856573|FG000|Baseline Participants|Lost to Follow-up|5|||
16100728|NCT00230971|38856574|FG001|Baseline Participants|Lost to Follow-up|12|||
16100729|NCT00230971|38856573|FG000|Baseline Participants|Death|6|||
16100730|NCT00230971|38856574|FG001|Baseline Participants|Death|5|||
16100731|NCT00230971|38856573|FG000|Baseline Participants|Withdrawal by Subject|7|||
16100732|NCT00230971|38856574|FG001|Baseline Participants|Withdrawal by Subject|1|||
16100733|NCT00230971|38856573|FG000|Baseline Participants|Adverse Event|1|||
16403359|NCT00075725|39956930|FG002|Overall Study|Pt non compliant with therapy|1|||
16403360|NCT00075725|39956931|FG003|Overall Study|Pt non compliant with therapy|0|||
16403361|NCT00075725|39956932|FG004|Overall Study|Pt non compliant with therapy|2|||
16403362|NCT00075725|39956933|FG005|Overall Study|Pt non compliant with therapy|14|||
16403363|NCT00075725|39956934|FG006|Overall Study|Pt non compliant with therapy|2|||
16403364|NCT00075725|39956935|FG007|Overall Study|Pt non compliant with therapy|5|||
16403365|NCT00075725|39956936|FG008|Overall Study|Pt non compliant with therapy|3|||
16403366|NCT00075725|39956937|FG009|Overall Study|Pt non compliant with therapy|0|||
16403367|NCT00075725|39956938|FG010|Overall Study|Pt non compliant with therapy|0|||
16403368|NCT00075725|39956939|FG011|Overall Study|Pt non compliant with therapy|0|||
16100734|NCT00230971|38856574|FG001|Baseline Participants|Adverse Event|0|||
16100735|NCT00230971|38856573|FG000|Baseline Participants|No bacteria observed|1|||
16100736|NCT00230971|38856574|FG001|Baseline Participants|No bacteria observed|0|||
16100737|NCT00230971|38856573|FG000|Baseline Participants|Failure to return|1|||
16403369|NCT00075725|39956928|FG000|Overall Study|Pt age out of range for treatment|0|||
16403370|NCT00075725|39956929|FG001|Overall Study|Pt age out of range for treatment|1|||
16100738|NCT00230971|38856574|FG001|Baseline Participants|Failure to return|1|||
16100739|NCT00230971|38856573|FG000|Baseline Participants|Reintervention|1|||
16100740|NCT00230971|38856574|FG001|Baseline Participants|Reintervention|0|||
16100741|NCT00002540|38856575|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
16100742|NCT00002540|38856576|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
16100743|NCT00002540|38856575|FG000|Overall Study|Died Before Randomization|2|||
16403371|NCT00075725|39956930|FG002|Overall Study|Pt age out of range for treatment|0|||
16403372|NCT00075725|39956931|FG003|Overall Study|Pt age out of range for treatment|0|||
16403373|NCT00075725|39956932|FG004|Overall Study|Pt age out of range for treatment|0|||
16403374|NCT00075725|39956933|FG005|Overall Study|Pt age out of range for treatment|1|||
16403375|NCT00075725|39956934|FG006|Overall Study|Pt age out of range for treatment|0|||
16403376|NCT00075725|39956935|FG007|Overall Study|Pt age out of range for treatment|1|||
16403377|NCT00075725|39956936|FG008|Overall Study|Pt age out of range for treatment|0|||
16403378|NCT00075725|39956937|FG009|Overall Study|Pt age out of range for treatment|0|||
16403379|NCT00075725|39956938|FG010|Overall Study|Pt age out of range for treatment|0|||
16403380|NCT00075725|39956939|FG011|Overall Study|Pt age out of range for treatment|0|||
16403381|NCT00075725|39956928|FG000|Overall Study|Insurance issues|0|||
16403382|NCT00075725|39956929|FG001|Overall Study|Insurance issues|1|||
16403383|NCT00075725|39956930|FG002|Overall Study|Insurance issues|0|||
16403384|NCT00075725|39956931|FG003|Overall Study|Insurance issues|1|||
16403385|NCT00075725|39956932|FG004|Overall Study|Insurance issues|1|||
16403386|NCT00075725|39956933|FG005|Overall Study|Insurance issues|1|||
16403387|NCT00075725|39956934|FG006|Overall Study|Insurance issues|0|||
16403388|NCT00075725|39956935|FG007|Overall Study|Insurance issues|1|||
16403389|NCT00075725|39956936|FG008|Overall Study|Insurance issues|0|||
16403390|NCT00075725|39956937|FG009|Overall Study|Insurance issues|0|||
16403391|NCT00075725|39956938|FG010|Overall Study|Insurance issues|0|||
16403392|NCT00075725|39956939|FG011|Overall Study|Insurance issues|0|||
16403393|NCT00075725|39956928|FG000|Overall Study|MRD positive after extended ind|0|||
16403394|NCT00075725|39956929|FG001|Overall Study|MRD positive after extended ind|1|||
16403395|NCT00075725|39956930|FG002|Overall Study|MRD positive after extended ind|1|||
16403396|NCT00075725|39956931|FG003|Overall Study|MRD positive after extended ind|0|||
16403397|NCT00075725|39956932|FG004|Overall Study|MRD positive after extended ind|1|||
16403398|NCT00075725|39956933|FG005|Overall Study|MRD positive after extended ind|2|||
16403399|NCT00075725|39956934|FG006|Overall Study|MRD positive after extended ind|0|||
16403400|NCT00075725|39956935|FG007|Overall Study|MRD positive after extended ind|1|||
16403401|NCT00075725|39956936|FG008|Overall Study|MRD positive after extended ind|0|||
16403402|NCT00075725|39956937|FG009|Overall Study|MRD positive after extended ind|0|||
16403403|NCT00075725|39956938|FG010|Overall Study|MRD positive after extended ind|0|||
16403404|NCT00075725|39956939|FG011|Overall Study|MRD positive after extended ind|0|||
16403405|NCT00075725|39956928|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
16403406|NCT00075725|39956929|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
16403407|NCT00075725|39956930|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
16403408|NCT00075725|39956931|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
16403409|NCT00075725|39956932|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
16403410|NCT00075725|39956933|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
16403411|NCT00075725|39956934|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
16403412|NCT00075725|39956935|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
16403413|NCT00075725|39956936|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
16403414|NCT00075725|39956937|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
16403415|NCT00075725|39956938|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
16403416|NCT00075725|39956939|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
16403417|NCT00075725|39956928|FG000|Overall Study|Inevaluable|1|||
16403418|NCT00075725|39956929|FG001|Overall Study|Inevaluable|1|||
16403419|NCT00075725|39956930|FG002|Overall Study|Inevaluable|4|||
16403420|NCT00075725|39956931|FG003|Overall Study|Inevaluable|2|||
16403421|NCT00075725|39956932|FG004|Overall Study|Inevaluable|2|||
16403422|NCT00075725|39956933|FG005|Overall Study|Inevaluable|9|||
16403423|NCT00075725|39956934|FG006|Overall Study|Inevaluable|1|||
16403424|NCT00075725|39956935|FG007|Overall Study|Inevaluable|11|||
16403425|NCT00075725|39956936|FG008|Overall Study|Inevaluable|2|||
16403426|NCT00075725|39956937|FG009|Overall Study|Inevaluable|0|||
16216179|NCT05333289|39272281|FG005|Overall Study|Other|2|||
16403427|NCT00075725|39956938|FG010|Overall Study|Inevaluable|1|||
16333415|NCT00938587|39707059|FG003|Overall Study|Withdrawal by Subject|0|||
16333416|NCT03217968|39707060|FG000|Overall Study|Withdrawal by Subject|4|||
16333417|NCT03217968|39707060|FG000|Overall Study|Lost to Follow-up|1|||
16333418|NCT03217968|39707060|FG000|Overall Study|Protocol Violation|6|||
16333419|NCT02362425|39707062|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
16333420|NCT02362425|39707063|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
16333421|NCT02362425|39707064|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
16333422|NCT02362425|39707065|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
16403428|NCT00075725|39956939|FG011|Overall Study|Inevaluable|0|||
16403429|NCT00075725|39956928|FG000|Overall Study|Other|4|||
16403430|NCT00075725|39956929|FG001|Overall Study|Other|2|||
16403431|NCT00075725|39956930|FG002|Overall Study|Other|1|||
16403432|NCT00075725|39956931|FG003|Overall Study|Other|1|||
16403433|NCT00075725|39956932|FG004|Overall Study|Other|1|||
16403434|NCT00075725|39956933|FG005|Overall Study|Other|4|||
16403435|NCT00075725|39956934|FG006|Overall Study|Other|2|||
16403436|NCT00075725|39956935|FG007|Overall Study|Other|9|||
16403437|NCT00075725|39956936|FG008|Overall Study|Other|2|||
16403438|NCT00075725|39956937|FG009|Overall Study|Other|1|||
16403439|NCT00075725|39956938|FG010|Overall Study|Other|0|||
16403440|NCT00075725|39956939|FG011|Overall Study|Other|3|||
16403441|NCT00075725|39956928|FG000|Overall Study|Pt trying to find a BM donor|0|||
16403442|NCT00075725|39956929|FG001|Overall Study|Pt trying to find a BM donor|1|||
16403443|NCT00075725|39956930|FG002|Overall Study|Pt trying to find a BM donor|0|||
16403444|NCT00075725|39956931|FG003|Overall Study|Pt trying to find a BM donor|0|||
16533185|NCT01781572|40417948|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
16533186|NCT01781572|40417949|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
16533187|NCT00971048|40417950|FG000|Overall Study|Protocol Violation|1|||
16533188|NCT00971048|40417951|FG001|Overall Study|Protocol Violation|2|||
16533189|NCT00971048|40417952|FG002|Overall Study|Protocol Violation|0|||
16533190|NCT00971048|40417953|FG003|Overall Study|Protocol Violation|1|||
16533191|NCT00971048|40417950|FG000|Overall Study|Adverse Event|0|||
16533192|NCT00971048|40417951|FG001|Overall Study|Adverse Event|0|||
16533193|NCT00971048|40417952|FG002|Overall Study|Adverse Event|1|||
16533194|NCT00971048|40417953|FG003|Overall Study|Adverse Event|0|||
16533195|NCT00971048|40417950|FG000|Overall Study|Physician Decision|0|||
16533196|NCT00971048|40417951|FG001|Overall Study|Physician Decision|0|||
16533197|NCT00971048|40417952|FG002|Overall Study|Physician Decision|0|||
16533198|NCT00971048|40417953|FG003|Overall Study|Physician Decision|1|||
16533199|NCT01388816|40417954|FG000|Overall Study|Adverse Event|0|||
16533200|NCT01388816|40417955|FG001|Overall Study|Adverse Event|2|||
16533201|NCT01388816|40417956|FG002|Overall Study|Adverse Event|0|||
16533202|NCT01388816|40417957|FG003|Overall Study|Adverse Event|0|||
16533203|NCT01388816|40417954|FG000|Overall Study|Lost to Follow-up|0|||
16533204|NCT01388816|40417955|FG001|Overall Study|Lost to Follow-up|1|||
16533205|NCT01388816|40417956|FG002|Overall Study|Lost to Follow-up|0|||
16533206|NCT01388816|40417957|FG003|Overall Study|Lost to Follow-up|0|||
16533207|NCT01388816|40417954|FG000|Overall Study|Withdrawal by Subject|2|||
16533208|NCT01388816|40417955|FG001|Overall Study|Withdrawal by Subject|1|||
16533209|NCT01388816|40417956|FG002|Overall Study|Withdrawal by Subject|1|||
16533210|NCT01388816|40417957|FG003|Overall Study|Withdrawal by Subject|0|||
16533211|NCT01388816|40417954|FG000|Overall Study|Protocol Violation|0|||
16533212|NCT01388816|40417955|FG001|Overall Study|Protocol Violation|0|||
16533213|NCT01388816|40417956|FG002|Overall Study|Protocol Violation|2|||
16533214|NCT01388816|40417957|FG003|Overall Study|Protocol Violation|0|||
16533215|NCT01400503|40417962|FG000|Overall Study|Withdrawal by Subject|1|||
16533216|NCT01400503|40417962|FG000|Overall Study|Study Terminated by Sponsor|58|||
16533217|NCT01400503|40417962|FG000|Overall Study|Other|1|||
16533218|NCT01587651|40417966|FG000|Overall Study|Adverse Event|0|||
16533219|NCT01587651|40417967|FG001|Overall Study|Adverse Event|1|||
16533220|NCT01587651|40417968|FG002|Overall Study|Adverse Event|0|||
16533221|NCT01587651|40417966|FG000|Overall Study|Protocol Violation|0|||
16533222|NCT01587651|40417967|FG001|Overall Study|Protocol Violation|1|||
16533223|NCT01587651|40417968|FG002|Overall Study|Protocol Violation|1|||
16533224|NCT01587651|40417966|FG000|Overall Study|Withdrawal by Subject|0|||
16533225|NCT01587651|40417967|FG001|Overall Study|Withdrawal by Subject|1|||
16533226|NCT01587651|40417968|FG002|Overall Study|Withdrawal by Subject|0|||
16533227|NCT04393441|40417980|FG000|Overall Study|Adverse Event|0|||
16533228|NCT04393441|40417981|FG001|Overall Study|Adverse Event|3|||
16533229|NCT04393441|40417980|FG000|Overall Study|Withdrawal by Subject|5|||
16533230|NCT04393441|40417981|FG001|Overall Study|Withdrawal by Subject|7|||
16533231|NCT04393441|40417980|FG000|Overall Study|Lost to Follow-up|0|||
16533232|NCT04393441|40417981|FG001|Overall Study|Lost to Follow-up|2|||
16403445|NCT00075725|39956932|FG004|Overall Study|Pt trying to find a BM donor|0|||
16533233|NCT04393441|40417980|FG000|Overall Study|Protocol Deviation|2|||
16533234|NCT04393441|40417981|FG001|Overall Study|Protocol Deviation|1|||
16333423|NCT02362425|39707062|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
16403446|NCT00075725|39956933|FG005|Overall Study|Pt trying to find a BM donor|0|||
16403447|NCT00075725|39956934|FG006|Overall Study|Pt trying to find a BM donor|0|||
16533235|NCT04393441|40417980|FG000|Overall Study|Reason not Specified|1|||
16533236|NCT04393441|40417981|FG001|Overall Study|Reason not Specified|1|||
16533237|NCT01300546|40417982|FG000|Overall Study|Withdrawal by Subject|1|||
16533238|NCT01300546|40417983|FG001|Overall Study|Withdrawal by Subject|0|||
16533239|NCT01300546|40417982|FG000|Overall Study|Lost to Follow-up|0|||
16533240|NCT01300546|40417983|FG001|Overall Study|Lost to Follow-up|2|||
16533241|NCT01300546|40417982|FG000|Overall Study|Lack of Efficacy|0|||
16533242|NCT01300546|40417983|FG001|Overall Study|Lack of Efficacy|3|||
16533243|NCT01300546|40417982|FG000|Overall Study|Adverse Event|0|||
16533244|NCT01300546|40417983|FG001|Overall Study|Adverse Event|1|||
16533245|NCT03137303|40417985|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
16533246|NCT03137303|40417986|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
16533247|NCT03137303|40417985|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
16533248|NCT03137303|40417986|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
16533249|NCT03137303|40417985|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
16533250|NCT03137303|40417986|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
16533251|NCT03137303|40417985|FG000|T3: 9-month Follow-up|Death|1|||
16533252|NCT03137303|40417986|FG001|T3: 9-month Follow-up|Death|0|||
16533253|NCT03137303|40417985|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
16533254|NCT03137303|40417986|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
16333424|NCT02362425|39707063|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
16333425|NCT02362425|39707064|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
16333426|NCT02362425|39707065|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
16333427|NCT02362425|39707062|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
16333428|NCT02362425|39707063|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
16333429|NCT02362425|39707064|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
16333430|NCT02362425|39707065|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
16333431|NCT02362425|39707062|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
16533255|NCT03137303|40417985|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
16533256|NCT03137303|40417986|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
16100744|NCT00002540|38856576|FG001|Overall Study|Died Before Randomization|6|||
16100745|NCT00002540|38856575|FG000|Overall Study|Died Before ASU (Control)|202|||
16100746|NCT00002540|38856576|FG001|Overall Study|Died Before ASU (Control)|0|||
16100747|NCT00002540|38856575|FG000|Overall Study|Refused ASU (Control)|597|||
16333432|NCT02362425|39707063|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
16333433|NCT02362425|39707064|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
16333434|NCT02362425|39707065|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
16333435|NCT02362425|39707062|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
16333436|NCT02362425|39707063|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
16333437|NCT02362425|39707064|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
16333438|NCT02362425|39707065|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
16333439|NCT02362425|39707062|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
16333440|NCT02362425|39707063|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
16333441|NCT02362425|39707064|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
16333442|NCT02362425|39707065|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
16333443|NCT02362425|39707062|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
16333444|NCT02362425|39707063|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
16403448|NCT00075725|39956935|FG007|Overall Study|Pt trying to find a BM donor|0|||
16403449|NCT00075725|39956936|FG008|Overall Study|Pt trying to find a BM donor|0|||
16403450|NCT00075725|39956937|FG009|Overall Study|Pt trying to find a BM donor|0|||
16333445|NCT02362425|39707064|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
16403451|NCT00075725|39956938|FG010|Overall Study|Pt trying to find a BM donor|0|||
16403452|NCT00075725|39956939|FG011|Overall Study|Pt trying to find a BM donor|0|||
16403453|NCT00075725|39956928|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
16403454|NCT00075725|39956929|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
16403455|NCT00075725|39956930|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
16403456|NCT00075725|39956931|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
16403457|NCT00075725|39956932|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
16403458|NCT00075725|39956933|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
16403459|NCT00075725|39956934|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
16403460|NCT00075725|39956935|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
16403461|NCT00075725|39956936|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
16403462|NCT00075725|39956937|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
16403463|NCT00075725|39956938|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
16403464|NCT00075725|39956939|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
16533257|NCT03137303|40417985|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
16533258|NCT03137303|40417986|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
16533259|NCT01343407|40417987|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
16100748|NCT00002540|38856576|FG001|Overall Study|Refused ASU (Control)|0|||
16533260|NCT01343407|40417988|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
16100749|NCT00002540|38856575|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
16100750|NCT00002540|38856576|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
16100751|NCT04057937|38856577|FG000|Placebo-controlled Phase|Adverse Event|3|||
16333446|NCT02362425|39707065|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
16533261|NCT01343407|40417989|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
16533262|NCT01343407|40417990|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
16533263|NCT01343407|40417991|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
16533264|NCT01343407|40417992|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
16533265|NCT01343407|40417987|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
16533266|NCT01343407|40417988|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
16533267|NCT01343407|40417989|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
16533268|NCT01343407|40417990|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
16533269|NCT01343407|40417991|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
16533270|NCT01343407|40417992|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
16533271|NCT04402866|40417993|FG000|Overall Study|Discontinued Prior to Treatment|0|||
16333447|NCT02362425|39707062|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
16333448|NCT02362425|39707063|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
16333449|NCT02362425|39707064|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
16333450|NCT02362425|39707065|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
16333451|NCT01741792|39707067|FG000|Overall Study|Death|6|||
16333452|NCT01741792|39707068|FG001|Overall Study|Death|1|||
16333453|NCT01741792|39707069|FG002|Overall Study|Death|12|||
16333454|NCT01273155|39707074|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
16333455|NCT01273155|39707075|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
16333456|NCT01273155|39707076|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
16333457|NCT01273155|39707077|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
16333458|NCT01273155|39707078|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
16333459|NCT01273155|39707079|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
16333460|NCT01273155|39707080|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
16333461|NCT01273155|39707074|FG000|Overall Study|Change in liver function/no longer eval.|0|||
16333462|NCT01273155|39707075|FG001|Overall Study|Change in liver function/no longer eval.|1|||
16333463|NCT01273155|39707076|FG002|Overall Study|Change in liver function/no longer eval.|0|||
16333464|NCT01273155|39707077|FG003|Overall Study|Change in liver function/no longer eval.|0|||
16333465|NCT01273155|39707078|FG004|Overall Study|Change in liver function/no longer eval.|1|||
16333466|NCT01273155|39707079|FG005|Overall Study|Change in liver function/no longer eval.|0|||
16333467|NCT01273155|39707080|FG006|Overall Study|Change in liver function/no longer eval.|0|||
16333468|NCT01273155|39707074|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
16333469|NCT01273155|39707075|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
16333470|NCT01273155|39707076|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
16333471|NCT01273155|39707077|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
16333472|NCT01273155|39707078|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
16403465|NCT00075725|39956928|FG000|Overall Study|Unsuccessful institutional transfer|0|||
16403466|NCT00075725|39956929|FG001|Overall Study|Unsuccessful institutional transfer|0|||
16533272|NCT04402866|40417994|FG001|Overall Study|Discontinued Prior to Treatment|0|||
16533273|NCT04402866|40417995|FG002|Overall Study|Discontinued Prior to Treatment|0|||
16100752|NCT04057937|38856578|FG001|Placebo-controlled Phase|Adverse Event|0|||
16100753|NCT04057937|38856577|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
16216180|NCT05333289|39272282|FG006|Overall Study|Other|2|||
16216181|NCT05333289|39272283|FG007|Overall Study|Other|0|||
16333473|NCT01273155|39707079|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
16333474|NCT01273155|39707080|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
16333475|NCT01273155|39707074|FG000|Overall Study|Died during Cycle 1|0|||
16333476|NCT01273155|39707075|FG001|Overall Study|Died during Cycle 1|0|||
16333477|NCT01273155|39707076|FG002|Overall Study|Died during Cycle 1|1|||
16333478|NCT01273155|39707077|FG003|Overall Study|Died during Cycle 1|1|||
16333479|NCT01273155|39707078|FG004|Overall Study|Died during Cycle 1|0|||
16333480|NCT01273155|39707079|FG005|Overall Study|Died during Cycle 1|2|||
16533274|NCT04402866|40417996|FG003|Overall Study|Discontinued Prior to Treatment|0|||
16533275|NCT04402866|40417997|FG004|Overall Study|Discontinued Prior to Treatment|2|||
16533276|NCT04402866|40417998|FG005|Overall Study|Discontinued Prior to Treatment|3|||
16533277|NCT04402866|40417993|FG000|Overall Study|Adverse Event|2|||
16533278|NCT04402866|40417994|FG001|Overall Study|Adverse Event|1|||
16533279|NCT04402866|40417995|FG002|Overall Study|Adverse Event|0|||
16533280|NCT04402866|40417996|FG003|Overall Study|Adverse Event|0|||
16533281|NCT04402866|40417997|FG004|Overall Study|Adverse Event|13|||
16533282|NCT04402866|40417998|FG005|Overall Study|Adverse Event|8|||
16533283|NCT04402866|40417993|FG000|Overall Study|Miscellaneous|0|||
16533284|NCT04402866|40417994|FG001|Overall Study|Miscellaneous|0|||
16533285|NCT04402866|40417995|FG002|Overall Study|Miscellaneous|1|||
16533286|NCT04402866|40417996|FG003|Overall Study|Miscellaneous|0|||
16533287|NCT04402866|40417997|FG004|Overall Study|Miscellaneous|0|||
16533288|NCT04402866|40417998|FG005|Overall Study|Miscellaneous|0|||
16533289|NCT04402866|40417993|FG000|Overall Study|Lost to Follow-up|0|||
16533290|NCT04402866|40417994|FG001|Overall Study|Lost to Follow-up|0|||
16533291|NCT04402866|40417995|FG002|Overall Study|Lost to Follow-up|0|||
16333481|NCT01273155|39707080|FG006|Overall Study|Died during Cycle 1|2|||
16403467|NCT00075725|39956930|FG002|Overall Study|Unsuccessful institutional transfer|2|||
16533292|NCT04402866|40417996|FG003|Overall Study|Lost to Follow-up|0|||
16533293|NCT04402866|40417997|FG004|Overall Study|Lost to Follow-up|0|||
16533294|NCT04402866|40417998|FG005|Overall Study|Lost to Follow-up|1|||
16533295|NCT04402866|40417993|FG000|Overall Study|Withdrawal by Subject|0|||
16533296|NCT04402866|40417994|FG001|Overall Study|Withdrawal by Subject|0|||
16533297|NCT04402866|40417995|FG002|Overall Study|Withdrawal by Subject|0|||
16533298|NCT04402866|40417996|FG003|Overall Study|Withdrawal by Subject|0|||
16533299|NCT04402866|40417997|FG004|Overall Study|Withdrawal by Subject|0|||
16533300|NCT04402866|40417998|FG005|Overall Study|Withdrawal by Subject|2|||
16533301|NCT02081846|40418000|FG000|Overall Study|Withdrawal by Subject|1|||
16533302|NCT02081846|40418001|FG001|Overall Study|Withdrawal by Subject|0|||
16533303|NCT02081846|40418000|FG000|Overall Study|invalid consent|1|||
16403468|NCT00075725|39956931|FG003|Overall Study|Unsuccessful institutional transfer|0|||
16403469|NCT00075725|39956932|FG004|Overall Study|Unsuccessful institutional transfer|0|||
16403470|NCT00075725|39956933|FG005|Overall Study|Unsuccessful institutional transfer|0|||
16403471|NCT00075725|39956934|FG006|Overall Study|Unsuccessful institutional transfer|0|||
16403472|NCT00075725|39956935|FG007|Overall Study|Unsuccessful institutional transfer|0|||
16403473|NCT00075725|39956936|FG008|Overall Study|Unsuccessful institutional transfer|0|||
16403474|NCT00075725|39956937|FG009|Overall Study|Unsuccessful institutional transfer|1|||
16333482|NCT01273155|39707074|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
16403475|NCT00075725|39956938|FG010|Overall Study|Unsuccessful institutional transfer|0|||
16533304|NCT02081846|40418001|FG001|Overall Study|invalid consent|0|||
16533305|NCT00791765|40418003|FG000|Weeks 1 to 12|Adverse Event|0|||
16533306|NCT00791765|40418004|FG001|Weeks 1 to 12|Adverse Event|1|||
16533307|NCT00791765|40418003|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
16533308|NCT00791765|40418004|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
16533309|NCT00791765|40418003|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
16533310|NCT00791765|40418004|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
16533311|NCT00791765|40418003|FG000|Weeks 1 to 12|Physician Decision|1|||
16533312|NCT00791765|40418004|FG001|Weeks 1 to 12|Physician Decision|0|||
16533313|NCT00791765|40418003|FG000|Weeks 1 to 12|Disease progression|3|||
16533314|NCT00791765|40418004|FG001|Weeks 1 to 12|Disease progression|0|||
16533315|NCT00791765|40418003|FG000|Weeks 1 to 12|Ineligibility determined|0|||
16533316|NCT00791765|40418004|FG001|Weeks 1 to 12|Ineligibility determined|3|||
16533317|NCT00791765|40418003|FG000|Weeks 13 to 24|Protocol deviation|2|||
16533318|NCT00791765|40418004|FG001|Weeks 13 to 24|Protocol deviation|0|||
16533319|NCT00791765|40418003|FG000|Weeks 13 to 24|Adverse Event|0|||
16533320|NCT00791765|40418004|FG001|Weeks 13 to 24|Adverse Event|3|||
16533321|NCT00791765|40418003|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
16533322|NCT00791765|40418004|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
16533323|NCT00791765|40418003|FG000|Weeks 13 to 24|Disease progression|0|||
16533324|NCT00791765|40418004|FG001|Weeks 13 to 24|Disease progression|1|||
16533325|NCT00791765|40418003|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
16533326|NCT00791765|40418004|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
16533327|NCT00791765|40418003|FG000|Weeks 13 to 24|Other|0|||
16533328|NCT00791765|40418004|FG001|Weeks 13 to 24|Other|1|||
16533329|NCT00784810|40418008|FG000|Overall Study|Adverse Event|32|||
16533330|NCT00784810|40418009|FG001|Overall Study|Adverse Event|20|||
16533331|NCT00784810|40418008|FG000|Overall Study|Lack of Efficacy|14|||
16533332|NCT00784810|40418009|FG001|Overall Study|Lack of Efficacy|11|||
16533333|NCT00784810|40418008|FG000|Overall Study|Withdrawal by Subject|11|||
16533334|NCT00784810|40418009|FG001|Overall Study|Withdrawal by Subject|9|||
16533335|NCT00784810|40418008|FG000|Overall Study|Administrative|5|||
16533336|NCT00784810|40418009|FG001|Overall Study|Administrative|8|||
16533337|NCT00784810|40418008|FG000|Overall Study|Lost to Follow-up|1|||
16533338|NCT00784810|40418009|FG001|Overall Study|Lost to Follow-up|1|||
16533339|NCT03695172|40418010|FG000|Overall Study|Withdrawal by Subject|1|||
16533340|NCT03695172|40418011|FG001|Overall Study|Withdrawal by Subject|1|||
16533341|NCT03695172|40418012|FG002|Overall Study|Withdrawal by Subject|0|||
16533342|NCT01353313|40418013|FG000|Overall Study|Lost to Follow-up|22|||
16533343|NCT01353313|40418014|FG001|Overall Study|Lost to Follow-up|23|||
16533344|NCT01353313|40418013|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
16533345|NCT01353313|40418014|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
16533346|NCT02130193|40418019|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
16533347|NCT02130193|40418020|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
16533348|NCT02130193|40418021|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
16533349|NCT02130193|40418019|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
16533350|NCT02130193|40418020|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
16533351|NCT02130193|40418021|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
16533352|NCT02130193|40418019|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
16533353|NCT02130193|40418020|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
16333483|NCT01273155|39707075|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
16333484|NCT01273155|39707076|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
16333485|NCT01273155|39707077|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
16333486|NCT01273155|39707078|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
16333487|NCT01273155|39707079|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
16333488|NCT01273155|39707080|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
16333489|NCT01211483|39707081|FG000|Phase 1b|Death|6|||
16333490|NCT01211483|39707082|FG001|Phase 1b|Death|0|||
16333491|NCT01211483|39707083|FG002|Phase 1b|Death|0|||
16333492|NCT01211483|39707084|FG003|Phase 1b|Death|0|||
16333493|NCT01211483|39707081|FG000|Phase 1b|Withdrawal by Subject|1|||
16333494|NCT01211483|39707082|FG001|Phase 1b|Withdrawal by Subject|0|||
16333495|NCT01211483|39707083|FG002|Phase 1b|Withdrawal by Subject|0|||
16533354|NCT02130193|40418021|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
16533355|NCT02130193|40418019|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
16533356|NCT02130193|40418020|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
16533357|NCT02130193|40418021|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
16533358|NCT01618838|40418022|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
16533359|NCT04058353|40418023|FG000|Overall Study|Adverse Event|2|||
16533360|NCT04058353|40418024|FG001|Overall Study|Adverse Event|1|||
16533361|NCT04058353|40418023|FG000|Overall Study|Physician Decision|1|||
16333496|NCT01211483|39707084|FG003|Phase 1b|Withdrawal by Subject|0|||
16533362|NCT04058353|40418024|FG001|Overall Study|Physician Decision|0|||
16533363|NCT04058353|40418023|FG000|Overall Study|Other|1|||
16533364|NCT04058353|40418024|FG001|Overall Study|Other|0|||
16533365|NCT04368429|40418025|FG000|Overall Study|Adverse Event|1|||
16533366|NCT04368429|40418026|FG001|Overall Study|Adverse Event|0|||
16533367|NCT00679939|40418027|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
16533368|NCT00679939|40418028|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
16533369|NCT00679939|40418027|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
16533370|NCT00679939|40418028|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
16533371|NCT00679939|40418027|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
16533372|NCT00679939|40418028|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
16533373|NCT00679939|40418027|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
16100754|NCT04057937|38856578|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
16100755|NCT04057937|38856577|FG000|Active-treatment Phase|Pregnancy|0|||
16100756|NCT04057937|38856578|FG001|Active-treatment Phase|Pregnancy|1|||
16216182|NCT05333289|39272276|FG000|Overall Study|Withdrawal by Subject|1|||
16216183|NCT05333289|39272277|FG001|Overall Study|Withdrawal by Subject|2|||
16216184|NCT05333289|39272278|FG002|Overall Study|Withdrawal by Subject|2|||
16216185|NCT05333289|39272279|FG003|Overall Study|Withdrawal by Subject|1|||
16216186|NCT05333289|39272280|FG004|Overall Study|Withdrawal by Subject|1|||
16216187|NCT05333289|39272281|FG005|Overall Study|Withdrawal by Subject|2|||
16216188|NCT05333289|39272282|FG006|Overall Study|Withdrawal by Subject|1|||
16216189|NCT05333289|39272283|FG007|Overall Study|Withdrawal by Subject|3|||
16216190|NCT05333289|39272276|FG000|Overall Study|Protocol Violation|1|||
16216191|NCT05333289|39272277|FG001|Overall Study|Protocol Violation|0|||
16216192|NCT05333289|39272278|FG002|Overall Study|Protocol Violation|0|||
16216193|NCT05333289|39272279|FG003|Overall Study|Protocol Violation|0|||
16216194|NCT05333289|39272280|FG004|Overall Study|Protocol Violation|0|||
16216195|NCT05333289|39272281|FG005|Overall Study|Protocol Violation|0|||
16216196|NCT05333289|39272282|FG006|Overall Study|Protocol Violation|0|||
16216197|NCT05333289|39272283|FG007|Overall Study|Protocol Violation|0|||
16100757|NCT04057937|38856577|FG000|Active-treatment Phase|Physician Decision|0|||
16100758|NCT04057937|38856578|FG001|Active-treatment Phase|Physician Decision|1|||
16100759|NCT01129011|38856579|FG000|Overall Study|Adverse Event|20|||
16100760|NCT01129011|38856580|FG001|Overall Study|Adverse Event|30|||
16216198|NCT05333289|39272276|FG000|Overall Study|Physician Decision|0|||
16216199|NCT05333289|39272277|FG001|Overall Study|Physician Decision|0|||
16216200|NCT05333289|39272278|FG002|Overall Study|Physician Decision|1|||
16216201|NCT05333289|39272279|FG003|Overall Study|Physician Decision|0|||
16216202|NCT05333289|39272280|FG004|Overall Study|Physician Decision|0|||
16216203|NCT05333289|39272281|FG005|Overall Study|Physician Decision|2|||
16216204|NCT05333289|39272282|FG006|Overall Study|Physician Decision|0|||
16216205|NCT05333289|39272283|FG007|Overall Study|Physician Decision|0|||
16216206|NCT05333289|39272276|FG000|Overall Study|Lost to Follow-up|6|||
16216207|NCT05333289|39272277|FG001|Overall Study|Lost to Follow-up|0|||
16216208|NCT05333289|39272278|FG002|Overall Study|Lost to Follow-up|1|||
16216209|NCT05333289|39272279|FG003|Overall Study|Lost to Follow-up|6|||
16216210|NCT05333289|39272280|FG004|Overall Study|Lost to Follow-up|3|||
16216211|NCT05333289|39272281|FG005|Overall Study|Lost to Follow-up|3|||
16333497|NCT01211483|39707081|FG000|Phase 2|Lost to Follow-up|0|||
16333498|NCT01211483|39707082|FG001|Phase 2|Lost to Follow-up|1|||
16333499|NCT01211483|39707083|FG002|Phase 2|Lost to Follow-up|1|||
16100761|NCT01129011|38856579|FG000|Overall Study|Withdrawal by Subject|24|||
16100762|NCT01129011|38856580|FG001|Overall Study|Withdrawal by Subject|8|||
16100763|NCT01129011|38856579|FG000|Overall Study|Lost to Follow-up|6|||
16100764|NCT01129011|38856580|FG001|Overall Study|Lost to Follow-up|7|||
16100765|NCT01129011|38856579|FG000|Overall Study|Duodenal Ulcer|2|||
16100766|NCT01129011|38856580|FG001|Overall Study|Duodenal Ulcer|8|||
16100767|NCT01129011|38856579|FG000|Overall Study|misc|7|||
16100768|NCT01129011|38856580|FG001|Overall Study|misc|4|||
16100769|NCT00759681|38856582|FG000|Overall Study|Death|2|||
16333500|NCT01211483|39707084|FG003|Phase 2|Lost to Follow-up|2|||
16333501|NCT01211483|39707081|FG000|Phase 2|Death|0|||
16333502|NCT01211483|39707082|FG001|Phase 2|Death|64|||
16333503|NCT01211483|39707083|FG002|Phase 2|Death|53|||
16333504|NCT01211483|39707084|FG003|Phase 2|Death|53|||
16333505|NCT01211483|39707081|FG000|Phase 2|Withdrawal by Subject|0|||
16333506|NCT01211483|39707082|FG001|Phase 2|Withdrawal by Subject|1|||
16333507|NCT01211483|39707083|FG002|Phase 2|Withdrawal by Subject|10|||
16333508|NCT01211483|39707084|FG003|Phase 2|Withdrawal by Subject|5|||
16333509|NCT01211483|39707081|FG000|Phase 2|Study terminated by Sponsor|0|||
16333510|NCT01211483|39707082|FG001|Phase 2|Study terminated by Sponsor|6|||
16533374|NCT00679939|40418028|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
16533375|NCT00679939|40418027|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
16533376|NCT00679939|40418028|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
16533377|NCT00679939|40418027|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
16533378|NCT00679939|40418028|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
16533379|NCT00679939|40418027|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
16533380|NCT00679939|40418028|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
16533381|NCT00679939|40418027|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
16100770|NCT00759681|38856583|FG001|Overall Study|Death|5|||
16100771|NCT00759681|38856582|FG000|Overall Study|Lost to Follow-up|8|||
16100772|NCT00759681|38856583|FG001|Overall Study|Lost to Follow-up|5|||
16100773|NCT00990821|38856586|FG000|Overall Study|Withdrawal by Subject|0|||
16216212|NCT05333289|39272282|FG006|Overall Study|Lost to Follow-up|2|||
16216213|NCT05333289|39272283|FG007|Overall Study|Lost to Follow-up|1|||
16216214|NCT05333289|39272276|FG000|Overall Study|Death|1|||
16333511|NCT01211483|39707083|FG002|Phase 2|Study terminated by Sponsor|8|||
16333512|NCT01211483|39707084|FG003|Phase 2|Study terminated by Sponsor|11|||
16533382|NCT00679939|40418028|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
16533383|NCT00679939|40418027|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
16533384|NCT00679939|40418028|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
16533385|NCT00679939|40418027|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
16533386|NCT00679939|40418028|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
16533387|NCT04026165|40418033|FG000|Run-in Placebo Period|Enrollment Error|13|||
16533388|NCT04026165|40418034|FG001|Run-in Placebo Period|Enrollment Error|0|||
16100774|NCT00990821|38856587|FG001|Overall Study|Withdrawal by Subject|2|||
16100775|NCT00990821|38856588|FG002|Overall Study|Withdrawal by Subject|0|||
16100776|NCT00990821|38856589|FG003|Overall Study|Withdrawal by Subject|0|||
16100777|NCT00990821|38856590|FG004|Overall Study|Withdrawal by Subject|3|||
16100778|NCT00990821|38856591|FG005|Overall Study|Withdrawal by Subject|3|||
16100779|NCT00990821|38856592|FG006|Overall Study|Withdrawal by Subject|1|||
16100780|NCT00990821|38856593|FG007|Overall Study|Withdrawal by Subject|0|||
16100781|NCT00990821|38856594|FG008|Overall Study|Withdrawal by Subject|0|||
16100782|NCT00990821|38856595|FG009|Overall Study|Withdrawal by Subject|1|||
16100783|NCT00990821|38856596|FG010|Overall Study|Withdrawal by Subject|3|||
16100784|NCT00990821|38856597|FG011|Overall Study|Withdrawal by Subject|5|||
16100785|NCT00990821|38856598|FG012|Overall Study|Withdrawal by Subject|2|||
16100786|NCT00990821|38856599|FG013|Overall Study|Withdrawal by Subject|1|||
16100787|NCT01107353|38856605|FG000|Overall Study|Positive Drug Screen|1|||
16100788|NCT01107353|38856606|FG001|Overall Study|Positive Drug Screen|0|||
16100789|NCT01780545|38856607|FG000|Overall Study|Withdrawal by Subject|3|||
16100790|NCT01780545|38856608|FG001|Overall Study|Withdrawal by Subject|1|||
16100791|NCT01780545|38856607|FG000|Overall Study|Lost to Follow-up|1|||
16100792|NCT01780545|38856608|FG001|Overall Study|Lost to Follow-up|1|||
16100793|NCT00126555|38856609|FG000|Overall Study|Withdrawal by Subject|1|||
16100794|NCT00126555|38856609|FG000|Overall Study|Adverse Event|2|||
16100795|NCT00126555|38856609|FG000|Overall Study|Progressive Disease|3|||
16100796|NCT01268488|38856624|FG000|Overall Study|Adverse Event|3|||
16216215|NCT05333289|39272277|FG001|Overall Study|Death|0|||
16216216|NCT05333289|39272278|FG002|Overall Study|Death|0|||
16216217|NCT05333289|39272279|FG003|Overall Study|Death|0|||
16216218|NCT05333289|39272280|FG004|Overall Study|Death|0|||
16216219|NCT05333289|39272281|FG005|Overall Study|Death|0|||
16216220|NCT05333289|39272282|FG006|Overall Study|Death|0|||
16216221|NCT05333289|39272283|FG007|Overall Study|Death|0|||
16216222|NCT01225211|39272284|FG000|Overall Study|Adverse Event|0|||
16216223|NCT01225211|39272285|FG001|Overall Study|Adverse Event|0|||
16216224|NCT01225211|39272286|FG002|Overall Study|Adverse Event|1|||
16216225|NCT01225211|39272287|FG003|Overall Study|Adverse Event|0|||
16216226|NCT01225211|39272288|FG004|Overall Study|Adverse Event|0|||
16216227|NCT01225211|39272289|FG005|Overall Study|Adverse Event|0|||
16216228|NCT01225211|39272290|FG006|Overall Study|Adverse Event|0|||
16533389|NCT04026165|40418035|FG002|Run-in Placebo Period|Enrollment Error|0|||
16533390|NCT04026165|40418036|FG003|Run-in Placebo Period|Enrollment Error|0|||
16533391|NCT04026165|40418033|FG000|Run-in Placebo Period|Run-in Failure|4|||
16533392|NCT04026165|40418034|FG001|Run-in Placebo Period|Run-in Failure|0|||
16533393|NCT04026165|40418035|FG002|Run-in Placebo Period|Run-in Failure|0|||
16533394|NCT04026165|40418036|FG003|Run-in Placebo Period|Run-in Failure|0|||
16533395|NCT04026165|40418033|FG000|Run-in Placebo Period|Protocol Violation|2|||
16533396|NCT04026165|40418034|FG001|Run-in Placebo Period|Protocol Violation|0|||
16533397|NCT04026165|40418035|FG002|Run-in Placebo Period|Protocol Violation|0|||
16533398|NCT04026165|40418036|FG003|Run-in Placebo Period|Protocol Violation|0|||
16333513|NCT02774005|39707085|FG000|Overall Study|Adverse Event|8|||
16333514|NCT02774005|39707085|FG000|Overall Study|Withdrawal by Subject|23|||
16533399|NCT04026165|40418033|FG000|Run-in Placebo Period|Withdrew Consent|2|||
16533400|NCT04026165|40418034|FG001|Run-in Placebo Period|Withdrew Consent|0|||
16533401|NCT04026165|40418035|FG002|Run-in Placebo Period|Withdrew Consent|0|||
16100797|NCT01268488|38856624|FG000|Overall Study|Physician Decision|2|||
16100798|NCT02166047|38856626|FG000|Overall Study|Withdrawal by Participant|0|||
16100799|NCT02166047|38856627|FG001|Overall Study|Withdrawal by Participant|1|||
16216229|NCT01225211|39272291|FG007|Overall Study|Adverse Event|0|||
16216230|NCT01225211|39272292|FG008|Overall Study|Adverse Event|0|||
16216231|NCT01225211|39272293|FG009|Overall Study|Adverse Event|1|||
16216232|NCT01225211|39272284|FG000|Overall Study|Withdrawal by Subject|0|||
16216233|NCT01225211|39272285|FG001|Overall Study|Withdrawal by Subject|0|||
16216234|NCT01225211|39272286|FG002|Overall Study|Withdrawal by Subject|0|||
16216235|NCT01225211|39272287|FG003|Overall Study|Withdrawal by Subject|0|||
16216236|NCT01225211|39272288|FG004|Overall Study|Withdrawal by Subject|0|||
16216237|NCT01225211|39272289|FG005|Overall Study|Withdrawal by Subject|0|||
16216238|NCT01225211|39272290|FG006|Overall Study|Withdrawal by Subject|1|||
16533402|NCT04026165|40418036|FG003|Run-in Placebo Period|Withdrew Consent|0|||
16533403|NCT04026165|40418033|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
16533404|NCT04026165|40418034|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
16533405|NCT04026165|40418035|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
16533406|NCT04026165|40418036|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
16533407|NCT04026165|40418033|FG000|Run-in SEL Period|Run-in Failure|0|||
16533408|NCT04026165|40418034|FG001|Run-in SEL Period|Run-in Failure|26|||
16533409|NCT04026165|40418035|FG002|Run-in SEL Period|Run-in Failure|0|||
16533410|NCT04026165|40418036|FG003|Run-in SEL Period|Run-in Failure|0|||
16533411|NCT04026165|40418033|FG000|Run-in SEL Period|Withdrew Consent|0|||
16533412|NCT04026165|40418034|FG001|Run-in SEL Period|Withdrew Consent|10|||
16533413|NCT04026165|40418035|FG002|Run-in SEL Period|Withdrew Consent|0|||
16533414|NCT04026165|40418036|FG003|Run-in SEL Period|Withdrew Consent|0|||
16533415|NCT04026165|40418033|FG000|Run-in SEL Period|Enrollment Error|0|||
16533416|NCT04026165|40418034|FG001|Run-in SEL Period|Enrollment Error|4|||
16533417|NCT04026165|40418035|FG002|Run-in SEL Period|Enrollment Error|0|||
16533418|NCT04026165|40418036|FG003|Run-in SEL Period|Enrollment Error|0|||
16216239|NCT01225211|39272291|FG007|Overall Study|Withdrawal by Subject|0|||
16216240|NCT01225211|39272292|FG008|Overall Study|Withdrawal by Subject|1|||
16216241|NCT01225211|39272293|FG009|Overall Study|Withdrawal by Subject|3|||
16216242|NCT01225211|39272284|FG000|Overall Study|Other|0|||
16216243|NCT01225211|39272285|FG001|Overall Study|Other|0|||
16216244|NCT01225211|39272286|FG002|Overall Study|Other|0|||
16216245|NCT01225211|39272287|FG003|Overall Study|Other|0|||
16333515|NCT02774005|39707085|FG000|Overall Study|Lost to Follow-up|7|||
16533419|NCT04026165|40418033|FG000|Run-in SEL Period|Protocol Violation|0|||
16533420|NCT04026165|40418034|FG001|Run-in SEL Period|Protocol Violation|3|||
16100800|NCT02166047|38856628|FG002|Overall Study|Withdrawal by Participant|2|||
16100801|NCT02166047|38856629|FG003|Overall Study|Withdrawal by Participant|0|||
16100802|NCT02166047|38856630|FG004|Overall Study|Withdrawal by Participant|0|||
16100803|NCT02166047|38856631|FG005|Overall Study|Withdrawal by Participant|0|||
16100804|NCT02166047|38856632|FG006|Overall Study|Withdrawal by Participant|1|||
16100805|NCT02166047|38856633|FG007|Overall Study|Withdrawal by Participant|0|||
16100806|NCT02166047|38856634|FG008|Overall Study|Withdrawal by Participant|0|||
16100807|NCT02166047|38856635|FG009|Overall Study|Withdrawal by Participant|0|||
16100808|NCT02166047|38856636|FG010|Overall Study|Withdrawal by Participant|0|||
16100809|NCT02166047|38856637|FG011|Overall Study|Withdrawal by Participant|0|||
16100810|NCT02166047|38856626|FG000|Overall Study|Adverse Event|0|||
16100811|NCT02166047|38856627|FG001|Overall Study|Adverse Event|0|||
16100812|NCT02166047|38856628|FG002|Overall Study|Adverse Event|0|||
16100813|NCT02166047|38856629|FG003|Overall Study|Adverse Event|0|||
16100814|NCT02166047|38856630|FG004|Overall Study|Adverse Event|1|||
16100815|NCT02166047|38856631|FG005|Overall Study|Adverse Event|0|||
16100816|NCT02166047|38856632|FG006|Overall Study|Adverse Event|1|||
16100817|NCT02166047|38856633|FG007|Overall Study|Adverse Event|0|||
16100818|NCT02166047|38856634|FG008|Overall Study|Adverse Event|0|||
16100819|NCT02166047|38856635|FG009|Overall Study|Adverse Event|0|||
16100820|NCT02166047|38856636|FG010|Overall Study|Adverse Event|2|||
16100821|NCT02166047|38856637|FG011|Overall Study|Adverse Event|0|||
16100822|NCT00145496|38856638|FG000|Overall Study|Adverse Event|42|||
16100823|NCT00145496|38856639|FG001|Overall Study|Adverse Event|30|||
16100824|NCT00145496|38856638|FG000|Overall Study|Lack of Efficacy|12|||
16100825|NCT00145496|38856639|FG001|Overall Study|Lack of Efficacy|7|||
16100826|NCT00145496|38856638|FG000|Overall Study|Withdrawal by Subject|32|||
16100827|NCT00145496|38856639|FG001|Overall Study|Withdrawal by Subject|26|||
16100828|NCT00145496|38856638|FG000|Overall Study|Lost to Follow-up|12|||
16216246|NCT01225211|39272288|FG004|Overall Study|Other|0|||
16216247|NCT01225211|39272289|FG005|Overall Study|Other|0|||
16333516|NCT02774005|39707085|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
16333517|NCT02774005|39707085|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
16333518|NCT02774005|39707085|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
16333519|NCT02774005|39707085|FG000|Overall Study|Death|1|||
16333520|NCT02774005|39707085|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
16333521|NCT02774005|39707085|FG000|Overall Study|Lack of compliance with study medication|4|||
16333522|NCT02774005|39707085|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
16216248|NCT01225211|39272290|FG006|Overall Study|Other|0|||
16216249|NCT01225211|39272291|FG007|Overall Study|Other|0|||
16403476|NCT00075725|39956939|FG011|Overall Study|Unsuccessful institutional transfer|0|||
16403477|NCT00075725|39956928|FG000|Overall Study|specimen(s) not submitted|0|||
16216250|NCT01225211|39272292|FG008|Overall Study|Other|0|||
16216251|NCT01225211|39272293|FG009|Overall Study|Other|1|||
16216252|NCT01081951|39272294|FG000|Overall Study|Death|54|||
16216253|NCT01081951|39272295|FG001|Overall Study|Death|47|||
16216254|NCT01081951|39272294|FG000|Overall Study|Withdrawal by Subject|2|||
16216255|NCT01081951|39272295|FG001|Overall Study|Withdrawal by Subject|6|||
16216256|NCT01081951|39272294|FG000|Overall Study|Allocated treatment but did not take it|0|||
16216257|NCT01081951|39272295|FG001|Overall Study|Allocated treatment but did not take it|1|||
16216258|NCT01081951|39272294|FG000|Overall Study|Lost to Follow-up|0|||
16216259|NCT01081951|39272295|FG001|Overall Study|Lost to Follow-up|1|||
16216260|NCT01469637|39272296|FG000|First Intervention|Unacceptable behavior|0|||
16216261|NCT01469637|39272297|FG001|First Intervention|Unacceptable behavior|1|||
16216262|NCT01469637|39272296|FG000|Second Intervention|Incarcerated|1|||
16216263|NCT01469637|39272297|FG001|Second Intervention|Incarcerated|0|||
16403478|NCT00075725|39956929|FG001|Overall Study|specimen(s) not submitted|0|||
16100829|NCT00145496|38856639|FG001|Overall Study|Lost to Follow-up|5|||
16100830|NCT00145496|38856638|FG000|Overall Study|Other|25|||
16403479|NCT00075725|39956930|FG002|Overall Study|specimen(s) not submitted|2|||
16533421|NCT04026165|40418035|FG002|Run-in SEL Period|Protocol Violation|0|||
16403480|NCT00075725|39956931|FG003|Overall Study|specimen(s) not submitted|0|||
16403481|NCT00075725|39956932|FG004|Overall Study|specimen(s) not submitted|0|||
16403482|NCT00075725|39956933|FG005|Overall Study|specimen(s) not submitted|0|||
16403483|NCT00075725|39956934|FG006|Overall Study|specimen(s) not submitted|0|||
16403484|NCT00075725|39956935|FG007|Overall Study|specimen(s) not submitted|0|||
16403485|NCT00075725|39956936|FG008|Overall Study|specimen(s) not submitted|0|||
16403486|NCT00075725|39956937|FG009|Overall Study|specimen(s) not submitted|0|||
16403487|NCT00075725|39956938|FG010|Overall Study|specimen(s) not submitted|0|||
16403488|NCT00075725|39956939|FG011|Overall Study|specimen(s) not submitted|0|||
16403489|NCT00075725|39956928|FG000|Overall Study|Pt went to transplant|0|||
16403490|NCT00075725|39956929|FG001|Overall Study|Pt went to transplant|0|||
16403491|NCT00075725|39956930|FG002|Overall Study|Pt went to transplant|0|||
16403492|NCT00075725|39956931|FG003|Overall Study|Pt went to transplant|1|||
16403493|NCT00075725|39956932|FG004|Overall Study|Pt went to transplant|0|||
16403494|NCT00075725|39956933|FG005|Overall Study|Pt went to transplant|1|||
16533422|NCT04026165|40418036|FG003|Run-in SEL Period|Protocol Violation|0|||
16533423|NCT04026165|40418033|FG000|Run-in SEL Period|Investigator's Discretion|0|||
16403495|NCT00075725|39956934|FG006|Overall Study|Pt went to transplant|0|||
16403496|NCT00075725|39956935|FG007|Overall Study|Pt went to transplant|0|||
16403497|NCT00075725|39956936|FG008|Overall Study|Pt went to transplant|0|||
16403498|NCT00075725|39956937|FG009|Overall Study|Pt went to transplant|0|||
16403499|NCT00075725|39956938|FG010|Overall Study|Pt went to transplant|0|||
16403500|NCT00075725|39956939|FG011|Overall Study|Pt went to transplant|0|||
16403501|NCT00075725|39956928|FG000|Overall Study|Pt received additional steroids|0|||
16403502|NCT00075725|39956929|FG001|Overall Study|Pt received additional steroids|0|||
16403503|NCT00075725|39956930|FG002|Overall Study|Pt received additional steroids|0|||
16403504|NCT00075725|39956931|FG003|Overall Study|Pt received additional steroids|1|||
16533424|NCT04026165|40418034|FG001|Run-in SEL Period|Investigator's Discretion|2|||
16533425|NCT04026165|40418035|FG002|Run-in SEL Period|Investigator's Discretion|0|||
16533426|NCT04026165|40418036|FG003|Run-in SEL Period|Investigator's Discretion|0|||
16533427|NCT04026165|40418033|FG000|Run-in SEL Period|Death|0|||
16533428|NCT04026165|40418034|FG001|Run-in SEL Period|Death|1|||
16533429|NCT04026165|40418035|FG002|Run-in SEL Period|Death|0|||
16533430|NCT04026165|40418036|FG003|Run-in SEL Period|Death|0|||
16533431|NCT04026165|40418033|FG000|Randomized Period|Withdrew Consent|0|||
16533432|NCT04026165|40418034|FG001|Randomized Period|Withdrew Consent|0|||
16533433|NCT04026165|40418035|FG002|Randomized Period|Withdrew Consent|5|||
16533434|NCT04026165|40418036|FG003|Randomized Period|Withdrew Consent|8|||
16533435|NCT04026165|40418033|FG000|Randomized Period|Death|0|||
16533436|NCT04026165|40418034|FG001|Randomized Period|Death|0|||
16533437|NCT04026165|40418035|FG002|Randomized Period|Death|5|||
16533438|NCT04026165|40418036|FG003|Randomized Period|Death|7|||
16533439|NCT04026165|40418033|FG000|Randomized Period|Investigator's Discretion|0|||
16533440|NCT04026165|40418034|FG001|Randomized Period|Investigator's Discretion|0|||
16533441|NCT04026165|40418035|FG002|Randomized Period|Investigator's Discretion|2|||
16533442|NCT04026165|40418036|FG003|Randomized Period|Investigator's Discretion|2|||
16533443|NCT04026165|40418033|FG000|Randomized Period|Lost to Follow-up|0|||
16100831|NCT00145496|38856639|FG001|Overall Study|Other|13|||
16100832|NCT00500539|38856640|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
16403505|NCT00075725|39956932|FG004|Overall Study|Pt received additional steroids|0|||
16403506|NCT00075725|39956933|FG005|Overall Study|Pt received additional steroids|0|||
16533444|NCT04026165|40418034|FG001|Randomized Period|Lost to Follow-up|0|||
16100833|NCT00500539|38856640|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
16216264|NCT00806494|39272298|FG000|Overall Study|Adverse Event|29|||
16216265|NCT00806494|39272298|FG000|Overall Study|Lack of Efficacy|6|||
16533445|NCT04026165|40418035|FG002|Randomized Period|Lost to Follow-up|2|||
16533446|NCT04026165|40418036|FG003|Randomized Period|Lost to Follow-up|2|||
16533447|NCT02618967|40418041|FG000|Overall Study|Lost to Follow-up|0|||
16533448|NCT02618967|40418042|FG001|Overall Study|Lost to Follow-up|0|||
16533449|NCT02618967|40418043|FG002|Overall Study|Lost to Follow-up|1|||
16533450|NCT02618967|40418044|FG003|Overall Study|Lost to Follow-up|0|||
16533451|NCT02618967|40418045|FG004|Overall Study|Lost to Follow-up|2|||
16533452|NCT02618967|40418046|FG005|Overall Study|Lost to Follow-up|0|||
16533453|NCT02618967|40418047|FG006|Overall Study|Lost to Follow-up|0|||
16533454|NCT02618967|40418048|FG007|Overall Study|Lost to Follow-up|0|||
16533455|NCT02618967|40418041|FG000|Overall Study|Withdrawal by Subject|1|||
16533456|NCT02618967|40418042|FG001|Overall Study|Withdrawal by Subject|0|||
16533457|NCT02618967|40418043|FG002|Overall Study|Withdrawal by Subject|0|||
16533458|NCT02618967|40418044|FG003|Overall Study|Withdrawal by Subject|0|||
16533459|NCT02618967|40418045|FG004|Overall Study|Withdrawal by Subject|0|||
16533460|NCT02618967|40418046|FG005|Overall Study|Withdrawal by Subject|0|||
16533461|NCT02618967|40418047|FG006|Overall Study|Withdrawal by Subject|0|||
16533462|NCT02618967|40418048|FG007|Overall Study|Withdrawal by Subject|0|||
16533463|NCT00535730|40418049|FG000|Overall Study|Adverse Event|1|||
16533464|NCT00535730|40418050|FG001|Overall Study|Adverse Event|1|||
16533465|NCT00535730|40418049|FG000|Overall Study|Lost to Follow-up|0|||
16533466|NCT00535730|40418050|FG001|Overall Study|Lost to Follow-up|1|||
16533467|NCT00535730|40418049|FG000|Overall Study|Physician Decision|0|||
16533468|NCT00535730|40418050|FG001|Overall Study|Physician Decision|1|||
16533469|NCT00535730|40418049|FG000|Overall Study|Protocol Violation|1|||
16533470|NCT00535730|40418050|FG001|Overall Study|Protocol Violation|0|||
16533471|NCT00535730|40418049|FG000|Overall Study|Withdrawal by Subject|0|||
16533472|NCT00535730|40418050|FG001|Overall Study|Withdrawal by Subject|4|||
16533473|NCT03320070|40418051|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
16533474|NCT03320070|40418052|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
16533475|NCT03320070|40418051|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
16216266|NCT00806494|39272298|FG000|Overall Study|Lost to Follow-up|10|||
16333523|NCT02774005|39707085|FG000|Overall Study|another study|1|||
16333524|NCT02774005|39707085|FG000|Overall Study|cardiologist imposed travel restriction|1|||
16333525|NCT00526331|39707087|FG000|Overall Study|Sponsor Termination|55|||
16333526|NCT04007107|39707088|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
16333527|NCT04007107|39707089|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
16333528|NCT04007107|39707090|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
16333529|NCT04007107|39707091|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
16333530|NCT03054064|39707092|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
16333531|NCT03054064|39707092|FG000|Overall Study|Investigator Decision|2|||
16333532|NCT03054064|39707092|FG000|Overall Study|Bladder Issue|1|||
16333533|NCT03054064|39707092|FG000|Overall Study|High Blood Pressure|1|||
16333534|NCT03054064|39707092|FG000|Overall Study|Change in Status|1|||
16333535|NCT02223819|39707097|FG000|Overall Study|Lost to Follow-up|2|||
16333536|NCT03419598|39707098|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
16333537|NCT00525902|39707105|FG000|Overall Study|Lack of Efficacy|1|||
16333538|NCT03099694|39707106|FG000|Overall Study|Withdrawal by Subject|11|||
16333539|NCT03099694|39707107|FG001|Overall Study|Withdrawal by Subject|13|||
16333540|NCT03099694|39707106|FG000|Overall Study|Lost to Follow-up|9|||
16333541|NCT03099694|39707107|FG001|Overall Study|Lost to Follow-up|5|||
16333542|NCT00986986|39707110|FG000|Overall Study|Lost to Follow-up|0|||
16333543|NCT00986986|39707111|FG001|Overall Study|Lost to Follow-up|1|||
16333544|NCT01346540|39707112|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
16333545|NCT01346540|39707113|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
16333546|NCT01346540|39707112|FG000|Overall Study|Adverse Event|0|||
16333547|NCT01346540|39707113|FG001|Overall Study|Adverse Event|4|||
16333548|NCT02636439|39707118|FG000|Overall Study|Adverse Event|2|||
16333549|NCT02636439|39707119|FG001|Overall Study|Adverse Event|2|||
16333550|NCT02636439|39707118|FG000|Overall Study|Lost to Follow-up|1|||
16333551|NCT02636439|39707119|FG001|Overall Study|Lost to Follow-up|0|||
16333552|NCT02636439|39707118|FG000|Overall Study|Non-compliance|1|||
16333553|NCT02636439|39707119|FG001|Overall Study|Non-compliance|1|||
16333554|NCT02636439|39707118|FG000|Overall Study|Personal reasons|2|||
16333555|NCT02636439|39707119|FG001|Overall Study|Personal reasons|0|||
16333556|NCT03434249|39707120|FG000|Overall Study|Adverse Event|1|||
16333557|NCT03434249|39707121|FG001|Overall Study|Adverse Event|0|||
16333558|NCT03434249|39707120|FG000|Overall Study|Lost to Follow-up|0|||
16333559|NCT03434249|39707121|FG001|Overall Study|Lost to Follow-up|1|||
16333560|NCT03434249|39707120|FG000|Overall Study|Non-compliance of family|2|||
16333561|NCT03434249|39707121|FG001|Overall Study|Non-compliance of family|1|||
16333562|NCT03434249|39707120|FG000|Overall Study|Difficulties in completing daily diary|2|||
16333563|NCT03434249|39707121|FG001|Overall Study|Difficulties in completing daily diary|1|||
16333564|NCT00085098|39707123|FG000|Overall Study|Withdrawal by Subject|0|||
16333565|NCT00085098|39707124|FG001|Overall Study|Withdrawal by Subject|1|||
16533476|NCT03320070|40418052|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
16333566|NCT00085098|39707123|FG000|Overall Study|Ineligible|1|||
16333567|NCT00085098|39707124|FG001|Overall Study|Ineligible|1|||
16533477|NCT03320070|40418051|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
16533478|NCT03320070|40418052|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
16533479|NCT03320070|40418051|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
16533480|NCT03320070|40418052|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
16533481|NCT03320070|40418051|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
16533482|NCT03320070|40418052|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
16533483|NCT03320070|40418051|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
16216267|NCT00806494|39272298|FG000|Overall Study|Other|30|||
16333568|NCT02588092|39707125|FG000|Overall Study|Death|4|||
16333569|NCT02588092|39707126|FG001|Overall Study|Death|3|||
16333570|NCT02588092|39707127|FG002|Overall Study|Death|3|||
16333571|NCT02588092|39707128|FG003|Overall Study|Death|3|||
16333572|NCT02588092|39707129|FG004|Overall Study|Death|2|||
16333573|NCT02588092|39707130|FG005|Overall Study|Death|2|||
16333574|NCT02588092|39707131|FG006|Overall Study|Death|2|||
16333575|NCT02588092|39707132|FG007|Overall Study|Death|1|||
16333576|NCT02588092|39707133|FG008|Overall Study|Death|5|||
16333577|NCT02588092|39707134|FG009|Overall Study|Death|2|||
16333578|NCT02588092|39707125|FG000|Overall Study|Withdrawal by Subject|0|||
16333579|NCT02588092|39707126|FG001|Overall Study|Withdrawal by Subject|0|||
16333580|NCT02588092|39707127|FG002|Overall Study|Withdrawal by Subject|0|||
16333581|NCT02588092|39707128|FG003|Overall Study|Withdrawal by Subject|0|||
16333582|NCT02588092|39707129|FG004|Overall Study|Withdrawal by Subject|0|||
16333583|NCT02588092|39707130|FG005|Overall Study|Withdrawal by Subject|1|||
16333584|NCT02588092|39707131|FG006|Overall Study|Withdrawal by Subject|1|||
16333585|NCT02588092|39707132|FG007|Overall Study|Withdrawal by Subject|2|||
16333586|NCT02588092|39707133|FG008|Overall Study|Withdrawal by Subject|0|||
16333587|NCT02588092|39707134|FG009|Overall Study|Withdrawal by Subject|0|||
16333588|NCT02588092|39707125|FG000|Overall Study|Started Another Treatment|0|||
16333589|NCT02588092|39707126|FG001|Overall Study|Started Another Treatment|0|||
16333590|NCT02588092|39707127|FG002|Overall Study|Started Another Treatment|0|||
16533484|NCT03320070|40418052|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
16333591|NCT02588092|39707128|FG003|Overall Study|Started Another Treatment|0|||
16333592|NCT02588092|39707129|FG004|Overall Study|Started Another Treatment|1|||
16333593|NCT02588092|39707130|FG005|Overall Study|Started Another Treatment|0|||
16333594|NCT02588092|39707131|FG006|Overall Study|Started Another Treatment|0|||
16216268|NCT00806494|39272298|FG000|Overall Study|Withdrawal by Subject|5|||
16216269|NCT04009824|39272301|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
16216270|NCT04009824|39272302|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
16216271|NCT04009824|39272303|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
16216272|NCT04009824|39272304|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
16216273|NCT04009824|39272305|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
16403507|NCT00075725|39956934|FG006|Overall Study|Pt received additional steroids|0|||
16403508|NCT00075725|39956935|FG007|Overall Study|Pt received additional steroids|0|||
16403509|NCT00075725|39956936|FG008|Overall Study|Pt received additional steroids|0|||
16403510|NCT00075725|39956937|FG009|Overall Study|Pt received additional steroids|0|||
16403511|NCT00075725|39956938|FG010|Overall Study|Pt received additional steroids|0|||
16403512|NCT00075725|39956939|FG011|Overall Study|Pt received additional steroids|0|||
16403513|NCT00075725|39956928|FG000|Overall Study|Pt relocated|0|||
16403514|NCT00075725|39956929|FG001|Overall Study|Pt relocated|0|||
16403515|NCT00075725|39956930|FG002|Overall Study|Pt relocated|0|||
16403516|NCT00075725|39956931|FG003|Overall Study|Pt relocated|2|||
16403517|NCT00075725|39956932|FG004|Overall Study|Pt relocated|0|||
16403518|NCT00075725|39956933|FG005|Overall Study|Pt relocated|1|||
16533485|NCT00605293|40418053|FG000|Overall Study|Death|2|||
16533486|NCT00605293|40418054|FG001|Overall Study|Death|1|||
16533487|NCT00605293|40418053|FG000|Overall Study|Insufficient Therapeutic Response|2|||
16533488|NCT00605293|40418054|FG001|Overall Study|Insufficient Therapeutic Response|0|||
16216274|NCT01875874|39272306|FG000|Overall Study|Death|3|||
16216275|NCT00088595|39272307|FG000|Overall Study|Adverse Event|11|||
16216276|NCT00088595|39272307|FG000|Overall Study|Withdrawal by Subject|8|||
16216277|NCT00088595|39272307|FG000|Overall Study|Ongoing (After Core)|7|||
16216278|NCT00088595|39272307|FG000|Overall Study|New Cancer Therapy|2|||
16216279|NCT00420212|39272308|FG000|Overall Study|Adverse Event|22|||
16216280|NCT00420212|39272309|FG001|Overall Study|Adverse Event|40|||
16216281|NCT00420212|39272310|FG002|Overall Study|Adverse Event|36|||
16216282|NCT00420212|39272308|FG000|Overall Study|Lost to Follow-up|9|||
16333595|NCT02588092|39707132|FG007|Overall Study|Started Another Treatment|1|||
16333596|NCT02588092|39707133|FG008|Overall Study|Started Another Treatment|0|||
16333597|NCT02588092|39707134|FG009|Overall Study|Started Another Treatment|0|||
16333598|NCT02588092|39707125|FG000|Overall Study|Sponsor Decision|0|||
16333599|NCT02588092|39707126|FG001|Overall Study|Sponsor Decision|0|||
16333600|NCT02588092|39707127|FG002|Overall Study|Sponsor Decision|0|||
16333601|NCT02588092|39707128|FG003|Overall Study|Sponsor Decision|0|||
16333602|NCT02588092|39707129|FG004|Overall Study|Sponsor Decision|0|||
16333603|NCT02588092|39707130|FG005|Overall Study|Sponsor Decision|0|||
16333604|NCT02588092|39707131|FG006|Overall Study|Sponsor Decision|0|||
16533489|NCT00605293|40418053|FG000|Overall Study|Adverse Event|1|||
16533490|NCT00605293|40418054|FG001|Overall Study|Adverse Event|0|||
16533491|NCT00605293|40418053|FG000|Overall Study|Holidays Dialysis Out|1|||
16533492|NCT00605293|40418054|FG001|Overall Study|Holidays Dialysis Out|0|||
16533493|NCT00605293|40418053|FG000|Overall Study|Blood Transfusion|7|||
16533494|NCT00605293|40418054|FG001|Overall Study|Blood Transfusion|1|||
16333605|NCT02588092|39707132|FG007|Overall Study|Sponsor Decision|0|||
16333606|NCT02588092|39707133|FG008|Overall Study|Sponsor Decision|1|||
16403519|NCT00075725|39956934|FG006|Overall Study|Pt relocated|1|||
16533495|NCT00605293|40418053|FG000|Overall Study|Renal Transplantation|3|||
16533496|NCT00605293|40418054|FG001|Overall Study|Renal Transplantation|1|||
16533497|NCT00605293|40418053|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
16533498|NCT00605293|40418054|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
16533499|NCT00605293|40418053|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
16533500|NCT00605293|40418054|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
16533501|NCT00605293|40418053|FG000|Overall Study|Principal Investigator Decision|0|||
16533502|NCT00605293|40418054|FG001|Overall Study|Principal Investigator Decision|1|||
16533503|NCT02479412|40418057|FG000|Overall Study|Adverse Event|0|||
16533504|NCT02479412|40418058|FG001|Overall Study|Adverse Event|0|||
16533505|NCT02479412|40418059|FG002|Overall Study|Adverse Event|1|||
16533506|NCT02479412|40418060|FG003|Overall Study|Adverse Event|0|||
16533507|NCT02479412|40418061|FG004|Overall Study|Adverse Event|0|||
16533508|NCT02479412|40418062|FG005|Overall Study|Adverse Event|0|||
16533509|NCT02479412|40418063|FG006|Overall Study|Adverse Event|0|||
16533510|NCT02479412|40418064|FG007|Overall Study|Adverse Event|0|||
16533511|NCT02479412|40418065|FG008|Overall Study|Adverse Event|0|||
16533512|NCT02479412|40418057|FG000|Overall Study|Study-specific withdrawal criteria|0|||
16533513|NCT02479412|40418058|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16533514|NCT02479412|40418059|FG002|Overall Study|Study-specific withdrawal criteria|1|||
16533515|NCT02479412|40418060|FG003|Overall Study|Study-specific withdrawal criteria|1|||
16216283|NCT00420212|39272309|FG001|Overall Study|Lost to Follow-up|11|||
16333607|NCT02588092|39707134|FG009|Overall Study|Sponsor Decision|1|||
16333608|NCT02719353|39707135|FG000|First Intervention|Physician Decision|0|||
16403520|NCT00075725|39956935|FG007|Overall Study|Pt relocated|2|||
16333609|NCT02719353|39707136|FG001|First Intervention|Physician Decision|1|||
16216284|NCT00420212|39272310|FG002|Overall Study|Lost to Follow-up|11|||
16216285|NCT00420212|39272308|FG000|Overall Study|Withdrawal by Subject|31|||
16216286|NCT00420212|39272309|FG001|Overall Study|Withdrawal by Subject|22|||
16333610|NCT00394433|39707137|FG000|Overall Study|Adverse Event|2|||
16333611|NCT00394433|39707137|FG000|Overall Study|Alternative Therapy|1|||
16403521|NCT00075725|39956936|FG008|Overall Study|Pt relocated|1|||
16403522|NCT00075725|39956937|FG009|Overall Study|Pt relocated|0|||
16403523|NCT00075725|39956938|FG010|Overall Study|Pt relocated|0|||
16403524|NCT00075725|39956939|FG011|Overall Study|Pt relocated|0|||
16403525|NCT00075725|39956928|FG000|Overall Study|Institution Terminated|0|||
16403526|NCT00075725|39956929|FG001|Overall Study|Institution Terminated|0|||
16403527|NCT00075725|39956930|FG002|Overall Study|Institution Terminated|0|||
16403528|NCT00075725|39956931|FG003|Overall Study|Institution Terminated|0|||
16403529|NCT00075725|39956932|FG004|Overall Study|Institution Terminated|1|||
16403530|NCT00075725|39956933|FG005|Overall Study|Institution Terminated|0|||
16403531|NCT00075725|39956934|FG006|Overall Study|Institution Terminated|0|||
16403532|NCT00075725|39956935|FG007|Overall Study|Institution Terminated|3|||
16403533|NCT00075725|39956936|FG008|Overall Study|Institution Terminated|0|||
16403534|NCT00075725|39956937|FG009|Overall Study|Institution Terminated|0|||
16403535|NCT00075725|39956938|FG010|Overall Study|Institution Terminated|0|||
16403536|NCT00075725|39956939|FG011|Overall Study|Institution Terminated|0|||
16403537|NCT00075725|39956928|FG000|Overall Study|Study Closure|1|||
16403538|NCT00075725|39956929|FG001|Overall Study|Study Closure|0|||
16403539|NCT00075725|39956930|FG002|Overall Study|Study Closure|0|||
16403540|NCT00075725|39956931|FG003|Overall Study|Study Closure|0|||
16403541|NCT00075725|39956932|FG004|Overall Study|Study Closure|1|||
16403542|NCT00075725|39956933|FG005|Overall Study|Study Closure|3|||
16403543|NCT00075725|39956934|FG006|Overall Study|Study Closure|0|||
16403544|NCT00075725|39956935|FG007|Overall Study|Study Closure|1|||
16403545|NCT00075725|39956936|FG008|Overall Study|Study Closure|0|||
16403546|NCT00075725|39956937|FG009|Overall Study|Study Closure|0|||
16403547|NCT00075725|39956938|FG010|Overall Study|Study Closure|0|||
16403548|NCT00075725|39956939|FG011|Overall Study|Study Closure|0|||
16333612|NCT00524173|39707138|FG000|Overall Study|Lost to Follow-up|0|||
16333613|NCT00524173|39707139|FG001|Overall Study|Lost to Follow-up|1|||
16333614|NCT00524173|39707138|FG000|Overall Study|Death|1|||
16333615|NCT00524173|39707139|FG001|Overall Study|Death|0|||
16333616|NCT00524173|39707138|FG000|Overall Study|Had not reached endpoint at study close|4|||
16333617|NCT00524173|39707139|FG001|Overall Study|Had not reached endpoint at study close|1|||
16333618|NCT00423813|39707142|FG000|Overall Study|Adverse Event|11|||
16403549|NCT00075725|39956928|FG000|Overall Study|Other complications|0|||
16403550|NCT00075725|39956929|FG001|Overall Study|Other complications|0|||
16333619|NCT00423813|39707143|FG001|Overall Study|Adverse Event|30|||
16333620|NCT00423813|39707144|FG002|Overall Study|Adverse Event|40|||
16333621|NCT00423813|39707142|FG000|Overall Study|Withdrawal by Subject|6|||
16333622|NCT00423813|39707143|FG001|Overall Study|Withdrawal by Subject|8|||
16333623|NCT00423813|39707144|FG002|Overall Study|Withdrawal by Subject|5|||
16333624|NCT00423813|39707142|FG000|Overall Study|Lost to Follow-up|5|||
16333625|NCT00423813|39707143|FG001|Overall Study|Lost to Follow-up|4|||
16333626|NCT00423813|39707144|FG002|Overall Study|Lost to Follow-up|4|||
16403551|NCT00075725|39956930|FG002|Overall Study|Other complications|0|||
16403552|NCT00075725|39956931|FG003|Overall Study|Other complications|0|||
16403553|NCT00075725|39956932|FG004|Overall Study|Other complications|0|||
16403554|NCT00075725|39956933|FG005|Overall Study|Other complications|1|||
16403555|NCT00075725|39956934|FG006|Overall Study|Other complications|0|||
16403556|NCT00075725|39956935|FG007|Overall Study|Other complications|0|||
16403557|NCT00075725|39956936|FG008|Overall Study|Other complications|0|||
16403558|NCT00075725|39956937|FG009|Overall Study|Other complications|0|||
16216287|NCT00420212|39272310|FG002|Overall Study|Withdrawal by Subject|19|||
16333627|NCT00423813|39707142|FG000|Overall Study|Lack of Efficacy|23|||
16333628|NCT00423813|39707143|FG001|Overall Study|Lack of Efficacy|18|||
16333629|NCT00423813|39707144|FG002|Overall Study|Lack of Efficacy|19|||
16333630|NCT00423813|39707142|FG000|Overall Study|Physician Decision|2|||
16333631|NCT00423813|39707143|FG001|Overall Study|Physician Decision|0|||
16333632|NCT00423813|39707144|FG002|Overall Study|Physician Decision|0|||
16333633|NCT00423813|39707142|FG000|Overall Study|Sponsor Decision|0|||
16403559|NCT00075725|39956938|FG010|Overall Study|Other complications|0|||
16533516|NCT02479412|40418061|FG004|Overall Study|Study-specific withdrawal criteria|0|||
16533517|NCT02479412|40418062|FG005|Overall Study|Study-specific withdrawal criteria|0|||
16533518|NCT02479412|40418063|FG006|Overall Study|Study-specific withdrawal criteria|0|||
16533519|NCT02479412|40418064|FG007|Overall Study|Study-specific withdrawal criteria|1|||
16533520|NCT02479412|40418065|FG008|Overall Study|Study-specific withdrawal criteria|1|||
16533521|NCT02479412|40418057|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
16533522|NCT02479412|40418058|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
16533523|NCT02479412|40418059|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
16533524|NCT02479412|40418060|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
16533525|NCT02479412|40418061|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
16533526|NCT02479412|40418062|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
16533527|NCT02479412|40418063|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
16533528|NCT02479412|40418064|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
16533529|NCT02479412|40418065|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
16533530|NCT02332590|40418067|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
16403560|NCT00075725|39956939|FG011|Overall Study|Other complications|0|||
16403561|NCT00075725|39956928|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
16403562|NCT00075725|39956929|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
16403563|NCT00075725|39956930|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
16403564|NCT00075725|39956931|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
16403565|NCT00075725|39956932|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
16403566|NCT00075725|39956933|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
16403567|NCT00075725|39956934|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
16403568|NCT00075725|39956935|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
16403569|NCT00075725|39956936|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
16403570|NCT00075725|39956937|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
16403571|NCT00075725|39956938|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
16403572|NCT00075725|39956939|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
16403573|NCT00075725|39956928|FG000|Overall Study|Pt incarcerated|0|||
16403574|NCT00075725|39956929|FG001|Overall Study|Pt incarcerated|0|||
16403575|NCT00075725|39956930|FG002|Overall Study|Pt incarcerated|0|||
16403576|NCT00075725|39956931|FG003|Overall Study|Pt incarcerated|0|||
16403577|NCT00075725|39956932|FG004|Overall Study|Pt incarcerated|0|||
16403578|NCT00075725|39956933|FG005|Overall Study|Pt incarcerated|0|||
16403579|NCT00075725|39956934|FG006|Overall Study|Pt incarcerated|0|||
16403580|NCT00075725|39956935|FG007|Overall Study|Pt incarcerated|1|||
16403581|NCT00075725|39956936|FG008|Overall Study|Pt incarcerated|0|||
16403582|NCT00075725|39956937|FG009|Overall Study|Pt incarcerated|0|||
16403583|NCT00075725|39956938|FG010|Overall Study|Pt incarcerated|0|||
16403584|NCT00075725|39956939|FG011|Overall Study|Pt incarcerated|0|||
16403585|NCT00132691|39956950|FG000|Overall Study|Lost to Follow-up|5|||
16403586|NCT00132691|39956951|FG001|Overall Study|Lost to Follow-up|8|||
16403587|NCT00132691|39956950|FG000|Overall Study|Missed 2-year visit|4|||
16403588|NCT00132691|39956951|FG001|Overall Study|Missed 2-year visit|4|||
16403589|NCT00132691|39956950|FG000|Overall Study|Death|2|||
16403590|NCT00132691|39956951|FG001|Overall Study|Death|0|||
16403591|NCT00252694|39956956|FG000|Overall Study|Withdrawal by Subject|83|||
16403592|NCT00252694|39956957|FG001|Overall Study|Withdrawal by Subject|91|||
16403593|NCT00252694|39956956|FG000|Overall Study|Death|36|||
16403594|NCT00252694|39956957|FG001|Overall Study|Death|34|||
16403595|NCT00252694|39956956|FG000|Overall Study|Mostly Lost to Follow Up|8|||
16403596|NCT00252694|39956957|FG001|Overall Study|Mostly Lost to Follow Up|13|||
16403597|NCT00252694|39956956|FG000|Overall Study|Patient Moving|17|||
16403598|NCT00252694|39956957|FG001|Overall Study|Patient Moving|16|||
16403599|NCT01110330|39956958|FG000|Overall Study|Adverse Event|0|||
16403600|NCT01110330|39956959|FG001|Overall Study|Adverse Event|4|||
16403601|NCT01110330|39956960|FG002|Overall Study|Adverse Event|3|||
16403602|NCT01110330|39956958|FG000|Overall Study|Lack of Efficacy|3|||
16403603|NCT01110330|39956959|FG001|Overall Study|Lack of Efficacy|1|||
16403604|NCT01110330|39956960|FG002|Overall Study|Lack of Efficacy|1|||
16403605|NCT01110330|39956958|FG000|Overall Study|Lost to Follow-up|9|||
16403606|NCT01110330|39956959|FG001|Overall Study|Lost to Follow-up|10|||
16403607|NCT01110330|39956960|FG002|Overall Study|Lost to Follow-up|15|||
16403608|NCT01110330|39956958|FG000|Overall Study|Physician Decision|0|||
16403609|NCT01110330|39956959|FG001|Overall Study|Physician Decision|1|||
16403610|NCT01110330|39956960|FG002|Overall Study|Physician Decision|0|||
16403611|NCT01110330|39956958|FG000|Overall Study|Protocol Violation|2|||
16403612|NCT01110330|39956959|FG001|Overall Study|Protocol Violation|0|||
16100834|NCT00500539|38856640|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
16403613|NCT01110330|39956960|FG002|Overall Study|Protocol Violation|4|||
16403614|NCT01110330|39956958|FG000|Overall Study|Withdrawal by Subject|0|||
16403615|NCT01110330|39956959|FG001|Overall Study|Withdrawal by Subject|6|||
16403616|NCT01110330|39956960|FG002|Overall Study|Withdrawal by Subject|2|||
16403617|NCT01110330|39956958|FG000|Overall Study|Other|1|||
16403618|NCT01110330|39956959|FG001|Overall Study|Other|1|||
16533531|NCT02332590|40418068|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
16533532|NCT02332590|40418067|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
16533533|NCT02332590|40418068|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
16533534|NCT02332590|40418067|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
16533535|NCT02332590|40418068|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
16533536|NCT02332590|40418067|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
16533537|NCT02332590|40418068|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
16533538|NCT02332590|40418067|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
16533539|NCT02332590|40418068|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
16533540|NCT02332590|40418067|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
16533541|NCT02332590|40418068|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
16533542|NCT02332590|40418067|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
16533543|NCT02332590|40418068|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
16533544|NCT02332590|40418067|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
16533545|NCT02332590|40418068|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
16533546|NCT02332590|40418067|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
16533547|NCT02332590|40418068|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
16533548|NCT00335322|40418069|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
16533549|NCT00335322|40418070|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
16533550|NCT00335322|40418071|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
16533551|NCT04764396|40418072|FG000|Overall Study|Physician Decision|1|||
16533552|NCT04764396|40418073|FG001|Overall Study|Physician Decision|0|||
16533553|NCT00529399|40418087|FG000|Overall Study|Lost to Follow-up|1|||
16533554|NCT00529399|40418088|FG001|Overall Study|Lost to Follow-up|0|||
16533555|NCT00529399|40418089|FG002|Overall Study|Lost to Follow-up|1|||
16533556|NCT00529399|40418087|FG000|Overall Study|Withdrawal by Subject|1|||
16533557|NCT00529399|40418088|FG001|Overall Study|Withdrawal by Subject|0|||
16533558|NCT00529399|40418089|FG002|Overall Study|Withdrawal by Subject|1|||
16533559|NCT00529399|40418087|FG000|Overall Study|Non-compliant|0|||
16533560|NCT00529399|40418088|FG001|Overall Study|Non-compliant|1|||
16100835|NCT00500539|38856640|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
16100836|NCT00500539|38856640|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
16100837|NCT00500539|38856640|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
16403619|NCT01110330|39956960|FG002|Overall Study|Other|1|||
16403620|NCT00473668|39956963|FG000|Overall Study|Withdrawal by Subject|0|||
16403621|NCT00473668|39956964|FG001|Overall Study|Withdrawal by Subject|2|||
16403622|NCT00473668|39956965|FG002|Overall Study|Withdrawal by Subject|0|||
16403623|NCT00473668|39956963|FG000|Overall Study|Migrated/moved from study area|3|||
16403624|NCT00473668|39956964|FG001|Overall Study|Migrated/moved from study area|2|||
16403625|NCT00473668|39956965|FG002|Overall Study|Migrated/moved from study area|0|||
16403626|NCT00473668|39956963|FG000|Overall Study|Lost to Follow-up|0|||
16403627|NCT00473668|39956964|FG001|Overall Study|Lost to Follow-up|4|||
16403628|NCT00473668|39956965|FG002|Overall Study|Lost to Follow-up|6|||
16403629|NCT00473668|39956963|FG000|Overall Study|Other|2|||
16403630|NCT00473668|39956964|FG001|Overall Study|Other|3|||
16403631|NCT00473668|39956965|FG002|Overall Study|Other|4|||
16403632|NCT01118520|39956966|FG000|Overall Study|AAA repair|9|||
16403633|NCT01118520|39956967|FG001|Overall Study|AAA repair|7|||
16403634|NCT01118520|39956968|FG002|Overall Study|AAA repair|9|||
16403635|NCT01118520|39956966|FG000|Overall Study|Adverse Event|3|||
16403636|NCT01118520|39956967|FG001|Overall Study|Adverse Event|3|||
16403637|NCT01118520|39956968|FG002|Overall Study|Adverse Event|3|||
16403638|NCT01118520|39956966|FG000|Overall Study|Withdrawal by Subject|8|||
16403639|NCT01118520|39956967|FG001|Overall Study|Withdrawal by Subject|13|||
16403640|NCT01118520|39956968|FG002|Overall Study|Withdrawal by Subject|8|||
16403641|NCT00765037|39956969|FG000|Overall Study|Lost to Follow-up|5|||
16403642|NCT00765037|39956969|FG000|Overall Study|Adverse Event|1|||
16403643|NCT01200407|39956973|FG000|Overall Study|Lost to Follow-up|56|||
16403644|NCT01200407|39956973|FG000|Overall Study|Adverse Event|3|||
16533561|NCT00529399|40418089|FG002|Overall Study|Non-compliant|0|||
16533562|NCT00917579|40418090|FG000|Washout >= 2 Weeks|Adverse Event|1|||
16533563|NCT00917579|40418091|FG001|Washout >= 2 Weeks|Adverse Event|0|||
16533564|NCT00917579|40418090|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
16533565|NCT00917579|40418091|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
16533566|NCT00760929|40418092|FG000|Overall Study|Adverse Event|2|||
16533567|NCT00760929|40418093|FG001|Overall Study|Adverse Event|0|||
16533568|NCT00760929|40418094|FG002|Overall Study|Adverse Event|6|||
16533569|NCT00760929|40418095|FG003|Overall Study|Adverse Event|10|||
16533570|NCT00760929|40418092|FG000|Overall Study|Lack of Efficacy|0|||
16100838|NCT00500539|38856640|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
16100839|NCT00500539|38856640|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
16100840|NCT00500539|38856640|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
16533571|NCT00760929|40418093|FG001|Overall Study|Lack of Efficacy|2|||
16533572|NCT00760929|40418094|FG002|Overall Study|Lack of Efficacy|1|||
16533573|NCT00760929|40418095|FG003|Overall Study|Lack of Efficacy|0|||
16533574|NCT00760929|40418092|FG000|Overall Study|Withdrawal by Subject|1|||
16533575|NCT00760929|40418093|FG001|Overall Study|Withdrawal by Subject|0|||
16533576|NCT00760929|40418094|FG002|Overall Study|Withdrawal by Subject|9|||
16533577|NCT00760929|40418095|FG003|Overall Study|Withdrawal by Subject|1|||
16533578|NCT00760929|40418092|FG000|Overall Study|Lost to Follow-up|0|||
16533579|NCT00760929|40418093|FG001|Overall Study|Lost to Follow-up|0|||
16533580|NCT00760929|40418094|FG002|Overall Study|Lost to Follow-up|1|||
16533581|NCT00760929|40418095|FG003|Overall Study|Lost to Follow-up|0|||
16533582|NCT00760929|40418092|FG000|Overall Study|Progression of Disease|21|||
16533583|NCT00760929|40418093|FG001|Overall Study|Progression of Disease|26|||
16533584|NCT00760929|40418094|FG002|Overall Study|Progression of Disease|38|||
16533585|NCT00760929|40418095|FG003|Overall Study|Progression of Disease|42|||
16533586|NCT00760929|40418092|FG000|Overall Study|Other|2|||
16533587|NCT00760929|40418093|FG001|Overall Study|Other|0|||
16533588|NCT00760929|40418094|FG002|Overall Study|Other|2|||
16533589|NCT00760929|40418095|FG003|Overall Study|Other|1|||
16533590|NCT00760929|40418092|FG000|Overall Study|Death|0|||
16100841|NCT00500539|38856640|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
16100842|NCT00500539|38856640|FG000|Follow-up Period (16 Weeks)|Death|1|||
16333634|NCT00423813|39707143|FG001|Overall Study|Sponsor Decision|1|||
16333635|NCT00423813|39707144|FG002|Overall Study|Sponsor Decision|0|||
16333636|NCT00423813|39707142|FG000|Overall Study|Protocol Violation|9|||
16333637|NCT00423813|39707143|FG001|Overall Study|Protocol Violation|4|||
16333638|NCT00423813|39707144|FG002|Overall Study|Protocol Violation|4|||
16333639|NCT00423813|39707142|FG000|Overall Study|Pregnancy|0|||
16333640|NCT00423813|39707143|FG001|Overall Study|Pregnancy|0|||
16333641|NCT00423813|39707144|FG002|Overall Study|Pregnancy|1|||
16333642|NCT00423813|39707142|FG000|Overall Study|Subject started night shift work|1|||
16333643|NCT00423813|39707143|FG001|Overall Study|Subject started night shift work|0|||
16333644|NCT00423813|39707144|FG002|Overall Study|Subject started night shift work|0|||
16333645|NCT00423813|39707142|FG000|Overall Study|Will start exclusionary medications|0|||
16333646|NCT00423813|39707143|FG001|Overall Study|Will start exclusionary medications|1|||
16333647|NCT00423813|39707144|FG002|Overall Study|Will start exclusionary medications|0|||
16333648|NCT00423813|39707142|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
16333649|NCT00423813|39707143|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
16333650|NCT00423813|39707144|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
16333651|NCT00553358|39707147|FG000|Overall Study|Randomized but did not receive treatment|3|||
16333652|NCT00553358|39707148|FG001|Overall Study|Randomized but did not receive treatment|3|||
16333653|NCT00553358|39707149|FG002|Overall Study|Randomized but did not receive treatment|1|||
16333654|NCT00553358|39707147|FG000|Overall Study|Lost to Follow-up|22|||
16333655|NCT00553358|39707148|FG001|Overall Study|Lost to Follow-up|26|||
16333656|NCT00553358|39707149|FG002|Overall Study|Lost to Follow-up|18|||
16333657|NCT00553358|39707147|FG000|Overall Study|Withdrew completely|23|||
16333658|NCT00553358|39707148|FG001|Overall Study|Withdrew completely|33|||
16333659|NCT00553358|39707149|FG002|Overall Study|Withdrew completely|34|||
16333660|NCT00553358|39707147|FG000|Overall Study|Died during clinical follow-up|25|||
16333661|NCT00553358|39707148|FG001|Overall Study|Died during clinical follow-up|29|||
16333662|NCT00553358|39707149|FG002|Overall Study|Died during clinical follow-up|32|||
16333663|NCT00553358|39707147|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
16333664|NCT00553358|39707148|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
16333665|NCT00553358|39707149|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
16333666|NCT00553358|39707147|FG000|Overall Study|Died after clinical follow-up ended|1|||
16333667|NCT00553358|39707148|FG001|Overall Study|Died after clinical follow-up ended|2|||
16333668|NCT00553358|39707149|FG002|Overall Study|Died after clinical follow-up ended|0|||
16333669|NCT00553358|39707147|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
16333670|NCT00553358|39707148|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
16533591|NCT00760929|40418093|FG001|Overall Study|Death|0|||
16216288|NCT00420212|39272308|FG000|Overall Study|Physician Decision|4|||
16333671|NCT00553358|39707149|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
16333672|NCT01618019|39707150|FG000|Overall Study|Withdrawal by Subject|14|||
16533592|NCT00760929|40418094|FG002|Overall Study|Death|1|||
16533593|NCT00760929|40418095|FG003|Overall Study|Death|0|||
16533594|NCT00760929|40418092|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
16533595|NCT00760929|40418093|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
16533596|NCT00760929|40418094|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
16533597|NCT00760929|40418095|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
16533598|NCT04987762|40418096|FG000|Overall Study|Study was Terminated by Sponsor|103|||
16533599|NCT03069482|40418097|FG000|Overall Study|Lost to Follow-up|0|||
16533600|NCT03069482|40418098|FG001|Overall Study|Lost to Follow-up|1|||
16533601|NCT03069482|40418097|FG000|Overall Study|Physician Decision|1|||
16533602|NCT03069482|40418098|FG001|Overall Study|Physician Decision|0|||
16533603|NCT02638948|40418099|FG000|Overall Study|Withdrawal by Subject|4|||
16533604|NCT02638948|40418100|FG001|Overall Study|Withdrawal by Subject|5|||
16533605|NCT02638948|40418101|FG002|Overall Study|Withdrawal by Subject|3|||
16533606|NCT02638948|40418102|FG003|Overall Study|Withdrawal by Subject|1|||
16533607|NCT02638948|40418099|FG000|Overall Study|Administrative Reason by Sponsor|0|||
16533608|NCT02638948|40418100|FG001|Overall Study|Administrative Reason by Sponsor|1|||
16533609|NCT02638948|40418101|FG002|Overall Study|Administrative Reason by Sponsor|0|||
16533610|NCT02638948|40418102|FG003|Overall Study|Administrative Reason by Sponsor|4|||
16333673|NCT01618019|39707151|FG001|Overall Study|Withdrawal by Subject|14|||
16333674|NCT03325894|39707154|FG000|Overall Study|Adverse Event|2|||
16333675|NCT03325894|39707155|FG001|Overall Study|Adverse Event|3|||
16333676|NCT03325894|39707154|FG000|Overall Study|Protocol Violation|1|||
16333677|NCT03325894|39707155|FG001|Overall Study|Protocol Violation|2|||
16333678|NCT03325894|39707154|FG000|Overall Study|Withdrawal by Subject|10|||
16333679|NCT03325894|39707155|FG001|Overall Study|Withdrawal by Subject|6|||
16333680|NCT03325894|39707154|FG000|Overall Study|Lost to Follow-up|4|||
16333681|NCT03325894|39707155|FG001|Overall Study|Lost to Follow-up|9|||
16333682|NCT03325894|39707154|FG000|Overall Study|Lack of Efficacy|8|||
16333683|NCT03325894|39707155|FG001|Overall Study|Lack of Efficacy|14|||
16403645|NCT01200407|39956973|FG000|Overall Study|Withdrawal by Subject|4|||
16533611|NCT02638948|40418099|FG000|Overall Study|Adverse Event|0|||
16533612|NCT02638948|40418100|FG001|Overall Study|Adverse Event|0|||
16533613|NCT02638948|40418101|FG002|Overall Study|Adverse Event|1|||
16533614|NCT02638948|40418102|FG003|Overall Study|Adverse Event|1|||
16100843|NCT00500539|38856640|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
16333684|NCT03325894|39707154|FG000|Overall Study|Study Terminated by Sponsor|38|||
16533615|NCT02638948|40418099|FG000|Overall Study|Lack of Efficacy|1|||
16533616|NCT02638948|40418100|FG001|Overall Study|Lack of Efficacy|1|||
16533617|NCT02638948|40418101|FG002|Overall Study|Lack of Efficacy|0|||
16533618|NCT02638948|40418102|FG003|Overall Study|Lack of Efficacy|0|||
16533619|NCT02638948|40418099|FG000|Overall Study|Lost to Follow-up|0|||
16533620|NCT02638948|40418100|FG001|Overall Study|Lost to Follow-up|0|||
16533621|NCT02638948|40418101|FG002|Overall Study|Lost to Follow-up|1|||
16533622|NCT02638948|40418102|FG003|Overall Study|Lost to Follow-up|1|||
16533623|NCT02638948|40418099|FG000|Overall Study|Poor/Non-Compliance|0|||
16533624|NCT02638948|40418100|FG001|Overall Study|Poor/Non-Compliance|2|||
16533625|NCT02638948|40418101|FG002|Overall Study|Poor/Non-Compliance|1|||
16533626|NCT02638948|40418102|FG003|Overall Study|Poor/Non-Compliance|0|||
16533627|NCT02638948|40418099|FG000|Overall Study|Participant no longer met study criteria|0|||
16533628|NCT02638948|40418100|FG001|Overall Study|Participant no longer met study criteria|1|||
16533629|NCT02638948|40418101|FG002|Overall Study|Participant no longer met study criteria|0|||
16533630|NCT02638948|40418102|FG003|Overall Study|Participant no longer met study criteria|0|||
16533631|NCT02638948|40418099|FG000|Overall Study|Other than specified above|4|||
16533632|NCT02638948|40418100|FG001|Overall Study|Other than specified above|1|||
16533633|NCT02638948|40418101|FG002|Overall Study|Other than specified above|1|||
16533634|NCT02638948|40418102|FG003|Overall Study|Other than specified above|1|||
16533635|NCT00636610|40418103|FG000|Overall Study|Adverse Event|4|||
16533636|NCT00636610|40418104|FG001|Overall Study|Adverse Event|4|||
16403646|NCT01200407|39956973|FG000|Overall Study|Other|19|||
16403647|NCT00969761|39956974|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
16403648|NCT00969761|39956975|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
16403649|NCT00969761|39956976|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
16403650|NCT00969761|39956977|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
16403651|NCT00969761|39956978|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
16533637|NCT00636610|40418103|FG000|Overall Study|Death|6|||
16533638|NCT00636610|40418104|FG001|Overall Study|Death|3|||
16533639|NCT00636610|40418103|FG000|Overall Study|Physician decision to withdraw patient|15|||
16533640|NCT00636610|40418104|FG001|Overall Study|Physician decision to withdraw patient|9|||
16533641|NCT00636610|40418103|FG000|Overall Study|Subject decision to withdraw|15|||
16533642|NCT00636610|40418104|FG001|Overall Study|Subject decision to withdraw|11|||
16533643|NCT00636610|40418103|FG000|Overall Study|Disease progression - radiographic|41|||
16333685|NCT03325894|39707155|FG001|Overall Study|Study Terminated by Sponsor|43|||
16533644|NCT00636610|40418104|FG001|Overall Study|Disease progression - radiographic|51|||
16533645|NCT00636610|40418103|FG000|Overall Study|Disease progression - clinical|8|||
16533646|NCT00636610|40418104|FG001|Overall Study|Disease progression - clinical|3|||
16533647|NCT00636610|40418103|FG000|Overall Study|Reason for discontinuation not available|3|||
16333686|NCT03325894|39707154|FG000|Overall Study|Other (Not received Treatment)|1|||
16100844|NCT00500539|38856640|FG000|Follow-up Period (16 Weeks)|Missing|3|||
16100845|NCT02784535|38856642|FG000|Overall Study|Adverse Event|1|||
16100846|NCT02784535|38856643|FG001|Overall Study|Adverse Event|0|||
16100847|NCT02784535|38856642|FG000|Overall Study|Withdrawal by Subject|0|||
16333687|NCT03325894|39707155|FG001|Overall Study|Other (Not received Treatment)|0|||
16333688|NCT03427268|39707159|FG000|Overall Study|Progressive disease|25|||
16333689|NCT03427268|39707159|FG000|Overall Study|Never treated|2|||
16333690|NCT03427268|39707159|FG000|Overall Study|Compassionate use|1|||
16333691|NCT03427268|39707159|FG000|Overall Study|Withdrawal by Subject|1|||
16333692|NCT03427268|39707159|FG000|Overall Study|Adverse Event|3|||
16333693|NCT00955968|39707160|FG000|Overall Study|Death|2|||
16333694|NCT00955968|39707161|FG001|Overall Study|Death|4|||
16333695|NCT00955968|39707160|FG000|Overall Study|Withdrawal by Subject|35|||
16333696|NCT00955968|39707161|FG001|Overall Study|Withdrawal by Subject|31|||
16333697|NCT00955968|39707160|FG000|Overall Study|Lost to Follow-up|45|||
16333698|NCT00955968|39707161|FG001|Overall Study|Lost to Follow-up|39|||
16333699|NCT00955968|39707160|FG000|Overall Study|Site closed|55|||
16333700|NCT00955968|39707161|FG001|Overall Study|Site closed|52|||
16333701|NCT00423189|39707162|FG000|Overall Study|Death|0|||
16333702|NCT00423189|39707163|FG001|Overall Study|Death|1|||
16333703|NCT00423189|39707164|FG002|Overall Study|Death|0|||
16333704|NCT03332628|39707171|FG000|Overall Study|Physician Decision|2|||
16333705|NCT01737268|39707176|FG000|Overall Study|Adverse Event|6|||
16333706|NCT01737268|39707176|FG000|Overall Study|Worsening of Target Disease|2|||
16333707|NCT01737268|39707176|FG000|Overall Study|In consideration of the patient's safety|1|||
16333708|NCT01472939|39707181|FG000|Overall Study|Adverse Event|3|||
16333709|NCT01472939|39707182|FG001|Overall Study|Adverse Event|7|||
16333710|NCT01472939|39707183|FG002|Overall Study|Adverse Event|7|||
16333711|NCT01472939|39707184|FG003|Overall Study|Adverse Event|14|||
16333712|NCT01472939|39707181|FG000|Overall Study|Lack of Efficacy|1|||
16333713|NCT01472939|39707182|FG001|Overall Study|Lack of Efficacy|0|||
16333714|NCT01472939|39707183|FG002|Overall Study|Lack of Efficacy|0|||
16333715|NCT01472939|39707184|FG003|Overall Study|Lack of Efficacy|1|||
16333716|NCT01472939|39707181|FG000|Overall Study|Lost to Follow-up|3|||
16333717|NCT01472939|39707182|FG001|Overall Study|Lost to Follow-up|0|||
16333718|NCT01472939|39707183|FG002|Overall Study|Lost to Follow-up|2|||
16333719|NCT01472939|39707184|FG003|Overall Study|Lost to Follow-up|0|||
16333720|NCT01472939|39707181|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
16333721|NCT01472939|39707182|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
16333722|NCT01472939|39707183|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
16333723|NCT01472939|39707184|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
16333724|NCT01472939|39707181|FG000|Overall Study|Prohibited Medication|0|||
16333725|NCT01472939|39707182|FG001|Overall Study|Prohibited Medication|1|||
16333726|NCT01472939|39707183|FG002|Overall Study|Prohibited Medication|0|||
16333727|NCT01472939|39707184|FG003|Overall Study|Prohibited Medication|0|||
16333728|NCT01472939|39707181|FG000|Overall Study|Withdrawal By PI|1|||
16333729|NCT01472939|39707182|FG001|Overall Study|Withdrawal By PI|0|||
16333730|NCT01472939|39707183|FG002|Overall Study|Withdrawal By PI|0|||
16333731|NCT01472939|39707184|FG003|Overall Study|Withdrawal By PI|0|||
16333732|NCT01472939|39707181|FG000|Overall Study|Protocol Violation|3|||
16333733|NCT01472939|39707182|FG001|Overall Study|Protocol Violation|3|||
16333734|NCT01472939|39707183|FG002|Overall Study|Protocol Violation|0|||
16333735|NCT01472939|39707184|FG003|Overall Study|Protocol Violation|1|||
16333736|NCT01472939|39707181|FG000|Overall Study|Withdrawal by Subject|9|||
16333737|NCT01472939|39707182|FG001|Overall Study|Withdrawal by Subject|3|||
16333738|NCT01472939|39707183|FG002|Overall Study|Withdrawal by Subject|1|||
16403652|NCT00969761|39956979|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
16403653|NCT00969761|39956980|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
16403654|NCT00969761|39956981|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
16403655|NCT00969761|39956982|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
16403656|NCT00969761|39956983|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
16403657|NCT00969761|39956984|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
16403658|NCT00969761|39956985|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
16403659|NCT00969761|39956974|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16403660|NCT00969761|39956975|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16403661|NCT00969761|39956976|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
16100848|NCT02784535|38856643|FG001|Overall Study|Withdrawal by Subject|1|||
16333739|NCT01472939|39707184|FG003|Overall Study|Withdrawal by Subject|4|||
16333740|NCT00535847|39707185|FG000|Overall Study|Adverse Event|5|||
16333741|NCT00535847|39707186|FG001|Overall Study|Adverse Event|3|||
16333742|NCT00535847|39707187|FG002|Overall Study|Adverse Event|2|||
16333743|NCT00535847|39707185|FG000|Overall Study|Non compliance|1|||
16333744|NCT00535847|39707186|FG001|Overall Study|Non compliance|1|||
16333745|NCT00535847|39707187|FG002|Overall Study|Non compliance|0|||
16333746|NCT00535847|39707185|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
16100849|NCT02784535|38856642|FG000|Overall Study|Physician Decision|0|||
16100850|NCT02784535|38856643|FG001|Overall Study|Physician Decision|1|||
16100851|NCT02256488|38856644|FG000|Overall Study|Lost to Follow-up|6|||
16100852|NCT02256488|38856645|FG001|Overall Study|Lost to Follow-up|6|||
16100853|NCT02256488|38856646|FG002|Overall Study|Lost to Follow-up|9|||
16100854|NCT02256488|38856647|FG003|Overall Study|Lost to Follow-up|3|||
16100855|NCT02256488|38856644|FG000|Overall Study|OTHER|1|||
16100856|NCT02256488|38856645|FG001|Overall Study|OTHER|0|||
16216289|NCT00420212|39272309|FG001|Overall Study|Physician Decision|4|||
16216290|NCT00420212|39272310|FG002|Overall Study|Physician Decision|3|||
16216291|NCT00420212|39272308|FG000|Overall Study|Protocol Violation|4|||
16216292|NCT00420212|39272309|FG001|Overall Study|Protocol Violation|4|||
16216293|NCT00420212|39272310|FG002|Overall Study|Protocol Violation|8|||
16216294|NCT00420212|39272308|FG000|Overall Study|Death|0|||
16100857|NCT02256488|38856646|FG002|Overall Study|OTHER|1|||
16100858|NCT02256488|38856647|FG003|Overall Study|OTHER|1|||
16100859|NCT02256488|38856644|FG000|Overall Study|Withdrawal by Subject|1|||
16100860|NCT02256488|38856645|FG001|Overall Study|Withdrawal by Subject|0|||
16100861|NCT02256488|38856646|FG002|Overall Study|Withdrawal by Subject|0|||
16100862|NCT02256488|38856647|FG003|Overall Study|Withdrawal by Subject|2|||
16100863|NCT02168478|38856648|FG000|Overall Study|Withdrawal by Subject|1|||
16100864|NCT02168478|38856648|FG000|Overall Study|Did Not Consent to Participation|2|||
16100865|NCT02168478|38856648|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
16100866|NCT02396758|38856650|FG000|Overall Study|Withdrawal by Subject|2|||
16100867|NCT02396758|38856651|FG001|Overall Study|Withdrawal by Subject|0|||
16100868|NCT02396758|38856652|FG002|Overall Study|Withdrawal by Subject|0|||
16100869|NCT02396758|38856653|FG003|Overall Study|Withdrawal by Subject|1|||
16403662|NCT00969761|39956977|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16100870|NCT02396758|38856650|FG000|Overall Study|Lost to Follow-up|8|||
16533648|NCT00636610|40418104|FG001|Overall Study|Reason for discontinuation not available|2|||
16100871|NCT02396758|38856651|FG001|Overall Study|Lost to Follow-up|5|||
16100872|NCT02396758|38856652|FG002|Overall Study|Lost to Follow-up|3|||
16100873|NCT02396758|38856653|FG003|Overall Study|Lost to Follow-up|3|||
16100874|NCT02396758|38856650|FG000|Overall Study|Death|1|||
16100875|NCT02396758|38856651|FG001|Overall Study|Death|1|||
16216295|NCT00420212|39272309|FG001|Overall Study|Death|0|||
16100876|NCT02396758|38856652|FG002|Overall Study|Death|0|||
16100877|NCT02396758|38856653|FG003|Overall Study|Death|1|||
16100878|NCT02396758|38856650|FG000|Overall Study|Randomized but not treated|1|||
16100879|NCT02396758|38856651|FG001|Overall Study|Randomized but not treated|0|||
16100880|NCT02396758|38856652|FG002|Overall Study|Randomized but not treated|1|||
16100881|NCT02396758|38856653|FG003|Overall Study|Randomized but not treated|0|||
16100882|NCT03029234|38856654|FG000|Overall Study|Sponsor Decision|1|||
16100883|NCT03029234|38856654|FG000|Overall Study|Withdrawal by Subject|5|||
16100884|NCT03029234|38856654|FG000|Overall Study|Death|91|||
16100885|NCT03029234|38856654|FG000|Overall Study|Lost to Follow-up|2|||
16100886|NCT00511147|38856656|FG000|Overall Study|Withdrawal by Subject|1|||
16100887|NCT00511147|38856656|FG000|Overall Study|Disease progression|5|||
16100888|NCT00511147|38856656|FG000|Overall Study|Required platelet transfusion|1|||
16100889|NCT01257698|38856658|FG000|Overall Study|Protocol Violation|4|||
16100890|NCT01257698|38856659|FG001|Overall Study|Protocol Violation|0|||
16100891|NCT00116584|38856662|FG000|Overall Study|Withdrawal by Subject|1|||
16100892|NCT00116584|38856663|FG001|Overall Study|Withdrawal by Subject|0|||
16533649|NCT03182868|40418107|FG000|Overall Study|Protocol Violation|3|||
16533650|NCT03182868|40418108|FG001|Overall Study|Protocol Violation|0|||
16533651|NCT03182868|40418109|FG002|Overall Study|Protocol Violation|4|||
16533652|NCT03182868|40418110|FG003|Overall Study|Protocol Violation|1|||
16533653|NCT03182868|40418111|FG004|Overall Study|Protocol Violation|8|||
16533654|NCT01693120|40418112|FG000|Enrollment|Lost to Follow-up|1|||
16533655|NCT01693120|40418112|FG000|Enrollment|Withdrawal by Subject|10|||
16533656|NCT01693120|40418112|FG000|Enrollment|Protocol Violation|46|||
16533657|NCT01693120|40418112|FG000|Enrollment|Physician Decision|3|||
16533658|NCT01693120|40418112|FG000|Enrollment|Adverse Event|1|||
16533659|NCT01693120|40418112|FG000|Enrollment|Study closed|8|||
16533660|NCT01693120|40418112|FG000|Enrollment|Other|1|||
16533661|NCT01693120|40418112|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
16100893|NCT00116584|38856662|FG000|Overall Study|Protocol Violation|1|||
16100894|NCT00116584|38856663|FG001|Overall Study|Protocol Violation|1|||
16100895|NCT01527500|38856666|FG000|Part A|Administrative|11|||
16216296|NCT00420212|39272310|FG002|Overall Study|Death|1|||
16100896|NCT01527500|38856667|FG001|Part A|Administrative|7|||
16533662|NCT01693120|40418112|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
16100897|NCT01527500|38856666|FG000|Part A|Adverse Event|4|||
16216297|NCT00420212|39272308|FG000|Overall Study|Other-Unspecified|21|||
16533663|NCT01693120|40418112|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
16100898|NCT01527500|38856667|FG001|Part A|Adverse Event|2|||
16100899|NCT01527500|38856666|FG000|Part A|Death|4|||
16100900|NCT01527500|38856667|FG001|Part A|Death|1|||
16100901|NCT01527500|38856666|FG000|Part A|Lost to Follow-up|0|||
16100902|NCT01527500|38856667|FG001|Part A|Lost to Follow-up|1|||
16100903|NCT01527500|38856666|FG000|Part A|Protocol Deviation|9|||
16100904|NCT01527500|38856667|FG001|Part A|Protocol Deviation|2|||
16100905|NCT01527500|38856666|FG000|Part A|Withdrawal by Subject|2|||
16100906|NCT01527500|38856667|FG001|Part A|Withdrawal by Subject|0|||
16100907|NCT01527500|38856666|FG000|Part B|Adverse Event|1|||
16100908|NCT01527500|38856667|FG001|Part B|Adverse Event|0|||
16100909|NCT02040532|38856671|FG000|Overall Study|Lost to Follow-up|1|||
16100910|NCT02040532|38856671|FG000|Overall Study|Physician Decision|4|||
16100911|NCT02040532|38856671|FG000|Overall Study|Adverse Event|4|||
16100912|NCT02040532|38856671|FG000|Overall Study|Withdrawal by Subject|3|||
16100913|NCT01148017|38856672|FG000|Overall Study|Withdrawal by Subject|31|||
16100914|NCT01148017|38856673|FG001|Overall Study|Withdrawal by Subject|14|||
16100915|NCT01148017|38856674|FG002|Overall Study|Withdrawal by Subject|0|||
16100916|NCT01148017|38856675|FG003|Overall Study|Withdrawal by Subject|0|||
16100917|NCT01148017|38856672|FG000|Overall Study|Lost to Follow-up|23|||
16100918|NCT01148017|38856673|FG001|Overall Study|Lost to Follow-up|10|||
16100919|NCT01148017|38856674|FG002|Overall Study|Lost to Follow-up|0|||
16100920|NCT01148017|38856675|FG003|Overall Study|Lost to Follow-up|0|||
16100921|NCT01148017|38856672|FG000|Overall Study|Inappropriate enrollment|1|||
16100922|NCT01148017|38856673|FG001|Overall Study|Inappropriate enrollment|0|||
16100923|NCT01148017|38856674|FG002|Overall Study|Inappropriate enrollment|0|||
16100924|NCT01148017|38856675|FG003|Overall Study|Inappropriate enrollment|0|||
16100925|NCT01148017|38856672|FG000|Overall Study|Administrative reason|22|||
16100926|NCT01148017|38856673|FG001|Overall Study|Administrative reason|9|||
16100927|NCT01148017|38856674|FG002|Overall Study|Administrative reason|0|||
16100928|NCT01148017|38856675|FG003|Overall Study|Administrative reason|0|||
16100929|NCT01148017|38856672|FG000|Overall Study|Unable to classify|3|||
16100930|NCT01148017|38856673|FG001|Overall Study|Unable to classify|1|||
16100931|NCT01148017|38856674|FG002|Overall Study|Unable to classify|0|||
16100932|NCT01148017|38856675|FG003|Overall Study|Unable to classify|0|||
16100933|NCT00734851|38856679|FG000|Overall Study|Withdrawal by Subject|2|||
16100934|NCT00734851|38856679|FG000|Overall Study|Lost to Follow-up|1|||
16100935|NCT00734851|38856679|FG000|Overall Study|Physician Decision|18|||
16100936|NCT02213458|38856680|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
16100937|NCT02213458|38856681|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
16100938|NCT02213458|38856680|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
16100939|NCT02213458|38856681|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
16100940|NCT02213458|38856680|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
16100941|NCT02213458|38856681|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
16100942|NCT02213458|38856680|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
16100943|NCT02213458|38856681|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
16100944|NCT02213458|38856680|FG000|Overall Study|Refused re-consent|6|||
16100945|NCT02213458|38856681|FG001|Overall Study|Refused re-consent|0|||
16100946|NCT02213458|38856680|FG000|Overall Study|Lost to Follow-up|2|||
16100947|NCT02213458|38856681|FG001|Overall Study|Lost to Follow-up|2|||
16100948|NCT02213458|38856680|FG000|Overall Study|Withdrawal by Subject|26|||
16100949|NCT02213458|38856681|FG001|Overall Study|Withdrawal by Subject|8|||
16100950|NCT01898442|38856684|FG000|Overall Study|Hemolysis/technical problems|1|||
16100951|NCT01898442|38856685|FG001|Overall Study|Hemolysis/technical problems|2|||
16100952|NCT01898442|38856686|FG002|Overall Study|Hemolysis/technical problems|2|||
16100953|NCT01898442|38856684|FG000|Overall Study|Patient vomited pills|0|||
16100954|NCT01898442|38856685|FG001|Overall Study|Patient vomited pills|0|||
16100955|NCT01898442|38856686|FG002|Overall Study|Patient vomited pills|1|||
16100956|NCT01329419|38856696|FG000|Overall Study|Protocol Violation|235|||
16100957|NCT01812837|38856697|FG000|Overall Study|Lost to Follow-up|1|||
16100958|NCT01812837|38856698|FG001|Overall Study|Lost to Follow-up|1|||
16100959|NCT01812837|38856699|FG002|Overall Study|Lost to Follow-up|0|||
16100960|NCT01812837|38856697|FG000|Overall Study|Protocol Violation|1|||
16100961|NCT01812837|38856698|FG001|Overall Study|Protocol Violation|0|||
16100962|NCT01812837|38856699|FG002|Overall Study|Protocol Violation|0|||
16100963|NCT03444155|38856701|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
16100964|NCT03444155|38856702|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
16100965|NCT00377312|38856703|FG000|Overall Study|Adverse Event|1|||
16100966|NCT00377312|38856704|FG001|Overall Study|Adverse Event|1|||
16100967|NCT00747149|38856705|FG000|Overall Study|Adverse Event|0|||
16100968|NCT00747149|38856706|FG001|Overall Study|Adverse Event|15|||
16403663|NCT00969761|39956978|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16100969|NCT00747149|38856705|FG000|Overall Study|Lost to Follow-up|0|||
16403664|NCT00969761|39956979|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16403665|NCT00969761|39956980|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16403666|NCT00969761|39956981|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16100970|NCT00747149|38856706|FG001|Overall Study|Lost to Follow-up|10|||
16403667|NCT00969761|39956982|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16403668|NCT00969761|39956983|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16403669|NCT00969761|39956984|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16403670|NCT00969761|39956985|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
16403671|NCT00969761|39956974|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403672|NCT00969761|39956975|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403673|NCT00969761|39956976|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
16403674|NCT00969761|39956977|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403675|NCT00969761|39956978|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403676|NCT00969761|39956979|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403677|NCT00969761|39956980|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403678|NCT00969761|39956981|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403679|NCT00969761|39956982|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403680|NCT00969761|39956983|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403681|NCT00969761|39956984|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403682|NCT00969761|39956985|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
16403683|NCT00969761|39956974|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403684|NCT00969761|39956975|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403685|NCT00969761|39956976|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403686|NCT00969761|39956977|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403687|NCT00969761|39956978|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403688|NCT00969761|39956979|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403689|NCT00969761|39956980|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403690|NCT00969761|39956981|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403691|NCT00969761|39956982|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
16403692|NCT00969761|39956983|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403693|NCT00969761|39956984|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403694|NCT00969761|39956985|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
16403695|NCT00969761|39956974|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
16403696|NCT00969761|39956975|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
16403697|NCT00969761|39956976|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
16403698|NCT00969761|39956977|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
16403699|NCT00969761|39956978|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
16403700|NCT00969761|39956979|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
16403701|NCT00969761|39956980|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
16403702|NCT00969761|39956981|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
16403703|NCT00969761|39956982|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
16403704|NCT00969761|39956983|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
16403705|NCT00969761|39956984|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
16533664|NCT01693120|40418112|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
16533665|NCT01693120|40418112|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
16533666|NCT02131272|40418114|FG000|Overall Study|Withdrawal by parent|0|||
16533667|NCT02131272|40418115|FG001|Overall Study|Withdrawal by parent|1|||
16533668|NCT02131272|40418114|FG000|Overall Study|Withdrawal by Subject|0|||
16533669|NCT02131272|40418115|FG001|Overall Study|Withdrawal by Subject|1|||
16100971|NCT00747149|38856705|FG000|Overall Study|Withdrawal by Subject|0|||
16100972|NCT00747149|38856706|FG001|Overall Study|Withdrawal by Subject|6|||
16100973|NCT00747149|38856705|FG000|Overall Study|Did not receive treatment|0|||
16100974|NCT00747149|38856706|FG001|Overall Study|Did not receive treatment|1|||
16100975|NCT00747149|38856705|FG000|Overall Study|Incorrect enrollment|0|||
16100976|NCT00747149|38856706|FG001|Overall Study|Incorrect enrollment|6|||
16100977|NCT00747149|38856705|FG000|Overall Study|Severe non-compliance to protocol|0|||
16100978|NCT00747149|38856706|FG001|Overall Study|Severe non-compliance to protocol|1|||
16100979|NCT00747149|38856705|FG000|Overall Study|Not reported|1|||
16100980|NCT00747149|38856706|FG001|Overall Study|Not reported|4|||
16100981|NCT02065895|38856707|FG000|Overall Study|Protocol Violation|1|||
16100982|NCT02065895|38856708|FG001|Overall Study|Protocol Violation|0|||
16100983|NCT02065895|38856709|FG002|Overall Study|Protocol Violation|0|||
16100984|NCT02065895|38856710|FG003|Overall Study|Protocol Violation|1|||
16100985|NCT02065895|38856711|FG004|Overall Study|Protocol Violation|0|||
16100986|NCT02065895|38856712|FG005|Overall Study|Protocol Violation|0|||
16100987|NCT02065895|38856707|FG000|Overall Study|Scheduling conflicts|0|||
16100988|NCT02065895|38856708|FG001|Overall Study|Scheduling conflicts|1|||
16100989|NCT02065895|38856709|FG002|Overall Study|Scheduling conflicts|0|||
16100990|NCT02065895|38856710|FG003|Overall Study|Scheduling conflicts|0|||
16100991|NCT02065895|38856711|FG004|Overall Study|Scheduling conflicts|0|||
16100992|NCT02065895|38856712|FG005|Overall Study|Scheduling conflicts|0|||
16216298|NCT00420212|39272309|FG001|Overall Study|Other-Unspecified|14|||
16216299|NCT00420212|39272310|FG002|Overall Study|Other-Unspecified|18|||
16216300|NCT01289028|39272311|FG000|Overall Study|Progressive Disease|49|||
16216301|NCT01289028|39272311|FG000|Overall Study|Adverse Event|14|||
16216302|NCT01289028|39272311|FG000|Overall Study|Withdrawal by Subject|6|||
16216303|NCT01289028|39272311|FG000|Overall Study|Death|4|||
16216304|NCT01289028|39272311|FG000|Overall Study|Lack of Efficacy|2|||
16216305|NCT01289028|39272311|FG000|Overall Study|No longer required|2|||
16333747|NCT00535847|39707186|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
16333748|NCT00535847|39707187|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
16333749|NCT02186847|39707188|FG000|Overall Study|Protocol Violation|3|||
16333750|NCT02186847|39707189|FG001|Overall Study|Protocol Violation|0|||
16333751|NCT01797081|39707190|FG000|Overall Study|Adverse Event|1|||
16333752|NCT01797081|39707191|FG001|Overall Study|Adverse Event|0|||
16333753|NCT01797081|39707192|FG002|Overall Study|Adverse Event|1|||
16403706|NCT00969761|39956985|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
16403707|NCT00969761|39956974|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16403708|NCT00969761|39956975|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16403709|NCT00969761|39956976|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16403710|NCT00969761|39956977|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
16403711|NCT00969761|39956978|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
16403712|NCT00969761|39956979|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16403713|NCT00969761|39956980|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16403714|NCT00969761|39956981|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16403715|NCT00969761|39956982|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
16403716|NCT00969761|39956983|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16403717|NCT00969761|39956984|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16403718|NCT00969761|39956985|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
16403719|NCT01369641|39956986|FG000|Overall Study|Withdrawal by Subject|1|||
16403720|NCT00596154|39956987|FG000|Overall Study|Not Evaluable|2|||
16403721|NCT01170065|39956988|FG000|Overall Study|Adverse Event|17|||
16403722|NCT01170065|39956989|FG001|Overall Study|Adverse Event|50|||
16403723|NCT01170065|39956990|FG002|Overall Study|Adverse Event|10|||
16533670|NCT02131272|40418114|FG000|Overall Study|Withdrawal Criteria|1|||
16533671|NCT02131272|40418115|FG001|Overall Study|Withdrawal Criteria|0|||
16403724|NCT01170065|39956988|FG000|Overall Study|Lost to Follow-up|1|||
16403725|NCT01170065|39956989|FG001|Overall Study|Lost to Follow-up|4|||
16403726|NCT01170065|39956990|FG002|Overall Study|Lost to Follow-up|1|||
16403727|NCT01170065|39956988|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
16403728|NCT01170065|39956989|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
16533672|NCT00295750|40418117|FG000|Overall Study|Adverse Event|19|||
16533673|NCT00295750|40418118|FG001|Overall Study|Adverse Event|15|||
16533674|NCT00295750|40418119|FG002|Overall Study|Adverse Event|12|||
16533675|NCT00295750|40418117|FG000|Overall Study|Lack of Efficacy|1|||
16533676|NCT00295750|40418118|FG001|Overall Study|Lack of Efficacy|1|||
16333754|NCT01797081|39707193|FG003|Overall Study|Adverse Event|0|||
16333755|NCT01797081|39707190|FG000|Overall Study|Pregnancy|1|||
16333756|NCT01797081|39707191|FG001|Overall Study|Pregnancy|0|||
16333757|NCT01797081|39707192|FG002|Overall Study|Pregnancy|0|||
16333758|NCT01797081|39707193|FG003|Overall Study|Pregnancy|0|||
16333759|NCT01797081|39707190|FG000|Overall Study|Personal Reasons|12|||
16333760|NCT01797081|39707191|FG001|Overall Study|Personal Reasons|4|||
16333761|NCT01797081|39707192|FG002|Overall Study|Personal Reasons|4|||
16333762|NCT01797081|39707193|FG003|Overall Study|Personal Reasons|8|||
16333763|NCT01797081|39707190|FG000|Overall Study|Protocol Violation|0|||
16333764|NCT01797081|39707191|FG001|Overall Study|Protocol Violation|0|||
16333765|NCT01797081|39707192|FG002|Overall Study|Protocol Violation|0|||
16533677|NCT00295750|40418119|FG002|Overall Study|Lack of Efficacy|0|||
16533678|NCT00295750|40418117|FG000|Overall Study|Lost to Follow-up|1|||
16533679|NCT00295750|40418118|FG001|Overall Study|Lost to Follow-up|4|||
16533680|NCT00295750|40418119|FG002|Overall Study|Lost to Follow-up|1|||
16533681|NCT00295750|40418117|FG000|Overall Study|Taking prohibited therapy|2|||
16533682|NCT00295750|40418118|FG001|Overall Study|Taking prohibited therapy|3|||
16533683|NCT00295750|40418119|FG002|Overall Study|Taking prohibited therapy|2|||
16533684|NCT00295750|40418117|FG000|Overall Study|Administrative errors|2|||
16533685|NCT00295750|40418118|FG001|Overall Study|Administrative errors|4|||
16533686|NCT00295750|40418119|FG002|Overall Study|Administrative errors|5|||
16533687|NCT00295750|40418117|FG000|Overall Study|Trial drug errors|1|||
16533688|NCT00295750|40418118|FG001|Overall Study|Trial drug errors|1|||
16533689|NCT00295750|40418119|FG002|Overall Study|Trial drug errors|0|||
16533690|NCT00295750|40418117|FG000|Overall Study|Disease progression|2|||
16533691|NCT00295750|40418118|FG001|Overall Study|Disease progression|1|||
16333766|NCT01797081|39707193|FG003|Overall Study|Protocol Violation|1|||
16333767|NCT02360475|39707194|FG000|Overall Study|Lost to Follow-up|4|||
16333768|NCT02360475|39707195|FG001|Overall Study|Lost to Follow-up|12|||
16533692|NCT00295750|40418119|FG002|Overall Study|Disease progression|0|||
16533693|NCT00295750|40418117|FG000|Overall Study|Personal reasons|0|||
16533694|NCT00295750|40418118|FG001|Overall Study|Personal reasons|1|||
16333769|NCT02360475|39707196|FG002|Overall Study|Lost to Follow-up|6|||
16333770|NCT02360475|39707197|FG003|Overall Study|Lost to Follow-up|4|||
16333771|NCT02360475|39707194|FG000|Overall Study|Withdrawal by Subject|0|||
16533695|NCT00295750|40418119|FG002|Overall Study|Personal reasons|0|||
16333772|NCT02360475|39707195|FG001|Overall Study|Withdrawal by Subject|1|||
16403729|NCT01170065|39956990|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
16333773|NCT02360475|39707196|FG002|Overall Study|Withdrawal by Subject|2|||
16333774|NCT02360475|39707197|FG003|Overall Study|Withdrawal by Subject|0|||
16333775|NCT02360475|39707194|FG000|Overall Study|Migrated/moved from study area|0|||
16333776|NCT02360475|39707195|FG001|Overall Study|Migrated/moved from study area|0|||
16333777|NCT02360475|39707196|FG002|Overall Study|Migrated/moved from study area|0|||
16333778|NCT02360475|39707197|FG003|Overall Study|Migrated/moved from study area|1|||
16333779|NCT00894790|39707198|FG000|Overall Study|Protocol Violation|0|||
16333780|NCT00894790|39707199|FG001|Overall Study|Protocol Violation|1|||
16333781|NCT00894790|39707198|FG000|Overall Study|Lost to Follow-up|0|||
16333782|NCT00894790|39707199|FG001|Overall Study|Lost to Follow-up|1|||
16333783|NCT00894790|39707198|FG000|Overall Study|Did not meet entrance criteria|1|||
16333784|NCT00894790|39707199|FG001|Overall Study|Did not meet entrance criteria|0|||
16333785|NCT00106639|39707200|FG000|Overall Study|Adverse Event|3|||
16333786|NCT00106639|39707201|FG001|Overall Study|Adverse Event|4|||
16333787|NCT00106639|39707202|FG002|Overall Study|Adverse Event|1|||
16333788|NCT00106639|39707200|FG000|Overall Study|Protocol Violation|0|||
16333789|NCT00106639|39707201|FG001|Overall Study|Protocol Violation|1|||
16333790|NCT00106639|39707202|FG002|Overall Study|Protocol Violation|0|||
16333791|NCT00106639|39707200|FG000|Overall Study|Withdrawal by Subject|0|||
16333792|NCT00106639|39707201|FG001|Overall Study|Withdrawal by Subject|1|||
16333793|NCT00106639|39707202|FG002|Overall Study|Withdrawal by Subject|0|||
16333794|NCT00106639|39707200|FG000|Overall Study|Participant defaulted|0|||
16333795|NCT00106639|39707201|FG001|Overall Study|Participant defaulted|1|||
16333796|NCT00106639|39707202|FG002|Overall Study|Participant defaulted|1|||
16333797|NCT01210144|39707203|FG000|Overall Study|Lack of ovarian response|1|||
16333798|NCT01210144|39707204|FG001|Overall Study|Lack of ovarian response|0|||
16333799|NCT01210144|39707203|FG000|Overall Study|No fertilization|1|||
16333800|NCT01210144|39707204|FG001|Overall Study|No fertilization|0|||
16333801|NCT01210144|39707203|FG000|Overall Study|No transfer|1|||
16333802|NCT01210144|39707204|FG001|Overall Study|No transfer|0|||
16333803|NCT01004406|39707205|FG000|Overall Study|Withdrawal by Subject|2|||
16333804|NCT01004406|39707206|FG001|Overall Study|Withdrawal by Subject|0|||
16333805|NCT01004406|39707205|FG000|Overall Study|Lost to Follow-up|1|||
16333806|NCT01004406|39707206|FG001|Overall Study|Lost to Follow-up|0|||
16333807|NCT01537068|39707207|FG000|Overall Study|Lost to Follow-up|2|||
16333808|NCT01537068|39707208|FG001|Overall Study|Lost to Follow-up|1|||
16333809|NCT01537068|39707207|FG000|Overall Study|Adverse Event|0|||
16333810|NCT01537068|39707208|FG001|Overall Study|Adverse Event|1|||
16333811|NCT01537068|39707207|FG000|Overall Study|Withdrawal by Subject|1|||
16333812|NCT01537068|39707208|FG001|Overall Study|Withdrawal by Subject|1|||
16333813|NCT01537068|39707207|FG000|Overall Study|Lack of Efficacy|1|||
16333814|NCT01537068|39707208|FG001|Overall Study|Lack of Efficacy|0|||
16333815|NCT00904917|39707210|FG000|Overall Study|Lost to Follow-up|2|||
16333816|NCT00904917|39707211|FG001|Overall Study|Lost to Follow-up|2|||
16333817|NCT00904917|39707212|FG002|Overall Study|Lost to Follow-up|2|||
16333818|NCT00904917|39707213|FG003|Overall Study|Lost to Follow-up|2|||
16333819|NCT01790516|39707214|FG000|Overall Study|Physician Decision|1|||
16333820|NCT01790516|39707215|FG001|Overall Study|Physician Decision|0|||
16333821|NCT00597506|39707216|FG000|Overall Study|Subject is being followed for survival|1|||
16333822|NCT03672461|39707228|FG000|Overall Study|COVID Related|4|||
16333823|NCT03672461|39707229|FG001|Overall Study|COVID Related|2|||
16333824|NCT03672461|39707228|FG000|Overall Study|Adverse Event|2|||
16333825|NCT03672461|39707229|FG001|Overall Study|Adverse Event|0|||
16333826|NCT03672461|39707228|FG000|Overall Study|Serious Adverse Event|0|||
16333827|NCT03672461|39707229|FG001|Overall Study|Serious Adverse Event|1|||
16333828|NCT03672461|39707228|FG000|Overall Study|Too Busy|3|||
16333829|NCT03672461|39707229|FG001|Overall Study|Too Busy|1|||
16333830|NCT03672461|39707228|FG000|Overall Study|Lost to Follow-up|1|||
16333831|NCT03672461|39707229|FG001|Overall Study|Lost to Follow-up|2|||
16333832|NCT03672461|39707228|FG000|Overall Study|Family|2|||
16333833|NCT03672461|39707229|FG001|Overall Study|Family|2|||
16333834|NCT03672461|39707228|FG000|Overall Study|No remote technology access|0|||
16333835|NCT03672461|39707229|FG001|Overall Study|No remote technology access|1|||
16333836|NCT03672461|39707228|FG000|Overall Study|Withdrawal by Subject|1|||
16333837|NCT03672461|39707229|FG001|Overall Study|Withdrawal by Subject|0|||
16333838|NCT03672461|39707228|FG000|Overall Study|Cannot tolerate intervention|1|||
16333839|NCT03672461|39707229|FG001|Overall Study|Cannot tolerate intervention|0|||
16333840|NCT03672461|39707228|FG000|Overall Study|Incomplete outcome data|6|||
16333841|NCT03672461|39707229|FG001|Overall Study|Incomplete outcome data|1|||
16333842|NCT02248974|39707230|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
16333843|NCT02248974|39707231|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
16333844|NCT02248974|39707230|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
16333845|NCT02248974|39707231|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
16333846|NCT02248974|39707230|FG000|1-Day Follow-Up|Enrolled in another study|1|||
16333847|NCT02248974|39707231|FG001|1-Day Follow-Up|Enrolled in another study|0|||
16403730|NCT01170065|39956988|FG000|Overall Study|Reason other than specified|3|||
16333848|NCT02248974|39707230|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
16403731|NCT01170065|39956989|FG001|Overall Study|Reason other than specified|8|||
16333849|NCT02248974|39707231|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
16333850|NCT02248974|39707230|FG000|1-Week Follow-Up|Enrolled in another study|1|||
16333851|NCT02248974|39707231|FG001|1-Week Follow-Up|Enrolled in another study|1|||
16333852|NCT02248974|39707230|FG000|1-Week Follow-Up|Transferred to another facility|1|||
16333853|NCT02248974|39707231|FG001|1-Week Follow-Up|Transferred to another facility|0|||
16333854|NCT02248974|39707230|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
16333855|NCT02248974|39707231|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
16333856|NCT02248974|39707230|FG000|1-Week Follow-Up|Death|1|||
16333857|NCT02248974|39707231|FG001|1-Week Follow-Up|Death|1|||
16333858|NCT02248974|39707230|FG000|1-Week Follow-Up|Excluded because of age|0|||
16333859|NCT02248974|39707231|FG001|1-Week Follow-Up|Excluded because of age|1|||
16333860|NCT02248974|39707230|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
16333861|NCT02248974|39707231|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
16333862|NCT02248974|39707230|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
16333863|NCT02248974|39707231|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
16333864|NCT02248974|39707230|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
16333865|NCT02248974|39707231|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
16333866|NCT02248974|39707230|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
16333867|NCT02248974|39707231|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
16333868|NCT02248974|39707230|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
16333869|NCT02248974|39707231|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
16333870|NCT01156051|39707237|FG000|Overall Study|Lost to Follow-up|1|||
16333871|NCT01156051|39707238|FG001|Overall Study|Lost to Follow-up|0|||
16333872|NCT01156051|39707237|FG000|Overall Study|patient not compliant with protocol|0|||
16333873|NCT01156051|39707238|FG001|Overall Study|patient not compliant with protocol|1|||
16333874|NCT01534208|39707239|FG000|Overall Study|Lost to Follow-up|19|||
16333875|NCT01534208|39707240|FG001|Overall Study|Lost to Follow-up|14|||
16333876|NCT01534208|39707239|FG000|Overall Study|Withdrawal by Subject|6|||
16333877|NCT01534208|39707240|FG001|Overall Study|Withdrawal by Subject|20|||
16333878|NCT01534208|39707239|FG000|Overall Study|Adverse Event|15|||
16333879|NCT01534208|39707240|FG001|Overall Study|Adverse Event|8|||
16333880|NCT01534208|39707239|FG000|Overall Study|Physician Decision|2|||
16333881|NCT01534208|39707240|FG001|Overall Study|Physician Decision|0|||
16333882|NCT01534208|39707239|FG000|Overall Study|Lack of Efficacy|0|||
16333883|NCT01534208|39707240|FG001|Overall Study|Lack of Efficacy|3|||
16333884|NCT01534208|39707239|FG000|Overall Study|Protocol Violation|2|||
16333885|NCT01534208|39707240|FG001|Overall Study|Protocol Violation|2|||
16333886|NCT01534208|39707239|FG000|Overall Study|Sponsor decision|4|||
16333887|NCT01534208|39707240|FG001|Overall Study|Sponsor decision|1|||
16333888|NCT01534208|39707239|FG000|Overall Study|Subject relocation|2|||
16333889|NCT01534208|39707240|FG001|Overall Study|Subject relocation|0|||
16333890|NCT01534208|39707239|FG000|Overall Study|Lab assessment|2|||
16333891|NCT01534208|39707240|FG001|Overall Study|Lab assessment|1|||
16333892|NCT01534208|39707239|FG000|Overall Study|Eligibility error|3|||
16333893|NCT01534208|39707240|FG001|Overall Study|Eligibility error|0|||
16333894|NCT01534208|39707239|FG000|Overall Study|PCP decision|1|||
16333895|NCT01534208|39707240|FG001|Overall Study|PCP decision|0|||
16333896|NCT01534208|39707239|FG000|Overall Study|Needed prohibited meds|1|||
16333897|NCT01534208|39707240|FG001|Overall Study|Needed prohibited meds|0|||
16333898|NCT01185509|39707244|FG000|Overall Study|Progression/Relapse|9|||
16333899|NCT01185509|39707245|FG001|Overall Study|Progression/Relapse|15|||
16333900|NCT01185509|39707244|FG000|Overall Study|Physician Decision|2|||
16333901|NCT01185509|39707245|FG001|Overall Study|Physician Decision|2|||
16403732|NCT01170065|39956990|FG002|Overall Study|Reason other than specified|3|||
16333902|NCT01185509|39707244|FG000|Overall Study|Withdrawal by Subject|0|||
16333903|NCT01185509|39707245|FG001|Overall Study|Withdrawal by Subject|1|||
16333904|NCT01185509|39707244|FG000|Overall Study|Death|0|||
16333905|NCT01185509|39707245|FG001|Overall Study|Death|1|||
16333906|NCT01185509|39707244|FG000|Overall Study|Intercurrent Illness|0|||
16333907|NCT01185509|39707245|FG001|Overall Study|Intercurrent Illness|1|||
16333908|NCT00725101|39707246|FG000|Overall Study|Death|3|||
16333909|NCT00725101|39707246|FG000|Overall Study|Lost to Follow-up|353|||
16333910|NCT00725101|39707246|FG000|Overall Study|Protocol Violation|1|||
16333911|NCT00725101|39707246|FG000|Overall Study|Withdrawal by Subject|127|||
16333912|NCT00725101|39707246|FG000|Overall Study|not specified/no reason given|11|||
16333913|NCT04459598|39707247|FG000|Overall Study|Adverse Event|1|||
16333914|NCT04459598|39707248|FG001|Overall Study|Adverse Event|1|||
16333915|NCT01634659|39707249|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
16333916|NCT01634659|39707250|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
16333917|NCT01634659|39707249|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
16333918|NCT01634659|39707250|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
16333919|NCT03003000|39707255|FG000|Overall Study|Adverse Event|1|||
16333920|NCT03003000|39707256|FG001|Overall Study|Adverse Event|2|||
16333921|NCT03003000|39707257|FG002|Overall Study|Adverse Event|3|||
16333922|NCT03003000|39707255|FG000|Overall Study|Lack of Efficacy|1|||
16333923|NCT03003000|39707256|FG001|Overall Study|Lack of Efficacy|0|||
16333924|NCT03003000|39707257|FG002|Overall Study|Lack of Efficacy|0|||
16333925|NCT03003000|39707255|FG000|Overall Study|Non-compliant with protocol|0|||
16333926|NCT03003000|39707256|FG001|Overall Study|Non-compliant with protocol|1|||
16333927|NCT03003000|39707257|FG002|Overall Study|Non-compliant with protocol|1|||
16333928|NCT03003000|39707255|FG000|Overall Study|Refused to continue medication|2|||
16333929|NCT03003000|39707256|FG001|Overall Study|Refused to continue medication|0|||
16333930|NCT03003000|39707257|FG002|Overall Study|Refused to continue medication|0|||
16333931|NCT03003000|39707255|FG000|Overall Study|Other than listed|1|||
16333932|NCT03003000|39707256|FG001|Overall Study|Other than listed|1|||
16333933|NCT03003000|39707257|FG002|Overall Study|Other than listed|1|||
16333934|NCT02607280|39707258|FG000|Overall Study|Adverse Event|4|||
16333935|NCT02607280|39707259|FG001|Overall Study|Adverse Event|0|||
16333936|NCT02607280|39707258|FG000|Overall Study|Decrease in CrCl <15|0|||
16333937|NCT02607280|39707259|FG001|Overall Study|Decrease in CrCl <15|1|||
16333938|NCT02332239|39707262|FG000|Overall Study|Lost to Follow-up|4|||
16333939|NCT02332239|39707263|FG001|Overall Study|Lost to Follow-up|6|||
16333940|NCT02101359|39707269|FG000|Overall Study|Not included|23|||
16333941|NCT02101359|39707270|FG001|Overall Study|Not included|13|||
16333942|NCT02101359|39707269|FG000|Overall Study|Withdrawal by Subject|5|||
16333943|NCT02101359|39707270|FG001|Overall Study|Withdrawal by Subject|4|||
16333944|NCT02101359|39707269|FG000|Overall Study|Lost to Follow-up|1|||
16333945|NCT02101359|39707270|FG001|Overall Study|Lost to Follow-up|0|||
16333946|NCT02101359|39707269|FG000|Overall Study|Protocol Violation|0|||
16333947|NCT02101359|39707270|FG001|Overall Study|Protocol Violation|2|||
16333948|NCT00860249|39707273|FG000|Overall Study|trial was terminated prior to completion|21|||
16333949|NCT00860249|39707274|FG001|Overall Study|trial was terminated prior to completion|18|||
16333950|NCT00860249|39707275|FG002|Overall Study|trial was terminated prior to completion|21|||
16533696|NCT00295750|40418117|FG000|Overall Study|Randomized but never received trial drug|4|||
16533697|NCT00295750|40418118|FG001|Overall Study|Randomized but never received trial drug|3|||
16533698|NCT00295750|40418119|FG002|Overall Study|Randomized but never received trial drug|3|||
16533699|NCT00295750|40418117|FG000|Overall Study|Withdrawal by Subject|9|||
16533700|NCT00295750|40418118|FG001|Overall Study|Withdrawal by Subject|4|||
16533701|NCT00295750|40418119|FG002|Overall Study|Withdrawal by Subject|7|||
16533702|NCT00295750|40418117|FG000|Overall Study|Protocol Violation|2|||
16533703|NCT00295750|40418118|FG001|Overall Study|Protocol Violation|4|||
16533704|NCT00295750|40418119|FG002|Overall Study|Protocol Violation|2|||
16533705|NCT01917526|40418120|FG000|Overall Study|Protocol Violation|1|||
16533706|NCT01917526|40418121|FG001|Overall Study|Protocol Violation|1|||
16533707|NCT01581281|40418124|FG000|Overall Study|Early Study Closure|15|||
16533708|NCT01581281|40418125|FG001|Overall Study|Early Study Closure|6|||
16533709|NCT01581281|40418126|FG002|Overall Study|Early Study Closure|12|||
16533710|NCT00047879|40418130|FG000|Overall Study|Progressive disease|4|||
16533711|NCT00047879|40418131|FG001|Overall Study|Progressive disease|3|||
16533712|NCT02099838|40418132|FG000|Overall Study|Death|1|||
16533713|NCT02099838|40418133|FG001|Overall Study|Death|0|||
16533714|NCT02099838|40418132|FG000|Overall Study|Lost to Follow-up|3|||
16533715|NCT02099838|40418133|FG001|Overall Study|Lost to Follow-up|1|||
16100993|NCT01107912|38856713|FG000|Period 1|Adverse Event|0|||
16100994|NCT01107912|38856714|FG001|Period 1|Adverse Event|0|||
16333951|NCT02382796|39707279|FG000|Overall Study|Global deterioration of health status|1|||
16333952|NCT02382796|39707279|FG000|Overall Study|Objective progression or relapse|3|||
16333953|NCT02382796|39707279|FG000|Overall Study|Commercial dacomitinib became available|3|||
16333954|NCT01826370|39707280|FG000|Overall Study|Protocol Violation|6|||
16333955|NCT01826370|39707280|FG000|Overall Study|Lost to Follow-up|12|||
16333956|NCT01826370|39707280|FG000|Overall Study|Other reason not defined above|2|||
16333957|NCT04526574|39707281|FG000|Overall Study|Protocol Violation|3|||
16333958|NCT04526574|39707282|FG001|Overall Study|Protocol Violation|1|||
16333959|NCT04526574|39707281|FG000|Overall Study|Withdrawal by Subject|12|||
16533716|NCT02099838|40418132|FG000|Overall Study|Withdrawal by Subject|0|||
16533717|NCT02099838|40418133|FG001|Overall Study|Withdrawal by Subject|1|||
16100995|NCT01107912|38856715|FG002|Period 1|Adverse Event|0|||
16333960|NCT04526574|39707282|FG001|Overall Study|Withdrawal by Subject|9|||
16333961|NCT04526574|39707281|FG000|Overall Study|Other|1|||
16333962|NCT04526574|39707282|FG001|Overall Study|Other|2|||
16333963|NCT04526574|39707281|FG000|Overall Study|Adverse Event|1|||
16333964|NCT04526574|39707282|FG001|Overall Study|Adverse Event|1|||
16333965|NCT04526574|39707281|FG000|Overall Study|Death|2|||
16333966|NCT04526574|39707282|FG001|Overall Study|Death|3|||
16333967|NCT04526574|39707281|FG000|Overall Study|Lost to Follow-up|9|||
16333968|NCT04526574|39707282|FG001|Overall Study|Lost to Follow-up|9|||
16533718|NCT02472964|40418134|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
16533719|NCT02472964|40418135|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
16533720|NCT02472964|40418134|FG000|Part 1 (up to Week 24)|disease progression|58|||
16533721|NCT02472964|40418135|FG001|Part 1 (up to Week 24)|disease progression|47|||
16533722|NCT02472964|40418134|FG000|Part 1 (up to Week 24)|Death|3|||
16333969|NCT04526574|39707281|FG000|Overall Study|No longer meets eligibility criteria|8|||
16333970|NCT04526574|39707282|FG001|Overall Study|No longer meets eligibility criteria|8|||
16333971|NCT02071082|39707283|FG000|Overall Study|Enrolled and Never Treated|1|||
16333972|NCT02071082|39707284|FG001|Overall Study|Enrolled and Never Treated|1|||
16333973|NCT02071082|39707283|FG000|Overall Study|Adverse Event|0|||
16333974|NCT02071082|39707284|FG001|Overall Study|Adverse Event|1|||
16533723|NCT02472964|40418135|FG001|Part 1 (up to Week 24)|Death|6|||
16533724|NCT02472964|40418134|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
16533725|NCT02472964|40418135|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
16533726|NCT02472964|40418134|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
16533727|NCT02472964|40418135|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
16333975|NCT02071082|39707283|FG000|Overall Study|Withdrew Consent|0|||
16333976|NCT02071082|39707284|FG001|Overall Study|Withdrew Consent|4|||
16333977|NCT02071082|39707283|FG000|Overall Study|Lost to Follow-up|1|||
16333978|NCT02071082|39707284|FG001|Overall Study|Lost to Follow-up|1|||
16333979|NCT02427802|39707285|FG000|Overall Study|Adverse Event|11|||
16333980|NCT02427802|39707286|FG001|Overall Study|Adverse Event|3|||
16533728|NCT02472964|40418134|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
16533729|NCT02472964|40418135|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
16533730|NCT02472964|40418134|FG000|Part 1 (up to Week 24)|Other|2|||
16333981|NCT02427802|39707287|FG002|Overall Study|Adverse Event|7|||
16533731|NCT02472964|40418135|FG001|Part 1 (up to Week 24)|Other|1|||
16533732|NCT02472964|40418134|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
16533733|NCT02472964|40418135|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
16533734|NCT02472964|40418134|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
16533735|NCT02472964|40418135|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
16533736|NCT02472964|40418134|FG000|Part 2 (Week 24-week 48)|Death|0|||
16533737|NCT02472964|40418135|FG001|Part 2 (Week 24-week 48)|Death|1|||
16533738|NCT02472964|40418134|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
16533739|NCT02472964|40418135|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
16533740|NCT02472964|40418134|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
16333982|NCT02427802|39707285|FG000|Overall Study|Death|0|||
16533741|NCT02472964|40418135|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
16533742|NCT02472964|40418134|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
16533743|NCT02472964|40418135|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
16533744|NCT02472964|40418134|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
16533745|NCT02472964|40418135|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
16333983|NCT02427802|39707286|FG001|Overall Study|Death|4|||
16333984|NCT02427802|39707287|FG002|Overall Study|Death|1|||
16533746|NCT03166618|40418138|FG000|Overall Study|Study was Terminated|0|||
16533747|NCT03166618|40418139|FG001|Overall Study|Study was Terminated|1|||
16533748|NCT01128413|40418140|FG000|Overall Study|Withdrawal by Subject|1|||
16533749|NCT01128413|40418141|FG001|Overall Study|Withdrawal by Subject|0|||
16533750|NCT01128413|40418140|FG000|Overall Study|NICOM Monitor Problems|2|||
16533751|NCT01128413|40418141|FG001|Overall Study|NICOM Monitor Problems|1|||
16533752|NCT01128413|40418140|FG000|Overall Study|Pt made DNR|1|||
16533753|NCT01128413|40418141|FG001|Overall Study|Pt made DNR|0|||
16533754|NCT02216123|40418144|FG000|Overall Study|Lost to Follow-up|4|||
16533755|NCT02216123|40418145|FG001|Overall Study|Lost to Follow-up|2|||
16533756|NCT02216123|40418144|FG000|Overall Study|Withdrawal by Subject|2|||
16533757|NCT02216123|40418145|FG001|Overall Study|Withdrawal by Subject|0|||
16533758|NCT00321919|40418146|FG000|Overall Study|Adverse Event|17|||
16533759|NCT00321919|40418147|FG001|Overall Study|Adverse Event|10|||
16533760|NCT00321919|40418146|FG000|Overall Study|Death|21|||
16533761|NCT00321919|40418147|FG001|Overall Study|Death|17|||
16533762|NCT00321919|40418146|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16533763|NCT00321919|40418147|FG001|Overall Study|Insufficient Therapeutic Response|0|||
16533764|NCT00321919|40418146|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
16533765|NCT00321919|40418147|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
16533766|NCT00321919|40418146|FG000|Overall Study|Refused Treatment|23|||
16533767|NCT00321919|40418147|FG001|Overall Study|Refused Treatment|14|||
16533768|NCT00321919|40418146|FG000|Overall Study|Other Protocol Violation|2|||
16533769|NCT00321919|40418147|FG001|Overall Study|Other Protocol Violation|3|||
16533770|NCT00321919|40418146|FG000|Overall Study|Failure to Return|3|||
16533771|NCT00321919|40418147|FG001|Overall Study|Failure to Return|1|||
16533772|NCT00321919|40418146|FG000|Overall Study|Other withdrawal reason|7|||
16533773|NCT00321919|40418147|FG001|Overall Study|Other withdrawal reason|6|||
16533774|NCT02298192|40418148|FG000|Overall Study|Unclassified|3|||
16533775|NCT02298192|40418149|FG001|Overall Study|Unclassified|2|||
16533776|NCT02298192|40418148|FG000|Overall Study|Withdrawal criteria|2|||
16533777|NCT02298192|40418149|FG001|Overall Study|Withdrawal criteria|0|||
16533778|NCT02298192|40418148|FG000|Overall Study|Withdrawal by Subject|6|||
16333985|NCT02427802|39707285|FG000|Overall Study|Lost to Follow-up|13|||
16333986|NCT02427802|39707286|FG001|Overall Study|Lost to Follow-up|8|||
16333987|NCT02427802|39707287|FG002|Overall Study|Lost to Follow-up|8|||
16333988|NCT02427802|39707285|FG000|Overall Study|Physician Decision|4|||
16333989|NCT02427802|39707286|FG001|Overall Study|Physician Decision|2|||
16333990|NCT02427802|39707287|FG002|Overall Study|Physician Decision|4|||
16333991|NCT02427802|39707285|FG000|Overall Study|Withdrawal by Subject|10|||
16333992|NCT02427802|39707286|FG001|Overall Study|Withdrawal by Subject|5|||
16333993|NCT02427802|39707287|FG002|Overall Study|Withdrawal by Subject|11|||
16333994|NCT02427802|39707285|FG000|Overall Study|Protocol Violation|3|||
16333995|NCT02427802|39707286|FG001|Overall Study|Protocol Violation|1|||
16333996|NCT02427802|39707287|FG002|Overall Study|Protocol Violation|1|||
16333997|NCT02427802|39707285|FG000|Overall Study|protocol specific treatment unrelated|18|||
16333998|NCT02427802|39707286|FG001|Overall Study|protocol specific treatment unrelated|11|||
16533779|NCT02298192|40418149|FG001|Overall Study|Withdrawal by Subject|1|||
16533780|NCT02298192|40418148|FG000|Overall Study|Lost to Follow-up|2|||
16533781|NCT02298192|40418149|FG001|Overall Study|Lost to Follow-up|1|||
16100996|NCT01107912|38856716|FG003|Period 1|Adverse Event|0|||
16333999|NCT02427802|39707287|FG002|Overall Study|protocol specific treatment unrelated|11|||
16334000|NCT00962091|39710646|FG000|Overall Study|Withdrawal by Subject|1|||
16334001|NCT00962091|39710647|FG001|Overall Study|Withdrawal by Subject|2|||
16334002|NCT00962091|39710648|FG002|Overall Study|Withdrawal by Subject|1|||
16334003|NCT00962091|39710649|FG003|Overall Study|Withdrawal by Subject|1|||
16334004|NCT00962091|39710650|FG004|Overall Study|Withdrawal by Subject|0|||
16334005|NCT00962091|39710651|FG005|Overall Study|Withdrawal by Subject|1|||
16334006|NCT00962091|39710652|FG006|Overall Study|Withdrawal by Subject|0|||
16334007|NCT00962091|39710646|FG000|Overall Study|Adverse Event|0|||
16334008|NCT00962091|39710647|FG001|Overall Study|Adverse Event|0|||
16533782|NCT02298192|40418148|FG000|Overall Study|Adverse Event|6|||
16533783|NCT02298192|40418149|FG001|Overall Study|Adverse Event|2|||
16533784|NCT02862106|40418152|FG000|Overall Study|Adverse Event|4|||
16533785|NCT02862106|40418153|FG001|Overall Study|Adverse Event|0|||
16533786|NCT02862106|40418152|FG000|Overall Study|Protocol Violation|16|||
16533787|NCT02862106|40418153|FG001|Overall Study|Protocol Violation|1|||
16533788|NCT02862106|40418152|FG000|Overall Study|Lost to Follow-up|15|||
16533789|NCT02862106|40418153|FG001|Overall Study|Lost to Follow-up|5|||
16533790|NCT02862106|40418152|FG000|Overall Study|Withdrawal by Subject|2|||
16533791|NCT02862106|40418153|FG001|Overall Study|Withdrawal by Subject|0|||
16100997|NCT01107912|38856717|FG004|Period 1|Adverse Event|2|||
16334009|NCT00962091|39710648|FG002|Overall Study|Adverse Event|0|||
16334010|NCT00962091|39710649|FG003|Overall Study|Adverse Event|0|||
16533792|NCT02862106|40418152|FG000|Overall Study|Subjects moved to other city|1|||
16533793|NCT02862106|40418153|FG001|Overall Study|Subjects moved to other city|0|||
16533794|NCT02911948|40418156|FG000|Overall Study|Protocol Violation|0|||
16533795|NCT02911948|40418157|FG001|Overall Study|Protocol Violation|1|||
16334011|NCT00962091|39710650|FG004|Overall Study|Adverse Event|0|||
16334012|NCT00962091|39710651|FG005|Overall Study|Adverse Event|0|||
16334013|NCT00962091|39710652|FG006|Overall Study|Adverse Event|1|||
16334014|NCT04811664|39710653|FG000|Overall Study|Lost to Follow-up|78|||
16334015|NCT04811664|39710654|FG001|Overall Study|Lost to Follow-up|125|||
16334016|NCT04811664|39710655|FG002|Overall Study|Lost to Follow-up|46|||
16334017|NCT04811664|39710653|FG000|Overall Study|Withdrawal by Subject|39|||
16334018|NCT04811664|39710654|FG001|Overall Study|Withdrawal by Subject|76|||
16334019|NCT04811664|39710655|FG002|Overall Study|Withdrawal by Subject|12|||
16334020|NCT04811664|39710653|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
16334021|NCT04811664|39710654|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
16334022|NCT04811664|39710655|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
16334023|NCT04811664|39710653|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
16334024|NCT04811664|39710654|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
16533796|NCT02911948|40418156|FG000|Overall Study|Withdrawal by Subject|0|||
16533797|NCT02911948|40418157|FG001|Overall Study|Withdrawal by Subject|2|||
16533798|NCT02911948|40418156|FG000|Overall Study|Lack of Efficacy|0|||
16533799|NCT02911948|40418157|FG001|Overall Study|Lack of Efficacy|1|||
16533800|NCT02911948|40418156|FG000|Overall Study|Unclassified|0|||
16533801|NCT02911948|40418157|FG001|Overall Study|Unclassified|3|||
16533802|NCT01754467|40418158|FG000|Overall Study|Lost to Follow-up|1|||
16533803|NCT03077724|40418159|FG000|Overall Study|Lost to Follow-up|5|||
16533804|NCT03077724|40418160|FG001|Overall Study|Lost to Follow-up|1|||
16533805|NCT03077724|40418159|FG000|Overall Study|Withdrawal by Subject|3|||
16533806|NCT03077724|40418160|FG001|Overall Study|Withdrawal by Subject|1|||
16533807|NCT00936858|40418161|FG000|Overall Study|Death|3|||
16533808|NCT00936858|40418161|FG000|Overall Study|Progression|29|||
16533809|NCT00936858|40418161|FG000|Overall Study|Withdrawal by Subject|5|||
16533810|NCT00936858|40418161|FG000|Overall Study|Adverse Event|1|||
16533811|NCT00936858|40418161|FG000|Overall Study|Physician Decision|7|||
16533812|NCT00936858|40418161|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
16533813|NCT00936858|40418161|FG000|Overall Study|Lost to Follow-up|1|||
16533814|NCT06281548|40418166|FG000|Overall Study|Lost to Follow-up|3|||
16533815|NCT01454583|40418170|FG000|1st Year|Lost to Follow-up|1057|||
16533816|NCT01454583|40418171|FG001|1st Year|Lost to Follow-up|318|||
16533817|NCT01454583|40418172|FG002|1st Year|Lost to Follow-up|180|||
16533818|NCT01454583|40418170|FG000|2nd Year|Lost to Follow-up|3965|||
16533819|NCT01454583|40418171|FG001|2nd Year|Lost to Follow-up|1049|||
16533820|NCT01454583|40418172|FG002|2nd Year|Lost to Follow-up|737|||
16533821|NCT01454583|40418170|FG000|3rd Year|Lost to Follow-up|1959|||
16533822|NCT01454583|40418171|FG001|3rd Year|Lost to Follow-up|512|||
16533823|NCT01454583|40418172|FG002|3rd Year|Lost to Follow-up|297|||
16533824|NCT03750552|40418173|FG000|Overall Study|Adverse Event|5|||
16533825|NCT03750552|40418174|FG001|Overall Study|Adverse Event|1|||
16533826|NCT03750552|40418173|FG000|Overall Study|Withdrawal by Subject|1|||
16533827|NCT03750552|40418174|FG001|Overall Study|Withdrawal by Subject|1|||
16533828|NCT03750552|40418173|FG000|Overall Study|Other|2|||
16533829|NCT03750552|40418174|FG001|Overall Study|Other|0|||
16533830|NCT00352365|40418175|FG000|Induction Therapy|Adverse Event|7|||
16533831|NCT00352365|40418175|FG000|Induction Therapy|Progression/Relapse|8|||
16533832|NCT00352365|40418175|FG000|Induction Therapy|Death|7|||
16533833|NCT00352365|40418175|FG000|Induction Therapy|Not protocol specified|1|||
16533834|NCT00352365|40418175|FG000|Induction Therapy|Not eligible|3|||
16533835|NCT00352365|40418175|FG000|Induction Therapy|Death before starting protocol therapy|1|||
16533836|NCT00352365|40418175|FG000|Maintenance Therapy|Progression/Relapse|3|||
16533837|NCT00352365|40418175|FG000|Maintenance Therapy|Death|2|||
16533838|NCT00352365|40418175|FG000|Maintenance Therapy|Not protocol specified|3|||
16533839|NCT00352365|40418175|FG000|Maintenance Therapy|Not eligible|4|||
16533840|NCT01563536|40418176|FG000|Overall Study|Withdrawal by Subject|0|||
16533841|NCT01563536|40418177|FG001|Overall Study|Withdrawal by Subject|2|||
16533842|NCT01563536|40418176|FG000|Overall Study|Lost to Follow-up|1|||
16334025|NCT04811664|39710655|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
16533843|NCT01563536|40418177|FG001|Overall Study|Lost to Follow-up|0|||
16533844|NCT04570436|40418181|FG000|Overall Study|Adverse Event|0|||
16533845|NCT04570436|40418182|FG001|Overall Study|Adverse Event|0|||
16533846|NCT04570436|40418183|FG002|Overall Study|Adverse Event|1|||
16533847|NCT04570436|40418184|FG003|Overall Study|Adverse Event|0|||
16533848|NCT04570436|40418185|FG004|Overall Study|Adverse Event|0|||
16403733|NCT01170065|39956988|FG000|Overall Study|Ongoing after planned observation time|5|||
16403734|NCT01170065|39956989|FG001|Overall Study|Ongoing after planned observation time|26|||
16403735|NCT01170065|39956990|FG002|Overall Study|Ongoing after planned observation time|10|||
16533849|NCT04570436|40418186|FG005|Overall Study|Adverse Event|0|||
16533850|NCT04570436|40418187|FG006|Overall Study|Adverse Event|0|||
16533851|NCT04570436|40418188|FG007|Overall Study|Adverse Event|0|||
16533852|NCT04570436|40418189|FG008|Overall Study|Adverse Event|0|||
16533853|NCT04570436|40418190|FG009|Overall Study|Adverse Event|0|||
16533854|NCT04570436|40418181|FG000|Overall Study|Physician Decision|1|||
16533855|NCT04570436|40418182|FG001|Overall Study|Physician Decision|0|||
16533856|NCT04570436|40418183|FG002|Overall Study|Physician Decision|0|||
16533857|NCT04570436|40418184|FG003|Overall Study|Physician Decision|0|||
16533858|NCT04570436|40418185|FG004|Overall Study|Physician Decision|0|||
16533859|NCT04570436|40418186|FG005|Overall Study|Physician Decision|0|||
16334026|NCT04811664|39710653|FG000|Overall Study|Protocol Violation|0|||
16334027|NCT04811664|39710654|FG001|Overall Study|Protocol Violation|5|||
16334028|NCT04811664|39710655|FG002|Overall Study|Protocol Violation|11|||
16334029|NCT04811664|39710653|FG000|Overall Study|Study Terminated by Sponsor|4|||
16334030|NCT04811664|39710654|FG001|Overall Study|Study Terminated by Sponsor|3|||
16334031|NCT04811664|39710655|FG002|Overall Study|Study Terminated by Sponsor|34|||
16334032|NCT04811664|39710653|FG000|Overall Study|Early Study Closure|3|||
16334033|NCT04811664|39710654|FG001|Overall Study|Early Study Closure|7|||
16334034|NCT04811664|39710655|FG002|Overall Study|Early Study Closure|79|||
16334035|NCT04811664|39710653|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
16334036|NCT04811664|39710654|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
16334037|NCT04811664|39710655|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
16334038|NCT01907217|39710656|FG000|Overall Study|Withdrawal by Subject|0|||
16334039|NCT01907217|39710657|FG001|Overall Study|Withdrawal by Subject|2|||
16334040|NCT03558152|39710658|FG000|Overall Study|Adverse Event|0|||
16334041|NCT03558152|39710659|FG001|Overall Study|Adverse Event|0|||
16334042|NCT03558152|39710660|FG002|Overall Study|Adverse Event|1|||
16334043|NCT03558152|39710661|FG003|Overall Study|Adverse Event|1|||
16334044|NCT03558152|39710662|FG004|Overall Study|Adverse Event|2|||
16334045|NCT03558152|39710663|FG005|Overall Study|Adverse Event|1|||
16334046|NCT03558152|39710664|FG006|Overall Study|Adverse Event|1|||
16334047|NCT03558152|39710665|FG007|Overall Study|Adverse Event|0|||
16334048|NCT03558152|39710658|FG000|Overall Study|Death|0|||
16334049|NCT03558152|39710659|FG001|Overall Study|Death|0|||
16334050|NCT03558152|39710660|FG002|Overall Study|Death|0|||
16334051|NCT03558152|39710661|FG003|Overall Study|Death|0|||
16334052|NCT03558152|39710662|FG004|Overall Study|Death|1|||
16334053|NCT03558152|39710663|FG005|Overall Study|Death|0|||
16334054|NCT03558152|39710664|FG006|Overall Study|Death|0|||
16334055|NCT03558152|39710665|FG007|Overall Study|Death|0|||
16334056|NCT03558152|39710658|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
16334057|NCT03558152|39710659|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
16334058|NCT03558152|39710660|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
16216306|NCT01289028|39272311|FG000|Overall Study|Lost to Follow-up|2|||
16216307|NCT01289028|39272311|FG000|Overall Study|New Cancer Therapy|2|||
16216308|NCT01289028|39272311|FG000|Overall Study|Abnormal Lab Value|1|||
16216309|NCT01289028|39272311|FG000|Overall Study|Missing reason for discon|1|||
16216310|NCT01987609|39272312|FG000|Overall Study|Adverse Event|1|||
16216311|NCT01468844|39272316|FG000|Overall Study|Adverse Event|1|||
16216312|NCT01468844|39272317|FG001|Overall Study|Adverse Event|0|||
16216313|NCT01468844|39272316|FG000|Overall Study|Withdrawal by Subject|1|||
16334059|NCT03558152|39710661|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
16334060|NCT03558152|39710662|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
16334061|NCT03558152|39710663|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
16334062|NCT03558152|39710664|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
16334063|NCT03558152|39710665|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
16334064|NCT03558152|39710658|FG000|Overall Study|Miscalculation in mmcs|0|||
16334065|NCT03558152|39710659|FG001|Overall Study|Miscalculation in mmcs|0|||
16334066|NCT03558152|39710660|FG002|Overall Study|Miscalculation in mmcs|0|||
16334067|NCT03558152|39710661|FG003|Overall Study|Miscalculation in mmcs|0|||
16334068|NCT03558152|39710662|FG004|Overall Study|Miscalculation in mmcs|0|||
16334069|NCT03558152|39710663|FG005|Overall Study|Miscalculation in mmcs|0|||
16533860|NCT04570436|40418187|FG006|Overall Study|Physician Decision|0|||
16533861|NCT04570436|40418188|FG007|Overall Study|Physician Decision|0|||
16334070|NCT03558152|39710664|FG006|Overall Study|Miscalculation in mmcs|1|||
16334071|NCT03558152|39710665|FG007|Overall Study|Miscalculation in mmcs|0|||
16100998|NCT01107912|38856718|FG005|Period 1|Adverse Event|0|||
16100999|NCT01107912|38856713|FG000|Period 1|Physician Decision|0|||
16101000|NCT01107912|38856714|FG001|Period 1|Physician Decision|0|||
16101001|NCT01107912|38856715|FG002|Period 1|Physician Decision|0|||
16101002|NCT01107912|38856716|FG003|Period 1|Physician Decision|0|||
16101003|NCT01107912|38856717|FG004|Period 1|Physician Decision|1|||
16101004|NCT01107912|38856718|FG005|Period 1|Physician Decision|0|||
16101005|NCT01107912|38856713|FG000|Period 1|Withdrawal by Subject|1|||
16101006|NCT01107912|38856714|FG001|Period 1|Withdrawal by Subject|0|||
16101007|NCT01107912|38856715|FG002|Period 1|Withdrawal by Subject|0|||
16101008|NCT01107912|38856716|FG003|Period 1|Withdrawal by Subject|0|||
16101009|NCT01107912|38856717|FG004|Period 1|Withdrawal by Subject|0|||
16101010|NCT01107912|38856718|FG005|Period 1|Withdrawal by Subject|0|||
16403736|NCT01127607|39956991|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
16403737|NCT01127607|39956992|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
16403738|NCT01127607|39956991|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
16403739|NCT01127607|39956992|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
16403740|NCT00920387|39956993|FG000|Stage 1|Adverse Event|1|||
16403741|NCT00920387|39956994|FG001|Stage 1|Adverse Event|0|||
16101011|NCT01107912|38856713|FG000|Period 2|Physician Decision|0|||
16101012|NCT01107912|38856714|FG001|Period 2|Physician Decision|0|||
16101013|NCT01107912|38856715|FG002|Period 2|Physician Decision|1|||
16101014|NCT01107912|38856716|FG003|Period 2|Physician Decision|0|||
16334072|NCT03558152|39710658|FG000|Overall Study|Mistake in calculation|0|||
16334073|NCT03558152|39710659|FG001|Overall Study|Mistake in calculation|0|||
16334074|NCT03558152|39710660|FG002|Overall Study|Mistake in calculation|0|||
16403742|NCT00920387|39956995|FG002|Stage 1|Adverse Event|0|||
16403743|NCT01973387|39956996|FG000|Overall Study|Adverse Event|14|||
16533862|NCT04570436|40418189|FG008|Overall Study|Physician Decision|0|||
16334075|NCT03558152|39710661|FG003|Overall Study|Mistake in calculation|1|||
16334076|NCT03558152|39710662|FG004|Overall Study|Mistake in calculation|0|||
16334077|NCT03558152|39710663|FG005|Overall Study|Mistake in calculation|0|||
16334078|NCT03558152|39710664|FG006|Overall Study|Mistake in calculation|0|||
16334079|NCT03558152|39710665|FG007|Overall Study|Mistake in calculation|0|||
16334080|NCT03558152|39710658|FG000|Overall Study|Mistake in evaluation of disease status|0|||
16334081|NCT03558152|39710659|FG001|Overall Study|Mistake in evaluation of disease status|0|||
16334082|NCT03558152|39710660|FG002|Overall Study|Mistake in evaluation of disease status|0|||
16334083|NCT03558152|39710661|FG003|Overall Study|Mistake in evaluation of disease status|0|||
16334084|NCT03558152|39710662|FG004|Overall Study|Mistake in evaluation of disease status|0|||
16334085|NCT03558152|39710663|FG005|Overall Study|Mistake in evaluation of disease status|0|||
16334086|NCT03558152|39710664|FG006|Overall Study|Mistake in evaluation of disease status|0|||
16533863|NCT04570436|40418190|FG009|Overall Study|Physician Decision|0|||
16533864|NCT03657277|40418191|FG000|Overall Study|Physician Decision|2|||
16533865|NCT03657277|40418191|FG000|Overall Study|Lost to Follow-up|1|||
16533866|NCT03657277|40418191|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
16533867|NCT01422408|40418192|FG000|Overall Study|Adverse Event|1|||
16533868|NCT01422408|40418192|FG000|Overall Study|Withdrawal by Subject|3|||
16533869|NCT02570126|40418201|FG000|Overall Study|Lost to Follow-up|2|||
16533870|NCT02570126|40418202|FG001|Overall Study|Lost to Follow-up|0|||
16533871|NCT02570126|40418201|FG000|Overall Study|Unable To Arrange Visit 3|1|||
16101015|NCT01107912|38856717|FG004|Period 2|Physician Decision|0|||
16101016|NCT01107912|38856718|FG005|Period 2|Physician Decision|0|||
16101017|NCT01107912|38856713|FG000|Period 3|Adverse Event|0|||
16101018|NCT01107912|38856714|FG001|Period 3|Adverse Event|1|||
16334087|NCT03558152|39710665|FG007|Overall Study|Mistake in evaluation of disease status|1|||
16403744|NCT01973387|39956997|FG001|Overall Study|Adverse Event|4|||
16403745|NCT01973387|39956996|FG000|Overall Study|Withdrawal by Subject|7|||
16101019|NCT01107912|38856715|FG002|Period 3|Adverse Event|1|||
16533872|NCT02570126|40418202|FG001|Overall Study|Unable To Arrange Visit 3|0|||
16403746|NCT01973387|39956997|FG001|Overall Study|Withdrawal by Subject|4|||
16403747|NCT01973387|39956996|FG000|Overall Study|Study terminated by sponsor|63|||
16403748|NCT01973387|39956997|FG001|Overall Study|Study terminated by sponsor|0|||
16403749|NCT01973387|39956996|FG000|Overall Study|Progressive disease or relapse|16|||
16403750|NCT01973387|39956997|FG001|Overall Study|Progressive disease or relapse|5|||
16403751|NCT01973387|39956996|FG000|Overall Study|Death|4|||
16403752|NCT01973387|39956997|FG001|Overall Study|Death|3|||
16403753|NCT01973387|39956996|FG000|Overall Study|Randomized, not treated|2|||
16334088|NCT03558152|39710658|FG000|Overall Study|Physician Decision|0|||
16334089|NCT03558152|39710659|FG001|Overall Study|Physician Decision|0|||
16403754|NCT01973387|39956997|FG001|Overall Study|Randomized, not treated|2|||
16403755|NCT00737711|39957003|FG000|Overall Study|Adverse Event|2|||
16533873|NCT02570126|40418201|FG000|Overall Study|Violation Of Procedures GSK|0|||
16533874|NCT02570126|40418202|FG001|Overall Study|Violation Of Procedures GSK|1|||
16533875|NCT02570126|40418201|FG000|Overall Study|Protocol Violation|0|||
16533876|NCT02570126|40418202|FG001|Overall Study|Protocol Violation|1|||
16533877|NCT02570126|40418201|FG000|Overall Study|Withdrawal by Subject|3|||
16216314|NCT01468844|39272317|FG001|Overall Study|Withdrawal by Subject|0|||
16216315|NCT01885104|39272318|FG000|Overall Study|Withdrawal of Consent|1|||
16216316|NCT01885104|39272319|FG001|Overall Study|Withdrawal of Consent|0|||
16216317|NCT01885104|39272318|FG000|Overall Study|Lost to Follow-up|0|||
16216318|NCT01885104|39272319|FG001|Overall Study|Lost to Follow-up|1|||
16403756|NCT00737711|39957003|FG000|Overall Study|Death|8|||
16403757|NCT00737711|39957003|FG000|Overall Study|Failure to return|4|||
16403758|NCT00737711|39957003|FG000|Overall Study|Protocol Violation|1|||
16403759|NCT00737711|39957003|FG000|Overall Study|Withdrawal by Subject|5|||
16533878|NCT02570126|40418202|FG001|Overall Study|Withdrawal by Subject|7|||
16533879|NCT01477853|40418203|FG000|Phase A|Adverse Event|1|||
16334090|NCT03558152|39710660|FG002|Overall Study|Physician Decision|0|||
16334091|NCT03558152|39710661|FG003|Overall Study|Physician Decision|0|||
16334092|NCT03558152|39710662|FG004|Overall Study|Physician Decision|0|||
16334093|NCT03558152|39710663|FG005|Overall Study|Physician Decision|0|||
16334094|NCT03558152|39710664|FG006|Overall Study|Physician Decision|1|||
16334095|NCT03558152|39710665|FG007|Overall Study|Physician Decision|0|||
16334096|NCT03558152|39710658|FG000|Overall Study|Withdrawal by Subject|2|||
16334097|NCT03558152|39710659|FG001|Overall Study|Withdrawal by Subject|3|||
16216319|NCT01885104|39272318|FG000|Overall Study|Physician Decision|1|||
16216320|NCT01885104|39272319|FG001|Overall Study|Physician Decision|0|||
16403760|NCT00737711|39957003|FG000|Overall Study|Blood transfusion|6|||
16533880|NCT01477853|40418204|FG001|Phase A|Adverse Event|2|||
16533881|NCT01477853|40418205|FG002|Phase A|Adverse Event|2|||
16533882|NCT01477853|40418203|FG000|Phase A|Lost to Follow-up|4|||
16533883|NCT01477853|40418204|FG001|Phase A|Lost to Follow-up|3|||
16533884|NCT01477853|40418205|FG002|Phase A|Lost to Follow-up|2|||
16533885|NCT01477853|40418203|FG000|Phase A|Physician Decision|1|||
16533886|NCT01477853|40418204|FG001|Phase A|Physician Decision|0|||
16533887|NCT01477853|40418205|FG002|Phase A|Physician Decision|1|||
16533888|NCT01477853|40418203|FG000|Phase A|Study terminated by sponsor|37|||
16533889|NCT01477853|40418204|FG001|Phase A|Study terminated by sponsor|40|||
16533890|NCT01477853|40418205|FG002|Phase A|Study terminated by sponsor|39|||
16216321|NCT03030261|39272321|FG000|Overall Study|Still receiving continuation therapy|5|||
16334098|NCT03558152|39710660|FG002|Overall Study|Withdrawal by Subject|2|||
16334099|NCT03558152|39710661|FG003|Overall Study|Withdrawal by Subject|1|||
16334100|NCT03558152|39710662|FG004|Overall Study|Withdrawal by Subject|1|||
16403761|NCT00737711|39957003|FG000|Overall Study|Other|5|||
16403762|NCT02763566|39957004|FG000|Overall Study|Lost to Follow-up|1|||
16403763|NCT02763566|39957005|FG001|Overall Study|Lost to Follow-up|4|||
16533891|NCT01477853|40418203|FG000|Phase B|Lost to Follow-up|0|||
16216322|NCT00846027|39272322|FG000|Overall Study|Death|3|||
16216323|NCT00846027|39272322|FG000|Overall Study|Disease Progression|30|||
16216324|NCT00846027|39272322|FG000|Overall Study|Toxicity|12|||
16216325|NCT00846027|39272322|FG000|Overall Study|Patient Decision|7|||
16216326|NCT00846027|39272322|FG000|Overall Study|Investigator Discretion|29|||
16216327|NCT00846027|39272322|FG000|Overall Study|Protocol Violation|2|||
16216328|NCT00846027|39272322|FG000|Overall Study|Subject Not Treated|7|||
16216329|NCT02449915|39272323|FG000|Overall Study|Exclusion criteria - drug use|1|||
16216330|NCT02449915|39272324|FG001|Overall Study|Exclusion criteria - drug use|0|||
16216331|NCT02449915|39272323|FG000|Overall Study|Withdrawal by Subject|0|||
16216332|NCT02449915|39272324|FG001|Overall Study|Withdrawal by Subject|2|||
16216333|NCT02449915|39272323|FG000|Overall Study|Intraoperative surgical findings|1|||
16216334|NCT02449915|39272324|FG001|Overall Study|Intraoperative surgical findings|1|||
16216335|NCT02449915|39272323|FG000|Overall Study|Abnormal preop lab|0|||
16216336|NCT02449915|39272324|FG001|Overall Study|Abnormal preop lab|1|||
16216337|NCT00939094|39272327|FG000|Overall Study|Adverse Event|9|||
16216338|NCT00939094|39272328|FG001|Overall Study|Adverse Event|0|||
16216339|NCT00939094|39272327|FG000|Overall Study|Withdrawal by Subject|1|||
16216340|NCT00939094|39272328|FG001|Overall Study|Withdrawal by Subject|6|||
16216341|NCT00939094|39272327|FG000|Overall Study|Lost to Follow-up|1|||
16216342|NCT00939094|39272328|FG001|Overall Study|Lost to Follow-up|1|||
16216343|NCT00939094|39272327|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16216344|NCT00939094|39272328|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16216345|NCT00939094|39272327|FG000|Overall Study|Severe non-compliance to protocol|0|||
16216346|NCT00939094|39272328|FG001|Overall Study|Severe non-compliance to protocol|1|||
16216347|NCT00939094|39272327|FG000|Overall Study|Study stopped by sponsor|0|||
16216348|NCT00939094|39272328|FG001|Overall Study|Study stopped by sponsor|2|||
16216349|NCT00939094|39272327|FG000|Overall Study|Abnormal ECG findings|1|||
16216350|NCT00939094|39272328|FG001|Overall Study|Abnormal ECG findings|0|||
16216351|NCT02142712|39272331|FG000|Overall Study|Lost to Follow-up|1|||
16216352|NCT02142712|39272332|FG001|Overall Study|Lost to Follow-up|1|||
16216353|NCT02142712|39272333|FG002|Overall Study|Lost to Follow-up|1|||
16216354|NCT02142712|39272334|FG003|Overall Study|Lost to Follow-up|0|||
16216355|NCT01142791|39272337|FG000|Overall Study|Alternative Treatment|1|||
16216356|NCT01142791|39272338|FG001|Overall Study|Alternative Treatment|0|||
16216357|NCT01142791|39272337|FG000|Overall Study|Lost to Follow-up|1|||
16216358|NCT01142791|39272338|FG001|Overall Study|Lost to Follow-up|0|||
16216359|NCT01142791|39272337|FG000|Overall Study|Withdrawal by Subject|5|||
16216360|NCT01142791|39272338|FG001|Overall Study|Withdrawal by Subject|0|||
16216361|NCT01142791|39272337|FG000|Overall Study|Received only 1 sonication|0|||
16216362|NCT01142791|39272338|FG001|Overall Study|Received only 1 sonication|6|||
16216363|NCT00957034|39272339|FG000|Overall Study|Adverse Event|0|||
16216364|NCT00957034|39272340|FG001|Overall Study|Adverse Event|1|||
16216365|NCT00957034|39272341|FG002|Overall Study|Adverse Event|1|||
16216366|NCT00957034|39272339|FG000|Overall Study|Sponsor Terminated Study|6|||
16216367|NCT00957034|39272340|FG001|Overall Study|Sponsor Terminated Study|1|||
16216368|NCT00957034|39272341|FG002|Overall Study|Sponsor Terminated Study|5|||
16216369|NCT00957034|39272339|FG000|Overall Study|Withdrawal by Subject|0|||
16533892|NCT01477853|40418204|FG001|Phase B|Lost to Follow-up|1|||
16533893|NCT01477853|40418205|FG002|Phase B|Lost to Follow-up|0|||
16533894|NCT01477853|40418203|FG000|Phase B|Study terminated by sponsor|12|||
16533895|NCT01477853|40418204|FG001|Phase B|Study terminated by sponsor|10|||
16533896|NCT01477853|40418205|FG002|Phase B|Study terminated by sponsor|11|||
16533897|NCT01260350|40418206|FG000|Overall Study|Lack of Efficacy|0|||
16533898|NCT01260350|40418207|FG001|Overall Study|Lack of Efficacy|0|||
16533899|NCT01260350|40418208|FG002|Overall Study|Lack of Efficacy|0|||
16533900|NCT01260350|40418209|FG003|Overall Study|Lack of Efficacy|0|||
16533901|NCT01260350|40418210|FG004|Overall Study|Lack of Efficacy|0|||
16533902|NCT01260350|40418211|FG005|Overall Study|Lack of Efficacy|0|||
16533903|NCT01260350|40418212|FG006|Overall Study|Lack of Efficacy|0|||
16533904|NCT01260350|40418213|FG007|Overall Study|Lack of Efficacy|0|||
16533905|NCT01260350|40418214|FG008|Overall Study|Lack of Efficacy|0|||
16533906|NCT01260350|40418215|FG009|Overall Study|Lack of Efficacy|0|||
16533907|NCT01260350|40418216|FG010|Overall Study|Lack of Efficacy|0|||
16533908|NCT01260350|40418217|FG011|Overall Study|Lack of Efficacy|0|||
16533909|NCT01260350|40418218|FG012|Overall Study|Lack of Efficacy|0|||
16533910|NCT01260350|40418219|FG013|Overall Study|Lack of Efficacy|0|||
16533911|NCT01260350|40418220|FG014|Overall Study|Lack of Efficacy|0|||
16533912|NCT01260350|40418221|FG015|Overall Study|Lack of Efficacy|0|||
16533913|NCT01260350|40418222|FG016|Overall Study|Lack of Efficacy|0|||
16533914|NCT01260350|40418223|FG017|Overall Study|Lack of Efficacy|1|||
16533915|NCT01260350|40418224|FG018|Overall Study|Lack of Efficacy|0|||
16533916|NCT01260350|40418225|FG019|Overall Study|Lack of Efficacy|0|||
16533917|NCT01260350|40418226|FG020|Overall Study|Lack of Efficacy|3|||
16533918|NCT01260350|40418227|FG021|Overall Study|Lack of Efficacy|0|||
16533919|NCT01260350|40418206|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533920|NCT01260350|40418207|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533921|NCT01260350|40418208|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16334101|NCT03558152|39710663|FG005|Overall Study|Withdrawal by Subject|1|||
16334102|NCT03558152|39710664|FG006|Overall Study|Withdrawal by Subject|3|||
16334103|NCT03558152|39710665|FG007|Overall Study|Withdrawal by Subject|2|||
16334104|NCT03558152|39710658|FG000|Overall Study|Lack of Efficacy|11|||
16334105|NCT03558152|39710659|FG001|Overall Study|Lack of Efficacy|11|||
16334106|NCT03558152|39710660|FG002|Overall Study|Lack of Efficacy|10|||
16334107|NCT03558152|39710661|FG003|Overall Study|Lack of Efficacy|11|||
16334108|NCT03558152|39710662|FG004|Overall Study|Lack of Efficacy|14|||
16334109|NCT03558152|39710663|FG005|Overall Study|Lack of Efficacy|12|||
16334110|NCT03558152|39710664|FG006|Overall Study|Lack of Efficacy|14|||
16334111|NCT03558152|39710665|FG007|Overall Study|Lack of Efficacy|13|||
16334112|NCT03558152|39710658|FG000|Overall Study|Protocol Violation|1|||
16334113|NCT03558152|39710659|FG001|Overall Study|Protocol Violation|1|||
16334114|NCT03558152|39710660|FG002|Overall Study|Protocol Violation|0|||
16334115|NCT03558152|39710661|FG003|Overall Study|Protocol Violation|1|||
16334116|NCT03558152|39710662|FG004|Overall Study|Protocol Violation|1|||
16334117|NCT03558152|39710663|FG005|Overall Study|Protocol Violation|0|||
16334118|NCT03558152|39710664|FG006|Overall Study|Protocol Violation|2|||
16334119|NCT03558152|39710665|FG007|Overall Study|Protocol Violation|0|||
16334120|NCT02079636|39710666|FG000|Overall Study|Death|2|||
16334121|NCT02079636|39710667|FG001|Overall Study|Death|1|||
16334122|NCT02079636|39710668|FG002|Overall Study|Death|0|||
16334123|NCT02079636|39710669|FG003|Overall Study|Death|5|||
16334124|NCT02079636|39710670|FG004|Overall Study|Death|1|||
16216370|NCT00957034|39272340|FG001|Overall Study|Withdrawal by Subject|2|||
16334125|NCT02079636|39710671|FG005|Overall Study|Death|2|||
16334126|NCT02079636|39710672|FG006|Overall Study|Death|1|||
16334127|NCT02079636|39710673|FG007|Overall Study|Death|0|||
16334128|NCT02079636|39710674|FG008|Overall Study|Death|0|||
16334129|NCT02079636|39710675|FG009|Overall Study|Death|0|||
16334130|NCT02079636|39710676|FG010|Overall Study|Death|0|||
16334131|NCT02079636|39710677|FG011|Overall Study|Death|1|||
16334132|NCT02079636|39710678|FG012|Overall Study|Death|1|||
16334133|NCT02079636|39710679|FG013|Overall Study|Death|0|||
16216371|NCT00957034|39272341|FG002|Overall Study|Withdrawal by Subject|0|||
16216372|NCT04005755|39272344|FG000|Overall Study|Adverse Event|6|||
16216373|NCT04005755|39272344|FG000|Overall Study|Physician Decision|3|||
16216374|NCT04005755|39272344|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
16216375|NCT04005755|39272344|FG000|Overall Study|Withdrawal by Subject|3|||
16216376|NCT04005755|39272344|FG000|Overall Study|Lost to Follow-up|1|||
16216377|NCT02178592|39272345|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
16216378|NCT02178592|39272346|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
16216379|NCT02178592|39272345|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
16216380|NCT02178592|39272346|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
16216381|NCT02178592|39272345|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
16216382|NCT02178592|39272346|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
16216383|NCT02178592|39272345|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
16216384|NCT02178592|39272346|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
16334134|NCT02079636|39710680|FG014|Overall Study|Death|2|||
16334135|NCT02079636|39710666|FG000|Overall Study|Adverse Event|1|||
16101020|NCT01107912|38856716|FG003|Period 3|Adverse Event|0|||
16216385|NCT02178592|39272345|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
16216386|NCT02178592|39272346|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
16334136|NCT02079636|39710667|FG001|Overall Study|Adverse Event|1|||
16334137|NCT02079636|39710668|FG002|Overall Study|Adverse Event|0|||
16334138|NCT02079636|39710669|FG003|Overall Study|Adverse Event|1|||
16334139|NCT02079636|39710670|FG004|Overall Study|Adverse Event|1|||
16334140|NCT02079636|39710671|FG005|Overall Study|Adverse Event|2|||
16334141|NCT02079636|39710672|FG006|Overall Study|Adverse Event|0|||
16334142|NCT02079636|39710673|FG007|Overall Study|Adverse Event|0|||
16334143|NCT02079636|39710674|FG008|Overall Study|Adverse Event|0|||
16334144|NCT02079636|39710675|FG009|Overall Study|Adverse Event|0|||
16216387|NCT02178592|39272345|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
16216388|NCT02178592|39272346|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
16216389|NCT02178592|39272345|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
16216390|NCT02178592|39272346|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
16216391|NCT02178592|39272345|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
16216392|NCT02178592|39272346|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
16216393|NCT02178592|39272345|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
16216394|NCT02178592|39272346|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
16216395|NCT02178592|39272345|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
16216396|NCT02178592|39272346|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
16216397|NCT02178592|39272345|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
16216398|NCT02178592|39272346|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
16216399|NCT02178592|39272345|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
16216400|NCT02178592|39272346|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
16216401|NCT03523715|39272347|FG000|Overall Study|Lost to Follow-up|11|||
16216402|NCT03523715|39272348|FG001|Overall Study|Lost to Follow-up|14|||
16216403|NCT03523715|39272347|FG000|Overall Study|Did not meet inclusion criteria|1|||
16216404|NCT03523715|39272348|FG001|Overall Study|Did not meet inclusion criteria|0|||
16216405|NCT03523715|39272347|FG000|Overall Study|Internally inconsistent reporting|0|||
16216406|NCT03523715|39272348|FG001|Overall Study|Internally inconsistent reporting|2|||
16216407|NCT01327573|39272352|FG000|Overall Study|Physician Decision|3|||
16216408|NCT01327573|39272353|FG001|Overall Study|Physician Decision|1|||
16216409|NCT00908895|39272354|FG000|Overall Study|Lost to Follow-up|1|||
16216410|NCT00908895|39272355|FG001|Overall Study|Lost to Follow-up|3|||
16216411|NCT00908895|39272354|FG000|Overall Study|algodystrophy|2|||
16216412|NCT00908895|39272355|FG001|Overall Study|algodystrophy|2|||
16216413|NCT00908895|39272354|FG000|Overall Study|Adverse Event|1|||
16216414|NCT00908895|39272355|FG001|Overall Study|Adverse Event|1|||
16216415|NCT03661983|39272356|FG000|Open Label Stabilization Phase|Adverse Event|5|||
16216416|NCT03661983|39272357|FG001|Open Label Stabilization Phase|Adverse Event|0|||
16216417|NCT03661983|39272358|FG002|Open Label Stabilization Phase|Adverse Event|0|||
16216418|NCT03661983|39272359|FG003|Open Label Stabilization Phase|Adverse Event|0|||
16216419|NCT03661983|39272356|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
16334145|NCT02079636|39710676|FG010|Overall Study|Adverse Event|0|||
16334146|NCT02079636|39710677|FG011|Overall Study|Adverse Event|0|||
16334147|NCT02079636|39710678|FG012|Overall Study|Adverse Event|0|||
16334148|NCT02079636|39710679|FG013|Overall Study|Adverse Event|0|||
16334149|NCT02079636|39710680|FG014|Overall Study|Adverse Event|0|||
16334150|NCT02079636|39710666|FG000|Overall Study|Progressive disease|0|||
16334151|NCT02079636|39710667|FG001|Overall Study|Progressive disease|0|||
16334152|NCT02079636|39710668|FG002|Overall Study|Progressive disease|0|||
16334153|NCT02079636|39710669|FG003|Overall Study|Progressive disease|2|||
16334154|NCT02079636|39710670|FG004|Overall Study|Progressive disease|0|||
16334155|NCT02079636|39710671|FG005|Overall Study|Progressive disease|0|||
16334156|NCT02079636|39710672|FG006|Overall Study|Progressive disease|0|||
16334157|NCT02079636|39710673|FG007|Overall Study|Progressive disease|0|||
16334158|NCT02079636|39710674|FG008|Overall Study|Progressive disease|0|||
16334159|NCT02079636|39710675|FG009|Overall Study|Progressive disease|0|||
16334160|NCT02079636|39710676|FG010|Overall Study|Progressive disease|0|||
16334161|NCT02079636|39710677|FG011|Overall Study|Progressive disease|0|||
16334162|NCT02079636|39710678|FG012|Overall Study|Progressive disease|1|||
16334163|NCT02079636|39710679|FG013|Overall Study|Progressive disease|0|||
16334164|NCT02079636|39710680|FG014|Overall Study|Progressive disease|0|||
16533922|NCT01260350|40418209|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16334165|NCT02079636|39710666|FG000|Overall Study|Withdrawal by Subject|0|||
16533923|NCT01260350|40418210|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533924|NCT01260350|40418211|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533925|NCT01260350|40418212|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533926|NCT01260350|40418213|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533927|NCT01260350|40418214|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
16533928|NCT01260350|40418215|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533929|NCT01260350|40418216|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533930|NCT01260350|40418217|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16216420|NCT03661983|39272357|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
16216421|NCT03661983|39272358|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
16216422|NCT03661983|39272359|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
16216423|NCT03661983|39272356|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
16334166|NCT02079636|39710667|FG001|Overall Study|Withdrawal by Subject|0|||
16334167|NCT02079636|39710668|FG002|Overall Study|Withdrawal by Subject|0|||
16334168|NCT02079636|39710669|FG003|Overall Study|Withdrawal by Subject|4|||
16334169|NCT02079636|39710670|FG004|Overall Study|Withdrawal by Subject|0|||
16334170|NCT02079636|39710671|FG005|Overall Study|Withdrawal by Subject|1|||
16334171|NCT02079636|39710672|FG006|Overall Study|Withdrawal by Subject|0|||
16334172|NCT02079636|39710673|FG007|Overall Study|Withdrawal by Subject|0|||
16216424|NCT03661983|39272357|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
16216425|NCT03661983|39272358|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
16216426|NCT03661983|39272359|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
16216427|NCT03661983|39272356|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
16216428|NCT03661983|39272357|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
16216429|NCT03661983|39272358|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
16216430|NCT03661983|39272359|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
16216431|NCT03661983|39272356|FG000|Double-blind Randomized Phase|Adverse Event|0|||
16216432|NCT03661983|39272357|FG001|Double-blind Randomized Phase|Adverse Event|1|||
16216433|NCT03661983|39272358|FG002|Double-blind Randomized Phase|Adverse Event|0|||
16216434|NCT03661983|39272359|FG003|Double-blind Randomized Phase|Adverse Event|0|||
16533931|NCT01260350|40418218|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533932|NCT01260350|40418219|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533933|NCT01260350|40418220|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533934|NCT01260350|40418221|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533935|NCT01260350|40418222|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533936|NCT01260350|40418223|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16216435|NCT03661983|39272356|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
16216436|NCT03661983|39272357|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
16216437|NCT03661983|39272358|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
16216438|NCT03661983|39272359|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
16216439|NCT03661983|39272356|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
16216440|NCT03661983|39272357|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
16216441|NCT03661983|39272358|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
16216442|NCT03661983|39272359|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
16216443|NCT03661983|39272356|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
16216444|NCT03661983|39272357|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
16216445|NCT03661983|39272358|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
16216446|NCT03661983|39272359|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
16216447|NCT01487863|39272360|FG000|Overall Study|Death|19|||
16216448|NCT01487863|39272361|FG001|Overall Study|Death|19|||
16216449|NCT00811395|39272364|FG000|Extension Treatment|Adverse Event|1|||
16216450|NCT00811395|39272365|FG001|Extension Treatment|Adverse Event|2|||
16216451|NCT00811395|39272366|FG002|Extension Treatment|Adverse Event|2|||
16216452|NCT00811395|39272367|FG003|Extension Treatment|Adverse Event|2|||
16216453|NCT00811395|39272368|FG004|Extension Treatment|Adverse Event|0|||
16216454|NCT00811395|39272369|FG005|Extension Treatment|Adverse Event|1|||
16216455|NCT00811395|39272364|FG000|Extension Treatment|Progressive disease|1|||
16216456|NCT00811395|39272365|FG001|Extension Treatment|Progressive disease|1|||
16216457|NCT00811395|39272366|FG002|Extension Treatment|Progressive disease|0|||
16216458|NCT00811395|39272367|FG003|Extension Treatment|Progressive disease|0|||
16216459|NCT00811395|39272368|FG004|Extension Treatment|Progressive disease|0|||
16334173|NCT02079636|39710674|FG008|Overall Study|Withdrawal by Subject|0|||
16334174|NCT02079636|39710675|FG009|Overall Study|Withdrawal by Subject|2|||
16334175|NCT02079636|39710676|FG010|Overall Study|Withdrawal by Subject|1|||
16334176|NCT02079636|39710677|FG011|Overall Study|Withdrawal by Subject|1|||
16334177|NCT02079636|39710678|FG012|Overall Study|Withdrawal by Subject|1|||
16334178|NCT02079636|39710679|FG013|Overall Study|Withdrawal by Subject|0|||
16334179|NCT02079636|39710680|FG014|Overall Study|Withdrawal by Subject|2|||
16334180|NCT02079636|39710666|FG000|Overall Study|Physician Decision|0|||
16334181|NCT02079636|39710667|FG001|Overall Study|Physician Decision|0|||
16334182|NCT02079636|39710668|FG002|Overall Study|Physician Decision|0|||
16334183|NCT02079636|39710669|FG003|Overall Study|Physician Decision|0|||
16334184|NCT02079636|39710670|FG004|Overall Study|Physician Decision|0|||
16334185|NCT02079636|39710671|FG005|Overall Study|Physician Decision|1|||
16533937|NCT01260350|40418224|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533938|NCT01260350|40418225|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533939|NCT01260350|40418226|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533940|NCT01260350|40418227|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
16533941|NCT00675766|40418231|FG000|Overall Study|Lost to Follow-up|6|||
16533942|NCT00675766|40418232|FG001|Overall Study|Lost to Follow-up|5|||
16533943|NCT00675766|40418233|FG002|Overall Study|Lost to Follow-up|21|||
16533944|NCT00675766|40418234|FG003|Overall Study|Lost to Follow-up|26|||
16533945|NCT01275625|40418235|FG000|Overall Study|Death|1|||
16216460|NCT00811395|39272369|FG005|Extension Treatment|Progressive disease|0|||
16216461|NCT00811395|39272364|FG000|Extension Treatment|Participant did not wish to continue|0|||
16216462|NCT00811395|39272365|FG001|Extension Treatment|Participant did not wish to continue|3|||
16334186|NCT02079636|39710672|FG006|Overall Study|Physician Decision|0|||
16334187|NCT02079636|39710673|FG007|Overall Study|Physician Decision|0|||
16216463|NCT00811395|39272366|FG002|Extension Treatment|Participant did not wish to continue|0|||
16216464|NCT00811395|39272367|FG003|Extension Treatment|Participant did not wish to continue|1|||
16216465|NCT00811395|39272368|FG004|Extension Treatment|Participant did not wish to continue|0|||
16216466|NCT00811395|39272369|FG005|Extension Treatment|Participant did not wish to continue|1|||
16216467|NCT00811395|39272364|FG000|Extension Treatment|Other than above|0|||
16216468|NCT00811395|39272365|FG001|Extension Treatment|Other than above|0|||
16216469|NCT00811395|39272366|FG002|Extension Treatment|Other than above|1|||
16216470|NCT00811395|39272367|FG003|Extension Treatment|Other than above|0|||
16216471|NCT00811395|39272368|FG004|Extension Treatment|Other than above|0|||
16216472|NCT00811395|39272369|FG005|Extension Treatment|Other than above|0|||
16216473|NCT00554840|39272373|FG000|Overall Study|Physician Decision|0|||
16216474|NCT00554840|39272374|FG001|Overall Study|Physician Decision|1|||
16216475|NCT05283499|39272377|FG000|Overall Study|Did not receive intervention|1|||
16216476|NCT05283499|39272378|FG001|Overall Study|Did not receive intervention|2|||
16216477|NCT02044822|39272380|FG000|Overall Study|Study Terminated by Sponsor|77|||
16216478|NCT02044822|39272380|FG000|Overall Study|Investigator's Discretion|10|||
16216479|NCT02044822|39272380|FG000|Overall Study|Withdrew Consent|3|||
16216480|NCT02044822|39272380|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
16216481|NCT02044822|39272380|FG000|Overall Study|Lost to Follow-up|1|||
16216482|NCT03756285|39272382|FG000|Overall Study|Lost to Follow-up|0|||
16216483|NCT03756285|39272383|FG001|Overall Study|Lost to Follow-up|1|||
16216484|NCT03756285|39272382|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
16216485|NCT03756285|39272383|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
16216486|NCT03756285|39272382|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
16216487|NCT03756285|39272383|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
16216488|NCT02203916|39272390|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16216489|NCT02203916|39272391|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
16334188|NCT02079636|39710674|FG008|Overall Study|Physician Decision|0|||
16334189|NCT02079636|39710675|FG009|Overall Study|Physician Decision|1|||
16334190|NCT02079636|39710676|FG010|Overall Study|Physician Decision|1|||
16334191|NCT02079636|39710677|FG011|Overall Study|Physician Decision|0|||
16334192|NCT02079636|39710678|FG012|Overall Study|Physician Decision|0|||
16334193|NCT02079636|39710679|FG013|Overall Study|Physician Decision|0|||
16334194|NCT02079636|39710680|FG014|Overall Study|Physician Decision|1|||
16334195|NCT02079636|39710666|FG000|Overall Study|Lost to Follow-up|0|||
16334196|NCT02079636|39710667|FG001|Overall Study|Lost to Follow-up|0|||
16334197|NCT02079636|39710668|FG002|Overall Study|Lost to Follow-up|0|||
16334198|NCT02079636|39710669|FG003|Overall Study|Lost to Follow-up|0|||
16403764|NCT02763566|39957006|FG002|Overall Study|Lost to Follow-up|0|||
16403765|NCT02763566|39957007|FG003|Overall Study|Lost to Follow-up|1|||
16403766|NCT02763566|39957004|FG000|Overall Study|On study treatment at study conclusion|114|||
16403767|NCT02763566|39957005|FG001|Overall Study|On study treatment at study conclusion|34|||
16403768|NCT02763566|39957006|FG002|Overall Study|On study treatment at study conclusion|54|||
16403769|NCT02763566|39957007|FG003|Overall Study|On study treatment at study conclusion|13|||
16403770|NCT02763566|39957004|FG000|Overall Study|Withdrawal by Subject|3|||
16403771|NCT02763566|39957005|FG001|Overall Study|Withdrawal by Subject|1|||
16403772|NCT02763566|39957006|FG002|Overall Study|Withdrawal by Subject|0|||
16403773|NCT02763566|39957007|FG003|Overall Study|Withdrawal by Subject|0|||
16403774|NCT05807464|39957008|FG000|Overall Study|Adverse Event|1|||
16403775|NCT04026009|39957009|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16403776|NCT04026009|39957010|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16403777|NCT04026009|39957011|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
16403778|NCT04026009|39957012|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
16533946|NCT01275625|40418235|FG000|Overall Study|Lack of Efficacy|2|||
16533947|NCT01275625|40418235|FG000|Overall Study|Lost to Follow-up|1|||
16334199|NCT02079636|39710670|FG004|Overall Study|Lost to Follow-up|0|||
16334200|NCT02079636|39710671|FG005|Overall Study|Lost to Follow-up|0|||
16334201|NCT02079636|39710672|FG006|Overall Study|Lost to Follow-up|0|||
16334202|NCT02079636|39710673|FG007|Overall Study|Lost to Follow-up|1|||
16334203|NCT02079636|39710674|FG008|Overall Study|Lost to Follow-up|0|||
16334204|NCT02079636|39710675|FG009|Overall Study|Lost to Follow-up|0|||
16334205|NCT02079636|39710676|FG010|Overall Study|Lost to Follow-up|0|||
16334206|NCT02079636|39710677|FG011|Overall Study|Lost to Follow-up|0|||
16334207|NCT02079636|39710678|FG012|Overall Study|Lost to Follow-up|0|||
16334208|NCT02079636|39710679|FG013|Overall Study|Lost to Follow-up|0|||
16533948|NCT01275625|40418235|FG000|Overall Study|Withdrawal by Subject|3|||
16533949|NCT01275625|40418235|FG000|Overall Study|Protocol Violation|1|||
16533950|NCT01275625|40418235|FG000|Overall Study|Adverse Event|4|||
16533951|NCT01275625|40418235|FG000|Overall Study|Other|1|||
16533952|NCT00328510|40418238|FG000|Overall Study|Gag disorder, could not use frame|4|||
16533953|NCT00328510|40418239|FG001|Overall Study|Gag disorder, could not use frame|0|||
16533954|NCT00328510|40418238|FG000|Overall Study|Dentition problems, could not use frame|1|||
16533955|NCT00328510|40418239|FG001|Overall Study|Dentition problems, could not use frame|0|||
16403779|NCT04026009|39957013|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
16403780|NCT04026009|39957009|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
16403781|NCT04026009|39957010|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
16403782|NCT04026009|39957011|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
16403783|NCT04026009|39957012|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
16403784|NCT04026009|39957013|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
16403785|NCT03362502|39959566|FG000|Overall Study|Death|0|||
16403786|NCT03362502|39959567|FG001|Overall Study|Death|0|||
16403787|NCT03362502|39959568|FG002|Overall Study|Death|1|||
16403788|NCT03344549|39959569|FG000|Overall Study|Withdrawal by Subject|3|||
16403789|NCT03344549|39959570|FG001|Overall Study|Withdrawal by Subject|2|||
16403790|NCT03344549|39959569|FG000|Overall Study|Dialysis|2|||
16403791|NCT03344549|39959570|FG001|Overall Study|Dialysis|0|||
16403792|NCT03344549|39959569|FG000|Overall Study|Cancer|1|||
16403793|NCT03344549|39959570|FG001|Overall Study|Cancer|0|||
16334209|NCT02079636|39710680|FG014|Overall Study|Lost to Follow-up|0|||
16334210|NCT04472026|39710685|FG000|Overall Study|Lost to Follow-up|5|||
16334211|NCT02923245|39710686|FG000|Overall Study|ultrasound order was cancelled|2|||
16334212|NCT02923245|39710687|FG001|Overall Study|ultrasound order was cancelled|1|||
16334213|NCT00084318|39710688|FG000|Overall Study|Withdrawal by Subject|5|||
16334214|NCT00084318|39710689|FG001|Overall Study|Withdrawal by Subject|2|||
16334215|NCT00084318|39710688|FG000|Overall Study|Protocol Violation|15|||
16334216|NCT00084318|39710689|FG001|Overall Study|Protocol Violation|11|||
16403794|NCT03344549|39959569|FG000|Overall Study|Lack of electronic device|1|||
16403795|NCT03344549|39959570|FG001|Overall Study|Lack of electronic device|0|||
16403796|NCT03344549|39959569|FG000|Overall Study|Transportation difficulty|0|||
16334217|NCT00084318|39710688|FG000|Overall Study|No protocol treatment|2|||
16334218|NCT00084318|39710689|FG001|Overall Study|No protocol treatment|0|||
16403797|NCT03344549|39959570|FG001|Overall Study|Transportation difficulty|13|||
16403798|NCT05463952|39959573|FG000|Treatment|Progressive disease|4|||
16403799|NCT05463952|39959573|FG000|Treatment|Ongoing|2|||
16334219|NCT04150068|39710690|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
16334220|NCT04150068|39710691|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
16334221|NCT04150068|39710692|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
16334222|NCT04150068|39710690|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
16334223|NCT04150068|39710691|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
16334224|NCT04150068|39710692|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
16403800|NCT04240457|39959579|FG000|Overall Study|Lost to Follow-up|5|||
16403801|NCT04240457|39959580|FG001|Overall Study|Lost to Follow-up|1|||
16403802|NCT03136497|39959581|FG000|Overall Study|Screen Failure|1|||
16334225|NCT04045132|39710700|FG000|Overall Study|Lost to Follow-up|3|||
16403803|NCT03136497|39959582|FG001|Overall Study|Screen Failure|0|||
16334226|NCT04045132|39710701|FG001|Overall Study|Lost to Follow-up|6|||
16334227|NCT01675154|39710702|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
16334228|NCT01675154|39710703|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
16334229|NCT01675154|39710704|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
16334230|NCT01675154|39710705|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
16334231|NCT00424021|39710715|FG000|NCT00046319 Study Period|Adverse Event|1|||
16334232|NCT00424021|39710716|FG001|NCT00046319 Study Period|Adverse Event|0|||
16334233|NCT00424021|39710717|FG002|NCT00046319 Study Period|Adverse Event|1|||
16334234|NCT00424021|39710718|FG003|NCT00046319 Study Period|Adverse Event|1|||
16334235|NCT00424021|39710715|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
16334236|NCT00424021|39710716|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
16334237|NCT00424021|39710717|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
16334238|NCT00424021|39710718|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
16334239|NCT00424021|39710715|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
16334240|NCT00424021|39710716|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
16334241|NCT00424021|39710717|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
16334242|NCT00424021|39710718|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
16334243|NCT00424021|39710715|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
16334244|NCT00424021|39710716|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
16334245|NCT00424021|39710717|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
16334246|NCT00424021|39710718|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
16334247|NCT00424021|39710715|FG000|AMB-220-E Study Period|Adverse Event|1|||
16334248|NCT00424021|39710716|FG001|AMB-220-E Study Period|Adverse Event|1|||
16334249|NCT00424021|39710717|FG002|AMB-220-E Study Period|Adverse Event|3|||
16334250|NCT00424021|39710718|FG003|AMB-220-E Study Period|Adverse Event|7|||
16334251|NCT00424021|39710715|FG000|AMB-220-E Study Period|Death|0|||
16334252|NCT00424021|39710716|FG001|AMB-220-E Study Period|Death|0|||
16334253|NCT00424021|39710717|FG002|AMB-220-E Study Period|Death|1|||
16334254|NCT00424021|39710718|FG003|AMB-220-E Study Period|Death|1|||
16334255|NCT00424021|39710715|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
16334256|NCT00424021|39710716|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
16334257|NCT00424021|39710717|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
16334258|NCT00424021|39710718|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
16334259|NCT00424021|39710715|FG000|AMB-220-E Study Period|Physician Decision|0|||
16334260|NCT00424021|39710716|FG001|AMB-220-E Study Period|Physician Decision|0|||
16334261|NCT00424021|39710717|FG002|AMB-220-E Study Period|Physician Decision|0|||
16334262|NCT00424021|39710718|FG003|AMB-220-E Study Period|Physician Decision|1|||
16334263|NCT02147067|39710719|FG000|Overall Study|Withdrawal by Subject|2|||
16334264|NCT02147067|39710720|FG001|Overall Study|Withdrawal by Subject|2|||
16334265|NCT02651688|39710723|FG000|Overall Study|Non-compliance|0|||
16334266|NCT02651688|39710724|FG001|Overall Study|Non-compliance|0|||
16334267|NCT02651688|39710725|FG002|Overall Study|Non-compliance|1|||
16334268|NCT02651688|39710723|FG000|Overall Study|Principal Investigator (PI) decision|0|||
16334269|NCT02651688|39710724|FG001|Overall Study|Principal Investigator (PI) decision|2|||
16334270|NCT02651688|39710725|FG002|Overall Study|Principal Investigator (PI) decision|0|||
16334271|NCT02651688|39710723|FG000|Overall Study|Lost to Follow-up|1|||
16334272|NCT02651688|39710724|FG001|Overall Study|Lost to Follow-up|3|||
16334273|NCT02651688|39710725|FG002|Overall Study|Lost to Follow-up|0|||
16334274|NCT02651688|39710723|FG000|Overall Study|Withdrawal by Subject|1|||
16334275|NCT02651688|39710724|FG001|Overall Study|Withdrawal by Subject|0|||
16334276|NCT02651688|39710725|FG002|Overall Study|Withdrawal by Subject|2|||
16334277|NCT01546038|39710726|FG000|Overall Study|Death|15|||
16334278|NCT01546038|39710727|FG001|Overall Study|Death|6|||
16334279|NCT01546038|39710728|FG002|Overall Study|Death|4|||
16334280|NCT01546038|39710729|FG003|Overall Study|Death|2|||
16334281|NCT01546038|39710730|FG004|Overall Study|Death|9|||
16334282|NCT01546038|39710731|FG005|Overall Study|Death|3|||
16334283|NCT01546038|39710732|FG006|Overall Study|Death|46|||
16334284|NCT01546038|39710733|FG007|Overall Study|Death|76|||
16334285|NCT01546038|39710734|FG008|Overall Study|Death|39|||
16334286|NCT01546038|39710726|FG000|Overall Study|Lost to Follow-up|0|||
16334287|NCT01546038|39710727|FG001|Overall Study|Lost to Follow-up|0|||
16334288|NCT01546038|39710728|FG002|Overall Study|Lost to Follow-up|0|||
16334289|NCT01546038|39710729|FG003|Overall Study|Lost to Follow-up|0|||
16334290|NCT01546038|39710730|FG004|Overall Study|Lost to Follow-up|1|||
16334291|NCT01546038|39710731|FG005|Overall Study|Lost to Follow-up|0|||
16334292|NCT01546038|39710732|FG006|Overall Study|Lost to Follow-up|2|||
16334293|NCT01546038|39710733|FG007|Overall Study|Lost to Follow-up|1|||
16334294|NCT01546038|39710734|FG008|Overall Study|Lost to Follow-up|0|||
16334295|NCT01546038|39710726|FG000|Overall Study|Withdrawal by Subject|1|||
16334296|NCT01546038|39710727|FG001|Overall Study|Withdrawal by Subject|0|||
16334297|NCT01546038|39710728|FG002|Overall Study|Withdrawal by Subject|0|||
16334298|NCT01546038|39710729|FG003|Overall Study|Withdrawal by Subject|1|||
16334299|NCT01546038|39710730|FG004|Overall Study|Withdrawal by Subject|0|||
16334300|NCT01546038|39710731|FG005|Overall Study|Withdrawal by Subject|1|||
16334301|NCT01546038|39710732|FG006|Overall Study|Withdrawal by Subject|3|||
16334302|NCT01546038|39710733|FG007|Overall Study|Withdrawal by Subject|3|||
16334303|NCT01546038|39710734|FG008|Overall Study|Withdrawal by Subject|1|||
16334304|NCT01546038|39710726|FG000|Overall Study|: Randomized, not treated|0|||
16334305|NCT01546038|39710727|FG001|Overall Study|: Randomized, not treated|0|||
16533956|NCT00328510|40418238|FG000|Overall Study|Withdrawal by Subject|4|||
16533957|NCT00328510|40418239|FG001|Overall Study|Withdrawal by Subject|2|||
16533958|NCT00328510|40418238|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
16533959|NCT00328510|40418239|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
16533960|NCT00328510|40418238|FG000|Overall Study|Treatment changed to a single fraction|1|||
16533961|NCT00328510|40418239|FG001|Overall Study|Treatment changed to a single fraction|1|||
16533962|NCT02495025|40418240|FG000|Overall Study|Lost to Follow-up|21|||
16533963|NCT02495025|40418241|FG001|Overall Study|Lost to Follow-up|14|||
16533964|NCT02495025|40418240|FG000|Overall Study|Withdrawal by Subject|5|||
16533965|NCT02495025|40418241|FG001|Overall Study|Withdrawal by Subject|0|||
16533966|NCT01749982|40418242|FG000|Overall Study|Physician Decision|0|||
16533967|NCT01749982|40418243|FG001|Overall Study|Physician Decision|0|||
16533968|NCT01749982|40418244|FG002|Overall Study|Physician Decision|0|||
16533969|NCT01749982|40418245|FG003|Overall Study|Physician Decision|1|||
16533970|NCT01749982|40418242|FG000|Overall Study|Lost to Follow-up|0|||
16533971|NCT01749982|40418243|FG001|Overall Study|Lost to Follow-up|0|||
16533972|NCT01749982|40418244|FG002|Overall Study|Lost to Follow-up|0|||
16533973|NCT01749982|40418245|FG003|Overall Study|Lost to Follow-up|1|||
16533974|NCT01749982|40418242|FG000|Overall Study|Withdrawal by Subject|0|||
16533975|NCT01749982|40418243|FG001|Overall Study|Withdrawal by Subject|0|||
16533976|NCT01749982|40418244|FG002|Overall Study|Withdrawal by Subject|0|||
16533977|NCT01749982|40418245|FG003|Overall Study|Withdrawal by Subject|1|||
16533978|NCT02105116|40418246|FG000|Overall Study|not eligible for step 2 of trial|5|||
16533979|NCT02105116|40418246|FG000|Overall Study|Death|1|||
16533980|NCT02828111|40418247|FG000|Overall Study|Withdrawal by Subject|0|||
16533981|NCT02828111|40418248|FG001|Overall Study|Withdrawal by Subject|0|||
16533982|NCT02828111|40418249|FG002|Overall Study|Withdrawal by Subject|2|||
16533983|NCT02828111|40418250|FG003|Overall Study|Withdrawal by Subject|0|||
16533984|NCT02828111|40418251|FG004|Overall Study|Withdrawal by Subject|0|||
16533985|NCT02828111|40418247|FG000|Overall Study|Lost to Follow-up|0|||
16533986|NCT02828111|40418248|FG001|Overall Study|Lost to Follow-up|0|||
16533987|NCT02828111|40418249|FG002|Overall Study|Lost to Follow-up|0|||
16533988|NCT02828111|40418250|FG003|Overall Study|Lost to Follow-up|1|||
16533989|NCT02828111|40418251|FG004|Overall Study|Lost to Follow-up|1|||
16533990|NCT02137369|40418252|FG000|Overall Study|Withdrawal by Subject|3|||
16533991|NCT02137369|40418253|FG001|Overall Study|Withdrawal by Subject|2|||
16533992|NCT02137369|40418252|FG000|Overall Study|Adverse Event|2|||
16533993|NCT02137369|40418253|FG001|Overall Study|Adverse Event|0|||
16533994|NCT02137369|40418252|FG000|Overall Study|Lost to Follow-up|1|||
16533995|NCT02137369|40418253|FG001|Overall Study|Lost to Follow-up|0|||
16533996|NCT02137369|40418252|FG000|Overall Study|Moved away|2|||
16533997|NCT02137369|40418253|FG001|Overall Study|Moved away|0|||
16533998|NCT05608629|40418259|FG000|Overall Study|Lost to Follow-up|2|||
16533999|NCT03230916|40418260|FG000|Overall Study|Withdrawal by Subject|0|||
16534000|NCT03230916|40418261|FG001|Overall Study|Withdrawal by Subject|0|||
16534001|NCT03230916|40418262|FG002|Overall Study|Withdrawal by Subject|0|||
16534002|NCT03230916|40418263|FG003|Overall Study|Withdrawal by Subject|0|||
16334306|NCT01546038|39710728|FG002|Overall Study|: Randomized, not treated|0|||
16534003|NCT03230916|40418264|FG004|Overall Study|Withdrawal by Subject|0|||
16534004|NCT03230916|40418265|FG005|Overall Study|Withdrawal by Subject|1|||
16534005|NCT03230916|40418266|FG006|Overall Study|Withdrawal by Subject|0|||
16534006|NCT03230916|40418267|FG007|Overall Study|Withdrawal by Subject|0|||
16534007|NCT03230916|40418268|FG008|Overall Study|Withdrawal by Subject|0|||
16534008|NCT03230916|40418269|FG009|Overall Study|Withdrawal by Subject|0|||
16534009|NCT03230916|40418270|FG010|Overall Study|Withdrawal by Subject|0|||
16334307|NCT01546038|39710729|FG003|Overall Study|: Randomized, not treated|0|||
16334308|NCT01546038|39710730|FG004|Overall Study|: Randomized, not treated|0|||
16334309|NCT01546038|39710731|FG005|Overall Study|: Randomized, not treated|0|||
16334310|NCT01546038|39710732|FG006|Overall Study|: Randomized, not treated|2|||
16334311|NCT01546038|39710733|FG007|Overall Study|: Randomized, not treated|4|||
16334312|NCT01546038|39710734|FG008|Overall Study|: Randomized, not treated|3|||
16334313|NCT04394624|39710735|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|6|||
16403804|NCT03136497|39959583|FG002|Overall Study|Screen Failure|0|||
16534010|NCT03762473|40418271|FG000|Overall Study|Death|1|||
16534011|NCT03762473|40418272|FG001|Overall Study|Death|0|||
16534012|NCT01217073|40418273|FG000|Base Period|Adverse Event|1|||
16534013|NCT01217073|40418274|FG001|Base Period|Adverse Event|0|||
16534014|NCT01217073|40418275|FG002|Base Period|Adverse Event|1|||
16534015|NCT01217073|40418276|FG003|Base Period|Adverse Event|0|||
16534016|NCT01217073|40418277|FG004|Base Period|Adverse Event|4|||
16534017|NCT01217073|40418278|FG005|Base Period|Adverse Event|1|||
16534018|NCT01217073|40418279|FG006|Base Period|Adverse Event|0|||
16534019|NCT01217073|40418280|FG007|Base Period|Adverse Event|0|||
16534020|NCT01217073|40418273|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
16534021|NCT01217073|40418274|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16534022|NCT01217073|40418275|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16334314|NCT04394624|39710735|FG000|Overall Study|Adverse Event|5|||
16334315|NCT04394624|39710735|FG000|Overall Study|Progressive disease|20|||
16334316|NCT01886781|39710738|FG000|Overall Study|Protocol Violation|5|||
16334317|NCT01886781|39710739|FG001|Overall Study|Protocol Violation|0|||
16534023|NCT01217073|40418276|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16534024|NCT01217073|40418277|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16534025|NCT01217073|40418278|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16534026|NCT01217073|40418279|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16534027|NCT01217073|40418280|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
16534028|NCT01217073|40418273|FG000|Base Period|Excluded medication|0|||
16534029|NCT01217073|40418274|FG001|Base Period|Excluded medication|0|||
16534030|NCT01217073|40418275|FG002|Base Period|Excluded medication|0|||
16101021|NCT01107912|38856717|FG004|Period 3|Adverse Event|0|||
16101022|NCT01107912|38856718|FG005|Period 3|Adverse Event|0|||
16101023|NCT01107912|38856713|FG000|Period 3|Withdrawal by Subject|0|||
16101024|NCT01107912|38856714|FG001|Period 3|Withdrawal by Subject|0|||
16101025|NCT01107912|38856715|FG002|Period 3|Withdrawal by Subject|0|||
16101026|NCT01107912|38856716|FG003|Period 3|Withdrawal by Subject|1|||
16101027|NCT01107912|38856717|FG004|Period 3|Withdrawal by Subject|0|||
16101028|NCT01107912|38856718|FG005|Period 3|Withdrawal by Subject|0|||
16101029|NCT00711555|38856724|FG000|Overall Study|Adverse Event|3|||
16101030|NCT01786551|38856725|FG000|Overall Study|Participant withdrew consent|2|||
16101031|NCT02206607|38856726|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
16101032|NCT02206607|38856727|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
16101033|NCT02206607|38856728|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
16101034|NCT02206607|38856729|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
16101035|NCT02206607|38856730|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
16101036|NCT02206607|38856726|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
16101037|NCT02206607|38856727|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
16101038|NCT02206607|38856728|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
16101039|NCT02206607|38856729|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
16101040|NCT02206607|38856730|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
16101041|NCT01536795|38856731|FG000|Overall Study|Lost to Follow-up|0|||
16101042|NCT01536795|38856732|FG001|Overall Study|Lost to Follow-up|2|||
16101043|NCT01536795|38856731|FG000|Overall Study|Lack of Efficacy|1|||
16101044|NCT01536795|38856732|FG001|Overall Study|Lack of Efficacy|0|||
16101045|NCT01136733|38856734|FG000|Phase 1b|Adverse Event|0|||
16101046|NCT01136733|38856735|FG001|Phase 1b|Adverse Event|3|||
16216490|NCT02203916|39272392|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
16334318|NCT01886781|39710738|FG000|Overall Study|Adverse Event|1|||
16334319|NCT01886781|39710739|FG001|Overall Study|Adverse Event|0|||
16334320|NCT01886781|39710738|FG000|Overall Study|Lost to Follow-up|5|||
16334321|NCT01886781|39710739|FG001|Overall Study|Lost to Follow-up|0|||
16334322|NCT01886781|39710738|FG000|Overall Study|Withdrawal by Subject|2|||
16334323|NCT01886781|39710739|FG001|Overall Study|Withdrawal by Subject|1|||
16334324|NCT01886781|39710738|FG000|Overall Study|Worsening of symptoms|1|||
16334325|NCT01886781|39710739|FG001|Overall Study|Worsening of symptoms|1|||
16334326|NCT02440854|39710740|FG000|Overall Study|Relocation of patient|1|||
16334327|NCT02440854|39710740|FG000|Overall Study|Death|6|||
16334328|NCT02440854|39710740|FG000|Overall Study|Lost to Follow-up|10|||
16334329|NCT02440854|39710740|FG000|Overall Study|Afatinib discontinuation|46|||
16334330|NCT02440854|39710740|FG000|Overall Study|stopped study at earlier timepoint|14|||
16334331|NCT02440854|39710740|FG000|Overall Study|Study medication not received|1|||
16334332|NCT02440854|39710740|FG000|Overall Study|Violation of inclusion criteria|2|||
16101047|NCT01136733|38856736|FG002|Phase 1b|Adverse Event|1|||
16101048|NCT01136733|38856737|FG003|Phase 1b|Adverse Event|0|||
16101049|NCT01136733|38856738|FG004|Phase 1b|Adverse Event|0|||
16534031|NCT01217073|40418276|FG003|Base Period|Excluded medication|0|||
16101050|NCT01136733|38856739|FG005|Phase 1b|Adverse Event|0|||
16101051|NCT01136733|38856740|FG006|Phase 1b|Adverse Event|0|||
16101052|NCT01136733|38856734|FG000|Phase 1b|Participant Choice|0|||
16534032|NCT01217073|40418277|FG004|Base Period|Excluded medication|1|||
16534033|NCT01217073|40418278|FG005|Base Period|Excluded medication|0|||
16534034|NCT01217073|40418279|FG006|Base Period|Excluded medication|0|||
16534035|NCT01217073|40418280|FG007|Base Period|Excluded medication|0|||
16534036|NCT01217073|40418273|FG000|Base Period|Lack of Efficacy|0|||
16534037|NCT01217073|40418274|FG001|Base Period|Lack of Efficacy|0|||
16534038|NCT01217073|40418275|FG002|Base Period|Lack of Efficacy|0|||
16534039|NCT01217073|40418276|FG003|Base Period|Lack of Efficacy|0|||
16534040|NCT01217073|40418277|FG004|Base Period|Lack of Efficacy|0|||
16534041|NCT01217073|40418278|FG005|Base Period|Lack of Efficacy|1|||
16534042|NCT01217073|40418279|FG006|Base Period|Lack of Efficacy|0|||
16534043|NCT01217073|40418280|FG007|Base Period|Lack of Efficacy|0|||
16534044|NCT01217073|40418273|FG000|Base Period|Lost to Follow-up|0|||
16534045|NCT01217073|40418274|FG001|Base Period|Lost to Follow-up|0|||
16534046|NCT01217073|40418275|FG002|Base Period|Lost to Follow-up|1|||
16534047|NCT01217073|40418276|FG003|Base Period|Lost to Follow-up|1|||
16534048|NCT01217073|40418277|FG004|Base Period|Lost to Follow-up|3|||
16534049|NCT01217073|40418278|FG005|Base Period|Lost to Follow-up|0|||
16534050|NCT01217073|40418279|FG006|Base Period|Lost to Follow-up|0|||
16534051|NCT01217073|40418280|FG007|Base Period|Lost to Follow-up|0|||
16534052|NCT01217073|40418273|FG000|Base Period|Physician Decision|0|||
16534053|NCT01217073|40418274|FG001|Base Period|Physician Decision|0|||
16534054|NCT01217073|40418275|FG002|Base Period|Physician Decision|0|||
16534055|NCT01217073|40418276|FG003|Base Period|Physician Decision|0|||
16403805|NCT00923975|39959592|FG000|Overall Study|Did not meet inclusion criteria|1|||
16403806|NCT04437511|39959602|FG000|Overall Study|Adverse Event|50|||
16403807|NCT04437511|39959603|FG001|Overall Study|Adverse Event|21|||
16403808|NCT04437511|39959602|FG000|Overall Study|Death|15|||
16403809|NCT04437511|39959603|FG001|Overall Study|Death|10|||
16403810|NCT04437511|39959602|FG000|Overall Study|Lost to Follow-up|11|||
16403811|NCT04437511|39959603|FG001|Overall Study|Lost to Follow-up|11|||
16403812|NCT04437511|39959602|FG000|Overall Study|Physician Decision|19|||
16403813|NCT04437511|39959603|FG001|Overall Study|Physician Decision|10|||
16403814|NCT04437511|39959602|FG000|Overall Study|Progressive Disease|4|||
16403815|NCT04437511|39959603|FG001|Overall Study|Progressive Disease|7|||
16403816|NCT04437511|39959602|FG000|Overall Study|Withdrawal by Subject|111|||
16403817|NCT04437511|39959603|FG001|Overall Study|Withdrawal by Subject|94|||
16403818|NCT04437511|39959602|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
16403819|NCT04437511|39959603|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
16403820|NCT04437511|39959602|FG000|Overall Study|Continuing Study|7|||
16403821|NCT04437511|39959603|FG001|Overall Study|Continuing Study|5|||
16403822|NCT04376684|39959605|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
16403823|NCT04376684|39959606|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
16403824|NCT04376684|39959607|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
16403825|NCT04376684|39959608|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
16403826|NCT04376684|39959605|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
16403827|NCT04376684|39959606|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
16403828|NCT04376684|39959607|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
16403829|NCT04376684|39959608|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
16403830|NCT04376684|39959605|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
16403831|NCT04376684|39959606|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
16403832|NCT04376684|39959607|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
16534056|NCT01217073|40418277|FG004|Base Period|Physician Decision|1|||
16534057|NCT01217073|40418278|FG005|Base Period|Physician Decision|0|||
16534058|NCT01217073|40418279|FG006|Base Period|Physician Decision|0|||
16534059|NCT01217073|40418280|FG007|Base Period|Physician Decision|0|||
16534060|NCT01217073|40418273|FG000|Base Period|Protocol Violation|1|||
16534061|NCT01217073|40418274|FG001|Base Period|Protocol Violation|0|||
16534062|NCT01217073|40418275|FG002|Base Period|Protocol Violation|0|||
16534063|NCT01217073|40418276|FG003|Base Period|Protocol Violation|0|||
16534064|NCT01217073|40418277|FG004|Base Period|Protocol Violation|1|||
16403833|NCT04376684|39959608|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
16403834|NCT04376684|39959605|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
16403835|NCT04376684|39959606|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
16403836|NCT04376684|39959607|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
16403837|NCT04376684|39959608|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
16534065|NCT01217073|40418278|FG005|Base Period|Protocol Violation|2|||
16534066|NCT01217073|40418279|FG006|Base Period|Protocol Violation|0|||
16403838|NCT04376684|39959605|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
16403839|NCT04376684|39959606|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
16403840|NCT04376684|39959607|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
16403841|NCT04376684|39959608|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
16403842|NCT04376684|39959605|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
16403843|NCT04376684|39959606|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
16403844|NCT04376684|39959607|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
16403845|NCT04376684|39959608|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
16403846|NCT04376684|39959605|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
16403847|NCT04376684|39959606|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
16403848|NCT04376684|39959607|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
16403849|NCT04376684|39959608|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
16403850|NCT04493333|39959609|FG000|Overall Study|Withdrawal by Subject|1|||
16403851|NCT04493333|39959610|FG001|Overall Study|Withdrawal by Subject|1|||
16403852|NCT04493333|39959609|FG000|Overall Study|Ineligible|0|||
16403853|NCT04493333|39959610|FG001|Overall Study|Ineligible|1|||
16403854|NCT04493333|39959609|FG000|Overall Study|Noncompliance|2|||
16403855|NCT04493333|39959610|FG001|Overall Study|Noncompliance|1|||
16403856|NCT02487654|39959613|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
16403857|NCT02487654|39959614|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
16403858|NCT02487654|39959613|FG000|Overall Study|Withdrawal by Subject|3|||
16403859|NCT02487654|39959614|FG001|Overall Study|Withdrawal by Subject|7|||
16403860|NCT05599451|39959616|FG000|Overall Study|Not randomized|11|||
16403861|NCT05599451|39959617|FG001|Overall Study|Not randomized|0|||
16403862|NCT05599451|39959618|FG002|Overall Study|Not randomized|0|||
16403863|NCT05599451|39959619|FG003|Overall Study|Not randomized|0|||
16403864|NCT05599451|39959620|FG004|Overall Study|Not randomized|0|||
16403865|NCT05599451|39959616|FG000|Overall Study|Physician Decision|0|||
16403866|NCT05599451|39959617|FG001|Overall Study|Physician Decision|0|||
16403867|NCT05599451|39959618|FG002|Overall Study|Physician Decision|0|||
16403868|NCT05599451|39959619|FG003|Overall Study|Physician Decision|1|||
16403869|NCT05599451|39959620|FG004|Overall Study|Physician Decision|0|||
16403870|NCT02509039|39959621|FG000|Overall Study|Adverse Event|0|||
16403871|NCT02509039|39959622|FG001|Overall Study|Adverse Event|1|||
16334333|NCT02554318|39710741|FG000|Overall Study|Withdrawal by Subject|10|||
16334334|NCT02554318|39710742|FG001|Overall Study|Withdrawal by Subject|8|||
16334335|NCT02432144|39710743|FG000|Overall Study|Participant Non-Compliance|1|||
16334336|NCT00637806|39710746|FG000|Double-blind Phase|Study Discontinued|2|||
16334337|NCT00637806|39710747|FG001|Double-blind Phase|Study Discontinued|0|||
16334338|NCT00637806|39710748|FG002|Double-blind Phase|Study Discontinued|1|||
16334339|NCT00637806|39710749|FG003|Double-blind Phase|Study Discontinued|0|||
16334340|NCT00637806|39710746|FG000|Extension Phase|Study Discontinued|0|||
16334341|NCT00637806|39710747|FG001|Extension Phase|Study Discontinued|0|||
16334342|NCT00637806|39710748|FG002|Extension Phase|Study Discontinued|0|||
16334343|NCT00637806|39710749|FG003|Extension Phase|Study Discontinued|1|||
16334344|NCT05385224|39710750|FG000|Overall Study|Unable to swallow capsule|2|||
16334345|NCT05385224|39710750|FG000|Overall Study|Withdrawal by Subject|2|||
16334346|NCT05385224|39710750|FG000|Overall Study|Did not meet study criteria|1|||
16334347|NCT00659776|39710751|FG000|Overall Study|Withdrawal by Subject|12|||
16334348|NCT00659776|39710752|FG001|Overall Study|Withdrawal by Subject|2|||
16334349|NCT00659776|39710753|FG002|Overall Study|Withdrawal by Subject|0|||
16334350|NCT05007041|39710758|FG000|Overall Study|Missing Diary Entries|0|||
16334351|NCT05007041|39710759|FG001|Overall Study|Missing Diary Entries|1|||
16334352|NCT04490018|39710760|FG000|Overall Study|Protocol Violation|0|||
16334353|NCT04490018|39710761|FG001|Overall Study|Protocol Violation|2|||
16334354|NCT04490018|39710762|FG002|Overall Study|Protocol Violation|1|||
16334355|NCT04490018|39710760|FG000|Overall Study|Lost to Follow-up|2|||
16334356|NCT04490018|39710761|FG001|Overall Study|Lost to Follow-up|2|||
16334357|NCT04490018|39710762|FG002|Overall Study|Lost to Follow-up|0|||
16334358|NCT04490018|39710760|FG000|Overall Study|Withdrawal by Subject|2|||
16403872|NCT02509039|39959623|FG002|Overall Study|Adverse Event|1|||
16403873|NCT02509039|39959624|FG003|Overall Study|Adverse Event|1|||
16403874|NCT02509039|39959621|FG000|Overall Study|Withdrawal by Subject|0|||
16403875|NCT02509039|39959622|FG001|Overall Study|Withdrawal by Subject|0|||
16334359|NCT04490018|39710761|FG001|Overall Study|Withdrawal by Subject|1|||
16403876|NCT02509039|39959623|FG002|Overall Study|Withdrawal by Subject|1|||
16403877|NCT02509039|39959624|FG003|Overall Study|Withdrawal by Subject|0|||
16403878|NCT02509039|39959621|FG000|Overall Study|Progressive disease|2|||
16403879|NCT02509039|39959622|FG001|Overall Study|Progressive disease|2|||
16403880|NCT02509039|39959623|FG002|Overall Study|Progressive disease|1|||
16403881|NCT02509039|39959624|FG003|Overall Study|Progressive disease|5|||
16403882|NCT02509039|39959621|FG000|Overall Study|Study terminated by Sponsor|1|||
16403883|NCT02509039|39959622|FG001|Overall Study|Study terminated by Sponsor|0|||
16403884|NCT02509039|39959623|FG002|Overall Study|Study terminated by Sponsor|0|||
16403885|NCT02509039|39959624|FG003|Overall Study|Study terminated by Sponsor|0|||
16403886|NCT04484649|39959625|FG000|Overall Study|Lost to Follow-up|2|||
16403887|NCT04484649|39959626|FG001|Overall Study|Lost to Follow-up|1|||
16334360|NCT04490018|39710762|FG002|Overall Study|Withdrawal by Subject|0|||
16334361|NCT04490018|39710760|FG000|Overall Study|Withdrawal by parent/guardian|2|||
16334362|NCT04490018|39710761|FG001|Overall Study|Withdrawal by parent/guardian|3|||
16334363|NCT04490018|39710762|FG002|Overall Study|Withdrawal by parent/guardian|0|||
16334364|NCT01955109|39710767|FG000|Overall Study|Adverse Event|2|||
16334365|NCT01955109|39710768|FG001|Overall Study|Adverse Event|0|||
16334366|NCT01955109|39710767|FG000|Overall Study|Participant unwilling to continue|35|||
16334367|NCT01955109|39710768|FG001|Overall Study|Participant unwilling to continue|7|||
16334368|NCT01955109|39710767|FG000|Overall Study|Physician Decision|2|||
16334369|NCT01955109|39710768|FG001|Overall Study|Physician Decision|0|||
16334370|NCT01955109|39710767|FG000|Overall Study|Lost to Follow-up|3|||
16334371|NCT01955109|39710768|FG001|Overall Study|Lost to Follow-up|1|||
16334372|NCT01955109|39710767|FG000|Overall Study|Non-compliance|3|||
16403888|NCT04484649|39959625|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
16403889|NCT04484649|39959626|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
16403890|NCT05659719|39959627|FG000|Overall Study|At sponsor's request|0|||
16403891|NCT05659719|39959628|FG001|Overall Study|At sponsor's request|0|||
16403892|NCT05659719|39959629|FG002|Overall Study|At sponsor's request|0|||
16403893|NCT05659719|39959630|FG003|Overall Study|At sponsor's request|95|||
16403894|NCT05659719|39959627|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
16403895|NCT05659719|39959628|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
16403896|NCT05659719|39959629|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
16403897|NCT05659719|39959630|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
16403898|NCT05659719|39959627|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
16334373|NCT01955109|39710768|FG001|Overall Study|Non-compliance|1|||
16334374|NCT01841567|39710769|FG000|Overall Study|Adverse Event|3|||
16334375|NCT03403621|39710772|FG000|Overall Study|Withdrawal by Subject|2|||
16334376|NCT03403621|39710773|FG001|Overall Study|Withdrawal by Subject|2|||
16101053|NCT01136733|38856735|FG001|Phase 1b|Participant Choice|0|||
16101054|NCT01136733|38856736|FG002|Phase 1b|Participant Choice|1|||
16334377|NCT00628927|39710774|FG000|Overall Study|Problems performing blood draw|6|||
16334378|NCT00628927|39710775|FG001|Overall Study|Problems performing blood draw|0|||
16334379|NCT00628927|39710774|FG000|Overall Study|Lost to Follow-up|1|||
16334380|NCT00628927|39710775|FG001|Overall Study|Lost to Follow-up|0|||
16334381|NCT00628927|39710774|FG000|Overall Study|Equipment failure|1|||
16334382|NCT00628927|39710775|FG001|Overall Study|Equipment failure|0|||
16334383|NCT03578146|39710776|FG000|Overall Study|Did Not Receive Treatment|1|||
16334384|NCT03578146|39710777|FG001|Overall Study|Did Not Receive Treatment|0|||
16334385|NCT03578146|39710778|FG002|Overall Study|Did Not Receive Treatment|0|||
16334386|NCT03578146|39710779|FG003|Overall Study|Did Not Receive Treatment|0|||
16334387|NCT03578146|39710780|FG004|Overall Study|Did Not Receive Treatment|0|||
16334388|NCT03578146|39710781|FG005|Overall Study|Did Not Receive Treatment|2|||
16334389|NCT03578146|39710776|FG000|Overall Study|Lost to Follow-up|0|||
16334390|NCT03578146|39710777|FG001|Overall Study|Lost to Follow-up|1|||
16334391|NCT03578146|39710778|FG002|Overall Study|Lost to Follow-up|1|||
16334392|NCT03578146|39710779|FG003|Overall Study|Lost to Follow-up|0|||
16334393|NCT03578146|39710780|FG004|Overall Study|Lost to Follow-up|0|||
16534067|NCT01217073|40418280|FG007|Base Period|Protocol Violation|0|||
16534068|NCT01217073|40418273|FG000|Base Period|Withdrawal by Subject|4|||
16534069|NCT01217073|40418274|FG001|Base Period|Withdrawal by Subject|5|||
16534070|NCT01217073|40418275|FG002|Base Period|Withdrawal by Subject|5|||
16534071|NCT01217073|40418276|FG003|Base Period|Withdrawal by Subject|1|||
16534072|NCT01217073|40418277|FG004|Base Period|Withdrawal by Subject|5|||
16534073|NCT01217073|40418278|FG005|Base Period|Withdrawal by Subject|5|||
16534074|NCT01217073|40418279|FG006|Base Period|Withdrawal by Subject|0|||
16534075|NCT01217073|40418280|FG007|Base Period|Withdrawal by Subject|0|||
16534076|NCT01217073|40418273|FG000|Extension Period|Adverse Event|0|||
16534077|NCT01217073|40418274|FG001|Extension Period|Adverse Event|0|||
16534078|NCT01217073|40418275|FG002|Extension Period|Adverse Event|0|||
16534079|NCT01217073|40418276|FG003|Extension Period|Adverse Event|0|||
16534080|NCT01217073|40418277|FG004|Extension Period|Adverse Event|0|||
16534081|NCT01217073|40418278|FG005|Extension Period|Adverse Event|0|||
16534082|NCT01217073|40418279|FG006|Extension Period|Adverse Event|19|||
16534083|NCT01217073|40418280|FG007|Extension Period|Adverse Event|5|||
16534084|NCT01217073|40418273|FG000|Extension Period|ALT/AST|0|||
16534085|NCT01217073|40418274|FG001|Extension Period|ALT/AST|0|||
16534086|NCT01217073|40418275|FG002|Extension Period|ALT/AST|0|||
16534087|NCT01217073|40418276|FG003|Extension Period|ALT/AST|0|||
16534088|NCT01217073|40418277|FG004|Extension Period|ALT/AST|0|||
16534089|NCT01217073|40418278|FG005|Extension Period|ALT/AST|0|||
16101055|NCT01136733|38856737|FG003|Phase 1b|Participant Choice|0|||
16101056|NCT01136733|38856738|FG004|Phase 1b|Participant Choice|0|||
16101057|NCT01136733|38856739|FG005|Phase 1b|Participant Choice|0|||
16334394|NCT03578146|39710781|FG005|Overall Study|Lost to Follow-up|1|||
16101058|NCT01136733|38856740|FG006|Phase 1b|Participant Choice|0|||
16101059|NCT01136733|38856734|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
16101060|NCT01136733|38856735|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
16101061|NCT01136733|38856736|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
16101062|NCT01136733|38856737|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
16101063|NCT01136733|38856738|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
16101064|NCT01136733|38856739|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
16101065|NCT01136733|38856740|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
16101066|NCT01136733|38856734|FG000|Phase 1b|Clinical Progression|1|||
16101067|NCT01136733|38856735|FG001|Phase 1b|Clinical Progression|1|||
16101068|NCT01136733|38856736|FG002|Phase 1b|Clinical Progression|0|||
16101069|NCT01136733|38856737|FG003|Phase 1b|Clinical Progression|0|||
16334395|NCT01592292|39710782|FG000|Overall Study|Follow-up loss|3|||
16334396|NCT01592292|39710783|FG001|Overall Study|Follow-up loss|3|||
16534090|NCT01217073|40418279|FG006|Extension Period|ALT/AST|2|||
16534091|NCT01217073|40418280|FG007|Extension Period|ALT/AST|0|||
16534092|NCT01217073|40418273|FG000|Extension Period|Contraindication to study medication|0|||
16534093|NCT01217073|40418274|FG001|Extension Period|Contraindication to study medication|0|||
16534094|NCT01217073|40418275|FG002|Extension Period|Contraindication to study medication|0|||
16101070|NCT01136733|38856738|FG004|Phase 1b|Clinical Progression|0|||
16101071|NCT01136733|38856739|FG005|Phase 1b|Clinical Progression|0|||
16534095|NCT01217073|40418276|FG003|Extension Period|Contraindication to study medication|0|||
16534096|NCT01217073|40418277|FG004|Extension Period|Contraindication to study medication|0|||
16101072|NCT01136733|38856740|FG006|Phase 1b|Clinical Progression|0|||
16101073|NCT01136733|38856734|FG000|Phase 2|Disease Progression|0|||
16101074|NCT01136733|38856735|FG001|Phase 2|Disease Progression|0|||
16101075|NCT01136733|38856736|FG002|Phase 2|Disease Progression|0|||
16334397|NCT01592292|39710784|FG002|Overall Study|Follow-up loss|1|||
16334398|NCT01592292|39710785|FG003|Overall Study|Follow-up loss|0|||
16334399|NCT01592292|39710782|FG000|Overall Study|Withdrew consent|2|||
16101076|NCT01136733|38856737|FG003|Phase 2|Disease Progression|0|||
16101077|NCT01136733|38856738|FG004|Phase 2|Disease Progression|30|||
16101078|NCT01136733|38856739|FG005|Phase 2|Disease Progression|32|||
16101079|NCT01136733|38856740|FG006|Phase 2|Disease Progression|38|||
16101080|NCT01136733|38856734|FG000|Phase 2|Adverse Event|0|||
16101081|NCT01136733|38856735|FG001|Phase 2|Adverse Event|0|||
16101082|NCT01136733|38856736|FG002|Phase 2|Adverse Event|0|||
16101083|NCT01136733|38856737|FG003|Phase 2|Adverse Event|0|||
16101084|NCT01136733|38856738|FG004|Phase 2|Adverse Event|11|||
16101085|NCT01136733|38856739|FG005|Phase 2|Adverse Event|13|||
16101086|NCT01136733|38856740|FG006|Phase 2|Adverse Event|5|||
16101087|NCT01136733|38856734|FG000|Phase 2|Participant Choice|0|||
16101088|NCT01136733|38856735|FG001|Phase 2|Participant Choice|0|||
16101089|NCT01136733|38856736|FG002|Phase 2|Participant Choice|0|||
16101090|NCT01136733|38856737|FG003|Phase 2|Participant Choice|0|||
16101091|NCT01136733|38856738|FG004|Phase 2|Participant Choice|3|||
16101092|NCT01136733|38856739|FG005|Phase 2|Participant Choice|0|||
16101093|NCT01136733|38856740|FG006|Phase 2|Participant Choice|1|||
16334400|NCT01592292|39710783|FG001|Overall Study|Withdrew consent|1|||
16334401|NCT01592292|39710784|FG002|Overall Study|Withdrew consent|0|||
16534097|NCT01217073|40418278|FG005|Extension Period|Contraindication to study medication|0|||
16534098|NCT01217073|40418279|FG006|Extension Period|Contraindication to study medication|1|||
16534099|NCT01217073|40418280|FG007|Extension Period|Contraindication to study medication|0|||
16534100|NCT01217073|40418273|FG000|Extension Period|Creatinine/eGFR|0|||
16534101|NCT01217073|40418274|FG001|Extension Period|Creatinine/eGFR|0|||
16534102|NCT01217073|40418275|FG002|Extension Period|Creatinine/eGFR|0|||
16534103|NCT01217073|40418276|FG003|Extension Period|Creatinine/eGFR|0|||
16534104|NCT01217073|40418277|FG004|Extension Period|Creatinine/eGFR|0|||
16534105|NCT01217073|40418278|FG005|Extension Period|Creatinine/eGFR|0|||
16534106|NCT01217073|40418279|FG006|Extension Period|Creatinine/eGFR|11|||
16534107|NCT01217073|40418280|FG007|Extension Period|Creatinine/eGFR|1|||
16534108|NCT01217073|40418273|FG000|Extension Period|Death|0|||
16534109|NCT01217073|40418274|FG001|Extension Period|Death|0|||
16534110|NCT01217073|40418275|FG002|Extension Period|Death|0|||
16534111|NCT01217073|40418276|FG003|Extension Period|Death|0|||
16534112|NCT01217073|40418277|FG004|Extension Period|Death|0|||
16534113|NCT01217073|40418278|FG005|Extension Period|Death|0|||
16534114|NCT01217073|40418279|FG006|Extension Period|Death|1|||
16534115|NCT01217073|40418280|FG007|Extension Period|Death|0|||
16534116|NCT01217073|40418273|FG000|Extension Period|Excluded medication|0|||
16534117|NCT01217073|40418274|FG001|Extension Period|Excluded medication|0|||
16534118|NCT01217073|40418275|FG002|Extension Period|Excluded medication|0|||
16534119|NCT01217073|40418276|FG003|Extension Period|Excluded medication|0|||
16534120|NCT01217073|40418277|FG004|Extension Period|Excluded medication|0|||
16101094|NCT01136733|38856734|FG000|Phase 2|Administrative-Withdrew Consent|0|||
16101095|NCT01136733|38856735|FG001|Phase 2|Administrative-Withdrew Consent|0|||
16334402|NCT01592292|39710785|FG003|Overall Study|Withdrew consent|0|||
16334403|NCT01592292|39710782|FG000|Overall Study|Other|1|||
16334404|NCT01592292|39710783|FG001|Overall Study|Other|1|||
16334405|NCT01592292|39710784|FG002|Overall Study|Other|2|||
16334406|NCT01592292|39710785|FG003|Overall Study|Other|1|||
16334407|NCT05940077|39710786|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
16334408|NCT01618916|39710787|FG000|Overall Study|Adverse Event|1|||
16334409|NCT01618916|39710788|FG001|Overall Study|Adverse Event|0|||
16334410|NCT01618916|39710789|FG002|Overall Study|Adverse Event|0|||
16334411|NCT01618916|39710790|FG003|Overall Study|Adverse Event|0|||
16334412|NCT01618916|39710791|FG004|Overall Study|Adverse Event|0|||
16334413|NCT01618916|39710792|FG005|Overall Study|Adverse Event|0|||
16334414|NCT01618916|39710787|FG000|Overall Study|Withdrawal by Subject|0|||
16334415|NCT01618916|39710788|FG001|Overall Study|Withdrawal by Subject|1|||
16334416|NCT01618916|39710789|FG002|Overall Study|Withdrawal by Subject|1|||
16334417|NCT01618916|39710790|FG003|Overall Study|Withdrawal by Subject|0|||
16334418|NCT01618916|39710791|FG004|Overall Study|Withdrawal by Subject|1|||
16334419|NCT01618916|39710792|FG005|Overall Study|Withdrawal by Subject|0|||
16334420|NCT01618916|39710787|FG000|Overall Study|Lost to Follow-up|1|||
16334421|NCT01618916|39710788|FG001|Overall Study|Lost to Follow-up|0|||
16334422|NCT01618916|39710789|FG002|Overall Study|Lost to Follow-up|0|||
16334423|NCT01618916|39710790|FG003|Overall Study|Lost to Follow-up|2|||
16334424|NCT01618916|39710791|FG004|Overall Study|Lost to Follow-up|0|||
16334425|NCT01618916|39710792|FG005|Overall Study|Lost to Follow-up|0|||
16334426|NCT00787917|39710793|FG000|Blinded Treatment|Adverse Event|1|||
16334427|NCT00787917|39710794|FG001|Blinded Treatment|Adverse Event|0|||
16334428|NCT00787917|39710793|FG000|Blinded Treatment|Lack of Efficacy|1|||
16334429|NCT00787917|39710794|FG001|Blinded Treatment|Lack of Efficacy|0|||
16334430|NCT00787917|39710793|FG000|Blinded Treatment|Administrative problems|3|||
16334431|NCT00787917|39710794|FG001|Blinded Treatment|Administrative problems|2|||
16101096|NCT01136733|38856736|FG002|Phase 2|Administrative-Withdrew Consent|0|||
16101097|NCT01136733|38856737|FG003|Phase 2|Administrative-Withdrew Consent|0|||
16101098|NCT01136733|38856738|FG004|Phase 2|Administrative-Withdrew Consent|1|||
16534121|NCT01217073|40418278|FG005|Extension Period|Excluded medication|0|||
16534122|NCT01217073|40418279|FG006|Extension Period|Excluded medication|2|||
16534123|NCT01217073|40418280|FG007|Extension Period|Excluded medication|0|||
16534124|NCT01217073|40418273|FG000|Extension Period|Lack of Efficacy|0|||
16534125|NCT01217073|40418274|FG001|Extension Period|Lack of Efficacy|0|||
16534126|NCT01217073|40418275|FG002|Extension Period|Lack of Efficacy|0|||
16534127|NCT01217073|40418276|FG003|Extension Period|Lack of Efficacy|0|||
16534128|NCT01217073|40418277|FG004|Extension Period|Lack of Efficacy|0|||
16534129|NCT01217073|40418278|FG005|Extension Period|Lack of Efficacy|0|||
16534130|NCT01217073|40418279|FG006|Extension Period|Lack of Efficacy|3|||
16534131|NCT01217073|40418280|FG007|Extension Period|Lack of Efficacy|0|||
16534132|NCT01217073|40418273|FG000|Extension Period|Lost to Follow-up|0|||
16534133|NCT01217073|40418274|FG001|Extension Period|Lost to Follow-up|0|||
16534134|NCT01217073|40418275|FG002|Extension Period|Lost to Follow-up|0|||
16534135|NCT01217073|40418276|FG003|Extension Period|Lost to Follow-up|0|||
16534136|NCT01217073|40418277|FG004|Extension Period|Lost to Follow-up|0|||
16534137|NCT01217073|40418278|FG005|Extension Period|Lost to Follow-up|0|||
16534138|NCT01217073|40418279|FG006|Extension Period|Lost to Follow-up|9|||
16534139|NCT01217073|40418280|FG007|Extension Period|Lost to Follow-up|1|||
16534140|NCT01217073|40418273|FG000|Extension Period|Non-compliance with study drug|0|||
16534141|NCT01217073|40418274|FG001|Extension Period|Non-compliance with study drug|0|||
16534142|NCT01217073|40418275|FG002|Extension Period|Non-compliance with study drug|0|||
16534143|NCT01217073|40418276|FG003|Extension Period|Non-compliance with study drug|0|||
16534144|NCT01217073|40418277|FG004|Extension Period|Non-compliance with study drug|0|||
16534145|NCT01217073|40418278|FG005|Extension Period|Non-compliance with study drug|0|||
16534146|NCT01217073|40418279|FG006|Extension Period|Non-compliance with study drug|0|||
16534147|NCT01217073|40418280|FG007|Extension Period|Non-compliance with study drug|1|||
16534148|NCT01217073|40418273|FG000|Extension Period|Physician Decision|0|||
16534149|NCT01217073|40418274|FG001|Extension Period|Physician Decision|0|||
16534150|NCT01217073|40418275|FG002|Extension Period|Physician Decision|0|||
16534151|NCT01217073|40418276|FG003|Extension Period|Physician Decision|0|||
16534152|NCT01217073|40418277|FG004|Extension Period|Physician Decision|0|||
16534153|NCT01217073|40418278|FG005|Extension Period|Physician Decision|0|||
16534154|NCT01217073|40418279|FG006|Extension Period|Physician Decision|4|||
16534155|NCT01217073|40418280|FG007|Extension Period|Physician Decision|1|||
16534156|NCT01217073|40418273|FG000|Extension Period|Protocol Violation|0|||
16534157|NCT01217073|40418274|FG001|Extension Period|Protocol Violation|0|||
16534158|NCT01217073|40418275|FG002|Extension Period|Protocol Violation|0|||
16534159|NCT01217073|40418276|FG003|Extension Period|Protocol Violation|0|||
16534160|NCT01217073|40418277|FG004|Extension Period|Protocol Violation|0|||
16534161|NCT01217073|40418278|FG005|Extension Period|Protocol Violation|0|||
16534162|NCT01217073|40418279|FG006|Extension Period|Protocol Violation|2|||
16534163|NCT01217073|40418280|FG007|Extension Period|Protocol Violation|1|||
16534164|NCT01217073|40418273|FG000|Extension Period|Site discontinued study participation|0|||
16534165|NCT01217073|40418274|FG001|Extension Period|Site discontinued study participation|0|||
16534166|NCT01217073|40418275|FG002|Extension Period|Site discontinued study participation|0|||
16534167|NCT01217073|40418276|FG003|Extension Period|Site discontinued study participation|0|||
16534168|NCT01217073|40418277|FG004|Extension Period|Site discontinued study participation|0|||
16534169|NCT01217073|40418278|FG005|Extension Period|Site discontinued study participation|0|||
16534170|NCT01217073|40418279|FG006|Extension Period|Site discontinued study participation|7|||
16534171|NCT01217073|40418280|FG007|Extension Period|Site discontinued study participation|2|||
16403899|NCT05659719|39959628|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
16403900|NCT05659719|39959629|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
16403901|NCT05659719|39959630|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
16403902|NCT05659719|39959627|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
16403903|NCT05659719|39959628|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
16403904|NCT05659719|39959629|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
16403905|NCT05659719|39959630|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
16403906|NCT05659719|39959627|FG000|Overall Study|Lost to Follow-up|0|||
16403907|NCT05659719|39959628|FG001|Overall Study|Lost to Follow-up|0|||
16403908|NCT05659719|39959629|FG002|Overall Study|Lost to Follow-up|0|||
16403909|NCT05659719|39959630|FG003|Overall Study|Lost to Follow-up|2|||
16403910|NCT05659719|39959627|FG000|Overall Study|Moved to another observational study|0|||
16403911|NCT05659719|39959628|FG001|Overall Study|Moved to another observational study|0|||
16403912|NCT05659719|39959629|FG002|Overall Study|Moved to another observational study|0|||
16534172|NCT01217073|40418273|FG000|Extension Period|Withdrawal by Subject|0|||
16534173|NCT01217073|40418274|FG001|Extension Period|Withdrawal by Subject|0|||
16534174|NCT01217073|40418275|FG002|Extension Period|Withdrawal by Subject|0|||
16534175|NCT01217073|40418276|FG003|Extension Period|Withdrawal by Subject|0|||
16534176|NCT01217073|40418277|FG004|Extension Period|Withdrawal by Subject|0|||
16534177|NCT01217073|40418278|FG005|Extension Period|Withdrawal by Subject|0|||
16534178|NCT01217073|40418279|FG006|Extension Period|Withdrawal by Subject|30|||
16534179|NCT01217073|40418280|FG007|Extension Period|Withdrawal by Subject|8|||
16534180|NCT02063828|40418282|FG000|Overall Study|Withdrawal by Subject|4|||
16534181|NCT02063828|40418283|FG001|Overall Study|Withdrawal by Subject|6|||
16534182|NCT02063828|40418284|FG002|Overall Study|Withdrawal by Subject|3|||
16534183|NCT02063828|40418282|FG000|Overall Study|Death|0|||
16534184|NCT02063828|40418283|FG001|Overall Study|Death|0|||
16534185|NCT02063828|40418284|FG002|Overall Study|Death|1|||
16534186|NCT01220557|40418285|FG000|Overall Study|Lost to Follow-up|5|||
16534187|NCT01220557|40418286|FG001|Overall Study|Lost to Follow-up|3|||
16101099|NCT01136733|38856739|FG005|Phase 2|Administrative-Withdrew Consent|0|||
16101100|NCT01136733|38856740|FG006|Phase 2|Administrative-Withdrew Consent|0|||
16534188|NCT01220557|40418285|FG000|Overall Study|attended less than 6 lessons|1|||
16534189|NCT01220557|40418286|FG001|Overall Study|attended less than 6 lessons|2|||
16101101|NCT01136733|38856734|FG000|Phase 2|Other|0|||
16101102|NCT01136733|38856735|FG001|Phase 2|Other|0|||
16101103|NCT01136733|38856736|FG002|Phase 2|Other|0|||
16101104|NCT01136733|38856737|FG003|Phase 2|Other|0|||
16101105|NCT01136733|38856738|FG004|Phase 2|Other|6|||
16101106|NCT01136733|38856739|FG005|Phase 2|Other|7|||
16101107|NCT01136733|38856740|FG006|Phase 2|Other|6|||
16101108|NCT01124916|38856743|FG000|Overall Study|Lost to Follow-up|3|||
16101109|NCT01124916|38856744|FG001|Overall Study|Lost to Follow-up|2|||
16101110|NCT00348283|38856745|FG000|Induction|Adverse Event|0|||
16101111|NCT00348283|38856746|FG001|Induction|Adverse Event|2|||
16101112|NCT00348283|38856745|FG000|Induction|Protocol Violation|0|||
16101113|NCT00348283|38856746|FG001|Induction|Protocol Violation|4|||
16101114|NCT00348283|38856745|FG000|Double Blind|Adverse Event|2|||
16216491|NCT02203916|39272390|FG000|Overall Study|Major Protocol Deviation|1|||
16216492|NCT02203916|39272391|FG001|Overall Study|Major Protocol Deviation|1|||
16334432|NCT00787917|39710793|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
16334433|NCT00787917|39710794|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
16334434|NCT00787917|39710793|FG000|Open Label|Administrative problems|3|||
16334435|NCT00787917|39710794|FG001|Open Label|Administrative problems|0|||
16334436|NCT00943670|39710795|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
16534190|NCT02576678|40418287|FG000|Overall Study|Adverse Event|0|||
16534191|NCT02576678|40418288|FG001|Overall Study|Adverse Event|0|||
16101115|NCT00348283|38856746|FG001|Double Blind|Adverse Event|5|||
16101116|NCT00348283|38856745|FG000|Double Blind|Withdrawal by Subject|1|||
16101117|NCT00348283|38856746|FG001|Double Blind|Withdrawal by Subject|1|||
16101118|NCT00348283|38856745|FG000|Double Blind|Protocol Violation|0|||
16534192|NCT02576678|40418289|FG002|Overall Study|Adverse Event|2|||
16101119|NCT00348283|38856746|FG001|Double Blind|Protocol Violation|1|||
16101120|NCT00348283|38856745|FG000|Double Blind|Lack of Efficacy|2|||
16101121|NCT00348283|38856746|FG001|Double Blind|Lack of Efficacy|2|||
16101122|NCT00348283|38856745|FG000|Double Blind|Pregnancy|0|||
16101123|NCT00348283|38856746|FG001|Double Blind|Pregnancy|1|||
16101124|NCT00348283|38856745|FG000|Open Label|Adverse Event|0|||
16534193|NCT02576678|40418287|FG000|Overall Study|Withdrawal by Subject|3|||
16534194|NCT02576678|40418288|FG001|Overall Study|Withdrawal by Subject|1|||
16534195|NCT02576678|40418289|FG002|Overall Study|Withdrawal by Subject|2|||
16534196|NCT02576678|40418287|FG000|Overall Study|Lost to Follow-up|0|||
16101125|NCT00348283|38856746|FG001|Open Label|Adverse Event|8|||
16101126|NCT00348283|38856745|FG000|Open Label|Withdrawal by Subject|0|||
16534197|NCT02576678|40418288|FG001|Overall Study|Lost to Follow-up|0|||
16534198|NCT02576678|40418289|FG002|Overall Study|Lost to Follow-up|1|||
16534199|NCT02576678|40418287|FG000|Overall Study|Miscellaneous|2|||
16534200|NCT02576678|40418288|FG001|Overall Study|Miscellaneous|0|||
16534201|NCT02576678|40418289|FG002|Overall Study|Miscellaneous|0|||
16534202|NCT03712917|40418294|FG000|Overall Study|Pregnancy|0|||
16534203|NCT03712917|40418295|FG001|Overall Study|Pregnancy|0|||
16101127|NCT00348283|38856746|FG001|Open Label|Withdrawal by Subject|4|||
16101128|NCT00348283|38856745|FG000|Open Label|Lost to Follow-up|0|||
16101129|NCT00348283|38856746|FG001|Open Label|Lost to Follow-up|1|||
16101130|NCT00348283|38856745|FG000|Open Label|Lack of Efficacy|0|||
16101131|NCT00348283|38856746|FG001|Open Label|Lack of Efficacy|13|||
16101132|NCT00348283|38856745|FG000|Open Label|Administrative reasons|0|||
16101133|NCT00348283|38856746|FG001|Open Label|Administrative reasons|5|||
16101134|NCT00348283|38856745|FG000|Open Label|Subject moved to the United States|0|||
16101135|NCT00348283|38856746|FG001|Open Label|Subject moved to the United States|1|||
16101136|NCT00348283|38856745|FG000|Open Label|Pregnancy|0|||
16101137|NCT00348283|38856746|FG001|Open Label|Pregnancy|1|||
16101138|NCT00348283|38856745|FG000|Open Label|Sponsor decision|0|||
16101139|NCT00348283|38856746|FG001|Open Label|Sponsor decision|1|||
16101140|NCT01533181|38856749|FG000|Overall Study|Disease progression pre-active treatment|0|||
16101141|NCT01533181|38856750|FG001|Overall Study|Disease progression pre-active treatment|1|||
16101142|NCT01533181|38856749|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
16101143|NCT01533181|38856750|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
16101144|NCT00588341|38856751|FG000|Overall Study|Withdrawal by Subject|3|||
16101145|NCT00588341|38856751|FG000|Overall Study|Not treated due to metastatic disease|1|||
16101146|NCT00588341|38856751|FG000|Overall Study|Patient ineligible|1|||
16101147|NCT00705614|38856752|FG000|Initial Intervention|Adverse Event|40|||
16101148|NCT00705614|38856753|FG001|Initial Intervention|Adverse Event|21|||
16101149|NCT00705614|38856752|FG000|Initial Intervention|Lost to Follow-up|310|||
16101150|NCT00705614|38856753|FG001|Initial Intervention|Lost to Follow-up|191|||
16101151|NCT00705614|38856752|FG000|Initial Intervention|Withdrawal by Subject|114|||
16101152|NCT00705614|38856753|FG001|Initial Intervention|Withdrawal by Subject|71|||
16101153|NCT00705614|38856752|FG000|Initial Intervention|Administrative Reason|51|||
16101154|NCT00705614|38856753|FG001|Initial Intervention|Administrative Reason|38|||
16101155|NCT00705614|38856752|FG000|Initial Intervention|Status completion unknown|3|||
16101156|NCT00705614|38856753|FG001|Initial Intervention|Status completion unknown|0|||
16101157|NCT00705614|38856752|FG000|Switch to Remicade|Adverse Event|0|||
16101158|NCT00705614|38856753|FG001|Switch to Remicade|Adverse Event|5|||
16101159|NCT00705614|38856752|FG000|Switch to Remicade|Lost to Follow-up|0|||
16334437|NCT00943670|39710795|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
16334438|NCT00943670|39710795|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
16334439|NCT00943670|39710795|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
16334440|NCT00943670|39710795|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
16334441|NCT00943670|39710795|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
16334442|NCT00943670|39710795|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
16334443|NCT00943670|39710795|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
16334444|NCT00943670|39710795|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
16334445|NCT00943670|39710795|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
16334446|NCT00994214|39710800|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
16334447|NCT00994214|39710801|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
16334448|NCT00994214|39710802|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
16334449|NCT00994214|39710803|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
16334450|NCT00994214|39710800|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
16334451|NCT00994214|39710801|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
16334452|NCT00994214|39710802|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
16334453|NCT00994214|39710803|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
16334454|NCT00994214|39710800|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
16534204|NCT03712917|40418296|FG002|Overall Study|Pregnancy|1|||
16534205|NCT03712917|40418294|FG000|Overall Study|Adverse Event|0|||
16101160|NCT00705614|38856753|FG001|Switch to Remicade|Lost to Follow-up|23|||
16101161|NCT00705614|38856752|FG000|Switch to Remicade|Withdrawal by Subject|0|||
16101162|NCT00705614|38856753|FG001|Switch to Remicade|Withdrawal by Subject|12|||
16101163|NCT00705614|38856752|FG000|Switch to Remicade|Administrative Reason|0|||
16101164|NCT00705614|38856753|FG001|Switch to Remicade|Administrative Reason|9|||
16101165|NCT01225159|38856754|FG000|Overall Study|Change operation|1|||
16101166|NCT01225159|38856755|FG001|Overall Study|Change operation|0|||
16101167|NCT00850993|38856760|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
16101168|NCT00850993|38856761|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
16101169|NCT00850993|38856762|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
16101170|NCT00850993|38856763|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
16101171|NCT00255944|38856764|FG000|Overall Study|Lost to Follow-up|797|||
16101172|NCT00255944|38856765|FG001|Overall Study|Lost to Follow-up|834|||
16101173|NCT00981578|38856766|FG000|Overall Study|Death|1|||
16101174|NCT00981578|38856766|FG000|Overall Study|Withdrawal by Subject|2|||
16101175|NCT03022045|38856767|FG000|Overall Study|Adverse Event|0|||
16101176|NCT03022045|38856768|FG001|Overall Study|Adverse Event|1|||
16101177|NCT03022045|38856767|FG000|Overall Study|Withdrawal by Subject|1|||
16101178|NCT03022045|38856768|FG001|Overall Study|Withdrawal by Subject|1|||
16101179|NCT01601821|38856769|FG000|Overall Study|Death|2|||
16101180|NCT01601821|38856770|FG001|Overall Study|Death|5|||
16101181|NCT01601821|38856769|FG000|Overall Study|Protocol Violation|2|||
16101182|NCT01601821|38856770|FG001|Overall Study|Protocol Violation|2|||
16101183|NCT01601821|38856769|FG000|Overall Study|Lost to Follow-up|6|||
16101184|NCT01601821|38856770|FG001|Overall Study|Lost to Follow-up|14|||
16101185|NCT01601821|38856769|FG000|Overall Study|Withdrawal by Subject|1|||
16101186|NCT01601821|38856770|FG001|Overall Study|Withdrawal by Subject|0|||
16101187|NCT01601821|38856769|FG000|Overall Study|Graft Loss|6|||
16101188|NCT01601821|38856770|FG001|Overall Study|Graft Loss|6|||
16101189|NCT01601821|38856769|FG000|Overall Study|Study Events|7|||
16101190|NCT01601821|38856770|FG001|Overall Study|Study Events|1|||
16101191|NCT01601821|38856769|FG000|Overall Study|Other|5|||
16101192|NCT01601821|38856770|FG001|Overall Study|Other|1|||
16101193|NCT00265096|38856773|FG000|Overall Study|Adverse Event|14|||
16101194|NCT00265096|38856774|FG001|Overall Study|Adverse Event|18|||
16101195|NCT00265096|38856775|FG002|Overall Study|Adverse Event|18|||
16101196|NCT00265096|38856773|FG000|Overall Study|Lost to Follow-up|2|||
16101197|NCT00265096|38856774|FG001|Overall Study|Lost to Follow-up|5|||
16101198|NCT00265096|38856775|FG002|Overall Study|Lost to Follow-up|3|||
16101199|NCT00265096|38856773|FG000|Overall Study|Death|0|||
16101200|NCT00265096|38856774|FG001|Overall Study|Death|1|||
16101201|NCT00265096|38856775|FG002|Overall Study|Death|2|||
16101202|NCT00265096|38856773|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
16101203|NCT00265096|38856774|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
16403913|NCT05659719|39959630|FG003|Overall Study|Moved to another observational study|1|||
16403914|NCT05659719|39959627|FG000|Overall Study|The child was enrolled in an interventional study|0|||
16403915|NCT05659719|39959628|FG001|Overall Study|The child was enrolled in an interventional study|0|||
16403916|NCT05659719|39959629|FG002|Overall Study|The child was enrolled in an interventional study|0|||
16403917|NCT05659719|39959630|FG003|Overall Study|The child was enrolled in an interventional study|55|||
16403918|NCT05659719|39959627|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
16403919|NCT05659719|39959628|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
16403920|NCT05659719|39959629|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
16403921|NCT05659719|39959630|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
16403922|NCT05659719|39959627|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
16403923|NCT05659719|39959628|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
16403924|NCT05659719|39959629|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
16403925|NCT05659719|39959630|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
16403926|NCT02578680|39959633|FG000|Overall Study|Death|329|||
16403927|NCT02578680|39959634|FG001|Overall Study|Death|181|||
16403928|NCT02578680|39959633|FG000|Overall Study|Lost to Follow-up|3|||
16403929|NCT02578680|39959634|FG001|Overall Study|Lost to Follow-up|1|||
16403930|NCT02578680|39959633|FG000|Overall Study|Physician Decision|0|||
16403931|NCT02578680|39959634|FG001|Overall Study|Physician Decision|1|||
16403932|NCT02578680|39959633|FG000|Overall Study|Protocol Violation|1|||
16403933|NCT02578680|39959634|FG001|Overall Study|Protocol Violation|1|||
16403934|NCT02578680|39959633|FG000|Overall Study|Sponsor Decision|64|||
16403935|NCT02578680|39959634|FG001|Overall Study|Sponsor Decision|13|||
16403936|NCT02578680|39959633|FG000|Overall Study|Withdrawal by Subject|13|||
16403937|NCT02578680|39959634|FG001|Overall Study|Withdrawal by Subject|9|||
16403938|NCT05275010|39959636|FG000|Overall Study|Reason Not Specified|4|||
16101204|NCT00265096|38856775|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
16101205|NCT00265096|38856773|FG000|Overall Study|Other|11|||
16101206|NCT00265096|38856774|FG001|Overall Study|Other|19|||
16101207|NCT00265096|38856775|FG002|Overall Study|Other|10|||
16101208|NCT05041439|38856777|FG000|Overall Study|Withdrawal by Subject|1|||
16101209|NCT05041439|38856778|FG001|Overall Study|Withdrawal by Subject|1|||
16403939|NCT05275010|39959637|FG001|Overall Study|Reason Not Specified|1|||
16403940|NCT05275010|39959636|FG000|Overall Study|Withdrawal by Subject|1|||
16403941|NCT05275010|39959637|FG001|Overall Study|Withdrawal by Subject|0|||
16403942|NCT05275010|39959636|FG000|Overall Study|Lost to Follow-up|0|||
16403943|NCT05275010|39959637|FG001|Overall Study|Lost to Follow-up|1|||
16403944|NCT03727646|39959638|FG000|Overall Study|Adverse Event|1|||
16403945|NCT03727646|39959639|FG001|Overall Study|Adverse Event|0|||
16403946|NCT04753658|39959640|FG000|Overall Study|Progressive disease|7|||
16403947|NCT04753658|39959640|FG000|Overall Study|Other|7|||
16403948|NCT04753658|39959640|FG000|Overall Study|Adverse Event|1|||
16403949|NCT05438602|39959641|FG000|Treatment (15 Days)|Adverse Event|2|||
16403950|NCT05438602|39959642|FG001|Treatment (15 Days)|Adverse Event|1|||
16403951|NCT05438602|39959643|FG002|Treatment (15 Days)|Adverse Event|3|||
16403952|NCT05438602|39959641|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
16403953|NCT05438602|39959642|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
16403954|NCT05438602|39959643|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
16403955|NCT05438602|39959641|FG000|Treatment (15 Days)|Other|0|||
16403956|NCT05438602|39959642|FG001|Treatment (15 Days)|Other|0|||
16403957|NCT05438602|39959643|FG002|Treatment (15 Days)|Other|1|||
16403958|NCT05438602|39959641|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
16403959|NCT05438602|39959642|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
16403960|NCT05438602|39959643|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
16403961|NCT05438602|39959641|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
16403962|NCT05438602|39959642|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
16403963|NCT05438602|39959643|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
16403964|NCT05438602|39959641|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
16403965|NCT05438602|39959642|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
16403966|NCT05438602|39959643|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
16334455|NCT00994214|39710801|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
16334456|NCT00994214|39710802|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
16334457|NCT00994214|39710803|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
16334458|NCT00994214|39710800|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
16334459|NCT00994214|39710801|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
16101210|NCT05041439|38856777|FG000|Overall Study|Death|1|||
16101211|NCT05041439|38856778|FG001|Overall Study|Death|0|||
16101212|NCT02110225|38856779|FG000|Overall Study|Lost to Follow-up|0|||
16101213|NCT02110225|38856780|FG001|Overall Study|Lost to Follow-up|1|||
16334460|NCT00994214|39710802|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
16334461|NCT00994214|39710803|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
16334462|NCT00994214|39710800|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
16334463|NCT00994214|39710801|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
16334464|NCT00994214|39710802|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
16334465|NCT00994214|39710803|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
16334466|NCT00994214|39710800|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
16334467|NCT00994214|39710801|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
16334468|NCT00994214|39710802|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
16334469|NCT00994214|39710803|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
16334470|NCT00904839|39710809|FG000|Overall Study|Adverse Event|0|||
16334471|NCT00904839|39710810|FG001|Overall Study|Adverse Event|5|||
16334472|NCT00904839|39710811|FG002|Overall Study|Adverse Event|4|||
16334473|NCT00904839|39710809|FG000|Overall Study|Protocol Violation|0|||
16334474|NCT00904839|39710810|FG001|Overall Study|Protocol Violation|1|||
16334475|NCT00904839|39710811|FG002|Overall Study|Protocol Violation|1|||
16334476|NCT00904839|39710809|FG000|Overall Study|Lost to Follow-up|0|||
16334477|NCT00904839|39710810|FG001|Overall Study|Lost to Follow-up|1|||
16403967|NCT05438602|39959641|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
16403968|NCT05438602|39959642|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
16534206|NCT03712917|40418295|FG001|Overall Study|Adverse Event|4|||
16101214|NCT02110225|38856781|FG002|Overall Study|Lost to Follow-up|0|||
16334478|NCT00904839|39710811|FG002|Overall Study|Lost to Follow-up|2|||
16334479|NCT00904839|39710809|FG000|Overall Study|Withdrawal by Subject|0|||
16334480|NCT00904839|39710810|FG001|Overall Study|Withdrawal by Subject|2|||
16334481|NCT00904839|39710811|FG002|Overall Study|Withdrawal by Subject|0|||
16334482|NCT00904839|39710809|FG000|Overall Study|Not treated|1|||
16334483|NCT00904839|39710810|FG001|Overall Study|Not treated|0|||
16101215|NCT02777242|38856782|FG000|Overall Study|Other|2|||
16101216|NCT02777242|38856782|FG000|Overall Study|Lost to Follow-up|1|||
16101217|NCT02777242|38856782|FG000|Overall Study|Multiple|1|||
16101218|NCT02777242|38856782|FG000|Overall Study|Sponsor's request|1|||
16101219|NCT02777242|38856782|FG000|Overall Study|Withdrawal by Subject|1|||
16101220|NCT02282917|38856783|FG000|Overall Study|Withdrawal by Subject|1|||
16101221|NCT02282917|38856783|FG000|Overall Study|Screen Failure/Not Eligible|1|||
16101222|NCT02556918|38856788|FG000|Overall Study|Protocol Violation|5|||
16101223|NCT02556918|38856789|FG001|Overall Study|Protocol Violation|6|||
16101224|NCT02556918|38856788|FG000|Overall Study|Withdrawal by Subject|4|||
16101225|NCT02556918|38856789|FG001|Overall Study|Withdrawal by Subject|4|||
16101226|NCT00762502|38856792|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
16101227|NCT00762502|38856793|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
16101228|NCT00762502|38856794|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
16101229|NCT00762502|38856792|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
16101230|NCT00762502|38856793|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
16101231|NCT00762502|38856794|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
16101232|NCT00762502|38856792|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
16101233|NCT00762502|38856793|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
16101234|NCT00762502|38856794|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
16101235|NCT05740371|38856795|FG000|Overall Study|Death|1|||
16101236|NCT01945593|38856803|FG000|Overall Study|Adverse Event|0|||
16101237|NCT01945593|38856804|FG001|Overall Study|Adverse Event|0|||
16101238|NCT01945593|38856805|FG002|Overall Study|Adverse Event|0|||
16101239|NCT01945593|38856806|FG003|Overall Study|Adverse Event|5|||
16101240|NCT01945593|38856803|FG000|Overall Study|Physician Decision|0|||
16101241|NCT01945593|38856804|FG001|Overall Study|Physician Decision|0|||
16101242|NCT01945593|38856805|FG002|Overall Study|Physician Decision|1|||
16101243|NCT01945593|38856806|FG003|Overall Study|Physician Decision|1|||
16101244|NCT01945593|38856803|FG000|Overall Study|Withdrawal by Subject|0|||
16101245|NCT01945593|38856804|FG001|Overall Study|Withdrawal by Subject|2|||
16101246|NCT01945593|38856805|FG002|Overall Study|Withdrawal by Subject|0|||
16334484|NCT00904839|39710811|FG002|Overall Study|Not treated|1|||
16334485|NCT00904839|39710809|FG000|Overall Study|Other than above|0|||
16101247|NCT01945593|38856806|FG003|Overall Study|Withdrawal by Subject|4|||
16101248|NCT01945593|38856803|FG000|Overall Study|Protocol Violation|0|||
16101249|NCT01945593|38856804|FG001|Overall Study|Protocol Violation|2|||
16101250|NCT01945593|38856805|FG002|Overall Study|Protocol Violation|1|||
16101251|NCT01945593|38856806|FG003|Overall Study|Protocol Violation|3|||
16334486|NCT00904839|39710810|FG001|Overall Study|Other than above|9|||
16334487|NCT00904839|39710811|FG002|Overall Study|Other than above|7|||
16403969|NCT05438602|39959643|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
16403970|NCT05438602|39959641|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
16403971|NCT05438602|39959642|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
16403972|NCT05438602|39959643|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
16403973|NCT05438602|39959641|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
16403974|NCT05438602|39959642|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
16403975|NCT05438602|39959643|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
16403976|NCT05438602|39959641|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
16403977|NCT05438602|39959642|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
16403978|NCT05438602|39959643|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
16403979|NCT04649359|39959644|FG000|Overall Study|Withdrawal by Subject|7|||
16403980|NCT04649359|39959645|FG001|Overall Study|Withdrawal by Subject|7|||
16403981|NCT04649359|39959644|FG000|Overall Study|Death|41|||
16403982|NCT04649359|39959645|FG001|Overall Study|Death|26|||
16403983|NCT04649359|39959644|FG000|Overall Study|Ongoing in the study|75|||
16403984|NCT04649359|39959645|FG001|Overall Study|Ongoing in the study|31|||
16403985|NCT05935878|39959649|FG000|Overall Study|Death|1|||
16403986|NCT05935878|39959650|FG001|Overall Study|Death|2|||
16403987|NCT05935878|39959649|FG000|Overall Study|Withdrawal by Subject|5|||
16403988|NCT05935878|39959650|FG001|Overall Study|Withdrawal by Subject|5|||
16403989|NCT05935878|39959649|FG000|Overall Study|Revision of implant|1|||
16403990|NCT05935878|39959650|FG001|Overall Study|Revision of implant|1|||
16403991|NCT05935878|39959649|FG000|Overall Study|Mobile bearing dislocation|0|||
16403992|NCT05935878|39959650|FG001|Overall Study|Mobile bearing dislocation|1|||
16403993|NCT05260073|39959651|FG000|Overall Study|Physician Decision|1|||
16403994|NCT05260073|39959651|FG000|Overall Study|Withdrawal by Subject|6|||
16403995|NCT05260073|39959651|FG000|Overall Study|Lost to Follow-up|14|||
16403996|NCT03901352|39959668|FG000|Double-blind Phase|Adverse Event|6|||
16403997|NCT03901352|39959669|FG001|Double-blind Phase|Adverse Event|4|||
16403998|NCT03901352|39959668|FG000|Double-blind Phase|Death|1|||
16403999|NCT03901352|39959669|FG001|Double-blind Phase|Death|0|||
16404000|NCT03901352|39959668|FG000|Double-blind Phase|Lack of Efficacy|0|||
16404001|NCT03901352|39959669|FG001|Double-blind Phase|Lack of Efficacy|1|||
16404002|NCT03901352|39959668|FG000|Double-blind Phase|Protocol Violation|0|||
16404003|NCT03901352|39959669|FG001|Double-blind Phase|Protocol Violation|1|||
16404004|NCT03901352|39959668|FG000|Double-blind Phase|Withdrawal by Subject|10|||
16404005|NCT03901352|39959669|FG001|Double-blind Phase|Withdrawal by Subject|8|||
16404006|NCT03901352|39959668|FG000|Open-label Extension Phase|Adverse Event|24|||
16404007|NCT03901352|39959669|FG001|Open-label Extension Phase|Adverse Event|0|||
16404008|NCT03901352|39959668|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
16404009|NCT03901352|39959669|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
16404010|NCT03901352|39959668|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
16404011|NCT03901352|39959669|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
16404012|NCT03901352|39959668|FG000|Open-label Extension Phase|Other|1|||
16404013|NCT03901352|39959669|FG001|Open-label Extension Phase|Other|0|||
16404014|NCT03895086|39959670|FG000|Overall Study|Early termination study|1|||
16404015|NCT03895086|39959671|FG001|Overall Study|Early termination study|0|||
16404016|NCT05312632|39959672|FG000|Overall Study|Adverse Event|12|||
16404017|NCT05312632|39959672|FG000|Overall Study|Withdrawal by Subject|10|||
16404018|NCT05312632|39959672|FG000|Overall Study|Lack of Efficacy|4|||
16404019|NCT05312632|39959672|FG000|Overall Study|Non-compliance with study procedures|9|||
16404020|NCT05312632|39959672|FG000|Overall Study|Other|4|||
16404021|NCT03100539|39959673|FG000|Overall Study|Lost to Follow-up|60|||
16404022|NCT03100539|39959674|FG001|Overall Study|Lost to Follow-up|54|||
16404023|NCT03100539|39959675|FG002|Overall Study|Lost to Follow-up|17|||
16404024|NCT03100539|39959673|FG000|Overall Study|Uncollected|8|||
16404025|NCT03100539|39959674|FG001|Overall Study|Uncollected|8|||
16404026|NCT03100539|39959675|FG002|Overall Study|Uncollected|0|||
16404027|NCT03100539|39959673|FG000|Overall Study|Ally Health|0|||
16404028|NCT03100539|39959674|FG001|Overall Study|Ally Health|0|||
16404029|NCT03100539|39959675|FG002|Overall Study|Ally Health|3|||
16404030|NCT03100539|39959673|FG000|Overall Study|Disinterest|0|||
16404031|NCT03100539|39959674|FG001|Overall Study|Disinterest|0|||
16404032|NCT03100539|39959675|FG002|Overall Study|Disinterest|22|||
16404033|NCT03100539|39959673|FG000|Overall Study|Veteran Health|0|||
16404034|NCT03100539|39959674|FG001|Overall Study|Veteran Health|0|||
16404035|NCT03100539|39959675|FG002|Overall Study|Veteran Health|8|||
16404036|NCT03100539|39959673|FG000|Overall Study|Moved|0|||
16534207|NCT03712917|40418296|FG002|Overall Study|Adverse Event|3|||
16534208|NCT03712917|40418294|FG000|Overall Study|Lost to Follow-up|9|||
16534209|NCT03712917|40418295|FG001|Overall Study|Lost to Follow-up|4|||
16534210|NCT03712917|40418296|FG002|Overall Study|Lost to Follow-up|5|||
16534211|NCT00951483|40418297|FG000|Overall Study|Physician Decision|4|||
16534212|NCT00951483|40418298|FG001|Overall Study|Physician Decision|0|||
16534213|NCT00951483|40418297|FG000|Overall Study|Withdrawal by Subject|15|||
16534214|NCT00951483|40418298|FG001|Overall Study|Withdrawal by Subject|0|||
16534215|NCT00058123|40418299|FG000|Overall Study|Wrong histology|9|||
16534216|NCT00058123|40418299|FG000|Overall Study|Received >3 prior treatments|1|||
16534217|NCT03301051|40418300|FG000|Overall Study|Adverse Event|0|||
16534218|NCT03301051|40418301|FG001|Overall Study|Adverse Event|4|||
16534219|NCT03301051|40418300|FG000|Overall Study|Withdrawal by Subject|59|||
16534220|NCT03301051|40418301|FG001|Overall Study|Withdrawal by Subject|65|||
16534221|NCT03301051|40418300|FG000|Overall Study|Lost to Follow-up|263|||
16534222|NCT03301051|40418301|FG001|Overall Study|Lost to Follow-up|282|||
16534223|NCT03301051|40418300|FG000|Overall Study|Protocol Violation|1|||
16534224|NCT03301051|40418301|FG001|Overall Study|Protocol Violation|3|||
16534225|NCT03301051|40418300|FG000|Overall Study|Physician Decision|1|||
16534226|NCT03301051|40418301|FG001|Overall Study|Physician Decision|3|||
16534227|NCT03301051|40418300|FG000|Overall Study|Death|1|||
16534228|NCT03301051|40418301|FG001|Overall Study|Death|1|||
16534229|NCT03301051|40418300|FG000|Overall Study|Miscellaneous|8|||
16534230|NCT03301051|40418301|FG001|Overall Study|Miscellaneous|4|||
16534231|NCT03301051|40418300|FG000|Overall Study|Randomized, not vaccinated|13|||
16534232|NCT03301051|40418301|FG001|Overall Study|Randomized, not vaccinated|10|||
16534233|NCT03966157|40418302|FG000|Overall Study|Physician Decision|1|||
16534234|NCT03966157|40418303|FG001|Overall Study|Physician Decision|0|||
16534235|NCT00092534|40418304|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
16534236|NCT00092534|40418305|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
16534237|NCT00092534|40418306|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
16534238|NCT00092534|40418307|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
16534239|NCT00092534|40418308|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
16534240|NCT00092534|40418304|FG000|Base Study Vaccination Period|Adverse Event|3|||
16534241|NCT00092534|40418305|FG001|Base Study Vaccination Period|Adverse Event|1|||
16534242|NCT00092534|40418306|FG002|Base Study Vaccination Period|Adverse Event|0|||
16534243|NCT00092534|40418307|FG003|Base Study Vaccination Period|Adverse Event|0|||
16534244|NCT00092534|40418308|FG004|Base Study Vaccination Period|Adverse Event|0|||
16534245|NCT00092534|40418304|FG000|Base Study Vaccination Period|Death|5|||
16534246|NCT00092534|40418305|FG001|Base Study Vaccination Period|Death|4|||
16534247|NCT00092534|40418306|FG002|Base Study Vaccination Period|Death|0|||
16534248|NCT00092534|40418307|FG003|Base Study Vaccination Period|Death|0|||
16534249|NCT00092534|40418308|FG004|Base Study Vaccination Period|Death|0|||
16534250|NCT00092534|40418304|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
16534251|NCT00092534|40418305|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
16534252|NCT00092534|40418306|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
16534253|NCT00092534|40418307|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
16534254|NCT00092534|40418308|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
16534255|NCT00092534|40418304|FG000|Base Study Vaccination Period|Physician Decision|1|||
16534256|NCT00092534|40418305|FG001|Base Study Vaccination Period|Physician Decision|0|||
16534257|NCT00092534|40418306|FG002|Base Study Vaccination Period|Physician Decision|0|||
16534258|NCT00092534|40418307|FG003|Base Study Vaccination Period|Physician Decision|0|||
16534259|NCT00092534|40418308|FG004|Base Study Vaccination Period|Physician Decision|0|||
16534260|NCT00092534|40418304|FG000|Base Study Vaccination Period|Pregnancy|9|||
16534261|NCT00092534|40418305|FG001|Base Study Vaccination Period|Pregnancy|7|||
16534262|NCT00092534|40418306|FG002|Base Study Vaccination Period|Pregnancy|0|||
16534263|NCT00092534|40418307|FG003|Base Study Vaccination Period|Pregnancy|0|||
16534264|NCT00092534|40418308|FG004|Base Study Vaccination Period|Pregnancy|0|||
16534265|NCT00092534|40418304|FG000|Base Study Vaccination Period|Protocol Violation|2|||
16534266|NCT00092534|40418305|FG001|Base Study Vaccination Period|Protocol Violation|1|||
16534267|NCT00092534|40418306|FG002|Base Study Vaccination Period|Protocol Violation|0|||
16534268|NCT00092534|40418307|FG003|Base Study Vaccination Period|Protocol Violation|0|||
16534269|NCT00092534|40418308|FG004|Base Study Vaccination Period|Protocol Violation|0|||
16534270|NCT00092534|40418304|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
16534271|NCT00092534|40418305|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
16101252|NCT01945593|38856803|FG000|Overall Study|Death|0|||
16404037|NCT03100539|39959674|FG001|Overall Study|Moved|0|||
16404038|NCT03100539|39959675|FG002|Overall Study|Moved|1|||
16404039|NCT03100539|39959673|FG000|Overall Study|Scheduling Conflicts|0|||
16404040|NCT03100539|39959674|FG001|Overall Study|Scheduling Conflicts|0|||
16404041|NCT03100539|39959675|FG002|Overall Study|Scheduling Conflicts|12|||
16404042|NCT03596047|39959679|FG000|Overall Study|Withdrawal by Subject|7|||
16404043|NCT03596047|39959680|FG001|Overall Study|Withdrawal by Subject|4|||
16404044|NCT03596047|39959679|FG000|Overall Study|Lost to Follow-up|0|||
16404045|NCT03596047|39959680|FG001|Overall Study|Lost to Follow-up|2|||
16404046|NCT05791565|39959681|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
16101253|NCT01945593|38856804|FG001|Overall Study|Death|0|||
16334488|NCT00329641|39710817|FG000|Overall Study|Did not start treatment|1|||
16334489|NCT00329641|39710817|FG000|Overall Study|Not eligible|1|||
16334490|NCT00329641|39710817|FG000|Overall Study|Adverse Event|3|||
16334491|NCT00329641|39710817|FG000|Overall Study|Other reason, not protocol specified|1|||
16334492|NCT00248833|39710818|FG000|Overall Study|Adverse Event|2|||
16334493|NCT00248833|39710819|FG001|Overall Study|Adverse Event|0|||
16334494|NCT00248833|39710820|FG002|Overall Study|Adverse Event|0|||
16334495|NCT00248833|39710818|FG000|Overall Study|Withdrawal by Subject|0|||
16334496|NCT00248833|39710819|FG001|Overall Study|Withdrawal by Subject|1|||
16334497|NCT00248833|39710820|FG002|Overall Study|Withdrawal by Subject|1|||
16334498|NCT00248833|39710818|FG000|Overall Study|Lost to Follow-up|1|||
16334499|NCT00248833|39710819|FG001|Overall Study|Lost to Follow-up|1|||
16334500|NCT00248833|39710820|FG002|Overall Study|Lost to Follow-up|1|||
16334501|NCT00248833|39710818|FG000|Overall Study|Other|0|||
16334502|NCT00248833|39710819|FG001|Overall Study|Other|1|||
16334503|NCT00248833|39710820|FG002|Overall Study|Other|0|||
16334504|NCT02570750|39710821|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
16334505|NCT02570750|39710822|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
16334506|NCT02570750|39710821|FG000|Overall Study|Protocol deviation|4|||
16334507|NCT02570750|39710822|FG001|Overall Study|Protocol deviation|2|||
16334508|NCT02570750|39710821|FG000|Overall Study|Withdrawal by Subject|5|||
16334509|NCT02570750|39710822|FG001|Overall Study|Withdrawal by Subject|0|||
16334510|NCT02570750|39710821|FG000|Overall Study|Lost to Follow-up|2|||
16334511|NCT02570750|39710822|FG001|Overall Study|Lost to Follow-up|2|||
16334512|NCT02570750|39710821|FG000|Overall Study|Adverse Event|2|||
16334513|NCT02570750|39710822|FG001|Overall Study|Adverse Event|1|||
16334514|NCT03197870|39710825|FG000|Overall Study|Adverse Event|9|||
16334515|NCT03197870|39710826|FG001|Overall Study|Adverse Event|4|||
16334516|NCT03197870|39710827|FG002|Overall Study|Adverse Event|6|||
16334517|NCT03197870|39710825|FG000|Overall Study|Withdrawal by Subject|2|||
16334518|NCT03197870|39710826|FG001|Overall Study|Withdrawal by Subject|3|||
16334519|NCT03197870|39710827|FG002|Overall Study|Withdrawal by Subject|0|||
16334520|NCT03197870|39710825|FG000|Overall Study|Lost to Follow-up|2|||
16334521|NCT03197870|39710826|FG001|Overall Study|Lost to Follow-up|2|||
16334522|NCT03197870|39710827|FG002|Overall Study|Lost to Follow-up|0|||
16334523|NCT03197870|39710825|FG000|Overall Study|data not available|1|||
16334524|NCT03197870|39710826|FG001|Overall Study|data not available|1|||
16334525|NCT03197870|39710827|FG002|Overall Study|data not available|0|||
16334526|NCT01380691|39710845|FG000|Washout (7 Days)|Protocol Violation|0|||
16334527|NCT01380691|39710846|FG001|Washout (7 Days)|Protocol Violation|0|||
16334528|NCT01380691|39710847|FG002|Washout (7 Days)|Protocol Violation|0|||
16334529|NCT01380691|39710848|FG003|Washout (7 Days)|Protocol Violation|1|||
16334530|NCT01380691|39710845|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
16334531|NCT01380691|39710846|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
16334532|NCT01380691|39710847|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
16334533|NCT01380691|39710848|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
16334534|NCT00306787|39710849|FG000|Overall Study|Discontinued without taking study drug|208|||
16334535|NCT00306787|39710850|FG001|Overall Study|Discontinued without taking study drug|215|||
16334536|NCT00306787|39710849|FG000|Overall Study|Adverse Event|1|||
16334537|NCT00306787|39710850|FG001|Overall Study|Adverse Event|1|||
16334538|NCT00306787|39710849|FG000|Overall Study|Lack of Efficacy|1|||
16334539|NCT00306787|39710850|FG001|Overall Study|Lack of Efficacy|0|||
16334540|NCT00306787|39710849|FG000|Overall Study|Protocol Violation|8|||
16334541|NCT00306787|39710850|FG001|Overall Study|Protocol Violation|10|||
16334542|NCT00306787|39710849|FG000|Overall Study|Withdrawal by Subject|2|||
16334543|NCT00306787|39710850|FG001|Overall Study|Withdrawal by Subject|9|||
16101254|NCT01945593|38856805|FG002|Overall Study|Death|1|||
16101255|NCT01945593|38856806|FG003|Overall Study|Death|0|||
16101256|NCT01945593|38856803|FG000|Overall Study|Other: Terminated|0|||
16101257|NCT01945593|38856804|FG001|Overall Study|Other: Terminated|0|||
16101258|NCT01945593|38856805|FG002|Overall Study|Other: Terminated|0|||
16101259|NCT01945593|38856806|FG003|Overall Study|Other: Terminated|1|||
16101260|NCT01945593|38856803|FG000|Overall Study|Other: Surgical Procedure|0|||
16216493|NCT02203916|39272392|FG002|Overall Study|Major Protocol Deviation|0|||
16334544|NCT00306787|39710849|FG000|Overall Study|Lost to Follow-up|9|||
16334545|NCT00306787|39710850|FG001|Overall Study|Lost to Follow-up|6|||
16404047|NCT05791565|39959682|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
16101261|NCT01945593|38856804|FG001|Overall Study|Other: Surgical Procedure|2|||
16101262|NCT01945593|38856805|FG002|Overall Study|Other: Surgical Procedure|0|||
16101263|NCT01945593|38856806|FG003|Overall Study|Other: Surgical Procedure|6|||
16101264|NCT01945593|38856803|FG000|Overall Study|Other: Screen Failure|0|||
16101265|NCT01945593|38856804|FG001|Overall Study|Other: Screen Failure|2|||
16101266|NCT01945593|38856805|FG002|Overall Study|Other: Screen Failure|0|||
16334546|NCT00306787|39710849|FG000|Overall Study|Administrative problems|4|||
16334547|NCT00306787|39710850|FG001|Overall Study|Administrative problems|0|||
16334548|NCT00306787|39710849|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16334549|NCT00306787|39710850|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16334550|NCT01651000|39710851|FG000|Overall Study|Adverse Event|2|||
16334551|NCT01651000|39710852|FG001|Overall Study|Adverse Event|8|||
16334552|NCT01651000|39710851|FG000|Overall Study|Lost to Follow-up|3|||
16334553|NCT01651000|39710852|FG001|Overall Study|Lost to Follow-up|2|||
16334554|NCT01651000|39710851|FG000|Overall Study|Protocol Violation|0|||
16334555|NCT01651000|39710852|FG001|Overall Study|Protocol Violation|3|||
16334556|NCT01651000|39710851|FG000|Overall Study|Withdrawal by Subject|2|||
16334557|NCT01651000|39710852|FG001|Overall Study|Withdrawal by Subject|10|||
16334558|NCT01651000|39710851|FG000|Overall Study|Subject noncompliance|0|||
16334559|NCT01651000|39710852|FG001|Overall Study|Subject noncompliance|3|||
16334560|NCT01651000|39710851|FG000|Overall Study|Lack of Efficacy|1|||
16334561|NCT01651000|39710852|FG001|Overall Study|Lack of Efficacy|1|||
16334562|NCT01651000|39710851|FG000|Overall Study|Physician Decision|1|||
16334563|NCT01651000|39710852|FG001|Overall Study|Physician Decision|0|||
16334564|NCT01651000|39710851|FG000|Overall Study|Administrative reason|1|||
16334565|NCT01651000|39710852|FG001|Overall Study|Administrative reason|0|||
16334566|NCT01651000|39710851|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
16334567|NCT01651000|39710852|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
16334568|NCT00379808|39710857|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
16334569|NCT00379808|39710858|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
16334570|NCT02539134|39710859|FG000|Overall Study|Lost to Follow-up|1|||
16404048|NCT00365105|39959691|FG000|Overall Study|Protocol Violation|5|||
16404049|NCT00365105|39959692|FG001|Overall Study|Protocol Violation|8|||
16404050|NCT03447314|39959693|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
16404051|NCT03447314|39959694|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
16404052|NCT03447314|39959695|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
16404053|NCT03447314|39959696|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
16404054|NCT03447314|39959697|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
16404055|NCT03447314|39959698|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
16216494|NCT02203916|39272390|FG000|Overall Study|Lost to Follow-up|0|||
16216495|NCT02203916|39272391|FG001|Overall Study|Lost to Follow-up|1|||
16216496|NCT02203916|39272392|FG002|Overall Study|Lost to Follow-up|0|||
16216497|NCT02203916|39272390|FG000|Overall Study|Voluntary Withdrawal|3|||
16216498|NCT02203916|39272391|FG001|Overall Study|Voluntary Withdrawal|3|||
16216499|NCT02203916|39272392|FG002|Overall Study|Voluntary Withdrawal|8|||
16404056|NCT03447314|39959699|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
16404057|NCT03447314|39959700|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
16404058|NCT03447314|39959701|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
16404059|NCT03447314|39959702|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
16404060|NCT03447314|39959703|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
16404061|NCT03447314|39959704|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
16404062|NCT03447314|39959705|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
16404063|NCT03447314|39959706|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
16404064|NCT03447314|39959707|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
16404065|NCT03447314|39959708|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
16404066|NCT03447314|39959709|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
16404067|NCT03447314|39959710|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
16404068|NCT03447314|39959693|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
16404069|NCT03447314|39959694|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404070|NCT03447314|39959695|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
16404071|NCT03447314|39959696|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404072|NCT03447314|39959697|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404073|NCT03447314|39959698|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
16404074|NCT03447314|39959699|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
16404075|NCT03447314|39959700|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16216500|NCT02203916|39272390|FG000|Overall Study|Lack of Efficacy|3|||
16216501|NCT02203916|39272391|FG001|Overall Study|Lack of Efficacy|0|||
16334571|NCT02539134|39710860|FG001|Overall Study|Lost to Follow-up|0|||
16334572|NCT02539134|39710861|FG002|Overall Study|Lost to Follow-up|0|||
16334573|NCT02539134|39710862|FG003|Overall Study|Lost to Follow-up|0|||
16404076|NCT03447314|39959701|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16216502|NCT02203916|39272392|FG002|Overall Study|Lack of Efficacy|0|||
16216503|NCT02203916|39272390|FG000|Overall Study|Reason Not Specified|0|||
16334574|NCT02539134|39710863|FG004|Overall Study|Lost to Follow-up|0|||
16404077|NCT03447314|39959702|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16334575|NCT02539134|39710864|FG005|Overall Study|Lost to Follow-up|0|||
16404078|NCT03447314|39959703|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404079|NCT03447314|39959704|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404080|NCT03447314|39959705|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404081|NCT03447314|39959706|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404082|NCT03447314|39959707|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404083|NCT03447314|39959708|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404084|NCT03447314|39959709|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404085|NCT03447314|39959710|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
16404086|NCT03447314|39959693|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404087|NCT03447314|39959694|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404088|NCT03447314|39959695|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
16404089|NCT03447314|39959696|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404090|NCT03447314|39959697|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16334576|NCT00539032|39710865|FG000|Overall Study|Withdrawal by Subject|2|||
16534272|NCT00092534|40418306|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
16534273|NCT00092534|40418307|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
16534274|NCT00092534|40418308|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
16534275|NCT00092534|40418304|FG000|Base Study Vaccination Period|Moved|14|||
16534276|NCT00092534|40418305|FG001|Base Study Vaccination Period|Moved|12|||
16534277|NCT00092534|40418306|FG002|Base Study Vaccination Period|Moved|0|||
16534278|NCT00092534|40418307|FG003|Base Study Vaccination Period|Moved|0|||
16534279|NCT00092534|40418308|FG004|Base Study Vaccination Period|Moved|0|||
16534280|NCT00092534|40418304|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
16334577|NCT00539032|39710866|FG001|Overall Study|Withdrawal by Subject|1|||
16334578|NCT00568334|39710867|FG000|Overall Study|Withdrawal by Subject|0|||
16334579|NCT00568334|39710868|FG001|Overall Study|Withdrawal by Subject|1|||
16101267|NCT01945593|38856806|FG003|Overall Study|Other: Screen Failure|0|||
16101268|NCT00714688|38856807|FG000|Overall Study|Lack of Efficacy|14|||
16101269|NCT00714688|38856808|FG001|Overall Study|Lack of Efficacy|1|||
16101270|NCT00714688|38856809|FG002|Overall Study|Lack of Efficacy|4|||
16101271|NCT00714688|38856807|FG000|Overall Study|Withdrawal by Subject|4|||
16101272|NCT00714688|38856808|FG001|Overall Study|Withdrawal by Subject|3|||
16101273|NCT00714688|38856809|FG002|Overall Study|Withdrawal by Subject|3|||
16101274|NCT00714688|38856807|FG000|Overall Study|Lost to Follow-up|5|||
16101275|NCT00714688|38856808|FG001|Overall Study|Lost to Follow-up|2|||
16101276|NCT00714688|38856809|FG002|Overall Study|Lost to Follow-up|0|||
16101277|NCT00714688|38856807|FG000|Overall Study|Adverse Event|2|||
16101278|NCT00714688|38856808|FG001|Overall Study|Adverse Event|15|||
16101279|NCT00714688|38856809|FG002|Overall Study|Adverse Event|19|||
16101280|NCT00714688|38856807|FG000|Overall Study|Subject Non-compliant|3|||
16101281|NCT00714688|38856808|FG001|Overall Study|Subject Non-compliant|5|||
16101282|NCT00714688|38856809|FG002|Overall Study|Subject Non-compliant|5|||
16101283|NCT00714688|38856807|FG000|Overall Study|Ineligible to Continue the Study|0|||
16101284|NCT00714688|38856808|FG001|Overall Study|Ineligible to Continue the Study|1|||
16101285|NCT00714688|38856809|FG002|Overall Study|Ineligible to Continue the Study|1|||
16101286|NCT00714688|38856807|FG000|Overall Study|Sponsor's Decision|0|||
16101287|NCT00714688|38856808|FG001|Overall Study|Sponsor's Decision|2|||
16101288|NCT00714688|38856809|FG002|Overall Study|Sponsor's Decision|0|||
16101289|NCT00714688|38856807|FG000|Overall Study|Other|1|||
16101290|NCT00714688|38856808|FG001|Overall Study|Other|6|||
16101291|NCT00714688|38856809|FG002|Overall Study|Other|5|||
16334580|NCT00568334|39710867|FG000|Overall Study|Lost to Follow-up|1|||
16334581|NCT00568334|39710868|FG001|Overall Study|Lost to Follow-up|0|||
16334582|NCT01712334|39710869|FG000|Treatment Period 1|Randomized in Error|0|||
16334583|NCT01712334|39710870|FG001|Treatment Period 1|Randomized in Error|2|||
16334584|NCT03304184|39710871|FG000|Overall Study|Withdrawal by Subject|1|||
16334585|NCT03304184|39710872|FG001|Overall Study|Withdrawal by Subject|2|||
16334586|NCT04933617|39710878|FG000|Dose Escalation|Early closure of study|0|||
16334587|NCT04933617|39710879|FG001|Dose Escalation|Early closure of study|3|||
16334588|NCT04933617|39710880|FG002|Dose Escalation|Early closure of study|0|||
16334589|NCT04933617|39710881|FG003|Dose Escalation|Early closure of study|0|||
16334590|NCT04933617|39710882|FG004|Dose Escalation|Early closure of study|0|||
16334591|NCT00662558|39710883|FG000|Overall Study|Adverse Event|21|||
16334592|NCT00662558|39710884|FG001|Overall Study|Adverse Event|59|||
16334593|NCT00662558|39710883|FG000|Overall Study|Lack of Efficacy|4|||
16334594|NCT00662558|39710884|FG001|Overall Study|Lack of Efficacy|7|||
16101292|NCT00946088|38856810|FG000|Overall Study|Withdrawal by Subject|0|||
16101293|NCT00946088|38856811|FG001|Overall Study|Withdrawal by Subject|1|||
16101294|NCT03303521|38859528|FG000|Overall Study|Withdrawal by Subject|2|||
16101295|NCT03303521|38859529|FG001|Overall Study|Withdrawal by Subject|0|||
16101296|NCT03303521|38859528|FG000|Overall Study|Death|1|||
16101297|NCT03303521|38859529|FG001|Overall Study|Death|0|||
16101298|NCT03303521|38859528|FG000|Overall Study|Kidney transplantation|0|||
16101299|NCT03303521|38859529|FG001|Overall Study|Kidney transplantation|1|||
16101300|NCT03303521|38859528|FG000|Overall Study|Investigational product discontinuation|0|||
16101301|NCT03303521|38859529|FG001|Overall Study|Investigational product discontinuation|1|||
16101302|NCT03303521|38859528|FG000|Overall Study|Transferred to non-study dialysis center|1|||
16101303|NCT03303521|38859529|FG001|Overall Study|Transferred to non-study dialysis center|0|||
16101304|NCT03303521|38859528|FG000|Overall Study|Non-comliance to study protocol|0|||
16334595|NCT00662558|39710883|FG000|Overall Study|Lost to Follow-up|13|||
16334596|NCT00662558|39710884|FG001|Overall Study|Lost to Follow-up|10|||
16334597|NCT00662558|39710883|FG000|Overall Study|Other|9|||
16334598|NCT00662558|39710884|FG001|Overall Study|Other|14|||
16334599|NCT00662558|39710883|FG000|Overall Study|Withdrawal by Subject|7|||
16334600|NCT00662558|39710884|FG001|Overall Study|Withdrawal by Subject|12|||
16334601|NCT00662558|39710883|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
16534281|NCT00092534|40418305|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
16534282|NCT00092534|40418306|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
16534283|NCT00092534|40418307|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
16534284|NCT00092534|40418308|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
16534285|NCT00092534|40418304|FG000|Base Study Vaccination Period|Travel|1|||
16534286|NCT00092534|40418305|FG001|Base Study Vaccination Period|Travel|0|||
16534287|NCT00092534|40418306|FG002|Base Study Vaccination Period|Travel|0|||
16534288|NCT00092534|40418307|FG003|Base Study Vaccination Period|Travel|0|||
16534289|NCT00092534|40418308|FG004|Base Study Vaccination Period|Travel|0|||
16534290|NCT00092534|40418304|FG000|Base Study Vaccination Period|Site Closed|0|||
16534291|NCT00092534|40418305|FG001|Base Study Vaccination Period|Site Closed|1|||
16534292|NCT00092534|40418306|FG002|Base Study Vaccination Period|Site Closed|0|||
16404091|NCT03447314|39959698|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404092|NCT03447314|39959699|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404093|NCT03447314|39959700|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404094|NCT03447314|39959701|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404095|NCT03447314|39959702|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404096|NCT03447314|39959703|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404097|NCT03447314|39959704|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404098|NCT03447314|39959705|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404099|NCT03447314|39959706|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404100|NCT03447314|39959707|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404101|NCT03447314|39959708|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404102|NCT03447314|39959709|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404103|NCT03447314|39959710|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
16404104|NCT03447314|39959693|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404105|NCT03447314|39959694|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404106|NCT03447314|39959695|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
16534293|NCT00092534|40418307|FG003|Base Study Vaccination Period|Site Closed|0|||
16534294|NCT00092534|40418308|FG004|Base Study Vaccination Period|Site Closed|0|||
16534295|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Adverse Event|2|||
16534296|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Adverse Event|4|||
16534297|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Adverse Event|0|||
16534298|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Adverse Event|0|||
16534299|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Adverse Event|0|||
16534300|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Death|2|||
16534301|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Death|1|||
16534302|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Death|0|||
16534303|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Death|0|||
16534304|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Death|0|||
16534305|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
16334602|NCT00662558|39710884|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
16334603|NCT00738062|39710885|FG000|Open Label Treatment|Lack of Efficacy|5|||
16334604|NCT00738062|39710886|FG001|Open Label Treatment|Lack of Efficacy|0|||
16334605|NCT00738062|39710887|FG002|Open Label Treatment|Lack of Efficacy|0|||
16404107|NCT03447314|39959696|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16334606|NCT00738062|39710885|FG000|Open Label Treatment|Adverse Event|11|||
16334607|NCT00738062|39710886|FG001|Open Label Treatment|Adverse Event|0|||
16534306|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
16534307|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
16534308|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
16534309|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
16534310|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Pregnancy|6|||
16534311|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Pregnancy|10|||
16534312|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Pregnancy|0|||
16534313|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Pregnancy|0|||
16534314|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Pregnancy|0|||
16534315|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
16534316|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
16534317|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
16534318|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
16534319|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
16534320|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
16534321|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
16534322|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
16534323|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
16534324|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
16534325|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Moved|62|||
16534326|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Moved|58|||
16534327|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Moved|0|||
16534328|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Moved|0|||
16534329|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Moved|0|||
16534330|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Travel|10|||
16534331|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Travel|7|||
16534332|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Travel|0|||
16334608|NCT00738062|39710887|FG002|Open Label Treatment|Adverse Event|0|||
16334609|NCT00738062|39710885|FG000|Open Label Treatment|Protocol Violation|2|||
16334610|NCT00738062|39710886|FG001|Open Label Treatment|Protocol Violation|0|||
16101305|NCT03303521|38859529|FG001|Overall Study|Non-comliance to study protocol|1|||
16101306|NCT03303521|38859528|FG000|Overall Study|Adverse Event|1|||
16334611|NCT00738062|39710887|FG002|Open Label Treatment|Protocol Violation|0|||
16334612|NCT00738062|39710885|FG000|Open Label Treatment|Withdrawal by Subject|9|||
16334613|NCT00738062|39710886|FG001|Open Label Treatment|Withdrawal by Subject|0|||
16334614|NCT00738062|39710887|FG002|Open Label Treatment|Withdrawal by Subject|0|||
16334615|NCT00738062|39710885|FG000|Open Label Treatment|Investigator Decision|1|||
16334616|NCT00738062|39710886|FG001|Open Label Treatment|Investigator Decision|0|||
16534333|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Travel|0|||
16534334|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Travel|0|||
16534335|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Site Closed|0|||
16534336|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Site Closed|2|||
16534337|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Site Closed|0|||
16534338|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Site Closed|0|||
16534339|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Site Closed|0|||
16534340|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
16534341|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
16534342|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
16534343|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
16534344|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
16534345|NCT00092534|40418304|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
16534346|NCT00092534|40418305|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
16534347|NCT00092534|40418306|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
16534348|NCT00092534|40418307|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
16534349|NCT00092534|40418308|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
16534350|NCT00092534|40418304|FG000|Base Study EXT|Lost to Follow-up|0|||
16534351|NCT00092534|40418305|FG001|Base Study EXT|Lost to Follow-up|0|||
16534352|NCT00092534|40418306|FG002|Base Study EXT|Lost to Follow-up|41|||
16534353|NCT00092534|40418307|FG003|Base Study EXT|Lost to Follow-up|0|||
16534354|NCT00092534|40418308|FG004|Base Study EXT|Lost to Follow-up|0|||
16534355|NCT00092534|40418304|FG000|Base Study EXT|Physician Decision|0|||
16534356|NCT00092534|40418305|FG001|Base Study EXT|Physician Decision|0|||
16534357|NCT00092534|40418306|FG002|Base Study EXT|Physician Decision|1|||
16534358|NCT00092534|40418307|FG003|Base Study EXT|Physician Decision|0|||
16534359|NCT00092534|40418308|FG004|Base Study EXT|Physician Decision|0|||
16534360|NCT00092534|40418304|FG000|Base Study EXT|Pregnancy|0|||
16534361|NCT00092534|40418305|FG001|Base Study EXT|Pregnancy|0|||
16534362|NCT00092534|40418306|FG002|Base Study EXT|Pregnancy|12|||
16534363|NCT00092534|40418307|FG003|Base Study EXT|Pregnancy|0|||
16534364|NCT00092534|40418308|FG004|Base Study EXT|Pregnancy|0|||
16534365|NCT00092534|40418304|FG000|Base Study EXT|Withdrawal by Subject|0|||
16534366|NCT00092534|40418305|FG001|Base Study EXT|Withdrawal by Subject|0|||
16101307|NCT03303521|38859529|FG001|Overall Study|Adverse Event|0|||
16334617|NCT00738062|39710887|FG002|Open Label Treatment|Investigator Decision|0|||
16534367|NCT00092534|40418306|FG002|Base Study EXT|Withdrawal by Subject|18|||
16534368|NCT00092534|40418307|FG003|Base Study EXT|Withdrawal by Subject|0|||
16534369|NCT00092534|40418308|FG004|Base Study EXT|Withdrawal by Subject|0|||
16534370|NCT00092534|40418304|FG000|Base Study EXT|Participant moved|0|||
16534371|NCT00092534|40418305|FG001|Base Study EXT|Participant moved|0|||
16534372|NCT00092534|40418306|FG002|Base Study EXT|Participant moved|6|||
16534373|NCT00092534|40418307|FG003|Base Study EXT|Participant moved|0|||
16534374|NCT00092534|40418308|FG004|Base Study EXT|Participant moved|0|||
16534375|NCT00092534|40418304|FG000|Base Study EXT|Travel|0|||
16534376|NCT00092534|40418305|FG001|Base Study EXT|Travel|0|||
16101308|NCT03220776|38859540|FG000|Overall Study|Claustrophobia|0|||
16101309|NCT03220776|38859541|FG001|Overall Study|Claustrophobia|1|||
16101310|NCT03220776|38859542|FG002|Overall Study|Claustrophobia|1|||
16101311|NCT03220776|38859543|FG003|Overall Study|Claustrophobia|0|||
16101312|NCT03220776|38859544|FG004|Overall Study|Claustrophobia|1|||
16101313|NCT03220776|38859545|FG005|Overall Study|Claustrophobia|0|||
16101314|NCT03220776|38859540|FG000|Overall Study|MRI Equipment Failure|1|||
16101315|NCT03220776|38859541|FG001|Overall Study|MRI Equipment Failure|0|||
16101316|NCT03220776|38859542|FG002|Overall Study|MRI Equipment Failure|0|||
16101317|NCT03220776|38859543|FG003|Overall Study|MRI Equipment Failure|0|||
16101318|NCT03220776|38859544|FG004|Overall Study|MRI Equipment Failure|0|||
16101319|NCT03220776|38859545|FG005|Overall Study|MRI Equipment Failure|0|||
16101320|NCT03220776|38859540|FG000|Overall Study|Inclimate Weather|0|||
16101321|NCT03220776|38859541|FG001|Overall Study|Inclimate Weather|0|||
16101322|NCT03220776|38859542|FG002|Overall Study|Inclimate Weather|0|||
16101323|NCT03220776|38859543|FG003|Overall Study|Inclimate Weather|0|||
16101324|NCT03220776|38859544|FG004|Overall Study|Inclimate Weather|0|||
16101325|NCT03220776|38859545|FG005|Overall Study|Inclimate Weather|1|||
16101326|NCT03220776|38859540|FG000|Overall Study|Physician Decision|0|||
16101327|NCT03220776|38859541|FG001|Overall Study|Physician Decision|0|||
16101328|NCT03220776|38859542|FG002|Overall Study|Physician Decision|0|||
16101329|NCT03220776|38859543|FG003|Overall Study|Physician Decision|1|||
16101330|NCT03220776|38859544|FG004|Overall Study|Physician Decision|0|||
16101331|NCT03220776|38859545|FG005|Overall Study|Physician Decision|0|||
16101332|NCT03220776|38859540|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
16101333|NCT03220776|38859541|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
16101334|NCT03220776|38859542|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
16101335|NCT03220776|38859543|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
16101336|NCT03220776|38859544|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
16101337|NCT03220776|38859545|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
16101338|NCT03220776|38859540|FG000|Overall Study|Protocol Violation|0|||
16101339|NCT03220776|38859541|FG001|Overall Study|Protocol Violation|0|||
16101340|NCT03220776|38859542|FG002|Overall Study|Protocol Violation|0|||
16101341|NCT03220776|38859543|FG003|Overall Study|Protocol Violation|2|||
16216504|NCT02203916|39272391|FG001|Overall Study|Reason Not Specified|2|||
16216505|NCT02203916|39272392|FG002|Overall Study|Reason Not Specified|1|||
16216506|NCT00643851|39272393|FG000|Overall Study|Death|0|||
16216507|NCT00643851|39272394|FG001|Overall Study|Death|1|||
16216508|NCT00643851|39272395|FG002|Overall Study|Death|0|||
16216509|NCT00643851|39272393|FG000|Overall Study|Lack of Efficacy|0|||
16216510|NCT00643851|39272394|FG001|Overall Study|Lack of Efficacy|1|||
16216511|NCT00643851|39272395|FG002|Overall Study|Lack of Efficacy|0|||
16101342|NCT03220776|38859544|FG004|Overall Study|Protocol Violation|0|||
16101343|NCT03220776|38859545|FG005|Overall Study|Protocol Violation|1|||
16534377|NCT00092534|40418306|FG002|Base Study EXT|Travel|2|||
16101344|NCT03220776|38859540|FG000|Overall Study|Withdrawal by Subject|1|||
16534378|NCT00092534|40418307|FG003|Base Study EXT|Travel|0|||
16534379|NCT00092534|40418308|FG004|Base Study EXT|Travel|0|||
16534380|NCT00092534|40418304|FG000|Base Study EXT|Site closed|0|||
16534381|NCT00092534|40418305|FG001|Base Study EXT|Site closed|0|||
16534382|NCT00092534|40418306|FG002|Base Study EXT|Site closed|21|||
16404108|NCT03447314|39959697|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404109|NCT03447314|39959698|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404110|NCT03447314|39959699|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16101345|NCT03220776|38859541|FG001|Overall Study|Withdrawal by Subject|0|||
16216512|NCT00643851|39272393|FG000|Overall Study|Adverse Event|2|||
16216513|NCT00643851|39272394|FG001|Overall Study|Adverse Event|6|||
16334618|NCT00738062|39710885|FG000|Open-Label Extension|Adverse Event|5|||
16334619|NCT00738062|39710886|FG001|Open-Label Extension|Adverse Event|0|||
16334620|NCT00738062|39710887|FG002|Open-Label Extension|Adverse Event|0|||
16404111|NCT03447314|39959700|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404112|NCT03447314|39959701|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404113|NCT03447314|39959702|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404114|NCT03447314|39959703|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404115|NCT03447314|39959704|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404116|NCT03447314|39959705|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404117|NCT03447314|39959706|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404118|NCT03447314|39959707|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404119|NCT03447314|39959708|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404120|NCT03447314|39959709|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404121|NCT03447314|39959710|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
16404122|NCT03447314|39959693|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404123|NCT03447314|39959694|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404124|NCT03447314|39959695|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404125|NCT03447314|39959696|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404126|NCT03447314|39959697|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404127|NCT03447314|39959698|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404128|NCT03447314|39959699|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404129|NCT03447314|39959700|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404130|NCT03447314|39959701|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16216514|NCT00643851|39272395|FG002|Overall Study|Adverse Event|6|||
16216515|NCT00643851|39272393|FG000|Overall Study|Lost to Follow-up|4|||
16216516|NCT00643851|39272394|FG001|Overall Study|Lost to Follow-up|6|||
16216517|NCT00643851|39272395|FG002|Overall Study|Lost to Follow-up|9|||
16216518|NCT00643851|39272393|FG000|Overall Study|Withdrawal by Subject|8|||
16216519|NCT00643851|39272394|FG001|Overall Study|Withdrawal by Subject|15|||
16216520|NCT00643851|39272395|FG002|Overall Study|Withdrawal by Subject|9|||
16334621|NCT00738062|39710885|FG000|Open-Label Extension|Physician Decision|1|||
16334622|NCT00738062|39710886|FG001|Open-Label Extension|Physician Decision|0|||
16334623|NCT00738062|39710887|FG002|Open-Label Extension|Physician Decision|0|||
16334624|NCT00738062|39710885|FG000|Open-Label Extension|Lack of Efficacy|2|||
16334625|NCT00738062|39710886|FG001|Open-Label Extension|Lack of Efficacy|0|||
16334626|NCT00738062|39710887|FG002|Open-Label Extension|Lack of Efficacy|0|||
16334627|NCT00738062|39710885|FG000|Open-Label Extension|Withdrawal by Subject|6|||
16334628|NCT00738062|39710886|FG001|Open-Label Extension|Withdrawal by Subject|0|||
16216521|NCT00643851|39272393|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
16216522|NCT00643851|39272394|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
16216523|NCT00643851|39272395|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
16334629|NCT00738062|39710887|FG002|Open-Label Extension|Withdrawal by Subject|0|||
16334630|NCT00738062|39710885|FG000|Open-Label Extension|Protocol Violation|1|||
16334631|NCT00738062|39710886|FG001|Open-Label Extension|Protocol Violation|0|||
16334632|NCT00738062|39710887|FG002|Open-Label Extension|Protocol Violation|0|||
16334633|NCT00738062|39710885|FG000|Open-Label Extension|Study Terminated|2|||
16334634|NCT00738062|39710886|FG001|Open-Label Extension|Study Terminated|0|||
16334635|NCT00738062|39710887|FG002|Open-Label Extension|Study Terminated|0|||
16216524|NCT00844415|39272396|FG000|Overall Study|Withdrawal by Subject|1|||
16216525|NCT04005885|39272399|FG000|First Intervention|Withdrawal by Subject|1|||
16334636|NCT01903993|39710889|FG000|Overall Study|Death|118|||
16216526|NCT04005885|39272400|FG001|First Intervention|Withdrawal by Subject|1|||
16404131|NCT03447314|39959702|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404132|NCT03447314|39959703|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
16404133|NCT03447314|39959704|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404134|NCT03447314|39959705|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404135|NCT03447314|39959706|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404136|NCT03447314|39959707|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404137|NCT03447314|39959708|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404138|NCT03447314|39959709|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404139|NCT03447314|39959710|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
16404140|NCT03447314|39959693|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404141|NCT03447314|39959694|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404142|NCT03447314|39959695|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404143|NCT03447314|39959696|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
16404144|NCT03447314|39959697|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404145|NCT03447314|39959698|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
16404146|NCT03447314|39959699|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404147|NCT03447314|39959700|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404148|NCT03447314|39959701|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404149|NCT03447314|39959702|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404150|NCT03447314|39959703|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404151|NCT03447314|39959704|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404152|NCT03447314|39959705|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404153|NCT03447314|39959706|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404154|NCT03447314|39959707|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404155|NCT03447314|39959708|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404156|NCT03447314|39959709|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404157|NCT03447314|39959710|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
16404158|NCT03834506|39959711|FG000|Overall Study|Death|336|||
16404159|NCT03834506|39959712|FG001|Overall Study|Death|326|||
16404160|NCT03834506|39959711|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
16404161|NCT03834506|39959712|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16404162|NCT03834506|39959711|FG000|Overall Study|Withdrawal by Subject|10|||
16334637|NCT01903993|39710890|FG001|Overall Study|Death|121|||
16334638|NCT01903993|39710889|FG000|Overall Study|Withdrawal by Subject|15|||
16334639|NCT01903993|39710890|FG001|Overall Study|Withdrawal by Subject|4|||
16334640|NCT01903993|39710889|FG000|Overall Study|Lost to Follow-up|2|||
16334641|NCT01903993|39710890|FG001|Overall Study|Lost to Follow-up|3|||
16334642|NCT01903993|39710889|FG000|Overall Study|Study Terminated by Sponsor|8|||
16334643|NCT01903993|39710890|FG001|Overall Study|Study Terminated by Sponsor|14|||
16334644|NCT01903993|39710889|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
16334645|NCT01903993|39710890|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
16334646|NCT04093492|39710893|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
16334647|NCT04093492|39710894|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
16334648|NCT04093492|39710895|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
16334649|NCT04093492|39710896|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
16334650|NCT04093492|39710893|FG000|25 Weeks Gestational Age (GA)|No response|5|||
16334651|NCT04093492|39710894|FG001|25 Weeks Gestational Age (GA)|No response|5|||
16334652|NCT04093492|39710895|FG002|25 Weeks Gestational Age (GA)|No response|5|||
16334653|NCT04093492|39710896|FG003|25 Weeks Gestational Age (GA)|No response|2|||
16334654|NCT04093492|39710893|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
16334655|NCT04093492|39710894|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
16334656|NCT04093492|39710895|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
16334657|NCT04093492|39710896|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
16334658|NCT04093492|39710893|FG000|30 Weeks GA|Delivered before assessment|1|||
16334659|NCT04093492|39710894|FG001|30 Weeks GA|Delivered before assessment|2|||
16334660|NCT04093492|39710895|FG002|30 Weeks GA|Delivered before assessment|0|||
16334661|NCT04093492|39710896|FG003|30 Weeks GA|Delivered before assessment|0|||
16334662|NCT04093492|39710893|FG000|30 Weeks GA|No response|7|||
16334663|NCT04093492|39710894|FG001|30 Weeks GA|No response|5|||
16334664|NCT04093492|39710895|FG002|30 Weeks GA|No response|5|||
16334665|NCT04093492|39710896|FG003|30 Weeks GA|No response|2|||
16334666|NCT04093492|39710893|FG000|30 Weeks GA|Lost to Follow-up|0|||
16334667|NCT04093492|39710894|FG001|30 Weeks GA|Lost to Follow-up|1|||
16404163|NCT03834506|39959712|FG001|Overall Study|Withdrawal by Subject|8|||
16404164|NCT03834506|39959711|FG000|Overall Study|Sponsor decision|165|||
16404165|NCT03834506|39959712|FG001|Overall Study|Sponsor decision|178|||
16404166|NCT03834506|39959711|FG000|Overall Study|Physician Decision|3|||
16404167|NCT03834506|39959712|FG001|Overall Study|Physician Decision|1|||
16404168|NCT03834506|39959711|FG000|Overall Study|Lost to Follow-up|0|||
16404169|NCT03834506|39959712|FG001|Overall Study|Lost to Follow-up|1|||
16404170|NCT03189719|39959713|FG000|Overall Study|Death|325|||
16404171|NCT03189719|39959714|FG001|Overall Study|Death|361|||
16404172|NCT03189719|39959713|FG000|Overall Study|Physician Decision|1|||
16404173|NCT03189719|39959714|FG001|Overall Study|Physician Decision|0|||
16404174|NCT03189719|39959713|FG000|Overall Study|Sponsor Decision|40|||
16404175|NCT03189719|39959714|FG001|Overall Study|Sponsor Decision|12|||
16404176|NCT03189719|39959713|FG000|Overall Study|Withdrawal by Subject|7|||
16404177|NCT03189719|39959714|FG001|Overall Study|Withdrawal by Subject|3|||
16404178|NCT03280303|39959715|FG000|Overall Study|Death|505|||
16404179|NCT03280303|39959715|FG000|Overall Study|Study terminated by sponsor|383|||
16404180|NCT03280303|39959715|FG000|Overall Study|Other|148|||
16404181|NCT03280303|39959715|FG000|Overall Study|No longer willing to participate in study|101|||
16404182|NCT03280303|39959715|FG000|Overall Study|Lost to follow up|39|||
16404183|NCT03280303|39959715|FG000|Overall Study|Adverse Event|20|||
16404184|NCT03839823|39959718|FG000|Overall Study|Adverse Event|8|||
16404185|NCT03839823|39959719|FG001|Overall Study|Adverse Event|4|||
16404186|NCT03839823|39959718|FG000|Overall Study|Death|1|||
16404187|NCT03839823|39959719|FG001|Overall Study|Death|0|||
16404188|NCT03839823|39959718|FG000|Overall Study|Physician Decision|1|||
16404189|NCT03839823|39959719|FG001|Overall Study|Physician Decision|5|||
16216527|NCT04005885|39272399|FG000|Second Intervention|Withdrawal by Subject|0|||
16216528|NCT04005885|39272400|FG001|Second Intervention|Withdrawal by Subject|2|||
16216529|NCT04157751|39272403|FG000|Overall Study|Withdrawal by Subject|12|||
16216530|NCT04157751|39272404|FG001|Overall Study|Withdrawal by Subject|17|||
16404190|NCT03839823|39959718|FG000|Overall Study|Progressive Disease (PD)|65|||
16404191|NCT03839823|39959719|FG001|Overall Study|Progressive Disease (PD)|65|||
16404192|NCT03839823|39959718|FG000|Overall Study|Subject Decision|2|||
16404193|NCT03839823|39959719|FG001|Overall Study|Subject Decision|9|||
16404194|NCT03839823|39959718|FG000|Overall Study|Not Treated|0|||
16404195|NCT03839823|39959719|FG001|Overall Study|Not Treated|10|||
16404196|NCT04173260|39959722|FG000|Overall Study|Early termination|4|||
16404197|NCT04795167|39959726|FG000|Overall Study|Death|1|||
16404198|NCT04795167|39959727|FG001|Overall Study|Death|18|||
16404199|NCT04795167|39959728|FG002|Overall Study|Death|1|||
16404200|NCT04795167|39959726|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
16404201|NCT04795167|39959727|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
16404202|NCT04795167|39959728|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
16404203|NCT01349322|39959729|FG000|Overall Study|Protocol Violation|45|||
16404204|NCT01349322|39959730|FG001|Overall Study|Protocol Violation|47|||
16404205|NCT03260894|39961792|FG000|Overall Study|Death|6|||
16404206|NCT03260894|39961793|FG001|Overall Study|Death|8|||
16404207|NCT03260894|39961792|FG000|Overall Study|Withdrawal by Subject|4|||
16404208|NCT03260894|39961793|FG001|Overall Study|Withdrawal by Subject|11|||
16404209|NCT03260894|39961792|FG000|Overall Study|On-going at clinical cut off date|36|||
16404210|NCT03260894|39961793|FG001|Overall Study|On-going at clinical cut off date|31|||
16404211|NCT04706273|39961797|FG000|Overall Study|Withdrawal by Subject|27|||
16404212|NCT04706273|39961797|FG000|Overall Study|Physician Decision|1|||
16404213|NCT04706273|39961797|FG000|Overall Study|Lost to Follow-up|42|||
16404214|NCT04706273|39961797|FG000|Overall Study|Death|85|||
16404215|NCT04706273|39961797|FG000|Overall Study|Amputation that removes study device|2|||
16404216|NCT04706273|39961797|FG000|Overall Study|Surgical bypass|3|||
16404217|NCT04706273|39961797|FG000|Overall Study|Changing hospital|23|||
16216531|NCT04157751|39272403|FG000|Overall Study|Lost to Follow-up|6|||
16216532|NCT04157751|39272404|FG001|Overall Study|Lost to Follow-up|2|||
16216533|NCT04157751|39272403|FG000|Overall Study|Adverse Event|34|||
16216534|NCT04157751|39272404|FG001|Overall Study|Adverse Event|23|||
16216535|NCT04157751|39272403|FG000|Overall Study|Not treated|1|||
16216536|NCT04157751|39272404|FG001|Overall Study|Not treated|5|||
16216537|NCT04157751|39272403|FG000|Overall Study|Other reason not stated above|10|||
16216538|NCT04157751|39272404|FG001|Overall Study|Other reason not stated above|10|||
16216539|NCT03424044|39272405|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
16216540|NCT03424044|39272406|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
16404218|NCT04706273|39961797|FG000|Overall Study|Unable to attend hospital|2|||
16404219|NCT03028480|39961798|FG000|Overall Study|No revisit after the first prescription date|2|||
16404220|NCT03028480|39961798|FG000|Overall Study|Did not use the drug|1|||
16404221|NCT03028480|39961798|FG000|Overall Study|Violation of the enrollment deadline|10|||
16404222|NCT03028480|39961798|FG000|Overall Study|Case report forms were not collected|21|||
16404223|NCT04647253|39961801|FG000|Overall Study|Death ≤ 365 Days|16|||
16216541|NCT03424044|39272407|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
16404224|NCT04647253|39961802|FG001|Overall Study|Death ≤ 365 Days|7|||
16404225|NCT04647253|39961801|FG000|Overall Study|Physician Decision|0|||
16404226|NCT04647253|39961802|FG001|Overall Study|Physician Decision|1|||
16404227|NCT04647253|39961801|FG000|Overall Study|Withdrawal by Subject|7|||
16404228|NCT04647253|39961802|FG001|Overall Study|Withdrawal by Subject|2|||
16404229|NCT04647253|39961801|FG000|Overall Study|Missed 12-Month Visit|9|||
16404230|NCT04647253|39961802|FG001|Overall Study|Missed 12-Month Visit|7|||
16404231|NCT04647253|39961801|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
16404232|NCT04647253|39961802|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
16404233|NCT04621240|39961809|FG000|Overall Study|Withdrawal by Subject|36|||
16404234|NCT04239222|39961814|FG000|Baseline|Withdrawal by Subject|0|||
16404235|NCT04239222|39961815|FG001|Baseline|Withdrawal by Subject|0|||
16404236|NCT04239222|39961816|FG002|Baseline|Withdrawal by Subject|1|||
16404237|NCT04239222|39961817|FG003|Baseline|Withdrawal by Subject|1|||
16404238|NCT04239222|39961814|FG000|First Foot Assignment|Withdrawal by Subject|0|||
16404239|NCT04239222|39961815|FG001|First Foot Assignment|Withdrawal by Subject|0|||
16404240|NCT04239222|39961816|FG002|First Foot Assignment|Withdrawal by Subject|1|||
16404241|NCT04239222|39961817|FG003|First Foot Assignment|Withdrawal by Subject|0|||
16404242|NCT04239222|39961814|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
16404243|NCT04239222|39961815|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
16404244|NCT04239222|39961816|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
16404245|NCT04239222|39961817|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
16404246|NCT05032690|39961818|FG000|Period 1|Adverse Event|0|||
16404247|NCT05032690|39961819|FG001|Period 1|Adverse Event|1|||
16404248|NCT05032690|39961820|FG002|Period 1|Adverse Event|0|||
16404249|NCT05032690|39961821|FG003|Period 1|Adverse Event|0|||
16404250|NCT05032690|39961818|FG000|Period 1|Withdrawal by Subject|1|||
16404251|NCT05032690|39961819|FG001|Period 1|Withdrawal by Subject|0|||
16534383|NCT00092534|40418307|FG003|Base Study EXT|Site closed|0|||
16534384|NCT00092534|40418308|FG004|Base Study EXT|Site closed|0|||
16534385|NCT00092534|40418304|FG000|Base Study EXT|Study ended|0|||
16101346|NCT03220776|38859542|FG002|Overall Study|Withdrawal by Subject|0|||
16101347|NCT03220776|38859543|FG003|Overall Study|Withdrawal by Subject|0|||
16101348|NCT03220776|38859544|FG004|Overall Study|Withdrawal by Subject|0|||
16101349|NCT03220776|38859545|FG005|Overall Study|Withdrawal by Subject|0|||
16101350|NCT04748445|38859554|FG000|Overall Study|No longer met eligibility criteria|12|||
16101351|NCT04748445|38859554|FG000|Overall Study|Other|36|||
16101352|NCT04748445|38859554|FG000|Overall Study|Withdrawal by Subject|553|||
16101353|NCT04748445|38859554|FG000|Overall Study|Lost to Follow-up|30|||
16101354|NCT01882088|38859555|FG000|Overall Study|Intolerance of esophageal manometry|1|||
16101355|NCT01882088|38859555|FG000|Overall Study|no possibility to place the catheter|1|||
16101356|NCT01882088|38859555|FG000|Overall Study|Protocol Violation|1|||
16101357|NCT01882088|38859555|FG000|Overall Study|inadequate pH-impedance tracings|2|||
16101358|NCT02267746|38859556|FG000|Overall Study|Adverse Event|0|||
16101359|NCT02267746|38859557|FG001|Overall Study|Adverse Event|2|||
16101360|NCT02267746|38859558|FG002|Overall Study|Adverse Event|1|||
16101361|NCT02267746|38859556|FG000|Overall Study|Protocol Violation|8|||
16101362|NCT02267746|38859557|FG001|Overall Study|Protocol Violation|7|||
16101363|NCT02267746|38859558|FG002|Overall Study|Protocol Violation|3|||
16101364|NCT02267746|38859556|FG000|Overall Study|Lack of Efficacy|11|||
16101365|NCT02267746|38859557|FG001|Overall Study|Lack of Efficacy|11|||
16101366|NCT02267746|38859558|FG002|Overall Study|Lack of Efficacy|15|||
16101367|NCT02267746|38859556|FG000|Overall Study|Protocol Violation|1|||
16101368|NCT02267746|38859557|FG001|Overall Study|Protocol Violation|2|||
16101369|NCT02267746|38859558|FG002|Overall Study|Protocol Violation|1|||
16101370|NCT02267746|38859556|FG000|Overall Study|Miscellaneous|1|||
16101371|NCT02267746|38859557|FG001|Overall Study|Miscellaneous|0|||
16101372|NCT02267746|38859558|FG002|Overall Study|Miscellaneous|1|||
16101373|NCT01887418|38859561|FG000|Overall Study|Travelling difficulties|0|||
16101374|NCT01887418|38859562|FG001|Overall Study|Travelling difficulties|0|||
16101375|NCT01887418|38859563|FG002|Overall Study|Travelling difficulties|1|||
16101376|NCT00514813|38859564|FG000|Overall Study|Study terminated|14|||
16101377|NCT00514813|38859565|FG001|Overall Study|Study terminated|74|||
16101378|NCT00514813|38859566|FG002|Overall Study|Study terminated|40|||
16101379|NCT00514813|38859567|FG003|Overall Study|Study terminated|2|||
16101380|NCT00514813|38859564|FG000|Overall Study|Adverse Event|0|||
16101381|NCT00514813|38859565|FG001|Overall Study|Adverse Event|2|||
16101382|NCT00514813|38859566|FG002|Overall Study|Adverse Event|2|||
16101383|NCT00514813|38859567|FG003|Overall Study|Adverse Event|0|||
16101384|NCT00514813|38859564|FG000|Overall Study|Protocol Violation|1|||
16101385|NCT00514813|38859565|FG001|Overall Study|Protocol Violation|0|||
16404252|NCT05032690|39961820|FG002|Period 1|Withdrawal by Subject|0|||
16404253|NCT05032690|39961821|FG003|Period 1|Withdrawal by Subject|0|||
16404254|NCT05032690|39961818|FG000|Period 1|No longer meets eligibility criteria|0|||
16404255|NCT05032690|39961819|FG001|Period 1|No longer meets eligibility criteria|1|||
16534386|NCT00092534|40418305|FG001|Base Study EXT|Study ended|0|||
16534387|NCT00092534|40418306|FG002|Base Study EXT|Study ended|29|||
16101386|NCT00514813|38859566|FG002|Overall Study|Protocol Violation|0|||
16534388|NCT00092534|40418307|FG003|Base Study EXT|Study ended|0|||
16534389|NCT00092534|40418308|FG004|Base Study EXT|Study ended|0|||
16101387|NCT00514813|38859567|FG003|Overall Study|Protocol Violation|0|||
16101388|NCT00514813|38859564|FG000|Overall Study|Withdrawal by Subject|0|||
16101389|NCT00514813|38859565|FG001|Overall Study|Withdrawal by Subject|1|||
16101390|NCT00514813|38859566|FG002|Overall Study|Withdrawal by Subject|0|||
16101391|NCT00514813|38859567|FG003|Overall Study|Withdrawal by Subject|0|||
16101392|NCT00514813|38859564|FG000|Overall Study|Lack of Efficacy|0|||
16101393|NCT00514813|38859565|FG001|Overall Study|Lack of Efficacy|1|||
16101394|NCT00514813|38859566|FG002|Overall Study|Lack of Efficacy|0|||
16101395|NCT00514813|38859567|FG003|Overall Study|Lack of Efficacy|0|||
16101396|NCT00514813|38859564|FG000|Overall Study|Kidney transplant|0|||
16101397|NCT00514813|38859565|FG001|Overall Study|Kidney transplant|6|||
16101398|NCT00514813|38859566|FG002|Overall Study|Kidney transplant|2|||
16101399|NCT00514813|38859567|FG003|Overall Study|Kidney transplant|0|||
16101400|NCT00514813|38859564|FG000|Overall Study|Death|0|||
16101401|NCT00514813|38859565|FG001|Overall Study|Death|2|||
16534390|NCT00092534|40418304|FG000|Base Study EXT|Protocol Violation|0|||
16101402|NCT00514813|38859566|FG002|Overall Study|Death|3|||
16334668|NCT04093492|39710895|FG002|30 Weeks GA|Lost to Follow-up|0|||
16334669|NCT04093492|39710896|FG003|30 Weeks GA|Lost to Follow-up|0|||
16334670|NCT04093492|39710893|FG000|34 Weeks GA|Delivered before assessment|6|||
16334671|NCT04093492|39710894|FG001|34 Weeks GA|Delivered before assessment|3|||
16334672|NCT04093492|39710895|FG002|34 Weeks GA|Delivered before assessment|0|||
16334673|NCT04093492|39710896|FG003|34 Weeks GA|Delivered before assessment|0|||
16334674|NCT04093492|39710893|FG000|34 Weeks GA|No response|0|||
16334675|NCT04093492|39710894|FG001|34 Weeks GA|No response|7|||
16334676|NCT04093492|39710895|FG002|34 Weeks GA|No response|5|||
16334677|NCT04093492|39710896|FG003|34 Weeks GA|No response|3|||
16334678|NCT04093492|39710893|FG000|34 Weeks GA|Lost to Follow-up|0|||
16334679|NCT04093492|39710894|FG001|34 Weeks GA|Lost to Follow-up|1|||
16334680|NCT04093492|39710895|FG002|34 Weeks GA|Lost to Follow-up|0|||
16101403|NCT00514813|38859567|FG003|Overall Study|Death|2|||
16101404|NCT02229396|38859568|FG000|Overall Study|Adverse Event|6|||
16101405|NCT02229396|38859569|FG001|Overall Study|Adverse Event|12|||
16101406|NCT02229396|38859570|FG002|Overall Study|Adverse Event|12|||
16334681|NCT04093492|39710896|FG003|34 Weeks GA|Lost to Follow-up|0|||
16334682|NCT00900757|39710897|FG000|Overall Study|screen failure|19|||
16334683|NCT02949908|39710900|FG000|Overall Study|Study termination|2|||
16334684|NCT00597012|39710905|FG000|Overall Study|Death|1|||
16334685|NCT00597012|39710906|FG001|Overall Study|Death|1|||
16334686|NCT00597012|39710905|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
16334687|NCT00597012|39710906|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
16334688|NCT00597012|39710905|FG000|Overall Study|Withdrawal by Subject|7|||
16334689|NCT00597012|39710906|FG001|Overall Study|Withdrawal by Subject|4|||
16334690|NCT00597012|39710905|FG000|Overall Study|Ineligible|2|||
16334691|NCT00597012|39710906|FG001|Overall Study|Ineligible|0|||
16101407|NCT02229396|38859568|FG000|Overall Study|Death|2|||
16101408|NCT02229396|38859569|FG001|Overall Study|Death|3|||
16101409|NCT02229396|38859570|FG002|Overall Study|Death|1|||
16101410|NCT02229396|38859568|FG000|Overall Study|Lost to Follow-up|14|||
16101411|NCT02229396|38859569|FG001|Overall Study|Lost to Follow-up|14|||
16101412|NCT02229396|38859570|FG002|Overall Study|Lost to Follow-up|21|||
16101413|NCT02229396|38859568|FG000|Overall Study|Protocol Violation|2|||
16101414|NCT02229396|38859569|FG001|Overall Study|Protocol Violation|1|||
16101415|NCT02229396|38859570|FG002|Overall Study|Protocol Violation|0|||
16101416|NCT02229396|38859568|FG000|Overall Study|Patient Incorrectly Randomized|0|||
16101417|NCT02229396|38859569|FG001|Overall Study|Patient Incorrectly Randomized|0|||
16101418|NCT02229396|38859570|FG002|Overall Study|Patient Incorrectly Randomized|1|||
16101419|NCT02229396|38859568|FG000|Overall Study|Other|10|||
16101420|NCT02229396|38859569|FG001|Overall Study|Other|18|||
16101421|NCT02229396|38859570|FG002|Overall Study|Other|15|||
16101422|NCT02229396|38859568|FG000|Overall Study|Withdrawal by Subject|42|||
16101423|NCT02229396|38859569|FG001|Overall Study|Withdrawal by Subject|28|||
16101424|NCT02229396|38859570|FG002|Overall Study|Withdrawal by Subject|41|||
16101425|NCT02229396|38859568|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
16101426|NCT02229396|38859569|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
16101427|NCT02229396|38859570|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
16101428|NCT02229396|38859568|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
16101429|NCT02229396|38859569|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
16101430|NCT02229396|38859570|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
16101431|NCT02507297|38859571|FG000|Overall Study|Withdrawal by Subject|1|||
16101432|NCT02507297|38859572|FG001|Overall Study|Withdrawal by Subject|0|||
16534391|NCT00092534|40418305|FG001|Base Study EXT|Protocol Violation|0|||
16534392|NCT00092534|40418306|FG002|Base Study EXT|Protocol Violation|15|||
16101433|NCT02507297|38859571|FG000|Overall Study|Lost to Follow-up|0|||
16101434|NCT02507297|38859572|FG001|Overall Study|Lost to Follow-up|1|||
16101435|NCT01026103|38859573|FG000|Overall Study|Physician Decision|1|||
16334692|NCT00597012|39710905|FG000|Overall Study|Lost to Follow-up|0|||
16334693|NCT00597012|39710906|FG001|Overall Study|Lost to Follow-up|2|||
16334694|NCT00078949|39710907|FG000|Overall Study|No treated|4|||
16404256|NCT05032690|39961820|FG002|Period 1|No longer meets eligibility criteria|0|||
16404257|NCT05032690|39961821|FG003|Period 1|No longer meets eligibility criteria|0|||
16404258|NCT05032690|39961818|FG000|Period 2|Adverse Event|1|||
16404259|NCT05032690|39961819|FG001|Period 2|Adverse Event|0|||
16404260|NCT05032690|39961820|FG002|Period 2|Adverse Event|0|||
16334695|NCT00078949|39710908|FG001|Overall Study|No treated|5|||
16334696|NCT00078949|39710909|FG002|Overall Study|No treated|3|||
16334697|NCT00078949|39710910|FG003|Overall Study|No treated|3|||
16334698|NCT00590538|39710934|FG000|Overall Study|Study terminated before completed|2|||
16334699|NCT02696434|39710935|FG000|Overall Study|Adverse Event|3|||
16334700|NCT02696434|39710936|FG001|Overall Study|Adverse Event|1|||
16334701|NCT02696434|39710935|FG000|Overall Study|Lost to Follow-up|5|||
16334702|NCT02696434|39710936|FG001|Overall Study|Lost to Follow-up|4|||
16334703|NCT02696434|39710935|FG000|Overall Study|Withdrawal by Subject|14|||
16334704|NCT02696434|39710936|FG001|Overall Study|Withdrawal by Subject|12|||
16334705|NCT02696434|39710935|FG000|Overall Study|Physician Decision|0|||
16334706|NCT02696434|39710936|FG001|Overall Study|Physician Decision|1|||
16334707|NCT03326518|39710937|FG000|Overall Study|Protocol Violation|1|||
16334708|NCT03326518|39710938|FG001|Overall Study|Protocol Violation|0|||
16334709|NCT03326518|39710939|FG002|Overall Study|Protocol Violation|0|||
16334710|NCT03326518|39710937|FG000|Overall Study|Withdrawal by Subject|1|||
16334711|NCT03326518|39710938|FG001|Overall Study|Withdrawal by Subject|0|||
16334712|NCT03326518|39710939|FG002|Overall Study|Withdrawal by Subject|0|||
16334713|NCT03326518|39710937|FG000|Overall Study|Lost to Follow-up|1|||
16334714|NCT03326518|39710938|FG001|Overall Study|Lost to Follow-up|0|||
16334715|NCT03326518|39710939|FG002|Overall Study|Lost to Follow-up|1|||
16334716|NCT00767039|39710943|FG000|Overall Study|Death|5|||
16334717|NCT00767039|39710944|FG001|Overall Study|Death|2|||
16334718|NCT00743288|39710945|FG000|Overall Study|Adverse Event|1|||
16334719|NCT00743288|39710946|FG001|Overall Study|Adverse Event|1|||
16334720|NCT00743288|39710947|FG002|Overall Study|Adverse Event|2|||
16334721|NCT00743288|39710948|FG003|Overall Study|Adverse Event|2|||
16334722|NCT00743288|39710949|FG004|Overall Study|Adverse Event|1|||
16404261|NCT05032690|39961821|FG003|Period 2|Adverse Event|0|||
16404262|NCT05032690|39961818|FG000|Period 2|Withdrawal by Subject|0|||
16404263|NCT05032690|39961819|FG001|Period 2|Withdrawal by Subject|1|||
16404264|NCT05032690|39961820|FG002|Period 2|Withdrawal by Subject|0|||
16404265|NCT05032690|39961821|FG003|Period 2|Withdrawal by Subject|0|||
16404266|NCT05032690|39961818|FG000|Period 2|No longer meets eligibility criteria|0|||
16404267|NCT05032690|39961819|FG001|Period 2|No longer meets eligibility criteria|1|||
16404268|NCT05032690|39961820|FG002|Period 2|No longer meets eligibility criteria|0|||
16404269|NCT05032690|39961821|FG003|Period 2|No longer meets eligibility criteria|0|||
16404270|NCT05032690|39961818|FG000|Period 3|Adverse Event|0|||
16404271|NCT05032690|39961819|FG001|Period 3|Adverse Event|1|||
16404272|NCT05032690|39961820|FG002|Period 3|Adverse Event|0|||
16404273|NCT05032690|39961821|FG003|Period 3|Adverse Event|0|||
16404274|NCT02999477|39961822|FG000|Overall Study|found ineligible after first dose|0|||
16404275|NCT02999477|39961823|FG001|Overall Study|found ineligible after first dose|1|||
16404276|NCT02999477|39961822|FG000|Overall Study|Withdrawal by Subject|1|||
16404277|NCT02999477|39961823|FG001|Overall Study|Withdrawal by Subject|1|||
16404278|NCT02685748|39961824|FG000|Overall Study|Withdrawal by Subject|3|||
16404279|NCT02685748|39961825|FG001|Overall Study|Withdrawal by Subject|2|||
16404280|NCT02358031|39961826|FG000|Overall Study|Death|253|||
16404281|NCT02358031|39961827|FG001|Overall Study|Death|237|||
16404282|NCT02358031|39961828|FG002|Overall Study|Death|266|||
16404283|NCT02358031|39961826|FG000|Overall Study|Lost to Follow-up|1|||
16404284|NCT02358031|39961827|FG001|Overall Study|Lost to Follow-up|1|||
16404285|NCT02358031|39961828|FG002|Overall Study|Lost to Follow-up|0|||
16404286|NCT02358031|39961826|FG000|Overall Study|Withdrawal by Subject|19|||
16404287|NCT02358031|39961827|FG001|Overall Study|Withdrawal by Subject|14|||
16404288|NCT02358031|39961828|FG002|Overall Study|Withdrawal by Subject|18|||
16404289|NCT02358031|39961826|FG000|Overall Study|Sponsor Decision|26|||
16404290|NCT02358031|39961827|FG001|Overall Study|Sponsor Decision|28|||
16404291|NCT02358031|39961828|FG002|Overall Study|Sponsor Decision|16|||
16404292|NCT03894969|39961829|FG000|Overall Study|Adverse Event|0|||
16404293|NCT03894969|39961830|FG001|Overall Study|Adverse Event|2|||
16404294|NCT03894969|39961831|FG002|Overall Study|Adverse Event|0|||
16334723|NCT00743288|39710950|FG005|Overall Study|Adverse Event|1|||
16334724|NCT00743288|39710951|FG006|Overall Study|Adverse Event|2|||
16404295|NCT03894969|39961832|FG003|Overall Study|Adverse Event|1|||
16404296|NCT03894969|39961833|FG004|Overall Study|Adverse Event|2|||
16404297|NCT03894969|39961829|FG000|Overall Study|Lost to Follow-up|3|||
16404298|NCT03894969|39961830|FG001|Overall Study|Lost to Follow-up|1|||
16404299|NCT03894969|39961831|FG002|Overall Study|Lost to Follow-up|1|||
16334725|NCT00743288|39710945|FG000|Overall Study|Withdrawal by Subject|0|||
16404300|NCT03894969|39961832|FG003|Overall Study|Lost to Follow-up|0|||
16334726|NCT00743288|39710946|FG001|Overall Study|Withdrawal by Subject|0|||
16404301|NCT03894969|39961833|FG004|Overall Study|Lost to Follow-up|0|||
16404302|NCT03894969|39961829|FG000|Overall Study|Withdrawal by Subject|2|||
16404303|NCT03894969|39961830|FG001|Overall Study|Withdrawal by Subject|1|||
16404304|NCT03894969|39961831|FG002|Overall Study|Withdrawal by Subject|3|||
16404305|NCT03894969|39961832|FG003|Overall Study|Withdrawal by Subject|4|||
16404306|NCT03894969|39961833|FG004|Overall Study|Withdrawal by Subject|8|||
16404307|NCT03894969|39961829|FG000|Overall Study|Other|0|||
16404308|NCT03894969|39961830|FG001|Overall Study|Other|0|||
16404309|NCT03894969|39961831|FG002|Overall Study|Other|0|||
16404310|NCT03894969|39961832|FG003|Overall Study|Other|0|||
16404311|NCT03894969|39961833|FG004|Overall Study|Other|3|||
16404312|NCT03894969|39961829|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
16404313|NCT03894969|39961830|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
16404314|NCT03894969|39961831|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
16404315|NCT03894969|39961832|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
16404316|NCT03894969|39961833|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
16404317|NCT03894969|39961829|FG000|Overall Study|Solicited Adverse Event|0|||
16404318|NCT03894969|39961830|FG001|Overall Study|Solicited Adverse Event|1|||
16404319|NCT03894969|39961831|FG002|Overall Study|Solicited Adverse Event|0|||
16404320|NCT03894969|39961832|FG003|Overall Study|Solicited Adverse Event|0|||
16404321|NCT03894969|39961833|FG004|Overall Study|Solicited Adverse Event|0|||
16404322|NCT04126564|39961834|FG000|Overall Study|Withdrawal by Subject|0|||
16404323|NCT04126564|39961835|FG001|Overall Study|Withdrawal by Subject|2|||
16404324|NCT04126564|39961834|FG000|Overall Study|Lost to Follow-up|0|||
16404325|NCT04126564|39961835|FG001|Overall Study|Lost to Follow-up|1|||
16404326|NCT03194568|39961837|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
16404327|NCT03483038|39961838|FG000|Overall Study|Subjects still in follow-up|18|||
16404328|NCT00191724|39961839|FG000|Overall Study|Adverse Event|0|||
16404329|NCT00191724|39961840|FG001|Overall Study|Adverse Event|0|||
16404330|NCT00191724|39961841|FG002|Overall Study|Adverse Event|1|||
16404331|NCT00191724|39961842|FG003|Overall Study|Adverse Event|0|||
16404332|NCT00191724|39961843|FG004|Overall Study|Adverse Event|0|||
16404333|NCT00191724|39961839|FG000|Overall Study|Lost to Follow-up|1|||
16404334|NCT00191724|39961840|FG001|Overall Study|Lost to Follow-up|1|||
16404335|NCT00191724|39961841|FG002|Overall Study|Lost to Follow-up|0|||
16404336|NCT00191724|39961842|FG003|Overall Study|Lost to Follow-up|2|||
16404337|NCT00191724|39961843|FG004|Overall Study|Lost to Follow-up|3|||
16404338|NCT00191724|39961839|FG000|Overall Study|Withdrawal by Subject|0|||
16404339|NCT00191724|39961840|FG001|Overall Study|Withdrawal by Subject|0|||
16404340|NCT00191724|39961841|FG002|Overall Study|Withdrawal by Subject|0|||
16404341|NCT00191724|39961842|FG003|Overall Study|Withdrawal by Subject|1|||
16404342|NCT00191724|39961843|FG004|Overall Study|Withdrawal by Subject|0|||
16404343|NCT02099344|39961846|FG000|Overall Study|Physician Decision|1|||
16404344|NCT02099344|39961847|FG001|Overall Study|Physician Decision|0|||
16404345|NCT01691885|39961848|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
16404346|NCT01691885|39961849|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
16404347|NCT01691885|39961848|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
16404348|NCT01691885|39961849|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
16404349|NCT01271010|39961850|FG000|Overall Study|Reason not specified|11|||
16404350|NCT01271010|39961850|FG000|Overall Study|Start of new CLL therapy|1|||
16404351|NCT01271010|39961850|FG000|Overall Study|Protocol Violation|1|||
16404352|NCT01271010|39961850|FG000|Overall Study|Death|2|||
16404353|NCT01271010|39961850|FG000|Overall Study|Progression and relapse of disease|1|||
16404354|NCT01271010|39961850|FG000|Overall Study|Withdrawal by Subject|18|||
16404355|NCT01271010|39961850|FG000|Overall Study|Disease progression|27|||
16404356|NCT00559845|39961851|FG000|Overall Study|Withdrew Consent|1|||
16404357|NCT00559845|39961851|FG000|Overall Study|Disease Progression|1|||
16404358|NCT00559845|39961851|FG000|Overall Study|Adverse Event|3|||
16404359|NCT00559845|39961851|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
16404360|NCT00559845|39961851|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
16404361|NCT00394251|39961854|FG000|Overall Study|Adverse Event|7|||
16404362|NCT00394251|39961855|FG001|Overall Study|Adverse Event|5|||
16404363|NCT00394251|39961854|FG000|Overall Study|Unacceptable Toxicity|20|||
16404364|NCT00394251|39961855|FG001|Overall Study|Unacceptable Toxicity|18|||
16404365|NCT00394251|39961854|FG000|Overall Study|Physician Decision|1|||
16404366|NCT00394251|39961855|FG001|Overall Study|Physician Decision|1|||
16404367|NCT00394251|39961854|FG000|Overall Study|Protocol Violation|0|||
16404368|NCT00394251|39961855|FG001|Overall Study|Protocol Violation|1|||
16404369|NCT00394251|39961854|FG000|Overall Study|Withdrawal by Subject|7|||
16404370|NCT00394251|39961855|FG001|Overall Study|Withdrawal by Subject|11|||
16404371|NCT00394251|39961854|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
16404372|NCT00394251|39961855|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
16404373|NCT02526524|39961856|FG000|Overall Study|Withdrawal by Subject|3|||
16404374|NCT02526524|39961857|FG001|Overall Study|Withdrawal by Subject|3|||
16404375|NCT02526524|39961858|FG002|Overall Study|Withdrawal by Subject|6|||
16404376|NCT02526524|39961859|FG003|Overall Study|Withdrawal by Subject|1|||
16404377|NCT02526524|39961860|FG004|Overall Study|Withdrawal by Subject|9|||
16404378|NCT02526524|39961861|FG005|Overall Study|Withdrawal by Subject|5|||
16404379|NCT02526524|39961856|FG000|Overall Study|Adverse Event|3|||
16404380|NCT02526524|39961857|FG001|Overall Study|Adverse Event|2|||
16404381|NCT02526524|39961858|FG002|Overall Study|Adverse Event|4|||
16404382|NCT02526524|39961859|FG003|Overall Study|Adverse Event|2|||
16404383|NCT02526524|39961860|FG004|Overall Study|Adverse Event|6|||
16404384|NCT02526524|39961861|FG005|Overall Study|Adverse Event|8|||
16404385|NCT02526524|39961856|FG000|Overall Study|Lost to Follow-up|2|||
16404386|NCT02526524|39961857|FG001|Overall Study|Lost to Follow-up|3|||
16404387|NCT02526524|39961858|FG002|Overall Study|Lost to Follow-up|8|||
16404388|NCT02526524|39961859|FG003|Overall Study|Lost to Follow-up|1|||
16534393|NCT00092534|40418307|FG003|Base Study EXT|Protocol Violation|0|||
16534394|NCT00092534|40418308|FG004|Base Study EXT|Protocol Violation|0|||
16534395|NCT00092534|40418304|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
16534396|NCT00092534|40418305|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
16534397|NCT00092534|40418306|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
16534398|NCT00092534|40418307|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
16534399|NCT00092534|40418308|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
16534400|NCT03150056|40421865|FG000|Overall Study|Withdrawal by Subject|0|||
16216542|NCT03424044|39272408|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
16216543|NCT03424044|39272409|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
16216544|NCT03424044|39272410|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
16216545|NCT03424044|39272411|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
16216546|NCT03424044|39272412|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
16404389|NCT02526524|39961860|FG004|Overall Study|Lost to Follow-up|2|||
16534401|NCT03150056|40421866|FG001|Overall Study|Withdrawal by Subject|0|||
16534402|NCT03150056|40421867|FG002|Overall Study|Withdrawal by Subject|0|||
16534403|NCT03150056|40421868|FG003|Overall Study|Withdrawal by Subject|0|||
16404390|NCT02526524|39961861|FG005|Overall Study|Lost to Follow-up|5|||
16404391|NCT02526524|39961856|FG000|Overall Study|Protocol Violation|3|||
16101436|NCT01026103|38859573|FG000|Overall Study|did not receive study device bc of error|1|||
16101437|NCT02815735|38859577|FG000|First Intervention (4 Weeks)|Discomfort|1|||
16101438|NCT02815735|38859578|FG001|First Intervention (4 Weeks)|Discomfort|0|||
16101439|NCT02815735|38859577|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
16101440|NCT02815735|38859578|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
16216547|NCT03424044|39272413|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
16534404|NCT03150056|40421869|FG004|Overall Study|Withdrawal by Subject|0|||
16534405|NCT03150056|40421870|FG005|Overall Study|Withdrawal by Subject|2|||
16534406|NCT03150056|40421865|FG000|Overall Study|Study terminated by Sponsor|1|||
16534407|NCT03150056|40421866|FG001|Overall Study|Study terminated by Sponsor|3|||
16534408|NCT03150056|40421867|FG002|Overall Study|Study terminated by Sponsor|1|||
16534409|NCT03150056|40421868|FG003|Overall Study|Study terminated by Sponsor|1|||
16534410|NCT03150056|40421869|FG004|Overall Study|Study terminated by Sponsor|5|||
16534411|NCT03150056|40421870|FG005|Overall Study|Study terminated by Sponsor|6|||
16534412|NCT03150056|40421865|FG000|Overall Study|Death|9|||
16534413|NCT03150056|40421866|FG001|Overall Study|Death|2|||
16534414|NCT03150056|40421867|FG002|Overall Study|Death|2|||
16534415|NCT03150056|40421868|FG003|Overall Study|Death|7|||
16534416|NCT03150056|40421869|FG004|Overall Study|Death|8|||
16534417|NCT03150056|40421870|FG005|Overall Study|Death|10|||
16534418|NCT02077166|40421871|FG000|Overall Study|Death|6|||
16534419|NCT02077166|40421872|FG001|Overall Study|Death|7|||
16534420|NCT02077166|40421873|FG002|Overall Study|Death|5|||
16216548|NCT03424044|39272405|FG000|First Intervention (76 Hours)|Adverse Event|0|||
16216549|NCT03424044|39272406|FG001|First Intervention (76 Hours)|Adverse Event|0|||
16334727|NCT00743288|39710947|FG002|Overall Study|Withdrawal by Subject|1|||
16404392|NCT02526524|39961857|FG001|Overall Study|Protocol Violation|1|||
16534421|NCT02077166|40421874|FG003|Overall Study|Death|6|||
16534422|NCT02077166|40421875|FG004|Overall Study|Death|4|||
16534423|NCT02077166|40421876|FG005|Overall Study|Death|32|||
16534424|NCT02077166|40421877|FG006|Overall Study|Death|22|||
16534425|NCT02077166|40421871|FG000|Overall Study|Study Closure by Sponsor|3|||
16334728|NCT00743288|39710948|FG003|Overall Study|Withdrawal by Subject|0|||
16334729|NCT00743288|39710949|FG004|Overall Study|Withdrawal by Subject|0|||
16334730|NCT00743288|39710950|FG005|Overall Study|Withdrawal by Subject|1|||
16334731|NCT00743288|39710951|FG006|Overall Study|Withdrawal by Subject|1|||
16334732|NCT00743288|39710945|FG000|Overall Study|Progressive disease (PD)|2|||
16334733|NCT00743288|39710946|FG001|Overall Study|Progressive disease (PD)|0|||
16334734|NCT00743288|39710947|FG002|Overall Study|Progressive disease (PD)|1|||
16334735|NCT00743288|39710948|FG003|Overall Study|Progressive disease (PD)|4|||
16334736|NCT00743288|39710949|FG004|Overall Study|Progressive disease (PD)|5|||
16334737|NCT00743288|39710950|FG005|Overall Study|Progressive disease (PD)|3|||
16334738|NCT00743288|39710951|FG006|Overall Study|Progressive disease (PD)|6|||
16334739|NCT00743288|39710945|FG000|Overall Study|Worsening of condition (Not PD)|0|||
16334740|NCT00743288|39710946|FG001|Overall Study|Worsening of condition (Not PD)|2|||
16404393|NCT02526524|39961858|FG002|Overall Study|Protocol Violation|5|||
16334741|NCT00743288|39710947|FG002|Overall Study|Worsening of condition (Not PD)|1|||
16334742|NCT00743288|39710948|FG003|Overall Study|Worsening of condition (Not PD)|1|||
16404394|NCT02526524|39961859|FG003|Overall Study|Protocol Violation|3|||
16404395|NCT02526524|39961860|FG004|Overall Study|Protocol Violation|4|||
16404396|NCT02526524|39961861|FG005|Overall Study|Protocol Violation|3|||
16404397|NCT02526524|39961856|FG000|Overall Study|Loss of Glucose Control|0|||
16404398|NCT02526524|39961857|FG001|Overall Study|Loss of Glucose Control|0|||
16404399|NCT02526524|39961858|FG002|Overall Study|Loss of Glucose Control|3|||
16404400|NCT02526524|39961859|FG003|Overall Study|Loss of Glucose Control|0|||
16404401|NCT02526524|39961860|FG004|Overall Study|Loss of Glucose Control|2|||
16404402|NCT02526524|39961861|FG005|Overall Study|Loss of Glucose Control|0|||
16404403|NCT02526524|39961856|FG000|Overall Study|Physician Decision|0|||
16404404|NCT02526524|39961857|FG001|Overall Study|Physician Decision|0|||
16404405|NCT02526524|39961858|FG002|Overall Study|Physician Decision|0|||
16404406|NCT02526524|39961859|FG003|Overall Study|Physician Decision|0|||
16404407|NCT02526524|39961860|FG004|Overall Study|Physician Decision|1|||
16334743|NCT00743288|39710949|FG004|Overall Study|Worsening of condition (Not PD)|0|||
16334744|NCT00743288|39710950|FG005|Overall Study|Worsening of condition (Not PD)|0|||
16334745|NCT00743288|39710951|FG006|Overall Study|Worsening of condition (Not PD)|0|||
16334746|NCT03877224|39710952|FG000|Overall Study|Death|3|||
16334747|NCT03877224|39710953|FG001|Overall Study|Death|2|||
16334748|NCT03877224|39710952|FG000|Overall Study|Withdrawal by Subject|1|||
16334749|NCT03877224|39710953|FG001|Overall Study|Withdrawal by Subject|6|||
16334750|NCT03877224|39710952|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
16334751|NCT03877224|39710953|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
16334752|NCT01068626|39710954|FG000|Overall Study|Adverse Event|3|||
16334753|NCT01068626|39710955|FG001|Overall Study|Adverse Event|0|||
16334754|NCT01068626|39710954|FG000|Overall Study|Withdrawal by Subject|0|||
16334755|NCT01068626|39710955|FG001|Overall Study|Withdrawal by Subject|2|||
16334756|NCT04015518|39710956|FG000|Overall Study|Adverse Event|6|||
16334757|NCT04015518|39710957|FG001|Overall Study|Adverse Event|1|||
16334758|NCT04015518|39710958|FG002|Overall Study|Adverse Event|1|||
16334759|NCT04015518|39710959|FG003|Overall Study|Adverse Event|3|||
16334760|NCT04015518|39710960|FG004|Overall Study|Adverse Event|3|||
16334761|NCT04015518|39710956|FG000|Overall Study|Lack of Efficacy|1|||
16334762|NCT04015518|39710957|FG001|Overall Study|Lack of Efficacy|0|||
16334763|NCT04015518|39710958|FG002|Overall Study|Lack of Efficacy|1|||
16334764|NCT04015518|39710959|FG003|Overall Study|Lack of Efficacy|0|||
16334765|NCT04015518|39710960|FG004|Overall Study|Lack of Efficacy|4|||
16334766|NCT04015518|39710956|FG000|Overall Study|Lost to Follow-up|0|||
16334767|NCT04015518|39710957|FG001|Overall Study|Lost to Follow-up|0|||
16334768|NCT04015518|39710958|FG002|Overall Study|Lost to Follow-up|0|||
16334769|NCT04015518|39710959|FG003|Overall Study|Lost to Follow-up|0|||
16334770|NCT04015518|39710960|FG004|Overall Study|Lost to Follow-up|1|||
16334771|NCT04015518|39710956|FG000|Overall Study|Withdrawal by Subject|0|||
16334772|NCT04015518|39710957|FG001|Overall Study|Withdrawal by Subject|1|||
16334773|NCT04015518|39710958|FG002|Overall Study|Withdrawal by Subject|0|||
16334774|NCT04015518|39710959|FG003|Overall Study|Withdrawal by Subject|1|||
16334775|NCT04015518|39710960|FG004|Overall Study|Withdrawal by Subject|1|||
16334776|NCT04015518|39710956|FG000|Overall Study|Patient did not come for consecutive visits|0|||
16334777|NCT04015518|39710957|FG001|Overall Study|Patient did not come for consecutive visits|1|||
16334778|NCT04015518|39710958|FG002|Overall Study|Patient did not come for consecutive visits|0|||
16334779|NCT04015518|39710959|FG003|Overall Study|Patient did not come for consecutive visits|0|||
16334780|NCT04015518|39710960|FG004|Overall Study|Patient did not come for consecutive visits|0|||
16334781|NCT04015518|39710956|FG000|Overall Study|not willing to travel due to Covid-19|0|||
16334782|NCT04015518|39710957|FG001|Overall Study|not willing to travel due to Covid-19|0|||
16334783|NCT04015518|39710958|FG002|Overall Study|not willing to travel due to Covid-19|1|||
16334784|NCT04015518|39710959|FG003|Overall Study|not willing to travel due to Covid-19|0|||
16334785|NCT04015518|39710960|FG004|Overall Study|not willing to travel due to Covid-19|0|||
16334786|NCT04015518|39710956|FG000|Overall Study|Patient wants to discontinue treatment|0|||
16334787|NCT04015518|39710957|FG001|Overall Study|Patient wants to discontinue treatment|0|||
16334788|NCT04015518|39710958|FG002|Overall Study|Patient wants to discontinue treatment|0|||
16334789|NCT04015518|39710959|FG003|Overall Study|Patient wants to discontinue treatment|1|||
16334790|NCT04015518|39710960|FG004|Overall Study|Patient wants to discontinue treatment|0|||
16334791|NCT04015518|39710956|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
16334792|NCT04015518|39710957|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
16334793|NCT04015518|39710958|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
16334794|NCT04015518|39710959|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
16334795|NCT04015518|39710960|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
16334796|NCT04015518|39710956|FG000|Overall Study|Pregnancy|0|||
16334797|NCT04015518|39710957|FG001|Overall Study|Pregnancy|0|||
16334798|NCT04015518|39710958|FG002|Overall Study|Pregnancy|0|||
16404408|NCT02526524|39961861|FG005|Overall Study|Physician Decision|0|||
16101441|NCT02815735|38859577|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
16101442|NCT02815735|38859578|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
16101443|NCT02815735|38859577|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
16101444|NCT02815735|38859578|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
16101445|NCT01757171|38859579|FG000|Overall Study|Adverse Event|5|||
16101446|NCT01757171|38859580|FG001|Overall Study|Adverse Event|1|||
16101447|NCT01757171|38859579|FG000|Overall Study|Disease Progression|1|||
16101448|NCT01757171|38859580|FG001|Overall Study|Disease Progression|0|||
16101449|NCT01757171|38859579|FG000|Overall Study|Hospitalization|1|||
16101450|NCT01757171|38859580|FG001|Overall Study|Hospitalization|0|||
16101451|NCT01757171|38859579|FG000|Overall Study|ECOG decline|1|||
16404409|NCT02526524|39961856|FG000|Overall Study|Sponsor Decision|1|||
16404410|NCT02526524|39961857|FG001|Overall Study|Sponsor Decision|0|||
16404411|NCT02526524|39961858|FG002|Overall Study|Sponsor Decision|0|||
16404412|NCT02526524|39961859|FG003|Overall Study|Sponsor Decision|0|||
16404413|NCT02526524|39961860|FG004|Overall Study|Sponsor Decision|0|||
16404414|NCT02526524|39961861|FG005|Overall Study|Sponsor Decision|0|||
16404415|NCT02370537|39961862|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
16404416|NCT02370537|39961863|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
16404417|NCT02370537|39961864|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
16404418|NCT02370537|39961862|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
16404419|NCT02370537|39961863|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
16404420|NCT02370537|39961864|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
16404421|NCT02370537|39961862|FG000|Part B|Not randomised to receive treatment|1|||
16534426|NCT02077166|40421872|FG001|Overall Study|Study Closure by Sponsor|0|||
16534427|NCT02077166|40421873|FG002|Overall Study|Study Closure by Sponsor|2|||
16534428|NCT02077166|40421874|FG003|Overall Study|Study Closure by Sponsor|2|||
16534429|NCT02077166|40421875|FG004|Overall Study|Study Closure by Sponsor|2|||
16534430|NCT02077166|40421876|FG005|Overall Study|Study Closure by Sponsor|12|||
16534431|NCT02077166|40421877|FG006|Overall Study|Study Closure by Sponsor|4|||
16534432|NCT02077166|40421871|FG000|Overall Study|Lost to Follow-up|0|||
16534433|NCT02077166|40421872|FG001|Overall Study|Lost to Follow-up|0|||
16534434|NCT02077166|40421873|FG002|Overall Study|Lost to Follow-up|0|||
16534435|NCT02077166|40421874|FG003|Overall Study|Lost to Follow-up|0|||
16534436|NCT02077166|40421875|FG004|Overall Study|Lost to Follow-up|0|||
16534437|NCT02077166|40421876|FG005|Overall Study|Lost to Follow-up|1|||
16534438|NCT02077166|40421877|FG006|Overall Study|Lost to Follow-up|0|||
16534439|NCT02077166|40421871|FG000|Overall Study|Withdrawal by Subject|3|||
16534440|NCT02077166|40421872|FG001|Overall Study|Withdrawal by Subject|0|||
16534441|NCT02077166|40421873|FG002|Overall Study|Withdrawal by Subject|1|||
16101452|NCT01757171|38859580|FG001|Overall Study|ECOG decline|0|||
16101453|NCT00577096|38859584|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
16404422|NCT02370537|39961863|FG001|Part B|Not randomised to receive treatment|2|||
16404423|NCT02370537|39961864|FG002|Part B|Not randomised to receive treatment|259|||
16404424|NCT02370537|39961862|FG000|Part B|Withdrawal by Subject|0|||
16534442|NCT02077166|40421874|FG003|Overall Study|Withdrawal by Subject|1|||
16404425|NCT02370537|39961863|FG001|Part B|Withdrawal by Subject|1|||
16404426|NCT02370537|39961864|FG002|Part B|Withdrawal by Subject|0|||
16404427|NCT00350870|39961865|FG000|Overall Study|Withdrawal by Subject|21|||
16404428|NCT00350870|39961866|FG001|Overall Study|Withdrawal by Subject|17|||
16404429|NCT00350870|39961867|FG002|Overall Study|Withdrawal by Subject|15|||
16404430|NCT00350870|39961868|FG003|Overall Study|Withdrawal by Subject|14|||
16404431|NCT00350870|39961865|FG000|Overall Study|Physician Decision|1|||
16404432|NCT00350870|39961866|FG001|Overall Study|Physician Decision|0|||
16404433|NCT00350870|39961867|FG002|Overall Study|Physician Decision|1|||
16404434|NCT00350870|39961868|FG003|Overall Study|Physician Decision|1|||
16404435|NCT01146652|39961869|FG000|Overall Study|Adverse Event|506|||
16404436|NCT01146652|39961870|FG001|Overall Study|Adverse Event|15|||
16404437|NCT01146652|39961869|FG000|Overall Study|Lack of Efficacy|91|||
16404438|NCT01146652|39961870|FG001|Overall Study|Lack of Efficacy|7|||
16404439|NCT01146652|39961869|FG000|Overall Study|Poor compliance to protocol|38|||
16404440|NCT01146652|39961870|FG001|Overall Study|Poor compliance to protocol|1|||
16404441|NCT01146652|39961869|FG000|Overall Study|Other unspecified reasons|314|||
16404442|NCT01146652|39961870|FG001|Overall Study|Other unspecified reasons|22|||
16404443|NCT01146652|39961869|FG000|Overall Study|Enrolled but not treated|2|||
16404444|NCT01146652|39961870|FG001|Overall Study|Enrolled but not treated|0|||
16404445|NCT02435680|39961871|FG000|Overall Study|Physician Decision|3|||
16404446|NCT02435680|39961872|FG001|Overall Study|Physician Decision|0|||
16404447|NCT02435680|39961873|FG002|Overall Study|Physician Decision|0|||
16404448|NCT02435680|39961871|FG000|Overall Study|subject / guardian decision|0|||
16404449|NCT02435680|39961872|FG001|Overall Study|subject / guardian decision|3|||
16404450|NCT02435680|39961873|FG002|Overall Study|subject / guardian decision|2|||
16404451|NCT02435680|39961871|FG000|Overall Study|Adverse Event|8|||
16404452|NCT02435680|39961872|FG001|Overall Study|Adverse Event|3|||
16404453|NCT02435680|39961873|FG002|Overall Study|Adverse Event|2|||
16404454|NCT02435680|39961871|FG000|Overall Study|progressive disease|10|||
16404455|NCT02435680|39961872|FG001|Overall Study|progressive disease|7|||
16404456|NCT02435680|39961873|FG002|Overall Study|progressive disease|11|||
16404457|NCT02435680|39961871|FG000|Overall Study|not treated|0|||
16404458|NCT02435680|39961872|FG001|Overall Study|not treated|0|||
16404459|NCT02435680|39961873|FG002|Overall Study|not treated|1|||
16404460|NCT01972308|39961874|FG000|Overall Study|Withdrawal by Subject|0|||
16404461|NCT01972308|39961875|FG001|Overall Study|Withdrawal by Subject|1|||
16404462|NCT01972308|39961874|FG000|Overall Study|Lost to Follow-up|4|||
16404463|NCT01972308|39961875|FG001|Overall Study|Lost to Follow-up|6|||
16404464|NCT01972308|39961874|FG000|Overall Study|Death|4|||
16404465|NCT01972308|39961875|FG001|Overall Study|Death|1|||
16404466|NCT01133405|39961876|FG000|Period 1|Withdrawal by Subject|0|||
16404467|NCT01133405|39961877|FG001|Period 1|Withdrawal by Subject|1|||
16404468|NCT01133405|39961878|FG002|Period 1|Withdrawal by Subject|0|||
16404469|NCT01133405|39961879|FG003|Period 1|Withdrawal by Subject|1|||
16404470|NCT01133405|39961880|FG004|Period 1|Withdrawal by Subject|0|||
16404471|NCT01133405|39961881|FG005|Period 1|Withdrawal by Subject|1|||
16404472|NCT01133405|39961882|FG006|Period 1|Withdrawal by Subject|0|||
16404473|NCT01133405|39961883|FG007|Period 1|Withdrawal by Subject|0|||
16404474|NCT01133405|39961884|FG008|Period 1|Withdrawal by Subject|0|||
16404475|NCT01133405|39961885|FG009|Period 1|Withdrawal by Subject|0|||
16404476|NCT01133405|39961876|FG000|Period 1|Physician Decision|0|||
16404477|NCT01133405|39961877|FG001|Period 1|Physician Decision|0|||
16101454|NCT00577096|38859585|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
16101455|NCT00577096|38859584|FG000|Short Term Participation|Withdrawal by Subject|3|||
16101456|NCT00577096|38859585|FG001|Short Term Participation|Withdrawal by Subject|5|||
16101457|NCT00577096|38859584|FG000|Short Term Participation|Death|1|||
16404478|NCT01133405|39961878|FG002|Period 1|Physician Decision|0|||
16101458|NCT00577096|38859585|FG001|Short Term Participation|Death|1|||
16101459|NCT02971683|38859586|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
16534443|NCT02077166|40421875|FG004|Overall Study|Withdrawal by Subject|1|||
16404479|NCT01133405|39961879|FG003|Period 1|Physician Decision|1|||
16404480|NCT01133405|39961880|FG004|Period 1|Physician Decision|0|||
16404481|NCT01133405|39961881|FG005|Period 1|Physician Decision|0|||
16404482|NCT01133405|39961882|FG006|Period 1|Physician Decision|0|||
16534444|NCT02077166|40421876|FG005|Overall Study|Withdrawal by Subject|3|||
16404483|NCT01133405|39961883|FG007|Period 1|Physician Decision|0|||
16404484|NCT01133405|39961884|FG008|Period 1|Physician Decision|0|||
16404485|NCT01133405|39961885|FG009|Period 1|Physician Decision|0|||
16404486|NCT01133405|39961876|FG000|Period 1|Discontinued after randomization|1|||
16404487|NCT01133405|39961877|FG001|Period 1|Discontinued after randomization|0|||
16404488|NCT01133405|39961878|FG002|Period 1|Discontinued after randomization|0|||
16101460|NCT02971683|38859587|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
16404489|NCT01133405|39961879|FG003|Period 1|Discontinued after randomization|0|||
16404490|NCT01133405|39961880|FG004|Period 1|Discontinued after randomization|0|||
16404491|NCT01133405|39961881|FG005|Period 1|Discontinued after randomization|0|||
16404492|NCT01133405|39961882|FG006|Period 1|Discontinued after randomization|1|||
16404493|NCT01133405|39961883|FG007|Period 1|Discontinued after randomization|0|||
16534445|NCT02077166|40421877|FG006|Overall Study|Withdrawal by Subject|0|||
16101461|NCT02971683|38859586|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
16101462|NCT02971683|38859587|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
16101463|NCT02971683|38859586|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
16101464|NCT02971683|38859587|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
16101465|NCT02971683|38859586|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
16101466|NCT02971683|38859587|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
16101467|NCT02971683|38859586|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
16101468|NCT02971683|38859587|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
16101469|NCT02971683|38859586|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
16101470|NCT02971683|38859587|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
16334799|NCT04015518|39710959|FG003|Overall Study|Pregnancy|0|||
16334800|NCT04015518|39710960|FG004|Overall Study|Pregnancy|1|||
16334801|NCT04015518|39710956|FG000|Overall Study|Personal reasons|1|||
16334802|NCT04015518|39710957|FG001|Overall Study|Personal reasons|0|||
16334803|NCT04015518|39710958|FG002|Overall Study|Personal reasons|0|||
16334804|NCT04015518|39710959|FG003|Overall Study|Personal reasons|0|||
16334805|NCT04015518|39710960|FG004|Overall Study|Personal reasons|1|||
16334806|NCT04015518|39710956|FG000|Overall Study|Withdrew consent|1|||
16404494|NCT01133405|39961884|FG008|Period 1|Discontinued after randomization|0|||
16404495|NCT01133405|39961885|FG009|Period 1|Discontinued after randomization|0|||
16404496|NCT01133405|39961876|FG000|Period 1|Received drug only in period 2|0|||
16404497|NCT01133405|39961877|FG001|Period 1|Received drug only in period 2|1|||
16404498|NCT01133405|39961878|FG002|Period 1|Received drug only in period 2|0|||
16404499|NCT01133405|39961879|FG003|Period 1|Received drug only in period 2|2|||
16404500|NCT01133405|39961880|FG004|Period 1|Received drug only in period 2|0|||
16404501|NCT01133405|39961881|FG005|Period 1|Received drug only in period 2|1|||
16404502|NCT01133405|39961882|FG006|Period 1|Received drug only in period 2|0|||
16404503|NCT01133405|39961883|FG007|Period 1|Received drug only in period 2|0|||
16404504|NCT01133405|39961884|FG008|Period 1|Received drug only in period 2|0|||
16334807|NCT04015518|39710957|FG001|Overall Study|Withdrew consent|0|||
16334808|NCT04015518|39710958|FG002|Overall Study|Withdrew consent|0|||
16334809|NCT04015518|39710959|FG003|Overall Study|Withdrew consent|0|||
16334810|NCT04015518|39710960|FG004|Overall Study|Withdrew consent|0|||
16334811|NCT04015518|39710956|FG000|Overall Study|Prostate carcinoma|1|||
16404505|NCT01133405|39961885|FG009|Period 1|Received drug only in period 2|0|||
16404506|NCT01133405|39961876|FG000|Period 1|Received drug only in period 3|0|||
16404507|NCT01133405|39961877|FG001|Period 1|Received drug only in period 3|1|||
16404508|NCT01133405|39961878|FG002|Period 1|Received drug only in period 3|1|||
16534446|NCT02077166|40421871|FG000|Overall Study|Other, Not Specified|0|||
16534447|NCT02077166|40421872|FG001|Overall Study|Other, Not Specified|0|||
16534448|NCT02077166|40421873|FG002|Overall Study|Other, Not Specified|1|||
16534449|NCT02077166|40421874|FG003|Overall Study|Other, Not Specified|0|||
16534450|NCT02077166|40421875|FG004|Overall Study|Other, Not Specified|1|||
16534451|NCT02077166|40421876|FG005|Overall Study|Other, Not Specified|7|||
16534452|NCT02077166|40421877|FG006|Overall Study|Other, Not Specified|8|||
16534453|NCT00831779|40421879|FG000|Overall Study|Lost to Follow-up|1|||
16534454|NCT00831779|40421880|FG001|Overall Study|Lost to Follow-up|0|||
16534455|NCT00831779|40421879|FG000|Overall Study|No longer met criteria|0|||
16534456|NCT00831779|40421880|FG001|Overall Study|No longer met criteria|1|||
16534457|NCT02491671|40421881|FG000|Overall Study|Adverse Event|6|||
16534458|NCT02491671|40421882|FG001|Overall Study|Adverse Event|8|||
16534459|NCT02491671|40421881|FG000|Overall Study|Death|0|||
16534460|NCT02491671|40421882|FG001|Overall Study|Death|2|||
16534461|NCT02491671|40421881|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
16534462|NCT02491671|40421882|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
16101471|NCT02971683|38859586|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
16101472|NCT02971683|38859587|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
16101473|NCT02971683|38859586|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
16101474|NCT02971683|38859587|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
16101475|NCT02971683|38859586|FG000|Open-Label|Lost to Follow-up|1|||
16101476|NCT02971683|38859587|FG001|Open-Label|Lost to Follow-up|0|||
16101477|NCT02971683|38859586|FG000|Open-Label|Participants withdrew consent|0|||
16101478|NCT02971683|38859587|FG001|Open-Label|Participants withdrew consent|2|||
16101479|NCT02971683|38859586|FG000|Open-Label|Participant request to discontinue study treatment|1|||
16101480|NCT02971683|38859587|FG001|Open-Label|Participant request to discontinue study treatment|0|||
16101481|NCT02971683|38859586|FG000|Open-Label|Lack of Efficacy|2|||
16101482|NCT02971683|38859587|FG001|Open-Label|Lack of Efficacy|0|||
16101483|NCT02971683|38859586|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
16534463|NCT01798927|40421883|FG000|Overall Study|Withdrawal by Subject|1|||
16101484|NCT02971683|38859587|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
16334812|NCT04015518|39710957|FG001|Overall Study|Prostate carcinoma|0|||
16334813|NCT04015518|39710958|FG002|Overall Study|Prostate carcinoma|0|||
16334814|NCT04015518|39710959|FG003|Overall Study|Prostate carcinoma|0|||
16534464|NCT01967732|40421886|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
16334815|NCT04015518|39710960|FG004|Overall Study|Prostate carcinoma|0|||
16334816|NCT04015518|39710956|FG000|Overall Study|Could not keep appointments due to work|1|||
16334817|NCT04015518|39710957|FG001|Overall Study|Could not keep appointments due to work|0|||
16334818|NCT04015518|39710958|FG002|Overall Study|Could not keep appointments due to work|0|||
16334819|NCT04015518|39710959|FG003|Overall Study|Could not keep appointments due to work|0|||
16334820|NCT04015518|39710960|FG004|Overall Study|Could not keep appointments due to work|0|||
16101485|NCT02971683|38859586|FG000|Long-Term Open Label|Participant withdrew consent|1|||
16101486|NCT02971683|38859587|FG001|Long-Term Open Label|Participant withdrew consent|0|||
16101487|NCT02971683|38859586|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
16101488|NCT02971683|38859587|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
16101489|NCT02971683|38859586|FG000|Long-Term Open Label|Adverse Event|1|||
16101490|NCT02971683|38859587|FG001|Long-Term Open Label|Adverse Event|2|||
16101491|NCT02971683|38859586|FG000|Long-Term Open Label|Lack of Efficacy|1|||
16101492|NCT02971683|38859587|FG001|Long-Term Open Label|Lack of Efficacy|1|||
16334821|NCT01375374|39710961|FG000|Overall Study|Adverse Event|1|||
16334822|NCT00524680|39710965|FG000|Overall Study|progression|0|||
16534465|NCT01967732|40421887|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
16534466|NCT01967732|40421888|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
16534467|NCT01967732|40421889|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
16534468|NCT01967732|40421886|FG000|First Intervention (Day 1)|Poor venous access|0|||
16534469|NCT01967732|40421887|FG001|First Intervention (Day 1)|Poor venous access|1|||
16534470|NCT01967732|40421888|FG002|First Intervention (Day 1)|Poor venous access|0|||
16534471|NCT01967732|40421889|FG003|First Intervention (Day 1)|Poor venous access|0|||
16534472|NCT01994954|40421890|FG000|Overall Study|Death|1|||
16534473|NCT01994954|40421891|FG001|Overall Study|Death|0|||
16534474|NCT01994954|40421890|FG000|Overall Study|Withdrawal by Subject|9|||
16534475|NCT01994954|40421891|FG001|Overall Study|Withdrawal by Subject|14|||
16534476|NCT01994954|40421890|FG000|Overall Study|Physician Decision|2|||
16534477|NCT01994954|40421891|FG001|Overall Study|Physician Decision|2|||
16534478|NCT01994954|40421890|FG000|Overall Study|Lost to Follow-up|8|||
16534479|NCT01994954|40421891|FG001|Overall Study|Lost to Follow-up|10|||
16534480|NCT01994954|40421890|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
16534481|NCT01994954|40421891|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
16534482|NCT00293267|40421892|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
16534483|NCT00293267|40421893|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
16534484|NCT00293267|40421892|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
16534485|NCT00293267|40421893|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
16534486|NCT00293267|40421892|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
16534487|NCT00293267|40421893|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
16534488|NCT00293267|40421892|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
16334823|NCT00524680|39710966|FG001|Overall Study|progression|0|||
16334824|NCT00524680|39710967|FG002|Overall Study|progression|0|||
16334825|NCT00524680|39710968|FG003|Overall Study|progression|1|||
16334826|NCT00524680|39710965|FG000|Overall Study|Adverse Event|2|||
16534489|NCT00293267|40421893|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
16534490|NCT00293267|40421892|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
16534491|NCT00293267|40421893|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
16534492|NCT00293267|40421892|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
16534493|NCT00293267|40421893|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
16534494|NCT00293267|40421892|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
16534495|NCT00293267|40421893|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
16534496|NCT00293267|40421892|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
16534497|NCT00293267|40421893|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
16534498|NCT00293267|40421892|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
16534499|NCT00293267|40421893|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
16534500|NCT00293267|40421892|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
16534501|NCT00293267|40421893|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
16534502|NCT00293267|40421892|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
16101493|NCT02253147|38859588|FG000|Overall Study|Protocol Violation|30|||
16101494|NCT02253147|38859588|FG000|Overall Study|Did not consent to study extension|9|||
16101495|NCT02253147|38859588|FG000|Overall Study|Conditional re-treatment at W52|5|||
16101496|NCT02253147|38859588|FG000|Overall Study|Lost to Follow-up|2|||
16101497|NCT02253147|38859588|FG000|Overall Study|Withdrawal by Subject|1|||
16101498|NCT01116440|38859589|FG000|Treatment|Withdrawal by Subject|2|||
16334827|NCT00524680|39710966|FG001|Overall Study|Adverse Event|0|||
16534503|NCT00293267|40421893|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
16101499|NCT01116440|38859590|FG001|Treatment|Withdrawal by Subject|2|||
16101500|NCT01116440|38859589|FG000|Treatment|Lost to Follow-up|1|||
16101501|NCT01116440|38859590|FG001|Treatment|Lost to Follow-up|1|||
16334828|NCT00524680|39710967|FG002|Overall Study|Adverse Event|0|||
16334829|NCT00524680|39710968|FG003|Overall Study|Adverse Event|1|||
16101502|NCT01116440|38859589|FG000|Treatment|Protocol Violation|0|||
16101503|NCT01116440|38859590|FG001|Treatment|Protocol Violation|2|||
16334830|NCT00524680|39710965|FG000|Overall Study|Other|0|||
16334831|NCT00524680|39710966|FG001|Overall Study|Other|1|||
16334832|NCT00524680|39710967|FG002|Overall Study|Other|2|||
16334833|NCT00524680|39710968|FG003|Overall Study|Other|3|||
16334834|NCT00524680|39710965|FG000|Overall Study|Withdrawal by Subject|1|||
16334835|NCT00524680|39710966|FG001|Overall Study|Withdrawal by Subject|0|||
16334836|NCT00524680|39710967|FG002|Overall Study|Withdrawal by Subject|1|||
16334837|NCT00524680|39710968|FG003|Overall Study|Withdrawal by Subject|1|||
16334838|NCT03564795|39710969|FG000|Overall Study|Withdrawal by Subject|3|||
16334839|NCT03564795|39710969|FG000|Overall Study|Lost to Follow-up|6|||
16334840|NCT03564795|39710969|FG000|Overall Study|Physician Decision|2|||
16334841|NCT01167634|39710970|FG000|Overall Study|Lost to Follow-up|1|||
16334842|NCT01167634|39710971|FG001|Overall Study|Lost to Follow-up|3|||
16534504|NCT00293267|40421892|FG000|Extension - Double-Blind Week 49-156|Death|3|||
16534505|NCT00293267|40421893|FG001|Extension - Double-Blind Week 49-156|Death|0|||
16534506|NCT00293267|40421892|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
16534507|NCT00293267|40421893|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
16534508|NCT00293267|40421892|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
16534509|NCT00293267|40421893|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
16534510|NCT00293267|40421892|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
16534511|NCT00293267|40421893|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
16534512|NCT00293267|40421892|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
16534513|NCT00293267|40421893|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
16534514|NCT00293267|40421892|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
16534515|NCT00293267|40421893|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
16534516|NCT00293267|40421892|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
16534517|NCT00293267|40421893|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
16534518|NCT00293267|40421892|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
16534519|NCT00293267|40421893|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
16534520|NCT00293267|40421892|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
16534521|NCT00293267|40421893|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
16534522|NCT00293267|40421892|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
16534523|NCT00293267|40421893|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
16534524|NCT00293267|40421892|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
16534525|NCT00293267|40421893|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
16534526|NCT00293267|40421892|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
16534527|NCT00293267|40421893|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
16534528|NCT00293267|40421892|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
16534529|NCT00293267|40421893|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
16534530|NCT00293267|40421892|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
16534531|NCT00293267|40421893|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
16534532|NCT00293267|40421892|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
16534533|NCT00293267|40421893|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
16534534|NCT00293267|40421892|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
16534535|NCT00293267|40421893|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
16534536|NCT00293267|40421892|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
16101504|NCT01116440|38859589|FG000|Treatment|Lack of Efficacy|0|||
16101505|NCT01116440|38859590|FG001|Treatment|Lack of Efficacy|1|||
16101506|NCT01116440|38859589|FG000|Treatment|Adverse Event|0|||
16101507|NCT01116440|38859590|FG001|Treatment|Adverse Event|1|||
16334843|NCT01167634|39710972|FG002|Overall Study|Lost to Follow-up|3|||
16334844|NCT01167634|39710973|FG003|Overall Study|Lost to Follow-up|4|||
16101508|NCT01116440|38859589|FG000|Withdrawal|Withdrawal by Subject|0|||
16101509|NCT01116440|38859590|FG001|Withdrawal|Withdrawal by Subject|1|||
16101510|NCT01116440|38859589|FG000|Withdrawal|Lost to Follow-up|0|||
16101511|NCT01116440|38859590|FG001|Withdrawal|Lost to Follow-up|1|||
16101512|NCT01116440|38859589|FG000|Follow-up|Lost to Follow-up|0|||
16101513|NCT01116440|38859590|FG001|Follow-up|Lost to Follow-up|1|||
16101514|NCT01116440|38859589|FG000|Follow-up|Withdrawal by Subject|0|||
16101515|NCT01116440|38859590|FG001|Follow-up|Withdrawal by Subject|1|||
16101516|NCT01287416|38859596|FG000|Pre-post Training|Withdrawal by Subject|17|||
16101517|NCT01287416|38859597|FG001|Pre-post Training|Withdrawal by Subject|24|||
16334845|NCT01167634|39710970|FG000|Overall Study|Withdrawal by Subject|1|||
16334846|NCT01167634|39710971|FG001|Overall Study|Withdrawal by Subject|1|||
16334847|NCT01167634|39710972|FG002|Overall Study|Withdrawal by Subject|0|||
16101518|NCT01287416|38859596|FG000|Pre-post Training|Lost to Follow-up|5|||
16334848|NCT01167634|39710973|FG003|Overall Study|Withdrawal by Subject|0|||
16334849|NCT00821015|39710977|FG000|Overall Study|Lost to Follow-up|12|||
16101519|NCT01287416|38859597|FG001|Pre-post Training|Lost to Follow-up|1|||
16101520|NCT01287416|38859596|FG000|6 Month Follow-up|Lost to Follow-up|3|||
16101521|NCT01287416|38859597|FG001|6 Month Follow-up|Lost to Follow-up|2|||
16101522|NCT02137239|38859598|FG000|Overall Study|Discontinued Study Treatment|0|||
16101523|NCT02137239|38859599|FG001|Overall Study|Discontinued Study Treatment|3|||
16101524|NCT02137239|38859598|FG000|Overall Study|Withdrew Consent|1|||
16101525|NCT02137239|38859599|FG001|Overall Study|Withdrew Consent|1|||
16101526|NCT02137239|38859598|FG000|Overall Study|Adverse Event|2|||
16101527|NCT02137239|38859599|FG001|Overall Study|Adverse Event|2|||
16101528|NCT05177770|38859601|FG000|Overall Study|Death|4|||
16101529|NCT05177770|38859601|FG000|Overall Study|Withdrawal by Subject|1|||
16101530|NCT05177770|38859601|FG000|Overall Study|Adverse Event prior to dosing|1|||
16101531|NCT02581189|38859604|FG000|Overall Study|Failure to return|36|||
16101532|NCT02581189|38859604|FG000|Overall Study|Withdrew consent|5|||
16101533|NCT02581189|38859604|FG000|Overall Study|Death|3|||
16101534|NCT02581189|38859604|FG000|Overall Study|Insufficient virological response|2|||
16101535|NCT02581189|38859604|FG000|Overall Study|Other, not specified|7|||
16101536|NCT03302559|38859605|FG000|Overall Study|Adverse Event|2|||
16534537|NCT00293267|40421893|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
16534538|NCT00651664|40421895|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
16534539|NCT00651664|40421896|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
16534540|NCT00651664|40421897|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
16534541|NCT00651664|40421898|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
16534542|NCT00651664|40421899|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
16216550|NCT03424044|39272407|FG002|First Intervention (76 Hours)|Adverse Event|0|||
16216551|NCT03424044|39272408|FG003|First Intervention (76 Hours)|Adverse Event|0|||
16534543|NCT00651664|40421900|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
16404509|NCT01133405|39961879|FG003|Period 1|Received drug only in period 3|0|||
16534544|NCT00651664|40421901|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
16534545|NCT00651664|40421902|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
16534546|NCT00651664|40421903|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
16534547|NCT00651664|40421904|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
16534548|NCT00651664|40421895|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
16534549|NCT00651664|40421896|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
16534550|NCT00651664|40421897|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
16534551|NCT00651664|40421898|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
16534552|NCT00651664|40421899|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
16534553|NCT00651664|40421900|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
16534554|NCT00651664|40421901|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
16534555|NCT00651664|40421902|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
16534556|NCT00651664|40421903|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
16534557|NCT00651664|40421904|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
16534558|NCT00651664|40421895|FG000|Overall Study|Progressive Disease|3|||
16534559|NCT00651664|40421896|FG001|Overall Study|Progressive Disease|3|||
16534560|NCT00651664|40421897|FG002|Overall Study|Progressive Disease|3|||
16534561|NCT00651664|40421898|FG003|Overall Study|Progressive Disease|12|||
16534562|NCT00651664|40421899|FG004|Overall Study|Progressive Disease|4|||
16534563|NCT00651664|40421900|FG005|Overall Study|Progressive Disease|1|||
16404510|NCT01133405|39961880|FG004|Period 1|Received drug only in period 3|0|||
16404511|NCT01133405|39961881|FG005|Period 1|Received drug only in period 3|0|||
16404512|NCT01133405|39961882|FG006|Period 1|Received drug only in period 3|0|||
16404513|NCT01133405|39961883|FG007|Period 1|Received drug only in period 3|0|||
16404514|NCT01133405|39961884|FG008|Period 1|Received drug only in period 3|0|||
16404515|NCT01133405|39961885|FG009|Period 1|Received drug only in period 3|0|||
16404516|NCT01133405|39961876|FG000|Period 2|Adverse Event|0|||
16404517|NCT01133405|39961877|FG001|Period 2|Adverse Event|0|||
16534564|NCT00651664|40421901|FG006|Overall Study|Progressive Disease|3|||
16534565|NCT00651664|40421902|FG007|Overall Study|Progressive Disease|6|||
16534566|NCT00651664|40421903|FG008|Overall Study|Progressive Disease|5|||
16534567|NCT00651664|40421904|FG009|Overall Study|Progressive Disease|5|||
16534568|NCT00651664|40421895|FG000|Overall Study|Patient Declined Further Treatment|0|||
16101537|NCT03302559|38859605|FG000|Overall Study|Lost to Follow-up|1|||
16101538|NCT03302559|38859605|FG000|Overall Study|Withdrew Consent|3|||
16101539|NCT00147745|38859606|FG000|Overall Study|Withdrawal by Subject|1|||
16404518|NCT01133405|39961878|FG002|Period 2|Adverse Event|1|||
16404519|NCT01133405|39961879|FG003|Period 2|Adverse Event|0|||
16404520|NCT01133405|39961880|FG004|Period 2|Adverse Event|0|||
16404521|NCT01133405|39961881|FG005|Period 2|Adverse Event|0|||
16404522|NCT01133405|39961882|FG006|Period 2|Adverse Event|0|||
16404523|NCT01133405|39961883|FG007|Period 2|Adverse Event|0|||
16404524|NCT01133405|39961884|FG008|Period 2|Adverse Event|0|||
16404525|NCT01133405|39961885|FG009|Period 2|Adverse Event|0|||
16404526|NCT01133405|39961876|FG000|Period 2|Withdrawal by Subject|0|||
16404527|NCT01133405|39961877|FG001|Period 2|Withdrawal by Subject|0|||
16404528|NCT01133405|39961878|FG002|Period 2|Withdrawal by Subject|0|||
16404529|NCT01133405|39961879|FG003|Period 2|Withdrawal by Subject|1|||
16404530|NCT01133405|39961880|FG004|Period 2|Withdrawal by Subject|0|||
16404531|NCT01133405|39961881|FG005|Period 2|Withdrawal by Subject|1|||
16404532|NCT01133405|39961882|FG006|Period 2|Withdrawal by Subject|0|||
16404533|NCT01133405|39961883|FG007|Period 2|Withdrawal by Subject|0|||
16534569|NCT00651664|40421896|FG001|Overall Study|Patient Declined Further Treatment|0|||
16534570|NCT00651664|40421897|FG002|Overall Study|Patient Declined Further Treatment|0|||
16534571|NCT00651664|40421898|FG003|Overall Study|Patient Declined Further Treatment|1|||
16534572|NCT00651664|40421899|FG004|Overall Study|Patient Declined Further Treatment|1|||
16534573|NCT00651664|40421900|FG005|Overall Study|Patient Declined Further Treatment|1|||
16534574|NCT00651664|40421901|FG006|Overall Study|Patient Declined Further Treatment|0|||
16534575|NCT00651664|40421902|FG007|Overall Study|Patient Declined Further Treatment|0|||
16534576|NCT00651664|40421903|FG008|Overall Study|Patient Declined Further Treatment|0|||
16534577|NCT00651664|40421904|FG009|Overall Study|Patient Declined Further Treatment|1|||
16534578|NCT00651664|40421895|FG000|Overall Study|Symptomatic Deterioration|0|||
16534579|NCT00651664|40421896|FG001|Overall Study|Symptomatic Deterioration|0|||
16534580|NCT00651664|40421897|FG002|Overall Study|Symptomatic Deterioration|0|||
16101540|NCT00147745|38859607|FG001|Overall Study|Withdrawal by Subject|0|||
16334850|NCT01900431|39710981|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
16334851|NCT01900431|39710982|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
16334852|NCT01900431|39710983|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
16334853|NCT01900431|39710981|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
16334854|NCT01900431|39710982|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
16334855|NCT01900431|39710983|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
16334856|NCT01900431|39710981|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
16334857|NCT01900431|39710982|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
16334858|NCT01900431|39710983|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
16334859|NCT01900431|39710981|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
16334860|NCT01900431|39710982|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
16334861|NCT01900431|39710983|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
16334862|NCT01900431|39710981|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
16334863|NCT01900431|39710982|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
16334864|NCT01900431|39710983|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
16334865|NCT01900431|39710981|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
16334866|NCT01900431|39710982|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
16334867|NCT01900431|39710983|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
16334868|NCT01900431|39710981|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
16334869|NCT01900431|39710982|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
16334870|NCT01900431|39710983|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
16334871|NCT01900431|39710981|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
16334872|NCT01900431|39710982|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
16334873|NCT01900431|39710983|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
16334874|NCT01900431|39710981|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
16334875|NCT01900431|39710982|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
16334876|NCT01900431|39710983|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
16334877|NCT00334295|39710984|FG000|Overall Study|Patients received fewer than 3 injection|5|||
16334878|NCT03172364|39710985|FG000|Overall Study|Adverse Event|1|||
16334879|NCT03172364|39710986|FG001|Overall Study|Adverse Event|1|||
16334880|NCT03172364|39710985|FG000|Overall Study|Protocol Violation|1|||
16334881|NCT03172364|39710986|FG001|Overall Study|Protocol Violation|0|||
16334882|NCT00480493|39710987|FG000|Overall Study|moved|2|||
16334883|NCT00480493|39710988|FG001|Overall Study|moved|7|||
16334884|NCT03673501|39710989|FG000|Overall Study|Participants ongoing.|36|||
16334885|NCT03673501|39710990|FG001|Overall Study|Participants ongoing.|24|||
16334886|NCT01969084|39710991|FG000|Overall Study|Adverse Event|0|||
16334887|NCT01969084|39710992|FG001|Overall Study|Adverse Event|1|||
16334888|NCT00438256|39710997|FG000|Overall Study|Ineligible for Resection|2|||
16334889|NCT00438256|39710998|FG001|Overall Study|Ineligible for Resection|1|||
16334890|NCT00438256|39710999|FG002|Overall Study|Ineligible for Resection|1|||
16404534|NCT01133405|39961884|FG008|Period 2|Withdrawal by Subject|0|||
16404535|NCT01133405|39961885|FG009|Period 2|Withdrawal by Subject|0|||
16404536|NCT01133405|39961876|FG000|Period 2|Entry Criteria Not Met|0|||
16404537|NCT01133405|39961877|FG001|Period 2|Entry Criteria Not Met|1|||
16404538|NCT01133405|39961878|FG002|Period 2|Entry Criteria Not Met|0|||
16404539|NCT01133405|39961879|FG003|Period 2|Entry Criteria Not Met|0|||
16404540|NCT01133405|39961880|FG004|Period 2|Entry Criteria Not Met|0|||
16404541|NCT01133405|39961881|FG005|Period 2|Entry Criteria Not Met|0|||
16404542|NCT01133405|39961882|FG006|Period 2|Entry Criteria Not Met|0|||
16404543|NCT01133405|39961883|FG007|Period 2|Entry Criteria Not Met|0|||
16404544|NCT01133405|39961884|FG008|Period 2|Entry Criteria Not Met|0|||
16404545|NCT01133405|39961885|FG009|Period 2|Entry Criteria Not Met|0|||
16404546|NCT01133405|39961876|FG000|Period 2|Physician Decision|0|||
16404547|NCT01133405|39961877|FG001|Period 2|Physician Decision|0|||
16404548|NCT01133405|39961878|FG002|Period 2|Physician Decision|0|||
16404549|NCT01133405|39961879|FG003|Period 2|Physician Decision|0|||
16404550|NCT01133405|39961880|FG004|Period 2|Physician Decision|0|||
16404551|NCT01133405|39961881|FG005|Period 2|Physician Decision|1|||
16404552|NCT01133405|39961882|FG006|Period 2|Physician Decision|0|||
16404553|NCT01133405|39961883|FG007|Period 2|Physician Decision|0|||
16404554|NCT01133405|39961884|FG008|Period 2|Physician Decision|0|||
16404555|NCT01133405|39961885|FG009|Period 2|Physician Decision|0|||
16404556|NCT01069861|39961886|FG000|Overall Study|Death|1|||
16334891|NCT00438256|39711000|FG003|Overall Study|Ineligible for Resection|7|||
16334892|NCT00438256|39710997|FG000|Overall Study|Excluded final Diagnosis|0|||
16404557|NCT01069861|39961886|FG000|Overall Study|Adverse Event|1|||
16404558|NCT01069861|39961886|FG000|Overall Study|Did not meet entrance criteria|1|||
16404559|NCT02242435|39961896|FG000|Overall Study|Lost to Follow-up|3|||
16404560|NCT02242435|39961897|FG001|Overall Study|Lost to Follow-up|4|||
16404561|NCT02242435|39961896|FG000|Overall Study|Adverse Event|3|||
16334893|NCT00438256|39710998|FG001|Overall Study|Excluded final Diagnosis|0|||
16334894|NCT00438256|39710999|FG002|Overall Study|Excluded final Diagnosis|0|||
16216552|NCT03424044|39272409|FG004|First Intervention (76 Hours)|Adverse Event|1|||
16216553|NCT03424044|39272410|FG005|First Intervention (76 Hours)|Adverse Event|0|||
16216554|NCT03424044|39272411|FG006|First Intervention (76 Hours)|Adverse Event|0|||
16334895|NCT00438256|39711000|FG003|Overall Study|Excluded final Diagnosis|2|||
16334896|NCT02879994|39711003|FG000|Overall Study|off treatment early|7|||
16334897|NCT02879994|39711003|FG000|Overall Study|Adverse Event|2|||
16334898|NCT02879994|39711003|FG000|Overall Study|Death|2|||
16334899|NCT00396383|39711008|FG000|Overall Study|Death|2|||
16334900|NCT00396383|39711008|FG000|Overall Study|Lost to Follow-up|1|||
16334901|NCT01917344|39711009|FG000|Overall Study|Withdrawal by Subject|1|||
16334902|NCT01549041|39711014|FG000|Overall Study|Lack of Efficacy|2|||
16404562|NCT02242435|39961897|FG001|Overall Study|Adverse Event|2|||
16404563|NCT02242435|39961896|FG000|Overall Study|Withdrawal by Subject|13|||
16404564|NCT02242435|39961897|FG001|Overall Study|Withdrawal by Subject|8|||
16404565|NCT02242435|39961896|FG000|Overall Study|Death|0|||
16404566|NCT02242435|39961897|FG001|Overall Study|Death|1|||
16334903|NCT01549041|39711015|FG001|Overall Study|Lack of Efficacy|4|||
16334904|NCT01549041|39711014|FG000|Overall Study|Adverse Event|0|||
16334905|NCT01549041|39711015|FG001|Overall Study|Adverse Event|4|||
16334906|NCT01283334|39711016|FG000|Overall Study|Withdrawal by Subject|1|||
16334907|NCT01283334|39711016|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
16334908|NCT01283334|39711016|FG000|Overall Study|Adverse Event|4|||
16334909|NCT01283334|39711016|FG000|Overall Study|Physician Decision|1|||
16334910|NCT01603407|39714659|FG000|Overall Study|Adverse Event|1|||
16334911|NCT01603407|39714660|FG001|Overall Study|Adverse Event|1|||
16334912|NCT01603407|39714661|FG002|Overall Study|Adverse Event|1|||
16334913|NCT01603407|39714659|FG000|Overall Study|Protocol Violation|2|||
16534581|NCT00651664|40421898|FG003|Overall Study|Symptomatic Deterioration|1|||
16534582|NCT00651664|40421899|FG004|Overall Study|Symptomatic Deterioration|0|||
16334914|NCT01603407|39714660|FG001|Overall Study|Protocol Violation|2|||
16334915|NCT01603407|39714661|FG002|Overall Study|Protocol Violation|0|||
16534583|NCT00651664|40421900|FG005|Overall Study|Symptomatic Deterioration|0|||
16534584|NCT00651664|40421901|FG006|Overall Study|Symptomatic Deterioration|1|||
16404567|NCT02242435|39961896|FG000|Overall Study|Protocol Violation|1|||
16404568|NCT02242435|39961897|FG001|Overall Study|Protocol Violation|0|||
16334916|NCT01603407|39714659|FG000|Overall Study|Withdrawal by Subject|8|||
16404569|NCT02242435|39961896|FG000|Overall Study|Physician Decision|0|||
16404570|NCT02242435|39961897|FG001|Overall Study|Physician Decision|1|||
16404571|NCT03920293|39961910|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
16404572|NCT03920293|39961911|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
16404573|NCT03920293|39961910|FG000|Randomized-Controlled Period|Physician Decision|1|||
16404574|NCT03920293|39961911|FG001|Randomized-Controlled Period|Physician Decision|2|||
16404575|NCT03920293|39961910|FG000|Randomized-Controlled Period|Adverse Event|0|||
16404576|NCT03920293|39961911|FG001|Randomized-Controlled Period|Adverse Event|2|||
16216555|NCT03424044|39272412|FG007|First Intervention (76 Hours)|Adverse Event|0|||
16334917|NCT01603407|39714660|FG001|Overall Study|Withdrawal by Subject|5|||
16334918|NCT01603407|39714661|FG002|Overall Study|Withdrawal by Subject|7|||
16334919|NCT01603407|39714659|FG000|Overall Study|Lost to Follow-up|0|||
16334920|NCT01603407|39714660|FG001|Overall Study|Lost to Follow-up|3|||
16404577|NCT03920293|39961910|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
16334921|NCT01603407|39714661|FG002|Overall Study|Lost to Follow-up|2|||
16334922|NCT00184093|39714664|FG000|Overall Study|Adverse Event|3|||
16334923|NCT00184093|39714664|FG000|Overall Study|Lost to Follow-up|3|||
16334924|NCT00184093|39714664|FG000|Overall Study|Physician Decision|1|||
16334925|NCT00184093|39714664|FG000|Overall Study|Withdrawal by Subject|2|||
16334926|NCT00856843|39714665|FG000|Overall Study|Withdrawal by Subject|1|||
16334927|NCT00856843|39714666|FG001|Overall Study|Withdrawal by Subject|5|||
16334928|NCT00856843|39714665|FG000|Overall Study|Lack of Efficacy|1|||
16334929|NCT00856843|39714666|FG001|Overall Study|Lack of Efficacy|0|||
16334930|NCT02772276|39714667|FG000|Overall Study|Lost to Follow-up|0|||
16334931|NCT02772276|39714668|FG001|Overall Study|Lost to Follow-up|0|||
16334932|NCT02772276|39714669|FG002|Overall Study|Lost to Follow-up|0|||
16334933|NCT02772276|39714670|FG003|Overall Study|Lost to Follow-up|0|||
16334934|NCT02772276|39714671|FG004|Overall Study|Lost to Follow-up|0|||
16334935|NCT02772276|39714672|FG005|Overall Study|Lost to Follow-up|0|||
16334936|NCT02772276|39714673|FG006|Overall Study|Lost to Follow-up|1|||
16334937|NCT02772276|39714674|FG007|Overall Study|Lost to Follow-up|0|||
16334938|NCT02772276|39714675|FG008|Overall Study|Lost to Follow-up|0|||
16334939|NCT02772276|39714676|FG009|Overall Study|Lost to Follow-up|0|||
16334940|NCT02772276|39714677|FG010|Overall Study|Lost to Follow-up|0|||
16334941|NCT02772276|39714678|FG011|Overall Study|Lost to Follow-up|0|||
16334942|NCT02772276|39714679|FG012|Overall Study|Lost to Follow-up|0|||
16334943|NCT02772276|39714667|FG000|Overall Study|Withdrew consent|0|||
16334944|NCT02772276|39714668|FG001|Overall Study|Withdrew consent|0|||
16334945|NCT02772276|39714669|FG002|Overall Study|Withdrew consent|0|||
16334946|NCT02772276|39714670|FG003|Overall Study|Withdrew consent|0|||
16334947|NCT02772276|39714671|FG004|Overall Study|Withdrew consent|0|||
16334948|NCT02772276|39714672|FG005|Overall Study|Withdrew consent|0|||
16334949|NCT02772276|39714673|FG006|Overall Study|Withdrew consent|0|||
16334950|NCT02772276|39714674|FG007|Overall Study|Withdrew consent|1|||
16334951|NCT02772276|39714675|FG008|Overall Study|Withdrew consent|0|||
16334952|NCT02772276|39714676|FG009|Overall Study|Withdrew consent|0|||
16334953|NCT02772276|39714677|FG010|Overall Study|Withdrew consent|0|||
16334954|NCT02772276|39714678|FG011|Overall Study|Withdrew consent|0|||
16334955|NCT02772276|39714679|FG012|Overall Study|Withdrew consent|0|||
16334956|NCT00347919|39714680|FG000|Overall Study|Lost to Follow-up|11|||
16334957|NCT00347919|39714681|FG001|Overall Study|Lost to Follow-up|13|||
16334958|NCT00347919|39714682|FG002|Overall Study|Lost to Follow-up|0|||
16334959|NCT00347919|39714680|FG000|Overall Study|Withdrawal by Subject|6|||
16334960|NCT00347919|39714681|FG001|Overall Study|Withdrawal by Subject|8|||
16334961|NCT00347919|39714682|FG002|Overall Study|Withdrawal by Subject|0|||
16334962|NCT00347919|39714680|FG000|Overall Study|Physician Decision|1|||
16334963|NCT00347919|39714681|FG001|Overall Study|Physician Decision|1|||
16334964|NCT00347919|39714682|FG002|Overall Study|Physician Decision|0|||
16334965|NCT00347919|39714680|FG000|Overall Study|Sponsor terminated study|15|||
16334966|NCT00347919|39714681|FG001|Overall Study|Sponsor terminated study|10|||
16334967|NCT00347919|39714682|FG002|Overall Study|Sponsor terminated study|16|||
16334968|NCT00347919|39714680|FG000|Overall Study|Death|35|||
16334969|NCT00347919|39714681|FG001|Overall Study|Death|42|||
16334970|NCT00347919|39714682|FG002|Overall Study|Death|19|||
16334971|NCT00347919|39714680|FG000|Overall Study|Par. Started Other Treatment|1|||
16334972|NCT00347919|39714681|FG001|Overall Study|Par. Started Other Treatment|1|||
16334973|NCT00347919|39714682|FG002|Overall Study|Par. Started Other Treatment|1|||
16334974|NCT00347919|39714680|FG000|Overall Study|Missing|2|||
16334975|NCT00347919|39714681|FG001|Overall Study|Missing|1|||
16334976|NCT00347919|39714682|FG002|Overall Study|Missing|2|||
16334977|NCT00114738|39714683|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
16334978|NCT00114738|39714684|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
16334979|NCT00114738|39714685|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
16334980|NCT00114738|39714683|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
16334981|NCT00114738|39714684|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
16334982|NCT00114738|39714685|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
16334983|NCT00114738|39714683|FG000|Screening for Randomization|Neuropathy|17|||
16334984|NCT00114738|39714684|FG001|Screening for Randomization|Neuropathy|0|||
16334985|NCT00114738|39714685|FG002|Screening for Randomization|Neuropathy|0|||
16334986|NCT00114738|39714683|FG000|Screening for Randomization|Progressive disease|2|||
16334987|NCT00114738|39714684|FG001|Screening for Randomization|Progressive disease|0|||
16334988|NCT00114738|39714685|FG002|Screening for Randomization|Progressive disease|0|||
16334989|NCT00114738|39714683|FG000|Screening for Randomization|CNS Hemorrhage|1|||
16334990|NCT00114738|39714684|FG001|Screening for Randomization|CNS Hemorrhage|0|||
16334991|NCT00114738|39714685|FG002|Screening for Randomization|CNS Hemorrhage|0|||
16334992|NCT00114738|39714683|FG000|Screening for Randomization|Other|1|||
16334993|NCT00114738|39714684|FG001|Screening for Randomization|Other|0|||
16334994|NCT00114738|39714685|FG002|Screening for Randomization|Other|0|||
16334995|NCT01632150|39714686|FG000|Overall Study|Disease progression|27|||
16334996|NCT01632150|39714686|FG000|Overall Study|Study drug toxicity|1|||
16334997|NCT01632150|39714686|FG000|Overall Study|Unrelated adverse event|7|||
16334998|NCT01632150|39714686|FG000|Overall Study|Withdrawal by Subject|2|||
16334999|NCT01632150|39714686|FG000|Overall Study|Patient underwent autologous transplant|1|||
16335000|NCT01632150|39714686|FG000|Overall Study|Moved to compassionate program|2|||
16335001|NCT01603394|39714689|FG000|Overall Study|Adverse Event|1|||
16335002|NCT01416155|39714690|FG000|Overall Study|Adverse Event|8|||
16335003|NCT01416155|39714690|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
16335004|NCT01416155|39714690|FG000|Overall Study|Withdrawal by Subject|33|||
16335005|NCT01416155|39714690|FG000|Overall Study|Investigator decision|8|||
16335006|NCT01416155|39714690|FG000|Overall Study|Other|7|||
16335007|NCT01554176|39714694|FG000|Treatment Phase|Protocol Violation|1|||
16335008|NCT01554176|39714695|FG001|Treatment Phase|Protocol Violation|2|||
16335009|NCT01554176|39714696|FG002|Treatment Phase|Protocol Violation|0|||
16335010|NCT01554176|39714697|FG003|Treatment Phase|Protocol Violation|0|||
16335011|NCT01554176|39714698|FG004|Treatment Phase|Protocol Violation|0|||
16335012|NCT01554176|39714694|FG000|Treatment Phase|Physician Decision|1|||
16335013|NCT01554176|39714695|FG001|Treatment Phase|Physician Decision|1|||
16335014|NCT01554176|39714696|FG002|Treatment Phase|Physician Decision|0|||
16534585|NCT00651664|40421902|FG007|Overall Study|Symptomatic Deterioration|0|||
16534586|NCT00651664|40421903|FG008|Overall Study|Symptomatic Deterioration|1|||
16534587|NCT00651664|40421904|FG009|Overall Study|Symptomatic Deterioration|0|||
16534588|NCT00651664|40421895|FG000|Overall Study|Reason not Specified|0|||
16534589|NCT00651664|40421896|FG001|Overall Study|Reason not Specified|0|||
16534590|NCT00651664|40421897|FG002|Overall Study|Reason not Specified|0|||
16534591|NCT00651664|40421898|FG003|Overall Study|Reason not Specified|0|||
16534592|NCT00651664|40421899|FG004|Overall Study|Reason not Specified|0|||
16534593|NCT00651664|40421900|FG005|Overall Study|Reason not Specified|0|||
16534594|NCT00651664|40421901|FG006|Overall Study|Reason not Specified|1|||
16534595|NCT00651664|40421902|FG007|Overall Study|Reason not Specified|0|||
16534596|NCT00651664|40421903|FG008|Overall Study|Reason not Specified|0|||
16101541|NCT00147745|38859608|FG002|Overall Study|Withdrawal by Subject|0|||
16101542|NCT02123797|38859609|FG000|Baseline Intervention|Death|9|||
16335015|NCT01554176|39714697|FG003|Treatment Phase|Physician Decision|0|||
16335016|NCT01554176|39714698|FG004|Treatment Phase|Physician Decision|0|||
16534597|NCT00651664|40421904|FG009|Overall Study|Reason not Specified|0|||
16534598|NCT01212770|40421905|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
16534599|NCT01212770|40421906|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
16534600|NCT01212770|40421907|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
16534601|NCT01212770|40421908|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16335017|NCT01554176|39714694|FG000|Treatment Phase|Lack of Efficacy|0|||
16335018|NCT01554176|39714695|FG001|Treatment Phase|Lack of Efficacy|1|||
16335019|NCT01554176|39714696|FG002|Treatment Phase|Lack of Efficacy|0|||
16335020|NCT01554176|39714697|FG003|Treatment Phase|Lack of Efficacy|0|||
16335021|NCT01554176|39714698|FG004|Treatment Phase|Lack of Efficacy|0|||
16335022|NCT01554176|39714694|FG000|Treatment Phase|Adverse event, non-fatal|1|||
16335023|NCT01554176|39714695|FG001|Treatment Phase|Adverse event, non-fatal|1|||
16335024|NCT01554176|39714696|FG002|Treatment Phase|Adverse event, non-fatal|0|||
16335025|NCT01554176|39714697|FG003|Treatment Phase|Adverse event, non-fatal|0|||
16335026|NCT01554176|39714698|FG004|Treatment Phase|Adverse event, non-fatal|0|||
16335027|NCT01554176|39714694|FG000|Treatment Phase|Non-compliance with study drug|1|||
16335028|NCT01554176|39714695|FG001|Treatment Phase|Non-compliance with study drug|0|||
16335029|NCT01554176|39714696|FG002|Treatment Phase|Non-compliance with study drug|0|||
16335030|NCT01554176|39714697|FG003|Treatment Phase|Non-compliance with study drug|0|||
16335031|NCT01554176|39714698|FG004|Treatment Phase|Non-compliance with study drug|0|||
16335032|NCT01554176|39714694|FG000|Treatment Phase|Withdrawal by Subject|1|||
16335033|NCT01554176|39714695|FG001|Treatment Phase|Withdrawal by Subject|0|||
16335034|NCT01554176|39714696|FG002|Treatment Phase|Withdrawal by Subject|0|||
16335035|NCT01554176|39714697|FG003|Treatment Phase|Withdrawal by Subject|0|||
16335036|NCT01554176|39714698|FG004|Treatment Phase|Withdrawal by Subject|0|||
16335037|NCT01554176|39714694|FG000|Treatment Phase|Lost to Follow-up|3|||
16335038|NCT01554176|39714695|FG001|Treatment Phase|Lost to Follow-up|0|||
16335039|NCT01554176|39714696|FG002|Treatment Phase|Lost to Follow-up|0|||
16534602|NCT01212770|40421909|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16335040|NCT01554176|39714697|FG003|Treatment Phase|Lost to Follow-up|0|||
16335041|NCT01554176|39714698|FG004|Treatment Phase|Lost to Follow-up|0|||
16335042|NCT01554176|39714694|FG000|Run-out Phase|Protocol Violation|0|||
16335043|NCT01554176|39714695|FG001|Run-out Phase|Protocol Violation|0|||
16335044|NCT01554176|39714696|FG002|Run-out Phase|Protocol Violation|0|||
16534603|NCT01212770|40421910|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16335045|NCT01554176|39714697|FG003|Run-out Phase|Protocol Violation|1|||
16534604|NCT01212770|40421911|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16534605|NCT01212770|40421912|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16534606|NCT01212770|40421913|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16534607|NCT01212770|40421905|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
16534608|NCT01212770|40421906|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
16534609|NCT01212770|40421907|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
16534610|NCT01212770|40421908|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16534611|NCT01212770|40421909|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16534612|NCT01212770|40421910|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16534613|NCT01212770|40421911|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16534614|NCT01212770|40421912|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16534615|NCT01212770|40421913|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16534616|NCT01212770|40421905|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
16534617|NCT01212770|40421906|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
16534618|NCT01212770|40421907|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
16534619|NCT01212770|40421908|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16534620|NCT01212770|40421909|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16534621|NCT01212770|40421910|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16534622|NCT01212770|40421911|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16534623|NCT01212770|40421912|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16534624|NCT01212770|40421913|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16534625|NCT01212770|40421905|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
16534626|NCT01212770|40421906|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16534627|NCT01212770|40421907|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
16534628|NCT01212770|40421908|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16534629|NCT01212770|40421909|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16534630|NCT01212770|40421910|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16534631|NCT01212770|40421911|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16534632|NCT01212770|40421912|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16534633|NCT01212770|40421913|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16534634|NCT01212770|40421905|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16534635|NCT01212770|40421906|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16534636|NCT01212770|40421907|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
16534637|NCT01212770|40421908|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16534638|NCT01212770|40421909|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16534639|NCT01212770|40421910|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16534640|NCT01212770|40421911|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16534641|NCT01212770|40421912|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16534642|NCT01212770|40421913|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16534643|NCT01212770|40421905|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
16335046|NCT01554176|39714698|FG004|Run-out Phase|Protocol Violation|0|||
16335047|NCT02920177|39714699|FG000|Overall Study|Withdrawal by Subject|1|||
16335048|NCT02920177|39714700|FG001|Overall Study|Withdrawal by Subject|1|||
16335049|NCT02920177|39714699|FG000|Overall Study|Physician Decision|1|||
16335050|NCT02920177|39714700|FG001|Overall Study|Physician Decision|0|||
16335051|NCT02920177|39714699|FG000|Overall Study|Lost to Follow-up|0|||
16335052|NCT02920177|39714700|FG001|Overall Study|Lost to Follow-up|1|||
16335053|NCT01853696|39714706|FG000|Overall Study|Withdrawal by Subject|1|||
16335054|NCT01853696|39714707|FG001|Overall Study|Withdrawal by Subject|1|||
16335055|NCT01853696|39714706|FG000|Overall Study|Lost to Follow-up|5|||
16335056|NCT01853696|39714707|FG001|Overall Study|Lost to Follow-up|4|||
16335057|NCT01451554|39714708|FG000|Overall Study|Withdrawal by Subject|14|||
16335058|NCT01451554|39714709|FG001|Overall Study|Withdrawal by Subject|9|||
16335059|NCT01702532|39714713|FG000|Overall Study|Adverse Event|0|||
16335060|NCT01702532|39714714|FG001|Overall Study|Adverse Event|1|||
16335061|NCT02418585|39714715|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
16335062|NCT02418585|39714716|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
16335063|NCT02418585|39714715|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
16335064|NCT02418585|39714716|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
16335065|NCT02418585|39714715|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
16335066|NCT02418585|39714716|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
16335067|NCT02418585|39714715|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
16335068|NCT02418585|39714716|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
16335069|NCT02418585|39714715|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
16335070|NCT02418585|39714716|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
16335071|NCT02418585|39714715|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
16335072|NCT02418585|39714716|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
16335073|NCT02418585|39714715|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
16335074|NCT02418585|39714716|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
16335075|NCT02418585|39714715|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
16335076|NCT02418585|39714716|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
16335077|NCT02418585|39714715|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
16335078|NCT02418585|39714716|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
16335079|NCT02418585|39714715|FG000|Follow-up Phase (24 Weeks)|Other|3|||
16335080|NCT02418585|39714716|FG001|Follow-up Phase (24 Weeks)|Other|2|||
16335081|NCT02326298|39714718|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335082|NCT02326298|39714719|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335083|NCT02326298|39714720|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
16335084|NCT02326298|39714721|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335085|NCT02326298|39714722|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16534644|NCT01212770|40421906|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
16534645|NCT01212770|40421907|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
16534646|NCT01212770|40421908|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16534647|NCT01212770|40421909|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16534648|NCT01212770|40421910|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16534649|NCT01212770|40421911|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16335086|NCT02326298|39714723|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335087|NCT02326298|39714724|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335088|NCT02326298|39714725|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335089|NCT02326298|39714726|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335090|NCT02326298|39714727|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335091|NCT02326298|39714728|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335092|NCT02326298|39714729|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335093|NCT02326298|39714730|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335094|NCT02326298|39714731|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16335095|NCT02326298|39714718|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
16335096|NCT02326298|39714719|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335097|NCT02326298|39714720|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335098|NCT02326298|39714721|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16534650|NCT01212770|40421912|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16534651|NCT01212770|40421913|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
16534652|NCT01212770|40421905|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
16534653|NCT01212770|40421906|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
16534654|NCT01212770|40421907|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
16534655|NCT01212770|40421908|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
16534656|NCT01212770|40421909|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
16534657|NCT01212770|40421910|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
16534658|NCT01212770|40421911|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
16534659|NCT01212770|40421912|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
16335099|NCT02326298|39714722|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335100|NCT02326298|39714723|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335101|NCT02326298|39714724|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335102|NCT02326298|39714725|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335103|NCT02326298|39714726|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335104|NCT02326298|39714727|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335105|NCT02326298|39714728|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335106|NCT02326298|39714729|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335107|NCT02326298|39714730|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335108|NCT02326298|39714731|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
16335109|NCT02326298|39714718|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
16335110|NCT02326298|39714719|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
16534660|NCT01212770|40421913|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
16534661|NCT01212770|40421905|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
16534662|NCT01212770|40421906|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
16335111|NCT02326298|39714720|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16335112|NCT02326298|39714721|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16335113|NCT02326298|39714722|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16335114|NCT02326298|39714723|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16335115|NCT02326298|39714724|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16534663|NCT01212770|40421907|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
16534664|NCT01212770|40421908|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
16534665|NCT01212770|40421909|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
16335116|NCT02326298|39714725|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16335117|NCT02326298|39714726|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16534666|NCT01212770|40421910|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
16534667|NCT01212770|40421911|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
16534668|NCT01212770|40421912|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
16534669|NCT01212770|40421913|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
16534670|NCT01212770|40421905|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
16534671|NCT01212770|40421906|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
16534672|NCT01212770|40421907|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
16534673|NCT01212770|40421908|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
16534674|NCT01212770|40421909|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
16534675|NCT01212770|40421910|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
16335118|NCT02326298|39714727|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16335119|NCT02326298|39714728|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16335120|NCT02326298|39714729|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16335121|NCT02326298|39714730|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16335122|NCT02326298|39714731|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16335123|NCT02326298|39714718|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
16335124|NCT02326298|39714719|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
16335125|NCT02326298|39714720|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335126|NCT02326298|39714721|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335127|NCT02326298|39714722|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335128|NCT02326298|39714723|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335129|NCT02326298|39714724|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335130|NCT02326298|39714725|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335131|NCT02326298|39714726|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335132|NCT02326298|39714727|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335133|NCT02326298|39714728|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335134|NCT02326298|39714729|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335135|NCT02326298|39714730|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335136|NCT02326298|39714731|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16335137|NCT02326298|39714718|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335138|NCT02326298|39714719|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335139|NCT02326298|39714720|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
16335140|NCT02326298|39714721|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335141|NCT02326298|39714722|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335142|NCT02326298|39714723|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335143|NCT02326298|39714724|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335144|NCT02326298|39714725|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335145|NCT02326298|39714726|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335146|NCT02326298|39714727|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335147|NCT02326298|39714728|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335148|NCT02326298|39714729|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335149|NCT02326298|39714730|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335150|NCT02326298|39714731|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
16335151|NCT02326298|39714718|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16335152|NCT02326298|39714719|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16335153|NCT02326298|39714720|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16335154|NCT02326298|39714721|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16335155|NCT02326298|39714722|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16335156|NCT02326298|39714723|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16335157|NCT02326298|39714724|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
16335158|NCT02326298|39714725|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16335159|NCT02326298|39714726|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16335160|NCT02326298|39714727|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16335161|NCT02326298|39714728|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16335162|NCT02326298|39714729|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16335163|NCT02326298|39714730|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16335164|NCT02326298|39714731|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16335165|NCT02326298|39714718|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16335166|NCT02326298|39714719|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16335167|NCT02326298|39714720|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16335168|NCT02326298|39714721|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16534676|NCT01212770|40421911|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
16335169|NCT02326298|39714722|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16335170|NCT02326298|39714723|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
16335171|NCT02326298|39714724|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
16335172|NCT02326298|39714725|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16335173|NCT02326298|39714726|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
16335174|NCT02326298|39714727|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16335175|NCT02326298|39714728|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16335176|NCT02326298|39714729|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16335177|NCT02326298|39714730|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16335178|NCT02326298|39714731|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
16335179|NCT02326298|39714718|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335180|NCT02326298|39714719|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335181|NCT02326298|39714720|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335182|NCT02326298|39714721|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335183|NCT02326298|39714722|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335184|NCT02326298|39714723|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
16335185|NCT02326298|39714724|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335186|NCT02326298|39714725|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335187|NCT02326298|39714726|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335188|NCT02326298|39714727|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335189|NCT02326298|39714728|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335190|NCT02326298|39714729|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335191|NCT02326298|39714730|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335192|NCT02326298|39714731|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
16335193|NCT02326298|39714718|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335194|NCT02326298|39714719|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335195|NCT02326298|39714720|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335196|NCT02326298|39714721|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335197|NCT02326298|39714722|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335198|NCT02326298|39714723|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335199|NCT02326298|39714724|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
16335200|NCT02326298|39714725|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335201|NCT02326298|39714726|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335202|NCT02326298|39714727|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335203|NCT02326298|39714728|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335204|NCT02326298|39714729|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335205|NCT02326298|39714730|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335206|NCT02326298|39714731|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16335207|NCT02326298|39714718|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335208|NCT02326298|39714719|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335209|NCT02326298|39714720|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335210|NCT02326298|39714721|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335211|NCT02326298|39714722|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335212|NCT02326298|39714723|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335213|NCT02326298|39714724|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335214|NCT02326298|39714725|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
16335215|NCT02326298|39714726|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335216|NCT02326298|39714727|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335217|NCT02326298|39714728|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335218|NCT02326298|39714729|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16534677|NCT01212770|40421912|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
16534678|NCT01212770|40421913|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
16534679|NCT01212770|40421905|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16534680|NCT01212770|40421906|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16534681|NCT01212770|40421907|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
16534682|NCT01212770|40421908|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16534683|NCT01212770|40421909|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16534684|NCT01212770|40421910|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16534685|NCT01212770|40421911|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16534686|NCT01212770|40421912|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16335219|NCT02326298|39714730|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335220|NCT02326298|39714731|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
16335221|NCT02326298|39714718|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335222|NCT02326298|39714719|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335223|NCT02326298|39714720|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335224|NCT02326298|39714721|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335225|NCT02326298|39714722|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335226|NCT02326298|39714723|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335227|NCT02326298|39714724|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
16335228|NCT02326298|39714725|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
16335229|NCT02326298|39714726|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335230|NCT02326298|39714727|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335231|NCT02326298|39714728|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335232|NCT02326298|39714729|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335233|NCT02326298|39714730|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16101543|NCT02123797|38859610|FG001|Baseline Intervention|Death|16|||
16101544|NCT02123797|38859611|FG002|Baseline Intervention|Death|0|||
16101545|NCT02123797|38859612|FG003|Baseline Intervention|Death|0|||
16101546|NCT02123797|38859613|FG004|Baseline Intervention|Death|0|||
16101547|NCT02123797|38859609|FG000|Baseline Intervention|Withdrawal by Subject|2|||
16101548|NCT02123797|38859610|FG001|Baseline Intervention|Withdrawal by Subject|8|||
16335234|NCT02326298|39714731|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16335235|NCT02326298|39714718|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16101549|NCT02123797|38859611|FG002|Baseline Intervention|Withdrawal by Subject|0|||
16101550|NCT02123797|38859612|FG003|Baseline Intervention|Withdrawal by Subject|0|||
16101551|NCT02123797|38859613|FG004|Baseline Intervention|Withdrawal by Subject|0|||
16101552|NCT02123797|38859609|FG000|Baseline Intervention|Relocation|2|||
16101553|NCT02123797|38859610|FG001|Baseline Intervention|Relocation|0|||
16101554|NCT02123797|38859611|FG002|Baseline Intervention|Relocation|0|||
16101555|NCT02123797|38859612|FG003|Baseline Intervention|Relocation|0|||
16101556|NCT02123797|38859613|FG004|Baseline Intervention|Relocation|0|||
16101557|NCT02123797|38859609|FG000|Baseline Intervention|Out of window for initial survey|6|||
16101558|NCT02123797|38859610|FG001|Baseline Intervention|Out of window for initial survey|13|||
16101559|NCT02123797|38859611|FG002|Baseline Intervention|Out of window for initial survey|0|||
16101560|NCT02123797|38859612|FG003|Baseline Intervention|Out of window for initial survey|0|||
16101561|NCT02123797|38859613|FG004|Baseline Intervention|Out of window for initial survey|0|||
16101562|NCT02123797|38859609|FG000|Baseline Intervention|Lost to Follow-up|0|||
16101563|NCT02123797|38859610|FG001|Baseline Intervention|Lost to Follow-up|5|||
16101564|NCT02123797|38859611|FG002|Baseline Intervention|Lost to Follow-up|0|||
16101565|NCT02123797|38859612|FG003|Baseline Intervention|Lost to Follow-up|0|||
16335236|NCT02326298|39714719|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16534687|NCT01212770|40421913|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
16534688|NCT01212770|40421905|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16335237|NCT02326298|39714720|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16335238|NCT02326298|39714721|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16335239|NCT02326298|39714722|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16404578|NCT03920293|39961911|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
16404579|NCT03920293|39961910|FG000|Randomized-Controlled Period|Death|2|||
16404580|NCT03920293|39961911|FG001|Randomized-Controlled Period|Death|0|||
16404581|NCT03920293|39961910|FG000|Randomized-Controlled Period|Protocol Violation|1|||
16404582|NCT03920293|39961911|FG001|Randomized-Controlled Period|Protocol Violation|0|||
16404583|NCT03920293|39961910|FG000|Randomized-Controlled Period|Noncompliance|1|||
16404584|NCT03920293|39961911|FG001|Randomized-Controlled Period|Noncompliance|0|||
16404585|NCT03920293|39961910|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
16404586|NCT03920293|39961911|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
16404587|NCT03920293|39961910|FG000|Open- Label Extension Period|Death|3|||
16404588|NCT03920293|39961911|FG001|Open- Label Extension Period|Death|3|||
16404589|NCT03920293|39961910|FG000|Open- Label Extension Period|Physician Decision|5|||
16404590|NCT03920293|39961911|FG001|Open- Label Extension Period|Physician Decision|3|||
16404591|NCT03920293|39961910|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
16404592|NCT03920293|39961911|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
16404593|NCT03372460|39961916|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
16534689|NCT01212770|40421906|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16534690|NCT01212770|40421907|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16534691|NCT01212770|40421908|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
16101566|NCT02123797|38859613|FG004|Baseline Intervention|Lost to Follow-up|0|||
16101567|NCT02123797|38859609|FG000|Baseline Intervention|Other Disease|3|||
16101568|NCT02123797|38859610|FG001|Baseline Intervention|Other Disease|0|||
16335240|NCT02326298|39714723|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16335241|NCT02326298|39714724|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16335242|NCT02326298|39714725|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
16335243|NCT02326298|39714726|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16335244|NCT02326298|39714727|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16335245|NCT02326298|39714728|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16335246|NCT02326298|39714729|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16335247|NCT02326298|39714730|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16335248|NCT02326298|39714731|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16335249|NCT02326298|39714718|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335250|NCT02326298|39714719|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335251|NCT02326298|39714720|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335252|NCT02326298|39714721|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335253|NCT02326298|39714722|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335254|NCT02326298|39714723|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
16335255|NCT02326298|39714724|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335256|NCT02326298|39714725|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335257|NCT02326298|39714726|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335258|NCT02326298|39714727|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335259|NCT02326298|39714728|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335260|NCT02326298|39714729|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335261|NCT02326298|39714730|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16335262|NCT02326298|39714731|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
16534692|NCT01212770|40421909|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16534693|NCT01212770|40421910|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16534694|NCT01212770|40421911|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16534695|NCT01212770|40421912|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16534696|NCT01212770|40421913|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
16534697|NCT01212770|40421905|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16534698|NCT01212770|40421906|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16534699|NCT01212770|40421907|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
16534700|NCT01212770|40421908|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
16534701|NCT01212770|40421909|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16534702|NCT01212770|40421910|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16534703|NCT01212770|40421911|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16534704|NCT01212770|40421912|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16534705|NCT01212770|40421913|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
16534706|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16534707|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
16534708|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
16534709|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16534710|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16534711|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16534712|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16534713|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
16534714|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
16534715|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16534716|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
16534717|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
16534718|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16534719|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16534720|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16534721|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
16534722|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
16534723|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
16534724|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16534725|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
16534726|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16534727|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16534728|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16534729|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16534730|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16534731|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16101569|NCT02123797|38859611|FG002|Baseline Intervention|Other Disease|0|||
16101570|NCT02123797|38859612|FG003|Baseline Intervention|Other Disease|0|||
16335263|NCT02326298|39714718|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
16335264|NCT02326298|39714719|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
16335265|NCT02326298|39714720|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
16335266|NCT02326298|39714721|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
16335267|NCT02326298|39714722|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
16335268|NCT02326298|39714723|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
16335269|NCT02326298|39714724|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
16335270|NCT02326298|39714725|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
16335271|NCT02326298|39714726|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
16335272|NCT02326298|39714727|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
16335273|NCT02326298|39714728|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
16335274|NCT02326298|39714729|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
16335275|NCT02326298|39714730|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
16335276|NCT02326298|39714731|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
16335277|NCT02326298|39714718|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335278|NCT02326298|39714719|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335279|NCT02326298|39714720|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335280|NCT02326298|39714721|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335281|NCT02326298|39714722|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335282|NCT02326298|39714723|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335283|NCT02326298|39714724|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335284|NCT02326298|39714725|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335285|NCT02326298|39714726|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335286|NCT02326298|39714727|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335287|NCT02326298|39714728|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335288|NCT02326298|39714729|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
16335289|NCT02326298|39714730|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
16335290|NCT02326298|39714731|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16335291|NCT02326298|39714718|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16335292|NCT02326298|39714719|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16335293|NCT02326298|39714720|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16335294|NCT02326298|39714721|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16335295|NCT02326298|39714722|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16335296|NCT02326298|39714723|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16335297|NCT02326298|39714724|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16335298|NCT02326298|39714725|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16404594|NCT03372460|39961917|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
16404595|NCT03510468|39961918|FG000|Overall Study|Lost to Follow-up|1|||
16404596|NCT03510468|39961918|FG000|Overall Study|Adverse Event|5|||
16404597|NCT03510468|39961918|FG000|Overall Study|Physician Decision|1|||
16404598|NCT03510468|39961918|FG000|Overall Study|non-compliant with treatment|2|||
16404599|NCT03510468|39961918|FG000|Overall Study|Missed visit|1|||
16404600|NCT00385944|39961919|FG000|1st Maintenance Dose Period|Physician Decision|1|||
16404601|NCT00385944|39961920|FG001|1st Maintenance Dose Period|Physician Decision|0|||
16404602|NCT00385944|39961921|FG002|1st Maintenance Dose Period|Physician Decision|0|||
16404603|NCT00385944|39961919|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
16404604|NCT00385944|39961920|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
16404605|NCT00385944|39961921|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
16404606|NCT00385944|39961919|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
16404607|NCT00385944|39961920|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
16404608|NCT00385944|39961921|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
16335299|NCT02326298|39714726|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16404609|NCT00385944|39961919|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
16404610|NCT00385944|39961920|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
16404611|NCT00385944|39961921|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
16404612|NCT00772369|39961925|FG000|Overall Study|Did not return record release form|1|||
16404613|NCT01574157|39961926|FG000|Overall Study|Withdrawal by Subject|4|||
16404614|NCT01574157|39961927|FG001|Overall Study|Withdrawal by Subject|5|||
16404615|NCT01574157|39961926|FG000|Overall Study|Lost to Follow-up|0|||
16404616|NCT01574157|39961927|FG001|Overall Study|Lost to Follow-up|3|||
16404617|NCT00283803|39961928|FG000|Overall Study|Physician Decision|9|||
16404618|NCT00283803|39961928|FG000|Overall Study|Withdrawal by Subject|4|||
16404619|NCT00433160|39961929|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
16404620|NCT00433160|39961930|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
16534732|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
16404621|NCT00433160|39961929|FG000|52-Week Double-Blind (DB) Period|Death|0|||
16534733|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16534734|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
16101571|NCT02123797|38859613|FG004|Baseline Intervention|Other Disease|0|||
16101572|NCT02123797|38859609|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
16101573|NCT02123797|38859610|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
16101574|NCT02123797|38859611|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
16101575|NCT02123797|38859612|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
16101576|NCT02123797|38859613|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
16101577|NCT02123797|38859609|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
16101578|NCT02123797|38859610|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
16101579|NCT02123797|38859611|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
16335300|NCT02326298|39714727|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16335301|NCT02326298|39714728|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16335302|NCT02326298|39714729|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16335303|NCT02326298|39714730|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16335304|NCT02326298|39714731|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16335305|NCT02326298|39714718|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335306|NCT02326298|39714719|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335307|NCT02326298|39714720|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335308|NCT02326298|39714721|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335309|NCT02326298|39714722|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335310|NCT02326298|39714723|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335311|NCT02326298|39714724|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335312|NCT02326298|39714725|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335313|NCT02326298|39714726|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335314|NCT02326298|39714727|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335315|NCT02326298|39714728|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335316|NCT02326298|39714729|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335317|NCT02326298|39714730|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16335318|NCT02326298|39714731|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
16335319|NCT02326298|39714718|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16335320|NCT02326298|39714719|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16335321|NCT02326298|39714720|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16335322|NCT02326298|39714721|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16335323|NCT02326298|39714722|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16335324|NCT02326298|39714723|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16335325|NCT02326298|39714724|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16534735|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
16534736|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16534737|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16534738|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16534739|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16534740|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
16534741|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
16534742|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
16534743|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
16534744|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
16534745|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
16534746|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
16534747|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
16534748|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
16534749|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
16534750|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
16534751|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16534752|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
16534753|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
16534754|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16534755|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16534756|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16534757|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16335326|NCT02326298|39714725|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16335327|NCT02326298|39714726|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16335328|NCT02326298|39714727|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16335329|NCT02326298|39714728|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16335330|NCT02326298|39714729|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
16101580|NCT02123797|38859612|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
16101581|NCT02123797|38859613|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
16101582|NCT02123797|38859609|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
16101583|NCT02123797|38859610|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
16101584|NCT02123797|38859611|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16101585|NCT02123797|38859612|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16101586|NCT02123797|38859613|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16101587|NCT02123797|38859609|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
16101588|NCT02123797|38859610|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
16101589|NCT02123797|38859611|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
16101590|NCT02123797|38859612|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
16101591|NCT02123797|38859613|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
16101592|NCT02123797|38859609|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
16101593|NCT02123797|38859610|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
16101594|NCT02123797|38859611|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
16101595|NCT02123797|38859612|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
16101596|NCT02123797|38859613|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
16101597|NCT02123797|38859609|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
16101598|NCT02123797|38859610|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
16101599|NCT02123797|38859611|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
16101600|NCT02123797|38859612|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
16101601|NCT02123797|38859613|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
16101602|NCT02123797|38859609|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
16101603|NCT02123797|38859610|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
16101604|NCT02123797|38859611|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
16101605|NCT02123797|38859612|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
16101606|NCT02123797|38859613|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
16101607|NCT02123797|38859609|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
16101608|NCT02123797|38859610|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
16101609|NCT02123797|38859611|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16101610|NCT02123797|38859612|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16534758|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
16534759|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
16101611|NCT02123797|38859613|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
16101612|NCT02123797|38859609|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
16101613|NCT02123797|38859610|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
16101614|NCT02123797|38859611|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
16101615|NCT02123797|38859612|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
16101616|NCT02123797|38859613|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
16101617|NCT00907517|38859614|FG000|Overall Study|Progressive Disease|3|||
16101618|NCT00907517|38859615|FG001|Overall Study|Progressive Disease|3|||
16101619|NCT00907517|38859616|FG002|Overall Study|Progressive Disease|4|||
16101620|NCT00907517|38859617|FG003|Overall Study|Progressive Disease|4|||
16101621|NCT00907517|38859618|FG004|Overall Study|Progressive Disease|4|||
16101622|NCT00907517|38859614|FG000|Overall Study|Symptomatic Deterioration|0|||
16101623|NCT00907517|38859615|FG001|Overall Study|Symptomatic Deterioration|0|||
16101624|NCT00907517|38859616|FG002|Overall Study|Symptomatic Deterioration|0|||
16101625|NCT00907517|38859617|FG003|Overall Study|Symptomatic Deterioration|0|||
16101626|NCT00907517|38859618|FG004|Overall Study|Symptomatic Deterioration|1|||
16101627|NCT01514864|38859619|FG000|Overall Study|Disease progression|7|||
16101628|NCT01514864|38859620|FG001|Overall Study|Disease progression|5|||
16101629|NCT01514864|38859619|FG000|Overall Study|Study drug toxicity|2|||
16101630|NCT01514864|38859620|FG001|Overall Study|Study drug toxicity|0|||
16101631|NCT03314233|38859621|FG000|Overall Study|No longer eligible at time of delivery|1|||
16101632|NCT02273180|38859626|FG000|Overall Study|Adverse Event|2|||
16101633|NCT02273180|38859627|FG001|Overall Study|Adverse Event|2|||
16101634|NCT02273180|38859626|FG000|Overall Study|Lack of Efficacy|1|||
16101635|NCT02273180|38859627|FG001|Overall Study|Lack of Efficacy|0|||
16101636|NCT02273180|38859626|FG000|Overall Study|Protocol Violation|1|||
16101637|NCT02273180|38859627|FG001|Overall Study|Protocol Violation|7|||
16101638|NCT02273180|38859626|FG000|Overall Study|Randomized but not treated|1|||
16101639|NCT02273180|38859627|FG001|Overall Study|Randomized but not treated|0|||
16101640|NCT02273180|38859626|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
16101641|NCT02273180|38859627|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
16101642|NCT02273180|38859626|FG000|Overall Study|Other than specified above|21|||
16101643|NCT02273180|38859627|FG001|Overall Study|Other than specified above|10|||
16101644|NCT00645099|38859630|FG000|Overall Study|Lack of Efficacy|15|||
16101645|NCT00645099|38859631|FG001|Overall Study|Lack of Efficacy|6|||
16101646|NCT00645099|38859630|FG000|Overall Study|Withdrawal by Subject|30|||
16101647|NCT00645099|38859631|FG001|Overall Study|Withdrawal by Subject|22|||
16101648|NCT00645099|38859630|FG000|Overall Study|Lost to Follow-up|6|||
16101649|NCT00645099|38859631|FG001|Overall Study|Lost to Follow-up|4|||
16101650|NCT00645099|38859630|FG000|Overall Study|Adverse Event|11|||
16101651|NCT00645099|38859631|FG001|Overall Study|Adverse Event|5|||
16101652|NCT00645099|38859630|FG000|Overall Study|Other|9|||
16101653|NCT00645099|38859631|FG001|Overall Study|Other|5|||
16101654|NCT00727259|38859644|FG000|Overall Study|Not all questionnaires completed|1055|||
16101655|NCT00187135|38859653|FG000|Visit One|Withdrawal by Subject|1|||
16101656|NCT00187135|38859654|FG001|Visit One|Withdrawal by Subject|0|||
16101657|NCT00187135|38859655|FG002|Visit One|Withdrawal by Subject|0|||
16101658|NCT00187135|38859656|FG003|Visit One|Withdrawal by Subject|0|||
16101659|NCT00187135|38859657|FG004|Visit One|Withdrawal by Subject|0|||
16101660|NCT00187135|38859658|FG005|Visit One|Withdrawal by Subject|1|||
16101661|NCT00187135|38859653|FG000|Visit One|Physician Decision|3|||
16101662|NCT00187135|38859654|FG001|Visit One|Physician Decision|1|||
16101663|NCT00187135|38859655|FG002|Visit One|Physician Decision|0|||
16101664|NCT00187135|38859656|FG003|Visit One|Physician Decision|0|||
16101665|NCT00187135|38859657|FG004|Visit One|Physician Decision|0|||
16101666|NCT00187135|38859658|FG005|Visit One|Physician Decision|1|||
16101667|NCT00187135|38859653|FG000|Visit Two|Death|0|||
16101668|NCT00187135|38859654|FG001|Visit Two|Death|0|||
16101669|NCT00187135|38859655|FG002|Visit Two|Death|0|||
16101670|NCT00187135|38859656|FG003|Visit Two|Death|1|||
16101671|NCT00187135|38859657|FG004|Visit Two|Death|0|||
16101672|NCT00187135|38859658|FG005|Visit Two|Death|1|||
16101673|NCT00187135|38859653|FG000|Visit Two|Physician Decision|1|||
16216556|NCT03424044|39272413|FG008|First Intervention (76 Hours)|Adverse Event|0|||
16216557|NCT03424044|39272405|FG000|First Intervention (76 Hours)|device issues|0|||
16216558|NCT03424044|39272406|FG001|First Intervention (76 Hours)|device issues|0|||
16216559|NCT03424044|39272407|FG002|First Intervention (76 Hours)|device issues|0|||
16216560|NCT03424044|39272408|FG003|First Intervention (76 Hours)|device issues|0|||
16216561|NCT03424044|39272409|FG004|First Intervention (76 Hours)|device issues|0|||
16216562|NCT03424044|39272410|FG005|First Intervention (76 Hours)|device issues|0|||
16216563|NCT03424044|39272411|FG006|First Intervention (76 Hours)|device issues|1|||
16216564|NCT03424044|39272412|FG007|First Intervention (76 Hours)|device issues|1|||
16216565|NCT03424044|39272413|FG008|First Intervention (76 Hours)|device issues|1|||
16216566|NCT03424044|39272405|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
16216567|NCT03424044|39272406|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
16216568|NCT03424044|39272407|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
16216569|NCT03424044|39272408|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
16216570|NCT03424044|39272409|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
16216571|NCT03424044|39272410|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
16216572|NCT03424044|39272411|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
16216573|NCT03424044|39272412|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
16216574|NCT03424044|39272413|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
16216575|NCT03424044|39272405|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
16216576|NCT03424044|39272406|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
16216577|NCT03424044|39272407|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
16216578|NCT03424044|39272408|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
16216579|NCT03424044|39272409|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
16216580|NCT03424044|39272410|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
16216581|NCT03424044|39272411|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
16216582|NCT03424044|39272412|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
16216583|NCT03424044|39272413|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
16216584|NCT01266070|39272414|FG000|Overall Study|Adverse Event|3|||
16216585|NCT01266070|39272414|FG000|Overall Study|Protocol Violation|1|||
16216586|NCT03236506|39272415|FG000|Overall Study|Death|1|||
16216587|NCT03236506|39272416|FG001|Overall Study|Death|1|||
16216588|NCT03236506|39272417|FG002|Overall Study|Death|1|||
16216589|NCT03236506|39272415|FG000|Overall Study|Withdrawal by Subject|3|||
16216590|NCT03236506|39272416|FG001|Overall Study|Withdrawal by Subject|3|||
16216591|NCT03236506|39272417|FG002|Overall Study|Withdrawal by Subject|4|||
16216592|NCT03236506|39272415|FG000|Overall Study|Did not initiate treatment|2|||
16216593|NCT03236506|39272416|FG001|Overall Study|Did not initiate treatment|1|||
16335331|NCT02326298|39714730|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
16335332|NCT02326298|39714731|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
16335333|NCT02326298|39714718|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16335334|NCT02326298|39714719|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16335335|NCT02326298|39714720|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16335336|NCT02326298|39714721|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16101674|NCT00187135|38859654|FG001|Visit Two|Physician Decision|0|||
16101675|NCT00187135|38859655|FG002|Visit Two|Physician Decision|0|||
16101676|NCT00187135|38859656|FG003|Visit Two|Physician Decision|0|||
16216594|NCT03236506|39272417|FG002|Overall Study|Did not initiate treatment|2|||
16216595|NCT03452397|39272418|FG000|Overall Study|Adverse Event|1|||
16335337|NCT02326298|39714722|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16335338|NCT02326298|39714723|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16335339|NCT02326298|39714724|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16335340|NCT02326298|39714725|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16335341|NCT02326298|39714726|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16335342|NCT02326298|39714727|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16335343|NCT02326298|39714728|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16335344|NCT02326298|39714729|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
16335345|NCT02326298|39714730|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
16335346|NCT02326298|39714731|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
16335347|NCT02326298|39714718|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335348|NCT02326298|39714719|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335349|NCT02326298|39714720|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335350|NCT02326298|39714721|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335351|NCT02326298|39714722|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335352|NCT02326298|39714723|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335353|NCT02326298|39714724|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335354|NCT02326298|39714725|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335355|NCT02326298|39714726|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335356|NCT02326298|39714727|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335357|NCT02326298|39714728|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16335358|NCT02326298|39714729|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
16335359|NCT02326298|39714730|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
16335360|NCT02326298|39714731|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
16335361|NCT00335959|39714732|FG000|Overall Study|Adverse Event|2|||
16335362|NCT00335959|39714732|FG000|Overall Study|Ineligible|1|||
16335363|NCT03235115|39714740|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
16335364|NCT03235115|39714741|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
16335365|NCT03235115|39714742|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
16335366|NCT03235115|39714743|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
16335367|NCT03235115|39714744|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
16534760|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16101677|NCT00187135|38859657|FG004|Visit Two|Physician Decision|0|||
16101678|NCT00187135|38859658|FG005|Visit Two|Physician Decision|0|||
16101679|NCT00187135|38859653|FG000|Visit Two|Withdrawal by Subject|1|||
16101680|NCT00187135|38859654|FG001|Visit Two|Withdrawal by Subject|1|||
16101681|NCT00187135|38859655|FG002|Visit Two|Withdrawal by Subject|1|||
16101682|NCT00187135|38859656|FG003|Visit Two|Withdrawal by Subject|0|||
16101683|NCT00187135|38859657|FG004|Visit Two|Withdrawal by Subject|1|||
16101684|NCT00187135|38859658|FG005|Visit Two|Withdrawal by Subject|1|||
16101685|NCT00187135|38859653|FG000|Visit Two|Study Discontinued|3|||
16101686|NCT00187135|38859654|FG001|Visit Two|Study Discontinued|2|||
16101687|NCT00187135|38859655|FG002|Visit Two|Study Discontinued|1|||
16101688|NCT00187135|38859656|FG003|Visit Two|Study Discontinued|7|||
16101689|NCT00187135|38859657|FG004|Visit Two|Study Discontinued|5|||
16101690|NCT00187135|38859658|FG005|Visit Two|Study Discontinued|6|||
16101691|NCT00187135|38859653|FG000|Visit Three|Death|0|||
16101692|NCT00187135|38859654|FG001|Visit Three|Death|0|||
16101693|NCT00187135|38859655|FG002|Visit Three|Death|1|||
16101694|NCT00187135|38859656|FG003|Visit Three|Death|0|||
16101695|NCT00187135|38859657|FG004|Visit Three|Death|1|||
16101696|NCT00187135|38859658|FG005|Visit Three|Death|0|||
16101697|NCT00187135|38859653|FG000|Visit Three|Withdrawal by Subject|0|||
16101698|NCT00187135|38859654|FG001|Visit Three|Withdrawal by Subject|1|||
16101699|NCT00187135|38859655|FG002|Visit Three|Withdrawal by Subject|1|||
16101700|NCT00187135|38859656|FG003|Visit Three|Withdrawal by Subject|2|||
16101701|NCT00187135|38859657|FG004|Visit Three|Withdrawal by Subject|0|||
16101702|NCT00187135|38859658|FG005|Visit Three|Withdrawal by Subject|0|||
16101703|NCT00187135|38859653|FG000|Visit Three|Study Discontinued|7|||
16101704|NCT00187135|38859654|FG001|Visit Three|Study Discontinued|6|||
16101705|NCT00187135|38859655|FG002|Visit Three|Study Discontinued|7|||
16101706|NCT00187135|38859656|FG003|Visit Three|Study Discontinued|7|||
16101707|NCT00187135|38859657|FG004|Visit Three|Study Discontinued|7|||
16101708|NCT00187135|38859658|FG005|Visit Three|Study Discontinued|6|||
16101709|NCT00809783|38859659|FG000|Overall Study|Death|1|||
16101710|NCT00809783|38859660|FG001|Overall Study|Death|0|||
16101711|NCT00809783|38859661|FG002|Overall Study|Death|0|||
16101712|NCT00809783|38859659|FG000|Overall Study|Adverse Event|34|||
16101713|NCT00809783|38859660|FG001|Overall Study|Adverse Event|52|||
16101714|NCT00809783|38859661|FG002|Overall Study|Adverse Event|71|||
16101715|NCT00809783|38859659|FG000|Overall Study|Lack of Efficacy|39|||
16101716|NCT00809783|38859660|FG001|Overall Study|Lack of Efficacy|52|||
16101717|NCT00809783|38859661|FG002|Overall Study|Lack of Efficacy|63|||
16101718|NCT00809783|38859659|FG000|Overall Study|Lost to Follow-up|0|||
16216596|NCT03452397|39272419|FG001|Overall Study|Adverse Event|0|||
16216597|NCT03452397|39272420|FG002|Overall Study|Adverse Event|0|||
16216598|NCT03452397|39272421|FG003|Overall Study|Adverse Event|0|||
16216599|NCT03452397|39272418|FG000|Overall Study|Administrative reason|0|||
16216600|NCT03452397|39272419|FG001|Overall Study|Administrative reason|0|||
16216601|NCT03452397|39272420|FG002|Overall Study|Administrative reason|1|||
16216602|NCT03452397|39272421|FG003|Overall Study|Administrative reason|1|||
16216603|NCT03452397|39272418|FG000|Overall Study|Withdrawal by Subject|0|||
16216604|NCT03452397|39272419|FG001|Overall Study|Withdrawal by Subject|0|||
16216605|NCT03452397|39272420|FG002|Overall Study|Withdrawal by Subject|1|||
16216606|NCT03452397|39272421|FG003|Overall Study|Withdrawal by Subject|0|||
16101719|NCT00809783|38859660|FG001|Overall Study|Lost to Follow-up|3|||
16101720|NCT00809783|38859661|FG002|Overall Study|Lost to Follow-up|4|||
16101721|NCT00809783|38859659|FG000|Overall Study|Withdrawal by Subject|47|||
16101722|NCT00809783|38859660|FG001|Overall Study|Withdrawal by Subject|72|||
16101723|NCT00809783|38859661|FG002|Overall Study|Withdrawal by Subject|64|||
16101724|NCT00809783|38859659|FG000|Overall Study|Protocol Violation|2|||
16101725|NCT00809783|38859660|FG001|Overall Study|Protocol Violation|6|||
16101726|NCT00809783|38859661|FG002|Overall Study|Protocol Violation|5|||
16101727|NCT00809783|38859659|FG000|Overall Study|Randomized, but not treated|3|||
16101728|NCT00809783|38859660|FG001|Overall Study|Randomized, but not treated|0|||
16101729|NCT00809783|38859661|FG002|Overall Study|Randomized, but not treated|2|||
16101730|NCT00809783|38859659|FG000|Overall Study|Study Terminated by Sponsor|378|||
16101731|NCT00809783|38859660|FG001|Overall Study|Study Terminated by Sponsor|626|||
16101732|NCT00809783|38859661|FG002|Overall Study|Study Terminated by Sponsor|565|||
16101733|NCT00809783|38859659|FG000|Overall Study|Other|21|||
16101734|NCT00809783|38859660|FG001|Overall Study|Other|21|||
16101735|NCT00809783|38859661|FG002|Overall Study|Other|16|||
16101736|NCT02775214|38859662|FG000|Overall Study|Withdrawal by Subject|2|||
16101737|NCT02775214|38859663|FG001|Overall Study|Withdrawal by Subject|0|||
16101738|NCT03802513|38859668|FG000|Overall Study|Lost to Follow-up|1|||
16101739|NCT02598934|38859669|FG000|Overall Study|Adverse Event|11|||
16101740|NCT02598934|38859670|FG001|Overall Study|Adverse Event|13|||
16101741|NCT02598934|38859669|FG000|Overall Study|Failure to Return|3|||
16101742|NCT02598934|38859670|FG001|Overall Study|Failure to Return|3|||
16101743|NCT02598934|38859669|FG000|Overall Study|Withdrawal by Subject|2|||
16101744|NCT02598934|38859670|FG001|Overall Study|Withdrawal by Subject|3|||
16101745|NCT02598934|38859669|FG000|Overall Study|Administrative|2|||
16101746|NCT02598934|38859670|FG001|Overall Study|Administrative|1|||
16101747|NCT02598934|38859669|FG000|Overall Study|Protocol Violation|1|||
16101748|NCT02598934|38859670|FG001|Overall Study|Protocol Violation|2|||
16101749|NCT03120949|38859675|FG000|Overall Study|randomized in error|1|||
16101750|NCT03120949|38859676|FG001|Overall Study|randomized in error|0|||
16101751|NCT03120949|38859675|FG000|Overall Study|Death|13|||
16216607|NCT02005211|39272423|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16101752|NCT03120949|38859676|FG001|Overall Study|Death|13|||
16101753|NCT03120949|38859675|FG000|Overall Study|Lost to Follow-up|23|||
16101754|NCT03120949|38859676|FG001|Overall Study|Lost to Follow-up|13|||
16101755|NCT03120949|38859675|FG000|Overall Study|Withdrawal by Subject|139|||
16101756|NCT03120949|38859676|FG001|Overall Study|Withdrawal by Subject|124|||
16101757|NCT03120949|38859675|FG000|Overall Study|Covid-19|43|||
16101758|NCT03120949|38859676|FG001|Overall Study|Covid-19|34|||
16101759|NCT03120949|38859675|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
16101760|NCT03120949|38859676|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
16101761|NCT03120949|38859675|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
16101762|NCT03120949|38859676|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
16101763|NCT03120949|38859675|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
16101764|NCT03120949|38859676|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
16101765|NCT03120949|38859675|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
16101766|NCT03120949|38859676|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
16101767|NCT03120949|38859675|FG000|Overall Study|Site was closed|2|||
16101768|NCT03120949|38859676|FG001|Overall Study|Site was closed|3|||
16101769|NCT03120949|38859675|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
16101770|NCT03120949|38859676|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
16101771|NCT03120949|38859675|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
16101772|NCT03120949|38859676|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
16101773|NCT03120949|38859675|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
16101774|NCT03120949|38859676|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
16101775|NCT03120949|38859675|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
16101776|NCT03120949|38859676|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
16101777|NCT03120949|38859675|FG000|Overall Study|Other: Adverse Event|0|||
16101778|NCT03120949|38859676|FG001|Overall Study|Other: Adverse Event|1|||
16101779|NCT03120949|38859675|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
16101780|NCT03120949|38859676|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
16101781|NCT03120949|38859675|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
16101782|NCT03120949|38859676|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
16101783|NCT03120949|38859675|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
16101784|NCT03120949|38859676|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
16101785|NCT03120949|38859675|FG000|Overall Study|Personal Reasons|0|||
16101786|NCT03120949|38859676|FG001|Overall Study|Personal Reasons|1|||
16101787|NCT03120949|38859675|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
16101788|NCT03120949|38859676|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
16101789|NCT03120949|38859675|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
16101790|NCT03120949|38859676|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
16101791|NCT03120949|38859675|FG000|Overall Study|Compliance With Medication|0|||
16101792|NCT03120949|38859676|FG001|Overall Study|Compliance With Medication|1|||
16335368|NCT03235115|39714745|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
16335369|NCT03970200|39714746|FG000|Overall Study|Death|2|||
16335370|NCT03970200|39714747|FG001|Overall Study|Death|2|||
16335371|NCT03970200|39714748|FG002|Overall Study|Death|1|||
16335372|NCT03970200|39714746|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
16335373|NCT03970200|39714747|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
16335374|NCT03970200|39714748|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
16335375|NCT03796676|39714750|FG000|Overall Study|Adverse Event|2|||
16335376|NCT03796676|39714751|FG001|Overall Study|Adverse Event|1|||
16335377|NCT03796676|39714752|FG002|Overall Study|Adverse Event|2|||
16335378|NCT03796676|39714750|FG000|Overall Study|Lost to Follow-up|2|||
16335379|NCT03796676|39714751|FG001|Overall Study|Lost to Follow-up|1|||
16335380|NCT03796676|39714752|FG002|Overall Study|Lost to Follow-up|0|||
16335381|NCT03796676|39714750|FG000|Overall Study|Protocol Violation|0|||
16335382|NCT03796676|39714751|FG001|Overall Study|Protocol Violation|0|||
16534761|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
16534762|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
16534763|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16534764|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16534765|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16534766|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
16534767|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
16534768|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
16404622|NCT00433160|39961930|FG001|52-Week Double-Blind (DB) Period|Death|0|||
16404623|NCT00433160|39961929|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
16101793|NCT03120949|38859675|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
16101794|NCT03120949|38859676|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
16101795|NCT03120949|38859675|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
16101796|NCT03120949|38859676|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
16101797|NCT03120949|38859675|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
16101798|NCT03120949|38859676|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
16101799|NCT05600036|38859677|FG000|Overall Study|Adverse Event|0|||
16101800|NCT05600036|38859678|FG001|Overall Study|Adverse Event|2|||
16404624|NCT00433160|39961930|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
16404625|NCT00433160|39961929|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
16404626|NCT00433160|39961930|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
16404627|NCT00433160|39961929|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
16404628|NCT00433160|39961930|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
16534769|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16216608|NCT02005211|39272424|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16216609|NCT02005211|39272425|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16335383|NCT03796676|39714752|FG002|Overall Study|Protocol Violation|1|||
16335384|NCT03796676|39714750|FG000|Overall Study|Withdrawal by Subject|1|||
16335385|NCT03796676|39714751|FG001|Overall Study|Withdrawal by Subject|1|||
16335386|NCT03796676|39714752|FG002|Overall Study|Withdrawal by Subject|0|||
16335387|NCT03796676|39714750|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
16335388|NCT03796676|39714751|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
16335389|NCT03796676|39714752|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
16335390|NCT01714609|39714757|FG000|Overall Study|Protocol Violation|1|||
16335391|NCT01714609|39714758|FG001|Overall Study|Protocol Violation|0|||
16335392|NCT02457832|39714759|FG000|Training|Lost to Follow-up|10|||
16335393|NCT02457832|39714760|FG001|Training|Lost to Follow-up|6|||
16335394|NCT02457832|39714761|FG002|Training|Lost to Follow-up|3|||
16335395|NCT02457832|39714759|FG000|One Month Washout|Lost to Follow-up|0|||
16335396|NCT02457832|39714760|FG001|One Month Washout|Lost to Follow-up|1|||
16335397|NCT02457832|39714761|FG002|One Month Washout|Lost to Follow-up|1|||
16335398|NCT00431067|39714765|FG000|Overall Study|Other Adverse Event|9|||
16335399|NCT00431067|39714765|FG000|Overall Study|Progressive disease|30|||
16335400|NCT00431067|39714765|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
16335401|NCT01094782|39714766|FG000|Overall Study|Withdrawal by Subject|5|||
16335402|NCT01094782|39714767|FG001|Overall Study|Withdrawal by Subject|5|||
16335403|NCT01094782|39714768|FG002|Overall Study|Withdrawal by Subject|1|||
16335404|NCT01094782|39714769|FG003|Overall Study|Withdrawal by Subject|5|||
16335405|NCT01094782|39714770|FG004|Overall Study|Withdrawal by Subject|5|||
16335406|NCT01094782|39714771|FG005|Overall Study|Withdrawal by Subject|0|||
16335407|NCT01094782|39714766|FG000|Overall Study|Lost to Follow-up|1|||
16335408|NCT01094782|39714767|FG001|Overall Study|Lost to Follow-up|0|||
16335409|NCT01094782|39714768|FG002|Overall Study|Lost to Follow-up|0|||
16335410|NCT01094782|39714769|FG003|Overall Study|Lost to Follow-up|2|||
16335411|NCT01094782|39714770|FG004|Overall Study|Lost to Follow-up|1|||
16335412|NCT01094782|39714771|FG005|Overall Study|Lost to Follow-up|4|||
16335413|NCT01094782|39714766|FG000|Overall Study|Positive Drug Screen|2|||
16335414|NCT01094782|39714767|FG001|Overall Study|Positive Drug Screen|2|||
16335415|NCT01094782|39714768|FG002|Overall Study|Positive Drug Screen|1|||
16335416|NCT01094782|39714769|FG003|Overall Study|Positive Drug Screen|1|||
16335417|NCT01094782|39714770|FG004|Overall Study|Positive Drug Screen|3|||
16335418|NCT01094782|39714771|FG005|Overall Study|Positive Drug Screen|2|||
16335419|NCT01094782|39714766|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
16335420|NCT01094782|39714767|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
16335421|NCT01094782|39714768|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
16335422|NCT01094782|39714769|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
16335423|NCT01094782|39714770|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
16335424|NCT01094782|39714771|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
16335425|NCT01094782|39714766|FG000|Overall Study|Unable to Complete Questionnaires|0|||
16335426|NCT01094782|39714767|FG001|Overall Study|Unable to Complete Questionnaires|1|||
16335427|NCT01094782|39714768|FG002|Overall Study|Unable to Complete Questionnaires|0|||
16335428|NCT01094782|39714769|FG003|Overall Study|Unable to Complete Questionnaires|0|||
16335429|NCT01094782|39714770|FG004|Overall Study|Unable to Complete Questionnaires|0|||
16335430|NCT01094782|39714771|FG005|Overall Study|Unable to Complete Questionnaires|0|||
16335431|NCT01094782|39714766|FG000|Overall Study|Healthy Subject Had Pain|0|||
16335432|NCT01094782|39714767|FG001|Overall Study|Healthy Subject Had Pain|1|||
16335433|NCT01094782|39714768|FG002|Overall Study|Healthy Subject Had Pain|0|||
16335434|NCT01094782|39714769|FG003|Overall Study|Healthy Subject Had Pain|0|||
16335435|NCT01094782|39714770|FG004|Overall Study|Healthy Subject Had Pain|0|||
16335436|NCT01094782|39714771|FG005|Overall Study|Healthy Subject Had Pain|0|||
16335437|NCT01094782|39714766|FG000|Overall Study|Hypertension|0|||
16335438|NCT01094782|39714767|FG001|Overall Study|Hypertension|0|||
16335439|NCT01094782|39714768|FG002|Overall Study|Hypertension|1|||
16335440|NCT01094782|39714769|FG003|Overall Study|Hypertension|0|||
16335441|NCT01094782|39714770|FG004|Overall Study|Hypertension|0|||
16335442|NCT01094782|39714771|FG005|Overall Study|Hypertension|0|||
16335443|NCT01094782|39714766|FG000|Overall Study|Wrong Pain Condition|0|||
16335444|NCT01094782|39714767|FG001|Overall Study|Wrong Pain Condition|0|||
16534770|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
16335445|NCT01094782|39714768|FG002|Overall Study|Wrong Pain Condition|0|||
16335446|NCT01094782|39714769|FG003|Overall Study|Wrong Pain Condition|2|||
16335447|NCT01094782|39714770|FG004|Overall Study|Wrong Pain Condition|1|||
16335448|NCT01094782|39714771|FG005|Overall Study|Wrong Pain Condition|1|||
16335449|NCT01094782|39714766|FG000|Overall Study|Recent Interventional Injection|0|||
16335450|NCT01094782|39714767|FG001|Overall Study|Recent Interventional Injection|0|||
16335451|NCT01094782|39714768|FG002|Overall Study|Recent Interventional Injection|0|||
16335452|NCT01094782|39714769|FG003|Overall Study|Recent Interventional Injection|0|||
16335453|NCT01094782|39714770|FG004|Overall Study|Recent Interventional Injection|0|||
16335454|NCT01094782|39714771|FG005|Overall Study|Recent Interventional Injection|1|||
16335455|NCT01094782|39714766|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
16335456|NCT01094782|39714767|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
16335457|NCT01094782|39714768|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
16335458|NCT01094782|39714769|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
16404629|NCT00433160|39961929|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
16404630|NCT00433160|39961930|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
16404631|NCT00433160|39961929|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
16404632|NCT00433160|39961930|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
16404633|NCT00433160|39961929|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
16404634|NCT00433160|39961930|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
16404635|NCT00433160|39961929|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
16404636|NCT00433160|39961930|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
16335459|NCT01094782|39714770|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
16335460|NCT01094782|39714771|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
16335461|NCT01094782|39714766|FG000|Overall Study|Noncompliance With Study Schedule|0|||
16335462|NCT01094782|39714767|FG001|Overall Study|Noncompliance With Study Schedule|0|||
16335463|NCT01094782|39714768|FG002|Overall Study|Noncompliance With Study Schedule|0|||
16335464|NCT01094782|39714769|FG003|Overall Study|Noncompliance With Study Schedule|1|||
16335465|NCT01094782|39714770|FG004|Overall Study|Noncompliance With Study Schedule|0|||
16335466|NCT01094782|39714771|FG005|Overall Study|Noncompliance With Study Schedule|0|||
16335467|NCT03885999|39714774|FG000|Overall Study|Adverse Event|1|||
16335468|NCT00723697|39714775|FG000|Overall Study|Physician questionnaires not received|2|||
16335469|NCT00723697|39714775|FG000|Overall Study|Missing Informed Consent Form|10|||
16335470|NCT00723697|39714775|FG000|Overall Study|Other exclusion criteria applied|6|||
16335471|NCT03391232|39714776|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
16335472|NCT03391232|39714777|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
16335473|NCT03391232|39714776|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
16335474|NCT03391232|39714777|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
16335475|NCT02735096|39714781|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
16335476|NCT02907619|39714789|FG000|Overall Study|Study terminated by sponsor|18|||
16335477|NCT02907619|39714790|FG001|Overall Study|Study terminated by sponsor|18|||
16335478|NCT02907619|39714791|FG002|Overall Study|Study terminated by sponsor|19|||
16335479|NCT02907619|39714789|FG000|Overall Study|Death|0|||
16335480|NCT02907619|39714790|FG001|Overall Study|Death|0|||
16335481|NCT02907619|39714791|FG002|Overall Study|Death|1|||
16404637|NCT00433160|39961929|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
16404638|NCT00433160|39961930|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
16404639|NCT00433160|39961929|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
16404640|NCT00433160|39961930|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
16404641|NCT00433160|39961929|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
16404642|NCT00433160|39961930|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
16404643|NCT00433160|39961929|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
16216610|NCT02005211|39272426|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16335482|NCT02907619|39714789|FG000|Overall Study|Withdrawal by Subject|1|||
16404644|NCT00433160|39961930|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
16404645|NCT00433160|39961929|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
16404646|NCT00433160|39961930|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
16404647|NCT00433160|39961929|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
16404648|NCT00433160|39961930|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
16404649|NCT00433160|39961929|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
16404650|NCT00433160|39961930|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
16404651|NCT02750345|39961933|FG000|Intervention 1|Adverse Event|0|||
16404652|NCT02750345|39961934|FG001|Intervention 1|Adverse Event|0|||
16335483|NCT02907619|39714790|FG001|Overall Study|Withdrawal by Subject|1|||
16335484|NCT02907619|39714791|FG002|Overall Study|Withdrawal by Subject|0|||
16335485|NCT02907619|39714789|FG000|Overall Study|Other|0|||
16335486|NCT02907619|39714790|FG001|Overall Study|Other|1|||
16335487|NCT02907619|39714791|FG002|Overall Study|Other|0|||
16404653|NCT02750345|39961935|FG002|Intervention 1|Adverse Event|0|||
16404654|NCT02750345|39961936|FG003|Intervention 1|Adverse Event|0|||
16404655|NCT02750345|39961937|FG004|Intervention 1|Adverse Event|1|||
16404656|NCT02750345|39961938|FG005|Intervention 1|Adverse Event|0|||
16404657|NCT02752958|39961939|FG000|Overall Study|Adverse Event|3|||
16404658|NCT02752958|39961939|FG000|Overall Study|Lost to Follow-up|1|||
16404659|NCT02752958|39961939|FG000|Overall Study|Protocol Violation|1|||
16404660|NCT02752958|39961939|FG000|Overall Study|Withdrawal by Subject|2|||
16404661|NCT02752958|39961939|FG000|Overall Study|Other (Reason not specified)|2|||
16404662|NCT03500172|39961940|FG000|Period 1: Baseline Randomization|Death|0|||
16404663|NCT03500172|39961941|FG001|Period 1: Baseline Randomization|Death|0|||
16404664|NCT03500172|39961942|FG002|Period 1: Baseline Randomization|Death|0|||
16335488|NCT01926197|39714794|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
16335489|NCT01926197|39714795|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
16335490|NCT01926197|39714794|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
16335491|NCT01926197|39714795|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
16335492|NCT03301740|39714797|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
16335493|NCT03301740|39714798|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
16335494|NCT03301740|39714797|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
16335495|NCT03301740|39714798|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
16335496|NCT03611582|39714803|FG000|Overall Study|Adverse Event|26|||
16335497|NCT03611582|39714804|FG001|Overall Study|Adverse Event|6|||
16335498|NCT03611582|39714803|FG000|Overall Study|Protocol Violation|0|||
16335499|NCT03611582|39714804|FG001|Overall Study|Protocol Violation|1|||
16335500|NCT03611582|39714803|FG000|Overall Study|Pregnancy|1|||
16335501|NCT03611582|39714804|FG001|Overall Study|Pregnancy|2|||
16335502|NCT03611582|39714803|FG000|Overall Study|Lack of Efficacy|0|||
16404665|NCT03500172|39961943|FG003|Period 1: Baseline Randomization|Death|0|||
16404666|NCT03500172|39961944|FG004|Period 1: Baseline Randomization|Death|0|||
16101801|NCT05600036|38859679|FG002|Overall Study|Adverse Event|1|||
16101802|NCT05600036|38859680|FG003|Overall Study|Adverse Event|0|||
16101803|NCT05600036|38859681|FG004|Overall Study|Adverse Event|1|||
16101804|NCT05600036|38859682|FG005|Overall Study|Adverse Event|0|||
16101805|NCT05600036|38859677|FG000|Overall Study|Lost to Follow-up|0|||
16101806|NCT05600036|38859678|FG001|Overall Study|Lost to Follow-up|2|||
16101807|NCT05600036|38859679|FG002|Overall Study|Lost to Follow-up|1|||
16101808|NCT05600036|38859680|FG003|Overall Study|Lost to Follow-up|1|||
16404667|NCT03500172|39961945|FG005|Period 1: Baseline Randomization|Death|0|||
16101809|NCT05600036|38859681|FG004|Overall Study|Lost to Follow-up|0|||
16101810|NCT05600036|38859682|FG005|Overall Study|Lost to Follow-up|0|||
16101811|NCT05600036|38859677|FG000|Overall Study|Protocol Violation|0|||
16101812|NCT05600036|38859678|FG001|Overall Study|Protocol Violation|0|||
16101813|NCT05600036|38859679|FG002|Overall Study|Protocol Violation|2|||
16101814|NCT05600036|38859680|FG003|Overall Study|Protocol Violation|0|||
16101815|NCT05600036|38859681|FG004|Overall Study|Protocol Violation|0|||
16101816|NCT05600036|38859682|FG005|Overall Study|Protocol Violation|0|||
16101817|NCT05600036|38859677|FG000|Overall Study|Withdrawal by Subject|0|||
16101818|NCT05600036|38859678|FG001|Overall Study|Withdrawal by Subject|1|||
16101819|NCT05600036|38859679|FG002|Overall Study|Withdrawal by Subject|2|||
16101820|NCT05600036|38859680|FG003|Overall Study|Withdrawal by Subject|0|||
16101821|NCT05600036|38859681|FG004|Overall Study|Withdrawal by Subject|3|||
16101822|NCT05600036|38859682|FG005|Overall Study|Withdrawal by Subject|5|||
16101823|NCT05600036|38859677|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
16101824|NCT05600036|38859678|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
16101825|NCT05600036|38859679|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
16404668|NCT03500172|39961946|FG006|Period 1: Baseline Randomization|Death|0|||
16404669|NCT03500172|39961947|FG007|Period 1: Baseline Randomization|Death|0|||
16404670|NCT03500172|39961948|FG008|Period 1: Baseline Randomization|Death|0|||
16404671|NCT03500172|39961949|FG009|Period 1: Baseline Randomization|Death|2|||
16404672|NCT03500172|39961950|FG010|Period 1: Baseline Randomization|Death|0|||
16404673|NCT03500172|39961940|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
16404674|NCT03500172|39961941|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
16404675|NCT03500172|39961942|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
16404676|NCT03500172|39961943|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
16404677|NCT03500172|39961944|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
16101826|NCT05600036|38859680|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
16335503|NCT03611582|39714804|FG001|Overall Study|Lack of Efficacy|1|||
16335504|NCT03611582|39714803|FG000|Overall Study|At the discretion of the investigator|1|||
16335505|NCT03611582|39714804|FG001|Overall Study|At the discretion of the investigator|0|||
16404678|NCT03500172|39961945|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
16404679|NCT03500172|39961946|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
16404680|NCT03500172|39961947|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
16404681|NCT03500172|39961948|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
16404682|NCT03500172|39961949|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
16404683|NCT03500172|39961950|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
16101827|NCT05600036|38859681|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
16101828|NCT05600036|38859682|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
16101829|NCT05600036|38859677|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
16335506|NCT03611582|39714803|FG000|Overall Study|Safety concern as judged by the investigator|1|||
16335507|NCT03611582|39714804|FG001|Overall Study|Safety concern as judged by the investigator|2|||
16335508|NCT03611582|39714803|FG000|Overall Study|Withdrawal by Subject|4|||
16335509|NCT03611582|39714804|FG001|Overall Study|Withdrawal by Subject|3|||
16335510|NCT03611582|39714803|FG000|Overall Study|Lost to Follow-up|18|||
16335511|NCT03611582|39714804|FG001|Overall Study|Lost to Follow-up|7|||
16335512|NCT03611582|39714803|FG000|Overall Study|other|17|||
16335513|NCT03611582|39714804|FG001|Overall Study|other|16|||
16335514|NCT00441363|39714805|FG000|Overall Study|Adverse Event|4|||
16534771|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
16534772|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16534773|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16534774|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16534775|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
16534776|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
16534777|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
16534778|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16534779|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
16534780|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
16335515|NCT00441363|39714806|FG001|Overall Study|Adverse Event|2|||
16335516|NCT00441363|39714805|FG000|Overall Study|Withdrawal by Subject|3|||
16335517|NCT00441363|39714806|FG001|Overall Study|Withdrawal by Subject|4|||
16335518|NCT00441363|39714805|FG000|Overall Study|Physician Decision|6|||
16335519|NCT00441363|39714806|FG001|Overall Study|Physician Decision|7|||
16335520|NCT00441363|39714805|FG000|Overall Study|Lost to Follow-up|2|||
16335521|NCT00441363|39714806|FG001|Overall Study|Lost to Follow-up|2|||
16335522|NCT00441363|39714805|FG000|Overall Study|Other|2|||
16335523|NCT00441363|39714806|FG001|Overall Study|Other|0|||
16335524|NCT00741091|39714807|FG000|Overall Study|Death|13|||
16335525|NCT00741091|39714807|FG000|Overall Study|Lost to Follow-up|16|||
16335526|NCT00741091|39714807|FG000|Overall Study|Withdrawal by Subject|6|||
16101830|NCT05600036|38859678|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
16101831|NCT05600036|38859679|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
16101832|NCT05600036|38859680|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
16101833|NCT05600036|38859681|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
16101834|NCT05600036|38859682|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
16101835|NCT05600036|38859677|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
16101836|NCT05600036|38859678|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
16101837|NCT05600036|38859679|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
16101838|NCT05600036|38859680|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
16101839|NCT05600036|38859681|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
16101840|NCT05600036|38859682|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
16101841|NCT04393779|38859683|FG000|Overall Study|Death|1|||
16101842|NCT04393779|38859683|FG000|Overall Study|Device reintervention or explant|4|||
16101843|NCT01126879|38859684|FG000|Overall Study|Progressive Disease|3|||
16101844|NCT01126879|38859685|FG001|Overall Study|Progressive Disease|1|||
16101845|NCT01126879|38859684|FG000|Overall Study|Withdrawal by Subject|1|||
16101846|NCT01126879|38859685|FG001|Overall Study|Withdrawal by Subject|0|||
16101847|NCT01126879|38859684|FG000|Overall Study|Adverse Event|0|||
16101848|NCT01126879|38859685|FG001|Overall Study|Adverse Event|1|||
16101849|NCT01126879|38859684|FG000|Overall Study|Physician Decision|1|||
16101850|NCT01126879|38859685|FG001|Overall Study|Physician Decision|0|||
16101851|NCT02250183|38859686|FG000|Overall Study|Withdrawal by Subject|2|||
16101852|NCT02250183|38859686|FG000|Overall Study|Adverse Event|5|||
16101853|NCT02250183|38859686|FG000|Overall Study|Lost to Follow-up|1|||
16101854|NCT03360071|38859687|FG000|Overall Study|Lost to Follow-up|1|||
16101855|NCT03360071|38859688|FG001|Overall Study|Lost to Follow-up|0|||
16101856|NCT03927222|38859690|FG000|Overall Study|Progression|3|||
16101857|NCT03927222|38859690|FG000|Overall Study|CMV testing results inconclusive|1|||
16534781|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16534782|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16534783|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16534784|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16335527|NCT00741091|39714807|FG000|Overall Study|Missed Visit|22|||
16335528|NCT03338569|39714808|FG000|Overall Study|Physician Decision|8|||
16335529|NCT03338569|39714809|FG001|Overall Study|Physician Decision|3|||
16534785|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
16101858|NCT03927222|38859690|FG000|Overall Study|Unable to generate enough vaccines|1|||
16335530|NCT03338569|39714808|FG000|Overall Study|Withdrawal by Subject|0|||
16335531|NCT03338569|39714809|FG001|Overall Study|Withdrawal by Subject|1|||
16335532|NCT03338569|39714808|FG000|Overall Study|Lost to Follow-up|0|||
16335533|NCT03338569|39714809|FG001|Overall Study|Lost to Follow-up|1|||
16335534|NCT00574249|39714810|FG000|Overall Study|Adverse Event|6|||
16335535|NCT00574249|39714811|FG001|Overall Study|Adverse Event|18|||
16335536|NCT00574249|39714810|FG000|Overall Study|Lack of Efficacy|5|||
16335537|NCT00574249|39714811|FG001|Overall Study|Lack of Efficacy|3|||
16335538|NCT00574249|39714810|FG000|Overall Study|Lost to Follow-up|4|||
16335539|NCT00574249|39714811|FG001|Overall Study|Lost to Follow-up|3|||
16335540|NCT00574249|39714810|FG000|Overall Study|Protocol Violation|5|||
16335541|NCT00574249|39714811|FG001|Overall Study|Protocol Violation|2|||
16335542|NCT00574249|39714810|FG000|Overall Study|History of carcinoma|1|||
16335543|NCT00574249|39714811|FG001|Overall Study|History of carcinoma|0|||
16335544|NCT00574249|39714810|FG000|Overall Study|Withdrawal by Subject|3|||
16335545|NCT00574249|39714811|FG001|Overall Study|Withdrawal by Subject|0|||
16335546|NCT00574249|39714810|FG000|Overall Study|Physician Decision|1|||
16335547|NCT00574249|39714811|FG001|Overall Study|Physician Decision|0|||
16335548|NCT00574249|39714810|FG000|Overall Study|Pregnancy|1|||
16335549|NCT00574249|39714811|FG001|Overall Study|Pregnancy|0|||
16335550|NCT00574249|39714810|FG000|Overall Study|Excluded by company|0|||
16335551|NCT00574249|39714811|FG001|Overall Study|Excluded by company|1|||
16335552|NCT00574249|39714810|FG000|Overall Study|PPD test taken twice|0|||
16335553|NCT00574249|39714811|FG001|Overall Study|PPD test taken twice|1|||
16335554|NCT00636961|39714812|FG000|Period 1|Administrative problems|1|||
16335555|NCT00636961|39714813|FG001|Period 1|Administrative problems|1|||
16335556|NCT00636961|39714812|FG000|Period 2|Adverse Event|1|||
16335557|NCT00636961|39714813|FG001|Period 2|Adverse Event|0|||
16335558|NCT03420222|39714814|FG000|Overall Study|Withdrawal by Subject|5|||
16335559|NCT03420222|39714815|FG001|Overall Study|Withdrawal by Subject|0|||
16335560|NCT03420222|39714814|FG000|Overall Study|Physician Decision|0|||
16335561|NCT03420222|39714815|FG001|Overall Study|Physician Decision|1|||
16335562|NCT03092791|39714817|FG000|Overall Study|Lost to Follow-up|0|||
16335563|NCT03092791|39714818|FG001|Overall Study|Lost to Follow-up|0|||
16335564|NCT03092791|39714819|FG002|Overall Study|Lost to Follow-up|0|||
16335565|NCT03092791|39714820|FG003|Overall Study|Lost to Follow-up|0|||
16335566|NCT03092791|39714821|FG004|Overall Study|Lost to Follow-up|0|||
16335567|NCT03092791|39714822|FG005|Overall Study|Lost to Follow-up|0|||
16335568|NCT03092791|39714823|FG006|Overall Study|Lost to Follow-up|1|||
16335569|NCT03092791|39714824|FG007|Overall Study|Lost to Follow-up|0|||
16335570|NCT03092791|39714817|FG000|Overall Study|Withdrawal of Consent|0|||
16335571|NCT03092791|39714818|FG001|Overall Study|Withdrawal of Consent|0|||
16335572|NCT03092791|39714819|FG002|Overall Study|Withdrawal of Consent|0|||
16335573|NCT03092791|39714820|FG003|Overall Study|Withdrawal of Consent|0|||
16335574|NCT03092791|39714821|FG004|Overall Study|Withdrawal of Consent|4|||
16335575|NCT03092791|39714822|FG005|Overall Study|Withdrawal of Consent|12|||
16335576|NCT03092791|39714823|FG006|Overall Study|Withdrawal of Consent|6|||
16335577|NCT03092791|39714824|FG007|Overall Study|Withdrawal of Consent|4|||
16335578|NCT03092791|39714817|FG000|Overall Study|Study Termination|0|||
16335579|NCT03092791|39714818|FG001|Overall Study|Study Termination|0|||
16335580|NCT03092791|39714819|FG002|Overall Study|Study Termination|0|||
16335581|NCT03092791|39714820|FG003|Overall Study|Study Termination|0|||
16335582|NCT03092791|39714821|FG004|Overall Study|Study Termination|55|||
16335583|NCT03092791|39714822|FG005|Overall Study|Study Termination|46|||
16335584|NCT03092791|39714823|FG006|Overall Study|Study Termination|53|||
16335585|NCT03092791|39714824|FG007|Overall Study|Study Termination|55|||
16335586|NCT03092791|39714817|FG000|Overall Study|Death|0|||
16335587|NCT03092791|39714818|FG001|Overall Study|Death|0|||
16335588|NCT03092791|39714819|FG002|Overall Study|Death|0|||
16335589|NCT03092791|39714820|FG003|Overall Study|Death|0|||
16335590|NCT03092791|39714821|FG004|Overall Study|Death|0|||
16335591|NCT03092791|39714822|FG005|Overall Study|Death|1|||
16335592|NCT03092791|39714823|FG006|Overall Study|Death|0|||
16335593|NCT03092791|39714824|FG007|Overall Study|Death|1|||
16335594|NCT03092791|39714817|FG000|Overall Study|Reason Not Specified|0|||
16335595|NCT03092791|39714818|FG001|Overall Study|Reason Not Specified|0|||
16335596|NCT03092791|39714819|FG002|Overall Study|Reason Not Specified|0|||
16335597|NCT03092791|39714820|FG003|Overall Study|Reason Not Specified|0|||
16335598|NCT03092791|39714821|FG004|Overall Study|Reason Not Specified|1|||
16335599|NCT03092791|39714822|FG005|Overall Study|Reason Not Specified|1|||
16335600|NCT03092791|39714823|FG006|Overall Study|Reason Not Specified|0|||
16335601|NCT03092791|39714824|FG007|Overall Study|Reason Not Specified|0|||
16335602|NCT00528372|39714825|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
16335603|NCT00528372|39714826|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
16335604|NCT00528372|39714827|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
16335605|NCT00528372|39714828|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
16335606|NCT00528372|39714829|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
16335607|NCT00528372|39714830|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
16335608|NCT00528372|39714831|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
16335609|NCT00528372|39714832|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
16335610|NCT00528372|39714833|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
16335611|NCT00528372|39714825|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
16335612|NCT00528372|39714826|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
16335613|NCT00528372|39714827|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
16335614|NCT00528372|39714828|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
16335615|NCT00528372|39714829|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
16335616|NCT00528372|39714830|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
16335617|NCT00528372|39714831|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
16335618|NCT00528372|39714832|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
16335619|NCT00528372|39714833|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
16335620|NCT00528372|39714825|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
16335621|NCT00528372|39714826|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
16335622|NCT00528372|39714827|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
16335623|NCT00528372|39714828|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
16335624|NCT00528372|39714829|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
16335625|NCT00528372|39714830|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
16335626|NCT00528372|39714831|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
16335627|NCT00528372|39714832|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
16335628|NCT00528372|39714833|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
16335629|NCT00528372|39714825|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
16335630|NCT00528372|39714826|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
16335631|NCT00528372|39714827|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
16335632|NCT00528372|39714828|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
16335633|NCT00528372|39714829|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
16335634|NCT00528372|39714830|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
16335635|NCT00528372|39714831|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
16335636|NCT00528372|39714832|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
16335637|NCT00528372|39714833|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
16335638|NCT00528372|39714825|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
16335639|NCT00528372|39714826|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
16335640|NCT00528372|39714827|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
16101859|NCT03927222|38859690|FG000|Overall Study|Early study termination|1|||
16101860|NCT01732627|38859699|FG000|Overall Study|Withdrawal by Subject|1|||
16101861|NCT01732627|38859700|FG001|Overall Study|Withdrawal by Subject|0|||
16101862|NCT01901302|38859701|FG000|Overall Study|Adverse Event|2|||
16101863|NCT01901302|38859702|FG001|Overall Study|Adverse Event|1|||
16101864|NCT01901302|38859701|FG000|Overall Study|Lack of Efficacy|0|||
16216611|NCT02005211|39272427|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
16216612|NCT02005211|39272428|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16335641|NCT00528372|39714828|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
16335642|NCT00528372|39714829|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
16335643|NCT00528372|39714830|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
16335644|NCT00528372|39714831|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
16335645|NCT00528372|39714832|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
16335646|NCT00528372|39714833|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
16335647|NCT00528372|39714825|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
16335648|NCT00528372|39714826|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
16335649|NCT00528372|39714827|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
16335650|NCT00528372|39714828|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
16335651|NCT00528372|39714829|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
16335652|NCT00528372|39714830|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
16335653|NCT00528372|39714831|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
16335654|NCT00528372|39714832|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
16335655|NCT00528372|39714833|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
16335656|NCT00528372|39714825|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
16335657|NCT00528372|39714826|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
16404684|NCT03500172|39961940|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
16404685|NCT03500172|39961941|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
16404686|NCT03500172|39961942|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
16404687|NCT03500172|39961943|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
16404688|NCT03500172|39961944|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
16404689|NCT03500172|39961945|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
16404690|NCT03500172|39961946|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
16404691|NCT03500172|39961947|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
16404692|NCT03500172|39961948|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
16101865|NCT01901302|38859702|FG001|Overall Study|Lack of Efficacy|2|||
16101866|NCT01901302|38859701|FG000|Overall Study|Study Terminated by Sponsor|23|||
16335658|NCT00528372|39714827|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
16335659|NCT00528372|39714828|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
16335660|NCT00528372|39714829|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
16335661|NCT00528372|39714830|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
16335662|NCT00528372|39714831|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
16335663|NCT00528372|39714832|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
16335664|NCT00528372|39714833|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
16335665|NCT00528372|39714825|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
16534786|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
16534787|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16534788|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
16534789|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16534790|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16534791|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16534792|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16534793|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16534794|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16534795|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
16534796|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16534797|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16534798|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16534799|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16534800|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16534801|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16534802|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16534803|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
16534804|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
16534805|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16534806|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
16335666|NCT00528372|39714826|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
16335667|NCT00528372|39714827|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
16335668|NCT00528372|39714828|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
16335669|NCT00528372|39714829|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
16335670|NCT00528372|39714830|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
16335671|NCT00528372|39714831|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
16335672|NCT00528372|39714832|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
16335673|NCT00528372|39714833|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
16335674|NCT00528372|39714825|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
16335675|NCT00528372|39714826|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
16335676|NCT00528372|39714827|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
16335677|NCT00528372|39714828|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
16335678|NCT00528372|39714829|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
16335679|NCT00528372|39714830|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
16335680|NCT00528372|39714831|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
16335681|NCT00528372|39714832|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
16534807|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
16534808|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16534809|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16534810|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16534811|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
16534812|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
16534813|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
16534814|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16534815|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
16534816|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
16534817|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16534818|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16534819|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16534820|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16534821|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
16534822|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
16534823|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16534824|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
16534825|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
16534826|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16534827|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16534828|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16534829|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16534830|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
16534831|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
16534832|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16534833|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
16534834|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
16534835|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16534836|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16534837|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16534838|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16534839|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
16534840|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
16534841|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16534842|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
16534843|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
16534844|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16534845|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16534846|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16534847|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16534848|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16216613|NCT02005211|39272429|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
16216614|NCT00252499|39272432|FG000|Overall Study|Lost to Follow-up|1|||
16216615|NCT00252499|39272433|FG001|Overall Study|Lost to Follow-up|0|||
16216616|NCT00252499|39272434|FG002|Overall Study|Lost to Follow-up|0|||
16216617|NCT02903966|39272435|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
16216618|NCT02903966|39272436|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
16216619|NCT02903966|39272435|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
16216620|NCT02903966|39272436|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
16216621|NCT02903966|39272435|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
16216622|NCT02903966|39272436|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
16216623|NCT03935594|39272437|FG000|Overall Study|Physician Decision|3|||
16534849|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16534850|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16534851|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16534852|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
16534853|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16534854|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16534855|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16534856|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16534857|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16534858|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
16534859|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16534860|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
16534861|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16534862|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16534863|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16534864|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16534865|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16534866|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
16534867|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
16534868|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
16534869|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
16534870|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
16534871|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
16534872|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
16534873|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
16534874|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
16534875|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
16534876|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
16534877|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16534878|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16534879|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
16534880|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16534881|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16534882|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16534883|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16216624|NCT04489940|39272438|FG000|Overall Study|Other|2|||
16216625|NCT04489940|39272438|FG000|Overall Study|Withdrawal by Subject|2|||
16216626|NCT04489940|39272438|FG000|Overall Study|Death|5|||
16216627|NCT04489940|39272438|FG000|Overall Study|Lost to Follow-up|1|||
16216628|NCT00191386|39272439|FG000|Overall Study|Adverse Event|16|||
16534884|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16534885|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
16534886|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16534887|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16534888|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
16534889|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16534890|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16534891|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16534892|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16534893|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
16534894|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
16534895|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16534896|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16534897|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
16534898|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16534899|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16534900|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16534901|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16534902|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16534903|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
16534904|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16534905|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
16534906|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
16534907|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16534908|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16534909|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16534910|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16534911|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
16534912|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16534913|NCT01212770|40421905|FG000|Long-term Safety Phase (Year 5)|Death|0|||
16534914|NCT01212770|40421906|FG001|Long-term Safety Phase (Year 5)|Death|0|||
16101867|NCT01901302|38859702|FG001|Overall Study|Study Terminated by Sponsor|20|||
16101868|NCT01901302|38859701|FG000|Overall Study|Withdrawal by Subject|2|||
16534915|NCT01212770|40421907|FG002|Long-term Safety Phase (Year 5)|Death|0|||
16534916|NCT01212770|40421908|FG003|Long-term Safety Phase (Year 5)|Death|0|||
16534917|NCT01212770|40421909|FG004|Long-term Safety Phase (Year 5)|Death|0|||
16534918|NCT01212770|40421910|FG005|Long-term Safety Phase (Year 5)|Death|0|||
16534919|NCT01212770|40421911|FG006|Long-term Safety Phase (Year 5)|Death|0|||
16534920|NCT01212770|40421912|FG007|Long-term Safety Phase (Year 5)|Death|1|||
16534921|NCT01212770|40421913|FG008|Long-term Safety Phase (Year 5)|Death|0|||
16534922|NCT04205630|40421914|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
16534923|NCT04205630|40421914|FG000|Overall Study|Disease clinical progression|7|||
16534924|NCT04205630|40421914|FG000|Overall Study|Withdrawal by Subject|2|||
16534925|NCT04205630|40421914|FG000|Overall Study|Adverse Event|17|||
16534926|NCT04205630|40421914|FG000|Overall Study|Other|1|||
16534927|NCT02065336|40421918|FG000|Extension Phase|Study Terminated by Sponsor|0|||
16534928|NCT02065336|40421919|FG001|Extension Phase|Study Terminated by Sponsor|0|||
16534929|NCT02065336|40421920|FG002|Extension Phase|Study Terminated by Sponsor|0|||
16534930|NCT02065336|40421921|FG003|Extension Phase|Study Terminated by Sponsor|0|||
16534931|NCT02065336|40421922|FG004|Extension Phase|Study Terminated by Sponsor|0|||
16534932|NCT02065336|40421923|FG005|Extension Phase|Study Terminated by Sponsor|0|||
16534933|NCT02065336|40421924|FG006|Extension Phase|Study Terminated by Sponsor|0|||
16534934|NCT02065336|40421925|FG007|Extension Phase|Study Terminated by Sponsor|0|||
16534935|NCT02065336|40421926|FG008|Extension Phase|Study Terminated by Sponsor|2|||
16534936|NCT02065336|40421927|FG009|Extension Phase|Study Terminated by Sponsor|8|||
16534937|NCT01328080|40421928|FG000|Overall Study|Lost to Follow-up|5|||
16101869|NCT01901302|38859702|FG001|Overall Study|Withdrawal by Subject|0|||
16101870|NCT01093222|38859704|FG000|Overall Study|Ineligible|6|||
16101871|NCT01093222|38859704|FG000|Overall Study|Adverse Event|7|||
16101872|NCT01093222|38859704|FG000|Overall Study|Progression/relapse|24|||
16534938|NCT03213158|40421929|FG000|Overall Study|Withdrawal by Subject|1|||
16534939|NCT03213158|40421929|FG000|Overall Study|Physician Decision|2|||
16534940|NCT04269889|40421932|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
16534941|NCT04269889|40421932|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
16534942|NCT01650259|40421946|FG000|Overall Study|Improvement|105|||
16534943|NCT01650259|40421947|FG001|Overall Study|Improvement|0|||
16534944|NCT01650259|40421946|FG000|Overall Study|Adverse Event|127|||
16534945|NCT01650259|40421947|FG001|Overall Study|Adverse Event|0|||
16534946|NCT01650259|40421946|FG000|Overall Study|Lack of Efficacy|143|||
16534947|NCT01650259|40421947|FG001|Overall Study|Lack of Efficacy|0|||
16101873|NCT01093222|38859704|FG000|Overall Study|Death|2|||
16101874|NCT01093222|38859704|FG000|Overall Study|Not protocol specified|1|||
16101875|NCT02515097|38859710|FG000|Overall Study|Lost to Follow-up|4|||
16101876|NCT02515097|38859711|FG001|Overall Study|Lost to Follow-up|2|||
16101877|NCT02515097|38859710|FG000|Overall Study|Withdrawal by Subject|1|||
16101878|NCT02515097|38859711|FG001|Overall Study|Withdrawal by Subject|3|||
16101879|NCT02515097|38859710|FG000|Overall Study|Adverse Event|2|||
16101880|NCT02515097|38859711|FG001|Overall Study|Adverse Event|1|||
16101881|NCT00240097|38859712|FG000|Part I|Adverse Event|1|||
16101882|NCT00240097|38859712|FG000|Part I|Death|1|||
16101883|NCT00240097|38859712|FG000|Part I|histology|1|||
16101884|NCT00240097|38859712|FG000|Part I|unevaluable|1|||
16101885|NCT00240097|38859712|FG000|Part II|did not continue from Part I|23|||
16101886|NCT00925288|38859715|FG000|Overall Study|Lost to Follow-up|9|||
16101887|NCT00925288|38859716|FG001|Overall Study|Lost to Follow-up|7|||
16101888|NCT03469258|38859717|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
16101889|NCT00665392|38859720|FG000|Overall Study|not treated|1|||
16101890|NCT00728884|38859721|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
16101891|NCT00728884|38859721|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
16101892|NCT01106586|38859724|FG000|Overall Study|Adverse Event|9|||
16101893|NCT01106586|38859725|FG001|Overall Study|Adverse Event|15|||
16101894|NCT01106586|38859724|FG000|Overall Study|Death|1|||
16101895|NCT01106586|38859725|FG001|Overall Study|Death|3|||
16101896|NCT01106586|38859724|FG000|Overall Study|Pregnancy|2|||
16101897|NCT01106586|38859725|FG001|Overall Study|Pregnancy|2|||
16101898|NCT01106586|38859724|FG000|Overall Study|Lack of Efficacy|1|||
16101899|NCT01106586|38859725|FG001|Overall Study|Lack of Efficacy|0|||
16101900|NCT01106586|38859724|FG000|Overall Study|Investigator's Discretion|5|||
16101901|NCT01106586|38859725|FG001|Overall Study|Investigator's Discretion|8|||
16101902|NCT01106586|38859724|FG000|Overall Study|Withdrew Consent|18|||
16101903|NCT01106586|38859725|FG001|Overall Study|Withdrew Consent|30|||
16101904|NCT01106586|38859724|FG000|Overall Study|Lost to Follow-up|24|||
16101905|NCT01106586|38859725|FG001|Overall Study|Lost to Follow-up|20|||
16101906|NCT01106586|38859724|FG000|Overall Study|Participant Noncompliance|12|||
16101907|NCT01106586|38859725|FG001|Overall Study|Participant Noncompliance|10|||
16101908|NCT01106586|38859724|FG000|Overall Study|Protocol Violation|1|||
16101909|NCT01106586|38859725|FG001|Overall Study|Protocol Violation|0|||
16101910|NCT01106586|38859724|FG000|Overall Study|Participant Transferred to Another Study|212|||
16101911|NCT01106586|38859725|FG001|Overall Study|Participant Transferred to Another Study|197|||
16101912|NCT00495612|38859726|FG000|Overall Study|Lost to Follow-up|1|||
16101913|NCT00495612|38859727|FG001|Overall Study|Lost to Follow-up|0|||
16101914|NCT00495612|38859726|FG000|Overall Study|Subject's Decision to Withdraw|3|||
16101915|NCT00495612|38859727|FG001|Overall Study|Subject's Decision to Withdraw|0|||
16101916|NCT01403805|38859728|FG000|Overall Study|Withdrawal by Subject|0|||
16101917|NCT01403805|38859729|FG001|Overall Study|Withdrawal by Subject|4|||
16101918|NCT01403805|38859728|FG000|Overall Study|Lost to Follow-up|0|||
16101919|NCT01403805|38859729|FG001|Overall Study|Lost to Follow-up|2|||
16101920|NCT01403805|38859728|FG000|Overall Study|Death|0|||
16101921|NCT01403805|38859729|FG001|Overall Study|Death|1|||
16101922|NCT01369147|38859735|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
16101923|NCT01369147|38859736|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
16101924|NCT01369147|38859737|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
16101925|NCT00246129|38859742|FG000|Overall Study|Lost to Follow-up|1|||
16101926|NCT00246129|38859743|FG001|Overall Study|Lost to Follow-up|0|||
16101927|NCT00246129|38859742|FG000|Overall Study|Death|2|||
16101928|NCT00246129|38859743|FG001|Overall Study|Death|1|||
16101929|NCT00246129|38859742|FG000|Overall Study|suffered primary non-function|1|||
16101930|NCT00246129|38859743|FG001|Overall Study|suffered primary non-function|0|||
16101931|NCT00246129|38859742|FG000|Overall Study|grafts failed|3|||
16101932|NCT00246129|38859743|FG001|Overall Study|grafts failed|1|||
16101933|NCT03045302|38859757|FG000|Overall Study|Pre-treatment adverse event|1|||
16101934|NCT04435522|38859758|FG000|Overall Study|Withdrawal by Subject|2|||
16101935|NCT02490878|38859772|FG000|Overall Study|deemed ineligible|0|||
16101936|NCT02490878|38859773|FG001|Overall Study|deemed ineligible|1|||
16101937|NCT02490878|38859772|FG000|Overall Study|progression prior to treatment|0|||
16534948|NCT01650259|40421946|FG000|Overall Study|Lost to Follow-up|435|||
16101938|NCT02490878|38859773|FG001|Overall Study|progression prior to treatment|1|||
16101939|NCT02490878|38859772|FG000|Overall Study|only submitted baseline QOL|0|||
16101940|NCT02490878|38859773|FG001|Overall Study|only submitted baseline QOL|1|||
16101941|NCT00385697|38859781|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
16101942|NCT00385697|38859782|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
16101943|NCT00385697|38859783|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
16101944|NCT00385697|38859784|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
16101945|NCT00385697|38859785|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
16101946|NCT00385697|38859781|FG000|Open-label Segment 1|Lost to Follow-up|1|||
16101947|NCT00385697|38859782|FG001|Open-label Segment 1|Lost to Follow-up|0|||
16101948|NCT00385697|38859783|FG002|Open-label Segment 1|Lost to Follow-up|0|||
16101949|NCT00385697|38859784|FG003|Open-label Segment 1|Lost to Follow-up|0|||
16101950|NCT00385697|38859785|FG004|Open-label Segment 1|Lost to Follow-up|0|||
16101951|NCT00385697|38859781|FG000|Double-blind Segment 2|Adverse Event|0|||
16101952|NCT00385697|38859782|FG001|Double-blind Segment 2|Adverse Event|3|||
16101953|NCT00385697|38859783|FG002|Double-blind Segment 2|Adverse Event|1|||
16101954|NCT00385697|38859784|FG003|Double-blind Segment 2|Adverse Event|0|||
16101955|NCT00385697|38859785|FG004|Double-blind Segment 2|Adverse Event|0|||
16101956|NCT00385697|38859781|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
16101957|NCT00385697|38859782|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
16101958|NCT00385697|38859783|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
16101959|NCT00385697|38859784|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
16101960|NCT00385697|38859785|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
16101961|NCT00385697|38859781|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
16101962|NCT00385697|38859782|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
16101963|NCT00385697|38859783|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
16101964|NCT00385697|38859784|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
16101965|NCT00385697|38859785|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
16101966|NCT00385697|38859781|FG000|Double-blind Segment 2|Other|0|||
16101967|NCT00385697|38859782|FG001|Double-blind Segment 2|Other|2|||
16101968|NCT00385697|38859783|FG002|Double-blind Segment 2|Other|0|||
16101969|NCT00385697|38859784|FG003|Double-blind Segment 2|Other|0|||
16101970|NCT00385697|38859785|FG004|Double-blind Segment 2|Other|0|||
16101971|NCT02660034|38859786|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
16101972|NCT02660034|38859787|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
16101973|NCT02660034|38859788|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
16101974|NCT02660034|38859789|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
16534949|NCT01650259|40421947|FG001|Overall Study|Lost to Follow-up|0|||
16534950|NCT01650259|40421946|FG000|Overall Study|Patients had no visit after entry|70|||
16534951|NCT01650259|40421947|FG001|Overall Study|Patients had no visit after entry|0|||
16534952|NCT01650259|40421946|FG000|Overall Study|CRF not collected|98|||
16534953|NCT01650259|40421947|FG001|Overall Study|CRF not collected|82|||
16534954|NCT01650259|40421946|FG000|Overall Study|Not treated|1|||
16534955|NCT01650259|40421947|FG001|Overall Study|Not treated|7|||
16534956|NCT01650259|40421946|FG000|Overall Study|Other than listed|64|||
16101975|NCT02660034|38859790|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
16101976|NCT02660034|38859791|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
16101977|NCT02660034|38859792|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
16101978|NCT02660034|38859793|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
16101979|NCT02660034|38859794|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
16101980|NCT02660034|38859795|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
16101981|NCT02660034|38859796|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
16216629|NCT00191386|39272439|FG000|Overall Study|Lost to Follow-up|1|||
16216630|NCT00191386|39272439|FG000|Overall Study|Entry Criteria Exclusion|3|||
16216631|NCT00191386|39272439|FG000|Overall Study|Protocol Violation|18|||
16404693|NCT03500172|39961949|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
16404694|NCT03500172|39961950|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
16404695|NCT03500172|39961940|FG000|Period 2: Re-Randomization|Death|0|||
16404696|NCT03500172|39961941|FG001|Period 2: Re-Randomization|Death|0|||
16404697|NCT03500172|39961942|FG002|Period 2: Re-Randomization|Death|0|||
16404698|NCT03500172|39961943|FG003|Period 2: Re-Randomization|Death|4|||
16404699|NCT03500172|39961944|FG004|Period 2: Re-Randomization|Death|2|||
16534957|NCT01650259|40421947|FG001|Overall Study|Other than listed|146|||
16534958|NCT00707031|40421955|FG000|Overall Study|Adverse Event|45|||
16534959|NCT00707031|40421956|FG001|Overall Study|Adverse Event|45|||
16534960|NCT00707031|40421955|FG000|Overall Study|Lack of Efficacy|19|||
16404700|NCT03500172|39961945|FG005|Period 2: Re-Randomization|Death|0|||
16404701|NCT03500172|39961946|FG006|Period 2: Re-Randomization|Death|5|||
16404702|NCT03500172|39961947|FG007|Period 2: Re-Randomization|Death|2|||
16404703|NCT03500172|39961948|FG008|Period 2: Re-Randomization|Death|0|||
16534961|NCT00707031|40421956|FG001|Overall Study|Lack of Efficacy|6|||
16534962|NCT00707031|40421955|FG000|Overall Study|Lost to Follow-up|2|||
16101982|NCT02660034|38859797|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
16101983|NCT02660034|38859798|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
16101984|NCT02660034|38859799|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
16101985|NCT02660034|38859786|FG000|Overall Study|Progressive Disease (Clinical)|7|||
16101986|NCT02660034|38859787|FG001|Overall Study|Progressive Disease (Clinical)|8|||
16216632|NCT00191386|39272439|FG000|Overall Study|Withdrawal by Subject|96|||
16404704|NCT03500172|39961949|FG009|Period 2: Re-Randomization|Death|0|||
16534963|NCT00707031|40421956|FG001|Overall Study|Lost to Follow-up|1|||
16534964|NCT00707031|40421955|FG000|Overall Study|Protocol Violation|1|||
16534965|NCT00707031|40421956|FG001|Overall Study|Protocol Violation|0|||
16534966|NCT00707031|40421955|FG000|Overall Study|Withdrawal by Subject|7|||
16534967|NCT00707031|40421956|FG001|Overall Study|Withdrawal by Subject|8|||
16534968|NCT00707031|40421955|FG000|Overall Study|Poor Compliance to Protocol|7|||
16101987|NCT02660034|38859788|FG002|Overall Study|Progressive Disease (Clinical)|3|||
16101988|NCT02660034|38859789|FG003|Overall Study|Progressive Disease (Clinical)|9|||
16101989|NCT02660034|38859790|FG004|Overall Study|Progressive Disease (Clinical)|3|||
16101990|NCT02660034|38859791|FG005|Overall Study|Progressive Disease (Clinical)|0|||
16101991|NCT02660034|38859792|FG006|Overall Study|Progressive Disease (Clinical)|0|||
16101992|NCT02660034|38859793|FG007|Overall Study|Progressive Disease (Clinical)|0|||
16101993|NCT02660034|38859794|FG008|Overall Study|Progressive Disease (Clinical)|0|||
16101994|NCT02660034|38859795|FG009|Overall Study|Progressive Disease (Clinical)|0|||
16101995|NCT02660034|38859796|FG010|Overall Study|Progressive Disease (Clinical)|0|||
16101996|NCT02660034|38859797|FG011|Overall Study|Progressive Disease (Clinical)|0|||
16101997|NCT02660034|38859798|FG012|Overall Study|Progressive Disease (Clinical)|0|||
16101998|NCT02660034|38859799|FG013|Overall Study|Progressive Disease (Clinical)|0|||
16101999|NCT02660034|38859786|FG000|Overall Study|Lost to Follow-up|0|||
16102000|NCT02660034|38859787|FG001|Overall Study|Lost to Follow-up|0|||
16102001|NCT02660034|38859788|FG002|Overall Study|Lost to Follow-up|1|||
16102002|NCT02660034|38859789|FG003|Overall Study|Lost to Follow-up|1|||
16102003|NCT02660034|38859790|FG004|Overall Study|Lost to Follow-up|0|||
16216633|NCT00191386|39272439|FG000|Overall Study|Physician Decision|11|||
16216634|NCT00191386|39272439|FG000|Overall Study|Lack of Efficacy|15|||
16534969|NCT00707031|40421956|FG001|Overall Study|Poor Compliance to Protocol|13|||
16216635|NCT02431793|39272440|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
16216636|NCT02431793|39272441|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
16216637|NCT02431793|39272442|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
16216638|NCT02431793|39272440|FG000|Overall Study|Withdrawal by Subject|7|||
16216639|NCT02431793|39272441|FG001|Overall Study|Withdrawal by Subject|5|||
16216640|NCT02431793|39272442|FG002|Overall Study|Withdrawal by Subject|5|||
16216641|NCT02431793|39272440|FG000|Overall Study|Lost to Follow-up|101|||
16216642|NCT02431793|39272441|FG001|Overall Study|Lost to Follow-up|122|||
16216643|NCT02431793|39272442|FG002|Overall Study|Lost to Follow-up|104|||
16216644|NCT02324049|39272443|FG000|Part C|Study terminated|11|||
16216645|NCT00703781|39272444|FG000|Overall Study|Withdrawal by Subject|1|||
16216646|NCT00703781|39272445|FG001|Overall Study|Withdrawal by Subject|2|||
16216647|NCT00703781|39272444|FG000|Overall Study|Cancelled surgery|1|||
16216648|NCT00703781|39272445|FG001|Overall Study|Cancelled surgery|0|||
16216649|NCT05091918|39272453|FG000|Overall Study|Adverse Event|1|||
16216650|NCT05091918|39272453|FG000|Overall Study|Withdrawal by Subject|81|||
16216651|NCT00981292|39272454|FG000|Day 1|Protocol Violation|1|||
16216652|NCT00981292|39272455|FG001|Day 1|Protocol Violation|0|||
16216653|NCT00981292|39272456|FG002|Day 1|Protocol Violation|0|||
16216654|NCT00981292|39272457|FG003|Day 1|Protocol Violation|0|||
16216655|NCT00981292|39272458|FG004|Day 1|Protocol Violation|0|||
16216656|NCT00981292|39272459|FG005|Day 1|Protocol Violation|2|||
16216657|NCT00981292|39272454|FG000|Day 2|Protocol Violation|2|||
16216658|NCT00981292|39272455|FG001|Day 2|Protocol Violation|0|||
16216659|NCT00981292|39272456|FG002|Day 2|Protocol Violation|0|||
16216660|NCT00981292|39272457|FG003|Day 2|Protocol Violation|0|||
16216661|NCT00981292|39272458|FG004|Day 2|Protocol Violation|0|||
16335682|NCT00528372|39714833|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
16335683|NCT00528372|39714825|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
16335684|NCT00528372|39714826|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
16534970|NCT00707031|40421955|FG000|Overall Study|Familial or Personal Reasons|12|||
16534971|NCT00707031|40421956|FG001|Overall Study|Familial or Personal Reasons|15|||
16534972|NCT00707031|40421955|FG000|Overall Study|Serious Noncompliance|2|||
16534973|NCT00707031|40421956|FG001|Overall Study|Serious Noncompliance|3|||
16534974|NCT00707031|40421955|FG000|Overall Study|Sponsor Decision|9|||
16534975|NCT00707031|40421956|FG001|Overall Study|Sponsor Decision|8|||
16534976|NCT00763958|40421962|FG000|Overall Study|did not meet final criteria|4|||
16534977|NCT00763958|40421963|FG001|Overall Study|did not meet final criteria|4|||
16534978|NCT00763958|40421962|FG000|Overall Study|Lost to Follow-up|10|||
16534979|NCT00763958|40421963|FG001|Overall Study|Lost to Follow-up|2|||
16335685|NCT00528372|39714827|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
16335686|NCT00528372|39714828|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
16335687|NCT00528372|39714829|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
16102004|NCT02660034|38859791|FG005|Overall Study|Lost to Follow-up|0|||
16102005|NCT02660034|38859792|FG006|Overall Study|Lost to Follow-up|0|||
16335688|NCT00528372|39714830|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
16335689|NCT00528372|39714831|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
16404705|NCT03500172|39961950|FG010|Period 2: Re-Randomization|Death|0|||
16216662|NCT00981292|39272459|FG005|Day 2|Protocol Violation|0|||
16216663|NCT00981292|39272454|FG000|Day 3|Protocol Violation|0|||
16216664|NCT00981292|39272455|FG001|Day 3|Protocol Violation|0|||
16216665|NCT00981292|39272456|FG002|Day 3|Protocol Violation|0|||
16216666|NCT00981292|39272457|FG003|Day 3|Protocol Violation|0|||
16216667|NCT00981292|39272458|FG004|Day 3|Protocol Violation|0|||
16216668|NCT00981292|39272459|FG005|Day 3|Protocol Violation|1|||
16216669|NCT02299206|39272460|FG000|Overall Study|Lost to Follow-up|1|||
16404706|NCT02334683|39961953|FG000|First 12 Week Period|Lost to Follow-up|1|||
16404707|NCT02334683|39961954|FG001|First 12 Week Period|Lost to Follow-up|0|||
16404708|NCT02334683|39961953|FG000|Second 12 Week Period|Adverse Event|0|||
16404709|NCT02334683|39961954|FG001|Second 12 Week Period|Adverse Event|1|||
16534980|NCT00763958|40421962|FG000|Overall Study|Believed they were receiving placebo|0|||
16404710|NCT00420004|39961955|FG000|Overall Study|Adverse Event|4|||
16404711|NCT00420004|39961956|FG001|Overall Study|Adverse Event|1|||
16404712|NCT00420004|39961957|FG002|Overall Study|Adverse Event|1|||
16404713|NCT00420004|39961955|FG000|Overall Study|Lack of Efficacy|5|||
16404714|NCT00420004|39961956|FG001|Overall Study|Lack of Efficacy|4|||
16404715|NCT00420004|39961957|FG002|Overall Study|Lack of Efficacy|1|||
16404716|NCT00420004|39961955|FG000|Overall Study|Lost to Follow-up|31|||
16404717|NCT00420004|39961956|FG001|Overall Study|Lost to Follow-up|12|||
16404718|NCT00420004|39961957|FG002|Overall Study|Lost to Follow-up|10|||
16404719|NCT00420004|39961955|FG000|Overall Study|Entry Criteria Not Met|0|||
16404720|NCT00420004|39961956|FG001|Overall Study|Entry Criteria Not Met|1|||
16404721|NCT00420004|39961957|FG002|Overall Study|Entry Criteria Not Met|0|||
16404722|NCT00420004|39961955|FG000|Overall Study|Physician Decision|14|||
16404723|NCT00420004|39961956|FG001|Overall Study|Physician Decision|4|||
16404724|NCT00420004|39961957|FG002|Overall Study|Physician Decision|2|||
16404725|NCT00420004|39961955|FG000|Overall Study|Protocol Violation|5|||
16404726|NCT00420004|39961956|FG001|Overall Study|Protocol Violation|4|||
16404727|NCT00420004|39961957|FG002|Overall Study|Protocol Violation|3|||
16404728|NCT00420004|39961955|FG000|Overall Study|Withdrawal by Subject|67|||
16404729|NCT00420004|39961956|FG001|Overall Study|Withdrawal by Subject|42|||
16404730|NCT00420004|39961957|FG002|Overall Study|Withdrawal by Subject|14|||
16404731|NCT00420004|39961955|FG000|Overall Study|Sponsor Decision|3|||
16404732|NCT00420004|39961956|FG001|Overall Study|Sponsor Decision|3|||
16404733|NCT00420004|39961957|FG002|Overall Study|Sponsor Decision|1|||
16404734|NCT03176472|39961958|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
16404735|NCT03176472|39961959|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
16404736|NCT03176472|39961958|FG000|Double Blind Treatment Period|Adverse Event|0|||
16404737|NCT03176472|39961959|FG001|Double Blind Treatment Period|Adverse Event|5|||
16404738|NCT03176472|39961958|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
16102006|NCT02660034|38859793|FG007|Overall Study|Lost to Follow-up|0|||
16102007|NCT02660034|38859794|FG008|Overall Study|Lost to Follow-up|0|||
16102008|NCT02660034|38859795|FG009|Overall Study|Lost to Follow-up|1|||
16102009|NCT02660034|38859796|FG010|Overall Study|Lost to Follow-up|1|||
16102010|NCT02660034|38859797|FG011|Overall Study|Lost to Follow-up|1|||
16102011|NCT02660034|38859798|FG012|Overall Study|Lost to Follow-up|0|||
16102012|NCT02660034|38859799|FG013|Overall Study|Lost to Follow-up|0|||
16102013|NCT02660034|38859786|FG000|Overall Study|Participant moved into special access scheme|1|||
16534981|NCT00763958|40421963|FG001|Overall Study|Believed they were receiving placebo|5|||
16534982|NCT00955357|40421965|FG000|Titration Phase|Adverse Event|9|||
16534983|NCT00955357|40421966|FG001|Titration Phase|Adverse Event|46|||
16534984|NCT00955357|40421965|FG000|Titration Phase|Lack of Efficacy|0|||
16534985|NCT00955357|40421966|FG001|Titration Phase|Lack of Efficacy|2|||
16534986|NCT00955357|40421965|FG000|Titration Phase|Protocol Violation|3|||
16534987|NCT00955357|40421966|FG001|Titration Phase|Protocol Violation|7|||
16534988|NCT00955357|40421965|FG000|Titration Phase|Lost to Follow-up|1|||
16534989|NCT00955357|40421966|FG001|Titration Phase|Lost to Follow-up|3|||
16534990|NCT00955357|40421965|FG000|Titration Phase|Withdrawal by Subject|3|||
16534991|NCT00955357|40421966|FG001|Titration Phase|Withdrawal by Subject|5|||
16534992|NCT00955357|40421965|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
16534993|NCT00955357|40421966|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
16534994|NCT00955357|40421965|FG000|Titration Phase|Study medication not tolerated|0|||
16534995|NCT00955357|40421966|FG001|Titration Phase|Study medication not tolerated|1|||
16534996|NCT00955357|40421965|FG000|Titration Phase|Non compliance to study procedures|0|||
16534997|NCT00955357|40421966|FG001|Titration Phase|Non compliance to study procedures|1|||
16534998|NCT00955357|40421965|FG000|Maintenance Phase|Adverse Event|3|||
16534999|NCT00955357|40421966|FG001|Maintenance Phase|Adverse Event|23|||
16535000|NCT00955357|40421965|FG000|Maintenance Phase|Lack of Efficacy|0|||
16102014|NCT02660034|38859787|FG001|Overall Study|Participant moved into special access scheme|2|||
16102015|NCT02660034|38859788|FG002|Overall Study|Participant moved into special access scheme|0|||
16102016|NCT02660034|38859789|FG003|Overall Study|Participant moved into special access scheme|0|||
16535001|NCT00955357|40421966|FG001|Maintenance Phase|Lack of Efficacy|4|||
16535002|NCT00955357|40421965|FG000|Maintenance Phase|Protocol Violation|2|||
16535003|NCT00955357|40421966|FG001|Maintenance Phase|Protocol Violation|6|||
16535004|NCT00955357|40421965|FG000|Maintenance Phase|Lost to Follow-up|2|||
16102017|NCT02660034|38859790|FG004|Overall Study|Participant moved into special access scheme|0|||
16102018|NCT02660034|38859791|FG005|Overall Study|Participant moved into special access scheme|0|||
16102019|NCT02660034|38859792|FG006|Overall Study|Participant moved into special access scheme|0|||
16404739|NCT03176472|39961959|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
16404740|NCT03176472|39961958|FG000|Double Blind Treatment Period|Physician Decision|0|||
16102020|NCT02660034|38859793|FG007|Overall Study|Participant moved into special access scheme|0|||
16102021|NCT02660034|38859794|FG008|Overall Study|Participant moved into special access scheme|0|||
16535005|NCT00955357|40421966|FG001|Maintenance Phase|Lost to Follow-up|7|||
16535006|NCT00955357|40421965|FG000|Maintenance Phase|Withdrawal by Subject|4|||
16535007|NCT00955357|40421966|FG001|Maintenance Phase|Withdrawal by Subject|4|||
16535008|NCT00955357|40421965|FG000|Maintenance Phase|Patient moving out of area|0|||
16535009|NCT00955357|40421966|FG001|Maintenance Phase|Patient moving out of area|1|||
16535010|NCT00955357|40421965|FG000|Maintenance Phase|Non compliance to study procedures|1|||
16535011|NCT00955357|40421966|FG001|Maintenance Phase|Non compliance to study procedures|0|||
16535012|NCT02834780|40421967|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
16102022|NCT02660034|38859795|FG009|Overall Study|Participant moved into special access scheme|0|||
16102023|NCT02660034|38859796|FG010|Overall Study|Participant moved into special access scheme|0|||
16102024|NCT02660034|38859797|FG011|Overall Study|Participant moved into special access scheme|0|||
16102025|NCT02660034|38859798|FG012|Overall Study|Participant moved into special access scheme|0|||
16102026|NCT02660034|38859799|FG013|Overall Study|Participant moved into special access scheme|0|||
16102027|NCT02660034|38859786|FG000|Overall Study|Adverse Event|1|||
16102028|NCT02660034|38859787|FG001|Overall Study|Adverse Event|0|||
16102029|NCT02660034|38859788|FG002|Overall Study|Adverse Event|0|||
16102030|NCT02660034|38859789|FG003|Overall Study|Adverse Event|0|||
16102031|NCT02660034|38859790|FG004|Overall Study|Adverse Event|0|||
16102032|NCT02660034|38859791|FG005|Overall Study|Adverse Event|0|||
16102033|NCT02660034|38859792|FG006|Overall Study|Adverse Event|0|||
16102034|NCT02660034|38859793|FG007|Overall Study|Adverse Event|0|||
16102035|NCT02660034|38859794|FG008|Overall Study|Adverse Event|0|||
16102036|NCT02660034|38859795|FG009|Overall Study|Adverse Event|0|||
16102037|NCT02660034|38859796|FG010|Overall Study|Adverse Event|0|||
16102038|NCT02660034|38859797|FG011|Overall Study|Adverse Event|0|||
16102039|NCT02660034|38859798|FG012|Overall Study|Adverse Event|0|||
16535013|NCT02834780|40421968|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
16535014|NCT02834780|40421969|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
16535015|NCT02834780|40421970|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
16535016|NCT02834780|40421971|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
16535017|NCT02834780|40421972|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
16535018|NCT02834780|40421973|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
16535019|NCT02834780|40421974|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
16535020|NCT02834780|40421975|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
16535021|NCT02834780|40421976|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
16535022|NCT02834780|40421977|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
16535023|NCT02834780|40421978|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
16535024|NCT02834780|40421979|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
16535025|NCT02834780|40421967|FG000|Overall Study|Withdrawal by Subject|0|||
16535026|NCT02834780|40421968|FG001|Overall Study|Withdrawal by Subject|0|||
16535027|NCT02834780|40421969|FG002|Overall Study|Withdrawal by Subject|1|||
16535028|NCT02834780|40421970|FG003|Overall Study|Withdrawal by Subject|0|||
16535029|NCT02834780|40421971|FG004|Overall Study|Withdrawal by Subject|0|||
16535030|NCT02834780|40421972|FG005|Overall Study|Withdrawal by Subject|0|||
16535031|NCT02834780|40421973|FG006|Overall Study|Withdrawal by Subject|0|||
16535032|NCT02834780|40421974|FG007|Overall Study|Withdrawal by Subject|0|||
16535033|NCT02834780|40421975|FG008|Overall Study|Withdrawal by Subject|0|||
16535034|NCT02834780|40421976|FG009|Overall Study|Withdrawal by Subject|0|||
16535035|NCT02834780|40421977|FG010|Overall Study|Withdrawal by Subject|1|||
16535036|NCT02834780|40421978|FG011|Overall Study|Withdrawal by Subject|0|||
16535037|NCT02834780|40421979|FG012|Overall Study|Withdrawal by Subject|0|||
16535038|NCT02834780|40421967|FG000|Overall Study|Adverse Event|0|||
16535039|NCT02834780|40421968|FG001|Overall Study|Adverse Event|0|||
16535040|NCT02834780|40421969|FG002|Overall Study|Adverse Event|0|||
16535041|NCT02834780|40421970|FG003|Overall Study|Adverse Event|0|||
16535042|NCT02834780|40421971|FG004|Overall Study|Adverse Event|1|||
16535043|NCT02834780|40421972|FG005|Overall Study|Adverse Event|0|||
16535044|NCT02834780|40421973|FG006|Overall Study|Adverse Event|1|||
16535045|NCT02834780|40421974|FG007|Overall Study|Adverse Event|1|||
16535046|NCT02834780|40421975|FG008|Overall Study|Adverse Event|0|||
16535047|NCT02834780|40421976|FG009|Overall Study|Adverse Event|2|||
16535048|NCT02834780|40421977|FG010|Overall Study|Adverse Event|0|||
16535049|NCT02834780|40421978|FG011|Overall Study|Adverse Event|3|||
16535050|NCT02834780|40421979|FG012|Overall Study|Adverse Event|2|||
16535051|NCT02834780|40421967|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
16535052|NCT02834780|40421968|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
16102040|NCT02660034|38859799|FG013|Overall Study|Adverse Event|0|||
16535053|NCT02834780|40421969|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
16102041|NCT02660034|38859786|FG000|Overall Study|Sponsor Decision|0|||
16102042|NCT02660034|38859787|FG001|Overall Study|Sponsor Decision|1|||
16535054|NCT02834780|40421970|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
16535055|NCT02834780|40421971|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
16535056|NCT02834780|40421972|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
16535057|NCT02834780|40421973|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
16535058|NCT02834780|40421974|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
16535059|NCT02834780|40421975|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
16535060|NCT02834780|40421976|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
16102043|NCT02660034|38859788|FG002|Overall Study|Sponsor Decision|2|||
16404741|NCT03176472|39961959|FG001|Double Blind Treatment Period|Physician Decision|1|||
16404742|NCT03176472|39961958|FG000|Double Blind Treatment Period|Protocol Violation|1|||
16404743|NCT03176472|39961959|FG001|Double Blind Treatment Period|Protocol Violation|0|||
16404744|NCT03176472|39961958|FG000|Double Blind Treatment Period|Not Provided|1|||
16404745|NCT03176472|39961959|FG001|Double Blind Treatment Period|Not Provided|0|||
16404746|NCT03176472|39961958|FG000|Open Label Extension|Withdrawal by Subject|3|||
16404747|NCT03176472|39961959|FG001|Open Label Extension|Withdrawal by Subject|4|||
16404748|NCT03176472|39961958|FG000|Open Label Extension|Adverse Event|2|||
16404749|NCT03176472|39961959|FG001|Open Label Extension|Adverse Event|4|||
16404750|NCT03176472|39961958|FG000|Open Label Extension|Lost to Follow-up|1|||
16404751|NCT03176472|39961959|FG001|Open Label Extension|Lost to Follow-up|2|||
16404752|NCT03176472|39961958|FG000|Open Label Extension|Protocol Violation|0|||
16535061|NCT02834780|40421977|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
16535062|NCT02834780|40421978|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
16535063|NCT02834780|40421979|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
16535064|NCT02834780|40421967|FG000|Overall Study|Other|1|||
16535065|NCT02834780|40421968|FG001|Overall Study|Other|0|||
16535066|NCT02834780|40421969|FG002|Overall Study|Other|1|||
16535067|NCT02834780|40421970|FG003|Overall Study|Other|2|||
16535068|NCT02834780|40421971|FG004|Overall Study|Other|0|||
16535069|NCT02834780|40421972|FG005|Overall Study|Other|0|||
16535070|NCT02834780|40421973|FG006|Overall Study|Other|0|||
16535071|NCT02834780|40421974|FG007|Overall Study|Other|0|||
16535072|NCT02834780|40421975|FG008|Overall Study|Other|0|||
16535073|NCT02834780|40421976|FG009|Overall Study|Other|0|||
16535074|NCT02834780|40421977|FG010|Overall Study|Other|0|||
16535075|NCT02834780|40421978|FG011|Overall Study|Other|0|||
16535076|NCT02834780|40421979|FG012|Overall Study|Other|1|||
16535077|NCT02453685|40421980|FG000|Overall Study|Adverse Event|0|||
16535078|NCT02453685|40421981|FG001|Overall Study|Adverse Event|1|||
16535079|NCT02453685|40421980|FG000|Overall Study|Protocol Violation|7|||
16535080|NCT02453685|40421981|FG001|Overall Study|Protocol Violation|4|||
16535081|NCT02453685|40421980|FG000|Overall Study|Lost to Follow-up|0|||
16535082|NCT02453685|40421981|FG001|Overall Study|Lost to Follow-up|1|||
16535083|NCT02453685|40421980|FG000|Overall Study|Withdrawal by Subject|8|||
16535084|NCT02453685|40421981|FG001|Overall Study|Withdrawal by Subject|4|||
16535085|NCT02453685|40421980|FG000|Overall Study|Unclassified|4|||
16535086|NCT02453685|40421981|FG001|Overall Study|Unclassified|2|||
16535087|NCT03280121|40421985|FG000|Overall Study|Physician Decision|1|||
16535088|NCT03280121|40421985|FG000|Overall Study|Lost to Follow-up|1|||
16535089|NCT03280121|40421985|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
16535090|NCT03593655|40421986|FG000|First Product Use Period|Withdrawal by Subject|1|||
16535091|NCT03593655|40421987|FG001|First Product Use Period|Withdrawal by Subject|1|||
16535092|NCT03593655|40421986|FG000|First Product Use Period|Lost to Follow-up|1|||
16535093|NCT03593655|40421987|FG001|First Product Use Period|Lost to Follow-up|3|||
16535094|NCT03593655|40421986|FG000|Second Product Use Period|Withdrawal by Subject|1|||
16535095|NCT03593655|40421987|FG001|Second Product Use Period|Withdrawal by Subject|1|||
16535096|NCT03593655|40421986|FG000|Second Product Use Period|Lost to Follow-up|1|||
16535097|NCT03593655|40421987|FG001|Second Product Use Period|Lost to Follow-up|0|||
16535098|NCT03593655|40421986|FG000|Third Product Use Period|Lost to Follow-up|1|||
16535099|NCT03593655|40421987|FG001|Third Product Use Period|Lost to Follow-up|2|||
16535100|NCT03593655|40421986|FG000|Third Product Use Period|Physician Decision|0|||
16535101|NCT03593655|40421987|FG001|Third Product Use Period|Physician Decision|1|||
16535102|NCT03593655|40421986|FG000|Third Product Use Period|Withdrawal by Subject|0|||
16535103|NCT03593655|40421987|FG001|Third Product Use Period|Withdrawal by Subject|1|||
16535104|NCT00829387|40421988|FG000|Overall Study|Withdrawal by Subject|2|||
16535105|NCT00829387|40421989|FG001|Overall Study|Withdrawal by Subject|3|||
16535106|NCT00829387|40421988|FG000|Overall Study|Disqualified by PI|1|||
16535107|NCT00829387|40421989|FG001|Overall Study|Disqualified by PI|0|||
16535108|NCT01428076|40421990|FG000|Overall Study|Adverse Event|0|||
16535109|NCT01428076|40421991|FG001|Overall Study|Adverse Event|1|||
16535110|NCT02943408|40421994|FG000|Overall Study|Lost to Follow-up|7|||
16535111|NCT02943408|40421995|FG001|Overall Study|Lost to Follow-up|1|||
16535112|NCT02943408|40421994|FG000|Overall Study|Withdrawal by Subject|0|||
16535113|NCT02943408|40421995|FG001|Overall Study|Withdrawal by Subject|1|||
16404753|NCT03176472|39961959|FG001|Open Label Extension|Protocol Violation|1|||
16404754|NCT03176472|39961958|FG000|Open Label Extension|Not Provided|2|||
16404755|NCT03176472|39961959|FG001|Open Label Extension|Not Provided|1|||
16535114|NCT00483184|40421996|FG000|Overall Study|Withdrawal by Subject|2|||
16535115|NCT00483184|40421997|FG001|Overall Study|Withdrawal by Subject|2|||
16535116|NCT00483184|40421998|FG002|Overall Study|Withdrawal by Subject|0|||
16535117|NCT00483184|40421996|FG000|Overall Study|Lost to Follow-up|1|||
16535118|NCT00483184|40421997|FG001|Overall Study|Lost to Follow-up|0|||
16535119|NCT00483184|40421998|FG002|Overall Study|Lost to Follow-up|0|||
16535120|NCT00483184|40421996|FG000|Overall Study|Adverse Event|1|||
16535121|NCT00483184|40421997|FG001|Overall Study|Adverse Event|2|||
16535122|NCT00483184|40421998|FG002|Overall Study|Adverse Event|2|||
16535123|NCT00483184|40421996|FG000|Overall Study|Protocol Violation|1|||
16535124|NCT00483184|40421997|FG001|Overall Study|Protocol Violation|0|||
16535125|NCT00483184|40421998|FG002|Overall Study|Protocol Violation|1|||
16535126|NCT02526693|40422000|FG000|Overall Study|Physician Decision|3|||
16535127|NCT02526693|40422001|FG001|Overall Study|Physician Decision|1|||
16535128|NCT00907153|40422002|FG000|Overall Study|Lost to Follow-up|1|||
16535129|NCT00907153|40422003|FG001|Overall Study|Lost to Follow-up|1|||
16535130|NCT00907153|40422002|FG000|Overall Study|Withdrawal by Subject|1|||
16535131|NCT00907153|40422003|FG001|Overall Study|Withdrawal by Subject|3|||
16535132|NCT03585244|40422004|FG000|Overall Study|Withdrawal by Subject|15|||
16535133|NCT01050816|40422007|FG000|Overall Study|Lost to Follow-up|2|||
16535134|NCT01050816|40422007|FG000|Overall Study|patient's refusal|2|||
16535135|NCT03265600|40422012|FG000|Overall Study|Lost to Follow-up|17|||
16535136|NCT03265600|40422013|FG001|Overall Study|Lost to Follow-up|5|||
16535137|NCT03265600|40422012|FG000|Overall Study|Withdrawal by Subject|4|||
16535138|NCT03265600|40422013|FG001|Overall Study|Withdrawal by Subject|2|||
16535139|NCT03265600|40422012|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
16535140|NCT03265600|40422013|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
16535141|NCT03321396|40422039|FG000|Overall Study|Physician Decision|1|||
16535142|NCT00325468|40422040|FG000|Overall Study|Adverse Event|1|||
16535143|NCT00325468|40422041|FG001|Overall Study|Adverse Event|1|||
16535144|NCT00325468|40422042|FG002|Overall Study|Adverse Event|0|||
16535145|NCT00325468|40422043|FG003|Overall Study|Adverse Event|5|||
16535146|NCT00325468|40422044|FG004|Overall Study|Adverse Event|1|||
16535147|NCT00325468|40422040|FG000|Overall Study|Death|2|||
16535148|NCT00325468|40422041|FG001|Overall Study|Death|0|||
16535149|NCT00325468|40422042|FG002|Overall Study|Death|2|||
16535150|NCT00325468|40422043|FG003|Overall Study|Death|4|||
16535151|NCT00325468|40422044|FG004|Overall Study|Death|0|||
16535152|NCT00325468|40422040|FG000|Overall Study|Lost to Follow-up|0|||
16535153|NCT00325468|40422041|FG001|Overall Study|Lost to Follow-up|0|||
16535154|NCT00325468|40422042|FG002|Overall Study|Lost to Follow-up|1|||
16535155|NCT00325468|40422043|FG003|Overall Study|Lost to Follow-up|2|||
16535156|NCT00325468|40422044|FG004|Overall Study|Lost to Follow-up|2|||
16535157|NCT00325468|40422040|FG000|Overall Study|Physician Decision|1|||
16535158|NCT00325468|40422041|FG001|Overall Study|Physician Decision|1|||
16535159|NCT00325468|40422042|FG002|Overall Study|Physician Decision|0|||
16535160|NCT00325468|40422043|FG003|Overall Study|Physician Decision|1|||
16535161|NCT00325468|40422044|FG004|Overall Study|Physician Decision|0|||
16535162|NCT00325468|40422040|FG000|Overall Study|Withdrawal by Subject|3|||
16535163|NCT00325468|40422041|FG001|Overall Study|Withdrawal by Subject|1|||
16535164|NCT00325468|40422042|FG002|Overall Study|Withdrawal by Subject|0|||
16535165|NCT00325468|40422043|FG003|Overall Study|Withdrawal by Subject|14|||
16535166|NCT00325468|40422044|FG004|Overall Study|Withdrawal by Subject|4|||
16535167|NCT00325468|40422040|FG000|Overall Study|site closure etc|4|||
16535168|NCT00325468|40422041|FG001|Overall Study|site closure etc|2|||
16535169|NCT00325468|40422042|FG002|Overall Study|site closure etc|1|||
16535170|NCT00325468|40422043|FG003|Overall Study|site closure etc|8|||
16535171|NCT00325468|40422044|FG004|Overall Study|site closure etc|1|||
16535172|NCT01857531|40422045|FG000|Overall Study|Withdrawal by Subject|4|||
16535173|NCT00857207|40422046|FG000|Overall Study|Withdrawal by Subject|13|||
16535174|NCT00857207|40422047|FG001|Overall Study|Withdrawal by Subject|0|||
16535175|NCT00857207|40422046|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
16535176|NCT00857207|40422047|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
16535177|NCT00857207|40422046|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
16535178|NCT00857207|40422047|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
16535179|NCT01864564|40422048|FG000|Overall Study|Lost to Follow-up|17|||
16535180|NCT01864564|40422049|FG001|Overall Study|Lost to Follow-up|23|||
16535181|NCT01864564|40422048|FG000|Overall Study|Withdrawal by Subject|20|||
16535182|NCT01864564|40422049|FG001|Overall Study|Withdrawal by Subject|11|||
16535183|NCT01864564|40422048|FG000|Overall Study|Protocol Violation|0|||
16535184|NCT01864564|40422049|FG001|Overall Study|Protocol Violation|27|||
16535185|NCT01864564|40422048|FG000|Overall Study|not reported|0|||
16535186|NCT01864564|40422049|FG001|Overall Study|not reported|34|||
16535187|NCT00608582|40422050|FG000|Overall Study|Lost to Follow-up|2|||
16535188|NCT00608582|40422051|FG001|Overall Study|Lost to Follow-up|0|||
16535189|NCT00608582|40422050|FG000|Overall Study|No Best Response in Phase 1 located|1|||
16535190|NCT00608582|40422051|FG001|Overall Study|No Best Response in Phase 1 located|1|||
16535191|NCT00608582|40422050|FG000|Overall Study|Illicit Drug Use|1|||
16535192|NCT00608582|40422051|FG001|Overall Study|Illicit Drug Use|0|||
16535193|NCT00608582|40422050|FG000|Overall Study|Early stage Design Change|0|||
16535194|NCT00608582|40422051|FG001|Overall Study|Early stage Design Change|3|||
16535195|NCT01654549|40422052|FG000|Overall Study|H.pylori eradication not successful|0|||
16535196|NCT01654549|40422053|FG001|Overall Study|H.pylori eradication not successful|1|||
16535197|NCT01218126|40422056|FG000|Overall Study|Adverse Event|8|||
16535198|NCT01218126|40422057|FG001|Overall Study|Adverse Event|10|||
16535199|NCT01218126|40422058|FG002|Overall Study|Adverse Event|12|||
16535200|NCT01218126|40422059|FG003|Overall Study|Adverse Event|16|||
16535201|NCT01218126|40422056|FG000|Overall Study|Lack of Efficacy|7|||
16535202|NCT01218126|40422057|FG001|Overall Study|Lack of Efficacy|2|||
16535203|NCT01218126|40422058|FG002|Overall Study|Lack of Efficacy|2|||
16535204|NCT01218126|40422059|FG003|Overall Study|Lack of Efficacy|6|||
16535205|NCT01218126|40422056|FG000|Overall Study|Protocol Violation|5|||
16535206|NCT01218126|40422057|FG001|Overall Study|Protocol Violation|2|||
16535207|NCT01218126|40422058|FG002|Overall Study|Protocol Violation|2|||
16535208|NCT01218126|40422059|FG003|Overall Study|Protocol Violation|3|||
16535209|NCT01218126|40422056|FG000|Overall Study|Protocol-defined stopping criteria|1|||
16535210|NCT01218126|40422057|FG001|Overall Study|Protocol-defined stopping criteria|1|||
16535211|NCT01218126|40422058|FG002|Overall Study|Protocol-defined stopping criteria|0|||
16535212|NCT01218126|40422059|FG003|Overall Study|Protocol-defined stopping criteria|0|||
16535213|NCT01218126|40422056|FG000|Overall Study|Lost to Follow-up|0|||
16535214|NCT01218126|40422057|FG001|Overall Study|Lost to Follow-up|0|||
16535215|NCT01218126|40422058|FG002|Overall Study|Lost to Follow-up|0|||
16535216|NCT01218126|40422059|FG003|Overall Study|Lost to Follow-up|2|||
16535217|NCT01218126|40422056|FG000|Overall Study|Physician Decision|1|||
16535218|NCT01218126|40422057|FG001|Overall Study|Physician Decision|2|||
16535219|NCT01218126|40422058|FG002|Overall Study|Physician Decision|4|||
16535220|NCT01218126|40422059|FG003|Overall Study|Physician Decision|2|||
16535221|NCT01218126|40422056|FG000|Overall Study|Withdrawal by Subject|2|||
16535222|NCT01218126|40422057|FG001|Overall Study|Withdrawal by Subject|5|||
16535223|NCT01218126|40422058|FG002|Overall Study|Withdrawal by Subject|4|||
16535224|NCT01218126|40422059|FG003|Overall Study|Withdrawal by Subject|6|||
16535225|NCT00815295|40422071|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
16535226|NCT00815295|40422072|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
16535227|NCT00815295|40422073|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
16535228|NCT02527798|40422074|FG000|Overall Study|Physician Decision|1|||
16535229|NCT02527798|40422075|FG001|Overall Study|Physician Decision|0|||
16535230|NCT02527798|40422076|FG002|Overall Study|Physician Decision|1|||
16535231|NCT02527798|40422077|FG003|Overall Study|Physician Decision|1|||
16535232|NCT02527798|40422078|FG004|Overall Study|Physician Decision|0|||
16535233|NCT02527798|40422079|FG005|Overall Study|Physician Decision|0|||
16535234|NCT02527798|40422074|FG000|Overall Study|Death|0|||
16535235|NCT02527798|40422075|FG001|Overall Study|Death|0|||
16535236|NCT02527798|40422076|FG002|Overall Study|Death|1|||
16535237|NCT02527798|40422077|FG003|Overall Study|Death|0|||
16535238|NCT02527798|40422078|FG004|Overall Study|Death|0|||
16535239|NCT02527798|40422079|FG005|Overall Study|Death|0|||
16535240|NCT02527798|40422074|FG000|Overall Study|Withdrawal by Subject|0|||
16535241|NCT02527798|40422075|FG001|Overall Study|Withdrawal by Subject|1|||
16535242|NCT02527798|40422076|FG002|Overall Study|Withdrawal by Subject|2|||
16535243|NCT02527798|40422077|FG003|Overall Study|Withdrawal by Subject|0|||
16535244|NCT02527798|40422078|FG004|Overall Study|Withdrawal by Subject|0|||
16535245|NCT02527798|40422079|FG005|Overall Study|Withdrawal by Subject|0|||
16535246|NCT02527798|40422074|FG000|Overall Study|Reason undisclosed|1|||
16535247|NCT02527798|40422075|FG001|Overall Study|Reason undisclosed|0|||
16535248|NCT02527798|40422076|FG002|Overall Study|Reason undisclosed|1|||
16535249|NCT02527798|40422077|FG003|Overall Study|Reason undisclosed|0|||
16535250|NCT02527798|40422078|FG004|Overall Study|Reason undisclosed|0|||
16535251|NCT02527798|40422079|FG005|Overall Study|Reason undisclosed|0|||
16535252|NCT02527798|40422074|FG000|Overall Study|Did not receive intervention|1|||
16535253|NCT02527798|40422075|FG001|Overall Study|Did not receive intervention|1|||
16535254|NCT02527798|40422076|FG002|Overall Study|Did not receive intervention|0|||
16535255|NCT02527798|40422077|FG003|Overall Study|Did not receive intervention|0|||
16535256|NCT02527798|40422078|FG004|Overall Study|Did not receive intervention|0|||
16535257|NCT02527798|40422079|FG005|Overall Study|Did not receive intervention|0|||
16335690|NCT00528372|39714832|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
16335691|NCT00528372|39714833|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
16335692|NCT00528372|39714825|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
16335693|NCT00528372|39714826|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
16335694|NCT00528372|39714827|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
16335695|NCT00528372|39714828|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
16335696|NCT00528372|39714829|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
16335697|NCT00528372|39714830|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
16335698|NCT00528372|39714831|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
16335699|NCT00528372|39714832|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
16535258|NCT01292239|40422081|FG000|Overall Study|Other|1|||
16335700|NCT00528372|39714833|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
16335701|NCT00528372|39714825|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
16102044|NCT02660034|38859789|FG003|Overall Study|Sponsor Decision|2|||
16102045|NCT02660034|38859790|FG004|Overall Study|Sponsor Decision|3|||
16102046|NCT02660034|38859791|FG005|Overall Study|Sponsor Decision|0|||
16102047|NCT02660034|38859792|FG006|Overall Study|Sponsor Decision|0|||
16102048|NCT02660034|38859793|FG007|Overall Study|Sponsor Decision|0|||
16102049|NCT02660034|38859794|FG008|Overall Study|Sponsor Decision|0|||
16102050|NCT02660034|38859795|FG009|Overall Study|Sponsor Decision|0|||
16335702|NCT00528372|39714826|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
16335703|NCT00528372|39714827|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
16335704|NCT00528372|39714828|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
16335705|NCT00528372|39714829|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
16335706|NCT00528372|39714830|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
16335707|NCT00528372|39714831|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
16535259|NCT01292239|40422082|FG001|Overall Study|Other|1|||
16535260|NCT01292239|40422081|FG000|Overall Study|Withdrawal by Subject|3|||
16535261|NCT01292239|40422082|FG001|Overall Study|Withdrawal by Subject|6|||
16535262|NCT04391023|40422087|FG000|Overall Study|Withdrawal by Subject|2|||
16535263|NCT04391023|40422088|FG001|Overall Study|Withdrawal by Subject|2|||
16535264|NCT00657618|40422089|FG000|Overall Study|Adverse Event|32|||
16535265|NCT00657618|40422089|FG000|Overall Study|Withdrawal by Subject|8|||
16535266|NCT00657618|40422089|FG000|Overall Study|negative for leishmaniasis|2|||
16535267|NCT00657618|40422089|FG000|Overall Study|didn't start due to schedule conflicts|1|||
16535268|NCT00381940|40422090|FG000|Overall Study|Lack of Efficacy|3|||
16535269|NCT00381940|40422090|FG000|Overall Study|Protocol Violation|1|||
16535270|NCT00381940|40422090|FG000|Overall Study|Ineligible|1|||
16535271|NCT00695669|40422091|FG000|Overall Study|Adverse Event|0|||
16535272|NCT00695669|40422092|FG001|Overall Study|Adverse Event|0|||
16535273|NCT00695669|40422093|FG002|Overall Study|Adverse Event|2|||
16535274|NCT00695669|40422094|FG003|Overall Study|Adverse Event|0|||
16535275|NCT00695669|40422091|FG000|Overall Study|Lost to Follow-up|4|||
16535276|NCT00695669|40422092|FG001|Overall Study|Lost to Follow-up|4|||
16102051|NCT02660034|38859796|FG010|Overall Study|Sponsor Decision|0|||
16102052|NCT02660034|38859797|FG011|Overall Study|Sponsor Decision|0|||
16535277|NCT00695669|40422093|FG002|Overall Study|Lost to Follow-up|1|||
16535278|NCT00695669|40422094|FG003|Overall Study|Lost to Follow-up|4|||
16535279|NCT00162370|40422097|FG000|Efficacy Population|Lost to Follow-up|51|||
16535280|NCT01860703|40422099|FG000|Overall Study|Adverse Event|1|||
16535281|NCT01860703|40422100|FG001|Overall Study|Adverse Event|4|||
16535282|NCT01860703|40422101|FG002|Overall Study|Adverse Event|0|||
16535283|NCT01860703|40422102|FG003|Overall Study|Adverse Event|2|||
16535284|NCT01860703|40422099|FG000|Overall Study|Withdrawal by Subject|0|||
16535285|NCT01860703|40422100|FG001|Overall Study|Withdrawal by Subject|1|||
16535286|NCT01860703|40422101|FG002|Overall Study|Withdrawal by Subject|0|||
16535287|NCT01860703|40422102|FG003|Overall Study|Withdrawal by Subject|0|||
16535288|NCT01860703|40422099|FG000|Overall Study|Personal reason|1|||
16535289|NCT01860703|40422100|FG001|Overall Study|Personal reason|0|||
16535290|NCT01860703|40422101|FG002|Overall Study|Personal reason|1|||
16535291|NCT01860703|40422102|FG003|Overall Study|Personal reason|0|||
16535292|NCT04089865|40422108|FG000|Overall Study|Withdrawal by Subject|2|||
16535293|NCT04089865|40422109|FG001|Overall Study|Withdrawal by Subject|2|||
16535294|NCT04089865|40422110|FG002|Overall Study|Withdrawal by Subject|7|||
16535295|NCT04089865|40422111|FG003|Overall Study|Withdrawal by Subject|2|||
16535296|NCT03185481|40422112|FG000|Overall Study|Adverse Event|1|||
16535297|NCT03185481|40422112|FG000|Overall Study|Study Terminated by Sponsor|4|||
16535298|NCT03162224|40422113|FG000|Overall Study|Death|4|||
16535299|NCT03162224|40422114|FG001|Overall Study|Death|5|||
16535300|NCT03162224|40422115|FG002|Overall Study|Death|8|||
16535301|NCT03162224|40422113|FG000|Overall Study|Withdrawal by Subject|1|||
16535302|NCT03162224|40422114|FG001|Overall Study|Withdrawal by Subject|0|||
16535303|NCT03162224|40422115|FG002|Overall Study|Withdrawal by Subject|1|||
16535304|NCT03162224|40422113|FG000|Overall Study|Lost to Follow-up|0|||
16535305|NCT03162224|40422114|FG001|Overall Study|Lost to Follow-up|1|||
16535306|NCT03162224|40422115|FG002|Overall Study|Lost to Follow-up|0|||
16535307|NCT03162224|40422113|FG000|Overall Study|Other|6|||
16535308|NCT03162224|40422114|FG001|Overall Study|Other|2|||
16535309|NCT03162224|40422115|FG002|Overall Study|Other|1|||
16535310|NCT02097108|40422116|FG000|Overall Study|Adverse Event|1|||
16535311|NCT02097108|40422116|FG000|Overall Study|patient was abroad for 6 months|1|||
16535312|NCT02782169|40422120|FG000|Overall Study|Lost to Follow-up|1|||
16535313|NCT02782169|40422121|FG001|Overall Study|Lost to Follow-up|2|||
16535314|NCT04004611|40422122|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
16535315|NCT04004611|40422123|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
16535316|NCT04004611|40422124|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
16102053|NCT02660034|38859798|FG012|Overall Study|Sponsor Decision|0|||
16102054|NCT02660034|38859799|FG013|Overall Study|Sponsor Decision|1|||
16102055|NCT02660034|38859786|FG000|Overall Study|Withdrawal by Subject|0|||
16102056|NCT02660034|38859787|FG001|Overall Study|Withdrawal by Subject|0|||
16102057|NCT02660034|38859788|FG002|Overall Study|Withdrawal by Subject|0|||
16102058|NCT02660034|38859789|FG003|Overall Study|Withdrawal by Subject|0|||
16102059|NCT02660034|38859790|FG004|Overall Study|Withdrawal by Subject|0|||
16102060|NCT02660034|38859791|FG005|Overall Study|Withdrawal by Subject|0|||
16102061|NCT02660034|38859792|FG006|Overall Study|Withdrawal by Subject|1|||
16102062|NCT02660034|38859793|FG007|Overall Study|Withdrawal by Subject|1|||
16102063|NCT02660034|38859794|FG008|Overall Study|Withdrawal by Subject|1|||
16102064|NCT02660034|38859795|FG009|Overall Study|Withdrawal by Subject|0|||
16102065|NCT02660034|38859796|FG010|Overall Study|Withdrawal by Subject|0|||
16102066|NCT02660034|38859797|FG011|Overall Study|Withdrawal by Subject|1|||
16102067|NCT02660034|38859798|FG012|Overall Study|Withdrawal by Subject|2|||
16102068|NCT02660034|38859799|FG013|Overall Study|Withdrawal by Subject|0|||
16102069|NCT02660034|38859786|FG000|Overall Study|Death|0|||
16102070|NCT02660034|38859787|FG001|Overall Study|Death|0|||
16102071|NCT02660034|38859788|FG002|Overall Study|Death|0|||
16102072|NCT02660034|38859789|FG003|Overall Study|Death|0|||
16102073|NCT02660034|38859790|FG004|Overall Study|Death|0|||
16102074|NCT02660034|38859791|FG005|Overall Study|Death|13|||
16102075|NCT02660034|38859792|FG006|Overall Study|Death|14|||
16102076|NCT02660034|38859793|FG007|Overall Study|Death|10|||
16102077|NCT02660034|38859794|FG008|Overall Study|Death|9|||
16102078|NCT02660034|38859795|FG009|Overall Study|Death|21|||
16102079|NCT02660034|38859796|FG010|Overall Study|Death|17|||
16102080|NCT02660034|38859797|FG011|Overall Study|Death|15|||
16102081|NCT02660034|38859798|FG012|Overall Study|Death|18|||
16102082|NCT02660034|38859799|FG013|Overall Study|Death|7|||
16535317|NCT04004611|40422125|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
16535318|NCT04004611|40422126|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
16535319|NCT04004611|40422127|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
16102083|NCT02660034|38859786|FG000|Overall Study|Physician Decision|0|||
16102084|NCT02660034|38859787|FG001|Overall Study|Physician Decision|0|||
16102085|NCT02660034|38859788|FG002|Overall Study|Physician Decision|0|||
16102086|NCT02660034|38859789|FG003|Overall Study|Physician Decision|0|||
16535320|NCT04004611|40422128|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
16535321|NCT04004611|40422129|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
16535322|NCT04004611|40422130|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
16535323|NCT04004611|40422122|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
16535324|NCT04004611|40422123|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
16535325|NCT04004611|40422124|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
16535326|NCT04004611|40422125|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
16535327|NCT04004611|40422126|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
16535328|NCT04004611|40422127|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
16535329|NCT04004611|40422128|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
16535330|NCT04004611|40422129|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
16535331|NCT04004611|40422130|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
16535332|NCT04004611|40422122|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
16535333|NCT04004611|40422123|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
16535334|NCT04004611|40422124|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
16535335|NCT04004611|40422125|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
16535336|NCT04004611|40422126|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
16535337|NCT04004611|40422127|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
16535338|NCT04004611|40422128|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
16535339|NCT04004611|40422129|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
16535340|NCT04004611|40422130|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
16535341|NCT04004611|40422122|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
16535342|NCT04004611|40422123|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
16535343|NCT04004611|40422124|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
16535344|NCT04004611|40422125|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
16535345|NCT04004611|40422126|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
16535346|NCT04004611|40422127|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
16535347|NCT04004611|40422128|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
16535348|NCT04004611|40422129|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
16535349|NCT04004611|40422130|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
16535350|NCT04004611|40422122|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
16535351|NCT04004611|40422123|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
16535352|NCT04004611|40422124|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
16535353|NCT04004611|40422125|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
16535354|NCT04004611|40422126|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
16535355|NCT04004611|40422127|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
16535356|NCT04004611|40422128|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
16535357|NCT04004611|40422129|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
16535358|NCT04004611|40422130|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
16535359|NCT04004611|40422122|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
16535360|NCT04004611|40422123|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
16535361|NCT04004611|40422124|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
16535362|NCT04004611|40422125|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
16535363|NCT04004611|40422126|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
16335708|NCT00528372|39714832|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
16335709|NCT00528372|39714833|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
16335710|NCT00528372|39714825|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
16335711|NCT00528372|39714826|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
16335712|NCT00528372|39714827|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
16335713|NCT00528372|39714828|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
16335714|NCT00528372|39714829|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
16335715|NCT00528372|39714830|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
16335716|NCT00528372|39714831|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
16335717|NCT00528372|39714832|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
16335718|NCT00528372|39714833|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
16335719|NCT00528372|39714825|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
16335720|NCT00528372|39714826|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
16335721|NCT00528372|39714827|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
16335722|NCT00528372|39714828|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
16335723|NCT00528372|39714829|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
16335724|NCT00528372|39714830|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
16335725|NCT00528372|39714831|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
16335726|NCT00528372|39714832|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
16404756|NCT00521599|39961960|FG000|Overall Study|Adverse Event|5|||
16404757|NCT00521599|39961961|FG001|Overall Study|Adverse Event|7|||
16404758|NCT00521599|39961962|FG002|Overall Study|Adverse Event|6|||
16535364|NCT04004611|40422127|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
16535365|NCT04004611|40422128|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
16102087|NCT02660034|38859790|FG004|Overall Study|Physician Decision|0|||
16335727|NCT00528372|39714833|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
16335728|NCT00528372|39714825|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
16335729|NCT00528372|39714826|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
16335730|NCT00528372|39714827|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
16535366|NCT04004611|40422129|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
16535367|NCT04004611|40422130|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
16535368|NCT03834779|40422131|FG000|Overall Study|Death|1|||
16535369|NCT03834779|40422132|FG001|Overall Study|Death|2|||
16535370|NCT03834779|40422131|FG000|Overall Study|Lost to Follow-up|6|||
16335731|NCT00528372|39714828|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
16335732|NCT00528372|39714829|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
16335733|NCT00528372|39714830|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
16335734|NCT00528372|39714831|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
16335735|NCT00528372|39714832|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
16335736|NCT00528372|39714833|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
16335737|NCT01573754|39714837|FG000|Overall Study|Noncompliance or remission not achieved|3|||
16335738|NCT01573754|39714838|FG001|Overall Study|Noncompliance or remission not achieved|15|||
16335739|NCT00382109|39714839|FG000|Overall Study|Adverse Event|3|||
16335740|NCT00382109|39714840|FG001|Overall Study|Adverse Event|0|||
16335741|NCT00382109|39714839|FG000|Overall Study|Physician Decision|6|||
16335742|NCT00382109|39714840|FG001|Overall Study|Physician Decision|1|||
16335743|NCT00382109|39714839|FG000|Overall Study|Withdrawal by Subject|1|||
16335744|NCT00382109|39714840|FG001|Overall Study|Withdrawal by Subject|0|||
16335745|NCT00382109|39714839|FG000|Overall Study|ineligible|2|||
16335746|NCT00382109|39714840|FG001|Overall Study|ineligible|0|||
16335747|NCT00382109|39714839|FG000|Overall Study|Other|0|||
16335748|NCT00382109|39714840|FG001|Overall Study|Other|2|||
16335749|NCT00382109|39714839|FG000|Overall Study|consent withdrawal|0|||
16335750|NCT00382109|39714840|FG001|Overall Study|consent withdrawal|1|||
16335751|NCT01643798|39714841|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
16335752|NCT01643798|39714842|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
16335753|NCT01428115|39714843|FG000|Overall Study|Lack of Efficacy|3|||
16535371|NCT03834779|40422132|FG001|Overall Study|Lost to Follow-up|4|||
16535372|NCT03969719|40422133|FG000|Overall Study|Other reasons not specified|1|||
16535373|NCT03969719|40422134|FG001|Overall Study|Other reasons not specified|1|||
16535374|NCT03969719|40422135|FG002|Overall Study|Other reasons not specified|3|||
16102088|NCT02660034|38859791|FG005|Overall Study|Physician Decision|0|||
16102089|NCT02660034|38859792|FG006|Overall Study|Physician Decision|0|||
16102090|NCT02660034|38859793|FG007|Overall Study|Physician Decision|0|||
16535375|NCT03969719|40422133|FG000|Overall Study|Withdrawal by Subject|2|||
16535376|NCT03969719|40422134|FG001|Overall Study|Withdrawal by Subject|3|||
16535377|NCT03969719|40422135|FG002|Overall Study|Withdrawal by Subject|2|||
16535378|NCT03969719|40422133|FG000|Overall Study|Protocol Violation|1|||
16535379|NCT03969719|40422134|FG001|Overall Study|Protocol Violation|2|||
16535380|NCT03969719|40422135|FG002|Overall Study|Protocol Violation|0|||
16535381|NCT03969719|40422133|FG000|Overall Study|Adverse Event|0|||
16535382|NCT03969719|40422134|FG001|Overall Study|Adverse Event|2|||
16535383|NCT03969719|40422135|FG002|Overall Study|Adverse Event|0|||
16535384|NCT03969719|40422133|FG000|Overall Study|Lost to Follow-up|0|||
16535385|NCT03969719|40422134|FG001|Overall Study|Lost to Follow-up|1|||
16535386|NCT03969719|40422135|FG002|Overall Study|Lost to Follow-up|0|||
16535387|NCT00725296|40422136|FG000|Overall Study|Adverse Event|11|||
16535388|NCT00725296|40422136|FG000|Overall Study|Lack of Efficacy|7|||
16535389|NCT00725296|40422136|FG000|Overall Study|Withdrawal by Subject|3|||
16535390|NCT00725296|40422136|FG000|Overall Study|Non-Compliance|2|||
16535391|NCT00725296|40422136|FG000|Overall Study|Lost to Follow-up|1|||
16535392|NCT00725296|40422136|FG000|Overall Study|Other|38|||
16535393|NCT01540851|40422144|FG000|Overall Study|Lost to Follow-up|14|||
16535394|NCT01540851|40422145|FG001|Overall Study|Lost to Follow-up|15|||
16535395|NCT01540851|40422144|FG000|Overall Study|Withdrawal by Subject|7|||
16535396|NCT01540851|40422145|FG001|Overall Study|Withdrawal by Subject|3|||
16102091|NCT02660034|38859794|FG008|Overall Study|Physician Decision|0|||
16335754|NCT01428115|39714843|FG000|Overall Study|Lost to Follow-up|10|||
16535397|NCT00700401|40422146|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
16535398|NCT00700401|40422146|FG000|Overall Study|Adverse Event|5|||
16535399|NCT00700401|40422146|FG000|Overall Study|Refused Treatment|2|||
16535400|NCT00700401|40422146|FG000|Overall Study|Lost to Follow-up|1|||
16535401|NCT00700401|40422146|FG000|Overall Study|Treatment never started|1|||
16535402|NCT00700401|40422146|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
16535403|NCT00700401|40422146|FG000|Overall Study|Withdrawal by Subject|2|||
16102092|NCT02660034|38859795|FG009|Overall Study|Physician Decision|0|||
16102093|NCT02660034|38859796|FG010|Overall Study|Physician Decision|0|||
16335755|NCT01428115|39714843|FG000|Overall Study|Pregnancy|1|||
16335756|NCT01428115|39714843|FG000|Overall Study|Protocol Violation|3|||
16335757|NCT01428115|39714843|FG000|Overall Study|Withdrawal by Subject|4|||
16335758|NCT05993299|39714844|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
16102094|NCT02660034|38859797|FG011|Overall Study|Physician Decision|0|||
16102095|NCT02660034|38859798|FG012|Overall Study|Physician Decision|0|||
16102096|NCT02660034|38859799|FG013|Overall Study|Physician Decision|1|||
16102097|NCT02660034|38859786|FG000|Overall Study|Participants transferred to LTE|0|||
16102098|NCT02660034|38859787|FG001|Overall Study|Participants transferred to LTE|0|||
16102099|NCT02660034|38859788|FG002|Overall Study|Participants transferred to LTE|0|||
16102100|NCT02660034|38859789|FG003|Overall Study|Participants transferred to LTE|0|||
16102101|NCT02660034|38859790|FG004|Overall Study|Participants transferred to LTE|0|||
16102102|NCT02660034|38859791|FG005|Overall Study|Participants transferred to LTE|10|||
16102103|NCT02660034|38859792|FG006|Overall Study|Participants transferred to LTE|8|||
16102104|NCT02660034|38859793|FG007|Overall Study|Participants transferred to LTE|8|||
16102105|NCT02660034|38859794|FG008|Overall Study|Participants transferred to LTE|10|||
16102106|NCT02660034|38859795|FG009|Overall Study|Participants transferred to LTE|1|||
16102107|NCT02660034|38859796|FG010|Overall Study|Participants transferred to LTE|2|||
16404759|NCT00521599|39961960|FG000|Overall Study|Treatment Failure|8|||
16404760|NCT00521599|39961961|FG001|Overall Study|Treatment Failure|9|||
16404761|NCT00521599|39961962|FG002|Overall Study|Treatment Failure|22|||
16404762|NCT00521599|39961960|FG000|Overall Study|Lost to Follow-up|2|||
16404763|NCT00521599|39961961|FG001|Overall Study|Lost to Follow-up|1|||
16404764|NCT00521599|39961962|FG002|Overall Study|Lost to Follow-up|2|||
16404765|NCT00521599|39961960|FG000|Overall Study|Withdrawal by Subject|3|||
16404766|NCT00521599|39961961|FG001|Overall Study|Withdrawal by Subject|5|||
16404767|NCT00521599|39961962|FG002|Overall Study|Withdrawal by Subject|1|||
16404768|NCT00521599|39961960|FG000|Overall Study|Withdrawal by subject treatment related|3|||
16404769|NCT00521599|39961961|FG001|Overall Study|Withdrawal by subject treatment related|1|||
16404770|NCT00521599|39961962|FG002|Overall Study|Withdrawal by subject treatment related|2|||
16404771|NCT00521599|39961960|FG000|Overall Study|Protocol Violation|2|||
16404772|NCT00521599|39961961|FG001|Overall Study|Protocol Violation|4|||
16535404|NCT02030015|40422150|FG000|Overall Study|Withdrawal by Subject|3|||
16535405|NCT02030015|40422150|FG000|Overall Study|Death|13|||
16535406|NCT00279201|40422151|FG000|Initiation|Death|1|||
16404773|NCT00521599|39961962|FG002|Overall Study|Protocol Violation|2|||
16404774|NCT00521599|39961960|FG000|Overall Study|Did not meet protocol eligibility|2|||
16404775|NCT00521599|39961961|FG001|Overall Study|Did not meet protocol eligibility|2|||
16535407|NCT00279201|40422152|FG001|Initiation|Death|5|||
16535408|NCT00279201|40422153|FG002|Initiation|Death|0|||
16535409|NCT00279201|40422154|FG003|Initiation|Death|0|||
16535410|NCT00279201|40422155|FG004|Initiation|Death|0|||
16535411|NCT00279201|40422156|FG005|Initiation|Death|0|||
16535412|NCT00279201|40422151|FG000|Initiation|Adverse Event|6|||
16535413|NCT00279201|40422152|FG001|Initiation|Adverse Event|15|||
16535414|NCT00279201|40422153|FG002|Initiation|Adverse Event|0|||
16535415|NCT00279201|40422154|FG003|Initiation|Adverse Event|0|||
16535416|NCT00279201|40422155|FG004|Initiation|Adverse Event|0|||
16535417|NCT00279201|40422156|FG005|Initiation|Adverse Event|0|||
16535418|NCT00279201|40422151|FG000|Initiation|Lost to Follow-up|42|||
16535419|NCT00279201|40422152|FG001|Initiation|Lost to Follow-up|41|||
16535420|NCT00279201|40422153|FG002|Initiation|Lost to Follow-up|0|||
16535421|NCT00279201|40422154|FG003|Initiation|Lost to Follow-up|0|||
16535422|NCT00279201|40422155|FG004|Initiation|Lost to Follow-up|0|||
16535423|NCT00279201|40422156|FG005|Initiation|Lost to Follow-up|0|||
16535424|NCT00279201|40422151|FG000|Initiation|Entry Criteria Exclusion|7|||
16535425|NCT00279201|40422152|FG001|Initiation|Entry Criteria Exclusion|9|||
16535426|NCT00279201|40422153|FG002|Initiation|Entry Criteria Exclusion|0|||
16535427|NCT00279201|40422154|FG003|Initiation|Entry Criteria Exclusion|0|||
16535428|NCT00279201|40422155|FG004|Initiation|Entry Criteria Exclusion|0|||
16102108|NCT02660034|38859797|FG011|Overall Study|Participants transferred to LTE|4|||
16102109|NCT02660034|38859798|FG012|Overall Study|Participants transferred to LTE|1|||
16404776|NCT00521599|39961962|FG002|Overall Study|Did not meet protocol eligibility|1|||
16404777|NCT01289353|39961966|FG000|Overall Study|Lost to Follow-up|2|||
16535429|NCT00279201|40422156|FG005|Initiation|Entry Criteria Exclusion|0|||
16535430|NCT00279201|40422151|FG000|Initiation|Protocol Violation|9|||
16535431|NCT00279201|40422152|FG001|Initiation|Protocol Violation|10|||
16102110|NCT02660034|38859799|FG013|Overall Study|Participants transferred to LTE|1|||
16102111|NCT02212197|38859800|FG000|Overall Study|Need for radiotherapy|1|||
16102112|NCT02212197|38859801|FG001|Overall Study|Need for radiotherapy|0|||
16335759|NCT05993299|39714844|FG000|Overall Study|Ongoing|4|||
16335760|NCT00236899|39714851|FG000|Overall Study|Adverse Event (Study Related)|1|||
16335761|NCT00236899|39714852|FG001|Overall Study|Adverse Event (Study Related)|1|||
16335762|NCT00236899|39714853|FG002|Overall Study|Adverse Event (Study Related)|2|||
16335763|NCT00236899|39714854|FG003|Overall Study|Adverse Event (Study Related)|1|||
16335764|NCT00236899|39714851|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
16335765|NCT00236899|39714852|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
16404778|NCT03334851|39961967|FG000|Overall Study|Other|0|||
16404779|NCT03334851|39961968|FG001|Overall Study|Other|0|||
16404780|NCT03334851|39961969|FG002|Overall Study|Other|0|||
16404781|NCT03334851|39961970|FG003|Overall Study|Other|0|||
16404782|NCT03334851|39961971|FG004|Overall Study|Other|0|||
16404783|NCT03334851|39961972|FG005|Overall Study|Other|0|||
16404784|NCT03334851|39961973|FG006|Overall Study|Other|0|||
16404785|NCT03334851|39961974|FG007|Overall Study|Other|1|||
16404786|NCT03334851|39961975|FG008|Overall Study|Other|0|||
16535432|NCT00279201|40422153|FG002|Initiation|Protocol Violation|0|||
16335766|NCT00236899|39714853|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
16404787|NCT03334851|39961976|FG009|Overall Study|Other|0|||
16404788|NCT03334851|39961977|FG010|Overall Study|Other|0|||
16404789|NCT03334851|39961978|FG011|Overall Study|Other|0|||
16404790|NCT03334851|39961979|FG012|Overall Study|Other|0|||
16535433|NCT00279201|40422154|FG003|Initiation|Protocol Violation|0|||
16535434|NCT00279201|40422155|FG004|Initiation|Protocol Violation|0|||
16535435|NCT00279201|40422156|FG005|Initiation|Protocol Violation|0|||
16535436|NCT00279201|40422151|FG000|Initiation|Withdrawal by Subject|35|||
16535437|NCT00279201|40422152|FG001|Initiation|Withdrawal by Subject|41|||
16535438|NCT00279201|40422153|FG002|Initiation|Withdrawal by Subject|0|||
16535439|NCT00279201|40422154|FG003|Initiation|Withdrawal by Subject|0|||
16535440|NCT00279201|40422155|FG004|Initiation|Withdrawal by Subject|0|||
16535441|NCT00279201|40422156|FG005|Initiation|Withdrawal by Subject|0|||
16535442|NCT00279201|40422151|FG000|Initiation|Physician Decision|15|||
16535443|NCT00279201|40422152|FG001|Initiation|Physician Decision|18|||
16535444|NCT00279201|40422153|FG002|Initiation|Physician Decision|0|||
16535445|NCT00279201|40422154|FG003|Initiation|Physician Decision|0|||
16535446|NCT00279201|40422155|FG004|Initiation|Physician Decision|0|||
16535447|NCT00279201|40422156|FG005|Initiation|Physician Decision|0|||
16535448|NCT00279201|40422151|FG000|Initiation|Sponsor Decision|13|||
16535449|NCT00279201|40422152|FG001|Initiation|Sponsor Decision|5|||
16535450|NCT00279201|40422153|FG002|Initiation|Sponsor Decision|0|||
16535451|NCT00279201|40422154|FG003|Initiation|Sponsor Decision|0|||
16535452|NCT00279201|40422155|FG004|Initiation|Sponsor Decision|0|||
16535453|NCT00279201|40422156|FG005|Initiation|Sponsor Decision|0|||
16535454|NCT00279201|40422151|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
16535455|NCT00279201|40422152|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
16535456|NCT00279201|40422153|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
16535457|NCT00279201|40422154|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
16535458|NCT00279201|40422155|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
16535459|NCT00279201|40422156|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
16535460|NCT00279201|40422151|FG000|Maintenance|Lack of Efficacy|32|||
16535461|NCT00279201|40422152|FG001|Maintenance|Lack of Efficacy|30|||
16535462|NCT00279201|40422153|FG002|Maintenance|Lack of Efficacy|0|||
16535463|NCT00279201|40422154|FG003|Maintenance|Lack of Efficacy|0|||
16535464|NCT00279201|40422155|FG004|Maintenance|Lack of Efficacy|0|||
16535465|NCT00279201|40422156|FG005|Maintenance|Lack of Efficacy|0|||
16535466|NCT00279201|40422151|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
16535467|NCT00279201|40422152|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
16535468|NCT00279201|40422153|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
16535469|NCT00279201|40422154|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
16535470|NCT00279201|40422155|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
16535471|NCT00279201|40422156|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
16535472|NCT00279201|40422151|FG000|Maintenance|Adverse Event|4|||
16535473|NCT00279201|40422152|FG001|Maintenance|Adverse Event|4|||
16535474|NCT00279201|40422153|FG002|Maintenance|Adverse Event|0|||
16535475|NCT00279201|40422154|FG003|Maintenance|Adverse Event|0|||
16535476|NCT00279201|40422155|FG004|Maintenance|Adverse Event|0|||
16102113|NCT02212197|38859802|FG002|Overall Study|Need for radiotherapy|0|||
16335767|NCT00236899|39714854|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
16335768|NCT00236899|39714851|FG000|Overall Study|Death (Study Disease)|1|||
16404791|NCT03334851|39961967|FG000|Overall Study|Adverse Event|0|||
16404792|NCT03334851|39961968|FG001|Overall Study|Adverse Event|0|||
16535477|NCT00279201|40422156|FG005|Maintenance|Adverse Event|0|||
16535478|NCT00279201|40422151|FG000|Maintenance|Death|4|||
16535479|NCT00279201|40422152|FG001|Maintenance|Death|4|||
16535480|NCT00279201|40422153|FG002|Maintenance|Death|0|||
16535481|NCT00279201|40422154|FG003|Maintenance|Death|0|||
16404793|NCT03334851|39961969|FG002|Overall Study|Adverse Event|0|||
16404794|NCT03334851|39961970|FG003|Overall Study|Adverse Event|0|||
16404795|NCT03334851|39961971|FG004|Overall Study|Adverse Event|0|||
16404796|NCT03334851|39961972|FG005|Overall Study|Adverse Event|0|||
16404797|NCT03334851|39961973|FG006|Overall Study|Adverse Event|0|||
16404798|NCT03334851|39961974|FG007|Overall Study|Adverse Event|1|||
16404799|NCT03334851|39961975|FG008|Overall Study|Adverse Event|0|||
16404800|NCT03334851|39961976|FG009|Overall Study|Adverse Event|0|||
16404801|NCT03334851|39961977|FG010|Overall Study|Adverse Event|0|||
16404802|NCT03334851|39961978|FG011|Overall Study|Adverse Event|0|||
16535482|NCT00279201|40422155|FG004|Maintenance|Death|0|||
16535483|NCT00279201|40422156|FG005|Maintenance|Death|0|||
16535484|NCT00279201|40422151|FG000|Maintenance|Lost to Follow-up|17|||
16535485|NCT00279201|40422152|FG001|Maintenance|Lost to Follow-up|13|||
16535486|NCT00279201|40422153|FG002|Maintenance|Lost to Follow-up|0|||
16535487|NCT00279201|40422154|FG003|Maintenance|Lost to Follow-up|0|||
16102114|NCT03852433|38859803|FG000|Overall Study|Withdrawal of consent|5|||
16404803|NCT03334851|39961979|FG012|Overall Study|Adverse Event|0|||
16404804|NCT03334851|39961967|FG000|Overall Study|Withdrawal by Subject|0|||
16404805|NCT03334851|39961968|FG001|Overall Study|Withdrawal by Subject|0|||
16404806|NCT03334851|39961969|FG002|Overall Study|Withdrawal by Subject|0|||
16404807|NCT03334851|39961970|FG003|Overall Study|Withdrawal by Subject|0|||
16404808|NCT03334851|39961971|FG004|Overall Study|Withdrawal by Subject|0|||
16404809|NCT03334851|39961972|FG005|Overall Study|Withdrawal by Subject|0|||
16404810|NCT03334851|39961973|FG006|Overall Study|Withdrawal by Subject|0|||
16404811|NCT03334851|39961974|FG007|Overall Study|Withdrawal by Subject|0|||
16404812|NCT03334851|39961975|FG008|Overall Study|Withdrawal by Subject|0|||
16404813|NCT03334851|39961976|FG009|Overall Study|Withdrawal by Subject|0|||
16404814|NCT03334851|39961977|FG010|Overall Study|Withdrawal by Subject|1|||
16404815|NCT03334851|39961978|FG011|Overall Study|Withdrawal by Subject|0|||
16404816|NCT03334851|39961979|FG012|Overall Study|Withdrawal by Subject|1|||
16404817|NCT03334851|39961967|FG000|Overall Study|Lost to Follow-up|0|||
16404818|NCT03334851|39961968|FG001|Overall Study|Lost to Follow-up|0|||
16404819|NCT03334851|39961969|FG002|Overall Study|Lost to Follow-up|0|||
16404820|NCT03334851|39961970|FG003|Overall Study|Lost to Follow-up|0|||
16404821|NCT03334851|39961971|FG004|Overall Study|Lost to Follow-up|0|||
16404822|NCT03334851|39961972|FG005|Overall Study|Lost to Follow-up|0|||
16404823|NCT03334851|39961973|FG006|Overall Study|Lost to Follow-up|0|||
16404824|NCT03334851|39961974|FG007|Overall Study|Lost to Follow-up|0|||
16404825|NCT03334851|39961975|FG008|Overall Study|Lost to Follow-up|0|||
16404826|NCT03334851|39961976|FG009|Overall Study|Lost to Follow-up|0|||
16404827|NCT03334851|39961977|FG010|Overall Study|Lost to Follow-up|2|||
16404828|NCT03334851|39961978|FG011|Overall Study|Lost to Follow-up|1|||
16102115|NCT03852433|38859804|FG001|Overall Study|Withdrawal of consent|8|||
16102116|NCT03852433|38859805|FG002|Overall Study|Withdrawal of consent|1|||
16102117|NCT03852433|38859806|FG003|Overall Study|Withdrawal of consent|1|||
16102118|NCT03852433|38859803|FG000|Overall Study|Adverse Event|1|||
16335769|NCT00236899|39714852|FG001|Overall Study|Death (Study Disease)|4|||
16335770|NCT00236899|39714853|FG002|Overall Study|Death (Study Disease)|0|||
16335771|NCT00236899|39714854|FG003|Overall Study|Death (Study Disease)|0|||
16335772|NCT00236899|39714851|FG000|Overall Study|Death (Not Study Related)|2|||
16335773|NCT00236899|39714852|FG001|Overall Study|Death (Not Study Related)|0|||
16335774|NCT00236899|39714853|FG002|Overall Study|Death (Not Study Related)|0|||
16335775|NCT00236899|39714854|FG003|Overall Study|Death (Not Study Related)|0|||
16335776|NCT00236899|39714851|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
16335777|NCT00236899|39714852|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
16335778|NCT00236899|39714853|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
16335779|NCT00236899|39714854|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
16335780|NCT00236899|39714851|FG000|Overall Study|Lost to Follow-up|0|||
16404829|NCT03334851|39961979|FG012|Overall Study|Lost to Follow-up|0|||
16404830|NCT01626118|39961980|FG000|Overall Study|Lack of Efficacy|1|||
16404831|NCT01626118|39961981|FG001|Overall Study|Lack of Efficacy|0|||
16404832|NCT01626118|39961982|FG002|Overall Study|Lack of Efficacy|1|||
16404833|NCT01626118|39961983|FG003|Overall Study|Lack of Efficacy|3|||
16535488|NCT00279201|40422155|FG004|Maintenance|Lost to Follow-up|0|||
16535489|NCT00279201|40422156|FG005|Maintenance|Lost to Follow-up|0|||
16535490|NCT00279201|40422151|FG000|Maintenance|Entry Criteria Exclusion|1|||
16535491|NCT00279201|40422152|FG001|Maintenance|Entry Criteria Exclusion|4|||
16535492|NCT00279201|40422153|FG002|Maintenance|Entry Criteria Exclusion|0|||
16535493|NCT00279201|40422154|FG003|Maintenance|Entry Criteria Exclusion|0|||
16535494|NCT00279201|40422155|FG004|Maintenance|Entry Criteria Exclusion|0|||
16535495|NCT00279201|40422156|FG005|Maintenance|Entry Criteria Exclusion|0|||
16535496|NCT00279201|40422151|FG000|Maintenance|Protocol Violation|16|||
16535497|NCT00279201|40422152|FG001|Maintenance|Protocol Violation|24|||
16535498|NCT00279201|40422153|FG002|Maintenance|Protocol Violation|0|||
16535499|NCT00279201|40422154|FG003|Maintenance|Protocol Violation|0|||
16535500|NCT00279201|40422155|FG004|Maintenance|Protocol Violation|0|||
16535501|NCT00279201|40422156|FG005|Maintenance|Protocol Violation|0|||
16535502|NCT00279201|40422151|FG000|Maintenance|Withdrawal by Subject|18|||
16535503|NCT00279201|40422152|FG001|Maintenance|Withdrawal by Subject|18|||
16535504|NCT00279201|40422153|FG002|Maintenance|Withdrawal by Subject|0|||
16535505|NCT00279201|40422154|FG003|Maintenance|Withdrawal by Subject|0|||
16535506|NCT00279201|40422155|FG004|Maintenance|Withdrawal by Subject|0|||
16535507|NCT00279201|40422156|FG005|Maintenance|Withdrawal by Subject|0|||
16535508|NCT00279201|40422151|FG000|Maintenance|Physician Decision|9|||
16535509|NCT00279201|40422152|FG001|Maintenance|Physician Decision|9|||
16535510|NCT00279201|40422153|FG002|Maintenance|Physician Decision|0|||
16535511|NCT00279201|40422154|FG003|Maintenance|Physician Decision|0|||
16535512|NCT00279201|40422155|FG004|Maintenance|Physician Decision|0|||
16535513|NCT00279201|40422156|FG005|Maintenance|Physician Decision|0|||
16535514|NCT00279201|40422151|FG000|Maintenance|Sponsor Decision|4|||
16535515|NCT00279201|40422152|FG001|Maintenance|Sponsor Decision|0|||
16535516|NCT00279201|40422153|FG002|Maintenance|Sponsor Decision|0|||
16535517|NCT00279201|40422154|FG003|Maintenance|Sponsor Decision|0|||
16535518|NCT00279201|40422155|FG004|Maintenance|Sponsor Decision|0|||
16535519|NCT00279201|40422156|FG005|Maintenance|Sponsor Decision|0|||
16535520|NCT00279201|40422151|FG000|Maintenance|HbA1c>7.5%|123|||
16535521|NCT00279201|40422152|FG001|Maintenance|HbA1c>7.5%|126|||
16535522|NCT00279201|40422153|FG002|Maintenance|HbA1c>7.5%|0|||
16535523|NCT00279201|40422154|FG003|Maintenance|HbA1c>7.5%|0|||
16535524|NCT00279201|40422155|FG004|Maintenance|HbA1c>7.5%|0|||
16535525|NCT00279201|40422156|FG005|Maintenance|HbA1c>7.5%|0|||
16535526|NCT00279201|40422151|FG000|Intensification Addendum|Withdrawal by Subject|0|||
16535527|NCT00279201|40422152|FG001|Intensification Addendum|Withdrawal by Subject|0|||
16535528|NCT00279201|40422153|FG002|Intensification Addendum|Withdrawal by Subject|12|||
16535529|NCT00279201|40422154|FG003|Intensification Addendum|Withdrawal by Subject|14|||
16535530|NCT00279201|40422155|FG004|Intensification Addendum|Withdrawal by Subject|9|||
16535531|NCT00279201|40422156|FG005|Intensification Addendum|Withdrawal by Subject|18|||
16535532|NCT00279201|40422151|FG000|Intensification Addendum|Lost to Follow-up|0|||
16535533|NCT00279201|40422152|FG001|Intensification Addendum|Lost to Follow-up|0|||
16535534|NCT00279201|40422153|FG002|Intensification Addendum|Lost to Follow-up|4|||
16535535|NCT00279201|40422154|FG003|Intensification Addendum|Lost to Follow-up|6|||
16535536|NCT00279201|40422155|FG004|Intensification Addendum|Lost to Follow-up|7|||
16535537|NCT00279201|40422156|FG005|Intensification Addendum|Lost to Follow-up|7|||
16535538|NCT00279201|40422151|FG000|Intensification Addendum|Protocol Violation|0|||
16535539|NCT00279201|40422152|FG001|Intensification Addendum|Protocol Violation|0|||
16535540|NCT00279201|40422153|FG002|Intensification Addendum|Protocol Violation|2|||
16535541|NCT00279201|40422154|FG003|Intensification Addendum|Protocol Violation|2|||
16535542|NCT00279201|40422155|FG004|Intensification Addendum|Protocol Violation|6|||
16535543|NCT00279201|40422156|FG005|Intensification Addendum|Protocol Violation|6|||
16535544|NCT00279201|40422151|FG000|Intensification Addendum|Adverse Event|0|||
16535545|NCT00279201|40422152|FG001|Intensification Addendum|Adverse Event|0|||
16535546|NCT00279201|40422153|FG002|Intensification Addendum|Adverse Event|0|||
16535547|NCT00279201|40422154|FG003|Intensification Addendum|Adverse Event|4|||
16535548|NCT00279201|40422155|FG004|Intensification Addendum|Adverse Event|1|||
16535549|NCT00279201|40422156|FG005|Intensification Addendum|Adverse Event|3|||
16535550|NCT00279201|40422151|FG000|Intensification Addendum|Physician Decision|0|||
16102119|NCT03852433|38859804|FG001|Overall Study|Adverse Event|1|||
16102120|NCT03852433|38859805|FG002|Overall Study|Adverse Event|1|||
16535551|NCT00279201|40422152|FG001|Intensification Addendum|Physician Decision|0|||
16535552|NCT00279201|40422153|FG002|Intensification Addendum|Physician Decision|4|||
16535553|NCT00279201|40422154|FG003|Intensification Addendum|Physician Decision|1|||
16535554|NCT00279201|40422155|FG004|Intensification Addendum|Physician Decision|3|||
16535555|NCT00279201|40422156|FG005|Intensification Addendum|Physician Decision|2|||
16535556|NCT00279201|40422151|FG000|Intensification Addendum|Sponsor Decision|0|||
16535557|NCT00279201|40422152|FG001|Intensification Addendum|Sponsor Decision|0|||
16535558|NCT00279201|40422153|FG002|Intensification Addendum|Sponsor Decision|0|||
16535559|NCT00279201|40422154|FG003|Intensification Addendum|Sponsor Decision|0|||
16535560|NCT00279201|40422155|FG004|Intensification Addendum|Sponsor Decision|1|||
16535561|NCT00279201|40422156|FG005|Intensification Addendum|Sponsor Decision|1|||
16535562|NCT00279201|40422151|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
16535563|NCT00279201|40422152|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
16535564|NCT00279201|40422153|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
16535565|NCT00279201|40422154|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
16535566|NCT00279201|40422155|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
16535567|NCT00279201|40422156|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
16535568|NCT00279201|40422151|FG000|Intensification Addendum|Lack of Efficacy|0|||
16535569|NCT00279201|40422152|FG001|Intensification Addendum|Lack of Efficacy|0|||
16535570|NCT00279201|40422153|FG002|Intensification Addendum|Lack of Efficacy|0|||
16535571|NCT00279201|40422154|FG003|Intensification Addendum|Lack of Efficacy|1|||
16535572|NCT00279201|40422155|FG004|Intensification Addendum|Lack of Efficacy|1|||
16535573|NCT00279201|40422156|FG005|Intensification Addendum|Lack of Efficacy|0|||
16535574|NCT00279201|40422151|FG000|Intensification Addendum|Death|0|||
16535575|NCT00279201|40422152|FG001|Intensification Addendum|Death|0|||
16404834|NCT01626118|39961980|FG000|Overall Study|Lost to Follow-up|1|||
16404835|NCT01626118|39961981|FG001|Overall Study|Lost to Follow-up|0|||
16404836|NCT01626118|39961982|FG002|Overall Study|Lost to Follow-up|0|||
16404837|NCT01626118|39961983|FG003|Overall Study|Lost to Follow-up|0|||
16404838|NCT01626118|39961980|FG000|Overall Study|Adverse Event|0|||
16404839|NCT01626118|39961981|FG001|Overall Study|Adverse Event|1|||
16404840|NCT01626118|39961982|FG002|Overall Study|Adverse Event|1|||
16404841|NCT01626118|39961983|FG003|Overall Study|Adverse Event|0|||
16404842|NCT01626118|39961980|FG000|Overall Study|Investigator Decision|0|||
16404843|NCT01626118|39961981|FG001|Overall Study|Investigator Decision|1|||
16404844|NCT01626118|39961982|FG002|Overall Study|Investigator Decision|0|||
16404845|NCT01626118|39961983|FG003|Overall Study|Investigator Decision|0|||
16404846|NCT00613925|39961984|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
16404847|NCT00613925|39961985|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
16404848|NCT03610581|39962002|FG000|Overall Study|Study terminated by sponsor|2|||
16404849|NCT03610581|39962003|FG001|Overall Study|Study terminated by sponsor|0|||
16404850|NCT03610581|39962002|FG000|Overall Study|Other|0|||
16404851|NCT03610581|39962003|FG001|Overall Study|Other|1|||
16404852|NCT03610581|39962002|FG000|Overall Study|Withdrawal by Subject|1|||
16404853|NCT03610581|39962003|FG001|Overall Study|Withdrawal by Subject|0|||
16404854|NCT01865812|39962008|FG000|Primary Treatment Phase|Adverse Event|2|||
16404855|NCT01865812|39962009|FG001|Primary Treatment Phase|Adverse Event|0|||
16404856|NCT01865812|39962008|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
16404857|NCT01865812|39962009|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
16404858|NCT01865812|39962008|FG000|Long-term Safety Extension Phase|Pruritus|0|||
16404859|NCT01865812|39962009|FG001|Long-term Safety Extension Phase|Pruritus|3|||
16404860|NCT01865812|39962008|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
16404861|NCT01865812|39962009|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
16404862|NCT01865812|39962008|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
16404863|NCT01865812|39962009|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
16404864|NCT02118766|39962010|FG000|Overall Study|Adverse Event|7|||
16404865|NCT02118766|39962011|FG001|Overall Study|Adverse Event|2|||
16404866|NCT02118766|39962010|FG000|Overall Study|Withdrawal by Subject|3|||
16404867|NCT02118766|39962011|FG001|Overall Study|Withdrawal by Subject|6|||
16404868|NCT02118766|39962010|FG000|Overall Study|Lost to Follow-up|5|||
16404869|NCT02118766|39962011|FG001|Overall Study|Lost to Follow-up|4|||
16404870|NCT02118766|39962010|FG000|Overall Study|Withdrawal by parent/guardian|12|||
16404871|NCT02118766|39962011|FG001|Overall Study|Withdrawal by parent/guardian|18|||
16404872|NCT02118766|39962010|FG000|Overall Study|Other|3|||
16404873|NCT02118766|39962011|FG001|Overall Study|Other|1|||
16404874|NCT03372551|39966227|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
16404875|NCT03372551|39966228|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
16404876|NCT03730961|39966229|FG000|Overall Study|Adverse Event|0|||
16404877|NCT03730961|39966230|FG001|Overall Study|Adverse Event|1|||
16404878|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Death|1|||
16404879|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Death|1|||
16404880|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Death|0|||
16404881|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Death|0|||
16404882|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Death|1|||
16404883|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Death|0|||
16404884|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Death|0|||
16404885|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Death|0|||
16404886|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Death|0|||
16404887|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Death|0|||
16404888|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
16404889|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
16404890|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
16404891|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
16404892|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
16404893|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
16404894|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
16404895|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
16404896|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
16404897|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
16404898|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
16404899|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
16404900|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
16404901|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
16404902|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
16404903|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
16404904|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
16404905|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
16404906|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
16404907|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
16404908|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
16404909|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
16404910|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
16404911|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
16404912|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
16404913|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
16404914|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
16404915|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
16404916|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
16404917|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
16404918|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
16404919|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
16404920|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
16404921|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
16404922|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
16404923|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
16404924|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
16404925|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
16404926|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
16404927|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
16404928|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
16404929|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
16404930|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
16404931|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
16404932|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
16404933|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
16404934|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
16404935|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
16404936|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
16404937|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
16404938|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
16404939|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
16404940|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
16404941|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
16404942|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
16404943|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
16404944|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
16404945|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
16404946|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
16404947|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
16404948|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
16404949|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
16404950|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
16404951|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16404952|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
16404953|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16404954|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16404955|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16404956|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16404957|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16404958|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
16404959|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
16404960|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
16404961|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
16404962|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
16535576|NCT00279201|40422153|FG002|Intensification Addendum|Death|0|||
16535577|NCT00279201|40422154|FG003|Intensification Addendum|Death|0|||
16535578|NCT00279201|40422155|FG004|Intensification Addendum|Death|1|||
16535579|NCT00279201|40422156|FG005|Intensification Addendum|Death|0|||
16404963|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
16404964|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
16404965|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
16404966|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
16404967|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
16102121|NCT03852433|38859806|FG003|Overall Study|Adverse Event|1|||
16335781|NCT00236899|39714852|FG001|Overall Study|Lost to Follow-up|1|||
16335782|NCT00236899|39714853|FG002|Overall Study|Lost to Follow-up|0|||
16335783|NCT00236899|39714854|FG003|Overall Study|Lost to Follow-up|0|||
16335784|NCT00236899|39714851|FG000|Overall Study|Entry Criteria Exclusion|0|||
16102122|NCT03852433|38859803|FG000|Overall Study|Lost to Follow-up|0|||
16102123|NCT03852433|38859804|FG001|Overall Study|Lost to Follow-up|1|||
16335785|NCT00236899|39714852|FG001|Overall Study|Entry Criteria Exclusion|1|||
16335786|NCT00236899|39714853|FG002|Overall Study|Entry Criteria Exclusion|1|||
16335787|NCT00236899|39714854|FG003|Overall Study|Entry Criteria Exclusion|0|||
16335788|NCT00236899|39714851|FG000|Overall Study|Protocol Violation|1|||
16102124|NCT03852433|38859805|FG002|Overall Study|Lost to Follow-up|0|||
16335789|NCT00236899|39714852|FG001|Overall Study|Protocol Violation|0|||
16335790|NCT00236899|39714853|FG002|Overall Study|Protocol Violation|0|||
16335791|NCT00236899|39714854|FG003|Overall Study|Protocol Violation|0|||
16335792|NCT00236899|39714851|FG000|Overall Study|Withdrawal by Subject|6|||
16335793|NCT00236899|39714852|FG001|Overall Study|Withdrawal by Subject|4|||
16335794|NCT00236899|39714853|FG002|Overall Study|Withdrawal by Subject|5|||
16335795|NCT00236899|39714854|FG003|Overall Study|Withdrawal by Subject|2|||
16102125|NCT03852433|38859806|FG003|Overall Study|Lost to Follow-up|1|||
16102126|NCT03852433|38859803|FG000|Overall Study|Pregnancy|0|||
16102127|NCT03852433|38859804|FG001|Overall Study|Pregnancy|1|||
16102128|NCT03852433|38859805|FG002|Overall Study|Pregnancy|1|||
16102129|NCT03852433|38859806|FG003|Overall Study|Pregnancy|0|||
16102130|NCT03852433|38859803|FG000|Overall Study|Protocol Violation|0|||
16335796|NCT00236899|39714851|FG000|Overall Study|Physician Decision|7|||
16335797|NCT00236899|39714852|FG001|Overall Study|Physician Decision|8|||
16335798|NCT00236899|39714853|FG002|Overall Study|Physician Decision|7|||
16335799|NCT00236899|39714854|FG003|Overall Study|Physician Decision|6|||
16335800|NCT00236899|39714851|FG000|Overall Study|Satisfactory Response|2|||
16335801|NCT00236899|39714852|FG001|Overall Study|Satisfactory Response|0|||
16335802|NCT00236899|39714853|FG002|Overall Study|Satisfactory Response|0|||
16335803|NCT00236899|39714854|FG003|Overall Study|Satisfactory Response|1|||
16335804|NCT00236899|39714851|FG000|Overall Study|Lack of Efficacy|18|||
16404968|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
16404969|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
16404970|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16404971|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
16404972|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
16404973|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16404974|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16335805|NCT00236899|39714852|FG001|Overall Study|Lack of Efficacy|18|||
16335806|NCT00236899|39714853|FG002|Overall Study|Lack of Efficacy|25|||
16335807|NCT00236899|39714854|FG003|Overall Study|Lack of Efficacy|23|||
16335808|NCT00473824|39714855|FG000|Overall Study|Virologic Breakthrough|1|||
16404975|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16404976|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16404977|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16404978|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
16404979|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
16404980|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
16102131|NCT03852433|38859804|FG001|Overall Study|Protocol Violation|0|||
16102132|NCT03852433|38859805|FG002|Overall Study|Protocol Violation|1|||
16404981|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
16404982|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
16404983|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
16404984|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
16404985|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
16404986|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
16404987|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
16404988|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
16404989|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
16404990|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
16404991|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
16404992|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
16404993|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
16102133|NCT03852433|38859806|FG003|Overall Study|Protocol Violation|1|||
16102134|NCT03852433|38859803|FG000|Overall Study|Death|0|||
16102135|NCT03852433|38859804|FG001|Overall Study|Death|0|||
16102136|NCT03852433|38859805|FG002|Overall Study|Death|1|||
16102137|NCT03852433|38859806|FG003|Overall Study|Death|0|||
16102138|NCT03852433|38859803|FG000|Overall Study|Lack of Efficacy|0|||
16102139|NCT03852433|38859804|FG001|Overall Study|Lack of Efficacy|1|||
16216670|NCT02299206|39272460|FG000|Overall Study|Withdrawal by Subject|1|||
16335809|NCT00473824|39714856|FG001|Overall Study|Virologic Breakthrough|0|||
16335810|NCT00473824|39714855|FG000|Overall Study|Adverse Event|1|||
16335811|NCT00473824|39714856|FG001|Overall Study|Adverse Event|0|||
16335812|NCT00473824|39714855|FG000|Overall Study|Death|1|||
16535580|NCT00514735|40422157|FG000|Overall Study|Withdrawal by Subject|13|||
16535581|NCT00514735|40422158|FG001|Overall Study|Withdrawal by Subject|5|||
16535582|NCT00514735|40422157|FG000|Overall Study|Death|1|||
16535583|NCT00514735|40422158|FG001|Overall Study|Death|0|||
16535584|NCT00514735|40422157|FG000|Overall Study|Lost to Follow-up|0|||
16535585|NCT00514735|40422158|FG001|Overall Study|Lost to Follow-up|1|||
16535586|NCT01368965|40422166|FG000|Overall Study|Lost to Follow-up|12|||
16535587|NCT00626028|40422167|FG000|Overall Study|Adverse Event|1|||
16102140|NCT03852433|38859805|FG002|Overall Study|Lack of Efficacy|0|||
16102141|NCT03852433|38859806|FG003|Overall Study|Lack of Efficacy|0|||
16102142|NCT03852433|38859803|FG000|Overall Study|Non-compliance with study drug|0|||
16102143|NCT03852433|38859804|FG001|Overall Study|Non-compliance with study drug|0|||
16102144|NCT03852433|38859805|FG002|Overall Study|Non-compliance with study drug|0|||
16102145|NCT03852433|38859806|FG003|Overall Study|Non-compliance with study drug|1|||
16102146|NCT03852433|38859803|FG000|Overall Study|Physician Decision|1|||
16102147|NCT03852433|38859804|FG001|Overall Study|Physician Decision|0|||
16102148|NCT03852433|38859805|FG002|Overall Study|Physician Decision|0|||
16102149|NCT03852433|38859806|FG003|Overall Study|Physician Decision|0|||
16102150|NCT03852433|38859803|FG000|Overall Study|Randomized but never treated|1|||
16102151|NCT03852433|38859804|FG001|Overall Study|Randomized but never treated|0|||
16102152|NCT03852433|38859805|FG002|Overall Study|Randomized but never treated|0|||
16102153|NCT03852433|38859806|FG003|Overall Study|Randomized but never treated|0|||
16102154|NCT03319719|38859807|FG000|Overall Study|Lost to Follow-up|1|||
16102155|NCT00474383|38859808|FG000|Main Study|Adverse Event|11|||
16102156|NCT00474383|38859809|FG001|Main Study|Adverse Event|0|||
16102157|NCT00474383|38859808|FG000|Main Study|Symptomatic Deterioration|1|||
16102158|NCT00474383|38859809|FG001|Main Study|Symptomatic Deterioration|0|||
16102159|NCT00474383|38859808|FG000|Main Study|Progressive Disease|23|||
16102160|NCT00474383|38859809|FG001|Main Study|Progressive Disease|0|||
16102161|NCT00474383|38859808|FG000|Main Study|Other|1|||
16102162|NCT00474383|38859809|FG001|Main Study|Other|0|||
16102163|NCT00474383|38859808|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
16102164|NCT00474383|38859809|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
16102165|NCT00474383|38859808|FG000|Extension|Progressive Disease|0|||
16102166|NCT00474383|38859809|FG001|Extension|Progressive Disease|5|||
16102167|NCT01024036|38859810|FG000|Blinded Treatment|Adverse Event|1|||
16102168|NCT01024036|38859811|FG001|Blinded Treatment|Adverse Event|1|||
16102169|NCT01024036|38859810|FG000|Blinded Treatment|Lack of Efficacy|16|||
16102170|NCT01024036|38859811|FG001|Blinded Treatment|Lack of Efficacy|14|||
16102171|NCT01024036|38859810|FG000|Blinded Treatment|Physician Decision|1|||
16102172|NCT01024036|38859811|FG001|Blinded Treatment|Physician Decision|0|||
16102173|NCT01024036|38859810|FG000|Blinded Treatment|Death|0|||
16102174|NCT01024036|38859811|FG001|Blinded Treatment|Death|2|||
16102175|NCT01024036|38859810|FG000|Blinded Treatment|Withdrawal by Subject|4|||
16102176|NCT01024036|38859811|FG001|Blinded Treatment|Withdrawal by Subject|3|||
16102177|NCT01024036|38859810|FG000|Unblinded Treatment|Adverse Event|0|||
16102178|NCT01024036|38859811|FG001|Unblinded Treatment|Adverse Event|1|||
16102179|NCT01024036|38859810|FG000|Unblinded Treatment|Lack of Efficacy|0|||
16102180|NCT01024036|38859811|FG001|Unblinded Treatment|Lack of Efficacy|2|||
16102181|NCT01024036|38859810|FG000|Follow-Up Period|Lost to Follow-up|1|||
16102182|NCT01024036|38859811|FG001|Follow-Up Period|Lost to Follow-up|1|||
16102183|NCT01024036|38859810|FG000|Follow-Up Period|Withdrawal by Subject|0|||
16102184|NCT01024036|38859811|FG001|Follow-Up Period|Withdrawal by Subject|1|||
16102185|NCT01024036|38859810|FG000|Follow-Up Period|Adverse Event|4|||
16102186|NCT01024036|38859811|FG001|Follow-Up Period|Adverse Event|1|||
16102187|NCT02642159|38859814|FG000|Overall Study|Randomized but not treated|1|||
16102188|NCT02642159|38859815|FG001|Overall Study|Randomized but not treated|0|||
16102189|NCT02642159|38859814|FG000|Overall Study|Adverse Event|10|||
16102190|NCT02642159|38859815|FG001|Overall Study|Adverse Event|4|||
16102191|NCT02642159|38859814|FG000|Overall Study|Withdrawal by Subject|9|||
16102192|NCT02642159|38859815|FG001|Overall Study|Withdrawal by Subject|1|||
16102193|NCT02642159|38859814|FG000|Overall Study|Poor compliance to study protocol|1|||
16535588|NCT00626028|40422168|FG001|Overall Study|Adverse Event|1|||
16535589|NCT00626028|40422167|FG000|Overall Study|Device Failure|0|||
16535590|NCT00626028|40422168|FG001|Overall Study|Device Failure|1|||
16535591|NCT00626028|40422167|FG000|Overall Study|Physician Decision|2|||
16102194|NCT02642159|38859815|FG001|Overall Study|Poor compliance to study protocol|0|||
16102195|NCT02642159|38859814|FG000|Overall Study|Other than specified above|10|||
16102196|NCT02642159|38859815|FG001|Overall Study|Other than specified above|3|||
16102197|NCT00497198|38859818|FG000|Overall Study|Adverse Event|4|||
16102198|NCT00497198|38859819|FG001|Overall Study|Adverse Event|2|||
16102199|NCT00497198|38859818|FG000|Overall Study|Physician Decision|1|||
16102200|NCT00497198|38859819|FG001|Overall Study|Physician Decision|2|||
16102201|NCT00497198|38859818|FG000|Overall Study|Withdrawal by Subject|0|||
16102202|NCT00497198|38859819|FG001|Overall Study|Withdrawal by Subject|1|||
16535592|NCT00626028|40422168|FG001|Overall Study|Physician Decision|1|||
16535593|NCT00626028|40422167|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
16535594|NCT00626028|40422168|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
16102203|NCT00428441|38859822|FG000|Overall Study|Lost to Follow-up|1|||
16102204|NCT00866918|38859823|FG000|Overall Study|Death|1|||
16102205|NCT00866918|38859824|FG001|Overall Study|Death|5|||
16102206|NCT00866918|38859823|FG000|Overall Study|Lack of Efficacy|1|||
16102207|NCT00866918|38859824|FG001|Overall Study|Lack of Efficacy|1|||
16102208|NCT00866918|38859823|FG000|Overall Study|Physician Decision|10|||
16102209|NCT00866918|38859824|FG001|Overall Study|Physician Decision|2|||
16102210|NCT00866918|38859823|FG000|Overall Study|Ineligible|2|||
16535595|NCT01261611|40422169|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
16535596|NCT01261611|40422170|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
16102211|NCT00866918|38859824|FG001|Overall Study|Ineligible|4|||
16102212|NCT00866918|38859823|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
16102213|NCT00866918|38859824|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
16102214|NCT00866918|38859823|FG000|Overall Study|Secondary malignancy|1|||
16102215|NCT00866918|38859824|FG001|Overall Study|Secondary malignancy|0|||
16102216|NCT02368691|38863129|FG000|Overall Study|Death|13|||
16102217|NCT02368691|38863129|FG000|Overall Study|Lack of Efficacy|15|||
16102218|NCT02368691|38863129|FG000|Overall Study|Physician Decision|4|||
16102219|NCT04054193|38863132|FG000|Cycle 1|Physician Decision|1|||
16102220|NCT04054193|38863132|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
16102221|NCT04054193|38863132|FG000|Cycle 1|Allocated but not treated|3|||
16102222|NCT04054193|38863132|FG000|Cycles 2-3|Physician Decision|2|||
16102223|NCT04054193|38863132|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
16102224|NCT04054193|38863132|FG000|Cycles 2-3|Various reasons|17|||
16102225|NCT01705145|38863133|FG000|Part B|Adverse Event|1|||
16102226|NCT01747837|38863134|FG000|Overall Study|Lost to Follow-up|5|||
16102227|NCT01747837|38863135|FG001|Overall Study|Lost to Follow-up|2|||
16102228|NCT01747837|38863134|FG000|Overall Study|Death|4|||
16102229|NCT01747837|38863135|FG001|Overall Study|Death|4|||
16102230|NCT01685047|38863136|FG000|Overall Study|Withdrawal by Subject|20|||
16102231|NCT01685047|38863136|FG000|Overall Study|Death|26|||
16102232|NCT01685047|38863136|FG000|Overall Study|Lost to Follow-up|8|||
16102233|NCT01685047|38863136|FG000|Overall Study|Physician Decision|25|||
16102234|NCT01685047|38863136|FG000|Overall Study|Adverse Event|5|||
16102235|NCT01685047|38863136|FG000|Overall Study|patient withdrawn by sponsor|1|||
16102236|NCT03226353|38863137|FG000|Overall Study|Withdrawal by Subject|1|||
16102237|NCT03226353|38863137|FG000|Overall Study|Screen Failure|5|||
16102238|NCT01379521|38863140|FG000|Overall Study -Treatment Period|Adverse Event|3|||
16102239|NCT01379521|38863141|FG001|Overall Study -Treatment Period|Adverse Event|0|||
16102240|NCT01379521|38863140|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
16102241|NCT01379521|38863141|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
16102242|NCT01379521|38863140|FG000|Overall Study -Treatment Period|Disease Progression|23|||
16102243|NCT01379521|38863141|FG001|Overall Study -Treatment Period|Disease Progression|22|||
16102244|NCT01379521|38863140|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
16102245|NCT01379521|38863141|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
16102246|NCT01379521|38863140|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
16102247|NCT01379521|38863141|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
16102248|NCT01379521|38863140|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
16102249|NCT01379521|38863141|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
16102250|NCT01379521|38863140|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
16102251|NCT01379521|38863141|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
16102252|NCT01379521|38863140|FG000|Overall Study -Treatment Period|Death|2|||
16102253|NCT01379521|38863141|FG001|Overall Study -Treatment Period|Death|1|||
16102254|NCT01379521|38863140|FG000|Post-Treatment Evaluations|Disease Progression|22|||
16102255|NCT01379521|38863141|FG001|Post-Treatment Evaluations|Disease Progression|20|||
16102256|NCT01379521|38863140|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
16102257|NCT01379521|38863141|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
16102258|NCT01379521|38863140|FG000|Post-Treatment Evaluations|Death|1|||
16102259|NCT01379521|38863141|FG001|Post-Treatment Evaluations|Death|0|||
16102260|NCT02475733|38863147|FG000|Overall Study|Withdrawal by Subject|1|||
16102261|NCT02475733|38863148|FG001|Overall Study|Withdrawal by Subject|0|||
16102262|NCT02475733|38863147|FG000|Overall Study|Physician Decision|1|||
16102263|NCT02475733|38863148|FG001|Overall Study|Physician Decision|0|||
16102264|NCT00762723|38863149|FG000|Overall Study|Study Terminated slow enrollement|5|||
16102265|NCT00762723|38863150|FG001|Overall Study|Study Terminated slow enrollement|5|||
16102266|NCT00762723|38863151|FG002|Overall Study|Study Terminated slow enrollement|3|||
16102267|NCT03635775|38863152|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
16102268|NCT03635775|38863153|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
16102269|NCT03635775|38863154|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
16102270|NCT03635775|38863155|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
16102271|NCT01157377|38863156|FG000|Overall Study|Lost to Follow-up|0|||
16102272|NCT01157377|38863157|FG001|Overall Study|Lost to Follow-up|0|||
16535597|NCT01261611|40422171|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
16102273|NCT01157377|38863158|FG002|Overall Study|Lost to Follow-up|1|||
16102274|NCT01157377|38863159|FG003|Overall Study|Lost to Follow-up|0|||
16102275|NCT01157377|38863160|FG004|Overall Study|Lost to Follow-up|1|||
16102276|NCT01157377|38863161|FG005|Overall Study|Lost to Follow-up|1|||
16102277|NCT01157377|38863162|FG006|Overall Study|Lost to Follow-up|0|||
16102278|NCT01157377|38863156|FG000|Overall Study|Personal Reasons|2|||
16102279|NCT01157377|38863157|FG001|Overall Study|Personal Reasons|1|||
16102280|NCT01157377|38863158|FG002|Overall Study|Personal Reasons|0|||
16102281|NCT01157377|38863159|FG003|Overall Study|Personal Reasons|1|||
16102282|NCT01157377|38863160|FG004|Overall Study|Personal Reasons|0|||
16102283|NCT01157377|38863161|FG005|Overall Study|Personal Reasons|0|||
16535598|NCT01261611|40422169|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
16535599|NCT01261611|40422170|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
16102284|NCT01157377|38863162|FG006|Overall Study|Personal Reasons|0|||
16102285|NCT01157377|38863156|FG000|Overall Study|Protocol Violation|0|||
16102286|NCT01157377|38863157|FG001|Overall Study|Protocol Violation|0|||
16102287|NCT01157377|38863158|FG002|Overall Study|Protocol Violation|0|||
16102288|NCT01157377|38863159|FG003|Overall Study|Protocol Violation|0|||
16102289|NCT01157377|38863160|FG004|Overall Study|Protocol Violation|0|||
16102290|NCT01157377|38863161|FG005|Overall Study|Protocol Violation|1|||
16102291|NCT01157377|38863162|FG006|Overall Study|Protocol Violation|0|||
16102292|NCT01157377|38863156|FG000|Overall Study|Lack of Efficacy|0|||
16102293|NCT01157377|38863157|FG001|Overall Study|Lack of Efficacy|0|||
16102294|NCT01157377|38863158|FG002|Overall Study|Lack of Efficacy|0|||
16102295|NCT01157377|38863159|FG003|Overall Study|Lack of Efficacy|0|||
16102296|NCT01157377|38863160|FG004|Overall Study|Lack of Efficacy|0|||
16102297|NCT01157377|38863161|FG005|Overall Study|Lack of Efficacy|0|||
16102298|NCT01157377|38863162|FG006|Overall Study|Lack of Efficacy|1|||
16102299|NCT01157377|38863156|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16102300|NCT01157377|38863157|FG001|Overall Study|Other Miscellaneous Reasons|2|||
16102301|NCT01157377|38863158|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16102302|NCT01157377|38863159|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16102303|NCT01157377|38863160|FG004|Overall Study|Other Miscellaneous Reasons|1|||
16102304|NCT01157377|38863161|FG005|Overall Study|Other Miscellaneous Reasons|1|||
16102305|NCT01157377|38863162|FG006|Overall Study|Other Miscellaneous Reasons|1|||
16102306|NCT01954771|38863163|FG000|Overall Study|Missing HbA1c of end-point|1|||
16102307|NCT01954771|38863164|FG001|Overall Study|Missing HbA1c of end-point|1|||
16102308|NCT01954771|38863165|FG002|Overall Study|Missing HbA1c of end-point|0|||
16102309|NCT01954771|38863163|FG000|Overall Study|Missing CGMS of end-point|1|||
16102310|NCT01954771|38863164|FG001|Overall Study|Missing CGMS of end-point|1|||
16102311|NCT01954771|38863165|FG002|Overall Study|Missing CGMS of end-point|0|||
16102312|NCT01954771|38863163|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
16102313|NCT01954771|38863164|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
16102314|NCT01954771|38863165|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
16102315|NCT04044352|38863166|FG000|Overall Study|Lost to Follow-up|9|||
16102316|NCT04044352|38863166|FG000|Overall Study|Withdrawal by Subject|2|||
16102317|NCT04167085|38863167|FG000|Baseline|Withdrawal by Subject|2|||
16102318|NCT04167085|38863168|FG001|Baseline|Withdrawal by Subject|1|||
16102319|NCT04167085|38863167|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
16102320|NCT04167085|38863168|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
16102321|NCT00776984|38863169|FG000|Overall Study|Adverse Event|8|||
16535600|NCT01261611|40422171|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
16535601|NCT01261611|40422169|FG000|Treatment Cycle 1|Adverse Event|0|||
16535602|NCT01261611|40422170|FG001|Treatment Cycle 1|Adverse Event|1|||
16535603|NCT01261611|40422171|FG002|Treatment Cycle 1|Adverse Event|0|||
16102322|NCT00776984|38863170|FG001|Overall Study|Adverse Event|2|||
16102323|NCT00776984|38863169|FG000|Overall Study|Protocol Violation|4|||
16102324|NCT00776984|38863170|FG001|Overall Study|Protocol Violation|2|||
16404994|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
16404995|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
16404996|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
16102325|NCT00776984|38863169|FG000|Overall Study|Lost to Follow-up|2|||
16102326|NCT00776984|38863170|FG001|Overall Study|Lost to Follow-up|0|||
16102327|NCT00776984|38863169|FG000|Overall Study|Withdrawal by Subject|12|||
16102328|NCT00776984|38863170|FG001|Overall Study|Withdrawal by Subject|7|||
16102329|NCT00776984|38863169|FG000|Overall Study|Lack of Efficacy|0|||
16216671|NCT00355615|39272461|FG000|Randomized Double Blind Period|Adverse Event|1|||
16535604|NCT01261611|40422169|FG000|Treatment Cycle 1|Protocol Violation|0|||
16102330|NCT00776984|38863170|FG001|Overall Study|Lack of Efficacy|1|||
16102331|NCT00776984|38863169|FG000|Overall Study|Other|5|||
16102332|NCT00776984|38863170|FG001|Overall Study|Other|9|||
16102333|NCT01078584|38863171|FG000|Overall Study|Final Status Unknown|1073|||
16102334|NCT01078584|38863171|FG000|Overall Study|Lost to Follow-up|670|||
16102335|NCT01078584|38863171|FG000|Overall Study|Non-serious Adverse Event|577|||
16102336|NCT01078584|38863171|FG000|Overall Study|Withdrawal of Consent|244|||
16102337|NCT01078584|38863171|FG000|Overall Study|Physician Withdrew from Study|90|||
16535605|NCT01261611|40422170|FG001|Treatment Cycle 1|Protocol Violation|0|||
16404997|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
16404998|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16404999|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405000|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405001|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
16102338|NCT01078584|38863171|FG000|Overall Study|Non-compliance|67|||
16405002|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
16405003|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405004|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405005|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405006|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405007|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405008|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
16405009|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16102339|NCT01078584|38863171|FG000|Overall Study|Blood Pressure Controlled|49|||
16102340|NCT01078584|38863171|FG000|Overall Study|Physician Switched Medication|26|||
16102341|NCT01078584|38863171|FG000|Overall Study|Physician Discontinued Patient|12|||
16102342|NCT01078584|38863171|FG000|Overall Study|Lack of Efficacy|98|||
16102343|NCT01078584|38863171|FG000|Overall Study|Protocol Violation|75|||
16102344|NCT01078584|38863171|FG000|Overall Study|Serious Adverse Event|27|||
16102345|NCT01078584|38863171|FG000|Overall Study|Multiple Reasons|2|||
16102346|NCT02394925|38863172|FG000|Overall Study|Adverse Event|1|||
16102347|NCT02394925|38863172|FG000|Overall Study|Lens Discomfort|3|||
16102348|NCT02394925|38863172|FG000|Overall Study|Lens handling difficulities|5|||
16102349|NCT02394925|38863172|FG000|Overall Study|Lost to Follow-up|9|||
16102350|NCT02394925|38863172|FG000|Overall Study|Protocol Violation|5|||
16102351|NCT02394925|38863172|FG000|Overall Study|No longer meet eligibility criteria|1|||
16102352|NCT02394925|38863172|FG000|Overall Study|Unsatisfactory Visual Response|5|||
16335813|NCT00473824|39714856|FG001|Overall Study|Death|0|||
16335814|NCT00473824|39714855|FG000|Overall Study|Lost to Follow-up|1|||
16335815|NCT00473824|39714856|FG001|Overall Study|Lost to Follow-up|0|||
16335816|NCT00473824|39714855|FG000|Overall Study|Withdrawal by physician|1|||
16335817|NCT00473824|39714856|FG001|Overall Study|Withdrawal by physician|0|||
16335818|NCT04643964|39714859|FG000|Overall Study|Lost to Follow-up|55|||
16335819|NCT04643964|39714860|FG001|Overall Study|Lost to Follow-up|59|||
16335820|NCT04643964|39714861|FG002|Overall Study|Lost to Follow-up|54|||
16335821|NCT04643964|39714862|FG003|Overall Study|Lost to Follow-up|129|||
16335822|NCT04643964|39714863|FG004|Overall Study|Lost to Follow-up|48|||
16335823|NCT04643964|39714859|FG000|Overall Study|Failed attention check|1|||
16335824|NCT04643964|39714860|FG001|Overall Study|Failed attention check|8|||
16335825|NCT04643964|39714861|FG002|Overall Study|Failed attention check|2|||
16335826|NCT04643964|39714862|FG003|Overall Study|Failed attention check|14|||
16335827|NCT04643964|39714863|FG004|Overall Study|Failed attention check|11|||
16335828|NCT00750919|39714864|FG000|Overall Study|Adverse Event|9|||
16335829|NCT00750919|39714864|FG000|Overall Study|Withdrawal by Subject|1|||
16335830|NCT00750919|39714864|FG000|Overall Study|Lack of Efficacy|8|||
16335831|NCT00750919|39714864|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
16335832|NCT00750919|39714864|FG000|Overall Study|Other|36|||
16102353|NCT01129115|38863175|FG000|Overall Study|Adverse Event|1|||
16335833|NCT03448939|39714865|FG000|Overall Study|Adverse Event|5|||
16335834|NCT03448939|39714866|FG001|Overall Study|Adverse Event|1|||
16335835|NCT03448939|39714865|FG000|Overall Study|Lost to Follow-up|6|||
16335836|NCT03448939|39714866|FG001|Overall Study|Lost to Follow-up|6|||
16335837|NCT03448939|39714865|FG000|Overall Study|Pregnancy|1|||
16335838|NCT03448939|39714866|FG001|Overall Study|Pregnancy|1|||
16335839|NCT03448939|39714865|FG000|Overall Study|Withdrawal by Subject|9|||
16335840|NCT03448939|39714866|FG001|Overall Study|Withdrawal by Subject|3|||
16335841|NCT00087126|39714867|FG000|Overall Study|Ineligible - second primary|1|||
16335842|NCT00087126|39714867|FG000|Overall Study|Never treated|1|||
16335843|NCT01941537|39714870|FG000|Overall Study|Lack of Efficacy|1|||
16335844|NCT01941537|39714871|FG001|Overall Study|Lack of Efficacy|2|||
16335845|NCT01941537|39714870|FG000|Overall Study|Lost to Follow-up|1|||
16335846|NCT01941537|39714871|FG001|Overall Study|Lost to Follow-up|0|||
16335847|NCT01941537|39714870|FG000|Overall Study|Pregnancy|1|||
16335848|NCT01941537|39714871|FG001|Overall Study|Pregnancy|0|||
16102354|NCT01129115|38863176|FG001|Overall Study|Adverse Event|2|||
16102355|NCT01129115|38863177|FG002|Overall Study|Adverse Event|3|||
16102356|NCT01129115|38863178|FG003|Overall Study|Adverse Event|3|||
16102357|NCT01129115|38863175|FG000|Overall Study|Withdrawal by Subject|1|||
16102358|NCT01129115|38863176|FG001|Overall Study|Withdrawal by Subject|3|||
16102359|NCT01129115|38863177|FG002|Overall Study|Withdrawal by Subject|1|||
16102360|NCT01129115|38863178|FG003|Overall Study|Withdrawal by Subject|4|||
16102361|NCT01129115|38863175|FG000|Overall Study|Protocol Violation|0|||
16102362|NCT01129115|38863176|FG001|Overall Study|Protocol Violation|2|||
16102363|NCT01129115|38863177|FG002|Overall Study|Protocol Violation|2|||
16102364|NCT01129115|38863178|FG003|Overall Study|Protocol Violation|2|||
16102365|NCT02186015|38863188|FG000|Overall Study|Physician Decision|1|||
16102366|NCT02186015|38863189|FG001|Overall Study|Physician Decision|0|||
16102367|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
16102368|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
16102369|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
16102370|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
16102371|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
16102372|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
16102373|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
16102374|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
16102375|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
16102376|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
16102377|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
16335849|NCT01941537|39714870|FG000|Overall Study|Adverse Event|1|||
16335850|NCT01941537|39714871|FG001|Overall Study|Adverse Event|0|||
16335851|NCT01941537|39714870|FG000|Overall Study|Withdrawal by Subject|0|||
16335852|NCT01941537|39714871|FG001|Overall Study|Withdrawal by Subject|1|||
16335853|NCT02655016|39714872|FG000|Overall Study|Disease progression|6|||
16335854|NCT02655016|39714873|FG001|Overall Study|Disease progression|4|||
16335855|NCT02655016|39714872|FG000|Overall Study|Site closed|0|||
16335856|NCT02655016|39714873|FG001|Overall Study|Site closed|1|||
16335857|NCT02655016|39714872|FG000|Overall Study|Death|30|||
16335858|NCT02655016|39714873|FG001|Overall Study|Death|48|||
16335859|NCT02655016|39714872|FG000|Overall Study|Lost to Follow-up|1|||
16335860|NCT02655016|39714873|FG001|Overall Study|Lost to Follow-up|1|||
16335861|NCT02655016|39714872|FG000|Overall Study|Withdrawal by Subject|18|||
16335862|NCT02655016|39714873|FG001|Overall Study|Withdrawal by Subject|36|||
16335863|NCT01606748|39714874|FG000|Overall Study|Adverse Event|1|||
16335864|NCT01606748|39714875|FG001|Overall Study|Adverse Event|0|||
16335865|NCT01606748|39714874|FG000|Overall Study|Progressive Disease|1|||
16405010|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
16102378|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
16102379|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
16102380|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
16102381|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
16102382|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
16102383|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
16102384|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
16102385|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
16102386|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
16102387|NCT02637856|38863191|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
16102388|NCT02637856|38863192|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
16335866|NCT01606748|39714875|FG001|Overall Study|Progressive Disease|0|||
16335867|NCT01606748|39714874|FG000|Overall Study|Withdrawal by Subject|1|||
16102389|NCT02637856|38863191|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
16335868|NCT01606748|39714875|FG001|Overall Study|Withdrawal by Subject|0|||
16335869|NCT02117713|39714876|FG000|Week 48|Adverse Event|4|||
16335870|NCT02117713|39714876|FG000|Week 48|Withdrawal by caregiver|2|||
16335871|NCT02117713|39714876|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
16335872|NCT02117713|39714876|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
16335873|NCT02117713|39714876|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
16335874|NCT02117713|39714876|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
16335875|NCT02984267|39714877|FG000|Overall Study|Protocol Violation|1|||
16335876|NCT02984267|39714878|FG001|Overall Study|Protocol Violation|0|||
16335877|NCT02984267|39714877|FG000|Overall Study|Withdrawal by Subject|0|||
16335878|NCT02984267|39714878|FG001|Overall Study|Withdrawal by Subject|1|||
16335879|NCT00552032|39714879|FG000|Overall Study|Withdrawal by Subject|2|||
16335880|NCT00552032|39714880|FG001|Overall Study|Withdrawal by Subject|2|||
16335881|NCT00552032|39714879|FG000|Overall Study|Protocol Violation|7|||
16335882|NCT00552032|39714880|FG001|Overall Study|Protocol Violation|12|||
16335883|NCT00552032|39714879|FG000|Overall Study|Lost to Follow-up|8|||
16335884|NCT00552032|39714880|FG001|Overall Study|Lost to Follow-up|5|||
16335885|NCT03209518|39714881|FG000|Overall Study|Case Report Forms Uncollected|1|||
16335886|NCT03209518|39714881|FG000|Overall Study|Protocol Deviation|1|||
16335887|NCT01738191|39714884|FG000|Overall Study|Withdrawal by Subject|4|||
16335888|NCT01738191|39714885|FG001|Overall Study|Withdrawal by Subject|1|||
16335889|NCT02717442|39714887|FG000|Overall Study|Study Terminated by Sponsor|31|||
16335890|NCT02717442|39714888|FG001|Overall Study|Study Terminated by Sponsor|29|||
16335891|NCT02717442|39714887|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
16335892|NCT02717442|39714888|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
16335893|NCT02717442|39714887|FG000|Overall Study|Other - Not Specified|2|||
16335894|NCT02717442|39714888|FG001|Overall Study|Other - Not Specified|0|||
16335895|NCT03871829|39714891|FG000|Overall Study|Lost to Follow-up|0|||
16335896|NCT03871829|39714892|FG001|Overall Study|Lost to Follow-up|1|||
16335897|NCT03871829|39714891|FG000|Overall Study|Withdrawal by Subject|1|||
16335898|NCT03871829|39714892|FG001|Overall Study|Withdrawal by Subject|1|||
16335899|NCT03871829|39714891|FG000|Overall Study|Death|12|||
16335900|NCT03871829|39714892|FG001|Overall Study|Death|8|||
16335901|NCT03871829|39714891|FG000|Overall Study|Study terminated by sponsor|31|||
16335902|NCT03871829|39714892|FG001|Overall Study|Study terminated by sponsor|34|||
16335903|NCT02667626|39714893|FG000|Overall Study|Withdrawal by Subject|0|||
16335904|NCT02667626|39714894|FG001|Overall Study|Withdrawal by Subject|1|||
16335905|NCT03597022|39714895|FG000|Overall Study|Premature termination of the study|7|||
16335906|NCT03597022|39714896|FG001|Overall Study|Premature termination of the study|7|||
16335907|NCT03597022|39714897|FG002|Overall Study|Premature termination of the study|8|||
16335908|NCT03597022|39714895|FG000|Overall Study|Serious adverse event|1|||
16335909|NCT03597022|39714896|FG001|Overall Study|Serious adverse event|1|||
16335910|NCT03597022|39714897|FG002|Overall Study|Serious adverse event|0|||
16335911|NCT03426436|39714898|FG000|Overall Study|Incorrect lead placement|12|||
16335912|NCT03426436|39714898|FG000|Overall Study|Withdrawal by Subject|2|||
16335913|NCT03426436|39714898|FG000|Overall Study|Consent issue|1|||
16335914|NCT03426436|39714898|FG000|Overall Study|ECGs not saved|4|||
16335915|NCT01606202|39714908|FG000|Overall Study|Adverse Event|5|||
16335916|NCT01606202|39714909|FG001|Overall Study|Adverse Event|0|||
16335917|NCT01606202|39714908|FG000|Overall Study|Withdrawal by Subject|2|||
16335918|NCT01606202|39714909|FG001|Overall Study|Withdrawal by Subject|1|||
16335919|NCT01606202|39714908|FG000|Overall Study|Personal problems|0|||
16335920|NCT01606202|39714909|FG001|Overall Study|Personal problems|1|||
16335921|NCT01606202|39714908|FG000|Overall Study|Problems with administration|0|||
16535606|NCT01261611|40422171|FG002|Treatment Cycle 1|Protocol Violation|2|||
16535607|NCT01261611|40422169|FG000|Treatment Cycle 2|Completed study|4|||
16535608|NCT01261611|40422170|FG001|Treatment Cycle 2|Completed study|0|||
16535609|NCT01261611|40422171|FG002|Treatment Cycle 2|Completed study|0|||
16535610|NCT01261611|40422169|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
16535611|NCT01261611|40422170|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
16535612|NCT01261611|40422171|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
16535613|NCT01261611|40422169|FG000|Treatment Cycle 2|Adverse Event|1|||
16535614|NCT01261611|40422170|FG001|Treatment Cycle 2|Adverse Event|0|||
16535615|NCT01261611|40422171|FG002|Treatment Cycle 2|Adverse Event|0|||
16535616|NCT01261611|40422169|FG000|Treatment Cycle 2|Protocol Violation|2|||
16535617|NCT01261611|40422170|FG001|Treatment Cycle 2|Protocol Violation|0|||
16535618|NCT01261611|40422171|FG002|Treatment Cycle 2|Protocol Violation|0|||
16335922|NCT01606202|39714909|FG001|Overall Study|Problems with administration|1|||
16335923|NCT00581542|39714910|FG000|Overall Study|they met an exclusion criteria|2|||
16335924|NCT00581542|39714911|FG001|Overall Study|they met an exclusion criteria|2|||
16335925|NCT00581542|39714910|FG000|Overall Study|Lost to Follow-up|9|||
16335926|NCT00581542|39714911|FG001|Overall Study|Lost to Follow-up|21|||
16335927|NCT02368210|39714912|FG000|Overall Study|Withdrawal by Subject|1|||
16335928|NCT02368210|39714913|FG001|Overall Study|Withdrawal by Subject|0|||
16335929|NCT02368210|39714912|FG000|Overall Study|Adverse Event|0|||
16335930|NCT02368210|39714913|FG001|Overall Study|Adverse Event|1|||
16335931|NCT03484403|39714914|FG000|Overall Study|Withdrawal by Subject|6|||
16535619|NCT01261611|40422169|FG000|Treatment Cycle 2|Not otherwise specified|2|||
16535620|NCT01261611|40422170|FG001|Treatment Cycle 2|Not otherwise specified|0|||
16535621|NCT01261611|40422171|FG002|Treatment Cycle 2|Not otherwise specified|0|||
16535622|NCT01261611|40422169|FG000|Treatment Cycle 3|Completed study|24|||
16535623|NCT01261611|40422170|FG001|Treatment Cycle 3|Completed study|0|||
16535624|NCT01261611|40422171|FG002|Treatment Cycle 3|Completed study|0|||
16535625|NCT01261611|40422169|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
16535626|NCT01261611|40422170|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
16535627|NCT01261611|40422171|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
16535628|NCT01261611|40422169|FG000|Treatment Cycle 3|Adverse Event|1|||
16535629|NCT01261611|40422170|FG001|Treatment Cycle 3|Adverse Event|0|||
16535630|NCT01261611|40422171|FG002|Treatment Cycle 3|Adverse Event|0|||
16535631|NCT01261611|40422169|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
16535632|NCT01261611|40422170|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
16535633|NCT01261611|40422171|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
16535634|NCT01261611|40422169|FG000|Treatment Cycle 4|Completed study|87|||
16535635|NCT01261611|40422170|FG001|Treatment Cycle 4|Completed study|0|||
16535636|NCT01261611|40422171|FG002|Treatment Cycle 4|Completed study|0|||
16535637|NCT01261611|40422169|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
16535638|NCT01261611|40422170|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
16535639|NCT01261611|40422171|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
16535640|NCT01261611|40422169|FG000|Treatment Cycle 4|Adverse Event|1|||
16535641|NCT01261611|40422170|FG001|Treatment Cycle 4|Adverse Event|0|||
16535642|NCT01261611|40422171|FG002|Treatment Cycle 4|Adverse Event|0|||
16535643|NCT01261611|40422169|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
16535644|NCT01261611|40422170|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
16535645|NCT01261611|40422171|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
16535646|NCT01261611|40422169|FG000|Treatment Cycle 4|Not otherwise specified|3|||
16535647|NCT01261611|40422170|FG001|Treatment Cycle 4|Not otherwise specified|0|||
16535648|NCT01261611|40422171|FG002|Treatment Cycle 4|Not otherwise specified|0|||
16535649|NCT01261611|40422169|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
16335932|NCT03484403|39714915|FG001|Overall Study|Withdrawal by Subject|4|||
16335933|NCT01420679|39714919|FG000|Overall Study|Disease Progression|3|||
16335934|NCT01420679|39714920|FG001|Overall Study|Disease Progression|2|||
16335935|NCT01420679|39714919|FG000|Overall Study|Adverse Event|4|||
16335936|NCT01420679|39714920|FG001|Overall Study|Adverse Event|0|||
16335937|NCT01420679|39714919|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
16535650|NCT01261611|40422170|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
16535651|NCT01261611|40422171|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
16535652|NCT01261611|40422169|FG000|Treatment Cycle 5|Adverse Event|1|||
16535653|NCT01261611|40422170|FG001|Treatment Cycle 5|Adverse Event|0|||
16535654|NCT01261611|40422171|FG002|Treatment Cycle 5|Adverse Event|0|||
16535655|NCT01261611|40422169|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
16535656|NCT01261611|40422170|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
16535657|NCT01261611|40422171|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
16535658|NCT01018394|40422172|FG000|Overall Study|Withdrawal by Subject|5|||
16535659|NCT01018394|40422173|FG001|Overall Study|Withdrawal by Subject|5|||
16535660|NCT01018394|40422172|FG000|Overall Study|Lost to Follow-up|4|||
16535661|NCT01018394|40422173|FG001|Overall Study|Lost to Follow-up|3|||
16535662|NCT00003298|40422174|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
16535663|NCT00003298|40422174|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
16535664|NCT00003298|40422174|FG000|Surgery|Unresectable at surgery|3|||
16535665|NCT00003298|40422174|FG000|Surgery|Progression before surgery|2|||
16535666|NCT00003298|40422174|FG000|Surgery|Unevaluable and off study|2|||
16535667|NCT00003298|40422174|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
16535668|NCT00003298|40422174|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
16535669|NCT00003298|40422174|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
16535670|NCT00003298|40422174|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
16535671|NCT00003298|40422174|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
16535672|NCT00003298|40422174|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
16535673|NCT00003298|40422174|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
16535674|NCT00003298|40422174|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
16535675|NCT00003298|40422174|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
16535676|NCT00003298|40422174|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
16535677|NCT00449176|40422175|FG000|Overall Study|Withdrawal by Subject|39|||
16535678|NCT00449176|40422176|FG001|Overall Study|Withdrawal by Subject|43|||
16535679|NCT00449176|40422177|FG002|Overall Study|Withdrawal by Subject|59|||
16535680|NCT00449176|40422175|FG000|Overall Study|Lost to Follow-up|13|||
16535681|NCT00449176|40422176|FG001|Overall Study|Lost to Follow-up|8|||
16535682|NCT00449176|40422177|FG002|Overall Study|Lost to Follow-up|12|||
16535683|NCT00449176|40422175|FG000|Overall Study|Adverse Event|51|||
16535684|NCT00449176|40422176|FG001|Overall Study|Adverse Event|107|||
16535685|NCT00449176|40422177|FG002|Overall Study|Adverse Event|15|||
16535686|NCT00449176|40422175|FG000|Overall Study|Lack of Efficacy|13|||
16535687|NCT00449176|40422176|FG001|Overall Study|Lack of Efficacy|7|||
16535688|NCT00449176|40422177|FG002|Overall Study|Lack of Efficacy|50|||
16535689|NCT00449176|40422175|FG000|Overall Study|Study drug non-compliant|14|||
16535690|NCT00449176|40422176|FG001|Overall Study|Study drug non-compliant|11|||
16535691|NCT00449176|40422177|FG002|Overall Study|Study drug non-compliant|11|||
16102390|NCT02637856|38863192|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
16102391|NCT02637856|38863191|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
16102392|NCT02637856|38863192|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
16102393|NCT01424189|38863193|FG000|Overall Study|Adverse Event|1|||
16102394|NCT01424189|38863194|FG001|Overall Study|Adverse Event|0|||
16102395|NCT01424189|38863193|FG000|Overall Study|Lost to Follow-up|4|||
16102396|NCT01424189|38863194|FG001|Overall Study|Lost to Follow-up|1|||
16102397|NCT01424189|38863193|FG000|Overall Study|Withdrawal by Subject|4|||
16102398|NCT01424189|38863194|FG001|Overall Study|Withdrawal by Subject|4|||
16102399|NCT01424189|38863193|FG000|Overall Study|Subject moved|1|||
16102400|NCT01424189|38863194|FG001|Overall Study|Subject moved|0|||
16102401|NCT01424189|38863193|FG000|Overall Study|Death|3|||
16102402|NCT01424189|38863194|FG001|Overall Study|Death|1|||
16102403|NCT02269917|38863195|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
16216672|NCT00355615|39272462|FG001|Randomized Double Blind Period|Adverse Event|0|||
16216673|NCT00355615|39272463|FG002|Randomized Double Blind Period|Adverse Event|0|||
16216674|NCT00355615|39272464|FG003|Randomized Double Blind Period|Adverse Event|0|||
16405011|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
16216675|NCT00355615|39272465|FG004|Randomized Double Blind Period|Adverse Event|0|||
16405012|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
16405013|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405014|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405015|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405016|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405017|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405018|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
16405019|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
16216676|NCT00355615|39272461|FG000|Randomized Double Blind Period|Protocol Violation|0|||
16535692|NCT00449176|40422175|FG000|Overall Study|all other|22|||
16535693|NCT00449176|40422176|FG001|Overall Study|all other|19|||
16535694|NCT00449176|40422177|FG002|Overall Study|all other|20|||
16535695|NCT02372396|40422178|FG000|Overall Study|Lost to Follow-up|7|||
16535696|NCT02372396|40422179|FG001|Overall Study|Lost to Follow-up|9|||
16216677|NCT00355615|39272462|FG001|Randomized Double Blind Period|Protocol Violation|0|||
16216678|NCT00355615|39272463|FG002|Randomized Double Blind Period|Protocol Violation|1|||
16216679|NCT00355615|39272464|FG003|Randomized Double Blind Period|Protocol Violation|1|||
16216680|NCT00355615|39272465|FG004|Randomized Double Blind Period|Protocol Violation|0|||
16216681|NCT00355615|39272461|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
16216682|NCT00355615|39272462|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
16405020|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
16405021|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
16405022|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
16405023|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
16405024|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
16405025|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
16405026|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
16405027|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
16405028|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405029|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405030|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405031|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405032|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
16405033|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405034|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405035|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405036|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405037|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16535697|NCT01881126|40422180|FG000|Overall Study|Non-compliance|1|||
16535698|NCT01881126|40422181|FG001|Overall Study|Non-compliance|1|||
16102404|NCT02269917|38863196|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
16102405|NCT02269917|38863197|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
16102406|NCT02269917|38863195|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
16335938|NCT01420679|39714920|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
16335939|NCT01420679|39714919|FG000|Overall Study|Patient Decision|1|||
16335940|NCT01420679|39714920|FG001|Overall Study|Patient Decision|0|||
16335941|NCT01420679|39714919|FG000|Overall Study|Investigator Decision|1|||
16335942|NCT01420679|39714920|FG001|Overall Study|Investigator Decision|2|||
16335943|NCT01420679|39714919|FG000|Overall Study|Sponsor Decision|3|||
16335944|NCT01420679|39714920|FG001|Overall Study|Sponsor Decision|3|||
16335945|NCT01420679|39714919|FG000|Overall Study|Other|1|||
16335946|NCT01420679|39714920|FG001|Overall Study|Other|0|||
16335947|NCT00455520|39714925|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
16335948|NCT00455520|39714926|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
16335949|NCT00455520|39714925|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
16335950|NCT00455520|39714926|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
16335951|NCT00455520|39714925|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
16335952|NCT00455520|39714926|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
16335953|NCT00455520|39714925|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
16335954|NCT00455520|39714926|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
16335955|NCT00455520|39714925|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
16335956|NCT00455520|39714926|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
16335957|NCT00455520|39714925|FG000|Open Label Tapentadol Extended Release|All other|33|||
16335958|NCT00455520|39714926|FG001|Open Label Tapentadol Extended Release|All other|0|||
16335959|NCT00455520|39714925|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
16335960|NCT00455520|39714926|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
16335961|NCT00455520|39714925|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
16335962|NCT00455520|39714926|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
16335963|NCT00455520|39714925|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
16335964|NCT00455520|39714926|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
16335965|NCT00455520|39714925|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
16335966|NCT00455520|39714926|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
16335967|NCT00455520|39714925|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
16405038|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
16405039|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
16405040|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
16405041|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
16405042|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
16405043|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
16405044|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
16405045|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
16405046|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
16405047|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
16405048|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
16405049|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
16405050|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
16405051|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
16405052|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
16405053|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
16405054|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
16405055|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
16405056|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
16405057|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
16405058|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
16405059|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
16405060|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
16405061|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
16405062|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
16405063|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
16405064|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
16405065|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
16405066|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
16405067|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
16405068|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Other|5|||
16405069|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Other|1|||
16405070|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Other|0|||
16405071|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Other|3|||
16405072|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Other|0|||
16405073|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Other|0|||
16405074|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Other|0|||
16405075|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Other|0|||
16335968|NCT00455520|39714926|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
16335969|NCT00455520|39714925|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
16535699|NCT01881126|40422180|FG000|Overall Study|Adverse Event|0|||
16535700|NCT01881126|40422181|FG001|Overall Study|Adverse Event|1|||
16535701|NCT02975973|40422182|FG000|Overall Study|Adverse Event|1|||
16535702|NCT02975973|40422183|FG001|Overall Study|Adverse Event|1|||
16535703|NCT02975973|40422184|FG002|Overall Study|Adverse Event|1|||
16535704|NCT02975973|40422185|FG003|Overall Study|Adverse Event|0|||
16535705|NCT00262821|40422186|FG000|Overall Study|Ineligible - wrong stage|0|||
16535706|NCT00262821|40422187|FG001|Overall Study|Ineligible - wrong stage|3|||
16535707|NCT00262821|40422186|FG000|Overall Study|Ineligible - wrong cell type|2|||
16535708|NCT00262821|40422187|FG001|Overall Study|Ineligible - wrong cell type|2|||
16535709|NCT00262821|40422186|FG000|Overall Study|Ineligible - wrong primary|0|||
16535710|NCT00262821|40422187|FG001|Overall Study|Ineligible - wrong primary|1|||
16535711|NCT00262821|40422186|FG000|Overall Study|Ineligible - inadequate pathology|1|||
16535712|NCT00262821|40422187|FG001|Overall Study|Ineligible - inadequate pathology|3|||
16535713|NCT00262821|40422186|FG000|Overall Study|Ineligible - elevated creatinine|0|||
16535714|NCT00262821|40422187|FG001|Overall Study|Ineligible - elevated creatinine|2|||
16535715|NCT00262821|40422186|FG000|Overall Study|Ineligible - required test not done|1|||
16535716|NCT00262821|40422187|FG001|Overall Study|Ineligible - required test not done|4|||
16535717|NCT00262821|40422186|FG000|Overall Study|Inevaluable - inadequate data|0|||
16535718|NCT00262821|40422187|FG001|Overall Study|Inevaluable - inadequate data|4|||
16535719|NCT00701038|40422188|FG000|Overall Study|study amended pilot group of patients|4|||
16535720|NCT00701038|40422189|FG001|Overall Study|study amended pilot group of patients|4|||
16535721|NCT02605954|40422190|FG000|Overall Study|Adverse Event|5|||
16535722|NCT02605954|40422191|FG001|Overall Study|Adverse Event|1|||
16535723|NCT02605954|40422190|FG000|Overall Study|Investigator's Discretion|1|||
16535724|NCT02605954|40422191|FG001|Overall Study|Investigator's Discretion|0|||
16535725|NCT02605954|40422190|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16535726|NCT02605954|40422191|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16535727|NCT02605954|40422190|FG000|Overall Study|Withdrew Consent|2|||
16535728|NCT02605954|40422191|FG001|Overall Study|Withdrew Consent|2|||
16535729|NCT02605954|40422190|FG000|Overall Study|Lost to Follow-up|3|||
16535730|NCT02605954|40422191|FG001|Overall Study|Lost to Follow-up|0|||
16535731|NCT02605954|40422190|FG000|Overall Study|Randomized but not treated|0|||
16535732|NCT02605954|40422191|FG001|Overall Study|Randomized but not treated|1|||
16535733|NCT01667432|40422192|FG000|Overall Study|Premature Study Termination|26|||
16535734|NCT01667432|40422192|FG000|Overall Study|Failure to Return|10|||
16535735|NCT01667432|40422192|FG000|Overall Study|Moved to Another Center|3|||
16535736|NCT01667432|40422192|FG000|Overall Study|Lost to Follow-up|3|||
16535737|NCT01667432|40422192|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
16535738|NCT01667432|40422192|FG000|Overall Study|Insufficient Therapeutic Response|4|||
16535739|NCT01667432|40422192|FG000|Overall Study|Adverse Event|1|||
16535740|NCT01667432|40422192|FG000|Overall Study|Protocol Deviation|2|||
16535741|NCT01667432|40422192|FG000|Overall Study|Principal Investigator Decision|1|||
16535742|NCT01667432|40422192|FG000|Overall Study|Reason Not Specified|2|||
16535743|NCT01667432|40422192|FG000|Overall Study|Missing Information|4|||
16535744|NCT02925455|40422193|FG000|Overall Study|Withdrawal by Subject|2|||
16535745|NCT02925455|40422194|FG001|Overall Study|Withdrawal by Subject|0|||
16535746|NCT02301143|40422197|FG000|Induction Period|Enrolled But Not Treated|1|||
16535747|NCT02301143|40422198|FG001|Induction Period|Enrolled But Not Treated|0|||
16535748|NCT02301143|40422197|FG000|Induction Period|Death|1|||
16535749|NCT02301143|40422198|FG001|Induction Period|Death|0|||
16535750|NCT02301143|40422197|FG000|Induction Period|Adverse Event|22|||
16535751|NCT02301143|40422198|FG001|Induction Period|Adverse Event|0|||
16535752|NCT02301143|40422197|FG000|Induction Period|Progressive Disease|8|||
16535753|NCT02301143|40422198|FG001|Induction Period|Progressive Disease|0|||
16535754|NCT02301143|40422197|FG000|Induction Period|Withdrawal by Subject|3|||
16535755|NCT02301143|40422198|FG001|Induction Period|Withdrawal by Subject|0|||
16535756|NCT02301143|40422197|FG000|Induction Period|Noncompliance with Study Drug|1|||
16535757|NCT02301143|40422198|FG001|Induction Period|Noncompliance with Study Drug|0|||
16535758|NCT02301143|40422197|FG000|Induction Period|Physician Decision|4|||
16335970|NCT00455520|39714926|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
16535759|NCT02301143|40422198|FG001|Induction Period|Physician Decision|0|||
16535760|NCT02301143|40422197|FG000|Induction Period|Symptomatic Deterioration|2|||
16535761|NCT02301143|40422198|FG001|Induction Period|Symptomatic Deterioration|0|||
16535762|NCT02301143|40422197|FG000|Induction Period|Protocol Violation|2|||
16535763|NCT02301143|40422198|FG001|Induction Period|Protocol Violation|0|||
16535764|NCT02301143|40422197|FG000|Induction Period|Other|1|||
16535765|NCT02301143|40422198|FG001|Induction Period|Other|0|||
16535766|NCT02301143|40422197|FG000|Investigator's Choice|Adverse Event|0|||
16535767|NCT02301143|40422198|FG001|Investigator's Choice|Adverse Event|3|||
16535768|NCT02301143|40422197|FG000|Investigator's Choice|Progressive Disease|0|||
16535769|NCT02301143|40422198|FG001|Investigator's Choice|Progressive Disease|3|||
16535770|NCT02301143|40422197|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
16102407|NCT02269917|38863196|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
16102408|NCT02269917|38863197|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
16405076|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Other|0|||
16405077|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Other|0|||
16405078|NCT03352557|39966231|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
16405079|NCT03352557|39966232|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
16405080|NCT03352557|39966233|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
16405081|NCT03352557|39966234|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
16405082|NCT03352557|39966235|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
16405083|NCT03352557|39966236|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
16405084|NCT03352557|39966237|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
16405085|NCT03352557|39966238|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
16405086|NCT03352557|39966239|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
16405087|NCT03352557|39966240|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
16405088|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Death|0|||
16405089|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Death|0|||
16405090|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Death|0|||
16405091|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Death|0|||
16405092|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Death|0|||
16405093|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Death|1|||
16405094|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Death|0|||
16405095|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Death|1|||
16405096|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Death|1|||
16405097|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Death|1|||
16405098|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
16405099|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
16405100|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
16405101|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
16405102|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
16405103|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
16405104|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
16405105|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
16405106|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
16405107|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
16405108|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
16405109|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
16405110|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
16405111|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
16405112|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
16405113|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
16405114|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
16405115|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
16405116|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
16405117|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
16405118|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
16405119|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
16405120|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
16405121|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
16405122|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
16405123|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
16405124|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
16102409|NCT02269917|38863195|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
16102410|NCT02269917|38863196|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
16102411|NCT02269917|38863197|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
16102412|NCT02269917|38863195|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
16535771|NCT02301143|40422198|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
16535772|NCT02301143|40422197|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
16535773|NCT02301143|40422198|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
16535774|NCT02301143|40422197|FG000|Investigator's Choice|Other|0|||
16535775|NCT02301143|40422198|FG001|Investigator's Choice|Other|1|||
16535776|NCT02301143|40422197|FG000|Investigator's Choice|Unresectable Surgery|0|||
16405125|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
16405126|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
16102413|NCT02269917|38863196|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
16535777|NCT02301143|40422198|FG001|Investigator's Choice|Unresectable Surgery|1|||
16535778|NCT00937924|40422199|FG000|Overall Study|Lost to Follow-up|44|||
16535779|NCT00937924|40422200|FG001|Overall Study|Lost to Follow-up|44|||
16535780|NCT00937924|40422201|FG002|Overall Study|Lost to Follow-up|41|||
16535781|NCT02962908|40422202|FG000|Overall Study|Lost to Follow-up|0|||
16535782|NCT02962908|40422203|FG001|Overall Study|Lost to Follow-up|3|||
16535783|NCT02962908|40422204|FG002|Overall Study|Lost to Follow-up|0|||
16535784|NCT02962908|40422205|FG003|Overall Study|Lost to Follow-up|1|||
16535785|NCT02962908|40422202|FG000|Overall Study|Withdrawal by Subject|0|||
16535786|NCT02962908|40422203|FG001|Overall Study|Withdrawal by Subject|3|||
16405127|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
16405128|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16405129|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16405130|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16405131|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16405132|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16405133|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
16405134|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
16405135|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
16405136|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
16405137|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
16405138|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16535787|NCT02962908|40422204|FG002|Overall Study|Withdrawal by Subject|0|||
16535788|NCT02962908|40422205|FG003|Overall Study|Withdrawal by Subject|2|||
16535789|NCT02962908|40422202|FG000|Overall Study|Protocol Violation|0|||
16535790|NCT02962908|40422203|FG001|Overall Study|Protocol Violation|1|||
16535791|NCT02962908|40422204|FG002|Overall Study|Protocol Violation|0|||
16535792|NCT02962908|40422205|FG003|Overall Study|Protocol Violation|0|||
16535793|NCT02962908|40422202|FG000|Overall Study|Physician Decision|0|||
16535794|NCT02962908|40422203|FG001|Overall Study|Physician Decision|1|||
16535795|NCT02962908|40422204|FG002|Overall Study|Physician Decision|0|||
16216683|NCT00355615|39272463|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
16535796|NCT02962908|40422205|FG003|Overall Study|Physician Decision|0|||
16535797|NCT01669629|40422208|FG000|Period 1|protocol deviation|1|||
16535798|NCT01669629|40422209|FG001|Period 1|protocol deviation|2|||
16535799|NCT01297062|40422212|FG000|Overall Study|Adverse Event|2|||
16535800|NCT01297062|40422213|FG001|Overall Study|Adverse Event|0|||
16535801|NCT01297062|40422214|FG002|Overall Study|Adverse Event|1|||
16535802|NCT01297062|40422215|FG003|Overall Study|Adverse Event|0|||
16535803|NCT01297062|40422216|FG004|Overall Study|Adverse Event|0|||
16535804|NCT01297062|40422217|FG005|Overall Study|Adverse Event|0|||
16535805|NCT01297062|40422218|FG006|Overall Study|Adverse Event|0|||
16535806|NCT01297062|40422212|FG000|Overall Study|Physician Decision|1|||
16535807|NCT01297062|40422213|FG001|Overall Study|Physician Decision|0|||
16535808|NCT01297062|40422214|FG002|Overall Study|Physician Decision|1|||
16535809|NCT01297062|40422215|FG003|Overall Study|Physician Decision|0|||
16535810|NCT01297062|40422216|FG004|Overall Study|Physician Decision|0|||
16535811|NCT01297062|40422217|FG005|Overall Study|Physician Decision|0|||
16535812|NCT01297062|40422218|FG006|Overall Study|Physician Decision|6|||
16535813|NCT01297062|40422212|FG000|Overall Study|Protocol Violation|0|||
16535814|NCT01297062|40422213|FG001|Overall Study|Protocol Violation|0|||
16535815|NCT01297062|40422214|FG002|Overall Study|Protocol Violation|0|||
16535816|NCT01297062|40422215|FG003|Overall Study|Protocol Violation|0|||
16535817|NCT01297062|40422216|FG004|Overall Study|Protocol Violation|1|||
16535818|NCT01297062|40422217|FG005|Overall Study|Protocol Violation|0|||
16535819|NCT01297062|40422218|FG006|Overall Study|Protocol Violation|0|||
16535820|NCT01297062|40422212|FG000|Overall Study|Subject Decision|1|||
16102414|NCT02269917|38863197|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
16535821|NCT01297062|40422213|FG001|Overall Study|Subject Decision|1|||
16535822|NCT01297062|40422214|FG002|Overall Study|Subject Decision|0|||
16102415|NCT02269917|38863195|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
16102416|NCT02269917|38863196|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
16535823|NCT01297062|40422215|FG003|Overall Study|Subject Decision|1|||
16102417|NCT02269917|38863197|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
16102418|NCT02269917|38863195|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
16102419|NCT02269917|38863196|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
16102420|NCT02269917|38863197|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
16102421|NCT02269917|38863195|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
16102422|NCT02269917|38863196|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
16102423|NCT02269917|38863197|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
16102424|NCT02269917|38863195|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
16216684|NCT00355615|39272464|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
16216685|NCT00355615|39272465|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
16216686|NCT00355615|39272461|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
16216687|NCT00355615|39272462|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
16216688|NCT00355615|39272463|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
16216689|NCT00355615|39272464|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
16216690|NCT00355615|39272465|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
16216691|NCT00355615|39272461|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
16216692|NCT00355615|39272462|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
16405139|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16535824|NCT01297062|40422216|FG004|Overall Study|Subject Decision|1|||
16535825|NCT01297062|40422217|FG005|Overall Study|Subject Decision|1|||
16535826|NCT01297062|40422218|FG006|Overall Study|Subject Decision|2|||
16535827|NCT01783418|40422219|FG000|Overall Study|Withdrawal by Subject|1|||
16535828|NCT01783418|40422220|FG001|Overall Study|Withdrawal by Subject|0|||
16535829|NCT02269670|40422224|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
16535830|NCT00781391|40422225|FG000|Overall Study|never received study drug|24|||
16535831|NCT00781391|40422226|FG001|Overall Study|never received study drug|23|||
16535832|NCT00781391|40422227|FG002|Overall Study|never received study drug|32|||
16535833|NCT00781391|40422225|FG000|Overall Study|Protocol Violation|19|||
16535834|NCT00781391|40422226|FG001|Overall Study|Protocol Violation|17|||
16535835|NCT00781391|40422227|FG002|Overall Study|Protocol Violation|20|||
16216693|NCT00355615|39272463|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
16216694|NCT00355615|39272464|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
16102425|NCT02269917|38863196|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
16216695|NCT00355615|39272465|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
16216696|NCT00355615|39272461|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
16216697|NCT00355615|39272462|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
16216698|NCT00355615|39272463|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
16216699|NCT00355615|39272464|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
16216700|NCT00355615|39272465|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
16216701|NCT00113555|39272466|FG000|Overall Study|Baseline Failure|59|||
16216702|NCT00113555|39272466|FG000|Overall Study|Permanently Explanted|7|||
16216703|NCT00113555|39272466|FG000|Overall Study|Death|1|||
16216704|NCT00113555|39272466|FG000|Overall Study|Missed Followup|4|||
16216705|NCT00113555|39272466|FG000|Overall Study|Lost to Follow-up|8|||
16216706|NCT00366444|39272467|FG000|Overall Study|Withdrawal by Subject|1|||
16216707|NCT00366444|39272468|FG001|Overall Study|Withdrawal by Subject|1|||
16216708|NCT00366444|39272467|FG000|Overall Study|Lack of Efficacy|0|||
16216709|NCT00366444|39272468|FG001|Overall Study|Lack of Efficacy|1|||
16216710|NCT00784459|39272469|FG000|Overall Study|Adverse Event|0|||
16216711|NCT00784459|39272470|FG001|Overall Study|Adverse Event|2|||
16216712|NCT01224106|39272472|FG000|Double-Blind Treatment Phase|Death|3|||
16216713|NCT01224106|39272473|FG001|Double-Blind Treatment Phase|Death|0|||
16216714|NCT01224106|39272474|FG002|Double-Blind Treatment Phase|Death|0|||
16216715|NCT01224106|39272475|FG003|Double-Blind Treatment Phase|Death|0|||
16216716|NCT01224106|39272476|FG004|Double-Blind Treatment Phase|Death|0|||
16216717|NCT01224106|39272472|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
16216718|NCT01224106|39272473|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
16216719|NCT01224106|39272474|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
16335971|NCT00530790|39714931|FG000|Overall Study|Adverse Event|2|||
16335972|NCT00530790|39714931|FG000|Overall Study|Withdrawal by Subject|2|||
16335973|NCT00530790|39714931|FG000|Overall Study|Physician Decision|1|||
16335974|NCT03015194|39714933|FG000|Overall Study|Death|10|||
16335975|NCT03015194|39714933|FG000|Overall Study|Withdrawal by Subject|2|||
16335976|NCT01124292|39714934|FG000|Overall Study|Lost to Follow-up|2|||
16335977|NCT01124292|39714935|FG001|Overall Study|Lost to Follow-up|4|||
16335978|NCT01124292|39714936|FG002|Overall Study|Lost to Follow-up|3|||
16335979|NCT01124292|39714934|FG000|Overall Study|Physician Decision|0|||
16335980|NCT01124292|39714935|FG001|Overall Study|Physician Decision|3|||
16335981|NCT01124292|39714936|FG002|Overall Study|Physician Decision|2|||
16335982|NCT01124292|39714934|FG000|Overall Study|Withdrawal by Subject|0|||
16335983|NCT01124292|39714935|FG001|Overall Study|Withdrawal by Subject|6|||
16335984|NCT01124292|39714936|FG002|Overall Study|Withdrawal by Subject|2|||
16335985|NCT01124292|39714934|FG000|Overall Study|medical issue unrelated to the study|0|||
16335986|NCT01124292|39714935|FG001|Overall Study|medical issue unrelated to the study|0|||
16335987|NCT01124292|39714936|FG002|Overall Study|medical issue unrelated to the study|2|||
16335988|NCT01124292|39714934|FG000|Overall Study|piercing track closed|0|||
16335989|NCT01124292|39714935|FG001|Overall Study|piercing track closed|2|||
16335990|NCT01124292|39714936|FG002|Overall Study|piercing track closed|1|||
16335991|NCT02686658|39714937|FG000|Overall Study|Adverse Event|0|||
16335992|NCT02686658|39714938|FG001|Overall Study|Adverse Event|0|||
16335993|NCT02686658|39714939|FG002|Overall Study|Adverse Event|1|||
16335994|NCT02686658|39714940|FG003|Overall Study|Adverse Event|1|||
16335995|NCT02686658|39714941|FG004|Overall Study|Adverse Event|2|||
16335996|NCT02686658|39714942|FG005|Overall Study|Adverse Event|1|||
16335997|NCT02686658|39714937|FG000|Overall Study|Investigator decision|0|||
16335998|NCT02686658|39714938|FG001|Overall Study|Investigator decision|0|||
16335999|NCT02686658|39714939|FG002|Overall Study|Investigator decision|0|||
16336000|NCT02686658|39714940|FG003|Overall Study|Investigator decision|1|||
16336001|NCT02686658|39714941|FG004|Overall Study|Investigator decision|2|||
16216720|NCT01224106|39272475|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
16216721|NCT01224106|39272476|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
16216722|NCT01224106|39272472|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
16336002|NCT02686658|39714942|FG005|Overall Study|Investigator decision|1|||
16336003|NCT02686658|39714937|FG000|Overall Study|Sponsor decision|1|||
16336004|NCT02686658|39714938|FG001|Overall Study|Sponsor decision|2|||
16336005|NCT02686658|39714939|FG002|Overall Study|Sponsor decision|1|||
16102426|NCT02269917|38863197|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
16102427|NCT02269917|38863195|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
16102428|NCT02269917|38863196|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
16102429|NCT02269917|38863197|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
16102430|NCT02269917|38863195|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
16535836|NCT00781391|40422225|FG000|Overall Study|Death|789|||
16535837|NCT00781391|40422226|FG001|Overall Study|Death|730|||
16535838|NCT00781391|40422227|FG002|Overall Study|Death|706|||
16535839|NCT00781391|40422225|FG000|Overall Study|Withdrawal by Subject|47|||
16535840|NCT00781391|40422226|FG001|Overall Study|Withdrawal by Subject|37|||
16535841|NCT00781391|40422227|FG002|Overall Study|Withdrawal by Subject|25|||
16535842|NCT00781391|40422225|FG000|Overall Study|Lost to Follow-up|0|||
16535843|NCT00781391|40422226|FG001|Overall Study|Lost to Follow-up|0|||
16535844|NCT00781391|40422227|FG002|Overall Study|Lost to Follow-up|1|||
16535845|NCT03086330|40422228|FG000|Overall Study|Withdrawal by Subject|3|||
16102431|NCT02269917|38863196|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
16102432|NCT02269917|38863197|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
16102433|NCT02269917|38863195|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
16102434|NCT02269917|38863196|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
16102435|NCT02269917|38863197|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
16102436|NCT02269917|38863195|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
16102437|NCT02269917|38863196|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
16102438|NCT02269917|38863197|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
16102439|NCT02269917|38863195|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
16102440|NCT02269917|38863196|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
16102441|NCT02269917|38863197|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
16102442|NCT02269917|38863195|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
16336006|NCT02686658|39714940|FG003|Overall Study|Sponsor decision|5|||
16336007|NCT02686658|39714941|FG004|Overall Study|Sponsor decision|13|||
16535846|NCT03086330|40422229|FG001|Overall Study|Withdrawal by Subject|2|||
16535847|NCT03086330|40422228|FG000|Overall Study|Lost to Follow-up|1|||
16535848|NCT03086330|40422229|FG001|Overall Study|Lost to Follow-up|2|||
16535849|NCT04512066|40422233|FG000|Double-blind Treatment Period|Adverse Event|6|||
16535850|NCT04512066|40422234|FG001|Double-blind Treatment Period|Adverse Event|4|||
16535851|NCT04512066|40422235|FG002|Double-blind Treatment Period|Adverse Event|5|||
16535852|NCT04512066|40422236|FG003|Double-blind Treatment Period|Adverse Event|1|||
16535853|NCT04512066|40422237|FG004|Double-blind Treatment Period|Adverse Event|0|||
16535854|NCT04512066|40422238|FG005|Double-blind Treatment Period|Adverse Event|0|||
16535855|NCT04512066|40422233|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
16535856|NCT04512066|40422234|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
16535857|NCT04512066|40422235|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
16535858|NCT04512066|40422236|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
16535859|NCT04512066|40422237|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
16535860|NCT04512066|40422238|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
16535861|NCT04512066|40422233|FG000|Double-blind Treatment Period|Physician Decision|1|||
16535862|NCT04512066|40422234|FG001|Double-blind Treatment Period|Physician Decision|0|||
16535863|NCT04512066|40422235|FG002|Double-blind Treatment Period|Physician Decision|1|||
16535864|NCT04512066|40422236|FG003|Double-blind Treatment Period|Physician Decision|0|||
16535865|NCT04512066|40422237|FG004|Double-blind Treatment Period|Physician Decision|0|||
16535866|NCT04512066|40422238|FG005|Double-blind Treatment Period|Physician Decision|0|||
16535867|NCT04512066|40422233|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
16535868|NCT04512066|40422234|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
16535869|NCT04512066|40422235|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
16336008|NCT02686658|39714942|FG005|Overall Study|Sponsor decision|2|||
16336009|NCT02686658|39714937|FG000|Overall Study|Lost to Follow-up|0|||
16336010|NCT02686658|39714938|FG001|Overall Study|Lost to Follow-up|0|||
16336011|NCT02686658|39714939|FG002|Overall Study|Lost to Follow-up|2|||
16336012|NCT02686658|39714940|FG003|Overall Study|Lost to Follow-up|0|||
16336013|NCT02686658|39714941|FG004|Overall Study|Lost to Follow-up|0|||
16336014|NCT02686658|39714942|FG005|Overall Study|Lost to Follow-up|1|||
16336015|NCT02686658|39714937|FG000|Overall Study|Death|1|||
16336016|NCT02686658|39714938|FG001|Overall Study|Death|0|||
16102443|NCT02269917|38863196|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
16336017|NCT02686658|39714939|FG002|Overall Study|Death|0|||
16336018|NCT02686658|39714940|FG003|Overall Study|Death|1|||
16336019|NCT02686658|39714941|FG004|Overall Study|Death|1|||
16336020|NCT02686658|39714942|FG005|Overall Study|Death|1|||
16336021|NCT02686658|39714937|FG000|Overall Study|Withdrawal by Subject|2|||
16336022|NCT02686658|39714938|FG001|Overall Study|Withdrawal by Subject|5|||
16336023|NCT02686658|39714939|FG002|Overall Study|Withdrawal by Subject|4|||
16336024|NCT02686658|39714940|FG003|Overall Study|Withdrawal by Subject|4|||
16535870|NCT04512066|40422236|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
16535871|NCT04512066|40422237|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
16535872|NCT04512066|40422238|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
16535873|NCT04512066|40422233|FG000|Extension Period|Adverse Event|0|||
16535874|NCT04512066|40422234|FG001|Extension Period|Adverse Event|1|||
16535875|NCT04512066|40422235|FG002|Extension Period|Adverse Event|4|||
16535876|NCT04512066|40422236|FG003|Extension Period|Adverse Event|3|||
16535877|NCT04512066|40422237|FG004|Extension Period|Adverse Event|1|||
16535878|NCT04512066|40422238|FG005|Extension Period|Adverse Event|3|||
16535879|NCT04512066|40422233|FG000|Extension Period|Death|0|||
16535880|NCT04512066|40422234|FG001|Extension Period|Death|0|||
16535881|NCT04512066|40422235|FG002|Extension Period|Death|0|||
16535882|NCT04512066|40422236|FG003|Extension Period|Death|0|||
16535883|NCT04512066|40422237|FG004|Extension Period|Death|0|||
16535884|NCT04512066|40422238|FG005|Extension Period|Death|1|||
16336025|NCT02686658|39714941|FG004|Overall Study|Withdrawal by Subject|17|||
16336026|NCT02686658|39714942|FG005|Overall Study|Withdrawal by Subject|8|||
16336027|NCT02686658|39714937|FG000|Overall Study|Placed in hospice care|0|||
16336028|NCT02686658|39714938|FG001|Overall Study|Placed in hospice care|0|||
16336029|NCT02686658|39714939|FG002|Overall Study|Placed in hospice care|1|||
16336030|NCT02686658|39714940|FG003|Overall Study|Placed in hospice care|0|||
16336031|NCT02686658|39714941|FG004|Overall Study|Placed in hospice care|0|||
16336032|NCT02686658|39714942|FG005|Overall Study|Placed in hospice care|0|||
16336033|NCT02686658|39714937|FG000|Overall Study|Participant non-compliance|0|||
16336034|NCT02686658|39714938|FG001|Overall Study|Participant non-compliance|0|||
16336035|NCT02686658|39714939|FG002|Overall Study|Participant non-compliance|0|||
16336036|NCT02686658|39714940|FG003|Overall Study|Participant non-compliance|0|||
16336037|NCT02686658|39714941|FG004|Overall Study|Participant non-compliance|0|||
16336038|NCT02686658|39714942|FG005|Overall Study|Participant non-compliance|1|||
16336039|NCT02686658|39714937|FG000|Overall Study|Concern over coronavirus disease care|0|||
16336040|NCT02686658|39714938|FG001|Overall Study|Concern over coronavirus disease care|0|||
16336041|NCT02686658|39714939|FG002|Overall Study|Concern over coronavirus disease care|0|||
16336042|NCT02686658|39714940|FG003|Overall Study|Concern over coronavirus disease care|0|||
16336043|NCT02686658|39714941|FG004|Overall Study|Concern over coronavirus disease care|2|||
16336044|NCT02686658|39714942|FG005|Overall Study|Concern over coronavirus disease care|1|||
16336045|NCT05052697|39714950|FG000|Substudy A|Lost to Follow-up|0|||
16336046|NCT05052697|39714951|FG001|Substudy A|Lost to Follow-up|0|||
16336047|NCT05052697|39714952|FG002|Substudy A|Lost to Follow-up|0|||
16336048|NCT05052697|39714953|FG003|Substudy A|Lost to Follow-up|0|||
16336049|NCT05052697|39714954|FG004|Substudy A|Lost to Follow-up|0|||
16336050|NCT05052697|39714955|FG005|Substudy A|Lost to Follow-up|1|||
16336051|NCT05052697|39714956|FG006|Substudy A|Lost to Follow-up|0|||
16336052|NCT05052697|39714957|FG007|Substudy A|Lost to Follow-up|0|||
16336053|NCT05052697|39714958|FG008|Substudy A|Lost to Follow-up|0|||
16336054|NCT05052697|39714959|FG009|Substudy A|Lost to Follow-up|0|||
16336055|NCT05052697|39714960|FG010|Substudy A|Lost to Follow-up|0|||
16336056|NCT05052697|39714961|FG011|Substudy A|Lost to Follow-up|0|||
16336057|NCT05052697|39714962|FG012|Substudy A|Lost to Follow-up|0|||
16336058|NCT05052697|39714963|FG013|Substudy A|Lost to Follow-up|0|||
16336059|NCT05052697|39714964|FG014|Substudy A|Lost to Follow-up|0|||
16336060|NCT05052697|39714965|FG015|Substudy A|Lost to Follow-up|2|||
16336061|NCT05052697|39714966|FG016|Substudy A|Lost to Follow-up|0|||
16336062|NCT05052697|39714967|FG017|Substudy A|Lost to Follow-up|0|||
16336063|NCT05052697|39714968|FG018|Substudy A|Lost to Follow-up|0|||
16336064|NCT05052697|39714969|FG019|Substudy A|Lost to Follow-up|0|||
16336065|NCT05052697|39714970|FG020|Substudy A|Lost to Follow-up|0|||
16336066|NCT05052697|39714971|FG021|Substudy A|Lost to Follow-up|0|||
16336067|NCT05052697|39714972|FG022|Substudy A|Lost to Follow-up|0|||
16336068|NCT05052697|39714973|FG023|Substudy A|Lost to Follow-up|0|||
16102444|NCT02269917|38863197|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
16336069|NCT05052697|39714974|FG024|Substudy A|Lost to Follow-up|0|||
16336070|NCT05052697|39714975|FG025|Substudy A|Lost to Follow-up|0|||
16535885|NCT04512066|40422233|FG000|Extension Period|Lack of Efficacy|0|||
16336071|NCT05052697|39714976|FG026|Substudy A|Lost to Follow-up|0|||
16336072|NCT05052697|39714977|FG027|Substudy A|Lost to Follow-up|0|||
16336073|NCT05052697|39714978|FG028|Substudy A|Lost to Follow-up|0|||
16535886|NCT04512066|40422234|FG001|Extension Period|Lack of Efficacy|4|||
16535887|NCT04512066|40422235|FG002|Extension Period|Lack of Efficacy|4|||
16535888|NCT04512066|40422236|FG003|Extension Period|Lack of Efficacy|1|||
16405140|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16405141|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16405142|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16405143|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
16336074|NCT05052697|39714979|FG029|Substudy A|Lost to Follow-up|0|||
16216723|NCT01224106|39272473|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
16405144|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16336075|NCT05052697|39714980|FG030|Substudy A|Lost to Follow-up|0|||
16336076|NCT05052697|39714981|FG031|Substudy A|Lost to Follow-up|0|||
16336077|NCT05052697|39714982|FG032|Substudy A|Lost to Follow-up|0|||
16336078|NCT05052697|39714983|FG033|Substudy A|Lost to Follow-up|0|||
16535889|NCT04512066|40422237|FG004|Extension Period|Lack of Efficacy|3|||
16535890|NCT04512066|40422238|FG005|Extension Period|Lack of Efficacy|3|||
16336079|NCT05052697|39714950|FG000|Substudy A|No longer met eligibility criteria|0|||
16336080|NCT05052697|39714951|FG001|Substudy A|No longer met eligibility criteria|0|||
16336081|NCT05052697|39714952|FG002|Substudy A|No longer met eligibility criteria|0|||
16336082|NCT05052697|39714953|FG003|Substudy A|No longer met eligibility criteria|0|||
16336083|NCT05052697|39714954|FG004|Substudy A|No longer met eligibility criteria|0|||
16336084|NCT05052697|39714955|FG005|Substudy A|No longer met eligibility criteria|0|||
16336085|NCT05052697|39714956|FG006|Substudy A|No longer met eligibility criteria|0|||
16336086|NCT05052697|39714957|FG007|Substudy A|No longer met eligibility criteria|0|||
16336087|NCT05052697|39714958|FG008|Substudy A|No longer met eligibility criteria|0|||
16336088|NCT05052697|39714959|FG009|Substudy A|No longer met eligibility criteria|0|||
16336089|NCT05052697|39714960|FG010|Substudy A|No longer met eligibility criteria|0|||
16336090|NCT05052697|39714961|FG011|Substudy A|No longer met eligibility criteria|0|||
16336091|NCT05052697|39714962|FG012|Substudy A|No longer met eligibility criteria|0|||
16336092|NCT05052697|39714963|FG013|Substudy A|No longer met eligibility criteria|1|||
16336093|NCT05052697|39714964|FG014|Substudy A|No longer met eligibility criteria|0|||
16405145|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
16405146|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
16405147|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
16405148|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
16405149|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
16405150|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
16405151|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
16405152|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
16535891|NCT04512066|40422233|FG000|Extension Period|Lost to Follow-up|0|||
16535892|NCT04512066|40422234|FG001|Extension Period|Lost to Follow-up|1|||
16535893|NCT04512066|40422235|FG002|Extension Period|Lost to Follow-up|5|||
16535894|NCT04512066|40422236|FG003|Extension Period|Lost to Follow-up|2|||
16535895|NCT04512066|40422237|FG004|Extension Period|Lost to Follow-up|3|||
16535896|NCT04512066|40422238|FG005|Extension Period|Lost to Follow-up|2|||
16535897|NCT04512066|40422233|FG000|Extension Period|Non-compliance with study drug|0|||
16336094|NCT05052697|39714965|FG015|Substudy A|No longer met eligibility criteria|0|||
16336095|NCT05052697|39714966|FG016|Substudy A|No longer met eligibility criteria|0|||
16336096|NCT05052697|39714967|FG017|Substudy A|No longer met eligibility criteria|0|||
16336097|NCT05052697|39714968|FG018|Substudy A|No longer met eligibility criteria|0|||
16336098|NCT05052697|39714969|FG019|Substudy A|No longer met eligibility criteria|0|||
16336099|NCT05052697|39714970|FG020|Substudy A|No longer met eligibility criteria|0|||
16336100|NCT05052697|39714971|FG021|Substudy A|No longer met eligibility criteria|0|||
16336101|NCT05052697|39714972|FG022|Substudy A|No longer met eligibility criteria|0|||
16336102|NCT05052697|39714973|FG023|Substudy A|No longer met eligibility criteria|0|||
16535898|NCT04512066|40422234|FG001|Extension Period|Non-compliance with study drug|1|||
16535899|NCT04512066|40422235|FG002|Extension Period|Non-compliance with study drug|0|||
16535900|NCT04512066|40422236|FG003|Extension Period|Non-compliance with study drug|0|||
16535901|NCT04512066|40422237|FG004|Extension Period|Non-compliance with study drug|0|||
16535902|NCT04512066|40422238|FG005|Extension Period|Non-compliance with study drug|1|||
16535903|NCT04512066|40422233|FG000|Extension Period|Other|0|||
16535904|NCT04512066|40422234|FG001|Extension Period|Other|2|||
16535905|NCT04512066|40422235|FG002|Extension Period|Other|0|||
16535906|NCT04512066|40422236|FG003|Extension Period|Other|0|||
16336103|NCT05052697|39714974|FG024|Substudy A|No longer met eligibility criteria|0|||
16336104|NCT05052697|39714975|FG025|Substudy A|No longer met eligibility criteria|0|||
16336105|NCT05052697|39714976|FG026|Substudy A|No longer met eligibility criteria|0|||
16336106|NCT05052697|39714977|FG027|Substudy A|No longer met eligibility criteria|0|||
16535907|NCT04512066|40422237|FG004|Extension Period|Other|0|||
16535908|NCT04512066|40422238|FG005|Extension Period|Other|0|||
16336107|NCT05052697|39714978|FG028|Substudy A|No longer met eligibility criteria|0|||
16535909|NCT04512066|40422233|FG000|Extension Period|Physician Decision|0|||
16535910|NCT04512066|40422234|FG001|Extension Period|Physician Decision|2|||
16336108|NCT05052697|39714979|FG029|Substudy A|No longer met eligibility criteria|0|||
16336109|NCT05052697|39714980|FG030|Substudy A|No longer met eligibility criteria|0|||
16336110|NCT05052697|39714981|FG031|Substudy A|No longer met eligibility criteria|0|||
16336111|NCT05052697|39714982|FG032|Substudy A|No longer met eligibility criteria|0|||
16336112|NCT05052697|39714983|FG033|Substudy A|No longer met eligibility criteria|0|||
16336113|NCT05052697|39714950|FG000|Substudy A|Not vaccinated|0|||
16535911|NCT04512066|40422235|FG002|Extension Period|Physician Decision|0|||
16535912|NCT04512066|40422236|FG003|Extension Period|Physician Decision|1|||
16535913|NCT04512066|40422237|FG004|Extension Period|Physician Decision|1|||
16535914|NCT04512066|40422238|FG005|Extension Period|Physician Decision|0|||
16535915|NCT04512066|40422233|FG000|Extension Period|Withdrawal by Subject|0|||
16535916|NCT04512066|40422234|FG001|Extension Period|Withdrawal by Subject|3|||
16535917|NCT04512066|40422235|FG002|Extension Period|Withdrawal by Subject|7|||
16535918|NCT04512066|40422236|FG003|Extension Period|Withdrawal by Subject|11|||
16535919|NCT04512066|40422237|FG004|Extension Period|Withdrawal by Subject|8|||
16535920|NCT04512066|40422238|FG005|Extension Period|Withdrawal by Subject|4|||
16535921|NCT00322348|40422241|FG000|Overall Study|Adverse Event|0|||
16535922|NCT00322348|40422242|FG001|Overall Study|Adverse Event|1|||
16535923|NCT00322348|40422241|FG000|Overall Study|Withdrawal by Subject|1|||
16535924|NCT00322348|40422242|FG001|Overall Study|Withdrawal by Subject|4|||
16535925|NCT00322348|40422241|FG000|Overall Study|Lost to Follow-up|1|||
16535926|NCT00322348|40422242|FG001|Overall Study|Lost to Follow-up|0|||
16535927|NCT00322348|40422241|FG000|Overall Study|Death|0|||
16535928|NCT00322348|40422242|FG001|Overall Study|Death|2|||
16535929|NCT00322348|40422241|FG000|Overall Study|Disease Progression|30|||
16535930|NCT00322348|40422242|FG001|Overall Study|Disease Progression|25|||
16535931|NCT00322348|40422241|FG000|Overall Study|Reasons not specified|5|||
16535932|NCT00322348|40422242|FG001|Overall Study|Reasons not specified|1|||
16535933|NCT02477111|40422247|FG000|Overall Study|Death|28|||
16535934|NCT02477111|40422247|FG000|Overall Study|Withdrawal by Subject|19|||
16535935|NCT02477111|40422247|FG000|Overall Study|Lost to Follow-up|4|||
16535936|NCT02820623|40426183|FG000|Overall Study|Withdrawal by Subject|1|||
16535937|NCT02820623|40426184|FG001|Overall Study|Withdrawal by Subject|3|||
16535938|NCT02820623|40426185|FG002|Overall Study|Withdrawal by Subject|3|||
16535939|NCT02820623|40426183|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
16535940|NCT02820623|40426184|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
16535941|NCT02820623|40426185|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
16535942|NCT02820623|40426183|FG000|Overall Study|Therapist unable to enroll clients|1|||
16535943|NCT02820623|40426184|FG001|Overall Study|Therapist unable to enroll clients|1|||
16535944|NCT02820623|40426185|FG002|Overall Study|Therapist unable to enroll clients|3|||
16535945|NCT02820623|40426183|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
16535946|NCT02820623|40426184|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
16535947|NCT02820623|40426185|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
16535948|NCT01995461|40426186|FG000|Overall Study|Death|1|||
16535949|NCT01995461|40426186|FG000|Overall Study|Lost to Follow-up|2|||
16535950|NCT01995461|40426186|FG000|Overall Study|Withdrawal by Subject|2|||
16535951|NCT00683644|40426187|FG000|Overall Study|Withdrawal by Subject|4|||
16535952|NCT00683644|40426188|FG001|Overall Study|Withdrawal by Subject|2|||
16535953|NCT00683644|40426187|FG000|Overall Study|Lost to Follow-up|1|||
16535954|NCT00683644|40426188|FG001|Overall Study|Lost to Follow-up|4|||
16535955|NCT00683644|40426187|FG000|Overall Study|Adverse Event|1|||
16535956|NCT00683644|40426188|FG001|Overall Study|Adverse Event|2|||
16535957|NCT00683644|40426187|FG000|Overall Study|Low copper, other health problems,|7|||
16535958|NCT00683644|40426188|FG001|Overall Study|Low copper, other health problems,|6|||
16535959|NCT01812655|40426190|FG000|Overall Study|Protocol Violation|1|||
16535960|NCT01812655|40426191|FG001|Overall Study|Protocol Violation|1|||
16535961|NCT01812655|40426192|FG002|Overall Study|Protocol Violation|0|||
16535962|NCT00996996|40426195|FG000|Overall Study|Progressive Disease|10|||
16535963|NCT00996996|40426195|FG000|Overall Study|Non-compliance|8|||
16535964|NCT00996996|40426195|FG000|Overall Study|Lost to Follow-up|9|||
16535965|NCT00996996|40426195|FG000|Overall Study|Death|5|||
16102445|NCT02269917|38863195|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
16102446|NCT02269917|38863196|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
16216724|NCT01224106|39272474|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
16336114|NCT05052697|39714951|FG001|Substudy A|Not vaccinated|0|||
16535966|NCT00996996|40426195|FG000|Overall Study|Did Not Receive Study Medications|1|||
16535967|NCT02522494|40426203|FG000|Overall Study|Lost to Follow-up|6|||
16535968|NCT02522494|40426204|FG001|Overall Study|Lost to Follow-up|2|||
16535969|NCT02522494|40426203|FG000|Overall Study|Withdrawal by Subject|1|||
16535970|NCT02522494|40426204|FG001|Overall Study|Withdrawal by Subject|0|||
16535971|NCT02522494|40426203|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
16535972|NCT02522494|40426204|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
16336115|NCT05052697|39714952|FG002|Substudy A|Not vaccinated|0|||
16336116|NCT05052697|39714953|FG003|Substudy A|Not vaccinated|1|||
16336117|NCT05052697|39714954|FG004|Substudy A|Not vaccinated|0|||
16336118|NCT05052697|39714955|FG005|Substudy A|Not vaccinated|0|||
16336119|NCT05052697|39714956|FG006|Substudy A|Not vaccinated|0|||
16336120|NCT05052697|39714957|FG007|Substudy A|Not vaccinated|0|||
16336121|NCT05052697|39714958|FG008|Substudy A|Not vaccinated|1|||
16535973|NCT02522494|40426203|FG000|Overall Study|Participant did not watch the video|1|||
16535974|NCT02522494|40426204|FG001|Overall Study|Participant did not watch the video|0|||
16535975|NCT02522494|40426203|FG000|Overall Study|Death|0|||
16535976|NCT02522494|40426204|FG001|Overall Study|Death|1|||
16535977|NCT01569438|40426205|FG000|Overall Study|Lack of Efficacy|1|||
16535978|NCT01569438|40426206|FG001|Overall Study|Lack of Efficacy|2|||
16535979|NCT01569438|40426205|FG000|Overall Study|Withdrawal by Subject|0|||
16535980|NCT01569438|40426206|FG001|Overall Study|Withdrawal by Subject|3|||
16535981|NCT01569438|40426205|FG000|Overall Study|Adverse Event|2|||
16535982|NCT01569438|40426206|FG001|Overall Study|Adverse Event|15|||
16535983|NCT01569438|40426205|FG000|Overall Study|Protocol Violation|2|||
16535984|NCT01569438|40426206|FG001|Overall Study|Protocol Violation|0|||
16535985|NCT01569438|40426205|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
16535986|NCT01569438|40426206|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
16535987|NCT01569438|40426205|FG000|Overall Study|Sponsor/Physician decision|1|||
16535988|NCT01569438|40426206|FG001|Overall Study|Sponsor/Physician decision|1|||
16535989|NCT01569438|40426205|FG000|Overall Study|Unable to adhere to study schedule|0|||
16336122|NCT05052697|39714959|FG009|Substudy A|Not vaccinated|0|||
16336123|NCT05052697|39714960|FG010|Substudy A|Not vaccinated|0|||
16336124|NCT05052697|39714961|FG011|Substudy A|Not vaccinated|0|||
16336125|NCT05052697|39714962|FG012|Substudy A|Not vaccinated|0|||
16336126|NCT05052697|39714963|FG013|Substudy A|Not vaccinated|0|||
16336127|NCT05052697|39714964|FG014|Substudy A|Not vaccinated|0|||
16336128|NCT05052697|39714965|FG015|Substudy A|Not vaccinated|0|||
16336129|NCT05052697|39714966|FG016|Substudy A|Not vaccinated|0|||
16336130|NCT05052697|39714967|FG017|Substudy A|Not vaccinated|0|||
16336131|NCT05052697|39714968|FG018|Substudy A|Not vaccinated|0|||
16336132|NCT05052697|39714969|FG019|Substudy A|Not vaccinated|0|||
16336133|NCT05052697|39714970|FG020|Substudy A|Not vaccinated|0|||
16336134|NCT05052697|39714971|FG021|Substudy A|Not vaccinated|0|||
16336135|NCT05052697|39714972|FG022|Substudy A|Not vaccinated|0|||
16336136|NCT05052697|39714973|FG023|Substudy A|Not vaccinated|0|||
16336137|NCT05052697|39714974|FG024|Substudy A|Not vaccinated|0|||
16336138|NCT05052697|39714975|FG025|Substudy A|Not vaccinated|0|||
16336139|NCT05052697|39714976|FG026|Substudy A|Not vaccinated|0|||
16336140|NCT05052697|39714977|FG027|Substudy A|Not vaccinated|0|||
16336141|NCT05052697|39714978|FG028|Substudy A|Not vaccinated|0|||
16336142|NCT05052697|39714979|FG029|Substudy A|Not vaccinated|0|||
16336143|NCT05052697|39714980|FG030|Substudy A|Not vaccinated|0|||
16535990|NCT01569438|40426206|FG001|Overall Study|Unable to adhere to study schedule|1|||
16535991|NCT01925950|40426207|FG000|Part 2|Withdrawal by Subject|1|||
16336144|NCT05052697|39714981|FG031|Substudy A|Not vaccinated|0|||
16336145|NCT05052697|39714982|FG032|Substudy A|Not vaccinated|0|||
16336146|NCT05052697|39714983|FG033|Substudy A|Not vaccinated|0|||
16336147|NCT05052697|39714950|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16535992|NCT01925950|40426208|FG001|Part 2|Withdrawal by Subject|0|||
16535993|NCT03583554|40426212|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
16102447|NCT02269917|38863197|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
16535994|NCT03583554|40426213|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
16535995|NCT03583554|40426214|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
16535996|NCT00045110|40426217|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
16535997|NCT00045110|40426218|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
16535998|NCT00045110|40426219|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
16102448|NCT02269917|38863195|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
16102449|NCT02269917|38863196|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
16102450|NCT02269917|38863197|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
16102451|NCT01220856|38863198|FG000|Overall Study|graft loss|3|||
16102452|NCT01220856|38863199|FG001|Overall Study|graft loss|3|||
16102453|NCT01220856|38863198|FG000|Overall Study|Lost to Follow-up|1|||
16102454|NCT01220856|38863199|FG001|Overall Study|Lost to Follow-up|0|||
16102455|NCT01838447|38863200|FG000|Overall Study|Change in surgical plan|1|||
16102456|NCT01838447|38863201|FG001|Overall Study|Change in surgical plan|2|||
16102457|NCT01838447|38863200|FG000|Overall Study|Withdrawal by Subject|1|||
16102458|NCT01838447|38863201|FG001|Overall Study|Withdrawal by Subject|1|||
16102459|NCT04124471|38863204|FG000|Overall Study|screen failure|1|||
16102460|NCT01894256|38863206|FG000|Part A|Adverse Event|0|||
16102461|NCT01894256|38863207|FG001|Part A|Adverse Event|1|||
16102462|NCT01894256|38863208|FG002|Part A|Adverse Event|0|||
16102463|NCT01894256|38863206|FG000|Part B|Death|0|||
16102464|NCT01894256|38863207|FG001|Part B|Death|1|||
16102465|NCT01894256|38863208|FG002|Part B|Death|1|||
16102466|NCT01894256|38863206|FG000|Part B|Withdrawal by Subject|0|||
16102467|NCT01894256|38863207|FG001|Part B|Withdrawal by Subject|1|||
16102468|NCT01894256|38863208|FG002|Part B|Withdrawal by Subject|0|||
16102469|NCT01894256|38863206|FG000|Part B|Lack of Efficacy|15|||
16102470|NCT01894256|38863207|FG001|Part B|Lack of Efficacy|12|||
16102471|NCT01894256|38863208|FG002|Part B|Lack of Efficacy|13|||
16102472|NCT02544113|38863212|FG000|Overall Study|Death|3|||
16102473|NCT02544113|38863213|FG001|Overall Study|Death|4|||
16102474|NCT01960114|38863214|FG000|Overall Study|Adverse Event|1|||
16102475|NCT01960114|38863215|FG001|Overall Study|Adverse Event|0|||
16102476|NCT01960114|38863214|FG000|Overall Study|Could not swallow study medication|0|||
16102477|NCT01960114|38863215|FG001|Overall Study|Could not swallow study medication|1|||
16102478|NCT01193283|38863218|FG000|Overall Study|Death|1|||
16102479|NCT01878253|38863219|FG000|Overall Study|Death|1|||
16102480|NCT01878253|38863219|FG000|Overall Study|SIdus System Removal|3|||
16102481|NCT01878253|38863219|FG000|Overall Study|Withdrawal by Subject|1|||
16102482|NCT01878253|38863219|FG000|Overall Study|Lost to Follow-up|2|||
16102483|NCT01878253|38863219|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
16216725|NCT01224106|39272475|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
16535999|NCT00045110|40426217|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
16536000|NCT00045110|40426218|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
16536001|NCT00045110|40426219|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
16536002|NCT00045110|40426217|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
16102484|NCT02085408|38863222|FG000|Step 1: Induction|Disease Progression|19|||
16102485|NCT02085408|38863223|FG001|Step 1: Induction|Disease Progression|19|||
16102486|NCT02085408|38863222|FG000|Step 1: Induction|Adverse Event|18|||
16102487|NCT02085408|38863223|FG001|Step 1: Induction|Adverse Event|17|||
16102488|NCT02085408|38863222|FG000|Step 1: Induction|Death|33|||
16102489|NCT02085408|38863223|FG001|Step 1: Induction|Death|30|||
16102490|NCT02085408|38863222|FG000|Step 1: Induction|Withdrawal by Subject|16|||
16102491|NCT02085408|38863223|FG001|Step 1: Induction|Withdrawal by Subject|8|||
16102492|NCT02085408|38863222|FG000|Step 1: Induction|Alternative Therapy|15|||
16536003|NCT00045110|40426218|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
16536004|NCT00045110|40426219|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
16536005|NCT01261338|40426227|FG000|Overall Study|Withdrawal by Subject|3|||
16536006|NCT01261338|40426228|FG001|Overall Study|Withdrawal by Subject|2|||
16536007|NCT02278328|40426229|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
16536008|NCT02278328|40426230|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
16536009|NCT02278328|40426231|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
16536010|NCT02278328|40426229|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
16536011|NCT02278328|40426230|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
16536012|NCT02278328|40426231|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
16536013|NCT02278328|40426229|FG000|Neuropsych Screening|incomplete consent|0|||
16536014|NCT02278328|40426230|FG001|Neuropsych Screening|incomplete consent|0|||
16536015|NCT02278328|40426231|FG002|Neuropsych Screening|incomplete consent|2|||
16536016|NCT02251990|40426232|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
16536017|NCT02251990|40426233|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
16536018|NCT02251990|40426232|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
16405153|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
16405154|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
16405155|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
16405156|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
16405157|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
16405158|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405159|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405160|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405161|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405162|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405163|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405164|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405165|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
16405166|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
16405167|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
16405168|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405169|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405170|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405171|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405172|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405173|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405174|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405175|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
16536019|NCT02251990|40426233|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
16536020|NCT02251990|40426232|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
16536021|NCT02251990|40426233|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
16536022|NCT02251990|40426232|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
16536023|NCT02251990|40426233|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
16536024|NCT02251990|40426232|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
16536025|NCT02251990|40426233|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
16536026|NCT02251990|40426232|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
16536027|NCT02251990|40426233|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
16536028|NCT01988779|40426234|FG000|Overall Study|Withdrawal by Subject|2|||
16536029|NCT01988779|40426235|FG001|Overall Study|Withdrawal by Subject|2|||
16336148|NCT05052697|39714951|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336149|NCT05052697|39714952|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336150|NCT05052697|39714953|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336151|NCT05052697|39714954|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336152|NCT05052697|39714955|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336153|NCT05052697|39714956|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336154|NCT05052697|39714957|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336155|NCT05052697|39714958|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336156|NCT05052697|39714959|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336157|NCT05052697|39714960|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336158|NCT05052697|39714961|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336159|NCT05052697|39714962|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336160|NCT05052697|39714963|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336161|NCT05052697|39714964|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16536030|NCT01988779|40426234|FG000|Overall Study|Protocol Violation|1|||
16536031|NCT01988779|40426235|FG001|Overall Study|Protocol Violation|0|||
16536032|NCT04162769|40426236|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
16336162|NCT05052697|39714965|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336163|NCT05052697|39714966|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336164|NCT05052697|39714967|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336165|NCT05052697|39714968|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
16336166|NCT05052697|39714969|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
16336167|NCT05052697|39714970|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336168|NCT05052697|39714971|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
16336169|NCT05052697|39714972|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
16336170|NCT05052697|39714973|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336171|NCT05052697|39714974|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336172|NCT05052697|39714975|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336173|NCT05052697|39714976|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336174|NCT05052697|39714977|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336175|NCT05052697|39714978|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16405176|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16405177|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
16336176|NCT05052697|39714979|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16405178|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
16405179|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
16405180|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
16405181|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
16405182|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
16405183|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
16405184|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
16405185|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
16405186|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
16405187|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
16405188|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405189|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405190|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405191|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405192|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405193|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405194|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405195|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
16405196|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
16405197|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
16405198|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
16405199|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
16405200|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
16405201|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
16405202|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
16405203|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
16405204|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
16405205|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
16405206|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
16405207|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
16405208|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
16405209|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
16405210|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
16405211|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
16405212|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
16405213|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
16405214|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
16405215|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
16405216|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
16405217|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
16405218|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
16405219|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
16405220|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
16405221|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
16405222|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
16405223|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
16405224|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
16405225|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
16405226|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
16405227|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
16405228|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
16405229|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
16405230|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
16405231|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
16405232|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
16405233|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
16405234|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
16405235|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
16405236|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
16405237|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
16405238|NCT03352557|39966231|FG000|LTE Period: Week 80 to Week 173|Other|0|||
16405239|NCT03352557|39966232|FG001|LTE Period: Week 80 to Week 173|Other|0|||
16405240|NCT03352557|39966233|FG002|LTE Period: Week 80 to Week 173|Other|0|||
16405241|NCT03352557|39966234|FG003|LTE Period: Week 80 to Week 173|Other|0|||
16405242|NCT03352557|39966235|FG004|LTE Period: Week 80 to Week 173|Other|0|||
16536033|NCT04162769|40426237|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
16336177|NCT05052697|39714980|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336178|NCT05052697|39714981|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336179|NCT05052697|39714982|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336180|NCT05052697|39714983|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
16336181|NCT05052697|39714950|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336182|NCT05052697|39714951|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336183|NCT05052697|39714952|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336184|NCT05052697|39714953|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336185|NCT05052697|39714954|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336186|NCT05052697|39714955|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336187|NCT05052697|39714956|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336188|NCT05052697|39714957|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336189|NCT05052697|39714958|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336190|NCT05052697|39714959|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336191|NCT05052697|39714960|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336192|NCT05052697|39714961|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336193|NCT05052697|39714962|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336194|NCT05052697|39714963|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336195|NCT05052697|39714964|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336196|NCT05052697|39714965|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336197|NCT05052697|39714966|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336198|NCT05052697|39714967|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
16336199|NCT05052697|39714968|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336200|NCT05052697|39714969|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336201|NCT05052697|39714970|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336202|NCT05052697|39714971|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336203|NCT05052697|39714972|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336204|NCT05052697|39714973|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336205|NCT05052697|39714974|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336206|NCT05052697|39714975|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336207|NCT05052697|39714976|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336208|NCT05052697|39714977|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336209|NCT05052697|39714978|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336210|NCT05052697|39714979|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336211|NCT05052697|39714980|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336212|NCT05052697|39714981|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336213|NCT05052697|39714982|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336214|NCT05052697|39714983|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
16336215|NCT05052697|39714950|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336216|NCT05052697|39714951|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336217|NCT05052697|39714952|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336218|NCT05052697|39714953|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336219|NCT05052697|39714954|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336220|NCT05052697|39714955|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336221|NCT05052697|39714956|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16405243|NCT03352557|39966236|FG005|LTE Period: Week 80 to Week 173|Other|0|||
16536034|NCT04162769|40426238|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
16536035|NCT04162769|40426239|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
16536036|NCT04162769|40426236|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
16536037|NCT04162769|40426237|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
16536038|NCT04162769|40426238|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
16536039|NCT04162769|40426239|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
16536040|NCT04162769|40426236|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
16536041|NCT04162769|40426237|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
16536042|NCT04162769|40426238|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
16536043|NCT04162769|40426239|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
16536044|NCT04162769|40426236|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
16536045|NCT04162769|40426237|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
16405244|NCT03352557|39966237|FG006|LTE Period: Week 80 to Week 173|Other|0|||
16536046|NCT04162769|40426238|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
16536047|NCT04162769|40426239|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
16536048|NCT04162769|40426236|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
16536049|NCT04162769|40426237|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
16536050|NCT04162769|40426238|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
16536051|NCT04162769|40426239|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
16536052|NCT04162769|40426236|FG000|Double-blind Treatment (12-Week)|Other|0|||
16536053|NCT04162769|40426237|FG001|Double-blind Treatment (12-Week)|Other|1|||
16536054|NCT04162769|40426238|FG002|Double-blind Treatment (12-Week)|Other|1|||
16536055|NCT04162769|40426239|FG003|Double-blind Treatment (12-Week)|Other|0|||
16536056|NCT04162769|40426236|FG000|OLE Period (52-Week)|Adverse Event|0|||
16536057|NCT04162769|40426237|FG001|OLE Period (52-Week)|Adverse Event|0|||
16536058|NCT04162769|40426238|FG002|OLE Period (52-Week)|Adverse Event|0|||
16536059|NCT04162769|40426239|FG003|OLE Period (52-Week)|Adverse Event|5|||
16536060|NCT04162769|40426236|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
16536061|NCT04162769|40426237|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
16536062|NCT04162769|40426238|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
16536063|NCT04162769|40426239|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
16536064|NCT04162769|40426236|FG000|OLE Period (52-Week)|Physician Decision|0|||
16536065|NCT04162769|40426237|FG001|OLE Period (52-Week)|Physician Decision|0|||
16536066|NCT04162769|40426238|FG002|OLE Period (52-Week)|Physician Decision|0|||
16536067|NCT04162769|40426239|FG003|OLE Period (52-Week)|Physician Decision|1|||
16536068|NCT04162769|40426236|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
16536069|NCT04162769|40426237|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
16536070|NCT04162769|40426238|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
16536071|NCT04162769|40426239|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
16536072|NCT04162769|40426236|FG000|OLE Period (52-Week)|Protocol deviation|0|||
16536073|NCT04162769|40426237|FG001|OLE Period (52-Week)|Protocol deviation|0|||
16536074|NCT04162769|40426238|FG002|OLE Period (52-Week)|Protocol deviation|0|||
16536075|NCT04162769|40426239|FG003|OLE Period (52-Week)|Protocol deviation|2|||
16536076|NCT02677116|40426240|FG000|Overall Study|Adverse Event|0|||
16536077|NCT02677116|40426241|FG001|Overall Study|Adverse Event|1|||
16536078|NCT02677116|40426242|FG002|Overall Study|Adverse Event|0|||
16536079|NCT02677116|40426243|FG003|Overall Study|Adverse Event|0|||
16536080|NCT02677116|40426244|FG004|Overall Study|Adverse Event|0|||
16536081|NCT02677116|40426245|FG005|Overall Study|Adverse Event|1|||
16405245|NCT03352557|39966238|FG007|LTE Period: Week 80 to Week 173|Other|1|||
16536082|NCT02677116|40426246|FG006|Overall Study|Adverse Event|1|||
16536083|NCT02677116|40426247|FG007|Overall Study|Adverse Event|0|||
16536084|NCT02677116|40426248|FG008|Overall Study|Adverse Event|0|||
16536085|NCT02677116|40426240|FG000|Overall Study|Physician Decision|0|||
16536086|NCT02677116|40426241|FG001|Overall Study|Physician Decision|2|||
16336222|NCT05052697|39714957|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336223|NCT05052697|39714958|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336224|NCT05052697|39714959|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336225|NCT05052697|39714960|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336226|NCT05052697|39714961|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336227|NCT05052697|39714962|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336228|NCT05052697|39714963|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336229|NCT05052697|39714964|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336230|NCT05052697|39714965|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16216726|NCT01224106|39272476|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
16336231|NCT05052697|39714966|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16216727|NCT01224106|39272472|FG000|Double-Blind Treatment Phase|Other|0|||
16216728|NCT01224106|39272473|FG001|Double-Blind Treatment Phase|Other|0|||
16216729|NCT01224106|39272474|FG002|Double-Blind Treatment Phase|Other|1|||
16216730|NCT01224106|39272475|FG003|Double-Blind Treatment Phase|Other|0|||
16216731|NCT01224106|39272476|FG004|Double-Blind Treatment Phase|Other|0|||
16216732|NCT01224106|39272472|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
16216733|NCT01224106|39272473|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
16216734|NCT01224106|39272474|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
16216735|NCT01224106|39272475|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
16216736|NCT01224106|39272476|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
16216737|NCT01224106|39272472|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
16216738|NCT01224106|39272473|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
16216739|NCT01224106|39272474|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
16216740|NCT01224106|39272475|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
16216741|NCT01224106|39272476|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
16216742|NCT01224106|39272472|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
16216743|NCT01224106|39272473|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16336232|NCT05052697|39714967|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336233|NCT05052697|39714968|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336234|NCT05052697|39714969|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
16336235|NCT05052697|39714970|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336236|NCT05052697|39714971|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336237|NCT05052697|39714972|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336238|NCT05052697|39714973|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336239|NCT05052697|39714974|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336240|NCT05052697|39714975|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336241|NCT05052697|39714976|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336242|NCT05052697|39714977|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336243|NCT05052697|39714978|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336244|NCT05052697|39714979|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336245|NCT05052697|39714980|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16536087|NCT02677116|40426242|FG002|Overall Study|Physician Decision|3|||
16336246|NCT05052697|39714981|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336247|NCT05052697|39714982|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16216744|NCT01224106|39272474|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
16216745|NCT01224106|39272475|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16216746|NCT01224106|39272476|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16216747|NCT01224106|39272472|FG000|Open-Label Extension (OLE) Phase|Death|0|||
16536088|NCT02677116|40426243|FG003|Overall Study|Physician Decision|2|||
16536089|NCT02677116|40426244|FG004|Overall Study|Physician Decision|1|||
16536090|NCT02677116|40426245|FG005|Overall Study|Physician Decision|3|||
16536091|NCT02677116|40426246|FG006|Overall Study|Physician Decision|1|||
16536092|NCT02677116|40426247|FG007|Overall Study|Physician Decision|1|||
16536093|NCT02677116|40426248|FG008|Overall Study|Physician Decision|2|||
16536094|NCT02677116|40426240|FG000|Overall Study|Withdrawal by parent or guardian|2|||
16536095|NCT02677116|40426241|FG001|Overall Study|Withdrawal by parent or guardian|1|||
16536096|NCT02677116|40426242|FG002|Overall Study|Withdrawal by parent or guardian|0|||
16536097|NCT02677116|40426243|FG003|Overall Study|Withdrawal by parent or guardian|1|||
16536098|NCT02677116|40426244|FG004|Overall Study|Withdrawal by parent or guardian|0|||
16216748|NCT01224106|39272473|FG001|Open-Label Extension (OLE) Phase|Death|0|||
16536099|NCT02677116|40426245|FG005|Overall Study|Withdrawal by parent or guardian|0|||
16536100|NCT02677116|40426246|FG006|Overall Study|Withdrawal by parent or guardian|2|||
16536101|NCT02677116|40426247|FG007|Overall Study|Withdrawal by parent or guardian|1|||
16536102|NCT02677116|40426248|FG008|Overall Study|Withdrawal by parent or guardian|0|||
16102493|NCT02085408|38863223|FG001|Step 1: Induction|Alternative Therapy|19|||
16102494|NCT02085408|38863222|FG000|Step 1: Induction|Complicating Disease|2|||
16102495|NCT02085408|38863223|FG001|Step 1: Induction|Complicating Disease|3|||
16102496|NCT02085408|38863222|FG000|Step 1: Induction|Other|27|||
16102497|NCT02085408|38863223|FG001|Step 1: Induction|Other|39|||
16102498|NCT02085408|38863222|FG000|Step 1: Induction|Never started treatment|6|||
16102499|NCT02085408|38863223|FG001|Step 1: Induction|Never started treatment|4|||
16102500|NCT02085408|38863222|FG000|Step 2: Consolidation|Disease Progression|5|||
16102501|NCT02085408|38863223|FG001|Step 2: Consolidation|Disease Progression|20|||
16102502|NCT02085408|38863222|FG000|Step 2: Consolidation|Adverse Event|9|||
16102503|NCT02085408|38863223|FG001|Step 2: Consolidation|Adverse Event|8|||
16102504|NCT02085408|38863222|FG000|Step 2: Consolidation|Death|4|||
16102505|NCT02085408|38863223|FG001|Step 2: Consolidation|Death|3|||
16102506|NCT02085408|38863222|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
16102507|NCT02085408|38863223|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
16102508|NCT02085408|38863222|FG000|Step 2: Consolidation|Alternative Therapy|9|||
16102509|NCT02085408|38863223|FG001|Step 2: Consolidation|Alternative Therapy|3|||
16102510|NCT02085408|38863222|FG000|Step 2: Consolidation|Complicating Disease|0|||
16336248|NCT05052697|39714983|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
16336249|NCT05052697|39714950|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336250|NCT05052697|39714951|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336251|NCT05052697|39714952|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336252|NCT05052697|39714953|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336253|NCT05052697|39714954|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336254|NCT05052697|39714955|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336255|NCT05052697|39714956|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336256|NCT05052697|39714957|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336257|NCT05052697|39714958|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336258|NCT05052697|39714959|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336259|NCT05052697|39714960|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336260|NCT05052697|39714961|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336261|NCT05052697|39714962|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336262|NCT05052697|39714963|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336263|NCT05052697|39714964|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336264|NCT05052697|39714965|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336265|NCT05052697|39714966|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336266|NCT05052697|39714967|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
16336267|NCT05052697|39714968|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336268|NCT05052697|39714969|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336269|NCT05052697|39714970|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336270|NCT05052697|39714971|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336271|NCT05052697|39714972|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336272|NCT05052697|39714973|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336273|NCT05052697|39714974|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336274|NCT05052697|39714975|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
16336275|NCT05052697|39714976|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336276|NCT05052697|39714977|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
16336277|NCT05052697|39714978|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336278|NCT05052697|39714979|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336279|NCT05052697|39714980|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336280|NCT05052697|39714981|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336281|NCT05052697|39714982|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336282|NCT05052697|39714983|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
16336283|NCT05052697|39714950|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336284|NCT05052697|39714951|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16102511|NCT02085408|38863223|FG001|Step 2: Consolidation|Complicating Disease|2|||
16102512|NCT02085408|38863222|FG000|Step 2: Consolidation|Other|6|||
16102513|NCT02085408|38863223|FG001|Step 2: Consolidation|Other|6|||
16336285|NCT05052697|39714952|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336286|NCT05052697|39714953|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336287|NCT05052697|39714954|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336288|NCT05052697|39714955|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336289|NCT05052697|39714956|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336290|NCT05052697|39714957|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336291|NCT05052697|39714958|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336292|NCT05052697|39714959|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336293|NCT05052697|39714960|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336294|NCT05052697|39714961|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336295|NCT05052697|39714962|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336296|NCT05052697|39714963|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336297|NCT05052697|39714964|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336298|NCT05052697|39714965|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336299|NCT05052697|39714966|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336300|NCT05052697|39714967|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336301|NCT05052697|39714968|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336302|NCT05052697|39714969|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336303|NCT05052697|39714970|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336304|NCT05052697|39714971|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336305|NCT05052697|39714972|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16536103|NCT02677116|40426240|FG000|Overall Study|Withdrawal by Subject|1|||
16536104|NCT02677116|40426241|FG001|Overall Study|Withdrawal by Subject|0|||
16536105|NCT02677116|40426242|FG002|Overall Study|Withdrawal by Subject|0|||
16536106|NCT02677116|40426243|FG003|Overall Study|Withdrawal by Subject|0|||
16336306|NCT05052697|39714973|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336307|NCT05052697|39714974|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336308|NCT05052697|39714975|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336309|NCT05052697|39714976|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336310|NCT05052697|39714977|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336311|NCT05052697|39714978|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
16336312|NCT05052697|39714979|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16405246|NCT03352557|39966239|FG008|LTE Period: Week 80 to Week 173|Other|0|||
16405247|NCT03352557|39966240|FG009|LTE Period: Week 80 to Week 173|Other|0|||
16405248|NCT01238835|39966243|FG000|Overall Study|Death|124|||
16405249|NCT01238835|39966243|FG000|Overall Study|Withdrawal by Subject|9|||
16405250|NCT01238835|39966243|FG000|Overall Study|Lost to Follow-up|1|||
16405251|NCT01238835|39966243|FG000|Overall Study|Site early discontinuation|2|||
16405252|NCT00744978|39966247|FG000|Period 1|Lost to Follow-up|1|||
16405253|NCT00744978|39966248|FG001|Period 1|Lost to Follow-up|0|||
16405254|NCT00744978|39966247|FG000|Period 1|Withdrawal by Subject|0|||
16405255|NCT00744978|39966248|FG001|Period 1|Withdrawal by Subject|2|||
16405256|NCT00744978|39966247|FG000|Period 1|Other|0|||
16536107|NCT02677116|40426244|FG004|Overall Study|Withdrawal by Subject|0|||
16536108|NCT02677116|40426245|FG005|Overall Study|Withdrawal by Subject|0|||
16536109|NCT02677116|40426246|FG006|Overall Study|Withdrawal by Subject|0|||
16536110|NCT02677116|40426247|FG007|Overall Study|Withdrawal by Subject|0|||
16536111|NCT02677116|40426248|FG008|Overall Study|Withdrawal by Subject|0|||
16536112|NCT02565914|40426249|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
16536113|NCT02565914|40426249|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
16536114|NCT02565914|40426249|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
16536115|NCT02565914|40426249|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
16536116|NCT02565914|40426249|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
16536117|NCT02565914|40426249|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
16336313|NCT05052697|39714980|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
16336314|NCT05052697|39714981|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
16336315|NCT05052697|39714982|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
16336316|NCT05052697|39714983|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
16336317|NCT05052697|39714950|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336318|NCT05052697|39714951|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336319|NCT05052697|39714952|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336320|NCT05052697|39714953|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336321|NCT05052697|39714954|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336322|NCT05052697|39714955|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336323|NCT05052697|39714956|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336324|NCT05052697|39714957|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336325|NCT05052697|39714958|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336326|NCT05052697|39714959|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336327|NCT05052697|39714960|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336328|NCT05052697|39714961|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336329|NCT05052697|39714962|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336330|NCT05052697|39714963|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16405257|NCT00744978|39966248|FG001|Period 1|Other|2|||
16405258|NCT00744978|39966247|FG000|Period 1|Adverse Event|4|||
16405259|NCT00744978|39966248|FG001|Period 1|Adverse Event|0|||
16405260|NCT00744978|39966247|FG000|Period 1|Randomized but not Treated|1|||
16405261|NCT00744978|39966248|FG001|Period 1|Randomized but not Treated|1|||
16405262|NCT00744978|39966247|FG000|Period 2|Adverse Event|0|||
16405263|NCT00744978|39966248|FG001|Period 2|Adverse Event|1|||
16405264|NCT00812006|39966250|FG000|Overall Study|Lost to Follow-up|0|||
16405265|NCT00812006|39966251|FG001|Overall Study|Lost to Follow-up|0|||
16405266|NCT00812006|39966252|FG002|Overall Study|Lost to Follow-up|2|||
16405267|NCT00812006|39966250|FG000|Overall Study|Physician Decision|0|||
16405268|NCT00812006|39966251|FG001|Overall Study|Physician Decision|0|||
16405269|NCT00812006|39966252|FG002|Overall Study|Physician Decision|1|||
16405270|NCT00812006|39966250|FG000|Overall Study|Withdrawal by Subject|2|||
16405271|NCT00812006|39966251|FG001|Overall Study|Withdrawal by Subject|1|||
16405272|NCT00812006|39966252|FG002|Overall Study|Withdrawal by Subject|1|||
16405273|NCT00812006|39966250|FG000|Overall Study|Lack of Qualifying Event|4|||
16405274|NCT00812006|39966251|FG001|Overall Study|Lack of Qualifying Event|2|||
16405275|NCT00812006|39966252|FG002|Overall Study|Lack of Qualifying Event|2|||
16405276|NCT00006046|39966255|FG000|Overall Study|Adverse Event|3|||
16405277|NCT00006046|39966256|FG001|Overall Study|Adverse Event|0|||
16405278|NCT00006046|39966257|FG002|Overall Study|Adverse Event|0|||
16405279|NCT00006046|39966258|FG003|Overall Study|Adverse Event|0|||
16405280|NCT00006046|39966259|FG004|Overall Study|Adverse Event|0|||
16405281|NCT00006046|39966255|FG000|Overall Study|Disease Progression|2|||
16405282|NCT00006046|39966256|FG001|Overall Study|Disease Progression|0|||
16405283|NCT00006046|39966257|FG002|Overall Study|Disease Progression|0|||
16336331|NCT05052697|39714964|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336332|NCT05052697|39714965|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336333|NCT05052697|39714966|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336334|NCT05052697|39714967|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336335|NCT05052697|39714968|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336336|NCT05052697|39714969|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336337|NCT05052697|39714970|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336338|NCT05052697|39714971|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336339|NCT05052697|39714972|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336340|NCT05052697|39714973|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336341|NCT05052697|39714974|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336342|NCT05052697|39714975|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336343|NCT05052697|39714976|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16405284|NCT00006046|39966258|FG003|Overall Study|Disease Progression|0|||
16405285|NCT00006046|39966259|FG004|Overall Study|Disease Progression|0|||
16336344|NCT05052697|39714977|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336345|NCT05052697|39714978|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
16336346|NCT05052697|39714979|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
16336347|NCT05052697|39714980|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
16336348|NCT05052697|39714981|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
16336349|NCT05052697|39714982|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
16336350|NCT05052697|39714983|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
16336351|NCT05052697|39714950|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336352|NCT05052697|39714951|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336353|NCT05052697|39714952|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336354|NCT05052697|39714953|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336355|NCT05052697|39714954|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336356|NCT05052697|39714955|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336357|NCT05052697|39714956|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336358|NCT05052697|39714957|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336359|NCT05052697|39714958|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16536118|NCT02565914|40426249|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
16536119|NCT02565914|40426249|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
16536120|NCT02565914|40426249|FG000|Part A (Up to 96 Weeks)|Other|18|||
16536121|NCT02565914|40426249|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
16336360|NCT05052697|39714959|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336361|NCT05052697|39714960|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336362|NCT05052697|39714961|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336363|NCT05052697|39714962|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336364|NCT05052697|39714963|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336365|NCT05052697|39714964|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336366|NCT05052697|39714965|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336367|NCT05052697|39714966|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336368|NCT05052697|39714967|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336369|NCT05052697|39714968|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16536122|NCT02565914|40426249|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
16536123|NCT02565914|40426249|FG000|Part B (Up to 96 Weeks)|Other|1|||
16536124|NCT02565914|40426249|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
16536125|NCT02565914|40426249|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
16536126|NCT02565914|40426249|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
16536127|NCT02565914|40426249|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
16536128|NCT02565914|40426249|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
16536129|NCT02565914|40426249|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
16536130|NCT02565914|40426249|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
16536131|NCT02565914|40426249|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
16536132|NCT02565914|40426249|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
16536133|NCT02565914|40426249|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
16536134|NCT02565914|40426249|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
16536135|NCT02565914|40426249|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
16536136|NCT00313820|40426250|FG000|Assigned to Treatment|Other|1|||
16536137|NCT00313820|40426251|FG001|Assigned to Treatment|Other|0|||
16536138|NCT00313820|40426250|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
16536139|NCT00313820|40426251|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
16536140|NCT00313820|40426250|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
16536141|NCT00313820|40426251|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
16536142|NCT00313820|40426250|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
16536143|NCT00313820|40426251|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
16536144|NCT00313820|40426250|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
16536145|NCT00313820|40426251|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
16536146|NCT00313820|40426250|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
16536147|NCT00313820|40426251|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
16536148|NCT00929162|40426252|FG000|Overall Study|Adverse Event|8|||
16536149|NCT00929162|40426253|FG001|Overall Study|Adverse Event|5|||
16536150|NCT00929162|40426252|FG000|Overall Study|Withdrawal by Subject|3|||
16536151|NCT00929162|40426253|FG001|Overall Study|Withdrawal by Subject|1|||
16536152|NCT00929162|40426252|FG000|Overall Study|Protocol Violation|32|||
16536153|NCT00929162|40426253|FG001|Overall Study|Protocol Violation|30|||
16536154|NCT00929162|40426252|FG000|Overall Study|Other termination reason|5|||
16536155|NCT00929162|40426253|FG001|Overall Study|Other termination reason|6|||
16536156|NCT01822587|40426254|FG000|Overall Study|Lost to Follow-up|7|||
16536157|NCT01822587|40426255|FG001|Overall Study|Lost to Follow-up|9|||
16536158|NCT01822587|40426256|FG002|Overall Study|Lost to Follow-up|12|||
16536159|NCT01822587|40426254|FG000|Overall Study|Physician Decision|9|||
16536160|NCT01822587|40426255|FG001|Overall Study|Physician Decision|6|||
16536161|NCT01822587|40426256|FG002|Overall Study|Physician Decision|6|||
16536162|NCT01814371|40426257|FG000|Overall Study|Lost to Follow-up|30|||
16536163|NCT01814371|40426258|FG001|Overall Study|Lost to Follow-up|27|||
16536164|NCT00686166|40426265|FG000|Overall Study|Adverse Event|7|||
16536165|NCT00686166|40426265|FG000|Overall Study|Withdrawal by Subject|1|||
16536166|NCT00686166|40426265|FG000|Overall Study|Progression/Relapse|1|||
16536167|NCT00686166|40426265|FG000|Overall Study|Death|1|||
16536168|NCT00686166|40426265|FG000|Overall Study|Not Protocol Specified|1|||
16536169|NCT00686166|40426265|FG000|Overall Study|Ineligible|5|||
16536170|NCT00686166|40426265|FG000|Overall Study|Did not begin protocol therapy|4|||
16536171|NCT02300220|40426268|FG000|Overall Study|Lost to Follow-up|1|||
16536172|NCT02300220|40426269|FG001|Overall Study|Lost to Follow-up|2|||
16536173|NCT02300220|40426268|FG000|Overall Study|Death|1|||
16536174|NCT02300220|40426269|FG001|Overall Study|Death|1|||
16536175|NCT02300220|40426268|FG000|Overall Study|Adverse Event|1|||
16536176|NCT02300220|40426269|FG001|Overall Study|Adverse Event|1|||
16536177|NCT02300220|40426268|FG000|Overall Study|Protocol Violation|1|||
16536178|NCT02300220|40426269|FG001|Overall Study|Protocol Violation|0|||
16536179|NCT02300220|40426268|FG000|Overall Study|Withdrawal by Subject|0|||
16336370|NCT05052697|39714969|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336371|NCT05052697|39714970|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336372|NCT05052697|39714971|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336373|NCT05052697|39714972|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336374|NCT05052697|39714973|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16405286|NCT00937404|39966262|FG000|Overall Study|Protocol Violation|1|||
16405287|NCT00937404|39966262|FG000|Overall Study|Withdrawal by Subject|1|||
16405288|NCT00543803|39966265|FG000|Overall Study|Adverse Event|14|||
16405289|NCT00543803|39966265|FG000|Overall Study|Lack of Efficacy|22|||
16405290|NCT00543803|39966265|FG000|Overall Study|Lost to Follow-up|20|||
16405291|NCT00543803|39966265|FG000|Overall Study|Other|86|||
16405292|NCT04358458|39966266|FG000|Overall Study|Death|1|||
16405293|NCT04358458|39966267|FG001|Overall Study|Death|1|||
16405294|NCT04358458|39966268|FG002|Overall Study|Death|3|||
16405295|NCT04358458|39966269|FG003|Overall Study|Death|8|||
16405296|NCT04358458|39966270|FG004|Overall Study|Death|1|||
16405297|NCT04358458|39966271|FG005|Overall Study|Death|6|||
16405298|NCT04358458|39966272|FG006|Overall Study|Death|2|||
16336375|NCT05052697|39714974|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336376|NCT05052697|39714975|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336377|NCT05052697|39714976|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336378|NCT05052697|39714977|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16405299|NCT04358458|39966273|FG007|Overall Study|Death|3|||
16405300|NCT04358458|39966266|FG000|Overall Study|Lost to Follow-up|0|||
16405301|NCT04358458|39966267|FG001|Overall Study|Lost to Follow-up|0|||
16405302|NCT04358458|39966268|FG002|Overall Study|Lost to Follow-up|0|||
16405303|NCT04358458|39966269|FG003|Overall Study|Lost to Follow-up|0|||
16405304|NCT04358458|39966270|FG004|Overall Study|Lost to Follow-up|0|||
16405305|NCT04358458|39966271|FG005|Overall Study|Lost to Follow-up|0|||
16405306|NCT04358458|39966272|FG006|Overall Study|Lost to Follow-up|0|||
16405307|NCT04358458|39966273|FG007|Overall Study|Lost to Follow-up|1|||
16405308|NCT04358458|39966266|FG000|Overall Study|Site is closing study participation|0|||
16405309|NCT04358458|39966267|FG001|Overall Study|Site is closing study participation|0|||
16405310|NCT04358458|39966268|FG002|Overall Study|Site is closing study participation|0|||
16405311|NCT04358458|39966269|FG003|Overall Study|Site is closing study participation|1|||
16405312|NCT04358458|39966270|FG004|Overall Study|Site is closing study participation|0|||
16405313|NCT04358458|39966271|FG005|Overall Study|Site is closing study participation|0|||
16405314|NCT04358458|39966272|FG006|Overall Study|Site is closing study participation|0|||
16536180|NCT02300220|40426269|FG001|Overall Study|Withdrawal by Subject|2|||
16536181|NCT02300220|40426268|FG000|Overall Study|Did not tolerate IMP|0|||
16536182|NCT02300220|40426269|FG001|Overall Study|Did not tolerate IMP|1|||
16536183|NCT01090453|40426272|FG000|Overall Study|Withdrawal by Subject|1|||
16536184|NCT01090453|40426273|FG001|Overall Study|Withdrawal by Subject|2|||
16536185|NCT01090453|40426272|FG000|Overall Study|Lost to Follow-up|7|||
16536186|NCT01090453|40426273|FG001|Overall Study|Lost to Follow-up|7|||
16336379|NCT05052697|39714978|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336380|NCT05052697|39714979|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336381|NCT05052697|39714980|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336382|NCT05052697|39714981|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336383|NCT05052697|39714982|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
16336384|NCT05052697|39714983|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
16336385|NCT05052697|39714950|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336386|NCT05052697|39714951|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336387|NCT05052697|39714952|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336388|NCT05052697|39714953|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336389|NCT05052697|39714954|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336390|NCT05052697|39714955|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336391|NCT05052697|39714956|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336392|NCT05052697|39714957|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336393|NCT05052697|39714958|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336394|NCT05052697|39714959|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336395|NCT05052697|39714960|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336396|NCT05052697|39714961|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336397|NCT05052697|39714962|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336398|NCT05052697|39714963|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336399|NCT05052697|39714964|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16405315|NCT04358458|39966273|FG007|Overall Study|Site is closing study participation|0|||
16405316|NCT04358458|39966266|FG000|Overall Study|Sponsor request|2|||
16405317|NCT04358458|39966267|FG001|Overall Study|Sponsor request|3|||
16405318|NCT04358458|39966268|FG002|Overall Study|Sponsor request|3|||
16405319|NCT04358458|39966269|FG003|Overall Study|Sponsor request|0|||
16405320|NCT04358458|39966270|FG004|Overall Study|Sponsor request|2|||
16536187|NCT01090453|40426272|FG000|Overall Study|Non serious AEs|1|||
16536188|NCT01090453|40426273|FG001|Overall Study|Non serious AEs|0|||
16336400|NCT05052697|39714965|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336401|NCT05052697|39714966|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336402|NCT05052697|39714967|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336403|NCT05052697|39714968|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336404|NCT05052697|39714969|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336405|NCT05052697|39714970|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336406|NCT05052697|39714971|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336407|NCT05052697|39714972|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336408|NCT05052697|39714973|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336409|NCT05052697|39714974|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336410|NCT05052697|39714975|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336411|NCT05052697|39714976|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336412|NCT05052697|39714977|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336413|NCT05052697|39714978|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
16336414|NCT05052697|39714979|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
16336415|NCT05052697|39714980|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
16336416|NCT05052697|39714981|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336417|NCT05052697|39714982|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336418|NCT05052697|39714983|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
16336419|NCT01259375|39714988|FG000|Overall Study|Adverse Event|1|||
16336420|NCT03004924|39717700|FG000|Overall Study|Adverse Event|6|||
16336421|NCT03004924|39717701|FG001|Overall Study|Adverse Event|5|||
16405321|NCT04358458|39966271|FG005|Overall Study|Sponsor request|3|||
16405322|NCT04358458|39966272|FG006|Overall Study|Sponsor request|1|||
16405323|NCT04358458|39966273|FG007|Overall Study|Sponsor request|1|||
16405324|NCT04358458|39966266|FG000|Overall Study|Withdrawal by Subject|0|||
16405325|NCT04358458|39966267|FG001|Overall Study|Withdrawal by Subject|0|||
16336422|NCT03004924|39717702|FG002|Overall Study|Adverse Event|10|||
16405326|NCT04358458|39966268|FG002|Overall Study|Withdrawal by Subject|1|||
16405327|NCT04358458|39966269|FG003|Overall Study|Withdrawal by Subject|1|||
16405328|NCT04358458|39966270|FG004|Overall Study|Withdrawal by Subject|0|||
16405329|NCT04358458|39966271|FG005|Overall Study|Withdrawal by Subject|1|||
16405330|NCT04358458|39966272|FG006|Overall Study|Withdrawal by Subject|0|||
16405331|NCT04358458|39966273|FG007|Overall Study|Withdrawal by Subject|1|||
16405332|NCT04600076|39966274|FG000|Overall Study|Lost to Follow-up|3|||
16405333|NCT01344538|39966275|FG000|Overall Study|Adverse Event|1|||
16405334|NCT01344538|39966276|FG001|Overall Study|Adverse Event|1|||
16405335|NCT01344538|39966275|FG000|Overall Study|Lost to Follow-up|1|||
16405336|NCT01344538|39966276|FG001|Overall Study|Lost to Follow-up|0|||
16405337|NCT02974855|39966277|FG000|Overall Study|Adverse Event|0|||
16405338|NCT02974855|39966278|FG001|Overall Study|Adverse Event|1|||
16405339|NCT02974855|39966279|FG002|Overall Study|Adverse Event|0|||
16405340|NCT02974855|39966280|FG003|Overall Study|Adverse Event|1|||
16405341|NCT03762616|39966285|FG000|Overall Study|Protocol Violation|2|||
16405342|NCT02240368|39966288|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
16405343|NCT02240368|39966289|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
16405344|NCT02240368|39966290|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
16405345|NCT02240368|39966288|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
16405346|NCT02240368|39966289|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
16405347|NCT02240368|39966290|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
16405348|NCT01457014|39966293|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
16336423|NCT03004924|39717700|FG000|Overall Study|Protocol Violation|4|||
16336424|NCT03004924|39717701|FG001|Overall Study|Protocol Violation|0|||
16336425|NCT03004924|39717702|FG002|Overall Study|Protocol Violation|1|||
16405349|NCT01457014|39966294|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
16405350|NCT01457014|39966295|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
16336426|NCT03004924|39717700|FG000|Overall Study|Withdrawal by Subject|5|||
16336427|NCT03004924|39717701|FG001|Overall Study|Withdrawal by Subject|3|||
16336428|NCT03004924|39717702|FG002|Overall Study|Withdrawal by Subject|5|||
16336429|NCT03004924|39717700|FG000|Overall Study|Lost to Follow-up|6|||
16336430|NCT03004924|39717701|FG001|Overall Study|Lost to Follow-up|1|||
16336431|NCT03004924|39717702|FG002|Overall Study|Lost to Follow-up|4|||
16336432|NCT03004924|39717700|FG000|Overall Study|Lack of Efficacy|2|||
16336433|NCT03004924|39717701|FG001|Overall Study|Lack of Efficacy|4|||
16336434|NCT03004924|39717702|FG002|Overall Study|Lack of Efficacy|2|||
16336435|NCT03004924|39717700|FG000|Overall Study|Physician Decision|1|||
16336436|NCT03004924|39717701|FG001|Overall Study|Physician Decision|0|||
16336437|NCT03004924|39717702|FG002|Overall Study|Physician Decision|1|||
16336438|NCT03004924|39717700|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16336439|NCT03004924|39717701|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16336440|NCT03004924|39717702|FG002|Overall Study|Withdrawal by parent/guardian|2|||
16336441|NCT03004924|39717700|FG000|Overall Study|Screen Failure|1|||
16336442|NCT03004924|39717701|FG001|Overall Study|Screen Failure|0|||
16336443|NCT03004924|39717702|FG002|Overall Study|Screen Failure|0|||
16336444|NCT03004924|39717700|FG000|Overall Study|Pregnancy|0|||
16336445|NCT03004924|39717701|FG001|Overall Study|Pregnancy|1|||
16336446|NCT03004924|39717702|FG002|Overall Study|Pregnancy|0|||
16336447|NCT03004924|39717700|FG000|Overall Study|Terminated by Sponsor|0|||
16336448|NCT03004924|39717701|FG001|Overall Study|Terminated by Sponsor|0|||
16336449|NCT03004924|39717702|FG002|Overall Study|Terminated by Sponsor|1|||
16336450|NCT03004924|39717700|FG000|Overall Study|Missed Study Visit|0|||
16336451|NCT03004924|39717701|FG001|Overall Study|Missed Study Visit|0|||
16336452|NCT03004924|39717702|FG002|Overall Study|Missed Study Visit|2|||
16336453|NCT03004924|39717700|FG000|Overall Study|HSV1 Positive|1|||
16336454|NCT03004924|39717701|FG001|Overall Study|HSV1 Positive|0|||
16336455|NCT03004924|39717702|FG002|Overall Study|HSV1 Positive|0|||
16336456|NCT02557516|39717703|FG000|Overall Study|Adverse Event|1|||
16336457|NCT02557516|39717704|FG001|Overall Study|Adverse Event|0|||
16336458|NCT02557516|39717705|FG002|Overall Study|Adverse Event|2|||
16336459|NCT02557516|39717706|FG003|Overall Study|Adverse Event|1|||
16336460|NCT02557516|39717703|FG000|Overall Study|Disease progression|0|||
16336461|NCT02557516|39717704|FG001|Overall Study|Disease progression|2|||
16336462|NCT02557516|39717705|FG002|Overall Study|Disease progression|0|||
16336463|NCT02557516|39717706|FG003|Overall Study|Disease progression|0|||
16336464|NCT02557516|39717703|FG000|Overall Study|Physician Decision|0|||
16336465|NCT02557516|39717704|FG001|Overall Study|Physician Decision|2|||
16336466|NCT02557516|39717705|FG002|Overall Study|Physician Decision|0|||
16336467|NCT02557516|39717706|FG003|Overall Study|Physician Decision|0|||
16336468|NCT02557516|39717703|FG000|Overall Study|Sponsor decision|0|||
16336469|NCT02557516|39717704|FG001|Overall Study|Sponsor decision|1|||
16336470|NCT02557516|39717705|FG002|Overall Study|Sponsor decision|2|||
16336471|NCT02557516|39717706|FG003|Overall Study|Sponsor decision|8|||
16336472|NCT00253370|39717707|FG000|Overall Study|Adverse Event|18|||
16336473|NCT00253370|39717707|FG000|Overall Study|Disease progression|13|||
16336474|NCT00253370|39717707|FG000|Overall Study|Death|2|||
16336475|NCT00253370|39717707|FG000|Overall Study|Withdrawal by Subject|6|||
16336476|NCT00253370|39717707|FG000|Overall Study|Non-protocol therapy|1|||
16336477|NCT00253370|39717707|FG000|Overall Study|Physician Decision|1|||
16336478|NCT00253370|39717707|FG000|Overall Study|Protocol Violation|1|||
16336479|NCT00253370|39717707|FG000|Overall Study|Abdominal pain due to disease|1|||
16336480|NCT04529850|39717713|FG000|Overall Study|Death|2|||
16336481|NCT04529850|39717713|FG000|Overall Study|Physician Decision|1|||
16336482|NCT04529850|39717713|FG000|Overall Study|Withdrawal by Subject|2|||
16336483|NCT01030718|39717715|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
16336484|NCT01030718|39717716|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
16336485|NCT01030718|39717717|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
16336486|NCT01030718|39717715|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
16336487|NCT01030718|39717716|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
16336488|NCT01030718|39717717|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
16336489|NCT01030718|39717715|FG000|Studies CA180-031 and -036 Combined|Death|0|||
16536189|NCT01090453|40426272|FG000|Overall Study|Protocol Violation|2|||
16536190|NCT01090453|40426273|FG001|Overall Study|Protocol Violation|0|||
16536191|NCT01090453|40426272|FG000|Overall Study|Other|2|||
16536192|NCT01090453|40426273|FG001|Overall Study|Other|4|||
16536193|NCT01090453|40426272|FG000|Overall Study|Eligibility Criteria|0|||
16336490|NCT01030718|39717716|FG001|Studies CA180-031 and -036 Combined|Death|1|||
16536194|NCT01090453|40426273|FG001|Overall Study|Eligibility Criteria|1|||
16336491|NCT01030718|39717717|FG002|Studies CA180-031 and -036 Combined|Death|0|||
16336492|NCT01030718|39717715|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
16336493|NCT01030718|39717716|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
16336494|NCT01030718|39717717|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
16336495|NCT01030718|39717715|FG000|Study CA180-036 Only|insufficient effect|1|||
16336496|NCT01030718|39717716|FG001|Study CA180-036 Only|insufficient effect|1|||
16336497|NCT01030718|39717717|FG002|Study CA180-036 Only|insufficient effect|5|||
16405351|NCT01457014|39966296|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
16405352|NCT01457014|39966293|FG000|First Night|Withdrawal by Subject|3|||
16405353|NCT01457014|39966294|FG001|First Night|Withdrawal by Subject|0|||
16405354|NCT01457014|39966295|FG002|First Night|Withdrawal by Subject|0|||
16405355|NCT01457014|39966296|FG003|First Night|Withdrawal by Subject|0|||
16405356|NCT02509052|39966297|FG000|Overall Study|Non compliance|0|||
16405357|NCT02509052|39966298|FG001|Overall Study|Non compliance|0|||
16405358|NCT02509052|39966299|FG002|Overall Study|Non compliance|1|||
16405359|NCT01466660|39966300|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
16405360|NCT01466660|39966301|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
16405361|NCT01466660|39966300|FG000|Overall Study|Worsening of underlying cancer disease|5|||
16405362|NCT01466660|39966301|FG001|Overall Study|Worsening of underlying cancer disease|2|||
16405363|NCT01466660|39966300|FG000|Overall Study|Other adverse event|19|||
16405364|NCT01466660|39966301|FG001|Overall Study|Other adverse event|18|||
16405365|NCT01466660|39966300|FG000|Overall Study|Protocol Violation|2|||
16405366|NCT01466660|39966301|FG001|Overall Study|Protocol Violation|1|||
16405367|NCT01466660|39966300|FG000|Overall Study|Refused continuation of trial medication|4|||
16405368|NCT01466660|39966301|FG001|Overall Study|Refused continuation of trial medication|3|||
16405369|NCT01466660|39966300|FG000|Overall Study|Other reason not defined above|10|||
16405370|NCT01466660|39966301|FG001|Overall Study|Other reason not defined above|8|||
16405371|NCT02136680|39966308|FG000|Overall Study|No Longer Interested|1|||
16405372|NCT02136680|39966309|FG001|Overall Study|No Longer Interested|1|||
16405373|NCT02136680|39966308|FG000|Overall Study|No longer receiving care at clinic|3|||
16405374|NCT02136680|39966309|FG001|Overall Study|No longer receiving care at clinic|5|||
16536195|NCT01041638|40426274|FG000|Overall Study|Adverse Event|4|||
16536196|NCT01041638|40426274|FG000|Overall Study|Death|1|||
16536197|NCT01041638|40426274|FG000|Overall Study|Lack of Efficacy|7|||
16536198|NCT01041638|40426274|FG000|Overall Study|Physician Decision|4|||
16405375|NCT02136680|39966308|FG000|Overall Study|Moved away|5|||
16405376|NCT02136680|39966309|FG001|Overall Study|Moved away|4|||
16405377|NCT02136680|39966308|FG000|Overall Study|Unable to schedule|17|||
16405378|NCT02136680|39966309|FG001|Overall Study|Unable to schedule|16|||
16405379|NCT02136680|39966308|FG000|Overall Study|Study ended before interview due|6|||
16405380|NCT02136680|39966309|FG001|Overall Study|Study ended before interview due|3|||
16405381|NCT02080481|39966310|FG000|Overall Study|Never received a block.|1|||
16405382|NCT02080481|39966311|FG001|Overall Study|Never received a block.|0|||
16405383|NCT01566149|39966312|FG000|Overall Study|Adverse Event|0|||
16405384|NCT01566149|39966313|FG001|Overall Study|Adverse Event|1|||
16405385|NCT01566149|39966312|FG000|Overall Study|Non-compliance with study medication|2|||
16405386|NCT01566149|39966313|FG001|Overall Study|Non-compliance with study medication|0|||
16536199|NCT01041638|40426274|FG000|Overall Study|Withdrawal by Subject|11|||
16102514|NCT02085408|38863222|FG000|Step 2: Consolidation|Never started treatment|4|||
16405387|NCT01566149|39966312|FG000|Overall Study|Protocol Violation|0|||
16405388|NCT01566149|39966313|FG001|Overall Study|Protocol Violation|1|||
16405389|NCT01566149|39966312|FG000|Overall Study|Withdrawal by Subject|1|||
16405390|NCT01566149|39966313|FG001|Overall Study|Withdrawal by Subject|0|||
16405391|NCT02298179|39966314|FG000|Overall Study|Lost to Follow-up|0|||
16405392|NCT02298179|39966315|FG001|Overall Study|Lost to Follow-up|0|||
16405393|NCT02298179|39966316|FG002|Overall Study|Lost to Follow-up|1|||
16405394|NCT02298179|39966317|FG003|Overall Study|Lost to Follow-up|0|||
16405395|NCT02298179|39966318|FG004|Overall Study|Lost to Follow-up|0|||
16405396|NCT02298179|39966319|FG005|Overall Study|Lost to Follow-up|0|||
16405397|NCT02298179|39966320|FG006|Overall Study|Lost to Follow-up|0|||
16405398|NCT02298179|39966321|FG007|Overall Study|Lost to Follow-up|1|||
16405399|NCT02298179|39966322|FG008|Overall Study|Lost to Follow-up|0|||
16405400|NCT02298179|39966323|FG009|Overall Study|Lost to Follow-up|0|||
16405401|NCT02298179|39966324|FG010|Overall Study|Lost to Follow-up|0|||
16405402|NCT02298179|39966325|FG011|Overall Study|Lost to Follow-up|0|||
16405403|NCT00096174|39966326|FG000|Overall Study|Lack of Efficacy|9|||
16102515|NCT02085408|38863223|FG001|Step 2: Consolidation|Never started treatment|3|||
16102516|NCT02085408|38863222|FG000|Step 3: Maintenance|Disease Progression|13|||
16102517|NCT02085408|38863223|FG001|Step 3: Maintenance|Disease Progression|11|||
16405404|NCT00096174|39966326|FG000|Overall Study|Adverse Event|15|||
16405405|NCT00096174|39966326|FG000|Overall Study|Death|6|||
16405406|NCT00096174|39966326|FG000|Overall Study|Withdrawal by Subject|15|||
16405407|NCT00096174|39966326|FG000|Overall Study|Not started protocol therapy|3|||
16405408|NCT00096174|39966326|FG000|Overall Study|Ineligible|6|||
16102518|NCT02085408|38863222|FG000|Step 3: Maintenance|Adverse Event|2|||
16405409|NCT00096174|39966326|FG000|Overall Study|other reason|8|||
16405410|NCT03095027|39966331|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
16405411|NCT03095027|39966332|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
16405412|NCT03054350|39966334|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
16405413|NCT03054350|39966335|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
16536200|NCT00417079|40426277|FG000|Overall Study|Disease progression|267|||
16536201|NCT00417079|40426278|FG001|Overall Study|Disease progression|180|||
16536202|NCT00417079|40426277|FG000|Overall Study|Adverse Event|32|||
16536203|NCT00417079|40426278|FG001|Overall Study|Adverse Event|67|||
16536204|NCT00417079|40426277|FG000|Overall Study|Non-compliance to protocol|0|||
16536205|NCT00417079|40426278|FG001|Overall Study|Non-compliance to protocol|1|||
16536206|NCT00417079|40426277|FG000|Overall Study|Lost to Follow-up|2|||
16536207|NCT00417079|40426278|FG001|Overall Study|Lost to Follow-up|0|||
16536208|NCT00417079|40426277|FG000|Overall Study|Withdrawal by Subject|17|||
16536209|NCT00417079|40426278|FG001|Overall Study|Withdrawal by Subject|8|||
16536210|NCT00417079|40426277|FG000|Overall Study|Not treated|6|||
16536211|NCT00417079|40426278|FG001|Overall Study|Not treated|7|||
16536212|NCT00417079|40426277|FG000|Overall Study|Screened failure|2|||
16536213|NCT00417079|40426278|FG001|Overall Study|Screened failure|1|||
16536214|NCT00417079|40426277|FG000|Overall Study|Investigator's decision|1|||
16536215|NCT00417079|40426278|FG001|Overall Study|Investigator's decision|4|||
16536216|NCT00417079|40426277|FG000|Overall Study|Non-confirmed Disease progression|1|||
16536217|NCT00417079|40426278|FG001|Overall Study|Non-confirmed Disease progression|1|||
16536218|NCT00417079|40426277|FG000|Overall Study|Clinical deterioration|1|||
16536219|NCT00417079|40426278|FG001|Overall Study|Clinical deterioration|0|||
16536220|NCT00417079|40426277|FG000|Overall Study|Screening error|2|||
16102519|NCT02085408|38863223|FG001|Step 3: Maintenance|Adverse Event|4|||
16102520|NCT02085408|38863222|FG000|Step 3: Maintenance|Death|1|||
16102521|NCT02085408|38863223|FG001|Step 3: Maintenance|Death|2|||
16102522|NCT02085408|38863222|FG000|Step 3: Maintenance|Alternative Therapy|1|||
16102523|NCT02085408|38863223|FG001|Step 3: Maintenance|Alternative Therapy|1|||
16102524|NCT02085408|38863222|FG000|Step 3: Maintenance|Complicating Disease|0|||
16336498|NCT01030718|39717715|FG000|Study CA180-036 Only|Adverse Event|2|||
16336499|NCT01030718|39717716|FG001|Study CA180-036 Only|Adverse Event|3|||
16336500|NCT01030718|39717717|FG002|Study CA180-036 Only|Adverse Event|0|||
16336501|NCT01030718|39717715|FG000|Study CA180-036 Only|Death|0|||
16336502|NCT01030718|39717716|FG001|Study CA180-036 Only|Death|1|||
16336503|NCT01030718|39717717|FG002|Study CA180-036 Only|Death|0|||
16336504|NCT01030718|39717715|FG000|Study CA180-036 Only|Other Reasons|0|||
16336505|NCT01030718|39717716|FG001|Study CA180-036 Only|Other Reasons|2|||
16336506|NCT01030718|39717717|FG002|Study CA180-036 Only|Other Reasons|0|||
16336507|NCT00308750|39717718|FG000|Overall Study|Adverse Event|9|||
16336508|NCT00308750|39717719|FG001|Overall Study|Adverse Event|9|||
16336509|NCT00308750|39717720|FG002|Overall Study|Adverse Event|13|||
16336510|NCT00308750|39717718|FG000|Overall Study|Withdrawal by Subject|6|||
16336511|NCT00308750|39717719|FG001|Overall Study|Withdrawal by Subject|2|||
16336512|NCT00308750|39717720|FG002|Overall Study|Withdrawal by Subject|3|||
16336513|NCT00308750|39717718|FG000|Overall Study|Physician Decision|3|||
16336514|NCT00308750|39717719|FG001|Overall Study|Physician Decision|4|||
16336515|NCT00308750|39717720|FG002|Overall Study|Physician Decision|3|||
16336516|NCT00308750|39717718|FG000|Overall Study|Sponsor Decision|1|||
16336517|NCT00308750|39717719|FG001|Overall Study|Sponsor Decision|0|||
16336518|NCT00308750|39717720|FG002|Overall Study|Sponsor Decision|0|||
16336519|NCT00308750|39717718|FG000|Overall Study|Disease Progression|47|||
16336520|NCT00308750|39717719|FG001|Overall Study|Disease Progression|24|||
16336521|NCT00308750|39717720|FG002|Overall Study|Disease Progression|28|||
16336522|NCT00308750|39717718|FG000|Overall Study|Unrelated Complication|3|||
16336523|NCT00308750|39717719|FG001|Overall Study|Unrelated Complication|0|||
16336524|NCT00308750|39717720|FG002|Overall Study|Unrelated Complication|1|||
16336525|NCT00308750|39717718|FG000|Overall Study|Death|1|||
16336526|NCT00308750|39717719|FG001|Overall Study|Death|0|||
16336527|NCT00308750|39717720|FG002|Overall Study|Death|1|||
16336528|NCT00308750|39717718|FG000|Overall Study|Protocol Violation|1|||
16336529|NCT00308750|39717719|FG001|Overall Study|Protocol Violation|0|||
16336530|NCT00308750|39717720|FG002|Overall Study|Protocol Violation|0|||
16336531|NCT00308750|39717718|FG000|Overall Study|New Primary Disease Identified|1|||
16336532|NCT00308750|39717719|FG001|Overall Study|New Primary Disease Identified|1|||
16336533|NCT00308750|39717720|FG002|Overall Study|New Primary Disease Identified|0|||
16336534|NCT00636636|39717725|FG000|Overall Study|Other reason|4|||
16336535|NCT00636636|39717726|FG001|Overall Study|Other reason|6|||
16336536|NCT00636636|39717725|FG000|Overall Study|Adverse Event|19|||
16336537|NCT00636636|39717726|FG001|Overall Study|Adverse Event|8|||
16336538|NCT00636636|39717725|FG000|Overall Study|Lack of Efficacy|7|||
16336539|NCT00636636|39717726|FG001|Overall Study|Lack of Efficacy|12|||
16336540|NCT00636636|39717725|FG000|Overall Study|Protocol Violation|2|||
16336541|NCT00636636|39717726|FG001|Overall Study|Protocol Violation|2|||
16536221|NCT00417079|40426278|FG001|Overall Study|Screening error|1|||
16102525|NCT02085408|38863223|FG001|Step 3: Maintenance|Complicating Disease|1|||
16102526|NCT02085408|38863222|FG000|Step 3: Maintenance|Other|3|||
16336542|NCT00636636|39717725|FG000|Overall Study|Lost to Follow-up|0|||
16336543|NCT00636636|39717726|FG001|Overall Study|Lost to Follow-up|1|||
16336544|NCT00636636|39717725|FG000|Overall Study|Death|0|||
16536222|NCT00417079|40426277|FG000|Overall Study|Withdrawal by subject's family|0|||
16336545|NCT00636636|39717726|FG001|Overall Study|Death|1|||
16336546|NCT00636636|39717725|FG000|Overall Study|Withdrawal by Subject|4|||
16536223|NCT00417079|40426278|FG001|Overall Study|Withdrawal by subject's family|1|||
16405414|NCT03054350|39966336|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
16405415|NCT03054350|39966337|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
16405416|NCT03054350|39966338|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
16405417|NCT03054350|39966339|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
16405418|NCT03054350|39966334|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
16405419|NCT03054350|39966335|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
16536224|NCT00417079|40426277|FG000|Overall Study|Patient unable to come to the clinic|0|||
16536225|NCT00417079|40426278|FG001|Overall Study|Patient unable to come to the clinic|1|||
16536226|NCT00417079|40426277|FG000|Overall Study|abnormal liver function tests|0|||
16536227|NCT00417079|40426278|FG001|Overall Study|abnormal liver function tests|1|||
16536228|NCT02883062|40426279|FG000|Overall Study|Withdrawal by Subject|6|||
16536229|NCT02883062|40426280|FG001|Overall Study|Withdrawal by Subject|0|||
16536230|NCT03519854|40426284|FG000|Overall Study|Technical Error|0|||
16536231|NCT03519854|40426285|FG001|Overall Study|Technical Error|0|||
16536232|NCT03519854|40426286|FG002|Overall Study|Technical Error|1|||
16336547|NCT00636636|39717726|FG001|Overall Study|Withdrawal by Subject|9|||
16336548|NCT04401202|39717727|FG000|Overall Study|Lost to Follow-up|2|||
16536233|NCT03519854|40426287|FG003|Overall Study|Technical Error|0|||
16536234|NCT03519854|40426288|FG004|Overall Study|Technical Error|0|||
16536235|NCT03519854|40426289|FG005|Overall Study|Technical Error|0|||
16536236|NCT03519854|40426290|FG006|Overall Study|Technical Error|0|||
16536237|NCT03519854|40426291|FG007|Overall Study|Technical Error|0|||
16336549|NCT04401202|39717728|FG001|Overall Study|Lost to Follow-up|2|||
16336550|NCT04401202|39717727|FG000|Overall Study|Adverse Event|0|||
16336551|NCT04401202|39717728|FG001|Overall Study|Adverse Event|1|||
16336552|NCT04401202|39717727|FG000|Overall Study|Hospitalized|4|||
16336553|NCT04401202|39717728|FG001|Overall Study|Hospitalized|1|||
16336554|NCT00099632|39717729|FG000|Overall Study|Lost to Follow-up|1|||
16336555|NCT00099632|39717730|FG001|Overall Study|Lost to Follow-up|0|||
16336556|NCT00099632|39717731|FG002|Overall Study|Lost to Follow-up|3|||
16336557|NCT00099632|39717732|FG003|Overall Study|Lost to Follow-up|1|||
16336558|NCT00099632|39717733|FG004|Overall Study|Lost to Follow-up|1|||
16336559|NCT00099632|39717734|FG005|Overall Study|Lost to Follow-up|0|||
16336560|NCT00099632|39717729|FG000|Overall Study|Withdrawal by Subject|0|||
16336561|NCT00099632|39717730|FG001|Overall Study|Withdrawal by Subject|1|||
16405420|NCT03054350|39966336|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
16102527|NCT02085408|38863223|FG001|Step 3: Maintenance|Other|2|||
16102528|NCT02085408|38863222|FG000|Step 3: Maintenance|Never started treatment|5|||
16102529|NCT02085408|38863223|FG001|Step 3: Maintenance|Never started treatment|1|||
16102530|NCT00463580|38863225|FG000|Overall Study|Lost to Follow-up|1|||
16102531|NCT00463580|38863226|FG001|Overall Study|Lost to Follow-up|0|||
16102532|NCT00463580|38863225|FG000|Overall Study|Schedule conflict|2|||
16102533|NCT00463580|38863226|FG001|Overall Study|Schedule conflict|0|||
16102534|NCT00463580|38863225|FG000|Overall Study|Medical/psychiatric complications|0|||
16102535|NCT00463580|38863226|FG001|Overall Study|Medical/psychiatric complications|2|||
16102536|NCT01075100|38863227|FG000|Overall Study|Adverse Event|15|||
16102537|NCT01075100|38863228|FG001|Overall Study|Adverse Event|18|||
16102538|NCT01075100|38863227|FG000|Overall Study|Patient Request|4|||
16102539|NCT01075100|38863228|FG001|Overall Study|Patient Request|4|||
16102540|NCT01075100|38863227|FG000|Overall Study|Investigator Request|2|||
16102541|NCT01075100|38863228|FG001|Overall Study|Investigator Request|1|||
16102542|NCT01075100|38863227|FG000|Overall Study|Disease Progression|25|||
16102543|NCT01075100|38863228|FG001|Overall Study|Disease Progression|29|||
16102544|NCT01075100|38863227|FG000|Overall Study|Other|3|||
16102545|NCT01075100|38863228|FG001|Overall Study|Other|1|||
16102546|NCT01184859|38863229|FG000|Period 1: Single Dose|Insufficient urine production|0|||
16102547|NCT01184859|38863230|FG001|Period 1: Single Dose|Insufficient urine production|1|||
16102548|NCT01184859|38863231|FG002|Period 1: Single Dose|Insufficient urine production|0|||
16102549|NCT01184859|38863232|FG003|Period 1: Single Dose|Insufficient urine production|0|||
16405421|NCT03054350|39966337|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
16405422|NCT03054350|39966338|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
16405423|NCT03054350|39966339|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
16405424|NCT03054350|39966334|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
16405425|NCT03054350|39966335|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
16405426|NCT03054350|39966336|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
16405427|NCT03054350|39966337|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
16405428|NCT03054350|39966338|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
16536238|NCT03519854|40426292|FG008|Overall Study|Technical Error|0|||
16536239|NCT03519854|40426293|FG009|Overall Study|Technical Error|0|||
16536240|NCT03519854|40426294|FG010|Overall Study|Technical Error|0|||
16536241|NCT03519854|40426295|FG011|Overall Study|Technical Error|0|||
16536242|NCT03519854|40426296|FG012|Overall Study|Technical Error|0|||
16536243|NCT03519854|40426297|FG013|Overall Study|Technical Error|0|||
16536244|NCT03519854|40426298|FG014|Overall Study|Technical Error|0|||
16536245|NCT03519854|40426299|FG015|Overall Study|Technical Error|0|||
16536246|NCT03519854|40426300|FG016|Overall Study|Technical Error|0|||
16536247|NCT03519854|40426301|FG017|Overall Study|Technical Error|0|||
16536248|NCT01515748|40426302|FG000|Overall Study|Withdrawal by Subject|32|||
16536249|NCT01515748|40426303|FG001|Overall Study|Withdrawal by Subject|41|||
16536250|NCT01515748|40426302|FG000|Overall Study|Lost to Follow-up|2|||
16536251|NCT01515748|40426303|FG001|Overall Study|Lost to Follow-up|4|||
16536252|NCT01515748|40426302|FG000|Overall Study|Other than specified above|5|||
16536253|NCT01515748|40426303|FG001|Overall Study|Other than specified above|10|||
16536254|NCT01506193|40426306|FG000|Overall Study|Protocol Violation|1|||
16536255|NCT01506193|40426307|FG001|Overall Study|Protocol Violation|0|||
16536256|NCT01506193|40426308|FG002|Overall Study|Protocol Violation|1|||
16536257|NCT01506193|40426306|FG000|Overall Study|Migrated/moved from study area|0|||
16536258|NCT01506193|40426307|FG001|Overall Study|Migrated/moved from study area|0|||
16536259|NCT01506193|40426308|FG002|Overall Study|Migrated/moved from study area|1|||
16536260|NCT01506193|40426306|FG000|Overall Study|Adverse event, non-fatal|0|||
16536261|NCT01506193|40426307|FG001|Overall Study|Adverse event, non-fatal|0|||
16536262|NCT01506193|40426308|FG002|Overall Study|Adverse event, non-fatal|1|||
16536263|NCT01506193|40426306|FG000|Overall Study|Withdrawal by Subject|5|||
16536264|NCT01506193|40426307|FG001|Overall Study|Withdrawal by Subject|1|||
16536265|NCT01506193|40426308|FG002|Overall Study|Withdrawal by Subject|8|||
16536266|NCT01506193|40426306|FG000|Overall Study|Lost to Follow-up|8|||
16536267|NCT01506193|40426307|FG001|Overall Study|Lost to Follow-up|3|||
16536268|NCT01506193|40426308|FG002|Overall Study|Lost to Follow-up|3|||
16536269|NCT00862134|40426309|FG000|Overall Study|Death|1|||
16536270|NCT00862134|40426310|FG001|Overall Study|Death|0|||
16536271|NCT00862134|40426309|FG000|Overall Study|Physician Decision|0|||
16536272|NCT00862134|40426310|FG001|Overall Study|Physician Decision|1|||
16536273|NCT00862134|40426309|FG000|Overall Study|Withdrawal by Subject|1|||
16536274|NCT00862134|40426310|FG001|Overall Study|Withdrawal by Subject|2|||
16536275|NCT00862134|40426309|FG000|Overall Study|Sponsor terminated study|5|||
16536276|NCT00862134|40426310|FG001|Overall Study|Sponsor terminated study|7|||
16536277|NCT00862134|40426309|FG000|Overall Study|Adverse Event|2|||
16102550|NCT01184859|38863233|FG004|Period 1: Single Dose|Insufficient urine production|0|||
16102551|NCT01184859|38863229|FG000|Period 1: Single Dose|Protocol Violation|0|||
16102552|NCT01184859|38863230|FG001|Period 1: Single Dose|Protocol Violation|1|||
16102553|NCT01184859|38863231|FG002|Period 1: Single Dose|Protocol Violation|0|||
16536278|NCT00862134|40426310|FG001|Overall Study|Adverse Event|2|||
16536279|NCT00862134|40426309|FG000|Overall Study|Withdrew prior to dosing|2|||
16536280|NCT00862134|40426310|FG001|Overall Study|Withdrew prior to dosing|0|||
16536281|NCT01588184|40426311|FG000|Overall Study|Death|1|||
16536282|NCT01588184|40426312|FG001|Overall Study|Death|0|||
16536283|NCT01588184|40426313|FG002|Overall Study|Death|0|||
16536284|NCT01588184|40426314|FG003|Overall Study|Death|1|||
16536285|NCT01588184|40426315|FG004|Overall Study|Death|1|||
16536286|NCT01588184|40426316|FG005|Overall Study|Death|1|||
16536287|NCT01588184|40426311|FG000|Overall Study|Withdrawal by Subject|2|||
16536288|NCT01588184|40426312|FG001|Overall Study|Withdrawal by Subject|4|||
16536289|NCT01588184|40426313|FG002|Overall Study|Withdrawal by Subject|0|||
16536290|NCT01588184|40426314|FG003|Overall Study|Withdrawal by Subject|1|||
16536291|NCT01588184|40426315|FG004|Overall Study|Withdrawal by Subject|0|||
16536292|NCT01588184|40426316|FG005|Overall Study|Withdrawal by Subject|0|||
16536293|NCT01588184|40426311|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
16536294|NCT01588184|40426312|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
16536295|NCT01588184|40426313|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
16536296|NCT01588184|40426314|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
16536297|NCT01588184|40426315|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
16536298|NCT01588184|40426316|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
16536299|NCT01588184|40426311|FG000|Overall Study|multiple reasons|0|||
16536300|NCT01588184|40426312|FG001|Overall Study|multiple reasons|3|||
16536301|NCT01588184|40426313|FG002|Overall Study|multiple reasons|0|||
16536302|NCT01588184|40426314|FG003|Overall Study|multiple reasons|1|||
16216749|NCT01224106|39272474|FG002|Open-Label Extension (OLE) Phase|Death|0|||
16536303|NCT01588184|40426315|FG004|Overall Study|multiple reasons|0|||
16536304|NCT01588184|40426316|FG005|Overall Study|multiple reasons|0|||
16536305|NCT01738984|40426319|FG000|Overall Study|Pregnancy|4|||
16536306|NCT01738984|40426320|FG001|Overall Study|Pregnancy|0|||
16536307|NCT01738984|40426319|FG000|Overall Study|Withdrawal by Subject|1|||
16336562|NCT00099632|39717731|FG002|Overall Study|Withdrawal by Subject|0|||
16336563|NCT00099632|39717732|FG003|Overall Study|Withdrawal by Subject|0|||
16405429|NCT03054350|39966339|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
16405430|NCT03054350|39966334|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
16336564|NCT00099632|39717733|FG004|Overall Study|Withdrawal by Subject|0|||
16405431|NCT03054350|39966335|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
16405432|NCT03054350|39966336|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
16405433|NCT03054350|39966337|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
16405434|NCT03054350|39966338|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
16405435|NCT03054350|39966339|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
16405436|NCT00790647|39966342|FG000|Overall Study|Adverse Event|1|||
16405437|NCT02754141|39966344|FG000|Overall Study|Disease progression|11|||
16405438|NCT02754141|39966345|FG001|Overall Study|Disease progression|7|||
16405439|NCT02754141|39966346|FG002|Overall Study|Disease progression|8|||
16405440|NCT02754141|39966347|FG003|Overall Study|Disease progression|5|||
16405441|NCT02754141|39966348|FG004|Overall Study|Disease progression|7|||
16405442|NCT02754141|39966349|FG005|Overall Study|Disease progression|7|||
16405443|NCT02754141|39966350|FG006|Overall Study|Disease progression|7|||
16405444|NCT02754141|39966351|FG007|Overall Study|Disease progression|6|||
16405445|NCT02754141|39966352|FG008|Overall Study|Disease progression|11|||
16405446|NCT02754141|39966353|FG009|Overall Study|Disease progression|16|||
16405447|NCT02754141|39966354|FG010|Overall Study|Disease progression|18|||
16405448|NCT02754141|39966355|FG011|Overall Study|Disease progression|13|||
16405449|NCT02754141|39966356|FG012|Overall Study|Disease progression|10|||
16405450|NCT02754141|39966357|FG013|Overall Study|Disease progression|12|||
16405451|NCT02754141|39966358|FG014|Overall Study|Disease progression|12|||
16405452|NCT02754141|39966359|FG015|Overall Study|Disease progression|14|||
16405453|NCT02754141|39966360|FG016|Overall Study|Disease progression|0|||
16405454|NCT02754141|39966361|FG017|Overall Study|Disease progression|1|||
16405455|NCT02754141|39966344|FG000|Overall Study|Study drug toxicity|1|||
16405456|NCT02754141|39966345|FG001|Overall Study|Study drug toxicity|1|||
16405457|NCT02754141|39966346|FG002|Overall Study|Study drug toxicity|0|||
16405458|NCT02754141|39966347|FG003|Overall Study|Study drug toxicity|0|||
16405459|NCT02754141|39966348|FG004|Overall Study|Study drug toxicity|0|||
16405460|NCT02754141|39966349|FG005|Overall Study|Study drug toxicity|0|||
16405461|NCT02754141|39966350|FG006|Overall Study|Study drug toxicity|0|||
16405462|NCT02754141|39966351|FG007|Overall Study|Study drug toxicity|0|||
16405463|NCT02754141|39966352|FG008|Overall Study|Study drug toxicity|0|||
16405464|NCT02754141|39966353|FG009|Overall Study|Study drug toxicity|0|||
16405465|NCT02754141|39966354|FG010|Overall Study|Study drug toxicity|2|||
16405466|NCT02754141|39966355|FG011|Overall Study|Study drug toxicity|1|||
16405467|NCT02754141|39966356|FG012|Overall Study|Study drug toxicity|1|||
16405468|NCT02754141|39966357|FG013|Overall Study|Study drug toxicity|0|||
16405469|NCT02754141|39966358|FG014|Overall Study|Study drug toxicity|0|||
16405470|NCT02754141|39966359|FG015|Overall Study|Study drug toxicity|0|||
16405471|NCT02754141|39966360|FG016|Overall Study|Study drug toxicity|0|||
16405472|NCT02754141|39966361|FG017|Overall Study|Study drug toxicity|0|||
16405473|NCT02754141|39966344|FG000|Overall Study|AE unrelated to study drug|1|||
16405474|NCT02754141|39966345|FG001|Overall Study|AE unrelated to study drug|1|||
16405475|NCT02754141|39966346|FG002|Overall Study|AE unrelated to study drug|0|||
16405476|NCT02754141|39966347|FG003|Overall Study|AE unrelated to study drug|1|||
16405477|NCT02754141|39966348|FG004|Overall Study|AE unrelated to study drug|3|||
16405478|NCT02754141|39966349|FG005|Overall Study|AE unrelated to study drug|2|||
16405479|NCT02754141|39966350|FG006|Overall Study|AE unrelated to study drug|1|||
16405480|NCT02754141|39966351|FG007|Overall Study|AE unrelated to study drug|0|||
16405481|NCT02754141|39966352|FG008|Overall Study|AE unrelated to study drug|0|||
16216750|NCT01224106|39272475|FG003|Open-Label Extension (OLE) Phase|Death|1|||
16336565|NCT00099632|39717734|FG005|Overall Study|Withdrawal by Subject|1|||
16336566|NCT00099632|39717729|FG000|Overall Study|Protocol Violation|0|||
16336567|NCT00099632|39717730|FG001|Overall Study|Protocol Violation|0|||
16336568|NCT00099632|39717731|FG002|Overall Study|Protocol Violation|0|||
16336569|NCT00099632|39717732|FG003|Overall Study|Protocol Violation|0|||
16405482|NCT02754141|39966353|FG009|Overall Study|AE unrelated to study drug|0|||
16405483|NCT02754141|39966354|FG010|Overall Study|AE unrelated to study drug|0|||
16405484|NCT02754141|39966355|FG011|Overall Study|AE unrelated to study drug|0|||
16405485|NCT02754141|39966356|FG012|Overall Study|AE unrelated to study drug|0|||
16405486|NCT02754141|39966357|FG013|Overall Study|AE unrelated to study drug|0|||
16405487|NCT02754141|39966358|FG014|Overall Study|AE unrelated to study drug|0|||
16405488|NCT02754141|39966359|FG015|Overall Study|AE unrelated to study drug|0|||
16405489|NCT02754141|39966360|FG016|Overall Study|AE unrelated to study drug|0|||
16405490|NCT02754141|39966361|FG017|Overall Study|AE unrelated to study drug|0|||
16336570|NCT00099632|39717733|FG004|Overall Study|Protocol Violation|0|||
16336571|NCT00099632|39717734|FG005|Overall Study|Protocol Violation|1|||
16336572|NCT00586508|39717735|FG000|Overall Study|Progressive disease|52|||
16336573|NCT00586508|39717736|FG001|Overall Study|Progressive disease|8|||
16336574|NCT00586508|39717735|FG000|Overall Study|Death|0|||
16336575|NCT00586508|39717736|FG001|Overall Study|Death|1|||
16336576|NCT00586508|39717735|FG000|Overall Study|Adverse Event|12|||
16336577|NCT00586508|39717736|FG001|Overall Study|Adverse Event|4|||
16336578|NCT00586508|39717735|FG000|Overall Study|Withdrawal by Subject|4|||
16336579|NCT00586508|39717736|FG001|Overall Study|Withdrawal by Subject|0|||
16336580|NCT03114657|39717737|FG000|Overall Study|Adverse Event|9|||
16336581|NCT03114657|39717738|FG001|Overall Study|Adverse Event|6|||
16336582|NCT03114657|39717737|FG000|Overall Study|Death|4|||
16336583|NCT03114657|39717738|FG001|Overall Study|Death|0|||
16336584|NCT03114657|39717737|FG000|Overall Study|Multiple Reasons|1|||
16336585|NCT03114657|39717738|FG001|Overall Study|Multiple Reasons|2|||
16336586|NCT03114657|39717737|FG000|Overall Study|Physician Decision|2|||
16336587|NCT03114657|39717738|FG001|Overall Study|Physician Decision|2|||
16336588|NCT03114657|39717737|FG000|Overall Study|Study Terminated By Sponsor|355|||
16336589|NCT03114657|39717738|FG001|Overall Study|Study Terminated By Sponsor|374|||
16336590|NCT03114657|39717737|FG000|Overall Study|Symptomatic Deterioration|0|||
16336591|NCT03114657|39717738|FG001|Overall Study|Symptomatic Deterioration|1|||
16336592|NCT03114657|39717737|FG000|Overall Study|Withdrawal by Subject|28|||
16336593|NCT03114657|39717738|FG001|Overall Study|Withdrawal by Subject|22|||
16336594|NCT00494221|39717739|FG000|Overall Study|Death|15|||
16336595|NCT00494221|39717740|FG001|Overall Study|Death|9|||
16336596|NCT00494221|39717741|FG002|Overall Study|Death|14|||
16336597|NCT00494221|39717739|FG000|Overall Study|Withdrawal by Subject|1|||
16336598|NCT00494221|39717740|FG001|Overall Study|Withdrawal by Subject|2|||
16336599|NCT00494221|39717741|FG002|Overall Study|Withdrawal by Subject|0|||
16336600|NCT01801280|39717745|FG000|Period 1|Withdrawal by Subject|0|||
16336601|NCT01801280|39717746|FG001|Period 1|Withdrawal by Subject|1|||
16336602|NCT01801280|39717747|FG002|Period 1|Withdrawal by Subject|0|||
16336603|NCT01801280|39717748|FG003|Period 1|Withdrawal by Subject|0|||
16336604|NCT01801280|39717745|FG000|Period 2|Withdrawal by Subject|1|||
16336605|NCT01801280|39717746|FG001|Period 2|Withdrawal by Subject|0|||
16336606|NCT01801280|39717747|FG002|Period 2|Withdrawal by Subject|0|||
16336607|NCT01801280|39717748|FG003|Period 2|Withdrawal by Subject|0|||
16336608|NCT01801280|39717745|FG000|Period 4|Protocol Violation|0|||
16336609|NCT01801280|39717746|FG001|Period 4|Protocol Violation|0|||
16336610|NCT01801280|39717747|FG002|Period 4|Protocol Violation|1|||
16336611|NCT01801280|39717748|FG003|Period 4|Protocol Violation|0|||
16336612|NCT04202965|39717753|FG000|Overall Study|Adverse Event|3|||
16336613|NCT04202965|39717753|FG000|Overall Study|Did not meet inclusion criteria|1|||
16336614|NCT02469168|39717762|FG000|Overall Study|Trial closed|1|||
16336615|NCT02469168|39717763|FG001|Overall Study|Trial closed|0|||
16336616|NCT00448812|39717768|FG000|Year 2|Missed visit but remained in study|4|||
16336617|NCT00448812|39717769|FG001|Year 2|Missed visit but remained in study|1|||
16336618|NCT00448812|39717768|FG000|Year 3|Withdrawal by Subject|1|||
16336619|NCT00448812|39717769|FG001|Year 3|Withdrawal by Subject|3|||
16336620|NCT00448812|39717768|FG000|Year 3|Lost to Follow-up|1|||
16336621|NCT00448812|39717769|FG001|Year 3|Lost to Follow-up|0|||
16336622|NCT00448812|39717768|FG000|Year 3|Missed visit but remained in study|2|||
16336623|NCT00448812|39717769|FG001|Year 3|Missed visit but remained in study|0|||
16336624|NCT00448812|39717768|FG000|Year 5|Missed visit but remained in study|1|||
16336625|NCT00448812|39717769|FG001|Year 5|Missed visit but remained in study|0|||
16336626|NCT00089635|39717770|FG000|Overall Study|Adverse Event|2|||
16336627|NCT00089635|39717770|FG000|Overall Study|Death|17|||
16336628|NCT00089635|39717770|FG000|Overall Study|Disease Progression|12|||
16336629|NCT00089635|39717770|FG000|Overall Study|Lost to Follow-up|3|||
16336630|NCT00089635|39717770|FG000|Overall Study|Withdrawal by Subject|6|||
16336631|NCT00089635|39717770|FG000|Overall Study|Ineligibility determined|1|||
16336632|NCT00089635|39717770|FG000|Overall Study|Other|2|||
16336633|NCT02012959|39717771|FG000|Treatment Phase A|Adverse Event|2|||
16336634|NCT02012959|39717772|FG001|Treatment Phase A|Adverse Event|0|||
16336635|NCT02012959|39717773|FG002|Treatment Phase A|Adverse Event|0|||
16336636|NCT02012959|39717774|FG003|Treatment Phase A|Adverse Event|0|||
16336637|NCT02012959|39717775|FG004|Treatment Phase A|Adverse Event|0|||
16336638|NCT00250458|39717779|FG000|Overall Study|Lost to Follow-up|4|||
16336639|NCT00250458|39717780|FG001|Overall Study|Lost to Follow-up|2|||
16336640|NCT00250458|39717779|FG000|Overall Study|Protocol Violation|0|||
16336641|NCT00250458|39717780|FG001|Overall Study|Protocol Violation|1|||
16336642|NCT00250458|39717779|FG000|Overall Study|Withdrawal by Subject|4|||
16336643|NCT00250458|39717780|FG001|Overall Study|Withdrawal by Subject|2|||
16336644|NCT00250458|39717779|FG000|Overall Study|Lack of Migraine Attack|20|||
16336645|NCT00250458|39717780|FG001|Overall Study|Lack of Migraine Attack|9|||
16336646|NCT00250458|39717779|FG000|Overall Study|Qualifying migraine but did not treat|3|||
16336647|NCT00250458|39717780|FG001|Overall Study|Qualifying migraine but did not treat|3|||
16336648|NCT00250458|39717779|FG000|Overall Study|Other|1|||
16336649|NCT00250458|39717780|FG001|Overall Study|Other|0|||
16405491|NCT02754141|39966344|FG000|Overall Study|Request to discontinue|0|||
16405492|NCT02754141|39966345|FG001|Overall Study|Request to discontinue|0|||
16405493|NCT02754141|39966346|FG002|Overall Study|Request to discontinue|0|||
16405494|NCT02754141|39966347|FG003|Overall Study|Request to discontinue|0|||
16536308|NCT01738984|40426320|FG001|Overall Study|Withdrawal by Subject|0|||
16536309|NCT01738984|40426319|FG000|Overall Study|Lost to Follow-up|59|||
16536310|NCT01738984|40426320|FG001|Overall Study|Lost to Follow-up|39|||
16536311|NCT00802074|40426323|FG000|Overall Study|Adverse Event|1|||
16536312|NCT00802074|40426324|FG001|Overall Study|Adverse Event|1|||
16536313|NCT00802074|40426325|FG002|Overall Study|Adverse Event|1|||
16536314|NCT00802074|40426326|FG003|Overall Study|Adverse Event|0|||
16536315|NCT00802074|40426327|FG004|Overall Study|Adverse Event|0|||
16536316|NCT00802074|40426328|FG005|Overall Study|Adverse Event|0|||
16536317|NCT00802074|40426323|FG000|Overall Study|Withdrawal by Subject|1|||
16536318|NCT00802074|40426324|FG001|Overall Study|Withdrawal by Subject|0|||
16536319|NCT00802074|40426325|FG002|Overall Study|Withdrawal by Subject|0|||
16536320|NCT00802074|40426326|FG003|Overall Study|Withdrawal by Subject|0|||
16536321|NCT00802074|40426327|FG004|Overall Study|Withdrawal by Subject|0|||
16536322|NCT00802074|40426328|FG005|Overall Study|Withdrawal by Subject|0|||
16536323|NCT02134587|40426329|FG000|Overall Study|Did not completed all meetings|30|||
16536324|NCT02173548|40426334|FG000|Overall Study|Lost to Follow-up|0|||
16536325|NCT02173548|40426335|FG001|Overall Study|Lost to Follow-up|2|||
16536326|NCT02173548|40426334|FG000|Overall Study|Withdrawal by Subject|1|||
16536327|NCT02173548|40426335|FG001|Overall Study|Withdrawal by Subject|0|||
16536328|NCT01970462|40426336|FG000|Overall Study|Lost to Follow-up|0|||
16536329|NCT01970462|40426337|FG001|Overall Study|Lost to Follow-up|2|||
16536330|NCT03053050|40426338|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
16536331|NCT03053050|40426339|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
16536332|NCT03053050|40426340|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
16536333|NCT03053050|40426341|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
16536334|NCT03053050|40426338|FG000|Randomized Phase|Withdrew Consent|16|||
16536335|NCT03053050|40426339|FG001|Randomized Phase|Withdrew Consent|8|||
16536336|NCT03053050|40426340|FG002|Randomized Phase|Withdrew Consent|9|||
16536337|NCT03053050|40426341|FG003|Randomized Phase|Withdrew Consent|0|||
16536338|NCT03053050|40426338|FG000|Randomized Phase|Investigator's Discretion|6|||
16536339|NCT03053050|40426339|FG001|Randomized Phase|Investigator's Discretion|6|||
16102554|NCT01184859|38863232|FG003|Period 1: Single Dose|Protocol Violation|0|||
16405495|NCT02754141|39966348|FG004|Overall Study|Request to discontinue|0|||
16405496|NCT02754141|39966349|FG005|Overall Study|Request to discontinue|0|||
16405497|NCT02754141|39966350|FG006|Overall Study|Request to discontinue|0|||
16405498|NCT02754141|39966351|FG007|Overall Study|Request to discontinue|0|||
16405499|NCT02754141|39966352|FG008|Overall Study|Request to discontinue|1|||
16405500|NCT02754141|39966353|FG009|Overall Study|Request to discontinue|0|||
16405501|NCT02754141|39966354|FG010|Overall Study|Request to discontinue|0|||
16405502|NCT02754141|39966355|FG011|Overall Study|Request to discontinue|0|||
16536340|NCT03053050|40426340|FG002|Randomized Phase|Investigator's Discretion|3|||
16536341|NCT03053050|40426341|FG003|Randomized Phase|Investigator's Discretion|0|||
16536342|NCT03053050|40426338|FG000|Randomized Phase|Lost to Follow-up|5|||
16536343|NCT03053050|40426339|FG001|Randomized Phase|Lost to Follow-up|1|||
16536344|NCT03053050|40426340|FG002|Randomized Phase|Lost to Follow-up|1|||
16536345|NCT03053050|40426341|FG003|Randomized Phase|Lost to Follow-up|0|||
16536346|NCT03053050|40426338|FG000|Randomized Phase|Adverse Event|0|||
16405503|NCT02754141|39966356|FG012|Overall Study|Request to discontinue|0|||
16405504|NCT02754141|39966357|FG013|Overall Study|Request to discontinue|1|||
16102555|NCT01184859|38863233|FG004|Period 1: Single Dose|Protocol Violation|0|||
16102556|NCT01184859|38863229|FG000|Period 1: Single Dose|Adverse Event|0|||
16102557|NCT01184859|38863230|FG001|Period 1: Single Dose|Adverse Event|0|||
16336650|NCT01690299|39717781|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
16536347|NCT03053050|40426339|FG001|Randomized Phase|Adverse Event|1|||
16536348|NCT03053050|40426340|FG002|Randomized Phase|Adverse Event|0|||
16536349|NCT03053050|40426341|FG003|Randomized Phase|Adverse Event|0|||
16536350|NCT03053050|40426338|FG000|Randomized Phase|Randomized but Never Treated|2|||
16536351|NCT03053050|40426339|FG001|Randomized Phase|Randomized but Never Treated|2|||
16536352|NCT03053050|40426340|FG002|Randomized Phase|Randomized but Never Treated|2|||
16536353|NCT03053050|40426341|FG003|Randomized Phase|Randomized but Never Treated|0|||
16536354|NCT03053050|40426338|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
16536355|NCT03053050|40426339|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
16536356|NCT03053050|40426340|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
16536357|NCT03053050|40426341|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
16536358|NCT03053050|40426338|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
16536359|NCT03053050|40426339|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
16536360|NCT03053050|40426340|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
16536361|NCT03053050|40426341|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
16536362|NCT03053050|40426338|FG000|Open-label Phase|Withdrew Consent|0|||
16536363|NCT03053050|40426339|FG001|Open-label Phase|Withdrew Consent|0|||
16536364|NCT03053050|40426340|FG002|Open-label Phase|Withdrew Consent|0|||
16102558|NCT01184859|38863231|FG002|Period 1: Single Dose|Adverse Event|0|||
16336651|NCT01690299|39717782|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
16336652|NCT01690299|39717783|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
16336653|NCT01690299|39717784|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
16336654|NCT01690299|39717785|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
16336655|NCT01690299|39717786|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
16336656|NCT01690299|39717781|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
16336657|NCT01690299|39717782|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16336658|NCT01690299|39717783|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16336659|NCT01690299|39717784|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16336660|NCT01690299|39717785|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16336661|NCT01690299|39717786|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16336662|NCT01690299|39717781|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
16336663|NCT01690299|39717782|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
16336664|NCT01690299|39717783|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16336665|NCT01690299|39717784|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16336666|NCT01690299|39717785|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16336667|NCT01690299|39717786|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16336668|NCT01690299|39717781|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
16336669|NCT01690299|39717782|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
16336670|NCT01690299|39717783|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
16336671|NCT01690299|39717784|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
16336672|NCT01690299|39717785|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
16336673|NCT01690299|39717786|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
16336674|NCT01690299|39717781|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
16336675|NCT01690299|39717782|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
16336676|NCT01690299|39717783|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
16336677|NCT01690299|39717784|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
16336678|NCT01690299|39717785|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
16336679|NCT01690299|39717786|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
16336680|NCT01690299|39717781|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
16336681|NCT01690299|39717782|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
16336682|NCT01690299|39717783|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
16336683|NCT01690299|39717784|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
16336684|NCT01690299|39717785|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
16336685|NCT01690299|39717786|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
16336686|NCT01690299|39717781|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
16336687|NCT01690299|39717782|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
16336688|NCT01690299|39717783|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
16336689|NCT01690299|39717784|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
16336690|NCT01690299|39717785|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
16336691|NCT01690299|39717786|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
16336692|NCT01690299|39717781|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
16336693|NCT01690299|39717782|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
16336694|NCT01690299|39717783|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
16405505|NCT02754141|39966358|FG014|Overall Study|Request to discontinue|1|||
16405506|NCT02754141|39966359|FG015|Overall Study|Request to discontinue|0|||
16405507|NCT02754141|39966360|FG016|Overall Study|Request to discontinue|0|||
16405508|NCT02754141|39966361|FG017|Overall Study|Request to discontinue|0|||
16405509|NCT02754141|39966344|FG000|Overall Study|Withdrew consent|0|||
16405510|NCT02754141|39966345|FG001|Overall Study|Withdrew consent|0|||
16405511|NCT02754141|39966346|FG002|Overall Study|Withdrew consent|0|||
16405512|NCT02754141|39966347|FG003|Overall Study|Withdrew consent|0|||
16405513|NCT02754141|39966348|FG004|Overall Study|Withdrew consent|0|||
16405514|NCT02754141|39966349|FG005|Overall Study|Withdrew consent|0|||
16405515|NCT02754141|39966350|FG006|Overall Study|Withdrew consent|0|||
16405516|NCT02754141|39966351|FG007|Overall Study|Withdrew consent|0|||
16405517|NCT02754141|39966352|FG008|Overall Study|Withdrew consent|0|||
16405518|NCT02754141|39966353|FG009|Overall Study|Withdrew consent|1|||
16405519|NCT02754141|39966354|FG010|Overall Study|Withdrew consent|0|||
16405520|NCT02754141|39966355|FG011|Overall Study|Withdrew consent|0|||
16405521|NCT02754141|39966356|FG012|Overall Study|Withdrew consent|0|||
16405522|NCT02754141|39966357|FG013|Overall Study|Withdrew consent|0|||
16405523|NCT02754141|39966358|FG014|Overall Study|Withdrew consent|0|||
16405524|NCT02754141|39966359|FG015|Overall Study|Withdrew consent|0|||
16405525|NCT02754141|39966360|FG016|Overall Study|Withdrew consent|0|||
16405526|NCT02754141|39966361|FG017|Overall Study|Withdrew consent|0|||
16405527|NCT02754141|39966344|FG000|Overall Study|Maximum clinical benefit|0|||
16405528|NCT02754141|39966345|FG001|Overall Study|Maximum clinical benefit|0|||
16405529|NCT02754141|39966346|FG002|Overall Study|Maximum clinical benefit|0|||
16405530|NCT02754141|39966347|FG003|Overall Study|Maximum clinical benefit|1|||
16405531|NCT02754141|39966348|FG004|Overall Study|Maximum clinical benefit|0|||
16405532|NCT02754141|39966349|FG005|Overall Study|Maximum clinical benefit|0|||
16405533|NCT02754141|39966350|FG006|Overall Study|Maximum clinical benefit|0|||
16405534|NCT02754141|39966351|FG007|Overall Study|Maximum clinical benefit|0|||
16405535|NCT02754141|39966352|FG008|Overall Study|Maximum clinical benefit|0|||
16405536|NCT02754141|39966353|FG009|Overall Study|Maximum clinical benefit|0|||
16405537|NCT02754141|39966354|FG010|Overall Study|Maximum clinical benefit|0|||
16405538|NCT02754141|39966355|FG011|Overall Study|Maximum clinical benefit|0|||
16405539|NCT02754141|39966356|FG012|Overall Study|Maximum clinical benefit|0|||
16405540|NCT02754141|39966357|FG013|Overall Study|Maximum clinical benefit|0|||
16405541|NCT02754141|39966358|FG014|Overall Study|Maximum clinical benefit|0|||
16405542|NCT02754141|39966359|FG015|Overall Study|Maximum clinical benefit|0|||
16405543|NCT02754141|39966360|FG016|Overall Study|Maximum clinical benefit|0|||
16405544|NCT02754141|39966361|FG017|Overall Study|Maximum clinical benefit|0|||
16405545|NCT02754141|39966344|FG000|Overall Study|No longer meets study criteria|0|||
16405546|NCT02754141|39966345|FG001|Overall Study|No longer meets study criteria|0|||
16405547|NCT02754141|39966346|FG002|Overall Study|No longer meets study criteria|0|||
16405548|NCT02754141|39966347|FG003|Overall Study|No longer meets study criteria|1|||
16405549|NCT02754141|39966348|FG004|Overall Study|No longer meets study criteria|0|||
16405550|NCT02754141|39966349|FG005|Overall Study|No longer meets study criteria|0|||
16405551|NCT02754141|39966350|FG006|Overall Study|No longer meets study criteria|0|||
16405552|NCT02754141|39966351|FG007|Overall Study|No longer meets study criteria|0|||
16405553|NCT02754141|39966352|FG008|Overall Study|No longer meets study criteria|0|||
16405554|NCT02754141|39966353|FG009|Overall Study|No longer meets study criteria|0|||
16405555|NCT02754141|39966354|FG010|Overall Study|No longer meets study criteria|0|||
16405556|NCT02754141|39966355|FG011|Overall Study|No longer meets study criteria|0|||
16405557|NCT02754141|39966356|FG012|Overall Study|No longer meets study criteria|0|||
16405558|NCT02754141|39966357|FG013|Overall Study|No longer meets study criteria|0|||
16405559|NCT02754141|39966358|FG014|Overall Study|No longer meets study criteria|0|||
16405560|NCT02754141|39966359|FG015|Overall Study|No longer meets study criteria|0|||
16405561|NCT02754141|39966360|FG016|Overall Study|No longer meets study criteria|0|||
16405562|NCT02754141|39966361|FG017|Overall Study|No longer meets study criteria|0|||
16336695|NCT01690299|39717784|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
16336696|NCT01690299|39717785|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
16336697|NCT01690299|39717786|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
16336698|NCT01690299|39717781|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
16336699|NCT01690299|39717782|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
16336700|NCT01690299|39717783|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
16336701|NCT01690299|39717784|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
16405563|NCT02754141|39966344|FG000|Overall Study|Other reasons|0|||
16405564|NCT02754141|39966345|FG001|Overall Study|Other reasons|0|||
16405565|NCT02754141|39966346|FG002|Overall Study|Other reasons|0|||
16405566|NCT02754141|39966347|FG003|Overall Study|Other reasons|0|||
16405567|NCT02754141|39966348|FG004|Overall Study|Other reasons|0|||
16405568|NCT02754141|39966349|FG005|Overall Study|Other reasons|0|||
16405569|NCT02754141|39966350|FG006|Overall Study|Other reasons|0|||
16405570|NCT02754141|39966351|FG007|Overall Study|Other reasons|1|||
16405571|NCT02754141|39966352|FG008|Overall Study|Other reasons|0|||
16405572|NCT02754141|39966353|FG009|Overall Study|Other reasons|0|||
16405573|NCT02754141|39966354|FG010|Overall Study|Other reasons|0|||
16405574|NCT02754141|39966355|FG011|Overall Study|Other reasons|0|||
16405575|NCT02754141|39966356|FG012|Overall Study|Other reasons|2|||
16405576|NCT02754141|39966357|FG013|Overall Study|Other reasons|0|||
16405577|NCT02754141|39966358|FG014|Overall Study|Other reasons|0|||
16405578|NCT02754141|39966359|FG015|Overall Study|Other reasons|0|||
16405579|NCT02754141|39966360|FG016|Overall Study|Other reasons|0|||
16536365|NCT03053050|40426341|FG003|Open-label Phase|Withdrew Consent|6|||
16216751|NCT01224106|39272476|FG004|Open-Label Extension (OLE) Phase|Death|3|||
16336702|NCT01690299|39717785|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
16336703|NCT01690299|39717786|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
16336704|NCT01690299|39717781|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
16336705|NCT01690299|39717782|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
16216752|NCT01224106|39272472|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
16216753|NCT01224106|39272473|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
16216754|NCT01224106|39272474|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
16216755|NCT01224106|39272475|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
16216756|NCT01224106|39272476|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
16216757|NCT01224106|39272472|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
16216758|NCT01224106|39272473|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
16336706|NCT01690299|39717783|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
16336707|NCT01690299|39717784|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
16336708|NCT01690299|39717785|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
16336709|NCT01690299|39717786|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
16336710|NCT02223364|39717787|FG000|Overall Study|Protocol Violation|3|||
16336711|NCT02223364|39717788|FG001|Overall Study|Protocol Violation|0|||
16336712|NCT02223364|39717789|FG002|Overall Study|Protocol Violation|3|||
16336713|NCT02223364|39717787|FG000|Overall Study|subject expired before surgery|1|||
16336714|NCT02223364|39717788|FG001|Overall Study|subject expired before surgery|0|||
16336715|NCT02223364|39717789|FG002|Overall Study|subject expired before surgery|0|||
16336716|NCT02223364|39717787|FG000|Overall Study|Physician Decision|1|||
16336717|NCT02223364|39717788|FG001|Overall Study|Physician Decision|0|||
16336718|NCT02223364|39717789|FG002|Overall Study|Physician Decision|0|||
16336724|NCT00463840|39717794|FG000|Overall Study|Disease progression|7|||
16336725|NCT00463840|39717794|FG000|Overall Study|Withdrawal by Subject|2|||
16336726|NCT00463840|39717794|FG000|Overall Study|Adverse Event|3|||
16336727|NCT02453256|39717795|FG000|Double Blind Period|Death|1|||
16336728|NCT02453256|39717796|FG001|Double Blind Period|Death|1|||
16336729|NCT02453256|39717795|FG000|Double Blind Period|Adverse Event|3|||
16336730|NCT02453256|39717796|FG001|Double Blind Period|Adverse Event|2|||
16336731|NCT02453256|39717795|FG000|Double Blind Period|Withdrawal by Subject|9|||
16336732|NCT02453256|39717796|FG001|Double Blind Period|Withdrawal by Subject|5|||
16336733|NCT02453256|39717795|FG000|Double Blind Period|Other|0|||
16336734|NCT02453256|39717796|FG001|Double Blind Period|Other|1|||
16336735|NCT02453256|39717795|FG000|Open Label Period|Adverse Event|1|||
16336736|NCT02453256|39717796|FG001|Open Label Period|Adverse Event|3|||
16336737|NCT02453256|39717795|FG000|Open Label Period|Death|0|||
16336738|NCT02453256|39717796|FG001|Open Label Period|Death|1|||
16336739|NCT02453256|39717795|FG000|Open Label Period|Lost to Follow-up|1|||
16336740|NCT02453256|39717796|FG001|Open Label Period|Lost to Follow-up|0|||
16336741|NCT02453256|39717795|FG000|Open Label Period|Other|0|||
16336742|NCT02453256|39717796|FG001|Open Label Period|Other|2|||
16336743|NCT02453256|39717795|FG000|Open Label Period|Withdrawal by Subject|5|||
16336744|NCT02453256|39717796|FG001|Open Label Period|Withdrawal by Subject|1|||
16336745|NCT01868165|39717797|FG000|Overall Study|Withdrawal by Subject|36|||
16336746|NCT01868165|39717797|FG000|Overall Study|Physician Decision|2|||
16336747|NCT01868165|39717797|FG000|Overall Study|Lost to Follow-up|3|||
16336748|NCT01868165|39717797|FG000|Overall Study|Death|4|||
16336749|NCT00337779|39717802|FG000|Overall Study|Withdrawal by Subject|10|||
16336750|NCT00337779|39717803|FG001|Overall Study|Withdrawal by Subject|12|||
16336751|NCT00337779|39717802|FG000|Overall Study|Sponsor decision|1|||
16336752|NCT00337779|39717803|FG001|Overall Study|Sponsor decision|1|||
16336753|NCT00337779|39717802|FG000|Overall Study|Physician Decision|3|||
16405580|NCT02754141|39966361|FG017|Overall Study|Other reasons|0|||
16536366|NCT03053050|40426338|FG000|Open-label Phase|Investigator's Discretion|0|||
16216759|NCT01224106|39272474|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
16336754|NCT00337779|39717803|FG001|Overall Study|Physician Decision|6|||
16336755|NCT00337779|39717802|FG000|Overall Study|Protocol Violation|1|||
16336756|NCT00337779|39717803|FG001|Overall Study|Protocol Violation|1|||
16336757|NCT00337779|39717802|FG000|Overall Study|Lost to Follow-up|6|||
16216760|NCT01224106|39272475|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
16216761|NCT01224106|39272476|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
16216762|NCT01224106|39272472|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
16216763|NCT01224106|39272473|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
16216764|NCT01224106|39272474|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
16216765|NCT01224106|39272475|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
16216766|NCT01224106|39272476|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
16216767|NCT01224106|39272472|FG000|Open-Label Extension (OLE) Phase|Other|0|||
16216768|NCT01224106|39272473|FG001|Open-Label Extension (OLE) Phase|Other|0|||
16336758|NCT00337779|39717803|FG001|Overall Study|Lost to Follow-up|5|||
16336759|NCT00337779|39717802|FG000|Overall Study|Adverse Event|28|||
16336760|NCT00337779|39717803|FG001|Overall Study|Adverse Event|51|||
16336761|NCT00337779|39717802|FG000|Overall Study|Pregnancy|3|||
16336762|NCT00337779|39717803|FG001|Overall Study|Pregnancy|2|||
16336763|NCT00337779|39717802|FG000|Overall Study|Death|0|||
16336764|NCT00337779|39717803|FG001|Overall Study|Death|1|||
16336765|NCT01937715|39717811|FG000|Overall Study|Death|0|||
16336766|NCT01937715|39717812|FG001|Overall Study|Death|0|||
16336767|NCT01937715|39717813|FG002|Overall Study|Death|0|||
16336768|NCT01937715|39717814|FG003|Overall Study|Death|1|||
16336769|NCT01937715|39717815|FG004|Overall Study|Death|0|||
16336770|NCT01937715|39717811|FG000|Overall Study|Withdrawal by Subject|0|||
16336771|NCT01937715|39717812|FG001|Overall Study|Withdrawal by Subject|1|||
16336772|NCT01937715|39717813|FG002|Overall Study|Withdrawal by Subject|0|||
16336773|NCT01937715|39717814|FG003|Overall Study|Withdrawal by Subject|0|||
16336774|NCT01937715|39717815|FG004|Overall Study|Withdrawal by Subject|2|||
16336775|NCT01937715|39717811|FG000|Overall Study|Other|0|||
16336776|NCT01937715|39717812|FG001|Overall Study|Other|0|||
16336777|NCT01937715|39717813|FG002|Overall Study|Other|0|||
16336778|NCT01937715|39717814|FG003|Overall Study|Other|3|||
16336779|NCT01937715|39717815|FG004|Overall Study|Other|0|||
16336780|NCT04686266|39717820|FG000|Overall Study|Withdrawal by Subject|0|||
16336781|NCT04686266|39717821|FG001|Overall Study|Withdrawal by Subject|1|||
16336782|NCT04908475|39717822|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
16336783|NCT04908475|39717823|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
16336784|NCT04908475|39717824|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
16336785|NCT04908475|39717825|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
16336786|NCT04908475|39717826|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
16336787|NCT04908475|39717827|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
16336788|NCT04908475|39717822|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
16336789|NCT04908475|39717823|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
16336790|NCT04908475|39717824|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
16336791|NCT04908475|39717825|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
16336792|NCT04908475|39717826|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
16336793|NCT04908475|39717827|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
16336794|NCT04908475|39717822|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
16336795|NCT04908475|39717823|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
16336796|NCT04908475|39717824|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
16336797|NCT04908475|39717825|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
16336798|NCT04908475|39717826|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
16336799|NCT04908475|39717827|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
16336800|NCT04908475|39717822|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
16336801|NCT04908475|39717823|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
16336802|NCT04908475|39717824|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
16336803|NCT04908475|39717825|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
16336804|NCT04908475|39717826|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
16336805|NCT04908475|39717827|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
16336806|NCT04908475|39717822|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
16336807|NCT04908475|39717823|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
16336808|NCT04908475|39717824|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
16336809|NCT04908475|39717825|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
16336810|NCT04908475|39717826|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
16336811|NCT04908475|39717827|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
16336812|NCT04908475|39717822|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
16336813|NCT04908475|39717823|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
16336814|NCT04908475|39717824|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
16336815|NCT04908475|39717825|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
16336816|NCT04908475|39717826|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
16336817|NCT04908475|39717827|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
16336818|NCT00388297|39717828|FG000|Overall Study|Lost to Follow-up|16|||
16336819|NCT00388297|39717829|FG001|Overall Study|Lost to Follow-up|12|||
16216769|NCT01224106|39272474|FG002|Open-Label Extension (OLE) Phase|Other|0|||
16336820|NCT00388297|39717830|FG002|Overall Study|Lost to Follow-up|11|||
16336821|NCT00388297|39717831|FG003|Overall Study|Lost to Follow-up|8|||
16336822|NCT00427999|39717835|FG000|Overall Study|Adverse Event|6|||
16336823|NCT00427999|39717835|FG000|Overall Study|Abnormal laboratory values|1|||
16336824|NCT00427999|39717835|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
16336825|NCT00427999|39717835|FG000|Overall Study|Protocol Violation|2|||
16336826|NCT00427999|39717835|FG000|Overall Study|Withdrawal by Subject|9|||
16536367|NCT03053050|40426339|FG001|Open-label Phase|Investigator's Discretion|0|||
16536368|NCT03053050|40426340|FG002|Open-label Phase|Investigator's Discretion|0|||
16536369|NCT03053050|40426341|FG003|Open-label Phase|Investigator's Discretion|4|||
16536370|NCT04020341|40426346|FG000|Overall Study|Adverse Event|8|||
16536371|NCT04020341|40426347|FG001|Overall Study|Adverse Event|6|||
16536372|NCT04020341|40426346|FG000|Overall Study|Lost to Follow-up|8|||
16536373|NCT04020341|40426347|FG001|Overall Study|Lost to Follow-up|2|||
16536374|NCT04020341|40426346|FG000|Overall Study|Withdrawal by Subject|16|||
16336827|NCT00427999|39717835|FG000|Overall Study|Death|1|||
16336828|NCT05095311|39717836|FG000|Overall Study|Lost to Follow-up|7|||
16336829|NCT05095311|39717837|FG001|Overall Study|Lost to Follow-up|0|||
16336830|NCT05095311|39717838|FG002|Overall Study|Lost to Follow-up|0|||
16336831|NCT01658904|39717839|FG000|Overall Study|Principal Investigator discretion|2|||
16336832|NCT01658904|39717840|FG001|Overall Study|Principal Investigator discretion|0|||
16336833|NCT01658904|39717841|FG002|Overall Study|Principal Investigator discretion|0|||
16336834|NCT03769194|39717842|FG000|Overall Study|Withdrawal by Subject|0|||
16336835|NCT03769194|39717843|FG001|Overall Study|Withdrawal by Subject|7|||
16336836|NCT03769194|39717844|FG002|Overall Study|Withdrawal by Subject|4|||
16336837|NCT03769194|39717845|FG003|Overall Study|Withdrawal by Subject|1|||
16336838|NCT03769194|39717842|FG000|Overall Study|moved from study area|0|||
16336839|NCT03769194|39717843|FG001|Overall Study|moved from study area|2|||
16336840|NCT03769194|39717844|FG002|Overall Study|moved from study area|1|||
16336841|NCT03769194|39717845|FG003|Overall Study|moved from study area|1|||
16336842|NCT03769194|39717842|FG000|Overall Study|Lost to Follow-up|3|||
16336843|NCT03769194|39717843|FG001|Overall Study|Lost to Follow-up|6|||
16336844|NCT03769194|39717844|FG002|Overall Study|Lost to Follow-up|3|||
16336845|NCT03769194|39717845|FG003|Overall Study|Lost to Follow-up|6|||
16336846|NCT03769194|39717842|FG000|Overall Study|other|1|||
16336847|NCT03769194|39717843|FG001|Overall Study|other|3|||
16336848|NCT03769194|39717844|FG002|Overall Study|other|0|||
16336849|NCT03769194|39717845|FG003|Overall Study|other|1|||
16336850|NCT01043705|39717848|FG000|Overall Study|Death|28|||
16336851|NCT01043705|39717849|FG001|Overall Study|Death|60|||
16336852|NCT01043705|39717850|FG002|Overall Study|Death|26|||
16336853|NCT01043705|39717848|FG000|Overall Study|Lost to Follow-up|27|||
16336854|NCT01043705|39717849|FG001|Overall Study|Lost to Follow-up|12|||
16336855|NCT01043705|39717850|FG002|Overall Study|Lost to Follow-up|0|||
16336856|NCT01043705|39717848|FG000|Overall Study|Multiple Reasons|4|||
16336857|NCT01043705|39717849|FG001|Overall Study|Multiple Reasons|7|||
16336858|NCT01043705|39717850|FG002|Overall Study|Multiple Reasons|0|||
16336859|NCT01043705|39717848|FG000|Overall Study|Protocol Violation|2|||
16336860|NCT01043705|39717849|FG001|Overall Study|Protocol Violation|1|||
16336861|NCT01043705|39717850|FG002|Overall Study|Protocol Violation|0|||
16336862|NCT01043705|39717848|FG000|Overall Study|Withdrawal by Subject|8|||
16336863|NCT01043705|39717849|FG001|Overall Study|Withdrawal by Subject|6|||
16336864|NCT01043705|39717850|FG002|Overall Study|Withdrawal by Subject|0|||
16336865|NCT01043705|39717848|FG000|Overall Study|Site Closure|8|||
16336866|NCT01043705|39717849|FG001|Overall Study|Site Closure|0|||
16336867|NCT01043705|39717850|FG002|Overall Study|Site Closure|0|||
16405581|NCT02754141|39966344|FG000|Overall Study|Completed treatment as per protocol|0|||
16405582|NCT02754141|39966345|FG001|Overall Study|Completed treatment as per protocol|1|||
16405583|NCT02754141|39966346|FG002|Overall Study|Completed treatment as per protocol|0|||
16405584|NCT02754141|39966347|FG003|Overall Study|Completed treatment as per protocol|0|||
16405585|NCT02754141|39966348|FG004|Overall Study|Completed treatment as per protocol|0|||
16536375|NCT04020341|40426347|FG001|Overall Study|Withdrawal by Subject|16|||
16536376|NCT04020341|40426346|FG000|Overall Study|Participant not able to swallow the tablet|1|||
16336868|NCT01043705|39717848|FG000|Overall Study|Subsequent Procedure|9|||
16336869|NCT01043705|39717849|FG001|Overall Study|Subsequent Procedure|24|||
16336870|NCT01043705|39717850|FG002|Overall Study|Subsequent Procedure|29|||
16336871|NCT01043705|39717848|FG000|Overall Study|Adverse Event|0|||
16336872|NCT01043705|39717849|FG001|Overall Study|Adverse Event|2|||
16336873|NCT01043705|39717850|FG002|Overall Study|Adverse Event|0|||
16336874|NCT01043705|39717848|FG000|Overall Study|Screen Fail|21|||
16336875|NCT01043705|39717849|FG001|Overall Study|Screen Fail|0|||
16336876|NCT01043705|39717850|FG002|Overall Study|Screen Fail|0|||
16336877|NCT01043705|39717848|FG000|Overall Study|Other|0|||
16336878|NCT01043705|39717849|FG001|Overall Study|Other|19|||
16336879|NCT01043705|39717850|FG002|Overall Study|Other|25|||
16336880|NCT00426660|39717851|FG000|Overall Study|Death|14|||
16336881|NCT00426660|39717851|FG000|Overall Study|Adverse Event|23|||
16336882|NCT00426660|39717851|FG000|Overall Study|Insufficient Clinical Response|22|||
16536377|NCT04020341|40426347|FG001|Overall Study|Participant not able to swallow the tablet|0|||
16536378|NCT04020341|40426346|FG000|Overall Study|Physician Decision|0|||
16536379|NCT04020341|40426347|FG001|Overall Study|Physician Decision|2|||
16216770|NCT01224106|39272475|FG003|Open-Label Extension (OLE) Phase|Other|5|||
16216771|NCT01224106|39272476|FG004|Open-Label Extension (OLE) Phase|Other|3|||
16336883|NCT00426660|39717851|FG000|Overall Study|Lost to Follow-up|15|||
16336884|NCT00426660|39717851|FG000|Overall Study|Other|23|||
16336885|NCT00426660|39717851|FG000|Overall Study|Withdrawal by Subject|18|||
16336886|NCT00426660|39717851|FG000|Overall Study|Protocol Violation|1|||
16336887|NCT00426660|39717851|FG000|Overall Study|Enrolled Not Treated|15|||
16336888|NCT00282152|39717854|FG000|Overall Study|Withdrawal by Subject|1|||
16336889|NCT00282152|39717855|FG001|Overall Study|Withdrawal by Subject|0|||
16336890|NCT00006305|39717858|FG000|Overall Study|Withdrawal by Subject|17|||
16336891|NCT00006305|39717859|FG001|Overall Study|Withdrawal by Subject|10|||
16336892|NCT00006305|39717860|FG002|Overall Study|Withdrawal by Subject|15|||
16336893|NCT00006305|39717861|FG003|Overall Study|Withdrawal by Subject|14|||
16336894|NCT01672294|39717862|FG000|Overall Study|Withdrawal by Subject|4|||
16336895|NCT01672294|39717863|FG001|Overall Study|Withdrawal by Subject|4|||
16336896|NCT01672294|39717864|FG002|Overall Study|Withdrawal by Subject|4|||
16336897|NCT01672294|39717865|FG003|Overall Study|Withdrawal by Subject|4|||
16336898|NCT01672294|39717862|FG000|Overall Study|Excluded by study|1|||
16336899|NCT01672294|39717863|FG001|Overall Study|Excluded by study|1|||
16336900|NCT01672294|39717864|FG002|Overall Study|Excluded by study|0|||
16336901|NCT01672294|39717865|FG003|Overall Study|Excluded by study|0|||
16336902|NCT01672294|39717862|FG000|Overall Study|Lost to Follow-up|1|||
16336903|NCT01672294|39717863|FG001|Overall Study|Lost to Follow-up|16|||
16336904|NCT01672294|39717864|FG002|Overall Study|Lost to Follow-up|7|||
16336905|NCT01672294|39717865|FG003|Overall Study|Lost to Follow-up|9|||
16336906|NCT01877551|39717868|FG000|Overall Study|Physician Decision|0|||
16336907|NCT01877551|39717869|FG001|Overall Study|Physician Decision|1|||
16336908|NCT02685072|39717870|FG000|Treatment Period|Lost to Follow-up|12|||
16336909|NCT02685072|39717871|FG001|Treatment Period|Lost to Follow-up|6|||
16336910|NCT02685072|39717870|FG000|Treatment Period|Withdrawal by Subject|1|||
16336911|NCT02685072|39717871|FG001|Treatment Period|Withdrawal by Subject|3|||
16336912|NCT02685072|39717870|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
16336913|NCT02685072|39717871|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
16336914|NCT02565706|39717896|FG000|Overall Study|Withdrawal by Subject|5|||
16336915|NCT02565706|39717897|FG001|Overall Study|Withdrawal by Subject|7|||
16336916|NCT02565706|39717898|FG002|Overall Study|Withdrawal by Subject|7|||
16336917|NCT02565706|39717899|FG003|Overall Study|Withdrawal by Subject|11|||
16336918|NCT02565706|39717896|FG000|Overall Study|Lost to Follow-up|72|||
16336919|NCT02565706|39717897|FG001|Overall Study|Lost to Follow-up|75|||
16336920|NCT02565706|39717898|FG002|Overall Study|Lost to Follow-up|82|||
16336921|NCT02565706|39717899|FG003|Overall Study|Lost to Follow-up|74|||
16336922|NCT03617861|39717900|FG000|Second Intervention (1 Day)|Adverse Event|0|||
16336923|NCT03617861|39717901|FG001|Second Intervention (1 Day)|Adverse Event|0|||
16336924|NCT03617861|39717902|FG002|Second Intervention (1 Day)|Adverse Event|1|||
16336925|NCT03617861|39717903|FG003|Second Intervention (1 Day)|Adverse Event|0|||
16336926|NCT01199822|39717904|FG000|Overall Study|Investigator discontinued therapy|0|||
16336927|NCT01199822|39717905|FG001|Overall Study|Investigator discontinued therapy|1|||
16336928|NCT01199822|39717906|FG002|Overall Study|Investigator discontinued therapy|0|||
16336929|NCT03013985|39717907|FG000|Overall Study|Protocol Violation|2|||
16336930|NCT03013985|39717908|FG001|Overall Study|Protocol Violation|2|||
16336931|NCT03013985|39717907|FG000|Overall Study|Withdrawal by Subject|14|||
16336932|NCT03013985|39717908|FG001|Overall Study|Withdrawal by Subject|17|||
16336933|NCT00958412|39717911|FG000|Overall Study|Study prematurely terminated|18|||
16336934|NCT02494401|39717914|FG000|Overall Study|Lost to Follow-up|22|||
16336935|NCT02494401|39717915|FG001|Overall Study|Lost to Follow-up|25|||
16336936|NCT02494401|39717914|FG000|Overall Study|Withdrawal by Subject|3|||
16336937|NCT02494401|39717915|FG001|Overall Study|Withdrawal by Subject|2|||
16336938|NCT04126317|39717919|FG000|Overall Study|Adverse Event|0|||
16336939|NCT04126317|39717920|FG001|Overall Study|Adverse Event|1|||
16536380|NCT04020341|40426346|FG000|Overall Study|Protocol Deviation|0|||
16536381|NCT04020341|40426347|FG001|Overall Study|Protocol Deviation|2|||
16216772|NCT01603615|39272477|FG000|Overall Study|Did not Receive Treatment|7|||
16216773|NCT01603615|39272477|FG000|Overall Study|Lost to Follow-up|9|||
16216774|NCT01603615|39272477|FG000|Overall Study|Personal Reasons|17|||
16216775|NCT01603615|39272477|FG000|Overall Study|Other Miscellaneous|1|||
16336940|NCT04126317|39717919|FG000|Overall Study|Withdrawal by Subject|4|||
16336941|NCT04126317|39717920|FG001|Overall Study|Withdrawal by Subject|1|||
16336942|NCT01554163|39717921|FG000|Overall Study|Adverse Event|3|||
16336943|NCT01554163|39717922|FG001|Overall Study|Adverse Event|0|||
16336944|NCT01554163|39717921|FG000|Overall Study|Lack of Efficacy|1|||
16336945|NCT01554163|39717922|FG001|Overall Study|Lack of Efficacy|0|||
16336946|NCT01554163|39717921|FG000|Overall Study|Lost to Follow-up|1|||
16216776|NCT00672139|39272479|FG000|Overall Study|Death|14|||
16216777|NCT00672139|39272480|FG001|Overall Study|Death|23|||
16336947|NCT01554163|39717922|FG001|Overall Study|Lost to Follow-up|0|||
16336948|NCT01554163|39717921|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16336949|NCT01554163|39717922|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16336950|NCT01554163|39717921|FG000|Overall Study|Protocol Violation|0|||
16336951|NCT01554163|39717922|FG001|Overall Study|Protocol Violation|4|||
16336952|NCT01554163|39717921|FG000|Overall Study|Withdrawal by Subject|1|||
16336953|NCT01554163|39717922|FG001|Overall Study|Withdrawal by Subject|5|||
16336954|NCT01554163|39717921|FG000|Overall Study|Not Treated|1|||
16336955|NCT01554163|39717922|FG001|Overall Study|Not Treated|0|||
16336956|NCT00577005|39717928|FG000|Overall Study|Lost to Follow-up|3|||
16336957|NCT00577005|39717929|FG001|Overall Study|Lost to Follow-up|2|||
16336958|NCT00577005|39717928|FG000|Overall Study|Withdrawal by Subject|2|||
16336959|NCT00577005|39717929|FG001|Overall Study|Withdrawal by Subject|1|||
16336960|NCT04594941|39717930|FG000|Overall Study|Other|0|||
16336961|NCT04594941|39717931|FG001|Overall Study|Other|3|||
16336962|NCT04594941|39717932|FG002|Overall Study|Other|1|||
16336963|NCT04594941|39717933|FG003|Overall Study|Other|0|||
16336964|NCT02854605|39717934|FG000|Overall Study|Adverse Event|1|||
16336965|NCT02854605|39717935|FG001|Overall Study|Adverse Event|5|||
16336966|NCT02854605|39717936|FG002|Overall Study|Adverse Event|2|||
16336967|NCT02854605|39717934|FG000|Overall Study|Lost to Follow-up|0|||
16336968|NCT02854605|39717935|FG001|Overall Study|Lost to Follow-up|2|||
16336969|NCT02854605|39717936|FG002|Overall Study|Lost to Follow-up|0|||
16336970|NCT02854605|39717934|FG000|Overall Study|Withdrew Consent|1|||
16336971|NCT02854605|39717935|FG001|Overall Study|Withdrew Consent|0|||
16336972|NCT02854605|39717936|FG002|Overall Study|Withdrew Consent|1|||
16405586|NCT02754141|39966349|FG005|Overall Study|Completed treatment as per protocol|0|||
16536382|NCT02080871|40426348|FG000|Overall Study|Death|1|||
16536383|NCT02080871|40426348|FG000|Overall Study|Lost to Follow-up|1|||
16536384|NCT04683926|40426349|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
16536385|NCT04683926|40426350|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
16536386|NCT04683926|40426351|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
16536387|NCT04683926|40426352|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
16536388|NCT03240692|40426358|FG000|Overall Study|Physician Decision|1|||
16536389|NCT03240692|40426358|FG000|Overall Study|Withdrawal by Subject|1|||
16536390|NCT03543254|40426362|FG000|Overall Study|Lost to Follow-up|1|||
16536391|NCT04537923|40426363|FG000|Overall Study|Adverse Event|2|||
16536392|NCT04537923|40426364|FG001|Overall Study|Adverse Event|1|||
16536393|NCT04537923|40426365|FG002|Overall Study|Adverse Event|2|||
16536394|NCT04537923|40426366|FG003|Overall Study|Adverse Event|4|||
16536395|NCT04537923|40426363|FG000|Overall Study|Death|3|||
16536396|NCT04537923|40426364|FG001|Overall Study|Death|3|||
16536397|NCT04537923|40426365|FG002|Overall Study|Death|1|||
16536398|NCT04537923|40426366|FG003|Overall Study|Death|11|||
16536399|NCT04537923|40426363|FG000|Overall Study|Lost to Follow-up|1|||
16405587|NCT02754141|39966350|FG006|Overall Study|Completed treatment as per protocol|0|||
16405588|NCT02754141|39966351|FG007|Overall Study|Completed treatment as per protocol|0|||
16405589|NCT02754141|39966352|FG008|Overall Study|Completed treatment as per protocol|0|||
16405590|NCT02754141|39966353|FG009|Overall Study|Completed treatment as per protocol|0|||
16405591|NCT02754141|39966354|FG010|Overall Study|Completed treatment as per protocol|0|||
16405592|NCT02754141|39966355|FG011|Overall Study|Completed treatment as per protocol|0|||
16405593|NCT02754141|39966356|FG012|Overall Study|Completed treatment as per protocol|1|||
16405594|NCT02754141|39966357|FG013|Overall Study|Completed treatment as per protocol|0|||
16405595|NCT02754141|39966358|FG014|Overall Study|Completed treatment as per protocol|0|||
16405596|NCT02754141|39966359|FG015|Overall Study|Completed treatment as per protocol|0|||
16405597|NCT02754141|39966360|FG016|Overall Study|Completed treatment as per protocol|0|||
16405598|NCT02754141|39966361|FG017|Overall Study|Completed treatment as per protocol|0|||
16405599|NCT02754141|39966344|FG000|Overall Study|Not completing monotherapy|0|||
16405600|NCT02754141|39966345|FG001|Overall Study|Not completing monotherapy|0|||
16405601|NCT02754141|39966346|FG002|Overall Study|Not completing monotherapy|0|||
16405602|NCT02754141|39966347|FG003|Overall Study|Not completing monotherapy|0|||
16405603|NCT02754141|39966348|FG004|Overall Study|Not completing monotherapy|0|||
16405604|NCT02754141|39966349|FG005|Overall Study|Not completing monotherapy|0|||
16405605|NCT02754141|39966350|FG006|Overall Study|Not completing monotherapy|0|||
16405606|NCT02754141|39966351|FG007|Overall Study|Not completing monotherapy|0|||
16405607|NCT02754141|39966352|FG008|Overall Study|Not completing monotherapy|0|||
16536400|NCT04537923|40426364|FG001|Overall Study|Lost to Follow-up|2|||
16536401|NCT04537923|40426365|FG002|Overall Study|Lost to Follow-up|1|||
16536402|NCT04537923|40426366|FG003|Overall Study|Lost to Follow-up|6|||
16536403|NCT04537923|40426363|FG000|Overall Study|Physician Decision|1|||
16536404|NCT04537923|40426364|FG001|Overall Study|Physician Decision|0|||
16336973|NCT02854605|39717934|FG000|Overall Study|Investigator's Discretion|1|||
16336974|NCT02854605|39717935|FG001|Overall Study|Investigator's Discretion|0|||
16336975|NCT02854605|39717936|FG002|Overall Study|Investigator's Discretion|0|||
16336976|NCT02854605|39717934|FG000|Overall Study|Protocol Violation|0|||
16336977|NCT02854605|39717935|FG001|Overall Study|Protocol Violation|0|||
16336978|NCT02854605|39717936|FG002|Overall Study|Protocol Violation|1|||
16336979|NCT01389258|39717937|FG000|Overall Study|Lost to Follow-up|5|||
16405608|NCT02754141|39966353|FG009|Overall Study|Not completing monotherapy|0|||
16405609|NCT02754141|39966354|FG010|Overall Study|Not completing monotherapy|0|||
16405610|NCT02754141|39966355|FG011|Overall Study|Not completing monotherapy|0|||
16405611|NCT02754141|39966356|FG012|Overall Study|Not completing monotherapy|0|||
16405612|NCT02754141|39966357|FG013|Overall Study|Not completing monotherapy|1|||
16405613|NCT02754141|39966358|FG014|Overall Study|Not completing monotherapy|0|||
16405614|NCT02754141|39966359|FG015|Overall Study|Not completing monotherapy|0|||
16405615|NCT02754141|39966360|FG016|Overall Study|Not completing monotherapy|0|||
16405616|NCT02754141|39966361|FG017|Overall Study|Not completing monotherapy|0|||
16405617|NCT00413920|39966362|FG000|Overall Study|Adverse Event|9|||
16405618|NCT00413920|39966363|FG001|Overall Study|Adverse Event|11|||
16405619|NCT00413920|39966362|FG000|Overall Study|Lack of Efficacy|11|||
16405620|NCT00413920|39966363|FG001|Overall Study|Lack of Efficacy|9|||
16405621|NCT00413920|39966362|FG000|Overall Study|Death|3|||
16405622|NCT00413920|39966363|FG001|Overall Study|Death|5|||
16405623|NCT00413920|39966362|FG000|Overall Study|Graft Loss|5|||
16405624|NCT00413920|39966363|FG001|Overall Study|Graft Loss|3|||
16405625|NCT01774253|39966364|FG000|Overall Study|Lack of Efficacy|4|||
16405626|NCT01774253|39966364|FG000|Overall Study|Physician Decision|2|||
16405627|NCT01774253|39966364|FG000|Overall Study|Withdrawal by Subject|2|||
16405628|NCT01774253|39966364|FG000|Overall Study|Death|1|||
16336980|NCT00980655|39717942|FG000|Overall Study|Adverse Event|13|||
16336981|NCT00980655|39717943|FG001|Overall Study|Adverse Event|31|||
16336982|NCT00980655|39717942|FG000|Overall Study|Death|0|||
16336983|NCT00980655|39717943|FG001|Overall Study|Death|7|||
16336984|NCT00980655|39717942|FG000|Overall Study|Protocol Violation|2|||
16336985|NCT00980655|39717943|FG001|Overall Study|Protocol Violation|7|||
16336986|NCT00980655|39717942|FG000|Overall Study|Withdrawal by Subject|0|||
16336987|NCT00980655|39717943|FG001|Overall Study|Withdrawal by Subject|4|||
16336988|NCT00980655|39717942|FG000|Overall Study|Lost to Follow-up|0|||
16336989|NCT00980655|39717943|FG001|Overall Study|Lost to Follow-up|1|||
16336990|NCT00980655|39717942|FG000|Overall Study|Parent/legal guardian request|1|||
16336991|NCT00980655|39717943|FG001|Overall Study|Parent/legal guardian request|0|||
16336992|NCT00980655|39717942|FG000|Overall Study|Other|0|||
16336993|NCT00980655|39717943|FG001|Overall Study|Other|1|||
16405629|NCT00503581|39966375|FG000|Overall Study|Study closed|3|||
16336994|NCT00520767|39717944|FG000|Overall Study|Death|2|||
16336995|NCT02561455|39717947|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
16405630|NCT00503581|39966376|FG001|Overall Study|Study closed|4|||
16405631|NCT00503581|39966377|FG002|Overall Study|Study closed|2|||
16336996|NCT02561455|39717948|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
16405632|NCT00585221|39966383|FG000|Overall Study|Protocol Violation|8|||
16536405|NCT04537923|40426365|FG002|Overall Study|Physician Decision|2|||
16536406|NCT04537923|40426366|FG003|Overall Study|Physician Decision|5|||
16536407|NCT04537923|40426363|FG000|Overall Study|Pregnancy|1|||
16536408|NCT04537923|40426364|FG001|Overall Study|Pregnancy|0|||
16536409|NCT04537923|40426365|FG002|Overall Study|Pregnancy|0|||
16536410|NCT04537923|40426366|FG003|Overall Study|Pregnancy|0|||
16536411|NCT04537923|40426363|FG000|Overall Study|Withdrawal by Subject|4|||
16536412|NCT04537923|40426364|FG001|Overall Study|Withdrawal by Subject|4|||
16536413|NCT04537923|40426365|FG002|Overall Study|Withdrawal by Subject|4|||
16536414|NCT04537923|40426366|FG003|Overall Study|Withdrawal by Subject|58|||
16536415|NCT04537923|40426363|FG000|Overall Study|Missed study visits|2|||
16216778|NCT00672139|39272479|FG000|Overall Study|Withdrawal by Subject|2|||
16216779|NCT00672139|39272480|FG001|Overall Study|Withdrawal by Subject|11|||
16216780|NCT00672139|39272479|FG000|Overall Study|Adverse Event|4|||
16216781|NCT00672139|39272480|FG001|Overall Study|Adverse Event|7|||
16216782|NCT00672139|39272479|FG000|Overall Study|Physician Decision|2|||
16216783|NCT00672139|39272480|FG001|Overall Study|Physician Decision|0|||
16216784|NCT00672139|39272479|FG000|Overall Study|Lack of Efficacy|4|||
16216785|NCT00672139|39272480|FG001|Overall Study|Lack of Efficacy|1|||
16216786|NCT00672139|39272479|FG000|Overall Study|Protocol Violation|1|||
16216787|NCT00672139|39272480|FG001|Overall Study|Protocol Violation|1|||
16216788|NCT00672139|39272479|FG000|Overall Study|hospice discharge, caregiver requests|3|||
16216789|NCT00672139|39272480|FG001|Overall Study|hospice discharge, caregiver requests|2|||
16216790|NCT00673816|39272481|FG000|Overall Study|Adverse Event|1|||
16216791|NCT00673816|39272481|FG000|Overall Study|Withdrawal by Subject|1|||
16216792|NCT00589602|39272489|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
16216793|NCT02408484|39272490|FG000|Overall Study|Withdrawal by Subject|3|||
16216794|NCT02408484|39272490|FG000|Overall Study|Not treated during study period|1|||
16216795|NCT00405275|39272501|FG000|Overall Study|Death|1|||
16216796|NCT00405275|39272502|FG001|Overall Study|Death|0|||
16216797|NCT00405275|39272501|FG000|Overall Study|Lost to Follow-up|5|||
16216798|NCT00405275|39272502|FG001|Overall Study|Lost to Follow-up|1|||
16216799|NCT00405275|39272501|FG000|Overall Study|Withdrawal by Subject|7|||
16216800|NCT00405275|39272502|FG001|Overall Study|Withdrawal by Subject|9|||
16216801|NCT00405275|39272501|FG000|Overall Study|Unwilling to continue|10|||
16216802|NCT00405275|39272502|FG001|Overall Study|Unwilling to continue|9|||
16216803|NCT02442765|39272503|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
16216804|NCT02442765|39272504|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
16216805|NCT02442765|39272505|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
16536416|NCT04537923|40426364|FG001|Overall Study|Missed study visits|0|||
16216806|NCT02442765|39272506|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
16216807|NCT02442765|39272507|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
16216808|NCT02442765|39272508|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
16216809|NCT02442765|39272509|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
16536417|NCT04537923|40426365|FG002|Overall Study|Missed study visits|0|||
16216810|NCT02442765|39272510|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
16216811|NCT02442765|39272503|FG000|Stage 2- (Days 43 to 85)|Death|0|||
16216812|NCT02442765|39272504|FG001|Stage 2- (Days 43 to 85)|Death|0|||
16216813|NCT02442765|39272505|FG002|Stage 2- (Days 43 to 85)|Death|0|||
16216814|NCT02442765|39272506|FG003|Stage 2- (Days 43 to 85)|Death|1|||
16216815|NCT02442765|39272507|FG004|Stage 2- (Days 43 to 85)|Death|1|||
16216816|NCT02442765|39272508|FG005|Stage 2- (Days 43 to 85)|Death|0|||
16216817|NCT02442765|39272509|FG006|Stage 2- (Days 43 to 85)|Death|2|||
16216818|NCT02442765|39272510|FG007|Stage 2- (Days 43 to 85)|Death|0|||
16216819|NCT02442765|39272503|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
16216820|NCT02442765|39272504|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
16216821|NCT02442765|39272505|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
16216822|NCT02442765|39272506|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
16216823|NCT02442765|39272507|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
16216824|NCT02442765|39272508|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
16216825|NCT02442765|39272509|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
16216826|NCT02442765|39272510|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
16216827|NCT02442765|39272503|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
16216828|NCT02442765|39272504|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
16216829|NCT02442765|39272505|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
16216830|NCT02442765|39272506|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
16216831|NCT02442765|39272507|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
16216832|NCT02442765|39272508|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
16216833|NCT02442765|39272509|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
16216834|NCT02442765|39272510|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
16216835|NCT02442765|39272503|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
16336997|NCT02561455|39717949|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
16336998|NCT02561455|39717950|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
16336999|NCT02561455|39717947|FG000|Overall Study|Withdrawal by Subject|1|||
16337000|NCT02561455|39717948|FG001|Overall Study|Withdrawal by Subject|0|||
16337001|NCT02561455|39717949|FG002|Overall Study|Withdrawal by Subject|1|||
16337002|NCT02561455|39717950|FG003|Overall Study|Withdrawal by Subject|0|||
16337003|NCT02561455|39717947|FG000|Overall Study|Disease Progression|0|||
16337004|NCT02561455|39717948|FG001|Overall Study|Disease Progression|1|||
16337005|NCT02561455|39717949|FG002|Overall Study|Disease Progression|0|||
16337006|NCT02561455|39717950|FG003|Overall Study|Disease Progression|0|||
16337007|NCT01243177|39717951|FG000|Overall Study|Lack of Efficacy|47|||
16337008|NCT01243177|39717952|FG001|Overall Study|Lack of Efficacy|31|||
16337009|NCT01243177|39717951|FG000|Overall Study|Protocol Violation|11|||
16337010|NCT01243177|39717952|FG001|Overall Study|Protocol Violation|10|||
16337011|NCT01243177|39717951|FG000|Overall Study|Lost to Follow-up|15|||
16337012|NCT01243177|39717952|FG001|Overall Study|Lost to Follow-up|18|||
16337013|NCT01243177|39717951|FG000|Overall Study|Withdrawal by Subject|46|||
16337014|NCT01243177|39717952|FG001|Overall Study|Withdrawal by Subject|38|||
16337015|NCT01243177|39717951|FG000|Overall Study|AE, serious fatal|0|||
16337016|NCT01243177|39717952|FG001|Overall Study|AE, serious fatal|1|||
16337017|NCT01243177|39717951|FG000|Overall Study|SAE, non-fatal|7|||
16337018|NCT01243177|39717952|FG001|Overall Study|SAE, non-fatal|9|||
16337019|NCT01243177|39717951|FG000|Overall Study|AE, non-serious non-fatal|40|||
16337020|NCT01243177|39717952|FG001|Overall Study|AE, non-serious non-fatal|58|||
16337021|NCT01243177|39717951|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
16337022|NCT01243177|39717952|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
16337023|NCT01243177|39717951|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
16337024|NCT01243177|39717952|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
16337025|NCT01243177|39717951|FG000|Overall Study|Other Reason|11|||
16337026|NCT01243177|39717952|FG001|Overall Study|Other Reason|12|||
16337027|NCT03383692|39717953|FG000|Overall Study|Progressive disease as per RECIST|3|||
16337028|NCT03383692|39717954|FG001|Overall Study|Progressive disease as per RECIST|3|||
16337029|NCT03383692|39717953|FG000|Overall Study|Clinical progression|0|||
16337030|NCT03383692|39717954|FG001|Overall Study|Clinical progression|1|||
16337031|NCT03383692|39717953|FG000|Overall Study|Adverse Event|3|||
16337032|NCT03383692|39717954|FG001|Overall Study|Adverse Event|0|||
16337033|NCT02697734|39717955|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
16337034|NCT02697734|39717956|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
16337035|NCT02697734|39717955|FG000|Core Phase - up to Week 48|Adverse Event|1|||
16337036|NCT02697734|39717956|FG001|Core Phase - up to Week 48|Adverse Event|2|||
16337037|NCT02697734|39717955|FG000|Core Phase - up to Week 48|Physician Decision|1|||
16337038|NCT02697734|39717956|FG001|Core Phase - up to Week 48|Physician Decision|0|||
16337039|NCT02697734|39717955|FG000|Optional Extension Phase|Adverse Event|5|||
16216836|NCT02442765|39272504|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
16216837|NCT02442765|39272505|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
16216838|NCT02442765|39272506|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
16337040|NCT02697734|39717956|FG001|Optional Extension Phase|Adverse Event|1|||
16337041|NCT02697734|39717955|FG000|Optional Extension Phase|Physician Decision|0|||
16405633|NCT01357161|39966384|FG000|Part 1 (Open Label Run-in)|Death|5|||
16216839|NCT02442765|39272507|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
16216840|NCT02442765|39272508|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
16216841|NCT02442765|39272509|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
16216842|NCT02442765|39272510|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
16337042|NCT02697734|39717956|FG001|Optional Extension Phase|Physician Decision|1|||
16536418|NCT04537923|40426366|FG003|Overall Study|Missed study visits|3|||
16536419|NCT04537923|40426363|FG000|Overall Study|Sponsor's decision|0|||
16536420|NCT04537923|40426364|FG001|Overall Study|Sponsor's decision|0|||
16536421|NCT04537923|40426365|FG002|Overall Study|Sponsor's decision|1|||
16536422|NCT04537923|40426366|FG003|Overall Study|Sponsor's decision|1|||
16536423|NCT04537923|40426363|FG000|Overall Study|Safety reasons|1|||
16536424|NCT04537923|40426364|FG001|Overall Study|Safety reasons|0|||
16536425|NCT04537923|40426365|FG002|Overall Study|Safety reasons|0|||
16536426|NCT04537923|40426366|FG003|Overall Study|Safety reasons|0|||
16536427|NCT02515279|40426367|FG000|Overall Study|Adverse Event|7|||
16536428|NCT02515279|40426367|FG000|Overall Study|Lack of Efficacy|31|||
16536429|NCT02515279|40426367|FG000|Overall Study|Lost to Follow-up|9|||
16337043|NCT00534105|39717959|FG000|Overall Study|Lost to Follow-up|23|||
16337044|NCT00534105|39717960|FG001|Overall Study|Lost to Follow-up|39|||
16337045|NCT01578499|39717963|FG000|Overall Study|Reason not Specified|0|||
16337046|NCT01578499|39717964|FG001|Overall Study|Reason not Specified|1|||
16337047|NCT01578499|39717963|FG000|Overall Study|Lost to Follow-up|2|||
16337048|NCT01578499|39717964|FG001|Overall Study|Lost to Follow-up|1|||
16536430|NCT02515279|40426367|FG000|Overall Study|Withdrawal by Subject|18|||
16337049|NCT01578499|39717963|FG000|Overall Study|Withdrawal by Subject|10|||
16337050|NCT01578499|39717964|FG001|Overall Study|Withdrawal by Subject|16|||
16337051|NCT01578499|39717963|FG000|Overall Study|Death|20|||
16337052|NCT01578499|39717964|FG001|Overall Study|Death|25|||
16536431|NCT02515279|40426367|FG000|Overall Study|End-of-treatment visit not attended|17|||
16337053|NCT01578499|39717963|FG000|Overall Study|Died and End of Study Page not Completed|2|||
16536432|NCT02515279|40426367|FG000|Overall Study|Other|22|||
16536433|NCT03804710|40426371|FG000|Overall Study|Adverse Event|0|||
16337054|NCT01578499|39717964|FG001|Overall Study|Died and End of Study Page not Completed|0|||
16337055|NCT02093390|39717967|FG000|Overall Study|Withdrawal by Subject|0|||
16536434|NCT03804710|40426372|FG001|Overall Study|Adverse Event|3|||
16536435|NCT03804710|40426371|FG000|Overall Study|Withdrawal by Subject|2|||
16536436|NCT03804710|40426372|FG001|Overall Study|Withdrawal by Subject|1|||
16536437|NCT03804710|40426371|FG000|Overall Study|Other|0|||
16536438|NCT03804710|40426372|FG001|Overall Study|Other|1|||
16536439|NCT01483924|40426373|FG000|Overall Study|Withdrawal by Subject|2|||
16337056|NCT02093390|39717968|FG001|Overall Study|Withdrawal by Subject|1|||
16337057|NCT01987232|39717969|FG000|Overall Study|Ongoing in Study|0|||
16337058|NCT01987232|39717970|FG001|Overall Study|Ongoing in Study|0|||
16337059|NCT01987232|39717971|FG002|Overall Study|Ongoing in Study|0|||
16337060|NCT01987232|39717972|FG003|Overall Study|Ongoing in Study|1|||
16337061|NCT01987232|39717973|FG004|Overall Study|Ongoing in Study|0|||
16337062|NCT02073656|39717978|FG000|Primary Study|Lost to Follow-up|6|||
16337063|NCT02073656|39717978|FG000|Primary Study|Death|1|||
16337064|NCT02073656|39717978|FG000|Primary Study|Withdrew Consent|1|||
16337065|NCT02086448|39717979|FG000|Overall Study|Withdrawal by Subject|1|||
16337066|NCT02086448|39717980|FG001|Overall Study|Withdrawal by Subject|0|||
16337067|NCT02086448|39717981|FG002|Overall Study|Withdrawal by Subject|0|||
16536440|NCT01483924|40426374|FG001|Overall Study|Withdrawal by Subject|0|||
16536441|NCT01483924|40426375|FG002|Overall Study|Withdrawal by Subject|0|||
16536442|NCT01483924|40426376|FG003|Overall Study|Withdrawal by Subject|1|||
16536443|NCT01483924|40426377|FG004|Overall Study|Withdrawal by Subject|1|||
16536444|NCT01483924|40426373|FG000|Overall Study|Adverse Event|0|||
16536445|NCT01483924|40426374|FG001|Overall Study|Adverse Event|0|||
16536446|NCT01483924|40426375|FG002|Overall Study|Adverse Event|1|||
16536447|NCT01483924|40426376|FG003|Overall Study|Adverse Event|1|||
16536448|NCT01483924|40426377|FG004|Overall Study|Adverse Event|0|||
16536449|NCT01483924|40426373|FG000|Overall Study|Non-compliance|0|||
16536450|NCT01483924|40426374|FG001|Overall Study|Non-compliance|0|||
16536451|NCT01483924|40426375|FG002|Overall Study|Non-compliance|0|||
16536452|NCT01483924|40426376|FG003|Overall Study|Non-compliance|1|||
16536453|NCT01483924|40426377|FG004|Overall Study|Non-compliance|1|||
16536454|NCT01483924|40426373|FG000|Overall Study|Sponsor concern over ECG result|0|||
16536455|NCT01483924|40426374|FG001|Overall Study|Sponsor concern over ECG result|0|||
16536456|NCT01483924|40426375|FG002|Overall Study|Sponsor concern over ECG result|0|||
16536457|NCT01483924|40426376|FG003|Overall Study|Sponsor concern over ECG result|1|||
16536458|NCT01483924|40426377|FG004|Overall Study|Sponsor concern over ECG result|0|||
16536459|NCT03364751|40426378|FG000|Overall Study|Withdrawal by Subject|1|||
16536460|NCT03364751|40426379|FG001|Overall Study|Withdrawal by Subject|0|||
16536461|NCT03364751|40426380|FG002|Overall Study|Withdrawal by Subject|0|||
16536462|NCT03364751|40426381|FG003|Overall Study|Withdrawal by Subject|0|||
16536463|NCT03364751|40426378|FG000|Overall Study|Lost to Follow-up|0|||
16536464|NCT03364751|40426379|FG001|Overall Study|Lost to Follow-up|1|||
16536465|NCT03364751|40426380|FG002|Overall Study|Lost to Follow-up|0|||
16536466|NCT03364751|40426381|FG003|Overall Study|Lost to Follow-up|0|||
16536467|NCT02858895|40426387|FG000|Overall Study|Disease progression|31|||
16536468|NCT02858895|40426387|FG000|Overall Study|Death|2|||
16536469|NCT02858895|40426387|FG000|Overall Study|Adverse Event|1|||
16536470|NCT02858895|40426387|FG000|Overall Study|Withdrawal by Subject|3|||
16536471|NCT02858895|40426387|FG000|Overall Study|hospice,|1|||
16536472|NCT02858895|40426387|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
16536473|NCT00541450|40426388|FG000|Phase A|Adverse Event|3|||
16536474|NCT00541450|40426389|FG001|Phase A|Adverse Event|0|||
16536475|NCT00541450|40426388|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
16536476|NCT00541450|40426389|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
16536477|NCT00541450|40426388|FG000|Phase A|Hyperglycemia|0|||
16536478|NCT00541450|40426389|FG001|Phase A|Hyperglycemia|1|||
16536479|NCT00541450|40426388|FG000|Phase A|Lost to Follow-up|6|||
16536480|NCT00541450|40426389|FG001|Phase A|Lost to Follow-up|4|||
16536481|NCT00541450|40426388|FG000|Phase A|Physician Decision|2|||
16536482|NCT00541450|40426389|FG001|Phase A|Physician Decision|0|||
16536483|NCT00541450|40426388|FG000|Phase A|Protocol Violation|2|||
16536484|NCT00541450|40426389|FG001|Phase A|Protocol Violation|3|||
16536485|NCT00541450|40426388|FG000|Phase A|Withdrawal by Subject|7|||
16536486|NCT00541450|40426389|FG001|Phase A|Withdrawal by Subject|7|||
16536487|NCT00541450|40426388|FG000|Phase B|Adverse Event|6|||
16536488|NCT00541450|40426389|FG001|Phase B|Adverse Event|6|||
16536489|NCT00541450|40426388|FG000|Phase B|Hyperglycemia|10|||
16337068|NCT02086448|39717982|FG003|Overall Study|Withdrawal by Subject|2|||
16337069|NCT02045732|39717985|FG000|Overall Study|At the discretion of the investigator|1|||
16405634|NCT01357161|39966385|FG001|Part 1 (Open Label Run-in)|Death|0|||
16536490|NCT00541450|40426389|FG001|Phase B|Hyperglycemia|9|||
16536491|NCT00541450|40426388|FG000|Phase B|Lost to Follow-up|6|||
16536492|NCT00541450|40426389|FG001|Phase B|Lost to Follow-up|4|||
16536493|NCT00541450|40426388|FG000|Phase B|Physician Decision|4|||
16536494|NCT00541450|40426389|FG001|Phase B|Physician Decision|2|||
16536495|NCT00541450|40426388|FG000|Phase B|Pregnancy|0|||
16536496|NCT00541450|40426389|FG001|Phase B|Pregnancy|1|||
16536497|NCT00541450|40426388|FG000|Phase B|Protocol Violation|3|||
16536498|NCT00541450|40426389|FG001|Phase B|Protocol Violation|3|||
16536499|NCT00541450|40426388|FG000|Phase B|Withdrawal by Subject|8|||
16536500|NCT00541450|40426389|FG001|Phase B|Withdrawal by Subject|6|||
16536501|NCT05763628|40426392|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
16536502|NCT05763628|40426393|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
16536503|NCT05763628|40426392|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
16337070|NCT02045732|39717986|FG001|Overall Study|At the discretion of the investigator|1|||
16337071|NCT01754766|39717987|FG000|Overall Study|Personal reasons|1|||
16337072|NCT01754766|39717988|FG001|Overall Study|Personal reasons|1|||
16337073|NCT01754766|39717989|FG002|Overall Study|Personal reasons|0|||
16337074|NCT01593254|39717990|FG000|Overall Study|Disease progression|2|||
16337075|NCT01593254|39717991|FG001|Overall Study|Disease progression|7|||
16337076|NCT01593254|39717990|FG000|Overall Study|Study drug toxicity|6|||
16337077|NCT01593254|39717991|FG001|Overall Study|Study drug toxicity|20|||
16337078|NCT01593254|39717990|FG000|Overall Study|Death|3|||
16337079|NCT01593254|39717991|FG001|Overall Study|Death|3|||
16337080|NCT01593254|39717990|FG000|Overall Study|AE unrelated to study drug|0|||
16337081|NCT01593254|39717991|FG001|Overall Study|AE unrelated to study drug|1|||
16337082|NCT01593254|39717990|FG000|Overall Study|participant request to discontinue study treatment|1|||
16337083|NCT01593254|39717991|FG001|Overall Study|participant request to discontinue study treatment|3|||
16337084|NCT01593254|39717990|FG000|Overall Study|participant withdrew consent|0|||
16337085|NCT01593254|39717991|FG001|Overall Study|participant withdrew consent|9|||
16337086|NCT01593254|39717990|FG000|Overall Study|lost to follow up|1|||
16337087|NCT01593254|39717991|FG001|Overall Study|lost to follow up|6|||
16337088|NCT01593254|39717990|FG000|Overall Study|maximum clinical benefit|1|||
16337089|NCT01593254|39717991|FG001|Overall Study|maximum clinical benefit|2|||
16337090|NCT01593254|39717990|FG000|Overall Study|Poor/non compliance|1|||
16337091|NCT01593254|39717991|FG001|Overall Study|Poor/non compliance|1|||
16337092|NCT01593254|39717990|FG000|Overall Study|Pregnancy|0|||
16337093|NCT01593254|39717991|FG001|Overall Study|Pregnancy|3|||
16337094|NCT01593254|39717990|FG000|Overall Study|participant no longer meets study criteria|1|||
16337095|NCT01593254|39717991|FG001|Overall Study|participant no longer meets study criteria|1|||
16337096|NCT01593254|39717990|FG000|Overall Study|Admin reason by sponsor|7|||
16337097|NCT01593254|39717991|FG001|Overall Study|Admin reason by sponsor|3|||
16337098|NCT01593254|39717990|FG000|Overall Study|Imatinib treatment failure|2|||
16337099|NCT01593254|39717991|FG001|Overall Study|Imatinib treatment failure|0|||
16337100|NCT01593254|39717990|FG000|Overall Study|Other Reasons|61|||
16337101|NCT01593254|39717991|FG001|Overall Study|Other Reasons|115|||
16337102|NCT01108237|39721022|FG000|Overall Study|No alignment data|2|||
16337103|NCT01108237|39721023|FG001|Overall Study|No alignment data|15|||
16337104|NCT01108237|39721022|FG000|Overall Study|Did not meet criteria for analysis|7|||
16337105|NCT01108237|39721023|FG001|Overall Study|Did not meet criteria for analysis|0|||
16536504|NCT05763628|40426393|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
16337106|NCT01908582|39721024|FG000|Period 2|Physician Decision|1|||
16337107|NCT01908582|39721024|FG000|Period 2|Withdrawal by Subject|1|||
16337108|NCT00422292|39721025|FG000|Overall Study|Serious adverse events|1|||
16337109|NCT00422292|39721026|FG001|Overall Study|Serious adverse events|4|||
16337110|NCT00422292|39721027|FG002|Overall Study|Serious adverse events|0|||
16337111|NCT00422292|39721028|FG003|Overall Study|Serious adverse events|0|||
16337112|NCT00422292|39721025|FG000|Overall Study|Adverse Event|1|||
16337113|NCT00422292|39721026|FG001|Overall Study|Adverse Event|0|||
16337114|NCT00422292|39721027|FG002|Overall Study|Adverse Event|1|||
16337115|NCT00422292|39721028|FG003|Overall Study|Adverse Event|0|||
16337116|NCT00422292|39721025|FG000|Overall Study|Protocol Violation|4|||
16337117|NCT00422292|39721026|FG001|Overall Study|Protocol Violation|25|||
16337118|NCT00422292|39721027|FG002|Overall Study|Protocol Violation|8|||
16337119|NCT00422292|39721028|FG003|Overall Study|Protocol Violation|5|||
16337120|NCT00422292|39721025|FG000|Overall Study|Lost to Follow-up|6|||
16337121|NCT00422292|39721026|FG001|Overall Study|Lost to Follow-up|12|||
16337122|NCT00422292|39721027|FG002|Overall Study|Lost to Follow-up|6|||
16337123|NCT00422292|39721028|FG003|Overall Study|Lost to Follow-up|6|||
16337124|NCT00422292|39721025|FG000|Overall Study|Withdrawal by Subject|6|||
16536505|NCT05763628|40426392|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
16536506|NCT05763628|40426393|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
16536507|NCT02341417|40426398|FG000|Overall Study|Withdrawal by Subject|0|||
16536508|NCT02341417|40426399|FG001|Overall Study|Withdrawal by Subject|2|||
16536509|NCT02341417|40426400|FG002|Overall Study|Withdrawal by Subject|0|||
16536510|NCT02341417|40426398|FG000|Overall Study|Decision by sponsor|2|||
16536511|NCT02341417|40426399|FG001|Overall Study|Decision by sponsor|0|||
16536512|NCT02341417|40426400|FG002|Overall Study|Decision by sponsor|0|||
16536513|NCT02341417|40426398|FG000|Overall Study|Death|0|||
16536514|NCT02341417|40426399|FG001|Overall Study|Death|0|||
16536515|NCT02341417|40426400|FG002|Overall Study|Death|1|||
16536516|NCT00160680|40426405|FG000|Overall Study|Adverse Event|0|||
16536517|NCT00160680|40426406|FG001|Overall Study|Adverse Event|1|||
16536518|NCT00160680|40426405|FG000|Overall Study|Lack of Efficacy|2|||
16536519|NCT00160680|40426406|FG001|Overall Study|Lack of Efficacy|1|||
16536520|NCT00160680|40426405|FG000|Overall Study|Lost to Follow-up|3|||
16536521|NCT00160680|40426406|FG001|Overall Study|Lost to Follow-up|2|||
16536522|NCT00160680|40426405|FG000|Overall Study|Withdrawal by Subject|4|||
16536523|NCT00160680|40426406|FG001|Overall Study|Withdrawal by Subject|9|||
16536524|NCT00423176|40426407|FG000|Overall Study|Adverse Event|4|||
16536525|NCT00423176|40426408|FG001|Overall Study|Adverse Event|6|||
16536526|NCT00423176|40426407|FG000|Overall Study|Treatment Failure|1|||
16536527|NCT00423176|40426408|FG001|Overall Study|Treatment Failure|6|||
16536528|NCT00423176|40426407|FG000|Overall Study|Lost to Follow-up|4|||
16536529|NCT00423176|40426408|FG001|Overall Study|Lost to Follow-up|7|||
16536530|NCT00423176|40426407|FG000|Overall Study|Withdrawal by Subject|4|||
16536531|NCT00423176|40426408|FG001|Overall Study|Withdrawal by Subject|3|||
16536532|NCT00423176|40426407|FG000|Overall Study|Protocol Violation|1|||
16536533|NCT00423176|40426408|FG001|Overall Study|Protocol Violation|3|||
16536534|NCT00423176|40426407|FG000|Overall Study|Did not meet protocol eligibility|2|||
16536535|NCT00423176|40426408|FG001|Overall Study|Did not meet protocol eligibility|4|||
16536536|NCT00951275|40426409|FG000|Overall Study|Administrative Reason|1|||
16536537|NCT00951275|40426409|FG000|Overall Study|Adverse Event|7|||
16536538|NCT00951275|40426409|FG000|Overall Study|Withdrawal by Subject|4|||
16536539|NCT00951275|40426409|FG000|Overall Study|Protocol Violation|1|||
16536540|NCT02660827|40426410|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
16536541|NCT02660827|40426410|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
16536542|NCT02660827|40426410|FG000|From Study to End of Continued Access|Adverse Event|3|||
16536543|NCT02660827|40426410|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
16536544|NCT02660827|40426410|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
16536545|NCT02660827|40426410|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
16536546|NCT02660827|40426410|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
16536547|NCT02660827|40426410|FG000|Period 2: Continued Access Period|Adverse Event|3|||
16536548|NCT01292876|40426414|FG000|Overall Study|Physician Decision|4|||
16536549|NCT00224874|40426417|FG000|Overall Study|Withdrawal by Subject|0|||
16536550|NCT00224874|40426418|FG001|Overall Study|Withdrawal by Subject|0|||
16536551|NCT00224874|40426419|FG002|Overall Study|Withdrawal by Subject|1|||
16536552|NCT00224874|40426420|FG003|Overall Study|Withdrawal by Subject|0|||
16536553|NCT01939548|40426423|FG000|Overall Study|Non compliance|0|||
16536554|NCT01939548|40426424|FG001|Overall Study|Non compliance|2|||
16536555|NCT01939548|40426425|FG002|Overall Study|Non compliance|0|||
16536556|NCT01939548|40426423|FG000|Overall Study|Study Terminated by Sponsor|17|||
16536557|NCT01939548|40426424|FG001|Overall Study|Study Terminated by Sponsor|19|||
16536558|NCT01939548|40426425|FG002|Overall Study|Study Terminated by Sponsor|12|||
16536559|NCT01939548|40426423|FG000|Overall Study|Insufficient Clinical Response|1|||
16536560|NCT01939548|40426424|FG001|Overall Study|Insufficient Clinical Response|0|||
16536561|NCT01939548|40426425|FG002|Overall Study|Insufficient Clinical Response|0|||
16536562|NCT01939548|40426423|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
16536563|NCT01939548|40426424|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
16536564|NCT01939548|40426425|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
16536565|NCT01939548|40426423|FG000|Overall Study|Withdrawal by Subject|4|||
16536566|NCT01939548|40426424|FG001|Overall Study|Withdrawal by Subject|4|||
16536567|NCT01939548|40426425|FG002|Overall Study|Withdrawal by Subject|1|||
16536568|NCT01939548|40426423|FG000|Overall Study|Protocol Violation|7|||
16536569|NCT01939548|40426424|FG001|Overall Study|Protocol Violation|6|||
16536570|NCT01939548|40426425|FG002|Overall Study|Protocol Violation|5|||
16536571|NCT01939548|40426423|FG000|Overall Study|Lost to Follow-up|5|||
16536572|NCT01939548|40426424|FG001|Overall Study|Lost to Follow-up|5|||
16536573|NCT01939548|40426425|FG002|Overall Study|Lost to Follow-up|3|||
16536574|NCT01939548|40426423|FG000|Overall Study|Adverse Event|2|||
16536575|NCT01939548|40426424|FG001|Overall Study|Adverse Event|9|||
16536576|NCT01939548|40426425|FG002|Overall Study|Adverse Event|7|||
16536577|NCT01939548|40426423|FG000|Overall Study|Death|0|||
16536578|NCT01939548|40426424|FG001|Overall Study|Death|0|||
16536579|NCT01939548|40426425|FG002|Overall Study|Death|1|||
16536580|NCT01939548|40426423|FG000|Overall Study|Participant dropped|0|||
16337125|NCT00422292|39721026|FG001|Overall Study|Withdrawal by Subject|25|||
16337126|NCT00422292|39721027|FG002|Overall Study|Withdrawal by Subject|7|||
16337127|NCT00422292|39721028|FG003|Overall Study|Withdrawal by Subject|13|||
16337128|NCT04122625|39721031|FG000|Part A (up to 2.92 Years)|Death|2|||
16337129|NCT04122625|39721032|FG001|Part A (up to 2.92 Years)|Death|4|||
16337130|NCT04122625|39721033|FG002|Part A (up to 2.92 Years)|Death|0|||
16337131|NCT04122625|39721034|FG003|Part A (up to 2.92 Years)|Death|0|||
16337132|NCT04122625|39721035|FG004|Part A (up to 2.92 Years)|Death|0|||
16337133|NCT04122625|39721036|FG005|Part A (up to 2.92 Years)|Death|0|||
16337134|NCT04122625|39721031|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
16337135|NCT04122625|39721032|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
16337136|NCT04122625|39721033|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
16337137|NCT04122625|39721034|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
16536581|NCT01939548|40426424|FG001|Overall Study|Participant dropped|0|||
16536582|NCT01939548|40426425|FG002|Overall Study|Participant dropped|1|||
16536583|NCT01939548|40426423|FG000|Overall Study|Participant unwilling to continue|0|||
16536584|NCT01939548|40426424|FG001|Overall Study|Participant unwilling to continue|1|||
16536585|NCT01939548|40426425|FG002|Overall Study|Participant unwilling to continue|0|||
16536586|NCT01939548|40426423|FG000|Overall Study|Participant withdrew consent|0|||
16536587|NCT01939548|40426424|FG001|Overall Study|Participant withdrew consent|2|||
16536588|NCT01939548|40426425|FG002|Overall Study|Participant withdrew consent|0|||
16536589|NCT01939548|40426423|FG000|Overall Study|Did not complete follow-up|0|||
16536590|NCT01939548|40426424|FG001|Overall Study|Did not complete follow-up|1|||
16536591|NCT01939548|40426425|FG002|Overall Study|Did not complete follow-up|0|||
16536592|NCT02753595|40426426|FG000|Overall Study|Sponsor termination|2|||
16536593|NCT02753595|40426427|FG001|Overall Study|Sponsor termination|2|||
16536594|NCT01227889|40426428|FG000|Randomized Phase (RP)|Adverse Event|13|||
16536595|NCT01227889|40426429|FG001|Randomized Phase (RP)|Adverse Event|0|||
16536596|NCT01227889|40426428|FG000|Randomized Phase (RP)|Physician Decision|13|||
16536597|NCT01227889|40426429|FG001|Randomized Phase (RP)|Physician Decision|5|||
16536598|NCT01227889|40426428|FG000|Randomized Phase (RP)|Progressive Disease|135|||
16536599|NCT01227889|40426429|FG001|Randomized Phase (RP)|Progressive Disease|52|||
16536600|NCT01227889|40426428|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
16536601|NCT01227889|40426429|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
16536602|NCT01227889|40426428|FG000|Randomized Phase (RP)|Missing|1|||
16536603|NCT01227889|40426429|FG001|Randomized Phase (RP)|Missing|3|||
16536604|NCT01227889|40426428|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
16536605|NCT01227889|40426429|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
16536606|NCT01227889|40426428|FG000|Crossover Phase|Adverse Event|0|||
16536607|NCT01227889|40426429|FG001|Crossover Phase|Adverse Event|1|||
16536608|NCT01227889|40426428|FG000|Crossover Phase|Physician Decision|0|||
16536609|NCT01227889|40426429|FG001|Crossover Phase|Physician Decision|3|||
16536610|NCT01227889|40426428|FG000|Crossover Phase|Progressive Disease|0|||
16536611|NCT01227889|40426429|FG001|Crossover Phase|Progressive Disease|31|||
16536612|NCT01227889|40426428|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
16536613|NCT01227889|40426429|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
16536614|NCT01227889|40426428|FG000|Crossover Phase|Withdrawal by Subject|0|||
16536615|NCT01227889|40426429|FG001|Crossover Phase|Withdrawal by Subject|1|||
16536616|NCT00584727|40426430|FG000|First Intervention|Discontinuation|0|||
16536617|NCT00584727|40426431|FG001|First Intervention|Discontinuation|0|||
16536618|NCT00584727|40426432|FG002|First Intervention|Discontinuation|1|||
16536619|NCT00584727|40426433|FG003|First Intervention|Discontinuation|0|||
16536620|NCT00584727|40426434|FG004|First Intervention|Discontinuation|0|||
16536621|NCT00584727|40426435|FG005|First Intervention|Discontinuation|0|||
16536622|NCT00584727|40426430|FG000|Third Intervention|Protocol Violation|0|||
16536623|NCT00584727|40426431|FG001|Third Intervention|Protocol Violation|0|||
16536624|NCT00584727|40426432|FG002|Third Intervention|Protocol Violation|1|||
16536625|NCT00584727|40426433|FG003|Third Intervention|Protocol Violation|0|||
16536626|NCT00584727|40426434|FG004|Third Intervention|Protocol Violation|4|||
16536627|NCT00584727|40426435|FG005|Third Intervention|Protocol Violation|2|||
16536628|NCT02310750|40426441|FG000|HP Period 1|Lost to Follow-up|0|||
16536629|NCT02310750|40426442|FG001|HP Period 1|Lost to Follow-up|0|||
16536630|NCT02310750|40426443|FG002|HP Period 1|Lost to Follow-up|0|||
16536631|NCT02310750|40426444|FG003|HP Period 1|Lost to Follow-up|0|||
16536632|NCT02310750|40426445|FG004|HP Period 1|Lost to Follow-up|0|||
16536633|NCT02310750|40426446|FG005|HP Period 1|Lost to Follow-up|0|||
16536634|NCT02310750|40426447|FG006|HP Period 1|Lost to Follow-up|1|||
16536635|NCT02310750|40426448|FG007|HP Period 1|Lost to Follow-up|0|||
16536636|NCT02310750|40426449|FG008|HP Period 1|Lost to Follow-up|0|||
16536637|NCT02310750|40426450|FG009|HP Period 1|Lost to Follow-up|0|||
16536638|NCT02310750|40426451|FG010|HP Period 1|Lost to Follow-up|0|||
16536639|NCT02310750|40426452|FG011|HP Period 1|Lost to Follow-up|0|||
16536640|NCT02310750|40426453|FG012|HP Period 1|Lost to Follow-up|0|||
16536641|NCT02310750|40426454|FG013|HP Period 1|Lost to Follow-up|0|||
16536642|NCT02310750|40426455|FG014|HP Period 1|Lost to Follow-up|0|||
16536643|NCT02310750|40426456|FG015|HP Period 1|Lost to Follow-up|0|||
16337138|NCT04122625|39721035|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
16337139|NCT04122625|39721036|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
16337140|NCT04122625|39721031|FG000|Part B (up to 2.33 Years)|Death|0|||
16337141|NCT04122625|39721032|FG001|Part B (up to 2.33 Years)|Death|0|||
16337142|NCT04122625|39721033|FG002|Part B (up to 2.33 Years)|Death|5|||
16337143|NCT04122625|39721034|FG003|Part B (up to 2.33 Years)|Death|7|||
16337144|NCT04122625|39721035|FG004|Part B (up to 2.33 Years)|Death|6|||
16337145|NCT04122625|39721036|FG005|Part B (up to 2.33 Years)|Death|7|||
16337146|NCT00575510|39721041|FG000|Overall Study|Lost to Follow-up|4|||
16337147|NCT00575510|39721042|FG001|Overall Study|Lost to Follow-up|6|||
16337148|NCT00575510|39721043|FG002|Overall Study|Lost to Follow-up|9|||
16337149|NCT00575510|39721041|FG000|Overall Study|Withdrawal by Subject|1|||
16337150|NCT00575510|39721042|FG001|Overall Study|Withdrawal by Subject|0|||
16337151|NCT00575510|39721043|FG002|Overall Study|Withdrawal by Subject|0|||
16337152|NCT00575510|39721041|FG000|Overall Study|Clinic Called Patient|7|||
16337153|NCT00575510|39721042|FG001|Overall Study|Clinic Called Patient|7|||
16337154|NCT00575510|39721043|FG002|Overall Study|Clinic Called Patient|7|||
16337155|NCT00575510|39721041|FG000|Overall Study|Pregnancy|0|||
16337156|NCT00575510|39721042|FG001|Overall Study|Pregnancy|0|||
16337157|NCT00575510|39721043|FG002|Overall Study|Pregnancy|1|||
16337158|NCT03170609|39721060|FG000|Overall Study|Death|0|||
16337159|NCT03170609|39721061|FG001|Overall Study|Death|0|||
16337160|NCT03170609|39721062|FG002|Overall Study|Death|1|||
16337161|NCT03170609|39721063|FG003|Overall Study|Death|0|||
16337162|NCT03170609|39721064|FG004|Overall Study|Death|0|||
16337163|NCT03170609|39721065|FG005|Overall Study|Death|0|||
16337164|NCT03170609|39721066|FG006|Overall Study|Death|0|||
16337165|NCT03170609|39721060|FG000|Overall Study|Withdrawal by Subject|1|||
16337166|NCT03170609|39721061|FG001|Overall Study|Withdrawal by Subject|2|||
16337167|NCT03170609|39721062|FG002|Overall Study|Withdrawal by Subject|0|||
16337168|NCT03170609|39721063|FG003|Overall Study|Withdrawal by Subject|0|||
16337169|NCT03170609|39721064|FG004|Overall Study|Withdrawal by Subject|0|||
16337170|NCT03170609|39721065|FG005|Overall Study|Withdrawal by Subject|0|||
16337171|NCT03170609|39721066|FG006|Overall Study|Withdrawal by Subject|1|||
16337172|NCT03170609|39721060|FG000|Overall Study|Lost to Follow-up|1|||
16337173|NCT03170609|39721061|FG001|Overall Study|Lost to Follow-up|0|||
16337174|NCT03170609|39721062|FG002|Overall Study|Lost to Follow-up|5|||
16337175|NCT03170609|39721063|FG003|Overall Study|Lost to Follow-up|2|||
16337176|NCT03170609|39721064|FG004|Overall Study|Lost to Follow-up|1|||
16337177|NCT03170609|39721065|FG005|Overall Study|Lost to Follow-up|1|||
16337178|NCT03170609|39721066|FG006|Overall Study|Lost to Follow-up|0|||
16337179|NCT03170609|39721060|FG000|Overall Study|Other|1|||
16337180|NCT03170609|39721061|FG001|Overall Study|Other|0|||
16337181|NCT03170609|39721062|FG002|Overall Study|Other|0|||
16337182|NCT03170609|39721063|FG003|Overall Study|Other|0|||
16337183|NCT03170609|39721064|FG004|Overall Study|Other|0|||
16337184|NCT03170609|39721065|FG005|Overall Study|Other|1|||
16337185|NCT03170609|39721066|FG006|Overall Study|Other|0|||
16337186|NCT00583102|39721072|FG000|Overall Study|Adverse Event|3|||
16337187|NCT01085084|39721075|FG000|Overall Study|Withdrawal by Subject|1|||
16337188|NCT01085084|39721076|FG001|Overall Study|Withdrawal by Subject|0|||
16337189|NCT01085084|39721077|FG002|Overall Study|Withdrawal by Subject|0|||
16337190|NCT01085084|39721075|FG000|Overall Study|Lost to Follow-up|2|||
16337191|NCT01085084|39721076|FG001|Overall Study|Lost to Follow-up|1|||
16337192|NCT01085084|39721077|FG002|Overall Study|Lost to Follow-up|1|||
16337193|NCT01085084|39721075|FG000|Overall Study|Adverse Event|4|||
16337194|NCT01085084|39721076|FG001|Overall Study|Adverse Event|3|||
16337195|NCT01085084|39721077|FG002|Overall Study|Adverse Event|6|||
16337196|NCT01085084|39721075|FG000|Overall Study|Treatment Failure|0|||
16337197|NCT01085084|39721076|FG001|Overall Study|Treatment Failure|1|||
16337198|NCT01085084|39721077|FG002|Overall Study|Treatment Failure|2|||
16337199|NCT02943785|39721079|FG000|Overall Study|Adverse Event|112|||
16337200|NCT02943785|39721080|FG001|Overall Study|Adverse Event|97|||
16337201|NCT02943785|39721079|FG000|Overall Study|Withdrawal by Subject|63|||
16337202|NCT02943785|39721080|FG001|Overall Study|Withdrawal by Subject|126|||
16337203|NCT02943785|39721079|FG000|Overall Study|Physician Decision|23|||
16337204|NCT02943785|39721080|FG001|Overall Study|Physician Decision|47|||
16337205|NCT02943785|39721079|FG000|Overall Study|Death|46|||
16337206|NCT02943785|39721080|FG001|Overall Study|Death|46|||
16337207|NCT02943785|39721079|FG000|Overall Study|Lost to Follow-up|1|||
16337208|NCT02943785|39721080|FG001|Overall Study|Lost to Follow-up|0|||
16337209|NCT02943785|39721079|FG000|Overall Study|Other|16|||
16337210|NCT02943785|39721080|FG001|Overall Study|Other|19|||
16337211|NCT02943785|39721079|FG000|Overall Study|Did not receive any study medication|21|||
16337212|NCT02943785|39721080|FG001|Overall Study|Did not receive any study medication|28|||
16337213|NCT01348100|39721081|FG000|Overall Study|Subject Withdrew Consent|0|||
16337214|NCT01348100|39721082|FG001|Overall Study|Subject Withdrew Consent|0|||
16337215|NCT01348100|39721083|FG002|Overall Study|Subject Withdrew Consent|2|||
16337216|NCT01348100|39721084|FG003|Overall Study|Subject Withdrew Consent|0|||
16337217|NCT01348100|39721085|FG004|Overall Study|Subject Withdrew Consent|1|||
16337218|NCT01348100|39721086|FG005|Overall Study|Subject Withdrew Consent|0|||
16337219|NCT01348100|39721087|FG006|Overall Study|Subject Withdrew Consent|1|||
16337220|NCT01348100|39721081|FG000|Overall Study|Protocol Deviation|0|||
16337221|NCT01348100|39721082|FG001|Overall Study|Protocol Deviation|0|||
16337222|NCT01348100|39721083|FG002|Overall Study|Protocol Deviation|0|||
16337223|NCT01348100|39721084|FG003|Overall Study|Protocol Deviation|1|||
16337224|NCT01348100|39721085|FG004|Overall Study|Protocol Deviation|0|||
16337225|NCT01348100|39721086|FG005|Overall Study|Protocol Deviation|0|||
16337226|NCT01348100|39721087|FG006|Overall Study|Protocol Deviation|0|||
16337227|NCT01348100|39721081|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16337228|NCT01348100|39721082|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16337229|NCT01348100|39721083|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16337230|NCT01348100|39721084|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16337231|NCT01348100|39721085|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16337232|NCT01348100|39721086|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
16337233|NCT01348100|39721087|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16337234|NCT01348100|39721081|FG000|Overall Study|Lost to Follow-up|0|||
16536644|NCT02310750|40426441|FG000|HP Period 1|Withdrawal by Subject|1|||
16536645|NCT02310750|40426442|FG001|HP Period 1|Withdrawal by Subject|0|||
16536646|NCT02310750|40426443|FG002|HP Period 1|Withdrawal by Subject|0|||
16536647|NCT02310750|40426444|FG003|HP Period 1|Withdrawal by Subject|1|||
16536648|NCT02310750|40426445|FG004|HP Period 1|Withdrawal by Subject|0|||
16536649|NCT02310750|40426446|FG005|HP Period 1|Withdrawal by Subject|0|||
16536650|NCT02310750|40426447|FG006|HP Period 1|Withdrawal by Subject|0|||
16536651|NCT02310750|40426448|FG007|HP Period 1|Withdrawal by Subject|0|||
16536652|NCT02310750|40426449|FG008|HP Period 1|Withdrawal by Subject|0|||
16536653|NCT02310750|40426450|FG009|HP Period 1|Withdrawal by Subject|0|||
16536654|NCT02310750|40426451|FG010|HP Period 1|Withdrawal by Subject|0|||
16536655|NCT02310750|40426452|FG011|HP Period 1|Withdrawal by Subject|0|||
16536656|NCT02310750|40426453|FG012|HP Period 1|Withdrawal by Subject|0|||
16536657|NCT02310750|40426454|FG013|HP Period 1|Withdrawal by Subject|0|||
16536658|NCT02310750|40426455|FG014|HP Period 1|Withdrawal by Subject|0|||
16536659|NCT02310750|40426456|FG015|HP Period 1|Withdrawal by Subject|0|||
16536660|NCT02310750|40426441|FG000|HP Washout 1|Lost to Follow-up|0|||
16536661|NCT02310750|40426442|FG001|HP Washout 1|Lost to Follow-up|0|||
16536662|NCT02310750|40426443|FG002|HP Washout 1|Lost to Follow-up|1|||
16536663|NCT02310750|40426444|FG003|HP Washout 1|Lost to Follow-up|1|||
16536664|NCT02310750|40426445|FG004|HP Washout 1|Lost to Follow-up|2|||
16536665|NCT02310750|40426446|FG005|HP Washout 1|Lost to Follow-up|2|||
16536666|NCT02310750|40426447|FG006|HP Washout 1|Lost to Follow-up|3|||
16536667|NCT02310750|40426448|FG007|HP Washout 1|Lost to Follow-up|0|||
16536668|NCT02310750|40426449|FG008|HP Washout 1|Lost to Follow-up|0|||
16536669|NCT02310750|40426450|FG009|HP Washout 1|Lost to Follow-up|0|||
16536670|NCT02310750|40426451|FG010|HP Washout 1|Lost to Follow-up|0|||
16536671|NCT02310750|40426452|FG011|HP Washout 1|Lost to Follow-up|0|||
16536672|NCT02310750|40426453|FG012|HP Washout 1|Lost to Follow-up|0|||
16536673|NCT02310750|40426454|FG013|HP Washout 1|Lost to Follow-up|0|||
16536674|NCT02310750|40426455|FG014|HP Washout 1|Lost to Follow-up|0|||
16536675|NCT02310750|40426456|FG015|HP Washout 1|Lost to Follow-up|0|||
16216843|NCT02442765|39272503|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
16337235|NCT01348100|39721082|FG001|Overall Study|Lost to Follow-up|0|||
16337236|NCT01348100|39721083|FG002|Overall Study|Lost to Follow-up|0|||
16337237|NCT01348100|39721084|FG003|Overall Study|Lost to Follow-up|0|||
16536676|NCT02310750|40426441|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536677|NCT02310750|40426442|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536678|NCT02310750|40426443|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536679|NCT02310750|40426444|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
16337238|NCT01348100|39721085|FG004|Overall Study|Lost to Follow-up|0|||
16337239|NCT01348100|39721086|FG005|Overall Study|Lost to Follow-up|0|||
16337240|NCT01348100|39721087|FG006|Overall Study|Lost to Follow-up|1|||
16536680|NCT02310750|40426445|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536681|NCT02310750|40426446|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
16536682|NCT02310750|40426447|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536683|NCT02310750|40426448|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536684|NCT02310750|40426449|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
16536685|NCT02310750|40426450|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
16536686|NCT02310750|40426451|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536687|NCT02310750|40426452|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536688|NCT02310750|40426453|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536689|NCT02310750|40426454|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536690|NCT02310750|40426455|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536691|NCT02310750|40426456|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
16536692|NCT02310750|40426441|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536693|NCT02310750|40426442|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536694|NCT02310750|40426443|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536695|NCT02310750|40426444|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536696|NCT02310750|40426445|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536697|NCT02310750|40426446|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536698|NCT02310750|40426447|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536699|NCT02310750|40426448|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536700|NCT02310750|40426449|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536701|NCT02310750|40426450|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
16536702|NCT02310750|40426451|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536703|NCT02310750|40426452|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536704|NCT02310750|40426453|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536705|NCT02310750|40426454|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536706|NCT02310750|40426455|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16536707|NCT02310750|40426456|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
16337241|NCT01348100|39721081|FG000|Overall Study|Administrative Problems|0|||
16337242|NCT01348100|39721082|FG001|Overall Study|Administrative Problems|0|||
16337243|NCT01348100|39721083|FG002|Overall Study|Administrative Problems|0|||
16337244|NCT01348100|39721084|FG003|Overall Study|Administrative Problems|0|||
16337245|NCT01348100|39721085|FG004|Overall Study|Administrative Problems|0|||
16337246|NCT01348100|39721086|FG005|Overall Study|Administrative Problems|1|||
16337247|NCT01348100|39721087|FG006|Overall Study|Administrative Problems|1|||
16337248|NCT03749109|39721089|FG000|Overall Study|Adverse Event|2|||
16536708|NCT02310750|40426441|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536709|NCT02310750|40426442|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536710|NCT02310750|40426443|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536711|NCT02310750|40426444|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536712|NCT02310750|40426445|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16337249|NCT03749109|39721090|FG001|Overall Study|Adverse Event|0|||
16337250|NCT01556932|39721091|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
16337251|NCT01556932|39721092|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
16337252|NCT00435188|39721095|FG000|Overall Study|Death|1|||
16337253|NCT00435188|39721096|FG001|Overall Study|Death|6|||
16337254|NCT00435188|39721095|FG000|Overall Study|Withdrawal by Subject|16|||
16337255|NCT00435188|39721096|FG001|Overall Study|Withdrawal by Subject|11|||
16337256|NCT00435188|39721095|FG000|Overall Study|Lost to Follow-up|5|||
16337257|NCT00435188|39721096|FG001|Overall Study|Lost to Follow-up|6|||
16337258|NCT01870297|39721100|FG000|Overall Study|Adverse Event|0|||
16337259|NCT01870297|39721101|FG001|Overall Study|Adverse Event|0|||
16337260|NCT01870297|39721102|FG002|Overall Study|Adverse Event|0|||
16337261|NCT01870297|39721103|FG003|Overall Study|Adverse Event|0|||
16337262|NCT01870297|39721104|FG004|Overall Study|Adverse Event|2|||
16536713|NCT02310750|40426446|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536714|NCT02310750|40426447|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16337263|NCT01870297|39721105|FG005|Overall Study|Adverse Event|0|||
16337264|NCT01870297|39721106|FG006|Overall Study|Adverse Event|0|||
16337265|NCT01870297|39721100|FG000|Overall Study|Lost to Follow-up|0|||
16536715|NCT02310750|40426448|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
16337266|NCT01870297|39721101|FG001|Overall Study|Lost to Follow-up|1|||
16337267|NCT01870297|39721102|FG002|Overall Study|Lost to Follow-up|1|||
16337268|NCT01870297|39721103|FG003|Overall Study|Lost to Follow-up|0|||
16337269|NCT01870297|39721104|FG004|Overall Study|Lost to Follow-up|0|||
16536716|NCT02310750|40426449|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
16536717|NCT02310750|40426450|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
16536718|NCT02310750|40426451|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536719|NCT02310750|40426452|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536720|NCT02310750|40426453|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536721|NCT02310750|40426454|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536722|NCT02310750|40426455|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536723|NCT02310750|40426456|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
16536724|NCT02310750|40426441|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536725|NCT02310750|40426442|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16337270|NCT01870297|39721105|FG005|Overall Study|Lost to Follow-up|0|||
16337271|NCT01870297|39721106|FG006|Overall Study|Lost to Follow-up|0|||
16337272|NCT01870297|39721100|FG000|Overall Study|Withdrawal by Subject|0|||
16337273|NCT01870297|39721101|FG001|Overall Study|Withdrawal by Subject|0|||
16337274|NCT01870297|39721102|FG002|Overall Study|Withdrawal by Subject|0|||
16337275|NCT01870297|39721103|FG003|Overall Study|Withdrawal by Subject|0|||
16337276|NCT01870297|39721104|FG004|Overall Study|Withdrawal by Subject|1|||
16337277|NCT01870297|39721105|FG005|Overall Study|Withdrawal by Subject|1|||
16536726|NCT02310750|40426443|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16337278|NCT01870297|39721106|FG006|Overall Study|Withdrawal by Subject|1|||
16337279|NCT01870297|39721100|FG000|Overall Study|Sponsor Decision|0|||
16337280|NCT01870297|39721101|FG001|Overall Study|Sponsor Decision|6|||
16405635|NCT01357161|39966386|FG002|Part 1 (Open Label Run-in)|Death|0|||
16405636|NCT01357161|39966384|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
16405637|NCT01357161|39966385|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
16405638|NCT01357161|39966386|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
16405639|NCT01357161|39966384|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
16405640|NCT01357161|39966385|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
16405641|NCT01357161|39966386|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
16405642|NCT01357161|39966384|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
16405643|NCT01357161|39966385|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
16405644|NCT01357161|39966386|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
16405645|NCT01357161|39966384|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
16405646|NCT01357161|39966385|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
16405647|NCT01357161|39966386|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
16405648|NCT01357161|39966384|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
16405649|NCT01357161|39966385|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
16405650|NCT01357161|39966386|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
16405651|NCT01357161|39966384|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
16405652|NCT01357161|39966385|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
16405653|NCT01357161|39966386|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
16405654|NCT01357161|39966384|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
16405655|NCT01357161|39966385|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
16405656|NCT01357161|39966386|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
16405657|NCT01357161|39966384|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
16405658|NCT01357161|39966385|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
16405659|NCT01357161|39966386|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
16405660|NCT01357161|39966384|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
16405661|NCT01357161|39966385|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
16405662|NCT01357161|39966386|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
16405663|NCT01357161|39966384|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
16405664|NCT01357161|39966385|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
16405665|NCT01357161|39966386|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
16337281|NCT01870297|39721102|FG002|Overall Study|Sponsor Decision|0|||
16337282|NCT01870297|39721103|FG003|Overall Study|Sponsor Decision|0|||
16337283|NCT01870297|39721104|FG004|Overall Study|Sponsor Decision|0|||
16337284|NCT01870297|39721105|FG005|Overall Study|Sponsor Decision|0|||
16337285|NCT01870297|39721106|FG006|Overall Study|Sponsor Decision|1|||
16337286|NCT01092637|39721107|FG000|Overall Study|Death|47|||
16337287|NCT01092637|39721108|FG001|Overall Study|Death|49|||
16337288|NCT01810783|39721109|FG000|Overall Study|Adverse Event|32|||
16337289|NCT01810783|39721109|FG000|Overall Study|Withdrawal by Subject|22|||
16337290|NCT01810783|39721109|FG000|Overall Study|Lack of Efficacy|12|||
16337291|NCT01810783|39721109|FG000|Overall Study|Lost to Follow-up|10|||
16337292|NCT01810783|39721109|FG000|Overall Study|Protocol Violation|5|||
16337293|NCT01810783|39721109|FG000|Overall Study|Non-compliance with IMP|4|||
16337294|NCT01810783|39721109|FG000|Overall Study|Adminstrative or other reason(s)|23|||
16337295|NCT01810783|39721109|FG000|Overall Study|Enrolled, not treated|1|||
16337296|NCT01210352|39721110|FG000|Overall Study|Adverse Event|0|||
16337297|NCT01210352|39721111|FG001|Overall Study|Adverse Event|0|||
16337298|NCT01210352|39721112|FG002|Overall Study|Adverse Event|0|||
16337299|NCT01210352|39721113|FG003|Overall Study|Adverse Event|0|||
16405666|NCT03319953|39966388|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
16405667|NCT03319953|39966389|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
16405668|NCT03319953|39966390|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
16405669|NCT03319953|39966391|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
16337300|NCT01210352|39721114|FG004|Overall Study|Adverse Event|0|||
16337301|NCT01210352|39721115|FG005|Overall Study|Adverse Event|0|||
16337302|NCT01210352|39721116|FG006|Overall Study|Adverse Event|0|||
16337303|NCT01210352|39721117|FG007|Overall Study|Adverse Event|2|||
16337304|NCT01210352|39721118|FG008|Overall Study|Adverse Event|1|||
16337305|NCT01210352|39721110|FG000|Overall Study|Lack of Efficacy|0|||
16102559|NCT01184859|38863232|FG003|Period 1: Single Dose|Adverse Event|0|||
16102560|NCT01184859|38863233|FG004|Period 1: Single Dose|Adverse Event|1|||
16102561|NCT01184859|38863229|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
16102562|NCT01184859|38863230|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
16102563|NCT01184859|38863231|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
16102564|NCT01184859|38863232|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
16102565|NCT01184859|38863233|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
16102566|NCT01184859|38863229|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
16102567|NCT01184859|38863230|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
16102568|NCT01184859|38863231|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
16102569|NCT01184859|38863232|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
16102570|NCT01184859|38863233|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
16102571|NCT01251887|38863234|FG000|Overall Study|Scheduling conflict|1|||
16102572|NCT01251887|38863235|FG001|Overall Study|Scheduling conflict|2|||
16102573|NCT01251887|38863236|FG002|Overall Study|Scheduling conflict|2|||
16102574|NCT01251887|38863234|FG000|Overall Study|Physician Decision|0|||
16102575|NCT01251887|38863235|FG001|Overall Study|Physician Decision|1|||
16102576|NCT01251887|38863236|FG002|Overall Study|Physician Decision|0|||
16102577|NCT01103141|38863237|FG000|Overall Study|Death|0|||
16102578|NCT01103141|38863238|FG001|Overall Study|Death|1|||
16102579|NCT01103141|38863237|FG000|Overall Study|Lost to Follow-up|2|||
16102580|NCT01103141|38863238|FG001|Overall Study|Lost to Follow-up|1|||
16102581|NCT00382408|38863239|FG000|Overall Study|Did not meet protocol requirement|3|||
16102582|NCT00382408|38863240|FG001|Overall Study|Did not meet protocol requirement|3|||
16102583|NCT00382408|38863239|FG000|Overall Study|Protocol Violation|2|||
16102584|NCT00382408|38863240|FG001|Overall Study|Protocol Violation|2|||
16102585|NCT00382408|38863239|FG000|Overall Study|Physician Decision|1|||
16102586|NCT00382408|38863240|FG001|Overall Study|Physician Decision|0|||
16102587|NCT00382408|38863239|FG000|Overall Study|Withdrawal by Subject|17|||
16102588|NCT00382408|38863240|FG001|Overall Study|Withdrawal by Subject|6|||
16102589|NCT00382408|38863239|FG000|Overall Study|Pregnancy|2|||
16405670|NCT03319953|39966388|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
16405671|NCT03319953|39966389|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
16536727|NCT02310750|40426444|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536728|NCT02310750|40426445|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536729|NCT02310750|40426446|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536730|NCT02310750|40426447|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536731|NCT02310750|40426448|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
16536732|NCT02310750|40426449|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
16536733|NCT02310750|40426450|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536734|NCT02310750|40426451|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536735|NCT02310750|40426452|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536736|NCT02310750|40426453|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536737|NCT02310750|40426454|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536738|NCT02310750|40426455|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536739|NCT02310750|40426456|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
16536740|NCT02310750|40426441|FG000|HP Washout 2|Lost to Follow-up|0|||
16536741|NCT02310750|40426442|FG001|HP Washout 2|Lost to Follow-up|0|||
16536742|NCT02310750|40426443|FG002|HP Washout 2|Lost to Follow-up|0|||
16536743|NCT02310750|40426444|FG003|HP Washout 2|Lost to Follow-up|0|||
16536744|NCT02310750|40426445|FG004|HP Washout 2|Lost to Follow-up|1|||
16536745|NCT02310750|40426446|FG005|HP Washout 2|Lost to Follow-up|0|||
16536746|NCT02310750|40426447|FG006|HP Washout 2|Lost to Follow-up|7|||
16536747|NCT02310750|40426448|FG007|HP Washout 2|Lost to Follow-up|0|||
16536748|NCT02310750|40426449|FG008|HP Washout 2|Lost to Follow-up|0|||
16536749|NCT02310750|40426450|FG009|HP Washout 2|Lost to Follow-up|0|||
16536750|NCT02310750|40426451|FG010|HP Washout 2|Lost to Follow-up|0|||
16536751|NCT02310750|40426452|FG011|HP Washout 2|Lost to Follow-up|0|||
16536752|NCT02310750|40426453|FG012|HP Washout 2|Lost to Follow-up|0|||
16536753|NCT02310750|40426454|FG013|HP Washout 2|Lost to Follow-up|0|||
16536754|NCT02310750|40426455|FG014|HP Washout 2|Lost to Follow-up|0|||
16536755|NCT02310750|40426456|FG015|HP Washout 2|Lost to Follow-up|0|||
16102590|NCT00382408|38863240|FG001|Overall Study|Pregnancy|0|||
16102591|NCT00382408|38863239|FG000|Overall Study|Lost to Follow-up|19|||
16102592|NCT00382408|38863240|FG001|Overall Study|Lost to Follow-up|8|||
16102593|NCT00382408|38863239|FG000|Overall Study|Other|100|||
16102594|NCT00382408|38863240|FG001|Overall Study|Other|35|||
16102595|NCT00975130|38863241|FG000|Study Part 1|Adverse Event|150|||
16102596|NCT00975130|38863242|FG001|Study Part 1|Adverse Event|0|||
16102597|NCT00975130|38863243|FG002|Study Part 1|Adverse Event|0|||
16102598|NCT00975130|38863241|FG000|Study Part 1|Lost to Follow-up|19|||
16102599|NCT00975130|38863242|FG001|Study Part 1|Lost to Follow-up|0|||
16536756|NCT02454101|40426467|FG000|Overall Study|Adverse Event|2|||
16536757|NCT02454101|40426468|FG001|Overall Study|Adverse Event|3|||
16536758|NCT02454101|40426467|FG000|Overall Study|Lost to Follow-up|3|||
16536759|NCT02454101|40426468|FG001|Overall Study|Lost to Follow-up|4|||
16405672|NCT03319953|39966390|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
16337306|NCT01210352|39721111|FG001|Overall Study|Lack of Efficacy|0|||
16337307|NCT01210352|39721112|FG002|Overall Study|Lack of Efficacy|0|||
16337308|NCT01210352|39721113|FG003|Overall Study|Lack of Efficacy|0|||
16337309|NCT01210352|39721114|FG004|Overall Study|Lack of Efficacy|0|||
16337310|NCT01210352|39721115|FG005|Overall Study|Lack of Efficacy|0|||
16337311|NCT01210352|39721116|FG006|Overall Study|Lack of Efficacy|1|||
16337312|NCT01210352|39721117|FG007|Overall Study|Lack of Efficacy|0|||
16337313|NCT01210352|39721118|FG008|Overall Study|Lack of Efficacy|0|||
16337314|NCT01210352|39721110|FG000|Overall Study|Physician Decision|0|||
16337315|NCT01210352|39721111|FG001|Overall Study|Physician Decision|0|||
16337316|NCT01210352|39721112|FG002|Overall Study|Physician Decision|0|||
16337317|NCT01210352|39721113|FG003|Overall Study|Physician Decision|0|||
16337318|NCT01210352|39721114|FG004|Overall Study|Physician Decision|0|||
16405673|NCT03319953|39966391|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
16337319|NCT01210352|39721115|FG005|Overall Study|Physician Decision|0|||
16337320|NCT01210352|39721116|FG006|Overall Study|Physician Decision|0|||
16337321|NCT01210352|39721117|FG007|Overall Study|Physician Decision|1|||
16337322|NCT01210352|39721118|FG008|Overall Study|Physician Decision|2|||
16337323|NCT01210352|39721110|FG000|Overall Study|Withdrawal by Subject|0|||
16337324|NCT01210352|39721111|FG001|Overall Study|Withdrawal by Subject|0|||
16337325|NCT01210352|39721112|FG002|Overall Study|Withdrawal by Subject|1|||
16337326|NCT01210352|39721113|FG003|Overall Study|Withdrawal by Subject|0|||
16337327|NCT01210352|39721114|FG004|Overall Study|Withdrawal by Subject|0|||
16102600|NCT00975130|38863243|FG002|Study Part 1|Lost to Follow-up|0|||
16102601|NCT00975130|38863241|FG000|Study Part 1|Withdrawal by Subject|61|||
16337328|NCT01210352|39721115|FG005|Overall Study|Withdrawal by Subject|0|||
16337329|NCT01210352|39721116|FG006|Overall Study|Withdrawal by Subject|1|||
16337330|NCT01210352|39721117|FG007|Overall Study|Withdrawal by Subject|0|||
16337331|NCT01210352|39721118|FG008|Overall Study|Withdrawal by Subject|1|||
16337332|NCT01210352|39721110|FG000|Overall Study|Patient Discharged Early|0|||
16337333|NCT01210352|39721111|FG001|Overall Study|Patient Discharged Early|0|||
16337334|NCT01210352|39721112|FG002|Overall Study|Patient Discharged Early|1|||
16337335|NCT01210352|39721113|FG003|Overall Study|Patient Discharged Early|0|||
16337336|NCT01210352|39721114|FG004|Overall Study|Patient Discharged Early|0|||
16337337|NCT01210352|39721115|FG005|Overall Study|Patient Discharged Early|0|||
16337338|NCT01210352|39721116|FG006|Overall Study|Patient Discharged Early|0|||
16337339|NCT01210352|39721117|FG007|Overall Study|Patient Discharged Early|0|||
16337340|NCT01210352|39721118|FG008|Overall Study|Patient Discharged Early|0|||
16337341|NCT03810235|39721119|FG000|Overall Study|Withdrawal by Subject|2|||
16337342|NCT03810235|39721120|FG001|Overall Study|Withdrawal by Subject|0|||
16337343|NCT01796301|39721127|FG000|Overall Study|Withdrawal by Subject|15|||
16337344|NCT01796301|39721128|FG001|Overall Study|Withdrawal by Subject|15|||
16337345|NCT01796301|39721127|FG000|Overall Study|Lost to Follow-up|3|||
16337346|NCT01796301|39721128|FG001|Overall Study|Lost to Follow-up|3|||
16405674|NCT03466099|39966392|FG000|Overall Study|Adverse Event|1|||
16536760|NCT01258608|40426473|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
16536761|NCT01258608|40426474|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
16536762|NCT01258608|40426473|FG000|Overall Study|Clinical progression|1|||
16536763|NCT01258608|40426474|FG001|Overall Study|Clinical progression|0|||
16536764|NCT01258608|40426473|FG000|Overall Study|Sponsor decision|0|||
16536765|NCT01258608|40426474|FG001|Overall Study|Sponsor decision|1|||
16536766|NCT01258608|40426473|FG000|Overall Study|Physician Decision|6|||
16536767|NCT01258608|40426474|FG001|Overall Study|Physician Decision|1|||
16536768|NCT01258608|40426473|FG000|Overall Study|Lost to Follow-up|0|||
16536769|NCT01258608|40426474|FG001|Overall Study|Lost to Follow-up|1|||
16536770|NCT01258608|40426473|FG000|Overall Study|Lack of compliance|1|||
16536771|NCT01258608|40426474|FG001|Overall Study|Lack of compliance|0|||
16536772|NCT01258608|40426473|FG000|Overall Study|Lack of Efficacy|0|||
16536773|NCT01258608|40426474|FG001|Overall Study|Lack of Efficacy|1|||
16536774|NCT01258608|40426473|FG000|Overall Study|Adverse Event|6|||
16536775|NCT01258608|40426474|FG001|Overall Study|Adverse Event|10|||
16337347|NCT01796301|39721127|FG000|Overall Study|Death|0|||
16337348|NCT01796301|39721128|FG001|Overall Study|Death|1|||
16405675|NCT03466099|39966393|FG001|Overall Study|Adverse Event|1|||
16536776|NCT01258608|40426473|FG000|Overall Study|Withdrawal by Subject|6|||
16536777|NCT01258608|40426474|FG001|Overall Study|Withdrawal by Subject|5|||
16536778|NCT00419263|40426475|FG000|Overall Study|Lost to Follow-up|2|||
16337349|NCT01796301|39721127|FG000|Overall Study|Decision by Sponsor|0|||
16337350|NCT01796301|39721128|FG001|Overall Study|Decision by Sponsor|1|||
16337351|NCT00369161|39721141|FG000|Overall Study|Adverse Event|15|||
16337352|NCT00369161|39721142|FG001|Overall Study|Adverse Event|13|||
16337353|NCT00369161|39721141|FG000|Overall Study|Abnormal laboratory value|0|||
16536779|NCT00419263|40426476|FG001|Overall Study|Lost to Follow-up|1|||
16337354|NCT00369161|39721142|FG001|Overall Study|Abnormal laboratory value|1|||
16337355|NCT00369161|39721141|FG000|Overall Study|Lack of Efficacy|3|||
16337356|NCT00369161|39721142|FG001|Overall Study|Lack of Efficacy|1|||
16337357|NCT00369161|39721141|FG000|Overall Study|Protocol Violation|0|||
16337358|NCT00369161|39721142|FG001|Overall Study|Protocol Violation|2|||
16337359|NCT00369161|39721141|FG000|Overall Study|Withdrawal by Subject|2|||
16337360|NCT00369161|39721142|FG001|Overall Study|Withdrawal by Subject|3|||
16337361|NCT00369161|39721141|FG000|Overall Study|Death|1|||
16337362|NCT00369161|39721142|FG001|Overall Study|Death|2|||
16337363|NCT00369161|39721141|FG000|Overall Study|Graft loss|4|||
16337364|NCT00369161|39721142|FG001|Overall Study|Graft loss|0|||
16337365|NCT00369161|39721141|FG000|Overall Study|Administrative Problem|2|||
16337366|NCT00369161|39721142|FG001|Overall Study|Administrative Problem|2|||
16337367|NCT04521114|39721143|FG000|Overall Study|Lost to Follow-up|1|||
16337368|NCT04521114|39721144|FG001|Overall Study|Lost to Follow-up|2|||
16337369|NCT04521114|39721145|FG002|Overall Study|Lost to Follow-up|0|||
16337370|NCT04521114|39721143|FG000|Overall Study|Withdrawal by Subject|1|||
16337371|NCT04521114|39721144|FG001|Overall Study|Withdrawal by Subject|2|||
16337372|NCT04521114|39721145|FG002|Overall Study|Withdrawal by Subject|2|||
16337373|NCT04521114|39721143|FG000|Overall Study|Adverse Event|1|||
16337374|NCT04521114|39721144|FG001|Overall Study|Adverse Event|0|||
16337375|NCT04521114|39721145|FG002|Overall Study|Adverse Event|0|||
16337376|NCT04521114|39721143|FG000|Overall Study|Sponsor Wish|1|||
16337377|NCT04521114|39721144|FG001|Overall Study|Sponsor Wish|0|||
16337378|NCT04521114|39721145|FG002|Overall Study|Sponsor Wish|0|||
16337379|NCT04521114|39721143|FG000|Overall Study|Withdrawal of Consent|2|||
16337380|NCT04521114|39721144|FG001|Overall Study|Withdrawal of Consent|2|||
16337381|NCT04521114|39721145|FG002|Overall Study|Withdrawal of Consent|0|||
16536780|NCT00419263|40426477|FG002|Overall Study|Lost to Follow-up|1|||
16536781|NCT00419263|40426475|FG000|Overall Study|Randomized in Error, Not Treated|1|||
16536782|NCT00419263|40426476|FG001|Overall Study|Randomized in Error, Not Treated|1|||
16536783|NCT00419263|40426477|FG002|Overall Study|Randomized in Error, Not Treated|0|||
16536784|NCT00419263|40426475|FG000|Overall Study|Adverse Event|0|||
16536785|NCT00419263|40426476|FG001|Overall Study|Adverse Event|0|||
16536786|NCT00419263|40426477|FG002|Overall Study|Adverse Event|1|||
16536787|NCT00419263|40426475|FG000|Overall Study|Withdrawal by Subject|0|||
16536788|NCT00419263|40426476|FG001|Overall Study|Withdrawal by Subject|0|||
16536789|NCT00419263|40426477|FG002|Overall Study|Withdrawal by Subject|1|||
16536790|NCT02778100|40426478|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
16536791|NCT02778100|40426479|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
16536792|NCT01912612|40426487|FG000|Overall Study|Adverse Event|4|||
16536793|NCT01912612|40426488|FG001|Overall Study|Adverse Event|0|||
16536794|NCT01912612|40426489|FG002|Overall Study|Adverse Event|0|||
16536795|NCT01912612|40426487|FG000|Overall Study|Withdrew consent|1|||
16536796|NCT01912612|40426488|FG001|Overall Study|Withdrew consent|0|||
16337382|NCT02442206|39721146|FG000|Period 1|Adverse Event|1|||
16337383|NCT02442206|39721147|FG001|Period 1|Adverse Event|1|||
16337384|NCT02442206|39721146|FG000|Period 1|withdrew consent|0|||
16337385|NCT02442206|39721147|FG001|Period 1|withdrew consent|1|||
16337386|NCT02442206|39721146|FG000|Period 1|COPD exacerbation|0|||
16337387|NCT02442206|39721147|FG001|Period 1|COPD exacerbation|1|||
16337388|NCT02442206|39721146|FG000|Period 2|Adverse Event|1|||
16337389|NCT02442206|39721147|FG001|Period 2|Adverse Event|0|||
16536797|NCT01912612|40426489|FG002|Overall Study|Withdrew consent|0|||
16337390|NCT02327013|39721148|FG000|Overall Study|Adverse Event|4|||
16337391|NCT02327013|39721149|FG001|Overall Study|Adverse Event|4|||
16337392|NCT02327013|39721150|FG002|Overall Study|Adverse Event|3|||
16337393|NCT02327013|39721151|FG003|Overall Study|Adverse Event|0|||
16337394|NCT02327013|39721152|FG004|Overall Study|Adverse Event|1|||
16337395|NCT02327013|39721148|FG000|Overall Study|Lack of Efficacy|2|||
16337396|NCT02327013|39721149|FG001|Overall Study|Lack of Efficacy|0|||
16337397|NCT02327013|39721150|FG002|Overall Study|Lack of Efficacy|5|||
16337398|NCT02327013|39721151|FG003|Overall Study|Lack of Efficacy|0|||
16337399|NCT02327013|39721152|FG004|Overall Study|Lack of Efficacy|1|||
16337400|NCT02327013|39721148|FG000|Overall Study|Non-compliance with IMP|1|||
16405676|NCT03466099|39966394|FG002|Overall Study|Adverse Event|1|||
16405677|NCT03466099|39966392|FG000|Overall Study|Withdrawal by Subject|2|||
16405678|NCT03466099|39966393|FG001|Overall Study|Withdrawal by Subject|3|||
16405679|NCT03466099|39966394|FG002|Overall Study|Withdrawal by Subject|1|||
16405680|NCT03466099|39966392|FG000|Overall Study|Use of rescue medication|8|||
16405681|NCT03466099|39966393|FG001|Overall Study|Use of rescue medication|9|||
16405682|NCT03466099|39966394|FG002|Overall Study|Use of rescue medication|13|||
16405683|NCT03466099|39966392|FG000|Overall Study|Rescued without meeting criteria|4|||
16536798|NCT01912612|40426487|FG000|Overall Study|Study design change|0|||
16536799|NCT01912612|40426488|FG001|Overall Study|Study design change|0|||
16405684|NCT03466099|39966393|FG001|Overall Study|Rescued without meeting criteria|1|||
16405685|NCT03466099|39966394|FG002|Overall Study|Rescued without meeting criteria|1|||
16405686|NCT03466099|39966392|FG000|Overall Study|Subject compliance|2|||
16405687|NCT03466099|39966393|FG001|Overall Study|Subject compliance|0|||
16405688|NCT03466099|39966394|FG002|Overall Study|Subject compliance|0|||
16405689|NCT03466099|39966392|FG000|Overall Study|Worsening disease|0|||
16405690|NCT03466099|39966393|FG001|Overall Study|Worsening disease|0|||
16405691|NCT03466099|39966394|FG002|Overall Study|Worsening disease|1|||
16536800|NCT01912612|40426489|FG002|Overall Study|Study design change|3|||
16536801|NCT01880424|40426490|FG000|Overall Study|Adverse Event|7|||
16536802|NCT01880424|40426491|FG001|Overall Study|Adverse Event|6|||
16536803|NCT01880424|40426490|FG000|Overall Study|Lack of Efficacy|1|||
16536804|NCT01880424|40426491|FG001|Overall Study|Lack of Efficacy|4|||
16536805|NCT01880424|40426490|FG000|Overall Study|Lost to Follow-up|3|||
16536806|NCT01880424|40426491|FG001|Overall Study|Lost to Follow-up|2|||
16536807|NCT01880424|40426490|FG000|Overall Study|Protocol Violation|11|||
16536808|NCT01880424|40426491|FG001|Overall Study|Protocol Violation|13|||
16536809|NCT01880424|40426490|FG000|Overall Study|Withdrawal by Subject|10|||
16536810|NCT01880424|40426491|FG001|Overall Study|Withdrawal by Subject|30|||
16536811|NCT01880424|40426490|FG000|Overall Study|Other|1|||
16536812|NCT01880424|40426491|FG001|Overall Study|Other|0|||
16536813|NCT05224050|40426492|FG000|Overall Study|Withdrawal by Subject|9|||
16536814|NCT05224050|40426492|FG000|Overall Study|Lost to Follow-up|3|||
16536815|NCT00113568|40426496|FG000|Overall Study|Adverse Event|97|||
16536816|NCT00113568|40426496|FG000|Overall Study|Death|1|||
16536817|NCT00113568|40426496|FG000|Overall Study|Lack of Efficacy|30|||
16536818|NCT00113568|40426496|FG000|Overall Study|Lost to Follow-up|156|||
16536819|NCT00113568|40426496|FG000|Overall Study|Protocol Violation|32|||
16536820|NCT00113568|40426496|FG000|Overall Study|Withdrawal by Subject|117|||
16536821|NCT00113568|40426496|FG000|Overall Study|Other|112|||
16536822|NCT00530855|40426505|FG000|Overall Study|Lack of Efficacy|20|||
16536823|NCT00530855|40426505|FG000|Overall Study|Withdrawal by Subject|30|||
16536824|NCT00530855|40426505|FG000|Overall Study|Fatal Serious AE|3|||
16536825|NCT00530855|40426505|FG000|Overall Study|Non Fatal Serious AE|7|||
16405692|NCT05426031|39966395|FG000|Overall Study|Circulatory Arrest|3|||
16405693|NCT05426031|39966396|FG001|Overall Study|Circulatory Arrest|2|||
16405694|NCT05593913|39966401|FG000|Overall Study|Insufficient image quality|39|||
16405695|NCT00171925|39966402|FG000|Overall Study|Adverse Event|10|||
16536826|NCT00530855|40426505|FG000|Overall Study|Non Fatal Non Serious AE|12|||
16536827|NCT00530855|40426505|FG000|Overall Study|Protocol Violation|3|||
16536828|NCT00530855|40426505|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
16536829|NCT00530855|40426505|FG000|Overall Study|Lost to Follow-up|9|||
16337401|NCT02327013|39721149|FG001|Overall Study|Non-compliance with IMP|2|||
16337402|NCT02327013|39721150|FG002|Overall Study|Non-compliance with IMP|7|||
16337403|NCT02327013|39721151|FG003|Overall Study|Non-compliance with IMP|0|||
16536830|NCT00530855|40426505|FG000|Overall Study|Other reason for premature termination|17|||
16536831|NCT01152580|40426506|FG000|Overall Study|Withdrawal by Subject|0|||
16337404|NCT02327013|39721152|FG004|Overall Study|Non-compliance with IMP|0|||
16337405|NCT02327013|39721148|FG000|Overall Study|Withdrawal of Consent|1|||
16337406|NCT02327013|39721149|FG001|Overall Study|Withdrawal of Consent|0|||
16337407|NCT02327013|39721150|FG002|Overall Study|Withdrawal of Consent|3|||
16337408|NCT02327013|39721151|FG003|Overall Study|Withdrawal of Consent|0|||
16337409|NCT02327013|39721152|FG004|Overall Study|Withdrawal of Consent|0|||
16337410|NCT02327013|39721148|FG000|Overall Study|Lost to Follow-up|2|||
16337411|NCT02327013|39721149|FG001|Overall Study|Lost to Follow-up|4|||
16337412|NCT02327013|39721150|FG002|Overall Study|Lost to Follow-up|5|||
16337413|NCT02327013|39721151|FG003|Overall Study|Lost to Follow-up|0|||
16337414|NCT02327013|39721152|FG004|Overall Study|Lost to Follow-up|0|||
16337415|NCT02327013|39721148|FG000|Overall Study|Administrative or other reason(s)|1|||
16337416|NCT02327013|39721149|FG001|Overall Study|Administrative or other reason(s)|5|||
16337417|NCT02327013|39721150|FG002|Overall Study|Administrative or other reason(s)|11|||
16337418|NCT02327013|39721151|FG003|Overall Study|Administrative or other reason(s)|1|||
16337419|NCT02327013|39721152|FG004|Overall Study|Administrative or other reason(s)|1|||
16337420|NCT02327013|39721148|FG000|Overall Study|Protocol Violation|0|||
16337421|NCT02327013|39721149|FG001|Overall Study|Protocol Violation|0|||
16337422|NCT02327013|39721150|FG002|Overall Study|Protocol Violation|3|||
16337423|NCT02327013|39721151|FG003|Overall Study|Protocol Violation|0|||
16337424|NCT02327013|39721152|FG004|Overall Study|Protocol Violation|1|||
16337425|NCT02327013|39721148|FG000|Overall Study|Withdrawal before treatment|2|||
16337426|NCT02327013|39721149|FG001|Overall Study|Withdrawal before treatment|1|||
16337427|NCT02327013|39721150|FG002|Overall Study|Withdrawal before treatment|5|||
16337428|NCT02327013|39721151|FG003|Overall Study|Withdrawal before treatment|0|||
16337429|NCT02327013|39721152|FG004|Overall Study|Withdrawal before treatment|0|||
16337430|NCT01752634|39721155|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
16337431|NCT01752634|39721156|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
16337432|NCT01752634|39721157|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
16405696|NCT00171925|39966403|FG001|Overall Study|Adverse Event|6|||
16405697|NCT00171925|39966402|FG000|Overall Study|Protocol Violation|1|||
16405698|NCT00171925|39966403|FG001|Overall Study|Protocol Violation|1|||
16405699|NCT00171925|39966402|FG000|Overall Study|Withdrawal by Subject|6|||
16405700|NCT00171925|39966403|FG001|Overall Study|Withdrawal by Subject|9|||
16405701|NCT00171925|39966402|FG000|Overall Study|Lost to Follow-up|2|||
16405702|NCT00171925|39966403|FG001|Overall Study|Lost to Follow-up|2|||
16405703|NCT00171925|39966402|FG000|Overall Study|Administrative problems|10|||
16405704|NCT00171925|39966403|FG001|Overall Study|Administrative problems|11|||
16405705|NCT00171925|39966402|FG000|Overall Study|Death|1|||
16405706|NCT00171925|39966403|FG001|Overall Study|Death|2|||
16405707|NCT02434354|39966404|FG000|Overall Study|screen fail|3|||
16405708|NCT00457821|39966405|FG000|Part 2|Withdrawal by Subject|0|||
16405709|NCT00457821|39966406|FG001|Part 2|Withdrawal by Subject|0|||
16405710|NCT00457821|39966407|FG002|Part 2|Withdrawal by Subject|0|||
16405711|NCT00457821|39966408|FG003|Part 2|Withdrawal by Subject|0|||
16405712|NCT00457821|39966409|FG004|Part 2|Withdrawal by Subject|0|||
16536832|NCT01152580|40426507|FG001|Overall Study|Withdrawal by Subject|1|||
16536833|NCT03581981|40426508|FG000|Overall Study|Withdrawal by Subject|12|||
16536834|NCT03581981|40426509|FG001|Overall Study|Withdrawal by Subject|13|||
16536835|NCT03581981|40426508|FG000|Overall Study|Physician Decision|1|||
16536836|NCT03581981|40426509|FG001|Overall Study|Physician Decision|2|||
16405713|NCT00457821|39966410|FG005|Part 2|Withdrawal by Subject|0|||
16405714|NCT00457821|39966411|FG006|Part 2|Withdrawal by Subject|0|||
16405715|NCT00457821|39966412|FG007|Part 2|Withdrawal by Subject|1|||
16536837|NCT03581981|40426508|FG000|Overall Study|Lost to Follow-up|0|||
16536838|NCT03581981|40426509|FG001|Overall Study|Lost to Follow-up|4|||
16337433|NCT01752634|39721158|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
16337434|NCT01752634|39721159|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
16337435|NCT01752634|39721160|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
16337436|NCT01752634|39721155|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
16337437|NCT01752634|39721156|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
16337438|NCT01752634|39721157|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
16405716|NCT02046226|39966413|FG000|Overall Study|Lost to Follow-up|7|||
16536839|NCT00765388|40426510|FG000|Period 1|Lack of Efficacy|1|||
16536840|NCT00765388|40426511|FG001|Period 1|Lack of Efficacy|2|||
16536841|NCT00765388|40426510|FG000|Period 1|Lost to Follow-up|0|||
16536842|NCT00765388|40426511|FG001|Period 1|Lost to Follow-up|1|||
16536843|NCT00765388|40426510|FG000|Period 1|Herpes Zoster|0|||
16536844|NCT00765388|40426511|FG001|Period 1|Herpes Zoster|1|||
16536845|NCT00765388|40426510|FG000|Period 1|Hip operation|0|||
16536846|NCT00765388|40426511|FG001|Period 1|Hip operation|1|||
16536847|NCT01262651|40426513|FG000|Overall Study|Adverse Event|40|||
16536848|NCT01262651|40426514|FG001|Overall Study|Adverse Event|35|||
16536849|NCT01262651|40426513|FG000|Overall Study|Withdrawal by Subject|15|||
16536850|NCT01262651|40426514|FG001|Overall Study|Withdrawal by Subject|11|||
16536851|NCT01262651|40426513|FG000|Overall Study|Withdrawal by Investigator|2|||
16536852|NCT01262651|40426514|FG001|Overall Study|Withdrawal by Investigator|2|||
16536853|NCT01262651|40426513|FG000|Overall Study|Met Withdrawal Criteria|1|||
16536854|NCT01262651|40426514|FG001|Overall Study|Met Withdrawal Criteria|0|||
16536855|NCT02395042|40426516|FG000|Treatment 1 Period|Adverse Event|1|||
16536856|NCT02395042|40426517|FG001|Treatment 1 Period|Adverse Event|3|||
16536857|NCT02395042|40426518|FG002|Treatment 1 Period|Adverse Event|1|||
16536858|NCT02395042|40426516|FG000|Treatment 1 Period|Lack of Efficacy|1|||
16536859|NCT02395042|40426517|FG001|Treatment 1 Period|Lack of Efficacy|1|||
16536860|NCT02395042|40426518|FG002|Treatment 1 Period|Lack of Efficacy|0|||
16536861|NCT02395042|40426516|FG000|Treatment 1 Period|Lost to Follow-up|1|||
16536862|NCT02395042|40426517|FG001|Treatment 1 Period|Lost to Follow-up|0|||
16536863|NCT02395042|40426518|FG002|Treatment 1 Period|Lost to Follow-up|0|||
16536864|NCT02395042|40426516|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
16536865|NCT02395042|40426517|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
16536866|NCT02395042|40426518|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
16536867|NCT02395042|40426516|FG000|Treatment 2 Period|Lack of Efficacy|1|||
16536868|NCT02395042|40426517|FG001|Treatment 2 Period|Lack of Efficacy|1|||
16536869|NCT02395042|40426518|FG002|Treatment 2 Period|Lack of Efficacy|0|||
16536870|NCT03835533|40426519|FG000|Overall Study|Death|5|||
16536871|NCT03835533|40426520|FG001|Overall Study|Death|10|||
16536872|NCT03835533|40426521|FG002|Overall Study|Death|9|||
16536873|NCT03835533|40426519|FG000|Overall Study|Withdrawal by Subject|2|||
16536874|NCT03835533|40426520|FG001|Overall Study|Withdrawal by Subject|2|||
16536875|NCT03835533|40426521|FG002|Overall Study|Withdrawal by Subject|2|||
16536876|NCT03835533|40426519|FG000|Overall Study|Lost to Follow-up|1|||
16536877|NCT03835533|40426520|FG001|Overall Study|Lost to Follow-up|0|||
16536878|NCT03835533|40426521|FG002|Overall Study|Lost to Follow-up|0|||
16536879|NCT04435665|40426522|FG000|Overall Study|Lost to Follow-up|0|||
16536880|NCT04435665|40426523|FG001|Overall Study|Lost to Follow-up|0|||
16536881|NCT04435665|40426524|FG002|Overall Study|Lost to Follow-up|0|||
16536882|NCT04435665|40426525|FG003|Overall Study|Lost to Follow-up|1|||
16536883|NCT03982186|40426526|FG000|Overall Study|Lost to Follow-up|0|||
16536884|NCT03982186|40426527|FG001|Overall Study|Lost to Follow-up|1|||
16536885|NCT03982186|40426528|FG002|Overall Study|Lost to Follow-up|2|||
16536886|NCT03982186|40426529|FG003|Overall Study|Lost to Follow-up|1|||
16536887|NCT03982186|40426530|FG004|Overall Study|Lost to Follow-up|1|||
16536888|NCT03982186|40426531|FG005|Overall Study|Lost to Follow-up|0|||
16536889|NCT03982186|40426526|FG000|Overall Study|Physician Decision|0|||
16536890|NCT03982186|40426527|FG001|Overall Study|Physician Decision|1|||
16536891|NCT03982186|40426528|FG002|Overall Study|Physician Decision|0|||
16536892|NCT03982186|40426529|FG003|Overall Study|Physician Decision|0|||
16536893|NCT03982186|40426530|FG004|Overall Study|Physician Decision|0|||
16536894|NCT03982186|40426531|FG005|Overall Study|Physician Decision|0|||
16536895|NCT03982186|40426526|FG000|Overall Study|Withdrawal by Subject|3|||
16536896|NCT03982186|40426527|FG001|Overall Study|Withdrawal by Subject|4|||
16536897|NCT03982186|40426528|FG002|Overall Study|Withdrawal by Subject|1|||
16536898|NCT03982186|40426529|FG003|Overall Study|Withdrawal by Subject|7|||
16536899|NCT03982186|40426530|FG004|Overall Study|Withdrawal by Subject|2|||
16536900|NCT03982186|40426531|FG005|Overall Study|Withdrawal by Subject|0|||
16536901|NCT03982186|40426526|FG000|Overall Study|Randomized and not treated|0|||
16536902|NCT03982186|40426527|FG001|Overall Study|Randomized and not treated|0|||
16536903|NCT03982186|40426528|FG002|Overall Study|Randomized and not treated|0|||
16536904|NCT03982186|40426529|FG003|Overall Study|Randomized and not treated|1|||
16536905|NCT03982186|40426530|FG004|Overall Study|Randomized and not treated|0|||
16536906|NCT03982186|40426531|FG005|Overall Study|Randomized and not treated|0|||
16536907|NCT03538951|40426533|FG000|Overall Study|Withdrawal by Subject|1|||
16536908|NCT03538951|40426534|FG001|Overall Study|Withdrawal by Subject|2|||
16536909|NCT01625897|40426535|FG000|Overall Study|Adverse Event|27|||
16536910|NCT01625897|40426536|FG001|Overall Study|Adverse Event|10|||
16536911|NCT01625897|40426535|FG000|Overall Study|Physician Decision|0|||
16536912|NCT01625897|40426536|FG001|Overall Study|Physician Decision|1|||
16536913|NCT01625897|40426535|FG000|Overall Study|Withdrawal by Subject|25|||
16536914|NCT01625897|40426536|FG001|Overall Study|Withdrawal by Subject|3|||
16536915|NCT00686881|40426537|FG000|Overall Study|Withdrawal by Subject|11|||
16536916|NCT00686881|40426538|FG001|Overall Study|Withdrawal by Subject|18|||
16536917|NCT00686881|40426537|FG000|Overall Study|Lost to Follow-up|0|||
16536918|NCT00686881|40426538|FG001|Overall Study|Lost to Follow-up|1|||
16536919|NCT00686881|40426537|FG000|Overall Study|Treatment-related adverse event|10|||
16536920|NCT00686881|40426538|FG001|Overall Study|Treatment-related adverse event|9|||
16536921|NCT00686881|40426537|FG000|Overall Study|Met discontinuation criteria|5|||
16337439|NCT01752634|39721158|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
16337440|NCT01752634|39721159|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
16337441|NCT01752634|39721160|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
16337442|NCT01752634|39721155|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
16337443|NCT01752634|39721156|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
16337444|NCT01752634|39721157|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
16337445|NCT01752634|39721158|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
16337446|NCT01752634|39721159|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
16337447|NCT01752634|39721160|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
16337448|NCT01752634|39721155|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
16337449|NCT01752634|39721156|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
16337450|NCT01752634|39721157|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
16337451|NCT01752634|39721158|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
16337452|NCT01752634|39721159|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
16337453|NCT01752634|39721160|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
16337454|NCT01752634|39721155|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
16337455|NCT01752634|39721156|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
16337456|NCT01752634|39721157|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
16337457|NCT01752634|39721158|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
16337458|NCT01752634|39721159|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
16337459|NCT01752634|39721160|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
16337460|NCT01752634|39721155|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
16337461|NCT01752634|39721156|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
16337462|NCT01752634|39721157|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
16337463|NCT01752634|39721158|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
16337464|NCT01752634|39721159|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
16337465|NCT01752634|39721160|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
16337466|NCT01752634|39721155|FG000|Week 24 to Week 260|Physician Decision|1|||
16337467|NCT01752634|39721156|FG001|Week 24 to Week 260|Physician Decision|2|||
16337468|NCT01752634|39721157|FG002|Week 24 to Week 260|Physician Decision|4|||
16337469|NCT01752634|39721158|FG003|Week 24 to Week 260|Physician Decision|2|||
16337470|NCT01752634|39721159|FG004|Week 24 to Week 260|Physician Decision|1|||
16337471|NCT01752634|39721160|FG005|Week 24 to Week 260|Physician Decision|0|||
16337472|NCT01752634|39721155|FG000|Week 24 to Week 260|Death|0|||
16337473|NCT01752634|39721156|FG001|Week 24 to Week 260|Death|1|||
16337474|NCT01752634|39721157|FG002|Week 24 to Week 260|Death|0|||
16337475|NCT01752634|39721158|FG003|Week 24 to Week 260|Death|0|||
16337476|NCT01752634|39721159|FG004|Week 24 to Week 260|Death|0|||
16337477|NCT01752634|39721160|FG005|Week 24 to Week 260|Death|0|||
16337478|NCT01752634|39721155|FG000|Week 24 to Week 260|Pregnancy|0|||
16337479|NCT01752634|39721156|FG001|Week 24 to Week 260|Pregnancy|0|||
16337480|NCT01752634|39721157|FG002|Week 24 to Week 260|Pregnancy|1|||
16337481|NCT01752634|39721158|FG003|Week 24 to Week 260|Pregnancy|0|||
16337482|NCT01752634|39721159|FG004|Week 24 to Week 260|Pregnancy|0|||
16536922|NCT00686881|40426538|FG001|Overall Study|Met discontinuation criteria|0|||
16337483|NCT01752634|39721160|FG005|Week 24 to Week 260|Pregnancy|0|||
16337484|NCT01752634|39721155|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
16337485|NCT01752634|39721156|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
16405717|NCT03549871|39966414|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
16337486|NCT01752634|39721157|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
16337487|NCT01752634|39721158|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
16337488|NCT01752634|39721159|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
16337489|NCT01752634|39721160|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
16337490|NCT01752634|39721155|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
16337491|NCT01752634|39721156|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
16337492|NCT01752634|39721157|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
16337493|NCT01752634|39721158|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
16337494|NCT01752634|39721159|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
16337495|NCT01752634|39721160|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
16337496|NCT01752634|39721155|FG000|Week 24 to Week 260|Adverse Event|4|||
16337497|NCT01752634|39721156|FG001|Week 24 to Week 260|Adverse Event|8|||
16337498|NCT01752634|39721157|FG002|Week 24 to Week 260|Adverse Event|8|||
16337499|NCT01752634|39721158|FG003|Week 24 to Week 260|Adverse Event|4|||
16337500|NCT01752634|39721159|FG004|Week 24 to Week 260|Adverse Event|2|||
16337501|NCT01752634|39721160|FG005|Week 24 to Week 260|Adverse Event|0|||
16337502|NCT00926536|39721178|FG000|Overall Study|Physician Decision|1|||
16405718|NCT03549871|39966415|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
16405719|NCT03549871|39966414|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
16405720|NCT03549871|39966415|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
16405721|NCT03549871|39966414|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
16405722|NCT03549871|39966415|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
16405723|NCT03549871|39966414|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
16405724|NCT03549871|39966415|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
16405725|NCT03549871|39966414|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
16405726|NCT03549871|39966415|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
16405727|NCT03549871|39966414|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
16405728|NCT03549871|39966415|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
16405729|NCT03549871|39966414|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
16405730|NCT03549871|39966415|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
16405731|NCT03549871|39966414|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
16405732|NCT03549871|39966415|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
16405733|NCT03549871|39966414|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
16405734|NCT03549871|39966415|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
16405735|NCT03549871|39966414|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
16405736|NCT03549871|39966415|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
16405737|NCT03549871|39966414|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
16405738|NCT03549871|39966415|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
16536923|NCT00686881|40426537|FG000|Overall Study|Onset of malignant tumor|11|||
16536924|NCT00686881|40426538|FG001|Overall Study|Onset of malignant tumor|11|||
16536925|NCT00686881|40426537|FG000|Overall Study|Lack of Efficacy|4|||
16536926|NCT00686881|40426538|FG001|Overall Study|Lack of Efficacy|3|||
16536927|NCT00686881|40426537|FG000|Overall Study|Physician Decision|1|||
16536928|NCT00686881|40426538|FG001|Overall Study|Physician Decision|0|||
16536929|NCT00686881|40426537|FG000|Overall Study|Circumstances of site|1|||
16536930|NCT00686881|40426538|FG001|Overall Study|Circumstances of site|1|||
16536931|NCT00686881|40426537|FG000|Overall Study|Did not meet protocol eligibility|1|||
16536932|NCT00686881|40426538|FG001|Overall Study|Did not meet protocol eligibility|0|||
16536933|NCT00686881|40426537|FG000|Overall Study|Irregular visits|1|||
16536934|NCT00686881|40426538|FG001|Overall Study|Irregular visits|0|||
16536935|NCT00686881|40426537|FG000|Overall Study|Study discontinuation|35|||
16536936|NCT00686881|40426538|FG001|Overall Study|Study discontinuation|32|||
16536937|NCT00686881|40426537|FG000|Overall Study|Never received study drug|2|||
16536938|NCT00686881|40426538|FG001|Overall Study|Never received study drug|6|||
16536939|NCT03371940|40429061|FG000|Overall Study|Withdrawal by Subject|8|||
16536940|NCT03371940|40429062|FG001|Overall Study|Withdrawal by Subject|1|||
16536941|NCT03371940|40429063|FG002|Overall Study|Withdrawal by Subject|3|||
16536942|NCT03371940|40429064|FG003|Overall Study|Withdrawal by Subject|4|||
16536943|NCT04672941|40429066|FG000|Overall Study|Investigator decision|1|||
16536944|NCT04672941|40429066|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
16536945|NCT04672941|40429066|FG000|Overall Study|COVID-19 related but no adverse event|1|||
16536946|NCT04672941|40429066|FG000|Overall Study|Adverse Event|2|||
16536947|NCT04672941|40429066|FG000|Overall Study|Lost to Follow-up|2|||
16536948|NCT01266850|40429067|FG000|Overall Study|Lost to Follow-up|19|||
16536949|NCT01266850|40429068|FG001|Overall Study|Lost to Follow-up|19|||
16536950|NCT01266850|40429069|FG002|Overall Study|Lost to Follow-up|13|||
16337503|NCT00926536|39721179|FG001|Overall Study|Physician Decision|2|||
16337504|NCT02282163|39721180|FG000|Overall Study|Protocol Violation|1|||
16337505|NCT00135356|39721187|FG000|Overall Study|Adverse Event|6|||
16405739|NCT02701777|39966417|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
16405740|NCT02701777|39966418|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
16405741|NCT02701777|39966419|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
16405742|NCT02701777|39966420|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
16405743|NCT02701777|39966417|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
16405744|NCT02701777|39966418|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
16337506|NCT00135356|39721188|FG001|Overall Study|Adverse Event|2|||
16405745|NCT02701777|39966419|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
16405746|NCT02701777|39966420|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
16405747|NCT00090142|39966424|FG000|Treatment Period I|Lost to Follow-up|1|||
16405748|NCT00090142|39966425|FG001|Treatment Period I|Lost to Follow-up|2|||
16405749|NCT00090142|39966424|FG000|Treatment Period I|Protocol Violation|2|||
16405750|NCT00090142|39966425|FG001|Treatment Period I|Protocol Violation|0|||
16405751|NCT00090142|39966424|FG000|Treatment Period I|Withdrawal by Subject|2|||
16405752|NCT00090142|39966425|FG001|Treatment Period I|Withdrawal by Subject|0|||
16405753|NCT00090142|39966424|FG000|Treatment Period I|Other|0|||
16405754|NCT00090142|39966425|FG001|Treatment Period I|Other|1|||
16405755|NCT00090142|39966424|FG000|Treatment Period II|Other|1|||
16405756|NCT00090142|39966425|FG001|Treatment Period II|Other|0|||
16405757|NCT02851407|39966428|FG000|Overall Study|Withdrawal by parent/guardian|2|||
16405758|NCT02851407|39966429|FG001|Overall Study|Withdrawal by parent/guardian|7|||
16405759|NCT02851407|39966428|FG000|Overall Study|Protocol deviation|0|||
16405760|NCT02851407|39966429|FG001|Overall Study|Protocol deviation|1|||
16405761|NCT02851407|39966428|FG000|Overall Study|Transferred to another hospital to continue|1|||
16405762|NCT02851407|39966429|FG001|Overall Study|Transferred to another hospital to continue|0|||
16405763|NCT02851407|39966428|FG000|Overall Study|Other Death|30|||
16405764|NCT02851407|39966429|FG001|Overall Study|Other Death|20|||
16337507|NCT00135356|39721187|FG000|Overall Study|Lack of Efficacy|2|||
16337508|NCT00135356|39721188|FG001|Overall Study|Lack of Efficacy|0|||
16337509|NCT00135356|39721187|FG000|Overall Study|Lost to Follow-up|3|||
16405765|NCT02851407|39966428|FG000|Overall Study|Adverse event, serious fatal|6|||
16405766|NCT02851407|39966429|FG001|Overall Study|Adverse event, serious fatal|8|||
16405767|NCT02851407|39966428|FG000|Overall Study|Consent withdrawn by participant|5|||
16405768|NCT02851407|39966429|FG001|Overall Study|Consent withdrawn by participant|3|||
16405769|NCT02851407|39966428|FG000|Overall Study|Screen failure|2|||
16405770|NCT02851407|39966429|FG001|Overall Study|Screen failure|1|||
16405771|NCT02851407|39966428|FG000|Overall Study|Disease relapse|9|||
16405772|NCT02851407|39966429|FG001|Overall Study|Disease relapse|6|||
16405773|NCT02851407|39966428|FG000|Overall Study|Physician Decision|7|||
16405774|NCT02851407|39966429|FG001|Overall Study|Physician Decision|6|||
16405775|NCT02851407|39966428|FG000|Overall Study|Transferred to hospital closer to home|0|||
16405776|NCT02851407|39966429|FG001|Overall Study|Transferred to hospital closer to home|1|||
16405777|NCT02851407|39966428|FG000|Overall Study|Enrolled in an investigational study|0|||
16405778|NCT02851407|39966429|FG001|Overall Study|Enrolled in an investigational study|1|||
16337510|NCT00135356|39721188|FG001|Overall Study|Lost to Follow-up|1|||
16405779|NCT02851407|39966428|FG000|Overall Study|Early recovery|1|||
16405780|NCT02851407|39966429|FG001|Overall Study|Early recovery|0|||
16405781|NCT02851407|39966428|FG000|Overall Study|Adverse event, non-fatal|7|||
16405782|NCT02851407|39966429|FG001|Overall Study|Adverse event, non-fatal|5|||
16405783|NCT02851407|39966428|FG000|Overall Study|Lost to Follow-up|0|||
16405784|NCT02851407|39966429|FG001|Overall Study|Lost to Follow-up|2|||
16405785|NCT02088073|39966430|FG000|Acute Phase|Withdrawal by Subject|5|||
16405786|NCT02088073|39966431|FG001|Acute Phase|Withdrawal by Subject|0|||
16405787|NCT02088073|39966432|FG002|Acute Phase|Withdrawal by Subject|0|||
16405788|NCT02088073|39966433|FG003|Acute Phase|Withdrawal by Subject|0|||
16405789|NCT02088073|39966434|FG004|Acute Phase|Withdrawal by Subject|0|||
16405790|NCT02088073|39966430|FG000|Acute Phase|Hyperkalemia|2|||
16405791|NCT02088073|39966431|FG001|Acute Phase|Hyperkalemia|0|||
16405792|NCT02088073|39966432|FG002|Acute Phase|Hyperkalemia|0|||
16405793|NCT02088073|39966433|FG003|Acute Phase|Hyperkalemia|0|||
16405794|NCT02088073|39966434|FG004|Acute Phase|Hyperkalemia|0|||
16405795|NCT02088073|39966430|FG000|Maintanance Phase|Withdrawal by Subject|0|||
16337511|NCT00135356|39721187|FG000|Overall Study|Surgery for abdominal fat|1|||
16337512|NCT00135356|39721188|FG001|Overall Study|Surgery for abdominal fat|0|||
16405796|NCT02088073|39966431|FG001|Maintanance Phase|Withdrawal by Subject|2|||
16405797|NCT02088073|39966432|FG002|Maintanance Phase|Withdrawal by Subject|0|||
16405798|NCT02088073|39966433|FG003|Maintanance Phase|Withdrawal by Subject|0|||
16405799|NCT02088073|39966434|FG004|Maintanance Phase|Withdrawal by Subject|0|||
16405800|NCT02088073|39966430|FG000|Maintanance Phase|Adverse Event|0|||
16405801|NCT02088073|39966431|FG001|Maintanance Phase|Adverse Event|0|||
16405802|NCT02088073|39966432|FG002|Maintanance Phase|Adverse Event|3|||
16337513|NCT00135356|39721187|FG000|Overall Study|Change in antiviral regimen|0|||
16405803|NCT02088073|39966433|FG003|Maintanance Phase|Adverse Event|0|||
16405804|NCT02088073|39966434|FG004|Maintanance Phase|Adverse Event|1|||
16405805|NCT02088073|39966430|FG000|Maintanance Phase|Physician Decision|0|||
16405806|NCT02088073|39966431|FG001|Maintanance Phase|Physician Decision|0|||
16337514|NCT00135356|39721188|FG001|Overall Study|Change in antiviral regimen|1|||
16337515|NCT00135356|39721187|FG000|Overall Study|Poor/noncompliance|1|||
16337516|NCT00135356|39721188|FG001|Overall Study|Poor/noncompliance|1|||
16337517|NCT00135356|39721187|FG000|Overall Study|No longer meets study criteria|2|||
16337518|NCT00135356|39721188|FG001|Overall Study|No longer meets study criteria|0|||
16337519|NCT00135356|39721187|FG000|Overall Study|Withdrawal by Subject|2|||
16337520|NCT00135356|39721188|FG001|Overall Study|Withdrawal by Subject|4|||
16337521|NCT04750278|39721189|FG000|Overall Study|Death|9|||
16337522|NCT04750278|39721190|FG001|Overall Study|Death|10|||
16337523|NCT04750278|39721191|FG002|Overall Study|Death|10|||
16337524|NCT04750278|39721189|FG000|Overall Study|Withdrawal by Subject|4|||
16337525|NCT04750278|39721190|FG001|Overall Study|Withdrawal by Subject|1|||
16337526|NCT04750278|39721191|FG002|Overall Study|Withdrawal by Subject|2|||
16337527|NCT04750278|39721189|FG000|Overall Study|Lost to Follow-up|1|||
16337528|NCT04750278|39721190|FG001|Overall Study|Lost to Follow-up|1|||
16337529|NCT04750278|39721191|FG002|Overall Study|Lost to Follow-up|1|||
16337530|NCT04750278|39721189|FG000|Overall Study|Pregnancy|1|||
16337531|NCT04750278|39721190|FG001|Overall Study|Pregnancy|0|||
16337532|NCT04750278|39721191|FG002|Overall Study|Pregnancy|0|||
16337533|NCT04750278|39721189|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
16337534|NCT04750278|39721190|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
16337535|NCT04750278|39721191|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
16337536|NCT04750278|39721189|FG000|Overall Study|Non-compliance|0|||
16337537|NCT04750278|39721190|FG001|Overall Study|Non-compliance|0|||
16337538|NCT04750278|39721191|FG002|Overall Study|Non-compliance|1|||
16337539|NCT04750278|39721189|FG000|Overall Study|Transfer to Outside Facility|0|||
16337540|NCT04750278|39721190|FG001|Overall Study|Transfer to Outside Facility|2|||
16337541|NCT04750278|39721191|FG002|Overall Study|Transfer to Outside Facility|1|||
16337542|NCT04750278|39721189|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
16216844|NCT02442765|39272504|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
16216845|NCT02442765|39272505|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
16216846|NCT02442765|39272506|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
16337543|NCT04750278|39721190|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
16216847|NCT02442765|39272507|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
16337544|NCT04750278|39721191|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
16216848|NCT02442765|39272508|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
16337545|NCT04750278|39721189|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
16346404|NCT01971567|39757132|FG001|Overall Study|Withdrawal by Subject|2|||
16346405|NCT01971567|39757131|FG000|Overall Study|Lost to Follow-up|1|||
16346406|NCT01971567|39757132|FG001|Overall Study|Lost to Follow-up|0|||
16346407|NCT02053493|39757135|FG000|Overall Study|Withdrawal by Subject|1|||
16346408|NCT02053493|39757136|FG001|Overall Study|Withdrawal by Subject|1|||
16346409|NCT00410072|39757155|FG000|Day 1 to Week 48|Adverse Event|1|||
16346410|NCT00410072|39757156|FG001|Day 1 to Week 48|Adverse Event|2|||
16346411|NCT00410072|39757155|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
16346412|NCT00410072|39757156|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
16346413|NCT00410072|39757155|FG000|Day 1 to Week 48|Other|0|||
16346414|NCT00410072|39757156|FG001|Day 1 to Week 48|Other|1|||
16346415|NCT00410072|39757155|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
16346416|NCT00410072|39757156|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
16346417|NCT00410072|39757155|FG000|Day 1 to Week 48|Pregnancy|0|||
16346418|NCT00410072|39757156|FG001|Day 1 to Week 48|Pregnancy|2|||
16346419|NCT00410072|39757155|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
16346420|NCT00410072|39757156|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
16346421|NCT00410072|39757155|FG000|After Week 48 to Week 96|Adverse Event|1|||
16346422|NCT00410072|39757156|FG001|After Week 48 to Week 96|Adverse Event|2|||
16346423|NCT00410072|39757155|FG000|After Week 48 to Week 96|Death|0|||
16346424|NCT00410072|39757156|FG001|After Week 48 to Week 96|Death|1|||
16346425|NCT00410072|39757155|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
16346426|NCT00410072|39757156|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
16346427|NCT00410072|39757155|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
16346428|NCT00410072|39757156|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
16346429|NCT00410072|39757155|FG000|After Week 48 to Week 96|Other|2|||
16346430|NCT00410072|39757156|FG001|After Week 48 to Week 96|Other|0|||
16346431|NCT00410072|39757155|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
16346432|NCT00410072|39757156|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
16346433|NCT00410072|39757155|FG000|After Week 48 to Week 96|Pregnancy|0|||
16346434|NCT00410072|39757156|FG001|After Week 48 to Week 96|Pregnancy|2|||
16346435|NCT00410072|39757155|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
16346436|NCT00410072|39757156|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
16346437|NCT00758498|39757157|FG000|Overall Study|Adverse Event|2|||
16346438|NCT00758498|39757158|FG001|Overall Study|Adverse Event|2|||
16346439|NCT00758498|39757159|FG002|Overall Study|Adverse Event|3|||
16405807|NCT02088073|39966432|FG002|Maintanance Phase|Physician Decision|0|||
16405808|NCT02088073|39966433|FG003|Maintanance Phase|Physician Decision|0|||
16405809|NCT02088073|39966434|FG004|Maintanance Phase|Physician Decision|1|||
16405810|NCT02088073|39966430|FG000|Maintanance Phase|Sponsor's decision|0|||
16405811|NCT02088073|39966431|FG001|Maintanance Phase|Sponsor's decision|2|||
16405812|NCT02088073|39966432|FG002|Maintanance Phase|Sponsor's decision|0|||
16405813|NCT02088073|39966433|FG003|Maintanance Phase|Sponsor's decision|2|||
16405814|NCT02088073|39966434|FG004|Maintanance Phase|Sponsor's decision|1|||
16405815|NCT02088073|39966430|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
16405816|NCT02088073|39966431|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
16405817|NCT02088073|39966432|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
16405818|NCT02088073|39966433|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
16405819|NCT02088073|39966434|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
16405820|NCT02088073|39966430|FG000|Maintanance Phase|Miscellaneous|0|||
16405821|NCT02088073|39966431|FG001|Maintanance Phase|Miscellaneous|2|||
16405822|NCT02088073|39966432|FG002|Maintanance Phase|Miscellaneous|1|||
16405823|NCT02088073|39966433|FG003|Maintanance Phase|Miscellaneous|2|||
16405824|NCT02088073|39966434|FG004|Maintanance Phase|Miscellaneous|1|||
16405825|NCT02088073|39966430|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
16405826|NCT02088073|39966431|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
16405827|NCT02088073|39966432|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
16405828|NCT02088073|39966433|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
16405829|NCT02088073|39966434|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
16405830|NCT02088073|39966430|FG000|Maintanance Phase|Subject compliance|0|||
16405831|NCT02088073|39966431|FG001|Maintanance Phase|Subject compliance|1|||
16405832|NCT02088073|39966432|FG002|Maintanance Phase|Subject compliance|0|||
16405833|NCT02088073|39966433|FG003|Maintanance Phase|Subject compliance|0|||
16405834|NCT02088073|39966434|FG004|Maintanance Phase|Subject compliance|0|||
16405835|NCT01328535|39966435|FG000|Overall Study|Ineligible|1|||
16536951|NCT01266850|40429070|FG003|Overall Study|Lost to Follow-up|13|||
16337546|NCT04750278|39721190|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
16337547|NCT04750278|39721191|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
16337548|NCT00513357|39721192|FG000|Overall Study|did not receive allocated placebo|2|||
16337549|NCT00513357|39721193|FG001|Overall Study|did not receive allocated placebo|3|||
16337550|NCT00513357|39721192|FG000|Overall Study|Adverse Event|4|||
16337551|NCT00513357|39721193|FG001|Overall Study|Adverse Event|2|||
16337552|NCT00513357|39721192|FG000|Overall Study|Death|2|||
16337553|NCT00513357|39721193|FG001|Overall Study|Death|0|||
16337554|NCT00513357|39721192|FG000|Overall Study|Withdrawal by Subject|5|||
16337555|NCT00513357|39721193|FG001|Overall Study|Withdrawal by Subject|4|||
16337556|NCT00513357|39721192|FG000|Overall Study|Disease Progression|2|||
16337557|NCT00513357|39721193|FG001|Overall Study|Disease Progression|1|||
16337558|NCT02131636|39721197|FG000|Overall Study|Personal Reasons|4|||
16337559|NCT02131636|39721198|FG001|Overall Study|Personal Reasons|4|||
16337560|NCT02131636|39721197|FG000|Overall Study|Lost to Follow-up|4|||
16337561|NCT02131636|39721198|FG001|Overall Study|Lost to Follow-up|0|||
16337562|NCT02131636|39721197|FG000|Overall Study|Adverse Event|4|||
16536952|NCT01266850|40429071|FG004|Overall Study|Lost to Follow-up|12|||
16536953|NCT01266850|40429067|FG000|Overall Study|Withdrawal by Subject|8|||
16337563|NCT02131636|39721198|FG001|Overall Study|Adverse Event|1|||
16536954|NCT01266850|40429068|FG001|Overall Study|Withdrawal by Subject|9|||
16536955|NCT01266850|40429069|FG002|Overall Study|Withdrawal by Subject|6|||
16536956|NCT01266850|40429070|FG003|Overall Study|Withdrawal by Subject|9|||
16536957|NCT01266850|40429071|FG004|Overall Study|Withdrawal by Subject|12|||
16536958|NCT01266850|40429067|FG000|Overall Study|Physician Decision|3|||
16536959|NCT01266850|40429068|FG001|Overall Study|Physician Decision|6|||
16536960|NCT01266850|40429069|FG002|Overall Study|Physician Decision|4|||
16337564|NCT02510820|39721199|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
16405836|NCT00129701|39966436|FG000|Overall Study|Withdrawal by Subject|33|||
16405837|NCT01819129|39966437|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
16405838|NCT01819129|39966438|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
16536961|NCT01266850|40429070|FG003|Overall Study|Physician Decision|4|||
16405839|NCT01819129|39966437|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
16405840|NCT01819129|39966438|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
16405841|NCT01819129|39966437|FG000|Overall Study|Other, Subject moved out of the country|0|||
16536962|NCT01266850|40429071|FG004|Overall Study|Physician Decision|3|||
16536963|NCT01266850|40429067|FG000|Overall Study|Protocol Violation|0|||
16536964|NCT01266850|40429068|FG001|Overall Study|Protocol Violation|1|||
16536965|NCT01266850|40429069|FG002|Overall Study|Protocol Violation|0|||
16536966|NCT01266850|40429070|FG003|Overall Study|Protocol Violation|1|||
16536967|NCT01266850|40429071|FG004|Overall Study|Protocol Violation|2|||
16536968|NCT01266850|40429067|FG000|Overall Study|Adverse Event|0|||
16536969|NCT01266850|40429068|FG001|Overall Study|Adverse Event|0|||
16536970|NCT01266850|40429069|FG002|Overall Study|Adverse Event|0|||
16536971|NCT01266850|40429070|FG003|Overall Study|Adverse Event|0|||
16536972|NCT01266850|40429071|FG004|Overall Study|Adverse Event|1|||
16536973|NCT01266850|40429067|FG000|Overall Study|Site Closure|0|||
16536974|NCT01266850|40429068|FG001|Overall Study|Site Closure|1|||
16536975|NCT01266850|40429069|FG002|Overall Study|Site Closure|1|||
16536976|NCT01266850|40429070|FG003|Overall Study|Site Closure|1|||
16536977|NCT01266850|40429071|FG004|Overall Study|Site Closure|0|||
16536978|NCT03595904|40429072|FG000|Overall Study|Protocol Violation|3|||
16536979|NCT03595904|40429073|FG001|Overall Study|Protocol Violation|1|||
16536980|NCT03595904|40429072|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
16536981|NCT03595904|40429073|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
16536982|NCT03595904|40429072|FG000|Overall Study|Insurance complications|1|||
16536983|NCT03595904|40429073|FG001|Overall Study|Insurance complications|0|||
16536984|NCT03595904|40429072|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
16536985|NCT03595904|40429073|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
16536986|NCT02013622|40429074|FG000|Overall Study|Lost to Follow-up|10|||
16536987|NCT02013622|40429074|FG000|Overall Study|Adverse Event|3|||
16536988|NCT02013622|40429074|FG000|Overall Study|Met Withdrawal Criteria|3|||
16536989|NCT02013622|40429074|FG000|Overall Study|Withdrawal by Subject|6|||
16536990|NCT02013622|40429074|FG000|Overall Study|Protocol Deviation|1|||
16102602|NCT00975130|38863242|FG001|Study Part 1|Withdrawal by Subject|0|||
16102603|NCT00975130|38863243|FG002|Study Part 1|Withdrawal by Subject|0|||
16102604|NCT00975130|38863241|FG000|Study Part 1|Protocol Violation|13|||
16102605|NCT00975130|38863242|FG001|Study Part 1|Protocol Violation|0|||
16102606|NCT00975130|38863243|FG002|Study Part 1|Protocol Violation|0|||
16102607|NCT00975130|38863241|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
16102608|NCT00975130|38863242|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
16102609|NCT00975130|38863243|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
16102610|NCT00975130|38863241|FG000|Study Part 1|Administrative|4|||
16102611|NCT00975130|38863242|FG001|Study Part 1|Administrative|0|||
16102612|NCT00975130|38863243|FG002|Study Part 1|Administrative|0|||
16536991|NCT02013622|40429074|FG000|Overall Study|Lack of Efficacy|1|||
16536992|NCT01936857|40429076|FG000|Overall Study|Sent to prison or 06 center|11|||
16536993|NCT01936857|40429077|FG001|Overall Study|Sent to prison or 06 center|12|||
16536994|NCT01936857|40429076|FG000|Overall Study|Lost to Follow-up|10|||
16536995|NCT01936857|40429077|FG001|Overall Study|Lost to Follow-up|7|||
16536996|NCT01936857|40429076|FG000|Overall Study|Death|7|||
16102613|NCT00975130|38863241|FG000|Study Part 1|Withdrew Consent|24|||
16536997|NCT01936857|40429077|FG001|Overall Study|Death|3|||
16536998|NCT01936857|40429076|FG000|Overall Study|Moved|2|||
16536999|NCT01936857|40429077|FG001|Overall Study|Moved|1|||
16537000|NCT01936857|40429076|FG000|Overall Study|Withdrawal by Subject|1|||
16537001|NCT01936857|40429077|FG001|Overall Study|Withdrawal by Subject|0|||
16537002|NCT01936857|40429076|FG000|Overall Study|Side effect of medication|1|||
16537003|NCT01936857|40429077|FG001|Overall Study|Side effect of medication|0|||
16537004|NCT01936857|40429076|FG000|Overall Study|Other|2|||
16537005|NCT01936857|40429077|FG001|Overall Study|Other|2|||
16537006|NCT01928719|40429078|FG000|Overall Study|Lost to Follow-up|26|||
16537007|NCT01928719|40429079|FG001|Overall Study|Lost to Follow-up|11|||
16537008|NCT01928719|40429078|FG000|Overall Study|Withdrawal by Subject|22|||
16537009|NCT01928719|40429079|FG001|Overall Study|Withdrawal by Subject|7|||
16537010|NCT01928719|40429078|FG000|Overall Study|Protocol Violation|3|||
16537011|NCT01928719|40429079|FG001|Overall Study|Protocol Violation|1|||
16537012|NCT01928719|40429078|FG000|Overall Study|Adverse Event|1|||
16537013|NCT01928719|40429079|FG001|Overall Study|Adverse Event|0|||
16537014|NCT01662310|40429080|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
16537015|NCT01662310|40429081|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
16537016|NCT01662310|40429082|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
16537017|NCT01662310|40429083|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
16537018|NCT01662310|40429084|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
16537019|NCT01662310|40429080|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
16537020|NCT01662310|40429081|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
16537021|NCT01662310|40429082|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
16537022|NCT01662310|40429083|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
16537023|NCT01662310|40429084|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
16537024|NCT01662310|40429080|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
16537025|NCT01662310|40429081|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
16537026|NCT01662310|40429082|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
16537027|NCT01662310|40429083|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
16537028|NCT01662310|40429084|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
16537029|NCT01662310|40429080|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
16537030|NCT01662310|40429081|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
16537031|NCT01662310|40429082|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
16537032|NCT01662310|40429083|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
16537033|NCT01662310|40429084|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
16537034|NCT01662310|40429080|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
16537035|NCT01662310|40429081|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
16537036|NCT01662310|40429082|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
16102614|NCT00975130|38863242|FG001|Study Part 1|Withdrew Consent|0|||
16102615|NCT00975130|38863243|FG002|Study Part 1|Withdrew Consent|0|||
16102616|NCT00975130|38863241|FG000|Study Part 2|Adverse Event|0|||
16537037|NCT01662310|40429083|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
16537038|NCT01662310|40429084|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
16537039|NCT01662310|40429080|FG000|Run-In or Stabilization Phase|Other|1|||
16337565|NCT02510820|39721200|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
16337566|NCT02510820|39721199|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16337567|NCT02510820|39721200|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
16337568|NCT02003963|39721201|FG000|Overall Study|Lost to Follow-up|2|||
16337569|NCT02003963|39721202|FG001|Overall Study|Lost to Follow-up|1|||
16337570|NCT02749799|39721203|FG000|Overall Study|Adverse Event|2|||
16337571|NCT02749799|39721203|FG000|Overall Study|Lost to Follow-up|4|||
16337572|NCT02749799|39721203|FG000|Overall Study|Protocol Violation|1|||
16337573|NCT02749799|39721203|FG000|Overall Study|Withdrawal by Subject|1|||
16337574|NCT02688764|39721211|FG000|Overall Study|Adverse Event|3|||
16337575|NCT02688764|39721212|FG001|Overall Study|Adverse Event|3|||
16337576|NCT02688764|39721211|FG000|Overall Study|AE/Kidney transplant|1|||
16337577|NCT02688764|39721212|FG001|Overall Study|AE/Kidney transplant|0|||
16337578|NCT02688764|39721211|FG000|Overall Study|AE/Lack of efficacy|1|||
16337579|NCT02688764|39721212|FG001|Overall Study|AE/Lack of efficacy|0|||
16337580|NCT02688764|39721211|FG000|Overall Study|AE/Non-compl.|1|||
16337581|NCT02688764|39721212|FG001|Overall Study|AE/Non-compl.|0|||
16337582|NCT02688764|39721211|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
16337583|NCT02688764|39721212|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
16337584|NCT02688764|39721211|FG000|Overall Study|AE/Other|0|||
16337585|NCT02688764|39721212|FG001|Overall Study|AE/Other|1|||
16337586|NCT02688764|39721211|FG000|Overall Study|AE/Physician decision|1|||
16337587|NCT02688764|39721212|FG001|Overall Study|AE/Physician decision|0|||
16337588|NCT02688764|39721211|FG000|Overall Study|AE/Withd. parent|3|||
16337589|NCT02688764|39721212|FG001|Overall Study|AE/Withd. parent|0|||
16405842|NCT01819129|39966438|FG001|Overall Study|Other, Subject moved out of the country|1|||
16405843|NCT01819129|39966437|FG000|Overall Study|Withdrawal by Subject|15|||
16405844|NCT01819129|39966438|FG001|Overall Study|Withdrawal by Subject|15|||
16405845|NCT01819129|39966437|FG000|Overall Study|Lost to Follow-up|5|||
16405846|NCT01819129|39966438|FG001|Overall Study|Lost to Follow-up|2|||
16405847|NCT01819129|39966437|FG000|Overall Study|Lack of Efficacy|0|||
16405848|NCT01819129|39966438|FG001|Overall Study|Lack of Efficacy|1|||
16337590|NCT02688764|39721211|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
16337591|NCT02688764|39721212|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
16405849|NCT01819129|39966437|FG000|Overall Study|Adverse Event|1|||
16405850|NCT01819129|39966438|FG001|Overall Study|Adverse Event|4|||
16405851|NCT01819129|39966437|FG000|Overall Study|Death|1|||
16405852|NCT01819129|39966438|FG001|Overall Study|Death|1|||
16405853|NCT01819129|39966437|FG000|Overall Study|Withdrawal Criteria|20|||
16405854|NCT01819129|39966438|FG001|Overall Study|Withdrawal Criteria|15|||
16405855|NCT03222973|39966442|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
16405856|NCT03222973|39966443|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
16405857|NCT03222973|39966444|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
16405858|NCT03222973|39966445|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
16405859|NCT03222973|39966442|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
16405860|NCT03222973|39966443|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
16405861|NCT03222973|39966444|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
16405862|NCT03222973|39966445|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
16405863|NCT03222973|39966442|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
16405864|NCT03222973|39966443|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
16405865|NCT03222973|39966444|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
16337592|NCT02688764|39721211|FG000|Overall Study|AE/Withd. subject|1|||
16337593|NCT02688764|39721212|FG001|Overall Study|AE/Withd. subject|0|||
16337594|NCT02688764|39721211|FG000|Overall Study|Kidney transplant|10|||
16337595|NCT02688764|39721212|FG001|Overall Study|Kidney transplant|4|||
16337596|NCT02688764|39721211|FG000|Overall Study|Lack of Efficacy|3|||
16337597|NCT02688764|39721212|FG001|Overall Study|Lack of Efficacy|2|||
16405866|NCT03222973|39966445|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
16405867|NCT03222973|39966442|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
16337598|NCT02688764|39721211|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
16337599|NCT02688764|39721212|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
16337600|NCT02688764|39721211|FG000|Overall Study|Non-compliance with study drug|4|||
16337601|NCT02688764|39721212|FG001|Overall Study|Non-compliance with study drug|0|||
16537040|NCT01662310|40429081|FG001|Run-In or Stabilization Phase|Other|0|||
16337602|NCT02688764|39721211|FG000|Overall Study|Non-compl./Physician decision|2|||
16337603|NCT02688764|39721212|FG001|Overall Study|Non-compl./Physician decision|0|||
16337604|NCT02688764|39721211|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
16337605|NCT02688764|39721212|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
16337606|NCT02688764|39721211|FG000|Overall Study|Non-compl./Withd. subject|0|||
16337607|NCT02688764|39721212|FG001|Overall Study|Non-compl./Withd. subject|2|||
16337608|NCT02688764|39721211|FG000|Overall Study|Phosphorus level outside safe range|0|||
16337609|NCT02688764|39721212|FG001|Overall Study|Phosphorus level outside safe range|1|||
16337610|NCT02688764|39721211|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
16337611|NCT02688764|39721212|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
16337612|NCT02688764|39721211|FG000|Overall Study|Study drug taste/Withd. parent|1|||
16337613|NCT02688764|39721212|FG001|Overall Study|Study drug taste/Withd. parent|0|||
16337614|NCT02688764|39721211|FG000|Overall Study|Subject moving out|2|||
16337615|NCT02688764|39721212|FG001|Overall Study|Subject moving out|0|||
16337616|NCT02688764|39721211|FG000|Overall Study|Subject taken off dialysis|1|||
16337617|NCT02688764|39721212|FG001|Overall Study|Subject taken off dialysis|0|||
16337618|NCT02688764|39721211|FG000|Overall Study|Withdrawal by parent|3|||
16337619|NCT02688764|39721212|FG001|Overall Study|Withdrawal by parent|0|||
16337620|NCT01125813|39721213|FG000|Overall Study|Death|1|||
16337621|NCT01125813|39721213|FG000|Overall Study|Withdrawal by Subject|1|||
16337622|NCT01125813|39721213|FG000|Overall Study|Screen Failures|4|||
16337623|NCT02109445|39721214|FG000|Overall Study|Symptomatic deterioration|2|||
16337624|NCT02109445|39721214|FG000|Overall Study|Adverse Event|1|||
16337625|NCT01502033|39721217|FG000|Overall Study|1 participant had scalp discomfort|1|||
16337626|NCT01502033|39721217|FG000|Overall Study|1 participant had worsening depression|1|||
16337627|NCT01502033|39721217|FG000|Overall Study|1 participant went back to school|1|||
16337628|NCT02655419|39721218|FG000|Overall Study|Enrolled but not treated|1|||
16337629|NCT02655419|39721219|FG001|Overall Study|Enrolled but not treated|5|||
16337630|NCT02655419|39721218|FG000|Overall Study|Withdrawal by Subject|4|||
16337631|NCT02655419|39721219|FG001|Overall Study|Withdrawal by Subject|1|||
16337632|NCT02655419|39721218|FG000|Overall Study|Other|0|||
16337633|NCT02655419|39721219|FG001|Overall Study|Other|1|||
16337634|NCT04679051|39721222|FG000|Overall Study|felt tired after restricted time in bed|3|||
16337635|NCT04679051|39721223|FG001|Overall Study|felt tired after restricted time in bed|0|||
16337636|NCT04679051|39721222|FG000|Overall Study|discomfort with blood pressure cuff|2|||
16337637|NCT04679051|39721223|FG001|Overall Study|discomfort with blood pressure cuff|0|||
16337638|NCT04679051|39721222|FG000|Overall Study|scheduling conflict|1|||
16337639|NCT04679051|39721223|FG001|Overall Study|scheduling conflict|1|||
16337640|NCT04679051|39721222|FG000|Overall Study|Protocol Violation|0|||
16337641|NCT04679051|39721223|FG001|Overall Study|Protocol Violation|4|||
16337642|NCT00272844|39721224|FG000|Overall Study|Withdrawal by Subject|5|||
16337643|NCT02190721|39721225|FG000|Overall Study|Patient was out of the city|0|||
16337644|NCT02190721|39721226|FG001|Overall Study|Patient was out of the city|1|||
16337645|NCT02190721|39721227|FG002|Overall Study|Patient was out of the city|0|||
16337646|NCT03681184|39721228|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
16337647|NCT03681184|39721229|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
16337648|NCT02634983|39721230|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
16337649|NCT02634983|39721231|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
16337650|NCT03913104|39721234|FG000|Overall Study|Lost to Follow-up|20|||
16337651|NCT03913104|39721234|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
16337652|NCT03913104|39721234|FG000|Overall Study|Withdrawal by Subject|2|||
16337653|NCT01533688|39721239|FG000|Overall Study|Withdrawal by Subject|5|||
16337654|NCT01533688|39721240|FG001|Overall Study|Withdrawal by Subject|4|||
16337655|NCT01533688|39721241|FG002|Overall Study|Withdrawal by Subject|3|||
16337656|NCT01533688|39721239|FG000|Overall Study|Medically unstable|1|||
16337657|NCT01533688|39721240|FG001|Overall Study|Medically unstable|3|||
16337658|NCT01533688|39721241|FG002|Overall Study|Medically unstable|3|||
16337659|NCT01533688|39721239|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
16337660|NCT01533688|39721240|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
16337661|NCT01533688|39721241|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
16337662|NCT02913105|39721242|FG000|Overall Study|Adverse Event|11|||
16337663|NCT02913105|39721243|FG001|Overall Study|Adverse Event|0|||
16337664|NCT02913105|39721244|FG002|Overall Study|Adverse Event|4|||
16337665|NCT02913105|39721242|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16337666|NCT02913105|39721243|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16337667|NCT02913105|39721244|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16337668|NCT02913105|39721242|FG000|Overall Study|Reason Not Specified|3|||
16405868|NCT03222973|39966443|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
16337669|NCT02913105|39721243|FG001|Overall Study|Reason Not Specified|1|||
16337670|NCT02913105|39721244|FG002|Overall Study|Reason Not Specified|1|||
16337671|NCT02913105|39721242|FG000|Overall Study|Physician Decision|1|||
16337672|NCT02913105|39721243|FG001|Overall Study|Physician Decision|1|||
16337673|NCT02913105|39721244|FG002|Overall Study|Physician Decision|0|||
16337674|NCT02913105|39721242|FG000|Overall Study|Withdrawal by Subject|0|||
16337675|NCT02913105|39721243|FG001|Overall Study|Withdrawal by Subject|3|||
16337676|NCT02913105|39721244|FG002|Overall Study|Withdrawal by Subject|1|||
16337677|NCT00312572|39721245|FG000|Overall Study|Adverse Event|10|||
16337678|NCT00312572|39721246|FG001|Overall Study|Adverse Event|16|||
16337679|NCT00312572|39721245|FG000|Overall Study|Lost to Follow-up|1|||
16337680|NCT00312572|39721246|FG001|Overall Study|Lost to Follow-up|1|||
16337681|NCT00312572|39721245|FG000|Overall Study|Administrative|4|||
16337682|NCT00312572|39721246|FG001|Overall Study|Administrative|2|||
16337683|NCT00312572|39721245|FG000|Overall Study|Lack of Efficacy|1|||
16337684|NCT00312572|39721246|FG001|Overall Study|Lack of Efficacy|2|||
16337685|NCT01653327|39721249|FG000|Overall Study|Withdrawal by Subject|1|||
16337686|NCT02578940|39721250|FG000|Overall Study|Screening failure|5|||
16337687|NCT02578940|39721250|FG000|Overall Study|Lost to Follow-up|1|||
16337688|NCT02431806|39721253|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
16337689|NCT02431806|39721254|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
16337690|NCT02431806|39721255|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
16337691|NCT02431806|39721256|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
16337692|NCT02431806|39721253|FG000|Double-blind Treatment Period|Adverse Event|4|||
16337693|NCT02431806|39721254|FG001|Double-blind Treatment Period|Adverse Event|7|||
16337694|NCT02431806|39721255|FG002|Double-blind Treatment Period|Adverse Event|11|||
16337695|NCT02431806|39721256|FG003|Double-blind Treatment Period|Adverse Event|7|||
16337696|NCT02431806|39721253|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
16337697|NCT02431806|39721254|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
16337698|NCT02431806|39721255|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
16405869|NCT03222973|39966444|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
16405870|NCT03222973|39966445|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
16405871|NCT03222973|39966442|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
16405872|NCT03222973|39966443|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
16405873|NCT03222973|39966444|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
16405874|NCT03222973|39966445|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
16405875|NCT03222973|39966442|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
16405876|NCT03222973|39966443|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
16405877|NCT03222973|39966444|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
16405878|NCT03222973|39966445|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
16405879|NCT03222973|39966442|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
16405880|NCT03222973|39966443|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
16405881|NCT03222973|39966444|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
16405882|NCT03222973|39966445|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
16405883|NCT03222973|39966442|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
16405884|NCT03222973|39966443|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
16405885|NCT03222973|39966444|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
16405886|NCT03222973|39966445|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
16337699|NCT02431806|39721256|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
16337700|NCT02431806|39721253|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
16337701|NCT02431806|39721254|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
16337702|NCT02431806|39721255|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
16337703|NCT02431806|39721256|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
16337704|NCT02431806|39721253|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
16337705|NCT02431806|39721254|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
16337706|NCT02431806|39721255|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
16337707|NCT02431806|39721256|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
16337708|NCT02431806|39721253|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
16337709|NCT02431806|39721254|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
16337710|NCT02431806|39721255|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
16337711|NCT02431806|39721256|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
16337712|NCT02431806|39721253|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
16337713|NCT02431806|39721254|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
16337714|NCT02431806|39721255|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
16337715|NCT02431806|39721256|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
16337716|NCT02603107|39721257|FG000|Randomized Phase|Withdrew consent|8|||
16337717|NCT02603107|39721258|FG001|Randomized Phase|Withdrew consent|15|||
16337718|NCT02603107|39721257|FG000|Randomized Phase|Lost to Follow-up|1|||
16102617|NCT00975130|38863242|FG001|Study Part 2|Adverse Event|14|||
16405887|NCT03222973|39966442|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
16405888|NCT03222973|39966443|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
16102618|NCT00975130|38863243|FG002|Study Part 2|Adverse Event|7|||
16337719|NCT02603107|39721258|FG001|Randomized Phase|Lost to Follow-up|3|||
16337720|NCT02603107|39721257|FG000|Randomized Phase|Adverse Event|2|||
16337721|NCT02603107|39721258|FG001|Randomized Phase|Adverse Event|0|||
16337722|NCT02603107|39721257|FG000|Randomized Phase|Death|1|||
16337723|NCT02603107|39721258|FG001|Randomized Phase|Death|1|||
16337724|NCT02603107|39721257|FG000|Randomized Phase|Non-compliance with study drug|1|||
16337725|NCT02603107|39721258|FG001|Randomized Phase|Non-compliance with study drug|1|||
16537041|NCT01662310|40429082|FG002|Run-In or Stabilization Phase|Other|0|||
16537042|NCT01662310|40429083|FG003|Run-In or Stabilization Phase|Other|0|||
16537043|NCT01662310|40429084|FG004|Run-In or Stabilization Phase|Other|0|||
16537044|NCT01662310|40429080|FG000|Double-Blind Phase|Adverse Event|0|||
16537045|NCT01662310|40429081|FG001|Double-Blind Phase|Adverse Event|0|||
16537046|NCT01662310|40429082|FG002|Double-Blind Phase|Adverse Event|1|||
16537047|NCT01662310|40429083|FG003|Double-Blind Phase|Adverse Event|0|||
16537048|NCT01662310|40429084|FG004|Double-Blind Phase|Adverse Event|0|||
16537049|NCT01662310|40429080|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16537050|NCT01662310|40429081|FG001|Double-Blind Phase|Lost to Follow-up|3|||
16537051|NCT01662310|40429082|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16537052|NCT01662310|40429083|FG003|Double-Blind Phase|Lost to Follow-up|0|||
16537053|NCT01662310|40429084|FG004|Double-Blind Phase|Lost to Follow-up|0|||
16537054|NCT01662310|40429080|FG000|Double-Blind Phase|Pregnancy|0|||
16537055|NCT01662310|40429081|FG001|Double-Blind Phase|Pregnancy|2|||
16537056|NCT01662310|40429082|FG002|Double-Blind Phase|Pregnancy|0|||
16537057|NCT01662310|40429083|FG003|Double-Blind Phase|Pregnancy|0|||
16537058|NCT01662310|40429084|FG004|Double-Blind Phase|Pregnancy|0|||
16537059|NCT01662310|40429080|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
16537060|NCT01662310|40429081|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
16537061|NCT01662310|40429082|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
16537062|NCT01662310|40429083|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
16537063|NCT01662310|40429084|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
16537064|NCT01662310|40429080|FG000|Double-Blind Phase|Other|0|||
16537065|NCT01662310|40429081|FG001|Double-Blind Phase|Other|0|||
16537066|NCT01662310|40429082|FG002|Double-Blind Phase|Other|1|||
16537067|NCT01662310|40429083|FG003|Double-Blind Phase|Other|0|||
16537068|NCT01662310|40429084|FG004|Double-Blind Phase|Other|0|||
16537069|NCT01662310|40429080|FG000|Double-Blind Phase|Randomized but not treated|0|||
16537070|NCT01662310|40429081|FG001|Double-Blind Phase|Randomized but not treated|1|||
16537071|NCT01662310|40429082|FG002|Double-Blind Phase|Randomized but not treated|0|||
16537072|NCT01662310|40429083|FG003|Double-Blind Phase|Randomized but not treated|0|||
16537073|NCT01662310|40429084|FG004|Double-Blind Phase|Randomized but not treated|0|||
16537074|NCT01662310|40429080|FG000|Open-Label Extension Phase|Adverse Event|0|||
16537075|NCT01662310|40429081|FG001|Open-Label Extension Phase|Adverse Event|0|||
16537076|NCT01662310|40429082|FG002|Open-Label Extension Phase|Adverse Event|0|||
16537077|NCT01662310|40429083|FG003|Open-Label Extension Phase|Adverse Event|3|||
16537078|NCT01662310|40429084|FG004|Open-Label Extension Phase|Adverse Event|0|||
16537079|NCT01662310|40429080|FG000|Open-Label Extension Phase|Death|0|||
16537080|NCT01662310|40429081|FG001|Open-Label Extension Phase|Death|0|||
16537081|NCT01662310|40429082|FG002|Open-Label Extension Phase|Death|0|||
16537082|NCT01662310|40429083|FG003|Open-Label Extension Phase|Death|1|||
16537083|NCT01662310|40429084|FG004|Open-Label Extension Phase|Death|0|||
16537084|NCT01662310|40429080|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
16537085|NCT01662310|40429081|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
16537086|NCT01662310|40429082|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
16537087|NCT01662310|40429083|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
16537088|NCT01662310|40429084|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
16102619|NCT00975130|38863241|FG000|Study Part 2|Lost to Follow-up|0|||
16102620|NCT00975130|38863242|FG001|Study Part 2|Lost to Follow-up|0|||
16337726|NCT02603107|39721257|FG000|Randomized Phase|Investigator's discretion|0|||
16337727|NCT02603107|39721258|FG001|Randomized Phase|Investigator's discretion|1|||
16337728|NCT02603107|39721257|FG000|Randomized Phase|Lack of Efficacy|1|||
16537089|NCT01662310|40429080|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
16537090|NCT01662310|40429081|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
16537091|NCT01662310|40429082|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
16537092|NCT01662310|40429083|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
16537093|NCT01662310|40429084|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
16537094|NCT01662310|40429080|FG000|Open-Label Extension Phase|Pregnancy|0|||
16537095|NCT01662310|40429081|FG001|Open-Label Extension Phase|Pregnancy|0|||
16537096|NCT01662310|40429082|FG002|Open-Label Extension Phase|Pregnancy|0|||
16537097|NCT01662310|40429083|FG003|Open-Label Extension Phase|Pregnancy|1|||
16537098|NCT01662310|40429084|FG004|Open-Label Extension Phase|Pregnancy|0|||
16537099|NCT01662310|40429080|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
16537100|NCT01662310|40429081|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
16537101|NCT01662310|40429082|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
16537102|NCT01662310|40429083|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
16405889|NCT03222973|39966444|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
16405890|NCT03222973|39966445|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
16405891|NCT03222973|39966442|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
16405892|NCT03222973|39966443|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
16405893|NCT03222973|39966444|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
16337729|NCT02603107|39721258|FG001|Randomized Phase|Lack of Efficacy|0|||
16337730|NCT02603107|39721257|FG000|Randomized Phase|Protocol Violation|1|||
16337731|NCT02603107|39721258|FG001|Randomized Phase|Protocol Violation|0|||
16337732|NCT02603107|39721257|FG000|Optional Extension Phase|Lost to Follow-up|3|||
16337733|NCT02603107|39721258|FG001|Optional Extension Phase|Lost to Follow-up|3|||
16337734|NCT02603107|39721257|FG000|Optional Extension Phase|Withdrew consent|3|||
16337735|NCT02603107|39721258|FG001|Optional Extension Phase|Withdrew consent|2|||
16337736|NCT02603107|39721257|FG000|Optional Extension Phase|Investigator's discretion|2|||
16337737|NCT02603107|39721258|FG001|Optional Extension Phase|Investigator's discretion|2|||
16337738|NCT02603107|39721257|FG000|Optional Extension Phase|Pregnancy|0|||
16337739|NCT02603107|39721258|FG001|Optional Extension Phase|Pregnancy|3|||
16337740|NCT02603107|39721257|FG000|Optional Extension Phase|Adverse Event|0|||
16337741|NCT02603107|39721258|FG001|Optional Extension Phase|Adverse Event|2|||
16337742|NCT02603107|39721257|FG000|Optional Extension Phase|Not treated in extension phase|0|||
16337743|NCT02603107|39721258|FG001|Optional Extension Phase|Not treated in extension phase|1|||
16337744|NCT02603107|39721257|FG000|Optional Extension Phase|Protocol Violation|1|||
16337745|NCT02603107|39721258|FG001|Optional Extension Phase|Protocol Violation|0|||
16337746|NCT00985426|39721260|FG000|Overall Study|Adverse Event|0|||
16337747|NCT00985426|39721261|FG001|Overall Study|Adverse Event|1|||
16337748|NCT00985426|39721260|FG000|Overall Study|Subject Non-Compliance|3|||
16337749|NCT00985426|39721261|FG001|Overall Study|Subject Non-Compliance|3|||
16337750|NCT00985426|39721260|FG000|Overall Study|Withdrawal by Subject|12|||
16337751|NCT00985426|39721261|FG001|Overall Study|Withdrawal by Subject|16|||
16337752|NCT00985426|39721260|FG000|Overall Study|Lost to Follow-up|8|||
16337753|NCT00985426|39721261|FG001|Overall Study|Lost to Follow-up|10|||
16337754|NCT00985426|39721260|FG000|Overall Study|Death|7|||
16337755|NCT00985426|39721261|FG001|Overall Study|Death|3|||
16337756|NCT00985426|39721260|FG000|Overall Study|Protocol Violation|2|||
16337757|NCT00985426|39721261|FG001|Overall Study|Protocol Violation|0|||
16102621|NCT00975130|38863243|FG002|Study Part 2|Lost to Follow-up|1|||
16102622|NCT00975130|38863241|FG000|Study Part 2|Withdrawal by Subject|0|||
16102623|NCT00975130|38863242|FG001|Study Part 2|Withdrawal by Subject|13|||
16102624|NCT00975130|38863243|FG002|Study Part 2|Withdrawal by Subject|5|||
16102625|NCT00975130|38863241|FG000|Study Part 2|Withdrew Consent|0|||
16102626|NCT00975130|38863242|FG001|Study Part 2|Withdrew Consent|6|||
16102627|NCT00975130|38863243|FG002|Study Part 2|Withdrew Consent|2|||
16102628|NCT00975130|38863241|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
16102629|NCT00975130|38863242|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
16337758|NCT00985426|39721260|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
16337759|NCT00985426|39721261|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
16337760|NCT00508157|39721264|FG000|Overall Study|Adverse Event|0|||
16337761|NCT00508157|39721265|FG001|Overall Study|Adverse Event|1|||
16337762|NCT00508157|39721264|FG000|Overall Study|Subject Withdrew Consent|1|||
16337763|NCT00508157|39721265|FG001|Overall Study|Subject Withdrew Consent|0|||
16102630|NCT00975130|38863243|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
16337764|NCT00508157|39721264|FG000|Overall Study|Lost to Follow-up|1|||
16337765|NCT00508157|39721265|FG001|Overall Study|Lost to Follow-up|0|||
16337766|NCT00508157|39721264|FG000|Overall Study|Subject no longer met study criteria|0|||
16337767|NCT00508157|39721265|FG001|Overall Study|Subject no longer met study criteria|1|||
16337768|NCT00508157|39721264|FG000|Overall Study|Other known cause|0|||
16337769|NCT00508157|39721265|FG001|Overall Study|Other known cause|1|||
16337770|NCT00048165|39721266|FG000|Completed 6 Months Study|Administration/Other|8|||
16337771|NCT00048165|39721267|FG001|Completed 6 Months Study|Administration/Other|8|||
16337772|NCT00048165|39721266|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
16337773|NCT00048165|39721267|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
16337774|NCT00048165|39721266|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
16337775|NCT00048165|39721267|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
16337776|NCT00048165|39721266|FG000|Completed 6 Months Study|Death|12|||
16337777|NCT00048165|39721267|FG001|Completed 6 Months Study|Death|6|||
16337778|NCT00048165|39721266|FG000|Completed 6 Months Study|Insufficient therapy|1|||
16337779|NCT00048165|39721267|FG001|Completed 6 Months Study|Insufficient therapy|4|||
16337780|NCT00048165|39721266|FG000|Completed 6 Months Study|Other violation|4|||
16337781|NCT00048165|39721267|FG001|Completed 6 Months Study|Other violation|6|||
16337782|NCT00048165|39721266|FG000|Completed 6 Months Study|Refused treatment|5|||
16337783|NCT00048165|39721267|FG001|Completed 6 Months Study|Refused treatment|5|||
16337784|NCT00048165|39721266|FG000|Completed 6 Months Study|Violation criteria|0|||
16337785|NCT00048165|39721267|FG001|Completed 6 Months Study|Violation criteria|2|||
16337786|NCT00048165|39721266|FG000|Completed 6 Months Study|Did not receive study drug|6|||
16337787|NCT00048165|39721267|FG001|Completed 6 Months Study|Did not receive study drug|6|||
16337788|NCT00048165|39721266|FG000|Completed 12 Months Study|Administration/Other|0|||
16337789|NCT00048165|39721267|FG001|Completed 12 Months Study|Administration/Other|2|||
16337790|NCT00048165|39721266|FG000|Completed 12 Months Study|Death|2|||
16337791|NCT00048165|39721267|FG001|Completed 12 Months Study|Death|1|||
16337792|NCT00048165|39721266|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
16337793|NCT00048165|39721267|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
16337794|NCT00195494|39721268|FG000|Year 1|Adverse Event|0|||
16337795|NCT00195494|39721269|FG001|Year 1|Adverse Event|0|||
16337796|NCT00195494|39721270|FG002|Year 1|Adverse Event|0|||
16337797|NCT00195494|39721271|FG003|Year 1|Adverse Event|0|||
16337798|NCT00195494|39721272|FG004|Year 1|Adverse Event|34|||
16337799|NCT00195494|39721273|FG005|Year 1|Adverse Event|27|||
16337800|NCT00195494|39721268|FG000|Year 1|System Toxicity|0|||
16337801|NCT00195494|39721269|FG001|Year 1|System Toxicity|0|||
16337802|NCT00195494|39721270|FG002|Year 1|System Toxicity|0|||
16337803|NCT00195494|39721271|FG003|Year 1|System Toxicity|0|||
16337804|NCT00195494|39721272|FG004|Year 1|System Toxicity|0|||
16337805|NCT00195494|39721273|FG005|Year 1|System Toxicity|1|||
16337806|NCT00195494|39721268|FG000|Year 1|Lack of Efficacy|0|||
16337807|NCT00195494|39721269|FG001|Year 1|Lack of Efficacy|0|||
16337808|NCT00195494|39721270|FG002|Year 1|Lack of Efficacy|0|||
16337809|NCT00195494|39721271|FG003|Year 1|Lack of Efficacy|0|||
16337810|NCT00195494|39721272|FG004|Year 1|Lack of Efficacy|24|||
16337811|NCT00195494|39721273|FG005|Year 1|Lack of Efficacy|9|||
16337812|NCT00195494|39721268|FG000|Year 1|Compliance|0|||
16337813|NCT00195494|39721269|FG001|Year 1|Compliance|0|||
16337814|NCT00195494|39721270|FG002|Year 1|Compliance|0|||
16337815|NCT00195494|39721271|FG003|Year 1|Compliance|0|||
16337816|NCT00195494|39721272|FG004|Year 1|Compliance|5|||
16337817|NCT00195494|39721273|FG005|Year 1|Compliance|1|||
16337818|NCT00195494|39721268|FG000|Year 1|Lost to Follow-up|0|||
16337819|NCT00195494|39721269|FG001|Year 1|Lost to Follow-up|0|||
16337820|NCT00195494|39721270|FG002|Year 1|Lost to Follow-up|0|||
16337821|NCT00195494|39721271|FG003|Year 1|Lost to Follow-up|0|||
16337822|NCT00195494|39721272|FG004|Year 1|Lost to Follow-up|1|||
16337823|NCT00195494|39721273|FG005|Year 1|Lost to Follow-up|0|||
16337824|NCT00195494|39721268|FG000|Year 1|Missed >4 consecutive doses|0|||
16337825|NCT00195494|39721269|FG001|Year 1|Missed >4 consecutive doses|0|||
16337826|NCT00195494|39721270|FG002|Year 1|Missed >4 consecutive doses|0|||
16337827|NCT00195494|39721271|FG003|Year 1|Missed >4 consecutive doses|0|||
16337828|NCT00195494|39721272|FG004|Year 1|Missed >4 consecutive doses|3|||
16337829|NCT00195494|39721273|FG005|Year 1|Missed >4 consecutive doses|2|||
16337830|NCT00195494|39721268|FG000|Year 1|Protocol deviation|0|||
16337831|NCT00195494|39721269|FG001|Year 1|Protocol deviation|0|||
16337832|NCT00195494|39721270|FG002|Year 1|Protocol deviation|0|||
16337833|NCT00195494|39721271|FG003|Year 1|Protocol deviation|0|||
16337834|NCT00195494|39721272|FG004|Year 1|Protocol deviation|2|||
16337835|NCT00195494|39721273|FG005|Year 1|Protocol deviation|3|||
16337836|NCT00195494|39721268|FG000|Year 1|Physician Decision|0|||
16337837|NCT00195494|39721269|FG001|Year 1|Physician Decision|0|||
16405894|NCT03222973|39966445|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
16337838|NCT00195494|39721270|FG002|Year 1|Physician Decision|0|||
16405895|NCT03222973|39966442|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
16337839|NCT00195494|39721271|FG003|Year 1|Physician Decision|0|||
16337840|NCT00195494|39721272|FG004|Year 1|Physician Decision|1|||
16337841|NCT00195494|39721273|FG005|Year 1|Physician Decision|0|||
16337842|NCT00195494|39721268|FG000|Year 1|Withdrawal by Subject|0|||
16337843|NCT00195494|39721269|FG001|Year 1|Withdrawal by Subject|0|||
16337844|NCT00195494|39721270|FG002|Year 1|Withdrawal by Subject|0|||
16337845|NCT00195494|39721271|FG003|Year 1|Withdrawal by Subject|0|||
16337846|NCT00195494|39721272|FG004|Year 1|Withdrawal by Subject|8|||
16337847|NCT00195494|39721273|FG005|Year 1|Withdrawal by Subject|9|||
16337848|NCT00195494|39721268|FG000|Year 1|Protocol Violation|0|||
16337849|NCT00195494|39721269|FG001|Year 1|Protocol Violation|0|||
16337850|NCT00195494|39721270|FG002|Year 1|Protocol Violation|0|||
16337851|NCT00195494|39721271|FG003|Year 1|Protocol Violation|0|||
16337852|NCT00195494|39721272|FG004|Year 1|Protocol Violation|1|||
16337853|NCT00195494|39721273|FG005|Year 1|Protocol Violation|1|||
16337854|NCT00195494|39721268|FG000|Year 2|Adverse Event|3|||
16337855|NCT00195494|39721269|FG001|Year 2|Adverse Event|7|||
16337856|NCT00195494|39721270|FG002|Year 2|Adverse Event|5|||
16337857|NCT00195494|39721271|FG003|Year 2|Adverse Event|9|||
16337858|NCT00195494|39721272|FG004|Year 2|Adverse Event|0|||
16337859|NCT00195494|39721273|FG005|Year 2|Adverse Event|0|||
16337860|NCT00195494|39721268|FG000|Year 2|Lack of Efficacy|0|||
16337861|NCT00195494|39721269|FG001|Year 2|Lack of Efficacy|1|||
16337862|NCT00195494|39721270|FG002|Year 2|Lack of Efficacy|7|||
16337863|NCT00195494|39721271|FG003|Year 2|Lack of Efficacy|7|||
16337864|NCT00195494|39721272|FG004|Year 2|Lack of Efficacy|0|||
16337865|NCT00195494|39721273|FG005|Year 2|Lack of Efficacy|0|||
16337866|NCT00195494|39721268|FG000|Year 2|Compliance|1|||
16337867|NCT00195494|39721269|FG001|Year 2|Compliance|0|||
16337868|NCT00195494|39721270|FG002|Year 2|Compliance|0|||
16337869|NCT00195494|39721271|FG003|Year 2|Compliance|2|||
16337870|NCT00195494|39721272|FG004|Year 2|Compliance|0|||
16337871|NCT00195494|39721273|FG005|Year 2|Compliance|0|||
16337872|NCT00195494|39721268|FG000|Year 2|Lost to Follow-up|0|||
16337873|NCT00195494|39721269|FG001|Year 2|Lost to Follow-up|0|||
16337874|NCT00195494|39721270|FG002|Year 2|Lost to Follow-up|1|||
16337875|NCT00195494|39721271|FG003|Year 2|Lost to Follow-up|1|||
16337876|NCT00195494|39721272|FG004|Year 2|Lost to Follow-up|0|||
16337877|NCT00195494|39721273|FG005|Year 2|Lost to Follow-up|0|||
16337878|NCT00195494|39721268|FG000|Year 2|Missed >4 consecutive doses|1|||
16337879|NCT00195494|39721269|FG001|Year 2|Missed >4 consecutive doses|1|||
16337880|NCT00195494|39721270|FG002|Year 2|Missed >4 consecutive doses|1|||
16337881|NCT00195494|39721271|FG003|Year 2|Missed >4 consecutive doses|0|||
16337882|NCT00195494|39721272|FG004|Year 2|Missed >4 consecutive doses|0|||
16337883|NCT00195494|39721273|FG005|Year 2|Missed >4 consecutive doses|0|||
16337884|NCT00195494|39721268|FG000|Year 2|Protocol deviation|0|||
16337885|NCT00195494|39721269|FG001|Year 2|Protocol deviation|1|||
16337886|NCT00195494|39721270|FG002|Year 2|Protocol deviation|0|||
16337887|NCT00195494|39721271|FG003|Year 2|Protocol deviation|0|||
16337888|NCT00195494|39721272|FG004|Year 2|Protocol deviation|0|||
16337889|NCT00195494|39721273|FG005|Year 2|Protocol deviation|0|||
16337890|NCT00195494|39721268|FG000|Year 2|Physician Decision|1|||
16337891|NCT00195494|39721269|FG001|Year 2|Physician Decision|1|||
16337892|NCT00195494|39721270|FG002|Year 2|Physician Decision|0|||
16337893|NCT00195494|39721271|FG003|Year 2|Physician Decision|0|||
16337894|NCT00195494|39721272|FG004|Year 2|Physician Decision|0|||
16337895|NCT00195494|39721273|FG005|Year 2|Physician Decision|0|||
16337896|NCT00195494|39721268|FG000|Year 2|Withdrawal by Subject|1|||
16337897|NCT00195494|39721269|FG001|Year 2|Withdrawal by Subject|5|||
16337898|NCT00195494|39721270|FG002|Year 2|Withdrawal by Subject|4|||
16337899|NCT00195494|39721271|FG003|Year 2|Withdrawal by Subject|3|||
16337900|NCT00195494|39721272|FG004|Year 2|Withdrawal by Subject|0|||
16337901|NCT00195494|39721273|FG005|Year 2|Withdrawal by Subject|0|||
16337902|NCT00195494|39721268|FG000|Year 2|System toxicity|0|||
16337903|NCT00195494|39721269|FG001|Year 2|System toxicity|0|||
16337904|NCT00195494|39721270|FG002|Year 2|System toxicity|0|||
16337905|NCT00195494|39721271|FG003|Year 2|System toxicity|1|||
16337906|NCT00195494|39721272|FG004|Year 2|System toxicity|0|||
16337907|NCT00195494|39721273|FG005|Year 2|System toxicity|0|||
16337908|NCT02007278|39721276|FG000|Overall Study|Failure to comply with an eligibility|0|||
16337909|NCT02007278|39721277|FG001|Overall Study|Failure to comply with an eligibility|1|||
16337910|NCT02007278|39721276|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
16337911|NCT02007278|39721277|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
16337912|NCT02007278|39721276|FG000|Overall Study|Incorrect medication administration|1|||
16337913|NCT02007278|39721277|FG001|Overall Study|Incorrect medication administration|0|||
16337914|NCT02007278|39721276|FG000|Overall Study|Mis-randomization|1|||
16337915|NCT02007278|39721277|FG001|Overall Study|Mis-randomization|1|||
16337916|NCT00481767|39721278|FG000|Overall Study|Withdrawal by Subject|16|||
16337917|NCT00481767|39721279|FG001|Overall Study|Withdrawal by Subject|11|||
16337918|NCT00481767|39721278|FG000|Overall Study|Lost to Follow-up|16|||
16337919|NCT00481767|39721279|FG001|Overall Study|Lost to Follow-up|10|||
16337920|NCT01254721|39721281|FG000|Overall Study|Lost to Follow-up|0|||
16337921|NCT01254721|39721282|FG001|Overall Study|Lost to Follow-up|4|||
16337922|NCT01254721|39721281|FG000|Overall Study|Lack of Efficacy|4|||
16337923|NCT01254721|39721282|FG001|Overall Study|Lack of Efficacy|2|||
16337924|NCT01254721|39721281|FG000|Overall Study|Death|0|||
16337925|NCT01254721|39721282|FG001|Overall Study|Death|1|||
16337926|NCT01254721|39721281|FG000|Overall Study|technical problum|1|||
16337927|NCT01254721|39721282|FG001|Overall Study|technical problum|0|||
16337928|NCT01254721|39721281|FG000|Overall Study|Adverse Event|2|||
16337929|NCT01254721|39721282|FG001|Overall Study|Adverse Event|3|||
16337930|NCT01254721|39721281|FG000|Overall Study|Withdrawal by Subject|8|||
16337931|NCT01254721|39721282|FG001|Overall Study|Withdrawal by Subject|11|||
16337932|NCT01254721|39721281|FG000|Overall Study|Wrongly randomization|0|||
16337933|NCT01254721|39721282|FG001|Overall Study|Wrongly randomization|1|||
16337934|NCT01313221|39725965|FG000|Overall Study|Protocol Violation|0|||
16337935|NCT01313221|39725966|FG001|Overall Study|Protocol Violation|1|||
16405896|NCT03222973|39966443|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
16405897|NCT03222973|39966444|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
16405898|NCT03222973|39966445|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
16405899|NCT03222973|39966442|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
16405900|NCT03222973|39966443|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
16405901|NCT03222973|39966444|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
16537103|NCT01662310|40429084|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
16337936|NCT01313221|39725967|FG002|Overall Study|Protocol Violation|1|||
16337937|NCT01313221|39725965|FG000|Overall Study|Non-compliance|3|||
16337938|NCT01313221|39725966|FG001|Overall Study|Non-compliance|0|||
16337939|NCT01313221|39725967|FG002|Overall Study|Non-compliance|2|||
16337940|NCT01313221|39725965|FG000|Overall Study|Withdrawal by Subject|2|||
16337941|NCT01313221|39725966|FG001|Overall Study|Withdrawal by Subject|3|||
16337942|NCT01313221|39725967|FG002|Overall Study|Withdrawal by Subject|5|||
16337943|NCT01313221|39725965|FG000|Overall Study|Requirement for alternative therapy|0|||
16337944|NCT01313221|39725966|FG001|Overall Study|Requirement for alternative therapy|1|||
16337945|NCT01313221|39725967|FG002|Overall Study|Requirement for alternative therapy|1|||
16337946|NCT01313221|39725965|FG000|Overall Study|Lost to Follow-up|6|||
16337947|NCT01313221|39725966|FG001|Overall Study|Lost to Follow-up|3|||
16337948|NCT01313221|39725967|FG002|Overall Study|Lost to Follow-up|1|||
16337949|NCT01313221|39725965|FG000|Overall Study|Other|1|||
16337950|NCT01313221|39725966|FG001|Overall Study|Other|0|||
16337951|NCT01313221|39725967|FG002|Overall Study|Other|0|||
16337952|NCT01313221|39725965|FG000|Overall Study|Adverse Event|0|||
16337953|NCT01313221|39725966|FG001|Overall Study|Adverse Event|0|||
16337954|NCT01313221|39725967|FG002|Overall Study|Adverse Event|7|||
16337955|NCT01313221|39725965|FG000|Overall Study|Disease progression|0|||
16337956|NCT01313221|39725966|FG001|Overall Study|Disease progression|0|||
16337957|NCT01313221|39725967|FG002|Overall Study|Disease progression|2|||
16337958|NCT01313221|39725965|FG000|Overall Study|Physician Decision|0|||
16337959|NCT01313221|39725966|FG001|Overall Study|Physician Decision|0|||
16337960|NCT01313221|39725967|FG002|Overall Study|Physician Decision|2|||
16337961|NCT01313221|39725965|FG000|Overall Study|Pregnancy|0|||
16337962|NCT01313221|39725966|FG001|Overall Study|Pregnancy|0|||
16337963|NCT01313221|39725967|FG002|Overall Study|Pregnancy|2|||
16337964|NCT03883477|39725968|FG000|Overall Study|Death|1|||
16337965|NCT03883477|39725969|FG001|Overall Study|Death|0|||
16337966|NCT03883477|39725968|FG000|Overall Study|Protocol Violation|0|||
16337967|NCT03883477|39725969|FG001|Overall Study|Protocol Violation|1|||
16337968|NCT01698268|39725970|FG000|Overall Study|Physician Decision|2|||
16337969|NCT01698268|39725971|FG001|Overall Study|Physician Decision|1|||
16337970|NCT01969058|39725972|FG000|Overall Study|Withdrawal by Subject|2|||
16337971|NCT01969058|39725973|FG001|Overall Study|Withdrawal by Subject|0|||
16337972|NCT01969058|39725972|FG000|Overall Study|Adverse Event|1|||
16337973|NCT01969058|39725973|FG001|Overall Study|Adverse Event|0|||
16337974|NCT03084315|39725974|FG000|Overall Study|Lost to Follow-up|8|||
16337975|NCT03084315|39725975|FG001|Overall Study|Lost to Follow-up|7|||
16337976|NCT03084315|39725974|FG000|Overall Study|Withdrawal by Subject|2|||
16337977|NCT03084315|39725975|FG001|Overall Study|Withdrawal by Subject|2|||
16337978|NCT01863732|39725980|FG000|Overall Study|Adverse Event|2|||
16337979|NCT01863732|39725981|FG001|Overall Study|Adverse Event|0|||
16337980|NCT01863732|39725982|FG002|Overall Study|Adverse Event|3|||
16337981|NCT01863732|39725983|FG003|Overall Study|Adverse Event|3|||
16337982|NCT01863732|39725980|FG000|Overall Study|Lack of Efficacy|1|||
16337983|NCT01863732|39725981|FG001|Overall Study|Lack of Efficacy|0|||
16337984|NCT01863732|39725982|FG002|Overall Study|Lack of Efficacy|2|||
16337985|NCT01863732|39725983|FG003|Overall Study|Lack of Efficacy|1|||
16337986|NCT01863732|39725980|FG000|Overall Study|Lost to Follow-up|2|||
16337987|NCT01863732|39725981|FG001|Overall Study|Lost to Follow-up|2|||
16337988|NCT01863732|39725982|FG002|Overall Study|Lost to Follow-up|1|||
16537104|NCT02089230|40429085|FG000|Overall Study|Death|0|||
16337989|NCT01863732|39725983|FG003|Overall Study|Lost to Follow-up|1|||
16337990|NCT01863732|39725980|FG000|Overall Study|Physician Decision|1|||
16337991|NCT01863732|39725981|FG001|Overall Study|Physician Decision|0|||
16337992|NCT01863732|39725982|FG002|Overall Study|Physician Decision|1|||
16337993|NCT01863732|39725983|FG003|Overall Study|Physician Decision|0|||
16337994|NCT01863732|39725980|FG000|Overall Study|Pregnancy|0|||
16337995|NCT01863732|39725981|FG001|Overall Study|Pregnancy|0|||
16337996|NCT01863732|39725982|FG002|Overall Study|Pregnancy|0|||
16337997|NCT01863732|39725983|FG003|Overall Study|Pregnancy|1|||
16337998|NCT01863732|39725980|FG000|Overall Study|Technical problems|0|||
16337999|NCT01863732|39725981|FG001|Overall Study|Technical problems|1|||
16338000|NCT01863732|39725982|FG002|Overall Study|Technical problems|1|||
16338001|NCT01863732|39725983|FG003|Overall Study|Technical problems|0|||
16338002|NCT01863732|39725980|FG000|Overall Study|Subject/guardian decision|6|||
16338003|NCT01863732|39725981|FG001|Overall Study|Subject/guardian decision|9|||
16338004|NCT01863732|39725982|FG002|Overall Study|Subject/guardian decision|3|||
16338005|NCT01863732|39725983|FG003|Overall Study|Subject/guardian decision|1|||
16338006|NCT01863732|39725980|FG000|Overall Study|Death|1|||
16405902|NCT03222973|39966445|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
16405903|NCT02310230|39966451|FG000|Overall Study|Physician Decision|1|||
16405904|NCT02310230|39966452|FG001|Overall Study|Physician Decision|3|||
16405905|NCT02310230|39966451|FG000|Overall Study|monitor baseline taken after induction|2|||
16405906|NCT02310230|39966452|FG001|Overall Study|monitor baseline taken after induction|7|||
16405907|NCT02310230|39966451|FG000|Overall Study|Poor signal quality|5|||
16405908|NCT02310230|39966452|FG001|Overall Study|Poor signal quality|8|||
16405909|NCT02310230|39966451|FG000|Overall Study|Case cancelled|1|||
16405910|NCT02310230|39966452|FG001|Overall Study|Case cancelled|0|||
16405911|NCT03263923|39966453|FG000|Overall Study|Withdrawal by Subject|10|||
16405912|NCT03263923|39966454|FG001|Overall Study|Withdrawal by Subject|8|||
16405913|NCT03263923|39966453|FG000|Overall Study|Lost to Follow-up|15|||
16405914|NCT03263923|39966454|FG001|Overall Study|Lost to Follow-up|13|||
16405915|NCT02186652|39966456|FG000|Overall Study|Lost to Follow-up|2|||
16405916|NCT02186652|39966457|FG001|Overall Study|Lost to Follow-up|0|||
16405917|NCT02220855|39966458|FG000|Overall Study|Adverse Event|8|||
16405918|NCT02220855|39966458|FG000|Overall Study|Disease Progression|5|||
16338007|NCT01863732|39725981|FG001|Overall Study|Death|0|||
16338008|NCT01863732|39725982|FG002|Overall Study|Death|0|||
16338009|NCT01863732|39725983|FG003|Overall Study|Death|1|||
16338010|NCT01210222|39725984|FG000|Overall Study|Ineligible|2|||
16338011|NCT01210222|39725984|FG000|Overall Study|Never treated|1|||
16338012|NCT02208050|39725985|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
16338013|NCT02208050|39725986|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
16338014|NCT00359294|39725991|FG000|Overall Study|Progressive disease|1|||
16338015|NCT00359294|39725992|FG001|Overall Study|Progressive disease|1|||
16338016|NCT00359294|39725993|FG002|Overall Study|Progressive disease|2|||
16405919|NCT02220855|39966458|FG000|Overall Study|Withdrawal by Subject|1|||
16405920|NCT01187446|39966459|FG000|Overall Study|Patient started non-protocol therapy|0|||
16405921|NCT01187446|39966460|FG001|Overall Study|Patient started non-protocol therapy|1|||
16338017|NCT00359294|39725994|FG003|Overall Study|Progressive disease|3|||
16338018|NCT00359294|39725995|FG004|Overall Study|Progressive disease|2|||
16338019|NCT00359294|39725991|FG000|Overall Study|Withdrawal by Subject|0|||
16338020|NCT00359294|39725992|FG001|Overall Study|Withdrawal by Subject|0|||
16338021|NCT00359294|39725993|FG002|Overall Study|Withdrawal by Subject|0|||
16405922|NCT02649218|39966461|FG000|Overall Study|Adverse Event|8|||
16405923|NCT02649218|39966461|FG000|Overall Study|Lack of Efficacy|8|||
16405924|NCT02649218|39966461|FG000|Overall Study|Pregnancy|3|||
16405925|NCT02649218|39966461|FG000|Overall Study|Protocol Violation|3|||
16405926|NCT02649218|39966461|FG000|Overall Study|Physician Decision|1|||
16405927|NCT02649218|39966461|FG000|Overall Study|Withdrawal by Subject|2|||
16405928|NCT02233738|39966464|FG000|Overall Study|Lost to Follow-up|5|||
16405929|NCT02233738|39966465|FG001|Overall Study|Lost to Follow-up|12|||
16405930|NCT02233738|39966464|FG000|Overall Study|Death|0|||
16405931|NCT02233738|39966465|FG001|Overall Study|Death|1|||
16405932|NCT02233738|39966464|FG000|Overall Study|Withdrawal by Subject|0|||
16405933|NCT02233738|39966465|FG001|Overall Study|Withdrawal by Subject|1|||
16405934|NCT02233738|39966464|FG000|Overall Study|Did not return after Baseline|3|||
16405935|NCT02233738|39966465|FG001|Overall Study|Did not return after Baseline|2|||
16405936|NCT00693017|39966466|FG000|Overall Study|Sponsor Decision|2|||
16405937|NCT00693017|39966467|FG001|Overall Study|Sponsor Decision|1|||
16405938|NCT00693017|39966466|FG000|Overall Study|Death|0|||
16216849|NCT02442765|39272509|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
16338022|NCT00359294|39725994|FG003|Overall Study|Withdrawal by Subject|0|||
16338023|NCT00359294|39725995|FG004|Overall Study|Withdrawal by Subject|1|||
16338024|NCT00359294|39725991|FG000|Overall Study|Not treated|0|||
16338025|NCT00359294|39725992|FG001|Overall Study|Not treated|0|||
16338026|NCT00359294|39725993|FG002|Overall Study|Not treated|0|||
16338027|NCT00359294|39725994|FG003|Overall Study|Not treated|1|||
16338028|NCT00359294|39725995|FG004|Overall Study|Not treated|0|||
16338029|NCT00359294|39725991|FG000|Overall Study|Physician Decision|0|||
16338030|NCT00359294|39725992|FG001|Overall Study|Physician Decision|0|||
16338031|NCT00359294|39725993|FG002|Overall Study|Physician Decision|1|||
16338032|NCT00359294|39725994|FG003|Overall Study|Physician Decision|0|||
16338033|NCT00359294|39725995|FG004|Overall Study|Physician Decision|0|||
16338034|NCT00350779|39725998|FG000|Overall Study|Adverse Event|4|||
16338035|NCT00350779|39725999|FG001|Overall Study|Adverse Event|2|||
16338036|NCT00350779|39725998|FG000|Overall Study|Lack of Efficacy|0|||
16338037|NCT00350779|39725999|FG001|Overall Study|Lack of Efficacy|4|||
16338038|NCT00350779|39725998|FG000|Overall Study|Lost to Follow-up|2|||
16338039|NCT00350779|39725999|FG001|Overall Study|Lost to Follow-up|0|||
16338040|NCT00350779|39725998|FG000|Overall Study|Physician Decision|2|||
16338041|NCT00350779|39725999|FG001|Overall Study|Physician Decision|4|||
16338042|NCT00350779|39725998|FG000|Overall Study|Protocol Violation|3|||
16338043|NCT00350779|39725999|FG001|Overall Study|Protocol Violation|1|||
16338044|NCT00350779|39725998|FG000|Overall Study|Withdrawal by Subject|9|||
16338045|NCT00350779|39725999|FG001|Overall Study|Withdrawal by Subject|8|||
16338046|NCT00350779|39725998|FG000|Overall Study|Patient Moved|2|||
16338047|NCT00350779|39725999|FG001|Overall Study|Patient Moved|1|||
16338048|NCT00350779|39725998|FG000|Overall Study|Non-compliance with study procedures|0|||
16405939|NCT00693017|39966467|FG001|Overall Study|Death|1|||
16405940|NCT00523705|39966468|FG000|Overall Study|No time for study.|0|||
16216850|NCT02442765|39272510|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
16338049|NCT00350779|39725999|FG001|Overall Study|Non-compliance with study procedures|1|||
16338050|NCT04710368|39726006|FG000|Overall Study|Withdrawal by Subject|9|||
16338051|NCT04710368|39726006|FG000|Overall Study|Lost to Follow-up|4|||
16338052|NCT04710368|39726006|FG000|Overall Study|Death|2|||
16338053|NCT04710368|39726006|FG000|Overall Study|Patient preference|11|||
16405941|NCT00523705|39966469|FG001|Overall Study|No time for study.|1|||
16405942|NCT01559259|39966470|FG000|Overall Study|Withdrawal by Subject|0|||
16405943|NCT01559259|39966471|FG001|Overall Study|Withdrawal by Subject|0|||
16405944|NCT01559259|39966472|FG002|Overall Study|Withdrawal by Subject|0|||
16405945|NCT01559259|39966473|FG003|Overall Study|Withdrawal by Subject|1|||
16405946|NCT01559259|39966474|FG004|Overall Study|Withdrawal by Subject|0|||
16405947|NCT01559259|39966470|FG000|Overall Study|Adverse Event|0|||
16405948|NCT01559259|39966471|FG001|Overall Study|Adverse Event|1|||
16405949|NCT01559259|39966472|FG002|Overall Study|Adverse Event|1|||
16405950|NCT01559259|39966473|FG003|Overall Study|Adverse Event|0|||
16405951|NCT01559259|39966474|FG004|Overall Study|Adverse Event|0|||
16405952|NCT02928029|39966494|FG000|Overall Study|Withdrawal by Subject|0|||
16405953|NCT02928029|39966495|FG001|Overall Study|Withdrawal by Subject|1|||
16405954|NCT02928029|39966494|FG000|Overall Study|Radiological progression|1|||
16405955|NCT02928029|39966495|FG001|Overall Study|Radiological progression|0|||
16405956|NCT02928029|39966494|FG000|Overall Study|Clinical progression|1|||
16405957|NCT02928029|39966495|FG001|Overall Study|Clinical progression|2|||
16405958|NCT02928029|39966494|FG000|Overall Study|AE not related to clinical progression|1|||
16405959|NCT02928029|39966495|FG001|Overall Study|AE not related to clinical progression|1|||
16405960|NCT03746600|39966496|FG000|Overall Study|Withdrawal by Subject|3|||
16405961|NCT03746600|39966497|FG001|Overall Study|Withdrawal by Subject|3|||
16405962|NCT03746600|39966496|FG000|Overall Study|dismissed from study|1|||
16405963|NCT03746600|39966497|FG001|Overall Study|dismissed from study|0|||
16405964|NCT03746600|39966496|FG000|Overall Study|Lost to Follow-up|1|||
16405965|NCT03746600|39966497|FG001|Overall Study|Lost to Follow-up|0|||
16405966|NCT00230282|39966499|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
16405967|NCT00230282|39966499|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
16405968|NCT00230282|39966499|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
16405969|NCT00230282|39966499|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
16405970|NCT01080768|39966500|FG000|Overall Study|Protocol Deviation|2|||
16405971|NCT01080768|39966501|FG001|Overall Study|Protocol Deviation|1|||
16405972|NCT02969590|39966502|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
16405973|NCT02969590|39966503|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
16405974|NCT02969590|39966504|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
16405975|NCT00758264|39966505|FG000|Active Phase|Withdrawal by Subject|0|||
16405976|NCT00758264|39966506|FG001|Active Phase|Withdrawal by Subject|0|||
16405977|NCT00758264|39966507|FG002|Active Phase|Withdrawal by Subject|1|||
16405978|NCT00758264|39966505|FG000|Active Phase|Lost to Follow-up|1|||
16405979|NCT00758264|39966506|FG001|Active Phase|Lost to Follow-up|0|||
16405980|NCT00758264|39966507|FG002|Active Phase|Lost to Follow-up|0|||
16405981|NCT00758264|39966505|FG000|Active Phase|Other|0|||
16405982|NCT00758264|39966506|FG001|Active Phase|Other|0|||
16405983|NCT00758264|39966507|FG002|Active Phase|Other|4|||
16405984|NCT03946124|39966518|FG000|Overall Study|Withdrawal by Subject|19|||
16405985|NCT01874275|39966519|FG000|Overall Study|Lost to Follow-up|1|||
16405986|NCT01874275|39966520|FG001|Overall Study|Lost to Follow-up|0|||
16405987|NCT01596335|39966521|FG000|Overall Study|exacerbation of primary disease|5|||
16405988|NCT01596335|39966522|FG001|Overall Study|exacerbation of primary disease|9|||
16405989|NCT02098369|39966523|FG000|Overall Study|Withdrawal by Subject|1|||
16405990|NCT02098369|39966524|FG001|Overall Study|Withdrawal by Subject|5|||
16405991|NCT02098369|39966525|FG002|Overall Study|Withdrawal by Subject|0|||
16405992|NCT02098369|39966523|FG000|Overall Study|Lost to Follow-up|5|||
16405993|NCT02098369|39966524|FG001|Overall Study|Lost to Follow-up|1|||
16405994|NCT02098369|39966525|FG002|Overall Study|Lost to Follow-up|3|||
16405995|NCT02098369|39966523|FG000|Overall Study|Death|1|||
16405996|NCT02098369|39966524|FG001|Overall Study|Death|1|||
16405997|NCT02098369|39966525|FG002|Overall Study|Death|1|||
16405998|NCT02098369|39966523|FG000|Overall Study|Other|0|||
16405999|NCT02098369|39966524|FG001|Overall Study|Other|2|||
16406000|NCT02098369|39966525|FG002|Overall Study|Other|1|||
16406001|NCT00931723|39966527|FG000|Overall Study|Withdrawal by Subject|11|||
16406002|NCT00931723|39966528|FG001|Overall Study|Withdrawal by Subject|13|||
16406003|NCT00931723|39966527|FG000|Overall Study|Adverse Event|6|||
16406004|NCT00931723|39966528|FG001|Overall Study|Adverse Event|13|||
16406005|NCT00931723|39966527|FG000|Overall Study|Lithium found in blood|0|||
16406006|NCT00931723|39966528|FG001|Overall Study|Lithium found in blood|1|||
16406007|NCT00931723|39966527|FG000|Overall Study|Condition under investigation worsened|1|||
16406008|NCT00931723|39966528|FG001|Overall Study|Condition under investigation worsened|2|||
16406009|NCT00931723|39966527|FG000|Overall Study|Lost to Follow-up|1|||
16406010|NCT00931723|39966528|FG001|Overall Study|Lost to Follow-up|2|||
16406011|NCT00931723|39966527|FG000|Overall Study|Study-specific discontinuation criteria|1|||
16537105|NCT02089230|40429086|FG001|Overall Study|Death|0|||
16537106|NCT02089230|40429087|FG002|Overall Study|Death|2|||
16537107|NCT02089230|40429085|FG000|Overall Study|Seeking Alternative Therapy|0|||
16537108|NCT02089230|40429086|FG001|Overall Study|Seeking Alternative Therapy|0|||
16537109|NCT02089230|40429087|FG002|Overall Study|Seeking Alternative Therapy|4|||
16537110|NCT00689221|40429098|FG000|Overall Study|Ongoing at cut-off date|39|||
16537111|NCT00689221|40429099|FG001|Overall Study|Ongoing at cut-off date|36|||
16338054|NCT04710368|39726006|FG000|Overall Study|Treatment discontinuation|1|||
16338055|NCT01915771|39726009|FG000|Day 1|Withdrawal by Subject|1|||
16338056|NCT01915771|39726009|FG000|Day 15|Withdrawal by Subject|1|||
16338057|NCT03275389|39726010|FG000|Overall Study|Lost to Follow-up|10|||
16338058|NCT03275389|39726011|FG001|Overall Study|Lost to Follow-up|10|||
16338059|NCT03275389|39726012|FG002|Overall Study|Lost to Follow-up|19|||
16338060|NCT03275389|39726013|FG003|Overall Study|Lost to Follow-up|12|||
16338061|NCT03275389|39726014|FG004|Overall Study|Lost to Follow-up|11|||
16406012|NCT00931723|39966528|FG001|Overall Study|Study-specific discontinuation criteria|1|||
16406013|NCT00931723|39966527|FG000|Overall Study|Severe non-compliance to protocol|2|||
16406014|NCT00931723|39966528|FG001|Overall Study|Severe non-compliance to protocol|0|||
16406015|NCT00931723|39966527|FG000|Overall Study|Safety reasons|0|||
16406016|NCT00931723|39966528|FG001|Overall Study|Safety reasons|1|||
16406017|NCT00931723|39966527|FG000|Overall Study|Took prohibited concomitant medication|0|||
16406018|NCT00931723|39966528|FG001|Overall Study|Took prohibited concomitant medication|1|||
16406019|NCT00931723|39966527|FG000|Overall Study|Lack or insufficient theraputic response|2|||
16406020|NCT00931723|39966528|FG001|Overall Study|Lack or insufficient theraputic response|5|||
16406021|NCT00931723|39966527|FG000|Overall Study|Sponsor decision|1|||
16406022|NCT00931723|39966528|FG001|Overall Study|Sponsor decision|0|||
16406023|NCT00931723|39966527|FG000|Overall Study|Late hospital discharge|1|||
16406024|NCT00931723|39966528|FG001|Overall Study|Late hospital discharge|0|||
16406025|NCT02891681|39966529|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
16406026|NCT02891681|39966530|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
16406027|NCT02891681|39966531|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
16406028|NCT02891681|39966529|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
16406029|NCT02891681|39966530|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
16406030|NCT02891681|39966531|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
16406031|NCT02891681|39966529|FG000|Overall Study|Taken off study after first imaging appointment|1|||
16406032|NCT02891681|39966530|FG001|Overall Study|Taken off study after first imaging appointment|0|||
16406033|NCT02891681|39966531|FG002|Overall Study|Taken off study after first imaging appointment|0|||
16406034|NCT03298984|39966532|FG000|Overall Study|Physician Decision|1|||
16406035|NCT03298984|39966533|FG001|Overall Study|Physician Decision|0|||
16406036|NCT03298984|39966534|FG002|Overall Study|Physician Decision|0|||
16406037|NCT03298984|39966535|FG003|Overall Study|Physician Decision|6|||
16406038|NCT03298984|39966532|FG000|Overall Study|Lack of Efficacy|0|||
16406039|NCT03298984|39966533|FG001|Overall Study|Lack of Efficacy|1|||
16406040|NCT03298984|39966534|FG002|Overall Study|Lack of Efficacy|1|||
16406041|NCT03298984|39966535|FG003|Overall Study|Lack of Efficacy|4|||
16406042|NCT03298984|39966532|FG000|Overall Study|Relapsed disease (following remission)|0|||
16406043|NCT03298984|39966533|FG001|Overall Study|Relapsed disease (following remission)|0|||
16406044|NCT03298984|39966534|FG002|Overall Study|Relapsed disease (following remission)|1|||
16406045|NCT03298984|39966535|FG003|Overall Study|Relapsed disease (following remission)|1|||
16406046|NCT03298984|39966532|FG000|Overall Study|Adverse Event|0|||
16406047|NCT03298984|39966533|FG001|Overall Study|Adverse Event|0|||
16406048|NCT03298984|39966534|FG002|Overall Study|Adverse Event|0|||
16406049|NCT03298984|39966535|FG003|Overall Study|Adverse Event|1|||
16406050|NCT03298984|39966532|FG000|Overall Study|Death|0|||
16406051|NCT03298984|39966533|FG001|Overall Study|Death|0|||
16406052|NCT03298984|39966534|FG002|Overall Study|Death|0|||
16406053|NCT03298984|39966535|FG003|Overall Study|Death|2|||
16406054|NCT03298984|39966532|FG000|Overall Study|Insurance Company Decision|0|||
16216851|NCT02442765|39272503|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
16406055|NCT03298984|39966533|FG001|Overall Study|Insurance Company Decision|0|||
16338062|NCT03275389|39726015|FG005|Overall Study|Lost to Follow-up|12|||
16338063|NCT03275389|39726016|FG006|Overall Study|Lost to Follow-up|21|||
16102631|NCT00975130|38863241|FG000|Study Part 2|Administrative|0|||
16102632|NCT00975130|38863242|FG001|Study Part 2|Administrative|1|||
16338064|NCT03275389|39726017|FG007|Overall Study|Lost to Follow-up|15|||
16338065|NCT03275389|39726018|FG008|Overall Study|Lost to Follow-up|12|||
16338066|NCT03275389|39726019|FG009|Overall Study|Lost to Follow-up|14|||
16338067|NCT03275389|39726010|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
16338068|NCT03275389|39726011|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
16338069|NCT03275389|39726012|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
16338070|NCT03275389|39726013|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
16338071|NCT03275389|39726014|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
16338072|NCT03275389|39726015|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
16338073|NCT03275389|39726016|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
16338074|NCT03275389|39726017|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
16338075|NCT03275389|39726018|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
16338076|NCT03275389|39726019|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
16338077|NCT03275389|39726010|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
16338078|NCT03275389|39726011|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
16338079|NCT03275389|39726012|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
16338080|NCT03275389|39726013|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
16338081|NCT03275389|39726014|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
16338082|NCT03275389|39726015|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
16338083|NCT03275389|39726016|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
16338084|NCT03275389|39726017|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
16338085|NCT03275389|39726018|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
16338086|NCT03275389|39726019|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
16338087|NCT03275389|39726010|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16338088|NCT03275389|39726011|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
16338089|NCT03275389|39726012|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16338090|NCT03275389|39726013|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
16338091|NCT03275389|39726014|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16338092|NCT03275389|39726015|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16338093|NCT03275389|39726016|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16338094|NCT03275389|39726017|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16338095|NCT03275389|39726018|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16338096|NCT03275389|39726019|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
16338097|NCT03275389|39726010|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
16338098|NCT03275389|39726011|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
16338099|NCT03275389|39726012|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
16338100|NCT03275389|39726013|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
16338101|NCT03275389|39726014|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
16338102|NCT03275389|39726015|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
16338103|NCT03275389|39726016|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
16338104|NCT03275389|39726017|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
16338105|NCT03275389|39726018|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
16338106|NCT03275389|39726019|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
16338107|NCT03275389|39726010|FG000|Overall Study|Other|0|||
16338108|NCT03275389|39726011|FG001|Overall Study|Other|4|||
16338109|NCT03275389|39726012|FG002|Overall Study|Other|3|||
16102633|NCT00975130|38863243|FG002|Study Part 2|Administrative|0|||
16102634|NCT00975130|38863241|FG000|Study Part 2|Protocol Violation|0|||
16102635|NCT00975130|38863242|FG001|Study Part 2|Protocol Violation|0|||
16102636|NCT00975130|38863243|FG002|Study Part 2|Protocol Violation|1|||
16102637|NCT03746483|38863244|FG000|Overall Study|Adverse Event|0|||
16102638|NCT03746483|38863245|FG001|Overall Study|Adverse Event|1|||
16102639|NCT03746483|38863244|FG000|Overall Study|Lack of Efficacy|3|||
16102640|NCT03746483|38863245|FG001|Overall Study|Lack of Efficacy|2|||
16102641|NCT03746483|38863244|FG000|Overall Study|Lost to Follow-up|1|||
16102642|NCT03746483|38863245|FG001|Overall Study|Lost to Follow-up|0|||
16102643|NCT03746483|38863244|FG000|Overall Study|Protocol Violation|2|||
16102644|NCT03746483|38863245|FG001|Overall Study|Protocol Violation|0|||
16102645|NCT03357471|38863246|FG000|Overall Study|Adverse Event|1|||
16338110|NCT03275389|39726013|FG003|Overall Study|Other|2|||
16338111|NCT03275389|39726014|FG004|Overall Study|Other|2|||
16102646|NCT03357471|38863247|FG001|Overall Study|Adverse Event|0|||
16406056|NCT03298984|39966534|FG002|Overall Study|Insurance Company Decision|0|||
16406057|NCT03298984|39966535|FG003|Overall Study|Insurance Company Decision|1|||
16406058|NCT04065074|39966536|FG000|Overall Study|Adverse Event|1|||
16406059|NCT04065074|39966536|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
16406060|NCT02403635|39966537|FG000|Overall Study|Not eligible|9|||
16406061|NCT00934947|39966540|FG000|Overall Study|Adverse Event|0|||
16406062|NCT00934947|39966541|FG001|Overall Study|Adverse Event|2|||
16406063|NCT02763254|39966544|FG000|Overall Study|Adverse Event|1|||
16406064|NCT00098722|39966545|FG000|Double Blind Phase|Adverse Event|7|||
16406065|NCT00098722|39966546|FG001|Double Blind Phase|Adverse Event|7|||
16406066|NCT00098722|39966547|FG002|Double Blind Phase|Adverse Event|3|||
16338112|NCT03275389|39726015|FG005|Overall Study|Other|2|||
16338113|NCT03275389|39726016|FG006|Overall Study|Other|0|||
16338114|NCT03275389|39726017|FG007|Overall Study|Other|0|||
16338115|NCT03275389|39726018|FG008|Overall Study|Other|1|||
16338116|NCT03275389|39726019|FG009|Overall Study|Other|0|||
16406067|NCT00098722|39966548|FG003|Double Blind Phase|Adverse Event|0|||
16406068|NCT00098722|39966549|FG004|Double Blind Phase|Adverse Event|0|||
16406069|NCT00098722|39966550|FG005|Double Blind Phase|Adverse Event|0|||
16406070|NCT00098722|39966551|FG006|Double Blind Phase|Adverse Event|0|||
16338117|NCT01410240|39726020|FG000|Overall Study|Physician Decision|0|||
16338118|NCT01410240|39726021|FG001|Overall Study|Physician Decision|0|||
16338119|NCT01410240|39726022|FG002|Overall Study|Physician Decision|1|||
16338120|NCT01410240|39726020|FG000|Overall Study|Missed week 6 assessments|1|||
16338121|NCT01410240|39726021|FG001|Overall Study|Missed week 6 assessments|1|||
16338122|NCT01410240|39726022|FG002|Overall Study|Missed week 6 assessments|1|||
16338123|NCT01964716|39726027|FG000|Overall Study|Withdrawal by Subject|2|||
16338124|NCT01964716|39726028|FG001|Overall Study|Withdrawal by Subject|3|||
16338125|NCT01964716|39726027|FG000|Overall Study|Lost to Follow-up|1|||
16338126|NCT01964716|39726028|FG001|Overall Study|Lost to Follow-up|2|||
16338127|NCT01964716|39726027|FG000|Overall Study|No longer met eligibility criteria|1|||
16338128|NCT01964716|39726028|FG001|Overall Study|No longer met eligibility criteria|1|||
16338129|NCT01964716|39726027|FG000|Overall Study|Death|1|||
16338130|NCT01964716|39726028|FG001|Overall Study|Death|0|||
16338131|NCT02304380|39726034|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
16338132|NCT02304380|39726035|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
16338133|NCT02304380|39726036|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
16338134|NCT02304380|39726037|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
16338135|NCT02304380|39726038|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
16338136|NCT02304380|39726039|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
16338137|NCT03544281|39726040|FG000|Overall Study|Death|3|||
16406071|NCT00098722|39966545|FG000|Double Blind Phase|Death|2|||
16406072|NCT00098722|39966546|FG001|Double Blind Phase|Death|5|||
16406073|NCT00098722|39966547|FG002|Double Blind Phase|Death|0|||
16406074|NCT00098722|39966548|FG003|Double Blind Phase|Death|0|||
16406075|NCT00098722|39966549|FG004|Double Blind Phase|Death|0|||
16338138|NCT03544281|39726041|FG001|Overall Study|Death|2|||
16338139|NCT03544281|39726042|FG002|Overall Study|Death|6|||
16338140|NCT03544281|39726043|FG003|Overall Study|Death|8|||
16338141|NCT03544281|39726044|FG004|Overall Study|Death|4|||
16338142|NCT03544281|39726045|FG005|Overall Study|Death|2|||
16406076|NCT00098722|39966550|FG005|Double Blind Phase|Death|0|||
16102647|NCT03357471|38863246|FG000|Overall Study|Lost to Follow-up|1|||
16102648|NCT03357471|38863247|FG001|Overall Study|Lost to Follow-up|0|||
16102649|NCT00069277|38863248|FG000|Overall Study|Adverse Event|3|||
16102650|NCT00069277|38863248|FG000|Overall Study|Withdrawal by Subject|1|||
16338143|NCT03544281|39726046|FG006|Overall Study|Death|4|||
16338144|NCT03544281|39726047|FG007|Overall Study|Death|5|||
16338145|NCT03544281|39726048|FG008|Overall Study|Death|5|||
16537112|NCT00633464|40429100|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
16537113|NCT00633464|40429101|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
16537114|NCT00633464|40429100|FG000|Overall Study|Never Treated (Randomized in error)|0|||
16537115|NCT00633464|40429101|FG001|Overall Study|Never Treated (Randomized in error)|1|||
16537116|NCT02192502|40429102|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
16537117|NCT02192502|40429103|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
16537118|NCT02192502|40429102|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
16537119|NCT02192502|40429103|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
16537120|NCT02192502|40429102|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
16537121|NCT02192502|40429103|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
16537122|NCT02195986|40429108|FG000|Overall Study|Adverse Event|3|||
16537123|NCT02195986|40429109|FG001|Overall Study|Adverse Event|0|||
16537124|NCT02195986|40429110|FG002|Overall Study|Adverse Event|0|||
16537125|NCT02195986|40429108|FG000|Overall Study|Withdrawal by Subject|0|||
16537126|NCT02195986|40429109|FG001|Overall Study|Withdrawal by Subject|3|||
16537127|NCT02195986|40429110|FG002|Overall Study|Withdrawal by Subject|0|||
16537128|NCT02195986|40429108|FG000|Overall Study|Family Emergency|0|||
16537129|NCT02195986|40429109|FG001|Overall Study|Family Emergency|0|||
16537130|NCT02195986|40429110|FG002|Overall Study|Family Emergency|1|||
16537131|NCT02195986|40429108|FG000|Overall Study|Protocol Violation|0|||
16537132|NCT02195986|40429109|FG001|Overall Study|Protocol Violation|1|||
16537133|NCT02195986|40429110|FG002|Overall Study|Protocol Violation|1|||
16537134|NCT02195986|40429108|FG000|Overall Study|Non-compliance|0|||
16537135|NCT02195986|40429109|FG001|Overall Study|Non-compliance|1|||
16537136|NCT02195986|40429110|FG002|Overall Study|Non-compliance|0|||
16537137|NCT01814748|40429121|FG000|Overall Study|Lost to Follow-up|1|||
16537138|NCT01814748|40429122|FG001|Overall Study|Lost to Follow-up|2|||
16537139|NCT01814748|40429121|FG000|Overall Study|Study site terminated by sponsor|1|||
16537140|NCT01814748|40429122|FG001|Overall Study|Study site terminated by sponsor|1|||
16537141|NCT01814748|40429121|FG000|Overall Study|Withdrawal by Subject|6|||
16537142|NCT01814748|40429122|FG001|Overall Study|Withdrawal by Subject|4|||
16537143|NCT00386022|40429123|FG000|Plus Estrogen|Lost to Follow-up|2|||
16537144|NCT00386022|40429124|FG001|Plus Estrogen|Lost to Follow-up|0|||
16537145|NCT00386022|40429123|FG000|Plus Estrogen|Adverse Event|0|||
16537146|NCT00386022|40429124|FG001|Plus Estrogen|Adverse Event|1|||
16338146|NCT03544281|39726049|FG009|Overall Study|Death|8|||
16338147|NCT03544281|39726050|FG010|Overall Study|Death|6|||
16338148|NCT03544281|39726051|FG011|Overall Study|Death|4|||
16338149|NCT03544281|39726040|FG000|Overall Study|Lost to Follow-up|0|||
16338150|NCT03544281|39726041|FG001|Overall Study|Lost to Follow-up|0|||
16338151|NCT03544281|39726042|FG002|Overall Study|Lost to Follow-up|0|||
16338152|NCT03544281|39726043|FG003|Overall Study|Lost to Follow-up|0|||
16406077|NCT00098722|39966551|FG006|Double Blind Phase|Death|0|||
16406078|NCT00098722|39966545|FG000|Double Blind Phase|Lack of Efficacy|21|||
16406079|NCT00098722|39966546|FG001|Double Blind Phase|Lack of Efficacy|23|||
16406080|NCT00098722|39966547|FG002|Double Blind Phase|Lack of Efficacy|15|||
16406081|NCT00098722|39966548|FG003|Double Blind Phase|Lack of Efficacy|0|||
16406082|NCT00098722|39966549|FG004|Double Blind Phase|Lack of Efficacy|0|||
16537147|NCT00594854|40429125|FG000|Overall Study|Study terminated|7|||
16537148|NCT00594854|40429126|FG001|Overall Study|Study terminated|10|||
16537149|NCT00902304|40429127|FG000|Overall Study|Adverse Event|4|||
16537150|NCT00902304|40429128|FG001|Overall Study|Adverse Event|10|||
16537151|NCT00902304|40429129|FG002|Overall Study|Adverse Event|25|||
16537152|NCT00902304|40429127|FG000|Overall Study|Investigator discretion|3|||
16537153|NCT00902304|40429128|FG001|Overall Study|Investigator discretion|5|||
16537154|NCT00902304|40429129|FG002|Overall Study|Investigator discretion|13|||
16537155|NCT00902304|40429127|FG000|Overall Study|Lost to Follow-up|7|||
16537156|NCT00902304|40429128|FG001|Overall Study|Lost to Follow-up|7|||
16102651|NCT00069277|38863248|FG000|Overall Study|Progressive Disease|15|||
16102652|NCT00069277|38863248|FG000|Overall Study|Physician Decision|2|||
16338153|NCT03544281|39726044|FG004|Overall Study|Lost to Follow-up|0|||
16338154|NCT03544281|39726045|FG005|Overall Study|Lost to Follow-up|0|||
16338155|NCT03544281|39726046|FG006|Overall Study|Lost to Follow-up|0|||
16338156|NCT03544281|39726047|FG007|Overall Study|Lost to Follow-up|0|||
16338157|NCT03544281|39726048|FG008|Overall Study|Lost to Follow-up|0|||
16338158|NCT03544281|39726049|FG009|Overall Study|Lost to Follow-up|0|||
16102653|NCT03184519|38863249|FG000|Overall Study|Lost to Follow-up|6|||
16338159|NCT03544281|39726050|FG010|Overall Study|Lost to Follow-up|1|||
16537157|NCT00902304|40429129|FG002|Overall Study|Lost to Follow-up|7|||
16338160|NCT03544281|39726051|FG011|Overall Study|Lost to Follow-up|0|||
16338161|NCT03544281|39726040|FG000|Overall Study|Physician Decision|0|||
16338162|NCT03544281|39726041|FG001|Overall Study|Physician Decision|0|||
16338163|NCT03544281|39726042|FG002|Overall Study|Physician Decision|0|||
16338164|NCT03544281|39726043|FG003|Overall Study|Physician Decision|0|||
16338165|NCT03544281|39726044|FG004|Overall Study|Physician Decision|0|||
16338166|NCT03544281|39726045|FG005|Overall Study|Physician Decision|0|||
16338167|NCT03544281|39726046|FG006|Overall Study|Physician Decision|0|||
16338168|NCT03544281|39726047|FG007|Overall Study|Physician Decision|1|||
16338169|NCT03544281|39726048|FG008|Overall Study|Physician Decision|0|||
16338170|NCT03544281|39726049|FG009|Overall Study|Physician Decision|0|||
16338171|NCT03544281|39726050|FG010|Overall Study|Physician Decision|0|||
16338172|NCT03544281|39726051|FG011|Overall Study|Physician Decision|0|||
16338173|NCT03544281|39726040|FG000|Overall Study|Withdrawal by Subject|2|||
16406083|NCT00098722|39966550|FG005|Double Blind Phase|Lack of Efficacy|0|||
16406084|NCT00098722|39966551|FG006|Double Blind Phase|Lack of Efficacy|0|||
16406085|NCT00098722|39966545|FG000|Double Blind Phase|Participant defaulted|16|||
16338174|NCT03544281|39726041|FG001|Overall Study|Withdrawal by Subject|0|||
16338175|NCT03544281|39726042|FG002|Overall Study|Withdrawal by Subject|1|||
16338176|NCT03544281|39726043|FG003|Overall Study|Withdrawal by Subject|2|||
16338177|NCT03544281|39726044|FG004|Overall Study|Withdrawal by Subject|0|||
16338178|NCT03544281|39726045|FG005|Overall Study|Withdrawal by Subject|0|||
16338179|NCT03544281|39726046|FG006|Overall Study|Withdrawal by Subject|0|||
16338180|NCT03544281|39726047|FG007|Overall Study|Withdrawal by Subject|0|||
16338181|NCT03544281|39726048|FG008|Overall Study|Withdrawal by Subject|2|||
16338182|NCT03544281|39726049|FG009|Overall Study|Withdrawal by Subject|3|||
16338183|NCT03544281|39726050|FG010|Overall Study|Withdrawal by Subject|0|||
16338184|NCT03544281|39726051|FG011|Overall Study|Withdrawal by Subject|4|||
16338185|NCT03544281|39726040|FG000|Overall Study|Ongoing at the time of analysis|7|||
16338186|NCT03544281|39726041|FG001|Overall Study|Ongoing at the time of analysis|2|||
16338187|NCT03544281|39726042|FG002|Overall Study|Ongoing at the time of analysis|6|||
16338188|NCT03544281|39726043|FG003|Overall Study|Ongoing at the time of analysis|6|||
16338189|NCT03544281|39726044|FG004|Overall Study|Ongoing at the time of analysis|8|||
16338190|NCT03544281|39726045|FG005|Overall Study|Ongoing at the time of analysis|10|||
16338191|NCT03544281|39726046|FG006|Overall Study|Ongoing at the time of analysis|8|||
16338192|NCT03544281|39726047|FG007|Overall Study|Ongoing at the time of analysis|6|||
16338193|NCT03544281|39726048|FG008|Overall Study|Ongoing at the time of analysis|6|||
16338194|NCT03544281|39726049|FG009|Overall Study|Ongoing at the time of analysis|6|||
16338195|NCT03544281|39726050|FG010|Overall Study|Ongoing at the time of analysis|5|||
16338196|NCT03544281|39726051|FG011|Overall Study|Ongoing at the time of analysis|8|||
16338197|NCT03544281|39726040|FG000|Overall Study|Investigator Site Closed|0|||
16338198|NCT03544281|39726041|FG001|Overall Study|Investigator Site Closed|0|||
16338199|NCT03544281|39726042|FG002|Overall Study|Investigator Site Closed|0|||
16338200|NCT03544281|39726043|FG003|Overall Study|Investigator Site Closed|0|||
16338201|NCT03544281|39726044|FG004|Overall Study|Investigator Site Closed|0|||
16338202|NCT03544281|39726045|FG005|Overall Study|Investigator Site Closed|0|||
16338203|NCT03544281|39726046|FG006|Overall Study|Investigator Site Closed|0|||
16338204|NCT03544281|39726047|FG007|Overall Study|Investigator Site Closed|0|||
16537158|NCT00902304|40429127|FG000|Overall Study|Protocol Violation|9|||
16537159|NCT00902304|40429128|FG001|Overall Study|Protocol Violation|18|||
16537160|NCT00902304|40429129|FG002|Overall Study|Protocol Violation|20|||
16537161|NCT00902304|40429127|FG000|Overall Study|Withdrawal by Subject|32|||
16338205|NCT03544281|39726048|FG008|Overall Study|Investigator Site Closed|0|||
16338206|NCT03544281|39726049|FG009|Overall Study|Investigator Site Closed|1|||
16338207|NCT03544281|39726050|FG010|Overall Study|Investigator Site Closed|0|||
16537162|NCT00902304|40429128|FG001|Overall Study|Withdrawal by Subject|22|||
16537163|NCT00902304|40429129|FG002|Overall Study|Withdrawal by Subject|43|||
16537164|NCT00902304|40429127|FG000|Overall Study|includes pregnancy|3|||
16537165|NCT00902304|40429128|FG001|Overall Study|includes pregnancy|9|||
16537166|NCT00902304|40429129|FG002|Overall Study|includes pregnancy|2|||
16537167|NCT00126438|40429132|FG000|Overall Study|Withdrawal due to adverse event|1|||
16537168|NCT00126438|40429133|FG001|Overall Study|Withdrawal due to adverse event|0|||
16537169|NCT00126438|40429132|FG000|Overall Study|Lost to Follow-up|22|||
16537170|NCT00126438|40429133|FG001|Overall Study|Lost to Follow-up|0|||
16338208|NCT03544281|39726051|FG011|Overall Study|Investigator Site Closed|0|||
16338209|NCT03544281|39726040|FG000|Overall Study|Did not receive study treatment|0|||
16338210|NCT03544281|39726041|FG001|Overall Study|Did not receive study treatment|0|||
16338211|NCT03544281|39726042|FG002|Overall Study|Did not receive study treatment|0|||
16406086|NCT00098722|39966546|FG001|Double Blind Phase|Participant defaulted|11|||
16338212|NCT03544281|39726043|FG003|Overall Study|Did not receive study treatment|0|||
16338213|NCT03544281|39726044|FG004|Overall Study|Did not receive study treatment|0|||
16537171|NCT00126438|40429132|FG000|Overall Study|Protocol Violation|8|||
16537172|NCT00126438|40429133|FG001|Overall Study|Protocol Violation|8|||
16537173|NCT00126438|40429132|FG000|Overall Study|Withdrawal by Subject|3|||
16537174|NCT00126438|40429133|FG001|Overall Study|Withdrawal by Subject|2|||
16537175|NCT04072159|40429134|FG000|Overall Study|Lost to Follow-up|6|||
16338214|NCT03544281|39726045|FG005|Overall Study|Did not receive study treatment|0|||
16537176|NCT04072159|40429135|FG001|Overall Study|Lost to Follow-up|6|||
16537177|NCT04072159|40429134|FG000|Overall Study|Withdrawal by Subject|2|||
16338215|NCT03544281|39726046|FG006|Overall Study|Did not receive study treatment|1|||
16338216|NCT03544281|39726047|FG007|Overall Study|Did not receive study treatment|0|||
16338217|NCT03544281|39726048|FG008|Overall Study|Did not receive study treatment|0|||
16338218|NCT03544281|39726049|FG009|Overall Study|Did not receive study treatment|0|||
16338219|NCT03544281|39726050|FG010|Overall Study|Did not receive study treatment|0|||
16338220|NCT03544281|39726051|FG011|Overall Study|Did not receive study treatment|0|||
16338221|NCT03816007|39726052|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
16338222|NCT03816007|39726053|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
16338223|NCT03816007|39726052|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
16338224|NCT03816007|39726053|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
16338225|NCT03816007|39726052|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
16338226|NCT03816007|39726053|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
16338227|NCT00492232|39726054|FG000|Placebo Run-in|Adverse Event|0|||
16338228|NCT00492232|39726055|FG001|Placebo Run-in|Adverse Event|2|||
16338229|NCT00492232|39726054|FG000|Placebo Run-in|Protocol Violation|0|||
16338230|NCT00492232|39726055|FG001|Placebo Run-in|Protocol Violation|3|||
16338231|NCT00492232|39726054|FG000|Placebo Run-in|Lost to Follow-up|0|||
16338232|NCT00492232|39726055|FG001|Placebo Run-in|Lost to Follow-up|3|||
16338233|NCT00492232|39726054|FG000|Placebo Run-in|Withdrawal by Subject|0|||
16338234|NCT00492232|39726055|FG001|Placebo Run-in|Withdrawal by Subject|8|||
16338235|NCT00492232|39726054|FG000|Placebo Run-in|Pregnancy|0|||
16338236|NCT00492232|39726055|FG001|Placebo Run-in|Pregnancy|1|||
16338237|NCT00492232|39726054|FG000|Placebo Run-in|Entrance criteria not met|0|||
16338238|NCT00492232|39726055|FG001|Placebo Run-in|Entrance criteria not met|45|||
16338239|NCT00492232|39726054|FG000|Placebo Run-in|Other|0|||
16338240|NCT00492232|39726055|FG001|Placebo Run-in|Other|6|||
16338241|NCT00492232|39726054|FG000|Placebo Run-in|Missing|0|||
16338242|NCT00492232|39726055|FG001|Placebo Run-in|Missing|2|||
16338243|NCT00492232|39726054|FG000|Double-Blind Treatment|Adverse Event|1|||
16338244|NCT00492232|39726055|FG001|Double-Blind Treatment|Adverse Event|2|||
16338245|NCT00492232|39726054|FG000|Double-Blind Treatment|Protocol Violation|3|||
16338246|NCT00492232|39726055|FG001|Double-Blind Treatment|Protocol Violation|7|||
16338247|NCT00492232|39726054|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
16338248|NCT00492232|39726055|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
16338249|NCT00492232|39726054|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
16338250|NCT00492232|39726055|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
16338251|NCT00492232|39726054|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
16338252|NCT00492232|39726055|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
16338253|NCT00492232|39726054|FG000|Double-Blind Treatment|Other|6|||
16338254|NCT00492232|39726055|FG001|Double-Blind Treatment|Other|5|||
16338255|NCT00492232|39726054|FG000|Double-Blind Treatment|Randomized not treated|1|||
16338256|NCT00492232|39726055|FG001|Double-Blind Treatment|Randomized not treated|0|||
16338257|NCT00492232|39726054|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
16338258|NCT00492232|39726055|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
16338259|NCT00734656|39726065|FG000|Lab Session 1|Withdrawal by Subject|2|||
16338260|NCT00734656|39726066|FG001|Lab Session 1|Withdrawal by Subject|0|||
16338261|NCT00734656|39726067|FG002|Lab Session 1|Withdrawal by Subject|0|||
16338262|NCT00734656|39726068|FG003|Lab Session 1|Withdrawal by Subject|0|||
16338263|NCT00734656|39726065|FG000|Washout 1|Withdrawal by Subject|1|||
16406087|NCT00098722|39966547|FG002|Double Blind Phase|Participant defaulted|9|||
16406088|NCT00098722|39966548|FG003|Double Blind Phase|Participant defaulted|0|||
16537178|NCT04072159|40429135|FG001|Overall Study|Withdrawal by Subject|0|||
16338264|NCT00734656|39726066|FG001|Washout 1|Withdrawal by Subject|5|||
16338265|NCT00734656|39726067|FG002|Washout 1|Withdrawal by Subject|2|||
16537179|NCT02255357|40429136|FG000|Overall Study|Physician Decision|10|||
16537180|NCT02255357|40429137|FG001|Overall Study|Physician Decision|24|||
16537181|NCT04528069|40429138|FG000|Overall Study|Adverse Event|1|||
16537182|NCT04528069|40429138|FG000|Overall Study|Lost to Follow-up|1|||
16537183|NCT04528069|40429138|FG000|Overall Study|Patient Unable to Come|1|||
16338266|NCT00734656|39726068|FG003|Washout 1|Withdrawal by Subject|3|||
16338267|NCT00734656|39726065|FG000|Lab Session 2|Withdrawal by Subject|1|||
16338268|NCT00734656|39726066|FG001|Lab Session 2|Withdrawal by Subject|0|||
16338269|NCT00734656|39726067|FG002|Lab Session 2|Withdrawal by Subject|0|||
16338270|NCT00734656|39726068|FG003|Lab Session 2|Withdrawal by Subject|1|||
16102654|NCT03184519|38863249|FG000|Overall Study|Physician Decision|21|||
16102655|NCT03740737|38863250|FG000|Overall Study|Protocol deviation|13|||
16338271|NCT00734656|39726065|FG000|Washout 2|Withdrawal by Subject|1|||
16338272|NCT00734656|39726066|FG001|Washout 2|Withdrawal by Subject|1|||
16338273|NCT00734656|39726067|FG002|Washout 2|Withdrawal by Subject|1|||
16338274|NCT00734656|39726068|FG003|Washout 2|Withdrawal by Subject|0|||
16338275|NCT00734656|39726065|FG000|Washout 3|Withdrawal by Subject|1|||
16338276|NCT00734656|39726066|FG001|Washout 3|Withdrawal by Subject|0|||
16338277|NCT00734656|39726067|FG002|Washout 3|Withdrawal by Subject|0|||
16338278|NCT00734656|39726068|FG003|Washout 3|Withdrawal by Subject|1|||
16338279|NCT00734656|39726065|FG000|Lab Session 4|Withdrawal by Subject|0|||
16338280|NCT00734656|39726066|FG001|Lab Session 4|Withdrawal by Subject|0|||
16338281|NCT00734656|39726067|FG002|Lab Session 4|Withdrawal by Subject|0|||
16338282|NCT00734656|39726068|FG003|Lab Session 4|Withdrawal by Subject|1|||
16338283|NCT01473394|39726069|FG000|Overall Study|Adverse Event|13|||
16338284|NCT01473394|39726070|FG001|Overall Study|Adverse Event|16|||
16338285|NCT01473394|39726069|FG000|Overall Study|Insufficient Therapeutic Response|4|||
16338286|NCT01473394|39726070|FG001|Overall Study|Insufficient Therapeutic Response|1|||
16338287|NCT01473394|39726069|FG000|Overall Study|Protocol Violation|7|||
16338288|NCT01473394|39726070|FG001|Overall Study|Protocol Violation|5|||
16338289|NCT01473394|39726069|FG000|Overall Study|Withdrew Consent|12|||
16338290|NCT01473394|39726070|FG001|Overall Study|Withdrew Consent|10|||
16338291|NCT01473394|39726069|FG000|Overall Study|Lost to Follow-up|9|||
16338292|NCT01473394|39726070|FG001|Overall Study|Lost to Follow-up|11|||
16338293|NCT03882957|39726077|FG000|Overall Study|Did not complete all three arms|1|||
16338294|NCT00632125|39726078|FG000|Overall Study|Death|82|||
16338295|NCT00632125|39726078|FG000|Overall Study|Withdrawal by Subject|44|||
16338296|NCT00632125|39726078|FG000|Overall Study|Adverse Event|36|||
16338297|NCT00632125|39726078|FG000|Overall Study|Renal transplantation|17|||
16338298|NCT00632125|39726078|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
16338299|NCT00632125|39726078|FG000|Overall Study|Non-compliance|8|||
16338300|NCT00632125|39726078|FG000|Overall Study|Development of uncontrolled hypertension|5|||
16338301|NCT00632125|39726078|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
16338302|NCT04424914|39726094|FG000|Overall Study|Other|0|||
16338303|NCT04424914|39726095|FG001|Overall Study|Other|0|||
16338304|NCT04424914|39726096|FG002|Overall Study|Other|28|||
16338305|NCT04424914|39726094|FG000|Overall Study|Withdrawal by Subject|3|||
16338306|NCT04424914|39726095|FG001|Overall Study|Withdrawal by Subject|0|||
16338307|NCT04424914|39726096|FG002|Overall Study|Withdrawal by Subject|0|||
16338308|NCT04424914|39726094|FG000|Overall Study|Study terminated by sponsor|23|||
16338309|NCT04424914|39726095|FG001|Overall Study|Study terminated by sponsor|7|||
16338310|NCT04424914|39726096|FG002|Overall Study|Study terminated by sponsor|0|||
16338311|NCT04424914|39726094|FG000|Overall Study|Lost to Follow-up|0|||
16406089|NCT00098722|39966549|FG004|Double Blind Phase|Participant defaulted|0|||
16406090|NCT00098722|39966550|FG005|Double Blind Phase|Participant defaulted|0|||
16406091|NCT00098722|39966551|FG006|Double Blind Phase|Participant defaulted|0|||
16406092|NCT00098722|39966545|FG000|Double Blind Phase|Pregnancy|1|||
16406093|NCT00098722|39966546|FG001|Double Blind Phase|Pregnancy|0|||
16406094|NCT00098722|39966547|FG002|Double Blind Phase|Pregnancy|0|||
16537184|NCT04528069|40429138|FG000|Overall Study|Patient Unable to Attend|1|||
16537185|NCT02489500|40429139|FG000|Overall Study|Death|1|||
16537186|NCT02489500|40429140|FG001|Overall Study|Death|1|||
16537187|NCT00924287|40429141|FG000|Overall Study|Death|1|||
16537188|NCT02621931|40429142|FG000|Overall Study|Death|0|||
16537189|NCT02621931|40429143|FG001|Overall Study|Death|1|||
16537190|NCT02621931|40429144|FG002|Overall Study|Death|0|||
16537191|NCT02621931|40429142|FG000|Overall Study|Adverse Event|8|||
16537192|NCT02621931|40429143|FG001|Overall Study|Adverse Event|5|||
16537193|NCT02621931|40429144|FG002|Overall Study|Adverse Event|7|||
16537194|NCT02621931|40429142|FG000|Overall Study|Withdrawal by Subject|12|||
16537195|NCT02621931|40429143|FG001|Overall Study|Withdrawal by Subject|10|||
16537196|NCT02621931|40429144|FG002|Overall Study|Withdrawal by Subject|11|||
16537197|NCT02621931|40429142|FG000|Overall Study|Protocol Violation|2|||
16537198|NCT02621931|40429143|FG001|Overall Study|Protocol Violation|2|||
16537199|NCT02621931|40429144|FG002|Overall Study|Protocol Violation|2|||
16537200|NCT02621931|40429142|FG000|Overall Study|Pregnancy|2|||
16537201|NCT02621931|40429143|FG001|Overall Study|Pregnancy|0|||
16537202|NCT02621931|40429144|FG002|Overall Study|Pregnancy|0|||
16537203|NCT02621931|40429142|FG000|Overall Study|Noncompliance to study procedures|0|||
16537204|NCT02621931|40429143|FG001|Overall Study|Noncompliance to study procedures|1|||
16537205|NCT02621931|40429144|FG002|Overall Study|Noncompliance to study procedures|2|||
16537206|NCT02621931|40429142|FG000|Overall Study|Lost to Follow-up|8|||
16537207|NCT02621931|40429143|FG001|Overall Study|Lost to Follow-up|7|||
16537208|NCT02621931|40429144|FG002|Overall Study|Lost to Follow-up|10|||
16537209|NCT02621931|40429142|FG000|Overall Study|Lack of Efficacy|0|||
16537210|NCT02621931|40429143|FG001|Overall Study|Lack of Efficacy|0|||
16537211|NCT02621931|40429144|FG002|Overall Study|Lack of Efficacy|1|||
16537212|NCT02621931|40429142|FG000|Overall Study|Other|1|||
16537213|NCT02621931|40429143|FG001|Overall Study|Other|1|||
16338312|NCT04424914|39726095|FG001|Overall Study|Lost to Follow-up|0|||
16338313|NCT04424914|39726096|FG002|Overall Study|Lost to Follow-up|1|||
16338314|NCT04424914|39726094|FG000|Overall Study|Death|3|||
16338315|NCT04424914|39726095|FG001|Overall Study|Death|1|||
16338316|NCT04424914|39726096|FG002|Overall Study|Death|0|||
16338317|NCT01289574|39726104|FG000|Overall Study|Lack of Efficacy|4|||
16338318|NCT01289574|39726105|FG001|Overall Study|Lack of Efficacy|0|||
16338319|NCT01289574|39726106|FG002|Overall Study|Lack of Efficacy|1|||
16338320|NCT01289574|39726104|FG000|Overall Study|Lost to Follow-up|2|||
16338321|NCT01289574|39726105|FG001|Overall Study|Lost to Follow-up|0|||
16338322|NCT01289574|39726106|FG002|Overall Study|Lost to Follow-up|1|||
16338323|NCT01289574|39726104|FG000|Overall Study|Withdrawal by Subject|1|||
16338324|NCT01289574|39726105|FG001|Overall Study|Withdrawal by Subject|1|||
16338325|NCT01289574|39726106|FG002|Overall Study|Withdrawal by Subject|1|||
16338326|NCT01289574|39726104|FG000|Overall Study|Adverse Event|0|||
16338327|NCT01289574|39726105|FG001|Overall Study|Adverse Event|1|||
16338328|NCT01289574|39726106|FG002|Overall Study|Adverse Event|0|||
16338329|NCT01289574|39726104|FG000|Overall Study|Subject wanted alternate treatment|0|||
16338330|NCT01289574|39726105|FG001|Overall Study|Subject wanted alternate treatment|1|||
16338331|NCT01289574|39726106|FG002|Overall Study|Subject wanted alternate treatment|0|||
16338332|NCT01260584|39726109|FG000|Period 1|Protocol Violation|0|||
16338333|NCT01260584|39726110|FG001|Period 1|Protocol Violation|0|||
16338334|NCT01260584|39726111|FG002|Period 1|Protocol Violation|1|||
16338335|NCT01260584|39726112|FG003|Period 1|Protocol Violation|1|||
16338336|NCT01260584|39726109|FG000|Period 1|Adverse Event|0|||
16338337|NCT01260584|39726110|FG001|Period 1|Adverse Event|0|||
16338338|NCT01260584|39726111|FG002|Period 1|Adverse Event|1|||
16338339|NCT01260584|39726112|FG003|Period 1|Adverse Event|0|||
16338340|NCT01260584|39726109|FG000|Period 2|Protocol Violation|0|||
16216852|NCT02442765|39272504|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
16338341|NCT01260584|39726110|FG001|Period 2|Protocol Violation|2|||
16338342|NCT01260584|39726111|FG002|Period 2|Protocol Violation|3|||
16338343|NCT01260584|39726112|FG003|Period 2|Protocol Violation|1|||
16537214|NCT02621931|40429144|FG002|Overall Study|Other|3|||
16537215|NCT05374421|40429149|FG000|Overall Study|Withdrawal by Subject|3|||
16537216|NCT05374421|40429150|FG001|Overall Study|Withdrawal by Subject|4|||
16537217|NCT01207102|40429153|FG000|Overall Study|Withdrawal by Subject|5|||
16537218|NCT01207102|40429153|FG000|Overall Study|Adverse Event|2|||
16537219|NCT01207102|40429153|FG000|Overall Study|progression|2|||
16537220|NCT01207102|40429153|FG000|Overall Study|Withdrawal by Treating Physician|1|||
16537221|NCT00911534|40429162|FG000|Overall Study|Adverse Event|4|||
16537222|NCT00911534|40429163|FG001|Overall Study|Adverse Event|4|||
16537223|NCT00911534|40429162|FG000|Overall Study|Lost to Follow-up|2|||
16537224|NCT00911534|40429163|FG001|Overall Study|Lost to Follow-up|4|||
16537225|NCT00911534|40429162|FG000|Overall Study|Withdrawal by Subject|2|||
16537226|NCT00911534|40429163|FG001|Overall Study|Withdrawal by Subject|1|||
16537227|NCT00911534|40429162|FG000|Overall Study|Lack of Efficacy|4|||
16537228|NCT00911534|40429163|FG001|Overall Study|Lack of Efficacy|1|||
16537229|NCT00911534|40429162|FG000|Overall Study|Withdrawal of consent|1|||
16537230|NCT00911534|40429163|FG001|Overall Study|Withdrawal of consent|4|||
16537231|NCT00911534|40429162|FG000|Overall Study|Other|2|||
16537232|NCT00911534|40429163|FG001|Overall Study|Other|2|||
16537233|NCT01003899|40429164|FG000|Overall Study|Other Adverse Event|8|||
16537234|NCT01003899|40429164|FG000|Overall Study|Not entered|4|||
16537235|NCT01003899|40429164|FG000|Overall Study|Not treated|1|||
16537236|NCT01003899|40429164|FG000|Overall Study|Progressive disease|34|||
16537237|NCT05182840|40429167|FG000|Run-in Period|Not treated|0|||
16537238|NCT05182840|40429168|FG001|Run-in Period|Not treated|1|||
16537239|NCT05182840|40429169|FG002|Run-in Period|Not treated|0|||
16537240|NCT05182840|40429170|FG003|Run-in Period|Not treated|0|||
16537241|NCT05182840|40429171|FG004|Run-in Period|Not treated|0|||
16537242|NCT05182840|40429172|FG005|Run-in Period|Not treated|0|||
16537243|NCT05182840|40429173|FG006|Run-in Period|Not treated|0|||
16537244|NCT05182840|40429174|FG007|Run-in Period|Not treated|0|||
16537245|NCT05182840|40429175|FG008|Run-in Period|Not treated|0|||
16537246|NCT05182840|40429176|FG009|Run-in Period|Not treated|0|||
16537247|NCT05182840|40429167|FG000|Run-in Period|Other reason but not sponsor termination|14|||
16537248|NCT05182840|40429168|FG001|Run-in Period|Other reason but not sponsor termination|18|||
16537249|NCT05182840|40429169|FG002|Run-in Period|Other reason but not sponsor termination|0|||
16537250|NCT05182840|40429170|FG003|Run-in Period|Other reason but not sponsor termination|0|||
16537251|NCT05182840|40429171|FG004|Run-in Period|Other reason but not sponsor termination|0|||
16537252|NCT05182840|40429172|FG005|Run-in Period|Other reason but not sponsor termination|0|||
16537253|NCT05182840|40429173|FG006|Run-in Period|Other reason but not sponsor termination|0|||
16537254|NCT05182840|40429174|FG007|Run-in Period|Other reason but not sponsor termination|0|||
16537255|NCT05182840|40429175|FG008|Run-in Period|Other reason but not sponsor termination|0|||
16537256|NCT05182840|40429176|FG009|Run-in Period|Other reason but not sponsor termination|0|||
16537257|NCT05182840|40429167|FG000|Run-in Period|No reason available|2|||
16537258|NCT05182840|40429168|FG001|Run-in Period|No reason available|2|||
16537259|NCT05182840|40429169|FG002|Run-in Period|No reason available|0|||
16537260|NCT05182840|40429170|FG003|Run-in Period|No reason available|0|||
16537261|NCT05182840|40429171|FG004|Run-in Period|No reason available|0|||
16537262|NCT05182840|40429172|FG005|Run-in Period|No reason available|0|||
16537263|NCT05182840|40429173|FG006|Run-in Period|No reason available|0|||
16537264|NCT05182840|40429174|FG007|Run-in Period|No reason available|0|||
16537265|NCT05182840|40429175|FG008|Run-in Period|No reason available|0|||
16537266|NCT05182840|40429176|FG009|Run-in Period|No reason available|0|||
16537267|NCT05182840|40429167|FG000|Run-in Period|Burden of study procedures|2|||
16537268|NCT05182840|40429168|FG001|Run-in Period|Burden of study procedures|2|||
16537269|NCT05182840|40429169|FG002|Run-in Period|Burden of study procedures|0|||
16537270|NCT05182840|40429170|FG003|Run-in Period|Burden of study procedures|0|||
16537271|NCT05182840|40429171|FG004|Run-in Period|Burden of study procedures|0|||
16537272|NCT05182840|40429172|FG005|Run-in Period|Burden of study procedures|0|||
16537273|NCT05182840|40429173|FG006|Run-in Period|Burden of study procedures|0|||
16537274|NCT05182840|40429174|FG007|Run-in Period|Burden of study procedures|0|||
16537275|NCT05182840|40429175|FG008|Run-in Period|Burden of study procedures|0|||
16537276|NCT05182840|40429176|FG009|Run-in Period|Burden of study procedures|0|||
16537277|NCT05182840|40429167|FG000|Run-in Period|Change of residence|1|||
16537278|NCT05182840|40429168|FG001|Run-in Period|Change of residence|0|||
16537279|NCT05182840|40429169|FG002|Run-in Period|Change of residence|0|||
16537280|NCT05182840|40429170|FG003|Run-in Period|Change of residence|0|||
16537281|NCT05182840|40429171|FG004|Run-in Period|Change of residence|0|||
16537282|NCT05182840|40429172|FG005|Run-in Period|Change of residence|0|||
16537283|NCT05182840|40429173|FG006|Run-in Period|Change of residence|0|||
16537284|NCT05182840|40429174|FG007|Run-in Period|Change of residence|0|||
16537285|NCT05182840|40429175|FG008|Run-in Period|Change of residence|0|||
16537286|NCT05182840|40429176|FG009|Run-in Period|Change of residence|0|||
16537287|NCT05182840|40429167|FG000|Run-in Period|Adverse Event|5|||
16537288|NCT05182840|40429168|FG001|Run-in Period|Adverse Event|5|||
16537289|NCT05182840|40429169|FG002|Run-in Period|Adverse Event|0|||
16537290|NCT05182840|40429170|FG003|Run-in Period|Adverse Event|0|||
16537291|NCT05182840|40429171|FG004|Run-in Period|Adverse Event|0|||
16537292|NCT05182840|40429172|FG005|Run-in Period|Adverse Event|0|||
16102656|NCT03740737|38863251|FG001|Overall Study|Protocol deviation|0|||
16102657|NCT03740737|38863250|FG000|Overall Study|Adverse Event|2|||
16102658|NCT03740737|38863251|FG001|Overall Study|Adverse Event|0|||
16102659|NCT03740737|38863250|FG000|Overall Study|Lost to Follow-up|1|||
16102660|NCT03740737|38863251|FG001|Overall Study|Lost to Follow-up|0|||
16102661|NCT03740737|38863250|FG000|Overall Study|Randomization failure|1|||
16102662|NCT03740737|38863251|FG001|Overall Study|Randomization failure|0|||
16102663|NCT03740737|38863250|FG000|Overall Study|Participant withdrew consent|1|||
16102664|NCT03740737|38863251|FG001|Overall Study|Participant withdrew consent|0|||
16102665|NCT03740737|38863250|FG000|Overall Study|Participant withdrew from trial|2|||
16102666|NCT03740737|38863251|FG001|Overall Study|Participant withdrew from trial|1|||
16102667|NCT01002547|38863252|FG000|Overall Study|Withdrawal by Subject|4|||
16102668|NCT01002547|38863253|FG001|Overall Study|Withdrawal by Subject|0|||
16102669|NCT01002547|38863254|FG002|Overall Study|Withdrawal by Subject|5|||
16102670|NCT01002547|38863252|FG000|Overall Study|Lost to Follow-up|2|||
16102671|NCT01002547|38863253|FG001|Overall Study|Lost to Follow-up|1|||
16102672|NCT01002547|38863254|FG002|Overall Study|Lost to Follow-up|1|||
16102673|NCT01002547|38863252|FG000|Overall Study|Physician Decision|1|||
16102674|NCT01002547|38863253|FG001|Overall Study|Physician Decision|0|||
16102675|NCT01002547|38863254|FG002|Overall Study|Physician Decision|0|||
16102676|NCT01002547|38863252|FG000|Overall Study|Death|0|||
16102677|NCT01002547|38863253|FG001|Overall Study|Death|2|||
16102678|NCT01002547|38863254|FG002|Overall Study|Death|2|||
16338344|NCT01260584|39726109|FG000|Period 2|Adverse Event|1|||
16338345|NCT01260584|39726110|FG001|Period 2|Adverse Event|0|||
16338346|NCT01260584|39726111|FG002|Period 2|Adverse Event|2|||
16338347|NCT01260584|39726112|FG003|Period 2|Adverse Event|0|||
16338348|NCT01260584|39726109|FG000|Period 2|Withdrawal by Subject|0|||
16102679|NCT01002547|38863252|FG000|Overall Study|Adverse Event|1|||
16338349|NCT01260584|39726110|FG001|Period 2|Withdrawal by Subject|1|||
16537293|NCT05182840|40429173|FG006|Run-in Period|Adverse Event|0|||
16537294|NCT05182840|40429174|FG007|Run-in Period|Adverse Event|0|||
16537295|NCT05182840|40429175|FG008|Run-in Period|Adverse Event|0|||
16537296|NCT05182840|40429176|FG009|Run-in Period|Adverse Event|0|||
16537297|NCT05182840|40429167|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
16537298|NCT05182840|40429168|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
16102680|NCT01002547|38863253|FG001|Overall Study|Adverse Event|0|||
16102681|NCT01002547|38863254|FG002|Overall Study|Adverse Event|0|||
16102682|NCT02604342|38863255|FG000|Overall Study|Death|32|||
16102683|NCT02604342|38863256|FG001|Overall Study|Death|16|||
16102684|NCT02604342|38863255|FG000|Overall Study|Progression of disease|1|||
16338350|NCT01260584|39726111|FG002|Period 2|Withdrawal by Subject|0|||
16102685|NCT02604342|38863256|FG001|Overall Study|Progression of disease|0|||
16537299|NCT05182840|40429169|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
16537300|NCT05182840|40429170|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
16537301|NCT05182840|40429171|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
16537302|NCT05182840|40429172|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
16537303|NCT05182840|40429173|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
16537304|NCT05182840|40429174|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
16537305|NCT05182840|40429175|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
16537306|NCT05182840|40429176|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
16537307|NCT05182840|40429167|FG000|Treatment Period|Reason missing|0|||
16537308|NCT05182840|40429168|FG001|Treatment Period|Reason missing|0|||
16537309|NCT05182840|40429169|FG002|Treatment Period|Reason missing|1|||
16537310|NCT05182840|40429170|FG003|Treatment Period|Reason missing|0|||
16537311|NCT05182840|40429171|FG004|Treatment Period|Reason missing|0|||
16537312|NCT05182840|40429172|FG005|Treatment Period|Reason missing|0|||
16537313|NCT05182840|40429173|FG006|Treatment Period|Reason missing|0|||
16537314|NCT05182840|40429174|FG007|Treatment Period|Reason missing|0|||
16537315|NCT05182840|40429175|FG008|Treatment Period|Reason missing|0|||
16537316|NCT05182840|40429176|FG009|Treatment Period|Reason missing|0|||
16537317|NCT05182840|40429167|FG000|Treatment Period|Other but not sponsor termination|0|||
16537318|NCT05182840|40429168|FG001|Treatment Period|Other but not sponsor termination|0|||
16537319|NCT05182840|40429169|FG002|Treatment Period|Other but not sponsor termination|8|||
16537320|NCT05182840|40429170|FG003|Treatment Period|Other but not sponsor termination|6|||
16537321|NCT05182840|40429171|FG004|Treatment Period|Other but not sponsor termination|6|||
16537322|NCT05182840|40429172|FG005|Treatment Period|Other but not sponsor termination|7|||
16537323|NCT05182840|40429173|FG006|Treatment Period|Other but not sponsor termination|5|||
16537324|NCT05182840|40429174|FG007|Treatment Period|Other but not sponsor termination|8|||
16537325|NCT05182840|40429175|FG008|Treatment Period|Other but not sponsor termination|7|||
16537326|NCT05182840|40429176|FG009|Treatment Period|Other but not sponsor termination|2|||
16537327|NCT05182840|40429167|FG000|Treatment Period|Protocol deviation|0|||
16537328|NCT05182840|40429168|FG001|Treatment Period|Protocol deviation|0|||
16537329|NCT05182840|40429169|FG002|Treatment Period|Protocol deviation|0|||
16537330|NCT05182840|40429170|FG003|Treatment Period|Protocol deviation|0|||
16338351|NCT01260584|39726112|FG003|Period 2|Withdrawal by Subject|0|||
16406095|NCT00098722|39966548|FG003|Double Blind Phase|Pregnancy|0|||
16406096|NCT00098722|39966549|FG004|Double Blind Phase|Pregnancy|0|||
16406097|NCT00098722|39966550|FG005|Double Blind Phase|Pregnancy|0|||
16406098|NCT00098722|39966551|FG006|Double Blind Phase|Pregnancy|0|||
16406099|NCT00098722|39966545|FG000|Double Blind Phase|Randomized, not treated|4|||
16537331|NCT05182840|40429171|FG004|Treatment Period|Protocol deviation|0|||
16102686|NCT02604342|38863255|FG000|Overall Study|Withdrawal by Subject|5|||
16102687|NCT02604342|38863256|FG001|Overall Study|Withdrawal by Subject|6|||
16102688|NCT02604342|38863255|FG000|Overall Study|Other|1|||
16338352|NCT00303472|39726117|FG000|Treatment Period|Adverse Event|0|||
16338353|NCT00303472|39726118|FG001|Treatment Period|Adverse Event|0|||
16338354|NCT00303472|39726119|FG002|Treatment Period|Adverse Event|0|||
16338355|NCT00303472|39726120|FG003|Treatment Period|Adverse Event|0|||
16338356|NCT00303472|39726121|FG004|Treatment Period|Adverse Event|1|||
16338357|NCT00303472|39726122|FG005|Treatment Period|Adverse Event|0|||
16338358|NCT00303472|39726123|FG006|Treatment Period|Adverse Event|0|||
16338359|NCT00303472|39726117|FG000|Treatment Period|Death|0|||
16338360|NCT00303472|39726118|FG001|Treatment Period|Death|0|||
16537332|NCT05182840|40429172|FG005|Treatment Period|Protocol deviation|0|||
16102689|NCT02604342|38863256|FG001|Overall Study|Other|0|||
16102690|NCT02604342|38863255|FG000|Overall Study|Study Termination by Sponsor|1|||
16102691|NCT02604342|38863256|FG001|Overall Study|Study Termination by Sponsor|0|||
16338361|NCT00303472|39726119|FG002|Treatment Period|Death|0|||
16406100|NCT00098722|39966546|FG001|Double Blind Phase|Randomized, not treated|3|||
16537333|NCT05182840|40429173|FG006|Treatment Period|Protocol deviation|0|||
16537334|NCT05182840|40429174|FG007|Treatment Period|Protocol deviation|0|||
16102692|NCT02604342|38863255|FG000|Overall Study|Lost to Follow-up|1|||
16102693|NCT02604342|38863256|FG001|Overall Study|Lost to Follow-up|1|||
16338362|NCT00303472|39726120|FG003|Treatment Period|Death|1|||
16338363|NCT00303472|39726121|FG004|Treatment Period|Death|0|||
16406101|NCT00098722|39966547|FG002|Double Blind Phase|Randomized, not treated|3|||
16537335|NCT05182840|40429175|FG008|Treatment Period|Protocol deviation|1|||
16537336|NCT05182840|40429176|FG009|Treatment Period|Protocol deviation|0|||
16537337|NCT05182840|40429167|FG000|Treatment Period|No reason available|0|||
16537338|NCT05182840|40429168|FG001|Treatment Period|No reason available|0|||
16537339|NCT05182840|40429169|FG002|Treatment Period|No reason available|0|||
16537340|NCT05182840|40429170|FG003|Treatment Period|No reason available|1|||
16537341|NCT05182840|40429171|FG004|Treatment Period|No reason available|0|||
16537342|NCT05182840|40429172|FG005|Treatment Period|No reason available|2|||
16537343|NCT05182840|40429173|FG006|Treatment Period|No reason available|0|||
16537344|NCT05182840|40429174|FG007|Treatment Period|No reason available|1|||
16537345|NCT05182840|40429175|FG008|Treatment Period|No reason available|0|||
16537346|NCT05182840|40429176|FG009|Treatment Period|No reason available|0|||
16537347|NCT05182840|40429167|FG000|Treatment Period|Burden of study procedures|0|||
16537348|NCT05182840|40429168|FG001|Treatment Period|Burden of study procedures|0|||
16537349|NCT05182840|40429169|FG002|Treatment Period|Burden of study procedures|0|||
16537350|NCT05182840|40429170|FG003|Treatment Period|Burden of study procedures|0|||
16537351|NCT05182840|40429171|FG004|Treatment Period|Burden of study procedures|1|||
16537352|NCT05182840|40429172|FG005|Treatment Period|Burden of study procedures|0|||
16537353|NCT05182840|40429173|FG006|Treatment Period|Burden of study procedures|0|||
16537354|NCT05182840|40429174|FG007|Treatment Period|Burden of study procedures|0|||
16537355|NCT05182840|40429175|FG008|Treatment Period|Burden of study procedures|0|||
16537356|NCT05182840|40429176|FG009|Treatment Period|Burden of study procedures|0|||
16537357|NCT05182840|40429167|FG000|Treatment Period|Change of residence|0|||
16537358|NCT05182840|40429168|FG001|Treatment Period|Change of residence|0|||
16537359|NCT05182840|40429169|FG002|Treatment Period|Change of residence|0|||
16537360|NCT05182840|40429170|FG003|Treatment Period|Change of residence|0|||
16537361|NCT05182840|40429171|FG004|Treatment Period|Change of residence|0|||
16338364|NCT00303472|39726122|FG005|Treatment Period|Death|0|||
16338365|NCT00303472|39726123|FG006|Treatment Period|Death|1|||
16338366|NCT00303472|39726117|FG000|Treatment Period|Withdrawal by Subject|0|||
16338367|NCT00303472|39726118|FG001|Treatment Period|Withdrawal by Subject|0|||
16338368|NCT00303472|39726119|FG002|Treatment Period|Withdrawal by Subject|0|||
16338369|NCT00303472|39726120|FG003|Treatment Period|Withdrawal by Subject|1|||
16338370|NCT00303472|39726121|FG004|Treatment Period|Withdrawal by Subject|0|||
16338371|NCT00303472|39726122|FG005|Treatment Period|Withdrawal by Subject|1|||
16338372|NCT00303472|39726123|FG006|Treatment Period|Withdrawal by Subject|0|||
16338373|NCT00303472|39726117|FG000|Treatment Period|Other|0|||
16338374|NCT00303472|39726118|FG001|Treatment Period|Other|0|||
16338375|NCT00303472|39726119|FG002|Treatment Period|Other|0|||
16338376|NCT00303472|39726120|FG003|Treatment Period|Other|0|||
16338377|NCT00303472|39726121|FG004|Treatment Period|Other|1|||
16338378|NCT00303472|39726122|FG005|Treatment Period|Other|0|||
16338379|NCT00303472|39726123|FG006|Treatment Period|Other|1|||
16338380|NCT00303472|39726117|FG000|Treatment Period|Disease Progression (to AML)|0|||
16338381|NCT00303472|39726118|FG001|Treatment Period|Disease Progression (to AML)|0|||
16338382|NCT00303472|39726119|FG002|Treatment Period|Disease Progression (to AML)|0|||
16338383|NCT00303472|39726120|FG003|Treatment Period|Disease Progression (to AML)|0|||
16338384|NCT00303472|39726121|FG004|Treatment Period|Disease Progression (to AML)|1|||
16338385|NCT00303472|39726122|FG005|Treatment Period|Disease Progression (to AML)|0|||
16338386|NCT00303472|39726123|FG006|Treatment Period|Disease Progression (to AML)|0|||
16338387|NCT00303472|39726117|FG000|Treatment Extension (Optional)|Adverse Event|1|||
16338388|NCT00303472|39726118|FG001|Treatment Extension (Optional)|Adverse Event|0|||
16338389|NCT00303472|39726119|FG002|Treatment Extension (Optional)|Adverse Event|1|||
16338390|NCT00303472|39726120|FG003|Treatment Extension (Optional)|Adverse Event|0|||
16338391|NCT00303472|39726121|FG004|Treatment Extension (Optional)|Adverse Event|0|||
16338392|NCT00303472|39726122|FG005|Treatment Extension (Optional)|Adverse Event|0|||
16338393|NCT00303472|39726123|FG006|Treatment Extension (Optional)|Adverse Event|0|||
16338394|NCT00303472|39726117|FG000|Treatment Extension (Optional)|Death|2|||
16338395|NCT00303472|39726118|FG001|Treatment Extension (Optional)|Death|0|||
16338396|NCT00303472|39726119|FG002|Treatment Extension (Optional)|Death|1|||
16338397|NCT00303472|39726120|FG003|Treatment Extension (Optional)|Death|0|||
16338398|NCT00303472|39726121|FG004|Treatment Extension (Optional)|Death|0|||
16338399|NCT00303472|39726122|FG005|Treatment Extension (Optional)|Death|0|||
16338400|NCT00303472|39726123|FG006|Treatment Extension (Optional)|Death|0|||
16338401|NCT00303472|39726117|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
16338402|NCT00303472|39726118|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
16338403|NCT00303472|39726119|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
16338404|NCT00303472|39726120|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
16338405|NCT00303472|39726121|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
16338406|NCT00303472|39726122|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
16338407|NCT00303472|39726123|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
16338408|NCT00303472|39726117|FG000|Treatment Extension (Optional)|Physician Decision|0|||
16338409|NCT00303472|39726118|FG001|Treatment Extension (Optional)|Physician Decision|4|||
16537362|NCT05182840|40429172|FG005|Treatment Period|Change of residence|1|||
16338410|NCT00303472|39726119|FG002|Treatment Extension (Optional)|Physician Decision|2|||
16338411|NCT00303472|39726120|FG003|Treatment Extension (Optional)|Physician Decision|3|||
16338412|NCT00303472|39726121|FG004|Treatment Extension (Optional)|Physician Decision|2|||
16338413|NCT00303472|39726122|FG005|Treatment Extension (Optional)|Physician Decision|0|||
16406102|NCT00098722|39966548|FG003|Double Blind Phase|Randomized, not treated|0|||
16406103|NCT00098722|39966549|FG004|Double Blind Phase|Randomized, not treated|0|||
16406104|NCT00098722|39966550|FG005|Double Blind Phase|Randomized, not treated|0|||
16338414|NCT00303472|39726123|FG006|Treatment Extension (Optional)|Physician Decision|0|||
16338415|NCT00303472|39726117|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
16338416|NCT00303472|39726118|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
16338417|NCT00303472|39726119|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
16338418|NCT00303472|39726120|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
16338419|NCT00303472|39726121|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
16338420|NCT00303472|39726122|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
16338421|NCT00303472|39726123|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
16338422|NCT00303472|39726117|FG000|Treatment Extension (Optional)|Other|0|||
16338423|NCT00303472|39726118|FG001|Treatment Extension (Optional)|Other|2|||
16338424|NCT00303472|39726119|FG002|Treatment Extension (Optional)|Other|4|||
16338425|NCT00303472|39726120|FG003|Treatment Extension (Optional)|Other|2|||
16338426|NCT00303472|39726121|FG004|Treatment Extension (Optional)|Other|1|||
16338427|NCT00303472|39726122|FG005|Treatment Extension (Optional)|Other|0|||
16338428|NCT00303472|39726123|FG006|Treatment Extension (Optional)|Other|0|||
16338429|NCT00303472|39726117|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
16406105|NCT00098722|39966551|FG006|Double Blind Phase|Randomized, not treated|0|||
16338430|NCT00303472|39726118|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
16338431|NCT00303472|39726119|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
16338432|NCT00303472|39726120|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
16338433|NCT00303472|39726121|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
16338434|NCT00303472|39726122|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
16338435|NCT00303472|39726123|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
16338436|NCT02191046|39726127|FG000|Overall Study|low compliance|5|||
16406106|NCT00098722|39966545|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
16406107|NCT00098722|39966546|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
16406108|NCT00098722|39966547|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
16406109|NCT00098722|39966548|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
16406110|NCT00098722|39966549|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
16406111|NCT00098722|39966550|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
16406112|NCT00098722|39966551|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
16406113|NCT00098722|39966545|FG000|Double Blind Phase|Other|7|||
16406114|NCT00098722|39966546|FG001|Double Blind Phase|Other|8|||
16406115|NCT00098722|39966547|FG002|Double Blind Phase|Other|7|||
16406116|NCT00098722|39966548|FG003|Double Blind Phase|Other|0|||
16406117|NCT00098722|39966549|FG004|Double Blind Phase|Other|0|||
16406118|NCT00098722|39966550|FG005|Double Blind Phase|Other|0|||
16406119|NCT00098722|39966551|FG006|Double Blind Phase|Other|0|||
16406120|NCT00098722|39966545|FG000|Open Label Phase|Adverse Event|0|||
16406121|NCT00098722|39966546|FG001|Open Label Phase|Adverse Event|0|||
16406122|NCT00098722|39966547|FG002|Open Label Phase|Adverse Event|0|||
16406123|NCT00098722|39966548|FG003|Open Label Phase|Adverse Event|5|||
16406124|NCT00098722|39966549|FG004|Open Label Phase|Adverse Event|0|||
16406125|NCT00098722|39966550|FG005|Open Label Phase|Adverse Event|0|||
16338437|NCT02191046|39726128|FG001|Overall Study|low compliance|1|||
16338438|NCT01281956|39726129|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
16338439|NCT01281956|39726130|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
16338440|NCT01994902|39726133|FG000|Test Period 1|Withdrawal by Subject|3|||
16338441|NCT01994902|39726134|FG001|Test Period 1|Withdrawal by Subject|0|||
16338442|NCT01994902|39726133|FG000|Test Period 1|device deficiency with adverse event|0|||
16338443|NCT01994902|39726134|FG001|Test Period 1|device deficiency with adverse event|1|||
16338444|NCT01994902|39726133|FG000|Test Period 1|Adverse Event|2|||
16338445|NCT01994902|39726134|FG001|Test Period 1|Adverse Event|1|||
16338446|NCT01994902|39726133|FG000|Test Period 1|Lack of Efficacy|0|||
16338447|NCT01994902|39726134|FG001|Test Period 1|Lack of Efficacy|1|||
16338448|NCT01994902|39726133|FG000|Test Period 1|bag too small|1|||
16338449|NCT01994902|39726134|FG001|Test Period 1|bag too small|0|||
16338450|NCT01994902|39726133|FG000|Test Period 2|Withdrawal by Subject|0|||
16338451|NCT01994902|39726134|FG001|Test Period 2|Withdrawal by Subject|2|||
16338452|NCT01994902|39726133|FG000|Test Period 2|Lack of Efficacy|0|||
16406126|NCT00098722|39966551|FG006|Open Label Phase|Adverse Event|0|||
16406127|NCT00098722|39966545|FG000|Open Label Phase|Death|0|||
16406128|NCT00098722|39966546|FG001|Open Label Phase|Death|0|||
16338453|NCT01994902|39726134|FG001|Test Period 2|Lack of Efficacy|1|||
16406129|NCT00098722|39966547|FG002|Open Label Phase|Death|0|||
16406130|NCT00098722|39966548|FG003|Open Label Phase|Death|2|||
16537363|NCT05182840|40429173|FG006|Treatment Period|Change of residence|0|||
16338454|NCT01994902|39726133|FG000|Test Period 2|Other|0|||
16338455|NCT01994902|39726134|FG001|Test Period 2|Other|3|||
16338456|NCT02000882|39726135|FG000|Overall Study|Adverse Event|3|||
16338457|NCT02000882|39726135|FG000|Overall Study|Physician Decision|2|||
16338458|NCT02000882|39726135|FG000|Overall Study|Withdrawal by Subject|1|||
16338459|NCT01522235|39726137|FG000|Overall Study|Physician Decision|1|||
16338460|NCT01522235|39726138|FG001|Overall Study|Physician Decision|1|||
16338461|NCT03246061|39726139|FG000|Overall Study|Still in follow-up|15|||
16338462|NCT03246061|39726140|FG001|Overall Study|Still in follow-up|21|||
16406131|NCT00098722|39966549|FG004|Open Label Phase|Death|0|||
16537364|NCT05182840|40429174|FG007|Treatment Period|Change of residence|0|||
16537365|NCT05182840|40429175|FG008|Treatment Period|Change of residence|0|||
16537366|NCT05182840|40429176|FG009|Treatment Period|Change of residence|0|||
16537367|NCT05182840|40429167|FG000|Treatment Period|Adverse Event|0|||
16537368|NCT05182840|40429168|FG001|Treatment Period|Adverse Event|0|||
16537369|NCT05182840|40429169|FG002|Treatment Period|Adverse Event|4|||
16537370|NCT05182840|40429170|FG003|Treatment Period|Adverse Event|16|||
16537371|NCT05182840|40429171|FG004|Treatment Period|Adverse Event|12|||
16537372|NCT05182840|40429172|FG005|Treatment Period|Adverse Event|6|||
16537373|NCT05182840|40429173|FG006|Treatment Period|Adverse Event|4|||
16537374|NCT05182840|40429174|FG007|Treatment Period|Adverse Event|8|||
16537375|NCT05182840|40429175|FG008|Treatment Period|Adverse Event|16|||
16537376|NCT05182840|40429176|FG009|Treatment Period|Adverse Event|5|||
16537377|NCT05182840|40429167|FG000|Treatment Period|Not treated with study drug|0|||
16537378|NCT05182840|40429168|FG001|Treatment Period|Not treated with study drug|0|||
16537379|NCT05182840|40429169|FG002|Treatment Period|Not treated with study drug|0|||
16537380|NCT05182840|40429170|FG003|Treatment Period|Not treated with study drug|1|||
16537381|NCT05182840|40429171|FG004|Treatment Period|Not treated with study drug|0|||
16537382|NCT05182840|40429172|FG005|Treatment Period|Not treated with study drug|0|||
16537383|NCT05182840|40429173|FG006|Treatment Period|Not treated with study drug|1|||
16537384|NCT05182840|40429174|FG007|Treatment Period|Not treated with study drug|1|||
16537385|NCT05182840|40429175|FG008|Treatment Period|Not treated with study drug|0|||
16537386|NCT05182840|40429176|FG009|Treatment Period|Not treated with study drug|0|||
16537387|NCT03561090|40429177|FG000|Overall Study|Adverse Event|11|||
16537388|NCT03561090|40429178|FG001|Overall Study|Adverse Event|7|||
16537389|NCT03561090|40429177|FG000|Overall Study|Non-Compliance With Study Drug|2|||
16537390|NCT03561090|40429178|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16537391|NCT03561090|40429177|FG000|Overall Study|Protocol Violation|2|||
16537392|NCT03561090|40429178|FG001|Overall Study|Protocol Violation|2|||
16537393|NCT03561090|40429177|FG000|Overall Study|Withdrawal by Subject|7|||
16537394|NCT03561090|40429178|FG001|Overall Study|Withdrawal by Subject|7|||
16537395|NCT03561090|40429177|FG000|Overall Study|Lost to Follow-up|7|||
16216853|NCT02442765|39272505|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
16537396|NCT03561090|40429178|FG001|Overall Study|Lost to Follow-up|2|||
16338463|NCT01588405|39726141|FG000|Overall Study|Adverse Event|1|||
16338464|NCT01588405|39726141|FG000|Overall Study|Clinical Worsening|1|||
16338465|NCT01066793|39726142|FG000|Overall Study|Death|4|||
16338466|NCT01066793|39726143|FG001|Overall Study|Death|1|||
16338467|NCT01066793|39726144|FG002|Overall Study|Death|1|||
16338468|NCT01066793|39726145|FG003|Overall Study|Death|0|||
16338469|NCT01066793|39726146|FG004|Overall Study|Death|0|||
16338470|NCT01066793|39726147|FG005|Overall Study|Death|0|||
16338471|NCT01066793|39726142|FG000|Overall Study|Lack of Efficacy|2|||
16338472|NCT01066793|39726143|FG001|Overall Study|Lack of Efficacy|1|||
16338473|NCT01066793|39726144|FG002|Overall Study|Lack of Efficacy|0|||
16338474|NCT01066793|39726145|FG003|Overall Study|Lack of Efficacy|0|||
16338475|NCT01066793|39726146|FG004|Overall Study|Lack of Efficacy|0|||
16338476|NCT01066793|39726147|FG005|Overall Study|Lack of Efficacy|0|||
16338477|NCT01066793|39726142|FG000|Overall Study|Lost to Follow-up|180|||
16338478|NCT01066793|39726143|FG001|Overall Study|Lost to Follow-up|39|||
16338479|NCT01066793|39726144|FG002|Overall Study|Lost to Follow-up|82|||
16338480|NCT01066793|39726145|FG003|Overall Study|Lost to Follow-up|16|||
16338481|NCT01066793|39726146|FG004|Overall Study|Lost to Follow-up|0|||
16338482|NCT01066793|39726147|FG005|Overall Study|Lost to Follow-up|1|||
16338483|NCT01066793|39726142|FG000|Overall Study|Physician Decision|3|||
16338484|NCT01066793|39726143|FG001|Overall Study|Physician Decision|0|||
16338485|NCT01066793|39726144|FG002|Overall Study|Physician Decision|0|||
16338486|NCT01066793|39726145|FG003|Overall Study|Physician Decision|0|||
16338487|NCT01066793|39726146|FG004|Overall Study|Physician Decision|0|||
16338488|NCT01066793|39726147|FG005|Overall Study|Physician Decision|0|||
16338489|NCT01066793|39726142|FG000|Overall Study|Protocol Violation|3|||
16537397|NCT03561090|40429177|FG000|Overall Study|Study Terminated by Sponsor|10|||
16537398|NCT03561090|40429178|FG001|Overall Study|Study Terminated by Sponsor|15|||
16537399|NCT03561090|40429177|FG000|Overall Study|Randomized by Mistake|1|||
16537400|NCT03561090|40429178|FG001|Overall Study|Randomized by Mistake|1|||
16537401|NCT03561090|40429177|FG000|Overall Study|Other Not Specified|0|||
16537402|NCT03561090|40429178|FG001|Overall Study|Other Not Specified|2|||
16537403|NCT02061202|40429182|FG000|Overall Study|Lost to Follow-up|1|||
16537404|NCT02061202|40429183|FG001|Overall Study|Lost to Follow-up|1|||
16537405|NCT02985866|40429184|FG000|Overall Study|Poor CGM data|1|||
16537406|NCT02985866|40429185|FG001|Overall Study|Poor CGM data|1|||
16537407|NCT03923933|40429186|FG000|Overall Study|Lost to Follow-up|1|||
16537408|NCT03923933|40429187|FG001|Overall Study|Lost to Follow-up|0|||
16537409|NCT03923933|40429186|FG000|Overall Study|Withdrawal by Subject|0|||
16537410|NCT03923933|40429187|FG001|Overall Study|Withdrawal by Subject|1|||
16537411|NCT00602667|40429189|FG000|Overall Study|Still on Therapy|0|||
16537412|NCT00602667|40429190|FG001|Overall Study|Still on Therapy|2|||
16537413|NCT00602667|40429191|FG002|Overall Study|Still on Therapy|2|||
16537414|NCT00602667|40429189|FG000|Overall Study|Death|0|||
16537415|NCT00602667|40429190|FG001|Overall Study|Death|1|||
16537416|NCT00602667|40429191|FG002|Overall Study|Death|1|||
16537417|NCT00602667|40429189|FG000|Overall Study|Family request|3|||
16537418|NCT00602667|40429190|FG001|Overall Study|Family request|25|||
16537419|NCT00602667|40429191|FG002|Overall Study|Family request|6|||
16537420|NCT00602667|40429189|FG000|Overall Study|Excessive toxicity|1|||
16537421|NCT00602667|40429190|FG001|Overall Study|Excessive toxicity|1|||
16537422|NCT00602667|40429191|FG002|Overall Study|Excessive toxicity|0|||
16537423|NCT00602667|40429189|FG000|Overall Study|Second malignancy|0|||
16537424|NCT00602667|40429190|FG001|Overall Study|Second malignancy|1|||
16537425|NCT00602667|40429191|FG002|Overall Study|Second malignancy|0|||
16537426|NCT00602667|40429189|FG000|Overall Study|Physician Decision|2|||
16338490|NCT01066793|39726143|FG001|Overall Study|Protocol Violation|2|||
16338491|NCT01066793|39726144|FG002|Overall Study|Protocol Violation|2|||
16338492|NCT01066793|39726145|FG003|Overall Study|Protocol Violation|0|||
16537427|NCT00602667|40429190|FG001|Overall Study|Physician Decision|3|||
16537428|NCT00602667|40429191|FG002|Overall Study|Physician Decision|8|||
16537429|NCT00602667|40429189|FG000|Overall Study|Progressive disease|13|||
16537430|NCT00602667|40429190|FG001|Overall Study|Progressive disease|48|||
16537431|NCT00602667|40429191|FG002|Overall Study|Progressive disease|45|||
16537432|NCT00602667|40429189|FG000|Overall Study|Progressive disease prior to therapy|0|||
16537433|NCT00602667|40429190|FG001|Overall Study|Progressive disease prior to therapy|0|||
16537434|NCT00602667|40429191|FG002|Overall Study|Progressive disease prior to therapy|1|||
16216854|NCT02442765|39272506|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
16216855|NCT02442765|39272507|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
16216856|NCT02442765|39272508|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
16216857|NCT02442765|39272509|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
16406132|NCT00098722|39966550|FG005|Open Label Phase|Death|0|||
16406133|NCT00098722|39966551|FG006|Open Label Phase|Death|0|||
16406134|NCT00098722|39966545|FG000|Open Label Phase|Lack of Efficacy|0|||
16406135|NCT00098722|39966546|FG001|Open Label Phase|Lack of Efficacy|0|||
16406136|NCT00098722|39966547|FG002|Open Label Phase|Lack of Efficacy|0|||
16406137|NCT00098722|39966548|FG003|Open Label Phase|Lack of Efficacy|8|||
16406138|NCT00098722|39966549|FG004|Open Label Phase|Lack of Efficacy|0|||
16406139|NCT00098722|39966550|FG005|Open Label Phase|Lack of Efficacy|0|||
16406140|NCT00098722|39966551|FG006|Open Label Phase|Lack of Efficacy|0|||
16406141|NCT00098722|39966545|FG000|Open Label Phase|Pregnancy|0|||
16406142|NCT00098722|39966546|FG001|Open Label Phase|Pregnancy|0|||
16537435|NCT03342638|40429192|FG000|Overall Study|Withdrawal by Subject|1|||
16537436|NCT03342638|40429193|FG001|Overall Study|Withdrawal by Subject|0|||
16537437|NCT03342638|40429192|FG000|Overall Study|Physician Decision|0|||
16537438|NCT03342638|40429193|FG001|Overall Study|Physician Decision|1|||
16537439|NCT00677352|40429196|FG000|Treatment Phase|Adverse Event|14|||
16537440|NCT00677352|40429197|FG001|Treatment Phase|Adverse Event|22|||
16537441|NCT00677352|40429196|FG000|Treatment Phase|Lack of Efficacy|2|||
16537442|NCT00677352|40429197|FG001|Treatment Phase|Lack of Efficacy|3|||
16537443|NCT00677352|40429196|FG000|Treatment Phase|Lost to Follow-up|0|||
16537444|NCT00677352|40429197|FG001|Treatment Phase|Lost to Follow-up|1|||
16537445|NCT00677352|40429196|FG000|Treatment Phase|Withdrawal by Subject|7|||
16537446|NCT00677352|40429197|FG001|Treatment Phase|Withdrawal by Subject|7|||
16537447|NCT00677352|40429196|FG000|Treatment Phase|Physician Decision|1|||
16537448|NCT00677352|40429197|FG001|Treatment Phase|Physician Decision|0|||
16537449|NCT00677352|40429196|FG000|Treatment Phase|Pregnancy|0|||
16537450|NCT00677352|40429197|FG001|Treatment Phase|Pregnancy|1|||
16537451|NCT00677352|40429196|FG000|Treatment Phase|Protocol Violation|1|||
16537452|NCT00677352|40429197|FG001|Treatment Phase|Protocol Violation|1|||
16537453|NCT00677352|40429196|FG000|Treatment Phase|Transference or work related matter|0|||
16537454|NCT00677352|40429197|FG001|Treatment Phase|Transference or work related matter|5|||
16537455|NCT00677352|40429196|FG000|Treatment Phase|Not treated|0|||
16537456|NCT00677352|40429197|FG001|Treatment Phase|Not treated|2|||
16537457|NCT00677352|40429196|FG000|Tapering Phase|Adverse Event|1|||
16537458|NCT00677352|40429197|FG001|Tapering Phase|Adverse Event|5|||
16537459|NCT00677352|40429196|FG000|Tapering Phase|Withdrawal by Subject|5|||
16537460|NCT00677352|40429197|FG001|Tapering Phase|Withdrawal by Subject|3|||
16537461|NCT00677352|40429196|FG000|Tapering Phase|Pregnancy|0|||
16537462|NCT00677352|40429197|FG001|Tapering Phase|Pregnancy|1|||
16537463|NCT00677352|40429196|FG000|Tapering Phase|Job transfer|0|||
16537464|NCT00677352|40429197|FG001|Tapering Phase|Job transfer|1|||
16537465|NCT01618864|40429198|FG000|Overall Study|Withdrawal by Subject|2|||
16537466|NCT01618864|40429198|FG000|Overall Study|Lost to Follow-up|2|||
16406143|NCT00098722|39966547|FG002|Open Label Phase|Pregnancy|0|||
16537467|NCT02525874|40429202|FG000|Overall Study|Other|1|||
16537468|NCT02525874|40429202|FG000|Overall Study|Investigator Decision|1|||
16537469|NCT02525874|40429202|FG000|Overall Study|Consent withdrawn|22|||
16537470|NCT02525874|40429202|FG000|Overall Study|Non-compliance with study drug|3|||
16338493|NCT01066793|39726146|FG004|Overall Study|Protocol Violation|0|||
16338494|NCT01066793|39726147|FG005|Overall Study|Protocol Violation|0|||
16338495|NCT01066793|39726142|FG000|Overall Study|Withdrawal by Subject|7|||
16338496|NCT01066793|39726143|FG001|Overall Study|Withdrawal by Subject|4|||
16338497|NCT01066793|39726144|FG002|Overall Study|Withdrawal by Subject|1|||
16216858|NCT02442765|39272510|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
16216859|NCT02442765|39272503|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
16338498|NCT01066793|39726145|FG003|Overall Study|Withdrawal by Subject|0|||
16338499|NCT01066793|39726146|FG004|Overall Study|Withdrawal by Subject|0|||
16338500|NCT01066793|39726147|FG005|Overall Study|Withdrawal by Subject|0|||
16338501|NCT01066793|39726142|FG000|Overall Study|Early Termination|3|||
16338502|NCT01066793|39726143|FG001|Overall Study|Early Termination|0|||
16338503|NCT01066793|39726144|FG002|Overall Study|Early Termination|0|||
16338504|NCT01066793|39726145|FG003|Overall Study|Early Termination|0|||
16338505|NCT01066793|39726146|FG004|Overall Study|Early Termination|0|||
16338506|NCT01066793|39726147|FG005|Overall Study|Early Termination|0|||
16338507|NCT01066793|39726142|FG000|Overall Study|Lab test not done|7|||
16338508|NCT01066793|39726143|FG001|Overall Study|Lab test not done|0|||
16338509|NCT01066793|39726144|FG002|Overall Study|Lab test not done|0|||
16338510|NCT01066793|39726145|FG003|Overall Study|Lab test not done|1|||
16338511|NCT01066793|39726146|FG004|Overall Study|Lab test not done|0|||
16338512|NCT01066793|39726147|FG005|Overall Study|Lab test not done|0|||
16338513|NCT01066793|39726142|FG000|Overall Study|Miscellaneous|4|||
16338514|NCT01066793|39726143|FG001|Overall Study|Miscellaneous|5|||
16338515|NCT01066793|39726144|FG002|Overall Study|Miscellaneous|6|||
16338516|NCT01066793|39726145|FG003|Overall Study|Miscellaneous|0|||
16338517|NCT01066793|39726146|FG004|Overall Study|Miscellaneous|0|||
16338518|NCT01066793|39726147|FG005|Overall Study|Miscellaneous|0|||
16338519|NCT01066793|39726142|FG000|Overall Study|Non-responders|104|||
16338520|NCT01066793|39726143|FG001|Overall Study|Non-responders|5|||
16338521|NCT01066793|39726144|FG002|Overall Study|Non-responders|11|||
16338522|NCT01066793|39726145|FG003|Overall Study|Non-responders|25|||
16338523|NCT01066793|39726146|FG004|Overall Study|Non-responders|0|||
16338524|NCT01066793|39726147|FG005|Overall Study|Non-responders|0|||
16338525|NCT01066793|39726142|FG000|Overall Study|Other|15|||
16338526|NCT01066793|39726143|FG001|Overall Study|Other|5|||
16338527|NCT01066793|39726144|FG002|Overall Study|Other|6|||
16338528|NCT01066793|39726145|FG003|Overall Study|Other|2|||
16406144|NCT00098722|39966548|FG003|Open Label Phase|Pregnancy|1|||
16406145|NCT00098722|39966549|FG004|Open Label Phase|Pregnancy|0|||
16406146|NCT00098722|39966550|FG005|Open Label Phase|Pregnancy|0|||
16406147|NCT00098722|39966551|FG006|Open Label Phase|Pregnancy|0|||
16406148|NCT00098722|39966545|FG000|Open Label Phase|Participant defaulted|0|||
16406149|NCT00098722|39966546|FG001|Open Label Phase|Participant defaulted|0|||
16406150|NCT00098722|39966547|FG002|Open Label Phase|Participant defaulted|0|||
16406151|NCT00098722|39966548|FG003|Open Label Phase|Participant defaulted|18|||
16406152|NCT00098722|39966549|FG004|Open Label Phase|Participant defaulted|0|||
16406153|NCT00098722|39966550|FG005|Open Label Phase|Participant defaulted|0|||
16406154|NCT00098722|39966551|FG006|Open Label Phase|Participant defaulted|0|||
16406155|NCT00098722|39966545|FG000|Open Label Phase|Ongoing at cut-off date|0|||
16406156|NCT00098722|39966546|FG001|Open Label Phase|Ongoing at cut-off date|0|||
16406157|NCT00098722|39966547|FG002|Open Label Phase|Ongoing at cut-off date|0|||
16406158|NCT00098722|39966548|FG003|Open Label Phase|Ongoing at cut-off date|220|||
16406159|NCT00098722|39966549|FG004|Open Label Phase|Ongoing at cut-off date|50|||
16406160|NCT00098722|39966550|FG005|Open Label Phase|Ongoing at cut-off date|0|||
16406161|NCT00098722|39966551|FG006|Open Label Phase|Ongoing at cut-off date|0|||
16406162|NCT00098722|39966545|FG000|Open Label Phase|Other|0|||
16406163|NCT00098722|39966546|FG001|Open Label Phase|Other|0|||
16406164|NCT00098722|39966547|FG002|Open Label Phase|Other|0|||
16406165|NCT00098722|39966548|FG003|Open Label Phase|Other|18|||
16406166|NCT00098722|39966549|FG004|Open Label Phase|Other|0|||
16406167|NCT00098722|39966550|FG005|Open Label Phase|Other|0|||
16406168|NCT00098722|39966551|FG006|Open Label Phase|Other|0|||
16406169|NCT00098722|39966545|FG000|Observation Phase|Death|0|||
16406170|NCT00098722|39966546|FG001|Observation Phase|Death|0|||
16406171|NCT00098722|39966547|FG002|Observation Phase|Death|0|||
16406172|NCT00098722|39966548|FG003|Observation Phase|Death|0|||
16338529|NCT01066793|39726146|FG004|Overall Study|Other|0|||
16406173|NCT00098722|39966549|FG004|Observation Phase|Death|0|||
16406174|NCT00098722|39966550|FG005|Observation Phase|Death|5|||
16406175|NCT00098722|39966551|FG006|Observation Phase|Death|3|||
16406176|NCT00098722|39966545|FG000|Observation Phase|Lack of Efficacy|0|||
16406177|NCT00098722|39966546|FG001|Observation Phase|Lack of Efficacy|0|||
16406178|NCT00098722|39966547|FG002|Observation Phase|Lack of Efficacy|0|||
16216860|NCT02442765|39272504|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
16338530|NCT01066793|39726147|FG005|Overall Study|Other|0|||
16338531|NCT01066793|39726142|FG000|Overall Study|Relapse|20|||
16338532|NCT01066793|39726143|FG001|Overall Study|Relapse|8|||
16338533|NCT01066793|39726144|FG002|Overall Study|Relapse|2|||
16406179|NCT00098722|39966548|FG003|Observation Phase|Lack of Efficacy|0|||
16406180|NCT00098722|39966549|FG004|Observation Phase|Lack of Efficacy|0|||
16406181|NCT00098722|39966550|FG005|Observation Phase|Lack of Efficacy|2|||
16338534|NCT01066793|39726145|FG003|Overall Study|Relapse|3|||
16338535|NCT01066793|39726146|FG004|Overall Study|Relapse|0|||
16338536|NCT01066793|39726147|FG005|Overall Study|Relapse|0|||
16338537|NCT01066793|39726142|FG000|Overall Study|Result Not Available|1|||
16338538|NCT01066793|39726143|FG001|Overall Study|Result Not Available|0|||
16338539|NCT01066793|39726144|FG002|Overall Study|Result Not Available|0|||
16338540|NCT01066793|39726145|FG003|Overall Study|Result Not Available|0|||
16338541|NCT01066793|39726146|FG004|Overall Study|Result Not Available|0|||
16338542|NCT01066793|39726147|FG005|Overall Study|Result Not Available|0|||
16338543|NCT01066793|39726142|FG000|Overall Study|Treatment Interrupted|1|||
16338544|NCT01066793|39726143|FG001|Overall Study|Treatment Interrupted|1|||
16338545|NCT01066793|39726144|FG002|Overall Study|Treatment Interrupted|0|||
16338546|NCT01066793|39726145|FG003|Overall Study|Treatment Interrupted|0|||
16338547|NCT01066793|39726146|FG004|Overall Study|Treatment Interrupted|0|||
16338548|NCT01066793|39726147|FG005|Overall Study|Treatment Interrupted|0|||
16338549|NCT01066793|39726142|FG000|Overall Study|Treatment Never Started|18|||
16406182|NCT00098722|39966551|FG006|Observation Phase|Lack of Efficacy|0|||
16406183|NCT00098722|39966545|FG000|Observation Phase|Participant defaulted|0|||
16338550|NCT01066793|39726143|FG001|Overall Study|Treatment Never Started|5|||
16338551|NCT01066793|39726144|FG002|Overall Study|Treatment Never Started|4|||
16338552|NCT01066793|39726145|FG003|Overall Study|Treatment Never Started|1|||
16216861|NCT02442765|39272505|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
16216862|NCT02442765|39272506|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
16537471|NCT02525874|40429202|FG000|Overall Study|Adverse Event|17|||
16537472|NCT02525874|40429202|FG000|Overall Study|Lost to Follow-up|7|||
16537473|NCT02525874|40429202|FG000|Overall Study|Disease progression, defined by protocol|2|||
16537474|NCT02525874|40429202|FG000|Overall Study|Disease relapse|4|||
16537475|NCT02525874|40429202|FG000|Overall Study|Alternative Treatment for MS|2|||
16537476|NCT02525874|40429202|FG000|Overall Study|New lesions in Brain|1|||
16537477|NCT00522275|40429203|FG000|Overall Study|Adverse Event|35|||
16537478|NCT00522275|40429203|FG000|Overall Study|Lack of Efficacy|80|||
16537479|NCT00522275|40429203|FG000|Overall Study|Subject withdrew consent|16|||
16537480|NCT00522275|40429203|FG000|Overall Study|Protocol deviation|1|||
16537481|NCT00522275|40429203|FG000|Overall Study|Unsatisfactory compliance|11|||
16537482|NCT00522275|40429203|FG000|Overall Study|Lost to Follow-up|8|||
16537483|NCT00522275|40429203|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
16537484|NCT00522275|40429203|FG000|Overall Study|Other: Subject is pregnant|2|||
16216863|NCT02442765|39272507|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
16216864|NCT02442765|39272508|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
16216865|NCT02442765|39272509|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
16216866|NCT02442765|39272510|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
16216867|NCT02996110|39272517|FG000|Pre-Treatment|Other Reasons|0|||
16216868|NCT02996110|39272518|FG001|Pre-Treatment|Other Reasons|1|||
16216869|NCT02996110|39272519|FG002|Pre-Treatment|Other Reasons|0|||
16216870|NCT02996110|39272520|FG003|Pre-Treatment|Other Reasons|0|||
16216871|NCT02996110|39272521|FG004|Pre-Treatment|Other Reasons|1|||
16216872|NCT02996110|39272517|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
16216873|NCT02996110|39272518|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
16216874|NCT02996110|39272519|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
16216875|NCT02996110|39272520|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
16216876|NCT02996110|39272521|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
16216877|NCT02996110|39272517|FG000|Track 1|Disease Progression|15|||
16216878|NCT02996110|39272518|FG001|Track 1|Disease Progression|17|||
16338553|NCT01066793|39726146|FG004|Overall Study|Treatment Never Started|0|||
16338554|NCT01066793|39726147|FG005|Overall Study|Treatment Never Started|0|||
16338555|NCT01066793|39726142|FG000|Overall Study|Treatment Stopped|2|||
16338556|NCT01066793|39726143|FG001|Overall Study|Treatment Stopped|1|||
16338557|NCT01066793|39726144|FG002|Overall Study|Treatment Stopped|0|||
16338558|NCT01066793|39726145|FG003|Overall Study|Treatment Stopped|1|||
16338559|NCT01066793|39726146|FG004|Overall Study|Treatment Stopped|0|||
16338560|NCT01066793|39726147|FG005|Overall Study|Treatment Stopped|0|||
16338561|NCT00419159|39726149|FG000|Overall Study|Adverse Event|7|||
16338562|NCT00419159|39726150|FG001|Overall Study|Adverse Event|15|||
16338563|NCT00419159|39726149|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16338564|NCT00419159|39726150|FG001|Overall Study|Abnormal laboratory value(s)|2|||
16338565|NCT00419159|39726149|FG000|Overall Study|Subject's no longer requires study drug|0|||
16338566|NCT00419159|39726150|FG001|Overall Study|Subject's no longer requires study drug|1|||
16338567|NCT00419159|39726149|FG000|Overall Study|Protocol Violation|1|||
16338568|NCT00419159|39726150|FG001|Overall Study|Protocol Violation|0|||
16338569|NCT00419159|39726149|FG000|Overall Study|Withdrawal by Subject|10|||
16338570|NCT00419159|39726150|FG001|Overall Study|Withdrawal by Subject|3|||
16338571|NCT00419159|39726149|FG000|Overall Study|Lost to Follow-up|0|||
16338572|NCT00419159|39726150|FG001|Overall Study|Lost to Follow-up|1|||
16537485|NCT00522275|40429203|FG000|Overall Study|Other: Subject relocated|2|||
16537486|NCT00522275|40429203|FG000|Overall Study|Other: Subject arrested|1|||
16338573|NCT00419159|39726149|FG000|Overall Study|Death|2|||
16338574|NCT00419159|39726150|FG001|Overall Study|Death|2|||
16338575|NCT00419159|39726149|FG000|Overall Study|Disease progression|79|||
16338576|NCT00419159|39726150|FG001|Overall Study|Disease progression|76|||
16338577|NCT02700698|39726151|FG000|Overall Study|Withdrawal by Subject|1|||
16338578|NCT02700698|39726152|FG001|Overall Study|Withdrawal by Subject|0|||
16406184|NCT00098722|39966546|FG001|Observation Phase|Participant defaulted|0|||
16338579|NCT01180049|39726158|FG000|Overall Study|Other|9|||
16338580|NCT01180049|39726159|FG001|Overall Study|Other|7|||
16406185|NCT00098722|39966547|FG002|Observation Phase|Participant defaulted|0|||
16406186|NCT00098722|39966548|FG003|Observation Phase|Participant defaulted|0|||
16406187|NCT00098722|39966549|FG004|Observation Phase|Participant defaulted|0|||
16406188|NCT00098722|39966550|FG005|Observation Phase|Participant defaulted|17|||
16406189|NCT00098722|39966551|FG006|Observation Phase|Participant defaulted|4|||
16406190|NCT00098722|39966545|FG000|Observation Phase|Other|0|||
16406191|NCT00098722|39966546|FG001|Observation Phase|Other|0|||
16406192|NCT00098722|39966547|FG002|Observation Phase|Other|0|||
16406193|NCT00098722|39966548|FG003|Observation Phase|Other|0|||
16406194|NCT00098722|39966549|FG004|Observation Phase|Other|0|||
16406195|NCT00098722|39966550|FG005|Observation Phase|Other|21|||
16406196|NCT00098722|39966551|FG006|Observation Phase|Other|10|||
16216879|NCT02996110|39272519|FG002|Track 1|Disease Progression|0|||
16216880|NCT02996110|39272520|FG003|Track 1|Disease Progression|0|||
16216881|NCT02996110|39272521|FG004|Track 1|Disease Progression|0|||
16216882|NCT02996110|39272517|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
16216883|NCT02996110|39272518|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
16216884|NCT02996110|39272519|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
16537487|NCT00522275|40429203|FG000|Overall Study|Other: Site / clinic closed|4|||
16216885|NCT02996110|39272520|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
16216886|NCT02996110|39272521|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
16216887|NCT02996110|39272517|FG000|Track 1|Study Drug Toxicity|5|||
16216888|NCT02996110|39272518|FG001|Track 1|Study Drug Toxicity|3|||
16216889|NCT02996110|39272519|FG002|Track 1|Study Drug Toxicity|0|||
16216890|NCT02996110|39272520|FG003|Track 1|Study Drug Toxicity|0|||
16216891|NCT02996110|39272521|FG004|Track 1|Study Drug Toxicity|0|||
16216892|NCT02996110|39272517|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
16216893|NCT02996110|39272518|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
16216894|NCT02996110|39272519|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
16338581|NCT01180049|39726158|FG000|Overall Study|Lost to Follow-up|8|||
16338582|NCT01180049|39726159|FG001|Overall Study|Lost to Follow-up|6|||
16338583|NCT01180049|39726158|FG000|Overall Study|Death|36|||
16338584|NCT01180049|39726159|FG001|Overall Study|Death|35|||
16338585|NCT04348500|39726160|FG000|Overall Study|Death|2|||
16338586|NCT04348500|39726161|FG001|Overall Study|Death|2|||
16338587|NCT04348500|39726160|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
16338588|NCT04348500|39726161|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
16338589|NCT00395642|39726162|FG000|Overall Study|Death|4|||
16338590|NCT00395642|39726162|FG000|Overall Study|Lost to Follow-up|1|||
16338591|NCT00395642|39726162|FG000|Overall Study|Physician Decision|7|||
16406197|NCT00688324|39966554|FG000|Overall Study|Withdrawal by Subject|2|||
16406198|NCT00688324|39966554|FG000|Overall Study|Physician Decision|5|||
16406199|NCT00688324|39966554|FG000|Overall Study|Lost to Follow-up|1|||
16406200|NCT03206918|39966555|FG000|Overall Study|Death|11|||
16537488|NCT00522275|40429203|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
16537489|NCT00522275|40429203|FG000|Overall Study|Other: Sponsor request|2|||
16537490|NCT00522275|40429203|FG000|Overall Study|Other: Subject ran out of medication|1|||
16537491|NCT00522275|40429203|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
16537492|NCT01292928|40429204|FG000|Overall Study|Death|8|||
16537493|NCT01292928|40429204|FG000|Overall Study|Withdrawal by Subject|8|||
16338592|NCT00395642|39726162|FG000|Overall Study|Withdrawal by Subject|1|||
16406201|NCT03206918|39966555|FG000|Overall Study|Withdrawal by Subject|5|||
16406202|NCT03206918|39966555|FG000|Overall Study|Study terminated by sponsor|12|||
16406203|NCT03206918|39966555|FG000|Overall Study|Lost to Follow-up|3|||
16406204|NCT03206918|39966555|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
16406205|NCT00367744|39966556|FG000|Overall Study|Lost to Follow-up|4|||
16406206|NCT00367744|39966557|FG001|Overall Study|Lost to Follow-up|5|||
16537494|NCT01292928|40429204|FG000|Overall Study|Lost to Follow-up|6|||
16216895|NCT02996110|39272520|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
16537495|NCT01292928|40429204|FG000|Overall Study|Physician Decision|2|||
16338593|NCT02028169|39726165|FG000|Overall Study|Lost to Follow-up|21|||
16338594|NCT02028169|39726165|FG000|Overall Study|Lack of Efficacy|2|||
16338595|NCT02028169|39726165|FG000|Overall Study|Withdrawal by Subject|2|||
16406207|NCT01804582|39966560|FG000|Overall Study|Lost to Follow-up|47|||
16216896|NCT02996110|39272521|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
16216897|NCT02996110|39272517|FG000|Track 1|Administrative Reason by Sponsor|0|||
16216898|NCT02996110|39272518|FG001|Track 1|Administrative Reason by Sponsor|1|||
16216899|NCT02996110|39272519|FG002|Track 1|Administrative Reason by Sponsor|0|||
16216900|NCT02996110|39272520|FG003|Track 1|Administrative Reason by Sponsor|0|||
16216901|NCT02996110|39272521|FG004|Track 1|Administrative Reason by Sponsor|0|||
16216902|NCT02996110|39272517|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
16216903|NCT02996110|39272518|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
16216904|NCT02996110|39272519|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
16216905|NCT02996110|39272520|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
16216906|NCT02996110|39272521|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
16216907|NCT02996110|39272517|FG000|Track 2|Disease Progression|33|||
16216908|NCT02996110|39272518|FG001|Track 2|Disease Progression|26|||
16216909|NCT02996110|39272519|FG002|Track 2|Disease Progression|19|||
16216910|NCT02996110|39272520|FG003|Track 2|Disease Progression|16|||
16406208|NCT01804582|39966561|FG001|Overall Study|Lost to Follow-up|56|||
16406209|NCT01804582|39966560|FG000|Overall Study|Physician Decision|2|||
16216911|NCT02996110|39272521|FG004|Track 2|Disease Progression|15|||
16216912|NCT02996110|39272517|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
16216913|NCT02996110|39272518|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
16216914|NCT02996110|39272519|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
16216915|NCT02996110|39272520|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
16216916|NCT02996110|39272521|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
16216917|NCT02996110|39272517|FG000|Track 2|Death|0|||
16216918|NCT02996110|39272518|FG001|Track 2|Death|0|||
16216919|NCT02996110|39272519|FG002|Track 2|Death|1|||
16216920|NCT02996110|39272520|FG003|Track 2|Death|0|||
16216921|NCT02996110|39272521|FG004|Track 2|Death|1|||
16216922|NCT02996110|39272517|FG000|Track 2|Study Drug Toxicity|4|||
16216923|NCT02996110|39272518|FG001|Track 2|Study Drug Toxicity|1|||
16216924|NCT02996110|39272519|FG002|Track 2|Study Drug Toxicity|4|||
16216925|NCT02996110|39272520|FG003|Track 2|Study Drug Toxicity|1|||
16216926|NCT02996110|39272521|FG004|Track 2|Study Drug Toxicity|0|||
16216927|NCT02996110|39272517|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
16216928|NCT02996110|39272518|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
16216929|NCT02996110|39272519|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
16216930|NCT02996110|39272520|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
16216931|NCT02996110|39272521|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
16216932|NCT02996110|39272517|FG000|Track 2|Participant Withdrew Consent|1|||
16216933|NCT02996110|39272518|FG001|Track 2|Participant Withdrew Consent|2|||
16216934|NCT02996110|39272519|FG002|Track 2|Participant Withdrew Consent|3|||
16216935|NCT02996110|39272520|FG003|Track 2|Participant Withdrew Consent|1|||
16216936|NCT02996110|39272521|FG004|Track 2|Participant Withdrew Consent|1|||
16216937|NCT02996110|39272517|FG000|Track 2|Other Reasons|0|||
16216938|NCT02996110|39272518|FG001|Track 2|Other Reasons|0|||
16216939|NCT02996110|39272519|FG002|Track 2|Other Reasons|1|||
16216940|NCT02996110|39272520|FG003|Track 2|Other Reasons|0|||
16216941|NCT02996110|39272521|FG004|Track 2|Other Reasons|1|||
16216942|NCT02870348|39272522|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
16216943|NCT00715949|39272523|FG000|Overall Study|could not finish first test|4|||
16216944|NCT00606229|39272525|FG000|Overall Study|Adverse Event|11|||
16406210|NCT01804582|39966561|FG001|Overall Study|Physician Decision|0|||
16406211|NCT01566695|39966564|FG000|Overall Study|Lack of Efficacy|18|||
16406212|NCT01566695|39966565|FG001|Overall Study|Lack of Efficacy|45|||
16406213|NCT01566695|39966564|FG000|Overall Study|Adverse Event|28|||
16406214|NCT01566695|39966565|FG001|Overall Study|Adverse Event|27|||
16406215|NCT01566695|39966564|FG000|Overall Study|Death|20|||
16406216|NCT01566695|39966565|FG001|Overall Study|Death|8|||
16406217|NCT01566695|39966564|FG000|Overall Study|Withdrawal by Subject|14|||
16406218|NCT01566695|39966565|FG001|Overall Study|Withdrawal by Subject|7|||
16406219|NCT01566695|39966564|FG000|Overall Study|Progressive Disease|11|||
16406220|NCT01566695|39966565|FG001|Overall Study|Progressive Disease|6|||
16406221|NCT01566695|39966564|FG000|Overall Study|Miscellaneous|4|||
16406222|NCT01566695|39966565|FG001|Overall Study|Miscellaneous|6|||
16406223|NCT00896363|39966566|FG000|Overall Study|Adverse Event|3|||
16406224|NCT00896363|39966567|FG001|Overall Study|Adverse Event|4|||
16406225|NCT00896363|39966568|FG002|Overall Study|Adverse Event|2|||
16406226|NCT00896363|39966566|FG000|Overall Study|Lack of Efficacy|0|||
16406227|NCT00896363|39966567|FG001|Overall Study|Lack of Efficacy|2|||
16216945|NCT00606229|39272525|FG000|Overall Study|Lack of Efficacy|1|||
16406228|NCT00896363|39966568|FG002|Overall Study|Lack of Efficacy|1|||
16406229|NCT00896363|39966566|FG000|Overall Study|Withdrawal by Subject|3|||
16406230|NCT00896363|39966567|FG001|Overall Study|Withdrawal by Subject|5|||
16406231|NCT00896363|39966568|FG002|Overall Study|Withdrawal by Subject|5|||
16406232|NCT00842153|39966569|FG000|Overall Study|Adverse Event|0|||
16406233|NCT00842153|39966570|FG001|Overall Study|Adverse Event|1|||
16406234|NCT00842153|39966569|FG000|Overall Study|Lost to Follow-up|1|||
16406235|NCT00842153|39966570|FG001|Overall Study|Lost to Follow-up|2|||
16406236|NCT01739933|39966577|FG000|Overall Study|Death|89|||
16406237|NCT01739933|39966578|FG001|Overall Study|Death|86|||
16406238|NCT01739933|39966577|FG000|Overall Study|Withdrawal by Subject|10|||
16338596|NCT02028169|39726165|FG000|Overall Study|Adverse Event|1|||
16338597|NCT02028169|39726165|FG000|Overall Study|Cessation of Drug|1|||
16338598|NCT02028169|39726165|FG000|Overall Study|Concomitant Medication Usage|1|||
16338599|NCT03035916|39726166|FG000|Overall Study|Puncture failed|0|||
16338600|NCT03035916|39726167|FG001|Overall Study|Puncture failed|2|||
16338601|NCT03035916|39726168|FG002|Overall Study|Puncture failed|0|||
16338602|NCT00792116|39726169|FG000|Overall Study|Lost to Follow-up|0|||
16338603|NCT00792116|39726170|FG001|Overall Study|Lost to Follow-up|1|||
16338604|NCT00792116|39726169|FG000|Overall Study|Discontnued intervention|1|||
16338605|NCT00792116|39726170|FG001|Overall Study|Discontnued intervention|0|||
16338606|NCT02014558|39726171|FG000|Overall Study|Never Received Study Drug|0|||
16338607|NCT02014558|39726172|FG001|Overall Study|Never Received Study Drug|0|||
16338608|NCT02014558|39726173|FG002|Overall Study|Never Received Study Drug|0|||
16338609|NCT02014558|39726174|FG003|Overall Study|Never Received Study Drug|0|||
16338610|NCT02014558|39726175|FG004|Overall Study|Never Received Study Drug|1|||
16338611|NCT02014558|39726176|FG005|Overall Study|Never Received Study Drug|0|||
16338612|NCT02014558|39726177|FG006|Overall Study|Never Received Study Drug|1|||
16338613|NCT02014558|39726178|FG007|Overall Study|Never Received Study Drug|0|||
16338614|NCT02014558|39726179|FG008|Overall Study|Never Received Study Drug|2|||
16338615|NCT02014558|39726180|FG009|Overall Study|Never Received Study Drug|0|||
16338616|NCT02014558|39726181|FG010|Overall Study|Never Received Study Drug|2|||
16338617|NCT02014558|39726182|FG011|Overall Study|Never Received Study Drug|2|||
16338618|NCT02014558|39726183|FG012|Overall Study|Never Received Study Drug|0|||
16338619|NCT02014558|39726171|FG000|Overall Study|Adverse Event|0|||
16338620|NCT02014558|39726172|FG001|Overall Study|Adverse Event|0|||
16338621|NCT02014558|39726173|FG002|Overall Study|Adverse Event|0|||
16537496|NCT04791761|40429209|FG000|Overall Study|Lost to Follow-up|8|||
16537497|NCT04791761|40429210|FG001|Overall Study|Lost to Follow-up|6|||
16537498|NCT04791761|40429211|FG002|Overall Study|Lost to Follow-up|10|||
16537499|NCT04791761|40429209|FG000|Overall Study|Withdrawal by Subject|0|||
16537500|NCT04791761|40429210|FG001|Overall Study|Withdrawal by Subject|1|||
16537501|NCT04791761|40429211|FG002|Overall Study|Withdrawal by Subject|1|||
16537502|NCT04791761|40429209|FG000|Overall Study|Protocol Violation|0|||
16537503|NCT04791761|40429210|FG001|Overall Study|Protocol Violation|1|||
16537504|NCT04791761|40429211|FG002|Overall Study|Protocol Violation|1|||
16216946|NCT00606229|39272525|FG000|Overall Study|Withdrawal by Subject|4|||
16338622|NCT02014558|39726174|FG003|Overall Study|Adverse Event|0|||
16338623|NCT02014558|39726175|FG004|Overall Study|Adverse Event|1|||
16338624|NCT02014558|39726176|FG005|Overall Study|Adverse Event|0|||
16338625|NCT02014558|39726177|FG006|Overall Study|Adverse Event|0|||
16338626|NCT02014558|39726178|FG007|Overall Study|Adverse Event|0|||
16338627|NCT02014558|39726179|FG008|Overall Study|Adverse Event|2|||
16338628|NCT02014558|39726180|FG009|Overall Study|Adverse Event|2|||
16338629|NCT02014558|39726181|FG010|Overall Study|Adverse Event|5|||
16338630|NCT02014558|39726182|FG011|Overall Study|Adverse Event|21|||
16338631|NCT02014558|39726183|FG012|Overall Study|Adverse Event|3|||
16338632|NCT02014558|39726171|FG000|Overall Study|Death|1|||
16338633|NCT02014558|39726172|FG001|Overall Study|Death|0|||
16338634|NCT02014558|39726173|FG002|Overall Study|Death|0|||
16338635|NCT02014558|39726174|FG003|Overall Study|Death|0|||
16338636|NCT02014558|39726175|FG004|Overall Study|Death|0|||
16338637|NCT02014558|39726176|FG005|Overall Study|Death|0|||
16338638|NCT02014558|39726177|FG006|Overall Study|Death|1|||
16338639|NCT02014558|39726178|FG007|Overall Study|Death|1|||
16338640|NCT02014558|39726179|FG008|Overall Study|Death|2|||
16338641|NCT02014558|39726180|FG009|Overall Study|Death|5|||
16406239|NCT01739933|39966578|FG001|Overall Study|Withdrawal by Subject|8|||
16406240|NCT01739933|39966577|FG000|Overall Study|Lost to Follow-up|3|||
16338642|NCT02014558|39726181|FG010|Overall Study|Death|5|||
16338643|NCT02014558|39726182|FG011|Overall Study|Death|19|||
16338644|NCT02014558|39726183|FG012|Overall Study|Death|2|||
16537505|NCT00289887|40429216|FG000|Overall Study|Adverse Event|3|||
16338645|NCT02014558|39726171|FG000|Overall Study|Lack of Efficacy|1|||
16338646|NCT02014558|39726172|FG001|Overall Study|Lack of Efficacy|2|||
16338647|NCT02014558|39726173|FG002|Overall Study|Lack of Efficacy|1|||
16338648|NCT02014558|39726174|FG003|Overall Study|Lack of Efficacy|1|||
16338649|NCT02014558|39726175|FG004|Overall Study|Lack of Efficacy|0|||
16338650|NCT02014558|39726176|FG005|Overall Study|Lack of Efficacy|0|||
16338651|NCT02014558|39726177|FG006|Overall Study|Lack of Efficacy|1|||
16338652|NCT02014558|39726178|FG007|Overall Study|Lack of Efficacy|3|||
16338653|NCT02014558|39726179|FG008|Overall Study|Lack of Efficacy|3|||
16338654|NCT02014558|39726180|FG009|Overall Study|Lack of Efficacy|3|||
16338655|NCT02014558|39726181|FG010|Overall Study|Lack of Efficacy|16|||
16338656|NCT02014558|39726182|FG011|Overall Study|Lack of Efficacy|8|||
16338657|NCT02014558|39726183|FG012|Overall Study|Lack of Efficacy|5|||
16338658|NCT02014558|39726171|FG000|Overall Study|Lost to Follow-up|0|||
16338659|NCT02014558|39726172|FG001|Overall Study|Lost to Follow-up|0|||
16338660|NCT02014558|39726173|FG002|Overall Study|Lost to Follow-up|0|||
16338661|NCT02014558|39726174|FG003|Overall Study|Lost to Follow-up|0|||
16338662|NCT02014558|39726175|FG004|Overall Study|Lost to Follow-up|0|||
16338663|NCT02014558|39726176|FG005|Overall Study|Lost to Follow-up|0|||
16338664|NCT02014558|39726177|FG006|Overall Study|Lost to Follow-up|0|||
16338665|NCT02014558|39726178|FG007|Overall Study|Lost to Follow-up|0|||
16338666|NCT02014558|39726179|FG008|Overall Study|Lost to Follow-up|0|||
16338667|NCT02014558|39726180|FG009|Overall Study|Lost to Follow-up|0|||
16338668|NCT02014558|39726181|FG010|Overall Study|Lost to Follow-up|1|||
16338669|NCT02014558|39726182|FG011|Overall Study|Lost to Follow-up|0|||
16338670|NCT02014558|39726183|FG012|Overall Study|Lost to Follow-up|0|||
16338671|NCT02014558|39726171|FG000|Overall Study|Progressive Disease|1|||
16338672|NCT02014558|39726172|FG001|Overall Study|Progressive Disease|0|||
16338673|NCT02014558|39726173|FG002|Overall Study|Progressive Disease|1|||
16338674|NCT02014558|39726174|FG003|Overall Study|Progressive Disease|1|||
16338675|NCT02014558|39726175|FG004|Overall Study|Progressive Disease|1|||
16537506|NCT00289887|40429217|FG001|Overall Study|Adverse Event|3|||
16537507|NCT00289887|40429216|FG000|Overall Study|Lack of Efficacy|3|||
16537508|NCT00289887|40429217|FG001|Overall Study|Lack of Efficacy|11|||
16537509|NCT00289887|40429216|FG000|Overall Study|Lost to Follow-up|3|||
16537510|NCT00289887|40429217|FG001|Overall Study|Lost to Follow-up|3|||
16537511|NCT00289887|40429216|FG000|Overall Study|Protocol Violation|3|||
16537512|NCT00289887|40429217|FG001|Overall Study|Protocol Violation|1|||
16537513|NCT00289887|40429216|FG000|Overall Study|Withdrawal by Subject|3|||
16537514|NCT00289887|40429217|FG001|Overall Study|Withdrawal by Subject|8|||
16537515|NCT00289887|40429216|FG000|Overall Study|Other|7|||
16537516|NCT00289887|40429217|FG001|Overall Study|Other|3|||
16537517|NCT03393000|40429218|FG000|Overall Study|Death|11|||
16537518|NCT03393000|40429218|FG000|Overall Study|Withdrawal by Subject|2|||
16537519|NCT03393000|40429218|FG000|Overall Study|Physician Decision|1|||
16537520|NCT05159622|40429223|FG000|Overall Study|Lost to Follow-up|4|||
16537521|NCT05159622|40429224|FG001|Overall Study|Lost to Follow-up|5|||
16537522|NCT01692782|40429231|FG000|Overall Study|Adverse Event|12|||
16537523|NCT01692782|40429232|FG001|Overall Study|Adverse Event|32|||
16537524|NCT01692782|40429233|FG002|Overall Study|Adverse Event|2|||
16537525|NCT01692782|40429231|FG000|Overall Study|Lack of Efficacy|1|||
16537526|NCT01692782|40429232|FG001|Overall Study|Lack of Efficacy|2|||
16537527|NCT01692782|40429233|FG002|Overall Study|Lack of Efficacy|0|||
16537528|NCT01692782|40429231|FG000|Overall Study|Lost to Follow-up|2|||
16537529|NCT01692782|40429232|FG001|Overall Study|Lost to Follow-up|7|||
16537530|NCT01692782|40429233|FG002|Overall Study|Lost to Follow-up|1|||
16537531|NCT01692782|40429231|FG000|Overall Study|Pregnancy|1|||
16537532|NCT01692782|40429232|FG001|Overall Study|Pregnancy|0|||
16537533|NCT01692782|40429233|FG002|Overall Study|Pregnancy|0|||
16537534|NCT01692782|40429231|FG000|Overall Study|Protocol Violation|1|||
16537535|NCT01692782|40429232|FG001|Overall Study|Protocol Violation|0|||
16537536|NCT01692782|40429233|FG002|Overall Study|Protocol Violation|2|||
16537537|NCT01692782|40429231|FG000|Overall Study|Non-complance with study drug|0|||
16537538|NCT01692782|40429232|FG001|Overall Study|Non-complance with study drug|4|||
16537539|NCT01692782|40429233|FG002|Overall Study|Non-complance with study drug|1|||
16537540|NCT01692782|40429231|FG000|Overall Study|Non-compliant with study visits|0|||
16537541|NCT01692782|40429232|FG001|Overall Study|Non-compliant with study visits|0|||
16537542|NCT01692782|40429233|FG002|Overall Study|Non-compliant with study visits|1|||
16537543|NCT01692782|40429231|FG000|Overall Study|SAE not related to study drug|0|||
16537544|NCT01692782|40429232|FG001|Overall Study|SAE not related to study drug|1|||
16537545|NCT01692782|40429233|FG002|Overall Study|SAE not related to study drug|0|||
16537546|NCT01692782|40429231|FG000|Overall Study|Withdrawal by Subject|3|||
16537547|NCT01692782|40429232|FG001|Overall Study|Withdrawal by Subject|10|||
16537548|NCT01692782|40429233|FG002|Overall Study|Withdrawal by Subject|3|||
16537549|NCT01777854|40429238|FG000|Overall Study|Physician Decision|3|||
16537550|NCT01777854|40429239|FG001|Overall Study|Physician Decision|3|||
16537551|NCT03846427|40429240|FG000|Overall Study|Death|13|||
16537552|NCT03846427|40429240|FG000|Overall Study|Withdrawal by Subject|3|||
16537553|NCT03846427|40429240|FG000|Overall Study|Physician Decision|1|||
16537554|NCT00092131|40429241|FG000|Treatment Period I|Adverse Event|1|||
16537555|NCT00092131|40429242|FG001|Treatment Period I|Adverse Event|0|||
16216947|NCT00606229|39272525|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
16216948|NCT00606229|39272525|FG000|Overall Study|change of residence or other commitments|2|||
16338676|NCT02014558|39726176|FG005|Overall Study|Progressive Disease|2|||
16338677|NCT02014558|39726177|FG006|Overall Study|Progressive Disease|1|||
16338678|NCT02014558|39726178|FG007|Overall Study|Progressive Disease|6|||
16338679|NCT02014558|39726179|FG008|Overall Study|Progressive Disease|5|||
16338680|NCT02014558|39726180|FG009|Overall Study|Progressive Disease|6|||
16338681|NCT02014558|39726181|FG010|Overall Study|Progressive Disease|22|||
16338682|NCT02014558|39726182|FG011|Overall Study|Progressive Disease|31|||
16338683|NCT02014558|39726183|FG012|Overall Study|Progressive Disease|6|||
16338684|NCT02014558|39726171|FG000|Overall Study|Withdrawal by Subject|0|||
16338685|NCT02014558|39726172|FG001|Overall Study|Withdrawal by Subject|0|||
16338686|NCT02014558|39726173|FG002|Overall Study|Withdrawal by Subject|0|||
16338687|NCT02014558|39726174|FG003|Overall Study|Withdrawal by Subject|0|||
16338688|NCT02014558|39726175|FG004|Overall Study|Withdrawal by Subject|1|||
16338689|NCT02014558|39726176|FG005|Overall Study|Withdrawal by Subject|0|||
16338690|NCT02014558|39726177|FG006|Overall Study|Withdrawal by Subject|0|||
16338691|NCT02014558|39726178|FG007|Overall Study|Withdrawal by Subject|0|||
16338692|NCT02014558|39726179|FG008|Overall Study|Withdrawal by Subject|0|||
16406241|NCT01739933|39966578|FG001|Overall Study|Lost to Follow-up|10|||
16406242|NCT01739933|39966577|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
16338693|NCT02014558|39726180|FG009|Overall Study|Withdrawal by Subject|2|||
16338694|NCT02014558|39726181|FG010|Overall Study|Withdrawal by Subject|6|||
16406243|NCT01739933|39966578|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
16406244|NCT01390779|39966579|FG000|Overall Study|Physician Decision|1|||
16406245|NCT01071200|39966584|FG000|Overall Study|Lack of ovarian response|1|||
16406246|NCT01071200|39966585|FG001|Overall Study|Lack of ovarian response|1|||
16406247|NCT01071200|39966584|FG000|Overall Study|No fertilization|4|||
16406248|NCT01071200|39966585|FG001|Overall Study|No fertilization|0|||
16406249|NCT01071200|39966584|FG000|Overall Study|No oocytes retrieved|1|||
16406250|NCT01071200|39966585|FG001|Overall Study|No oocytes retrieved|1|||
16406251|NCT01071200|39966584|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
16406252|NCT01071200|39966585|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
16406253|NCT01071200|39966584|FG000|Overall Study|No viable embryos|0|||
16406254|NCT01071200|39966585|FG001|Overall Study|No viable embryos|1|||
16406255|NCT02374814|39966591|FG000|Overall Study|Lost to Follow-up|1|||
16406256|NCT02374814|39966592|FG001|Overall Study|Lost to Follow-up|1|||
16406257|NCT02374814|39966593|FG002|Overall Study|Lost to Follow-up|0|||
16406258|NCT02374814|39966594|FG003|Overall Study|Lost to Follow-up|1|||
16406259|NCT02374814|39966595|FG004|Overall Study|Lost to Follow-up|0|||
16406260|NCT02374814|39966596|FG005|Overall Study|Lost to Follow-up|0|||
16406261|NCT02374814|39966591|FG000|Overall Study|Withdrawal by Subject|0|||
16406262|NCT02374814|39966592|FG001|Overall Study|Withdrawal by Subject|0|||
16406263|NCT02374814|39966593|FG002|Overall Study|Withdrawal by Subject|1|||
16406264|NCT02374814|39966594|FG003|Overall Study|Withdrawal by Subject|1|||
16406265|NCT02374814|39966595|FG004|Overall Study|Withdrawal by Subject|0|||
16406266|NCT02374814|39966596|FG005|Overall Study|Withdrawal by Subject|0|||
16406267|NCT01380535|39966606|FG000|Overall Study|Adverse Event|3|||
16406268|NCT01380535|39966607|FG001|Overall Study|Adverse Event|3|||
16406269|NCT01380535|39966606|FG000|Overall Study|Death|3|||
16406270|NCT01380535|39966607|FG001|Overall Study|Death|0|||
16406271|NCT01380535|39966606|FG000|Overall Study|Study site closed|0|||
16406272|NCT01380535|39966607|FG001|Overall Study|Study site closed|5|||
16406273|NCT01380535|39966606|FG000|Overall Study|Withdrawal by Subject|1|||
16406274|NCT01380535|39966607|FG001|Overall Study|Withdrawal by Subject|2|||
16406275|NCT01380535|39966606|FG000|Overall Study|Protocol Violation|0|||
16406276|NCT01380535|39966607|FG001|Overall Study|Protocol Violation|2|||
16406277|NCT01380535|39966606|FG000|Overall Study|Lack of Efficacy|0|||
16406278|NCT01380535|39966607|FG001|Overall Study|Lack of Efficacy|3|||
16406279|NCT00835640|39966608|FG000|Second Intervention|Protocol Violation|1|||
16406280|NCT00835640|39966609|FG001|Second Intervention|Protocol Violation|0|||
16406281|NCT00996281|39966614|FG000|Overall Study|Adverse Event|75|||
16406282|NCT00996281|39966615|FG001|Overall Study|Adverse Event|37|||
16338695|NCT02014558|39726182|FG011|Overall Study|Withdrawal by Subject|10|||
16338696|NCT02014558|39726183|FG012|Overall Study|Withdrawal by Subject|0|||
16338697|NCT02014558|39726171|FG000|Overall Study|Miscellaneous|2|||
16338698|NCT02014558|39726172|FG001|Overall Study|Miscellaneous|1|||
16406283|NCT00996281|39966614|FG000|Overall Study|Major Protocol Deviation|6|||
16406284|NCT00996281|39966615|FG001|Overall Study|Major Protocol Deviation|7|||
16406285|NCT00996281|39966614|FG000|Overall Study|Lost to Follow-up|14|||
16406286|NCT00996281|39966615|FG001|Overall Study|Lost to Follow-up|16|||
16406287|NCT00996281|39966614|FG000|Overall Study|Withdrawal by Subject|31|||
16406288|NCT00996281|39966615|FG001|Overall Study|Withdrawal by Subject|20|||
16406289|NCT00996281|39966614|FG000|Overall Study|Lack of Efficacy|0|||
16406290|NCT00996281|39966615|FG001|Overall Study|Lack of Efficacy|2|||
16406291|NCT00996281|39966614|FG000|Overall Study|Other|5|||
16406292|NCT00996281|39966615|FG001|Overall Study|Other|7|||
16406293|NCT02780856|39966622|FG000|Overall Study|Lost to Follow-up|1|||
16406294|NCT02692040|39966623|FG000|Overall Study|Protocol Violation|0|||
16406295|NCT02692040|39966624|FG001|Overall Study|Protocol Violation|0|||
16406296|NCT02692040|39966625|FG002|Overall Study|Protocol Violation|0|||
16406297|NCT02692040|39966626|FG003|Overall Study|Protocol Violation|0|||
16406298|NCT02692040|39966627|FG004|Overall Study|Protocol Violation|0|||
16406299|NCT02692040|39966628|FG005|Overall Study|Protocol Violation|0|||
16406300|NCT02692040|39966629|FG006|Overall Study|Protocol Violation|0|||
16406301|NCT02692040|39966630|FG007|Overall Study|Protocol Violation|0|||
16406302|NCT02692040|39966631|FG008|Overall Study|Protocol Violation|0|||
16406303|NCT02692040|39966632|FG009|Overall Study|Protocol Violation|0|||
16406304|NCT02692040|39966633|FG010|Overall Study|Protocol Violation|0|||
16406305|NCT02692040|39966634|FG011|Overall Study|Protocol Violation|0|||
16406306|NCT02692040|39966635|FG012|Overall Study|Protocol Violation|1|||
16406307|NCT02692040|39966636|FG013|Overall Study|Protocol Violation|0|||
16406308|NCT02692040|39966637|FG014|Overall Study|Protocol Violation|0|||
16406309|NCT02692040|39966638|FG015|Overall Study|Protocol Violation|0|||
16406310|NCT02692040|39966639|FG016|Overall Study|Protocol Violation|0|||
16406311|NCT02692040|39966623|FG000|Overall Study|Adverse Event|0|||
16406312|NCT02692040|39966624|FG001|Overall Study|Adverse Event|0|||
16406313|NCT02692040|39966625|FG002|Overall Study|Adverse Event|0|||
16406314|NCT02692040|39966626|FG003|Overall Study|Adverse Event|0|||
16406315|NCT02692040|39966627|FG004|Overall Study|Adverse Event|0|||
16406316|NCT02692040|39966628|FG005|Overall Study|Adverse Event|0|||
16406317|NCT02692040|39966629|FG006|Overall Study|Adverse Event|0|||
16406318|NCT02692040|39966630|FG007|Overall Study|Adverse Event|0|||
16406319|NCT02692040|39966631|FG008|Overall Study|Adverse Event|0|||
16406320|NCT02692040|39966632|FG009|Overall Study|Adverse Event|0|||
16406321|NCT02692040|39966633|FG010|Overall Study|Adverse Event|0|||
16406322|NCT02692040|39966634|FG011|Overall Study|Adverse Event|0|||
16406323|NCT02692040|39966635|FG012|Overall Study|Adverse Event|0|||
16406324|NCT02692040|39966636|FG013|Overall Study|Adverse Event|3|||
16406325|NCT02692040|39966637|FG014|Overall Study|Adverse Event|1|||
16406326|NCT02692040|39966638|FG015|Overall Study|Adverse Event|1|||
16406327|NCT02692040|39966639|FG016|Overall Study|Adverse Event|0|||
16406328|NCT00916058|39969774|FG000|Phase 1|Screen Failure|0|||
16406329|NCT00916058|39969775|FG001|Phase 1|Screen Failure|0|||
16406330|NCT00916058|39969776|FG002|Phase 1|Screen Failure|0|||
16406331|NCT00916058|39969777|FG003|Phase 1|Screen Failure|0|||
16406332|NCT00916058|39969778|FG004|Phase 1|Screen Failure|0|||
16406333|NCT00916058|39969779|FG005|Phase 1|Screen Failure|1|||
16406334|NCT00916058|39969780|FG006|Phase 1|Screen Failure|0|||
16406335|NCT00916058|39969774|FG000|Phase 2|Screen Failure|0|||
16406336|NCT00916058|39969775|FG001|Phase 2|Screen Failure|0|||
16406337|NCT00916058|39969776|FG002|Phase 2|Screen Failure|0|||
16406338|NCT00916058|39969777|FG003|Phase 2|Screen Failure|0|||
16406339|NCT00916058|39969778|FG004|Phase 2|Screen Failure|0|||
16406340|NCT00916058|39969779|FG005|Phase 2|Screen Failure|0|||
16406341|NCT00916058|39969780|FG006|Phase 2|Screen Failure|3|||
16406342|NCT02264665|39969785|FG000|Overall Study|Other|0|||
16406343|NCT02264665|39969786|FG001|Overall Study|Other|0|||
16406344|NCT02264665|39969787|FG002|Overall Study|Other|3|||
16406345|NCT02264665|39969788|FG003|Overall Study|Other|0|||
16406346|NCT02264665|39969789|FG004|Overall Study|Other|0|||
16406347|NCT02264665|39969790|FG005|Overall Study|Other|0|||
16406348|NCT02264665|39969791|FG006|Overall Study|Other|0|||
16406349|NCT02264665|39969785|FG000|Overall Study|Death|9|||
16406350|NCT02264665|39969786|FG001|Overall Study|Death|8|||
16406351|NCT02264665|39969787|FG002|Overall Study|Death|13|||
16406352|NCT02264665|39969788|FG003|Overall Study|Death|5|||
16537556|NCT00092131|40429241|FG000|Treatment Period II|Adverse Event|0|||
16537557|NCT00092131|40429242|FG001|Treatment Period II|Adverse Event|1|||
16406353|NCT02264665|39969789|FG004|Overall Study|Death|0|||
16406354|NCT02264665|39969790|FG005|Overall Study|Death|0|||
16406355|NCT02264665|39969791|FG006|Overall Study|Death|1|||
16406356|NCT02264665|39969785|FG000|Overall Study|Lost to Follow-up|1|||
16537558|NCT03318523|40429248|FG000|PC Period: Up to Year 1|Adverse Event|1|||
16406357|NCT02264665|39969786|FG001|Overall Study|Lost to Follow-up|0|||
16406358|NCT02264665|39969787|FG002|Overall Study|Lost to Follow-up|2|||
16406359|NCT02264665|39969788|FG003|Overall Study|Lost to Follow-up|1|||
16406360|NCT02264665|39969789|FG004|Overall Study|Lost to Follow-up|0|||
16406361|NCT02264665|39969790|FG005|Overall Study|Lost to Follow-up|0|||
16406362|NCT02264665|39969791|FG006|Overall Study|Lost to Follow-up|0|||
16102694|NCT02604342|38863255|FG000|Overall Study|Physician Decision|2|||
16102695|NCT02604342|38863256|FG001|Overall Study|Physician Decision|0|||
16102696|NCT03042559|38863257|FG000|Overall Study|drop out|1|||
16102697|NCT03042559|38863258|FG001|Overall Study|drop out|1|||
16102698|NCT01670188|38863259|FG000|Overall Study|Death|0|||
16102699|NCT01670188|38863260|FG001|Overall Study|Death|1|||
16102700|NCT04883541|38863261|FG000|Overall Study|Not attending regular yoga class|16|||
16102701|NCT04883541|38863262|FG001|Overall Study|Not attending regular yoga class|0|||
16102702|NCT04883541|38863261|FG000|Overall Study|Not attending the pregnancy school|0|||
16102703|NCT04883541|38863262|FG001|Overall Study|Not attending the pregnancy school|9|||
16102704|NCT00858247|38863263|FG000|Baseline Assessment|Withdrawal by Subject|1|||
16102705|NCT00858247|38863264|FG001|Baseline Assessment|Withdrawal by Subject|1|||
16102706|NCT00858247|38863263|FG000|Baseline Assessment|Poor IV access|1|||
16102707|NCT00858247|38863264|FG001|Baseline Assessment|Poor IV access|0|||
16102708|NCT00858247|38863263|FG000|Baseline Assessment|Protocol Violation|0|||
16102709|NCT00858247|38863264|FG001|Baseline Assessment|Protocol Violation|1|||
16102710|NCT00858247|38863263|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
16102711|NCT00858247|38863264|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
16102712|NCT03168425|38863265|FG000|Overall Study|Lost to Follow-up|5|||
16102713|NCT03168425|38863266|FG001|Overall Study|Lost to Follow-up|8|||
16102714|NCT03168425|38863265|FG000|Overall Study|unable to confirm post op opioids|2|||
16102715|NCT03168425|38863266|FG001|Overall Study|unable to confirm post op opioids|3|||
16102716|NCT04206384|38863267|FG000|Overall Study|Withdrawal by Subject|8|||
16102717|NCT04206384|38863267|FG000|Overall Study|Adverse Event|2|||
16102718|NCT02212301|38863268|FG000|Period 1|Lost to Follow-up|0|||
16102719|NCT02212301|38863269|FG001|Period 1|Lost to Follow-up|1|||
16102720|NCT03193216|38863270|FG000|Overall Study|Lost to Follow-up|1|||
16102721|NCT03193216|38863271|FG001|Overall Study|Lost to Follow-up|0|||
16102722|NCT03193216|38863270|FG000|Overall Study|Withdrawal by Subject|5|||
16102723|NCT03193216|38863271|FG001|Overall Study|Withdrawal by Subject|0|||
16102724|NCT03193216|38863270|FG000|Overall Study|Physician Decision|4|||
16102725|NCT03193216|38863271|FG001|Overall Study|Physician Decision|0|||
16102726|NCT03494985|38863272|FG000|Overall Study|Adverse Event|3|||
16102727|NCT03494985|38863273|FG001|Overall Study|Adverse Event|2|||
16102728|NCT03494985|38863274|FG002|Overall Study|Adverse Event|3|||
16102729|NCT03494985|38863275|FG003|Overall Study|Adverse Event|0|||
16102730|NCT03494985|38863272|FG000|Overall Study|Other (Withdrawal of consent)|2|||
16102731|NCT03494985|38863273|FG001|Overall Study|Other (Withdrawal of consent)|3|||
16102732|NCT03494985|38863274|FG002|Overall Study|Other (Withdrawal of consent)|2|||
16102733|NCT03494985|38863275|FG003|Overall Study|Other (Withdrawal of consent)|5|||
16102734|NCT03494985|38863272|FG000|Overall Study|Other (Not specified)|0|||
16102735|NCT03494985|38863273|FG001|Overall Study|Other (Not specified)|1|||
16338699|NCT02014558|39726173|FG002|Overall Study|Miscellaneous|1|||
16338700|NCT02014558|39726174|FG003|Overall Study|Miscellaneous|1|||
16338701|NCT02014558|39726175|FG004|Overall Study|Miscellaneous|0|||
16338702|NCT02014558|39726176|FG005|Overall Study|Miscellaneous|1|||
16338703|NCT02014558|39726177|FG006|Overall Study|Miscellaneous|0|||
16338704|NCT02014558|39726178|FG007|Overall Study|Miscellaneous|1|||
16338705|NCT02014558|39726179|FG008|Overall Study|Miscellaneous|1|||
16338706|NCT02014558|39726180|FG009|Overall Study|Miscellaneous|3|||
16338707|NCT02014558|39726181|FG010|Overall Study|Miscellaneous|12|||
16102736|NCT03494985|38863274|FG002|Overall Study|Other (Not specified)|1|||
16102737|NCT03494985|38863275|FG003|Overall Study|Other (Not specified)|0|||
16216949|NCT04315298|39272527|FG000|Overall Study|Withdrawal by Subject|0|||
16338708|NCT02014558|39726182|FG011|Overall Study|Miscellaneous|11|||
16102738|NCT01837797|38863276|FG000|Period 1|Adverse Event|9|||
16102739|NCT01837797|38863277|FG001|Period 1|Adverse Event|0|||
16102740|NCT01837797|38863278|FG002|Period 1|Adverse Event|0|||
16102741|NCT01837797|38863279|FG003|Period 1|Adverse Event|0|||
16102742|NCT01837797|38863280|FG004|Period 1|Adverse Event|0|||
16102743|NCT01837797|38863276|FG000|Period 1|Withdrawal by Subject|6|||
16102744|NCT01837797|38863277|FG001|Period 1|Withdrawal by Subject|0|||
16102745|NCT01837797|38863278|FG002|Period 1|Withdrawal by Subject|0|||
16102746|NCT01837797|38863279|FG003|Period 1|Withdrawal by Subject|0|||
16102747|NCT01837797|38863280|FG004|Period 1|Withdrawal by Subject|0|||
16102748|NCT01837797|38863276|FG000|Period 1|Administrative reasons|76|||
16338709|NCT02014558|39726183|FG012|Overall Study|Miscellaneous|1|||
16338710|NCT04186221|39726184|FG000|Overall Study|Death|1|||
16338711|NCT02412878|39726187|FG000|Overall Study|Withdrawal by Subject|19|||
16338712|NCT02412878|39726188|FG001|Overall Study|Withdrawal by Subject|10|||
16102749|NCT01837797|38863277|FG001|Period 1|Administrative reasons|0|||
16102750|NCT01837797|38863278|FG002|Period 1|Administrative reasons|0|||
16102751|NCT01837797|38863279|FG003|Period 1|Administrative reasons|0|||
16102752|NCT01837797|38863280|FG004|Period 1|Administrative reasons|0|||
16102753|NCT01837797|38863276|FG000|Period 1|Withdrawal of consent before treatment|1|||
16102754|NCT01837797|38863277|FG001|Period 1|Withdrawal of consent before treatment|0|||
16102755|NCT01837797|38863278|FG002|Period 1|Withdrawal of consent before treatment|0|||
16102756|NCT01837797|38863279|FG003|Period 1|Withdrawal of consent before treatment|0|||
16102757|NCT01837797|38863280|FG004|Period 1|Withdrawal of consent before treatment|0|||
16102758|NCT01837797|38863276|FG000|Period 1|Other|10|||
16102759|NCT01837797|38863277|FG001|Period 1|Other|0|||
16102760|NCT01837797|38863278|FG002|Period 1|Other|0|||
16102761|NCT01837797|38863279|FG003|Period 1|Other|0|||
16102762|NCT01837797|38863280|FG004|Period 1|Other|0|||
16102763|NCT01837797|38863276|FG000|Period 2|Administrative or other reasons|0|||
16102764|NCT01837797|38863277|FG001|Period 2|Administrative or other reasons|5|||
16102765|NCT01837797|38863278|FG002|Period 2|Administrative or other reasons|2|||
16102766|NCT01837797|38863279|FG003|Period 2|Administrative or other reasons|4|||
16102767|NCT01837797|38863280|FG004|Period 2|Administrative or other reasons|0|||
16102768|NCT01837797|38863276|FG000|Period 2|Adverse Event|0|||
16102769|NCT01837797|38863277|FG001|Period 2|Adverse Event|0|||
16102770|NCT01837797|38863278|FG002|Period 2|Adverse Event|0|||
16102771|NCT01837797|38863279|FG003|Period 2|Adverse Event|1|||
16102772|NCT01837797|38863280|FG004|Period 2|Adverse Event|0|||
16102773|NCT01837797|38863276|FG000|Period 3|Adverse Event|0|||
16102774|NCT01837797|38863277|FG001|Period 3|Adverse Event|0|||
16102775|NCT01837797|38863278|FG002|Period 3|Adverse Event|0|||
16102776|NCT01837797|38863279|FG003|Period 3|Adverse Event|0|||
16102777|NCT01837797|38863280|FG004|Period 3|Adverse Event|1|||
16102778|NCT01837797|38863276|FG000|Period 3|Administrative reasons|0|||
16102779|NCT01837797|38863277|FG001|Period 3|Administrative reasons|0|||
16102780|NCT01837797|38863278|FG002|Period 3|Administrative reasons|0|||
16102781|NCT01837797|38863279|FG003|Period 3|Administrative reasons|0|||
16102782|NCT01837797|38863280|FG004|Period 3|Administrative reasons|20|||
16102783|NCT01837797|38863276|FG000|Period 3|Other|0|||
16338713|NCT02412878|39726187|FG000|Overall Study|Lost to Follow-up|2|||
16102784|NCT01837797|38863277|FG001|Period 3|Other|0|||
16102785|NCT01837797|38863278|FG002|Period 3|Other|0|||
16102786|NCT01837797|38863279|FG003|Period 3|Other|0|||
16102787|NCT01837797|38863280|FG004|Period 3|Other|2|||
16102788|NCT02621424|38863284|FG000|Overall Study|Withdrawal by Subject|1|||
16102789|NCT02621424|38863285|FG001|Overall Study|Withdrawal by Subject|2|||
16102790|NCT00582114|38863286|FG000|Overall Study|Death|4|||
16102791|NCT00582114|38863287|FG001|Overall Study|Death|4|||
16102792|NCT00582114|38863286|FG000|Overall Study|Kidney Transplant|3|||
16338714|NCT02412878|39726188|FG001|Overall Study|Lost to Follow-up|3|||
16338715|NCT03853291|39726189|FG000|Overall Study|Lost to Follow-up|1|||
16338716|NCT03853291|39726190|FG001|Overall Study|Lost to Follow-up|2|||
16338717|NCT03853291|39726191|FG002|Overall Study|Lost to Follow-up|0|||
16338718|NCT03853291|39726192|FG003|Overall Study|Lost to Follow-up|0|||
16338719|NCT03853291|39726193|FG004|Overall Study|Lost to Follow-up|0|||
16338720|NCT03853291|39726194|FG005|Overall Study|Lost to Follow-up|0|||
16338721|NCT03853291|39726189|FG000|Overall Study|Determined to be ineligible|1|||
16338722|NCT03853291|39726190|FG001|Overall Study|Determined to be ineligible|1|||
16338723|NCT03853291|39726191|FG002|Overall Study|Determined to be ineligible|0|||
16338724|NCT03853291|39726192|FG003|Overall Study|Determined to be ineligible|0|||
16102793|NCT00582114|38863287|FG001|Overall Study|Kidney Transplant|1|||
16102794|NCT00582114|38863286|FG000|Overall Study|Lost to Follow-up|7|||
16102795|NCT00582114|38863287|FG001|Overall Study|Lost to Follow-up|6|||
16102796|NCT00582114|38863286|FG000|Overall Study|Withdrawal by Subject|8|||
16102797|NCT00582114|38863287|FG001|Overall Study|Withdrawal by Subject|16|||
16102798|NCT00582114|38863286|FG000|Overall Study|Adverse Event|1|||
16102799|NCT00582114|38863287|FG001|Overall Study|Adverse Event|1|||
16102800|NCT00582114|38863286|FG000|Overall Study|Physician Decision|0|||
16102801|NCT00582114|38863287|FG001|Overall Study|Physician Decision|6|||
16102802|NCT00582114|38863286|FG000|Overall Study|Stopped by data safety monitoring board|19|||
16338725|NCT03853291|39726193|FG004|Overall Study|Determined to be ineligible|0|||
16338726|NCT03853291|39726194|FG005|Overall Study|Determined to be ineligible|0|||
16102803|NCT00582114|38863287|FG001|Overall Study|Stopped by data safety monitoring board|20|||
16102804|NCT01011049|38863288|FG000|Overall Study|Protocol Violation|0|||
16102805|NCT01011049|38863289|FG001|Overall Study|Protocol Violation|0|||
16338727|NCT00957905|39726195|FG000|Part B|Not Treated|0|||
16338728|NCT00957905|39726196|FG001|Part B|Not Treated|1|||
16338729|NCT00957905|39726195|FG000|Part B|Physician Decision|0|||
16338730|NCT00957905|39726196|FG001|Part B|Physician Decision|1|||
16338731|NCT00957905|39726195|FG000|Part B|Death|0|||
16338732|NCT00957905|39726196|FG001|Part B|Death|1|||
16338733|NCT00957905|39726195|FG000|Part B|Protocol Violation|0|||
16338734|NCT00957905|39726196|FG001|Part B|Protocol Violation|1|||
16338735|NCT00772005|39726199|FG000|Overall Study|Adverse Event|9|||
16338736|NCT00772005|39726200|FG001|Overall Study|Adverse Event|14|||
16338737|NCT00772005|39726201|FG002|Overall Study|Adverse Event|10|||
16338738|NCT00772005|39726202|FG003|Overall Study|Adverse Event|13|||
16338739|NCT00772005|39726199|FG000|Overall Study|Lack of Efficacy|0|||
16338740|NCT00772005|39726200|FG001|Overall Study|Lack of Efficacy|1|||
16338741|NCT00772005|39726201|FG002|Overall Study|Lack of Efficacy|0|||
16338742|NCT00772005|39726202|FG003|Overall Study|Lack of Efficacy|0|||
16338743|NCT00772005|39726199|FG000|Overall Study|Withdrawal by Subject|3|||
16338744|NCT00772005|39726200|FG001|Overall Study|Withdrawal by Subject|7|||
16338745|NCT00772005|39726201|FG002|Overall Study|Withdrawal by Subject|10|||
16338746|NCT00772005|39726202|FG003|Overall Study|Withdrawal by Subject|2|||
16338747|NCT00772005|39726199|FG000|Overall Study|Protocol Violation|2|||
16338748|NCT00772005|39726200|FG001|Overall Study|Protocol Violation|4|||
16338749|NCT00772005|39726201|FG002|Overall Study|Protocol Violation|1|||
16338750|NCT00772005|39726202|FG003|Overall Study|Protocol Violation|6|||
16338751|NCT00772005|39726199|FG000|Overall Study|Lost to Follow-up|7|||
16338752|NCT00772005|39726200|FG001|Overall Study|Lost to Follow-up|3|||
16338753|NCT00772005|39726201|FG002|Overall Study|Lost to Follow-up|6|||
16338754|NCT00772005|39726202|FG003|Overall Study|Lost to Follow-up|3|||
16338755|NCT00772005|39726199|FG000|Overall Study|Non-compliance with study procedures|1|||
16338756|NCT00772005|39726200|FG001|Overall Study|Non-compliance with study procedures|1|||
16338757|NCT00772005|39726201|FG002|Overall Study|Non-compliance with study procedures|0|||
16338758|NCT00772005|39726202|FG003|Overall Study|Non-compliance with study procedures|1|||
16338759|NCT00772005|39726199|FG000|Overall Study|Non-compliance with drug administration|3|||
16338760|NCT00772005|39726200|FG001|Overall Study|Non-compliance with drug administration|0|||
16338761|NCT00772005|39726201|FG002|Overall Study|Non-compliance with drug administration|1|||
16338762|NCT00772005|39726202|FG003|Overall Study|Non-compliance with drug administration|1|||
16338763|NCT00433017|39726203|FG000|Overall Study|Adverse Event|5|||
16338764|NCT00433017|39726204|FG001|Overall Study|Adverse Event|3|||
16338765|NCT00433017|39726203|FG000|Overall Study|Withdrawal by Subject|4|||
16338766|NCT00433017|39726204|FG001|Overall Study|Withdrawal by Subject|5|||
16102806|NCT01011049|38863290|FG002|Overall Study|Protocol Violation|2|||
16102807|NCT01011049|38863291|FG003|Overall Study|Protocol Violation|0|||
16102808|NCT01011049|38863288|FG000|Overall Study|Lost to Follow-up|1|||
16102809|NCT01011049|38863289|FG001|Overall Study|Lost to Follow-up|2|||
16102810|NCT01011049|38863290|FG002|Overall Study|Lost to Follow-up|1|||
16102811|NCT01011049|38863291|FG003|Overall Study|Lost to Follow-up|0|||
16102812|NCT01011049|38863288|FG000|Overall Study|Withdrawal by Subject|0|||
16102813|NCT01011049|38863289|FG001|Overall Study|Withdrawal by Subject|0|||
16102814|NCT01011049|38863290|FG002|Overall Study|Withdrawal by Subject|1|||
16102815|NCT01011049|38863291|FG003|Overall Study|Withdrawal by Subject|0|||
16102816|NCT01485991|38863292|FG000|Overall Study|Adverse Event|0|||
16102817|NCT01485991|38863293|FG001|Overall Study|Adverse Event|4|||
16216950|NCT04315298|39272528|FG001|Overall Study|Withdrawal by Subject|0|||
16102818|NCT01485991|38863292|FG000|Overall Study|Lost to Follow-up|13|||
16102819|NCT01485991|38863293|FG001|Overall Study|Lost to Follow-up|10|||
16102820|NCT01485991|38863292|FG000|Overall Study|Withdrawal by Subject|13|||
16102821|NCT01485991|38863293|FG001|Overall Study|Withdrawal by Subject|20|||
16216951|NCT04315298|39272529|FG002|Overall Study|Withdrawal by Subject|0|||
16216952|NCT04315298|39272530|FG003|Overall Study|Withdrawal by Subject|2|||
16216953|NCT04315298|39272531|FG004|Overall Study|Withdrawal by Subject|2|||
16216954|NCT04315298|39272532|FG005|Overall Study|Withdrawal by Subject|2|||
16216955|NCT04315298|39272533|FG006|Overall Study|Withdrawal by Subject|0|||
16216956|NCT04315298|39272534|FG007|Overall Study|Withdrawal by Subject|1|||
16338767|NCT00433017|39726203|FG000|Overall Study|Lost to Follow-up|3|||
16338768|NCT00433017|39726204|FG001|Overall Study|Lost to Follow-up|4|||
16338769|NCT00433017|39726203|FG000|Overall Study|Administrative problems|80|||
16338770|NCT00433017|39726204|FG001|Overall Study|Administrative problems|86|||
16102822|NCT01485991|38863292|FG000|Overall Study|randomized but not treated|6|||
16102823|NCT01485991|38863293|FG001|Overall Study|randomized but not treated|2|||
16216957|NCT04315298|39272535|FG008|Overall Study|Withdrawal by Subject|1|||
16216958|NCT04315298|39272536|FG009|Overall Study|Withdrawal by Subject|1|||
16216959|NCT04315298|39272537|FG010|Overall Study|Withdrawal by Subject|0|||
16216960|NCT04315298|39272538|FG011|Overall Study|Withdrawal by Subject|0|||
16216961|NCT04315298|39272539|FG012|Overall Study|Withdrawal by Subject|0|||
16216962|NCT04315298|39272540|FG013|Overall Study|Withdrawal by Subject|0|||
16216963|NCT04315298|39272541|FG014|Overall Study|Withdrawal by Subject|0|||
16216964|NCT04315298|39272542|FG015|Overall Study|Withdrawal by Subject|0|||
16216965|NCT04315298|39272543|FG016|Overall Study|Withdrawal by Subject|0|||
16216966|NCT04315298|39272544|FG017|Overall Study|Withdrawal by Subject|0|||
16216967|NCT04315298|39272545|FG018|Overall Study|Withdrawal by Subject|0|||
16216968|NCT04315298|39272527|FG000|Overall Study|Physician Decision|0|||
16216969|NCT04315298|39272528|FG001|Overall Study|Physician Decision|0|||
16216970|NCT04315298|39272529|FG002|Overall Study|Physician Decision|0|||
16216971|NCT04315298|39272530|FG003|Overall Study|Physician Decision|0|||
16216972|NCT04315298|39272531|FG004|Overall Study|Physician Decision|1|||
16216973|NCT04315298|39272532|FG005|Overall Study|Physician Decision|0|||
16216974|NCT04315298|39272533|FG006|Overall Study|Physician Decision|0|||
16216975|NCT04315298|39272534|FG007|Overall Study|Physician Decision|0|||
16216976|NCT04315298|39272535|FG008|Overall Study|Physician Decision|0|||
16216977|NCT04315298|39272536|FG009|Overall Study|Physician Decision|0|||
16216978|NCT04315298|39272537|FG010|Overall Study|Physician Decision|0|||
16216979|NCT04315298|39272538|FG011|Overall Study|Physician Decision|0|||
16216980|NCT04315298|39272539|FG012|Overall Study|Physician Decision|0|||
16102824|NCT05135156|38863295|FG000|Overall Study|Lost to Follow-up|0|||
16537559|NCT03318523|40429249|FG001|PC Period: Up to Year 1|Adverse Event|0|||
16537560|NCT03318523|40429250|FG002|PC Period: Up to Year 1|Adverse Event|2|||
16537561|NCT03318523|40429251|FG003|PC Period: Up to Year 1|Adverse Event|0|||
16537562|NCT03318523|40429252|FG004|PC Period: Up to Year 1|Adverse Event|0|||
16537563|NCT03318523|40429253|FG005|PC Period: Up to Year 1|Adverse Event|0|||
16537564|NCT03318523|40429254|FG006|PC Period: Up to Year 1|Adverse Event|0|||
16537565|NCT03318523|40429255|FG007|PC Period: Up to Year 1|Adverse Event|0|||
16537566|NCT03318523|40429256|FG008|PC Period: Up to Year 1|Adverse Event|0|||
16537567|NCT03318523|40429257|FG009|PC Period: Up to Year 1|Adverse Event|0|||
16537568|NCT03318523|40429248|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
16537569|NCT03318523|40429249|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
16537570|NCT03318523|40429250|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
16537571|NCT03318523|40429251|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
16537572|NCT03318523|40429252|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
16537573|NCT03318523|40429253|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
16537574|NCT03318523|40429254|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
16537575|NCT03318523|40429255|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
16537576|NCT03318523|40429256|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
16537577|NCT03318523|40429257|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
16537578|NCT03318523|40429248|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16537579|NCT03318523|40429249|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16537580|NCT03318523|40429250|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16537581|NCT03318523|40429251|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16537582|NCT03318523|40429252|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
16537583|NCT03318523|40429253|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16537584|NCT03318523|40429254|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16537585|NCT03318523|40429255|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
16537586|NCT03318523|40429256|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
16537587|NCT03318523|40429257|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
16537588|NCT03318523|40429248|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16537589|NCT03318523|40429249|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16537590|NCT03318523|40429250|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16537591|NCT03318523|40429251|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16537592|NCT03318523|40429252|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
16537593|NCT03318523|40429253|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16537594|NCT03318523|40429254|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
16537595|NCT03318523|40429255|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
16216981|NCT04315298|39272540|FG013|Overall Study|Physician Decision|0|||
16216982|NCT04315298|39272541|FG014|Overall Study|Physician Decision|0|||
16216983|NCT04315298|39272542|FG015|Overall Study|Physician Decision|0|||
16102825|NCT05135156|38863296|FG001|Overall Study|Lost to Follow-up|0|||
16102826|NCT05135156|38863297|FG002|Overall Study|Lost to Follow-up|2|||
16102827|NCT00404547|38863298|FG000|Overall Study|Adverse Event|39|||
16102828|NCT00404547|38863299|FG001|Overall Study|Adverse Event|6|||
16102829|NCT00404547|38863298|FG000|Overall Study|Withdrawal by Subject|19|||
16102830|NCT00404547|38863299|FG001|Overall Study|Withdrawal by Subject|2|||
16102831|NCT00404547|38863298|FG000|Overall Study|Protocol Violation|0|||
16102832|NCT00404547|38863299|FG001|Overall Study|Protocol Violation|1|||
16102833|NCT00404547|38863298|FG000|Overall Study|Lost to Follow-up|20|||
16102834|NCT00404547|38863299|FG001|Overall Study|Lost to Follow-up|9|||
16102835|NCT00404547|38863298|FG000|Overall Study|Lack of compliance|5|||
16102836|NCT00404547|38863299|FG001|Overall Study|Lack of compliance|1|||
16102837|NCT00404547|38863298|FG000|Overall Study|Other|4|||
16102838|NCT00404547|38863299|FG001|Overall Study|Other|0|||
16102839|NCT00404547|38863298|FG000|Overall Study|Reason not stated|3|||
16102840|NCT00404547|38863299|FG001|Overall Study|Reason not stated|6|||
16102841|NCT03974100|38863300|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
16102842|NCT03974100|38863301|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
16102843|NCT03974100|38863302|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
16102844|NCT03974100|38863303|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
16102845|NCT03974100|38863304|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
16102846|NCT03974100|38863300|FG000|TP1 - Day 1 to Week 52|Death|1|||
16102847|NCT03974100|38863301|FG001|TP1 - Day 1 to Week 52|Death|0|||
16102848|NCT03974100|38863302|FG002|TP1 - Day 1 to Week 52|Death|0|||
16102849|NCT03974100|38863303|FG003|TP1 - Day 1 to Week 52|Death|0|||
16102850|NCT03974100|38863304|FG004|TP1 - Day 1 to Week 52|Death|0|||
16102851|NCT03974100|38863300|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
16102852|NCT03974100|38863301|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
16102853|NCT03974100|38863302|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
16102854|NCT03974100|38863303|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
16102855|NCT03974100|38863304|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
16216984|NCT04315298|39272543|FG016|Overall Study|Physician Decision|0|||
16216985|NCT04315298|39272544|FG017|Overall Study|Physician Decision|0|||
16216986|NCT04315298|39272545|FG018|Overall Study|Physician Decision|0|||
16216987|NCT04315298|39272527|FG000|Overall Study|Lost to Follow-up|5|||
16216988|NCT04315298|39272528|FG001|Overall Study|Lost to Follow-up|10|||
16537596|NCT03318523|40429256|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
16537597|NCT03318523|40429257|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
16537598|NCT03318523|40429248|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16537599|NCT03318523|40429249|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16537600|NCT03318523|40429250|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16537601|NCT03318523|40429251|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16537602|NCT03318523|40429252|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16537603|NCT03318523|40429253|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
16102856|NCT03974100|38863300|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
16102857|NCT03974100|38863301|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
16102858|NCT03974100|38863302|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
16102859|NCT03974100|38863303|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
16102860|NCT03974100|38863304|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
16102861|NCT03974100|38863300|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
16102862|NCT03974100|38863301|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
16102863|NCT03974100|38863302|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
16102864|NCT03974100|38863303|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
16102865|NCT03974100|38863304|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
16102866|NCT03974100|38863300|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
16102867|NCT03974100|38863301|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
16102868|NCT03974100|38863302|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
16102869|NCT03974100|38863303|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
16102870|NCT03974100|38863304|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
16102871|NCT03974100|38863300|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
16102872|NCT03974100|38863301|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
16102873|NCT03974100|38863302|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
16102874|NCT03974100|38863303|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
16102875|NCT03974100|38863304|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
16102876|NCT02930837|38863305|FG000|Overall Study|Adverse Event|6|||
16102877|NCT02930837|38863305|FG000|Overall Study|Lost to Follow-up|5|||
16102878|NCT02930837|38863305|FG000|Overall Study|Withdrawal by Subject|1|||
16102879|NCT01196741|38863306|FG000|Overall Study|Disease progression|34|||
16102880|NCT01196741|38863307|FG001|Overall Study|Disease progression|14|||
16102881|NCT01196741|38863306|FG000|Overall Study|Adverse Event|10|||
16102882|NCT01196741|38863307|FG001|Overall Study|Adverse Event|6|||
16102883|NCT01196741|38863306|FG000|Overall Study|Serious Adverse Event|3|||
16102884|NCT01196741|38863307|FG001|Overall Study|Serious Adverse Event|1|||
16102885|NCT01196741|38863306|FG000|Overall Study|Dose limiting Adverse Event|2|||
16102886|NCT01196741|38863307|FG001|Overall Study|Dose limiting Adverse Event|1|||
16216989|NCT04315298|39272529|FG002|Overall Study|Lost to Follow-up|6|||
16216990|NCT04315298|39272530|FG003|Overall Study|Lost to Follow-up|8|||
16216991|NCT04315298|39272531|FG004|Overall Study|Lost to Follow-up|12|||
16216992|NCT04315298|39272532|FG005|Overall Study|Lost to Follow-up|13|||
16537604|NCT03318523|40429254|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16537605|NCT03318523|40429255|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16216993|NCT04315298|39272533|FG006|Overall Study|Lost to Follow-up|9|||
16216994|NCT04315298|39272534|FG007|Overall Study|Lost to Follow-up|16|||
16216995|NCT04315298|39272535|FG008|Overall Study|Lost to Follow-up|14|||
16216996|NCT04315298|39272536|FG009|Overall Study|Lost to Follow-up|0|||
16216997|NCT04315298|39272537|FG010|Overall Study|Lost to Follow-up|2|||
16216998|NCT04315298|39272538|FG011|Overall Study|Lost to Follow-up|1|||
16216999|NCT04315298|39272539|FG012|Overall Study|Lost to Follow-up|0|||
16217000|NCT04315298|39272540|FG013|Overall Study|Lost to Follow-up|0|||
16217001|NCT04315298|39272541|FG014|Overall Study|Lost to Follow-up|0|||
16217002|NCT04315298|39272542|FG015|Overall Study|Lost to Follow-up|2|||
16217003|NCT04315298|39272543|FG016|Overall Study|Lost to Follow-up|0|||
16217004|NCT04315298|39272544|FG017|Overall Study|Lost to Follow-up|0|||
16217005|NCT04315298|39272545|FG018|Overall Study|Lost to Follow-up|0|||
16217006|NCT04315298|39272527|FG000|Overall Study|Death|24|||
16217007|NCT04315298|39272528|FG001|Overall Study|Death|60|||
16217008|NCT04315298|39272529|FG002|Overall Study|Death|49|||
16217009|NCT04315298|39272530|FG003|Overall Study|Death|59|||
16217010|NCT04315298|39272531|FG004|Overall Study|Death|70|||
16217011|NCT04315298|39272532|FG005|Overall Study|Death|114|||
16217012|NCT04315298|39272533|FG006|Overall Study|Death|9|||
16217013|NCT04315298|39272534|FG007|Overall Study|Death|12|||
16217014|NCT04315298|39272535|FG008|Overall Study|Death|21|||
16217015|NCT04315298|39272536|FG009|Overall Study|Death|16|||
16217016|NCT04315298|39272537|FG010|Overall Study|Death|40|||
16217017|NCT04315298|39272538|FG011|Overall Study|Death|40|||
16217018|NCT04315298|39272539|FG012|Overall Study|Death|3|||
16217019|NCT04315298|39272540|FG013|Overall Study|Death|4|||
16217020|NCT04315298|39272541|FG014|Overall Study|Death|6|||
16217021|NCT04315298|39272542|FG015|Overall Study|Death|4|||
16217022|NCT04315298|39272543|FG016|Overall Study|Death|3|||
16217023|NCT04315298|39272544|FG017|Overall Study|Death|1|||
16217024|NCT04315298|39272545|FG018|Overall Study|Death|0|||
16217025|NCT02243306|39275833|FG000|Overall Study|Adverse Event|0|||
16217026|NCT02243306|39275834|FG001|Overall Study|Adverse Event|1|||
16217027|NCT02243306|39275833|FG000|Overall Study|Other: Reached stopping criteria|0|||
16217028|NCT02243306|39275834|FG001|Overall Study|Other: Reached stopping criteria|1|||
16217029|NCT02243306|39275833|FG000|Overall Study|Physician Decision|0|||
16338771|NCT00433017|39726203|FG000|Overall Study|Protocol Violation|1|||
16338772|NCT00433017|39726204|FG001|Overall Study|Protocol Violation|0|||
16338773|NCT00433017|39726203|FG000|Overall Study|Death|2|||
16338774|NCT00433017|39726204|FG001|Overall Study|Death|2|||
16338775|NCT00433017|39726203|FG000|Overall Study|Subject no longer requires study drug|1|||
16338776|NCT00433017|39726204|FG001|Overall Study|Subject no longer requires study drug|1|||
16338777|NCT00153816|39726205|FG000|Overall Study|Death|6|||
16338778|NCT00153816|39726206|FG001|Overall Study|Death|5|||
16338779|NCT00153816|39726207|FG002|Overall Study|Death|4|||
16338780|NCT00153816|39726208|FG003|Overall Study|Death|6|||
16338781|NCT00153816|39726209|FG004|Overall Study|Death|0|||
16338782|NCT00153816|39726210|FG005|Overall Study|Death|2|||
16338783|NCT00153816|39726205|FG000|Overall Study|Lost to Follow-up|7|||
16338784|NCT00153816|39726206|FG001|Overall Study|Lost to Follow-up|8|||
16338785|NCT00153816|39726207|FG002|Overall Study|Lost to Follow-up|5|||
16338786|NCT00153816|39726208|FG003|Overall Study|Lost to Follow-up|8|||
16338787|NCT00153816|39726209|FG004|Overall Study|Lost to Follow-up|7|||
16338788|NCT00153816|39726210|FG005|Overall Study|Lost to Follow-up|9|||
16338789|NCT00153816|39726205|FG000|Overall Study|Withdrawal by Subject|9|||
16338790|NCT00153816|39726206|FG001|Overall Study|Withdrawal by Subject|9|||
16338791|NCT00153816|39726207|FG002|Overall Study|Withdrawal by Subject|9|||
16338792|NCT00153816|39726208|FG003|Overall Study|Withdrawal by Subject|4|||
16338793|NCT00153816|39726209|FG004|Overall Study|Withdrawal by Subject|1|||
16217030|NCT02243306|39275834|FG001|Overall Study|Physician Decision|1|||
16217031|NCT00266695|39275837|FG000|Overall Study|Adverse Event|1|||
16217032|NCT00266695|39275837|FG000|Overall Study|Death|9|||
16217033|NCT00266695|39275837|FG000|Overall Study|Physician Decision|1|||
16217034|NCT00266695|39275837|FG000|Overall Study|Lost to Follow-up|3|||
16217035|NCT00266695|39275837|FG000|Overall Study|Withdrawal by Subject|15|||
16217036|NCT05013385|39275838|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
16217037|NCT00537810|39275839|FG000|Overall Study|Withdrawal by Subject|4|||
16338794|NCT00153816|39726210|FG005|Overall Study|Withdrawal by Subject|5|||
16338795|NCT00153816|39726205|FG000|Overall Study|Follow-up exam not done|8|||
16338796|NCT00153816|39726206|FG001|Overall Study|Follow-up exam not done|7|||
16338797|NCT00153816|39726207|FG002|Overall Study|Follow-up exam not done|11|||
16338798|NCT00153816|39726208|FG003|Overall Study|Follow-up exam not done|10|||
16338799|NCT00153816|39726209|FG004|Overall Study|Follow-up exam not done|8|||
16217038|NCT00537810|39275840|FG001|Overall Study|Withdrawal by Subject|11|||
16102887|NCT01196741|38863306|FG000|Overall Study|Withdrawal by Subject|3|||
16102888|NCT01196741|38863307|FG001|Overall Study|Withdrawal by Subject|0|||
16102889|NCT01196741|38863306|FG000|Overall Study|Other reason|3|||
16102890|NCT01196741|38863307|FG001|Overall Study|Other reason|3|||
16102891|NCT01196741|38863306|FG000|Overall Study|Other|3|||
16102892|NCT01196741|38863307|FG001|Overall Study|Other|2|||
16102893|NCT01196741|38863306|FG000|Overall Study|Protocol Violation|2|||
16102894|NCT01196741|38863307|FG001|Overall Study|Protocol Violation|1|||
16537606|NCT03318523|40429256|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16537607|NCT03318523|40429257|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
16537608|NCT03318523|40429248|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16537609|NCT03318523|40429249|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16537610|NCT03318523|40429250|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16537611|NCT03318523|40429251|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16537612|NCT03318523|40429252|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16537613|NCT03318523|40429253|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16537614|NCT03318523|40429254|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16537615|NCT03318523|40429255|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16537616|NCT03318523|40429256|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
16537617|NCT03318523|40429257|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
16537618|NCT03318523|40429248|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
16537619|NCT03318523|40429249|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
16537620|NCT03318523|40429250|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
16537621|NCT03318523|40429251|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
16537622|NCT03318523|40429252|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
16537623|NCT03318523|40429253|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
16537624|NCT03318523|40429254|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
16537625|NCT03318523|40429255|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
16537626|NCT03318523|40429256|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
16537627|NCT03318523|40429257|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
16537628|NCT03318523|40429248|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16537629|NCT03318523|40429249|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16537630|NCT03318523|40429250|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16537631|NCT03318523|40429251|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16537632|NCT03318523|40429252|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
16537633|NCT03318523|40429253|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16537634|NCT03318523|40429254|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16537635|NCT03318523|40429255|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
16537636|NCT03318523|40429256|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
16537637|NCT03318523|40429257|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
16537638|NCT00941330|40429258|FG000|Overall Study|Other|1|||
16537639|NCT00941330|40429259|FG001|Overall Study|Other|0|||
16537640|NCT00941330|40429258|FG000|Overall Study|Physician Decision|0|||
16537641|NCT00941330|40429259|FG001|Overall Study|Physician Decision|2|||
16537642|NCT03221387|40429265|FG000|Overall Study|Lost to Follow-up|1|||
16537643|NCT03221387|40429265|FG000|Overall Study|Lung transplant|1|||
16537644|NCT02182973|40429267|FG000|Overall Study|Withdrawal by Subject|3|||
16537645|NCT02182973|40429268|FG001|Overall Study|Withdrawal by Subject|0|||
16537646|NCT01059175|40429269|FG000|Overall Study|Death|17|||
16537647|NCT01059175|40429270|FG001|Overall Study|Death|17|||
16537648|NCT01059175|40429269|FG000|Overall Study|Adverse Event|4|||
16537649|NCT01059175|40429270|FG001|Overall Study|Adverse Event|2|||
16537650|NCT01059175|40429269|FG000|Overall Study|Lost to Follow-up|0|||
16537651|NCT01059175|40429270|FG001|Overall Study|Lost to Follow-up|1|||
16537652|NCT01274182|40429273|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
16537653|NCT01274182|40429274|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16537654|NCT01274182|40429275|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
16102895|NCT02131155|38863308|FG000|Overall Study|Adverse Event|1|||
16102896|NCT02131155|38863309|FG001|Overall Study|Adverse Event|0|||
16102897|NCT02131155|38863308|FG000|Overall Study|Treatment completed|1|||
16102898|NCT02131155|38863309|FG001|Overall Study|Treatment completed|0|||
16102899|NCT02131155|38863308|FG000|Overall Study|Primary tumour recurrence|2|||
16102900|NCT02131155|38863309|FG001|Overall Study|Primary tumour recurrence|1|||
16102901|NCT02131155|38863308|FG000|Overall Study|Refused to continue study medication|1|||
16537655|NCT01274182|40429273|FG000|Overall Study|Adverse Event|4|||
16537656|NCT01274182|40429274|FG001|Overall Study|Adverse Event|5|||
16537657|NCT01274182|40429275|FG002|Overall Study|Adverse Event|3|||
16537658|NCT01274182|40429273|FG000|Overall Study|Withdrawal by Subject|5|||
16537659|NCT01274182|40429274|FG001|Overall Study|Withdrawal by Subject|5|||
16537660|NCT01274182|40429275|FG002|Overall Study|Withdrawal by Subject|3|||
16537661|NCT01274182|40429273|FG000|Overall Study|Lost to Follow-up|2|||
16537662|NCT01274182|40429274|FG001|Overall Study|Lost to Follow-up|3|||
16537663|NCT01274182|40429275|FG002|Overall Study|Lost to Follow-up|1|||
16537664|NCT01274182|40429273|FG000|Overall Study|Protocol Violation|3|||
16537665|NCT01274182|40429274|FG001|Overall Study|Protocol Violation|2|||
16537666|NCT01274182|40429275|FG002|Overall Study|Protocol Violation|0|||
16537667|NCT01274182|40429273|FG000|Overall Study|Death|1|||
16537668|NCT01274182|40429274|FG001|Overall Study|Death|0|||
16217039|NCT00537810|39275841|FG002|Overall Study|Withdrawal by Subject|4|||
16217040|NCT00537810|39275842|FG003|Overall Study|Withdrawal by Subject|3|||
16217041|NCT00537810|39275839|FG000|Overall Study|Medically withdrawn|2|||
16217042|NCT00537810|39275840|FG001|Overall Study|Medically withdrawn|2|||
16217043|NCT00537810|39275841|FG002|Overall Study|Medically withdrawn|0|||
16217044|NCT00537810|39275842|FG003|Overall Study|Medically withdrawn|1|||
16217045|NCT01017549|39275848|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
16338800|NCT00153816|39726210|FG005|Overall Study|Follow-up exam not done|9|||
16338801|NCT00153816|39726205|FG000|Overall Study|Follow-up exam done, histology missing|2|||
16338802|NCT00153816|39726206|FG001|Overall Study|Follow-up exam done, histology missing|3|||
16338803|NCT00153816|39726207|FG002|Overall Study|Follow-up exam done, histology missing|3|||
16338804|NCT00153816|39726208|FG003|Overall Study|Follow-up exam done, histology missing|3|||
16338805|NCT00153816|39726209|FG004|Overall Study|Follow-up exam done, histology missing|1|||
16338806|NCT00153816|39726210|FG005|Overall Study|Follow-up exam done, histology missing|2|||
16338807|NCT01366638|39726211|FG000|Overall Study|Withdrawal by Subject|0|||
16338808|NCT01366638|39726212|FG001|Overall Study|Withdrawal by Subject|0|||
16338809|NCT01366638|39726213|FG002|Overall Study|Withdrawal by Subject|6|||
16338810|NCT01366638|39726211|FG000|Overall Study|Other|1|||
16338811|NCT01366638|39726212|FG001|Overall Study|Other|0|||
16338812|NCT01366638|39726213|FG002|Overall Study|Other|0|||
16338813|NCT02772809|39726215|FG000|Overall Study|not completed some tasks|6|||
16338814|NCT00585325|39726216|FG000|Overall Study|Withdrawal by Subject|1|||
16338815|NCT00585325|39726217|FG001|Overall Study|Withdrawal by Subject|1|||
16338816|NCT04631107|39726221|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
16338817|NCT04631107|39726221|FG000|Second Intervention (1 Night)|Adverse Event|1|||
16338818|NCT04631107|39726221|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
16338819|NCT04631107|39726221|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
16338820|NCT00422422|39726224|FG000|Overall Study|Lack of Efficacy|1|||
16338821|NCT00422422|39726224|FG000|Overall Study|Protocol Violation|1|||
16338822|NCT00422422|39726224|FG000|Overall Study|Withdrawal by Subject|2|||
16338823|NCT00422422|39726224|FG000|Overall Study|SAE, non-fatal|1|||
16338824|NCT00422422|39726224|FG000|Overall Study|AE, non-serious non-fatal|5|||
16338825|NCT01935128|39726225|FG000|Overall Study|Death|1|||
16338826|NCT01935128|39726225|FG000|Overall Study|Adverse Event|6|||
16338827|NCT02113007|39726226|FG000|Overall Study|Progressive disease|2|||
16338828|NCT01775787|39726227|FG000|First 7-10 Days|Adverse Event|0|||
16338829|NCT01775787|39726228|FG001|First 7-10 Days|Adverse Event|1|||
16537669|NCT01274182|40429275|FG002|Overall Study|Death|1|||
16537670|NCT00827918|40429276|FG000|Overall Study|Adverse Event|4|||
16537671|NCT00827918|40429277|FG001|Overall Study|Adverse Event|0|||
16537672|NCT00827918|40429278|FG002|Overall Study|Adverse Event|0|||
16537673|NCT00827918|40429276|FG000|Overall Study|Lack of Efficacy|16|||
16537674|NCT00827918|40429277|FG001|Overall Study|Lack of Efficacy|4|||
16537675|NCT00827918|40429278|FG002|Overall Study|Lack of Efficacy|15|||
16537676|NCT00827918|40429276|FG000|Overall Study|Physician Decision|1|||
16537677|NCT00827918|40429277|FG001|Overall Study|Physician Decision|0|||
16537678|NCT00827918|40429278|FG002|Overall Study|Physician Decision|0|||
16537679|NCT00827918|40429276|FG000|Overall Study|Pregnancy|0|||
16537680|NCT00827918|40429277|FG001|Overall Study|Pregnancy|1|||
16537681|NCT00827918|40429278|FG002|Overall Study|Pregnancy|0|||
16537682|NCT00827918|40429276|FG000|Overall Study|Progressive Disease|1|||
16537683|NCT00827918|40429277|FG001|Overall Study|Progressive Disease|1|||
16537684|NCT00827918|40429278|FG002|Overall Study|Progressive Disease|0|||
16537685|NCT00827918|40429276|FG000|Overall Study|Protocol Violation|0|||
16537686|NCT00827918|40429277|FG001|Overall Study|Protocol Violation|1|||
16537687|NCT00827918|40429278|FG002|Overall Study|Protocol Violation|0|||
16537688|NCT00827918|40429276|FG000|Overall Study|Withdrawal by Subject|6|||
16537689|NCT00827918|40429277|FG001|Overall Study|Withdrawal by Subject|2|||
16217046|NCT01017549|39275848|FG000|One-year Follow-up|Lost to Follow-up|2|||
16217047|NCT01017549|39275848|FG000|One-year Follow-up|Withdrawal by Subject|5|||
16338830|NCT01775787|39726227|FG000|First 7-10 Days|family emergency|0|||
16338831|NCT01775787|39726228|FG001|First 7-10 Days|family emergency|1|||
16338832|NCT01775787|39726227|FG000|First 7-10 Days|time commitment|0|||
16338833|NCT01775787|39726228|FG001|First 7-10 Days|time commitment|2|||
16537690|NCT00827918|40429278|FG002|Overall Study|Withdrawal by Subject|6|||
16537691|NCT00377234|40429281|FG000|Overall Study|Adverse Event|14|||
16537692|NCT00377234|40429282|FG001|Overall Study|Adverse Event|17|||
16537693|NCT00377234|40429281|FG000|Overall Study|Withdrawal by Subject|11|||
16537694|NCT00377234|40429282|FG001|Overall Study|Withdrawal by Subject|9|||
16537695|NCT00377234|40429281|FG000|Overall Study|Lost to Follow-up|4|||
16537696|NCT00377234|40429282|FG001|Overall Study|Lost to Follow-up|2|||
16537697|NCT00377234|40429281|FG000|Overall Study|Administrative|2|||
16338834|NCT01775787|39726227|FG000|First 7-10 Days|concerns with using IV|1|||
16338835|NCT01775787|39726228|FG001|First 7-10 Days|concerns with using IV|2|||
16338836|NCT01775787|39726227|FG000|Second 7-10 Days|time commitment|0|||
16338837|NCT01775787|39726228|FG001|Second 7-10 Days|time commitment|1|||
16338838|NCT01775787|39726227|FG000|Second 7-10 Days|concerns with using IV|0|||
16338839|NCT01775787|39726228|FG001|Second 7-10 Days|concerns with using IV|1|||
16338840|NCT03268005|39726232|FG000|Overall Study|Death|2|||
16338841|NCT03268005|39726233|FG001|Overall Study|Death|1|||
16338842|NCT03268005|39726232|FG000|Overall Study|Lost to Follow-up|2|||
16338843|NCT03268005|39726233|FG001|Overall Study|Lost to Follow-up|2|||
16338844|NCT03268005|39726232|FG000|Overall Study|Withdrawal by Subject|11|||
16338845|NCT03268005|39726233|FG001|Overall Study|Withdrawal by Subject|11|||
16338846|NCT01038752|39726237|FG000|Overall Study|Tumor Progression|2|||
16338847|NCT01038752|39726238|FG001|Overall Study|Tumor Progression|2|||
16338848|NCT01038752|39726237|FG000|Overall Study|Lost to Follow-up|3|||
16338849|NCT01038752|39726238|FG001|Overall Study|Lost to Follow-up|3|||
16338850|NCT00840034|39726241|FG000|Acute Treatment Phase|Adverse Event|6|||
16338851|NCT00840034|39726242|FG001|Acute Treatment Phase|Adverse Event|8|||
16338852|NCT00840034|39726241|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
16102902|NCT02131155|38863309|FG001|Overall Study|Refused to continue study medication|0|||
16338853|NCT00840034|39726242|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
16338854|NCT00840034|39726241|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
16338855|NCT00840034|39726242|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
16338856|NCT00840034|39726241|FG000|Acute Treatment Phase|Physician Decision|0|||
16338857|NCT00840034|39726242|FG001|Acute Treatment Phase|Physician Decision|1|||
16338858|NCT00840034|39726241|FG000|Acute Treatment Phase|Protocol Violation|2|||
16338859|NCT00840034|39726242|FG001|Acute Treatment Phase|Protocol Violation|4|||
16338860|NCT00840034|39726241|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
16338861|NCT00840034|39726242|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
16338862|NCT00840034|39726241|FG000|Taper Phase|Adverse Event|1|||
16338863|NCT00840034|39726242|FG001|Taper Phase|Adverse Event|0|||
16338864|NCT00840034|39726241|FG000|Taper Phase|Lost to Follow-up|1|||
16338865|NCT00840034|39726242|FG001|Taper Phase|Lost to Follow-up|1|||
16338866|NCT00840034|39726241|FG000|Taper Phase|Withdrawal by Subject|1|||
16537698|NCT00377234|40429282|FG001|Overall Study|Administrative|1|||
16537699|NCT00377234|40429281|FG000|Overall Study|Not assigned|3|||
16537700|NCT00377234|40429282|FG001|Overall Study|Not assigned|2|||
16537701|NCT04050865|40429283|FG000|Overall Study|Adverse Event|1|||
16537702|NCT04050865|40429284|FG001|Overall Study|Adverse Event|0|||
16537703|NCT04050865|40429283|FG000|Overall Study|no insert|1|||
16537704|NCT04050865|40429284|FG001|Overall Study|no insert|0|||
16537705|NCT04050865|40429283|FG000|Overall Study|Only 1 insert|2|||
16537706|NCT04050865|40429284|FG001|Overall Study|Only 1 insert|3|||
16537707|NCT04050865|40429283|FG000|Overall Study|Physician Decision|0|||
16537708|NCT04050865|40429284|FG001|Overall Study|Physician Decision|1|||
16537709|NCT04050865|40429283|FG000|Overall Study|Withdrawal by Subject|0|||
16537710|NCT04050865|40429284|FG001|Overall Study|Withdrawal by Subject|1|||
16537711|NCT00810264|40429285|FG000|Overall Study|Lost to Follow-up|191|||
16537712|NCT00810264|40429285|FG000|Overall Study|Withdrawal by subject or physician|721|||
16537713|NCT00810264|40429285|FG000|Overall Study|Death|641|||
16537714|NCT03802123|40429289|FG000|Overall Study|Withdrawal by Subject|3|||
16537715|NCT03802123|40429289|FG000|Overall Study|Physician Decision|1|||
16537716|NCT03802123|40429289|FG000|Overall Study|Subject moved to hospice care|1|||
16537717|NCT03802123|40429289|FG000|Overall Study|technician error|1|||
16537718|NCT03802123|40429289|FG000|Overall Study|Death|3|||
16537719|NCT02487810|40429292|FG000|Overall Study|Withdrawal by Subject|1|||
16537720|NCT02487810|40429293|FG001|Overall Study|Withdrawal by Subject|0|||
16537721|NCT01854827|40429298|FG000|Overall Study|Death|1|||
16537722|NCT00645164|40429301|FG000|Overall Study|Lost to Follow-up|2|||
16537723|NCT00645164|40429301|FG000|Overall Study|Withdrawal by Subject|4|||
16537724|NCT00645164|40429301|FG000|Overall Study|Protocol Violation|1|||
16537725|NCT02199028|40429306|FG000|Week 1|Adverse Event|1|||
16537726|NCT02199028|40429307|FG001|Week 1|Adverse Event|0|||
16338867|NCT00840034|39726242|FG001|Taper Phase|Withdrawal by Subject|1|||
16537727|NCT02199028|40429306|FG000|Week 3|Adverse Event|1|||
16537728|NCT02199028|40429307|FG001|Week 3|Adverse Event|0|||
16537729|NCT02349295|40429308|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
16537730|NCT02349295|40429309|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
16537731|NCT02349295|40429310|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
16537732|NCT02349295|40429311|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16338868|NCT00096993|39726243|FG000|Overall Study|Death|1|||
16338869|NCT00096993|39726244|FG001|Overall Study|Death|0|||
16338870|NCT00096993|39726243|FG000|Overall Study|Disease progression|56|||
16537733|NCT02349295|40429312|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16537734|NCT02349295|40429313|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16338871|NCT00096993|39726244|FG001|Overall Study|Disease progression|53|||
16537735|NCT02349295|40429314|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16537736|NCT02349295|40429315|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16338872|NCT00096993|39726243|FG000|Overall Study|Adverse Event|2|||
16338873|NCT00096993|39726244|FG001|Overall Study|Adverse Event|8|||
16338874|NCT00096993|39726243|FG000|Overall Study|Subject's decision|3|||
16338875|NCT00096993|39726244|FG001|Overall Study|Subject's decision|1|||
16338876|NCT00096993|39726243|FG000|Overall Study|Physician Decision|2|||
16338877|NCT00096993|39726244|FG001|Overall Study|Physician Decision|1|||
16338878|NCT00096993|39726243|FG000|Overall Study|Non-compliance|0|||
16338879|NCT00096993|39726244|FG001|Overall Study|Non-compliance|1|||
16338880|NCT00096993|39726243|FG000|Overall Study|Other unspecified|1|||
16338881|NCT00096993|39726244|FG001|Overall Study|Other unspecified|1|||
16338882|NCT01797094|39726245|FG000|Overall Study|Adverse Event|1|||
16338883|NCT01797094|39726246|FG001|Overall Study|Adverse Event|1|||
16338884|NCT01797094|39726245|FG000|Overall Study|Personal Reasons|4|||
16338885|NCT01797094|39726246|FG001|Overall Study|Personal Reasons|0|||
16338886|NCT01797094|39726245|FG000|Overall Study|Protocol Violation|0|||
16338887|NCT01797094|39726246|FG001|Overall Study|Protocol Violation|1|||
16338888|NCT01797094|39726245|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16338889|NCT01797094|39726246|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16338890|NCT04318132|39726249|FG000|Overall Study|Protocol Violation|0|||
16338891|NCT04318132|39726250|FG001|Overall Study|Protocol Violation|0|||
16338892|NCT04318132|39726251|FG002|Overall Study|Protocol Violation|3|||
16338893|NCT04318132|39726252|FG003|Overall Study|Protocol Violation|0|||
16338894|NCT02452554|39726255|FG000|Overall Study|Death|2|||
16338895|NCT02452554|39726256|FG001|Overall Study|Death|1|||
16338896|NCT02452554|39726257|FG002|Overall Study|Death|0|||
16338897|NCT02452554|39726258|FG003|Overall Study|Death|0|||
16338898|NCT02452554|39726259|FG004|Overall Study|Death|0|||
16338899|NCT02452554|39726260|FG005|Overall Study|Death|0|||
16338900|NCT02452554|39726255|FG000|Overall Study|Lack of Efficacy|13|||
16338901|NCT02452554|39726256|FG001|Overall Study|Lack of Efficacy|14|||
16338902|NCT02452554|39726257|FG002|Overall Study|Lack of Efficacy|9|||
16338903|NCT02452554|39726258|FG003|Overall Study|Lack of Efficacy|1|||
16338904|NCT02452554|39726259|FG004|Overall Study|Lack of Efficacy|5|||
16338905|NCT02452554|39726260|FG005|Overall Study|Lack of Efficacy|8|||
16338906|NCT02452554|39726255|FG000|Overall Study|Physician Decision|0|||
16338907|NCT02452554|39726256|FG001|Overall Study|Physician Decision|1|||
16338908|NCT02452554|39726257|FG002|Overall Study|Physician Decision|0|||
16338909|NCT02452554|39726258|FG003|Overall Study|Physician Decision|0|||
16338910|NCT02452554|39726259|FG004|Overall Study|Physician Decision|0|||
16338911|NCT02452554|39726260|FG005|Overall Study|Physician Decision|0|||
16338912|NCT02452554|39726255|FG000|Overall Study|Withdrawal by Subject|1|||
16338913|NCT02452554|39726256|FG001|Overall Study|Withdrawal by Subject|0|||
16338914|NCT02452554|39726257|FG002|Overall Study|Withdrawal by Subject|2|||
16338915|NCT02452554|39726258|FG003|Overall Study|Withdrawal by Subject|0|||
16102903|NCT02131155|38863308|FG000|Overall Study|Study early termination|20|||
16102904|NCT02131155|38863309|FG001|Overall Study|Study early termination|10|||
16102905|NCT02025985|38863310|FG000|Overall Study|Consent withdrawn|0|||
16102906|NCT02025985|38863311|FG001|Overall Study|Consent withdrawn|0|||
16537737|NCT02349295|40429316|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16537738|NCT02349295|40429317|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16537739|NCT02349295|40429318|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16537740|NCT02349295|40429319|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16537741|NCT02349295|40429320|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16537742|NCT02349295|40429321|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
16537743|NCT02349295|40429308|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
16537744|NCT02349295|40429309|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
16537745|NCT02349295|40429310|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
16537746|NCT02349295|40429311|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16537747|NCT02349295|40429312|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16537748|NCT02349295|40429313|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16537749|NCT02349295|40429314|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16338916|NCT02452554|39726259|FG004|Overall Study|Withdrawal by Subject|0|||
16338917|NCT02452554|39726260|FG005|Overall Study|Withdrawal by Subject|1|||
16338918|NCT02452554|39726255|FG000|Overall Study|Ineligible|0|||
16338919|NCT02452554|39726256|FG001|Overall Study|Ineligible|1|||
16338920|NCT02452554|39726257|FG002|Overall Study|Ineligible|0|||
16338921|NCT02452554|39726258|FG003|Overall Study|Ineligible|0|||
16537750|NCT02349295|40429315|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16537751|NCT02349295|40429316|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16338922|NCT02452554|39726259|FG004|Overall Study|Ineligible|0|||
16338923|NCT02452554|39726260|FG005|Overall Study|Ineligible|0|||
16338924|NCT02452554|39726255|FG000|Overall Study|Never Received Treatment|1|||
16338925|NCT02452554|39726256|FG001|Overall Study|Never Received Treatment|0|||
16338926|NCT02452554|39726257|FG002|Overall Study|Never Received Treatment|0|||
16338927|NCT02452554|39726258|FG003|Overall Study|Never Received Treatment|0|||
16338928|NCT02452554|39726259|FG004|Overall Study|Never Received Treatment|0|||
16338929|NCT02452554|39726260|FG005|Overall Study|Never Received Treatment|0|||
16102907|NCT02025985|38863312|FG002|Overall Study|Consent withdrawn|1|||
16102908|NCT02025985|38863313|FG003|Overall Study|Consent withdrawn|0|||
16102909|NCT02025985|38863314|FG004|Overall Study|Consent withdrawn|0|||
16102910|NCT02025985|38863310|FG000|Overall Study|Termination of study by Sponsor|4|||
16102911|NCT02025985|38863311|FG001|Overall Study|Termination of study by Sponsor|3|||
16102912|NCT02025985|38863312|FG002|Overall Study|Termination of study by Sponsor|1|||
16102913|NCT02025985|38863313|FG003|Overall Study|Termination of study by Sponsor|1|||
16102914|NCT02025985|38863314|FG004|Overall Study|Termination of study by Sponsor|3|||
16102915|NCT02025985|38863310|FG000|Overall Study|Death|21|||
16102916|NCT02025985|38863311|FG001|Overall Study|Death|20|||
16102917|NCT02025985|38863312|FG002|Overall Study|Death|23|||
16102918|NCT02025985|38863313|FG003|Overall Study|Death|20|||
16102919|NCT02025985|38863314|FG004|Overall Study|Death|17|||
16102920|NCT04413149|38863322|FG000|Overall Study|Death|10|||
16102921|NCT04413149|38863323|FG001|Overall Study|Death|5|||
16102922|NCT04413149|38863322|FG000|Overall Study|Lung transplantation|1|||
16102923|NCT04413149|38863323|FG001|Overall Study|Lung transplantation|0|||
16102924|NCT01772147|38863324|FG000|Overall Study|Adverse Event|13|||
16102925|NCT01772147|38863325|FG001|Overall Study|Adverse Event|10|||
16102926|NCT01772147|38863326|FG002|Overall Study|Adverse Event|6|||
16102927|NCT01772147|38863324|FG000|Overall Study|Withdrew Consent|7|||
16102928|NCT01772147|38863325|FG001|Overall Study|Withdrew Consent|8|||
16102929|NCT01772147|38863326|FG002|Overall Study|Withdrew Consent|4|||
16102930|NCT01772147|38863324|FG000|Overall Study|Lost to Follow-up|1|||
16102931|NCT01772147|38863325|FG001|Overall Study|Lost to Follow-up|0|||
16102932|NCT01772147|38863326|FG002|Overall Study|Lost to Follow-up|1|||
16102933|NCT01772147|38863324|FG000|Overall Study|Protocol Deviation|2|||
16537752|NCT02349295|40429317|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16537753|NCT02349295|40429318|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16338930|NCT02797678|39726261|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
16338931|NCT02797678|39726262|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
16338932|NCT02797678|39726263|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
16338933|NCT02797678|39726264|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
16338934|NCT02797678|39726261|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
16338935|NCT02797678|39726262|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
16338936|NCT02797678|39726263|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
16338937|NCT02797678|39726264|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
16102934|NCT01772147|38863325|FG001|Overall Study|Protocol Deviation|1|||
16537754|NCT02349295|40429319|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16537755|NCT02349295|40429320|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16537756|NCT02349295|40429321|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
16537757|NCT02349295|40429308|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
16537758|NCT02349295|40429309|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
16537759|NCT02349295|40429310|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
16537760|NCT02349295|40429311|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537761|NCT02349295|40429312|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537762|NCT02349295|40429313|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537763|NCT02349295|40429314|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537764|NCT02349295|40429315|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537765|NCT02349295|40429316|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537766|NCT02349295|40429317|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537767|NCT02349295|40429318|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537768|NCT02349295|40429319|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537769|NCT02349295|40429320|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537770|NCT02349295|40429321|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
16537771|NCT02349295|40429308|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
16537772|NCT02349295|40429309|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
16537773|NCT02349295|40429310|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
16537774|NCT02349295|40429311|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16537775|NCT02349295|40429312|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16537776|NCT02349295|40429313|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16537777|NCT02349295|40429314|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16537778|NCT02349295|40429315|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16102935|NCT01772147|38863326|FG002|Overall Study|Protocol Deviation|1|||
16102936|NCT01772147|38863324|FG000|Overall Study|Lack of Efficacy|8|||
16102937|NCT01772147|38863325|FG001|Overall Study|Lack of Efficacy|6|||
16102938|NCT01772147|38863326|FG002|Overall Study|Lack of Efficacy|6|||
16102939|NCT01797705|38863327|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
16102940|NCT01797705|38863327|FG000|Overall Study|Withdrawal by Subject|1|||
16102941|NCT01363297|38863328|FG000|Overall Study|Other|0|||
16102942|NCT01363297|38863329|FG001|Overall Study|Other|0|||
16102943|NCT01363297|38863330|FG002|Overall Study|Other|0|||
16102944|NCT01363297|38863331|FG003|Overall Study|Other|0|||
16102945|NCT01363297|38863332|FG004|Overall Study|Other|1|||
16102946|NCT01363297|38863328|FG000|Overall Study|Death|3|||
16102947|NCT01363297|38863329|FG001|Overall Study|Death|6|||
16102948|NCT01363297|38863330|FG002|Overall Study|Death|6|||
16102949|NCT01363297|38863331|FG003|Overall Study|Death|10|||
16102950|NCT01363297|38863332|FG004|Overall Study|Death|30|||
16102951|NCT00527514|38863337|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
16102952|NCT00527514|38863337|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
16102953|NCT00527514|38863337|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
16102954|NCT00527514|38863337|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
16102955|NCT00527514|38863337|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
16102956|NCT00527514|38863337|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
16102957|NCT00527514|38863337|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
16102958|NCT00461123|38863338|FG000|Overall Study|Adverse Event|1|||
16102959|NCT00461123|38863339|FG001|Overall Study|Adverse Event|0|||
16102960|NCT00461123|38863338|FG000|Overall Study|Lost to Follow-up|1|||
16102961|NCT00461123|38863339|FG001|Overall Study|Lost to Follow-up|1|||
16102962|NCT00461123|38863338|FG000|Overall Study|Protocol Violation|3|||
16102963|NCT00461123|38863339|FG001|Overall Study|Protocol Violation|2|||
16102964|NCT00461123|38863338|FG000|Overall Study|Withdrawal by Subject|1|||
16102965|NCT00461123|38863339|FG001|Overall Study|Withdrawal by Subject|3|||
16102966|NCT02261285|38863340|FG000|Overall Study|Disease progression|0|||
16102967|NCT02261285|38863341|FG001|Overall Study|Disease progression|0|||
16102968|NCT02261285|38863342|FG002|Overall Study|Disease progression|1|||
16102969|NCT00815919|38863343|FG000|Overall Study|Unrelated Fungal Infection|1|||
16102970|NCT00815919|38863343|FG000|Overall Study|AML Relapse|1|||
16102971|NCT00815919|38863343|FG000|Overall Study|Lack of Efficacy|2|||
16102972|NCT01837719|38863347|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
16102973|NCT01837719|38863347|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
16102974|NCT02779855|38863349|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
16102975|NCT02779855|38863350|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
16102976|NCT02779855|38863351|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
16102977|NCT01284634|38863353|FG000|Overall Study|Adverse Event|1|||
16102978|NCT01284634|38863354|FG001|Overall Study|Adverse Event|0|||
16102979|NCT01284634|38863355|FG002|Overall Study|Adverse Event|2|||
16102980|NCT01284634|38863356|FG003|Overall Study|Adverse Event|1|||
16102981|NCT02329223|38863357|FG000|Overall Study|Withdrawal by Subject|1|||
16102982|NCT02329223|38863358|FG001|Overall Study|Withdrawal by Subject|2|||
16102983|NCT02329223|38863359|FG002|Overall Study|Withdrawal by Subject|5|||
16102984|NCT02329223|38863357|FG000|Overall Study|Physician Decision|0|||
16102985|NCT02329223|38863358|FG001|Overall Study|Physician Decision|0|||
16102986|NCT02329223|38863359|FG002|Overall Study|Physician Decision|1|||
16102987|NCT02329223|38863357|FG000|Overall Study|Adverse Event|0|||
16102988|NCT02329223|38863358|FG001|Overall Study|Adverse Event|1|||
16102989|NCT02329223|38863359|FG002|Overall Study|Adverse Event|0|||
16102990|NCT03738397|38863360|FG000|Overall Study|Adverse Event|3|||
16102991|NCT03738397|38863361|FG001|Overall Study|Adverse Event|7|||
16102992|NCT03738397|38863360|FG000|Overall Study|Withdrawal by Subject|8|||
16102993|NCT03738397|38863361|FG001|Overall Study|Withdrawal by Subject|11|||
16102994|NCT03738397|38863360|FG000|Overall Study|Lost to Follow-up|7|||
16102995|NCT03738397|38863361|FG001|Overall Study|Lost to Follow-up|5|||
16102996|NCT03738397|38863360|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
16102997|NCT03738397|38863361|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
16102998|NCT03738397|38863360|FG000|Overall Study|Other|4|||
16102999|NCT03738397|38863361|FG001|Overall Study|Other|6|||
16103000|NCT00496834|38863362|FG000|Overall Study|Withdrawal by Subject|4|||
16103001|NCT00496834|38863363|FG001|Overall Study|Withdrawal by Subject|6|||
16103002|NCT00496834|38863362|FG000|Overall Study|Contraindicated medication administered|0|||
16103003|NCT00496834|38863363|FG001|Overall Study|Contraindicated medication administered|1|||
16103004|NCT00496834|38863362|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
16103005|NCT00496834|38863363|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
16103006|NCT00496834|38863362|FG000|Overall Study|Adverse Event|5|||
16103007|NCT00496834|38863363|FG001|Overall Study|Adverse Event|3|||
16103008|NCT00496834|38863362|FG000|Overall Study|IP administration violation|2|||
16103009|NCT00496834|38863363|FG001|Overall Study|IP administration violation|0|||
16103010|NCT00496834|38863362|FG000|Overall Study|Lost to Follow-up|2|||
16103011|NCT00496834|38863363|FG001|Overall Study|Lost to Follow-up|0|||
16103012|NCT00496834|38863362|FG000|Overall Study|Blood Pressure control failure|2|||
16103013|NCT00496834|38863363|FG001|Overall Study|Blood Pressure control failure|1|||
16103014|NCT02567227|38863364|FG000|9 Weeks|Adverse Event|5|||
16103015|NCT02567227|38863365|FG001|9 Weeks|Adverse Event|5|||
16103016|NCT02567227|38863364|FG000|9 Weeks|Withdrawal by Subject|18|||
16103017|NCT02567227|38863365|FG001|9 Weeks|Withdrawal by Subject|8|||
16103018|NCT02567227|38863364|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
16103019|NCT02567227|38863365|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
16103020|NCT02567227|38863364|FG000|6 Month|Death|2|||
16103021|NCT02567227|38863365|FG001|6 Month|Death|0|||
16103022|NCT02567227|38863364|FG000|6 Month|Lost to Follow-up|43|||
16103023|NCT02567227|38863365|FG001|6 Month|Lost to Follow-up|40|||
16103024|NCT02567227|38863364|FG000|12 Months|Lost to Follow-up|31|||
16103025|NCT02567227|38863365|FG001|12 Months|Lost to Follow-up|32|||
16103026|NCT02567227|38863364|FG000|12 Months|Death|0|||
16103027|NCT02567227|38863365|FG001|12 Months|Death|2|||
16103028|NCT01049984|38863366|FG000|Overall Study|Withdrawal by Subject|1|||
16103029|NCT01049984|38863367|FG001|Overall Study|Withdrawal by Subject|5|||
16103030|NCT01049984|38863366|FG000|Overall Study|Protocol Violation|3|||
16103031|NCT01049984|38863367|FG001|Overall Study|Protocol Violation|4|||
16103032|NCT01049984|38863366|FG000|Overall Study|Lost to Follow-up|2|||
16537779|NCT02349295|40429316|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16537780|NCT02349295|40429317|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16537781|NCT02349295|40429318|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16537782|NCT02349295|40429319|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16537783|NCT02349295|40429320|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16537784|NCT02349295|40429321|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
16537785|NCT02349295|40429308|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16103033|NCT01049984|38863367|FG001|Overall Study|Lost to Follow-up|1|||
16103034|NCT01049984|38863366|FG000|Overall Study|Adverse Event|13|||
16103035|NCT01049984|38863367|FG001|Overall Study|Adverse Event|7|||
16537786|NCT02349295|40429309|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
16537787|NCT02349295|40429310|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
16537788|NCT02349295|40429311|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16537789|NCT02349295|40429312|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16537790|NCT02349295|40429313|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16537791|NCT02349295|40429314|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16537792|NCT02349295|40429315|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16537793|NCT02349295|40429316|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16537794|NCT02349295|40429317|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16537795|NCT02349295|40429318|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16537796|NCT02349295|40429319|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16537797|NCT02349295|40429320|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16338938|NCT02797678|39726261|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
16338939|NCT02797678|39726262|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
16338940|NCT02797678|39726263|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
16338941|NCT02797678|39726264|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
16338942|NCT02971800|39726265|FG000|Overall Study|Protocol Violation|1|||
16338943|NCT02971800|39726265|FG000|Overall Study|Withdrawal by Subject|1|||
16338944|NCT02971800|39726265|FG000|Overall Study|Exclusion criteria prior intervention|1|||
16338945|NCT02971800|39726265|FG000|Overall Study|Number evaluable participant already reached|4|||
16338946|NCT01709409|39726266|FG000|Overall Study|Protocol Violation|1|||
16338947|NCT01709409|39726267|FG001|Overall Study|Protocol Violation|0|||
16338948|NCT00572455|39726268|FG000|Stage I (14 Days)|Adverse Event|0|||
16338949|NCT00572455|39726269|FG001|Stage I (14 Days)|Adverse Event|0|||
16338950|NCT00572455|39726270|FG002|Stage I (14 Days)|Adverse Event|0|||
16338951|NCT00572455|39726271|FG003|Stage I (14 Days)|Adverse Event|0|||
16338952|NCT00572455|39726272|FG004|Stage I (14 Days)|Adverse Event|0|||
16338953|NCT00572455|39726273|FG005|Stage I (14 Days)|Adverse Event|3|||
16338954|NCT00572455|39726274|FG006|Stage I (14 Days)|Adverse Event|0|||
16338955|NCT00572455|39726275|FG007|Stage I (14 Days)|Adverse Event|0|||
16338956|NCT00572455|39726276|FG008|Stage I (14 Days)|Adverse Event|0|||
16338957|NCT00572455|39726277|FG009|Stage I (14 Days)|Adverse Event|0|||
16338958|NCT00572455|39726278|FG010|Stage I (14 Days)|Adverse Event|0|||
16338959|NCT00572455|39726279|FG011|Stage I (14 Days)|Adverse Event|0|||
16338960|NCT00572455|39726280|FG012|Stage I (14 Days)|Adverse Event|0|||
16338961|NCT00572455|39726281|FG013|Stage I (14 Days)|Adverse Event|0|||
16338962|NCT00572455|39726268|FG000|Stage I (14 Days)|Other|0|||
16338963|NCT00572455|39726269|FG001|Stage I (14 Days)|Other|0|||
16338964|NCT00572455|39726270|FG002|Stage I (14 Days)|Other|0|||
16338965|NCT00572455|39726271|FG003|Stage I (14 Days)|Other|0|||
16338966|NCT00572455|39726272|FG004|Stage I (14 Days)|Other|1|||
16338967|NCT00572455|39726273|FG005|Stage I (14 Days)|Other|0|||
16103036|NCT01049984|38863366|FG000|Overall Study|Treatment failure|0|||
16103037|NCT01049984|38863367|FG001|Overall Study|Treatment failure|2|||
16537798|NCT02349295|40429321|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
16338968|NCT00572455|39726274|FG006|Stage I (14 Days)|Other|0|||
16338969|NCT00572455|39726275|FG007|Stage I (14 Days)|Other|0|||
16103038|NCT01675050|38863370|FG000|Period One Treatment|Withdrawal by Subject|1|||
16103039|NCT01675050|38863371|FG001|Period One Treatment|Withdrawal by Subject|0|||
16103040|NCT01203956|38863372|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
16103041|NCT01203956|38863373|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
16103042|NCT00985621|38863374|FG000|Overall Study|Adverse Event|2|||
16103043|NCT00985621|38863375|FG001|Overall Study|Adverse Event|3|||
16103044|NCT00985621|38863376|FG002|Overall Study|Adverse Event|4|||
16103045|NCT00985621|38863377|FG003|Overall Study|Adverse Event|16|||
16103046|NCT00985621|38863374|FG000|Overall Study|Lack of Efficacy|10|||
16103047|NCT00985621|38863375|FG001|Overall Study|Lack of Efficacy|6|||
16103048|NCT00985621|38863376|FG002|Overall Study|Lack of Efficacy|5|||
16103049|NCT00985621|38863377|FG003|Overall Study|Lack of Efficacy|12|||
16103050|NCT00985621|38863374|FG000|Overall Study|Lost to Follow-up|2|||
16103051|NCT00985621|38863375|FG001|Overall Study|Lost to Follow-up|3|||
16103052|NCT00985621|38863376|FG002|Overall Study|Lost to Follow-up|4|||
16103053|NCT00985621|38863377|FG003|Overall Study|Lost to Follow-up|4|||
16338970|NCT00572455|39726276|FG008|Stage I (14 Days)|Other|0|||
16338971|NCT00572455|39726277|FG009|Stage I (14 Days)|Other|0|||
16338972|NCT00572455|39726278|FG010|Stage I (14 Days)|Other|0|||
16338973|NCT00572455|39726279|FG011|Stage I (14 Days)|Other|0|||
16338974|NCT00572455|39726280|FG012|Stage I (14 Days)|Other|0|||
16338975|NCT00572455|39726281|FG013|Stage I (14 Days)|Other|0|||
16338976|NCT00572455|39726268|FG000|Stage II (28 Days)|Adverse Event|0|||
16103054|NCT00985621|38863374|FG000|Overall Study|Study Terminated by Sponsor|89|||
16103055|NCT00985621|38863375|FG001|Overall Study|Study Terminated by Sponsor|108|||
16103056|NCT00985621|38863376|FG002|Overall Study|Study Terminated by Sponsor|99|||
16338977|NCT00572455|39726269|FG001|Stage II (28 Days)|Adverse Event|0|||
16338978|NCT00572455|39726270|FG002|Stage II (28 Days)|Adverse Event|0|||
16338979|NCT00572455|39726271|FG003|Stage II (28 Days)|Adverse Event|0|||
16338980|NCT00572455|39726272|FG004|Stage II (28 Days)|Adverse Event|0|||
16338981|NCT00572455|39726273|FG005|Stage II (28 Days)|Adverse Event|0|||
16338982|NCT00572455|39726274|FG006|Stage II (28 Days)|Adverse Event|0|||
16338983|NCT00572455|39726275|FG007|Stage II (28 Days)|Adverse Event|0|||
16338984|NCT00572455|39726276|FG008|Stage II (28 Days)|Adverse Event|1|||
16338985|NCT00572455|39726277|FG009|Stage II (28 Days)|Adverse Event|3|||
16338986|NCT00572455|39726278|FG010|Stage II (28 Days)|Adverse Event|3|||
16338987|NCT00572455|39726279|FG011|Stage II (28 Days)|Adverse Event|4|||
16338988|NCT00572455|39726280|FG012|Stage II (28 Days)|Adverse Event|5|||
16338989|NCT00572455|39726281|FG013|Stage II (28 Days)|Adverse Event|1|||
16338990|NCT00572455|39726268|FG000|Stage II (28 Days)|Death|0|||
16338991|NCT00572455|39726269|FG001|Stage II (28 Days)|Death|0|||
16338992|NCT00572455|39726270|FG002|Stage II (28 Days)|Death|0|||
16338993|NCT00572455|39726271|FG003|Stage II (28 Days)|Death|0|||
16338994|NCT00572455|39726272|FG004|Stage II (28 Days)|Death|0|||
16338995|NCT00572455|39726273|FG005|Stage II (28 Days)|Death|0|||
16338996|NCT00572455|39726274|FG006|Stage II (28 Days)|Death|0|||
16338997|NCT00572455|39726275|FG007|Stage II (28 Days)|Death|0|||
16338998|NCT00572455|39726276|FG008|Stage II (28 Days)|Death|1|||
16338999|NCT00572455|39726277|FG009|Stage II (28 Days)|Death|0|||
16339000|NCT00572455|39726278|FG010|Stage II (28 Days)|Death|0|||
16339001|NCT00572455|39726279|FG011|Stage II (28 Days)|Death|0|||
16339002|NCT00572455|39726280|FG012|Stage II (28 Days)|Death|0|||
16339003|NCT00572455|39726281|FG013|Stage II (28 Days)|Death|0|||
16537799|NCT02349295|40429308|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
16537800|NCT02349295|40429309|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
16537801|NCT02349295|40429310|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
16537802|NCT02349295|40429311|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
16537803|NCT02349295|40429312|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
16537804|NCT02349295|40429313|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
16537805|NCT02349295|40429314|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
16537806|NCT02349295|40429315|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
16537807|NCT02349295|40429316|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
16537808|NCT02349295|40429317|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
16537809|NCT02349295|40429318|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
16537810|NCT02349295|40429319|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
16537811|NCT02349295|40429320|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
16537812|NCT02349295|40429321|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
16537813|NCT02349295|40429308|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16537814|NCT02349295|40429309|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16537815|NCT02349295|40429310|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16537816|NCT02349295|40429311|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16537817|NCT02349295|40429312|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16537818|NCT02349295|40429313|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16103057|NCT00985621|38863377|FG003|Overall Study|Study Terminated by Sponsor|92|||
16103058|NCT00985621|38863374|FG000|Overall Study|Protocol Violation|1|||
16103059|NCT00985621|38863375|FG001|Overall Study|Protocol Violation|1|||
16339004|NCT00572455|39726268|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
16339005|NCT00572455|39726269|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
16537819|NCT02349295|40429314|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16537820|NCT02349295|40429315|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
16339006|NCT00572455|39726270|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
16339007|NCT00572455|39726271|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
16339008|NCT00572455|39726272|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
16339009|NCT00572455|39726273|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
16339010|NCT00572455|39726274|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
16339011|NCT00572455|39726275|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
16339012|NCT00572455|39726276|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
16339013|NCT00572455|39726277|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
16339014|NCT00572455|39726278|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
16339015|NCT00572455|39726279|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
16339016|NCT00572455|39726280|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
16339017|NCT00572455|39726281|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
16339018|NCT00572455|39726268|FG000|Stage II (28 Days)|Other|0|||
16339019|NCT00572455|39726269|FG001|Stage II (28 Days)|Other|0|||
16339020|NCT00572455|39726270|FG002|Stage II (28 Days)|Other|0|||
16339021|NCT00572455|39726271|FG003|Stage II (28 Days)|Other|0|||
16339022|NCT00572455|39726272|FG004|Stage II (28 Days)|Other|0|||
16339023|NCT00572455|39726273|FG005|Stage II (28 Days)|Other|0|||
16339024|NCT00572455|39726274|FG006|Stage II (28 Days)|Other|0|||
16339025|NCT00572455|39726275|FG007|Stage II (28 Days)|Other|0|||
16339026|NCT00572455|39726276|FG008|Stage II (28 Days)|Other|1|||
16537821|NCT02349295|40429316|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
16537822|NCT02349295|40429317|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
16537823|NCT02349295|40429318|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
16537824|NCT02349295|40429319|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16537825|NCT02349295|40429320|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16537826|NCT02349295|40429321|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
16537827|NCT02349295|40429308|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16537828|NCT02349295|40429309|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16537829|NCT02349295|40429310|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16537830|NCT02349295|40429311|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16537831|NCT02349295|40429312|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16537832|NCT02349295|40429313|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16537833|NCT02349295|40429314|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16537834|NCT02349295|40429315|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
16537835|NCT02349295|40429316|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
16537836|NCT02349295|40429317|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
16537837|NCT02349295|40429318|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
16537838|NCT02349295|40429319|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16537839|NCT02349295|40429320|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16537840|NCT02349295|40429321|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
16537841|NCT02349295|40429308|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537842|NCT02349295|40429309|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537843|NCT02349295|40429310|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537844|NCT02349295|40429311|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537845|NCT02349295|40429312|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537846|NCT02349295|40429313|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537847|NCT02349295|40429314|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537848|NCT02349295|40429315|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
16537849|NCT02349295|40429316|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16103060|NCT00985621|38863376|FG002|Overall Study|Protocol Violation|1|||
16103061|NCT00985621|38863377|FG003|Overall Study|Protocol Violation|0|||
16103062|NCT00985621|38863374|FG000|Overall Study|Withdrawal by Subject|8|||
16103063|NCT00985621|38863375|FG001|Overall Study|Withdrawal by Subject|10|||
16103064|NCT00985621|38863376|FG002|Overall Study|Withdrawal by Subject|8|||
16103065|NCT00985621|38863377|FG003|Overall Study|Withdrawal by Subject|12|||
16339027|NCT00572455|39726277|FG009|Stage II (28 Days)|Other|0|||
16537850|NCT02349295|40429317|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
16537851|NCT02349295|40429318|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537852|NCT02349295|40429319|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537853|NCT02349295|40429320|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537854|NCT02349295|40429321|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
16537855|NCT02349295|40429308|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
16537856|NCT02349295|40429309|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
16537857|NCT02349295|40429310|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
16103066|NCT00985621|38863374|FG000|Overall Study|Other|1|||
16103067|NCT00985621|38863375|FG001|Overall Study|Other|0|||
16339028|NCT00572455|39726278|FG010|Stage II (28 Days)|Other|0|||
16339029|NCT00572455|39726279|FG011|Stage II (28 Days)|Other|0|||
16339030|NCT00572455|39726280|FG012|Stage II (28 Days)|Other|0|||
16103068|NCT00985621|38863376|FG002|Overall Study|Other|0|||
16103069|NCT00985621|38863377|FG003|Overall Study|Other|0|||
16103070|NCT00985621|38863374|FG000|Overall Study|Randomized but not Treated|1|||
16103071|NCT00985621|38863375|FG001|Overall Study|Randomized but not Treated|0|||
16103072|NCT00985621|38863376|FG002|Overall Study|Randomized but not Treated|2|||
16103073|NCT00985621|38863377|FG003|Overall Study|Randomized but not Treated|1|||
16103074|NCT01114217|38863379|FG000|Overall Study|Adverse Event|5|||
16103075|NCT01114217|38863380|FG001|Overall Study|Adverse Event|3|||
16103076|NCT01114217|38863379|FG000|Overall Study|Lost to Follow-up|17|||
16103077|NCT01114217|38863380|FG001|Overall Study|Lost to Follow-up|33|||
16103078|NCT01114217|38863379|FG000|Overall Study|Withdrawal by Subject|21|||
16103079|NCT01114217|38863380|FG001|Overall Study|Withdrawal by Subject|28|||
16103080|NCT01114217|38863379|FG000|Overall Study|Other-Clerical Error|3|||
16103081|NCT01114217|38863380|FG001|Overall Study|Other-Clerical Error|0|||
16103082|NCT01114217|38863379|FG000|Overall Study|Other-Early termination|6|||
16103083|NCT01114217|38863380|FG001|Overall Study|Other-Early termination|10|||
16103084|NCT01114217|38863379|FG000|Overall Study|Other-Procedure|1|||
16103085|NCT01114217|38863380|FG001|Overall Study|Other-Procedure|1|||
16103086|NCT01114217|38863379|FG000|Overall Study|Other-Pregnancy|2|||
16339031|NCT00572455|39726281|FG013|Stage II (28 Days)|Other|0|||
16339032|NCT00572455|39726268|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
16339033|NCT00572455|39726269|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
16339034|NCT00572455|39726270|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
16339035|NCT00572455|39726271|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
16339036|NCT00572455|39726272|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
16339037|NCT00572455|39726273|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
16339038|NCT00572455|39726274|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
16339039|NCT00572455|39726275|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
16103087|NCT01114217|38863380|FG001|Overall Study|Other-Pregnancy|4|||
16103088|NCT01114217|38863379|FG000|Overall Study|Other-Protocol Violation|1|||
16103089|NCT01114217|38863380|FG001|Overall Study|Other-Protocol Violation|3|||
16103090|NCT01114217|38863379|FG000|Overall Study|Other-Lack of Efficacy|1|||
16103091|NCT01114217|38863380|FG001|Overall Study|Other-Lack of Efficacy|0|||
16103092|NCT01114217|38863379|FG000|Overall Study|Other-Non Compliance|2|||
16103093|NCT01114217|38863380|FG001|Overall Study|Other-Non Compliance|0|||
16103094|NCT01114217|38863379|FG000|Overall Study|Other-Physician Decision|1|||
16103095|NCT01114217|38863380|FG001|Overall Study|Other-Physician Decision|1|||
16103096|NCT01114217|38863379|FG000|Overall Study|Other-Sponsor Decision|10|||
16537858|NCT02349295|40429311|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
16537859|NCT02349295|40429312|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
16537860|NCT02349295|40429313|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
16537861|NCT02349295|40429314|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
16537862|NCT02349295|40429315|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
16537863|NCT02349295|40429316|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
16537864|NCT02349295|40429317|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
16537865|NCT02349295|40429318|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
16537866|NCT02349295|40429319|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
16537867|NCT02349295|40429320|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
16537868|NCT02349295|40429321|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
16537869|NCT02349295|40429308|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16537870|NCT02349295|40429309|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16537871|NCT02349295|40429310|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16537872|NCT02349295|40429311|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16537873|NCT02349295|40429312|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16537874|NCT02349295|40429313|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16537875|NCT02349295|40429314|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16537876|NCT02349295|40429315|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
16537877|NCT02349295|40429316|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
16537878|NCT02349295|40429317|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
16537879|NCT02349295|40429318|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
16537880|NCT02349295|40429319|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16537881|NCT02349295|40429320|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16537882|NCT02349295|40429321|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
16537883|NCT02349295|40429308|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16537884|NCT02349295|40429309|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16537885|NCT02349295|40429310|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16537886|NCT02349295|40429311|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16537887|NCT02349295|40429312|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16103097|NCT01114217|38863380|FG001|Overall Study|Other-Sponsor Decision|12|||
16103098|NCT01114217|38863379|FG000|Overall Study|Other-Study Termination|0|||
16103099|NCT01114217|38863380|FG001|Overall Study|Other-Study Termination|1|||
16103100|NCT01114217|38863379|FG000|Overall Study|Other-Study Withdrawn|1|||
16103101|NCT01114217|38863380|FG001|Overall Study|Other-Study Withdrawn|1|||
16103102|NCT01114217|38863379|FG000|Overall Study|Other-Site Stopped Communicating|2|||
16103103|NCT01114217|38863380|FG001|Overall Study|Other-Site Stopped Communicating|0|||
16103104|NCT01114217|38863379|FG000|Overall Study|Other-Lost to Follow-up|1|||
16103105|NCT01114217|38863380|FG001|Overall Study|Other-Lost to Follow-up|0|||
16103106|NCT01114217|38863379|FG000|Overall Study|Other-Withdrawal by Subject|1|||
16103107|NCT01114217|38863380|FG001|Overall Study|Other-Withdrawal by Subject|1|||
16103108|NCT02538471|38863387|FG000|Overall Study|Progression of disease|2|||
16103109|NCT01732926|38863390|FG000|Overall Study|Study Terminated by Sponsor|168|||
16103110|NCT01732926|38863391|FG001|Overall Study|Study Terminated by Sponsor|80|||
16103111|NCT01732926|38863390|FG000|Overall Study|Withdrawal by Subject|46|||
16103112|NCT01732926|38863391|FG001|Overall Study|Withdrawal by Subject|8|||
16103113|NCT01732926|38863390|FG000|Overall Study|Physician Decision|24|||
16103114|NCT01732926|38863391|FG001|Overall Study|Physician Decision|11|||
16103115|NCT01732926|38863390|FG000|Overall Study|Other Reason|21|||
16103116|NCT01732926|38863391|FG001|Overall Study|Other Reason|4|||
16103117|NCT01732926|38863390|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
16103118|NCT01732926|38863391|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
16103119|NCT01732926|38863390|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
16103120|NCT01732926|38863391|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
16103121|NCT02512861|38863392|FG000|Overall Study|Protocol Violation|3|||
16103122|NCT02512861|38863393|FG001|Overall Study|Protocol Violation|7|||
16103123|NCT02512861|38863392|FG000|Overall Study|Physician Decision|3|||
16103124|NCT02512861|38863393|FG001|Overall Study|Physician Decision|1|||
16103125|NCT02512861|38863392|FG000|Overall Study|Withdrawal by Subject|0|||
16103126|NCT02512861|38863393|FG001|Overall Study|Withdrawal by Subject|1|||
16103127|NCT01208870|38865373|FG000|Overall Study|Lost to Follow-up|2|||
16103128|NCT01208870|38865374|FG001|Overall Study|Lost to Follow-up|8|||
16103129|NCT01959607|38865375|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
16103130|NCT01959607|38865376|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
16103131|NCT01959607|38865377|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
16103132|NCT01959607|38865378|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
16103133|NCT02998918|38865379|FG000|Overall Study|Withdrawal by Subject|1|||
16103134|NCT02998918|38865380|FG001|Overall Study|Withdrawal by Subject|0|||
16103135|NCT00475735|38865383|FG000|Treatment Period 1|Adverse Event|2|||
16103136|NCT00475735|38865384|FG001|Treatment Period 1|Adverse Event|0|||
16103137|NCT00475735|38865385|FG002|Treatment Period 1|Adverse Event|0|||
16103138|NCT00475735|38865386|FG003|Treatment Period 1|Adverse Event|0|||
16103139|NCT00475735|38865387|FG004|Treatment Period 1|Adverse Event|0|||
16103140|NCT00475735|38865388|FG005|Treatment Period 1|Adverse Event|0|||
16103141|NCT00475735|38865383|FG000|Treatment Period 1|Lack of Efficacy|1|||
16103142|NCT00475735|38865384|FG001|Treatment Period 1|Lack of Efficacy|0|||
16103143|NCT00475735|38865385|FG002|Treatment Period 1|Lack of Efficacy|0|||
16103144|NCT00475735|38865386|FG003|Treatment Period 1|Lack of Efficacy|0|||
16103145|NCT00475735|38865387|FG004|Treatment Period 1|Lack of Efficacy|0|||
16103146|NCT00475735|38865388|FG005|Treatment Period 1|Lack of Efficacy|0|||
16103147|NCT00475735|38865383|FG000|Treatment Period 1|Lost to Follow-up|0|||
16103148|NCT00475735|38865384|FG001|Treatment Period 1|Lost to Follow-up|0|||
16103149|NCT00475735|38865385|FG002|Treatment Period 1|Lost to Follow-up|0|||
16103150|NCT00475735|38865386|FG003|Treatment Period 1|Lost to Follow-up|0|||
16103151|NCT00475735|38865387|FG004|Treatment Period 1|Lost to Follow-up|0|||
16103152|NCT00475735|38865388|FG005|Treatment Period 1|Lost to Follow-up|1|||
16103153|NCT00475735|38865383|FG000|Treatment Period 1|Protocol Violation|0|||
16103154|NCT00475735|38865384|FG001|Treatment Period 1|Protocol Violation|0|||
16103155|NCT00475735|38865385|FG002|Treatment Period 1|Protocol Violation|0|||
16103156|NCT00475735|38865386|FG003|Treatment Period 1|Protocol Violation|1|||
16103157|NCT00475735|38865387|FG004|Treatment Period 1|Protocol Violation|0|||
16103158|NCT00475735|38865388|FG005|Treatment Period 1|Protocol Violation|0|||
16103159|NCT00475735|38865383|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16103160|NCT00475735|38865384|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16103161|NCT00475735|38865385|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16103162|NCT00475735|38865386|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16103163|NCT00475735|38865387|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16103164|NCT00475735|38865388|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16103165|NCT00475735|38865383|FG000|Treatment Period 1|DC due to AE but continuing|0|||
16103166|NCT00475735|38865384|FG001|Treatment Period 1|DC due to AE but continuing|0|||
16103167|NCT00475735|38865385|FG002|Treatment Period 1|DC due to AE but continuing|0|||
16103168|NCT00475735|38865386|FG003|Treatment Period 1|DC due to AE but continuing|1|||
16103169|NCT00475735|38865387|FG004|Treatment Period 1|DC due to AE but continuing|2|||
16103170|NCT00475735|38865388|FG005|Treatment Period 1|DC due to AE but continuing|2|||
16103171|NCT00475735|38865383|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
16103172|NCT00475735|38865384|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
16103173|NCT00475735|38865385|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
16103174|NCT00475735|38865386|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
16103175|NCT00475735|38865387|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
16103176|NCT00475735|38865388|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
16103177|NCT00475735|38865383|FG000|Treatment Washout|Lost to Follow-up|0|||
16103178|NCT00475735|38865384|FG001|Treatment Washout|Lost to Follow-up|1|||
16103179|NCT00475735|38865385|FG002|Treatment Washout|Lost to Follow-up|0|||
16103180|NCT00475735|38865386|FG003|Treatment Washout|Lost to Follow-up|0|||
16103181|NCT00475735|38865387|FG004|Treatment Washout|Lost to Follow-up|0|||
16103182|NCT00475735|38865388|FG005|Treatment Washout|Lost to Follow-up|0|||
16103183|NCT00475735|38865383|FG000|Treatment Washout|Protocol Violation|0|||
16103184|NCT00475735|38865384|FG001|Treatment Washout|Protocol Violation|1|||
16103185|NCT00475735|38865385|FG002|Treatment Washout|Protocol Violation|0|||
16103186|NCT00475735|38865386|FG003|Treatment Washout|Protocol Violation|0|||
16103187|NCT00475735|38865387|FG004|Treatment Washout|Protocol Violation|0|||
16103188|NCT00475735|38865388|FG005|Treatment Washout|Protocol Violation|0|||
16103189|NCT00475735|38865383|FG000|Treatment Period 2|Adverse Event|0|||
16103190|NCT00475735|38865384|FG001|Treatment Period 2|Adverse Event|1|||
16103191|NCT00475735|38865385|FG002|Treatment Period 2|Adverse Event|0|||
16103192|NCT00475735|38865386|FG003|Treatment Period 2|Adverse Event|2|||
16103193|NCT00475735|38865387|FG004|Treatment Period 2|Adverse Event|0|||
16103194|NCT00475735|38865388|FG005|Treatment Period 2|Adverse Event|0|||
16103195|NCT00475735|38865383|FG000|Treatment Period 2|Lack of Efficacy|0|||
16103196|NCT00475735|38865384|FG001|Treatment Period 2|Lack of Efficacy|0|||
16103197|NCT00475735|38865385|FG002|Treatment Period 2|Lack of Efficacy|0|||
16103198|NCT00475735|38865386|FG003|Treatment Period 2|Lack of Efficacy|0|||
16103199|NCT00475735|38865387|FG004|Treatment Period 2|Lack of Efficacy|0|||
16103200|NCT00475735|38865388|FG005|Treatment Period 2|Lack of Efficacy|1|||
16103201|NCT00475735|38865383|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16103202|NCT00475735|38865384|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16217048|NCT01017549|39275848|FG000|5 Year Follow-up|Lost to Follow-up|9|||
16217049|NCT01017549|39275848|FG000|5 Year Follow-up|Mastectomy|3|||
16217050|NCT03261037|39275849|FG000|Overall Study|Withdrawal by Subject|2|||
16217051|NCT03261037|39275850|FG001|Overall Study|Withdrawal by Subject|13|||
16217052|NCT03261037|39275851|FG002|Overall Study|Withdrawal by Subject|0|||
16217053|NCT03261037|39275852|FG003|Overall Study|Withdrawal by Subject|18|||
16217054|NCT03261037|39275849|FG000|Overall Study|Non-compliance with study procedures|0|||
16217055|NCT03261037|39275850|FG001|Overall Study|Non-compliance with study procedures|2|||
16217056|NCT03261037|39275851|FG002|Overall Study|Non-compliance with study procedures|0|||
16217057|NCT03261037|39275852|FG003|Overall Study|Non-compliance with study procedures|6|||
16217058|NCT03261037|39275849|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
16217059|NCT03261037|39275850|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
16217060|NCT03261037|39275851|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
16217061|NCT03261037|39275852|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
16217062|NCT03261037|39275849|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
16217063|NCT03261037|39275850|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
16217064|NCT03261037|39275851|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
16217065|NCT03261037|39275852|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
16217066|NCT03261037|39275849|FG000|Overall Study|Diagnosed but protocol deviation|1|||
16217067|NCT03261037|39275850|FG001|Overall Study|Diagnosed but protocol deviation|0|||
16217068|NCT03261037|39275851|FG002|Overall Study|Diagnosed but protocol deviation|0|||
16217069|NCT03261037|39275852|FG003|Overall Study|Diagnosed but protocol deviation|0|||
16217070|NCT03261037|39275849|FG000|Overall Study|Participant did not want to continue the study|0|||
16217071|NCT03261037|39275850|FG001|Overall Study|Participant did not want to continue the study|1|||
16217072|NCT03261037|39275851|FG002|Overall Study|Participant did not want to continue the study|0|||
16217073|NCT03261037|39275852|FG003|Overall Study|Participant did not want to continue the study|0|||
16217074|NCT03261037|39275849|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
16339040|NCT00572455|39726276|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
16339041|NCT00572455|39726277|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
16339042|NCT00572455|39726278|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
16339043|NCT00572455|39726279|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
16339044|NCT00572455|39726280|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
16339045|NCT00572455|39726281|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
16339046|NCT03430856|39726283|FG000|Overall Study|Adverse Event|0|||
16339047|NCT03430856|39726284|FG001|Overall Study|Adverse Event|1|||
16339048|NCT03430856|39726285|FG002|Overall Study|Adverse Event|0|||
16339049|NCT03430856|39726283|FG000|Overall Study|Rescue criteria|1|||
16339050|NCT03430856|39726284|FG001|Overall Study|Rescue criteria|1|||
16339051|NCT03430856|39726285|FG002|Overall Study|Rescue criteria|0|||
16339052|NCT03430856|39726283|FG000|Overall Study|Voluntary withdrawal of consent|1|||
16339053|NCT03430856|39726284|FG001|Overall Study|Voluntary withdrawal of consent|1|||
16339054|NCT03430856|39726285|FG002|Overall Study|Voluntary withdrawal of consent|1|||
16339055|NCT03066778|39730127|FG000|Overall Study|Death|195|||
16339056|NCT03066778|39730128|FG001|Overall Study|Death|205|||
16339057|NCT03066778|39730127|FG000|Overall Study|Withdrawal by Subject|5|||
16339058|NCT03066778|39730128|FG001|Overall Study|Withdrawal by Subject|7|||
16339059|NCT01607346|39730129|FG000|Overall Study|Adverse Event|3|||
16339060|NCT03309696|39730130|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
16339061|NCT03309696|39730131|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
16103203|NCT00475735|38865385|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16103204|NCT00475735|38865386|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16339062|NCT03309696|39730132|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
16217075|NCT03261037|39275850|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
16217076|NCT03261037|39275851|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
16217077|NCT03261037|39275852|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
16217078|NCT03261037|39275849|FG000|Overall Study|Participant presented clinical improvement|0|||
16217079|NCT03261037|39275850|FG001|Overall Study|Participant presented clinical improvement|2|||
16217080|NCT03261037|39275851|FG002|Overall Study|Participant presented clinical improvement|0|||
16217081|NCT03261037|39275852|FG003|Overall Study|Participant presented clinical improvement|0|||
16217082|NCT03261037|39275849|FG000|Overall Study|Technical difficulties|0|||
16103205|NCT00475735|38865387|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16103206|NCT00475735|38865388|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16103207|NCT02262364|38865389|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
16103208|NCT03821064|38865390|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
16103209|NCT02299427|38865391|FG000|Overall Study|Withdrawal by Subject|1|||
16103210|NCT02299427|38865392|FG001|Overall Study|Withdrawal by Subject|0|||
16103211|NCT02299427|38865391|FG000|Overall Study|Lost to Follow-up|1|||
16103212|NCT02299427|38865392|FG001|Overall Study|Lost to Follow-up|3|||
16103213|NCT02299427|38865391|FG000|Overall Study|not adherent to dog website use|21|||
16217083|NCT03261037|39275850|FG001|Overall Study|Technical difficulties|0|||
16339063|NCT03309696|39730133|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
16339064|NCT02380859|39730134|FG000|Overall Study|Withdrawal by Subject|2|||
16537888|NCT02349295|40429313|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16537889|NCT02349295|40429314|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16103214|NCT02299427|38865392|FG001|Overall Study|not adherent to dog website use|0|||
16103215|NCT01040403|38865397|FG000|Overall Study|Adverse Event|10|||
16103216|NCT01040403|38865397|FG000|Overall Study|Protocol Violation|2|||
16103217|NCT01040403|38865397|FG000|Overall Study|Lost to Follow-up|1|||
16103218|NCT01040403|38865397|FG000|Overall Study|Not treated|1|||
16103219|NCT01040403|38865397|FG000|Overall Study|Other reason not defined above|6|||
16103220|NCT00817336|38865398|FG000|Overall Study|Withdrawal by Subject|1|||
16103221|NCT00817336|38865399|FG001|Overall Study|Withdrawal by Subject|1|||
16103222|NCT02744898|38865402|FG000|Overall Study|Progressive Disease|2|||
16103223|NCT02744898|38865402|FG000|Overall Study|Physician Decision|1|||
16103224|NCT02744898|38865402|FG000|Overall Study|Toxicity|1|||
16103225|NCT01592383|38865410|FG000|Overall Study|Adverse Event|1|||
16103226|NCT02847637|38865411|FG000|Overall Study|Withdrawal by Subject|0|||
16103227|NCT02847637|38865412|FG001|Overall Study|Withdrawal by Subject|1|||
16103228|NCT02847637|38865413|FG002|Overall Study|Withdrawal by Subject|1|||
16103229|NCT02847637|38865414|FG003|Overall Study|Withdrawal by Subject|0|||
16103230|NCT02847637|38865411|FG000|Overall Study|Lost to Follow-up|1|||
16103231|NCT02847637|38865412|FG001|Overall Study|Lost to Follow-up|1|||
16103232|NCT02847637|38865413|FG002|Overall Study|Lost to Follow-up|0|||
16103233|NCT02847637|38865414|FG003|Overall Study|Lost to Follow-up|0|||
16103234|NCT00760877|38865418|FG000|Overall Study|Protocol Violation|1|||
16103235|NCT00760877|38865419|FG001|Overall Study|Protocol Violation|0|||
16103236|NCT00760877|38865418|FG000|Overall Study|Non-compliance with protocol treatment|2|||
16103237|NCT00760877|38865419|FG001|Overall Study|Non-compliance with protocol treatment|1|||
16103238|NCT00760877|38865418|FG000|Overall Study|Pregnancy|1|||
16103239|NCT00760877|38865419|FG001|Overall Study|Pregnancy|4|||
16103240|NCT00760877|38865418|FG000|Overall Study|Death|2|||
16103241|NCT00760877|38865419|FG001|Overall Study|Death|1|||
16103242|NCT00760877|38865418|FG000|Overall Study|Withdrawal by Subject|7|||
16103243|NCT00760877|38865419|FG001|Overall Study|Withdrawal by Subject|3|||
16103244|NCT00760877|38865418|FG000|Overall Study|Adverse Event|19|||
16103245|NCT00760877|38865419|FG001|Overall Study|Adverse Event|12|||
16103246|NCT00760877|38865418|FG000|Overall Study|Participant diagnosed with AML|0|||
16103247|NCT00760877|38865419|FG001|Overall Study|Participant diagnosed with AML|1|||
16103248|NCT00760877|38865418|FG000|Overall Study|Participant not eligible to cross-over|0|||
16103249|NCT00760877|38865419|FG001|Overall Study|Participant not eligible to cross-over|1|||
16537890|NCT02349295|40429315|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
16339065|NCT02380859|39730135|FG001|Overall Study|Withdrawal by Subject|0|||
16103250|NCT00760877|38865418|FG000|Overall Study|Physician Decision|1|||
16103251|NCT00760877|38865419|FG001|Overall Study|Physician Decision|2|||
16103252|NCT00760877|38865418|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
16103253|NCT00760877|38865419|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
16103254|NCT00760877|38865418|FG000|Overall Study|Treatment failure|1|||
16217084|NCT03261037|39275851|FG002|Overall Study|Technical difficulties|0|||
16339066|NCT00660595|39730138|FG000|Overall Study|Lost to Follow-up|0|||
16339067|NCT00660595|39730139|FG001|Overall Study|Lost to Follow-up|1|||
16339068|NCT00660595|39730138|FG000|Overall Study|Did not consent to participate in study|12|||
16339069|NCT00660595|39730139|FG001|Overall Study|Did not consent to participate in study|8|||
16339070|NCT00660595|39730138|FG000|Overall Study|Participant left hospital|1|||
16339071|NCT00660595|39730139|FG001|Overall Study|Participant left hospital|0|||
16339072|NCT00660595|39730138|FG000|Overall Study|Non Specified reasons|5|||
16103255|NCT00760877|38865419|FG001|Overall Study|Treatment failure|0|||
16103256|NCT02081196|38865420|FG000|Overall Study|Lost to Follow-up|1|||
16103257|NCT04362176|38865422|FG000|Overall Study|Lost to Follow-up|5|||
16103258|NCT04362176|38865423|FG001|Overall Study|Lost to Follow-up|8|||
16103259|NCT04362176|38865422|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
16103260|NCT04362176|38865423|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
16103261|NCT01747629|38865426|FG000|Overall Study|Adverse Event|1|||
16103262|NCT01747629|38865427|FG001|Overall Study|Adverse Event|2|||
16339073|NCT00660595|39730139|FG001|Overall Study|Non Specified reasons|0|||
16339074|NCT00467558|39730141|FG000|Overall Study|Lost to Follow-up|2|||
16339075|NCT00467558|39730142|FG001|Overall Study|Lost to Follow-up|0|||
16339076|NCT00830518|39730143|FG000|Overall Study|Progressive Disease|18|||
16339077|NCT00830518|39730144|FG001|Overall Study|Progressive Disease|8|||
16339078|NCT00830518|39730143|FG000|Overall Study|Symptomatic Deterioration|4|||
16339079|NCT00830518|39730144|FG001|Overall Study|Symptomatic Deterioration|1|||
16339080|NCT00830518|39730143|FG000|Overall Study|Adverse Event|14|||
16339081|NCT00830518|39730144|FG001|Overall Study|Adverse Event|1|||
16339082|NCT00830518|39730143|FG000|Overall Study|Withdrawal by Patient|2|||
16339083|NCT00830518|39730144|FG001|Overall Study|Withdrawal by Patient|0|||
16339084|NCT00830518|39730143|FG000|Overall Study|Reason not Specified|8|||
16339085|NCT00830518|39730144|FG001|Overall Study|Reason not Specified|1|||
16339086|NCT02869893|39730147|FG000|Overall Study|participant aversion to IV|5|||
16339087|NCT02869893|39730147|FG000|Overall Study|participant fear of MRI scanner|2|||
16339088|NCT00534638|39730148|FG000|Overall Study|Withdrawal by Subject|3|||
16339089|NCT00534638|39730149|FG001|Overall Study|Withdrawal by Subject|4|||
16339090|NCT00534638|39730148|FG000|Overall Study|Migrated/moved from study area|13|||
16339091|NCT00534638|39730149|FG001|Overall Study|Migrated/moved from study area|11|||
16339092|NCT00534638|39730148|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
16339093|NCT00534638|39730149|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
16339094|NCT00534638|39730148|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
16339095|NCT00534638|39730149|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
16339096|NCT00534638|39730148|FG000|Overall Study|Other|1685|||
16339097|NCT00534638|39730149|FG001|Overall Study|Other|902|||
16339098|NCT01884545|39730150|FG000|Overall Study|Lost to Follow-up|6|||
16339099|NCT01884545|39730151|FG001|Overall Study|Lost to Follow-up|4|||
16339100|NCT01884545|39730152|FG002|Overall Study|Lost to Follow-up|9|||
16339101|NCT01884545|39730153|FG003|Overall Study|Lost to Follow-up|4|||
16339102|NCT01884545|39730150|FG000|Overall Study|Patient withdrawn|7|||
16339103|NCT01884545|39730151|FG001|Overall Study|Patient withdrawn|12|||
16339104|NCT01884545|39730152|FG002|Overall Study|Patient withdrawn|5|||
16339105|NCT01884545|39730153|FG003|Overall Study|Patient withdrawn|5|||
16339106|NCT01884545|39730150|FG000|Overall Study|Non-adherence|0|||
16339107|NCT01884545|39730151|FG001|Overall Study|Non-adherence|2|||
16339108|NCT01884545|39730152|FG002|Overall Study|Non-adherence|0|||
16339109|NCT01884545|39730153|FG003|Overall Study|Non-adherence|0|||
16339110|NCT01709864|39730154|FG000|Overall Study|Physician Decision|0|||
16339111|NCT01709864|39730155|FG001|Overall Study|Physician Decision|1|||
16339112|NCT01709864|39730154|FG000|Overall Study|subject/guardian decision|5|||
16339113|NCT01709864|39730155|FG001|Overall Study|subject/guardian decision|6|||
16339114|NCT01709864|39730154|FG000|Overall Study|Lost to Follow-up|1|||
16339115|NCT01709864|39730155|FG001|Overall Study|Lost to Follow-up|0|||
16339116|NCT01709864|39730154|FG000|Overall Study|non-compliance with study treatment|1|||
16339117|NCT01709864|39730155|FG001|Overall Study|non-compliance with study treatment|1|||
16339118|NCT01709864|39730154|FG000|Overall Study|Adverse Event|0|||
16339119|NCT01709864|39730155|FG001|Overall Study|Adverse Event|2|||
16339120|NCT01709864|39730154|FG000|Overall Study|Death|0|||
16339121|NCT01709864|39730155|FG001|Overall Study|Death|1|||
16339122|NCT02263729|39730157|FG000|Overall Study|Lost to Follow-up|1|||
16339123|NCT02263729|39730158|FG001|Overall Study|Lost to Follow-up|1|||
16103263|NCT01747629|38865426|FG000|Overall Study|Withdrawal by Subject|2|||
16103264|NCT01747629|38865427|FG001|Overall Study|Withdrawal by Subject|2|||
16217085|NCT03261037|39275852|FG003|Overall Study|Technical difficulties|1|||
16339124|NCT01778751|39730162|FG000|Overall Study|Lost to Follow-up|1|||
16339125|NCT01778751|39730163|FG001|Overall Study|Lost to Follow-up|0|||
16339126|NCT01778751|39730162|FG000|Overall Study|Withdrawal by Subject|0|||
16339127|NCT01778751|39730163|FG001|Overall Study|Withdrawal by Subject|2|||
16339128|NCT01778751|39730162|FG000|Overall Study|Transfered care|1|||
16339129|NCT01778751|39730163|FG001|Overall Study|Transfered care|0|||
16339130|NCT00802672|39730164|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
16339131|NCT00802672|39730165|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
16339132|NCT00802672|39730166|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
16339133|NCT00802672|39730164|FG000|Overall Study|Adverse Event|1|||
16339134|NCT00802672|39730165|FG001|Overall Study|Adverse Event|1|||
16339135|NCT00802672|39730166|FG002|Overall Study|Adverse Event|1|||
16339136|NCT00802672|39730164|FG000|Overall Study|Protocol Violation|2|||
16103265|NCT01747629|38865426|FG000|Overall Study|Noncompliance|1|||
16103266|NCT01747629|38865427|FG001|Overall Study|Noncompliance|1|||
16103267|NCT01747629|38865426|FG000|Overall Study|Inclusion criteria not met|1|||
16103268|NCT01747629|38865427|FG001|Overall Study|Inclusion criteria not met|0|||
16103269|NCT01747629|38865426|FG000|Overall Study|Not treated|1|||
16103270|NCT01747629|38865427|FG001|Overall Study|Not treated|0|||
16103271|NCT01747629|38865426|FG000|Overall Study|Other|2|||
16103272|NCT01747629|38865427|FG001|Overall Study|Other|1|||
16103273|NCT02979613|38865428|FG000|Double-Blind Phase|Withdrew Consent|2|||
16103274|NCT02979613|38865429|FG001|Double-Blind Phase|Withdrew Consent|4|||
16103275|NCT02979613|38865428|FG000|Double-Blind Phase|Pregnancy|2|||
16103276|NCT02979613|38865429|FG001|Double-Blind Phase|Pregnancy|2|||
16103277|NCT02979613|38865428|FG000|Double-Blind Phase|Adverse Event|2|||
16103278|NCT02979613|38865429|FG001|Double-Blind Phase|Adverse Event|0|||
16103279|NCT02979613|38865428|FG000|Double-Blind Phase|Lost to Follow-up|1|||
16103280|NCT02979613|38865429|FG001|Double-Blind Phase|Lost to Follow-up|1|||
16103281|NCT02979613|38865428|FG000|Double-Blind Phase|Protocol Violation|1|||
16103282|NCT02979613|38865429|FG001|Double-Blind Phase|Protocol Violation|1|||
16103283|NCT02979613|38865428|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
16103284|NCT02979613|38865429|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
16103285|NCT02979613|38865428|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
16103286|NCT02979613|38865429|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
16103287|NCT02979613|38865428|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
16103288|NCT02979613|38865429|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
16103289|NCT02979613|38865428|FG000|Open-Label Extension (OLE) Phase|Death|0|||
16103290|NCT02979613|38865429|FG001|Open-Label Extension (OLE) Phase|Death|1|||
16103291|NCT02979613|38865428|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
16103292|NCT02979613|38865429|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
16103293|NCT03675308|38865433|FG000|Overall Study|Adverse Event|3|||
16103294|NCT03675308|38865434|FG001|Overall Study|Adverse Event|2|||
16103295|NCT03675308|38865433|FG000|Overall Study|Withdrawal by Subject|6|||
16103296|NCT03675308|38865434|FG001|Overall Study|Withdrawal by Subject|4|||
16103297|NCT03675308|38865433|FG000|Overall Study|Lost to Follow-up|3|||
16103298|NCT03675308|38865434|FG001|Overall Study|Lost to Follow-up|0|||
16103299|NCT03675308|38865433|FG000|Overall Study|Lack of Efficacy|1|||
16103300|NCT03675308|38865434|FG001|Overall Study|Lack of Efficacy|1|||
16103301|NCT03675308|38865433|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
16103302|NCT03675308|38865434|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
16103303|NCT03675308|38865433|FG000|Overall Study|Other|0|||
16103304|NCT03675308|38865434|FG001|Overall Study|Other|1|||
16103305|NCT02254681|38865435|FG000|Overall Study|Lack of Efficacy|6|||
16103306|NCT01831726|38865437|FG000|Overall Study|Adverse Event|16|||
16103307|NCT01831726|38865437|FG000|Overall Study|Death|7|||
16103308|NCT01831726|38865437|FG000|Overall Study|Disease Progression|49|||
16103309|NCT01831726|38865437|FG000|Overall Study|Physician Decision|1|||
16103310|NCT01831726|38865437|FG000|Overall Study|Subject/guardian decision|7|||
16103311|NCT00515112|38865442|FG000|Overall Study|Death|0|||
16103312|NCT00515112|38865443|FG001|Overall Study|Death|1|||
16103313|NCT00515112|38865442|FG000|Overall Study|The study was terminated|3|||
16103314|NCT00515112|38865443|FG001|Overall Study|The study was terminated|2|||
16103315|NCT00088452|38865444|FG000|Overall Study|Did not receive intervention|1|||
16103316|NCT00088452|38865445|FG001|Overall Study|Did not receive intervention|0|||
16103317|NCT00088452|38865446|FG002|Overall Study|Did not receive intervention|1|||
16103318|NCT01201915|38865450|FG000|Overall Study|Adverse Event|2|||
16103319|NCT01201915|38865451|FG001|Overall Study|Adverse Event|1|||
16103320|NCT01201915|38865452|FG002|Overall Study|Adverse Event|1|||
16103321|NCT01201915|38865450|FG000|Overall Study|Lost to Follow-up|0|||
16103322|NCT01201915|38865451|FG001|Overall Study|Lost to Follow-up|4|||
16103323|NCT01201915|38865452|FG002|Overall Study|Lost to Follow-up|0|||
16103324|NCT01201915|38865450|FG000|Overall Study|Physician Decision|3|||
16103325|NCT01201915|38865451|FG001|Overall Study|Physician Decision|0|||
16103326|NCT01201915|38865452|FG002|Overall Study|Physician Decision|0|||
16103327|NCT01201915|38865450|FG000|Overall Study|Subject Decision|3|||
16103328|NCT01201915|38865451|FG001|Overall Study|Subject Decision|3|||
16103329|NCT01201915|38865452|FG002|Overall Study|Subject Decision|5|||
16103330|NCT01201915|38865450|FG000|Overall Study|Target Lesion Progression|0|||
16103331|NCT01201915|38865451|FG001|Overall Study|Target Lesion Progression|3|||
16103332|NCT01201915|38865452|FG002|Overall Study|Target Lesion Progression|0|||
16103333|NCT03275402|38865453|FG000|Overall Study|Death|17|||
16103334|NCT03275402|38865453|FG000|Overall Study|Study terminated by sponsor|21|||
16103335|NCT03275402|38865453|FG000|Overall Study|Withdrawal by Subject|1|||
16103336|NCT00168805|38865456|FG000|Overall Study|Adverse Event|7|||
16103337|NCT00168805|38865457|FG001|Overall Study|Adverse Event|11|||
16103338|NCT00168805|38865458|FG002|Overall Study|Adverse Event|16|||
16103339|NCT00168805|38865456|FG000|Overall Study|Protocol Violation|12|||
16103340|NCT00168805|38865457|FG001|Overall Study|Protocol Violation|11|||
16103341|NCT00168805|38865458|FG002|Overall Study|Protocol Violation|8|||
16103342|NCT00168805|38865456|FG000|Overall Study|Lost to Follow-up|12|||
16103343|NCT00168805|38865457|FG001|Overall Study|Lost to Follow-up|17|||
16103344|NCT00168805|38865458|FG002|Overall Study|Lost to Follow-up|11|||
16103345|NCT00168805|38865456|FG000|Overall Study|Withdrawal by Subject|16|||
16103346|NCT00168805|38865457|FG001|Overall Study|Withdrawal by Subject|18|||
16103347|NCT00168805|38865458|FG002|Overall Study|Withdrawal by Subject|21|||
16103348|NCT00168805|38865456|FG000|Overall Study|Other|24|||
16103349|NCT00168805|38865457|FG001|Overall Study|Other|21|||
16103350|NCT00168805|38865458|FG002|Overall Study|Other|22|||
16103351|NCT00168805|38865456|FG000|Treatment|Adverse Event|25|||
16103352|NCT00168805|38865457|FG001|Treatment|Adverse Event|26|||
16103353|NCT00168805|38865458|FG002|Treatment|Adverse Event|32|||
16103354|NCT00168805|38865456|FG000|Treatment|Protocol Violation|3|||
16103355|NCT00168805|38865457|FG001|Treatment|Protocol Violation|5|||
16103356|NCT00168805|38865458|FG002|Treatment|Protocol Violation|5|||
16103357|NCT00168805|38865456|FG000|Treatment|Withdrawal by Subject|3|||
16103358|NCT00168805|38865457|FG001|Treatment|Withdrawal by Subject|7|||
16103359|NCT00168805|38865458|FG002|Treatment|Withdrawal by Subject|8|||
16103360|NCT00168805|38865456|FG000|Treatment|Other|18|||
16103361|NCT00168805|38865457|FG001|Treatment|Other|18|||
16103362|NCT00168805|38865458|FG002|Treatment|Other|17|||
16103363|NCT04545476|38865462|FG000|Overall Study|Lost to Follow-up|1|||
16103364|NCT04545476|38865463|FG001|Overall Study|Lost to Follow-up|1|||
16103365|NCT04545476|38865464|FG002|Overall Study|Lost to Follow-up|0|||
16103366|NCT04545476|38865465|FG003|Overall Study|Lost to Follow-up|0|||
16103367|NCT02504502|38865469|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
16103368|NCT02504502|38865470|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
16103369|NCT02504502|38865469|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
16103370|NCT02504502|38865470|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
16103371|NCT04491006|38865477|FG000|Overall Study|Adverse Event|0|||
16103372|NCT04491006|38865478|FG001|Overall Study|Adverse Event|3|||
16103373|NCT04491006|38865479|FG002|Overall Study|Adverse Event|5|||
16103374|NCT04491006|38865477|FG000|Overall Study|Withdrawal by Subject|1|||
16103375|NCT04491006|38865478|FG001|Overall Study|Withdrawal by Subject|0|||
16103376|NCT04491006|38865479|FG002|Overall Study|Withdrawal by Subject|2|||
16103377|NCT01395914|38865480|FG000|Overall Study|Unrelated to study drug AE|6|||
16103378|NCT01395914|38865481|FG001|Overall Study|Unrelated to study drug AE|1|||
16103379|NCT01395914|38865480|FG000|Overall Study|Death|23|||
16103380|NCT01395914|38865481|FG001|Overall Study|Death|17|||
16103381|NCT01395914|38865480|FG000|Overall Study|Other|9|||
16103382|NCT01395914|38865481|FG001|Overall Study|Other|3|||
16103383|NCT01395914|38865480|FG000|Overall Study|Withdrawal by patient|27|||
16103384|NCT01395914|38865481|FG001|Overall Study|Withdrawal by patient|14|||
16103385|NCT01395914|38865480|FG000|Overall Study|Study drug-related AE|1|||
16103386|NCT01395914|38865481|FG001|Overall Study|Study drug-related AE|0|||
16103387|NCT01395914|38865480|FG000|Overall Study|Lost to Follow-up|6|||
16103388|NCT01395914|38865481|FG001|Overall Study|Lost to Follow-up|2|||
16103389|NCT00498433|38865482|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
16103390|NCT00498433|38865483|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
16103391|NCT00498433|38865484|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
16103392|NCT00498433|38865482|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
16103393|NCT00498433|38865483|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
16103394|NCT00498433|38865484|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
16103395|NCT00498433|38865482|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
16103396|NCT00498433|38865483|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
16103397|NCT00498433|38865484|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
16103398|NCT00498433|38865482|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
16103399|NCT00498433|38865483|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
16103400|NCT00498433|38865484|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
16103401|NCT02864147|38865487|FG000|Overall Study|Withdrawal by Subject|3|||
16103402|NCT02864147|38865488|FG001|Overall Study|Withdrawal by Subject|2|||
16103403|NCT02864147|38865489|FG002|Overall Study|Withdrawal by Subject|1|||
16103404|NCT02864147|38865487|FG000|Overall Study|Lost to Follow-up|0|||
16103405|NCT02864147|38865488|FG001|Overall Study|Lost to Follow-up|4|||
16103406|NCT02864147|38865489|FG002|Overall Study|Lost to Follow-up|0|||
16103407|NCT02864147|38865487|FG000|Overall Study|Adverse Event|0|||
16103408|NCT02864147|38865488|FG001|Overall Study|Adverse Event|1|||
16103409|NCT02864147|38865489|FG002|Overall Study|Adverse Event|0|||
16103410|NCT02864147|38865487|FG000|Overall Study|Pregnancy|4|||
16103411|NCT02864147|38865488|FG001|Overall Study|Pregnancy|0|||
16103412|NCT02864147|38865489|FG002|Overall Study|Pregnancy|0|||
16103413|NCT02864147|38865487|FG000|Overall Study|Physician Decision|0|||
16103414|NCT02864147|38865488|FG001|Overall Study|Physician Decision|0|||
16103415|NCT02864147|38865489|FG002|Overall Study|Physician Decision|1|||
16103416|NCT02864147|38865487|FG000|Overall Study|Opted for excisional procedures|0|||
16103417|NCT02864147|38865488|FG001|Overall Study|Opted for excisional procedures|0|||
16537891|NCT02349295|40429316|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
16103418|NCT02864147|38865489|FG002|Overall Study|Opted for excisional procedures|3|||
16103419|NCT01703988|38865490|FG000|Overall Study|Investigator Judgment|0|||
16103420|NCT01703988|38865491|FG001|Overall Study|Investigator Judgment|0|||
16103421|NCT01703988|38865492|FG002|Overall Study|Investigator Judgment|0|||
16103422|NCT01703988|38865493|FG003|Overall Study|Investigator Judgment|1|||
16103423|NCT03214250|38865494|FG000|Overall Study|Death|5|||
16103424|NCT03214250|38865495|FG001|Overall Study|Death|5|||
16103425|NCT03214250|38865496|FG002|Overall Study|Death|7|||
16103426|NCT03214250|38865497|FG003|Overall Study|Death|4|||
16103427|NCT03214250|38865498|FG004|Overall Study|Death|23|||
16103428|NCT03214250|38865499|FG005|Overall Study|Death|23|||
16103429|NCT03214250|38865500|FG006|Overall Study|Death|24|||
16103430|NCT03214250|38865494|FG000|Overall Study|Lost to Follow-up|0|||
16103431|NCT03214250|38865495|FG001|Overall Study|Lost to Follow-up|0|||
16103432|NCT03214250|38865496|FG002|Overall Study|Lost to Follow-up|0|||
16103433|NCT03214250|38865497|FG003|Overall Study|Lost to Follow-up|1|||
16103434|NCT03214250|38865498|FG004|Overall Study|Lost to Follow-up|1|||
16103435|NCT03214250|38865499|FG005|Overall Study|Lost to Follow-up|2|||
16103436|NCT03214250|38865500|FG006|Overall Study|Lost to Follow-up|0|||
16103437|NCT03214250|38865494|FG000|Overall Study|Other|0|||
16103438|NCT03214250|38865495|FG001|Overall Study|Other|0|||
16103439|NCT03214250|38865496|FG002|Overall Study|Other|0|||
16103440|NCT03214250|38865497|FG003|Overall Study|Other|0|||
16103441|NCT03214250|38865498|FG004|Overall Study|Other|1|||
16103442|NCT03214250|38865499|FG005|Overall Study|Other|1|||
16537892|NCT02349295|40429317|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16537893|NCT02349295|40429318|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16537894|NCT02349295|40429319|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16537895|NCT02349295|40429320|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16537896|NCT02349295|40429321|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
16537897|NCT02349295|40429308|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16537898|NCT02349295|40429309|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16537899|NCT02349295|40429310|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16537900|NCT02349295|40429311|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16537901|NCT02349295|40429312|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16103443|NCT03214250|38865500|FG006|Overall Study|Other|2|||
16103444|NCT03214250|38865494|FG000|Overall Study|Remains on Study|2|||
16103445|NCT03214250|38865495|FG001|Overall Study|Remains on Study|2|||
16103446|NCT03214250|38865496|FG002|Overall Study|Remains on Study|0|||
16103447|NCT03214250|38865497|FG003|Overall Study|Remains on Study|1|||
16103448|NCT03214250|38865498|FG004|Overall Study|Remains on Study|7|||
16103449|NCT03214250|38865499|FG005|Overall Study|Remains on Study|5|||
16103450|NCT03214250|38865500|FG006|Overall Study|Remains on Study|3|||
16103451|NCT03214250|38865494|FG000|Overall Study|Withdrawal by Subject|0|||
16537902|NCT02349295|40429313|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16537903|NCT02349295|40429314|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16537904|NCT02349295|40429315|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
16537905|NCT02349295|40429316|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
16537906|NCT02349295|40429317|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16537907|NCT02349295|40429318|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16537908|NCT02349295|40429319|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16537909|NCT02349295|40429320|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16103452|NCT03214250|38865495|FG001|Overall Study|Withdrawal by Subject|0|||
16103453|NCT03214250|38865496|FG002|Overall Study|Withdrawal by Subject|1|||
16103454|NCT03214250|38865497|FG003|Overall Study|Withdrawal by Subject|2|||
16103455|NCT03214250|38865498|FG004|Overall Study|Withdrawal by Subject|5|||
16103456|NCT03214250|38865499|FG005|Overall Study|Withdrawal by Subject|0|||
16103457|NCT03214250|38865500|FG006|Overall Study|Withdrawal by Subject|2|||
16103458|NCT02383927|38865501|FG000|Overall Study|Disease Progression|8|||
16103459|NCT02383927|38865502|FG001|Overall Study|Disease Progression|8|||
16103460|NCT02383927|38865503|FG002|Overall Study|Disease Progression|15|||
16103461|NCT02383927|38865504|FG003|Overall Study|Disease Progression|4|||
16103462|NCT02383927|38865501|FG000|Overall Study|Physician Decision|0|||
16103463|NCT02383927|38865502|FG001|Overall Study|Physician Decision|0|||
16103464|NCT02383927|38865503|FG002|Overall Study|Physician Decision|2|||
16103465|NCT02383927|38865504|FG003|Overall Study|Physician Decision|0|||
16103466|NCT02383927|38865501|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
16103467|NCT02383927|38865502|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
16103468|NCT02383927|38865503|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
16103469|NCT02383927|38865504|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
16103470|NCT02383927|38865501|FG000|Overall Study|Adverse Event|4|||
16103471|NCT02383927|38865502|FG001|Overall Study|Adverse Event|1|||
16103472|NCT02383927|38865503|FG002|Overall Study|Adverse Event|3|||
16103473|NCT02383927|38865504|FG003|Overall Study|Adverse Event|5|||
16103474|NCT02383927|38865501|FG000|Overall Study|Miscellaneous|1|||
16103475|NCT02383927|38865502|FG001|Overall Study|Miscellaneous|0|||
16103476|NCT02383927|38865503|FG002|Overall Study|Miscellaneous|0|||
16103477|NCT02383927|38865504|FG003|Overall Study|Miscellaneous|1|||
16103478|NCT02383927|38865501|FG000|Overall Study|Withdrawal by Subject|0|||
16103479|NCT02383927|38865502|FG001|Overall Study|Withdrawal by Subject|1|||
16103480|NCT02383927|38865503|FG002|Overall Study|Withdrawal by Subject|4|||
16103481|NCT02383927|38865504|FG003|Overall Study|Withdrawal by Subject|0|||
16103482|NCT01649297|38865505|FG000|Overall Study|Adverse Event|5|||
16103483|NCT01649297|38865506|FG001|Overall Study|Adverse Event|5|||
16103484|NCT01649297|38865507|FG002|Overall Study|Adverse Event|4|||
16103485|NCT01649297|38865508|FG003|Overall Study|Adverse Event|13|||
16103486|NCT01649297|38865509|FG004|Overall Study|Adverse Event|1|||
16103487|NCT01649297|38865505|FG000|Overall Study|Lack of Efficacy|0|||
16103488|NCT01649297|38865506|FG001|Overall Study|Lack of Efficacy|0|||
16103489|NCT01649297|38865507|FG002|Overall Study|Lack of Efficacy|0|||
16103490|NCT01649297|38865508|FG003|Overall Study|Lack of Efficacy|0|||
16103491|NCT01649297|38865509|FG004|Overall Study|Lack of Efficacy|1|||
16103492|NCT01649297|38865505|FG000|Overall Study|Non compliant with Protocol|1|||
16103493|NCT01649297|38865506|FG001|Overall Study|Non compliant with Protocol|0|||
16103494|NCT01649297|38865507|FG002|Overall Study|Non compliant with Protocol|3|||
16103495|NCT01649297|38865508|FG003|Overall Study|Non compliant with Protocol|2|||
16103496|NCT01649297|38865509|FG004|Overall Study|Non compliant with Protocol|1|||
16103497|NCT01649297|38865505|FG000|Overall Study|Lost to Follow-up|1|||
16103498|NCT01649297|38865506|FG001|Overall Study|Lost to Follow-up|1|||
16103499|NCT01649297|38865507|FG002|Overall Study|Lost to Follow-up|4|||
16103500|NCT01649297|38865508|FG003|Overall Study|Lost to Follow-up|3|||
16103501|NCT01649297|38865509|FG004|Overall Study|Lost to Follow-up|0|||
16103502|NCT01649297|38865505|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
16103503|NCT01649297|38865506|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
16103504|NCT01649297|38865507|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
16103505|NCT01649297|38865508|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
16103506|NCT01649297|38865509|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
16103507|NCT01649297|38865505|FG000|Overall Study|For other reason|4|||
16103508|NCT01649297|38865506|FG001|Overall Study|For other reason|1|||
16103509|NCT01649297|38865507|FG002|Overall Study|For other reason|2|||
16103510|NCT01649297|38865508|FG003|Overall Study|For other reason|0|||
16103511|NCT01649297|38865509|FG004|Overall Study|For other reason|0|||
16103512|NCT02413593|38865510|FG000|Overall Study|Lost to Follow-up|3|||
16103513|NCT02413593|38865510|FG000|Overall Study|Adverse Event|1|||
16103514|NCT00118703|38865511|FG000|Overall Study|Protocol Violation|1|||
16103515|NCT00118703|38865512|FG001|Overall Study|Protocol Violation|0|||
16103516|NCT00118703|38865511|FG000|Overall Study|Adverse Event|1|||
16103517|NCT00118703|38865512|FG001|Overall Study|Adverse Event|1|||
16103518|NCT00118703|38865511|FG000|Overall Study|Participant took two different treatment|0|||
16103519|NCT00118703|38865512|FG001|Overall Study|Participant took two different treatment|1|||
16103520|NCT00118703|38865511|FG000|Overall Study|Withdrawal by Subject|2|||
16103521|NCT00118703|38865512|FG001|Overall Study|Withdrawal by Subject|5|||
16103522|NCT00118703|38865511|FG000|Overall Study|Lost to Follow-up|1|||
16103523|NCT00118703|38865512|FG001|Overall Study|Lost to Follow-up|2|||
16103524|NCT03322514|38865513|FG000|Overall Study|Withdrawal by Subject|1|||
16103525|NCT03322514|38865514|FG001|Overall Study|Withdrawal by Subject|1|||
16103526|NCT03785210|38865518|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
16103527|NCT03785210|38865519|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
16103528|NCT02996097|38865520|FG000|Overall Study|Lost to Follow-up|11|||
16103529|NCT02996097|38865521|FG001|Overall Study|Lost to Follow-up|11|||
16103530|NCT00105521|38865524|FG000|Overall Study|Other|1|||
16103531|NCT00105521|38865525|FG001|Overall Study|Other|1|||
16103532|NCT00105521|38865526|FG002|Overall Study|Other|2|||
16103533|NCT00105521|38865527|FG003|Overall Study|Other|0|||
16103534|NCT00105521|38865524|FG000|Overall Study|Adverse Event|10|||
16103535|NCT00105521|38865525|FG001|Overall Study|Adverse Event|4|||
16103536|NCT00105521|38865526|FG002|Overall Study|Adverse Event|10|||
16103537|NCT00105521|38865527|FG003|Overall Study|Adverse Event|8|||
16103538|NCT00105521|38865524|FG000|Overall Study|Withdrawal by Subject|1|||
16103539|NCT00105521|38865525|FG001|Overall Study|Withdrawal by Subject|0|||
16103540|NCT00105521|38865526|FG002|Overall Study|Withdrawal by Subject|1|||
16103541|NCT00105521|38865527|FG003|Overall Study|Withdrawal by Subject|4|||
16103542|NCT00105521|38865524|FG000|Overall Study|Lack of Efficacy|0|||
16103543|NCT00105521|38865525|FG001|Overall Study|Lack of Efficacy|0|||
16103544|NCT00105521|38865526|FG002|Overall Study|Lack of Efficacy|0|||
16103545|NCT00105521|38865527|FG003|Overall Study|Lack of Efficacy|1|||
16103546|NCT00105521|38865524|FG000|Overall Study|Protocol Violation|3|||
16103547|NCT00105521|38865525|FG001|Overall Study|Protocol Violation|5|||
16103548|NCT00105521|38865526|FG002|Overall Study|Protocol Violation|4|||
16103549|NCT00105521|38865527|FG003|Overall Study|Protocol Violation|4|||
16103550|NCT00105521|38865524|FG000|Overall Study|Lost to Follow-up|0|||
16103551|NCT00105521|38865525|FG001|Overall Study|Lost to Follow-up|1|||
16103552|NCT00105521|38865526|FG002|Overall Study|Lost to Follow-up|0|||
16103553|NCT00105521|38865527|FG003|Overall Study|Lost to Follow-up|0|||
16103554|NCT00550771|38865528|FG000|Overall Study|Adverse Event|11|||
16103555|NCT00550771|38865529|FG001|Overall Study|Adverse Event|3|||
16103556|NCT00550771|38865528|FG000|Overall Study|Discontinued for study-related reasons|0|||
16103557|NCT00550771|38865529|FG001|Overall Study|Discontinued for study-related reasons|1|||
16103558|NCT00550771|38865528|FG000|Overall Study|Physician Decision|2|||
16103559|NCT00550771|38865529|FG001|Overall Study|Physician Decision|0|||
16103560|NCT00550771|38865528|FG000|Overall Study|Withdrawal by Subject|0|||
16103561|NCT00550771|38865529|FG001|Overall Study|Withdrawal by Subject|1|||
16103562|NCT00550771|38865528|FG000|Overall Study|Protocol Violation|4|||
16103563|NCT00550771|38865529|FG001|Overall Study|Protocol Violation|5|||
16103564|NCT01232569|38865532|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
16537910|NCT02349295|40429321|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
16537911|NCT02349295|40429308|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537912|NCT02349295|40429309|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537913|NCT02349295|40429310|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537914|NCT02349295|40429311|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537915|NCT02349295|40429312|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537916|NCT02349295|40429313|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537917|NCT02349295|40429314|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537918|NCT02349295|40429315|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537919|NCT02349295|40429316|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537920|NCT02349295|40429317|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537921|NCT02349295|40429318|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
16537922|NCT02349295|40429319|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
16537923|NCT02349295|40429320|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
16537924|NCT02349295|40429321|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
16537925|NCT02349295|40429308|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16537926|NCT02349295|40429309|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16103565|NCT01232569|38865533|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
16103566|NCT01232569|38865534|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16103567|NCT01232569|38865535|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
16103568|NCT01232569|38865532|FG000|Double-blind Treatment Period|Escape|2|||
16103569|NCT01232569|38865533|FG001|Double-blind Treatment Period|Escape|2|||
16103570|NCT01232569|38865534|FG002|Double-blind Treatment Period|Escape|0|||
16103571|NCT01232569|38865535|FG003|Double-blind Treatment Period|Escape|0|||
16103572|NCT01232569|38865532|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
16339137|NCT00802672|39730165|FG001|Overall Study|Protocol Violation|1|||
16103573|NCT01232569|38865533|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
16103574|NCT01232569|38865534|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
16103575|NCT01232569|38865535|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
16103576|NCT01232569|38865532|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
16103577|NCT01232569|38865533|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
16103578|NCT01232569|38865534|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
16103579|NCT01232569|38865535|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
16103580|NCT01232569|38865532|FG000|Double-blind Treatment Period|Physician Decision|1|||
16103581|NCT01232569|38865533|FG001|Double-blind Treatment Period|Physician Decision|0|||
16103582|NCT01232569|38865534|FG002|Double-blind Treatment Period|Physician Decision|0|||
16103583|NCT01232569|38865535|FG003|Double-blind Treatment Period|Physician Decision|0|||
16103584|NCT01232569|38865532|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
16103585|NCT01232569|38865533|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
16103586|NCT01232569|38865534|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
16103587|NCT01232569|38865535|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
16103588|NCT01232569|38865532|FG000|Double-blind Treatment Period|Death|2|||
16103589|NCT01232569|38865533|FG001|Double-blind Treatment Period|Death|0|||
16103590|NCT01232569|38865534|FG002|Double-blind Treatment Period|Death|0|||
16103591|NCT01232569|38865535|FG003|Double-blind Treatment Period|Death|0|||
16103592|NCT00627523|38865536|FG000|Overall Study|Lack of Efficacy|1|||
16103593|NCT00627523|38865537|FG001|Overall Study|Lack of Efficacy|0|||
16103594|NCT00627523|38865536|FG000|Overall Study|Withdrawal by Subject|0|||
16103595|NCT00627523|38865537|FG001|Overall Study|Withdrawal by Subject|2|||
16103596|NCT00627523|38865536|FG000|Overall Study|Other|1|||
16406363|NCT02264665|39969785|FG000|Overall Study|Participant decision|0|||
16406364|NCT02264665|39969786|FG001|Overall Study|Participant decision|0|||
16406365|NCT02264665|39969787|FG002|Overall Study|Participant decision|0|||
16406366|NCT02264665|39969788|FG003|Overall Study|Participant decision|1|||
16406367|NCT02264665|39969789|FG004|Overall Study|Participant decision|0|||
16406368|NCT02264665|39969790|FG005|Overall Study|Participant decision|0|||
16406369|NCT02264665|39969791|FG006|Overall Study|Participant decision|0|||
16406370|NCT02264665|39969785|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
16406371|NCT02264665|39969786|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
16406372|NCT02264665|39969787|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
16406373|NCT02264665|39969788|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
16406374|NCT02264665|39969789|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
16103597|NCT00627523|38865537|FG001|Overall Study|Other|0|||
16103598|NCT04750577|38865539|FG000|Overall Study|Adverse Event|2|||
16103599|NCT04750577|38865540|FG001|Overall Study|Adverse Event|10|||
16103600|NCT04750577|38865541|FG002|Overall Study|Adverse Event|8|||
16103601|NCT04750577|38865542|FG003|Overall Study|Adverse Event|1|||
16103602|NCT04750577|38865539|FG000|Overall Study|Change of residence|0|||
16217086|NCT03261037|39275849|FG000|Overall Study|Equipment failed to work|0|||
16339138|NCT00802672|39730166|FG002|Overall Study|Protocol Violation|1|||
16339139|NCT00802672|39730164|FG000|Overall Study|Lost to Follow-up|5|||
16406375|NCT02264665|39969790|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
16406376|NCT02264665|39969791|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
16406377|NCT02264665|39969785|FG000|Overall Study|Data Missing|0|||
16406378|NCT02264665|39969786|FG001|Overall Study|Data Missing|0|||
16406379|NCT02264665|39969787|FG002|Overall Study|Data Missing|1|||
16537927|NCT02349295|40429310|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16537928|NCT02349295|40429311|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16339140|NCT00802672|39730165|FG001|Overall Study|Lost to Follow-up|5|||
16339141|NCT00802672|39730166|FG002|Overall Study|Lost to Follow-up|3|||
16339142|NCT00802672|39730164|FG000|Overall Study|Withdrawal by Subject|1|||
16339143|NCT00802672|39730165|FG001|Overall Study|Withdrawal by Subject|1|||
16339144|NCT00802672|39730166|FG002|Overall Study|Withdrawal by Subject|2|||
16339145|NCT00802672|39730164|FG000|Overall Study|other|3|||
16339146|NCT00802672|39730165|FG001|Overall Study|other|1|||
16339147|NCT00802672|39730166|FG002|Overall Study|other|2|||
16339148|NCT00548249|39730167|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
16406380|NCT02264665|39969788|FG003|Overall Study|Data Missing|0|||
16406381|NCT02264665|39969789|FG004|Overall Study|Data Missing|0|||
16537929|NCT02349295|40429312|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16537930|NCT02349295|40429313|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16537931|NCT02349295|40429314|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16537932|NCT02349295|40429315|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16537933|NCT02349295|40429316|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16406382|NCT02264665|39969790|FG005|Overall Study|Data Missing|0|||
16406383|NCT02264665|39969791|FG006|Overall Study|Data Missing|0|||
16406384|NCT00320255|39969792|FG000|Overall Study|Lack of Efficacy|1|||
16406385|NCT00320255|39969793|FG001|Overall Study|Lack of Efficacy|0|||
16339149|NCT00548249|39730168|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
16339150|NCT00548249|39730169|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
16339151|NCT00548249|39730170|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
16339152|NCT00548249|39730171|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
16339153|NCT00548249|39730167|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
16339154|NCT00548249|39730168|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
16339155|NCT00548249|39730169|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
16339156|NCT00548249|39730170|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
16339157|NCT00548249|39730171|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
16103603|NCT04750577|38865540|FG001|Overall Study|Change of residence|0|||
16103604|NCT04750577|38865541|FG002|Overall Study|Change of residence|1|||
16406386|NCT00320255|39969794|FG002|Overall Study|Lack of Efficacy|0|||
16103605|NCT04750577|38865542|FG003|Overall Study|Change of residence|0|||
16406387|NCT00320255|39969795|FG003|Overall Study|Lack of Efficacy|0|||
16339158|NCT00548249|39730167|FG000|Overall Study|Protocol Violation|1|||
16339159|NCT00548249|39730168|FG001|Overall Study|Protocol Violation|1|||
16339160|NCT00548249|39730169|FG002|Overall Study|Protocol Violation|4|||
16339161|NCT00548249|39730170|FG003|Overall Study|Protocol Violation|0|||
16339162|NCT00548249|39730171|FG004|Overall Study|Protocol Violation|3|||
16339163|NCT00548249|39730167|FG000|Overall Study|Miscellaneous|2|||
16339164|NCT00548249|39730168|FG001|Overall Study|Miscellaneous|3|||
16339165|NCT00548249|39730169|FG002|Overall Study|Miscellaneous|2|||
16339166|NCT00548249|39730170|FG003|Overall Study|Miscellaneous|0|||
16339167|NCT00548249|39730171|FG004|Overall Study|Miscellaneous|2|||
16339168|NCT00548249|39730167|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
16339169|NCT00548249|39730168|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
16339170|NCT00548249|39730169|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
16339171|NCT00548249|39730170|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
16339172|NCT00548249|39730171|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
16339173|NCT00548249|39730167|FG000|Overall Study|Adverse Event|2|||
16339174|NCT00548249|39730168|FG001|Overall Study|Adverse Event|2|||
16339175|NCT00548249|39730169|FG002|Overall Study|Adverse Event|0|||
16339176|NCT00548249|39730170|FG003|Overall Study|Adverse Event|1|||
16339177|NCT00548249|39730171|FG004|Overall Study|Adverse Event|1|||
16339178|NCT00548249|39730167|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
16339179|NCT00548249|39730168|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
16339180|NCT00548249|39730169|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
16339181|NCT00548249|39730170|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
16339182|NCT00548249|39730171|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
16339183|NCT00548249|39730167|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
16339184|NCT00548249|39730168|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
16339185|NCT00548249|39730169|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
16339186|NCT00548249|39730170|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
16339187|NCT00548249|39730171|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
16339188|NCT00548249|39730167|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
16339189|NCT00548249|39730168|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
16339190|NCT00548249|39730169|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
16339191|NCT00548249|39730170|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
16339192|NCT00548249|39730171|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
16339193|NCT00548249|39730167|FG000|Overall Study|Prolonged hospitalization|0|||
16339194|NCT00548249|39730168|FG001|Overall Study|Prolonged hospitalization|0|||
16339195|NCT00548249|39730169|FG002|Overall Study|Prolonged hospitalization|2|||
16339196|NCT00548249|39730170|FG003|Overall Study|Prolonged hospitalization|1|||
16339197|NCT00548249|39730171|FG004|Overall Study|Prolonged hospitalization|0|||
16339198|NCT00548249|39730167|FG000|Overall Study|Withdrawal by Subject|2|||
16339199|NCT00548249|39730168|FG001|Overall Study|Withdrawal by Subject|0|||
16339200|NCT00548249|39730169|FG002|Overall Study|Withdrawal by Subject|0|||
16339201|NCT00548249|39730170|FG003|Overall Study|Withdrawal by Subject|0|||
16339202|NCT00548249|39730171|FG004|Overall Study|Withdrawal by Subject|0|||
16339203|NCT00548249|39730167|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
16339204|NCT00548249|39730168|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
16339205|NCT00548249|39730169|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
16339206|NCT00548249|39730170|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
16339207|NCT00548249|39730171|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
16339208|NCT00548249|39730167|FG000|Overall Study|Sponsor's request|0|||
16339209|NCT00548249|39730168|FG001|Overall Study|Sponsor's request|0|||
16339210|NCT00548249|39730169|FG002|Overall Study|Sponsor's request|0|||
16339211|NCT00548249|39730170|FG003|Overall Study|Sponsor's request|1|||
16339212|NCT00548249|39730171|FG004|Overall Study|Sponsor's request|0|||
16339213|NCT01256385|39730172|FG000|Overall Study|Physician Decision|1|||
16339214|NCT01256385|39730173|FG001|Overall Study|Physician Decision|1|||
16339215|NCT01256385|39730172|FG000|Overall Study|Withdrawal by Subject|2|||
16339216|NCT01256385|39730173|FG001|Overall Study|Withdrawal by Subject|2|||
16339217|NCT00869128|39730175|FG000|Overall Study|lack of Compliance|6|||
16339218|NCT00869128|39730176|FG001|Overall Study|lack of Compliance|6|||
16339219|NCT02324699|39730181|FG000|Overall Study|study terminated|1|||
16339220|NCT04769739|39730182|FG000|Overall Study|Colorectal cancer obstruction|2|||
16339221|NCT04769739|39730183|FG001|Overall Study|Colorectal cancer obstruction|0|||
16339222|NCT04769739|39730184|FG002|Overall Study|Colorectal cancer obstruction|0|||
16339223|NCT04769739|39730185|FG003|Overall Study|Colorectal cancer obstruction|0|||
16339224|NCT04769739|39730182|FG000|Overall Study|Failed cecal intubation|1|||
16406388|NCT00320255|39969796|FG004|Overall Study|Lack of Efficacy|0|||
16406389|NCT00320255|39969797|FG005|Overall Study|Lack of Efficacy|0|||
16406390|NCT00320255|39969792|FG000|Overall Study|Adverse Event|5|||
16406391|NCT00320255|39969793|FG001|Overall Study|Adverse Event|2|||
16406392|NCT00320255|39969794|FG002|Overall Study|Adverse Event|3|||
16537934|NCT02349295|40429317|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16537935|NCT02349295|40429318|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16537936|NCT02349295|40429319|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
16537937|NCT02349295|40429320|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
16537938|NCT02349295|40429321|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
16537939|NCT02349295|40429308|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16339225|NCT04769739|39730183|FG001|Overall Study|Failed cecal intubation|0|||
16339226|NCT04769739|39730184|FG002|Overall Study|Failed cecal intubation|0|||
16339227|NCT04769739|39730185|FG003|Overall Study|Failed cecal intubation|1|||
16339228|NCT04769739|39730182|FG000|Overall Study|Poor bowel preparation|0|||
16339229|NCT04769739|39730183|FG001|Overall Study|Poor bowel preparation|0|||
16339230|NCT04769739|39730184|FG002|Overall Study|Poor bowel preparation|0|||
16339231|NCT04769739|39730185|FG003|Overall Study|Poor bowel preparation|1|||
16339232|NCT01048099|39730186|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
16339233|NCT01048099|39730186|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
16339234|NCT00869557|39730187|FG000|Randomized Phase|Lost to Follow-up|2|||
16339235|NCT00869557|39730188|FG001|Randomized Phase|Lost to Follow-up|1|||
16339236|NCT00869557|39730187|FG000|Randomized Phase|Investigator's Discretion|1|||
16339237|NCT00869557|39730188|FG001|Randomized Phase|Investigator's Discretion|0|||
16406393|NCT00320255|39969795|FG003|Overall Study|Adverse Event|2|||
16406394|NCT00320255|39969796|FG004|Overall Study|Adverse Event|0|||
16406395|NCT00320255|39969797|FG005|Overall Study|Adverse Event|0|||
16406396|NCT00320255|39969792|FG000|Overall Study|Withdrawal by Subject|1|||
16406397|NCT00320255|39969793|FG001|Overall Study|Withdrawal by Subject|2|||
16406398|NCT00320255|39969794|FG002|Overall Study|Withdrawal by Subject|2|||
16406399|NCT00320255|39969795|FG003|Overall Study|Withdrawal by Subject|4|||
16103606|NCT04750577|38865539|FG000|Overall Study|Burden of study procedures|0|||
16103607|NCT04750577|38865540|FG001|Overall Study|Burden of study procedures|2|||
16103608|NCT04750577|38865541|FG002|Overall Study|Burden of study procedures|2|||
16103609|NCT04750577|38865542|FG003|Overall Study|Burden of study procedures|0|||
16406400|NCT00320255|39969796|FG004|Overall Study|Withdrawal by Subject|0|||
16406401|NCT00320255|39969797|FG005|Overall Study|Withdrawal by Subject|0|||
16406402|NCT00320255|39969792|FG000|Overall Study|Poor compliance/noncompliance|1|||
16406403|NCT00320255|39969793|FG001|Overall Study|Poor compliance/noncompliance|1|||
16406404|NCT00320255|39969794|FG002|Overall Study|Poor compliance/noncompliance|0|||
16103610|NCT04750577|38865539|FG000|Overall Study|Prematurely discontinued|0|||
16103611|NCT04750577|38865540|FG001|Overall Study|Prematurely discontinued|0|||
16103612|NCT04750577|38865541|FG002|Overall Study|Prematurely discontinued|0|||
16103613|NCT04750577|38865542|FG003|Overall Study|Prematurely discontinued|2|||
16103614|NCT04750577|38865539|FG000|Overall Study|Protocol deviation|1|||
16537940|NCT02349295|40429309|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16537941|NCT02349295|40429310|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16537942|NCT02349295|40429311|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16537943|NCT02349295|40429312|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16537944|NCT02349295|40429313|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16103615|NCT04750577|38865540|FG001|Overall Study|Protocol deviation|1|||
16339238|NCT00869557|39730187|FG000|Randomized Phase|Withdrew Consent|0|||
16339239|NCT00869557|39730188|FG001|Randomized Phase|Withdrew Consent|1|||
16339240|NCT00869557|39730187|FG000|Extension Phase|Adverse Event|2|||
16406405|NCT00320255|39969795|FG003|Overall Study|Poor compliance/noncompliance|1|||
16339241|NCT00869557|39730188|FG001|Extension Phase|Adverse Event|2|||
16339242|NCT00869557|39730187|FG000|Extension Phase|Lack of Efficacy|1|||
16339243|NCT00869557|39730188|FG001|Extension Phase|Lack of Efficacy|0|||
16339244|NCT00869557|39730187|FG000|Extension Phase|Lost to Follow-up|3|||
16339245|NCT00869557|39730188|FG001|Extension Phase|Lost to Follow-up|1|||
16339246|NCT00869557|39730187|FG000|Extension Phase|Investigator's Discretion|2|||
16339247|NCT00869557|39730188|FG001|Extension Phase|Investigator's Discretion|0|||
16339248|NCT00869557|39730187|FG000|Extension Phase|Withdrew Consent|2|||
16339249|NCT00869557|39730188|FG001|Extension Phase|Withdrew Consent|0|||
16339250|NCT01737879|39730189|FG000|Overall Study|Death|1|||
16339251|NCT01737879|39730189|FG000|Overall Study|Sponsor decision|40|||
16339252|NCT01857102|39730191|FG000|Period 1|No longer meets Eligibility Criteria|0|||
16339253|NCT01857102|39730192|FG001|Period 1|No longer meets Eligibility Criteria|2|||
16339254|NCT01857102|39730191|FG000|Period 1|Lost to Follow-up|0|||
16339255|NCT01857102|39730192|FG001|Period 1|Lost to Follow-up|3|||
16339256|NCT01857102|39730191|FG000|Period 1|Unsatisfactory Lens Fit|1|||
16339257|NCT01857102|39730192|FG001|Period 1|Unsatisfactory Lens Fit|0|||
16339258|NCT01857102|39730191|FG000|Period 1|Unsatisfactory Visual Response|1|||
16339259|NCT01857102|39730192|FG001|Period 1|Unsatisfactory Visual Response|0|||
16339260|NCT01857102|39730191|FG000|Period 1|Physician Decision|1|||
16339261|NCT01857102|39730192|FG001|Period 1|Physician Decision|0|||
16339262|NCT01857102|39730191|FG000|Period 2|Lens Discomfort|1|||
16339263|NCT01857102|39730192|FG001|Period 2|Lens Discomfort|0|||
16339264|NCT01857102|39730191|FG000|Period 2|Unsatisfactory Lens Fit|1|||
16339265|NCT01857102|39730192|FG001|Period 2|Unsatisfactory Lens Fit|0|||
16339266|NCT01172808|39730195|FG000|Overall Study|Adverse Event|8|||
16339267|NCT01172808|39730196|FG001|Overall Study|Adverse Event|4|||
16339268|NCT01172808|39730197|FG002|Overall Study|Adverse Event|8|||
16339269|NCT01172808|39730198|FG003|Overall Study|Adverse Event|3|||
16339270|NCT01172808|39730195|FG000|Overall Study|Lack of Efficacy|1|||
16339271|NCT01172808|39730196|FG001|Overall Study|Lack of Efficacy|0|||
16339272|NCT01172808|39730197|FG002|Overall Study|Lack of Efficacy|0|||
16339273|NCT01172808|39730198|FG003|Overall Study|Lack of Efficacy|0|||
16339274|NCT01172808|39730195|FG000|Overall Study|Protocol Violation|2|||
16339275|NCT01172808|39730196|FG001|Overall Study|Protocol Violation|2|||
16339276|NCT01172808|39730197|FG002|Overall Study|Protocol Violation|2|||
16339277|NCT01172808|39730198|FG003|Overall Study|Protocol Violation|0|||
16339278|NCT01172808|39730195|FG000|Overall Study|Lost to Follow-up|0|||
16339279|NCT01172808|39730196|FG001|Overall Study|Lost to Follow-up|1|||
16339280|NCT01172808|39730197|FG002|Overall Study|Lost to Follow-up|1|||
16339281|NCT01172808|39730198|FG003|Overall Study|Lost to Follow-up|3|||
16339282|NCT01172808|39730195|FG000|Overall Study|Withdrawal by Subject|4|||
16339283|NCT01172808|39730196|FG001|Overall Study|Withdrawal by Subject|1|||
16339284|NCT01172808|39730197|FG002|Overall Study|Withdrawal by Subject|3|||
16537945|NCT02349295|40429314|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16537946|NCT02349295|40429315|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16537947|NCT02349295|40429316|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16537948|NCT02349295|40429317|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16537949|NCT02349295|40429318|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16537950|NCT02349295|40429319|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
16537951|NCT02349295|40429320|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
16537952|NCT02349295|40429321|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
16537953|NCT02349295|40429308|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537954|NCT02349295|40429309|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537955|NCT02349295|40429310|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537956|NCT02349295|40429311|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537957|NCT02349295|40429312|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537958|NCT02349295|40429313|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537959|NCT02349295|40429314|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537960|NCT02349295|40429315|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537961|NCT02349295|40429316|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537962|NCT02349295|40429317|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537963|NCT02349295|40429318|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537964|NCT02349295|40429319|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
16537965|NCT02349295|40429320|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537966|NCT02349295|40429321|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
16537967|NCT02349295|40429308|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537968|NCT02349295|40429309|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537969|NCT02349295|40429310|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537970|NCT02349295|40429311|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537971|NCT02349295|40429312|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537972|NCT02349295|40429313|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537973|NCT02349295|40429314|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537974|NCT02349295|40429315|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537975|NCT02349295|40429316|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537976|NCT02349295|40429317|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537977|NCT02349295|40429318|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537978|NCT02349295|40429319|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
16537979|NCT02349295|40429320|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537980|NCT02349295|40429321|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
16537981|NCT01059565|40432747|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
16537982|NCT01059565|40432748|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
16537983|NCT01059565|40432747|FG000|24-Week Randomized Phase|Adverse Event|5|||
16537984|NCT01059565|40432748|FG001|24-Week Randomized Phase|Adverse Event|0|||
16537985|NCT01059565|40432747|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
16537986|NCT01059565|40432748|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
16537987|NCT01059565|40432747|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
16537988|NCT01059565|40432748|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
16537989|NCT01059565|40432747|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
16537990|NCT01059565|40432748|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
16537991|NCT01059565|40432747|FG000|24-Week Open-Label Phase|Adverse Event|2|||
16537992|NCT01059565|40432748|FG001|24-Week Open-Label Phase|Adverse Event|0|||
16537993|NCT01059565|40432747|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
16537994|NCT01059565|40432748|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
16537995|NCT01059565|40432747|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
16537996|NCT01059565|40432748|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
16537997|NCT01059565|40432747|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
16537998|NCT01059565|40432748|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
16537999|NCT01059565|40432747|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
16538000|NCT01059565|40432748|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
16538001|NCT01059565|40432747|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
16538002|NCT01059565|40432748|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
16538003|NCT02355002|40432750|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
16538004|NCT02355002|40432751|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
16538005|NCT02355002|40432750|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
16538006|NCT02355002|40432751|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
16538007|NCT02355002|40432750|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
16538008|NCT02355002|40432751|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
16538009|NCT02355002|40432750|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
16538010|NCT02355002|40432751|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
16538011|NCT02355002|40432750|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
16538012|NCT02355002|40432751|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
16538013|NCT02355002|40432750|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
16538014|NCT02355002|40432751|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
16538015|NCT02355002|40432750|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
16538016|NCT02355002|40432751|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
16538017|NCT01381692|40432758|FG000|Overall Study|Adverse Event|1|||
16538018|NCT01381692|40432759|FG001|Overall Study|Adverse Event|0|||
16538019|NCT01381692|40432760|FG002|Overall Study|Adverse Event|0|||
16538020|NCT01381692|40432761|FG003|Overall Study|Adverse Event|0|||
16538021|NCT01381692|40432762|FG004|Overall Study|Adverse Event|0|||
16538022|NCT01381692|40432763|FG005|Overall Study|Adverse Event|0|||
16538023|NCT02450331|40432764|FG000|Overall Study|Death|162|||
16538024|NCT02450331|40432765|FG001|Overall Study|Death|171|||
16538025|NCT02450331|40432764|FG000|Overall Study|Lost to Follow-up|14|||
16538026|NCT02450331|40432765|FG001|Overall Study|Lost to Follow-up|12|||
16538027|NCT02450331|40432764|FG000|Overall Study|Withdrawal by Subject|55|||
16538028|NCT02450331|40432765|FG001|Overall Study|Withdrawal by Subject|44|||
16538029|NCT02450331|40432764|FG000|Overall Study|Non-specified other|1|||
16538030|NCT02450331|40432765|FG001|Overall Study|Non-specified other|1|||
16538031|NCT05338333|40432769|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
16538032|NCT05338333|40432770|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
16538033|NCT00074282|40432771|FG000|Step 1|Adverse Event|32|||
16538034|NCT00074282|40432772|FG001|Step 1|Adverse Event|0|||
16538035|NCT00074282|40432773|FG002|Step 1|Adverse Event|0|||
16538036|NCT00074282|40432771|FG000|Step 1|Death|6|||
16538037|NCT00074282|40432772|FG001|Step 1|Death|0|||
16538038|NCT00074282|40432773|FG002|Step 1|Death|0|||
16538039|NCT00074282|40432771|FG000|Step 1|Withdrawal by Subject|7|||
16538040|NCT00074282|40432772|FG001|Step 1|Withdrawal by Subject|0|||
16538041|NCT00074282|40432773|FG002|Step 1|Withdrawal by Subject|0|||
16538042|NCT00074282|40432771|FG000|Step 1|Disease progression|2|||
16538043|NCT00074282|40432772|FG001|Step 1|Disease progression|0|||
16538044|NCT00074282|40432773|FG002|Step 1|Disease progression|0|||
16538045|NCT00074282|40432771|FG000|Step 1|Alternative therapy|2|||
16538046|NCT00074282|40432772|FG001|Step 1|Alternative therapy|0|||
16538047|NCT00074282|40432773|FG002|Step 1|Alternative therapy|0|||
16538048|NCT00074282|40432771|FG000|Step 1|Other complicating disease|2|||
16538049|NCT00074282|40432772|FG001|Step 1|Other complicating disease|0|||
16538050|NCT00074282|40432773|FG002|Step 1|Other complicating disease|0|||
16538051|NCT00074282|40432771|FG000|Step 1|Physician Decision|1|||
16538052|NCT00074282|40432772|FG001|Step 1|Physician Decision|0|||
16538053|NCT00074282|40432773|FG002|Step 1|Physician Decision|0|||
16538054|NCT00074282|40432771|FG000|Step 1|Ineligible|4|||
16538055|NCT00074282|40432772|FG001|Step 1|Ineligible|0|||
16538056|NCT00074282|40432773|FG002|Step 1|Ineligible|0|||
16538057|NCT00074282|40432771|FG000|Step 1|Never started treatment|2|||
16538058|NCT00074282|40432772|FG001|Step 1|Never started treatment|0|||
16538059|NCT00074282|40432773|FG002|Step 1|Never started treatment|0|||
16538060|NCT00074282|40432771|FG000|Step 2|Adverse Event|0|||
16538061|NCT00074282|40432772|FG001|Step 2|Adverse Event|2|||
16538062|NCT00074282|40432773|FG002|Step 2|Adverse Event|12|||
16538063|NCT00074282|40432771|FG000|Step 2|Disease progression|0|||
16538064|NCT00074282|40432772|FG001|Step 2|Disease progression|0|||
16538065|NCT00074282|40432773|FG002|Step 2|Disease progression|5|||
16538066|NCT00074282|40432771|FG000|Step 2|Death|0|||
16538067|NCT00074282|40432772|FG001|Step 2|Death|0|||
16538068|NCT00074282|40432773|FG002|Step 2|Death|3|||
16538069|NCT00074282|40432771|FG000|Step 2|Withdrawal by Subject|0|||
16538070|NCT00074282|40432772|FG001|Step 2|Withdrawal by Subject|0|||
16538071|NCT00074282|40432773|FG002|Step 2|Withdrawal by Subject|2|||
16538072|NCT00074282|40432771|FG000|Step 2|Physician Decision|0|||
16538073|NCT00074282|40432772|FG001|Step 2|Physician Decision|0|||
16538074|NCT00074282|40432773|FG002|Step 2|Physician Decision|1|||
16217087|NCT03261037|39275850|FG001|Overall Study|Equipment failed to work|0|||
16538075|NCT00074282|40432771|FG000|Step 2|Ineligible|0|||
16538076|NCT00074282|40432772|FG001|Step 2|Ineligible|0|||
16538077|NCT00074282|40432773|FG002|Step 2|Ineligible|1|||
16538078|NCT00504426|40432774|FG000|Overall Study|Adverse Event|0|||
16538079|NCT00504426|40432775|FG001|Overall Study|Adverse Event|0|||
16538080|NCT00504426|40432776|FG002|Overall Study|Adverse Event|2|||
16538081|NCT00504426|40432777|FG003|Overall Study|Adverse Event|0|||
16538082|NCT00504426|40432774|FG000|Overall Study|Protocol Violation|1|||
16538083|NCT00504426|40432775|FG001|Overall Study|Protocol Violation|1|||
16538084|NCT00504426|40432776|FG002|Overall Study|Protocol Violation|2|||
16538085|NCT00504426|40432777|FG003|Overall Study|Protocol Violation|0|||
16538086|NCT00504426|40432774|FG000|Overall Study|Withdrawal by Subject|2|||
16538087|NCT00504426|40432775|FG001|Overall Study|Withdrawal by Subject|0|||
16538088|NCT00504426|40432776|FG002|Overall Study|Withdrawal by Subject|0|||
16538089|NCT00504426|40432777|FG003|Overall Study|Withdrawal by Subject|0|||
16339285|NCT01172808|39730198|FG003|Overall Study|Withdrawal by Subject|2|||
16538090|NCT01368900|40432778|FG000|Overall Study|Lost to Follow-up|7|||
16538091|NCT01297959|40432781|FG000|Overall Study|Adverse Event|0|||
16339286|NCT01172808|39730195|FG000|Overall Study|Other|6|||
16339287|NCT01172808|39730196|FG001|Overall Study|Other|5|||
16339288|NCT01172808|39730197|FG002|Overall Study|Other|9|||
16339289|NCT01172808|39730198|FG003|Overall Study|Other|7|||
16339290|NCT02697591|39730199|FG000|Overall Study|Lost to Follow-up|0|||
16339291|NCT02697591|39730200|FG001|Overall Study|Lost to Follow-up|0|||
16339292|NCT02697591|39730201|FG002|Overall Study|Lost to Follow-up|0|||
16339293|NCT02697591|39730202|FG003|Overall Study|Lost to Follow-up|0|||
16339294|NCT02697591|39730203|FG004|Overall Study|Lost to Follow-up|0|||
16339295|NCT02697591|39730204|FG005|Overall Study|Lost to Follow-up|1|||
16339296|NCT02697591|39730205|FG006|Overall Study|Lost to Follow-up|1|||
16339297|NCT02697591|39730206|FG007|Overall Study|Lost to Follow-up|0|||
16339298|NCT02697591|39730207|FG008|Overall Study|Lost to Follow-up|0|||
16339299|NCT02697591|39730208|FG009|Overall Study|Lost to Follow-up|1|||
16339300|NCT02697591|39730199|FG000|Overall Study|Withdrawal by Subject|1|||
16339301|NCT02697591|39730200|FG001|Overall Study|Withdrawal by Subject|1|||
16339302|NCT02697591|39730201|FG002|Overall Study|Withdrawal by Subject|2|||
16339303|NCT02697591|39730202|FG003|Overall Study|Withdrawal by Subject|1|||
16339304|NCT02697591|39730203|FG004|Overall Study|Withdrawal by Subject|7|||
16538092|NCT01297959|40432782|FG001|Overall Study|Adverse Event|1|||
16538093|NCT01297959|40432781|FG000|Overall Study|Protocol Violation|2|||
16538094|NCT01297959|40432782|FG001|Overall Study|Protocol Violation|1|||
16538095|NCT01297959|40432781|FG000|Overall Study|Withdrawal by Subject|5|||
16538096|NCT01297959|40432782|FG001|Overall Study|Withdrawal by Subject|4|||
16538097|NCT01297959|40432781|FG000|Overall Study|Physician Decision|0|||
16538098|NCT01297959|40432782|FG001|Overall Study|Physician Decision|1|||
16538099|NCT01297959|40432781|FG000|Overall Study|Unrelated medical illness / complication|0|||
16538100|NCT01297959|40432782|FG001|Overall Study|Unrelated medical illness / complication|2|||
16538101|NCT01297959|40432781|FG000|Overall Study|Other|13|||
16538102|NCT01297959|40432782|FG001|Overall Study|Other|7|||
16538103|NCT00729833|40432783|FG000|Overall Study|Death|5|||
16538104|NCT00729833|40432784|FG001|Overall Study|Death|1|||
16538105|NCT00729833|40432785|FG002|Overall Study|Death|3|||
16538106|NCT00729833|40432786|FG003|Overall Study|Death|5|||
16538107|NCT00729833|40432783|FG000|Overall Study|Study Terminated by Sponsor|0|||
16538108|NCT00729833|40432784|FG001|Overall Study|Study Terminated by Sponsor|0|||
16538109|NCT00729833|40432785|FG002|Overall Study|Study Terminated by Sponsor|1|||
16538110|NCT00729833|40432786|FG003|Overall Study|Study Terminated by Sponsor|0|||
16538111|NCT00729833|40432783|FG000|Overall Study|Lost to Follow-up|1|||
16538112|NCT00729833|40432784|FG001|Overall Study|Lost to Follow-up|0|||
16538113|NCT00729833|40432785|FG002|Overall Study|Lost to Follow-up|0|||
16538114|NCT00729833|40432786|FG003|Overall Study|Lost to Follow-up|0|||
16538115|NCT00729833|40432783|FG000|Overall Study|Withdrawal by Subject|3|||
16538116|NCT00729833|40432784|FG001|Overall Study|Withdrawal by Subject|1|||
16538117|NCT00729833|40432785|FG002|Overall Study|Withdrawal by Subject|3|||
16538118|NCT00729833|40432786|FG003|Overall Study|Withdrawal by Subject|0|||
16538119|NCT00729833|40432783|FG000|Overall Study|Unspecified Reasons|11|||
16538120|NCT00729833|40432784|FG001|Overall Study|Unspecified Reasons|5|||
16538121|NCT00729833|40432785|FG002|Overall Study|Unspecified Reasons|5|||
16538122|NCT00729833|40432786|FG003|Overall Study|Unspecified Reasons|1|||
16538123|NCT02366910|40432787|FG000|Overall Study|Withdrawal by Subject|2|||
16538124|NCT02366910|40432787|FG000|Overall Study|Screen Failure|3|||
16538125|NCT02114151|40432801|FG000|Overall Study|Death|1|||
16538126|NCT02114151|40432801|FG000|Overall Study|Lost to Follow-up|1|||
16538127|NCT02114151|40432801|FG000|Overall Study|Withdrawal by Subject|5|||
16538128|NCT00765674|40432802|FG000|Overall Study|Adverse Event|7|||
16538129|NCT00765674|40432803|FG001|Overall Study|Adverse Event|2|||
16538130|NCT00765674|40432804|FG002|Overall Study|Adverse Event|8|||
16538131|NCT00765674|40432805|FG003|Overall Study|Adverse Event|11|||
16538132|NCT00765674|40432802|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
16538133|NCT00765674|40432803|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
16538134|NCT00765674|40432804|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
16538135|NCT00765674|40432805|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
16538136|NCT00765674|40432802|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
16538137|NCT00765674|40432803|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
16538138|NCT00765674|40432804|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
16339305|NCT02697591|39730204|FG005|Overall Study|Withdrawal by Subject|6|||
16339306|NCT02697591|39730205|FG006|Overall Study|Withdrawal by Subject|9|||
16339307|NCT02697591|39730206|FG007|Overall Study|Withdrawal by Subject|1|||
16339308|NCT02697591|39730207|FG008|Overall Study|Withdrawal by Subject|6|||
16339309|NCT02697591|39730208|FG009|Overall Study|Withdrawal by Subject|10|||
16339310|NCT02697591|39730199|FG000|Overall Study|Physician Decision|1|||
16538139|NCT00765674|40432805|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
16538140|NCT00765674|40432802|FG000|Overall Study|Lack of Efficacy|2|||
16538141|NCT00765674|40432803|FG001|Overall Study|Lack of Efficacy|3|||
16103616|NCT04750577|38865541|FG002|Overall Study|Protocol deviation|1|||
16103617|NCT04750577|38865542|FG003|Overall Study|Protocol deviation|1|||
16103618|NCT04750577|38865539|FG000|Overall Study|Other than listed|3|||
16103619|NCT04750577|38865540|FG001|Overall Study|Other than listed|2|||
16103620|NCT04750577|38865541|FG002|Overall Study|Other than listed|2|||
16538142|NCT00765674|40432804|FG002|Overall Study|Lack of Efficacy|1|||
16538143|NCT00765674|40432805|FG003|Overall Study|Lack of Efficacy|2|||
16538144|NCT00765674|40432802|FG000|Overall Study|Protocol Violation|2|||
16103621|NCT04750577|38865542|FG003|Overall Study|Other than listed|1|||
16103622|NCT04750577|38865539|FG000|Overall Study|Not treated|0|||
16103623|NCT04750577|38865540|FG001|Overall Study|Not treated|0|||
16103624|NCT04750577|38865541|FG002|Overall Study|Not treated|0|||
16103625|NCT04750577|38865542|FG003|Overall Study|Not treated|2|||
16103626|NCT00946998|38865545|FG000|Overall Study|Exited prior to first outcome assessment|5|||
16103627|NCT00946998|38865546|FG001|Overall Study|Exited prior to first outcome assessment|3|||
16103628|NCT03078751|38865548|FG000|Overall Study|Adverse Event|4|||
16103629|NCT03078751|38865549|FG001|Overall Study|Adverse Event|0|||
16103630|NCT03078751|38865548|FG000|Overall Study|Physician Decision|1|||
16103631|NCT03078751|38865549|FG001|Overall Study|Physician Decision|0|||
16103632|NCT03078751|38865548|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
16103633|NCT03078751|38865549|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
16103634|NCT03078751|38865548|FG000|Overall Study|Subject/guardian decision|8|||
16103635|NCT03078751|38865549|FG001|Overall Study|Subject/guardian decision|1|||
16103636|NCT03078751|38865548|FG000|Overall Study|Untreated|0|||
16103637|NCT03078751|38865549|FG001|Overall Study|Untreated|4|||
16103638|NCT02030847|38865556|FG000|Overall Study|Death|10|||
16103639|NCT02030847|38865556|FG000|Overall Study|Disease Progression|15|||
16103640|NCT02030847|38865556|FG000|Overall Study|New Cancer Therapy|8|||
16103641|NCT02030847|38865556|FG000|Overall Study|Physician Decision|3|||
16103642|NCT02030847|38865556|FG000|Overall Study|Withdrawal by Subject|1|||
16103643|NCT02986659|38865558|FG000|First Intervention Period|Adverse Event|3|||
16103644|NCT02986659|38865559|FG001|First Intervention Period|Adverse Event|1|||
16103645|NCT02986659|38865558|FG000|First Intervention Period|Lost to Follow-up|1|||
16103646|NCT02986659|38865559|FG001|First Intervention Period|Lost to Follow-up|0|||
16103647|NCT02986659|38865558|FG000|First Intervention Period|Withdrawal by Subject|0|||
16103648|NCT02986659|38865559|FG001|First Intervention Period|Withdrawal by Subject|1|||
16103649|NCT02986659|38865558|FG000|Second Intervention Period|Adverse Event|0|||
16103650|NCT02986659|38865559|FG001|Second Intervention Period|Adverse Event|6|||
16103651|NCT02809677|38865562|FG000|Overall Study|Withdrawal by Subject|8|||
16103652|NCT00920699|38865569|FG000|Overall Study|Withdrawal by Subject|2|||
16103653|NCT00920699|38865570|FG001|Overall Study|Withdrawal by Subject|0|||
16103654|NCT00920699|38865571|FG002|Overall Study|Withdrawal by Subject|2|||
16103655|NCT00920699|38865569|FG000|Overall Study|no longer met eligibility|0|||
16103656|NCT00920699|38865570|FG001|Overall Study|no longer met eligibility|1|||
16339311|NCT02697591|39730200|FG001|Overall Study|Physician Decision|0|||
16339312|NCT02697591|39730201|FG002|Overall Study|Physician Decision|0|||
16339313|NCT02697591|39730202|FG003|Overall Study|Physician Decision|0|||
16339314|NCT02697591|39730203|FG004|Overall Study|Physician Decision|1|||
16339315|NCT02697591|39730204|FG005|Overall Study|Physician Decision|2|||
16339316|NCT02697591|39730205|FG006|Overall Study|Physician Decision|0|||
16339317|NCT02697591|39730206|FG007|Overall Study|Physician Decision|0|||
16339318|NCT02697591|39730207|FG008|Overall Study|Physician Decision|1|||
16339319|NCT02697591|39730208|FG009|Overall Study|Physician Decision|1|||
16339320|NCT02697591|39730199|FG000|Overall Study|Death|2|||
16339321|NCT02697591|39730200|FG001|Overall Study|Death|3|||
16339322|NCT02697591|39730201|FG002|Overall Study|Death|1|||
16339323|NCT02697591|39730202|FG003|Overall Study|Death|1|||
16339324|NCT02697591|39730203|FG004|Overall Study|Death|4|||
16339325|NCT02697591|39730204|FG005|Overall Study|Death|5|||
16339326|NCT02697591|39730205|FG006|Overall Study|Death|3|||
16339327|NCT02697591|39730206|FG007|Overall Study|Death|1|||
16339328|NCT02697591|39730207|FG008|Overall Study|Death|1|||
16339329|NCT02697591|39730208|FG009|Overall Study|Death|5|||
16339330|NCT02697591|39730199|FG000|Overall Study|Reason not Specified|0|||
16339331|NCT02697591|39730200|FG001|Overall Study|Reason not Specified|0|||
16339332|NCT02697591|39730201|FG002|Overall Study|Reason not Specified|0|||
16339333|NCT02697591|39730202|FG003|Overall Study|Reason not Specified|1|||
16339334|NCT02697591|39730203|FG004|Overall Study|Reason not Specified|1|||
16538145|NCT00765674|40432803|FG001|Overall Study|Protocol Violation|0|||
16538146|NCT00765674|40432804|FG002|Overall Study|Protocol Violation|1|||
16103657|NCT00920699|38865571|FG002|Overall Study|no longer met eligibility|0|||
16103658|NCT00920699|38865569|FG000|Overall Study|Lost to Follow-up|0|||
16103659|NCT00920699|38865570|FG001|Overall Study|Lost to Follow-up|0|||
16103660|NCT00920699|38865571|FG002|Overall Study|Lost to Follow-up|2|||
16103661|NCT00361842|38865572|FG000|Overall Study|Withdrawal by Subject|2|||
16339335|NCT02697591|39730204|FG005|Overall Study|Reason not Specified|2|||
16339336|NCT02697591|39730205|FG006|Overall Study|Reason not Specified|3|||
16339337|NCT02697591|39730206|FG007|Overall Study|Reason not Specified|1|||
16339338|NCT02697591|39730207|FG008|Overall Study|Reason not Specified|1|||
16103662|NCT00361842|38865573|FG001|Overall Study|Withdrawal by Subject|3|||
16103663|NCT00361842|38865572|FG000|Overall Study|Death|2|||
16103664|NCT00361842|38865573|FG001|Overall Study|Death|1|||
16103665|NCT00361842|38865572|FG000|Overall Study|Disease progression|19|||
16103666|NCT00361842|38865573|FG001|Overall Study|Disease progression|20|||
16103667|NCT00361842|38865572|FG000|Overall Study|Adverse Event|2|||
16103668|NCT00361842|38865573|FG001|Overall Study|Adverse Event|3|||
16103669|NCT00361842|38865572|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
16103670|NCT00361842|38865573|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
16103671|NCT00361842|38865572|FG000|Overall Study|Other|1|||
16103672|NCT00361842|38865573|FG001|Overall Study|Other|0|||
16103673|NCT00361842|38865572|FG000|Overall Study|Other|0|||
16103674|NCT00361842|38865573|FG001|Overall Study|Other|2|||
16103675|NCT00546078|38865576|FG000|Overall Study|Lost to Follow-up|1|||
16103676|NCT00546078|38865577|FG001|Overall Study|Lost to Follow-up|3|||
16103677|NCT00546078|38865576|FG000|Overall Study|Withdrawal by Subject|2|||
16103678|NCT00546078|38865577|FG001|Overall Study|Withdrawal by Subject|3|||
16103679|NCT00546078|38865576|FG000|Overall Study|Other reason|1|||
16103680|NCT00546078|38865577|FG001|Overall Study|Other reason|1|||
16103681|NCT00676195|38865578|FG000|Overall Study|Lost to Follow-up|1|||
16103682|NCT00676195|38865578|FG000|Overall Study|Adverse Event|1|||
16103683|NCT00676195|38865578|FG000|Overall Study|Physician Decision|1|||
16103684|NCT00740597|38865579|FG000|Overall Study|insurance would not cover treatment|1|||
16103685|NCT01730118|38865581|FG000|Dose Escalation|Death on study|5|||
16103686|NCT01730118|38865582|FG001|Dose Escalation|Death on study|7|||
16103687|NCT01730118|38865583|FG002|Dose Escalation|Death on study|2|||
16103688|NCT01730118|38865584|FG003|Dose Escalation|Death on study|6|||
16103689|NCT01730118|38865585|FG004|Dose Escalation|Death on study|0|||
16103690|NCT01730118|38865586|FG005|Dose Escalation|Death on study|0|||
16103691|NCT01730118|38865587|FG006|Dose Escalation|Death on study|0|||
16103692|NCT01730118|38865581|FG000|Dose Escalation|Died before treatment|0|||
16103693|NCT01730118|38865582|FG001|Dose Escalation|Died before treatment|0|||
16103694|NCT01730118|38865583|FG002|Dose Escalation|Died before treatment|0|||
16103695|NCT01730118|38865584|FG003|Dose Escalation|Died before treatment|0|||
16103696|NCT01730118|38865585|FG004|Dose Escalation|Died before treatment|0|||
16103697|NCT01730118|38865586|FG005|Dose Escalation|Died before treatment|0|||
16103698|NCT01730118|38865587|FG006|Dose Escalation|Died before treatment|1|||
16103699|NCT01730118|38865581|FG000|Dose Escalation|Chose to start a different treatment|1|||
16103700|NCT01730118|38865582|FG001|Dose Escalation|Chose to start a different treatment|0|||
16103701|NCT01730118|38865583|FG002|Dose Escalation|Chose to start a different treatment|0|||
16103702|NCT01730118|38865584|FG003|Dose Escalation|Chose to start a different treatment|0|||
16103703|NCT01730118|38865585|FG004|Dose Escalation|Chose to start a different treatment|0|||
16103704|NCT01730118|38865586|FG005|Dose Escalation|Chose to start a different treatment|0|||
16103705|NCT01730118|38865587|FG006|Dose Escalation|Chose to start a different treatment|0|||
16103706|NCT01730118|38865581|FG000|Dose Escalation|Withdrawal by Subject|0|||
16103707|NCT01730118|38865582|FG001|Dose Escalation|Withdrawal by Subject|0|||
16103708|NCT01730118|38865583|FG002|Dose Escalation|Withdrawal by Subject|1|||
16103709|NCT01730118|38865584|FG003|Dose Escalation|Withdrawal by Subject|0|||
16103710|NCT01730118|38865585|FG004|Dose Escalation|Withdrawal by Subject|0|||
16103711|NCT01730118|38865586|FG005|Dose Escalation|Withdrawal by Subject|0|||
16103712|NCT01730118|38865587|FG006|Dose Escalation|Withdrawal by Subject|0|||
16217088|NCT03261037|39275851|FG002|Overall Study|Equipment failed to work|0|||
16217089|NCT03261037|39275852|FG003|Overall Study|Equipment failed to work|1|||
16217090|NCT03261037|39275849|FG000|Overall Study|End of study for participant and no follow up|0|||
16217091|NCT03261037|39275850|FG001|Overall Study|End of study for participant and no follow up|0|||
16538147|NCT00765674|40432805|FG003|Overall Study|Protocol Violation|0|||
16538148|NCT00765674|40432802|FG000|Overall Study|Withdrawal by Subject|5|||
16538149|NCT00765674|40432803|FG001|Overall Study|Withdrawal by Subject|7|||
16538150|NCT00765674|40432804|FG002|Overall Study|Withdrawal by Subject|3|||
16538151|NCT00765674|40432805|FG003|Overall Study|Withdrawal by Subject|8|||
16538152|NCT00765674|40432802|FG000|Overall Study|Lost to Follow-up|4|||
16217092|NCT03261037|39275851|FG002|Overall Study|End of study for participant and no follow up|0|||
16217093|NCT03261037|39275852|FG003|Overall Study|End of study for participant and no follow up|1|||
16217094|NCT03261037|39275849|FG000|Overall Study|Participant was too weak to continue in study|1|||
16217095|NCT03261037|39275850|FG001|Overall Study|Participant was too weak to continue in study|0|||
16103713|NCT01730118|38865581|FG000|Dose Escalation|Disease progression prior to treatment|0|||
16103714|NCT01730118|38865582|FG001|Dose Escalation|Disease progression prior to treatment|0|||
16103715|NCT01730118|38865583|FG002|Dose Escalation|Disease progression prior to treatment|0|||
16217096|NCT03261037|39275851|FG002|Overall Study|Participant was too weak to continue in study|0|||
16538153|NCT00765674|40432803|FG001|Overall Study|Lost to Follow-up|6|||
16538154|NCT00765674|40432804|FG002|Overall Study|Lost to Follow-up|2|||
16103716|NCT01730118|38865584|FG003|Dose Escalation|Disease progression prior to treatment|0|||
16103717|NCT01730118|38865585|FG004|Dose Escalation|Disease progression prior to treatment|0|||
16103718|NCT01730118|38865586|FG005|Dose Escalation|Disease progression prior to treatment|0|||
16217097|NCT03261037|39275852|FG003|Overall Study|Participant was too weak to continue in study|0|||
16217098|NCT02147691|39275853|FG000|Overall Study|Withdrawal by Subject|2|||
16217099|NCT02147691|39275854|FG001|Overall Study|Withdrawal by Subject|0|||
16217100|NCT02147691|39275853|FG000|Overall Study|Adverse Event|2|||
16217101|NCT02147691|39275854|FG001|Overall Study|Adverse Event|0|||
16217102|NCT02147691|39275853|FG000|Overall Study|Lost to Follow-up|0|||
16217103|NCT02147691|39275854|FG001|Overall Study|Lost to Follow-up|1|||
16217104|NCT02139280|39275856|FG000|Overall Study|No longer eligible|2|||
16217105|NCT02139280|39275857|FG001|Overall Study|No longer eligible|0|||
16217106|NCT00819052|39275858|FG000|Overall Study|Adverse Event|0|||
16217107|NCT00819052|39275859|FG001|Overall Study|Adverse Event|5|||
16217108|NCT00819052|39275858|FG000|Overall Study|Protocol Violation|1|||
16217109|NCT00819052|39275859|FG001|Overall Study|Protocol Violation|2|||
16217110|NCT00819052|39275858|FG000|Overall Study|Lost to Follow-up|1|||
16217111|NCT00819052|39275859|FG001|Overall Study|Lost to Follow-up|2|||
16217112|NCT00819052|39275858|FG000|Overall Study|Withdrawal by Subject|1|||
16217113|NCT00819052|39275859|FG001|Overall Study|Withdrawal by Subject|2|||
16217114|NCT00819052|39275858|FG000|Overall Study|Lack of Efficacy|1|||
16217115|NCT00819052|39275859|FG001|Overall Study|Lack of Efficacy|1|||
16217116|NCT00819052|39275858|FG000|Overall Study|Pregnancy|1|||
16217117|NCT00819052|39275859|FG001|Overall Study|Pregnancy|2|||
16217118|NCT00819052|39275858|FG000|Overall Study|Death or events leading to death|1|||
16217119|NCT00819052|39275859|FG001|Overall Study|Death or events leading to death|0|||
16217120|NCT01057394|39275860|FG000|Overall Study|Not eligible|0|||
16217121|NCT01057394|39275861|FG001|Overall Study|Not eligible|2|||
16217122|NCT04490499|39275872|FG000|Overall Study|Withdrawal by Subject|2|||
16217123|NCT04905563|39275873|FG000|Overall Study|Withdrawal by Subject|1|||
16217124|NCT04905563|39275874|FG001|Overall Study|Withdrawal by Subject|0|||
16217125|NCT04905563|39275873|FG000|Overall Study|Standard of care orders entered by resident|1|||
16217126|NCT04905563|39275874|FG001|Overall Study|Standard of care orders entered by resident|0|||
16217127|NCT04905563|39275873|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
16217128|NCT04905563|39275874|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
16217129|NCT04905563|39275873|FG000|Overall Study|Withdrawal by Subject|0|||
16217130|NCT04905563|39275874|FG001|Overall Study|Withdrawal by Subject|1|||
16217131|NCT00994890|39275875|FG000|Overall Study|Adverse Event|13|||
16217132|NCT00994890|39275876|FG001|Overall Study|Adverse Event|9|||
16339339|NCT02697591|39730208|FG009|Overall Study|Reason not Specified|3|||
16339340|NCT03089853|39730209|FG000|Overall Study|Lost to Follow-up|2|||
16538155|NCT00765674|40432805|FG003|Overall Study|Lost to Follow-up|1|||
16538156|NCT00765674|40432802|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
16538157|NCT00765674|40432803|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
16538158|NCT00765674|40432804|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
16538159|NCT00765674|40432805|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
16538160|NCT03263429|40432806|FG000|Overall Study|Withdrawal by Subject|0|||
16538161|NCT03263429|40432807|FG001|Overall Study|Withdrawal by Subject|1|||
16538162|NCT03263429|40432808|FG002|Overall Study|Withdrawal by Subject|0|||
16538163|NCT03263429|40432806|FG000|Overall Study|Follow-Up Period Completed|0|||
16538164|NCT03263429|40432807|FG001|Overall Study|Follow-Up Period Completed|2|||
16538165|NCT03263429|40432808|FG002|Overall Study|Follow-Up Period Completed|0|||
16538166|NCT03263429|40432806|FG000|Overall Study|Death|3|||
16339341|NCT03089853|39730210|FG001|Overall Study|Lost to Follow-up|1|||
16339342|NCT05459558|39730211|FG000|Overall Study|Adverse Event|1|||
16339343|NCT05459558|39730212|FG001|Overall Study|Adverse Event|0|||
16339344|NCT05459558|39730213|FG002|Overall Study|Adverse Event|0|||
16339345|NCT05459558|39730211|FG000|Overall Study|Scheduling issue|0|||
16339346|NCT05459558|39730212|FG001|Overall Study|Scheduling issue|1|||
16339347|NCT05459558|39730213|FG002|Overall Study|Scheduling issue|3|||
16339348|NCT05459558|39730211|FG000|Overall Study|Withdrawal by Subject|0|||
16339349|NCT05459558|39730212|FG001|Overall Study|Withdrawal by Subject|0|||
16339350|NCT05459558|39730213|FG002|Overall Study|Withdrawal by Subject|2|||
16339351|NCT02937636|39730214|FG000|Overall Study|Other (Not specified)|3|||
16339352|NCT02937636|39730215|FG001|Overall Study|Other (Not specified)|2|||
16217133|NCT00994890|39275877|FG002|Overall Study|Adverse Event|11|||
16217134|NCT00994890|39275875|FG000|Overall Study|Lack of Efficacy|0|||
16217135|NCT00994890|39275876|FG001|Overall Study|Lack of Efficacy|0|||
16339353|NCT01342445|39730216|FG000|Overall Study|Experienced side effects|0|||
16538167|NCT03263429|40432807|FG001|Overall Study|Death|5|||
16538168|NCT03263429|40432808|FG002|Overall Study|Death|16|||
16103719|NCT01730118|38865587|FG006|Dose Escalation|Disease progression prior to treatment|1|||
16103720|NCT01730118|38865581|FG000|Dose Expansion|Death|0|||
16103721|NCT01730118|38865582|FG001|Dose Expansion|Death|0|||
16103722|NCT01730118|38865583|FG002|Dose Expansion|Death|0|||
16103723|NCT01730118|38865584|FG003|Dose Expansion|Death|0|||
16103724|NCT01730118|38865585|FG004|Dose Expansion|Death|1|||
16103725|NCT01730118|38865586|FG005|Dose Expansion|Death|0|||
16339354|NCT01342445|39730217|FG001|Overall Study|Experienced side effects|2|||
16339355|NCT02069093|39730218|FG000|Overall Study|Disease progression|14|||
16339356|NCT02069093|39730218|FG000|Overall Study|New cancer therapy|1|||
16339357|NCT02069093|39730218|FG000|Overall Study|Death|1|||
16339358|NCT02069093|39730218|FG000|Overall Study|Administrative problems|1|||
16339359|NCT02069093|39730218|FG000|Overall Study|Withdrawal by Subject|2|||
16339360|NCT02069093|39730218|FG000|Overall Study|Abnormal laboratory values|1|||
16339361|NCT02069093|39730218|FG000|Overall Study|Adverse Event|10|||
16339362|NCT02417961|39730220|FG000|Overall Study|Adverse Event|1|||
16339363|NCT02417961|39730220|FG000|Overall Study|Lost to Follow-up|1|||
16339364|NCT02417961|39730220|FG000|Overall Study|Withdrawal by Subject|2|||
16339365|NCT04527978|39730221|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
16339366|NCT04527978|39730222|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
16339367|NCT03131687|39730223|FG000|Overall Study|Adverse Event|0|||
16339368|NCT03131687|39730224|FG001|Overall Study|Adverse Event|1|||
16339369|NCT03131687|39730225|FG002|Overall Study|Adverse Event|0|||
16339370|NCT03131687|39730226|FG003|Overall Study|Adverse Event|1|||
16339371|NCT03131687|39730227|FG004|Overall Study|Adverse Event|2|||
16339372|NCT03131687|39730228|FG005|Overall Study|Adverse Event|2|||
16339373|NCT03131687|39730223|FG000|Overall Study|Death|1|||
16339374|NCT03131687|39730224|FG001|Overall Study|Death|0|||
16339375|NCT03131687|39730225|FG002|Overall Study|Death|0|||
16339376|NCT03131687|39730226|FG003|Overall Study|Death|0|||
16339377|NCT03131687|39730227|FG004|Overall Study|Death|0|||
16339378|NCT03131687|39730228|FG005|Overall Study|Death|0|||
16339379|NCT03131687|39730223|FG000|Overall Study|Withdrawal by Subject|3|||
16339380|NCT03131687|39730224|FG001|Overall Study|Withdrawal by Subject|3|||
16339381|NCT03131687|39730225|FG002|Overall Study|Withdrawal by Subject|3|||
16339382|NCT03131687|39730226|FG003|Overall Study|Withdrawal by Subject|1|||
16339383|NCT03131687|39730227|FG004|Overall Study|Withdrawal by Subject|2|||
16339384|NCT03131687|39730228|FG005|Overall Study|Withdrawal by Subject|1|||
16339385|NCT03131687|39730223|FG000|Overall Study|Lost to Follow-up|1|||
16339386|NCT03131687|39730224|FG001|Overall Study|Lost to Follow-up|4|||
16339387|NCT03131687|39730225|FG002|Overall Study|Lost to Follow-up|0|||
16339388|NCT03131687|39730226|FG003|Overall Study|Lost to Follow-up|1|||
16339389|NCT03131687|39730227|FG004|Overall Study|Lost to Follow-up|4|||
16339390|NCT03131687|39730228|FG005|Overall Study|Lost to Follow-up|2|||
16339391|NCT03131687|39730223|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
16339392|NCT03131687|39730224|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
16339393|NCT03131687|39730225|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
16538169|NCT03263429|40432806|FG000|Overall Study|Participant unable to return|0|||
16538170|NCT03263429|40432807|FG001|Overall Study|Participant unable to return|0|||
16538171|NCT03263429|40432808|FG002|Overall Study|Participant unable to return|1|||
16538172|NCT03263429|40432806|FG000|Overall Study|Study Closed|0|||
16538173|NCT03263429|40432807|FG001|Overall Study|Study Closed|0|||
16538174|NCT03263429|40432808|FG002|Overall Study|Study Closed|1|||
16538175|NCT01112579|40432809|FG000|Overall Study|Missed Visit|1|||
16538176|NCT01112579|40432810|FG001|Overall Study|Missed Visit|1|||
16538177|NCT01112579|40432809|FG000|Overall Study|Death|0|||
16538178|NCT01112579|40432810|FG001|Overall Study|Death|2|||
16538179|NCT02693743|40432811|FG000|Overall Study|Physician Decision|1|||
16538180|NCT02693743|40432812|FG001|Overall Study|Physician Decision|0|||
16538181|NCT05711641|40432818|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
16538182|NCT05711641|40432819|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
16538183|NCT05711641|40432818|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
16538184|NCT05711641|40432819|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
16538185|NCT02794285|40432824|FG000|Overall Study|Adverse Event|11|||
16538186|NCT02794285|40432825|FG001|Overall Study|Adverse Event|4|||
16538187|NCT02794285|40432826|FG002|Overall Study|Adverse Event|5|||
16538188|NCT02794285|40432827|FG003|Overall Study|Adverse Event|8|||
16538189|NCT02794285|40432824|FG000|Overall Study|Condition Under Investigation Improved|1|||
16538190|NCT02794285|40432825|FG001|Overall Study|Condition Under Investigation Improved|0|||
16103726|NCT01730118|38865587|FG006|Dose Expansion|Death|0|||
16103727|NCT01730118|38865581|FG000|Dose Expansion|Other medical condition|0|||
16339394|NCT03131687|39730226|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
16339395|NCT03131687|39730227|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
16538191|NCT02794285|40432826|FG002|Overall Study|Condition Under Investigation Improved|0|||
16339396|NCT03131687|39730228|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
16339397|NCT03131687|39730223|FG000|Overall Study|Principle Investigator Decision|0|||
16538192|NCT02794285|40432827|FG003|Overall Study|Condition Under Investigation Improved|0|||
16339398|NCT03131687|39730224|FG001|Overall Study|Principle Investigator Decision|1|||
16339399|NCT03131687|39730225|FG002|Overall Study|Principle Investigator Decision|0|||
16339400|NCT03131687|39730226|FG003|Overall Study|Principle Investigator Decision|0|||
16339401|NCT03131687|39730227|FG004|Overall Study|Principle Investigator Decision|0|||
16339402|NCT03131687|39730228|FG005|Overall Study|Principle Investigator Decision|0|||
16339403|NCT03131687|39730223|FG000|Overall Study|Inadvertent Enrollment|0|||
16339404|NCT03131687|39730224|FG001|Overall Study|Inadvertent Enrollment|0|||
16339405|NCT03131687|39730225|FG002|Overall Study|Inadvertent Enrollment|0|||
16339406|NCT03131687|39730226|FG003|Overall Study|Inadvertent Enrollment|1|||
16339407|NCT03131687|39730227|FG004|Overall Study|Inadvertent Enrollment|0|||
16339408|NCT03131687|39730228|FG005|Overall Study|Inadvertent Enrollment|0|||
16339409|NCT01438814|39730229|FG000|Overall Study|Adverse Event|3|||
16339410|NCT01438814|39730230|FG001|Overall Study|Adverse Event|3|||
16339411|NCT01438814|39730229|FG000|Overall Study|Protocol Violation|1|||
16339412|NCT01438814|39730230|FG001|Overall Study|Protocol Violation|2|||
16339413|NCT01438814|39730229|FG000|Overall Study|Lost to Follow-up|4|||
16339414|NCT01438814|39730230|FG001|Overall Study|Lost to Follow-up|3|||
16339415|NCT01438814|39730229|FG000|Overall Study|Withdrawal by Subject|4|||
16339416|NCT01438814|39730230|FG001|Overall Study|Withdrawal by Subject|2|||
16538193|NCT02794285|40432824|FG000|Overall Study|Condition Under Investigation Worsened|0|||
16538194|NCT02794285|40432825|FG001|Overall Study|Condition Under Investigation Worsened|2|||
16538195|NCT02794285|40432826|FG002|Overall Study|Condition Under Investigation Worsened|1|||
16538196|NCT02794285|40432827|FG003|Overall Study|Condition Under Investigation Worsened|0|||
16538197|NCT02794285|40432824|FG000|Overall Study|Death|2|||
16538198|NCT02794285|40432825|FG001|Overall Study|Death|1|||
16339417|NCT01438814|39730229|FG000|Overall Study|Other|2|||
16339418|NCT01438814|39730230|FG001|Overall Study|Other|4|||
16339419|NCT00703326|39730231|FG000|Overall Study|Lost to Follow-up|47|||
16339420|NCT00703326|39730232|FG001|Overall Study|Lost to Follow-up|18|||
16339421|NCT00703326|39730231|FG000|Overall Study|Withdrawal by Subject|54|||
16339422|NCT00703326|39730232|FG001|Overall Study|Withdrawal by Subject|20|||
16538199|NCT02794285|40432826|FG002|Overall Study|Death|2|||
16538200|NCT02794285|40432827|FG003|Overall Study|Death|0|||
16538201|NCT02794285|40432824|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
16538202|NCT02794285|40432825|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
16538203|NCT02794285|40432826|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
16103728|NCT01730118|38865582|FG001|Dose Expansion|Other medical condition|0|||
16103729|NCT01730118|38865583|FG002|Dose Expansion|Other medical condition|0|||
16103730|NCT01730118|38865584|FG003|Dose Expansion|Other medical condition|0|||
16103731|NCT01730118|38865585|FG004|Dose Expansion|Other medical condition|1|||
16103732|NCT01730118|38865586|FG005|Dose Expansion|Other medical condition|0|||
16103733|NCT01730118|38865587|FG006|Dose Expansion|Other medical condition|0|||
16103734|NCT01730118|38865581|FG000|Dose Expansion|Withdrawal by Subject|0|||
16103735|NCT01730118|38865582|FG001|Dose Expansion|Withdrawal by Subject|0|||
16103736|NCT01730118|38865583|FG002|Dose Expansion|Withdrawal by Subject|0|||
16103737|NCT01730118|38865584|FG003|Dose Expansion|Withdrawal by Subject|0|||
16103738|NCT01730118|38865585|FG004|Dose Expansion|Withdrawal by Subject|1|||
16103739|NCT01730118|38865586|FG005|Dose Expansion|Withdrawal by Subject|0|||
16103740|NCT01730118|38865587|FG006|Dose Expansion|Withdrawal by Subject|0|||
16103741|NCT01730118|38865581|FG000|Dose Expansion|Disease progression|0|||
16103742|NCT01730118|38865582|FG001|Dose Expansion|Disease progression|0|||
16103743|NCT01730118|38865583|FG002|Dose Expansion|Disease progression|0|||
16339423|NCT00703326|39730231|FG000|Overall Study|Adverse Event|1|||
16339424|NCT00703326|39730232|FG001|Overall Study|Adverse Event|0|||
16339425|NCT00404924|39730234|FG000|Overall Study|Adverse Event|75|||
16339426|NCT00404924|39730235|FG001|Overall Study|Adverse Event|16|||
16339427|NCT00404924|39730234|FG000|Overall Study|Condition under investigation worsened|475|||
16339428|NCT00404924|39730235|FG001|Overall Study|Condition under investigation worsened|264|||
16339429|NCT00404924|39730234|FG000|Overall Study|Lost to Follow-up|1|||
16339430|NCT00404924|39730235|FG001|Overall Study|Lost to Follow-up|1|||
16339431|NCT00404924|39730234|FG000|Overall Study|Withdrawal by Subject|26|||
16339432|NCT00404924|39730235|FG001|Overall Study|Withdrawal by Subject|13|||
16339433|NCT00404924|39730234|FG000|Overall Study|Other|25|||
16339434|NCT00404924|39730235|FG001|Overall Study|Other|11|||
16339435|NCT00404924|39730234|FG000|Overall Study|Randomised but not received treatment|1|||
16339436|NCT00404924|39730235|FG001|Overall Study|Randomised but not received treatment|1|||
16339437|NCT02187861|39730236|FG000|Overall Study|Adverse Event|2|||
16339438|NCT02187861|39730237|FG001|Overall Study|Adverse Event|1|||
16339439|NCT02187861|39730238|FG002|Overall Study|Adverse Event|2|||
16339440|NCT02187861|39730239|FG003|Overall Study|Adverse Event|1|||
16103744|NCT01730118|38865584|FG003|Dose Expansion|Disease progression|0|||
16103745|NCT01730118|38865585|FG004|Dose Expansion|Disease progression|0|||
16339441|NCT02187861|39730236|FG000|Overall Study|Death|0|||
16339442|NCT02187861|39730237|FG001|Overall Study|Death|3|||
16339443|NCT02187861|39730238|FG002|Overall Study|Death|1|||
16103746|NCT01730118|38865586|FG005|Dose Expansion|Disease progression|1|||
16339444|NCT02187861|39730239|FG003|Overall Study|Death|2|||
16339445|NCT02187861|39730236|FG000|Overall Study|Physician Decision|0|||
16339446|NCT02187861|39730237|FG001|Overall Study|Physician Decision|1|||
16339447|NCT02187861|39730238|FG002|Overall Study|Physician Decision|0|||
16339448|NCT02187861|39730239|FG003|Overall Study|Physician Decision|3|||
16339449|NCT02187861|39730236|FG000|Overall Study|Progressive Disease|4|||
16339450|NCT02187861|39730237|FG001|Overall Study|Progressive Disease|42|||
16339451|NCT02187861|39730238|FG002|Overall Study|Progressive Disease|19|||
16339452|NCT02187861|39730239|FG003|Overall Study|Progressive Disease|22|||
16339453|NCT02187861|39730236|FG000|Overall Study|Withdrawal by Subject|0|||
16339454|NCT02187861|39730237|FG001|Overall Study|Withdrawal by Subject|0|||
16339455|NCT02187861|39730238|FG002|Overall Study|Withdrawal by Subject|3|||
16339456|NCT02187861|39730239|FG003|Overall Study|Withdrawal by Subject|3|||
16339457|NCT02187861|39730236|FG000|Overall Study|Other|0|||
16339458|NCT02187861|39730237|FG001|Overall Study|Other|1|||
16339459|NCT02187861|39730238|FG002|Overall Study|Other|7|||
16339460|NCT02187861|39730239|FG003|Overall Study|Other|1|||
16339461|NCT01285492|39730248|FG000|Overall Study|Adverse Event|11|||
16339462|NCT01285492|39730249|FG001|Overall Study|Adverse Event|0|||
16339463|NCT01285492|39730248|FG000|Overall Study|Protocol Violation|3|||
16339464|NCT01285492|39730249|FG001|Overall Study|Protocol Violation|0|||
16339465|NCT01285492|39730248|FG000|Overall Study|Withdrawal by Subject|2|||
16339466|NCT01285492|39730249|FG001|Overall Study|Withdrawal by Subject|1|||
16339467|NCT01285492|39730248|FG000|Overall Study|Death|1|||
16339468|NCT01285492|39730249|FG001|Overall Study|Death|0|||
16339469|NCT03677934|39730250|FG000|Overall Study|Adverse Event|1|||
16339470|NCT03677934|39730251|FG001|Overall Study|Adverse Event|1|||
16339471|NCT03677934|39730250|FG000|Overall Study|Death|8|||
16339472|NCT03677934|39730251|FG001|Overall Study|Death|4|||
16103747|NCT01730118|38865587|FG006|Dose Expansion|Disease progression|0|||
16103748|NCT01730118|38865581|FG000|Dose Expansion|Inability to return|0|||
16339473|NCT03677934|39730250|FG000|Overall Study|Lost to Follow-up|3|||
16339474|NCT03677934|39730251|FG001|Overall Study|Lost to Follow-up|0|||
16339475|NCT03677934|39730250|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16339476|NCT03677934|39730251|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16339477|NCT03677934|39730250|FG000|Overall Study|Physician Decision|0|||
16339478|NCT03677934|39730251|FG001|Overall Study|Physician Decision|1|||
16339479|NCT03677934|39730250|FG000|Overall Study|Withdrawal by Subject|1|||
16339480|NCT03677934|39730251|FG001|Overall Study|Withdrawal by Subject|7|||
16339481|NCT00593606|39730252|FG000|Overall Study|Adverse Event|13|||
16339482|NCT00593606|39730252|FG000|Overall Study|Withdrawal by Subject|1|||
16339483|NCT00593606|39730252|FG000|Overall Study|Protocol Violation|3|||
16339484|NCT00593606|39730252|FG000|Overall Study|Lost to Follow-up|2|||
16339485|NCT00593606|39730252|FG000|Overall Study|Run-In Failure|5|||
16339486|NCT00593606|39730252|FG000|Overall Study|Screen Failure|3|||
16339487|NCT01424241|39730253|FG000|Overall Study|Withdrawal by Subject|1|||
16339488|NCT01424241|39730253|FG000|Overall Study|Time constraints|2|||
16339489|NCT01739764|39730254|FG000|Overall Study|Adverse Event|0|||
16339490|NCT01739764|39730255|FG001|Overall Study|Adverse Event|3|||
16339491|NCT01739764|39730256|FG002|Overall Study|Adverse Event|4|||
16339492|NCT01739764|39730254|FG000|Overall Study|Death|4|||
16339493|NCT01739764|39730255|FG001|Overall Study|Death|6|||
16339494|NCT01739764|39730256|FG002|Overall Study|Death|38|||
16339495|NCT01739764|39730254|FG000|Overall Study|Lost to Follow-up|0|||
16339496|NCT01739764|39730255|FG001|Overall Study|Lost to Follow-up|0|||
16339497|NCT01739764|39730256|FG002|Overall Study|Lost to Follow-up|5|||
16339498|NCT01739764|39730254|FG000|Overall Study|Non-Compliance|0|||
16339499|NCT01739764|39730255|FG001|Overall Study|Non-Compliance|0|||
16339500|NCT01739764|39730256|FG002|Overall Study|Non-Compliance|1|||
16339501|NCT01739764|39730254|FG000|Overall Study|Multiple Reasons|3|||
16339502|NCT01739764|39730255|FG001|Overall Study|Multiple Reasons|2|||
16339503|NCT01739764|39730256|FG002|Overall Study|Multiple Reasons|3|||
16339504|NCT01739764|39730254|FG000|Overall Study|Physician Decision|2|||
16339505|NCT01739764|39730255|FG001|Overall Study|Physician Decision|2|||
16339506|NCT01739764|39730256|FG002|Overall Study|Physician Decision|4|||
16339507|NCT01739764|39730254|FG000|Overall Study|Progressive Disease|3|||
16339508|NCT01739764|39730255|FG001|Overall Study|Progressive Disease|5|||
16339509|NCT01739764|39730256|FG002|Overall Study|Progressive Disease|16|||
16339510|NCT01739764|39730254|FG000|Overall Study|Protocol Violation|0|||
16339511|NCT01739764|39730255|FG001|Overall Study|Protocol Violation|0|||
16339512|NCT01739764|39730256|FG002|Overall Study|Protocol Violation|2|||
16217136|NCT00994890|39275877|FG002|Overall Study|Lack of Efficacy|1|||
16339513|NCT01739764|39730254|FG000|Overall Study|Study Terminated by Sponsor|8|||
16339514|NCT01739764|39730255|FG001|Overall Study|Study Terminated by Sponsor|13|||
16339515|NCT01739764|39730256|FG002|Overall Study|Study Terminated by Sponsor|26|||
16217137|NCT00994890|39275875|FG000|Overall Study|Lost to Follow-up|6|||
16339516|NCT01739764|39730254|FG000|Overall Study|Withdrawal by Subject|6|||
16339517|NCT01739764|39730255|FG001|Overall Study|Withdrawal by Subject|5|||
16339518|NCT01739764|39730256|FG002|Overall Study|Withdrawal by Subject|27|||
16339519|NCT01451164|39730263|FG000|Overall Study|Adverse Event|19|||
16339520|NCT01451164|39730264|FG001|Overall Study|Adverse Event|12|||
16339521|NCT01451164|39730265|FG002|Overall Study|Adverse Event|18|||
16339522|NCT01451164|39730266|FG003|Overall Study|Adverse Event|21|||
16339523|NCT01451164|39730263|FG000|Overall Study|Withdrawal Criteria|1|||
16339524|NCT01451164|39730264|FG001|Overall Study|Withdrawal Criteria|1|||
16339525|NCT01451164|39730265|FG002|Overall Study|Withdrawal Criteria|1|||
16339526|NCT01451164|39730266|FG003|Overall Study|Withdrawal Criteria|1|||
16339527|NCT01451164|39730263|FG000|Overall Study|Physician Decision|2|||
16339528|NCT01451164|39730264|FG001|Overall Study|Physician Decision|0|||
16339529|NCT01451164|39730265|FG002|Overall Study|Physician Decision|1|||
16339530|NCT01451164|39730266|FG003|Overall Study|Physician Decision|0|||
16339531|NCT01451164|39730263|FG000|Overall Study|Withdrawal by Subject|14|||
16339532|NCT01451164|39730264|FG001|Overall Study|Withdrawal by Subject|11|||
16339533|NCT01451164|39730265|FG002|Overall Study|Withdrawal by Subject|16|||
16339534|NCT01451164|39730266|FG003|Overall Study|Withdrawal by Subject|17|||
16339535|NCT01451164|39730263|FG000|Overall Study|Protocol Violation|0|||
16339536|NCT01451164|39730264|FG001|Overall Study|Protocol Violation|1|||
16339537|NCT01451164|39730265|FG002|Overall Study|Protocol Violation|0|||
16339538|NCT01451164|39730266|FG003|Overall Study|Protocol Violation|0|||
16339539|NCT01451164|39730263|FG000|Overall Study|Lack of Efficacy|7|||
16339540|NCT01451164|39730264|FG001|Overall Study|Lack of Efficacy|9|||
16339541|NCT01451164|39730265|FG002|Overall Study|Lack of Efficacy|9|||
16339542|NCT01451164|39730266|FG003|Overall Study|Lack of Efficacy|7|||
16339543|NCT00715520|39730267|FG000|Overall Study|Screen failure|8|||
16339544|NCT00715520|39730268|FG001|Overall Study|Screen failure|1|||
16339545|NCT00715520|39730269|FG002|Overall Study|Screen failure|1|||
16339546|NCT00715520|39730267|FG000|Overall Study|Withdrawal by Subject|2|||
16339547|NCT00715520|39730268|FG001|Overall Study|Withdrawal by Subject|0|||
16339548|NCT00715520|39730269|FG002|Overall Study|Withdrawal by Subject|1|||
16339549|NCT04304508|39730270|FG000|Overall Study|Subject Decision|29|||
16339550|NCT04304508|39730271|FG001|Overall Study|Subject Decision|39|||
16339551|NCT04304508|39730272|FG002|Overall Study|Subject Decision|37|||
16339552|NCT04304508|39730273|FG003|Overall Study|Subject Decision|48|||
16339553|NCT04304508|39730270|FG000|Overall Study|Death|6|||
16339554|NCT04304508|39730271|FG001|Overall Study|Death|1|||
16339555|NCT04304508|39730272|FG002|Overall Study|Death|8|||
16339556|NCT04304508|39730273|FG003|Overall Study|Death|5|||
16339557|NCT04304508|39730270|FG000|Overall Study|Non-compliance With Study Drug|3|||
16339558|NCT04304508|39730271|FG001|Overall Study|Non-compliance With Study Drug|1|||
16339559|NCT04304508|39730272|FG002|Overall Study|Non-compliance With Study Drug|2|||
16339560|NCT04304508|39730273|FG003|Overall Study|Non-compliance With Study Drug|0|||
16339561|NCT04304508|39730270|FG000|Overall Study|Switching To Other Therapy|1|||
16339562|NCT04304508|39730271|FG001|Overall Study|Switching To Other Therapy|1|||
16339563|NCT04304508|39730272|FG002|Overall Study|Switching To Other Therapy|1|||
16339564|NCT04304508|39730273|FG003|Overall Study|Switching To Other Therapy|2|||
16339565|NCT04304508|39730270|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
16339566|NCT04304508|39730271|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
16339567|NCT04304508|39730272|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
16339568|NCT04304508|39730273|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
16339569|NCT04304508|39730270|FG000|Overall Study|Withdrawal by Subject|7|||
16339570|NCT04304508|39730271|FG001|Overall Study|Withdrawal by Subject|5|||
16339571|NCT04304508|39730272|FG002|Overall Study|Withdrawal by Subject|11|||
16339572|NCT04304508|39730273|FG003|Overall Study|Withdrawal by Subject|6|||
16339573|NCT04304508|39730270|FG000|Overall Study|Logistical Difficulties|2|||
16339574|NCT04304508|39730271|FG001|Overall Study|Logistical Difficulties|2|||
16339575|NCT04304508|39730272|FG002|Overall Study|Logistical Difficulties|3|||
16339576|NCT04304508|39730273|FG003|Overall Study|Logistical Difficulties|2|||
16339577|NCT04304508|39730270|FG000|Overall Study|Missing Information|1|||
16339578|NCT04304508|39730271|FG001|Overall Study|Missing Information|2|||
16339579|NCT04304508|39730272|FG002|Overall Study|Missing Information|1|||
16339580|NCT04304508|39730273|FG003|Overall Study|Missing Information|3|||
16538204|NCT02794285|40432827|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
16538205|NCT02794285|40432824|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
16538206|NCT02794285|40432825|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
16538207|NCT02794285|40432826|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
16538208|NCT02794285|40432827|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
16538209|NCT02794285|40432824|FG000|Overall Study|Lack of Efficacy|10|||
16538210|NCT02794285|40432825|FG001|Overall Study|Lack of Efficacy|6|||
16538211|NCT02794285|40432826|FG002|Overall Study|Lack of Efficacy|3|||
16339581|NCT04304508|39730270|FG000|Overall Study|Other|7|||
16339582|NCT04304508|39730271|FG001|Overall Study|Other|6|||
16339583|NCT04304508|39730272|FG002|Overall Study|Other|5|||
16339584|NCT04304508|39730273|FG003|Overall Study|Other|4|||
16406406|NCT00320255|39969796|FG004|Overall Study|Poor compliance/noncompliance|0|||
16538212|NCT02794285|40432827|FG003|Overall Study|Lack of Efficacy|3|||
16538213|NCT02794285|40432824|FG000|Overall Study|Lost to Follow-up|5|||
16339585|NCT04304508|39730270|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
16339586|NCT04304508|39730271|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
16538214|NCT02794285|40432825|FG001|Overall Study|Lost to Follow-up|6|||
16538215|NCT02794285|40432826|FG002|Overall Study|Lost to Follow-up|3|||
16538216|NCT02794285|40432827|FG003|Overall Study|Lost to Follow-up|1|||
16538217|NCT02794285|40432824|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
16538218|NCT02794285|40432825|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
16339587|NCT04304508|39730272|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
16339588|NCT04304508|39730273|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
16339589|NCT04304508|39730270|FG000|Overall Study|Physician Decision|3|||
16339590|NCT04304508|39730271|FG001|Overall Study|Physician Decision|4|||
16339591|NCT04304508|39730272|FG002|Overall Study|Physician Decision|9|||
16339592|NCT04304508|39730273|FG003|Overall Study|Physician Decision|7|||
16339593|NCT04304508|39730270|FG000|Overall Study|Study drug never administered|10|||
16339594|NCT04304508|39730271|FG001|Overall Study|Study drug never administered|4|||
16339595|NCT04304508|39730272|FG002|Overall Study|Study drug never administered|4|||
16339596|NCT04304508|39730273|FG003|Overall Study|Study drug never administered|4|||
16339597|NCT04304508|39730270|FG000|Overall Study|Adverse Event|49|||
16538219|NCT02794285|40432826|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
16538220|NCT02794285|40432827|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
16538221|NCT02794285|40432824|FG000|Overall Study|Withdrawal by Subject|38|||
16538222|NCT02794285|40432825|FG001|Overall Study|Withdrawal by Subject|29|||
16538223|NCT02794285|40432826|FG002|Overall Study|Withdrawal by Subject|20|||
16538224|NCT02794285|40432827|FG003|Overall Study|Withdrawal by Subject|12|||
16538225|NCT02794285|40432824|FG000|Overall Study|Missing|1|||
16538226|NCT02794285|40432825|FG001|Overall Study|Missing|0|||
16538227|NCT02794285|40432826|FG002|Overall Study|Missing|0|||
16538228|NCT02794285|40432827|FG003|Overall Study|Missing|0|||
16538229|NCT02794285|40432824|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
16538230|NCT02794285|40432825|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
16538231|NCT02794285|40432826|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
16538232|NCT02794285|40432827|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
16538233|NCT02794285|40432824|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
16538234|NCT02794285|40432825|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
16538235|NCT02794285|40432826|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
16538236|NCT02794285|40432827|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
16538237|NCT01843374|40432832|FG000|Overall Study|Death|155|||
16538238|NCT01843374|40432833|FG001|Overall Study|Death|313|||
16538239|NCT01843374|40432832|FG000|Overall Study|Withdrawal by Subject|14|||
16538240|NCT01843374|40432833|FG001|Overall Study|Withdrawal by Subject|20|||
16217138|NCT00994890|39275876|FG001|Overall Study|Lost to Follow-up|1|||
16538241|NCT01843374|40432832|FG000|Overall Study|Withdrawing due to Other reason|20|||
16339598|NCT04304508|39730271|FG001|Overall Study|Adverse Event|50|||
16103749|NCT01730118|38865582|FG001|Dose Expansion|Inability to return|0|||
16103750|NCT01730118|38865583|FG002|Dose Expansion|Inability to return|0|||
16103751|NCT01730118|38865584|FG003|Dose Expansion|Inability to return|0|||
16538242|NCT01843374|40432833|FG001|Overall Study|Withdrawing due to Other reason|46|||
16538243|NCT04052204|40432834|FG000|Overall Study|Death|1|||
16538244|NCT04052204|40432835|FG001|Overall Study|Death|0|||
16538245|NCT04052204|40432836|FG002|Overall Study|Death|0|||
16538246|NCT04052204|40432834|FG000|Overall Study|Progressive disease|1|||
16538247|NCT04052204|40432835|FG001|Overall Study|Progressive disease|0|||
16538248|NCT04052204|40432836|FG002|Overall Study|Progressive disease|0|||
16538249|NCT04052204|40432834|FG000|Overall Study|Other|1|||
16538250|NCT04052204|40432835|FG001|Overall Study|Other|0|||
16538251|NCT04052204|40432836|FG002|Overall Study|Other|0|||
16538252|NCT03832595|40432837|FG000|Overall Study|Death|142|||
16538253|NCT03832595|40432838|FG001|Overall Study|Death|130|||
16538254|NCT03832595|40432837|FG000|Overall Study|Medical management without dialysis|37|||
16538255|NCT03832595|40432838|FG001|Overall Study|Medical management without dialysis|1|||
16538256|NCT00428090|40432841|FG000|Overall Study|Adverse Event|10|||
16538257|NCT00428090|40432842|FG001|Overall Study|Adverse Event|8|||
16538258|NCT00428090|40432843|FG002|Overall Study|Adverse Event|10|||
16538259|NCT00428090|40432844|FG003|Overall Study|Adverse Event|11|||
16538260|NCT00428090|40432841|FG000|Overall Study|Lost to Follow-up|3|||
16538261|NCT00428090|40432842|FG001|Overall Study|Lost to Follow-up|6|||
16538262|NCT00428090|40432843|FG002|Overall Study|Lost to Follow-up|1|||
16538263|NCT00428090|40432844|FG003|Overall Study|Lost to Follow-up|4|||
16538264|NCT00428090|40432841|FG000|Overall Study|Protocol Violation|3|||
16538265|NCT00428090|40432842|FG001|Overall Study|Protocol Violation|1|||
16538266|NCT00428090|40432843|FG002|Overall Study|Protocol Violation|3|||
16538267|NCT00428090|40432844|FG003|Overall Study|Protocol Violation|3|||
16538268|NCT00428090|40432841|FG000|Overall Study|Withdrawal by Subject|10|||
16538269|NCT00428090|40432842|FG001|Overall Study|Withdrawal by Subject|12|||
16538270|NCT00428090|40432843|FG002|Overall Study|Withdrawal by Subject|15|||
16538271|NCT00428090|40432844|FG003|Overall Study|Withdrawal by Subject|5|||
16538272|NCT00428090|40432841|FG000|Overall Study|Sponsor terminated study|0|||
16538273|NCT00428090|40432842|FG001|Overall Study|Sponsor terminated study|1|||
16538274|NCT00428090|40432843|FG002|Overall Study|Sponsor terminated study|0|||
16538275|NCT00428090|40432844|FG003|Overall Study|Sponsor terminated study|0|||
16538276|NCT00428090|40432841|FG000|Overall Study|Non-compliance|4|||
16538277|NCT00428090|40432842|FG001|Overall Study|Non-compliance|0|||
16538278|NCT00428090|40432843|FG002|Overall Study|Non-compliance|1|||
16538279|NCT00428090|40432844|FG003|Overall Study|Non-compliance|3|||
16538280|NCT00428090|40432841|FG000|Overall Study|Par. did not returned to visit|1|||
16538281|NCT00428090|40432842|FG001|Overall Study|Par. did not returned to visit|0|||
16538282|NCT00428090|40432843|FG002|Overall Study|Par. did not returned to visit|0|||
16538283|NCT00428090|40432844|FG003|Overall Study|Par. did not returned to visit|1|||
16538284|NCT00428090|40432841|FG000|Overall Study|Follow-Up visit not possible|1|||
16538285|NCT00428090|40432842|FG001|Overall Study|Follow-Up visit not possible|0|||
16538286|NCT00428090|40432843|FG002|Overall Study|Follow-Up visit not possible|0|||
16538287|NCT00428090|40432844|FG003|Overall Study|Follow-Up visit not possible|0|||
16538288|NCT00428090|40432841|FG000|Overall Study|Prohibited medication used for SAE|1|||
16538289|NCT00428090|40432842|FG001|Overall Study|Prohibited medication used for SAE|0|||
16538290|NCT00428090|40432843|FG002|Overall Study|Prohibited medication used for SAE|0|||
16538291|NCT00428090|40432844|FG003|Overall Study|Prohibited medication used for SAE|0|||
16538292|NCT00428090|40432841|FG000|Overall Study|Death of par.|1|||
16538293|NCT00428090|40432842|FG001|Overall Study|Death of par.|0|||
16538294|NCT00428090|40432843|FG002|Overall Study|Death of par.|1|||
16538295|NCT00428090|40432844|FG003|Overall Study|Death of par.|0|||
16538296|NCT00428090|40432841|FG000|Overall Study|Visit 7 exceed the visit window|0|||
16538297|NCT00428090|40432842|FG001|Overall Study|Visit 7 exceed the visit window|1|||
16538298|NCT00428090|40432843|FG002|Overall Study|Visit 7 exceed the visit window|0|||
16538299|NCT00428090|40432844|FG003|Overall Study|Visit 7 exceed the visit window|0|||
16538300|NCT00428090|40432841|FG000|Overall Study|Medical monitor terminated par.|0|||
16538301|NCT00428090|40432842|FG001|Overall Study|Medical monitor terminated par.|1|||
16538302|NCT00428090|40432843|FG002|Overall Study|Medical monitor terminated par.|0|||
16538303|NCT00428090|40432844|FG003|Overall Study|Medical monitor terminated par.|0|||
16538304|NCT00428090|40432841|FG000|Overall Study|Mental status of par. was|0|||
16538305|NCT00428090|40432842|FG001|Overall Study|Mental status of par. was|1|||
16103752|NCT01730118|38865585|FG004|Dose Expansion|Inability to return|0|||
16538306|NCT00428090|40432843|FG002|Overall Study|Mental status of par. was|0|||
16538307|NCT00428090|40432844|FG003|Overall Study|Mental status of par. was|0|||
16538308|NCT00428090|40432841|FG000|Overall Study|Worsening of AD|0|||
16538309|NCT00428090|40432842|FG001|Overall Study|Worsening of AD|0|||
16538310|NCT00428090|40432843|FG002|Overall Study|Worsening of AD|1|||
16538311|NCT00428090|40432844|FG003|Overall Study|Worsening of AD|0|||
16538312|NCT00428090|40432841|FG000|Overall Study|Excluded for concerning QTc value|0|||
16538313|NCT00428090|40432842|FG001|Overall Study|Excluded for concerning QTc value|0|||
16538314|NCT00428090|40432843|FG002|Overall Study|Excluded for concerning QTc value|1|||
16538315|NCT00428090|40432844|FG003|Overall Study|Excluded for concerning QTc value|0|||
16538316|NCT00428090|40432841|FG000|Overall Study|Insufficient AD documentation|0|||
16538317|NCT00428090|40432842|FG001|Overall Study|Insufficient AD documentation|0|||
16538318|NCT00428090|40432843|FG002|Overall Study|Insufficient AD documentation|1|||
16538319|NCT00428090|40432844|FG003|Overall Study|Insufficient AD documentation|0|||
16339599|NCT04304508|39730272|FG002|Overall Study|Adverse Event|51|||
16339600|NCT04304508|39730273|FG003|Overall Study|Adverse Event|56|||
16339601|NCT04304508|39730270|FG000|Overall Study|Lost to Follow-up|1|||
16339602|NCT04304508|39730271|FG001|Overall Study|Lost to Follow-up|5|||
16339603|NCT04304508|39730272|FG002|Overall Study|Lost to Follow-up|2|||
16538320|NCT00428090|40432841|FG000|Overall Study|High MMSE scores|0|||
16538321|NCT00428090|40432842|FG001|Overall Study|High MMSE scores|0|||
16538322|NCT00428090|40432843|FG002|Overall Study|High MMSE scores|1|||
16538323|NCT00428090|40432844|FG003|Overall Study|High MMSE scores|0|||
16538324|NCT00428090|40432841|FG000|Overall Study|Deterioration of cognitive status|0|||
16538325|NCT00428090|40432842|FG001|Overall Study|Deterioration of cognitive status|0|||
16538326|NCT00428090|40432843|FG002|Overall Study|Deterioration of cognitive status|1|||
16538327|NCT00428090|40432844|FG003|Overall Study|Deterioration of cognitive status|0|||
16538328|NCT00428090|40432841|FG000|Overall Study|Serious adverse event|0|||
16538329|NCT00428090|40432842|FG001|Overall Study|Serious adverse event|0|||
16538330|NCT00428090|40432843|FG002|Overall Study|Serious adverse event|1|||
16538331|NCT00428090|40432844|FG003|Overall Study|Serious adverse event|0|||
16538332|NCT00428090|40432841|FG000|Overall Study|Excluded for heart insufficiency|0|||
16538333|NCT00428090|40432842|FG001|Overall Study|Excluded for heart insufficiency|0|||
16538334|NCT00428090|40432843|FG002|Overall Study|Excluded for heart insufficiency|1|||
16538335|NCT00428090|40432844|FG003|Overall Study|Excluded for heart insufficiency|0|||
16538336|NCT00428090|40432841|FG000|Overall Study|Raised Creatinine Value|0|||
16538337|NCT00428090|40432842|FG001|Overall Study|Raised Creatinine Value|0|||
16538338|NCT00428090|40432843|FG002|Overall Study|Raised Creatinine Value|0|||
16538339|NCT00428090|40432844|FG003|Overall Study|Raised Creatinine Value|1|||
16538340|NCT00316173|40432848|FG000|Run-in Phase|Adverse Event|1|||
16538341|NCT00316173|40432849|FG001|Run-in Phase|Adverse Event|0|||
16538342|NCT00316173|40432848|FG000|Run-in Phase|Protocol Violation|1|||
16538343|NCT00316173|40432849|FG001|Run-in Phase|Protocol Violation|0|||
16538344|NCT00316173|40432848|FG000|Run-in Phase|Study Follow-up Stopped|5|||
16538345|NCT00316173|40432849|FG001|Run-in Phase|Study Follow-up Stopped|0|||
16538346|NCT00316173|40432848|FG000|Treatment Phase|Adverse Event|0|||
16538347|NCT00316173|40432849|FG001|Treatment Phase|Adverse Event|1|||
16538348|NCT00316173|40432848|FG000|Treatment Phase|Lack of Efficacy|0|||
16538349|NCT00316173|40432849|FG001|Treatment Phase|Lack of Efficacy|3|||
16538350|NCT00316173|40432848|FG000|Treatment Phase|Lost to Follow-up|0|||
16538351|NCT00316173|40432849|FG001|Treatment Phase|Lost to Follow-up|3|||
16538352|NCT00316173|40432848|FG000|Treatment Phase|Withdrawal by Subject|0|||
16538353|NCT00316173|40432849|FG001|Treatment Phase|Withdrawal by Subject|1|||
16538354|NCT00316173|40432848|FG000|Treatment Phase|Study Follow-up Stopped|0|||
16538355|NCT00316173|40432849|FG001|Treatment Phase|Study Follow-up Stopped|34|||
16538356|NCT01123382|40432852|FG000|Overall Study|Withdrawal by Subject|1|||
16538357|NCT01123382|40432853|FG001|Overall Study|Withdrawal by Subject|4|||
16538358|NCT01123382|40432852|FG000|Overall Study|Lost to Follow-up|1|||
16538359|NCT01123382|40432853|FG001|Overall Study|Lost to Follow-up|2|||
16538360|NCT02723864|40432854|FG000|Overall Study|Refused further treatment|1|||
16538361|NCT02723864|40432855|FG001|Overall Study|Refused further treatment|0|||
16538362|NCT02723864|40432856|FG002|Overall Study|Refused further treatment|0|||
16538363|NCT02723864|40432857|FG003|Overall Study|Refused further treatment|0|||
16538364|NCT02723864|40432858|FG004|Overall Study|Refused further treatment|1|||
16538365|NCT02723864|40432859|FG005|Overall Study|Refused further treatment|2|||
16538366|NCT02723864|40432860|FG006|Overall Study|Refused further treatment|0|||
16538367|NCT02723864|40432854|FG000|Overall Study|Exceed treatment hold time|0|||
16538368|NCT02723864|40432855|FG001|Overall Study|Exceed treatment hold time|1|||
16538369|NCT02723864|40432856|FG002|Overall Study|Exceed treatment hold time|0|||
16538370|NCT02723864|40432857|FG003|Overall Study|Exceed treatment hold time|0|||
16538371|NCT02723864|40432858|FG004|Overall Study|Exceed treatment hold time|0|||
16538372|NCT02723864|40432859|FG005|Overall Study|Exceed treatment hold time|0|||
16538373|NCT02723864|40432860|FG006|Overall Study|Exceed treatment hold time|0|||
16538374|NCT02723864|40432854|FG000|Overall Study|Clinical progression|0|||
16538375|NCT02723864|40432855|FG001|Overall Study|Clinical progression|0|||
16538376|NCT02723864|40432856|FG002|Overall Study|Clinical progression|1|||
16538377|NCT02723864|40432857|FG003|Overall Study|Clinical progression|0|||
16103753|NCT01730118|38865586|FG005|Dose Expansion|Inability to return|1|||
16538378|NCT02723864|40432858|FG004|Overall Study|Clinical progression|0|||
16538379|NCT02723864|40432859|FG005|Overall Study|Clinical progression|3|||
16538380|NCT02723864|40432860|FG006|Overall Study|Clinical progression|1|||
16538381|NCT02723864|40432854|FG000|Overall Study|Physician Decision|0|||
16217139|NCT00994890|39275877|FG002|Overall Study|Lost to Follow-up|3|||
16339604|NCT04304508|39730273|FG003|Overall Study|Lost to Follow-up|3|||
16339605|NCT00055497|39730277|FG000|Overall Study|Adverse Event|1|||
16339606|NCT00055497|39730278|FG001|Overall Study|Adverse Event|1|||
16339607|NCT00055497|39730279|FG002|Overall Study|Adverse Event|1|||
16339608|NCT00055497|39730280|FG003|Overall Study|Adverse Event|28|||
16339609|NCT00055497|39730277|FG000|Overall Study|Withdrawal by Subject|3|||
16339610|NCT00055497|39730278|FG001|Overall Study|Withdrawal by Subject|1|||
16339611|NCT00055497|39730279|FG002|Overall Study|Withdrawal by Subject|1|||
16339612|NCT00055497|39730280|FG003|Overall Study|Withdrawal by Subject|15|||
16339613|NCT00055497|39730277|FG000|Overall Study|Lost to Follow-up|0|||
16339614|NCT00055497|39730278|FG001|Overall Study|Lost to Follow-up|1|||
16339615|NCT00055497|39730279|FG002|Overall Study|Lost to Follow-up|0|||
16339616|NCT00055497|39730280|FG003|Overall Study|Lost to Follow-up|5|||
16339617|NCT00055497|39730277|FG000|Overall Study|Protocol Violation|0|||
16339618|NCT00055497|39730278|FG001|Overall Study|Protocol Violation|0|||
16339619|NCT00055497|39730279|FG002|Overall Study|Protocol Violation|0|||
16339620|NCT00055497|39730280|FG003|Overall Study|Protocol Violation|3|||
16339621|NCT00055497|39730277|FG000|Overall Study|Lack of Efficacy|1|||
16339622|NCT00055497|39730278|FG001|Overall Study|Lack of Efficacy|0|||
16339623|NCT00055497|39730279|FG002|Overall Study|Lack of Efficacy|0|||
16339624|NCT00055497|39730280|FG003|Overall Study|Lack of Efficacy|27|||
16339625|NCT00055497|39730277|FG000|Overall Study|Administrative Reasons|0|||
16339626|NCT00055497|39730278|FG001|Overall Study|Administrative Reasons|0|||
16339627|NCT00055497|39730279|FG002|Overall Study|Administrative Reasons|0|||
16339628|NCT00055497|39730280|FG003|Overall Study|Administrative Reasons|1|||
16339629|NCT00055497|39730277|FG000|Overall Study|Other|0|||
16339630|NCT00055497|39730278|FG001|Overall Study|Other|0|||
16339631|NCT00055497|39730279|FG002|Overall Study|Other|0|||
16339632|NCT00055497|39730280|FG003|Overall Study|Other|11|||
16339633|NCT00298363|39730283|FG000|Overall Study|Lost to Follow-up|0|||
16339634|NCT00298363|39730284|FG001|Overall Study|Lost to Follow-up|0|||
16339635|NCT00298363|39730285|FG002|Overall Study|Lost to Follow-up|1|||
16339636|NCT00298363|39730283|FG000|Overall Study|Physician Decision|4|||
16339637|NCT00298363|39730284|FG001|Overall Study|Physician Decision|1|||
16339638|NCT00298363|39730285|FG002|Overall Study|Physician Decision|0|||
16339639|NCT00298363|39730283|FG000|Overall Study|Protocol Violation|1|||
16339640|NCT00298363|39730284|FG001|Overall Study|Protocol Violation|1|||
16339641|NCT00298363|39730285|FG002|Overall Study|Protocol Violation|0|||
16339642|NCT00298363|39730283|FG000|Overall Study|Withdrawal by Subject|5|||
16339643|NCT00298363|39730284|FG001|Overall Study|Withdrawal by Subject|1|||
16339644|NCT00298363|39730285|FG002|Overall Study|Withdrawal by Subject|3|||
16339645|NCT00298363|39730283|FG000|Overall Study|Adverse Event|5|||
16339646|NCT00298363|39730284|FG001|Overall Study|Adverse Event|2|||
16339647|NCT00298363|39730285|FG002|Overall Study|Adverse Event|2|||
16339648|NCT00298363|39730283|FG000|Overall Study|Lack of Efficacy|2|||
16339649|NCT00298363|39730284|FG001|Overall Study|Lack of Efficacy|3|||
16339650|NCT00298363|39730285|FG002|Overall Study|Lack of Efficacy|0|||
16339651|NCT01483599|39730289|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
16339652|NCT01483599|39730290|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16217140|NCT00994890|39275875|FG000|Overall Study|No longer willing to participate|8|||
16339653|NCT01483599|39730291|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16339654|NCT01483599|39730292|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
16339655|NCT01483599|39730293|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
16339656|NCT01483599|39730294|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
16339657|NCT01483599|39730295|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
16538382|NCT02723864|40432855|FG001|Overall Study|Physician Decision|0|||
16538383|NCT02723864|40432856|FG002|Overall Study|Physician Decision|0|||
16538384|NCT02723864|40432857|FG003|Overall Study|Physician Decision|0|||
16538385|NCT02723864|40432858|FG004|Overall Study|Physician Decision|0|||
16538386|NCT02723864|40432859|FG005|Overall Study|Physician Decision|0|||
16538387|NCT02723864|40432860|FG006|Overall Study|Physician Decision|1|||
16538388|NCT02723864|40432854|FG000|Overall Study|Changes in patient condition|0|||
16538389|NCT02723864|40432855|FG001|Overall Study|Changes in patient condition|0|||
16538390|NCT02723864|40432856|FG002|Overall Study|Changes in patient condition|0|||
16538391|NCT02723864|40432857|FG003|Overall Study|Changes in patient condition|0|||
16538392|NCT02723864|40432858|FG004|Overall Study|Changes in patient condition|0|||
16538393|NCT02723864|40432859|FG005|Overall Study|Changes in patient condition|1|||
16538394|NCT02723864|40432860|FG006|Overall Study|Changes in patient condition|0|||
16103754|NCT01730118|38865587|FG006|Dose Expansion|Inability to return|0|||
16103755|NCT01730118|38865581|FG000|Dose Expansion|Physician Decision|0|||
16103756|NCT01730118|38865582|FG001|Dose Expansion|Physician Decision|0|||
16103757|NCT01730118|38865583|FG002|Dose Expansion|Physician Decision|0|||
16103758|NCT01730118|38865584|FG003|Dose Expansion|Physician Decision|0|||
16103759|NCT01730118|38865585|FG004|Dose Expansion|Physician Decision|0|||
16103760|NCT01730118|38865586|FG005|Dose Expansion|Physician Decision|1|||
16103761|NCT01730118|38865587|FG006|Dose Expansion|Physician Decision|0|||
16103762|NCT03723915|38865588|FG000|Screening|Failed to meet screening requirements.|2|||
16103763|NCT03723915|38865588|FG000|On Treatment|Failed to meet treatment requirements|2|||
16103764|NCT03840200|38865589|FG000|Overall Study|Death|6|||
16103765|NCT03840200|38865590|FG001|Overall Study|Death|3|||
16103766|NCT03840200|38865591|FG002|Overall Study|Death|6|||
16103767|NCT03840200|38865592|FG003|Overall Study|Death|10|||
16103768|NCT03840200|38865589|FG000|Overall Study|Reason Not Specified|2|||
16103769|NCT03840200|38865590|FG001|Overall Study|Reason Not Specified|2|||
16103770|NCT03840200|38865591|FG002|Overall Study|Reason Not Specified|1|||
16103771|NCT03840200|38865592|FG003|Overall Study|Reason Not Specified|15|||
16103772|NCT03840200|38865589|FG000|Overall Study|Physician Decision|0|||
16103773|NCT03840200|38865590|FG001|Overall Study|Physician Decision|0|||
16103774|NCT03840200|38865591|FG002|Overall Study|Physician Decision|0|||
16103775|NCT03840200|38865592|FG003|Overall Study|Physician Decision|2|||
16103776|NCT03840200|38865589|FG000|Overall Study|Progressive Disease|0|||
16103777|NCT03840200|38865590|FG001|Overall Study|Progressive Disease|0|||
16103778|NCT03840200|38865591|FG002|Overall Study|Progressive Disease|0|||
16103779|NCT03840200|38865592|FG003|Overall Study|Progressive Disease|1|||
16103780|NCT03840200|38865589|FG000|Overall Study|Withdrawal by Subject|0|||
16103781|NCT03840200|38865590|FG001|Overall Study|Withdrawal by Subject|1|||
16103782|NCT03840200|38865591|FG002|Overall Study|Withdrawal by Subject|0|||
16103783|NCT03840200|38865592|FG003|Overall Study|Withdrawal by Subject|2|||
16103784|NCT02427958|38865593|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
16103785|NCT02427958|38865593|FG000|Overall Study|Lost to Follow-up|6|||
16339658|NCT01483599|39730296|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16339659|NCT01483599|39730297|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16339660|NCT01483599|39730298|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16339661|NCT01483599|39730299|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16339662|NCT01483599|39730300|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16339663|NCT01483599|39730301|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16339664|NCT01483599|39730302|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
16339665|NCT01483599|39730289|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339666|NCT01483599|39730290|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
16339667|NCT01483599|39730291|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339668|NCT01483599|39730292|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
16339669|NCT01483599|39730293|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339670|NCT01483599|39730294|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339671|NCT01483599|39730295|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
16103786|NCT02427958|38865593|FG000|Overall Study|Withdrawal by Subject|14|||
16103787|NCT02427958|38865593|FG000|Overall Study|Lack of Efficacy|1|||
16103788|NCT00678899|38865596|FG000|Overall Study|Adverse Event|1|||
16103789|NCT01209286|38868491|FG000|Overall Study|Adverse Event|4|||
16103790|NCT01209286|38868492|FG001|Overall Study|Adverse Event|3|||
16103791|NCT01209286|38868493|FG002|Overall Study|Adverse Event|1|||
16103792|NCT01209286|38868491|FG000|Overall Study|Hematological Relapse After Remission|0|||
16103793|NCT01209286|38868492|FG001|Overall Study|Hematological Relapse After Remission|1|||
16103794|NCT01209286|38868493|FG002|Overall Study|Hematological Relapse After Remission|1|||
16103795|NCT01209286|38868491|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
16103796|NCT01209286|38868492|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
16103797|NCT01209286|38868493|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
16103798|NCT01209286|38868491|FG000|Overall Study|Physician Decision|0|||
16103799|NCT01209286|38868492|FG001|Overall Study|Physician Decision|2|||
16103800|NCT01209286|38868493|FG002|Overall Study|Physician Decision|0|||
16103801|NCT01209286|38868491|FG000|Overall Study|Other|0|||
16103802|NCT01209286|38868492|FG001|Overall Study|Other|1|||
16103803|NCT01209286|38868493|FG002|Overall Study|Other|0|||
16103804|NCT02973477|38868494|FG000|First Intervention|Lost to Follow-up|0|||
16103805|NCT02973477|38868495|FG001|First Intervention|Lost to Follow-up|2|||
16103806|NCT02973477|38868494|FG000|Washout|Withdrawal by Subject|1|||
16103807|NCT02973477|38868495|FG001|Washout|Withdrawal by Subject|0|||
16103808|NCT02973477|38868494|FG000|Second Intervention|Lost to Follow-up|1|||
16103809|NCT02973477|38868495|FG001|Second Intervention|Lost to Follow-up|0|||
16103810|NCT03036150|38868496|FG000|Overall Study|Withdrawal by Subject|8|||
16103811|NCT03036150|38868497|FG001|Overall Study|Withdrawal by Subject|3|||
16103812|NCT03036150|38868496|FG000|Overall Study|Lost to Follow-up|2|||
16103813|NCT03036150|38868497|FG001|Overall Study|Lost to Follow-up|2|||
16103814|NCT02845375|38868498|FG000|Overall Study|upper airway obstruction|1|||
16103815|NCT02845375|38868499|FG001|Overall Study|upper airway obstruction|2|||
16103816|NCT02845375|38868500|FG002|Overall Study|upper airway obstruction|1|||
16103817|NCT02165397|38868501|FG000|Overall Study|Death|7|||
16103818|NCT02165397|38868502|FG001|Overall Study|Death|10|||
16103819|NCT02165397|38868503|FG002|Overall Study|Death|8|||
16103820|NCT02165397|38868501|FG000|Overall Study|Lost to Follow-up|1|||
16103821|NCT02165397|38868502|FG001|Overall Study|Lost to Follow-up|3|||
16103822|NCT02165397|38868503|FG002|Overall Study|Lost to Follow-up|0|||
16103823|NCT02165397|38868501|FG000|Overall Study|Withdrawal by Subject|6|||
16103824|NCT02165397|38868502|FG001|Overall Study|Withdrawal by Subject|6|||
16538395|NCT02723864|40432854|FG000|Overall Study|Patient choice|0|||
16538396|NCT02723864|40432855|FG001|Overall Study|Patient choice|0|||
16103825|NCT02165397|38868503|FG002|Overall Study|Withdrawal by Subject|1|||
16103826|NCT02165397|38868501|FG000|Overall Study|Other, Not Specified|0|||
16103827|NCT02165397|38868502|FG001|Overall Study|Other, Not Specified|0|||
16103828|NCT02165397|38868503|FG002|Overall Study|Other, Not Specified|1|||
16103829|NCT01121185|38868504|FG000|Overall Study|Not infused|0|||
16103830|NCT01121185|38868505|FG001|Overall Study|Not infused|1|||
16103831|NCT01121185|38868504|FG000|Overall Study|Not transplanted|1|||
16103832|NCT01121185|38868505|FG001|Overall Study|Not transplanted|0|||
16103833|NCT01182181|38868506|FG000|First Intervention|Adverse Event|1|||
16103834|NCT01182181|38868507|FG001|First Intervention|Adverse Event|0|||
16103835|NCT01182181|38868506|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
16103836|NCT01182181|38868507|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
16103837|NCT04052997|38868508|FG000|Overall Study|Withdrawal by Subject|17|||
16103838|NCT04052997|38868508|FG000|Overall Study|Physician Decision|50|||
16103839|NCT04052997|38868508|FG000|Overall Study|Death|43|||
16103840|NCT04052997|38868508|FG000|Overall Study|Lost to Follow-up|5|||
16103841|NCT04052997|38868508|FG000|Overall Study|Progression of Disease|1|||
16103842|NCT03294941|38868509|FG000|Overall Study|Withdrawal by Subject|0|||
16406407|NCT00320255|39969797|FG005|Overall Study|Poor compliance/noncompliance|0|||
16406408|NCT00320255|39969792|FG000|Overall Study|No longer meets study criteria|0|||
16406409|NCT00320255|39969793|FG001|Overall Study|No longer meets study criteria|0|||
16538397|NCT02723864|40432856|FG002|Overall Study|Patient choice|0|||
16538398|NCT02723864|40432857|FG003|Overall Study|Patient choice|0|||
16538399|NCT02723864|40432858|FG004|Overall Study|Patient choice|0|||
16538400|NCT02723864|40432859|FG005|Overall Study|Patient choice|1|||
16538401|NCT02723864|40432860|FG006|Overall Study|Patient choice|0|||
16103843|NCT03294941|38868510|FG001|Overall Study|Withdrawal by Subject|2|||
16103844|NCT03132753|38868511|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
16103845|NCT03132753|38868512|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
16103846|NCT03132753|38868511|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
16103847|NCT03132753|38868512|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
16406410|NCT00320255|39969794|FG002|Overall Study|No longer meets study criteria|0|||
16538402|NCT02723864|40432854|FG000|Overall Study|Adverse Event|0|||
16538403|NCT02723864|40432855|FG001|Overall Study|Adverse Event|0|||
16103848|NCT01431950|38868513|FG000|Overall Study|Study Site Closed/Terminated|7|||
16538404|NCT02723864|40432856|FG002|Overall Study|Adverse Event|0|||
16406411|NCT00320255|39969795|FG003|Overall Study|No longer meets study criteria|1|||
16406412|NCT00320255|39969796|FG004|Overall Study|No longer meets study criteria|0|||
16406413|NCT00320255|39969797|FG005|Overall Study|No longer meets study criteria|0|||
16406414|NCT00320255|39969792|FG000|Overall Study|Other|3|||
16406415|NCT00320255|39969793|FG001|Overall Study|Other|2|||
16406416|NCT00320255|39969794|FG002|Overall Study|Other|1|||
16406417|NCT00320255|39969795|FG003|Overall Study|Other|0|||
16217141|NCT00994890|39275876|FG001|Overall Study|No longer willing to participate|5|||
16217142|NCT00994890|39275877|FG002|Overall Study|No longer willing to participate|13|||
16217143|NCT00994890|39275875|FG000|Overall Study|Protocol Violation|2|||
16217144|NCT00994890|39275876|FG001|Overall Study|Protocol Violation|4|||
16217145|NCT00994890|39275877|FG002|Overall Study|Protocol Violation|0|||
16217146|NCT00994890|39275875|FG000|Overall Study|Study terminated by sponsor|199|||
16217147|NCT00994890|39275876|FG001|Overall Study|Study terminated by sponsor|201|||
16217148|NCT00994890|39275877|FG002|Overall Study|Study terminated by sponsor|197|||
16217149|NCT00994890|39275875|FG000|Overall Study|Randomized, but not treated|1|||
16217150|NCT00994890|39275876|FG001|Overall Study|Randomized, but not treated|0|||
16217151|NCT00994890|39275877|FG002|Overall Study|Randomized, but not treated|0|||
16217152|NCT00994890|39275875|FG000|Overall Study|Other|2|||
16217153|NCT00994890|39275876|FG001|Overall Study|Other|2|||
16217154|NCT00994890|39275877|FG002|Overall Study|Other|1|||
16217155|NCT02254304|39275878|FG000|Overall Study|Adverse Event|2|||
16217156|NCT02254304|39275879|FG001|Overall Study|Adverse Event|1|||
16217157|NCT02254304|39275878|FG000|Overall Study|Lost to Follow-up|2|||
16217158|NCT02254304|39275879|FG001|Overall Study|Lost to Follow-up|2|||
16217159|NCT02254304|39275878|FG000|Overall Study|Protocol Violation|1|||
16217160|NCT02254304|39275879|FG001|Overall Study|Protocol Violation|0|||
16217161|NCT02254304|39275878|FG000|Overall Study|Withdrawal by Subject|3|||
16103849|NCT01431950|38868514|FG001|Overall Study|Study Site Closed/Terminated|3|||
16103850|NCT01431950|38868513|FG000|Overall Study|Withdrawal by Subject|4|||
16103851|NCT01431950|38868514|FG001|Overall Study|Withdrawal by Subject|3|||
16103852|NCT01431950|38868513|FG000|Overall Study|Protocol Violation|2|||
16103853|NCT01431950|38868514|FG001|Overall Study|Protocol Violation|3|||
16103854|NCT01431950|38868513|FG000|Overall Study|Adverse Event|2|||
16103855|NCT01431950|38868514|FG001|Overall Study|Adverse Event|2|||
16103856|NCT01431950|38868513|FG000|Overall Study|Physician Decision|2|||
16103857|NCT01431950|38868514|FG001|Overall Study|Physician Decision|1|||
16103858|NCT01431950|38868513|FG000|Overall Study|Lack of Efficacy|2|||
16103859|NCT01431950|38868514|FG001|Overall Study|Lack of Efficacy|1|||
16103860|NCT01431950|38868513|FG000|Overall Study|Lost to Follow-up|0|||
16103861|NCT01431950|38868514|FG001|Overall Study|Lost to Follow-up|1|||
16103862|NCT01431950|38868513|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16103863|NCT01431950|38868514|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16103864|NCT01475370|38868518|FG000|Overall Study|Exacerbation of primary disease|2|||
16103865|NCT01475370|38868519|FG001|Overall Study|Exacerbation of primary disease|2|||
16103866|NCT01475370|38868520|FG002|Overall Study|Exacerbation of primary disease|2|||
16103867|NCT01475370|38868518|FG000|Overall Study|Study drug administration difficult|0|||
16103868|NCT01475370|38868519|FG001|Overall Study|Study drug administration difficult|1|||
16103869|NCT01475370|38868520|FG002|Overall Study|Study drug administration difficult|1|||
16103870|NCT01475370|38868518|FG000|Overall Study|Other than specified|1|||
16103871|NCT01475370|38868519|FG001|Overall Study|Other than specified|0|||
16103872|NCT01475370|38868520|FG002|Overall Study|Other than specified|0|||
16103873|NCT02109107|38868521|FG000|Overall Study|Lost to Follow-up|2|||
16217162|NCT02254304|39275879|FG001|Overall Study|Withdrawal by Subject|0|||
16217163|NCT02254304|39275878|FG000|Overall Study|Injection site pain and Injection fear|1|||
16217164|NCT02254304|39275879|FG001|Overall Study|Injection site pain and Injection fear|0|||
16406418|NCT00320255|39969796|FG004|Overall Study|Other|0|||
16103874|NCT00690378|38868522|FG000|Overall Study|Adverse Event|1|||
16103875|NCT00690378|38868523|FG001|Overall Study|Adverse Event|0|||
16103876|NCT00690378|38868522|FG000|Overall Study|Withdrawal by Subject|2|||
16103877|NCT00690378|38868523|FG001|Overall Study|Withdrawal by Subject|0|||
16103878|NCT00690378|38868522|FG000|Overall Study|Protocol Violation|1|||
16103879|NCT00690378|38868523|FG001|Overall Study|Protocol Violation|0|||
16103880|NCT00690378|38868522|FG000|Overall Study|Lost to Follow-up|2|||
16103881|NCT00690378|38868523|FG001|Overall Study|Lost to Follow-up|3|||
16339672|NCT01483599|39730296|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339673|NCT01483599|39730297|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339674|NCT01483599|39730298|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339675|NCT01483599|39730299|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339676|NCT01483599|39730300|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339677|NCT01483599|39730301|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339678|NCT01483599|39730302|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
16339679|NCT01483599|39730289|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
16339680|NCT01483599|39730290|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339681|NCT01483599|39730291|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339682|NCT01483599|39730292|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339683|NCT01483599|39730293|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339684|NCT01483599|39730294|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339685|NCT01483599|39730295|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339686|NCT01483599|39730296|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339687|NCT01483599|39730297|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339688|NCT01483599|39730298|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339689|NCT01483599|39730299|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339690|NCT01483599|39730300|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339691|NCT01483599|39730301|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339692|NCT01483599|39730302|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
16339693|NCT01483599|39730289|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
16339694|NCT01483599|39730290|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
16339695|NCT01483599|39730291|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
16339696|NCT01483599|39730292|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
16339697|NCT01483599|39730293|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
16339698|NCT01483599|39730294|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
16339699|NCT01483599|39730295|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
16339700|NCT01483599|39730296|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
16339701|NCT01483599|39730297|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
16103882|NCT00690378|38868522|FG000|Overall Study|Did not meet inc/exc criteria|13|||
16103883|NCT00690378|38868523|FG001|Overall Study|Did not meet inc/exc criteria|11|||
16339702|NCT01483599|39730298|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
16339703|NCT01483599|39730299|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
16103884|NCT00690378|38868522|FG000|Overall Study|Social problem|1|||
16103885|NCT00690378|38868523|FG001|Overall Study|Social problem|0|||
16339704|NCT01483599|39730300|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
16339705|NCT01483599|39730301|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
16339706|NCT01483599|39730302|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
16339707|NCT01483599|39730289|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
16339708|NCT01483599|39730290|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
16103886|NCT02257918|38868524|FG000|Overall Study|Lost to Follow-up|4|||
16339709|NCT01483599|39730291|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
16339710|NCT01483599|39730292|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
16406419|NCT00320255|39969797|FG005|Overall Study|Other|0|||
16103887|NCT02257918|38868525|FG001|Overall Study|Lost to Follow-up|1|||
16339711|NCT01483599|39730293|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
16339712|NCT01483599|39730294|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
16339713|NCT01483599|39730295|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
16339714|NCT01483599|39730296|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
16339715|NCT01483599|39730297|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
16339716|NCT01483599|39730298|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
16339717|NCT01483599|39730299|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
16406420|NCT03622112|39969798|FG000|Overall Study|Withdrawal by Subject|6|||
16406421|NCT03622112|39969799|FG001|Overall Study|Withdrawal by Subject|2|||
16406422|NCT03622112|39969800|FG002|Overall Study|Withdrawal by Subject|4|||
16406423|NCT03622112|39969801|FG003|Overall Study|Withdrawal by Subject|2|||
16406424|NCT03622112|39969802|FG004|Overall Study|Withdrawal by Subject|1|||
16406425|NCT03622112|39969803|FG005|Overall Study|Withdrawal by Subject|2|||
16406426|NCT03622112|39969804|FG006|Overall Study|Withdrawal by Subject|2|||
16406427|NCT03622112|39969798|FG000|Overall Study|Death|0|||
16406428|NCT03622112|39969799|FG001|Overall Study|Death|0|||
16406429|NCT03622112|39969800|FG002|Overall Study|Death|0|||
16406430|NCT03622112|39969801|FG003|Overall Study|Death|1|||
16406431|NCT03622112|39969802|FG004|Overall Study|Death|0|||
16406432|NCT03622112|39969803|FG005|Overall Study|Death|0|||
16406433|NCT03622112|39969804|FG006|Overall Study|Death|0|||
16406434|NCT03622112|39969798|FG000|Overall Study|Lost to Follow-up|1|||
16406435|NCT03622112|39969799|FG001|Overall Study|Lost to Follow-up|1|||
16406436|NCT03622112|39969800|FG002|Overall Study|Lost to Follow-up|0|||
16406437|NCT03622112|39969801|FG003|Overall Study|Lost to Follow-up|0|||
16406438|NCT03622112|39969802|FG004|Overall Study|Lost to Follow-up|0|||
16406439|NCT03622112|39969803|FG005|Overall Study|Lost to Follow-up|0|||
16103888|NCT02257918|38868526|FG002|Overall Study|Lost to Follow-up|0|||
16103889|NCT02257918|38868524|FG000|Overall Study|Withdrawal by Subject|0|||
16103890|NCT02257918|38868525|FG001|Overall Study|Withdrawal by Subject|0|||
16103891|NCT02257918|38868526|FG002|Overall Study|Withdrawal by Subject|1|||
16103892|NCT02257918|38868524|FG000|Overall Study|Pregnancy|0|||
16103893|NCT02257918|38868525|FG001|Overall Study|Pregnancy|0|||
16103894|NCT02257918|38868526|FG002|Overall Study|Pregnancy|1|||
16103895|NCT03463577|38868531|FG000|Overall Study|Lost to Follow-up|238|||
16103896|NCT03463577|38868532|FG001|Overall Study|Lost to Follow-up|435|||
16103897|NCT03463577|38868533|FG002|Overall Study|Lost to Follow-up|0|||
16103898|NCT03463577|38868534|FG003|Overall Study|Lost to Follow-up|0|||
16103899|NCT03463577|38868535|FG004|Overall Study|Lost to Follow-up|0|||
16103900|NCT03463577|38868536|FG005|Overall Study|Lost to Follow-up|0|||
16103901|NCT03463577|38868531|FG000|Overall Study|With unknown pregnancy outcome|0|||
16103902|NCT03463577|38868532|FG001|Overall Study|With unknown pregnancy outcome|5|||
16103903|NCT03463577|38868533|FG002|Overall Study|With unknown pregnancy outcome|0|||
16103904|NCT03463577|38868534|FG003|Overall Study|With unknown pregnancy outcome|0|||
16103905|NCT03463577|38868535|FG004|Overall Study|With unknown pregnancy outcome|0|||
16103906|NCT03463577|38868536|FG005|Overall Study|With unknown pregnancy outcome|0|||
16103907|NCT03463577|38868531|FG000|Overall Study|Maternal death|2|||
16103908|NCT03463577|38868532|FG001|Overall Study|Maternal death|0|||
16103909|NCT03463577|38868533|FG002|Overall Study|Maternal death|0|||
16103910|NCT03463577|38868534|FG003|Overall Study|Maternal death|0|||
16103911|NCT03463577|38868535|FG004|Overall Study|Maternal death|0|||
16103912|NCT03463577|38868536|FG005|Overall Study|Maternal death|0|||
16103913|NCT03463577|38868531|FG000|Overall Study|Neonatal death|0|||
16103914|NCT03463577|38868532|FG001|Overall Study|Neonatal death|0|||
16103915|NCT03463577|38868533|FG002|Overall Study|Neonatal death|0|||
16103916|NCT03463577|38868534|FG003|Overall Study|Neonatal death|15|||
16103917|NCT03463577|38868535|FG004|Overall Study|Neonatal death|17|||
16103918|NCT03463577|38868536|FG005|Overall Study|Neonatal death|0|||
16103919|NCT06247488|38868537|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
16538405|NCT02723864|40432857|FG003|Overall Study|Adverse Event|0|||
16538406|NCT02723864|40432858|FG004|Overall Study|Adverse Event|0|||
16538407|NCT02723864|40432859|FG005|Overall Study|Adverse Event|1|||
16538408|NCT02723864|40432860|FG006|Overall Study|Adverse Event|0|||
16538409|NCT02723864|40432854|FG000|Overall Study|Started new treatment|0|||
16538410|NCT02723864|40432855|FG001|Overall Study|Started new treatment|0|||
16538411|NCT02723864|40432856|FG002|Overall Study|Started new treatment|0|||
16538412|NCT02723864|40432857|FG003|Overall Study|Started new treatment|0|||
16538413|NCT02723864|40432858|FG004|Overall Study|Started new treatment|0|||
16538414|NCT02723864|40432859|FG005|Overall Study|Started new treatment|1|||
16538415|NCT02723864|40432860|FG006|Overall Study|Started new treatment|0|||
16538416|NCT02723864|40432854|FG000|Overall Study|Switched to alternative treatment|0|||
16217165|NCT02254304|39275878|FG000|Overall Study|Personal causes|4|||
16217166|NCT02254304|39275879|FG001|Overall Study|Personal causes|1|||
16406440|NCT03622112|39969804|FG006|Overall Study|Lost to Follow-up|0|||
16406441|NCT03622112|39969798|FG000|Overall Study|Study-specific withdrawal criteria|10|||
16406442|NCT03622112|39969799|FG001|Overall Study|Study-specific withdrawal criteria|8|||
16538417|NCT02723864|40432855|FG001|Overall Study|Switched to alternative treatment|0|||
16538418|NCT02723864|40432856|FG002|Overall Study|Switched to alternative treatment|0|||
16339718|NCT01483599|39730300|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
16339719|NCT01483599|39730301|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
16339720|NCT01483599|39730302|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
16339721|NCT01483599|39730289|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16339722|NCT01483599|39730290|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16339723|NCT01483599|39730291|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16339724|NCT01483599|39730292|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16339725|NCT01483599|39730293|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16339726|NCT01483599|39730294|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16339727|NCT01483599|39730295|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16339728|NCT01483599|39730296|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
16339729|NCT01483599|39730297|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
16339730|NCT01483599|39730298|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16339731|NCT01483599|39730299|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16339732|NCT01483599|39730300|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
16339733|NCT01483599|39730301|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
16339734|NCT01483599|39730302|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
16339735|NCT01483599|39730289|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339736|NCT01483599|39730290|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339737|NCT01483599|39730291|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339738|NCT01483599|39730292|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339739|NCT01483599|39730293|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339740|NCT01483599|39730294|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339741|NCT01483599|39730295|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339742|NCT01483599|39730296|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339743|NCT01483599|39730297|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
16339744|NCT01483599|39730298|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339745|NCT01483599|39730299|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339746|NCT01483599|39730300|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
16339747|NCT01483599|39730301|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
16339748|NCT01483599|39730302|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
16339749|NCT01483599|39730289|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339750|NCT01483599|39730290|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339751|NCT01483599|39730291|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339752|NCT01483599|39730292|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339753|NCT01483599|39730293|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339754|NCT01483599|39730294|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339755|NCT01483599|39730295|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339756|NCT01483599|39730296|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339757|NCT01483599|39730297|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
16339758|NCT01483599|39730298|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339759|NCT01483599|39730299|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
16339760|NCT01483599|39730300|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339761|NCT01483599|39730301|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
16339762|NCT01483599|39730302|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
16339763|NCT01483599|39730289|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339764|NCT01483599|39730290|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339765|NCT01483599|39730291|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339766|NCT01483599|39730292|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339767|NCT01483599|39730293|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339768|NCT01483599|39730294|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339769|NCT01483599|39730295|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339770|NCT01483599|39730296|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339771|NCT01483599|39730297|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
16339772|NCT01483599|39730298|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339773|NCT01483599|39730299|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339774|NCT01483599|39730300|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
16339775|NCT01483599|39730301|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
16339776|NCT01483599|39730302|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
16339777|NCT01483599|39730289|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
16339778|NCT01483599|39730290|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
16339779|NCT01483599|39730291|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
16339780|NCT01483599|39730292|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
16339781|NCT01483599|39730293|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
16339782|NCT01483599|39730294|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
16339783|NCT01483599|39730295|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
16339784|NCT01483599|39730296|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
16339785|NCT01483599|39730297|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
16339786|NCT01483599|39730298|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
16339787|NCT01483599|39730299|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
16339788|NCT01483599|39730300|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
16339789|NCT01483599|39730301|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
16339790|NCT01483599|39730302|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
16339791|NCT03747302|39730303|FG000|Overall Study|Withdrawal by Subject|1|||
16339792|NCT03747302|39730304|FG001|Overall Study|Withdrawal by Subject|2|||
16339793|NCT01386944|39730306|FG000|Overall Study|Adverse Event|26|||
16339794|NCT01386944|39730306|FG000|Overall Study|Lack of Efficacy|14|||
16339795|NCT01386944|39730306|FG000|Overall Study|Lost to Follow-up|8|||
16339796|NCT01386944|39730306|FG000|Overall Study|Unspecified reason|8|||
16339797|NCT00849290|39730307|FG000|Overall Study|Adverse Event|3|||
16339798|NCT00849290|39730307|FG000|Overall Study|Death|14|||
16339799|NCT00849290|39730307|FG000|Overall Study|Withdrawal by Subject|11|||
16339800|NCT00849290|39730307|FG000|Overall Study|Lost to Follow-up|2|||
16339801|NCT00849290|39730307|FG000|Overall Study|Protocol Violation|5|||
16339802|NCT00849290|39730307|FG000|Overall Study|Disease Progression|20|||
16339803|NCT02178358|39730308|FG000|Overall Study|Withdrawal by Subject|0|||
16339804|NCT02178358|39730309|FG001|Overall Study|Withdrawal by Subject|2|||
16339805|NCT02178358|39730310|FG002|Overall Study|Withdrawal by Subject|2|||
16339806|NCT02178358|39730308|FG000|Overall Study|Lost to Follow-up|1|||
16339807|NCT02178358|39730309|FG001|Overall Study|Lost to Follow-up|0|||
16339808|NCT02178358|39730310|FG002|Overall Study|Lost to Follow-up|0|||
16538419|NCT02723864|40432857|FG003|Overall Study|Switched to alternative treatment|0|||
16538420|NCT02723864|40432858|FG004|Overall Study|Switched to alternative treatment|0|||
16538421|NCT02723864|40432859|FG005|Overall Study|Switched to alternative treatment|1|||
16538422|NCT02723864|40432860|FG006|Overall Study|Switched to alternative treatment|0|||
16538423|NCT02723864|40432854|FG000|Overall Study|Late determination of ineligibility|0|||
16538424|NCT02723864|40432855|FG001|Overall Study|Late determination of ineligibility|0|||
16538425|NCT02723864|40432856|FG002|Overall Study|Late determination of ineligibility|0|||
16538426|NCT02723864|40432857|FG003|Overall Study|Late determination of ineligibility|0|||
16538427|NCT02723864|40432858|FG004|Overall Study|Late determination of ineligibility|0|||
16538428|NCT02723864|40432859|FG005|Overall Study|Late determination of ineligibility|1|||
16538429|NCT02723864|40432860|FG006|Overall Study|Late determination of ineligibility|0|||
16538430|NCT02481310|40432861|FG000|Follow up|Still in follow up|0|||
16538431|NCT02481310|40432862|FG001|Follow up|Still in follow up|3|||
16538432|NCT02481310|40432863|FG002|Follow up|Still in follow up|0|||
16538433|NCT00089141|40432864|FG000|Overall Study|Termination of trial|18|||
16538434|NCT00089141|40432865|FG001|Overall Study|Termination of trial|24|||
16538435|NCT02822222|40432866|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
16538436|NCT02822222|40432867|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
16538437|NCT01410474|40432870|FG000|Overall Study|Withdrawal by Subject|0|||
16538438|NCT01410474|40432871|FG001|Overall Study|Withdrawal by Subject|1|||
16538439|NCT00295022|40432875|FG000|Overall Study|Adverse Event|1|||
16538440|NCT00295022|40432876|FG001|Overall Study|Adverse Event|1|||
16538441|NCT00295022|40432877|FG002|Overall Study|Adverse Event|2|||
16538442|NCT00295022|40432875|FG000|Overall Study|Lost to Follow-up|0|||
16538443|NCT00295022|40432876|FG001|Overall Study|Lost to Follow-up|0|||
16538444|NCT00295022|40432877|FG002|Overall Study|Lost to Follow-up|1|||
16538445|NCT00295022|40432875|FG000|Overall Study|Withdrawal by Subject|0|||
16538446|NCT00295022|40432876|FG001|Overall Study|Withdrawal by Subject|0|||
16538447|NCT00295022|40432877|FG002|Overall Study|Withdrawal by Subject|2|||
16538448|NCT01693068|40432885|FG000|Randomization Period|On-study|2|||
16538449|NCT01693068|40432886|FG001|Randomization Period|On-study|5|||
16538450|NCT01693068|40432887|FG002|Randomization Period|On-study|0|||
16538451|NCT01693068|40432885|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
16538452|NCT01693068|40432886|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
16538453|NCT01693068|40432887|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
16538454|NCT02925676|40432888|FG000|Overall Study|Withdrawal by Subject|1|||
16538455|NCT00156065|40432889|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
16538456|NCT00156065|40432890|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
16538457|NCT00156065|40432891|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
16538458|NCT00156065|40432889|FG000|Overall Study|Adverse Event|8|||
16538459|NCT00156065|40432890|FG001|Overall Study|Adverse Event|11|||
16339809|NCT03124537|39730313|FG000|Overall Study|Lost to Follow-up|3|||
16339810|NCT03124537|39730314|FG001|Overall Study|Lost to Follow-up|5|||
16538460|NCT00156065|40432891|FG002|Overall Study|Adverse Event|4|||
16339811|NCT03124537|39730313|FG000|Overall Study|App Crash, Incomplete Data|7|||
16339812|NCT03124537|39730314|FG001|Overall Study|App Crash, Incomplete Data|8|||
16339813|NCT03251482|39730315|FG000|Overall Study|Withdrawal by Subject|0|||
16339814|NCT03251482|39730316|FG001|Overall Study|Withdrawal by Subject|1|||
16339815|NCT03251482|39730317|FG002|Overall Study|Withdrawal by Subject|0|||
16339816|NCT03251482|39730318|FG003|Overall Study|Withdrawal by Subject|0|||
16339817|NCT03251482|39730319|FG004|Overall Study|Withdrawal by Subject|0|||
16339818|NCT02649426|39730320|FG000|Overall Study|Follow-up on going|1|||
16339819|NCT02649426|39730321|FG001|Overall Study|Follow-up on going|26|||
16339820|NCT02649426|39730322|FG002|Overall Study|Follow-up on going|28|||
16339821|NCT02649426|39730323|FG003|Overall Study|Follow-up on going|31|||
16339822|NCT01471444|39730331|FG000|Overall Study|Physician Decision|3|||
16339823|NCT01471444|39730332|FG001|Overall Study|Physician Decision|2|||
16339824|NCT01471444|39730331|FG000|Overall Study|Withdrawal by Subject|0|||
16339825|NCT01471444|39730332|FG001|Overall Study|Withdrawal by Subject|1|||
16339826|NCT01464619|39730333|FG000|Overall Study|Lost to Follow-up|3|||
16339827|NCT01464619|39730334|FG001|Overall Study|Lost to Follow-up|4|||
16339828|NCT04165135|39730335|FG000|Overall Study|Protocol Violation|10|||
16339829|NCT04165135|39730335|FG000|Overall Study|Participants withdrawal of consent|5|||
16339830|NCT02864316|39730336|FG000|Overall Study|Progressive Disease|2|||
16339831|NCT02864316|39730337|FG001|Overall Study|Progressive Disease|1|||
16339832|NCT02864316|39730336|FG000|Overall Study|Adverse Event|0|||
16339833|NCT02864316|39730337|FG001|Overall Study|Adverse Event|1|||
16339834|NCT02187029|39730338|FG000|Overall Study|Adverse Event|0|||
16103920|NCT06247488|38868538|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
16103921|NCT06247488|38868539|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
16103922|NCT06247488|38868540|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
16103923|NCT06247488|38868541|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
16103924|NCT06247488|38868542|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
16103925|NCT06247488|38868537|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
16103926|NCT06247488|38868538|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
16103927|NCT06247488|38868539|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
16103928|NCT06247488|38868540|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
16103929|NCT06247488|38868541|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
16103930|NCT06247488|38868542|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
16103931|NCT06247488|38868537|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
16103932|NCT06247488|38868538|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
16103933|NCT06247488|38868539|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
16103934|NCT06247488|38868540|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
16103935|NCT06247488|38868541|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
16103936|NCT06247488|38868542|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
16103937|NCT06247488|38868537|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
16103938|NCT06247488|38868538|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
16339835|NCT02187029|39730339|FG001|Overall Study|Adverse Event|1|||
16103939|NCT06247488|38868539|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
16103940|NCT06247488|38868540|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
16103941|NCT06247488|38868541|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
16103942|NCT06247488|38868542|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
16103943|NCT06247488|38868537|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
16339836|NCT02187029|39730340|FG002|Overall Study|Adverse Event|1|||
16339837|NCT02187029|39730341|FG003|Overall Study|Adverse Event|0|||
16339838|NCT02187029|39730338|FG000|Overall Study|Study Terminated by Sponsor|0|||
16339839|NCT02187029|39730339|FG001|Overall Study|Study Terminated by Sponsor|0|||
16339840|NCT02187029|39730340|FG002|Overall Study|Study Terminated by Sponsor|10|||
16339841|NCT02187029|39730341|FG003|Overall Study|Study Terminated by Sponsor|3|||
16339842|NCT02187029|39730338|FG000|Overall Study|Withdrawal by Subject|1|||
16339843|NCT02187029|39730339|FG001|Overall Study|Withdrawal by Subject|0|||
16339844|NCT02187029|39730340|FG002|Overall Study|Withdrawal by Subject|0|||
16339845|NCT02187029|39730341|FG003|Overall Study|Withdrawal by Subject|0|||
16339846|NCT03538691|39730342|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
16103944|NCT06247488|38868538|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
16103945|NCT06247488|38868539|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
16103946|NCT06247488|38868540|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
16103947|NCT06247488|38868541|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
16103948|NCT06247488|38868542|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
16103949|NCT06247488|38868537|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
16103950|NCT06247488|38868538|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
16103951|NCT06247488|38868539|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
16103952|NCT06247488|38868540|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
16103953|NCT06247488|38868541|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
16103954|NCT06247488|38868542|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
16103955|NCT06247488|38868537|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
16103956|NCT06247488|38868538|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
16103957|NCT06247488|38868539|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
16103958|NCT06247488|38868540|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
16103959|NCT06247488|38868541|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
16103960|NCT06247488|38868542|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
16103961|NCT01260142|38868543|FG000|Treatment Period 1|Study on hold|1|||
16103962|NCT01260142|38868544|FG001|Treatment Period 1|Study on hold|1|||
16103963|NCT01260142|38868545|FG002|Treatment Period 1|Study on hold|0|||
16103964|NCT01260142|38868546|FG003|Treatment Period 1|Study on hold|0|||
16103965|NCT01260142|38868547|FG004|Treatment Period 1|Study on hold|1|||
16103966|NCT01260142|38868548|FG005|Treatment Period 1|Study on hold|2|||
16103967|NCT01260142|38868543|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
16103968|NCT01260142|38868544|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
16103969|NCT01260142|38868545|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
16103970|NCT01260142|38868546|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
16538461|NCT00156065|40432889|FG000|Overall Study|Lack of Efficacy|2|||
16538462|NCT00156065|40432890|FG001|Overall Study|Lack of Efficacy|9|||
16339847|NCT03538691|39730343|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
16538463|NCT00156065|40432891|FG002|Overall Study|Lack of Efficacy|3|||
16103971|NCT01260142|38868547|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
16103972|NCT01260142|38868548|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
16103973|NCT01260142|38868543|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16217167|NCT02254304|39275878|FG000|Overall Study|Personal decision|1|||
16103974|NCT01260142|38868544|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16103975|NCT01260142|38868545|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16103976|NCT01260142|38868546|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16103977|NCT01260142|38868547|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16103978|NCT01260142|38868548|FG005|Treatment Period 1|Withdrawal by Subject|1|||
16103979|NCT01904019|38868549|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
16103980|NCT01904019|38868549|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
16103981|NCT01904019|38868549|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
16103982|NCT01904019|38868549|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
16103983|NCT01904019|38868549|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
16103984|NCT01904019|38868549|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
16103985|NCT02573883|38868550|FG000|Six Month Follow Up|Lost to Follow-up|1|||
16103986|NCT02573883|38868551|FG001|Six Month Follow Up|Lost to Follow-up|0|||
16103987|NCT02573883|38868552|FG002|Six Month Follow Up|Lost to Follow-up|0|||
16103988|NCT02573883|38868553|FG003|Six Month Follow Up|Lost to Follow-up|0|||
16103989|NCT02573883|38868550|FG000|One Year Follow Up|Lost to Follow-up|2|||
16103990|NCT02573883|38868551|FG001|One Year Follow Up|Lost to Follow-up|1|||
16103991|NCT02573883|38868552|FG002|One Year Follow Up|Lost to Follow-up|0|||
16103992|NCT02573883|38868553|FG003|One Year Follow Up|Lost to Follow-up|0|||
16103993|NCT00424177|38868554|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
16103994|NCT00424177|38868554|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
16103995|NCT00424177|38868554|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
16103996|NCT00424177|38868554|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
16103997|NCT00424177|38868554|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
16103998|NCT00424177|38868554|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
16103999|NCT00424177|38868554|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
16104000|NCT00424177|38868554|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
16104001|NCT00424177|38868554|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
16104002|NCT00424177|38868554|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
16104003|NCT00520403|38868559|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
16104004|NCT00520403|38868559|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
16104005|NCT00520403|38868559|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
16104006|NCT00520403|38868559|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
16104007|NCT00520403|38868559|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
16104008|NCT00520403|38868559|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
16104009|NCT00520403|38868559|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
16104010|NCT00520403|38868559|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
16104011|NCT01746108|38868561|FG000|Overall Study|Migrated /moved from study area|0|||
16104012|NCT01746108|38868562|FG001|Overall Study|Migrated /moved from study area|1|||
16104013|NCT01746108|38868563|FG002|Overall Study|Migrated /moved from study area|0|||
16104014|NCT01746108|38868561|FG000|Overall Study|Adverse event, non-fatal|0|||
16104015|NCT01746108|38868562|FG001|Overall Study|Adverse event, non-fatal|1|||
16104016|NCT01746108|38868563|FG002|Overall Study|Adverse event, non-fatal|0|||
16104017|NCT01746108|38868561|FG000|Overall Study|Withdrawal by Subject|0|||
16104018|NCT01746108|38868562|FG001|Overall Study|Withdrawal by Subject|1|||
16104019|NCT01746108|38868563|FG002|Overall Study|Withdrawal by Subject|0|||
16104020|NCT01746108|38868561|FG000|Overall Study|Lost to Follow-up|0|||
16104021|NCT01746108|38868562|FG001|Overall Study|Lost to Follow-up|1|||
16104022|NCT01746108|38868563|FG002|Overall Study|Lost to Follow-up|0|||
16104023|NCT01202409|38868568|FG000|Overall Study|Adverse Event|1|||
16104024|NCT01202409|38868568|FG000|Overall Study|Ineligible - KRAS mutants|7|||
16104025|NCT00578318|38868571|FG000|Overall Study|Lost to Follow-up|2|||
16104026|NCT00578318|38868572|FG001|Overall Study|Lost to Follow-up|0|||
16104027|NCT00578318|38868571|FG000|Overall Study|Physician Decision|1|||
16104028|NCT00578318|38868572|FG001|Overall Study|Physician Decision|0|||
16104029|NCT02005029|38868573|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
16104030|NCT02005029|38868574|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
16104031|NCT04572997|38868575|FG000|Overall Study|Adverse Event|1|||
16104032|NCT02287883|38868576|FG000|Overall Study|Death|8|||
16104033|NCT02287883|38868577|FG001|Overall Study|Death|7|||
16104034|NCT02287883|38868576|FG000|Overall Study|No longer eligible|222|||
16538464|NCT00156065|40432889|FG000|Overall Study|Withdrawal by Subject|13|||
16538465|NCT00156065|40432890|FG001|Overall Study|Withdrawal by Subject|26|||
16538466|NCT00156065|40432891|FG002|Overall Study|Withdrawal by Subject|16|||
16538467|NCT00156065|40432889|FG000|Overall Study|Lost to Follow-up|5|||
16104035|NCT02287883|38868577|FG001|Overall Study|No longer eligible|182|||
16104036|NCT02287883|38868576|FG000|Overall Study|Non-response to survey|229|||
16104037|NCT02287883|38868577|FG001|Overall Study|Non-response to survey|237|||
16104038|NCT02973802|38868578|FG000|Overall Study|Lost to Follow-up|1|||
16104039|NCT02973802|38868578|FG000|Overall Study|Withdrawal by Subject|1|||
16104040|NCT00796614|38868579|FG000|Overall Study|Adverse Event|1|||
16104041|NCT00796614|38868580|FG001|Overall Study|Adverse Event|2|||
16538468|NCT00156065|40432890|FG001|Overall Study|Lost to Follow-up|7|||
16104042|NCT00796614|38868581|FG002|Overall Study|Adverse Event|0|||
16104043|NCT00796614|38868582|FG003|Overall Study|Adverse Event|0|||
16538469|NCT00156065|40432891|FG002|Overall Study|Lost to Follow-up|1|||
16538470|NCT00156065|40432889|FG000|Overall Study|Other|2|||
16538471|NCT00156065|40432890|FG001|Overall Study|Other|9|||
16339848|NCT03538691|39730344|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
16339849|NCT03538691|39730345|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
16339850|NCT03538691|39730342|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
16339851|NCT03538691|39730343|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
16339852|NCT03538691|39730344|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
16339853|NCT03538691|39730345|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
16339854|NCT03538691|39730342|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
16339855|NCT03538691|39730343|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
16339856|NCT03538691|39730344|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
16339857|NCT03538691|39730345|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
16339858|NCT03538691|39730342|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
16339859|NCT03538691|39730343|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
16339860|NCT03538691|39730344|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
16339861|NCT03538691|39730345|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
16339862|NCT03538691|39730342|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
16104044|NCT00796614|38868579|FG000|Overall Study|Protocol Violation|0|||
16538472|NCT00156065|40432891|FG002|Overall Study|Other|3|||
16538473|NCT01256411|40432892|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
16538474|NCT01256411|40432893|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
16538475|NCT01256411|40432894|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
16538476|NCT01256411|40432895|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
16538477|NCT01256411|40432896|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
16538478|NCT01256411|40432897|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
16538479|NCT01256411|40432892|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
16538480|NCT01256411|40432893|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
16104045|NCT00796614|38868580|FG001|Overall Study|Protocol Violation|0|||
16104046|NCT00796614|38868581|FG002|Overall Study|Protocol Violation|2|||
16339863|NCT03538691|39730343|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
16339864|NCT03538691|39730344|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
16104047|NCT00796614|38868582|FG003|Overall Study|Protocol Violation|0|||
16104048|NCT00796614|38868579|FG000|Overall Study|Lost to Follow-up|2|||
16339865|NCT03538691|39730345|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
16538481|NCT01256411|40432894|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
16538482|NCT01256411|40432895|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
16538483|NCT01256411|40432896|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
16538484|NCT01256411|40432897|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
16538485|NCT01256411|40432892|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
16538486|NCT01256411|40432893|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
16538487|NCT01256411|40432894|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
16538488|NCT01256411|40432895|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
16538489|NCT01256411|40432896|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
16538490|NCT01256411|40432897|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
16538491|NCT01256411|40432892|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
16538492|NCT01256411|40432893|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
16538493|NCT01256411|40432894|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
16538494|NCT01256411|40432895|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
16538495|NCT01256411|40432896|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
16538496|NCT01256411|40432897|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
16538497|NCT01256411|40432892|FG000|Extension by Maximum Treatment|Adverse Event|4|||
16538498|NCT01256411|40432893|FG001|Extension by Maximum Treatment|Adverse Event|2|||
16538499|NCT01256411|40432894|FG002|Extension by Maximum Treatment|Adverse Event|1|||
16538500|NCT01256411|40432895|FG003|Extension by Maximum Treatment|Adverse Event|0|||
16538501|NCT01256411|40432896|FG004|Extension by Maximum Treatment|Adverse Event|0|||
16538502|NCT01256411|40432897|FG005|Extension by Maximum Treatment|Adverse Event|0|||
16538503|NCT01256411|40432892|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
16538504|NCT01256411|40432893|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
16538505|NCT01256411|40432894|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
16538506|NCT01256411|40432895|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
16538507|NCT01256411|40432896|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
16538508|NCT01256411|40432897|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
16538509|NCT01256411|40432892|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
16538510|NCT01256411|40432893|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
16538511|NCT01256411|40432894|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
16538512|NCT01256411|40432895|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
16538513|NCT01256411|40432896|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
16538514|NCT01256411|40432897|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
16538515|NCT01256411|40432892|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
16538516|NCT01256411|40432893|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
16538517|NCT01256411|40432894|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
16538518|NCT01256411|40432895|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
16538519|NCT01256411|40432896|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
16538520|NCT01256411|40432897|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
16538521|NCT01256411|40432892|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
16538522|NCT01256411|40432893|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
16538523|NCT01256411|40432894|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
16538524|NCT01256411|40432895|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
16538525|NCT01256411|40432896|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
16538526|NCT01256411|40432897|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
16538527|NCT01256411|40432892|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
16538528|NCT01256411|40432893|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
16538529|NCT01256411|40432894|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
16538530|NCT01256411|40432895|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
16538531|NCT01256411|40432896|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
16538532|NCT01256411|40432897|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
16538533|NCT02390531|40432899|FG000|Overall Study|Death|0|||
16538534|NCT02390531|40432900|FG001|Overall Study|Death|2|||
16538535|NCT02390531|40432901|FG002|Overall Study|Death|0|||
16538536|NCT02390531|40432902|FG003|Overall Study|Death|1|||
16538537|NCT02390531|40432903|FG004|Overall Study|Death|0|||
16538538|NCT02390531|40432904|FG005|Overall Study|Death|0|||
16538539|NCT02390531|40432905|FG006|Overall Study|Death|0|||
16538540|NCT02390531|40432906|FG007|Overall Study|Death|1|||
16538541|NCT02390531|40432899|FG000|Overall Study|Protocol Violation|0|||
16538542|NCT02390531|40432900|FG001|Overall Study|Protocol Violation|0|||
16538543|NCT02390531|40432901|FG002|Overall Study|Protocol Violation|0|||
16538544|NCT02390531|40432902|FG003|Overall Study|Protocol Violation|0|||
16538545|NCT02390531|40432903|FG004|Overall Study|Protocol Violation|1|||
16538546|NCT02390531|40432904|FG005|Overall Study|Protocol Violation|0|||
16538547|NCT02390531|40432905|FG006|Overall Study|Protocol Violation|2|||
16538548|NCT02390531|40432906|FG007|Overall Study|Protocol Violation|0|||
16538549|NCT02740049|40432908|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
16538550|NCT00409682|40432909|FG000|Open-label Induction Period|Adverse Event|1|||
16538551|NCT00409682|40432910|FG001|Open-label Induction Period|Adverse Event|0|||
16538552|NCT00409682|40432911|FG002|Open-label Induction Period|Adverse Event|0|||
16538553|NCT00409682|40432909|FG000|Open-label Induction Period|Lack of Efficacy|1|||
16538554|NCT00409682|40432910|FG001|Open-label Induction Period|Lack of Efficacy|0|||
16538555|NCT00409682|40432911|FG002|Open-label Induction Period|Lack of Efficacy|0|||
16538556|NCT00409682|40432909|FG000|Open-label Induction Period|Protocol Violation|1|||
16538557|NCT00409682|40432910|FG001|Open-label Induction Period|Protocol Violation|0|||
16538558|NCT00409682|40432911|FG002|Open-label Induction Period|Protocol Violation|0|||
16538559|NCT00409682|40432909|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
16538560|NCT00409682|40432910|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
16538561|NCT00409682|40432911|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
16538562|NCT00409682|40432909|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
16538563|NCT00409682|40432910|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
16538564|NCT00409682|40432911|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
16538565|NCT00409682|40432909|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
16538566|NCT00409682|40432910|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
16538567|NCT00409682|40432911|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
16538568|NCT00409682|40432909|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
16538569|NCT00409682|40432910|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
16538570|NCT00409682|40432911|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
16538571|NCT00409682|40432909|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
16538572|NCT00409682|40432910|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
16538573|NCT00409682|40432911|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
16538574|NCT00409682|40432909|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
16538575|NCT00409682|40432910|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
16538576|NCT00409682|40432911|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
16538577|NCT00409682|40432909|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
16538578|NCT00409682|40432910|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
16538579|NCT00409682|40432911|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
16538580|NCT03685591|40432917|FG000|Overall Study|Global Deterioration of Health Status|0|||
16538581|NCT03685591|40432918|FG001|Overall Study|Global Deterioration of Health Status|0|||
16538582|NCT03685591|40432919|FG002|Overall Study|Global Deterioration of Health Status|0|||
16538583|NCT03685591|40432920|FG003|Overall Study|Global Deterioration of Health Status|1|||
16538584|NCT03685591|40432921|FG004|Overall Study|Global Deterioration of Health Status|2|||
16538585|NCT03685591|40432922|FG005|Overall Study|Global Deterioration of Health Status|4|||
16538586|NCT03685591|40432923|FG006|Overall Study|Global Deterioration of Health Status|1|||
16538587|NCT03685591|40432924|FG007|Overall Study|Global Deterioration of Health Status|1|||
16538588|NCT03685591|40432925|FG008|Overall Study|Global Deterioration of Health Status|0|||
16538589|NCT03685591|40432917|FG000|Overall Study|Progressive Disease|1|||
16538590|NCT03685591|40432918|FG001|Overall Study|Progressive Disease|1|||
16538591|NCT03685591|40432919|FG002|Overall Study|Progressive Disease|0|||
16538592|NCT03685591|40432920|FG003|Overall Study|Progressive Disease|3|||
16538593|NCT03685591|40432921|FG004|Overall Study|Progressive Disease|5|||
16538594|NCT03685591|40432922|FG005|Overall Study|Progressive Disease|4|||
16538595|NCT03685591|40432923|FG006|Overall Study|Progressive Disease|3|||
16538596|NCT03685591|40432924|FG007|Overall Study|Progressive Disease|2|||
16538597|NCT03685591|40432925|FG008|Overall Study|Progressive Disease|1|||
16538598|NCT03685591|40432917|FG000|Overall Study|Other|0|||
16538599|NCT03685591|40432918|FG001|Overall Study|Other|0|||
16538600|NCT03685591|40432919|FG002|Overall Study|Other|1|||
16538601|NCT03685591|40432920|FG003|Overall Study|Other|0|||
16538602|NCT03685591|40432921|FG004|Overall Study|Other|2|||
16538603|NCT03685591|40432922|FG005|Overall Study|Other|3|||
16538604|NCT03685591|40432923|FG006|Overall Study|Other|0|||
16538605|NCT03685591|40432924|FG007|Overall Study|Other|0|||
16538606|NCT03685591|40432925|FG008|Overall Study|Other|0|||
16538607|NCT03685591|40432917|FG000|Overall Study|Withdrawal by Subject|0|||
16104049|NCT00796614|38868580|FG001|Overall Study|Lost to Follow-up|2|||
16104050|NCT00796614|38868581|FG002|Overall Study|Lost to Follow-up|1|||
16104051|NCT00796614|38868582|FG003|Overall Study|Lost to Follow-up|0|||
16104052|NCT00796614|38868579|FG000|Overall Study|Withdrawal by Subject|1|||
16104053|NCT00796614|38868580|FG001|Overall Study|Withdrawal by Subject|0|||
16538608|NCT03685591|40432918|FG001|Overall Study|Withdrawal by Subject|0|||
16538609|NCT03685591|40432919|FG002|Overall Study|Withdrawal by Subject|0|||
16538610|NCT03685591|40432920|FG003|Overall Study|Withdrawal by Subject|0|||
16538611|NCT03685591|40432921|FG004|Overall Study|Withdrawal by Subject|3|||
16538612|NCT03685591|40432922|FG005|Overall Study|Withdrawal by Subject|2|||
16538613|NCT03685591|40432923|FG006|Overall Study|Withdrawal by Subject|0|||
16217168|NCT02254304|39275879|FG001|Overall Study|Personal decision|0|||
16538614|NCT03685591|40432924|FG007|Overall Study|Withdrawal by Subject|0|||
16538615|NCT03685591|40432925|FG008|Overall Study|Withdrawal by Subject|1|||
16538616|NCT03685591|40432917|FG000|Overall Study|Adverse Event|0|||
16538617|NCT03685591|40432918|FG001|Overall Study|Adverse Event|0|||
16538618|NCT03685591|40432919|FG002|Overall Study|Adverse Event|0|||
16217169|NCT03006926|39275880|FG000|Overall Study|Adverse Event|0|||
16217170|NCT03006926|39275881|FG001|Overall Study|Adverse Event|27|||
16217171|NCT03006926|39275880|FG000|Overall Study|Withdrawal by Subject|0|||
16217172|NCT03006926|39275881|FG001|Overall Study|Withdrawal by Subject|1|||
16217173|NCT03006926|39275880|FG000|Overall Study|Radiological Disease Progression|0|||
16217174|NCT03006926|39275881|FG001|Overall Study|Radiological Disease Progression|52|||
16217175|NCT03006926|39275880|FG000|Overall Study|Clinical Disease Progression|0|||
16217176|NCT03006926|39275881|FG001|Overall Study|Clinical Disease Progression|10|||
16217177|NCT03006926|39275880|FG000|Overall Study|Other|0|||
16217178|NCT03006926|39275881|FG001|Overall Study|Other|8|||
16217179|NCT02092324|39275882|FG000|Overall Study|Adverse Event|1|||
16217180|NCT02092324|39275882|FG000|Overall Study|Lack of Efficacy|6|||
16217181|NCT02092324|39275882|FG000|Overall Study|Proceed to Transplant|3|||
16217182|NCT02092324|39275882|FG000|Overall Study|Physician Decision|7|||
16217183|NCT02092324|39275882|FG000|Overall Study|Misdiagnosis|2|||
16217184|NCT03738228|39275883|FG000|Overall Study|Never received study treatment|2|||
16217185|NCT03738228|39275884|FG001|Overall Study|Never received study treatment|2|||
16217186|NCT02417935|39275885|FG000|Treatment Period|Adverse Event|12|||
16217187|NCT02417935|39275886|FG001|Treatment Period|Adverse Event|10|||
16217188|NCT02417935|39275885|FG000|Treatment Period|Lost to Follow-up|1|||
16217189|NCT02417935|39275886|FG001|Treatment Period|Lost to Follow-up|0|||
16217190|NCT02417935|39275885|FG000|Treatment Period|Entry Criteria not met|0|||
16217191|NCT02417935|39275886|FG001|Treatment Period|Entry Criteria not met|1|||
16217192|NCT02417935|39275885|FG000|Treatment Period|Protocol Violation|2|||
16217193|NCT02417935|39275886|FG001|Treatment Period|Protocol Violation|1|||
16217194|NCT02417935|39275885|FG000|Treatment Period|Withdrawal by Subject|3|||
16217195|NCT02417935|39275886|FG001|Treatment Period|Withdrawal by Subject|3|||
16217196|NCT02417935|39275885|FG000|Treatment Period|Physician Decision|3|||
16217197|NCT02417935|39275886|FG001|Treatment Period|Physician Decision|1|||
16217198|NCT00877890|39275887|FG000|Overall Study|Adverse Event|6|||
16217199|NCT00877890|39275888|FG001|Overall Study|Adverse Event|6|||
16217200|NCT00877890|39275887|FG000|Overall Study|Lost to Follow-up|5|||
16217201|NCT00877890|39275888|FG001|Overall Study|Lost to Follow-up|5|||
16217202|NCT00877890|39275887|FG000|Overall Study|Protocol Violation|0|||
16217203|NCT00877890|39275888|FG001|Overall Study|Protocol Violation|1|||
16217204|NCT00877890|39275887|FG000|Overall Study|Withdrawal of Consent|6|||
16538619|NCT03685591|40432920|FG003|Overall Study|Adverse Event|1|||
16538620|NCT03685591|40432921|FG004|Overall Study|Adverse Event|1|||
16538621|NCT03685591|40432922|FG005|Overall Study|Adverse Event|4|||
16538622|NCT03685591|40432923|FG006|Overall Study|Adverse Event|0|||
16538623|NCT03685591|40432924|FG007|Overall Study|Adverse Event|1|||
16538624|NCT03685591|40432925|FG008|Overall Study|Adverse Event|1|||
16538625|NCT00234065|40432926|FG000|Overall Study|Adverse Event|268|||
16538626|NCT00234065|40432927|FG001|Overall Study|Adverse Event|166|||
16538627|NCT00234065|40432926|FG000|Overall Study|Withdrawal by Subject|73|||
16538628|NCT00234065|40432927|FG001|Overall Study|Withdrawal by Subject|56|||
16104054|NCT00796614|38868581|FG002|Overall Study|Withdrawal by Subject|0|||
16217205|NCT00877890|39275888|FG001|Overall Study|Withdrawal of Consent|12|||
16217206|NCT00877890|39275887|FG000|Overall Study|Investigator Decision|0|||
16217207|NCT00877890|39275888|FG001|Overall Study|Investigator Decision|2|||
16217208|NCT00877890|39275887|FG000|Overall Study|Loss of Glucose Control|3|||
16217209|NCT00877890|39275888|FG001|Overall Study|Loss of Glucose Control|4|||
16217210|NCT03483012|39275889|FG000|Overall Study|Lack of Efficacy|6|||
16217211|NCT01590810|39275890|FG000|Overall Study|Physician Decision|0|||
16217212|NCT01590810|39275891|FG001|Overall Study|Physician Decision|1|||
16217213|NCT01590810|39275892|FG002|Overall Study|Physician Decision|1|||
16538629|NCT00234065|40432926|FG000|Overall Study|Physician Decision|23|||
16538630|NCT00234065|40432927|FG001|Overall Study|Physician Decision|22|||
16538631|NCT00234065|40432926|FG000|Overall Study|Not Classified|111|||
16538632|NCT00234065|40432927|FG001|Overall Study|Not Classified|112|||
16217214|NCT01590810|39275893|FG003|Overall Study|Physician Decision|0|||
16217215|NCT01590810|39275894|FG004|Overall Study|Physician Decision|0|||
16217216|NCT00364611|39275896|FG000|Overall Study|Did not receive study medication|0|||
16217217|NCT00364611|39275897|FG001|Overall Study|Did not receive study medication|1|||
16217218|NCT00364611|39275896|FG000|Overall Study|Adverse Event|7|||
16104055|NCT00796614|38868582|FG003|Overall Study|Withdrawal by Subject|1|||
16104056|NCT00796614|38868579|FG000|Overall Study|Other than stated|1|||
16217219|NCT00364611|39275897|FG001|Overall Study|Adverse Event|4|||
16217220|NCT00364611|39275896|FG000|Overall Study|Participant's Request|3|||
16217221|NCT00364611|39275897|FG001|Overall Study|Participant's Request|4|||
16217222|NCT00364611|39275896|FG000|Overall Study|Disease Progression|38|||
16217223|NCT00364611|39275897|FG001|Overall Study|Disease Progression|8|||
16217224|NCT00364611|39275896|FG000|Overall Study|Investigator decision|2|||
16104057|NCT00796614|38868580|FG001|Overall Study|Other than stated|0|||
16104058|NCT00796614|38868581|FG002|Overall Study|Other than stated|0|||
16104059|NCT00796614|38868582|FG003|Overall Study|Other than stated|0|||
16104060|NCT02956278|38868583|FG000|Overall Study|Withdrawal by Subject|6|||
16104061|NCT02956278|38868584|FG001|Overall Study|Withdrawal by Subject|2|||
16104062|NCT02956278|38868585|FG002|Overall Study|Withdrawal by Subject|0|||
16406443|NCT03622112|39969800|FG002|Overall Study|Study-specific withdrawal criteria|7|||
16406444|NCT03622112|39969801|FG003|Overall Study|Study-specific withdrawal criteria|6|||
16104063|NCT00814632|38868586|FG000|Overall Study|Lack of Efficacy|2|||
16104064|NCT01276509|38868587|FG000|Overall Study|Adverse Event|9|||
16104065|NCT01276509|38868588|FG001|Overall Study|Adverse Event|8|||
16104066|NCT01276509|38868589|FG002|Overall Study|Adverse Event|4|||
16104067|NCT01276509|38868590|FG003|Overall Study|Adverse Event|3|||
16104068|NCT01276509|38868587|FG000|Overall Study|Lack of Efficacy|2|||
16104069|NCT01276509|38868588|FG001|Overall Study|Lack of Efficacy|1|||
16104070|NCT01276509|38868589|FG002|Overall Study|Lack of Efficacy|1|||
16104071|NCT01276509|38868590|FG003|Overall Study|Lack of Efficacy|2|||
16406445|NCT03622112|39969802|FG004|Overall Study|Study-specific withdrawal criteria|4|||
16406446|NCT03622112|39969803|FG005|Overall Study|Study-specific withdrawal criteria|18|||
16104072|NCT01276509|38868587|FG000|Overall Study|Pregnancy|1|||
16104073|NCT01276509|38868588|FG001|Overall Study|Pregnancy|0|||
16104074|NCT01276509|38868589|FG002|Overall Study|Pregnancy|0|||
16406447|NCT03622112|39969804|FG006|Overall Study|Study-specific withdrawal criteria|4|||
16406448|NCT03622112|39969798|FG000|Overall Study|Protocol Violation|2|||
16406449|NCT03622112|39969799|FG001|Overall Study|Protocol Violation|0|||
16339866|NCT03538691|39730342|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
16339867|NCT03538691|39730343|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
16339868|NCT03538691|39730344|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
16339869|NCT03538691|39730345|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
16339870|NCT03538691|39730342|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
16339871|NCT03538691|39730343|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
16339872|NCT03538691|39730344|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
16406450|NCT03622112|39969800|FG002|Overall Study|Protocol Violation|1|||
16406451|NCT03622112|39969801|FG003|Overall Study|Protocol Violation|1|||
16406452|NCT03622112|39969802|FG004|Overall Study|Protocol Violation|0|||
16406453|NCT03622112|39969803|FG005|Overall Study|Protocol Violation|0|||
16406454|NCT03622112|39969804|FG006|Overall Study|Protocol Violation|0|||
16406455|NCT03622112|39969798|FG000|Overall Study|Adverse Event|6|||
16406456|NCT03622112|39969799|FG001|Overall Study|Adverse Event|8|||
16406457|NCT03622112|39969800|FG002|Overall Study|Adverse Event|4|||
16406458|NCT03622112|39969801|FG003|Overall Study|Adverse Event|11|||
16406459|NCT03622112|39969802|FG004|Overall Study|Adverse Event|4|||
16406460|NCT03622112|39969803|FG005|Overall Study|Adverse Event|20|||
16406461|NCT03622112|39969804|FG006|Overall Study|Adverse Event|2|||
16406462|NCT03622112|39969798|FG000|Overall Study|Reason not specified|0|||
16406463|NCT03622112|39969799|FG001|Overall Study|Reason not specified|1|||
16406464|NCT03622112|39969800|FG002|Overall Study|Reason not specified|0|||
16406465|NCT03622112|39969801|FG003|Overall Study|Reason not specified|1|||
16406466|NCT03622112|39969802|FG004|Overall Study|Reason not specified|1|||
16406467|NCT03622112|39969803|FG005|Overall Study|Reason not specified|2|||
16406468|NCT03622112|39969804|FG006|Overall Study|Reason not specified|1|||
16406469|NCT00223977|39969805|FG000|Overall Study|Adverse Event|7|||
16406470|NCT00223977|39969806|FG001|Overall Study|Adverse Event|10|||
16406471|NCT00223977|39969807|FG002|Overall Study|Adverse Event|0|||
16406472|NCT00223977|39969805|FG000|Overall Study|Protocol Violation|0|||
16104075|NCT01276509|38868590|FG003|Overall Study|Pregnancy|0|||
16104076|NCT01276509|38868587|FG000|Overall Study|Withdrawal by Subject|1|||
16104077|NCT01276509|38868588|FG001|Overall Study|Withdrawal by Subject|2|||
16104078|NCT01276509|38868589|FG002|Overall Study|Withdrawal by Subject|0|||
16104079|NCT01276509|38868590|FG003|Overall Study|Withdrawal by Subject|0|||
16104080|NCT01276509|38868587|FG000|Overall Study|Other|0|||
16406473|NCT00223977|39969806|FG001|Overall Study|Protocol Violation|0|||
16406474|NCT00223977|39969807|FG002|Overall Study|Protocol Violation|1|||
16406475|NCT00223977|39969805|FG000|Overall Study|Withdrawal by Subject|1|||
16406476|NCT00223977|39969806|FG001|Overall Study|Withdrawal by Subject|1|||
16406477|NCT00223977|39969807|FG002|Overall Study|Withdrawal by Subject|2|||
16406478|NCT00223977|39969805|FG000|Overall Study|Other|1|||
16406479|NCT00223977|39969806|FG001|Overall Study|Other|0|||
16406480|NCT00223977|39969807|FG002|Overall Study|Other|0|||
16406481|NCT00866047|39969808|FG000|Treatment Period|Progressive disease|13|||
16406482|NCT00866047|39969808|FG000|Treatment Period|Adverse Event|16|||
16104081|NCT01276509|38868588|FG001|Overall Study|Other|1|||
16104082|NCT01276509|38868589|FG002|Overall Study|Other|0|||
16406483|NCT00866047|39969808|FG000|Treatment Period|Physician Decision|14|||
16406484|NCT00866047|39969808|FG000|Treatment Period|Withdrawal by Subject|5|||
16217225|NCT00364611|39275897|FG001|Overall Study|Investigator decision|2|||
16217226|NCT00364611|39275896|FG000|Overall Study|Found Ineligible|1|||
16406485|NCT00866047|39969808|FG000|Follow-up Period|Lost to Follow-up|5|||
16406486|NCT03773133|39969809|FG000|Overall Study|Screen Failure|8|||
16406487|NCT00570037|39969810|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
16104083|NCT01276509|38868590|FG003|Overall Study|Other|0|||
16104084|NCT02316847|38868593|FG000|Overall Study|Adverse Event|0|||
16104085|NCT02316847|38868594|FG001|Overall Study|Adverse Event|3|||
16104086|NCT02316847|38868593|FG000|Overall Study|Lost to Follow-up|0|||
16104087|NCT02316847|38868594|FG001|Overall Study|Lost to Follow-up|2|||
16104088|NCT02316847|38868593|FG000|Overall Study|Physician Decision|0|||
16104089|NCT02316847|38868594|FG001|Overall Study|Physician Decision|1|||
16104090|NCT02316847|38868593|FG000|Overall Study|Pregnancy|0|||
16104091|NCT02316847|38868594|FG001|Overall Study|Pregnancy|1|||
16104092|NCT02316847|38868593|FG000|Overall Study|Withdrawal by Subject|2|||
16104093|NCT02316847|38868594|FG001|Overall Study|Withdrawal by Subject|9|||
16104094|NCT02316847|38868593|FG000|Overall Study|Noncompliance with study drug|0|||
16104095|NCT02316847|38868594|FG001|Overall Study|Noncompliance with study drug|3|||
16104096|NCT02316847|38868593|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
16104097|NCT02316847|38868594|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
16104098|NCT02172950|38868596|FG000|Overall Study|Physician Decision|3|||
16104099|NCT02172950|38868597|FG001|Overall Study|Physician Decision|3|||
16104100|NCT02172950|38868596|FG000|Overall Study|Lack of Efficacy|1|||
16104101|NCT02172950|38868597|FG001|Overall Study|Lack of Efficacy|0|||
16104102|NCT02172950|38868596|FG000|Overall Study|Adverse Event|4|||
16104103|NCT02172950|38868597|FG001|Overall Study|Adverse Event|1|||
16104104|NCT02172950|38868596|FG000|Overall Study|Withdrawal by Subject|10|||
16104105|NCT02172950|38868597|FG001|Overall Study|Withdrawal by Subject|0|||
16104106|NCT02172950|38868596|FG000|Overall Study|Protocol Violation|1|||
16104107|NCT02172950|38868597|FG001|Overall Study|Protocol Violation|0|||
16104108|NCT02172950|38868596|FG000|Overall Study|Lost to Follow-up|1|||
16104109|NCT02172950|38868597|FG001|Overall Study|Lost to Follow-up|0|||
16104110|NCT02172950|38868596|FG000|Overall Study|Death|1|||
16104111|NCT02172950|38868597|FG001|Overall Study|Death|0|||
16104112|NCT02172950|38868596|FG000|Overall Study|Patient traveling|1|||
16104113|NCT02172950|38868597|FG001|Overall Study|Patient traveling|0|||
16104114|NCT02172950|38868596|FG000|Overall Study|Patient went to other country|1|||
16104115|NCT02172950|38868597|FG001|Overall Study|Patient went to other country|0|||
16104116|NCT02172950|38868596|FG000|Overall Study|Patient relocated overseas|1|||
16104117|NCT02172950|38868597|FG001|Overall Study|Patient relocated overseas|1|||
16104118|NCT02172950|38868596|FG000|Overall Study|Patient moving|1|||
16104119|NCT02172950|38868597|FG001|Overall Study|Patient moving|0|||
16104120|NCT03605368|38868598|FG000|Overall Study|Lost to Follow-up|2|||
16104121|NCT03605368|38868599|FG001|Overall Study|Lost to Follow-up|1|||
16104122|NCT03605368|38868600|FG002|Overall Study|Lost to Follow-up|3|||
16104123|NCT03605368|38868601|FG003|Overall Study|Lost to Follow-up|2|||
16104124|NCT03605368|38868598|FG000|Overall Study|Withdrawal by Subject|0|||
16104125|NCT03605368|38868599|FG001|Overall Study|Withdrawal by Subject|0|||
16104126|NCT03605368|38868600|FG002|Overall Study|Withdrawal by Subject|4|||
16104127|NCT03605368|38868601|FG003|Overall Study|Withdrawal by Subject|3|||
16104128|NCT02154347|38868607|FG000|Double-blind Period|Adverse Event|1|||
16104129|NCT02154347|38868608|FG001|Double-blind Period|Adverse Event|2|||
16104130|NCT02154347|38868607|FG000|Double-blind Period|Lack of Efficacy|1|||
16104131|NCT02154347|38868608|FG001|Double-blind Period|Lack of Efficacy|0|||
16104132|NCT02154347|38868607|FG000|Double-blind Period|Physician Decision|0|||
16104133|NCT02154347|38868608|FG001|Double-blind Period|Physician Decision|1|||
16104134|NCT02154347|38868607|FG000|Double-blind Period|Withdrawal by Subject|1|||
16104135|NCT02154347|38868608|FG001|Double-blind Period|Withdrawal by Subject|1|||
16104136|NCT02154347|38868607|FG000|Open-label Period|Adverse Event|3|||
16104137|NCT02154347|38868608|FG001|Open-label Period|Adverse Event|4|||
16104138|NCT02154347|38868607|FG000|Open-label Period|Lack of Efficacy|4|||
16104139|NCT02154347|38868608|FG001|Open-label Period|Lack of Efficacy|19|||
16104140|NCT02154347|38868607|FG000|Open-label Period|Protocol Violation|0|||
16104141|NCT02154347|38868608|FG001|Open-label Period|Protocol Violation|1|||
16104142|NCT02154347|38868607|FG000|Open-label Period|Withdrawal by Subject|0|||
16104143|NCT02154347|38868608|FG001|Open-label Period|Withdrawal by Subject|1|||
16104144|NCT00143598|38868609|FG000|Overall Study|Lost to Follow-up|23|||
16104145|NCT00143598|38868610|FG001|Overall Study|Lost to Follow-up|21|||
16104146|NCT00143598|38868609|FG000|Overall Study|Withdrawal by Subject|33|||
16104147|NCT00143598|38868610|FG001|Overall Study|Withdrawal by Subject|37|||
16104148|NCT00143598|38868609|FG000|Overall Study|Death|36|||
16104149|NCT00143598|38868610|FG001|Overall Study|Death|36|||
16104150|NCT02859558|38868615|FG000|Step 1|Not Eligible|0|||
16339873|NCT03538691|39730345|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
16339874|NCT03538691|39730342|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
16339875|NCT03538691|39730343|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
16339876|NCT03538691|39730344|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
16104151|NCT02859558|38868616|FG001|Step 1|Not Eligible|0|||
16104152|NCT02859558|38868617|FG002|Step 1|Not Eligible|0|||
16104153|NCT02859558|38868618|FG003|Step 1|Not Eligible|0|||
16104154|NCT02859558|38868619|FG004|Step 1|Not Eligible|3|||
16104155|NCT02859558|38868615|FG000|Step 1|Lost to Follow-up|1|||
16339877|NCT03538691|39730345|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
16104156|NCT02859558|38868616|FG001|Step 1|Lost to Follow-up|3|||
16104157|NCT02859558|38868617|FG002|Step 1|Lost to Follow-up|3|||
16104158|NCT02859558|38868618|FG003|Step 1|Lost to Follow-up|0|||
16104159|NCT02859558|38868619|FG004|Step 1|Lost to Follow-up|0|||
16104160|NCT02859558|38868615|FG000|Step 1|Did Not Return to Clinic|2|||
16104161|NCT02859558|38868616|FG001|Step 1|Did Not Return to Clinic|3|||
16104162|NCT02859558|38868617|FG002|Step 1|Did Not Return to Clinic|4|||
16104163|NCT02859558|38868618|FG003|Step 1|Did Not Return to Clinic|0|||
16104164|NCT02859558|38868619|FG004|Step 1|Did Not Return to Clinic|0|||
16104165|NCT02859558|38868615|FG000|Step 1|Moved|0|||
16104166|NCT02859558|38868616|FG001|Step 1|Moved|1|||
16104167|NCT02859558|38868617|FG002|Step 1|Moved|1|||
16104168|NCT02859558|38868618|FG003|Step 1|Moved|0|||
16104169|NCT02859558|38868619|FG004|Step 1|Moved|0|||
16104170|NCT02859558|38868615|FG000|Step 1|Withdrawal By Participant|1|||
16104171|NCT02859558|38868616|FG001|Step 1|Withdrawal By Participant|2|||
16104172|NCT02859558|38868617|FG002|Step 1|Withdrawal By Participant|1|||
16104173|NCT02859558|38868618|FG003|Step 1|Withdrawal By Participant|0|||
16104174|NCT02859558|38868619|FG004|Step 1|Withdrawal By Participant|0|||
16104175|NCT02859558|38868615|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
16104176|NCT02859558|38868616|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
16104177|NCT02859558|38868617|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
16104178|NCT02859558|38868618|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
16104179|NCT02859558|38868619|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
16104180|NCT02859558|38868615|FG000|Step 1|Incarceration|0|||
16104181|NCT02859558|38868616|FG001|Step 1|Incarceration|1|||
16104182|NCT02859558|38868617|FG002|Step 1|Incarceration|0|||
16104183|NCT02859558|38868618|FG003|Step 1|Incarceration|0|||
16104184|NCT02859558|38868619|FG004|Step 1|Incarceration|0|||
16104185|NCT02859558|38868615|FG000|Step 1|Non-Adherence to Study Drug|2|||
16104186|NCT02859558|38868616|FG001|Step 1|Non-Adherence to Study Drug|0|||
16104187|NCT02859558|38868617|FG002|Step 1|Non-Adherence to Study Drug|1|||
16104188|NCT02859558|38868618|FG003|Step 1|Non-Adherence to Study Drug|0|||
16104189|NCT02859558|38868619|FG004|Step 1|Non-Adherence to Study Drug|0|||
16104190|NCT02859558|38868615|FG000|Step 1|Non-Adherence to Study Requirements|3|||
16104191|NCT02859558|38868616|FG001|Step 1|Non-Adherence to Study Requirements|1|||
16104192|NCT02859558|38868617|FG002|Step 1|Non-Adherence to Study Requirements|0|||
16104193|NCT02859558|38868618|FG003|Step 1|Non-Adherence to Study Requirements|0|||
16104194|NCT02859558|38868619|FG004|Step 1|Non-Adherence to Study Requirements|0|||
16104195|NCT02859558|38868615|FG000|Step 1|Virologic Failure|2|||
16104196|NCT02859558|38868616|FG001|Step 1|Virologic Failure|1|||
16104197|NCT02859558|38868617|FG002|Step 1|Virologic Failure|1|||
16104198|NCT02859558|38868618|FG003|Step 1|Virologic Failure|0|||
16104199|NCT02859558|38868619|FG004|Step 1|Virologic Failure|0|||
16104200|NCT02859558|38868615|FG000|Step 2|Active On Study|23|||
16104201|NCT02859558|38868616|FG001|Step 2|Active On Study|38|||
16104202|NCT02859558|38868617|FG002|Step 2|Active On Study|20|||
16104203|NCT02859558|38868618|FG003|Step 2|Active On Study|0|||
16104204|NCT02859558|38868619|FG004|Step 2|Active On Study|0|||
16104205|NCT02859558|38868615|FG000|Step 2|Did Not Return to Clinic|2|||
16104206|NCT02859558|38868616|FG001|Step 2|Did Not Return to Clinic|0|||
16104207|NCT02859558|38868617|FG002|Step 2|Did Not Return to Clinic|0|||
16104208|NCT02859558|38868618|FG003|Step 2|Did Not Return to Clinic|0|||
16104209|NCT02859558|38868619|FG004|Step 2|Did Not Return to Clinic|0|||
16104210|NCT02859558|38868615|FG000|Step 2|Unexpected Closure of Site|0|||
16104211|NCT02859558|38868616|FG001|Step 2|Unexpected Closure of Site|1|||
16104212|NCT02859558|38868617|FG002|Step 2|Unexpected Closure of Site|1|||
16104213|NCT02859558|38868618|FG003|Step 2|Unexpected Closure of Site|0|||
16104214|NCT02859558|38868619|FG004|Step 2|Unexpected Closure of Site|0|||
16104215|NCT01059526|38868620|FG000|Overall Study|Patient enrolled but not treated|20|||
16104216|NCT01059526|38868621|FG001|Overall Study|Patient enrolled but not treated|17|||
16104217|NCT01059526|38868620|FG000|Overall Study|Adverse Event|2|||
16104218|NCT01059526|38868621|FG001|Overall Study|Adverse Event|2|||
16104219|NCT01059526|38868620|FG000|Overall Study|Protocol Violation|0|||
16104220|NCT01059526|38868621|FG001|Overall Study|Protocol Violation|1|||
16104221|NCT01059526|38868620|FG000|Overall Study|Withdrawal by Subject|3|||
16104222|NCT01059526|38868621|FG001|Overall Study|Withdrawal by Subject|1|||
16104223|NCT01059526|38868620|FG000|Overall Study|Lost to Follow-up|4|||
16104224|NCT01059526|38868621|FG001|Overall Study|Lost to Follow-up|1|||
16104225|NCT01059526|38868620|FG000|Overall Study|Patient found to be dermatographic|1|||
16104226|NCT01059526|38868621|FG001|Overall Study|Patient found to be dermatographic|0|||
16104227|NCT03098797|38868627|FG000|Part 2 Open Label Extension|Adverse Event|2|||
16104228|NCT03098797|38868628|FG001|Part 2 Open Label Extension|Adverse Event|0|||
16104229|NCT04194541|38868629|FG000|Day 1 Through 13|Lost to Follow-up|3|||
16104230|NCT04194541|38868629|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
16104231|NCT04194541|38868629|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
16104232|NCT04414397|38868632|FG000|Control Period|Withdrawal by Subject|2|||
16104233|NCT04414397|38868633|FG001|Control Period|Withdrawal by Subject|2|||
16104234|NCT04414397|38868632|FG000|Control Period|Lost to Follow-up|0|||
16104235|NCT04414397|38868633|FG001|Control Period|Lost to Follow-up|4|||
16104236|NCT04414397|38868632|FG000|Control Period|Protocol deviation|0|||
16104237|NCT04414397|38868633|FG001|Control Period|Protocol deviation|1|||
16104238|NCT04414397|38868632|FG000|Post-Control Period|Withdrawal by Subject|3|||
16104239|NCT04414397|38868633|FG001|Post-Control Period|Withdrawal by Subject|6|||
16104240|NCT04414397|38868632|FG000|Post-Control Period|Lost to Follow-up|4|||
16104241|NCT04414397|38868633|FG001|Post-Control Period|Lost to Follow-up|9|||
16104242|NCT04414397|38868632|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
16104243|NCT04414397|38868633|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
16339878|NCT03538691|39730342|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
16104244|NCT04414397|38868632|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
16104245|NCT04414397|38868633|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
16104246|NCT00988117|38868634|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
16104247|NCT00988117|38868634|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
16104248|NCT00553605|38868635|FG000|Overall Study|Did not meet entrance criteria|1|||
16104249|NCT00553605|38868636|FG001|Overall Study|Did not meet entrance criteria|3|||
16104250|NCT00553605|38868635|FG000|Overall Study|Did not receive full dose|1|||
16104251|NCT00553605|38868636|FG001|Overall Study|Did not receive full dose|0|||
16104252|NCT00553605|38868635|FG000|Overall Study|Randomized but not treated|2|||
16104253|NCT00553605|38868636|FG001|Overall Study|Randomized but not treated|0|||
16104254|NCT00551135|38868637|FG000|Overall Study|Adverse Event|1|||
16104255|NCT00551135|38868638|FG001|Overall Study|Adverse Event|0|||
16538633|NCT03015402|40432928|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
16538634|NCT03015402|40432929|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
16538635|NCT03015402|40432928|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
16538636|NCT03015402|40432929|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
16538637|NCT02953938|40432930|FG000|Overall Study|Adverse Event|0|||
16538638|NCT02953938|40432931|FG001|Overall Study|Adverse Event|1|||
16217227|NCT00364611|39275897|FG001|Overall Study|Found Ineligible|0|||
16538639|NCT02953938|40432930|FG000|Overall Study|Withdrawal by Subject|1|||
16538640|NCT02953938|40432931|FG001|Overall Study|Withdrawal by Subject|1|||
16538641|NCT03252587|40432934|FG000|Overall Study|Adverse Event|3|||
16538642|NCT03252587|40432935|FG001|Overall Study|Adverse Event|8|||
16538643|NCT03252587|40432936|FG002|Overall Study|Adverse Event|6|||
16538644|NCT03252587|40432937|FG003|Overall Study|Adverse Event|12|||
16538645|NCT03252587|40432934|FG000|Overall Study|Lack of Efficacy|7|||
16538646|NCT03252587|40432935|FG001|Overall Study|Lack of Efficacy|2|||
16538647|NCT03252587|40432936|FG002|Overall Study|Lack of Efficacy|2|||
16538648|NCT03252587|40432937|FG003|Overall Study|Lack of Efficacy|4|||
16538649|NCT03252587|40432934|FG000|Overall Study|Lost to Follow-up|2|||
16538650|NCT03252587|40432935|FG001|Overall Study|Lost to Follow-up|0|||
16538651|NCT03252587|40432936|FG002|Overall Study|Lost to Follow-up|0|||
16538652|NCT03252587|40432937|FG003|Overall Study|Lost to Follow-up|2|||
16538653|NCT03252587|40432934|FG000|Overall Study|Pregnancy|2|||
16104256|NCT00551135|38868639|FG002|Overall Study|Adverse Event|1|||
16104257|NCT00551135|38868640|FG003|Overall Study|Adverse Event|1|||
16217228|NCT00364611|39275896|FG000|Overall Study|Presumed CR on Study|0|||
16339879|NCT03538691|39730343|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
16339880|NCT03538691|39730344|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
16346440|NCT00758498|39757157|FG000|Overall Study|Subject legally detained out of state|1|||
16538654|NCT03252587|40432935|FG001|Overall Study|Pregnancy|1|||
16538655|NCT03252587|40432936|FG002|Overall Study|Pregnancy|0|||
16538656|NCT03252587|40432937|FG003|Overall Study|Pregnancy|1|||
16104258|NCT00551135|38868637|FG000|Overall Study|Lost to Follow-up|0|||
16104259|NCT00551135|38868638|FG001|Overall Study|Lost to Follow-up|0|||
16104260|NCT00551135|38868639|FG002|Overall Study|Lost to Follow-up|0|||
16104261|NCT00551135|38868640|FG003|Overall Study|Lost to Follow-up|1|||
16104262|NCT00551135|38868637|FG000|Overall Study|Other|3|||
16538657|NCT03252587|40432934|FG000|Overall Study|Withdrawal by Subject|8|||
16538658|NCT03252587|40432935|FG001|Overall Study|Withdrawal by Subject|4|||
16538659|NCT03252587|40432936|FG002|Overall Study|Withdrawal by Subject|4|||
16538660|NCT03252587|40432937|FG003|Overall Study|Withdrawal by Subject|4|||
16538661|NCT03252587|40432934|FG000|Overall Study|Other Reasons|2|||
16538662|NCT03252587|40432935|FG001|Overall Study|Other Reasons|5|||
16538663|NCT03252587|40432936|FG002|Overall Study|Other Reasons|5|||
16538664|NCT03252587|40432937|FG003|Overall Study|Other Reasons|4|||
16538665|NCT04040751|40432938|FG000|Overall Study|Withdrawal by Subject|2|||
16538666|NCT04040751|40432939|FG001|Overall Study|Withdrawal by Subject|0|||
16538667|NCT04040751|40432940|FG002|Overall Study|Withdrawal by Subject|2|||
16339881|NCT03538691|39730345|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
16339882|NCT03538691|39730342|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
16339883|NCT03538691|39730343|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
16339884|NCT03538691|39730344|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
16339885|NCT03538691|39730345|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
16339886|NCT03538691|39730342|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
16339887|NCT03538691|39730343|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
16339888|NCT03538691|39730344|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
16339889|NCT03538691|39730345|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
16339890|NCT03538691|39730342|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
16339891|NCT03538691|39730343|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
16339892|NCT03538691|39730344|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
16339893|NCT03538691|39730345|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
16339894|NCT03538691|39730342|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
16339895|NCT03538691|39730343|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
16339896|NCT03538691|39730344|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
16339897|NCT03538691|39730345|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
16339898|NCT03538691|39730342|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
16339899|NCT03538691|39730343|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
16339900|NCT03538691|39730344|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
16339901|NCT03538691|39730345|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
16339902|NCT03538691|39730342|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
16339903|NCT03538691|39730343|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
16339904|NCT03538691|39730344|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
16339905|NCT03538691|39730345|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
16538668|NCT04040751|40432941|FG003|Overall Study|Withdrawal by Subject|0|||
16538669|NCT02008890|40432942|FG000|Period 1|Withdrawal by Subject|7|||
16538670|NCT02008890|40432943|FG001|Period 1|Withdrawal by Subject|7|||
16538671|NCT02008890|40432944|FG002|Period 1|Withdrawal by Subject|5|||
16538672|NCT02008890|40432945|FG003|Period 1|Withdrawal by Subject|0|||
16538673|NCT02008890|40432946|FG004|Period 1|Withdrawal by Subject|0|||
16538674|NCT02008890|40432942|FG000|Period 1|Pregnancy|1|||
16538675|NCT02008890|40432943|FG001|Period 1|Pregnancy|0|||
16538676|NCT02008890|40432944|FG002|Period 1|Pregnancy|0|||
16538677|NCT02008890|40432945|FG003|Period 1|Pregnancy|0|||
16538678|NCT02008890|40432946|FG004|Period 1|Pregnancy|0|||
16538679|NCT02008890|40432942|FG000|Period 1|Physician Decision|1|||
16538680|NCT02008890|40432943|FG001|Period 1|Physician Decision|0|||
16538681|NCT02008890|40432944|FG002|Period 1|Physician Decision|1|||
16538682|NCT02008890|40432945|FG003|Period 1|Physician Decision|0|||
16538683|NCT02008890|40432946|FG004|Period 1|Physician Decision|0|||
16538684|NCT02008890|40432942|FG000|Period 1|Adverse Event|6|||
16538685|NCT02008890|40432943|FG001|Period 1|Adverse Event|8|||
16538686|NCT02008890|40432944|FG002|Period 1|Adverse Event|6|||
16538687|NCT02008890|40432945|FG003|Period 1|Adverse Event|0|||
16538688|NCT02008890|40432946|FG004|Period 1|Adverse Event|0|||
16538689|NCT02008890|40432942|FG000|Period 2|Adverse Event|12|||
16538690|NCT02008890|40432943|FG001|Period 2|Adverse Event|7|||
16538691|NCT02008890|40432944|FG002|Period 2|Adverse Event|0|||
16538692|NCT02008890|40432945|FG003|Period 2|Adverse Event|5|||
16538693|NCT02008890|40432946|FG004|Period 2|Adverse Event|5|||
16339906|NCT03538691|39730342|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
16339907|NCT03538691|39730343|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
16538694|NCT02008890|40432942|FG000|Period 2|Withdrawal by Subject|11|||
16104263|NCT00551135|38868638|FG001|Overall Study|Other|2|||
16538695|NCT02008890|40432943|FG001|Period 2|Withdrawal by Subject|8|||
16538696|NCT02008890|40432944|FG002|Period 2|Withdrawal by Subject|0|||
16538697|NCT02008890|40432945|FG003|Period 2|Withdrawal by Subject|7|||
16538698|NCT02008890|40432946|FG004|Period 2|Withdrawal by Subject|2|||
16538699|NCT02008890|40432942|FG000|Period 2|Physician Decision|4|||
16538700|NCT02008890|40432943|FG001|Period 2|Physician Decision|0|||
16538701|NCT02008890|40432944|FG002|Period 2|Physician Decision|0|||
16538702|NCT02008890|40432945|FG003|Period 2|Physician Decision|2|||
16538703|NCT02008890|40432946|FG004|Period 2|Physician Decision|1|||
16538704|NCT02008890|40432942|FG000|Period 2|Lost to Follow-up|0|||
16538705|NCT02008890|40432943|FG001|Period 2|Lost to Follow-up|0|||
16538706|NCT02008890|40432944|FG002|Period 2|Lost to Follow-up|1|||
16538707|NCT02008890|40432945|FG003|Period 2|Lost to Follow-up|0|||
16538708|NCT02008890|40432946|FG004|Period 2|Lost to Follow-up|0|||
16538709|NCT02008890|40432942|FG000|Extension Period|Withdrawal by Subject|3|||
16538710|NCT02008890|40432943|FG001|Extension Period|Withdrawal by Subject|2|||
16538711|NCT02008890|40432944|FG002|Extension Period|Withdrawal by Subject|0|||
16538712|NCT02008890|40432945|FG003|Extension Period|Withdrawal by Subject|4|||
16538713|NCT02008890|40432946|FG004|Extension Period|Withdrawal by Subject|2|||
16538714|NCT02008890|40432942|FG000|Extension Period|Lost to Follow-up|1|||
16538715|NCT02008890|40432943|FG001|Extension Period|Lost to Follow-up|0|||
16538716|NCT02008890|40432944|FG002|Extension Period|Lost to Follow-up|0|||
16538717|NCT02008890|40432945|FG003|Extension Period|Lost to Follow-up|0|||
16538718|NCT02008890|40432946|FG004|Extension Period|Lost to Follow-up|0|||
16538719|NCT02008890|40432942|FG000|Extension Period|Adverse Event|1|||
16538720|NCT02008890|40432943|FG001|Extension Period|Adverse Event|3|||
16538721|NCT02008890|40432944|FG002|Extension Period|Adverse Event|0|||
16538722|NCT02008890|40432945|FG003|Extension Period|Adverse Event|0|||
16538723|NCT02008890|40432946|FG004|Extension Period|Adverse Event|2|||
16538724|NCT00951041|40432947|FG000|Overall Study|Withdrawal by Subject|1|||
16538725|NCT00951041|40432948|FG001|Overall Study|Withdrawal by Subject|1|||
16538726|NCT00951041|40432947|FG000|Overall Study|Lost to Follow-up|1|||
16538727|NCT00951041|40432948|FG001|Overall Study|Lost to Follow-up|0|||
16538728|NCT00951041|40432947|FG000|Overall Study|Other|3|||
16538729|NCT00951041|40432948|FG001|Overall Study|Other|0|||
16538730|NCT00569582|40432959|FG000|Overall Study|Withdrawal by Subject|5|||
16538731|NCT00569582|40432959|FG000|Overall Study|Death|2|||
16538732|NCT00569582|40432959|FG000|Overall Study|Adverse Event|7|||
16538733|NCT00569582|40432959|FG000|Overall Study|Subject was too ill to travel.|1|||
16538734|NCT00569582|40432959|FG000|Overall Study|Subject was non-compliant.|1|||
16538735|NCT00130533|40432960|FG000|Overall Study|Withdrawal by Subject|33|||
16538736|NCT00130533|40432961|FG001|Overall Study|Withdrawal by Subject|6|||
16538737|NCT00130533|40432960|FG000|Overall Study|Adverse Event|34|||
16538738|NCT00130533|40432961|FG001|Overall Study|Adverse Event|1|||
16538739|NCT00130533|40432960|FG000|Overall Study|Disease relapse|9|||
16538740|NCT00130533|40432961|FG001|Overall Study|Disease relapse|13|||
16538741|NCT00130533|40432960|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
16538742|NCT00130533|40432961|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
16538743|NCT00130533|40432960|FG000|Overall Study|Death|4|||
16538744|NCT00130533|40432961|FG001|Overall Study|Death|2|||
16538745|NCT00130533|40432960|FG000|Overall Study|Protocol Violation|5|||
16538746|NCT00130533|40432961|FG001|Overall Study|Protocol Violation|1|||
16538747|NCT00130533|40432960|FG000|Overall Study|Lost to Follow-up|1|||
16538748|NCT00130533|40432961|FG001|Overall Study|Lost to Follow-up|1|||
16538749|NCT00130533|40432960|FG000|Overall Study|Sponsor´s decision|2|||
16538750|NCT00130533|40432961|FG001|Overall Study|Sponsor´s decision|0|||
16538751|NCT00130533|40432960|FG000|Overall Study|Second Primary Malignancy|0|||
16538752|NCT00130533|40432961|FG001|Overall Study|Second Primary Malignancy|1|||
16538753|NCT00130533|40432960|FG000|Overall Study|Other|12|||
16538754|NCT00130533|40432961|FG001|Overall Study|Other|5|||
16538755|NCT04385368|40432962|FG000|Overall Study|Death|5|||
16538756|NCT04385368|40432963|FG001|Overall Study|Death|5|||
16538757|NCT04385368|40432962|FG000|Overall Study|Physician Decision|3|||
16538758|NCT04385368|40432963|FG001|Overall Study|Physician Decision|0|||
16538759|NCT04385368|40432962|FG000|Overall Study|Withdrawal by Subject|4|||
16538760|NCT04385368|40432963|FG001|Overall Study|Withdrawal by Subject|3|||
16538761|NCT02633137|40432964|FG000|Overall Study|Adverse Event|1|||
16538762|NCT02633137|40432964|FG000|Overall Study|Lack of Efficacy|2|||
16538763|NCT02633137|40432964|FG000|Overall Study|Withdrawal by Subject|1|||
16538764|NCT00677833|40432965|FG000|Overall Study|Withdrawal by Subject|4|||
16538765|NCT00677833|40432966|FG001|Overall Study|Withdrawal by Subject|0|||
16538766|NCT00677833|40432967|FG002|Overall Study|Withdrawal by Subject|1|||
16538767|NCT00677833|40432968|FG003|Overall Study|Withdrawal by Subject|3|||
16538768|NCT00677833|40432965|FG000|Overall Study|Lost to Follow-up|0|||
16538769|NCT00677833|40432966|FG001|Overall Study|Lost to Follow-up|0|||
16538770|NCT00677833|40432967|FG002|Overall Study|Lost to Follow-up|1|||
16538771|NCT00677833|40432968|FG003|Overall Study|Lost to Follow-up|0|||
16538772|NCT02844946|40432971|FG000|Overall Study|Lost to Follow-up|7|||
16538773|NCT02844946|40432972|FG001|Overall Study|Lost to Follow-up|0|||
16538774|NCT02816138|40432973|FG000|Overall Study|Adverse Event|1|||
16538775|NCT02313428|40432978|FG000|Overall Study|Lost to Follow-up|1|||
16538776|NCT02313428|40432979|FG001|Overall Study|Lost to Follow-up|1|||
16538777|NCT01338025|40432980|FG000|Overall Study|Unexpected closure of study|10|||
16538778|NCT01338025|40432981|FG001|Overall Study|Unexpected closure of study|9|||
16538779|NCT01338025|40432980|FG000|Overall Study|Withdrawal by Subject|0|||
16538780|NCT01338025|40432981|FG001|Overall Study|Withdrawal by Subject|2|||
16538781|NCT01338025|40432980|FG000|Overall Study|Found ineligible after starting|1|||
16538782|NCT01338025|40432981|FG001|Overall Study|Found ineligible after starting|0|||
16538783|NCT04198805|40432982|FG000|Overall Study|Death|0|||
16538784|NCT04198805|40432983|FG001|Overall Study|Death|0|||
16538785|NCT04198805|40432984|FG002|Overall Study|Death|0|||
16538786|NCT04198805|40432985|FG003|Overall Study|Death|1|||
16538787|NCT04198805|40432982|FG000|Overall Study|Early Termination|8|||
16538788|NCT04198805|40432983|FG001|Overall Study|Early Termination|4|||
16538789|NCT04198805|40432984|FG002|Overall Study|Early Termination|6|||
16538790|NCT04198805|40432985|FG003|Overall Study|Early Termination|9|||
16538791|NCT02275065|40432988|FG000|Overall Study|Randomized but not treated|1|||
16538792|NCT02275065|40432989|FG001|Overall Study|Randomized but not treated|0|||
16538793|NCT02275065|40432990|FG002|Overall Study|Randomized but not treated|1|||
16538794|NCT02275065|40432991|FG003|Overall Study|Randomized but not treated|1|||
16538795|NCT02275065|40432992|FG004|Overall Study|Randomized but not treated|0|||
16538796|NCT02181803|40432993|FG000|Overall Study|Withdrawal by Subject|0|||
16538797|NCT02181803|40432994|FG001|Overall Study|Withdrawal by Subject|2|||
16538798|NCT02181803|40432995|FG002|Overall Study|Withdrawal by Subject|0|||
16538799|NCT02181803|40432996|FG003|Overall Study|Withdrawal by Subject|0|||
16538800|NCT02181803|40432997|FG004|Overall Study|Withdrawal by Subject|0|||
16538801|NCT02181803|40432998|FG005|Overall Study|Withdrawal by Subject|0|||
16538802|NCT02181803|40432999|FG006|Overall Study|Withdrawal by Subject|0|||
16538803|NCT02181803|40433000|FG007|Overall Study|Withdrawal by Subject|0|||
16538804|NCT02181803|40433001|FG008|Overall Study|Withdrawal by Subject|0|||
16538805|NCT02181803|40432993|FG000|Overall Study|Physician Decision|0|||
16538806|NCT02181803|40432994|FG001|Overall Study|Physician Decision|0|||
16538807|NCT02181803|40432995|FG002|Overall Study|Physician Decision|0|||
16538808|NCT02181803|40432996|FG003|Overall Study|Physician Decision|1|||
16538809|NCT02181803|40432997|FG004|Overall Study|Physician Decision|0|||
16538810|NCT02181803|40432998|FG005|Overall Study|Physician Decision|0|||
16538811|NCT02181803|40432999|FG006|Overall Study|Physician Decision|0|||
16538812|NCT02181803|40433000|FG007|Overall Study|Physician Decision|1|||
16538813|NCT02181803|40433001|FG008|Overall Study|Physician Decision|0|||
16538814|NCT02181803|40432993|FG000|Overall Study|Adverse Event|0|||
16538815|NCT02181803|40432994|FG001|Overall Study|Adverse Event|2|||
16538816|NCT02181803|40432995|FG002|Overall Study|Adverse Event|0|||
16538817|NCT02181803|40432996|FG003|Overall Study|Adverse Event|1|||
16538818|NCT02181803|40432997|FG004|Overall Study|Adverse Event|0|||
16538819|NCT02181803|40432998|FG005|Overall Study|Adverse Event|0|||
16538820|NCT02181803|40432999|FG006|Overall Study|Adverse Event|1|||
16538821|NCT02181803|40433000|FG007|Overall Study|Adverse Event|0|||
16538822|NCT02181803|40433001|FG008|Overall Study|Adverse Event|0|||
16538823|NCT03355326|40433002|FG000|Overall Study|Protocol Violation|3|||
16538824|NCT03355326|40433003|FG001|Overall Study|Protocol Violation|3|||
16538825|NCT00989287|40433004|FG000|Overall Study|Adverse Event|1|||
16538826|NCT00989287|40433005|FG001|Overall Study|Adverse Event|0|||
16538827|NCT00989287|40433004|FG000|Overall Study|Lost to Follow-up|0|||
16538828|NCT00989287|40433005|FG001|Overall Study|Lost to Follow-up|1|||
16538829|NCT02970318|40433006|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
16538830|NCT02970318|40433007|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
16538831|NCT02970318|40433008|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
16538832|NCT02970318|40433009|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
16538833|NCT02970318|40433006|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
16538834|NCT02970318|40433007|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
16538835|NCT02970318|40433008|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
16538836|NCT02970318|40433009|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
16538837|NCT02970318|40433006|FG000|Overall for Arm A & Main for Arm B|Death|41|||
16538838|NCT02970318|40433007|FG001|Overall for Arm A & Main for Arm B|Death|33|||
16538839|NCT02970318|40433008|FG002|Overall for Arm A & Main for Arm B|Death|0|||
16538840|NCT02970318|40433009|FG003|Overall for Arm A & Main for Arm B|Death|0|||
16538841|NCT02970318|40433006|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
16538842|NCT02970318|40433007|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
16538843|NCT02970318|40433008|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
16538844|NCT02970318|40433009|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
16538845|NCT02970318|40433006|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
16538846|NCT02970318|40433007|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
16538847|NCT02970318|40433008|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
16538848|NCT02970318|40433009|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
16538849|NCT02970318|40433006|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
16538850|NCT02970318|40433007|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
16538851|NCT02970318|40433008|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
16538852|NCT02970318|40433009|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
16538853|NCT02970318|40433006|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
16538854|NCT02970318|40433007|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
16538855|NCT02970318|40433008|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
16538856|NCT02970318|40433009|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
16538857|NCT00553696|40433012|FG000|Overall Study|Adverse Event|2|||
16538858|NCT00553696|40433013|FG001|Overall Study|Adverse Event|4|||
16538859|NCT00553696|40433014|FG002|Overall Study|Adverse Event|0|||
16538860|NCT00553696|40433015|FG003|Overall Study|Adverse Event|1|||
16538861|NCT00553696|40433012|FG000|Overall Study|Global deterioration of health status|0|||
16538862|NCT00553696|40433013|FG001|Overall Study|Global deterioration of health status|2|||
16538863|NCT00553696|40433014|FG002|Overall Study|Global deterioration of health status|0|||
16538864|NCT00553696|40433015|FG003|Overall Study|Global deterioration of health status|0|||
16538865|NCT00553696|40433012|FG000|Overall Study|Objective progression or relapse|2|||
16538866|NCT00553696|40433013|FG001|Overall Study|Objective progression or relapse|9|||
16538867|NCT00553696|40433014|FG002|Overall Study|Objective progression or relapse|6|||
16538868|NCT00553696|40433015|FG003|Overall Study|Objective progression or relapse|0|||
16538869|NCT00553696|40433012|FG000|Overall Study|Withdrawal by Subject|0|||
16538870|NCT00553696|40433013|FG001|Overall Study|Withdrawal by Subject|1|||
16538871|NCT00553696|40433014|FG002|Overall Study|Withdrawal by Subject|0|||
16538872|NCT00553696|40433015|FG003|Overall Study|Withdrawal by Subject|0|||
16538873|NCT00515502|40433016|FG000|Treatment Period 1|Adverse Event|0|||
16538874|NCT00515502|40433017|FG001|Treatment Period 1|Adverse Event|0|||
16538875|NCT00515502|40433018|FG002|Treatment Period 1|Adverse Event|0|||
16538876|NCT00515502|40433019|FG003|Treatment Period 1|Adverse Event|0|||
16538877|NCT00515502|40433020|FG004|Treatment Period 1|Adverse Event|0|||
16538878|NCT00515502|40433021|FG005|Treatment Period 1|Adverse Event|0|||
16538879|NCT00515502|40433022|FG006|Treatment Period 1|Adverse Event|1|||
16538880|NCT00515502|40433023|FG007|Treatment Period 1|Adverse Event|0|||
16538881|NCT00515502|40433024|FG008|Treatment Period 1|Adverse Event|1|||
16538882|NCT00515502|40433025|FG009|Treatment Period 1|Adverse Event|0|||
16538883|NCT00515502|40433026|FG010|Treatment Period 1|Adverse Event|0|||
16538884|NCT00515502|40433027|FG011|Treatment Period 1|Adverse Event|1|||
16538885|NCT00515502|40433016|FG000|Treatment Period 2|Adverse Event|0|||
16538886|NCT00515502|40433017|FG001|Treatment Period 2|Adverse Event|1|||
16538887|NCT00515502|40433018|FG002|Treatment Period 2|Adverse Event|0|||
16538888|NCT00515502|40433019|FG003|Treatment Period 2|Adverse Event|0|||
16538889|NCT00515502|40433020|FG004|Treatment Period 2|Adverse Event|0|||
16538890|NCT00515502|40433021|FG005|Treatment Period 2|Adverse Event|0|||
16538891|NCT00515502|40433022|FG006|Treatment Period 2|Adverse Event|0|||
16538892|NCT00515502|40433023|FG007|Treatment Period 2|Adverse Event|0|||
16538893|NCT00515502|40433024|FG008|Treatment Period 2|Adverse Event|0|||
16538894|NCT00515502|40433025|FG009|Treatment Period 2|Adverse Event|0|||
16538895|NCT00515502|40433026|FG010|Treatment Period 2|Adverse Event|0|||
16538896|NCT00515502|40433027|FG011|Treatment Period 2|Adverse Event|0|||
16538897|NCT00528775|40433032|FG000|Overall Study|Other not specified|1|||
16538898|NCT03822533|40433033|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
16538899|NCT03822533|40433034|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
16538900|NCT03822533|40433033|FG000|3 Month Follow-up|Lost to Follow-up|2|||
16538901|NCT03822533|40433034|FG001|3 Month Follow-up|Lost to Follow-up|2|||
16538902|NCT03822533|40433033|FG000|6 Month Follow-up|Lost to Follow-up|3|||
16538903|NCT03822533|40433034|FG001|6 Month Follow-up|Lost to Follow-up|0|||
16538904|NCT03822533|40433033|FG000|12 Month Follow-up|Lost to Follow-up|2|||
16538905|NCT03822533|40433034|FG001|12 Month Follow-up|Lost to Follow-up|3|||
16538906|NCT03822533|40433033|FG000|12 Month Follow-up|Pregnancy|0|||
16538907|NCT03822533|40433034|FG001|12 Month Follow-up|Pregnancy|1|||
16538908|NCT03822533|40433033|FG000|12 Month Follow-up|Surgery|2|||
16538909|NCT03822533|40433034|FG001|12 Month Follow-up|Surgery|0|||
16538910|NCT03822533|40433033|FG000|12 Month Follow-up|Wrong address|1|||
16538911|NCT03822533|40433034|FG001|12 Month Follow-up|Wrong address|0|||
16538912|NCT03822533|40433033|FG000|12 Month Follow-up|No symptoms|1|||
16538913|NCT03822533|40433034|FG001|12 Month Follow-up|No symptoms|0|||
16538914|NCT03822533|40433033|FG000|12 Month Follow-up|Changed primary care center|0|||
16538915|NCT03822533|40433034|FG001|12 Month Follow-up|Changed primary care center|1|||
16104264|NCT00551135|38868639|FG002|Overall Study|Other|1|||
16104265|NCT00551135|38868640|FG003|Overall Study|Other|2|||
16538916|NCT02732938|40433041|FG000|Overall Study|Death|0|||
16538917|NCT02732938|40433042|FG001|Overall Study|Death|11|||
16538918|NCT02732938|40433043|FG002|Overall Study|Death|0|||
16538919|NCT02732938|40433041|FG000|Overall Study|Randomized but did not receive treatment|0|||
16538920|NCT02732938|40433042|FG001|Overall Study|Randomized but did not receive treatment|1|||
16538921|NCT02732938|40433043|FG002|Overall Study|Randomized but did not receive treatment|0|||
16538922|NCT02732938|40433041|FG000|Overall Study|Refused further follow-up|1|||
16538923|NCT02732938|40433042|FG001|Overall Study|Refused further follow-up|0|||
16538924|NCT02732938|40433043|FG002|Overall Study|Refused further follow-up|0|||
16538925|NCT02732938|40433041|FG000|Overall Study|Study terminated by sponsor|3|||
16538926|NCT02732938|40433042|FG001|Overall Study|Study terminated by sponsor|6|||
16538927|NCT02732938|40433043|FG002|Overall Study|Study terminated by sponsor|0|||
16538928|NCT02459262|40433044|FG000|Overall Study|Withdrawal by Subject|0|||
16538929|NCT02459262|40433045|FG001|Overall Study|Withdrawal by Subject|0|||
16538930|NCT02459262|40433046|FG002|Overall Study|Withdrawal by Subject|0|||
16538931|NCT02459262|40433047|FG003|Overall Study|Withdrawal by Subject|0|||
16538932|NCT02459262|40433048|FG004|Overall Study|Withdrawal by Subject|0|||
16538933|NCT02459262|40433049|FG005|Overall Study|Withdrawal by Subject|0|||
16538934|NCT02459262|40433050|FG006|Overall Study|Withdrawal by Subject|0|||
16538935|NCT02459262|40433051|FG007|Overall Study|Withdrawal by Subject|0|||
16538936|NCT02459262|40433052|FG008|Overall Study|Withdrawal by Subject|0|||
16538937|NCT02459262|40433053|FG009|Overall Study|Withdrawal by Subject|1|||
16538938|NCT02459262|40433054|FG010|Overall Study|Withdrawal by Subject|0|||
16538939|NCT00981084|40433055|FG000|Post Intervention (Data Analysis)|poor effort|1|||
16538940|NCT00981084|40433056|FG001|Post Intervention (Data Analysis)|poor effort|1|||
16538941|NCT00981084|40433055|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
16538942|NCT00981084|40433056|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
16538943|NCT03141359|40433057|FG000|Overall Study|Death|32|||
16538944|NCT03141359|40433057|FG000|Overall Study|Still On Study (in follow up)|29|||
16538945|NCT01064297|40433058|FG000|Overall Study|Lost to Follow-up|791|||
16538946|NCT01064297|40433059|FG001|Overall Study|Lost to Follow-up|48|||
16538947|NCT01064297|40433060|FG002|Overall Study|Lost to Follow-up|133|||
16538948|NCT00511875|40433064|FG000|Overall Study|Lost to Follow-up|4|||
16538949|NCT00511875|40433065|FG001|Overall Study|Lost to Follow-up|0|||
16538950|NCT00511875|40433064|FG000|Overall Study|Missing variables|1|||
16538951|NCT00511875|40433065|FG001|Overall Study|Missing variables|0|||
16538952|NCT03311373|40433066|FG000|Overall Study|Adverse Event|1|||
16538953|NCT03311373|40433066|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
16538954|NCT03311373|40433066|FG000|Overall Study|Lost to Follow-up|1|||
16538955|NCT03311373|40433066|FG000|Overall Study|Physician Decision|1|||
16538956|NCT03311373|40433066|FG000|Overall Study|Withdrawal by Subject|3|||
16538957|NCT03014674|40433067|FG000|Overall Study|Withdrawal by Subject|1|||
16538958|NCT03014674|40433068|FG001|Overall Study|Withdrawal by Subject|0|||
16538959|NCT03014674|40433069|FG002|Overall Study|Withdrawal by Subject|0|||
16538960|NCT01970982|40433070|FG000|Overall Study|Withdrawal by Subject|0|||
16538961|NCT01970982|40433071|FG001|Overall Study|Withdrawal by Subject|0|||
16538962|NCT01970982|40433072|FG002|Overall Study|Withdrawal by Subject|2|||
16538963|NCT03151005|40433075|FG000|Overall Study|Lost to Follow-up|5|||
16538964|NCT03151005|40433076|FG001|Overall Study|Lost to Follow-up|5|||
16538965|NCT02497287|40433085|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
16538966|NCT02497287|40433085|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
16538967|NCT02497287|40433085|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
16538968|NCT02497287|40433085|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
16538969|NCT02497287|40433085|FG000|Induction Phase (4 Weeks)|Other|13|||
16538970|NCT02497287|40433085|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
16538971|NCT02497287|40433085|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
16538972|NCT02497287|40433085|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
16538973|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
16538974|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
16538975|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
16538976|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
16538977|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
16538978|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
16538979|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
16538980|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
16538981|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
16538982|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
16538983|NCT02497287|40433085|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
16538984|NCT02497287|40433085|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
16538985|NCT02497287|40433085|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
16538986|NCT02497287|40433085|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
16538987|NCT02497287|40433085|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
16538988|NCT02497287|40433085|FG000|Follow-up Phase (4 Week)|Other|1|||
16538989|NCT03365882|40433086|FG000|Randomization|Still Receiving Protocol Treatment|2|||
16538990|NCT03365882|40433087|FG001|Randomization|Still Receiving Protocol Treatment|0|||
16538991|NCT03365882|40433086|FG000|Randomization|Adverse Event|1|||
16538992|NCT03365882|40433087|FG001|Randomization|Adverse Event|2|||
16538993|NCT03365882|40433086|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
16538994|NCT03365882|40433087|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
16538995|NCT03365882|40433086|FG000|Randomization|Progression/Relapse|21|||
16538996|NCT03365882|40433087|FG001|Randomization|Progression/Relapse|3|||
16538997|NCT03365882|40433086|FG000|Randomization|Death|1|||
16538998|NCT03365882|40433087|FG001|Randomization|Death|0|||
16538999|NCT03365882|40433086|FG000|Randomization|Other - Not Protocol Specified|1|||
16539000|NCT03365882|40433087|FG001|Randomization|Other - Not Protocol Specified|1|||
16539001|NCT03365882|40433086|FG000|Randomization|Major Protocol Deviation|0|||
16539002|NCT03365882|40433087|FG001|Randomization|Major Protocol Deviation|1|||
16539003|NCT03365882|40433086|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
16539004|NCT03365882|40433087|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
16539005|NCT03365882|40433086|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
16539006|NCT03365882|40433087|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
16539007|NCT03365882|40433086|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
16539008|NCT03365882|40433087|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
16539009|NCT03365882|40433086|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
16539010|NCT03365882|40433087|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
16539011|NCT00265889|40435860|FG000|Overall Study|Physician Decision|1|||
16539012|NCT00265889|40435860|FG000|Overall Study|Protocol Violation|1|||
16339908|NCT03538691|39730344|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
16339909|NCT03538691|39730345|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
16339910|NCT03538691|39730342|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
16339911|NCT03538691|39730343|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
16339912|NCT03538691|39730344|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
16339913|NCT03538691|39730345|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
16339914|NCT03538691|39730342|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
16339915|NCT03538691|39730343|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
16339916|NCT03538691|39730344|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
16339917|NCT03538691|39730345|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
16339918|NCT03538691|39730342|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
16339919|NCT03538691|39730343|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
16539013|NCT00265889|40435860|FG000|Overall Study|Insurance denied the request|3|||
16539014|NCT00671931|40435864|FG000|Overall Study|Physician Decision|1|||
16539015|NCT00671931|40435865|FG001|Overall Study|Physician Decision|0|||
16539016|NCT00671931|40435866|FG002|Overall Study|Physician Decision|0|||
16539017|NCT00671931|40435867|FG003|Overall Study|Physician Decision|2|||
16104266|NCT00551135|38868637|FG000|Overall Study|Withdrawal by Subject|1|||
16104267|NCT00551135|38868638|FG001|Overall Study|Withdrawal by Subject|0|||
16104268|NCT00551135|38868639|FG002|Overall Study|Withdrawal by Subject|3|||
16104269|NCT00551135|38868640|FG003|Overall Study|Withdrawal by Subject|1|||
16104270|NCT02469077|38868642|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
16104271|NCT02469077|38868643|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
16539018|NCT00671931|40435868|FG004|Overall Study|Physician Decision|1|||
16339920|NCT03538691|39730344|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
16539019|NCT05072080|40435869|FG000|Overall Study|Death|0|||
16539020|NCT05072080|40435870|FG001|Overall Study|Death|0|||
16539021|NCT05072080|40435871|FG002|Overall Study|Death|1|||
16539022|NCT05072080|40435872|FG003|Overall Study|Death|0|||
16539023|NCT05072080|40435869|FG000|Overall Study|Lost to Follow-up|65|||
16539024|NCT05072080|40435870|FG001|Overall Study|Lost to Follow-up|70|||
16539025|NCT05072080|40435871|FG002|Overall Study|Lost to Follow-up|58|||
16539026|NCT05072080|40435872|FG003|Overall Study|Lost to Follow-up|23|||
16539027|NCT05072080|40435869|FG000|Overall Study|Physician Decision|2|||
16539028|NCT05072080|40435870|FG001|Overall Study|Physician Decision|1|||
16539029|NCT05072080|40435871|FG002|Overall Study|Physician Decision|1|||
16539030|NCT05072080|40435872|FG003|Overall Study|Physician Decision|0|||
16539031|NCT05072080|40435869|FG000|Overall Study|Withdrawal by Subject|45|||
16539032|NCT05072080|40435870|FG001|Overall Study|Withdrawal by Subject|30|||
16539033|NCT05072080|40435871|FG002|Overall Study|Withdrawal by Subject|27|||
16539034|NCT05072080|40435872|FG003|Overall Study|Withdrawal by Subject|7|||
16539035|NCT05072080|40435869|FG000|Overall Study|Sponsor Decision|0|||
16104272|NCT02469077|38868642|FG000|Post Randomization/Intervention Period|Relocated|1|||
16539036|NCT05072080|40435870|FG001|Overall Study|Sponsor Decision|1|||
16539037|NCT05072080|40435871|FG002|Overall Study|Sponsor Decision|0|||
16539038|NCT05072080|40435872|FG003|Overall Study|Sponsor Decision|0|||
16539039|NCT05072080|40435869|FG000|Overall Study|Subject moved|1|||
16539040|NCT05072080|40435870|FG001|Overall Study|Subject moved|3|||
16539041|NCT05072080|40435871|FG002|Overall Study|Subject moved|5|||
16539042|NCT05072080|40435872|FG003|Overall Study|Subject moved|2|||
16539043|NCT05072080|40435869|FG000|Overall Study|Withdrawal by parent|0|||
16539044|NCT05072080|40435870|FG001|Overall Study|Withdrawal by parent|0|||
16539045|NCT05072080|40435871|FG002|Overall Study|Withdrawal by parent|1|||
16539046|NCT05072080|40435872|FG003|Overall Study|Withdrawal by parent|0|||
16539047|NCT05072080|40435869|FG000|Overall Study|Subject was deployed|0|||
16539048|NCT05072080|40435870|FG001|Overall Study|Subject was deployed|1|||
16539049|NCT05072080|40435871|FG002|Overall Study|Subject was deployed|0|||
16539050|NCT05072080|40435872|FG003|Overall Study|Subject was deployed|0|||
16539051|NCT05072080|40435869|FG000|Overall Study|Subject left site without receiving dose|0|||
16539052|NCT05072080|40435870|FG001|Overall Study|Subject left site without receiving dose|1|||
16539053|NCT05072080|40435871|FG002|Overall Study|Subject left site without receiving dose|0|||
16539054|NCT05072080|40435872|FG003|Overall Study|Subject left site without receiving dose|0|||
16539055|NCT05072080|40435869|FG000|Overall Study|Subject incarcerated|0|||
16539056|NCT05072080|40435870|FG001|Overall Study|Subject incarcerated|1|||
16539057|NCT05072080|40435871|FG002|Overall Study|Subject incarcerated|0|||
16539058|NCT05072080|40435872|FG003|Overall Study|Subject incarcerated|1|||
16539059|NCT05072080|40435869|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
16539060|NCT05072080|40435870|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
16539061|NCT05072080|40435871|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
16539062|NCT05072080|40435872|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
16539063|NCT05072080|40435869|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
16539064|NCT05072080|40435870|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
16539065|NCT05072080|40435871|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
16539066|NCT05072080|40435872|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
16539067|NCT01137474|40435873|FG000|Overall Study|Adverse Event|3|||
16539068|NCT01137474|40435874|FG001|Overall Study|Adverse Event|5|||
16539069|NCT01137474|40435875|FG002|Overall Study|Adverse Event|1|||
16539070|NCT01137474|40435876|FG003|Overall Study|Adverse Event|3|||
16539071|NCT01137474|40435873|FG000|Overall Study|Withdrawal by Subject|7|||
16539072|NCT01137474|40435874|FG001|Overall Study|Withdrawal by Subject|2|||
16104273|NCT02469077|38868643|FG001|Post Randomization/Intervention Period|Relocated|1|||
16104274|NCT02469077|38868642|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
16104275|NCT02469077|38868643|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
16104276|NCT02469077|38868642|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
16104277|NCT02469077|38868643|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
16104278|NCT00651937|38868644|FG000|Overall Study|Withdrawal by Subject|4|||
16104279|NCT00651937|38868645|FG001|Overall Study|Withdrawal by Subject|1|||
16104280|NCT01665599|38868648|FG000|Overall Study|Adverse Event|1|||
16104281|NCT01665599|38868648|FG000|Overall Study|Consent Withdrawn|1|||
16104282|NCT01665599|38868648|FG000|Overall Study|Investigator/Sponsor decision|1|||
16104283|NCT01665599|38868648|FG000|Overall Study|Death|1|||
16104284|NCT01665599|38868648|FG000|Overall Study|Lost to Follow-up|2|||
16104285|NCT01665599|38868648|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
16104286|NCT01665599|38868648|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
16104287|NCT02093897|38868649|FG000|Overall Study|Physician Decision|1|||
16104288|NCT02093897|38868649|FG000|Overall Study|Planned age group closure - no's reached|17|||
16104289|NCT02093897|38868649|FG000|Overall Study|Adverse event, non-fatal|1|||
16104290|NCT01062971|38868653|FG000|Overall Study|Protocol Violation|1|||
16104291|NCT01062971|38868654|FG001|Overall Study|Protocol Violation|3|||
16104292|NCT01062971|38868653|FG000|Overall Study|Lost to Follow-up|3|||
16104293|NCT01062971|38868654|FG001|Overall Study|Lost to Follow-up|4|||
16104294|NCT03461211|38868657|FG000|Overall Study|Adverse Event|1|||
16104295|NCT03461211|38868658|FG001|Overall Study|Adverse Event|1|||
16104296|NCT03461211|38868657|FG000|Overall Study|Lack of Efficacy|0|||
16104297|NCT03461211|38868658|FG001|Overall Study|Lack of Efficacy|1|||
16104298|NCT01180790|38868670|FG000|Overall Study|Adverse Event|1|||
16104299|NCT01180790|38868671|FG001|Overall Study|Adverse Event|1|||
16104300|NCT01180790|38868672|FG002|Overall Study|Adverse Event|2|||
16539073|NCT01137474|40435875|FG002|Overall Study|Withdrawal by Subject|6|||
16539074|NCT01137474|40435876|FG003|Overall Study|Withdrawal by Subject|9|||
16539075|NCT01137474|40435873|FG000|Overall Study|No longer met study criteria|6|||
16539076|NCT01137474|40435874|FG001|Overall Study|No longer met study criteria|1|||
16539077|NCT01137474|40435875|FG002|Overall Study|No longer met study criteria|0|||
16104301|NCT01180790|38868673|FG003|Overall Study|Adverse Event|0|||
16104302|NCT01180790|38868674|FG004|Overall Study|Adverse Event|1|||
16104303|NCT01180790|38868675|FG005|Overall Study|Adverse Event|3|||
16104304|NCT01180790|38868676|FG006|Overall Study|Adverse Event|0|||
16104305|NCT01180790|38868670|FG000|Overall Study|Withdrawal by Subject|3|||
16104306|NCT01180790|38868671|FG001|Overall Study|Withdrawal by Subject|0|||
16104307|NCT01180790|38868672|FG002|Overall Study|Withdrawal by Subject|5|||
16104308|NCT01180790|38868673|FG003|Overall Study|Withdrawal by Subject|0|||
16104309|NCT01180790|38868674|FG004|Overall Study|Withdrawal by Subject|2|||
16104310|NCT01180790|38868675|FG005|Overall Study|Withdrawal by Subject|1|||
16539078|NCT01137474|40435876|FG003|Overall Study|No longer met study criteria|5|||
16539079|NCT01137474|40435873|FG000|Overall Study|Lost to Follow-up|5|||
16539080|NCT01137474|40435874|FG001|Overall Study|Lost to Follow-up|1|||
16539081|NCT01137474|40435875|FG002|Overall Study|Lost to Follow-up|0|||
16539082|NCT01137474|40435876|FG003|Overall Study|Lost to Follow-up|2|||
16539083|NCT01137474|40435873|FG000|Overall Study|Lack of Efficacy|0|||
16539084|NCT01137474|40435874|FG001|Overall Study|Lack of Efficacy|0|||
16539085|NCT01137474|40435875|FG002|Overall Study|Lack of Efficacy|0|||
16104311|NCT01180790|38868676|FG006|Overall Study|Withdrawal by Subject|0|||
16104312|NCT01180790|38868670|FG000|Overall Study|Lost to Follow-up|3|||
16104313|NCT01180790|38868671|FG001|Overall Study|Lost to Follow-up|1|||
16104314|NCT01180790|38868672|FG002|Overall Study|Lost to Follow-up|0|||
16104315|NCT01180790|38868673|FG003|Overall Study|Lost to Follow-up|2|||
16104316|NCT01180790|38868674|FG004|Overall Study|Lost to Follow-up|1|||
16104317|NCT01180790|38868675|FG005|Overall Study|Lost to Follow-up|0|||
16104318|NCT01180790|38868676|FG006|Overall Study|Lost to Follow-up|1|||
16104319|NCT01180790|38868670|FG000|Overall Study|Physician Decision|1|||
16104320|NCT01180790|38868671|FG001|Overall Study|Physician Decision|0|||
16104321|NCT01180790|38868672|FG002|Overall Study|Physician Decision|0|||
16104322|NCT01180790|38868673|FG003|Overall Study|Physician Decision|1|||
16104323|NCT01180790|38868674|FG004|Overall Study|Physician Decision|0|||
16104324|NCT01180790|38868675|FG005|Overall Study|Physician Decision|0|||
16104325|NCT01180790|38868676|FG006|Overall Study|Physician Decision|0|||
16104326|NCT01180790|38868670|FG000|Overall Study|Lack of Efficacy|1|||
16104327|NCT01180790|38868671|FG001|Overall Study|Lack of Efficacy|2|||
16104328|NCT01180790|38868672|FG002|Overall Study|Lack of Efficacy|5|||
16104329|NCT01180790|38868673|FG003|Overall Study|Lack of Efficacy|6|||
16104330|NCT01180790|38868674|FG004|Overall Study|Lack of Efficacy|1|||
16104331|NCT01180790|38868675|FG005|Overall Study|Lack of Efficacy|3|||
16104332|NCT01180790|38868676|FG006|Overall Study|Lack of Efficacy|0|||
16104333|NCT01180790|38868670|FG000|Overall Study|compliance|0|||
16104334|NCT01180790|38868671|FG001|Overall Study|compliance|1|||
16104335|NCT01180790|38868672|FG002|Overall Study|compliance|0|||
16104336|NCT01180790|38868673|FG003|Overall Study|compliance|0|||
16104337|NCT01180790|38868674|FG004|Overall Study|compliance|0|||
16104338|NCT01180790|38868675|FG005|Overall Study|compliance|0|||
16104339|NCT01180790|38868676|FG006|Overall Study|compliance|0|||
16104340|NCT01180790|38868670|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
16104341|NCT01180790|38868671|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
16104342|NCT01180790|38868672|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
16104343|NCT01180790|38868673|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
16104344|NCT01180790|38868674|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
16104345|NCT01180790|38868675|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
16104346|NCT01180790|38868676|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
16104347|NCT02720185|38868679|FG000|Overall Study|Lost to Follow-up|1|||
16104348|NCT03318783|38868681|FG000|Overall Study|Withdrawal by Subject|0|||
16104349|NCT03318783|38868682|FG001|Overall Study|Withdrawal by Subject|1|||
16104350|NCT03318783|38868681|FG000|Overall Study|Death|0|||
16104351|NCT03318783|38868682|FG001|Overall Study|Death|1|||
16339921|NCT03538691|39730345|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
16539086|NCT01137474|40435876|FG003|Overall Study|Lack of Efficacy|2|||
16539087|NCT01137474|40435873|FG000|Overall Study|Other|3|||
16539088|NCT01137474|40435874|FG001|Overall Study|Other|1|||
16539089|NCT01137474|40435875|FG002|Overall Study|Other|0|||
16539090|NCT01137474|40435876|FG003|Overall Study|Other|0|||
16539091|NCT01137474|40435873|FG000|Overall Study|Pregnancy|0|||
16104352|NCT00726388|38868683|FG000|Overall Study|Withdrawal by Subject|5|||
16104353|NCT00726388|38868683|FG000|Overall Study|Adverse Event|3|||
16104354|NCT00726388|38868683|FG000|Overall Study|Lost to Follow-up|10|||
16104355|NCT00726388|38868683|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
16539092|NCT01137474|40435874|FG001|Overall Study|Pregnancy|1|||
16104356|NCT00726388|38868683|FG000|Overall Study|Other|5|||
16104357|NCT00726388|38868683|FG000|Overall Study|Enrolled, Not Treated|79|||
16539093|NCT01137474|40435875|FG002|Overall Study|Pregnancy|0|||
16104358|NCT00961896|38868684|FG000|Overall Study|Abnormal laboratory value|0|||
16104359|NCT00961896|38868685|FG001|Overall Study|Abnormal laboratory value|0|||
16104360|NCT00961896|38868686|FG002|Overall Study|Abnormal laboratory value|1|||
16539094|NCT01137474|40435876|FG003|Overall Study|Pregnancy|0|||
16539095|NCT01137474|40435873|FG000|Overall Study|Administrative reason by sponsor|0|||
16539096|NCT01137474|40435874|FG001|Overall Study|Administrative reason by sponsor|1|||
16539097|NCT01137474|40435875|FG002|Overall Study|Administrative reason by sponsor|0|||
16539098|NCT01137474|40435876|FG003|Overall Study|Administrative reason by sponsor|0|||
16539099|NCT00886340|40435877|FG000|Overall Study|Withdrawal by Subject|0|||
16539100|NCT00886340|40435878|FG001|Overall Study|Withdrawal by Subject|7|||
16104361|NCT02661490|38868689|FG000|Overall Study|Lost to Follow-up|0|||
16104362|NCT02661490|38868690|FG001|Overall Study|Lost to Follow-up|1|||
16104363|NCT02661490|38868691|FG002|Overall Study|Lost to Follow-up|0|||
16104364|NCT02661490|38868692|FG003|Overall Study|Lost to Follow-up|0|||
16104365|NCT02661490|38868693|FG004|Overall Study|Lost to Follow-up|2|||
16104366|NCT02661490|38868689|FG000|Overall Study|Withdrawal by Subject|2|||
16104367|NCT02661490|38868690|FG001|Overall Study|Withdrawal by Subject|0|||
16104368|NCT02661490|38868691|FG002|Overall Study|Withdrawal by Subject|2|||
16104369|NCT02661490|38868692|FG003|Overall Study|Withdrawal by Subject|0|||
16104370|NCT02661490|38868693|FG004|Overall Study|Withdrawal by Subject|0|||
16104371|NCT02661490|38868689|FG000|Overall Study|Death|1|||
16104372|NCT02661490|38868690|FG001|Overall Study|Death|1|||
16104373|NCT02661490|38868691|FG002|Overall Study|Death|0|||
16104374|NCT02661490|38868692|FG003|Overall Study|Death|1|||
16104375|NCT02661490|38868693|FG004|Overall Study|Death|0|||
16104376|NCT02661490|38868689|FG000|Overall Study|Reason not Specified|0|||
16104377|NCT02661490|38868690|FG001|Overall Study|Reason not Specified|0|||
16104378|NCT02661490|38868691|FG002|Overall Study|Reason not Specified|0|||
16104379|NCT02661490|38868692|FG003|Overall Study|Reason not Specified|0|||
16104380|NCT02661490|38868693|FG004|Overall Study|Reason not Specified|1|||
16104381|NCT01020487|38868694|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
16104382|NCT01020487|38868695|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
16539101|NCT04252742|40435879|FG000|Overall Study|Decision by sponsor|0|||
16104383|NCT01020487|38868696|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
16104384|NCT01020487|38868694|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
16104385|NCT01020487|38868695|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
16104386|NCT01020487|38868696|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
16104387|NCT01020487|38868694|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
16104388|NCT01020487|38868695|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
16104389|NCT01020487|38868696|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
16104390|NCT01020487|38868694|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
16104391|NCT01020487|38868695|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
16104392|NCT01020487|38868696|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
16104393|NCT01020487|38868694|FG000|Part 2 Open-label Period|Adverse Event|0|||
16104394|NCT01020487|38868695|FG001|Part 2 Open-label Period|Adverse Event|4|||
16104395|NCT01020487|38868696|FG002|Part 2 Open-label Period|Adverse Event|1|||
16104396|NCT01978236|38868701|FG000|Overall Study|Discontinued due to study close|2|||
16104397|NCT02176356|38868705|FG000|Overall Study|Screen Failure|14|||
16104398|NCT02176356|38868705|FG000|Overall Study|Lost to Follow-up|4|||
16104399|NCT02176356|38868705|FG000|Overall Study|Personal Reasons|3|||
16104400|NCT02176356|38868705|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16104401|NCT03015181|38868706|FG000|Overall Study|Enrolled, but product never administered|1|||
16539102|NCT04252742|40435880|FG001|Overall Study|Decision by sponsor|2|||
16539103|NCT04252742|40435879|FG000|Overall Study|Withdrawal by Subject|15|||
16539104|NCT04252742|40435880|FG001|Overall Study|Withdrawal by Subject|9|||
16539105|NCT04252742|40435879|FG000|Overall Study|Lost to Follow-up|0|||
16539106|NCT04252742|40435880|FG001|Overall Study|Lost to Follow-up|1|||
16539107|NCT00238433|40435881|FG000|Overall Study|Screen failure|1|||
16539108|NCT00238433|40435881|FG000|Overall Study|Lost to Follow-up|1|||
16539109|NCT00238433|40435881|FG000|Overall Study|Death|1|||
16539110|NCT01877408|40435882|FG000|Overall Study|Lost to Follow-up|0|||
16539111|NCT01877408|40435883|FG001|Overall Study|Lost to Follow-up|2|||
16539112|NCT01649232|40435885|FG000|Overall Study|Physician Decision|2|||
16539113|NCT01649232|40435886|FG001|Overall Study|Physician Decision|0|||
16539114|NCT00499031|40435887|FG000|Overall Study|Improper pre-protocol treatment|1|||
16539115|NCT00499031|40435887|FG000|Overall Study|Required test not done|1|||
16539116|NCT00499031|40435887|FG000|Overall Study|Never treated|1|||
16539117|NCT01591382|40435888|FG000|Overall Study|Discharged Prior to Study Completion|2|||
16539118|NCT01591382|40435889|FG001|Overall Study|Discharged Prior to Study Completion|1|||
16539119|NCT01591382|40435888|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
16104402|NCT03015181|38868707|FG001|Overall Study|Enrolled, but product never administered|0|||
16104403|NCT03015181|38868708|FG002|Overall Study|Enrolled, but product never administered|0|||
16104404|NCT03015181|38868709|FG003|Overall Study|Enrolled, but product never administered|0|||
16217229|NCT00364611|39275897|FG001|Overall Study|Presumed CR on Study|1|||
16217230|NCT00364611|39275896|FG000|Overall Study|Receiving Liver Ablation|0|||
16539120|NCT01591382|40435889|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
16539121|NCT02173054|40435890|FG000|Overall Study|lack of compliance|1|||
16539122|NCT02173054|40435891|FG001|Overall Study|lack of compliance|0|||
16539123|NCT02173054|40435892|FG002|Overall Study|lack of compliance|0|||
16539124|NCT02173054|40435890|FG000|Overall Study|Withdrawal by Subject|0|||
16539125|NCT02173054|40435891|FG001|Overall Study|Withdrawal by Subject|0|||
16539126|NCT02173054|40435892|FG002|Overall Study|Withdrawal by Subject|1|||
16539127|NCT00377403|40435893|FG000|Overall Study|Unable to contact for telephone intervie|4|||
16539128|NCT00377403|40435894|FG001|Overall Study|Unable to contact for telephone intervie|7|||
16539129|NCT03238300|40435895|FG000|Baseline (Before Intervention)|Physician Decision|0|||
16539130|NCT03238300|40435896|FG001|Baseline (Before Intervention)|Physician Decision|1|||
16539131|NCT03238300|40435895|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
16539132|NCT03238300|40435896|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
16539133|NCT03238300|40435895|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
16217231|NCT00364611|39275897|FG001|Overall Study|Receiving Liver Ablation|1|||
16217232|NCT00398086|39275898|FG000|Overall Study|Unacceptable Toxicity|2|||
16217233|NCT00398086|39275899|FG001|Overall Study|Unacceptable Toxicity|8|||
16217234|NCT00398086|39275900|FG002|Overall Study|Unacceptable Toxicity|2|||
16217235|NCT00398086|39275898|FG000|Overall Study|Adverse Event|1|||
16217236|NCT00398086|39275899|FG001|Overall Study|Adverse Event|4|||
16217237|NCT00398086|39275900|FG002|Overall Study|Adverse Event|0|||
16217238|NCT00398086|39275898|FG000|Overall Study|Physician Decision|1|||
16217239|NCT00398086|39275899|FG001|Overall Study|Physician Decision|4|||
16217240|NCT00398086|39275900|FG002|Overall Study|Physician Decision|0|||
16217241|NCT00398086|39275898|FG000|Overall Study|Withdrawal by Subject|5|||
16217242|NCT00398086|39275899|FG001|Overall Study|Withdrawal by Subject|7|||
16217243|NCT00398086|39275900|FG002|Overall Study|Withdrawal by Subject|0|||
16217244|NCT00303719|39275901|FG000|Overall Study|Not evaluable, prior therapies|0|||
16217245|NCT00303719|39275902|FG001|Overall Study|Not evaluable, prior therapies|30|||
16217246|NCT00303719|39275901|FG000|Overall Study|Lost to Follow-up|0|||
16217247|NCT00303719|39275902|FG001|Overall Study|Lost to Follow-up|7|||
16217248|NCT02504424|39275903|FG000|Overall Study|Withdrawal by Subject|2|||
16217249|NCT03619902|39275904|FG000|Overall Study|Termination of Study by Investigator|1|||
16217250|NCT03619902|39275904|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
16217251|NCT01495689|39275905|FG000|Overall Study|Death|0|||
16217252|NCT01495689|39275906|FG001|Overall Study|Death|1|||
16217253|NCT01495689|39275905|FG000|Overall Study|Withdrawal by Subject|3|||
16217254|NCT01495689|39275906|FG001|Overall Study|Withdrawal by Subject|0|||
16217255|NCT01495689|39275905|FG000|Overall Study|Lost to Follow-up|7|||
16217256|NCT01495689|39275906|FG001|Overall Study|Lost to Follow-up|6|||
16217257|NCT02159365|39275907|FG000|Overall Study|Disease Progression|23|||
16217258|NCT02159365|39275907|FG000|Overall Study|Other reasons|11|||
16217259|NCT02159365|39275907|FG000|Overall Study|Administrative reason by Sponsor|9|||
16217260|NCT02159365|39275907|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
16217261|NCT02159365|39275907|FG000|Overall Study|Study drug toxicity|7|||
16217262|NCT02159365|39275907|FG000|Overall Study|Maximum clinical benefit|3|||
16217263|NCT02159365|39275907|FG000|Overall Study|Subject request to discontinue treatment|3|||
16217264|NCT02159365|39275907|FG000|Overall Study|Subject withdrew consent|3|||
16217265|NCT02159365|39275907|FG000|Overall Study|Death|1|||
16217266|NCT02159365|39275907|FG000|Overall Study|Lost to Follow-up|1|||
16217267|NCT01362049|39275908|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
16217268|NCT01362049|39275909|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
16217269|NCT01362049|39275910|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
16539134|NCT03238300|40435896|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
16539135|NCT03238300|40435895|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
16539136|NCT03238300|40435896|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
16539137|NCT00948974|40435897|FG000|Overall Study|Lost to Follow-up|23|||
16539138|NCT00948974|40435898|FG001|Overall Study|Lost to Follow-up|20|||
16539139|NCT02856113|40435901|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16539140|NCT02856113|40435902|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
16539141|NCT02856113|40435901|FG000|Overall Study|Significant Protocol Deviation|1|||
16539142|NCT02856113|40435902|FG001|Overall Study|Significant Protocol Deviation|0|||
16539143|NCT02856113|40435901|FG000|Overall Study|Lost to Follow-up|3|||
16539144|NCT02856113|40435902|FG001|Overall Study|Lost to Follow-up|5|||
16539145|NCT02856113|40435901|FG000|Overall Study|Voluntary Withdrawal|3|||
16539146|NCT02856113|40435902|FG001|Overall Study|Voluntary Withdrawal|5|||
16217270|NCT01362049|39275911|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
16217271|NCT01362049|39275908|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
16217272|NCT01362049|39275909|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
16217273|NCT01362049|39275910|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
16217274|NCT01362049|39275911|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
16217275|NCT01603628|39275916|FG000|Overall Study|Personal Reasons|1|||
16339922|NCT03538691|39730342|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
16539147|NCT02856113|40435901|FG000|Overall Study|Pregnancy|0|||
16539148|NCT02856113|40435902|FG001|Overall Study|Pregnancy|1|||
16539149|NCT02856113|40435901|FG000|Overall Study|Principal Investigator Discretion|2|||
16217276|NCT01603628|39275917|FG001|Overall Study|Personal Reasons|1|||
16217277|NCT01603628|39275918|FG002|Overall Study|Personal Reasons|2|||
16217278|NCT01603628|39275916|FG000|Overall Study|Protocol Violation|1|||
16217279|NCT01603628|39275917|FG001|Overall Study|Protocol Violation|1|||
16217280|NCT01603628|39275918|FG002|Overall Study|Protocol Violation|0|||
16217281|NCT01603628|39275916|FG000|Overall Study|Lost to Follow-up|0|||
16217282|NCT01603628|39275917|FG001|Overall Study|Lost to Follow-up|1|||
16217283|NCT01603628|39275918|FG002|Overall Study|Lost to Follow-up|0|||
16217284|NCT01603628|39275916|FG000|Overall Study|Other Miscellaneous Reason|1|||
16217285|NCT01603628|39275917|FG001|Overall Study|Other Miscellaneous Reason|0|||
16217286|NCT01603628|39275918|FG002|Overall Study|Other Miscellaneous Reason|0|||
16217287|NCT04652102|39275921|FG000|Overall Study|Adverse Event|14|||
16217288|NCT04652102|39275922|FG001|Overall Study|Adverse Event|13|||
16217289|NCT04652102|39275921|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
16217290|NCT04652102|39275922|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
16217291|NCT04652102|39275921|FG000|Overall Study|Physician Decision|78|||
16217292|NCT04652102|39275922|FG001|Overall Study|Physician Decision|40|||
16217293|NCT04652102|39275921|FG000|Overall Study|Study Ended by Sponsor|64|||
16217294|NCT04652102|39275922|FG001|Overall Study|Study Ended by Sponsor|17|||
16217295|NCT04652102|39275921|FG000|Overall Study|Withdrawal by Subject|4625|||
16217296|NCT04652102|39275922|FG001|Overall Study|Withdrawal by Subject|5594|||
16217297|NCT04652102|39275921|FG000|Overall Study|Lost to Follow-up|2019|||
16217298|NCT04652102|39275922|FG001|Overall Study|Lost to Follow-up|1082|||
16217299|NCT04652102|39275921|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
16539150|NCT02856113|40435902|FG001|Overall Study|Principal Investigator Discretion|1|||
16539151|NCT02856113|40435901|FG000|Overall Study|Randomized but not Treated|1|||
16539152|NCT02856113|40435902|FG001|Overall Study|Randomized but not Treated|0|||
16539153|NCT02856113|40435901|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
16539154|NCT02856113|40435902|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
16539155|NCT04517864|40435905|FG000|Placebo-Controlled Phase|Adverse Event|1|||
16539156|NCT04517864|40435906|FG001|Placebo-Controlled Phase|Adverse Event|0|||
16539157|NCT04517864|40435905|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
16539158|NCT04517864|40435906|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
16539159|NCT04517864|40435905|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
16539160|NCT04517864|40435906|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
16539161|NCT04517864|40435905|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
16539162|NCT04517864|40435906|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
16539163|NCT04517864|40435905|FG000|Active Therapy Extension Phase|Adverse Event|1|||
16539164|NCT04517864|40435906|FG001|Active Therapy Extension Phase|Adverse Event|0|||
16539165|NCT04517864|40435905|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
16539166|NCT04517864|40435906|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
16104405|NCT03015181|38868710|FG004|Overall Study|Enrolled, but product never administered|0|||
16104406|NCT03015181|38868711|FG005|Overall Study|Enrolled, but product never administered|0|||
16104407|NCT03015181|38868712|FG006|Overall Study|Enrolled, but product never administered|0|||
16104408|NCT03015181|38868706|FG000|Overall Study|Withdrawal by Subject|0|||
16104409|NCT03015181|38868707|FG001|Overall Study|Withdrawal by Subject|0|||
16104410|NCT03015181|38868708|FG002|Overall Study|Withdrawal by Subject|0|||
16104411|NCT03015181|38868709|FG003|Overall Study|Withdrawal by Subject|0|||
16104412|NCT03015181|38868710|FG004|Overall Study|Withdrawal by Subject|0|||
16104413|NCT03015181|38868711|FG005|Overall Study|Withdrawal by Subject|1|||
16104414|NCT03015181|38868712|FG006|Overall Study|Withdrawal by Subject|0|||
16104415|NCT03015181|38868706|FG000|Overall Study|Physician Decision|0|||
16104416|NCT03015181|38868707|FG001|Overall Study|Physician Decision|0|||
16104417|NCT03015181|38868708|FG002|Overall Study|Physician Decision|0|||
16104418|NCT03015181|38868709|FG003|Overall Study|Physician Decision|0|||
16104419|NCT03015181|38868710|FG004|Overall Study|Physician Decision|0|||
16104420|NCT03015181|38868711|FG005|Overall Study|Physician Decision|0|||
16104421|NCT03015181|38868712|FG006|Overall Study|Physician Decision|1|||
16104422|NCT01774019|38868713|FG000|Overall Study|No longer meets protocol criteria|2|||
16104423|NCT01774019|38868714|FG001|Overall Study|No longer meets protocol criteria|0|||
16104424|NCT01774019|38868713|FG000|Overall Study|Withdrawal by Subject|1|||
16104425|NCT01774019|38868714|FG001|Overall Study|Withdrawal by Subject|0|||
16104426|NCT01774019|38868713|FG000|Overall Study|Surgery delayed > 120 days|1|||
16104427|NCT01774019|38868714|FG001|Overall Study|Surgery delayed > 120 days|0|||
16104428|NCT01774019|38868713|FG000|Overall Study|Patient refused surgery|1|||
16217300|NCT04652102|39275922|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
16339923|NCT03538691|39730343|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
16104429|NCT01774019|38868714|FG001|Overall Study|Patient refused surgery|1|||
16217301|NCT04652102|39275921|FG000|Overall Study|Miscellaneous|80|||
16217302|NCT04652102|39275922|FG001|Overall Study|Miscellaneous|64|||
16217303|NCT02094612|39275930|FG000|Overall Study|Lost to Follow-up|47|||
16217304|NCT02094612|39275931|FG001|Overall Study|Lost to Follow-up|47|||
16104430|NCT01774019|38868713|FG000|Overall Study|Unable to implant study device|1|||
16217305|NCT02094612|39275930|FG000|Overall Study|Never started ADHD medication|32|||
16217306|NCT02094612|39275931|FG001|Overall Study|Never started ADHD medication|23|||
16217307|NCT01051856|39275933|FG000|Overall Study|Withdrawal by Subject|1|||
16217308|NCT01051856|39275934|FG001|Overall Study|Withdrawal by Subject|0|||
16217309|NCT03303625|39275935|FG000|Overall Study|Withdrawal by Subject|2|||
16217310|NCT03303625|39275936|FG001|Overall Study|Withdrawal by Subject|0|||
16217311|NCT03303625|39275937|FG002|Overall Study|Withdrawal by Subject|0|||
16217312|NCT03303625|39275938|FG003|Overall Study|Withdrawal by Subject|0|||
16217313|NCT04062240|39275939|FG000|Overall Study|equipment malfunction|1|||
16217314|NCT00827112|39275942|FG000|Overall Study|Adverse Event|2|||
16217315|NCT00827112|39275943|FG001|Overall Study|Adverse Event|0|||
16217316|NCT00827112|39275942|FG000|Overall Study|Lack of Efficacy|2|||
16217317|NCT00827112|39275943|FG001|Overall Study|Lack of Efficacy|0|||
16217318|NCT00827112|39275942|FG000|Overall Study|Lost to Follow-up|3|||
16217319|NCT00827112|39275943|FG001|Overall Study|Lost to Follow-up|2|||
16217320|NCT00827112|39275942|FG000|Overall Study|Pregnancy|0|||
16217321|NCT00827112|39275943|FG001|Overall Study|Pregnancy|1|||
16217322|NCT00827112|39275942|FG000|Overall Study|Protocol Violation|0|||
16339924|NCT03538691|39730344|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
16217323|NCT00827112|39275943|FG001|Overall Study|Protocol Violation|2|||
16217324|NCT00827112|39275942|FG000|Overall Study|Withdrawal by Subject|2|||
16217325|NCT00827112|39275943|FG001|Overall Study|Withdrawal by Subject|1|||
16217326|NCT00827112|39275942|FG000|Overall Study|Randomized but not treated|5|||
16217327|NCT00827112|39275943|FG001|Overall Study|Randomized but not treated|3|||
16217328|NCT00827112|39275942|FG000|Overall Study|Other|1|||
16217329|NCT00827112|39275943|FG001|Overall Study|Other|3|||
16217330|NCT03598140|39275944|FG000|Overall Study|enrolled but didn't start|1|||
16217331|NCT03598140|39275945|FG001|Overall Study|enrolled but didn't start|0|||
16217332|NCT00338806|39275946|FG000|Acute Phase|Withdrawal by Subject|0|||
16217333|NCT00338806|39275947|FG001|Acute Phase|Withdrawal by Subject|1|||
16339925|NCT03538691|39730345|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
16339926|NCT03538691|39730342|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
16339927|NCT03538691|39730343|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
16217334|NCT00338806|39275946|FG000|Follow-up|Lost to Follow-up|1|||
16217335|NCT00338806|39275947|FG001|Follow-up|Lost to Follow-up|3|||
16217336|NCT00098865|39275948|FG000|Overall Study|Progressive Disease|6|||
16217337|NCT00098865|39275948|FG000|Overall Study|Adverse Event|2|||
16217338|NCT00098865|39275948|FG000|Overall Study|Alternative Therapy|1|||
16539167|NCT04517864|40435905|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
16539168|NCT04517864|40435906|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
16539169|NCT04517864|40435905|FG000|Active Therapy Extension Phase|Physician Decision|1|||
16539170|NCT04517864|40435906|FG001|Active Therapy Extension Phase|Physician Decision|0|||
16539171|NCT04517864|40435905|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
16539172|NCT04517864|40435906|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
16539173|NCT04517864|40435905|FG000|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|20|||
16539174|NCT04517864|40435906|FG001|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|24|||
16539175|NCT03266770|40435911|FG000|Overall Study|Physician Decision|3|||
16539176|NCT03266770|40435911|FG000|Overall Study|Insufficient study supplies|1|||
16539177|NCT03266770|40435911|FG000|Overall Study|Adverse Event|1|||
16539178|NCT03927950|40435912|FG000|Overall Study|Adverse Event|9|||
16539179|NCT01441102|40435913|FG000|Overall Study|Adverse Event|1|||
16539180|NCT01441102|40435913|FG000|Overall Study|Withdrawal by Subject|2|||
16539181|NCT03260868|40435919|FG000|Overall Study|Poor Compliance to Protocol|0|||
16539182|NCT03260868|40435920|FG001|Overall Study|Poor Compliance to Protocol|2|||
16539183|NCT03260868|40435919|FG000|Overall Study|Study Terminated By Sponsor|2|||
16539184|NCT03260868|40435920|FG001|Overall Study|Study Terminated By Sponsor|1|||
16539185|NCT03260868|40435919|FG000|Overall Study|Other than specified above|1|||
16539186|NCT03260868|40435920|FG001|Overall Study|Other than specified above|0|||
16539187|NCT00031486|40435924|FG000|Overall Study|Adverse Event|1|||
16539188|NCT00031486|40435925|FG001|Overall Study|Adverse Event|0|||
16539189|NCT00031486|40435924|FG000|Overall Study|Lost to Follow-up|0|||
16539190|NCT00031486|40435925|FG001|Overall Study|Lost to Follow-up|1|||
16539191|NCT00031486|40435924|FG000|Overall Study|Withdrawal by Subject|3|||
16539192|NCT00031486|40435925|FG001|Overall Study|Withdrawal by Subject|2|||
16539193|NCT00031486|40435924|FG000|Overall Study|Death|0|||
16539194|NCT00031486|40435925|FG001|Overall Study|Death|3|||
16539195|NCT00031486|40435924|FG000|Overall Study|Non-compliant|0|||
16539196|NCT00031486|40435925|FG001|Overall Study|Non-compliant|4|||
16539197|NCT00031486|40435924|FG000|Overall Study|Did not meet eligibility requirement|2|||
16539198|NCT00031486|40435925|FG001|Overall Study|Did not meet eligibility requirement|1|||
16539199|NCT00031486|40435924|FG000|Overall Study|Other|1|||
16539200|NCT00031486|40435925|FG001|Overall Study|Other|1|||
16539201|NCT03298451|40435926|FG000|Overall Study|Death|275|||
16539202|NCT03298451|40435927|FG001|Overall Study|Death|260|||
16539203|NCT03298451|40435928|FG002|Overall Study|Death|122|||
16539204|NCT03298451|40435929|FG003|Overall Study|Death|280|||
16539205|NCT03298451|40435926|FG000|Overall Study|Lost to Follow-up|1|||
16539206|NCT03298451|40435927|FG001|Overall Study|Lost to Follow-up|1|||
16539207|NCT03298451|40435928|FG002|Overall Study|Lost to Follow-up|0|||
16539208|NCT03298451|40435929|FG003|Overall Study|Lost to Follow-up|7|||
16539209|NCT03298451|40435926|FG000|Overall Study|Withdrawal by Subject|9|||
16539210|NCT03298451|40435927|FG001|Overall Study|Withdrawal by Subject|7|||
16539211|NCT03298451|40435928|FG002|Overall Study|Withdrawal by Subject|1|||
16539212|NCT03298451|40435929|FG003|Overall Study|Withdrawal by Subject|20|||
16539213|NCT02332720|40435930|FG000|Part A and Part B|Lost to Follow-up|1|||
16539214|NCT02332720|40435931|FG001|Part A and Part B|Lost to Follow-up|0|||
16539215|NCT02332720|40435932|FG002|Part A and Part B|Lost to Follow-up|0|||
16539216|NCT02332720|40435933|FG003|Part A and Part B|Lost to Follow-up|0|||
16539217|NCT02332720|40435934|FG004|Part A and Part B|Lost to Follow-up|0|||
16539218|NCT02332720|40435935|FG005|Part A and Part B|Lost to Follow-up|2|||
16539219|NCT02332720|40435936|FG006|Part A and Part B|Lost to Follow-up|1|||
16539220|NCT02332720|40435937|FG007|Part A and Part B|Lost to Follow-up|1|||
16539221|NCT02332720|40435938|FG008|Part A and Part B|Lost to Follow-up|0|||
16539222|NCT02332720|40435939|FG009|Part A and Part B|Lost to Follow-up|0|||
16539223|NCT02332720|40435940|FG010|Part A and Part B|Lost to Follow-up|0|||
16539224|NCT02332720|40435941|FG011|Part A and Part B|Lost to Follow-up|0|||
16539225|NCT02332720|40435942|FG012|Part A and Part B|Lost to Follow-up|0|||
16539226|NCT02332720|40435943|FG013|Part A and Part B|Lost to Follow-up|0|||
16539227|NCT02332720|40435944|FG014|Part A and Part B|Lost to Follow-up|0|||
16539228|NCT02332720|40435945|FG015|Part A and Part B|Lost to Follow-up|1|||
16539229|NCT02332720|40435946|FG016|Part A and Part B|Lost to Follow-up|0|||
16539230|NCT02332720|40435947|FG017|Part A and Part B|Lost to Follow-up|0|||
16539231|NCT02332720|40435948|FG018|Part A and Part B|Lost to Follow-up|0|||
16539232|NCT02332720|40435949|FG019|Part A and Part B|Lost to Follow-up|0|||
16539233|NCT02332720|40435950|FG020|Part A and Part B|Lost to Follow-up|0|||
16539234|NCT02332720|40435951|FG021|Part A and Part B|Lost to Follow-up|0|||
16539235|NCT02332720|40435952|FG022|Part A and Part B|Lost to Follow-up|0|||
16539236|NCT02332720|40435930|FG000|Part A and Part B|Adverse Event|0|||
16539237|NCT02332720|40435931|FG001|Part A and Part B|Adverse Event|0|||
16539238|NCT02332720|40435932|FG002|Part A and Part B|Adverse Event|0|||
16539239|NCT02332720|40435933|FG003|Part A and Part B|Adverse Event|0|||
16539240|NCT02332720|40435934|FG004|Part A and Part B|Adverse Event|0|||
16539241|NCT02332720|40435935|FG005|Part A and Part B|Adverse Event|0|||
16539242|NCT02332720|40435936|FG006|Part A and Part B|Adverse Event|0|||
16539243|NCT02332720|40435937|FG007|Part A and Part B|Adverse Event|0|||
16539244|NCT02332720|40435938|FG008|Part A and Part B|Adverse Event|0|||
16539245|NCT02332720|40435939|FG009|Part A and Part B|Adverse Event|0|||
16539246|NCT02332720|40435940|FG010|Part A and Part B|Adverse Event|0|||
16539247|NCT02332720|40435941|FG011|Part A and Part B|Adverse Event|0|||
16539248|NCT02332720|40435942|FG012|Part A and Part B|Adverse Event|0|||
16539249|NCT02332720|40435943|FG013|Part A and Part B|Adverse Event|0|||
16539250|NCT02332720|40435944|FG014|Part A and Part B|Adverse Event|0|||
16539251|NCT02332720|40435945|FG015|Part A and Part B|Adverse Event|0|||
16539252|NCT02332720|40435946|FG016|Part A and Part B|Adverse Event|0|||
16539253|NCT02332720|40435947|FG017|Part A and Part B|Adverse Event|1|||
16539254|NCT02332720|40435948|FG018|Part A and Part B|Adverse Event|0|||
16539255|NCT02332720|40435949|FG019|Part A and Part B|Adverse Event|0|||
16539256|NCT02332720|40435950|FG020|Part A and Part B|Adverse Event|0|||
16539257|NCT02332720|40435951|FG021|Part A and Part B|Adverse Event|0|||
16539258|NCT02332720|40435952|FG022|Part A and Part B|Adverse Event|0|||
16539259|NCT02332720|40435930|FG000|Part A and Part B|Physician Decision|0|||
16539260|NCT02332720|40435931|FG001|Part A and Part B|Physician Decision|0|||
16539261|NCT02332720|40435932|FG002|Part A and Part B|Physician Decision|0|||
16539262|NCT02332720|40435933|FG003|Part A and Part B|Physician Decision|0|||
16539263|NCT02332720|40435934|FG004|Part A and Part B|Physician Decision|0|||
16539264|NCT02332720|40435935|FG005|Part A and Part B|Physician Decision|0|||
16539265|NCT02332720|40435936|FG006|Part A and Part B|Physician Decision|0|||
16539266|NCT02332720|40435937|FG007|Part A and Part B|Physician Decision|0|||
16539267|NCT02332720|40435938|FG008|Part A and Part B|Physician Decision|0|||
16539268|NCT02332720|40435939|FG009|Part A and Part B|Physician Decision|0|||
16539269|NCT02332720|40435940|FG010|Part A and Part B|Physician Decision|0|||
16539270|NCT02332720|40435941|FG011|Part A and Part B|Physician Decision|0|||
16539271|NCT02332720|40435942|FG012|Part A and Part B|Physician Decision|0|||
16539272|NCT02332720|40435943|FG013|Part A and Part B|Physician Decision|0|||
16539273|NCT02332720|40435944|FG014|Part A and Part B|Physician Decision|0|||
16539274|NCT02332720|40435945|FG015|Part A and Part B|Physician Decision|0|||
16539275|NCT02332720|40435946|FG016|Part A and Part B|Physician Decision|0|||
16539276|NCT02332720|40435947|FG017|Part A and Part B|Physician Decision|0|||
16539277|NCT02332720|40435948|FG018|Part A and Part B|Physician Decision|1|||
16539278|NCT02332720|40435949|FG019|Part A and Part B|Physician Decision|0|||
16539279|NCT02332720|40435950|FG020|Part A and Part B|Physician Decision|0|||
16539280|NCT02332720|40435951|FG021|Part A and Part B|Physician Decision|0|||
16539281|NCT02332720|40435952|FG022|Part A and Part B|Physician Decision|0|||
16539282|NCT02332720|40435930|FG000|Part A and Part B|Withdrawal by Subject|0|||
16539283|NCT02332720|40435931|FG001|Part A and Part B|Withdrawal by Subject|0|||
16539284|NCT02332720|40435932|FG002|Part A and Part B|Withdrawal by Subject|0|||
16539285|NCT02332720|40435933|FG003|Part A and Part B|Withdrawal by Subject|0|||
16539286|NCT02332720|40435934|FG004|Part A and Part B|Withdrawal by Subject|0|||
16539287|NCT02332720|40435935|FG005|Part A and Part B|Withdrawal by Subject|1|||
16539288|NCT02332720|40435936|FG006|Part A and Part B|Withdrawal by Subject|0|||
16539289|NCT02332720|40435937|FG007|Part A and Part B|Withdrawal by Subject|0|||
16539290|NCT02332720|40435938|FG008|Part A and Part B|Withdrawal by Subject|0|||
16539291|NCT02332720|40435939|FG009|Part A and Part B|Withdrawal by Subject|0|||
16539292|NCT02332720|40435940|FG010|Part A and Part B|Withdrawal by Subject|0|||
16539293|NCT02332720|40435941|FG011|Part A and Part B|Withdrawal by Subject|0|||
16539294|NCT02332720|40435942|FG012|Part A and Part B|Withdrawal by Subject|0|||
16539295|NCT02332720|40435943|FG013|Part A and Part B|Withdrawal by Subject|0|||
16539296|NCT02332720|40435944|FG014|Part A and Part B|Withdrawal by Subject|0|||
16539297|NCT02332720|40435945|FG015|Part A and Part B|Withdrawal by Subject|0|||
16539298|NCT02332720|40435946|FG016|Part A and Part B|Withdrawal by Subject|0|||
16539299|NCT02332720|40435947|FG017|Part A and Part B|Withdrawal by Subject|0|||
16539300|NCT02332720|40435948|FG018|Part A and Part B|Withdrawal by Subject|0|||
16539301|NCT02332720|40435949|FG019|Part A and Part B|Withdrawal by Subject|1|||
16539302|NCT02332720|40435950|FG020|Part A and Part B|Withdrawal by Subject|0|||
16539303|NCT02332720|40435951|FG021|Part A and Part B|Withdrawal by Subject|0|||
16539304|NCT02332720|40435952|FG022|Part A and Part B|Withdrawal by Subject|0|||
16339928|NCT03538691|39730344|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
16104431|NCT01774019|38868714|FG001|Overall Study|Unable to implant study device|0|||
16104432|NCT01774019|38868713|FG000|Overall Study|Lost to Follow-up|0|||
16104433|NCT01774019|38868714|FG001|Overall Study|Lost to Follow-up|3|||
16104434|NCT00745121|38868716|FG000|Overall Study|Death|3|||
16104435|NCT00745121|38868717|FG001|Overall Study|Death|0|||
16104436|NCT00745121|38868716|FG000|Overall Study|Adverse Event|1|||
16104437|NCT00745121|38868717|FG001|Overall Study|Adverse Event|0|||
16104438|NCT00745121|38868716|FG000|Overall Study|Lost to Follow-up|1|||
16104439|NCT00745121|38868717|FG001|Overall Study|Lost to Follow-up|0|||
16104440|NCT00745121|38868716|FG000|Overall Study|Withdrawal by Subject|4|||
16104441|NCT00745121|38868717|FG001|Overall Study|Withdrawal by Subject|2|||
16104442|NCT02600897|38868718|FG000|Overall Study|Death|1|||
16104443|NCT02600897|38868719|FG001|Overall Study|Death|2|||
16104444|NCT02600897|38868720|FG002|Overall Study|Death|1|||
16104445|NCT02600897|38868721|FG003|Overall Study|Death|2|||
16104446|NCT02600897|38868722|FG004|Overall Study|Death|3|||
16104447|NCT02600897|38868723|FG005|Overall Study|Death|2|||
16104448|NCT02600897|38868724|FG006|Overall Study|Death|10|||
16104449|NCT02600897|38868725|FG007|Overall Study|Death|7|||
16104450|NCT02600897|38868726|FG008|Overall Study|Death|20|||
16104451|NCT02600897|38868718|FG000|Overall Study|Lost to Follow-up|1|||
16104452|NCT02600897|38868719|FG001|Overall Study|Lost to Follow-up|0|||
16104453|NCT02600897|38868720|FG002|Overall Study|Lost to Follow-up|0|||
16104454|NCT02600897|38868721|FG003|Overall Study|Lost to Follow-up|0|||
16104455|NCT02600897|38868722|FG004|Overall Study|Lost to Follow-up|0|||
16104456|NCT02600897|38868723|FG005|Overall Study|Lost to Follow-up|0|||
16104457|NCT02600897|38868724|FG006|Overall Study|Lost to Follow-up|0|||
16104458|NCT02600897|38868725|FG007|Overall Study|Lost to Follow-up|1|||
16104459|NCT02600897|38868726|FG008|Overall Study|Lost to Follow-up|0|||
16104460|NCT02600897|38868718|FG000|Overall Study|Withdrawal by Subject|0|||
16104461|NCT02600897|38868719|FG001|Overall Study|Withdrawal by Subject|0|||
16104462|NCT02600897|38868720|FG002|Overall Study|Withdrawal by Subject|0|||
16104463|NCT02600897|38868721|FG003|Overall Study|Withdrawal by Subject|0|||
16104464|NCT02600897|38868722|FG004|Overall Study|Withdrawal by Subject|0|||
16104465|NCT02600897|38868723|FG005|Overall Study|Withdrawal by Subject|0|||
16104466|NCT02600897|38868724|FG006|Overall Study|Withdrawal by Subject|0|||
16104467|NCT02600897|38868725|FG007|Overall Study|Withdrawal by Subject|4|||
16104468|NCT02600897|38868726|FG008|Overall Study|Withdrawal by Subject|2|||
16104469|NCT02600897|38868718|FG000|Overall Study|Reason Not Specified|0|||
16104470|NCT02600897|38868719|FG001|Overall Study|Reason Not Specified|0|||
16104471|NCT02600897|38868720|FG002|Overall Study|Reason Not Specified|0|||
16539305|NCT00567190|40435953|FG000|Overall Study|Death|235|||
16539306|NCT00567190|40435954|FG001|Overall Study|Death|280|||
16539307|NCT00567190|40435953|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
16539308|NCT00567190|40435954|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
16539309|NCT01951625|40435955|FG000|Treatment Period|Protocol Violation|2|||
16539310|NCT01951625|40435956|FG001|Treatment Period|Protocol Violation|0|||
16539311|NCT01951625|40435957|FG002|Treatment Period|Protocol Violation|1|||
16539312|NCT01951625|40435958|FG003|Treatment Period|Protocol Violation|3|||
16539313|NCT01951625|40435959|FG004|Treatment Period|Protocol Violation|2|||
16539314|NCT01951625|40435955|FG000|Treatment Period|Physician Decision|0|||
16539315|NCT01951625|40435956|FG001|Treatment Period|Physician Decision|0|||
16539316|NCT01951625|40435957|FG002|Treatment Period|Physician Decision|0|||
16539317|NCT01951625|40435958|FG003|Treatment Period|Physician Decision|0|||
16539318|NCT01951625|40435959|FG004|Treatment Period|Physician Decision|1|||
16539319|NCT01951625|40435955|FG000|Treatment Period|Protocol driven decision point|0|||
16539320|NCT01951625|40435956|FG001|Treatment Period|Protocol driven decision point|5|||
16539321|NCT01951625|40435957|FG002|Treatment Period|Protocol driven decision point|0|||
16539322|NCT01951625|40435958|FG003|Treatment Period|Protocol driven decision point|2|||
16539323|NCT01951625|40435959|FG004|Treatment Period|Protocol driven decision point|1|||
16539324|NCT01951625|40435955|FG000|Treatment Period|Non compliance with study drug|1|||
16539325|NCT01951625|40435956|FG001|Treatment Period|Non compliance with study drug|2|||
16539326|NCT01951625|40435957|FG002|Treatment Period|Non compliance with study drug|2|||
16539327|NCT01951625|40435958|FG003|Treatment Period|Non compliance with study drug|0|||
16539328|NCT01951625|40435959|FG004|Treatment Period|Non compliance with study drug|0|||
16104472|NCT02600897|38868721|FG003|Overall Study|Reason Not Specified|0|||
16104473|NCT02600897|38868722|FG004|Overall Study|Reason Not Specified|0|||
16104474|NCT02600897|38868723|FG005|Overall Study|Reason Not Specified|0|||
16104475|NCT02600897|38868724|FG006|Overall Study|Reason Not Specified|0|||
16104476|NCT02600897|38868725|FG007|Overall Study|Reason Not Specified|0|||
16339929|NCT03538691|39730345|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
16539329|NCT01951625|40435955|FG000|Treatment Period|Death|3|||
16539330|NCT01951625|40435956|FG001|Treatment Period|Death|2|||
16104477|NCT02600897|38868726|FG008|Overall Study|Reason Not Specified|1|||
16104478|NCT01215032|38868727|FG000|Overall Study|Adverse Event|3|||
16104479|NCT01215032|38868727|FG000|Overall Study|Lack of Efficacy|17|||
16104480|NCT01885936|38868728|FG000|Overall Study|Withdrawal by Subject|1|||
16104481|NCT01885936|38868729|FG001|Overall Study|Withdrawal by Subject|0|||
16104482|NCT01123642|38868734|FG000|Overall Study|Lost to Follow-up|23|||
16104483|NCT01123642|38868734|FG000|Overall Study|Withdrawal by Subject|9|||
16104484|NCT01123642|38868734|FG000|Overall Study|ineligible at baseline assessment|36|||
16104485|NCT02720081|38868738|FG000|Overall Study|Adverse Event|0|||
16104486|NCT02720081|38868739|FG001|Overall Study|Adverse Event|3|||
16539331|NCT01951625|40435957|FG002|Treatment Period|Death|2|||
16539332|NCT01951625|40435958|FG003|Treatment Period|Death|1|||
16539333|NCT01951625|40435959|FG004|Treatment Period|Death|2|||
16539334|NCT01951625|40435955|FG000|Treatment Period|Adverse Event|7|||
16539335|NCT01951625|40435956|FG001|Treatment Period|Adverse Event|10|||
16539336|NCT01951625|40435957|FG002|Treatment Period|Adverse Event|9|||
16539337|NCT01951625|40435958|FG003|Treatment Period|Adverse Event|8|||
16539338|NCT01951625|40435959|FG004|Treatment Period|Adverse Event|8|||
16539339|NCT01951625|40435955|FG000|Treatment Period|Withdrawal by Subject|5|||
16539340|NCT01951625|40435956|FG001|Treatment Period|Withdrawal by Subject|2|||
16539341|NCT01951625|40435957|FG002|Treatment Period|Withdrawal by Subject|1|||
16539342|NCT01951625|40435958|FG003|Treatment Period|Withdrawal by Subject|7|||
16539343|NCT01951625|40435959|FG004|Treatment Period|Withdrawal by Subject|3|||
16539344|NCT01951625|40435955|FG000|Treatment Period|Lost to Follow-up|1|||
16539345|NCT01951625|40435956|FG001|Treatment Period|Lost to Follow-up|0|||
16539346|NCT01951625|40435957|FG002|Treatment Period|Lost to Follow-up|0|||
16539347|NCT01951625|40435958|FG003|Treatment Period|Lost to Follow-up|1|||
16539348|NCT01951625|40435959|FG004|Treatment Period|Lost to Follow-up|0|||
16539349|NCT01951625|40435955|FG000|Follow Up Period|Non-compliance with study drug|1|||
16339930|NCT03538691|39730342|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
16339931|NCT03538691|39730343|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
16339932|NCT03538691|39730344|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
16339933|NCT03538691|39730345|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
16339934|NCT03538691|39730342|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
16339935|NCT03538691|39730343|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
16339936|NCT03538691|39730344|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
16339937|NCT03538691|39730345|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
16339938|NCT03538691|39730342|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
16339939|NCT03538691|39730343|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
16339940|NCT03538691|39730344|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
16339941|NCT03538691|39730345|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
16339942|NCT03538691|39730342|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
16339943|NCT03538691|39730343|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
16339944|NCT03538691|39730344|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
16339945|NCT03538691|39730345|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
16339946|NCT03538691|39730342|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
16339947|NCT03538691|39730343|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
16339948|NCT03538691|39730344|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
16339949|NCT03538691|39730345|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
16339950|NCT03538691|39730342|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
16339951|NCT03538691|39730343|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
16104487|NCT02720081|38868738|FG000|Overall Study|Protocol Violation|4|||
16104488|NCT02720081|38868739|FG001|Overall Study|Protocol Violation|1|||
16539350|NCT01951625|40435956|FG001|Follow Up Period|Non-compliance with study drug|0|||
16539351|NCT01951625|40435957|FG002|Follow Up Period|Non-compliance with study drug|0|||
16539352|NCT01951625|40435958|FG003|Follow Up Period|Non-compliance with study drug|0|||
16539353|NCT01951625|40435959|FG004|Follow Up Period|Non-compliance with study drug|0|||
16539354|NCT01951625|40435955|FG000|Follow Up Period|Death|1|||
16539355|NCT01951625|40435956|FG001|Follow Up Period|Death|3|||
16539356|NCT01951625|40435957|FG002|Follow Up Period|Death|2|||
16539357|NCT01951625|40435958|FG003|Follow Up Period|Death|2|||
16539358|NCT01951625|40435959|FG004|Follow Up Period|Death|1|||
16539359|NCT01951625|40435955|FG000|Follow Up Period|Logistical difficulties|1|||
16539360|NCT01951625|40435956|FG001|Follow Up Period|Logistical difficulties|2|||
16539361|NCT01951625|40435957|FG002|Follow Up Period|Logistical difficulties|0|||
16539362|NCT01951625|40435958|FG003|Follow Up Period|Logistical difficulties|0|||
16539363|NCT01951625|40435959|FG004|Follow Up Period|Logistical difficulties|0|||
16539364|NCT01951625|40435955|FG000|Follow Up Period|Adverse Event|0|||
16539365|NCT01951625|40435956|FG001|Follow Up Period|Adverse Event|3|||
16539366|NCT01951625|40435957|FG002|Follow Up Period|Adverse Event|2|||
16539367|NCT01951625|40435958|FG003|Follow Up Period|Adverse Event|3|||
16539368|NCT01951625|40435959|FG004|Follow Up Period|Adverse Event|5|||
16539369|NCT01951625|40435955|FG000|Follow Up Period|Withdrawal by Subject|4|||
16104489|NCT02435381|38868740|FG000|Overall Study|Lost to Follow-up|2|||
16104490|NCT02435381|38868741|FG001|Overall Study|Lost to Follow-up|1|||
16539370|NCT01951625|40435956|FG001|Follow Up Period|Withdrawal by Subject|1|||
16539371|NCT01951625|40435957|FG002|Follow Up Period|Withdrawal by Subject|0|||
16539372|NCT01951625|40435958|FG003|Follow Up Period|Withdrawal by Subject|5|||
16539373|NCT01951625|40435959|FG004|Follow Up Period|Withdrawal by Subject|3|||
16539374|NCT01951625|40435955|FG000|Follow Up Period|Lost to Follow-up|1|||
16539375|NCT01951625|40435956|FG001|Follow Up Period|Lost to Follow-up|0|||
16539376|NCT01951625|40435957|FG002|Follow Up Period|Lost to Follow-up|0|||
16539377|NCT01951625|40435958|FG003|Follow Up Period|Lost to Follow-up|1|||
16539378|NCT01951625|40435959|FG004|Follow Up Period|Lost to Follow-up|1|||
16539379|NCT01089374|40435960|FG000|Overall Study|Lost to Follow-up|3|||
16539380|NCT01089374|40435961|FG001|Overall Study|Lost to Follow-up|0|||
16539381|NCT01089374|40435960|FG000|Overall Study|Withdrawal by Subject|1|||
16539382|NCT01089374|40435961|FG001|Overall Study|Withdrawal by Subject|0|||
16539383|NCT01089374|40435960|FG000|Overall Study|Study closed early - low accrual|6|||
16539384|NCT01089374|40435961|FG001|Overall Study|Study closed early - low accrual|0|||
16539385|NCT02657317|40435965|FG000|Overall Study|Withdrawal by Subject|2|||
16539386|NCT02657317|40435966|FG001|Overall Study|Withdrawal by Subject|0|||
16539387|NCT02657317|40435965|FG000|Overall Study|Lost to Follow-up|3|||
16539388|NCT02657317|40435966|FG001|Overall Study|Lost to Follow-up|3|||
16539389|NCT03750006|40435967|FG000|Overall Study|Withdrawal by Subject|8|||
16539390|NCT03750006|40435967|FG000|Overall Study|COVID PANDEMIC|11|||
16539391|NCT01120249|40435968|FG000|Overall Study|No protocol treatment received|21|||
16539392|NCT01120249|40435969|FG001|Overall Study|No protocol treatment received|15|||
16539393|NCT01120249|40435968|FG000|Overall Study|Disease recurrence|107|||
16539394|NCT01120249|40435969|FG001|Overall Study|Disease recurrence|57|||
16539395|NCT01120249|40435968|FG000|Overall Study|Death|1|||
16539396|NCT01120249|40435969|FG001|Overall Study|Death|0|||
16539397|NCT01120249|40435968|FG000|Overall Study|Adverse Event|40|||
16539398|NCT01120249|40435969|FG001|Overall Study|Adverse Event|276|||
16539399|NCT01120249|40435968|FG000|Overall Study|Participant refusal|34|||
16539400|NCT01120249|40435969|FG001|Overall Study|Participant refusal|42|||
16539401|NCT01120249|40435968|FG000|Overall Study|Other reasons, not protocol specified|29|||
16539402|NCT01120249|40435969|FG001|Overall Study|Other reasons, not protocol specified|22|||
16539403|NCT01621126|40435970|FG000|Overall Study|Physician Decision|6|||
16539404|NCT01949311|40435972|FG000|Overall Study|Lost to Follow-up|73|||
16539405|NCT01949311|40435972|FG000|Overall Study|Terminated by Sponsor|708|||
16539406|NCT01949311|40435972|FG000|Overall Study|Withdrawal by Subject|375|||
16539407|NCT01949311|40435972|FG000|Overall Study|Lack of Efficacy|50|||
16539408|NCT01949311|40435972|FG000|Overall Study|Protocol Deviation|34|||
16539409|NCT01949311|40435972|FG000|Overall Study|Pregnancy|20|||
16539410|NCT01949311|40435972|FG000|Overall Study|Physician Decision|9|||
16539411|NCT01949311|40435972|FG000|Overall Study|Other|4|||
16539412|NCT01949311|40435972|FG000|Overall Study|Adverse Event|107|||
16539413|NCT00708916|40435973|FG000|Overall Study|Subject Noncompliance|2|||
16539414|NCT00708916|40435973|FG000|Overall Study|Adverse Event|2|||
16104491|NCT02551692|38868746|FG000|Overall Study|Lost to Follow-up|0|||
16104492|NCT02551692|38868747|FG001|Overall Study|Lost to Follow-up|1|||
16104493|NCT02551692|38868748|FG002|Overall Study|Lost to Follow-up|4|||
16539415|NCT02747238|40435974|FG000|Overall Study|Lack of Efficacy|0|||
16539416|NCT02747238|40435975|FG001|Overall Study|Lack of Efficacy|1|||
16539417|NCT02747238|40435974|FG000|Overall Study|Data lost|3|||
16539418|NCT02747238|40435975|FG001|Overall Study|Data lost|5|||
16539419|NCT03574597|40435976|FG000|Overall Study|Withdrawal by Subject|67|||
16539420|NCT03574597|40435977|FG001|Overall Study|Withdrawal by Subject|96|||
16539421|NCT03574597|40435976|FG000|Overall Study|Lost to Follow-up|192|||
16539422|NCT03574597|40435977|FG001|Overall Study|Lost to Follow-up|188|||
16539423|NCT00952822|40435978|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
16539424|NCT00952822|40435979|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
16539425|NCT00952822|40435980|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
16104494|NCT02551692|38868746|FG000|Overall Study|Withdrawal by Subject|1|||
16539426|NCT00952822|40435981|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
16104495|NCT02551692|38868747|FG001|Overall Study|Withdrawal by Subject|0|||
16406488|NCT00570037|39969811|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
16406489|NCT02150057|39969812|FG000|Overall Study|Lost to Follow-up|6|||
16406490|NCT02150057|39969813|FG001|Overall Study|Lost to Follow-up|4|||
16406491|NCT00076336|39969815|FG000|Overall Study|Death|13|||
16406492|NCT00076336|39969816|FG001|Overall Study|Death|17|||
16406493|NCT00076336|39969815|FG000|Overall Study|Adverse Event|4|||
16406494|NCT00076336|39969816|FG001|Overall Study|Adverse Event|4|||
16539427|NCT00952822|40435978|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
16539428|NCT00952822|40435979|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
16539429|NCT00952822|40435980|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
16539430|NCT00952822|40435981|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
16539431|NCT00447057|40435982|FG000|Overall Study|Adverse Event|4|||
16406495|NCT00076336|39969815|FG000|Overall Study|Lost to Follow-up|4|||
16104496|NCT02551692|38868748|FG002|Overall Study|Withdrawal by Subject|1|||
16104497|NCT00434577|38868749|FG000|Months 0-3|Serious Adverse Event|0|||
16539432|NCT00447057|40435983|FG001|Overall Study|Adverse Event|10|||
16339952|NCT03538691|39730344|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
16539433|NCT00447057|40435984|FG002|Overall Study|Adverse Event|0|||
16539434|NCT00447057|40435985|FG003|Overall Study|Adverse Event|3|||
16539435|NCT00447057|40435982|FG000|Overall Study|Death due to study disease|6|||
16539436|NCT00447057|40435983|FG001|Overall Study|Death due to study disease|4|||
16539437|NCT00447057|40435984|FG002|Overall Study|Death due to study disease|1|||
16539438|NCT00447057|40435985|FG003|Overall Study|Death due to study disease|1|||
16539439|NCT00447057|40435982|FG000|Overall Study|Lost to Follow-up|0|||
16539440|NCT00447057|40435983|FG001|Overall Study|Lost to Follow-up|1|||
16539441|NCT00447057|40435984|FG002|Overall Study|Lost to Follow-up|0|||
16539442|NCT00447057|40435985|FG003|Overall Study|Lost to Follow-up|0|||
16539443|NCT00447057|40435982|FG000|Overall Study|Entry criteria not met|1|||
16539444|NCT00447057|40435983|FG001|Overall Study|Entry criteria not met|1|||
16539445|NCT00447057|40435984|FG002|Overall Study|Entry criteria not met|0|||
16539446|NCT00447057|40435985|FG003|Overall Study|Entry criteria not met|0|||
16539447|NCT00447057|40435982|FG000|Overall Study|Protocol Violation|0|||
16539448|NCT00447057|40435983|FG001|Overall Study|Protocol Violation|1|||
16339953|NCT03538691|39730345|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
16339954|NCT03538691|39730342|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
16339955|NCT03538691|39730343|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
16339956|NCT03538691|39730344|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
16339957|NCT03538691|39730345|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
16539449|NCT00447057|40435984|FG002|Overall Study|Protocol Violation|0|||
16539450|NCT00447057|40435985|FG003|Overall Study|Protocol Violation|0|||
16539451|NCT00447057|40435982|FG000|Overall Study|Withdrawal by Subject|4|||
16539452|NCT00447057|40435983|FG001|Overall Study|Withdrawal by Subject|5|||
16539453|NCT00447057|40435984|FG002|Overall Study|Withdrawal by Subject|1|||
16539454|NCT00447057|40435985|FG003|Overall Study|Withdrawal by Subject|1|||
16539455|NCT00447057|40435982|FG000|Overall Study|Physician Decision|9|||
16539456|NCT00447057|40435983|FG001|Overall Study|Physician Decision|6|||
16539457|NCT00447057|40435984|FG002|Overall Study|Physician Decision|3|||
16539458|NCT00447057|40435985|FG003|Overall Study|Physician Decision|1|||
16539459|NCT00447057|40435982|FG000|Overall Study|Sponsor decision|1|||
16539460|NCT00447057|40435983|FG001|Overall Study|Sponsor decision|1|||
16539461|NCT00447057|40435984|FG002|Overall Study|Sponsor decision|0|||
16539462|NCT00447057|40435985|FG003|Overall Study|Sponsor decision|0|||
16539463|NCT00447057|40435982|FG000|Overall Study|Progressive disease|58|||
16539464|NCT00447057|40435983|FG001|Overall Study|Progressive disease|43|||
16539465|NCT00447057|40435984|FG002|Overall Study|Progressive disease|13|||
16539466|NCT00447057|40435985|FG003|Overall Study|Progressive disease|18|||
16539467|NCT00447057|40435982|FG000|Overall Study|Death due to adverse event|0|||
16539468|NCT00447057|40435983|FG001|Overall Study|Death due to adverse event|0|||
16539469|NCT00447057|40435984|FG002|Overall Study|Death due to adverse event|1|||
16539470|NCT00447057|40435985|FG003|Overall Study|Death due to adverse event|2|||
16539471|NCT00447057|40435982|FG000|Overall Study|Death, study drug related|0|||
16539472|NCT00447057|40435983|FG001|Overall Study|Death, study drug related|1|||
16539473|NCT00447057|40435984|FG002|Overall Study|Death, study drug related|0|||
16539474|NCT00447057|40435985|FG003|Overall Study|Death, study drug related|0|||
16539475|NCT00168038|40435989|FG000|Overall Study|Adverse Event|1|||
16539476|NCT00168038|40435989|FG000|Overall Study|Therapy failure|1|||
16539477|NCT03076970|40435997|FG000|Washout Period 2|Adverse Event|0|||
16539478|NCT03076970|40435998|FG001|Washout Period 2|Adverse Event|0|||
16539479|NCT03076970|40435999|FG002|Washout Period 2|Adverse Event|0|||
16539480|NCT03076970|40436000|FG003|Washout Period 2|Adverse Event|0|||
16539481|NCT03076970|40436001|FG004|Washout Period 2|Adverse Event|1|||
16539482|NCT03076970|40436002|FG005|Washout Period 2|Adverse Event|0|||
16539483|NCT03076970|40435997|FG000|Period 3|Withdrawal by Subject|0|||
16339958|NCT03055494|39730349|FG000|Overall Study|Lost to Follow-up|6|||
16539484|NCT03076970|40435998|FG001|Period 3|Withdrawal by Subject|0|||
16539485|NCT03076970|40435999|FG002|Period 3|Withdrawal by Subject|0|||
16539486|NCT03076970|40436000|FG003|Period 3|Withdrawal by Subject|0|||
16539487|NCT03076970|40436001|FG004|Period 3|Withdrawal by Subject|0|||
16539488|NCT03076970|40436002|FG005|Period 3|Withdrawal by Subject|1|||
16539489|NCT03076970|40435997|FG000|Period 3|Failure to meet I/E criteria|0|||
16539490|NCT03076970|40435998|FG001|Period 3|Failure to meet I/E criteria|0|||
16539491|NCT03076970|40435999|FG002|Period 3|Failure to meet I/E criteria|0|||
16539492|NCT03076970|40436000|FG003|Period 3|Failure to meet I/E criteria|0|||
16539493|NCT03076970|40436001|FG004|Period 3|Failure to meet I/E criteria|1|||
16539494|NCT03076970|40436002|FG005|Period 3|Failure to meet I/E criteria|0|||
16539495|NCT01592370|40436003|FG000|Overall Study|Disease Progression|62|||
16539496|NCT01592370|40436004|FG001|Overall Study|Disease Progression|16|||
16539497|NCT01592370|40436005|FG002|Overall Study|Disease Progression|52|||
16539498|NCT01592370|40436006|FG003|Overall Study|Disease Progression|3|||
16104498|NCT00434577|38868750|FG001|Months 0-3|Serious Adverse Event|0|||
16104499|NCT00434577|38868751|FG002|Months 0-3|Serious Adverse Event|1|||
16104500|NCT00434577|38868752|FG003|Months 0-3|Serious Adverse Event|0|||
16104501|NCT00434577|38868753|FG004|Months 0-3|Serious Adverse Event|0|||
16104502|NCT00434577|38868749|FG000|Months 0-3|Adverse Event|0|||
16104503|NCT00434577|38868750|FG001|Months 0-3|Adverse Event|1|||
16104504|NCT00434577|38868751|FG002|Months 0-3|Adverse Event|1|||
16104505|NCT00434577|38868752|FG003|Months 0-3|Adverse Event|0|||
16104506|NCT00434577|38868753|FG004|Months 0-3|Adverse Event|0|||
16104507|NCT00434577|38868749|FG000|Months 0-3|Lost to Follow-up|0|||
16104508|NCT00434577|38868750|FG001|Months 0-3|Lost to Follow-up|0|||
16104509|NCT00434577|38868751|FG002|Months 0-3|Lost to Follow-up|0|||
16104510|NCT00434577|38868752|FG003|Months 0-3|Lost to Follow-up|0|||
16104511|NCT00434577|38868753|FG004|Months 0-3|Lost to Follow-up|2|||
16539499|NCT01592370|40436007|FG004|Overall Study|Disease Progression|3|||
16539500|NCT01592370|40436008|FG005|Overall Study|Disease Progression|31|||
16539501|NCT01592370|40436009|FG006|Overall Study|Disease Progression|14|||
16539502|NCT01592370|40436003|FG000|Overall Study|Study Drug Toxicity|14|||
16539503|NCT01592370|40436004|FG001|Overall Study|Study Drug Toxicity|3|||
16539504|NCT01592370|40436005|FG002|Overall Study|Study Drug Toxicity|0|||
16539505|NCT01592370|40436006|FG003|Overall Study|Study Drug Toxicity|0|||
16539506|NCT01592370|40436007|FG004|Overall Study|Study Drug Toxicity|0|||
16539507|NCT01592370|40436008|FG005|Overall Study|Study Drug Toxicity|0|||
16539508|NCT01592370|40436009|FG006|Overall Study|Study Drug Toxicity|1|||
16539509|NCT01592370|40436003|FG000|Overall Study|AE unrelated to study drug|4|||
16539510|NCT01592370|40436004|FG001|Overall Study|AE unrelated to study drug|3|||
16539511|NCT01592370|40436005|FG002|Overall Study|AE unrelated to study drug|0|||
16539512|NCT01592370|40436006|FG003|Overall Study|AE unrelated to study drug|0|||
16539513|NCT01592370|40436007|FG004|Overall Study|AE unrelated to study drug|0|||
16539514|NCT01592370|40436008|FG005|Overall Study|AE unrelated to study drug|0|||
16539515|NCT01592370|40436009|FG006|Overall Study|AE unrelated to study drug|1|||
16539516|NCT01592370|40436003|FG000|Overall Study|Request to discontinue study treatment|5|||
16539517|NCT01592370|40436004|FG001|Overall Study|Request to discontinue study treatment|0|||
16539518|NCT01592370|40436005|FG002|Overall Study|Request to discontinue study treatment|2|||
16539519|NCT01592370|40436006|FG003|Overall Study|Request to discontinue study treatment|0|||
16539520|NCT01592370|40436007|FG004|Overall Study|Request to discontinue study treatment|1|||
16539521|NCT01592370|40436008|FG005|Overall Study|Request to discontinue study treatment|2|||
16539522|NCT01592370|40436009|FG006|Overall Study|Request to discontinue study treatment|0|||
16539523|NCT01592370|40436003|FG000|Overall Study|Withdrew consent|1|||
16539524|NCT01592370|40436004|FG001|Overall Study|Withdrew consent|2|||
16539525|NCT01592370|40436005|FG002|Overall Study|Withdrew consent|1|||
16539526|NCT01592370|40436006|FG003|Overall Study|Withdrew consent|1|||
16539527|NCT01592370|40436007|FG004|Overall Study|Withdrew consent|0|||
16539528|NCT01592370|40436008|FG005|Overall Study|Withdrew consent|0|||
16539529|NCT01592370|40436009|FG006|Overall Study|Withdrew consent|0|||
16539530|NCT01592370|40436003|FG000|Overall Study|Maximum clinical benefit|11|||
16539531|NCT01592370|40436004|FG001|Overall Study|Maximum clinical benefit|1|||
16539532|NCT01592370|40436005|FG002|Overall Study|Maximum clinical benefit|7|||
16539533|NCT01592370|40436006|FG003|Overall Study|Maximum clinical benefit|1|||
16539534|NCT01592370|40436007|FG004|Overall Study|Maximum clinical benefit|0|||
16539535|NCT01592370|40436008|FG005|Overall Study|Maximum clinical benefit|0|||
16539536|NCT01592370|40436009|FG006|Overall Study|Maximum clinical benefit|0|||
16539537|NCT01592370|40436003|FG000|Overall Study|No longer meets study criteria|1|||
16539538|NCT01592370|40436004|FG001|Overall Study|No longer meets study criteria|0|||
16539539|NCT01592370|40436005|FG002|Overall Study|No longer meets study criteria|0|||
16539540|NCT01592370|40436006|FG003|Overall Study|No longer meets study criteria|0|||
16539541|NCT01592370|40436007|FG004|Overall Study|No longer meets study criteria|0|||
16539542|NCT01592370|40436008|FG005|Overall Study|No longer meets study criteria|0|||
16539543|NCT01592370|40436009|FG006|Overall Study|No longer meets study criteria|0|||
16539544|NCT01592370|40436003|FG000|Overall Study|Other Reasons|6|||
16539545|NCT01592370|40436004|FG001|Overall Study|Other Reasons|0|||
16104512|NCT00434577|38868749|FG000|Months 0-3|Protocol Violation|1|||
16104513|NCT00434577|38868750|FG001|Months 0-3|Protocol Violation|0|||
16104514|NCT00434577|38868751|FG002|Months 0-3|Protocol Violation|1|||
16104515|NCT00434577|38868752|FG003|Months 0-3|Protocol Violation|0|||
16104516|NCT00434577|38868753|FG004|Months 0-3|Protocol Violation|0|||
16104517|NCT00434577|38868749|FG000|Months 0-3|Withdrawal by Subject|2|||
16539546|NCT01592370|40436005|FG002|Overall Study|Other Reasons|10|||
16539547|NCT01592370|40436006|FG003|Overall Study|Other Reasons|0|||
16539548|NCT01592370|40436007|FG004|Overall Study|Other Reasons|0|||
16539549|NCT01592370|40436008|FG005|Overall Study|Other Reasons|1|||
16539550|NCT01592370|40436009|FG006|Overall Study|Other Reasons|0|||
16539551|NCT02436330|40436017|FG000|Cohort 1|Lost to Follow-up|5|||
16539552|NCT02436330|40436018|FG001|Cohort 1|Lost to Follow-up|2|||
16539553|NCT02436330|40436017|FG000|Cohort 1|Withdrawal by Subject|0|||
16539554|NCT02436330|40436018|FG001|Cohort 1|Withdrawal by Subject|1|||
16539555|NCT02436330|40436017|FG000|Cohort 2|Lost to Follow-up|2|||
16104518|NCT00434577|38868750|FG001|Months 0-3|Withdrawal by Subject|1|||
16104519|NCT00434577|38868751|FG002|Months 0-3|Withdrawal by Subject|1|||
16104520|NCT00434577|38868752|FG003|Months 0-3|Withdrawal by Subject|1|||
16104521|NCT00434577|38868753|FG004|Months 0-3|Withdrawal by Subject|1|||
16104522|NCT02236598|38868754|FG000|Overall Study|Adverse Event|0|||
16539556|NCT02436330|40436018|FG001|Cohort 2|Lost to Follow-up|0|||
16104523|NCT02236598|38868755|FG001|Overall Study|Adverse Event|1|||
16104524|NCT02236598|38868754|FG000|Overall Study|Withdrawal by Subject|0|||
16104525|NCT02236598|38868755|FG001|Overall Study|Withdrawal by Subject|1|||
16104526|NCT00644332|38868756|FG000|Overall Study|Adverse Event|11|||
16104527|NCT00644332|38868756|FG000|Overall Study|Withdrawal by Subject|6|||
16104528|NCT00644332|38868756|FG000|Overall Study|Completion Status Unknown|2|||
16104529|NCT00644332|38868756|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
16104530|NCT00644332|38868756|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
16104531|NCT01393613|38868758|FG000|Overall Study|Adverse Event|11|||
16104532|NCT01393613|38868759|FG001|Overall Study|Adverse Event|11|||
16104533|NCT01393613|38868760|FG002|Overall Study|Adverse Event|13|||
16104534|NCT01393613|38868761|FG003|Overall Study|Adverse Event|22|||
16104535|NCT01393613|38868758|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
16539557|NCT02436330|40436017|FG000|Cohort 2|Withdrawal by Subject|2|||
16539558|NCT02436330|40436018|FG001|Cohort 2|Withdrawal by Subject|3|||
16539559|NCT02436330|40436017|FG000|Cohort 3|Lost to Follow-up|1|||
16539560|NCT02436330|40436018|FG001|Cohort 3|Lost to Follow-up|0|||
16539561|NCT02436330|40436017|FG000|Cohort 3|Withdrawal by Subject|4|||
16539562|NCT02436330|40436018|FG001|Cohort 3|Withdrawal by Subject|0|||
16539563|NCT02436330|40436017|FG000|Cohort 4|Lost to Follow-up|1|||
16104536|NCT01393613|38868759|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
16104537|NCT01393613|38868760|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
16104538|NCT01393613|38868761|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
16104539|NCT01393613|38868758|FG000|Overall Study|Physician Decision|2|||
16104540|NCT01393613|38868759|FG001|Overall Study|Physician Decision|0|||
16104541|NCT01393613|38868760|FG002|Overall Study|Physician Decision|0|||
16104542|NCT01393613|38868761|FG003|Overall Study|Physician Decision|1|||
16217339|NCT01610414|39275949|FG000|Study Start - Month 13|Serious Adverse Event|65|||
16339959|NCT03055494|39730350|FG001|Overall Study|Lost to Follow-up|0|||
16339960|NCT03055494|39730349|FG000|Overall Study|Physician Decision|2|||
16339961|NCT03055494|39730350|FG001|Overall Study|Physician Decision|0|||
16339962|NCT03055494|39730349|FG000|Overall Study|Withdrawal by Subject|1|||
16539564|NCT02436330|40436018|FG001|Cohort 4|Lost to Follow-up|0|||
16539565|NCT02436330|40436017|FG000|Cohort 4|Withdrawal by Subject|1|||
16539566|NCT02436330|40436018|FG001|Cohort 4|Withdrawal by Subject|0|||
16217340|NCT01610414|39275950|FG001|Study Start - Month 13|Serious Adverse Event|67|||
16339963|NCT03055494|39730350|FG001|Overall Study|Withdrawal by Subject|0|||
16539567|NCT02436330|40436017|FG000|Cohort 5|Lost to Follow-up|3|||
16539568|NCT02436330|40436018|FG001|Cohort 5|Lost to Follow-up|2|||
16539569|NCT02436330|40436017|FG000|Cohort 5|Withdrawal by Subject|3|||
16539570|NCT02436330|40436018|FG001|Cohort 5|Withdrawal by Subject|2|||
16539571|NCT02436330|40436017|FG000|Cohort 6|Lost to Follow-up|2|||
16539572|NCT02436330|40436018|FG001|Cohort 6|Lost to Follow-up|0|||
16539573|NCT02436330|40436017|FG000|Cohort 6|Withdrawal by Subject|1|||
16539574|NCT02436330|40436018|FG001|Cohort 6|Withdrawal by Subject|1|||
16539575|NCT00117676|40436019|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
16539576|NCT00117676|40436020|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
16539577|NCT00117676|40436019|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
16104543|NCT01393613|38868758|FG000|Overall Study|Withdrawal by Subject|15|||
16104544|NCT01393613|38868759|FG001|Overall Study|Withdrawal by Subject|25|||
16339964|NCT03055494|39730349|FG000|Overall Study|Adverse Event|0|||
16339965|NCT03055494|39730350|FG001|Overall Study|Adverse Event|1|||
16339966|NCT03055494|39730349|FG000|Overall Study|Non-compliance with study treatment|1|||
16339967|NCT03055494|39730350|FG001|Overall Study|Non-compliance with study treatment|0|||
16339968|NCT00314808|39730351|FG000|Overall Study|Disease Progression without AE|4|||
16406496|NCT00076336|39969816|FG001|Overall Study|Lost to Follow-up|4|||
16539578|NCT00117676|40436020|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
16539579|NCT00117676|40436019|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
16104545|NCT01393613|38868760|FG002|Overall Study|Withdrawal by Subject|23|||
16104546|NCT01393613|38868761|FG003|Overall Study|Withdrawal by Subject|21|||
16104547|NCT01393613|38868758|FG000|Overall Study|Protocol Deviation|2|||
16339969|NCT00314808|39730351|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
16406497|NCT00076336|39969815|FG000|Overall Study|Non-Compliance|2|||
16539580|NCT00117676|40436020|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
16539581|NCT00117676|40436019|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
16104548|NCT01393613|38868759|FG001|Overall Study|Protocol Deviation|1|||
16104549|NCT01393613|38868760|FG002|Overall Study|Protocol Deviation|0|||
16104550|NCT01393613|38868761|FG003|Overall Study|Protocol Deviation|0|||
16104551|NCT01393613|38868758|FG000|Overall Study|Lack of Efficacy|9|||
16104552|NCT01393613|38868759|FG001|Overall Study|Lack of Efficacy|20|||
16104553|NCT01393613|38868760|FG002|Overall Study|Lack of Efficacy|16|||
16104554|NCT01393613|38868761|FG003|Overall Study|Lack of Efficacy|21|||
16104555|NCT00084747|38868767|FG000|Overall Study|Relapsed|8|||
16104556|NCT00084747|38868767|FG000|Overall Study|Death|3|||
16104557|NCT00084747|38868767|FG000|Overall Study|Withdrawal by Subject|2|||
16104558|NCT01537120|38868768|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
16104559|NCT01537120|38868768|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
16104560|NCT01183013|38872047|FG000|Overall Study|Adverse Event|6|||
16104561|NCT01183013|38872048|FG001|Overall Study|Adverse Event|8|||
16104562|NCT01183013|38872049|FG002|Overall Study|Adverse Event|5|||
16104563|NCT01183013|38872050|FG003|Overall Study|Adverse Event|5|||
16104564|NCT01183013|38872051|FG004|Overall Study|Adverse Event|10|||
16217341|NCT01610414|39275949|FG000|Study Start - Month 13|Adverse Event|14|||
16217342|NCT01610414|39275950|FG001|Study Start - Month 13|Adverse Event|14|||
16217343|NCT01610414|39275949|FG000|Study Start - Month 13|Protocol Violation|3|||
16217344|NCT01610414|39275950|FG001|Study Start - Month 13|Protocol Violation|1|||
16217345|NCT01610414|39275949|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
16217346|NCT01610414|39275950|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
16217347|NCT01610414|39275949|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
16217348|NCT01610414|39275950|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
16217349|NCT01610414|39275949|FG000|Study Start - Month 13|Lost to Follow-up|4|||
16217350|NCT01610414|39275950|FG001|Study Start - Month 13|Lost to Follow-up|6|||
16217351|NCT01610414|39275949|FG000|Study Start - Month 13|Suspected HZ episode|1|||
16217352|NCT01610414|39275950|FG001|Study Start - Month 13|Suspected HZ episode|3|||
16217353|NCT01610414|39275949|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
16217354|NCT01610414|39275950|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
16217355|NCT01610414|39275949|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
16217356|NCT01610414|39275950|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
16217357|NCT01610414|39275949|FG000|Month 13 - Month 25|Adverse Event|8|||
16217358|NCT01610414|39275950|FG001|Month 13 - Month 25|Adverse Event|4|||
16217359|NCT01610414|39275949|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
16217360|NCT01610414|39275950|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
16217361|NCT01610414|39275949|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
16217362|NCT01610414|39275950|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
16217363|NCT01610414|39275949|FG000|Month 13 - Month 25|Protocol Violation|0|||
16217364|NCT01610414|39275950|FG001|Month 13 - Month 25|Protocol Violation|2|||
16217365|NCT01610414|39275949|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
16217366|NCT01610414|39275950|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
16217367|NCT01610414|39275949|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
16217368|NCT01610414|39275950|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
16217369|NCT01610414|39275949|FG000|After Month 25|Study end not reached|48|||
16104565|NCT01183013|38872052|FG005|Overall Study|Adverse Event|10|||
16104566|NCT01183013|38872053|FG006|Overall Study|Adverse Event|6|||
16104567|NCT01183013|38872047|FG000|Overall Study|Lack of Efficacy|3|||
16104568|NCT01183013|38872048|FG001|Overall Study|Lack of Efficacy|2|||
16104569|NCT01183013|38872049|FG002|Overall Study|Lack of Efficacy|1|||
16104570|NCT01183013|38872050|FG003|Overall Study|Lack of Efficacy|2|||
16217370|NCT01610414|39275950|FG001|After Month 25|Study end not reached|53|||
16217371|NCT00939341|39275951|FG000|Overall Study|Adverse Event|15|||
16217372|NCT00939341|39275951|FG000|Overall Study|Pregnancy|1|||
16217373|NCT00939341|39275951|FG000|Overall Study|Lost to Follow-up|23|||
16217374|NCT00939341|39275951|FG000|Overall Study|Withdrawal by Subject|13|||
16104571|NCT01183013|38872051|FG004|Overall Study|Lack of Efficacy|1|||
16104572|NCT01183013|38872052|FG005|Overall Study|Lack of Efficacy|2|||
16104573|NCT01183013|38872053|FG006|Overall Study|Lack of Efficacy|0|||
16104574|NCT01183013|38872047|FG000|Overall Study|Protocol Violation|5|||
16217375|NCT00939341|39275951|FG000|Overall Study|Protocol Violation|6|||
16217376|NCT00939341|39275951|FG000|Overall Study|Incorrect enrolment|8|||
16217377|NCT00394654|39275952|FG000|Overall Study|Lost to Follow-up|1|||
16104575|NCT01183013|38872048|FG001|Overall Study|Protocol Violation|2|||
16104576|NCT01183013|38872049|FG002|Overall Study|Protocol Violation|4|||
16104577|NCT01183013|38872050|FG003|Overall Study|Protocol Violation|0|||
16104578|NCT01183013|38872051|FG004|Overall Study|Protocol Violation|4|||
16104579|NCT01183013|38872052|FG005|Overall Study|Protocol Violation|3|||
16104580|NCT01183013|38872053|FG006|Overall Study|Protocol Violation|3|||
16104581|NCT01183013|38872047|FG000|Overall Study|Lost to Follow-up|7|||
16104582|NCT01183013|38872048|FG001|Overall Study|Lost to Follow-up|3|||
16104583|NCT01183013|38872049|FG002|Overall Study|Lost to Follow-up|4|||
16104584|NCT01183013|38872050|FG003|Overall Study|Lost to Follow-up|3|||
16104585|NCT01183013|38872051|FG004|Overall Study|Lost to Follow-up|2|||
16104586|NCT01183013|38872052|FG005|Overall Study|Lost to Follow-up|6|||
16104587|NCT01183013|38872053|FG006|Overall Study|Lost to Follow-up|5|||
16104588|NCT01183013|38872047|FG000|Overall Study|Withdrawal by Subject|9|||
16104589|NCT01183013|38872048|FG001|Overall Study|Withdrawal by Subject|13|||
16104590|NCT01183013|38872049|FG002|Overall Study|Withdrawal by Subject|10|||
16104591|NCT01183013|38872050|FG003|Overall Study|Withdrawal by Subject|8|||
16104592|NCT01183013|38872051|FG004|Overall Study|Withdrawal by Subject|7|||
16104593|NCT01183013|38872052|FG005|Overall Study|Withdrawal by Subject|9|||
16104594|NCT01183013|38872053|FG006|Overall Study|Withdrawal by Subject|10|||
16104595|NCT01183013|38872047|FG000|Overall Study|Reasons other than stated above|15|||
16104596|NCT01183013|38872048|FG001|Overall Study|Reasons other than stated above|11|||
16104597|NCT01183013|38872049|FG002|Overall Study|Reasons other than stated above|17|||
16104598|NCT01183013|38872050|FG003|Overall Study|Reasons other than stated above|12|||
16104599|NCT01183013|38872051|FG004|Overall Study|Reasons other than stated above|12|||
16104600|NCT01183013|38872052|FG005|Overall Study|Reasons other than stated above|15|||
16104601|NCT01183013|38872053|FG006|Overall Study|Reasons other than stated above|13|||
16104602|NCT01004185|38872054|FG000|Overall Study|Adverse Event|1|||
16104603|NCT01004185|38872055|FG001|Overall Study|Adverse Event|1|||
16104604|NCT01004185|38872054|FG000|Overall Study|Lost to Follow-up|0|||
16104605|NCT01004185|38872055|FG001|Overall Study|Lost to Follow-up|1|||
16104606|NCT01004185|38872054|FG000|Overall Study|Lack of Efficacy|2|||
16104607|NCT01004185|38872055|FG001|Overall Study|Lack of Efficacy|1|||
16104608|NCT01004185|38872054|FG000|Overall Study|Sponsor Terminated Study|4|||
16104609|NCT01004185|38872055|FG001|Overall Study|Sponsor Terminated Study|5|||
16104610|NCT01004185|38872054|FG000|Overall Study|Withdrawal by Subject|2|||
16104611|NCT01004185|38872055|FG001|Overall Study|Withdrawal by Subject|1|||
16104612|NCT02158247|38872058|FG000|Overall Study|Invisible vocal cords|5|||
16104613|NCT00092521|38872066|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
16104614|NCT00092521|38872067|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
16104615|NCT00092521|38872068|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
16104616|NCT00092521|38872069|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
16104617|NCT00092521|38872066|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
16104618|NCT00092521|38872067|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
16104619|NCT00092521|38872068|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
16104620|NCT00092521|38872069|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
16104621|NCT00092521|38872066|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
16104622|NCT00092521|38872067|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
16104623|NCT00092521|38872068|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
16104624|NCT00092521|38872069|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
16104625|NCT00092521|38872066|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
16104626|NCT00092521|38872067|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
16217378|NCT00394654|39275953|FG001|Overall Study|Lost to Follow-up|0|||
16217379|NCT00394654|39275952|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
16217380|NCT00394654|39275953|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
16217381|NCT03419741|39275955|FG000|Overall Study|Adverse Event|1|||
16217382|NCT03419741|39275956|FG001|Overall Study|Adverse Event|0|||
16406498|NCT00076336|39969816|FG001|Overall Study|Non-Compliance|0|||
16104627|NCT00092521|38872068|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
16406499|NCT00076336|39969815|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
16406500|NCT00076336|39969816|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
16104628|NCT00092521|38872069|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
16104629|NCT00092521|38872066|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
16104630|NCT00092521|38872067|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
16104631|NCT00092521|38872068|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
16104632|NCT00092521|38872069|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
16104633|NCT00092521|38872066|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
16104634|NCT00092521|38872067|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
16104635|NCT00092521|38872068|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
16104636|NCT00092521|38872069|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
16104637|NCT00092521|38872066|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
16104638|NCT00092521|38872067|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
16104639|NCT00092521|38872068|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
16104640|NCT00092521|38872069|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
16104641|NCT00092521|38872066|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
16104642|NCT00092521|38872067|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
16104643|NCT00092521|38872068|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
16104644|NCT00092521|38872069|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
16104645|NCT00092521|38872066|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
16406501|NCT00076336|39969815|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
16406502|NCT00076336|39969816|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
16406503|NCT00076336|39969815|FG000|Overall Study|Liver Transplantation|3|||
16406504|NCT00076336|39969816|FG001|Overall Study|Liver Transplantation|3|||
16406505|NCT00076336|39969815|FG000|Overall Study|Virologic Breakthrough|14|||
16406506|NCT00076336|39969816|FG001|Overall Study|Virologic Breakthrough|16|||
16406507|NCT00076336|39969815|FG000|Overall Study|Treatment failure|4|||
16406508|NCT00076336|39969816|FG001|Overall Study|Treatment failure|5|||
16406509|NCT03351114|39969828|FG000|Overall Study|Withdrawal by Subject|1|||
16406510|NCT00515294|39969833|FG000|Overall Study|Lost to Follow-up|3|||
16406511|NCT00515294|39969834|FG001|Overall Study|Lost to Follow-up|2|||
16406512|NCT00515294|39969835|FG002|Overall Study|Lost to Follow-up|3|||
16406513|NCT00515294|39969836|FG003|Overall Study|Lost to Follow-up|1|||
16406514|NCT00515294|39969833|FG000|Overall Study|Driver simulator problems|1|||
16406515|NCT00515294|39969834|FG001|Overall Study|Driver simulator problems|1|||
16406516|NCT00515294|39969835|FG002|Overall Study|Driver simulator problems|1|||
16406517|NCT00515294|39969836|FG003|Overall Study|Driver simulator problems|3|||
16406518|NCT00515294|39969833|FG000|Overall Study|Caffeine amount inaccurate|5|||
16406519|NCT00515294|39969834|FG001|Overall Study|Caffeine amount inaccurate|0|||
16406520|NCT00515294|39969835|FG002|Overall Study|Caffeine amount inaccurate|7|||
16406521|NCT00515294|39969836|FG003|Overall Study|Caffeine amount inaccurate|0|||
16406522|NCT02596958|39969837|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
16406523|NCT02596958|39969837|FG000|Overall Study|Cancer Progression|441|||
16406524|NCT02596958|39969837|FG000|Overall Study|Death From Cancer|112|||
16406525|NCT02596958|39969837|FG000|Overall Study|Death From Other Cause|33|||
16406526|NCT02596958|39969837|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
16104646|NCT00092521|38872067|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
16104647|NCT00092521|38872068|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
16104648|NCT00092521|38872069|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
16104649|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
16104650|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
16104651|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
16104652|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
16104653|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
16104654|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
16104655|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
16104656|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
16104657|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
16104658|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
16104659|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
16104660|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
16104661|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Death|2|||
16104662|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Death|0|||
16104663|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Death|1|||
16104664|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Death|0|||
16104665|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
16104666|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
16104667|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
16104668|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
16104669|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
16104670|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
16104671|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
16104672|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
16104673|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
16104674|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
16104675|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
16104676|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
16104677|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Moved|32|||
16104678|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Moved|2|||
16104679|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Moved|28|||
16104680|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Moved|0|||
16104681|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
16339970|NCT03594955|39730352|FG000|Overall Study|Adverse Event|1|||
16406527|NCT02596958|39969837|FG000|Overall Study|Administrative Reasons/Other|231|||
16406528|NCT02596958|39969837|FG000|Overall Study|Lost to Follow-up|33|||
16104682|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
16104683|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
16104684|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
16104685|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Travel|2|||
16104686|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Travel|0|||
16104687|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Travel|0|||
16104688|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Travel|0|||
16104689|NCT00092521|38872066|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
16104690|NCT00092521|38872067|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
16104691|NCT00092521|38872068|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
16104692|NCT00092521|38872069|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
16104693|NCT00092521|38872066|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
16104694|NCT00092521|38872067|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
16104695|NCT00092521|38872068|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
16104696|NCT00092521|38872069|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
16104697|NCT00092521|38872066|FG000|Extension Study (Group 4)|Adverse Event|0|||
16104698|NCT00092521|38872067|FG001|Extension Study (Group 4)|Adverse Event|0|||
16104699|NCT00092521|38872068|FG002|Extension Study (Group 4)|Adverse Event|0|||
16104700|NCT00092521|38872069|FG003|Extension Study (Group 4)|Adverse Event|2|||
16104701|NCT00092521|38872066|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
16104702|NCT00092521|38872067|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
16104703|NCT00092521|38872068|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
16104704|NCT00092521|38872069|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
16104705|NCT00092521|38872066|FG000|Extension Study (Group 4)|Pregnancy|0|||
16104706|NCT00092521|38872067|FG001|Extension Study (Group 4)|Pregnancy|0|||
16104707|NCT00092521|38872068|FG002|Extension Study (Group 4)|Pregnancy|0|||
16104708|NCT00092521|38872069|FG003|Extension Study (Group 4)|Pregnancy|4|||
16104709|NCT00092521|38872066|FG000|Extension Study (Group 4)|Protocol Violation|0|||
16104710|NCT00092521|38872067|FG001|Extension Study (Group 4)|Protocol Violation|0|||
16104711|NCT00092521|38872068|FG002|Extension Study (Group 4)|Protocol Violation|0|||
16104712|NCT00092521|38872069|FG003|Extension Study (Group 4)|Protocol Violation|2|||
16104713|NCT00092521|38872066|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
16104714|NCT00092521|38872067|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
16104715|NCT00092521|38872068|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
16104716|NCT00092521|38872069|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
16104717|NCT00092521|38872066|FG000|Extension Study (Group 4)|Moved|0|||
16104718|NCT00092521|38872067|FG001|Extension Study (Group 4)|Moved|0|||
16104719|NCT00092521|38872068|FG002|Extension Study (Group 4)|Moved|0|||
16104720|NCT00092521|38872069|FG003|Extension Study (Group 4)|Moved|16|||
16104721|NCT00092521|38872066|FG000|Extension Study (Group 4)|Site Terminated|0|||
16104722|NCT00092521|38872067|FG001|Extension Study (Group 4)|Site Terminated|0|||
16104723|NCT00092521|38872068|FG002|Extension Study (Group 4)|Site Terminated|0|||
16104724|NCT00092521|38872069|FG003|Extension Study (Group 4)|Site Terminated|4|||
16104725|NCT00092521|38872066|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
16104726|NCT00092521|38872067|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
16104727|NCT00092521|38872068|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
16104728|NCT00092521|38872069|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
16104729|NCT00451555|38872070|FG000|Overall Study|Protocol Violation|2|||
16104730|NCT00451555|38872071|FG001|Overall Study|Protocol Violation|2|||
16104731|NCT00451555|38872070|FG000|Overall Study|Adverse Event|3|||
16104732|NCT00451555|38872071|FG001|Overall Study|Adverse Event|1|||
16104733|NCT00451555|38872070|FG000|Overall Study|Withdrawal by Subject|6|||
16104734|NCT00451555|38872071|FG001|Overall Study|Withdrawal by Subject|0|||
16104735|NCT00451555|38872070|FG000|Overall Study|Physician Decision|2|||
16339971|NCT03594955|39730352|FG000|Overall Study|Progressive disease|5|||
16339972|NCT03594955|39730352|FG000|Overall Study|Sponsor's decision|1|||
16339973|NCT04676152|39730353|FG000|Overall Study|screen fail|9|||
16339974|NCT02776670|39730354|FG000|Overall Study|Adverse Event|0|||
16339975|NCT02776670|39730355|FG001|Overall Study|Adverse Event|2|||
16339976|NCT02776670|39730354|FG000|Overall Study|Protocol Violation|0|||
16339977|NCT02776670|39730355|FG001|Overall Study|Protocol Violation|2|||
16339978|NCT02776670|39730354|FG000|Overall Study|Withdrawal by Subject|0|||
16339979|NCT02776670|39730355|FG001|Overall Study|Withdrawal by Subject|1|||
16339980|NCT02776670|39730354|FG000|Overall Study|Other - Reason not given|0|||
16339981|NCT02776670|39730355|FG001|Overall Study|Other - Reason not given|1|||
16339982|NCT00966355|39730358|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
16339983|NCT00966355|39730359|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
16339984|NCT00966355|39730360|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
16339985|NCT00966355|39730358|FG000|Overall Study|newly diagnosed advanced HCC|11|||
16104736|NCT00451555|38872071|FG001|Overall Study|Physician Decision|1|||
16339986|NCT00966355|39730359|FG001|Overall Study|newly diagnosed advanced HCC|12|||
16339987|NCT00966355|39730360|FG002|Overall Study|newly diagnosed advanced HCC|10|||
16339988|NCT00966355|39730358|FG000|Overall Study|Lost to Follow-up|5|||
16339989|NCT00966355|39730359|FG001|Overall Study|Lost to Follow-up|4|||
16104737|NCT03410108|38872072|FG000|Overall Study|Ongoing|41|||
16104738|NCT03410108|38872072|FG000|Overall Study|Adverse Event|4|||
16104739|NCT03410108|38872072|FG000|Overall Study|Progressive Disease|58|||
16104740|NCT03410108|38872072|FG000|Overall Study|Withdrawal by Subject|1|||
16104741|NCT03796208|38872073|FG000|Overall Study|Withdrawal by Subject|3|||
16104742|NCT03796208|38872074|FG001|Overall Study|Withdrawal by Subject|0|||
16104743|NCT03796208|38872073|FG000|Overall Study|Loss of pregnancy|1|||
16104744|NCT03796208|38872074|FG001|Overall Study|Loss of pregnancy|1|||
16104745|NCT03796208|38872073|FG000|Overall Study|Changed prenatal clinics|0|||
16104746|NCT03796208|38872074|FG001|Overall Study|Changed prenatal clinics|5|||
16104747|NCT03796208|38872073|FG000|Overall Study|Lost to Follow-up|20|||
16104748|NCT03796208|38872074|FG001|Overall Study|Lost to Follow-up|16|||
16104749|NCT03807700|38872077|FG000|Overall Study|Withdrawal by Subject|2|||
16104750|NCT03807700|38872078|FG001|Overall Study|Withdrawal by Subject|1|||
16104751|NCT00439647|38872079|FG000|Overall Study|Withdrawal by Subject|25|||
16104752|NCT00439647|38872080|FG001|Overall Study|Withdrawal by Subject|22|||
16104753|NCT00439647|38872079|FG000|Overall Study|Death|15|||
16104754|NCT00439647|38872080|FG001|Overall Study|Death|18|||
16104755|NCT00439647|38872079|FG000|Overall Study|Adverse Event|11|||
16104756|NCT00439647|38872080|FG001|Overall Study|Adverse Event|11|||
16104757|NCT00439647|38872079|FG000|Overall Study|Lost to Follow-up|4|||
16104758|NCT00439647|38872080|FG001|Overall Study|Lost to Follow-up|12|||
16104759|NCT00439647|38872079|FG000|Overall Study|Protocol Violation|3|||
16104760|NCT00439647|38872080|FG001|Overall Study|Protocol Violation|4|||
16104761|NCT00439647|38872079|FG000|Overall Study|Lack of Efficacy|0|||
16104762|NCT00439647|38872080|FG001|Overall Study|Lack of Efficacy|4|||
16104763|NCT00396097|38872083|FG000|Overall Study|Withdrawal by Subject|17|||
16104764|NCT00396097|38872084|FG001|Overall Study|Withdrawal by Subject|17|||
16104765|NCT00396097|38872083|FG000|Overall Study|Lost to Follow-up|4|||
16104766|NCT00396097|38872084|FG001|Overall Study|Lost to Follow-up|9|||
16104767|NCT00396097|38872083|FG000|Overall Study|Other|3|||
16104768|NCT00396097|38872084|FG001|Overall Study|Other|5|||
16104769|NCT00396097|38872083|FG000|Overall Study|Protocol Violation|0|||
16104770|NCT00396097|38872084|FG001|Overall Study|Protocol Violation|6|||
16104771|NCT00396097|38872083|FG000|Overall Study|Adverse Event|1|||
16104772|NCT00396097|38872084|FG001|Overall Study|Adverse Event|5|||
16104773|NCT00396097|38872083|FG000|Overall Study|Insufficient Clinical Response|1|||
16104774|NCT00396097|38872084|FG001|Overall Study|Insufficient Clinical Response|4|||
16104775|NCT00594178|38872090|FG000|Overall Study|Physician Decision|5|||
16104776|NCT02705625|38872091|FG000|Overall Study|Protocol Violation|1|||
16104777|NCT02705625|38872092|FG001|Overall Study|Protocol Violation|0|||
16104778|NCT02705625|38872093|FG002|Overall Study|Protocol Violation|0|||
16104779|NCT02705625|38872091|FG000|Overall Study|Adverse Event|6|||
16104780|NCT02705625|38872092|FG001|Overall Study|Adverse Event|5|||
16104781|NCT02705625|38872093|FG002|Overall Study|Adverse Event|2|||
16104782|NCT02705625|38872091|FG000|Overall Study|Death|0|||
16104783|NCT02705625|38872092|FG001|Overall Study|Death|0|||
16104784|NCT02705625|38872093|FG002|Overall Study|Death|1|||
16104785|NCT02705625|38872091|FG000|Overall Study|Withdrawal by Subject|1|||
16104786|NCT02705625|38872092|FG001|Overall Study|Withdrawal by Subject|4|||
16406529|NCT02596958|39969837|FG000|Overall Study|Missing|32|||
16406530|NCT02596958|39969837|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
16406531|NCT01945216|39969838|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
16406532|NCT01945216|39969838|FG000|Overall Study|Protocol Violation|42|||
16406533|NCT01945216|39969838|FG000|Overall Study|CRF not assured by investigators|5|||
16406534|NCT03943550|39969839|FG000|Overall Study|Adverse Event|0|||
16406535|NCT03943550|39969840|FG001|Overall Study|Adverse Event|0|||
16406536|NCT03943550|39969841|FG002|Overall Study|Adverse Event|1|||
16406537|NCT03943550|39969839|FG000|Overall Study|Lost to Follow-up|0|||
16406538|NCT03943550|39969840|FG001|Overall Study|Lost to Follow-up|0|||
16406539|NCT03943550|39969841|FG002|Overall Study|Lost to Follow-up|1|||
16406540|NCT03943550|39969839|FG000|Overall Study|Progressive Disease|0|||
16406541|NCT03943550|39969840|FG001|Overall Study|Progressive Disease|0|||
16406542|NCT03943550|39969841|FG002|Overall Study|Progressive Disease|2|||
16104787|NCT02705625|38872093|FG002|Overall Study|Withdrawal by Subject|5|||
16104788|NCT02705625|38872091|FG000|Overall Study|Lost to Follow-up|0|||
16104789|NCT02705625|38872092|FG001|Overall Study|Lost to Follow-up|0|||
16104790|NCT02705625|38872093|FG002|Overall Study|Lost to Follow-up|1|||
16406543|NCT03943550|39969839|FG000|Overall Study|Participant Moved Out of the Country|0|||
16406544|NCT03943550|39969840|FG001|Overall Study|Participant Moved Out of the Country|1|||
16539582|NCT00117676|40436020|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
16104791|NCT02705625|38872091|FG000|Overall Study|Non-compliance|0|||
16104792|NCT02705625|38872092|FG001|Overall Study|Non-compliance|1|||
16104793|NCT02705625|38872093|FG002|Overall Study|Non-compliance|1|||
16104794|NCT02705625|38872091|FG000|Overall Study|Overdosing|0|||
16104795|NCT02705625|38872092|FG001|Overall Study|Overdosing|0|||
16104796|NCT02705625|38872093|FG002|Overall Study|Overdosing|1|||
16104797|NCT02972242|38872096|FG000|Overall Study|Withdrawal by Subject|1|||
16104798|NCT02972242|38872097|FG001|Overall Study|Withdrawal by Subject|0|||
16104799|NCT01494298|38872100|FG000|Overall Study|Protocol Violation|2|||
16104800|NCT01494298|38872101|FG001|Overall Study|Protocol Violation|8|||
16104801|NCT00115336|38872102|FG000|Overall Study|Hospital discharge before study drug|0|||
16104802|NCT00115336|38872103|FG001|Overall Study|Hospital discharge before study drug|1|||
16104803|NCT02019641|38872107|FG000|10-Week Follow up|Withdrawal by investigator|2|||
16104804|NCT02019641|38872108|FG001|10-Week Follow up|Withdrawal by investigator|0|||
16104805|NCT02019641|38872109|FG002|10-Week Follow up|Withdrawal by investigator|0|||
16104806|NCT02019641|38872107|FG000|10-Week Follow up|Withdrawal by Subject|1|||
16104807|NCT02019641|38872108|FG001|10-Week Follow up|Withdrawal by Subject|1|||
16104808|NCT02019641|38872109|FG002|10-Week Follow up|Withdrawal by Subject|0|||
16104809|NCT02019641|38872107|FG000|20-Week Follow up|Withdrawal by investigator|0|||
16104810|NCT02019641|38872108|FG001|20-Week Follow up|Withdrawal by investigator|0|||
16104811|NCT02019641|38872109|FG002|20-Week Follow up|Withdrawal by investigator|1|||
16104812|NCT01878383|38872112|FG000|Overall Study|Lost to Follow-up|0|||
16104813|NCT01878383|38872113|FG001|Overall Study|Lost to Follow-up|1499|||
16104814|NCT03511378|38872116|FG000|Overall Study|Withdrawal by Subject|2|||
16104815|NCT03511378|38872117|FG001|Overall Study|Withdrawal by Subject|2|||
16104816|NCT03511378|38872116|FG000|Overall Study|Patient not coming or schedule visit|1|||
16104817|NCT03511378|38872117|FG001|Overall Study|Patient not coming or schedule visit|0|||
16104818|NCT00931918|38872118|FG000|Overall Study|Adverse Event|4|||
16104819|NCT00931918|38872119|FG001|Overall Study|Adverse Event|6|||
16104820|NCT00931918|38872118|FG000|Overall Study|Progressive Disease|2|||
16104821|NCT00931918|38872119|FG001|Overall Study|Progressive Disease|1|||
16104822|NCT00931918|38872118|FG000|Overall Study|Symptomatic Deterioration|1|||
16104823|NCT00931918|38872119|FG001|Overall Study|Symptomatic Deterioration|0|||
16104824|NCT00931918|38872118|FG000|Overall Study|Withdrawal by Patient|3|||
16104825|NCT00931918|38872119|FG001|Overall Study|Withdrawal by Patient|4|||
16104826|NCT00931918|38872118|FG000|Overall Study|Other Reason not Specified|4|||
16104827|NCT00931918|38872119|FG001|Overall Study|Other Reason not Specified|4|||
16104828|NCT00931918|38872118|FG000|Overall Study|Did not receive study drug|3|||
16104829|NCT00931918|38872119|FG001|Overall Study|Did not receive study drug|2|||
16104830|NCT03918447|38872120|FG000|Overall Study|Death|1|||
16104831|NCT03918447|38872121|FG001|Overall Study|Death|0|||
16104832|NCT03918447|38872120|FG000|Overall Study|Lost to Follow-up|13|||
16104833|NCT03918447|38872121|FG001|Overall Study|Lost to Follow-up|6|||
16104834|NCT03918447|38872120|FG000|Overall Study|Withdrawal by Subject|19|||
16104835|NCT03918447|38872121|FG001|Overall Study|Withdrawal by Subject|17|||
16104836|NCT03918447|38872120|FG000|Overall Study|Study Terminated by Sponsor|195|||
16104837|NCT03918447|38872121|FG001|Overall Study|Study Terminated by Sponsor|197|||
16104838|NCT03918447|38872120|FG000|Overall Study|Reason not Specified|0|||
16104839|NCT03918447|38872121|FG001|Overall Study|Reason not Specified|1|||
16104840|NCT03041701|38872122|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
16104841|NCT03041701|38872123|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
16104842|NCT03041701|38872124|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
16104843|NCT03041701|38872122|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
16104844|NCT03041701|38872123|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
16104845|NCT03041701|38872124|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
16104846|NCT02592707|38872125|FG000|Overall Study|Consent Withdrawn|0|||
16104847|NCT02592707|38872126|FG001|Overall Study|Consent Withdrawn|1|||
16104848|NCT02592707|38872127|FG002|Overall Study|Consent Withdrawn|2|||
16104849|NCT02592707|38872128|FG003|Overall Study|Consent Withdrawn|0|||
16104850|NCT02592707|38872125|FG000|Overall Study|Death|1|||
16104851|NCT02592707|38872126|FG001|Overall Study|Death|0|||
16104852|NCT02592707|38872127|FG002|Overall Study|Death|0|||
16104853|NCT02592707|38872128|FG003|Overall Study|Death|0|||
16104854|NCT02592707|38872125|FG000|Overall Study|Progressive Disease|4|||
16104855|NCT02592707|38872126|FG001|Overall Study|Progressive Disease|4|||
16104856|NCT02592707|38872127|FG002|Overall Study|Progressive Disease|3|||
16104857|NCT02592707|38872128|FG003|Overall Study|Progressive Disease|3|||
16104858|NCT02592707|38872125|FG000|Overall Study|Other|0|||
16104859|NCT02592707|38872126|FG001|Overall Study|Other|0|||
16104860|NCT02592707|38872127|FG002|Overall Study|Other|1|||
16104861|NCT02592707|38872128|FG003|Overall Study|Other|2|||
16104862|NCT02592707|38872125|FG000|Overall Study|Never entered LTFU period|1|||
16104863|NCT02592707|38872126|FG001|Overall Study|Never entered LTFU period|0|||
16104864|NCT02592707|38872127|FG002|Overall Study|Never entered LTFU period|0|||
16104865|NCT02592707|38872128|FG003|Overall Study|Never entered LTFU period|2|||
16104866|NCT00604188|38872129|FG000|Overall Study|Adverse Event|1|||
16104867|NCT00604188|38872130|FG001|Overall Study|Adverse Event|4|||
16104868|NCT00604188|38872129|FG000|Overall Study|Lost to Follow-up|17|||
16104869|NCT00604188|38872130|FG001|Overall Study|Lost to Follow-up|15|||
16104870|NCT00604188|38872129|FG000|Overall Study|Withdrawal by Subject|5|||
16104871|NCT00604188|38872130|FG001|Overall Study|Withdrawal by Subject|1|||
16104872|NCT00604188|38872129|FG000|Overall Study|Non-compliance with protocol|4|||
16104873|NCT00604188|38872130|FG001|Overall Study|Non-compliance with protocol|4|||
16406545|NCT03943550|39969841|FG002|Overall Study|Participant Moved Out of the Country|0|||
16406546|NCT01904149|39969842|FG000|Overall Study|Adverse Event|3|||
16406547|NCT01904149|39969843|FG001|Overall Study|Adverse Event|4|||
16406548|NCT01904149|39969844|FG002|Overall Study|Adverse Event|0|||
16406549|NCT01904149|39969845|FG003|Overall Study|Adverse Event|1|||
16406550|NCT01904149|39969846|FG004|Overall Study|Adverse Event|1|||
16406551|NCT01904149|39969847|FG005|Overall Study|Adverse Event|2|||
16406552|NCT01904149|39969842|FG000|Overall Study|Lack of Efficacy|0|||
16406553|NCT01904149|39969843|FG001|Overall Study|Lack of Efficacy|3|||
16406554|NCT01904149|39969844|FG002|Overall Study|Lack of Efficacy|1|||
16406555|NCT01904149|39969845|FG003|Overall Study|Lack of Efficacy|3|||
16406556|NCT01904149|39969846|FG004|Overall Study|Lack of Efficacy|3|||
16406557|NCT01904149|39969847|FG005|Overall Study|Lack of Efficacy|1|||
16406558|NCT01904149|39969842|FG000|Overall Study|Withdrawal by Subject|1|||
16406559|NCT01904149|39969843|FG001|Overall Study|Withdrawal by Subject|3|||
16406560|NCT01904149|39969844|FG002|Overall Study|Withdrawal by Subject|1|||
16406561|NCT01904149|39969845|FG003|Overall Study|Withdrawal by Subject|0|||
16406562|NCT01904149|39969846|FG004|Overall Study|Withdrawal by Subject|1|||
16406563|NCT01904149|39969847|FG005|Overall Study|Withdrawal by Subject|0|||
16406564|NCT01904149|39969842|FG000|Overall Study|Protocol Violation|0|||
16406565|NCT01904149|39969843|FG001|Overall Study|Protocol Violation|1|||
16406566|NCT01904149|39969844|FG002|Overall Study|Protocol Violation|0|||
16406567|NCT01904149|39969845|FG003|Overall Study|Protocol Violation|0|||
16406568|NCT01904149|39969846|FG004|Overall Study|Protocol Violation|0|||
16406569|NCT01904149|39969847|FG005|Overall Study|Protocol Violation|0|||
16406570|NCT01904149|39969842|FG000|Overall Study|non compliance with study drug|1|||
16406571|NCT01904149|39969843|FG001|Overall Study|non compliance with study drug|0|||
16406572|NCT01904149|39969844|FG002|Overall Study|non compliance with study drug|0|||
16406573|NCT01904149|39969845|FG003|Overall Study|non compliance with study drug|0|||
16406574|NCT01904149|39969846|FG004|Overall Study|non compliance with study drug|0|||
16406575|NCT01904149|39969847|FG005|Overall Study|non compliance with study drug|0|||
16406576|NCT02791191|39969848|FG000|Overall Study|Adverse Event|2|||
16406577|NCT02791191|39969849|FG001|Overall Study|Adverse Event|4|||
16406578|NCT02791191|39969850|FG002|Overall Study|Adverse Event|5|||
16406579|NCT02791191|39969848|FG000|Overall Study|Lack of Efficacy|0|||
16406580|NCT02791191|39969849|FG001|Overall Study|Lack of Efficacy|1|||
16406581|NCT02791191|39969850|FG002|Overall Study|Lack of Efficacy|0|||
16406582|NCT02791191|39969848|FG000|Overall Study|Study Drug Non-Compliance|0|||
16406583|NCT02791191|39969849|FG001|Overall Study|Study Drug Non-Compliance|2|||
16406584|NCT02791191|39969850|FG002|Overall Study|Study Drug Non-Compliance|0|||
16406585|NCT02791191|39969848|FG000|Overall Study|Site Closed by Sponsor|1|||
16406586|NCT02791191|39969849|FG001|Overall Study|Site Closed by Sponsor|1|||
16406587|NCT02791191|39969850|FG002|Overall Study|Site Closed by Sponsor|3|||
16406588|NCT02791191|39969848|FG000|Overall Study|Progressive Disease|1|||
16406589|NCT02791191|39969849|FG001|Overall Study|Progressive Disease|0|||
16406590|NCT02791191|39969850|FG002|Overall Study|Progressive Disease|0|||
16406591|NCT02791191|39969848|FG000|Overall Study|Study Terminated by Sponsor|29|||
16406592|NCT02791191|39969849|FG001|Overall Study|Study Terminated by Sponsor|101|||
16406593|NCT02791191|39969850|FG002|Overall Study|Study Terminated by Sponsor|109|||
16406594|NCT02791191|39969848|FG000|Overall Study|Withdrawal by Subject|3|||
16406595|NCT02791191|39969849|FG001|Overall Study|Withdrawal by Subject|1|||
16406596|NCT02791191|39969850|FG002|Overall Study|Withdrawal by Subject|3|||
16406597|NCT02791191|39969848|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
16406598|NCT02791191|39969849|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
16406599|NCT02791191|39969850|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
16406600|NCT00468676|39969851|FG000|Overall Study|Lost to Follow-up|14|||
16406601|NCT00468676|39969852|FG001|Overall Study|Lost to Follow-up|11|||
16406602|NCT00468676|39969851|FG000|Overall Study|Death|2|||
16406603|NCT00468676|39969852|FG001|Overall Study|Death|1|||
16406604|NCT04677660|39969853|FG000|Overall Study|Lost to Follow-up|0|||
16406605|NCT04677660|39969854|FG001|Overall Study|Lost to Follow-up|2|||
16406606|NCT04677660|39969853|FG000|Overall Study|Withdrawal by Subject|0|||
16406607|NCT04677660|39969854|FG001|Overall Study|Withdrawal by Subject|1|||
16406608|NCT04677660|39969853|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
16406609|NCT04677660|39969854|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
16406610|NCT00068250|39969855|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
16406611|NCT00068250|39969856|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
16406612|NCT00068250|39969857|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
16104874|NCT00604188|38872129|FG000|Overall Study|Did not receive study drug|0|||
16104875|NCT00604188|38872130|FG001|Overall Study|Did not receive study drug|1|||
16104876|NCT01435798|38872131|FG000|Overall Study|Withdrawal by Subject|1|||
16406613|NCT00068250|39969858|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
16406614|NCT00980460|39969859|FG000|Overall Study|Death|0|||
16406615|NCT00980460|39969860|FG001|Overall Study|Death|0|||
16406616|NCT00980460|39969861|FG002|Overall Study|Death|1|||
16406617|NCT00980460|39969862|FG003|Overall Study|Death|2|||
16406618|NCT00980460|39969863|FG004|Overall Study|Death|1|||
16104877|NCT01085812|38872134|FG000|Open-Label Period|Adverse Event|0|||
16104878|NCT01085812|38872135|FG001|Open-Label Period|Adverse Event|80|||
16104879|NCT01085812|38872134|FG000|Open-Label Period|Lack of Efficacy|0|||
16104880|NCT01085812|38872135|FG001|Open-Label Period|Lack of Efficacy|26|||
16104881|NCT01085812|38872134|FG000|Open-Label Period|Protocol Violation|0|||
16406619|NCT00980460|39969859|FG000|Overall Study|Lack of Efficacy|0|||
16406620|NCT00980460|39969860|FG001|Overall Study|Lack of Efficacy|0|||
16406621|NCT00980460|39969861|FG002|Overall Study|Lack of Efficacy|10|||
16406622|NCT00980460|39969862|FG003|Overall Study|Lack of Efficacy|6|||
16406623|NCT00980460|39969863|FG004|Overall Study|Lack of Efficacy|8|||
16406624|NCT00980460|39969859|FG000|Overall Study|Lost to Follow-up|0|||
16406625|NCT00980460|39969860|FG001|Overall Study|Lost to Follow-up|0|||
16406626|NCT00980460|39969861|FG002|Overall Study|Lost to Follow-up|0|||
16406627|NCT00980460|39969862|FG003|Overall Study|Lost to Follow-up|1|||
16406628|NCT00980460|39969863|FG004|Overall Study|Lost to Follow-up|0|||
16406629|NCT00980460|39969859|FG000|Overall Study|Physician Decision|0|||
16406630|NCT00980460|39969860|FG001|Overall Study|Physician Decision|0|||
16339990|NCT00966355|39730360|FG002|Overall Study|Lost to Follow-up|3|||
16339991|NCT02756819|39730363|FG000|Overall Study|Lost for observation|23|||
16339992|NCT02756819|39730363|FG000|Overall Study|Patient's unwillingness|16|||
16339993|NCT02756819|39730363|FG000|Overall Study|Insufficient efficacy|2|||
16339994|NCT02756819|39730363|FG000|Overall Study|Adverse Event|2|||
16339995|NCT02756819|39730363|FG000|Overall Study|Reason not Specified|9|||
16339996|NCT03597139|39730365|FG000|Overall Study|Adverse Event|3|||
16339997|NCT03597139|39730366|FG001|Overall Study|Adverse Event|0|||
16406631|NCT00980460|39969861|FG002|Overall Study|Physician Decision|11|||
16339998|NCT03597139|39730365|FG000|Overall Study|Protocol Non-compliance|1|||
16339999|NCT03597139|39730366|FG001|Overall Study|Protocol Non-compliance|0|||
16539583|NCT00117676|40436019|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
16539584|NCT00117676|40436020|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
16539585|NCT00117676|40436019|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
16539586|NCT00117676|40436020|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
16539587|NCT00117676|40436019|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
16539588|NCT00117676|40436020|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
16340000|NCT03951753|39730367|FG000|Overall Study|Adverse Event|1|||
16340001|NCT03951753|39730368|FG001|Overall Study|Adverse Event|0|||
16340002|NCT03951753|39730369|FG002|Overall Study|Adverse Event|3|||
16340003|NCT03951753|39730367|FG000|Overall Study|Withdrawal by Subject|3|||
16340004|NCT03951753|39730368|FG001|Overall Study|Withdrawal by Subject|1|||
16340005|NCT03951753|39730369|FG002|Overall Study|Withdrawal by Subject|0|||
16539589|NCT00117676|40436019|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
16539590|NCT00117676|40436020|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
16539591|NCT00117676|40436019|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
16539592|NCT00117676|40436020|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
16539593|NCT00117676|40436019|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
16340006|NCT03951753|39730367|FG000|Overall Study|Lost to Follow-up|0|||
16340007|NCT03951753|39730368|FG001|Overall Study|Lost to Follow-up|0|||
16340008|NCT03951753|39730369|FG002|Overall Study|Lost to Follow-up|1|||
16406632|NCT00980460|39969862|FG003|Overall Study|Physician Decision|5|||
16406633|NCT00980460|39969863|FG004|Overall Study|Physician Decision|3|||
16406634|NCT00980460|39969859|FG000|Overall Study|Withdrawal by Subject|0|||
16406635|NCT00980460|39969860|FG001|Overall Study|Withdrawal by Subject|0|||
16406636|NCT00980460|39969861|FG002|Overall Study|Withdrawal by Subject|1|||
16539594|NCT00117676|40436020|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
16539595|NCT00117676|40436019|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
16539596|NCT00117676|40436020|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
16539597|NCT00117676|40436019|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
16539598|NCT00117676|40436020|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
16539599|NCT00117676|40436019|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
16539600|NCT00117676|40436020|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
16539601|NCT00117676|40436019|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
16539602|NCT00117676|40436020|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
16406637|NCT00980460|39969862|FG003|Overall Study|Withdrawal by Subject|0|||
16340009|NCT01080391|39730370|FG000|Overall Study|Randomized but not treated|7|||
16104882|NCT01085812|38872135|FG001|Open-Label Period|Protocol Violation|39|||
16340010|NCT01080391|39730371|FG001|Overall Study|Randomized but not treated|4|||
16340011|NCT02669667|39730372|FG000|Overall Study|Lost to Follow-up|0|||
16340012|NCT02669667|39730373|FG001|Overall Study|Lost to Follow-up|0|||
16406638|NCT00980460|39969863|FG004|Overall Study|Withdrawal by Subject|0|||
16340013|NCT02669667|39730374|FG002|Overall Study|Lost to Follow-up|0|||
16406639|NCT00980460|39969859|FG000|Overall Study|Ineligible|0|||
16406640|NCT00980460|39969860|FG001|Overall Study|Ineligible|2|||
16406641|NCT00980460|39969861|FG002|Overall Study|Ineligible|3|||
16406642|NCT00980460|39969862|FG003|Overall Study|Ineligible|1|||
16539603|NCT00117676|40436019|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
16539604|NCT00117676|40436020|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
16539605|NCT00117676|40436019|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
16539606|NCT00117676|40436020|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
16104883|NCT01085812|38872134|FG000|Open-Label Period|Withdrawal by Subject|0|||
16539607|NCT00117676|40436019|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
16539608|NCT00117676|40436020|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
16539609|NCT00117676|40436019|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
16539610|NCT00117676|40436020|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
16539611|NCT00117676|40436019|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
16539612|NCT00117676|40436020|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
16539613|NCT00117676|40436019|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
16539614|NCT00117676|40436020|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
16539615|NCT00117676|40436019|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
16539616|NCT00117676|40436020|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
16539617|NCT00117676|40436019|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
16539618|NCT00117676|40436020|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
16539619|NCT00117676|40436019|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
16539620|NCT00117676|40436020|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
16539621|NCT00117676|40436019|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
16539622|NCT00117676|40436020|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
16539623|NCT00117676|40436019|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
16539624|NCT00117676|40436020|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
16539625|NCT00117676|40436019|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
16539626|NCT00117676|40436020|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
16539627|NCT00117676|40436019|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
16539628|NCT00117676|40436020|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
16539629|NCT00117676|40436019|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
16539630|NCT00117676|40436020|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
16539631|NCT00117676|40436019|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
16539632|NCT00117676|40436020|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
16539633|NCT00117676|40436019|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
16539634|NCT00117676|40436020|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
16539635|NCT00117676|40436019|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
16539636|NCT00117676|40436020|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
16539637|NCT00117676|40436019|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
16539638|NCT00117676|40436020|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
16539639|NCT00117676|40436019|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
16539640|NCT00117676|40436020|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
16104884|NCT01085812|38872135|FG001|Open-Label Period|Withdrawal by Subject|53|||
16104885|NCT01085812|38872134|FG000|Open-Label Period|Lost to Follow-up|0|||
16104886|NCT01085812|38872135|FG001|Open-Label Period|Lost to Follow-up|42|||
16104887|NCT01085812|38872134|FG000|Double-Blind Period|Adverse Event|3|||
16104888|NCT01085812|38872135|FG001|Double-Blind Period|Adverse Event|8|||
16104889|NCT01085812|38872134|FG000|Double-Blind Period|Protocol Violation|2|||
16104890|NCT01085812|38872135|FG001|Double-Blind Period|Protocol Violation|7|||
16104891|NCT01085812|38872134|FG000|Double-Blind Period|Withdrawal by Subject|11|||
16104892|NCT01085812|38872135|FG001|Double-Blind Period|Withdrawal by Subject|24|||
16104893|NCT01085812|38872134|FG000|Double-Blind Period|Lost to Follow-up|5|||
16104894|NCT01085812|38872135|FG001|Double-Blind Period|Lost to Follow-up|17|||
16104895|NCT01085812|38872134|FG000|Double-Blind Period|Other Reasons|0|||
16104896|NCT01085812|38872135|FG001|Double-Blind Period|Other Reasons|2|||
16539641|NCT00117676|40436019|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
16104897|NCT01085812|38872134|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
16104898|NCT01085812|38872135|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
16340014|NCT02669667|39730375|FG003|Overall Study|Lost to Follow-up|0|||
16340015|NCT02669667|39730376|FG004|Overall Study|Lost to Follow-up|0|||
16340016|NCT02669667|39730377|FG005|Overall Study|Lost to Follow-up|1|||
16340017|NCT02669667|39730378|FG006|Overall Study|Lost to Follow-up|0|||
16340018|NCT03000530|39730384|FG000|Overall Study|Adverse Event|0|||
16340019|NCT03000530|39730385|FG001|Overall Study|Adverse Event|0|||
16340020|NCT03000530|39730386|FG002|Overall Study|Adverse Event|2|||
16340021|NCT03000530|39730384|FG000|Overall Study|Lost to Follow-up|0|||
16406643|NCT00980460|39969863|FG004|Overall Study|Ineligible|4|||
16406644|NCT00980460|39969859|FG000|Overall Study|Refusal of further therapy|0|||
16539642|NCT00117676|40436020|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
16406645|NCT00980460|39969860|FG001|Overall Study|Refusal of further therapy|2|||
16539643|NCT00117676|40436019|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
16539644|NCT00117676|40436020|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
16104899|NCT01085812|38872134|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
16539645|NCT01687257|40436021|FG000|Overall Study|Efficacy Failure|6|||
16539646|NCT01687257|40436022|FG001|Overall Study|Efficacy Failure|0|||
16539647|NCT01687257|40436023|FG002|Overall Study|Efficacy Failure|5|||
16539648|NCT01687257|40436021|FG000|Overall Study|Subject Withdrew Consent|1|||
16539649|NCT01687257|40436022|FG001|Overall Study|Subject Withdrew Consent|1|||
16539650|NCT01687257|40436023|FG002|Overall Study|Subject Withdrew Consent|1|||
16539651|NCT01687257|40436021|FG000|Overall Study|Adverse Event|1|||
16539652|NCT01687257|40436022|FG001|Overall Study|Adverse Event|0|||
16539653|NCT01687257|40436023|FG002|Overall Study|Adverse Event|0|||
16539654|NCT01687257|40436021|FG000|Overall Study|Investigator's Discretion|0|||
16539655|NCT01687257|40436022|FG001|Overall Study|Investigator's Discretion|3|||
16539656|NCT01687257|40436023|FG002|Overall Study|Investigator's Discretion|0|||
16539657|NCT00522626|40436024|FG000|Overall Study|Lost to Follow-up|7|||
16539658|NCT00689026|40436025|FG000|Overall Study|Withdrawal by Subject|13|||
16539659|NCT00689026|40436026|FG001|Overall Study|Withdrawal by Subject|6|||
16539660|NCT02355743|40436027|FG000|Overall Study|Withdrawal by Subject|1|||
16539661|NCT02355743|40436027|FG000|Overall Study|Lost to Follow-up|1|||
16539662|NCT00828984|40436028|FG000|Overall Study|Adverse Event|2|||
16539663|NCT00828984|40436029|FG001|Overall Study|Adverse Event|3|||
16539664|NCT00828984|40436030|FG002|Overall Study|Adverse Event|0|||
16539665|NCT00828984|40436028|FG000|Overall Study|Lost to Follow-up|5|||
16539666|NCT00828984|40436029|FG001|Overall Study|Lost to Follow-up|3|||
16539667|NCT00828984|40436030|FG002|Overall Study|Lost to Follow-up|1|||
16539668|NCT00828984|40436028|FG000|Overall Study|Withdrawal by Subject|4|||
16539669|NCT00828984|40436029|FG001|Overall Study|Withdrawal by Subject|4|||
16539670|NCT00828984|40436030|FG002|Overall Study|Withdrawal by Subject|4|||
16539671|NCT00828984|40436028|FG000|Overall Study|Ineligable|1|||
16539672|NCT00828984|40436029|FG001|Overall Study|Ineligable|2|||
16539673|NCT00828984|40436030|FG002|Overall Study|Ineligable|0|||
16539674|NCT00828984|40436028|FG000|Overall Study|Medical Contraindication|0|||
16539675|NCT00828984|40436029|FG001|Overall Study|Medical Contraindication|1|||
16539676|NCT00828984|40436030|FG002|Overall Study|Medical Contraindication|0|||
16539677|NCT00828984|40436028|FG000|Overall Study|Noncompliant|1|||
16539678|NCT00828984|40436029|FG001|Overall Study|Noncompliant|2|||
16539679|NCT00828984|40436030|FG002|Overall Study|Noncompliant|3|||
16539680|NCT00828984|40436028|FG000|Overall Study|ConMed|1|||
16539681|NCT00828984|40436029|FG001|Overall Study|ConMed|1|||
16539682|NCT00828984|40436030|FG002|Overall Study|ConMed|1|||
16539683|NCT02314624|40436037|FG000|Overall Study|No participating patient|16|||
16539684|NCT02314624|40436038|FG001|Overall Study|No participating patient|13|||
16539685|NCT02314624|40436037|FG000|Overall Study|Participant withdrew|7|||
16539686|NCT02314624|40436038|FG001|Overall Study|Participant withdrew|2|||
16539687|NCT02314624|40436037|FG000|Overall Study|Lost to Follow-up|2|||
16539688|NCT02314624|40436038|FG001|Overall Study|Lost to Follow-up|5|||
16104900|NCT01085812|38872135|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
16104901|NCT01085812|38872134|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
16104902|NCT01085812|38872135|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
16104903|NCT01085812|38872134|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
16104904|NCT01085812|38872135|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
16104905|NCT01085812|38872134|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
16104906|NCT01085812|38872135|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
16104907|NCT01525641|38872138|FG000|Overall Study|Case report form not collected|25|||
16104908|NCT01525641|38872138|FG000|Overall Study|No visit since the first visit|16|||
16104909|NCT01525641|38872138|FG000|Overall Study|Adverse Event|73|||
16217383|NCT03419741|39275955|FG000|Overall Study|Withdrawal by Subject|1|||
16217384|NCT03419741|39275956|FG001|Overall Study|Withdrawal by Subject|2|||
16539689|NCT02314624|40436037|FG000|Overall Study|Dropped/Excluded by PI|6|||
16539690|NCT02314624|40436038|FG001|Overall Study|Dropped/Excluded by PI|6|||
16539691|NCT01514448|40436039|FG000|Overall Study|Death|7|||
16539692|NCT01514448|40436040|FG001|Overall Study|Death|8|||
16539693|NCT01514448|40436039|FG000|Overall Study|Withdrawal by Subject|2|||
16217385|NCT03233308|39275957|FG000|Overall Study|Adverse Event|1|||
16217386|NCT03233308|39275957|FG000|Overall Study|Protocol Violation|1|||
16217387|NCT00679354|39275958|FG000|Overall Study|Death|3|||
16217388|NCT00679354|39275958|FG000|Overall Study|Lack of Efficacy|22|||
16217389|NCT00679354|39275958|FG000|Overall Study|Physician Decision|4|||
16217390|NCT00679354|39275958|FG000|Overall Study|Ineligible|1|||
16217391|NCT03687827|39275959|FG000|Treatment Period 1|Death|0|||
16217392|NCT03687827|39275960|FG001|Treatment Period 1|Death|1|||
16217393|NCT03687827|39275959|FG000|Treatment Period 1|Lost to Follow-up|2|||
16217394|NCT03687827|39275960|FG001|Treatment Period 1|Lost to Follow-up|2|||
16217395|NCT03687827|39275959|FG000|Treatment Period 1|Physician Decision|5|||
16217396|NCT03687827|39275960|FG001|Treatment Period 1|Physician Decision|2|||
16217397|NCT03687827|39275959|FG000|Treatment Period 1|Withdrawal by Subject|7|||
16217398|NCT03687827|39275960|FG001|Treatment Period 1|Withdrawal by Subject|3|||
16217399|NCT03687827|39275959|FG000|Treatment Period 2|Physician Decision|4|||
16217400|NCT03687827|39275960|FG001|Treatment Period 2|Physician Decision|1|||
16217401|NCT03687827|39275959|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16104910|NCT01525641|38872138|FG000|Overall Study|Lack of Efficacy|24|||
16104911|NCT01525641|38872138|FG000|Overall Study|Improvement|5|||
16104912|NCT01525641|38872138|FG000|Overall Study|Lost to follow-up (relocation)|1|||
16104913|NCT01525641|38872138|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
16104914|NCT01525641|38872138|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
16104915|NCT01525641|38872138|FG000|Overall Study|Other than stated above|7|||
16104916|NCT02725008|38872139|FG000|Overall Study|Lost to Follow-up|7|||
16104917|NCT02725008|38872140|FG001|Overall Study|Lost to Follow-up|9|||
16104918|NCT02725008|38872139|FG000|Overall Study|Withdrawal by Subject|2|||
16104919|NCT02725008|38872140|FG001|Overall Study|Withdrawal by Subject|2|||
16104920|NCT02725008|38872139|FG000|Overall Study|Admitted to hospital|0|||
16104921|NCT02725008|38872140|FG001|Overall Study|Admitted to hospital|1|||
16104922|NCT00797511|38872143|FG000|Overall Study|Withdrawal by Subject|1|||
16104923|NCT01704547|38872144|FG000|Overall Study|Physician Decision|4|||
16104924|NCT01704547|38872144|FG000|Overall Study|Withdrawal by Subject|1|||
16104925|NCT00605566|38872147|FG000|Overall Study|Adverse Event|1|||
16104926|NCT00605566|38872147|FG000|Overall Study|Clinical deterioration|1|||
16104927|NCT00605566|38872147|FG000|Overall Study|Poor compliance in run-in period|1|||
16104928|NCT02382406|38872148|FG000|Study Treatment|Disease Progression|8|||
16104929|NCT02382406|38872149|FG001|Study Treatment|Disease Progression|0|||
16104930|NCT02382406|38872150|FG002|Study Treatment|Disease Progression|20|||
16104931|NCT02382406|38872148|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
16104932|NCT02382406|38872149|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
16104933|NCT02382406|38872150|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
16104934|NCT02382406|38872148|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
16104935|NCT02382406|38872149|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
16104936|NCT02382406|38872150|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
16104937|NCT02382406|38872148|FG000|Study Treatment|symptomatic deterioration|1|||
16104938|NCT02382406|38872149|FG001|Study Treatment|symptomatic deterioration|0|||
16104939|NCT02382406|38872150|FG002|Study Treatment|symptomatic deterioration|1|||
16217402|NCT03687827|39275960|FG001|Treatment Period 2|Withdrawal by Subject|2|||
16217403|NCT00731666|39275961|FG000|Overall Study|Adverse Event|2|||
16217404|NCT00731666|39275961|FG000|Overall Study|Lost to Follow-up|8|||
16217405|NCT00731666|39275961|FG000|Overall Study|Withdrawal by Subject|2|||
16340022|NCT03000530|39730385|FG001|Overall Study|Lost to Follow-up|3|||
16340023|NCT03000530|39730386|FG002|Overall Study|Lost to Follow-up|1|||
16340024|NCT03000530|39730384|FG000|Overall Study|Withdrawal by Subject|0|||
16340025|NCT03000530|39730385|FG001|Overall Study|Withdrawal by Subject|2|||
16340026|NCT03000530|39730386|FG002|Overall Study|Withdrawal by Subject|1|||
16539694|NCT01514448|40436040|FG001|Overall Study|Withdrawal by Subject|0|||
16539695|NCT01514448|40436039|FG000|Overall Study|Lost to Follow-up|2|||
16539696|NCT01514448|40436040|FG001|Overall Study|Lost to Follow-up|0|||
16104940|NCT02382406|38872148|FG000|Study Treatment|Death|0|||
16104941|NCT02382406|38872149|FG001|Study Treatment|Death|0|||
16104942|NCT02382406|38872150|FG002|Study Treatment|Death|2|||
16104943|NCT02382406|38872148|FG000|Follow up|Death|11|||
16104944|NCT02382406|38872149|FG001|Follow up|Death|0|||
16104945|NCT02382406|38872150|FG002|Follow up|Death|19|||
16104946|NCT02382406|38872148|FG000|Follow up|Symptomatic deterioration|1|||
16104947|NCT02382406|38872149|FG001|Follow up|Symptomatic deterioration|0|||
16104948|NCT02382406|38872150|FG002|Follow up|Symptomatic deterioration|1|||
16104949|NCT02382406|38872148|FG000|Follow up|Patient Refused Follow-up|1|||
16104950|NCT02382406|38872149|FG001|Follow up|Patient Refused Follow-up|0|||
16104951|NCT02382406|38872150|FG002|Follow up|Patient Refused Follow-up|0|||
16539697|NCT01514448|40436039|FG000|Overall Study|New Cancer Therapy|1|||
16539698|NCT01514448|40436040|FG001|Overall Study|New Cancer Therapy|0|||
16539699|NCT00803452|40436041|FG000|Overall Study|Adverse Event|0|||
16539700|NCT00803452|40436042|FG001|Overall Study|Adverse Event|2|||
16539701|NCT00803452|40436041|FG000|Overall Study|Lost to Follow-up|0|||
16539702|NCT00803452|40436042|FG001|Overall Study|Lost to Follow-up|3|||
16539703|NCT02123108|40436045|FG000|Overall Study|Death|2|||
16539704|NCT02123108|40436046|FG001|Overall Study|Death|3|||
16539705|NCT00453986|40436049|FG000|Overall Study|Lost to Follow-up|6|||
16539706|NCT00453986|40436050|FG001|Overall Study|Lost to Follow-up|5|||
16539707|NCT00453986|40436051|FG002|Overall Study|Lost to Follow-up|6|||
16539708|NCT00453986|40436052|FG003|Overall Study|Lost to Follow-up|2|||
16539709|NCT00453986|40436053|FG004|Overall Study|Lost to Follow-up|0|||
16539710|NCT03382782|40436054|FG000|Cohort 1|Withdrawal by Subject|11|||
16539711|NCT03382782|40436055|FG001|Cohort 1|Withdrawal by Subject|5|||
16539712|NCT03382782|40436056|FG002|Cohort 1|Withdrawal by Subject|0|||
16539713|NCT03382782|40436054|FG000|Cohort 2|Withdrawal by Subject|1|||
16539714|NCT03382782|40436055|FG001|Cohort 2|Withdrawal by Subject|1|||
16539715|NCT03382782|40436056|FG002|Cohort 2|Withdrawal by Subject|0|||
16539716|NCT03382782|40436054|FG000|Cohort 3|Withdrawal by Subject|1|||
16539717|NCT03382782|40436055|FG001|Cohort 3|Withdrawal by Subject|2|||
16539718|NCT03382782|40436056|FG002|Cohort 3|Withdrawal by Subject|0|||
16539719|NCT04495179|40436057|FG000|Overall Study|Lost to Follow-up|0|||
16539720|NCT04495179|40436058|FG001|Overall Study|Lost to Follow-up|1|||
16104952|NCT02382406|38872148|FG000|Follow up|Study Terminated|1|||
16104953|NCT02382406|38872149|FG001|Follow up|Study Terminated|0|||
16104954|NCT02382406|38872150|FG002|Follow up|Study Terminated|8|||
16104955|NCT02382406|38872148|FG000|Follow up|Withdrawal by Subject|0|||
16104956|NCT02382406|38872149|FG001|Follow up|Withdrawal by Subject|0|||
16104957|NCT02382406|38872150|FG002|Follow up|Withdrawal by Subject|2|||
16104958|NCT01161628|38872152|FG000|Overall Study|Death|6|||
16104959|NCT01161628|38872152|FG000|Overall Study|Lack of Efficacy|2|||
16104960|NCT01091519|38872158|FG000|Overall Study|Adverse Event|12|||
16104961|NCT01091519|38872159|FG001|Overall Study|Adverse Event|16|||
16104962|NCT01091519|38872158|FG000|Overall Study|Death|1|||
16104963|NCT01091519|38872159|FG001|Overall Study|Death|0|||
16104964|NCT01091519|38872158|FG000|Overall Study|Lack of Efficacy|16|||
16104965|NCT01091519|38872159|FG001|Overall Study|Lack of Efficacy|19|||
16104966|NCT01091519|38872158|FG000|Overall Study|Lost to Follow-up|14|||
16104967|NCT01091519|38872159|FG001|Overall Study|Lost to Follow-up|24|||
16104968|NCT01091519|38872158|FG000|Overall Study|Withdrawal by Subject|2|||
16104969|NCT01091519|38872159|FG001|Overall Study|Withdrawal by Subject|2|||
16539721|NCT04495179|40436057|FG000|Overall Study|Withdrawal by Subject|2|||
16104970|NCT01091519|38872158|FG000|Overall Study|Other|6|||
16104971|NCT01091519|38872159|FG001|Overall Study|Other|8|||
16104972|NCT01091519|38872158|FG000|Overall Study|Randomized not treated|4|||
16104973|NCT01091519|38872159|FG001|Overall Study|Randomized not treated|4|||
16104974|NCT02878590|38872161|FG000|Overall Study|Withdrawal by Subject|2|||
16104975|NCT01187407|38872165|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
16104976|NCT01187407|38872166|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16104977|NCT01187407|38872167|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16104978|NCT01187407|38872168|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16539722|NCT04495179|40436058|FG001|Overall Study|Withdrawal by Subject|4|||
16539723|NCT04495179|40436057|FG000|Overall Study|Study terminated by sponsor|0|||
16539724|NCT04495179|40436058|FG001|Overall Study|Study terminated by sponsor|18|||
16539725|NCT04495179|40436057|FG000|Overall Study|Death|0|||
16539726|NCT04495179|40436058|FG001|Overall Study|Death|4|||
16217406|NCT03702166|39275962|FG000|Overall Study|Lost to Follow-up|1|||
16217407|NCT03702166|39275962|FG000|Overall Study|Withdrawal by Subject|1|||
16217408|NCT04610827|39275964|FG000|Overall Study|Withdrawal by Subject|1|||
16217409|NCT04610827|39275965|FG001|Overall Study|Withdrawal by Subject|1|||
16217410|NCT04610827|39275966|FG002|Overall Study|Withdrawal by Subject|0|||
16217411|NCT02116582|39275967|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
16217412|NCT02116582|39275967|FG000|Overall Study|Adverse Event|22|||
16217413|NCT02116582|39275967|FG000|Overall Study|Death|9|||
16217414|NCT02116582|39275967|FG000|Overall Study|Progressive Disease|148|||
16217415|NCT02116582|39275967|FG000|Overall Study|Protocol Violation|3|||
16217416|NCT02116582|39275967|FG000|Overall Study|Withdrawal by Subject|8|||
16217417|NCT02116582|39275967|FG000|Overall Study|Other: Miscellaneous|11|||
16217418|NCT02116582|39275967|FG000|Overall Study|Lost to Follow-up|1|||
16217419|NCT02116582|39275967|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
16104979|NCT01187407|38872169|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16104980|NCT01187407|38872165|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
16104981|NCT01187407|38872166|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16104982|NCT01187407|38872167|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16104983|NCT01187407|38872168|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16104984|NCT01187407|38872169|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16104985|NCT01187407|38872165|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
16104986|NCT01187407|38872166|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16104987|NCT01187407|38872167|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16104988|NCT01187407|38872168|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16104989|NCT01187407|38872169|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16104990|NCT01187407|38872165|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
16104991|NCT01187407|38872166|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16104992|NCT01187407|38872167|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16104993|NCT01187407|38872168|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16104994|NCT01187407|38872169|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16104995|NCT01187407|38872165|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
16104996|NCT01187407|38872166|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16104997|NCT01187407|38872167|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16104998|NCT01187407|38872168|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16104999|NCT01187407|38872169|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16105000|NCT01187407|38872165|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
16105001|NCT01187407|38872166|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16105002|NCT01187407|38872167|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16105003|NCT01187407|38872168|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16105004|NCT01187407|38872169|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16105005|NCT01187407|38872165|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
16105006|NCT01187407|38872166|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16105007|NCT01187407|38872167|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16105008|NCT01187407|38872168|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16105009|NCT01187407|38872169|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16105010|NCT01187407|38872165|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
16105011|NCT01187407|38872166|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
16105012|NCT01187407|38872167|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
16105013|NCT01187407|38872168|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
16105014|NCT01187407|38872169|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
16105015|NCT01187407|38872165|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
16105016|NCT01187407|38872166|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
16105017|NCT01187407|38872167|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
16105018|NCT01187407|38872168|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
16105019|NCT01187407|38872169|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
16105020|NCT01187407|38872165|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
16105021|NCT01187407|38872166|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
16105022|NCT01187407|38872167|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
16105023|NCT01187407|38872168|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
16105024|NCT01187407|38872169|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
16105025|NCT01187407|38872165|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16105026|NCT01187407|38872166|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16105027|NCT01187407|38872167|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16105028|NCT01187407|38872168|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
16105029|NCT01187407|38872169|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
16105030|NCT01187407|38872165|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
16105031|NCT01187407|38872166|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
16105032|NCT01187407|38872167|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
16105033|NCT01187407|38872168|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
16105034|NCT01187407|38872169|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
16105035|NCT01187407|38872165|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
16105036|NCT01187407|38872166|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
16105037|NCT01187407|38872167|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
16105038|NCT01187407|38872168|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
16105039|NCT01187407|38872169|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
16105040|NCT01187407|38872165|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16105041|NCT01187407|38872166|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
16105042|NCT01187407|38872167|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
16105043|NCT01187407|38872168|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
16105044|NCT01187407|38872169|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
16105045|NCT00427778|38872170|FG000|First Intervention (4 Weeks)|no longer interested|1|||
16105046|NCT00427778|38872171|FG001|First Intervention (4 Weeks)|no longer interested|0|||
16105047|NCT00427778|38872170|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
16105048|NCT00427778|38872171|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
16105049|NCT00427778|38872170|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
16105050|NCT00427778|38872171|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
16105051|NCT00427778|38872170|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
16105052|NCT00427778|38872171|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
16105053|NCT01077622|38872176|FG000|Overall Study|Physician Decision|2|||
16105054|NCT01077622|38872176|FG000|Overall Study|Withdrawal by Subject|1|||
16105055|NCT02024750|38872179|FG000|Overall Study|Withdrawal by Subject|2|||
16105056|NCT02024750|38872180|FG001|Overall Study|Withdrawal by Subject|1|||
16105057|NCT04680637|38872181|FG000|Overall Study|Lost to Follow-up|0|||
16105058|NCT04680637|38872182|FG001|Overall Study|Lost to Follow-up|1|||
16105059|NCT04680637|38872183|FG002|Overall Study|Lost to Follow-up|0|||
16105060|NCT04680637|38872184|FG003|Overall Study|Lost to Follow-up|1|||
16105061|NCT04680637|38872181|FG000|Overall Study|Death|1|||
16105062|NCT04680637|38872182|FG001|Overall Study|Death|0|||
16105063|NCT04680637|38872183|FG002|Overall Study|Death|0|||
16105064|NCT04680637|38872184|FG003|Overall Study|Death|0|||
16105065|NCT04680637|38872181|FG000|Overall Study|Withdrawal by Subject|7|||
16217420|NCT00732472|39275968|FG000|Overall Study|Adverse Event|0|||
16217421|NCT00732472|39275969|FG001|Overall Study|Adverse Event|1|||
16217422|NCT00732472|39275970|FG002|Overall Study|Adverse Event|1|||
16217423|NCT00732472|39275971|FG003|Overall Study|Adverse Event|1|||
16217424|NCT00732472|39275968|FG000|Overall Study|Protocol Violation|0|||
16217425|NCT00732472|39275969|FG001|Overall Study|Protocol Violation|0|||
16217426|NCT00732472|39275970|FG002|Overall Study|Protocol Violation|0|||
16217427|NCT00732472|39275971|FG003|Overall Study|Protocol Violation|1|||
16217428|NCT00732472|39275968|FG000|Overall Study|Withdrawal by Subject|0|||
16217429|NCT00732472|39275969|FG001|Overall Study|Withdrawal by Subject|2|||
16217430|NCT00732472|39275970|FG002|Overall Study|Withdrawal by Subject|0|||
16217431|NCT00732472|39275971|FG003|Overall Study|Withdrawal by Subject|1|||
16217432|NCT02061540|39275972|FG000|Overall Study|Adverse Event|2|||
16217433|NCT02061540|39275972|FG000|Overall Study|Withdrawal by Subject|2|||
16217434|NCT00414973|39275974|FG000|Overall Study|Withdrawal by Subject|14|||
16217435|NCT00414973|39275975|FG001|Overall Study|Withdrawal by Subject|4|||
16217436|NCT00414973|39275976|FG002|Overall Study|Withdrawal by Subject|1|||
16105066|NCT04680637|38872182|FG001|Overall Study|Withdrawal by Subject|10|||
16105067|NCT04680637|38872183|FG002|Overall Study|Withdrawal by Subject|17|||
16105068|NCT04680637|38872184|FG003|Overall Study|Withdrawal by Subject|15|||
16105069|NCT04680637|38872181|FG000|Overall Study|Decision by Sponsor|21|||
16105070|NCT04680637|38872182|FG001|Overall Study|Decision by Sponsor|15|||
16105071|NCT04680637|38872183|FG002|Overall Study|Decision by Sponsor|7|||
16105072|NCT04680637|38872184|FG003|Overall Study|Decision by Sponsor|32|||
16217437|NCT00414973|39275977|FG003|Overall Study|Withdrawal by Subject|0|||
16217438|NCT00414973|39275974|FG000|Overall Study|Adverse Event|10|||
16217439|NCT00414973|39275975|FG001|Overall Study|Adverse Event|0|||
16217440|NCT00414973|39275976|FG002|Overall Study|Adverse Event|1|||
16217441|NCT00414973|39275977|FG003|Overall Study|Adverse Event|0|||
16217442|NCT00414973|39275974|FG000|Overall Study|Protocol Violation|3|||
16217443|NCT00414973|39275975|FG001|Overall Study|Protocol Violation|4|||
16217444|NCT00414973|39275976|FG002|Overall Study|Protocol Violation|0|||
16217445|NCT00414973|39275977|FG003|Overall Study|Protocol Violation|0|||
16217446|NCT00414973|39275974|FG000|Overall Study|Lost to Follow-up|0|||
16217447|NCT00414973|39275975|FG001|Overall Study|Lost to Follow-up|2|||
16217448|NCT00414973|39275976|FG002|Overall Study|Lost to Follow-up|0|||
16217449|NCT00414973|39275977|FG003|Overall Study|Lost to Follow-up|0|||
16217450|NCT00414973|39275974|FG000|Overall Study|Sponsor Decision|1|||
16217451|NCT00414973|39275975|FG001|Overall Study|Sponsor Decision|0|||
16539727|NCT04495179|40436057|FG000|Overall Study|Adverse Event|0|||
16539728|NCT04495179|40436058|FG001|Overall Study|Adverse Event|1|||
16539729|NCT01024608|40436059|FG000|Overall Study|Adverse Event|1|||
16539730|NCT01024608|40436060|FG001|Overall Study|Adverse Event|0|||
16539731|NCT01024608|40436059|FG000|Overall Study|Withdrawal by Subject|1|||
16539732|NCT01024608|40436060|FG001|Overall Study|Withdrawal by Subject|0|||
16539733|NCT01024608|40436059|FG000|Overall Study|Lost to Follow-up|0|||
16539734|NCT01024608|40436060|FG001|Overall Study|Lost to Follow-up|1|||
16539735|NCT01024608|40436059|FG000|Overall Study|Protocol Violation|0|||
16539736|NCT01024608|40436060|FG001|Overall Study|Protocol Violation|3|||
16539737|NCT01024608|40436059|FG000|Overall Study|Never received study treatment|2|||
16539738|NCT01024608|40436060|FG001|Overall Study|Never received study treatment|0|||
16539739|NCT01951638|40436061|FG000|Treatment Period|Protocol Violation|0|||
16539740|NCT01951638|40436062|FG001|Treatment Period|Protocol Violation|0|||
16539741|NCT01951638|40436063|FG002|Treatment Period|Protocol Violation|0|||
16539742|NCT01951638|40436064|FG003|Treatment Period|Protocol Violation|2|||
16539743|NCT01951638|40436065|FG004|Treatment Period|Protocol Violation|0|||
16539744|NCT01951638|40436061|FG000|Treatment Period|Protocol-driven decision point|1|||
16539745|NCT01951638|40436062|FG001|Treatment Period|Protocol-driven decision point|3|||
16539746|NCT01951638|40436063|FG002|Treatment Period|Protocol-driven decision point|0|||
16539747|NCT01951638|40436064|FG003|Treatment Period|Protocol-driven decision point|0|||
16217452|NCT00414973|39275976|FG002|Overall Study|Sponsor Decision|0|||
16217453|NCT00414973|39275977|FG003|Overall Study|Sponsor Decision|0|||
16217454|NCT00414973|39275974|FG000|Overall Study|Death|0|||
16217455|NCT00414973|39275975|FG001|Overall Study|Death|0|||
16217456|NCT00414973|39275976|FG002|Overall Study|Death|1|||
16217457|NCT00414973|39275977|FG003|Overall Study|Death|0|||
16217458|NCT01466062|39275982|FG000|Overall Study|Adverse Event|1|||
16217459|NCT01466062|39275982|FG000|Overall Study|Withdrawal by Subject|1|||
16217460|NCT02811640|39275985|FG000|Overall Study|Technology malfunction|2|||
16217461|NCT01222416|39275986|FG000|Overall Study|ineligible;metastasis|3|||
16217462|NCT01222416|39275987|FG001|Overall Study|ineligible;metastasis|0|||
16217463|NCT01222416|39275986|FG000|Overall Study|Adverse Event|4|||
16217464|NCT01222416|39275987|FG001|Overall Study|Adverse Event|0|||
16217465|NCT01222416|39275986|FG000|Overall Study|Withdrawal by Subject|5|||
16217466|NCT01222416|39275987|FG001|Overall Study|Withdrawal by Subject|0|||
16217467|NCT01222416|39275986|FG000|Overall Study|scheduling|6|||
16217468|NCT01222416|39275987|FG001|Overall Study|scheduling|0|||
16217469|NCT01222416|39275986|FG000|Overall Study|missed view/scan|1|||
16217470|NCT01222416|39275987|FG001|Overall Study|missed view/scan|0|||
16217471|NCT01222416|39275986|FG000|Overall Study|Death|1|||
16217472|NCT01222416|39275987|FG001|Overall Study|Death|0|||
16217473|NCT02010567|39275988|FG000|Overall Study|Adverse Event|0|||
16217474|NCT02010567|39275989|FG001|Overall Study|Adverse Event|0|||
16217475|NCT02010567|39275990|FG002|Overall Study|Adverse Event|1|||
16217476|NCT02010567|39275991|FG003|Overall Study|Adverse Event|0|||
16217477|NCT02010567|39275992|FG004|Overall Study|Adverse Event|1|||
16217478|NCT02471586|39275994|FG000|Overall Study|Lost to Follow-up|3|||
16217479|NCT02471586|39275995|FG001|Overall Study|Lost to Follow-up|8|||
16217480|NCT02471586|39275996|FG002|Overall Study|Lost to Follow-up|4|||
16217481|NCT02471586|39275994|FG000|Overall Study|Death|2|||
16539748|NCT01951638|40436065|FG004|Treatment Period|Protocol-driven decision point|0|||
16539749|NCT01951638|40436061|FG000|Treatment Period|Logistical difficulties|0|||
16539750|NCT01951638|40436062|FG001|Treatment Period|Logistical difficulties|1|||
16217482|NCT02471586|39275995|FG001|Overall Study|Death|2|||
16217483|NCT02471586|39275996|FG002|Overall Study|Death|0|||
16217484|NCT00610714|39275999|FG000|Overall Study|Adverse Event|3|||
16217485|NCT00610714|39276000|FG001|Overall Study|Adverse Event|1|||
16217486|NCT00610714|39275999|FG000|Overall Study|Death|12|||
16217487|NCT00610714|39276000|FG001|Overall Study|Death|18|||
16340027|NCT02437188|39730387|FG000|Overall Study|Randomized but did not receive surgery|4|||
16340028|NCT02437188|39730388|FG001|Overall Study|Randomized but did not receive surgery|8|||
16340029|NCT02437188|39730387|FG000|Overall Study|Adverse Event|0|||
16340030|NCT02437188|39730388|FG001|Overall Study|Adverse Event|1|||
16340031|NCT01048944|39730390|FG000|Overall Study|Protocol Violation|8|||
16340032|NCT01048944|39730391|FG001|Overall Study|Protocol Violation|10|||
16340033|NCT01048944|39730392|FG002|Overall Study|Protocol Violation|10|||
16340034|NCT01048944|39730393|FG003|Overall Study|Protocol Violation|2|||
16340035|NCT01832818|39730394|FG000|Overall Study|Lost to Follow-up|6|||
16340036|NCT00396877|39730399|FG000|Overall Study|Lost to Follow-up|2|||
16340037|NCT00396877|39730400|FG001|Overall Study|Lost to Follow-up|1|||
16340038|NCT00396877|39730399|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
16340039|NCT00396877|39730400|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
16340040|NCT01031004|39730401|FG000|Overall Study|Protocol Violation|0|||
16340041|NCT01031004|39730402|FG001|Overall Study|Protocol Violation|1|||
16340042|NCT01031004|39730401|FG000|Overall Study|Lost to Follow-up|1|||
16340043|NCT01031004|39730402|FG001|Overall Study|Lost to Follow-up|0|||
16105073|NCT02412111|38872185|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
16105074|NCT02412111|38872186|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
16105075|NCT02412111|38872187|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
16105076|NCT02412111|38872185|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
16105077|NCT02412111|38872186|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
16105078|NCT02412111|38872187|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
16105079|NCT02412111|38872185|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
16105080|NCT02412111|38872186|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
16105081|NCT02412111|38872187|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
16105082|NCT02412111|38872185|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
16105083|NCT02412111|38872186|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
16105084|NCT02412111|38872187|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
16105085|NCT02412111|38872185|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
16105086|NCT02412111|38872186|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
16105087|NCT02412111|38872187|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
16105088|NCT02412111|38872185|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
16105089|NCT02412111|38872186|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
16105090|NCT02412111|38872187|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
16105091|NCT02412111|38872185|FG000|Active Comparator Period (8 Weeks)|Other|0|||
16105092|NCT02412111|38872186|FG001|Active Comparator Period (8 Weeks)|Other|0|||
16105093|NCT02412111|38872187|FG002|Active Comparator Period (8 Weeks)|Other|2|||
16105094|NCT03891641|38872197|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
16105095|NCT03891641|38872198|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
16105096|NCT01379703|38872199|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
16105097|NCT01379703|38872200|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
16105098|NCT01379703|38872201|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
16105099|NCT01379703|38872199|FG000|Study Start Through 9 Months|Adverse Event|0|||
16105100|NCT01379703|38872200|FG001|Study Start Through 9 Months|Adverse Event|14|||
16105101|NCT01379703|38872201|FG002|Study Start Through 9 Months|Adverse Event|10|||
16105102|NCT01379703|38872199|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
16105103|NCT01379703|38872200|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
16105104|NCT01379703|38872201|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
16105105|NCT01379703|38872199|FG000|Study Start Through 9 Months|Treatment Failure|0|||
16105106|NCT01379703|38872200|FG001|Study Start Through 9 Months|Treatment Failure|2|||
16105107|NCT01379703|38872201|FG002|Study Start Through 9 Months|Treatment Failure|2|||
16105108|NCT01379703|38872199|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
16105109|NCT01379703|38872200|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
16105110|NCT01379703|38872201|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
16105111|NCT01379703|38872199|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
16105112|NCT01379703|38872200|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
16105113|NCT01379703|38872201|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
16105114|NCT01379703|38872199|FG000|Study Start Through 9 Months|Medication not available|0|||
16217488|NCT00610714|39275999|FG000|Overall Study|Withdrawal by Subject|9|||
16217489|NCT00610714|39276000|FG001|Overall Study|Withdrawal by Subject|3|||
16217490|NCT00610714|39275999|FG000|Overall Study|Study completion at 120 PFS events|2|||
16217491|NCT00610714|39276000|FG001|Overall Study|Study completion at 120 PFS events|2|||
16340044|NCT02328937|39730403|FG000|Period 1|Lost to Follow-up|0|||
16217492|NCT02382276|39276007|FG000|Overall Study|Withdrawal by Subject|4|||
16217493|NCT02382276|39276008|FG001|Overall Study|Withdrawal by Subject|8|||
16217494|NCT02382276|39276009|FG002|Overall Study|Withdrawal by Subject|5|||
16217495|NCT02382276|39276007|FG000|Overall Study|Adverse Event|7|||
16217496|NCT02382276|39276008|FG001|Overall Study|Adverse Event|2|||
16217497|NCT02382276|39276009|FG002|Overall Study|Adverse Event|32|||
16217498|NCT02382276|39276007|FG000|Overall Study|Physician Decision|0|||
16217499|NCT02382276|39276008|FG001|Overall Study|Physician Decision|0|||
16217500|NCT02382276|39276009|FG002|Overall Study|Physician Decision|2|||
16217501|NCT02087241|39276010|FG000|Overall Study|Death|2|||
16217502|NCT02087241|39276011|FG001|Overall Study|Death|1|||
16217503|NCT02087241|39276012|FG002|Overall Study|Death|1|||
16217504|NCT02087241|39276013|FG003|Overall Study|Death|1|||
16217505|NCT02087241|39276010|FG000|Overall Study|Withdrawal by Subject|1|||
16217506|NCT02087241|39276011|FG001|Overall Study|Withdrawal by Subject|0|||
16217507|NCT02087241|39276012|FG002|Overall Study|Withdrawal by Subject|0|||
16217508|NCT02087241|39276013|FG003|Overall Study|Withdrawal by Subject|1|||
16217509|NCT02087241|39276010|FG000|Overall Study|Progressive Disease|0|||
16217510|NCT02087241|39276011|FG001|Overall Study|Progressive Disease|0|||
16217511|NCT02087241|39276012|FG002|Overall Study|Progressive Disease|0|||
16217512|NCT02087241|39276013|FG003|Overall Study|Progressive Disease|1|||
16217513|NCT02087241|39276010|FG000|Overall Study|Study Terminated by Sponsor|0|||
16217514|NCT02087241|39276011|FG001|Overall Study|Study Terminated by Sponsor|2|||
16217515|NCT02087241|39276012|FG002|Overall Study|Study Terminated by Sponsor|0|||
16217516|NCT02087241|39276013|FG003|Overall Study|Study Terminated by Sponsor|4|||
16217517|NCT02477800|39276017|FG000|Placebo-Controlled Period|Adverse Event|16|||
16105115|NCT01379703|38872200|FG001|Study Start Through 9 Months|Medication not available|2|||
16105116|NCT01379703|38872201|FG002|Study Start Through 9 Months|Medication not available|1|||
16105117|NCT01379703|38872199|FG000|Study Start Through 9 Months|Poor general condition|0|||
16105118|NCT01379703|38872200|FG001|Study Start Through 9 Months|Poor general condition|1|||
16105119|NCT01379703|38872201|FG002|Study Start Through 9 Months|Poor general condition|0|||
16105120|NCT01379703|38872199|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
16105121|NCT01379703|38872200|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
16105122|NCT01379703|38872201|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
16105123|NCT01379703|38872199|FG000|Study Start Through 9 Months|Reason unknown|2|||
16105124|NCT01379703|38872200|FG001|Study Start Through 9 Months|Reason unknown|31|||
16105125|NCT01379703|38872201|FG002|Study Start Through 9 Months|Reason unknown|24|||
16105126|NCT01379703|38872199|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
16105127|NCT01379703|38872200|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
16105128|NCT01379703|38872201|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
16105129|NCT01379703|38872199|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
16105130|NCT01379703|38872200|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
16105131|NCT01379703|38872201|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
16105132|NCT01379703|38872199|FG000|9 Months Through 18 Months|Adverse Event|0|||
16105133|NCT01379703|38872200|FG001|9 Months Through 18 Months|Adverse Event|6|||
16217518|NCT02477800|39276018|FG001|Placebo-Controlled Period|Adverse Event|25|||
16217519|NCT02477800|39276019|FG002|Placebo-Controlled Period|Adverse Event|28|||
16539751|NCT01951638|40436063|FG002|Treatment Period|Logistical difficulties|1|||
16539752|NCT01951638|40436064|FG003|Treatment Period|Logistical difficulties|0|||
16539753|NCT01951638|40436065|FG004|Treatment Period|Logistical difficulties|0|||
16539754|NCT01951638|40436061|FG000|Treatment Period|Withdrawal by Subject|9|||
16539755|NCT01951638|40436062|FG001|Treatment Period|Withdrawal by Subject|6|||
16539756|NCT01951638|40436063|FG002|Treatment Period|Withdrawal by Subject|4|||
16539757|NCT01951638|40436064|FG003|Treatment Period|Withdrawal by Subject|5|||
16539758|NCT01951638|40436065|FG004|Treatment Period|Withdrawal by Subject|4|||
16539759|NCT01951638|40436061|FG000|Treatment Period|Death|0|||
16539760|NCT01951638|40436062|FG001|Treatment Period|Death|0|||
16539761|NCT01951638|40436063|FG002|Treatment Period|Death|0|||
16539762|NCT01951638|40436064|FG003|Treatment Period|Death|3|||
16539763|NCT01951638|40436065|FG004|Treatment Period|Death|1|||
16539764|NCT01951638|40436061|FG000|Treatment Period|Adverse Event|3|||
16539765|NCT01951638|40436062|FG001|Treatment Period|Adverse Event|4|||
16539766|NCT01951638|40436063|FG002|Treatment Period|Adverse Event|8|||
16539767|NCT01951638|40436064|FG003|Treatment Period|Adverse Event|6|||
16539768|NCT01951638|40436065|FG004|Treatment Period|Adverse Event|5|||
16539769|NCT01951638|40436061|FG000|Follow-up Period|Protocol Violation|0|||
16539770|NCT01951638|40436062|FG001|Follow-up Period|Protocol Violation|0|||
16539771|NCT01951638|40436063|FG002|Follow-up Period|Protocol Violation|0|||
16539772|NCT01951638|40436064|FG003|Follow-up Period|Protocol Violation|1|||
16539773|NCT01951638|40436065|FG004|Follow-up Period|Protocol Violation|0|||
16539774|NCT01951638|40436061|FG000|Follow-up Period|Logistical difficulties|0|||
16539775|NCT01951638|40436062|FG001|Follow-up Period|Logistical difficulties|2|||
16105134|NCT01379703|38872201|FG002|9 Months Through 18 Months|Adverse Event|0|||
16217520|NCT02477800|39276020|FG003|Placebo-Controlled Period|Adverse Event|0|||
16539776|NCT01951638|40436063|FG002|Follow-up Period|Logistical difficulties|0|||
16539777|NCT01951638|40436064|FG003|Follow-up Period|Logistical difficulties|0|||
16105135|NCT01379703|38872199|FG000|9 Months Through 18 Months|Treatment failure|0|||
16105136|NCT01379703|38872200|FG001|9 Months Through 18 Months|Treatment failure|5|||
16105137|NCT01379703|38872201|FG002|9 Months Through 18 Months|Treatment failure|0|||
16105138|NCT01379703|38872199|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
16105139|NCT01379703|38872200|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
16105140|NCT01379703|38872201|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
16105141|NCT01379703|38872199|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
16105142|NCT01379703|38872200|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
16105143|NCT01379703|38872201|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
16105144|NCT01379703|38872199|FG000|9 Months Through 18 Months|Fatigue|0|||
16105145|NCT01379703|38872200|FG001|9 Months Through 18 Months|Fatigue|1|||
16105146|NCT01379703|38872201|FG002|9 Months Through 18 Months|Fatigue|0|||
16105147|NCT01379703|38872199|FG000|9 Months Through 18 Months|Reason Unknown|0|||
16105148|NCT01379703|38872200|FG001|9 Months Through 18 Months|Reason Unknown|23|||
16105149|NCT01379703|38872201|FG002|9 Months Through 18 Months|Reason Unknown|0|||
16105150|NCT00961298|38872202|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
16105151|NCT00961298|38872202|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
16105152|NCT00961298|38872202|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
16105153|NCT02995733|38872203|FG000|Overall Study|Study site closed|9|||
16105154|NCT02995733|38872204|FG001|Overall Study|Study site closed|10|||
16105155|NCT02995733|38872203|FG000|Overall Study|Death|3|||
16105156|NCT02995733|38872204|FG001|Overall Study|Death|4|||
16105157|NCT02995733|38872203|FG000|Overall Study|Withdrawal by Subject|6|||
16105158|NCT02995733|38872204|FG001|Overall Study|Withdrawal by Subject|2|||
16105159|NCT02995733|38872203|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
16105160|NCT02995733|38872204|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
16105161|NCT02995733|38872203|FG000|Overall Study|Lost to Follow-up|48|||
16105162|NCT02995733|38872204|FG001|Overall Study|Lost to Follow-up|37|||
16105163|NCT02995733|38872203|FG000|Overall Study|Other|0|||
16105164|NCT02995733|38872204|FG001|Overall Study|Other|1|||
16105165|NCT05523219|38872207|FG000|Overall Study|Wrong inclusion|1|||
16105166|NCT05523219|38872207|FG000|Overall Study|Lost to Follow-up|7|||
16105167|NCT01967719|38872208|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
16105168|NCT01967719|38872209|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
16105169|NCT01967719|38872210|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
16105170|NCT01967719|38872211|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
16105171|NCT01967719|38872208|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
16105172|NCT01967719|38872209|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
16105173|NCT01967719|38872210|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
16105174|NCT01967719|38872211|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
16105175|NCT04159805|38872212|FG000|Overall Study|Withdrawal by Subject|0|||
16105176|NCT04159805|38872213|FG001|Overall Study|Withdrawal by Subject|2|||
16105177|NCT04159805|38872214|FG002|Overall Study|Withdrawal by Subject|2|||
16105178|NCT00507429|38872215|FG000|Treatment Phase|Disease Progression|12|||
16105179|NCT00507429|38872216|FG001|Treatment Phase|Disease Progression|5|||
16105180|NCT00507429|38872215|FG000|Treatment Phase|Adverse Event|12|||
16105181|NCT00507429|38872216|FG001|Treatment Phase|Adverse Event|5|||
16105182|NCT00507429|38872215|FG000|Treatment Phase|Withdrawal by Subject|3|||
16105183|NCT00507429|38872216|FG001|Treatment Phase|Withdrawal by Subject|3|||
16105184|NCT00507429|38872215|FG000|Treatment Phase|Physician Decision|4|||
16105185|NCT00507429|38872216|FG001|Treatment Phase|Physician Decision|2|||
16105186|NCT00507429|38872215|FG000|Treatment Phase|Other|6|||
16105187|NCT00507429|38872216|FG001|Treatment Phase|Other|3|||
16105188|NCT00507429|38872215|FG000|Maintenance Phase|Progressive Disease|14|||
16105189|NCT00507429|38872216|FG001|Maintenance Phase|Progressive Disease|0|||
16105190|NCT00922441|38872217|FG000|Overall Study|Protocol Violation|0|||
16105191|NCT00922441|38872218|FG001|Overall Study|Protocol Violation|0|||
16105192|NCT00922441|38872219|FG002|Overall Study|Protocol Violation|2|||
16105193|NCT00922441|38872217|FG000|Overall Study|Withdrawal by Subject|0|||
16105194|NCT00922441|38872218|FG001|Overall Study|Withdrawal by Subject|0|||
16105195|NCT00922441|38872219|FG002|Overall Study|Withdrawal by Subject|1|||
16217521|NCT02477800|39276021|FG004|Placebo-Controlled Period|Adverse Event|0|||
16217522|NCT02477800|39276022|FG005|Placebo-Controlled Period|Adverse Event|0|||
16217523|NCT02477800|39276023|FG006|Placebo-Controlled Period|Adverse Event|0|||
16217524|NCT02477800|39276017|FG000|Placebo-Controlled Period|Change of Treatment|1|||
16105196|NCT00904722|38872225|FG000|Overall Study|Physician Decision|1|||
16105197|NCT01702519|38872226|FG000|Washout Period|Lost to Follow-up|1|||
16105198|NCT01702519|38872227|FG001|Washout Period|Lost to Follow-up|0|||
16105199|NCT01702519|38872226|FG000|Washout Period|Withdrawal by Subject|0|||
16105200|NCT01702519|38872227|FG001|Washout Period|Withdrawal by Subject|2|||
16105201|NCT00511797|38872228|FG000|Overall Study|Adverse Event|1|||
16105202|NCT00511797|38872229|FG001|Overall Study|Adverse Event|2|||
16105203|NCT00511797|38872230|FG002|Overall Study|Adverse Event|2|||
16105204|NCT00511797|38872231|FG003|Overall Study|Adverse Event|2|||
16105205|NCT00511797|38872228|FG000|Overall Study|Lost to Follow-up|1|||
16539778|NCT01951638|40436065|FG004|Follow-up Period|Logistical difficulties|1|||
16539779|NCT01951638|40436061|FG000|Follow-up Period|Withdrawal by Subject|1|||
16105206|NCT00511797|38872229|FG001|Overall Study|Lost to Follow-up|0|||
16217525|NCT02477800|39276018|FG001|Placebo-Controlled Period|Change of Treatment|2|||
16217526|NCT02477800|39276019|FG002|Placebo-Controlled Period|Change of Treatment|1|||
16217527|NCT02477800|39276020|FG003|Placebo-Controlled Period|Change of Treatment|0|||
16217528|NCT02477800|39276021|FG004|Placebo-Controlled Period|Change of Treatment|0|||
16217529|NCT02477800|39276022|FG005|Placebo-Controlled Period|Change of Treatment|0|||
16217530|NCT02477800|39276023|FG006|Placebo-Controlled Period|Change of Treatment|0|||
16217531|NCT02477800|39276017|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
16105207|NCT00511797|38872230|FG002|Overall Study|Lost to Follow-up|0|||
16105208|NCT00511797|38872231|FG003|Overall Study|Lost to Follow-up|1|||
16105209|NCT00511797|38872228|FG000|Overall Study|Pregnancy|0|||
16105210|NCT00511797|38872229|FG001|Overall Study|Pregnancy|0|||
16105211|NCT00511797|38872230|FG002|Overall Study|Pregnancy|0|||
16105212|NCT00511797|38872231|FG003|Overall Study|Pregnancy|1|||
16105213|NCT00511797|38872228|FG000|Overall Study|Protocol Violation|0|||
16105214|NCT00511797|38872229|FG001|Overall Study|Protocol Violation|2|||
16105215|NCT00511797|38872230|FG002|Overall Study|Protocol Violation|2|||
16105216|NCT00511797|38872231|FG003|Overall Study|Protocol Violation|3|||
16105217|NCT00511797|38872228|FG000|Overall Study|Withdrawal by Subject|3|||
16105218|NCT00511797|38872229|FG001|Overall Study|Withdrawal by Subject|3|||
16105219|NCT00511797|38872230|FG002|Overall Study|Withdrawal by Subject|4|||
16105220|NCT00511797|38872231|FG003|Overall Study|Withdrawal by Subject|2|||
16105221|NCT00511797|38872228|FG000|Overall Study|Never dispensed|1|||
16105222|NCT00511797|38872229|FG001|Overall Study|Never dispensed|0|||
16105223|NCT00511797|38872230|FG002|Overall Study|Never dispensed|1|||
16105224|NCT00511797|38872231|FG003|Overall Study|Never dispensed|3|||
16105225|NCT00511797|38872228|FG000|Overall Study|Study drug not taken|0|||
16105226|NCT00511797|38872229|FG001|Overall Study|Study drug not taken|1|||
16105227|NCT00511797|38872230|FG002|Overall Study|Study drug not taken|0|||
16340045|NCT02328937|39730404|FG001|Period 1|Lost to Follow-up|0|||
16105228|NCT00511797|38872231|FG003|Overall Study|Study drug not taken|1|||
16105229|NCT00511797|38872228|FG000|Overall Study|Partially missing diary|0|||
16105230|NCT00511797|38872229|FG001|Overall Study|Partially missing diary|0|||
16105231|NCT00511797|38872230|FG002|Overall Study|Partially missing diary|1|||
16105232|NCT00511797|38872231|FG003|Overall Study|Partially missing diary|0|||
16105233|NCT00511797|38872228|FG000|Overall Study|Other (moving etc)|1|||
16105234|NCT00511797|38872229|FG001|Overall Study|Other (moving etc)|0|||
16340046|NCT02328937|39730405|FG002|Period 1|Lost to Follow-up|0|||
16340047|NCT02328937|39730406|FG003|Period 1|Lost to Follow-up|1|||
16340048|NCT02328937|39730407|FG004|Period 1|Lost to Follow-up|0|||
16340049|NCT02328937|39730408|FG005|Period 1|Lost to Follow-up|0|||
16340050|NCT02328937|39730403|FG000|Period 2|Adverse Event|0|||
16340051|NCT02328937|39730404|FG001|Period 2|Adverse Event|0|||
16340052|NCT02328937|39730405|FG002|Period 2|Adverse Event|1|||
16340053|NCT02328937|39730406|FG003|Period 2|Adverse Event|0|||
16340054|NCT02328937|39730407|FG004|Period 2|Adverse Event|0|||
16340055|NCT02328937|39730408|FG005|Period 2|Adverse Event|0|||
16105235|NCT00511797|38872230|FG002|Overall Study|Other (moving etc)|1|||
16105236|NCT00511797|38872231|FG003|Overall Study|Other (moving etc)|2|||
16105237|NCT00236184|38872232|FG000|Overall Study|Adverse Event|5|||
16105238|NCT00236184|38872233|FG001|Overall Study|Adverse Event|2|||
16105239|NCT00236184|38872232|FG000|Overall Study|Lack of Efficacy|0|||
16105240|NCT00236184|38872233|FG001|Overall Study|Lack of Efficacy|1|||
16105241|NCT00236184|38872232|FG000|Overall Study|Lost to Follow-up|3|||
16105242|NCT00236184|38872233|FG001|Overall Study|Lost to Follow-up|4|||
16105243|NCT00236184|38872232|FG000|Overall Study|Physician Decision|1|||
16105244|NCT00236184|38872233|FG001|Overall Study|Physician Decision|1|||
16105245|NCT00236184|38872232|FG000|Overall Study|Withdrawal by Subject|3|||
16539780|NCT01951638|40436062|FG001|Follow-up Period|Withdrawal by Subject|5|||
16105246|NCT00236184|38872233|FG001|Overall Study|Withdrawal by Subject|0|||
16105247|NCT00236184|38872232|FG000|Overall Study|Protocol Violation|3|||
16105248|NCT00236184|38872233|FG001|Overall Study|Protocol Violation|0|||
16105249|NCT00236184|38872232|FG000|Overall Study|non-compliance with study drug|2|||
16105250|NCT00236184|38872233|FG001|Overall Study|non-compliance with study drug|1|||
16105251|NCT00236184|38872232|FG000|Overall Study|other|1|||
16105252|NCT00236184|38872233|FG001|Overall Study|other|2|||
16105253|NCT00509821|38872234|FG000|Study Period 1 (Induction)|Death|0|||
16105254|NCT00509821|38872235|FG001|Study Period 1 (Induction)|Death|1|||
16105255|NCT00509821|38872234|FG000|Study Period 1 (Induction)|Adverse Event|0|||
16105256|NCT00509821|38872235|FG001|Study Period 1 (Induction)|Adverse Event|2|||
16105257|NCT00509821|38872234|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
16105258|NCT00509821|38872235|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
16105259|NCT00679549|38872236|FG000|Overall Study|dropout|2|||
16105260|NCT00679549|38872237|FG001|Overall Study|dropout|4|||
16340056|NCT01402986|39730409|FG000|Overall Study|Withdrawal by Subject|7|||
16340057|NCT01402986|39730410|FG001|Overall Study|Withdrawal by Subject|10|||
16340058|NCT01402986|39730411|FG002|Overall Study|Withdrawal by Subject|7|||
16105261|NCT00679549|38872236|FG000|Overall Study|missing outcome echocardiograms|4|||
16105262|NCT00679549|38872237|FG001|Overall Study|missing outcome echocardiograms|5|||
16105263|NCT01172639|38872242|FG000|Overall Study|Death|1|||
16105264|NCT01172639|38872243|FG001|Overall Study|Death|1|||
16105265|NCT01172639|38872244|FG002|Overall Study|Death|0|||
16105266|NCT01172639|38872245|FG003|Overall Study|Death|0|||
16105267|NCT01172639|38872246|FG004|Overall Study|Death|0|||
16105268|NCT01172639|38872242|FG000|Overall Study|Lost to Follow-up|9|||
16105269|NCT01172639|38872243|FG001|Overall Study|Lost to Follow-up|7|||
16105270|NCT01172639|38872244|FG002|Overall Study|Lost to Follow-up|11|||
16105271|NCT01172639|38872245|FG003|Overall Study|Lost to Follow-up|6|||
16105272|NCT01172639|38872246|FG004|Overall Study|Lost to Follow-up|6|||
16105273|NCT01172639|38872242|FG000|Overall Study|Withdrawal by Subject|3|||
16105274|NCT01172639|38872243|FG001|Overall Study|Withdrawal by Subject|3|||
16105275|NCT01172639|38872244|FG002|Overall Study|Withdrawal by Subject|5|||
16539781|NCT01951638|40436063|FG002|Follow-up Period|Withdrawal by Subject|2|||
16105276|NCT01172639|38872245|FG003|Overall Study|Withdrawal by Subject|5|||
16105277|NCT01172639|38872246|FG004|Overall Study|Withdrawal by Subject|0|||
16105278|NCT01145417|38872247|FG000|Overall Study|Death|1|||
16105279|NCT01145417|38872248|FG001|Overall Study|Death|0|||
16105280|NCT01145417|38872247|FG000|Overall Study|Lost to Follow-up|2|||
16105281|NCT01145417|38872248|FG001|Overall Study|Lost to Follow-up|1|||
16105282|NCT01145417|38872247|FG000|Overall Study|Withdrawal by Subject|1|||
16105283|NCT01145417|38872248|FG001|Overall Study|Withdrawal by Subject|2|||
16105284|NCT01145417|38872247|FG000|Overall Study|Pregnancy|1|||
16105285|NCT01145417|38872248|FG001|Overall Study|Pregnancy|0|||
16105286|NCT01145417|38872247|FG000|Overall Study|Adverse Event|0|||
16105287|NCT01145417|38872248|FG001|Overall Study|Adverse Event|1|||
16105288|NCT01145417|38872247|FG000|Overall Study|Study terminated by sponsor|35|||
16105289|NCT01145417|38872248|FG001|Overall Study|Study terminated by sponsor|43|||
16105290|NCT01145417|38872247|FG000|Overall Study|Other|1|||
16105291|NCT01145417|38872248|FG001|Overall Study|Other|0|||
16105292|NCT00297778|38872252|FG000|Overall Study|Adverse Event|16|||
16105293|NCT00297778|38872253|FG001|Overall Study|Adverse Event|10|||
16105294|NCT00297778|38872252|FG000|Overall Study|Withdrawal by Subject|1|||
16105295|NCT00297778|38872253|FG001|Overall Study|Withdrawal by Subject|5|||
16105296|NCT00297778|38872252|FG000|Overall Study|Lack of Efficacy|2|||
16105297|NCT00297778|38872253|FG001|Overall Study|Lack of Efficacy|1|||
16105298|NCT00297778|38872252|FG000|Overall Study|Non-compliant with trial protocol|0|||
16105299|NCT00297778|38872253|FG001|Overall Study|Non-compliant with trial protocol|3|||
16105300|NCT00297778|38872252|FG000|Overall Study|Other|0|||
16105301|NCT00297778|38872253|FG001|Overall Study|Other|1|||
16105302|NCT01125566|38872254|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
16105303|NCT01125566|38872255|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
16105304|NCT01125566|38872256|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
16105305|NCT01125566|38872254|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
16105306|NCT01125566|38872255|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
16105307|NCT01125566|38872256|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
16105308|NCT01125566|38872254|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
16105309|NCT01125566|38872255|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
16105310|NCT01125566|38872256|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
16105311|NCT01125566|38872254|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
16105312|NCT01125566|38872255|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
16105313|NCT01125566|38872256|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
16539782|NCT01951638|40436064|FG003|Follow-up Period|Withdrawal by Subject|1|||
16105314|NCT01125566|38872254|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
16105315|NCT01125566|38872255|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
16105316|NCT01125566|38872256|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
16105317|NCT01125566|38872254|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
16105318|NCT01125566|38872255|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
16105319|NCT01125566|38872256|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
16105320|NCT01125566|38872254|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
16539783|NCT01951638|40436065|FG004|Follow-up Period|Withdrawal by Subject|2|||
16539784|NCT01951638|40436061|FG000|Follow-up Period|Lost to Follow-up|0|||
16539785|NCT01951638|40436062|FG001|Follow-up Period|Lost to Follow-up|1|||
16539786|NCT01951638|40436063|FG002|Follow-up Period|Lost to Follow-up|0|||
16539787|NCT01951638|40436064|FG003|Follow-up Period|Lost to Follow-up|1|||
16539788|NCT01951638|40436065|FG004|Follow-up Period|Lost to Follow-up|0|||
16539789|NCT01951638|40436061|FG000|Follow-up Period|Death|1|||
16539790|NCT01951638|40436062|FG001|Follow-up Period|Death|0|||
16539791|NCT01951638|40436063|FG002|Follow-up Period|Death|1|||
16539792|NCT01951638|40436064|FG003|Follow-up Period|Death|4|||
16539793|NCT01951638|40436065|FG004|Follow-up Period|Death|1|||
16539794|NCT01951638|40436061|FG000|Follow-up Period|Adverse Event|0|||
16105321|NCT01125566|38872255|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
16105322|NCT01125566|38872256|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
16105323|NCT01125566|38872254|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
16105324|NCT01125566|38872255|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
16105325|NCT01125566|38872256|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
16105326|NCT01125566|38872254|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
16105327|NCT01125566|38872255|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
16105328|NCT01125566|38872256|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
16105329|NCT01125566|38872254|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
16105330|NCT01125566|38872255|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
16105331|NCT01125566|38872256|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
16105332|NCT01125566|38872254|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
16105333|NCT01125566|38872255|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
16105334|NCT01125566|38872256|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
16105335|NCT01125566|38872254|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
16105336|NCT01125566|38872255|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
16105337|NCT01125566|38872256|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
16105338|NCT00352053|38872259|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
16340059|NCT01402986|39730412|FG003|Overall Study|Withdrawal by Subject|13|||
16340060|NCT01402986|39730409|FG000|Overall Study|Death|0|||
16340061|NCT01402986|39730410|FG001|Overall Study|Death|0|||
16340062|NCT01402986|39730411|FG002|Overall Study|Death|0|||
16340063|NCT01402986|39730412|FG003|Overall Study|Death|2|||
16340064|NCT01402986|39730409|FG000|Overall Study|Lost to Follow-up|0|||
16340065|NCT01402986|39730410|FG001|Overall Study|Lost to Follow-up|0|||
16340066|NCT01402986|39730411|FG002|Overall Study|Lost to Follow-up|0|||
16340067|NCT01402986|39730412|FG003|Overall Study|Lost to Follow-up|1|||
16340068|NCT01402986|39730409|FG000|Overall Study|Other|2|||
16340069|NCT01402986|39730410|FG001|Overall Study|Other|5|||
16340070|NCT01402986|39730411|FG002|Overall Study|Other|1|||
16340071|NCT01402986|39730412|FG003|Overall Study|Other|6|||
16340072|NCT01299896|39730413|FG000|Overall Study|Withdrawal by Subject|1|||
16340073|NCT01299896|39730414|FG001|Overall Study|Withdrawal by Subject|7|||
16340074|NCT01299896|39730413|FG000|Overall Study|Lost to Follow-up|0|||
16340075|NCT01299896|39730414|FG001|Overall Study|Lost to Follow-up|11|||
16340076|NCT02347072|39730415|FG000|Overall Study|Adverse Event|2|||
16340077|NCT02347072|39730415|FG000|Overall Study|Withdrawal by Subject|6|||
16340078|NCT02347072|39730415|FG000|Overall Study|Physician Decision|1|||
16340079|NCT02347072|39730415|FG000|Overall Study|Lost to Follow-up|2|||
16340080|NCT02347072|39730415|FG000|Overall Study|Protocol Violation|1|||
16340081|NCT02347072|39730415|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
16340082|NCT03762681|39730416|FG000|Part 1|Withdrawal by Subject|0|||
16340083|NCT03762681|39730417|FG001|Part 1|Withdrawal by Subject|0|||
16340084|NCT03762681|39730418|FG002|Part 1|Withdrawal by Subject|0|||
16340085|NCT03762681|39730419|FG003|Part 1|Withdrawal by Subject|1|||
16340086|NCT03762681|39730420|FG004|Part 1|Withdrawal by Subject|0|||
16340087|NCT03762681|39730421|FG005|Part 1|Withdrawal by Subject|0|||
16340088|NCT03762681|39730422|FG006|Part 1|Withdrawal by Subject|0|||
16340089|NCT03762681|39730423|FG007|Part 1|Withdrawal by Subject|0|||
16340090|NCT03762681|39730416|FG000|Part 2a|Pandemic Travel Restrictions|0|||
16340091|NCT03762681|39730417|FG001|Part 2a|Pandemic Travel Restrictions|0|||
16340092|NCT03762681|39730418|FG002|Part 2a|Pandemic Travel Restrictions|0|||
16340093|NCT03762681|39730419|FG003|Part 2a|Pandemic Travel Restrictions|0|||
16340094|NCT03762681|39730420|FG004|Part 2a|Pandemic Travel Restrictions|0|||
16340095|NCT03762681|39730421|FG005|Part 2a|Pandemic Travel Restrictions|0|||
16340096|NCT03762681|39730422|FG006|Part 2a|Pandemic Travel Restrictions|0|||
16340097|NCT03762681|39730423|FG007|Part 2a|Pandemic Travel Restrictions|1|||
16340098|NCT00957424|39730424|FG000|Overall Study|Lost to Follow-up|19|||
16340099|NCT00957424|39730424|FG000|Overall Study|Protocol Violation|3|||
16340100|NCT00957424|39730424|FG000|Overall Study|Withdrawal by Subject|1|||
16340101|NCT01470144|39730426|FG000|Overall Study|Adverse Event|2|||
16340102|NCT01470144|39730426|FG000|Overall Study|Death|1|||
16340103|NCT01470144|39730426|FG000|Overall Study|Lung transplant|6|||
16105339|NCT00352053|38872260|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
16105340|NCT00352053|38872259|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
16105341|NCT00352053|38872260|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
16105342|NCT00352053|38872259|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
16105343|NCT00352053|38872260|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
16105344|NCT00352053|38872259|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
16105345|NCT00352053|38872260|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
16105346|NCT00352053|38872259|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
16105347|NCT00352053|38872260|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
16105348|NCT00352053|38872259|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
16105349|NCT00352053|38872260|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
16105350|NCT00352053|38872259|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
16105351|NCT00352053|38872260|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
16105352|NCT00352053|38872259|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
16105353|NCT00352053|38872260|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
16105354|NCT00352053|38872259|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
16105355|NCT00352053|38872260|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
16105356|NCT00352053|38872259|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
16105357|NCT00352053|38872260|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
16340104|NCT01470144|39730426|FG000|Overall Study|Patient's and investigator's decision|1|||
16340105|NCT00269477|39730427|FG000|Overall Study|Protocol Violation|5|||
16340106|NCT00269477|39730428|FG001|Overall Study|Protocol Violation|5|||
16340107|NCT00269477|39730429|FG002|Overall Study|Protocol Violation|1|||
16340108|NCT00269477|39730430|FG003|Overall Study|Protocol Violation|0|||
16340109|NCT00269477|39730427|FG000|Overall Study|Missed post-vaccination blood draw|0|||
16340110|NCT00269477|39730428|FG001|Overall Study|Missed post-vaccination blood draw|1|||
16340111|NCT00269477|39730429|FG002|Overall Study|Missed post-vaccination blood draw|0|||
16340112|NCT00269477|39730430|FG003|Overall Study|Missed post-vaccination blood draw|0|||
16340113|NCT01017601|39730431|FG000|Overall Study|Disease Progression|12|||
16105358|NCT00352053|38872259|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
16105359|NCT00352053|38872260|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
16340114|NCT01017601|39730432|FG001|Overall Study|Disease Progression|12|||
16340115|NCT01017601|39730431|FG000|Overall Study|Withdrawal by Subject|0|||
16340116|NCT01017601|39730432|FG001|Overall Study|Withdrawal by Subject|1|||
16340117|NCT00908596|39730433|FG000|Overall Study|Other reasons|46|||
16340118|NCT00908596|39730434|FG001|Overall Study|Other reasons|6|||
16340119|NCT00908596|39730435|FG002|Overall Study|Other reasons|2|||
16340120|NCT00908596|39730436|FG003|Overall Study|Other reasons|0|||
16105360|NCT00352053|38872259|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
16105361|NCT00352053|38872260|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
16105362|NCT00352053|38872259|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
16105363|NCT00352053|38872260|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
16340121|NCT00908596|39730433|FG000|Overall Study|Lost to Follow-up|0|||
16340122|NCT00908596|39730434|FG001|Overall Study|Lost to Follow-up|1|||
16340123|NCT00908596|39730435|FG002|Overall Study|Lost to Follow-up|12|||
16340124|NCT00908596|39730436|FG003|Overall Study|Lost to Follow-up|4|||
16340125|NCT00908596|39730433|FG000|Overall Study|Death|0|||
16340126|NCT00908596|39730434|FG001|Overall Study|Death|5|||
16340127|NCT00908596|39730435|FG002|Overall Study|Death|57|||
16340128|NCT00908596|39730436|FG003|Overall Study|Death|32|||
16340129|NCT00908596|39730433|FG000|Overall Study|Protocol Violation|1|||
16340130|NCT00908596|39730434|FG001|Overall Study|Protocol Violation|0|||
16340131|NCT00908596|39730435|FG002|Overall Study|Protocol Violation|0|||
16340132|NCT00908596|39730436|FG003|Overall Study|Protocol Violation|0|||
16340133|NCT00908596|39730433|FG000|Overall Study|Withdrawal by Subject|0|||
16340134|NCT00908596|39730434|FG001|Overall Study|Withdrawal by Subject|1|||
16340135|NCT00908596|39730435|FG002|Overall Study|Withdrawal by Subject|3|||
16340136|NCT00908596|39730436|FG003|Overall Study|Withdrawal by Subject|1|||
16340137|NCT04571385|39730437|FG000|Overall Study|Participant non-compliance|1|||
16340138|NCT04571385|39730438|FG001|Overall Study|Participant non-compliance|0|||
16340139|NCT04571385|39730439|FG002|Overall Study|Participant non-compliance|0|||
16340140|NCT04571385|39730437|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
16340141|NCT04571385|39730438|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
16340142|NCT04571385|39730439|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
16340143|NCT04571385|39730437|FG000|Overall Study|Screen failure|0|||
16340144|NCT04571385|39730438|FG001|Overall Study|Screen failure|0|||
16340145|NCT04571385|39730439|FG002|Overall Study|Screen failure|1|||
16340146|NCT00345878|39730440|FG000|Overall Study|Adverse Event|1|||
16340147|NCT00345878|39730441|FG001|Overall Study|Adverse Event|0|||
16340148|NCT00345878|39730440|FG000|Overall Study|Lost to Follow-up|2|||
16340149|NCT00345878|39730441|FG001|Overall Study|Lost to Follow-up|1|||
16340150|NCT00345878|39730440|FG000|Overall Study|Other|1|||
16340151|NCT00345878|39730441|FG001|Overall Study|Other|0|||
16340152|NCT02172040|39730442|FG000|Overall Study|Adverse Event|0|||
16340153|NCT02172040|39730443|FG001|Overall Study|Adverse Event|2|||
16340154|NCT02172040|39730444|FG002|Overall Study|Adverse Event|0|||
16340155|NCT02172040|39730445|FG003|Overall Study|Adverse Event|0|||
16340156|NCT02172040|39730442|FG000|Overall Study|Protocol Violation|0|||
16340157|NCT02172040|39730443|FG001|Overall Study|Protocol Violation|1|||
16340158|NCT02172040|39730444|FG002|Overall Study|Protocol Violation|0|||
16340159|NCT02172040|39730445|FG003|Overall Study|Protocol Violation|0|||
16340160|NCT02172040|39730442|FG000|Overall Study|Withdrawal by Subject|0|||
16340161|NCT02172040|39730443|FG001|Overall Study|Withdrawal by Subject|0|||
16340162|NCT02172040|39730444|FG002|Overall Study|Withdrawal by Subject|1|||
16340163|NCT02172040|39730445|FG003|Overall Study|Withdrawal by Subject|0|||
16340164|NCT02172040|39730442|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
16539795|NCT01951638|40436062|FG001|Follow-up Period|Adverse Event|1|||
16539796|NCT01951638|40436063|FG002|Follow-up Period|Adverse Event|2|||
16539797|NCT01951638|40436064|FG003|Follow-up Period|Adverse Event|1|||
16539798|NCT01951638|40436065|FG004|Follow-up Period|Adverse Event|1|||
16539799|NCT00234052|40436067|FG000|Treatment|Withdrawal by Subject|3|||
16539800|NCT00234052|40436067|FG000|Treatment|Adverse Event|5|||
16539801|NCT00234052|40436067|FG000|Treatment|Death|2|||
16539802|NCT00234052|40436067|FG000|Treatment|Progressive Disease|11|||
16539803|NCT00234052|40436067|FG000|Follow-up for 5 Years|Death|41|||
16539804|NCT00234052|40436067|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
16539805|NCT00234052|40436067|FG000|Follow-up for 5 Years|Other|7|||
16539806|NCT03945188|40436068|FG000|Overall Study|Protocol Violation|1|||
16539807|NCT03945188|40436069|FG001|Overall Study|Protocol Violation|0|||
16539808|NCT03945188|40436068|FG000|Overall Study|Disease worsening|79|||
16539809|NCT03945188|40436069|FG001|Overall Study|Disease worsening|73|||
16539810|NCT03945188|40436068|FG000|Overall Study|Physician Decision|2|||
16539811|NCT03945188|40436069|FG001|Overall Study|Physician Decision|2|||
16105364|NCT00332488|38872263|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
16539812|NCT03945188|40436068|FG000|Overall Study|Lack of Efficacy|7|||
16539813|NCT03945188|40436069|FG001|Overall Study|Lack of Efficacy|4|||
16340165|NCT02172040|39730443|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
16340166|NCT02172040|39730444|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
16340167|NCT02172040|39730445|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
16340168|NCT02172040|39730442|FG000|Overall Study|Family emergency abroad|0|||
16340169|NCT02172040|39730443|FG001|Overall Study|Family emergency abroad|0|||
16340170|NCT02172040|39730444|FG002|Overall Study|Family emergency abroad|0|||
16340171|NCT02172040|39730445|FG003|Overall Study|Family emergency abroad|1|||
16340172|NCT01324570|39730459|FG000|Overall Study|Adverse Event|4|||
16340173|NCT01324570|39730460|FG001|Overall Study|Adverse Event|7|||
16340174|NCT01324570|39730459|FG000|Overall Study|Withdrawal by Subject|0|||
16340175|NCT01324570|39730460|FG001|Overall Study|Withdrawal by Subject|3|||
16340176|NCT01324570|39730459|FG000|Overall Study|Lack of Efficacy|0|||
16340177|NCT01324570|39730460|FG001|Overall Study|Lack of Efficacy|1|||
16340178|NCT01324570|39730459|FG000|Overall Study|Confirmed or suspected diversion|0|||
16340179|NCT01324570|39730460|FG001|Overall Study|Confirmed or suspected diversion|1|||
16539814|NCT03945188|40436068|FG000|Overall Study|Pregnancy|2|||
16217532|NCT02477800|39276018|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
16217533|NCT02477800|39276019|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
16217534|NCT02477800|39276020|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
16340180|NCT01324570|39730459|FG000|Overall Study|Administrative|0|||
16539815|NCT03945188|40436069|FG001|Overall Study|Pregnancy|0|||
16105365|NCT00332488|38872264|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
16105366|NCT00332488|38872265|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
16105367|NCT00332488|38872263|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
16105368|NCT00332488|38872264|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
16105369|NCT00332488|38872265|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
16105370|NCT00332488|38872263|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
16105371|NCT00332488|38872264|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
16105372|NCT00332488|38872265|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
16105373|NCT00332488|38872263|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
16105374|NCT00332488|38872264|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
16105375|NCT00332488|38872265|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
16105376|NCT00332488|38872263|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
16105377|NCT00332488|38872264|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
16105378|NCT00332488|38872265|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
16105379|NCT00332488|38872263|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
16105380|NCT00332488|38872264|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
16105381|NCT00332488|38872265|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
16105382|NCT00332488|38872263|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
16105383|NCT00332488|38872264|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
16105384|NCT00332488|38872265|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
16105385|NCT00332488|38872263|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
16105386|NCT00332488|38872264|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
16105387|NCT00332488|38872265|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
16105388|NCT00332488|38872263|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
16105389|NCT00332488|38872264|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
16105390|NCT00332488|38872265|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
16105391|NCT00332488|38872263|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
16105392|NCT00332488|38872264|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
16105393|NCT00332488|38872265|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
16105394|NCT00332488|38872263|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
16105395|NCT00332488|38872264|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
16105396|NCT00332488|38872265|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
16105397|NCT00332488|38872263|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
16217535|NCT02477800|39276021|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
16217536|NCT02477800|39276022|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
16217537|NCT02477800|39276023|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
16539816|NCT03945188|40436068|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
16539817|NCT03945188|40436069|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
16539818|NCT03945188|40436068|FG000|Overall Study|Adverse Event|10|||
16539819|NCT03945188|40436069|FG001|Overall Study|Adverse Event|5|||
16539820|NCT03945188|40436068|FG000|Overall Study|Other|2|||
16539821|NCT03945188|40436069|FG001|Overall Study|Other|2|||
16539822|NCT03945188|40436068|FG000|Overall Study|Lost to Follow-up|1|||
16539823|NCT03945188|40436069|FG001|Overall Study|Lost to Follow-up|2|||
16539824|NCT05045625|40436070|FG000|Overall Study|Lost to Follow-up|3|||
16539825|NCT03494166|40436071|FG000|Overall Study|Death|0|||
16539826|NCT03494166|40436072|FG001|Overall Study|Death|0|||
16539827|NCT03494166|40436073|FG002|Overall Study|Death|0|||
16539828|NCT03494166|40436074|FG003|Overall Study|Death|1|||
16539829|NCT03494166|40436075|FG004|Overall Study|Death|3|||
16105398|NCT00332488|38872264|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
16105399|NCT00332488|38872265|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
16105400|NCT00721214|38872266|FG000|Overall Study|Chose another center for transplant|1|||
16340181|NCT01324570|39730460|FG001|Overall Study|Administrative|2|||
16340182|NCT00705341|39734320|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
16539830|NCT03494166|40436076|FG005|Overall Study|Death|0|||
16539831|NCT03494166|40436071|FG000|Overall Study|Lost to Follow-up|2|||
16105401|NCT00721214|38872266|FG000|Overall Study|Death|3|||
16105402|NCT01222078|38872267|FG000|Overall Study|Early termination of the study|1|||
16105403|NCT02803593|38872268|FG000|Overall Study|Lost to Follow-up|17|||
16105404|NCT02803593|38872269|FG001|Overall Study|Lost to Follow-up|35|||
16105405|NCT01084239|38872270|FG000|28-Day Follow-up|Lost to Follow-up|4|||
16105406|NCT01084239|38872271|FG001|28-Day Follow-up|Lost to Follow-up|9|||
16105407|NCT01177137|38872272|FG000|Overall Study|Withdrawal by Subject|10|||
16105408|NCT01177137|38872273|FG001|Overall Study|Withdrawal by Subject|10|||
16105409|NCT01177137|38872274|FG002|Overall Study|Withdrawal by Subject|2|||
16105410|NCT01560585|38872275|FG000|Overall Study|Physician Decision|3|||
16105411|NCT00875615|38872278|FG000|Overall Study|Withdrawal by Subject|1|||
16105412|NCT01171183|38872279|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
16105413|NCT01171183|38872280|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
16105414|NCT01171183|38872279|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
16105415|NCT01171183|38872280|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
16105416|NCT01171183|38872279|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
16105417|NCT01171183|38872280|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
16105418|NCT01171183|38872279|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
16105419|NCT01171183|38872280|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
16105420|NCT01171183|38872279|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
16105421|NCT01171183|38872280|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
16105422|NCT01171183|38872279|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
16105423|NCT01171183|38872280|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
16105424|NCT04811339|38872281|FG000|Overall Study|lack of transportation not wanting to return|4|||
16105425|NCT04811339|38872282|FG001|Overall Study|lack of transportation not wanting to return|8|||
16105426|NCT04811339|38872283|FG002|Overall Study|lack of transportation not wanting to return|0|||
16105427|NCT04811339|38872281|FG000|Overall Study|Adverse Event|3|||
16105428|NCT04811339|38872282|FG001|Overall Study|Adverse Event|0|||
16105429|NCT04811339|38872283|FG002|Overall Study|Adverse Event|0|||
16105430|NCT04811339|38872281|FG000|Overall Study|Lost to Follow-up|1|||
16105431|NCT04811339|38872282|FG001|Overall Study|Lost to Follow-up|0|||
16105432|NCT04811339|38872283|FG002|Overall Study|Lost to Follow-up|0|||
16105433|NCT04811339|38872281|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
16105434|NCT04811339|38872282|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
16105435|NCT04811339|38872283|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
16105436|NCT04811339|38872281|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
16105437|NCT04811339|38872282|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
16105438|NCT04811339|38872283|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
16105439|NCT04811339|38872281|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
16105440|NCT04811339|38872282|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
16105441|NCT04811339|38872283|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
16105442|NCT04811339|38872281|FG000|Overall Study|Withdrawal by Subject|0|||
16105443|NCT04811339|38872282|FG001|Overall Study|Withdrawal by Subject|3|||
16105444|NCT04811339|38872283|FG002|Overall Study|Withdrawal by Subject|0|||
16105445|NCT04811339|38872281|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
16105446|NCT04811339|38872282|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
16105447|NCT04811339|38872283|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
16105448|NCT04811339|38872281|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
16105449|NCT04811339|38872282|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
16105450|NCT04811339|38872283|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
16406646|NCT00980460|39969861|FG002|Overall Study|Refusal of further therapy|3|||
16105452|NCT03464383|38872290|FG000|Overall Study|Lost to Follow-up|1|||
16105453|NCT03464383|38872291|FG001|Overall Study|Lost to Follow-up|0|||
16105454|NCT03464383|38872292|FG002|Overall Study|Lost to Follow-up|0|||
16105455|NCT03464383|38872290|FG000|Overall Study|Withdrawal by Subject|0|||
16105456|NCT03464383|38872291|FG001|Overall Study|Withdrawal by Subject|1|||
16105457|NCT03464383|38872292|FG002|Overall Study|Withdrawal by Subject|0|||
16539832|NCT03494166|40436072|FG001|Overall Study|Lost to Follow-up|2|||
16539833|NCT03494166|40436073|FG002|Overall Study|Lost to Follow-up|2|||
16539834|NCT03494166|40436074|FG003|Overall Study|Lost to Follow-up|2|||
16539835|NCT03494166|40436075|FG004|Overall Study|Lost to Follow-up|14|||
16539836|NCT03494166|40436076|FG005|Overall Study|Lost to Follow-up|0|||
16105458|NCT03419897|38872293|FG000|Overall Study|Death|180|||
16105459|NCT03419897|38872293|FG000|Overall Study|Lost to Follow-up|1|||
16105460|NCT03419897|38872293|FG000|Overall Study|Withdrawal by Subject|6|||
16105461|NCT03419897|38872293|FG000|Overall Study|Sponsor Decision|61|||
16105462|NCT03419897|38872293|FG000|Overall Study|Physician Decision|1|||
16105463|NCT00489489|38872298|FG000|Overall Study|Not treated due to protocol violation|0|||
16539837|NCT03494166|40436071|FG000|Overall Study|Withdrawal by Subject|10|||
16105464|NCT00489489|38872299|FG001|Overall Study|Not treated due to protocol violation|1|||
16105465|NCT00489489|38872300|FG002|Overall Study|Not treated due to protocol violation|1|||
16105466|NCT00489489|38872298|FG000|Overall Study|Adverse Event|1|||
16105467|NCT00489489|38872299|FG001|Overall Study|Adverse Event|1|||
16105468|NCT00489489|38872300|FG002|Overall Study|Adverse Event|1|||
16340183|NCT00705341|39734321|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
16340184|NCT00705341|39734322|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
16105469|NCT00489489|38872298|FG000|Overall Study|Protocol Violation|1|||
16105470|NCT00489489|38872299|FG001|Overall Study|Protocol Violation|0|||
16105471|NCT00489489|38872300|FG002|Overall Study|Protocol Violation|1|||
16105472|NCT00489489|38872298|FG000|Overall Study|Progressive disease|0|||
16105473|NCT00489489|38872299|FG001|Overall Study|Progressive disease|1|||
16340185|NCT00705341|39734323|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
16340186|NCT00705341|39734320|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
16340187|NCT00705341|39734321|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
16340188|NCT00705341|39734322|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
16340189|NCT00705341|39734323|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
16340190|NCT03469999|39734326|FG000|Overall Study|Lost to Follow-up|2|||
16340191|NCT00703677|39734329|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
16340192|NCT02686814|39734330|FG000|Overall Study|Physician Decision|14|||
16340193|NCT02686814|39734330|FG000|Overall Study|Withdrawal by Subject|4|||
16340194|NCT02686814|39734330|FG000|Overall Study|Death|1|||
16340195|NCT01250171|39734336|FG000|Overall Study|Administrative reasons|1|||
16340196|NCT01250171|39734337|FG001|Overall Study|Administrative reasons|0|||
16340197|NCT01250171|39734338|FG002|Overall Study|Administrative reasons|0|||
16340198|NCT03034135|39734341|FG000|Overall Study|Withdrawal by Subject|2|||
16340199|NCT03859648|39734342|FG000|Overall Study|Lost to Follow-up|1|||
16340200|NCT03859648|39734342|FG000|Overall Study|Adverse Event|1|||
16340201|NCT01777139|39734343|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
16539838|NCT03494166|40436072|FG001|Overall Study|Withdrawal by Subject|7|||
16539839|NCT03494166|40436073|FG002|Overall Study|Withdrawal by Subject|0|||
16539840|NCT03494166|40436074|FG003|Overall Study|Withdrawal by Subject|5|||
16539841|NCT03494166|40436075|FG004|Overall Study|Withdrawal by Subject|3|||
16340202|NCT01777139|39734344|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
16340203|NCT01777139|39734343|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
16340204|NCT01777139|39734344|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
16340205|NCT01777139|39734343|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
16340206|NCT01777139|39734344|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
16340207|NCT01777139|39734343|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
16340208|NCT01777139|39734344|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
16340209|NCT01777139|39734343|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
16340210|NCT01777139|39734344|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
16539842|NCT03494166|40436076|FG005|Overall Study|Withdrawal by Subject|17|||
16539843|NCT03494166|40436071|FG000|Overall Study|Screen failure|1|||
16539844|NCT03494166|40436072|FG001|Overall Study|Screen failure|0|||
16539845|NCT03494166|40436073|FG002|Overall Study|Screen failure|0|||
16539846|NCT03494166|40436074|FG003|Overall Study|Screen failure|0|||
16539847|NCT03494166|40436075|FG004|Overall Study|Screen failure|1|||
16539848|NCT03494166|40436076|FG005|Overall Study|Screen failure|0|||
16539849|NCT01843192|40436077|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
16539850|NCT01843192|40436078|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
16539851|NCT01843192|40436079|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
16539852|NCT01552954|40436083|FG000|Overall Study|Adverse Event|1|||
16539853|NCT01552954|40436084|FG001|Overall Study|Adverse Event|2|||
16539854|NCT01552954|40436083|FG000|Overall Study|Lost to Follow-up|1|||
16539855|NCT01552954|40436084|FG001|Overall Study|Lost to Follow-up|1|||
16539856|NCT01552954|40436083|FG000|Overall Study|Withdrawal by Subject|1|||
16539857|NCT01552954|40436084|FG001|Overall Study|Withdrawal by Subject|1|||
16539858|NCT01552954|40436083|FG000|Overall Study|Protocol Violation|1|||
16539859|NCT01552954|40436084|FG001|Overall Study|Protocol Violation|2|||
16539860|NCT01552954|40436083|FG000|Overall Study|diagnosed DM|1|||
16539861|NCT01552954|40436084|FG001|Overall Study|diagnosed DM|0|||
16105474|NCT00489489|38872300|FG002|Overall Study|Progressive disease|0|||
16105475|NCT00489489|38872298|FG000|Overall Study|Participant did not wish to continue|1|||
16105476|NCT00489489|38872299|FG001|Overall Study|Participant did not wish to continue|1|||
16217538|NCT02477800|39276017|FG000|Placebo-Controlled Period|Death|0|||
16539862|NCT02178566|40436085|FG000|Overall Study|patient did not complete due to noncompliance|0|||
16539863|NCT02178566|40436086|FG001|Overall Study|patient did not complete due to noncompliance|1|||
16539864|NCT01065350|40436087|FG000|Overall Study|Received incorrect drug allocation|0|||
16539865|NCT01065350|40436088|FG001|Overall Study|Received incorrect drug allocation|1|||
16539866|NCT03403426|40436089|FG000|Overall Study|Death|1|||
16539867|NCT03403426|40436089|FG000|Overall Study|Lost to Follow-up|2|||
16539868|NCT01362439|40436090|FG000|Overall Study|Adverse Event|1|||
16340211|NCT01777139|39734343|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
16340212|NCT01777139|39734344|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
16340213|NCT01777139|39734343|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
16340214|NCT01777139|39734344|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
16340215|NCT01777139|39734343|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
16340216|NCT01777139|39734344|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
16340217|NCT02683239|39734345|FG000|Overall Study|Protocol Violation|35|||
16340218|NCT02683239|39734346|FG001|Overall Study|Protocol Violation|23|||
16340219|NCT02683239|39734347|FG002|Overall Study|Protocol Violation|26|||
16340220|NCT02683239|39734348|FG003|Overall Study|Protocol Violation|4|||
16340221|NCT02683239|39734349|FG004|Overall Study|Protocol Violation|35|||
16340222|NCT02683239|39734350|FG005|Overall Study|Protocol Violation|4|||
16340223|NCT02683239|39734351|FG006|Overall Study|Protocol Violation|5|||
16105477|NCT00489489|38872300|FG002|Overall Study|Participant did not wish to continue|0|||
16105478|NCT00489489|38872298|FG000|Overall Study|Other than above|0|||
16105479|NCT00489489|38872299|FG001|Overall Study|Other than above|1|||
16105480|NCT00489489|38872300|FG002|Overall Study|Other than above|0|||
16105481|NCT03175198|38872305|FG000|Overall Study|Adverse Event|480|||
16105482|NCT03175198|38872305|FG000|Overall Study|No actual visit|120|||
16105483|NCT03175198|38872305|FG000|Overall Study|Registration rule not followed|4|||
16105484|NCT03175198|38872305|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
16105485|NCT03175198|38872305|FG000|Overall Study|Other personal reason|509|||
16105486|NCT03175198|38872305|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
16105487|NCT03175198|38872305|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
16105488|NCT03175198|38872305|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
16105489|NCT03175198|38872305|FG000|Overall Study|To conduct invasive treatment of operation|53|||
16105490|NCT03175198|38872305|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
16105491|NCT01904136|38872306|FG000|Overall Study|Physician Decision|0|||
16105492|NCT01904136|38872307|FG001|Overall Study|Physician Decision|0|||
16105493|NCT01904136|38872308|FG002|Overall Study|Physician Decision|0|||
16105494|NCT01904136|38872309|FG003|Overall Study|Physician Decision|0|||
16105495|NCT01904136|38872310|FG004|Overall Study|Physician Decision|0|||
16105496|NCT01904136|38872311|FG005|Overall Study|Physician Decision|1|||
16105497|NCT01904136|38872312|FG006|Overall Study|Physician Decision|0|||
16105498|NCT01904136|38872313|FG007|Overall Study|Physician Decision|0|||
16105499|NCT01904136|38872314|FG008|Overall Study|Physician Decision|0|||
16105500|NCT00125853|38872316|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
16105501|NCT00125853|38872317|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
16105502|NCT04191148|38872320|FG000|Overall Study|Withdrawal by Subject|1|||
16105503|NCT04191148|38872321|FG001|Overall Study|Withdrawal by Subject|0|||
16105504|NCT04191148|38872320|FG000|Overall Study|Adverse Event|1|||
16105505|NCT04191148|38872321|FG001|Overall Study|Adverse Event|0|||
16105506|NCT00570921|38872327|FG000|Overall Study|Protocol Violation|1|||
16105507|NCT00570921|38872327|FG000|Overall Study|Physician Decision|1|||
16105508|NCT00635570|38872328|FG000|Overall Study|Lost to Follow-up|8|||
16105509|NCT00635570|38872329|FG001|Overall Study|Lost to Follow-up|8|||
16105510|NCT00635570|38872328|FG000|Overall Study|Withdrawal by Subject|1|||
16105511|NCT00635570|38872329|FG001|Overall Study|Withdrawal by Subject|1|||
16105512|NCT00635570|38872328|FG000|Overall Study|Adverse Event|2|||
16105513|NCT00635570|38872329|FG001|Overall Study|Adverse Event|0|||
16105514|NCT00635570|38872328|FG000|Overall Study|Physician Decision|1|||
16105515|NCT00635570|38872329|FG001|Overall Study|Physician Decision|0|||
16105516|NCT00635570|38872328|FG000|Overall Study|Did not complete survey|2|||
16105517|NCT00635570|38872329|FG001|Overall Study|Did not complete survey|1|||
16105518|NCT00635570|38872328|FG000|Overall Study|Early termination(No sexual activity)|1|||
16105519|NCT00635570|38872329|FG001|Overall Study|Early termination(No sexual activity)|1|||
16105520|NCT00087555|38872330|FG000|Overall Study|Adverse Event|3|||
16105521|NCT00087555|38872331|FG001|Overall Study|Adverse Event|6|||
16105522|NCT00087555|38872332|FG002|Overall Study|Adverse Event|14|||
16105523|NCT00087555|38872330|FG000|Overall Study|Lost to Follow-up|0|||
16105524|NCT00087555|38872331|FG001|Overall Study|Lost to Follow-up|1|||
16105525|NCT00087555|38872332|FG002|Overall Study|Lost to Follow-up|1|||
16105526|NCT00087555|38872330|FG000|Overall Study|Non - Compliance|1|||
16105527|NCT00087555|38872331|FG001|Overall Study|Non - Compliance|0|||
16105528|NCT00087555|38872332|FG002|Overall Study|Non - Compliance|0|||
16105529|NCT00087555|38872330|FG000|Overall Study|Protocol Violation|0|||
16105530|NCT00087555|38872331|FG001|Overall Study|Protocol Violation|0|||
16105531|NCT00087555|38872332|FG002|Overall Study|Protocol Violation|2|||
16105532|NCT00087555|38872330|FG000|Overall Study|Screen Failure|1|||
16105533|NCT00087555|38872331|FG001|Overall Study|Screen Failure|1|||
16105534|NCT00087555|38872332|FG002|Overall Study|Screen Failure|0|||
16105535|NCT00087555|38872330|FG000|Overall Study|Pregnancy|0|||
16105536|NCT00087555|38872331|FG001|Overall Study|Pregnancy|1|||
16105537|NCT00087555|38872332|FG002|Overall Study|Pregnancy|1|||
16340224|NCT02683239|39734345|FG000|Overall Study|Adverse Event|64|||
16340225|NCT02683239|39734346|FG001|Overall Study|Adverse Event|39|||
16105538|NCT00087555|38872330|FG000|Overall Study|Withdrawal by Subject|3|||
16105539|NCT00087555|38872331|FG001|Overall Study|Withdrawal by Subject|2|||
16105540|NCT00087555|38872332|FG002|Overall Study|Withdrawal by Subject|1|||
16105541|NCT00087555|38872330|FG000|Overall Study|Lack of Efficacy|2|||
16105542|NCT00087555|38872331|FG001|Overall Study|Lack of Efficacy|0|||
16105543|NCT00087555|38872332|FG002|Overall Study|Lack of Efficacy|1|||
16105544|NCT00087555|38872330|FG000|Overall Study|Non Compliance|0|||
16105545|NCT00087555|38872331|FG001|Overall Study|Non Compliance|0|||
16105546|NCT00087555|38872332|FG002|Overall Study|Non Compliance|1|||
16105547|NCT00087555|38872330|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
16105548|NCT00087555|38872331|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
16105549|NCT00087555|38872332|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
16105550|NCT00087555|38872330|FG000|Overall Study|Patient wanted to go back on Med|1|||
16105551|NCT00087555|38872331|FG001|Overall Study|Patient wanted to go back on Med|0|||
16105552|NCT00087555|38872332|FG002|Overall Study|Patient wanted to go back on Med|0|||
16105553|NCT03280108|38872333|FG000|Overall Study|Lost to Follow-up|2|||
16105554|NCT03280108|38872334|FG001|Overall Study|Lost to Follow-up|0|||
16105555|NCT00053352|38872338|FG000|Overall Study|Lost to Follow-up|0|||
16105556|NCT00053352|38872339|FG001|Overall Study|Lost to Follow-up|1|||
16105557|NCT00053352|38872338|FG000|Overall Study|Physician Decision|11|||
16105558|NCT00053352|38872339|FG001|Overall Study|Physician Decision|1|||
16105559|NCT00053352|38872338|FG000|Overall Study|Withdrawal by Subject|1|||
16105560|NCT00053352|38872339|FG001|Overall Study|Withdrawal by Subject|0|||
16105561|NCT00053352|38872338|FG000|Overall Study|Ineligible|8|||
16105562|NCT00053352|38872339|FG001|Overall Study|Ineligible|8|||
16105563|NCT00053352|38872338|FG000|Overall Study|Disease at new site|1|||
16105564|NCT00053352|38872339|FG001|Overall Study|Disease at new site|0|||
16105565|NCT00317603|38872340|FG000|Overall Study|Progressive Disease|3|||
16105566|NCT03924947|38872343|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
16105567|NCT03924947|38872344|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
16105568|NCT03924947|38872345|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
16105569|NCT03924947|38872346|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
16105570|NCT03924947|38872347|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
16105571|NCT03924947|38872348|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
16105572|NCT02621047|38872349|FG000|Overall Study|Adverse Event|0|||
16105573|NCT02621047|38872350|FG001|Overall Study|Adverse Event|0|||
16105574|NCT02621047|38872351|FG002|Overall Study|Adverse Event|1|||
16105575|NCT00655668|38872358|FG000|Overall Study|Adverse Event|6|||
16105576|NCT00655668|38872358|FG000|Overall Study|Death|5|||
16105577|NCT00655668|38872358|FG000|Overall Study|Disease Progression|27|||
16105578|NCT00655668|38872358|FG000|Overall Study|Study Terminated|9|||
16105579|NCT00655668|38872358|FG000|Overall Study|Other|1|||
16105580|NCT00655668|38872358|FG000|Overall Study|New Lymphoma Treatment Started|4|||
16105581|NCT00655668|38872358|FG000|Overall Study|Withdrawal by Subject|2|||
16105582|NCT01990664|38875276|FG000|Overall Study|Lost to Follow-up|2|||
16105583|NCT01990664|38875277|FG001|Overall Study|Lost to Follow-up|6|||
16105584|NCT01990664|38875276|FG000|Overall Study|Withdrawal by Subject|2|||
16105585|NCT01990664|38875277|FG001|Overall Study|Withdrawal by Subject|3|||
16105586|NCT01990664|38875276|FG000|Overall Study|Protocol Violation|1|||
16105587|NCT01990664|38875277|FG001|Overall Study|Protocol Violation|0|||
16105588|NCT01990664|38875276|FG000|Overall Study|Lens Discomfort|1|||
16340226|NCT02683239|39734347|FG002|Overall Study|Adverse Event|42|||
16340227|NCT02683239|39734348|FG003|Overall Study|Adverse Event|16|||
16340228|NCT02683239|39734349|FG004|Overall Study|Adverse Event|189|||
16340229|NCT02683239|39734350|FG005|Overall Study|Adverse Event|9|||
16340230|NCT02683239|39734351|FG006|Overall Study|Adverse Event|9|||
16340231|NCT02683239|39734345|FG000|Overall Study|Physician Decision|38|||
16340232|NCT02683239|39734346|FG001|Overall Study|Physician Decision|19|||
16340233|NCT02683239|39734347|FG002|Overall Study|Physician Decision|14|||
16340234|NCT02683239|39734348|FG003|Overall Study|Physician Decision|73|||
16340235|NCT02683239|39734349|FG004|Overall Study|Physician Decision|143|||
16340236|NCT02683239|39734350|FG005|Overall Study|Physician Decision|14|||
16105589|NCT01990664|38875277|FG001|Overall Study|Lens Discomfort|1|||
16105590|NCT01990664|38875276|FG000|Overall Study|Lens Handling Difficulties|1|||
16340237|NCT02683239|39734351|FG006|Overall Study|Physician Decision|15|||
16105591|NCT01990664|38875277|FG001|Overall Study|Lens Handling Difficulties|0|||
16105592|NCT01990664|38875276|FG000|Overall Study|Unsatisfactory Visual Response|0|||
16105593|NCT01990664|38875277|FG001|Overall Study|Unsatisfactory Visual Response|1|||
16105594|NCT04984278|38875278|FG000|Period 1|Withdrawal by Subject|1|||
16105595|NCT04984278|38875279|FG001|Period 1|Withdrawal by Subject|0|||
16105596|NCT04984278|38875278|FG000|Period 1|Other|0|||
16105597|NCT04984278|38875279|FG001|Period 1|Other|1|||
16105598|NCT04984278|38875278|FG000|Period 2|Adverse Event|1|||
16105599|NCT04984278|38875279|FG001|Period 2|Adverse Event|0|||
16105600|NCT04984278|38875278|FG000|Period 2|Other|0|||
16105601|NCT04984278|38875279|FG001|Period 2|Other|1|||
16105602|NCT00874497|38875283|FG000|Overall Study|Lost to Follow-up|2|||
16340238|NCT02683239|39734345|FG000|Overall Study|Withdrawal by Subject|187|||
16105603|NCT00874497|38875284|FG001|Overall Study|Lost to Follow-up|4|||
16105604|NCT00874497|38875283|FG000|Overall Study|Adverse Event|9|||
16105605|NCT00874497|38875284|FG001|Overall Study|Adverse Event|4|||
16105606|NCT00874497|38875283|FG000|Overall Study|Sponsor Discontinued Trial|7|||
16105607|NCT00874497|38875284|FG001|Overall Study|Sponsor Discontinued Trial|3|||
16105608|NCT00874497|38875283|FG000|Overall Study|Met Withdrawal Criteria|4|||
16539869|NCT01362439|40436090|FG000|Overall Study|Lack of Efficacy|3|||
16105609|NCT00874497|38875284|FG001|Overall Study|Met Withdrawal Criteria|2|||
16105610|NCT00874497|38875283|FG000|Overall Study|Physician Decision|1|||
16105611|NCT00874497|38875284|FG001|Overall Study|Physician Decision|1|||
16105612|NCT00874497|38875283|FG000|Overall Study|Withdrawal by Subject|5|||
16105613|NCT00874497|38875284|FG001|Overall Study|Withdrawal by Subject|4|||
16105614|NCT02353871|38875285|FG000|Overall Study|Protocol deviation|0|||
16340239|NCT02683239|39734346|FG001|Overall Study|Withdrawal by Subject|99|||
16539870|NCT01362439|40436090|FG000|Overall Study|Lost to Follow-up|2|||
16539871|NCT01362439|40436090|FG000|Overall Study|Study medication non-compliant|1|||
16539872|NCT01362439|40436090|FG000|Overall Study|Participant who withdrew consent|8|||
16539873|NCT00387894|40436091|FG000|Overall Study|Withdrawal by Subject|1|||
16539874|NCT00166296|40436092|FG000|Overall Study|Withdrawal by Subject|1|||
16539875|NCT00166296|40436093|FG001|Overall Study|Withdrawal by Subject|3|||
16539876|NCT00166296|40436092|FG000|Overall Study|Adverse Event|2|||
16340240|NCT02683239|39734347|FG002|Overall Study|Withdrawal by Subject|91|||
16340241|NCT02683239|39734348|FG003|Overall Study|Withdrawal by Subject|18|||
16340242|NCT02683239|39734349|FG004|Overall Study|Withdrawal by Subject|248|||
16340243|NCT02683239|39734350|FG005|Overall Study|Withdrawal by Subject|22|||
16340244|NCT02683239|39734351|FG006|Overall Study|Withdrawal by Subject|28|||
16340245|NCT02683239|39734345|FG000|Overall Study|Lost to Follow-up|77|||
16340246|NCT02683239|39734346|FG001|Overall Study|Lost to Follow-up|24|||
16340247|NCT02683239|39734347|FG002|Overall Study|Lost to Follow-up|25|||
16340248|NCT02683239|39734348|FG003|Overall Study|Lost to Follow-up|7|||
16340249|NCT02683239|39734349|FG004|Overall Study|Lost to Follow-up|88|||
16340250|NCT02683239|39734350|FG005|Overall Study|Lost to Follow-up|8|||
16340251|NCT02683239|39734351|FG006|Overall Study|Lost to Follow-up|11|||
16340252|NCT02683239|39734345|FG000|Overall Study|Death|9|||
16340253|NCT02683239|39734346|FG001|Overall Study|Death|5|||
16340254|NCT02683239|39734347|FG002|Overall Study|Death|8|||
16340255|NCT02683239|39734348|FG003|Overall Study|Death|0|||
16340256|NCT02683239|39734349|FG004|Overall Study|Death|12|||
16340257|NCT02683239|39734350|FG005|Overall Study|Death|1|||
16340258|NCT02683239|39734351|FG006|Overall Study|Death|0|||
16340259|NCT02683239|39734345|FG000|Overall Study|Lack of Efficacy|50|||
16340260|NCT02683239|39734346|FG001|Overall Study|Lack of Efficacy|23|||
16340261|NCT02683239|39734347|FG002|Overall Study|Lack of Efficacy|12|||
16340262|NCT02683239|39734348|FG003|Overall Study|Lack of Efficacy|2|||
16340263|NCT02683239|39734349|FG004|Overall Study|Lack of Efficacy|29|||
16340264|NCT02683239|39734350|FG005|Overall Study|Lack of Efficacy|2|||
16340265|NCT02683239|39734351|FG006|Overall Study|Lack of Efficacy|3|||
16340266|NCT02683239|39734345|FG000|Overall Study|Missing data|0|||
16340267|NCT02683239|39734346|FG001|Overall Study|Missing data|1|||
16340268|NCT02683239|39734347|FG002|Overall Study|Missing data|1|||
16340269|NCT02683239|39734348|FG003|Overall Study|Missing data|0|||
16340270|NCT02683239|39734349|FG004|Overall Study|Missing data|1|||
16340271|NCT02683239|39734350|FG005|Overall Study|Missing data|0|||
16340272|NCT02683239|39734351|FG006|Overall Study|Missing data|0|||
16340273|NCT01146561|39734352|FG000|Overall Study|Withdrawal by Subject|1|||
16340274|NCT01146561|39734352|FG000|Overall Study|Lost to Follow-up|1|||
16340275|NCT01882803|39734353|FG000|Overall Study|Disease Progression|1|||
16340276|NCT01882803|39734353|FG000|Overall Study|Withdrawal by Subject|9|||
16340277|NCT01882803|39734353|FG000|Overall Study|Death|68|||
16340278|NCT01882803|39734353|FG000|Overall Study|Physician Decision|3|||
16340279|NCT01882803|39734353|FG000|Overall Study|Lost to Follow-up|3|||
16340280|NCT01882803|39734353|FG000|Overall Study|Follow-up Completed|39|||
16340281|NCT01882803|39734353|FG000|Overall Study|Study Terminated by the Sponsor|6|||
16340282|NCT00483704|39734354|FG000|Randomization|Withdrawal by Subject|19|||
16340283|NCT00483704|39734355|FG001|Randomization|Withdrawal by Subject|28|||
16340284|NCT00483704|39734356|FG002|Randomization|Withdrawal by Subject|18|||
16340285|NCT00483704|39734354|FG000|Randomization|Protocol Violation|14|||
16340286|NCT00483704|39734355|FG001|Randomization|Protocol Violation|25|||
16340287|NCT00483704|39734356|FG002|Randomization|Protocol Violation|22|||
16340288|NCT00483704|39734354|FG000|Randomization|Lost to Follow-up|14|||
16340289|NCT00483704|39734355|FG001|Randomization|Lost to Follow-up|14|||
16539877|NCT00166296|40436093|FG001|Overall Study|Adverse Event|4|||
16105615|NCT02353871|38875286|FG001|Overall Study|Protocol deviation|1|||
16105616|NCT02353871|38875285|FG000|Overall Study|Consent withdrawn|1|||
16105617|NCT02353871|38875286|FG001|Overall Study|Consent withdrawn|8|||
16340290|NCT00483704|39734356|FG002|Randomization|Lost to Follow-up|19|||
16340291|NCT00483704|39734354|FG000|Randomization|Pregnancy|1|||
16340292|NCT00483704|39734355|FG001|Randomization|Pregnancy|0|||
16340293|NCT00483704|39734356|FG002|Randomization|Pregnancy|0|||
16340294|NCT00483704|39734354|FG000|Randomization|Physician Decision|2|||
16340295|NCT00483704|39734355|FG001|Randomization|Physician Decision|4|||
16340296|NCT00483704|39734356|FG002|Randomization|Physician Decision|0|||
16340297|NCT00483704|39734354|FG000|Randomization|Progressive disease|0|||
16340298|NCT00483704|39734355|FG001|Randomization|Progressive disease|0|||
16539878|NCT00166296|40436092|FG000|Overall Study|Lost to Follow-up|4|||
16340299|NCT00483704|39734356|FG002|Randomization|Progressive disease|1|||
16539879|NCT00166296|40436093|FG001|Overall Study|Lost to Follow-up|2|||
16539880|NCT03432364|40436094|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
16539881|NCT03751631|40436095|FG000|Overall Study|Withdrawal by Subject|0|||
16539882|NCT03751631|40436096|FG001|Overall Study|Withdrawal by Subject|0|||
16539883|NCT03751631|40436097|FG002|Overall Study|Withdrawal by Subject|1|||
16340300|NCT00483704|39734354|FG000|Randomization|Lack of qualifying migraines|21|||
16340301|NCT00483704|39734355|FG001|Randomization|Lack of qualifying migraines|25|||
16340302|NCT00483704|39734356|FG002|Randomization|Lack of qualifying migraines|31|||
16340303|NCT00483704|39734354|FG000|Treatment|Lack of qualifying migraines|101|||
16340304|NCT00483704|39734355|FG001|Treatment|Lack of qualifying migraines|99|||
16340305|NCT00483704|39734356|FG002|Treatment|Lack of qualifying migraines|116|||
16105618|NCT02353871|38875285|FG000|Overall Study|Lost to Follow-up|2|||
16539884|NCT03751631|40436098|FG003|Overall Study|Withdrawal by Subject|1|||
16539885|NCT03751631|40436099|FG004|Overall Study|Withdrawal by Subject|0|||
16539886|NCT03751631|40436100|FG005|Overall Study|Withdrawal by Subject|0|||
16539887|NCT03848403|40436103|FG000|Period 2 (Day 8)|Adverse Event|1|||
16539888|NCT03848403|40436104|FG001|Period 2 (Day 8)|Adverse Event|2|||
16539889|NCT03848403|40436105|FG002|Period 2 (Day 8)|Adverse Event|2|||
16539890|NCT03848403|40436103|FG000|Period 2 (Day 8)|Physician Decision|0|||
16105619|NCT02353871|38875286|FG001|Overall Study|Lost to Follow-up|0|||
16105620|NCT01121913|38875289|FG000|First Intervention Period|Adverse Event|0|||
16105621|NCT01121913|38875290|FG001|First Intervention Period|Adverse Event|0|||
16105622|NCT01121913|38875291|FG002|First Intervention Period|Adverse Event|1|||
16105623|NCT01121913|38875292|FG003|First Intervention Period|Adverse Event|0|||
16105624|NCT01121913|38875289|FG000|First Washout Period|Withdrawal by Subject|1|||
16105625|NCT01121913|38875290|FG001|First Washout Period|Withdrawal by Subject|0|||
16105626|NCT01121913|38875291|FG002|First Washout Period|Withdrawal by Subject|0|||
16105627|NCT01121913|38875292|FG003|First Washout Period|Withdrawal by Subject|0|||
16105628|NCT01121913|38875289|FG000|Second Intervention Period|Adverse Event|0|||
16105629|NCT01121913|38875290|FG001|Second Intervention Period|Adverse Event|0|||
16105630|NCT01121913|38875291|FG002|Second Intervention Period|Adverse Event|1|||
16105631|NCT01121913|38875292|FG003|Second Intervention Period|Adverse Event|0|||
16105632|NCT01121913|38875289|FG000|Second Washout Period|Withdrawal by Subject|0|||
16105633|NCT01121913|38875290|FG001|Second Washout Period|Withdrawal by Subject|0|||
16105634|NCT01121913|38875291|FG002|Second Washout Period|Withdrawal by Subject|1|||
16105635|NCT01121913|38875292|FG003|Second Washout Period|Withdrawal by Subject|0|||
16105636|NCT01121913|38875289|FG000|Third Washout Period|Adverse Event|1|||
16105637|NCT01121913|38875290|FG001|Third Washout Period|Adverse Event|0|||
16105638|NCT01121913|38875291|FG002|Third Washout Period|Adverse Event|0|||
16105639|NCT01121913|38875292|FG003|Third Washout Period|Adverse Event|0|||
16105640|NCT01427738|38875296|FG000|Overall Study|Death|12|||
16105641|NCT01427738|38875297|FG001|Overall Study|Death|9|||
16105642|NCT01427738|38875296|FG000|Overall Study|Severe debilitation, unable to continue|0|||
16105643|NCT01427738|38875297|FG001|Overall Study|Severe debilitation, unable to continue|1|||
16105644|NCT01427738|38875296|FG000|Overall Study|Subject unable to get to clinic|5|||
16340306|NCT00483704|39734354|FG000|Treatment|Adverse Event|3|||
16539891|NCT03848403|40436104|FG001|Period 2 (Day 8)|Physician Decision|1|||
16539892|NCT03848403|40436105|FG002|Period 2 (Day 8)|Physician Decision|0|||
16539893|NCT03848403|40436103|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
16105645|NCT01427738|38875297|FG001|Overall Study|Subject unable to get to clinic|2|||
16105646|NCT01427738|38875296|FG000|Overall Study|Withdrawal by Subject|0|||
16105647|NCT01427738|38875297|FG001|Overall Study|Withdrawal by Subject|2|||
16340307|NCT00483704|39734355|FG001|Treatment|Adverse Event|5|||
16340308|NCT00483704|39734356|FG002|Treatment|Adverse Event|4|||
16340309|NCT00483704|39734354|FG000|Treatment|Withdrawal by Subject|16|||
16340310|NCT00483704|39734355|FG001|Treatment|Withdrawal by Subject|12|||
16340311|NCT00483704|39734356|FG002|Treatment|Withdrawal by Subject|21|||
16340312|NCT00483704|39734354|FG000|Treatment|Protocol Violation|6|||
16340313|NCT00483704|39734355|FG001|Treatment|Protocol Violation|3|||
16340314|NCT00483704|39734356|FG002|Treatment|Protocol Violation|5|||
16340315|NCT00483704|39734354|FG000|Treatment|Lost to Follow-up|2|||
16340316|NCT00483704|39734355|FG001|Treatment|Lost to Follow-up|7|||
16340317|NCT00483704|39734356|FG002|Treatment|Lost to Follow-up|5|||
16340318|NCT00483704|39734354|FG000|Treatment|Lack of Efficacy|1|||
16340319|NCT00483704|39734355|FG001|Treatment|Lack of Efficacy|1|||
16340320|NCT00483704|39734356|FG002|Treatment|Lack of Efficacy|1|||
16340321|NCT00483704|39734354|FG000|Treatment|Pregnancy|0|||
16340322|NCT00483704|39734355|FG001|Treatment|Pregnancy|1|||
16340323|NCT00483704|39734356|FG002|Treatment|Pregnancy|0|||
16340324|NCT00483704|39734354|FG000|Treatment|Physician Decision|0|||
16340325|NCT00483704|39734355|FG001|Treatment|Physician Decision|1|||
16340326|NCT00483704|39734356|FG002|Treatment|Physician Decision|4|||
16340327|NCT01370616|39734359|FG000|Overall Study|Adverse Event|11|||
16340328|NCT01370616|39734360|FG001|Overall Study|Adverse Event|16|||
16340329|NCT01370616|39734359|FG000|Overall Study|Death|1|||
16340330|NCT01370616|39734360|FG001|Overall Study|Death|0|||
16340331|NCT01370616|39734359|FG000|Overall Study|Lack of Efficacy|6|||
16340332|NCT01370616|39734360|FG001|Overall Study|Lack of Efficacy|2|||
16340333|NCT01370616|39734359|FG000|Overall Study|Lost to Follow-up|0|||
16340334|NCT01370616|39734360|FG001|Overall Study|Lost to Follow-up|3|||
16340335|NCT01370616|39734359|FG000|Overall Study|Physician Decision|6|||
16340336|NCT01370616|39734360|FG001|Overall Study|Physician Decision|6|||
16340337|NCT01370616|39734359|FG000|Overall Study|Progressive Disease|0|||
16340338|NCT01370616|39734360|FG001|Overall Study|Progressive Disease|1|||
16340339|NCT01370616|39734359|FG000|Overall Study|Recovery|1|||
16340340|NCT01370616|39734360|FG001|Overall Study|Recovery|0|||
16340341|NCT01370616|39734359|FG000|Overall Study|Technical Problems|3|||
16340342|NCT01370616|39734360|FG001|Overall Study|Technical Problems|5|||
16340343|NCT01370616|39734359|FG000|Overall Study|Withdrawal by Subject|34|||
16340344|NCT01370616|39734360|FG001|Overall Study|Withdrawal by Subject|34|||
16340345|NCT02579382|39734364|FG000|Main Study Phase|Lost to Follow-up|0|||
16340346|NCT02579382|39734365|FG001|Main Study Phase|Lost to Follow-up|0|||
16340347|NCT02579382|39734366|FG002|Main Study Phase|Lost to Follow-up|2|||
16340348|NCT02579382|39734367|FG003|Main Study Phase|Lost to Follow-up|0|||
16340349|NCT02579382|39734364|FG000|Main Study Phase|Withdrew Consent|0|||
16340350|NCT02579382|39734365|FG001|Main Study Phase|Withdrew Consent|0|||
16340351|NCT02579382|39734366|FG002|Main Study Phase|Withdrew Consent|0|||
16340352|NCT02579382|39734367|FG003|Main Study Phase|Withdrew Consent|2|||
16340353|NCT02579382|39734364|FG000|Main Study Phase|Lack of Efficacy|0|||
16105648|NCT01427738|38875296|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
16105649|NCT01427738|38875297|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
16105650|NCT01427738|38875296|FG000|Overall Study|Lost to Follow-up|1|||
16105651|NCT01427738|38875297|FG001|Overall Study|Lost to Follow-up|5|||
16105652|NCT03029819|38875298|FG000|Overall Study|Lost to Follow-up|3|||
16105653|NCT03029819|38875299|FG001|Overall Study|Lost to Follow-up|5|||
16105654|NCT03029819|38875298|FG000|Overall Study|Removed due to disruptive behavior|0|||
16105655|NCT03029819|38875299|FG001|Overall Study|Removed due to disruptive behavior|1|||
16105656|NCT01281917|38875302|FG000|Overall Study|Withdrawal by Subject|1|||
16105657|NCT00746356|38875304|FG000|Overall Study|Withdrawal by Subject|2|||
16105658|NCT00746356|38875305|FG001|Overall Study|Withdrawal by Subject|3|||
16340354|NCT02579382|39734365|FG001|Main Study Phase|Lack of Efficacy|0|||
16340355|NCT02579382|39734366|FG002|Main Study Phase|Lack of Efficacy|0|||
16340356|NCT02579382|39734367|FG003|Main Study Phase|Lack of Efficacy|1|||
16340357|NCT02579382|39734364|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
16340358|NCT02579382|39734365|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
16340359|NCT02579382|39734366|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
16340360|NCT02579382|39734367|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
16217539|NCT02477800|39276018|FG001|Placebo-Controlled Period|Death|3|||
16340361|NCT02579382|39734364|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
16340362|NCT02579382|39734365|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
16340363|NCT02579382|39734366|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
16340364|NCT02579382|39734367|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
16340365|NCT02579382|39734364|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
16340366|NCT02579382|39734365|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
16340367|NCT02579382|39734366|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
16340368|NCT02579382|39734367|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
16340369|NCT02579382|39734364|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
16340370|NCT02579382|39734365|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
16340371|NCT02579382|39734366|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
16340372|NCT02579382|39734367|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
16340373|NCT02579382|39734364|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
16340374|NCT02579382|39734365|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
16340375|NCT02579382|39734366|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
16340376|NCT02579382|39734367|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
16340377|NCT02579382|39734364|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
16340378|NCT02579382|39734365|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
16340379|NCT02579382|39734366|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
16340380|NCT02579382|39734367|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
16340381|NCT02634801|39734370|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
16340382|NCT02634801|39734371|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
16340383|NCT02634801|39734372|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
16340384|NCT02634801|39734370|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
16340385|NCT02634801|39734371|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
16340386|NCT02634801|39734372|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
16340387|NCT02634801|39734370|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
16340388|NCT02634801|39734371|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
16340389|NCT02634801|39734372|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
16340390|NCT02634801|39734370|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
16340391|NCT02634801|39734371|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
16340392|NCT02634801|39734372|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
16340393|NCT02634801|39734370|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
16340394|NCT02634801|39734371|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
16340395|NCT02634801|39734372|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
16340396|NCT02634801|39734370|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
16340397|NCT02634801|39734371|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
16340398|NCT02634801|39734372|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
16340399|NCT02634801|39734370|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
16340400|NCT02634801|39734371|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
16340401|NCT02634801|39734372|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
16105659|NCT00746356|38875304|FG000|Overall Study|Death|7|||
16539894|NCT03848403|40436104|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
16539895|NCT03848403|40436105|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
16539896|NCT02151266|40436106|FG000|Overall Study|Lost to Follow-up|1|||
16539897|NCT02151266|40436107|FG001|Overall Study|Lost to Follow-up|4|||
16539898|NCT02151266|40436108|FG002|Overall Study|Lost to Follow-up|1|||
16539899|NCT02151266|40436106|FG000|Overall Study|Did NOT receive intervention|3|||
16539900|NCT02151266|40436107|FG001|Overall Study|Did NOT receive intervention|6|||
16539901|NCT02151266|40436108|FG002|Overall Study|Did NOT receive intervention|2|||
16539902|NCT02151266|40436106|FG000|Overall Study|Not able to exercise|4|||
16539903|NCT02151266|40436107|FG001|Overall Study|Not able to exercise|5|||
16539904|NCT02151266|40436108|FG002|Overall Study|Not able to exercise|4|||
16539905|NCT04120233|40436109|FG000|Overall Study|Adverse Event|0|||
16539906|NCT04120233|40436110|FG001|Overall Study|Adverse Event|0|||
16539907|NCT04120233|40436111|FG002|Overall Study|Adverse Event|0|||
16539908|NCT04120233|40436112|FG003|Overall Study|Adverse Event|0|||
16539909|NCT04120233|40436113|FG004|Overall Study|Adverse Event|1|||
16539910|NCT04120233|40436114|FG005|Overall Study|Adverse Event|0|||
16539911|NCT02618616|40436121|FG000|Overall Study|Lack of Efficacy|4|||
16539912|NCT02618616|40436122|FG001|Overall Study|Lack of Efficacy|0|||
16539913|NCT02618616|40436121|FG000|Overall Study|Pregnancy|0|||
16539914|NCT02618616|40436122|FG001|Overall Study|Pregnancy|1|||
16539915|NCT02618616|40436121|FG000|Overall Study|Adverse Event|8|||
16539916|NCT02618616|40436122|FG001|Overall Study|Adverse Event|0|||
16539917|NCT02618616|40436121|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
16539918|NCT02618616|40436122|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
16340402|NCT02634801|39734370|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
16340403|NCT02634801|39734371|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
16340404|NCT02634801|39734372|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
16340405|NCT02634801|39734370|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
16340406|NCT02634801|39734371|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
16340407|NCT02634801|39734372|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
16340408|NCT02634801|39734370|FG000|Follow-up Period|Lost to Follow-up|3|||
16340409|NCT02634801|39734371|FG001|Follow-up Period|Lost to Follow-up|1|||
16340410|NCT02634801|39734372|FG002|Follow-up Period|Lost to Follow-up|2|||
16340411|NCT02634801|39734370|FG000|Follow-up Period|Physician Decision|0|||
16340412|NCT02634801|39734371|FG001|Follow-up Period|Physician Decision|0|||
16340413|NCT02634801|39734372|FG002|Follow-up Period|Physician Decision|1|||
16340414|NCT02634801|39734370|FG000|Follow-up Period|Withdrawal by Subject|1|||
16340415|NCT02634801|39734371|FG001|Follow-up Period|Withdrawal by Subject|2|||
16340416|NCT02634801|39734372|FG002|Follow-up Period|Withdrawal by Subject|5|||
16340417|NCT02634801|39734370|FG000|Follow-up Period|Adverse Event|1|||
16340418|NCT02634801|39734371|FG001|Follow-up Period|Adverse Event|5|||
16340419|NCT02634801|39734372|FG002|Follow-up Period|Adverse Event|0|||
16340420|NCT01931397|39734373|FG000|Overall Study|Physician Decision|2|||
16340421|NCT01931397|39734373|FG000|Overall Study|Withdrawal by Subject|8|||
16340422|NCT01931397|39734373|FG000|Overall Study|moved out of state|1|||
16340423|NCT00824655|39734374|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
16340424|NCT00824655|39734375|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
16340425|NCT00824655|39734374|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
16340426|NCT00824655|39734375|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
16340427|NCT04702997|39734376|FG000|Overall Study|Withdrawal by Subject|1|||
16539919|NCT02618616|40436121|FG000|Overall Study|Consent withdrawn by subject|8|||
16539920|NCT02618616|40436122|FG001|Overall Study|Consent withdrawn by subject|5|||
16539921|NCT02618616|40436121|FG000|Overall Study|Lost to Follow-up|0|||
16539922|NCT02618616|40436122|FG001|Overall Study|Lost to Follow-up|1|||
16539923|NCT00736645|40436127|FG000|Overall Study|Adverse Event|0|||
16539924|NCT00736645|40436128|FG001|Overall Study|Adverse Event|2|||
16539925|NCT00736645|40436129|FG002|Overall Study|Adverse Event|0|||
16539926|NCT00736645|40436130|FG003|Overall Study|Adverse Event|0|||
16105660|NCT00746356|38875305|FG001|Overall Study|Death|3|||
16105661|NCT00746356|38875304|FG000|Overall Study|Lost to Follow-up|1|||
16105662|NCT00746356|38875305|FG001|Overall Study|Lost to Follow-up|0|||
16105663|NCT00746356|38875304|FG000|Overall Study|Removal of Device|0|||
16105664|NCT00746356|38875305|FG001|Overall Study|Removal of Device|1|||
16105665|NCT00746356|38875304|FG000|Overall Study|Patient relocated|1|||
16105666|NCT00746356|38875305|FG001|Overall Study|Patient relocated|0|||
16105667|NCT02201771|38875308|FG000|Overall Study|Death|3|||
16105668|NCT02201771|38875309|FG001|Overall Study|Death|2|||
16105669|NCT02201771|38875310|FG002|Overall Study|Death|0|||
16105670|NCT02201771|38875308|FG000|Overall Study|Protocol Violation|10|||
16105671|NCT02201771|38875309|FG001|Overall Study|Protocol Violation|8|||
16105672|NCT02201771|38875310|FG002|Overall Study|Protocol Violation|10|||
16105673|NCT01087814|38875311|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
16105674|NCT01087814|38875312|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
16105675|NCT01087814|38875311|FG000|Second Intervention (5 Days)|Physician Decision|1|||
16105676|NCT01087814|38875312|FG001|Second Intervention (5 Days)|Physician Decision|0|||
16105677|NCT00337285|38875314|FG000|Overall Study|Withdrawal by Subject|42|||
16105678|NCT00337285|38875314|FG000|Overall Study|Lost to Follow-up|41|||
16105679|NCT00337285|38875314|FG000|Overall Study|Adverse Event|28|||
16105680|NCT00337285|38875314|FG000|Overall Study|Protocol Violation|27|||
16105681|NCT00337285|38875314|FG000|Overall Study|Lack of Efficacy|11|||
16105682|NCT00337285|38875314|FG000|Overall Study|Death|1|||
16105683|NCT00337285|38875314|FG000|Overall Study|Physician Decision|1|||
16105684|NCT00337285|38875314|FG000|Overall Study|Lack of protocol compliance|7|||
16105685|NCT01820637|38875315|FG000|Overall Study|Death|2|||
16105686|NCT01820637|38875315|FG000|Overall Study|Withdrawal by Subject|1|||
16105687|NCT00927901|38875316|FG000|Treatment Period 1|Subject withdrew consent|0|||
16105688|NCT00927901|38875317|FG001|Treatment Period 1|Subject withdrew consent|0|||
16105689|NCT00927901|38875318|FG002|Treatment Period 1|Subject withdrew consent|1|||
16105690|NCT00927901|38875319|FG003|Treatment Period 1|Subject withdrew consent|0|||
16105691|NCT00927901|38875316|FG000|Treatment Period 4|Adverse Event|0|||
16105692|NCT00927901|38875317|FG001|Treatment Period 4|Adverse Event|0|||
16105693|NCT00927901|38875318|FG002|Treatment Period 4|Adverse Event|0|||
16105694|NCT00927901|38875319|FG003|Treatment Period 4|Adverse Event|1|||
16105695|NCT00927901|38875316|FG000|Treatment Period 4|Subject withdrew consent|0|||
16105696|NCT00927901|38875317|FG001|Treatment Period 4|Subject withdrew consent|0|||
16105697|NCT00927901|38875318|FG002|Treatment Period 4|Subject withdrew consent|1|||
16105698|NCT00927901|38875319|FG003|Treatment Period 4|Subject withdrew consent|0|||
16105699|NCT01732588|38875320|FG000|First Intervention (7 Days)|Adverse Event|0|||
16105700|NCT01732588|38875321|FG001|First Intervention (7 Days)|Adverse Event|1|||
16105701|NCT01732588|38875322|FG002|First Intervention (7 Days)|Adverse Event|0|||
16105702|NCT00487552|38875323|FG000|Overall Study|Unsuccessful magnet placements|3|||
16105703|NCT00487552|38875323|FG000|Overall Study|Death due to progressive malignancy|2|||
16105704|NCT00487552|38875323|FG000|Overall Study|Stent not placed|1|||
16105705|NCT00583115|38875327|FG000|Overall Study|Death|1|||
16105706|NCT02204319|38875328|FG000|Overall Study|Pregnancy|1|||
16105707|NCT02204319|38875328|FG000|Overall Study|Withdrawal by Subject|2|||
16105708|NCT02741713|38875330|FG000|Overall Study|Surgery type changed intra-operatively|2|||
16105709|NCT02741713|38875331|FG001|Overall Study|Surgery type changed intra-operatively|1|||
16105710|NCT02104505|38875332|FG000|First Intervention (14 Days)|Adverse Event|2|||
16105711|NCT02104505|38875333|FG001|First Intervention (14 Days)|Adverse Event|0|||
16217540|NCT02477800|39276019|FG002|Placebo-Controlled Period|Death|2|||
16105712|NCT02104505|38875332|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
16105713|NCT02104505|38875333|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
16105714|NCT02104505|38875332|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
16105715|NCT02104505|38875333|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
16105716|NCT02104505|38875332|FG000|First Intervention (14 Days)|exclusionary condition|0|||
16105717|NCT02104505|38875333|FG001|First Intervention (14 Days)|exclusionary condition|1|||
16105718|NCT02104505|38875332|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
16105719|NCT02104505|38875333|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
16105720|NCT02104505|38875332|FG000|Second Intervention (14 Days)|Adverse Event|2|||
16105721|NCT02104505|38875333|FG001|Second Intervention (14 Days)|Adverse Event|0|||
16105722|NCT03845075|38875338|FG000|Part 1 - DB|Withdrawal by Subject|1|||
16105723|NCT03845075|38875339|FG001|Part 1 - DB|Withdrawal by Subject|1|||
16105724|NCT03845075|38875340|FG002|Part 1 - DB|Withdrawal by Subject|0|||
16105725|NCT03845075|38875341|FG003|Part 1 - DB|Withdrawal by Subject|0|||
16105726|NCT03845075|38875338|FG000|Part 1 - DB|Adverse Event|0|||
16105727|NCT03845075|38875339|FG001|Part 1 - DB|Adverse Event|1|||
16105728|NCT03845075|38875340|FG002|Part 1 - DB|Adverse Event|0|||
16105729|NCT03845075|38875341|FG003|Part 1 - DB|Adverse Event|0|||
16105730|NCT03845075|38875338|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
16105731|NCT03845075|38875339|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
16105732|NCT03845075|38875340|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
16105733|NCT03845075|38875341|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
16539927|NCT03520400|40436131|FG000|Overall Study|Physician Decision|15|||
16539928|NCT03520400|40436132|FG001|Overall Study|Physician Decision|7|||
16539929|NCT03599349|40436133|FG000|Overall Study|Lost to Follow-up|1|||
16539930|NCT02085252|40436134|FG000|Overall Study|Withdrawal of Consent|1|||
16105734|NCT03845023|38875342|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
16105735|NCT03845023|38875343|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
16105736|NCT03845023|38875344|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
16105737|NCT03845023|38875345|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
16105738|NCT03845023|38875342|FG000|Follow-Up (14 Days)|Adverse Event|0|||
16105739|NCT03845023|38875343|FG001|Follow-Up (14 Days)|Adverse Event|0|||
16105740|NCT03845023|38875344|FG002|Follow-Up (14 Days)|Adverse Event|1|||
16105741|NCT03845023|38875345|FG003|Follow-Up (14 Days)|Adverse Event|1|||
16105742|NCT00001941|38875346|FG000|Overall Study|not treated- rapidly progressing disease|0|||
16105743|NCT00001941|38875347|FG001|Overall Study|not treated- rapidly progressing disease|0|||
16105744|NCT00001941|38875348|FG002|Overall Study|not treated- rapidly progressing disease|0|||
16105745|NCT00001941|38875349|FG003|Overall Study|not treated- rapidly progressing disease|0|||
16105746|NCT00001941|38875350|FG004|Overall Study|not treated- rapidly progressing disease|1|||
16105747|NCT02101983|38875351|FG000|Overall Study|Physician Decision|1|||
16105748|NCT02101983|38875352|FG001|Overall Study|Physician Decision|0|||
16105749|NCT01816685|38875355|FG000|Overall Study|Lost to Follow-up|7|||
16105750|NCT01816685|38875356|FG001|Overall Study|Lost to Follow-up|9|||
16105751|NCT01816685|38875355|FG000|Overall Study|Surgery Cancelled|3|||
16105752|NCT01816685|38875356|FG001|Overall Study|Surgery Cancelled|2|||
16105753|NCT00469859|38875357|FG000|Overall Study|Inevaluable|0|||
16105754|NCT00469859|38875358|FG001|Overall Study|Inevaluable|2|||
16105755|NCT00510783|38875359|FG000|Overall Study|Lost to Follow-up|29|||
16105756|NCT00510783|38875360|FG001|Overall Study|Lost to Follow-up|25|||
16105757|NCT00510783|38875359|FG000|Overall Study|Withdrawal by Subject|2|||
16105758|NCT00510783|38875360|FG001|Overall Study|Withdrawal by Subject|3|||
16105759|NCT00510783|38875359|FG000|Overall Study|Protocol Violation|0|||
16105760|NCT00510783|38875360|FG001|Overall Study|Protocol Violation|1|||
16105761|NCT03371485|38875361|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
16105762|NCT03371485|38875361|FG000|2-year Follow-up|Death|5|||
16539931|NCT02085252|40436135|FG001|Overall Study|Withdrawal of Consent|0|||
16539932|NCT02085252|40436134|FG000|Overall Study|Adverse Event|0|||
16539933|NCT02085252|40436135|FG001|Overall Study|Adverse Event|1|||
16539934|NCT02085252|40436134|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
16539935|NCT02085252|40436135|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
16539936|NCT02085252|40436134|FG000|Overall Study|Reason Not Specified|0|||
16539937|NCT02085252|40436135|FG001|Overall Study|Reason Not Specified|1|||
16539938|NCT02085252|40436134|FG000|Overall Study|Reason Unknown|0|||
16539939|NCT02085252|40436135|FG001|Overall Study|Reason Unknown|1|||
16539940|NCT00713648|40436136|FG000|Overall Study|Adverse Event|1|||
16539941|NCT00713648|40436136|FG000|Overall Study|Unclassified|2|||
16539942|NCT00713648|40436136|FG000|Overall Study|According to Protocol|2|||
16539943|NCT00713648|40436136|FG000|Overall Study|Development of antibodies|3|||
16539944|NCT02365519|40436140|FG000|Randomized and Treated|Adverse Event|0|||
16539945|NCT02365519|40436141|FG001|Randomized and Treated|Adverse Event|1|||
16539946|NCT02365519|40436142|FG002|Randomized and Treated|Adverse Event|0|||
16539947|NCT02365519|40436140|FG000|Randomized and Treated|Withdrawal by Subject|0|||
16539948|NCT02365519|40436141|FG001|Randomized and Treated|Withdrawal by Subject|1|||
16539949|NCT02365519|40436142|FG002|Randomized and Treated|Withdrawal by Subject|1|||
16539950|NCT00643916|40436143|FG000|Overall Study|Protocol Violation|0|||
16539951|NCT00643916|40436144|FG001|Overall Study|Protocol Violation|1|||
16539952|NCT00643916|40436145|FG002|Overall Study|Protocol Violation|1|||
16539953|NCT00643916|40436146|FG003|Overall Study|Protocol Violation|1|||
16539954|NCT00643916|40436147|FG004|Overall Study|Protocol Violation|0|||
16539955|NCT00643916|40436148|FG005|Overall Study|Protocol Violation|0|||
16539956|NCT00643916|40436143|FG000|Overall Study|Lost to Follow-up|0|||
16539957|NCT00643916|40436144|FG001|Overall Study|Lost to Follow-up|1|||
16539958|NCT00643916|40436145|FG002|Overall Study|Lost to Follow-up|0|||
16539959|NCT00643916|40436146|FG003|Overall Study|Lost to Follow-up|0|||
16539960|NCT00643916|40436147|FG004|Overall Study|Lost to Follow-up|0|||
16539961|NCT00643916|40436148|FG005|Overall Study|Lost to Follow-up|0|||
16539962|NCT00643916|40436143|FG000|Overall Study|Withdrawal by Subject|2|||
16539963|NCT00643916|40436144|FG001|Overall Study|Withdrawal by Subject|2|||
16539964|NCT00643916|40436145|FG002|Overall Study|Withdrawal by Subject|2|||
16539965|NCT00643916|40436146|FG003|Overall Study|Withdrawal by Subject|1|||
16539966|NCT00643916|40436147|FG004|Overall Study|Withdrawal by Subject|0|||
16539967|NCT00643916|40436148|FG005|Overall Study|Withdrawal by Subject|1|||
16539968|NCT00643916|40436143|FG000|Overall Study|Not Vaccinated|2|||
16539969|NCT00643916|40436144|FG001|Overall Study|Not Vaccinated|2|||
16539970|NCT00643916|40436145|FG002|Overall Study|Not Vaccinated|3|||
16539971|NCT00643916|40436146|FG003|Overall Study|Not Vaccinated|0|||
16105763|NCT03481556|38875362|FG000|Overall Study|Adverse Event|1|||
16105764|NCT03481556|38875363|FG001|Overall Study|Adverse Event|0|||
16105765|NCT03481556|38875364|FG002|Overall Study|Adverse Event|0|||
16539972|NCT00643916|40436147|FG004|Overall Study|Not Vaccinated|2|||
16539973|NCT00643916|40436148|FG005|Overall Study|Not Vaccinated|0|||
16539974|NCT01688466|40436149|FG000|Overall Study|Withdrawal by Subject|2|||
16539975|NCT01688466|40436150|FG001|Overall Study|Withdrawal by Subject|1|||
16539976|NCT01688466|40436149|FG000|Overall Study|Death|0|||
16539977|NCT01688466|40436150|FG001|Overall Study|Death|1|||
16539978|NCT01688466|40436149|FG000|Overall Study|Adverse Event|0|||
16539979|NCT01688466|40436150|FG001|Overall Study|Adverse Event|4|||
16105766|NCT03481556|38875365|FG003|Overall Study|Adverse Event|0|||
16105767|NCT03481556|38875362|FG000|Overall Study|Death|4|||
16105768|NCT03481556|38875363|FG001|Overall Study|Death|2|||
16105769|NCT03481556|38875364|FG002|Overall Study|Death|3|||
16105770|NCT03481556|38875365|FG003|Overall Study|Death|16|||
16105771|NCT03481556|38875362|FG000|Overall Study|Study Terminated by Sponsor|10|||
16105772|NCT03481556|38875363|FG001|Overall Study|Study Terminated by Sponsor|5|||
16105773|NCT03481556|38875364|FG002|Overall Study|Study Terminated by Sponsor|2|||
16105774|NCT03481556|38875365|FG003|Overall Study|Study Terminated by Sponsor|9|||
16105775|NCT00634049|38875366|FG000|Overall Study|Never received study drug|1|||
16105776|NCT00634049|38875366|FG000|Overall Study|Died prior to receiving study drug|1|||
16340428|NCT04702997|39734377|FG001|Overall Study|Withdrawal by Subject|1|||
16340429|NCT01148459|39734378|FG000|Overall Study|Serious Adverse Event|5|||
16340430|NCT01148459|39734379|FG001|Overall Study|Serious Adverse Event|4|||
16340431|NCT01148459|39734378|FG000|Overall Study|Withdrawal by Subject|1|||
16340432|NCT01148459|39734379|FG001|Overall Study|Withdrawal by Subject|0|||
16340433|NCT01148459|39734378|FG000|Overall Study|Migrated/moved from study area|3|||
16340434|NCT01148459|39734379|FG001|Overall Study|Migrated/moved from study area|6|||
16340435|NCT01148459|39734378|FG000|Overall Study|Lost to Follow-up|2|||
16340436|NCT01148459|39734379|FG001|Overall Study|Lost to Follow-up|0|||
16340437|NCT01148459|39734378|FG000|Overall Study|Refusal|1|||
16340438|NCT01148459|39734379|FG001|Overall Study|Refusal|0|||
16340439|NCT01148459|39734378|FG000|Overall Study|Failure to comply with study procedures|0|||
16340440|NCT01148459|39734379|FG001|Overall Study|Failure to comply with study procedures|1|||
16340441|NCT03313310|39734380|FG000|Phase 2|Lost to Follow-up|4|||
16340442|NCT03313310|39734381|FG001|Phase 2|Lost to Follow-up|0|||
16340443|NCT03313310|39734380|FG000|Phase 3|Lost to Follow-up|0|||
16340444|NCT03313310|39734381|FG001|Phase 3|Lost to Follow-up|1|||
16340445|NCT00076999|39734382|FG000|Overall Study|Adverse Event|2|||
16340446|NCT00076999|39734383|FG001|Overall Study|Adverse Event|8|||
16340447|NCT00076999|39734384|FG002|Overall Study|Adverse Event|6|||
16340448|NCT00076999|39734385|FG003|Overall Study|Adverse Event|0|||
16340449|NCT00076999|39734386|FG004|Overall Study|Adverse Event|2|||
16340450|NCT00076999|39734382|FG000|Overall Study|Protocol Violation|0|||
16340451|NCT00076999|39734383|FG001|Overall Study|Protocol Violation|3|||
16340452|NCT00076999|39734384|FG002|Overall Study|Protocol Violation|4|||
16340453|NCT00076999|39734385|FG003|Overall Study|Protocol Violation|0|||
16340454|NCT00076999|39734386|FG004|Overall Study|Protocol Violation|9|||
16340455|NCT00076999|39734382|FG000|Overall Study|Lost to Follow-up|2|||
16539980|NCT01688466|40436149|FG000|Overall Study|Not evaluable|0|||
16340456|NCT00076999|39734383|FG001|Overall Study|Lost to Follow-up|1|||
16340457|NCT00076999|39734384|FG002|Overall Study|Lost to Follow-up|0|||
16340458|NCT00076999|39734385|FG003|Overall Study|Lost to Follow-up|0|||
16340459|NCT00076999|39734386|FG004|Overall Study|Lost to Follow-up|0|||
16539981|NCT01688466|40436150|FG001|Overall Study|Not evaluable|1|||
16539982|NCT00724152|40436151|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
16539983|NCT00724152|40436152|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
16539984|NCT00724152|40436153|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
16105777|NCT00634049|38875366|FG000|Overall Study|Screening failure|1|||
16105778|NCT00661713|38875372|FG000|Overall Study|Death|1|||
16105779|NCT00661713|38875373|FG001|Overall Study|Death|0|||
16340460|NCT00076999|39734382|FG000|Overall Study|Withdrawal by Subject|0|||
16539985|NCT00724152|40436151|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
16105780|NCT00661713|38875374|FG002|Overall Study|Death|0|||
16105781|NCT00661713|38875375|FG003|Overall Study|Death|0|||
16105782|NCT00661713|38875376|FG004|Overall Study|Death|1|||
16105783|NCT00661713|38875377|FG005|Overall Study|Death|0|||
16105784|NCT00661713|38875378|FG006|Overall Study|Death|0|||
16105785|NCT00661713|38875379|FG007|Overall Study|Death|0|||
16105786|NCT00661713|38875372|FG000|Overall Study|Unable to Classify|1|||
16105787|NCT00661713|38875373|FG001|Overall Study|Unable to Classify|0|||
16105788|NCT00661713|38875374|FG002|Overall Study|Unable to Classify|0|||
16105789|NCT00661713|38875375|FG003|Overall Study|Unable to Classify|0|||
16105790|NCT00661713|38875376|FG004|Overall Study|Unable to Classify|0|||
16105791|NCT00661713|38875377|FG005|Overall Study|Unable to Classify|0|||
16105792|NCT00661713|38875378|FG006|Overall Study|Unable to Classify|0|||
16105793|NCT00661713|38875379|FG007|Overall Study|Unable to Classify|0|||
16105794|NCT00661713|38875372|FG000|Overall Study|Protocol Violation|1|||
16105795|NCT00661713|38875373|FG001|Overall Study|Protocol Violation|6|||
16105796|NCT00661713|38875374|FG002|Overall Study|Protocol Violation|3|||
16539986|NCT00724152|40436152|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
16539987|NCT00724152|40436153|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
16539988|NCT01298999|40436154|FG000|Overall Study|Physician Decision|0|||
16539989|NCT01298999|40436155|FG001|Overall Study|Physician Decision|1|||
16539990|NCT01298999|40436154|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
16539991|NCT01298999|40436155|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
16105797|NCT00661713|38875375|FG003|Overall Study|Protocol Violation|3|||
16105798|NCT00661713|38875376|FG004|Overall Study|Protocol Violation|0|||
16105799|NCT00661713|38875377|FG005|Overall Study|Protocol Violation|2|||
16105800|NCT00661713|38875378|FG006|Overall Study|Protocol Violation|2|||
16105801|NCT00661713|38875379|FG007|Overall Study|Protocol Violation|1|||
16105802|NCT00661713|38875372|FG000|Overall Study|Withdrawal by Subject|11|||
16105803|NCT00661713|38875373|FG001|Overall Study|Withdrawal by Subject|25|||
16105804|NCT00661713|38875374|FG002|Overall Study|Withdrawal by Subject|12|||
16105805|NCT00661713|38875375|FG003|Overall Study|Withdrawal by Subject|21|||
16105806|NCT00661713|38875376|FG004|Overall Study|Withdrawal by Subject|12|||
16105807|NCT00661713|38875377|FG005|Overall Study|Withdrawal by Subject|26|||
16105808|NCT00661713|38875378|FG006|Overall Study|Withdrawal by Subject|45|||
16105809|NCT00661713|38875379|FG007|Overall Study|Withdrawal by Subject|9|||
16217541|NCT02477800|39276020|FG003|Placebo-Controlled Period|Death|0|||
16539992|NCT01984697|40439909|FG000|Overall Study|Adverse Event|0|||
16539993|NCT01984697|40439910|FG001|Overall Study|Adverse Event|0|||
16539994|NCT01984697|40439911|FG002|Overall Study|Adverse Event|2|||
16539995|NCT01984697|40439912|FG003|Overall Study|Adverse Event|0|||
16539996|NCT01984697|40439913|FG004|Overall Study|Adverse Event|0|||
16539997|NCT01984697|40439909|FG000|Overall Study|Lost to Follow-up|14|||
16539998|NCT01984697|40439910|FG001|Overall Study|Lost to Follow-up|5|||
16539999|NCT01984697|40439911|FG002|Overall Study|Lost to Follow-up|10|||
16540000|NCT01984697|40439912|FG003|Overall Study|Lost to Follow-up|6|||
16540001|NCT01984697|40439913|FG004|Overall Study|Lost to Follow-up|21|||
16540002|NCT01984697|40439909|FG000|Overall Study|Physician Decision|3|||
16540003|NCT01984697|40439910|FG001|Overall Study|Physician Decision|0|||
16540004|NCT01984697|40439911|FG002|Overall Study|Physician Decision|0|||
16540005|NCT01984697|40439912|FG003|Overall Study|Physician Decision|1|||
16540006|NCT01984697|40439913|FG004|Overall Study|Physician Decision|0|||
16540007|NCT01984697|40439909|FG000|Overall Study|Protocol Violation|8|||
16540008|NCT01984697|40439910|FG001|Overall Study|Protocol Violation|5|||
16540009|NCT01984697|40439911|FG002|Overall Study|Protocol Violation|3|||
16540010|NCT01984697|40439912|FG003|Overall Study|Protocol Violation|2|||
16540011|NCT01984697|40439913|FG004|Overall Study|Protocol Violation|0|||
16540012|NCT01984697|40439909|FG000|Overall Study|Withdrawal by Subject|15|||
16540013|NCT01984697|40439910|FG001|Overall Study|Withdrawal by Subject|21|||
16540014|NCT01984697|40439911|FG002|Overall Study|Withdrawal by Subject|13|||
16540015|NCT01984697|40439912|FG003|Overall Study|Withdrawal by Subject|11|||
16540016|NCT01984697|40439913|FG004|Overall Study|Withdrawal by Subject|13|||
16540017|NCT01984697|40439909|FG000|Overall Study|Missed last follow-up visit|1|||
16540018|NCT01984697|40439910|FG001|Overall Study|Missed last follow-up visit|0|||
16540019|NCT01984697|40439911|FG002|Overall Study|Missed last follow-up visit|0|||
16540020|NCT01984697|40439912|FG003|Overall Study|Missed last follow-up visit|0|||
16540021|NCT01984697|40439913|FG004|Overall Study|Missed last follow-up visit|0|||
16540022|NCT01984697|40439909|FG000|Overall Study|Death|0|||
16540023|NCT01984697|40439910|FG001|Overall Study|Death|0|||
16540024|NCT01984697|40439911|FG002|Overall Study|Death|0|||
16540025|NCT01984697|40439912|FG003|Overall Study|Death|1|||
16540026|NCT01984697|40439913|FG004|Overall Study|Death|0|||
16105810|NCT00661713|38875372|FG000|Overall Study|Lost to Follow-up|2|||
16105811|NCT00661713|38875373|FG001|Overall Study|Lost to Follow-up|7|||
16105812|NCT00661713|38875374|FG002|Overall Study|Lost to Follow-up|2|||
16217542|NCT02477800|39276021|FG004|Placebo-Controlled Period|Death|0|||
16217543|NCT02477800|39276022|FG005|Placebo-Controlled Period|Death|0|||
16217544|NCT02477800|39276023|FG006|Placebo-Controlled Period|Death|0|||
16217545|NCT02477800|39276017|FG000|Placebo-Controlled Period|Disease Progression|1|||
16105813|NCT00661713|38875375|FG003|Overall Study|Lost to Follow-up|2|||
16217546|NCT02477800|39276018|FG001|Placebo-Controlled Period|Disease Progression|0|||
16217547|NCT02477800|39276019|FG002|Placebo-Controlled Period|Disease Progression|1|||
16540027|NCT01984697|40439909|FG000|Overall Study|Pregnancy|2|||
16540028|NCT01984697|40439910|FG001|Overall Study|Pregnancy|0|||
16540029|NCT01984697|40439911|FG002|Overall Study|Pregnancy|1|||
16540030|NCT01984697|40439912|FG003|Overall Study|Pregnancy|0|||
16540031|NCT01984697|40439913|FG004|Overall Study|Pregnancy|1|||
16540032|NCT04259450|40439914|FG000|Overall Study|Adverse event/ Toxicity|0|||
16540033|NCT04259450|40439915|FG001|Overall Study|Adverse event/ Toxicity|3|||
16540034|NCT04259450|40439916|FG002|Overall Study|Adverse event/ Toxicity|0|||
16540035|NCT04259450|40439917|FG003|Overall Study|Adverse event/ Toxicity|1|||
16540036|NCT04259450|40439918|FG004|Overall Study|Adverse event/ Toxicity|0|||
16540037|NCT04259450|40439919|FG005|Overall Study|Adverse event/ Toxicity|0|||
16105814|NCT00661713|38875376|FG004|Overall Study|Lost to Follow-up|5|||
16540038|NCT04259450|40439920|FG006|Overall Study|Adverse event/ Toxicity|0|||
16540039|NCT04259450|40439921|FG007|Overall Study|Adverse event/ Toxicity|1|||
16540040|NCT04259450|40439922|FG008|Overall Study|Adverse event/ Toxicity|0|||
16540041|NCT04259450|40439923|FG009|Overall Study|Adverse event/ Toxicity|3|||
16540042|NCT04259450|40439914|FG000|Overall Study|Disease progression|2|||
16540043|NCT04259450|40439915|FG001|Overall Study|Disease progression|3|||
16540044|NCT04259450|40439916|FG002|Overall Study|Disease progression|4|||
16540045|NCT04259450|40439917|FG003|Overall Study|Disease progression|4|||
16540046|NCT04259450|40439918|FG004|Overall Study|Disease progression|6|||
16540047|NCT04259450|40439919|FG005|Overall Study|Disease progression|6|||
16540048|NCT04259450|40439920|FG006|Overall Study|Disease progression|5|||
16540049|NCT04259450|40439921|FG007|Overall Study|Disease progression|15|||
16540050|NCT04259450|40439922|FG008|Overall Study|Disease progression|6|||
16540051|NCT04259450|40439923|FG009|Overall Study|Disease progression|17|||
16540052|NCT04259450|40439914|FG000|Overall Study|Death|0|||
16540053|NCT04259450|40439915|FG001|Overall Study|Death|0|||
16540054|NCT04259450|40439916|FG002|Overall Study|Death|0|||
16540055|NCT04259450|40439917|FG003|Overall Study|Death|0|||
16540056|NCT04259450|40439918|FG004|Overall Study|Death|0|||
16540057|NCT04259450|40439919|FG005|Overall Study|Death|0|||
16540058|NCT04259450|40439920|FG006|Overall Study|Death|0|||
16540059|NCT04259450|40439921|FG007|Overall Study|Death|1|||
16217548|NCT02477800|39276020|FG003|Placebo-Controlled Period|Disease Progression|0|||
16217549|NCT02477800|39276021|FG004|Placebo-Controlled Period|Disease Progression|0|||
16340461|NCT00076999|39734383|FG001|Overall Study|Withdrawal by Subject|4|||
16340462|NCT00076999|39734384|FG002|Overall Study|Withdrawal by Subject|3|||
16340463|NCT00076999|39734385|FG003|Overall Study|Withdrawal by Subject|0|||
16340464|NCT00076999|39734386|FG004|Overall Study|Withdrawal by Subject|1|||
16340465|NCT00076999|39734382|FG000|Overall Study|Other reason (not specified)|8|||
16340466|NCT00076999|39734383|FG001|Overall Study|Other reason (not specified)|8|||
16340467|NCT00076999|39734384|FG002|Overall Study|Other reason (not specified)|4|||
16340468|NCT00076999|39734385|FG003|Overall Study|Other reason (not specified)|1|||
16340469|NCT00076999|39734386|FG004|Overall Study|Other reason (not specified)|13|||
16340470|NCT02661061|39734387|FG000|Overall Study|Lack of Efficacy|1|||
16340471|NCT02661061|39734388|FG001|Overall Study|Lack of Efficacy|1|||
16340472|NCT02661061|39734387|FG000|Overall Study|Withdrawal by Subject|1|||
16340473|NCT02661061|39734388|FG001|Overall Study|Withdrawal by Subject|1|||
16340474|NCT02075008|39734389|FG000|Overall Study|Technical problems|1|||
16340475|NCT02075008|39734389|FG000|Overall Study|Pregnancy|1|||
16340476|NCT02075008|39734389|FG000|Overall Study|Physician Decision|1|||
16340477|NCT02075008|39734389|FG000|Overall Study|Lost to Follow-up|1|||
16340478|NCT02075008|39734389|FG000|Overall Study|Lack of Efficacy|1|||
16340479|NCT02075008|39734389|FG000|Overall Study|Death|1|||
16340480|NCT02075008|39734389|FG000|Overall Study|Adverse Event|5|||
16340481|NCT02075008|39734389|FG000|Overall Study|Withdrawal by Subject|6|||
16340482|NCT02075008|39734389|FG000|Overall Study|Study terminated by Sponsor|159|||
16340483|NCT01026818|39734390|FG000|Screening Period|Entry Criteria Not Met|105|||
16340484|NCT01026818|39734391|FG001|Screening Period|Entry Criteria Not Met|0|||
16340485|NCT01026818|39734392|FG002|Screening Period|Entry Criteria Not Met|0|||
16540060|NCT04259450|40439922|FG008|Overall Study|Death|1|||
16540061|NCT04259450|40439923|FG009|Overall Study|Death|0|||
16540062|NCT04259450|40439914|FG000|Overall Study|Withdrawal by Subject|0|||
16540063|NCT04259450|40439915|FG001|Overall Study|Withdrawal by Subject|0|||
16540064|NCT04259450|40439916|FG002|Overall Study|Withdrawal by Subject|0|||
16540065|NCT04259450|40439917|FG003|Overall Study|Withdrawal by Subject|0|||
16217550|NCT02477800|39276022|FG005|Placebo-Controlled Period|Disease Progression|0|||
16217551|NCT02477800|39276023|FG006|Placebo-Controlled Period|Disease Progression|0|||
16217552|NCT02477800|39276017|FG000|Placebo-Controlled Period|Investigator Decision|3|||
16217553|NCT02477800|39276018|FG001|Placebo-Controlled Period|Investigator Decision|2|||
16217554|NCT02477800|39276019|FG002|Placebo-Controlled Period|Investigator Decision|1|||
16217555|NCT02477800|39276020|FG003|Placebo-Controlled Period|Investigator Decision|0|||
16217556|NCT02477800|39276021|FG004|Placebo-Controlled Period|Investigator Decision|0|||
16217557|NCT02477800|39276022|FG005|Placebo-Controlled Period|Investigator Decision|0|||
16217558|NCT02477800|39276023|FG006|Placebo-Controlled Period|Investigator Decision|0|||
16540066|NCT04259450|40439918|FG004|Overall Study|Withdrawal by Subject|0|||
16540067|NCT04259450|40439919|FG005|Overall Study|Withdrawal by Subject|0|||
16540068|NCT04259450|40439920|FG006|Overall Study|Withdrawal by Subject|0|||
16540069|NCT04259450|40439921|FG007|Overall Study|Withdrawal by Subject|1|||
16540070|NCT04259450|40439922|FG008|Overall Study|Withdrawal by Subject|0|||
16540071|NCT04259450|40439923|FG009|Overall Study|Withdrawal by Subject|0|||
16540072|NCT04259450|40439914|FG000|Overall Study|Long Term Adverse Event|0|||
16540073|NCT04259450|40439915|FG001|Overall Study|Long Term Adverse Event|0|||
16540074|NCT04259450|40439916|FG002|Overall Study|Long Term Adverse Event|0|||
16540075|NCT04259450|40439917|FG003|Overall Study|Long Term Adverse Event|0|||
16540076|NCT04259450|40439918|FG004|Overall Study|Long Term Adverse Event|0|||
16540077|NCT04259450|40439919|FG005|Overall Study|Long Term Adverse Event|0|||
16540078|NCT04259450|40439920|FG006|Overall Study|Long Term Adverse Event|0|||
16540079|NCT04259450|40439921|FG007|Overall Study|Long Term Adverse Event|0|||
16540080|NCT04259450|40439922|FG008|Overall Study|Long Term Adverse Event|0|||
16540081|NCT04259450|40439923|FG009|Overall Study|Long Term Adverse Event|1|||
16217559|NCT02477800|39276017|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
16340486|NCT01026818|39734393|FG003|Screening Period|Entry Criteria Not Met|0|||
16340487|NCT01026818|39734390|FG000|Screening Period|Withdrawal by Subject|49|||
16340488|NCT01026818|39734391|FG001|Screening Period|Withdrawal by Subject|0|||
16340489|NCT01026818|39734392|FG002|Screening Period|Withdrawal by Subject|0|||
16340490|NCT01026818|39734393|FG003|Screening Period|Withdrawal by Subject|0|||
16340491|NCT01026818|39734390|FG000|Screening Period|Protocol Deviation|3|||
16340492|NCT01026818|39734391|FG001|Screening Period|Protocol Deviation|0|||
16340493|NCT01026818|39734392|FG002|Screening Period|Protocol Deviation|0|||
16340494|NCT01026818|39734393|FG003|Screening Period|Protocol Deviation|0|||
16105815|NCT00661713|38875377|FG005|Overall Study|Lost to Follow-up|7|||
16105816|NCT00661713|38875378|FG006|Overall Study|Lost to Follow-up|14|||
16105817|NCT00661713|38875379|FG007|Overall Study|Lost to Follow-up|1|||
16105818|NCT00661713|38875372|FG000|Overall Study|Administrative Reason|0|||
16105819|NCT00661713|38875373|FG001|Overall Study|Administrative Reason|1|||
16105820|NCT00661713|38875374|FG002|Overall Study|Administrative Reason|0|||
16105821|NCT00661713|38875375|FG003|Overall Study|Administrative Reason|2|||
16105822|NCT00661713|38875376|FG004|Overall Study|Administrative Reason|2|||
16105823|NCT00661713|38875377|FG005|Overall Study|Administrative Reason|2|||
16105824|NCT00661713|38875378|FG006|Overall Study|Administrative Reason|1|||
16105825|NCT00661713|38875379|FG007|Overall Study|Administrative Reason|0|||
16105826|NCT00661713|38875372|FG000|Overall Study|Adverse Event|0|||
16105827|NCT00661713|38875373|FG001|Overall Study|Adverse Event|0|||
16217560|NCT02477800|39276018|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
16217561|NCT02477800|39276019|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
16217562|NCT02477800|39276020|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
16217563|NCT02477800|39276021|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
16217564|NCT02477800|39276022|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
16105828|NCT00661713|38875374|FG002|Overall Study|Adverse Event|0|||
16105829|NCT00661713|38875375|FG003|Overall Study|Adverse Event|0|||
16105830|NCT00661713|38875376|FG004|Overall Study|Adverse Event|0|||
16105831|NCT00661713|38875377|FG005|Overall Study|Adverse Event|0|||
16105832|NCT00661713|38875378|FG006|Overall Study|Adverse Event|1|||
16217565|NCT02477800|39276023|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
16340495|NCT01026818|39734390|FG000|Screening Period|Adverse Event|2|||
16340496|NCT01026818|39734391|FG001|Screening Period|Adverse Event|0|||
16540082|NCT02889133|40439924|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
16540083|NCT02889133|40439925|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
16540084|NCT02889133|40439924|FG000|Completed Primary Outcome|Manufacturing error|3|||
16217566|NCT02477800|39276017|FG000|Placebo-Controlled Period|Relocation|2|||
16217567|NCT02477800|39276018|FG001|Placebo-Controlled Period|Relocation|0|||
16217568|NCT02477800|39276019|FG002|Placebo-Controlled Period|Relocation|0|||
16217569|NCT02477800|39276020|FG003|Placebo-Controlled Period|Relocation|0|||
16217570|NCT02477800|39276021|FG004|Placebo-Controlled Period|Relocation|0|||
16217571|NCT02477800|39276022|FG005|Placebo-Controlled Period|Relocation|0|||
16217572|NCT02477800|39276023|FG006|Placebo-Controlled Period|Relocation|0|||
16217573|NCT02477800|39276017|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
16217574|NCT02477800|39276018|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
16217575|NCT02477800|39276019|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
16217576|NCT02477800|39276020|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
16217577|NCT02477800|39276021|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
16217578|NCT02477800|39276022|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
16217579|NCT02477800|39276023|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
16217580|NCT02477800|39276017|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
16217581|NCT02477800|39276018|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
16217582|NCT02477800|39276019|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
16217583|NCT02477800|39276020|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
16217584|NCT02477800|39276021|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
16217585|NCT02477800|39276022|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
16217586|NCT02477800|39276023|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
16217587|NCT02477800|39276017|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
16217588|NCT02477800|39276018|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
16217589|NCT02477800|39276019|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
16217590|NCT02477800|39276020|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
16217591|NCT02477800|39276021|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
16217592|NCT02477800|39276022|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
16217593|NCT02477800|39276023|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
16217594|NCT02477800|39276017|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
16217595|NCT02477800|39276018|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
16217596|NCT02477800|39276019|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
16217597|NCT02477800|39276020|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16217598|NCT02477800|39276021|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16217599|NCT02477800|39276022|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16217600|NCT02477800|39276023|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16217601|NCT02477800|39276017|FG000|Placebo-Controlled Period|Reason not Specified|161|||
16217602|NCT02477800|39276018|FG001|Placebo-Controlled Period|Reason not Specified|161|||
16217603|NCT02477800|39276019|FG002|Placebo-Controlled Period|Reason not Specified|189|||
16217604|NCT02477800|39276020|FG003|Placebo-Controlled Period|Reason not Specified|0|||
16217605|NCT02477800|39276021|FG004|Placebo-Controlled Period|Reason not Specified|0|||
16217606|NCT02477800|39276022|FG005|Placebo-Controlled Period|Reason not Specified|0|||
16217607|NCT02477800|39276023|FG006|Placebo-Controlled Period|Reason not Specified|0|||
16217608|NCT02477800|39276017|FG000|Long Term Extension Period|Adverse Event|0|||
16217609|NCT02477800|39276018|FG001|Long Term Extension Period|Adverse Event|0|||
16217610|NCT02477800|39276019|FG002|Long Term Extension Period|Adverse Event|0|||
16217611|NCT02477800|39276020|FG003|Long Term Extension Period|Adverse Event|6|||
16217612|NCT02477800|39276021|FG004|Long Term Extension Period|Adverse Event|2|||
16217613|NCT02477800|39276022|FG005|Long Term Extension Period|Adverse Event|4|||
16217614|NCT02477800|39276023|FG006|Long Term Extension Period|Adverse Event|3|||
16217615|NCT02477800|39276017|FG000|Long Term Extension Period|Death|0|||
16217616|NCT02477800|39276018|FG001|Long Term Extension Period|Death|0|||
16217617|NCT02477800|39276019|FG002|Long Term Extension Period|Death|0|||
16217618|NCT02477800|39276020|FG003|Long Term Extension Period|Death|1|||
16217619|NCT02477800|39276021|FG004|Long Term Extension Period|Death|1|||
16217620|NCT02477800|39276022|FG005|Long Term Extension Period|Death|1|||
16217621|NCT02477800|39276023|FG006|Long Term Extension Period|Death|2|||
16217622|NCT02477800|39276017|FG000|Long Term Extension Period|Consent Withdrawn|0|||
16217623|NCT02477800|39276018|FG001|Long Term Extension Period|Consent Withdrawn|0|||
16217624|NCT02477800|39276019|FG002|Long Term Extension Period|Consent Withdrawn|0|||
16217625|NCT02477800|39276020|FG003|Long Term Extension Period|Consent Withdrawn|10|||
16217626|NCT02477800|39276021|FG004|Long Term Extension Period|Consent Withdrawn|4|||
16217627|NCT02477800|39276022|FG005|Long Term Extension Period|Consent Withdrawn|13|||
16217628|NCT02477800|39276023|FG006|Long Term Extension Period|Consent Withdrawn|16|||
16217629|NCT02477800|39276017|FG000|Long Term Extension Period|Disease Progression|0|||
16217630|NCT02477800|39276018|FG001|Long Term Extension Period|Disease Progression|0|||
16217631|NCT02477800|39276019|FG002|Long Term Extension Period|Disease Progression|0|||
16217632|NCT02477800|39276020|FG003|Long Term Extension Period|Disease Progression|3|||
16217633|NCT02477800|39276021|FG004|Long Term Extension Period|Disease Progression|1|||
16217634|NCT02477800|39276022|FG005|Long Term Extension Period|Disease Progression|1|||
16217635|NCT02477800|39276023|FG006|Long Term Extension Period|Disease Progression|0|||
16217636|NCT02477800|39276017|FG000|Long Term Extension Period|Investigator Decision|0|||
16217637|NCT02477800|39276018|FG001|Long Term Extension Period|Investigator Decision|0|||
16217638|NCT02477800|39276019|FG002|Long Term Extension Period|Investigator Decision|0|||
16217639|NCT02477800|39276020|FG003|Long Term Extension Period|Investigator Decision|0|||
16217640|NCT02477800|39276021|FG004|Long Term Extension Period|Investigator Decision|0|||
16217641|NCT02477800|39276022|FG005|Long Term Extension Period|Investigator Decision|0|||
16217642|NCT02477800|39276023|FG006|Long Term Extension Period|Investigator Decision|2|||
16217643|NCT02477800|39276017|FG000|Long Term Extension Period|Lost to Follow-up|0|||
16217644|NCT02477800|39276018|FG001|Long Term Extension Period|Lost to Follow-up|0|||
16217645|NCT02477800|39276019|FG002|Long Term Extension Period|Lost to Follow-up|0|||
16217646|NCT02477800|39276020|FG003|Long Term Extension Period|Lost to Follow-up|0|||
16217647|NCT02477800|39276021|FG004|Long Term Extension Period|Lost to Follow-up|1|||
16217648|NCT02477800|39276022|FG005|Long Term Extension Period|Lost to Follow-up|3|||
16217649|NCT02477800|39276023|FG006|Long Term Extension Period|Lost to Follow-up|0|||
16340497|NCT01026818|39734392|FG002|Screening Period|Adverse Event|0|||
16340498|NCT01026818|39734393|FG003|Screening Period|Adverse Event|0|||
16340499|NCT01026818|39734390|FG000|Screening Period|Physician Decision|1|||
16540085|NCT02889133|40439925|FG001|Completed Primary Outcome|Manufacturing error|8|||
16540086|NCT02889133|40439924|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
16540087|NCT02889133|40439925|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
16540088|NCT02889133|40439924|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
16540089|NCT02889133|40439925|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
16340500|NCT01026818|39734391|FG001|Screening Period|Physician Decision|0|||
16540090|NCT02889133|40439924|FG000|Completed Primary Outcome|Protocol Violation|1|||
16540091|NCT02889133|40439925|FG001|Completed Primary Outcome|Protocol Violation|0|||
16540092|NCT02889133|40439924|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
16540093|NCT02889133|40439925|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
16540094|NCT02889133|40439924|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
16540095|NCT02889133|40439925|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
16540096|NCT02889133|40439924|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
16540097|NCT02889133|40439925|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
16540098|NCT02889133|40439924|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
16540099|NCT02889133|40439925|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
16540100|NCT02889133|40439924|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
16340501|NCT01026818|39734392|FG002|Screening Period|Physician Decision|0|||
16340502|NCT01026818|39734393|FG003|Screening Period|Physician Decision|0|||
16340503|NCT01026818|39734390|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
16340504|NCT01026818|39734391|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
16217650|NCT02477800|39276017|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
16340505|NCT01026818|39734392|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
16340506|NCT01026818|39734393|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
16540101|NCT02889133|40439925|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
16217651|NCT02477800|39276018|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
16340507|NCT01026818|39734390|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
16340508|NCT01026818|39734391|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
16540102|NCT01433354|40439926|FG000|Overall Study|Adverse Event|6|||
16217652|NCT02477800|39276019|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
16217653|NCT02477800|39276020|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
16217654|NCT02477800|39276021|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
16217655|NCT02477800|39276022|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
16217656|NCT02477800|39276023|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
16217657|NCT02477800|39276017|FG000|Long Term Extension Period|Study Visit Burden|0|||
16217658|NCT02477800|39276018|FG001|Long Term Extension Period|Study Visit Burden|0|||
16217659|NCT02477800|39276019|FG002|Long Term Extension Period|Study Visit Burden|0|||
16217660|NCT02477800|39276020|FG003|Long Term Extension Period|Study Visit Burden|3|||
16217661|NCT02477800|39276021|FG004|Long Term Extension Period|Study Visit Burden|0|||
16217662|NCT02477800|39276022|FG005|Long Term Extension Period|Study Visit Burden|2|||
16217663|NCT02477800|39276023|FG006|Long Term Extension Period|Study Visit Burden|2|||
16540103|NCT01433354|40439926|FG000|Overall Study|Lost to Follow-up|1|||
16540104|NCT01433354|40439926|FG000|Overall Study|Administrative problems|90|||
16540105|NCT01433354|40439926|FG000|Overall Study|Protocol Violation|2|||
16540106|NCT01433354|40439926|FG000|Overall Study|Lack of Efficacy|17|||
16540107|NCT01433354|40439926|FG000|Overall Study|Subject Withdrew Consent|3|||
16540108|NCT01181726|40439927|FG000|First Intervention|Adverse Event|1|||
16540109|NCT01181726|40439928|FG001|First Intervention|Adverse Event|0|||
16540110|NCT04530448|40439929|FG000|Overall Study|Physician Decision|3|||
16540111|NCT04530448|40439930|FG001|Overall Study|Physician Decision|0|||
16540112|NCT05232864|40439931|FG000|Overall Study|Adverse Event|0|||
16540113|NCT05232864|40439932|FG001|Overall Study|Adverse Event|1|||
16540114|NCT05232864|40439931|FG000|Overall Study|Study terminated by sponsor|16|||
16540115|NCT05232864|40439932|FG001|Overall Study|Study terminated by sponsor|14|||
16540116|NCT02589522|40439940|FG000|Overall Study|Physician Decision|1|||
16540117|NCT02589522|40439941|FG001|Overall Study|Physician Decision|2|||
16540118|NCT02589522|40439942|FG002|Overall Study|Physician Decision|0|||
16540119|NCT02589522|40439940|FG000|Overall Study|Did not start treatment|1|||
16540120|NCT02589522|40439941|FG001|Overall Study|Did not start treatment|0|||
16540121|NCT02589522|40439942|FG002|Overall Study|Did not start treatment|0|||
16540122|NCT00415610|40439949|FG000|Overall Study|Death|3|||
16540123|NCT00415610|40439950|FG001|Overall Study|Death|2|||
16540124|NCT00415610|40439951|FG002|Overall Study|Death|5|||
16540125|NCT01685138|40439952|FG000|Overall Study|Lost to Follow-up|1|||
16540126|NCT01685138|40439952|FG000|Overall Study|Protocol Violation|1|||
16540127|NCT01685138|40439952|FG000|Overall Study|No longer requires treatment|1|||
16540128|NCT01685138|40439952|FG000|Overall Study|Subject/guardian decision|2|||
16540129|NCT01685138|40439952|FG000|Overall Study|Physician Decision|6|||
16540130|NCT01685138|40439952|FG000|Overall Study|Death|10|||
16540131|NCT01685138|40439952|FG000|Overall Study|Adverse Event|18|||
16540132|NCT01685138|40439952|FG000|Overall Study|Progressive disease|53|||
16540133|NCT02163733|40439953|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
16540134|NCT02163733|40439954|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
16540135|NCT02163733|40439955|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
16540136|NCT02163733|40439953|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
16540137|NCT02163733|40439954|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
16540138|NCT02163733|40439955|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
16540139|NCT01972529|40439958|FG000|Overall Study|Adverse Event|0|||
16540140|NCT01972529|40439959|FG001|Overall Study|Adverse Event|1|||
16540141|NCT01972529|40439960|FG002|Overall Study|Adverse Event|0|||
16540142|NCT01972529|40439961|FG003|Overall Study|Adverse Event|0|||
16540143|NCT01972529|40439958|FG000|Overall Study|Lost to Follow-up|1|||
16540144|NCT01972529|40439959|FG001|Overall Study|Lost to Follow-up|0|||
16540145|NCT01972529|40439960|FG002|Overall Study|Lost to Follow-up|0|||
16540146|NCT01972529|40439961|FG003|Overall Study|Lost to Follow-up|0|||
16540147|NCT01972529|40439958|FG000|Overall Study|Participant Choice|0|||
16540148|NCT01972529|40439959|FG001|Overall Study|Participant Choice|1|||
16540149|NCT01972529|40439960|FG002|Overall Study|Participant Choice|0|||
16540150|NCT01972529|40439961|FG003|Overall Study|Participant Choice|0|||
16540151|NCT01972529|40439958|FG000|Overall Study|Withdrawl of Consent|1|||
16540152|NCT01972529|40439959|FG001|Overall Study|Withdrawl of Consent|2|||
16540153|NCT01972529|40439960|FG002|Overall Study|Withdrawl of Consent|0|||
16540154|NCT01972529|40439961|FG003|Overall Study|Withdrawl of Consent|1|||
16217664|NCT02477800|39276017|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
16217665|NCT02477800|39276018|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
16540155|NCT01972529|40439958|FG000|Overall Study|Other|0|||
16540156|NCT01972529|40439959|FG001|Overall Study|Other|0|||
16540157|NCT01972529|40439960|FG002|Overall Study|Other|0|||
16540158|NCT01972529|40439961|FG003|Overall Study|Other|2|||
16540159|NCT01972529|40439958|FG000|Overall Study|Not treated|0|||
16540160|NCT01972529|40439959|FG001|Overall Study|Not treated|1|||
16540161|NCT01972529|40439960|FG002|Overall Study|Not treated|2|||
16540162|NCT01972529|40439961|FG003|Overall Study|Not treated|1|||
16540163|NCT02701985|40439964|FG000|Overall Study|Withdrawal by Subject|1|||
16540164|NCT02701985|40439965|FG001|Overall Study|Withdrawal by Subject|1|||
16540165|NCT02701985|40439964|FG000|Overall Study|Lost to Follow-up|1|||
16105833|NCT00661713|38875379|FG007|Overall Study|Adverse Event|0|||
16105834|NCT00661713|38875372|FG000|Overall Study|Inappropriate Enrollment|0|||
16105835|NCT00661713|38875373|FG001|Overall Study|Inappropriate Enrollment|0|||
16105836|NCT00661713|38875374|FG002|Overall Study|Inappropriate Enrollment|0|||
16217666|NCT02477800|39276019|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
16540166|NCT02701985|40439965|FG001|Overall Study|Lost to Follow-up|0|||
16540167|NCT02701985|40439964|FG000|Overall Study|Death|1|||
16540168|NCT02701985|40439965|FG001|Overall Study|Death|0|||
16540169|NCT02701985|40439964|FG000|Overall Study|Adverse Event|0|||
16540170|NCT02701985|40439965|FG001|Overall Study|Adverse Event|5|||
16540171|NCT00082173|40439966|FG000|Overall Study|Withdrawal by Subject|3|||
16540172|NCT00082173|40439967|FG001|Overall Study|Withdrawal by Subject|5|||
16540173|NCT00082173|40439966|FG000|Overall Study|Lost to Follow-up|1|||
16540174|NCT00082173|40439967|FG001|Overall Study|Lost to Follow-up|0|||
16540175|NCT00082173|40439966|FG000|Overall Study|Adverse Event|1|||
16540176|NCT00082173|40439967|FG001|Overall Study|Adverse Event|0|||
16540177|NCT00082173|40439966|FG000|Overall Study|Culture negative or resistant at baselin|5|||
16540178|NCT00082173|40439967|FG001|Overall Study|Culture negative or resistant at baselin|6|||
16540179|NCT01169675|40439975|FG000|Overall Study|Progressive disease|13|||
16540180|NCT01169675|40439976|FG001|Overall Study|Progressive disease|2|||
16540181|NCT01169675|40439977|FG002|Overall Study|Progressive disease|5|||
16540182|NCT01169675|40439978|FG003|Overall Study|Progressive disease|15|||
16540183|NCT01169675|40439979|FG004|Overall Study|Progressive disease|1|||
16540184|NCT01169675|40439975|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
16540185|NCT01169675|40439976|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16540186|NCT01169675|40439977|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16540187|NCT01169675|40439978|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16540188|NCT01169675|40439979|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
16540189|NCT01169675|40439975|FG000|Overall Study|Adverse Event|5|||
16540190|NCT01169675|40439976|FG001|Overall Study|Adverse Event|1|||
16105837|NCT00661713|38875375|FG003|Overall Study|Inappropriate Enrollment|0|||
16105838|NCT00661713|38875376|FG004|Overall Study|Inappropriate Enrollment|0|||
16105839|NCT00661713|38875377|FG005|Overall Study|Inappropriate Enrollment|0|||
16105840|NCT00661713|38875378|FG006|Overall Study|Inappropriate Enrollment|1|||
16105841|NCT00661713|38875379|FG007|Overall Study|Inappropriate Enrollment|0|||
16105842|NCT02760485|38875380|FG000|Phase 1|Death|3|||
16105843|NCT02760485|38875381|FG001|Phase 1|Death|6|||
16105844|NCT02760485|38875382|FG002|Phase 1|Death|0|||
16105845|NCT02760485|38875380|FG000|Phase 1|Withdrawal by Subject|2|||
16105846|NCT02760485|38875381|FG001|Phase 1|Withdrawal by Subject|0|||
16105847|NCT02760485|38875382|FG002|Phase 1|Withdrawal by Subject|0|||
16105848|NCT02760485|38875380|FG000|Phase 1|Progressive Disease|1|||
16105849|NCT02760485|38875381|FG001|Phase 1|Progressive Disease|0|||
16105850|NCT02760485|38875382|FG002|Phase 1|Progressive Disease|0|||
16105851|NCT02760485|38875380|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
16105852|NCT02760485|38875381|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
16105853|NCT02760485|38875382|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
16105854|NCT02760485|38875380|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
16105855|NCT02760485|38875381|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
16105856|NCT02760485|38875382|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
16105857|NCT02760485|38875380|FG000|Phase 2|Death|0|||
16105858|NCT02760485|38875381|FG001|Phase 2|Death|0|||
16105859|NCT02760485|38875382|FG002|Phase 2|Death|12|||
16105860|NCT02760485|38875380|FG000|Phase 2|Withdrawal by Subject|0|||
16105861|NCT02760485|38875381|FG001|Phase 2|Withdrawal by Subject|0|||
16105862|NCT02760485|38875382|FG002|Phase 2|Withdrawal by Subject|3|||
16105863|NCT02760485|38875380|FG000|Phase 2|Progressive Disease|0|||
16105864|NCT02760485|38875381|FG001|Phase 2|Progressive Disease|0|||
16105865|NCT02760485|38875382|FG002|Phase 2|Progressive Disease|1|||
16340509|NCT01026818|39734392|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
16340510|NCT01026818|39734393|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
16340511|NCT01026818|39734390|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
16540191|NCT01169675|40439977|FG002|Overall Study|Adverse Event|2|||
16540192|NCT01169675|40439978|FG003|Overall Study|Adverse Event|0|||
16540193|NCT01169675|40439979|FG004|Overall Study|Adverse Event|0|||
16540194|NCT01169675|40439975|FG000|Overall Study|Withdrawal by Subject|1|||
16540195|NCT01169675|40439976|FG001|Overall Study|Withdrawal by Subject|0|||
16540196|NCT01169675|40439977|FG002|Overall Study|Withdrawal by Subject|0|||
16540197|NCT01169675|40439978|FG003|Overall Study|Withdrawal by Subject|1|||
16540198|NCT01169675|40439979|FG004|Overall Study|Withdrawal by Subject|2|||
16540199|NCT01169675|40439975|FG000|Overall Study|Other Reason Not Defined Above|0|||
16540200|NCT01169675|40439976|FG001|Overall Study|Other Reason Not Defined Above|0|||
16540201|NCT01169675|40439977|FG002|Overall Study|Other Reason Not Defined Above|0|||
16540202|NCT01169675|40439978|FG003|Overall Study|Other Reason Not Defined Above|1|||
16340512|NCT01026818|39734391|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
16340513|NCT01026818|39734392|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
16340514|NCT01026818|39734393|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
16340515|NCT01026818|39734390|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
16340516|NCT01026818|39734391|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
16540203|NCT01169675|40439979|FG004|Overall Study|Other Reason Not Defined Above|1|||
16105866|NCT02760485|38875380|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
16340517|NCT01026818|39734392|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
16340518|NCT01026818|39734393|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
16340519|NCT01026818|39734390|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
16340520|NCT01026818|39734391|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
16340521|NCT01026818|39734392|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
16340522|NCT01026818|39734393|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
16340523|NCT01026818|39734390|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
16340524|NCT01026818|39734391|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
16340525|NCT01026818|39734392|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
16540204|NCT02969525|40439980|FG000|Double-Blind Period|Adverse Event|0|||
16540205|NCT02969525|40439981|FG001|Double-Blind Period|Adverse Event|0|||
16105867|NCT02760485|38875381|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
16540206|NCT02969525|40439982|FG002|Double-Blind Period|Adverse Event|1|||
16540207|NCT02969525|40439983|FG003|Double-Blind Period|Adverse Event|1|||
16105868|NCT02760485|38875382|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
16340526|NCT01026818|39734393|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
16340527|NCT01026818|39734390|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
16340528|NCT01026818|39734391|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
16340529|NCT01026818|39734392|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
16340530|NCT01026818|39734393|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
16340531|NCT01026818|39734390|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
16340532|NCT01026818|39734391|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
16340533|NCT01026818|39734392|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
16340534|NCT01026818|39734393|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
16540208|NCT02969525|40439984|FG004|Double-Blind Period|Adverse Event|0|||
16540209|NCT02969525|40439985|FG005|Double-Blind Period|Adverse Event|0|||
16540210|NCT02969525|40439986|FG006|Double-Blind Period|Adverse Event|0|||
16105869|NCT00843115|38875383|FG000|Overall Study|Death|4|||
16105870|NCT00843115|38875383|FG000|Overall Study|Adverse Event|30|||
16105871|NCT00843115|38875383|FG000|Overall Study|Lost to Follow-up|4|||
16105872|NCT00843115|38875383|FG000|Overall Study|Withdrawal by Subject|17|||
16105873|NCT00843115|38875383|FG000|Overall Study|Family wanted meds stopped|1|||
16105874|NCT00843115|38875383|FG000|Overall Study|Family does not want continuation|1|||
16105875|NCT00843115|38875383|FG000|Overall Study|Patient forgot to take meds|1|||
16105876|NCT00843115|38875383|FG000|Overall Study|Does not meet entrance criteria|1|||
16105877|NCT00843115|38875383|FG000|Overall Study|Physician Decision|1|||
16105878|NCT00843115|38875383|FG000|Overall Study|Family discontinued meds|1|||
16105879|NCT00843115|38875383|FG000|Overall Study|patient took for 2 days then stopped|1|||
16105880|NCT00843115|38875383|FG000|Overall Study|patient never took the medication|1|||
16105881|NCT00843115|38875383|FG000|Overall Study|hospitalized due to deterioration|1|||
16105882|NCT00843115|38875383|FG000|Overall Study|week 12 not done|1|||
16105883|NCT00843115|38875383|FG000|Overall Study|Syndrome De Glissement|1|||
16105884|NCT00468858|38875384|FG000|Overall Study|Adverse Event|0|||
16540211|NCT02969525|40439987|FG007|Double-Blind Period|Adverse Event|0|||
16105885|NCT00468858|38875385|FG001|Overall Study|Adverse Event|1|||
16540212|NCT02969525|40439988|FG008|Double-Blind Period|Adverse Event|0|||
16540213|NCT02969525|40439989|FG009|Double-Blind Period|Adverse Event|0|||
16540214|NCT02969525|40439990|FG010|Double-Blind Period|Adverse Event|0|||
16540215|NCT02969525|40439991|FG011|Double-Blind Period|Adverse Event|0|||
16540216|NCT02969525|40439980|FG000|Double-Blind Period|LOW EGFR|0|||
16540217|NCT02969525|40439981|FG001|Double-Blind Period|LOW EGFR|0|||
16540218|NCT02969525|40439982|FG002|Double-Blind Period|LOW EGFR|0|||
16540219|NCT02969525|40439983|FG003|Double-Blind Period|LOW EGFR|1|||
16540220|NCT02969525|40439984|FG004|Double-Blind Period|LOW EGFR|0|||
16540221|NCT02969525|40439985|FG005|Double-Blind Period|LOW EGFR|0|||
16540222|NCT02969525|40439986|FG006|Double-Blind Period|LOW EGFR|0|||
16540223|NCT02969525|40439987|FG007|Double-Blind Period|LOW EGFR|0|||
16540224|NCT02969525|40439988|FG008|Double-Blind Period|LOW EGFR|0|||
16540225|NCT02969525|40439989|FG009|Double-Blind Period|LOW EGFR|0|||
16540226|NCT02969525|40439990|FG010|Double-Blind Period|LOW EGFR|0|||
16540227|NCT02969525|40439991|FG011|Double-Blind Period|LOW EGFR|0|||
16540228|NCT02969525|40439980|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
16540229|NCT02969525|40439981|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16540230|NCT02969525|40439982|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16540231|NCT02969525|40439983|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
16540232|NCT02969525|40439984|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16540233|NCT02969525|40439985|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16540234|NCT02969525|40439986|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16540235|NCT02969525|40439987|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16540236|NCT02969525|40439988|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16105886|NCT00468858|38875386|FG002|Overall Study|Adverse Event|0|||
16105887|NCT00468858|38875384|FG000|Overall Study|Withdrawal by Subject|7|||
16105888|NCT00468858|38875385|FG001|Overall Study|Withdrawal by Subject|4|||
16540237|NCT02969525|40439989|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16540238|NCT02969525|40439990|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16540239|NCT02969525|40439991|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
16540240|NCT02969525|40439980|FG000|Dose-Blind Period|Adverse Event|0|||
16540241|NCT02969525|40439981|FG001|Dose-Blind Period|Adverse Event|0|||
16540242|NCT02969525|40439982|FG002|Dose-Blind Period|Adverse Event|0|||
16540243|NCT02969525|40439983|FG003|Dose-Blind Period|Adverse Event|0|||
16540244|NCT02969525|40439984|FG004|Dose-Blind Period|Adverse Event|0|||
16540245|NCT02969525|40439985|FG005|Dose-Blind Period|Adverse Event|0|||
16540246|NCT02969525|40439986|FG006|Dose-Blind Period|Adverse Event|0|||
16540247|NCT02969525|40439987|FG007|Dose-Blind Period|Adverse Event|0|||
16540248|NCT02969525|40439988|FG008|Dose-Blind Period|Adverse Event|0|||
16540249|NCT02969525|40439989|FG009|Dose-Blind Period|Adverse Event|1|||
16540250|NCT02969525|40439990|FG010|Dose-Blind Period|Adverse Event|1|||
16540251|NCT02969525|40439991|FG011|Dose-Blind Period|Adverse Event|1|||
16540252|NCT02969525|40439980|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
16540253|NCT02969525|40439981|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
16540254|NCT02969525|40439982|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
16540255|NCT02969525|40439983|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
16540256|NCT02969525|40439984|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
16540257|NCT02969525|40439985|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
16540258|NCT02969525|40439986|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
16540259|NCT02969525|40439987|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
16540260|NCT02969525|40439988|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
16540261|NCT02969525|40439989|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
16540262|NCT02969525|40439990|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
16540263|NCT02969525|40439991|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
16540264|NCT02969525|40439980|FG000|Dose-Blind Period|Non-cooperating patient|0|||
16540265|NCT02969525|40439981|FG001|Dose-Blind Period|Non-cooperating patient|0|||
16540266|NCT02969525|40439982|FG002|Dose-Blind Period|Non-cooperating patient|0|||
16540267|NCT02969525|40439983|FG003|Dose-Blind Period|Non-cooperating patient|0|||
16540268|NCT02969525|40439984|FG004|Dose-Blind Period|Non-cooperating patient|0|||
16540269|NCT02969525|40439985|FG005|Dose-Blind Period|Non-cooperating patient|0|||
16540270|NCT02969525|40439986|FG006|Dose-Blind Period|Non-cooperating patient|0|||
16540271|NCT02969525|40439987|FG007|Dose-Blind Period|Non-cooperating patient|0|||
16340535|NCT01026818|39734390|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
16340536|NCT01026818|39734391|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
16340537|NCT01026818|39734392|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
16340538|NCT01026818|39734393|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
16340539|NCT01026818|39734390|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
16340540|NCT01026818|39734391|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
16340541|NCT01026818|39734392|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
16340542|NCT01026818|39734393|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
16340543|NCT01026818|39734390|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
16340544|NCT01026818|39734391|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
16340545|NCT01026818|39734392|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
16540272|NCT02969525|40439988|FG008|Dose-Blind Period|Non-cooperating patient|0|||
16105889|NCT00468858|38875386|FG002|Overall Study|Withdrawal by Subject|5|||
16105890|NCT00468858|38875384|FG000|Overall Study|Relocation|1|||
16217667|NCT02477800|39276020|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
16105891|NCT00468858|38875385|FG001|Overall Study|Relocation|3|||
16105892|NCT00468858|38875386|FG002|Overall Study|Relocation|3|||
16105893|NCT00468858|38875384|FG000|Overall Study|Lost to Follow-up|1|||
16105894|NCT00468858|38875385|FG001|Overall Study|Lost to Follow-up|2|||
16105895|NCT00468858|38875386|FG002|Overall Study|Lost to Follow-up|5|||
16105896|NCT00468858|38875384|FG000|Overall Study|Other|0|||
16540273|NCT02969525|40439989|FG009|Dose-Blind Period|Non-cooperating patient|0|||
16540274|NCT02969525|40439990|FG010|Dose-Blind Period|Non-cooperating patient|0|||
16540275|NCT02969525|40439991|FG011|Dose-Blind Period|Non-cooperating patient|1|||
16540276|NCT02969525|40439980|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16540277|NCT02969525|40439981|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16105897|NCT00468858|38875385|FG001|Overall Study|Other|0|||
16217668|NCT02477800|39276021|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
16540278|NCT02969525|40439982|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16540279|NCT02969525|40439983|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16105898|NCT00468858|38875386|FG002|Overall Study|Other|1|||
16105899|NCT01530087|38875387|FG000|Overall Study|Physician Decision|2|||
16105900|NCT04522778|38875388|FG000|Overall Study|Patient did not want to wear the device|1|||
16540280|NCT02969525|40439984|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16340546|NCT01026818|39734393|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
16340547|NCT01026818|39734390|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
16340548|NCT01026818|39734391|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
16340549|NCT01026818|39734392|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
16340550|NCT01026818|39734393|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
16340551|NCT01026818|39734390|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
16340552|NCT01026818|39734391|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
16340553|NCT01026818|39734392|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
16340554|NCT01026818|39734393|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
16340555|NCT01026818|39734390|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
16340556|NCT01026818|39734391|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
16340557|NCT01026818|39734392|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
16340558|NCT01026818|39734393|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
16340559|NCT01026818|39734390|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
16340560|NCT01026818|39734391|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
16340561|NCT01026818|39734392|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
16340562|NCT01026818|39734393|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
16340563|NCT01026818|39734390|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
16340564|NCT01026818|39734391|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
16340565|NCT01026818|39734392|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
16340566|NCT01026818|39734393|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
16340567|NCT01026818|39734390|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
16340568|NCT01026818|39734391|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
16340569|NCT01026818|39734392|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
16340570|NCT01026818|39734393|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
16340571|NCT01026818|39734390|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
16340572|NCT01026818|39734391|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
16340573|NCT01026818|39734392|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
16340574|NCT01026818|39734393|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
16340575|NCT01026818|39734390|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
16340576|NCT01026818|39734391|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
16340577|NCT01026818|39734392|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
16340578|NCT01026818|39734393|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
16340579|NCT01358578|39734394|FG000|Induction Period|Adverse Event|2|||
16340580|NCT01358578|39734395|FG001|Induction Period|Adverse Event|4|||
16340581|NCT01358578|39734396|FG002|Induction Period|Adverse Event|2|||
16340582|NCT01358578|39734397|FG003|Induction Period|Adverse Event|6|||
16340583|NCT01358578|39734398|FG004|Induction Period|Adverse Event|0|||
16340584|NCT01358578|39734399|FG005|Induction Period|Adverse Event|0|||
16340585|NCT01358578|39734394|FG000|Induction Period|Lack of Efficacy|0|||
16340586|NCT01358578|39734395|FG001|Induction Period|Lack of Efficacy|0|||
16540281|NCT02969525|40439985|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16540282|NCT02969525|40439986|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16540283|NCT02969525|40439987|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16540284|NCT02969525|40439988|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16540285|NCT02969525|40439989|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16540286|NCT02969525|40439990|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
16540287|NCT02969525|40439991|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
16540288|NCT01773070|40439992|FG000|Overall Study|Withdrawal by Subject|24|||
16540289|NCT01773070|40439992|FG000|Overall Study|Lost to Follow-up|39|||
16540290|NCT01773070|40439992|FG000|Overall Study|Other|15|||
16540291|NCT01773070|40439992|FG000|Overall Study|Death (unrelated to study procedures)|3|||
16540292|NCT01239030|40439993|FG000|Double Blind|Adverse Event|0|||
16540293|NCT01239030|40439994|FG001|Double Blind|Adverse Event|1|||
16540294|NCT01239030|40439995|FG002|Double Blind|Adverse Event|0|||
16540295|NCT01239030|40439996|FG003|Double Blind|Adverse Event|2|||
16540296|NCT01239030|40439997|FG004|Double Blind|Adverse Event|0|||
16540297|NCT01239030|40439993|FG000|Double Blind|Withdrawal by Subject|0|||
16340587|NCT01358578|39734396|FG002|Induction Period|Lack of Efficacy|9|||
16340588|NCT01358578|39734397|FG003|Induction Period|Lack of Efficacy|1|||
16340589|NCT01358578|39734398|FG004|Induction Period|Lack of Efficacy|0|||
16540298|NCT01239030|40439994|FG001|Double Blind|Withdrawal by Subject|1|||
16340590|NCT01358578|39734399|FG005|Induction Period|Lack of Efficacy|0|||
16340591|NCT01358578|39734394|FG000|Induction Period|Lost to Follow-up|0|||
16340592|NCT01358578|39734395|FG001|Induction Period|Lost to Follow-up|0|||
16340593|NCT01358578|39734396|FG002|Induction Period|Lost to Follow-up|1|||
16340594|NCT01358578|39734397|FG003|Induction Period|Lost to Follow-up|4|||
16340595|NCT01358578|39734398|FG004|Induction Period|Lost to Follow-up|0|||
16340596|NCT01358578|39734399|FG005|Induction Period|Lost to Follow-up|0|||
16105901|NCT04522778|38875389|FG001|Overall Study|Patient did not want to wear the device|0|||
16105902|NCT04522778|38875388|FG000|Overall Study|Lost to Follow-up|0|||
16105903|NCT04522778|38875389|FG001|Overall Study|Lost to Follow-up|1|||
16105904|NCT01157351|38875392|FG000|Overall Study|Adverse Event|5|||
16105905|NCT01157351|38875393|FG001|Overall Study|Adverse Event|4|||
16540299|NCT01239030|40439995|FG002|Double Blind|Withdrawal by Subject|1|||
16540300|NCT01239030|40439996|FG003|Double Blind|Withdrawal by Subject|0|||
16540301|NCT01239030|40439997|FG004|Double Blind|Withdrawal by Subject|1|||
16540302|NCT01239030|40439993|FG000|Double Blind|Lost to Follow-up|1|||
16105906|NCT01157351|38875392|FG000|Overall Study|Death|1|||
16105907|NCT01157351|38875393|FG001|Overall Study|Death|0|||
16105908|NCT01157351|38875392|FG000|Overall Study|Lost to Follow-up|53|||
16105909|NCT01157351|38875393|FG001|Overall Study|Lost to Follow-up|55|||
16105910|NCT01157351|38875392|FG000|Overall Study|Withdrawal by Subject|37|||
16105911|NCT01157351|38875393|FG001|Overall Study|Withdrawal by Subject|27|||
16105912|NCT01157351|38875392|FG000|Overall Study|Physician Decision|5|||
16105913|NCT01157351|38875393|FG001|Overall Study|Physician Decision|4|||
16105914|NCT01157351|38875392|FG000|Overall Study|Protocol Violation|0|||
16105915|NCT01157351|38875393|FG001|Overall Study|Protocol Violation|1|||
16105916|NCT01157351|38875392|FG000|Overall Study|Other|32|||
16105917|NCT01157351|38875393|FG001|Overall Study|Other|36|||
16105918|NCT01157351|38875392|FG000|Overall Study|Noncompliance with Study Drug|0|||
16105919|NCT01157351|38875393|FG001|Overall Study|Noncompliance with Study Drug|3|||
16105920|NCT01157351|38875392|FG000|Overall Study|Randomized but not Treated|4|||
16105921|NCT01157351|38875393|FG001|Overall Study|Randomized but not Treated|2|||
16105922|NCT02564718|38875397|FG000|Overall Study|Withdrew from treatment|0|||
16105923|NCT02564718|38875398|FG001|Overall Study|Withdrew from treatment|1|||
16340597|NCT01358578|39734394|FG000|Induction Period|Physician Decision|2|||
16340598|NCT01358578|39734395|FG001|Induction Period|Physician Decision|1|||
16340599|NCT01358578|39734396|FG002|Induction Period|Physician Decision|2|||
16340600|NCT01358578|39734397|FG003|Induction Period|Physician Decision|0|||
16340601|NCT01358578|39734398|FG004|Induction Period|Physician Decision|0|||
16340602|NCT01358578|39734399|FG005|Induction Period|Physician Decision|0|||
16340603|NCT01358578|39734394|FG000|Induction Period|Protocol Deviation|3|||
16340604|NCT01358578|39734395|FG001|Induction Period|Protocol Deviation|5|||
16340605|NCT01358578|39734396|FG002|Induction Period|Protocol Deviation|0|||
16340606|NCT01358578|39734397|FG003|Induction Period|Protocol Deviation|3|||
16340607|NCT01358578|39734398|FG004|Induction Period|Protocol Deviation|0|||
16340608|NCT01358578|39734399|FG005|Induction Period|Protocol Deviation|0|||
16340609|NCT01358578|39734394|FG000|Induction Period|technical problems|0|||
16340610|NCT01358578|39734395|FG001|Induction Period|technical problems|0|||
16540303|NCT01239030|40439994|FG001|Double Blind|Lost to Follow-up|1|||
16540304|NCT01239030|40439995|FG002|Double Blind|Lost to Follow-up|0|||
16540305|NCT01239030|40439996|FG003|Double Blind|Lost to Follow-up|0|||
16540306|NCT01239030|40439997|FG004|Double Blind|Lost to Follow-up|0|||
16540307|NCT01239030|40439993|FG000|Double Blind|Physician Decision|0|||
16540308|NCT01239030|40439994|FG001|Double Blind|Physician Decision|1|||
16540309|NCT01239030|40439995|FG002|Double Blind|Physician Decision|0|||
16105924|NCT00937521|38875399|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16540310|NCT01239030|40439996|FG003|Double Blind|Physician Decision|0|||
16540311|NCT01239030|40439997|FG004|Double Blind|Physician Decision|0|||
16540312|NCT01239030|40439993|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
16540313|NCT01239030|40439994|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
16540314|NCT01239030|40439995|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
16540315|NCT01239030|40439996|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
16540316|NCT01239030|40439997|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
16540317|NCT01239030|40439993|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
16540318|NCT01239030|40439994|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
16540319|NCT01239030|40439995|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
16540320|NCT01239030|40439996|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
16540321|NCT01239030|40439997|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
16540322|NCT01239030|40439993|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
16540323|NCT01239030|40439994|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
16540324|NCT01239030|40439995|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
16540325|NCT01239030|40439996|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
16540326|NCT01239030|40439997|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
16540327|NCT01239030|40439993|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
16105925|NCT00937521|38875400|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16105926|NCT00937521|38875401|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
16340611|NCT01358578|39734396|FG002|Induction Period|technical problems|1|||
16340612|NCT01358578|39734397|FG003|Induction Period|technical problems|1|||
16340613|NCT01358578|39734398|FG004|Induction Period|technical problems|0|||
16105927|NCT00937521|38875402|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16105928|NCT00937521|38875403|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16105929|NCT00937521|38875404|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16105930|NCT00937521|38875405|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
16105931|NCT00937521|38875406|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
16105932|NCT00937521|38875399|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
16105933|NCT00937521|38875400|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
16105934|NCT00937521|38875401|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
16105935|NCT00937521|38875402|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
16105936|NCT00937521|38875403|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
16105937|NCT00937521|38875404|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
16105938|NCT00937521|38875405|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
16105939|NCT00937521|38875406|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
16105940|NCT00937521|38875399|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16105941|NCT00937521|38875400|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16105942|NCT00937521|38875401|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
16105943|NCT00937521|38875402|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
16105944|NCT00937521|38875403|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16105945|NCT00937521|38875404|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16105946|NCT00937521|38875405|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16105947|NCT00937521|38875406|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
16105948|NCT00937521|38875399|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
16105949|NCT00937521|38875400|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
16105950|NCT00937521|38875401|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
16105951|NCT00937521|38875402|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
16105952|NCT00937521|38875403|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
16105953|NCT00937521|38875404|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
16105954|NCT00937521|38875405|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
16105955|NCT00937521|38875406|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
16105956|NCT00937521|38875399|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
16105957|NCT00937521|38875400|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16105958|NCT00937521|38875401|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16105959|NCT00937521|38875402|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16105960|NCT00937521|38875403|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16105961|NCT00937521|38875404|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16105962|NCT00937521|38875405|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
16105963|NCT00937521|38875406|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
16105964|NCT00937521|38875399|FG000|Booster Phase|Adverse Event|0|||
16105965|NCT00937521|38875400|FG001|Booster Phase|Adverse Event|0|||
16105966|NCT00937521|38875401|FG002|Booster Phase|Adverse Event|0|||
16105967|NCT00937521|38875402|FG003|Booster Phase|Adverse Event|0|||
16105968|NCT00937521|38875403|FG004|Booster Phase|Adverse Event|0|||
16105969|NCT00937521|38875404|FG005|Booster Phase|Adverse Event|0|||
16105970|NCT00937521|38875405|FG006|Booster Phase|Adverse Event|1|||
16105971|NCT00937521|38875406|FG007|Booster Phase|Adverse Event|0|||
16105972|NCT00937521|38875399|FG000|Booster Phase|Withdrawal by Subject|1|||
16105973|NCT00937521|38875400|FG001|Booster Phase|Withdrawal by Subject|0|||
16105974|NCT00937521|38875401|FG002|Booster Phase|Withdrawal by Subject|0|||
16105975|NCT00937521|38875402|FG003|Booster Phase|Withdrawal by Subject|1|||
16105976|NCT00937521|38875403|FG004|Booster Phase|Withdrawal by Subject|0|||
16105977|NCT00937521|38875404|FG005|Booster Phase|Withdrawal by Subject|0|||
16105978|NCT00937521|38875405|FG006|Booster Phase|Withdrawal by Subject|0|||
16105979|NCT00937521|38875406|FG007|Booster Phase|Withdrawal by Subject|2|||
16105980|NCT00937521|38875399|FG000|Booster Phase|Lost to Follow-up|2|||
16540328|NCT01239030|40439994|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
16540329|NCT01239030|40439995|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
16540330|NCT01239030|40439996|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
16540331|NCT01239030|40439997|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
16540332|NCT01559844|40439999|FG000|Overall Study|Consent Withdrawn|7|||
16540333|NCT01559844|40439999|FG000|Overall Study|Death|5|||
16540334|NCT01559844|40439999|FG000|Overall Study|Efficacy Failure|10|||
16540335|NCT01559844|40439999|FG000|Overall Study|No Longer A Transplant Candidate|3|||
16540336|NCT01959425|40440000|FG000|Overall Study|Withdrawal by Subject|5|||
16540337|NCT01959425|40440001|FG001|Overall Study|Withdrawal by Subject|4|||
16105981|NCT00937521|38875400|FG001|Booster Phase|Lost to Follow-up|2|||
16105982|NCT00937521|38875401|FG002|Booster Phase|Lost to Follow-up|4|||
16105983|NCT00937521|38875402|FG003|Booster Phase|Lost to Follow-up|2|||
16105984|NCT00937521|38875403|FG004|Booster Phase|Lost to Follow-up|4|||
16217669|NCT02477800|39276022|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
16340614|NCT01358578|39734399|FG005|Induction Period|technical problems|0|||
16340615|NCT01358578|39734394|FG000|Induction Period|Withdrawal by Subject|5|||
16540338|NCT01959425|40440000|FG000|Overall Study|Lost to Follow-up|1|||
16540339|NCT01959425|40440001|FG001|Overall Study|Lost to Follow-up|0|||
16540340|NCT01959425|40440000|FG000|Overall Study|Discontinued Subjects|6|||
16540341|NCT01959425|40440001|FG001|Overall Study|Discontinued Subjects|4|||
16340616|NCT01358578|39734395|FG001|Induction Period|Withdrawal by Subject|5|||
16340617|NCT01358578|39734396|FG002|Induction Period|Withdrawal by Subject|10|||
16340618|NCT01358578|39734397|FG003|Induction Period|Withdrawal by Subject|6|||
16340619|NCT01358578|39734398|FG004|Induction Period|Withdrawal by Subject|0|||
16340620|NCT01358578|39734399|FG005|Induction Period|Withdrawal by Subject|0|||
16340621|NCT01358578|39734394|FG000|Maintenance Period|Adverse Event|2|||
16340622|NCT01358578|39734395|FG001|Maintenance Period|Adverse Event|7|||
16340623|NCT01358578|39734396|FG002|Maintenance Period|Adverse Event|0|||
16340624|NCT01358578|39734397|FG003|Maintenance Period|Adverse Event|6|||
16340625|NCT01358578|39734398|FG004|Maintenance Period|Adverse Event|4|||
16540342|NCT00445679|40440007|FG000|Overall Study|Adverse Event|22|||
16540343|NCT00445679|40440008|FG001|Overall Study|Adverse Event|12|||
16540344|NCT00445679|40440009|FG002|Overall Study|Adverse Event|30|||
16540345|NCT00445679|40440010|FG003|Overall Study|Adverse Event|19|||
16540346|NCT00445679|40440007|FG000|Overall Study|Failed to return|1|||
16540347|NCT00445679|40440008|FG001|Overall Study|Failed to return|3|||
16540348|NCT00445679|40440009|FG002|Overall Study|Failed to return|2|||
16540349|NCT00445679|40440010|FG003|Overall Study|Failed to return|2|||
16540350|NCT00445679|40440007|FG000|Overall Study|Physician Decision|0|||
16540351|NCT00445679|40440008|FG001|Overall Study|Physician Decision|0|||
16540352|NCT00445679|40440009|FG002|Overall Study|Physician Decision|1|||
16540353|NCT00445679|40440010|FG003|Overall Study|Physician Decision|0|||
16540354|NCT00445679|40440007|FG000|Overall Study|Lost to Follow-up|10|||
16540355|NCT00445679|40440008|FG001|Overall Study|Lost to Follow-up|6|||
16540356|NCT00445679|40440009|FG002|Overall Study|Lost to Follow-up|6|||
16540357|NCT00445679|40440010|FG003|Overall Study|Lost to Follow-up|5|||
16540358|NCT00445679|40440007|FG000|Overall Study|Compliance|3|||
16540359|NCT00445679|40440008|FG001|Overall Study|Compliance|2|||
16540360|NCT00445679|40440009|FG002|Overall Study|Compliance|1|||
16540361|NCT00445679|40440010|FG003|Overall Study|Compliance|2|||
16540362|NCT00445679|40440007|FG000|Overall Study|Withdrawal of Informed Consent|0|||
16540363|NCT00445679|40440008|FG001|Overall Study|Withdrawal of Informed Consent|0|||
16540364|NCT00445679|40440009|FG002|Overall Study|Withdrawal of Informed Consent|1|||
16540365|NCT00445679|40440010|FG003|Overall Study|Withdrawal of Informed Consent|0|||
16540366|NCT00445679|40440007|FG000|Overall Study|Protocol Violation|2|||
16540367|NCT00445679|40440008|FG001|Overall Study|Protocol Violation|3|||
16540368|NCT00445679|40440009|FG002|Overall Study|Protocol Violation|3|||
16540369|NCT00445679|40440010|FG003|Overall Study|Protocol Violation|1|||
16540370|NCT00445679|40440007|FG000|Overall Study|Withdrawal by Subject|8|||
16540371|NCT00445679|40440008|FG001|Overall Study|Withdrawal by Subject|14|||
16540372|NCT00445679|40440009|FG002|Overall Study|Withdrawal by Subject|20|||
16540373|NCT00445679|40440010|FG003|Overall Study|Withdrawal by Subject|18|||
16540374|NCT00445679|40440007|FG000|Overall Study|Lack of Efficacy|2|||
16540375|NCT00445679|40440008|FG001|Overall Study|Lack of Efficacy|6|||
16340626|NCT01358578|39734399|FG005|Maintenance Period|Adverse Event|3|||
16340627|NCT01358578|39734394|FG000|Maintenance Period|Lack of Efficacy|10|||
16540376|NCT00445679|40440009|FG002|Overall Study|Lack of Efficacy|2|||
16540377|NCT00445679|40440010|FG003|Overall Study|Lack of Efficacy|0|||
16540378|NCT00316082|40440011|FG000|Overall Study|Lack of Efficacy|2|||
16540379|NCT00316082|40440012|FG001|Overall Study|Lack of Efficacy|3|||
16540380|NCT00316082|40440013|FG002|Overall Study|Lack of Efficacy|3|||
16540381|NCT00316082|40440014|FG003|Overall Study|Lack of Efficacy|4|||
16540382|NCT00316082|40440015|FG004|Overall Study|Lack of Efficacy|6|||
16540383|NCT00316082|40440011|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
16540384|NCT00316082|40440012|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
16540385|NCT00316082|40440013|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
16340628|NCT01358578|39734395|FG001|Maintenance Period|Lack of Efficacy|2|||
16340629|NCT01358578|39734396|FG002|Maintenance Period|Lack of Efficacy|0|||
16340630|NCT01358578|39734397|FG003|Maintenance Period|Lack of Efficacy|11|||
16540386|NCT00316082|40440014|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
16540387|NCT00316082|40440015|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
16540388|NCT00316082|40440011|FG000|Overall Study|Lost to Follow-up|7|||
16540389|NCT00316082|40440012|FG001|Overall Study|Lost to Follow-up|6|||
16540390|NCT00316082|40440013|FG002|Overall Study|Lost to Follow-up|7|||
16540391|NCT00316082|40440014|FG003|Overall Study|Lost to Follow-up|8|||
16540392|NCT00316082|40440015|FG004|Overall Study|Lost to Follow-up|6|||
16540393|NCT00316082|40440011|FG000|Overall Study|Poor/noncompliance|6|||
16540394|NCT00316082|40440012|FG001|Overall Study|Poor/noncompliance|1|||
16340631|NCT01358578|39734398|FG004|Maintenance Period|Lack of Efficacy|3|||
16340632|NCT01358578|39734399|FG005|Maintenance Period|Lack of Efficacy|0|||
16540395|NCT00316082|40440013|FG002|Overall Study|Poor/noncompliance|4|||
16540396|NCT00316082|40440014|FG003|Overall Study|Poor/noncompliance|1|||
16540397|NCT00316082|40440015|FG004|Overall Study|Poor/noncompliance|4|||
16540398|NCT00316082|40440011|FG000|Overall Study|Adverse Event|4|||
16540399|NCT00316082|40440012|FG001|Overall Study|Adverse Event|2|||
16540400|NCT00316082|40440013|FG002|Overall Study|Adverse Event|5|||
16540401|NCT00316082|40440014|FG003|Overall Study|Adverse Event|1|||
16540402|NCT00316082|40440015|FG004|Overall Study|Adverse Event|3|||
16540403|NCT00316082|40440011|FG000|Overall Study|Subject no longer meets study criteria|3|||
16540404|NCT00316082|40440012|FG001|Overall Study|Subject no longer meets study criteria|1|||
16540405|NCT00316082|40440013|FG002|Overall Study|Subject no longer meets study criteria|2|||
16540406|NCT00316082|40440014|FG003|Overall Study|Subject no longer meets study criteria|2|||
16540407|NCT00316082|40440015|FG004|Overall Study|Subject no longer meets study criteria|1|||
16540408|NCT00316082|40440011|FG000|Overall Study|Physician Decision|1|||
16540409|NCT00316082|40440012|FG001|Overall Study|Physician Decision|1|||
16540410|NCT00316082|40440013|FG002|Overall Study|Physician Decision|2|||
16540411|NCT00316082|40440014|FG003|Overall Study|Physician Decision|1|||
16540412|NCT00316082|40440015|FG004|Overall Study|Physician Decision|1|||
16105985|NCT00937521|38875404|FG005|Booster Phase|Lost to Follow-up|4|||
16105986|NCT00937521|38875405|FG006|Booster Phase|Lost to Follow-up|3|||
16105987|NCT00937521|38875406|FG007|Booster Phase|Lost to Follow-up|0|||
16105988|NCT00937521|38875399|FG000|Booster Phase|Administrative Reason|0|||
16105989|NCT00937521|38875400|FG001|Booster Phase|Administrative Reason|0|||
16105990|NCT00937521|38875401|FG002|Booster Phase|Administrative Reason|1|||
16105991|NCT00937521|38875402|FG003|Booster Phase|Administrative Reason|0|||
16105992|NCT00937521|38875403|FG004|Booster Phase|Administrative Reason|1|||
16105993|NCT00937521|38875404|FG005|Booster Phase|Administrative Reason|1|||
16105994|NCT00937521|38875405|FG006|Booster Phase|Administrative Reason|0|||
16105995|NCT00937521|38875406|FG007|Booster Phase|Administrative Reason|0|||
16105996|NCT00937521|38875399|FG000|Booster Phase|Protocol Deviation|0|||
16105997|NCT00937521|38875400|FG001|Booster Phase|Protocol Deviation|0|||
16105998|NCT00937521|38875401|FG002|Booster Phase|Protocol Deviation|0|||
16105999|NCT00937521|38875402|FG003|Booster Phase|Protocol Deviation|0|||
16106000|NCT00937521|38875403|FG004|Booster Phase|Protocol Deviation|0|||
16106001|NCT00937521|38875404|FG005|Booster Phase|Protocol Deviation|0|||
16106002|NCT00937521|38875405|FG006|Booster Phase|Protocol Deviation|1|||
16106003|NCT00937521|38875406|FG007|Booster Phase|Protocol Deviation|0|||
16106004|NCT00239681|38875408|FG000|Overall Study|Adverse Event|100|||
16106005|NCT00239681|38875409|FG001|Overall Study|Adverse Event|99|||
16106006|NCT00239681|38875408|FG000|Overall Study|Withdrawal by Subject|458|||
16106007|NCT00239681|38875409|FG001|Overall Study|Withdrawal by Subject|489|||
16106008|NCT00239681|38875408|FG000|Overall Study|Lost to Follow-up|28|||
16106009|NCT00239681|38875409|FG001|Overall Study|Lost to Follow-up|22|||
16106010|NCT00239681|38875408|FG000|Overall Study|Protocol Violation|4|||
16106011|NCT00239681|38875409|FG001|Overall Study|Protocol Violation|4|||
16106012|NCT00239681|38875408|FG000|Overall Study|Physician Decision|13|||
16106013|NCT00239681|38875409|FG001|Overall Study|Physician Decision|17|||
16106014|NCT00239681|38875408|FG000|Overall Study|No information chacked on CaseReportForm|90|||
16106015|NCT00239681|38875409|FG001|Overall Study|No information chacked on CaseReportForm|84|||
16106016|NCT00853021|38875410|FG000|Overall Study|Adverse Event|2|||
16106017|NCT00853021|38875410|FG000|Overall Study|Withdrawal by Subject|2|||
16106018|NCT00853021|38875410|FG000|Overall Study|Death|1|||
16106019|NCT00469456|38875411|FG000|Overall Study|Adverse Event|4|||
16106020|NCT00469456|38875412|FG001|Overall Study|Adverse Event|3|||
16106021|NCT00469456|38875411|FG000|Overall Study|Protocol Violation|1|||
16106022|NCT00469456|38875412|FG001|Overall Study|Protocol Violation|0|||
16106023|NCT00469456|38875411|FG000|Overall Study|Withdrawal by Subject|4|||
16106024|NCT00469456|38875412|FG001|Overall Study|Withdrawal by Subject|1|||
16540413|NCT00316082|40440011|FG000|Overall Study|Death|0|||
16540414|NCT00316082|40440012|FG001|Overall Study|Death|0|||
16540415|NCT00316082|40440013|FG002|Overall Study|Death|1|||
16106025|NCT00819013|38875417|FG000|Overall Study|Not meeting continuing study eligibility|2|||
16106026|NCT00819013|38875418|FG001|Overall Study|Not meeting continuing study eligibility|1|||
16106027|NCT00819013|38875419|FG002|Overall Study|Not meeting continuing study eligibility|2|||
16540416|NCT00316082|40440014|FG003|Overall Study|Death|0|||
16540417|NCT00316082|40440015|FG004|Overall Study|Death|0|||
16540418|NCT00316082|40440011|FG000|Overall Study|Administrative reason by sponsor|0|||
16540419|NCT00316082|40440012|FG001|Overall Study|Administrative reason by sponsor|0|||
16540420|NCT00316082|40440013|FG002|Overall Study|Administrative reason by sponsor|1|||
16540421|NCT00316082|40440014|FG003|Overall Study|Administrative reason by sponsor|0|||
16540422|NCT00316082|40440015|FG004|Overall Study|Administrative reason by sponsor|0|||
16540423|NCT01648348|40440016|FG000|Overall Study|Cancel|1|||
16540424|NCT01648348|40440017|FG001|Overall Study|Cancel|0|||
16340633|NCT01358578|39734394|FG000|Maintenance Period|Lost to Follow-up|4|||
16340634|NCT01358578|39734395|FG001|Maintenance Period|Lost to Follow-up|0|||
16340635|NCT01358578|39734396|FG002|Maintenance Period|Lost to Follow-up|0|||
16340636|NCT01358578|39734397|FG003|Maintenance Period|Lost to Follow-up|5|||
16340637|NCT01358578|39734398|FG004|Maintenance Period|Lost to Follow-up|1|||
16340638|NCT01358578|39734399|FG005|Maintenance Period|Lost to Follow-up|1|||
16340639|NCT01358578|39734394|FG000|Maintenance Period|Non-compliance with study treatment|3|||
16340640|NCT01358578|39734395|FG001|Maintenance Period|Non-compliance with study treatment|1|||
16106028|NCT00819013|38875420|FG003|Overall Study|Not meeting continuing study eligibility|1|||
16106029|NCT00819013|38875417|FG000|Overall Study|Adverse Event|0|||
16106030|NCT00819013|38875418|FG001|Overall Study|Adverse Event|0|||
16106031|NCT00819013|38875419|FG002|Overall Study|Adverse Event|1|||
16106032|NCT00819013|38875420|FG003|Overall Study|Adverse Event|0|||
16106033|NCT00819013|38875417|FG000|Overall Study|Withdrawal by Subject|1|||
16106034|NCT00819013|38875418|FG001|Overall Study|Withdrawal by Subject|0|||
16106035|NCT00819013|38875419|FG002|Overall Study|Withdrawal by Subject|1|||
16106036|NCT00819013|38875420|FG003|Overall Study|Withdrawal by Subject|0|||
16106037|NCT00819013|38875417|FG000|Overall Study|Lost to Follow-up|0|||
16106038|NCT00819013|38875418|FG001|Overall Study|Lost to Follow-up|0|||
16106039|NCT00819013|38875419|FG002|Overall Study|Lost to Follow-up|1|||
16106040|NCT00819013|38875420|FG003|Overall Study|Lost to Follow-up|2|||
16106041|NCT00819013|38875417|FG000|Overall Study|Death|0|||
16540425|NCT01648348|40440018|FG002|Overall Study|Cancel|0|||
16540426|NCT01648348|40440019|FG003|Overall Study|Cancel|0|||
16540427|NCT01648348|40440020|FG004|Overall Study|Cancel|3|||
16106042|NCT00819013|38875418|FG001|Overall Study|Death|0|||
16106043|NCT00819013|38875419|FG002|Overall Study|Death|0|||
16106044|NCT00819013|38875420|FG003|Overall Study|Death|1|||
16540428|NCT01648348|40440021|FG005|Overall Study|Cancel|6|||
16106045|NCT02108652|38875424|FG000|Overall Study|Death|253|||
16106046|NCT02108652|38875424|FG000|Overall Study|Lost to Follow-up|2|||
16540429|NCT01648348|40440016|FG000|Overall Study|Replaced for MTD analysis|1|||
16540430|NCT01648348|40440017|FG001|Overall Study|Replaced for MTD analysis|0|||
16540431|NCT01648348|40440018|FG002|Overall Study|Replaced for MTD analysis|1|||
16540432|NCT01648348|40440019|FG003|Overall Study|Replaced for MTD analysis|0|||
16540433|NCT01648348|40440020|FG004|Overall Study|Replaced for MTD analysis|0|||
16540434|NCT01648348|40440021|FG005|Overall Study|Replaced for MTD analysis|0|||
16540435|NCT00490282|40440022|FG000|Overall Study|Withdrawal by Subject|3|||
16217670|NCT02477800|39276023|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
16217671|NCT02477800|39276017|FG000|Long Term Extension Period|Reason not Specified|0|||
16217672|NCT02477800|39276018|FG001|Long Term Extension Period|Reason not Specified|0|||
16217673|NCT02477800|39276019|FG002|Long Term Extension Period|Reason not Specified|0|||
16217674|NCT02477800|39276020|FG003|Long Term Extension Period|Reason not Specified|126|||
16217675|NCT02477800|39276021|FG004|Long Term Extension Period|Reason not Specified|140|||
16217676|NCT02477800|39276022|FG005|Long Term Extension Period|Reason not Specified|270|||
16217677|NCT02477800|39276023|FG006|Long Term Extension Period|Reason not Specified|224|||
16217678|NCT04043416|39276024|FG000|Washout|Change in health condition|0|||
16217679|NCT04043416|39276025|FG001|Washout|Change in health condition|1|||
16217680|NCT02520141|39276026|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
16217681|NCT01784211|39276027|FG000|Part A (Days 1-15)|Adverse Event|1|||
16217682|NCT01784211|39276028|FG001|Part A (Days 1-15)|Adverse Event|1|||
16217683|NCT01784211|39276029|FG002|Part A (Days 1-15)|Adverse Event|0|||
16217684|NCT01784211|39276030|FG003|Part A (Days 1-15)|Adverse Event|0|||
16217685|NCT01784211|39276031|FG004|Part A (Days 1-15)|Adverse Event|0|||
16217686|NCT01784211|39276032|FG005|Part A (Days 1-15)|Adverse Event|0|||
16217687|NCT01784211|39276027|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
16217688|NCT01784211|39276028|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
16217689|NCT01784211|39276029|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
16217690|NCT01784211|39276030|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
16540436|NCT02612064|40440023|FG000|Overall Study|Withdrawal by Subject|1|||
16540437|NCT02612064|40440024|FG001|Overall Study|Withdrawal by Subject|1|||
16540438|NCT02612064|40440023|FG000|Overall Study|Other|0|||
16540439|NCT02612064|40440024|FG001|Overall Study|Other|2|||
16540440|NCT00952367|40440025|FG000|Overall Study|Withdrawal by Subject|2|||
16540441|NCT00952367|40440025|FG000|Overall Study|Noncoordination|1|||
16540442|NCT00952367|40440025|FG000|Overall Study|Protocol Violation|3|||
16540443|NCT01132326|40440028|FG000|Overall Study|Lack of Efficacy|25|||
16540444|NCT01132326|40440028|FG000|Overall Study|Adverse Event|37|||
16540445|NCT01132326|40440028|FG000|Overall Study|Protocol Violation|1|||
16540446|NCT01132326|40440028|FG000|Overall Study|Lost to Follow-up|16|||
16540447|NCT01132326|40440028|FG000|Overall Study|Withdrawal by Subject|40|||
16540448|NCT01132326|40440028|FG000|Overall Study|Physician Decision|10|||
16540449|NCT01132326|40440028|FG000|Overall Study|Study Termination|80|||
16540450|NCT01132326|40440028|FG000|Overall Study|Declining Health|1|||
16540451|NCT01132326|40440028|FG000|Overall Study|Pregnancy|1|||
16540452|NCT01132326|40440028|FG000|Overall Study|Caregiver Withdrew Consent|1|||
16540453|NCT01132326|40440028|FG000|Overall Study|Death|5|||
16217691|NCT01784211|39276031|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
16217692|NCT01784211|39276032|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
16217693|NCT01975376|39276033|FG000|Overall Study|Adverse Event|5|||
16217694|NCT01975376|39276034|FG001|Overall Study|Adverse Event|5|||
16217695|NCT01975376|39276033|FG000|Overall Study|Death|65|||
16217696|NCT01975376|39276034|FG001|Overall Study|Death|72|||
16217697|NCT01975376|39276033|FG000|Overall Study|Lost to Follow-up|70|||
16217698|NCT01975376|39276034|FG001|Overall Study|Lost to Follow-up|66|||
16217699|NCT01975376|39276033|FG000|Overall Study|Withdrew consent|68|||
16217700|NCT01975376|39276034|FG001|Overall Study|Withdrew consent|62|||
16217701|NCT01975376|39276033|FG000|Overall Study|Other|2|||
16217702|NCT01975376|39276034|FG001|Overall Study|Other|4|||
16217703|NCT01975376|39276033|FG000|Overall Study|Randomized, Not Treated|16|||
16217704|NCT01975376|39276034|FG001|Overall Study|Randomized, Not Treated|8|||
16217705|NCT00372489|39276036|FG000|Overall Study|Adverse Event|18|||
16217706|NCT00372489|39276036|FG000|Overall Study|Lack of Efficacy|1|||
16217707|NCT00372489|39276036|FG000|Overall Study|Lost to Follow-up|3|||
16540454|NCT01132326|40440028|FG000|Overall Study|Subject Unable to Come To Visits|1|||
16540455|NCT00558064|40440029|FG000|Overall Study|Adverse Event|3|||
16217708|NCT00372489|39276036|FG000|Overall Study|Physician Decision|3|||
16217709|NCT00372489|39276036|FG000|Overall Study|Withdrawal by Subject|5|||
16217710|NCT00372489|39276036|FG000|Overall Study|Patient Relocation|2|||
16217711|NCT00372489|39276036|FG000|Overall Study|Renal transplant|6|||
16217712|NCT00372489|39276036|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
16217713|NCT01708915|39276037|FG000|Overall Study|Adverse Event|1|||
16217714|NCT01708915|39276038|FG001|Overall Study|Adverse Event|0|||
16217715|NCT01708915|39276039|FG002|Overall Study|Adverse Event|9|||
16540456|NCT00558064|40440030|FG001|Overall Study|Adverse Event|2|||
16217716|NCT01708915|39276040|FG003|Overall Study|Adverse Event|13|||
16217717|NCT01708915|39276037|FG000|Overall Study|Lack of Efficacy|84|||
16217718|NCT01708915|39276038|FG001|Overall Study|Lack of Efficacy|60|||
16217719|NCT01708915|39276039|FG002|Overall Study|Lack of Efficacy|35|||
16217720|NCT01708915|39276040|FG003|Overall Study|Lack of Efficacy|15|||
16217721|NCT01708915|39276037|FG000|Overall Study|Protocol Violation|0|||
16217722|NCT01708915|39276038|FG001|Overall Study|Protocol Violation|0|||
16217723|NCT01708915|39276039|FG002|Overall Study|Protocol Violation|0|||
16217724|NCT01708915|39276040|FG003|Overall Study|Protocol Violation|1|||
16217725|NCT01708915|39276037|FG000|Overall Study|Withdrawal by Subject|0|||
16217726|NCT01708915|39276038|FG001|Overall Study|Withdrawal by Subject|1|||
16217727|NCT01708915|39276039|FG002|Overall Study|Withdrawal by Subject|2|||
16217728|NCT01708915|39276040|FG003|Overall Study|Withdrawal by Subject|2|||
16217729|NCT01708915|39276037|FG000|Overall Study|Other reasons than stated above|1|||
16217730|NCT01708915|39276038|FG001|Overall Study|Other reasons than stated above|1|||
16217731|NCT01708915|39276039|FG002|Overall Study|Other reasons than stated above|0|||
16217732|NCT01708915|39276040|FG003|Overall Study|Other reasons than stated above|2|||
16217733|NCT01183104|39276043|FG000|Overall Study|Adverse Event|8|||
16217734|NCT01183104|39276044|FG001|Overall Study|Adverse Event|6|||
16217735|NCT01183104|39276043|FG000|Overall Study|Death|0|||
16217736|NCT01183104|39276044|FG001|Overall Study|Death|1|||
16217737|NCT01183104|39276043|FG000|Overall Study|Lost to Follow-up|14|||
16217738|NCT01183104|39276044|FG001|Overall Study|Lost to Follow-up|7|||
16217739|NCT01183104|39276043|FG000|Overall Study|Physician Decision|5|||
16217740|NCT01183104|39276044|FG001|Overall Study|Physician Decision|8|||
16217741|NCT01183104|39276043|FG000|Overall Study|Withdrawal by Subject|6|||
16217742|NCT01183104|39276044|FG001|Overall Study|Withdrawal by Subject|11|||
16217743|NCT01183104|39276043|FG000|Overall Study|Nonparticipation in Extension Study|39|||
16217744|NCT01183104|39276044|FG001|Overall Study|Nonparticipation in Extension Study|50|||
16217745|NCT01183104|39276043|FG000|Overall Study|Did not receive study drug|5|||
16217746|NCT01183104|39276044|FG001|Overall Study|Did not receive study drug|9|||
16217747|NCT03595176|39276053|FG000|Overall Study|Death|0|||
16217748|NCT03595176|39276054|FG001|Overall Study|Death|2|||
16217749|NCT03595176|39276053|FG000|Overall Study|Lost to Follow-up|0|||
16217750|NCT03595176|39276054|FG001|Overall Study|Lost to Follow-up|1|||
16217751|NCT03227692|39276055|FG000|Overall Study|Protocol Violation|1|||
16217752|NCT03227692|39276056|FG001|Overall Study|Protocol Violation|1|||
16217753|NCT03227692|39276055|FG000|Overall Study|Lost to Follow-up|4|||
16217754|NCT03227692|39276056|FG001|Overall Study|Lost to Follow-up|2|||
16217755|NCT03227692|39276055|FG000|Overall Study|Adverse Event|0|||
16217756|NCT03227692|39276056|FG001|Overall Study|Adverse Event|2|||
16217757|NCT02607865|39276057|FG000|Overall Study|Lost to Follow-up|9|||
16217758|NCT02607865|39276058|FG001|Overall Study|Lost to Follow-up|7|||
16217759|NCT02607865|39276059|FG002|Overall Study|Lost to Follow-up|7|||
16217760|NCT02607865|39276060|FG003|Overall Study|Lost to Follow-up|5|||
16217761|NCT02607865|39276057|FG000|Overall Study|Withdrawal by Subject|18|||
16217762|NCT02607865|39276058|FG001|Overall Study|Withdrawal by Subject|18|||
16217763|NCT02607865|39276059|FG002|Overall Study|Withdrawal by Subject|17|||
16217764|NCT02607865|39276060|FG003|Overall Study|Withdrawal by Subject|8|||
16217765|NCT02607865|39276057|FG000|Overall Study|Death|5|||
16217766|NCT02607865|39276058|FG001|Overall Study|Death|4|||
16217767|NCT02607865|39276059|FG002|Overall Study|Death|1|||
16217768|NCT02607865|39276060|FG003|Overall Study|Death|3|||
16217769|NCT02607865|39276057|FG000|Overall Study|Unclassified|1|||
16217770|NCT02607865|39276058|FG001|Overall Study|Unclassified|1|||
16217771|NCT02607865|39276059|FG002|Overall Study|Unclassified|2|||
16217772|NCT02607865|39276060|FG003|Overall Study|Unclassified|0|||
16217773|NCT00718887|39276061|FG000|Overall Study|Withdrawal by Subject|3|||
16217774|NCT00718887|39276062|FG001|Overall Study|Withdrawal by Subject|2|||
16217775|NCT00718887|39276061|FG000|Overall Study|Not identified|2|||
16217776|NCT00718887|39276062|FG001|Overall Study|Not identified|7|||
16217777|NCT02309372|39276063|FG000|Overall Study|Lost to Follow-up|3|||
16217778|NCT02309372|39276064|FG001|Overall Study|Lost to Follow-up|2|||
16217779|NCT02828644|39276065|FG000|Overall Study|Lost to Follow-up|23|||
16217780|NCT02828644|39276066|FG001|Overall Study|Lost to Follow-up|22|||
16217781|NCT00911144|39276069|FG000|Overall Study|Withdrawal by Subject|16|||
16217782|NCT00911144|39276070|FG001|Overall Study|Withdrawal by Subject|5|||
16217783|NCT02140762|39276071|FG000|Overall Study|Adverse Event|1|||
16217784|NCT02140762|39276072|FG001|Overall Study|Adverse Event|1|||
16217785|NCT02140762|39276071|FG000|Overall Study|Lost to Follow-up|9|||
16217786|NCT02140762|39276072|FG001|Overall Study|Lost to Follow-up|5|||
16217787|NCT02140762|39276071|FG000|Overall Study|Protocol Violation|1|||
16217788|NCT02140762|39276072|FG001|Overall Study|Protocol Violation|1|||
16217789|NCT02140762|39276071|FG000|Overall Study|Withdrawal by Subject|6|||
16217790|NCT02140762|39276072|FG001|Overall Study|Withdrawal by Subject|4|||
16217791|NCT02140762|39276071|FG000|Overall Study|Other|0|||
16217792|NCT02140762|39276072|FG001|Overall Study|Other|1|||
16217793|NCT05466240|39276075|FG000|Overall Study|Adverse Event|1|||
16217794|NCT05466240|39276076|FG001|Overall Study|Adverse Event|0|||
16217795|NCT05466240|39276075|FG000|Overall Study|Withdrawal by Subject|1|||
16217796|NCT05466240|39276076|FG001|Overall Study|Withdrawal by Subject|0|||
16217797|NCT00584987|39276079|FG000|Overall Study|Protocol Violation|1|||
16217798|NCT00584987|39276080|FG001|Overall Study|Protocol Violation|1|||
16217799|NCT00584987|39276081|FG002|Overall Study|Protocol Violation|1|||
16217800|NCT00584987|39276082|FG003|Overall Study|Protocol Violation|0|||
16217801|NCT00584987|39276079|FG000|Overall Study|Adverse Event|0|||
16217802|NCT00584987|39276080|FG001|Overall Study|Adverse Event|0|||
16217803|NCT00584987|39276081|FG002|Overall Study|Adverse Event|0|||
16217804|NCT00584987|39276082|FG003|Overall Study|Adverse Event|1|||
16217805|NCT01536418|39276087|FG000|Overall Study|Protocol Violation|2|||
16217806|NCT01536418|39276088|FG001|Overall Study|Protocol Violation|3|||
16217807|NCT01536418|39276087|FG000|Overall Study|Physician Decision|1|||
16217808|NCT01536418|39276088|FG001|Overall Study|Physician Decision|3|||
16217809|NCT01536418|39276087|FG000|Overall Study|Study closed/terminated|41|||
16217810|NCT01536418|39276088|FG001|Overall Study|Study closed/terminated|37|||
16217811|NCT01536418|39276087|FG000|Overall Study|Lack of Efficacy|10|||
16217812|NCT01536418|39276088|FG001|Overall Study|Lack of Efficacy|16|||
16217813|NCT01536418|39276087|FG000|Overall Study|Adverse Event|9|||
16217814|NCT01536418|39276088|FG001|Overall Study|Adverse Event|4|||
16217815|NCT01536418|39276087|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
16217816|NCT01536418|39276088|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
16217817|NCT01536418|39276087|FG000|Overall Study|Withdrawal by Subject|5|||
16217818|NCT01536418|39276088|FG001|Overall Study|Withdrawal by Subject|3|||
16217819|NCT03462030|39276089|FG000|Overall Study|Withdrawal by Subject|1|||
16217820|NCT03462030|39276090|FG001|Overall Study|Withdrawal by Subject|1|||
16217821|NCT03196973|39276091|FG000|Overall Study|Adverse Event|1|||
16217822|NCT03196973|39276092|FG001|Overall Study|Adverse Event|1|||
16217823|NCT03196973|39276093|FG002|Overall Study|Adverse Event|2|||
16217824|NCT03196973|39276091|FG000|Overall Study|Lack of Efficacy|2|||
16217825|NCT03196973|39276092|FG001|Overall Study|Lack of Efficacy|6|||
16217826|NCT03196973|39276093|FG002|Overall Study|Lack of Efficacy|1|||
16217827|NCT03196973|39276091|FG000|Overall Study|Lost to Follow-up|4|||
16217828|NCT03196973|39276092|FG001|Overall Study|Lost to Follow-up|3|||
16217829|NCT03196973|39276093|FG002|Overall Study|Lost to Follow-up|2|||
16217830|NCT03196973|39276091|FG000|Overall Study|Consent withdrawn|2|||
16217831|NCT03196973|39276092|FG001|Overall Study|Consent withdrawn|1|||
16217832|NCT03196973|39276093|FG002|Overall Study|Consent withdrawn|0|||
16217833|NCT03196973|39276091|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
16217834|NCT03196973|39276092|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
16217835|NCT03196973|39276093|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
16217836|NCT01263470|39276096|FG000|Overall Study|Adverse Event|2|||
16217837|NCT01263470|39276097|FG001|Overall Study|Adverse Event|2|||
16217838|NCT01263470|39276098|FG002|Overall Study|Adverse Event|1|||
16217839|NCT01263470|39276099|FG003|Overall Study|Adverse Event|1|||
16217840|NCT01263470|39276100|FG004|Overall Study|Adverse Event|2|||
16217841|NCT01263470|39276101|FG005|Overall Study|Adverse Event|2|||
16217842|NCT01263470|39276096|FG000|Overall Study|Protocol Violation|0|||
16217843|NCT01263470|39276097|FG001|Overall Study|Protocol Violation|1|||
16217844|NCT01263470|39276098|FG002|Overall Study|Protocol Violation|0|||
16217845|NCT01263470|39276099|FG003|Overall Study|Protocol Violation|0|||
16217846|NCT01263470|39276100|FG004|Overall Study|Protocol Violation|0|||
16217847|NCT01263470|39276101|FG005|Overall Study|Protocol Violation|1|||
16217848|NCT01263470|39276096|FG000|Overall Study|Withdrawal by Subject|0|||
16217849|NCT01263470|39276097|FG001|Overall Study|Withdrawal by Subject|1|||
16217850|NCT01263470|39276098|FG002|Overall Study|Withdrawal by Subject|1|||
16217851|NCT01263470|39276099|FG003|Overall Study|Withdrawal by Subject|2|||
16217852|NCT01263470|39276100|FG004|Overall Study|Withdrawal by Subject|0|||
16217853|NCT01263470|39276101|FG005|Overall Study|Withdrawal by Subject|2|||
16217854|NCT01263470|39276096|FG000|Overall Study|Lack of Efficacy|0|||
16217855|NCT01263470|39276097|FG001|Overall Study|Lack of Efficacy|0|||
16217856|NCT01263470|39276098|FG002|Overall Study|Lack of Efficacy|2|||
16217857|NCT01263470|39276099|FG003|Overall Study|Lack of Efficacy|0|||
16217858|NCT01263470|39276100|FG004|Overall Study|Lack of Efficacy|0|||
16217859|NCT01263470|39276101|FG005|Overall Study|Lack of Efficacy|0|||
16217860|NCT01263470|39276096|FG000|Overall Study|Participant Unavailability|0|||
16217861|NCT01263470|39276097|FG001|Overall Study|Participant Unavailability|1|||
16217862|NCT01263470|39276098|FG002|Overall Study|Participant Unavailability|0|||
16217863|NCT01263470|39276099|FG003|Overall Study|Participant Unavailability|0|||
16217864|NCT01263470|39276100|FG004|Overall Study|Participant Unavailability|0|||
16217865|NCT01263470|39276101|FG005|Overall Study|Participant Unavailability|0|||
16217866|NCT01263470|39276096|FG000|Overall Study|Study Drug Non-compliance|0|||
16217867|NCT01263470|39276097|FG001|Overall Study|Study Drug Non-compliance|0|||
16217868|NCT01263470|39276098|FG002|Overall Study|Study Drug Non-compliance|0|||
16217869|NCT01263470|39276099|FG003|Overall Study|Study Drug Non-compliance|0|||
16217870|NCT01263470|39276100|FG004|Overall Study|Study Drug Non-compliance|1|||
16217871|NCT01263470|39276101|FG005|Overall Study|Study Drug Non-compliance|0|||
16217872|NCT02516306|39276103|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
16217873|NCT02516306|39276104|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
16217874|NCT01625611|39276106|FG000|Overall Study|No adlib drinks Lab 1|3|||
16217875|NCT01625611|39276107|FG001|Overall Study|No adlib drinks Lab 1|0|||
16217876|NCT01625611|39276106|FG000|Overall Study|Technical issues with PET|1|||
16217877|NCT01625611|39276107|FG001|Overall Study|Technical issues with PET|0|||
16217878|NCT01625611|39276106|FG000|Overall Study|Unable to complete study procedures|1|||
16217879|NCT01625611|39276107|FG001|Overall Study|Unable to complete study procedures|0|||
16217880|NCT01625611|39276106|FG000|Overall Study|Withdrawal by Subject|3|||
16217881|NCT01625611|39276107|FG001|Overall Study|Withdrawal by Subject|0|||
16217882|NCT00089505|39278581|FG000|Overall Study|Death|4|||
16217883|NCT00089505|39278582|FG001|Overall Study|Death|1|||
16217884|NCT00089505|39278583|FG002|Overall Study|Death|5|||
16217885|NCT00089505|39278584|FG003|Overall Study|Death|8|||
16217886|NCT00089505|39278581|FG000|Overall Study|Withdrawal by Subject|3|||
16217887|NCT00089505|39278582|FG001|Overall Study|Withdrawal by Subject|0|||
16217888|NCT00089505|39278583|FG002|Overall Study|Withdrawal by Subject|6|||
16217889|NCT00089505|39278584|FG003|Overall Study|Withdrawal by Subject|6|||
16217890|NCT00089505|39278581|FG000|Overall Study|Lost to Follow-up|1|||
16217891|NCT00089505|39278582|FG001|Overall Study|Lost to Follow-up|1|||
16217892|NCT00089505|39278583|FG002|Overall Study|Lost to Follow-up|9|||
16217893|NCT00089505|39278584|FG003|Overall Study|Lost to Follow-up|7|||
16217894|NCT00089505|39278581|FG000|Overall Study|Physician Decision|1|||
16217895|NCT00089505|39278582|FG001|Overall Study|Physician Decision|0|||
16217896|NCT00089505|39278583|FG002|Overall Study|Physician Decision|0|||
16217897|NCT00089505|39278584|FG003|Overall Study|Physician Decision|0|||
16217898|NCT00089505|39278581|FG000|Overall Study|Protocol Violation|0|||
16217899|NCT00089505|39278582|FG001|Overall Study|Protocol Violation|0|||
16217900|NCT00089505|39278583|FG002|Overall Study|Protocol Violation|1|||
16217901|NCT00089505|39278584|FG003|Overall Study|Protocol Violation|0|||
16217902|NCT03395704|39278585|FG000|Overall Study|Adverse Event|2|||
16217903|NCT03395704|39278586|FG001|Overall Study|Adverse Event|1|||
16217904|NCT03395704|39278585|FG000|Overall Study|Withdrawal by Subject|2|||
16217905|NCT03395704|39278586|FG001|Overall Study|Withdrawal by Subject|1|||
16217906|NCT03395704|39278585|FG000|Overall Study|Physician Decision|0|||
16217907|NCT03395704|39278586|FG001|Overall Study|Physician Decision|1|||
16217908|NCT03147495|39278595|FG000|Overall Study|Physician Decision|0|||
16217909|NCT03147495|39278596|FG001|Overall Study|Physician Decision|6|||
16217910|NCT00397631|39278600|FG000|Overall Study|Adverse Event|5|||
16217911|NCT00397631|39278601|FG001|Overall Study|Adverse Event|6|||
16217912|NCT00397631|39278600|FG000|Overall Study|Lack of Efficacy|7|||
16217913|NCT00397631|39278601|FG001|Overall Study|Lack of Efficacy|10|||
16217914|NCT00397631|39278600|FG000|Overall Study|Lost to Follow-up|8|||
16217915|NCT00397631|39278601|FG001|Overall Study|Lost to Follow-up|9|||
16217916|NCT00397631|39278600|FG000|Overall Study|Physician Decision|2|||
16217917|NCT00397631|39278601|FG001|Overall Study|Physician Decision|0|||
16217918|NCT00397631|39278600|FG000|Overall Study|Protocol Violation|0|||
16217919|NCT00397631|39278601|FG001|Overall Study|Protocol Violation|1|||
16217920|NCT00397631|39278600|FG000|Overall Study|Withdrawal by Subject|7|||
16217921|NCT00397631|39278601|FG001|Overall Study|Withdrawal by Subject|14|||
16217922|NCT00397631|39278600|FG000|Overall Study|protocol discontinuation criteria|1|||
16217923|NCT00397631|39278601|FG001|Overall Study|protocol discontinuation criteria|4|||
16217924|NCT02559115|39278603|FG000|Overall Study|Withdrawal by Subject|3|||
16217925|NCT04109066|39278604|FG000|Pre-treatment|Participant withdrew consent|2|||
16217926|NCT04109066|39278605|FG001|Pre-treatment|Participant withdrew consent|0|||
16217927|NCT04109066|39278604|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
16217928|NCT04109066|39278605|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
16217929|NCT04109066|39278604|FG000|Treatment|Lack of Efficacy|2|||
16217930|NCT04109066|39278605|FG001|Treatment|Lack of Efficacy|3|||
16217931|NCT04109066|39278604|FG000|Treatment|Adverse Event|19|||
16217932|NCT04109066|39278605|FG001|Treatment|Adverse Event|6|||
16217933|NCT04109066|39278604|FG000|Treatment|Participant request to discontinue Study treatment|12|||
16217934|NCT04109066|39278605|FG001|Treatment|Participant request to discontinue Study treatment|14|||
16217935|NCT04109066|39278604|FG000|Treatment|Withdrawal by Subject|7|||
16217936|NCT04109066|39278605|FG001|Treatment|Withdrawal by Subject|8|||
16217937|NCT04109066|39278604|FG000|Treatment|Death|3|||
16217938|NCT04109066|39278605|FG001|Treatment|Death|0|||
16217939|NCT04109066|39278604|FG000|Treatment|Participant no longer meets study criteria|3|||
16217940|NCT04109066|39278605|FG001|Treatment|Participant no longer meets study criteria|1|||
16217941|NCT04109066|39278604|FG000|Treatment|Administrative reasons by sponsor|2|||
16217942|NCT04109066|39278605|FG001|Treatment|Administrative reasons by sponsor|3|||
16217943|NCT04109066|39278604|FG000|Treatment|Other reasons|17|||
16217944|NCT04109066|39278605|FG001|Treatment|Other reasons|23|||
16217945|NCT04109066|39278604|FG000|Treatment|Disease Progression|4|||
16217946|NCT04109066|39278605|FG001|Treatment|Disease Progression|7|||
16217947|NCT04109066|39278604|FG000|Treatment|Study drug toxicity|13|||
16217948|NCT04109066|39278605|FG001|Treatment|Study drug toxicity|5|||
16217949|NCT04109066|39278604|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
16217950|NCT04109066|39278605|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
16217951|NCT04109066|39278604|FG000|Treatment|Disease Recurrence|0|||
16217952|NCT04109066|39278605|FG001|Treatment|Disease Recurrence|2|||
16217953|NCT04109066|39278604|FG000|Treatment|Not reported|6|||
16217954|NCT04109066|39278605|FG001|Treatment|Not reported|8|||
16217955|NCT04109066|39278604|FG000|Treatment|On-going treatment|48|||
16217956|NCT04109066|39278605|FG001|Treatment|On-going treatment|52|||
16217957|NCT03049852|39278606|FG000|Overall Study|Lost to Follow-up|0|||
16106047|NCT02108652|38875424|FG000|Overall Study|Withdrawal by Subject|16|||
16106048|NCT02108652|38875424|FG000|Overall Study|Study Terminated By Sponsor|31|||
16106049|NCT02108652|38875424|FG000|Overall Study|Non-Compliance|1|||
16106050|NCT02108652|38875424|FG000|Overall Study|Physician Decision|6|||
16217958|NCT03049852|39278607|FG001|Overall Study|Lost to Follow-up|1|||
16217959|NCT03049852|39278608|FG002|Overall Study|Lost to Follow-up|0|||
16217960|NCT01156012|39278609|FG000|Overall Study|Adverse Event|3|||
16217961|NCT01156012|39278610|FG001|Overall Study|Adverse Event|1|||
16217962|NCT01156012|39278609|FG000|Overall Study|Lost to Follow-up|1|||
16217963|NCT01156012|39278610|FG001|Overall Study|Lost to Follow-up|0|||
16217964|NCT01156012|39278609|FG000|Overall Study|Withdrawal by Subject|1|||
16217965|NCT01156012|39278610|FG001|Overall Study|Withdrawal by Subject|0|||
16217966|NCT01156012|39278609|FG000|Overall Study|use of commercial drug instead of study|0|||
16217967|NCT01156012|39278610|FG001|Overall Study|use of commercial drug instead of study|1|||
16217968|NCT01156012|39278609|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
16217969|NCT01156012|39278610|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
16217970|NCT01981096|39278611|FG000|Overall Study|Parent illness|1|||
16217971|NCT01981096|39278612|FG001|Overall Study|Parent illness|0|||
16217972|NCT01981096|39278611|FG000|Overall Study|Withdrawal by Subject|0|||
16217973|NCT01981096|39278612|FG001|Overall Study|Withdrawal by Subject|1|||
16217974|NCT01981096|39278611|FG000|Overall Study|Lost to Follow-up|2|||
16217975|NCT01981096|39278612|FG001|Overall Study|Lost to Follow-up|0|||
16217976|NCT01875731|39278615|FG000|Overall Study|Fail to obtain lab sample|1|||
16217977|NCT01875731|39278616|FG001|Overall Study|Fail to obtain lab sample|0|||
16217978|NCT03267511|39278617|FG000|Overall Study|Lost to Follow-up|0|||
16540457|NCT00558064|40440029|FG000|Overall Study|Lack of Efficacy|0|||
16540458|NCT00558064|40440030|FG001|Overall Study|Lack of Efficacy|1|||
16540459|NCT00558064|40440029|FG000|Overall Study|Protocol Violation|1|||
16540460|NCT00558064|40440030|FG001|Overall Study|Protocol Violation|0|||
16540461|NCT00558064|40440029|FG000|Overall Study|Lost to Follow-up|0|||
16540462|NCT00558064|40440030|FG001|Overall Study|Lost to Follow-up|1|||
16540463|NCT00558064|40440029|FG000|Overall Study|Withdrawal by Subject|0|||
16540464|NCT00558064|40440030|FG001|Overall Study|Withdrawal by Subject|1|||
16540465|NCT00558064|40440029|FG000|Overall Study|No visit within allowance period|1|||
16540466|NCT00558064|40440030|FG001|Overall Study|No visit within allowance period|0|||
16540467|NCT03703466|40440031|FG000|Overall Study|Death|2|||
16540468|NCT03703466|40440032|FG001|Overall Study|Death|1|||
16540469|NCT03703466|40440033|FG002|Overall Study|Death|0|||
16540470|NCT03703466|40440031|FG000|Overall Study|Withdrawal by Subject|0|||
16540471|NCT03703466|40440032|FG001|Overall Study|Withdrawal by Subject|3|||
16540472|NCT03703466|40440033|FG002|Overall Study|Withdrawal by Subject|0|||
16540473|NCT03703466|40440031|FG000|Overall Study|Completed < 3 Cycles|2|||
16540474|NCT03703466|40440032|FG001|Overall Study|Completed < 3 Cycles|2|||
16540475|NCT03703466|40440033|FG002|Overall Study|Completed < 3 Cycles|2|||
16540476|NCT00999466|40440034|FG000|Main Part|Withdrawal by Subject|0|||
16540477|NCT00999466|40440035|FG001|Main Part|Withdrawal by Subject|0|||
16540478|NCT00999466|40440036|FG002|Main Part|Withdrawal by Subject|2|||
16540479|NCT00999466|40440034|FG000|Main Part|Adverse Event|0|||
16540480|NCT00999466|40440035|FG001|Main Part|Adverse Event|4|||
16540481|NCT00999466|40440036|FG002|Main Part|Adverse Event|2|||
16540482|NCT01040260|40440037|FG000|Overall Study|Withdrawal by Subject|12|||
16540483|NCT01040260|40440038|FG001|Overall Study|Withdrawal by Subject|6|||
16540484|NCT01040260|40440037|FG000|Overall Study|Lost to Follow-up|3|||
16540485|NCT01040260|40440038|FG001|Overall Study|Lost to Follow-up|5|||
16106051|NCT02108652|38875424|FG000|Overall Study|Progression Of Disease|1|||
16217979|NCT03267511|39278618|FG001|Overall Study|Lost to Follow-up|0|||
16217980|NCT03267511|39278619|FG002|Overall Study|Lost to Follow-up|0|||
16217981|NCT03267511|39278620|FG003|Overall Study|Lost to Follow-up|1|||
16217982|NCT00661362|39278623|FG000|Overall Study|Adverse Event|5|||
16217983|NCT00661362|39278624|FG001|Overall Study|Adverse Event|4|||
16217984|NCT00661362|39278623|FG000|Overall Study|Incorrect enrollment|2|||
16217985|NCT00661362|39278624|FG001|Overall Study|Incorrect enrollment|0|||
16217986|NCT00661362|39278623|FG000|Overall Study|Study specific discontinuation criteria|4|||
16217987|NCT00661362|39278624|FG001|Overall Study|Study specific discontinuation criteria|11|||
16217988|NCT00661362|39278623|FG000|Overall Study|Withdrawal by Subject|13|||
16540486|NCT02626780|40440040|FG000|Overall Study|Withdrawal by Subject|3|||
16540487|NCT03395405|40440041|FG000|Overall Study|Death|0|||
16106052|NCT00706914|38875427|FG000|Overall Study|Lack of Efficacy|0|||
16217989|NCT00661362|39278624|FG001|Overall Study|Withdrawal by Subject|23|||
16217990|NCT00661362|39278623|FG000|Overall Study|Lost to Follow-up|3|||
16217991|NCT00661362|39278624|FG001|Overall Study|Lost to Follow-up|1|||
16540488|NCT03395405|40440042|FG001|Overall Study|Death|2|||
16540489|NCT03395405|40440041|FG000|Overall Study|Lost to Follow-up|0|||
16106053|NCT00706914|38875428|FG001|Overall Study|Lack of Efficacy|1|||
16217992|NCT00661362|39278623|FG000|Overall Study|Severe non-compliance to protocol|0|||
16540490|NCT03395405|40440042|FG001|Overall Study|Lost to Follow-up|1|||
16540491|NCT03395405|40440041|FG000|Overall Study|Protocol Violation|0|||
16217993|NCT00661362|39278624|FG001|Overall Study|Severe non-compliance to protocol|1|||
16217994|NCT00661362|39278623|FG000|Overall Study|Safety reasons|1|||
16217995|NCT00661362|39278624|FG001|Overall Study|Safety reasons|0|||
16106054|NCT00706914|38875429|FG002|Overall Study|Lack of Efficacy|0|||
16106055|NCT00706914|38875427|FG000|Overall Study|Lost to Follow-up|1|||
16106056|NCT00706914|38875428|FG001|Overall Study|Lost to Follow-up|0|||
16106057|NCT00706914|38875429|FG002|Overall Study|Lost to Follow-up|0|||
16217996|NCT00661362|39278623|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
16217997|NCT00661362|39278624|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
16217998|NCT01058395|39278630|FG000|Overall Study|Death|2|||
16217999|NCT01058395|39278631|FG001|Overall Study|Death|1|||
16218000|NCT01058395|39278630|FG000|Overall Study|Lost to Follow-up|1|||
16106058|NCT00706914|38875427|FG000|Overall Study|Adverse Event|2|||
16106059|NCT00706914|38875428|FG001|Overall Study|Adverse Event|2|||
16106060|NCT00706914|38875429|FG002|Overall Study|Adverse Event|0|||
16106061|NCT00706914|38875427|FG000|Overall Study|Protocol Violation|3|||
16218001|NCT01058395|39278631|FG001|Overall Study|Lost to Follow-up|0|||
16218002|NCT05060003|39278632|FG000|Overall Study|ctDNA negative|7|||
16218003|NCT03289676|39278633|FG000|Overall Study|Withdrawal by Subject|2|||
16218004|NCT03289676|39278634|FG001|Overall Study|Withdrawal by Subject|0|||
16218005|NCT03289676|39278633|FG000|Overall Study|Protocol Violation|2|||
16218006|NCT03289676|39278634|FG001|Overall Study|Protocol Violation|0|||
16218007|NCT03289676|39278633|FG000|Overall Study|Lost to Follow-up|0|||
16218008|NCT03289676|39278634|FG001|Overall Study|Lost to Follow-up|1|||
16218009|NCT01535638|39278635|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
16218010|NCT01535638|39278636|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
16218011|NCT01535638|39278637|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
16218012|NCT01535638|39278638|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
16218013|NCT01535638|39278639|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
16218014|NCT01535638|39278640|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
16218015|NCT01535638|39278635|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
16218016|NCT01535638|39278636|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
16218017|NCT01535638|39278637|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
16218018|NCT01535638|39278638|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
16218019|NCT01535638|39278639|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
16218020|NCT01535638|39278640|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
16218021|NCT02274766|39278643|FG000|Overall Study|Withdrawal by Subject|3|||
16218022|NCT02274766|39278644|FG001|Overall Study|Withdrawal by Subject|6|||
16218023|NCT02274766|39278643|FG000|Overall Study|Did Not Receive Study Drug|1|||
16218024|NCT02274766|39278644|FG001|Overall Study|Did Not Receive Study Drug|1|||
16218025|NCT02274766|39278643|FG000|Overall Study|Subject Unwilling to Proceed|0|||
16218026|NCT02274766|39278644|FG001|Overall Study|Subject Unwilling to Proceed|1|||
16218027|NCT02274766|39278643|FG000|Overall Study|Adverse Event|0|||
16218028|NCT02274766|39278644|FG001|Overall Study|Adverse Event|1|||
16218029|NCT00606931|39278649|FG000|Overall Study|Withdrawal by Subject|3|||
16106062|NCT00706914|38875428|FG001|Overall Study|Protocol Violation|1|||
16106063|NCT00706914|38875429|FG002|Overall Study|Protocol Violation|1|||
16106064|NCT03681353|38875434|FG000|Overall Study|Lost to Follow-up|2|||
16106065|NCT03681353|38875434|FG000|Overall Study|Withdrawal by Subject|3|||
16106066|NCT03681353|38875434|FG000|Overall Study|withdrawn by PI|2|||
16106067|NCT00496626|38875438|FG000|Overall Study|Lost to Follow-up|0|||
16106068|NCT00496626|38875439|FG001|Overall Study|Lost to Follow-up|1|||
16106069|NCT00496626|38875438|FG000|Overall Study|Protocol Violation|1|||
16106070|NCT00496626|38875439|FG001|Overall Study|Protocol Violation|0|||
16106071|NCT00496626|38875438|FG000|Overall Study|Withdrawal by Subject|5|||
16106072|NCT00496626|38875439|FG001|Overall Study|Withdrawal by Subject|4|||
16106073|NCT00496626|38875438|FG000|Overall Study|Relocated|0|||
16106074|NCT00496626|38875439|FG001|Overall Study|Relocated|1|||
16106075|NCT00523549|38875440|FG000|Overall Study|Adverse Event|6|||
16106076|NCT00523549|38875441|FG001|Overall Study|Adverse Event|3|||
16106077|NCT00523549|38875440|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16106078|NCT00523549|38875441|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16106079|NCT00523549|38875440|FG000|Overall Study|Protocol Deviation|3|||
16106080|NCT00523549|38875441|FG001|Overall Study|Protocol Deviation|1|||
16106081|NCT00523549|38875440|FG000|Overall Study|Patient withdrew consent|7|||
16218030|NCT00631969|39278660|FG000|Overall Study|Adverse Event|3|||
16540492|NCT03395405|40440042|FG001|Overall Study|Protocol Violation|1|||
16106082|NCT00523549|38875441|FG001|Overall Study|Patient withdrew consent|6|||
16106083|NCT00523549|38875440|FG000|Overall Study|Lost to Follow-up|3|||
16106084|NCT00523549|38875441|FG001|Overall Study|Lost to Follow-up|5|||
16540493|NCT03395405|40440041|FG000|Overall Study|Withdrawal by Subject|3|||
16106085|NCT01101997|38875442|FG000|Overall Study|Withdrawal by Subject|2|||
16106086|NCT00560313|38875452|FG000|Overall Study|Adverse Events or Death|2|||
16106087|NCT00560313|38875452|FG000|Overall Study|Withdrawal by Subject|2|||
16106088|NCT00560313|38875452|FG000|Overall Study|Lost to Follow-up|1|||
16106089|NCT00560313|38875452|FG000|Overall Study|Protocol Violation|1|||
16106090|NCT00619983|38875453|FG000|Test Drug Alone|Withdrawal by Subject|1|||
16106091|NCT00619983|38875454|FG001|Test Drug Alone|Withdrawal by Subject|0|||
16106092|NCT00619983|38875455|FG002|Test Drug Alone|Withdrawal by Subject|0|||
16106093|NCT00619983|38875456|FG003|Test Drug Alone|Withdrawal by Subject|1|||
16106094|NCT00619983|38875453|FG000|Test Drug Alone|Failure of daily diary device|1|||
16106095|NCT00619983|38875454|FG001|Test Drug Alone|Failure of daily diary device|1|||
16106096|NCT00619983|38875455|FG002|Test Drug Alone|Failure of daily diary device|2|||
16106097|NCT00619983|38875456|FG003|Test Drug Alone|Failure of daily diary device|2|||
16106098|NCT02330562|38875465|FG000|Overall Study|Adverse Event|0|||
16106099|NCT02330562|38875466|FG001|Overall Study|Adverse Event|0|||
16106100|NCT02330562|38875467|FG002|Overall Study|Adverse Event|3|||
16106101|NCT02330562|38875468|FG003|Overall Study|Adverse Event|0|||
16106102|NCT02330562|38875469|FG004|Overall Study|Adverse Event|3|||
16218031|NCT00631969|39278661|FG001|Overall Study|Adverse Event|1|||
16218032|NCT00631969|39278660|FG000|Overall Study|Lack of Efficacy|2|||
16218033|NCT00631969|39278661|FG001|Overall Study|Lack of Efficacy|8|||
16106103|NCT02330562|38875470|FG005|Overall Study|Adverse Event|1|||
16106104|NCT02330562|38875471|FG006|Overall Study|Adverse Event|0|||
16106105|NCT02330562|38875472|FG007|Overall Study|Adverse Event|0|||
16106106|NCT02330562|38875473|FG008|Overall Study|Adverse Event|0|||
16106107|NCT02330562|38875474|FG009|Overall Study|Adverse Event|1|||
16106108|NCT02330562|38875475|FG010|Overall Study|Adverse Event|1|||
16106109|NCT02330562|38875465|FG000|Overall Study|Participant decision|1|||
16106110|NCT02330562|38875466|FG001|Overall Study|Participant decision|0|||
16106111|NCT02330562|38875467|FG002|Overall Study|Participant decision|4|||
16106112|NCT02330562|38875468|FG003|Overall Study|Participant decision|1|||
16106113|NCT02330562|38875469|FG004|Overall Study|Participant decision|5|||
16106114|NCT02330562|38875470|FG005|Overall Study|Participant decision|2|||
16106115|NCT02330562|38875471|FG006|Overall Study|Participant decision|0|||
16106116|NCT02330562|38875472|FG007|Overall Study|Participant decision|0|||
16106117|NCT02330562|38875473|FG008|Overall Study|Participant decision|0|||
16106118|NCT02330562|38875474|FG009|Overall Study|Participant decision|3|||
16106119|NCT02330562|38875475|FG010|Overall Study|Participant decision|0|||
16106120|NCT02330562|38875465|FG000|Overall Study|Disease progression|5|||
16106121|NCT02330562|38875466|FG001|Overall Study|Disease progression|3|||
16106122|NCT02330562|38875467|FG002|Overall Study|Disease progression|20|||
16106123|NCT02330562|38875468|FG003|Overall Study|Disease progression|28|||
16106124|NCT02330562|38875469|FG004|Overall Study|Disease progression|23|||
16106125|NCT02330562|38875470|FG005|Overall Study|Disease progression|7|||
16218034|NCT00631969|39278660|FG000|Overall Study|Lost to Follow-up|2|||
16218035|NCT00631969|39278661|FG001|Overall Study|Lost to Follow-up|1|||
16218036|NCT00631969|39278660|FG000|Overall Study|Protocol Violation|1|||
16218037|NCT00631969|39278661|FG001|Overall Study|Protocol Violation|1|||
16218038|NCT00631969|39278660|FG000|Overall Study|Consent Withdrawn|5|||
16218039|NCT00631969|39278661|FG001|Overall Study|Consent Withdrawn|7|||
16218040|NCT00631969|39278660|FG000|Overall Study|Noncompliant With Study Medication|0|||
16218041|NCT00631969|39278661|FG001|Overall Study|Noncompliant With Study Medication|1|||
16218042|NCT00631969|39278660|FG000|Overall Study|No Drug Exposure|2|||
16106126|NCT02330562|38875471|FG006|Overall Study|Disease progression|1|||
16106127|NCT02330562|38875472|FG007|Overall Study|Disease progression|1|||
16106128|NCT02330562|38875473|FG008|Overall Study|Disease progression|1|||
16106129|NCT02330562|38875474|FG009|Overall Study|Disease progression|0|||
16106130|NCT02330562|38875475|FG010|Overall Study|Disease progression|5|||
16106131|NCT02330562|38875465|FG000|Overall Study|Other reasons|0|||
16106132|NCT02330562|38875466|FG001|Overall Study|Other reasons|0|||
16106133|NCT02330562|38875467|FG002|Overall Study|Other reasons|0|||
16106134|NCT02330562|38875468|FG003|Overall Study|Other reasons|1|||
16106135|NCT02330562|38875469|FG004|Overall Study|Other reasons|0|||
16106136|NCT02330562|38875470|FG005|Overall Study|Other reasons|0|||
16106137|NCT02330562|38875471|FG006|Overall Study|Other reasons|0|||
16106138|NCT02330562|38875472|FG007|Overall Study|Other reasons|0|||
16106139|NCT02330562|38875473|FG008|Overall Study|Other reasons|0|||
16106140|NCT02330562|38875474|FG009|Overall Study|Other reasons|0|||
16106141|NCT02330562|38875475|FG010|Overall Study|Other reasons|0|||
16106142|NCT02330562|38875465|FG000|Overall Study|Withdrawal by Subject|0|||
16106143|NCT02330562|38875466|FG001|Overall Study|Withdrawal by Subject|0|||
16106144|NCT02330562|38875467|FG002|Overall Study|Withdrawal by Subject|0|||
16106145|NCT02330562|38875468|FG003|Overall Study|Withdrawal by Subject|0|||
16106146|NCT02330562|38875469|FG004|Overall Study|Withdrawal by Subject|0|||
16106147|NCT02330562|38875470|FG005|Overall Study|Withdrawal by Subject|0|||
16106148|NCT02330562|38875471|FG006|Overall Study|Withdrawal by Subject|0|||
16218043|NCT00631969|39278661|FG001|Overall Study|No Drug Exposure|2|||
16218044|NCT00634751|39278662|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
16218045|NCT00634751|39278663|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
16218046|NCT00634751|39278664|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
16106149|NCT02330562|38875472|FG007|Overall Study|Withdrawal by Subject|0|||
16106150|NCT02330562|38875473|FG008|Overall Study|Withdrawal by Subject|0|||
16106151|NCT02330562|38875474|FG009|Overall Study|Withdrawal by Subject|1|||
16106152|NCT02330562|38875475|FG010|Overall Study|Withdrawal by Subject|0|||
16106153|NCT01037413|38875476|FG000|Part A: Skin Testing|Adverse Event|1|||
16106154|NCT01037413|38875477|FG001|Part A: Skin Testing|Adverse Event|0|||
16106155|NCT01037413|38875476|FG000|Part A: Skin Testing|Protocol Violation|1|||
16106156|NCT01037413|38875477|FG001|Part A: Skin Testing|Protocol Violation|0|||
16106157|NCT01037413|38875476|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
16106158|NCT01037413|38875477|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
16106159|NCT01037413|38875476|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
16106160|NCT01037413|38875477|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
16106161|NCT05239598|38875478|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
16106162|NCT05239598|38875479|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
16106163|NCT05239598|38875478|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
16218047|NCT00634751|39278665|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
16218048|NCT00634751|39278662|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
16218049|NCT00634751|39278663|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
16218050|NCT00634751|39278664|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
16218051|NCT00634751|39278665|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
16218052|NCT00634751|39278662|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
16218053|NCT00634751|39278663|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
16218054|NCT00634751|39278664|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
16218055|NCT00634751|39278665|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
16218056|NCT00086385|39278666|FG000|Overall Study|Death|2|||
16218057|NCT00086385|39278667|FG001|Overall Study|Death|2|||
16218058|NCT00086385|39278668|FG002|Overall Study|Death|1|||
16218059|NCT00086385|39278669|FG003|Overall Study|Death|1|||
16218060|NCT01693562|39278670|FG000|Escalation Phase|Withdrawal by Subject|0|||
16218061|NCT01693562|39278671|FG001|Escalation Phase|Withdrawal by Subject|1|||
16218062|NCT01693562|39278672|FG002|Escalation Phase|Withdrawal by Subject|0|||
16218063|NCT01693562|39278673|FG003|Escalation Phase|Withdrawal by Subject|0|||
16218064|NCT01693562|39278674|FG004|Escalation Phase|Withdrawal by Subject|0|||
16218065|NCT01693562|39278675|FG005|Escalation Phase|Withdrawal by Subject|2|||
16218066|NCT01693562|39278676|FG006|Escalation Phase|Withdrawal by Subject|0|||
16218067|NCT01693562|39278677|FG007|Escalation Phase|Withdrawal by Subject|0|||
16218068|NCT01693562|39278678|FG008|Escalation Phase|Withdrawal by Subject|0|||
16218069|NCT01693562|39278679|FG009|Escalation Phase|Withdrawal by Subject|0|||
16218070|NCT01693562|39278680|FG010|Escalation Phase|Withdrawal by Subject|0|||
16218071|NCT01693562|39278681|FG011|Escalation Phase|Withdrawal by Subject|0|||
16218072|NCT01693562|39278682|FG012|Escalation Phase|Withdrawal by Subject|0|||
16218073|NCT01693562|39278683|FG013|Escalation Phase|Withdrawal by Subject|0|||
16218074|NCT01693562|39278684|FG014|Escalation Phase|Withdrawal by Subject|0|||
16218075|NCT01693562|39278685|FG015|Escalation Phase|Withdrawal by Subject|0|||
16218076|NCT01693562|39278686|FG016|Escalation Phase|Withdrawal by Subject|0|||
16218077|NCT01693562|39278687|FG017|Escalation Phase|Withdrawal by Subject|0|||
16218078|NCT01693562|39278688|FG018|Escalation Phase|Withdrawal by Subject|0|||
16218079|NCT01693562|39278689|FG019|Escalation Phase|Withdrawal by Subject|0|||
16218080|NCT01693562|39278690|FG020|Escalation Phase|Withdrawal by Subject|0|||
16218081|NCT01693562|39278691|FG021|Escalation Phase|Withdrawal by Subject|0|||
16218082|NCT01693562|39278692|FG022|Escalation Phase|Withdrawal by Subject|0|||
16218083|NCT01693562|39278670|FG000|Escalation Phase|Death|4|||
16218084|NCT01693562|39278671|FG001|Escalation Phase|Death|2|||
16218085|NCT01693562|39278672|FG002|Escalation Phase|Death|0|||
16218086|NCT01693562|39278673|FG003|Escalation Phase|Death|3|||
16218087|NCT01693562|39278674|FG004|Escalation Phase|Death|6|||
16218088|NCT01693562|39278675|FG005|Escalation Phase|Death|4|||
16218089|NCT01693562|39278676|FG006|Escalation Phase|Death|0|||
16218090|NCT01693562|39278677|FG007|Escalation Phase|Death|0|||
16218091|NCT01693562|39278678|FG008|Escalation Phase|Death|0|||
16218092|NCT01693562|39278679|FG009|Escalation Phase|Death|0|||
16218093|NCT01693562|39278680|FG010|Escalation Phase|Death|0|||
16340641|NCT01358578|39734396|FG002|Maintenance Period|Non-compliance with study treatment|0|||
16218094|NCT01693562|39278681|FG011|Escalation Phase|Death|0|||
16218095|NCT01693562|39278682|FG012|Escalation Phase|Death|0|||
16218096|NCT01693562|39278683|FG013|Escalation Phase|Death|0|||
16218097|NCT01693562|39278684|FG014|Escalation Phase|Death|0|||
16218098|NCT01693562|39278685|FG015|Escalation Phase|Death|0|||
16340642|NCT01358578|39734397|FG003|Maintenance Period|Non-compliance with study treatment|2|||
16218099|NCT01693562|39278686|FG016|Escalation Phase|Death|0|||
16218100|NCT01693562|39278687|FG017|Escalation Phase|Death|0|||
16106164|NCT05239598|38875479|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
16106165|NCT04225039|38875480|FG000|Overall Study|Withdrawal by Subject|1|||
16106166|NCT04225039|38875481|FG001|Overall Study|Withdrawal by Subject|0|||
16106167|NCT04225039|38875482|FG002|Overall Study|Withdrawal by Subject|0|||
16106168|NCT04225039|38875483|FG003|Overall Study|Withdrawal by Subject|1|||
16218101|NCT01693562|39278688|FG018|Escalation Phase|Death|0|||
16218102|NCT01693562|39278689|FG019|Escalation Phase|Death|0|||
16540494|NCT03395405|40440042|FG001|Overall Study|Withdrawal by Subject|1|||
16218103|NCT01693562|39278690|FG020|Escalation Phase|Death|0|||
16218104|NCT01693562|39278691|FG021|Escalation Phase|Death|0|||
16218105|NCT01693562|39278692|FG022|Escalation Phase|Death|0|||
16218106|NCT01693562|39278670|FG000|Escalation Phase|Lost to Follow-up|0|||
16218107|NCT01693562|39278671|FG001|Escalation Phase|Lost to Follow-up|1|||
16218108|NCT01693562|39278672|FG002|Escalation Phase|Lost to Follow-up|1|||
16218109|NCT01693562|39278673|FG003|Escalation Phase|Lost to Follow-up|0|||
16218110|NCT01693562|39278674|FG004|Escalation Phase|Lost to Follow-up|0|||
16218111|NCT01693562|39278675|FG005|Escalation Phase|Lost to Follow-up|0|||
16218112|NCT01693562|39278676|FG006|Escalation Phase|Lost to Follow-up|0|||
16218113|NCT01693562|39278677|FG007|Escalation Phase|Lost to Follow-up|0|||
16218114|NCT01693562|39278678|FG008|Escalation Phase|Lost to Follow-up|0|||
16218115|NCT01693562|39278679|FG009|Escalation Phase|Lost to Follow-up|0|||
16218116|NCT01693562|39278680|FG010|Escalation Phase|Lost to Follow-up|0|||
16218117|NCT01693562|39278681|FG011|Escalation Phase|Lost to Follow-up|0|||
16218118|NCT01693562|39278682|FG012|Escalation Phase|Lost to Follow-up|0|||
16218119|NCT01693562|39278683|FG013|Escalation Phase|Lost to Follow-up|0|||
16218120|NCT01693562|39278684|FG014|Escalation Phase|Lost to Follow-up|0|||
16218121|NCT01693562|39278685|FG015|Escalation Phase|Lost to Follow-up|0|||
16218122|NCT01693562|39278686|FG016|Escalation Phase|Lost to Follow-up|0|||
16218123|NCT01693562|39278687|FG017|Escalation Phase|Lost to Follow-up|0|||
16218124|NCT01693562|39278688|FG018|Escalation Phase|Lost to Follow-up|0|||
16218125|NCT01693562|39278689|FG019|Escalation Phase|Lost to Follow-up|0|||
16218126|NCT01693562|39278690|FG020|Escalation Phase|Lost to Follow-up|0|||
16218127|NCT01693562|39278691|FG021|Escalation Phase|Lost to Follow-up|0|||
16218128|NCT01693562|39278692|FG022|Escalation Phase|Lost to Follow-up|0|||
16218129|NCT01693562|39278670|FG000|Escalation Phase|Other|0|||
16218130|NCT01693562|39278671|FG001|Escalation Phase|Other|0|||
16218131|NCT01693562|39278672|FG002|Escalation Phase|Other|2|||
16218132|NCT01693562|39278673|FG003|Escalation Phase|Other|0|||
16218133|NCT01693562|39278674|FG004|Escalation Phase|Other|0|||
16218134|NCT01693562|39278675|FG005|Escalation Phase|Other|1|||
16218135|NCT01693562|39278676|FG006|Escalation Phase|Other|0|||
16106169|NCT04225039|38875480|FG000|Overall Study|Currently active on study treatment|0|||
16106170|NCT04225039|38875481|FG001|Overall Study|Currently active on study treatment|1|||
16106171|NCT04225039|38875482|FG002|Overall Study|Currently active on study treatment|0|||
16106172|NCT04225039|38875483|FG003|Overall Study|Currently active on study treatment|0|||
16218136|NCT01693562|39278677|FG007|Escalation Phase|Other|0|||
16218137|NCT01693562|39278678|FG008|Escalation Phase|Other|0|||
16218138|NCT01693562|39278679|FG009|Escalation Phase|Other|0|||
16218139|NCT01693562|39278680|FG010|Escalation Phase|Other|0|||
16218140|NCT01693562|39278681|FG011|Escalation Phase|Other|0|||
16218141|NCT01693562|39278682|FG012|Escalation Phase|Other|0|||
16218142|NCT01693562|39278683|FG013|Escalation Phase|Other|0|||
16218143|NCT01693562|39278684|FG014|Escalation Phase|Other|0|||
16218144|NCT01693562|39278685|FG015|Escalation Phase|Other|0|||
16218145|NCT01693562|39278686|FG016|Escalation Phase|Other|0|||
16218146|NCT01693562|39278687|FG017|Escalation Phase|Other|0|||
16218147|NCT01693562|39278688|FG018|Escalation Phase|Other|0|||
16218148|NCT01693562|39278689|FG019|Escalation Phase|Other|0|||
16340643|NCT01358578|39734398|FG004|Maintenance Period|Non-compliance with study treatment|1|||
16340644|NCT01358578|39734399|FG005|Maintenance Period|Non-compliance with study treatment|2|||
16340645|NCT01358578|39734394|FG000|Maintenance Period|Physician Decision|0|||
16340646|NCT01358578|39734395|FG001|Maintenance Period|Physician Decision|1|||
16340647|NCT01358578|39734396|FG002|Maintenance Period|Physician Decision|0|||
16218149|NCT01693562|39278690|FG020|Escalation Phase|Other|0|||
16340648|NCT01358578|39734397|FG003|Maintenance Period|Physician Decision|1|||
16340649|NCT01358578|39734398|FG004|Maintenance Period|Physician Decision|0|||
16340650|NCT01358578|39734399|FG005|Maintenance Period|Physician Decision|0|||
16340651|NCT01358578|39734394|FG000|Maintenance Period|Pregnancy|1|||
16340652|NCT01358578|39734395|FG001|Maintenance Period|Pregnancy|0|||
16340653|NCT01358578|39734396|FG002|Maintenance Period|Pregnancy|0|||
16340654|NCT01358578|39734397|FG003|Maintenance Period|Pregnancy|0|||
16340655|NCT01358578|39734398|FG004|Maintenance Period|Pregnancy|0|||
16340656|NCT01358578|39734399|FG005|Maintenance Period|Pregnancy|0|||
16340657|NCT01358578|39734394|FG000|Maintenance Period|Protocol deviation|7|||
16340658|NCT01358578|39734395|FG001|Maintenance Period|Protocol deviation|4|||
16340659|NCT01358578|39734396|FG002|Maintenance Period|Protocol deviation|0|||
16106173|NCT04225039|38875480|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
16218150|NCT01693562|39278691|FG021|Escalation Phase|Other|0|||
16218151|NCT01693562|39278692|FG022|Escalation Phase|Other|0|||
16218152|NCT01693562|39278670|FG000|Exploration Phase|Withdrawal by Subject|0|||
16218153|NCT01693562|39278671|FG001|Exploration Phase|Withdrawal by Subject|0|||
16218154|NCT01693562|39278672|FG002|Exploration Phase|Withdrawal by Subject|0|||
16218155|NCT01693562|39278673|FG003|Exploration Phase|Withdrawal by Subject|0|||
16218156|NCT01693562|39278674|FG004|Exploration Phase|Withdrawal by Subject|0|||
16340660|NCT01358578|39734397|FG003|Maintenance Period|Protocol deviation|2|||
16340661|NCT01358578|39734398|FG004|Maintenance Period|Protocol deviation|2|||
16340662|NCT01358578|39734399|FG005|Maintenance Period|Protocol deviation|2|||
16106174|NCT04225039|38875481|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
16106175|NCT04225039|38875482|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
16340663|NCT01358578|39734394|FG000|Maintenance Period|Withdrawal by Subject|12|||
16340664|NCT01358578|39734395|FG001|Maintenance Period|Withdrawal by Subject|7|||
16340665|NCT01358578|39734396|FG002|Maintenance Period|Withdrawal by Subject|2|||
16340666|NCT01358578|39734397|FG003|Maintenance Period|Withdrawal by Subject|15|||
16340667|NCT01358578|39734398|FG004|Maintenance Period|Withdrawal by Subject|6|||
16540495|NCT03395405|40440041|FG000|Overall Study|COVID-19 Pandemic|1|||
16540496|NCT03395405|40440042|FG001|Overall Study|COVID-19 Pandemic|0|||
16540497|NCT03152526|40440050|FG000|Overall Study|Withdrawal by Subject|0|||
16540498|NCT03152526|40440051|FG001|Overall Study|Withdrawal by Subject|1|||
16540499|NCT02428296|40440052|FG000|Overall Study|Adverse Event|7|||
16540500|NCT02428296|40440052|FG000|Overall Study|Withdrawal by Subject|2|||
16540501|NCT04027348|40440053|FG000|Overall Study|Adverse Event|2|||
16540502|NCT01111838|40440054|FG000|Overall Study|Patient Ineligible|2|||
16540503|NCT01111838|40440054|FG000|Overall Study|Not Treated|3|||
16540504|NCT01111838|40440054|FG000|Overall Study|Clinical deterioration|1|||
16540505|NCT01111838|40440054|FG000|Overall Study|Other Complicating Disease|1|||
16540506|NCT02403180|40440055|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
16540507|NCT02403180|40440056|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
16540508|NCT02403180|40440055|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
16340668|NCT01358578|39734399|FG005|Maintenance Period|Withdrawal by Subject|3|||
16340669|NCT01358578|39734394|FG000|Follow-up Period|Adverse Event|1|||
16106176|NCT04225039|38875483|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
16106177|NCT04225039|38875480|FG000|Overall Study|Ineligible for treatment|0|||
16106178|NCT04225039|38875481|FG001|Overall Study|Ineligible for treatment|0|||
16106179|NCT04225039|38875482|FG002|Overall Study|Ineligible for treatment|0|||
16106180|NCT04225039|38875483|FG003|Overall Study|Ineligible for treatment|4|||
16106181|NCT02720198|38875485|FG000|Overall Study|Withdrawal by Subject|0|||
16106182|NCT02720198|38875486|FG001|Overall Study|Withdrawal by Subject|1|||
16106183|NCT02624869|38875489|FG000|Overall Study|Lost to Follow-up|0|||
16106184|NCT02624869|38875490|FG001|Overall Study|Lost to Follow-up|0|||
16106185|NCT02624869|38875491|FG002|Overall Study|Lost to Follow-up|1|||
16106186|NCT02624869|38875489|FG000|Overall Study|Withdrawal by Subject|1|||
16106187|NCT02624869|38875490|FG001|Overall Study|Withdrawal by Subject|3|||
16106188|NCT02624869|38875491|FG002|Overall Study|Withdrawal by Subject|1|||
16106189|NCT04969224|38875495|FG000|Overall Study|Adverse Event|1|||
16106190|NCT04969224|38875495|FG000|Overall Study|Enrolled but never dosed|1|||
16106191|NCT00225277|38875508|FG000|Overall Study|Adverse Event|30|||
16106192|NCT00225277|38875509|FG001|Overall Study|Adverse Event|34|||
16106193|NCT00225277|38875508|FG000|Overall Study|Lack of Efficacy|4|||
16106194|NCT00225277|38875509|FG001|Overall Study|Lack of Efficacy|1|||
16106195|NCT00225277|38875508|FG000|Overall Study|Lost to Follow-up|4|||
16106196|NCT00225277|38875509|FG001|Overall Study|Lost to Follow-up|6|||
16106197|NCT00225277|38875508|FG000|Overall Study|Physician Decision|6|||
16106198|NCT00225277|38875509|FG001|Overall Study|Physician Decision|8|||
16106199|NCT00225277|38875508|FG000|Overall Study|Protocol Violation|6|||
16340670|NCT01358578|39734395|FG001|Follow-up Period|Adverse Event|1|||
16340671|NCT01358578|39734396|FG002|Follow-up Period|Adverse Event|0|||
16106200|NCT00225277|38875509|FG001|Overall Study|Protocol Violation|3|||
16106201|NCT00225277|38875508|FG000|Overall Study|Withdrawal by Subject|40|||
16106202|NCT00225277|38875509|FG001|Overall Study|Withdrawal by Subject|34|||
16106203|NCT00225277|38875508|FG000|Overall Study|Other|7|||
16106204|NCT00225277|38875509|FG001|Overall Study|Other|9|||
16106205|NCT01253447|38875512|FG000|Overall Study|Adverse Event|2|||
16106206|NCT02049515|38875513|FG000|Overall Study|Adverse Event|46|||
16106207|NCT02049515|38875514|FG001|Overall Study|Adverse Event|2|||
16540509|NCT02403180|40440056|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
16340672|NCT01358578|39734397|FG003|Follow-up Period|Adverse Event|0|||
16540510|NCT02207816|40440057|FG000|Overall Study|Serious Adverse Event|0|||
16106208|NCT02049515|38875513|FG000|Overall Study|Protocol-specified Disease Progression|23|||
16106209|NCT02049515|38875514|FG001|Overall Study|Protocol-specified Disease Progression|2|||
16106210|NCT02049515|38875513|FG000|Overall Study|Death|6|||
16106211|NCT02049515|38875514|FG001|Overall Study|Death|0|||
16340673|NCT01358578|39734398|FG004|Follow-up Period|Adverse Event|0|||
16340674|NCT01358578|39734399|FG005|Follow-up Period|Adverse Event|0|||
16340675|NCT01358578|39734394|FG000|Follow-up Period|Lack of Efficacy|3|||
16340676|NCT01358578|39734395|FG001|Follow-up Period|Lack of Efficacy|0|||
16340677|NCT01358578|39734396|FG002|Follow-up Period|Lack of Efficacy|4|||
16340678|NCT01358578|39734397|FG003|Follow-up Period|Lack of Efficacy|1|||
16340679|NCT01358578|39734398|FG004|Follow-up Period|Lack of Efficacy|0|||
16340680|NCT01358578|39734399|FG005|Follow-up Period|Lack of Efficacy|0|||
16340681|NCT01358578|39734394|FG000|Follow-up Period|Lost to Follow-up|0|||
16340682|NCT01358578|39734395|FG001|Follow-up Period|Lost to Follow-up|1|||
16340683|NCT01358578|39734396|FG002|Follow-up Period|Lost to Follow-up|0|||
16340684|NCT01358578|39734397|FG003|Follow-up Period|Lost to Follow-up|4|||
16340685|NCT01358578|39734398|FG004|Follow-up Period|Lost to Follow-up|0|||
16340686|NCT01358578|39734399|FG005|Follow-up Period|Lost to Follow-up|0|||
16106212|NCT02049515|38875513|FG000|Overall Study|Physician Decision|5|||
16106213|NCT02049515|38875514|FG001|Overall Study|Physician Decision|1|||
16106214|NCT02049515|38875513|FG000|Overall Study|Withdrawal by Subject|3|||
16106215|NCT02049515|38875514|FG001|Overall Study|Withdrawal by Subject|0|||
16106216|NCT02049515|38875513|FG000|Overall Study|Termination of the Study by Sponsor|2|||
16106217|NCT02049515|38875514|FG001|Overall Study|Termination of the Study by Sponsor|0|||
16106218|NCT02049515|38875513|FG000|Overall Study|Protocol Violation|1|||
16106219|NCT02049515|38875514|FG001|Overall Study|Protocol Violation|1|||
16106220|NCT02049515|38875513|FG000|Overall Study|Clinical Deterioration|1|||
16106221|NCT02049515|38875514|FG001|Overall Study|Clinical Deterioration|0|||
16106222|NCT02049515|38875513|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
16106223|NCT02049515|38875514|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
16106224|NCT02049515|38875513|FG000|Overall Study|Treatment Interruption >42 Days|1|||
16106225|NCT02049515|38875514|FG001|Overall Study|Treatment Interruption >42 Days|0|||
16106226|NCT02049515|38875513|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
16106227|NCT02049515|38875514|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
16106228|NCT02675998|38875516|FG000|8-Week Treatment Period|Adverse Event|6|||
16106229|NCT02675998|38875517|FG001|8-Week Treatment Period|Adverse Event|5|||
16106230|NCT02675998|38875518|FG002|8-Week Treatment Period|Adverse Event|6|||
16106231|NCT02675998|38875519|FG003|8-Week Treatment Period|Adverse Event|0|||
16106232|NCT02675998|38875516|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
16106233|NCT02675998|38875517|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
16106234|NCT02675998|38875518|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
16106235|NCT02675998|38875519|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
16106236|NCT02675998|38875516|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
16106237|NCT02675998|38875517|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
16106238|NCT02675998|38875518|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
16106239|NCT02675998|38875519|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
16106240|NCT02675998|38875516|FG000|8-Week Treatment Period|Physician Decision|1|||
16106241|NCT02675998|38875517|FG001|8-Week Treatment Period|Physician Decision|0|||
16106242|NCT02675998|38875518|FG002|8-Week Treatment Period|Physician Decision|2|||
16106243|NCT02675998|38875519|FG003|8-Week Treatment Period|Physician Decision|0|||
16106244|NCT02675998|38875516|FG000|8-Week Treatment Period|GI side Effects|1|||
16106245|NCT02675998|38875517|FG001|8-Week Treatment Period|GI side Effects|4|||
16106246|NCT02675998|38875518|FG002|8-Week Treatment Period|GI side Effects|2|||
16106247|NCT02675998|38875519|FG003|8-Week Treatment Period|GI side Effects|0|||
16106248|NCT02675998|38875516|FG000|8-Week Treatment Period|Protocol Violation|1|||
16106249|NCT02675998|38875517|FG001|8-Week Treatment Period|Protocol Violation|1|||
16106250|NCT02675998|38875518|FG002|8-Week Treatment Period|Protocol Violation|1|||
16106251|NCT02675998|38875519|FG003|8-Week Treatment Period|Protocol Violation|0|||
16106252|NCT02675998|38875516|FG000|8-Week Treatment Period|Other|3|||
16106253|NCT02675998|38875517|FG001|8-Week Treatment Period|Other|1|||
16106254|NCT02675998|38875518|FG002|8-Week Treatment Period|Other|2|||
16106255|NCT02675998|38875519|FG003|8-Week Treatment Period|Other|0|||
16106256|NCT02675998|38875516|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
16106257|NCT02675998|38875517|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
16106258|NCT02675998|38875518|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
16106259|NCT02675998|38875519|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
16106260|NCT02675998|38875516|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
16106261|NCT02675998|38875517|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
16106262|NCT02675998|38875518|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
16106263|NCT02675998|38875519|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
16106264|NCT02675998|38875516|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
16106265|NCT02675998|38875517|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
16340687|NCT01358578|39734394|FG000|Follow-up Period|non- compliance with study treatment|1|||
16340688|NCT01358578|39734395|FG001|Follow-up Period|non- compliance with study treatment|0|||
16340689|NCT01358578|39734396|FG002|Follow-up Period|non- compliance with study treatment|0|||
16340690|NCT01358578|39734397|FG003|Follow-up Period|non- compliance with study treatment|0|||
16340691|NCT01358578|39734398|FG004|Follow-up Period|non- compliance with study treatment|0|||
16106266|NCT02675998|38875518|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
16106267|NCT02675998|38875519|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
16106268|NCT02675998|38875516|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
16106269|NCT02675998|38875517|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
16106270|NCT02675998|38875518|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
16106271|NCT02675998|38875519|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
16106272|NCT02675998|38875516|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
16106273|NCT02675998|38875517|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
16106274|NCT02675998|38875518|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
16106275|NCT02675998|38875519|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
16106276|NCT00857233|38875520|FG000|Overall Study|Adverse Event|24|||
16106277|NCT00857233|38875520|FG000|Overall Study|Lack of Efficacy|1|||
16106278|NCT00857233|38875520|FG000|Overall Study|Non-compliance|1|||
16106279|NCT00857233|38875520|FG000|Overall Study|Withdrawal of Consent|9|||
16106280|NCT00857233|38875520|FG000|Overall Study|Lost to Follow-up|4|||
16106281|NCT00857233|38875520|FG000|Overall Study|Nursing Home Placement|14|||
16106282|NCT00857233|38875520|FG000|Overall Study|Other Reasons|2|||
16106283|NCT00727415|38875523|FG000|Phase I|Dose Limiting Toxicity|2|||
16106284|NCT02507687|38875524|FG000|Overall Study|Adverse Event|3|||
16106285|NCT02507687|38875525|FG001|Overall Study|Adverse Event|2|||
16106286|NCT02507687|38875526|FG002|Overall Study|Adverse Event|2|||
16106287|NCT02507687|38875527|FG003|Overall Study|Adverse Event|2|||
16106288|NCT02507687|38875524|FG000|Overall Study|Withdrawal by Subject|1|||
16106289|NCT02507687|38875525|FG001|Overall Study|Withdrawal by Subject|4|||
16106290|NCT02507687|38875526|FG002|Overall Study|Withdrawal by Subject|6|||
16106291|NCT02507687|38875527|FG003|Overall Study|Withdrawal by Subject|6|||
16106292|NCT02507687|38875524|FG000|Overall Study|Protocol Violation|1|||
16106293|NCT02507687|38875525|FG001|Overall Study|Protocol Violation|0|||
16106294|NCT02507687|38875526|FG002|Overall Study|Protocol Violation|2|||
16106295|NCT02507687|38875527|FG003|Overall Study|Protocol Violation|0|||
16106296|NCT02507687|38875524|FG000|Overall Study|Lost to Follow-up|0|||
16106297|NCT02507687|38875525|FG001|Overall Study|Lost to Follow-up|0|||
16106298|NCT02507687|38875526|FG002|Overall Study|Lost to Follow-up|2|||
16106299|NCT02507687|38875527|FG003|Overall Study|Lost to Follow-up|1|||
16106300|NCT02507687|38875524|FG000|Overall Study|Screen Failure|0|||
16106301|NCT02507687|38875525|FG001|Overall Study|Screen Failure|0|||
16106302|NCT02507687|38875526|FG002|Overall Study|Screen Failure|1|||
16106303|NCT02507687|38875527|FG003|Overall Study|Screen Failure|0|||
16106304|NCT02507687|38875524|FG000|Overall Study|Other, Not Specified|0|||
16106305|NCT02507687|38875525|FG001|Overall Study|Other, Not Specified|0|||
16106306|NCT02507687|38875526|FG002|Overall Study|Other, Not Specified|2|||
16106307|NCT02507687|38875527|FG003|Overall Study|Other, Not Specified|4|||
16106308|NCT00826228|38875533|FG000|Overall Study|Withdrawal by Subject|1|||
16106309|NCT01370018|38875537|FG000|Overall Study|Did not meet criteria for analysis|1|||
16106310|NCT00107978|38875538|FG000|Overall Study|Adverse Event|1|||
16106311|NCT00107978|38875539|FG001|Overall Study|Adverse Event|5|||
16106312|NCT00107978|38875538|FG000|Overall Study|Death|3|||
16106313|NCT00107978|38875539|FG001|Overall Study|Death|3|||
16106314|NCT00107978|38875538|FG000|Overall Study|Lost to Follow-up|20|||
16106315|NCT00107978|38875539|FG001|Overall Study|Lost to Follow-up|28|||
16106316|NCT00107978|38875538|FG000|Overall Study|Withdrawal by Subject|4|||
16106317|NCT00107978|38875539|FG001|Overall Study|Withdrawal by Subject|9|||
16106318|NCT00107978|38875538|FG000|Overall Study|Protocol Violation|0|||
16106319|NCT00107978|38875539|FG001|Overall Study|Protocol Violation|1|||
16106320|NCT00107978|38875538|FG000|Overall Study|Other|5|||
16106321|NCT00107978|38875539|FG001|Overall Study|Other|4|||
16106322|NCT02230306|38875544|FG000|Overall Study|Did not receive study treatment|1|||
16106323|NCT02918292|38875546|FG000|Study Enrollment Prior to Transplant|Death|1|||
16106324|NCT02918292|38875546|FG000|Study Follow up After Transplant|Death|6|||
16540511|NCT02207816|40440058|FG001|Overall Study|Serious Adverse Event|5|||
16540512|NCT02207816|40440059|FG002|Overall Study|Serious Adverse Event|2|||
16106325|NCT02959177|38875549|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
16106326|NCT02959177|38875550|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
16540513|NCT02207816|40440057|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
16540514|NCT02207816|40440058|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
16540515|NCT02207816|40440059|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
16540516|NCT02207816|40440057|FG000|Overall Study|Withdrawal by Subject|4|||
16540517|NCT02207816|40440058|FG001|Overall Study|Withdrawal by Subject|9|||
16540518|NCT02207816|40440059|FG002|Overall Study|Withdrawal by Subject|7|||
16106327|NCT02959177|38875551|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
16106328|NCT02959177|38875549|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
16106329|NCT02959177|38875550|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
16106330|NCT02959177|38875551|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
16106331|NCT02959177|38875549|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
16106332|NCT02959177|38875550|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
16106333|NCT02959177|38875551|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
16106334|NCT02959177|38875549|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
16106335|NCT02959177|38875550|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16106336|NCT02959177|38875551|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
16106337|NCT02959177|38875549|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
16106338|NCT02959177|38875550|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
16106339|NCT02959177|38875551|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
16540519|NCT02207816|40440057|FG000|Overall Study|Migrated/Moved From Study Area|41|||
16106340|NCT02959177|38875549|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
16106341|NCT02959177|38875550|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
16540520|NCT02207816|40440058|FG001|Overall Study|Migrated/Moved From Study Area|60|||
16540521|NCT02207816|40440059|FG002|Overall Study|Migrated/Moved From Study Area|51|||
16540522|NCT02207816|40440057|FG000|Overall Study|Lost to Follow-up|3|||
16540523|NCT02207816|40440058|FG001|Overall Study|Lost to Follow-up|9|||
16540524|NCT02207816|40440059|FG002|Overall Study|Lost to Follow-up|1|||
16106342|NCT02959177|38875551|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
16106343|NCT02959177|38875549|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
16106344|NCT02959177|38875550|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
16106345|NCT02959177|38875551|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
16106346|NCT00809341|38875552|FG000|Overall Study|Physician Decision|0|||
16106347|NCT00809341|38875553|FG001|Overall Study|Physician Decision|1|||
16106348|NCT02101268|38875555|FG000|Randomized Treatment Phase|Subject Decision|8|||
16106349|NCT02101268|38875556|FG001|Randomized Treatment Phase|Subject Decision|4|||
16106350|NCT02101268|38875557|FG002|Randomized Treatment Phase|Subject Decision|0|||
16540525|NCT02207816|40440057|FG000|Overall Study|Other|1|||
16540526|NCT02207816|40440058|FG001|Overall Study|Other|2|||
16340692|NCT01358578|39734399|FG005|Follow-up Period|non- compliance with study treatment|0|||
16340693|NCT01358578|39734394|FG000|Follow-up Period|Pregnancy|1|||
16340694|NCT01358578|39734395|FG001|Follow-up Period|Pregnancy|0|||
16340695|NCT01358578|39734396|FG002|Follow-up Period|Pregnancy|0|||
16340696|NCT01358578|39734397|FG003|Follow-up Period|Pregnancy|0|||
16340697|NCT01358578|39734398|FG004|Follow-up Period|Pregnancy|0|||
16340698|NCT01358578|39734399|FG005|Follow-up Period|Pregnancy|0|||
16340699|NCT01358578|39734394|FG000|Follow-up Period|Withdrawal by Subject|3|||
16340700|NCT01358578|39734395|FG001|Follow-up Period|Withdrawal by Subject|3|||
16340701|NCT01358578|39734396|FG002|Follow-up Period|Withdrawal by Subject|1|||
16340702|NCT01358578|39734397|FG003|Follow-up Period|Withdrawal by Subject|12|||
16340703|NCT01358578|39734398|FG004|Follow-up Period|Withdrawal by Subject|0|||
16340704|NCT01358578|39734399|FG005|Follow-up Period|Withdrawal by Subject|0|||
16340705|NCT01358578|39734394|FG000|Follow-up Period|Physician Decision|1|||
16340706|NCT01358578|39734395|FG001|Follow-up Period|Physician Decision|1|||
16540527|NCT02207816|40440059|FG002|Overall Study|Other|4|||
16540528|NCT04465357|40440060|FG000|Overall Study|Adverse Event|2|||
16540529|NCT04465357|40440060|FG000|Overall Study|Lack of Efficacy|1|||
16540530|NCT04465357|40440060|FG000|Overall Study|Lost to Follow-up|2|||
16540531|NCT04465357|40440060|FG000|Overall Study|Withdrawal by Subject|6|||
16540532|NCT04465357|40440060|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
16540533|NCT02633800|40440061|FG000|Overall Study|Death|3|||
16540534|NCT02633800|40440062|FG001|Overall Study|Death|3|||
16540535|NCT02633800|40440061|FG000|Overall Study|Reason not provided|1|||
16540536|NCT02633800|40440062|FG001|Overall Study|Reason not provided|0|||
16540537|NCT02633800|40440061|FG000|Overall Study|Radiologic(al) progression|23|||
16540538|NCT02633800|40440062|FG001|Overall Study|Radiologic(al) progression|23|||
16540539|NCT02633800|40440061|FG000|Overall Study|Clinical progression|3|||
16540540|NCT02633800|40440062|FG001|Overall Study|Clinical progression|6|||
16540541|NCT02633800|40440061|FG000|Overall Study|Study terminated by sponsor|6|||
16540542|NCT02633800|40440062|FG001|Overall Study|Study terminated by sponsor|5|||
16106351|NCT02101268|38875558|FG003|Randomized Treatment Phase|Subject Decision|0|||
16340707|NCT01358578|39734396|FG002|Follow-up Period|Physician Decision|0|||
16340708|NCT01358578|39734397|FG003|Follow-up Period|Physician Decision|2|||
16340709|NCT01358578|39734398|FG004|Follow-up Period|Physician Decision|0|||
16340710|NCT01358578|39734399|FG005|Follow-up Period|Physician Decision|0|||
16340711|NCT02168777|39734400|FG000|Overall Study|Withdrawal by Subject|1|||
16340712|NCT02168777|39734401|FG001|Overall Study|Withdrawal by Subject|0|||
16340713|NCT02168777|39734402|FG002|Overall Study|Withdrawal by Subject|2|||
16340714|NCT02168777|39734400|FG000|Overall Study|Adverse Event|1|||
16540543|NCT02633800|40440061|FG000|Overall Study|Adverse event, non-fatal|7|||
16540544|NCT02633800|40440062|FG001|Overall Study|Adverse event, non-fatal|2|||
16540545|NCT02633800|40440061|FG000|Overall Study|Withdrawal by Subject|0|||
16540546|NCT02633800|40440062|FG001|Overall Study|Withdrawal by Subject|3|||
16540547|NCT02633800|40440061|FG000|Overall Study|Patient Request|1|||
16540548|NCT02633800|40440062|FG001|Overall Study|Patient Request|1|||
16540549|NCT05099926|40440063|FG000|Overall Study|Lost to Follow-up|1|||
16540550|NCT04839965|40440064|FG000|Overall Study|Death|6|||
16540551|NCT04839965|40440065|FG001|Overall Study|Death|6|||
16540552|NCT04839965|40440064|FG000|Overall Study|Lost to Follow-up|1|||
16540553|NCT04839965|40440065|FG001|Overall Study|Lost to Follow-up|0|||
16540554|NCT03879408|40440084|FG000|Overall Study|Lost to Follow-up|0|||
16540555|NCT03879408|40440085|FG001|Overall Study|Lost to Follow-up|3|||
16540556|NCT03879408|40440086|FG002|Overall Study|Lost to Follow-up|2|||
16540557|NCT03879408|40440087|FG003|Overall Study|Lost to Follow-up|1|||
16540558|NCT03879408|40440088|FG004|Overall Study|Lost to Follow-up|0|||
16540559|NCT03879408|40440084|FG000|Overall Study|Withdrawal by Subject|2|||
16540560|NCT03879408|40440085|FG001|Overall Study|Withdrawal by Subject|1|||
16540561|NCT03879408|40440086|FG002|Overall Study|Withdrawal by Subject|1|||
16540562|NCT03879408|40440087|FG003|Overall Study|Withdrawal by Subject|0|||
16540563|NCT03879408|40440088|FG004|Overall Study|Withdrawal by Subject|1|||
16540564|NCT01533493|40440089|FG000|Overall Study|Adverse Event|2|||
16540565|NCT01533493|40440090|FG001|Overall Study|Adverse Event|1|||
16540566|NCT01533493|40440089|FG000|Overall Study|Withdrawal by Subject|1|||
16540567|NCT01533493|40440090|FG001|Overall Study|Withdrawal by Subject|2|||
16540568|NCT01533493|40440089|FG000|Overall Study|Lost to Follow-up|2|||
16540569|NCT01533493|40440090|FG001|Overall Study|Lost to Follow-up|0|||
16540570|NCT00337272|40440091|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
16540571|NCT00337272|40440092|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
16540572|NCT00337272|40440091|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
16540573|NCT00337272|40440092|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
16540574|NCT00337272|40440091|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
16540575|NCT00337272|40440092|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
16540576|NCT00337272|40440091|FG000|Treatment Period|Non-compliance|1|||
16540577|NCT00337272|40440092|FG001|Treatment Period|Non-compliance|1|||
16540578|NCT00337272|40440091|FG000|Treatment Period|Withdrawal by Subject|0|||
16540579|NCT00337272|40440092|FG001|Treatment Period|Withdrawal by Subject|1|||
16540580|NCT00337272|40440091|FG000|Withdrawal Period|Non-compliance|0|||
16540581|NCT00337272|40440092|FG001|Withdrawal Period|Non-compliance|1|||
16540582|NCT02216773|40440093|FG000|Overall Study|Disease progression|4|||
16540583|NCT02216773|40440094|FG001|Overall Study|Disease progression|2|||
16540584|NCT02216773|40440093|FG000|Overall Study|Insufficient FLRV|4|||
16540585|NCT02216773|40440094|FG001|Overall Study|Insufficient FLRV|0|||
16540586|NCT02216773|40440093|FG000|Overall Study|Abandoned|4|||
16540587|NCT02216773|40440094|FG001|Overall Study|Abandoned|3|||
16540588|NCT02158884|40440096|FG000|Baseline Assessment|Missed performance assessment|3|||
16540589|NCT02158884|40440096|FG000|Baseline Assessment|Missed SMFA|1|||
16540590|NCT02158884|40440096|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
16540591|NCT02158884|40440096|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
16540592|NCT02158884|40440096|FG000|6 Month Assessment|Missed SMFA|20|||
16540593|NCT02158884|40440096|FG000|12 Month Assessment|Missed SMFA|17|||
16540594|NCT00542880|40440097|FG000|Period 1|Eligibility criteria not fulfilled|2|||
16540595|NCT00542880|40440098|FG001|Period 1|Eligibility criteria not fulfilled|6|||
16540596|NCT00542880|40440097|FG000|Period 1|Adverse Event|2|||
16540597|NCT00542880|40440098|FG001|Period 1|Adverse Event|2|||
16540598|NCT00542880|40440097|FG000|Period 1|Development of study-specific criteria|1|||
16540599|NCT00542880|40440098|FG001|Period 1|Development of study-specific criteria|2|||
16540600|NCT00542880|40440097|FG000|Period 1|Withdrawal by Subject|1|||
16540601|NCT00542880|40440098|FG001|Period 1|Withdrawal by Subject|1|||
16540602|NCT00542880|40440097|FG000|Period 1|Protocol Violation|0|||
16540603|NCT00542880|40440098|FG001|Period 1|Protocol Violation|1|||
16540604|NCT00542880|40440097|FG000|Period 2|Adverse Event|5|||
16540605|NCT00542880|40440098|FG001|Period 2|Adverse Event|7|||
16540606|NCT00542880|40440097|FG000|Period 2|Eligibility not fulfilled|0|||
16540607|NCT00542880|40440098|FG001|Period 2|Eligibility not fulfilled|1|||
16106352|NCT02101268|38875555|FG000|Randomized Treatment Phase|Physician Decision|4|||
16106353|NCT02101268|38875556|FG001|Randomized Treatment Phase|Physician Decision|1|||
16540608|NCT00542880|40440097|FG000|Period 2|Discontinuation criteria|2|||
16540609|NCT00542880|40440098|FG001|Period 2|Discontinuation criteria|0|||
16540610|NCT00542880|40440097|FG000|Period 2|Severe non-compliance|0|||
16540611|NCT00542880|40440098|FG001|Period 2|Severe non-compliance|1|||
16540612|NCT00542880|40440097|FG000|Period 2|Other|0|||
16540613|NCT00542880|40440098|FG001|Period 2|Other|1|||
16540614|NCT00542880|40440097|FG000|Period 3|Adverse Event|0|||
16540615|NCT00542880|40440098|FG001|Period 3|Adverse Event|2|||
16540616|NCT00526630|40440115|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
16540617|NCT00526630|40440116|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
16540618|NCT00526630|40440115|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
16540619|NCT00526630|40440116|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
16540620|NCT01756352|40440120|FG000|Overall Study|moved away and lost to followup|1|||
16106354|NCT02101268|38875557|FG002|Randomized Treatment Phase|Physician Decision|0|||
16106355|NCT02101268|38875558|FG003|Randomized Treatment Phase|Physician Decision|0|||
16106356|NCT02101268|38875555|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
16106357|NCT02101268|38875556|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
16106358|NCT02101268|38875557|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
16106359|NCT02101268|38875558|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
16106360|NCT02101268|38875555|FG000|Randomized Treatment Phase|Adverse Event|6|||
16106361|NCT02101268|38875556|FG001|Randomized Treatment Phase|Adverse Event|0|||
16106362|NCT02101268|38875557|FG002|Randomized Treatment Phase|Adverse Event|0|||
16106363|NCT02101268|38875558|FG003|Randomized Treatment Phase|Adverse Event|0|||
16106364|NCT02101268|38875555|FG000|Randomized Treatment Phase|Death|5|||
16106365|NCT02101268|38875556|FG001|Randomized Treatment Phase|Death|4|||
16106366|NCT02101268|38875557|FG002|Randomized Treatment Phase|Death|0|||
16106367|NCT02101268|38875558|FG003|Randomized Treatment Phase|Death|0|||
16106368|NCT02101268|38875555|FG000|Randomized Treatment Phase|Disease Progression|4|||
16106369|NCT02101268|38875556|FG001|Randomized Treatment Phase|Disease Progression|1|||
16106370|NCT02101268|38875557|FG002|Randomized Treatment Phase|Disease Progression|0|||
16106371|NCT02101268|38875558|FG003|Randomized Treatment Phase|Disease Progression|0|||
16106372|NCT02101268|38875555|FG000|Extended Treatment Phase|Subject Decision|0|||
16106373|NCT02101268|38875556|FG001|Extended Treatment Phase|Subject Decision|0|||
16106374|NCT02101268|38875557|FG002|Extended Treatment Phase|Subject Decision|3|||
16106375|NCT02101268|38875558|FG003|Extended Treatment Phase|Subject Decision|2|||
16106376|NCT02101268|38875555|FG000|Extended Treatment Phase|Physician Decision|0|||
16106377|NCT02101268|38875556|FG001|Extended Treatment Phase|Physician Decision|0|||
16106378|NCT02101268|38875557|FG002|Extended Treatment Phase|Physician Decision|5|||
16106379|NCT02101268|38875558|FG003|Extended Treatment Phase|Physician Decision|2|||
16106380|NCT02101268|38875555|FG000|Extended Treatment Phase|Adverse Event|0|||
16106381|NCT02101268|38875556|FG001|Extended Treatment Phase|Adverse Event|0|||
16106382|NCT02101268|38875557|FG002|Extended Treatment Phase|Adverse Event|14|||
16106383|NCT02101268|38875558|FG003|Extended Treatment Phase|Adverse Event|18|||
16106384|NCT02101268|38875555|FG000|Extended Treatment Phase|Death|0|||
16106385|NCT02101268|38875556|FG001|Extended Treatment Phase|Death|0|||
16106386|NCT02101268|38875557|FG002|Extended Treatment Phase|Death|5|||
16106387|NCT02101268|38875558|FG003|Extended Treatment Phase|Death|1|||
16106388|NCT02101268|38875555|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
16106389|NCT02101268|38875556|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
16106390|NCT02101268|38875557|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
16106391|NCT02101268|38875558|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
16106392|NCT02101268|38875555|FG000|Extended Treatment Phase|Disease Progression|0|||
16106393|NCT02101268|38875556|FG001|Extended Treatment Phase|Disease Progression|0|||
16106394|NCT02101268|38875557|FG002|Extended Treatment Phase|Disease Progression|13|||
16106395|NCT02101268|38875558|FG003|Extended Treatment Phase|Disease Progression|6|||
16106396|NCT02101268|38875555|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
16106397|NCT02101268|38875556|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
16106398|NCT02101268|38875557|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
16106399|NCT02101268|38875558|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
16106400|NCT02853305|38875561|FG000|Overall Study|Death|287|||
16106401|NCT02853305|38875562|FG001|Overall Study|Death|249|||
16106402|NCT02853305|38875563|FG002|Overall Study|Death|300|||
16106403|NCT02853305|38875561|FG000|Overall Study|Withdrawal by Subject|2|||
16106404|NCT02853305|38875562|FG001|Overall Study|Withdrawal by Subject|8|||
16106405|NCT02853305|38875563|FG002|Overall Study|Withdrawal by Subject|3|||
16106406|NCT02853305|38875561|FG000|Overall Study|Transferred to Extension Study|46|||
16106407|NCT02853305|38875562|FG001|Overall Study|Transferred to Extension Study|30|||
16106408|NCT02853305|38875563|FG002|Overall Study|Transferred to Extension Study|25|||
16106409|NCT02853305|38875561|FG000|Overall Study|Did Not Continue on Extension Study|16|||
16106410|NCT02853305|38875562|FG001|Overall Study|Did Not Continue on Extension Study|20|||
16106411|NCT02853305|38875563|FG002|Overall Study|Did Not Continue on Extension Study|24|||
16106412|NCT01101334|38875571|FG000|Overall Study|Adverse Event|9|||
16106413|NCT01101334|38875572|FG001|Overall Study|Adverse Event|4|||
16106414|NCT01101334|38875571|FG000|Overall Study|Death|7|||
16106415|NCT01101334|38875572|FG001|Overall Study|Death|1|||
16106416|NCT01101334|38875571|FG000|Overall Study|Withdrawal by Subject|4|||
16106417|NCT01101334|38875572|FG001|Overall Study|Withdrawal by Subject|3|||
16106418|NCT01101334|38875571|FG000|Overall Study|Withdrawal by Sponsor|1|||
16106419|NCT01101334|38875572|FG001|Overall Study|Withdrawal by Sponsor|1|||
16106420|NCT01101334|38875571|FG000|Overall Study|Progressive Disease|22|||
16106421|NCT01101334|38875572|FG001|Overall Study|Progressive Disease|35|||
16106422|NCT01101334|38875571|FG000|Overall Study|Other|2|||
16106423|NCT01101334|38875572|FG001|Overall Study|Other|1|||
16106424|NCT01388478|38875573|FG000|Overall Study|Adverse Event|4|||
16106425|NCT01388478|38875573|FG000|Overall Study|Withdrawal by Subject|1|||
16106426|NCT00292981|38875580|FG000|Overall Study|Adverse Event|1|||
16106427|NCT00292981|38875580|FG000|Overall Study|Lost to Follow-up|13|||
16106428|NCT00292981|38875580|FG000|Overall Study|Withdrawal by Subject|22|||
16106429|NCT00292981|38875580|FG000|Overall Study|Other|3|||
16106430|NCT02391545|38875581|FG000|Overall Study|Death|0|||
16106431|NCT02391545|38875582|FG001|Overall Study|Death|2|||
16106432|NCT02391545|38875581|FG000|Overall Study|Lost to Follow-up|0|||
16106433|NCT02391545|38875582|FG001|Overall Study|Lost to Follow-up|1|||
16106434|NCT02391545|38875581|FG000|Overall Study|Termination of study by sponsor|20|||
16540621|NCT00540124|40440123|FG000|Overall Study|Adverse Event|0|||
16540622|NCT00540124|40440124|FG001|Overall Study|Adverse Event|2|||
16106435|NCT02391545|38875582|FG001|Overall Study|Termination of study by sponsor|20|||
16106436|NCT02391545|38875581|FG000|Overall Study|Withdrawal by Subject|0|||
16106437|NCT02391545|38875582|FG001|Overall Study|Withdrawal by Subject|1|||
16106438|NCT02391545|38875581|FG000|Overall Study|Other Reasons|6|||
16106439|NCT02391545|38875582|FG001|Overall Study|Other Reasons|4|||
16106440|NCT00552513|38875583|FG000|Overall Study|Lost to Follow-up|5|||
16106441|NCT00552513|38875584|FG001|Overall Study|Lost to Follow-up|1|||
16106442|NCT01990313|38875585|FG000|Overall Study|Lost to Follow-up|1|||
16106443|NCT02138253|38875590|FG000|Overall Study|Adverse Event|3|||
16106444|NCT02138253|38875591|FG001|Overall Study|Adverse Event|3|||
16106445|NCT02138253|38875590|FG000|Overall Study|Lost to Follow-up|2|||
16106446|NCT02138253|38875591|FG001|Overall Study|Lost to Follow-up|1|||
16106447|NCT02138253|38875590|FG000|Overall Study|Physician Decision|2|||
16106448|NCT02138253|38875591|FG001|Overall Study|Physician Decision|0|||
16106449|NCT02138253|38875590|FG000|Overall Study|Non compliance|1|||
16106450|NCT02138253|38875591|FG001|Overall Study|Non compliance|0|||
16106451|NCT02138253|38875590|FG000|Overall Study|Withdrawal by Subject|1|||
16106452|NCT02138253|38875591|FG001|Overall Study|Withdrawal by Subject|0|||
16106453|NCT00264498|38878737|FG000|Randomized Treatment|Death|0|||
16106454|NCT00264498|38878738|FG001|Randomized Treatment|Death|3|||
16106455|NCT00264498|38878737|FG000|Randomized Treatment|Withdrawal by Subject|0|||
16106456|NCT00264498|38878738|FG001|Randomized Treatment|Withdrawal by Subject|1|||
16106457|NCT00264498|38878737|FG000|Randomized Treatment|Objective disease Progression|13|||
16106458|NCT00264498|38878738|FG001|Randomized Treatment|Objective disease Progression|14|||
16106459|NCT00264498|38878737|FG000|Randomized Treatment|Physician Decision|1|||
16106460|NCT00264498|38878738|FG001|Randomized Treatment|Physician Decision|0|||
16106461|NCT00264498|38878737|FG000|Randomized Treatment|Incorrectly randomized|1|||
16106462|NCT00264498|38878738|FG001|Randomized Treatment|Incorrectly randomized|0|||
16106463|NCT00264498|38878737|FG000|Randomized Treatment|Study Closure|1|||
16106464|NCT00264498|38878738|FG001|Randomized Treatment|Study Closure|0|||
16106465|NCT00264498|38878737|FG000|Randomized Treatment|Protocol Violation|1|||
16106466|NCT00264498|38878738|FG001|Randomized Treatment|Protocol Violation|0|||
16106467|NCT00264498|38878737|FG000|Crossover Treatment|Death|1|||
16106468|NCT00264498|38878738|FG001|Crossover Treatment|Death|3|||
16106469|NCT00264498|38878737|FG000|Crossover Treatment|Objective disease progression|4|||
16106470|NCT00264498|38878738|FG001|Crossover Treatment|Objective disease progression|5|||
16106471|NCT00264498|38878737|FG000|Crossover Treatment|Study closure|0|||
16106472|NCT00264498|38878738|FG001|Crossover Treatment|Study closure|1|||
16106473|NCT00264498|38878737|FG000|Crossover Treatment|Withdrawal by Subject|1|||
16106474|NCT00264498|38878738|FG001|Crossover Treatment|Withdrawal by Subject|0|||
16106475|NCT01101061|38878739|FG000|Overall Study|Adverse Event|0|||
16106476|NCT01101061|38878740|FG001|Overall Study|Adverse Event|0|||
16340715|NCT02168777|39734401|FG001|Overall Study|Adverse Event|0|||
16340716|NCT02168777|39734402|FG002|Overall Study|Adverse Event|1|||
16340717|NCT02168777|39734400|FG000|Overall Study|Disease recurrence|0|||
16340718|NCT02168777|39734401|FG001|Overall Study|Disease recurrence|0|||
16340719|NCT02168777|39734402|FG002|Overall Study|Disease recurrence|1|||
16340720|NCT02168777|39734400|FG000|Overall Study|Radiological disease progression|0|||
16340721|NCT02168777|39734401|FG001|Overall Study|Radiological disease progression|5|||
16340722|NCT02168777|39734402|FG002|Overall Study|Radiological disease progression|5|||
16340723|NCT02168777|39734400|FG000|Overall Study|Clinical disease progression|0|||
16340724|NCT02168777|39734401|FG001|Overall Study|Clinical disease progression|1|||
16340725|NCT02168777|39734402|FG002|Overall Study|Clinical disease progression|2|||
16340726|NCT02168777|39734400|FG000|Overall Study|Other reason|0|||
16340727|NCT02168777|39734401|FG001|Overall Study|Other reason|1|||
16340728|NCT02168777|39734402|FG002|Overall Study|Other reason|0|||
16340729|NCT01563913|39734403|FG000|Overall Study|Physician Decision|1|||
16340730|NCT01563913|39734404|FG001|Overall Study|Physician Decision|0|||
16340731|NCT01563913|39734403|FG000|Overall Study|Spouse Passed Away|1|||
16106477|NCT01101061|38878741|FG002|Overall Study|Adverse Event|1|||
16106478|NCT01101061|38878742|FG003|Overall Study|Adverse Event|0|||
16106479|NCT01101061|38878743|FG004|Overall Study|Adverse Event|0|||
16106480|NCT01101061|38878744|FG005|Overall Study|Adverse Event|0|||
16106481|NCT00691678|38878747|FG000|Overall Study|Adverse Event|5|||
16340732|NCT01563913|39734404|FG001|Overall Study|Spouse Passed Away|0|||
16340733|NCT02334384|39734407|FG000|Overall Study|Lost to Follow-up|1|||
16340734|NCT02334384|39734408|FG001|Overall Study|Lost to Follow-up|1|||
16540623|NCT00540124|40440125|FG002|Overall Study|Adverse Event|1|||
16540624|NCT00540124|40440123|FG000|Overall Study|Entry Criteria Not Met|2|||
16106482|NCT00691678|38878747|FG000|Overall Study|life events, pain|11|||
16106483|NCT01193218|38878748|FG000|0-12 Weeks|Adverse Event|6|||
16106484|NCT01193218|38878749|FG001|0-12 Weeks|Adverse Event|0|||
16106485|NCT01193218|38878750|FG002|0-12 Weeks|Adverse Event|1|||
16106486|NCT01193218|38878751|FG003|0-12 Weeks|Adverse Event|0|||
16106487|NCT01193218|38878752|FG004|0-12 Weeks|Adverse Event|0|||
16106488|NCT01193218|38878753|FG005|0-12 Weeks|Adverse Event|2|||
16106489|NCT01193218|38878754|FG006|0-12 Weeks|Adverse Event|2|||
16106490|NCT01193218|38878755|FG007|0-12 Weeks|Adverse Event|0|||
16106491|NCT01193218|38878748|FG000|0-12 Weeks|Protocol Violation|0|||
16106492|NCT01193218|38878749|FG001|0-12 Weeks|Protocol Violation|0|||
16106493|NCT01193218|38878750|FG002|0-12 Weeks|Protocol Violation|0|||
16106494|NCT01193218|38878751|FG003|0-12 Weeks|Protocol Violation|0|||
16540625|NCT00540124|40440124|FG001|Overall Study|Entry Criteria Not Met|0|||
16540626|NCT00540124|40440125|FG002|Overall Study|Entry Criteria Not Met|0|||
16540627|NCT00540124|40440123|FG000|Overall Study|Lack of Efficacy|1|||
16540628|NCT00540124|40440124|FG001|Overall Study|Lack of Efficacy|0|||
16540629|NCT00540124|40440125|FG002|Overall Study|Lack of Efficacy|0|||
16540630|NCT00540124|40440123|FG000|Overall Study|Withdrawal by Subject|1|||
16540631|NCT00540124|40440124|FG001|Overall Study|Withdrawal by Subject|1|||
16106495|NCT01193218|38878752|FG004|0-12 Weeks|Protocol Violation|1|||
16106496|NCT01193218|38878753|FG005|0-12 Weeks|Protocol Violation|1|||
16106497|NCT01193218|38878754|FG006|0-12 Weeks|Protocol Violation|0|||
16106498|NCT01193218|38878755|FG007|0-12 Weeks|Protocol Violation|0|||
16106499|NCT01193218|38878748|FG000|0-12 Weeks|Withdrawal by Subject|3|||
16106500|NCT01193218|38878749|FG001|0-12 Weeks|Withdrawal by Subject|0|||
16106501|NCT01193218|38878750|FG002|0-12 Weeks|Withdrawal by Subject|2|||
16106502|NCT01193218|38878751|FG003|0-12 Weeks|Withdrawal by Subject|0|||
16106503|NCT01193218|38878752|FG004|0-12 Weeks|Withdrawal by Subject|0|||
16106504|NCT01193218|38878753|FG005|0-12 Weeks|Withdrawal by Subject|0|||
16106505|NCT01193218|38878754|FG006|0-12 Weeks|Withdrawal by Subject|1|||
16106506|NCT01193218|38878755|FG007|0-12 Weeks|Withdrawal by Subject|0|||
16106507|NCT01193218|38878748|FG000|12-52 Weeks|Adverse Event|1|||
16106508|NCT01193218|38878749|FG001|12-52 Weeks|Adverse Event|0|||
16106509|NCT01193218|38878750|FG002|12-52 Weeks|Adverse Event|1|||
16106510|NCT01193218|38878751|FG003|12-52 Weeks|Adverse Event|2|||
16106511|NCT01193218|38878752|FG004|12-52 Weeks|Adverse Event|3|||
16106512|NCT01193218|38878753|FG005|12-52 Weeks|Adverse Event|3|||
16106513|NCT01193218|38878754|FG006|12-52 Weeks|Adverse Event|1|||
16106514|NCT01193218|38878755|FG007|12-52 Weeks|Adverse Event|2|||
16106515|NCT01193218|38878748|FG000|12-52 Weeks|Lack of Efficacy|0|||
16106516|NCT01193218|38878749|FG001|12-52 Weeks|Lack of Efficacy|0|||
16106517|NCT01193218|38878750|FG002|12-52 Weeks|Lack of Efficacy|0|||
16106518|NCT01193218|38878751|FG003|12-52 Weeks|Lack of Efficacy|0|||
16106519|NCT01193218|38878752|FG004|12-52 Weeks|Lack of Efficacy|0|||
16106520|NCT01193218|38878753|FG005|12-52 Weeks|Lack of Efficacy|0|||
16106521|NCT01193218|38878754|FG006|12-52 Weeks|Lack of Efficacy|1|||
16106522|NCT01193218|38878755|FG007|12-52 Weeks|Lack of Efficacy|0|||
16106523|NCT01193218|38878748|FG000|12-52 Weeks|Withdrawal by Subject|3|||
16106524|NCT01193218|38878749|FG001|12-52 Weeks|Withdrawal by Subject|0|||
16106525|NCT01193218|38878750|FG002|12-52 Weeks|Withdrawal by Subject|3|||
16106526|NCT01193218|38878751|FG003|12-52 Weeks|Withdrawal by Subject|0|||
16106527|NCT01193218|38878752|FG004|12-52 Weeks|Withdrawal by Subject|0|||
16106528|NCT01193218|38878753|FG005|12-52 Weeks|Withdrawal by Subject|2|||
16106529|NCT01193218|38878754|FG006|12-52 Weeks|Withdrawal by Subject|1|||
16106530|NCT01193218|38878755|FG007|12-52 Weeks|Withdrawal by Subject|2|||
16106531|NCT01193218|38878748|FG000|12-52 Weeks|Other reason than above|1|||
16106532|NCT01193218|38878749|FG001|12-52 Weeks|Other reason than above|0|||
16106533|NCT01193218|38878750|FG002|12-52 Weeks|Other reason than above|0|||
16106534|NCT01193218|38878751|FG003|12-52 Weeks|Other reason than above|1|||
16540632|NCT00540124|40440125|FG002|Overall Study|Withdrawal by Subject|0|||
16540633|NCT02338154|40440126|FG000|Overall Study|Death|46|||
16106535|NCT01193218|38878752|FG004|12-52 Weeks|Other reason than above|1|||
16106536|NCT01193218|38878753|FG005|12-52 Weeks|Other reason than above|0|||
16106537|NCT01193218|38878754|FG006|12-52 Weeks|Other reason than above|0|||
16106538|NCT01193218|38878755|FG007|12-52 Weeks|Other reason than above|0|||
16106539|NCT00792259|38878756|FG000|Overall Study|Poor Quality Scans|1|||
16106540|NCT00792259|38878757|FG001|Overall Study|Poor Quality Scans|0|||
16106541|NCT00792259|38878758|FG002|Overall Study|Poor Quality Scans|0|||
16106542|NCT00519285|38878759|FG000|Overall Study|Adverse Event|127|||
16106543|NCT00519285|38878760|FG001|Overall Study|Adverse Event|266|||
16106544|NCT00519285|38878759|FG000|Overall Study|Disease progression|334|||
16106545|NCT00519285|38878760|FG001|Overall Study|Disease progression|186|||
16106546|NCT00519285|38878759|FG000|Overall Study|Physician Decision|75|||
16106547|NCT00519285|38878760|FG001|Overall Study|Physician Decision|47|||
16106548|NCT00519285|38878759|FG000|Overall Study|Participant's request|53|||
16106549|NCT00519285|38878760|FG001|Overall Study|Participant's request|84|||
16106550|NCT00519285|38878759|FG000|Overall Study|Consent withdrawn|4|||
16540634|NCT02338154|40440126|FG000|Overall Study|Valve Implant Failure|17|||
16540635|NCT02338154|40440126|FG000|Overall Study|Valve Explant|11|||
16540636|NCT02338154|40440126|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
16540637|NCT02338154|40440126|FG000|Overall Study|Lost to Follow-up|8|||
16540638|NCT02338154|40440126|FG000|Overall Study|Other Reason|3|||
16540639|NCT02338154|40440126|FG000|Overall Study|Patients Without Exit Form|47|||
16340735|NCT04227405|39734410|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
16340736|NCT04227405|39734411|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
16340737|NCT04227405|39734410|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
16340738|NCT04227405|39734411|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
16340739|NCT04227405|39734410|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
16340740|NCT04227405|39734411|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
16340741|NCT01808222|39734413|FG000|Overall Study|mpMR scan was not performed|1|||
16340742|NCT03230838|39734414|FG000|Overall Study|Withdrawal by Subject|3|||
16340743|NCT03230838|39734415|FG001|Overall Study|Withdrawal by Subject|0|||
16340744|NCT03230838|39734414|FG000|Overall Study|Temperature excursion|1|||
16340745|NCT03230838|39734415|FG001|Overall Study|Temperature excursion|0|||
16340746|NCT02821416|39734418|FG000|Overall Study|Adverse Event|0|||
16340747|NCT02821416|39734419|FG001|Overall Study|Adverse Event|1|||
16340748|NCT02821416|39734418|FG000|Overall Study|Withdrawal by Subject|2|||
16340749|NCT02821416|39734419|FG001|Overall Study|Withdrawal by Subject|0|||
16340750|NCT02821416|39734418|FG000|Overall Study|Lost to Follow-up|1|||
16340751|NCT02821416|39734419|FG001|Overall Study|Lost to Follow-up|0|||
16340752|NCT04105842|39734425|FG000|Overall Study|Withdrawal by Subject|2|||
16340753|NCT00551525|39734426|FG000|Overall Study|Protocol Violation|5|||
16340754|NCT00162097|39734430|FG000|Overall Study|Participant no longer met study criteria|0|||
16340755|NCT00162097|39734431|FG001|Overall Study|Participant no longer met study criteria|0|||
16340756|NCT00162097|39734432|FG002|Overall Study|Participant no longer met study criteria|0|||
16106551|NCT00519285|38878760|FG001|Overall Study|Consent withdrawn|5|||
16106552|NCT00519285|38878759|FG000|Overall Study|Poor compliance to protocol|5|||
16106553|NCT00519285|38878760|FG001|Overall Study|Poor compliance to protocol|7|||
16106554|NCT00519285|38878759|FG000|Overall Study|Reason unspecified|5|||
16106555|NCT00519285|38878760|FG001|Overall Study|Reason unspecified|8|||
16106556|NCT00519285|38878759|FG000|Overall Study|Not treated|8|||
16106557|NCT00519285|38878760|FG001|Overall Study|Not treated|7|||
16106558|NCT00519285|38878759|FG000|Overall Study|Treatment ongoing|1|||
16106559|NCT00519285|38878760|FG001|Overall Study|Treatment ongoing|2|||
16540640|NCT02338154|40440126|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
16540641|NCT00587964|40440130|FG000|Overall Study|Withdrawal by Subject|1|||
16540642|NCT00587964|40440130|FG000|Overall Study|Lost to Follow-up|1|||
16540643|NCT00587964|40440130|FG000|Overall Study|Patient found to be ineligible|1|||
16540644|NCT00587964|40440130|FG000|Overall Study|Patient did not receive intervention|5|||
16540645|NCT00587964|40440130|FG000|Overall Study|Progression of Disease|4|||
16540646|NCT01471054|40440132|FG000|Overall Study|Study terminated prematurely|4|||
16540647|NCT01471054|40440133|FG001|Overall Study|Study terminated prematurely|0|||
16540648|NCT02954354|40440134|FG000|Overall Study|Adverse Event|2|||
16540649|NCT02954354|40440135|FG001|Overall Study|Adverse Event|2|||
16540650|NCT02954354|40440136|FG002|Overall Study|Adverse Event|4|||
16540651|NCT02954354|40440134|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
16540652|NCT02954354|40440135|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
16540653|NCT02954354|40440136|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
16540654|NCT02954354|40440134|FG000|Overall Study|Lack of Efficacy|0|||
16540655|NCT02954354|40440135|FG001|Overall Study|Lack of Efficacy|2|||
16106560|NCT02647788|38878761|FG000|Overall Study|Lost to Follow-up|13|||
16106561|NCT02647788|38878762|FG001|Overall Study|Lost to Follow-up|11|||
16106562|NCT02647788|38878761|FG000|Overall Study|Did not want opiate|0|||
16106563|NCT02647788|38878762|FG001|Overall Study|Did not want opiate|1|||
16540656|NCT02954354|40440136|FG002|Overall Study|Lack of Efficacy|0|||
16540657|NCT02954354|40440134|FG000|Overall Study|Withdrawal by Subject|17|||
16540658|NCT02954354|40440135|FG001|Overall Study|Withdrawal by Subject|9|||
16540659|NCT02954354|40440136|FG002|Overall Study|Withdrawal by Subject|11|||
16540660|NCT02954354|40440134|FG000|Overall Study|Lost to Follow-up|12|||
16540661|NCT02954354|40440135|FG001|Overall Study|Lost to Follow-up|5|||
16540662|NCT02954354|40440136|FG002|Overall Study|Lost to Follow-up|0|||
16540663|NCT02954354|40440134|FG000|Overall Study|Miscellaneous|2|||
16106564|NCT02647788|38878761|FG000|Overall Study|Withdrawal by Subject|1|||
16340757|NCT00162097|39734433|FG003|Overall Study|Participant no longer met study criteria|1|||
16340758|NCT02588664|39734434|FG000|Overall Study|Death|56|||
16540664|NCT02954354|40440135|FG001|Overall Study|Miscellaneous|2|||
16540665|NCT02954354|40440136|FG002|Overall Study|Miscellaneous|1|||
16540666|NCT00620750|40440137|FG000|Overall Study|Lost to Follow-up|25|||
16540667|NCT01944631|40440138|FG000|Overall Study|Adverse Event|1|||
16540668|NCT01944631|40440139|FG001|Overall Study|Adverse Event|0|||
16540669|NCT01944631|40440138|FG000|Overall Study|Lost to Follow-up|3|||
16106565|NCT02647788|38878762|FG001|Overall Study|Withdrawal by Subject|0|||
16540670|NCT01944631|40440139|FG001|Overall Study|Lost to Follow-up|1|||
16340759|NCT02588664|39734435|FG001|Overall Study|Death|55|||
16340760|NCT02588664|39734434|FG000|Overall Study|Lost to Follow-up|1305|||
16340761|NCT02588664|39734435|FG001|Overall Study|Lost to Follow-up|990|||
16340762|NCT04152083|39734436|FG000|Overall Study|Lost to Follow-up|2|||
16340763|NCT04152083|39734437|FG001|Overall Study|Lost to Follow-up|1|||
16340764|NCT04152083|39734436|FG000|Overall Study|Adverse Event|1|||
16340765|NCT04152083|39734437|FG001|Overall Study|Adverse Event|0|||
16340766|NCT04152083|39734436|FG000|Overall Study|Randomized but not treated|3|||
16340767|NCT04152083|39734437|FG001|Overall Study|Randomized but not treated|2|||
16340768|NCT00594386|39734438|FG000|Overall Study|Major protocol violation|2|||
16340769|NCT00594386|39734438|FG000|Overall Study|Lack of Efficacy|12|||
16340770|NCT00594386|39734438|FG000|Overall Study|Adverse Event|68|||
16340771|NCT00594386|39734438|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
16106566|NCT02647788|38878761|FG000|Overall Study|Felt itchy with assigned medication|1|||
16106567|NCT02647788|38878762|FG001|Overall Study|Felt itchy with assigned medication|0|||
16106568|NCT02647788|38878761|FG000|Overall Study|Felt nauseous with assigned medication|1|||
16106569|NCT02647788|38878762|FG001|Overall Study|Felt nauseous with assigned medication|1|||
16106570|NCT00746785|38878772|FG000|Overall Study|Lost to Follow-up|29|||
16106571|NCT00746785|38878773|FG001|Overall Study|Lost to Follow-up|25|||
16106572|NCT00746785|38878774|FG002|Overall Study|Lost to Follow-up|27|||
16106573|NCT01841697|38878775|FG000|Overall Study|Death|0|||
16106574|NCT01841697|38878776|FG001|Overall Study|Death|1|||
16340772|NCT00594386|39734438|FG000|Overall Study|Subject withdrew consent|35|||
16340773|NCT00594386|39734438|FG000|Overall Study|Study ended per sponsor|115|||
16340774|NCT00594386|39734438|FG000|Overall Study|Lost to Follow-up|6|||
16340775|NCT00594386|39734438|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
16340776|NCT00594386|39734438|FG000|Overall Study|Other: Subject moved to Seattle|1|||
16340777|NCT00594386|39734438|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
16340778|NCT00594386|39734438|FG000|Overall Study|Other: Study terminated per investigator|2|||
16340779|NCT00594386|39734438|FG000|Overall Study|Other: Sponsor closure of study|1|||
16340780|NCT00594386|39734438|FG000|Overall Study|Other: Site terminated participation|1|||
16340781|NCT00594386|39734438|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
16340782|NCT00594386|39734438|FG000|Overall Study|Other: Loss of drivers license|1|||
16340783|NCT01162122|39734439|FG000|Overall Study|Withdrawal by Subject|52|||
16340784|NCT01162122|39734440|FG001|Overall Study|Withdrawal by Subject|43|||
16340785|NCT01162122|39734439|FG000|Overall Study|Lost to Follow-up|73|||
16340786|NCT01162122|39734440|FG001|Overall Study|Lost to Follow-up|91|||
16340787|NCT01162122|39734439|FG000|Overall Study|Adverse Event|3|||
16340788|NCT01162122|39734440|FG001|Overall Study|Adverse Event|2|||
16340789|NCT01162122|39734439|FG000|Overall Study|Death|51|||
16340790|NCT01162122|39734440|FG001|Overall Study|Death|46|||
16340791|NCT01162122|39734439|FG000|Overall Study|Protocol Violation|2|||
16340792|NCT01162122|39734440|FG001|Overall Study|Protocol Violation|2|||
16340793|NCT01162122|39734439|FG000|Overall Study|Inappropriate enrollment|5|||
16340794|NCT01162122|39734440|FG001|Overall Study|Inappropriate enrollment|4|||
16340795|NCT01162122|39734439|FG000|Overall Study|Administrative reason|1|||
16340796|NCT01162122|39734440|FG001|Overall Study|Administrative reason|1|||
16340797|NCT01162122|39734439|FG000|Overall Study|Unable to classify|3|||
16340798|NCT01162122|39734440|FG001|Overall Study|Unable to classify|7|||
16340799|NCT01162122|39734439|FG000|Overall Study|Missing primary reason|1|||
16340800|NCT01162122|39734440|FG001|Overall Study|Missing primary reason|0|||
16340801|NCT02065518|39734441|FG000|Overall Study|Lost to Follow-up|3|||
16340802|NCT02065518|39734442|FG001|Overall Study|Lost to Follow-up|4|||
16340803|NCT02065518|39734443|FG002|Overall Study|Lost to Follow-up|0|||
16340804|NCT02065518|39734444|FG003|Overall Study|Lost to Follow-up|3|||
16340805|NCT02065518|39734441|FG000|Overall Study|Withdrawal by Subject|3|||
16340806|NCT02065518|39734442|FG001|Overall Study|Withdrawal by Subject|4|||
16340807|NCT02065518|39734443|FG002|Overall Study|Withdrawal by Subject|9|||
16340808|NCT02065518|39734444|FG003|Overall Study|Withdrawal by Subject|2|||
16340809|NCT02584959|39734445|FG000|Period 1|Withdrawn from study|3|||
16340810|NCT02584959|39734446|FG001|Period 1|Withdrawn from study|4|||
16340811|NCT02584959|39734447|FG002|Period 1|Withdrawn from study|0|||
16340812|NCT02584959|39734445|FG000|Period 2|Withdrawn from study|6|||
16340813|NCT02584959|39734446|FG001|Period 2|Withdrawn from study|1|||
16340814|NCT02584959|39734447|FG002|Period 2|Withdrawn from study|2|||
16340815|NCT00731731|39734448|FG000|Overall Study|Protocol Violation|0|||
16340816|NCT00731731|39734449|FG001|Overall Study|Protocol Violation|0|||
16340817|NCT00731731|39734450|FG002|Overall Study|Protocol Violation|1|||
16340818|NCT00731731|39734448|FG000|Overall Study|Cancel prior to treatment|0|||
16340819|NCT00731731|39734449|FG001|Overall Study|Cancel prior to treatment|0|||
16340820|NCT00731731|39734450|FG002|Overall Study|Cancel prior to treatment|2|||
16340821|NCT01928199|39734451|FG000|Overall Study|Lost to Follow-up|2|||
16340822|NCT01928199|39734452|FG001|Overall Study|Lost to Follow-up|1|||
16340823|NCT01928199|39734451|FG000|Overall Study|Withdrawal by Subject|3|||
16340824|NCT01928199|39734452|FG001|Overall Study|Withdrawal by Subject|5|||
16340825|NCT02933528|39734453|FG000|Overall Study|Lost to Follow-up|2|||
16106575|NCT01841697|38878775|FG000|Overall Study|Lost to Follow-up|4|||
16540671|NCT01944631|40440138|FG000|Overall Study|Withdrawal by Subject|0|||
16540672|NCT01944631|40440139|FG001|Overall Study|Withdrawal by Subject|1|||
16540673|NCT01345630|40440140|FG000|Overall Study|Adverse Event|22|||
16540674|NCT01345630|40440141|FG001|Overall Study|Adverse Event|23|||
16540675|NCT01345630|40440140|FG000|Overall Study|Lost to Follow-up|17|||
16540676|NCT01345630|40440141|FG001|Overall Study|Lost to Follow-up|16|||
16540677|NCT01345630|40440140|FG000|Overall Study|Protocol Violation|4|||
16540678|NCT01345630|40440141|FG001|Overall Study|Protocol Violation|1|||
16540679|NCT01345630|40440140|FG000|Overall Study|Medication error without associated AE|0|||
16540680|NCT01345630|40440141|FG001|Overall Study|Medication error without associated AE|1|||
16540681|NCT01345630|40440140|FG000|Overall Study|Study terminated by sponsor|254|||
16540682|NCT01345630|40440141|FG001|Overall Study|Study terminated by sponsor|285|||
16540683|NCT01345630|40440140|FG000|Overall Study|Other reasons|6|||
16540684|NCT01345630|40440141|FG001|Overall Study|Other reasons|8|||
16540685|NCT01345630|40440140|FG000|Overall Study|Withdrawn due to pregnancy|1|||
16540686|NCT01345630|40440141|FG001|Overall Study|Withdrawn due to pregnancy|2|||
16540687|NCT01345630|40440140|FG000|Overall Study|No longer willing to participate|9|||
16340826|NCT00313586|39734456|FG000|Overall Study|Disease progression|14|||
16340827|NCT00313586|39734457|FG001|Overall Study|Disease progression|19|||
16540688|NCT01345630|40440141|FG001|Overall Study|No longer willing to participate|12|||
16540689|NCT01345630|40440140|FG000|Overall Study|Insufficient clinical response|48|||
16540690|NCT01345630|40440141|FG001|Overall Study|Insufficient clinical response|11|||
16540691|NCT00441701|40440142|FG000|Overall Study|Adverse Event|3|||
16540692|NCT00441701|40440143|FG001|Overall Study|Adverse Event|2|||
16540693|NCT00441701|40440144|FG002|Overall Study|Adverse Event|1|||
16540694|NCT00441701|40440145|FG003|Overall Study|Adverse Event|0|||
16540695|NCT00441701|40440146|FG004|Overall Study|Adverse Event|2|||
16540696|NCT00441701|40440147|FG005|Overall Study|Adverse Event|2|||
16540697|NCT00441701|40440148|FG006|Overall Study|Adverse Event|0|||
16540698|NCT00441701|40440149|FG007|Overall Study|Adverse Event|0|||
16540699|NCT00441701|40440150|FG008|Overall Study|Adverse Event|0|||
16540700|NCT00441701|40440151|FG009|Overall Study|Adverse Event|0|||
16540701|NCT00441701|40440142|FG000|Overall Study|Lack of Efficacy|2|||
16540702|NCT00441701|40440143|FG001|Overall Study|Lack of Efficacy|0|||
16540703|NCT00441701|40440144|FG002|Overall Study|Lack of Efficacy|2|||
16540704|NCT00441701|40440145|FG003|Overall Study|Lack of Efficacy|2|||
16540705|NCT00441701|40440146|FG004|Overall Study|Lack of Efficacy|0|||
16540706|NCT00441701|40440147|FG005|Overall Study|Lack of Efficacy|1|||
16540707|NCT00441701|40440148|FG006|Overall Study|Lack of Efficacy|0|||
16540708|NCT00441701|40440149|FG007|Overall Study|Lack of Efficacy|0|||
16540709|NCT00441701|40440150|FG008|Overall Study|Lack of Efficacy|0|||
16218157|NCT01693562|39278675|FG005|Exploration Phase|Withdrawal by Subject|0|||
16540710|NCT00441701|40440151|FG009|Overall Study|Lack of Efficacy|0|||
16540711|NCT00441701|40440142|FG000|Overall Study|Withdrawal by Subject|0|||
16540712|NCT00441701|40440143|FG001|Overall Study|Withdrawal by Subject|2|||
16218158|NCT01693562|39278676|FG006|Exploration Phase|Withdrawal by Subject|2|||
16218159|NCT01693562|39278677|FG007|Exploration Phase|Withdrawal by Subject|0|||
16340828|NCT00313586|39734458|FG002|Overall Study|Disease progression|10|||
16340829|NCT00313586|39734459|FG003|Overall Study|Disease progression|3|||
16340830|NCT00313586|39734456|FG000|Overall Study|Adverse Event|12|||
16340831|NCT00313586|39734457|FG001|Overall Study|Adverse Event|18|||
16340832|NCT00313586|39734458|FG002|Overall Study|Adverse Event|3|||
16340833|NCT00313586|39734459|FG003|Overall Study|Adverse Event|10|||
16340834|NCT00313586|39734456|FG000|Overall Study|Death|11|||
16340835|NCT00313586|39734457|FG001|Overall Study|Death|8|||
16540713|NCT00441701|40440144|FG002|Overall Study|Withdrawal by Subject|1|||
16106576|NCT01841697|38878776|FG001|Overall Study|Lost to Follow-up|1|||
16218160|NCT01693562|39278678|FG008|Exploration Phase|Withdrawal by Subject|0|||
16340836|NCT00313586|39734458|FG002|Overall Study|Death|1|||
16340837|NCT00313586|39734459|FG003|Overall Study|Death|7|||
16340838|NCT00313586|39734456|FG000|Overall Study|Withdrawal by Subject|13|||
16540714|NCT00441701|40440145|FG003|Overall Study|Withdrawal by Subject|1|||
16540715|NCT00441701|40440146|FG004|Overall Study|Withdrawal by Subject|0|||
16540716|NCT00441701|40440147|FG005|Overall Study|Withdrawal by Subject|0|||
16540717|NCT00441701|40440148|FG006|Overall Study|Withdrawal by Subject|0|||
16540718|NCT00441701|40440149|FG007|Overall Study|Withdrawal by Subject|0|||
16540719|NCT00441701|40440150|FG008|Overall Study|Withdrawal by Subject|0|||
16540720|NCT00441701|40440151|FG009|Overall Study|Withdrawal by Subject|0|||
16540721|NCT00833560|40440153|FG000|Overall Study|Toxicity|13|||
16340839|NCT00313586|39734457|FG001|Overall Study|Withdrawal by Subject|6|||
16340840|NCT00313586|39734458|FG002|Overall Study|Withdrawal by Subject|6|||
16340841|NCT00313586|39734459|FG003|Overall Study|Withdrawal by Subject|2|||
16340842|NCT00313586|39734456|FG000|Overall Study|Alternative therapy|3|||
16340843|NCT00313586|39734457|FG001|Overall Study|Alternative therapy|6|||
16340844|NCT00313586|39734458|FG002|Overall Study|Alternative therapy|2|||
16540722|NCT00833560|40440153|FG000|Overall Study|Adverse Event|11|||
16540723|NCT00833560|40440153|FG000|Overall Study|Protocol Violation|6|||
16540724|NCT00833560|40440153|FG000|Overall Study|Lack of Efficacy|4|||
16540725|NCT00833560|40440153|FG000|Overall Study|Death|2|||
16540726|NCT00833560|40440153|FG000|Overall Study|Pregression of other disease|1|||
16540727|NCT00833560|40440153|FG000|Overall Study|Other|5|||
16540728|NCT01505387|40440154|FG000|Overall Study|Protocol Violation|1|||
16540729|NCT01505387|40440155|FG001|Overall Study|Protocol Violation|0|||
16540730|NCT01505387|40440154|FG000|Overall Study|Withdrawal by Subject|1|||
16540731|NCT01505387|40440155|FG001|Overall Study|Withdrawal by Subject|1|||
16540732|NCT00335452|40440156|FG000|Overall Study|Death|156|||
16540733|NCT00335452|40440157|FG001|Overall Study|Death|144|||
16540734|NCT00335452|40440158|FG002|Overall Study|Death|158|||
16540735|NCT00335452|40440159|FG003|Overall Study|Death|129|||
16540736|NCT00335452|40440156|FG000|Overall Study|Lost to Follow-up|2|||
16540737|NCT00335452|40440157|FG001|Overall Study|Lost to Follow-up|3|||
16540738|NCT00335452|40440158|FG002|Overall Study|Lost to Follow-up|1|||
16540739|NCT00335452|40440159|FG003|Overall Study|Lost to Follow-up|2|||
16540740|NCT04044456|40440160|FG000|Overall Study|Lost to Follow-up|4|||
16540741|NCT04044456|40440161|FG001|Overall Study|Lost to Follow-up|1|||
16540742|NCT04044456|40440160|FG000|Overall Study|Withdrawal by Subject|1|||
16540743|NCT04044456|40440161|FG001|Overall Study|Withdrawal by Subject|0|||
16540744|NCT02274857|40440162|FG000|Overall Study|Adverse Event|1|||
16340845|NCT00313586|39734459|FG003|Overall Study|Alternative therapy|0|||
16340846|NCT00313586|39734456|FG000|Overall Study|Other complicating disease|2|||
16340847|NCT00313586|39734457|FG001|Overall Study|Other complicating disease|2|||
16340848|NCT00313586|39734458|FG002|Overall Study|Other complicating disease|0|||
16340849|NCT00313586|39734459|FG003|Overall Study|Other complicating disease|0|||
16340850|NCT00313586|39734456|FG000|Overall Study|Did not achieve HI-major/better response|10|||
16340851|NCT00313586|39734457|FG001|Overall Study|Did not achieve HI-major/better response|7|||
16106577|NCT01841697|38878775|FG000|Overall Study|Withdrawal by Subject|16|||
16106578|NCT01841697|38878776|FG001|Overall Study|Withdrawal by Subject|16|||
16106579|NCT03023423|38878777|FG000|Overall Study|Death|5|||
16106580|NCT03023423|38878778|FG001|Overall Study|Death|12|||
16106581|NCT03023423|38878779|FG002|Overall Study|Death|20|||
16106582|NCT03023423|38878777|FG000|Overall Study|Other|0|||
16106583|NCT03023423|38878778|FG001|Overall Study|Other|2|||
16106584|NCT03023423|38878779|FG002|Overall Study|Other|2|||
16106585|NCT03023423|38878777|FG000|Overall Study|Ongoing|2|||
16106586|NCT03023423|38878778|FG001|Overall Study|Ongoing|32|||
16106587|NCT03023423|38878779|FG002|Overall Study|Ongoing|24|||
16106588|NCT01263925|38878781|FG000|Overall Study|Protocol Violation|1|||
16106589|NCT01263925|38878782|FG001|Overall Study|Protocol Violation|0|||
16106590|NCT01263925|38878781|FG000|Overall Study|Lack of Efficacy|0|||
16106591|NCT01263925|38878782|FG001|Overall Study|Lack of Efficacy|1|||
16106592|NCT01263925|38878781|FG000|Overall Study|Adverse Event|23|||
16106593|NCT01263925|38878782|FG001|Overall Study|Adverse Event|22|||
16106594|NCT01263925|38878781|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
16106595|NCT01263925|38878782|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
16106596|NCT01263925|38878781|FG000|Overall Study|Withdrawal by Subject|6|||
16106597|NCT01263925|38878782|FG001|Overall Study|Withdrawal by Subject|8|||
16218161|NCT01693562|39278679|FG009|Exploration Phase|Withdrawal by Subject|0|||
16540745|NCT02274857|40440163|FG001|Overall Study|Adverse Event|0|||
16540746|NCT02274857|40440162|FG000|Overall Study|Death|1|||
16218162|NCT01693562|39278680|FG010|Exploration Phase|Withdrawal by Subject|0|||
16340852|NCT00313586|39734458|FG002|Overall Study|Did not achieve HI-major/better response|2|||
16340853|NCT00313586|39734459|FG003|Overall Study|Did not achieve HI-major/better response|1|||
16540747|NCT02274857|40440163|FG001|Overall Study|Death|2|||
16106598|NCT01263925|38878781|FG000|Overall Study|Other|4|||
16106599|NCT01263925|38878782|FG001|Overall Study|Other|4|||
16106600|NCT01263925|38878781|FG000|Overall Study|Lost to Follow-up|3|||
16106601|NCT01263925|38878782|FG001|Overall Study|Lost to Follow-up|1|||
16540748|NCT02274857|40440162|FG000|Overall Study|Lost to Follow-up|3|||
16540749|NCT02274857|40440163|FG001|Overall Study|Lost to Follow-up|0|||
16540750|NCT02274857|40440162|FG000|Overall Study|Physician Decision|2|||
16540751|NCT02274857|40440163|FG001|Overall Study|Physician Decision|0|||
16340854|NCT00313586|39734456|FG000|Overall Study|Physician Decision|2|||
16340855|NCT00313586|39734457|FG001|Overall Study|Physician Decision|1|||
16340856|NCT00313586|39734458|FG002|Overall Study|Physician Decision|0|||
16340857|NCT00313586|39734459|FG003|Overall Study|Physician Decision|0|||
16340858|NCT00313586|39734456|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
16340859|NCT00313586|39734457|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
16340860|NCT00313586|39734458|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
16340861|NCT00313586|39734459|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
16340862|NCT00313586|39734456|FG000|Overall Study|Lost insurance|0|||
16340863|NCT00313586|39734457|FG001|Overall Study|Lost insurance|1|||
16340864|NCT00313586|39734458|FG002|Overall Study|Lost insurance|0|||
16340865|NCT00313586|39734459|FG003|Overall Study|Lost insurance|0|||
16340866|NCT00313586|39734456|FG000|Overall Study|Moved|0|||
16340867|NCT00313586|39734457|FG001|Overall Study|Moved|1|||
16540752|NCT02274857|40440162|FG000|Overall Study|Trial screen failure|0|||
16540753|NCT02274857|40440163|FG001|Overall Study|Trial screen failure|2|||
16540754|NCT02274857|40440162|FG000|Overall Study|Withdrawal by Subject|11|||
16540755|NCT02274857|40440163|FG001|Overall Study|Withdrawal by Subject|2|||
16540756|NCT02274857|40440162|FG000|Overall Study|Other|2|||
16540757|NCT02274857|40440163|FG001|Overall Study|Other|0|||
16540758|NCT04398537|40440164|FG000|Overall Study|Physician Decision|10|||
16540759|NCT04398537|40440165|FG001|Overall Study|Physician Decision|15|||
16540760|NCT00180479|40440171|FG000|Overall Study|Death|4|||
16540761|NCT00180479|40440172|FG001|Overall Study|Death|2|||
16540762|NCT00180479|40440171|FG000|Overall Study|Lost to Follow-up|9|||
16540763|NCT00180479|40440172|FG001|Overall Study|Lost to Follow-up|7|||
16540764|NCT00180479|40440171|FG000|Overall Study|Withdrawal by Subject|3|||
16340868|NCT00313586|39734458|FG002|Overall Study|Moved|0|||
16340869|NCT00313586|39734459|FG003|Overall Study|Moved|0|||
16340870|NCT00313586|39734456|FG000|Overall Study|Death before starting treatment|1|||
16340871|NCT00313586|39734457|FG001|Overall Study|Death before starting treatment|0|||
16540765|NCT00180479|40440172|FG001|Overall Study|Withdrawal by Subject|3|||
16540766|NCT00180479|40440171|FG000|Overall Study|Informed consent not signed|0|||
16540767|NCT00180479|40440172|FG001|Overall Study|Informed consent not signed|1|||
16540768|NCT02384759|40440173|FG000|Overall Study|Patients not treated|3|||
16540769|NCT02384759|40440174|FG001|Overall Study|Patients not treated|2|||
16540770|NCT04721925|40440184|FG000|2-Month Assessment|Lost to Follow-up|5|||
16540771|NCT04721925|40440185|FG001|2-Month Assessment|Lost to Follow-up|3|||
16540772|NCT04721925|40440184|FG000|4-Month Assessment|Lost to Follow-up|3|||
16540773|NCT04721925|40440185|FG001|4-Month Assessment|Lost to Follow-up|6|||
16540774|NCT01654601|40440186|FG000|1st Administration|Withdrawal by Subject|2|||
16540775|NCT01654601|40440187|FG001|1st Administration|Withdrawal by Subject|0|||
16540776|NCT01654601|40440186|FG000|1st Administration|Protocol Violation|0|||
16540777|NCT01654601|40440187|FG001|1st Administration|Protocol Violation|2|||
16540778|NCT01654601|40440186|FG000|2nd Administration|Adverse Event|1|||
16540779|NCT01654601|40440187|FG001|2nd Administration|Adverse Event|0|||
16540780|NCT01654601|40440186|FG000|2nd Administration|Protocol Violation|0|||
16540781|NCT01654601|40440187|FG001|2nd Administration|Protocol Violation|1|||
16540782|NCT01221948|40440188|FG000|Overall Study|Physician Decision|5|||
16540783|NCT01221948|40440188|FG000|Overall Study|Withdrawal by Subject|2|||
16540784|NCT01221948|40440188|FG000|Overall Study|not disclosed|2|||
16540785|NCT01221948|40440188|FG000|Overall Study|Death|1|||
16540786|NCT01221948|40440188|FG000|Overall Study|Protocol Violation|4|||
16218163|NCT01693562|39278681|FG011|Exploration Phase|Withdrawal by Subject|0|||
16540787|NCT03496662|40440191|FG000|Overall Study|Adverse Event|1|||
16540788|NCT03496662|40440192|FG001|Overall Study|Adverse Event|0|||
16540789|NCT03496662|40440193|FG002|Overall Study|Adverse Event|1|||
16540790|NCT03496662|40440191|FG000|Overall Study|Physician Decision|1|||
16540791|NCT03496662|40440192|FG001|Overall Study|Physician Decision|0|||
16540792|NCT03496662|40440193|FG002|Overall Study|Physician Decision|3|||
16540793|NCT03496662|40440191|FG000|Overall Study|Withdrawal by Subject|0|||
16540794|NCT03496662|40440192|FG001|Overall Study|Withdrawal by Subject|0|||
16540795|NCT03496662|40440193|FG002|Overall Study|Withdrawal by Subject|2|||
16540796|NCT03496662|40440191|FG000|Overall Study|Death|0|||
16218164|NCT01693562|39278682|FG012|Exploration Phase|Withdrawal by Subject|0|||
16218165|NCT01693562|39278683|FG013|Exploration Phase|Withdrawal by Subject|0|||
16340872|NCT00313586|39734458|FG002|Overall Study|Death before starting treatment|0|||
16340873|NCT00313586|39734459|FG003|Overall Study|Death before starting treatment|0|||
16340874|NCT01306214|39734460|FG000|Overall Study|Death|0|||
16340875|NCT01306214|39734461|FG001|Overall Study|Death|0|||
16540797|NCT03496662|40440192|FG001|Overall Study|Death|0|||
16540798|NCT03496662|40440193|FG002|Overall Study|Death|2|||
16540799|NCT03496662|40440191|FG000|Overall Study|Noncompliance|0|||
16540800|NCT03496662|40440192|FG001|Overall Study|Noncompliance|0|||
16540801|NCT03496662|40440193|FG002|Overall Study|Noncompliance|1|||
16540802|NCT02120027|40440194|FG000|Overall Study|Adverse Event|4|||
16540803|NCT02120027|40440195|FG001|Overall Study|Adverse Event|5|||
16540804|NCT02120027|40440194|FG000|Overall Study|Lack of Efficacy|3|||
16540805|NCT02120027|40440195|FG001|Overall Study|Lack of Efficacy|5|||
16340876|NCT01306214|39734462|FG002|Overall Study|Death|1|||
16340877|NCT01306214|39734460|FG000|Overall Study|Lost to Follow-up|3|||
16340878|NCT01306214|39734461|FG001|Overall Study|Lost to Follow-up|5|||
16340879|NCT01306214|39734462|FG002|Overall Study|Lost to Follow-up|4|||
16340880|NCT01306214|39734460|FG000|Overall Study|Withdrawal by Subject|24|||
16340881|NCT01306214|39734461|FG001|Overall Study|Withdrawal by Subject|22|||
16340882|NCT01306214|39734462|FG002|Overall Study|Withdrawal by Subject|16|||
16340883|NCT01306214|39734460|FG000|Overall Study|Not treated|1|||
16340884|NCT01306214|39734461|FG001|Overall Study|Not treated|1|||
16340885|NCT01306214|39734462|FG002|Overall Study|Not treated|1|||
16340886|NCT00885378|39734465|FG000|Overall Study|Lack of Efficacy|2|||
16340887|NCT00885378|39734466|FG001|Overall Study|Lack of Efficacy|2|||
16106602|NCT01263925|38878781|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
16106603|NCT01263925|38878782|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
16106604|NCT01263925|38878781|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
16106605|NCT01263925|38878782|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
16106606|NCT01263925|38878781|FG000|Overall Study|AE/ Withdrawal|1|||
16106607|NCT01263925|38878782|FG001|Overall Study|AE/ Withdrawal|4|||
16106608|NCT01263925|38878781|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
16106609|NCT01263925|38878782|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
16540806|NCT02120027|40440194|FG000|Overall Study|Lost to Follow-up|5|||
16540807|NCT02120027|40440195|FG001|Overall Study|Lost to Follow-up|13|||
16106610|NCT01263925|38878781|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
16106611|NCT01263925|38878782|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
16106612|NCT01263925|38878781|FG000|Overall Study|Withdrawal/ Not specified|0|||
16106613|NCT01263925|38878782|FG001|Overall Study|Withdrawal/ Not specified|1|||
16106614|NCT01278615|38878783|FG000|Overall Study|Withdrawal by Subject|2|||
16106615|NCT04486313|38878784|FG000|Overall Study|Lost to Follow-up|7|||
16106616|NCT04486313|38878785|FG001|Overall Study|Lost to Follow-up|9|||
16106617|NCT04486313|38878784|FG000|Overall Study|Withdrawal by Subject|8|||
16106618|NCT04486313|38878785|FG001|Overall Study|Withdrawal by Subject|6|||
16106619|NCT04486313|38878784|FG000|Overall Study|Physician Decision|1|||
16106620|NCT04486313|38878785|FG001|Overall Study|Physician Decision|1|||
16106621|NCT04486313|38878784|FG000|Overall Study|Death|2|||
16106622|NCT04486313|38878785|FG001|Overall Study|Death|0|||
16106623|NCT04486313|38878784|FG000|Overall Study|Protocol Violation|1|||
16106624|NCT04486313|38878785|FG001|Overall Study|Protocol Violation|1|||
16106625|NCT04772313|38878786|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
16106626|NCT04772313|38878786|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
16106627|NCT01797562|38878787|FG000|Overall Study|Protocol Violation|5|||
16106628|NCT02633397|38878788|FG000|Overall Study|Adverse Event|8|||
16106629|NCT02633397|38878789|FG001|Overall Study|Adverse Event|8|||
16106630|NCT02633397|38878788|FG000|Overall Study|Study Burden|4|||
16106631|NCT02633397|38878789|FG001|Overall Study|Study Burden|1|||
16106632|NCT02633397|38878788|FG000|Overall Study|Treatment interruption|2|||
16106633|NCT02633397|38878789|FG001|Overall Study|Treatment interruption|5|||
16106634|NCT02633397|38878788|FG000|Overall Study|Death|2|||
16340888|NCT00885378|39734465|FG000|Overall Study|Withdrawal by Subject|1|||
16340889|NCT00885378|39734466|FG001|Overall Study|Withdrawal by Subject|2|||
16540808|NCT02120027|40440194|FG000|Overall Study|Other|4|||
16540809|NCT02120027|40440195|FG001|Overall Study|Other|0|||
16540810|NCT02120027|40440194|FG000|Overall Study|Physician Decision|4|||
16540811|NCT02120027|40440195|FG001|Overall Study|Physician Decision|3|||
16540812|NCT02120027|40440194|FG000|Overall Study|Protocol Violation|18|||
16540813|NCT02120027|40440195|FG001|Overall Study|Protocol Violation|21|||
16540814|NCT02120027|40440194|FG000|Overall Study|Study terminated by Sponsor|45|||
16540815|NCT02120027|40440195|FG001|Overall Study|Study terminated by Sponsor|47|||
16540816|NCT02120027|40440194|FG000|Overall Study|Withdrawal by Subject|33|||
16540817|NCT02120027|40440195|FG001|Overall Study|Withdrawal by Subject|25|||
16540818|NCT02342886|40440197|FG000|Overall Study|Treatment non-compliance|1|||
16540819|NCT02342886|40440198|FG001|Overall Study|Treatment non-compliance|0|||
16540820|NCT02342886|40440199|FG002|Overall Study|Treatment non-compliance|0|||
16540821|NCT02342886|40440200|FG003|Overall Study|Treatment non-compliance|1|||
16540822|NCT02342886|40440201|FG004|Overall Study|Treatment non-compliance|0|||
16540823|NCT02342886|40440197|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
16540824|NCT02342886|40440198|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
16540825|NCT02342886|40440199|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
16540826|NCT02342886|40440200|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
16540827|NCT02342886|40440201|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
16540828|NCT02342886|40440197|FG000|Overall Study|Adverse event/specific toxicity|4|||
16340890|NCT00885378|39734465|FG000|Overall Study|Lost to Follow-up|1|||
16540829|NCT02342886|40440198|FG001|Overall Study|Adverse event/specific toxicity|3|||
16106635|NCT02633397|38878789|FG001|Overall Study|Death|2|||
16106636|NCT02633397|38878788|FG000|Overall Study|Physician Decision|0|||
16106637|NCT02633397|38878789|FG001|Overall Study|Physician Decision|1|||
16340891|NCT00885378|39734466|FG001|Overall Study|Lost to Follow-up|2|||
16106638|NCT01066936|38878790|FG000|Overall Study|Death|2|||
16106639|NCT01066936|38878790|FG000|Overall Study|Device revised/removed|1|||
16106640|NCT01066936|38878790|FG000|Overall Study|Lost to Follow-up|3|||
16106641|NCT01066936|38878790|FG000|Overall Study|Withdrawal by Subject|4|||
16106642|NCT03772613|38878796|FG000|Overall Study|Lost to Follow-up|0|||
16106643|NCT03772613|38878797|FG001|Overall Study|Lost to Follow-up|1|||
16540830|NCT02342886|40440199|FG002|Overall Study|Adverse event/specific toxicity|11|||
16540831|NCT02342886|40440200|FG003|Overall Study|Adverse event/specific toxicity|2|||
16106644|NCT03772613|38878798|FG002|Overall Study|Lost to Follow-up|1|||
16106645|NCT01274559|38878802|FG000|Overall Study|Adverse Event|57|||
16106646|NCT01274559|38878803|FG001|Overall Study|Adverse Event|13|||
16106647|NCT01274559|38878802|FG000|Overall Study|Death|1|||
16106648|NCT01274559|38878803|FG001|Overall Study|Death|1|||
16106649|NCT01274559|38878802|FG000|Overall Study|Lost to Follow-up|3|||
16106650|NCT01274559|38878803|FG001|Overall Study|Lost to Follow-up|3|||
16106651|NCT01274559|38878802|FG000|Overall Study|Non-compliance with Study Drug|2|||
16106652|NCT01274559|38878803|FG001|Overall Study|Non-compliance with Study Drug|4|||
16106653|NCT01274559|38878802|FG000|Overall Study|Physician Decision|2|||
16106654|NCT01274559|38878803|FG001|Overall Study|Physician Decision|1|||
16106655|NCT01274559|38878802|FG000|Overall Study|Protocol Violation|28|||
16540832|NCT02342886|40440201|FG004|Overall Study|Adverse event/specific toxicity|1|||
16540833|NCT02342886|40440197|FG000|Overall Study|Lost to Follow-up|1|||
16540834|NCT02342886|40440198|FG001|Overall Study|Lost to Follow-up|0|||
16540835|NCT02342886|40440199|FG002|Overall Study|Lost to Follow-up|0|||
16540836|NCT02342886|40440200|FG003|Overall Study|Lost to Follow-up|0|||
16540837|NCT02342886|40440201|FG004|Overall Study|Lost to Follow-up|0|||
16106656|NCT01274559|38878803|FG001|Overall Study|Protocol Violation|23|||
16106657|NCT01274559|38878802|FG000|Overall Study|Study Terminated by Sponsor|79|||
16106658|NCT01274559|38878803|FG001|Overall Study|Study Terminated by Sponsor|87|||
16106659|NCT01274559|38878802|FG000|Overall Study|Withdrawal by Subject|25|||
16106660|NCT01274559|38878803|FG001|Overall Study|Withdrawal by Subject|13|||
16106661|NCT01222533|38878804|FG000|Overall Study|Adverse Event|5|||
16106662|NCT01222533|38878804|FG000|Overall Study|Withdrawal by Subject|5|||
16106663|NCT01222533|38878804|FG000|Overall Study|Other|4|||
16106664|NCT03245619|38878805|FG000|Part A (Up to Day 22)|Physician Decision|4|||
16106665|NCT03245619|38878806|FG001|Part A (Up to Day 22)|Physician Decision|6|||
16106666|NCT03245619|38878807|FG002|Part A (Up to Day 22)|Physician Decision|6|||
16106667|NCT03245619|38878808|FG003|Part A (Up to Day 22)|Physician Decision|0|||
16106668|NCT03245619|38878809|FG004|Part A (Up to Day 22)|Physician Decision|0|||
16106669|NCT03245619|38878810|FG005|Part A (Up to Day 22)|Physician Decision|0|||
16106670|NCT03245619|38878811|FG006|Part A (Up to Day 22)|Physician Decision|0|||
16106671|NCT03245619|38878812|FG007|Part A (Up to Day 22)|Physician Decision|0|||
16106672|NCT03245619|38878813|FG008|Part A (Up to Day 22)|Physician Decision|0|||
16106673|NCT03245619|38878814|FG009|Part A (Up to Day 22)|Physician Decision|0|||
16106674|NCT03245619|38878815|FG010|Part A (Up to Day 22)|Physician Decision|0|||
16106675|NCT03245619|38878816|FG011|Part A (Up to Day 22)|Physician Decision|0|||
16106676|NCT03245619|38878817|FG012|Part A (Up to Day 22)|Physician Decision|0|||
16106677|NCT03245619|38878818|FG013|Part A (Up to Day 22)|Physician Decision|0|||
16106678|NCT03245619|38878819|FG014|Part A (Up to Day 22)|Physician Decision|0|||
16106679|NCT03245619|38878820|FG015|Part A (Up to Day 22)|Physician Decision|0|||
16106680|NCT03245619|38878821|FG016|Part A (Up to Day 22)|Physician Decision|0|||
16540838|NCT02342886|40440197|FG000|Overall Study|Death|1|||
16106681|NCT01726049|38878822|FG000|Overall Study|Death|1|||
16106682|NCT01726049|38878823|FG001|Overall Study|Death|1|||
16106683|NCT01726049|38878822|FG000|Overall Study|Adverse Event|4|||
16106684|NCT01726049|38878823|FG001|Overall Study|Adverse Event|1|||
16540839|NCT02342886|40440198|FG001|Overall Study|Death|2|||
16540840|NCT02342886|40440199|FG002|Overall Study|Death|1|||
16540841|NCT02342886|40440200|FG003|Overall Study|Death|0|||
16540842|NCT02342886|40440201|FG004|Overall Study|Death|1|||
16540843|NCT02342886|40440197|FG000|Overall Study|Withdrawal by Subject|0|||
16540844|NCT02342886|40440198|FG001|Overall Study|Withdrawal by Subject|1|||
16540845|NCT02342886|40440199|FG002|Overall Study|Withdrawal by Subject|0|||
16540846|NCT02342886|40440200|FG003|Overall Study|Withdrawal by Subject|1|||
16540847|NCT02342886|40440201|FG004|Overall Study|Withdrawal by Subject|0|||
16540848|NCT02342886|40440197|FG000|Overall Study|Investigator/sponsor decision|0|||
16540849|NCT02342886|40440198|FG001|Overall Study|Investigator/sponsor decision|2|||
16540850|NCT02342886|40440199|FG002|Overall Study|Investigator/sponsor decision|0|||
16540851|NCT02342886|40440200|FG003|Overall Study|Investigator/sponsor decision|3|||
16540852|NCT02342886|40440201|FG004|Overall Study|Investigator/sponsor decision|1|||
16540853|NCT02342886|40440197|FG000|Overall Study|Pregnancy|0|||
16540854|NCT02342886|40440198|FG001|Overall Study|Pregnancy|0|||
16540855|NCT02342886|40440199|FG002|Overall Study|Pregnancy|2|||
16540856|NCT02342886|40440200|FG003|Overall Study|Pregnancy|0|||
16540857|NCT02342886|40440201|FG004|Overall Study|Pregnancy|0|||
16540858|NCT02342886|40440197|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
16540859|NCT02342886|40440198|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
16540860|NCT02342886|40440199|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
16540861|NCT02342886|40440200|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
16540862|NCT02342886|40440201|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
16540863|NCT02342886|40440197|FG000|Overall Study|Protocol Violation|0|||
16540864|NCT02342886|40440198|FG001|Overall Study|Protocol Violation|0|||
16540865|NCT02342886|40440199|FG002|Overall Study|Protocol Violation|0|||
16540866|NCT02342886|40440200|FG003|Overall Study|Protocol Violation|2|||
16340892|NCT00885378|39734465|FG000|Overall Study|Poor/Noncompliance|2|||
16340893|NCT00885378|39734466|FG001|Overall Study|Poor/Noncompliance|2|||
16340894|NCT00885378|39734465|FG000|Overall Study|Protocol Violation|2|||
16340895|NCT00885378|39734466|FG001|Overall Study|Protocol Violation|0|||
16340896|NCT03332095|39734471|FG000|Overall Study|Lost to Follow-up|1|||
16340897|NCT03332095|39734472|FG001|Overall Study|Lost to Follow-up|0|||
16340898|NCT03332095|39734471|FG000|Overall Study|Pregnancy|0|||
16340899|NCT03332095|39734472|FG001|Overall Study|Pregnancy|1|||
16340900|NCT01905592|39734473|FG000|Overall Study|Disease Progression|51|||
16540867|NCT02342886|40440201|FG004|Overall Study|Protocol Violation|0|||
16540868|NCT01060553|40440202|FG000|Overall Study|Lost to Follow-up|3|||
16540869|NCT01060553|40440203|FG001|Overall Study|Lost to Follow-up|5|||
16540870|NCT01060553|40440202|FG000|Overall Study|Withdrawal by Subject|5|||
16540871|NCT01060553|40440203|FG001|Overall Study|Withdrawal by Subject|5|||
16540872|NCT01060553|40440202|FG000|Overall Study|Lack of Efficacy|1|||
16540873|NCT01060553|40440203|FG001|Overall Study|Lack of Efficacy|0|||
16540874|NCT01353222|40440204|FG000|Overall Study|Death|30|||
16540875|NCT01353222|40440205|FG001|Overall Study|Death|30|||
16540876|NCT01353222|40440204|FG000|Overall Study|Withdrawal by Subject|8|||
16540877|NCT01353222|40440205|FG001|Overall Study|Withdrawal by Subject|5|||
16540878|NCT01353222|40440204|FG000|Overall Study|Study Terminated|31|||
16540879|NCT01353222|40440205|FG001|Overall Study|Study Terminated|37|||
16540880|NCT01353222|40440204|FG000|Overall Study|Site closed research department|1|||
16540881|NCT01353222|40440205|FG001|Overall Study|Site closed research department|0|||
16540882|NCT00330174|40440206|FG000|Overall Study|Withdrawal by Subject|7|||
16540883|NCT00330174|40440207|FG001|Overall Study|Withdrawal by Subject|7|||
16540884|NCT00330174|40440206|FG000|Overall Study|Lost to Follow-up|4|||
16540885|NCT00330174|40440207|FG001|Overall Study|Lost to Follow-up|1|||
16540886|NCT00330174|40440206|FG000|Overall Study|Clinical deterioration|1|||
16106685|NCT01726049|38878822|FG000|Overall Study|refused second HC|0|||
16340901|NCT01905592|39734474|FG001|Overall Study|Disease Progression|110|||
16340902|NCT01905592|39734473|FG000|Overall Study|Toxicity|1|||
16340903|NCT01905592|39734474|FG001|Overall Study|Toxicity|16|||
16340904|NCT01905592|39734473|FG000|Overall Study|Physician Decision|0|||
16540887|NCT00330174|40440207|FG001|Overall Study|Clinical deterioration|2|||
16540888|NCT00330174|40440206|FG000|Overall Study|Excessive missed visits|3|||
16540889|NCT00330174|40440207|FG001|Overall Study|Excessive missed visits|8|||
16540890|NCT00330174|40440206|FG000|Overall Study|Miscellaneous reasons|7|||
16540891|NCT00330174|40440207|FG001|Overall Study|Miscellaneous reasons|1|||
16540892|NCT03224182|40440212|FG000|Overall Study|Study Drug Not Instilled|6|||
16540893|NCT03224182|40440213|FG001|Overall Study|Study Drug Not Instilled|1|||
16540894|NCT03224182|40440212|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
16540895|NCT03224182|40440213|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
16540896|NCT03224182|40440212|FG000|Overall Study|Withdrew of Consent|4|||
16540897|NCT03224182|40440213|FG001|Overall Study|Withdrew of Consent|2|||
16540898|NCT03224182|40440212|FG000|Overall Study|Investigator Decision|3|||
16540899|NCT03224182|40440213|FG001|Overall Study|Investigator Decision|1|||
16540900|NCT03224182|40440212|FG000|Overall Study|Sponsor Decision|26|||
16540901|NCT03224182|40440213|FG001|Overall Study|Sponsor Decision|12|||
16540902|NCT03224182|40440212|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
16540903|NCT03224182|40440213|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
16540904|NCT03224182|40440212|FG000|Overall Study|Lost to Follow-up|1|||
16540905|NCT03224182|40440213|FG001|Overall Study|Lost to Follow-up|0|||
16540906|NCT03224182|40440212|FG000|Overall Study|Participant Had Recurrence|11|||
16540907|NCT03224182|40440213|FG001|Overall Study|Participant Had Recurrence|5|||
16540908|NCT03224182|40440212|FG000|Overall Study|Death|0|||
16540909|NCT03224182|40440213|FG001|Overall Study|Death|1|||
16540910|NCT03224182|40440212|FG000|Overall Study|Reason not Specified|3|||
16540911|NCT03224182|40440213|FG001|Overall Study|Reason not Specified|3|||
16540912|NCT03224182|40440212|FG000|Overall Study|Other|1|||
16540913|NCT03224182|40440213|FG001|Overall Study|Other|0|||
16540914|NCT04546581|40440214|FG000|Overall Study|Adverse Event|9|||
16540915|NCT04546581|40440215|FG001|Overall Study|Adverse Event|3|||
16540916|NCT04546581|40440214|FG000|Overall Study|Physician Decision|0|||
16540917|NCT04546581|40440215|FG001|Overall Study|Physician Decision|1|||
16540918|NCT04546581|40440214|FG000|Overall Study|Protocol Violation|1|||
16540919|NCT04546581|40440215|FG001|Overall Study|Protocol Violation|2|||
16540920|NCT04546581|40440214|FG000|Overall Study|Withdrawal by Subject|3|||
16540921|NCT04546581|40440215|FG001|Overall Study|Withdrawal by Subject|7|||
16106686|NCT01726049|38878823|FG001|Overall Study|refused second HC|2|||
16106687|NCT00740870|38878824|FG000|Overall Study|Not Catheterized|4|||
16106688|NCT00740870|38878824|FG000|Overall Study|Further testing contraindicated implant|17|||
16340905|NCT01905592|39734474|FG001|Overall Study|Physician Decision|2|||
16540922|NCT02719990|40440217|FG000|Overall Study|Physician Decision|2|||
16540923|NCT02719990|40440217|FG000|Overall Study|Withdrawal by Subject|2|||
16540924|NCT02719990|40440217|FG000|Overall Study|Study Terminated By Sponsor|32|||
16106689|NCT00505414|38878825|FG000|Titration Phase|Adverse Event|0|||
16106690|NCT00505414|38878826|FG001|Titration Phase|Adverse Event|0|||
16106691|NCT00505414|38878827|FG002|Titration Phase|Adverse Event|0|||
16106692|NCT00505414|38878828|FG003|Titration Phase|Adverse Event|8|||
16106693|NCT00505414|38878829|FG004|Titration Phase|Adverse Event|3|||
16106694|NCT00505414|38878825|FG000|Titration Phase|Death|0|||
16106695|NCT00505414|38878826|FG001|Titration Phase|Death|0|||
16106696|NCT00505414|38878827|FG002|Titration Phase|Death|0|||
16106697|NCT00505414|38878828|FG003|Titration Phase|Death|2|||
16106698|NCT00505414|38878829|FG004|Titration Phase|Death|0|||
16106699|NCT00505414|38878825|FG000|Titration Phase|Lack of Efficacy|0|||
16106700|NCT00505414|38878826|FG001|Titration Phase|Lack of Efficacy|0|||
16540925|NCT02355028|40440218|FG000|Overall Study|Adverse Event|2|||
16540926|NCT02355028|40440219|FG001|Overall Study|Adverse Event|0|||
16540927|NCT02355028|40440218|FG000|Overall Study|Withdrawal by Subject|1|||
16540928|NCT02355028|40440219|FG001|Overall Study|Withdrawal by Subject|1|||
16540929|NCT02355028|40440218|FG000|Overall Study|Deemed ineligible after randomization|8|||
16106701|NCT00505414|38878827|FG002|Titration Phase|Lack of Efficacy|0|||
16106702|NCT00505414|38878828|FG003|Titration Phase|Lack of Efficacy|10|||
16106703|NCT00505414|38878829|FG004|Titration Phase|Lack of Efficacy|1|||
16106704|NCT00505414|38878825|FG000|Titration Phase|Protocol Violation|0|||
16106705|NCT00505414|38878826|FG001|Titration Phase|Protocol Violation|0|||
16106706|NCT00505414|38878827|FG002|Titration Phase|Protocol Violation|0|||
16106707|NCT00505414|38878828|FG003|Titration Phase|Protocol Violation|0|||
16106708|NCT00505414|38878829|FG004|Titration Phase|Protocol Violation|1|||
16106709|NCT00505414|38878825|FG000|Titration Phase|Withdrawal by Subject|0|||
16106710|NCT00505414|38878826|FG001|Titration Phase|Withdrawal by Subject|0|||
16106711|NCT00505414|38878827|FG002|Titration Phase|Withdrawal by Subject|0|||
16540930|NCT02355028|40440219|FG001|Overall Study|Deemed ineligible after randomization|4|||
16540931|NCT00766675|40440220|FG000|Overall Study|Adverse Event|16|||
16540932|NCT00766675|40440220|FG000|Overall Study|Lost to Follow-up|2|||
16540933|NCT00766675|40440220|FG000|Overall Study|Withdrawal by Subject|11|||
16540934|NCT00766675|40440220|FG000|Overall Study|Protocol Violation|8|||
16540935|NCT00766675|40440220|FG000|Overall Study|Participant took prohibited medication|1|||
16106712|NCT00505414|38878828|FG003|Titration Phase|Withdrawal by Subject|3|||
16106713|NCT00505414|38878829|FG004|Titration Phase|Withdrawal by Subject|4|||
16106714|NCT00505414|38878825|FG000|Titration Phase|Underlying disease and therapy required|0|||
16106715|NCT00505414|38878826|FG001|Titration Phase|Underlying disease and therapy required|0|||
16106716|NCT00505414|38878827|FG002|Titration Phase|Underlying disease and therapy required|0|||
16106717|NCT00505414|38878828|FG003|Titration Phase|Underlying disease and therapy required|7|||
16106718|NCT00505414|38878829|FG004|Titration Phase|Underlying disease and therapy required|3|||
16106719|NCT00505414|38878825|FG000|Maintenance Phase|Adverse Event|2|||
16106720|NCT00505414|38878826|FG001|Maintenance Phase|Adverse Event|2|||
16106721|NCT00505414|38878827|FG002|Maintenance Phase|Adverse Event|3|||
16106722|NCT00505414|38878828|FG003|Maintenance Phase|Adverse Event|0|||
16106723|NCT00505414|38878829|FG004|Maintenance Phase|Adverse Event|0|||
16106724|NCT00505414|38878825|FG000|Maintenance Phase|Death|2|||
16106725|NCT00505414|38878826|FG001|Maintenance Phase|Death|0|||
16106726|NCT00505414|38878827|FG002|Maintenance Phase|Death|1|||
16106727|NCT00505414|38878828|FG003|Maintenance Phase|Death|0|||
16106728|NCT00505414|38878829|FG004|Maintenance Phase|Death|0|||
16106729|NCT00505414|38878825|FG000|Maintenance Phase|Lack of Efficacy|2|||
16106730|NCT00505414|38878826|FG001|Maintenance Phase|Lack of Efficacy|1|||
16106731|NCT00505414|38878827|FG002|Maintenance Phase|Lack of Efficacy|1|||
16106732|NCT00505414|38878828|FG003|Maintenance Phase|Lack of Efficacy|0|||
16106733|NCT00505414|38878829|FG004|Maintenance Phase|Lack of Efficacy|0|||
16106734|NCT00505414|38878825|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16106735|NCT00505414|38878826|FG001|Maintenance Phase|Withdrawal by Subject|0|||
16106736|NCT00505414|38878827|FG002|Maintenance Phase|Withdrawal by Subject|1|||
16106737|NCT00505414|38878828|FG003|Maintenance Phase|Withdrawal by Subject|0|||
16218166|NCT01693562|39278684|FG014|Exploration Phase|Withdrawal by Subject|0|||
16218167|NCT01693562|39278685|FG015|Exploration Phase|Withdrawal by Subject|0|||
16218168|NCT01693562|39278686|FG016|Exploration Phase|Withdrawal by Subject|0|||
16218169|NCT01693562|39278687|FG017|Exploration Phase|Withdrawal by Subject|0|||
16540936|NCT00766675|40440220|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
16540937|NCT00766675|40440220|FG000|Overall Study|Insufficient therapy|1|||
16540938|NCT01813474|40440226|FG000|Overall Study|Withdrawal by Subject|0|||
16540939|NCT01813474|40440227|FG001|Overall Study|Withdrawal by Subject|0|||
16540940|NCT01813474|40440228|FG002|Overall Study|Withdrawal by Subject|1|||
16540941|NCT01813474|40440226|FG000|Overall Study|Adverse Event|1|||
16540942|NCT01813474|40440227|FG001|Overall Study|Adverse Event|1|||
16540943|NCT01813474|40440228|FG002|Overall Study|Adverse Event|0|||
16540944|NCT01813474|40440226|FG000|Overall Study|Lack of Efficacy|2|||
16106738|NCT00505414|38878829|FG004|Maintenance Phase|Withdrawal by Subject|0|||
16218170|NCT01693562|39278688|FG018|Exploration Phase|Withdrawal by Subject|0|||
16218171|NCT01693562|39278689|FG019|Exploration Phase|Withdrawal by Subject|0|||
16218172|NCT01693562|39278690|FG020|Exploration Phase|Withdrawal by Subject|0|||
16218173|NCT01693562|39278691|FG021|Exploration Phase|Withdrawal by Subject|0|||
16218174|NCT01693562|39278692|FG022|Exploration Phase|Withdrawal by Subject|0|||
16218175|NCT01693562|39278670|FG000|Exploration Phase|Death|0|||
16218176|NCT01693562|39278671|FG001|Exploration Phase|Death|0|||
16218177|NCT01693562|39278672|FG002|Exploration Phase|Death|0|||
16218178|NCT01693562|39278673|FG003|Exploration Phase|Death|0|||
16218179|NCT01693562|39278674|FG004|Exploration Phase|Death|0|||
16106739|NCT00505414|38878825|FG000|Maintenance Phase|underlying disease and therapy required|0|||
16106740|NCT00505414|38878826|FG001|Maintenance Phase|underlying disease and therapy required|2|||
16106741|NCT00505414|38878827|FG002|Maintenance Phase|underlying disease and therapy required|2|||
16106742|NCT00505414|38878828|FG003|Maintenance Phase|underlying disease and therapy required|0|||
16218180|NCT01693562|39278675|FG005|Exploration Phase|Death|0|||
16218181|NCT01693562|39278676|FG006|Exploration Phase|Death|17|||
16218182|NCT01693562|39278677|FG007|Exploration Phase|Death|0|||
16218183|NCT01693562|39278678|FG008|Exploration Phase|Death|0|||
16218184|NCT01693562|39278679|FG009|Exploration Phase|Death|0|||
16540945|NCT01813474|40440227|FG001|Overall Study|Lack of Efficacy|6|||
16540946|NCT01813474|40440228|FG002|Overall Study|Lack of Efficacy|9|||
16218185|NCT01693562|39278680|FG010|Exploration Phase|Death|0|||
16218186|NCT01693562|39278681|FG011|Exploration Phase|Death|0|||
16218187|NCT01693562|39278682|FG012|Exploration Phase|Death|0|||
16218188|NCT01693562|39278683|FG013|Exploration Phase|Death|0|||
16218189|NCT01693562|39278684|FG014|Exploration Phase|Death|0|||
16218190|NCT01693562|39278685|FG015|Exploration Phase|Death|0|||
16218191|NCT01693562|39278686|FG016|Exploration Phase|Death|0|||
16218192|NCT01693562|39278687|FG017|Exploration Phase|Death|0|||
16218193|NCT01693562|39278688|FG018|Exploration Phase|Death|0|||
16218194|NCT01693562|39278689|FG019|Exploration Phase|Death|0|||
16218195|NCT01693562|39278690|FG020|Exploration Phase|Death|0|||
16218196|NCT01693562|39278691|FG021|Exploration Phase|Death|0|||
16218197|NCT01693562|39278692|FG022|Exploration Phase|Death|0|||
16218198|NCT01693562|39278670|FG000|Exploration Phase|Other|0|||
16218199|NCT01693562|39278671|FG001|Exploration Phase|Other|0|||
16218200|NCT01693562|39278672|FG002|Exploration Phase|Other|0|||
16218201|NCT01693562|39278673|FG003|Exploration Phase|Other|0|||
16218202|NCT01693562|39278674|FG004|Exploration Phase|Other|0|||
16218203|NCT01693562|39278675|FG005|Exploration Phase|Other|0|||
16218204|NCT01693562|39278676|FG006|Exploration Phase|Other|2|||
16218205|NCT01693562|39278677|FG007|Exploration Phase|Other|0|||
16218206|NCT01693562|39278678|FG008|Exploration Phase|Other|0|||
16218207|NCT01693562|39278679|FG009|Exploration Phase|Other|0|||
16218208|NCT01693562|39278680|FG010|Exploration Phase|Other|0|||
16218209|NCT01693562|39278681|FG011|Exploration Phase|Other|0|||
16218210|NCT01693562|39278682|FG012|Exploration Phase|Other|0|||
16218211|NCT01693562|39278683|FG013|Exploration Phase|Other|0|||
16218212|NCT01693562|39278684|FG014|Exploration Phase|Other|0|||
16218213|NCT01693562|39278685|FG015|Exploration Phase|Other|0|||
16218214|NCT01693562|39278686|FG016|Exploration Phase|Other|0|||
16218215|NCT01693562|39278687|FG017|Exploration Phase|Other|0|||
16218216|NCT01693562|39278688|FG018|Exploration Phase|Other|0|||
16218217|NCT01693562|39278689|FG019|Exploration Phase|Other|0|||
16218218|NCT01693562|39278690|FG020|Exploration Phase|Other|0|||
16218219|NCT01693562|39278691|FG021|Exploration Phase|Other|0|||
16218220|NCT01693562|39278692|FG022|Exploration Phase|Other|0|||
16218221|NCT01693562|39278670|FG000|Expansion Phase|Withdrawal by Subject|0|||
16218222|NCT01693562|39278671|FG001|Expansion Phase|Withdrawal by Subject|0|||
16218223|NCT01693562|39278672|FG002|Expansion Phase|Withdrawal by Subject|0|||
16218224|NCT01693562|39278673|FG003|Expansion Phase|Withdrawal by Subject|0|||
16218225|NCT01693562|39278674|FG004|Expansion Phase|Withdrawal by Subject|0|||
16218226|NCT01693562|39278675|FG005|Expansion Phase|Withdrawal by Subject|0|||
16218227|NCT01693562|39278676|FG006|Expansion Phase|Withdrawal by Subject|0|||
16218228|NCT01693562|39278677|FG007|Expansion Phase|Withdrawal by Subject|16|||
16218229|NCT01693562|39278678|FG008|Expansion Phase|Withdrawal by Subject|2|||
16218230|NCT01693562|39278679|FG009|Expansion Phase|Withdrawal by Subject|54|||
16218231|NCT01693562|39278680|FG010|Expansion Phase|Withdrawal by Subject|2|||
16218232|NCT01693562|39278681|FG011|Expansion Phase|Withdrawal by Subject|2|||
16218233|NCT01693562|39278682|FG012|Expansion Phase|Withdrawal by Subject|3|||
16218234|NCT01693562|39278683|FG013|Expansion Phase|Withdrawal by Subject|5|||
16218235|NCT01693562|39278684|FG014|Expansion Phase|Withdrawal by Subject|16|||
16218236|NCT01693562|39278685|FG015|Expansion Phase|Withdrawal by Subject|7|||
16218237|NCT01693562|39278686|FG016|Expansion Phase|Withdrawal by Subject|40|||
16218238|NCT01693562|39278687|FG017|Expansion Phase|Withdrawal by Subject|4|||
16218239|NCT01693562|39278688|FG018|Expansion Phase|Withdrawal by Subject|8|||
16218240|NCT01693562|39278689|FG019|Expansion Phase|Withdrawal by Subject|3|||
16218241|NCT01693562|39278690|FG020|Expansion Phase|Withdrawal by Subject|1|||
16218242|NCT01693562|39278691|FG021|Expansion Phase|Withdrawal by Subject|8|||
16218243|NCT01693562|39278692|FG022|Expansion Phase|Withdrawal by Subject|1|||
16218244|NCT01693562|39278670|FG000|Expansion Phase|Death|0|||
16218245|NCT01693562|39278671|FG001|Expansion Phase|Death|0|||
16218246|NCT01693562|39278672|FG002|Expansion Phase|Death|0|||
16106743|NCT00505414|38878829|FG004|Maintenance Phase|underlying disease and therapy required|0|||
16218247|NCT01693562|39278673|FG003|Expansion Phase|Death|0|||
16218248|NCT01693562|39278674|FG004|Expansion Phase|Death|0|||
16218249|NCT01693562|39278675|FG005|Expansion Phase|Death|0|||
16106744|NCT01951378|38878830|FG000|Overall Study|Study Terminated-Not completed|23|||
16218250|NCT01693562|39278676|FG006|Expansion Phase|Death|0|||
16218251|NCT01693562|39278677|FG007|Expansion Phase|Death|42|||
16218252|NCT01693562|39278678|FG008|Expansion Phase|Death|17|||
16218253|NCT01693562|39278679|FG009|Expansion Phase|Death|208|||
16218254|NCT01693562|39278680|FG010|Expansion Phase|Death|30|||
16218255|NCT01693562|39278681|FG011|Expansion Phase|Death|8|||
16218256|NCT01693562|39278682|FG012|Expansion Phase|Death|19|||
16218257|NCT01693562|39278683|FG013|Expansion Phase|Death|42|||
16218258|NCT01693562|39278684|FG014|Expansion Phase|Death|23|||
16218259|NCT01693562|39278685|FG015|Expansion Phase|Death|23|||
16218260|NCT01693562|39278686|FG016|Expansion Phase|Death|128|||
16218261|NCT01693562|39278687|FG017|Expansion Phase|Death|16|||
16218262|NCT01693562|39278688|FG018|Expansion Phase|Death|36|||
16218263|NCT01693562|39278689|FG019|Expansion Phase|Death|16|||
16218264|NCT01693562|39278690|FG020|Expansion Phase|Death|17|||
16218265|NCT01693562|39278691|FG021|Expansion Phase|Death|35|||
16218266|NCT01693562|39278692|FG022|Expansion Phase|Death|7|||
16218267|NCT01693562|39278670|FG000|Expansion Phase|Lost to Follow-up|0|||
16218268|NCT01693562|39278671|FG001|Expansion Phase|Lost to Follow-up|0|||
16218269|NCT01693562|39278672|FG002|Expansion Phase|Lost to Follow-up|0|||
16218270|NCT01693562|39278673|FG003|Expansion Phase|Lost to Follow-up|0|||
16218271|NCT01693562|39278674|FG004|Expansion Phase|Lost to Follow-up|0|||
16218272|NCT01693562|39278675|FG005|Expansion Phase|Lost to Follow-up|0|||
16218273|NCT01693562|39278676|FG006|Expansion Phase|Lost to Follow-up|0|||
16218274|NCT01693562|39278677|FG007|Expansion Phase|Lost to Follow-up|1|||
16218275|NCT01693562|39278678|FG008|Expansion Phase|Lost to Follow-up|2|||
16218276|NCT01693562|39278679|FG009|Expansion Phase|Lost to Follow-up|10|||
16218277|NCT01693562|39278680|FG010|Expansion Phase|Lost to Follow-up|4|||
16218278|NCT01693562|39278681|FG011|Expansion Phase|Lost to Follow-up|4|||
16218279|NCT01693562|39278682|FG012|Expansion Phase|Lost to Follow-up|1|||
16218280|NCT01693562|39278683|FG013|Expansion Phase|Lost to Follow-up|3|||
16218281|NCT01693562|39278684|FG014|Expansion Phase|Lost to Follow-up|0|||
16218282|NCT01693562|39278685|FG015|Expansion Phase|Lost to Follow-up|1|||
16218283|NCT01693562|39278686|FG016|Expansion Phase|Lost to Follow-up|1|||
16218284|NCT01693562|39278687|FG017|Expansion Phase|Lost to Follow-up|0|||
16218285|NCT01693562|39278688|FG018|Expansion Phase|Lost to Follow-up|2|||
16218286|NCT01693562|39278689|FG019|Expansion Phase|Lost to Follow-up|1|||
16218287|NCT01693562|39278690|FG020|Expansion Phase|Lost to Follow-up|2|||
16218288|NCT01693562|39278691|FG021|Expansion Phase|Lost to Follow-up|2|||
16218289|NCT01693562|39278692|FG022|Expansion Phase|Lost to Follow-up|1|||
16218290|NCT01693562|39278670|FG000|Expansion Phase|Other|0|||
16218291|NCT01693562|39278671|FG001|Expansion Phase|Other|0|||
16218292|NCT01693562|39278672|FG002|Expansion Phase|Other|0|||
16218293|NCT01693562|39278673|FG003|Expansion Phase|Other|0|||
16218294|NCT01693562|39278674|FG004|Expansion Phase|Other|0|||
16218295|NCT01693562|39278675|FG005|Expansion Phase|Other|0|||
16218296|NCT01693562|39278676|FG006|Expansion Phase|Other|0|||
16218297|NCT01693562|39278677|FG007|Expansion Phase|Other|3|||
16218298|NCT01693562|39278678|FG008|Expansion Phase|Other|1|||
16218299|NCT01693562|39278679|FG009|Expansion Phase|Other|28|||
16218300|NCT01693562|39278680|FG010|Expansion Phase|Other|4|||
16218301|NCT01693562|39278681|FG011|Expansion Phase|Other|7|||
16218302|NCT01693562|39278682|FG012|Expansion Phase|Other|0|||
16218303|NCT01693562|39278683|FG013|Expansion Phase|Other|1|||
16218304|NCT01693562|39278684|FG014|Expansion Phase|Other|1|||
16218305|NCT01693562|39278685|FG015|Expansion Phase|Other|0|||
16218306|NCT01693562|39278686|FG016|Expansion Phase|Other|28|||
16218307|NCT01693562|39278687|FG017|Expansion Phase|Other|0|||
16218308|NCT01693562|39278688|FG018|Expansion Phase|Other|1|||
16218309|NCT01693562|39278689|FG019|Expansion Phase|Other|0|||
16218310|NCT01693562|39278690|FG020|Expansion Phase|Other|1|||
16218311|NCT01693562|39278691|FG021|Expansion Phase|Other|17|||
16106745|NCT01951378|38878831|FG001|Overall Study|Study Terminated-Not completed|17|||
16106746|NCT03772041|38878832|FG000|Overall Study|Adverse Event|8|||
16106747|NCT03772041|38878833|FG001|Overall Study|Adverse Event|3|||
16106748|NCT03772041|38878832|FG000|Overall Study|Withdrawal by Subject|0|||
16106749|NCT03772041|38878833|FG001|Overall Study|Withdrawal by Subject|2|||
16106750|NCT03772041|38878832|FG000|Overall Study|Protocol Violation|4|||
16106751|NCT03772041|38878833|FG001|Overall Study|Protocol Violation|2|||
16106752|NCT03772041|38878832|FG000|Overall Study|Physician Decision|2|||
16106753|NCT03772041|38878833|FG001|Overall Study|Physician Decision|3|||
16106754|NCT01316887|38878834|FG000|Overall Study|Adverse Event|13|||
16106755|NCT01316887|38878835|FG001|Overall Study|Adverse Event|21|||
16106756|NCT01316887|38878836|FG002|Overall Study|Adverse Event|17|||
16106757|NCT01316887|38878834|FG000|Overall Study|Lack of Efficacy|9|||
16106758|NCT01316887|38878835|FG001|Overall Study|Lack of Efficacy|3|||
16218312|NCT01693562|39278692|FG022|Expansion Phase|Other|1|||
16218313|NCT04474366|39278693|FG000|Overall Study|Lost to Follow-up|2|||
16218314|NCT04474366|39278694|FG001|Overall Study|Lost to Follow-up|5|||
16218315|NCT01425528|39278695|FG000|Overall Study|Withdrawal by Subject|1|||
16218316|NCT01425528|39278696|FG001|Overall Study|Withdrawal by Subject|1|||
16218317|NCT01029691|39278702|FG000|Continued APAP to Delivery|Death|0|||
16218318|NCT01029691|39278703|FG001|Continued APAP to Delivery|Death|0|||
16218319|NCT01029691|39278704|FG002|Continued APAP to Delivery|Death|1|||
16218320|NCT03083470|39278713|FG000|Overall Study|Lost to Follow-up|0|||
16218321|NCT03083470|39278714|FG001|Overall Study|Lost to Follow-up|0|||
16218322|NCT03083470|39278715|FG002|Overall Study|Lost to Follow-up|0|||
16106759|NCT01316887|38878836|FG002|Overall Study|Lack of Efficacy|1|||
16218323|NCT03083470|39278716|FG003|Overall Study|Lost to Follow-up|0|||
16218324|NCT03083470|39278717|FG004|Overall Study|Lost to Follow-up|1|||
16106760|NCT01316887|38878834|FG000|Overall Study|Protocol Violation|2|||
16218325|NCT03083470|39278713|FG000|Overall Study|Withdrawal by Subject|0|||
16218326|NCT03083470|39278714|FG001|Overall Study|Withdrawal by Subject|0|||
16106761|NCT01316887|38878835|FG001|Overall Study|Protocol Violation|6|||
16106762|NCT01316887|38878836|FG002|Overall Study|Protocol Violation|6|||
16106763|NCT01316887|38878834|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
16106764|NCT01316887|38878835|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
16106765|NCT01316887|38878836|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
16106766|NCT01316887|38878834|FG000|Overall Study|Study Closed/Terminated|2|||
16106767|NCT01316887|38878835|FG001|Overall Study|Study Closed/Terminated|4|||
16106768|NCT01316887|38878836|FG002|Overall Study|Study Closed/Terminated|3|||
16106769|NCT01316887|38878834|FG000|Overall Study|Lost to Follow-up|1|||
16106770|NCT01316887|38878835|FG001|Overall Study|Lost to Follow-up|7|||
16106771|NCT01316887|38878836|FG002|Overall Study|Lost to Follow-up|5|||
16106772|NCT01316887|38878834|FG000|Overall Study|Withdrawal by Subject|8|||
16106773|NCT01316887|38878835|FG001|Overall Study|Withdrawal by Subject|16|||
16106774|NCT01316887|38878836|FG002|Overall Study|Withdrawal by Subject|15|||
16106775|NCT00506922|38878837|FG000|Overall Study|Physician Decision|0|||
16106776|NCT00506922|38878838|FG001|Overall Study|Physician Decision|0|||
16106777|NCT00506922|38878839|FG002|Overall Study|Physician Decision|0|||
16106778|NCT00506922|38878840|FG003|Overall Study|Physician Decision|2|||
16106779|NCT00506922|38878841|FG004|Overall Study|Physician Decision|0|||
16106780|NCT00506922|38878837|FG000|Overall Study|Withdrawal by Subject|0|||
16106781|NCT00506922|38878838|FG001|Overall Study|Withdrawal by Subject|0|||
16106782|NCT00506922|38878839|FG002|Overall Study|Withdrawal by Subject|0|||
16106783|NCT00506922|38878840|FG003|Overall Study|Withdrawal by Subject|0|||
16106784|NCT00506922|38878841|FG004|Overall Study|Withdrawal by Subject|1|||
16106785|NCT00381888|38878842|FG000|Overall Study|Death|1|||
16106786|NCT00381888|38878842|FG000|Overall Study|Withdrawal by Subject|1|||
16106787|NCT00381888|38878842|FG000|Overall Study|Physician Decision|1|||
16106788|NCT00381888|38878842|FG000|Overall Study|Protocol Violation|9|||
16106789|NCT00381888|38878842|FG000|Overall Study|Had laparoscopic surgery|2|||
16106790|NCT00381888|38878842|FG000|Overall Study|Surgery was cancelled|2|||
16106791|NCT00381888|38878842|FG000|Overall Study|Adverse Event|1|||
16106792|NCT00730847|38878846|FG000|Overall Study|Adverse Event|1|||
16106793|NCT00730847|38878846|FG000|Overall Study|Protocol Violation|2|||
16106794|NCT00730847|38878846|FG000|Overall Study|Withdrawal by Subject|16|||
16106795|NCT00730847|38878846|FG000|Overall Study|Lost to Follow-up|67|||
16106796|NCT00730847|38878846|FG000|Overall Study|Unknown completion status|21|||
16106797|NCT00730847|38878846|FG000|Overall Study|Other|24|||
16106798|NCT00846768|38878847|FG000|Overall Study|Adverse Event|0|||
16106799|NCT00846768|38878848|FG001|Overall Study|Adverse Event|1|||
16106800|NCT00846768|38878849|FG002|Overall Study|Adverse Event|0|||
16106801|NCT00846768|38878850|FG003|Overall Study|Adverse Event|0|||
16106802|NCT02980705|38878851|FG000|Overall Study|Adverse Event|0|||
16106803|NCT02980705|38878852|FG001|Overall Study|Adverse Event|1|||
16106804|NCT02980705|38878851|FG000|Overall Study|Withdrawal by Subject|6|||
16540947|NCT01813474|40440226|FG000|Overall Study|Death|0|||
16540948|NCT01813474|40440227|FG001|Overall Study|Death|0|||
16540949|NCT01813474|40440228|FG002|Overall Study|Death|1|||
16540950|NCT02281084|40440229|FG000|Overall Study|Adverse Event|1|||
16540951|NCT02281084|40440230|FG001|Overall Study|Adverse Event|0|||
16106805|NCT02980705|38878852|FG001|Overall Study|Withdrawal by Subject|9|||
16106806|NCT02980705|38878851|FG000|Overall Study|withdrew participation|0|||
16106807|NCT02980705|38878852|FG001|Overall Study|withdrew participation|1|||
16106808|NCT02980705|38878851|FG000|Overall Study|Lost to Follow-up|2|||
16106809|NCT02980705|38878852|FG001|Overall Study|Lost to Follow-up|0|||
16106810|NCT02344173|38878853|FG000|Procedure|Ablation Procedure Not Performed|7|||
16106811|NCT02344173|38878853|FG000|12-month Visit|Death|8|||
16106812|NCT02344173|38878853|FG000|12-month Visit|Withdrawal by Subject|30|||
16106813|NCT02344173|38878853|FG000|12-month Visit|Lost to Follow-up|58|||
16106814|NCT01182207|38878854|FG000|First Intervention|Positive Hepatitis Results|0|||
16106815|NCT01182207|38878855|FG001|First Intervention|Positive Hepatitis Results|1|||
16106816|NCT01182207|38878854|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
16106817|NCT01182207|38878855|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
16106818|NCT04150341|38878858|FG000|Overall Study|Physician Decision|0|||
16106819|NCT04150341|38878859|FG001|Overall Study|Physician Decision|0|||
16106820|NCT04150341|38878860|FG002|Overall Study|Physician Decision|1|||
16106821|NCT04150341|38878861|FG003|Overall Study|Physician Decision|0|||
16106822|NCT04150341|38878862|FG004|Overall Study|Physician Decision|0|||
16106823|NCT04150341|38878863|FG005|Overall Study|Physician Decision|0|||
16106824|NCT04150341|38878858|FG000|Overall Study|Adverse Event|0|||
16106825|NCT04150341|38878859|FG001|Overall Study|Adverse Event|0|||
16106826|NCT04150341|38878860|FG002|Overall Study|Adverse Event|0|||
16106827|NCT04150341|38878861|FG003|Overall Study|Adverse Event|0|||
16106828|NCT04150341|38878862|FG004|Overall Study|Adverse Event|1|||
16106829|NCT04150341|38878863|FG005|Overall Study|Adverse Event|0|||
16540952|NCT02281084|40440231|FG002|Overall Study|Adverse Event|0|||
16106830|NCT00957996|38878868|FG000|Overall Study|Death|4|||
16106831|NCT00957996|38878869|FG001|Overall Study|Death|10|||
16106832|NCT00957996|38878868|FG000|Overall Study|Lost to Follow-up|4|||
16540953|NCT02281084|40440232|FG003|Overall Study|Adverse Event|0|||
16106833|NCT00957996|38878869|FG001|Overall Study|Lost to Follow-up|7|||
16106834|NCT00957996|38878868|FG000|Overall Study|Withdrawal by Subject|9|||
16106835|NCT00957996|38878869|FG001|Overall Study|Withdrawal by Subject|2|||
16106836|NCT00957996|38878868|FG000|Overall Study|Adverse Event|2|||
16106837|NCT00957996|38878869|FG001|Overall Study|Adverse Event|1|||
16106838|NCT00957996|38878868|FG000|Overall Study|Physician Decision|1|||
16106839|NCT00957996|38878869|FG001|Overall Study|Physician Decision|1|||
16106840|NCT00957996|38878868|FG000|Overall Study|Influenza-related complication|0|||
16106841|NCT00957996|38878869|FG001|Overall Study|Influenza-related complication|1|||
16106842|NCT00957996|38878868|FG000|Overall Study|Missing|1|||
16106843|NCT00957996|38878869|FG001|Overall Study|Missing|0|||
16106844|NCT00957996|38878868|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
16106845|NCT00957996|38878869|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
16106846|NCT00802438|38878870|FG000|Overall Study|Screen Failure|20|||
16106847|NCT00802438|38878870|FG000|Overall Study|Withdrawal by Subject|7|||
16106848|NCT00802438|38878870|FG000|Overall Study|Physician Decision|1|||
16106849|NCT04353817|38878871|FG000|Overall Study|Adverse Event|0|||
16106850|NCT04353817|38878872|FG001|Overall Study|Adverse Event|1|||
16106851|NCT03305809|38878874|FG000|Overall Study|Adverse Event|2|||
16106852|NCT03305809|38878875|FG001|Overall Study|Adverse Event|2|||
16106853|NCT03305809|38878876|FG002|Overall Study|Adverse Event|6|||
16106854|NCT03305809|38878877|FG003|Overall Study|Adverse Event|6|||
16106855|NCT03305809|38878874|FG000|Overall Study|Death|0|||
16106856|NCT03305809|38878875|FG001|Overall Study|Death|0|||
16106857|NCT03305809|38878876|FG002|Overall Study|Death|1|||
16106858|NCT03305809|38878877|FG003|Overall Study|Death|1|||
16106859|NCT03305809|38878874|FG000|Overall Study|Lost to Follow-up|1|||
16106860|NCT03305809|38878875|FG001|Overall Study|Lost to Follow-up|2|||
16106861|NCT03305809|38878876|FG002|Overall Study|Lost to Follow-up|0|||
16106862|NCT03305809|38878877|FG003|Overall Study|Lost to Follow-up|0|||
16106863|NCT03305809|38878874|FG000|Overall Study|Sponsor Decision|1|||
16106864|NCT03305809|38878875|FG001|Overall Study|Sponsor Decision|0|||
16106865|NCT03305809|38878876|FG002|Overall Study|Sponsor Decision|1|||
16106866|NCT03305809|38878877|FG003|Overall Study|Sponsor Decision|8|||
16106867|NCT03305809|38878874|FG000|Overall Study|Physician Decision|0|||
16106868|NCT03305809|38878875|FG001|Overall Study|Physician Decision|0|||
16106869|NCT03305809|38878876|FG002|Overall Study|Physician Decision|2|||
16106870|NCT03305809|38878877|FG003|Overall Study|Physician Decision|4|||
16106871|NCT03305809|38878874|FG000|Overall Study|Progressive Disease|0|||
16106872|NCT03305809|38878875|FG001|Overall Study|Progressive Disease|0|||
16106873|NCT03305809|38878876|FG002|Overall Study|Progressive Disease|1|||
16106874|NCT03305809|38878877|FG003|Overall Study|Progressive Disease|0|||
16106875|NCT03305809|38878874|FG000|Overall Study|Protocol Violation|1|||
16106876|NCT03305809|38878875|FG001|Overall Study|Protocol Violation|0|||
16106877|NCT03305809|38878876|FG002|Overall Study|Protocol Violation|2|||
16106878|NCT03305809|38878877|FG003|Overall Study|Protocol Violation|3|||
16106879|NCT03305809|38878874|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
16106880|NCT03305809|38878875|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
16106881|NCT03305809|38878876|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
16106882|NCT03305809|38878877|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
16106883|NCT03305809|38878874|FG000|Overall Study|Withdrawal by Subject|2|||
16106884|NCT03305809|38878875|FG001|Overall Study|Withdrawal by Subject|4|||
16106885|NCT03305809|38878876|FG002|Overall Study|Withdrawal by Subject|5|||
16106886|NCT03305809|38878877|FG003|Overall Study|Withdrawal by Subject|2|||
16106887|NCT03305809|38878874|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
16106888|NCT03305809|38878875|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
16106889|NCT03305809|38878876|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
16106890|NCT03305809|38878877|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
16106891|NCT01313624|38878878|FG000|Double-Blind Phase|Adverse Event|27|||
16106892|NCT01313624|38878879|FG001|Double-Blind Phase|Adverse Event|4|||
16106893|NCT01313624|38878878|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
16106894|NCT01313624|38878879|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
16106895|NCT01313624|38878878|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16106896|NCT01313624|38878879|FG001|Double-Blind Phase|Lost to Follow-up|2|||
16106897|NCT01313624|38878878|FG000|Double-Blind Phase|Physician Decision|1|||
16106898|NCT01313624|38878879|FG001|Double-Blind Phase|Physician Decision|0|||
16106899|NCT01313624|38878878|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16340906|NCT01905592|39734473|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
16540954|NCT02281084|40440229|FG000|Overall Study|Withdrawal by Subject|1|||
16106900|NCT01313624|38878879|FG001|Double-Blind Phase|Lack of Efficacy|0|||
16106901|NCT01313624|38878878|FG000|Open-Label Phase|Adverse Event|1|||
16106902|NCT01313624|38878879|FG001|Open-Label Phase|Adverse Event|10|||
16106903|NCT01313624|38878878|FG000|Open-Label Phase|Withdrawal by Subject|2|||
16106904|NCT01313624|38878879|FG001|Open-Label Phase|Withdrawal by Subject|2|||
16106905|NCT01313624|38878878|FG000|Open-Label Phase|Lost to Follow-up|1|||
16106906|NCT01313624|38878879|FG001|Open-Label Phase|Lost to Follow-up|1|||
16106907|NCT03449134|38878883|FG000|52-Week Treatment Period|Death|2|||
16106908|NCT03449134|38878884|FG001|52-Week Treatment Period|Death|1|||
16106909|NCT03449134|38878885|FG002|52-Week Treatment Period|Death|0|||
16106910|NCT03449134|38878883|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
16106911|NCT03449134|38878884|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
16106912|NCT03449134|38878885|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
16106913|NCT03449134|38878883|FG000|52-Week Treatment Period|Physician Decision|2|||
16106914|NCT03449134|38878884|FG001|52-Week Treatment Period|Physician Decision|3|||
16106915|NCT03449134|38878885|FG002|52-Week Treatment Period|Physician Decision|3|||
16106916|NCT03449134|38878883|FG000|52-Week Treatment Period|Screen Failure|1|||
16106917|NCT03449134|38878884|FG001|52-Week Treatment Period|Screen Failure|0|||
16106918|NCT03449134|38878885|FG002|52-Week Treatment Period|Screen Failure|1|||
16106919|NCT03449134|38878883|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
16106920|NCT03449134|38878884|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
16106921|NCT03449134|38878885|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
16106922|NCT03449134|38878883|FG000|52-Week Treatment Period|Site Closure|1|||
16106923|NCT03449134|38878884|FG001|52-Week Treatment Period|Site Closure|0|||
16106924|NCT03449134|38878885|FG002|52-Week Treatment Period|Site Closure|0|||
16540955|NCT02281084|40440230|FG001|Overall Study|Withdrawal by Subject|2|||
16540956|NCT02281084|40440231|FG002|Overall Study|Withdrawal by Subject|0|||
16540957|NCT02281084|40440232|FG003|Overall Study|Withdrawal by Subject|0|||
16540958|NCT02281084|40440229|FG000|Overall Study|Death|20|||
16540959|NCT02281084|40440230|FG001|Overall Study|Death|16|||
16540960|NCT02281084|40440231|FG002|Overall Study|Death|3|||
16540961|NCT02281084|40440232|FG003|Overall Study|Death|5|||
16540962|NCT02281084|40440229|FG000|Overall Study|Physician Decision|0|||
16540963|NCT02281084|40440230|FG001|Overall Study|Physician Decision|0|||
16540964|NCT02281084|40440231|FG002|Overall Study|Physician Decision|1|||
16540965|NCT02281084|40440232|FG003|Overall Study|Physician Decision|0|||
16540966|NCT02219048|40440233|FG000|Overall Study|Adverse Event|2|||
16540967|NCT02219048|40440234|FG001|Overall Study|Adverse Event|5|||
16540968|NCT02219048|40440233|FG000|Overall Study|No longer meets eligibility criteria|1|||
16540969|NCT02219048|40440234|FG001|Overall Study|No longer meets eligibility criteria|0|||
16540970|NCT02219048|40440233|FG000|Overall Study|Study terminated by sponsor|16|||
16540971|NCT02219048|40440234|FG001|Overall Study|Study terminated by sponsor|15|||
16540972|NCT02219048|40440233|FG000|Overall Study|Withdrawal by Subject|2|||
16540973|NCT02219048|40440234|FG001|Overall Study|Withdrawal by Subject|0|||
16540974|NCT02219048|40440233|FG000|Overall Study|Other|0|||
16106925|NCT01020747|38878886|FG000|Overall Study|Withdrawal by Subject|1|||
16106926|NCT00935259|38878897|FG000|Period 1|Administrative (scheduling conflict)|1|||
16106927|NCT00935259|38878898|FG001|Period 1|Administrative (scheduling conflict)|1|||
16106928|NCT00280683|38878899|FG000|Overall Study|Withdrawal by Subject|1|||
16540975|NCT02219048|40440234|FG001|Overall Study|Other|1|||
16540976|NCT00716092|40440237|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
16540977|NCT00716092|40440238|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
16540978|NCT00716092|40440239|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
16540979|NCT04477187|40440240|FG000|Overall Study|Lost to Follow-up|2|||
16540980|NCT02044848|40440241|FG000|Overall Study|Administrative Problems|2|||
16540981|NCT02044848|40440242|FG001|Overall Study|Administrative Problems|3|||
16540982|NCT04241094|40440243|FG000|Overall Study|Dropped out of treatment|4|||
16540983|NCT04241094|40440243|FG000|Overall Study|Ineligible after clinical assessment|2|||
16540984|NCT04241094|40440243|FG000|Overall Study|Lost to Follow-up|2|||
16540985|NCT01235546|40443150|FG000|Overall Study|Staff error, medication not administered|1|||
16106929|NCT00280683|38878900|FG001|Overall Study|Withdrawal by Subject|2|||
16106930|NCT00280683|38878899|FG000|Overall Study|Adverse Event|1|||
16106931|NCT00280683|38878900|FG001|Overall Study|Adverse Event|1|||
16106932|NCT03856047|38878903|FG000|Overall Study|Withdrawal by Subject|0|||
16106933|NCT03856047|38878904|FG001|Overall Study|Withdrawal by Subject|1|||
16106934|NCT03856047|38878905|FG002|Overall Study|Withdrawal by Subject|1|||
16106935|NCT03856047|38878906|FG003|Overall Study|Withdrawal by Subject|0|||
16106936|NCT03856047|38878907|FG004|Overall Study|Withdrawal by Subject|3|||
16106937|NCT03856047|38878908|FG005|Overall Study|Withdrawal by Subject|0|||
16106938|NCT03856047|38878909|FG006|Overall Study|Withdrawal by Subject|2|||
16106939|NCT03856047|38878903|FG000|Overall Study|Lost to Follow-up|4|||
16106940|NCT03856047|38878904|FG001|Overall Study|Lost to Follow-up|2|||
16106941|NCT03856047|38878905|FG002|Overall Study|Lost to Follow-up|3|||
16106942|NCT03856047|38878906|FG003|Overall Study|Lost to Follow-up|1|||
16106943|NCT03856047|38878907|FG004|Overall Study|Lost to Follow-up|4|||
16540986|NCT01235546|40443151|FG001|Overall Study|Staff error, medication not administered|0|||
16106944|NCT03856047|38878908|FG005|Overall Study|Lost to Follow-up|4|||
16106945|NCT03856047|38878909|FG006|Overall Study|Lost to Follow-up|4|||
16106946|NCT03475056|38878910|FG000|Overall Study|Lost to Follow-up|0|||
16540987|NCT01235546|40443150|FG000|Overall Study|Protocol Violation|1|||
16540988|NCT01235546|40443151|FG001|Overall Study|Protocol Violation|1|||
16540989|NCT04279314|40443158|FG000|Overall Study|Adverse Event|55|||
16540990|NCT04279314|40443158|FG000|Overall Study|Withdrawal by Subject|5|||
16540991|NCT04279314|40443158|FG000|Overall Study|Lack of Efficacy|5|||
16106947|NCT03475056|38878911|FG001|Overall Study|Lost to Follow-up|1|||
16106948|NCT03475056|38878910|FG000|Overall Study|Moved from Area|0|||
16106949|NCT03475056|38878911|FG001|Overall Study|Moved from Area|2|||
16106950|NCT04334278|38878912|FG000|Overall Study|Lost to Follow-up|0|||
16106951|NCT04334278|38878913|FG001|Overall Study|Lost to Follow-up|3|||
16106952|NCT04334278|38878912|FG000|Overall Study|Withdrawal by Subject|4|||
16106953|NCT04334278|38878913|FG001|Overall Study|Withdrawal by Subject|2|||
16106954|NCT04358068|38878919|FG000|Overall Study|Did not initiate study treatment|2|||
16106955|NCT04358068|38878920|FG001|Overall Study|Did not initiate study treatment|2|||
16106956|NCT05006417|38878921|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
16106957|NCT01128114|38878922|FG000|Overall Study|Treatment Withdrawn|6|||
16106958|NCT01128114|38878922|FG000|Overall Study|Screening Failed|2|||
16106959|NCT01821729|38878929|FG000|Overall Study|Withdrawal by Subject|1|||
16106960|NCT01349036|38878930|FG000|Overall Study|Disease progression|13|||
16540992|NCT04279314|40443158|FG000|Overall Study|Protocol Violation|3|||
16540993|NCT04279314|40443158|FG000|Overall Study|Other (not COVID-19 related)|2|||
16540994|NCT01615328|40443161|FG000|Overall Study|Lost to Follow-up|3|||
16540995|NCT01615328|40443162|FG001|Overall Study|Lost to Follow-up|5|||
16540996|NCT02184611|40443165|FG000|Overall Study|Lack of Efficacy|11|||
16540997|NCT02184611|40443166|FG001|Overall Study|Lack of Efficacy|15|||
16540998|NCT02184611|40443165|FG000|Overall Study|Withdrawal by Subject|5|||
16540999|NCT02184611|40443166|FG001|Overall Study|Withdrawal by Subject|6|||
16541000|NCT02184611|40443165|FG000|Overall Study|Adverse Event|4|||
16541001|NCT02184611|40443166|FG001|Overall Study|Adverse Event|5|||
16541002|NCT02184611|40443165|FG000|Overall Study|Protocol Violation|1|||
16541003|NCT02184611|40443166|FG001|Overall Study|Protocol Violation|1|||
16541004|NCT02184611|40443165|FG000|Overall Study|Protocol defined stopping criteria|0|||
16541005|NCT02184611|40443166|FG001|Overall Study|Protocol defined stopping criteria|1|||
16541006|NCT02001194|40443167|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
16541007|NCT02001194|40443168|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
16541008|NCT02001194|40443169|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
16541009|NCT02001194|40443170|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
16541010|NCT02001194|40443167|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
16541011|NCT02001194|40443168|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
16541012|NCT02001194|40443169|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
16541013|NCT02001194|40443170|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
16541014|NCT05056870|40443171|FG000|Period 1|Site COVID-19 Related|3|||
16541015|NCT05056870|40443172|FG001|Period 1|Site COVID-19 Related|3|||
16541016|NCT05056870|40443171|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
16541017|NCT05056870|40443172|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
16541018|NCT05056870|40443171|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
16541019|NCT05056870|40443172|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
16541020|NCT05056870|40443171|FG000|Period 2|COVID-19 Related|1|||
16541021|NCT05056870|40443172|FG001|Period 2|COVID-19 Related|0|||
16541022|NCT05056870|40443171|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
16541023|NCT05056870|40443172|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
16541024|NCT00500903|40443173|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
16541025|NCT00500903|40443174|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
16541026|NCT00500903|40443175|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
16541027|NCT00500903|40443173|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
16541028|NCT00500903|40443174|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
16541029|NCT00500903|40443175|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
16541030|NCT00500903|40443173|FG000|Overall Study|Progressive Disease|41|||
16541031|NCT00500903|40443174|FG001|Overall Study|Progressive Disease|2|||
16541032|NCT00500903|40443175|FG002|Overall Study|Progressive Disease|15|||
16541033|NCT00500903|40443173|FG000|Overall Study|Patient Declined Further Treatment|0|||
16541034|NCT00500903|40443174|FG001|Overall Study|Patient Declined Further Treatment|0|||
16541035|NCT00500903|40443175|FG002|Overall Study|Patient Declined Further Treatment|3|||
16541036|NCT00500903|40443173|FG000|Overall Study|Symptomatic Deterioration|2|||
16541037|NCT00500903|40443174|FG001|Overall Study|Symptomatic Deterioration|0|||
16541038|NCT00500903|40443175|FG002|Overall Study|Symptomatic Deterioration|0|||
16541039|NCT00500903|40443173|FG000|Overall Study|Reason Not Specified|10|||
16541040|NCT00500903|40443174|FG001|Overall Study|Reason Not Specified|0|||
16541041|NCT00500903|40443175|FG002|Overall Study|Reason Not Specified|2|||
16541042|NCT01971723|40443176|FG000|Overall Study|Withdrawal by Subject|1|||
16541043|NCT01971723|40443177|FG001|Overall Study|Withdrawal by Subject|1|||
16541044|NCT01971723|40443176|FG000|Overall Study|Protocol Violation|1|||
16541045|NCT01971723|40443177|FG001|Overall Study|Protocol Violation|2|||
16541046|NCT01791725|40443178|FG000|Overall Study|Withdrawal by Subject|0|||
16541047|NCT01791725|40443179|FG001|Overall Study|Withdrawal by Subject|1|||
16106961|NCT01349036|38878931|FG001|Overall Study|Disease progression|22|||
16106962|NCT01349036|38878930|FG000|Overall Study|Other|1|||
16106963|NCT01349036|38878931|FG001|Overall Study|Other|0|||
16106964|NCT01349036|38878930|FG000|Overall Study|Withdrawal by Subject|0|||
16106965|NCT01349036|38878931|FG001|Overall Study|Withdrawal by Subject|2|||
16106966|NCT00611715|38878932|FG000|Overall Study|Disease Progression|24|||
16106967|NCT00611715|38878933|FG001|Overall Study|Disease Progression|4|||
16106968|NCT00611715|38878932|FG000|Overall Study|Withdrawal by Subject|5|||
16106969|NCT00611715|38878933|FG001|Overall Study|Withdrawal by Subject|1|||
16106970|NCT00611715|38878932|FG000|Overall Study|Adverse Event|9|||
16106971|NCT00611715|38878933|FG001|Overall Study|Adverse Event|1|||
16106972|NCT00611715|38878932|FG000|Overall Study|Death|1|||
16106973|NCT00611715|38878933|FG001|Overall Study|Death|0|||
16106974|NCT00611715|38878932|FG000|Overall Study|two patients are still on treatment|2|||
16106975|NCT00611715|38878933|FG001|Overall Study|two patients are still on treatment|0|||
16106976|NCT01426113|38878938|FG000|Overall Study|Study Discontinued|1|||
16106977|NCT01426113|38878939|FG001|Overall Study|Study Discontinued|1|||
16106978|NCT01426113|38878938|FG000|Overall Study|Adverse Event|0|||
16106979|NCT01426113|38878939|FG001|Overall Study|Adverse Event|1|||
16106980|NCT00350298|38878941|FG000|Overall Study|Death|7|||
16106981|NCT00350298|38878942|FG001|Overall Study|Death|8|||
16106982|NCT00350298|38878941|FG000|Overall Study|Lost to Follow-up|1|||
16106983|NCT00350298|38878942|FG001|Overall Study|Lost to Follow-up|2|||
16106984|NCT00350298|38878941|FG000|Overall Study|Withdrawal by Subject|1|||
16106985|NCT00350298|38878942|FG001|Overall Study|Withdrawal by Subject|3|||
16106986|NCT00545571|38878943|FG000|Overall Study|Administrative Reasons|1|||
16106987|NCT00545571|38878943|FG000|Overall Study|Adverse Event|2|||
16106988|NCT00545571|38878943|FG000|Overall Study|Death|5|||
16106989|NCT00545571|38878943|FG000|Overall Study|Lack of Efficacy|1|||
16106990|NCT00545571|38878943|FG000|Overall Study|Protocol Violation|2|||
16106991|NCT00545571|38878943|FG000|Overall Study|Refused Treatment|1|||
16106992|NCT00545571|38878943|FG000|Overall Study|Screen Failure|16|||
16106993|NCT00545571|38878943|FG000|Overall Study|Transfusion|12|||
16106994|NCT00545571|38878943|FG000|Overall Study|Early Termination of Study|24|||
16106995|NCT00545571|38878943|FG000|Overall Study|Kidney Transplantation|3|||
16106996|NCT04629443|38878944|FG000|Overall Study|Adverse Event|2|||
16106997|NCT04629443|38878945|FG001|Overall Study|Adverse Event|1|||
16106998|NCT04629443|38878946|FG002|Overall Study|Adverse Event|2|||
16106999|NCT04629443|38878944|FG000|Overall Study|Progressive Disease|2|||
16107000|NCT04629443|38878945|FG001|Overall Study|Progressive Disease|3|||
16107001|NCT04629443|38878946|FG002|Overall Study|Progressive Disease|3|||
16107002|NCT04629443|38878944|FG000|Overall Study|Physician Decision|1|||
16107003|NCT04629443|38878945|FG001|Overall Study|Physician Decision|3|||
16107004|NCT04629443|38878946|FG002|Overall Study|Physician Decision|0|||
16107005|NCT02554383|38878948|FG000|Overall Study|Ineligible|3|||
16107006|NCT02554383|38878949|FG001|Overall Study|Ineligible|2|||
16107007|NCT02554383|38878948|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
16107008|NCT02554383|38878949|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
16541048|NCT01791725|40443180|FG002|Overall Study|Withdrawal by Subject|0|||
16541049|NCT00710606|40443181|FG000|Overall Study|Adverse Event|0|||
16541050|NCT00710606|40443182|FG001|Overall Study|Adverse Event|2|||
16541051|NCT01424930|40443183|FG000|Overall Study|Adverse Event|0|||
16541052|NCT01424930|40443184|FG001|Overall Study|Adverse Event|1|||
16541053|NCT01424930|40443183|FG000|Overall Study|Death|1|||
16541054|NCT01424930|40443184|FG001|Overall Study|Death|0|||
16541055|NCT01424930|40443183|FG000|Overall Study|Progressive Disease|3|||
16541056|NCT01424930|40443184|FG001|Overall Study|Progressive Disease|6|||
16541057|NCT01424930|40443183|FG000|Overall Study|Screen Failure|0|||
16541058|NCT01424930|40443184|FG001|Overall Study|Screen Failure|1|||
16541059|NCT01424930|40443183|FG000|Overall Study|Reason not specified|0|||
16541060|NCT01424930|40443184|FG001|Overall Study|Reason not specified|6|||
16541061|NCT01194570|40443185|FG000|Overall Study|Adverse Event|22|||
16541062|NCT01194570|40443186|FG001|Overall Study|Adverse Event|40|||
16541063|NCT01194570|40443185|FG000|Overall Study|Death|6|||
16541064|NCT01194570|40443186|FG001|Overall Study|Death|20|||
16541065|NCT01194570|40443185|FG000|Overall Study|Lack of Efficacy|32|||
16107009|NCT02554383|38878948|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
16107010|NCT02554383|38878949|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
16107011|NCT02554383|38878948|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
16107012|NCT02554383|38878949|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
16541066|NCT01194570|40443186|FG001|Overall Study|Lack of Efficacy|33|||
16541067|NCT01194570|40443185|FG000|Overall Study|Lost to Follow-up|4|||
16541068|NCT01194570|40443186|FG001|Overall Study|Lost to Follow-up|15|||
16218327|NCT03083470|39278715|FG002|Overall Study|Withdrawal by Subject|0|||
16218328|NCT03083470|39278716|FG003|Overall Study|Withdrawal by Subject|0|||
16218329|NCT03083470|39278717|FG004|Overall Study|Withdrawal by Subject|1|||
16218330|NCT03330106|39278719|FG000|Part A|Withdrawal by Subject|1|||
16218331|NCT03330106|39278720|FG001|Part A|Withdrawal by Subject|1|||
16218332|NCT03330106|39278721|FG002|Part A|Withdrawal by Subject|0|||
16218333|NCT03330106|39278722|FG003|Part A|Withdrawal by Subject|0|||
16218334|NCT03330106|39278719|FG000|Part A|Death|2|||
16218335|NCT03330106|39278720|FG001|Part A|Death|1|||
16218336|NCT03330106|39278721|FG002|Part A|Death|0|||
16218337|NCT03330106|39278722|FG003|Part A|Death|0|||
16218338|NCT03330106|39278719|FG000|Part A|Adverse Event|0|||
16218339|NCT03330106|39278720|FG001|Part A|Adverse Event|1|||
16218340|NCT03330106|39278721|FG002|Part A|Adverse Event|0|||
16218341|NCT03330106|39278722|FG003|Part A|Adverse Event|0|||
16218342|NCT03330106|39278719|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
16218343|NCT03330106|39278720|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
16218344|NCT03330106|39278721|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
16218345|NCT03330106|39278722|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
16218346|NCT03330106|39278719|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
16218347|NCT03330106|39278720|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
16218348|NCT03330106|39278721|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
16218349|NCT03330106|39278722|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
16218350|NCT03330106|39278719|FG000|Part A|Progressive Disease|0|||
16218351|NCT03330106|39278720|FG001|Part A|Progressive Disease|1|||
16218352|NCT03330106|39278721|FG002|Part A|Progressive Disease|0|||
16218353|NCT03330106|39278722|FG003|Part A|Progressive Disease|0|||
16218354|NCT03330106|39278719|FG000|Part B|Lost to Follow-up|0|||
16218355|NCT03330106|39278720|FG001|Part B|Lost to Follow-up|0|||
16218356|NCT03330106|39278721|FG002|Part B|Lost to Follow-up|0|||
16541069|NCT01194570|40443185|FG000|Overall Study|Non-Compliance|2|||
16541070|NCT01194570|40443186|FG001|Overall Study|Non-Compliance|2|||
16541071|NCT01194570|40443185|FG000|Overall Study|Non-Compliance With Study Drug|2|||
16541072|NCT01194570|40443186|FG001|Overall Study|Non-Compliance With Study Drug|2|||
16541073|NCT01194570|40443185|FG000|Overall Study|Other|18|||
16541074|NCT01194570|40443186|FG001|Overall Study|Other|47|||
16541075|NCT01194570|40443185|FG000|Overall Study|Physician Decision|10|||
16541076|NCT01194570|40443186|FG001|Overall Study|Physician Decision|25|||
16541077|NCT01194570|40443185|FG000|Overall Study|Protocol Violation|1|||
16541078|NCT01194570|40443186|FG001|Overall Study|Protocol Violation|2|||
16541079|NCT01194570|40443185|FG000|Overall Study|Study Terminated By Sponsor|0|||
16541080|NCT01194570|40443186|FG001|Overall Study|Study Terminated By Sponsor|1|||
16541081|NCT01194570|40443185|FG000|Overall Study|Withdrawal by Subject|57|||
16541082|NCT01194570|40443186|FG001|Overall Study|Withdrawal by Subject|82|||
16541083|NCT01194570|40443185|FG000|Overall Study|Pregnancy|1|||
16541084|NCT01194570|40443186|FG001|Overall Study|Pregnancy|1|||
16541085|NCT04510675|40443188|FG000|Overall Study|Withdrawal by Subject|5|||
16541086|NCT02240108|40443189|FG000|Overall Study|Other than specified|8|||
16541087|NCT02240108|40443190|FG001|Overall Study|Other than specified|6|||
16541088|NCT02240108|40443189|FG000|Overall Study|Adverse Event|1|||
16541089|NCT02240108|40443190|FG001|Overall Study|Adverse Event|9|||
16541090|NCT02240108|40443189|FG000|Overall Study|Pregnancy|1|||
16541091|NCT02240108|40443190|FG001|Overall Study|Pregnancy|0|||
16541092|NCT02240108|40443189|FG000|Overall Study|Withdrawal by Subject|4|||
16541093|NCT02240108|40443190|FG001|Overall Study|Withdrawal by Subject|9|||
16541094|NCT02240108|40443189|FG000|Overall Study|StudyTerminated by Sponsor|0|||
16541095|NCT02240108|40443190|FG001|Overall Study|StudyTerminated by Sponsor|1|||
16541096|NCT00734630|40443191|FG000|Overall Study|Lack of Efficacy|4|||
16541097|NCT00734630|40443192|FG001|Overall Study|Lack of Efficacy|4|||
16541098|NCT00734630|40443191|FG000|Overall Study|Withdrawal by Subject|7|||
16541099|NCT00734630|40443192|FG001|Overall Study|Withdrawal by Subject|9|||
16541100|NCT00734630|40443191|FG000|Overall Study|Lost to Follow-up|13|||
16541101|NCT00734630|40443192|FG001|Overall Study|Lost to Follow-up|7|||
16541102|NCT00734630|40443191|FG000|Overall Study|Protocol Violation|0|||
16541103|NCT00734630|40443192|FG001|Overall Study|Protocol Violation|3|||
16541104|NCT00734630|40443191|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
16541105|NCT00734630|40443192|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
16541106|NCT00734630|40443191|FG000|Overall Study|Adverse Event|3|||
16541107|NCT00734630|40443192|FG001|Overall Study|Adverse Event|6|||
16218357|NCT03330106|39278722|FG003|Part B|Lost to Follow-up|1|||
16218358|NCT03330106|39278719|FG000|Part B|Withdrawal by Subject|0|||
16218359|NCT03330106|39278720|FG001|Part B|Withdrawal by Subject|0|||
16218360|NCT03330106|39278721|FG002|Part B|Withdrawal by Subject|4|||
16541108|NCT00734630|40443191|FG000|Overall Study|Randomized in Error|0|||
16218361|NCT03330106|39278722|FG003|Part B|Withdrawal by Subject|0|||
16218362|NCT03330106|39278719|FG000|Part B|Death|0|||
16541109|NCT00734630|40443192|FG001|Overall Study|Randomized in Error|1|||
16218363|NCT03330106|39278720|FG001|Part B|Death|0|||
16218364|NCT03330106|39278721|FG002|Part B|Death|2|||
16218365|NCT03330106|39278722|FG003|Part B|Death|0|||
16218366|NCT03330106|39278719|FG000|Part B|Clinical Progression|0|||
16218367|NCT03330106|39278720|FG001|Part B|Clinical Progression|0|||
16218368|NCT03330106|39278721|FG002|Part B|Clinical Progression|1|||
16218369|NCT03330106|39278722|FG003|Part B|Clinical Progression|1|||
16218370|NCT03330106|39278719|FG000|Part B|Symptomatic Deterioration|0|||
16218371|NCT03330106|39278720|FG001|Part B|Symptomatic Deterioration|0|||
16218372|NCT03330106|39278721|FG002|Part B|Symptomatic Deterioration|0|||
16218373|NCT03330106|39278722|FG003|Part B|Symptomatic Deterioration|1|||
16218374|NCT03330106|39278719|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
16218375|NCT03330106|39278720|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
16218376|NCT03330106|39278721|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
16218377|NCT03330106|39278722|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
16218378|NCT03330106|39278719|FG000|Part B|Progressive Disease|0|||
16218379|NCT03330106|39278720|FG001|Part B|Progressive Disease|0|||
16218380|NCT03330106|39278721|FG002|Part B|Progressive Disease|11|||
16218381|NCT03330106|39278722|FG003|Part B|Progressive Disease|4|||
16218382|NCT03480841|39278734|FG000|Overall Study|Lost to Follow-up|2|||
16218383|NCT03018340|39278735|FG000|Overall Study|Adverse Event|1|||
16218384|NCT03018340|39278736|FG001|Overall Study|Adverse Event|2|||
16218385|NCT03018340|39278735|FG000|Overall Study|Withdrawal by Subject|0|||
16218386|NCT03018340|39278736|FG001|Overall Study|Withdrawal by Subject|8|||
16218387|NCT03018340|39278735|FG000|Overall Study|Lack of Efficacy|0|||
16218388|NCT03018340|39278736|FG001|Overall Study|Lack of Efficacy|1|||
16218389|NCT03018340|39278735|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
16218390|NCT03018340|39278736|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
16218391|NCT03018340|39278735|FG000|Overall Study|Lost to Follow-up|1|||
16218392|NCT03018340|39278736|FG001|Overall Study|Lost to Follow-up|7|||
16218393|NCT03018340|39278735|FG000|Overall Study|Protocol Violation|3|||
16218394|NCT03018340|39278736|FG001|Overall Study|Protocol Violation|7|||
16218395|NCT03018340|39278735|FG000|Overall Study|Not further specified|0|||
16218396|NCT03018340|39278736|FG001|Overall Study|Not further specified|1|||
16218397|NCT01279954|39278742|FG000|Overall Study|Lack of Efficacy|3|||
16218398|NCT01279954|39278743|FG001|Overall Study|Lack of Efficacy|4|||
16218399|NCT02483611|39278744|FG000|Overall Study|Protocol Violation|0|||
16218400|NCT02483611|39278745|FG001|Overall Study|Protocol Violation|0|||
16218401|NCT02483611|39278746|FG002|Overall Study|Protocol Violation|1|||
16218402|NCT03824704|39278747|FG000|Overall Study|Study Terminated by Sponsor|1|||
16218403|NCT02646332|39278748|FG000|Overall Study|Lost to Follow-up|0|||
16218404|NCT02646332|39278749|FG001|Overall Study|Lost to Follow-up|3|||
16218405|NCT01241318|39278753|FG000|Overall Study|Woman: false pregnancies|27|||
16218406|NCT01241318|39278754|FG001|Overall Study|Woman: false pregnancies|15|||
16218407|NCT01241318|39278753|FG000|Overall Study|Woman: miscarriage/abortion|46|||
16218408|NCT01241318|39278754|FG001|Overall Study|Woman: miscarriage/abortion|38|||
16218409|NCT01241318|39278753|FG000|Overall Study|Withdrawal by Subject|175|||
16218410|NCT01241318|39278754|FG001|Overall Study|Withdrawal by Subject|46|||
16218411|NCT01241318|39278753|FG000|Overall Study|Lost to Follow-up|740|||
16218412|NCT01241318|39278754|FG001|Overall Study|Lost to Follow-up|455|||
16218413|NCT01241318|39278753|FG000|Overall Study|Death|2|||
16218414|NCT01241318|39278754|FG001|Overall Study|Death|4|||
16218415|NCT01241318|39278753|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
16218416|NCT01241318|39278754|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
16218417|NCT01241318|39278753|FG000|Overall Study|Woman: Stillborn infant|129|||
16218418|NCT01241318|39278754|FG001|Overall Study|Woman: Stillborn infant|146|||
16218419|NCT01594749|39278755|FG000|Overall Study|Adverse Event|2|||
16218420|NCT01594749|39278756|FG001|Overall Study|Adverse Event|1|||
16218421|NCT01594749|39278755|FG000|Overall Study|Withdrawal by Subject|2|||
16218422|NCT01594749|39278756|FG001|Overall Study|Withdrawal by Subject|2|||
16218423|NCT01594749|39278755|FG000|Overall Study|Protocol Violation|2|||
16218424|NCT01594749|39278756|FG001|Overall Study|Protocol Violation|0|||
16218425|NCT01594749|39278755|FG000|Overall Study|Physician Decision|1|||
16541110|NCT00734630|40443191|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
16218426|NCT01594749|39278756|FG001|Overall Study|Physician Decision|1|||
16218427|NCT01594749|39278755|FG000|Overall Study|Non-compliance with Protocol|0|||
16218428|NCT01594749|39278756|FG001|Overall Study|Non-compliance with Protocol|1|||
16218429|NCT01594749|39278755|FG000|Overall Study|Lost to Follow-up|1|||
16218430|NCT01594749|39278756|FG001|Overall Study|Lost to Follow-up|0|||
16218431|NCT01594749|39278755|FG000|Overall Study|Death|9|||
16218432|NCT01594749|39278756|FG001|Overall Study|Death|3|||
16218433|NCT01594749|39278755|FG000|Overall Study|Not Treated|4|||
16218434|NCT01594749|39278756|FG001|Overall Study|Not Treated|10|||
16218435|NCT01594749|39278755|FG000|Overall Study|Lost Source Documentation|1|||
16218436|NCT01594749|39278756|FG001|Overall Study|Lost Source Documentation|0|||
16218437|NCT02045979|39278757|FG000|Overall Study|Informed Consent Withdrawn|2|||
16218438|NCT02045979|39278758|FG001|Overall Study|Informed Consent Withdrawn|0|||
16218439|NCT02045979|39278759|FG002|Overall Study|Informed Consent Withdrawn|1|||
16218440|NCT02045979|39278757|FG000|Overall Study|not specified above|0|||
16218441|NCT02045979|39278758|FG001|Overall Study|not specified above|1|||
16218442|NCT02045979|39278759|FG002|Overall Study|not specified above|0|||
16218443|NCT01227252|39278760|FG000|Overall Study|Sponsor Decision|0|||
16218444|NCT01227252|39278761|FG001|Overall Study|Sponsor Decision|1|||
16218445|NCT01227252|39278762|FG002|Overall Study|Sponsor Decision|0|||
16218446|NCT01227252|39278763|FG003|Overall Study|Sponsor Decision|0|||
16218447|NCT01227252|39278760|FG000|Overall Study|Lost to Follow-up|0|||
16218448|NCT01227252|39278761|FG001|Overall Study|Lost to Follow-up|1|||
16218449|NCT01227252|39278762|FG002|Overall Study|Lost to Follow-up|0|||
16218450|NCT01227252|39278763|FG003|Overall Study|Lost to Follow-up|0|||
16218451|NCT01227252|39278760|FG000|Overall Study|Withdrawal by Subject|0|||
16218452|NCT01227252|39278761|FG001|Overall Study|Withdrawal by Subject|1|||
16218453|NCT01227252|39278762|FG002|Overall Study|Withdrawal by Subject|0|||
16218454|NCT01227252|39278763|FG003|Overall Study|Withdrawal by Subject|0|||
16218455|NCT00836953|39278764|FG000|Overall Study|Withdrawal by Subject|1|||
16218456|NCT00836953|39278764|FG000|Overall Study|Lost to Follow-up|1|||
16218457|NCT00129376|39278765|FG000|Overall Study|Adverse Event|1|||
16218458|NCT00129376|39278765|FG000|Overall Study|Lack of Efficacy|1|||
16218459|NCT03662789|39278766|FG000|Overall Study|Lost to Follow-up|1|||
16218460|NCT03662789|39278767|FG001|Overall Study|Lost to Follow-up|2|||
16218461|NCT03662789|39278766|FG000|Overall Study|Could not perform treadmill test|4|||
16218462|NCT03662789|39278767|FG001|Overall Study|Could not perform treadmill test|4|||
16218463|NCT03662789|39278766|FG000|Overall Study|Death|0|||
16218464|NCT03662789|39278767|FG001|Overall Study|Death|1|||
16218465|NCT00826540|39278774|FG000|Overall Study|ineligible|3|||
16218466|NCT00826540|39278774|FG000|Overall Study|Withdrawal by Subject|1|||
16218467|NCT04129242|39278775|FG000|Overall Study|Physician Decision|1|||
16218468|NCT04129242|39278776|FG001|Overall Study|Physician Decision|1|||
16541111|NCT00734630|40443192|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
16541112|NCT00734630|40443191|FG000|Overall Study|Poor Compliance|1|||
16218469|NCT04129242|39278775|FG000|Overall Study|Protocol Violation|0|||
16218470|NCT04129242|39278776|FG001|Overall Study|Protocol Violation|1|||
16218471|NCT01809327|39278777|FG000|Overall Study|Lost to Follow-up|5|||
16218472|NCT01809327|39278778|FG001|Overall Study|Lost to Follow-up|2|||
16218473|NCT01809327|39278779|FG002|Overall Study|Lost to Follow-up|4|||
16541113|NCT00734630|40443192|FG001|Overall Study|Poor Compliance|1|||
16541114|NCT02047045|40443194|FG000|Baseline|Withdrawal by Subject|3|||
16541115|NCT02047045|40443195|FG001|Baseline|Withdrawal by Subject|2|||
16541116|NCT02047045|40443194|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
16541117|NCT02047045|40443195|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
16541118|NCT02047045|40443194|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
16541119|NCT02047045|40443195|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
16541120|NCT02047045|40443194|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
16541121|NCT02047045|40443195|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
16541122|NCT02047045|40443194|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
16541123|NCT02047045|40443195|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
16541124|NCT02047045|40443194|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
16541125|NCT02047045|40443195|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
16541126|NCT02047045|40443194|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
16541127|NCT02047045|40443195|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
16541128|NCT02047045|40443194|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
16541129|NCT02047045|40443195|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
16541130|NCT02047045|40443194|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
16541131|NCT02047045|40443195|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
16541132|NCT02686034|40443198|FG000|Run-In Period 1|Eligibility|12|||
16541133|NCT02686034|40443199|FG001|Run-In Period 1|Eligibility|10|||
16541134|NCT02686034|40443198|FG000|Run-In Period 1|Withdrawal by Subject|4|||
16541135|NCT02686034|40443199|FG001|Run-In Period 1|Withdrawal by Subject|3|||
16541136|NCT02686034|40443198|FG000|Run-In Period 1|Lost to Follow-up|4|||
16541137|NCT02686034|40443199|FG001|Run-In Period 1|Lost to Follow-up|4|||
16541138|NCT02686034|40443198|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
16541139|NCT02686034|40443199|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
16218474|NCT01809327|39278780|FG003|Overall Study|Lost to Follow-up|2|||
16218475|NCT01809327|39278781|FG004|Overall Study|Lost to Follow-up|3|||
16218476|NCT01809327|39278777|FG000|Overall Study|Withdrawal by Subject|6|||
16218477|NCT01809327|39278778|FG001|Overall Study|Withdrawal by Subject|4|||
16218478|NCT01809327|39278779|FG002|Overall Study|Withdrawal by Subject|4|||
16541140|NCT02686034|40443198|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
16541141|NCT02686034|40443199|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
16541142|NCT02686034|40443198|FG000|Randomized Controlled Period 2|Adverse Event|0|||
16541143|NCT02686034|40443199|FG001|Randomized Controlled Period 2|Adverse Event|2|||
16107013|NCT01231464|38878950|FG000|Overall Study|Adverse Event|0|||
16107014|NCT01231464|38878951|FG001|Overall Study|Adverse Event|1|||
16218479|NCT01809327|39278780|FG003|Overall Study|Withdrawal by Subject|2|||
16218480|NCT01809327|39278781|FG004|Overall Study|Withdrawal by Subject|5|||
16218481|NCT01809327|39278777|FG000|Overall Study|Adverse Event|4|||
16218482|NCT01809327|39278778|FG001|Overall Study|Adverse Event|3|||
16218483|NCT01809327|39278779|FG002|Overall Study|Adverse Event|7|||
16218484|NCT01809327|39278780|FG003|Overall Study|Adverse Event|4|||
16218485|NCT01809327|39278781|FG004|Overall Study|Adverse Event|8|||
16218486|NCT01809327|39278777|FG000|Overall Study|Death|1|||
16218487|NCT01809327|39278778|FG001|Overall Study|Death|0|||
16218488|NCT01809327|39278779|FG002|Overall Study|Death|0|||
16218489|NCT01809327|39278780|FG003|Overall Study|Death|0|||
16218490|NCT01809327|39278781|FG004|Overall Study|Death|0|||
16218491|NCT01809327|39278777|FG000|Overall Study|Protocol Violation|0|||
16218492|NCT01809327|39278778|FG001|Overall Study|Protocol Violation|1|||
16218493|NCT01809327|39278779|FG002|Overall Study|Protocol Violation|0|||
16218494|NCT01809327|39278780|FG003|Overall Study|Protocol Violation|0|||
16218495|NCT01809327|39278781|FG004|Overall Study|Protocol Violation|0|||
16218496|NCT01809327|39278777|FG000|Overall Study|Physician Decision|1|||
16218497|NCT01809327|39278778|FG001|Overall Study|Physician Decision|1|||
16218498|NCT01809327|39278779|FG002|Overall Study|Physician Decision|0|||
16541144|NCT02686034|40443198|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
16541145|NCT02686034|40443199|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
16541146|NCT02686034|40443198|FG000|Open Label Period 3|Lost to Follow-up|0|||
16541147|NCT02686034|40443199|FG001|Open Label Period 3|Lost to Follow-up|1|||
16541148|NCT04918784|40443202|FG000|Overall Study|Amputation - no longer eligible|1|||
16541149|NCT04918784|40443203|FG001|Overall Study|Amputation - no longer eligible|2|||
16541150|NCT04918784|40443202|FG000|Overall Study|Death|1|||
16541151|NCT04918784|40443203|FG001|Overall Study|Death|0|||
16541152|NCT04918784|40443202|FG000|Overall Study|patient non-compliance|3|||
16541153|NCT04918784|40443203|FG001|Overall Study|patient non-compliance|1|||
16541154|NCT04918784|40443202|FG000|Overall Study|Adverse Event|1|||
16541155|NCT04918784|40443203|FG001|Overall Study|Adverse Event|0|||
16541156|NCT01113502|40443206|FG000|Overall Study|Withdrawal by Subject|1|||
16218499|NCT01809327|39278780|FG003|Overall Study|Physician Decision|0|||
16218500|NCT01809327|39278781|FG004|Overall Study|Physician Decision|0|||
16218501|NCT01809327|39278777|FG000|Overall Study|Pregnancy|1|||
16218502|NCT01809327|39278778|FG001|Overall Study|Pregnancy|0|||
16218503|NCT01809327|39278779|FG002|Overall Study|Pregnancy|0|||
16218504|NCT01809327|39278780|FG003|Overall Study|Pregnancy|0|||
16218505|NCT01809327|39278781|FG004|Overall Study|Pregnancy|0|||
16218506|NCT01809327|39278777|FG000|Overall Study|Other|14|||
16218507|NCT01809327|39278778|FG001|Overall Study|Other|15|||
16218508|NCT01809327|39278779|FG002|Overall Study|Other|7|||
16218509|NCT01809327|39278780|FG003|Overall Study|Other|4|||
16218510|NCT01809327|39278781|FG004|Overall Study|Other|9|||
16218511|NCT01435122|39278782|FG000|Overall Study|Early withdrawal due to toxicity|8|||
16218512|NCT00281528|39278784|FG000|Overall Study|Progressive Disease|28|||
16218513|NCT00281528|39278785|FG001|Overall Study|Progressive Disease|18|||
16218514|NCT00281528|39278786|FG002|Overall Study|Progressive Disease|27|||
16218515|NCT00281528|39278784|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
16218516|NCT00281528|39278785|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
16218517|NCT00281528|39278786|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
16218518|NCT00281528|39278784|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
16218519|NCT00281528|39278785|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
16218520|NCT00281528|39278786|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
16218521|NCT00281528|39278784|FG000|Overall Study|Physician Decision|11|||
16218522|NCT00281528|39278785|FG001|Overall Study|Physician Decision|4|||
16218523|NCT00281528|39278786|FG002|Overall Study|Physician Decision|5|||
16218524|NCT00281528|39278784|FG000|Overall Study|Protocol Violation|1|||
16218525|NCT00281528|39278785|FG001|Overall Study|Protocol Violation|0|||
16218526|NCT00281528|39278786|FG002|Overall Study|Protocol Violation|1|||
16218527|NCT00281528|39278784|FG000|Overall Study|Withdrawal by Subject|5|||
16218528|NCT00281528|39278785|FG001|Overall Study|Withdrawal by Subject|5|||
16218529|NCT00281528|39278786|FG002|Overall Study|Withdrawal by Subject|7|||
16218530|NCT00281528|39278784|FG000|Overall Study|Other|6|||
16218531|NCT00281528|39278785|FG001|Overall Study|Other|3|||
16218532|NCT00281528|39278786|FG002|Overall Study|Other|5|||
16218533|NCT03228836|39278787|FG000|Overall Study|Adverse Event|3|||
16218534|NCT03228836|39278787|FG000|Overall Study|Withdrawal by Subject|1|||
16218535|NCT03228836|39278787|FG000|Overall Study|Death|1|||
16541157|NCT01113502|40443207|FG001|Overall Study|Withdrawal by Subject|0|||
16541158|NCT01113502|40443208|FG002|Overall Study|Withdrawal by Subject|1|||
16218536|NCT03228836|39278787|FG000|Overall Study|Physician Decision|1|||
16218537|NCT03228836|39278787|FG000|Overall Study|Disease Progression|7|||
16218538|NCT03228836|39278787|FG000|Overall Study|Other|4|||
16218539|NCT03797144|39278790|FG000|Enrollment|Protocol Violation|4|||
16218540|NCT03797144|39278791|FG001|Enrollment|Protocol Violation|1|||
16218541|NCT03797144|39278790|FG000|Surgery|Protocol Violation|1|||
16218542|NCT03797144|39278791|FG001|Surgery|Protocol Violation|0|||
16218543|NCT03797144|39278790|FG000|3 Month|Early termination cut-off date|2|||
16218544|NCT03797144|39278791|FG001|3 Month|Early termination cut-off date|0|||
16218545|NCT03797144|39278790|FG000|12 Month|Early termination cut-off date|8|||
16218546|NCT03797144|39278791|FG001|12 Month|Early termination cut-off date|9|||
16218547|NCT03797144|39278790|FG000|24 Month|Early termination cut-off date|1|||
16218548|NCT03797144|39278791|FG001|24 Month|Early termination cut-off date|1|||
16218549|NCT03590613|39278792|FG000|Period 2, 4 Days|Physician Decision|0|||
16218550|NCT03590613|39278793|FG001|Period 2, 4 Days|Physician Decision|0|||
16218551|NCT03590613|39278794|FG002|Period 2, 4 Days|Physician Decision|0|||
16218552|NCT03590613|39278795|FG003|Period 2, 4 Days|Physician Decision|1|||
16218553|NCT02975206|39278798|FG000|Overall Study|Withdrawal by Subject|14|||
16218554|NCT02975206|39278799|FG001|Overall Study|Withdrawal by Subject|11|||
16218555|NCT02975206|39278800|FG002|Overall Study|Withdrawal by Subject|11|||
16218556|NCT02975206|39278798|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
16218557|NCT02975206|39278799|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
16218558|NCT02975206|39278800|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
16218559|NCT04048876|39278801|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
16218560|NCT04048876|39278802|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
16218561|NCT04048876|39278803|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
16218562|NCT04048876|39278804|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
16218563|NCT04048876|39278801|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
16218564|NCT04048876|39278802|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
16218565|NCT04048876|39278803|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
16218566|NCT04048876|39278804|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
16218567|NCT04048876|39278801|FG000|Placebo Controlled Phase|Adverse Event|0|||
16218568|NCT04048876|39278802|FG001|Placebo Controlled Phase|Adverse Event|1|||
16218569|NCT04048876|39278803|FG002|Placebo Controlled Phase|Adverse Event|0|||
16218570|NCT04048876|39278804|FG003|Placebo Controlled Phase|Adverse Event|0|||
16218571|NCT04048876|39278801|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
16218572|NCT04048876|39278802|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
16218573|NCT04048876|39278803|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
16218574|NCT04048876|39278804|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
16218575|NCT03258762|39278810|FG000|Overall Study|Lost to Follow-up|0|||
16218576|NCT03258762|39278811|FG001|Overall Study|Lost to Follow-up|1|||
16218577|NCT00323479|39278813|FG000|Overall Study|Adverse Event|2|||
16218578|NCT00323479|39278813|FG000|Overall Study|Withdrawal by Subject|2|||
16218579|NCT00323479|39278813|FG000|Overall Study|Protocol Violation|3|||
16218580|NCT00323479|39278813|FG000|Overall Study|house moving|1|||
16218581|NCT03818399|39278816|FG000|Overall Study|Lost to Follow-up|11|||
16218582|NCT03818399|39278816|FG000|Overall Study|Withdrawal by Subject|1|||
16218583|NCT03818399|39278816|FG000|Overall Study|Protocol Violation|2|||
16218584|NCT03432819|39278821|FG000|Overall Study|Lost to Follow-up|2|||
16218585|NCT03432819|39278822|FG001|Overall Study|Lost to Follow-up|2|||
16218586|NCT03432819|39278821|FG000|Overall Study|Withdrawal by Subject|5|||
16218587|NCT03432819|39278822|FG001|Overall Study|Withdrawal by Subject|3|||
16218588|NCT01408732|39278823|FG000|Overall Study|Withdrawal by Subject|2|||
16218589|NCT01408732|39278824|FG001|Overall Study|Withdrawal by Subject|2|||
16541159|NCT01113502|40443209|FG003|Overall Study|Withdrawal by Subject|1|||
16541160|NCT01113502|40443210|FG004|Overall Study|Withdrawal by Subject|0|||
16541161|NCT01113502|40443206|FG000|Overall Study|Adverse Event|0|||
16541162|NCT01113502|40443207|FG001|Overall Study|Adverse Event|0|||
16218590|NCT04590963|39278828|FG000|Overall Study|Death|118|||
16218591|NCT04590963|39278829|FG001|Overall Study|Death|59|||
16218592|NCT04590963|39278828|FG000|Overall Study|Lost to Follow-up|1|||
16340907|NCT01905592|39734474|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
16541163|NCT01113502|40443208|FG002|Overall Study|Adverse Event|3|||
16541164|NCT01113502|40443209|FG003|Overall Study|Adverse Event|2|||
16541165|NCT01113502|40443210|FG004|Overall Study|Adverse Event|0|||
16541166|NCT02130284|40443211|FG000|Overall Study|Withdrawal by Subject|3|||
16541167|NCT02130284|40443211|FG000|Overall Study|Subject Withdrew Consent|1|||
16541168|NCT02130284|40443211|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
16218593|NCT04590963|39278829|FG001|Overall Study|Lost to Follow-up|1|||
16218594|NCT04590963|39278828|FG000|Overall Study|Progressive disease|0|||
16218595|NCT04590963|39278829|FG001|Overall Study|Progressive disease|1|||
16218596|NCT04590963|39278828|FG000|Overall Study|Study terminated by sponsor|103|||
16218597|NCT04590963|39278829|FG001|Overall Study|Study terminated by sponsor|50|||
16218598|NCT04590963|39278828|FG000|Overall Study|Withdrawal by Subject|15|||
16218599|NCT04590963|39278829|FG001|Overall Study|Withdrawal by Subject|8|||
16218600|NCT04590963|39278828|FG000|Overall Study|Ongoing at data cut-off|9|||
16218601|NCT04590963|39278829|FG001|Overall Study|Ongoing at data cut-off|4|||
16218602|NCT04590963|39278828|FG000|Overall Study|Screen failure|1|||
16218603|NCT04590963|39278829|FG001|Overall Study|Screen failure|0|||
16218604|NCT04124952|39278830|FG000|Overall Study|Lost to Follow-up|1|||
16218605|NCT01191190|39278831|FG000|Overall Study|Withdrawal by Subject|1|||
16218606|NCT00392210|39278832|FG000|First Voiding Trial|Physician Decision|2|||
16218607|NCT00392210|39278833|FG001|First Voiding Trial|Physician Decision|2|||
16218608|NCT00112840|39278834|FG000|Overall Study|Physician Decision|1|||
16218609|NCT00112840|39278835|FG001|Overall Study|Physician Decision|0|||
16218610|NCT00112840|39278836|FG002|Overall Study|Physician Decision|0|||
16218611|NCT00112840|39278834|FG000|Overall Study|Withdrawal by Subject|1|||
16218612|NCT00112840|39278835|FG001|Overall Study|Withdrawal by Subject|0|||
16218613|NCT00112840|39278836|FG002|Overall Study|Withdrawal by Subject|1|||
16218614|NCT00112840|39278834|FG000|Overall Study|Protocol Violation|0|||
16218615|NCT00112840|39278835|FG001|Overall Study|Protocol Violation|0|||
16218616|NCT00112840|39278836|FG002|Overall Study|Protocol Violation|5|||
16218617|NCT05049122|39278839|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
16218618|NCT05049122|39278839|FG000|Overall Study|Participant moved|1|||
16218619|NCT05049122|39278839|FG000|Overall Study|At the direction of the doctor|1|||
16218620|NCT01326481|39278849|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
16541169|NCT02130284|40443211|FG000|Overall Study|Subject was screened as backup for study|3|||
16541170|NCT02130284|40443211|FG000|Overall Study|Screen Failure|1|||
16541171|NCT00522301|40443212|FG000|Overall Study|Withdrawal by Subject|1|||
16541172|NCT00522301|40443212|FG000|Overall Study|Adverse Event|5|||
16541173|NCT00785291|40443213|FG000|Overall Study|Never began treatment|8|||
16541174|NCT00785291|40443214|FG001|Overall Study|Never began treatment|4|||
16541175|NCT00785291|40443215|FG002|Overall Study|Never began treatment|4|||
16541176|NCT00785291|40443213|FG000|Overall Study|Adverse Event|39|||
16541177|NCT00785291|40443214|FG001|Overall Study|Adverse Event|70|||
16541178|NCT00785291|40443215|FG002|Overall Study|Adverse Event|56|||
16541179|NCT00785291|40443213|FG000|Overall Study|Death|7|||
16541180|NCT00785291|40443214|FG001|Overall Study|Death|4|||
16541181|NCT00785291|40443215|FG002|Overall Study|Death|3|||
16218621|NCT01333865|39278850|FG000|Overall Study|Adverse Event|2|||
16218622|NCT04397757|39278851|FG000|Overall Study|Death|3|||
16218623|NCT04397757|39278852|FG001|Overall Study|Death|11|||
16218624|NCT04397757|39278851|FG000|Overall Study|Withdrawal by Subject|2|||
16218625|NCT04397757|39278852|FG001|Overall Study|Withdrawal by Subject|0|||
16218626|NCT04397757|39278851|FG000|Overall Study|Lost to Follow-up|4|||
16218627|NCT04397757|39278852|FG001|Overall Study|Lost to Follow-up|3|||
16218628|NCT00424099|39278853|FG000|Overall Study|Adverse Event|0|||
16218629|NCT00424099|39278854|FG001|Overall Study|Adverse Event|1|||
16218630|NCT00424099|39278855|FG002|Overall Study|Adverse Event|1|||
16218631|NCT00424099|39278856|FG003|Overall Study|Adverse Event|0|||
16218632|NCT00424099|39278853|FG000|Overall Study|Death|0|||
16218633|NCT00424099|39278854|FG001|Overall Study|Death|1|||
16541182|NCT00785291|40443213|FG000|Overall Study|Withdrawal by Subject|35|||
16541183|NCT00785291|40443214|FG001|Overall Study|Withdrawal by Subject|36|||
16541184|NCT00785291|40443215|FG002|Overall Study|Withdrawal by Subject|17|||
16218634|NCT00424099|39278855|FG002|Overall Study|Death|0|||
16218635|NCT00424099|39278856|FG003|Overall Study|Death|0|||
16218636|NCT00424099|39278853|FG000|Overall Study|Illness|2|||
16218637|NCT00424099|39278854|FG001|Overall Study|Illness|0|||
16218638|NCT00424099|39278855|FG002|Overall Study|Illness|1|||
16218639|NCT00424099|39278856|FG003|Overall Study|Illness|4|||
16218640|NCT00424099|39278853|FG000|Overall Study|Lost to Follow-up|0|||
16218641|NCT00424099|39278854|FG001|Overall Study|Lost to Follow-up|0|||
16218642|NCT00424099|39278855|FG002|Overall Study|Lost to Follow-up|3|||
16218643|NCT00424099|39278856|FG003|Overall Study|Lost to Follow-up|0|||
16218644|NCT00424099|39278853|FG000|Overall Study|Hospitalized|1|||
16218645|NCT00424099|39278854|FG001|Overall Study|Hospitalized|2|||
16218646|NCT00424099|39278855|FG002|Overall Study|Hospitalized|1|||
16218647|NCT00424099|39278856|FG003|Overall Study|Hospitalized|3|||
16218648|NCT00424099|39278853|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
16218649|NCT00424099|39278854|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
16218650|NCT00424099|39278855|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
16218651|NCT00424099|39278856|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
16541185|NCT00785291|40443213|FG000|Overall Study|Alternative Therapy|12|||
16218652|NCT00424099|39278853|FG000|Overall Study|Withdrawal by Subject|1|||
16218653|NCT00424099|39278854|FG001|Overall Study|Withdrawal by Subject|9|||
16218654|NCT00424099|39278855|FG002|Overall Study|Withdrawal by Subject|4|||
16218655|NCT00424099|39278856|FG003|Overall Study|Withdrawal by Subject|6|||
16218656|NCT00424099|39278853|FG000|Overall Study|Physician Decision|0|||
16218657|NCT00424099|39278854|FG001|Overall Study|Physician Decision|0|||
16541186|NCT00785291|40443214|FG001|Overall Study|Alternative Therapy|6|||
16218658|NCT00424099|39278855|FG002|Overall Study|Physician Decision|1|||
16218659|NCT00424099|39278856|FG003|Overall Study|Physician Decision|0|||
16218660|NCT00424099|39278853|FG000|Overall Study|Missing|0|||
16218661|NCT00424099|39278854|FG001|Overall Study|Missing|0|||
16218662|NCT00424099|39278855|FG002|Overall Study|Missing|1|||
16218663|NCT00424099|39278856|FG003|Overall Study|Missing|0|||
16218664|NCT00423267|39282763|FG000|Period A|Withdrawal by Subject|0|||
16218665|NCT00423267|39282764|FG001|Period A|Withdrawal by Subject|1|||
16218666|NCT00423267|39282763|FG000|Period A|Non-compliance with protocol|1|||
16218667|NCT00423267|39282764|FG001|Period A|Non-compliance with protocol|0|||
16218668|NCT00423267|39282763|FG000|Period A|Administrative|1|||
16218669|NCT00423267|39282764|FG001|Period A|Administrative|0|||
16107015|NCT01231464|38878950|FG000|Overall Study|Protocol Violation|1|||
16218670|NCT01646255|39282765|FG000|Overall Study|Adverse Event|7|||
16218671|NCT01646255|39282766|FG001|Overall Study|Adverse Event|8|||
16218672|NCT01646255|39282765|FG000|Overall Study|Lack of Efficacy|2|||
16218673|NCT01646255|39282766|FG001|Overall Study|Lack of Efficacy|0|||
16218674|NCT01646255|39282765|FG000|Overall Study|Withdrawal by Subject|10|||
16218675|NCT01646255|39282766|FG001|Overall Study|Withdrawal by Subject|6|||
16218676|NCT01646255|39282765|FG000|Overall Study|Compliance is not well|1|||
16218677|NCT01646255|39282766|FG001|Overall Study|Compliance is not well|0|||
16218678|NCT01646255|39282765|FG000|Overall Study|Inclusion Criteria Deviation|1|||
16218679|NCT01646255|39282766|FG001|Overall Study|Inclusion Criteria Deviation|0|||
16218680|NCT00542425|39282772|FG000|Initial 24 Weeks|Administrative reasons|0|||
16218681|NCT00542425|39282773|FG001|Initial 24 Weeks|Administrative reasons|0|||
16218682|NCT00542425|39282774|FG002|Initial 24 Weeks|Administrative reasons|1|||
16218683|NCT00542425|39282775|FG003|Initial 24 Weeks|Administrative reasons|1|||
16218684|NCT00542425|39282776|FG004|Initial 24 Weeks|Administrative reasons|0|||
16218685|NCT00542425|39282772|FG000|Initial 24 Weeks|Adverse Event|0|||
16218686|NCT00542425|39282773|FG001|Initial 24 Weeks|Adverse Event|1|||
16218687|NCT00542425|39282774|FG002|Initial 24 Weeks|Adverse Event|1|||
16218688|NCT00542425|39282775|FG003|Initial 24 Weeks|Adverse Event|3|||
16218689|NCT00542425|39282776|FG004|Initial 24 Weeks|Adverse Event|2|||
16218690|NCT00542425|39282772|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
16218691|NCT00542425|39282773|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
16218692|NCT00542425|39282774|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
16218693|NCT00542425|39282775|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
16218694|NCT00542425|39282776|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
16218695|NCT00542425|39282772|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
16218696|NCT00542425|39282773|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
16218697|NCT00542425|39282774|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
16218698|NCT00542425|39282775|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
16218699|NCT00542425|39282776|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
16218700|NCT00542425|39282772|FG000|Initial 24 Weeks|Non-compliance|0|||
16218701|NCT00542425|39282773|FG001|Initial 24 Weeks|Non-compliance|0|||
16218702|NCT00542425|39282774|FG002|Initial 24 Weeks|Non-compliance|0|||
16218703|NCT00542425|39282775|FG003|Initial 24 Weeks|Non-compliance|1|||
16218704|NCT00542425|39282776|FG004|Initial 24 Weeks|Non-compliance|1|||
16218705|NCT00542425|39282772|FG000|Initial 24 Weeks|Protocol Violation|0|||
16218706|NCT00542425|39282773|FG001|Initial 24 Weeks|Protocol Violation|0|||
16218707|NCT00542425|39282774|FG002|Initial 24 Weeks|Protocol Violation|0|||
16218708|NCT00542425|39282775|FG003|Initial 24 Weeks|Protocol Violation|1|||
16218709|NCT00542425|39282776|FG004|Initial 24 Weeks|Protocol Violation|0|||
16218710|NCT00542425|39282772|FG000|Initial 24 Weeks|Refusal of treatment|2|||
16218711|NCT00542425|39282773|FG001|Initial 24 Weeks|Refusal of treatment|2|||
16218712|NCT00542425|39282774|FG002|Initial 24 Weeks|Refusal of treatment|1|||
16218713|NCT00542425|39282775|FG003|Initial 24 Weeks|Refusal of treatment|4|||
16218714|NCT00542425|39282776|FG004|Initial 24 Weeks|Refusal of treatment|1|||
16218715|NCT00542425|39282772|FG000|Initial 24 Weeks|Other|0|||
16218716|NCT00542425|39282773|FG001|Initial 24 Weeks|Other|2|||
16218717|NCT00542425|39282774|FG002|Initial 24 Weeks|Other|1|||
16218718|NCT00542425|39282775|FG003|Initial 24 Weeks|Other|0|||
16218719|NCT00542425|39282776|FG004|Initial 24 Weeks|Other|0|||
16218720|NCT00542425|39282772|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
16218721|NCT00542425|39282773|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
16218722|NCT00542425|39282774|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
16218723|NCT00542425|39282775|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
16107016|NCT01231464|38878951|FG001|Overall Study|Protocol Violation|2|||
16218724|NCT00542425|39282776|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
16218725|NCT00542425|39282772|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
16218726|NCT00542425|39282773|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
16218727|NCT00542425|39282774|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
16218728|NCT00542425|39282775|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
16218729|NCT00542425|39282776|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
16218730|NCT00542425|39282772|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
16218731|NCT00542425|39282773|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
16218732|NCT00542425|39282774|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
16218733|NCT00542425|39282775|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
16218734|NCT00542425|39282776|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
16218735|NCT00542425|39282772|FG000|Extended 24 Weeks of Treatment|Other|1|||
16218736|NCT00542425|39282773|FG001|Extended 24 Weeks of Treatment|Other|1|||
16218737|NCT00542425|39282774|FG002|Extended 24 Weeks of Treatment|Other|0|||
16218738|NCT00542425|39282775|FG003|Extended 24 Weeks of Treatment|Other|0|||
16218739|NCT00542425|39282776|FG004|Extended 24 Weeks of Treatment|Other|1|||
16218740|NCT00540228|39282779|FG000|Overall Study|Adverse Event|2|||
16218741|NCT00540228|39282780|FG001|Overall Study|Adverse Event|0|||
16218742|NCT00540228|39282781|FG002|Overall Study|Adverse Event|0|||
16218743|NCT00540228|39282782|FG003|Overall Study|Adverse Event|0|||
16218744|NCT00540228|39282783|FG004|Overall Study|Adverse Event|0|||
16218745|NCT00540228|39282779|FG000|Overall Study|Lost to Follow-up|1|||
16218746|NCT00540228|39282780|FG001|Overall Study|Lost to Follow-up|1|||
16541187|NCT00785291|40443215|FG002|Overall Study|Alternative Therapy|7|||
16541188|NCT00785291|40443213|FG000|Overall Study|Complicating illness|6|||
16541189|NCT00785291|40443214|FG001|Overall Study|Complicating illness|4|||
16541190|NCT00785291|40443215|FG002|Overall Study|Complicating illness|4|||
16541191|NCT00785291|40443213|FG000|Overall Study|Other Medical Reasons|29|||
16541192|NCT00785291|40443214|FG001|Overall Study|Other Medical Reasons|25|||
16541193|NCT00785291|40443215|FG002|Overall Study|Other Medical Reasons|15|||
16218747|NCT00540228|39282781|FG002|Overall Study|Lost to Follow-up|0|||
16218748|NCT00540228|39282782|FG003|Overall Study|Lost to Follow-up|0|||
16218749|NCT00540228|39282783|FG004|Overall Study|Lost to Follow-up|0|||
16218750|NCT03347279|39282784|FG000|Overall Study|Withdrawal by Subject|8|||
16218751|NCT03347279|39282785|FG001|Overall Study|Withdrawal by Subject|15|||
16218752|NCT03347279|39282784|FG000|Overall Study|Death|0|||
16218753|NCT03347279|39282785|FG001|Overall Study|Death|2|||
16218754|NCT03347279|39282784|FG000|Overall Study|Lost to Follow-up|5|||
16218755|NCT03347279|39282785|FG001|Overall Study|Lost to Follow-up|2|||
16218756|NCT03347279|39282784|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
16218757|NCT03347279|39282785|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
16218758|NCT01196091|39282790|FG000|Overall Study|Adverse Event|22|||
16218759|NCT01196091|39282791|FG001|Overall Study|Adverse Event|27|||
16218760|NCT01196091|39282792|FG002|Overall Study|Adverse Event|26|||
16218761|NCT01196091|39282790|FG000|Overall Study|Death|3|||
16218762|NCT01196091|39282791|FG001|Overall Study|Death|2|||
16218763|NCT01196091|39282792|FG002|Overall Study|Death|2|||
16218764|NCT01196091|39282790|FG000|Overall Study|Entry Criteria Not Met|11|||
16218765|NCT01196091|39282791|FG001|Overall Study|Entry Criteria Not Met|11|||
16218766|NCT01196091|39282792|FG002|Overall Study|Entry Criteria Not Met|10|||
16218767|NCT01196091|39282790|FG000|Overall Study|Lack of Efficacy|15|||
16218768|NCT01196091|39282791|FG001|Overall Study|Lack of Efficacy|12|||
16218769|NCT01196091|39282792|FG002|Overall Study|Lack of Efficacy|17|||
16218770|NCT01196091|39282790|FG000|Overall Study|Lost to Follow-up|5|||
16218771|NCT01196091|39282791|FG001|Overall Study|Lost to Follow-up|5|||
16218772|NCT01196091|39282792|FG002|Overall Study|Lost to Follow-up|6|||
16218773|NCT01196091|39282790|FG000|Overall Study|Parent/Caregiver Decision|0|||
16218774|NCT01196091|39282791|FG001|Overall Study|Parent/Caregiver Decision|0|||
16218775|NCT01196091|39282792|FG002|Overall Study|Parent/Caregiver Decision|1|||
16218776|NCT01196091|39282790|FG000|Overall Study|Withdrawal by Subject|16|||
16218777|NCT01196091|39282791|FG001|Overall Study|Withdrawal by Subject|19|||
16218778|NCT01196091|39282792|FG002|Overall Study|Withdrawal by Subject|22|||
16218779|NCT01196091|39282790|FG000|Overall Study|Physician Decision|3|||
16218780|NCT01196091|39282791|FG001|Overall Study|Physician Decision|3|||
16218781|NCT01196091|39282792|FG002|Overall Study|Physician Decision|4|||
16218782|NCT01196091|39282790|FG000|Overall Study|Protocol Violation|1|||
16218783|NCT01196091|39282791|FG001|Overall Study|Protocol Violation|3|||
16218784|NCT01196091|39282792|FG002|Overall Study|Protocol Violation|3|||
16218785|NCT01196091|39282790|FG000|Overall Study|Sponsor Decision|6|||
16218786|NCT01196091|39282791|FG001|Overall Study|Sponsor Decision|5|||
16218787|NCT01196091|39282792|FG002|Overall Study|Sponsor Decision|4|||
16218788|NCT01196091|39282790|FG000|Overall Study|Excluded Site|5|||
16218789|NCT01196091|39282791|FG001|Overall Study|Excluded Site|11|||
16218790|NCT01196091|39282792|FG002|Overall Study|Excluded Site|8|||
16218791|NCT01196091|39282790|FG000|Overall Study|Randomized, No Study Drug Received|1|||
16218792|NCT01196091|39282791|FG001|Overall Study|Randomized, No Study Drug Received|0|||
16218793|NCT01196091|39282792|FG002|Overall Study|Randomized, No Study Drug Received|1|||
16541194|NCT00508261|40443220|FG000|Overall Study|Other|0|||
16541195|NCT00508261|40443221|FG001|Overall Study|Other|1|||
16541196|NCT00508261|40443222|FG002|Overall Study|Other|1|||
16107017|NCT01231464|38878950|FG000|Overall Study|Lost to Follow-up|1|||
16218794|NCT00125268|39282795|FG000|Overall Study|Withdrawal by Subject|1|||
16218795|NCT00125268|39282796|FG001|Overall Study|Withdrawal by Subject|1|||
16218796|NCT01566981|39282797|FG000|Overall Study|Lost to Follow-up|5|||
16218797|NCT01566981|39282798|FG001|Overall Study|Lost to Follow-up|8|||
16218798|NCT00083616|39282799|FG000|Overall Study|Disease Progression|16|||
16218799|NCT00083616|39282799|FG000|Overall Study|Lost to Follow-up|1|||
16218800|NCT00083616|39282799|FG000|Overall Study|Physician Decision|2|||
16541197|NCT00508261|40443223|FG003|Overall Study|Other|0|||
16218801|NCT00083616|39282799|FG000|Overall Study|Withdrawal by Subject|3|||
16218802|NCT00083616|39282799|FG000|Overall Study|Ineligibility determined|2|||
16218803|NCT00083616|39282799|FG000|Overall Study|Non-compliance|1|||
16218804|NCT00083616|39282799|FG000|Overall Study|Other|6|||
16218805|NCT01351415|39282800|FG000|Overall Study|Withdrawal by Subject|15|||
16218806|NCT01351415|39282801|FG001|Overall Study|Withdrawal by Subject|17|||
16218807|NCT01351415|39282800|FG000|Overall Study|Trial termination by the Sponsor|28|||
16218808|NCT01351415|39282801|FG001|Overall Study|Trial termination by the Sponsor|19|||
16218809|NCT01351415|39282800|FG000|Overall Study|Lost to Follow-up|5|||
16218810|NCT01351415|39282801|FG001|Overall Study|Lost to Follow-up|7|||
16218811|NCT01351415|39282800|FG000|Overall Study|Death|190|||
16218812|NCT01351415|39282801|FG001|Overall Study|Death|187|||
16541198|NCT00508261|40443220|FG000|Overall Study|Serious Adverse Event|0|||
16541199|NCT00508261|40443221|FG001|Overall Study|Serious Adverse Event|1|||
16541200|NCT00508261|40443222|FG002|Overall Study|Serious Adverse Event|0|||
16541201|NCT00508261|40443223|FG003|Overall Study|Serious Adverse Event|0|||
16541202|NCT00508261|40443220|FG000|Overall Study|Withdrawal by Subject|3|||
16541203|NCT00508261|40443221|FG001|Overall Study|Withdrawal by Subject|4|||
16541204|NCT00508261|40443222|FG002|Overall Study|Withdrawal by Subject|4|||
16541205|NCT00508261|40443223|FG003|Overall Study|Withdrawal by Subject|0|||
16541206|NCT00508261|40443220|FG000|Overall Study|Migrated/ moved from study area|0|||
16218813|NCT01351415|39282800|FG000|Overall Study|Physician Decision|2|||
16218814|NCT01351415|39282801|FG001|Overall Study|Physician Decision|3|||
16218815|NCT01351415|39282800|FG000|Overall Study|Reason unknown|0|||
16218816|NCT01351415|39282801|FG001|Overall Study|Reason unknown|2|||
16218817|NCT01351415|39282800|FG000|Overall Study|Never Started|5|||
16218818|NCT01351415|39282801|FG001|Overall Study|Never Started|5|||
16218819|NCT00901394|39282802|FG000|Overall Study|Physician Decision|1|||
16218820|NCT00901394|39282803|FG001|Overall Study|Physician Decision|1|||
16107018|NCT01231464|38878951|FG001|Overall Study|Lost to Follow-up|2|||
16340908|NCT01905592|39734473|FG000|Overall Study|Protocol Violation|0|||
16340909|NCT01905592|39734474|FG001|Overall Study|Protocol Violation|1|||
16218821|NCT00901394|39282804|FG002|Overall Study|Physician Decision|2|||
16541207|NCT00508261|40443221|FG001|Overall Study|Migrated/ moved from study area|1|||
16541208|NCT00508261|40443222|FG002|Overall Study|Migrated/ moved from study area|0|||
16218822|NCT04430036|39282808|FG000|Safety Run in Phase|Progression of disease|2|||
16218823|NCT01888367|39282815|FG000|Overall Study|Physician Decision|3|||
16218824|NCT01888367|39282816|FG001|Overall Study|Physician Decision|4|||
16218825|NCT01888367|39282817|FG002|Overall Study|Physician Decision|2|||
16218826|NCT01888367|39282815|FG000|Overall Study|Death|2|||
16218827|NCT01888367|39282816|FG001|Overall Study|Death|0|||
16218828|NCT01888367|39282817|FG002|Overall Study|Death|1|||
16218829|NCT01888367|39282815|FG000|Overall Study|Withdrawal by Subject|1|||
16218830|NCT01888367|39282816|FG001|Overall Study|Withdrawal by Subject|0|||
16218831|NCT01888367|39282817|FG002|Overall Study|Withdrawal by Subject|1|||
16218832|NCT01888367|39282815|FG000|Overall Study|Lost to Follow-up|1|||
16218833|NCT01888367|39282816|FG001|Overall Study|Lost to Follow-up|1|||
16218834|NCT01888367|39282817|FG002|Overall Study|Lost to Follow-up|0|||
16218835|NCT01888367|39282815|FG000|Overall Study|Protocol Violation|0|||
16218836|NCT01888367|39282816|FG001|Overall Study|Protocol Violation|0|||
16218837|NCT01888367|39282817|FG002|Overall Study|Protocol Violation|1|||
16218838|NCT01888367|39282815|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
16218839|NCT01888367|39282816|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
16218840|NCT01888367|39282817|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
16218841|NCT01797302|39282818|FG000|Overall Study|Lost to Follow-up|16|||
16218842|NCT01797302|39282819|FG001|Overall Study|Lost to Follow-up|23|||
16218843|NCT01797302|39282820|FG002|Overall Study|Lost to Follow-up|22|||
16218844|NCT01797302|39282818|FG000|Overall Study|Withdrawal by Subject|1|||
16218845|NCT01797302|39282819|FG001|Overall Study|Withdrawal by Subject|3|||
16218846|NCT01797302|39282820|FG002|Overall Study|Withdrawal by Subject|4|||
16218847|NCT02380703|39282827|FG000|Overall Study|Withdrawal by Subject|12|||
16218848|NCT02380703|39282828|FG001|Overall Study|Withdrawal by Subject|9|||
16218849|NCT02380703|39282827|FG000|Overall Study|Lost to Follow-up|12|||
16218850|NCT02380703|39282828|FG001|Overall Study|Lost to Follow-up|12|||
16218851|NCT02380703|39282827|FG000|Overall Study|Caregiver death|1|||
16218852|NCT02380703|39282828|FG001|Overall Study|Caregiver death|0|||
16218853|NCT02380703|39282827|FG000|Overall Study|Person with dementia (PWD) death|7|||
16218854|NCT02380703|39282828|FG001|Overall Study|Person with dementia (PWD) death|8|||
16218855|NCT02380703|39282827|FG000|Overall Study|Entered Long-term Care|4|||
16107019|NCT01231464|38878950|FG000|Overall Study|Withdrawal by Subject|3|||
16107020|NCT01231464|38878951|FG001|Overall Study|Withdrawal by Subject|2|||
16107021|NCT01560871|38878952|FG000|Overall Study|transportation issues|2|||
16107022|NCT01560871|38878953|FG001|Overall Study|transportation issues|1|||
16107023|NCT01560871|38878952|FG000|Overall Study|relocation|1|||
16107024|NCT01560871|38878953|FG001|Overall Study|relocation|0|||
16107025|NCT01560871|38878952|FG000|Overall Study|readmission to a hospital|2|||
16107026|NCT01560871|38878953|FG001|Overall Study|readmission to a hospital|1|||
16107027|NCT01560871|38878952|FG000|Overall Study|Lost to Follow-up|1|||
16107028|NCT01560871|38878953|FG001|Overall Study|Lost to Follow-up|0|||
16107029|NCT01588366|38878955|FG000|Overall Study|Adverse Event|0|||
16107030|NCT01588366|38878956|FG001|Overall Study|Adverse Event|1|||
16107031|NCT01588366|38878957|FG002|Overall Study|Adverse Event|0|||
16107032|NCT01588366|38878958|FG003|Overall Study|Adverse Event|1|||
16107033|NCT01588366|38878959|FG004|Overall Study|Adverse Event|0|||
16107034|NCT01588366|38878960|FG005|Overall Study|Adverse Event|2|||
16107035|NCT02647645|38878961|FG000|Overall Study|Lost to Follow-up|2|||
16107036|NCT02647645|38878962|FG001|Overall Study|Lost to Follow-up|1|||
16107037|NCT01841112|38878967|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
16107038|NCT01841112|38878968|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
16107039|NCT01841112|38878969|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
16107040|NCT01841112|38878970|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
16107041|NCT01841112|38878971|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
16107042|NCT01891890|38878973|FG000|Overall Study|Lost to Follow-up|0|||
16107043|NCT01891890|38878974|FG001|Overall Study|Lost to Follow-up|0|||
16107044|NCT01891890|38878975|FG002|Overall Study|Lost to Follow-up|1|||
16107045|NCT01891890|38878973|FG000|Overall Study|Study ended before endpoint reached|7|||
16218856|NCT02380703|39282828|FG001|Overall Study|Entered Long-term Care|7|||
16218857|NCT02773849|39282829|FG000|Overall Study|Lost to Follow-up|11|||
16218858|NCT02773849|39282829|FG000|Overall Study|Death|26|||
16218859|NCT02773849|39282829|FG000|Overall Study|Withdrawal by Subject|5|||
16218860|NCT02773849|39282829|FG000|Overall Study|Withdrawal of Consent|9|||
16340910|NCT01905592|39734473|FG000|Overall Study|Sponsor's decision|1|||
16107046|NCT01891890|38878974|FG001|Overall Study|Study ended before endpoint reached|3|||
16107047|NCT01891890|38878975|FG002|Overall Study|Study ended before endpoint reached|6|||
16107048|NCT00702650|38878976|FG000|Overall Study|Withdrawal by Subject|9|||
16107049|NCT00702650|38878976|FG000|Overall Study|Non-Compliance of Study Drug|3|||
16107050|NCT00702650|38878976|FG000|Overall Study|Lost to Follow-up|2|||
16107051|NCT00702650|38878976|FG000|Overall Study|Non-Compliance with Site Directives|1|||
16107052|NCT00702650|38878976|FG000|Overall Study|Sponsor Request|1|||
16107053|NCT00702650|38878976|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
16107054|NCT00702650|38878976|FG000|Overall Study|Adverse Event|3|||
16107055|NCT00510198|38878977|FG000|Overall Study|Withdrawal by Subject|5|||
16107056|NCT00510198|38878978|FG001|Overall Study|Withdrawal by Subject|4|||
16107057|NCT01777490|38878979|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
16107058|NCT01777490|38878980|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
16107059|NCT01777490|38878981|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
16107060|NCT01777490|38878982|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
16107061|NCT01920178|38878983|FG000|Overall Study|Lost to Follow-up|2|||
16107062|NCT01920178|38878984|FG001|Overall Study|Lost to Follow-up|1|||
16107063|NCT00104637|38878985|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
16107064|NCT00104637|38878986|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
16107065|NCT00409409|38878987|FG000|Overall Study|Adverse Event|7|||
16107066|NCT00409409|38878988|FG001|Overall Study|Adverse Event|2|||
16107067|NCT00409409|38878987|FG000|Overall Study|Withdrawal by Subject|1|||
16107068|NCT00409409|38878988|FG001|Overall Study|Withdrawal by Subject|1|||
16107069|NCT00409409|38878987|FG000|Overall Study|Any other reason not above-mentioned|0|||
16107070|NCT00409409|38878988|FG001|Overall Study|Any other reason not above-mentioned|1|||
16107071|NCT04816708|38878989|FG000|Overall Study|Lost to Follow-up|10|||
16107072|NCT04816708|38878990|FG001|Overall Study|Lost to Follow-up|4|||
16107073|NCT00644878|38878991|FG000|Overall Study|Adverse Event|2|||
16107074|NCT00644878|38878991|FG000|Overall Study|Abnormal laboratory value|3|||
16107075|NCT00644878|38878991|FG000|Overall Study|Protocol deviation|2|||
16541209|NCT00508261|40443223|FG003|Overall Study|Migrated/ moved from study area|0|||
16541210|NCT00508261|40443220|FG000|Overall Study|Lost to Follow-up|0|||
16541211|NCT00508261|40443221|FG001|Overall Study|Lost to Follow-up|1|||
16541212|NCT00508261|40443222|FG002|Overall Study|Lost to Follow-up|1|||
16541213|NCT00508261|40443223|FG003|Overall Study|Lost to Follow-up|1|||
16541214|NCT02124265|40443224|FG000|Overall Study|Adverse Event|1|||
16541215|NCT00338884|40443225|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
16541216|NCT00338884|40443225|FG000|Overall Study|Adverse Event|14|||
16541217|NCT00338884|40443225|FG000|Overall Study|Death|8|||
16541218|NCT00338884|40443225|FG000|Overall Study|Other|4|||
16541219|NCT00338884|40443225|FG000|Overall Study|Global Deterioration of Health Status|3|||
16541220|NCT00338884|40443225|FG000|Overall Study|Withdrawal by Subject|3|||
16541221|NCT00338884|40443225|FG000|Overall Study|Lost to Follow-up|1|||
16541222|NCT00338884|40443225|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
16541223|NCT02487498|40443228|FG000|Period: Period 1|Adverse Event|2|||
16541224|NCT02487498|40443229|FG001|Period: Period 1|Adverse Event|4|||
16541225|NCT02487498|40443228|FG000|Period: Period 1|Subject/guardian decision|2|||
16541226|NCT02487498|40443229|FG001|Period: Period 1|Subject/guardian decision|4|||
16541227|NCT02487498|40443228|FG000|Period: Period 1|Lost to Follow-up|0|||
16541228|NCT02487498|40443229|FG001|Period: Period 1|Lost to Follow-up|2|||
16541229|NCT02487498|40443228|FG000|Period: Period 1|Lack of Efficacy|1|||
16541230|NCT02487498|40443229|FG001|Period: Period 1|Lack of Efficacy|0|||
16541231|NCT02487498|40443228|FG000|Period: Period 1|Physician Decision|0|||
16541232|NCT02487498|40443229|FG001|Period: Period 1|Physician Decision|1|||
16541233|NCT02487498|40443228|FG000|Period: Period 1|Protocol deviation|1|||
16541234|NCT02487498|40443229|FG001|Period: Period 1|Protocol deviation|0|||
16541235|NCT02487498|40443228|FG000|Period: Washout|Subject/guardian decision|0|||
16541236|NCT02487498|40443229|FG001|Period: Washout|Subject/guardian decision|5|||
16541237|NCT02487498|40443228|FG000|Period: Washout|Lack of Efficacy|1|||
16541238|NCT02487498|40443229|FG001|Period: Washout|Lack of Efficacy|1|||
16541239|NCT02487498|40443228|FG000|Period: Washout|Physician Decision|1|||
16541240|NCT02487498|40443229|FG001|Period: Washout|Physician Decision|0|||
16541241|NCT02487498|40443228|FG000|Period: Washout|Non-compliance with study treatment|0|||
16541242|NCT02487498|40443229|FG001|Period: Washout|Non-compliance with study treatment|1|||
16541243|NCT02487498|40443228|FG000|Period: Period 2|Adverse Event|2|||
16541244|NCT02487498|40443229|FG001|Period: Period 2|Adverse Event|2|||
16107076|NCT00644878|38878991|FG000|Overall Study|Treatment duration completed as per protocol|11|||
16107077|NCT01255761|38878995|FG000|Overall Study|Adverse Event|29|||
16107078|NCT01255761|38878996|FG001|Overall Study|Adverse Event|43|||
16107079|NCT01255761|38878995|FG000|Overall Study|Lack of Efficacy|86|||
16107080|NCT01255761|38878996|FG001|Overall Study|Lack of Efficacy|74|||
16107081|NCT01255761|38878995|FG000|Overall Study|Protocol Violation|9|||
16107082|NCT01255761|38878996|FG001|Overall Study|Protocol Violation|5|||
16541245|NCT02487498|40443228|FG000|Period: Period 2|Subject/guardian decision|2|||
16541246|NCT02487498|40443229|FG001|Period: Period 2|Subject/guardian decision|1|||
16541247|NCT02487498|40443228|FG000|Period: Period 2|Lost to Follow-up|1|||
16541248|NCT02487498|40443229|FG001|Period: Period 2|Lost to Follow-up|1|||
16541249|NCT02487498|40443228|FG000|Period: Period 2|Death|0|||
16541250|NCT02487498|40443229|FG001|Period: Period 2|Death|1|||
16541251|NCT02487498|40443228|FG000|Period: Period 2|Physician Decision|1|||
16541252|NCT02487498|40443229|FG001|Period: Period 2|Physician Decision|0|||
16541253|NCT01499082|40443230|FG000|Overall Study|Randomized but not Treated|0|||
16541254|NCT01499082|40443231|FG001|Overall Study|Randomized but not Treated|1|||
16541255|NCT01499082|40443230|FG000|Overall Study|Adverse Event|12|||
16541256|NCT01499082|40443231|FG001|Overall Study|Adverse Event|16|||
16541257|NCT01499082|40443230|FG000|Overall Study|Lack of Efficacy|1|||
16541258|NCT01499082|40443231|FG001|Overall Study|Lack of Efficacy|1|||
16541259|NCT01499082|40443230|FG000|Overall Study|Protocol Violation|6|||
16541260|NCT01499082|40443231|FG001|Overall Study|Protocol Violation|8|||
16541261|NCT01499082|40443230|FG000|Overall Study|Diverse Reasons|18|||
16541262|NCT01499082|40443231|FG001|Overall Study|Diverse Reasons|14|||
16541263|NCT01499082|40443230|FG000|Overall Study|Site Closure for Noncompliance|5|||
16541264|NCT01499082|40443231|FG001|Overall Study|Site Closure for Noncompliance|2|||
16541265|NCT01499082|40443230|FG000|Overall Study|Hypoglycemia|2|||
16541266|NCT01499082|40443231|FG001|Overall Study|Hypoglycemia|3|||
16541267|NCT01499082|40443230|FG000|Overall Study|Lost to Follow-up|1|||
16541268|NCT01499082|40443231|FG001|Overall Study|Lost to Follow-up|3|||
16541269|NCT01111123|40443232|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
16541270|NCT01111123|40443233|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
16541271|NCT01111123|40443232|FG000|Maintenance Phase|Lost to Follow-up|0|||
16541272|NCT01111123|40443233|FG001|Maintenance Phase|Lost to Follow-up|2|||
16541273|NCT03409666|40443234|FG000|Overall Study|Physician Decision|0|||
16541274|NCT03409666|40443235|FG001|Overall Study|Physician Decision|1|||
16541275|NCT03409666|40443234|FG000|Overall Study|Protocol Violation|0|||
16541276|NCT03409666|40443235|FG001|Overall Study|Protocol Violation|3|||
16541277|NCT02238379|40443236|FG000|Overall Study|Lost to Follow-up|1|||
16541278|NCT02238379|40443237|FG001|Overall Study|Lost to Follow-up|0|||
16541279|NCT04080752|40443238|FG000|Overall Study|Adverse Event|2|||
16541280|NCT04080752|40443239|FG001|Overall Study|Adverse Event|3|||
16541281|NCT04080752|40443238|FG000|Overall Study|Lack of Efficacy|1|||
16541282|NCT04080752|40443239|FG001|Overall Study|Lack of Efficacy|0|||
16541283|NCT04080752|40443238|FG000|Overall Study|Lost to Follow-up|1|||
16541284|NCT04080752|40443239|FG001|Overall Study|Lost to Follow-up|0|||
16541285|NCT04080752|40443238|FG000|Overall Study|Pregnancy|0|||
16541286|NCT04080752|40443239|FG001|Overall Study|Pregnancy|1|||
16541287|NCT04080752|40443238|FG000|Overall Study|Withdrawal by Subject|7|||
16541288|NCT04080752|40443239|FG001|Overall Study|Withdrawal by Subject|0|||
16541289|NCT04080752|40443238|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16541290|NCT04080752|40443239|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16541291|NCT04080752|40443238|FG000|Overall Study|Other|2|||
16541292|NCT04080752|40443239|FG001|Overall Study|Other|1|||
16541293|NCT03232983|40443242|FG000|Period 1|Physician Decision|0|||
16541294|NCT03232983|40443243|FG001|Period 1|Physician Decision|0|||
16541295|NCT03232983|40443244|FG002|Period 1|Physician Decision|1|||
16541296|NCT03232983|40443245|FG003|Period 1|Physician Decision|0|||
16541297|NCT03232983|40443242|FG000|Washout Period 2|Physician Decision|0|||
16541298|NCT03232983|40443243|FG001|Washout Period 2|Physician Decision|0|||
16541299|NCT03232983|40443244|FG002|Washout Period 2|Physician Decision|1|||
16541300|NCT03232983|40443245|FG003|Washout Period 2|Physician Decision|0|||
16541301|NCT03232983|40443242|FG000|Washout Period 2|Withdrawal by Subject|0|||
16541302|NCT03232983|40443243|FG001|Washout Period 2|Withdrawal by Subject|0|||
16541303|NCT03232983|40443244|FG002|Washout Period 2|Withdrawal by Subject|0|||
16541304|NCT03232983|40443245|FG003|Washout Period 2|Withdrawal by Subject|1|||
16541305|NCT03232983|40443242|FG000|Period 4|Withdrawal by Subject|1|||
16541306|NCT03232983|40443243|FG001|Period 4|Withdrawal by Subject|0|||
16541307|NCT03232983|40443244|FG002|Period 4|Withdrawal by Subject|0|||
16541308|NCT03232983|40443245|FG003|Period 4|Withdrawal by Subject|0|||
16541309|NCT00765843|40443246|FG000|Overall Study|Lost to Follow-up|1|||
16541310|NCT00765843|40443247|FG001|Overall Study|Lost to Follow-up|3|||
16541311|NCT00765843|40443248|FG002|Overall Study|Lost to Follow-up|2|||
16541312|NCT00765843|40443246|FG000|Overall Study|did not return to receive intervention|0|||
16541313|NCT00765843|40443247|FG001|Overall Study|did not return to receive intervention|1|||
16541314|NCT00765843|40443248|FG002|Overall Study|did not return to receive intervention|0|||
16541315|NCT00765843|40443246|FG000|Overall Study|Adverse Event|0|||
16541316|NCT00765843|40443247|FG001|Overall Study|Adverse Event|0|||
16541317|NCT00765843|40443248|FG002|Overall Study|Adverse Event|1|||
16541318|NCT00512148|40443249|FG000|Primay Study Period|Withdrawal by Subject|1|||
16541319|NCT02054806|40443250|FG000|Overall Study|Sponsor Decision|31|||
16541320|NCT02054806|40443250|FG000|Overall Study|Withdrawal by Subject|43|||
16541321|NCT02054806|40443250|FG000|Overall Study|Protocol Violation|2|||
16541322|NCT02054806|40443250|FG000|Overall Study|Lost to Follow-up|10|||
16541323|NCT02054806|40443250|FG000|Overall Study|Death|391|||
16340911|NCT01905592|39734474|FG001|Overall Study|Sponsor's decision|1|||
16541324|NCT04123067|40443251|FG000|Overall Study|Lost to Follow-up|0|||
16541325|NCT04123067|40443252|FG001|Overall Study|Lost to Follow-up|1|||
16541326|NCT04274894|40443253|FG000|Overall Study|Adverse Event|7|||
16541327|NCT04274894|40443253|FG000|Overall Study|Withdrew consent|5|||
16340912|NCT01905592|39734473|FG000|Overall Study|Not treated|7|||
16340913|NCT01905592|39734474|FG001|Overall Study|Not treated|3|||
16541328|NCT04274894|40443253|FG000|Overall Study|Lost to Follow-up|9|||
16541329|NCT04274894|40443253|FG000|Overall Study|COVID-19 infection|1|||
16541330|NCT04274894|40443253|FG000|Overall Study|Other, not specified|20|||
16541331|NCT02070484|40443254|FG000|Overall Study|Withdrawal by Subject|1|||
16541332|NCT02070484|40443255|FG001|Overall Study|Withdrawal by Subject|0|||
16541333|NCT01357616|40443261|FG000|Overall Study|Adverse Event|1|||
16541334|NCT01357616|40443262|FG001|Overall Study|Adverse Event|1|||
16541335|NCT01357616|40443261|FG000|Overall Study|Lost to Follow-up|4|||
16340914|NCT01905592|39734473|FG000|Overall Study|Withdrawal by Subject|10|||
16340915|NCT01905592|39734474|FG001|Overall Study|Withdrawal by Subject|2|||
16340916|NCT01492101|39734476|FG000|Overall Study|Death|323|||
16340917|NCT01492101|39734477|FG001|Overall Study|Death|322|||
16340918|NCT01492101|39734476|FG000|Overall Study|Withdrawal by Subject|14|||
16340919|NCT01492101|39734477|FG001|Overall Study|Withdrawal by Subject|18|||
16340920|NCT01492101|39734476|FG000|Overall Study|Lost to Follow-up|0|||
16340921|NCT01492101|39734477|FG001|Overall Study|Lost to Follow-up|2|||
16340922|NCT02824562|39734478|FG000|Overall Study|Lost to Follow-up|3|||
16340923|NCT02824562|39734479|FG001|Overall Study|Lost to Follow-up|4|||
16340924|NCT02824562|39734478|FG000|Overall Study|Death|0|||
16340925|NCT02824562|39734479|FG001|Overall Study|Death|1|||
16340926|NCT01119846|39734480|FG000|Overall Study|Adverse Event|1|||
16340927|NCT01119846|39734481|FG001|Overall Study|Adverse Event|0|||
16340928|NCT01119846|39734482|FG002|Overall Study|Adverse Event|6|||
16340929|NCT01119846|39734480|FG000|Overall Study|Physician Decision|1|||
16340930|NCT01119846|39734481|FG001|Overall Study|Physician Decision|0|||
16340931|NCT01119846|39734482|FG002|Overall Study|Physician Decision|0|||
16340932|NCT01119846|39734480|FG000|Overall Study|Protocol Violation|0|||
16107083|NCT01255761|38878995|FG000|Overall Study|Lost to Follow-up|10|||
16107084|NCT01255761|38878996|FG001|Overall Study|Lost to Follow-up|8|||
16340933|NCT01119846|39734481|FG001|Overall Study|Protocol Violation|0|||
16340934|NCT01119846|39734482|FG002|Overall Study|Protocol Violation|1|||
16340935|NCT01119846|39734480|FG000|Overall Study|Withdrawal by Subject|0|||
16340936|NCT01119846|39734481|FG001|Overall Study|Withdrawal by Subject|0|||
16340937|NCT01119846|39734482|FG002|Overall Study|Withdrawal by Subject|4|||
16340938|NCT02509078|39734483|FG000|Overall Study|Protocol Violation|1|||
16541336|NCT01357616|40443262|FG001|Overall Study|Lost to Follow-up|3|||
16541337|NCT01357616|40443261|FG000|Overall Study|Protocol Violation|0|||
16541338|NCT01357616|40443262|FG001|Overall Study|Protocol Violation|2|||
16541339|NCT01357616|40443261|FG000|Overall Study|Inadequate Control of IOP|1|||
16541340|NCT01357616|40443262|FG001|Overall Study|Inadequate Control of IOP|2|||
16340939|NCT02509078|39734484|FG001|Overall Study|Protocol Violation|1|||
16340940|NCT02985021|39734485|FG000|Overall Study|Inability to comply with study procedures|1|||
16340941|NCT01133288|39734486|FG000|Eligibility Assessment|met exclusion criteria|5|||
16340942|NCT01133288|39734486|FG000|Intervention Allocation|study terminated|2|||
16340943|NCT03887117|39734487|FG000|Overall Study|Discontinued prematurely|0|||
16340944|NCT03887117|39734488|FG001|Overall Study|Discontinued prematurely|1|||
16541341|NCT01357616|40443261|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
16541342|NCT01357616|40443262|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
16340945|NCT03887117|39734489|FG002|Overall Study|Discontinued prematurely|1|||
16340946|NCT03887117|39734490|FG003|Overall Study|Discontinued prematurely|2|||
16340947|NCT01027897|39734493|FG000|Overall Study|Protocol Violation|1|||
16340948|NCT01027897|39734493|FG000|Overall Study|Withdrawal by Subject|1|||
16340949|NCT00531947|39734496|FG000|Overall Study|Adverse Event|5|||
16340950|NCT00531947|39734497|FG001|Overall Study|Adverse Event|10|||
16340951|NCT00531947|39734496|FG000|Overall Study|Lost to Follow-up|12|||
16340952|NCT00531947|39734497|FG001|Overall Study|Lost to Follow-up|9|||
16340953|NCT00531947|39734496|FG000|Overall Study|Withdrawal by Subject|14|||
16340954|NCT00531947|39734497|FG001|Overall Study|Withdrawal by Subject|19|||
16340955|NCT00531947|39734496|FG000|Overall Study|Protocol Violation|2|||
16340956|NCT00531947|39734497|FG001|Overall Study|Protocol Violation|1|||
16340957|NCT00531947|39734496|FG000|Overall Study|Non-Compliance|4|||
16340958|NCT00531947|39734497|FG001|Overall Study|Non-Compliance|7|||
16340959|NCT00531947|39734496|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
16340960|NCT00531947|39734497|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
16340961|NCT02005627|39734498|FG000|Overall Study|Lost to Follow-up|1|||
16340962|NCT02005627|39734499|FG001|Overall Study|Lost to Follow-up|2|||
16340963|NCT02005627|39734498|FG000|Overall Study|Withdrawal by Subject|1|||
16340964|NCT02005627|39734499|FG001|Overall Study|Withdrawal by Subject|2|||
16340965|NCT01204918|39734503|FG000|Overall Study|Withdrawal by Subject|4|||
16340966|NCT01204918|39734504|FG001|Overall Study|Withdrawal by Subject|10|||
16107085|NCT01255761|38878995|FG000|Overall Study|Withdrawal by Subject|11|||
16107086|NCT01255761|38878996|FG001|Overall Study|Withdrawal by Subject|27|||
16107087|NCT01255761|38878995|FG000|Overall Study|Other Reasons|37|||
16107088|NCT01255761|38878996|FG001|Overall Study|Other Reasons|18|||
16107089|NCT03811834|38878997|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
16107090|NCT02514577|38878998|FG000|Overall Study|Lost to Follow-up|6|||
16107091|NCT02514577|38878999|FG001|Overall Study|Lost to Follow-up|6|||
16107092|NCT02514577|38878998|FG000|Overall Study|Protocol Violation|1|||
16107093|NCT02514577|38878999|FG001|Overall Study|Protocol Violation|0|||
16107094|NCT02514577|38878998|FG000|Overall Study|Withdrawal by Subject|6|||
16107095|NCT02514577|38878999|FG001|Overall Study|Withdrawal by Subject|6|||
16541343|NCT01357616|40443261|FG000|Overall Study|Withdrawal by Subject|1|||
16541344|NCT01357616|40443262|FG001|Overall Study|Withdrawal by Subject|0|||
16541345|NCT00746590|40443263|FG000|Overall Study|Death|1|||
16541346|NCT01313286|40443264|FG000|Period 1|Withdrawal by Subject|2|||
16541347|NCT01313286|40443265|FG001|Period 1|Withdrawal by Subject|0|||
16541348|NCT03338894|40443275|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
16541349|NCT01922076|40443276|FG000|Overall Study|Adverse Event|0|||
16541350|NCT01922076|40443277|FG001|Overall Study|Adverse Event|0|||
16541351|NCT01922076|40443278|FG002|Overall Study|Adverse Event|0|||
16541352|NCT01922076|40443279|FG003|Overall Study|Adverse Event|0|||
16541353|NCT01922076|40443280|FG004|Overall Study|Adverse Event|1|||
16541354|NCT01922076|40443281|FG005|Overall Study|Adverse Event|0|||
16541355|NCT01922076|40443282|FG006|Overall Study|Adverse Event|0|||
16541356|NCT01922076|40443276|FG000|Overall Study|Physician Decision|0|||
16541357|NCT01922076|40443277|FG001|Overall Study|Physician Decision|0|||
16541358|NCT01922076|40443278|FG002|Overall Study|Physician Decision|1|||
16541359|NCT01922076|40443279|FG003|Overall Study|Physician Decision|0|||
16541360|NCT01922076|40443280|FG004|Overall Study|Physician Decision|0|||
16541361|NCT01922076|40443281|FG005|Overall Study|Physician Decision|0|||
16541362|NCT01922076|40443282|FG006|Overall Study|Physician Decision|0|||
16541363|NCT01922076|40443276|FG000|Overall Study|Withdrawal by Subject|0|||
16541364|NCT01922076|40443277|FG001|Overall Study|Withdrawal by Subject|0|||
16340967|NCT01204918|39734505|FG002|Overall Study|Withdrawal by Subject|5|||
16340968|NCT00002525|39734506|FG000|Overall Study|Adverse Event|36|||
16107096|NCT02514577|38878998|FG000|Overall Study|Adverse Event|1|||
16541365|NCT01922076|40443278|FG002|Overall Study|Withdrawal by Subject|0|||
16541366|NCT01922076|40443279|FG003|Overall Study|Withdrawal by Subject|1|||
16541367|NCT01922076|40443280|FG004|Overall Study|Withdrawal by Subject|0|||
16541368|NCT01922076|40443281|FG005|Overall Study|Withdrawal by Subject|1|||
16107097|NCT02514577|38878999|FG001|Overall Study|Adverse Event|1|||
16541369|NCT01922076|40443282|FG006|Overall Study|Withdrawal by Subject|1|||
16340969|NCT00002525|39734507|FG001|Overall Study|Adverse Event|0|||
16340970|NCT00002525|39734506|FG000|Overall Study|Death|5|||
16541370|NCT02217280|40443284|FG000|Overall Study|Withdrawal by Subject|2|||
16541371|NCT02217280|40443284|FG000|Overall Study|Post-consent sceen fail|2|||
16541372|NCT02279043|40443285|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
16541373|NCT02279043|40443286|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
16541374|NCT02279043|40443287|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
16541375|NCT02279043|40443285|FG000|Overall Study|Lost to Follow-up|46|||
16541376|NCT02279043|40443286|FG001|Overall Study|Lost to Follow-up|88|||
16541377|NCT02279043|40443287|FG002|Overall Study|Lost to Follow-up|0|||
16541378|NCT02191267|40443289|FG000|Overall Study|Withdrawal by Subject|1|||
16541379|NCT02191267|40443290|FG001|Overall Study|Withdrawal by Subject|0|||
16541380|NCT02191267|40443291|FG002|Overall Study|Withdrawal by Subject|0|||
16541381|NCT00045305|40443294|FG000|Overall Study|Lack of Efficacy|6|||
16541382|NCT00045305|40443294|FG000|Overall Study|Adverse Event|3|||
16541383|NCT00045305|40443294|FG000|Overall Study|Death|3|||
16541384|NCT00045305|40443294|FG000|Overall Study|site error|2|||
16541385|NCT02291679|40443298|FG000|Overall Study|Adverse Event|2|||
16218861|NCT02773849|39282829|FG000|Overall Study|Other: not due to lack of tolerability|11|||
16107098|NCT00436956|38879001|FG000|Overall Study|Not evaluable|1|||
16107099|NCT00436956|38879002|FG001|Overall Study|Not evaluable|0|||
16541386|NCT02291679|40443299|FG001|Overall Study|Adverse Event|12|||
16541387|NCT02291679|40443300|FG002|Overall Study|Adverse Event|19|||
16541388|NCT02291679|40443298|FG000|Overall Study|Protocol Violation|5|||
16541389|NCT02291679|40443299|FG001|Overall Study|Protocol Violation|1|||
16541390|NCT02291679|40443300|FG002|Overall Study|Protocol Violation|7|||
16541391|NCT02291679|40443298|FG000|Overall Study|Withdrew Consent|18|||
16541392|NCT02291679|40443299|FG001|Overall Study|Withdrew Consent|10|||
16541393|NCT02291679|40443300|FG002|Overall Study|Withdrew Consent|15|||
16541394|NCT02291679|40443298|FG000|Overall Study|Lost to Follow-up|12|||
16541395|NCT02291679|40443299|FG001|Overall Study|Lost to Follow-up|10|||
16541396|NCT02291679|40443300|FG002|Overall Study|Lost to Follow-up|9|||
16541397|NCT02291679|40443298|FG000|Overall Study|Insufficient Therapeutic Response|5|||
16541398|NCT02291679|40443299|FG001|Overall Study|Insufficient Therapeutic Response|5|||
16541399|NCT02291679|40443300|FG002|Overall Study|Insufficient Therapeutic Response|7|||
16541400|NCT02291679|40443298|FG000|Overall Study|Other|2|||
16541401|NCT02291679|40443299|FG001|Overall Study|Other|4|||
16541402|NCT02291679|40443300|FG002|Overall Study|Other|2|||
16541403|NCT01445652|40443302|FG000|Overall Study|Not comfortable in lenses|5|||
16541404|NCT01445652|40443303|FG001|Overall Study|Not comfortable in lenses|0|||
16541405|NCT01445652|40443302|FG000|Overall Study|Failed to attend scheduled visit|2|||
16541406|NCT01445652|40443303|FG001|Overall Study|Failed to attend scheduled visit|3|||
16541407|NCT01445652|40443302|FG000|Overall Study|Failed teach session|2|||
16541408|NCT01445652|40443303|FG001|Overall Study|Failed teach session|0|||
16541409|NCT01445652|40443302|FG000|Overall Study|Adverse Event|1|||
16541410|NCT01445652|40443303|FG001|Overall Study|Adverse Event|0|||
16541411|NCT01235403|40443308|FG000|Overall Study|Adverse Event|14|||
16541412|NCT01235403|40443308|FG000|Overall Study|Lost to Follow-up|2|||
16541413|NCT01235403|40443308|FG000|Overall Study|Withdrawal by Subject|4|||
16541414|NCT01235403|40443308|FG000|Overall Study|Lack of Efficacy|2|||
16541415|NCT01235403|40443308|FG000|Overall Study|Other reasons for premature termination|4|||
16541416|NCT01281644|40443309|FG000|Overall Study|Lost to Follow-up|3|||
16107100|NCT00848393|38879003|FG000|Overall Study|Protocol Violation|0|||
16107101|NCT00848393|38879004|FG001|Overall Study|Protocol Violation|0|||
16107102|NCT00848393|38879005|FG002|Overall Study|Protocol Violation|1|||
16107103|NCT00848393|38879003|FG000|Overall Study|surgical complications unrelated to stud|0|||
16107104|NCT00848393|38879004|FG001|Overall Study|surgical complications unrelated to stud|0|||
16107105|NCT00848393|38879005|FG002|Overall Study|surgical complications unrelated to stud|2|||
16107106|NCT03544229|38879008|FG000|Overall Study|Adverse Event|1|||
16107107|NCT03544229|38879009|FG001|Overall Study|Adverse Event|0|||
16107108|NCT03544229|38879010|FG002|Overall Study|Adverse Event|1|||
16107109|NCT03544229|38879011|FG003|Overall Study|Adverse Event|0|||
16107110|NCT03544229|38879008|FG000|Overall Study|Protocol Deviation|0|||
16107111|NCT03544229|38879009|FG001|Overall Study|Protocol Deviation|0|||
16107112|NCT03544229|38879010|FG002|Overall Study|Protocol Deviation|1|||
16107113|NCT03544229|38879011|FG003|Overall Study|Protocol Deviation|0|||
16107114|NCT03544229|38879008|FG000|Overall Study|Lost to Follow-up|3|||
16107115|NCT03544229|38879009|FG001|Overall Study|Lost to Follow-up|0|||
16107116|NCT03544229|38879010|FG002|Overall Study|Lost to Follow-up|0|||
16107117|NCT03544229|38879011|FG003|Overall Study|Lost to Follow-up|2|||
16107118|NCT03544229|38879008|FG000|Overall Study|Voluntary Withdrawal|2|||
16541417|NCT01281644|40443309|FG000|Overall Study|Withdrawal by Subject|2|||
16541418|NCT01078155|40443310|FG000|Overall Study|Adverse Event|7|||
16541419|NCT01078155|40443310|FG000|Overall Study|Lack of Efficacy|16|||
16107119|NCT03544229|38879009|FG001|Overall Study|Voluntary Withdrawal|1|||
16541420|NCT01078155|40443310|FG000|Overall Study|Participant's Decision|6|||
16541421|NCT01078155|40443310|FG000|Overall Study|Lost to Follow-up|15|||
16541422|NCT00733499|40443313|FG000|Pre-operative|Protocol Violation|0|||
16541423|NCT00733499|40443314|FG001|Pre-operative|Protocol Violation|1|||
16541424|NCT00733499|40443313|FG000|3 Months Follow-up|Death|1|||
16541425|NCT00733499|40443314|FG001|3 Months Follow-up|Death|2|||
16541426|NCT00733499|40443313|FG000|6 Months Follow-up|Death|0|||
16541427|NCT00733499|40443314|FG001|6 Months Follow-up|Death|2|||
16541428|NCT00733499|40443313|FG000|6 Months Follow-up|Adverse Event|0|||
16541429|NCT00733499|40443314|FG001|6 Months Follow-up|Adverse Event|1|||
16541430|NCT00733499|40443313|FG000|12 Months Follow-up|Death|2|||
16541431|NCT00733499|40443314|FG001|12 Months Follow-up|Death|1|||
16541432|NCT00733499|40443313|FG000|24 Months Follow-up|Death|0|||
16541433|NCT00733499|40443314|FG001|24 Months Follow-up|Death|1|||
16541434|NCT00733499|40443313|FG000|5 Year Followup|Adverse Event|2|||
16541435|NCT00733499|40443314|FG001|5 Year Followup|Adverse Event|2|||
16541436|NCT00733499|40443313|FG000|5 Year Followup|Non device related AE|0|||
16541437|NCT00733499|40443314|FG001|5 Year Followup|Non device related AE|1|||
16541438|NCT00733499|40443313|FG000|5 Year Followup|Revision of Study Implant|0|||
16541439|NCT00733499|40443314|FG001|5 Year Followup|Revision of Study Implant|1|||
16107120|NCT03544229|38879010|FG002|Overall Study|Voluntary Withdrawal|3|||
16107121|NCT03544229|38879011|FG003|Overall Study|Voluntary Withdrawal|0|||
16107122|NCT03544229|38879008|FG000|Overall Study|Lack of Efficacy|0|||
16107123|NCT03544229|38879009|FG001|Overall Study|Lack of Efficacy|1|||
16541440|NCT00733499|40443313|FG000|5 Year Followup|Lost to Follow-up|2|||
16541441|NCT00733499|40443314|FG001|5 Year Followup|Lost to Follow-up|0|||
16541442|NCT00733499|40443313|FG000|5 Year Followup|Death|13|||
16541443|NCT00733499|40443314|FG001|5 Year Followup|Death|19|||
16541444|NCT00733499|40443313|FG000|5 Year Followup|missing, unable to locate|0|||
16541445|NCT00733499|40443314|FG001|5 Year Followup|missing, unable to locate|1|||
16541446|NCT00733499|40443313|FG000|5 Year Followup|Withdrawal by Subject|4|||
16541447|NCT00733499|40443314|FG001|5 Year Followup|Withdrawal by Subject|1|||
16541448|NCT00733499|40443313|FG000|10 Year Followup|Death|9|||
16541449|NCT00733499|40443314|FG001|10 Year Followup|Death|7|||
16541450|NCT00733499|40443313|FG000|10 Year Followup|Adverse Event|3|||
16541451|NCT00733499|40443314|FG001|10 Year Followup|Adverse Event|3|||
16541452|NCT00733499|40443313|FG000|10 Year Followup|Lost to Follow-up|3|||
16541453|NCT00733499|40443314|FG001|10 Year Followup|Lost to Follow-up|2|||
16541454|NCT00733499|40443313|FG000|10 Year Followup|Withdrawal by Subject|5|||
16541455|NCT00733499|40443314|FG001|10 Year Followup|Withdrawal by Subject|5|||
16541456|NCT00733499|40443313|FG000|10 Year Followup|missing, unable to locate|0|||
16541457|NCT00733499|40443314|FG001|10 Year Followup|missing, unable to locate|2|||
16541458|NCT01330316|40443315|FG000|Overall Study|Adverse Event|2|||
16541459|NCT01330316|40443316|FG001|Overall Study|Adverse Event|2|||
16541460|NCT01330316|40443315|FG000|Overall Study|Lack of Efficacy|0|||
16541461|NCT01330316|40443316|FG001|Overall Study|Lack of Efficacy|10|||
16541462|NCT01330316|40443315|FG000|Overall Study|Lost to Follow-up|0|||
16541463|NCT01330316|40443316|FG001|Overall Study|Lost to Follow-up|1|||
16541464|NCT01330316|40443315|FG000|Overall Study|Withdrawal by Subject|0|||
16541465|NCT01330316|40443316|FG001|Overall Study|Withdrawal by Subject|1|||
16541466|NCT01330316|40443315|FG000|Overall Study|other than above|0|||
16541467|NCT01330316|40443316|FG001|Overall Study|other than above|1|||
16541468|NCT02657031|40443317|FG000|Overall Study|Adverse Event|1|||
16541469|NCT02657031|40443318|FG001|Overall Study|Adverse Event|2|||
16541470|NCT01896869|40443330|FG000|Overall Study|Withdrawal by Subject|0|||
16541471|NCT01896869|40443331|FG001|Overall Study|Withdrawal by Subject|6|||
16541472|NCT01896869|40443330|FG000|Overall Study|Lost to Follow-up|1|||
16541473|NCT01896869|40443331|FG001|Overall Study|Lost to Follow-up|0|||
16541474|NCT00441090|40443336|FG000|Overall Study|Adverse Event|0|||
16541475|NCT00441090|40443337|FG001|Overall Study|Adverse Event|1|||
16541476|NCT00441090|40443338|FG002|Overall Study|Adverse Event|1|||
16541477|NCT00441090|40443339|FG003|Overall Study|Adverse Event|0|||
16541478|NCT00441090|40443340|FG004|Overall Study|Adverse Event|0|||
16541479|NCT00441090|40443336|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
16541480|NCT00441090|40443337|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
16107124|NCT03544229|38879010|FG002|Overall Study|Lack of Efficacy|0|||
16541481|NCT00441090|40443338|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
16541482|NCT00441090|40443339|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
16541483|NCT00441090|40443340|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
16107125|NCT03544229|38879011|FG003|Overall Study|Lack of Efficacy|0|||
16107126|NCT00944229|38879012|FG000|Overall Study|Withdrawal by Subject|11|||
16107127|NCT00944229|38879012|FG000|Overall Study|Physician Decision|14|||
16107128|NCT01194271|38879013|FG000|Overall Study|Withdrawal by Subject|1|||
16541484|NCT00441090|40443336|FG000|Overall Study|Withdrawal by Subject|1|||
16541485|NCT00441090|40443337|FG001|Overall Study|Withdrawal by Subject|0|||
16541486|NCT00441090|40443338|FG002|Overall Study|Withdrawal by Subject|1|||
16541487|NCT00441090|40443339|FG003|Overall Study|Withdrawal by Subject|0|||
16541488|NCT00441090|40443340|FG004|Overall Study|Withdrawal by Subject|0|||
16107129|NCT01194271|38879013|FG000|Overall Study|Ineligible, Screen Failure|1|||
16107130|NCT01194271|38879013|FG000|Overall Study|Death|1|||
16541489|NCT00441090|40443336|FG000|Overall Study|Lack of Efficacy|1|||
16541490|NCT00441090|40443337|FG001|Overall Study|Lack of Efficacy|0|||
16541491|NCT00441090|40443338|FG002|Overall Study|Lack of Efficacy|0|||
16541492|NCT00441090|40443339|FG003|Overall Study|Lack of Efficacy|0|||
16541493|NCT00441090|40443340|FG004|Overall Study|Lack of Efficacy|0|||
16541494|NCT01559454|40443353|FG000|Overall Study|Lost to Follow-up|3|||
16541495|NCT01559454|40443354|FG001|Overall Study|Lost to Follow-up|2|||
16541496|NCT01559454|40443353|FG000|Overall Study|Withdrawal by Subject|0|||
16541497|NCT01559454|40443354|FG001|Overall Study|Withdrawal by Subject|1|||
16541498|NCT01559454|40443353|FG000|Overall Study|Physician Decision|0|||
16541499|NCT01559454|40443354|FG001|Overall Study|Physician Decision|1|||
16541500|NCT01559454|40443353|FG000|Overall Study|Protocol Violation|0|||
16541501|NCT01559454|40443354|FG001|Overall Study|Protocol Violation|1|||
16541502|NCT01559454|40443353|FG000|Overall Study|Lack of Efficacy|0|||
16541503|NCT01559454|40443354|FG001|Overall Study|Lack of Efficacy|1|||
16541504|NCT00440531|40443355|FG000|Overall Study|Adverse Event|1|||
16541505|NCT00440531|40443356|FG001|Overall Study|Adverse Event|0|||
16107131|NCT00002597|38879016|FG000|Overall Study|Protocol Violation|19|||
16107132|NCT00002597|38879017|FG001|Overall Study|Protocol Violation|17|||
16541506|NCT00440531|40443357|FG002|Overall Study|Adverse Event|2|||
16541507|NCT00440531|40443355|FG000|Overall Study|Withdrawal by Subject|2|||
16107133|NCT00002597|38879016|FG000|Overall Study|Withdrawal by Subject|7|||
16107134|NCT00002597|38879017|FG001|Overall Study|Withdrawal by Subject|6|||
16107135|NCT00887198|38879018|FG000|Randomized Period|Ongoing|42|||
16107136|NCT00887198|38879019|FG001|Randomized Period|Ongoing|0|||
16107137|NCT00887198|38879020|FG002|Randomized Period|Ongoing|0|||
16107138|NCT00887198|38879018|FG000|Randomized Period|Adverse Event|50|||
16107139|NCT00887198|38879019|FG001|Randomized Period|Adverse Event|33|||
16107140|NCT00887198|38879020|FG002|Randomized Period|Adverse Event|0|||
16107141|NCT00887198|38879018|FG000|Randomized Period|Lost to Follow-up|1|||
16107142|NCT00887198|38879019|FG001|Randomized Period|Lost to Follow-up|0|||
16107143|NCT00887198|38879020|FG002|Randomized Period|Lost to Follow-up|0|||
16107144|NCT00887198|38879018|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
16107145|NCT00887198|38879019|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
16107146|NCT00887198|38879020|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
16107147|NCT00887198|38879018|FG000|Randomized Period|Withdrawal by Subject|41|||
16107148|NCT00887198|38879019|FG001|Randomized Period|Withdrawal by Subject|56|||
16541508|NCT00440531|40443356|FG001|Overall Study|Withdrawal by Subject|0|||
16541509|NCT00440531|40443357|FG002|Overall Study|Withdrawal by Subject|0|||
16541510|NCT00440531|40443355|FG000|Overall Study|Protocol Violation|1|||
16541511|NCT00440531|40443356|FG001|Overall Study|Protocol Violation|2|||
16541512|NCT00440531|40443357|FG002|Overall Study|Protocol Violation|0|||
16107149|NCT00887198|38879020|FG002|Randomized Period|Withdrawal by Subject|0|||
16107150|NCT00887198|38879018|FG000|Randomized Period|Progressive disease|366|||
16107151|NCT00887198|38879019|FG001|Randomized Period|Progressive disease|370|||
16107152|NCT00887198|38879020|FG002|Randomized Period|Progressive disease|0|||
16107153|NCT00887198|38879018|FG000|Randomized Period|Other|42|||
16107154|NCT00887198|38879019|FG001|Randomized Period|Other|30|||
16107155|NCT00887198|38879020|FG002|Randomized Period|Other|0|||
16107156|NCT00887198|38879018|FG000|Randomized Period|Randomized, Not treated|4|||
16107157|NCT00887198|38879019|FG001|Randomized Period|Randomized, Not treated|2|||
16107158|NCT00887198|38879020|FG002|Randomized Period|Randomized, Not treated|0|||
16107159|NCT00887198|38879018|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
16107160|NCT00887198|38879019|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
16107161|NCT00887198|38879020|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
16107162|NCT00887198|38879018|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
16107163|NCT00887198|38879019|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
16107164|NCT00887198|38879020|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
16107165|NCT00887198|38879018|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
16107166|NCT00887198|38879019|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
16107167|NCT00887198|38879020|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
16541513|NCT00440531|40443355|FG000|Overall Study|Lost to Follow-up|4|||
16541514|NCT00440531|40443356|FG001|Overall Study|Lost to Follow-up|3|||
16107168|NCT00887198|38879018|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
16107169|NCT00887198|38879019|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
16107170|NCT00887198|38879020|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
16107171|NCT00887198|38879018|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
16541515|NCT00440531|40443357|FG002|Overall Study|Lost to Follow-up|5|||
16107172|NCT00887198|38879019|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
16107173|NCT00887198|38879020|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
16107174|NCT00887198|38879018|FG000|Cross Over (Placebo to AA)|Other|0|||
16107175|NCT00887198|38879019|FG001|Cross Over (Placebo to AA)|Other|0|||
16107176|NCT00887198|38879020|FG002|Cross Over (Placebo to AA)|Other|19|||
16107177|NCT03842436|38879021|FG000|Overall Study|Lost to Follow-up|1|||
16107178|NCT00634920|38879022|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
16107179|NCT00634920|38879023|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
16107180|NCT00634920|38879024|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
16107181|NCT00634920|38879022|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
16107182|NCT00634920|38879023|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
16107183|NCT00634920|38879024|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
16107184|NCT00634920|38879022|FG000|Period 1 - Pre-Randomization|Rejections|0|||
16107185|NCT00634920|38879023|FG001|Period 1 - Pre-Randomization|Rejections|0|||
16107186|NCT00634920|38879024|FG002|Period 1 - Pre-Randomization|Rejections|55|||
16107187|NCT00634920|38879022|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
16107188|NCT00634920|38879023|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
16107189|NCT00634920|38879024|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
16107190|NCT00634920|38879022|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
16107191|NCT00634920|38879023|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
16107192|NCT00634920|38879024|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
16107193|NCT00634920|38879022|FG000|Period 1 - Pre-Randomization|Other issues|0|||
16107194|NCT00634920|38879023|FG001|Period 1 - Pre-Randomization|Other issues|0|||
16107195|NCT00634920|38879024|FG002|Period 1 - Pre-Randomization|Other issues|6|||
16107196|NCT00634920|38879022|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
16107197|NCT00634920|38879023|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
16107198|NCT00634920|38879024|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
16107199|NCT00634920|38879022|FG000|Period 2 - Post-Randomization|Rejection|11|||
16107200|NCT00634920|38879023|FG001|Period 2 - Post-Randomization|Rejection|5|||
16107201|NCT00634920|38879024|FG002|Period 2 - Post-Randomization|Rejection|0|||
16107202|NCT00634920|38879022|FG000|Period 2 - Post-Randomization|Death|2|||
16107203|NCT00634920|38879023|FG001|Period 2 - Post-Randomization|Death|5|||
16107204|NCT00634920|38879024|FG002|Period 2 - Post-Randomization|Death|0|||
16107205|NCT00634920|38879022|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
16107206|NCT00634920|38879023|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
16107207|NCT00634920|38879024|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
16541516|NCT00440531|40443355|FG000|Overall Study|see pre-assignment details|2|||
16541517|NCT00440531|40443356|FG001|Overall Study|see pre-assignment details|0|||
16541518|NCT00440531|40443357|FG002|Overall Study|see pre-assignment details|0|||
16541519|NCT03649230|40443365|FG000|Overall Study|Adverse Event|12|||
16541520|NCT03649230|40443365|FG000|Overall Study|Death|8|||
16541521|NCT03649230|40443365|FG000|Overall Study|Withdrawal by Subject|6|||
16107208|NCT00634920|38879022|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
16107209|NCT00634920|38879023|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
16107210|NCT00634920|38879024|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
16107211|NCT02517528|38879025|FG000|Overall Study|Withdrawal by Subject|1|||
16541522|NCT03649230|40443365|FG000|Overall Study|Physician Decision|5|||
16107212|NCT01850823|38879026|FG000|Overall Study|Early Visit Window|0|||
16107213|NCT01850823|38879027|FG001|Overall Study|Early Visit Window|1|||
16107214|NCT01850823|38879028|FG002|Overall Study|Early Visit Window|4|||
16107215|NCT01850823|38879026|FG000|Overall Study|Enrolled in Error|0|||
16107216|NCT01850823|38879027|FG001|Overall Study|Enrolled in Error|1|||
16107217|NCT01850823|38879028|FG002|Overall Study|Enrolled in Error|2|||
16107218|NCT01850823|38879026|FG000|Overall Study|Lack of Efficacy|1|||
16541523|NCT03649230|40443365|FG000|Overall Study|Disease progression|5|||
16541524|NCT03649230|40443365|FG000|Overall Study|Switched to non-HEC|5|||
16541525|NCT03649230|40443365|FG000|Overall Study|Chemotherapy discontinued|4|||
16541526|NCT03649230|40443365|FG000|Overall Study|Received only 3 HEC cycles|4|||
16541527|NCT03649230|40443365|FG000|Overall Study|Screen Failure|3|||
16541528|NCT03649230|40443365|FG000|Overall Study|Patient stopped treatment|2|||
16541529|NCT03649230|40443365|FG000|Overall Study|Protocol Violation|1|||
16541530|NCT03649230|40443365|FG000|Overall Study|Non-compliance|1|||
16107219|NCT01850823|38879027|FG001|Overall Study|Lack of Efficacy|0|||
16107220|NCT01850823|38879028|FG002|Overall Study|Lack of Efficacy|0|||
16107221|NCT01850823|38879026|FG000|Overall Study|Lost to Follow-up|0|||
16107222|NCT01850823|38879027|FG001|Overall Study|Lost to Follow-up|0|||
16107223|NCT01850823|38879028|FG002|Overall Study|Lost to Follow-up|1|||
16107224|NCT01850823|38879026|FG000|Overall Study|Restricted Medication|0|||
16107225|NCT01850823|38879027|FG001|Overall Study|Restricted Medication|0|||
16107226|NCT01850823|38879028|FG002|Overall Study|Restricted Medication|2|||
16107227|NCT01850823|38879026|FG000|Overall Study|Significant worstening of SAR|0|||
16541531|NCT03649230|40443365|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
16541532|NCT04870710|40443366|FG000|Overall Study|Lost to Follow-up|3|||
16541533|NCT00725452|40443367|FG000|Overall Study|Adverse Event|3|||
16541534|NCT00725452|40443367|FG000|Overall Study|Lack of Efficacy|2|||
16541535|NCT00725452|40443367|FG000|Overall Study|Reason not specified|1|||
16541536|NCT00725452|40443367|FG000|Overall Study|Physician Decision|1|||
16541537|NCT00725452|40443367|FG000|Overall Study|Withdrawal by Subject|3|||
16541538|NCT00725452|40443367|FG000|Overall Study|Lost to Follow-up|1|||
16107228|NCT01850823|38879027|FG001|Overall Study|Significant worstening of SAR|1|||
16107229|NCT01850823|38879028|FG002|Overall Study|Significant worstening of SAR|0|||
16107230|NCT01850823|38879026|FG000|Overall Study|Withdrawal by Subject|2|||
16107231|NCT01850823|38879027|FG001|Overall Study|Withdrawal by Subject|0|||
16107232|NCT01850823|38879028|FG002|Overall Study|Withdrawal by Subject|1|||
16107233|NCT00233389|38879029|FG000|Overall Study|Adverse Event|5|||
16107234|NCT00233389|38879030|FG001|Overall Study|Adverse Event|5|||
16107235|NCT00233389|38879029|FG000|Overall Study|Lack of Efficacy|11|||
16107236|NCT00233389|38879030|FG001|Overall Study|Lack of Efficacy|8|||
16107237|NCT00233389|38879029|FG000|Overall Study|Lost to Follow-up|1|||
16107238|NCT00233389|38879030|FG001|Overall Study|Lost to Follow-up|1|||
16107239|NCT00233389|38879029|FG000|Overall Study|Physician Decision|1|||
16107240|NCT00233389|38879030|FG001|Overall Study|Physician Decision|0|||
16107241|NCT00233389|38879029|FG000|Overall Study|Protocol Violation|0|||
16107242|NCT00233389|38879030|FG001|Overall Study|Protocol Violation|1|||
16107243|NCT00233389|38879029|FG000|Overall Study|Withdrawal by Subject|0|||
16107244|NCT00233389|38879030|FG001|Overall Study|Withdrawal by Subject|1|||
16107245|NCT01836198|38879031|FG000|Part A, Period 2|Protocol Violation|0|||
16107246|NCT01836198|38879032|FG001|Part A, Period 2|Protocol Violation|1|||
16107247|NCT01836198|38879033|FG002|Part A, Period 2|Protocol Violation|0|||
16107248|NCT03503162|38879036|FG000|Overall Study|did not meet eligibility|1|||
16107249|NCT00004445|38881240|FG000|Overall Study|Physician Decision|2|||
16107250|NCT00004445|38881240|FG000|Overall Study|Withdrawal by Subject|1|||
16107251|NCT01243411|38881243|FG000|Overall Study|Withdrawal by Subject|18|||
16107252|NCT01243411|38881243|FG000|Overall Study|Lost to Follow-up|10|||
16107253|NCT01243411|38881243|FG000|Overall Study|Adverse Event|5|||
16107254|NCT01243411|38881243|FG000|Overall Study|Other|8|||
16107255|NCT00908349|38881244|FG000|Overall Study|Adverse Event|10|||
16107256|NCT00908349|38881244|FG000|Overall Study|Withdrawal by Subject|9|||
16107257|NCT00908349|38881244|FG000|Overall Study|Physician Decision|5|||
16107258|NCT00908349|38881244|FG000|Overall Study|Lost to Follow-up|5|||
16107259|NCT00908349|38881244|FG000|Overall Study|Various|6|||
16107260|NCT00468130|38881247|FG000|Overall Study|Adverse Event|2|||
16107261|NCT00468130|38881248|FG001|Overall Study|Adverse Event|1|||
16107262|NCT00468130|38881247|FG000|Overall Study|Withdrawal by Subject|0|||
16107263|NCT00468130|38881248|FG001|Overall Study|Withdrawal by Subject|1|||
16107264|NCT01503164|38881249|FG000|Overall Study|Withdrawal by Subject|2|||
16107265|NCT01503164|38881250|FG001|Overall Study|Withdrawal by Subject|1|||
16541539|NCT01693692|40443368|FG000|Overall Study|Withdrawal by Subject|12|||
16107266|NCT03022578|38881255|FG000|Overall Study|Adverse Event|1|||
16107267|NCT03022578|38881255|FG000|Overall Study|Lack of Efficacy|2|||
16107268|NCT03022578|38881255|FG000|Overall Study|Withdrawal by Subject|1|||
16541540|NCT01693692|40443369|FG001|Overall Study|Withdrawal by Subject|10|||
16218862|NCT02425891|39282830|FG000|Overall Study|Death|333|||
16218863|NCT02425891|39282831|FG001|Overall Study|Death|314|||
16218864|NCT02425891|39282830|FG000|Overall Study|Lost to Follow-up|4|||
16218865|NCT02425891|39282831|FG001|Overall Study|Lost to Follow-up|6|||
16218866|NCT02425891|39282830|FG000|Overall Study|Non-Compliance|1|||
16218867|NCT02425891|39282831|FG001|Overall Study|Non-Compliance|1|||
16218868|NCT02425891|39282830|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
16218869|NCT02425891|39282831|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
16218870|NCT02425891|39282830|FG000|Overall Study|Physician Decision|0|||
16218871|NCT02425891|39282831|FG001|Overall Study|Physician Decision|1|||
16218872|NCT02425891|39282830|FG000|Overall Study|Protocol Violation|1|||
16218873|NCT02425891|39282831|FG001|Overall Study|Protocol Violation|1|||
16218874|NCT02425891|39282830|FG000|Overall Study|Study Terminated By Sponsor|85|||
16218875|NCT02425891|39282831|FG001|Overall Study|Study Terminated By Sponsor|95|||
16218876|NCT02425891|39282830|FG000|Overall Study|Withdrawal by Subject|27|||
16218877|NCT02425891|39282831|FG001|Overall Study|Withdrawal by Subject|32|||
16218878|NCT00735072|39282832|FG000|Overall Study|interrupted study med during ARV change|1|||
16218879|NCT00735072|39282833|FG001|Overall Study|interrupted study med during ARV change|0|||
16218880|NCT00735072|39282832|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
16218881|NCT00735072|39282833|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
16218882|NCT01682759|39282834|FG000|Overall Study|Death|2|||
16218883|NCT01682759|39282835|FG001|Overall Study|Death|1|||
16218884|NCT01682759|39282834|FG000|Overall Study|Lost to Follow-up|10|||
16218885|NCT01682759|39282835|FG001|Overall Study|Lost to Follow-up|13|||
16218886|NCT01682759|39282834|FG000|Overall Study|Physician Decision|1|||
16218887|NCT01682759|39282835|FG001|Overall Study|Physician Decision|1|||
16218888|NCT01682759|39282834|FG000|Overall Study|Withdrawal by Subject|56|||
16218889|NCT01682759|39282835|FG001|Overall Study|Withdrawal by Subject|55|||
16218890|NCT02918006|39282836|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
16218891|NCT02918006|39282837|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
16218892|NCT02918006|39282838|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
16218893|NCT02918006|39282836|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
16218894|NCT02918006|39282837|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
16218895|NCT02918006|39282838|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
16218896|NCT02918006|39282836|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
16218897|NCT02918006|39282837|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
16218898|NCT02918006|39282838|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
16218899|NCT02918006|39282836|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
16218900|NCT02918006|39282837|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
16218901|NCT02918006|39282838|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
16218902|NCT02918006|39282836|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
16218903|NCT02918006|39282837|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
16218904|NCT02918006|39282838|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
16218905|NCT02918006|39282836|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
16218906|NCT02918006|39282837|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
16218907|NCT02918006|39282838|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
16218908|NCT02918006|39282836|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
16218909|NCT02918006|39282837|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
16107269|NCT01644188|38881256|FG000|Overall Study|Adverse Event|44|||
16107270|NCT01644188|38881257|FG001|Overall Study|Adverse Event|20|||
16107271|NCT01644188|38881256|FG000|Overall Study|Poor compliance to protocol|26|||
16107272|NCT01644188|38881257|FG001|Overall Study|Poor compliance to protocol|14|||
16107273|NCT01644188|38881256|FG000|Overall Study|Physician Decision|1|||
16107274|NCT01644188|38881257|FG001|Overall Study|Physician Decision|3|||
16107275|NCT01644188|38881256|FG000|Overall Study|Participant moved|7|||
16107276|NCT01644188|38881257|FG001|Overall Study|Participant moved|2|||
16107277|NCT01644188|38881256|FG000|Overall Study|Related to auto-injector administration|2|||
16107278|NCT01644188|38881257|FG001|Overall Study|Related to auto-injector administration|2|||
16107279|NCT01644188|38881256|FG000|Overall Study|Consent withdrawn by participant|14|||
16107280|NCT01644188|38881257|FG001|Overall Study|Consent withdrawn by participant|7|||
16107281|NCT01644188|38881256|FG000|Overall Study|Selection criteria finally not met|2|||
16107282|NCT01644188|38881257|FG001|Overall Study|Selection criteria finally not met|0|||
16107283|NCT01644188|38881256|FG000|Overall Study|Lost to Follow-up|1|||
16107284|NCT01644188|38881257|FG001|Overall Study|Lost to Follow-up|0|||
16218910|NCT02918006|39282838|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
16218911|NCT02918006|39282836|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
16107285|NCT01644188|38881256|FG000|Overall Study|Death|4|||
16107286|NCT01644188|38881257|FG001|Overall Study|Death|3|||
16218912|NCT02918006|39282837|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
16218913|NCT02918006|39282838|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
16218914|NCT02918006|39282836|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
16218915|NCT02918006|39282837|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
16107287|NCT01644188|38881256|FG000|Overall Study|Last visit outside protocol visit window|14|||
16107288|NCT01644188|38881257|FG001|Overall Study|Last visit outside protocol visit window|16|||
16107289|NCT01644188|38881256|FG000|Overall Study|Site closure|1|||
16107290|NCT01644188|38881257|FG001|Overall Study|Site closure|1|||
16107291|NCT01644188|38881256|FG000|Overall Study|Other than specified above|6|||
16107292|NCT01644188|38881257|FG001|Overall Study|Other than specified above|7|||
16107293|NCT00338949|38881260|FG000|Subject Screening|Screen failures|11|||
16107294|NCT00338949|38881261|FG001|Subject Screening|Screen failures|11|||
16406647|NCT00980460|39969862|FG003|Overall Study|Refusal of further therapy|2|||
16406648|NCT00980460|39969863|FG004|Overall Study|Refusal of further therapy|0|||
16107295|NCT00338949|38881260|FG000|Randomization|Withdrawal by Subject|1|||
16340971|NCT00002525|39734507|FG001|Overall Study|Death|0|||
16340972|NCT00002525|39734506|FG000|Overall Study|Withdrawal by Subject|11|||
16340973|NCT00002525|39734507|FG001|Overall Study|Withdrawal by Subject|0|||
16340974|NCT00002525|39734506|FG000|Overall Study|Start non-protocol therapy|1|||
16340975|NCT00002525|39734507|FG001|Overall Study|Start non-protocol therapy|0|||
16340976|NCT00002525|39734506|FG000|Overall Study|Other complicating disease|1|||
16340977|NCT00002525|39734507|FG001|Overall Study|Other complicating disease|0|||
16340978|NCT00002525|39734506|FG000|Overall Study|Duke's A, B1, D disease|92|||
16340979|NCT00002525|39734507|FG001|Overall Study|Duke's A, B1, D disease|0|||
16340980|NCT00002525|39734506|FG000|Overall Study|Error|6|||
16340981|NCT00002525|39734507|FG001|Overall Study|Error|0|||
16340982|NCT00002525|39734506|FG000|Overall Study|Other|26|||
16340983|NCT00002525|39734507|FG001|Overall Study|Other|0|||
16340984|NCT00002525|39734506|FG000|Overall Study|Never start protocol therapy|8|||
16340985|NCT00002525|39734507|FG001|Overall Study|Never start protocol therapy|0|||
16340986|NCT00321906|39734508|FG000|Overall Study|Adverse Event|36|||
16340987|NCT00321906|39734509|FG001|Overall Study|Adverse Event|44|||
16340988|NCT00321906|39734508|FG000|Overall Study|Death|9|||
16340989|NCT00321906|39734509|FG001|Overall Study|Death|6|||
16340990|NCT00321906|39734508|FG000|Overall Study|Lost to Follow-up|1|||
16340991|NCT00321906|39734509|FG001|Overall Study|Lost to Follow-up|2|||
16340992|NCT00321906|39734508|FG000|Overall Study|Withdrawal by Subject|0|||
16340993|NCT00321906|39734509|FG001|Overall Study|Withdrawal by Subject|4|||
16340994|NCT03373461|39734510|FG000|Part 2|Adverse Event|0|||
16340995|NCT03373461|39734511|FG001|Part 2|Adverse Event|1|||
16340996|NCT03373461|39734512|FG002|Part 2|Adverse Event|0|||
16340997|NCT03373461|39734513|FG003|Part 2|Adverse Event|0|||
16107296|NCT00338949|38881261|FG001|Randomization|Withdrawal by Subject|0|||
16107297|NCT00338949|38881260|FG000|Randomization|Adverse Event|0|||
16541541|NCT01693692|40443370|FG002|Overall Study|Withdrawal by Subject|11|||
16340998|NCT03373461|39734514|FG004|Part 2|Adverse Event|1|||
16340999|NCT02560623|39734515|FG000|Overall Study|Unable to swallow sponge|0|||
16341000|NCT02560623|39734516|FG001|Overall Study|Unable to swallow sponge|1|||
16341001|NCT02560623|39734517|FG002|Overall Study|Unable to swallow sponge|0|||
16341002|NCT02560623|39734518|FG003|Overall Study|Unable to swallow sponge|0|||
16341003|NCT02560623|39734515|FG000|Overall Study|Intervention prior to sponge administration|0|||
16341004|NCT02560623|39734516|FG001|Overall Study|Intervention prior to sponge administration|1|||
16341005|NCT02560623|39734517|FG002|Overall Study|Intervention prior to sponge administration|0|||
16541542|NCT01693692|40443368|FG000|Overall Study|Adverse Event|7|||
16541543|NCT01693692|40443369|FG001|Overall Study|Adverse Event|14|||
16541544|NCT01693692|40443370|FG002|Overall Study|Adverse Event|9|||
16107298|NCT00338949|38881261|FG001|Randomization|Adverse Event|5|||
16541545|NCT01693692|40443368|FG000|Overall Study|Physician Decision|0|||
16541546|NCT01693692|40443369|FG001|Overall Study|Physician Decision|0|||
16541547|NCT01693692|40443370|FG002|Overall Study|Physician Decision|1|||
16541548|NCT01693692|40443368|FG000|Overall Study|Protocol Violation|5|||
16541549|NCT01693692|40443369|FG001|Overall Study|Protocol Violation|4|||
16541550|NCT01693692|40443370|FG002|Overall Study|Protocol Violation|6|||
16541551|NCT01693692|40443368|FG000|Overall Study|Lost to Follow-up|2|||
16107299|NCT02669407|38881262|FG000|Overall Study|Physician Decision|3|||
16107300|NCT00719043|38881265|FG000|Overall Study|Adverse Event|5|||
16341006|NCT02560623|39734518|FG003|Overall Study|Intervention prior to sponge administration|0|||
16341007|NCT02499263|39734520|FG000|Overall Study|Lost to Follow-up|9|||
16341008|NCT02499263|39734520|FG000|Overall Study|Participant's withdrawal of consent|4|||
16341009|NCT02499263|39734520|FG000|Overall Study|Lack of Efficacy|22|||
16406649|NCT00980460|39969859|FG000|Overall Study|No therapy within 42 days of resection|0|||
16107301|NCT00719043|38881266|FG001|Overall Study|Adverse Event|1|||
16107302|NCT00719043|38881267|FG002|Overall Study|Adverse Event|2|||
16541552|NCT01693692|40443369|FG001|Overall Study|Lost to Follow-up|2|||
16107303|NCT00719043|38881268|FG003|Overall Study|Adverse Event|2|||
16107304|NCT00719043|38881269|FG004|Overall Study|Adverse Event|1|||
16107305|NCT00719043|38881270|FG005|Overall Study|Adverse Event|4|||
16107306|NCT00719043|38881271|FG006|Overall Study|Adverse Event|4|||
16107307|NCT00719043|38881265|FG000|Overall Study|Lost to Follow-up|14|||
16107308|NCT00719043|38881266|FG001|Overall Study|Lost to Follow-up|10|||
16107309|NCT00719043|38881267|FG002|Overall Study|Lost to Follow-up|8|||
16341010|NCT02499263|39734520|FG000|Overall Study|investigator's judgment|12|||
16341011|NCT02499263|39734520|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
16107310|NCT00719043|38881268|FG003|Overall Study|Lost to Follow-up|9|||
16107311|NCT00719043|38881269|FG004|Overall Study|Lost to Follow-up|10|||
16107312|NCT00719043|38881270|FG005|Overall Study|Lost to Follow-up|9|||
16107313|NCT00719043|38881271|FG006|Overall Study|Lost to Follow-up|9|||
16107314|NCT00719043|38881265|FG000|Overall Study|Protocol Violation|0|||
16107315|NCT00719043|38881266|FG001|Overall Study|Protocol Violation|0|||
16107316|NCT00719043|38881267|FG002|Overall Study|Protocol Violation|0|||
16341012|NCT02499263|39734520|FG000|Overall Study|Participant's decision|3|||
16341013|NCT02499263|39734520|FG000|Overall Study|Pregnancy|1|||
16341014|NCT01711619|39734521|FG000|Overall Study|Early study termination|10|||
16341015|NCT01711619|39734522|FG001|Overall Study|Early study termination|14|||
16341016|NCT01711619|39734521|FG000|Overall Study|Withdrawal by Subject|3|||
16341017|NCT01711619|39734522|FG001|Overall Study|Withdrawal by Subject|7|||
16341018|NCT01711619|39734521|FG000|Overall Study|Protocol Violation|2|||
16341019|NCT01711619|39734522|FG001|Overall Study|Protocol Violation|3|||
16341020|NCT01711619|39734521|FG000|Overall Study|Adverse Event|2|||
16341021|NCT01711619|39734522|FG001|Overall Study|Adverse Event|0|||
16341022|NCT01711619|39734521|FG000|Overall Study|Lost to Follow-up|1|||
16218916|NCT02918006|39282838|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
16218917|NCT00808132|39282841|FG000|Overall Study|Adverse Event|34|||
16218918|NCT00808132|39282842|FG001|Overall Study|Adverse Event|33|||
16218919|NCT00808132|39282843|FG002|Overall Study|Adverse Event|16|||
16341023|NCT01711619|39734522|FG001|Overall Study|Lost to Follow-up|0|||
16341024|NCT01897571|39734523|FG000|Overall Study|Lost to Follow-up|3|||
16341025|NCT01897571|39734524|FG001|Overall Study|Lost to Follow-up|0|||
16341026|NCT01897571|39734525|FG002|Overall Study|Lost to Follow-up|0|||
16341027|NCT01897571|39734526|FG003|Overall Study|Lost to Follow-up|0|||
16341028|NCT01897571|39734527|FG004|Overall Study|Lost to Follow-up|2|||
16341029|NCT01897571|39734528|FG005|Overall Study|Lost to Follow-up|0|||
16341030|NCT01897571|39734529|FG006|Overall Study|Lost to Follow-up|0|||
16341031|NCT01897571|39734530|FG007|Overall Study|Lost to Follow-up|0|||
16341032|NCT01897571|39734531|FG008|Overall Study|Lost to Follow-up|1|||
16341033|NCT01897571|39734532|FG009|Overall Study|Lost to Follow-up|2|||
16341034|NCT01897571|39734533|FG010|Overall Study|Lost to Follow-up|4|||
16341035|NCT01897571|39734523|FG000|Overall Study|Withdrawal by Subject|0|||
16341036|NCT01897571|39734524|FG001|Overall Study|Withdrawal by Subject|0|||
16341037|NCT01897571|39734525|FG002|Overall Study|Withdrawal by Subject|0|||
16341038|NCT01897571|39734526|FG003|Overall Study|Withdrawal by Subject|0|||
16341039|NCT01897571|39734527|FG004|Overall Study|Withdrawal by Subject|0|||
16341040|NCT01897571|39734528|FG005|Overall Study|Withdrawal by Subject|0|||
16341041|NCT01897571|39734529|FG006|Overall Study|Withdrawal by Subject|0|||
16341042|NCT01897571|39734530|FG007|Overall Study|Withdrawal by Subject|1|||
16341043|NCT01897571|39734531|FG008|Overall Study|Withdrawal by Subject|4|||
16341044|NCT01897571|39734532|FG009|Overall Study|Withdrawal by Subject|3|||
16341045|NCT01897571|39734533|FG010|Overall Study|Withdrawal by Subject|1|||
16541553|NCT01693692|40443370|FG002|Overall Study|Lost to Follow-up|3|||
16541554|NCT01693692|40443368|FG000|Overall Study|Other|4|||
16541555|NCT01693692|40443369|FG001|Overall Study|Other|4|||
16541556|NCT01693692|40443370|FG002|Overall Study|Other|6|||
16541557|NCT04493931|40443377|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
16541558|NCT04493931|40443378|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
16341046|NCT01897571|39734523|FG000|Overall Study|Other|1|||
16341047|NCT01897571|39734524|FG001|Overall Study|Other|0|||
16341048|NCT01897571|39734525|FG002|Overall Study|Other|0|||
16341049|NCT01897571|39734526|FG003|Overall Study|Other|3|||
16341050|NCT01897571|39734527|FG004|Overall Study|Other|3|||
16341051|NCT01897571|39734528|FG005|Overall Study|Other|4|||
16541559|NCT04493931|40443379|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
16541560|NCT04493931|40443380|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
16341052|NCT01897571|39734529|FG006|Overall Study|Other|7|||
16341053|NCT01897571|39734530|FG007|Overall Study|Other|0|||
16341054|NCT01897571|39734531|FG008|Overall Study|Other|0|||
16341055|NCT01897571|39734532|FG009|Overall Study|Other|0|||
16341056|NCT01897571|39734533|FG010|Overall Study|Other|0|||
16107317|NCT00719043|38881268|FG003|Overall Study|Protocol Violation|0|||
16107318|NCT00719043|38881269|FG004|Overall Study|Protocol Violation|0|||
16107319|NCT00719043|38881270|FG005|Overall Study|Protocol Violation|1|||
16107320|NCT00719043|38881271|FG006|Overall Study|Protocol Violation|0|||
16218920|NCT00808132|39282844|FG003|Overall Study|Adverse Event|31|||
16341057|NCT01897571|39734523|FG000|Overall Study|Enrolled in rollover study|0|||
16107321|NCT00719043|38881265|FG000|Overall Study|Other|1|||
16107322|NCT00719043|38881266|FG001|Overall Study|Other|0|||
16107323|NCT00719043|38881267|FG002|Overall Study|Other|1|||
16107324|NCT00719043|38881268|FG003|Overall Study|Other|2|||
16107325|NCT00719043|38881269|FG004|Overall Study|Other|0|||
16107326|NCT00719043|38881270|FG005|Overall Study|Other|2|||
16107327|NCT00719043|38881271|FG006|Overall Study|Other|1|||
16107328|NCT00719043|38881265|FG000|Overall Study|Withdrawal by Subject|12|||
16107329|NCT00719043|38881266|FG001|Overall Study|Withdrawal by Subject|14|||
16107330|NCT00719043|38881267|FG002|Overall Study|Withdrawal by Subject|9|||
16107331|NCT00719043|38881268|FG003|Overall Study|Withdrawal by Subject|10|||
16107332|NCT00719043|38881269|FG004|Overall Study|Withdrawal by Subject|16|||
16107333|NCT00719043|38881270|FG005|Overall Study|Withdrawal by Subject|18|||
16107334|NCT00719043|38881271|FG006|Overall Study|Withdrawal by Subject|14|||
16107335|NCT00371462|38881272|FG000|Overall Study|Withdrawal by Subject|1|||
16107336|NCT00371462|38881273|FG001|Overall Study|Withdrawal by Subject|0|||
16107337|NCT00371462|38881272|FG000|Overall Study|Other|7|||
16107338|NCT00371462|38881273|FG001|Overall Study|Other|8|||
16107339|NCT03594747|38881274|FG000|Overall Study|Death|78|||
16107340|NCT03594747|38881275|FG001|Overall Study|Death|86|||
16107341|NCT03594747|38881276|FG002|Overall Study|Death|87|||
16107342|NCT03594747|38881274|FG000|Overall Study|Withdrawal by Subject|5|||
16107343|NCT03594747|38881275|FG001|Overall Study|Withdrawal by Subject|2|||
16107344|NCT03594747|38881276|FG002|Overall Study|Withdrawal by Subject|11|||
16107345|NCT03594747|38881274|FG000|Overall Study|Lost to Follow-up|4|||
16107346|NCT03594747|38881275|FG001|Overall Study|Lost to Follow-up|1|||
16107347|NCT03594747|38881276|FG002|Overall Study|Lost to Follow-up|1|||
16107348|NCT03594747|38881274|FG000|Overall Study|Physician Decision|0|||
16107349|NCT03594747|38881275|FG001|Overall Study|Physician Decision|1|||
16107350|NCT03594747|38881276|FG002|Overall Study|Physician Decision|0|||
16107351|NCT03594747|38881274|FG000|Overall Study|Sponsor decision|23|||
16107352|NCT03594747|38881275|FG001|Overall Study|Sponsor decision|17|||
16107353|NCT03594747|38881276|FG002|Overall Study|Sponsor decision|16|||
16107354|NCT03594747|38881274|FG000|Overall Study|Did not meet inclusion criteria|0|||
16107355|NCT03594747|38881275|FG001|Overall Study|Did not meet inclusion criteria|0|||
16107356|NCT03594747|38881276|FG002|Overall Study|Did not meet inclusion criteria|1|||
16107357|NCT03594747|38881274|FG000|Overall Study|Transfer to long term extension study|10|||
16107358|NCT03594747|38881275|FG001|Overall Study|Transfer to long term extension study|12|||
16107359|NCT03594747|38881276|FG002|Overall Study|Transfer to long term extension study|5|||
16107360|NCT03082612|38881277|FG000|Overall Study|Lost to Follow-up|2|||
16107361|NCT03082612|38881278|FG001|Overall Study|Lost to Follow-up|0|||
16107362|NCT00733226|38881284|FG000|Overall Study|Withdrawal by Subject|1|||
16107363|NCT00733226|38881285|FG001|Overall Study|Withdrawal by Subject|0|||
16107364|NCT00733226|38881284|FG000|Overall Study|Lost to Follow-up|2|||
16107365|NCT00733226|38881285|FG001|Overall Study|Lost to Follow-up|0|||
16541561|NCT04493931|40443381|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
16541562|NCT04493931|40443382|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
16541563|NCT04493931|40443383|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
16541564|NCT04493931|40443377|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
16541565|NCT04493931|40443378|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
16541566|NCT04493931|40443379|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
16541567|NCT04493931|40443380|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
16541568|NCT04493931|40443381|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
16541569|NCT04493931|40443382|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
16541570|NCT04493931|40443383|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
16107366|NCT00733226|38881284|FG000|Overall Study|moved to another place|2|||
16107367|NCT00733226|38881285|FG001|Overall Study|moved to another place|0|||
16107368|NCT05043883|38881286|FG000|Overall Study|Minimum required measurements could not be taken|4|||
16107369|NCT00275301|38881289|FG000|Overall Study|Adverse Event|5|||
16107370|NCT04016805|38881290|FG000|Overall Study|Sponsor's Discretion|30|||
16107371|NCT04016805|38881291|FG001|Overall Study|Sponsor's Discretion|6|||
16107372|NCT04016805|38881292|FG002|Overall Study|Sponsor's Discretion|5|||
16107373|NCT04582669|38881295|FG000|Overall Study|Subject missed appointment(s).|1|||
16107374|NCT04582669|38881296|FG001|Overall Study|Subject missed appointment(s).|0|||
16107375|NCT04582669|38881297|FG002|Overall Study|Subject missed appointment(s).|1|||
16107376|NCT04582669|38881298|FG003|Overall Study|Subject missed appointment(s).|2|||
16107377|NCT04582669|38881295|FG000|Overall Study|Protocol Violation|0|||
16107378|NCT04582669|38881296|FG001|Overall Study|Protocol Violation|1|||
16107379|NCT04582669|38881297|FG002|Overall Study|Protocol Violation|1|||
16107380|NCT04582669|38881298|FG003|Overall Study|Protocol Violation|0|||
16107381|NCT04531813|38881301|FG000|Overall Study|Protocol Violation|1|||
16107382|NCT04531813|38881301|FG000|Overall Study|Withdrawal by Subject|1|||
16107383|NCT02396953|38881302|FG000|Overall Study|Withdrawal by Subject|0|||
16107384|NCT02396953|38881303|FG001|Overall Study|Withdrawal by Subject|0|||
16341058|NCT01897571|39734524|FG001|Overall Study|Enrolled in rollover study|0|||
16341059|NCT01897571|39734525|FG002|Overall Study|Enrolled in rollover study|0|||
16107385|NCT02396953|38881304|FG002|Overall Study|Withdrawal by Subject|1|||
16107386|NCT02396953|38881302|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
16107387|NCT02396953|38881303|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
16107388|NCT02396953|38881304|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
16107389|NCT02396953|38881302|FG000|Overall Study|Personal Reasons|1|||
16107390|NCT02396953|38881303|FG001|Overall Study|Personal Reasons|1|||
16107391|NCT02396953|38881304|FG002|Overall Study|Personal Reasons|0|||
16107392|NCT02447432|38881305|FG000|Epoch 001|Adverse Event|1|||
16107393|NCT02447432|38881306|FG001|Epoch 001|Adverse Event|1|||
16107394|NCT02447432|38881305|FG000|Epoch 001|Withdrawal by Subject|0|||
16107395|NCT02447432|38881306|FG001|Epoch 001|Withdrawal by Subject|4|||
16107396|NCT02447432|38881305|FG000|Epoch 001|Migrated/moved from study area|3|||
16107397|NCT02447432|38881306|FG001|Epoch 001|Migrated/moved from study area|5|||
16107398|NCT02447432|38881305|FG000|Epoch 001|Lost to Follow-up|1|||
16341060|NCT01897571|39734526|FG003|Overall Study|Enrolled in rollover study|0|||
16107399|NCT02447432|38881306|FG001|Epoch 001|Lost to Follow-up|3|||
16107400|NCT01801982|38881307|FG000|Overall Study|Lost to Follow-up|1|||
16107401|NCT00405912|38881310|FG000|Overall Study|Withdrawal by Subject|12|||
16107402|NCT00405912|38881311|FG001|Overall Study|Withdrawal by Subject|11|||
16107403|NCT00405912|38881312|FG002|Overall Study|Withdrawal by Subject|12|||
16107404|NCT00405912|38881310|FG000|Overall Study|Lost to Follow-up|4|||
16107405|NCT00405912|38881311|FG001|Overall Study|Lost to Follow-up|8|||
16107406|NCT00405912|38881312|FG002|Overall Study|Lost to Follow-up|4|||
16107407|NCT04357964|38881315|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
16107408|NCT04357964|38881316|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
16107409|NCT04357964|38881315|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
16541571|NCT04493931|40443377|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
16341061|NCT01897571|39734527|FG004|Overall Study|Enrolled in rollover study|0|||
16341062|NCT01897571|39734528|FG005|Overall Study|Enrolled in rollover study|0|||
16107410|NCT04357964|38881316|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
16541572|NCT04493931|40443378|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
16541573|NCT04493931|40443379|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
16541574|NCT04493931|40443380|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
16541575|NCT04493931|40443381|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
16541576|NCT04493931|40443382|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
16541577|NCT04493931|40443383|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
16541578|NCT04493931|40443377|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
16341063|NCT01897571|39734529|FG006|Overall Study|Enrolled in rollover study|0|||
16341064|NCT01897571|39734530|FG007|Overall Study|Enrolled in rollover study|9|||
16341065|NCT01897571|39734531|FG008|Overall Study|Enrolled in rollover study|7|||
16341066|NCT01897571|39734532|FG009|Overall Study|Enrolled in rollover study|9|||
16541579|NCT04493931|40443378|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
16541580|NCT04493931|40443379|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
16541581|NCT04493931|40443380|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
16107411|NCT04357964|38881315|FG000|Overall Study|Adipose sample was insufficient quality|0|||
16107412|NCT04357964|38881316|FG001|Overall Study|Adipose sample was insufficient quality|1|||
16107413|NCT00591591|38881318|FG000|Overall Study|Withdrawal by Subject|1|||
16107414|NCT00591591|38881319|FG001|Overall Study|Withdrawal by Subject|37|||
16107415|NCT00591591|38881318|FG000|Overall Study|Lack of Efficacy|10|||
16341067|NCT01897571|39734533|FG010|Overall Study|Enrolled in rollover study|1|||
16107416|NCT00591591|38881319|FG001|Overall Study|Lack of Efficacy|2|||
16107417|NCT01589523|38881320|FG000|Overall Study|Withdrawal by Subject|1|||
16107418|NCT00363649|38881321|FG000|Overall Study|Withdrawal by Subject|1|||
16107419|NCT00363649|38881322|FG001|Overall Study|Withdrawal by Subject|1|||
16107420|NCT00363649|38881321|FG000|Overall Study|Adverse Event|6|||
16107421|NCT00363649|38881322|FG001|Overall Study|Adverse Event|0|||
16107422|NCT01703845|38881323|FG000|Overall Study|Adverse Event|1|||
16107423|NCT01703845|38881324|FG001|Overall Study|Adverse Event|0|||
16107424|NCT01703845|38881323|FG000|Overall Study|Protocol Violation|1|||
16107425|NCT01703845|38881324|FG001|Overall Study|Protocol Violation|0|||
16107426|NCT01703845|38881323|FG000|Overall Study|other than stated above|1|||
16107427|NCT01703845|38881324|FG001|Overall Study|other than stated above|0|||
16107428|NCT01227928|38881325|FG000|Overall Study|Lost to Follow-up|4|||
16107429|NCT01227928|38881326|FG001|Overall Study|Lost to Follow-up|2|||
16107430|NCT01227928|38881325|FG000|Overall Study|Withdrawal by Subject|4|||
16107431|NCT01227928|38881326|FG001|Overall Study|Withdrawal by Subject|3|||
16107432|NCT01227928|38881325|FG000|Overall Study|Death|14|||
16107433|NCT01227928|38881326|FG001|Overall Study|Death|12|||
16107434|NCT03730662|38881327|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
16107435|NCT03730662|38881328|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
16107436|NCT03730662|38881329|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
16541582|NCT04493931|40443381|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
16541583|NCT04493931|40443382|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
16107437|NCT03730662|38881330|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
16107438|NCT03730662|38881327|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
16107439|NCT03730662|38881328|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
16107440|NCT03730662|38881329|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
16107441|NCT03730662|38881330|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
16107442|NCT03730662|38881327|FG000|Treatment Period (52 Weeks)|Death|6|||
16107443|NCT03730662|38881328|FG001|Treatment Period (52 Weeks)|Death|2|||
16107444|NCT03730662|38881329|FG002|Treatment Period (52 Weeks)|Death|2|||
16541584|NCT04493931|40443383|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
16107445|NCT03730662|38881330|FG003|Treatment Period (52 Weeks)|Death|9|||
16541585|NCT01059630|40443384|FG000|Overall Study|Death|100|||
16541586|NCT01059630|40443385|FG001|Overall Study|Death|84|||
16541587|NCT01059630|40443384|FG000|Overall Study|Lost to Follow-up|4|||
16541588|NCT01059630|40443385|FG001|Overall Study|Lost to Follow-up|1|||
16541589|NCT01059630|40443384|FG000|Overall Study|Physician Decision|2|||
16541590|NCT01059630|40443385|FG001|Overall Study|Physician Decision|4|||
16541591|NCT01059630|40443384|FG000|Overall Study|Withdrawal by Subject|21|||
16541592|NCT01059630|40443385|FG001|Overall Study|Withdrawal by Subject|14|||
16541593|NCT01833143|40443394|FG000|Overall Study|Not Treated|1|||
16541594|NCT00593567|40443405|FG000|Overall Study|Adverse Event|2|||
16541595|NCT00593567|40443406|FG001|Overall Study|Adverse Event|0|||
16541596|NCT00593567|40443405|FG000|Overall Study|Physician Decision|2|||
16541597|NCT00593567|40443406|FG001|Overall Study|Physician Decision|0|||
16541598|NCT00593567|40443405|FG000|Overall Study|Protocol Violation|13|||
16541599|NCT00593567|40443406|FG001|Overall Study|Protocol Violation|7|||
16541600|NCT00593567|40443405|FG000|Overall Study|Lack of Efficacy|2|||
16541601|NCT00593567|40443406|FG001|Overall Study|Lack of Efficacy|1|||
16541602|NCT00593567|40443405|FG000|Overall Study|Withdrawal by Subject|1|||
16541603|NCT00593567|40443406|FG001|Overall Study|Withdrawal by Subject|2|||
16541604|NCT04003155|40443407|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
16541605|NCT04003155|40443408|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
16541606|NCT04003155|40443409|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
16541607|NCT04003155|40443410|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
16541608|NCT04003155|40443411|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
16541609|NCT04003155|40443407|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
16541610|NCT04003155|40443408|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
16541611|NCT04003155|40443409|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
16541612|NCT04003155|40443410|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
16541613|NCT04003155|40443411|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
16541614|NCT04003155|40443407|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
16541615|NCT04003155|40443408|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
16541616|NCT04003155|40443409|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
16541617|NCT04003155|40443410|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
16541618|NCT04003155|40443411|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
16541619|NCT04003155|40443407|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
16541620|NCT04003155|40443408|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
16541621|NCT04003155|40443409|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
16541622|NCT04003155|40443410|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
16107446|NCT03730662|38881327|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
16107447|NCT03730662|38881328|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
16107448|NCT03730662|38881329|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
16107449|NCT03730662|38881330|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
16107450|NCT03730662|38881327|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
16107451|NCT03730662|38881328|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
16107452|NCT03730662|38881329|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
16107453|NCT03730662|38881330|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
16107454|NCT03730662|38881327|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
16541623|NCT04003155|40443411|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
16541624|NCT04003155|40443407|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
16541625|NCT04003155|40443408|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
16541626|NCT04003155|40443409|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
16541627|NCT04003155|40443410|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
16541628|NCT04003155|40443411|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
16218921|NCT00808132|39282845|FG004|Overall Study|Adverse Event|33|||
16218922|NCT00808132|39282841|FG000|Overall Study|Death|0|||
16541629|NCT04003155|40443407|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
16541630|NCT04003155|40443408|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
16541631|NCT04003155|40443409|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
16541632|NCT04003155|40443410|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
16541633|NCT04003155|40443411|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
16541634|NCT04003155|40443407|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
16541635|NCT04003155|40443408|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
16541636|NCT04003155|40443409|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
16541637|NCT04003155|40443410|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
16541638|NCT04003155|40443411|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
16541639|NCT04003155|40443407|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
16541640|NCT04003155|40443408|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
16218923|NCT00808132|39282842|FG001|Overall Study|Death|0|||
16218924|NCT00808132|39282843|FG002|Overall Study|Death|0|||
16218925|NCT00808132|39282844|FG003|Overall Study|Death|0|||
16218926|NCT00808132|39282845|FG004|Overall Study|Death|1|||
16218927|NCT00808132|39282841|FG000|Overall Study|Physician Decision|0|||
16218928|NCT00808132|39282842|FG001|Overall Study|Physician Decision|1|||
16218929|NCT00808132|39282843|FG002|Overall Study|Physician Decision|0|||
16218930|NCT00808132|39282844|FG003|Overall Study|Physician Decision|0|||
16218931|NCT00808132|39282845|FG004|Overall Study|Physician Decision|0|||
16218932|NCT00808132|39282841|FG000|Overall Study|Lost to Follow-up|8|||
16218933|NCT00808132|39282842|FG001|Overall Study|Lost to Follow-up|10|||
16218934|NCT00808132|39282843|FG002|Overall Study|Lost to Follow-up|11|||
16218935|NCT00808132|39282844|FG003|Overall Study|Lost to Follow-up|8|||
16218936|NCT00808132|39282845|FG004|Overall Study|Lost to Follow-up|9|||
16218937|NCT00808132|39282841|FG000|Overall Study|Protocol Violation|8|||
16541641|NCT04003155|40443409|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
16107455|NCT03730662|38881328|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
16218938|NCT00808132|39282842|FG001|Overall Study|Protocol Violation|9|||
16218939|NCT00808132|39282843|FG002|Overall Study|Protocol Violation|4|||
16218940|NCT00808132|39282844|FG003|Overall Study|Protocol Violation|9|||
16541642|NCT04003155|40443410|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
16218941|NCT00808132|39282845|FG004|Overall Study|Protocol Violation|5|||
16218942|NCT00808132|39282841|FG000|Overall Study|Withdrawal by Subject|27|||
16218943|NCT00808132|39282842|FG001|Overall Study|Withdrawal by Subject|18|||
16541643|NCT04003155|40443411|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
16541644|NCT04003155|40443407|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
16541645|NCT04003155|40443408|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
16541646|NCT04003155|40443409|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
16541647|NCT04003155|40443410|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
16541648|NCT04003155|40443411|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
16541649|NCT01964326|40446644|FG000|Overall Study|Adverse Event|48|||
16541650|NCT01964326|40446644|FG000|Overall Study|Death|2|||
16541651|NCT01964326|40446644|FG000|Overall Study|Protocol Violation|4|||
16541652|NCT01964326|40446644|FG000|Overall Study|Lost to Follow-up|88|||
16541653|NCT01964326|40446644|FG000|Overall Study|Withdrawal by Subject|87|||
16541654|NCT01964326|40446644|FG000|Overall Study|Pregnancy|1|||
16541655|NCT01964326|40446644|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
16541656|NCT01964326|40446644|FG000|Overall Study|Physician Decision|55|||
16541657|NCT01964326|40446644|FG000|Overall Study|Investigator Discretion|1|||
16541658|NCT01964326|40446644|FG000|Overall Study|Other|9|||
16541659|NCT01964326|40446644|FG000|Overall Study|Did not meet eligibility criteria|1|||
16541660|NCT00863655|40446645|FG000|Overall Study|Protocol Violation|4|||
16541661|NCT00863655|40446646|FG001|Overall Study|Protocol Violation|0|||
16341068|NCT01897571|39734523|FG000|Overall Study|Death|2|||
16341069|NCT01897571|39734524|FG001|Overall Study|Death|2|||
16341070|NCT01897571|39734525|FG002|Overall Study|Death|3|||
16341071|NCT01897571|39734526|FG003|Overall Study|Death|6|||
16341072|NCT01897571|39734527|FG004|Overall Study|Death|7|||
16341073|NCT01897571|39734528|FG005|Overall Study|Death|9|||
16341074|NCT01897571|39734529|FG006|Overall Study|Death|5|||
16341075|NCT01897571|39734530|FG007|Overall Study|Death|22|||
16341076|NCT01897571|39734531|FG008|Overall Study|Death|23|||
16341077|NCT01897571|39734532|FG009|Overall Study|Death|129|||
16341078|NCT01897571|39734533|FG010|Overall Study|Death|59|||
16341079|NCT04446429|39734534|FG000|Overall Study|Lost to Follow-up|6|||
16341080|NCT04446429|39734535|FG001|Overall Study|Lost to Follow-up|0|||
16341081|NCT00862459|39734536|FG000|Overall Study|Lost to Follow-up|1|||
16341082|NCT00862459|39734537|FG001|Overall Study|Lost to Follow-up|2|||
16341083|NCT00862459|39734538|FG002|Overall Study|Lost to Follow-up|2|||
16541662|NCT00863655|40446645|FG000|Overall Study|Adverse Event|52|||
16541663|NCT00863655|40446646|FG001|Overall Study|Adverse Event|8|||
16541664|NCT00863655|40446645|FG000|Overall Study|Withdrawal by Subject|47|||
16541665|NCT00863655|40446646|FG001|Overall Study|Withdrawal by Subject|7|||
16541666|NCT00863655|40446645|FG000|Overall Study|Administrative problems|1|||
16541667|NCT00863655|40446646|FG001|Overall Study|Administrative problems|0|||
16541668|NCT00863655|40446645|FG000|Overall Study|Death|7|||
16541669|NCT00863655|40446646|FG001|Overall Study|Death|1|||
16541670|NCT00863655|40446645|FG000|Overall Study|New cancer therapy|5|||
16541671|NCT00863655|40446646|FG001|Overall Study|New cancer therapy|1|||
16541672|NCT00863655|40446645|FG000|Overall Study|Disease progression|364|||
16541673|NCT00863655|40446646|FG001|Overall Study|Disease progression|221|||
16341084|NCT00862459|39734536|FG000|Overall Study|Protocol Violation|1|||
16341085|NCT00862459|39734537|FG001|Overall Study|Protocol Violation|0|||
16341086|NCT00862459|39734538|FG002|Overall Study|Protocol Violation|0|||
16341087|NCT00862459|39734536|FG000|Overall Study|Withdrawal by Subject|1|||
16341088|NCT00862459|39734537|FG001|Overall Study|Withdrawal by Subject|1|||
16341089|NCT00862459|39734538|FG002|Overall Study|Withdrawal by Subject|3|||
16341090|NCT00862459|39734536|FG000|Overall Study|Adverse Event|0|||
16341091|NCT00862459|39734537|FG001|Overall Study|Adverse Event|1|||
16341092|NCT00862459|39734538|FG002|Overall Study|Adverse Event|0|||
16341093|NCT00862459|39734536|FG000|Overall Study|Personal reasons|1|||
16341094|NCT00862459|39734537|FG001|Overall Study|Personal reasons|0|||
16341095|NCT00862459|39734538|FG002|Overall Study|Personal reasons|0|||
16341096|NCT00862459|39734536|FG000|Overall Study|Operation|1|||
16341097|NCT00862459|39734537|FG001|Overall Study|Operation|1|||
16341098|NCT00862459|39734538|FG002|Overall Study|Operation|0|||
16341099|NCT00862459|39734536|FG000|Overall Study|Intravenous (IV) site problems|1|||
16341100|NCT00862459|39734537|FG001|Overall Study|Intravenous (IV) site problems|0|||
16341101|NCT00862459|39734538|FG002|Overall Study|Intravenous (IV) site problems|1|||
16341102|NCT00862459|39734536|FG000|Overall Study|Unable to hold still for imaging|0|||
16341103|NCT00862459|39734537|FG001|Overall Study|Unable to hold still for imaging|1|||
16541674|NCT00863655|40446645|FG000|Overall Study|Treatment completed as per protocol|5|||
16541675|NCT00863655|40446646|FG001|Overall Study|Treatment completed as per protocol|1|||
16541676|NCT02277743|40446649|FG000|Overall Study|Protocol Violation|1|||
16541677|NCT02277743|40446650|FG001|Overall Study|Protocol Violation|1|||
16341104|NCT00862459|39734538|FG002|Overall Study|Unable to hold still for imaging|0|||
16341105|NCT00862459|39734536|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
16541678|NCT02277743|40446651|FG002|Overall Study|Protocol Violation|1|||
16341106|NCT00862459|39734537|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
16341107|NCT00862459|39734538|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
16341108|NCT00862459|39734536|FG000|Overall Study|Administrative problems|0|||
16341109|NCT00862459|39734537|FG001|Overall Study|Administrative problems|1|||
16541679|NCT02277743|40446649|FG000|Overall Study|Adverse Event|10|||
16341110|NCT00862459|39734538|FG002|Overall Study|Administrative problems|0|||
16341111|NCT01212159|39734539|FG000|Overall Study|Withdrawal by Subject|12|||
16341112|NCT01212159|39734540|FG001|Overall Study|Withdrawal by Subject|12|||
16341113|NCT01605825|39734547|FG000|Overall Study|Adverse Event|4|||
16341114|NCT01605825|39734548|FG001|Overall Study|Adverse Event|2|||
16541680|NCT02277743|40446650|FG001|Overall Study|Adverse Event|6|||
16541681|NCT02277743|40446651|FG002|Overall Study|Adverse Event|6|||
16541682|NCT02277743|40446649|FG000|Overall Study|Lack of Efficacy|11|||
16541683|NCT02277743|40446650|FG001|Overall Study|Lack of Efficacy|4|||
16541684|NCT02277743|40446651|FG002|Overall Study|Lack of Efficacy|3|||
16541685|NCT02277743|40446649|FG000|Overall Study|Other than specified above|18|||
16541686|NCT02277743|40446650|FG001|Overall Study|Other than specified above|5|||
16541687|NCT02277743|40446651|FG002|Overall Study|Other than specified above|16|||
16541688|NCT01256567|40446654|FG000|Overall Study|Withdrawal by Subject|1|||
16541689|NCT03338790|40446663|FG000|Overall Study|Disease Progression|65|||
16541690|NCT03338790|40446664|FG001|Overall Study|Disease Progression|43|||
16541691|NCT03338790|40446665|FG002|Overall Study|Disease Progression|50|||
16541692|NCT03338790|40446666|FG003|Overall Study|Disease Progression|37|||
16541693|NCT03338790|40446663|FG000|Overall Study|Study Drug Toxicity|9|||
16541694|NCT03338790|40446664|FG001|Overall Study|Study Drug Toxicity|8|||
16541695|NCT03338790|40446665|FG002|Overall Study|Study Drug Toxicity|15|||
16541696|NCT03338790|40446666|FG003|Overall Study|Study Drug Toxicity|0|||
16541697|NCT03338790|40446663|FG000|Overall Study|Death|1|||
16541698|NCT03338790|40446664|FG001|Overall Study|Death|1|||
16541699|NCT03338790|40446665|FG002|Overall Study|Death|1|||
16541700|NCT03338790|40446666|FG003|Overall Study|Death|0|||
16541701|NCT03338790|40446663|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
16541702|NCT03338790|40446664|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
16541703|NCT03338790|40446665|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
16541704|NCT03338790|40446666|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
16541705|NCT03338790|40446663|FG000|Overall Study|Participant request to discontinue study treatment|3|||
16541706|NCT03338790|40446664|FG001|Overall Study|Participant request to discontinue study treatment|3|||
16541707|NCT03338790|40446665|FG002|Overall Study|Participant request to discontinue study treatment|2|||
16541708|NCT03338790|40446666|FG003|Overall Study|Participant request to discontinue study treatment|1|||
16541709|NCT03338790|40446663|FG000|Overall Study|Poor/non-compliance|0|||
16541710|NCT03338790|40446664|FG001|Overall Study|Poor/non-compliance|1|||
16541711|NCT03338790|40446665|FG002|Overall Study|Poor/non-compliance|0|||
16541712|NCT03338790|40446666|FG003|Overall Study|Poor/non-compliance|0|||
16541713|NCT03338790|40446663|FG000|Overall Study|Participant withdrew consent|1|||
16541714|NCT03338790|40446664|FG001|Overall Study|Participant withdrew consent|0|||
16541715|NCT03338790|40446665|FG002|Overall Study|Participant withdrew consent|1|||
16541716|NCT03338790|40446666|FG003|Overall Study|Participant withdrew consent|1|||
16541717|NCT03338790|40446663|FG000|Overall Study|Other reasons|0|||
16541718|NCT03338790|40446664|FG001|Overall Study|Other reasons|5|||
16541719|NCT03338790|40446665|FG002|Overall Study|Other reasons|0|||
16541720|NCT03338790|40446666|FG003|Overall Study|Other reasons|2|||
16541721|NCT03338790|40446663|FG000|Overall Study|Not reported|0|||
16541722|NCT03338790|40446664|FG001|Overall Study|Not reported|0|||
16541723|NCT03338790|40446665|FG002|Overall Study|Not reported|1|||
16541724|NCT03338790|40446666|FG003|Overall Study|Not reported|0|||
16541725|NCT03338790|40446663|FG000|Overall Study|Completed treatment period|1|||
16541726|NCT03338790|40446664|FG001|Overall Study|Completed treatment period|2|||
16541727|NCT03338790|40446665|FG002|Overall Study|Completed treatment period|0|||
16541728|NCT03338790|40446666|FG003|Overall Study|Completed treatment period|0|||
16541729|NCT03255824|40446670|FG000|Overall Study|Under-sedation|2|||
16541730|NCT03255824|40446671|FG001|Overall Study|Under-sedation|1|||
16541731|NCT01657266|40446674|FG000|Overall Study|Lost to Follow-up|2|||
16541732|NCT01657266|40446675|FG001|Overall Study|Lost to Follow-up|2|||
16541733|NCT01657266|40446674|FG000|Overall Study|Adverse Event|2|||
16541734|NCT01657266|40446675|FG001|Overall Study|Adverse Event|3|||
16541735|NCT04082884|40446682|FG000|Overall Study|Withdrawal by Subject|1|||
16541736|NCT01114204|40446684|FG000|Overall Study|Adverse Event|3|||
16541737|NCT01114204|40446685|FG001|Overall Study|Adverse Event|2|||
16541738|NCT01114204|40446684|FG000|Overall Study|Lost to Follow-up|1|||
16541739|NCT01114204|40446685|FG001|Overall Study|Lost to Follow-up|0|||
16541740|NCT01114204|40446684|FG000|Overall Study|Withdrawal by Subject|10|||
16541741|NCT01114204|40446685|FG001|Overall Study|Withdrawal by Subject|6|||
16341115|NCT01605825|39734547|FG000|Overall Study|Withdrawal by Subject|0|||
16341116|NCT01605825|39734548|FG001|Overall Study|Withdrawal by Subject|1|||
16541742|NCT01114204|40446684|FG000|Overall Study|Death|1|||
16541743|NCT01114204|40446685|FG001|Overall Study|Death|0|||
16541744|NCT01114204|40446684|FG000|Overall Study|Other-Personal reasons|2|||
16541745|NCT01114204|40446685|FG001|Overall Study|Other-Personal reasons|0|||
16541746|NCT01114204|40446684|FG000|Overall Study|Other-Medical monitor request|1|||
16541747|NCT01114204|40446685|FG001|Overall Study|Other-Medical monitor request|0|||
16541748|NCT01114204|40446684|FG000|Overall Study|Other-Participant request|2|||
16541749|NCT01114204|40446685|FG001|Overall Study|Other-Participant request|0|||
16541750|NCT01114204|40446684|FG000|Overall Study|Other-Protocol Violation|1|||
16541751|NCT01114204|40446685|FG001|Overall Study|Other-Protocol Violation|0|||
16541752|NCT00733980|40446689|FG000|Overall Study|Adverse Event|5|||
16541753|NCT00733980|40446690|FG001|Overall Study|Adverse Event|2|||
16541754|NCT00733980|40446689|FG000|Overall Study|Lack of Efficacy|0|||
16541755|NCT00733980|40446690|FG001|Overall Study|Lack of Efficacy|1|||
16541756|NCT00733980|40446689|FG000|Overall Study|Protocol Violation|2|||
16107456|NCT03730662|38881329|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
16107457|NCT03730662|38881330|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
16541757|NCT00733980|40446690|FG001|Overall Study|Protocol Violation|1|||
16541758|NCT00733980|40446689|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
16541759|NCT00733980|40446690|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
16541760|NCT00733980|40446689|FG000|Overall Study|Lost to Follow-up|6|||
16541761|NCT00733980|40446690|FG001|Overall Study|Lost to Follow-up|11|||
16541762|NCT00733980|40446689|FG000|Overall Study|Physician Decision|2|||
16541763|NCT00733980|40446690|FG001|Overall Study|Physician Decision|3|||
16541764|NCT00733980|40446689|FG000|Overall Study|Withdrawal by Subject|6|||
16541765|NCT00733980|40446690|FG001|Overall Study|Withdrawal by Subject|2|||
16541766|NCT02276222|40446691|FG000|Overall Study|Adverse Event|62|||
16541767|NCT02276222|40446692|FG001|Overall Study|Adverse Event|11|||
16541768|NCT02276222|40446691|FG000|Overall Study|Death|3|||
16541769|NCT02276222|40446692|FG001|Overall Study|Death|4|||
16541770|NCT02276222|40446691|FG000|Overall Study|Lack of Efficacy|13|||
16541771|NCT02276222|40446692|FG001|Overall Study|Lack of Efficacy|3|||
16541772|NCT02276222|40446691|FG000|Overall Study|Protocol Violation|3|||
16541773|NCT02276222|40446692|FG001|Overall Study|Protocol Violation|2|||
16541774|NCT02276222|40446691|FG000|Overall Study|Withdrawal by Subject|79|||
16541775|NCT02276222|40446692|FG001|Overall Study|Withdrawal by Subject|33|||
16541776|NCT02276222|40446691|FG000|Overall Study|non compliance with study medication|6|||
16541777|NCT02276222|40446692|FG001|Overall Study|non compliance with study medication|2|||
16541778|NCT02276222|40446691|FG000|Overall Study|sponsor decision|0|||
16541779|NCT02276222|40446692|FG001|Overall Study|sponsor decision|3|||
16541780|NCT02276222|40446691|FG000|Overall Study|Lost to Follow-up|15|||
16541781|NCT02276222|40446692|FG001|Overall Study|Lost to Follow-up|5|||
16541782|NCT02276222|40446691|FG000|Overall Study|Physician Decision|2|||
16541783|NCT02276222|40446692|FG001|Overall Study|Physician Decision|1|||
16541784|NCT02276222|40446691|FG000|Overall Study|sheduling conflict|1|||
16541785|NCT02276222|40446692|FG001|Overall Study|sheduling conflict|0|||
16541786|NCT02276222|40446691|FG000|Overall Study|subject withdrew after randomization|1|||
16541787|NCT02276222|40446692|FG001|Overall Study|subject withdrew after randomization|0|||
16541788|NCT03988166|40446694|FG000|Overall Study|Lost to Follow-up|2|||
16541789|NCT03988166|40446694|FG000|Overall Study|Death|1|||
16541790|NCT00654901|40446695|FG000|Overall Study|Lost to Follow-up|1|||
16541791|NCT00654901|40446696|FG001|Overall Study|Lost to Follow-up|0|||
16541792|NCT00654901|40446697|FG002|Overall Study|Lost to Follow-up|1|||
16541793|NCT00654901|40446698|FG003|Overall Study|Lost to Follow-up|0|||
16541794|NCT00654901|40446695|FG000|Overall Study|Withdrawal by Subject|3|||
16541795|NCT00654901|40446696|FG001|Overall Study|Withdrawal by Subject|0|||
16541796|NCT00654901|40446697|FG002|Overall Study|Withdrawal by Subject|1|||
16541797|NCT00654901|40446698|FG003|Overall Study|Withdrawal by Subject|0|||
16541798|NCT03320018|40446701|FG000|Treatment Period|Withdrawal by Subject|1|||
16541799|NCT03320018|40446702|FG001|Treatment Period|Withdrawal by Subject|0|||
16541800|NCT03320018|40446701|FG000|Day 90 Follow up|Death|0|||
16541801|NCT03320018|40446702|FG001|Day 90 Follow up|Death|1|||
16541802|NCT03929562|40446703|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
16541803|NCT03929562|40446704|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
16107458|NCT03730662|38881327|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
16107459|NCT03730662|38881328|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
16107460|NCT03730662|38881329|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
16107461|NCT03730662|38881330|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
16107462|NCT03730662|38881327|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
16541804|NCT03929562|40446703|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
16541805|NCT03929562|40446704|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
16541806|NCT03929562|40446703|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
16541807|NCT03929562|40446704|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
16541808|NCT00676130|40446709|FG000|Overall Study|Lost to Follow-up|0|||
16541809|NCT00676130|40446710|FG001|Overall Study|Lost to Follow-up|1|||
16541810|NCT00676130|40446709|FG000|Overall Study|Found ineligible|3|||
16541811|NCT00676130|40446710|FG001|Overall Study|Found ineligible|2|||
16541812|NCT00676130|40446709|FG000|Overall Study|Withdrawal by Subject|0|||
16541813|NCT00676130|40446710|FG001|Overall Study|Withdrawal by Subject|1|||
16541814|NCT02548455|40446711|FG000|Overall Study|Withdrawal by Subject|27|||
16541815|NCT02548455|40446711|FG000|Overall Study|Death|26|||
16541816|NCT02548455|40446711|FG000|Overall Study|Lost to Follow-up|14|||
16541817|NCT02548455|40446711|FG000|Overall Study|Visit not completed|173|||
16541818|NCT04710927|40446712|FG000|Overall Study|Lost to Follow-up|7|||
16541819|NCT04710927|40446713|FG001|Overall Study|Lost to Follow-up|6|||
16541820|NCT04710927|40446714|FG002|Overall Study|Lost to Follow-up|5|||
16541821|NCT02034708|40446715|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
16541822|NCT02034708|40446716|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
16541823|NCT02034708|40446715|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
16541824|NCT02034708|40446716|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
16541825|NCT02034708|40446715|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
16541826|NCT02034708|40446716|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
16541827|NCT02034708|40446715|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
16541828|NCT02034708|40446716|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
16541829|NCT00266825|40446717|FG000|Completed Follow-Up|Lost to Follow-up|14|||
16541830|NCT00266825|40446718|FG001|Completed Follow-Up|Lost to Follow-up|19|||
16541831|NCT00266825|40446717|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
16541832|NCT00266825|40446718|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
16541833|NCT00119405|40446719|FG000|Overall Study|Withdrawal by Subject|1|||
16541834|NCT00136955|40446720|FG000|Overall Study|Adverse Event|8|||
16541835|NCT00136955|40446720|FG000|Overall Study|Lost to Follow-up|1|||
16541836|NCT00136955|40446720|FG000|Overall Study|Withdrawal by Subject|2|||
16541837|NCT00136955|40446720|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
16541838|NCT00855062|40446721|FG000|Step1|Early Study Closure|5|||
16541839|NCT00855062|40446722|FG001|Step1|Early Study Closure|7|||
16541840|NCT00855062|40446721|FG000|Step1|Adverse Event|1|||
16107463|NCT03730662|38881328|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
16107464|NCT03730662|38881329|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
16107465|NCT03730662|38881330|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
16107466|NCT03730662|38881327|FG000|Variable Treatment Period|Adverse Event|1|||
16107467|NCT03730662|38881328|FG001|Variable Treatment Period|Adverse Event|2|||
16107468|NCT03730662|38881329|FG002|Variable Treatment Period|Adverse Event|0|||
16107469|NCT03730662|38881330|FG003|Variable Treatment Period|Adverse Event|7|||
16107470|NCT03730662|38881327|FG000|Variable Treatment Period|Death|9|||
16107471|NCT03730662|38881328|FG001|Variable Treatment Period|Death|0|||
16107472|NCT03730662|38881329|FG002|Variable Treatment Period|Death|6|||
16107473|NCT03730662|38881330|FG003|Variable Treatment Period|Death|26|||
16107474|NCT03730662|38881327|FG000|Variable Treatment Period|Lost to Follow-up|2|||
16107475|NCT03730662|38881328|FG001|Variable Treatment Period|Lost to Follow-up|1|||
16107476|NCT03730662|38881329|FG002|Variable Treatment Period|Lost to Follow-up|4|||
16107477|NCT03730662|38881330|FG003|Variable Treatment Period|Lost to Follow-up|11|||
16107478|NCT03730662|38881327|FG000|Variable Treatment Period|Personal Reason|0|||
16107479|NCT03730662|38881328|FG001|Variable Treatment Period|Personal Reason|2|||
16107480|NCT03730662|38881329|FG002|Variable Treatment Period|Personal Reason|1|||
16107481|NCT03730662|38881330|FG003|Variable Treatment Period|Personal Reason|6|||
16107482|NCT03730662|38881327|FG000|Variable Treatment Period|Physician Decision|0|||
16107483|NCT03730662|38881328|FG001|Variable Treatment Period|Physician Decision|0|||
16107484|NCT03730662|38881329|FG002|Variable Treatment Period|Physician Decision|0|||
16107485|NCT03730662|38881330|FG003|Variable Treatment Period|Physician Decision|3|||
16107486|NCT03730662|38881327|FG000|Variable Treatment Period|Protocol Violation|0|||
16107487|NCT03730662|38881328|FG001|Variable Treatment Period|Protocol Violation|1|||
16107488|NCT03730662|38881329|FG002|Variable Treatment Period|Protocol Violation|1|||
16107489|NCT03730662|38881330|FG003|Variable Treatment Period|Protocol Violation|1|||
16218944|NCT00808132|39282843|FG002|Overall Study|Withdrawal by Subject|2|||
16218945|NCT00808132|39282844|FG003|Overall Study|Withdrawal by Subject|7|||
16341117|NCT01605825|39734547|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
16341118|NCT01605825|39734548|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
16341119|NCT01605825|39734547|FG000|Overall Study|Non-Compliance with Protocol|3|||
16341120|NCT01605825|39734548|FG001|Overall Study|Non-Compliance with Protocol|0|||
16341121|NCT01133704|39734549|FG000|Overall Study|Death|44|||
16341122|NCT01133704|39734550|FG001|Overall Study|Death|26|||
16341123|NCT01133704|39734549|FG000|Overall Study|Patient refused to continue|4|||
16341124|NCT01133704|39734550|FG001|Overall Study|Patient refused to continue|0|||
16341125|NCT01133704|39734549|FG000|Overall Study|Study Closure|1|||
16341126|NCT01133704|39734550|FG001|Overall Study|Study Closure|0|||
16107490|NCT03730662|38881327|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
16541841|NCT00855062|40446722|FG001|Step1|Adverse Event|1|||
16107491|NCT03730662|38881328|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
16107492|NCT03730662|38881329|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
16107493|NCT03730662|38881330|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
16107494|NCT02195479|38881331|FG000|Overall Study|Lost to Follow-up|3|||
16107495|NCT02195479|38881332|FG001|Overall Study|Lost to Follow-up|0|||
16107496|NCT02195479|38881331|FG000|Overall Study|Death|48|||
16107497|NCT02195479|38881332|FG001|Overall Study|Death|45|||
16541842|NCT00855062|40446721|FG000|Step1|Protocol Violation|1|||
16541843|NCT00855062|40446722|FG001|Step1|Protocol Violation|0|||
16541844|NCT00855062|40446721|FG000|Step1|Pregnancy|1|||
16541845|NCT00855062|40446722|FG001|Step1|Pregnancy|0|||
16341127|NCT02840474|39734558|FG000|Overall Study|Lost to Follow-up|1|||
16341128|NCT02840474|39734559|FG001|Overall Study|Lost to Follow-up|0|||
16341129|NCT04003623|39734562|FG000|Overall Study|Withdrawal by Subject|1|||
16341130|NCT04003623|39734563|FG001|Overall Study|Withdrawal by Subject|0|||
16341131|NCT02849171|39734574|FG000|Overall Study|Withdrawal by Subject|1|||
16341132|NCT02849171|39734574|FG000|Overall Study|Not treated|1|||
16341133|NCT04336475|39734576|FG000|Overall Study|pain|1|||
16341134|NCT04336475|39734577|FG001|Overall Study|pain|0|||
16541846|NCT00855062|40446721|FG000|Step1|Withdrawal by Subject|2|||
16541847|NCT00855062|40446722|FG001|Step1|Withdrawal by Subject|3|||
16541848|NCT00855062|40446721|FG000|Step2|Early Study Closure|6|||
16541849|NCT00855062|40446722|FG001|Step2|Early Study Closure|2|||
16541850|NCT00855062|40446721|FG000|Step2|Adverse Event|0|||
16541851|NCT00855062|40446722|FG001|Step2|Adverse Event|3|||
16541852|NCT00855062|40446721|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
16541853|NCT00855062|40446722|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
16541854|NCT01735201|40446723|FG000|Overall Study|Adverse Event|1|||
16541855|NCT01735201|40446724|FG001|Overall Study|Adverse Event|1|||
16541856|NCT01735201|40446725|FG002|Overall Study|Adverse Event|0|||
16541857|NCT01735201|40446726|FG003|Overall Study|Adverse Event|1|||
16541858|NCT01735201|40446727|FG004|Overall Study|Adverse Event|1|||
16541859|NCT01735201|40446728|FG005|Overall Study|Adverse Event|3|||
16541860|NCT01735201|40446729|FG006|Overall Study|Adverse Event|2|||
16541861|NCT01735201|40446730|FG007|Overall Study|Adverse Event|1|||
16541862|NCT01735201|40446723|FG000|Overall Study|Personal Reasons|1|||
16541863|NCT01735201|40446724|FG001|Overall Study|Personal Reasons|0|||
16541864|NCT01735201|40446725|FG002|Overall Study|Personal Reasons|0|||
16541865|NCT01735201|40446726|FG003|Overall Study|Personal Reasons|0|||
16541866|NCT01735201|40446727|FG004|Overall Study|Personal Reasons|0|||
16541867|NCT01735201|40446728|FG005|Overall Study|Personal Reasons|0|||
16541868|NCT01735201|40446729|FG006|Overall Study|Personal Reasons|0|||
16541869|NCT01735201|40446730|FG007|Overall Study|Personal Reasons|0|||
16541870|NCT01735201|40446723|FG000|Overall Study|Protocol Violation|1|||
16541871|NCT01735201|40446724|FG001|Overall Study|Protocol Violation|0|||
16541872|NCT01735201|40446725|FG002|Overall Study|Protocol Violation|0|||
16541873|NCT01735201|40446726|FG003|Overall Study|Protocol Violation|0|||
16541874|NCT01735201|40446727|FG004|Overall Study|Protocol Violation|0|||
16541875|NCT01735201|40446728|FG005|Overall Study|Protocol Violation|0|||
16541876|NCT01735201|40446729|FG006|Overall Study|Protocol Violation|0|||
16541877|NCT01735201|40446730|FG007|Overall Study|Protocol Violation|0|||
16541878|NCT01735201|40446723|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16541879|NCT01735201|40446724|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16218946|NCT00808132|39282845|FG004|Overall Study|Withdrawal by Subject|16|||
16341135|NCT04336475|39734576|FG000|Overall Study|upper respiratory infection|1|||
16341136|NCT04336475|39734577|FG001|Overall Study|upper respiratory infection|0|||
16341137|NCT04336475|39734576|FG000|Overall Study|Lost to Follow-up|0|||
16341138|NCT04336475|39734577|FG001|Overall Study|Lost to Follow-up|2|||
16341139|NCT03130959|39734581|FG000|Overall Study|Disease progression|19|||
16341140|NCT03130959|39734582|FG001|Overall Study|Disease progression|7|||
16341141|NCT03130959|39734583|FG002|Overall Study|Disease progression|12|||
16341142|NCT03130959|39734584|FG003|Overall Study|Disease progression|7|||
16341143|NCT03130959|39734585|FG004|Overall Study|Disease progression|12|||
16341144|NCT03130959|39734586|FG005|Overall Study|Disease progression|3|||
16541880|NCT01735201|40446725|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16541881|NCT01735201|40446726|FG003|Overall Study|Other Miscellaneous Reasons|1|||
16541882|NCT01735201|40446727|FG004|Overall Study|Other Miscellaneous Reasons|0|||
16541883|NCT01735201|40446728|FG005|Overall Study|Other Miscellaneous Reasons|2|||
16541884|NCT01735201|40446729|FG006|Overall Study|Other Miscellaneous Reasons|1|||
16541885|NCT01735201|40446730|FG007|Overall Study|Other Miscellaneous Reasons|1|||
16541886|NCT01122381|40446731|FG000|Overall Study|study terminated early|0|||
16541887|NCT01122381|40446732|FG001|Overall Study|study terminated early|1|||
16541888|NCT01844284|40446733|FG000|Overall Study|Lost to Follow-up|12|||
16341145|NCT03130959|39734587|FG006|Overall Study|Disease progression|6|||
16341146|NCT03130959|39734588|FG007|Overall Study|Disease progression|3|||
16341147|NCT03130959|39734589|FG008|Overall Study|Disease progression|15|||
16341148|NCT03130959|39734590|FG009|Overall Study|Disease progression|8|||
16341149|NCT03130959|39734581|FG000|Overall Study|Study drug toxicity|2|||
16341150|NCT03130959|39734582|FG001|Overall Study|Study drug toxicity|2|||
16341151|NCT03130959|39734583|FG002|Overall Study|Study drug toxicity|1|||
16218947|NCT00808132|39282841|FG000|Overall Study|Other|6|||
16218948|NCT00808132|39282842|FG001|Overall Study|Other|4|||
16218949|NCT00808132|39282843|FG002|Overall Study|Other|6|||
16218950|NCT00808132|39282844|FG003|Overall Study|Other|2|||
16218951|NCT00808132|39282845|FG004|Overall Study|Other|15|||
16218952|NCT00808132|39282841|FG000|Overall Study|Randomized, but not treated|10|||
16218953|NCT00808132|39282842|FG001|Overall Study|Randomized, but not treated|7|||
16218954|NCT00808132|39282843|FG002|Overall Study|Randomized, but not treated|9|||
16218955|NCT00808132|39282844|FG003|Overall Study|Randomized, but not treated|8|||
16218956|NCT00808132|39282845|FG004|Overall Study|Randomized, but not treated|9|||
16218957|NCT00808132|39282841|FG000|Overall Study|Unsatisfactory response|5|||
16218958|NCT00808132|39282842|FG001|Overall Study|Unsatisfactory response|6|||
16218959|NCT00808132|39282843|FG002|Overall Study|Unsatisfactory response|6|||
16218960|NCT00808132|39282844|FG003|Overall Study|Unsatisfactory response|4|||
16218961|NCT00808132|39282845|FG004|Overall Study|Unsatisfactory response|12|||
16218962|NCT00286234|39282848|FG000|Overall Study|Protocol Violation|1|||
16218963|NCT00286234|39282849|FG001|Overall Study|Protocol Violation|2|||
16218964|NCT00286234|39282850|FG002|Overall Study|Protocol Violation|0|||
16218965|NCT00286234|39282851|FG003|Overall Study|Protocol Violation|1|||
16218966|NCT00286234|39282848|FG000|Overall Study|Physician Decision|1|||
16218967|NCT00286234|39282849|FG001|Overall Study|Physician Decision|0|||
16218968|NCT00286234|39282850|FG002|Overall Study|Physician Decision|0|||
16218969|NCT00286234|39282851|FG003|Overall Study|Physician Decision|1|||
16218970|NCT00286234|39282848|FG000|Overall Study|Adverse Event|0|||
16218971|NCT00286234|39282849|FG001|Overall Study|Adverse Event|0|||
16218972|NCT00286234|39282850|FG002|Overall Study|Adverse Event|0|||
16218973|NCT00286234|39282851|FG003|Overall Study|Adverse Event|1|||
16218974|NCT00286234|39282848|FG000|Overall Study|Adverse Event|0|||
16218975|NCT00286234|39282849|FG001|Overall Study|Adverse Event|0|||
16218976|NCT00286234|39282850|FG002|Overall Study|Adverse Event|0|||
16218977|NCT00286234|39282851|FG003|Overall Study|Adverse Event|1|||
16218978|NCT03125902|39282856|FG000|Overall Study|Adverse Event|0|||
16218979|NCT03125902|39282857|FG001|Overall Study|Adverse Event|1|||
16218980|NCT03125902|39282856|FG000|Overall Study|Death|119|||
16218981|NCT03125902|39282857|FG001|Overall Study|Death|229|||
16218982|NCT03125902|39282856|FG000|Overall Study|Lost to Follow-up|4|||
16218983|NCT03125902|39282857|FG001|Overall Study|Lost to Follow-up|13|||
16218984|NCT03125902|39282856|FG000|Overall Study|Other|0|||
16218985|NCT03125902|39282857|FG001|Overall Study|Other|4|||
16218986|NCT03125902|39282856|FG000|Overall Study|Physician Decision|2|||
16341152|NCT03130959|39734584|FG003|Overall Study|Study drug toxicity|2|||
16218987|NCT03125902|39282857|FG001|Overall Study|Physician Decision|1|||
16341153|NCT03130959|39734585|FG004|Overall Study|Study drug toxicity|1|||
16218988|NCT03125902|39282856|FG000|Overall Study|Progressive Disease|0|||
16218989|NCT03125902|39282857|FG001|Overall Study|Progressive Disease|3|||
16218990|NCT03125902|39282856|FG000|Overall Study|Study Terminated By Sponsor|74|||
16218991|NCT03125902|39282857|FG001|Overall Study|Study Terminated By Sponsor|143|||
16218992|NCT03125902|39282856|FG000|Overall Study|Withdrawal by Subject|21|||
16341154|NCT03130959|39734586|FG005|Overall Study|Study drug toxicity|1|||
16341155|NCT03130959|39734587|FG006|Overall Study|Study drug toxicity|3|||
16218993|NCT03125902|39282857|FG001|Overall Study|Withdrawal by Subject|37|||
16218994|NCT02463331|39282858|FG000|Overall Study|Adverse Event|4|||
16218995|NCT02463331|39282859|FG001|Overall Study|Adverse Event|2|||
16218996|NCT02463331|39282858|FG000|Overall Study|Lost to Follow-up|1|||
16218997|NCT02463331|39282859|FG001|Overall Study|Lost to Follow-up|1|||
16218998|NCT02463331|39282858|FG000|Overall Study|Pregnancy|2|||
16218999|NCT02463331|39282859|FG001|Overall Study|Pregnancy|3|||
16219000|NCT02463331|39282858|FG000|Overall Study|Lack of Efficacy|6|||
16219001|NCT02463331|39282859|FG001|Overall Study|Lack of Efficacy|0|||
16219002|NCT02463331|39282858|FG000|Overall Study|Physician Decision|3|||
16219003|NCT02463331|39282859|FG001|Overall Study|Physician Decision|0|||
16219004|NCT01521494|39282860|FG000|Overall Study|Adverse Event|1|||
16219005|NCT01521494|39282861|FG001|Overall Study|Adverse Event|2|||
16219006|NCT01521494|39282862|FG002|Overall Study|Adverse Event|9|||
16219007|NCT01521494|39282863|FG003|Overall Study|Adverse Event|6|||
16219008|NCT01521494|39282864|FG004|Overall Study|Adverse Event|2|||
16219009|NCT01521494|39282860|FG000|Overall Study|Lack of Efficacy|0|||
16219010|NCT01521494|39282861|FG001|Overall Study|Lack of Efficacy|0|||
16219011|NCT01521494|39282862|FG002|Overall Study|Lack of Efficacy|0|||
16219012|NCT01521494|39282863|FG003|Overall Study|Lack of Efficacy|0|||
16219013|NCT01521494|39282864|FG004|Overall Study|Lack of Efficacy|2|||
16219014|NCT01521494|39282860|FG000|Overall Study|Withdrawal by Subject|1|||
16219015|NCT01521494|39282861|FG001|Overall Study|Withdrawal by Subject|1|||
16219016|NCT01521494|39282862|FG002|Overall Study|Withdrawal by Subject|0|||
16219017|NCT01521494|39282863|FG003|Overall Study|Withdrawal by Subject|2|||
16219018|NCT01521494|39282864|FG004|Overall Study|Withdrawal by Subject|0|||
16219019|NCT01521494|39282860|FG000|Overall Study|Decrease in serum phosphate|0|||
16219020|NCT01521494|39282861|FG001|Overall Study|Decrease in serum phosphate|2|||
16219021|NCT01521494|39282862|FG002|Overall Study|Decrease in serum phosphate|3|||
16219022|NCT01521494|39282863|FG003|Overall Study|Decrease in serum phosphate|12|||
16219023|NCT01521494|39282864|FG004|Overall Study|Decrease in serum phosphate|0|||
16219024|NCT01521494|39282860|FG000|Overall Study|Decrease in serum calcium|0|||
16219025|NCT01521494|39282861|FG001|Overall Study|Decrease in serum calcium|0|||
16219026|NCT01521494|39282862|FG002|Overall Study|Decrease in serum calcium|0|||
16219027|NCT01521494|39282863|FG003|Overall Study|Decrease in serum calcium|1|||
16219028|NCT01521494|39282864|FG004|Overall Study|Decrease in serum calcium|1|||
16219029|NCT01521494|39282860|FG000|Overall Study|Physician Decision|0|||
16219030|NCT01521494|39282861|FG001|Overall Study|Physician Decision|0|||
16219031|NCT01521494|39282862|FG002|Overall Study|Physician Decision|0|||
16219032|NCT01521494|39282863|FG003|Overall Study|Physician Decision|0|||
16219033|NCT01521494|39282864|FG004|Overall Study|Physician Decision|2|||
16219034|NCT01512693|39282865|FG000|Overall Study|Withdrawal by Subject|0|||
16219035|NCT01512693|39282866|FG001|Overall Study|Withdrawal by Subject|1|||
16219036|NCT01950364|39282867|FG000|Overall Study|Adverse Event|3|||
16219037|NCT01950364|39282868|FG001|Overall Study|Adverse Event|0|||
16219038|NCT01950364|39282867|FG000|Overall Study|Stem Cell Transplant|2|||
16219039|NCT01950364|39282868|FG001|Overall Study|Stem Cell Transplant|6|||
16219040|NCT01950364|39282867|FG000|Overall Study|Disease Progression|5|||
16219041|NCT01950364|39282868|FG001|Overall Study|Disease Progression|2|||
16219042|NCT01950364|39282867|FG000|Overall Study|Withdrawal by Subject|0|||
16219043|NCT01950364|39282868|FG001|Overall Study|Withdrawal by Subject|1|||
16219044|NCT01950364|39282867|FG000|Overall Study|Protocol Violation|0|||
16219045|NCT01950364|39282868|FG001|Overall Study|Protocol Violation|1|||
16219046|NCT00775138|39282869|FG000|Overall Study|Withdrawal by Subject|0|||
16219047|NCT00775138|39282870|FG001|Overall Study|Withdrawal by Subject|0|||
16219048|NCT00775138|39282871|FG002|Overall Study|Withdrawal by Subject|2|||
16219049|NCT00775138|39282872|FG003|Overall Study|Withdrawal by Subject|2|||
16219050|NCT00775138|39282869|FG000|Overall Study|Adverse Event|0|||
16219051|NCT00775138|39282870|FG001|Overall Study|Adverse Event|0|||
16219052|NCT00775138|39282871|FG002|Overall Study|Adverse Event|1|||
16219053|NCT00775138|39282872|FG003|Overall Study|Adverse Event|0|||
16219054|NCT01957111|39282873|FG000|Overall Study|Withdrawal by Subject|1|||
16219055|NCT01957111|39282874|FG001|Overall Study|Withdrawal by Subject|1|||
16107498|NCT02195479|38881331|FG000|Overall Study|Physician Decision|1|||
16219056|NCT00413231|39282876|FG000|0 to 30-day Post Treatment|Death|5|||
16219057|NCT00413231|39282876|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
16219058|NCT00413231|39282876|FG000|30-day to 365-day Post Treatment|Death|13|||
16219059|NCT00413231|39282876|FG000|365-day to 60-month Post Treatment|Death|36|||
16219060|NCT00413231|39282876|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
16219061|NCT00413231|39282876|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
16219062|NCT00413231|39282876|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
16219063|NCT04815291|39282877|FG000|Overall Study|Lost to Follow-up|1|||
16219064|NCT04815291|39282877|FG000|Overall Study|Physician Decision|4|||
16219065|NCT04815291|39282877|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
16219066|NCT05158244|39282878|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
16219067|NCT05158244|39282879|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
16219068|NCT05158244|39282880|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
16219069|NCT05158244|39282881|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
16219070|NCT05158244|39282882|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
16219071|NCT05158244|39282878|FG000|Overall Study|Withdrawal by Subject|0|||
16219072|NCT05158244|39282879|FG001|Overall Study|Withdrawal by Subject|0|||
16219073|NCT05158244|39282880|FG002|Overall Study|Withdrawal by Subject|1|||
16219074|NCT05158244|39282881|FG003|Overall Study|Withdrawal by Subject|0|||
16219075|NCT05158244|39282882|FG004|Overall Study|Withdrawal by Subject|0|||
16219076|NCT02394028|39282886|FG000|Induction Phase|Adverse Event|2|||
16219077|NCT02394028|39282887|FG001|Induction Phase|Adverse Event|4|||
16219078|NCT02394028|39282888|FG002|Induction Phase|Adverse Event|1|||
16219079|NCT02394028|39282889|FG003|Induction Phase|Adverse Event|2|||
16219080|NCT02394028|39282890|FG004|Induction Phase|Adverse Event|5|||
16219081|NCT02394028|39282891|FG005|Induction Phase|Adverse Event|2|||
16219082|NCT02394028|39282892|FG006|Induction Phase|Adverse Event|0|||
16219083|NCT02394028|39282893|FG007|Induction Phase|Adverse Event|0|||
16219084|NCT02394028|39282894|FG008|Induction Phase|Adverse Event|0|||
16219085|NCT02394028|39282895|FG009|Induction Phase|Adverse Event|0|||
16219086|NCT02394028|39282896|FG010|Induction Phase|Adverse Event|0|||
16219087|NCT02394028|39282886|FG000|Induction Phase|Lack of Efficacy|3|||
16219088|NCT02394028|39282887|FG001|Induction Phase|Lack of Efficacy|6|||
16219089|NCT02394028|39282888|FG002|Induction Phase|Lack of Efficacy|2|||
16219090|NCT02394028|39282889|FG003|Induction Phase|Lack of Efficacy|17|||
16219091|NCT02394028|39282890|FG004|Induction Phase|Lack of Efficacy|14|||
16219092|NCT02394028|39282891|FG005|Induction Phase|Lack of Efficacy|8|||
16219093|NCT02394028|39282892|FG006|Induction Phase|Lack of Efficacy|17|||
16219094|NCT02394028|39282893|FG007|Induction Phase|Lack of Efficacy|23|||
16219095|NCT02394028|39282894|FG008|Induction Phase|Lack of Efficacy|0|||
16219096|NCT02394028|39282895|FG009|Induction Phase|Lack of Efficacy|0|||
16219097|NCT02394028|39282896|FG010|Induction Phase|Lack of Efficacy|0|||
16219098|NCT02394028|39282886|FG000|Induction Phase|Lost to Follow-up|1|||
16219099|NCT02394028|39282887|FG001|Induction Phase|Lost to Follow-up|0|||
16219100|NCT02394028|39282888|FG002|Induction Phase|Lost to Follow-up|0|||
16219101|NCT02394028|39282889|FG003|Induction Phase|Lost to Follow-up|1|||
16219102|NCT02394028|39282890|FG004|Induction Phase|Lost to Follow-up|0|||
16219103|NCT02394028|39282891|FG005|Induction Phase|Lost to Follow-up|0|||
16219104|NCT02394028|39282892|FG006|Induction Phase|Lost to Follow-up|1|||
16219105|NCT02394028|39282893|FG007|Induction Phase|Lost to Follow-up|0|||
16219106|NCT02394028|39282894|FG008|Induction Phase|Lost to Follow-up|0|||
16219107|NCT02394028|39282895|FG009|Induction Phase|Lost to Follow-up|0|||
16219108|NCT02394028|39282896|FG010|Induction Phase|Lost to Follow-up|0|||
16219109|NCT02394028|39282886|FG000|Induction Phase|Non-compliance|0|||
16219110|NCT02394028|39282887|FG001|Induction Phase|Non-compliance|1|||
16219111|NCT02394028|39282888|FG002|Induction Phase|Non-compliance|3|||
16219112|NCT02394028|39282889|FG003|Induction Phase|Non-compliance|1|||
16219113|NCT02394028|39282890|FG004|Induction Phase|Non-compliance|3|||
16219114|NCT02394028|39282891|FG005|Induction Phase|Non-compliance|0|||
16219115|NCT02394028|39282892|FG006|Induction Phase|Non-compliance|1|||
16219116|NCT02394028|39282893|FG007|Induction Phase|Non-compliance|1|||
16219117|NCT02394028|39282894|FG008|Induction Phase|Non-compliance|0|||
16219118|NCT02394028|39282895|FG009|Induction Phase|Non-compliance|0|||
16219119|NCT02394028|39282896|FG010|Induction Phase|Non-compliance|0|||
16219120|NCT02394028|39282886|FG000|Induction Phase|Physician Decision|0|||
16219121|NCT02394028|39282887|FG001|Induction Phase|Physician Decision|0|||
16219122|NCT02394028|39282888|FG002|Induction Phase|Physician Decision|1|||
16219123|NCT02394028|39282889|FG003|Induction Phase|Physician Decision|4|||
16219124|NCT02394028|39282890|FG004|Induction Phase|Physician Decision|0|||
16219125|NCT02394028|39282891|FG005|Induction Phase|Physician Decision|2|||
16219126|NCT02394028|39282892|FG006|Induction Phase|Physician Decision|1|||
16219127|NCT02394028|39282893|FG007|Induction Phase|Physician Decision|0|||
16219128|NCT02394028|39282894|FG008|Induction Phase|Physician Decision|0|||
16219129|NCT02394028|39282895|FG009|Induction Phase|Physician Decision|0|||
16219130|NCT02394028|39282896|FG010|Induction Phase|Physician Decision|0|||
16219131|NCT02394028|39282886|FG000|Induction Phase|Protocol Violation|0|||
16219132|NCT02394028|39282887|FG001|Induction Phase|Protocol Violation|2|||
16219133|NCT02394028|39282888|FG002|Induction Phase|Protocol Violation|0|||
16219134|NCT02394028|39282889|FG003|Induction Phase|Protocol Violation|3|||
16219135|NCT02394028|39282890|FG004|Induction Phase|Protocol Violation|0|||
16219136|NCT02394028|39282891|FG005|Induction Phase|Protocol Violation|1|||
16219137|NCT02394028|39282892|FG006|Induction Phase|Protocol Violation|1|||
16219138|NCT02394028|39282893|FG007|Induction Phase|Protocol Violation|0|||
16219139|NCT02394028|39282894|FG008|Induction Phase|Protocol Violation|0|||
16541889|NCT01844284|40446734|FG001|Overall Study|Lost to Follow-up|7|||
16541890|NCT01224158|40446735|FG000|Overall Study|Withdrawal by Subject|1|||
16541891|NCT01224158|40446736|FG001|Overall Study|Withdrawal by Subject|0|||
16541892|NCT00685945|40446737|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
16541893|NCT02691182|40446741|FG000|Overall Study|Withdrawal by Subject|4|||
16541894|NCT02691182|40446742|FG001|Overall Study|Withdrawal by Subject|7|||
16541895|NCT02691182|40446743|FG002|Overall Study|Withdrawal by Subject|6|||
16541896|NCT02691182|40446744|FG003|Overall Study|Withdrawal by Subject|8|||
16541897|NCT02691182|40446741|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
16541898|NCT02691182|40446742|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
16541899|NCT02691182|40446743|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
16541900|NCT02691182|40446744|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
16541901|NCT02691182|40446741|FG000|Overall Study|Lost to Follow-up|8|||
16541902|NCT02691182|40446742|FG001|Overall Study|Lost to Follow-up|33|||
16541903|NCT02691182|40446743|FG002|Overall Study|Lost to Follow-up|19|||
16541904|NCT02691182|40446744|FG003|Overall Study|Lost to Follow-up|22|||
16219140|NCT02394028|39282895|FG009|Induction Phase|Protocol Violation|0|||
16219141|NCT02394028|39282896|FG010|Induction Phase|Protocol Violation|0|||
16219142|NCT02394028|39282886|FG000|Induction Phase|Withdrawal by Subject|1|||
16219143|NCT02394028|39282887|FG001|Induction Phase|Withdrawal by Subject|2|||
16219144|NCT02394028|39282888|FG002|Induction Phase|Withdrawal by Subject|4|||
16219145|NCT02394028|39282889|FG003|Induction Phase|Withdrawal by Subject|6|||
16219146|NCT02394028|39282890|FG004|Induction Phase|Withdrawal by Subject|7|||
16219147|NCT02394028|39282891|FG005|Induction Phase|Withdrawal by Subject|4|||
16219148|NCT02394028|39282892|FG006|Induction Phase|Withdrawal by Subject|3|||
16219149|NCT02394028|39282893|FG007|Induction Phase|Withdrawal by Subject|6|||
16219150|NCT02394028|39282894|FG008|Induction Phase|Withdrawal by Subject|0|||
16219151|NCT02394028|39282895|FG009|Induction Phase|Withdrawal by Subject|0|||
16219152|NCT02394028|39282896|FG010|Induction Phase|Withdrawal by Subject|0|||
16219153|NCT02394028|39282886|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
16219154|NCT02394028|39282887|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
16219155|NCT02394028|39282888|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
16219156|NCT02394028|39282889|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
16219157|NCT02394028|39282890|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
16219158|NCT02394028|39282891|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
16219159|NCT02394028|39282892|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
16219160|NCT02394028|39282893|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
16219161|NCT02394028|39282894|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
16219162|NCT02394028|39282895|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
16219163|NCT02394028|39282896|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
16219164|NCT02394028|39282886|FG000|Induction Phase|Sponsor decision|0|||
16219165|NCT02394028|39282887|FG001|Induction Phase|Sponsor decision|1|||
16219166|NCT02394028|39282888|FG002|Induction Phase|Sponsor decision|2|||
16219167|NCT02394028|39282889|FG003|Induction Phase|Sponsor decision|0|||
16219168|NCT02394028|39282890|FG004|Induction Phase|Sponsor decision|0|||
16219169|NCT02394028|39282891|FG005|Induction Phase|Sponsor decision|0|||
16219170|NCT02394028|39282892|FG006|Induction Phase|Sponsor decision|0|||
16219171|NCT02394028|39282893|FG007|Induction Phase|Sponsor decision|0|||
16219172|NCT02394028|39282894|FG008|Induction Phase|Sponsor decision|0|||
16219173|NCT02394028|39282895|FG009|Induction Phase|Sponsor decision|0|||
16219174|NCT02394028|39282896|FG010|Induction Phase|Sponsor decision|0|||
16219175|NCT02394028|39282886|FG000|Induction Phase|Technical reason|0|||
16219176|NCT02394028|39282887|FG001|Induction Phase|Technical reason|0|||
16219177|NCT02394028|39282888|FG002|Induction Phase|Technical reason|0|||
16219178|NCT02394028|39282889|FG003|Induction Phase|Technical reason|1|||
16219179|NCT02394028|39282890|FG004|Induction Phase|Technical reason|0|||
16219180|NCT02394028|39282891|FG005|Induction Phase|Technical reason|0|||
16219181|NCT02394028|39282892|FG006|Induction Phase|Technical reason|0|||
16541905|NCT02691182|40446741|FG000|Overall Study|Adverse Event|3|||
16541906|NCT02691182|40446742|FG001|Overall Study|Adverse Event|10|||
16219182|NCT02394028|39282893|FG007|Induction Phase|Technical reason|0|||
16219183|NCT02394028|39282894|FG008|Induction Phase|Technical reason|0|||
16219184|NCT02394028|39282895|FG009|Induction Phase|Technical reason|0|||
16219185|NCT02394028|39282896|FG010|Induction Phase|Technical reason|0|||
16219186|NCT02394028|39282886|FG000|Induction Phase|:ack of calculation|0|||
16219187|NCT02394028|39282887|FG001|Induction Phase|:ack of calculation|0|||
16219188|NCT02394028|39282888|FG002|Induction Phase|:ack of calculation|0|||
16219189|NCT02394028|39282889|FG003|Induction Phase|:ack of calculation|0|||
16219190|NCT02394028|39282890|FG004|Induction Phase|:ack of calculation|0|||
16219191|NCT02394028|39282891|FG005|Induction Phase|:ack of calculation|0|||
16219192|NCT02394028|39282892|FG006|Induction Phase|:ack of calculation|0|||
16219193|NCT02394028|39282893|FG007|Induction Phase|:ack of calculation|1|||
16219194|NCT02394028|39282894|FG008|Induction Phase|:ack of calculation|0|||
16219195|NCT02394028|39282895|FG009|Induction Phase|:ack of calculation|0|||
16219196|NCT02394028|39282896|FG010|Induction Phase|:ack of calculation|0|||
16219197|NCT02394028|39282886|FG000|Maintenance Phase|Protocol Violation|0|||
16219198|NCT02394028|39282887|FG001|Maintenance Phase|Protocol Violation|0|||
16219199|NCT02394028|39282888|FG002|Maintenance Phase|Protocol Violation|0|||
16219200|NCT02394028|39282889|FG003|Maintenance Phase|Protocol Violation|0|||
16219201|NCT02394028|39282890|FG004|Maintenance Phase|Protocol Violation|0|||
16219202|NCT02394028|39282891|FG005|Maintenance Phase|Protocol Violation|0|||
16219203|NCT02394028|39282892|FG006|Maintenance Phase|Protocol Violation|0|||
16219204|NCT02394028|39282893|FG007|Maintenance Phase|Protocol Violation|0|||
16219205|NCT02394028|39282894|FG008|Maintenance Phase|Protocol Violation|0|||
16219206|NCT02394028|39282895|FG009|Maintenance Phase|Protocol Violation|0|||
16219207|NCT02394028|39282896|FG010|Maintenance Phase|Protocol Violation|1|||
16219208|NCT02394028|39282886|FG000|Maintenance Phase|Physician Decision|0|||
16219209|NCT02394028|39282887|FG001|Maintenance Phase|Physician Decision|0|||
16219210|NCT02394028|39282888|FG002|Maintenance Phase|Physician Decision|0|||
16219211|NCT02394028|39282889|FG003|Maintenance Phase|Physician Decision|0|||
16219212|NCT02394028|39282890|FG004|Maintenance Phase|Physician Decision|0|||
16219213|NCT02394028|39282891|FG005|Maintenance Phase|Physician Decision|0|||
16219214|NCT02394028|39282892|FG006|Maintenance Phase|Physician Decision|0|||
16219215|NCT02394028|39282893|FG007|Maintenance Phase|Physician Decision|0|||
16219216|NCT02394028|39282894|FG008|Maintenance Phase|Physician Decision|1|||
16219217|NCT02394028|39282895|FG009|Maintenance Phase|Physician Decision|3|||
16219218|NCT02394028|39282896|FG010|Maintenance Phase|Physician Decision|2|||
16219219|NCT02394028|39282886|FG000|Maintenance Phase|Lack of Efficacy|0|||
16219220|NCT02394028|39282887|FG001|Maintenance Phase|Lack of Efficacy|0|||
16219221|NCT02394028|39282888|FG002|Maintenance Phase|Lack of Efficacy|0|||
16219222|NCT02394028|39282889|FG003|Maintenance Phase|Lack of Efficacy|0|||
16219223|NCT02394028|39282890|FG004|Maintenance Phase|Lack of Efficacy|0|||
16219224|NCT02394028|39282891|FG005|Maintenance Phase|Lack of Efficacy|0|||
16219225|NCT02394028|39282892|FG006|Maintenance Phase|Lack of Efficacy|0|||
16219226|NCT02394028|39282893|FG007|Maintenance Phase|Lack of Efficacy|0|||
16219227|NCT02394028|39282894|FG008|Maintenance Phase|Lack of Efficacy|7|||
16219228|NCT02394028|39282895|FG009|Maintenance Phase|Lack of Efficacy|25|||
16219229|NCT02394028|39282896|FG010|Maintenance Phase|Lack of Efficacy|33|||
16219230|NCT02394028|39282886|FG000|Maintenance Phase|Death|0|||
16219231|NCT02394028|39282887|FG001|Maintenance Phase|Death|0|||
16219232|NCT02394028|39282888|FG002|Maintenance Phase|Death|0|||
16219233|NCT02394028|39282889|FG003|Maintenance Phase|Death|0|||
16219234|NCT02394028|39282890|FG004|Maintenance Phase|Death|0|||
16219235|NCT02394028|39282891|FG005|Maintenance Phase|Death|0|||
16219236|NCT02394028|39282892|FG006|Maintenance Phase|Death|0|||
16219237|NCT02394028|39282893|FG007|Maintenance Phase|Death|0|||
16219238|NCT02394028|39282894|FG008|Maintenance Phase|Death|0|||
16219239|NCT02394028|39282895|FG009|Maintenance Phase|Death|0|||
16219240|NCT02394028|39282896|FG010|Maintenance Phase|Death|1|||
16219241|NCT02394028|39282886|FG000|Maintenance Phase|Adverse Event|0|||
16219242|NCT02394028|39282887|FG001|Maintenance Phase|Adverse Event|0|||
16219243|NCT02394028|39282888|FG002|Maintenance Phase|Adverse Event|0|||
16219244|NCT02394028|39282889|FG003|Maintenance Phase|Adverse Event|0|||
16219245|NCT02394028|39282890|FG004|Maintenance Phase|Adverse Event|0|||
16219246|NCT02394028|39282891|FG005|Maintenance Phase|Adverse Event|0|||
16219247|NCT02394028|39282892|FG006|Maintenance Phase|Adverse Event|0|||
16219248|NCT02394028|39282893|FG007|Maintenance Phase|Adverse Event|0|||
16219249|NCT02394028|39282894|FG008|Maintenance Phase|Adverse Event|1|||
16219250|NCT02394028|39282895|FG009|Maintenance Phase|Adverse Event|1|||
16219251|NCT02394028|39282896|FG010|Maintenance Phase|Adverse Event|3|||
16219252|NCT02394028|39282886|FG000|Maintenance Phase|Site closure|0|||
16219253|NCT02394028|39282887|FG001|Maintenance Phase|Site closure|0|||
16219254|NCT02394028|39282888|FG002|Maintenance Phase|Site closure|0|||
16219255|NCT02394028|39282889|FG003|Maintenance Phase|Site closure|0|||
16219256|NCT02394028|39282890|FG004|Maintenance Phase|Site closure|0|||
16219257|NCT02394028|39282891|FG005|Maintenance Phase|Site closure|0|||
16219258|NCT02394028|39282892|FG006|Maintenance Phase|Site closure|0|||
16219259|NCT02394028|39282893|FG007|Maintenance Phase|Site closure|0|||
16219260|NCT02394028|39282894|FG008|Maintenance Phase|Site closure|0|||
16219261|NCT02394028|39282895|FG009|Maintenance Phase|Site closure|1|||
16219262|NCT02394028|39282896|FG010|Maintenance Phase|Site closure|0|||
16219263|NCT02394028|39282886|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16219264|NCT02394028|39282887|FG001|Maintenance Phase|Withdrawal by Subject|0|||
16219265|NCT02394028|39282888|FG002|Maintenance Phase|Withdrawal by Subject|0|||
16219266|NCT02394028|39282889|FG003|Maintenance Phase|Withdrawal by Subject|0|||
16219267|NCT02394028|39282890|FG004|Maintenance Phase|Withdrawal by Subject|0|||
16219268|NCT02394028|39282891|FG005|Maintenance Phase|Withdrawal by Subject|0|||
16219269|NCT02394028|39282892|FG006|Maintenance Phase|Withdrawal by Subject|0|||
16219270|NCT02394028|39282893|FG007|Maintenance Phase|Withdrawal by Subject|0|||
16219271|NCT02394028|39282894|FG008|Maintenance Phase|Withdrawal by Subject|3|||
16219272|NCT02394028|39282895|FG009|Maintenance Phase|Withdrawal by Subject|12|||
16219273|NCT02394028|39282896|FG010|Maintenance Phase|Withdrawal by Subject|12|||
16219274|NCT02658149|39282897|FG000|Overall Study|Physician Decision|1|||
16219275|NCT02658149|39282898|FG001|Overall Study|Physician Decision|0|||
16219276|NCT02531633|39282899|FG000|Part A (52 Weeks)|Sponsor request|24|||
16219277|NCT02531633|39282900|FG001|Part A (52 Weeks)|Sponsor request|24|||
16219278|NCT02531633|39282901|FG002|Part A (52 Weeks)|Sponsor request|18|||
16219279|NCT02531633|39282902|FG003|Part A (52 Weeks)|Sponsor request|18|||
16219280|NCT02531633|39282903|FG004|Part A (52 Weeks)|Sponsor request|19|||
16219281|NCT02531633|39282904|FG005|Part A (52 Weeks)|Sponsor request|0|||
16219282|NCT02531633|39282905|FG006|Part A (52 Weeks)|Sponsor request|0|||
16219283|NCT02531633|39282906|FG007|Part A (52 Weeks)|Sponsor request|0|||
16219284|NCT02531633|39282907|FG008|Part A (52 Weeks)|Sponsor request|0|||
16219285|NCT02531633|39282908|FG009|Part A (52 Weeks)|Sponsor request|0|||
16219286|NCT02531633|39282899|FG000|Part A (52 Weeks)|Protocol Violation|1|||
16219287|NCT02531633|39282900|FG001|Part A (52 Weeks)|Protocol Violation|0|||
16219288|NCT02531633|39282901|FG002|Part A (52 Weeks)|Protocol Violation|0|||
16219289|NCT02531633|39282902|FG003|Part A (52 Weeks)|Protocol Violation|0|||
16219290|NCT02531633|39282903|FG004|Part A (52 Weeks)|Protocol Violation|0|||
16219291|NCT02531633|39282904|FG005|Part A (52 Weeks)|Protocol Violation|0|||
16219292|NCT02531633|39282905|FG006|Part A (52 Weeks)|Protocol Violation|0|||
16219293|NCT02531633|39282906|FG007|Part A (52 Weeks)|Protocol Violation|0|||
16219294|NCT02531633|39282907|FG008|Part A (52 Weeks)|Protocol Violation|0|||
16219295|NCT02531633|39282908|FG009|Part A (52 Weeks)|Protocol Violation|0|||
16219296|NCT02531633|39282899|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
16219297|NCT02531633|39282900|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
16219298|NCT02531633|39282901|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
16219299|NCT02531633|39282902|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
16219300|NCT02531633|39282903|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
16219301|NCT02531633|39282904|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
16219302|NCT02531633|39282905|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
16541907|NCT02691182|40446743|FG002|Overall Study|Adverse Event|10|||
16541908|NCT02691182|40446744|FG003|Overall Study|Adverse Event|11|||
16219303|NCT02531633|39282906|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
16219304|NCT02531633|39282907|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
16219305|NCT02531633|39282908|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
16219306|NCT02531633|39282899|FG000|Part A (52 Weeks)|Physician Decision|1|||
16219307|NCT02531633|39282900|FG001|Part A (52 Weeks)|Physician Decision|4|||
16219308|NCT02531633|39282901|FG002|Part A (52 Weeks)|Physician Decision|3|||
16341156|NCT03130959|39734588|FG007|Overall Study|Study drug toxicity|0|||
16541909|NCT02691182|40446741|FG000|Overall Study|Physician Decision|3|||
16541910|NCT02691182|40446742|FG001|Overall Study|Physician Decision|7|||
16541911|NCT02691182|40446743|FG002|Overall Study|Physician Decision|14|||
16541912|NCT02691182|40446744|FG003|Overall Study|Physician Decision|8|||
16541913|NCT02691182|40446741|FG000|Overall Study|Lack of Efficacy|0|||
16541914|NCT02691182|40446742|FG001|Overall Study|Lack of Efficacy|0|||
16541915|NCT02691182|40446743|FG002|Overall Study|Lack of Efficacy|0|||
16541916|NCT02691182|40446744|FG003|Overall Study|Lack of Efficacy|4|||
16541917|NCT02691182|40446741|FG000|Overall Study|Protocol Violation|2|||
16541918|NCT02691182|40446742|FG001|Overall Study|Protocol Violation|6|||
16541919|NCT02691182|40446743|FG002|Overall Study|Protocol Violation|6|||
16541920|NCT02691182|40446744|FG003|Overall Study|Protocol Violation|8|||
16541921|NCT02691182|40446741|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
16541922|NCT02691182|40446742|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
16541923|NCT02691182|40446743|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
16541924|NCT02691182|40446744|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
16541925|NCT02691182|40446741|FG000|Overall Study|Missing|0|||
16541926|NCT02691182|40446742|FG001|Overall Study|Missing|5|||
16541927|NCT02691182|40446743|FG002|Overall Study|Missing|1|||
16541928|NCT02691182|40446744|FG003|Overall Study|Missing|5|||
16541929|NCT00659490|40446745|FG000|Overall Study|Lost to Follow-up|2|||
16219309|NCT02531633|39282902|FG003|Part A (52 Weeks)|Physician Decision|1|||
16219310|NCT02531633|39282903|FG004|Part A (52 Weeks)|Physician Decision|0|||
16219311|NCT02531633|39282904|FG005|Part A (52 Weeks)|Physician Decision|0|||
16219312|NCT02531633|39282905|FG006|Part A (52 Weeks)|Physician Decision|0|||
16219313|NCT02531633|39282906|FG007|Part A (52 Weeks)|Physician Decision|0|||
16341157|NCT03130959|39734589|FG008|Overall Study|Study drug toxicity|3|||
16219314|NCT02531633|39282907|FG008|Part A (52 Weeks)|Physician Decision|0|||
16219315|NCT02531633|39282908|FG009|Part A (52 Weeks)|Physician Decision|0|||
16541930|NCT00659490|40446746|FG001|Overall Study|Lost to Follow-up|0|||
16541931|NCT00659490|40446747|FG002|Overall Study|Lost to Follow-up|1|||
16219316|NCT02531633|39282899|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
16219317|NCT02531633|39282900|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
16219318|NCT02531633|39282901|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
16219319|NCT02531633|39282902|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
16219320|NCT02531633|39282903|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
16541932|NCT00621543|40446748|FG000|Overall Study|Lost to Follow-up|23|||
16541933|NCT02347657|40446754|FG000|Overall Study|Physician Decision|0|||
16541934|NCT02347657|40446755|FG001|Overall Study|Physician Decision|1|||
16541935|NCT02347657|40446754|FG000|Overall Study|Adverse Event|8|||
16541936|NCT02347657|40446755|FG001|Overall Study|Adverse Event|4|||
16541937|NCT02347657|40446754|FG000|Overall Study|Withdrawal by Subject|6|||
16541938|NCT02347657|40446755|FG001|Overall Study|Withdrawal by Subject|7|||
16541939|NCT02347657|40446754|FG000|Overall Study|Randomized but not treated|1|||
16541940|NCT02347657|40446755|FG001|Overall Study|Randomized but not treated|0|||
16541941|NCT02347657|40446754|FG000|Overall Study|Other|3|||
16541942|NCT02347657|40446755|FG001|Overall Study|Other|3|||
16541943|NCT01696981|40446756|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
16541944|NCT01696981|40446757|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
16541945|NCT01696981|40446756|FG000|Overall Study|Died Before Randomization|3|||
16219321|NCT02531633|39282904|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
16219322|NCT02531633|39282905|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
16341158|NCT03130959|39734590|FG009|Overall Study|Study drug toxicity|3|||
16541946|NCT01696981|40446757|FG001|Overall Study|Died Before Randomization|8|||
16541947|NCT01696981|40446756|FG000|Overall Study|Died Before ASU (Control)|278|||
16341159|NCT03130959|39734581|FG000|Overall Study|Other reasons|0|||
16541948|NCT01696981|40446757|FG001|Overall Study|Died Before ASU (Control)|0|||
16541949|NCT01696981|40446756|FG000|Overall Study|Refused ASU (Control)|920|||
16541950|NCT01696981|40446757|FG001|Overall Study|Refused ASU (Control)|0|||
16107499|NCT02195479|38881332|FG001|Overall Study|Physician Decision|0|||
16107500|NCT02195479|38881331|FG000|Overall Study|Withdrawal by Subject|11|||
16107501|NCT02195479|38881332|FG001|Overall Study|Withdrawal by Subject|6|||
16107502|NCT02195479|38881331|FG000|Overall Study|Other|2|||
16107503|NCT02195479|38881332|FG001|Overall Study|Other|2|||
16107504|NCT02195479|38881331|FG000|Overall Study|Ongoing|291|||
16107505|NCT02195479|38881332|FG001|Overall Study|Ongoing|297|||
16107506|NCT01264887|38881335|FG000|Overall Study|Adverse Event|5|||
16107507|NCT01264887|38881335|FG000|Overall Study|Death|7|||
16107508|NCT01264887|38881335|FG000|Overall Study|Lack of Efficacy|5|||
16107509|NCT01264887|38881335|FG000|Overall Study|Physician Decision|4|||
16107510|NCT01264887|38881335|FG000|Overall Study|Withdrawal by Subject|6|||
16107511|NCT01264887|38881335|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
16107512|NCT01264887|38881335|FG000|Overall Study|Other|2|||
16107513|NCT01960348|38881341|FG000|Overall Study|Adverse event, not serious|2|||
16107514|NCT01960348|38881342|FG001|Overall Study|Adverse event, not serious|2|||
16107515|NCT01960348|38881341|FG000|Overall Study|Adverse event, serious fatal|6|||
16107516|NCT01960348|38881342|FG001|Overall Study|Adverse event, serious fatal|5|||
16107517|NCT01960348|38881341|FG000|Overall Study|Adverse event, serious non-fatal|0|||
16107518|NCT01960348|38881342|FG001|Overall Study|Adverse event, serious non-fatal|3|||
16107519|NCT01960348|38881341|FG000|Overall Study|Withdrawal by Subject|1|||
16107520|NCT01960348|38881342|FG001|Overall Study|Withdrawal by Subject|11|||
16107521|NCT01960348|38881341|FG000|Overall Study|Physician Decision|0|||
16107522|NCT01960348|38881342|FG001|Overall Study|Physician Decision|1|||
16107523|NCT01960348|38881341|FG000|Overall Study|Protocol Violation|1|||
16107524|NCT01960348|38881342|FG001|Overall Study|Protocol Violation|0|||
16107525|NCT01713998|38881343|FG000|Overall Study|Lost to Follow-up|2|||
16107526|NCT01713998|38881344|FG001|Overall Study|Lost to Follow-up|0|||
16107527|NCT01713998|38881345|FG002|Overall Study|Lost to Follow-up|2|||
16341160|NCT03130959|39734582|FG001|Overall Study|Other reasons|0|||
16341161|NCT03130959|39734583|FG002|Overall Study|Other reasons|0|||
16341162|NCT03130959|39734584|FG003|Overall Study|Other reasons|0|||
16341163|NCT03130959|39734585|FG004|Overall Study|Other reasons|0|||
16107528|NCT01713998|38881343|FG000|Overall Study|Withdrawal by Subject|1|||
16107529|NCT01713998|38881344|FG001|Overall Study|Withdrawal by Subject|0|||
16107530|NCT01713998|38881345|FG002|Overall Study|Withdrawal by Subject|0|||
16541951|NCT01696981|40446756|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
16541952|NCT01696981|40446757|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
16541953|NCT01490125|40446758|FG000|Period I|Adverse Event|4|||
16541954|NCT01490125|40446759|FG001|Period I|Adverse Event|1|||
16541955|NCT01490125|40446760|FG002|Period I|Adverse Event|1|||
16541956|NCT01490125|40446761|FG003|Period I|Adverse Event|3|||
16541957|NCT01490125|40446762|FG004|Period I|Adverse Event|2|||
16107531|NCT03016598|38881346|FG000|Overall Study|Lost to Follow-up|0|||
16107532|NCT03016598|38881347|FG001|Overall Study|Lost to Follow-up|2|||
16107533|NCT00813098|38881351|FG000|Overall Study|Adverse Event|2|||
16107534|NCT00813098|38881352|FG001|Overall Study|Adverse Event|4|||
16107535|NCT00813098|38881353|FG002|Overall Study|Adverse Event|1|||
16107536|NCT00813098|38881351|FG000|Overall Study|Withdrawal by Subject|0|||
16107537|NCT00813098|38881352|FG001|Overall Study|Withdrawal by Subject|1|||
16341164|NCT03130959|39734586|FG005|Overall Study|Other reasons|1|||
16341165|NCT03130959|39734587|FG006|Overall Study|Other reasons|1|||
16341166|NCT03130959|39734588|FG007|Overall Study|Other reasons|0|||
16341167|NCT03130959|39734589|FG008|Overall Study|Other reasons|0|||
16341168|NCT03130959|39734590|FG009|Overall Study|Other reasons|0|||
16341169|NCT03130959|39734581|FG000|Overall Study|Subject request to discontinue therapy|0|||
16341170|NCT03130959|39734582|FG001|Overall Study|Subject request to discontinue therapy|0|||
16107538|NCT00813098|38881353|FG002|Overall Study|Withdrawal by Subject|0|||
16107539|NCT00813098|38881351|FG000|Overall Study|Inability to complete study procedures|1|||
16107540|NCT00813098|38881352|FG001|Overall Study|Inability to complete study procedures|0|||
16107541|NCT00813098|38881353|FG002|Overall Study|Inability to complete study procedures|0|||
16107542|NCT00813098|38881351|FG000|Overall Study|Lost to Follow-up|0|||
16107543|NCT00813098|38881352|FG001|Overall Study|Lost to Follow-up|1|||
16107544|NCT00813098|38881353|FG002|Overall Study|Lost to Follow-up|0|||
16107545|NCT00813098|38881351|FG000|Overall Study|Protocol Violation|0|||
16107546|NCT00813098|38881352|FG001|Overall Study|Protocol Violation|0|||
16541958|NCT01490125|40446763|FG005|Period I|Adverse Event|4|||
16541959|NCT01490125|40446758|FG000|Period I|Protocol Violation|1|||
16341171|NCT03130959|39734583|FG002|Overall Study|Subject request to discontinue therapy|1|||
16341172|NCT03130959|39734584|FG003|Overall Study|Subject request to discontinue therapy|1|||
16341173|NCT03130959|39734585|FG004|Overall Study|Subject request to discontinue therapy|0|||
16341174|NCT03130959|39734586|FG005|Overall Study|Subject request to discontinue therapy|0|||
16341175|NCT03130959|39734587|FG006|Overall Study|Subject request to discontinue therapy|1|||
16341176|NCT03130959|39734588|FG007|Overall Study|Subject request to discontinue therapy|1|||
16341177|NCT03130959|39734589|FG008|Overall Study|Subject request to discontinue therapy|0|||
16341178|NCT03130959|39734590|FG009|Overall Study|Subject request to discontinue therapy|0|||
16341179|NCT03130959|39734581|FG000|Overall Study|Not reported|0|||
16341180|NCT03130959|39734582|FG001|Overall Study|Not reported|0|||
16341181|NCT03130959|39734583|FG002|Overall Study|Not reported|0|||
16341182|NCT03130959|39734584|FG003|Overall Study|Not reported|1|||
16341183|NCT03130959|39734585|FG004|Overall Study|Not reported|0|||
16341184|NCT03130959|39734586|FG005|Overall Study|Not reported|1|||
16341185|NCT03130959|39734587|FG006|Overall Study|Not reported|0|||
16341186|NCT03130959|39734588|FG007|Overall Study|Not reported|0|||
16341187|NCT03130959|39734589|FG008|Overall Study|Not reported|0|||
16341188|NCT03130959|39734590|FG009|Overall Study|Not reported|1|||
16341189|NCT03130959|39734581|FG000|Overall Study|Adverse Event unrelated to drug|0|||
16341190|NCT03130959|39734582|FG001|Overall Study|Adverse Event unrelated to drug|0|||
16341191|NCT03130959|39734583|FG002|Overall Study|Adverse Event unrelated to drug|1|||
16341192|NCT03130959|39734584|FG003|Overall Study|Adverse Event unrelated to drug|1|||
16341193|NCT03130959|39734585|FG004|Overall Study|Adverse Event unrelated to drug|1|||
16341194|NCT03130959|39734586|FG005|Overall Study|Adverse Event unrelated to drug|0|||
16341195|NCT03130959|39734587|FG006|Overall Study|Adverse Event unrelated to drug|1|||
16341196|NCT03130959|39734588|FG007|Overall Study|Adverse Event unrelated to drug|0|||
16341197|NCT03130959|39734589|FG008|Overall Study|Adverse Event unrelated to drug|1|||
16341198|NCT03130959|39734590|FG009|Overall Study|Adverse Event unrelated to drug|1|||
16341199|NCT03130959|39734581|FG000|Overall Study|Participant withdrew consent|0|||
16341200|NCT03130959|39734582|FG001|Overall Study|Participant withdrew consent|1|||
16341201|NCT03130959|39734583|FG002|Overall Study|Participant withdrew consent|0|||
16341202|NCT03130959|39734584|FG003|Overall Study|Participant withdrew consent|2|||
16341203|NCT03130959|39734585|FG004|Overall Study|Participant withdrew consent|1|||
16341204|NCT03130959|39734586|FG005|Overall Study|Participant withdrew consent|0|||
16341205|NCT03130959|39734587|FG006|Overall Study|Participant withdrew consent|0|||
16341206|NCT03130959|39734588|FG007|Overall Study|Participant withdrew consent|0|||
16341207|NCT03130959|39734589|FG008|Overall Study|Participant withdrew consent|0|||
16341208|NCT03130959|39734590|FG009|Overall Study|Participant withdrew consent|2|||
16341209|NCT03130959|39734581|FG000|Overall Study|Administrative reason by sponsor|1|||
16341210|NCT03130959|39734582|FG001|Overall Study|Administrative reason by sponsor|0|||
16341211|NCT03130959|39734583|FG002|Overall Study|Administrative reason by sponsor|1|||
16341212|NCT03130959|39734584|FG003|Overall Study|Administrative reason by sponsor|0|||
16341213|NCT03130959|39734585|FG004|Overall Study|Administrative reason by sponsor|0|||
16341214|NCT03130959|39734586|FG005|Overall Study|Administrative reason by sponsor|0|||
16341215|NCT03130959|39734587|FG006|Overall Study|Administrative reason by sponsor|0|||
16341216|NCT03130959|39734588|FG007|Overall Study|Administrative reason by sponsor|0|||
16341217|NCT03130959|39734589|FG008|Overall Study|Administrative reason by sponsor|0|||
16341218|NCT03130959|39734590|FG009|Overall Study|Administrative reason by sponsor|0|||
16341219|NCT03130959|39734581|FG000|Overall Study|Lost to Follow-up|1|||
16341220|NCT03130959|39734582|FG001|Overall Study|Lost to Follow-up|0|||
16341221|NCT03130959|39734583|FG002|Overall Study|Lost to Follow-up|0|||
16341222|NCT03130959|39734584|FG003|Overall Study|Lost to Follow-up|0|||
16341223|NCT03130959|39734585|FG004|Overall Study|Lost to Follow-up|0|||
16341224|NCT03130959|39734586|FG005|Overall Study|Lost to Follow-up|0|||
16107547|NCT00813098|38881353|FG002|Overall Study|Protocol Violation|1|||
16107548|NCT00813098|38881351|FG000|Overall Study|Principal Investigator decision|0|||
16107549|NCT00813098|38881352|FG001|Overall Study|Principal Investigator decision|1|||
16107550|NCT00813098|38881353|FG002|Overall Study|Principal Investigator decision|0|||
16107551|NCT00813098|38881351|FG000|Overall Study|Withdrew Consent|0|||
16107552|NCT00813098|38881352|FG001|Overall Study|Withdrew Consent|1|||
16107553|NCT00813098|38881353|FG002|Overall Study|Withdrew Consent|0|||
16107554|NCT00263575|38881369|FG000|Titration Period|Adverse Event|14|||
16107555|NCT00263575|38881369|FG000|Titration Period|Withdrawal by Subject|10|||
16107556|NCT00263575|38881369|FG000|Titration Period|Protocol Violation|9|||
16107557|NCT00263575|38881369|FG000|Titration Period|Sponsor Decision|2|||
16107558|NCT00263575|38881369|FG000|Titration Period|Other|2|||
16107559|NCT00263575|38881369|FG000|Titration Period|Lack of Efficacy|6|||
16107560|NCT00263575|38881369|FG000|Maintence Period|Adverse Event|23|||
16107561|NCT00263575|38881369|FG000|Maintence Period|Withdrawal by Subject|8|||
16219323|NCT02531633|39282906|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
16341225|NCT03130959|39734587|FG006|Overall Study|Lost to Follow-up|0|||
16341226|NCT03130959|39734588|FG007|Overall Study|Lost to Follow-up|0|||
16107562|NCT00263575|38881369|FG000|Maintence Period|Protocol Violation|4|||
16107563|NCT00263575|38881369|FG000|Maintence Period|Lack of Efficacy|4|||
16107564|NCT00263575|38881369|FG000|Maintence Period|Physician Decision|6|||
16107565|NCT00263575|38881369|FG000|Maintence Period|Lost to Follow-up|1|||
16107566|NCT00263575|38881369|FG000|Maintence Period|Sponsor Decision|24|||
16107567|NCT00263575|38881369|FG000|Maintence Period|Other|7|||
16107568|NCT00591409|38881370|FG000|Overall Study|Not Treated|0|||
16107569|NCT00591409|38881371|FG001|Overall Study|Not Treated|0|||
16107570|NCT00591409|38881372|FG002|Overall Study|Not Treated|0|||
16107571|NCT00591409|38881373|FG003|Overall Study|Not Treated|0|||
16341227|NCT03130959|39734589|FG008|Overall Study|Lost to Follow-up|0|||
16107572|NCT00591409|38881374|FG004|Overall Study|Not Treated|1|||
16107573|NCT00591409|38881375|FG005|Overall Study|Not Treated|0|||
16107574|NCT00591409|38881376|FG006|Overall Study|Not Treated|0|||
16341228|NCT03130959|39734590|FG009|Overall Study|Lost to Follow-up|0|||
16341229|NCT03046056|39734591|FG000|Overall Study|Non-responder at Week 10|6|||
16341230|NCT03046056|39734592|FG001|Overall Study|Non-responder at Week 10|6|||
16341231|NCT03046056|39734593|FG002|Overall Study|Non-responder at Week 10|4|||
16107575|NCT00591409|38881377|FG007|Overall Study|Not Treated|0|||
16541960|NCT01490125|40446759|FG001|Period I|Protocol Violation|1|||
16341232|NCT03046056|39734591|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
16341233|NCT03046056|39734592|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
16341234|NCT03046056|39734593|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
16341235|NCT03046056|39734591|FG000|Overall Study|Adverse Event|1|||
16341236|NCT03046056|39734592|FG001|Overall Study|Adverse Event|5|||
16341237|NCT03046056|39734593|FG002|Overall Study|Adverse Event|0|||
16341238|NCT03046056|39734591|FG000|Overall Study|Non-compliance With Study Drug|0|||
16541961|NCT01490125|40446760|FG002|Period I|Protocol Violation|1|||
16541962|NCT01490125|40446761|FG003|Period I|Protocol Violation|1|||
16541963|NCT01490125|40446762|FG004|Period I|Protocol Violation|0|||
16341239|NCT03046056|39734592|FG001|Overall Study|Non-compliance With Study Drug|0|||
16341240|NCT03046056|39734593|FG002|Overall Study|Non-compliance With Study Drug|2|||
16341241|NCT03046056|39734591|FG000|Overall Study|Protocol Violation|1|||
16341242|NCT03046056|39734592|FG001|Overall Study|Protocol Violation|1|||
16341243|NCT03046056|39734593|FG002|Overall Study|Protocol Violation|0|||
16341244|NCT03046056|39734591|FG000|Overall Study|Investigator's Discretion|0|||
16341245|NCT03046056|39734592|FG001|Overall Study|Investigator's Discretion|1|||
16341246|NCT03046056|39734593|FG002|Overall Study|Investigator's Discretion|0|||
16541964|NCT01490125|40446763|FG005|Period I|Protocol Violation|0|||
16541965|NCT01490125|40446758|FG000|Period I|Withdrawal by Subject|1|||
16107576|NCT00591409|38881378|FG008|Overall Study|Not Treated|0|||
16107577|NCT00591409|38881379|FG009|Overall Study|Not Treated|1|||
16107578|NCT00951171|38881381|FG000|Overall Study|Adverse Event|2|||
16107579|NCT00951171|38881382|FG001|Overall Study|Adverse Event|0|||
16107580|NCT01845649|38881383|FG000|Overall Study|Adverse Event|7|||
16341247|NCT03046056|39734591|FG000|Overall Study|Withdrew Consent|1|||
16341248|NCT03046056|39734592|FG001|Overall Study|Withdrew Consent|0|||
16341249|NCT03046056|39734593|FG002|Overall Study|Withdrew Consent|0|||
16341250|NCT02155322|39734594|FG000|Overall Study|Adverse Event|1|||
16541966|NCT01490125|40446759|FG001|Period I|Withdrawal by Subject|3|||
16541967|NCT01490125|40446760|FG002|Period I|Withdrawal by Subject|2|||
16541968|NCT01490125|40446761|FG003|Period I|Withdrawal by Subject|1|||
16541969|NCT01490125|40446762|FG004|Period I|Withdrawal by Subject|2|||
16541970|NCT01490125|40446763|FG005|Period I|Withdrawal by Subject|1|||
16541971|NCT01490125|40446758|FG000|Period II|Adverse Event|2|||
16541972|NCT01490125|40446759|FG001|Period II|Adverse Event|3|||
16541973|NCT01490125|40446760|FG002|Period II|Adverse Event|2|||
16541974|NCT01490125|40446761|FG003|Period II|Adverse Event|2|||
16541975|NCT01490125|40446762|FG004|Period II|Adverse Event|4|||
16541976|NCT01490125|40446763|FG005|Period II|Adverse Event|2|||
16541977|NCT01490125|40446758|FG000|Period II|Protocol Violation|0|||
16541978|NCT01490125|40446759|FG001|Period II|Protocol Violation|0|||
16541979|NCT01490125|40446760|FG002|Period II|Protocol Violation|1|||
16541980|NCT01490125|40446761|FG003|Period II|Protocol Violation|1|||
16541981|NCT01490125|40446762|FG004|Period II|Protocol Violation|0|||
16541982|NCT01490125|40446763|FG005|Period II|Protocol Violation|0|||
16541983|NCT01490125|40446758|FG000|Period II|Lost to Follow-up|0|||
16541984|NCT01490125|40446759|FG001|Period II|Lost to Follow-up|1|||
16541985|NCT01490125|40446760|FG002|Period II|Lost to Follow-up|0|||
16541986|NCT01490125|40446761|FG003|Period II|Lost to Follow-up|0|||
16541987|NCT01490125|40446762|FG004|Period II|Lost to Follow-up|0|||
16541988|NCT01490125|40446763|FG005|Period II|Lost to Follow-up|0|||
16541989|NCT01490125|40446758|FG000|Period II|Withdrawal by Subject|1|||
16341251|NCT02155322|39734594|FG000|Overall Study|Physician Decision|1|||
16341252|NCT02155322|39734594|FG000|Overall Study|Relapse/Recurrence|8|||
16341253|NCT02155322|39734594|FG000|Overall Study|Withdrawal by Subject|4|||
16341254|NCT00080483|39734595|FG000|Overall Study|Lost to Follow-up|1|||
16341255|NCT00080483|39734596|FG001|Overall Study|Lost to Follow-up|1|||
16341256|NCT00080483|39734595|FG000|Overall Study|Physician Decision|1|||
16341257|NCT00080483|39734596|FG001|Overall Study|Physician Decision|1|||
16341258|NCT01641471|39734605|FG000|Overall Study|Withdrawal by Subject|19|||
16341259|NCT01641471|39734606|FG001|Overall Study|Withdrawal by Subject|19|||
16341260|NCT01641471|39734605|FG000|Overall Study|Lost to Follow-up|2|||
16341261|NCT01641471|39734606|FG001|Overall Study|Lost to Follow-up|4|||
16341262|NCT01641471|39734605|FG000|Overall Study|Protocol Violation|2|||
16341263|NCT01641471|39734606|FG001|Overall Study|Protocol Violation|4|||
16341264|NCT00073008|39734607|FG000|Overall Study|Missing|6|||
16341265|NCT00073008|39734608|FG001|Overall Study|Missing|6|||
16341266|NCT00073008|39734607|FG000|Overall Study|Withdrawal by Subject|2|||
16341267|NCT00073008|39734608|FG001|Overall Study|Withdrawal by Subject|2|||
16341268|NCT00073008|39734607|FG000|Overall Study|Lost to Follow-up|1|||
16341269|NCT00073008|39734608|FG001|Overall Study|Lost to Follow-up|3|||
16341270|NCT00073008|39734607|FG000|Overall Study|Death|46|||
16107581|NCT01845649|38881384|FG001|Overall Study|Adverse Event|10|||
16107582|NCT01845649|38881383|FG000|Overall Study|Lack of Efficacy|1|||
16107583|NCT01845649|38881384|FG001|Overall Study|Lack of Efficacy|1|||
16107584|NCT01845649|38881383|FG000|Overall Study|Lost to Follow-up|2|||
16107585|NCT01845649|38881384|FG001|Overall Study|Lost to Follow-up|2|||
16107586|NCT01845649|38881383|FG000|Overall Study|Withdrew Consent|12|||
16107587|NCT01845649|38881384|FG001|Overall Study|Withdrew Consent|4|||
16107588|NCT01845649|38881383|FG000|Overall Study|Protocol Deviation|7|||
16107589|NCT01845649|38881384|FG001|Overall Study|Protocol Deviation|4|||
16107590|NCT01845649|38881383|FG000|Overall Study|Reason not Specified|2|||
16107591|NCT01845649|38881384|FG001|Overall Study|Reason not Specified|1|||
16107592|NCT01580995|38881385|FG000|Overall Study|Lost to Follow-up|2|||
16107593|NCT01580995|38881386|FG001|Overall Study|Lost to Follow-up|2|||
16107594|NCT01375114|38881388|FG000|Overall Study|Lost to Follow-up|1|||
16107595|NCT01375114|38881389|FG001|Overall Study|Lost to Follow-up|0|||
16107596|NCT01375114|38881390|FG002|Overall Study|Lost to Follow-up|1|||
16107597|NCT01375114|38881388|FG000|Overall Study|Disease Progression|3|||
16107598|NCT01375114|38881389|FG001|Overall Study|Disease Progression|2|||
16107599|NCT01375114|38881390|FG002|Overall Study|Disease Progression|2|||
16107600|NCT01375114|38881388|FG000|Overall Study|Patient Changed Mind|0|||
16341271|NCT00073008|39734608|FG001|Overall Study|Death|47|||
16341272|NCT00073008|39734607|FG000|Overall Study|"Other selected on Case Report Form"|7|||
16541990|NCT01490125|40446759|FG001|Period II|Withdrawal by Subject|0|||
16541991|NCT01490125|40446760|FG002|Period II|Withdrawal by Subject|0|||
16541992|NCT01490125|40446761|FG003|Period II|Withdrawal by Subject|0|||
16541993|NCT01490125|40446762|FG004|Period II|Withdrawal by Subject|0|||
16541994|NCT01490125|40446763|FG005|Period II|Withdrawal by Subject|0|||
16541995|NCT01490125|40446758|FG000|Period III|Adverse Event|3|||
16541996|NCT01490125|40446759|FG001|Period III|Adverse Event|1|||
16541997|NCT01490125|40446760|FG002|Period III|Adverse Event|0|||
16541998|NCT01490125|40446761|FG003|Period III|Adverse Event|1|||
16541999|NCT01490125|40446762|FG004|Period III|Adverse Event|0|||
16542000|NCT01490125|40446763|FG005|Period III|Adverse Event|0|||
16542001|NCT01490125|40446758|FG000|Period III|Death|0|||
16542002|NCT01490125|40446759|FG001|Period III|Death|0|||
16542003|NCT01490125|40446760|FG002|Period III|Death|0|||
16542004|NCT01490125|40446761|FG003|Period III|Death|1|||
16542005|NCT01490125|40446762|FG004|Period III|Death|0|||
16542006|NCT01490125|40446763|FG005|Period III|Death|0|||
16107601|NCT01375114|38881389|FG001|Overall Study|Patient Changed Mind|0|||
16107602|NCT01375114|38881390|FG002|Overall Study|Patient Changed Mind|2|||
16107603|NCT01375114|38881388|FG000|Overall Study|Pruritus|0|||
16107604|NCT01375114|38881389|FG001|Overall Study|Pruritus|0|||
16107605|NCT01375114|38881390|FG002|Overall Study|Pruritus|1|||
16341273|NCT00073008|39734608|FG001|Overall Study|"Other selected on Case Report Form"|5|||
16341274|NCT02070978|39734611|FG000|Overall Study|Adverse Event|6|||
16542007|NCT01490125|40446758|FG000|Period III|Lack of Efficacy|0|||
16542008|NCT01490125|40446759|FG001|Period III|Lack of Efficacy|0|||
16542009|NCT01490125|40446760|FG002|Period III|Lack of Efficacy|0|||
16542010|NCT01490125|40446761|FG003|Period III|Lack of Efficacy|0|||
16542011|NCT01490125|40446762|FG004|Period III|Lack of Efficacy|1|||
16542012|NCT01490125|40446763|FG005|Period III|Lack of Efficacy|0|||
16542013|NCT02636270|40446765|FG000|Overall Study|Adverse Event|1|||
16542014|NCT02636270|40446766|FG001|Overall Study|Adverse Event|0|||
16542015|NCT02636270|40446767|FG002|Overall Study|Adverse Event|0|||
16542016|NCT02636270|40446765|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
16542017|NCT02636270|40446766|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
16542018|NCT02636270|40446767|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
16542019|NCT04493216|40446781|FG000|Overall Study|Study terminated by sponsor|30|||
16542020|NCT04493216|40446782|FG001|Overall Study|Study terminated by sponsor|33|||
16542021|NCT04493216|40446783|FG002|Overall Study|Study terminated by sponsor|28|||
16542022|NCT04493216|40446784|FG003|Overall Study|Study terminated by sponsor|27|||
16542023|NCT04493216|40446781|FG000|Overall Study|Withdrawal by Subject|2|||
16542024|NCT04493216|40446782|FG001|Overall Study|Withdrawal by Subject|1|||
16542025|NCT04493216|40446783|FG002|Overall Study|Withdrawal by Subject|1|||
16542026|NCT04493216|40446784|FG003|Overall Study|Withdrawal by Subject|2|||
16542027|NCT04493216|40446781|FG000|Overall Study|Protocol Violation|1|||
16542028|NCT04493216|40446782|FG001|Overall Study|Protocol Violation|2|||
16219324|NCT02531633|39282907|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
16542029|NCT04493216|40446783|FG002|Overall Study|Protocol Violation|0|||
16542030|NCT04493216|40446784|FG003|Overall Study|Protocol Violation|2|||
16542031|NCT04493216|40446781|FG000|Overall Study|Physician Decision|0|||
16542032|NCT04493216|40446782|FG001|Overall Study|Physician Decision|0|||
16542033|NCT04493216|40446783|FG002|Overall Study|Physician Decision|1|||
16542034|NCT04493216|40446784|FG003|Overall Study|Physician Decision|0|||
16542035|NCT04493216|40446781|FG000|Overall Study|Lost to Follow-up|2|||
16542036|NCT04493216|40446782|FG001|Overall Study|Lost to Follow-up|1|||
16542037|NCT04493216|40446783|FG002|Overall Study|Lost to Follow-up|0|||
16107606|NCT01375114|38881388|FG000|Overall Study|Restlessness|0|||
16542038|NCT04493216|40446784|FG003|Overall Study|Lost to Follow-up|1|||
16542039|NCT04493216|40446781|FG000|Overall Study|Adverse Event|1|||
16542040|NCT04493216|40446782|FG001|Overall Study|Adverse Event|4|||
16542041|NCT04493216|40446783|FG002|Overall Study|Adverse Event|5|||
16542042|NCT04493216|40446784|FG003|Overall Study|Adverse Event|2|||
16542043|NCT04493216|40446781|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
16542044|NCT04493216|40446782|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
16542045|NCT04493216|40446783|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
16542046|NCT04493216|40446784|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
16542047|NCT03445065|40446787|FG000|Overall Study|Withdrawal by Subject|3|||
16542048|NCT03445065|40446788|FG001|Overall Study|Withdrawal by Subject|6|||
16542049|NCT03445065|40446789|FG002|Overall Study|Withdrawal by Subject|2|||
16542050|NCT03445065|40446790|FG003|Overall Study|Withdrawal by Subject|2|||
16542051|NCT03445065|40446787|FG000|Overall Study|Other|4|||
16542052|NCT03445065|40446788|FG001|Overall Study|Other|3|||
16542053|NCT03445065|40446789|FG002|Overall Study|Other|3|||
16542054|NCT03445065|40446790|FG003|Overall Study|Other|1|||
16542055|NCT05899686|40446791|FG000|Overall Study|Protocol Violation|1|||
16542056|NCT04535947|40446793|FG000|Overall Study|Adverse Event|1|||
16542057|NCT04535947|40446794|FG001|Overall Study|Adverse Event|4|||
16542058|NCT04535947|40446793|FG000|Overall Study|Other reasons not specified|2|||
16542059|NCT04535947|40446794|FG001|Overall Study|Other reasons not specified|0|||
16542060|NCT04535947|40446793|FG000|Overall Study|Withdrawal by Subject|1|||
16542061|NCT04535947|40446794|FG001|Overall Study|Withdrawal by Subject|1|||
16542062|NCT01337674|40446803|FG000|Treatment Period 1|Adverse Event|0|||
16542063|NCT01337674|40446804|FG001|Treatment Period 1|Adverse Event|1|||
16542064|NCT01337674|40446805|FG002|Treatment Period 1|Adverse Event|0|||
16542065|NCT01337674|40446806|FG003|Treatment Period 1|Adverse Event|0|||
16542066|NCT01337674|40446803|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
16107607|NCT01375114|38881389|FG001|Overall Study|Restlessness|0|||
16107608|NCT01375114|38881390|FG002|Overall Study|Restlessness|1|||
16107609|NCT01375114|38881388|FG000|Overall Study|Diarrhea|0|||
16107610|NCT01375114|38881389|FG001|Overall Study|Diarrhea|0|||
16107611|NCT01375114|38881390|FG002|Overall Study|Diarrhea|1|||
16107612|NCT01375114|38881388|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
16107613|NCT01375114|38881389|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
16107614|NCT01375114|38881390|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
16107615|NCT01375114|38881388|FG000|Overall Study|Nausea|0|||
16107616|NCT01375114|38881389|FG001|Overall Study|Nausea|1|||
16341275|NCT02070978|39734612|FG001|Overall Study|Adverse Event|2|||
16341276|NCT02070978|39734613|FG002|Overall Study|Adverse Event|0|||
16341277|NCT02070978|39734611|FG000|Overall Study|Lost to Follow-up|1|||
16341278|NCT02070978|39734612|FG001|Overall Study|Lost to Follow-up|3|||
16341279|NCT02070978|39734613|FG002|Overall Study|Lost to Follow-up|4|||
16341280|NCT02070978|39734611|FG000|Overall Study|Withdrawal by Subject|3|||
16542067|NCT01337674|40446804|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
16107617|NCT01375114|38881390|FG002|Overall Study|Nausea|0|||
16107618|NCT01375114|38881388|FG000|Overall Study|Increased AST/ALT|0|||
16107619|NCT01375114|38881389|FG001|Overall Study|Increased AST/ALT|1|||
16107620|NCT01375114|38881390|FG002|Overall Study|Increased AST/ALT|0|||
16107621|NCT01375114|38881388|FG000|Overall Study|Vaginal Hemorrhage|0|||
16107622|NCT01375114|38881389|FG001|Overall Study|Vaginal Hemorrhage|1|||
16107623|NCT01375114|38881390|FG002|Overall Study|Vaginal Hemorrhage|0|||
16107624|NCT01375114|38881388|FG000|Overall Study|Family problem|0|||
16107625|NCT01375114|38881389|FG001|Overall Study|Family problem|1|||
16107626|NCT01375114|38881390|FG002|Overall Study|Family problem|0|||
16219325|NCT02531633|39282908|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
16219326|NCT02531633|39282899|FG000|Part A (52 Weeks)|Other|2|||
16219327|NCT02531633|39282900|FG001|Part A (52 Weeks)|Other|0|||
16219328|NCT02531633|39282901|FG002|Part A (52 Weeks)|Other|0|||
16219329|NCT02531633|39282902|FG003|Part A (52 Weeks)|Other|0|||
16219330|NCT02531633|39282903|FG004|Part A (52 Weeks)|Other|0|||
16219331|NCT02531633|39282904|FG005|Part A (52 Weeks)|Other|0|||
16219332|NCT02531633|39282905|FG006|Part A (52 Weeks)|Other|0|||
16219333|NCT02531633|39282906|FG007|Part A (52 Weeks)|Other|0|||
16219334|NCT02531633|39282907|FG008|Part A (52 Weeks)|Other|0|||
16219335|NCT02531633|39282908|FG009|Part A (52 Weeks)|Other|0|||
16219336|NCT02531633|39282899|FG000|Part B (104 Weeks)|Sponsor request|0|||
16219337|NCT02531633|39282900|FG001|Part B (104 Weeks)|Sponsor request|0|||
16219338|NCT02531633|39282901|FG002|Part B (104 Weeks)|Sponsor request|0|||
16219339|NCT02531633|39282902|FG003|Part B (104 Weeks)|Sponsor request|0|||
16219340|NCT02531633|39282903|FG004|Part B (104 Weeks)|Sponsor request|0|||
16542068|NCT01337674|40446805|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
16542069|NCT01337674|40446806|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
16542070|NCT01337674|40446803|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16542071|NCT01337674|40446804|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16542072|NCT01337674|40446805|FG002|Treatment Period 2|Withdrawal by Subject|1|||
16107627|NCT01375114|38881388|FG000|Overall Study|Protocol Violation|2|||
16107628|NCT01375114|38881389|FG001|Overall Study|Protocol Violation|0|||
16107629|NCT01375114|38881390|FG002|Overall Study|Protocol Violation|0|||
16107630|NCT03440047|38881391|FG000|Overall Study|Withdrawal by Subject|2|||
16107631|NCT00905359|38881394|FG000|Overall Study|Lost to Follow-up|17|||
16107632|NCT00905359|38881395|FG001|Overall Study|Lost to Follow-up|10|||
16107633|NCT00905359|38881394|FG000|Overall Study|Death|2|||
16107634|NCT00905359|38881395|FG001|Overall Study|Death|0|||
16107635|NCT00905359|38881394|FG000|Overall Study|Withdrawal consent|5|||
16107636|NCT00905359|38881395|FG001|Overall Study|Withdrawal consent|6|||
16107637|NCT02560389|38881398|FG000|Overall Study|Lost to Follow-up|1|||
16107638|NCT02560389|38881399|FG001|Overall Study|Lost to Follow-up|2|||
16107639|NCT02560389|38881400|FG002|Overall Study|Lost to Follow-up|2|||
16107640|NCT02560389|38881398|FG000|Overall Study|Tested positive for illicit substance|0|||
16107641|NCT02560389|38881399|FG001|Overall Study|Tested positive for illicit substance|1|||
16542073|NCT01337674|40446806|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16542074|NCT00840801|40446810|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
16542075|NCT00840801|40446811|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
16542076|NCT00840801|40446812|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
16542077|NCT00840801|40446810|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
16542078|NCT00840801|40446811|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
16542079|NCT00840801|40446812|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
16542080|NCT00840801|40446810|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
16542081|NCT00840801|40446811|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
16542082|NCT00840801|40446812|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
16542083|NCT00840801|40446810|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
16542084|NCT00840801|40446811|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
16542085|NCT00840801|40446812|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
16542086|NCT02586025|40446813|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
16542087|NCT02586025|40446814|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
16542088|NCT02586025|40446813|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
16542089|NCT02586025|40446814|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
16542090|NCT02586025|40446813|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
16542091|NCT02586025|40446814|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
16542092|NCT02586025|40446813|FG000|Neoadjuvant Treatment|Death|1|||
16542093|NCT02586025|40446814|FG001|Neoadjuvant Treatment|Death|0|||
16542094|NCT02586025|40446813|FG000|Neoadjuvant Treatment|Adverse Event|1|||
16542095|NCT02586025|40446814|FG001|Neoadjuvant Treatment|Adverse Event|0|||
16542096|NCT02586025|40446813|FG000|Neoadjuvant Treatment|Physician Decision|2|||
16542097|NCT02586025|40446814|FG001|Neoadjuvant Treatment|Physician Decision|1|||
16542098|NCT02586025|40446813|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
16542099|NCT02586025|40446814|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
16542100|NCT02586025|40446813|FG000|Adjuvant Treatment|Recurrent Disease|4|||
16107642|NCT02560389|38881400|FG002|Overall Study|Tested positive for illicit substance|0|||
16107643|NCT03028012|38881404|FG000|Overall Study|Lost to Follow-up|2|||
16107644|NCT03028012|38881405|FG001|Overall Study|Lost to Follow-up|3|||
16219341|NCT02531633|39282904|FG005|Part B (104 Weeks)|Sponsor request|8|||
16219342|NCT02531633|39282905|FG006|Part B (104 Weeks)|Sponsor request|5|||
16219343|NCT02531633|39282906|FG007|Part B (104 Weeks)|Sponsor request|3|||
16219344|NCT02531633|39282907|FG008|Part B (104 Weeks)|Sponsor request|5|||
16219345|NCT02531633|39282908|FG009|Part B (104 Weeks)|Sponsor request|4|||
16219346|NCT02531633|39282899|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
16219347|NCT02531633|39282900|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
16219348|NCT02531633|39282901|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
16219349|NCT02531633|39282902|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
16219350|NCT02531633|39282903|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
16219351|NCT02531633|39282904|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
16219352|NCT02531633|39282905|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
16219353|NCT02531633|39282906|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
16219354|NCT02531633|39282907|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
16219355|NCT02531633|39282908|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
16219356|NCT00697255|39282912|FG000|Stage 1a|Insufficient ovarian response|1|||
16219357|NCT00697255|39282913|FG001|Stage 1a|Insufficient ovarian response|0|||
16219358|NCT00697255|39282912|FG000|Stage 1a|Multifollicular growth|1|||
16219359|NCT00697255|39282913|FG001|Stage 1a|Multifollicular growth|0|||
16219360|NCT00697255|39282912|FG000|Stage 1a|Not growing of dominant follicle|1|||
16219361|NCT00697255|39282913|FG001|Stage 1a|Not growing of dominant follicle|0|||
16219362|NCT00697255|39282912|FG000|Stage 1b|Not growing of dominant follicle|0|||
16219363|NCT00697255|39282913|FG001|Stage 1b|Not growing of dominant follicle|1|||
16219364|NCT00697255|39282912|FG000|Stage 1b|Insufficient ovarian response|0|||
16219365|NCT00697255|39282913|FG001|Stage 1b|Insufficient ovarian response|1|||
16219366|NCT01320033|39282916|FG000|Overall Study|Lack of Efficacy|0|||
16219367|NCT01320033|39282917|FG001|Overall Study|Lack of Efficacy|0|||
16219368|NCT01320033|39282918|FG002|Overall Study|Lack of Efficacy|1|||
16219369|NCT01320033|39282916|FG000|Overall Study|Adverse Event|9|||
16219370|NCT01320033|39282917|FG001|Overall Study|Adverse Event|7|||
16219371|NCT01320033|39282918|FG002|Overall Study|Adverse Event|8|||
16219372|NCT01320033|39282916|FG000|Overall Study|Withdrawal by Subject|22|||
16219373|NCT01320033|39282917|FG001|Overall Study|Withdrawal by Subject|23|||
16219374|NCT01320033|39282918|FG002|Overall Study|Withdrawal by Subject|23|||
16219375|NCT01320033|39282916|FG000|Overall Study|Protocol Violation|3|||
16219376|NCT01320033|39282917|FG001|Overall Study|Protocol Violation|5|||
16219377|NCT01320033|39282918|FG002|Overall Study|Protocol Violation|3|||
16219378|NCT01320033|39282916|FG000|Overall Study|Lost to Follow-up|22|||
16219379|NCT01320033|39282917|FG001|Overall Study|Lost to Follow-up|26|||
16219380|NCT01320033|39282918|FG002|Overall Study|Lost to Follow-up|17|||
16219381|NCT01320033|39282916|FG000|Overall Study|Other|2|||
16219382|NCT01320033|39282917|FG001|Overall Study|Other|3|||
16219383|NCT01320033|39282918|FG002|Overall Study|Other|1|||
16219384|NCT00887913|39282920|FG000|Overall Study|Withdrawal by Subject|6|||
16219385|NCT02117024|39282921|FG000|Overall Study|Progressive Disease|26|||
16219386|NCT02117024|39282922|FG001|Overall Study|Progressive Disease|9|||
16219387|NCT02117024|39282921|FG000|Overall Study|Significant Clinical Progression|7|||
16219388|NCT02117024|39282922|FG001|Overall Study|Significant Clinical Progression|4|||
16219389|NCT02117024|39282921|FG000|Overall Study|Death|5|||
16219390|NCT02117024|39282922|FG001|Overall Study|Death|0|||
16219391|NCT02117024|39282921|FG000|Overall Study|Withdrawal by Subject|3|||
16219392|NCT02117024|39282922|FG001|Overall Study|Withdrawal by Subject|1|||
16219393|NCT02117024|39282921|FG000|Overall Study|Protocol Violation|1|||
16219394|NCT02117024|39282922|FG001|Overall Study|Protocol Violation|0|||
16219395|NCT02117024|39282921|FG000|Overall Study|Adverse Event|1|||
16219396|NCT02117024|39282922|FG001|Overall Study|Adverse Event|2|||
16219397|NCT02117024|39282921|FG000|Overall Study|Randomized in Error|1|||
16219398|NCT02117024|39282922|FG001|Overall Study|Randomized in Error|0|||
16219399|NCT02117024|39282921|FG000|Overall Study|Patient returned to primary oncologist|0|||
16219400|NCT02117024|39282922|FG001|Overall Study|Patient returned to primary oncologist|1|||
16219401|NCT02117024|39282921|FG000|Overall Study|Patient took treatment break|0|||
16219402|NCT02117024|39282922|FG001|Overall Study|Patient took treatment break|1|||
16219403|NCT02117024|39282921|FG000|Overall Study|Physician Decision|0|||
16219404|NCT02117024|39282922|FG001|Overall Study|Physician Decision|2|||
16219405|NCT01021293|39282924|FG000|Overall Study|Serious Adverse Event|2|||
16341281|NCT02070978|39734612|FG001|Overall Study|Withdrawal by Subject|5|||
16107645|NCT03028012|38881406|FG002|Overall Study|Lost to Follow-up|3|||
16219406|NCT01021293|39282925|FG001|Overall Study|Serious Adverse Event|1|||
16219407|NCT01021293|39282924|FG000|Overall Study|Adverse Event|2|||
16219408|NCT01021293|39282925|FG001|Overall Study|Adverse Event|1|||
16219409|NCT01021293|39282924|FG000|Overall Study|Withdrawal by Subject|1|||
16219410|NCT01021293|39282925|FG001|Overall Study|Withdrawal by Subject|3|||
16219411|NCT01021293|39282924|FG000|Overall Study|Migrated/moved from study area|6|||
16219412|NCT01021293|39282925|FG001|Overall Study|Migrated/moved from study area|18|||
16219413|NCT01021293|39282924|FG000|Overall Study|Lost to Follow-up|1|||
16219414|NCT01021293|39282925|FG001|Overall Study|Lost to Follow-up|1|||
16219415|NCT01108263|39282926|FG000|Overall Study|Adverse Event|0|||
16219416|NCT01108263|39282927|FG001|Overall Study|Adverse Event|1|||
16219417|NCT01291511|39282928|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
16219418|NCT01291511|39282929|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
16219419|NCT01291511|39282928|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
16219420|NCT01291511|39282929|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
16219421|NCT01291511|39282928|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
16219422|NCT01291511|39282929|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
16219423|NCT01291511|39282928|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
16219424|NCT01291511|39282929|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
16219425|NCT01291511|39282928|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
16219426|NCT01291511|39282929|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
16219427|NCT01291511|39282928|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
16219428|NCT01291511|39282929|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
16219429|NCT01291511|39282928|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
16219430|NCT01291511|39282929|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
16219431|NCT01291511|39282928|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
16219432|NCT01291511|39282929|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
16219433|NCT01291511|39282928|FG000|Cross-Titration and Stabilization Phase|Death|1|||
16219434|NCT01291511|39282929|FG001|Cross-Titration and Stabilization Phase|Death|0|||
16219435|NCT01291511|39282928|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
16219436|NCT01291511|39282929|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
16219437|NCT01291511|39282928|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
16219438|NCT01291511|39282929|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
16219439|NCT01291511|39282928|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
16219440|NCT01291511|39282929|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
16219441|NCT01291511|39282928|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
16219442|NCT01291511|39282929|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
16219443|NCT01291511|39282928|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
16219444|NCT01291511|39282929|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
16219445|NCT01291511|39282928|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
16219446|NCT01291511|39282929|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
16219447|NCT01291511|39282928|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
16219448|NCT01291511|39282929|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
16219449|NCT01291511|39282928|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
16219450|NCT01291511|39282929|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
16107646|NCT02388932|38881420|FG000|Overall Study|Death|1|||
16107647|NCT00621192|38881426|FG000|Overall Study|Withdrawal by Subject|0|||
16107648|NCT00621192|38881427|FG001|Overall Study|Withdrawal by Subject|0|||
16107649|NCT00621192|38881428|FG002|Overall Study|Withdrawal by Subject|2|||
16107650|NCT00621192|38881429|FG003|Overall Study|Withdrawal by Subject|0|||
16107651|NCT00621192|38881426|FG000|Overall Study|Physician Decision|1|||
16107652|NCT00621192|38881427|FG001|Overall Study|Physician Decision|3|||
16107653|NCT00621192|38881428|FG002|Overall Study|Physician Decision|0|||
16107654|NCT00621192|38881429|FG003|Overall Study|Physician Decision|0|||
16107655|NCT00621192|38881426|FG000|Overall Study|Protocol Violation|1|||
16107656|NCT00621192|38881427|FG001|Overall Study|Protocol Violation|0|||
16107657|NCT00621192|38881428|FG002|Overall Study|Protocol Violation|0|||
16107658|NCT00621192|38881429|FG003|Overall Study|Protocol Violation|1|||
16107659|NCT00621192|38881426|FG000|Overall Study|Adverse Event|0|||
16107660|NCT00621192|38881427|FG001|Overall Study|Adverse Event|1|||
16107661|NCT00621192|38881428|FG002|Overall Study|Adverse Event|0|||
16107662|NCT00621192|38881429|FG003|Overall Study|Adverse Event|1|||
16107663|NCT00621192|38881426|FG000|Overall Study|Death|2|||
16107664|NCT00621192|38881427|FG001|Overall Study|Death|5|||
16107665|NCT00621192|38881428|FG002|Overall Study|Death|0|||
16107666|NCT00621192|38881429|FG003|Overall Study|Death|0|||
16542101|NCT02586025|40446814|FG001|Adjuvant Treatment|Recurrent Disease|5|||
16107667|NCT00621192|38881426|FG000|Overall Study|Final Assessments not Completed|0|||
16107668|NCT00621192|38881427|FG001|Overall Study|Final Assessments not Completed|0|||
16542102|NCT02586025|40446813|FG000|Adjuvant Treatment|Physician Decision|0|||
16542103|NCT02586025|40446814|FG001|Adjuvant Treatment|Physician Decision|1|||
16542104|NCT02586025|40446813|FG000|Adjuvant Treatment|Pregnancy|1|||
16542105|NCT02586025|40446814|FG001|Adjuvant Treatment|Pregnancy|0|||
16542106|NCT02586025|40446813|FG000|Treatment-Free Follow-Up|Death|11|||
16542107|NCT02586025|40446814|FG001|Treatment-Free Follow-Up|Death|11|||
16542108|NCT02586025|40446813|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
16542109|NCT02586025|40446814|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
16542110|NCT02586025|40446813|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
16107669|NCT00621192|38881428|FG002|Overall Study|Final Assessments not Completed|3|||
16107670|NCT00621192|38881429|FG003|Overall Study|Final Assessments not Completed|1|||
16107671|NCT00576823|38881430|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
16107672|NCT00576823|38881431|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
16219451|NCT01291511|39282928|FG000|Double-blind Relapse Prevention Phase|Death|1|||
16542111|NCT02586025|40446814|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
16219452|NCT01291511|39282929|FG001|Double-blind Relapse Prevention Phase|Death|0|||
16219453|NCT01497899|39282936|FG000|Double-Blind Phase|Randomized but not Treated|1|||
16219454|NCT01497899|39282937|FG001|Double-Blind Phase|Randomized but not Treated|0|||
16219455|NCT01497899|39282938|FG002|Double-Blind Phase|Randomized but not Treated|0|||
16219456|NCT01497899|39282939|FG003|Double-Blind Phase|Randomized but not Treated|0|||
16219457|NCT01497899|39282936|FG000|Double-Blind Phase|Adverse Event|1|||
16219458|NCT01497899|39282937|FG001|Double-Blind Phase|Adverse Event|0|||
16542112|NCT02586025|40446813|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
16542113|NCT02586025|40446814|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
16542114|NCT02586025|40446813|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
16542115|NCT02586025|40446814|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
16542116|NCT04843930|40446815|FG000|Randomization|Withdrawal by Subject|6|||
16542117|NCT04843930|40446816|FG001|Randomization|Withdrawal by Subject|6|||
16542118|NCT04843930|40446817|FG002|Randomization|Withdrawal by Subject|0|||
16542119|NCT04843930|40446818|FG003|Randomization|Withdrawal by Subject|0|||
16542120|NCT04843930|40446815|FG000|Week 6 Assessment|Adverse Event|3|||
16542121|NCT04843930|40446816|FG001|Week 6 Assessment|Adverse Event|0|||
16542122|NCT04843930|40446817|FG002|Week 6 Assessment|Adverse Event|0|||
16542123|NCT04843930|40446818|FG003|Week 6 Assessment|Adverse Event|0|||
16542124|NCT04843930|40446815|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
16542125|NCT04843930|40446816|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
16542126|NCT04843930|40446817|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
16542127|NCT04843930|40446818|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
16542128|NCT04843930|40446815|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
16542129|NCT04843930|40446816|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
16542130|NCT04843930|40446817|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
16542131|NCT04843930|40446818|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
16219459|NCT01497899|39282938|FG002|Double-Blind Phase|Adverse Event|0|||
16219460|NCT01497899|39282939|FG003|Double-Blind Phase|Adverse Event|0|||
16219461|NCT01497899|39282936|FG000|Double-Blind Phase|Lack of Efficacy|0|||
16219462|NCT01497899|39282937|FG001|Double-Blind Phase|Lack of Efficacy|1|||
16219463|NCT01497899|39282938|FG002|Double-Blind Phase|Lack of Efficacy|0|||
16219464|NCT01497899|39282939|FG003|Double-Blind Phase|Lack of Efficacy|0|||
16219465|NCT01497899|39282936|FG000|Double-Blind Phase|Investigator's Discretion|1|||
16542132|NCT01807650|40446819|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
16542133|NCT01807650|40446819|FG000|Overall Study|Adverse Event|5|||
16542134|NCT01807650|40446819|FG000|Overall Study|Other|2|||
16406650|NCT00980460|39969860|FG001|Overall Study|No therapy within 42 days of resection|0|||
16406651|NCT00980460|39969861|FG002|Overall Study|No therapy within 42 days of resection|3|||
16219466|NCT01497899|39282937|FG001|Double-Blind Phase|Investigator's Discretion|0|||
16107673|NCT00576823|38881432|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
16219467|NCT01497899|39282938|FG002|Double-Blind Phase|Investigator's Discretion|0|||
16219468|NCT01497899|39282939|FG003|Double-Blind Phase|Investigator's Discretion|0|||
16219469|NCT01497899|39282936|FG000|Double-Blind Phase|Withdrew Consent|0|||
16219470|NCT01497899|39282937|FG001|Double-Blind Phase|Withdrew Consent|1|||
16219471|NCT01497899|39282938|FG002|Double-Blind Phase|Withdrew Consent|0|||
16341282|NCT02070978|39734613|FG002|Overall Study|Withdrawal by Subject|3|||
16107674|NCT00576823|38881430|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
16107675|NCT00576823|38881431|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
16107676|NCT00576823|38881432|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
16107677|NCT00349622|38881433|FG000|Overall Study|Death|168|||
16107678|NCT00349622|38881434|FG001|Overall Study|Death|86|||
16107679|NCT00349622|38881433|FG000|Overall Study|Lost to Follow-up|5|||
16219472|NCT01497899|39282939|FG003|Double-Blind Phase|Withdrew Consent|0|||
16219473|NCT01497899|39282936|FG000|Double-Blind Phase|Lost to Follow-up|3|||
16406652|NCT00980460|39969862|FG003|Overall Study|No therapy within 42 days of resection|1|||
16406653|NCT00980460|39969863|FG004|Overall Study|No therapy within 42 days of resection|0|||
16406654|NCT00980460|39969859|FG000|Overall Study|No transplant by protocol timepoints|0|||
16406655|NCT00980460|39969860|FG001|Overall Study|No transplant by protocol timepoints|0|||
16406656|NCT00980460|39969861|FG002|Overall Study|No transplant by protocol timepoints|3|||
16219474|NCT01497899|39282937|FG001|Double-Blind Phase|Lost to Follow-up|2|||
16219475|NCT01497899|39282938|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16219476|NCT01497899|39282939|FG003|Double-Blind Phase|Lost to Follow-up|0|||
16219477|NCT01497899|39282936|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
16219478|NCT01497899|39282937|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
16219479|NCT01497899|39282938|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
16219480|NCT01497899|39282939|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
16219481|NCT01497899|39282936|FG000|Open-Label Extension Phase|Adverse Event|1|||
16219482|NCT01497899|39282937|FG001|Open-Label Extension Phase|Adverse Event|0|||
16219483|NCT01497899|39282938|FG002|Open-Label Extension Phase|Adverse Event|0|||
16219484|NCT01497899|39282939|FG003|Open-Label Extension Phase|Adverse Event|0|||
16219485|NCT01497899|39282936|FG000|Open-Label Extension Phase|Death|1|||
16107680|NCT00349622|38881434|FG001|Overall Study|Lost to Follow-up|1|||
16107681|NCT00349622|38881433|FG000|Overall Study|Withdrawal by Subject|5|||
16107682|NCT00349622|38881434|FG001|Overall Study|Withdrawal by Subject|9|||
16107683|NCT03927690|38881437|FG000|Overall Study|Withdrawal by Subject|3|||
16107684|NCT03927690|38881438|FG001|Overall Study|Withdrawal by Subject|1|||
16107685|NCT03927690|38881439|FG002|Overall Study|Withdrawal by Subject|1|||
16107686|NCT03927690|38881437|FG000|Overall Study|Adverse Event|1|||
16107687|NCT03927690|38881438|FG001|Overall Study|Adverse Event|0|||
16107688|NCT03927690|38881439|FG002|Overall Study|Adverse Event|0|||
16107689|NCT03927690|38881437|FG000|Overall Study|Death|1|||
16107690|NCT03927690|38881438|FG001|Overall Study|Death|0|||
16107691|NCT03927690|38881439|FG002|Overall Study|Death|0|||
16107692|NCT03927690|38881437|FG000|Overall Study|Lost to Follow-up|2|||
16107693|NCT03927690|38881438|FG001|Overall Study|Lost to Follow-up|2|||
16107694|NCT03927690|38881439|FG002|Overall Study|Lost to Follow-up|1|||
16107695|NCT00761956|38881440|FG000|Overall Study|Lost to Follow-up|6|||
16107696|NCT00761956|38881441|FG001|Overall Study|Lost to Follow-up|11|||
16107697|NCT00761956|38881440|FG000|Overall Study|Withdrawal by Subject|3|||
16107698|NCT00761956|38881441|FG001|Overall Study|Withdrawal by Subject|8|||
16107699|NCT00761956|38881440|FG000|Overall Study|Death|0|||
16107700|NCT00761956|38881441|FG001|Overall Study|Death|1|||
16107701|NCT00761956|38881440|FG000|Overall Study|Adverse Event|26|||
16107702|NCT00761956|38881441|FG001|Overall Study|Adverse Event|34|||
16107703|NCT04706793|38881447|FG000|Treatment|Disease worsening|10|||
16107704|NCT04706793|38881448|FG001|Treatment|Disease worsening|10|||
16107705|NCT04706793|38881447|FG000|Follow-up|Lack of Efficacy|1|||
16107706|NCT04706793|38881448|FG001|Follow-up|Lack of Efficacy|0|||
16107707|NCT04706793|38881447|FG000|Follow-up|Disease worsening|8|||
16107708|NCT04706793|38881448|FG001|Follow-up|Disease worsening|10|||
16107709|NCT04706793|38881447|FG000|Follow-up|Adverse Event|1|||
16107710|NCT04706793|38881448|FG001|Follow-up|Adverse Event|0|||
16107711|NCT00478647|38881449|FG000|Overall Study|Adverse Event|1|||
16219486|NCT01497899|39282937|FG001|Open-Label Extension Phase|Death|0|||
16219487|NCT01497899|39282938|FG002|Open-Label Extension Phase|Death|0|||
16107712|NCT00478647|38881449|FG000|Overall Study|Withdrawal by Subject|1|||
16107713|NCT00632931|38881450|FG000|Part 1, Period 1|Protocol Violation|1|||
16107714|NCT00632931|38881451|FG001|Part 1, Period 1|Protocol Violation|0|||
16107715|NCT00632931|38881452|FG002|Part 1, Period 1|Protocol Violation|0|||
16107716|NCT00632931|38881450|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
16107717|NCT00632931|38881451|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
16107718|NCT00632931|38881452|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
16107719|NCT00632931|38881450|FG000|Part 2|Adverse Event|0|||
16107720|NCT00632931|38881451|FG001|Part 2|Adverse Event|0|||
16107721|NCT00632931|38881452|FG002|Part 2|Adverse Event|3|||
16107722|NCT00632931|38881450|FG000|Part 2|Death|0|||
16107723|NCT00632931|38881451|FG001|Part 2|Death|0|||
16107724|NCT00632931|38881452|FG002|Part 2|Death|1|||
16107725|NCT00632931|38881450|FG000|Part 2|Lack of Efficacy|0|||
16107726|NCT00632931|38881451|FG001|Part 2|Lack of Efficacy|0|||
16107727|NCT00632931|38881452|FG002|Part 2|Lack of Efficacy|17|||
16107728|NCT00632931|38881450|FG000|Part 2|Withdrawal by Subject|0|||
16107729|NCT00632931|38881451|FG001|Part 2|Withdrawal by Subject|0|||
16107730|NCT00632931|38881452|FG002|Part 2|Withdrawal by Subject|3|||
16107731|NCT00715117|38881453|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
16107732|NCT00715117|38881454|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
16107733|NCT01587118|38881455|FG000|Overall Study|Adverse Event|3|||
16107734|NCT01587118|38881455|FG000|Overall Study|Lost to Follow-up|2|||
16107735|NCT01587118|38881455|FG000|Overall Study|Relocation|1|||
16107736|NCT01587118|38881455|FG000|Overall Study|nonresponse|1|||
16107737|NCT00776659|38881467|FG000|Overall Study|Lost to Follow-up|15|||
16107738|NCT00776659|38881467|FG000|Overall Study|Withdrawal by Subject|10|||
16107739|NCT00776659|38881467|FG000|Overall Study|Study Terminated by Sponsor|1|||
16107740|NCT01161446|38881468|FG000|Overall Study|Lost to Follow-up|18|||
16107741|NCT01161446|38881469|FG001|Overall Study|Lost to Follow-up|14|||
16107742|NCT01161446|38881468|FG000|Overall Study|Withdrawal by Subject|0|||
16107743|NCT01161446|38881469|FG001|Overall Study|Withdrawal by Subject|1|||
16107744|NCT03561597|38881470|FG000|Overall Study|Lost to Follow-up|20|||
16107745|NCT00537329|38881473|FG000|Overall Study|Death|10|||
16341283|NCT02070978|39734611|FG000|Overall Study|Protocol Violation|1|||
16341284|NCT02070978|39734612|FG001|Overall Study|Protocol Violation|0|||
16341285|NCT02070978|39734613|FG002|Overall Study|Protocol Violation|3|||
16341286|NCT02070978|39734611|FG000|Overall Study|Lack of Efficacy|0|||
16341287|NCT02070978|39734612|FG001|Overall Study|Lack of Efficacy|1|||
16341288|NCT02070978|39734613|FG002|Overall Study|Lack of Efficacy|0|||
16341289|NCT02070978|39734611|FG000|Overall Study|Death|0|||
16341290|NCT02070978|39734612|FG001|Overall Study|Death|0|||
16107746|NCT00537329|38881473|FG000|Overall Study|Adverse Event|3|||
16107747|NCT00537329|38881473|FG000|Overall Study|Lack of Efficacy|2|||
16107748|NCT00537329|38881473|FG000|Overall Study|Lost to Follow-up|6|||
16107749|NCT00537329|38881473|FG000|Overall Study|Withdrawal by Subject|4|||
16107750|NCT00537329|38881473|FG000|Overall Study|Other|1|||
16107751|NCT03599622|38881474|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
16107752|NCT03599622|38881475|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
16341291|NCT02070978|39734613|FG002|Overall Study|Death|2|||
16107753|NCT03599622|38881476|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
16107754|NCT03599622|38881477|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
16107755|NCT03599622|38881474|FG000|Pre-Treatment Period|Other reasons|1|||
16341292|NCT02070978|39734611|FG000|Overall Study|Un-specified|3|||
16341293|NCT02070978|39734612|FG001|Overall Study|Un-specified|2|||
16107756|NCT03599622|38881475|FG001|Pre-Treatment Period|Other reasons|1|||
16107757|NCT03599622|38881476|FG002|Pre-Treatment Period|Other reasons|1|||
16107758|NCT03599622|38881477|FG003|Pre-Treatment Period|Other reasons|0|||
16107759|NCT03599622|38881474|FG000|Treatment Period|Adverse Event|11|||
16341294|NCT02070978|39734613|FG002|Overall Study|Un-specified|2|||
16341295|NCT02070978|39734611|FG000|Overall Study|Terminated by Sponsor|33|||
16341296|NCT02070978|39734612|FG001|Overall Study|Terminated by Sponsor|40|||
16341297|NCT02070978|39734613|FG002|Overall Study|Terminated by Sponsor|39|||
16341298|NCT01900899|39734614|FG000|Overall Study|Withdrawal by Subject|7|||
16341299|NCT01900899|39734615|FG001|Overall Study|Withdrawal by Subject|1|||
16341300|NCT01900899|39734614|FG000|Overall Study|Migrated from study area|2|||
16341301|NCT01900899|39734615|FG001|Overall Study|Migrated from study area|0|||
16341302|NCT01677182|39734616|FG000|Overall Study|Adverse Event|2|||
16341303|NCT01677182|39734617|FG001|Overall Study|Adverse Event|1|||
16341304|NCT01677182|39734618|FG002|Overall Study|Adverse Event|8|||
16341305|NCT01677182|39734616|FG000|Overall Study|Protocol Violation|5|||
16341306|NCT01677182|39734617|FG001|Overall Study|Protocol Violation|1|||
16341307|NCT01677182|39734618|FG002|Overall Study|Protocol Violation|4|||
16341308|NCT01677182|39734616|FG000|Overall Study|Lost to Follow-up|4|||
16341309|NCT01677182|39734617|FG001|Overall Study|Lost to Follow-up|0|||
16341310|NCT01677182|39734618|FG002|Overall Study|Lost to Follow-up|3|||
16341311|NCT01677182|39734616|FG000|Overall Study|Withdrawal by Subject|7|||
16341312|NCT01677182|39734617|FG001|Overall Study|Withdrawal by Subject|12|||
16341313|NCT01677182|39734618|FG002|Overall Study|Withdrawal by Subject|10|||
16341314|NCT01677182|39734616|FG000|Overall Study|Study termination|12|||
16341315|NCT01677182|39734617|FG001|Overall Study|Study termination|9|||
16341316|NCT01677182|39734618|FG002|Overall Study|Study termination|11|||
16341317|NCT01677182|39734616|FG000|Overall Study|Lack of Efficacy|3|||
16341318|NCT01677182|39734617|FG001|Overall Study|Lack of Efficacy|0|||
16341319|NCT01677182|39734618|FG002|Overall Study|Lack of Efficacy|1|||
16341320|NCT01677182|39734616|FG000|Overall Study|Other reasons|1|||
16341321|NCT01677182|39734617|FG001|Overall Study|Other reasons|5|||
16341322|NCT01677182|39734618|FG002|Overall Study|Other reasons|2|||
16341323|NCT01084538|39734621|FG000|Overall Study|Drug not available|30|||
16341324|NCT01084538|39734621|FG000|Overall Study|Adverse Event|9|||
16341325|NCT01084538|39734621|FG000|Overall Study|Kidney transplant|6|||
16341326|NCT01084538|39734621|FG000|Overall Study|Serious Adverse Event|3|||
16219488|NCT01497899|39282939|FG003|Open-Label Extension Phase|Death|0|||
16219489|NCT01497899|39282936|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
16341327|NCT01084538|39734621|FG000|Overall Study|Lack of effectiveness|2|||
16341328|NCT01084538|39734621|FG000|Overall Study|Patient noncompliance|2|||
16341329|NCT01084538|39734621|FG000|Overall Study|Hyperphosphatemia|2|||
16341330|NCT01084538|39734621|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
16341331|NCT01084538|39734621|FG000|Overall Study|Change of residence|2|||
16341332|NCT01084538|39734621|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
16341333|NCT01084538|39734621|FG000|Overall Study|Reason unknown|8|||
16341334|NCT01004432|39734622|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
16341335|NCT01004432|39734623|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
16341336|NCT01004432|39734624|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
16341337|NCT01004432|39734625|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
16341338|NCT01004432|39734626|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
16341339|NCT01004432|39734622|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
16341340|NCT01004432|39734623|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
16341341|NCT01004432|39734624|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
16341342|NCT01004432|39734625|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
16341343|NCT01004432|39734626|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
16341344|NCT01004432|39734622|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
16341345|NCT01004432|39734623|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
16341346|NCT01004432|39734624|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
16341347|NCT01004432|39734625|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
16341348|NCT01004432|39734626|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
16341349|NCT01004432|39734622|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
16341350|NCT01004432|39734623|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
16341351|NCT01004432|39734624|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
16341352|NCT01004432|39734625|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
16341353|NCT01004432|39734626|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
16341354|NCT01004432|39734622|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
16341355|NCT01004432|39734623|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
16341356|NCT01004432|39734624|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
16341357|NCT01004432|39734625|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
16341358|NCT01004432|39734626|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
16341359|NCT01004432|39734622|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
16341360|NCT01004432|39734623|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
16341361|NCT01004432|39734624|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
16341362|NCT01004432|39734625|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
16341363|NCT01004432|39734626|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
16341364|NCT01004432|39734622|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
16341365|NCT01004432|39734623|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
16341366|NCT01004432|39734624|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
16341367|NCT01004432|39734625|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
16341368|NCT01004432|39734626|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
16341369|NCT01004432|39734622|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
16341370|NCT01004432|39734623|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
16341371|NCT01004432|39734624|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
16341372|NCT01004432|39734625|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
16341373|NCT01004432|39734626|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
16341374|NCT01004432|39734622|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
16341375|NCT01004432|39734623|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
16341376|NCT01004432|39734624|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
16341377|NCT01004432|39734625|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
16341378|NCT01004432|39734626|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
16341379|NCT01004432|39734622|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
16341380|NCT01004432|39734623|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
16341381|NCT01004432|39734624|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
16341382|NCT01004432|39734625|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
16341383|NCT01004432|39734626|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
16341384|NCT01004432|39734622|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
16341385|NCT01004432|39734623|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
16341386|NCT01004432|39734624|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
16341387|NCT01004432|39734625|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
16341388|NCT01004432|39734626|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
16219490|NCT01497899|39282937|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
16107760|NCT03599622|38881475|FG001|Treatment Period|Adverse Event|20|||
16107761|NCT03599622|38881476|FG002|Treatment Period|Adverse Event|18|||
16107762|NCT03599622|38881477|FG003|Treatment Period|Adverse Event|2|||
16107763|NCT03599622|38881474|FG000|Treatment Period|Lack of Efficacy|18|||
16107764|NCT03599622|38881475|FG001|Treatment Period|Lack of Efficacy|12|||
16107765|NCT03599622|38881476|FG002|Treatment Period|Lack of Efficacy|13|||
16107766|NCT03599622|38881477|FG003|Treatment Period|Lack of Efficacy|2|||
16107767|NCT03599622|38881474|FG000|Treatment Period|Withdrawal by Subject|5|||
16107768|NCT03599622|38881475|FG001|Treatment Period|Withdrawal by Subject|11|||
16107769|NCT03599622|38881476|FG002|Treatment Period|Withdrawal by Subject|16|||
16107770|NCT03599622|38881477|FG003|Treatment Period|Withdrawal by Subject|1|||
16107771|NCT03599622|38881474|FG000|Treatment Period|Other reasons|4|||
16107772|NCT03599622|38881475|FG001|Treatment Period|Other reasons|6|||
16107773|NCT03599622|38881476|FG002|Treatment Period|Other reasons|7|||
16107774|NCT03599622|38881477|FG003|Treatment Period|Other reasons|0|||
16107775|NCT03599622|38881474|FG000|Treatment Period|Lost to Follow-up|1|||
16107776|NCT03599622|38881475|FG001|Treatment Period|Lost to Follow-up|0|||
16107777|NCT03599622|38881476|FG002|Treatment Period|Lost to Follow-up|0|||
16107778|NCT03599622|38881477|FG003|Treatment Period|Lost to Follow-up|0|||
16107779|NCT03599622|38881474|FG000|Treatment Period|Study terminated by sponsor|7|||
16107780|NCT03599622|38881475|FG001|Treatment Period|Study terminated by sponsor|20|||
16107781|NCT03599622|38881476|FG002|Treatment Period|Study terminated by sponsor|15|||
16107782|NCT03599622|38881477|FG003|Treatment Period|Study terminated by sponsor|0|||
16107783|NCT03599622|38881474|FG000|Treatment Period|Site terminated by sponsor|0|||
16107784|NCT03599622|38881475|FG001|Treatment Period|Site terminated by sponsor|1|||
16107785|NCT03599622|38881476|FG002|Treatment Period|Site terminated by sponsor|0|||
16107786|NCT03599622|38881477|FG003|Treatment Period|Site terminated by sponsor|0|||
16107787|NCT00983905|38881478|FG000|Theophylline Alone|Adverse Event|1|||
16406657|NCT00980460|39969862|FG003|Overall Study|No transplant by protocol timepoints|0|||
16406658|NCT00980460|39969863|FG004|Overall Study|No transplant by protocol timepoints|0|||
16406659|NCT00919867|39969864|FG000|First Intervention|Withdrawal by Subject|0|||
16406660|NCT00919867|39969865|FG001|First Intervention|Withdrawal by Subject|0|||
16406661|NCT00919867|39969866|FG002|First Intervention|Withdrawal by Subject|1|||
16406662|NCT00919867|39969867|FG003|First Intervention|Withdrawal by Subject|0|||
16406663|NCT00919867|39969868|FG004|First Intervention|Withdrawal by Subject|0|||
16406664|NCT00919867|39969869|FG005|First Intervention|Withdrawal by Subject|0|||
16406665|NCT00919867|39969864|FG000|First Intervention|Physician Decision|0|||
16406666|NCT00919867|39969865|FG001|First Intervention|Physician Decision|0|||
16406667|NCT00919867|39969866|FG002|First Intervention|Physician Decision|0|||
16107788|NCT00983905|38881478|FG000|Colchicine Alone|Adverse Event|2|||
16107789|NCT02175745|38885077|FG000|Overall Study|Not Eligible|1|||
16107790|NCT04969276|38885078|FG000|Overall Study|Protocol Deviation|0|||
16107791|NCT04969276|38885079|FG001|Overall Study|Protocol Deviation|1|||
16406668|NCT00919867|39969867|FG003|First Intervention|Physician Decision|0|||
16406669|NCT00919867|39969868|FG004|First Intervention|Physician Decision|0|||
16406670|NCT00919867|39969869|FG005|First Intervention|Physician Decision|1|||
16542135|NCT04102579|40446820|FG000|Overall Study|Withdrawal by Subject|3|||
16542136|NCT04102579|40446821|FG001|Overall Study|Withdrawal by Subject|4|||
16542137|NCT04102579|40446820|FG000|Overall Study|Lost to Follow-up|0|||
16542138|NCT04102579|40446821|FG001|Overall Study|Lost to Follow-up|1|||
16542139|NCT04102579|40446820|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
16542140|NCT04102579|40446821|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
16542141|NCT04102579|40446820|FG000|Overall Study|Other than Specified|1|||
16542142|NCT04102579|40446821|FG001|Overall Study|Other than Specified|0|||
16542143|NCT04102579|40446820|FG000|Overall Study|Not Dosed with Study Drug|0|||
16542144|NCT04102579|40446821|FG001|Overall Study|Not Dosed with Study Drug|1|||
16542145|NCT01323530|40446822|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
16542146|NCT01323530|40446823|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16542147|NCT01323530|40446824|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16542148|NCT01323530|40446825|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16542149|NCT01323530|40446826|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16542150|NCT01323530|40446827|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
16542151|NCT01323530|40446828|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16542152|NCT01323530|40446822|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
16107792|NCT04969276|38885080|FG002|Overall Study|Protocol Deviation|0|||
16406671|NCT00624819|39969871|FG000|Follow-up Period: Year 4|Parents decision|0|||
16406672|NCT00624819|39969872|FG001|Follow-up Period: Year 4|Parents decision|0|||
16406673|NCT00624819|39969873|FG002|Follow-up Period: Year 4|Parents decision|1|||
16406674|NCT00624819|39969874|FG003|Follow-up Period: Year 4|Parents decision|0|||
16542153|NCT01323530|40446823|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
16542154|NCT01323530|40446824|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
16542155|NCT01323530|40446825|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16107793|NCT04969276|38885078|FG000|Overall Study|Withdrawal by Subject|1|||
16107794|NCT04969276|38885079|FG001|Overall Study|Withdrawal by Subject|10|||
16406675|NCT00624819|39969871|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
16406676|NCT00624819|39969872|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
16406677|NCT00624819|39969873|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
16107795|NCT04969276|38885080|FG002|Overall Study|Withdrawal by Subject|0|||
16107796|NCT04969276|38885078|FG000|Overall Study|Lost to Follow-up|0|||
16107797|NCT04969276|38885079|FG001|Overall Study|Lost to Follow-up|1|||
16107798|NCT04969276|38885080|FG002|Overall Study|Lost to Follow-up|0|||
16107799|NCT03128671|38885082|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
16107800|NCT03128671|38885083|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
16107801|NCT03128671|38885082|FG000|Allocation|Death|1|||
16107802|NCT03128671|38885083|FG001|Allocation|Death|0|||
16107803|NCT03128671|38885082|FG000|Allocation|Withdrawal by Subject|4|||
16107804|NCT03128671|38885083|FG001|Allocation|Withdrawal by Subject|0|||
16107805|NCT03128671|38885082|FG000|Intervention|Withdrawal by Subject|11|||
16107806|NCT03128671|38885083|FG001|Intervention|Withdrawal by Subject|10|||
16406678|NCT00624819|39969874|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
16406679|NCT01218100|39969875|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
16406680|NCT01218100|39969876|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
16406681|NCT01218100|39969877|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
16406682|NCT01218100|39969878|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
16406683|NCT01218100|39969875|FG000|Overall Study|Adverse Event|4|||
16406684|NCT01218100|39969876|FG001|Overall Study|Adverse Event|6|||
16406685|NCT01218100|39969877|FG002|Overall Study|Adverse Event|6|||
16107807|NCT03128671|38885082|FG000|Intervention|Palliative/hospice care initiated|9|||
16107808|NCT03128671|38885083|FG001|Intervention|Palliative/hospice care initiated|10|||
16406686|NCT01218100|39969878|FG003|Overall Study|Adverse Event|7|||
16406687|NCT01218100|39969875|FG000|Overall Study|Lack of Efficacy|9|||
16406688|NCT01218100|39969876|FG001|Overall Study|Lack of Efficacy|6|||
16406689|NCT01218100|39969877|FG002|Overall Study|Lack of Efficacy|5|||
16406690|NCT01218100|39969878|FG003|Overall Study|Lack of Efficacy|12|||
16406691|NCT01218100|39969875|FG000|Overall Study|Protocol Violation|0|||
16406692|NCT01218100|39969876|FG001|Overall Study|Protocol Violation|0|||
16406693|NCT01218100|39969877|FG002|Overall Study|Protocol Violation|1|||
16406694|NCT01218100|39969878|FG003|Overall Study|Protocol Violation|1|||
16406695|NCT01218100|39969875|FG000|Overall Study|Withdrawal by Subject|5|||
16406696|NCT01218100|39969876|FG001|Overall Study|Withdrawal by Subject|2|||
16406697|NCT01218100|39969877|FG002|Overall Study|Withdrawal by Subject|6|||
16406698|NCT01218100|39969878|FG003|Overall Study|Withdrawal by Subject|7|||
16406699|NCT01218100|39969875|FG000|Overall Study|Lost to Follow-up|3|||
16406700|NCT01218100|39969876|FG001|Overall Study|Lost to Follow-up|8|||
16406701|NCT01218100|39969877|FG002|Overall Study|Lost to Follow-up|2|||
16542156|NCT01323530|40446826|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
16542157|NCT01323530|40446827|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16542158|NCT01323530|40446828|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16542159|NCT01323530|40446822|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
16542160|NCT01323530|40446823|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
16542161|NCT01323530|40446824|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
16542162|NCT01323530|40446825|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
16542163|NCT01323530|40446826|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
16542164|NCT01323530|40446827|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
16542165|NCT01323530|40446828|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
16542166|NCT01323530|40446822|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16542167|NCT01323530|40446823|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16542168|NCT01323530|40446824|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16542169|NCT01323530|40446825|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16542170|NCT01323530|40446826|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16542171|NCT01323530|40446827|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
16542172|NCT01323530|40446828|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
16542173|NCT01323530|40446822|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16542174|NCT01323530|40446823|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16542175|NCT01323530|40446824|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16542176|NCT01323530|40446825|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16542177|NCT01323530|40446826|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16406702|NCT01218100|39969878|FG003|Overall Study|Lost to Follow-up|1|||
16406703|NCT01218100|39969875|FG000|Overall Study|Other Reason|2|||
16406704|NCT01218100|39969876|FG001|Overall Study|Other Reason|2|||
16406705|NCT01218100|39969877|FG002|Overall Study|Other Reason|6|||
16542178|NCT01323530|40446827|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
16542179|NCT01323530|40446828|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
16107809|NCT03128671|38885082|FG000|Intervention|Death|13|||
16107810|NCT03128671|38885083|FG001|Intervention|Death|11|||
16406706|NCT01218100|39969878|FG003|Overall Study|Other Reason|4|||
16406707|NCT00681564|39969883|FG000|Overall Study|Lost to Follow-up|6|||
16406708|NCT00681564|39969884|FG001|Overall Study|Lost to Follow-up|6|||
16107811|NCT03128671|38885082|FG000|Intervention|Interrupted by hurricane|1|||
16107812|NCT03128671|38885083|FG001|Intervention|Interrupted by hurricane|0|||
16107813|NCT03128671|38885082|FG000|Intervention|Physician Decision|2|||
16107814|NCT03128671|38885083|FG001|Intervention|Physician Decision|3|||
16107815|NCT01111240|38885084|FG000|Overall Study|Adverse Event|190|||
16107816|NCT01111240|38885084|FG000|Overall Study|Lack of Efficacy|545|||
16107817|NCT01111240|38885084|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
16107818|NCT01111240|38885084|FG000|Overall Study|Other|312|||
16107819|NCT02151643|38885087|FG000|Overall Study|Adverse Event|2|||
16107820|NCT02151643|38885088|FG001|Overall Study|Adverse Event|0|||
16107821|NCT02151643|38885089|FG002|Overall Study|Adverse Event|1|||
16107822|NCT02151643|38885090|FG003|Overall Study|Adverse Event|4|||
16107823|NCT02151643|38885091|FG004|Overall Study|Adverse Event|0|||
16107824|NCT02151643|38885087|FG000|Overall Study|Withdrawal by Subject|0|||
16107825|NCT02151643|38885088|FG001|Overall Study|Withdrawal by Subject|1|||
16107826|NCT02151643|38885089|FG002|Overall Study|Withdrawal by Subject|1|||
16107827|NCT02151643|38885090|FG003|Overall Study|Withdrawal by Subject|1|||
16406709|NCT00681564|39969883|FG000|Overall Study|Withdrawal by Subject|0|||
16406710|NCT00681564|39969884|FG001|Overall Study|Withdrawal by Subject|1|||
16406711|NCT00681564|39969883|FG000|Overall Study|Death|0|||
16406712|NCT00681564|39969884|FG001|Overall Study|Death|1|||
16406713|NCT02226562|39969885|FG000|Overall Study|Lost to Follow-up|0|||
16107828|NCT02151643|38885091|FG004|Overall Study|Withdrawal by Subject|1|||
16107829|NCT02151643|38885087|FG000|Overall Study|Hyperphosphataemia|1|||
16107830|NCT02151643|38885088|FG001|Overall Study|Hyperphosphataemia|0|||
16107831|NCT02151643|38885089|FG002|Overall Study|Hyperphosphataemia|0|||
16107832|NCT02151643|38885090|FG003|Overall Study|Hyperphosphataemia|0|||
16107833|NCT02151643|38885091|FG004|Overall Study|Hyperphosphataemia|1|||
16107834|NCT02151643|38885087|FG000|Overall Study|High Ferritin levels|3|||
16406714|NCT02226562|39969886|FG001|Overall Study|Lost to Follow-up|1|||
16341389|NCT01004432|39734622|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
16341390|NCT01004432|39734623|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
16341391|NCT01004432|39734624|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
16107835|NCT02151643|38885088|FG001|Overall Study|High Ferritin levels|3|||
16107836|NCT02151643|38885089|FG002|Overall Study|High Ferritin levels|2|||
16107837|NCT02151643|38885090|FG003|Overall Study|High Ferritin levels|2|||
16107838|NCT02151643|38885091|FG004|Overall Study|High Ferritin levels|1|||
16107839|NCT00695136|38885092|FG000|Overall Study|Withdrawal by Subject|1|||
16107840|NCT00695136|38885092|FG000|Overall Study|unrelated adverse event|1|||
16107841|NCT01657877|38885093|FG000|Overall Study|Withdrawal by Subject|4|||
16107842|NCT01657877|38885093|FG000|Overall Study|Protocol Violation|6|||
16107843|NCT01657877|38885093|FG000|Overall Study|Adverse Event|2|||
16107844|NCT01657877|38885093|FG000|Overall Study|Other Reason|2|||
16107845|NCT02381652|38885094|FG000|Overall Study|Withdrawal by Subject|0|||
16107846|NCT02381652|38885095|FG001|Overall Study|Withdrawal by Subject|0|||
16107847|NCT02381652|38885096|FG002|Overall Study|Withdrawal by Subject|1|||
16107848|NCT03864341|38885100|FG000|Overall Study|Withdrawal by Subject|1|||
16107849|NCT00129649|38885101|FG000|Overall Study|Withdrawal by Subject|76|||
16107850|NCT00129649|38885102|FG001|Overall Study|Withdrawal by Subject|65|||
16107851|NCT00770588|38885103|FG000|Overall Study|Adverse Event|9|||
16107852|NCT00770588|38885104|FG001|Overall Study|Adverse Event|2|||
16107853|NCT00770588|38885103|FG000|Overall Study|Death caused by progression of disease|70|||
16107854|NCT00770588|38885104|FG001|Overall Study|Death caused by progression of disease|91|||
16107855|NCT00770588|38885103|FG000|Overall Study|Lost to Follow-up|1|||
16107856|NCT00770588|38885104|FG001|Overall Study|Lost to Follow-up|1|||
16107857|NCT00770588|38885103|FG000|Overall Study|Withdrawal by Subject|1|||
16107858|NCT00770588|38885104|FG001|Overall Study|Withdrawal by Subject|1|||
16107859|NCT02196077|38885105|FG000|Overall Study|Adverse Event|4|||
16107860|NCT02196077|38885105|FG000|Overall Study|Lack of Efficacy|1|||
16107861|NCT02196077|38885105|FG000|Overall Study|Withdrawal by Subject|14|||
16107862|NCT02196077|38885105|FG000|Overall Study|Physician Decision|1|||
16107863|NCT02196077|38885105|FG000|Overall Study|Lost to Follow-up|3|||
16107864|NCT02196077|38885105|FG000|Overall Study|Protocol Violation|24|||
16107865|NCT00704171|38885108|FG000|Overall Study|Withdrawal by Subject|1|||
16107866|NCT00704171|38885109|FG001|Overall Study|Withdrawal by Subject|0|||
16107867|NCT01181609|38885110|FG000|Overall Study|Adverse Event|1|||
16107868|NCT01181609|38885110|FG000|Overall Study|Withdrawal by Subject|1|||
16406715|NCT01323270|39969887|FG000|Overall Study|Withdrawal by Subject|19|||
16107869|NCT01181609|38885110|FG000|Overall Study|Lost to Follow-up|1|||
16107870|NCT01181609|38885110|FG000|Overall Study|Death|50|||
16406716|NCT01323270|39969888|FG001|Overall Study|Withdrawal by Subject|10|||
16406717|NCT01323270|39969887|FG000|Overall Study|Protocol Violation|9|||
16406718|NCT01323270|39969888|FG001|Overall Study|Protocol Violation|7|||
16406719|NCT01323270|39969887|FG000|Overall Study|Lost to Follow-up|4|||
16406720|NCT01323270|39969888|FG001|Overall Study|Lost to Follow-up|6|||
16107871|NCT02826798|38885112|FG000|Overall Study|Withdrawal by Subject|0|||
16107872|NCT02826798|38885113|FG001|Overall Study|Withdrawal by Subject|1|||
16219491|NCT01497899|39282938|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
16219492|NCT01497899|39282939|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
16219493|NCT01497899|39282936|FG000|Open-Label Extension Phase|Pregnancy|0|||
16219494|NCT01497899|39282937|FG001|Open-Label Extension Phase|Pregnancy|1|||
16219495|NCT01497899|39282938|FG002|Open-Label Extension Phase|Pregnancy|1|||
16219496|NCT01497899|39282939|FG003|Open-Label Extension Phase|Pregnancy|0|||
16219497|NCT01497899|39282936|FG000|Open-Label Extension Phase|Protocol Violation|0|||
16219498|NCT01497899|39282937|FG001|Open-Label Extension Phase|Protocol Violation|0|||
16219499|NCT01497899|39282938|FG002|Open-Label Extension Phase|Protocol Violation|1|||
16219500|NCT01497899|39282939|FG003|Open-Label Extension Phase|Protocol Violation|0|||
16219501|NCT01497899|39282936|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
16219502|NCT01497899|39282937|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
16219503|NCT01497899|39282938|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
16219504|NCT01497899|39282939|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
16219505|NCT02041533|39282940|FG000|Pre-Treatment Period|Disease Progression|1|||
16219506|NCT02041533|39282941|FG001|Pre-Treatment Period|Disease Progression|1|||
16219507|NCT02041533|39282940|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
16219508|NCT02041533|39282941|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
16219509|NCT02041533|39282940|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
16219510|NCT02041533|39282941|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
16219511|NCT02041533|39282940|FG000|Treatment Period|Disease progression|189|||
16219512|NCT02041533|39282941|FG001|Treatment Period|Disease progression|146|||
16219513|NCT02041533|39282940|FG000|Treatment Period|Study drug toxicity|30|||
16219514|NCT02041533|39282941|FG001|Treatment Period|Study drug toxicity|34|||
16219515|NCT02041533|39282940|FG000|Treatment Period|Death|1|||
16219516|NCT02041533|39282941|FG001|Treatment Period|Death|0|||
16219517|NCT02041533|39282940|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
16219518|NCT02041533|39282941|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
16219519|NCT02041533|39282940|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
16219520|NCT02041533|39282941|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
16219521|NCT02041533|39282940|FG000|Treatment Period|Participant withdrew consent|2|||
16341392|NCT01004432|39734625|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
16341393|NCT01004432|39734626|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
16341394|NCT01004432|39734622|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
16341395|NCT01004432|39734623|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
16341396|NCT01004432|39734624|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
16341397|NCT01004432|39734625|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
16341398|NCT01004432|39734626|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
16341399|NCT01004432|39734622|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
16341400|NCT01004432|39734623|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
16341401|NCT01004432|39734624|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
16341402|NCT01004432|39734625|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
16341403|NCT01004432|39734626|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
16341404|NCT01004432|39734622|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
16341405|NCT01004432|39734623|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
16341406|NCT01004432|39734624|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
16341407|NCT01004432|39734625|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
16341408|NCT01004432|39734626|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
16341409|NCT02299388|39734627|FG000|Overall Study|Withdrawal by Subject|0|||
16341410|NCT02299388|39734628|FG001|Overall Study|Withdrawal by Subject|1|||
16341411|NCT05268016|39737985|FG000|Overall Study|Unacceptable toxicity or AE|2|||
16341412|NCT05268016|39737986|FG001|Overall Study|Unacceptable toxicity or AE|2|||
16341413|NCT05268016|39737987|FG002|Overall Study|Unacceptable toxicity or AE|4|||
16341414|NCT05268016|39737988|FG003|Overall Study|Unacceptable toxicity or AE|3|||
16341415|NCT05268016|39737989|FG004|Overall Study|Unacceptable toxicity or AE|1|||
16341416|NCT05268016|39737985|FG000|Overall Study|Withdrawal by Subject|1|||
16341417|NCT05268016|39737986|FG001|Overall Study|Withdrawal by Subject|3|||
16341418|NCT05268016|39737987|FG002|Overall Study|Withdrawal by Subject|2|||
16341419|NCT05268016|39737988|FG003|Overall Study|Withdrawal by Subject|2|||
16341420|NCT05268016|39737989|FG004|Overall Study|Withdrawal by Subject|1|||
16341421|NCT05268016|39737985|FG000|Overall Study|Lost to Follow-up|4|||
16341422|NCT05268016|39737986|FG001|Overall Study|Lost to Follow-up|7|||
16341423|NCT05268016|39737987|FG002|Overall Study|Lost to Follow-up|1|||
16341424|NCT05268016|39737988|FG003|Overall Study|Lost to Follow-up|3|||
16341425|NCT05268016|39737989|FG004|Overall Study|Lost to Follow-up|5|||
16341426|NCT05268016|39737985|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
16341427|NCT05268016|39737986|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
16219522|NCT02041533|39282941|FG001|Treatment Period|Participant withdrew consent|2|||
16341428|NCT05268016|39737987|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
16219523|NCT02041533|39282940|FG000|Treatment Period|Maximum clinical benefit|0|||
16107873|NCT02826798|38885114|FG002|Overall Study|Withdrawal by Subject|0|||
16107874|NCT02826798|38885115|FG003|Overall Study|Withdrawal by Subject|1|||
16107875|NCT02826798|38885116|FG004|Overall Study|Withdrawal by Subject|0|||
16107876|NCT03246347|38885117|FG000|Overall Study|On Study|23|||
16107877|NCT01192776|38885118|FG000|Overall Study|Death|8|||
16107878|NCT01192776|38885119|FG001|Overall Study|Death|15|||
16406721|NCT01323270|39969887|FG000|Overall Study|Adverse Event|8|||
16406722|NCT01323270|39969888|FG001|Overall Study|Adverse Event|0|||
16406723|NCT01323270|39969887|FG000|Overall Study|Other|0|||
16406724|NCT01323270|39969888|FG001|Overall Study|Other|3|||
16406725|NCT01323270|39969887|FG000|Overall Study|Physician Decision|0|||
16406726|NCT01323270|39969888|FG001|Overall Study|Physician Decision|2|||
16406727|NCT01323270|39969887|FG000|Overall Study|Not eligible|1|||
16406728|NCT01323270|39969888|FG001|Overall Study|Not eligible|1|||
16406729|NCT01323270|39969887|FG000|Overall Study|Death|1|||
16406730|NCT01323270|39969888|FG001|Overall Study|Death|0|||
16406731|NCT01323270|39969887|FG000|Overall Study|Randomized, but not vaccinated|1|||
16406732|NCT01323270|39969888|FG001|Overall Study|Randomized, but not vaccinated|0|||
16406733|NCT01165320|39969889|FG000|Overall Study|Clinical adverse experience|2|||
16406734|NCT01165320|39969890|FG001|Overall Study|Clinical adverse experience|1|||
16406735|NCT01165320|39969891|FG002|Overall Study|Clinical adverse experience|0|||
16219524|NCT02041533|39282941|FG001|Treatment Period|Maximum clinical benefit|18|||
16219525|NCT02041533|39282940|FG000|Treatment Period|Poor/Non-compliance|1|||
16219526|NCT02041533|39282941|FG001|Treatment Period|Poor/Non-compliance|0|||
16219527|NCT02041533|39282940|FG000|Treatment Period|Administrative reason by sponsor|1|||
16219528|NCT02041533|39282941|FG001|Treatment Period|Administrative reason by sponsor|0|||
16219529|NCT02041533|39282940|FG000|Treatment Period|Other reasons|9|||
16219530|NCT02041533|39282941|FG001|Treatment Period|Other reasons|2|||
16219531|NCT02041533|39282940|FG000|Treatment Period|Not Reported|0|||
16219532|NCT02041533|39282941|FG001|Treatment Period|Not Reported|1|||
16219533|NCT03245840|39282942|FG000|Overall Study|Adverse Event|6|||
16219534|NCT03245840|39282943|FG001|Overall Study|Adverse Event|0|||
16219535|NCT03245840|39282942|FG000|Overall Study|Death|2|||
16219536|NCT03245840|39282943|FG001|Overall Study|Death|0|||
16219537|NCT03245840|39282942|FG000|Overall Study|Withdrawal by Subject|31|||
16219538|NCT03245840|39282943|FG001|Overall Study|Withdrawal by Subject|1|||
16219539|NCT03245840|39282942|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
16219540|NCT03245840|39282943|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16219541|NCT03245840|39282942|FG000|Overall Study|Physician Decision|4|||
16219542|NCT03245840|39282943|FG001|Overall Study|Physician Decision|1|||
16219543|NCT03245840|39282942|FG000|Overall Study|Study Terminated by Sponsor|56|||
16219544|NCT03245840|39282943|FG001|Overall Study|Study Terminated by Sponsor|6|||
16219545|NCT03245840|39282942|FG000|Overall Study|Site Terminated by Sponsor|4|||
16219546|NCT03245840|39282943|FG001|Overall Study|Site Terminated by Sponsor|0|||
16219547|NCT03245840|39282942|FG000|Overall Study|Lost to Follow-up|12|||
16219548|NCT03245840|39282943|FG001|Overall Study|Lost to Follow-up|2|||
16219549|NCT03245840|39282942|FG000|Overall Study|Pregnancy|2|||
16219550|NCT03245840|39282943|FG001|Overall Study|Pregnancy|0|||
16406736|NCT01165320|39969889|FG000|Overall Study|Laboratory adverse experience|1|||
16406737|NCT01165320|39969890|FG001|Overall Study|Laboratory adverse experience|0|||
16406738|NCT01165320|39969891|FG002|Overall Study|Laboratory adverse experience|0|||
16219551|NCT03245840|39282942|FG000|Overall Study|Non-Compliance with Study Drug|2|||
16219552|NCT03245840|39282943|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16219553|NCT03245840|39282942|FG000|Overall Study|Not treated|1|||
16406739|NCT01165320|39969889|FG000|Overall Study|Lack of Efficacy|0|||
16406740|NCT01165320|39969890|FG001|Overall Study|Lack of Efficacy|2|||
16406741|NCT01165320|39969891|FG002|Overall Study|Lack of Efficacy|0|||
16107879|NCT01192776|38885120|FG002|Overall Study|Death|18|||
16219554|NCT03245840|39282943|FG001|Overall Study|Not treated|1|||
16219555|NCT00963469|39282944|FG000|Overall Study|Adverse Event|15|||
16219556|NCT00963469|39282945|FG001|Overall Study|Adverse Event|11|||
16219557|NCT00963469|39282946|FG002|Overall Study|Adverse Event|1|||
16219558|NCT00963469|39282944|FG000|Overall Study|Lack of Efficacy|10|||
16219559|NCT00963469|39282945|FG001|Overall Study|Lack of Efficacy|7|||
16219560|NCT00963469|39282946|FG002|Overall Study|Lack of Efficacy|2|||
16219561|NCT00963469|39282944|FG000|Overall Study|Lost to Follow-up|1|||
16219562|NCT00963469|39282945|FG001|Overall Study|Lost to Follow-up|1|||
16219563|NCT00963469|39282946|FG002|Overall Study|Lost to Follow-up|0|||
16219564|NCT00963469|39282944|FG000|Overall Study|Protocol Violation|5|||
16219565|NCT00963469|39282945|FG001|Overall Study|Protocol Violation|5|||
16219566|NCT00963469|39282946|FG002|Overall Study|Protocol Violation|3|||
16219567|NCT00963469|39282944|FG000|Overall Study|Withdrawal by Subject|4|||
16219568|NCT00963469|39282945|FG001|Overall Study|Withdrawal by Subject|1|||
16219569|NCT00963469|39282946|FG002|Overall Study|Withdrawal by Subject|1|||
16542180|NCT01323530|40446822|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16542181|NCT01323530|40446823|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16542182|NCT01323530|40446824|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16542183|NCT01323530|40446825|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16542184|NCT01323530|40446826|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16542185|NCT01323530|40446827|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
16542186|NCT01323530|40446828|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
16542187|NCT01323530|40446822|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16542188|NCT01323530|40446823|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16542189|NCT01323530|40446824|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16542190|NCT01323530|40446825|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16542191|NCT01323530|40446826|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16542192|NCT01323530|40446827|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
16542193|NCT01323530|40446828|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
16542194|NCT01323530|40446822|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16542195|NCT01323530|40446823|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16542196|NCT01323530|40446824|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16542197|NCT01323530|40446825|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16542198|NCT01323530|40446826|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16542199|NCT01323530|40446827|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
16542200|NCT01323530|40446828|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
16542201|NCT01320943|40446836|FG000|Overall Study|Lost to Follow-up|1|||
16542202|NCT01320943|40446837|FG001|Overall Study|Lost to Follow-up|0|||
16406742|NCT01165320|39969889|FG000|Overall Study|Reason unknown|0|||
16219570|NCT00963469|39282944|FG000|Overall Study|Pre-randomization Adverse Event|1|||
16219571|NCT00963469|39282945|FG001|Overall Study|Pre-randomization Adverse Event|2|||
16219572|NCT00963469|39282946|FG002|Overall Study|Pre-randomization Adverse Event|0|||
16219573|NCT00963469|39282944|FG000|Overall Study|Moved|1|||
16219574|NCT00963469|39282945|FG001|Overall Study|Moved|0|||
16219575|NCT00963469|39282946|FG002|Overall Study|Moved|0|||
16219576|NCT00963469|39282944|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
16406743|NCT01165320|39969890|FG001|Overall Study|Reason unknown|1|||
16107880|NCT01192776|38885121|FG003|Overall Study|Death|15|||
16107881|NCT01192776|38885118|FG000|Overall Study|Lost to Follow-up|3|||
16107882|NCT01192776|38885119|FG001|Overall Study|Lost to Follow-up|6|||
16107883|NCT01192776|38885120|FG002|Overall Study|Lost to Follow-up|3|||
16107884|NCT01192776|38885121|FG003|Overall Study|Lost to Follow-up|5|||
16107885|NCT00727506|38885122|FG000|Overall Study|Adverse Event|0|||
16107886|NCT00727506|38885123|FG001|Overall Study|Adverse Event|0|||
16107887|NCT00727506|38885124|FG002|Overall Study|Adverse Event|4|||
16107888|NCT00727506|38885125|FG003|Overall Study|Adverse Event|4|||
16107889|NCT00727506|38885126|FG004|Overall Study|Adverse Event|1|||
16107890|NCT00727506|38885127|FG005|Overall Study|Adverse Event|8|||
16107891|NCT00727506|38885122|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
16107892|NCT00727506|38885123|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16107893|NCT00727506|38885124|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
16219577|NCT00963469|39282945|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
16406744|NCT01165320|39969891|FG002|Overall Study|Reason unknown|0|||
16107894|NCT00727506|38885125|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16107895|NCT00727506|38885126|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16341429|NCT05268016|39737988|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
16406745|NCT01643850|39969892|FG000|Overall Study|Withdrawal by Subject|0|||
16406746|NCT01643850|39969893|FG001|Overall Study|Withdrawal by Subject|0|||
16406747|NCT01643850|39969894|FG002|Overall Study|Withdrawal by Subject|0|||
16406748|NCT01643850|39969895|FG003|Overall Study|Withdrawal by Subject|0|||
16406749|NCT01643850|39969896|FG004|Overall Study|Withdrawal by Subject|1|||
16406750|NCT01643850|39969897|FG005|Overall Study|Withdrawal by Subject|0|||
16341430|NCT05268016|39737989|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
16341431|NCT05268016|39737985|FG000|Overall Study|Lack of Efficacy|0|||
16341432|NCT05268016|39737986|FG001|Overall Study|Lack of Efficacy|0|||
16341433|NCT05268016|39737987|FG002|Overall Study|Lack of Efficacy|0|||
16341434|NCT05268016|39737988|FG003|Overall Study|Lack of Efficacy|0|||
16341435|NCT05268016|39737989|FG004|Overall Study|Lack of Efficacy|4|||
16341436|NCT05268016|39737985|FG000|Overall Study|Physician Decision|0|||
16341437|NCT05268016|39737986|FG001|Overall Study|Physician Decision|0|||
16341438|NCT05268016|39737987|FG002|Overall Study|Physician Decision|0|||
16341439|NCT05268016|39737988|FG003|Overall Study|Physician Decision|1|||
16341440|NCT05268016|39737989|FG004|Overall Study|Physician Decision|0|||
16406751|NCT01643850|39969898|FG006|Overall Study|Withdrawal by Subject|0|||
16406752|NCT01643850|39969899|FG007|Overall Study|Withdrawal by Subject|0|||
16406753|NCT01643850|39969900|FG008|Overall Study|Withdrawal by Subject|0|||
16406754|NCT01643850|39969892|FG000|Overall Study|Lost to Follow-up|0|||
16406755|NCT01643850|39969893|FG001|Overall Study|Lost to Follow-up|0|||
16406756|NCT01643850|39969894|FG002|Overall Study|Lost to Follow-up|0|||
16406757|NCT01643850|39969895|FG003|Overall Study|Lost to Follow-up|0|||
16406758|NCT01643850|39969896|FG004|Overall Study|Lost to Follow-up|0|||
16406759|NCT01643850|39969897|FG005|Overall Study|Lost to Follow-up|0|||
16406760|NCT01643850|39969898|FG006|Overall Study|Lost to Follow-up|1|||
16406761|NCT01643850|39969899|FG007|Overall Study|Lost to Follow-up|0|||
16406762|NCT01643850|39969900|FG008|Overall Study|Lost to Follow-up|1|||
16406763|NCT01643850|39969892|FG000|Overall Study|Adverse Event|0|||
16406764|NCT01643850|39969893|FG001|Overall Study|Adverse Event|0|||
16406765|NCT01643850|39969894|FG002|Overall Study|Adverse Event|0|||
16406766|NCT01643850|39969895|FG003|Overall Study|Adverse Event|0|||
16406767|NCT01643850|39969896|FG004|Overall Study|Adverse Event|1|||
16406768|NCT01643850|39969897|FG005|Overall Study|Adverse Event|0|||
16406769|NCT01643850|39969898|FG006|Overall Study|Adverse Event|0|||
16406770|NCT01643850|39969899|FG007|Overall Study|Adverse Event|0|||
16406771|NCT01643850|39969900|FG008|Overall Study|Adverse Event|0|||
16406772|NCT01643850|39969892|FG000|Overall Study|Administrative Problems|0|||
16406773|NCT01643850|39969893|FG001|Overall Study|Administrative Problems|0|||
16406774|NCT01643850|39969894|FG002|Overall Study|Administrative Problems|1|||
16406775|NCT01643850|39969895|FG003|Overall Study|Administrative Problems|0|||
16406776|NCT01643850|39969896|FG004|Overall Study|Administrative Problems|1|||
16406777|NCT01643850|39969897|FG005|Overall Study|Administrative Problems|0|||
16406778|NCT01643850|39969898|FG006|Overall Study|Administrative Problems|0|||
16406779|NCT01643850|39969899|FG007|Overall Study|Administrative Problems|0|||
16406780|NCT01643850|39969900|FG008|Overall Study|Administrative Problems|0|||
16406781|NCT03733028|39969901|FG000|Overall Study|Study was stopped by PI|1|||
16406782|NCT03733028|39969902|FG001|Overall Study|Study was stopped by PI|2|||
16406783|NCT01846663|39969903|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
16406784|NCT01846663|39969904|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
16406785|NCT01846663|39969903|FG000|Overall Study|Withdrawal by Subject|1|||
16406786|NCT01846663|39969904|FG001|Overall Study|Withdrawal by Subject|0|||
16406787|NCT01846663|39969903|FG000|Overall Study|Adverse Event|1|||
16406788|NCT01846663|39969904|FG001|Overall Study|Adverse Event|2|||
16406789|NCT02185014|39969908|FG000|Overall Study|Adverse Event|18|||
16406790|NCT02185014|39969908|FG000|Overall Study|Withdrew Consent|8|||
16406791|NCT02185014|39969908|FG000|Overall Study|Lost to Follow-up|4|||
16406792|NCT02185014|39969908|FG000|Overall Study|Lack of Efficacy|14|||
16406793|NCT02185014|39969908|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
16406794|NCT02185014|39969908|FG000|Overall Study|Subject Noncompliance|1|||
16406795|NCT02185014|39969908|FG000|Overall Study|Other|4|||
16406796|NCT00608023|39969909|FG000|Overall Study|Withdrawal by Subject|8|||
16406797|NCT00608023|39969910|FG001|Overall Study|Withdrawal by Subject|10|||
16341441|NCT05268016|39737985|FG000|Overall Study|Other|1|||
16341442|NCT05268016|39737986|FG001|Overall Study|Other|0|||
16406798|NCT00608023|39969911|FG002|Overall Study|Withdrawal by Subject|7|||
16406799|NCT00608023|39969909|FG000|Overall Study|Adverse Event|1|||
16406800|NCT00608023|39969910|FG001|Overall Study|Adverse Event|4|||
16406801|NCT00608023|39969911|FG002|Overall Study|Adverse Event|5|||
16406802|NCT00608023|39969909|FG000|Overall Study|Lost to Follow-up|2|||
16406803|NCT00608023|39969910|FG001|Overall Study|Lost to Follow-up|2|||
16406804|NCT00608023|39969911|FG002|Overall Study|Lost to Follow-up|1|||
16542203|NCT01320943|40446836|FG000|Overall Study|Physician Decision|0|||
16542204|NCT01320943|40446837|FG001|Overall Study|Physician Decision|1|||
16542205|NCT01320943|40446836|FG000|Overall Study|Randomized but not Treated|0|||
16542206|NCT01320943|40446837|FG001|Overall Study|Randomized but not Treated|1|||
16542207|NCT00827541|40446838|FG000|Overall Study|Exitus|1|||
16542208|NCT00827541|40446839|FG001|Overall Study|Exitus|8|||
16542209|NCT00827541|40446838|FG000|Overall Study|Other|1|||
16542210|NCT00827541|40446839|FG001|Overall Study|Other|3|||
16542211|NCT00827541|40446838|FG000|Overall Study|Pathogen not susceptible|1|||
16542212|NCT00827541|40446839|FG001|Overall Study|Pathogen not susceptible|0|||
16107896|NCT00727506|38885127|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16107897|NCT00727506|38885122|FG000|Overall Study|Progressive disease|4|||
16107898|NCT00727506|38885123|FG001|Overall Study|Progressive disease|7|||
16107899|NCT00727506|38885124|FG002|Overall Study|Progressive disease|9|||
16107900|NCT00727506|38885125|FG003|Overall Study|Progressive disease|28|||
16107901|NCT00727506|38885126|FG004|Overall Study|Progressive disease|38|||
16107902|NCT00727506|38885127|FG005|Overall Study|Progressive disease|28|||
16107903|NCT00727506|38885122|FG000|Overall Study|Refused to continue medication|0|||
16107904|NCT00727506|38885123|FG001|Overall Study|Refused to continue medication|1|||
16107905|NCT00727506|38885124|FG002|Overall Study|Refused to continue medication|2|||
16107906|NCT00727506|38885125|FG003|Overall Study|Refused to continue medication|3|||
16107907|NCT00727506|38885126|FG004|Overall Study|Refused to continue medication|1|||
16107908|NCT00727506|38885127|FG005|Overall Study|Refused to continue medication|2|||
16107909|NCT00727506|38885122|FG000|Overall Study|Other reason not described above|0|||
16107910|NCT00727506|38885123|FG001|Overall Study|Other reason not described above|0|||
16107911|NCT00727506|38885124|FG002|Overall Study|Other reason not described above|1|||
16107912|NCT00727506|38885125|FG003|Overall Study|Other reason not described above|4|||
16107913|NCT00727506|38885126|FG004|Overall Study|Other reason not described above|1|||
16107914|NCT00727506|38885127|FG005|Overall Study|Other reason not described above|1|||
16107915|NCT01340300|38885128|FG000|Overall Study|Lost to Follow-up|3|||
16107916|NCT01340300|38885129|FG001|Overall Study|Lost to Follow-up|0|||
16107917|NCT01340300|38885130|FG002|Overall Study|Lost to Follow-up|5|||
16107918|NCT01340300|38885131|FG003|Overall Study|Lost to Follow-up|10|||
16107919|NCT01340300|38885128|FG000|Overall Study|Withdrawal by Subject|5|||
16107920|NCT01340300|38885129|FG001|Overall Study|Withdrawal by Subject|6|||
16107921|NCT01340300|38885130|FG002|Overall Study|Withdrawal by Subject|6|||
16107922|NCT01340300|38885131|FG003|Overall Study|Withdrawal by Subject|3|||
16107923|NCT01340300|38885128|FG000|Overall Study|Adverse Event|1|||
16107924|NCT01340300|38885129|FG001|Overall Study|Adverse Event|0|||
16107925|NCT01340300|38885130|FG002|Overall Study|Adverse Event|4|||
16107926|NCT01340300|38885131|FG003|Overall Study|Adverse Event|0|||
16107927|NCT01340300|38885128|FG000|Overall Study|Physician Decision|0|||
16107928|NCT01340300|38885129|FG001|Overall Study|Physician Decision|1|||
16107929|NCT01340300|38885130|FG002|Overall Study|Physician Decision|0|||
16107930|NCT01340300|38885131|FG003|Overall Study|Physician Decision|0|||
16107931|NCT01340300|38885128|FG000|Overall Study|Unrelated sickness|0|||
16107932|NCT01340300|38885129|FG001|Overall Study|Unrelated sickness|2|||
16107933|NCT01340300|38885130|FG002|Overall Study|Unrelated sickness|0|||
16107934|NCT01340300|38885131|FG003|Overall Study|Unrelated sickness|1|||
16107935|NCT01270828|38885132|FG000|Pregabalin CR SB|Reason Unspecified|0|||
16107936|NCT01270828|38885133|FG001|Pregabalin CR SB|Reason Unspecified|0|||
16107937|NCT01270828|38885134|FG002|Pregabalin CR SB|Reason Unspecified|8|||
16107938|NCT01270828|38885132|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
16107939|NCT01270828|38885133|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
16107940|NCT01270828|38885134|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
16107941|NCT01270828|38885132|FG000|Pregabalin CR SB|Related adverse event|0|||
16107942|NCT01270828|38885133|FG001|Pregabalin CR SB|Related adverse event|0|||
16107943|NCT01270828|38885134|FG002|Pregabalin CR SB|Related adverse event|46|||
16107944|NCT01270828|38885132|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
16107945|NCT01270828|38885133|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
16107946|NCT01270828|38885134|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
16107947|NCT01270828|38885132|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
16107948|NCT01270828|38885133|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
16107949|NCT01270828|38885134|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
16107950|NCT01270828|38885132|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
16107951|NCT01270828|38885133|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
16107952|NCT01270828|38885134|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
16107953|NCT01270828|38885132|FG000|Pregabalin CR SB|Unrelated AE|0|||
16107954|NCT01270828|38885133|FG001|Pregabalin CR SB|Unrelated AE|0|||
16107955|NCT01270828|38885134|FG002|Pregabalin CR SB|Unrelated AE|8|||
16107956|NCT01270828|38885132|FG000|Pregabalin CR SB|Protocol Violation|0|||
16406805|NCT00608023|39969909|FG000|Overall Study|Protocol Violation|1|||
16406806|NCT00608023|39969910|FG001|Overall Study|Protocol Violation|3|||
16406807|NCT00608023|39969911|FG002|Overall Study|Protocol Violation|1|||
16406808|NCT00608023|39969909|FG000|Overall Study|Unknown reason|0|||
16107957|NCT01270828|38885133|FG001|Pregabalin CR SB|Protocol Violation|0|||
16107958|NCT01270828|38885134|FG002|Pregabalin CR SB|Protocol Violation|8|||
16107959|NCT01270828|38885132|FG000|Double Blind Phase|Death|0|||
16107960|NCT01270828|38885133|FG001|Double Blind Phase|Death|1|||
16107961|NCT01270828|38885134|FG002|Double Blind Phase|Death|0|||
16107962|NCT01270828|38885132|FG000|Double Blind Phase|Protocol Violation|0|||
16107963|NCT01270828|38885133|FG001|Double Blind Phase|Protocol Violation|1|||
16107964|NCT01270828|38885134|FG002|Double Blind Phase|Protocol Violation|0|||
16107965|NCT01270828|38885132|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
16107966|NCT01270828|38885133|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
16107967|NCT01270828|38885134|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
16107968|NCT01270828|38885132|FG000|Double Blind Phase|Reason Unspecified|7|||
16107969|NCT01270828|38885133|FG001|Double Blind Phase|Reason Unspecified|4|||
16107970|NCT01270828|38885134|FG002|Double Blind Phase|Reason Unspecified|0|||
16107971|NCT01270828|38885132|FG000|Double Blind Phase|Withdrawal by Subject|6|||
16107972|NCT01270828|38885133|FG001|Double Blind Phase|Withdrawal by Subject|15|||
16107973|NCT01270828|38885134|FG002|Double Blind Phase|Withdrawal by Subject|0|||
16107974|NCT01270828|38885132|FG000|Double Blind Phase|Lost to Follow-up|1|||
16107975|NCT01270828|38885133|FG001|Double Blind Phase|Lost to Follow-up|2|||
16107976|NCT01270828|38885134|FG002|Double Blind Phase|Lost to Follow-up|0|||
16107977|NCT01270828|38885132|FG000|Double Blind Phase|Lack of Efficacy|2|||
16107978|NCT01270828|38885133|FG001|Double Blind Phase|Lack of Efficacy|11|||
16107979|NCT01270828|38885134|FG002|Double Blind Phase|Lack of Efficacy|0|||
16107980|NCT01270828|38885132|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
16107981|NCT01270828|38885133|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
16406809|NCT00608023|39969910|FG001|Overall Study|Unknown reason|3|||
16406810|NCT00608023|39969911|FG002|Overall Study|Unknown reason|0|||
16406811|NCT01367704|39969916|FG000|Overall Study|Lost to Follow-up|47|||
16107982|NCT01270828|38885134|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
16107983|NCT01270828|38885132|FG000|Double Blind Phase|Adverse event related to study drug|5|||
16107984|NCT01270828|38885133|FG001|Double Blind Phase|Adverse event related to study drug|7|||
16107985|NCT01270828|38885134|FG002|Double Blind Phase|Adverse event related to study drug|0|||
16107986|NCT03774875|38885135|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
16107987|NCT03774875|38885136|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
16107988|NCT03774875|38885135|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
16406812|NCT01367704|39969917|FG001|Overall Study|Lost to Follow-up|161|||
16406813|NCT00350272|39969918|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
16406814|NCT00350272|39969919|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
16406815|NCT00350272|39969918|FG000|Blinded 12-Week Treatment|Death|1|||
16406816|NCT00350272|39969919|FG001|Blinded 12-Week Treatment|Death|0|||
16406817|NCT00350272|39969918|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
16406818|NCT00350272|39969919|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
16406819|NCT00350272|39969918|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
16406820|NCT00350272|39969919|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
16406821|NCT00350272|39969918|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
16406822|NCT00350272|39969919|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
16406823|NCT00350272|39969918|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
16406824|NCT00350272|39969919|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
16406825|NCT00350272|39969918|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
16542213|NCT00827541|40446838|FG000|Overall Study|Lack of effectiveness|1|||
16542214|NCT00827541|40446839|FG001|Overall Study|Lack of effectiveness|0|||
16542215|NCT02055157|40446846|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
16542216|NCT02055157|40446847|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
16542217|NCT02055157|40446848|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
16542218|NCT02055157|40446849|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
16542219|NCT02055157|40446846|FG000|Initial 6 Months|Adverse Event|0|||
16542220|NCT02055157|40446847|FG001|Initial 6 Months|Adverse Event|0|||
16542221|NCT02055157|40446848|FG002|Initial 6 Months|Adverse Event|0|||
16542222|NCT02055157|40446849|FG003|Initial 6 Months|Adverse Event|1|||
16542223|NCT02055157|40446846|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
16542224|NCT02055157|40446847|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
16542225|NCT02055157|40446848|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
16542226|NCT02055157|40446849|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
16406826|NCT00350272|39969919|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
16406827|NCT00350272|39969918|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
16406828|NCT00350272|39969919|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
16542227|NCT02055157|40446846|FG000|18-month Extension|Investigator decision|0|||
16542228|NCT02055157|40446847|FG001|18-month Extension|Investigator decision|1|||
16107989|NCT03774875|38885136|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
16107990|NCT03774875|38885135|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
16107991|NCT03774875|38885136|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
16107992|NCT03774875|38885135|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
16107993|NCT03774875|38885136|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
16107994|NCT03774875|38885135|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
16107995|NCT03774875|38885136|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
16341443|NCT05268016|39737987|FG002|Overall Study|Other|1|||
16341444|NCT05268016|39737988|FG003|Overall Study|Other|2|||
16341445|NCT05268016|39737989|FG004|Overall Study|Other|0|||
16341446|NCT03539484|39737990|FG000|Overall Study|Death|1|||
16341447|NCT03539484|39737991|FG001|Overall Study|Death|0|||
16341448|NCT03539484|39737992|FG002|Overall Study|Death|0|||
16341449|NCT03539484|39737993|FG003|Overall Study|Death|2|||
16341450|NCT03539484|39737994|FG004|Overall Study|Death|8|||
16341451|NCT03539484|39737995|FG005|Overall Study|Death|3|||
16341452|NCT03539484|39737996|FG006|Overall Study|Death|0|||
16341453|NCT03539484|39737990|FG000|Overall Study|Lost to Follow-up|0|||
16341454|NCT03539484|39737991|FG001|Overall Study|Lost to Follow-up|1|||
16341455|NCT03539484|39737992|FG002|Overall Study|Lost to Follow-up|0|||
16341456|NCT03539484|39737993|FG003|Overall Study|Lost to Follow-up|0|||
16341457|NCT03539484|39737994|FG004|Overall Study|Lost to Follow-up|1|||
16341458|NCT03539484|39737995|FG005|Overall Study|Lost to Follow-up|0|||
16341459|NCT03539484|39737996|FG006|Overall Study|Lost to Follow-up|0|||
16341460|NCT03539484|39737990|FG000|Overall Study|Withdrawal by Subject|0|||
16542229|NCT02055157|40446848|FG002|18-month Extension|Investigator decision|0|||
16542230|NCT02055157|40446849|FG003|18-month Extension|Investigator decision|0|||
16542231|NCT02055157|40446846|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
16542232|NCT02055157|40446847|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
16542233|NCT02055157|40446848|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
16542234|NCT02055157|40446849|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
16542235|NCT02048072|40446852|FG000|Overall Study|Adverse Event|3|||
16341461|NCT03539484|39737991|FG001|Overall Study|Withdrawal by Subject|0|||
16341462|NCT03539484|39737992|FG002|Overall Study|Withdrawal by Subject|0|||
16341463|NCT03539484|39737993|FG003|Overall Study|Withdrawal by Subject|0|||
16341464|NCT03539484|39737994|FG004|Overall Study|Withdrawal by Subject|2|||
16341465|NCT03539484|39737995|FG005|Overall Study|Withdrawal by Subject|0|||
16341466|NCT03539484|39737996|FG006|Overall Study|Withdrawal by Subject|1|||
16542236|NCT02048072|40446852|FG000|Overall Study|Lost to Follow-up|1|||
16542237|NCT03508843|40446853|FG000|Overall Study|Withdrawal by Subject|1|||
16542238|NCT03508843|40446853|FG000|Overall Study|technical difficulties|2|||
16542239|NCT00696384|40446854|FG000|Open Label Phase|Adverse Event|27|||
16542240|NCT00696384|40446855|FG001|Open Label Phase|Adverse Event|0|||
16542241|NCT00696384|40446856|FG002|Open Label Phase|Adverse Event|0|||
16542242|NCT00696384|40446854|FG000|Open Label Phase|Protocol Violation|18|||
16542243|NCT00696384|40446855|FG001|Open Label Phase|Protocol Violation|0|||
16542244|NCT00696384|40446856|FG002|Open Label Phase|Protocol Violation|0|||
16542245|NCT00696384|40446854|FG000|Open Label Phase|Lost to Follow-up|24|||
16542246|NCT00696384|40446855|FG001|Open Label Phase|Lost to Follow-up|0|||
16542247|NCT00696384|40446856|FG002|Open Label Phase|Lost to Follow-up|0|||
16542248|NCT00696384|40446854|FG000|Open Label Phase|Withdrawal by Subject|37|||
16542249|NCT00696384|40446855|FG001|Open Label Phase|Withdrawal by Subject|0|||
16542250|NCT00696384|40446856|FG002|Open Label Phase|Withdrawal by Subject|0|||
16341467|NCT03539484|39737990|FG000|Overall Study|Study Terminated by Sponsor|0|||
16341468|NCT03539484|39737991|FG001|Overall Study|Study Terminated by Sponsor|0|||
16341469|NCT03539484|39737992|FG002|Overall Study|Study Terminated by Sponsor|1|||
16542251|NCT00696384|40446854|FG000|Open Label Phase|Other|6|||
16107996|NCT03774875|38885135|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
16107997|NCT03774875|38885136|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
16107998|NCT03774875|38885135|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
16107999|NCT03774875|38885136|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
16108000|NCT03774875|38885135|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
16108001|NCT03774875|38885136|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
16108002|NCT03774875|38885135|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
16108003|NCT03774875|38885136|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
16219578|NCT00963469|39282946|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
16219579|NCT00397891|39282950|FG000|Overall Study|Withdrawal by Subject|1|||
16542252|NCT00696384|40446855|FG001|Open Label Phase|Other|0|||
16542253|NCT00696384|40446856|FG002|Open Label Phase|Other|0|||
16542254|NCT00696384|40446854|FG000|Open Label Phase|Lack of Efficacy|3|||
16542255|NCT00696384|40446855|FG001|Open Label Phase|Lack of Efficacy|0|||
16542256|NCT00696384|40446856|FG002|Open Label Phase|Lack of Efficacy|0|||
16406829|NCT00350272|39969918|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
16406830|NCT00350272|39969919|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
16219580|NCT00397891|39282951|FG001|Overall Study|Withdrawal by Subject|0|||
16406831|NCT00350272|39969918|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
16406832|NCT00350272|39969919|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
16406833|NCT00350272|39969918|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
16406834|NCT00350272|39969919|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
16406835|NCT04224272|39969920|FG000|Part 1 - Dose Finding|Death|4|||
16406836|NCT04224272|39969920|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
16406837|NCT04224272|39969920|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
16406838|NCT04224272|39969920|FG000|Part 2 - Dose Expansion|Death|10|||
16406839|NCT04224272|39969920|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
16406840|NCT02300558|39969921|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
16406841|NCT02300558|39969921|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
16406842|NCT02300558|39969921|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
16406843|NCT02300558|39969921|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
16406844|NCT01474772|39969923|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
16406845|NCT01474772|39969924|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
16406846|NCT01474772|39969923|FG000|Period 1|AE not Related to Study Drug|1|||
16406847|NCT01474772|39969924|FG001|Period 1|AE not Related to Study Drug|0|||
16406848|NCT01474772|39969923|FG000|Period 1|Withdrawal by Subject|3|||
16406849|NCT01474772|39969924|FG001|Period 1|Withdrawal by Subject|1|||
16406850|NCT01474772|39969923|FG000|Period 1|Lost to Follow-up|1|||
16406851|NCT01474772|39969924|FG001|Period 1|Lost to Follow-up|0|||
16406852|NCT01474772|39969923|FG000|Period 1|Reason not Specified|1|||
16406853|NCT01474772|39969924|FG001|Period 1|Reason not Specified|1|||
16542257|NCT00696384|40446854|FG000|Open Label Phase|Physician Decision|4|||
16542258|NCT00696384|40446855|FG001|Open Label Phase|Physician Decision|0|||
16542259|NCT00696384|40446856|FG002|Open Label Phase|Physician Decision|0|||
16542260|NCT00696384|40446854|FG000|Double Blind Phase|Adverse Event|0|||
16542261|NCT00696384|40446855|FG001|Double Blind Phase|Adverse Event|2|||
16542262|NCT00696384|40446856|FG002|Double Blind Phase|Adverse Event|2|||
16406854|NCT01474772|39969923|FG000|Washout|AE not Related to Study Drug|2|||
16406855|NCT01474772|39969924|FG001|Washout|AE not Related to Study Drug|0|||
16542263|NCT00696384|40446854|FG000|Double Blind Phase|Lost to Follow-up|0|||
16111465|NCT00760747|38897275|FG001|Study Period II|No drug administered|1|||
16406856|NCT01474772|39969923|FG000|Washout|Withdrawal by Subject|1|||
16406857|NCT01474772|39969924|FG001|Washout|Withdrawal by Subject|0|||
16406858|NCT01474772|39969923|FG000|Washout|Lost to Follow-up|0|||
16406859|NCT01474772|39969924|FG001|Washout|Lost to Follow-up|1|||
16542264|NCT00696384|40446855|FG001|Double Blind Phase|Lost to Follow-up|2|||
16108004|NCT03774875|38885135|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
16108005|NCT03774875|38885136|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
16108006|NCT03774875|38885135|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
16108007|NCT03774875|38885136|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
16108008|NCT03774875|38885135|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
16108009|NCT03774875|38885136|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
16108010|NCT03774875|38885135|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
16108011|NCT03774875|38885136|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
16108012|NCT01726517|38885137|FG000|Overall Study|Withdrawal by Subject|0|||
16108013|NCT01726517|38885138|FG001|Overall Study|Withdrawal by Subject|0|||
16108014|NCT01726517|38885139|FG002|Overall Study|Withdrawal by Subject|1|||
16108015|NCT01726517|38885140|FG003|Overall Study|Withdrawal by Subject|0|||
16108016|NCT01726517|38885141|FG004|Overall Study|Withdrawal by Subject|0|||
16108017|NCT02171130|38885142|FG000|Overall Study|Death|1|||
16108018|NCT02171130|38885142|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
16108019|NCT02171130|38885142|FG000|Overall Study|Discontinued; Site Termination|5|||
16108020|NCT02171130|38885142|FG000|Overall Study|Withdrawal by Subject|3|||
16108021|NCT02171130|38885142|FG000|Overall Study|Physician Decision|1|||
16108022|NCT02171130|38885142|FG000|Overall Study|Lost to Follow-up|1|||
16108023|NCT02171130|38885142|FG000|Overall Study|Met Exclusion Criteria|1|||
16108024|NCT00344032|38885144|FG000|Overall Study|Adverse Event|0|||
16108025|NCT00344032|38885145|FG001|Overall Study|Adverse Event|1|||
16108026|NCT00344032|38885144|FG000|Overall Study|Withdrawal by Subject|6|||
16108027|NCT00344032|38885145|FG001|Overall Study|Withdrawal by Subject|2|||
16108028|NCT00344032|38885144|FG000|Overall Study|Lost to Follow-up|4|||
16108029|NCT00344032|38885145|FG001|Overall Study|Lost to Follow-up|6|||
16108030|NCT00344032|38885144|FG000|Overall Study|Physician Decision|4|||
16108031|NCT00344032|38885145|FG001|Overall Study|Physician Decision|1|||
16108032|NCT01547117|38885146|FG000|Overall Study|Physician Decision|0|||
16108033|NCT01547117|38885147|FG001|Overall Study|Physician Decision|1|||
16108034|NCT01547117|38885148|FG002|Overall Study|Physician Decision|1|||
16108035|NCT01547117|38885149|FG003|Overall Study|Physician Decision|3|||
16108036|NCT01547117|38885146|FG000|Overall Study|Withdrawal by Subject|1|||
16108037|NCT01547117|38885147|FG001|Overall Study|Withdrawal by Subject|2|||
16108038|NCT01547117|38885148|FG002|Overall Study|Withdrawal by Subject|1|||
16108039|NCT01547117|38885149|FG003|Overall Study|Withdrawal by Subject|2|||
16108040|NCT00381797|38885157|FG000|Overall Study|Withdrawal by Subject|1|||
16108041|NCT00381797|38885158|FG001|Overall Study|Withdrawal by Subject|1|||
16108042|NCT00381797|38885159|FG002|Overall Study|Withdrawal by Subject|0|||
16108043|NCT00381797|38885160|FG003|Overall Study|Withdrawal by Subject|0|||
16108044|NCT00381797|38885161|FG004|Overall Study|Withdrawal by Subject|2|||
16108045|NCT00381797|38885157|FG000|Overall Study|Ineligible|0|||
16108046|NCT00381797|38885158|FG001|Overall Study|Ineligible|0|||
16108047|NCT00381797|38885159|FG002|Overall Study|Ineligible|0|||
16108048|NCT00381797|38885160|FG003|Overall Study|Ineligible|1|||
16108049|NCT00381797|38885161|FG004|Overall Study|Ineligible|0|||
16108050|NCT00043186|38885163|FG000|Overall Study|Physician Decision|0|||
16108051|NCT00043186|38885164|FG001|Overall Study|Physician Decision|0|||
16108052|NCT00043186|38885165|FG002|Overall Study|Physician Decision|3|||
16542265|NCT00696384|40446856|FG002|Double Blind Phase|Lost to Follow-up|1|||
16108053|NCT00043186|38885166|FG003|Overall Study|Physician Decision|0|||
16108054|NCT00043186|38885167|FG004|Overall Study|Physician Decision|1|||
16108055|NCT00043186|38885168|FG005|Overall Study|Physician Decision|0|||
16108056|NCT00043186|38885169|FG006|Overall Study|Physician Decision|0|||
16406860|NCT01474772|39969923|FG000|Washout|Reason not Specified|0|||
16406861|NCT01474772|39969924|FG001|Washout|Reason not Specified|1|||
16406862|NCT01474772|39969923|FG000|Period 2|Death|0|||
16406863|NCT01474772|39969924|FG001|Period 2|Death|1|||
16406864|NCT01474772|39969923|FG000|Period 2|AE Related to Study Drug|0|||
16406865|NCT01474772|39969924|FG001|Period 2|AE Related to Study Drug|1|||
16406866|NCT01474772|39969923|FG000|Period 2|AE not Related to Study Drug|4|||
16406867|NCT01474772|39969924|FG001|Period 2|AE not Related to Study Drug|1|||
16406868|NCT01474772|39969923|FG000|Period 2|Lack of Efficacy|1|||
16406869|NCT01474772|39969924|FG001|Period 2|Lack of Efficacy|0|||
16406870|NCT01474772|39969923|FG000|Period 2|Withdrawal by Subject|3|||
16542266|NCT00696384|40446854|FG000|Double Blind Phase|Withdrawal by Subject|0|||
16542267|NCT00696384|40446855|FG001|Double Blind Phase|Withdrawal by Subject|4|||
16542268|NCT00696384|40446856|FG002|Double Blind Phase|Withdrawal by Subject|3|||
16542269|NCT00696384|40446854|FG000|Double Blind Phase|Lack of Efficacy|0|||
16542270|NCT00696384|40446855|FG001|Double Blind Phase|Lack of Efficacy|1|||
16542271|NCT00696384|40446856|FG002|Double Blind Phase|Lack of Efficacy|0|||
16542272|NCT00696384|40446854|FG000|Double Blind Phase|Physician Decision|0|||
16542273|NCT00696384|40446855|FG001|Double Blind Phase|Physician Decision|2|||
16542274|NCT00696384|40446856|FG002|Double Blind Phase|Physician Decision|0|||
16542275|NCT00844857|40446863|FG000|Overall Study|Adverse Event|24|||
16542276|NCT00844857|40446864|FG001|Overall Study|Adverse Event|5|||
16542277|NCT00844857|40446863|FG000|Overall Study|Sponsor Decision|1|||
16108057|NCT00043186|38885170|FG007|Overall Study|Physician Decision|1|||
16108058|NCT00043186|38885171|FG008|Overall Study|Physician Decision|1|||
16108059|NCT00043186|38885163|FG000|Overall Study|Adverse Event|2|||
16108060|NCT00043186|38885164|FG001|Overall Study|Adverse Event|2|||
16108061|NCT00043186|38885165|FG002|Overall Study|Adverse Event|2|||
16108062|NCT00043186|38885166|FG003|Overall Study|Adverse Event|3|||
16108063|NCT00043186|38885167|FG004|Overall Study|Adverse Event|2|||
16108064|NCT00043186|38885168|FG005|Overall Study|Adverse Event|1|||
16108065|NCT00043186|38885169|FG006|Overall Study|Adverse Event|2|||
16108066|NCT00043186|38885170|FG007|Overall Study|Adverse Event|1|||
16108067|NCT00043186|38885171|FG008|Overall Study|Adverse Event|3|||
16108068|NCT00043186|38885163|FG000|Overall Study|Withdrawal by Subject|11|||
16108069|NCT00043186|38885164|FG001|Overall Study|Withdrawal by Subject|8|||
16108070|NCT00043186|38885165|FG002|Overall Study|Withdrawal by Subject|11|||
16108071|NCT00043186|38885166|FG003|Overall Study|Withdrawal by Subject|13|||
16108072|NCT00043186|38885167|FG004|Overall Study|Withdrawal by Subject|14|||
16108073|NCT00043186|38885168|FG005|Overall Study|Withdrawal by Subject|6|||
16108074|NCT00043186|38885169|FG006|Overall Study|Withdrawal by Subject|12|||
16108075|NCT00043186|38885170|FG007|Overall Study|Withdrawal by Subject|9|||
16108076|NCT00043186|38885171|FG008|Overall Study|Withdrawal by Subject|10|||
16108077|NCT00043186|38885163|FG000|Overall Study|Death|0|||
16108078|NCT00043186|38885164|FG001|Overall Study|Death|0|||
16108079|NCT00043186|38885165|FG002|Overall Study|Death|1|||
16108080|NCT00043186|38885166|FG003|Overall Study|Death|0|||
16108081|NCT00043186|38885167|FG004|Overall Study|Death|0|||
16108082|NCT00043186|38885168|FG005|Overall Study|Death|0|||
16108083|NCT00043186|38885169|FG006|Overall Study|Death|2|||
16108084|NCT00043186|38885170|FG007|Overall Study|Death|0|||
16108085|NCT00043186|38885171|FG008|Overall Study|Death|0|||
16108086|NCT00043186|38885163|FG000|Overall Study|Disease progression|1|||
16108087|NCT00043186|38885164|FG001|Overall Study|Disease progression|0|||
16108088|NCT00043186|38885165|FG002|Overall Study|Disease progression|0|||
16108089|NCT00043186|38885166|FG003|Overall Study|Disease progression|3|||
16108090|NCT00043186|38885167|FG004|Overall Study|Disease progression|0|||
16108091|NCT00043186|38885168|FG005|Overall Study|Disease progression|0|||
16108092|NCT00043186|38885169|FG006|Overall Study|Disease progression|0|||
16108093|NCT00043186|38885170|FG007|Overall Study|Disease progression|4|||
16108094|NCT00043186|38885171|FG008|Overall Study|Disease progression|0|||
16108095|NCT00043186|38885163|FG000|Overall Study|Ineligibility determined|0|||
16108096|NCT00043186|38885164|FG001|Overall Study|Ineligibility determined|0|||
16108097|NCT00043186|38885165|FG002|Overall Study|Ineligibility determined|0|||
16108098|NCT00043186|38885166|FG003|Overall Study|Ineligibility determined|0|||
16108099|NCT00043186|38885167|FG004|Overall Study|Ineligibility determined|0|||
16108100|NCT00043186|38885168|FG005|Overall Study|Ineligibility determined|0|||
16108101|NCT00043186|38885169|FG006|Overall Study|Ineligibility determined|0|||
16108102|NCT00043186|38885170|FG007|Overall Study|Ineligibility determined|0|||
16108103|NCT00043186|38885171|FG008|Overall Study|Ineligibility determined|1|||
16108104|NCT00043186|38885163|FG000|Overall Study|Lost to Follow-up|3|||
16108105|NCT00043186|38885164|FG001|Overall Study|Lost to Follow-up|5|||
16108106|NCT00043186|38885165|FG002|Overall Study|Lost to Follow-up|1|||
16108107|NCT00043186|38885166|FG003|Overall Study|Lost to Follow-up|1|||
16108108|NCT00043186|38885167|FG004|Overall Study|Lost to Follow-up|1|||
16108109|NCT00043186|38885168|FG005|Overall Study|Lost to Follow-up|1|||
16108110|NCT00043186|38885169|FG006|Overall Study|Lost to Follow-up|1|||
16108111|NCT00043186|38885170|FG007|Overall Study|Lost to Follow-up|1|||
16108112|NCT00043186|38885171|FG008|Overall Study|Lost to Follow-up|2|||
16108113|NCT00043186|38885163|FG000|Overall Study|Noncompliance|0|||
16108114|NCT00043186|38885164|FG001|Overall Study|Noncompliance|0|||
16108115|NCT00043186|38885165|FG002|Overall Study|Noncompliance|1|||
16406871|NCT01474772|39969924|FG001|Period 2|Withdrawal by Subject|4|||
16406872|NCT01474772|39969923|FG000|Period 2|Lost to Follow-up|1|||
16406873|NCT01474772|39969924|FG001|Period 2|Lost to Follow-up|1|||
16406874|NCT01474772|39969923|FG000|Period 2|Reason not Specified|0|||
16108116|NCT00043186|38885166|FG003|Overall Study|Noncompliance|1|||
16108117|NCT00043186|38885167|FG004|Overall Study|Noncompliance|0|||
16108118|NCT00043186|38885168|FG005|Overall Study|Noncompliance|0|||
16108119|NCT00043186|38885169|FG006|Overall Study|Noncompliance|0|||
16108120|NCT00043186|38885170|FG007|Overall Study|Noncompliance|0|||
16108121|NCT00043186|38885171|FG008|Overall Study|Noncompliance|0|||
16108122|NCT00043186|38885163|FG000|Overall Study|Other|0|||
16108123|NCT00043186|38885164|FG001|Overall Study|Other|0|||
16108124|NCT00043186|38885165|FG002|Overall Study|Other|1|||
16108125|NCT00043186|38885166|FG003|Overall Study|Other|1|||
16108126|NCT00043186|38885167|FG004|Overall Study|Other|0|||
16108127|NCT00043186|38885168|FG005|Overall Study|Other|0|||
16108128|NCT00043186|38885169|FG006|Overall Study|Other|0|||
16108129|NCT00043186|38885170|FG007|Overall Study|Other|0|||
16108130|NCT00043186|38885171|FG008|Overall Study|Other|0|||
16108131|NCT01721746|38885172|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
16108132|NCT01721746|38885173|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
16406875|NCT01474772|39969924|FG001|Period 2|Reason not Specified|2|||
16108133|NCT01721746|38885172|FG000|Pre-Treatment|Withdrawal by Subject|1|||
16108134|NCT01721746|38885173|FG001|Pre-Treatment|Withdrawal by Subject|16|||
16108135|NCT01721746|38885172|FG000|Pre-Treatment|Poor/Non-compliance|1|||
16108136|NCT01721746|38885173|FG001|Pre-Treatment|Poor/Non-compliance|0|||
16108137|NCT01721746|38885172|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
16108138|NCT01721746|38885173|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
16108139|NCT01721746|38885172|FG000|Treatment|Disease Progression|192|||
16108140|NCT01721746|38885173|FG001|Treatment|Disease Progression|74|||
16108141|NCT01721746|38885172|FG000|Treatment|Study Drug Toxicity|19|||
16108142|NCT01721746|38885173|FG001|Treatment|Study Drug Toxicity|11|||
16108143|NCT01721746|38885172|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
16108144|NCT01721746|38885173|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
16108145|NCT01721746|38885172|FG000|Treatment|Participant request to discontinue Study treatment|26|||
16108146|NCT01721746|38885173|FG001|Treatment|Participant request to discontinue Study treatment|7|||
16108147|NCT01721746|38885172|FG000|Treatment|Participant withdrew consent|4|||
16108148|NCT01721746|38885173|FG001|Treatment|Participant withdrew consent|2|||
16108149|NCT01721746|38885172|FG000|Treatment|Maximum Clinical Benefit|9|||
16108150|NCT01721746|38885173|FG001|Treatment|Maximum Clinical Benefit|3|||
16108151|NCT01721746|38885172|FG000|Treatment|Poor/Non-compliance|2|||
16341470|NCT03539484|39737993|FG003|Overall Study|Study Terminated by Sponsor|1|||
16341471|NCT03539484|39737994|FG004|Overall Study|Study Terminated by Sponsor|2|||
16341472|NCT03539484|39737995|FG005|Overall Study|Study Terminated by Sponsor|2|||
16341473|NCT03539484|39737996|FG006|Overall Study|Study Terminated by Sponsor|1|||
16341474|NCT00593918|39737999|FG000|Overall Study|Withdrawal by Subject|5|||
16341475|NCT00593918|39738000|FG001|Overall Study|Withdrawal by Subject|24|||
16341476|NCT03272347|39738001|FG000|Overall Study|Death|0|||
16341477|NCT03272347|39738002|FG001|Overall Study|Death|0|||
16341478|NCT03272347|39738003|FG002|Overall Study|Death|0|||
16341479|NCT03272347|39738004|FG003|Overall Study|Death|1|||
16341480|NCT03272347|39738001|FG000|Overall Study|Lost to Follow-up|1|||
16341481|NCT03272347|39738002|FG001|Overall Study|Lost to Follow-up|3|||
16341482|NCT03272347|39738003|FG002|Overall Study|Lost to Follow-up|5|||
16341483|NCT03272347|39738004|FG003|Overall Study|Lost to Follow-up|1|||
16341484|NCT03272347|39738001|FG000|Overall Study|Physician Decision|4|||
16341485|NCT03272347|39738002|FG001|Overall Study|Physician Decision|2|||
16341486|NCT03272347|39738003|FG002|Overall Study|Physician Decision|5|||
16341487|NCT03272347|39738004|FG003|Overall Study|Physician Decision|4|||
16341488|NCT03272347|39738001|FG000|Overall Study|Screen Failure|1|||
16341489|NCT03272347|39738002|FG001|Overall Study|Screen Failure|0|||
16341490|NCT03272347|39738003|FG002|Overall Study|Screen Failure|0|||
16341491|NCT03272347|39738004|FG003|Overall Study|Screen Failure|0|||
16341492|NCT03272347|39738001|FG000|Overall Study|Withdrawal by Subject|5|||
16341493|NCT03272347|39738002|FG001|Overall Study|Withdrawal by Subject|1|||
16341494|NCT03272347|39738003|FG002|Overall Study|Withdrawal by Subject|2|||
16341495|NCT03272347|39738004|FG003|Overall Study|Withdrawal by Subject|1|||
16341496|NCT04391842|39738005|FG000|Overall Study|Withdrawal by Subject|2|||
16341497|NCT00791492|39738006|FG000|Overall Study|Withdrawal by Subject|1|||
16341498|NCT00791492|39738007|FG001|Overall Study|Withdrawal by Subject|2|||
16341499|NCT00791492|39738006|FG000|Overall Study|Liver transplantation|5|||
16341500|NCT00791492|39738007|FG001|Overall Study|Liver transplantation|1|||
16341501|NCT01636947|39738011|FG000|Overall Study|Not Treated|2|||
16341502|NCT01636947|39738012|FG001|Overall Study|Not Treated|2|||
16341503|NCT01636947|39738011|FG000|Overall Study|Lost to Follow-up|4|||
16341504|NCT01636947|39738012|FG001|Overall Study|Lost to Follow-up|0|||
16341505|NCT01636947|39738011|FG000|Overall Study|Protocol Violation|1|||
16341506|NCT01636947|39738012|FG001|Overall Study|Protocol Violation|1|||
16341507|NCT01636947|39738011|FG000|Overall Study|Withdrawal by Subject|3|||
16341508|NCT01636947|39738012|FG001|Overall Study|Withdrawal by Subject|3|||
16341509|NCT01636947|39738011|FG000|Overall Study|Adverse Event|1|||
16341510|NCT01636947|39738012|FG001|Overall Study|Adverse Event|1|||
16341511|NCT01636947|39738011|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
16341512|NCT01636947|39738012|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
16341513|NCT01663857|39738013|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
16341514|NCT01663857|39738014|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
16341515|NCT01663857|39738015|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
16341516|NCT01663857|39738016|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
16341517|NCT01663857|39738013|FG000|Overall Study|Lost to Follow-up|0|||
16542278|NCT00844857|40446864|FG001|Overall Study|Sponsor Decision|1|||
16108152|NCT01721746|38885173|FG001|Treatment|Poor/Non-compliance|0|||
16108153|NCT01721746|38885172|FG000|Treatment|Participant no longer met Study criteria|4|||
16108154|NCT01721746|38885173|FG001|Treatment|Participant no longer met Study criteria|0|||
16341518|NCT01663857|39738014|FG001|Overall Study|Lost to Follow-up|0|||
16341519|NCT01663857|39738015|FG002|Overall Study|Lost to Follow-up|3|||
16341520|NCT01663857|39738016|FG003|Overall Study|Lost to Follow-up|1|||
16341521|NCT03423147|39738025|FG000|Overall Study|Lost to Follow-up|5|||
16341522|NCT03423147|39738026|FG001|Overall Study|Lost to Follow-up|8|||
16341523|NCT03423147|39738025|FG000|Overall Study|Withdrawal by Subject|1|||
16341524|NCT03423147|39738026|FG001|Overall Study|Withdrawal by Subject|0|||
16341525|NCT03423147|39738025|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
16406876|NCT01474772|39969923|FG000|Follow-up|AE not Related to Study Drug|0|||
16406877|NCT01474772|39969924|FG001|Follow-up|AE not Related to Study Drug|1|||
16406878|NCT02460783|39969925|FG000|Overall Study|Withdrawal by Subject|1|||
16406879|NCT02460783|39969926|FG001|Overall Study|Withdrawal by Subject|3|||
16406880|NCT02460783|39969925|FG000|Overall Study|Lost to Follow-up|1|||
16406881|NCT02460783|39969926|FG001|Overall Study|Lost to Follow-up|1|||
16406882|NCT01713283|39969927|FG000|Overall Study|Lack of Efficacy|10|||
16406883|NCT01713283|39969928|FG001|Overall Study|Lack of Efficacy|2|||
16406884|NCT01713283|39969927|FG000|Overall Study|Lost to Follow-up|1|||
16406885|NCT01713283|39969928|FG001|Overall Study|Lost to Follow-up|1|||
16406886|NCT00006164|39969931|FG000|Overall Study|Withdrew or lost to follow-up|70|||
16406887|NCT00006164|39969932|FG001|Overall Study|Withdrew or lost to follow-up|81|||
16406888|NCT03272828|39969933|FG000|Overall Study|Lost to Follow-up|7|||
16406889|NCT03272828|39969934|FG001|Overall Study|Lost to Follow-up|7|||
16406890|NCT03272828|39969933|FG000|Overall Study|Withdrawal by Subject|2|||
16406891|NCT03272828|39969934|FG001|Overall Study|Withdrawal by Subject|0|||
16108155|NCT01721746|38885172|FG000|Treatment|Other reasons|6|||
16108156|NCT01721746|38885173|FG001|Treatment|Other reasons|2|||
16108157|NCT03634839|38885174|FG000|First Intervention (2 Hours)|Adverse Event|0|||
16108158|NCT03634839|38885175|FG001|First Intervention (2 Hours)|Adverse Event|2|||
16108159|NCT02016690|38885176|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
16108160|NCT02016690|38885176|FG000|Overall Study|Excluded from SAS: Duplication|2|||
16108161|NCT02016690|38885176|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
16341526|NCT03423147|39738026|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
16341527|NCT03423147|39738025|FG000|Overall Study|Age < 18|1|||
16341528|NCT03423147|39738026|FG001|Overall Study|Age < 18|0|||
16341529|NCT03423147|39738025|FG000|Overall Study|No Trial of Labor|0|||
16341530|NCT03423147|39738026|FG001|Overall Study|No Trial of Labor|1|||
16341531|NCT00741598|39738029|FG000|Overall Study|Lost to Follow-up|3|||
16341532|NCT00741598|39738030|FG001|Overall Study|Lost to Follow-up|4|||
16341533|NCT00741598|39738029|FG000|Overall Study|Lack of Efficacy|1|||
16341534|NCT00741598|39738030|FG001|Overall Study|Lack of Efficacy|2|||
16341535|NCT00741598|39738029|FG000|Overall Study|Physician Decision|1|||
16341536|NCT00741598|39738030|FG001|Overall Study|Physician Decision|1|||
16341537|NCT00741598|39738029|FG000|Overall Study|Pregnancy|1|||
16341538|NCT00741598|39738030|FG001|Overall Study|Pregnancy|0|||
16341539|NCT00741598|39738029|FG000|Overall Study|Withdrawal by Subject|3|||
16341540|NCT00741598|39738030|FG001|Overall Study|Withdrawal by Subject|2|||
16341541|NCT01429441|39738033|FG000|Overall Study|Adverse Event|5|||
16108162|NCT02016690|38885176|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
16108163|NCT02016690|38885176|FG000|Overall Study|Did not meet inclusion criteria|13|||
16108164|NCT02016690|38885176|FG000|Overall Study|Hospitalized for RSV at study start|3|||
16108165|NCT02806505|38885182|FG000|Overall Study|Adverse event/intercurrent illness|1|||
16108166|NCT02806505|38885183|FG001|Overall Study|Adverse event/intercurrent illness|3|||
16108167|NCT02806505|38885182|FG000|Overall Study|Death|4|||
16108168|NCT02806505|38885183|FG001|Overall Study|Death|0|||
16108169|NCT02806505|38885182|FG000|Overall Study|Did not cooperate/refused treatment|3|||
16108170|NCT02806505|38885183|FG001|Overall Study|Did not cooperate/refused treatment|3|||
16108171|NCT02806505|38885182|FG000|Overall Study|Failure to return|0|||
16341542|NCT01429441|39738034|FG001|Overall Study|Adverse Event|1|||
16341543|NCT01429441|39738033|FG000|Overall Study|Death|0|||
16341544|NCT01429441|39738034|FG001|Overall Study|Death|2|||
16341545|NCT01429441|39738033|FG000|Overall Study|Lost to Follow-up|5|||
16108172|NCT02806505|38885183|FG001|Overall Study|Failure to return|1|||
16108173|NCT02806505|38885182|FG000|Overall Study|Insufficient therapeutic response|2|||
16406892|NCT03272828|39969933|FG000|Overall Study|Deceased|1|||
16406893|NCT03272828|39969934|FG001|Overall Study|Deceased|1|||
16406894|NCT03272828|39969933|FG000|Overall Study|Failed implant|1|||
16406895|NCT03272828|39969934|FG001|Overall Study|Failed implant|2|||
16406896|NCT01598753|39969945|FG000|Overall Study|Adverse Event|1|||
16542279|NCT00844857|40446863|FG000|Overall Study|Physician Decision|2|||
16542280|NCT00844857|40446864|FG001|Overall Study|Physician Decision|0|||
16542281|NCT00844857|40446863|FG000|Overall Study|Parent/Caregiver Decision|6|||
16542282|NCT00844857|40446864|FG001|Overall Study|Parent/Caregiver Decision|2|||
16542283|NCT00844857|40446863|FG000|Overall Study|Withdrawal by Subject|8|||
16341546|NCT01429441|39738034|FG001|Overall Study|Lost to Follow-up|2|||
16341547|NCT01429441|39738033|FG000|Overall Study|Physician Decision|1|||
16341548|NCT01429441|39738034|FG001|Overall Study|Physician Decision|0|||
16341549|NCT01429441|39738033|FG000|Overall Study|Withdrawal by Subject|27|||
16108174|NCT02806505|38885183|FG001|Overall Study|Insufficient therapeutic response|4|||
16108175|NCT03269695|38885184|FG000|Overall Study|Adverse Event|2|||
16341550|NCT01429441|39738034|FG001|Overall Study|Withdrawal by Subject|18|||
16341551|NCT01301079|39738041|FG000|Overall Study|Lost to Follow-up|2|||
16108176|NCT03269695|38885185|FG001|Overall Study|Adverse Event|1|||
16108177|NCT03269695|38885184|FG000|Overall Study|Lack of Efficacy|0|||
16108178|NCT03269695|38885185|FG001|Overall Study|Lack of Efficacy|1|||
16341552|NCT01301079|39738042|FG001|Overall Study|Lost to Follow-up|2|||
16341553|NCT01118663|39738043|FG000|Overall Study|Adverse Event|2|||
16341554|NCT01118663|39738044|FG001|Overall Study|Adverse Event|1|||
16341555|NCT01118663|39738043|FG000|Overall Study|Withdrawal by Subject|0|||
16341556|NCT01118663|39738044|FG001|Overall Study|Withdrawal by Subject|1|||
16341557|NCT03504189|39738055|FG000|Overall Study|Withdrawal by Subject|1|||
16341558|NCT03504189|39738055|FG000|Overall Study|Screening Failure|1|||
16341559|NCT03504189|39738055|FG000|Overall Study|Device Failure|2|||
16341560|NCT00069823|39738058|FG000|Overall Study|Did not have follow-up diary cards|6|||
16341561|NCT00069823|39738059|FG001|Overall Study|Did not have follow-up diary cards|3|||
16341562|NCT01300247|39738060|FG000|Overall Study|Death|1|||
16341563|NCT01300247|39738061|FG001|Overall Study|Death|1|||
16341564|NCT01300247|39738060|FG000|Overall Study|Lost to Follow-up|2|||
16341565|NCT01300247|39738061|FG001|Overall Study|Lost to Follow-up|0|||
16341566|NCT01300247|39738060|FG000|Overall Study|Withdrawal by Subject|1|||
16341567|NCT01300247|39738061|FG001|Overall Study|Withdrawal by Subject|0|||
16341568|NCT01300247|39738060|FG000|Overall Study|Non-Compliance|0|||
16341569|NCT01300247|39738061|FG001|Overall Study|Non-Compliance|1|||
16341570|NCT01398358|39738062|FG000|Overall Study|Lost to Follow-up|11|||
16341571|NCT01398358|39738063|FG001|Overall Study|Lost to Follow-up|21|||
16341572|NCT01398358|39738064|FG002|Overall Study|Lost to Follow-up|18|||
16341573|NCT01398358|39738062|FG000|Overall Study|Withdrawal by Subject|3|||
16341574|NCT01398358|39738063|FG001|Overall Study|Withdrawal by Subject|2|||
16341575|NCT01398358|39738064|FG002|Overall Study|Withdrawal by Subject|2|||
16341576|NCT01398358|39738062|FG000|Overall Study|no longer eligible|1|||
16341577|NCT01398358|39738063|FG001|Overall Study|no longer eligible|0|||
16341578|NCT01398358|39738064|FG002|Overall Study|no longer eligible|1|||
16341579|NCT04676724|39738065|FG000|Overall Study|Adverse Event|2|||
16108179|NCT03269695|38885184|FG000|Overall Study|Withdrawal by Subject|0|||
16341580|NCT04676724|39738066|FG001|Overall Study|Adverse Event|0|||
16341581|NCT04676724|39738065|FG000|Overall Study|Lost to Follow-up|1|||
16108180|NCT03269695|38885185|FG001|Overall Study|Withdrawal by Subject|1|||
16108181|NCT04599907|38885186|FG000|Overall Study|Withdrawal by Subject|1|||
16108182|NCT04599907|38885187|FG001|Overall Study|Withdrawal by Subject|7|||
16108183|NCT04599907|38885188|FG002|Overall Study|Withdrawal by Subject|6|||
16219581|NCT00397891|39282952|FG002|Overall Study|Withdrawal by Subject|0|||
16219582|NCT00397891|39282953|FG003|Overall Study|Withdrawal by Subject|0|||
16219583|NCT00397891|39282954|FG004|Overall Study|Withdrawal by Subject|1|||
16219584|NCT03231228|39282955|FG000|Overall Study|Lost to Follow-up|2|||
16219585|NCT03231228|39282956|FG001|Overall Study|Lost to Follow-up|0|||
16108184|NCT04599907|38885186|FG000|Overall Study|Lost to Follow-up|0|||
16219586|NCT03231228|39282955|FG000|Overall Study|Physician Decision|1|||
16341582|NCT04676724|39738066|FG001|Overall Study|Lost to Follow-up|0|||
16341583|NCT04676724|39738065|FG000|Overall Study|Physician Decision|0|||
16341584|NCT04676724|39738066|FG001|Overall Study|Physician Decision|1|||
16108185|NCT04599907|38885187|FG001|Overall Study|Lost to Follow-up|1|||
16108186|NCT04599907|38885188|FG002|Overall Study|Lost to Follow-up|0|||
16341585|NCT04676724|39738065|FG000|Overall Study|Withdrawal by Subject|3|||
16341586|NCT04676724|39738066|FG001|Overall Study|Withdrawal by Subject|2|||
16341587|NCT02131233|39738067|FG000|Overall Study|Not Treated|2|||
16341588|NCT02131233|39738068|FG001|Overall Study|Not Treated|3|||
16341589|NCT02131233|39738067|FG000|Overall Study|Adverse Event|7|||
16341590|NCT02131233|39738068|FG001|Overall Study|Adverse Event|6|||
16341591|NCT02131233|39738067|FG000|Overall Study|Death|0|||
16341592|NCT02131233|39738068|FG001|Overall Study|Death|1|||
16341593|NCT02131233|39738067|FG000|Overall Study|Lack of Efficacy|6|||
16341594|NCT02131233|39738068|FG001|Overall Study|Lack of Efficacy|3|||
16341595|NCT02131233|39738067|FG000|Overall Study|Lost to Follow-up|14|||
16341596|NCT02131233|39738068|FG001|Overall Study|Lost to Follow-up|13|||
16341597|NCT02131233|39738067|FG000|Overall Study|Non-Compliance With Study Drug|8|||
16341598|NCT02131233|39738068|FG001|Overall Study|Non-Compliance With Study Drug|5|||
16341599|NCT02131233|39738067|FG000|Overall Study|Physician Decision|7|||
16341600|NCT02131233|39738068|FG001|Overall Study|Physician Decision|0|||
16341601|NCT02131233|39738067|FG000|Overall Study|Pregnancy|4|||
16341602|NCT02131233|39738068|FG001|Overall Study|Pregnancy|0|||
16341603|NCT02131233|39738067|FG000|Overall Study|Withdrawal by Subject|18|||
16341604|NCT02131233|39738068|FG001|Overall Study|Withdrawal by Subject|11|||
16108187|NCT03000348|38885189|FG000|Overall Study|Adverse Event|1|||
16406897|NCT01598753|39969946|FG001|Overall Study|Adverse Event|9|||
16406898|NCT01598753|39969947|FG002|Overall Study|Adverse Event|1|||
16406899|NCT01598753|39969948|FG003|Overall Study|Adverse Event|7|||
16406900|NCT01598753|39969945|FG000|Overall Study|Lost to Follow-up|4|||
16406901|NCT01598753|39969946|FG001|Overall Study|Lost to Follow-up|3|||
16406902|NCT01598753|39969947|FG002|Overall Study|Lost to Follow-up|7|||
16406903|NCT01598753|39969948|FG003|Overall Study|Lost to Follow-up|5|||
16406904|NCT01598753|39969945|FG000|Overall Study|Physician Decision|0|||
16406905|NCT01598753|39969946|FG001|Overall Study|Physician Decision|1|||
16406906|NCT01598753|39969947|FG002|Overall Study|Physician Decision|0|||
16406907|NCT01598753|39969948|FG003|Overall Study|Physician Decision|2|||
16406908|NCT01598753|39969945|FG000|Overall Study|Withdrawal by Subject|7|||
16406909|NCT01598753|39969946|FG001|Overall Study|Withdrawal by Subject|2|||
16406910|NCT01598753|39969947|FG002|Overall Study|Withdrawal by Subject|0|||
16406911|NCT01598753|39969948|FG003|Overall Study|Withdrawal by Subject|1|||
16108188|NCT03000348|38885190|FG001|Overall Study|Adverse Event|1|||
16108189|NCT03000348|38885191|FG002|Overall Study|Adverse Event|1|||
16108190|NCT03000348|38885192|FG003|Overall Study|Adverse Event|1|||
16108191|NCT03000348|38885193|FG004|Overall Study|Adverse Event|1|||
16108192|NCT03000348|38885194|FG005|Overall Study|Adverse Event|1|||
16108193|NCT03000348|38885189|FG000|Overall Study|Lost to Follow-up|0|||
16108194|NCT03000348|38885190|FG001|Overall Study|Lost to Follow-up|0|||
16108195|NCT03000348|38885191|FG002|Overall Study|Lost to Follow-up|1|||
16108196|NCT03000348|38885192|FG003|Overall Study|Lost to Follow-up|0|||
16108197|NCT03000348|38885193|FG004|Overall Study|Lost to Follow-up|0|||
16108198|NCT03000348|38885194|FG005|Overall Study|Lost to Follow-up|0|||
16108199|NCT03000348|38885189|FG000|Overall Study|Withdrawal by Subject|0|||
16341605|NCT03699540|39738071|FG000|Overall Study|Lost to Follow-up|1|||
16406912|NCT04508751|39969949|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
16406913|NCT04508751|39969950|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
16406914|NCT04508751|39969951|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
16406915|NCT02323204|39969952|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
16406916|NCT02323204|39969953|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
16406917|NCT02323204|39969954|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
16542284|NCT00844857|40446864|FG001|Overall Study|Withdrawal by Subject|7|||
16542285|NCT00844857|40446863|FG000|Overall Study|Protocol Violation|6|||
16542286|NCT00844857|40446864|FG001|Overall Study|Protocol Violation|0|||
16542287|NCT00844857|40446863|FG000|Overall Study|Lack of Efficacy|5|||
16542288|NCT00844857|40446864|FG001|Overall Study|Lack of Efficacy|5|||
16542289|NCT00844857|40446863|FG000|Overall Study|Clinical Relapse|0|||
16542290|NCT00844857|40446864|FG001|Overall Study|Clinical Relapse|1|||
16542291|NCT00844857|40446863|FG000|Overall Study|Entry Criteria Not Met|0|||
16542292|NCT00844857|40446864|FG001|Overall Study|Entry Criteria Not Met|1|||
16542293|NCT00844857|40446863|FG000|Overall Study|Lost to Follow-up|2|||
16406918|NCT02323204|39969955|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
16406919|NCT02323204|39969952|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
16406920|NCT02323204|39969953|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
16542294|NCT00844857|40446864|FG001|Overall Study|Lost to Follow-up|3|||
16108200|NCT03000348|38885190|FG001|Overall Study|Withdrawal by Subject|1|||
16108201|NCT03000348|38885191|FG002|Overall Study|Withdrawal by Subject|0|||
16341606|NCT02585713|39738072|FG000|Overall Study|Withdrew prior to treatment|2|||
16341607|NCT02585713|39738073|FG001|Overall Study|Withdrew prior to treatment|7|||
16341608|NCT02585713|39738072|FG000|Overall Study|Other|3|||
16341609|NCT02585713|39738073|FG001|Overall Study|Other|1|||
16341610|NCT02998996|39738076|FG000|Overall Study|Lost to Follow-up|0|||
16341611|NCT02998996|39738077|FG001|Overall Study|Lost to Follow-up|0|||
16341612|NCT02998996|39738078|FG002|Overall Study|Lost to Follow-up|1|||
16341613|NCT02998996|39738079|FG003|Overall Study|Lost to Follow-up|0|||
16341614|NCT02998996|39738080|FG004|Overall Study|Lost to Follow-up|0|||
16341615|NCT02998996|39738081|FG005|Overall Study|Lost to Follow-up|0|||
16341616|NCT02998996|39738076|FG000|Overall Study|Pregnancy|0|||
16341617|NCT02998996|39738077|FG001|Overall Study|Pregnancy|1|||
16341618|NCT02998996|39738078|FG002|Overall Study|Pregnancy|0|||
16341619|NCT02998996|39738079|FG003|Overall Study|Pregnancy|0|||
16341620|NCT02998996|39738080|FG004|Overall Study|Pregnancy|0|||
16341621|NCT02998996|39738081|FG005|Overall Study|Pregnancy|0|||
16341622|NCT02998996|39738076|FG000|Overall Study|Family reasons|0|||
16341623|NCT02998996|39738077|FG001|Overall Study|Family reasons|0|||
16341624|NCT02998996|39738078|FG002|Overall Study|Family reasons|0|||
16341625|NCT02998996|39738079|FG003|Overall Study|Family reasons|0|||
16341626|NCT02998996|39738080|FG004|Overall Study|Family reasons|1|||
16341627|NCT02998996|39738081|FG005|Overall Study|Family reasons|0|||
16341628|NCT03743025|39738083|FG000|Overall Study|Surgery was cancelled|2|||
16341629|NCT03743025|39738084|FG001|Overall Study|Surgery was cancelled|1|||
16219587|NCT03231228|39282956|FG001|Overall Study|Physician Decision|0|||
16219588|NCT01938391|39282957|FG000|6 Month Follow up|Withdrawal by Subject|1|||
16219589|NCT01938391|39282957|FG000|12 Month Follow up|Physician Decision|1|||
16219590|NCT01938391|39282957|FG000|12 Month Follow up|Withdrawal by Subject|1|||
16219591|NCT00443534|39282958|FG000|Overall Study|Lack of Efficacy|67|||
16219592|NCT00443534|39282958|FG000|Overall Study|Adverse Event|16|||
16219593|NCT00443534|39282958|FG000|Overall Study|Death|9|||
16219594|NCT00443534|39282958|FG000|Overall Study|Withdrawal by Subject|8|||
16219595|NCT00443534|39282958|FG000|Overall Study|Study Terminated by Sponsor|12|||
16219596|NCT00443534|39282958|FG000|Overall Study|Other|10|||
16219597|NCT00443534|39282958|FG000|Overall Study|Enrolled, Not Treated|1|||
16219598|NCT00886587|39282959|FG000|Overall Study|Adverse Event|2|||
16219599|NCT00886587|39282960|FG001|Overall Study|Adverse Event|1|||
16219600|NCT00886587|39282959|FG000|Overall Study|Protocol Violation|2|||
16219601|NCT00886587|39282960|FG001|Overall Study|Protocol Violation|0|||
16219602|NCT00886587|39282959|FG000|Overall Study|Withdrawal by Subject|0|||
16219603|NCT00886587|39282960|FG001|Overall Study|Withdrawal by Subject|1|||
16219604|NCT02436915|39282963|FG000|Overall Study|Withdrawal by Subject|0|||
16219605|NCT02436915|39282964|FG001|Overall Study|Withdrawal by Subject|1|||
16219606|NCT01815099|39282966|FG000|Overall Study|Lack of Efficacy|1|||
16219607|NCT01815099|39282966|FG000|Overall Study|unable to attend study visits|1|||
16219608|NCT00434876|39282967|FG000|Overall Study|Lost to Follow-up|1|||
16219609|NCT00434876|39282968|FG001|Overall Study|Lost to Follow-up|1|||
16219610|NCT03500419|39282969|FG000|Overall Study|Withdrawal by Subject|2|||
16219611|NCT03500419|39282970|FG001|Overall Study|Withdrawal by Subject|25|||
16219612|NCT01038635|39282971|FG000|Overall Study|Disease Progression|2|||
16219613|NCT01038635|39282972|FG001|Overall Study|Disease Progression|0|||
16219614|NCT01038635|39282973|FG002|Overall Study|Disease Progression|0|||
16219615|NCT01038635|39282974|FG003|Overall Study|Disease Progression|0|||
16219616|NCT01038635|39282975|FG004|Overall Study|Disease Progression|0|||
16219617|NCT01038635|39282976|FG005|Overall Study|Disease Progression|0|||
16219618|NCT01038635|39282977|FG006|Overall Study|Disease Progression|1|||
16219619|NCT01038635|39282978|FG007|Overall Study|Disease Progression|4|||
16219620|NCT01038635|39282979|FG008|Overall Study|Disease Progression|0|||
16219621|NCT01038635|39282971|FG000|Overall Study|Death|0|||
16219622|NCT01038635|39282972|FG001|Overall Study|Death|0|||
16219623|NCT01038635|39282973|FG002|Overall Study|Death|0|||
16219624|NCT01038635|39282974|FG003|Overall Study|Death|0|||
16219625|NCT01038635|39282975|FG004|Overall Study|Death|1|||
16341630|NCT01087203|39738089|FG000|Overall Study|Lost to Follow-up|2|||
16341631|NCT01087203|39738090|FG001|Overall Study|Lost to Follow-up|0|||
16341632|NCT01087203|39738089|FG000|Overall Study|Withdrawal by Subject|2|||
16341633|NCT01087203|39738090|FG001|Overall Study|Withdrawal by Subject|6|||
16341634|NCT01087203|39738089|FG000|Overall Study|Lack of Efficacy|1|||
16341635|NCT01087203|39738090|FG001|Overall Study|Lack of Efficacy|2|||
16341636|NCT01087203|39738089|FG000|Overall Study|Study terminated by sponsor|27|||
16406921|NCT02323204|39969954|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
16406922|NCT02323204|39969955|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
16406923|NCT02323204|39969952|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
16406924|NCT02323204|39969953|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
16111466|NCT00760747|38897274|FG000|Study Period III|Adverse Event|1|||
16406925|NCT02323204|39969954|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
16219626|NCT01038635|39282976|FG005|Overall Study|Death|0|||
16219627|NCT01038635|39282977|FG006|Overall Study|Death|1|||
16219628|NCT01038635|39282978|FG007|Overall Study|Death|1|||
16219629|NCT01038635|39282979|FG008|Overall Study|Death|2|||
16219630|NCT03969589|39282980|FG000|Overall Study|Lost to Follow-up|3|||
16219631|NCT03969589|39282981|FG001|Overall Study|Lost to Follow-up|2|||
16219632|NCT03969589|39282980|FG000|Overall Study|Declined Follow-Up|0|||
16219633|NCT03969589|39282981|FG001|Overall Study|Declined Follow-Up|1|||
16219634|NCT00590031|39282982|FG000|Overall Study|Adverse Event|3|||
16219635|NCT00590031|39282982|FG000|Overall Study|Withdrawal by Subject|1|||
16219636|NCT00590031|39282982|FG000|Overall Study|Metastatic Disease|1|||
16219637|NCT00590031|39282982|FG000|Overall Study|Admin Hold|1|||
16219638|NCT00736450|39282983|FG000|Overall Study|Not ABC gene eligible|19|||
16219639|NCT00736450|39282983|FG000|Overall Study|Withdrawal by Subject|5|||
16406926|NCT02323204|39969955|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
16542295|NCT00844857|40446863|FG000|Overall Study|Did Not Take Study Drug|3|||
16542296|NCT00844857|40446864|FG001|Overall Study|Did Not Take Study Drug|1|||
16542297|NCT00844857|40446863|FG000|Overall Study|Good Clinical Practice Violations|21|||
16542298|NCT00844857|40446864|FG001|Overall Study|Good Clinical Practice Violations|11|||
16542299|NCT03286751|40446865|FG000|Washout Period 1|Withdrawal by Subject|0|||
16542300|NCT03286751|40446866|FG001|Washout Period 1|Withdrawal by Subject|0|||
16542301|NCT03286751|40446867|FG002|Washout Period 1|Withdrawal by Subject|0|||
16542302|NCT03286751|40446868|FG003|Washout Period 1|Withdrawal by Subject|0|||
16542303|NCT03286751|40446869|FG004|Washout Period 1|Withdrawal by Subject|1|||
16542304|NCT03286751|40446870|FG005|Washout Period 1|Withdrawal by Subject|0|||
16542305|NCT03286751|40446865|FG000|Washout Period 2|Personal Reasons|0|||
16341637|NCT01087203|39738090|FG001|Overall Study|Study terminated by sponsor|27|||
16341638|NCT00913770|39738091|FG000|Overall Study|Unable to contact|24|||
16341639|NCT00913770|39738092|FG001|Overall Study|Unable to contact|19|||
16341640|NCT00913770|39738093|FG002|Overall Study|Unable to contact|13|||
16341641|NCT00913770|39738091|FG000|Overall Study|Refused|11|||
16341642|NCT00913770|39738092|FG001|Overall Study|Refused|10|||
16341643|NCT00913770|39738093|FG002|Overall Study|Refused|8|||
16341644|NCT02107313|39738096|FG000|Overall Study|One participant did not do the FED cohor|0|||
16341645|NCT02107313|39738097|FG001|Overall Study|One participant did not do the FED cohor|1|||
16341646|NCT03488563|39738103|FG000|Overall Study|Lost to Follow-up|7|||
16341647|NCT03488563|39738104|FG001|Overall Study|Lost to Follow-up|6|||
16341648|NCT03488563|39738105|FG002|Overall Study|Lost to Follow-up|7|||
16341649|NCT03488563|39738103|FG000|Overall Study|Withdrawal by Subject|8|||
16341650|NCT03488563|39738104|FG001|Overall Study|Withdrawal by Subject|7|||
16341651|NCT03488563|39738105|FG002|Overall Study|Withdrawal by Subject|7|||
16341652|NCT03488563|39738103|FG000|Overall Study|Physician Decision|0|||
16341653|NCT03488563|39738104|FG001|Overall Study|Physician Decision|0|||
16341654|NCT03488563|39738105|FG002|Overall Study|Physician Decision|1|||
16108202|NCT03000348|38885192|FG003|Overall Study|Withdrawal by Subject|0|||
16341655|NCT03488563|39738103|FG000|Overall Study|Protocol Violation|3|||
16341656|NCT03488563|39738104|FG001|Overall Study|Protocol Violation|2|||
16341657|NCT03488563|39738105|FG002|Overall Study|Protocol Violation|6|||
16341658|NCT03488563|39738103|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
16341659|NCT03488563|39738104|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
16341660|NCT03488563|39738105|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
16341661|NCT03488563|39738103|FG000|Overall Study|Use of prohibited medication|2|||
16341662|NCT03488563|39738104|FG001|Overall Study|Use of prohibited medication|0|||
16341663|NCT03488563|39738105|FG002|Overall Study|Use of prohibited medication|0|||
16341664|NCT03488563|39738103|FG000|Overall Study|Adverse Event|1|||
16341665|NCT03488563|39738104|FG001|Overall Study|Adverse Event|0|||
16341666|NCT03488563|39738105|FG002|Overall Study|Adverse Event|1|||
16341667|NCT03488563|39738103|FG000|Overall Study|Subject returned for ET visit|0|||
16406927|NCT02323204|39969952|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
16406928|NCT02323204|39969953|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
16341668|NCT03488563|39738104|FG001|Overall Study|Subject returned for ET visit|1|||
16341669|NCT03488563|39738105|FG002|Overall Study|Subject returned for ET visit|0|||
16341670|NCT03488563|39738103|FG000|Overall Study|Sponsor's decision|0|||
16341671|NCT03488563|39738104|FG001|Overall Study|Sponsor's decision|0|||
16341672|NCT03488563|39738105|FG002|Overall Study|Sponsor's decision|1|||
16341673|NCT02496039|39738106|FG000|Overall Study|Adverse Event|3|||
16341674|NCT02496039|39738106|FG000|Overall Study|Protocol Violation|1|||
16341675|NCT01911793|39738107|FG000|Overall Study|Physician Decision|1|||
16341676|NCT01911793|39738108|FG001|Overall Study|Physician Decision|5|||
16341677|NCT01216332|39738109|FG000|Overall Study|Withdrawal by Subject|4|||
16341678|NCT01216332|39738110|FG001|Overall Study|Withdrawal by Subject|0|||
16341679|NCT00262002|39738111|FG000|Overall Study|Adverse Event|2|||
16341680|NCT00262002|39738112|FG001|Overall Study|Adverse Event|1|||
16341681|NCT00262002|39738113|FG002|Overall Study|Adverse Event|0|||
16341682|NCT00262002|39738114|FG003|Overall Study|Adverse Event|0|||
16341683|NCT00262002|39738115|FG004|Overall Study|Adverse Event|0|||
16341684|NCT00262002|39738116|FG005|Overall Study|Adverse Event|1|||
16341685|NCT00262002|39738117|FG006|Overall Study|Adverse Event|0|||
16108203|NCT03000348|38885193|FG004|Overall Study|Withdrawal by Subject|0|||
16108204|NCT03000348|38885194|FG005|Overall Study|Withdrawal by Subject|0|||
16341686|NCT00262002|39738111|FG000|Overall Study|Withdrawal by Subject|4|||
16341687|NCT00262002|39738112|FG001|Overall Study|Withdrawal by Subject|2|||
16341688|NCT00262002|39738113|FG002|Overall Study|Withdrawal by Subject|0|||
16341689|NCT00262002|39738114|FG003|Overall Study|Withdrawal by Subject|1|||
16108205|NCT03000348|38885189|FG000|Overall Study|Consent|0|||
16341690|NCT00262002|39738115|FG004|Overall Study|Withdrawal by Subject|2|||
16341691|NCT00262002|39738116|FG005|Overall Study|Withdrawal by Subject|2|||
16341692|NCT00262002|39738117|FG006|Overall Study|Withdrawal by Subject|2|||
16341693|NCT00262002|39738111|FG000|Overall Study|Lost to Follow-up|2|||
16341694|NCT00262002|39738112|FG001|Overall Study|Lost to Follow-up|0|||
16341695|NCT00262002|39738113|FG002|Overall Study|Lost to Follow-up|0|||
16341696|NCT00262002|39738114|FG003|Overall Study|Lost to Follow-up|2|||
16341697|NCT00262002|39738115|FG004|Overall Study|Lost to Follow-up|0|||
16341698|NCT00262002|39738116|FG005|Overall Study|Lost to Follow-up|1|||
16341699|NCT00262002|39738117|FG006|Overall Study|Lost to Follow-up|0|||
16341700|NCT00262002|39738111|FG000|Overall Study|Inapropriate enrollment|0|||
16341701|NCT00262002|39738112|FG001|Overall Study|Inapropriate enrollment|1|||
16341702|NCT00262002|39738113|FG002|Overall Study|Inapropriate enrollment|0|||
16341703|NCT00262002|39738114|FG003|Overall Study|Inapropriate enrollment|0|||
16341704|NCT00262002|39738115|FG004|Overall Study|Inapropriate enrollment|0|||
16341705|NCT00262002|39738116|FG005|Overall Study|Inapropriate enrollment|0|||
16341706|NCT00262002|39738117|FG006|Overall Study|Inapropriate enrollment|0|||
16341707|NCT00262002|39738111|FG000|Overall Study|Protocol Violation|3|||
16341708|NCT00262002|39738112|FG001|Overall Study|Protocol Violation|2|||
16341709|NCT00262002|39738113|FG002|Overall Study|Protocol Violation|0|||
16341710|NCT00262002|39738114|FG003|Overall Study|Protocol Violation|2|||
16341711|NCT00262002|39738115|FG004|Overall Study|Protocol Violation|5|||
16341712|NCT00262002|39738116|FG005|Overall Study|Protocol Violation|3|||
16341713|NCT00262002|39738117|FG006|Overall Study|Protocol Violation|2|||
16341714|NCT00262002|39738111|FG000|Overall Study|Unable to classify|0|||
16341715|NCT00262002|39738112|FG001|Overall Study|Unable to classify|0|||
16341716|NCT00262002|39738113|FG002|Overall Study|Unable to classify|0|||
16341717|NCT00262002|39738114|FG003|Overall Study|Unable to classify|0|||
16341718|NCT00262002|39738115|FG004|Overall Study|Unable to classify|0|||
16341719|NCT00262002|39738116|FG005|Overall Study|Unable to classify|0|||
16341720|NCT00262002|39738117|FG006|Overall Study|Unable to classify|2|||
16341721|NCT01066663|39738118|FG000|Overall Study|Adverse Event|0|||
16341722|NCT01066663|39738119|FG001|Overall Study|Adverse Event|0|||
16341723|NCT01066663|39738120|FG002|Overall Study|Adverse Event|1|||
16341724|NCT00940888|39738121|FG000|Overall Study|Unsuccessful Implant|4|||
16341725|NCT00940888|39738121|FG000|Overall Study|Death|461|||
16341726|NCT00940888|39738121|FG000|Overall Study|Withdrawn - Non-Death|364|||
16341727|NCT00940888|39738121|FG000|Overall Study|Lost to Follow-up|6|||
16341728|NCT02886884|39738127|FG000|Follow-up|Withdrawal by Subject|0|||
16341729|NCT02886884|39738128|FG001|Follow-up|Withdrawal by Subject|0|||
16341730|NCT02886884|39738129|FG002|Follow-up|Withdrawal by Subject|0|||
16341731|NCT02886884|39738130|FG003|Follow-up|Withdrawal by Subject|1|||
16341732|NCT03396822|39738131|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
16341733|NCT03396822|39738131|FG000|Overall Study|Physician Decision|1|||
16341734|NCT04441788|39738135|FG000|Overall Study|Voluntary Withdrawl|0|||
16341735|NCT04441788|39738136|FG001|Overall Study|Voluntary Withdrawl|1|||
16341736|NCT04441788|39738137|FG002|Overall Study|Voluntary Withdrawl|0|||
16341737|NCT04441788|39738135|FG000|Overall Study|Ineligibility|1|||
16341738|NCT04441788|39738136|FG001|Overall Study|Ineligibility|0|||
16341739|NCT04441788|39738137|FG002|Overall Study|Ineligibility|0|||
16341740|NCT04441788|39738135|FG000|Overall Study|Adverse Event|0|||
16341741|NCT04441788|39738136|FG001|Overall Study|Adverse Event|0|||
16341742|NCT04441788|39738137|FG002|Overall Study|Adverse Event|4|||
16341743|NCT04441788|39738135|FG000|Overall Study|Study Terminated by Sponsor|16|||
16341744|NCT04441788|39738136|FG001|Overall Study|Study Terminated by Sponsor|16|||
16341745|NCT04441788|39738137|FG002|Overall Study|Study Terminated by Sponsor|12|||
16341746|NCT03824366|39738140|FG000|Overall Study|Death|1|||
16341747|NCT03824366|39738140|FG000|Overall Study|Previously unidentified metal artifact|1|||
16341748|NCT03824366|39738140|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
16341749|NCT03824366|39738140|FG000|Overall Study|Withdrawal by Subject|1|||
16341750|NCT04399538|39738141|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
16341751|NCT04399538|39738142|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
16341752|NCT04399538|39738143|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
16341753|NCT04399538|39738144|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
16341754|NCT04399538|39738145|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
16341755|NCT04399538|39738141|FG000|Double-Blind Treatment|Adverse Event|0|||
16341756|NCT04399538|39738142|FG001|Double-Blind Treatment|Adverse Event|0|||
16341757|NCT04399538|39738143|FG002|Double-Blind Treatment|Adverse Event|0|||
16341758|NCT04399538|39738144|FG003|Double-Blind Treatment|Adverse Event|0|||
16341759|NCT04399538|39738145|FG004|Double-Blind Treatment|Adverse Event|1|||
16341760|NCT04399538|39738141|FG000|Follow-Up|Adverse Event|0|||
16341761|NCT04399538|39738142|FG001|Follow-Up|Adverse Event|0|||
16341762|NCT04399538|39738143|FG002|Follow-Up|Adverse Event|0|||
16341763|NCT04399538|39738144|FG003|Follow-Up|Adverse Event|0|||
16542306|NCT03286751|40446866|FG001|Washout Period 2|Personal Reasons|1|||
16542307|NCT03286751|40446867|FG002|Washout Period 2|Personal Reasons|0|||
16341764|NCT04399538|39738145|FG004|Follow-Up|Adverse Event|1|||
16542308|NCT03286751|40446868|FG003|Washout Period 2|Personal Reasons|0|||
16542309|NCT03286751|40446869|FG004|Washout Period 2|Personal Reasons|0|||
16542310|NCT03286751|40446870|FG005|Washout Period 2|Personal Reasons|0|||
16542311|NCT03286751|40446865|FG000|Washout Period 5|Adverse Event|0|||
16219640|NCT00736450|39282983|FG000|Overall Study|Physician Decision|1|||
16219641|NCT02871791|39282984|FG000|Phase 1b|Death|0|||
16219642|NCT02871791|39282985|FG001|Phase 1b|Death|1|||
16219643|NCT02871791|39282984|FG000|Phase 1b|progressive disease|6|||
16542312|NCT03286751|40446866|FG001|Washout Period 5|Adverse Event|0|||
16542313|NCT03286751|40446867|FG002|Washout Period 5|Adverse Event|0|||
16542314|NCT03286751|40446868|FG003|Washout Period 5|Adverse Event|0|||
16219644|NCT02871791|39282985|FG001|Phase 1b|progressive disease|2|||
16219645|NCT02871791|39282984|FG000|Phase 2|Death|1|||
16219646|NCT02871791|39282985|FG001|Phase 2|Death|0|||
16219647|NCT02871791|39282984|FG000|Phase 2|Lost to Follow-up|2|||
16219648|NCT02871791|39282985|FG001|Phase 2|Lost to Follow-up|0|||
16219649|NCT00303329|39282986|FG000|Overall Study|Adverse Event|7|||
16219650|NCT00303329|39282987|FG001|Overall Study|Adverse Event|14|||
16219651|NCT00303329|39282986|FG000|Overall Study|Abnormal Laboratory Values|0|||
16219652|NCT00303329|39282987|FG001|Overall Study|Abnormal Laboratory Values|1|||
16406929|NCT02323204|39969954|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
16406930|NCT02323204|39969955|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
16406931|NCT02323204|39969952|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
16406932|NCT02323204|39969953|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
16406933|NCT02323204|39969954|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
16406934|NCT02323204|39969955|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
16406935|NCT02323204|39969952|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
16406936|NCT02323204|39969953|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
16406937|NCT02323204|39969954|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
16406938|NCT02323204|39969955|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
16406939|NCT02323204|39969952|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
16406940|NCT02323204|39969953|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
16406941|NCT02323204|39969954|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
16406942|NCT02323204|39969955|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
16406943|NCT02323204|39969952|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
16406944|NCT02323204|39969953|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
16406945|NCT02323204|39969954|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
16219653|NCT00303329|39282986|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
16219654|NCT00303329|39282987|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16219655|NCT00303329|39282986|FG000|Overall Study|Condition no longer requires study drug|0|||
16219656|NCT00303329|39282987|FG001|Overall Study|Condition no longer requires study drug|8|||
16219657|NCT00303329|39282986|FG000|Overall Study|Protocol Violation|3|||
16219658|NCT00303329|39282987|FG001|Overall Study|Protocol Violation|0|||
16219659|NCT00303329|39282986|FG000|Overall Study|Withdrawal by Subject|9|||
16219660|NCT00303329|39282987|FG001|Overall Study|Withdrawal by Subject|15|||
16219661|NCT00303329|39282986|FG000|Overall Study|Lost to Follow-up|0|||
16219662|NCT00303329|39282987|FG001|Overall Study|Lost to Follow-up|1|||
16406946|NCT02323204|39969955|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
16406947|NCT02323204|39969952|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
16406948|NCT02323204|39969953|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
16406949|NCT02323204|39969954|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
16542315|NCT03286751|40446869|FG004|Washout Period 5|Adverse Event|1|||
16542316|NCT03286751|40446870|FG005|Washout Period 5|Adverse Event|0|||
16542317|NCT02057874|40446881|FG000|Overall Study|participant did not return for scan|1|||
16542318|NCT00985725|40446882|FG000|Overall Study|Adverse Event|4|||
16542319|NCT00985725|40446883|FG001|Overall Study|Adverse Event|1|||
16542320|NCT00985725|40446882|FG000|Overall Study|Protocol Violation|1|||
16542321|NCT00985725|40446883|FG001|Overall Study|Protocol Violation|3|||
16542322|NCT00985725|40446882|FG000|Overall Study|Withdrawal by Subject|4|||
16542323|NCT00985725|40446883|FG001|Overall Study|Withdrawal by Subject|4|||
16542324|NCT00985725|40446882|FG000|Overall Study|Lost to Follow-up|1|||
16542325|NCT00985725|40446883|FG001|Overall Study|Lost to Follow-up|1|||
16542326|NCT00985725|40446882|FG000|Overall Study|Lack of Efficacy|0|||
16542327|NCT00985725|40446883|FG001|Overall Study|Lack of Efficacy|1|||
16542328|NCT00985725|40446882|FG000|Overall Study|Non-compliance|1|||
16542329|NCT00985725|40446883|FG001|Overall Study|Non-compliance|2|||
16219663|NCT00303329|39282986|FG000|Overall Study|Administrative problems|1|||
16219664|NCT00303329|39282987|FG001|Overall Study|Administrative problems|0|||
16219665|NCT00303329|39282986|FG000|Overall Study|Death|2|||
16219666|NCT00303329|39282987|FG001|Overall Study|Death|12|||
16219667|NCT00303329|39282986|FG000|Overall Study|Stopped at end of core|3|||
16219668|NCT00303329|39282987|FG001|Overall Study|Stopped at end of core|9|||
16219669|NCT00303329|39282986|FG000|Overall Study|Stopped at end of extension 1|1|||
16219670|NCT00303329|39282987|FG001|Overall Study|Stopped at end of extension 1|0|||
16219671|NCT01117428|39282990|FG000|Overall Study|Lack of Efficacy|1|||
16219672|NCT01117428|39282991|FG001|Overall Study|Lack of Efficacy|0|||
16219673|NCT01117428|39282992|FG002|Overall Study|Lack of Efficacy|0|||
16219674|NCT01117428|39282993|FG003|Overall Study|Lack of Efficacy|0|||
16219675|NCT01117428|39282994|FG004|Overall Study|Lack of Efficacy|0|||
16219676|NCT01117428|39282995|FG005|Overall Study|Lack of Efficacy|0|||
16219677|NCT01117428|39282990|FG000|Overall Study|Adverse Event|4|||
16341765|NCT04399538|39738141|FG000|Follow-Up|Withdrawal by Subject|0|||
16341766|NCT04399538|39738142|FG001|Follow-Up|Withdrawal by Subject|0|||
16341767|NCT04399538|39738143|FG002|Follow-Up|Withdrawal by Subject|0|||
16341768|NCT04399538|39738144|FG003|Follow-Up|Withdrawal by Subject|2|||
16341769|NCT04399538|39738145|FG004|Follow-Up|Withdrawal by Subject|0|||
16341770|NCT00624832|39738149|FG000|Overall Study|Adverse Event|0|||
16341771|NCT00624832|39738150|FG001|Overall Study|Adverse Event|1|||
16341772|NCT00624832|39738151|FG002|Overall Study|Adverse Event|0|||
16341773|NCT00624832|39738152|FG003|Overall Study|Adverse Event|1|||
16341774|NCT00624832|39738149|FG000|Overall Study|Abnormal Laboratory Value|2|||
16341775|NCT00624832|39738150|FG001|Overall Study|Abnormal Laboratory Value|0|||
16341776|NCT00624832|39738151|FG002|Overall Study|Abnormal Laboratory Value|0|||
16341777|NCT00624832|39738152|FG003|Overall Study|Abnormal Laboratory Value|0|||
16341778|NCT00549601|39738154|FG000|Randomized|Protocol Violation|0|||
16341779|NCT00549601|39738155|FG001|Randomized|Protocol Violation|0|||
16341780|NCT00549601|39738156|FG002|Randomized|Protocol Violation|1|||
16341781|NCT00549601|39738154|FG000|Randomized|Withdrawal by Subject|0|||
16341782|NCT00549601|39738155|FG001|Randomized|Withdrawal by Subject|1|||
16341783|NCT00549601|39738156|FG002|Randomized|Withdrawal by Subject|1|||
16219678|NCT01117428|39282991|FG001|Overall Study|Adverse Event|0|||
16219679|NCT01117428|39282992|FG002|Overall Study|Adverse Event|0|||
16219680|NCT01117428|39282993|FG003|Overall Study|Adverse Event|0|||
16341784|NCT00549601|39738154|FG000|Received Study Drug|Adverse Event|2|||
16341785|NCT00549601|39738155|FG001|Received Study Drug|Adverse Event|5|||
16219681|NCT01117428|39282994|FG004|Overall Study|Adverse Event|1|||
16341786|NCT00549601|39738156|FG002|Received Study Drug|Adverse Event|1|||
16341787|NCT00549601|39738154|FG000|Received Study Drug|Death|0|||
16341788|NCT00549601|39738155|FG001|Received Study Drug|Death|1|||
16341789|NCT00549601|39738156|FG002|Received Study Drug|Death|0|||
16108206|NCT03000348|38885190|FG001|Overall Study|Consent|0|||
16108207|NCT03000348|38885191|FG002|Overall Study|Consent|0|||
16108208|NCT03000348|38885192|FG003|Overall Study|Consent|0|||
16108209|NCT03000348|38885193|FG004|Overall Study|Consent|1|||
16108210|NCT03000348|38885194|FG005|Overall Study|Consent|0|||
16108211|NCT03000348|38885189|FG000|Overall Study|Failure to expectorate sputum|1|||
16108212|NCT03000348|38885190|FG001|Overall Study|Failure to expectorate sputum|0|||
16108213|NCT03000348|38885191|FG002|Overall Study|Failure to expectorate sputum|1|||
16108214|NCT03000348|38885192|FG003|Overall Study|Failure to expectorate sputum|0|||
16108215|NCT03000348|38885193|FG004|Overall Study|Failure to expectorate sputum|1|||
16108216|NCT03000348|38885194|FG005|Overall Study|Failure to expectorate sputum|0|||
16108217|NCT03000348|38885189|FG000|Overall Study|No gram negative|1|||
16108218|NCT03000348|38885190|FG001|Overall Study|No gram negative|2|||
16108219|NCT03000348|38885191|FG002|Overall Study|No gram negative|1|||
16108220|NCT03000348|38885192|FG003|Overall Study|No gram negative|1|||
16108221|NCT03000348|38885193|FG004|Overall Study|No gram negative|1|||
16108222|NCT03000348|38885194|FG005|Overall Study|No gram negative|1|||
16108223|NCT03000348|38885189|FG000|Overall Study|Patient had no transport|0|||
16108224|NCT03000348|38885190|FG001|Overall Study|Patient had no transport|0|||
16108225|NCT03000348|38885191|FG002|Overall Study|Patient had no transport|0|||
16108226|NCT03000348|38885192|FG003|Overall Study|Patient had no transport|1|||
16108227|NCT03000348|38885193|FG004|Overall Study|Patient had no transport|0|||
16108228|NCT03000348|38885194|FG005|Overall Study|Patient had no transport|0|||
16108229|NCT03000348|38885189|FG000|Overall Study|Dosing|0|||
16108230|NCT03000348|38885190|FG001|Overall Study|Dosing|0|||
16108231|NCT03000348|38885191|FG002|Overall Study|Dosing|0|||
16542330|NCT00985725|40446882|FG000|Overall Study|Out-of-window visits|0|||
16542331|NCT00985725|40446883|FG001|Overall Study|Out-of-window visits|1|||
16542332|NCT02658630|40446885|FG000|Overall Study|Withdrawal by Subject|4|||
16108232|NCT03000348|38885192|FG003|Overall Study|Dosing|0|||
16108233|NCT03000348|38885193|FG004|Overall Study|Dosing|1|||
16108234|NCT03000348|38885194|FG005|Overall Study|Dosing|0|||
16108235|NCT01772563|38885199|FG000|Cycle 1|Dose limiting toxicity|2|||
16108236|NCT01772563|38885199|FG000|Cycle 1|Progressive disease|2|||
16108237|NCT01772563|38885199|FG000|Cycle 2 and Beyond|Progressive disease|17|||
16108238|NCT01772563|38885199|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
16542333|NCT02220894|40446888|FG000|Overall Study|Adverse Event|127|||
16542334|NCT02220894|40446889|FG001|Overall Study|Adverse Event|74|||
16542335|NCT02220894|40446888|FG000|Overall Study|Death|418|||
16542336|NCT02220894|40446889|FG001|Overall Study|Death|508|||
16542337|NCT02220894|40446888|FG000|Overall Study|Lost to Follow-up|0|||
16542338|NCT02220894|40446889|FG001|Overall Study|Lost to Follow-up|4|||
16542339|NCT02220894|40446888|FG000|Overall Study|Site Terminated by Sponsor|2|||
16542340|NCT02220894|40446889|FG001|Overall Study|Site Terminated by Sponsor|0|||
16542341|NCT02220894|40446888|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
16542342|NCT02220894|40446889|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
16542343|NCT02220894|40446888|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16542344|NCT02220894|40446889|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16542345|NCT02220894|40446888|FG000|Overall Study|Withdrawal by Subject|10|||
16542346|NCT02220894|40446889|FG001|Overall Study|Withdrawal by Subject|9|||
16542347|NCT03017079|40446892|FG000|Overall Study|Physician Decision|1|||
16542348|NCT03017079|40446893|FG001|Overall Study|Physician Decision|1|||
16542349|NCT03017079|40446892|FG000|Overall Study|Death|3|||
16542350|NCT03017079|40446893|FG001|Overall Study|Death|2|||
16542351|NCT03017079|40446892|FG000|Overall Study|Lack of Efficacy|2|||
16542352|NCT03017079|40446893|FG001|Overall Study|Lack of Efficacy|2|||
16542353|NCT03017079|40446892|FG000|Overall Study|Protocol Violation|0|||
16542354|NCT03017079|40446893|FG001|Overall Study|Protocol Violation|1|||
16542355|NCT02487472|40446898|FG000|Overall Study|Did not complete telephonic interviews|9|||
16542356|NCT02487472|40446898|FG000|Overall Study|Other|2|||
16542357|NCT01666951|40446899|FG000|Overall Study|Not dosed|1|||
16542358|NCT01666951|40446900|FG001|Overall Study|Not dosed|1|||
16542359|NCT00394355|40446901|FG000|Overall Study|Adverse Event|10|||
16542360|NCT00394355|40446902|FG001|Overall Study|Adverse Event|6|||
16542361|NCT00394355|40446903|FG002|Overall Study|Adverse Event|7|||
16542362|NCT00394355|40446904|FG003|Overall Study|Adverse Event|8|||
16542363|NCT00394355|40446901|FG000|Overall Study|Did not meet protocol eligibility|1|||
16542364|NCT00394355|40446902|FG001|Overall Study|Did not meet protocol eligibility|5|||
16542365|NCT00394355|40446903|FG002|Overall Study|Did not meet protocol eligibility|4|||
16542366|NCT00394355|40446904|FG003|Overall Study|Did not meet protocol eligibility|2|||
16108239|NCT01772563|38885199|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
16108240|NCT03279978|38885200|FG000|Overall Study|Withdrawal by Subject|0|||
16108241|NCT03279978|38885201|FG001|Overall Study|Withdrawal by Subject|1|||
16108242|NCT03279978|38885202|FG002|Overall Study|Withdrawal by Subject|0|||
16108243|NCT03279978|38885203|FG003|Overall Study|Withdrawal by Subject|0|||
16108244|NCT03279978|38885204|FG004|Overall Study|Withdrawal by Subject|0|||
16108245|NCT03279978|38885205|FG005|Overall Study|Withdrawal by Subject|0|||
16108246|NCT03279978|38885206|FG006|Overall Study|Withdrawal by Subject|0|||
16219682|NCT01117428|39282995|FG005|Overall Study|Adverse Event|2|||
16219683|NCT01117428|39282990|FG000|Overall Study|Death|0|||
16219684|NCT01117428|39282991|FG001|Overall Study|Death|1|||
16219685|NCT01117428|39282992|FG002|Overall Study|Death|2|||
16219686|NCT01117428|39282993|FG003|Overall Study|Death|0|||
16219687|NCT01117428|39282994|FG004|Overall Study|Death|0|||
16219688|NCT01117428|39282995|FG005|Overall Study|Death|1|||
16406950|NCT02323204|39969955|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
16406951|NCT04863248|39969956|FG000|Overall Study|Sponsor Terminated|4|||
16406952|NCT04863248|39969957|FG001|Overall Study|Sponsor Terminated|1|||
16406953|NCT04863248|39969956|FG000|Overall Study|Death|0|||
16219689|NCT01117428|39282990|FG000|Overall Study|Physician Decision|0|||
16219690|NCT01117428|39282991|FG001|Overall Study|Physician Decision|1|||
16219691|NCT01117428|39282992|FG002|Overall Study|Physician Decision|0|||
16219692|NCT01117428|39282993|FG003|Overall Study|Physician Decision|0|||
16219693|NCT01117428|39282994|FG004|Overall Study|Physician Decision|0|||
16219694|NCT01117428|39282995|FG005|Overall Study|Physician Decision|0|||
16219695|NCT01117428|39282990|FG000|Overall Study|Withdrawal by Subject|0|||
16219696|NCT01117428|39282991|FG001|Overall Study|Withdrawal by Subject|0|||
16219697|NCT01117428|39282992|FG002|Overall Study|Withdrawal by Subject|1|||
16219698|NCT01117428|39282993|FG003|Overall Study|Withdrawal by Subject|0|||
16219699|NCT01117428|39282994|FG004|Overall Study|Withdrawal by Subject|0|||
16219700|NCT01117428|39282995|FG005|Overall Study|Withdrawal by Subject|0|||
16406954|NCT04863248|39969957|FG001|Overall Study|Death|1|||
16406955|NCT04863248|39969956|FG000|Overall Study|Withdrawal by Subject|0|||
16406956|NCT04863248|39969957|FG001|Overall Study|Withdrawal by Subject|1|||
16406957|NCT02419131|39969958|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
16542367|NCT00394355|40446901|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
16542368|NCT00394355|40446902|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
16542369|NCT00394355|40446903|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
16542370|NCT00394355|40446904|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
16542371|NCT00394355|40446901|FG000|Overall Study|Subject withdrawal - related to drug|1|||
16542372|NCT00394355|40446902|FG001|Overall Study|Subject withdrawal - related to drug|0|||
16406958|NCT02419131|39969959|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
16406959|NCT02419131|39969960|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
16406960|NCT02419131|39969958|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
16406961|NCT02419131|39969959|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
16406962|NCT02419131|39969960|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
16406963|NCT03440918|39969961|FG000|Overall Study|Protocol Violation|0|||
16406964|NCT03440918|39969962|FG001|Overall Study|Protocol Violation|16|||
16406965|NCT02351349|39969963|FG000|Overall Study|Withdrawal by Subject|2|||
16406966|NCT02351349|39969964|FG001|Overall Study|Withdrawal by Subject|3|||
16406967|NCT01133626|39969965|FG000|Overall Study|Adverse Event|0|||
16406968|NCT01133626|39969966|FG001|Overall Study|Adverse Event|1|||
16406969|NCT01133626|39969967|FG002|Overall Study|Adverse Event|0|||
16406970|NCT01133626|39969965|FG000|Overall Study|Withdrawal by Subject|1|||
16406971|NCT01133626|39969966|FG001|Overall Study|Withdrawal by Subject|2|||
16406972|NCT01133626|39969967|FG002|Overall Study|Withdrawal by Subject|2|||
16406973|NCT01133626|39969965|FG000|Overall Study|Other|0|||
16406974|NCT01133626|39969966|FG001|Overall Study|Other|2|||
16406975|NCT01133626|39969967|FG002|Overall Study|Other|0|||
16406976|NCT04569136|39969969|FG000|Overall Study|Lost to Follow-up|2|||
16406977|NCT04569136|39969970|FG001|Overall Study|Lost to Follow-up|0|||
16406978|NCT04569136|39969971|FG002|Overall Study|Lost to Follow-up|1|||
16406979|NCT02826421|39969973|FG000|Overall Study|Adverse Event|1|||
16406980|NCT02826421|39969974|FG001|Overall Study|Adverse Event|0|||
16406981|NCT02826421|39969975|FG002|Overall Study|Adverse Event|0|||
16406982|NCT02826421|39969976|FG003|Overall Study|Adverse Event|1|||
16542373|NCT00394355|40446903|FG002|Overall Study|Subject withdrawal - related to drug|0|||
16542374|NCT00394355|40446904|FG003|Overall Study|Subject withdrawal - related to drug|0|||
16542375|NCT00394355|40446901|FG000|Overall Study|Lost to Follow-up|7|||
16542376|NCT00394355|40446902|FG001|Overall Study|Lost to Follow-up|5|||
16542377|NCT00394355|40446903|FG002|Overall Study|Lost to Follow-up|4|||
16542378|NCT00394355|40446904|FG003|Overall Study|Lost to Follow-up|3|||
16542379|NCT00394355|40446901|FG000|Overall Study|Noncompliance with protocol|4|||
16219701|NCT01117428|39282990|FG000|Overall Study|Progressive disease|15|||
16219702|NCT01117428|39282991|FG001|Overall Study|Progressive disease|27|||
16219703|NCT01117428|39282992|FG002|Overall Study|Progressive disease|10|||
16219704|NCT01117428|39282993|FG003|Overall Study|Progressive disease|12|||
16406983|NCT02826421|39969973|FG000|Overall Study|Withdrawal by Subject|1|||
16406984|NCT02826421|39969974|FG001|Overall Study|Withdrawal by Subject|3|||
16542380|NCT00394355|40446902|FG001|Overall Study|Noncompliance with protocol|3|||
16542381|NCT00394355|40446903|FG002|Overall Study|Noncompliance with protocol|10|||
16219705|NCT01117428|39282994|FG004|Overall Study|Progressive disease|16|||
16219706|NCT01117428|39282995|FG005|Overall Study|Progressive disease|17|||
16219707|NCT02407236|39282996|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
16406985|NCT02826421|39969975|FG002|Overall Study|Withdrawal by Subject|1|||
16406986|NCT02826421|39969976|FG003|Overall Study|Withdrawal by Subject|1|||
16406987|NCT02826421|39969973|FG000|Overall Study|Reason not given|1|||
16406988|NCT02826421|39969974|FG001|Overall Study|Reason not given|0|||
16406989|NCT02826421|39969975|FG002|Overall Study|Reason not given|1|||
16406990|NCT02826421|39969976|FG003|Overall Study|Reason not given|0|||
16406991|NCT01824823|39969977|FG000|Overall Study|Lack of Efficacy|1|||
16406992|NCT01824823|39969978|FG001|Overall Study|Lack of Efficacy|1|||
16406993|NCT01824823|39969977|FG000|Overall Study|Off-treatment reason not submitted|1|||
16406994|NCT01824823|39969978|FG001|Overall Study|Off-treatment reason not submitted|0|||
16406995|NCT01396265|39969979|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
16406996|NCT03195660|39969980|FG000|Overall Study|The study was terminated|2|||
16406997|NCT04979897|39969983|FG000|Overall Study|Death|1|||
16406998|NCT04979897|39969984|FG001|Overall Study|Death|8|||
16406999|NCT04979897|39969983|FG000|Overall Study|Lost to Follow-up|111|||
16108247|NCT03279978|38885207|FG007|Overall Study|Withdrawal by Subject|0|||
16108248|NCT03279978|38885208|FG008|Overall Study|Withdrawal by Subject|0|||
16108249|NCT03279978|38885209|FG009|Overall Study|Withdrawal by Subject|1|||
16108250|NCT03279978|38885200|FG000|Overall Study|Lost to Follow-up|1|||
16108251|NCT03279978|38885201|FG001|Overall Study|Lost to Follow-up|0|||
16108252|NCT03279978|38885202|FG002|Overall Study|Lost to Follow-up|1|||
16108253|NCT03279978|38885203|FG003|Overall Study|Lost to Follow-up|0|||
16108254|NCT03279978|38885204|FG004|Overall Study|Lost to Follow-up|0|||
16108255|NCT03279978|38885205|FG005|Overall Study|Lost to Follow-up|0|||
16108256|NCT03279978|38885206|FG006|Overall Study|Lost to Follow-up|0|||
16108257|NCT03279978|38885207|FG007|Overall Study|Lost to Follow-up|0|||
16108258|NCT03279978|38885208|FG008|Overall Study|Lost to Follow-up|0|||
16108259|NCT03279978|38885209|FG009|Overall Study|Lost to Follow-up|0|||
16108260|NCT03279978|38885200|FG000|Overall Study|Other than stated above|0|||
16108261|NCT03279978|38885201|FG001|Overall Study|Other than stated above|0|||
16219708|NCT02407236|39282997|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
16219709|NCT02407236|39282998|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
16219710|NCT02407236|39282999|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
16219711|NCT02407236|39283000|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
16219712|NCT02407236|39283001|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
16219713|NCT02407236|39283002|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
16219714|NCT02407236|39283003|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
16219715|NCT02407236|39283004|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
16219716|NCT02407236|39283005|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
16219717|NCT02407236|39283006|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
16219718|NCT02407236|39283007|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
16219719|NCT02407236|39283008|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
16219720|NCT02407236|39282996|FG000|Induction Study (8 Weeks)|Death|0|||
16219721|NCT02407236|39282997|FG001|Induction Study (8 Weeks)|Death|0|||
16219722|NCT02407236|39282998|FG002|Induction Study (8 Weeks)|Death|1|||
16108262|NCT03279978|38885202|FG002|Overall Study|Other than stated above|0|||
16108263|NCT03279978|38885203|FG003|Overall Study|Other than stated above|0|||
16108264|NCT03279978|38885204|FG004|Overall Study|Other than stated above|0|||
16108265|NCT03279978|38885205|FG005|Overall Study|Other than stated above|0|||
16108266|NCT03279978|38885206|FG006|Overall Study|Other than stated above|1|||
16542382|NCT00394355|40446904|FG003|Overall Study|Noncompliance with protocol|8|||
16108267|NCT03279978|38885207|FG007|Overall Study|Other than stated above|0|||
16219723|NCT02407236|39282999|FG003|Induction Study (8 Weeks)|Death|0|||
16542383|NCT00394355|40446901|FG000|Overall Study|Administrative|0|||
16542384|NCT00394355|40446902|FG001|Overall Study|Administrative|1|||
16542385|NCT00394355|40446903|FG002|Overall Study|Administrative|1|||
16542386|NCT00394355|40446904|FG003|Overall Study|Administrative|1|||
16542387|NCT00394355|40446901|FG000|Overall Study|Lack of Efficacy|0|||
16542388|NCT00394355|40446902|FG001|Overall Study|Lack of Efficacy|0|||
16542389|NCT00394355|40446903|FG002|Overall Study|Lack of Efficacy|2|||
16542390|NCT00394355|40446904|FG003|Overall Study|Lack of Efficacy|3|||
16542391|NCT02543658|40446907|FG000|Overall Study|Lack of Efficacy|0|||
16542392|NCT02543658|40446908|FG001|Overall Study|Lack of Efficacy|4|||
16108268|NCT03279978|38885208|FG008|Overall Study|Other than stated above|0|||
16108269|NCT03279978|38885209|FG009|Overall Study|Other than stated above|0|||
16219724|NCT02407236|39283000|FG004|Induction Study (8 Weeks)|Death|0|||
16219725|NCT02407236|39283001|FG005|Induction Study (8 Weeks)|Death|0|||
16219726|NCT02407236|39283002|FG006|Induction Study (8 Weeks)|Death|0|||
16542393|NCT03764072|40446914|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
16542394|NCT03764072|40446915|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
16108270|NCT00665223|38885210|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
16108271|NCT00665223|38885211|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
16108272|NCT00665223|38885212|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
16108273|NCT00665223|38885210|FG000|Randomized Phase (26 Weeks)|Death|0|||
16108274|NCT00665223|38885211|FG001|Randomized Phase (26 Weeks)|Death|0|||
16108275|NCT00665223|38885212|FG002|Randomized Phase (26 Weeks)|Death|1|||
16108276|NCT00665223|38885210|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
16108277|NCT00665223|38885211|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
16407000|NCT04979897|39969984|FG001|Overall Study|Lost to Follow-up|56|||
16407001|NCT04979897|39969983|FG000|Overall Study|Withdrawal by Subject|7|||
16407002|NCT04979897|39969984|FG001|Overall Study|Withdrawal by Subject|2|||
16407003|NCT00489424|39969987|FG000|Overall Study|Adverse Event|3|||
16407004|NCT00489424|39969988|FG001|Overall Study|Adverse Event|3|||
16407005|NCT00489424|39969989|FG002|Overall Study|Adverse Event|4|||
16407006|NCT00489424|39969987|FG000|Overall Study|Lack of Efficacy|1|||
16407007|NCT00489424|39969988|FG001|Overall Study|Lack of Efficacy|0|||
16407008|NCT00489424|39969989|FG002|Overall Study|Lack of Efficacy|0|||
16407009|NCT00489424|39969987|FG000|Overall Study|Administrative problems|0|||
16407010|NCT00489424|39969988|FG001|Overall Study|Administrative problems|2|||
16407011|NCT00489424|39969989|FG002|Overall Study|Administrative problems|1|||
16407012|NCT03060512|39969994|FG000|Overall Study|Adverse Event|4|||
16407013|NCT03060512|39969995|FG001|Overall Study|Adverse Event|6|||
16407014|NCT03060512|39969994|FG000|Overall Study|Lost to Follow-up|1|||
16407015|NCT03060512|39969995|FG001|Overall Study|Lost to Follow-up|1|||
16108278|NCT00665223|38885212|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
16108279|NCT00665223|38885210|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
16108280|NCT00665223|38885211|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
16108281|NCT00665223|38885212|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
16108282|NCT00665223|38885210|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
16108283|NCT00665223|38885211|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
16108284|NCT00665223|38885212|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
16108285|NCT00665223|38885210|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
16108286|NCT00665223|38885211|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
16108287|NCT00665223|38885212|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
16108288|NCT00665223|38885210|FG000|Open-Label Period (26 Weeks)|Death|0|||
16108289|NCT00665223|38885211|FG001|Open-Label Period (26 Weeks)|Death|1|||
16108290|NCT00665223|38885212|FG002|Open-Label Period (26 Weeks)|Death|0|||
16108291|NCT00665223|38885210|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
16542395|NCT03764072|40446916|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
16542396|NCT03764072|40446917|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
16542397|NCT03764072|40446918|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
16108292|NCT00665223|38885211|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
16108293|NCT00665223|38885212|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
16542398|NCT03764072|40446919|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
16542399|NCT03764072|40446914|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
16542400|NCT03764072|40446915|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
16542401|NCT03764072|40446916|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
16542402|NCT03764072|40446917|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
16542403|NCT03764072|40446918|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
16542404|NCT03764072|40446919|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
16542405|NCT03764072|40446914|FG000|Overall Study|Lost to Follow-up|0|||
16542406|NCT03764072|40446915|FG001|Overall Study|Lost to Follow-up|0|||
16542407|NCT03764072|40446916|FG002|Overall Study|Lost to Follow-up|0|||
16542408|NCT03764072|40446917|FG003|Overall Study|Lost to Follow-up|0|||
16542409|NCT03764072|40446918|FG004|Overall Study|Lost to Follow-up|1|||
16108294|NCT00665223|38885210|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
16108295|NCT00665223|38885211|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
16108296|NCT00665223|38885212|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
16108297|NCT00665223|38885210|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
16542410|NCT03764072|40446919|FG005|Overall Study|Lost to Follow-up|0|||
16542411|NCT00742079|40446920|FG000|Overall Study|Lost to Follow-up|0|||
16542412|NCT00742079|40446921|FG001|Overall Study|Lost to Follow-up|1|||
16542413|NCT02690974|40446922|FG000|Overall Study|Adverse Event|16|||
16542414|NCT02690974|40446922|FG000|Overall Study|Death|9|||
16542415|NCT02690974|40446922|FG000|Overall Study|Subject/guardian decision|4|||
16542416|NCT02690974|40446922|FG000|Overall Study|Lost to Follow-up|3|||
16108298|NCT00665223|38885211|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
16108299|NCT00665223|38885212|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
16108300|NCT00665223|38885210|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
16108301|NCT00665223|38885211|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
16108302|NCT00665223|38885212|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
16108303|NCT01017263|38885215|FG000|Overall Study|not eligible|12|||
16108304|NCT00488319|38885216|FG000|Overall Study|Adverse Event|1|||
16108305|NCT00488319|38885217|FG001|Overall Study|Adverse Event|2|||
16108306|NCT00488319|38885218|FG002|Overall Study|Adverse Event|23|||
16108307|NCT00488319|38885216|FG000|Overall Study|Lack of Efficacy|6|||
16108308|NCT00488319|38885217|FG001|Overall Study|Lack of Efficacy|12|||
16108309|NCT00488319|38885218|FG002|Overall Study|Lack of Efficacy|27|||
16341790|NCT00549601|39738154|FG000|Received Study Drug|Lost to Follow-up|0|||
16108310|NCT00488319|38885216|FG000|Overall Study|Lost to Follow-up|3|||
16108311|NCT00488319|38885217|FG001|Overall Study|Lost to Follow-up|5|||
16108312|NCT00488319|38885218|FG002|Overall Study|Lost to Follow-up|16|||
16108313|NCT00488319|38885216|FG000|Overall Study|Withdrawal by Subject|5|||
16108314|NCT00488319|38885217|FG001|Overall Study|Withdrawal by Subject|20|||
16108315|NCT00488319|38885218|FG002|Overall Study|Withdrawal by Subject|44|||
16108316|NCT00488319|38885216|FG000|Overall Study|Other reasons for withdrawal|0|||
16108317|NCT00488319|38885217|FG001|Overall Study|Other reasons for withdrawal|4|||
16108318|NCT00488319|38885218|FG002|Overall Study|Other reasons for withdrawal|12|||
16108319|NCT01664923|38885239|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
16108320|NCT01664923|38885240|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
16108321|NCT01664923|38885239|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
16108322|NCT01664923|38885240|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
16108323|NCT01664923|38885239|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
16341791|NCT00549601|39738155|FG001|Received Study Drug|Lost to Follow-up|1|||
16341792|NCT00549601|39738156|FG002|Received Study Drug|Lost to Follow-up|1|||
16341793|NCT00549601|39738154|FG000|Received Study Drug|Protocol Violation|3|||
16341794|NCT00549601|39738155|FG001|Received Study Drug|Protocol Violation|4|||
16341795|NCT00549601|39738156|FG002|Received Study Drug|Protocol Violation|1|||
16341796|NCT00549601|39738154|FG000|Received Study Drug|Withdrawal by Subject|2|||
16341797|NCT00549601|39738155|FG001|Received Study Drug|Withdrawal by Subject|0|||
16341798|NCT00549601|39738156|FG002|Received Study Drug|Withdrawal by Subject|1|||
16341799|NCT02889835|39738157|FG000|Overall Study|Lost to Follow-up|13|||
16341800|NCT02889835|39738158|FG001|Overall Study|Lost to Follow-up|13|||
16341801|NCT02889835|39738159|FG002|Overall Study|Lost to Follow-up|13|||
16341802|NCT02889835|39738157|FG000|Overall Study|Withdrawal by Subject|2|||
16341803|NCT02889835|39738158|FG001|Overall Study|Withdrawal by Subject|2|||
16341804|NCT02889835|39738159|FG002|Overall Study|Withdrawal by Subject|2|||
16341805|NCT02889835|39738157|FG000|Overall Study|Protocol Violation|1|||
16341806|NCT02889835|39738158|FG001|Overall Study|Protocol Violation|1|||
16108324|NCT01664923|38885240|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
16108325|NCT01664923|38885239|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
16108326|NCT01664923|38885240|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
16108327|NCT01664923|38885239|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
16108328|NCT01664923|38885240|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
16341807|NCT02889835|39738159|FG002|Overall Study|Protocol Violation|1|||
16341808|NCT02889835|39738157|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
16341809|NCT02889835|39738158|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
16108329|NCT01664923|38885239|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
16108330|NCT01664923|38885240|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
16108331|NCT01664923|38885239|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
16108332|NCT01664923|38885240|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
16108333|NCT01664923|38885239|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
16108334|NCT01664923|38885240|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
16108335|NCT01664923|38885239|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
16108336|NCT01664923|38885240|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
16108337|NCT01664923|38885239|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
16108338|NCT01664923|38885240|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
16108339|NCT01664923|38885239|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
16108340|NCT01664923|38885240|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
16108341|NCT01664923|38885239|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
16108342|NCT01664923|38885240|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
16108343|NCT01664923|38885239|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
16108344|NCT01664923|38885240|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
16108345|NCT01664923|38885239|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
16108346|NCT01664923|38885240|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
16108347|NCT00853229|38885241|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
16108348|NCT00853229|38885242|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
16108349|NCT04035577|38885243|FG000|Overall Study|Lost to Follow-up|1|||
16108350|NCT04035577|38885243|FG000|Overall Study|Withdrawal by Subject|1|||
16341810|NCT02889835|39738159|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
16341811|NCT02889835|39738157|FG000|Overall Study|Death|1|||
16341812|NCT02889835|39738158|FG001|Overall Study|Death|1|||
16108351|NCT00853372|38885244|FG000|Overall Study|Death|30|||
16108352|NCT00853372|38885245|FG001|Overall Study|Death|26|||
16108353|NCT00853372|38885244|FG000|Overall Study|Lost to Follow-up|1|||
16108354|NCT00853372|38885245|FG001|Overall Study|Lost to Follow-up|2|||
16108355|NCT00853372|38885244|FG000|Overall Study|Full Consent Withdrawn|1|||
16108356|NCT00853372|38885245|FG001|Overall Study|Full Consent Withdrawn|1|||
16108357|NCT02210208|38885246|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
16108358|NCT02210208|38885246|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
16108359|NCT02210208|38885246|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
16108360|NCT02971228|38885247|FG000|Overall Study|Withdrawal by Subject|1|||
16108361|NCT02971228|38885248|FG001|Overall Study|Withdrawal by Subject|1|||
16108362|NCT02971228|38885249|FG002|Overall Study|Withdrawal by Subject|0|||
16108363|NCT02971228|38885250|FG003|Overall Study|Withdrawal by Subject|0|||
16108364|NCT02971228|38885251|FG004|Overall Study|Withdrawal by Subject|0|||
16108365|NCT02971228|38885247|FG000|Overall Study|Logistical challenges|0|||
16108366|NCT02971228|38885248|FG001|Overall Study|Logistical challenges|1|||
16108367|NCT02971228|38885249|FG002|Overall Study|Logistical challenges|0|||
16108368|NCT02971228|38885250|FG003|Overall Study|Logistical challenges|0|||
16108369|NCT02971228|38885251|FG004|Overall Study|Logistical challenges|0|||
16108370|NCT04696146|38885252|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
16108371|NCT04696146|38885253|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
16108372|NCT04696146|38885252|FG000|Overall Study|Off hours issue with product|1|||
16108373|NCT04696146|38885253|FG001|Overall Study|Off hours issue with product|0|||
16108374|NCT00766142|38885262|FG000|Overall Study|Protocol Violation|4|||
16108375|NCT02506881|38885263|FG000|First Intervention (Day 1)|Protocol Violation|0|||
16108376|NCT02506881|38885264|FG001|First Intervention (Day 1)|Protocol Violation|0|||
16108377|NCT02506881|38885265|FG002|First Intervention (Day 1)|Protocol Violation|1|||
16108378|NCT02506881|38885266|FG003|First Intervention (Day 1)|Protocol Violation|0|||
16108379|NCT02506881|38885263|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
16341813|NCT02889835|39738159|FG002|Overall Study|Death|1|||
16341814|NCT01904032|39738161|FG000|Overall Study|Adverse Event|3|||
16341815|NCT01904032|39738162|FG001|Overall Study|Adverse Event|1|||
16341816|NCT01904032|39738161|FG000|Overall Study|Lost to Follow-up|4|||
16341817|NCT01904032|39738162|FG001|Overall Study|Lost to Follow-up|2|||
16341818|NCT01066871|39738163|FG000|Overall Study|Lost to Follow-up|0|||
16341819|NCT01066871|39738164|FG001|Overall Study|Lost to Follow-up|2|||
16341820|NCT01066871|39738165|FG002|Overall Study|Lost to Follow-up|2|||
16341821|NCT01066871|39738166|FG003|Overall Study|Lost to Follow-up|0|||
16341822|NCT01066871|39738163|FG000|Overall Study|Protocol Violation|1|||
16341823|NCT01066871|39738164|FG001|Overall Study|Protocol Violation|0|||
16108380|NCT02506881|38885264|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
16108381|NCT02506881|38885265|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
16341824|NCT01066871|39738165|FG002|Overall Study|Protocol Violation|3|||
16341825|NCT01066871|39738166|FG003|Overall Study|Protocol Violation|2|||
16341826|NCT01066871|39738163|FG000|Overall Study|Lack of Efficacy|0|||
16542417|NCT02690974|40446922|FG000|Overall Study|Withdrawal of Informed Consent|3|||
16341827|NCT01066871|39738164|FG001|Overall Study|Lack of Efficacy|0|||
16108382|NCT02506881|38885266|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
16108383|NCT02506881|38885263|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
16108384|NCT02506881|38885264|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
16108385|NCT02506881|38885265|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
16108386|NCT02506881|38885266|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
16108387|NCT01919398|38885269|FG000|Overall Study|Progressive Disease|0|||
16108388|NCT01919398|38885270|FG001|Overall Study|Progressive Disease|0|||
16108389|NCT01919398|38885271|FG002|Overall Study|Progressive Disease|4|||
16108390|NCT01874665|38885276|FG000|Overall Study|Adverse Event|6|||
16108391|NCT01874665|38885277|FG001|Overall Study|Adverse Event|2|||
16108392|NCT01874665|38885276|FG000|Overall Study|Withdrawal by Subject|4|||
16108393|NCT01874665|38885277|FG001|Overall Study|Withdrawal by Subject|1|||
16108394|NCT01874665|38885276|FG000|Overall Study|Physician Decision|3|||
16108395|NCT01874665|38885277|FG001|Overall Study|Physician Decision|0|||
16108396|NCT01874665|38885276|FG000|Overall Study|Clinical Progressive Disease|4|||
16108397|NCT01874665|38885277|FG001|Overall Study|Clinical Progressive Disease|3|||
16108398|NCT01874665|38885276|FG000|Overall Study|Study Terminated by Sponsor|0|||
16108399|NCT01874665|38885277|FG001|Overall Study|Study Terminated by Sponsor|2|||
16108400|NCT01874665|38885276|FG000|Overall Study|Documented Progressive Disease|11|||
16108401|NCT01874665|38885277|FG001|Overall Study|Documented Progressive Disease|7|||
16108402|NCT01874665|38885276|FG000|Overall Study|Other|2|||
16108403|NCT01874665|38885277|FG001|Overall Study|Other|0|||
16108404|NCT02057575|38885282|FG000|Overall Study|Adverse Event|0|||
16108405|NCT02057575|38885283|FG001|Overall Study|Adverse Event|2|||
16108406|NCT02057575|38885284|FG002|Overall Study|Adverse Event|0|||
16108407|NCT02057575|38885285|FG003|Overall Study|Adverse Event|1|||
16108408|NCT02057575|38885282|FG000|Overall Study|Withdrawal by Subject|1|||
16108409|NCT02057575|38885283|FG001|Overall Study|Withdrawal by Subject|0|||
16108410|NCT02057575|38885284|FG002|Overall Study|Withdrawal by Subject|0|||
16108411|NCT02057575|38885285|FG003|Overall Study|Withdrawal by Subject|0|||
16108412|NCT02057575|38885282|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
16108413|NCT02057575|38885283|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
16108414|NCT02057575|38885284|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
16108415|NCT02057575|38885285|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
16108416|NCT02057575|38885282|FG000|Overall Study|Protocol Violation|0|||
16108417|NCT02057575|38885283|FG001|Overall Study|Protocol Violation|1|||
16108418|NCT02057575|38885284|FG002|Overall Study|Protocol Violation|0|||
16108419|NCT02057575|38885285|FG003|Overall Study|Protocol Violation|0|||
16108420|NCT02561078|38885286|FG000|Overall Study|Adverse Event|5|||
16108421|NCT02561078|38885287|FG001|Overall Study|Adverse Event|2|||
16108422|NCT02561078|38885286|FG000|Overall Study|Death|2|||
16108423|NCT02561078|38885287|FG001|Overall Study|Death|1|||
16108424|NCT02561078|38885286|FG000|Overall Study|Lost to Follow-up|2|||
16108425|NCT02561078|38885287|FG001|Overall Study|Lost to Follow-up|6|||
16108426|NCT02561078|38885286|FG000|Overall Study|Non-Compliance with Study Drug|6|||
16108427|NCT02561078|38885287|FG001|Overall Study|Non-Compliance with Study Drug|3|||
16108428|NCT02561078|38885286|FG000|Overall Study|Physician Decision|2|||
16108429|NCT02561078|38885287|FG001|Overall Study|Physician Decision|3|||
16108430|NCT02561078|38885286|FG000|Overall Study|Withdrawal by Subject|13|||
16108431|NCT02561078|38885287|FG001|Overall Study|Withdrawal by Subject|10|||
16108432|NCT04245345|38885288|FG000|Overall Study|Death|1|||
16108433|NCT04245345|38885288|FG000|Overall Study|Exited prior to implant|5|||
16341828|NCT01066871|39738165|FG002|Overall Study|Lack of Efficacy|0|||
16341829|NCT01066871|39738166|FG003|Overall Study|Lack of Efficacy|1|||
16341830|NCT01066871|39738163|FG000|Overall Study|Withdrawal by Subject|3|||
16341831|NCT01066871|39738164|FG001|Overall Study|Withdrawal by Subject|1|||
16341832|NCT01066871|39738165|FG002|Overall Study|Withdrawal by Subject|0|||
16341833|NCT01066871|39738166|FG003|Overall Study|Withdrawal by Subject|0|||
16341834|NCT01066871|39738163|FG000|Overall Study|Other|0|||
16341835|NCT01066871|39738164|FG001|Overall Study|Other|2|||
16341836|NCT01066871|39738165|FG002|Overall Study|Other|1|||
16341837|NCT01066871|39738166|FG003|Overall Study|Other|2|||
16341838|NCT01308463|39738169|FG000|Overall Study|Study Discontinued|23|||
16108434|NCT04245345|38885288|FG000|Overall Study|Exited prior to 1-month|9|||
16108435|NCT04245345|38885288|FG000|Overall Study|Missed 1-month visit|3|||
16219727|NCT02407236|39283003|FG007|Induction Study (8 Weeks)|Death|0|||
16341839|NCT01308463|39738169|FG000|Overall Study|Death|4|||
16341840|NCT01308463|39738169|FG000|Overall Study|Revision|2|||
16341841|NCT00003483|39738170|FG000|Overall Study|Not evaluable|1|||
16341842|NCT03026283|39738171|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
16341843|NCT03026283|39738172|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
16341844|NCT03026283|39738173|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
16341845|NCT03026283|39738174|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
16341846|NCT03026283|39738175|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
16341847|NCT03026283|39738176|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
16341848|NCT03026283|39738177|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
16341849|NCT03026283|39738178|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
16341850|NCT03026283|39738171|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
16341851|NCT03026283|39738172|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
16341852|NCT03026283|39738173|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
16542418|NCT02690974|40446922|FG000|Overall Study|Physician Decision|2|||
16542419|NCT02690974|40446922|FG000|Overall Study|Non-compliance with study treatment|1|||
16542420|NCT02690974|40446922|FG000|Overall Study|Protocol-defined stopping criteria|1|||
16542421|NCT02690974|40446922|FG000|Overall Study|Protocol Deviation|1|||
16542422|NCT03420781|40446923|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
16542423|NCT03420781|40446924|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
16542424|NCT03420781|40446925|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
16542425|NCT03420781|40446926|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
16542426|NCT03420781|40446927|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
16542427|NCT03420781|40446923|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
16542428|NCT03420781|40446924|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
16542429|NCT03420781|40446925|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
16542430|NCT03420781|40446926|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
16542431|NCT03420781|40446927|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
16542432|NCT03420781|40446923|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
16542433|NCT03420781|40446924|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
16542434|NCT03420781|40446925|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
16542435|NCT03420781|40446926|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
16542436|NCT03420781|40446927|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
16542437|NCT03420781|40446923|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
16542438|NCT03420781|40446924|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
16542439|NCT03420781|40446925|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
16542440|NCT03420781|40446926|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
16542441|NCT03420781|40446927|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
16542442|NCT03420781|40446923|FG000|Treatment Period (40 Weeks)|Death|2|||
16542443|NCT03420781|40446924|FG001|Treatment Period (40 Weeks)|Death|2|||
16542444|NCT03420781|40446925|FG002|Treatment Period (40 Weeks)|Death|0|||
16542445|NCT03420781|40446926|FG003|Treatment Period (40 Weeks)|Death|0|||
16542446|NCT03420781|40446927|FG004|Treatment Period (40 Weeks)|Death|0|||
16542447|NCT03420781|40446923|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
16542448|NCT03420781|40446924|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
16542449|NCT03420781|40446925|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
16542450|NCT03420781|40446926|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
16542451|NCT03420781|40446927|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
16542452|NCT03420781|40446923|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
16542453|NCT03420781|40446924|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
16542454|NCT03420781|40446925|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
16542455|NCT03420781|40446926|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
16542456|NCT03420781|40446927|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
16542457|NCT03420781|40446923|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
16542458|NCT03420781|40446924|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
16542459|NCT03420781|40446925|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
16542460|NCT03420781|40446926|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
16542461|NCT03420781|40446927|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
16542462|NCT03420781|40446923|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
16542463|NCT03420781|40446924|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
16542464|NCT03420781|40446925|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
16542465|NCT03420781|40446926|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
16542466|NCT03420781|40446927|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
16542467|NCT03420781|40446923|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
16542468|NCT03420781|40446924|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
16542469|NCT03420781|40446925|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
16542470|NCT03420781|40446926|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
16542471|NCT03420781|40446927|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
16542472|NCT03420781|40446923|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
16542473|NCT03420781|40446924|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
16542474|NCT03420781|40446925|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
16341853|NCT03026283|39738174|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
16108436|NCT04245345|38885288|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
16341854|NCT03026283|39738175|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
16341855|NCT03026283|39738176|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
16341856|NCT03026283|39738177|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
16341857|NCT03026283|39738178|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
16341858|NCT03026283|39738171|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
16341859|NCT03026283|39738172|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
16341860|NCT03026283|39738173|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
16341861|NCT03026283|39738174|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
16341862|NCT03026283|39738175|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
16341863|NCT03026283|39738176|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
16341864|NCT03026283|39738177|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
16341865|NCT03026283|39738178|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
16341866|NCT03026283|39738171|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
16341867|NCT03026283|39738172|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
16341868|NCT03026283|39738173|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
16341869|NCT03026283|39738174|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
16341870|NCT03026283|39738175|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
16341871|NCT03026283|39738176|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
16341872|NCT03026283|39738177|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
16341873|NCT03026283|39738178|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
16341874|NCT03026283|39738171|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
16341875|NCT03026283|39738172|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
16341876|NCT03026283|39738173|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
16219728|NCT02407236|39283004|FG008|Induction Study (8 Weeks)|Death|0|||
16341877|NCT03026283|39738174|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
16111467|NCT00760747|38897275|FG001|Study Period III|Adverse Event|0|||
16341878|NCT03026283|39738175|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
16341879|NCT03026283|39738176|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
16341880|NCT03026283|39738177|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
16341881|NCT03026283|39738178|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
16341882|NCT03026283|39738171|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
16341883|NCT03026283|39738172|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
16341884|NCT03026283|39738173|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
16341885|NCT03026283|39738174|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
16341886|NCT03026283|39738175|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
16341887|NCT03026283|39738176|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
16341888|NCT03026283|39738177|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
16341889|NCT03026283|39738178|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
16341890|NCT03026283|39738171|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
16341891|NCT03026283|39738172|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
16341892|NCT03026283|39738173|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
16341893|NCT03026283|39738174|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
16341894|NCT03026283|39738175|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
16341895|NCT03026283|39738176|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
16341896|NCT03026283|39738177|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
16341897|NCT03026283|39738178|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
16341898|NCT03026283|39738171|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
16341899|NCT03026283|39738172|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
16341900|NCT03026283|39738173|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
16341901|NCT03026283|39738174|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
16341902|NCT03026283|39738175|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
16341903|NCT03026283|39738176|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
16341904|NCT03026283|39738177|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
16341905|NCT03026283|39738178|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
16341906|NCT03026283|39738171|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
16341907|NCT03026283|39738172|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
16341908|NCT03026283|39738173|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
16341909|NCT03026283|39738174|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
16341910|NCT03026283|39738175|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
16341911|NCT03026283|39738176|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
16341912|NCT03026283|39738177|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
16341913|NCT03026283|39738178|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
16341914|NCT01616758|39738179|FG000|Overall Study|Adverse Event|1|||
16341915|NCT01616758|39738179|FG000|Overall Study|Withdrawal by Subject|2|||
16341916|NCT01616758|39738179|FG000|Overall Study|Disease progression|18|||
16341917|NCT01616758|39738179|FG000|Overall Study|Study termination by Sponsor|1|||
16341918|NCT04575584|39738180|FG000|Overall Study|Death|6|||
16341919|NCT04575584|39738181|FG001|Overall Study|Death|4|||
16341920|NCT04575584|39738182|FG002|Overall Study|Death|6|||
16341921|NCT04575584|39738183|FG003|Overall Study|Death|2|||
16341922|NCT04575584|39738184|FG004|Overall Study|Death|0|||
16341923|NCT04575584|39738185|FG005|Overall Study|Death|0|||
16341924|NCT04575584|39738180|FG000|Overall Study|Lost to Follow-up|1|||
16341925|NCT04575584|39738181|FG001|Overall Study|Lost to Follow-up|1|||
16219729|NCT02407236|39283005|FG009|Induction Study (8 Weeks)|Death|0|||
16219730|NCT02407236|39283006|FG010|Induction Study (8 Weeks)|Death|0|||
16219731|NCT02407236|39283007|FG011|Induction Study (8 Weeks)|Death|0|||
16219732|NCT02407236|39283008|FG012|Induction Study (8 Weeks)|Death|0|||
16219733|NCT02407236|39282996|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
16219734|NCT02407236|39282997|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
16219735|NCT02407236|39282998|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
16219736|NCT02407236|39282999|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16219737|NCT02407236|39283000|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16219738|NCT02407236|39283001|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16219739|NCT02407236|39283002|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16219740|NCT02407236|39283003|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16219741|NCT02407236|39283004|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16219742|NCT02407236|39283005|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16219743|NCT02407236|39283006|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16219744|NCT02407236|39283007|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16219745|NCT02407236|39283008|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
16219746|NCT02407236|39282996|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16219747|NCT02407236|39282997|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16219748|NCT02407236|39282998|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
16219749|NCT02407236|39282999|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16219750|NCT02407236|39283000|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16219751|NCT02407236|39283001|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16219752|NCT02407236|39283002|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16219753|NCT02407236|39283003|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16219754|NCT02407236|39283004|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16219755|NCT02407236|39283005|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16219756|NCT02407236|39283006|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16219757|NCT02407236|39283007|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16341926|NCT04575584|39738182|FG002|Overall Study|Lost to Follow-up|1|||
16219758|NCT02407236|39283008|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
16341927|NCT04575584|39738183|FG003|Overall Study|Lost to Follow-up|1|||
16341928|NCT04575584|39738184|FG004|Overall Study|Lost to Follow-up|0|||
16341929|NCT04575584|39738185|FG005|Overall Study|Lost to Follow-up|0|||
16341930|NCT04575584|39738180|FG000|Overall Study|Physician Decision|0|||
16341931|NCT04575584|39738181|FG001|Overall Study|Physician Decision|1|||
16341932|NCT04575584|39738182|FG002|Overall Study|Physician Decision|1|||
16108437|NCT04245345|38885288|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
16219759|NCT02407236|39282996|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
16219760|NCT02407236|39282997|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
16341933|NCT04575584|39738183|FG003|Overall Study|Physician Decision|1|||
16341934|NCT04575584|39738184|FG004|Overall Study|Physician Decision|0|||
16341935|NCT04575584|39738185|FG005|Overall Study|Physician Decision|0|||
16341936|NCT04575584|39738180|FG000|Overall Study|Withdrawal by Subject|7|||
16341937|NCT04575584|39738181|FG001|Overall Study|Withdrawal by Subject|9|||
16219761|NCT02407236|39282998|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
16219762|NCT02407236|39282999|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
16219763|NCT02407236|39283000|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
16108438|NCT02658175|38885289|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
16108439|NCT02658175|38885290|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
16108440|NCT02658175|38885291|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
16108441|NCT02658175|38885289|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
16108442|NCT02658175|38885290|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
16108443|NCT02658175|38885291|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
16108444|NCT02658175|38885289|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
16108445|NCT02658175|38885290|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
16108446|NCT02658175|38885291|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
16108447|NCT02658175|38885289|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
16108448|NCT02658175|38885290|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
16108449|NCT02658175|38885291|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
16108450|NCT02658175|38885289|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
16108451|NCT02658175|38885290|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
16108452|NCT02658175|38885291|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
16108453|NCT02658175|38885289|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
16108454|NCT02658175|38885290|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
16108455|NCT02658175|38885291|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
16108456|NCT02658175|38885289|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
16108457|NCT02658175|38885290|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
16108458|NCT02658175|38885291|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
16108459|NCT02658175|38885289|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
16108460|NCT02658175|38885290|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
16108461|NCT02658175|38885291|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
16108462|NCT02658175|38885289|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
16108463|NCT02658175|38885290|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
16108464|NCT02658175|38885291|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
16108465|NCT02658175|38885289|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
16407016|NCT03060512|39969994|FG000|Overall Study|Withdrawal by Subject|1|||
16407017|NCT03060512|39969995|FG001|Overall Study|Withdrawal by Subject|0|||
16407018|NCT03060512|39969994|FG000|Overall Study|Non-compliance with study medication|1|||
16407019|NCT03060512|39969995|FG001|Overall Study|Non-compliance with study medication|2|||
16407020|NCT00496483|39969996|FG000|Overall Study|Not dosed|9|||
16407021|NCT00496483|39969996|FG000|Overall Study|Adverse Event|2|||
16407022|NCT00496483|39969996|FG000|Overall Study|Lack of Efficacy|1|||
16407023|NCT01777542|39970002|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
16407024|NCT01777542|39970003|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
16407025|NCT01799239|39970015|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
16407026|NCT01799239|39970016|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
16542475|NCT03420781|40446926|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
16542476|NCT03420781|40446927|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
16542477|NCT03420781|40446923|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
16542478|NCT03420781|40446924|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
16542479|NCT03420781|40446925|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
16542480|NCT03420781|40446926|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
16542481|NCT03420781|40446927|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
16542482|NCT03420781|40446923|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
16542483|NCT03420781|40446924|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
16542484|NCT03420781|40446925|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
16542485|NCT03420781|40446926|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
16542486|NCT03420781|40446927|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
16542487|NCT02606279|40446930|FG000|Overall Study|Lost to Follow-up|0|||
16542488|NCT02606279|40446931|FG001|Overall Study|Lost to Follow-up|1|||
16542489|NCT00003508|40446932|FG000|Overall Study|Not evaluable|5|||
16542490|NCT02007434|40446933|FG000|Overall Study|Lost to Follow-up|0|||
16542491|NCT02007434|40446934|FG001|Overall Study|Lost to Follow-up|1|||
16542492|NCT02007434|40446935|FG002|Overall Study|Lost to Follow-up|0|||
16542493|NCT02007434|40446936|FG003|Overall Study|Lost to Follow-up|0|||
16542494|NCT02007434|40446937|FG004|Overall Study|Lost to Follow-up|0|||
16542495|NCT02007434|40446938|FG005|Overall Study|Lost to Follow-up|0|||
16542496|NCT02007434|40446939|FG006|Overall Study|Lost to Follow-up|0|||
16542497|NCT02007434|40446940|FG007|Overall Study|Lost to Follow-up|0|||
16542498|NCT02007434|40446933|FG000|Overall Study|Non-compliance|1|||
16542499|NCT02007434|40446934|FG001|Overall Study|Non-compliance|0|||
16542500|NCT02007434|40446935|FG002|Overall Study|Non-compliance|1|||
16542501|NCT02007434|40446936|FG003|Overall Study|Non-compliance|0|||
16542502|NCT02007434|40446937|FG004|Overall Study|Non-compliance|0|||
16407027|NCT01799239|39970015|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
16407028|NCT01799239|39970016|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
16407029|NCT01799239|39970015|FG000|Period 1 (7 Days)|Protocol Violation|0|||
16407030|NCT01799239|39970016|FG001|Period 1 (7 Days)|Protocol Violation|1|||
16407031|NCT01799239|39970015|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
16407032|NCT01799239|39970016|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
16407033|NCT01799239|39970015|FG000|Period 2 (7 Days)|Protocol Violation|1|||
16407034|NCT01799239|39970016|FG001|Period 2 (7 Days)|Protocol Violation|0|||
16407035|NCT01456195|39970019|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
16407036|NCT01456195|39970020|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
16407037|NCT01456195|39970021|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
16407038|NCT01456195|39970019|FG000|Overall Study|Lost to Follow-up|3|||
16407039|NCT01456195|39970020|FG001|Overall Study|Lost to Follow-up|1|||
16108466|NCT02658175|38885290|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
16108467|NCT02658175|38885291|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
16108468|NCT03470545|38885294|FG000|Overall Study|Death|0|||
16108469|NCT03470545|38885295|FG001|Overall Study|Death|1|||
16108470|NCT03470545|38885294|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
16108471|NCT03470545|38885295|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
16108472|NCT03470545|38885294|FG000|Overall Study|Adverse Event|2|||
16108473|NCT03470545|38885295|FG001|Overall Study|Adverse Event|0|||
16108474|NCT03470545|38885294|FG000|Overall Study|Withdrawal by Subject|1|||
16108475|NCT03470545|38885295|FG001|Overall Study|Withdrawal by Subject|1|||
16108476|NCT03470545|38885294|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
16108477|NCT03470545|38885295|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
16108478|NCT01321723|38885296|FG000|Overall Study|Adverse Event|3|||
16108479|NCT01321723|38885297|FG001|Overall Study|Adverse Event|5|||
16108480|NCT01321723|38885298|FG002|Overall Study|Adverse Event|2|||
16108481|NCT01321723|38885296|FG000|Overall Study|Withdrawal by Subject|2|||
16108482|NCT01321723|38885297|FG001|Overall Study|Withdrawal by Subject|0|||
16108483|NCT01321723|38885298|FG002|Overall Study|Withdrawal by Subject|2|||
16108484|NCT02599688|38885299|FG000|Overall Study|Lack of Efficacy|1|||
16108485|NCT02599688|38885299|FG000|Overall Study|Withdrawal by Subject|1|||
16108486|NCT02599688|38885299|FG000|Overall Study|Termination by Sponsor|2|||
16108487|NCT01114139|38885302|FG000|Overall Study|Adverse Event|3|||
16108488|NCT01114139|38885303|FG001|Overall Study|Adverse Event|2|||
16219764|NCT02407236|39283001|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
16108489|NCT01114139|38885302|FG000|Overall Study|Lost to Follow-up|15|||
16108490|NCT01114139|38885303|FG001|Overall Study|Lost to Follow-up|3|||
16407040|NCT01456195|39970021|FG002|Overall Study|Lost to Follow-up|3|||
16407041|NCT01456195|39970019|FG000|Overall Study|Voluntary Withdrawal|5|||
16407042|NCT01456195|39970020|FG001|Overall Study|Voluntary Withdrawal|3|||
16407043|NCT01456195|39970021|FG002|Overall Study|Voluntary Withdrawal|7|||
16407044|NCT01456195|39970019|FG000|Overall Study|Lack of Efficacy|0|||
16407045|NCT01456195|39970020|FG001|Overall Study|Lack of Efficacy|1|||
16407046|NCT01456195|39970021|FG002|Overall Study|Lack of Efficacy|0|||
16108491|NCT01114139|38885302|FG000|Overall Study|Withdrawal by Subject|17|||
16108492|NCT01114139|38885303|FG001|Overall Study|Withdrawal by Subject|6|||
16108493|NCT01114139|38885302|FG000|Overall Study|Other-Missed 1 visit|1|||
16108494|NCT01114139|38885303|FG001|Overall Study|Other-Missed 1 visit|0|||
16108495|NCT01114139|38885302|FG000|Overall Study|Other-Protocol Violation|1|||
16108496|NCT01114139|38885303|FG001|Overall Study|Other-Protocol Violation|0|||
16108497|NCT01114139|38885302|FG000|Overall Study|Other-Out of window for study drug dose|1|||
16108498|NCT01114139|38885303|FG001|Overall Study|Other-Out of window for study drug dose|0|||
16108499|NCT01114139|38885302|FG000|Overall Study|Other-Participant falsified records|0|||
16108500|NCT01114139|38885303|FG001|Overall Study|Other-Participant falsified records|1|||
16108501|NCT01114139|38885302|FG000|Overall Study|Other-Participant went on hospice|0|||
16108502|NCT01114139|38885303|FG001|Overall Study|Other-Participant went on hospice|1|||
16108503|NCT01114139|38885302|FG000|Overall Study|Other-Physician changed treatment|1|||
16108504|NCT01114139|38885303|FG001|Overall Study|Other-Physician changed treatment|0|||
16108505|NCT01114139|38885302|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
16108506|NCT01114139|38885303|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
16108507|NCT01880437|38885304|FG000|Overall Study|Death|12|||
16108508|NCT01880437|38885305|FG001|Overall Study|Death|4|||
16108509|NCT01880437|38885306|FG002|Overall Study|Death|17|||
16108510|NCT01880437|38885304|FG000|Overall Study|Study terminated by Sponsor|3|||
16108511|NCT01880437|38885305|FG001|Overall Study|Study terminated by Sponsor|0|||
16108512|NCT01880437|38885306|FG002|Overall Study|Study terminated by Sponsor|2|||
16108513|NCT03834623|38885307|FG000|Overall Study|Progression|0|||
16108514|NCT03834623|38885308|FG001|Overall Study|Progression|1|||
16108515|NCT00719212|38885309|FG000|Overall Study|Death|41|||
16219765|NCT02407236|39283002|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
16108516|NCT00719212|38885309|FG000|Overall Study|Lost to Follow-up|2|||
16108517|NCT00719212|38885309|FG000|Overall Study|Withdrawal by Subject|1|||
16108518|NCT00508274|38885315|FG000|Overall Study|Adverse Event|5|||
16108519|NCT00508274|38885315|FG000|Overall Study|Death|7|||
16108520|NCT00508274|38885315|FG000|Overall Study|Disease progression|32|||
16108521|NCT00508274|38885315|FG000|Overall Study|Withdrawal by Subject|1|||
16108522|NCT00508274|38885315|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
16108523|NCT00508274|38885315|FG000|Overall Study|Missing|3|||
16341938|NCT04575584|39738182|FG002|Overall Study|Withdrawal by Subject|5|||
16341939|NCT04575584|39738183|FG003|Overall Study|Withdrawal by Subject|3|||
16108524|NCT01167192|38885317|FG000|Overall Study|Adverse Event|1|||
16108525|NCT01167192|38885317|FG000|Overall Study|Death|1|||
16108526|NCT01167192|38885317|FG000|Overall Study|Withdrawal by Subject|1|||
16108527|NCT01167192|38885317|FG000|Overall Study|Insurance denial|1|||
16108528|NCT01214421|38885322|FG000|Overall Study|Lost to Follow-up|7|||
16108529|NCT01214421|38885323|FG001|Overall Study|Lost to Follow-up|3|||
16108530|NCT01214421|38885324|FG002|Overall Study|Lost to Follow-up|7|||
16108531|NCT01214421|38885325|FG003|Overall Study|Lost to Follow-up|3|||
16108532|NCT01214421|38885322|FG000|Overall Study|Adverse Event|16|||
16108533|NCT01214421|38885323|FG001|Overall Study|Adverse Event|35|||
16108534|NCT01214421|38885324|FG002|Overall Study|Adverse Event|14|||
16108535|NCT01214421|38885325|FG003|Overall Study|Adverse Event|3|||
16341940|NCT04575584|39738184|FG004|Overall Study|Withdrawal by Subject|0|||
16341941|NCT04575584|39738185|FG005|Overall Study|Withdrawal by Subject|0|||
16341942|NCT04575584|39738180|FG000|Overall Study|Not recorded|0|||
16341943|NCT04575584|39738181|FG001|Overall Study|Not recorded|0|||
16341944|NCT04575584|39738182|FG002|Overall Study|Not recorded|0|||
16341945|NCT04575584|39738183|FG003|Overall Study|Not recorded|1|||
16341946|NCT04575584|39738184|FG004|Overall Study|Not recorded|0|||
16341947|NCT04575584|39738185|FG005|Overall Study|Not recorded|0|||
16108536|NCT01214421|38885322|FG000|Overall Study|Sponsor Discontinued Site|1|||
16108537|NCT01214421|38885323|FG001|Overall Study|Sponsor Discontinued Site|2|||
16108538|NCT01214421|38885324|FG002|Overall Study|Sponsor Discontinued Site|0|||
16108539|NCT01214421|38885325|FG003|Overall Study|Sponsor Discontinued Site|0|||
16108540|NCT01214421|38885322|FG000|Overall Study|Withdrawal Criteria Met|3|||
16108541|NCT01214421|38885323|FG001|Overall Study|Withdrawal Criteria Met|0|||
16108542|NCT01214421|38885324|FG002|Overall Study|Withdrawal Criteria Met|2|||
16341948|NCT02784288|39738186|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
16341949|NCT01808261|39738187|FG000|Overall Study|Physician Decision|0|||
16341950|NCT01808261|39738188|FG001|Overall Study|Physician Decision|2|||
16341951|NCT01808261|39738187|FG000|Overall Study|Study Closed/Terminated|25|||
16341952|NCT01808261|39738188|FG001|Overall Study|Study Closed/Terminated|23|||
16341953|NCT01808261|39738187|FG000|Overall Study|Adverse event, non-fatal|2|||
16341954|NCT01808261|39738188|FG001|Overall Study|Adverse event, non-fatal|0|||
16108543|NCT01214421|38885325|FG003|Overall Study|Withdrawal Criteria Met|1|||
16108544|NCT01214421|38885322|FG000|Overall Study|Physician Decision|2|||
16108545|NCT01214421|38885323|FG001|Overall Study|Physician Decision|0|||
16108546|NCT01214421|38885324|FG002|Overall Study|Physician Decision|4|||
16108547|NCT01214421|38885325|FG003|Overall Study|Physician Decision|0|||
16341955|NCT01808261|39738187|FG000|Overall Study|Consent withdrawn by subject|6|||
16341956|NCT01808261|39738188|FG001|Overall Study|Consent withdrawn by subject|7|||
16341957|NCT01808261|39738187|FG000|Overall Study|Lost to Follow-up|3|||
16341958|NCT01808261|39738188|FG001|Overall Study|Lost to Follow-up|1|||
16341959|NCT02983045|39738191|FG000|Overall Study|Withdrawal by Subject|0|||
16341960|NCT02983045|39738192|FG001|Overall Study|Withdrawal by Subject|1|||
16341961|NCT02983045|39738193|FG002|Overall Study|Withdrawal by Subject|0|||
16341962|NCT02983045|39738194|FG003|Overall Study|Withdrawal by Subject|5|||
16341963|NCT02983045|39738195|FG004|Overall Study|Withdrawal by Subject|0|||
16341964|NCT02983045|39738196|FG005|Overall Study|Withdrawal by Subject|72|||
16108548|NCT01214421|38885322|FG000|Overall Study|Withdrawal by Subject|21|||
16108549|NCT01214421|38885323|FG001|Overall Study|Withdrawal by Subject|18|||
16108550|NCT01214421|38885324|FG002|Overall Study|Withdrawal by Subject|11|||
16108551|NCT01214421|38885325|FG003|Overall Study|Withdrawal by Subject|2|||
16108552|NCT03414047|38885326|FG000|Overall Study|Adverse Event|0|||
16108553|NCT03414047|38885327|FG001|Overall Study|Adverse Event|0|||
16108554|NCT03414047|38885328|FG002|Overall Study|Adverse Event|1|||
16108555|NCT03414047|38885329|FG003|Overall Study|Adverse Event|1|||
16108556|NCT03414047|38885326|FG000|Overall Study|Physician Decision|1|||
16108557|NCT03414047|38885327|FG001|Overall Study|Physician Decision|0|||
16108558|NCT03414047|38885328|FG002|Overall Study|Physician Decision|0|||
16108559|NCT03414047|38885329|FG003|Overall Study|Physician Decision|1|||
16108560|NCT03414047|38885326|FG000|Overall Study|Withdrawal by Subject|1|||
16108561|NCT03414047|38885327|FG001|Overall Study|Withdrawal by Subject|0|||
16108562|NCT03414047|38885328|FG002|Overall Study|Withdrawal by Subject|2|||
16108563|NCT03414047|38885329|FG003|Overall Study|Withdrawal by Subject|0|||
16108564|NCT00598871|38885330|FG000|Overall Study|Adverse Event|0|||
16108565|NCT00598871|38885331|FG001|Overall Study|Adverse Event|1|||
16108566|NCT02859064|38885334|FG000|Overall Study|Progressive Disease|3|||
16108567|NCT02859064|38885334|FG000|Overall Study|Physician Decision|1|||
16108568|NCT02859064|38885334|FG000|Overall Study|Withdrawal by Subject|1|||
16341965|NCT02983045|39738197|FG006|Overall Study|Withdrawal by Subject|0|||
16341966|NCT02983045|39738198|FG007|Overall Study|Withdrawal by Subject|0|||
16341967|NCT02983045|39738199|FG008|Overall Study|Withdrawal by Subject|0|||
16341968|NCT02983045|39738200|FG009|Overall Study|Withdrawal by Subject|2|||
16341969|NCT02983045|39738191|FG000|Overall Study|Lost to Follow-up|0|||
16341970|NCT02983045|39738192|FG001|Overall Study|Lost to Follow-up|0|||
16341971|NCT02983045|39738193|FG002|Overall Study|Lost to Follow-up|0|||
16341972|NCT02983045|39738194|FG003|Overall Study|Lost to Follow-up|0|||
16341973|NCT02983045|39738195|FG004|Overall Study|Lost to Follow-up|0|||
16341974|NCT02983045|39738196|FG005|Overall Study|Lost to Follow-up|10|||
16108569|NCT02859064|38885334|FG000|Overall Study|Death|1|||
16108570|NCT02561806|38885338|FG000|Induction Period|Adverse Event|0|||
16108571|NCT02561806|38885339|FG001|Induction Period|Adverse Event|2|||
16108572|NCT02561806|38885338|FG000|Induction Period|Lack of Efficacy|1|||
16108573|NCT02561806|38885339|FG001|Induction Period|Lack of Efficacy|0|||
16108574|NCT02561806|38885338|FG000|Induction Period|Withdrawal by Subject|0|||
16108575|NCT02561806|38885339|FG001|Induction Period|Withdrawal by Subject|2|||
16108576|NCT02561806|38885338|FG000|Induction Period|Site staff became unblinded|1|||
16108577|NCT02561806|38885339|FG001|Induction Period|Site staff became unblinded|0|||
16108578|NCT02561806|38885338|FG000|Induction Period|Randomized but not treated|0|||
16108579|NCT02561806|38885339|FG001|Induction Period|Randomized but not treated|1|||
16108580|NCT02561806|38885338|FG000|Maintenance Period|Adverse Event|2|||
16341975|NCT02983045|39738197|FG006|Overall Study|Lost to Follow-up|0|||
16341976|NCT02983045|39738198|FG007|Overall Study|Lost to Follow-up|0|||
16341977|NCT02983045|39738199|FG008|Overall Study|Lost to Follow-up|0|||
16341978|NCT02983045|39738200|FG009|Overall Study|Lost to Follow-up|0|||
16341979|NCT03297021|39738201|FG000|Overall Study|Incomplete/illegible data sheet|4|||
16407047|NCT01456195|39970019|FG000|Overall Study|Other Reasons|2|||
16341980|NCT03297021|39738202|FG001|Overall Study|Incomplete/illegible data sheet|2|||
16341981|NCT03297021|39738203|FG002|Overall Study|Incomplete/illegible data sheet|3|||
16108581|NCT02561806|38885339|FG001|Maintenance Period|Adverse Event|1|||
16108582|NCT02561806|38885338|FG000|Maintenance Period|Lack of Efficacy|3|||
16108583|NCT02561806|38885339|FG001|Maintenance Period|Lack of Efficacy|1|||
16108584|NCT02561806|38885338|FG000|Maintenance Period|Lost to Follow-up|2|||
16341982|NCT03297021|39738201|FG000|Overall Study|Missing Post-Op Data|1|||
16341983|NCT03297021|39738202|FG001|Overall Study|Missing Post-Op Data|2|||
16407048|NCT01456195|39970020|FG001|Overall Study|Other Reasons|1|||
16407049|NCT01456195|39970021|FG002|Overall Study|Other Reasons|3|||
16108585|NCT02561806|38885339|FG001|Maintenance Period|Lost to Follow-up|2|||
16108586|NCT02561806|38885338|FG000|Maintenance Period|Protocol Violation|1|||
16108587|NCT02561806|38885339|FG001|Maintenance Period|Protocol Violation|0|||
16108588|NCT02561806|38885338|FG000|Maintenance Period|Withdrawal by Subject|5|||
16108589|NCT02561806|38885339|FG001|Maintenance Period|Withdrawal by Subject|3|||
16108590|NCT02561806|38885338|FG000|Maintenance Period|Site staff became unblinded|0|||
16341984|NCT03297021|39738203|FG002|Overall Study|Missing Post-Op Data|1|||
16341985|NCT01121536|39738204|FG000|Overall Study|Adverse Event|63|||
16341986|NCT01121536|39738204|FG000|Overall Study|Lack of Efficacy|35|||
16341987|NCT01121536|39738204|FG000|Overall Study|Withdrawal by Subject|65|||
16341988|NCT01121536|39738204|FG000|Overall Study|Protocol Violation|20|||
16108591|NCT02561806|38885339|FG001|Maintenance Period|Site staff became unblinded|1|||
16108592|NCT02561806|38885338|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
16108593|NCT02561806|38885339|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
16108594|NCT02561806|38885338|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
16108595|NCT02561806|38885339|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
16108596|NCT03458728|38885340|FG000|Overall Study|Adverse Event|1|||
16108597|NCT03458728|38885341|FG001|Overall Study|Adverse Event|0|||
16108598|NCT03458728|38885340|FG000|Overall Study|Physician Decision|1|||
16108599|NCT03458728|38885341|FG001|Overall Study|Physician Decision|0|||
16108600|NCT03458728|38885340|FG000|Overall Study|Progressive disease - clinical assessment|1|||
16108601|NCT03458728|38885341|FG001|Overall Study|Progressive disease - clinical assessment|0|||
16108602|NCT03458728|38885340|FG000|Overall Study|Progressive disease - radiological progression|21|||
16108603|NCT03458728|38885341|FG001|Overall Study|Progressive disease - radiological progression|6|||
16108604|NCT03458728|38885340|FG000|Overall Study|Withdrawal by Subject|0|||
16108605|NCT03458728|38885341|FG001|Overall Study|Withdrawal by Subject|1|||
16108606|NCT00526097|38885342|FG000|Overall Study|Adverse Event|6|||
16108607|NCT00526097|38885343|FG001|Overall Study|Adverse Event|44|||
16108608|NCT00526097|38885342|FG000|Overall Study|Protocol Violation|4|||
16108609|NCT00526097|38885343|FG001|Overall Study|Protocol Violation|10|||
16108610|NCT00526097|38885342|FG000|Overall Study|Withdrawal by Subject|3|||
16108611|NCT00526097|38885343|FG001|Overall Study|Withdrawal by Subject|1|||
16108612|NCT00526097|38885342|FG000|Overall Study|Other|2|||
16108613|NCT00526097|38885343|FG001|Overall Study|Other|1|||
16108614|NCT00197106|38885346|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
16108615|NCT00197106|38885347|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
16108616|NCT00197106|38885348|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
16108617|NCT00197106|38885346|FG000|Overall Treatment Period|Lack of Efficacy|0|||
16108618|NCT00197106|38885347|FG001|Overall Treatment Period|Lack of Efficacy|1|||
16108619|NCT00197106|38885348|FG002|Overall Treatment Period|Lack of Efficacy|0|||
16108620|NCT00197106|38885346|FG000|Overall Treatment Period|Lost to Follow-up|0|||
16108621|NCT00197106|38885347|FG001|Overall Treatment Period|Lost to Follow-up|0|||
16108622|NCT00197106|38885348|FG002|Overall Treatment Period|Lost to Follow-up|2|||
16108623|NCT00197106|38885346|FG000|Overall Treatment Period|Protocol Violation|0|||
16108624|NCT00197106|38885347|FG001|Overall Treatment Period|Protocol Violation|0|||
16108625|NCT00197106|38885348|FG002|Overall Treatment Period|Protocol Violation|2|||
16108626|NCT00197106|38885346|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
16108627|NCT00197106|38885347|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
16108628|NCT00197106|38885348|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
16341989|NCT01121536|39738204|FG000|Overall Study|Noncompliance with study medication|12|||
16341990|NCT01121536|39738204|FG000|Overall Study|Noncompliance with study procedures|9|||
16108629|NCT03409731|38885353|FG000|Overall Study|Withdrawal by Subject|17|||
16108630|NCT03409731|38885353|FG000|Overall Study|Death|4|||
16108631|NCT00816556|38885357|FG000|Overall Study|Adverse Event|1|||
16108632|NCT00816556|38885358|FG001|Overall Study|Adverse Event|1|||
16108633|NCT00816556|38885359|FG002|Overall Study|Adverse Event|1|||
16108634|NCT00816556|38885357|FG000|Overall Study|Withdrawal by Subject|1|||
16108635|NCT00816556|38885358|FG001|Overall Study|Withdrawal by Subject|1|||
16108636|NCT00816556|38885359|FG002|Overall Study|Withdrawal by Subject|1|||
16108637|NCT00816556|38885357|FG000|Overall Study|Lost to Follow-up|0|||
16108638|NCT00816556|38885358|FG001|Overall Study|Lost to Follow-up|0|||
16108639|NCT00816556|38885359|FG002|Overall Study|Lost to Follow-up|1|||
16219766|NCT02407236|39283003|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
16219767|NCT02407236|39283004|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
16219768|NCT02407236|39283005|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
16219769|NCT02407236|39283006|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
16219770|NCT02407236|39283007|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
16219771|NCT02407236|39283008|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
16219772|NCT02407236|39282996|FG000|Induction Study (8 Weeks)|Other|2|||
16219773|NCT02407236|39282997|FG001|Induction Study (8 Weeks)|Other|1|||
16108640|NCT02246218|38885360|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16108641|NCT02246218|38885361|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16108642|NCT02246218|38885360|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
16108643|NCT02246218|38885361|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
16108644|NCT02246218|38885360|FG000|Overall Study|Adverse Event|1|||
16108645|NCT02246218|38885361|FG001|Overall Study|Adverse Event|1|||
16108646|NCT02246218|38885360|FG000|Overall Study|Lost to Follow-up|1|||
16108647|NCT02246218|38885361|FG001|Overall Study|Lost to Follow-up|0|||
16108648|NCT01710800|38885365|FG000|Overall Study|Withdrawal by Subject|21|||
16108649|NCT01710800|38885365|FG000|Overall Study|Protocol Violation|1|||
16108650|NCT02143063|38885366|FG000|Overall Study|Lost to Follow-up|16|||
16108651|NCT02143063|38885367|FG001|Overall Study|Lost to Follow-up|28|||
16108652|NCT02143063|38885368|FG002|Overall Study|Lost to Follow-up|29|||
16108653|NCT02143063|38885366|FG000|Overall Study|Withdrawal by Subject|0|||
16108654|NCT02143063|38885367|FG001|Overall Study|Withdrawal by Subject|1|||
16108655|NCT02143063|38885368|FG002|Overall Study|Withdrawal by Subject|0|||
16108656|NCT02143063|38885366|FG000|Overall Study|Death|0|||
16108657|NCT02143063|38885367|FG001|Overall Study|Death|1|||
16108658|NCT02143063|38885368|FG002|Overall Study|Death|1|||
16108659|NCT02037256|38885369|FG000|Overall Study|Protocol Violation|0|||
16108660|NCT02037256|38885370|FG001|Overall Study|Protocol Violation|1|||
16108661|NCT02037256|38885369|FG000|Overall Study|Withdrawn prior to Velcade|0|||
16108662|NCT02037256|38885370|FG001|Overall Study|Withdrawn prior to Velcade|2|||
16108663|NCT02970305|38885371|FG000|Overall Study|Adverse Event|10|||
16108664|NCT02970305|38885372|FG001|Overall Study|Adverse Event|6|||
16108665|NCT02970305|38885371|FG000|Overall Study|Lack of Efficacy|1|||
16108666|NCT02970305|38885372|FG001|Overall Study|Lack of Efficacy|1|||
16108667|NCT02970305|38885371|FG000|Overall Study|Noncompliance with study drug|2|||
16542503|NCT02007434|40446938|FG005|Overall Study|Non-compliance|0|||
16542504|NCT02007434|40446939|FG006|Overall Study|Non-compliance|0|||
16542505|NCT02007434|40446940|FG007|Overall Study|Non-compliance|0|||
16542506|NCT01678131|40446941|FG000|Overall Study|Adverse Event|0|||
16542507|NCT01678131|40446942|FG001|Overall Study|Adverse Event|1|||
16542508|NCT01678131|40446943|FG002|Overall Study|Adverse Event|0|||
16542509|NCT01678131|40446941|FG000|Overall Study|Withdrawal by Subject|0|||
16542510|NCT01678131|40446942|FG001|Overall Study|Withdrawal by Subject|0|||
16542511|NCT01678131|40446943|FG002|Overall Study|Withdrawal by Subject|2|||
16542512|NCT01806584|40446946|FG000|Overall Study|Adverse Event|2|||
16542513|NCT01806584|40446947|FG001|Overall Study|Adverse Event|1|||
16542514|NCT01806584|40446946|FG000|Overall Study|Death|1|||
16542515|NCT01806584|40446947|FG001|Overall Study|Death|0|||
16542516|NCT01806584|40446946|FG000|Overall Study|Lost to Follow-up|0|||
16542517|NCT01806584|40446947|FG001|Overall Study|Lost to Follow-up|2|||
16542518|NCT01806584|40446946|FG000|Overall Study|Study terminated by sponsor|9|||
16542519|NCT01806584|40446947|FG001|Overall Study|Study terminated by sponsor|14|||
16542520|NCT01806584|40446946|FG000|Overall Study|Withdrawal by Subject|1|||
16542521|NCT01806584|40446947|FG001|Overall Study|Withdrawal by Subject|1|||
16542522|NCT01806584|40446946|FG000|Overall Study|Other unspecified|1|||
16542523|NCT01806584|40446947|FG001|Overall Study|Other unspecified|0|||
16542524|NCT03295318|40450200|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
16542525|NCT03295318|40450201|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
16542526|NCT03295318|40450202|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
16542527|NCT03295318|40450200|FG000|Overall Study|Death|1|||
16542528|NCT03295318|40450201|FG001|Overall Study|Death|1|||
16542529|NCT03295318|40450202|FG002|Overall Study|Death|1|||
16542530|NCT03295318|40450200|FG000|Overall Study|Protocol Violation|4|||
16542531|NCT03295318|40450201|FG001|Overall Study|Protocol Violation|3|||
16542532|NCT03295318|40450202|FG002|Overall Study|Protocol Violation|3|||
16542533|NCT03295318|40450200|FG000|Overall Study|Withdrawal by Subject|0|||
16219774|NCT02407236|39282998|FG002|Induction Study (8 Weeks)|Other|5|||
16219775|NCT02407236|39282999|FG003|Induction Study (8 Weeks)|Other|0|||
16108668|NCT02970305|38885372|FG001|Overall Study|Noncompliance with study drug|4|||
16108669|NCT02970305|38885371|FG000|Overall Study|Protocol Violation|2|||
16108670|NCT02970305|38885372|FG001|Overall Study|Protocol Violation|2|||
16407050|NCT03532932|39970026|FG000|Overall Study|Protocol Deviation|33|||
16542534|NCT03295318|40450201|FG001|Overall Study|Withdrawal by Subject|0|||
16542535|NCT03295318|40450202|FG002|Overall Study|Withdrawal by Subject|1|||
16542536|NCT03295318|40450200|FG000|Overall Study|Subject discontinued due to travel|0|||
16108671|NCT02970305|38885371|FG000|Overall Study|Withdrawal by Subject|12|||
16341991|NCT01121536|39738204|FG000|Overall Study|Lost to Follow-up|39|||
16341992|NCT01121536|39738204|FG000|Overall Study|Other|118|||
16341993|NCT03076515|39738205|FG000|Overall Study|DMC decision based on interim analysis|25|||
16341994|NCT03076515|39738206|FG001|Overall Study|DMC decision based on interim analysis|29|||
16341995|NCT01134393|39738207|FG000|Overall Study|Adverse Event|18|||
16341996|NCT01134393|39738207|FG000|Overall Study|Lack of Efficacy|2|||
16341997|NCT01134393|39738207|FG000|Overall Study|Protocol Violation|12|||
16341998|NCT01134393|39738207|FG000|Overall Study|Lost to Follow-up|3|||
16341999|NCT01134393|39738207|FG000|Overall Study|Withdrawal by Subject|11|||
16342000|NCT01134393|39738207|FG000|Overall Study|Other|6|||
16342001|NCT02782377|39738210|FG000|Overall Study|Physician Decision|5|||
16342002|NCT03042910|39738211|FG000|Overall Study|Adverse Event|1|||
16542537|NCT03295318|40450201|FG001|Overall Study|Subject discontinued due to travel|1|||
16542538|NCT03295318|40450202|FG002|Overall Study|Subject discontinued due to travel|0|||
16542539|NCT01733732|40450203|FG000|Overall Study|Adverse Event|1|||
16542540|NCT01733732|40450204|FG001|Overall Study|Adverse Event|0|||
16542541|NCT01733732|40450203|FG000|Overall Study|Did not attend all study visits|1|||
16542542|NCT01733732|40450204|FG001|Overall Study|Did not attend all study visits|0|||
16542543|NCT00321048|40450205|FG000|Overall Study|Withdrawal by Subject|6|||
16542544|NCT00321048|40450206|FG001|Overall Study|Withdrawal by Subject|8|||
16542545|NCT02532179|40450207|FG000|Overall Study|Lost to Follow-up|1|||
16542546|NCT02532179|40450207|FG000|Overall Study|Pregnancy|1|||
16542547|NCT02532179|40450207|FG000|Overall Study|Subject received depot steroid injection|1|||
16542548|NCT00045708|40450209|FG000|Phase 1|early progressive disease|0|||
16542549|NCT00045708|40450210|FG001|Phase 1|early progressive disease|1|||
16342003|NCT03042910|39738211|FG000|Overall Study|Disease Progression|2|||
16342004|NCT03042910|39738211|FG000|Overall Study|Withdrawal by Subject|3|||
16108672|NCT02970305|38885372|FG001|Overall Study|Withdrawal by Subject|11|||
16108673|NCT02970305|38885371|FG000|Overall Study|Not further specified|1|||
16108674|NCT02970305|38885372|FG001|Overall Study|Not further specified|2|||
16108675|NCT02970305|38885371|FG000|Overall Study|Lost to Follow-up|1|||
16108676|NCT02970305|38885372|FG001|Overall Study|Lost to Follow-up|2|||
16108677|NCT03512197|38885373|FG000|Overall Study|Guardian decision|1|||
16108678|NCT03512197|38885374|FG001|Overall Study|Guardian decision|1|||
16108679|NCT03512197|38885373|FG000|Overall Study|Lack of Efficacy|19|||
16108680|NCT03512197|38885374|FG001|Overall Study|Lack of Efficacy|11|||
16108681|NCT03512197|38885373|FG000|Overall Study|New Therapy for Study Indication|16|||
16108682|NCT03512197|38885374|FG001|Overall Study|New Therapy for Study Indication|16|||
16108683|NCT03512197|38885373|FG000|Overall Study|Physician Decision|60|||
16342005|NCT03042910|39738211|FG000|Overall Study|Enrolled but not treated|1|||
16342006|NCT03585712|39738212|FG000|Treatment Period 1|Protocol Violation|1|||
16342007|NCT03585712|39738213|FG001|Treatment Period 1|Protocol Violation|0|||
16342008|NCT03585712|39738214|FG002|Treatment Period 1|Protocol Violation|0|||
16342009|NCT03585712|39738212|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
16342010|NCT03585712|39738213|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
16342011|NCT03585712|39738214|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
16342012|NCT03585712|39738212|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
16108684|NCT03512197|38885374|FG001|Overall Study|Physician Decision|60|||
16108685|NCT03512197|38885373|FG000|Overall Study|Protocol Violation|0|||
16108686|NCT03512197|38885374|FG001|Overall Study|Protocol Violation|2|||
16342013|NCT03585712|39738213|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
16342014|NCT03585712|39738214|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
16342015|NCT03585712|39738212|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
16342016|NCT03585712|39738213|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
16342017|NCT03585712|39738214|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
16342018|NCT00642954|39738215|FG000|Overall Study|Progressive Disease|3|||
16342019|NCT00642954|39738216|FG001|Overall Study|Progressive Disease|3|||
16342020|NCT00642954|39738217|FG002|Overall Study|Progressive Disease|3|||
16342021|NCT00642954|39738218|FG003|Overall Study|Progressive Disease|3|||
16342022|NCT00642954|39738219|FG004|Overall Study|Progressive Disease|9|||
16342023|NCT00642954|39738215|FG000|Overall Study|Withdrawal by Subject|0|||
16108687|NCT03512197|38885373|FG000|Overall Study|Terminated by Sponsored|46|||
16108688|NCT03512197|38885374|FG001|Overall Study|Terminated by Sponsored|50|||
16108689|NCT03512197|38885373|FG000|Overall Study|Subject Decision|15|||
16108690|NCT03512197|38885374|FG001|Overall Study|Subject Decision|12|||
16108691|NCT03512197|38885373|FG000|Overall Study|Withdrawal of informed consent|20|||
16108692|NCT03512197|38885374|FG001|Overall Study|Withdrawal of informed consent|14|||
16108693|NCT03512197|38885373|FG000|Overall Study|Adverse Event|30|||
16108694|NCT03512197|38885374|FG001|Overall Study|Adverse Event|34|||
16108695|NCT03512197|38885373|FG000|Overall Study|Death|14|||
16108696|NCT03512197|38885374|FG001|Overall Study|Death|9|||
16108697|NCT03512197|38885373|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
16108698|NCT03512197|38885374|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
16108699|NCT03512197|38885373|FG000|Overall Study|Missing|3|||
16108700|NCT03512197|38885374|FG001|Overall Study|Missing|13|||
16108701|NCT00808899|38885375|FG000|Overall Study|Death|1|||
16108702|NCT00808899|38885375|FG000|Overall Study|Physician Decision|3|||
16108703|NCT00510146|38885376|FG000|Double-Blind Treatment|Adverse Event|30|||
16342024|NCT00642954|39738216|FG001|Overall Study|Withdrawal by Subject|0|||
16342025|NCT00642954|39738217|FG002|Overall Study|Withdrawal by Subject|0|||
16342026|NCT00642954|39738218|FG003|Overall Study|Withdrawal by Subject|0|||
16342027|NCT00642954|39738219|FG004|Overall Study|Withdrawal by Subject|1|||
16542550|NCT00045708|40450211|FG002|Phase 1|early progressive disease|0|||
16108704|NCT00510146|38885377|FG001|Double-Blind Treatment|Adverse Event|13|||
16108705|NCT00510146|38885376|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
16108706|NCT00510146|38885377|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
16108707|NCT00510146|38885376|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
16108708|NCT00510146|38885377|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
16108709|NCT00510146|38885376|FG000|Double-Blind Treatment|Physician Decision|6|||
16108710|NCT00510146|38885377|FG001|Double-Blind Treatment|Physician Decision|0|||
16108711|NCT00510146|38885376|FG000|Double-Blind Treatment|Protocol Violation|1|||
16219776|NCT02407236|39283000|FG004|Induction Study (8 Weeks)|Other|0|||
16542551|NCT01712009|40450216|FG000|Overall Study|Withdrawal by Subject|24|||
16542552|NCT01712009|40450217|FG001|Overall Study|Withdrawal by Subject|15|||
16542553|NCT01712009|40450218|FG002|Overall Study|Withdrawal by Subject|8|||
16542554|NCT01712009|40450216|FG000|Overall Study|Lost to Follow-up|2|||
16542555|NCT01712009|40450217|FG001|Overall Study|Lost to Follow-up|0|||
16542556|NCT01712009|40450218|FG002|Overall Study|Lost to Follow-up|1|||
16542557|NCT01712009|40450216|FG000|Overall Study|Decision by Sponsor|12|||
16542558|NCT01712009|40450217|FG001|Overall Study|Decision by Sponsor|14|||
16542559|NCT01712009|40450218|FG002|Overall Study|Decision by Sponsor|12|||
16542560|NCT00514683|40450219|FG000|Overall Study|Not treated|2|||
16542561|NCT00514683|40450220|FG001|Overall Study|Not treated|1|||
16542562|NCT00514683|40450221|FG002|Overall Study|Not treated|0|||
16542563|NCT00514683|40450222|FG003|Overall Study|Not treated|0|||
16542564|NCT00514683|40450223|FG004|Overall Study|Not treated|1|||
16542565|NCT00514683|40450219|FG000|Overall Study|Adverse Event|21|||
16542566|NCT00514683|40450220|FG001|Overall Study|Adverse Event|20|||
16542567|NCT00514683|40450221|FG002|Overall Study|Adverse Event|15|||
16542568|NCT00514683|40450222|FG003|Overall Study|Adverse Event|13|||
16542569|NCT00514683|40450223|FG004|Overall Study|Adverse Event|27|||
16108712|NCT00510146|38885377|FG001|Double-Blind Treatment|Protocol Violation|2|||
16108713|NCT00510146|38885376|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
16108714|NCT00510146|38885377|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
16108715|NCT00510146|38885376|FG000|Double-Blind Treatment|Clinical Relapse|0|||
16342028|NCT00642954|39738215|FG000|Overall Study|Adverse Event|1|||
16342029|NCT00642954|39738216|FG001|Overall Study|Adverse Event|1|||
16542570|NCT00514683|40450219|FG000|Overall Study|Protocol Violation|1|||
16542571|NCT00514683|40450220|FG001|Overall Study|Protocol Violation|1|||
16542572|NCT00514683|40450221|FG002|Overall Study|Protocol Violation|0|||
16542573|NCT00514683|40450222|FG003|Overall Study|Protocol Violation|1|||
16219777|NCT02407236|39283001|FG005|Induction Study (8 Weeks)|Other|0|||
16219778|NCT02407236|39283002|FG006|Induction Study (8 Weeks)|Other|0|||
16219779|NCT02407236|39283003|FG007|Induction Study (8 Weeks)|Other|0|||
16219780|NCT02407236|39283004|FG008|Induction Study (8 Weeks)|Other|0|||
16219781|NCT02407236|39283005|FG009|Induction Study (8 Weeks)|Other|0|||
16219782|NCT02407236|39283006|FG010|Induction Study (8 Weeks)|Other|0|||
16219783|NCT02407236|39283007|FG011|Induction Study (8 Weeks)|Other|0|||
16219784|NCT02407236|39283008|FG012|Induction Study (8 Weeks)|Other|0|||
16219785|NCT02407236|39282996|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
16219786|NCT02407236|39282997|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
16219787|NCT02407236|39282998|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
16219788|NCT02407236|39282999|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
16219789|NCT02407236|39283000|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
16219790|NCT02407236|39283001|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
16219791|NCT02407236|39283002|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
16542574|NCT00514683|40450223|FG004|Overall Study|Protocol Violation|0|||
16219792|NCT02407236|39283003|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
16219793|NCT02407236|39283004|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
16219794|NCT02407236|39283005|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
16219795|NCT02407236|39283006|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
16219796|NCT02407236|39283007|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
16542575|NCT00514683|40450219|FG000|Overall Study|Withdrawal by Subject|2|||
16542576|NCT00514683|40450220|FG001|Overall Study|Withdrawal by Subject|2|||
16542577|NCT00514683|40450221|FG002|Overall Study|Withdrawal by Subject|1|||
16542578|NCT00514683|40450222|FG003|Overall Study|Withdrawal by Subject|0|||
16542579|NCT00514683|40450223|FG004|Overall Study|Withdrawal by Subject|4|||
16542580|NCT00514683|40450219|FG000|Overall Study|Reason other than listed above|0|||
16542581|NCT00514683|40450220|FG001|Overall Study|Reason other than listed above|1|||
16542582|NCT00514683|40450221|FG002|Overall Study|Reason other than listed above|2|||
16542583|NCT00514683|40450222|FG003|Overall Study|Reason other than listed above|0|||
16542584|NCT00514683|40450223|FG004|Overall Study|Reason other than listed above|1|||
16542585|NCT00077064|40450227|FG000|Overall Study|Adverse Event|0|||
16542586|NCT00077064|40450228|FG001|Overall Study|Adverse Event|4|||
16542587|NCT00077064|40450227|FG000|Overall Study|Patient refusal|0|||
16542588|NCT00077064|40450228|FG001|Overall Study|Patient refusal|2|||
16542589|NCT02839343|40450229|FG000|Overall Study|Withdrawal by Subject|3|||
16542590|NCT02839343|40450230|FG001|Overall Study|Withdrawal by Subject|1|||
16542591|NCT02839343|40450229|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
16542592|NCT02839343|40450230|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
16542593|NCT02839343|40450229|FG000|Overall Study|Adverse Event|1|||
16542594|NCT02839343|40450230|FG001|Overall Study|Adverse Event|0|||
16542595|NCT00677235|40450231|FG000|Overall Study|Withdrawal by Subject|1|||
16542596|NCT00677235|40450232|FG001|Overall Study|Withdrawal by Subject|1|||
16542597|NCT00677235|40450231|FG000|Overall Study|Lost to Follow-up|2|||
16542598|NCT00677235|40450232|FG001|Overall Study|Lost to Follow-up|1|||
16542599|NCT00677235|40450231|FG000|Overall Study|Death|37|||
16542600|NCT00677235|40450232|FG001|Overall Study|Death|36|||
16542601|NCT00677235|40450231|FG000|Overall Study|Adverse Experience|1|||
16542602|NCT00677235|40450232|FG001|Overall Study|Adverse Experience|0|||
16542603|NCT00943306|40450233|FG000|Overall Study|Physician Decision|1|||
16542604|NCT00943306|40450233|FG000|Overall Study|Death|1|||
16542605|NCT00943306|40450233|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
16542606|NCT03010462|40450234|FG000|Overall Study|Withdrawal by Subject|3|||
16542607|NCT03010462|40450235|FG001|Overall Study|Withdrawal by Subject|1|||
16542608|NCT01699022|40450236|FG000|Overall Study|Early discontinuation from the study|3|||
16542609|NCT01061333|40450238|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
16542610|NCT01061333|40450239|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
16542611|NCT01281202|40450240|FG000|Overall Study|Adverse Event|2|||
16542612|NCT01281202|40450241|FG001|Overall Study|Adverse Event|0|||
16542613|NCT01281202|40450240|FG000|Overall Study|Withdrawal by Subject|2|||
16542614|NCT01281202|40450241|FG001|Overall Study|Withdrawal by Subject|2|||
16219797|NCT02407236|39283008|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
16542615|NCT01281202|40450240|FG000|Overall Study|Protocol Violation|11|||
16542616|NCT01281202|40450241|FG001|Overall Study|Protocol Violation|10|||
16542617|NCT01281202|40450240|FG000|Overall Study|Administrative|2|||
16108716|NCT00510146|38885377|FG001|Double-Blind Treatment|Clinical Relapse|1|||
16219798|NCT02407236|39282996|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16219799|NCT02407236|39282997|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16219800|NCT02407236|39282998|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16219801|NCT02407236|39282999|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
16219802|NCT02407236|39283000|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
16219803|NCT02407236|39283001|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
16219804|NCT02407236|39283002|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
16219805|NCT02407236|39283003|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
16219806|NCT02407236|39283004|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16219807|NCT02407236|39283005|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16219808|NCT02407236|39283006|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16219809|NCT02407236|39283007|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16219810|NCT02407236|39283008|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
16542618|NCT01281202|40450241|FG001|Overall Study|Administrative|8|||
16542619|NCT01281202|40450240|FG000|Overall Study|Lost to Follow-up|11|||
16542620|NCT01281202|40450241|FG001|Overall Study|Lost to Follow-up|13|||
16542621|NCT01281202|40450240|FG000|Overall Study|Incarceration|0|||
16219811|NCT02407236|39282996|FG000|Maintenance Study (44 Weeks)|Other|0|||
16219812|NCT02407236|39282997|FG001|Maintenance Study (44 Weeks)|Other|0|||
16542622|NCT01281202|40450241|FG001|Overall Study|Incarceration|3|||
16542623|NCT01572389|40450242|FG000|Overall Study|Death|1|||
16542624|NCT01572389|40450243|FG001|Overall Study|Death|3|||
16542625|NCT01572389|40450242|FG000|Overall Study|Withdrawal by Subject|14|||
16542626|NCT01572389|40450243|FG001|Overall Study|Withdrawal by Subject|2|||
16542627|NCT01572389|40450242|FG000|Overall Study|Lost to Follow-up|25|||
16542628|NCT01572389|40450243|FG001|Overall Study|Lost to Follow-up|14|||
16542629|NCT01572389|40450242|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
16542630|NCT01572389|40450243|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
16542631|NCT02569710|40450247|FG000|Overall Study|Adverse Event|1|||
16542632|NCT02569710|40450248|FG001|Overall Study|Adverse Event|0|||
16542633|NCT02569710|40450249|FG002|Overall Study|Adverse Event|0|||
16542634|NCT02569710|40450250|FG003|Overall Study|Adverse Event|0|||
16542635|NCT02569710|40450251|FG004|Overall Study|Adverse Event|0|||
16542636|NCT02569710|40450252|FG005|Overall Study|Adverse Event|0|||
16542637|NCT02569710|40450253|FG006|Overall Study|Adverse Event|0|||
16542638|NCT02569710|40450254|FG007|Overall Study|Adverse Event|0|||
16542639|NCT02569710|40450255|FG008|Overall Study|Adverse Event|0|||
16542640|NCT02569710|40450256|FG009|Overall Study|Adverse Event|0|||
16542641|NCT02569710|40450247|FG000|Overall Study|Lost to Follow-up|0|||
16542642|NCT02569710|40450248|FG001|Overall Study|Lost to Follow-up|0|||
16542643|NCT02569710|40450249|FG002|Overall Study|Lost to Follow-up|0|||
16542644|NCT02569710|40450250|FG003|Overall Study|Lost to Follow-up|0|||
16542645|NCT02569710|40450251|FG004|Overall Study|Lost to Follow-up|0|||
16542646|NCT02569710|40450252|FG005|Overall Study|Lost to Follow-up|0|||
16542647|NCT02569710|40450253|FG006|Overall Study|Lost to Follow-up|1|||
16108717|NCT00510146|38885376|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
16108718|NCT00510146|38885377|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
16219813|NCT02407236|39282998|FG002|Maintenance Study (44 Weeks)|Other|0|||
16219814|NCT02407236|39282999|FG003|Maintenance Study (44 Weeks)|Other|5|||
16219815|NCT02407236|39283000|FG004|Maintenance Study (44 Weeks)|Other|7|||
16219816|NCT02407236|39283001|FG005|Maintenance Study (44 Weeks)|Other|8|||
16542648|NCT02569710|40450254|FG007|Overall Study|Lost to Follow-up|0|||
16542649|NCT02569710|40450255|FG008|Overall Study|Lost to Follow-up|1|||
16542650|NCT02569710|40450256|FG009|Overall Study|Lost to Follow-up|0|||
16542651|NCT02569710|40450247|FG000|Overall Study|Virologic failure|0|||
16542652|NCT02569710|40450248|FG001|Overall Study|Virologic failure|0|||
16542653|NCT02569710|40450249|FG002|Overall Study|Virologic failure|0|||
16542654|NCT02569710|40450250|FG003|Overall Study|Virologic failure|0|||
16542655|NCT02569710|40450251|FG004|Overall Study|Virologic failure|1|||
16219817|NCT02407236|39283002|FG006|Maintenance Study (44 Weeks)|Other|4|||
16219818|NCT02407236|39283003|FG007|Maintenance Study (44 Weeks)|Other|6|||
16219819|NCT02407236|39283004|FG008|Maintenance Study (44 Weeks)|Other|0|||
16219820|NCT02407236|39283005|FG009|Maintenance Study (44 Weeks)|Other|0|||
16219821|NCT02407236|39283006|FG010|Maintenance Study (44 Weeks)|Other|0|||
16219822|NCT02407236|39283007|FG011|Maintenance Study (44 Weeks)|Other|0|||
16219823|NCT02407236|39283008|FG012|Maintenance Study (44 Weeks)|Other|0|||
16219824|NCT02407236|39282996|FG000|Maintenance Study (44 Weeks)|Death|0|||
16219825|NCT02407236|39282997|FG001|Maintenance Study (44 Weeks)|Death|0|||
16219826|NCT02407236|39282998|FG002|Maintenance Study (44 Weeks)|Death|0|||
16219827|NCT02407236|39282999|FG003|Maintenance Study (44 Weeks)|Death|0|||
16219828|NCT02407236|39283000|FG004|Maintenance Study (44 Weeks)|Death|0|||
16219829|NCT02407236|39283001|FG005|Maintenance Study (44 Weeks)|Death|0|||
16219830|NCT02407236|39283002|FG006|Maintenance Study (44 Weeks)|Death|0|||
16219831|NCT02407236|39283003|FG007|Maintenance Study (44 Weeks)|Death|1|||
16219832|NCT02407236|39283004|FG008|Maintenance Study (44 Weeks)|Death|0|||
16219833|NCT02407236|39283005|FG009|Maintenance Study (44 Weeks)|Death|0|||
16219834|NCT02407236|39283006|FG010|Maintenance Study (44 Weeks)|Death|0|||
16219835|NCT02407236|39283007|FG011|Maintenance Study (44 Weeks)|Death|0|||
16219836|NCT02407236|39283008|FG012|Maintenance Study (44 Weeks)|Death|0|||
16219837|NCT02407236|39282996|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16219838|NCT02407236|39282997|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16219839|NCT02407236|39282998|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16219840|NCT02407236|39282999|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16219841|NCT02407236|39283000|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16219842|NCT02407236|39283001|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16219843|NCT02407236|39283002|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16219844|NCT02407236|39283003|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
16219845|NCT02407236|39283004|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
16219846|NCT02407236|39283005|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
16219847|NCT02407236|39283006|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
16219848|NCT02407236|39283007|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
16219849|NCT02407236|39283008|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
16219850|NCT02407236|39282996|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219851|NCT02407236|39282997|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219852|NCT02407236|39282998|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219853|NCT02407236|39282999|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219854|NCT02407236|39283000|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219855|NCT02407236|39283001|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219856|NCT02407236|39283002|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219857|NCT02407236|39283003|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219858|NCT02407236|39283004|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219859|NCT02407236|39283005|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219860|NCT02407236|39283006|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
16219861|NCT02407236|39283007|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219862|NCT02407236|39283008|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
16219863|NCT02407236|39282996|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16219864|NCT02407236|39282997|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16219865|NCT02407236|39282998|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16219866|NCT02407236|39282999|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16219867|NCT02407236|39283000|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16219868|NCT02407236|39283001|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16219869|NCT02407236|39283002|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16219870|NCT02407236|39283003|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
16219871|NCT02407236|39283004|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
16219872|NCT02407236|39283005|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
16219873|NCT02407236|39283006|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
16219874|NCT02407236|39283007|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
16219875|NCT02407236|39283008|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
16219876|NCT02407236|39282996|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
16219877|NCT02407236|39282997|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
16219878|NCT02407236|39282998|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
16219879|NCT02407236|39282999|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
16219880|NCT02407236|39283000|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
16219881|NCT02407236|39283001|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
16219882|NCT02407236|39283002|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
16108719|NCT00510146|38885376|FG000|Open-Label Treatment|Adverse Event|22|||
16542656|NCT02569710|40450252|FG005|Overall Study|Virologic failure|0|||
16542657|NCT02569710|40450253|FG006|Overall Study|Virologic failure|1|||
16219883|NCT02407236|39283003|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
16219884|NCT02407236|39283004|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
16219885|NCT02407236|39283005|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
16219886|NCT02407236|39283006|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
16219887|NCT02407236|39283007|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
16219888|NCT02407236|39283008|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
16219889|NCT03267576|39283009|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
16219890|NCT03267576|39283010|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
16219891|NCT03267576|39283009|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
16219892|NCT03267576|39283010|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
16219893|NCT01657253|39283015|FG000|Overall Study|Lost to Follow-up|6|||
16219894|NCT01657253|39283016|FG001|Overall Study|Lost to Follow-up|5|||
16219895|NCT01657253|39283015|FG000|Overall Study|Withdrawal by Subject|11|||
16219896|NCT01657253|39283016|FG001|Overall Study|Withdrawal by Subject|12|||
16219897|NCT01657253|39283015|FG000|Overall Study|Adverse Event|0|||
16219898|NCT01657253|39283016|FG001|Overall Study|Adverse Event|1|||
16219899|NCT02545049|39283017|FG000|Overall Study|Withdrawal by Subject|1|||
16219900|NCT02545049|39283018|FG001|Overall Study|Withdrawal by Subject|7|||
16219901|NCT02545049|39283017|FG000|Overall Study|Lost to Follow-up|4|||
16219902|NCT02545049|39283018|FG001|Overall Study|Lost to Follow-up|6|||
16219903|NCT02545049|39283017|FG000|Overall Study|GCP violations|37|||
16219904|NCT02545049|39283018|FG001|Overall Study|GCP violations|48|||
16219905|NCT02802735|39283020|FG000|Overall Study|Withdrawal by Subject|0|||
16219906|NCT02802735|39283021|FG001|Overall Study|Withdrawal by Subject|1|||
16219907|NCT02802735|39283022|FG002|Overall Study|Withdrawal by Subject|0|||
16219908|NCT02802735|39283023|FG003|Overall Study|Withdrawal by Subject|0|||
16219909|NCT02802735|39283024|FG004|Overall Study|Withdrawal by Subject|0|||
16219910|NCT02202161|39283035|FG000|Overall Study|Adverse Event|1|||
16219911|NCT02202161|39283036|FG001|Overall Study|Adverse Event|1|||
16219912|NCT02202161|39283037|FG002|Overall Study|Adverse Event|0|||
16219913|NCT02202161|39283038|FG003|Overall Study|Adverse Event|0|||
16219914|NCT02202161|39283039|FG004|Overall Study|Adverse Event|0|||
16219915|NCT02202161|39283040|FG005|Overall Study|Adverse Event|1|||
16219916|NCT02202161|39283041|FG006|Overall Study|Adverse Event|0|||
16219917|NCT02202161|39283042|FG007|Overall Study|Adverse Event|0|||
16219918|NCT02202161|39283035|FG000|Overall Study|Did not meet continuation criteria|0|||
16219919|NCT02202161|39283036|FG001|Overall Study|Did not meet continuation criteria|0|||
16219920|NCT02202161|39283037|FG002|Overall Study|Did not meet continuation criteria|0|||
16219921|NCT02202161|39283038|FG003|Overall Study|Did not meet continuation criteria|0|||
16219922|NCT02202161|39283039|FG004|Overall Study|Did not meet continuation criteria|0|||
16219923|NCT02202161|39283040|FG005|Overall Study|Did not meet continuation criteria|0|||
16219924|NCT02202161|39283041|FG006|Overall Study|Did not meet continuation criteria|0|||
16219925|NCT02202161|39283042|FG007|Overall Study|Did not meet continuation criteria|3|||
16219926|NCT02202161|39283035|FG000|Overall Study|Physician Decision|0|||
16219927|NCT02202161|39283036|FG001|Overall Study|Physician Decision|0|||
16219928|NCT02202161|39283037|FG002|Overall Study|Physician Decision|0|||
16219929|NCT02202161|39283038|FG003|Overall Study|Physician Decision|0|||
16219930|NCT02202161|39283039|FG004|Overall Study|Physician Decision|0|||
16219931|NCT02202161|39283040|FG005|Overall Study|Physician Decision|0|||
16219932|NCT02202161|39283041|FG006|Overall Study|Physician Decision|0|||
16219933|NCT02202161|39283042|FG007|Overall Study|Physician Decision|3|||
16219934|NCT02202161|39283035|FG000|Overall Study|Withdrawal by Subject|0|||
16219935|NCT02202161|39283036|FG001|Overall Study|Withdrawal by Subject|0|||
16219936|NCT02202161|39283037|FG002|Overall Study|Withdrawal by Subject|0|||
16219937|NCT02202161|39283038|FG003|Overall Study|Withdrawal by Subject|0|||
16219938|NCT02202161|39283039|FG004|Overall Study|Withdrawal by Subject|1|||
16219939|NCT02202161|39283040|FG005|Overall Study|Withdrawal by Subject|0|||
16219940|NCT02202161|39283041|FG006|Overall Study|Withdrawal by Subject|0|||
16219941|NCT02202161|39283042|FG007|Overall Study|Withdrawal by Subject|0|||
16219942|NCT01657903|39283043|FG000|Overall Study|Lost to Follow-up|1|||
16219943|NCT01657903|39283043|FG000|Overall Study|Withdrawal by Subject|1|||
16219944|NCT01853397|39283050|FG000|Overall Study|Withdrawal by Subject|0|||
16219945|NCT01853397|39283051|FG001|Overall Study|Withdrawal by Subject|0|||
16219946|NCT01853397|39283052|FG002|Overall Study|Withdrawal by Subject|0|||
16219947|NCT01853397|39283053|FG003|Overall Study|Withdrawal by Subject|1|||
16219948|NCT01853397|39283050|FG000|Overall Study|Subject Noncompliance|0|||
16219949|NCT01853397|39283051|FG001|Overall Study|Subject Noncompliance|0|||
16219950|NCT01853397|39283052|FG002|Overall Study|Subject Noncompliance|0|||
16219951|NCT01853397|39283053|FG003|Overall Study|Subject Noncompliance|1|||
16219952|NCT02500706|39283054|FG000|Overall Study|Adverse Event|0|||
16219953|NCT02500706|39283055|FG001|Overall Study|Adverse Event|0|||
16219954|NCT02500706|39283056|FG002|Overall Study|Adverse Event|1|||
16219955|NCT02500706|39283054|FG000|Overall Study|Lost to Follow-up|0|||
16219956|NCT02500706|39283055|FG001|Overall Study|Lost to Follow-up|1|||
16219957|NCT02500706|39283056|FG002|Overall Study|Lost to Follow-up|1|||
16219958|NCT02500706|39283054|FG000|Overall Study|Withdrawal by Subject|4|||
16219959|NCT02500706|39283055|FG001|Overall Study|Withdrawal by Subject|6|||
16219960|NCT02500706|39283056|FG002|Overall Study|Withdrawal by Subject|4|||
16219961|NCT02500706|39283054|FG000|Overall Study|Unclassified|0|||
16219962|NCT02500706|39283055|FG001|Overall Study|Unclassified|0|||
16219963|NCT02500706|39283056|FG002|Overall Study|Unclassified|1|||
16219964|NCT00550615|39283057|FG000|Overall Study|Withdrawal by Subject|0|||
16219965|NCT00550615|39283058|FG001|Overall Study|Withdrawal by Subject|0|||
16219966|NCT00550615|39283059|FG002|Overall Study|Withdrawal by Subject|2|||
16219967|NCT00550615|39283060|FG003|Overall Study|Withdrawal by Subject|3|||
16219968|NCT00550615|39283057|FG000|Overall Study|Not evaluable|0|||
16219969|NCT00550615|39283058|FG001|Overall Study|Not evaluable|0|||
16219970|NCT00550615|39283059|FG002|Overall Study|Not evaluable|2|||
16219971|NCT00550615|39283060|FG003|Overall Study|Not evaluable|7|||
16219972|NCT00638989|39283061|FG000|Overall Study|Lost to Follow-up|0|||
16219973|NCT00638989|39283062|FG001|Overall Study|Lost to Follow-up|0|||
16219974|NCT00638989|39283063|FG002|Overall Study|Lost to Follow-up|1|||
16219975|NCT03377452|39283064|FG000|Overall Study|Refused assessment|0|||
16219976|NCT03377452|39283065|FG001|Overall Study|Refused assessment|2|||
16219977|NCT03377452|39283064|FG000|Overall Study|Lost to Follow-up|5|||
16219978|NCT03377452|39283065|FG001|Overall Study|Lost to Follow-up|4|||
16219979|NCT01843933|39283071|FG000|Overall Study|Data lost|6|||
16219980|NCT01843933|39283072|FG001|Overall Study|Data lost|4|||
16219981|NCT01034709|39283073|FG000|Overall Study|Protocol Violation|9|||
16219982|NCT01034709|39283074|FG001|Overall Study|Protocol Violation|16|||
16542658|NCT02569710|40450254|FG007|Overall Study|Virologic failure|0|||
16542659|NCT02569710|40450255|FG008|Overall Study|Virologic failure|0|||
16542660|NCT02569710|40450256|FG009|Overall Study|Virologic failure|0|||
16542661|NCT02569710|40450247|FG000|Overall Study|Withdrawal by Subject|0|||
16542662|NCT02569710|40450248|FG001|Overall Study|Withdrawal by Subject|0|||
16542663|NCT02569710|40450249|FG002|Overall Study|Withdrawal by Subject|0|||
16542664|NCT02569710|40450250|FG003|Overall Study|Withdrawal by Subject|0|||
16542665|NCT02569710|40450251|FG004|Overall Study|Withdrawal by Subject|0|||
16542666|NCT02569710|40450252|FG005|Overall Study|Withdrawal by Subject|1|||
16542667|NCT02569710|40450253|FG006|Overall Study|Withdrawal by Subject|0|||
16542668|NCT02569710|40450254|FG007|Overall Study|Withdrawal by Subject|0|||
16542669|NCT02569710|40450255|FG008|Overall Study|Withdrawal by Subject|0|||
16219983|NCT00545740|39283075|FG000|Overall Study|Lack of Efficacy|34|||
16219984|NCT00545740|39283076|FG001|Overall Study|Lack of Efficacy|35|||
16219985|NCT00545740|39283077|FG002|Overall Study|Lack of Efficacy|47|||
16219986|NCT00545740|39283078|FG003|Overall Study|Lack of Efficacy|36|||
16219987|NCT00545740|39283075|FG000|Overall Study|Withdrawal by Subject|17|||
16219988|NCT00545740|39283076|FG001|Overall Study|Withdrawal by Subject|15|||
16219989|NCT00545740|39283077|FG002|Overall Study|Withdrawal by Subject|16|||
16219990|NCT00545740|39283078|FG003|Overall Study|Withdrawal by Subject|18|||
16219991|NCT00545740|39283075|FG000|Overall Study|Adverse Event|10|||
16219992|NCT00545740|39283076|FG001|Overall Study|Adverse Event|18|||
16219993|NCT00545740|39283077|FG002|Overall Study|Adverse Event|19|||
16219994|NCT00545740|39283078|FG003|Overall Study|Adverse Event|9|||
16219995|NCT00545740|39283075|FG000|Overall Study|Lost to Follow-up|7|||
16219996|NCT00545740|39283076|FG001|Overall Study|Lost to Follow-up|5|||
16542670|NCT02569710|40450256|FG009|Overall Study|Withdrawal by Subject|0|||
16542671|NCT01242748|40450259|FG000|Overall Study|Adverse Event|10|||
16542672|NCT01242748|40450260|FG001|Overall Study|Adverse Event|5|||
16542673|NCT01242748|40450259|FG000|Overall Study|Lost to Follow-up|6|||
16219997|NCT00545740|39283077|FG002|Overall Study|Lost to Follow-up|5|||
16542674|NCT01242748|40450260|FG001|Overall Study|Lost to Follow-up|2|||
16542675|NCT01242748|40450259|FG000|Overall Study|Physician Decision|3|||
16542676|NCT01242748|40450260|FG001|Overall Study|Physician Decision|2|||
16542677|NCT01242748|40450259|FG000|Overall Study|Protocol Violation|1|||
16542678|NCT01242748|40450260|FG001|Overall Study|Protocol Violation|0|||
16542679|NCT01242748|40450259|FG000|Overall Study|Withdrawal by Subject|10|||
16542680|NCT01242748|40450260|FG001|Overall Study|Withdrawal by Subject|2|||
16542681|NCT01242748|40450259|FG000|Overall Study|Miscellaneous reasons|8|||
16542682|NCT01242748|40450260|FG001|Overall Study|Miscellaneous reasons|3|||
16542683|NCT00590902|40450261|FG000|Overall Study|Death|1|||
16542684|NCT02068495|40450266|FG000|Overall Study|Case Report Forms Uncollected|60|||
16542685|NCT02068495|40450266|FG000|Overall Study|Protocol Deviation|49|||
16542686|NCT03315143|40450272|FG000|Overall Study|Death|240|||
16542687|NCT03315143|40450273|FG001|Overall Study|Death|246|||
16542688|NCT03315143|40450272|FG000|Overall Study|Withdrawal by Subject|57|||
16542689|NCT03315143|40450273|FG001|Overall Study|Withdrawal by Subject|68|||
16542690|NCT03315143|40450272|FG000|Overall Study|Site Terminated by Sponsor|256|||
16542691|NCT03315143|40450273|FG001|Overall Study|Site Terminated by Sponsor|282|||
16542692|NCT03315143|40450272|FG000|Overall Study|Study Terminated by Sponsor|4723|||
16542693|NCT03315143|40450273|FG001|Overall Study|Study Terminated by Sponsor|4664|||
16542694|NCT03315143|40450272|FG000|Overall Study|Reason not Specified|16|||
16542695|NCT03315143|40450273|FG001|Overall Study|Reason not Specified|32|||
16542696|NCT03419364|40450278|FG000|Overall Study|Delivery due to maternal condition|2|||
16542697|NCT03419364|40450279|FG001|Overall Study|Delivery due to maternal condition|0|||
16542698|NCT03419364|40450280|FG002|Overall Study|Delivery due to maternal condition|0|||
16542699|NCT02417064|40450281|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
16542700|NCT02417064|40450282|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
16542701|NCT02417064|40450283|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
16542702|NCT02417064|40450281|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
16542703|NCT02417064|40450282|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
16542704|NCT02417064|40450283|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
16542705|NCT02417064|40450281|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
16542706|NCT02417064|40450282|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
16542707|NCT02417064|40450283|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
16219998|NCT00545740|39283078|FG003|Overall Study|Lost to Follow-up|6|||
16219999|NCT00545740|39283075|FG000|Overall Study|Protocol Violation|1|||
16220000|NCT00545740|39283076|FG001|Overall Study|Protocol Violation|3|||
16220001|NCT00545740|39283077|FG002|Overall Study|Protocol Violation|1|||
16542708|NCT02417064|40450281|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
16542709|NCT02417064|40450282|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
16542710|NCT02417064|40450283|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
16220002|NCT00545740|39283078|FG003|Overall Study|Protocol Violation|0|||
16342030|NCT00642954|39738217|FG002|Overall Study|Adverse Event|0|||
16342031|NCT00642954|39738218|FG003|Overall Study|Adverse Event|0|||
16342032|NCT00642954|39738219|FG004|Overall Study|Adverse Event|6|||
16342033|NCT03173456|39738220|FG000|Baseline|Medication dispensing system malfunction'|0|||
16342034|NCT03173456|39738221|FG001|Baseline|Medication dispensing system malfunction'|1|||
16342035|NCT03173456|39738222|FG002|Baseline|Medication dispensing system malfunction'|0|||
16342036|NCT03173456|39738223|FG003|Baseline|Medication dispensing system malfunction'|0|||
16342037|NCT03173456|39738224|FG004|Baseline|Medication dispensing system malfunction'|2|||
16342038|NCT03173456|39738220|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
16342039|NCT03173456|39738221|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
16342040|NCT03173456|39738222|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
16342041|NCT03173456|39738223|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
16342042|NCT03173456|39738224|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
16342043|NCT00893971|39738227|FG000|Overall Study|Physician Decision|3|||
16342044|NCT01693185|39738233|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
16342045|NCT01693185|39738234|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
16342046|NCT00264290|39738237|FG000|Intervention (8 Weeks)|Adverse Event|1|||
16342047|NCT00264290|39738238|FG001|Intervention (8 Weeks)|Adverse Event|0|||
16342048|NCT00571103|39738239|FG000|Overall Study|Withdrawal by Subject|1|||
16342049|NCT00571103|39738239|FG000|Overall Study|Lost to Follow-up|1|||
16342050|NCT01962948|39738240|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
16342051|NCT01962948|39738241|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
16342052|NCT01962948|39738242|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
16342053|NCT01962948|39738243|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
16342054|NCT01491841|39738244|FG000|Overall Study|Screen Failure|10|||
16342055|NCT01491841|39738244|FG000|Overall Study|Withdrawal by Subject|1|||
16342056|NCT00204477|39738246|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
16342057|NCT00204477|39738247|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
16342058|NCT00204477|39738246|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
16342059|NCT00204477|39738247|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
16342060|NCT01859949|39738249|FG000|Overall Study|Family Matters|0|||
16342061|NCT01859949|39738250|FG001|Overall Study|Family Matters|1|||
16342062|NCT01859949|39738249|FG000|Overall Study|Physician Decision|2|||
16342063|NCT01859949|39738250|FG001|Overall Study|Physician Decision|4|||
16342064|NCT01859949|39738249|FG000|Overall Study|Withdrawal by Subject|11|||
16342065|NCT01859949|39738250|FG001|Overall Study|Withdrawal by Subject|10|||
16342066|NCT01859949|39738249|FG000|Overall Study|Protocol Violation|1|||
16342067|NCT01859949|39738250|FG001|Overall Study|Protocol Violation|1|||
16342068|NCT01859949|39738249|FG000|Overall Study|Adverse Event|0|||
16342069|NCT01859949|39738250|FG001|Overall Study|Adverse Event|1|||
16342070|NCT02716779|39738251|FG000|Monotherapy|Adverse Event|0|||
16342071|NCT02716779|39738252|FG001|Monotherapy|Adverse Event|1|||
16342072|NCT02716779|39738253|FG002|Monotherapy|Adverse Event|1|||
16342073|NCT02716779|39738251|FG000|Combination Therapy|Adverse Event|0|||
16342074|NCT02716779|39738252|FG001|Combination Therapy|Adverse Event|2|||
16342075|NCT02716779|39738253|FG002|Combination Therapy|Adverse Event|1|||
16342076|NCT00621517|39738256|FG000|Overall Study|Lost to Follow-up|3|||
16342077|NCT00621517|39738257|FG001|Overall Study|Lost to Follow-up|3|||
16342078|NCT00621517|39738256|FG000|Overall Study|Withdrawal by Subject|3|||
16342079|NCT00621517|39738257|FG001|Overall Study|Withdrawal by Subject|4|||
16342080|NCT00621517|39738256|FG000|Overall Study|Adverse Event|1|||
16342081|NCT00621517|39738257|FG001|Overall Study|Adverse Event|0|||
16342082|NCT02401035|39738258|FG000|Overall Study|Withdrawal by Subject|1|||
16342083|NCT02401035|39738259|FG001|Overall Study|Withdrawal by Subject|0|||
16342084|NCT02385110|39738260|FG000|Overall Study|Early Death|1|||
16342085|NCT02385110|39738261|FG001|Overall Study|Early Death|0|||
16342086|NCT03465709|39738264|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
16342087|NCT03465709|39738264|FG000|Overall Study|Withdrawal by Subject|3|||
16342088|NCT03333486|39738265|FG000|Overall Study|Withdrawal by Subject|1|||
16342089|NCT03333486|39738265|FG000|Overall Study|Lost to Follow-up|1|||
16342090|NCT01006590|39738266|FG000|Overall Study|Adverse Event|2|||
16342091|NCT01006590|39738267|FG001|Overall Study|Adverse Event|3|||
16342092|NCT01006590|39738266|FG000|Overall Study|Death|1|||
16342093|NCT01006590|39738267|FG001|Overall Study|Death|1|||
16342094|NCT01006590|39738266|FG000|Overall Study|Lost to Follow-up|1|||
16342095|NCT01006590|39738267|FG001|Overall Study|Lost to Follow-up|1|||
16342096|NCT01006590|39738266|FG000|Overall Study|Protocol Violation|1|||
16342097|NCT01006590|39738267|FG001|Overall Study|Protocol Violation|0|||
16342098|NCT01006590|39738266|FG000|Overall Study|Withdrawal by Subject|4|||
16342099|NCT01006590|39738267|FG001|Overall Study|Withdrawal by Subject|2|||
16342100|NCT01006590|39738266|FG000|Overall Study|Study specific discontinuation criteria|16|||
16342101|NCT01006590|39738267|FG001|Overall Study|Study specific discontinuation criteria|23|||
16342102|NCT01006590|39738266|FG000|Overall Study|Other|3|||
16342103|NCT01006590|39738267|FG001|Overall Study|Other|2|||
16220003|NCT00545740|39283075|FG000|Overall Study|Non-compliance|0|||
16220004|NCT00545740|39283076|FG001|Overall Study|Non-compliance|2|||
16220005|NCT00545740|39283077|FG002|Overall Study|Non-compliance|1|||
16220006|NCT00545740|39283078|FG003|Overall Study|Non-compliance|0|||
16220007|NCT00545740|39283075|FG000|Overall Study|Moved|2|||
16220008|NCT00545740|39283076|FG001|Overall Study|Moved|0|||
16220009|NCT00545740|39283077|FG002|Overall Study|Moved|1|||
16220010|NCT00545740|39283078|FG003|Overall Study|Moved|0|||
16220011|NCT00545740|39283075|FG000|Overall Study|Diverticulitis attack|0|||
16220012|NCT00545740|39283076|FG001|Overall Study|Diverticulitis attack|0|||
16220013|NCT00545740|39283077|FG002|Overall Study|Diverticulitis attack|1|||
16220014|NCT00545740|39283078|FG003|Overall Study|Diverticulitis attack|1|||
16220015|NCT00545740|39283075|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
16220016|NCT00545740|39283076|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
16220017|NCT00545740|39283077|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
16220018|NCT00545740|39283078|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
16220019|NCT00545740|39283075|FG000|Overall Study|Site closure|1|||
16220020|NCT00545740|39283076|FG001|Overall Study|Site closure|0|||
16220021|NCT00545740|39283077|FG002|Overall Study|Site closure|0|||
16220022|NCT00545740|39283078|FG003|Overall Study|Site closure|0|||
16108720|NCT00510146|38885377|FG001|Open-Label Treatment|Adverse Event|8|||
16108721|NCT00510146|38885376|FG000|Open-Label Treatment|Death|1|||
16108722|NCT00510146|38885377|FG001|Open-Label Treatment|Death|1|||
16108723|NCT00510146|38885376|FG000|Open-Label Treatment|Lack of Efficacy|4|||
16108724|NCT00510146|38885377|FG001|Open-Label Treatment|Lack of Efficacy|0|||
16108725|NCT00510146|38885376|FG000|Open-Label Treatment|Lost to Follow-up|10|||
16108726|NCT00510146|38885377|FG001|Open-Label Treatment|Lost to Follow-up|1|||
16108727|NCT00510146|38885376|FG000|Open-Label Treatment|Physician Decision|3|||
16108728|NCT00510146|38885377|FG001|Open-Label Treatment|Physician Decision|1|||
16108729|NCT00510146|38885376|FG000|Open-Label Treatment|Protocol Violation|4|||
16108730|NCT00510146|38885377|FG001|Open-Label Treatment|Protocol Violation|2|||
16108731|NCT00510146|38885376|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
16108732|NCT00510146|38885377|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
16108733|NCT00510146|38885376|FG000|Open-Label Treatment|Clinical Relapse|1|||
16108734|NCT00510146|38885377|FG001|Open-Label Treatment|Clinical Relapse|1|||
16108735|NCT00510146|38885376|FG000|Open-Label Treatment|Sponsor Decision|2|||
16108736|NCT00510146|38885377|FG001|Open-Label Treatment|Sponsor Decision|0|||
16108737|NCT01086384|38885378|FG000|2-week Run-in Period|Adverse Event|1|||
16108738|NCT01086384|38885379|FG001|2-week Run-in Period|Adverse Event|0|||
16108739|NCT01086384|38885380|FG002|2-week Run-in Period|Adverse Event|0|||
16108740|NCT01086384|38885378|FG000|2-week Run-in Period|Protocol Violation|1|||
16108741|NCT01086384|38885379|FG001|2-week Run-in Period|Protocol Violation|0|||
16108742|NCT01086384|38885380|FG002|2-week Run-in Period|Protocol Violation|0|||
16108743|NCT01086384|38885378|FG000|2-week Run-in Period|Lost to Follow-up|1|||
16108744|NCT01086384|38885379|FG001|2-week Run-in Period|Lost to Follow-up|0|||
16108745|NCT01086384|38885380|FG002|2-week Run-in Period|Lost to Follow-up|0|||
16108746|NCT01086384|38885378|FG000|2-week Run-in Period|Physician Decision|6|||
16108747|NCT01086384|38885379|FG001|2-week Run-in Period|Physician Decision|0|||
16108748|NCT01086384|38885380|FG002|2-week Run-in Period|Physician Decision|0|||
16108749|NCT01086384|38885378|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
16108750|NCT01086384|38885379|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16108751|NCT01086384|38885380|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16108752|NCT01086384|38885378|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
16108753|NCT01086384|38885379|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
16108754|NCT01086384|38885380|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
16108755|NCT01086384|38885378|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
16108756|NCT01086384|38885379|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
16108757|NCT01086384|38885380|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
16108758|NCT01086384|38885378|FG000|2-week Run-in Period|Randomized in Error|1|||
16407051|NCT03532932|39970027|FG001|Overall Study|Protocol Deviation|31|||
16407052|NCT03532932|39970026|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
16108759|NCT01086384|38885379|FG001|2-week Run-in Period|Randomized in Error|0|||
16108760|NCT01086384|38885380|FG002|2-week Run-in Period|Randomized in Error|0|||
16108761|NCT01086384|38885378|FG000|Treatment Period|Withdrawal by Subject|0|||
16108762|NCT01086384|38885379|FG001|Treatment Period|Withdrawal by Subject|53|||
16108763|NCT01086384|38885380|FG002|Treatment Period|Withdrawal by Subject|55|||
16108764|NCT01086384|38885378|FG000|Treatment Period|Protocol Violation|0|||
16108765|NCT01086384|38885379|FG001|Treatment Period|Protocol Violation|26|||
16108766|NCT01086384|38885380|FG002|Treatment Period|Protocol Violation|17|||
16108767|NCT01086384|38885378|FG000|Treatment Period|Lack of Efficacy|0|||
16108768|NCT01086384|38885379|FG001|Treatment Period|Lack of Efficacy|22|||
16108769|NCT01086384|38885380|FG002|Treatment Period|Lack of Efficacy|13|||
16108770|NCT01086384|38885378|FG000|Treatment Period|Adverse Event|0|||
16108771|NCT01086384|38885379|FG001|Treatment Period|Adverse Event|19|||
16108772|NCT01086384|38885380|FG002|Treatment Period|Adverse Event|15|||
16108773|NCT01086384|38885378|FG000|Treatment Period|Lost to Follow-up|0|||
16108774|NCT01086384|38885379|FG001|Treatment Period|Lost to Follow-up|11|||
16108775|NCT01086384|38885380|FG002|Treatment Period|Lost to Follow-up|9|||
16108776|NCT01086384|38885378|FG000|Treatment Period|Physician Decision|0|||
16108777|NCT01086384|38885379|FG001|Treatment Period|Physician Decision|9|||
16108778|NCT01086384|38885380|FG002|Treatment Period|Physician Decision|6|||
16108779|NCT01086384|38885378|FG000|Treatment Period|Study Closed/Terminated|0|||
16108780|NCT01086384|38885379|FG001|Treatment Period|Study Closed/Terminated|7|||
16108781|NCT01086384|38885380|FG002|Treatment Period|Study Closed/Terminated|8|||
16108782|NCT01086384|38885378|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
16108783|NCT01086384|38885379|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
16108784|NCT01086384|38885380|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
16108785|NCT01086384|38885378|FG000|Treatment Period|Received Treatment in Error|0|||
16407053|NCT03532932|39970027|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
16407054|NCT03532932|39970026|FG000|Overall Study|Withdrawal by Subject|2|||
16407055|NCT03532932|39970027|FG001|Overall Study|Withdrawal by Subject|0|||
16342104|NCT00667992|39738269|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
16342105|NCT00667992|39738270|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
16342106|NCT00667992|39738269|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
16342107|NCT00667992|39738270|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
16342108|NCT00667992|39738269|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
16342109|NCT00667992|39738270|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
16342110|NCT00667992|39738269|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
16342111|NCT00667992|39738270|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
16342112|NCT00667992|39738269|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
16342113|NCT00667992|39738270|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
16342114|NCT00667992|39738269|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
16542711|NCT02417064|40450281|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
16542712|NCT02417064|40450282|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
16542713|NCT02417064|40450283|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
16542714|NCT02417064|40450281|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
16542715|NCT02417064|40450282|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
16542716|NCT02417064|40450283|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
16542717|NCT02417064|40450281|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
16542718|NCT02417064|40450282|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
16542719|NCT02417064|40450283|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
16542720|NCT02417064|40450281|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
16542721|NCT02417064|40450282|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
16542722|NCT02417064|40450283|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
16542723|NCT02417064|40450281|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
16542724|NCT02417064|40450282|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
16542725|NCT02417064|40450283|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
16542726|NCT02417064|40450281|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
16542727|NCT02417064|40450282|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
16542728|NCT02417064|40450283|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
16542729|NCT02417064|40450281|FG000|Follow-up Phase (24 Weeks)|Other|2|||
16542730|NCT02417064|40450282|FG001|Follow-up Phase (24 Weeks)|Other|2|||
16542731|NCT02417064|40450283|FG002|Follow-up Phase (24 Weeks)|Other|3|||
16542732|NCT00989092|40450284|FG000|Overall Study|Physician Decision|9|||
16542733|NCT00989092|40450285|FG001|Overall Study|Physician Decision|6|||
16542734|NCT00989092|40450284|FG000|Overall Study|Adverse Event|20|||
16542735|NCT00989092|40450285|FG001|Overall Study|Adverse Event|1|||
16542736|NCT00989092|40450284|FG000|Overall Study|Chemotherapy initiated|12|||
16542737|NCT00989092|40450285|FG001|Overall Study|Chemotherapy initiated|4|||
16542738|NCT00989092|40450284|FG000|Overall Study|Withdrawal by Subject|17|||
16542739|NCT00989092|40450285|FG001|Overall Study|Withdrawal by Subject|9|||
16542740|NCT00989092|40450284|FG000|Overall Study|Death|14|||
16542741|NCT00989092|40450285|FG001|Overall Study|Death|2|||
16542742|NCT00989092|40450284|FG000|Overall Study|Ineligibility determined|3|||
16542743|NCT00989092|40450285|FG001|Overall Study|Ineligibility determined|3|||
16542744|NCT00989092|40450284|FG000|Overall Study|Lost to Follow-up|6|||
16542745|NCT00989092|40450285|FG001|Overall Study|Lost to Follow-up|2|||
16542746|NCT00989092|40450284|FG000|Overall Study|Other|3|||
16542747|NCT00989092|40450285|FG001|Overall Study|Other|1|||
16542748|NCT00989092|40450284|FG000|Overall Study|Protocol deviation|2|||
16542749|NCT00989092|40450285|FG001|Overall Study|Protocol deviation|0|||
16542750|NCT00989092|40450284|FG000|Overall Study|Erythropoietin therapy initiated|2|||
16542751|NCT00989092|40450285|FG001|Overall Study|Erythropoietin therapy initiated|0|||
16542752|NCT00989092|40450284|FG000|Overall Study|Did not receive study drug|2|||
16542753|NCT00989092|40450285|FG001|Overall Study|Did not receive study drug|0|||
16542754|NCT01197508|40450288|FG000|Overall Study|Withdrawal by Subject|8|||
16108786|NCT01086384|38885379|FG001|Treatment Period|Received Treatment in Error|1|||
16108787|NCT01086384|38885380|FG002|Treatment Period|Received Treatment in Error|0|||
16108788|NCT04270747|38885381|FG000|Through Week 16|Adverse Event|1|||
16108789|NCT04270747|38885382|FG001|Through Week 16|Adverse Event|2|||
16108790|NCT04270747|38885383|FG002|Through Week 16|Adverse Event|0|||
16108791|NCT04270747|38885381|FG000|Through Week 16|Death|0|||
16108792|NCT04270747|38885382|FG001|Through Week 16|Death|2|||
16108793|NCT04270747|38885383|FG002|Through Week 16|Death|0|||
16108794|NCT04270747|38885381|FG000|Through Week 16|Consent Withdrawn|3|||
16108795|NCT04270747|38885382|FG001|Through Week 16|Consent Withdrawn|3|||
16108796|NCT04270747|38885383|FG002|Through Week 16|Consent Withdrawn|0|||
16108797|NCT04270747|38885381|FG000|Through Week 16|Physician Decision|1|||
16108798|NCT04270747|38885382|FG001|Through Week 16|Physician Decision|1|||
16108799|NCT04270747|38885383|FG002|Through Week 16|Physician Decision|0|||
16108800|NCT04270747|38885381|FG000|Through Week 16|Lost to Follow-up|2|||
16108801|NCT04270747|38885382|FG001|Through Week 16|Lost to Follow-up|0|||
16108802|NCT04270747|38885383|FG002|Through Week 16|Lost to Follow-up|0|||
16108803|NCT04270747|38885381|FG000|Through Week 16|Protocol Violation|1|||
16108804|NCT04270747|38885382|FG001|Through Week 16|Protocol Violation|2|||
16108805|NCT04270747|38885383|FG002|Through Week 16|Protocol Violation|0|||
16108806|NCT04270747|38885381|FG000|Through Week 16|Protocol Specified Criteria|6|||
16108807|NCT04270747|38885382|FG001|Through Week 16|Protocol Specified Criteria|7|||
16108808|NCT04270747|38885383|FG002|Through Week 16|Protocol Specified Criteria|0|||
16108809|NCT04270747|38885381|FG000|Through Week 16|Miscellaneous|1|||
16108810|NCT04270747|38885382|FG001|Through Week 16|Miscellaneous|1|||
16108811|NCT04270747|38885383|FG002|Through Week 16|Miscellaneous|0|||
16108812|NCT04270747|38885381|FG000|Post Week 16|Adverse Event|7|||
16542755|NCT01197508|40450289|FG001|Overall Study|Withdrawal by Subject|7|||
16542756|NCT01197508|40450290|FG002|Overall Study|Withdrawal by Subject|15|||
16542757|NCT01197508|40450291|FG003|Overall Study|Withdrawal by Subject|4|||
16542758|NCT01197508|40450288|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
16542759|NCT01197508|40450289|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
16542760|NCT01197508|40450290|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
16542761|NCT01197508|40450291|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
16542762|NCT01197508|40450288|FG000|Overall Study|Adverse Event|10|||
16542763|NCT01197508|40450289|FG001|Overall Study|Adverse Event|13|||
16542764|NCT01197508|40450290|FG002|Overall Study|Adverse Event|23|||
16542765|NCT01197508|40450291|FG003|Overall Study|Adverse Event|3|||
16542766|NCT01197508|40450288|FG000|Overall Study|Severe non-compliance to protocol|0|||
16542767|NCT01197508|40450289|FG001|Overall Study|Severe non-compliance to protocol|3|||
16542768|NCT01197508|40450290|FG002|Overall Study|Severe non-compliance to protocol|1|||
16542769|NCT01197508|40450291|FG003|Overall Study|Severe non-compliance to protocol|3|||
16542770|NCT01197508|40450288|FG000|Overall Study|Condition under investigation worsened|1|||
16542771|NCT01197508|40450289|FG001|Overall Study|Condition under investigation worsened|1|||
16542772|NCT01197508|40450290|FG002|Overall Study|Condition under investigation worsened|1|||
16542773|NCT01197508|40450291|FG003|Overall Study|Condition under investigation worsened|1|||
16542774|NCT01197508|40450288|FG000|Overall Study|Lack of Efficacy|1|||
16542775|NCT01197508|40450289|FG001|Overall Study|Lack of Efficacy|2|||
16542776|NCT01197508|40450290|FG002|Overall Study|Lack of Efficacy|2|||
16542777|NCT01197508|40450291|FG003|Overall Study|Lack of Efficacy|1|||
16542778|NCT01197508|40450288|FG000|Overall Study|Study-specific withdrawal criteria|0|||
16542779|NCT01197508|40450289|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16542780|NCT01197508|40450290|FG002|Overall Study|Study-specific withdrawal criteria|1|||
16542781|NCT01197508|40450291|FG003|Overall Study|Study-specific withdrawal criteria|2|||
16542782|NCT01197508|40450288|FG000|Overall Study|Lost to Follow-up|1|||
16542783|NCT01197508|40450289|FG001|Overall Study|Lost to Follow-up|1|||
16542784|NCT01197508|40450290|FG002|Overall Study|Lost to Follow-up|2|||
16542785|NCT01197508|40450291|FG003|Overall Study|Lost to Follow-up|0|||
16542786|NCT01197508|40450288|FG000|Overall Study|Other|2|||
16542787|NCT01197508|40450289|FG001|Overall Study|Other|3|||
16542788|NCT01197508|40450290|FG002|Overall Study|Other|2|||
16542789|NCT01197508|40450291|FG003|Overall Study|Other|2|||
16542790|NCT02857426|40450297|FG000|Overall Study|Disease progression|34|||
16542791|NCT02857426|40450298|FG001|Overall Study|Disease progression|13|||
16108813|NCT04270747|38885382|FG001|Post Week 16|Adverse Event|5|||
16108814|NCT04270747|38885383|FG002|Post Week 16|Adverse Event|1|||
16108815|NCT04270747|38885381|FG000|Post Week 16|Death|2|||
16108816|NCT04270747|38885382|FG001|Post Week 16|Death|0|||
16342115|NCT00667992|39738270|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
16342116|NCT00667992|39738269|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
16542792|NCT02857426|40450297|FG000|Overall Study|Study drug toxicity|4|||
16542793|NCT02857426|40450298|FG001|Overall Study|Study drug toxicity|1|||
16542794|NCT02857426|40450297|FG000|Overall Study|Death|1|||
16342117|NCT00667992|39738270|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
16342118|NCT00667992|39738269|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
16342119|NCT00667992|39738270|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
16342120|NCT00667992|39738269|FG000|Wash-out|Not within one doubling dilution|4|||
16342121|NCT00667992|39738270|FG001|Wash-out|Not within one doubling dilution|3|||
16342122|NCT00667992|39738269|FG000|Wash-out|Failure to wash-out|2|||
16342123|NCT00667992|39738270|FG001|Wash-out|Failure to wash-out|2|||
16342124|NCT00667992|39738269|FG000|Wash-out|Withdrawal by Subject|1|||
16342125|NCT00667992|39738270|FG001|Wash-out|Withdrawal by Subject|0|||
16342126|NCT00667992|39738269|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
16342127|NCT00667992|39738270|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
16342128|NCT00667992|39738269|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
16342129|NCT00667992|39738270|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
16542795|NCT02857426|40450298|FG001|Overall Study|Death|0|||
16542796|NCT02857426|40450297|FG000|Overall Study|Adverse event unrelated to study drug|6|||
16542797|NCT02857426|40450298|FG001|Overall Study|Adverse event unrelated to study drug|2|||
16542798|NCT02857426|40450297|FG000|Overall Study|Participant withdrew consent|1|||
16542799|NCT02857426|40450298|FG001|Overall Study|Participant withdrew consent|1|||
16542800|NCT02857426|40450297|FG000|Overall Study|Maximum clinical benefit|1|||
16542801|NCT02857426|40450298|FG001|Overall Study|Maximum clinical benefit|0|||
16542802|NCT02857426|40450297|FG000|Overall Study|Completed treatment|0|||
16542803|NCT02857426|40450298|FG001|Overall Study|Completed treatment|2|||
16542804|NCT02160314|40450299|FG000|Overall Study|Adverse Event|0|||
16542805|NCT02160314|40450300|FG001|Overall Study|Adverse Event|6|||
16542806|NCT02160314|40450299|FG000|Overall Study|Protocol Violation|0|||
16542807|NCT02160314|40450300|FG001|Overall Study|Protocol Violation|4|||
16542808|NCT02160314|40450299|FG000|Overall Study|Withdrawal by Subject|1|||
16542809|NCT02160314|40450300|FG001|Overall Study|Withdrawal by Subject|2|||
16542810|NCT02160314|40450299|FG000|Overall Study|Lost to Follow-up|0|||
16542811|NCT02160314|40450300|FG001|Overall Study|Lost to Follow-up|1|||
16542812|NCT00696410|40450301|FG000|Overall Study|Lost to Follow-up|2|||
16542813|NCT00696410|40450302|FG001|Overall Study|Lost to Follow-up|0|||
16542814|NCT00696410|40450301|FG000|Overall Study|Withdrawal by Subject|8|||
16542815|NCT00696410|40450302|FG001|Overall Study|Withdrawal by Subject|0|||
16542816|NCT00696410|40450301|FG000|Overall Study|Physician Decision|3|||
16542817|NCT00696410|40450302|FG001|Overall Study|Physician Decision|0|||
16542818|NCT01301391|40450303|FG000|Overall Study|Death|13|||
16542819|NCT01301391|40450303|FG000|Overall Study|Lost to Follow-up|3|||
16542820|NCT01301391|40450303|FG000|Overall Study|Physician Decision|2|||
16542821|NCT01301391|40450303|FG000|Overall Study|Sponsor's decision|8|||
16542822|NCT01750879|40450304|FG000|Overall Study|Adverse Event|8|||
16542823|NCT01750879|40450305|FG001|Overall Study|Adverse Event|0|||
16542824|NCT01750879|40450304|FG000|Overall Study|Lack of Efficacy|1|||
16542825|NCT01750879|40450305|FG001|Overall Study|Lack of Efficacy|0|||
16542826|NCT01750879|40450304|FG000|Overall Study|Withdrawal by Subject|1|||
16542827|NCT01750879|40450305|FG001|Overall Study|Withdrawal by Subject|0|||
16542828|NCT01750879|40450304|FG000|Overall Study|Did not complete per protocol|0|||
16542829|NCT01750879|40450305|FG001|Overall Study|Did not complete per protocol|3|||
16542830|NCT00570674|40450306|FG000|Overall Study|Withdrawal by Subject|0|||
16542831|NCT00570674|40450307|FG001|Overall Study|Withdrawal by Subject|0|||
16542832|NCT00570674|40450308|FG002|Overall Study|Withdrawal by Subject|1|||
16542833|NCT00570674|40450309|FG003|Overall Study|Withdrawal by Subject|0|||
16542834|NCT00570674|40450310|FG004|Overall Study|Withdrawal by Subject|0|||
16542835|NCT00570674|40450311|FG005|Overall Study|Withdrawal by Subject|0|||
16542836|NCT00570674|40450312|FG006|Overall Study|Withdrawal by Subject|0|||
16542837|NCT02807636|40450320|FG000|Overall Study|Lost to Follow-up|9|||
16542838|NCT02807636|40450321|FG001|Overall Study|Lost to Follow-up|12|||
16542839|NCT02807636|40450322|FG002|Overall Study|Lost to Follow-up|6|||
16342130|NCT02315664|39738271|FG000|Overall Study|Lost to Follow-up|1|||
16342131|NCT02315664|39738272|FG001|Overall Study|Lost to Follow-up|1|||
16342132|NCT02315664|39738271|FG000|Overall Study|Withdrawal by Subject|0|||
16542840|NCT02807636|40450320|FG000|Overall Study|Protocol Deviation|2|||
16542841|NCT02807636|40450321|FG001|Overall Study|Protocol Deviation|0|||
16542842|NCT02807636|40450322|FG002|Overall Study|Protocol Deviation|0|||
16542843|NCT02807636|40450320|FG000|Overall Study|Symptomatic Deterioration|0|||
16542844|NCT02807636|40450321|FG001|Overall Study|Symptomatic Deterioration|1|||
16542845|NCT02807636|40450322|FG002|Overall Study|Symptomatic Deterioration|0|||
16542846|NCT02807636|40450320|FG000|Overall Study|Withdrawal by Subject|39|||
16108817|NCT04270747|38885383|FG002|Post Week 16|Death|2|||
16108818|NCT04270747|38885381|FG000|Post Week 16|Consent Withdrawn|4|||
16108819|NCT04270747|38885382|FG001|Post Week 16|Consent Withdrawn|3|||
16108820|NCT04270747|38885383|FG002|Post Week 16|Consent Withdrawn|6|||
16108821|NCT04270747|38885381|FG000|Post Week 16|Physician Decision|3|||
16108822|NCT04270747|38885382|FG001|Post Week 16|Physician Decision|1|||
16108823|NCT04270747|38885383|FG002|Post Week 16|Physician Decision|1|||
16108824|NCT04270747|38885381|FG000|Post Week 16|Lost to Follow-up|2|||
16108825|NCT04270747|38885382|FG001|Post Week 16|Lost to Follow-up|1|||
16108826|NCT04270747|38885383|FG002|Post Week 16|Lost to Follow-up|0|||
16342133|NCT02315664|39738272|FG001|Overall Study|Withdrawal by Subject|3|||
16342134|NCT02256917|39738273|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
16342135|NCT02256917|39738273|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
16342136|NCT02256917|39738273|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
16342137|NCT02256917|39738273|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
16342138|NCT02256917|39738273|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
16342139|NCT01270321|39738274|FG000|Overall Study|Death|3|||
16342140|NCT01270321|39738275|FG001|Overall Study|Death|1|||
16342141|NCT01270321|39738276|FG002|Overall Study|Death|4|||
16342142|NCT01270321|39738274|FG000|Overall Study|Adverse Event|7|||
16342143|NCT01270321|39738275|FG001|Overall Study|Adverse Event|9|||
16342144|NCT01270321|39738276|FG002|Overall Study|Adverse Event|5|||
16342145|NCT01189461|39738289|FG000|Overall Study|Lack of Efficacy|13|||
16342146|NCT01189461|39738289|FG000|Overall Study|Lost to Follow-up|1|||
16108827|NCT04270747|38885381|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
16342147|NCT01189461|39738289|FG000|Overall Study|Withdrawal by Subject|6|||
16342148|NCT01189461|39738289|FG000|Overall Study|Protocol Violation|1|||
16342149|NCT01189461|39738289|FG000|Overall Study|Adverse Event|2|||
16342150|NCT01189461|39738289|FG000|Overall Study|Did not meet entrance criteria|3|||
16542847|NCT02807636|40450321|FG001|Overall Study|Withdrawal by Subject|27|||
16542848|NCT02807636|40450322|FG002|Overall Study|Withdrawal by Subject|23|||
16542849|NCT02807636|40450320|FG000|Overall Study|Death|298|||
16542850|NCT02807636|40450321|FG001|Overall Study|Death|327|||
16542851|NCT02807636|40450322|FG002|Overall Study|Death|266|||
16542852|NCT02807636|40450320|FG000|Overall Study|Ongoing in Study|52|||
16542853|NCT02807636|40450321|FG001|Overall Study|Ongoing in Study|84|||
16542854|NCT02807636|40450322|FG002|Overall Study|Ongoing in Study|67|||
16542855|NCT02432105|40450323|FG000|Overall Study|Lost to Follow-up|1|||
16542856|NCT02432105|40450324|FG001|Overall Study|Lost to Follow-up|1|||
16542857|NCT02432105|40450325|FG002|Overall Study|Lost to Follow-up|0|||
16542858|NCT02432105|40450323|FG000|Overall Study|Withdrawal by Subject|1|||
16542859|NCT02432105|40450324|FG001|Overall Study|Withdrawal by Subject|0|||
16542860|NCT02432105|40450325|FG002|Overall Study|Withdrawal by Subject|1|||
16542861|NCT02432105|40450323|FG000|Overall Study|Culture positive for yeast|0|||
16542862|NCT02432105|40450324|FG001|Overall Study|Culture positive for yeast|1|||
16220023|NCT00545740|39283075|FG000|Overall Study|Missed visit|1|||
16220024|NCT00545740|39283076|FG001|Overall Study|Missed visit|0|||
16220025|NCT00545740|39283077|FG002|Overall Study|Missed visit|0|||
16220026|NCT00545740|39283078|FG003|Overall Study|Missed visit|0|||
16220027|NCT00545740|39283075|FG000|Overall Study|Physician Decision|0|||
16220028|NCT00545740|39283076|FG001|Overall Study|Physician Decision|0|||
16220029|NCT00545740|39283077|FG002|Overall Study|Physician Decision|3|||
16220030|NCT00545740|39283078|FG003|Overall Study|Physician Decision|0|||
16220031|NCT00545740|39283075|FG000|Overall Study|Accepted only monthly telephone calls|1|||
16342151|NCT01189461|39738289|FG000|Overall Study|Other|8|||
16342152|NCT02227368|39738296|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
16342153|NCT02227368|39738297|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
16342154|NCT02227368|39738296|FG000|Overall Study|Lost to Follow-up|1|||
16342155|NCT02227368|39738297|FG001|Overall Study|Lost to Follow-up|0|||
16342156|NCT02227368|39738296|FG000|Overall Study|Adverse Event|1|||
16342157|NCT02227368|39738297|FG001|Overall Study|Adverse Event|0|||
16342158|NCT01502956|39738298|FG000|Overall Study|Death|0|||
16342159|NCT01502956|39738299|FG001|Overall Study|Death|2|||
16342160|NCT01502956|39738298|FG000|Overall Study|Lost to Follow-up|14|||
16342161|NCT01502956|39738299|FG001|Overall Study|Lost to Follow-up|11|||
16342162|NCT01502956|39738298|FG000|Overall Study|Physician Decision|2|||
16342163|NCT01502956|39738299|FG001|Overall Study|Physician Decision|3|||
16342164|NCT01502956|39738298|FG000|Overall Study|Withdrawal by Subject|8|||
16342165|NCT01502956|39738299|FG001|Overall Study|Withdrawal by Subject|10|||
16342166|NCT02081001|39738300|FG000|Overall Study|Adverse Event|0|||
16342167|NCT02081001|39738301|FG001|Overall Study|Adverse Event|0|||
16342168|NCT02081001|39738302|FG002|Overall Study|Adverse Event|0|||
16342169|NCT02081001|39738303|FG003|Overall Study|Adverse Event|0|||
16342170|NCT02081001|39738304|FG004|Overall Study|Adverse Event|1|||
16342171|NCT02081001|39738305|FG005|Overall Study|Adverse Event|0|||
16342172|NCT02081001|39738306|FG006|Overall Study|Adverse Event|0|||
16342173|NCT02081001|39738307|FG007|Overall Study|Adverse Event|0|||
16342174|NCT02081001|39738308|FG008|Overall Study|Adverse Event|0|||
16342175|NCT02081001|39738309|FG009|Overall Study|Adverse Event|0|||
16342176|NCT02081001|39738310|FG010|Overall Study|Adverse Event|0|||
16342177|NCT02081001|39738311|FG011|Overall Study|Adverse Event|0|||
16342178|NCT00742027|39738312|FG000|Overall Study|Disease Progression|76|||
16342179|NCT00742027|39738312|FG000|Overall Study|New Cancer Therapy|19|||
16342180|NCT00742027|39738312|FG000|Overall Study|Withdrawal by Subject|18|||
16342181|NCT00742027|39738312|FG000|Overall Study|Death|7|||
16342182|NCT00742027|39738312|FG000|Overall Study|Lost to Follow-up|4|||
16342183|NCT00742027|39738312|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
16342184|NCT00742027|39738312|FG000|Overall Study|Missing|2|||
16342185|NCT00742027|39738312|FG000|Overall Study|Administrative Problems|1|||
16342186|NCT01844817|39738313|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
16342187|NCT01844817|39738314|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
16342188|NCT01844817|39738313|FG000|Treatment|Progressive Disease|27|||
16342189|NCT01844817|39738314|FG001|Treatment|Progressive Disease|36|||
16342190|NCT01844817|39738313|FG000|Treatment|Adverse Event|17|||
16342191|NCT01844817|39738314|FG001|Treatment|Adverse Event|9|||
16342192|NCT01844817|39738313|FG000|Treatment|Withdrawal by Subject|10|||
16342193|NCT01844817|39738314|FG001|Treatment|Withdrawal by Subject|6|||
16542863|NCT02432105|40450325|FG002|Overall Study|Culture positive for yeast|0|||
16220032|NCT00545740|39283076|FG001|Overall Study|Accepted only monthly telephone calls|0|||
16542864|NCT02432105|40450323|FG000|Overall Study|Randomized in error|0|||
16542865|NCT02432105|40450324|FG001|Overall Study|Randomized in error|0|||
16542866|NCT02432105|40450325|FG002|Overall Study|Randomized in error|2|||
16220033|NCT00545740|39283077|FG002|Overall Study|Accepted only monthly telephone calls|0|||
16342194|NCT01844817|39738313|FG000|Treatment|Death|10|||
16342195|NCT01844817|39738314|FG001|Treatment|Death|8|||
16342196|NCT01844817|39738313|FG000|Treatment|Lost to Follow-up|0|||
16342197|NCT01844817|39738314|FG001|Treatment|Lost to Follow-up|1|||
16342198|NCT01844817|39738313|FG000|Treatment|Other|0|||
16342199|NCT01844817|39738314|FG001|Treatment|Other|3|||
16342200|NCT00978341|39738315|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
16342201|NCT00978341|39738316|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
16342202|NCT04114656|39738317|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
16342203|NCT04114656|39738318|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
16342204|NCT04114656|39738317|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
16342205|NCT04114656|39738318|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
16342206|NCT04114656|39738317|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
16342207|NCT04114656|39738318|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
16342208|NCT04114656|39738317|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
16342209|NCT04114656|39738318|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
16342210|NCT04114656|39738317|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
16342211|NCT04114656|39738318|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
16342212|NCT03307837|39738319|FG000|Overall Study|Withdrawal by Subject|0|||
16342213|NCT03307837|39738320|FG001|Overall Study|Withdrawal by Subject|0|||
16342214|NCT03307837|39738321|FG002|Overall Study|Withdrawal by Subject|1|||
16342215|NCT03307837|39738322|FG003|Overall Study|Withdrawal by Subject|0|||
16342216|NCT03307837|39738323|FG004|Overall Study|Withdrawal by Subject|0|||
16342217|NCT03307837|39738324|FG005|Overall Study|Withdrawal by Subject|1|||
16342218|NCT03307837|39738319|FG000|Overall Study|Lost to Follow-up|1|||
16342219|NCT03307837|39738320|FG001|Overall Study|Lost to Follow-up|1|||
16342220|NCT03307837|39738321|FG002|Overall Study|Lost to Follow-up|0|||
16342221|NCT03307837|39738322|FG003|Overall Study|Lost to Follow-up|0|||
16342222|NCT03307837|39738323|FG004|Overall Study|Lost to Follow-up|0|||
16342223|NCT03307837|39738324|FG005|Overall Study|Lost to Follow-up|1|||
16342224|NCT01687283|39738325|FG000|Overall Study|Adverse Event|11|||
16342225|NCT01687283|39738326|FG001|Overall Study|Adverse Event|4|||
16342226|NCT01687283|39738325|FG000|Overall Study|Lack of Efficacy|3|||
16342227|NCT01687283|39738326|FG001|Overall Study|Lack of Efficacy|1|||
16342228|NCT01687283|39738325|FG000|Overall Study|Protocol Violation|1|||
16342229|NCT01687283|39738326|FG001|Overall Study|Protocol Violation|3|||
16342230|NCT01687283|39738325|FG000|Overall Study|protocol defined stopping criteria|8|||
16342231|NCT01687283|39738326|FG001|Overall Study|protocol defined stopping criteria|10|||
16342232|NCT01687283|39738325|FG000|Overall Study|Lost to Follow-up|1|||
16342233|NCT01687283|39738326|FG001|Overall Study|Lost to Follow-up|1|||
16342234|NCT01687283|39738325|FG000|Overall Study|Investigator discretion|2|||
16342235|NCT01687283|39738326|FG001|Overall Study|Investigator discretion|0|||
16342236|NCT01687283|39738325|FG000|Overall Study|Withdrawal by Subject|9|||
16342237|NCT01687283|39738326|FG001|Overall Study|Withdrawal by Subject|8|||
16342238|NCT00703118|39740866|FG000|Overall Study|Adverse Event|1|||
16342239|NCT00703118|39740867|FG001|Overall Study|Adverse Event|2|||
16342240|NCT00703118|39740868|FG002|Overall Study|Adverse Event|2|||
16342241|NCT00703118|39740866|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
16342242|NCT00703118|39740867|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
16342243|NCT00703118|39740868|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
16342244|NCT00703118|39740866|FG000|Overall Study|Lost to Follow-up|6|||
16342245|NCT00703118|39740867|FG001|Overall Study|Lost to Follow-up|4|||
16342246|NCT00703118|39740868|FG002|Overall Study|Lost to Follow-up|4|||
16342247|NCT00703118|39740866|FG000|Overall Study|Withdrawal by Subject|8|||
16342248|NCT00703118|39740867|FG001|Overall Study|Withdrawal by Subject|7|||
16342249|NCT00703118|39740868|FG002|Overall Study|Withdrawal by Subject|13|||
16342250|NCT00703118|39740866|FG000|Overall Study|Other|0|||
16342251|NCT00703118|39740867|FG001|Overall Study|Other|0|||
16342252|NCT00703118|39740868|FG002|Overall Study|Other|1|||
16342253|NCT02500719|39740869|FG000|Overall Study|Lost to Follow-up|2|||
16542867|NCT00116844|40450326|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
16542868|NCT00116844|40450327|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
16342254|NCT02500719|39740870|FG001|Overall Study|Lost to Follow-up|3|||
16342255|NCT02500719|39740869|FG000|Overall Study|Trauma history|1|||
16542869|NCT00116844|40450326|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
16542870|NCT00116844|40450327|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
16542871|NCT00116844|40450326|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
16542872|NCT00116844|40450327|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
16342256|NCT02500719|39740870|FG001|Overall Study|Trauma history|0|||
16342257|NCT02500719|39740869|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
16342258|NCT02500719|39740870|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
16342259|NCT02500719|39740869|FG000|Overall Study|Did not meet criteria for PTSD|0|||
16542873|NCT00116844|40450326|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
16542874|NCT00116844|40450327|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
16542875|NCT00116844|40450326|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
16342260|NCT02500719|39740870|FG001|Overall Study|Did not meet criteria for PTSD|1|||
16542876|NCT00116844|40450327|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
16342261|NCT02500719|39740869|FG000|Overall Study|Claustrophobia|0|||
16342262|NCT02500719|39740870|FG001|Overall Study|Claustrophobia|1|||
16342263|NCT02500719|39740869|FG000|Overall Study|History of head trauma|0|||
16342264|NCT02500719|39740870|FG001|Overall Study|History of head trauma|1|||
16342265|NCT03411902|39740871|FG000|Overall Study|Lost to Follow-up|3|||
16342266|NCT03411902|39740872|FG001|Overall Study|Lost to Follow-up|0|||
16342267|NCT01134263|39740873|FG000|Overall Study|Serious adverse event|2|||
16342268|NCT01134263|39740874|FG001|Overall Study|Serious adverse event|1|||
16342269|NCT01134263|39740875|FG002|Overall Study|Serious adverse event|1|||
16342270|NCT01134263|39740876|FG003|Overall Study|Serious adverse event|1|||
16342271|NCT01134263|39740877|FG004|Overall Study|Serious adverse event|1|||
16342272|NCT01134263|39740873|FG000|Overall Study|Other adverse event|1|||
16342273|NCT01134263|39740874|FG001|Overall Study|Other adverse event|2|||
16342274|NCT01134263|39740875|FG002|Overall Study|Other adverse event|5|||
16342275|NCT01134263|39740876|FG003|Overall Study|Other adverse event|3|||
16342276|NCT01134263|39740877|FG004|Overall Study|Other adverse event|0|||
16342277|NCT01134263|39740873|FG000|Overall Study|Protocol Violation|8|||
16342278|NCT01134263|39740874|FG001|Overall Study|Protocol Violation|7|||
16342279|NCT01134263|39740875|FG002|Overall Study|Protocol Violation|2|||
16542877|NCT00116844|40450326|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
16542878|NCT00116844|40450327|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
16542879|NCT00116844|40450326|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
16108828|NCT04270747|38885382|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
16108829|NCT04270747|38885383|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
16108830|NCT04270747|38885381|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
16108831|NCT04270747|38885382|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
16108832|NCT04270747|38885383|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
16108833|NCT04270747|38885381|FG000|Post Week 16|Miscellaneous|1|||
16342280|NCT01134263|39740876|FG003|Overall Study|Protocol Violation|4|||
16342281|NCT01134263|39740877|FG004|Overall Study|Protocol Violation|2|||
16342282|NCT01134263|39740873|FG000|Overall Study|Lost to Follow-up|4|||
16342283|NCT01134263|39740874|FG001|Overall Study|Lost to Follow-up|3|||
16342284|NCT01134263|39740875|FG002|Overall Study|Lost to Follow-up|5|||
16342285|NCT01134263|39740876|FG003|Overall Study|Lost to Follow-up|3|||
16342286|NCT01134263|39740877|FG004|Overall Study|Lost to Follow-up|1|||
16342287|NCT01134263|39740873|FG000|Overall Study|Withdrawal by Subject|8|||
16342288|NCT01134263|39740874|FG001|Overall Study|Withdrawal by Subject|6|||
16342289|NCT01134263|39740875|FG002|Overall Study|Withdrawal by Subject|16|||
16342290|NCT01134263|39740876|FG003|Overall Study|Withdrawal by Subject|7|||
16342291|NCT01134263|39740877|FG004|Overall Study|Withdrawal by Subject|5|||
16342292|NCT01134263|39740873|FG000|Overall Study|Enrolled, but not treated|1|||
16342293|NCT01134263|39740874|FG001|Overall Study|Enrolled, but not treated|1|||
16342294|NCT01134263|39740875|FG002|Overall Study|Enrolled, but not treated|0|||
16342295|NCT01134263|39740876|FG003|Overall Study|Enrolled, but not treated|1|||
16342296|NCT01134263|39740877|FG004|Overall Study|Enrolled, but not treated|0|||
16342297|NCT02087943|39740878|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
16342298|NCT02087943|39740879|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
16342299|NCT02087943|39740880|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
16342300|NCT02087943|39740881|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
16342301|NCT02087943|39740882|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
16342302|NCT02087943|39740878|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
16342303|NCT02087943|39740879|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
16342304|NCT02087943|39740880|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
16342305|NCT02087943|39740881|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
16342306|NCT02087943|39740882|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
16342307|NCT02087943|39740878|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
16342308|NCT02087943|39740879|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
16342309|NCT02087943|39740880|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
16342310|NCT02087943|39740881|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
16342311|NCT02087943|39740882|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
16342312|NCT02087943|39740878|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
16342313|NCT02087943|39740879|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
16342314|NCT02087943|39740880|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
16342315|NCT02087943|39740881|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
16342316|NCT02087943|39740882|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
16542880|NCT00116844|40450327|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
16542881|NCT00116844|40450326|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
16542882|NCT00116844|40450327|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
16108834|NCT04270747|38885382|FG001|Post Week 16|Miscellaneous|0|||
16407056|NCT03532932|39970026|FG000|Overall Study|Lost to Follow-up|15|||
16542883|NCT00116844|40450326|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
16542884|NCT00116844|40450327|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
16108835|NCT04270747|38885383|FG002|Post Week 16|Miscellaneous|1|||
16108836|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
16108837|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
16108838|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
16108839|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
16108840|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
16108841|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
16108842|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
16108843|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
16108844|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
16108845|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
16108846|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
16108847|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
16108848|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
16108849|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
16108850|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
16108851|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
16108852|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
16108853|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
16108854|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Missing|2|||
16108855|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Missing|1|||
16342317|NCT02087943|39740878|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
16342318|NCT02087943|39740879|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
16342319|NCT02087943|39740880|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
16108856|NCT00443209|38885384|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
16220034|NCT00545740|39283078|FG003|Overall Study|Accepted only monthly telephone calls|0|||
16220035|NCT00545740|39283075|FG000|Overall Study|Sponsor decision|0|||
16220036|NCT00545740|39283076|FG001|Overall Study|Sponsor decision|1|||
16220037|NCT00545740|39283077|FG002|Overall Study|Sponsor decision|0|||
16220038|NCT00545740|39283078|FG003|Overall Study|Sponsor decision|0|||
16220039|NCT00545740|39283075|FG000|Overall Study|Lack of time|0|||
16220040|NCT00545740|39283076|FG001|Overall Study|Lack of time|1|||
16220041|NCT00545740|39283077|FG002|Overall Study|Lack of time|0|||
16342320|NCT02087943|39740881|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
16342321|NCT02087943|39740882|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
16342322|NCT02087943|39740878|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
16342323|NCT02087943|39740879|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
16342324|NCT02087943|39740880|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
16342325|NCT02087943|39740881|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
16342326|NCT02087943|39740882|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
16342327|NCT02087943|39740878|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
16342328|NCT02087943|39740879|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
16342329|NCT02087943|39740880|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
16108857|NCT00443209|38885385|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
16108858|NCT00443209|38885384|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
16108859|NCT00443209|38885385|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
16108860|NCT00443209|38885384|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
16108861|NCT00443209|38885385|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
16108862|NCT00443209|38885384|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
16108863|NCT00443209|38885385|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
16108864|NCT00443209|38885384|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
16108865|NCT00443209|38885385|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
16108866|NCT00443209|38885384|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
16342330|NCT02087943|39740881|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
16342331|NCT02087943|39740882|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
16108867|NCT00443209|38885385|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
16108868|NCT00443209|38885384|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
16108869|NCT00443209|38885385|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
16220042|NCT00545740|39283078|FG003|Overall Study|Lack of time|0|||
16220043|NCT00545740|39283075|FG000|Overall Study|Non-adherence to visits|0|||
16220044|NCT00545740|39283076|FG001|Overall Study|Non-adherence to visits|1|||
16108870|NCT00713206|38885386|FG000|Overall Study|Lost to Follow-up|4|||
16108871|NCT00713206|38885387|FG001|Overall Study|Lost to Follow-up|4|||
16108872|NCT00713206|38885386|FG000|Overall Study|Death|1|||
16108873|NCT00713206|38885387|FG001|Overall Study|Death|0|||
16108874|NCT01268098|38885388|FG000|Overall Study|Adverse Event|1|||
16108875|NCT01268098|38885389|FG001|Overall Study|Adverse Event|0|||
16108876|NCT01340014|38885393|FG000|Period 1, First 7 Days|Adverse Event|1|||
16108877|NCT01340014|38885394|FG001|Period 1, First 7 Days|Adverse Event|0|||
16108878|NCT01340014|38885393|FG000|Period 1, First 7 Days|Personal Reasons|1|||
16108879|NCT01340014|38885394|FG001|Period 1, First 7 Days|Personal Reasons|0|||
16108880|NCT01340014|38885393|FG000|Period 2, Second 7 Days|Adverse Event|0|||
16108881|NCT01340014|38885394|FG001|Period 2, Second 7 Days|Adverse Event|1|||
16108882|NCT00607997|38885395|FG000|Overall Study|Lack of Efficacy|6|||
16108883|NCT00607997|38885396|FG001|Overall Study|Lack of Efficacy|20|||
16108884|NCT00607997|38885397|FG002|Overall Study|Lack of Efficacy|14|||
16108885|NCT00607997|38885398|FG003|Overall Study|Lack of Efficacy|10|||
16108886|NCT00607997|38885395|FG000|Overall Study|Death|8|||
16342332|NCT02087943|39740878|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
16342333|NCT02087943|39740879|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
16342334|NCT02087943|39740880|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
16342335|NCT02087943|39740881|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
16342336|NCT02087943|39740882|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
16342337|NCT02087943|39740878|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
16342338|NCT02087943|39740879|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
16342339|NCT02087943|39740880|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
16342340|NCT02087943|39740881|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
16342341|NCT02087943|39740882|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
16342342|NCT02087943|39740878|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
16342343|NCT02087943|39740879|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
16342344|NCT02087943|39740880|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
16342345|NCT02087943|39740881|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
16342346|NCT02087943|39740882|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
16342347|NCT00631163|39740889|FG000|Number of Participants in Year 1|Adverse Event|12|||
16342348|NCT00631163|39740889|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
16342349|NCT00631163|39740889|FG000|Number of Participants in Year 1|Death|6|||
16342350|NCT00631163|39740889|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
16342351|NCT00631163|39740889|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
16342352|NCT00631163|39740889|FG000|Number of Participants in Year 1|Administrative problems|6|||
16342353|NCT00631163|39740889|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
16342354|NCT00631163|39740889|FG000|Number of Participants in Year 2|Adverse Event|1|||
16342355|NCT00631163|39740889|FG000|Number of Participants in Year 2|Protocol Violation|1|||
16220045|NCT00545740|39283077|FG002|Overall Study|Non-adherence to visits|0|||
16220046|NCT00545740|39283078|FG003|Overall Study|Non-adherence to visits|0|||
16220047|NCT00545740|39283075|FG000|Overall Study|Patient difficulties|0|||
16220048|NCT00545740|39283076|FG001|Overall Study|Patient difficulties|1|||
16220049|NCT00545740|39283077|FG002|Overall Study|Patient difficulties|0|||
16342356|NCT00631163|39740889|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
16342357|NCT01393106|39740890|FG000|Overall Study|Adverse Event|3|||
16108887|NCT00607997|38885396|FG001|Overall Study|Death|5|||
16108888|NCT00607997|38885397|FG002|Overall Study|Death|2|||
16108889|NCT00607997|38885398|FG003|Overall Study|Death|5|||
16108890|NCT00607997|38885395|FG000|Overall Study|Adverse Event|3|||
16108891|NCT00607997|38885396|FG001|Overall Study|Adverse Event|1|||
16108892|NCT00607997|38885397|FG002|Overall Study|Adverse Event|2|||
16108893|NCT00607997|38885398|FG003|Overall Study|Adverse Event|0|||
16108894|NCT00607997|38885395|FG000|Overall Study|Physician Decision|4|||
16108895|NCT00607997|38885396|FG001|Overall Study|Physician Decision|1|||
16108896|NCT00607997|38885397|FG002|Overall Study|Physician Decision|0|||
16220050|NCT00545740|39283078|FG003|Overall Study|Patient difficulties|0|||
16220051|NCT00545740|39283075|FG000|Overall Study|Husband against study|0|||
16342358|NCT01393106|39740890|FG000|Overall Study|Withdrawal by Subject|1|||
16342359|NCT01393106|39740890|FG000|Overall Study|Lack of Efficacy|1|||
16342360|NCT02734862|39740894|FG000|Part A|Death|3|||
16342361|NCT02734862|39740895|FG001|Part A|Death|4|||
16342362|NCT02734862|39740896|FG002|Part A|Death|6|||
16342363|NCT02734862|39740894|FG000|Part A|Lost to Follow-up|2|||
16407057|NCT03532932|39970027|FG001|Overall Study|Lost to Follow-up|9|||
16407058|NCT03532932|39970026|FG000|Overall Study|Adverse Event|4|||
16407059|NCT03532932|39970027|FG001|Overall Study|Adverse Event|3|||
16542885|NCT00539279|40450331|FG000|Treatment|Withdrawal by Subject|10|||
16542886|NCT00539279|40450332|FG001|Treatment|Withdrawal by Subject|8|||
16542887|NCT00539279|40450331|FG000|Treatment|Death|1|||
16542888|NCT00539279|40450332|FG001|Treatment|Death|0|||
16542889|NCT00539279|40450331|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
16542890|NCT00539279|40450332|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
16342364|NCT02734862|39740895|FG001|Part A|Lost to Follow-up|1|||
16342365|NCT02734862|39740896|FG002|Part A|Lost to Follow-up|1|||
16342366|NCT02734862|39740894|FG000|Part A|Withdrawal by Subject|1|||
16342367|NCT02734862|39740895|FG001|Part A|Withdrawal by Subject|1|||
16342368|NCT02734862|39740896|FG002|Part A|Withdrawal by Subject|2|||
16342369|NCT02734862|39740894|FG000|Part A|Physician Decision|2|||
16342370|NCT02734862|39740895|FG001|Part A|Physician Decision|0|||
16342371|NCT02734862|39740896|FG002|Part A|Physician Decision|1|||
16342372|NCT02734862|39740894|FG000|Part A|Adverse Event|2|||
16342373|NCT02734862|39740895|FG001|Part A|Adverse Event|0|||
16342374|NCT02734862|39740896|FG002|Part A|Adverse Event|1|||
16342375|NCT02734862|39740894|FG000|Part A|Noncompliance|1|||
16342376|NCT02734862|39740895|FG001|Part A|Noncompliance|1|||
16342377|NCT02734862|39740896|FG002|Part A|Noncompliance|0|||
16342378|NCT02734862|39740894|FG000|Part A|Other|1|||
16342379|NCT02734862|39740895|FG001|Part A|Other|1|||
16342380|NCT02734862|39740896|FG002|Part A|Other|3|||
16342381|NCT02734862|39740894|FG000|Part B|Death|8|||
16342382|NCT02734862|39740895|FG001|Part B|Death|3|||
16342383|NCT02734862|39740896|FG002|Part B|Death|5|||
16342384|NCT02734862|39740894|FG000|Part B|Lost to Follow-up|2|||
16342385|NCT02734862|39740895|FG001|Part B|Lost to Follow-up|2|||
16342386|NCT02734862|39740896|FG002|Part B|Lost to Follow-up|0|||
16342387|NCT02734862|39740894|FG000|Part B|Withdrawal by Subject|3|||
16342388|NCT02734862|39740895|FG001|Part B|Withdrawal by Subject|1|||
16342389|NCT02734862|39740896|FG002|Part B|Withdrawal by Subject|0|||
16342390|NCT02734862|39740894|FG000|Part B|Other|0|||
16220052|NCT00545740|39283076|FG001|Overall Study|Husband against study|0|||
16220053|NCT00545740|39283077|FG002|Overall Study|Husband against study|1|||
16220054|NCT00545740|39283078|FG003|Overall Study|Husband against study|0|||
16220055|NCT02710422|39283079|FG000|Overall Study|Termination of study|9|||
16220056|NCT02710422|39283080|FG001|Overall Study|Termination of study|9|||
16220057|NCT01685060|39283081|FG000|Overall Study|Rollover patients|16|||
16220058|NCT01685060|39283081|FG000|Overall Study|Adverse Event|12|||
16220059|NCT01685060|39283081|FG000|Overall Study|Progressive disease|69|||
16220060|NCT01685060|39283081|FG000|Overall Study|Physician Decision|14|||
16220061|NCT01685060|39283081|FG000|Overall Study|Subject/guardian decision|20|||
16220062|NCT01685060|39283081|FG000|Overall Study|Lost to Follow-up|1|||
16220063|NCT01685060|39283081|FG000|Overall Study|Death|8|||
16223458|NCT02275780|39298683|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
16223459|NCT02275780|39298682|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
16223460|NCT02275780|39298683|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
16223461|NCT02275780|39298682|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
16223462|NCT02275780|39298683|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
16223463|NCT02275780|39298682|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
16223464|NCT02275780|39298683|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
16342391|NCT02734862|39740895|FG001|Part B|Other|1|||
16342392|NCT02734862|39740896|FG002|Part B|Other|0|||
16342393|NCT01390428|39740897|FG000|Overall Study|Elective Surgery|0|||
16342394|NCT01390428|39740898|FG001|Overall Study|Elective Surgery|0|||
16342395|NCT01390428|39740899|FG002|Overall Study|Elective Surgery|0|||
16342396|NCT01390428|39740900|FG003|Overall Study|Elective Surgery|0|||
16342397|NCT01390428|39740901|FG004|Overall Study|Elective Surgery|1|||
16342398|NCT01390428|39740902|FG005|Overall Study|Elective Surgery|0|||
16342399|NCT01390428|39740897|FG000|Overall Study|Withdrawal by Subject|0|||
16342400|NCT01390428|39740898|FG001|Overall Study|Withdrawal by Subject|0|||
16108897|NCT00607997|38885398|FG003|Overall Study|Physician Decision|0|||
16108898|NCT00607997|38885395|FG000|Overall Study|Relapse, recurrent illness|4|||
16108899|NCT00607997|38885396|FG001|Overall Study|Relapse, recurrent illness|0|||
16108900|NCT00607997|38885397|FG002|Overall Study|Relapse, recurrent illness|2|||
16108901|NCT00607997|38885398|FG003|Overall Study|Relapse, recurrent illness|0|||
16108902|NCT00607997|38885395|FG000|Overall Study|Other without explanation|2|||
16108903|NCT00607997|38885396|FG001|Overall Study|Other without explanation|0|||
16108904|NCT00607997|38885397|FG002|Overall Study|Other without explanation|4|||
16108905|NCT00607997|38885398|FG003|Overall Study|Other without explanation|1|||
16108906|NCT02835092|38885401|FG000|Overall Study|Withdrawal by Subject|3|||
16108907|NCT02835092|38885402|FG001|Overall Study|Withdrawal by Subject|6|||
16108908|NCT02835092|38885403|FG002|Overall Study|Withdrawal by Subject|3|||
16108909|NCT02835092|38885401|FG000|Overall Study|Lost to Follow-up|0|||
16407060|NCT03532932|39970026|FG000|Overall Study|Death|0|||
16407061|NCT03532932|39970027|FG001|Overall Study|Death|2|||
16407062|NCT03532932|39970026|FG000|Overall Study|Other|11|||
16407063|NCT03532932|39970027|FG001|Overall Study|Other|16|||
16407064|NCT02078102|39970028|FG000|Overall Study|Adverse Event|1|||
16407065|NCT02078102|39970029|FG001|Overall Study|Adverse Event|0|||
16407066|NCT02078102|39970028|FG000|Overall Study|Withdrawal by Subject|1|||
16407067|NCT02078102|39970029|FG001|Overall Study|Withdrawal by Subject|0|||
16407068|NCT02078102|39970028|FG000|Overall Study|Physician Decision|0|||
16407069|NCT02078102|39970029|FG001|Overall Study|Physician Decision|1|||
16407070|NCT03242772|39970030|FG000|Overall Study|Lost to Follow-up|2|||
16407071|NCT03242772|39970031|FG001|Overall Study|Lost to Follow-up|0|||
16407072|NCT03242772|39970030|FG000|Overall Study|Physician Decision|0|||
16407073|NCT03242772|39970031|FG001|Overall Study|Physician Decision|1|||
16407074|NCT03242772|39970030|FG000|Overall Study|Withdrawal by Subject|1|||
16407075|NCT03242772|39970031|FG001|Overall Study|Withdrawal by Subject|0|||
16407076|NCT03366103|39970039|FG000|Overall Study|Disease Progression|3|||
16407077|NCT03366103|39970040|FG001|Overall Study|Disease Progression|1|||
16407078|NCT03366103|39970041|FG002|Overall Study|Disease Progression|0|||
16407079|NCT03366103|39970039|FG000|Overall Study|Adverse Event|0|||
16407080|NCT03366103|39970040|FG001|Overall Study|Adverse Event|1|||
16407081|NCT03366103|39970041|FG002|Overall Study|Adverse Event|0|||
16108910|NCT02835092|38885402|FG001|Overall Study|Lost to Follow-up|2|||
16108911|NCT02835092|38885403|FG002|Overall Study|Lost to Follow-up|0|||
16108912|NCT02916706|38888937|FG000|Overall Study|Adverse Event|0|||
16108913|NCT02916706|38888938|FG001|Overall Study|Adverse Event|1|||
16108914|NCT02916706|38888937|FG000|Overall Study|Lost to Follow-up|0|||
16108915|NCT02916706|38888938|FG001|Overall Study|Lost to Follow-up|1|||
16108916|NCT02916706|38888937|FG000|Overall Study|Physician Decision|1|||
16342401|NCT01390428|39740899|FG002|Overall Study|Withdrawal by Subject|1|||
16342402|NCT01390428|39740900|FG003|Overall Study|Withdrawal by Subject|0|||
16342403|NCT01390428|39740901|FG004|Overall Study|Withdrawal by Subject|0|||
16342404|NCT01390428|39740902|FG005|Overall Study|Withdrawal by Subject|0|||
16342405|NCT05114564|39740904|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
16342406|NCT05114564|39740905|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
16342407|NCT05114564|39740904|FG000|First Intervention|Adverse Event|0|||
16342408|NCT05114564|39740905|FG001|First Intervention|Adverse Event|1|||
16342409|NCT01317004|39740906|FG000|Overall Study|Withdrawal by Subject|1|||
16342410|NCT01317004|39740907|FG001|Overall Study|Withdrawal by Subject|4|||
16407082|NCT00888329|39970045|FG000|Overall Study|Physician Decision|6|||
16220064|NCT03793010|39286235|FG000|Overall Study|Withdrawal by Subject|5|||
16220065|NCT03793010|39286236|FG001|Overall Study|Withdrawal by Subject|7|||
16220066|NCT03793010|39286235|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
16220067|NCT03793010|39286236|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
16108917|NCT02916706|38888938|FG001|Overall Study|Physician Decision|0|||
16108918|NCT02916706|38888937|FG000|Overall Study|Protocol Violation|3|||
16108919|NCT02916706|38888938|FG001|Overall Study|Protocol Violation|1|||
16108920|NCT02916706|38888937|FG000|Overall Study|Withdrawal by Subject|6|||
16108921|NCT02916706|38888938|FG001|Overall Study|Withdrawal by Subject|9|||
16220068|NCT03793010|39286235|FG000|Overall Study|Lost to Follow-up|1|||
16220069|NCT03793010|39286236|FG001|Overall Study|Lost to Follow-up|2|||
16220070|NCT03793010|39286235|FG000|Overall Study|Patient couldn't sit still for injection|1|||
16407083|NCT00888329|39970046|FG001|Overall Study|Physician Decision|9|||
16108922|NCT02916706|38888937|FG000|Overall Study|Other|5|||
16108923|NCT02916706|38888938|FG001|Overall Study|Other|19|||
16108924|NCT03991988|38888939|FG000|Overall Study|Withdrawal by Subject|2|||
16108925|NCT03991988|38888940|FG001|Overall Study|Withdrawal by Subject|2|||
16108926|NCT01834586|38888941|FG000|Overall Study|Adverse Event|1|||
16108927|NCT00677092|38888942|FG000|Overall Study|Adverse Event|1|||
16108928|NCT00677092|38888942|FG000|Overall Study|Lost to Follow-up|1|||
16342411|NCT01317004|39740906|FG000|Overall Study|Protocol Violation|0|||
16342412|NCT01317004|39740907|FG001|Overall Study|Protocol Violation|2|||
16342413|NCT01317004|39740906|FG000|Overall Study|Adverse Event|3|||
16407084|NCT02075047|39970047|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
16220071|NCT03793010|39286236|FG001|Overall Study|Patient couldn't sit still for injection|0|||
16220072|NCT03793010|39286235|FG000|Overall Study|Withdrew to pursue other treatment|1|||
16220073|NCT03793010|39286236|FG001|Overall Study|Withdrew to pursue other treatment|0|||
16220074|NCT03793010|39286235|FG000|Overall Study|Did not meet eligibility criteria|1|||
16220075|NCT03793010|39286236|FG001|Overall Study|Did not meet eligibility criteria|0|||
16220076|NCT02058966|39286237|FG000|Open-Label Methamphetamine|Adverse Event|1|||
16220077|NCT02058966|39286237|FG000|First Intervention|Withdrawal by Subject|1|||
16220078|NCT01005875|39286238|FG000|Overall Study|Death|3|||
16220079|NCT00137267|39286244|FG000|Overall Study|Lost to Follow-up|15|||
16220080|NCT00137267|39286245|FG001|Overall Study|Lost to Follow-up|21|||
16220081|NCT02607735|39286246|FG000|Primary Study|Randomized but Never Treated|1|||
16220082|NCT02607735|39286247|FG001|Primary Study|Randomized but Never Treated|0|||
16220083|NCT02607735|39286248|FG002|Primary Study|Randomized but Never Treated|0|||
16220084|NCT02607735|39286246|FG000|Primary Study|Lost to Follow-up|4|||
16220085|NCT02607735|39286247|FG001|Primary Study|Lost to Follow-up|0|||
16220086|NCT02607735|39286248|FG002|Primary Study|Lost to Follow-up|0|||
16220087|NCT02607735|39286246|FG000|Primary Study|Withdrew Consent|2|||
16220088|NCT02607735|39286247|FG001|Primary Study|Withdrew Consent|0|||
16220089|NCT02607735|39286248|FG002|Primary Study|Withdrew Consent|0|||
16220090|NCT02607735|39286246|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
16220091|NCT02607735|39286247|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
16220092|NCT02607735|39286248|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
16220093|NCT02607735|39286246|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
16220094|NCT02607735|39286247|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
16220095|NCT02607735|39286248|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
16220096|NCT02939287|39286249|FG000|Overall Study|met exclusion criteria|1|||
16220097|NCT02939287|39286250|FG001|Overall Study|met exclusion criteria|1|||
16220098|NCT02939287|39286251|FG002|Overall Study|met exclusion criteria|1|||
16220099|NCT02939287|39286249|FG000|Overall Study|Did not complete survey|2|||
16220100|NCT02939287|39286250|FG001|Overall Study|Did not complete survey|2|||
16220101|NCT02939287|39286251|FG002|Overall Study|Did not complete survey|0|||
16220102|NCT02939287|39286249|FG000|Overall Study|Withdrawal by Subject|1|||
16220103|NCT02939287|39286250|FG001|Overall Study|Withdrawal by Subject|1|||
16220104|NCT02939287|39286251|FG002|Overall Study|Withdrawal by Subject|0|||
16220105|NCT00471276|39286254|FG000|Overall Study|Death|2|||
16220106|NCT00471276|39286254|FG000|Overall Study|Adverse Event|16|||
16220107|NCT00471276|39286254|FG000|Overall Study|Protocol Violation|1|||
16220108|NCT00471276|39286254|FG000|Overall Study|Objective progression or relapse|54|||
16220109|NCT00471276|39286254|FG000|Overall Study|Global deterioration of health status|1|||
16220110|NCT00471276|39286254|FG000|Overall Study|Other|3|||
16220111|NCT00471276|39286254|FG000|Overall Study|Refused treatment|6|||
16220112|NCT02853318|39286255|FG000|Overall Study|Withdrawal by Subject|1|||
16220113|NCT00440232|39286256|FG000|Overall Study|Lost to Follow-up|1|||
16220114|NCT00440232|39286257|FG001|Overall Study|Lost to Follow-up|1|||
16220115|NCT00440232|39286256|FG000|Overall Study|Unable to treat within allowed time|0|||
16220116|NCT00440232|39286257|FG001|Overall Study|Unable to treat within allowed time|1|||
16220117|NCT00440232|39286256|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
16220118|NCT00440232|39286257|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
16220119|NCT02146352|39286259|FG000|Overall Study|Death|1|||
16220120|NCT02146352|39286259|FG000|Overall Study|Patient entered hospice care|1|||
16220121|NCT02141854|39286260|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
16220122|NCT02141854|39286261|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16220123|NCT02141854|39286262|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16220124|NCT02141854|39286263|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16220125|NCT02141854|39286264|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16220126|NCT02141854|39286265|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
16220127|NCT02141854|39286260|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
16220128|NCT02141854|39286261|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16220129|NCT02141854|39286262|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16220130|NCT02141854|39286263|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16220131|NCT02141854|39286264|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16220132|NCT02141854|39286265|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
16220133|NCT02141854|39286260|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
16108929|NCT00677092|38888942|FG000|Overall Study|Withdrawal by Subject|3|||
16220134|NCT02141854|39286261|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16220135|NCT02141854|39286262|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16108930|NCT00677092|38888942|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
16108931|NCT01952847|38888945|FG000|Overall Study|Ineligible|1|||
16220136|NCT02141854|39286263|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16220137|NCT02141854|39286264|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16220138|NCT02141854|39286265|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
16220139|NCT02141854|39286260|FG000|Run-In Period (Pre-assignment)|Other|14|||
16220140|NCT02141854|39286261|FG001|Run-In Period (Pre-assignment)|Other|0|||
16220141|NCT02141854|39286262|FG002|Run-In Period (Pre-assignment)|Other|0|||
16220142|NCT02141854|39286263|FG003|Run-In Period (Pre-assignment)|Other|0|||
16220143|NCT02141854|39286264|FG004|Run-In Period (Pre-assignment)|Other|0|||
16220144|NCT02141854|39286265|FG005|Run-In Period (Pre-assignment)|Other|0|||
16220145|NCT02141854|39286260|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
16220146|NCT02141854|39286261|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
16220147|NCT02141854|39286262|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
16220148|NCT02141854|39286263|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
16220149|NCT02141854|39286264|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
16220150|NCT02141854|39286265|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
16220151|NCT02141854|39286260|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
16220152|NCT02141854|39286261|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16220153|NCT02141854|39286262|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16220154|NCT02141854|39286263|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16220155|NCT02141854|39286264|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16220156|NCT02141854|39286265|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
16220157|NCT02141854|39286260|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
16220158|NCT02141854|39286261|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16220159|NCT02141854|39286262|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16220160|NCT02141854|39286263|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16220161|NCT02141854|39286264|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16220162|NCT02141854|39286265|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
16220163|NCT02141854|39286260|FG000|Treatment Period|Protocol Violation|0|||
16220164|NCT02141854|39286261|FG001|Treatment Period|Protocol Violation|1|||
16220165|NCT02141854|39286262|FG002|Treatment Period|Protocol Violation|0|||
16220166|NCT02141854|39286263|FG003|Treatment Period|Protocol Violation|2|||
16220167|NCT02141854|39286264|FG004|Treatment Period|Protocol Violation|2|||
16220168|NCT02141854|39286265|FG005|Treatment Period|Protocol Violation|1|||
16220169|NCT02141854|39286260|FG000|Treatment Period|Noncompliance|0|||
16220170|NCT02141854|39286261|FG001|Treatment Period|Noncompliance|0|||
16220171|NCT02141854|39286262|FG002|Treatment Period|Noncompliance|0|||
16220172|NCT02141854|39286263|FG003|Treatment Period|Noncompliance|1|||
16220173|NCT02141854|39286264|FG004|Treatment Period|Noncompliance|0|||
16220174|NCT02141854|39286265|FG005|Treatment Period|Noncompliance|0|||
16220175|NCT02141854|39286260|FG000|Treatment Period|Lack of Efficacy|0|||
16220176|NCT02141854|39286261|FG001|Treatment Period|Lack of Efficacy|0|||
16220177|NCT02141854|39286262|FG002|Treatment Period|Lack of Efficacy|0|||
16220178|NCT02141854|39286263|FG003|Treatment Period|Lack of Efficacy|1|||
16220179|NCT02141854|39286264|FG004|Treatment Period|Lack of Efficacy|1|||
16220180|NCT02141854|39286265|FG005|Treatment Period|Lack of Efficacy|7|||
16220181|NCT02141854|39286260|FG000|Treatment Period|Pregnancy|0|||
16220182|NCT02141854|39286261|FG001|Treatment Period|Pregnancy|1|||
16220183|NCT02141854|39286262|FG002|Treatment Period|Pregnancy|0|||
16220184|NCT02141854|39286263|FG003|Treatment Period|Pregnancy|0|||
16220185|NCT02141854|39286264|FG004|Treatment Period|Pregnancy|0|||
16220186|NCT02141854|39286265|FG005|Treatment Period|Pregnancy|0|||
16220187|NCT02141854|39286260|FG000|Treatment Period|Other|0|||
16220188|NCT02141854|39286261|FG001|Treatment Period|Other|1|||
16220189|NCT02141854|39286262|FG002|Treatment Period|Other|2|||
16220190|NCT02141854|39286263|FG003|Treatment Period|Other|0|||
16220191|NCT02141854|39286264|FG004|Treatment Period|Other|1|||
16220192|NCT02141854|39286265|FG005|Treatment Period|Other|2|||
16220193|NCT02141854|39286260|FG000|Treatment Period|Adverse Event|0|||
16342414|NCT01317004|39740907|FG001|Overall Study|Adverse Event|3|||
16342415|NCT00845676|39740908|FG000|Overall Study|Virologic breakthrough at week 20|1|||
16342416|NCT00845676|39740908|FG000|Overall Study|Adverse Event|1|||
16342417|NCT03472521|39740909|FG000|Overall Study|Lost to Follow-up|3|||
16342418|NCT03472521|39740910|FG001|Overall Study|Lost to Follow-up|2|||
16342419|NCT03472521|39740909|FG000|Overall Study|Discontinued intervention|3|||
16342420|NCT03472521|39740910|FG001|Overall Study|Discontinued intervention|1|||
16342421|NCT03774394|39740913|FG000|Overall Study|Withdrawal by Subject|2|||
16342422|NCT03774394|39740914|FG001|Overall Study|Withdrawal by Subject|0|||
16342423|NCT04035499|39740915|FG000|Overall Study|Death|2|||
16342424|NCT04035499|39740915|FG000|Overall Study|Withdrawal by Subject|1|||
16542891|NCT00539279|40450331|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
16220194|NCT02141854|39286261|FG001|Treatment Period|Adverse Event|2|||
16220195|NCT02141854|39286262|FG002|Treatment Period|Adverse Event|2|||
16220196|NCT02141854|39286263|FG003|Treatment Period|Adverse Event|0|||
16220197|NCT02141854|39286264|FG004|Treatment Period|Adverse Event|2|||
16220198|NCT02141854|39286265|FG005|Treatment Period|Adverse Event|2|||
16220199|NCT02141854|39286260|FG000|Treatment Period|Withdrawal by Subject|0|||
16220200|NCT02141854|39286261|FG001|Treatment Period|Withdrawal by Subject|2|||
16220201|NCT02141854|39286262|FG002|Treatment Period|Withdrawal by Subject|3|||
16342425|NCT03162328|39740921|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
16342426|NCT03162328|39740922|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
16108932|NCT01952847|38888946|FG001|Overall Study|Ineligible|0|||
16108933|NCT01952847|38888947|FG002|Overall Study|Ineligible|0|||
16342427|NCT03162328|39740923|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
16342428|NCT03162328|39740921|FG000|Screening Period|Withdrawal by Subject|1|||
16342429|NCT03162328|39740922|FG001|Screening Period|Withdrawal by Subject|0|||
16342430|NCT03162328|39740923|FG002|Screening Period|Withdrawal by Subject|0|||
16342431|NCT03162328|39740921|FG000|Study Period|Withdrawal by Subject|0|||
16342432|NCT03162328|39740922|FG001|Study Period|Withdrawal by Subject|0|||
16342433|NCT03162328|39740923|FG002|Study Period|Withdrawal by Subject|1|||
16342434|NCT02232061|39740924|FG000|Overall Study|Administrative problems|1|||
16342435|NCT02232061|39740924|FG000|Overall Study|Withdrawal by Subject|1|||
16342436|NCT00003896|39740925|FG000|Overall Study|Adverse Event|16|||
16342437|NCT00003896|39740925|FG000|Overall Study|Withdrawal by Subject|1|||
16342438|NCT00003896|39740925|FG000|Overall Study|Lack of Efficacy|1|||
16342439|NCT00003896|39740925|FG000|Overall Study|Death|3|||
16342440|NCT00003896|39740925|FG000|Overall Study|not protocol specified|3|||
16342441|NCT00003896|39740925|FG000|Overall Study|ineligible|5|||
16342442|NCT00694356|39740926|FG000|Overall Study|Adverse Event|1|||
16342443|NCT00694356|39740927|FG001|Overall Study|Adverse Event|0|||
16342444|NCT00694356|39740928|FG002|Overall Study|Adverse Event|0|||
16342445|NCT00694356|39740926|FG000|Overall Study|Progressive Disease|2|||
16342446|NCT00694356|39740927|FG001|Overall Study|Progressive Disease|6|||
16342447|NCT00694356|39740928|FG002|Overall Study|Progressive Disease|6|||
16108934|NCT01952847|38888948|FG003|Overall Study|Ineligible|0|||
16108935|NCT01952847|38888945|FG000|Overall Study|Lack of Insurance Coverage|0|||
16108936|NCT01952847|38888946|FG001|Overall Study|Lack of Insurance Coverage|1|||
16108937|NCT01952847|38888947|FG002|Overall Study|Lack of Insurance Coverage|0|||
16108938|NCT01952847|38888948|FG003|Overall Study|Lack of Insurance Coverage|0|||
16108939|NCT01952847|38888945|FG000|Overall Study|Withdrawal by Subject|1|||
16108940|NCT01952847|38888946|FG001|Overall Study|Withdrawal by Subject|1|||
16108941|NCT01952847|38888947|FG002|Overall Study|Withdrawal by Subject|0|||
16108942|NCT01952847|38888948|FG003|Overall Study|Withdrawal by Subject|1|||
16108943|NCT01806389|38888949|FG000|Overall Study|Withdrawal by Subject|4|||
16108944|NCT04962698|38888950|FG000|Motor Imagery|Technical difficulty|1|||
16108945|NCT04962698|38888951|FG001|Motor Imagery|Technical difficulty|0|||
16108946|NCT04962698|38888950|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
16108947|NCT04962698|38888951|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
16108948|NCT04962698|38888950|FG000|Kinesthetic MI|Technical difficulty|1|||
16108949|NCT04962698|38888951|FG001|Kinesthetic MI|Technical difficulty|0|||
16108950|NCT04962698|38888950|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
16108951|NCT04962698|38888951|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
16108952|NCT04962698|38888950|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
16108953|NCT04962698|38888951|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
16342448|NCT00791700|39740929|FG000|Overall Study|Insufficient clinical response|1|||
16542892|NCT00539279|40450332|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
16542893|NCT01553318|40450337|FG000|Overall Study|Protocol Violation|3|||
16542894|NCT01553318|40450338|FG001|Overall Study|Protocol Violation|2|||
16542895|NCT03284788|40450342|FG000|Overall Study|Withdrawal by Subject|2|||
16542896|NCT00538590|40450345|FG000|Overall Study|Death|1|||
16542897|NCT00538590|40450346|FG001|Overall Study|Death|0|||
16542898|NCT00105235|40450352|FG000|Overall Study|Death|4|||
16542899|NCT00105235|40450352|FG000|Overall Study|Physician Decision|1|||
16542900|NCT00105235|40450352|FG000|Overall Study|Withdrawal by Subject|2|||
16542901|NCT00982930|40450353|FG000|Overall Study|Adverse Event|1|||
16542902|NCT00982930|40450353|FG000|Overall Study|Withdrawal by Subject|1|||
16542903|NCT00982930|40450353|FG000|Overall Study|Administrative Problems|2|||
16542904|NCT03021668|40450354|FG000|Overall Study|Physician Decision|0|||
16542905|NCT03021668|40450355|FG001|Overall Study|Physician Decision|1|||
16542906|NCT02979639|40450356|FG000|Overall Study|Withdrawal based on medical judgement|1|||
16542907|NCT02979639|40450356|FG000|Overall Study|Lost to Follow-up|8|||
16542908|NCT02979639|40450356|FG000|Overall Study|Withdrawal by Subject|3|||
16542909|NCT02979639|40450356|FG000|Overall Study|Adverse Event|2|||
16342449|NCT00791700|39740930|FG001|Overall Study|Insufficient clinical response|4|||
16342450|NCT00791700|39740931|FG002|Overall Study|Insufficient clinical response|1|||
16542910|NCT02230956|40450359|FG000|Overall Study|Adverse Event|1|||
16542911|NCT02230956|40450360|FG001|Overall Study|Adverse Event|1|||
16542912|NCT02230956|40450361|FG002|Overall Study|Adverse Event|0|||
16108954|NCT04962698|38888950|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
16108955|NCT04962698|38888951|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
16108956|NCT04962698|38888950|FG000|Virtual-hand Interaction|Technical difficulty|1|||
16108957|NCT04962698|38888951|FG001|Virtual-hand Interaction|Technical difficulty|0|||
16108958|NCT04962698|38888950|FG000|Robotic Action Observation|Technical difficulty|1|||
16108959|NCT04962698|38888951|FG001|Robotic Action Observation|Technical difficulty|0|||
16108960|NCT04962698|38888950|FG000|Rest|Technical difficulty|1|||
16108961|NCT04962698|38888951|FG001|Rest|Technical difficulty|0|||
16407085|NCT02075047|39970048|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
16407086|NCT02075047|39970047|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
16407087|NCT02075047|39970048|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
16407088|NCT02075047|39970047|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
16407089|NCT02075047|39970048|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
16407090|NCT02075047|39970047|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
16407091|NCT02075047|39970048|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
16407092|NCT02075047|39970047|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
16407093|NCT02075047|39970048|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
16407094|NCT02075047|39970047|FG000|Treatment Phase (4 Weeks)|Other|1|||
16407095|NCT02075047|39970048|FG001|Treatment Phase (4 Weeks)|Other|1|||
16407096|NCT02075047|39970047|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
16407097|NCT02075047|39970048|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
16407098|NCT02075047|39970047|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
16407099|NCT02075047|39970048|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
16407100|NCT02075047|39970047|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
16407101|NCT02075047|39970048|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
16407102|NCT02075047|39970047|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
16108962|NCT04962698|38888950|FG000|Rest|Exclusion criteria met after enrollment|0|||
16108963|NCT04962698|38888951|FG001|Rest|Exclusion criteria met after enrollment|2|||
16108964|NCT01918371|38888957|FG000|Overall Study|Missing Data|1|||
16108965|NCT01918371|38888958|FG001|Overall Study|Missing Data|1|||
16108966|NCT01013740|38888968|FG000|Overall Study|Lost to Follow-up|3|||
16108967|NCT01013740|38888969|FG001|Overall Study|Lost to Follow-up|5|||
16108968|NCT01013740|38888968|FG000|Overall Study|Physician Decision|2|||
16108969|NCT01013740|38888969|FG001|Overall Study|Physician Decision|0|||
16108970|NCT01013740|38888968|FG000|Overall Study|Withdrawal by Subject|2|||
16108971|NCT01013740|38888969|FG001|Overall Study|Withdrawal by Subject|10|||
16108972|NCT01013740|38888968|FG000|Overall Study|study close / terminated : done in error|2|||
16108973|NCT01013740|38888969|FG001|Overall Study|study close / terminated : done in error|1|||
16108974|NCT01013740|38888968|FG000|Overall Study|Missing|2|||
16108975|NCT01013740|38888969|FG001|Overall Study|Missing|1|||
16220202|NCT02141854|39286263|FG003|Treatment Period|Withdrawal by Subject|3|||
16220203|NCT02141854|39286264|FG004|Treatment Period|Withdrawal by Subject|4|||
16407103|NCT02075047|39970048|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
16407104|NCT02075047|39970047|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
16407105|NCT02075047|39970048|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
16407106|NCT02075047|39970047|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
16407107|NCT02075047|39970048|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
16407108|NCT02075047|39970047|FG000|Follow up Phase (5 Weeks)|Other|1|||
16407109|NCT02075047|39970048|FG001|Follow up Phase (5 Weeks)|Other|2|||
16407110|NCT02075047|39970047|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
16407111|NCT02075047|39970048|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
16407112|NCT02785458|39970049|FG000|1 Month|Withdrawal by Subject|2|||
16542913|NCT02230956|40450359|FG000|Overall Study|Lack of Efficacy|1|||
16542914|NCT02230956|40450360|FG001|Overall Study|Lack of Efficacy|1|||
16542915|NCT02230956|40450361|FG002|Overall Study|Lack of Efficacy|1|||
16542916|NCT02230956|40450359|FG000|Overall Study|Lost to Follow-up|1|||
16542917|NCT02230956|40450360|FG001|Overall Study|Lost to Follow-up|1|||
16542918|NCT02230956|40450361|FG002|Overall Study|Lost to Follow-up|2|||
16542919|NCT02230956|40450359|FG000|Overall Study|Personal Reasons|2|||
16542920|NCT02230956|40450360|FG001|Overall Study|Personal Reasons|1|||
16542921|NCT02230956|40450361|FG002|Overall Study|Personal Reasons|1|||
16542922|NCT02230956|40450359|FG000|Overall Study|Protocol Violation|0|||
16542923|NCT02230956|40450360|FG001|Overall Study|Protocol Violation|1|||
16542924|NCT02230956|40450361|FG002|Overall Study|Protocol Violation|1|||
16542925|NCT02230956|40450359|FG000|Overall Study|Other Miscellaneous Reason|0|||
16542926|NCT02230956|40450360|FG001|Overall Study|Other Miscellaneous Reason|1|||
16542927|NCT02230956|40450361|FG002|Overall Study|Other Miscellaneous Reason|2|||
16542928|NCT00430248|40450362|FG000|Overall Study|Adverse Event|49|||
16542929|NCT00430248|40450363|FG001|Overall Study|Adverse Event|61|||
16542930|NCT00430248|40450364|FG002|Overall Study|Adverse Event|64|||
16542931|NCT00430248|40450362|FG000|Overall Study|Protocol Violation|10|||
16542932|NCT00430248|40450363|FG001|Overall Study|Protocol Violation|2|||
16542933|NCT00430248|40450364|FG002|Overall Study|Protocol Violation|4|||
16542934|NCT00430248|40450362|FG000|Overall Study|Personal Reasons|12|||
16407113|NCT02785458|39970050|FG001|1 Month|Withdrawal by Subject|1|||
16407114|NCT02785458|39970049|FG000|1 Month|Lost to Follow-up|38|||
16407115|NCT02785458|39970050|FG001|1 Month|Lost to Follow-up|31|||
16407116|NCT02785458|39970049|FG000|1 Month|Deemed Ineligible|1|||
16407117|NCT02785458|39970050|FG001|1 Month|Deemed Ineligible|0|||
16407118|NCT02785458|39970049|FG000|1 Month|Completed Evaluation by Baseline|42|||
16407119|NCT02785458|39970050|FG001|1 Month|Completed Evaluation by Baseline|39|||
16407120|NCT02785458|39970049|FG000|1 Month|Partial Interview|0|||
16407121|NCT02785458|39970050|FG001|1 Month|Partial Interview|4|||
16407122|NCT02785458|39970049|FG000|3 Months|Withdrawal by Subject|3|||
16407123|NCT02785458|39970050|FG001|3 Months|Withdrawal by Subject|1|||
16407124|NCT02785458|39970049|FG000|3 Months|Lost to Follow-up|25|||
16108976|NCT01013740|38888968|FG000|Overall Study|Ongoing: Study records not completed|0|||
16108977|NCT01013740|38888969|FG001|Overall Study|Ongoing: Study records not completed|2|||
16108978|NCT03201900|38888973|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
16220204|NCT02141854|39286265|FG005|Treatment Period|Withdrawal by Subject|7|||
16220205|NCT02141854|39286260|FG000|Treatment Period|Disease progression|0|||
16220206|NCT02141854|39286261|FG001|Treatment Period|Disease progression|2|||
16220207|NCT02141854|39286262|FG002|Treatment Period|Disease progression|1|||
16220208|NCT02141854|39286263|FG003|Treatment Period|Disease progression|3|||
16108979|NCT03201900|38888973|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
16108980|NCT03201900|38888973|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
16108981|NCT03201900|38888973|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
16108982|NCT03201900|38888973|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
16108983|NCT03201900|38888973|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
16108984|NCT03201900|38888973|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
16108985|NCT03201900|38888973|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
16108986|NCT03201900|38888973|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
16108987|NCT03201900|38888973|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
16108988|NCT03201900|38888973|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
16108989|NCT03201900|38888973|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
16108990|NCT03201900|38888973|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
16108991|NCT02194829|38888976|FG000|Overall Study|Adverse Event|2|||
16108992|NCT02194829|38888977|FG001|Overall Study|Adverse Event|2|||
16108993|NCT02194829|38888976|FG000|Overall Study|Death|0|||
16108994|NCT02194829|38888977|FG001|Overall Study|Death|1|||
16108995|NCT02194829|38888976|FG000|Overall Study|Disease progression|0|||
16108996|NCT02194829|38888977|FG001|Overall Study|Disease progression|1|||
16108997|NCT02194829|38888976|FG000|Overall Study|Withdrawal by Subject|0|||
16108998|NCT02194829|38888977|FG001|Overall Study|Withdrawal by Subject|1|||
16108999|NCT02194829|38888976|FG000|Overall Study|Never started protocol therapy|0|||
16109000|NCT02194829|38888977|FG001|Overall Study|Never started protocol therapy|1|||
16109001|NCT01233999|38888979|FG000|Overall Study|Withdrawal by Subject|1|||
16109002|NCT01233999|38888979|FG000|Overall Study|Lost to Follow-up|1|||
16109003|NCT00548847|38888980|FG000|Overall Study|Disease progression|7|||
16407125|NCT02785458|39970050|FG001|3 Months|Lost to Follow-up|21|||
16407126|NCT02785458|39970049|FG000|3 Months|Completed Evaluation at 1 Month|100|||
16109006|NCT03187353|38888987|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
16109007|NCT03187353|38888988|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
16109008|NCT03187353|38888987|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
16109009|NCT03187353|38888988|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
16109010|NCT03187353|38888987|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
16109011|NCT03187353|38888988|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
16109012|NCT03187353|38888987|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
16109013|NCT03187353|38888988|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
16109014|NCT03187353|38888987|FG000|Washout (2 Weeks)|Adverse Event|2|||
16109015|NCT03187353|38888988|FG001|Washout (2 Weeks)|Adverse Event|0|||
16109016|NCT03187353|38888987|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
16109017|NCT03187353|38888988|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
16109018|NCT00617929|38888989|FG000|Overall Study|Physician Decision|1|||
16109019|NCT00983892|38888990|FG000|Overall Study|Withdrawal by Subject|10|||
16109020|NCT00983892|38888991|FG001|Overall Study|Withdrawal by Subject|12|||
16109021|NCT03296566|38888992|FG000|Overall Study|Lost to Follow-up|19|||
16109022|NCT03296566|38888993|FG001|Overall Study|Lost to Follow-up|46|||
16109023|NCT03296566|38888992|FG000|Overall Study|Withdrawal by Subject|0|||
16109024|NCT03296566|38888993|FG001|Overall Study|Withdrawal by Subject|3|||
16407127|NCT02785458|39970050|FG001|3 Months|Completed Evaluation at 1 Month|89|||
16109025|NCT01006616|38888994|FG000|Period 1 (6 Months)|Adverse Event|10|||
16109026|NCT01006616|38888995|FG001|Period 1 (6 Months)|Adverse Event|31|||
16109027|NCT01006616|38888996|FG002|Period 1 (6 Months)|Adverse Event|37|||
16407128|NCT00235391|39970051|FG000|Overall Study|Adverse Event|4|||
16220209|NCT02141854|39286264|FG004|Treatment Period|Disease progression|0|||
16220210|NCT02141854|39286265|FG005|Treatment Period|Disease progression|18|||
16220211|NCT02141854|39286260|FG000|Treatment Period|Lost to Follow-up|0|||
16220212|NCT02141854|39286261|FG001|Treatment Period|Lost to Follow-up|1|||
16220213|NCT02141854|39286262|FG002|Treatment Period|Lost to Follow-up|1|||
16220214|NCT02141854|39286263|FG003|Treatment Period|Lost to Follow-up|1|||
16220215|NCT02141854|39286264|FG004|Treatment Period|Lost to Follow-up|0|||
16220216|NCT02141854|39286265|FG005|Treatment Period|Lost to Follow-up|1|||
16109028|NCT01006616|38888997|FG003|Period 1 (6 Months)|Adverse Event|9|||
16109029|NCT01006616|38888994|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
16109030|NCT01006616|38888995|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
16407129|NCT00235391|39970052|FG001|Overall Study|Adverse Event|5|||
16407130|NCT00235391|39970053|FG002|Overall Study|Adverse Event|10|||
16407131|NCT00235391|39970054|FG003|Overall Study|Adverse Event|72|||
16407132|NCT00235391|39970055|FG004|Overall Study|Adverse Event|5|||
16407133|NCT00235391|39970056|FG005|Overall Study|Adverse Event|2|||
16407134|NCT00235391|39970051|FG000|Overall Study|Abnormal laboratory value(s)|3|||
16407135|NCT00235391|39970052|FG001|Overall Study|Abnormal laboratory value(s)|5|||
16407136|NCT00235391|39970053|FG002|Overall Study|Abnormal laboratory value(s)|4|||
16109031|NCT01006616|38888996|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
16220217|NCT00490815|39286266|FG000|Overall Study|Adverse Event|2|||
16220218|NCT00490815|39286267|FG001|Overall Study|Adverse Event|3|||
16342451|NCT00791700|39740932|FG003|Overall Study|Insufficient clinical response|8|||
16342452|NCT00791700|39740929|FG000|Overall Study|No longer willing to participate|1|||
16342453|NCT00791700|39740930|FG001|Overall Study|No longer willing to participate|1|||
16342454|NCT00791700|39740931|FG002|Overall Study|No longer willing to participate|0|||
16342455|NCT00791700|39740932|FG003|Overall Study|No longer willing to participate|8|||
16342456|NCT00791700|39740929|FG000|Overall Study|Non-compliance with study treatment|0|||
16342457|NCT00791700|39740930|FG001|Overall Study|Non-compliance with study treatment|2|||
16342458|NCT00791700|39740931|FG002|Overall Study|Non-compliance with study treatment|0|||
16342459|NCT00791700|39740932|FG003|Overall Study|Non-compliance with study treatment|4|||
16342460|NCT00791700|39740929|FG000|Overall Study|Withdrawn due to pregnancy|0|||
16342461|NCT00791700|39740930|FG001|Overall Study|Withdrawn due to pregnancy|0|||
16342462|NCT00791700|39740931|FG002|Overall Study|Withdrawn due to pregnancy|0|||
16342463|NCT00791700|39740932|FG003|Overall Study|Withdrawn due to pregnancy|1|||
16342464|NCT00791700|39740929|FG000|Overall Study|Other|0|||
16342465|NCT00791700|39740930|FG001|Overall Study|Other|1|||
16342466|NCT00791700|39740931|FG002|Overall Study|Other|0|||
16342467|NCT00791700|39740932|FG003|Overall Study|Other|1|||
16342468|NCT00791700|39740929|FG000|Overall Study|Death|0|||
16342469|NCT00791700|39740930|FG001|Overall Study|Death|0|||
16342470|NCT00791700|39740931|FG002|Overall Study|Death|0|||
16342471|NCT00791700|39740932|FG003|Overall Study|Death|1|||
16342472|NCT00791700|39740929|FG000|Overall Study|Lost to Follow-up|4|||
16342473|NCT00791700|39740930|FG001|Overall Study|Lost to Follow-up|3|||
16342474|NCT00791700|39740931|FG002|Overall Study|Lost to Follow-up|4|||
16342475|NCT00791700|39740932|FG003|Overall Study|Lost to Follow-up|6|||
16220219|NCT00490815|39286266|FG000|Overall Study|Withdrawal by Subject|4|||
16342476|NCT00791700|39740929|FG000|Overall Study|Adverse Event|0|||
16342477|NCT00791700|39740930|FG001|Overall Study|Adverse Event|0|||
16342478|NCT00791700|39740931|FG002|Overall Study|Adverse Event|1|||
16342479|NCT00791700|39740932|FG003|Overall Study|Adverse Event|1|||
16109032|NCT01006616|38888997|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
16109033|NCT01006616|38888994|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
16407137|NCT00235391|39970054|FG003|Overall Study|Abnormal laboratory value(s)|27|||
16407138|NCT00235391|39970055|FG004|Overall Study|Abnormal laboratory value(s)|1|||
16407139|NCT00235391|39970056|FG005|Overall Study|Abnormal laboratory value(s)|2|||
16407140|NCT00235391|39970051|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16407141|NCT00235391|39970052|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16407142|NCT00235391|39970053|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
16407143|NCT00235391|39970054|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
16407144|NCT00235391|39970055|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
16407145|NCT00235391|39970056|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
16407146|NCT00235391|39970051|FG000|Overall Study|Condition no longer requires treatment|3|||
16407147|NCT00235391|39970052|FG001|Overall Study|Condition no longer requires treatment|0|||
16407148|NCT00235391|39970053|FG002|Overall Study|Condition no longer requires treatment|0|||
16407149|NCT00235391|39970054|FG003|Overall Study|Condition no longer requires treatment|11|||
16407150|NCT00235391|39970055|FG004|Overall Study|Condition no longer requires treatment|1|||
16407151|NCT00235391|39970056|FG005|Overall Study|Condition no longer requires treatment|0|||
16407152|NCT00235391|39970051|FG000|Overall Study|Protocol deviation|0|||
16407153|NCT00235391|39970052|FG001|Overall Study|Protocol deviation|0|||
16407154|NCT00235391|39970053|FG002|Overall Study|Protocol deviation|1|||
16407155|NCT00235391|39970054|FG003|Overall Study|Protocol deviation|11|||
16407156|NCT00235391|39970055|FG004|Overall Study|Protocol deviation|0|||
16407157|NCT00235391|39970056|FG005|Overall Study|Protocol deviation|0|||
16407158|NCT00235391|39970051|FG000|Overall Study|Withdrawal by Subject|2|||
16407159|NCT00235391|39970052|FG001|Overall Study|Withdrawal by Subject|3|||
16407160|NCT00235391|39970053|FG002|Overall Study|Withdrawal by Subject|3|||
16407161|NCT00235391|39970054|FG003|Overall Study|Withdrawal by Subject|61|||
16407162|NCT00235391|39970055|FG004|Overall Study|Withdrawal by Subject|5|||
16407163|NCT00235391|39970056|FG005|Overall Study|Withdrawal by Subject|0|||
16407164|NCT00235391|39970051|FG000|Overall Study|Lost to Follow-up|0|||
16407165|NCT00235391|39970052|FG001|Overall Study|Lost to Follow-up|3|||
16407166|NCT00235391|39970053|FG002|Overall Study|Lost to Follow-up|3|||
16407167|NCT00235391|39970054|FG003|Overall Study|Lost to Follow-up|16|||
16407168|NCT00235391|39970055|FG004|Overall Study|Lost to Follow-up|0|||
16407169|NCT00235391|39970056|FG005|Overall Study|Lost to Follow-up|0|||
16407170|NCT00235391|39970051|FG000|Overall Study|Administrative problems|0|||
16407171|NCT00235391|39970052|FG001|Overall Study|Administrative problems|0|||
16407172|NCT00235391|39970053|FG002|Overall Study|Administrative problems|0|||
16109034|NCT01006616|38888995|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
16109035|NCT01006616|38888996|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
16109036|NCT01006616|38888997|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
16109037|NCT01006616|38888994|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
16109038|NCT01006616|38888995|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
16407173|NCT00235391|39970054|FG003|Overall Study|Administrative problems|1|||
16407174|NCT00235391|39970055|FG004|Overall Study|Administrative problems|0|||
16407175|NCT00235391|39970056|FG005|Overall Study|Administrative problems|0|||
16407176|NCT00235391|39970051|FG000|Overall Study|Death|0|||
16407177|NCT00235391|39970052|FG001|Overall Study|Death|0|||
16407178|NCT00235391|39970053|FG002|Overall Study|Death|1|||
16407179|NCT00235391|39970054|FG003|Overall Study|Death|4|||
16109039|NCT01006616|38888996|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
16407180|NCT00235391|39970055|FG004|Overall Study|Death|0|||
16407181|NCT00235391|39970056|FG005|Overall Study|Death|0|||
16407182|NCT03831880|39970059|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
16407183|NCT03831880|39970060|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
16407184|NCT03831880|39970059|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
16109040|NCT01006616|38888997|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
16407185|NCT03831880|39970060|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
16407186|NCT00977938|39970075|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
16407187|NCT00977938|39970076|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
16407188|NCT00977938|39970077|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
16342480|NCT02465437|39740933|FG000|Overall Study|Physician Decision|0|||
16342481|NCT02465437|39740934|FG001|Overall Study|Physician Decision|0|||
16342482|NCT02465437|39740935|FG002|Overall Study|Physician Decision|1|||
16342483|NCT02465437|39740936|FG003|Overall Study|Physician Decision|0|||
16342484|NCT02465437|39740933|FG000|Overall Study|Withdrawal by Subject|1|||
16342485|NCT02465437|39740934|FG001|Overall Study|Withdrawal by Subject|0|||
16342486|NCT02465437|39740935|FG002|Overall Study|Withdrawal by Subject|0|||
16342487|NCT02465437|39740936|FG003|Overall Study|Withdrawal by Subject|1|||
16342488|NCT02465437|39740933|FG000|Overall Study|Adverse Event|0|||
16342489|NCT02465437|39740934|FG001|Overall Study|Adverse Event|1|||
16342490|NCT02465437|39740935|FG002|Overall Study|Adverse Event|0|||
16342491|NCT02465437|39740936|FG003|Overall Study|Adverse Event|0|||
16342492|NCT03665077|39740937|FG000|Overall Study|Lost to Follow-up|2|||
16342493|NCT03665077|39740937|FG000|Overall Study|Physician Decision|2|||
16342494|NCT02087670|39740938|FG000|Overall Study|Withdrawal by Subject|3|||
16342495|NCT02087670|39740939|FG001|Overall Study|Withdrawal by Subject|2|||
16342496|NCT02626000|39740940|FG000|Overall Study|Decision by Sponsor|1|||
16342497|NCT02626000|39740940|FG000|Overall Study|Death|29|||
16342498|NCT01990768|39740947|FG000|Intervention Started|Found to be ineligible|14|||
16342499|NCT01990768|39740948|FG001|Intervention Started|Found to be ineligible|13|||
16342500|NCT01990768|39740949|FG002|Intervention Started|Found to be ineligible|11|||
16342501|NCT01990768|39740947|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
16542935|NCT00430248|40450363|FG001|Overall Study|Personal Reasons|24|||
16542936|NCT00430248|40450364|FG002|Overall Study|Personal Reasons|9|||
16542937|NCT00430248|40450362|FG000|Overall Study|Lost to Follow-up|28|||
16542938|NCT00430248|40450363|FG001|Overall Study|Lost to Follow-up|33|||
16542939|NCT00430248|40450364|FG002|Overall Study|Lost to Follow-up|28|||
16542940|NCT00430248|40450362|FG000|Overall Study|Therapeutic Failure|1|||
16542941|NCT00430248|40450363|FG001|Overall Study|Therapeutic Failure|1|||
16542942|NCT00430248|40450364|FG002|Overall Study|Therapeutic Failure|1|||
16542943|NCT00430248|40450362|FG000|Overall Study|Withdrawal by Subject|14|||
16542944|NCT00430248|40450363|FG001|Overall Study|Withdrawal by Subject|20|||
16542945|NCT00430248|40450364|FG002|Overall Study|Withdrawal by Subject|16|||
16542946|NCT00430248|40450362|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16542947|NCT00430248|40450363|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
16542948|NCT00430248|40450364|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16542949|NCT00430248|40450362|FG000|Overall Study|Gout Flare|3|||
16542950|NCT00430248|40450363|FG001|Overall Study|Gout Flare|7|||
16542951|NCT00430248|40450364|FG002|Overall Study|Gout Flare|2|||
16542952|NCT00430248|40450362|FG000|Overall Study|Reason Not Specified|8|||
16542953|NCT00430248|40450363|FG001|Overall Study|Reason Not Specified|8|||
16542954|NCT00430248|40450364|FG002|Overall Study|Reason Not Specified|11|||
16542955|NCT00662857|40450369|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
16542956|NCT00662857|40450370|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
16542957|NCT00662857|40450369|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
16542958|NCT00662857|40450370|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
16542959|NCT00662857|40450369|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
16542960|NCT00662857|40450370|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
16542961|NCT02243280|40450371|FG000|Treated|Adverse Event|1|||
16542962|NCT02243280|40450372|FG001|Treated|Adverse Event|0|||
16542963|NCT02243280|40450373|FG002|Treated|Adverse Event|0|||
16542964|NCT02243280|40450374|FG003|Treated|Adverse Event|0|||
16542965|NCT02243280|40450375|FG004|Treated|Adverse Event|0|||
16542966|NCT02243280|40450376|FG005|Treated|Adverse Event|0|||
16542967|NCT02243280|40450377|FG006|Treated|Adverse Event|0|||
16542968|NCT02243280|40450378|FG007|Treated|Adverse Event|0|||
16542969|NCT02243280|40450379|FG008|Treated|Adverse Event|0|||
16542970|NCT02243280|40450380|FG009|Treated|Adverse Event|0|||
16542971|NCT02243280|40450381|FG010|Treated|Adverse Event|1|||
16542972|NCT02243280|40450371|FG000|Treated|Lost to Follow-up|0|||
16542973|NCT02243280|40450372|FG001|Treated|Lost to Follow-up|0|||
16542974|NCT02243280|40450373|FG002|Treated|Lost to Follow-up|0|||
16542975|NCT02243280|40450374|FG003|Treated|Lost to Follow-up|0|||
16542976|NCT02243280|40450375|FG004|Treated|Lost to Follow-up|0|||
16542977|NCT02243280|40450376|FG005|Treated|Lost to Follow-up|0|||
16542978|NCT02243280|40450377|FG006|Treated|Lost to Follow-up|0|||
16542979|NCT02243280|40450378|FG007|Treated|Lost to Follow-up|0|||
16542980|NCT02243280|40450379|FG008|Treated|Lost to Follow-up|1|||
16542981|NCT02243280|40450380|FG009|Treated|Lost to Follow-up|0|||
16542982|NCT02243280|40450381|FG010|Treated|Lost to Follow-up|2|||
16542983|NCT00977665|40450383|FG000|Overall Study|Withdrawal by Subject|1|||
16542984|NCT00977665|40450384|FG001|Overall Study|Withdrawal by Subject|3|||
16542985|NCT00977665|40450383|FG000|Overall Study|Physician Decision|2|||
16542986|NCT00977665|40450384|FG001|Overall Study|Physician Decision|1|||
16542987|NCT00977665|40450383|FG000|Overall Study|Sponsor requested withdrawal|0|||
16542988|NCT00977665|40450384|FG001|Overall Study|Sponsor requested withdrawal|1|||
16542989|NCT00977665|40450383|FG000|Overall Study|Lost to Follow-up|1|||
16542990|NCT00977665|40450384|FG001|Overall Study|Lost to Follow-up|0|||
16542991|NCT00977665|40450383|FG000|Overall Study|Death|3|||
16542992|NCT00977665|40450384|FG001|Overall Study|Death|2|||
16342502|NCT01990768|39740948|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
16342503|NCT01990768|39740949|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
16109041|NCT01006616|38888994|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
16342504|NCT01990768|39740947|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
16220220|NCT00490815|39286267|FG001|Overall Study|Withdrawal by Subject|0|||
16342505|NCT01990768|39740948|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
16342506|NCT01990768|39740949|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
16109042|NCT01006616|38888995|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
16109043|NCT01006616|38888996|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
16109044|NCT01006616|38888997|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
16109045|NCT01006616|38888994|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
16109046|NCT01006616|38888995|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
16342507|NCT01990768|39740947|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
16109047|NCT01006616|38888996|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
16109048|NCT01006616|38888997|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
16109049|NCT01006616|38888994|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
16109050|NCT01006616|38888995|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
16109051|NCT01006616|38888996|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
16109052|NCT01006616|38888997|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
16109053|NCT01006616|38888994|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
16109054|NCT01006616|38888995|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
16109055|NCT01006616|38888996|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
16109056|NCT01006616|38888997|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
16109057|NCT01006616|38888994|FG000|Period 1 (6 Months)|Not Treated|0|||
16220221|NCT00490815|39286266|FG000|Overall Study|Lost to Follow-up|1|||
16109058|NCT01006616|38888995|FG001|Period 1 (6 Months)|Not Treated|0|||
16109059|NCT01006616|38888996|FG002|Period 1 (6 Months)|Not Treated|1|||
16109060|NCT01006616|38888997|FG003|Period 1 (6 Months)|Not Treated|1|||
16220222|NCT00490815|39286267|FG001|Overall Study|Lost to Follow-up|3|||
16220223|NCT00490815|39286266|FG000|Overall Study|Death|1|||
16220224|NCT00490815|39286267|FG001|Overall Study|Death|3|||
16220225|NCT00656799|39286269|FG000|Overall Study|Death|2|||
16220226|NCT01426009|39286272|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
16220227|NCT01426009|39286272|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
16220228|NCT01426009|39286272|FG000|Washout 1|Withdrawal by Subject|1|||
16220229|NCT01426009|39286272|FG000|Washout 1|Personal Reasons|1|||
16220230|NCT01426009|39286272|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
16220231|NCT01426009|39286272|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
16220232|NCT01426009|39286272|FG000|Washout 2|electrive surgery|1|||
16220233|NCT01426009|39286272|FG000|Washout 3|personal reasons|1|||
16220234|NCT01426009|39286272|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
16220235|NCT01426009|39286272|FG000|Washout 4|Lost to Follow-up|1|||
16220236|NCT02543801|39286275|FG000|Overall Study|Protocol Violation|1|||
16220237|NCT02543801|39286276|FG001|Overall Study|Protocol Violation|2|||
16220238|NCT02543801|39286277|FG002|Overall Study|Protocol Violation|0|||
16220239|NCT02543801|39286278|FG003|Overall Study|Protocol Violation|0|||
16220240|NCT03091920|39286279|FG000|Overall Study|Adverse Event|0|||
16220241|NCT03091920|39286280|FG001|Overall Study|Adverse Event|1|||
16220242|NCT03091920|39286281|FG002|Overall Study|Adverse Event|0|||
16220243|NCT04035473|39286284|FG000|Screening/Baseline|Death|0|||
16220244|NCT04035473|39286285|FG001|Screening/Baseline|Death|1|||
16220245|NCT04035473|39286284|FG000|Screening/Baseline|Adverse Event|0|||
16220246|NCT04035473|39286285|FG001|Screening/Baseline|Adverse Event|1|||
16220247|NCT04035473|39286284|FG000|Follow-up Period|Adverse Event|2|||
16220248|NCT04035473|39286285|FG001|Follow-up Period|Adverse Event|0|||
16220249|NCT02176226|39286286|FG000|Overall Study|Lost to Follow-up|3|||
16220250|NCT02176226|39286286|FG000|Overall Study|Withdrew prior to treatment|6|||
16220251|NCT02681094|39286295|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
16220252|NCT02681094|39286296|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
16220253|NCT02681094|39286297|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
16220254|NCT02681094|39286295|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
16220255|NCT02681094|39286296|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
16220256|NCT02681094|39286297|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
16220257|NCT02681094|39286295|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
16220258|NCT02681094|39286296|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
16220259|NCT02681094|39286297|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
16342508|NCT01990768|39740948|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
16220260|NCT02681094|39286295|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
16542993|NCT00977665|40450383|FG000|Overall Study|Adverse Event|14|||
16220261|NCT02681094|39286296|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
16220262|NCT02681094|39286297|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
16220263|NCT02681094|39286295|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
16220264|NCT02681094|39286296|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
16220265|NCT02681094|39286297|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
16220266|NCT02681094|39286295|FG000|1 -Modified Enrolled Participants Set|Other|6|||
16220267|NCT02681094|39286296|FG001|1 -Modified Enrolled Participants Set|Other|6|||
16220268|NCT02681094|39286297|FG002|1 -Modified Enrolled Participants Set|Other|7|||
16220269|NCT02681094|39286295|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
16220270|NCT02681094|39286296|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
16220271|NCT02681094|39286297|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
16220272|NCT02681094|39286295|FG000|2 - Enrolled Participants Set|Participant decision|7|||
16220273|NCT02681094|39286296|FG001|2 - Enrolled Participants Set|Participant decision|10|||
16220274|NCT02681094|39286297|FG002|2 - Enrolled Participants Set|Participant decision|9|||
16220275|NCT02681094|39286295|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
16220276|NCT02681094|39286296|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
16220277|NCT02681094|39286297|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
16220278|NCT02681094|39286295|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
16220279|NCT02681094|39286296|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
16220280|NCT02681094|39286297|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
16220281|NCT02681094|39286295|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
16220282|NCT02681094|39286296|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
16220283|NCT02681094|39286297|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
16220284|NCT02681094|39286295|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
16220285|NCT02681094|39286296|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
16220286|NCT02681094|39286297|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
16220287|NCT02681094|39286295|FG000|2 - Enrolled Participants Set|Other|6|||
16220288|NCT02681094|39286296|FG001|2 - Enrolled Participants Set|Other|6|||
16220289|NCT02681094|39286297|FG002|2 - Enrolled Participants Set|Other|7|||
16220290|NCT02681094|39286295|FG000|2 - Enrolled Participants Set|No treatment given|0|||
16220291|NCT02681094|39286296|FG001|2 - Enrolled Participants Set|No treatment given|1|||
16220292|NCT02681094|39286297|FG002|2 - Enrolled Participants Set|No treatment given|1|||
16220293|NCT00959192|39286303|FG000|Overall Study|Adverse Event|1|||
16220294|NCT00959192|39286304|FG001|Overall Study|Adverse Event|1|||
16220295|NCT00959192|39286305|FG002|Overall Study|Adverse Event|1|||
16220296|NCT00959192|39286306|FG003|Overall Study|Adverse Event|0|||
16220297|NCT00959192|39286303|FG000|Overall Study|Investigator Request|1|||
16220298|NCT00959192|39286304|FG001|Overall Study|Investigator Request|0|||
16220299|NCT00959192|39286305|FG002|Overall Study|Investigator Request|0|||
16220300|NCT00959192|39286306|FG003|Overall Study|Investigator Request|0|||
16220301|NCT00959192|39286303|FG000|Overall Study|Caregiver Request|0|||
16220302|NCT00959192|39286304|FG001|Overall Study|Caregiver Request|0|||
16220303|NCT00959192|39286305|FG002|Overall Study|Caregiver Request|2|||
16220304|NCT00959192|39286306|FG003|Overall Study|Caregiver Request|1|||
16220305|NCT01524900|39286307|FG000|Overall Study|Lost to Follow-up|3|||
16220306|NCT01524900|39286308|FG001|Overall Study|Lost to Follow-up|12|||
16220307|NCT01524900|39286309|FG002|Overall Study|Lost to Follow-up|1|||
16220308|NCT01524900|39286310|FG003|Overall Study|Lost to Follow-up|0|||
16220309|NCT01524900|39286311|FG004|Overall Study|Lost to Follow-up|0|||
16220310|NCT01524900|39286307|FG000|Overall Study|Other reason than stated above|1|||
16220311|NCT01524900|39286308|FG001|Overall Study|Other reason than stated above|1|||
16220312|NCT01524900|39286309|FG002|Overall Study|Other reason than stated above|0|||
16220313|NCT01524900|39286310|FG003|Overall Study|Other reason than stated above|0|||
16220314|NCT01524900|39286311|FG004|Overall Study|Other reason than stated above|0|||
16220315|NCT01524900|39286307|FG000|Overall Study|No reason documented|2|||
16220316|NCT01524900|39286308|FG001|Overall Study|No reason documented|1|||
16220317|NCT01524900|39286309|FG002|Overall Study|No reason documented|0|||
16220318|NCT01524900|39286310|FG003|Overall Study|No reason documented|1|||
16220319|NCT01524900|39286311|FG004|Overall Study|No reason documented|0|||
16220320|NCT03340766|39286312|FG000|Overall Study|Death|6|||
16220321|NCT03340766|39286313|FG001|Overall Study|Death|6|||
16542994|NCT00977665|40450384|FG001|Overall Study|Adverse Event|7|||
16542995|NCT00977665|40450383|FG000|Overall Study|Treatment failure|0|||
16542996|NCT00977665|40450384|FG001|Overall Study|Treatment failure|1|||
16542997|NCT03172702|40450385|FG000|Overall Study|Adverse Event|9|||
16542998|NCT03172702|40450385|FG000|Overall Study|Death|2|||
16542999|NCT03172702|40450385|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
16543000|NCT03172702|40450385|FG000|Overall Study|Withdrawal by Subject|5|||
16543001|NCT03172702|40450385|FG000|Overall Study|Other|2|||
16543002|NCT01376323|40450389|FG000|Overall Study|Adverse Event|1|||
16543003|NCT01376323|40450390|FG001|Overall Study|Adverse Event|0|||
16220322|NCT03340766|39286314|FG002|Overall Study|Death|2|||
16220323|NCT03340766|39286312|FG000|Overall Study|Withdrawal by Subject|2|||
16220324|NCT03340766|39286313|FG001|Overall Study|Withdrawal by Subject|1|||
16220325|NCT03340766|39286314|FG002|Overall Study|Withdrawal by Subject|2|||
16220326|NCT03340766|39286312|FG000|Overall Study|Continuing Study|3|||
16220327|NCT03340766|39286313|FG001|Overall Study|Continuing Study|3|||
16220328|NCT03340766|39286314|FG002|Overall Study|Continuing Study|5|||
16220329|NCT02926833|39286315|FG000|Overall Study|Death|1|||
16220330|NCT02926833|39286316|FG001|Overall Study|Death|1|||
16220331|NCT02926833|39286317|FG002|Overall Study|Death|2|||
16220332|NCT02926833|39286318|FG003|Overall Study|Death|13|||
16220333|NCT02926833|39286315|FG000|Overall Study|Lost to Follow-up|1|||
16220334|NCT02926833|39286316|FG001|Overall Study|Lost to Follow-up|2|||
16220335|NCT02926833|39286317|FG002|Overall Study|Lost to Follow-up|0|||
16220336|NCT02926833|39286318|FG003|Overall Study|Lost to Follow-up|3|||
16220337|NCT02926833|39286315|FG000|Overall Study|Full Consent Withdrawal|0|||
16220338|NCT02926833|39286316|FG001|Overall Study|Full Consent Withdrawal|0|||
16220339|NCT02926833|39286317|FG002|Overall Study|Full Consent Withdrawal|0|||
16220340|NCT02926833|39286318|FG003|Overall Study|Full Consent Withdrawal|2|||
16220341|NCT02926833|39286315|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
16220342|NCT02926833|39286316|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
16220343|NCT02926833|39286317|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
16220344|NCT02926833|39286318|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
16220345|NCT02926833|39286315|FG000|Overall Study|Investigator Decision|0|||
16220346|NCT02926833|39286316|FG001|Overall Study|Investigator Decision|1|||
16220347|NCT02926833|39286317|FG002|Overall Study|Investigator Decision|0|||
16220348|NCT02926833|39286318|FG003|Overall Study|Investigator Decision|0|||
16220349|NCT02926833|39286315|FG000|Overall Study|Adverse Event|0|||
16220350|NCT02926833|39286316|FG001|Overall Study|Adverse Event|0|||
16220351|NCT02926833|39286317|FG002|Overall Study|Adverse Event|1|||
16220352|NCT02926833|39286318|FG003|Overall Study|Adverse Event|0|||
16220353|NCT02926833|39286315|FG000|Overall Study|Partial Withdrawal of Consent|0|||
16220354|NCT02926833|39286316|FG001|Overall Study|Partial Withdrawal of Consent|0|||
16220355|NCT02926833|39286317|FG002|Overall Study|Partial Withdrawal of Consent|0|||
16220356|NCT02926833|39286318|FG003|Overall Study|Partial Withdrawal of Consent|1|||
16220357|NCT01775995|39286319|FG000|Overall Study|Lost to Follow-up|1|||
16220358|NCT01775995|39286320|FG001|Overall Study|Lost to Follow-up|1|||
16220359|NCT00526227|39286321|FG000|Overall Study|Device not implanted|1|||
16220360|NCT00526227|39286321|FG000|Overall Study|Death|1|||
16220361|NCT03287830|39286324|FG000|Overall Study|Withdrawal by Subject|1|||
16220362|NCT03287830|39286325|FG001|Overall Study|Withdrawal by Subject|1|||
16220363|NCT03287830|39286324|FG000|Overall Study|not meeting inclusion criteria|5|||
16220364|NCT03287830|39286325|FG001|Overall Study|not meeting inclusion criteria|12|||
16220365|NCT01078974|39286326|FG000|Overall Study|Adverse Event|3|||
16220366|NCT01790633|39286327|FG000|Overall Study|Protocol Violation|1|||
16220367|NCT01790633|39286328|FG001|Overall Study|Protocol Violation|2|||
16220368|NCT01790633|39286327|FG000|Overall Study|Did not have serology performed|47|||
16220369|NCT01790633|39286328|FG001|Overall Study|Did not have serology performed|0|||
16220370|NCT01790633|39286327|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
16220371|NCT01790633|39286328|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
16220372|NCT00736385|39286332|FG000|Overall Study|Withdrawal by Subject|2|||
16220373|NCT00736385|39286333|FG001|Overall Study|Withdrawal by Subject|2|||
16220374|NCT00736385|39286332|FG000|Overall Study|Adverse Event|0|||
16220375|NCT00736385|39286333|FG001|Overall Study|Adverse Event|1|||
16220376|NCT01072500|39286338|FG000|Overall Study|Death|2|||
16220377|NCT01072500|39286339|FG001|Overall Study|Death|2|||
16220378|NCT01072500|39286338|FG000|Overall Study|Lost to Follow-up|5|||
16220379|NCT01072500|39286339|FG001|Overall Study|Lost to Follow-up|2|||
16220380|NCT01072500|39286338|FG000|Overall Study|Withdrawal by Subject|17|||
16220381|NCT01072500|39286339|FG001|Overall Study|Withdrawal by Subject|10|||
16220382|NCT01970540|39286340|FG000|Overall Study|Non-treatment-related AE|0|||
16220383|NCT01970540|39286341|FG001|Overall Study|Non-treatment-related AE|0|||
16220384|NCT01970540|39286342|FG002|Overall Study|Non-treatment-related AE|1|||
16220385|NCT01970540|39286340|FG000|Overall Study|Progressive disease|55|||
16220386|NCT01970540|39286341|FG001|Overall Study|Progressive disease|23|||
16220387|NCT01970540|39286342|FG002|Overall Study|Progressive disease|10|||
16220388|NCT01970540|39286340|FG000|Overall Study|Treatment delay over protocol|0|||
16220389|NCT01970540|39286341|FG001|Overall Study|Treatment delay over protocol|0|||
16220390|NCT01970540|39286342|FG002|Overall Study|Treatment delay over protocol|1|||
16220391|NCT01970540|39286340|FG000|Overall Study|Physician Decision|7|||
16220392|NCT01970540|39286341|FG001|Overall Study|Physician Decision|2|||
16220393|NCT01970540|39286342|FG002|Overall Study|Physician Decision|0|||
16220394|NCT01970540|39286340|FG000|Overall Study|Clinical progression|0|||
16220395|NCT01970540|39286341|FG001|Overall Study|Clinical progression|1|||
16220396|NCT01970540|39286342|FG002|Overall Study|Clinical progression|1|||
16220397|NCT01970540|39286340|FG000|Overall Study|End of study|2|||
16220398|NCT01970540|39286341|FG001|Overall Study|End of study|0|||
16220399|NCT01970540|39286342|FG002|Overall Study|End of study|2|||
16220400|NCT01970540|39286340|FG000|Overall Study|Adverse Event|0|||
16220401|NCT01970540|39286341|FG001|Overall Study|Adverse Event|2|||
16220402|NCT01970540|39286342|FG002|Overall Study|Adverse Event|1|||
16220403|NCT01970540|39286340|FG000|Overall Study|Treatment-related AE|4|||
16220404|NCT01970540|39286341|FG001|Overall Study|Treatment-related AE|0|||
16220405|NCT01970540|39286342|FG002|Overall Study|Treatment-related AE|2|||
16220406|NCT01970540|39286340|FG000|Overall Study|Withdrawal by Subject|4|||
16220407|NCT01970540|39286341|FG001|Overall Study|Withdrawal by Subject|0|||
16220408|NCT01970540|39286342|FG002|Overall Study|Withdrawal by Subject|1|||
16220409|NCT01970540|39286340|FG000|Overall Study|Clinical deterioration|1|||
16220410|NCT01970540|39286341|FG001|Overall Study|Clinical deterioration|0|||
16220411|NCT01970540|39286342|FG002|Overall Study|Clinical deterioration|0|||
16220412|NCT00850135|39286343|FG000|Overall Study|Physician Decision|1|||
16220413|NCT00934791|39286344|FG000|Overall Study|Withdrawal by Subject|1|||
16220414|NCT00934791|39286345|FG001|Overall Study|Withdrawal by Subject|0|||
16220415|NCT02067104|39286348|FG000|Overall Study|Study termination due to low accrual|4|||
16220416|NCT02067104|39286349|FG001|Overall Study|Study termination due to low accrual|5|||
16220417|NCT05643170|39286350|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
16543004|NCT01376323|40450391|FG002|Overall Study|Adverse Event|0|||
16543005|NCT01376323|40450392|FG003|Overall Study|Adverse Event|2|||
16543006|NCT01376323|40450393|FG004|Overall Study|Adverse Event|0|||
16543007|NCT01376323|40450389|FG000|Overall Study|Lost to Follow-up|0|||
16543008|NCT01376323|40450390|FG001|Overall Study|Lost to Follow-up|0|||
16543009|NCT01376323|40450391|FG002|Overall Study|Lost to Follow-up|0|||
16543010|NCT01376323|40450392|FG003|Overall Study|Lost to Follow-up|2|||
16543011|NCT01376323|40450393|FG004|Overall Study|Lost to Follow-up|0|||
16543012|NCT01376323|40450389|FG000|Overall Study|Physician Decision|1|||
16543013|NCT01376323|40450390|FG001|Overall Study|Physician Decision|0|||
16543014|NCT01376323|40450391|FG002|Overall Study|Physician Decision|2|||
16543015|NCT01376323|40450392|FG003|Overall Study|Physician Decision|1|||
16342509|NCT01990768|39740949|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
16342510|NCT01990768|39740947|FG000|Intervention Started|Patient care priority|1|||
16342511|NCT01990768|39740948|FG001|Intervention Started|Patient care priority|2|||
16342512|NCT01990768|39740949|FG002|Intervention Started|Patient care priority|3|||
16342513|NCT01990768|39740947|FG000|Intervention Started|IV lost|2|||
16342514|NCT01990768|39740948|FG001|Intervention Started|IV lost|2|||
16342515|NCT01990768|39740949|FG002|Intervention Started|IV lost|2|||
16342516|NCT01990768|39740947|FG000|Intervention Started|Required CPR|1|||
16342517|NCT01990768|39740948|FG001|Intervention Started|Required CPR|1|||
16342518|NCT01990768|39740949|FG002|Intervention Started|Required CPR|0|||
16342519|NCT01990768|39740947|FG000|Intervention Started|Seizure or hx of seizure|0|||
16342520|NCT01990768|39740948|FG001|Intervention Started|Seizure or hx of seizure|0|||
16342521|NCT01990768|39740949|FG002|Intervention Started|Seizure or hx of seizure|2|||
16342522|NCT01990768|39740947|FG000|Intervention Started|Discovered to be pregnant|0|||
16342523|NCT01990768|39740948|FG001|Intervention Started|Discovered to be pregnant|1|||
16407189|NCT00977938|39970078|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
16407190|NCT00977938|39970075|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
16407191|NCT00977938|39970076|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
16407192|NCT00977938|39970077|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
16407193|NCT00977938|39970078|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
16407194|NCT00977938|39970075|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
16407195|NCT00977938|39970076|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
16407196|NCT00977938|39970077|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
16407197|NCT00977938|39970078|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
16543016|NCT01376323|40450393|FG004|Overall Study|Physician Decision|1|||
16543017|NCT01376323|40450389|FG000|Overall Study|Withdrawal by Subject|0|||
16109061|NCT01006616|38888994|FG000|Period 2 (18 Months)|Adverse Event|6|||
16109062|NCT01006616|38888995|FG001|Period 2 (18 Months)|Adverse Event|6|||
16109063|NCT01006616|38888996|FG002|Period 2 (18 Months)|Adverse Event|6|||
16109064|NCT01006616|38888997|FG003|Period 2 (18 Months)|Adverse Event|4|||
16109065|NCT01006616|38888994|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
16543018|NCT01376323|40450390|FG001|Overall Study|Withdrawal by Subject|1|||
16543019|NCT01376323|40450391|FG002|Overall Study|Withdrawal by Subject|1|||
16109066|NCT01006616|38888995|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
16543020|NCT01376323|40450392|FG003|Overall Study|Withdrawal by Subject|0|||
16543021|NCT01376323|40450393|FG004|Overall Study|Withdrawal by Subject|0|||
16543022|NCT02901626|40450400|FG000|Overall Study|Lost to Follow-up|1|||
16543023|NCT02901626|40450401|FG001|Overall Study|Lost to Follow-up|1|||
16543024|NCT00790452|40450402|FG000|Overall Study|Drug supply issue|1|||
16220418|NCT05643170|39286350|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
16342524|NCT01990768|39740949|FG002|Intervention Started|Discovered to be pregnant|0|||
16342525|NCT01990768|39740947|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
16342526|NCT01990768|39740948|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
16109067|NCT01006616|38888996|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
16109068|NCT01006616|38888997|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
16109069|NCT01006616|38888994|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
16109070|NCT01006616|38888995|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
16109071|NCT01006616|38888996|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
16109072|NCT01006616|38888997|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
16543025|NCT00790452|40450403|FG001|Overall Study|Drug supply issue|0|||
16543026|NCT02052310|40450404|FG000|Overall Study|Death|64|||
16220419|NCT00462488|39286361|FG000|Overall Study|Protocol Violation|1|||
16220420|NCT00462488|39286362|FG001|Overall Study|Protocol Violation|0|||
16220421|NCT00462488|39286361|FG000|Overall Study|Lack of Efficacy|19|||
16220422|NCT00462488|39286362|FG001|Overall Study|Lack of Efficacy|17|||
16220423|NCT00750867|39286363|FG000|Overall Study|Adverse Event|2|||
16220424|NCT01947127|39286364|FG000|Overall Study|Protocol Violation|18|||
16220425|NCT01947127|39286365|FG001|Overall Study|Protocol Violation|38|||
16220426|NCT01947127|39286364|FG000|Overall Study|Withdrawal by Subject|1|||
16220427|NCT01947127|39286365|FG001|Overall Study|Withdrawal by Subject|1|||
16220428|NCT01947127|39286364|FG000|Overall Study|Data loss|4|||
16220429|NCT01947127|39286365|FG001|Overall Study|Data loss|4|||
16220430|NCT01284127|39286372|FG000|Overall Study|Adverse Event|2|||
16220431|NCT01284127|39286372|FG000|Overall Study|Withdrawal by Subject|4|||
16220432|NCT01284127|39286372|FG000|Overall Study|Physician Decision|1|||
16220433|NCT01362062|39286373|FG000|Overall Study|Adverse Event|1|||
16220434|NCT01362062|39286374|FG001|Overall Study|Adverse Event|0|||
16220435|NCT01362062|39286373|FG000|Overall Study|Lost to Follow-up|11|||
16342527|NCT01990768|39740949|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
16342528|NCT01990768|39740947|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
16342529|NCT01990768|39740948|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
16342530|NCT01990768|39740949|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
16342531|NCT01990768|39740947|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
16342532|NCT01990768|39740948|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
16342533|NCT01990768|39740949|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
16342534|NCT01990768|39740947|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
16342535|NCT01990768|39740948|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
16342536|NCT01990768|39740949|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
16543027|NCT02052310|40450405|FG001|Overall Study|Death|54|||
16543028|NCT02052310|40450404|FG000|Overall Study|Withdrawal by Subject|37|||
16543029|NCT02052310|40450405|FG001|Overall Study|Withdrawal by Subject|49|||
16543030|NCT02052310|40450404|FG000|Overall Study|Other than specified|32|||
16543031|NCT02052310|40450405|FG001|Overall Study|Other than specified|29|||
16543032|NCT02052310|40450404|FG000|Overall Study|Adverse Event|29|||
16543033|NCT02052310|40450405|FG001|Overall Study|Adverse Event|22|||
16543034|NCT02052310|40450404|FG000|Overall Study|Kidney Transplant|23|||
16342537|NCT01990768|39740947|FG000|Prehospital Study Drug Infusion|Death|3|||
16342538|NCT01990768|39740948|FG001|Prehospital Study Drug Infusion|Death|1|||
16543035|NCT02052310|40450405|FG001|Overall Study|Kidney Transplant|29|||
16543036|NCT02052310|40450404|FG000|Overall Study|Physician Decision|14|||
16543037|NCT02052310|40450405|FG001|Overall Study|Physician Decision|7|||
16543038|NCT02052310|40450404|FG000|Overall Study|Lack of Efficacy|6|||
16543039|NCT02052310|40450405|FG001|Overall Study|Lack of Efficacy|1|||
16543040|NCT02052310|40450404|FG000|Overall Study|Site Terminated by Sponsor|5|||
16543041|NCT02052310|40450405|FG001|Overall Study|Site Terminated by Sponsor|13|||
16543042|NCT02052310|40450404|FG000|Overall Study|Lost to Follow-up|4|||
16543043|NCT02052310|40450405|FG001|Overall Study|Lost to Follow-up|2|||
16543044|NCT02052310|40450404|FG000|Overall Study|Protocol Violation|1|||
16543045|NCT02052310|40450405|FG001|Overall Study|Protocol Violation|6|||
16543046|NCT02157779|40450406|FG000|Overall Study|Logistical|9|||
16543047|NCT02157779|40450407|FG001|Overall Study|Logistical|3|||
16543048|NCT02157779|40450406|FG000|Overall Study|Stopped attending, reason unknown|11|||
16543049|NCT02157779|40450407|FG001|Overall Study|Stopped attending, reason unknown|7|||
16543050|NCT02157779|40450406|FG000|Overall Study|No response to outreach after Baseline|1|||
16543051|NCT02157779|40450407|FG001|Overall Study|No response to outreach after Baseline|1|||
16543052|NCT02157779|40450406|FG000|Overall Study|Moved|1|||
16220436|NCT01362062|39286374|FG001|Overall Study|Lost to Follow-up|0|||
16342539|NCT01990768|39740949|FG002|Prehospital Study Drug Infusion|Death|1|||
16342540|NCT01990768|39740947|FG000|Prehospital Study Drug Infusion|Discharged|2|||
16109073|NCT01006616|38888994|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
16109074|NCT01006616|38888995|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
16220437|NCT01362062|39286373|FG000|Overall Study|Withdrawal by Subject|2|||
16220438|NCT01362062|39286374|FG001|Overall Study|Withdrawal by Subject|0|||
16342541|NCT01990768|39740948|FG001|Prehospital Study Drug Infusion|Discharged|1|||
16543053|NCT02157779|40450407|FG001|Overall Study|Moved|0|||
16543054|NCT02157779|40450406|FG000|Overall Study|Medical|1|||
16342542|NCT01990768|39740949|FG002|Prehospital Study Drug Infusion|Discharged|0|||
16543055|NCT02157779|40450407|FG001|Overall Study|Medical|0|||
16543056|NCT02157779|40450406|FG000|Overall Study|Legal issue|1|||
16543057|NCT02157779|40450407|FG001|Overall Study|Legal issue|0|||
16543058|NCT00459342|40450408|FG000|Overall Study|Not eligible|1|||
16342543|NCT01990768|39740947|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
16342544|NCT01990768|39740948|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
16543059|NCT01373931|40450409|FG000|Lead-in Period|Adverse Event|2|||
16342545|NCT01990768|39740949|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
16342546|NCT01990768|39740947|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
16342547|NCT01990768|39740948|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
16342548|NCT01990768|39740949|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
16342549|NCT01990768|39740947|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
16342550|NCT01990768|39740948|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
16342551|NCT01990768|39740949|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
16342552|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
16342553|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
16342554|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
16342555|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
16342556|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
16342557|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
16342558|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
16342559|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
16342560|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
16342561|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
16342562|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
16342563|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
16342564|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
16342565|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
16342566|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
16342567|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
16342568|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
16342569|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
16342570|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
16342571|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
16342572|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
16342573|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
16342574|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
16342575|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
16342576|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
16342577|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
16342578|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
16342579|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
16543060|NCT01373931|40450410|FG001|Lead-in Period|Adverse Event|0|||
16543061|NCT01373931|40450409|FG000|Period 1|Adverse Event|2|||
16543062|NCT01373931|40450410|FG001|Period 1|Adverse Event|0|||
16543063|NCT01373931|40450409|FG000|Period 1|Withdrawal by Subject|0|||
16543064|NCT01373931|40450410|FG001|Period 1|Withdrawal by Subject|2|||
16543065|NCT00331344|40450411|FG000|Phase I|Adverse Event|0|||
16543066|NCT00331344|40450412|FG001|Phase I|Adverse Event|0|||
16543067|NCT00331344|40450413|FG002|Phase I|Adverse Event|0|||
16543068|NCT00331344|40450414|FG003|Phase I|Adverse Event|1|||
16543069|NCT00331344|40450415|FG004|Phase I|Adverse Event|2|||
16543070|NCT00331344|40450416|FG005|Phase I|Adverse Event|2|||
16543071|NCT00331344|40450417|FG006|Phase I|Adverse Event|0|||
16543072|NCT00331344|40450418|FG007|Phase I|Adverse Event|1|||
16543073|NCT00331344|40450419|FG008|Phase I|Adverse Event|0|||
16543074|NCT00331344|40450411|FG000|Phase II|Death|0|||
16543075|NCT00331344|40450412|FG001|Phase II|Death|0|||
16543076|NCT00331344|40450413|FG002|Phase II|Death|0|||
16543077|NCT00331344|40450414|FG003|Phase II|Death|0|||
16543078|NCT00331344|40450415|FG004|Phase II|Death|0|||
16543079|NCT00331344|40450416|FG005|Phase II|Death|0|||
16543080|NCT00331344|40450417|FG006|Phase II|Death|0|||
16543081|NCT00331344|40450418|FG007|Phase II|Death|0|||
16543082|NCT00331344|40450419|FG008|Phase II|Death|4|||
16543083|NCT00464815|40450425|FG000|Overall Study|Withdrawal by Subject|6|||
16543084|NCT00464815|40450426|FG001|Overall Study|Withdrawal by Subject|3|||
16543085|NCT04349280|40450427|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
16543086|NCT04349280|40450428|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
16543087|NCT04349280|40450427|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
16543088|NCT04349280|40450428|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
16543089|NCT04349280|40450427|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
16543090|NCT04349280|40450428|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
16543091|NCT01059643|40450429|FG000|Overall Study|Adverse Event|3|||
16109075|NCT01006616|38888996|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
16109076|NCT01006616|38888997|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
16109077|NCT01006616|38888994|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
16109078|NCT01006616|38888995|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
16109079|NCT01006616|38888996|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
16109080|NCT01006616|38888997|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
16109081|NCT01006616|38888994|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
16109082|NCT01006616|38888995|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
16109083|NCT01006616|38888996|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
16109084|NCT01006616|38888997|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
16109085|NCT01006616|38888994|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
16109086|NCT01006616|38888995|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
16220439|NCT01362062|39286373|FG000|Overall Study|Non-compliant participant|2|||
16220440|NCT01362062|39286374|FG001|Overall Study|Non-compliant participant|0|||
16220441|NCT01362062|39286373|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
16543092|NCT01059643|40450429|FG000|Overall Study|Withdrawal by Subject|2|||
16543093|NCT01059643|40450429|FG000|Overall Study|Physician Decision|1|||
16543094|NCT02441686|40450434|FG000|Induction|Adverse Event|4|||
16543095|NCT02441686|40450434|FG000|Induction|Complicating disease|1|||
16543096|NCT02441686|40450434|FG000|Induction|Physician Decision|1|||
16543097|NCT02441686|40450434|FG000|Induction|Withdrawal by Subject|1|||
16220442|NCT01362062|39286374|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
16220443|NCT01362062|39286373|FG000|Overall Study|Had significant improvement|9|||
16220444|NCT01362062|39286374|FG001|Overall Study|Had significant improvement|0|||
16220445|NCT02129192|39286375|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
16220446|NCT02129192|39286376|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
16220447|NCT00312728|39286377|FG000|Overall Study|Progressive disease|53|||
16220448|NCT00312728|39286377|FG000|Overall Study|Adverse Event|32|||
16220449|NCT00312728|39286377|FG000|Overall Study|Withdrawal by Subject|10|||
16109087|NCT01006616|38888996|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
16109088|NCT01006616|38888997|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
16109089|NCT01006616|38888994|FG000|Period 2 (18 Months)|Study Terminated|63|||
16109090|NCT01006616|38888995|FG001|Period 2 (18 Months)|Study Terminated|46|||
16109091|NCT01006616|38888996|FG002|Period 2 (18 Months)|Study Terminated|44|||
16109092|NCT01006616|38888997|FG003|Period 2 (18 Months)|Study Terminated|70|||
16109093|NCT03635086|38888998|FG000|Overall Study|Withdrawal of consent|0|||
16109094|NCT03635086|38888999|FG001|Overall Study|Withdrawal of consent|0|||
16109095|NCT03635086|38889000|FG002|Overall Study|Withdrawal of consent|1|||
16109096|NCT03635086|38889001|FG003|Overall Study|Withdrawal of consent|0|||
16109097|NCT03635086|38889002|FG004|Overall Study|Withdrawal of consent|0|||
16109098|NCT03635086|38888998|FG000|Overall Study|Adverse Event|0|||
16109099|NCT03635086|38888999|FG001|Overall Study|Adverse Event|1|||
16109100|NCT03635086|38889000|FG002|Overall Study|Adverse Event|0|||
16109101|NCT03635086|38889001|FG003|Overall Study|Adverse Event|0|||
16109102|NCT03635086|38889002|FG004|Overall Study|Adverse Event|0|||
16543098|NCT02441686|40450434|FG000|Induction|Did not receive treatment|1|||
16543099|NCT02441686|40450434|FG000|Maintenance|Remaining on Treatment|23|||
16543100|NCT02441686|40450434|FG000|Maintenance|Physician Decision|1|||
16543101|NCT02441686|40450434|FG000|Maintenance|Adverse Event|3|||
16543102|NCT02441686|40450434|FG000|Maintenance|Progressive Disease|10|||
16543103|NCT02441686|40450434|FG000|Maintenance|Withdrawal by Subject|1|||
16543104|NCT02119260|40450435|FG000|Overall Study|Adverse Event|1|||
16543105|NCT02119260|40450436|FG001|Overall Study|Adverse Event|0|||
16543106|NCT02119260|40450437|FG002|Overall Study|Adverse Event|0|||
16543107|NCT02119260|40450438|FG003|Overall Study|Adverse Event|0|||
16543108|NCT02119260|40450439|FG004|Overall Study|Adverse Event|0|||
16543109|NCT02119260|40450440|FG005|Overall Study|Adverse Event|0|||
16109103|NCT03635086|38888998|FG000|Overall Study|Lost to Follow-up|1|||
16109104|NCT03635086|38888999|FG001|Overall Study|Lost to Follow-up|0|||
16109105|NCT03635086|38889000|FG002|Overall Study|Lost to Follow-up|0|||
16109106|NCT03635086|38889001|FG003|Overall Study|Lost to Follow-up|0|||
16109107|NCT03635086|38889002|FG004|Overall Study|Lost to Follow-up|0|||
16109108|NCT01983462|38889003|FG000|Overall Study|Adverse Event|1|||
16109109|NCT01983462|38889004|FG001|Overall Study|Adverse Event|0|||
16109110|NCT01983462|38889005|FG002|Overall Study|Adverse Event|0|||
16109111|NCT04009629|38889008|FG000|Overall Study|Withdrawal by Subject|2|||
16109112|NCT04009629|38889009|FG001|Overall Study|Withdrawal by Subject|0|||
16543110|NCT02119260|40450441|FG006|Overall Study|Adverse Event|0|||
16543111|NCT02119260|40450435|FG000|Overall Study|Withdrew consent|0|||
16109113|NCT00365547|38889010|FG000|Overall Study|Insurance did not cover Avastin|1|||
16109114|NCT00365547|38889010|FG000|Overall Study|Screen failure|1|||
16109115|NCT00365547|38889010|FG000|Overall Study|Withdrawal by Subject|1|||
16109116|NCT01099579|38889011|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
16109117|NCT01099579|38889012|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
16109118|NCT01099579|38889013|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
16109119|NCT01099579|38889011|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
16109120|NCT01099579|38889012|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
16109121|NCT01099579|38889013|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
16109122|NCT01099579|38889011|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
16109123|NCT01099579|38889012|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
16109124|NCT01099579|38889013|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
16109125|NCT01099579|38889011|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
16109126|NCT01099579|38889012|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
16109127|NCT01099579|38889013|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
16109128|NCT01099579|38889011|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
16109129|NCT01099579|38889012|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
16109130|NCT01099579|38889013|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
16109131|NCT01099579|38889011|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
16109132|NCT01099579|38889012|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
16109133|NCT01099579|38889013|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
16109134|NCT01099579|38889011|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
16109135|NCT01099579|38889012|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
16109136|NCT01099579|38889013|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
16109137|NCT01099579|38889011|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
16109138|NCT01099579|38889012|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
16109139|NCT01099579|38889013|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
16109140|NCT01099579|38889011|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
16109141|NCT01099579|38889012|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
16342580|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
16342581|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
16342582|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
16342583|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
16342584|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
16342585|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
16342586|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
16342587|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
16342588|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
16342589|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
16342590|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
16342591|NCT01990768|39740947|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
16342592|NCT01990768|39740948|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
16342593|NCT01990768|39740949|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
16342594|NCT01990768|39740947|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
16342595|NCT01990768|39740948|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
16342596|NCT01990768|39740949|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
16342597|NCT01990768|39740947|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
16342598|NCT01990768|39740948|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
16342599|NCT01990768|39740949|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
16342600|NCT01990768|39740947|FG000|6-Month Follow-up|No contact information|5|||
16342601|NCT01990768|39740948|FG001|6-Month Follow-up|No contact information|6|||
16342602|NCT01990768|39740949|FG002|6-Month Follow-up|No contact information|5|||
16342603|NCT01990768|39740947|FG000|6-Month Follow-up|Homeless|4|||
16342604|NCT01990768|39740948|FG001|6-Month Follow-up|Homeless|3|||
16342605|NCT01990768|39740949|FG002|6-Month Follow-up|Homeless|6|||
16342606|NCT01990768|39740947|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
16342607|NCT01990768|39740948|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
16342608|NCT01990768|39740949|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
16342609|NCT01990768|39740947|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
16342610|NCT01990768|39740948|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
16342611|NCT01990768|39740949|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
16342612|NCT01990768|39740947|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
16342613|NCT01990768|39740948|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
16109142|NCT01099579|38889013|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
16109143|NCT01099579|38889011|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
16109144|NCT01099579|38889012|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
16342614|NCT01990768|39740949|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
16342615|NCT03337048|39740953|FG000|Overall Study|Withdrawal by Subject|2|||
16342616|NCT03337048|39740954|FG001|Overall Study|Withdrawal by Subject|0|||
16109145|NCT01099579|38889013|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
16109146|NCT02447718|38889014|FG000|Overall Study|Lost to Follow-up|8|||
16109147|NCT02447718|38889015|FG001|Overall Study|Lost to Follow-up|0|||
16109148|NCT02447718|38889014|FG000|Overall Study|Withdrawal by Subject|3|||
16109149|NCT02447718|38889015|FG001|Overall Study|Withdrawal by Subject|0|||
16109150|NCT02447718|38889014|FG000|Overall Study|Screen Failure|1|||
16109151|NCT02447718|38889015|FG001|Overall Study|Screen Failure|0|||
16109152|NCT01093599|38889018|FG000|Overall Study|Lost to Follow-up|32|||
16109153|NCT01093599|38889019|FG001|Overall Study|Lost to Follow-up|46|||
16109154|NCT02250534|38889020|FG000|Overall Study|Lost to Follow-up|18|||
16109155|NCT02250534|38889021|FG001|Overall Study|Lost to Follow-up|28|||
16109156|NCT02250534|38889022|FG002|Overall Study|Lost to Follow-up|33|||
16109157|NCT02250534|38889020|FG000|Overall Study|Personal reasons|7|||
16109158|NCT02250534|38889021|FG001|Overall Study|Personal reasons|8|||
16109159|NCT02250534|38889022|FG002|Overall Study|Personal reasons|14|||
16109160|NCT02250534|38889020|FG000|Overall Study|Adverse Event|6|||
16109161|NCT02250534|38889021|FG001|Overall Study|Adverse Event|3|||
16109162|NCT02250534|38889022|FG002|Overall Study|Adverse Event|8|||
16109163|NCT02250534|38889020|FG000|Overall Study|incarcerated|2|||
16109164|NCT02250534|38889021|FG001|Overall Study|incarcerated|1|||
16109165|NCT02250534|38889022|FG002|Overall Study|incarcerated|2|||
16109166|NCT02250534|38889020|FG000|Overall Study|Withdrawal by Subject|0|||
16109167|NCT02250534|38889021|FG001|Overall Study|Withdrawal by Subject|1|||
16109168|NCT02250534|38889022|FG002|Overall Study|Withdrawal by Subject|2|||
16109169|NCT02250534|38889020|FG000|Overall Study|Death|0|||
16109170|NCT02250534|38889021|FG001|Overall Study|Death|1|||
16109171|NCT02250534|38889022|FG002|Overall Study|Death|1|||
16109172|NCT02250534|38889020|FG000|Overall Study|Physician Decision|1|||
16109173|NCT02250534|38889021|FG001|Overall Study|Physician Decision|3|||
16109174|NCT02250534|38889022|FG002|Overall Study|Physician Decision|1|||
16109175|NCT02250534|38889020|FG000|Overall Study|Protocol Violation|1|||
16109176|NCT02250534|38889021|FG001|Overall Study|Protocol Violation|0|||
16109177|NCT02250534|38889022|FG002|Overall Study|Protocol Violation|1|||
16109178|NCT02250534|38889020|FG000|Overall Study|Reason unknown|1|||
16109179|NCT02250534|38889021|FG001|Overall Study|Reason unknown|0|||
16109180|NCT02250534|38889022|FG002|Overall Study|Reason unknown|0|||
16109181|NCT00684203|38889023|FG000|Overall Study|Adverse Event|6|||
16109182|NCT00684203|38889024|FG001|Overall Study|Adverse Event|4|||
16109183|NCT00684203|38889025|FG002|Overall Study|Adverse Event|8|||
16109184|NCT00684203|38889026|FG003|Overall Study|Adverse Event|0|||
16109185|NCT00684203|38889027|FG004|Overall Study|Adverse Event|0|||
16109186|NCT00684203|38889028|FG005|Overall Study|Adverse Event|0|||
16109187|NCT00684203|38889023|FG000|Overall Study|Protocol-defined clinical event|3|||
16109188|NCT00684203|38889024|FG001|Overall Study|Protocol-defined clinical event|1|||
16109189|NCT00684203|38889025|FG002|Overall Study|Protocol-defined clinical event|0|||
16109190|NCT00684203|38889026|FG003|Overall Study|Protocol-defined clinical event|0|||
16109191|NCT00684203|38889027|FG004|Overall Study|Protocol-defined clinical event|0|||
16109192|NCT00684203|38889028|FG005|Overall Study|Protocol-defined clinical event|0|||
16109193|NCT00684203|38889023|FG000|Overall Study|Withdrawal by Subject|0|||
16109194|NCT00684203|38889024|FG001|Overall Study|Withdrawal by Subject|2|||
16109195|NCT00684203|38889025|FG002|Overall Study|Withdrawal by Subject|1|||
16109196|NCT00684203|38889026|FG003|Overall Study|Withdrawal by Subject|0|||
16109197|NCT00684203|38889027|FG004|Overall Study|Withdrawal by Subject|0|||
16109198|NCT00684203|38889028|FG005|Overall Study|Withdrawal by Subject|0|||
16342617|NCT03337048|39740955|FG002|Overall Study|Withdrawal by Subject|0|||
16342618|NCT00435461|39740960|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
16342619|NCT00435461|39740961|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
16342620|NCT00435461|39740962|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
16342621|NCT00435461|39740960|FG000|Overall Study|Protocol Violation|6|||
16342622|NCT00435461|39740961|FG001|Overall Study|Protocol Violation|9|||
16342623|NCT00435461|39740962|FG002|Overall Study|Protocol Violation|10|||
16342624|NCT00435461|39740960|FG000|Overall Study|Participant randomized(inadequate score)|1|||
16342625|NCT00435461|39740961|FG001|Overall Study|Participant randomized(inadequate score)|0|||
16342626|NCT00435461|39740962|FG002|Overall Study|Participant randomized(inadequate score)|0|||
16342627|NCT00435461|39740960|FG000|Overall Study|Compliance less than 80 percent|1|||
16342628|NCT00435461|39740961|FG001|Overall Study|Compliance less than 80 percent|0|||
16109199|NCT00684203|38889023|FG000|Overall Study|Did not meet protocol eligibility|0|||
16109200|NCT00684203|38889024|FG001|Overall Study|Did not meet protocol eligibility|1|||
16109201|NCT00684203|38889025|FG002|Overall Study|Did not meet protocol eligibility|0|||
16109202|NCT00684203|38889026|FG003|Overall Study|Did not meet protocol eligibility|0|||
16109203|NCT00684203|38889027|FG004|Overall Study|Did not meet protocol eligibility|0|||
16109204|NCT00684203|38889028|FG005|Overall Study|Did not meet protocol eligibility|0|||
16109205|NCT00329550|38889029|FG000|Overall Study|Adverse Event|3|||
16109206|NCT00329550|38889030|FG001|Overall Study|Adverse Event|4|||
16109207|NCT00329550|38889031|FG002|Overall Study|Adverse Event|2|||
16342629|NCT00435461|39740962|FG002|Overall Study|Compliance less than 80 percent|0|||
16543112|NCT02119260|40450436|FG001|Overall Study|Withdrew consent|1|||
16342630|NCT00435461|39740960|FG000|Overall Study|In error, two study medications switched|1|||
16342631|NCT00435461|39740961|FG001|Overall Study|In error, two study medications switched|0|||
16109208|NCT00329550|38889029|FG000|Overall Study|Withdrawal of Consent|1|||
16109209|NCT00329550|38889030|FG001|Overall Study|Withdrawal of Consent|0|||
16109210|NCT00329550|38889031|FG002|Overall Study|Withdrawal of Consent|1|||
16109211|NCT00329550|38889029|FG000|Overall Study|Due to Relocation|0|||
16109212|NCT00329550|38889030|FG001|Overall Study|Due to Relocation|0|||
16109213|NCT00329550|38889031|FG002|Overall Study|Due to Relocation|1|||
16109214|NCT02561247|38889032|FG000|Overall Study|Protocol Violation|1|||
16109215|NCT02561247|38889032|FG000|Overall Study|Withdrawal by Subject|1|||
16109216|NCT02561247|38889032|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
16109217|NCT00755417|38889033|FG000|Overall Study|Adverse Event|28|||
16109218|NCT00755417|38889034|FG001|Overall Study|Adverse Event|20|||
16342632|NCT00435461|39740962|FG002|Overall Study|In error, two study medications switched|0|||
16342633|NCT00435461|39740960|FG000|Overall Study|Lack of Efficacy|2|||
16342634|NCT00435461|39740961|FG001|Overall Study|Lack of Efficacy|1|||
16342635|NCT00435461|39740962|FG002|Overall Study|Lack of Efficacy|0|||
16342636|NCT00435461|39740960|FG000|Overall Study|Withdrawal by Subject|1|||
16342637|NCT00435461|39740961|FG001|Overall Study|Withdrawal by Subject|0|||
16342638|NCT00435461|39740962|FG002|Overall Study|Withdrawal by Subject|2|||
16342639|NCT00435461|39740960|FG000|Overall Study|Randomized in error|1|||
16342640|NCT00435461|39740961|FG001|Overall Study|Randomized in error|0|||
16342641|NCT00435461|39740962|FG002|Overall Study|Randomized in error|0|||
16342642|NCT00435461|39740960|FG000|Overall Study|Participant could not tolerate symptoms|0|||
16342643|NCT00435461|39740961|FG001|Overall Study|Participant could not tolerate symptoms|0|||
16342644|NCT00435461|39740962|FG002|Overall Study|Participant could not tolerate symptoms|1|||
16109219|NCT00755417|38889035|FG002|Overall Study|Adverse Event|7|||
16109220|NCT00755417|38889033|FG000|Overall Study|Lack of Efficacy|8|||
16109221|NCT00755417|38889034|FG001|Overall Study|Lack of Efficacy|4|||
16342645|NCT00435461|39740960|FG000|Overall Study|Participant could not swallow capsule|0|||
16109222|NCT00755417|38889035|FG002|Overall Study|Lack of Efficacy|9|||
16109223|NCT00755417|38889033|FG000|Overall Study|Protocol Violation|2|||
16342646|NCT00435461|39740961|FG001|Overall Study|Participant could not swallow capsule|0|||
16342647|NCT00435461|39740962|FG002|Overall Study|Participant could not swallow capsule|1|||
16342648|NCT00435461|39740960|FG000|Overall Study|Pregnancy|2|||
16342649|NCT00435461|39740961|FG001|Overall Study|Pregnancy|0|||
16342650|NCT00435461|39740962|FG002|Overall Study|Pregnancy|0|||
16342651|NCT00435461|39740960|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
16109224|NCT00755417|38889034|FG001|Overall Study|Protocol Violation|1|||
16109225|NCT00755417|38889035|FG002|Overall Study|Protocol Violation|1|||
16342652|NCT00435461|39740961|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
16342653|NCT00435461|39740962|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
16342654|NCT00435461|39740960|FG000|Overall Study|Participant ended study one day early|1|||
16342655|NCT00435461|39740961|FG001|Overall Study|Participant ended study one day early|0|||
16342656|NCT00435461|39740962|FG002|Overall Study|Participant ended study one day early|0|||
16342657|NCT00435461|39740960|FG000|Overall Study|Noncompliance with study requirements|1|||
16342658|NCT00435461|39740961|FG001|Overall Study|Noncompliance with study requirements|1|||
16342659|NCT00435461|39740962|FG002|Overall Study|Noncompliance with study requirements|1|||
16342660|NCT00435461|39740960|FG000|Overall Study|Adverse Event|1|||
16342661|NCT00435461|39740961|FG001|Overall Study|Adverse Event|2|||
16342662|NCT00435461|39740962|FG002|Overall Study|Adverse Event|6|||
16342663|NCT00435461|39740960|FG000|Overall Study|Non-Compliance of diary|2|||
16342664|NCT00435461|39740961|FG001|Overall Study|Non-Compliance of diary|0|||
16342665|NCT00435461|39740962|FG002|Overall Study|Non-Compliance of diary|1|||
16342666|NCT00435461|39740960|FG000|Overall Study|Lost to Follow-up|1|||
16342667|NCT00435461|39740961|FG001|Overall Study|Lost to Follow-up|1|||
16342668|NCT00435461|39740962|FG002|Overall Study|Lost to Follow-up|2|||
16342669|NCT04727528|39740966|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
16342670|NCT04727528|39740967|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
16342671|NCT04727528|39740966|FG000|Open-label Period|Randomized who did not receive treatment|1|||
16342672|NCT04727528|39740967|FG001|Open-label Period|Randomized who did not receive treatment|0|||
16342673|NCT04727528|39740966|FG000|Double-blind Treatment Phase|Adverse Event|0|||
16342674|NCT04727528|39740967|FG001|Double-blind Treatment Phase|Adverse Event|1|||
16342675|NCT04727528|39740966|FG000|Double-blind Treatment Phase|Death|0|||
16342676|NCT04727528|39740967|FG001|Double-blind Treatment Phase|Death|1|||
16342677|NCT04727528|39740966|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
16342678|NCT04727528|39740967|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
16342679|NCT04727528|39740966|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
16342680|NCT04727528|39740967|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
16342681|NCT04727528|39740966|FG000|Double-blind Treatment Phase|Physician Decision|0|||
16342682|NCT04727528|39740967|FG001|Double-blind Treatment Phase|Physician Decision|1|||
16342683|NCT04727528|39740966|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
16342684|NCT04727528|39740967|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16342685|NCT04153565|39740968|FG000|Overall Study|Death|13|||
16342686|NCT00564278|39740972|FG000|Overall Study|Lost to Follow-up|35|||
16109226|NCT00755417|38889033|FG000|Overall Study|Lost to Follow-up|3|||
16109227|NCT00755417|38889034|FG001|Overall Study|Lost to Follow-up|0|||
16109228|NCT00755417|38889035|FG002|Overall Study|Lost to Follow-up|1|||
16109229|NCT00755417|38889033|FG000|Overall Study|Withdrawal by Subject|12|||
16342687|NCT00564278|39740973|FG001|Overall Study|Lost to Follow-up|33|||
16342688|NCT00564278|39740972|FG000|Overall Study|Physician Decision|1|||
16109230|NCT00755417|38889034|FG001|Overall Study|Withdrawal by Subject|12|||
16109231|NCT00755417|38889035|FG002|Overall Study|Withdrawal by Subject|12|||
16109232|NCT00755417|38889033|FG000|Overall Study|Not specified or missing data|9|||
16109233|NCT00755417|38889034|FG001|Overall Study|Not specified or missing data|18|||
16109234|NCT00755417|38889035|FG002|Overall Study|Not specified or missing data|12|||
16109235|NCT00368641|38889040|FG000|Overall Study|Adverse Event|2|||
16109236|NCT00368641|38889041|FG001|Overall Study|Adverse Event|1|||
16109237|NCT00368641|38889040|FG000|Overall Study|Death|1|||
16109238|NCT00368641|38889041|FG001|Overall Study|Death|0|||
16109239|NCT00368641|38889040|FG000|Overall Study|Withdrawal by Subject|1|||
16109240|NCT00368641|38889041|FG001|Overall Study|Withdrawal by Subject|0|||
16109241|NCT00368641|38889040|FG000|Overall Study|Sponsor decision to terminate study|2|||
16342689|NCT00564278|39740973|FG001|Overall Study|Physician Decision|2|||
16342690|NCT00564278|39740972|FG000|Overall Study|Withdrawal by Subject|11|||
16342691|NCT00564278|39740973|FG001|Overall Study|Withdrawal by Subject|7|||
16342692|NCT02469961|39740974|FG000|Overall Study|Physician Decision|4|||
16342693|NCT02469961|39740975|FG001|Overall Study|Physician Decision|1|||
16342694|NCT00765817|39740980|FG000|Overall Study|Adverse Event|13|||
16109242|NCT00368641|38889041|FG001|Overall Study|Sponsor decision to terminate study|5|||
16109243|NCT01728623|38889042|FG000|Overall Study|Disease progression|26|||
16220450|NCT00312728|39286377|FG000|Overall Study|Required non-protocol cancer treatment|2|||
16342695|NCT00765817|39740981|FG001|Overall Study|Adverse Event|1|||
16342696|NCT00765817|39740980|FG000|Overall Study|Death|0|||
16109244|NCT01728623|38889042|FG000|Overall Study|Adverse Event|1|||
16109245|NCT01728623|38889042|FG000|Overall Study|Withdrawal by Subject|1|||
16109246|NCT00494026|38889043|FG000|Overall Study|Sponsor Decision|4|||
16109247|NCT01845805|38889044|FG000|Overall Study|Withdrawal by Subject|1|||
16109248|NCT01845805|38889045|FG001|Overall Study|Withdrawal by Subject|2|||
16109249|NCT01845805|38889044|FG000|Overall Study|Disease Progression|13|||
16342697|NCT00765817|39740981|FG001|Overall Study|Death|1|||
16342698|NCT00765817|39740980|FG000|Overall Study|Entry criteria not met|2|||
16342699|NCT00765817|39740981|FG001|Overall Study|Entry criteria not met|2|||
16342700|NCT00765817|39740980|FG000|Overall Study|Loss of glucose control|0|||
16342701|NCT00765817|39740981|FG001|Overall Study|Loss of glucose control|2|||
16342702|NCT00765817|39740980|FG000|Overall Study|Lost to Follow-up|1|||
16342703|NCT00765817|39740981|FG001|Overall Study|Lost to Follow-up|3|||
16342704|NCT00765817|39740980|FG000|Overall Study|Physician Decision|2|||
16342705|NCT00765817|39740981|FG001|Overall Study|Physician Decision|1|||
16342706|NCT00765817|39740980|FG000|Overall Study|Protocol Violation|1|||
16342707|NCT00765817|39740981|FG001|Overall Study|Protocol Violation|1|||
16342708|NCT00765817|39740980|FG000|Overall Study|Subject decision|7|||
16109250|NCT01845805|38889045|FG001|Overall Study|Disease Progression|14|||
16109251|NCT01845805|38889044|FG000|Overall Study|Drug-related Toxicity|4|||
16109252|NCT01845805|38889045|FG001|Overall Study|Drug-related Toxicity|0|||
16342709|NCT00765817|39740981|FG001|Overall Study|Subject decision|11|||
16342710|NCT00376532|39740982|FG000|Overall Study|Lack sufficient blood sample|6|||
16342711|NCT00376532|39740983|FG001|Overall Study|Lack sufficient blood sample|6|||
16342712|NCT01153009|39740986|FG000|Overall Study|Adverse Event|4|||
16342713|NCT01153009|39740987|FG001|Overall Study|Adverse Event|14|||
16342714|NCT01153009|39740988|FG002|Overall Study|Adverse Event|14|||
16342715|NCT01153009|39740989|FG003|Overall Study|Adverse Event|10|||
16342716|NCT01153009|39740986|FG000|Overall Study|Lack of Efficacy|9|||
16342717|NCT01153009|39740987|FG001|Overall Study|Lack of Efficacy|0|||
16543113|NCT02119260|40450437|FG002|Overall Study|Withdrew consent|1|||
16109253|NCT00302159|38889046|FG000|Overall Study|pt declined before treatment started|1|||
16109254|NCT00302159|38889046|FG000|Overall Study|pt started Avastin|1|||
16109255|NCT00585975|38889047|FG000|Overall Study|Withdrawal by Subject|3|||
16109256|NCT00585975|38889048|FG001|Overall Study|Withdrawal by Subject|3|||
16220451|NCT00312728|39286377|FG000|Overall Study|Protocol Violation|2|||
16220452|NCT00312728|39286377|FG000|Overall Study|Other|10|||
16220453|NCT00312728|39286377|FG000|Overall Study|Other|1|||
16220454|NCT00157157|39286378|FG000|Overall Study|Withdrawal by Subject|6|||
16220455|NCT00157157|39286378|FG000|Overall Study|Physician Decision|1|||
16220456|NCT00157157|39286378|FG000|Overall Study|Lost to Follow-up|1|||
16220457|NCT00157157|39286378|FG000|Overall Study|Enrolled in another study|1|||
16220458|NCT00157157|39286378|FG000|Overall Study|Met exclusion criteria|1|||
16220459|NCT00157157|39286378|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
16220460|NCT03188991|39286379|FG000|Overall Study|Withdrawal by Subject|0|||
16220461|NCT03188991|39286380|FG001|Overall Study|Withdrawal by Subject|0|||
16220462|NCT03188991|39286381|FG002|Overall Study|Withdrawal by Subject|0|||
16220463|NCT03188991|39286382|FG003|Overall Study|Withdrawal by Subject|1|||
16220464|NCT01882439|39286389|FG000|Overall Study|Adverse event related to study drug|3|||
16220465|NCT01882439|39286390|FG001|Overall Study|Adverse event related to study drug|8|||
16220466|NCT01882439|39286391|FG002|Overall Study|Adverse event related to study drug|1|||
16220467|NCT01882439|39286392|FG003|Overall Study|Adverse event related to study drug|2|||
16220468|NCT01882439|39286389|FG000|Overall Study|Pregnancy|0|||
16543114|NCT02119260|40450438|FG003|Overall Study|Withdrew consent|0|||
16543115|NCT02119260|40450439|FG004|Overall Study|Withdrew consent|0|||
16543116|NCT02119260|40450440|FG005|Overall Study|Withdrew consent|0|||
16543117|NCT02119260|40450441|FG006|Overall Study|Withdrew consent|0|||
16543118|NCT04124926|40450442|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
16220469|NCT01882439|39286390|FG001|Overall Study|Pregnancy|1|||
16220470|NCT01882439|39286391|FG002|Overall Study|Pregnancy|0|||
16220471|NCT01882439|39286392|FG003|Overall Study|Pregnancy|0|||
16220472|NCT01882439|39286389|FG000|Overall Study|Protocol Violation|2|||
16220473|NCT01882439|39286390|FG001|Overall Study|Protocol Violation|2|||
16220474|NCT01882439|39286391|FG002|Overall Study|Protocol Violation|0|||
16220475|NCT01882439|39286392|FG003|Overall Study|Protocol Violation|1|||
16220476|NCT01882439|39286389|FG000|Overall Study|No longer willing to participate|1|||
16220477|NCT01882439|39286390|FG001|Overall Study|No longer willing to participate|4|||
16220478|NCT01882439|39286391|FG002|Overall Study|No longer willing to participate|2|||
16220479|NCT01882439|39286392|FG003|Overall Study|No longer willing to participate|3|||
16220480|NCT01882439|39286389|FG000|Overall Study|Medication error with no associated AE|0|||
16220481|NCT01882439|39286390|FG001|Overall Study|Medication error with no associated AE|0|||
16220482|NCT01882439|39286391|FG002|Overall Study|Medication error with no associated AE|2|||
16220483|NCT01882439|39286392|FG003|Overall Study|Medication error with no associated AE|0|||
16220484|NCT01882439|39286389|FG000|Overall Study|Insufficient clinical response|1|||
16220485|NCT01882439|39286390|FG001|Overall Study|Insufficient clinical response|4|||
16220486|NCT01882439|39286391|FG002|Overall Study|Insufficient clinical response|4|||
16220487|NCT01882439|39286392|FG003|Overall Study|Insufficient clinical response|2|||
16220488|NCT01882439|39286389|FG000|Overall Study|Adverse event unrelated to study drug|2|||
16543119|NCT04124926|40450443|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
16543120|NCT04124926|40450444|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
16543121|NCT04124926|40450445|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
16543122|NCT04124926|40450446|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
16543123|NCT04124926|40450442|FG000|Healing Phase|Protocol Violation|0|||
16543124|NCT04124926|40450443|FG001|Healing Phase|Protocol Violation|1|||
16543125|NCT04124926|40450444|FG002|Healing Phase|Protocol Violation|0|||
16543126|NCT04124926|40450445|FG003|Healing Phase|Protocol Violation|0|||
16543127|NCT04124926|40450446|FG004|Healing Phase|Protocol Violation|0|||
16543128|NCT04124926|40450442|FG000|Healing Phase|Lost to Follow-up|5|||
16543129|NCT04124926|40450443|FG001|Healing Phase|Lost to Follow-up|4|||
16543130|NCT04124926|40450444|FG002|Healing Phase|Lost to Follow-up|0|||
16543131|NCT04124926|40450445|FG003|Healing Phase|Lost to Follow-up|0|||
16220489|NCT01882439|39286390|FG001|Overall Study|Adverse event unrelated to study drug|2|||
16342718|NCT01153009|39740988|FG002|Overall Study|Lack of Efficacy|2|||
16342719|NCT01153009|39740989|FG003|Overall Study|Lack of Efficacy|1|||
16342720|NCT01153009|39740986|FG000|Overall Study|Noncompliance with Study Medication|1|||
16342721|NCT01153009|39740987|FG001|Overall Study|Noncompliance with Study Medication|3|||
16220490|NCT01882439|39286391|FG002|Overall Study|Adverse event unrelated to study drug|1|||
16220491|NCT01882439|39286392|FG003|Overall Study|Adverse event unrelated to study drug|1|||
16220492|NCT00362297|39286404|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
16220493|NCT00362297|39286405|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
16220494|NCT00779506|39286406|FG000|Overall Study|Screening Failed|2|||
16342722|NCT01153009|39740988|FG002|Overall Study|Noncompliance with Study Medication|4|||
16342723|NCT01153009|39740989|FG003|Overall Study|Noncompliance with Study Medication|1|||
16342724|NCT01153009|39740986|FG000|Overall Study|Protocol Deviations|4|||
16342725|NCT01153009|39740987|FG001|Overall Study|Protocol Deviations|3|||
16342726|NCT01153009|39740988|FG002|Overall Study|Protocol Deviations|3|||
16342727|NCT01153009|39740989|FG003|Overall Study|Protocol Deviations|2|||
16342728|NCT01153009|39740986|FG000|Overall Study|Withdrawal of Consent|5|||
16342729|NCT01153009|39740987|FG001|Overall Study|Withdrawal of Consent|5|||
16342730|NCT01153009|39740988|FG002|Overall Study|Withdrawal of Consent|4|||
16342731|NCT01153009|39740989|FG003|Overall Study|Withdrawal of Consent|6|||
16342732|NCT01153009|39740986|FG000|Overall Study|Lost to Follow-up|8|||
16342733|NCT01153009|39740987|FG001|Overall Study|Lost to Follow-up|8|||
16342734|NCT01153009|39740988|FG002|Overall Study|Lost to Follow-up|11|||
16342735|NCT01153009|39740989|FG003|Overall Study|Lost to Follow-up|15|||
16342736|NCT01153009|39740986|FG000|Overall Study|Other|1|||
16342737|NCT01153009|39740987|FG001|Overall Study|Other|1|||
16342738|NCT01153009|39740988|FG002|Overall Study|Other|3|||
16342739|NCT01153009|39740989|FG003|Overall Study|Other|2|||
16342740|NCT01744483|39740993|FG000|Overall Study|Death|9|||
16342741|NCT01744483|39740994|FG001|Overall Study|Death|4|||
16342742|NCT01744483|39740995|FG002|Overall Study|Death|11|||
16342743|NCT01744483|39740993|FG000|Overall Study|Lost to Follow-up|8|||
16342744|NCT01744483|39740994|FG001|Overall Study|Lost to Follow-up|9|||
16342745|NCT01744483|39740995|FG002|Overall Study|Lost to Follow-up|11|||
16342746|NCT01744483|39740993|FG000|Overall Study|Protocol Violation|1|||
16342747|NCT01744483|39740994|FG001|Overall Study|Protocol Violation|2|||
16342748|NCT01744483|39740995|FG002|Overall Study|Protocol Violation|1|||
16342749|NCT01744483|39740993|FG000|Overall Study|Withdrawal by Subject|4|||
16342750|NCT01744483|39740994|FG001|Overall Study|Withdrawal by Subject|6|||
16342751|NCT01744483|39740995|FG002|Overall Study|Withdrawal by Subject|2|||
16342752|NCT01744483|39740993|FG000|Overall Study|No ICU Admit|5|||
16342753|NCT01744483|39740994|FG001|Overall Study|No ICU Admit|1|||
16342754|NCT01744483|39740995|FG002|Overall Study|No ICU Admit|2|||
16342755|NCT01744483|39740993|FG000|Overall Study|Routed to OSH|2|||
16342756|NCT01744483|39740994|FG001|Overall Study|Routed to OSH|0|||
16342757|NCT01744483|39740995|FG002|Overall Study|Routed to OSH|1|||
16342758|NCT02383355|39740996|FG000|Overall Study|Adverse Event|2|||
16342759|NCT02383355|39740997|FG001|Overall Study|Adverse Event|0|||
16342760|NCT00985686|39740998|FG000|Overall Study|Lost to Follow-up|1|||
16342761|NCT00985686|39740999|FG001|Overall Study|Lost to Follow-up|1|||
16342762|NCT00985686|39741000|FG002|Overall Study|Lost to Follow-up|0|||
16342763|NCT00985686|39741001|FG003|Overall Study|Lost to Follow-up|2|||
16342764|NCT04447287|39741002|FG000|Period 1: Run-in Period|Adverse Event|3|||
16342765|NCT04447287|39741003|FG001|Period 1: Run-in Period|Adverse Event|0|||
16342766|NCT04447287|39741004|FG002|Period 1: Run-in Period|Adverse Event|0|||
16342767|NCT04447287|39741002|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
16342768|NCT04447287|39741003|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
16342769|NCT04447287|39741004|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
16342770|NCT04447287|39741002|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
16543132|NCT04124926|40450446|FG004|Healing Phase|Lost to Follow-up|0|||
16543133|NCT04124926|40450442|FG000|Healing Phase|Voluntary Withdrawal|10|||
16543134|NCT04124926|40450443|FG001|Healing Phase|Voluntary Withdrawal|7|||
16543135|NCT04124926|40450444|FG002|Healing Phase|Voluntary Withdrawal|0|||
16543136|NCT04124926|40450445|FG003|Healing Phase|Voluntary Withdrawal|0|||
16543137|NCT04124926|40450446|FG004|Healing Phase|Voluntary Withdrawal|0|||
16543138|NCT04124926|40450442|FG000|Healing Phase|Withdrawal of Consent|5|||
16220495|NCT00779506|39286406|FG000|Overall Study|Adverse Event|4|||
16220496|NCT00779506|39286406|FG000|Overall Study|Lack of Efficacy|11|||
16220497|NCT00779506|39286406|FG000|Overall Study|Protocol Violation|5|||
16220498|NCT00779506|39286406|FG000|Overall Study|Withdrawal by Subject|6|||
16220499|NCT00779506|39286406|FG000|Overall Study|Lost to Follow-up|1|||
16220500|NCT00256204|39286414|FG000|Overall Study|Adverse Event|10|||
16220501|NCT00256204|39286415|FG001|Overall Study|Adverse Event|14|||
16220502|NCT00256204|39286416|FG002|Overall Study|Adverse Event|16|||
16220503|NCT00256204|39286417|FG003|Overall Study|Adverse Event|14|||
16220504|NCT00256204|39286414|FG000|Overall Study|Death|0|||
16220505|NCT00256204|39286415|FG001|Overall Study|Death|1|||
16220506|NCT00256204|39286416|FG002|Overall Study|Death|0|||
16220507|NCT00256204|39286417|FG003|Overall Study|Death|0|||
16220508|NCT00256204|39286414|FG000|Overall Study|Lost to Follow-up|1|||
16220509|NCT00256204|39286415|FG001|Overall Study|Lost to Follow-up|1|||
16220510|NCT00256204|39286416|FG002|Overall Study|Lost to Follow-up|1|||
16220511|NCT00256204|39286417|FG003|Overall Study|Lost to Follow-up|2|||
16220512|NCT00256204|39286414|FG000|Overall Study|Protocol Violation|1|||
16220513|NCT00256204|39286415|FG001|Overall Study|Protocol Violation|0|||
16220514|NCT00256204|39286416|FG002|Overall Study|Protocol Violation|2|||
16220515|NCT00256204|39286417|FG003|Overall Study|Protocol Violation|1|||
16220516|NCT00256204|39286414|FG000|Overall Study|Physician Decision|0|||
16220517|NCT00256204|39286415|FG001|Overall Study|Physician Decision|0|||
16220518|NCT00256204|39286416|FG002|Overall Study|Physician Decision|1|||
16220519|NCT00256204|39286417|FG003|Overall Study|Physician Decision|2|||
16220520|NCT00256204|39286414|FG000|Overall Study|Withdrawal by Subject|17|||
16220521|NCT00256204|39286415|FG001|Overall Study|Withdrawal by Subject|6|||
16342771|NCT04447287|39741003|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
16220522|NCT00256204|39286416|FG002|Overall Study|Withdrawal by Subject|7|||
16220523|NCT00256204|39286417|FG003|Overall Study|Withdrawal by Subject|5|||
16220524|NCT00256204|39286414|FG000|Overall Study|Need for additional prohibited treatment|38|||
16342772|NCT04447287|39741004|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
16342773|NCT00948922|39741007|FG000|Overall Study|Did not start study treatment|2|||
16342774|NCT00948922|39741008|FG001|Overall Study|Did not start study treatment|5|||
16543139|NCT04124926|40450443|FG001|Healing Phase|Withdrawal of Consent|3|||
16543140|NCT04124926|40450444|FG002|Healing Phase|Withdrawal of Consent|0|||
16543141|NCT04124926|40450445|FG003|Healing Phase|Withdrawal of Consent|0|||
16543142|NCT04124926|40450446|FG004|Healing Phase|Withdrawal of Consent|0|||
16543143|NCT04124926|40450442|FG000|Healing Phase|Miscellaneous|8|||
16543144|NCT04124926|40450443|FG001|Healing Phase|Miscellaneous|7|||
16543145|NCT04124926|40450444|FG002|Healing Phase|Miscellaneous|0|||
16543146|NCT04124926|40450445|FG003|Healing Phase|Miscellaneous|0|||
16543147|NCT04124926|40450446|FG004|Healing Phase|Miscellaneous|0|||
16543148|NCT04124926|40450442|FG000|Healing Phase|Randomized but not Treated|0|||
16543149|NCT04124926|40450443|FG001|Healing Phase|Randomized but not Treated|3|||
16220525|NCT00256204|39286415|FG001|Overall Study|Need for additional prohibited treatment|28|||
16342775|NCT00948922|39741009|FG002|Overall Study|Did not start study treatment|0|||
16342776|NCT00948922|39741007|FG000|Overall Study|Withdrawal by Subject|0|||
16342777|NCT00948922|39741008|FG001|Overall Study|Withdrawal by Subject|2|||
16342778|NCT00948922|39741009|FG002|Overall Study|Withdrawal by Subject|1|||
16543150|NCT04124926|40450444|FG002|Healing Phase|Randomized but not Treated|0|||
16543151|NCT04124926|40450445|FG003|Healing Phase|Randomized but not Treated|0|||
16543152|NCT04124926|40450446|FG004|Healing Phase|Randomized but not Treated|0|||
16543153|NCT04124926|40450442|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
16220526|NCT00256204|39286416|FG002|Overall Study|Need for additional prohibited treatment|27|||
16543154|NCT04124926|40450443|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
16543155|NCT04124926|40450444|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
16543156|NCT04124926|40450445|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
16543157|NCT04124926|40450446|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
16543158|NCT04124926|40450442|FG000|Maintenance Phase|Protocol Violation|0|||
16543159|NCT04124926|40450443|FG001|Maintenance Phase|Protocol Violation|0|||
16543160|NCT04124926|40450444|FG002|Maintenance Phase|Protocol Violation|3|||
16543161|NCT04124926|40450445|FG003|Maintenance Phase|Protocol Violation|0|||
16543162|NCT04124926|40450446|FG004|Maintenance Phase|Protocol Violation|0|||
16543163|NCT04124926|40450442|FG000|Maintenance Phase|Lost to Follow-up|0|||
16543164|NCT04124926|40450443|FG001|Maintenance Phase|Lost to Follow-up|0|||
16543165|NCT04124926|40450444|FG002|Maintenance Phase|Lost to Follow-up|7|||
16543166|NCT04124926|40450445|FG003|Maintenance Phase|Lost to Follow-up|8|||
16543167|NCT04124926|40450446|FG004|Maintenance Phase|Lost to Follow-up|9|||
16220527|NCT00256204|39286417|FG003|Overall Study|Need for additional prohibited treatment|25|||
16220528|NCT03345849|39286427|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
16220529|NCT03345849|39286428|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
16109257|NCT00585975|38889047|FG000|Overall Study|Lost to Follow-up|2|||
16109258|NCT00585975|38889048|FG001|Overall Study|Lost to Follow-up|1|||
16109259|NCT00585975|38889047|FG000|Overall Study|Enrollment met/over-enrolled|10|||
16109260|NCT00585975|38889048|FG001|Overall Study|Enrollment met/over-enrolled|9|||
16109261|NCT01240915|38889051|FG000|Overall Study|Adverse Event|0|||
16109262|NCT01240915|38889052|FG001|Overall Study|Adverse Event|0|||
16109263|NCT01240915|38889053|FG002|Overall Study|Adverse Event|0|||
16109264|NCT01240915|38889054|FG003|Overall Study|Adverse Event|1|||
16109265|NCT01240915|38889055|FG004|Overall Study|Adverse Event|0|||
16109266|NCT01240915|38889056|FG005|Overall Study|Adverse Event|2|||
16109267|NCT01240915|38889057|FG006|Overall Study|Adverse Event|0|||
16109268|NCT01240915|38889058|FG007|Overall Study|Adverse Event|0|||
16109269|NCT01240915|38889059|FG008|Overall Study|Adverse Event|1|||
16109270|NCT01240915|38889051|FG000|Overall Study|Lost to Follow-up|0|||
16109271|NCT01240915|38889052|FG001|Overall Study|Lost to Follow-up|0|||
16109272|NCT01240915|38889053|FG002|Overall Study|Lost to Follow-up|0|||
16109273|NCT01240915|38889054|FG003|Overall Study|Lost to Follow-up|0|||
16109274|NCT01240915|38889055|FG004|Overall Study|Lost to Follow-up|1|||
16109275|NCT01240915|38889056|FG005|Overall Study|Lost to Follow-up|1|||
16109276|NCT01240915|38889057|FG006|Overall Study|Lost to Follow-up|0|||
16109277|NCT01240915|38889058|FG007|Overall Study|Lost to Follow-up|1|||
16109278|NCT01240915|38889059|FG008|Overall Study|Lost to Follow-up|1|||
16109279|NCT01240915|38889051|FG000|Overall Study|Withdrawal by Subject|2|||
16109280|NCT01240915|38889052|FG001|Overall Study|Withdrawal by Subject|1|||
16220530|NCT03345849|39286429|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
16109281|NCT01240915|38889053|FG002|Overall Study|Withdrawal by Subject|0|||
16109282|NCT01240915|38889054|FG003|Overall Study|Withdrawal by Subject|2|||
16109283|NCT01240915|38889055|FG004|Overall Study|Withdrawal by Subject|0|||
16109284|NCT01240915|38889056|FG005|Overall Study|Withdrawal by Subject|4|||
16109285|NCT01240915|38889057|FG006|Overall Study|Withdrawal by Subject|2|||
16109286|NCT01240915|38889058|FG007|Overall Study|Withdrawal by Subject|3|||
16109287|NCT01240915|38889059|FG008|Overall Study|Withdrawal by Subject|3|||
16109288|NCT01240915|38889051|FG000|Overall Study|Other|0|||
16109289|NCT01240915|38889052|FG001|Overall Study|Other|0|||
16109290|NCT01240915|38889053|FG002|Overall Study|Other|0|||
16109291|NCT01240915|38889054|FG003|Overall Study|Other|0|||
16109292|NCT01240915|38889055|FG004|Overall Study|Other|2|||
16109293|NCT01240915|38889056|FG005|Overall Study|Other|0|||
16109294|NCT01240915|38889057|FG006|Overall Study|Other|0|||
16109295|NCT01240915|38889058|FG007|Overall Study|Other|0|||
16109296|NCT01240915|38889059|FG008|Overall Study|Other|0|||
16109297|NCT01240915|38889051|FG000|Overall Study|Insufficient Clinical Response|0|||
16109298|NCT01240915|38889052|FG001|Overall Study|Insufficient Clinical Response|0|||
16109299|NCT01240915|38889053|FG002|Overall Study|Insufficient Clinical Response|0|||
16109300|NCT01240915|38889054|FG003|Overall Study|Insufficient Clinical Response|0|||
16109301|NCT01240915|38889055|FG004|Overall Study|Insufficient Clinical Response|1|||
16109302|NCT01240915|38889056|FG005|Overall Study|Insufficient Clinical Response|3|||
16220531|NCT03345849|39286430|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
16543168|NCT04124926|40450442|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
16543169|NCT04124926|40450443|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
16109303|NCT01240915|38889057|FG006|Overall Study|Insufficient Clinical Response|6|||
16109304|NCT01240915|38889058|FG007|Overall Study|Insufficient Clinical Response|0|||
16109305|NCT01240915|38889059|FG008|Overall Study|Insufficient Clinical Response|3|||
16109306|NCT00025506|38889060|FG000|Overall Study|Ineligible: clerical error|1|||
16109307|NCT00025506|38889060|FG000|Overall Study|Ineligible: wrong cell type|5|||
16109308|NCT00025506|38889060|FG000|Overall Study|Ineligible: inadequate pathology|2|||
16109309|NCT00025506|38889060|FG000|Overall Study|Never Treated|2|||
16109310|NCT00243022|38889061|FG000|Overall Study|Withdrawal by Subject|1|||
16109311|NCT00243022|38889062|FG001|Overall Study|Withdrawal by Subject|0|||
16109312|NCT00243022|38889061|FG000|Overall Study|Death|1|||
16109313|NCT00243022|38889062|FG001|Overall Study|Death|0|||
16109314|NCT00243022|38889061|FG000|Overall Study|Difficult Travel Distance|0|||
16109315|NCT00243022|38889062|FG001|Overall Study|Difficult Travel Distance|1|||
16109316|NCT03020069|38889063|FG000|Overall Study|Lost to Follow-up|0|||
16109317|NCT03020069|38889064|FG001|Overall Study|Lost to Follow-up|1|||
16220532|NCT03345849|39286427|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
16220533|NCT03345849|39286428|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
16220534|NCT03345849|39286429|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
16109318|NCT02215954|38889066|FG000|Overall Study|Adverse Event|0|||
16109319|NCT02215954|38889067|FG001|Overall Study|Adverse Event|0|||
16109320|NCT02215954|38889068|FG002|Overall Study|Adverse Event|1|||
16109321|NCT02215954|38889066|FG000|Overall Study|Withdrawal by Subject|0|||
16109322|NCT02215954|38889067|FG001|Overall Study|Withdrawal by Subject|0|||
16109323|NCT02215954|38889068|FG002|Overall Study|Withdrawal by Subject|2|||
16109324|NCT02215954|38889066|FG000|Overall Study|Not exposed|1|||
16109325|NCT02215954|38889067|FG001|Overall Study|Not exposed|1|||
16109326|NCT02215954|38889068|FG002|Overall Study|Not exposed|3|||
16109327|NCT04952701|38889072|FG000|Control Lens|Physician Decision|4|||
16109328|NCT04952701|38889072|FG000|Test Lens|Physician Decision|1|||
16109329|NCT00988533|38889073|FG000|Overall Study|Lost to Follow-up|3|||
16109330|NCT02202109|38889079|FG000|Overall Study|Lost to Follow-up|88|||
16109331|NCT02202109|38889080|FG001|Overall Study|Lost to Follow-up|87|||
16109332|NCT02202109|38889079|FG000|Overall Study|Withdrawal by Subject|2|||
16109333|NCT02202109|38889080|FG001|Overall Study|Withdrawal by Subject|0|||
16109334|NCT01309243|38889081|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
16109335|NCT01309243|38889082|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
16109336|NCT01309243|38889081|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
16109337|NCT01309243|38889082|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
16109338|NCT01309243|38889081|FG000|Randomized Phase Through Week 96|Death|0|||
16109339|NCT01309243|38889082|FG001|Randomized Phase Through Week 96|Death|1|||
16109340|NCT01309243|38889081|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
16109341|NCT01309243|38889082|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
16109342|NCT01309243|38889081|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
16109343|NCT01309243|38889082|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
16109344|NCT01309243|38889081|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
16109345|NCT01309243|38889082|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
16109346|NCT01309243|38889081|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
16109347|NCT01309243|38889082|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
16109348|NCT01309243|38889081|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
16109349|NCT01309243|38889082|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
16109350|NCT01309243|38889081|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
16109351|NCT01309243|38889082|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
16220535|NCT03345849|39286430|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
16220536|NCT03345849|39286427|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
16109352|NCT01309243|38889081|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
16109353|NCT01309243|38889082|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
16109354|NCT01309243|38889081|FG000|Extension Phase|Lost to Follow-up|6|||
16109355|NCT01309243|38889082|FG001|Extension Phase|Lost to Follow-up|0|||
16109356|NCT02482935|38889083|FG000|Period 1|Withdrawal by Subject|1|||
16109357|NCT02482935|38889084|FG001|Period 1|Withdrawal by Subject|0|||
16109358|NCT02438371|38889085|FG000|Overall Study|Lost to Follow-up|3|||
16109359|NCT02438371|38889086|FG001|Overall Study|Lost to Follow-up|2|||
16109360|NCT02438371|38889085|FG000|Overall Study|Withdrawal by Subject|1|||
16109361|NCT02438371|38889086|FG001|Overall Study|Withdrawal by Subject|1|||
16109362|NCT03119688|38889091|FG000|Overall Study|Adverse Event|4|||
16342779|NCT00948922|39741007|FG000|Overall Study|Death|3|||
16342780|NCT00948922|39741008|FG001|Overall Study|Death|0|||
16342781|NCT00948922|39741009|FG002|Overall Study|Death|0|||
16342782|NCT00948922|39741007|FG000|Overall Study|Disease progression|0|||
16342783|NCT00948922|39741008|FG001|Overall Study|Disease progression|1|||
16109363|NCT01689363|38889092|FG000|Overall Study|Protocol Violation|0|||
16109364|NCT01689363|38889093|FG001|Overall Study|Protocol Violation|1|||
16342784|NCT00948922|39741009|FG002|Overall Study|Disease progression|0|||
16342785|NCT00948922|39741007|FG000|Overall Study|Insurance issues|1|||
16342786|NCT00948922|39741008|FG001|Overall Study|Insurance issues|0|||
16342787|NCT00948922|39741009|FG002|Overall Study|Insurance issues|0|||
16342788|NCT00948922|39741007|FG000|Overall Study|Transplant eligibility issues|2|||
16342789|NCT00948922|39741008|FG001|Overall Study|Transplant eligibility issues|3|||
16342790|NCT00948922|39741009|FG002|Overall Study|Transplant eligibility issues|0|||
16342791|NCT00948922|39741007|FG000|Overall Study|Not evaluable at time of analysis|0|||
16342792|NCT00948922|39741008|FG001|Overall Study|Not evaluable at time of analysis|3|||
16342793|NCT00948922|39741009|FG002|Overall Study|Not evaluable at time of analysis|0|||
16342794|NCT00565604|39741010|FG000|Overall Study|Failure to treat|2|||
16342795|NCT00565604|39741010|FG000|Overall Study|Lost to Follow-up|2|||
16342796|NCT03091738|39741011|FG000|Overall Study|Adverse Event|1|||
16109365|NCT01689363|38889094|FG002|Overall Study|Protocol Violation|0|||
16109366|NCT01689363|38889095|FG003|Overall Study|Protocol Violation|0|||
16109367|NCT01689363|38889096|FG004|Overall Study|Protocol Violation|0|||
16543170|NCT04124926|40450444|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
16543171|NCT04124926|40450445|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
16543172|NCT04124926|40450446|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
16543173|NCT04124926|40450442|FG000|Maintenance Phase|Pregnancy|0|||
16543174|NCT04124926|40450443|FG001|Maintenance Phase|Pregnancy|0|||
16543175|NCT04124926|40450444|FG002|Maintenance Phase|Pregnancy|0|||
16543176|NCT04124926|40450445|FG003|Maintenance Phase|Pregnancy|1|||
16543177|NCT04124926|40450446|FG004|Maintenance Phase|Pregnancy|0|||
16543178|NCT04124926|40450442|FG000|Maintenance Phase|Lack of Efficacy|0|||
16543179|NCT04124926|40450443|FG001|Maintenance Phase|Lack of Efficacy|0|||
16543180|NCT04124926|40450444|FG002|Maintenance Phase|Lack of Efficacy|0|||
16543181|NCT04124926|40450445|FG003|Maintenance Phase|Lack of Efficacy|0|||
16543182|NCT04124926|40450446|FG004|Maintenance Phase|Lack of Efficacy|1|||
16543183|NCT04124926|40450442|FG000|Maintenance Phase|Withdrawal of Consent|0|||
16543184|NCT04124926|40450443|FG001|Maintenance Phase|Withdrawal of Consent|0|||
16543185|NCT04124926|40450444|FG002|Maintenance Phase|Withdrawal of Consent|5|||
16543186|NCT04124926|40450445|FG003|Maintenance Phase|Withdrawal of Consent|5|||
16543187|NCT04124926|40450446|FG004|Maintenance Phase|Withdrawal of Consent|5|||
16543188|NCT04124926|40450442|FG000|Maintenance Phase|Miscellaneous|0|||
16543189|NCT04124926|40450443|FG001|Maintenance Phase|Miscellaneous|0|||
16543190|NCT04124926|40450444|FG002|Maintenance Phase|Miscellaneous|1|||
16543191|NCT04124926|40450445|FG003|Maintenance Phase|Miscellaneous|2|||
16543192|NCT04124926|40450446|FG004|Maintenance Phase|Miscellaneous|4|||
16543193|NCT04124926|40450442|FG000|Maintenance Phase|Randomized but not Treated|0|||
16543194|NCT04124926|40450443|FG001|Maintenance Phase|Randomized but not Treated|0|||
16543195|NCT04124926|40450444|FG002|Maintenance Phase|Randomized but not Treated|2|||
16543196|NCT04124926|40450445|FG003|Maintenance Phase|Randomized but not Treated|2|||
16543197|NCT04124926|40450446|FG004|Maintenance Phase|Randomized but not Treated|0|||
16543198|NCT00789815|40450447|FG000|Overall Study|Protocol Violation|6|||
16543199|NCT00789815|40450448|FG001|Overall Study|Protocol Violation|1|||
16543200|NCT00789815|40450447|FG000|Overall Study|Intubation due to massive bleeding|1|||
16543201|NCT00789815|40450448|FG001|Overall Study|Intubation due to massive bleeding|0|||
16543202|NCT02623322|40450449|FG000|Overall Study|Lost to Follow-up|2|||
16543203|NCT02623322|40450450|FG001|Overall Study|Lost to Follow-up|1|||
16543204|NCT02623322|40450451|FG002|Overall Study|Lost to Follow-up|0|||
16342797|NCT03091738|39741011|FG000|Overall Study|Lost to Follow-up|1|||
16109368|NCT01689363|38889097|FG005|Overall Study|Protocol Violation|0|||
16109369|NCT01689363|38889098|FG006|Overall Study|Protocol Violation|0|||
16109370|NCT01689363|38889099|FG007|Overall Study|Protocol Violation|0|||
16342798|NCT03628716|39741012|FG000|Overall Study|Adverse Event|1|||
16543205|NCT04209725|40450452|FG000|Overall Study|Adverse Event|1|||
16543206|NCT05168579|40450453|FG000|Overall Study|Lack of Consent|1|||
16543207|NCT05168579|40450454|FG001|Overall Study|Lack of Consent|0|||
16543208|NCT05168579|40450453|FG000|Overall Study|Conflicts with time|2|||
16543209|NCT05168579|40450454|FG001|Overall Study|Conflicts with time|0|||
16342799|NCT03628716|39741013|FG001|Overall Study|Adverse Event|1|||
16111468|NCT00760747|38897274|FG000|Study Period III|Lack of Efficacy|1|||
16342800|NCT03628716|39741012|FG000|Overall Study|Death|1|||
16109371|NCT00833898|38889100|FG000|Overall Study|Withdrawal by Subject|33|||
16109372|NCT00833898|38889101|FG001|Overall Study|Withdrawal by Subject|27|||
16109373|NCT00833898|38889100|FG000|Overall Study|Lost to Follow-up|7|||
16109374|NCT00833898|38889101|FG001|Overall Study|Lost to Follow-up|7|||
16109375|NCT00833898|38889100|FG000|Overall Study|Patient did not receive transplant|0|||
16109376|NCT00833898|38889101|FG001|Overall Study|Patient did not receive transplant|2|||
16109377|NCT01296555|38889103|FG000|Overall Study|Adverse Event|0|||
16109378|NCT01296555|38889104|FG001|Overall Study|Adverse Event|0|||
16109379|NCT01296555|38889105|FG002|Overall Study|Adverse Event|1|||
16109380|NCT01296555|38889106|FG003|Overall Study|Adverse Event|1|||
16109381|NCT01296555|38889107|FG004|Overall Study|Adverse Event|2|||
16109382|NCT01296555|38889108|FG005|Overall Study|Adverse Event|4|||
16109383|NCT01296555|38889109|FG006|Overall Study|Adverse Event|1|||
16109384|NCT01296555|38889110|FG007|Overall Study|Adverse Event|4|||
16109385|NCT01296555|38889111|FG008|Overall Study|Adverse Event|3|||
16109386|NCT01296555|38889112|FG009|Overall Study|Adverse Event|1|||
16109387|NCT01296555|38889113|FG010|Overall Study|Adverse Event|0|||
16109388|NCT01296555|38889114|FG011|Overall Study|Adverse Event|4|||
16109389|NCT01296555|38889115|FG012|Overall Study|Adverse Event|1|||
16109390|NCT01296555|38889116|FG013|Overall Study|Adverse Event|4|||
16109391|NCT01296555|38889117|FG014|Overall Study|Adverse Event|0|||
16109392|NCT01296555|38889118|FG015|Overall Study|Adverse Event|0|||
16109393|NCT01296555|38889119|FG016|Overall Study|Adverse Event|0|||
16109394|NCT01296555|38889120|FG017|Overall Study|Adverse Event|0|||
16109395|NCT01296555|38889121|FG018|Overall Study|Adverse Event|0|||
16109396|NCT01296555|38889122|FG019|Overall Study|Adverse Event|1|||
16109397|NCT01296555|38889123|FG020|Overall Study|Adverse Event|0|||
16109398|NCT01296555|38889124|FG021|Overall Study|Adverse Event|0|||
16109399|NCT01296555|38889125|FG022|Overall Study|Adverse Event|0|||
16109400|NCT01296555|38889126|FG023|Overall Study|Adverse Event|0|||
16109401|NCT01296555|38889127|FG024|Overall Study|Adverse Event|0|||
16109402|NCT01296555|38889128|FG025|Overall Study|Adverse Event|0|||
16109403|NCT01296555|38889129|FG026|Overall Study|Adverse Event|0|||
16109404|NCT01296555|38889130|FG027|Overall Study|Adverse Event|0|||
16109405|NCT01296555|38889131|FG028|Overall Study|Adverse Event|0|||
16109406|NCT01296555|38889103|FG000|Overall Study|Reason Not Specified|0|||
16109407|NCT01296555|38889104|FG001|Overall Study|Reason Not Specified|0|||
16109408|NCT01296555|38889105|FG002|Overall Study|Reason Not Specified|0|||
16109409|NCT01296555|38889106|FG003|Overall Study|Reason Not Specified|0|||
16109410|NCT01296555|38889107|FG004|Overall Study|Reason Not Specified|0|||
16109411|NCT01296555|38889108|FG005|Overall Study|Reason Not Specified|0|||
16109412|NCT01296555|38889109|FG006|Overall Study|Reason Not Specified|0|||
16109413|NCT01296555|38889110|FG007|Overall Study|Reason Not Specified|0|||
16109414|NCT01296555|38889111|FG008|Overall Study|Reason Not Specified|0|||
16109415|NCT01296555|38889112|FG009|Overall Study|Reason Not Specified|0|||
16342801|NCT03628716|39741013|FG001|Overall Study|Death|0|||
16342802|NCT03628716|39741012|FG000|Overall Study|Lack of Efficacy|15|||
16342803|NCT03628716|39741013|FG001|Overall Study|Lack of Efficacy|20|||
16342804|NCT03628716|39741012|FG000|Overall Study|Withdrawal by Subject|1|||
16342805|NCT03628716|39741013|FG001|Overall Study|Withdrawal by Subject|2|||
16342806|NCT03628716|39741012|FG000|Overall Study|Study Terminated by Sponsor|1|||
16342807|NCT03628716|39741013|FG001|Overall Study|Study Terminated by Sponsor|0|||
16342808|NCT00496587|39741014|FG000|Overall Study|Adverse Event|2|||
16342809|NCT00496587|39741014|FG000|Overall Study|Progressive Disease|24|||
16342810|NCT00496587|39741014|FG000|Overall Study|Withdrawal by Subject|2|||
16342811|NCT00496587|39741014|FG000|Overall Study|Death|1|||
16342812|NCT00496587|39741014|FG000|Overall Study|Complications unrelated|2|||
16342813|NCT01215435|39741024|FG000|Overall Study|Adverse Event|1|||
16342814|NCT01215435|39741025|FG001|Overall Study|Adverse Event|0|||
16342815|NCT01215435|39741024|FG000|Overall Study|Protocol Violation|2|||
16342816|NCT01215435|39741025|FG001|Overall Study|Protocol Violation|0|||
16342817|NCT01215435|39741024|FG000|Overall Study|Withdrawal Criteria|8|||
16342818|NCT01215435|39741025|FG001|Overall Study|Withdrawal Criteria|11|||
16342819|NCT01215435|39741024|FG000|Overall Study|Lost to Follow-up|3|||
16342820|NCT01215435|39741025|FG001|Overall Study|Lost to Follow-up|0|||
16342821|NCT01215435|39741024|FG000|Overall Study|Unclassified|5|||
16342822|NCT01215435|39741025|FG001|Overall Study|Unclassified|5|||
16342823|NCT02779075|39741029|FG000|Overall Study|Withdrawal by Subject|1|||
16342824|NCT02779075|39741030|FG001|Overall Study|Withdrawal by Subject|3|||
16342825|NCT02779075|39741029|FG000|Overall Study|IV lost during 2nd study|1|||
16342826|NCT02779075|39741030|FG001|Overall Study|IV lost during 2nd study|0|||
16342827|NCT01597492|39741031|FG000|Overall Study|Withdrawal by Subject|1|||
16342828|NCT01597492|39741032|FG001|Overall Study|Withdrawal by Subject|2|||
16342829|NCT01597492|39741031|FG000|Overall Study|Adverse Event|3|||
16342830|NCT01597492|39741032|FG001|Overall Study|Adverse Event|0|||
16342831|NCT01597492|39741031|FG000|Overall Study|Lost to Follow-up|0|||
16342832|NCT01597492|39741032|FG001|Overall Study|Lost to Follow-up|2|||
16342833|NCT01597492|39741031|FG000|Overall Study|Other Reason|2|||
16342834|NCT01597492|39741032|FG001|Overall Study|Other Reason|0|||
16342835|NCT00790556|39741033|FG000|Treatment Period 1|Physician Decision|1|||
16342836|NCT00790556|39741034|FG001|Treatment Period 1|Physician Decision|0|||
16342837|NCT00790556|39741033|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16109416|NCT01296555|38889113|FG010|Overall Study|Reason Not Specified|0|||
16109417|NCT01296555|38889114|FG011|Overall Study|Reason Not Specified|0|||
16109418|NCT01296555|38889115|FG012|Overall Study|Reason Not Specified|0|||
16109419|NCT01296555|38889116|FG013|Overall Study|Reason Not Specified|1|||
16109420|NCT01296555|38889117|FG014|Overall Study|Reason Not Specified|2|||
16109421|NCT01296555|38889118|FG015|Overall Study|Reason Not Specified|3|||
16109422|NCT01296555|38889119|FG016|Overall Study|Reason Not Specified|7|||
16109423|NCT01296555|38889120|FG017|Overall Study|Reason Not Specified|4|||
16109424|NCT01296555|38889121|FG018|Overall Study|Reason Not Specified|3|||
16109425|NCT01296555|38889122|FG019|Overall Study|Reason Not Specified|7|||
16109426|NCT01296555|38889123|FG020|Overall Study|Reason Not Specified|11|||
16543210|NCT05168579|40450453|FG000|Overall Study|Time slots were full|3|||
16543211|NCT05168579|40450454|FG001|Overall Study|Time slots were full|0|||
16543212|NCT05168579|40450453|FG000|Overall Study|Lost to Follow-up|0|||
16543213|NCT05168579|40450454|FG001|Overall Study|Lost to Follow-up|15|||
16543214|NCT02641392|40450455|FG000|Overall Study|Lost to Follow-up|0|||
16543215|NCT02641392|40450456|FG001|Overall Study|Lost to Follow-up|0|||
16543216|NCT02641392|40450457|FG002|Overall Study|Lost to Follow-up|2|||
16543217|NCT02641392|40450455|FG000|Overall Study|Withdrawal by Subject|0|||
16543218|NCT02641392|40450456|FG001|Overall Study|Withdrawal by Subject|0|||
16543219|NCT02641392|40450457|FG002|Overall Study|Withdrawal by Subject|17|||
16543220|NCT02641392|40450455|FG000|Overall Study|Adverse Event|0|||
16543221|NCT02641392|40450456|FG001|Overall Study|Adverse Event|1|||
16543222|NCT02641392|40450457|FG002|Overall Study|Adverse Event|25|||
16543223|NCT02641392|40450455|FG000|Overall Study|Study Terminated by Sponsor|4|||
16543224|NCT02641392|40450456|FG001|Overall Study|Study Terminated by Sponsor|12|||
16543225|NCT02641392|40450457|FG002|Overall Study|Study Terminated by Sponsor|144|||
16543226|NCT02641392|40450455|FG000|Overall Study|Lack of Efficacy|0|||
16543227|NCT02641392|40450456|FG001|Overall Study|Lack of Efficacy|0|||
16543228|NCT02641392|40450457|FG002|Overall Study|Lack of Efficacy|101|||
16109427|NCT01296555|38889124|FG021|Overall Study|Reason Not Specified|5|||
16109428|NCT01296555|38889125|FG022|Overall Study|Reason Not Specified|5|||
16109429|NCT01296555|38889126|FG023|Overall Study|Reason Not Specified|7|||
16342838|NCT00790556|39741034|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16342839|NCT03727841|39741035|FG000|Overall Study|Physician Decision|3|||
16342840|NCT03727841|39741036|FG001|Overall Study|Physician Decision|1|||
16543229|NCT02641392|40450455|FG000|Overall Study|Miscellaneous|0|||
16543230|NCT02641392|40450456|FG001|Overall Study|Miscellaneous|0|||
16109430|NCT01296555|38889127|FG024|Overall Study|Reason Not Specified|2|||
16109431|NCT01296555|38889128|FG025|Overall Study|Reason Not Specified|2|||
16342841|NCT02497404|39741039|FG000|Overall Study|Adverse Event|1|||
16342842|NCT02732327|39741047|FG000|Overall Study|Protocol Violation|0|||
16342843|NCT02732327|39741048|FG001|Overall Study|Protocol Violation|1|||
16342844|NCT01190189|39741051|FG000|Overall Study|Lost to Follow-up|4|||
16342845|NCT01190189|39741051|FG000|Overall Study|Withdrawal by Subject|1|||
16342846|NCT01190189|39741051|FG000|Overall Study|Migrated/moved from study area|1|||
16342847|NCT02447328|39741052|FG000|Overall Study|Withdrawal by Subject|1|||
16342848|NCT03178851|39741055|FG000|Overall Study|Death|48|||
16342849|NCT03178851|39741056|FG001|Overall Study|Death|2|||
16342850|NCT03178851|39741057|FG002|Overall Study|Death|25|||
16342851|NCT03178851|39741055|FG000|Overall Study|Withdrawal by Subject|8|||
16342852|NCT03178851|39741056|FG001|Overall Study|Withdrawal by Subject|0|||
16342853|NCT03178851|39741057|FG002|Overall Study|Withdrawal by Subject|0|||
16109432|NCT01296555|38889129|FG026|Overall Study|Reason Not Specified|19|||
16109433|NCT01296555|38889130|FG027|Overall Study|Reason Not Specified|11|||
16109434|NCT01296555|38889131|FG028|Overall Study|Reason Not Specified|9|||
16109435|NCT01296555|38889103|FG000|Overall Study|Physician Decision|0|||
16109436|NCT01296555|38889104|FG001|Overall Study|Physician Decision|0|||
16109437|NCT01296555|38889105|FG002|Overall Study|Physician Decision|0|||
16109438|NCT01296555|38889106|FG003|Overall Study|Physician Decision|0|||
16109439|NCT01296555|38889107|FG004|Overall Study|Physician Decision|1|||
16109440|NCT01296555|38889108|FG005|Overall Study|Physician Decision|0|||
16109441|NCT01296555|38889109|FG006|Overall Study|Physician Decision|0|||
16109442|NCT01296555|38889110|FG007|Overall Study|Physician Decision|0|||
16342854|NCT03178851|39741055|FG000|Overall Study|Lost to Follow-up|5|||
16109443|NCT01296555|38889111|FG008|Overall Study|Physician Decision|0|||
16109444|NCT01296555|38889112|FG009|Overall Study|Physician Decision|0|||
16109445|NCT01296555|38889113|FG010|Overall Study|Physician Decision|0|||
16109446|NCT01296555|38889114|FG011|Overall Study|Physician Decision|0|||
16109447|NCT01296555|38889115|FG012|Overall Study|Physician Decision|0|||
16109448|NCT01296555|38889116|FG013|Overall Study|Physician Decision|1|||
16109449|NCT01296555|38889117|FG014|Overall Study|Physician Decision|0|||
16109450|NCT01296555|38889118|FG015|Overall Study|Physician Decision|0|||
16109451|NCT01296555|38889119|FG016|Overall Study|Physician Decision|0|||
16109452|NCT01296555|38889120|FG017|Overall Study|Physician Decision|0|||
16109453|NCT01296555|38889121|FG018|Overall Study|Physician Decision|0|||
16109454|NCT01296555|38889122|FG019|Overall Study|Physician Decision|1|||
16109455|NCT01296555|38889123|FG020|Overall Study|Physician Decision|0|||
16109456|NCT01296555|38889124|FG021|Overall Study|Physician Decision|0|||
16109457|NCT01296555|38889125|FG022|Overall Study|Physician Decision|0|||
16109458|NCT01296555|38889126|FG023|Overall Study|Physician Decision|0|||
16220537|NCT03345849|39286428|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
16220538|NCT03345849|39286429|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
16220539|NCT03345849|39286430|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
16220540|NCT03345849|39286427|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
16342855|NCT03178851|39741056|FG001|Overall Study|Lost to Follow-up|2|||
16109459|NCT01296555|38889127|FG024|Overall Study|Physician Decision|0|||
16109460|NCT01296555|38889128|FG025|Overall Study|Physician Decision|0|||
16220541|NCT03345849|39286428|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
16220542|NCT03345849|39286429|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
16543231|NCT02641392|40450457|FG002|Overall Study|Miscellaneous|3|||
16543232|NCT02641392|40450455|FG000|Overall Study|Death|0|||
16543233|NCT02641392|40450456|FG001|Overall Study|Death|0|||
16543234|NCT02641392|40450457|FG002|Overall Study|Death|1|||
16543235|NCT05050578|40450458|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
16543236|NCT05050578|40450459|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
16543237|NCT05050578|40450458|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
16543238|NCT05050578|40450459|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
16543239|NCT05050578|40450458|FG000|Period 2, 30 Days|Protocol Violation|0|||
16543240|NCT05050578|40450459|FG001|Period 2, 30 Days|Protocol Violation|1|||
16543241|NCT00658567|40450460|FG000|Overall Study|Adverse Event|5|||
16543242|NCT00658567|40450461|FG001|Overall Study|Adverse Event|2|||
16543243|NCT00658567|40450462|FG002|Overall Study|Adverse Event|3|||
16543244|NCT00658567|40450460|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
16543245|NCT00658567|40450461|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
16543246|NCT00658567|40450462|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
16543247|NCT00658567|40450460|FG000|Overall Study|Physician Decision|0|||
16543248|NCT00658567|40450461|FG001|Overall Study|Physician Decision|1|||
16543249|NCT00658567|40450462|FG002|Overall Study|Physician Decision|0|||
16543250|NCT00658567|40450460|FG000|Overall Study|At Discretion of Sponsor|1|||
16543251|NCT00658567|40450461|FG001|Overall Study|At Discretion of Sponsor|1|||
16543252|NCT00658567|40450462|FG002|Overall Study|At Discretion of Sponsor|1|||
16543253|NCT03976466|40450463|FG000|Overall Study|Lost to Follow-up|1|||
16543254|NCT03976466|40450464|FG001|Overall Study|Lost to Follow-up|3|||
16543255|NCT00641719|40450465|FG000|Overall Study|Lack of Efficacy|1|||
16220543|NCT03345849|39286430|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
16220544|NCT03345849|39286427|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
16220545|NCT03345849|39286428|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
16220546|NCT03345849|39286429|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
16109461|NCT01296555|38889129|FG026|Overall Study|Physician Decision|0|||
16109462|NCT01296555|38889130|FG027|Overall Study|Physician Decision|0|||
16109463|NCT01296555|38889131|FG028|Overall Study|Physician Decision|0|||
16109464|NCT01296555|38889103|FG000|Overall Study|Progressive Disease|6|||
16109465|NCT01296555|38889104|FG001|Overall Study|Progressive Disease|3|||
16543256|NCT00641719|40450466|FG001|Overall Study|Lack of Efficacy|2|||
16543257|NCT00641719|40450465|FG000|Overall Study|Adverse Event|24|||
16543258|NCT00641719|40450466|FG001|Overall Study|Adverse Event|29|||
16342856|NCT03178851|39741057|FG002|Overall Study|Lost to Follow-up|0|||
16109466|NCT01296555|38889105|FG002|Overall Study|Progressive Disease|3|||
16109467|NCT01296555|38889106|FG003|Overall Study|Progressive Disease|7|||
16109468|NCT01296555|38889107|FG004|Overall Study|Progressive Disease|6|||
16109469|NCT01296555|38889108|FG005|Overall Study|Progressive Disease|16|||
16342857|NCT03178851|39741055|FG000|Overall Study|Adverse Event|0|||
16543259|NCT00641719|40450465|FG000|Overall Study|Withdrawal by Subject|4|||
16220547|NCT03345849|39286430|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
16220548|NCT03345849|39286427|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
16220549|NCT03345849|39286428|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
16220550|NCT03345849|39286429|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
16220551|NCT03345849|39286430|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
16220552|NCT03345849|39286427|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
16220553|NCT03345849|39286428|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
16220554|NCT03345849|39286429|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
16220555|NCT03345849|39286430|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
16220556|NCT03345849|39286427|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
16220557|NCT03345849|39286428|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
16220558|NCT03345849|39286429|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
16220559|NCT03345849|39286430|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
16220560|NCT03345849|39286427|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
16220561|NCT03345849|39286428|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
16220562|NCT03345849|39286429|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
16220563|NCT03345849|39286430|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
16220564|NCT03345849|39286427|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
16220565|NCT03345849|39286428|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
16220566|NCT03345849|39286429|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
16220567|NCT03345849|39286430|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
16220568|NCT03345849|39286427|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
16220569|NCT03345849|39286428|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
16220570|NCT03345849|39286429|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
16220571|NCT03345849|39286430|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
16220572|NCT03035409|39286431|FG000|Overall Study|Adverse Event|5|||
16220573|NCT03035409|39286431|FG000|Overall Study|Death|2|||
16220574|NCT03035409|39286431|FG000|Overall Study|Withdrawal by Subject|2|||
16220575|NCT03035409|39286431|FG000|Overall Study|Non compliance|4|||
16220576|NCT03035409|39286431|FG000|Overall Study|Patient was jittery|1|||
16220577|NCT03035409|39286431|FG000|Overall Study|Did not like Questionnaire|1|||
16220578|NCT03035409|39286431|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
16220579|NCT03035409|39286431|FG000|Overall Study|Did not like taking drugs|1|||
16220580|NCT01195636|39286432|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
16543260|NCT00641719|40450466|FG001|Overall Study|Withdrawal by Subject|4|||
16543261|NCT00641719|40450465|FG000|Overall Study|Reason Not Specified|1|||
16543262|NCT00641719|40450466|FG001|Overall Study|Reason Not Specified|2|||
16543263|NCT01494584|40450474|FG000|Overall Study|Study Closed/Terminated|1|||
16543264|NCT00939484|40450476|FG000|Overall Study|Progression/Relapse|8|||
16543265|NCT00939484|40450477|FG001|Overall Study|Progression/Relapse|20|||
16109470|NCT01296555|38889109|FG006|Overall Study|Progressive Disease|16|||
16109471|NCT01296555|38889110|FG007|Overall Study|Progressive Disease|8|||
16109472|NCT01296555|38889111|FG008|Overall Study|Progressive Disease|7|||
16109473|NCT01296555|38889112|FG009|Overall Study|Progressive Disease|18|||
16109474|NCT01296555|38889113|FG010|Overall Study|Progressive Disease|7|||
16543266|NCT00939484|40450478|FG002|Overall Study|Progression/Relapse|3|||
16543267|NCT04605978|40450479|FG000|Overall Study|Adverse Event|2|||
16109475|NCT01296555|38889114|FG011|Overall Study|Progressive Disease|14|||
16543268|NCT04605978|40450480|FG001|Overall Study|Adverse Event|1|||
16543269|NCT04605978|40450479|FG000|Overall Study|Withdrawal nonmedical reason|1|||
16543270|NCT04605978|40450480|FG001|Overall Study|Withdrawal nonmedical reason|1|||
16543271|NCT02736825|40453569|FG000|Overall Study|Lost to Follow-up|10|||
16543272|NCT02736825|40453570|FG001|Overall Study|Lost to Follow-up|11|||
16543273|NCT02736825|40453569|FG000|Overall Study|Early Termination|0|||
16543274|NCT02736825|40453570|FG001|Overall Study|Early Termination|1|||
16543275|NCT03183388|40453574|FG000|Overall Study|Lost to Follow-up|3|||
16543276|NCT03183388|40453575|FG001|Overall Study|Lost to Follow-up|5|||
16543277|NCT03183388|40453574|FG000|Overall Study|Physician Decision|1|||
16543278|NCT03183388|40453575|FG001|Overall Study|Physician Decision|4|||
16543279|NCT03183388|40453574|FG000|Overall Study|Withdrawal by Subject|4|||
16543280|NCT03183388|40453575|FG001|Overall Study|Withdrawal by Subject|1|||
16543281|NCT03183388|40453574|FG000|Overall Study|Moved|1|||
16543282|NCT03183388|40453575|FG001|Overall Study|Moved|0|||
16543283|NCT03183388|40453574|FG000|Overall Study|Met Exclusion Criteria|2|||
16543284|NCT03183388|40453575|FG001|Overall Study|Met Exclusion Criteria|2|||
16543285|NCT03183388|40453574|FG000|Overall Study|COVID Pandemic Related|2|||
16543286|NCT03183388|40453575|FG001|Overall Study|COVID Pandemic Related|4|||
16109476|NCT01296555|38889115|FG012|Overall Study|Progressive Disease|5|||
16109477|NCT01296555|38889116|FG013|Overall Study|Progressive Disease|12|||
16109478|NCT01296555|38889117|FG014|Overall Study|Progressive Disease|1|||
16109479|NCT01296555|38889118|FG015|Overall Study|Progressive Disease|1|||
16109480|NCT01296555|38889119|FG016|Overall Study|Progressive Disease|0|||
16543287|NCT00457639|40453576|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
16109481|NCT01296555|38889120|FG017|Overall Study|Progressive Disease|0|||
16109482|NCT01296555|38889121|FG018|Overall Study|Progressive Disease|0|||
16109483|NCT01296555|38889122|FG019|Overall Study|Progressive Disease|1|||
16109484|NCT01296555|38889123|FG020|Overall Study|Progressive Disease|0|||
16109485|NCT01296555|38889124|FG021|Overall Study|Progressive Disease|0|||
16109486|NCT01296555|38889125|FG022|Overall Study|Progressive Disease|0|||
16109487|NCT01296555|38889126|FG023|Overall Study|Progressive Disease|0|||
16109488|NCT01296555|38889127|FG024|Overall Study|Progressive Disease|1|||
16109489|NCT01296555|38889128|FG025|Overall Study|Progressive Disease|0|||
16543288|NCT00457639|40453577|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
16543289|NCT00457639|40453576|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
16543290|NCT00457639|40453577|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
16543291|NCT00457639|40453576|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
16543292|NCT00457639|40453577|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
16543293|NCT03002610|40453579|FG000|Overall Study|Withdrawal by Subject|6|||
16543294|NCT03002610|40453580|FG001|Overall Study|Withdrawal by Subject|25|||
16543295|NCT03002610|40453581|FG002|Overall Study|Withdrawal by Subject|13|||
16543296|NCT04247282|40453584|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
16543297|NCT04247282|40453585|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
16543298|NCT04247282|40453586|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
16543299|NCT04247282|40453587|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
16543300|NCT04247282|40453584|FG000|Overall Study|Refused further treatment|0|||
16543301|NCT04247282|40453585|FG001|Overall Study|Refused further treatment|1|||
16543302|NCT04247282|40453586|FG002|Overall Study|Refused further treatment|0|||
16543303|NCT04247282|40453587|FG003|Overall Study|Refused further treatment|0|||
16543304|NCT02535364|40453588|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
16543305|NCT02535364|40453588|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
16543306|NCT02535364|40453588|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
16543307|NCT02535364|40453588|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
16543308|NCT02535364|40453588|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
16543309|NCT02535364|40453588|FG000|Part B Screening|Death|2|||
16543310|NCT02535364|40453588|FG000|Part B Screening|Physician Decision|1|||
16543311|NCT02535364|40453588|FG000|Part B Screening|Withdrawal by Subject|1|||
16543312|NCT02535364|40453588|FG000|Part B Screening|Adverse Event|1|||
16543313|NCT02535364|40453588|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
16109490|NCT01296555|38889129|FG026|Overall Study|Progressive Disease|5|||
16109491|NCT01296555|38889130|FG027|Overall Study|Progressive Disease|1|||
16109492|NCT01296555|38889131|FG028|Overall Study|Progressive Disease|0|||
16109493|NCT01296555|38889103|FG000|Overall Study|Protocol Violation|0|||
16543314|NCT02535364|40453588|FG000|Study Treatment|Death|1|||
16543315|NCT02535364|40453588|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
16543316|NCT02535364|40453588|FG000|12-Month Follow-up Period|Disease progression|22|||
16543317|NCT02535364|40453588|FG000|12-Month Follow-up Period|Death|5|||
16543318|NCT02535364|40453588|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
16543319|NCT02535364|40453588|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
16543320|NCT02535364|40453588|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
16543321|NCT01264380|40453590|FG000|Period C|Disease Progression|0|||
16543322|NCT01264380|40453591|FG001|Period C|Disease Progression|0|||
16543323|NCT01264380|40453592|FG002|Period C|Disease Progression|4|||
16543324|NCT01264380|40453590|FG000|Period C|Death|0|||
16543325|NCT01264380|40453591|FG001|Period C|Death|0|||
16543326|NCT01264380|40453592|FG002|Period C|Death|2|||
16543327|NCT01264380|40453590|FG000|Period C|Follow-up for survival status|0|||
16109494|NCT01296555|38889104|FG001|Overall Study|Protocol Violation|0|||
16109495|NCT01296555|38889105|FG002|Overall Study|Protocol Violation|0|||
16109496|NCT01296555|38889106|FG003|Overall Study|Protocol Violation|0|||
16109497|NCT01296555|38889107|FG004|Overall Study|Protocol Violation|0|||
16109498|NCT01296555|38889108|FG005|Overall Study|Protocol Violation|0|||
16109499|NCT01296555|38889109|FG006|Overall Study|Protocol Violation|0|||
16109500|NCT01296555|38889110|FG007|Overall Study|Protocol Violation|0|||
16109501|NCT01296555|38889111|FG008|Overall Study|Protocol Violation|0|||
16109502|NCT01296555|38889112|FG009|Overall Study|Protocol Violation|0|||
16109503|NCT01296555|38889113|FG010|Overall Study|Protocol Violation|0|||
16109504|NCT01296555|38889114|FG011|Overall Study|Protocol Violation|0|||
16109505|NCT01296555|38889115|FG012|Overall Study|Protocol Violation|0|||
16109506|NCT01296555|38889116|FG013|Overall Study|Protocol Violation|1|||
16543328|NCT01264380|40453591|FG001|Period C|Follow-up for survival status|0|||
16543329|NCT01264380|40453592|FG002|Period C|Follow-up for survival status|6|||
16543330|NCT01264380|40453590|FG000|Period C|Withdrawal by Subject|0|||
16543331|NCT01264380|40453591|FG001|Period C|Withdrawal by Subject|0|||
16543332|NCT01264380|40453592|FG002|Period C|Withdrawal by Subject|1|||
16543333|NCT01264380|40453590|FG000|Period C|Adverse Event|0|||
16543334|NCT01264380|40453591|FG001|Period C|Adverse Event|0|||
16543335|NCT01264380|40453592|FG002|Period C|Adverse Event|1|||
16109507|NCT01296555|38889117|FG014|Overall Study|Protocol Violation|0|||
16109508|NCT01296555|38889118|FG015|Overall Study|Protocol Violation|0|||
16109509|NCT01296555|38889119|FG016|Overall Study|Protocol Violation|0|||
16109510|NCT01296555|38889120|FG017|Overall Study|Protocol Violation|0|||
16109511|NCT01296555|38889121|FG018|Overall Study|Protocol Violation|0|||
16109512|NCT01296555|38889122|FG019|Overall Study|Protocol Violation|0|||
16109513|NCT01296555|38889123|FG020|Overall Study|Protocol Violation|0|||
16109514|NCT01296555|38889124|FG021|Overall Study|Protocol Violation|0|||
16109515|NCT01296555|38889125|FG022|Overall Study|Protocol Violation|0|||
16109516|NCT01296555|38889126|FG023|Overall Study|Protocol Violation|0|||
16109517|NCT01296555|38889127|FG024|Overall Study|Protocol Violation|0|||
16109518|NCT01296555|38889128|FG025|Overall Study|Protocol Violation|0|||
16109519|NCT01296555|38889129|FG026|Overall Study|Protocol Violation|0|||
16109520|NCT01296555|38889130|FG027|Overall Study|Protocol Violation|0|||
16109521|NCT01296555|38889131|FG028|Overall Study|Protocol Violation|0|||
16109522|NCT01296555|38889103|FG000|Overall Study|Study Terminated By Sponsor|0|||
16109523|NCT01296555|38889104|FG001|Overall Study|Study Terminated By Sponsor|0|||
16109524|NCT01296555|38889105|FG002|Overall Study|Study Terminated By Sponsor|0|||
16109525|NCT01296555|38889106|FG003|Overall Study|Study Terminated By Sponsor|0|||
16109526|NCT01296555|38889107|FG004|Overall Study|Study Terminated By Sponsor|0|||
16109527|NCT01296555|38889108|FG005|Overall Study|Study Terminated By Sponsor|0|||
16109528|NCT01296555|38889109|FG006|Overall Study|Study Terminated By Sponsor|0|||
16109529|NCT01296555|38889110|FG007|Overall Study|Study Terminated By Sponsor|0|||
16109530|NCT01296555|38889111|FG008|Overall Study|Study Terminated By Sponsor|0|||
16109531|NCT01296555|38889112|FG009|Overall Study|Study Terminated By Sponsor|0|||
16109532|NCT01296555|38889113|FG010|Overall Study|Study Terminated By Sponsor|0|||
16109533|NCT01296555|38889114|FG011|Overall Study|Study Terminated By Sponsor|0|||
16109534|NCT01296555|38889115|FG012|Overall Study|Study Terminated By Sponsor|0|||
16407198|NCT00977938|39970075|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
16407199|NCT00977938|39970076|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
16407200|NCT00977938|39970077|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
16407201|NCT00977938|39970078|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
16407202|NCT00977938|39970075|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
16407203|NCT00977938|39970076|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
16407204|NCT00977938|39970077|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
16407205|NCT00977938|39970078|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
16407206|NCT00977938|39970075|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
16407207|NCT00977938|39970076|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
16407208|NCT00977938|39970077|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
16407209|NCT00977938|39970078|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
16407210|NCT02182440|39970080|FG000|Overall Study|Adverse Event|0|||
16407211|NCT02182440|39970081|FG001|Overall Study|Adverse Event|1|||
16407212|NCT02182440|39970082|FG002|Overall Study|Adverse Event|0|||
16407213|NCT02182440|39970083|FG003|Overall Study|Adverse Event|0|||
16407214|NCT02182440|39970080|FG000|Overall Study|Death|31|||
16407215|NCT02182440|39970081|FG001|Overall Study|Death|8|||
16407216|NCT02182440|39970082|FG002|Overall Study|Death|5|||
16407217|NCT02182440|39970083|FG003|Overall Study|Death|16|||
16407218|NCT02182440|39970080|FG000|Overall Study|Protocol Violation|0|||
16407219|NCT02182440|39970081|FG001|Overall Study|Protocol Violation|1|||
16407220|NCT02182440|39970082|FG002|Overall Study|Protocol Violation|0|||
16407221|NCT02182440|39970083|FG003|Overall Study|Protocol Violation|0|||
16407222|NCT02182440|39970080|FG000|Overall Study|Physician Decision|1|||
16407223|NCT02182440|39970081|FG001|Overall Study|Physician Decision|0|||
16407224|NCT02182440|39970082|FG002|Overall Study|Physician Decision|0|||
16407225|NCT02182440|39970083|FG003|Overall Study|Physician Decision|0|||
16407226|NCT02182440|39970080|FG000|Overall Study|Withdrawal by Subject|1|||
16109535|NCT01296555|38889116|FG013|Overall Study|Study Terminated By Sponsor|0|||
16109536|NCT01296555|38889117|FG014|Overall Study|Study Terminated By Sponsor|0|||
16109537|NCT01296555|38889118|FG015|Overall Study|Study Terminated By Sponsor|0|||
16111469|NCT00760747|38897275|FG001|Study Period III|Lack of Efficacy|0|||
16109538|NCT01296555|38889119|FG016|Overall Study|Study Terminated By Sponsor|0|||
16109539|NCT01296555|38889120|FG017|Overall Study|Study Terminated By Sponsor|0|||
16109540|NCT01296555|38889121|FG018|Overall Study|Study Terminated By Sponsor|0|||
16109541|NCT01296555|38889122|FG019|Overall Study|Study Terminated By Sponsor|0|||
16109542|NCT01296555|38889123|FG020|Overall Study|Study Terminated By Sponsor|0|||
16109543|NCT01296555|38889124|FG021|Overall Study|Study Terminated By Sponsor|0|||
16109544|NCT01296555|38889125|FG022|Overall Study|Study Terminated By Sponsor|0|||
16109545|NCT01296555|38889126|FG023|Overall Study|Study Terminated By Sponsor|0|||
16109546|NCT01296555|38889127|FG024|Overall Study|Study Terminated By Sponsor|0|||
16109547|NCT01296555|38889128|FG025|Overall Study|Study Terminated By Sponsor|1|||
16109548|NCT01296555|38889129|FG026|Overall Study|Study Terminated By Sponsor|0|||
16109549|NCT01296555|38889130|FG027|Overall Study|Study Terminated By Sponsor|0|||
16109550|NCT01296555|38889131|FG028|Overall Study|Study Terminated By Sponsor|0|||
16109551|NCT01296555|38889103|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109552|NCT01296555|38889104|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109553|NCT01296555|38889105|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109554|NCT01296555|38889106|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109555|NCT01296555|38889107|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109556|NCT01296555|38889108|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109557|NCT01296555|38889109|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16407227|NCT02182440|39970081|FG001|Overall Study|Withdrawal by Subject|1|||
16407228|NCT02182440|39970082|FG002|Overall Study|Withdrawal by Subject|3|||
16407229|NCT02182440|39970083|FG003|Overall Study|Withdrawal by Subject|4|||
16407230|NCT02182440|39970080|FG000|Overall Study|different, e.g adm other hospital|12|||
16407231|NCT02182440|39970081|FG001|Overall Study|different, e.g adm other hospital|3|||
16407232|NCT02182440|39970082|FG002|Overall Study|different, e.g adm other hospital|3|||
16407233|NCT02182440|39970083|FG003|Overall Study|different, e.g adm other hospital|10|||
16407234|NCT00445848|39970090|FG000|Overall Study|Adverse Event|14|||
16407235|NCT00445848|39970090|FG000|Overall Study|Withdrawal by Subject|4|||
16407236|NCT00445848|39970090|FG000|Overall Study|Progression|62|||
16407237|NCT00445848|39970090|FG000|Overall Study|Other-Not protocol specified|5|||
16543336|NCT00509236|40453593|FG000|Overall Study|Adverse Event|7|||
16109558|NCT01296555|38889110|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16342858|NCT03178851|39741056|FG001|Overall Study|Adverse Event|0|||
16342859|NCT03178851|39741057|FG002|Overall Study|Adverse Event|1|||
16342860|NCT03178851|39741055|FG000|Overall Study|Study Termination by Sponsor|31|||
16543337|NCT00509236|40453594|FG001|Overall Study|Adverse Event|9|||
16543338|NCT00509236|40453593|FG000|Overall Study|Withdrawal by Subject|5|||
16543339|NCT00509236|40453594|FG001|Overall Study|Withdrawal by Subject|10|||
16543340|NCT00509236|40453593|FG000|Overall Study|Protocol Violation|3|||
16543341|NCT00509236|40453594|FG001|Overall Study|Protocol Violation|0|||
16342861|NCT03178851|39741056|FG001|Overall Study|Study Termination by Sponsor|7|||
16342862|NCT03178851|39741057|FG002|Overall Study|Study Termination by Sponsor|26|||
16342863|NCT02501161|39741058|FG000|Overall Study|Adverse Event|2|||
16342864|NCT02501161|39741059|FG001|Overall Study|Adverse Event|6|||
16342865|NCT02501161|39741058|FG000|Overall Study|Lost to Follow-up|7|||
16342866|NCT02501161|39741059|FG001|Overall Study|Lost to Follow-up|4|||
16342867|NCT02501161|39741058|FG000|Overall Study|Withdrawal by Subject|10|||
16342868|NCT02501161|39741059|FG001|Overall Study|Withdrawal by Subject|15|||
16342869|NCT02501161|39741058|FG000|Overall Study|Other|3|||
16543342|NCT00509236|40453593|FG000|Overall Study|Excluded Medication|1|||
16543343|NCT00509236|40453594|FG001|Overall Study|Excluded Medication|1|||
16543344|NCT00509236|40453593|FG000|Overall Study|Scheduled Kidney Transplant|1|||
16543345|NCT00509236|40453594|FG001|Overall Study|Scheduled Kidney Transplant|0|||
16543346|NCT01931735|40453595|FG000|Randomized Phase|Lost to Follow-up|2|||
16543347|NCT01931735|40453596|FG001|Randomized Phase|Lost to Follow-up|2|||
16543348|NCT01931735|40453597|FG002|Randomized Phase|Lost to Follow-up|5|||
16543349|NCT01931735|40453598|FG003|Randomized Phase|Lost to Follow-up|0|||
16543350|NCT01931735|40453595|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
16543351|NCT01931735|40453596|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
16543352|NCT01931735|40453597|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
16543353|NCT01931735|40453598|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
16543354|NCT01931735|40453595|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
16543355|NCT01931735|40453596|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
16543356|NCT01931735|40453597|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
16543357|NCT01931735|40453598|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
16543358|NCT01435655|40453602|FG000|Overall Study|Death|2|||
16109559|NCT01296555|38889111|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16407238|NCT02230683|39973160|FG000|Overall Study|Adverse Event|1|||
16407239|NCT01665430|39973161|FG000|Overall Study|Adverse Event|1|||
16407240|NCT01665430|39973161|FG000|Overall Study|Withdrawal by Subject|6|||
16407241|NCT01665430|39973161|FG000|Overall Study|Other Unspecified|2|||
16543359|NCT01435655|40453602|FG000|Overall Study|Other|1|||
16543360|NCT02831257|40453605|FG000|Overall Study|Lack of Efficacy|3|||
16543361|NCT02831257|40453605|FG000|Overall Study|Adverse Event|2|||
16342870|NCT02501161|39741059|FG001|Overall Study|Other|0|||
16342871|NCT02290925|39741060|FG000|First Period of Three Months|Lost to Follow-up|2|||
16109560|NCT01296555|38889112|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16342872|NCT02290925|39741061|FG001|First Period of Three Months|Lost to Follow-up|1|||
16342873|NCT02290925|39741060|FG000|First Period of Three Months|Death|1|||
16342874|NCT02290925|39741061|FG001|First Period of Three Months|Death|0|||
16342875|NCT02290925|39741060|FG000|First Period of Three Months|Insulin Started|1|||
16342876|NCT02290925|39741061|FG001|First Period of Three Months|Insulin Started|1|||
16342877|NCT02290925|39741060|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
16342878|NCT02290925|39741061|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
16342879|NCT02290925|39741060|FG000|Second Period of 3 Months|insulin started|0|||
16342880|NCT02290925|39741061|FG001|Second Period of 3 Months|insulin started|1|||
16342881|NCT03360019|39741062|FG000|Overall Study|Withdrawal by Subject|2|||
16342882|NCT03360019|39741063|FG001|Overall Study|Withdrawal by Subject|0|||
16342883|NCT03360019|39741064|FG002|Overall Study|Withdrawal by Subject|0|||
16342884|NCT03360019|39741062|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
16342885|NCT03360019|39741063|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
16342886|NCT03360019|39741064|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
16342887|NCT00645671|39741067|FG000|Overall Study|Protocol Violation|1|||
16342888|NCT00645671|39741068|FG001|Overall Study|Protocol Violation|0|||
16342889|NCT00645671|39741067|FG000|Overall Study|Withdrawal by Subject|0|||
16342890|NCT00645671|39741068|FG001|Overall Study|Withdrawal by Subject|4|||
16342891|NCT00645671|39741067|FG000|Overall Study|Adverse Event|0|||
16342892|NCT00645671|39741068|FG001|Overall Study|Adverse Event|1|||
16342893|NCT00645671|39741067|FG000|Overall Study|Physician Decision|0|||
16342894|NCT00645671|39741068|FG001|Overall Study|Physician Decision|1|||
16342895|NCT01911780|39741069|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
16342896|NCT01911780|39741070|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
16342897|NCT01911780|39741069|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
16342898|NCT01911780|39741070|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
16342899|NCT01911780|39741069|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
16342900|NCT01911780|39741070|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
16342901|NCT01911780|39741069|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
16342902|NCT01911780|39741070|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
16342903|NCT01911780|39741069|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
16342904|NCT01911780|39741070|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
16342905|NCT01911780|39741069|FG000|Extension Period (52 Weeks)|Personal reason|1|||
16342906|NCT01911780|39741070|FG001|Extension Period (52 Weeks)|Personal reason|1|||
16342907|NCT02769312|39741071|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
16342908|NCT02769312|39741072|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
16342909|NCT02769312|39741071|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
16342910|NCT02769312|39741072|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
16342911|NCT02769312|39741071|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
16342912|NCT02769312|39741072|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
16342913|NCT02769312|39741071|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
16342914|NCT02769312|39741072|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
16342915|NCT02769312|39741071|FG000|Follow-up|Lost to Follow-up|1|||
16342916|NCT02769312|39741072|FG001|Follow-up|Lost to Follow-up|1|||
16342917|NCT02559570|39741073|FG000|Overall Study|Adverse Event|0|||
16342918|NCT02559570|39741074|FG001|Overall Study|Adverse Event|2|||
16342919|NCT02559570|39741075|FG002|Overall Study|Adverse Event|0|||
16342920|NCT02559570|39741076|FG003|Overall Study|Adverse Event|1|||
16342921|NCT02559570|39741077|FG004|Overall Study|Adverse Event|0|||
16342922|NCT02559570|39741073|FG000|Overall Study|Withdrawal of Consent|0|||
16342923|NCT02559570|39741074|FG001|Overall Study|Withdrawal of Consent|0|||
16342924|NCT02559570|39741075|FG002|Overall Study|Withdrawal of Consent|1|||
16342925|NCT02559570|39741076|FG003|Overall Study|Withdrawal of Consent|2|||
16342926|NCT02559570|39741077|FG004|Overall Study|Withdrawal of Consent|1|||
16342927|NCT02559570|39741073|FG000|Overall Study|Lost to Follow-up|1|||
16342928|NCT02559570|39741074|FG001|Overall Study|Lost to Follow-up|0|||
16109561|NCT01296555|38889113|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16342929|NCT02559570|39741075|FG002|Overall Study|Lost to Follow-up|0|||
16407242|NCT02231762|39973162|FG000|Combination Phase|Adverse Event|10|||
16109562|NCT01296555|38889114|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16342930|NCT02559570|39741076|FG003|Overall Study|Lost to Follow-up|0|||
16342931|NCT02559570|39741077|FG004|Overall Study|Lost to Follow-up|0|||
16342932|NCT02559570|39741073|FG000|Overall Study|Protocol Violation|1|||
16342933|NCT02559570|39741074|FG001|Overall Study|Protocol Violation|0|||
16342934|NCT02559570|39741075|FG002|Overall Study|Protocol Violation|0|||
16342935|NCT02559570|39741076|FG003|Overall Study|Protocol Violation|0|||
16342936|NCT02559570|39741077|FG004|Overall Study|Protocol Violation|1|||
16342937|NCT02559570|39741073|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16342938|NCT02559570|39741074|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16342939|NCT02559570|39741075|FG002|Overall Study|Other Miscellaneous Reasons|1|||
16342940|NCT02559570|39741076|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16342941|NCT02559570|39741077|FG004|Overall Study|Other Miscellaneous Reasons|0|||
16342942|NCT02697916|39741080|FG000|Overall Study|Death|357|||
16342943|NCT02697916|39741081|FG001|Overall Study|Death|315|||
16342944|NCT02697916|39741080|FG000|Overall Study|Withdrawal by Subject|221|||
16342945|NCT02697916|39741081|FG001|Overall Study|Withdrawal by Subject|393|||
16342946|NCT00662311|39741084|FG000|Overall Study|Respiratory Infection|1|||
16342947|NCT00662311|39741085|FG001|Overall Study|Respiratory Infection|0|||
16342948|NCT00662311|39741086|FG002|Overall Study|Respiratory Infection|0|||
16342949|NCT01090050|39741087|FG000|Overall Study|Lost to Follow-up|0|||
16342950|NCT01090050|39741088|FG001|Overall Study|Lost to Follow-up|1|||
16407243|NCT02231762|39973163|FG001|Combination Phase|Adverse Event|0|||
16407244|NCT02231762|39973164|FG002|Combination Phase|Adverse Event|0|||
16407245|NCT02231762|39973165|FG003|Combination Phase|Adverse Event|0|||
16342951|NCT01090050|39741087|FG000|Overall Study|Lack of Efficacy|1|||
16407246|NCT02231762|39973162|FG000|Combination Phase|Withdrawal by Subject|2|||
16407247|NCT02231762|39973163|FG001|Combination Phase|Withdrawal by Subject|0|||
16407248|NCT02231762|39973164|FG002|Combination Phase|Withdrawal by Subject|0|||
16407249|NCT02231762|39973165|FG003|Combination Phase|Withdrawal by Subject|0|||
16407250|NCT02231762|39973162|FG000|Combination Phase|Disease Progression|6|||
16407251|NCT02231762|39973163|FG001|Combination Phase|Disease Progression|0|||
16407252|NCT02231762|39973164|FG002|Combination Phase|Disease Progression|0|||
16109563|NCT01296555|38889115|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16407253|NCT02231762|39973165|FG003|Combination Phase|Disease Progression|0|||
16407254|NCT02231762|39973162|FG000|Combination Phase|Did not meet inclusion criteria|1|||
16109564|NCT01296555|38889116|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109565|NCT01296555|38889117|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109566|NCT01296555|38889118|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109567|NCT01296555|38889119|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109568|NCT01296555|38889120|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109569|NCT01296555|38889121|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109570|NCT01296555|38889122|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
16109571|NCT01296555|38889123|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109572|NCT01296555|38889124|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109573|NCT01296555|38889125|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109574|NCT01296555|38889126|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109575|NCT01296555|38889127|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16220581|NCT01195636|39286433|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
16220582|NCT01195636|39286432|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
16220583|NCT01195636|39286433|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
16220584|NCT01195636|39286432|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16220585|NCT01195636|39286433|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
16220586|NCT01195636|39286432|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
16220587|NCT01195636|39286433|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
16220588|NCT01195636|39286432|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
16220589|NCT01195636|39286433|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
16220590|NCT01195636|39286432|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
16220591|NCT01195636|39286433|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
16220592|NCT01195636|39286432|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
16220593|NCT01195636|39286433|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
16220594|NCT01195636|39286432|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
16220595|NCT01195636|39286433|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
16220596|NCT02576652|39286434|FG000|Overall Study|Withdrawal by Subject|2|||
16220597|NCT00305773|39286435|FG000|Overall Study|Death|3|||
16220598|NCT00305773|39286436|FG001|Overall Study|Death|2|||
16220599|NCT00305773|39286435|FG000|Overall Study|Adverse Event|1|||
16220600|NCT00305773|39286436|FG001|Overall Study|Adverse Event|2|||
16220601|NCT00305773|39286435|FG000|Overall Study|Alternative Treatment|4|||
16220602|NCT00305773|39286436|FG001|Overall Study|Alternative Treatment|4|||
16220603|NCT00305773|39286435|FG000|Overall Study|Physician Decision|1|||
16220604|NCT00305773|39286436|FG001|Overall Study|Physician Decision|1|||
16220605|NCT00305773|39286435|FG000|Overall Study|Withdrawal by Subject|1|||
16109576|NCT01296555|38889128|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16220606|NCT00305773|39286436|FG001|Overall Study|Withdrawal by Subject|4|||
16220607|NCT00305773|39286435|FG000|Overall Study|Disease Progression|1|||
16220608|NCT00305773|39286436|FG001|Overall Study|Disease Progression|3|||
16220609|NCT00305773|39286435|FG000|Overall Study|All other reasons|3|||
16220610|NCT00305773|39286436|FG001|Overall Study|All other reasons|2|||
16220611|NCT00170846|39286441|FG000|Overall Study|Subject withdrew Informed Consent|5|||
16220612|NCT00170846|39286442|FG001|Overall Study|Subject withdrew Informed Consent|12|||
16220613|NCT00170846|39286443|FG002|Overall Study|Subject withdrew Informed Consent|8|||
16220614|NCT00170846|39286441|FG000|Overall Study|Lost to Follow-up|6|||
16220615|NCT00170846|39286442|FG001|Overall Study|Lost to Follow-up|3|||
16220616|NCT00170846|39286443|FG002|Overall Study|Lost to Follow-up|2|||
16220617|NCT00170846|39286441|FG000|Overall Study|Death|0|||
16220618|NCT00170846|39286442|FG001|Overall Study|Death|3|||
16220619|NCT00170846|39286443|FG002|Overall Study|Death|3|||
16220620|NCT00170846|39286441|FG000|Overall Study|Reason Missing|0|||
16220621|NCT00170846|39286442|FG001|Overall Study|Reason Missing|1|||
16220622|NCT00170846|39286443|FG002|Overall Study|Reason Missing|0|||
16220623|NCT01796106|39286444|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
16220624|NCT01796106|39286445|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
16220625|NCT03812224|39286451|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
16220626|NCT03812224|39286452|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
16220627|NCT03812224|39286451|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
16220628|NCT03812224|39286452|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
16220629|NCT03812224|39286451|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
16220630|NCT03812224|39286452|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
16220631|NCT03812224|39286451|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
16220632|NCT03812224|39286452|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
16220633|NCT03322540|39286456|FG000|Overall Study|Death|21|||
16220634|NCT03322540|39286457|FG001|Overall Study|Death|28|||
16220635|NCT03322540|39286456|FG000|Overall Study|Lost to Follow-up|0|||
16220636|NCT03322540|39286457|FG001|Overall Study|Lost to Follow-up|1|||
16220637|NCT03322540|39286456|FG000|Overall Study|Physician Decision|7|||
16220638|NCT03322540|39286457|FG001|Overall Study|Physician Decision|6|||
16220639|NCT03322540|39286456|FG000|Overall Study|Withdrawal by Subject|3|||
16220640|NCT03322540|39286457|FG001|Overall Study|Withdrawal by Subject|1|||
16220641|NCT03322540|39286456|FG000|Overall Study|Study terminated by sponsor|0|||
16220642|NCT03322540|39286457|FG001|Overall Study|Study terminated by sponsor|1|||
16220643|NCT02813681|39286458|FG000|Overall Study|Physician Decision|5|||
16220644|NCT02813681|39286459|FG001|Overall Study|Physician Decision|5|||
16220645|NCT02813681|39286460|FG002|Overall Study|Physician Decision|0|||
16220646|NCT02813681|39286458|FG000|Overall Study|Lost to Follow-up|0|||
16543362|NCT02831257|40453605|FG000|Overall Study|Physician Decision|1|||
16543363|NCT02831257|40453605|FG000|Overall Study|Withdrawal by Subject|6|||
16543364|NCT02172625|40453608|FG000|Overall Study|Adverse Event|0|||
16543365|NCT02172625|40453609|FG001|Overall Study|Adverse Event|1|||
16543366|NCT02172625|40453608|FG000|Overall Study|Pregnancy|0|||
16543367|NCT02172625|40453609|FG001|Overall Study|Pregnancy|1|||
16543368|NCT02172625|40453608|FG000|Overall Study|car accident|0|||
16543369|NCT02172625|40453609|FG001|Overall Study|car accident|1|||
16543370|NCT02709005|40453610|FG000|Overall Study|Lost to Follow-up|1|||
16543371|NCT02709005|40453611|FG001|Overall Study|Lost to Follow-up|1|||
16220647|NCT02813681|39286459|FG001|Overall Study|Lost to Follow-up|1|||
16220648|NCT02813681|39286460|FG002|Overall Study|Lost to Follow-up|0|||
16543372|NCT02709005|40453610|FG000|Overall Study|Withdrawal by Subject|3|||
16543373|NCT02709005|40453611|FG001|Overall Study|Withdrawal by Subject|0|||
16220649|NCT03557801|39286465|FG000|Overall Study|Protocol Violation|1|||
16543374|NCT00991341|40453612|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
16543375|NCT00991341|40453613|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
16543376|NCT00991341|40453612|FG000|Overall Study|Death|3|||
16543377|NCT00991341|40453613|FG001|Overall Study|Death|0|||
16543378|NCT00991341|40453612|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
16543379|NCT00991341|40453613|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
16543380|NCT00991341|40453612|FG000|Overall Study|Physician Decision|1|||
16220650|NCT03557801|39286466|FG001|Overall Study|Protocol Violation|0|||
16543381|NCT00991341|40453613|FG001|Overall Study|Physician Decision|2|||
16543382|NCT00991341|40453612|FG000|Overall Study|Withdrawal by Subject|3|||
16543383|NCT00991341|40453613|FG001|Overall Study|Withdrawal by Subject|4|||
16543384|NCT00674570|40453614|FG000|Overall Study|Withdrawal by Subject|0|||
16543385|NCT00674570|40453615|FG001|Overall Study|Withdrawal by Subject|2|||
16543386|NCT00674570|40453616|FG002|Overall Study|Withdrawal by Subject|0|||
16543387|NCT01412801|40453617|FG000|Overall Study|Death|0|||
16543388|NCT01412801|40453618|FG001|Overall Study|Death|1|||
16543389|NCT01412801|40453619|FG002|Overall Study|Death|0|||
16543390|NCT01412801|40453620|FG003|Overall Study|Death|4|||
16543391|NCT01412801|40453621|FG004|Overall Study|Death|2|||
16543392|NCT01412801|40453622|FG005|Overall Study|Death|2|||
16543393|NCT01412801|40453617|FG000|Overall Study|Lost to Follow-up|1|||
16543394|NCT01412801|40453618|FG001|Overall Study|Lost to Follow-up|2|||
16543395|NCT01412801|40453619|FG002|Overall Study|Lost to Follow-up|4|||
16543396|NCT01412801|40453620|FG003|Overall Study|Lost to Follow-up|0|||
16543397|NCT01412801|40453621|FG004|Overall Study|Lost to Follow-up|1|||
16543398|NCT01412801|40453622|FG005|Overall Study|Lost to Follow-up|1|||
16543399|NCT01412801|40453617|FG000|Overall Study|Withdrawal by Subject|3|||
16543400|NCT01412801|40453618|FG001|Overall Study|Withdrawal by Subject|2|||
16543401|NCT01412801|40453619|FG002|Overall Study|Withdrawal by Subject|1|||
16543402|NCT01412801|40453620|FG003|Overall Study|Withdrawal by Subject|0|||
16543403|NCT01412801|40453621|FG004|Overall Study|Withdrawal by Subject|0|||
16543404|NCT01412801|40453622|FG005|Overall Study|Withdrawal by Subject|0|||
16220651|NCT03557801|39286467|FG002|Overall Study|Protocol Violation|0|||
16220652|NCT03557801|39286465|FG000|Overall Study|Withdrawal by Subject|1|||
16543405|NCT01412801|40453617|FG000|Overall Study|Relocated to another area|0|||
16543406|NCT01412801|40453618|FG001|Overall Study|Relocated to another area|0|||
16220653|NCT03557801|39286466|FG001|Overall Study|Withdrawal by Subject|0|||
16220654|NCT03557801|39286467|FG002|Overall Study|Withdrawal by Subject|3|||
16220655|NCT03557801|39286465|FG000|Overall Study|Lost to Follow-up|0|||
16220656|NCT03557801|39286466|FG001|Overall Study|Lost to Follow-up|1|||
16220657|NCT03557801|39286467|FG002|Overall Study|Lost to Follow-up|0|||
16220658|NCT00925522|39286469|FG000|Overall Study|study closed -- business decision|20|||
16220659|NCT04107935|39286472|FG000|Overall Study|Death|1|||
16220660|NCT04107935|39286473|FG001|Overall Study|Death|0|||
16220661|NCT00890201|39286481|FG000|Overall Study|Protocol Violation|5|||
16220662|NCT00890201|39286482|FG001|Overall Study|Protocol Violation|56|||
16220663|NCT00842829|39286483|FG000|Dose Titration Period|Adverse Event|11|||
16220664|NCT00842829|39286484|FG001|Dose Titration Period|Adverse Event|10|||
16220665|NCT00842829|39286485|FG002|Dose Titration Period|Adverse Event|0|||
16220666|NCT00842829|39286483|FG000|Dose Titration Period|Lack of Efficacy|4|||
16220667|NCT00842829|39286484|FG001|Dose Titration Period|Lack of Efficacy|1|||
16220668|NCT00842829|39286485|FG002|Dose Titration Period|Lack of Efficacy|0|||
16220669|NCT00842829|39286483|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
16220670|NCT00842829|39286484|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
16220671|NCT00842829|39286485|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
16220672|NCT00842829|39286483|FG000|Dose Titration Period|Withdrawal by Subject|2|||
16220673|NCT00842829|39286484|FG001|Dose Titration Period|Withdrawal by Subject|6|||
16220674|NCT00842829|39286485|FG002|Dose Titration Period|Withdrawal by Subject|0|||
16220675|NCT00842829|39286483|FG000|Dose Titration Period|Other|5|||
16220676|NCT00842829|39286484|FG001|Dose Titration Period|Other|4|||
16220677|NCT00842829|39286485|FG002|Dose Titration Period|Other|0|||
16220678|NCT00842829|39286483|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
16220679|NCT00842829|39286484|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
16220680|NCT00842829|39286485|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
16220681|NCT00842829|39286483|FG000|Dose Titration Period|Non-compliance to study drug|2|||
16220682|NCT00842829|39286484|FG001|Dose Titration Period|Non-compliance to study drug|1|||
16220683|NCT00842829|39286485|FG002|Dose Titration Period|Non-compliance to study drug|0|||
16220684|NCT00842829|39286483|FG000|Treatment Period|Adverse Event|0|||
16220685|NCT00842829|39286484|FG001|Treatment Period|Adverse Event|0|||
16543407|NCT01412801|40453619|FG002|Overall Study|Relocated to another area|2|||
16220686|NCT00842829|39286485|FG002|Treatment Period|Adverse Event|15|||
16220687|NCT00842829|39286483|FG000|Treatment Period|Lack of Efficacy|0|||
16220688|NCT00842829|39286484|FG001|Treatment Period|Lack of Efficacy|0|||
16220689|NCT00842829|39286485|FG002|Treatment Period|Lack of Efficacy|6|||
16220690|NCT00842829|39286483|FG000|Treatment Period|Unstable persistent cancer pain|0|||
16543408|NCT01412801|40453620|FG003|Overall Study|Relocated to another area|0|||
16543409|NCT01412801|40453621|FG004|Overall Study|Relocated to another area|0|||
16543410|NCT01412801|40453622|FG005|Overall Study|Relocated to another area|0|||
16543411|NCT02192970|40453623|FG000|Overall Study|Lost to Follow-up|6|||
16543412|NCT02192970|40453624|FG001|Overall Study|Lost to Follow-up|0|||
16543413|NCT02207725|40453627|FG000|Overall Study|Did Not Receive Treatment|0|||
16543414|NCT02207725|40453628|FG001|Overall Study|Did Not Receive Treatment|1|||
16543415|NCT02207725|40453629|FG002|Overall Study|Did Not Receive Treatment|1|||
16220691|NCT00842829|39286484|FG001|Treatment Period|Unstable persistent cancer pain|0|||
16220692|NCT00842829|39286485|FG002|Treatment Period|Unstable persistent cancer pain|5|||
16220693|NCT00842829|39286483|FG000|Treatment Period|Withdrawal by Subject|0|||
16220694|NCT00842829|39286484|FG001|Treatment Period|Withdrawal by Subject|0|||
16220695|NCT00842829|39286485|FG002|Treatment Period|Withdrawal by Subject|11|||
16220696|NCT00842829|39286483|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
16220697|NCT00842829|39286484|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
16220698|NCT00842829|39286485|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
16220699|NCT00842829|39286483|FG000|Treatment Period|Protocol Violation|0|||
16220700|NCT00842829|39286484|FG001|Treatment Period|Protocol Violation|0|||
16220701|NCT00842829|39286485|FG002|Treatment Period|Protocol Violation|2|||
16342952|NCT01090050|39741088|FG001|Overall Study|Lack of Efficacy|5|||
16543416|NCT02207725|40453630|FG003|Overall Study|Did Not Receive Treatment|1|||
16543417|NCT04934722|40453636|FG000|Overall Study|Death|4|||
16543418|NCT04934722|40453637|FG001|Overall Study|Death|3|||
16543419|NCT04934722|40453636|FG000|Overall Study|Participants Ongoing|88|||
16543420|NCT04934722|40453637|FG001|Overall Study|Participants Ongoing|91|||
16543421|NCT01377480|40453641|FG000|Overall Study|Protocol Violation|0|||
16342953|NCT01090050|39741087|FG000|Overall Study|Physician Decision|0|||
16543422|NCT01377480|40453642|FG001|Overall Study|Protocol Violation|0|||
16543423|NCT01377480|40453643|FG002|Overall Study|Protocol Violation|0|||
16543424|NCT01377480|40453644|FG003|Overall Study|Protocol Violation|4|||
16543425|NCT01377480|40453641|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
16543426|NCT01377480|40453642|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
16543427|NCT01377480|40453643|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
16543428|NCT01377480|40453644|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
16543429|NCT01377480|40453641|FG000|Overall Study|Withdrawal by Subject|0|||
16543430|NCT01377480|40453642|FG001|Overall Study|Withdrawal by Subject|0|||
16543431|NCT01377480|40453643|FG002|Overall Study|Withdrawal by Subject|1|||
16543432|NCT01377480|40453644|FG003|Overall Study|Withdrawal by Subject|0|||
16543433|NCT01377480|40453641|FG000|Overall Study|Serious adverse event|0|||
16543434|NCT01377480|40453642|FG001|Overall Study|Serious adverse event|0|||
16543435|NCT01377480|40453643|FG002|Overall Study|Serious adverse event|1|||
16543436|NCT01377480|40453644|FG003|Overall Study|Serious adverse event|1|||
16543437|NCT01377480|40453641|FG000|Overall Study|Other|0|||
16543438|NCT01377480|40453642|FG001|Overall Study|Other|0|||
16543439|NCT01377480|40453643|FG002|Overall Study|Other|7|||
16543440|NCT01377480|40453644|FG003|Overall Study|Other|6|||
16543441|NCT01407354|40453646|FG000|First Intervention|Withdrawal by Subject|0|||
16543442|NCT01407354|40453647|FG001|First Intervention|Withdrawal by Subject|2|||
16543443|NCT01407354|40453646|FG000|First Intervention|Adverse Event|1|||
16543444|NCT01407354|40453647|FG001|First Intervention|Adverse Event|0|||
16543445|NCT01407354|40453646|FG000|First Intervention|Physician Decision|1|||
16543446|NCT01407354|40453647|FG001|First Intervention|Physician Decision|0|||
16543447|NCT05292534|40453648|FG000|Overall Study|Protocol Violation|3|||
16543448|NCT05292534|40453649|FG001|Overall Study|Protocol Violation|4|||
16220702|NCT00842829|39286483|FG000|Treatment Period|Other|0|||
16543449|NCT05292534|40453648|FG000|Overall Study|Withdrawal by Subject|0|||
16543450|NCT05292534|40453649|FG001|Overall Study|Withdrawal by Subject|1|||
16543451|NCT02170025|40453651|FG000|Overall Study|Adverse Event|2|||
16543452|NCT02170025|40453652|FG001|Overall Study|Adverse Event|0|||
16543453|NCT01690130|40453653|FG000|Overall Study|Subject have cancelled visit.|1|||
16543454|NCT01690130|40453654|FG001|Overall Study|Subject have cancelled visit.|0|||
16543455|NCT03466086|40453656|FG000|Period 1|Sponsor decision due to study timeline|1|||
16543456|NCT03466086|40453657|FG001|Period 1|Sponsor decision due to study timeline|0|||
16543457|NCT03466086|40453656|FG000|Period 1|Withdrawal by Subject|1|||
16543458|NCT03466086|40453657|FG001|Period 1|Withdrawal by Subject|0|||
16543459|NCT02272725|40453661|FG000|Overall Study|equipment malfunction|2|||
16543460|NCT02272725|40453662|FG001|Overall Study|equipment malfunction|0|||
16543461|NCT03587142|40453663|FG000|Overall Study|Lost to Follow-up|5|||
16543462|NCT03587142|40453664|FG001|Overall Study|Lost to Follow-up|3|||
16543463|NCT03587142|40453663|FG000|Overall Study|Did not complete the f4 visit|3|||
16543464|NCT03587142|40453664|FG001|Overall Study|Did not complete the f4 visit|7|||
16543465|NCT00152464|40453665|FG000|Overall Study|Adverse Event|3|||
16220703|NCT00842829|39286484|FG001|Treatment Period|Other|0|||
16220704|NCT00842829|39286485|FG002|Treatment Period|Other|18|||
16220705|NCT00842829|39286483|FG000|Treatment Period|Non-compliance to study procedures|0|||
16220706|NCT00842829|39286484|FG001|Treatment Period|Non-compliance to study procedures|0|||
16220707|NCT00842829|39286485|FG002|Treatment Period|Non-compliance to study procedures|4|||
16220708|NCT00842829|39286483|FG000|Treatment Period|Unclear completion status|0|||
16543466|NCT00152464|40453666|FG001|Overall Study|Adverse Event|6|||
16543467|NCT00152464|40453665|FG000|Overall Study|Lost to Follow-up|8|||
16220709|NCT00842829|39286484|FG001|Treatment Period|Unclear completion status|0|||
16543468|NCT00152464|40453666|FG001|Overall Study|Lost to Follow-up|4|||
16220710|NCT00842829|39286485|FG002|Treatment Period|Unclear completion status|1|||
16220711|NCT00842829|39286483|FG000|Continuation Period|Adverse Event|0|||
16220712|NCT00842829|39286484|FG001|Continuation Period|Adverse Event|0|||
16220713|NCT00842829|39286485|FG002|Continuation Period|Adverse Event|32|||
16220714|NCT00842829|39286483|FG000|Continuation Period|Lack of Efficacy|0|||
16220715|NCT00842829|39286484|FG001|Continuation Period|Lack of Efficacy|0|||
16220716|NCT00842829|39286485|FG002|Continuation Period|Lack of Efficacy|6|||
16220717|NCT00842829|39286483|FG000|Continuation Period|Unstable persistent cancer pain|0|||
16220718|NCT00842829|39286484|FG001|Continuation Period|Unstable persistent cancer pain|0|||
16220719|NCT00842829|39286485|FG002|Continuation Period|Unstable persistent cancer pain|3|||
16220720|NCT00842829|39286483|FG000|Continuation Period|Withdrawal by Subject|0|||
16220721|NCT00842829|39286484|FG001|Continuation Period|Withdrawal by Subject|0|||
16220722|NCT00842829|39286485|FG002|Continuation Period|Withdrawal by Subject|10|||
16220723|NCT00842829|39286483|FG000|Continuation Period|Other|0|||
16543469|NCT00152464|40453665|FG000|Overall Study|Protocol Violation|3|||
16543470|NCT00152464|40453666|FG001|Overall Study|Protocol Violation|1|||
16543471|NCT00152464|40453665|FG000|Overall Study|Withdrawal by Subject|21|||
16543472|NCT00152464|40453666|FG001|Overall Study|Withdrawal by Subject|22|||
16543473|NCT00152464|40453665|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
16543474|NCT00152464|40453666|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
16543475|NCT00152464|40453665|FG000|Overall Study|Eczema deterioration|0|||
16543476|NCT00152464|40453666|FG001|Overall Study|Eczema deterioration|1|||
16543477|NCT00152464|40453665|FG000|Overall Study|Parent decision|1|||
16543478|NCT00152464|40453666|FG001|Overall Study|Parent decision|1|||
16543479|NCT00152464|40453665|FG000|Overall Study|Investigator decision|1|||
16543480|NCT00152464|40453666|FG001|Overall Study|Investigator decision|0|||
16543481|NCT00152464|40453665|FG000|Overall Study|Lack of Efficacy|1|||
16543482|NCT00152464|40453666|FG001|Overall Study|Lack of Efficacy|0|||
16543483|NCT00152464|40453665|FG000|Overall Study|Eczema poorly controlled|1|||
16543484|NCT00152464|40453666|FG001|Overall Study|Eczema poorly controlled|0|||
16543485|NCT00152464|40453665|FG000|Overall Study|Patient relocated|1|||
16543486|NCT00152464|40453666|FG001|Overall Study|Patient relocated|0|||
16543487|NCT00261495|40453667|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
16543488|NCT00261495|40453668|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
16543489|NCT00261495|40453667|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
16543490|NCT00261495|40453668|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
16543491|NCT00261495|40453667|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
16543492|NCT00261495|40453668|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
16543493|NCT00261495|40453667|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
16543494|NCT00261495|40453668|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
16543495|NCT00261495|40453667|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
16543496|NCT00261495|40453668|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
16543497|NCT00261495|40453667|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
16220724|NCT00842829|39286484|FG001|Continuation Period|Other|0|||
16220725|NCT00842829|39286485|FG002|Continuation Period|Other|7|||
16220726|NCT00842829|39286483|FG000|Continuation Period|Non-compliance to study procedures|0|||
16342954|NCT01090050|39741088|FG001|Overall Study|Physician Decision|1|||
16543498|NCT00261495|40453668|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
16543499|NCT00261495|40453667|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
16543500|NCT00261495|40453668|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
16543501|NCT00261495|40453667|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
16543502|NCT00261495|40453668|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
16543503|NCT00261495|40453667|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
16543504|NCT00261495|40453668|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
16543505|NCT00261495|40453667|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
16543506|NCT00261495|40453668|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
16220727|NCT00842829|39286484|FG001|Continuation Period|Non-compliance to study procedures|0|||
16220728|NCT00842829|39286485|FG002|Continuation Period|Non-compliance to study procedures|2|||
16220729|NCT00842829|39286483|FG000|Continuation Period|Non-compliance to study drug|0|||
16220730|NCT00842829|39286484|FG001|Continuation Period|Non-compliance to study drug|0|||
16220731|NCT00842829|39286485|FG002|Continuation Period|Non-compliance to study drug|1|||
16220732|NCT01070381|39286494|FG000|Period 2, 1 Week of Wear|Handling|0|||
16342955|NCT03373760|39741089|FG000|Overall Study|Adverse Event|8|||
16342956|NCT03373760|39741089|FG000|Overall Study|Disease Progression|46|||
16342957|NCT03373760|39741089|FG000|Overall Study|Death|4|||
16342958|NCT01972464|39741090|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
16342959|NCT01972464|39741091|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
16342960|NCT01972464|39741090|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
16342961|NCT01972464|39741091|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
16342962|NCT01972464|39741090|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
16342963|NCT01972464|39741091|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
16342964|NCT01972464|39741090|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
16342965|NCT01972464|39741091|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
16342966|NCT00460746|39741092|FG000|Overall Study|Adverse Event|1|||
16342967|NCT00460746|39741092|FG000|Overall Study|Lost to Follow-up|1|||
16342968|NCT03134911|39741101|FG000|Overall Study|Screen failure|31|||
16342969|NCT03134911|39741101|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
16220733|NCT01070381|39286495|FG001|Period 2, 1 Week of Wear|Handling|1|||
16220734|NCT01070381|39286494|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
16342970|NCT01763203|39741103|FG000|Overall Study|Death|4|||
16342971|NCT01763203|39741104|FG001|Overall Study|Death|7|||
16342972|NCT01763203|39741103|FG000|Overall Study|Lost to Follow-up|12|||
16342973|NCT01763203|39741104|FG001|Overall Study|Lost to Follow-up|12|||
16342974|NCT01763203|39741103|FG000|Overall Study|Withdrawal by Subject|8|||
16342975|NCT01763203|39741104|FG001|Overall Study|Withdrawal by Subject|12|||
16342976|NCT01763203|39741103|FG000|Overall Study|Moved out of study region|7|||
16342977|NCT01763203|39741104|FG001|Overall Study|Moved out of study region|10|||
16342978|NCT01763203|39741103|FG000|Overall Study|Physician Decision|2|||
16407255|NCT02231762|39973163|FG001|Combination Phase|Did not meet inclusion criteria|0|||
16220735|NCT01070381|39286495|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
16220736|NCT01259388|39286496|FG000|Overall Study|Adverse Event|3|||
16220737|NCT01259388|39286497|FG001|Overall Study|Adverse Event|0|||
16220738|NCT01259388|39286496|FG000|Overall Study|Withdrawal by Subject|1|||
16220739|NCT01259388|39286497|FG001|Overall Study|Withdrawal by Subject|1|||
16220740|NCT01259388|39286496|FG000|Overall Study|Physician Decision|1|||
16220741|NCT01259388|39286497|FG001|Overall Study|Physician Decision|0|||
16220742|NCT02363322|39286498|FG000|Overall Study|Lost to Follow-up|1|||
16220743|NCT02363322|39286499|FG001|Overall Study|Lost to Follow-up|0|||
16342979|NCT01763203|39741104|FG001|Overall Study|Physician Decision|1|||
16342980|NCT01760447|39741106|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
16342981|NCT01760447|39741107|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
16342982|NCT01760447|39741108|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
16543507|NCT00261495|40453667|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
16543508|NCT00261495|40453668|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
16543509|NCT00261495|40453667|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
16543510|NCT00261495|40453668|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
16543511|NCT00261495|40453667|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
16543512|NCT00261495|40453668|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
16543513|NCT00261495|40453667|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
16543514|NCT00261495|40453668|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
16543515|NCT00261495|40453667|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
16342983|NCT01760447|39741109|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
16342984|NCT01760447|39741106|FG000|Weeks 0-20|Withdrawal by Subject|2|||
16342985|NCT01760447|39741107|FG001|Weeks 0-20|Withdrawal by Subject|0|||
16342986|NCT01760447|39741108|FG002|Weeks 0-20|Withdrawal by Subject|1|||
16342987|NCT01760447|39741109|FG003|Weeks 0-20|Withdrawal by Subject|0|||
16342988|NCT01760447|39741106|FG000|Weeks 0-20|Lost to Follow-up|1|||
16342989|NCT01760447|39741107|FG001|Weeks 0-20|Lost to Follow-up|0|||
16342990|NCT01760447|39741108|FG002|Weeks 0-20|Lost to Follow-up|1|||
16342991|NCT01760447|39741109|FG003|Weeks 0-20|Lost to Follow-up|1|||
16342992|NCT01760447|39741106|FG000|Weeks 0-20|Randomized but not treated|0|||
16342993|NCT01760447|39741107|FG001|Weeks 0-20|Randomized but not treated|0|||
16342994|NCT01760447|39741108|FG002|Weeks 0-20|Randomized but not treated|2|||
16342995|NCT01760447|39741109|FG003|Weeks 0-20|Randomized but not treated|0|||
16342996|NCT01760447|39741106|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
16342997|NCT01760447|39741107|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
16342998|NCT01760447|39741108|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
16342999|NCT01760447|39741109|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
16343000|NCT01760447|39741106|FG000|Weeks 20-54|Withdrawal by Subject|2|||
16343001|NCT01760447|39741107|FG001|Weeks 20-54|Withdrawal by Subject|1|||
16343002|NCT01760447|39741108|FG002|Weeks 20-54|Withdrawal by Subject|1|||
16343003|NCT01760447|39741109|FG003|Weeks 20-54|Withdrawal by Subject|2|||
16543516|NCT00261495|40453668|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
16343004|NCT01760447|39741106|FG000|Weeks 20-54|Lost to Follow-up|0|||
16543517|NCT00261495|40453667|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
16109577|NCT01296555|38889129|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16343005|NCT01760447|39741107|FG001|Weeks 20-54|Lost to Follow-up|0|||
16343006|NCT01760447|39741108|FG002|Weeks 20-54|Lost to Follow-up|1|||
16343007|NCT01760447|39741109|FG003|Weeks 20-54|Lost to Follow-up|2|||
16343008|NCT00420628|39741112|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
16343009|NCT00420628|39741113|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
16343010|NCT00420628|39741112|FG000|Overall Study|Lost to Follow-up|3|||
16343011|NCT00420628|39741113|FG001|Overall Study|Lost to Follow-up|2|||
16407256|NCT02231762|39973164|FG002|Combination Phase|Did not meet inclusion criteria|0|||
16407257|NCT02231762|39973165|FG003|Combination Phase|Did not meet inclusion criteria|0|||
16407258|NCT02231762|39973162|FG000|Combination Phase|Protocol Violation|1|||
16407259|NCT02231762|39973163|FG001|Combination Phase|Protocol Violation|0|||
16407260|NCT02231762|39973164|FG002|Combination Phase|Protocol Violation|0|||
16407261|NCT02231762|39973165|FG003|Combination Phase|Protocol Violation|0|||
16407262|NCT02231762|39973162|FG000|Maintenance Phase|Disease progression|0|||
16407263|NCT02231762|39973163|FG001|Maintenance Phase|Disease progression|3|||
16407264|NCT02231762|39973164|FG002|Maintenance Phase|Disease progression|4|||
16407265|NCT02231762|39973165|FG003|Maintenance Phase|Disease progression|3|||
16407266|NCT02231762|39973162|FG000|Maintenance Phase|Adverse Event|0|||
16407267|NCT02231762|39973163|FG001|Maintenance Phase|Adverse Event|0|||
16407268|NCT02231762|39973164|FG002|Maintenance Phase|Adverse Event|1|||
16407269|NCT02231762|39973165|FG003|Maintenance Phase|Adverse Event|2|||
16407270|NCT04346108|39973168|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
16407271|NCT04346108|39973169|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
16407272|NCT04346108|39973170|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
16407273|NCT04346108|39973168|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
16407274|NCT04346108|39973169|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
16407275|NCT04346108|39973170|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
16407276|NCT00539513|39973171|FG000|Overall Study|Withdrawal by Subject|2|||
16407277|NCT00539513|39973172|FG001|Overall Study|Withdrawal by Subject|1|||
16407278|NCT00539513|39973171|FG000|Overall Study|Lost to Follow-up|0|||
16407279|NCT00539513|39973172|FG001|Overall Study|Lost to Follow-up|1|||
16407280|NCT01962987|39973179|FG000|Overall Study|Adverse Event|4|||
16407281|NCT01962987|39973180|FG001|Overall Study|Adverse Event|4|||
16407282|NCT01962987|39973181|FG002|Overall Study|Adverse Event|0|||
16407283|NCT01962987|39973179|FG000|Overall Study|Lost to Follow-up|0|||
16407284|NCT01962987|39973180|FG001|Overall Study|Lost to Follow-up|0|||
16407285|NCT01962987|39973181|FG002|Overall Study|Lost to Follow-up|1|||
16407286|NCT01962987|39973179|FG000|Overall Study|Non compliance with dosing requirements|4|||
16407287|NCT01962987|39973180|FG001|Overall Study|Non compliance with dosing requirements|2|||
16407288|NCT01962987|39973181|FG002|Overall Study|Non compliance with dosing requirements|0|||
16407289|NCT01962987|39973179|FG000|Overall Study|Miscellaneous|1|||
16407290|NCT01962987|39973180|FG001|Overall Study|Miscellaneous|9|||
16407291|NCT01962987|39973181|FG002|Overall Study|Miscellaneous|2|||
16407292|NCT01962987|39973179|FG000|Overall Study|Restricted medication|5|||
16407293|NCT01962987|39973180|FG001|Overall Study|Restricted medication|1|||
16407294|NCT01962987|39973181|FG002|Overall Study|Restricted medication|1|||
16407295|NCT01962987|39973179|FG000|Overall Study|Serious Adverse Event|1|||
16543518|NCT00261495|40453668|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
16543519|NCT00261495|40453667|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
16543520|NCT00261495|40453668|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
16543521|NCT00261495|40453667|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
16543522|NCT00261495|40453668|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
16543523|NCT00261495|40453667|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16543524|NCT00261495|40453668|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
16543525|NCT00261495|40453667|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
16543526|NCT00261495|40453668|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
16543527|NCT00261495|40453667|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
16543528|NCT00261495|40453668|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16543529|NCT05158296|40453669|FG000|Overall Study|Sponsor Decision|2|||
16543530|NCT05158296|40453670|FG001|Overall Study|Sponsor Decision|3|||
16543531|NCT05158296|40453671|FG002|Overall Study|Sponsor Decision|2|||
16543532|NCT00838682|40453674|FG000|Overall Study|Lost to Follow-up|21|||
16543533|NCT00838682|40453675|FG001|Overall Study|Lost to Follow-up|14|||
16543534|NCT00838682|40453674|FG000|Overall Study|detection of exclusion criteria|4|||
16220744|NCT02807376|39286500|FG000|Overall Study|Intra-operative exclusion criteria|3|||
16343012|NCT00420628|39741112|FG000|Overall Study|Adverse Event|1|||
16343013|NCT00420628|39741113|FG001|Overall Study|Adverse Event|0|||
16407296|NCT01962987|39973180|FG001|Overall Study|Serious Adverse Event|0|||
16407297|NCT01962987|39973181|FG002|Overall Study|Serious Adverse Event|0|||
16407298|NCT01962987|39973179|FG000|Overall Study|Withdrawal by Subject|11|||
16543535|NCT00838682|40453675|FG001|Overall Study|detection of exclusion criteria|3|||
16543536|NCT00838682|40453674|FG000|Overall Study|Protocol Violation|0|||
16407299|NCT01962987|39973180|FG001|Overall Study|Withdrawal by Subject|10|||
16407300|NCT01962987|39973181|FG002|Overall Study|Withdrawal by Subject|6|||
16407301|NCT01962987|39973179|FG000|Overall Study|Randomized in Error|4|||
16407302|NCT01962987|39973180|FG001|Overall Study|Randomized in Error|2|||
16407303|NCT01962987|39973181|FG002|Overall Study|Randomized in Error|2|||
16407304|NCT02214225|39973184|FG000|Overall Study|Lost to Follow-up|46|||
16407305|NCT02214225|39973185|FG001|Overall Study|Lost to Follow-up|18|||
16407306|NCT02214225|39973186|FG002|Overall Study|Lost to Follow-up|18|||
16407307|NCT02214225|39973184|FG000|Overall Study|Withdrawal by Subject|2|||
16407308|NCT02214225|39973185|FG001|Overall Study|Withdrawal by Subject|0|||
16407309|NCT02214225|39973186|FG002|Overall Study|Withdrawal by Subject|2|||
16407310|NCT02214225|39973184|FG000|Overall Study|Death|5|||
16407311|NCT02214225|39973185|FG001|Overall Study|Death|0|||
16407312|NCT02214225|39973186|FG002|Overall Study|Death|1|||
16407313|NCT02214225|39973184|FG000|Overall Study|randomized in error, not vaccinated|2|||
16407314|NCT02214225|39973185|FG001|Overall Study|randomized in error, not vaccinated|1|||
16407315|NCT02214225|39973186|FG002|Overall Study|randomized in error, not vaccinated|1|||
16407316|NCT00694096|39973189|FG000|Overall Study|Withdrawal by Subject|5|||
16407317|NCT03754582|39973190|FG000|Treatment Phase|Adverse Event|0|||
16407318|NCT03754582|39973191|FG001|Treatment Phase|Adverse Event|1|||
16343014|NCT00564395|39741114|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
16343015|NCT00564395|39741115|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
16407319|NCT03754582|39973192|FG002|Treatment Phase|Adverse Event|0|||
16407320|NCT03754582|39973190|FG000|Follow-up Phase|Other|0|||
16407321|NCT03754582|39973191|FG001|Follow-up Phase|Other|0|||
16407322|NCT03754582|39973192|FG002|Follow-up Phase|Other|1|||
16407323|NCT02446418|39973193|FG000|Overall Study|Adverse Event|4|||
16407324|NCT02446418|39973194|FG001|Overall Study|Adverse Event|8|||
16407325|NCT02446418|39973193|FG000|Overall Study|Physician Decision|5|||
16407326|NCT02446418|39973194|FG001|Overall Study|Physician Decision|1|||
16407327|NCT02446418|39973193|FG000|Overall Study|Withdrawal by Subject|3|||
16407328|NCT02446418|39973194|FG001|Overall Study|Withdrawal by Subject|3|||
16343016|NCT00564395|39741114|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
16343017|NCT00564395|39741115|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
16343018|NCT02091414|39741125|FG000|Overall Study|Withdrawal by Subject|2|||
16343019|NCT02091414|39741125|FG000|Overall Study|Death|2|||
16343020|NCT03959488|39741126|FG000|Season 1|Other|6|||
16343021|NCT03959488|39741127|FG001|Season 1|Other|7|||
16407329|NCT02446418|39973193|FG000|Overall Study|Lost to Follow-up|2|||
16407330|NCT02446418|39973194|FG001|Overall Study|Lost to Follow-up|2|||
16407331|NCT02446418|39973193|FG000|Overall Study|Protocol Violation|1|||
16407332|NCT02446418|39973194|FG001|Overall Study|Protocol Violation|2|||
16407333|NCT02446418|39973193|FG000|Overall Study|Lack of Efficacy|2|||
16407334|NCT02446418|39973194|FG001|Overall Study|Lack of Efficacy|0|||
16407335|NCT02446418|39973193|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
16407336|NCT02446418|39973194|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
16543537|NCT00838682|40453675|FG001|Overall Study|Protocol Violation|1|||
16543538|NCT00838682|40453674|FG000|Overall Study|Withdrawal by Subject|0|||
16543539|NCT00838682|40453675|FG001|Overall Study|Withdrawal by Subject|1|||
16543540|NCT03248375|40453678|FG000|Overall Study|Lost to Follow-up|5|||
16543541|NCT03585296|40453681|FG000|Overall Study|Adverse Event|1|||
16543542|NCT03585296|40453681|FG000|Overall Study|Lost to Follow-up|2|||
16407337|NCT03249935|39973195|FG000|Overall Study|Discharged from facility early|36|||
16407338|NCT03249935|39973195|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
16407339|NCT03249935|39973195|FG000|Overall Study|Protocol Violation|5|||
16407340|NCT03385265|39973196|FG000|Overall Study|Withdrawal by Subject|5|||
16407341|NCT03385265|39973197|FG001|Overall Study|Withdrawal by Subject|2|||
16407342|NCT03385265|39973198|FG002|Overall Study|Withdrawal by Subject|5|||
16543543|NCT03585296|40453681|FG000|Overall Study|Withdrawal by Subject|2|||
16543544|NCT04062448|40453682|FG000|Overall Study|Lost to Follow-up|1|||
16543545|NCT04062448|40453682|FG000|Overall Study|Withdrawal by Subject|2|||
16543546|NCT01786330|40453684|FG000|Overall Study|Withdrawal by Subject|0|||
16543547|NCT01786330|40453685|FG001|Overall Study|Withdrawal by Subject|1|||
16543548|NCT01786330|40453684|FG000|Overall Study|Lost to Follow-up|0|||
16543549|NCT01786330|40453685|FG001|Overall Study|Lost to Follow-up|1|||
16543550|NCT01786330|40453684|FG000|Overall Study|Excluded intraoperatively|0|||
16543551|NCT01786330|40453685|FG001|Overall Study|Excluded intraoperatively|1|||
16543552|NCT01786330|40453684|FG000|Overall Study|Protocol Violation|1|||
16543553|NCT01786330|40453685|FG001|Overall Study|Protocol Violation|0|||
16543554|NCT03813238|40453686|FG000|Overall Study|Adverse Event|0|||
16343022|NCT03959488|39741128|FG002|Season 1|Other|0|||
16343023|NCT03959488|39741129|FG003|Season 1|Other|0|||
16407343|NCT03385265|39973199|FG003|Overall Study|Withdrawal by Subject|2|||
16543555|NCT03813238|40453687|FG001|Overall Study|Adverse Event|6|||
16543556|NCT03813238|40453686|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16543557|NCT03813238|40453687|FG001|Overall Study|Withdrawal by parent/guardian|2|||
16543558|NCT03813238|40453686|FG000|Overall Study|Lost to Follow-up|0|||
16543559|NCT03813238|40453687|FG001|Overall Study|Lost to Follow-up|1|||
16343024|NCT03959488|39741130|FG004|Season 1|Other|0|||
16109578|NCT01296555|38889130|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109579|NCT01296555|38889131|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
16109580|NCT01296555|38889103|FG000|Overall Study|Death|0|||
16343025|NCT03959488|39741126|FG000|Season 1|Withdrawal by parent/guardian|43|||
16343026|NCT03959488|39741127|FG001|Season 1|Withdrawal by parent/guardian|28|||
16343027|NCT03959488|39741128|FG002|Season 1|Withdrawal by parent/guardian|0|||
16343028|NCT03959488|39741129|FG003|Season 1|Withdrawal by parent/guardian|0|||
16343029|NCT03959488|39741130|FG004|Season 1|Withdrawal by parent/guardian|0|||
16343030|NCT03959488|39741126|FG000|Season 1|Due to COVID-19 pandemic|2|||
16343031|NCT03959488|39741127|FG001|Season 1|Due to COVID-19 pandemic|3|||
16343032|NCT03959488|39741128|FG002|Season 1|Due to COVID-19 pandemic|0|||
16343033|NCT03959488|39741129|FG003|Season 1|Due to COVID-19 pandemic|0|||
16343034|NCT03959488|39741130|FG004|Season 1|Due to COVID-19 pandemic|0|||
16343035|NCT03959488|39741126|FG000|Season 1|Lost to Follow-up|17|||
16343036|NCT03959488|39741127|FG001|Season 1|Lost to Follow-up|7|||
16343037|NCT03959488|39741128|FG002|Season 1|Lost to Follow-up|0|||
16343038|NCT03959488|39741129|FG003|Season 1|Lost to Follow-up|0|||
16343039|NCT03959488|39741130|FG004|Season 1|Lost to Follow-up|0|||
16343040|NCT03959488|39741126|FG000|Season 1|Death|5|||
16343041|NCT03959488|39741127|FG001|Season 1|Death|1|||
16343042|NCT03959488|39741128|FG002|Season 1|Death|0|||
16343043|NCT03959488|39741129|FG003|Season 1|Death|0|||
16343044|NCT03959488|39741130|FG004|Season 1|Death|0|||
16343045|NCT03959488|39741126|FG000|Season 2|Other|0|||
16343046|NCT03959488|39741127|FG001|Season 2|Other|0|||
16343047|NCT03959488|39741128|FG002|Season 2|Other|2|||
16343048|NCT03959488|39741129|FG003|Season 2|Other|0|||
16343049|NCT03959488|39741130|FG004|Season 2|Other|0|||
16343050|NCT03959488|39741126|FG000|Season 2|Withdrawal by parent/guardian|0|||
16343051|NCT03959488|39741127|FG001|Season 2|Withdrawal by parent/guardian|0|||
16343052|NCT03959488|39741128|FG002|Season 2|Withdrawal by parent/guardian|3|||
16343053|NCT03959488|39741129|FG003|Season 2|Withdrawal by parent/guardian|1|||
16343054|NCT03959488|39741130|FG004|Season 2|Withdrawal by parent/guardian|1|||
16343055|NCT03959488|39741126|FG000|Season 2|Lost to Follow-up|0|||
16343056|NCT03959488|39741127|FG001|Season 2|Lost to Follow-up|0|||
16343057|NCT03959488|39741128|FG002|Season 2|Lost to Follow-up|1|||
16543560|NCT03813238|40453686|FG000|Overall Study|Other than specified|1|||
16543561|NCT03813238|40453687|FG001|Overall Study|Other than specified|2|||
16543562|NCT00118716|40453688|FG000|Overall Study|Adverse Event|2|||
16543563|NCT00118716|40453689|FG001|Overall Study|Adverse Event|7|||
16543564|NCT00118716|40453688|FG000|Overall Study|Protocol Violation|5|||
16543565|NCT00118716|40453689|FG001|Overall Study|Protocol Violation|4|||
16543566|NCT00118716|40453688|FG000|Overall Study|Withdrawal by Subject|0|||
16543567|NCT00118716|40453689|FG001|Overall Study|Withdrawal by Subject|1|||
16543568|NCT00118716|40453688|FG000|Overall Study|Exacerbation|2|||
16343058|NCT03959488|39741129|FG003|Season 2|Lost to Follow-up|0|||
16407344|NCT01920893|39973200|FG000|Overall Study|Adverse Event|5|||
16109581|NCT01296555|38889104|FG001|Overall Study|Death|0|||
16343059|NCT03959488|39741130|FG004|Season 2|Lost to Follow-up|1|||
16407345|NCT01920893|39973201|FG001|Overall Study|Adverse Event|2|||
16543569|NCT00118716|40453689|FG001|Overall Study|Exacerbation|2|||
16543570|NCT00118716|40453688|FG000|Overall Study|Discontinued by sponsor|1|||
16407346|NCT01920893|39973200|FG000|Overall Study|Lack of Efficacy|2|||
16407347|NCT01920893|39973201|FG001|Overall Study|Lack of Efficacy|0|||
16407348|NCT01340937|39973204|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
16407349|NCT01340937|39973205|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
16407350|NCT01340937|39973206|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
16407351|NCT01340937|39973207|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
16407352|NCT01340937|39973204|FG000|Period 1: Infant Series|Adverse Event|0|||
16407353|NCT01340937|39973205|FG001|Period 1: Infant Series|Adverse Event|1|||
16407354|NCT01340937|39973206|FG002|Period 1: Infant Series|Adverse Event|4|||
16407355|NCT01340937|39973207|FG003|Period 1: Infant Series|Adverse Event|0|||
16407356|NCT01340937|39973204|FG000|Period 1: Infant Series|Death|2|||
16407357|NCT01340937|39973205|FG001|Period 1: Infant Series|Death|0|||
16407358|NCT01340937|39973206|FG002|Period 1: Infant Series|Death|2|||
16407359|NCT01340937|39973207|FG003|Period 1: Infant Series|Death|0|||
16407360|NCT01340937|39973204|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
16407361|NCT01340937|39973205|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
16407362|NCT01340937|39973206|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
16407363|NCT01340937|39973207|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
16407364|NCT01340937|39973204|FG000|Period 1: Infant Series|Physician Decision|2|||
16407365|NCT01340937|39973205|FG001|Period 1: Infant Series|Physician Decision|3|||
16407366|NCT01340937|39973206|FG002|Period 1: Infant Series|Physician Decision|1|||
16407367|NCT01340937|39973207|FG003|Period 1: Infant Series|Physician Decision|0|||
16407368|NCT01340937|39973204|FG000|Period 1: Infant Series|Protocol Violation|1|||
16407369|NCT01340937|39973205|FG001|Period 1: Infant Series|Protocol Violation|4|||
16407370|NCT01340937|39973206|FG002|Period 1: Infant Series|Protocol Violation|4|||
16407371|NCT01340937|39973207|FG003|Period 1: Infant Series|Protocol Violation|3|||
16407372|NCT01340937|39973204|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
16407373|NCT01340937|39973205|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
16407374|NCT01340937|39973206|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
16407375|NCT01340937|39973207|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
16407376|NCT01340937|39973204|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
16407377|NCT01340937|39973205|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
16407378|NCT01340937|39973206|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
16407379|NCT01340937|39973207|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
16407380|NCT01340937|39973204|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
16407381|NCT01340937|39973205|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
16407382|NCT01340937|39973206|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
16407383|NCT01340937|39973207|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
16407384|NCT01340937|39973204|FG000|Period 2: Interim Period|Adverse Event|1|||
16407385|NCT01340937|39973205|FG001|Period 2: Interim Period|Adverse Event|0|||
16407386|NCT01340937|39973206|FG002|Period 2: Interim Period|Adverse Event|1|||
16407387|NCT01340937|39973207|FG003|Period 2: Interim Period|Adverse Event|0|||
16407388|NCT01340937|39973204|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
16407389|NCT01340937|39973205|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
16407390|NCT01340937|39973206|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
16407391|NCT01340937|39973207|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
16407392|NCT01340937|39973204|FG000|Period 2: Interim Period|Physician Decision|0|||
16407393|NCT01340937|39973205|FG001|Period 2: Interim Period|Physician Decision|1|||
16407394|NCT01340937|39973206|FG002|Period 2: Interim Period|Physician Decision|1|||
16407395|NCT01340937|39973207|FG003|Period 2: Interim Period|Physician Decision|0|||
16343060|NCT00316914|39741133|FG000|Overall Study|Withdrawal by Subject|5|||
16343061|NCT00316914|39741134|FG001|Overall Study|Withdrawal by Subject|3|||
16343062|NCT00316914|39741133|FG000|Overall Study|Adverse Event|8|||
16343063|NCT00316914|39741134|FG001|Overall Study|Adverse Event|7|||
16343064|NCT00316914|39741133|FG000|Overall Study|Other Problems|6|||
16343065|NCT00316914|39741134|FG001|Overall Study|Other Problems|11|||
16343066|NCT00316914|39741133|FG000|Overall Study|Missing end of treatment documentation|14|||
16343067|NCT00316914|39741134|FG001|Overall Study|Missing end of treatment documentation|15|||
16343068|NCT03041467|39741135|FG000|Overall Study|Death|46|||
16407396|NCT01340937|39973204|FG000|Period 2: Interim Period|Protocol Violation|5|||
16407397|NCT01340937|39973205|FG001|Period 2: Interim Period|Protocol Violation|3|||
16407398|NCT01340937|39973206|FG002|Period 2: Interim Period|Protocol Violation|6|||
16407399|NCT01340937|39973207|FG003|Period 2: Interim Period|Protocol Violation|3|||
16407400|NCT01340937|39973204|FG000|Period 2: Interim Period|Technical problems|4|||
16407401|NCT01340937|39973205|FG001|Period 2: Interim Period|Technical problems|4|||
16407402|NCT01340937|39973206|FG002|Period 2: Interim Period|Technical problems|6|||
16407403|NCT01340937|39973207|FG003|Period 2: Interim Period|Technical problems|3|||
16407404|NCT01340937|39973204|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
16407405|NCT01340937|39973205|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
16407406|NCT01340937|39973206|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
16407407|NCT01340937|39973207|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
16407408|NCT01340937|39973204|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
16407409|NCT01340937|39973205|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
16407410|NCT01340937|39973206|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
16407411|NCT01340937|39973207|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
16543571|NCT00118716|40453689|FG001|Overall Study|Discontinued by sponsor|1|||
16543572|NCT00118716|40453688|FG000|Overall Study|Non-compliance|1|||
16543573|NCT00118716|40453689|FG001|Overall Study|Non-compliance|3|||
16543574|NCT00118716|40453688|FG000|Overall Study|misrandomized|1|||
16543575|NCT00118716|40453689|FG001|Overall Study|misrandomized|1|||
16543576|NCT00118716|40453688|FG000|Overall Study|Expired drug use|1|||
16543577|NCT00118716|40453689|FG001|Overall Study|Expired drug use|2|||
16543578|NCT00118716|40453688|FG000|Overall Study|Investigator discretion|0|||
16543579|NCT00118716|40453689|FG001|Overall Study|Investigator discretion|1|||
16543580|NCT05674890|40453690|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
16543581|NCT05674890|40453691|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
16543582|NCT05674890|40453690|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
16543583|NCT05674890|40453691|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
16543584|NCT05674890|40453690|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
16543585|NCT05674890|40453691|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
16543586|NCT01564368|40453692|FG000|Overall Study|Ineligible|18|||
16543587|NCT01564368|40453692|FG000|Overall Study|Not Randomized in Parent study|116|||
16543588|NCT01564368|40453692|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
16543589|NCT01564368|40453692|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
16543590|NCT00454571|40453693|FG000|Overall Study|Adverse Event|2|||
16543591|NCT00454571|40453694|FG001|Overall Study|Adverse Event|0|||
16543592|NCT00454571|40453693|FG000|Overall Study|Physician Decision|0|||
16543593|NCT00454571|40453694|FG001|Overall Study|Physician Decision|1|||
16543594|NCT00454571|40453693|FG000|Overall Study|Protocol Violation|1|||
16543595|NCT00454571|40453694|FG001|Overall Study|Protocol Violation|0|||
16543596|NCT00454571|40453693|FG000|Overall Study|Withdrawal by Subject|10|||
16543597|NCT00454571|40453694|FG001|Overall Study|Withdrawal by Subject|5|||
16543598|NCT00903786|40453695|FG000|Overall Study|Physician Decision|6|||
16543599|NCT00903786|40453695|FG000|Overall Study|Lack of Efficacy|5|||
16543600|NCT00903786|40453695|FG000|Overall Study|Reason other than lack of efficacy|4|||
16543601|NCT02027402|40453700|FG000|Overall Study|Withdrawal by Subject|4|||
16543602|NCT02027402|40453701|FG001|Overall Study|Withdrawal by Subject|1|||
16543603|NCT01330433|40453706|FG000|Overall Study|Death|1|||
16543604|NCT01330433|40453707|FG001|Overall Study|Death|3|||
16543605|NCT01330433|40453706|FG000|Overall Study|Lost to Follow-up|1|||
16343069|NCT03041467|39741136|FG001|Overall Study|Death|39|||
16407412|NCT01340937|39973204|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
16407413|NCT01340937|39973205|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
16407414|NCT01340937|39973206|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
16407415|NCT01340937|39973207|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
16407416|NCT01340937|39973204|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
16343070|NCT03041467|39741135|FG000|Overall Study|Withdrawal by Subject|36|||
16343071|NCT03041467|39741136|FG001|Overall Study|Withdrawal by Subject|37|||
16407417|NCT01340937|39973205|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
16543606|NCT01330433|40453707|FG001|Overall Study|Lost to Follow-up|0|||
16543607|NCT00572195|40453708|FG000|Overall Study|Withdrawal by Subject|50|||
16543608|NCT00572195|40453708|FG000|Overall Study|Death|9|||
16343072|NCT03041467|39741135|FG000|Overall Study|Lost to Follow-up|6|||
16343073|NCT03041467|39741136|FG001|Overall Study|Lost to Follow-up|8|||
16343074|NCT03041467|39741135|FG000|Overall Study|Declined consent for study extension|21|||
16343075|NCT03041467|39741136|FG001|Overall Study|Declined consent for study extension|33|||
16343076|NCT03041467|39741135|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
16343077|NCT03041467|39741136|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
16343078|NCT03214679|39741137|FG000|Overall Study|Lost to Follow-up|12|||
16343079|NCT03214679|39741138|FG001|Overall Study|Lost to Follow-up|14|||
16343080|NCT03214679|39741137|FG000|Overall Study|not eligible|2|||
16343081|NCT03214679|39741138|FG001|Overall Study|not eligible|0|||
16343082|NCT01887678|39744316|FG000|Overall Study|Adverse Event|4|||
16343083|NCT01887678|39744317|FG001|Overall Study|Adverse Event|6|||
16343084|NCT01887678|39744316|FG000|Overall Study|Exceeded rescue medication dosage|4|||
16343085|NCT01887678|39744317|FG001|Overall Study|Exceeded rescue medication dosage|5|||
16343086|NCT01887678|39744316|FG000|Overall Study|Withdrawal of consent|3|||
16343087|NCT01887678|39744317|FG001|Overall Study|Withdrawal of consent|4|||
16343088|NCT01887678|39744316|FG000|Overall Study|Lost to Follow-up|4|||
16343089|NCT01887678|39744317|FG001|Overall Study|Lost to Follow-up|2|||
16343090|NCT01887678|39744316|FG000|Overall Study|Deterioration of clinical condition|0|||
16343091|NCT01887678|39744317|FG001|Overall Study|Deterioration of clinical condition|4|||
16343092|NCT01887678|39744316|FG000|Overall Study|Lack of Efficacy|1|||
16343093|NCT01887678|39744317|FG001|Overall Study|Lack of Efficacy|2|||
16343094|NCT01887678|39744316|FG000|Overall Study|Non-compliance|0|||
16343095|NCT01887678|39744317|FG001|Overall Study|Non-compliance|3|||
16343096|NCT01887678|39744316|FG000|Overall Study|Specified|1|||
16343097|NCT01887678|39744317|FG001|Overall Study|Specified|2|||
16343098|NCT01421147|39744318|FG000|Treatment Period|Adverse Event|2|||
16343099|NCT01421147|39744319|FG001|Treatment Period|Adverse Event|3|||
16343100|NCT01421147|39744318|FG000|Treatment Period|Lost to Follow-up|2|||
16343101|NCT01421147|39744319|FG001|Treatment Period|Lost to Follow-up|1|||
16343102|NCT01421147|39744318|FG000|Treatment Period|Physician Decision|2|||
16343103|NCT01421147|39744319|FG001|Treatment Period|Physician Decision|2|||
16343104|NCT01421147|39744318|FG000|Treatment Period|Withdrawal by Subject|10|||
16343105|NCT01421147|39744319|FG001|Treatment Period|Withdrawal by Subject|5|||
16343106|NCT01421147|39744318|FG000|Extension Period|Adverse Event|0|||
16343107|NCT01421147|39744319|FG001|Extension Period|Adverse Event|2|||
16343108|NCT01421147|39744318|FG000|Extension Period|Death|0|||
16343109|NCT01421147|39744319|FG001|Extension Period|Death|1|||
16343110|NCT01421147|39744318|FG000|Extension Period|Lost to Follow-up|2|||
16343111|NCT01421147|39744319|FG001|Extension Period|Lost to Follow-up|5|||
16343112|NCT01421147|39744318|FG000|Extension Period|Physician Decision|1|||
16343113|NCT01421147|39744319|FG001|Extension Period|Physician Decision|0|||
16343114|NCT01421147|39744318|FG000|Extension Period|Withdrawal by Subject|5|||
16343115|NCT01421147|39744319|FG001|Extension Period|Withdrawal by Subject|3|||
16343116|NCT01670045|39744320|FG000|Overall Study|Withdrawal by Subject|3|||
16343117|NCT01670045|39744320|FG000|Overall Study|Adverse Event|1|||
16343118|NCT01670045|39744320|FG000|Overall Study|Death|1|||
16343119|NCT01670045|39744320|FG000|Overall Study|Lost to Follow-up|11|||
16343120|NCT00329745|39744321|FG000|Overall Study|Protocol Violation|1|||
16343121|NCT00329745|39744322|FG001|Overall Study|Protocol Violation|0|||
16343122|NCT00329745|39744321|FG000|Overall Study|Withdrawal by Subject|0|||
16343123|NCT00329745|39744322|FG001|Overall Study|Withdrawal by Subject|1|||
16343124|NCT00329745|39744321|FG000|Overall Study|Lost to Follow-up|86|||
16343125|NCT00329745|39744322|FG001|Overall Study|Lost to Follow-up|101|||
16343126|NCT02216214|39744328|FG000|Overall Study|Randomized Never Received Study Drug|1|||
16343127|NCT02216214|39744329|FG001|Overall Study|Randomized Never Received Study Drug|0|||
16343128|NCT02216214|39744328|FG000|Overall Study|Adverse Event|10|||
16343129|NCT02216214|39744329|FG001|Overall Study|Adverse Event|8|||
16343130|NCT02216214|39744328|FG000|Overall Study|Lack of Efficacy|2|||
16343131|NCT02216214|39744329|FG001|Overall Study|Lack of Efficacy|2|||
16343132|NCT02216214|39744328|FG000|Overall Study|Lost to Follow-up|3|||
16343133|NCT02216214|39744329|FG001|Overall Study|Lost to Follow-up|2|||
16343134|NCT02216214|39744328|FG000|Overall Study|Protocol Violation|4|||
16343135|NCT02216214|39744329|FG001|Overall Study|Protocol Violation|2|||
16543609|NCT00572195|40453708|FG000|Overall Study|Adverse Event|4|||
16543610|NCT00572195|40453708|FG000|Overall Study|Lost to Follow-up|5|||
16343136|NCT02216214|39744328|FG000|Overall Study|Withdrawal by Subject|22|||
16343137|NCT02216214|39744329|FG001|Overall Study|Withdrawal by Subject|20|||
16343138|NCT02216214|39744328|FG000|Overall Study|Study Terminated By Sponsor|0|||
16343139|NCT02216214|39744329|FG001|Overall Study|Study Terminated By Sponsor|1|||
16343140|NCT02216214|39744328|FG000|Overall Study|Miscellaneous|1|||
16343141|NCT02216214|39744329|FG001|Overall Study|Miscellaneous|1|||
16343142|NCT03754972|39744331|FG000|Overall Study|Protocol Violation|25|||
16343143|NCT05446142|39744333|FG000|Period 2|Adverse Event|1|||
16343144|NCT05446142|39744334|FG001|Period 2|Adverse Event|0|||
16343145|NCT05446142|39744335|FG002|Period 2|Adverse Event|0|||
16543611|NCT02472652|40453710|FG000|Overall Study|Lost to Follow-up|1|||
16343146|NCT05446142|39744336|FG003|Period 2|Adverse Event|0|||
16343147|NCT05446142|39744337|FG004|Period 2|Adverse Event|0|||
16343148|NCT05446142|39744338|FG005|Period 2|Adverse Event|0|||
16343149|NCT02097823|39744340|FG000|Overall Study|Withdrawal by Subject|1|||
16343150|NCT02097823|39744341|FG001|Overall Study|Withdrawal by Subject|1|||
16343151|NCT00625183|39744342|FG000|Overall Study|Disease Progression|1|||
16343152|NCT00977613|39744343|FG000|Overall Study|Lost to Follow-up|16|||
16343153|NCT01054222|39744350|FG000|Overall Study|Lack of Efficacy|1|||
16343154|NCT01054222|39744350|FG000|Overall Study|Lost to Follow-up|4|||
16343155|NCT01054222|39744350|FG000|Overall Study|Withdrawal by Subject|6|||
16343156|NCT01765569|39744353|FG000|Period B|Withdrawal by Subject|1|||
16343157|NCT01765569|39744353|FG000|Period C|Death|1|||
16343158|NCT01272908|39744354|FG000|Initial Treatment Period|Adverse Event|1|||
16343159|NCT01272908|39744354|FG000|Initial Treatment Period|Lack of Efficacy|5|||
16343160|NCT01272908|39744354|FG000|Initial Treatment Period|Protocol Violation|1|||
16343161|NCT01272908|39744354|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
16343162|NCT01272908|39744354|FG000|Re-Treatment Period|Adverse Event|2|||
16343163|NCT01272908|39744354|FG000|Re-Treatment Period|Lack of Efficacy|3|||
16343164|NCT01272908|39744354|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
16343165|NCT01980628|39744357|FG000|Overall Study|Adverse Event|12|||
16343166|NCT01980628|39744357|FG000|Overall Study|Physician Decision|5|||
16343167|NCT01980628|39744357|FG000|Overall Study|Withdrawal by Subject|4|||
16343168|NCT01980628|39744357|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
16343169|NCT01763827|39744362|FG000|Overall Study|Withdrawal by Subject|1|||
16343170|NCT01763827|39744363|FG001|Overall Study|Withdrawal by Subject|0|||
16343171|NCT01763827|39744364|FG002|Overall Study|Withdrawal by Subject|0|||
16343172|NCT01763827|39744365|FG003|Overall Study|Withdrawal by Subject|0|||
16343173|NCT01763827|39744366|FG004|Overall Study|Withdrawal by Subject|2|||
16343174|NCT01763827|39744367|FG005|Overall Study|Withdrawal by Subject|0|||
16343175|NCT01763827|39744362|FG000|Overall Study|Decision by sponsor|2|||
16343176|NCT01763827|39744363|FG001|Overall Study|Decision by sponsor|0|||
16343177|NCT01763827|39744364|FG002|Overall Study|Decision by sponsor|3|||
16343178|NCT01763827|39744365|FG003|Overall Study|Decision by sponsor|0|||
16343179|NCT01763827|39744366|FG004|Overall Study|Decision by sponsor|2|||
16343180|NCT01763827|39744367|FG005|Overall Study|Decision by sponsor|1|||
16343181|NCT01763827|39744362|FG000|Overall Study|Lost to Follow-up|0|||
16343182|NCT01763827|39744363|FG001|Overall Study|Lost to Follow-up|1|||
16343183|NCT01763827|39744364|FG002|Overall Study|Lost to Follow-up|1|||
16343184|NCT01763827|39744365|FG003|Overall Study|Lost to Follow-up|1|||
16343185|NCT01763827|39744366|FG004|Overall Study|Lost to Follow-up|2|||
16343186|NCT01763827|39744367|FG005|Overall Study|Lost to Follow-up|1|||
16343187|NCT02182830|39744370|FG000|Overall Study|Not Treated|1|||
16109582|NCT01296555|38889105|FG002|Overall Study|Death|0|||
16109583|NCT01296555|38889106|FG003|Overall Study|Death|2|||
16109584|NCT01296555|38889107|FG004|Overall Study|Death|1|||
16109585|NCT01296555|38889108|FG005|Overall Study|Death|0|||
16109586|NCT01296555|38889109|FG006|Overall Study|Death|2|||
16343188|NCT02182830|39744371|FG001|Overall Study|Not Treated|1|||
16343189|NCT02182830|39744370|FG000|Overall Study|Trial stopped, reason missing|3|||
16343190|NCT02182830|39744371|FG001|Overall Study|Trial stopped, reason missing|3|||
16343191|NCT02182830|39744370|FG000|Overall Study|Consent withdrawn|8|||
16343192|NCT02182830|39744371|FG001|Overall Study|Consent withdrawn|8|||
16343193|NCT02182830|39744370|FG000|Overall Study|Lost to Follow-up|3|||
16343194|NCT02182830|39744371|FG001|Overall Study|Lost to Follow-up|3|||
16343195|NCT01831427|39744375|FG000|Overall Study|Adverse Event|0|||
16343196|NCT01831427|39744376|FG001|Overall Study|Adverse Event|1|||
16343197|NCT01831427|39744377|FG002|Overall Study|Adverse Event|0|||
16343198|NCT01831427|39744378|FG003|Overall Study|Adverse Event|0|||
16343199|NCT01831427|39744379|FG004|Overall Study|Adverse Event|0|||
16343200|NCT01831427|39744380|FG005|Overall Study|Adverse Event|1|||
16343201|NCT01831427|39744381|FG006|Overall Study|Adverse Event|0|||
16343202|NCT01831427|39744382|FG007|Overall Study|Adverse Event|1|||
16343203|NCT01831427|39744383|FG008|Overall Study|Adverse Event|0|||
16343204|NCT01831427|39744384|FG009|Overall Study|Adverse Event|0|||
16109587|NCT01296555|38889110|FG007|Overall Study|Death|0|||
16109588|NCT01296555|38889111|FG008|Overall Study|Death|0|||
16343205|NCT01831427|39744385|FG010|Overall Study|Adverse Event|2|||
16343206|NCT01831427|39744375|FG000|Overall Study|Investigator's Discretion|0|||
16343207|NCT01831427|39744376|FG001|Overall Study|Investigator's Discretion|0|||
16343208|NCT01831427|39744377|FG002|Overall Study|Investigator's Discretion|0|||
16343209|NCT01831427|39744378|FG003|Overall Study|Investigator's Discretion|1|||
16343210|NCT01831427|39744379|FG004|Overall Study|Investigator's Discretion|0|||
16343211|NCT01831427|39744380|FG005|Overall Study|Investigator's Discretion|0|||
16343212|NCT01831427|39744381|FG006|Overall Study|Investigator's Discretion|0|||
16343213|NCT01831427|39744382|FG007|Overall Study|Investigator's Discretion|0|||
16343214|NCT01831427|39744383|FG008|Overall Study|Investigator's Discretion|0|||
16343215|NCT01831427|39744384|FG009|Overall Study|Investigator's Discretion|0|||
16343216|NCT01831427|39744385|FG010|Overall Study|Investigator's Discretion|0|||
16343217|NCT01831427|39744375|FG000|Overall Study|Withdrew Consent|0|||
16343218|NCT01831427|39744376|FG001|Overall Study|Withdrew Consent|0|||
16343219|NCT01831427|39744377|FG002|Overall Study|Withdrew Consent|0|||
16343220|NCT01831427|39744378|FG003|Overall Study|Withdrew Consent|0|||
16343221|NCT01831427|39744379|FG004|Overall Study|Withdrew Consent|0|||
16343222|NCT01831427|39744380|FG005|Overall Study|Withdrew Consent|0|||
16343223|NCT01831427|39744381|FG006|Overall Study|Withdrew Consent|2|||
16343224|NCT01831427|39744382|FG007|Overall Study|Withdrew Consent|0|||
16343225|NCT01831427|39744383|FG008|Overall Study|Withdrew Consent|0|||
16343226|NCT01831427|39744384|FG009|Overall Study|Withdrew Consent|1|||
16343227|NCT01831427|39744385|FG010|Overall Study|Withdrew Consent|1|||
16343228|NCT01949142|39744390|FG000|Overall Study|Withdrawal of consent|1|||
16343229|NCT01949142|39744391|FG001|Overall Study|Withdrawal of consent|0|||
16343230|NCT01949142|39744390|FG000|Overall Study|Lost to Follow-up|1|||
16343231|NCT01949142|39744391|FG001|Overall Study|Lost to Follow-up|1|||
16343232|NCT01949142|39744390|FG000|Overall Study|Parent changed their mind|1|||
16343233|NCT01949142|39744391|FG001|Overall Study|Parent changed their mind|0|||
16343234|NCT03014206|39744399|FG000|Overall Study|Registration Violation|12|||
16343235|NCT03243305|39744403|FG000|Overall Study|Lost to Follow-up|250|||
16343236|NCT03243305|39744403|FG000|Overall Study|Withdrawal by Subject|170|||
16343237|NCT03243305|39744403|FG000|Overall Study|Pregnancy|104|||
16343238|NCT03243305|39744403|FG000|Overall Study|Non-Compliance with Study Drug|38|||
16343239|NCT03243305|39744403|FG000|Overall Study|Adverse Event|23|||
16343240|NCT03243305|39744403|FG000|Overall Study|No sexually active|26|||
16343241|NCT03243305|39744403|FG000|Overall Study|Physician Decision|22|||
16343242|NCT03243305|39744403|FG000|Overall Study|Protocol Violation|22|||
16343243|NCT03243305|39744403|FG000|Overall Study|Study method no longer primary method|12|||
16343244|NCT03243305|39744403|FG000|Overall Study|Study Terminated by Sponsor|1|||
16343245|NCT03243305|39744403|FG000|Overall Study|Early terminations|267|||
16343246|NCT04074330|39744408|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
16343247|NCT04074330|39744409|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
16343248|NCT04074330|39744410|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
16343249|NCT04074330|39744411|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
16343250|NCT04074330|39744412|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
16343251|NCT04074330|39744413|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
16343252|NCT04074330|39744414|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
16343253|NCT04074330|39744415|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
16343254|NCT04074330|39744416|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
16343255|NCT04074330|39744417|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
16343256|NCT04074330|39744408|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
16343257|NCT04074330|39744409|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
16343258|NCT04074330|39744410|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
16343259|NCT04074330|39744411|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
16343260|NCT04074330|39744412|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
16343261|NCT04074330|39744413|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
16343262|NCT04074330|39744414|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
16343263|NCT04074330|39744415|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
16343264|NCT04074330|39744416|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
16343265|NCT04074330|39744417|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
16343266|NCT04074330|39744408|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
16343267|NCT04074330|39744409|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
16343268|NCT04074330|39744410|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
16343269|NCT04074330|39744411|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
16343270|NCT04074330|39744412|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
16343271|NCT04074330|39744413|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
16343272|NCT04074330|39744414|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
16343273|NCT04074330|39744415|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
16343274|NCT04074330|39744416|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
16343275|NCT04074330|39744417|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
16343276|NCT04074330|39744408|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
16343277|NCT04074330|39744409|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
16109589|NCT01296555|38889112|FG009|Overall Study|Death|1|||
16109590|NCT01296555|38889113|FG010|Overall Study|Death|0|||
16109591|NCT01296555|38889114|FG011|Overall Study|Death|1|||
16109592|NCT01296555|38889115|FG012|Overall Study|Death|0|||
16109593|NCT01296555|38889116|FG013|Overall Study|Death|2|||
16109594|NCT01296555|38889117|FG014|Overall Study|Death|27|||
16109595|NCT01296555|38889118|FG015|Overall Study|Death|15|||
16343278|NCT04074330|39744410|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
16343279|NCT04074330|39744411|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
16343280|NCT04074330|39744412|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
16343281|NCT04074330|39744413|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
16343282|NCT04074330|39744414|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
16343283|NCT04074330|39744415|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
16343284|NCT04074330|39744416|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
16343285|NCT04074330|39744417|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
16343286|NCT04074330|39744408|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
16343287|NCT04074330|39744409|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
16343288|NCT04074330|39744410|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
16343289|NCT04074330|39744411|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
16343290|NCT04074330|39744412|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
16343291|NCT04074330|39744413|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
16343292|NCT04074330|39744414|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
16343293|NCT04074330|39744415|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
16343294|NCT04074330|39744416|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
16343295|NCT04074330|39744417|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
16543612|NCT03145766|40453711|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
16109596|NCT01296555|38889119|FG016|Overall Study|Death|11|||
16109597|NCT01296555|38889120|FG017|Overall Study|Death|11|||
16109598|NCT01296555|38889121|FG018|Overall Study|Death|17|||
16343296|NCT04074330|39744408|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
16343297|NCT04074330|39744409|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
16343298|NCT04074330|39744410|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
16343299|NCT04074330|39744411|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
16343300|NCT04074330|39744412|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
16343301|NCT04074330|39744413|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
16343302|NCT04074330|39744414|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
16343303|NCT04074330|39744415|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
16343304|NCT04074330|39744416|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
16343305|NCT04074330|39744417|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
16343306|NCT04074330|39744408|FG000|Dose Expansion (up to 42 Months)|Death|0|||
16343307|NCT04074330|39744409|FG001|Dose Expansion (up to 42 Months)|Death|0|||
16343308|NCT04074330|39744410|FG002|Dose Expansion (up to 42 Months)|Death|0|||
16343309|NCT04074330|39744411|FG003|Dose Expansion (up to 42 Months)|Death|0|||
16343310|NCT04074330|39744412|FG004|Dose Expansion (up to 42 Months)|Death|0|||
16343311|NCT04074330|39744413|FG005|Dose Expansion (up to 42 Months)|Death|0|||
16343312|NCT04074330|39744414|FG006|Dose Expansion (up to 42 Months)|Death|0|||
16343313|NCT04074330|39744415|FG007|Dose Expansion (up to 42 Months)|Death|0|||
16343314|NCT04074330|39744416|FG008|Dose Expansion (up to 42 Months)|Death|1|||
16343315|NCT04074330|39744417|FG009|Dose Expansion (up to 42 Months)|Death|0|||
16343316|NCT04074330|39744408|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
16343317|NCT04074330|39744409|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
16343318|NCT04074330|39744410|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
16343319|NCT04074330|39744411|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
16343320|NCT04074330|39744412|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
16343321|NCT04074330|39744413|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
16343322|NCT04074330|39744414|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
16343323|NCT04074330|39744415|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
16343324|NCT04074330|39744416|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
16343325|NCT04074330|39744417|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
16343326|NCT02861664|39744418|FG000|Overall Study|Withdrawal of Consent|0|||
16343327|NCT02861664|39744419|FG001|Overall Study|Withdrawal of Consent|1|||
16343328|NCT00759655|39744422|FG000|Overall Study|Termination of the study by sponsor|1|||
16343329|NCT01404949|39744423|FG000|Overall Study|Not Treated|1|||
16343330|NCT01042392|39744424|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
16343331|NCT01042392|39744425|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
16343332|NCT01042392|39744426|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
16343333|NCT01042392|39744427|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
16343334|NCT01042392|39744424|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
16343335|NCT01042392|39744425|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
16407418|NCT01340937|39973206|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
16407419|NCT01340937|39973207|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
16220745|NCT02807376|39286501|FG001|Overall Study|Intra-operative exclusion criteria|0|||
16220746|NCT02807376|39286500|FG000|Overall Study|Lost to Follow-up|0|||
16220747|NCT02807376|39286501|FG001|Overall Study|Lost to Follow-up|1|||
16220748|NCT00307736|39286518|FG000|Overall Study|Adverse Event|0|||
16220749|NCT00307736|39286519|FG001|Overall Study|Adverse Event|0|||
16220750|NCT00307736|39286520|FG002|Overall Study|Adverse Event|1|||
16220751|NCT00307736|39286521|FG003|Overall Study|Adverse Event|3|||
16220752|NCT00307736|39286518|FG000|Overall Study|Withdrawal by Subject|0|||
16343336|NCT01042392|39744426|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
16343337|NCT01042392|39744427|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
16343338|NCT01042392|39744424|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
16343339|NCT01042392|39744425|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
16343340|NCT01042392|39744426|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
16343341|NCT01042392|39744427|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
16220753|NCT00307736|39286519|FG001|Overall Study|Withdrawal by Subject|0|||
16220754|NCT00307736|39286520|FG002|Overall Study|Withdrawal by Subject|2|||
16220755|NCT00307736|39286521|FG003|Overall Study|Withdrawal by Subject|0|||
16220756|NCT00684073|39286522|FG000|Selection|Selection/non-selection criteria|3|||
16343342|NCT01042392|39744424|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
16343343|NCT01042392|39744425|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
16343344|NCT01042392|39744426|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
16343345|NCT01042392|39744427|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
16543613|NCT03145766|40453712|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
16543614|NCT03145766|40453713|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
16543615|NCT03145766|40453714|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
16220757|NCT00684073|39286522|FG000|Selection|Death|1|||
16543616|NCT03145766|40453715|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
16543617|NCT03145766|40453711|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
16543618|NCT03145766|40453712|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
16543619|NCT03145766|40453713|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
16220758|NCT00684073|39286522|FG000|Selection|noncompliance|1|||
16220759|NCT00684073|39286522|FG000|Selection|Lost to Follow-up|1|||
16220760|NCT00684073|39286522|FG000|Selection|request of the sponsor|1|||
16220761|NCT00684073|39286522|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
16220762|NCT01731600|39286523|FG000|Overall Study|Adverse Event|2|||
16220763|NCT01731600|39286524|FG001|Overall Study|Adverse Event|0|||
16220764|NCT01731600|39286523|FG000|Overall Study|Withdrawal criteria|1|||
16220765|NCT01731600|39286524|FG001|Overall Study|Withdrawal criteria|0|||
16220766|NCT01731600|39286523|FG000|Overall Study|Other reasons|3|||
16220767|NCT01731600|39286524|FG001|Overall Study|Other reasons|0|||
16220768|NCT00095836|39286525|FG000|Overall Study|Lost to Follow-up|1|||
16220769|NCT00095836|39286525|FG000|Overall Study|Adverse Event|1|||
16220770|NCT00095836|39286525|FG000|Overall Study|Death|2|||
16220771|NCT00033293|39286526|FG000|Overall Study|Death|0|||
16220772|NCT00033293|39286527|FG001|Overall Study|Death|1|||
16220773|NCT00033293|39286526|FG000|Overall Study|Lack of Efficacy|5|||
16543620|NCT03145766|40453714|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
16543621|NCT03145766|40453715|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
16543622|NCT03145766|40453711|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
16543623|NCT03145766|40453712|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
16543624|NCT03145766|40453713|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
16543625|NCT03145766|40453714|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
16543626|NCT03145766|40453715|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
16220774|NCT00033293|39286527|FG001|Overall Study|Lack of Efficacy|8|||
16220775|NCT00033293|39286526|FG000|Overall Study|Lost to Follow-up|0|||
16220776|NCT00033293|39286527|FG001|Overall Study|Lost to Follow-up|1|||
16220777|NCT00033293|39286526|FG000|Overall Study|Physician Decision|3|||
16220778|NCT00033293|39286527|FG001|Overall Study|Physician Decision|1|||
16220779|NCT00033293|39286526|FG000|Overall Study|Withdrawal by Subject|1|||
16109599|NCT01296555|38889122|FG019|Overall Study|Death|12|||
16109600|NCT01296555|38889123|FG020|Overall Study|Death|13|||
16109601|NCT01296555|38889124|FG021|Overall Study|Death|12|||
16109602|NCT01296555|38889125|FG022|Overall Study|Death|12|||
16109603|NCT01296555|38889126|FG023|Overall Study|Death|13|||
16109604|NCT01296555|38889127|FG024|Overall Study|Death|7|||
16109605|NCT01296555|38889128|FG025|Overall Study|Death|7|||
16343346|NCT01042392|39744424|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
16343347|NCT01042392|39744425|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
16343348|NCT01042392|39744426|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
16343349|NCT01042392|39744427|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
16343350|NCT01042392|39744424|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
16343351|NCT01042392|39744425|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
16343352|NCT01042392|39744426|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
16343353|NCT01042392|39744427|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
16343354|NCT01042392|39744424|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
16343355|NCT01042392|39744425|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
16109606|NCT01296555|38889129|FG026|Overall Study|Death|35|||
16109607|NCT01296555|38889130|FG027|Overall Study|Death|92|||
16109608|NCT01296555|38889131|FG028|Overall Study|Death|44|||
16109609|NCT01296555|38889103|FG000|Overall Study|Lost to Follow-up|0|||
16109610|NCT01296555|38889104|FG001|Overall Study|Lost to Follow-up|0|||
16109611|NCT01296555|38889105|FG002|Overall Study|Lost to Follow-up|0|||
16109612|NCT01296555|38889106|FG003|Overall Study|Lost to Follow-up|0|||
16109613|NCT01296555|38889107|FG004|Overall Study|Lost to Follow-up|0|||
16109614|NCT01296555|38889108|FG005|Overall Study|Lost to Follow-up|0|||
16109615|NCT01296555|38889109|FG006|Overall Study|Lost to Follow-up|0|||
16109616|NCT01296555|38889110|FG007|Overall Study|Lost to Follow-up|0|||
16109617|NCT01296555|38889111|FG008|Overall Study|Lost to Follow-up|0|||
16109618|NCT01296555|38889112|FG009|Overall Study|Lost to Follow-up|0|||
16109619|NCT01296555|38889113|FG010|Overall Study|Lost to Follow-up|0|||
16109620|NCT01296555|38889114|FG011|Overall Study|Lost to Follow-up|0|||
16109621|NCT01296555|38889115|FG012|Overall Study|Lost to Follow-up|0|||
16343356|NCT01042392|39744426|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
16407420|NCT03158012|39973208|FG000|Overall Study|Withdrawal by Subject|0|||
16407421|NCT03158012|39973209|FG001|Overall Study|Withdrawal by Subject|1|||
16407422|NCT01468207|39973210|FG000|Treatment Period 1|Adverse Event|1|||
16109622|NCT01296555|38889116|FG013|Overall Study|Lost to Follow-up|0|||
16109623|NCT01296555|38889117|FG014|Overall Study|Lost to Follow-up|2|||
16109624|NCT01296555|38889118|FG015|Overall Study|Lost to Follow-up|1|||
16109625|NCT01296555|38889119|FG016|Overall Study|Lost to Follow-up|0|||
16109626|NCT01296555|38889120|FG017|Overall Study|Lost to Follow-up|2|||
16109627|NCT01296555|38889121|FG018|Overall Study|Lost to Follow-up|0|||
16407423|NCT01468207|39973211|FG001|Treatment Period 1|Adverse Event|0|||
16407424|NCT01468207|39973212|FG002|Treatment Period 1|Adverse Event|0|||
16407425|NCT01468207|39973213|FG003|Treatment Period 1|Adverse Event|0|||
16407426|NCT01468207|39973214|FG004|Treatment Period 1|Adverse Event|0|||
16407427|NCT01468207|39973215|FG005|Treatment Period 1|Adverse Event|0|||
16407428|NCT01468207|39973210|FG000|Treatment Period 1|Protocol Violation|1|||
16407429|NCT01468207|39973211|FG001|Treatment Period 1|Protocol Violation|1|||
16407430|NCT01468207|39973212|FG002|Treatment Period 1|Protocol Violation|0|||
16407431|NCT01468207|39973213|FG003|Treatment Period 1|Protocol Violation|0|||
16220780|NCT00033293|39286527|FG001|Overall Study|Withdrawal by Subject|0|||
16220781|NCT00033293|39286526|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
16220782|NCT00033293|39286527|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
16220783|NCT00033293|39286526|FG000|Overall Study|Treatment refused|0|||
16407432|NCT01468207|39973214|FG004|Treatment Period 1|Protocol Violation|0|||
16407433|NCT01468207|39973215|FG005|Treatment Period 1|Protocol Violation|0|||
16407434|NCT01468207|39973210|FG000|Treatment Period 1|Withdrawal by Subject|5|||
16407435|NCT01468207|39973211|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16407436|NCT01468207|39973212|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16407437|NCT01468207|39973213|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16407438|NCT01468207|39973214|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16109628|NCT01296555|38889122|FG019|Overall Study|Lost to Follow-up|2|||
16109629|NCT01296555|38889123|FG020|Overall Study|Lost to Follow-up|3|||
16109630|NCT01296555|38889124|FG021|Overall Study|Lost to Follow-up|2|||
16109631|NCT01296555|38889125|FG022|Overall Study|Lost to Follow-up|0|||
16109632|NCT01296555|38889126|FG023|Overall Study|Lost to Follow-up|0|||
16109633|NCT01296555|38889127|FG024|Overall Study|Lost to Follow-up|0|||
16407439|NCT01468207|39973215|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16407440|NCT01468207|39973210|FG000|Treatment Period 1|Lost to Follow-up|2|||
16109634|NCT01296555|38889128|FG025|Overall Study|Lost to Follow-up|0|||
16109635|NCT01296555|38889129|FG026|Overall Study|Lost to Follow-up|3|||
16109636|NCT01296555|38889130|FG027|Overall Study|Lost to Follow-up|13|||
16109637|NCT01296555|38889131|FG028|Overall Study|Lost to Follow-up|5|||
16109638|NCT01296555|38889103|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16109639|NCT01296555|38889104|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16220784|NCT00033293|39286527|FG001|Overall Study|Treatment refused|6|||
16220785|NCT01977040|39286531|FG000|Overall Study|Vasa previa not confirmed|2|||
16220786|NCT01277666|39286532|FG000|Overall Study|Adverse Event|26|||
16220787|NCT01277666|39286533|FG001|Overall Study|Adverse Event|25|||
16220788|NCT01277666|39286534|FG002|Overall Study|Adverse Event|20|||
16220789|NCT01277666|39286532|FG000|Overall Study|Lack of Efficacy|8|||
16220790|NCT01277666|39286533|FG001|Overall Study|Lack of Efficacy|20|||
16220791|NCT01277666|39286534|FG002|Overall Study|Lack of Efficacy|12|||
16220792|NCT01277666|39286532|FG000|Overall Study|Protocol Violation|2|||
16220793|NCT01277666|39286533|FG001|Overall Study|Protocol Violation|3|||
16220794|NCT01277666|39286534|FG002|Overall Study|Protocol Violation|2|||
16109640|NCT01296555|38889105|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16109641|NCT01296555|38889106|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16109642|NCT01296555|38889107|FG004|Overall Study|Non-Compliance With Study Drug|0|||
16109643|NCT01296555|38889108|FG005|Overall Study|Non-Compliance With Study Drug|0|||
16109644|NCT01296555|38889109|FG006|Overall Study|Non-Compliance With Study Drug|0|||
16109645|NCT01296555|38889110|FG007|Overall Study|Non-Compliance With Study Drug|1|||
16220795|NCT01277666|39286532|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
16220796|NCT01277666|39286533|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
16220797|NCT01277666|39286534|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
16220798|NCT01277666|39286532|FG000|Overall Study|Lost to Follow-up|1|||
16220799|NCT01277666|39286533|FG001|Overall Study|Lost to Follow-up|1|||
16220800|NCT01277666|39286534|FG002|Overall Study|Lost to Follow-up|2|||
16220801|NCT01277666|39286532|FG000|Overall Study|Withdrawal by Subject|7|||
16220802|NCT01277666|39286533|FG001|Overall Study|Withdrawal by Subject|8|||
16109646|NCT01296555|38889111|FG008|Overall Study|Non-Compliance With Study Drug|0|||
16109647|NCT01296555|38889112|FG009|Overall Study|Non-Compliance With Study Drug|0|||
16109648|NCT01296555|38889113|FG010|Overall Study|Non-Compliance With Study Drug|0|||
16109649|NCT01296555|38889114|FG011|Overall Study|Non-Compliance With Study Drug|0|||
16220803|NCT01277666|39286534|FG002|Overall Study|Withdrawal by Subject|6|||
16220804|NCT01277666|39286532|FG000|Overall Study|Death|0|||
16220805|NCT01277666|39286533|FG001|Overall Study|Death|0|||
16220806|NCT01277666|39286534|FG002|Overall Study|Death|1|||
16220807|NCT01728194|39286535|FG000|Overall Study|Lost to Follow-up|4|||
16220808|NCT01728194|39286536|FG001|Overall Study|Lost to Follow-up|3|||
16220809|NCT01728194|39286535|FG000|Overall Study|Physician Decision|4|||
16109650|NCT01296555|38889115|FG012|Overall Study|Non-Compliance With Study Drug|0|||
16109651|NCT01296555|38889116|FG013|Overall Study|Non-Compliance With Study Drug|0|||
16109652|NCT01296555|38889117|FG014|Overall Study|Non-Compliance With Study Drug|0|||
16109653|NCT01296555|38889118|FG015|Overall Study|Non-Compliance With Study Drug|0|||
16220810|NCT01728194|39286536|FG001|Overall Study|Physician Decision|0|||
16220811|NCT01728194|39286535|FG000|Overall Study|Withdrawal by Subject|7|||
16220812|NCT01728194|39286536|FG001|Overall Study|Withdrawal by Subject|3|||
16220813|NCT01728194|39286535|FG000|Overall Study|Perceived Medication Side Effects|4|||
16220814|NCT01728194|39286536|FG001|Overall Study|Perceived Medication Side Effects|0|||
16543627|NCT03145766|40453711|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
16543628|NCT03145766|40453712|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
16220815|NCT01728194|39286535|FG000|Overall Study|Family Member Request|1|||
16220816|NCT01728194|39286536|FG001|Overall Study|Family Member Request|0|||
16220817|NCT01766401|39286542|FG000|Overall Study|Adverse Event|7|||
16220818|NCT01766401|39286543|FG001|Overall Study|Adverse Event|22|||
16220819|NCT01766401|39286542|FG000|Overall Study|Lack of Efficacy|1|||
16343357|NCT01042392|39744427|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
16543629|NCT03145766|40453713|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
16543630|NCT03145766|40453714|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
16109654|NCT01296555|38889119|FG016|Overall Study|Non-Compliance With Study Drug|0|||
16109655|NCT01296555|38889120|FG017|Overall Study|Non-Compliance With Study Drug|0|||
16109656|NCT01296555|38889121|FG018|Overall Study|Non-Compliance With Study Drug|0|||
16109657|NCT01296555|38889122|FG019|Overall Study|Non-Compliance With Study Drug|0|||
16220820|NCT01766401|39286543|FG001|Overall Study|Lack of Efficacy|2|||
16220821|NCT01766401|39286542|FG000|Overall Study|Protocol Violation|3|||
16343358|NCT01042392|39744424|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
16343359|NCT01042392|39744425|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
16343360|NCT01042392|39744426|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
16343361|NCT01042392|39744427|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
16343362|NCT01042392|39744424|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
16343363|NCT01042392|39744425|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
16220822|NCT01766401|39286543|FG001|Overall Study|Protocol Violation|8|||
16220823|NCT01766401|39286542|FG000|Overall Study|Withdrawal by Subject|15|||
16220824|NCT01766401|39286543|FG001|Overall Study|Withdrawal by Subject|12|||
16220825|NCT01766401|39286542|FG000|Overall Study|Lost to Follow-up|10|||
16220826|NCT01766401|39286543|FG001|Overall Study|Lost to Follow-up|11|||
16220827|NCT01766401|39286542|FG000|Overall Study|Pregnancy|1|||
16220828|NCT01766401|39286543|FG001|Overall Study|Pregnancy|1|||
16220829|NCT02909504|39286544|FG000|Overall Study|Adverse Event|2|||
16220830|NCT02909504|39286544|FG000|Overall Study|Lack of Efficacy|3|||
16220831|NCT02909504|39286544|FG000|Overall Study|Withdrawal by Subject|4|||
16220832|NCT02909504|39286544|FG000|Overall Study|Pregnancy|1|||
16220833|NCT02909504|39286544|FG000|Overall Study|Subject moved|1|||
16220834|NCT02909504|39286544|FG000|Overall Study|Lost to Follow-up|1|||
16220835|NCT00635804|39286545|FG000|Overall Study|Adverse Event|0|||
16220836|NCT00635804|39286546|FG001|Overall Study|Adverse Event|0|||
16220837|NCT00635804|39286547|FG002|Overall Study|Adverse Event|0|||
16220838|NCT00635804|39286548|FG003|Overall Study|Adverse Event|0|||
16220839|NCT00635804|39286549|FG004|Overall Study|Adverse Event|0|||
16220840|NCT00635804|39286550|FG005|Overall Study|Adverse Event|1|||
16220841|NCT00635804|39286551|FG006|Overall Study|Adverse Event|0|||
16220842|NCT00635804|39286552|FG007|Overall Study|Adverse Event|0|||
16109658|NCT01296555|38889123|FG020|Overall Study|Non-Compliance With Study Drug|0|||
16109659|NCT01296555|38889124|FG021|Overall Study|Non-Compliance With Study Drug|0|||
16220843|NCT00635804|39286545|FG000|Overall Study|Withdrawal by Subject|1|||
16220844|NCT00635804|39286546|FG001|Overall Study|Withdrawal by Subject|0|||
16220845|NCT00635804|39286547|FG002|Overall Study|Withdrawal by Subject|0|||
16220846|NCT00635804|39286548|FG003|Overall Study|Withdrawal by Subject|0|||
16220847|NCT00635804|39286549|FG004|Overall Study|Withdrawal by Subject|0|||
16220848|NCT00635804|39286550|FG005|Overall Study|Withdrawal by Subject|0|||
16220849|NCT00635804|39286551|FG006|Overall Study|Withdrawal by Subject|0|||
16220850|NCT00635804|39286552|FG007|Overall Study|Withdrawal by Subject|0|||
16220851|NCT02405091|39286555|FG000|Overall Study|Adverse Event|16|||
16220852|NCT02405091|39286556|FG001|Overall Study|Adverse Event|10|||
16220853|NCT02405091|39286557|FG002|Overall Study|Adverse Event|0|||
16220854|NCT02405091|39286555|FG000|Overall Study|Protocol Violation|1|||
16220855|NCT02405091|39286556|FG001|Overall Study|Protocol Violation|0|||
16220856|NCT02405091|39286557|FG002|Overall Study|Protocol Violation|0|||
16220857|NCT02405091|39286555|FG000|Overall Study|Noncompliance|1|||
16220858|NCT02405091|39286556|FG001|Overall Study|Noncompliance|6|||
16220859|NCT02405091|39286557|FG002|Overall Study|Noncompliance|2|||
16220860|NCT02405091|39286555|FG000|Overall Study|Withdrawal by Subject|4|||
16220861|NCT02405091|39286556|FG001|Overall Study|Withdrawal by Subject|8|||
16220862|NCT02405091|39286557|FG002|Overall Study|Withdrawal by Subject|0|||
16220863|NCT02405091|39286555|FG000|Overall Study|Death|0|||
16220864|NCT02405091|39286556|FG001|Overall Study|Death|1|||
16220865|NCT02405091|39286557|FG002|Overall Study|Death|0|||
16220866|NCT02405091|39286555|FG000|Overall Study|Lost to Follow-up|5|||
16220867|NCT02405091|39286556|FG001|Overall Study|Lost to Follow-up|6|||
16220868|NCT02405091|39286557|FG002|Overall Study|Lost to Follow-up|0|||
16220869|NCT02405091|39286555|FG000|Overall Study|Physician Decision|2|||
16220870|NCT02405091|39286556|FG001|Overall Study|Physician Decision|2|||
16220871|NCT02405091|39286557|FG002|Overall Study|Physician Decision|0|||
16220872|NCT03730987|39286558|FG000|Overall Study|Lost to Follow-up|2|||
16220873|NCT03730987|39286559|FG001|Overall Study|Lost to Follow-up|0|||
16220874|NCT03730987|39286560|FG002|Overall Study|Lost to Follow-up|2|||
16220875|NCT03730987|39286561|FG003|Overall Study|Lost to Follow-up|0|||
16220876|NCT01488994|39286563|FG000|Overall Study|Withdrawal by Subject|0|||
16220877|NCT01488994|39286564|FG001|Overall Study|Withdrawal by Subject|1|||
16220878|NCT02260791|39286565|FG000|Overall Study|Lost to Follow-up|4|||
16220879|NCT02260791|39286566|FG001|Overall Study|Lost to Follow-up|4|||
16220880|NCT02260791|39286565|FG000|Overall Study|Lack of Efficacy|2|||
16220881|NCT02260791|39286566|FG001|Overall Study|Lack of Efficacy|1|||
16220882|NCT02260791|39286565|FG000|Overall Study|Adverse Event|13|||
16220883|NCT02260791|39286566|FG001|Overall Study|Adverse Event|9|||
16220884|NCT02260791|39286565|FG000|Overall Study|Death|1|||
16220885|NCT02260791|39286566|FG001|Overall Study|Death|0|||
16407441|NCT01468207|39973211|FG001|Treatment Period 1|Lost to Follow-up|1|||
16407442|NCT01468207|39973212|FG002|Treatment Period 1|Lost to Follow-up|0|||
16220886|NCT02260791|39286565|FG000|Overall Study|Withdrawal by Subject|11|||
16220887|NCT02260791|39286566|FG001|Overall Study|Withdrawal by Subject|16|||
16220888|NCT02260791|39286565|FG000|Overall Study|Screen failure|0|||
16220889|NCT02260791|39286566|FG001|Overall Study|Screen failure|1|||
16220890|NCT02260791|39286565|FG000|Overall Study|Protocol deviation|2|||
16220891|NCT02260791|39286566|FG001|Overall Study|Protocol deviation|3|||
16220892|NCT00087685|39290500|FG000|Overall Study|Adverse Event|5|||
16220893|NCT00087685|39290500|FG000|Overall Study|Non-Compliance|1|||
16220894|NCT00087685|39290500|FG000|Overall Study|Progressive Disease|5|||
16220895|NCT00087685|39290500|FG000|Overall Study|Withdrawal by Subject|3|||
16407443|NCT01468207|39973213|FG003|Treatment Period 1|Lost to Follow-up|0|||
16220896|NCT00529152|39290503|FG000|Overall Study|Adverse Event|2|||
16220897|NCT00529152|39290503|FG000|Overall Study|Withdrawal by Subject|2|||
16220898|NCT00529152|39290503|FG000|Overall Study|Lost to Follow-up|1|||
16220899|NCT00945945|39290506|FG000|Overall Study|Adverse Event|15|||
16220900|NCT00945945|39290507|FG001|Overall Study|Adverse Event|35|||
16220901|NCT00945945|39290506|FG000|Overall Study|Withdrawal by Subject|7|||
16220902|NCT00945945|39290507|FG001|Overall Study|Withdrawal by Subject|10|||
16220903|NCT00945945|39290506|FG000|Overall Study|Lost to Follow-up|4|||
16220904|NCT00945945|39290507|FG001|Overall Study|Lost to Follow-up|5|||
16220905|NCT00945945|39290506|FG000|Overall Study|Lack of Efficacy|6|||
16220906|NCT00945945|39290507|FG001|Overall Study|Lack of Efficacy|2|||
16220907|NCT00945945|39290506|FG000|Overall Study|Protocol Violation|4|||
16220908|NCT00945945|39290507|FG001|Overall Study|Protocol Violation|2|||
16220909|NCT00945945|39290506|FG000|Overall Study|Entry Criteria Not Met|0|||
16220910|NCT00945945|39290507|FG001|Overall Study|Entry Criteria Not Met|1|||
16220911|NCT03225833|39290512|FG000|Overall Study|Adverse Event|0|||
16220912|NCT03225833|39290513|FG001|Overall Study|Adverse Event|1|||
16220913|NCT03225833|39290514|FG002|Overall Study|Adverse Event|2|||
16220914|NCT03225833|39290515|FG003|Overall Study|Adverse Event|0|||
16220915|NCT03225833|39290516|FG004|Overall Study|Adverse Event|0|||
16220916|NCT03225833|39290517|FG005|Overall Study|Adverse Event|2|||
16220917|NCT03225833|39290512|FG000|Overall Study|Withdrawal by Subject|1|||
16220918|NCT03225833|39290513|FG001|Overall Study|Withdrawal by Subject|0|||
16220919|NCT03225833|39290514|FG002|Overall Study|Withdrawal by Subject|0|||
16220920|NCT03225833|39290515|FG003|Overall Study|Withdrawal by Subject|0|||
16220921|NCT03225833|39290516|FG004|Overall Study|Withdrawal by Subject|1|||
16220922|NCT03225833|39290517|FG005|Overall Study|Withdrawal by Subject|0|||
16220923|NCT03225833|39290512|FG000|Overall Study|Termination of Study by Sponsor|4|||
16220924|NCT03225833|39290513|FG001|Overall Study|Termination of Study by Sponsor|0|||
16220925|NCT03225833|39290514|FG002|Overall Study|Termination of Study by Sponsor|0|||
16220926|NCT03225833|39290515|FG003|Overall Study|Termination of Study by Sponsor|0|||
16220927|NCT03225833|39290516|FG004|Overall Study|Termination of Study by Sponsor|0|||
16220928|NCT03225833|39290517|FG005|Overall Study|Termination of Study by Sponsor|7|||
16220929|NCT03225833|39290512|FG000|Overall Study|Sponsor Decision|0|||
16220930|NCT03225833|39290513|FG001|Overall Study|Sponsor Decision|0|||
16220931|NCT03225833|39290514|FG002|Overall Study|Sponsor Decision|0|||
16220932|NCT03225833|39290515|FG003|Overall Study|Sponsor Decision|0|||
16220933|NCT03225833|39290516|FG004|Overall Study|Sponsor Decision|0|||
16220934|NCT03225833|39290517|FG005|Overall Study|Sponsor Decision|1|||
16220935|NCT02242305|39290518|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
16220936|NCT02242305|39290519|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
16220937|NCT02242305|39290518|FG000|Overall Study|Adverse Event|1|||
16220938|NCT02242305|39290519|FG001|Overall Study|Adverse Event|0|||
16220939|NCT02242305|39290518|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
16220940|NCT02242305|39290519|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
16220941|NCT02242305|39290518|FG000|Overall Study|Subject withdraws inform consent|0|||
16220942|NCT02242305|39290519|FG001|Overall Study|Subject withdraws inform consent|4|||
16109660|NCT01296555|38889125|FG022|Overall Study|Non-Compliance With Study Drug|0|||
16109661|NCT01296555|38889126|FG023|Overall Study|Non-Compliance With Study Drug|0|||
16109662|NCT01296555|38889127|FG024|Overall Study|Non-Compliance With Study Drug|0|||
16109663|NCT01296555|38889128|FG025|Overall Study|Non-Compliance With Study Drug|0|||
16109664|NCT01296555|38889129|FG026|Overall Study|Non-Compliance With Study Drug|0|||
16220943|NCT02242305|39290518|FG000|Overall Study|Lost to Follow-up|2|||
16220944|NCT02242305|39290519|FG001|Overall Study|Lost to Follow-up|0|||
16343364|NCT01042392|39744426|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
16343365|NCT01042392|39744427|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
16343366|NCT00048997|39744429|FG000|Overall Study|Protocol Violation|7|||
16343367|NCT00048997|39744430|FG001|Overall Study|Protocol Violation|2|||
16343368|NCT00048997|39744429|FG000|Overall Study|Withdrawal by Subject|6|||
16343369|NCT00048997|39744430|FG001|Overall Study|Withdrawal by Subject|1|||
16343370|NCT02757625|39744431|FG000|Overall Study|Investigator's discretion|0|||
16343371|NCT02757625|39744432|FG001|Overall Study|Investigator's discretion|0|||
16343372|NCT02757625|39744433|FG002|Overall Study|Investigator's discretion|1|||
16343373|NCT02757625|39744434|FG003|Overall Study|Investigator's discretion|0|||
16343374|NCT02757625|39744431|FG000|Overall Study|Adverse Event|0|||
16343375|NCT02757625|39744432|FG001|Overall Study|Adverse Event|0|||
16343376|NCT02757625|39744433|FG002|Overall Study|Adverse Event|1|||
16343377|NCT02757625|39744434|FG003|Overall Study|Adverse Event|0|||
16343378|NCT02348008|39744435|FG000|Overall Study|Adverse Event|2|||
16343379|NCT02348008|39744436|FG001|Overall Study|Adverse Event|3|||
16343380|NCT02348008|39744437|FG002|Overall Study|Adverse Event|3|||
16343381|NCT02348008|39744435|FG000|Overall Study|Disease Progression|1|||
16343382|NCT02348008|39744436|FG001|Overall Study|Disease Progression|5|||
16220945|NCT03481634|39290522|FG000|Overall Study|Withdrawal by Subject|16|||
16220946|NCT03481634|39290523|FG001|Overall Study|Withdrawal by Subject|19|||
16220947|NCT03481634|39290524|FG002|Overall Study|Withdrawal by Subject|14|||
16220948|NCT03481634|39290522|FG000|Overall Study|Protocol Violation|1|||
16220949|NCT03481634|39290523|FG001|Overall Study|Protocol Violation|0|||
16343383|NCT02348008|39744437|FG002|Overall Study|Disease Progression|16|||
16343384|NCT02348008|39744435|FG000|Overall Study|Withdrawal by Subject|0|||
16343385|NCT02348008|39744436|FG001|Overall Study|Withdrawal by Subject|1|||
16343386|NCT02348008|39744437|FG002|Overall Study|Withdrawal by Subject|0|||
16343387|NCT02348008|39744435|FG000|Overall Study|Symptomatic Deterioration|0|||
16220950|NCT03481634|39290524|FG002|Overall Study|Protocol Violation|1|||
16220951|NCT03481634|39290522|FG000|Overall Study|Progressive disease|0|||
16220952|NCT03481634|39290523|FG001|Overall Study|Progressive disease|1|||
16220953|NCT03481634|39290524|FG002|Overall Study|Progressive disease|0|||
16220954|NCT03481634|39290522|FG000|Overall Study|Physician Decision|3|||
16220955|NCT03481634|39290523|FG001|Overall Study|Physician Decision|0|||
16220956|NCT03481634|39290524|FG002|Overall Study|Physician Decision|1|||
16220957|NCT03481634|39290522|FG000|Overall Study|Lost to Follow-up|3|||
16220958|NCT03481634|39290523|FG001|Overall Study|Lost to Follow-up|4|||
16220959|NCT03481634|39290524|FG002|Overall Study|Lost to Follow-up|4|||
16220960|NCT03481634|39290522|FG000|Overall Study|Death|4|||
16220961|NCT03481634|39290523|FG001|Overall Study|Death|8|||
16220962|NCT03481634|39290524|FG002|Overall Study|Death|7|||
16220963|NCT03481634|39290522|FG000|Overall Study|Adverse Event|6|||
16220964|NCT03481634|39290523|FG001|Overall Study|Adverse Event|3|||
16220965|NCT03481634|39290524|FG002|Overall Study|Adverse Event|7|||
16220966|NCT01230489|39290525|FG000|Overall Study|Death|2|||
16220967|NCT01230489|39290525|FG000|Overall Study|Adverse Event|2|||
16220968|NCT01230489|39290525|FG000|Overall Study|Treatment modality changed|1|||
16220969|NCT01526928|39290531|FG000|Overall Study|Progressive Disease|35|||
16220970|NCT01526928|39290532|FG001|Overall Study|Progressive Disease|17|||
16220971|NCT01526928|39290533|FG002|Overall Study|Progressive Disease|150|||
16220972|NCT01526928|39290534|FG003|Overall Study|Progressive Disease|182|||
16220973|NCT01526928|39290535|FG004|Overall Study|Progressive Disease|76|||
16220974|NCT01526928|39290536|FG005|Overall Study|Progressive Disease|4|||
16220975|NCT01526928|39290531|FG000|Overall Study|Adverse Event|2|||
16220976|NCT01526928|39290532|FG001|Overall Study|Adverse Event|1|||
16220977|NCT01526928|39290533|FG002|Overall Study|Adverse Event|29|||
16220978|NCT01526928|39290534|FG003|Overall Study|Adverse Event|40|||
16220979|NCT01526928|39290535|FG004|Overall Study|Adverse Event|13|||
16220980|NCT01526928|39290536|FG005|Overall Study|Adverse Event|2|||
16220981|NCT01526928|39290531|FG000|Overall Study|Death|0|||
16220982|NCT01526928|39290532|FG001|Overall Study|Death|0|||
16220983|NCT01526928|39290533|FG002|Overall Study|Death|3|||
16220984|NCT01526928|39290534|FG003|Overall Study|Death|0|||
16220985|NCT01526928|39290535|FG004|Overall Study|Death|0|||
16220986|NCT01526928|39290536|FG005|Overall Study|Death|0|||
16220987|NCT01526928|39290531|FG000|Overall Study|Withdrawal by Subject|1|||
16220988|NCT01526928|39290532|FG001|Overall Study|Withdrawal by Subject|0|||
16220989|NCT01526928|39290533|FG002|Overall Study|Withdrawal by Subject|13|||
16220990|NCT01526928|39290534|FG003|Overall Study|Withdrawal by Subject|11|||
16220991|NCT01526928|39290535|FG004|Overall Study|Withdrawal by Subject|3|||
16220992|NCT01526928|39290536|FG005|Overall Study|Withdrawal by Subject|0|||
16220993|NCT01526928|39290531|FG000|Overall Study|Physician Decision|0|||
16220994|NCT01526928|39290532|FG001|Overall Study|Physician Decision|0|||
16220995|NCT01526928|39290533|FG002|Overall Study|Physician Decision|2|||
16220996|NCT01526928|39290534|FG003|Overall Study|Physician Decision|5|||
16220997|NCT01526928|39290535|FG004|Overall Study|Physician Decision|0|||
16220998|NCT01526928|39290536|FG005|Overall Study|Physician Decision|0|||
16220999|NCT01526928|39290531|FG000|Overall Study|Other Reason|0|||
16221000|NCT01526928|39290532|FG001|Overall Study|Other Reason|1|||
16221001|NCT01526928|39290533|FG002|Overall Study|Other Reason|11|||
16221002|NCT01526928|39290534|FG003|Overall Study|Other Reason|4|||
16221003|NCT01526928|39290535|FG004|Overall Study|Other Reason|1|||
16221004|NCT01526928|39290536|FG005|Overall Study|Other Reason|0|||
16221005|NCT01526928|39290531|FG000|Overall Study|Lost to Follow-up|0|||
16221006|NCT01526928|39290532|FG001|Overall Study|Lost to Follow-up|0|||
16221007|NCT01526928|39290533|FG002|Overall Study|Lost to Follow-up|0|||
16221008|NCT01526928|39290534|FG003|Overall Study|Lost to Follow-up|1|||
16221009|NCT01526928|39290535|FG004|Overall Study|Lost to Follow-up|0|||
16221010|NCT01526928|39290536|FG005|Overall Study|Lost to Follow-up|0|||
16221011|NCT01526928|39290531|FG000|Overall Study|Protocol Deviation|0|||
16407444|NCT01468207|39973214|FG004|Treatment Period 1|Lost to Follow-up|0|||
16407445|NCT01468207|39973215|FG005|Treatment Period 1|Lost to Follow-up|0|||
16407446|NCT01468207|39973210|FG000|Treatment Period 1|Other|0|||
16407447|NCT01468207|39973211|FG001|Treatment Period 1|Other|2|||
16407448|NCT01468207|39973212|FG002|Treatment Period 1|Other|0|||
16221012|NCT01526928|39290532|FG001|Overall Study|Protocol Deviation|0|||
16407449|NCT01468207|39973213|FG003|Treatment Period 1|Other|0|||
16407450|NCT01468207|39973214|FG004|Treatment Period 1|Other|0|||
16221013|NCT01526928|39290533|FG002|Overall Study|Protocol Deviation|0|||
16407451|NCT01468207|39973215|FG005|Treatment Period 1|Other|0|||
16407452|NCT01468207|39973210|FG000|Treatment Period 2|Adverse Event|0|||
16221014|NCT01526928|39290534|FG003|Overall Study|Protocol Deviation|2|||
16221015|NCT01526928|39290535|FG004|Overall Study|Protocol Deviation|0|||
16221016|NCT01526928|39290536|FG005|Overall Study|Protocol Deviation|0|||
16221017|NCT01526928|39290531|FG000|Overall Study|Missing|0|||
16221018|NCT01526928|39290532|FG001|Overall Study|Missing|0|||
16221019|NCT01526928|39290533|FG002|Overall Study|Missing|1|||
16221020|NCT01526928|39290534|FG003|Overall Study|Missing|0|||
16221021|NCT01526928|39290535|FG004|Overall Study|Missing|2|||
16221022|NCT01526928|39290536|FG005|Overall Study|Missing|0|||
16407453|NCT01468207|39973211|FG001|Treatment Period 2|Adverse Event|0|||
16407454|NCT01468207|39973212|FG002|Treatment Period 2|Adverse Event|6|||
16407455|NCT01468207|39973213|FG003|Treatment Period 2|Adverse Event|1|||
16407456|NCT01468207|39973214|FG004|Treatment Period 2|Adverse Event|2|||
16407457|NCT01468207|39973215|FG005|Treatment Period 2|Adverse Event|1|||
16407458|NCT01468207|39973210|FG000|Treatment Period 2|Lack of Efficacy|0|||
16407459|NCT01468207|39973211|FG001|Treatment Period 2|Lack of Efficacy|0|||
16407460|NCT01468207|39973212|FG002|Treatment Period 2|Lack of Efficacy|1|||
16407461|NCT01468207|39973213|FG003|Treatment Period 2|Lack of Efficacy|1|||
16407462|NCT01468207|39973214|FG004|Treatment Period 2|Lack of Efficacy|0|||
16407463|NCT01468207|39973215|FG005|Treatment Period 2|Lack of Efficacy|2|||
16407464|NCT01468207|39973210|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16407465|NCT01468207|39973211|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16407466|NCT01468207|39973212|FG002|Treatment Period 2|Withdrawal by Subject|5|||
16407467|NCT01468207|39973213|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16407468|NCT01468207|39973214|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16407469|NCT01468207|39973215|FG005|Treatment Period 2|Withdrawal by Subject|2|||
16407470|NCT01468207|39973210|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
16407471|NCT01468207|39973211|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
16407472|NCT01468207|39973212|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
16407473|NCT01468207|39973213|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
16407474|NCT01468207|39973214|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
16407475|NCT01468207|39973215|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
16407476|NCT01468207|39973210|FG000|Treatment Period 2|Lost to Follow-up|0|||
16407477|NCT01468207|39973211|FG001|Treatment Period 2|Lost to Follow-up|0|||
16407478|NCT01468207|39973212|FG002|Treatment Period 2|Lost to Follow-up|5|||
16407479|NCT01468207|39973213|FG003|Treatment Period 2|Lost to Follow-up|1|||
16407480|NCT01468207|39973214|FG004|Treatment Period 2|Lost to Follow-up|0|||
16407481|NCT01468207|39973215|FG005|Treatment Period 2|Lost to Follow-up|0|||
16407482|NCT01468207|39973210|FG000|Treatment Period 2|Other|0|||
16407483|NCT01468207|39973211|FG001|Treatment Period 2|Other|0|||
16407484|NCT01468207|39973212|FG002|Treatment Period 2|Other|5|||
16407485|NCT01468207|39973213|FG003|Treatment Period 2|Other|1|||
16407486|NCT01468207|39973214|FG004|Treatment Period 2|Other|1|||
16109665|NCT01296555|38889130|FG027|Overall Study|Non-Compliance With Study Drug|0|||
16109666|NCT01296555|38889131|FG028|Overall Study|Non-Compliance With Study Drug|0|||
16407487|NCT01468207|39973215|FG005|Treatment Period 2|Other|2|||
16407488|NCT03405935|39973216|FG000|Overall Study|Adverse Event|3|||
16109667|NCT01296555|38889103|FG000|Overall Study|Withdrawal by Subject|0|||
16343388|NCT02348008|39744436|FG001|Overall Study|Symptomatic Deterioration|1|||
16343389|NCT02348008|39744437|FG002|Overall Study|Symptomatic Deterioration|0|||
16343390|NCT00560703|39744440|FG000|Overall Study|Adverse Event|0|||
16343391|NCT00560703|39744441|FG001|Overall Study|Adverse Event|2|||
16343392|NCT00560703|39744440|FG000|Overall Study|Protocol Violation|0|||
16343393|NCT00560703|39744441|FG001|Overall Study|Protocol Violation|2|||
16343394|NCT00560703|39744440|FG000|Overall Study|Withdrawal by Subject|0|||
16343395|NCT00560703|39744441|FG001|Overall Study|Withdrawal by Subject|1|||
16343396|NCT00560703|39744440|FG000|Overall Study|non-compliance|0|||
16343397|NCT00560703|39744441|FG001|Overall Study|non-compliance|1|||
16343398|NCT03334422|39744442|FG000|Overall Study|Adverse Event|1|||
16343399|NCT03334422|39744443|FG001|Overall Study|Adverse Event|3|||
16343400|NCT03334422|39744444|FG002|Overall Study|Adverse Event|2|||
16343401|NCT03334422|39744445|FG003|Overall Study|Adverse Event|2|||
16343402|NCT03334422|39744442|FG000|Overall Study|Lack of Efficacy|10|||
16343403|NCT03334422|39744443|FG001|Overall Study|Lack of Efficacy|2|||
16343404|NCT03334422|39744444|FG002|Overall Study|Lack of Efficacy|7|||
16343405|NCT03334422|39744445|FG003|Overall Study|Lack of Efficacy|3|||
16343406|NCT03334422|39744442|FG000|Overall Study|Withdrawal by Subject|8|||
16343407|NCT03334422|39744443|FG001|Overall Study|Withdrawal by Subject|3|||
16343408|NCT03334422|39744444|FG002|Overall Study|Withdrawal by Subject|1|||
16343409|NCT03334422|39744445|FG003|Overall Study|Withdrawal by Subject|0|||
16343410|NCT03334422|39744442|FG000|Overall Study|Lost to Follow-up|0|||
16343411|NCT03334422|39744443|FG001|Overall Study|Lost to Follow-up|0|||
16343412|NCT03334422|39744444|FG002|Overall Study|Lost to Follow-up|0|||
16343413|NCT03334422|39744445|FG003|Overall Study|Lost to Follow-up|1|||
16343414|NCT03334422|39744442|FG000|Overall Study|Inability to obtain laboratory samples|0|||
16109668|NCT01296555|38889104|FG001|Overall Study|Withdrawal by Subject|0|||
16109669|NCT01296555|38889105|FG002|Overall Study|Withdrawal by Subject|0|||
16109670|NCT01296555|38889106|FG003|Overall Study|Withdrawal by Subject|0|||
16109671|NCT01296555|38889107|FG004|Overall Study|Withdrawal by Subject|1|||
16109672|NCT01296555|38889108|FG005|Overall Study|Withdrawal by Subject|0|||
16109673|NCT01296555|38889109|FG006|Overall Study|Withdrawal by Subject|1|||
16109674|NCT01296555|38889110|FG007|Overall Study|Withdrawal by Subject|0|||
16109675|NCT01296555|38889111|FG008|Overall Study|Withdrawal by Subject|0|||
16109676|NCT01296555|38889112|FG009|Overall Study|Withdrawal by Subject|0|||
16109677|NCT01296555|38889113|FG010|Overall Study|Withdrawal by Subject|1|||
16109678|NCT01296555|38889114|FG011|Overall Study|Withdrawal by Subject|1|||
16109679|NCT01296555|38889115|FG012|Overall Study|Withdrawal by Subject|0|||
16109680|NCT01296555|38889116|FG013|Overall Study|Withdrawal by Subject|0|||
16109681|NCT01296555|38889117|FG014|Overall Study|Withdrawal by Subject|3|||
16109682|NCT01296555|38889118|FG015|Overall Study|Withdrawal by Subject|0|||
16109683|NCT01296555|38889119|FG016|Overall Study|Withdrawal by Subject|2|||
16109684|NCT01296555|38889120|FG017|Overall Study|Withdrawal by Subject|1|||
16109685|NCT01296555|38889121|FG018|Overall Study|Withdrawal by Subject|0|||
16109686|NCT01296555|38889122|FG019|Overall Study|Withdrawal by Subject|1|||
16109687|NCT01296555|38889123|FG020|Overall Study|Withdrawal by Subject|1|||
16343415|NCT03334422|39744443|FG001|Overall Study|Inability to obtain laboratory samples|1|||
16343416|NCT03334422|39744444|FG002|Overall Study|Inability to obtain laboratory samples|0|||
16109688|NCT01296555|38889124|FG021|Overall Study|Withdrawal by Subject|1|||
16109689|NCT01296555|38889125|FG022|Overall Study|Withdrawal by Subject|3|||
16109690|NCT01296555|38889126|FG023|Overall Study|Withdrawal by Subject|0|||
16109691|NCT01296555|38889127|FG024|Overall Study|Withdrawal by Subject|0|||
16109692|NCT01296555|38889128|FG025|Overall Study|Withdrawal by Subject|0|||
16109693|NCT01296555|38889129|FG026|Overall Study|Withdrawal by Subject|8|||
16109694|NCT01296555|38889130|FG027|Overall Study|Withdrawal by Subject|4|||
16109695|NCT01296555|38889131|FG028|Overall Study|Withdrawal by Subject|2|||
16343417|NCT03334422|39744445|FG003|Overall Study|Inability to obtain laboratory samples|0|||
16343418|NCT03334422|39744442|FG000|Overall Study|Pregnancy|0|||
16343419|NCT03334422|39744443|FG001|Overall Study|Pregnancy|1|||
16343420|NCT03334422|39744444|FG002|Overall Study|Pregnancy|0|||
16343421|NCT03334422|39744445|FG003|Overall Study|Pregnancy|0|||
16343422|NCT01516736|39744446|FG000|Overall Study|Withdrawal by Subject|10|||
16343423|NCT01516736|39744447|FG001|Overall Study|Withdrawal by Subject|4|||
16109696|NCT01018732|38889136|FG000|Overall Study|Lost to Follow-up|0|||
16109697|NCT01018732|38889137|FG001|Overall Study|Lost to Follow-up|0|||
16109698|NCT01018732|38889138|FG002|Overall Study|Lost to Follow-up|3|||
16109699|NCT01018732|38889136|FG000|Overall Study|Protocol Violation|1|||
16109700|NCT01018732|38889137|FG001|Overall Study|Protocol Violation|1|||
16109701|NCT01018732|38889138|FG002|Overall Study|Protocol Violation|0|||
16109702|NCT01018732|38889136|FG000|Overall Study|Inappropriate Enrollment|0|||
16109703|NCT01018732|38889137|FG001|Overall Study|Inappropriate Enrollment|1|||
16109704|NCT01018732|38889138|FG002|Overall Study|Inappropriate Enrollment|0|||
16109705|NCT01018732|38889136|FG000|Overall Study|Unable to Classify|0|||
16109706|NCT01018732|38889137|FG001|Overall Study|Unable to Classify|0|||
16109707|NCT01018732|38889138|FG002|Overall Study|Unable to Classify|1|||
16109708|NCT03602586|38889139|FG000|Overall Study|Withdrawal by Subject|3|||
16109709|NCT03371823|38889140|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
16109710|NCT03371823|38889141|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
16109711|NCT00912223|38889147|FG000|Overall Study|Withdrawal by Subject|1|||
16109712|NCT00912223|38889147|FG000|Overall Study|Not transplanted|1|||
16109713|NCT00912223|38889147|FG000|Overall Study|Transformed disease|1|||
16109714|NCT02781311|38889148|FG000|Overall Study|Adverse Event|2|||
16109715|NCT02781311|38889149|FG001|Overall Study|Adverse Event|6|||
16109716|NCT02781311|38889150|FG002|Overall Study|Adverse Event|1|||
16109717|NCT02781311|38889148|FG000|Overall Study|Withdrawal of Consent|11|||
16109718|NCT02781311|38889149|FG001|Overall Study|Withdrawal of Consent|12|||
16109719|NCT02781311|38889150|FG002|Overall Study|Withdrawal of Consent|2|||
16109720|NCT02781311|38889148|FG000|Overall Study|Lost to Follow-up|11|||
16109721|NCT02781311|38889149|FG001|Overall Study|Lost to Follow-up|8|||
16109722|NCT02781311|38889150|FG002|Overall Study|Lost to Follow-up|1|||
16109723|NCT02781311|38889148|FG000|Overall Study|Non-Compliance with Study Drug|2|||
16109724|NCT02781311|38889149|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16109725|NCT02781311|38889150|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16109726|NCT01336205|38889153|FG000|Overall Study|Other|22|||
16109727|NCT01336205|38889154|FG001|Overall Study|Other|9|||
16109728|NCT01336205|38889153|FG000|Overall Study|Lost to Follow-up|40|||
16109729|NCT01336205|38889154|FG001|Overall Study|Lost to Follow-up|20|||
16109730|NCT01336205|38889153|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
16109731|NCT01336205|38889154|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
16109732|NCT01336205|38889153|FG000|Overall Study|Lack of Efficacy|4|||
16109733|NCT01336205|38889154|FG001|Overall Study|Lack of Efficacy|0|||
16109734|NCT01336205|38889153|FG000|Overall Study|Severe noncompliance with protocol|9|||
16109735|NCT01336205|38889154|FG001|Overall Study|Severe noncompliance with protocol|2|||
16109736|NCT01336205|38889153|FG000|Overall Study|Adverse Event|56|||
16343424|NCT01516736|39744446|FG000|Overall Study|Adverse Event|4|||
16109737|NCT01336205|38889154|FG001|Overall Study|Adverse Event|6|||
16109738|NCT01336205|38889153|FG000|Overall Study|Death|1|||
16109739|NCT01336205|38889154|FG001|Overall Study|Death|1|||
16109740|NCT01336205|38889153|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
16109741|NCT01336205|38889154|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
16109742|NCT01336205|38889153|FG000|Overall Study|Withdrawal by Subject|72|||
16109743|NCT01336205|38889154|FG001|Overall Study|Withdrawal by Subject|38|||
16109744|NCT01336205|38889153|FG000|Overall Study|Did not receive treatment|4|||
16109745|NCT01336205|38889154|FG001|Overall Study|Did not receive treatment|0|||
16109746|NCT01813305|38889155|FG000|Overall Study|Withdrawal by Subject|12|||
16109747|NCT01813305|38889156|FG001|Overall Study|Withdrawal by Subject|5|||
16109748|NCT01813305|38889155|FG000|Overall Study|Safety Concern|4|||
16109749|NCT01813305|38889156|FG001|Overall Study|Safety Concern|0|||
16109750|NCT01813305|38889155|FG000|Overall Study|Ulcer became worse|4|||
16109751|NCT01813305|38889156|FG001|Overall Study|Ulcer became worse|0|||
16109752|NCT01813305|38889155|FG000|Overall Study|Physician Decision|4|||
16109753|NCT01813305|38889156|FG001|Overall Study|Physician Decision|0|||
16109754|NCT01813305|38889155|FG000|Overall Study|Lost to Follow-up|3|||
16109755|NCT01813305|38889156|FG001|Overall Study|Lost to Follow-up|1|||
16109756|NCT01813305|38889155|FG000|Overall Study|Protocol Violation|1|||
16109757|NCT01813305|38889156|FG001|Overall Study|Protocol Violation|0|||
16109758|NCT01813305|38889155|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
16109759|NCT01813305|38889156|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
16109760|NCT00839332|38889157|FG000|Phase 1|Disease Progression|38|||
16109761|NCT00839332|38889158|FG001|Phase 1|Disease Progression|0|||
16109762|NCT00839332|38889159|FG002|Phase 1|Disease Progression|0|||
16109763|NCT00839332|38889157|FG000|Phase 1|Adverse Event|6|||
16109764|NCT00839332|38889158|FG001|Phase 1|Adverse Event|0|||
16109765|NCT00839332|38889159|FG002|Phase 1|Adverse Event|0|||
16109766|NCT00839332|38889157|FG000|Phase 1|Withdrawal by Subject|4|||
16109767|NCT00839332|38889158|FG001|Phase 1|Withdrawal by Subject|0|||
16109768|NCT00839332|38889159|FG002|Phase 1|Withdrawal by Subject|0|||
16109769|NCT00839332|38889157|FG000|Phase 1|Physician Decision|2|||
16109770|NCT00839332|38889158|FG001|Phase 1|Physician Decision|0|||
16109771|NCT00839332|38889159|FG002|Phase 1|Physician Decision|0|||
16109772|NCT00839332|38889157|FG000|Phase 2|Protocol Violation|0|||
16109773|NCT00839332|38889158|FG001|Phase 2|Protocol Violation|1|||
16109774|NCT00839332|38889159|FG002|Phase 2|Protocol Violation|0|||
16109775|NCT00839332|38889157|FG000|Phase 2|Disease Progression|0|||
16109776|NCT00839332|38889158|FG001|Phase 2|Disease Progression|46|||
16109777|NCT00839332|38889159|FG002|Phase 2|Disease Progression|21|||
16109778|NCT00839332|38889157|FG000|Phase 2|Adverse Event|0|||
16109779|NCT00839332|38889158|FG001|Phase 2|Adverse Event|8|||
16109780|NCT00839332|38889159|FG002|Phase 2|Adverse Event|6|||
16109781|NCT00839332|38889157|FG000|Phase 2|Death|0|||
16109782|NCT00839332|38889158|FG001|Phase 2|Death|4|||
16343425|NCT01516736|39744447|FG001|Overall Study|Adverse Event|5|||
16343426|NCT01516736|39744446|FG000|Overall Study|Death|3|||
16343427|NCT01516736|39744447|FG001|Overall Study|Death|1|||
16343428|NCT01516736|39744446|FG000|Overall Study|Physician Decision|2|||
16343429|NCT01516736|39744447|FG001|Overall Study|Physician Decision|1|||
16343430|NCT01516736|39744446|FG000|Overall Study|Lack of Efficacy|1|||
16343431|NCT01516736|39744447|FG001|Overall Study|Lack of Efficacy|0|||
16109783|NCT00839332|38889159|FG002|Phase 2|Death|2|||
16109784|NCT00839332|38889157|FG000|Phase 2|Withdrawal by Subject|0|||
16109785|NCT00839332|38889158|FG001|Phase 2|Withdrawal by Subject|5|||
16109786|NCT00839332|38889159|FG002|Phase 2|Withdrawal by Subject|8|||
16109787|NCT00839332|38889157|FG000|Phase 2|Physician Decision|0|||
16109788|NCT00839332|38889158|FG001|Phase 2|Physician Decision|4|||
16109789|NCT00839332|38889159|FG002|Phase 2|Physician Decision|1|||
16109790|NCT00839332|38889157|FG000|Phase 2|Lost to Follow-up|0|||
16109791|NCT00839332|38889158|FG001|Phase 2|Lost to Follow-up|0|||
16109792|NCT00839332|38889159|FG002|Phase 2|Lost to Follow-up|1|||
16109793|NCT02418845|38889164|FG000|Overall Study|Lost to Follow-up|7|||
16343432|NCT01516736|39744446|FG000|Overall Study|Protocol Violation|0|||
16109794|NCT02418845|38889165|FG001|Overall Study|Lost to Follow-up|2|||
16109795|NCT02418845|38889164|FG000|Overall Study|Lack of Efficacy|0|||
16109796|NCT02418845|38889165|FG001|Overall Study|Lack of Efficacy|3|||
16221023|NCT02381795|39290539|FG000|Overall Study|Withdrawal by Subject|1|||
16109797|NCT02418845|38889164|FG000|Overall Study|Physician Decision|5|||
16109798|NCT02418845|38889165|FG001|Overall Study|Physician Decision|5|||
16221024|NCT02381795|39290539|FG000|Overall Study|Study Terminated|2|||
16343433|NCT01516736|39744447|FG001|Overall Study|Protocol Violation|1|||
16343434|NCT01516736|39744446|FG000|Overall Study|Other (not specified)|0|||
16343435|NCT01516736|39744447|FG001|Overall Study|Other (not specified)|1|||
16343436|NCT00520039|39744450|FG000|Overall Study|Exclusion criteria met at first visit|7|||
16343437|NCT00520039|39744451|FG001|Overall Study|Exclusion criteria met at first visit|5|||
16343438|NCT03782571|39744452|FG000|Period 1|Withdrawal by Subject|1|||
16343439|NCT03782571|39744453|FG001|Period 1|Withdrawal by Subject|0|||
16343440|NCT03782571|39744454|FG002|Period 1|Withdrawal by Subject|0|||
16343441|NCT03782571|39744455|FG003|Period 1|Withdrawal by Subject|0|||
16343442|NCT03782571|39744452|FG000|Period 3|Subject Unable to Attend V5|1|||
16343443|NCT03782571|39744453|FG001|Period 3|Subject Unable to Attend V5|0|||
16343444|NCT03782571|39744454|FG002|Period 3|Subject Unable to Attend V5|0|||
16343445|NCT03782571|39744455|FG003|Period 3|Subject Unable to Attend V5|0|||
16343446|NCT03782571|39744452|FG000|Period 3|Adverse Event|1|||
16343447|NCT03782571|39744453|FG001|Period 3|Adverse Event|0|||
16343448|NCT03782571|39744454|FG002|Period 3|Adverse Event|0|||
16343449|NCT03782571|39744455|FG003|Period 3|Adverse Event|0|||
16343450|NCT03148067|39744456|FG000|Overall Study|Lost to Follow-up|3|||
16343451|NCT03148067|39744456|FG000|Overall Study|Death|1|||
16543631|NCT03145766|40453715|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
16543632|NCT03145766|40453711|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
16543633|NCT03145766|40453712|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
16543634|NCT03145766|40453713|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
16543635|NCT03145766|40453714|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
16543636|NCT03145766|40453715|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
16543637|NCT03145766|40453711|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
16221025|NCT01512108|39290540|FG000|Overall Study|Adverse Event|9|||
16343452|NCT00627926|39744459|FG000|Overall Study|Adverse Event|26|||
16343453|NCT00627926|39744460|FG001|Overall Study|Adverse Event|37|||
16343454|NCT00627926|39744461|FG002|Overall Study|Adverse Event|36|||
16343455|NCT00627926|39744459|FG000|Overall Study|Death|1|||
16343456|NCT00627926|39744460|FG001|Overall Study|Death|0|||
16343457|NCT00627926|39744461|FG002|Overall Study|Death|0|||
16343458|NCT00627926|39744459|FG000|Overall Study|Lost to Follow-up|4|||
16343459|NCT00627926|39744460|FG001|Overall Study|Lost to Follow-up|3|||
16343460|NCT00627926|39744461|FG002|Overall Study|Lost to Follow-up|4|||
16343461|NCT00627926|39744459|FG000|Overall Study|Withdrawal by Subject|2|||
16343462|NCT00627926|39744460|FG001|Overall Study|Withdrawal by Subject|1|||
16343463|NCT00627926|39744461|FG002|Overall Study|Withdrawal by Subject|0|||
16343464|NCT00627926|39744459|FG000|Overall Study|Lack of Efficacy|118|||
16343465|NCT00627926|39744460|FG001|Overall Study|Lack of Efficacy|40|||
16343466|NCT00627926|39744461|FG002|Overall Study|Lack of Efficacy|38|||
16343467|NCT00627926|39744459|FG000|Overall Study|Noncompliance/unspecified|8|||
16343468|NCT00627926|39744460|FG001|Overall Study|Noncompliance/unspecified|23|||
16343469|NCT00627926|39744461|FG002|Overall Study|Noncompliance/unspecified|17|||
16343470|NCT04547140|39744462|FG000|Overall Study|Adverse Event|0|||
16343471|NCT04547140|39744463|FG001|Overall Study|Adverse Event|1|||
16343472|NCT04547140|39744462|FG000|Overall Study|Withdrawal by Subject|0|||
16343473|NCT04547140|39744463|FG001|Overall Study|Withdrawal by Subject|1|||
16343474|NCT04547140|39744462|FG000|Overall Study|Lost to Follow-up|3|||
16343475|NCT04547140|39744463|FG001|Overall Study|Lost to Follow-up|1|||
16343476|NCT04547140|39744462|FG000|Overall Study|Death|2|||
16343477|NCT04547140|39744463|FG001|Overall Study|Death|1|||
16343478|NCT04547140|39744462|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
16343479|NCT04547140|39744463|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
16343480|NCT04547140|39744462|FG000|Overall Study|Pregnancy|1|||
16343481|NCT04547140|39744463|FG001|Overall Study|Pregnancy|0|||
16343482|NCT04547140|39744462|FG000|Overall Study|Reason Not Specified|4|||
16343483|NCT04547140|39744463|FG001|Overall Study|Reason Not Specified|1|||
16343484|NCT00103662|39744469|FG000|Overall Study|Entered Rescue Procedure|0|||
16109799|NCT02418845|38889164|FG000|Overall Study|Protocol Violation|1|||
16109800|NCT02418845|38889165|FG001|Overall Study|Protocol Violation|0|||
16109801|NCT02418845|38889164|FG000|Overall Study|Withdrawal by Subject|3|||
16109802|NCT02418845|38889165|FG001|Overall Study|Withdrawal by Subject|2|||
16109803|NCT01461005|38889166|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
16109804|NCT03174782|38889167|FG000|Overall Study|Protocol Violation|1|||
16109805|NCT03174782|38889168|FG001|Overall Study|Protocol Violation|0|||
16109806|NCT03174782|38889167|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
16109807|NCT03174782|38889168|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
16109808|NCT01103232|38889169|FG000|Overall Study|Withdrawal by Subject|1|||
16109809|NCT01103232|38889170|FG001|Overall Study|Withdrawal by Subject|1|||
16109810|NCT01103232|38889169|FG000|Overall Study|Protocol Violation|0|||
16109811|NCT01103232|38889170|FG001|Overall Study|Protocol Violation|1|||
16109812|NCT00550446|38889173|FG000|Up To Week 12|Adverse Event|2|||
16109813|NCT00550446|38889174|FG001|Up To Week 12|Adverse Event|2|||
16109814|NCT00550446|38889175|FG002|Up To Week 12|Adverse Event|0|||
16109815|NCT00550446|38889176|FG003|Up To Week 12|Adverse Event|0|||
16109816|NCT00550446|38889177|FG004|Up To Week 12|Adverse Event|2|||
16109817|NCT00550446|38889178|FG005|Up To Week 12|Adverse Event|2|||
16109818|NCT00550446|38889179|FG006|Up To Week 12|Adverse Event|1|||
16221026|NCT01512108|39290541|FG001|Overall Study|Adverse Event|4|||
16109819|NCT00550446|38889180|FG007|Up To Week 12|Adverse Event|0|||
16109820|NCT00550446|38889181|FG008|Up To Week 12|Adverse Event|0|||
16109821|NCT00550446|38889182|FG009|Up To Week 12|Adverse Event|0|||
16109822|NCT00550446|38889183|FG010|Up To Week 12|Adverse Event|0|||
16109823|NCT00550446|38889173|FG000|Up To Week 12|Lack of Efficacy|3|||
16109824|NCT00550446|38889174|FG001|Up To Week 12|Lack of Efficacy|1|||
16109825|NCT00550446|38889175|FG002|Up To Week 12|Lack of Efficacy|0|||
16343485|NCT00103662|39744470|FG001|Overall Study|Entered Rescue Procedure|7|||
16343486|NCT00103662|39744469|FG000|Overall Study|Death|7|||
16343487|NCT00103662|39744470|FG001|Overall Study|Death|7|||
16343488|NCT00103662|39744469|FG000|Overall Study|Elective Withdrawal|5|||
16109826|NCT00550446|38889176|FG003|Up To Week 12|Lack of Efficacy|1|||
16109827|NCT00550446|38889177|FG004|Up To Week 12|Lack of Efficacy|0|||
16109828|NCT00550446|38889178|FG005|Up To Week 12|Lack of Efficacy|3|||
16221027|NCT01512108|39290540|FG000|Overall Study|Protocol Violation|1|||
16221028|NCT01512108|39290541|FG001|Overall Study|Protocol Violation|2|||
16221029|NCT01512108|39290540|FG000|Overall Study|Withdrawal Criteria|1|||
16221030|NCT01512108|39290541|FG001|Overall Study|Withdrawal Criteria|0|||
16343489|NCT00103662|39744470|FG001|Overall Study|Elective Withdrawal|5|||
16343490|NCT00103662|39744469|FG000|Overall Study|Lost to Follow-up|0|||
16221031|NCT01512108|39290540|FG000|Overall Study|Unclassified|11|||
16221032|NCT01512108|39290541|FG001|Overall Study|Unclassified|3|||
16221033|NCT02155660|39290542|FG000|Overall Study|Other Reason|8|||
16221034|NCT02155660|39290543|FG001|Overall Study|Other Reason|6|||
16343491|NCT00103662|39744470|FG001|Overall Study|Lost to Follow-up|1|||
16343492|NCT00103662|39744469|FG000|Overall Study|Other|6|||
16343493|NCT00103662|39744470|FG001|Overall Study|Other|9|||
16343494|NCT00103662|39744469|FG000|Overall Study|Failed mobilization|0|||
16343495|NCT00103662|39744470|FG001|Overall Study|Failed mobilization|4|||
16343496|NCT00103662|39744469|FG000|Overall Study|Intercurrent illness|1|||
16343497|NCT00103662|39744470|FG001|Overall Study|Intercurrent illness|0|||
16343498|NCT00385827|39744471|FG000|Part 1|Adverse Event|1|||
16343499|NCT00385827|39744472|FG001|Part 1|Adverse Event|0|||
16343500|NCT00385827|39744473|FG002|Part 1|Adverse Event|0|||
16109829|NCT00550446|38889179|FG006|Up To Week 12|Lack of Efficacy|3|||
16109830|NCT00550446|38889180|FG007|Up To Week 12|Lack of Efficacy|0|||
16343501|NCT00385827|39744471|FG000|Part 1|Death|2|||
16343502|NCT00385827|39744472|FG001|Part 1|Death|0|||
16343503|NCT00385827|39744473|FG002|Part 1|Death|0|||
16109831|NCT00550446|38889181|FG008|Up To Week 12|Lack of Efficacy|0|||
16109832|NCT00550446|38889182|FG009|Up To Week 12|Lack of Efficacy|0|||
16109833|NCT00550446|38889183|FG010|Up To Week 12|Lack of Efficacy|0|||
16109834|NCT00550446|38889173|FG000|Up To Week 12|Lost to Follow-up|0|||
16109835|NCT00550446|38889174|FG001|Up To Week 12|Lost to Follow-up|1|||
16109836|NCT00550446|38889175|FG002|Up To Week 12|Lost to Follow-up|0|||
16109837|NCT00550446|38889176|FG003|Up To Week 12|Lost to Follow-up|0|||
16109838|NCT00550446|38889177|FG004|Up To Week 12|Lost to Follow-up|1|||
16109839|NCT00550446|38889178|FG005|Up To Week 12|Lost to Follow-up|1|||
16109840|NCT00550446|38889179|FG006|Up To Week 12|Lost to Follow-up|2|||
16109841|NCT00550446|38889180|FG007|Up To Week 12|Lost to Follow-up|0|||
16109842|NCT00550446|38889181|FG008|Up To Week 12|Lost to Follow-up|0|||
16221035|NCT02155660|39290544|FG002|Overall Study|Other Reason|10|||
16221036|NCT02155660|39290545|FG003|Overall Study|Other Reason|10|||
16343504|NCT00385827|39744471|FG000|Part 1|Lack of Efficacy|5|||
16109843|NCT00550446|38889182|FG009|Up To Week 12|Lost to Follow-up|0|||
16109844|NCT00550446|38889183|FG010|Up To Week 12|Lost to Follow-up|0|||
16109845|NCT00550446|38889173|FG000|Up To Week 12|Withdrawal by Subject|2|||
16109846|NCT00550446|38889174|FG001|Up To Week 12|Withdrawal by Subject|0|||
16221037|NCT02155660|39290542|FG000|Overall Study|Study-specific withdrawal criteria|0|||
16343505|NCT00385827|39744472|FG001|Part 1|Lack of Efficacy|0|||
16221038|NCT02155660|39290543|FG001|Overall Study|Study-specific withdrawal criteria|1|||
16221039|NCT02155660|39290544|FG002|Overall Study|Study-specific withdrawal criteria|1|||
16221040|NCT02155660|39290545|FG003|Overall Study|Study-specific withdrawal criteria|1|||
16221041|NCT02155660|39290542|FG000|Overall Study|Severe non-compliance|0|||
16407489|NCT03405935|39973216|FG000|Overall Study|Death|2|||
16407490|NCT03405935|39973216|FG000|Overall Study|Withdrawal by Subject|1|||
16407491|NCT03405935|39973216|FG000|Overall Study|Lost to Follow-up|2|||
16407492|NCT03276052|39973217|FG000|Overall Study|Withdrawal by Subject|5|||
16407493|NCT03276052|39973217|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
16407494|NCT01813721|39973218|FG000|Overall Study|Ineligibility determined|63|||
16407495|NCT01813721|39973218|FG000|Overall Study|Withdrawal by Subject|1|||
16407496|NCT02014480|39973219|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16407497|NCT02014480|39973220|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16407498|NCT02014480|39973221|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
16407499|NCT02014480|39973222|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16407500|NCT02014480|39973223|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16407501|NCT02014480|39973224|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
16407502|NCT02014480|39973219|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16407503|NCT02014480|39973220|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16407504|NCT02014480|39973221|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16407505|NCT02014480|39973222|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
16407506|NCT02014480|39973223|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16407507|NCT02014480|39973224|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16407508|NCT02014480|39973219|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16407509|NCT02014480|39973220|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16407510|NCT02014480|39973221|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
16407511|NCT02014480|39973222|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16407512|NCT02014480|39973223|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16407513|NCT02014480|39973224|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16407514|NCT02014480|39973219|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
16407515|NCT02014480|39973220|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
16407516|NCT02014480|39973221|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
16407517|NCT02014480|39973222|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
16407518|NCT02014480|39973223|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16407519|NCT02014480|39973224|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16407520|NCT02014480|39973219|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16407521|NCT02014480|39973220|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
16407522|NCT02014480|39973221|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16407523|NCT02014480|39973222|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16407524|NCT02014480|39973223|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16407525|NCT02014480|39973224|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16407526|NCT02014480|39973219|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
16407527|NCT02014480|39973220|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
16407528|NCT02014480|39973221|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
16407529|NCT02014480|39973222|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
16407530|NCT02014480|39973223|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
16407531|NCT02014480|39973224|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
16407532|NCT02014480|39973219|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16407533|NCT02014480|39973220|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16407534|NCT02014480|39973221|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16407535|NCT02014480|39973222|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16407536|NCT02014480|39973223|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16407537|NCT02014480|39973224|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
16407538|NCT02387164|39973225|FG000|Overall Study|Lost to Follow-up|2|||
16221042|NCT02155660|39290543|FG001|Overall Study|Severe non-compliance|4|||
16343506|NCT00385827|39744473|FG002|Part 1|Lack of Efficacy|0|||
16407539|NCT02387164|39973226|FG001|Overall Study|Lost to Follow-up|0|||
16407540|NCT02387164|39973225|FG000|Overall Study|Diagnosed|1|||
16407541|NCT02387164|39973226|FG001|Overall Study|Diagnosed|2|||
16407542|NCT02688088|39973227|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
16407543|NCT02688088|39973228|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
16407544|NCT02688088|39973229|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
16407545|NCT02688088|39973230|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
16407546|NCT02688088|39973231|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
16407547|NCT02688088|39973227|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
16407548|NCT02688088|39973228|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
16407549|NCT02688088|39973229|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
16407550|NCT02688088|39973230|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
16343507|NCT00385827|39744471|FG000|Part 1|Other|1|||
16343508|NCT00385827|39744472|FG001|Part 1|Other|0|||
16343509|NCT00385827|39744473|FG002|Part 1|Other|0|||
16343510|NCT00385827|39744471|FG000|Part 2|Adverse Event|0|||
16407551|NCT02688088|39973231|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
16407552|NCT02688088|39973227|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
16407553|NCT02688088|39973228|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
16407554|NCT02688088|39973229|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
16407555|NCT02688088|39973230|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
16407556|NCT02688088|39973231|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
16343511|NCT00385827|39744472|FG001|Part 2|Adverse Event|6|||
16343512|NCT00385827|39744473|FG002|Part 2|Adverse Event|10|||
16343513|NCT00385827|39744471|FG000|Part 2|Death|0|||
16343514|NCT00385827|39744472|FG001|Part 2|Death|0|||
16343515|NCT00385827|39744473|FG002|Part 2|Death|2|||
16343516|NCT00385827|39744471|FG000|Part 2|Lack of Efficacy|0|||
16343517|NCT00385827|39744472|FG001|Part 2|Lack of Efficacy|14|||
16343518|NCT00385827|39744473|FG002|Part 2|Lack of Efficacy|13|||
16343519|NCT00385827|39744471|FG000|Part 2|Randomized but not treated|0|||
16407557|NCT02688088|39973227|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
16407558|NCT02688088|39973228|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
16407559|NCT02688088|39973229|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
16407560|NCT02688088|39973230|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
16407561|NCT02688088|39973231|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
16407562|NCT02688088|39973227|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
16343520|NCT00385827|39744472|FG001|Part 2|Randomized but not treated|2|||
16343521|NCT00385827|39744473|FG002|Part 2|Randomized but not treated|2|||
16343522|NCT00385827|39744471|FG000|Part 2|Other|0|||
16343523|NCT00385827|39744472|FG001|Part 2|Other|11|||
16343524|NCT00385827|39744473|FG002|Part 2|Other|21|||
16407563|NCT02688088|39973228|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
16407564|NCT02688088|39973229|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
16407565|NCT02688088|39973230|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
16407566|NCT02688088|39973231|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
16407567|NCT02688088|39973227|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
16407568|NCT02688088|39973228|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
16407569|NCT02688088|39973229|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
16407570|NCT02688088|39973230|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
16407571|NCT02688088|39973231|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
16407572|NCT02688088|39973227|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
16407573|NCT02688088|39973228|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
16407574|NCT02688088|39973229|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
16407575|NCT02688088|39973230|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
16407576|NCT02688088|39973231|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
16407577|NCT02688088|39973227|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
16407578|NCT02688088|39973228|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
16407579|NCT02688088|39973229|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
16407580|NCT02688088|39973230|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
16407581|NCT02688088|39973231|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
16407582|NCT02688088|39973227|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
16407583|NCT02688088|39973228|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
16407584|NCT02688088|39973229|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
16407585|NCT02688088|39973230|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
16407586|NCT02688088|39973231|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
16343525|NCT02781818|39744476|FG000|Overall Study|Lost to Follow-up|4|||
16343526|NCT02781818|39744477|FG001|Overall Study|Lost to Follow-up|2|||
16407587|NCT00790868|39973235|FG000|Overall Study|Withdrawal by Subject|4|||
16407588|NCT00790868|39973236|FG001|Overall Study|Withdrawal by Subject|5|||
16407589|NCT00790868|39973235|FG000|Overall Study|Lost to Follow-up|2|||
16543638|NCT03145766|40453712|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
16343527|NCT02781818|39744478|FG002|Overall Study|Lost to Follow-up|1|||
16543639|NCT03145766|40453713|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
16343528|NCT04039204|39744479|FG000|Overall Study|Withdrawal by Subject|0|||
16343529|NCT04039204|39744480|FG001|Overall Study|Withdrawal by Subject|2|||
16343530|NCT04162795|39744483|FG000|Overall Study|Other|16|||
16343531|NCT04162795|39744483|FG000|Overall Study|Screen failures|10|||
16343532|NCT02095197|39744486|FG000|Overall Study|Lost to Follow-up|0|||
16407590|NCT00790868|39973236|FG001|Overall Study|Lost to Follow-up|12|||
16543640|NCT03145766|40453714|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
16543641|NCT03145766|40453715|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
16543642|NCT03145766|40453711|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
16543643|NCT03145766|40453712|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
16543644|NCT03145766|40453713|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
16543645|NCT03145766|40453714|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
16543646|NCT03145766|40453715|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
16543647|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
16543648|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
16543649|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
16543650|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
16543651|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
16543652|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
16543653|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
16543654|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
16543655|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
16543656|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
16543657|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
16543658|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
16543659|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
16543660|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
16543661|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
16543662|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
16543663|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
16543664|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
16543665|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
16343533|NCT02095197|39744487|FG001|Overall Study|Lost to Follow-up|3|||
16343534|NCT02226120|39744488|FG000|Overall Study|Adverse Event|60|||
16343535|NCT02226120|39744488|FG000|Overall Study|Death|172|||
16343536|NCT02226120|39744488|FG000|Overall Study|Study terminated by sponsor|1|||
16343537|NCT02226120|39744488|FG000|Overall Study|Technical problems|4|||
16343538|NCT02226120|39744488|FG000|Overall Study|Lost to Follow-up|13|||
16343539|NCT02226120|39744488|FG000|Overall Study|Physician Decision|21|||
16343540|NCT02226120|39744488|FG000|Overall Study|Withdrawal by parent/guardian|36|||
16343541|NCT02226120|39744488|FG000|Overall Study|Non-compliance with study drug|10|||
16343542|NCT02226120|39744488|FG000|Overall Study|Protocol deviation|1|||
16343543|NCT02226120|39744488|FG000|Overall Study|missing treatment disposition pages|2|||
16407591|NCT01571284|39973237|FG000|Overall Study|Participant's decision|84|||
16407592|NCT01571284|39973237|FG000|Overall Study|Lost to Follow-up|3|||
16407593|NCT01571284|39973237|FG000|Overall Study|Enrolled but not treated|2|||
16407594|NCT01571284|39973237|FG000|Overall Study|Other than specified above|80|||
16407595|NCT01095653|39973239|FG000|Overall Study|Lack of Efficacy|3|||
16407596|NCT01095653|39973240|FG001|Overall Study|Lack of Efficacy|0|||
16407597|NCT01095653|39973241|FG002|Overall Study|Lack of Efficacy|0|||
16407598|NCT01095653|39973239|FG000|Overall Study|Adverse Event|1|||
16407599|NCT01095653|39973240|FG001|Overall Study|Adverse Event|4|||
16407600|NCT01095653|39973241|FG002|Overall Study|Adverse Event|4|||
16407601|NCT01095653|39973239|FG000|Overall Study|Lost to Follow-up|1|||
16407602|NCT01095653|39973240|FG001|Overall Study|Lost to Follow-up|0|||
16407603|NCT01095653|39973241|FG002|Overall Study|Lost to Follow-up|4|||
16407604|NCT01095653|39973239|FG000|Overall Study|Withdrawal by Subject|4|||
16407605|NCT01095653|39973240|FG001|Overall Study|Withdrawal by Subject|5|||
16407606|NCT01095653|39973241|FG002|Overall Study|Withdrawal by Subject|3|||
16407607|NCT01095653|39973239|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
16407608|NCT01095653|39973240|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
16407609|NCT01095653|39973241|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
16407610|NCT03294135|39973242|FG000|Overall Study|Serious Adverse Event|1|||
16407611|NCT03294135|39973243|FG001|Overall Study|Serious Adverse Event|0|||
16407612|NCT03294135|39973244|FG002|Overall Study|Serious Adverse Event|0|||
16407613|NCT03294135|39973242|FG000|Overall Study|Lost to Follow-up|1|||
16407614|NCT03294135|39973243|FG001|Overall Study|Lost to Follow-up|0|||
16407615|NCT03294135|39973244|FG002|Overall Study|Lost to Follow-up|1|||
16407616|NCT03294135|39973242|FG000|Overall Study|Withdrawal by Subject|0|||
16407617|NCT03294135|39973243|FG001|Overall Study|Withdrawal by Subject|0|||
16407618|NCT03294135|39973244|FG002|Overall Study|Withdrawal by Subject|1|||
16407619|NCT03294135|39973242|FG000|Overall Study|Other|2|||
16407620|NCT03294135|39973243|FG001|Overall Study|Other|0|||
16407621|NCT03294135|39973244|FG002|Overall Study|Other|0|||
16407622|NCT03455829|39973251|FG000|Overall Study|Death|2|||
16343544|NCT02849704|39744489|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
16343545|NCT02849704|39744490|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
16407623|NCT03455829|39973252|FG001|Overall Study|Death|3|||
16407624|NCT03455829|39973253|FG002|Overall Study|Death|2|||
16407625|NCT03455829|39973254|FG003|Overall Study|Death|4|||
16407626|NCT03455829|39973255|FG004|Overall Study|Death|2|||
16407627|NCT03455829|39973251|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
16407628|NCT03455829|39973252|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
16543666|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
16407629|NCT03455829|39973253|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
16407630|NCT03455829|39973254|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
16543667|NCT00549757|40453718|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
16543668|NCT00549757|40453719|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
16109847|NCT00550446|38889175|FG002|Up To Week 12|Withdrawal by Subject|3|||
16109848|NCT00550446|38889176|FG003|Up To Week 12|Withdrawal by Subject|2|||
16109849|NCT00550446|38889177|FG004|Up To Week 12|Withdrawal by Subject|0|||
16109850|NCT00550446|38889178|FG005|Up To Week 12|Withdrawal by Subject|1|||
16109851|NCT00550446|38889179|FG006|Up To Week 12|Withdrawal by Subject|3|||
16109852|NCT00550446|38889180|FG007|Up To Week 12|Withdrawal by Subject|0|||
16109853|NCT00550446|38889181|FG008|Up To Week 12|Withdrawal by Subject|0|||
16109854|NCT00550446|38889182|FG009|Up To Week 12|Withdrawal by Subject|0|||
16109855|NCT00550446|38889183|FG010|Up To Week 12|Withdrawal by Subject|0|||
16109856|NCT00550446|38889173|FG000|Up To Week 12|Other|3|||
16109857|NCT00550446|38889174|FG001|Up To Week 12|Other|0|||
16109858|NCT00550446|38889175|FG002|Up To Week 12|Other|0|||
16109859|NCT00550446|38889176|FG003|Up To Week 12|Other|0|||
16109860|NCT00550446|38889177|FG004|Up To Week 12|Other|0|||
16343546|NCT02849704|39744489|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
16343547|NCT02849704|39744490|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
16343548|NCT02849704|39744489|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
16109861|NCT00550446|38889178|FG005|Up To Week 12|Other|1|||
16109862|NCT00550446|38889179|FG006|Up To Week 12|Other|4|||
16109863|NCT00550446|38889180|FG007|Up To Week 12|Other|0|||
16109864|NCT00550446|38889181|FG008|Up To Week 12|Other|0|||
16109865|NCT00550446|38889182|FG009|Up To Week 12|Other|0|||
16343549|NCT02849704|39744490|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
16343550|NCT03126786|39744494|FG000|Overall Study|Adverse Event|3|||
16343551|NCT03126786|39744495|FG001|Overall Study|Adverse Event|0|||
16343552|NCT03126786|39744494|FG000|Overall Study|Lost to Follow-up|0|||
16109866|NCT00550446|38889183|FG010|Up To Week 12|Other|0|||
16109867|NCT00550446|38889173|FG000|Up To Week 12|Randomized not treated|0|||
16109868|NCT00550446|38889174|FG001|Up To Week 12|Randomized not treated|1|||
16109869|NCT00550446|38889175|FG002|Up To Week 12|Randomized not treated|1|||
16109870|NCT00550446|38889176|FG003|Up To Week 12|Randomized not treated|0|||
16109871|NCT00550446|38889177|FG004|Up To Week 12|Randomized not treated|0|||
16109872|NCT00550446|38889178|FG005|Up To Week 12|Randomized not treated|0|||
16109873|NCT00550446|38889179|FG006|Up To Week 12|Randomized not treated|0|||
16109874|NCT00550446|38889180|FG007|Up To Week 12|Randomized not treated|0|||
16109875|NCT00550446|38889181|FG008|Up To Week 12|Randomized not treated|0|||
16109876|NCT00550446|38889182|FG009|Up To Week 12|Randomized not treated|0|||
16109877|NCT00550446|38889183|FG010|Up To Week 12|Randomized not treated|0|||
16109878|NCT00550446|38889173|FG000|Post Week 12|Adverse Event|2|||
16109879|NCT00550446|38889174|FG001|Post Week 12|Adverse Event|1|||
16109880|NCT00550446|38889175|FG002|Post Week 12|Adverse Event|1|||
16109881|NCT00550446|38889176|FG003|Post Week 12|Adverse Event|1|||
16109882|NCT00550446|38889177|FG004|Post Week 12|Adverse Event|1|||
16109883|NCT00550446|38889178|FG005|Post Week 12|Adverse Event|1|||
16109884|NCT00550446|38889179|FG006|Post Week 12|Adverse Event|0|||
16109885|NCT00550446|38889180|FG007|Post Week 12|Adverse Event|0|||
16343553|NCT03126786|39744495|FG001|Overall Study|Lost to Follow-up|1|||
16343554|NCT03126786|39744494|FG000|Overall Study|Withdrawal by Subject|3|||
16343555|NCT03126786|39744495|FG001|Overall Study|Withdrawal by Subject|1|||
16343556|NCT01121263|39744498|FG000|Overall Study|Death|3|||
16343557|NCT01121263|39744499|FG001|Overall Study|Death|2|||
16343558|NCT01121263|39744498|FG000|Overall Study|Lost to Follow-up|22|||
16343559|NCT01121263|39744499|FG001|Overall Study|Lost to Follow-up|12|||
16343560|NCT01121263|39744498|FG000|Overall Study|Withdrawal by Subject|0|||
16343561|NCT01121263|39744499|FG001|Overall Study|Withdrawal by Subject|1|||
16343562|NCT03959527|39744500|FG000|Overall Study|Withdrawal by Subject|8|||
16343563|NCT03959527|39744501|FG001|Overall Study|Withdrawal by Subject|3|||
16543669|NCT00549757|40453718|FG000|Extension Period (in Average 9 Months)|Death|143|||
16543670|NCT00549757|40453719|FG001|Extension Period (in Average 9 Months)|Death|136|||
16543671|NCT00549757|40453718|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
16543672|NCT00549757|40453719|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
16543673|NCT00549757|40453718|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
16543674|NCT00549757|40453719|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
16543675|NCT00549757|40453718|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
16543676|NCT00549757|40453719|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
16543677|NCT00524030|40453722|FG000|Overall Study|Lack of Efficacy|10|||
16543678|NCT00524030|40453723|FG001|Overall Study|Lack of Efficacy|24|||
16543679|NCT00524030|40453722|FG000|Overall Study|Lost to Follow-up|0|||
16543680|NCT00524030|40453723|FG001|Overall Study|Lost to Follow-up|2|||
16543681|NCT00524030|40453722|FG000|Overall Study|Withdrawal by Subject|3|||
16543682|NCT00524030|40453723|FG001|Overall Study|Withdrawal by Subject|8|||
16543683|NCT00524030|40453722|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
16543684|NCT00524030|40453723|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
16543685|NCT00524030|40453722|FG000|Overall Study|Protocol Violation|0|||
16543686|NCT00524030|40453723|FG001|Overall Study|Protocol Violation|1|||
16543687|NCT00524030|40453722|FG000|Overall Study|Pregnancy|1|||
16543688|NCT00524030|40453723|FG001|Overall Study|Pregnancy|0|||
16543689|NCT00524030|40453722|FG000|Overall Study|Adverse Event|3|||
16543690|NCT00524030|40453723|FG001|Overall Study|Adverse Event|21|||
16543691|NCT00524030|40453722|FG000|Overall Study|Death|0|||
16543692|NCT00524030|40453723|FG001|Overall Study|Death|1|||
16543693|NCT00643123|40453724|FG000|Overall Study|Lost to Follow-up|4|||
16543694|NCT00643123|40453725|FG001|Overall Study|Lost to Follow-up|0|||
16543695|NCT00643123|40453724|FG000|Overall Study|Withdrawal by Subject|1|||
16543696|NCT00643123|40453725|FG001|Overall Study|Withdrawal by Subject|1|||
16543697|NCT00118898|40453726|FG000|Overall Study|Death|6|||
16543698|NCT00118898|40453727|FG001|Overall Study|Death|11|||
16543699|NCT00118898|40453728|FG002|Overall Study|Death|6|||
16543700|NCT00118898|40453729|FG003|Overall Study|Death|8|||
16543701|NCT00118898|40453726|FG000|Overall Study|Lost to Follow-up|26|||
16543702|NCT00118898|40453727|FG001|Overall Study|Lost to Follow-up|34|||
16543703|NCT00118898|40453728|FG002|Overall Study|Lost to Follow-up|33|||
16543704|NCT00118898|40453729|FG003|Overall Study|Lost to Follow-up|33|||
16543705|NCT00118898|40453726|FG000|Overall Study|Withdrawal by Subject|10|||
16543706|NCT00118898|40453727|FG001|Overall Study|Withdrawal by Subject|5|||
16543707|NCT00118898|40453728|FG002|Overall Study|Withdrawal by Subject|8|||
16543708|NCT00118898|40453729|FG003|Overall Study|Withdrawal by Subject|8|||
16543709|NCT00118898|40453726|FG000|Overall Study|Site Closure|33|||
16543710|NCT00118898|40453727|FG001|Overall Study|Site Closure|31|||
16543711|NCT00118898|40453728|FG002|Overall Study|Site Closure|28|||
16543712|NCT00118898|40453729|FG003|Overall Study|Site Closure|37|||
16543713|NCT00118898|40453726|FG000|Overall Study|Severe debilitation|1|||
16543714|NCT00118898|40453727|FG001|Overall Study|Severe debilitation|4|||
16543715|NCT00118898|40453728|FG002|Overall Study|Severe debilitation|6|||
16543716|NCT00118898|40453729|FG003|Overall Study|Severe debilitation|4|||
16221043|NCT02155660|39290544|FG002|Overall Study|Severe non-compliance|0|||
16343564|NCT03959527|39744500|FG000|Overall Study|Lost to Follow-up|31|||
16343565|NCT03959527|39744501|FG001|Overall Study|Lost to Follow-up|15|||
16343566|NCT03959527|39744500|FG000|Overall Study|Did not meet eligibility criteria|1|||
16543717|NCT00118898|40453726|FG000|Overall Study|Not compliant with requirements|11|||
16543718|NCT00118898|40453727|FG001|Overall Study|Not compliant with requirements|13|||
16543719|NCT00118898|40453728|FG002|Overall Study|Not compliant with requirements|11|||
16543720|NCT00118898|40453729|FG003|Overall Study|Not compliant with requirements|11|||
16543721|NCT00118898|40453726|FG000|Overall Study|Not able to get to clinic|34|||
16543722|NCT00118898|40453727|FG001|Overall Study|Not able to get to clinic|43|||
16543723|NCT00118898|40453728|FG002|Overall Study|Not able to get to clinic|31|||
16543724|NCT00118898|40453729|FG003|Overall Study|Not able to get to clinic|40|||
16543725|NCT03308825|40453730|FG000|Overall Study|Lost to Follow-up|2|||
16543726|NCT03308825|40453731|FG001|Overall Study|Lost to Follow-up|2|||
16543727|NCT03308825|40453732|FG002|Overall Study|Lost to Follow-up|1|||
16343567|NCT03959527|39744501|FG001|Overall Study|Did not meet eligibility criteria|1|||
16343568|NCT03959527|39744500|FG000|Overall Study|Protocol Violation|10|||
16343569|NCT03959527|39744501|FG001|Overall Study|Protocol Violation|5|||
16343570|NCT02173379|39744506|FG000|Overall Study|Lost to Follow-up|89|||
16109886|NCT00550446|38889181|FG008|Post Week 12|Adverse Event|0|||
16109887|NCT00550446|38889182|FG009|Post Week 12|Adverse Event|4|||
16109888|NCT00550446|38889183|FG010|Post Week 12|Adverse Event|0|||
16109889|NCT00550446|38889173|FG000|Post Week 12|Lack of Efficacy|0|||
16109890|NCT00550446|38889174|FG001|Post Week 12|Lack of Efficacy|0|||
16109891|NCT00550446|38889175|FG002|Post Week 12|Lack of Efficacy|1|||
16109892|NCT00550446|38889176|FG003|Post Week 12|Lack of Efficacy|0|||
16109893|NCT00550446|38889177|FG004|Post Week 12|Lack of Efficacy|0|||
16109894|NCT00550446|38889178|FG005|Post Week 12|Lack of Efficacy|0|||
16109895|NCT00550446|38889179|FG006|Post Week 12|Lack of Efficacy|0|||
16109896|NCT00550446|38889180|FG007|Post Week 12|Lack of Efficacy|1|||
16109897|NCT00550446|38889181|FG008|Post Week 12|Lack of Efficacy|1|||
16109898|NCT00550446|38889182|FG009|Post Week 12|Lack of Efficacy|2|||
16109899|NCT00550446|38889183|FG010|Post Week 12|Lack of Efficacy|1|||
16109900|NCT00550446|38889173|FG000|Post Week 12|Lost to Follow-up|0|||
16109901|NCT00550446|38889174|FG001|Post Week 12|Lost to Follow-up|0|||
16109902|NCT00550446|38889175|FG002|Post Week 12|Lost to Follow-up|1|||
16109903|NCT00550446|38889176|FG003|Post Week 12|Lost to Follow-up|1|||
16109904|NCT00550446|38889177|FG004|Post Week 12|Lost to Follow-up|0|||
16343571|NCT02173379|39744507|FG001|Overall Study|Lost to Follow-up|81|||
16343572|NCT02173379|39744506|FG000|Overall Study|Withdrawal by Subject|24|||
16109905|NCT00550446|38889178|FG005|Post Week 12|Lost to Follow-up|0|||
16109906|NCT00550446|38889179|FG006|Post Week 12|Lost to Follow-up|1|||
16109907|NCT00550446|38889180|FG007|Post Week 12|Lost to Follow-up|0|||
16221044|NCT02155660|39290545|FG003|Overall Study|Severe non-compliance|1|||
16343573|NCT02173379|39744507|FG001|Overall Study|Withdrawal by Subject|29|||
16543728|NCT03308825|40453733|FG003|Overall Study|Lost to Follow-up|0|||
16543729|NCT03308825|40453730|FG000|Overall Study|Protocol Violation|0|||
16109908|NCT00550446|38889181|FG008|Post Week 12|Lost to Follow-up|0|||
16109909|NCT00550446|38889182|FG009|Post Week 12|Lost to Follow-up|0|||
16109910|NCT00550446|38889183|FG010|Post Week 12|Lost to Follow-up|0|||
16109911|NCT00550446|38889173|FG000|Post Week 12|Withdrawal by Subject|0|||
16109912|NCT00550446|38889174|FG001|Post Week 12|Withdrawal by Subject|0|||
16109913|NCT00550446|38889175|FG002|Post Week 12|Withdrawal by Subject|0|||
16109914|NCT00550446|38889176|FG003|Post Week 12|Withdrawal by Subject|0|||
16109915|NCT00550446|38889177|FG004|Post Week 12|Withdrawal by Subject|1|||
16109916|NCT00550446|38889178|FG005|Post Week 12|Withdrawal by Subject|0|||
16109917|NCT00550446|38889179|FG006|Post Week 12|Withdrawal by Subject|0|||
16109918|NCT00550446|38889180|FG007|Post Week 12|Withdrawal by Subject|0|||
16109919|NCT00550446|38889181|FG008|Post Week 12|Withdrawal by Subject|0|||
16109920|NCT00550446|38889182|FG009|Post Week 12|Withdrawal by Subject|0|||
16109921|NCT00550446|38889183|FG010|Post Week 12|Withdrawal by Subject|0|||
16109922|NCT00550446|38889173|FG000|Post Week 12|Other|1|||
16109923|NCT00550446|38889174|FG001|Post Week 12|Other|1|||
16109924|NCT00550446|38889175|FG002|Post Week 12|Other|0|||
16109925|NCT00550446|38889176|FG003|Post Week 12|Other|1|||
16109926|NCT00550446|38889177|FG004|Post Week 12|Other|0|||
16109927|NCT00550446|38889178|FG005|Post Week 12|Other|0|||
16109928|NCT00550446|38889179|FG006|Post Week 12|Other|1|||
16109929|NCT00550446|38889180|FG007|Post Week 12|Other|0|||
16109930|NCT00550446|38889181|FG008|Post Week 12|Other|1|||
16109931|NCT00550446|38889182|FG009|Post Week 12|Other|1|||
16109932|NCT00550446|38889183|FG010|Post Week 12|Other|0|||
16109933|NCT01585298|38889197|FG000|Overall Study|Study completion was not documented.|1|||
16543730|NCT03308825|40453731|FG001|Overall Study|Protocol Violation|2|||
16543731|NCT03308825|40453732|FG002|Overall Study|Protocol Violation|0|||
16543732|NCT03308825|40453733|FG003|Overall Study|Protocol Violation|0|||
16543733|NCT01669798|40453743|FG000|Overall Study|Physician Decision|5|||
16109934|NCT01585298|38889197|FG000|Overall Study|Protocol deviation|1|||
16109935|NCT01585298|38889197|FG000|Overall Study|Administrative problems|4|||
16109936|NCT01585298|38889197|FG000|Overall Study|Lost to Follow-up|2|||
16109937|NCT01585298|38889197|FG000|Overall Study|Withdrawal by Subject|4|||
16109938|NCT01585298|38889197|FG000|Overall Study|Abnormal test procedure results|1|||
16109939|NCT01585298|38889197|FG000|Overall Study|Adverse Event|24|||
16343574|NCT02173379|39744506|FG000|Overall Study|Physician Decision|8|||
16109940|NCT02484547|38889198|FG000|Placebo-Controlled Period|Adverse Event|10|||
16543734|NCT01119898|40453744|FG000|Overall Study|Adverse Event|4|||
16221045|NCT02155660|39290542|FG000|Overall Study|Adverse Event|2|||
16221046|NCT02155660|39290543|FG001|Overall Study|Adverse Event|6|||
16221047|NCT02155660|39290544|FG002|Overall Study|Adverse Event|3|||
16221048|NCT02155660|39290545|FG003|Overall Study|Adverse Event|1|||
16221049|NCT02155660|39290542|FG000|Overall Study|Lost to Follow-up|3|||
16221050|NCT02155660|39290543|FG001|Overall Study|Lost to Follow-up|6|||
16221051|NCT02155660|39290544|FG002|Overall Study|Lost to Follow-up|5|||
16221052|NCT02155660|39290545|FG003|Overall Study|Lost to Follow-up|8|||
16221053|NCT02155660|39290542|FG000|Overall Study|Death|17|||
16221054|NCT02155660|39290543|FG001|Overall Study|Death|19|||
16221055|NCT02155660|39290544|FG002|Overall Study|Death|17|||
16221056|NCT02155660|39290545|FG003|Overall Study|Death|19|||
16221057|NCT02155660|39290542|FG000|Overall Study|Withdrawal by Subject|28|||
16221058|NCT02155660|39290543|FG001|Overall Study|Withdrawal by Subject|31|||
16221059|NCT02155660|39290544|FG002|Overall Study|Withdrawal by Subject|24|||
16221060|NCT02155660|39290545|FG003|Overall Study|Withdrawal by Subject|21|||
16221061|NCT02146274|39290546|FG000|Overall Study|Protocol Violation|73|||
16221062|NCT01683058|39290547|FG000|Overall Study|Lost to Follow-up|9|||
16221063|NCT01683058|39290547|FG000|Overall Study|Adverse Event|6|||
16221064|NCT01683058|39290547|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
16221065|NCT01683058|39290547|FG000|Overall Study|Withdrawal by Subject|7|||
16221066|NCT01683058|39290547|FG000|Overall Study|Lack of Efficacy|2|||
16221067|NCT00917553|39290553|FG000|Overall Study|Lost to Follow-up|2|||
16221068|NCT00917553|39290554|FG001|Overall Study|Lost to Follow-up|1|||
16221069|NCT00620815|39290556|FG000|Overall Study|Adverse Event|1|||
16221070|NCT00620815|39290557|FG001|Overall Study|Adverse Event|1|||
16221071|NCT00620815|39290558|FG002|Overall Study|Adverse Event|2|||
16221072|NCT00620815|39290556|FG000|Overall Study|Withdrawal by Subject|1|||
16221073|NCT00620815|39290557|FG001|Overall Study|Withdrawal by Subject|2|||
16221074|NCT00620815|39290558|FG002|Overall Study|Withdrawal by Subject|0|||
16221075|NCT00620815|39290556|FG000|Overall Study|Lost to Follow-up|1|||
16221076|NCT00620815|39290557|FG001|Overall Study|Lost to Follow-up|6|||
16221077|NCT00620815|39290558|FG002|Overall Study|Lost to Follow-up|3|||
16221078|NCT00620815|39290556|FG000|Overall Study|Inappropriate enrolment|0|||
16221079|NCT00620815|39290557|FG001|Overall Study|Inappropriate enrolment|0|||
16221080|NCT00620815|39290558|FG002|Overall Study|Inappropriate enrolment|1|||
16221081|NCT00620815|39290556|FG000|Overall Study|Protocol Violation|1|||
16221082|NCT00620815|39290557|FG001|Overall Study|Protocol Violation|2|||
16221083|NCT00620815|39290558|FG002|Overall Study|Protocol Violation|1|||
16221084|NCT01696396|39290559|FG000|Overall Study|Withdrawal by Subject|19|||
16221085|NCT01696396|39290560|FG001|Overall Study|Withdrawal by Subject|5|||
16221086|NCT01696396|39290561|FG002|Overall Study|Withdrawal by Subject|19|||
16221087|NCT01696396|39290562|FG003|Overall Study|Withdrawal by Subject|11|||
16221088|NCT01696396|39290559|FG000|Overall Study|Decision by Sponsor|3|||
16221089|NCT01696396|39290560|FG001|Overall Study|Decision by Sponsor|1|||
16221090|NCT01696396|39290561|FG002|Overall Study|Decision by Sponsor|2|||
16221091|NCT01696396|39290562|FG003|Overall Study|Decision by Sponsor|2|||
16221092|NCT01696396|39290559|FG000|Overall Study|Lost to Follow-up|9|||
16221093|NCT01696396|39290560|FG001|Overall Study|Lost to Follow-up|1|||
16221094|NCT01696396|39290561|FG002|Overall Study|Lost to Follow-up|4|||
16221095|NCT01696396|39290562|FG003|Overall Study|Lost to Follow-up|1|||
16221096|NCT01696396|39290559|FG000|Overall Study|Death|0|||
16221097|NCT01696396|39290560|FG001|Overall Study|Death|0|||
16221098|NCT01696396|39290561|FG002|Overall Study|Death|1|||
16221099|NCT01696396|39290562|FG003|Overall Study|Death|0|||
16221100|NCT04450394|39290565|FG000|Overall Study|Adverse Event|2|||
16221101|NCT04450394|39290566|FG001|Overall Study|Adverse Event|0|||
16221102|NCT04450394|39290567|FG002|Overall Study|Adverse Event|0|||
16221103|NCT04450394|39290565|FG000|Overall Study|Death|0|||
16221104|NCT04450394|39290566|FG001|Overall Study|Death|1|||
16221105|NCT04450394|39290567|FG002|Overall Study|Death|0|||
16221106|NCT04450394|39290565|FG000|Overall Study|Lost to Follow-up|0|||
16221107|NCT04450394|39290566|FG001|Overall Study|Lost to Follow-up|3|||
16221108|NCT04450394|39290567|FG002|Overall Study|Lost to Follow-up|0|||
16221109|NCT04450394|39290565|FG000|Overall Study|Physician Decision|0|||
16221110|NCT04450394|39290566|FG001|Overall Study|Physician Decision|1|||
16221111|NCT04450394|39290567|FG002|Overall Study|Physician Decision|0|||
16221112|NCT04450394|39290565|FG000|Overall Study|Protocol Violation|2|||
16221113|NCT04450394|39290566|FG001|Overall Study|Protocol Violation|0|||
16221114|NCT04450394|39290567|FG002|Overall Study|Protocol Violation|0|||
16221115|NCT04450394|39290565|FG000|Overall Study|Withdrawal by Subject|6|||
16221116|NCT04450394|39290566|FG001|Overall Study|Withdrawal by Subject|9|||
16221117|NCT04450394|39290567|FG002|Overall Study|Withdrawal by Subject|0|||
16221118|NCT03958149|39290568|FG000|Overall Study|Withdrawal by Subject|0|||
16221119|NCT03958149|39290569|FG001|Overall Study|Withdrawal by Subject|1|||
16221120|NCT00606021|39290570|FG000|Induction Phase|Death|73|||
16221121|NCT00606021|39290571|FG001|Induction Phase|Death|0|||
16221122|NCT00606021|39290572|FG002|Induction Phase|Death|0|||
16221123|NCT00606021|39290570|FG000|Induction Phase|Physician Decision|2|||
16221124|NCT00606021|39290571|FG001|Induction Phase|Physician Decision|0|||
16221125|NCT00606021|39290572|FG002|Induction Phase|Physician Decision|0|||
16221126|NCT00606021|39290570|FG000|Induction Phase|Withdrawal by Subject|2|||
16221127|NCT00606021|39290571|FG001|Induction Phase|Withdrawal by Subject|0|||
16221128|NCT00606021|39290572|FG002|Induction Phase|Withdrawal by Subject|0|||
16221129|NCT00606021|39290570|FG000|Induction Phase|Lost to Follow-up|10|||
16221130|NCT00606021|39290571|FG001|Induction Phase|Lost to Follow-up|0|||
16221131|NCT00606021|39290572|FG002|Induction Phase|Lost to Follow-up|0|||
16221132|NCT00606021|39290570|FG000|Maintenance Phase|Death|0|||
16221133|NCT00606021|39290571|FG001|Maintenance Phase|Death|17|||
16221134|NCT00606021|39290572|FG002|Maintenance Phase|Death|15|||
16221135|NCT00606021|39290570|FG000|Maintenance Phase|Physician Decision|0|||
16221136|NCT00606021|39290571|FG001|Maintenance Phase|Physician Decision|1|||
16221137|NCT00606021|39290572|FG002|Maintenance Phase|Physician Decision|0|||
16221138|NCT00606021|39290570|FG000|Maintenance Phase|Lost to Follow-up|0|||
16221139|NCT00606021|39290571|FG001|Maintenance Phase|Lost to Follow-up|5|||
16221140|NCT00606021|39290572|FG002|Maintenance Phase|Lost to Follow-up|2|||
16221141|NCT02795182|39290573|FG000|Overall Study|Death|5|||
16221142|NCT02795182|39290574|FG001|Overall Study|Death|4|||
16221143|NCT02795182|39290575|FG002|Overall Study|Death|4|||
16221144|NCT02795182|39290576|FG003|Overall Study|Death|18|||
16221145|NCT02795182|39290573|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
16221146|NCT02795182|39290574|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
16221147|NCT02795182|39290575|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
16221148|NCT02795182|39290576|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
16221149|NCT02795182|39290573|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
16221150|NCT02795182|39290574|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
16221151|NCT02795182|39290575|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
16221152|NCT02795182|39290576|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
16221153|NCT02795182|39290573|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
16221154|NCT02795182|39290574|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
16221155|NCT02795182|39290575|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
16221156|NCT02795182|39290576|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
16221157|NCT02795182|39290573|FG000|Overall Study|Withdrawal by Subject|4|||
16543735|NCT01119898|40453745|FG001|Overall Study|Adverse Event|5|||
16543736|NCT01119898|40453744|FG000|Overall Study|Withdrawal by Subject|1|||
16543737|NCT01119898|40453745|FG001|Overall Study|Withdrawal by Subject|4|||
16543738|NCT01119898|40453744|FG000|Overall Study|Lack of Efficacy|0|||
16543739|NCT01119898|40453745|FG001|Overall Study|Lack of Efficacy|2|||
16543740|NCT01119898|40453744|FG000|Overall Study|Protocol Violation|1|||
16543741|NCT01119898|40453745|FG001|Overall Study|Protocol Violation|1|||
16543742|NCT01119898|40453744|FG000|Overall Study|Medical procedure|1|||
16543743|NCT01119898|40453745|FG001|Overall Study|Medical procedure|0|||
16543744|NCT01119898|40453744|FG000|Overall Study|Randomized in error did not participate|1|||
16221158|NCT02795182|39290574|FG001|Overall Study|Withdrawal by Subject|0|||
16221159|NCT02795182|39290575|FG002|Overall Study|Withdrawal by Subject|0|||
16221160|NCT02795182|39290576|FG003|Overall Study|Withdrawal by Subject|3|||
16343575|NCT02173379|39744507|FG001|Overall Study|Physician Decision|8|||
16343576|NCT02173379|39744506|FG000|Overall Study|Death|75|||
16343577|NCT02173379|39744507|FG001|Overall Study|Death|72|||
16343578|NCT02173379|39744506|FG000|Overall Study|Other Reason|1|||
16343579|NCT02173379|39744507|FG001|Overall Study|Other Reason|0|||
16343580|NCT01371981|39744508|FG000|Overall Study|Adverse Event|12|||
16343581|NCT01371981|39744509|FG001|Overall Study|Adverse Event|17|||
16343582|NCT01371981|39744510|FG002|Overall Study|Adverse Event|0|||
16343583|NCT01371981|39744511|FG003|Overall Study|Adverse Event|4|||
16343584|NCT01371981|39744512|FG004|Overall Study|Adverse Event|1|||
16343585|NCT01371981|39744513|FG005|Overall Study|Adverse Event|0|||
16343586|NCT01371981|39744508|FG000|Overall Study|Death|22|||
16343587|NCT01371981|39744509|FG001|Overall Study|Death|16|||
16343588|NCT01371981|39744510|FG002|Overall Study|Death|0|||
16221161|NCT02795182|39290573|FG000|Overall Study|Lost to Follow-up|0|||
16343589|NCT01371981|39744511|FG003|Overall Study|Death|0|||
16343590|NCT01371981|39744512|FG004|Overall Study|Death|2|||
16543745|NCT01119898|40453745|FG001|Overall Study|Randomized in error did not participate|0|||
16543746|NCT00944125|40453749|FG000|3 to 6 Months|Withdrawal by Subject|0|||
16407631|NCT03455829|39973255|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
16407632|NCT03455829|39973251|FG000|Overall Study|Disease progression|0|||
16407633|NCT03455829|39973252|FG001|Overall Study|Disease progression|0|||
16407634|NCT03455829|39973253|FG002|Overall Study|Disease progression|0|||
16407635|NCT03455829|39973254|FG003|Overall Study|Disease progression|1|||
16407636|NCT03455829|39973255|FG004|Overall Study|Disease progression|1|||
16407637|NCT00645528|39973258|FG000|Overall Study|Did not show up for Visit 2|7|||
16407638|NCT03444766|39973259|FG000|Overall Study|Other Reasons|2|||
16407639|NCT03444766|39973259|FG000|Overall Study|Participant Withdrew Consent|5|||
16407640|NCT03444766|39973259|FG000|Overall Study|Lost to Follow-up|2|||
16407641|NCT03444766|39973259|FG000|Overall Study|Death|2|||
16407642|NCT03444766|39973259|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
16407643|NCT03444766|39973259|FG000|Overall Study|Disease Progression|49|||
16407644|NCT04465877|39973262|FG000|Overall Study|Noncompliant with study requirements|0|||
16407645|NCT04465877|39973263|FG001|Overall Study|Noncompliant with study requirements|0|||
16407646|NCT04465877|39973264|FG002|Overall Study|Noncompliant with study requirements|1|||
16407647|NCT04465877|39973265|FG003|Overall Study|Noncompliant with study requirements|0|||
16407648|NCT01866423|39973266|FG000|Overall Study|Lack of Efficacy|3|||
16407649|NCT01866423|39973266|FG000|Overall Study|Sponsor Decision|1|||
16407650|NCT01996592|39973275|FG000|Overall Study|no response to text/no diary entry|32|||
16407651|NCT01996592|39973275|FG000|Overall Study|change in surgical date|4|||
16407652|NCT01996592|39973275|FG000|Overall Study|Withdrawal by Subject|5|||
16407653|NCT01996592|39973275|FG000|Overall Study|change in mode of delivery|4|||
16407654|NCT03784846|39973276|FG000|Pre-COVID Study|Lost to Follow-up|3|||
16407655|NCT03784846|39973277|FG001|Pre-COVID Study|Lost to Follow-up|3|||
16407656|NCT03784846|39973278|FG002|Pre-COVID Study|Lost to Follow-up|2|||
16407657|NCT03784846|39973276|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
16407658|NCT03784846|39973277|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
16407659|NCT03784846|39973278|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
16407660|NCT03784846|39973276|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
16407661|NCT03784846|39973277|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
16407662|NCT03784846|39973278|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
16343591|NCT01371981|39744513|FG005|Overall Study|Death|2|||
16343592|NCT01371981|39744508|FG000|Overall Study|Lack of Efficacy|69|||
16343593|NCT01371981|39744509|FG001|Overall Study|Lack of Efficacy|61|||
16343594|NCT01371981|39744510|FG002|Overall Study|Lack of Efficacy|4|||
16343595|NCT01371981|39744511|FG003|Overall Study|Lack of Efficacy|8|||
16343596|NCT01371981|39744512|FG004|Overall Study|Lack of Efficacy|5|||
16343597|NCT01371981|39744513|FG005|Overall Study|Lack of Efficacy|0|||
16343598|NCT01371981|39744508|FG000|Overall Study|Physician Decision|48|||
16343599|NCT01371981|39744509|FG001|Overall Study|Physician Decision|63|||
16407663|NCT03784846|39973276|FG000|Post-COVID Study|Lost to Follow-up|3|||
16407664|NCT03784846|39973277|FG001|Post-COVID Study|Lost to Follow-up|5|||
16407665|NCT03784846|39973278|FG002|Post-COVID Study|Lost to Follow-up|1|||
16407666|NCT03784846|39973276|FG000|Post-COVID Study|Withdrawal by Subject|1|||
16407667|NCT03784846|39973277|FG001|Post-COVID Study|Withdrawal by Subject|2|||
16407668|NCT03784846|39973278|FG002|Post-COVID Study|Withdrawal by Subject|0|||
16407669|NCT02825420|39973279|FG000|Overall Study|Death|30|||
16407670|NCT02825420|39973280|FG001|Overall Study|Death|12|||
16407671|NCT02825420|39973279|FG000|Overall Study|Progressive disease|6|||
16407672|NCT02825420|39973280|FG001|Overall Study|Progressive disease|1|||
16407673|NCT02825420|39973279|FG000|Overall Study|Lost to Follow-up|2|||
16407674|NCT02825420|39973280|FG001|Overall Study|Lost to Follow-up|2|||
16407675|NCT02825420|39973279|FG000|Overall Study|Withdrawal by Subject|1|||
16407676|NCT02825420|39973280|FG001|Overall Study|Withdrawal by Subject|1|||
16407677|NCT02825420|39973279|FG000|Overall Study|Protocol amendment not signed|1|||
16407678|NCT02825420|39973280|FG001|Overall Study|Protocol amendment not signed|1|||
16407679|NCT02825420|39973279|FG000|Overall Study|Physician Decision|1|||
16407680|NCT02825420|39973280|FG001|Overall Study|Physician Decision|0|||
16407681|NCT02825420|39973279|FG000|Overall Study|Did not receive PLD|2|||
16407682|NCT02825420|39973280|FG001|Overall Study|Did not receive PLD|0|||
16407683|NCT03627065|39973281|FG000|Overall Study|Study Terminated by sponsor|1|||
16407684|NCT03627065|39973281|FG000|Overall Study|Withdrawal by Subject|2|||
16407685|NCT00765882|39973282|FG000|Overall Study|Adverse Event|10|||
16407686|NCT00765882|39973283|FG001|Overall Study|Adverse Event|21|||
16407687|NCT00765882|39973284|FG002|Overall Study|Adverse Event|20|||
16407688|NCT00765882|39973282|FG000|Overall Study|Lack of Efficacy|4|||
16407689|NCT00765882|39973283|FG001|Overall Study|Lack of Efficacy|0|||
16407690|NCT00765882|39973284|FG002|Overall Study|Lack of Efficacy|1|||
16407691|NCT00765882|39973282|FG000|Overall Study|Protocol Violation|4|||
16407692|NCT00765882|39973283|FG001|Overall Study|Protocol Violation|3|||
16109941|NCT02484547|38889199|FG001|Placebo-Controlled Period|Adverse Event|13|||
16343600|NCT01371981|39744510|FG002|Overall Study|Physician Decision|1|||
16407693|NCT00765882|39973284|FG002|Overall Study|Protocol Violation|1|||
16407694|NCT00765882|39973282|FG000|Overall Study|Withdrawal by Subject|2|||
16407695|NCT00765882|39973283|FG001|Overall Study|Withdrawal by Subject|6|||
16343601|NCT01371981|39744511|FG003|Overall Study|Physician Decision|7|||
16407696|NCT00765882|39973284|FG002|Overall Study|Withdrawal by Subject|6|||
16407697|NCT00765882|39973282|FG000|Overall Study|Lost to Follow-up|1|||
16407698|NCT00765882|39973283|FG001|Overall Study|Lost to Follow-up|9|||
16407699|NCT00765882|39973284|FG002|Overall Study|Lost to Follow-up|6|||
16407700|NCT00765882|39973282|FG000|Overall Study|Other Reason|3|||
16407701|NCT00765882|39973283|FG001|Overall Study|Other Reason|1|||
16407702|NCT00765882|39973284|FG002|Overall Study|Other Reason|2|||
16407703|NCT00241631|39973285|FG000|Run in (2 Weeks)|Physician Decision|3|||
16407704|NCT00241631|39973286|FG001|Run in (2 Weeks)|Physician Decision|3|||
16407705|NCT00241631|39973285|FG000|Phase 1 (4 Weeks)|sore throat|1|||
16407706|NCT00241631|39973286|FG001|Phase 1 (4 Weeks)|sore throat|0|||
16407707|NCT00241631|39973285|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
16407708|NCT00241631|39973286|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
16407709|NCT00241631|39973285|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
16407710|NCT00241631|39973286|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
16407711|NCT00241631|39973285|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
16407712|NCT00241631|39973286|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
16407713|NCT00856206|39973289|FG000|Overall Study|Protocol Violation|6|||
16407714|NCT00856206|39973290|FG001|Overall Study|Protocol Violation|18|||
16407715|NCT00856206|39973289|FG000|Overall Study|Adverse Event|10|||
16407716|NCT00856206|39973290|FG001|Overall Study|Adverse Event|46|||
16407717|NCT00856206|39973289|FG000|Overall Study|Lack of Efficacy|1|||
16407718|NCT00856206|39973290|FG001|Overall Study|Lack of Efficacy|2|||
16407719|NCT00856206|39973289|FG000|Overall Study|Withdrawal by Subject|15|||
16407720|NCT00856206|39973290|FG001|Overall Study|Withdrawal by Subject|36|||
16407721|NCT00856206|39973289|FG000|Overall Study|Lost to Follow-up|13|||
16407722|NCT00856206|39973290|FG001|Overall Study|Lost to Follow-up|39|||
16407723|NCT00856206|39973289|FG000|Overall Study|Death|2|||
16407724|NCT00856206|39973290|FG001|Overall Study|Death|2|||
16407725|NCT00856206|39973289|FG000|Overall Study|Decision by the Sponsor|4|||
16407726|NCT00856206|39973290|FG001|Overall Study|Decision by the Sponsor|8|||
16407727|NCT00856206|39973289|FG000|Overall Study|Other than specified above|3|||
16407728|NCT00856206|39973290|FG001|Overall Study|Other than specified above|10|||
16407729|NCT00683917|39973291|FG000|Overall Study|Study prematurely terminated|10|||
16407730|NCT00107315|39973292|FG000|Overall Study|Disease Progression|9|||
16407731|NCT00107315|39973292|FG000|Overall Study|Adverse Event|4|||
16407732|NCT00107315|39973292|FG000|Overall Study|Withdrawal by Subject|2|||
16407733|NCT02437305|39973293|FG000|Overall Study|Lost to Follow-up|18|||
16407734|NCT02437305|39973294|FG001|Overall Study|Lost to Follow-up|12|||
16407735|NCT02251717|39973295|FG000|Overall Study|Adverse Event|0|||
16407736|NCT02251717|39973296|FG001|Overall Study|Adverse Event|1|||
16407737|NCT02251717|39973295|FG000|Overall Study|Withdrew Consent|1|||
16407738|NCT02251717|39973296|FG001|Overall Study|Withdrew Consent|0|||
16407739|NCT02813668|39973297|FG000|Overall Study|Death|4|||
16407740|NCT02813668|39973297|FG000|Overall Study|Lost to Follow-up|509|||
16407741|NCT02813668|39973297|FG000|Overall Study|Withdrawal by Subject|148|||
16407742|NCT02813668|39973297|FG000|Overall Study|No longer at worksite|85|||
16407743|NCT02813668|39973297|FG000|Overall Study|Medical reasons not related to the study|4|||
16407744|NCT04612842|39973300|FG000|Overall Study|Lost to Follow-up|20|||
16407745|NCT04612842|39973301|FG001|Overall Study|Lost to Follow-up|11|||
16407746|NCT04612842|39973300|FG000|Overall Study|Withdrawal by Subject|26|||
16407747|NCT04612842|39973301|FG001|Overall Study|Withdrawal by Subject|15|||
16407748|NCT04612842|39973300|FG000|Overall Study|Death|2|||
16407749|NCT04612842|39973301|FG001|Overall Study|Death|2|||
16407750|NCT02046174|39973306|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
16407751|NCT02046174|39973307|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
16407752|NCT03703817|39973310|FG000|Overall Study|Not meeting eligibility criteria|7|||
16407753|NCT03703817|39973311|FG001|Overall Study|Not meeting eligibility criteria|4|||
16407754|NCT03362931|39973312|FG000|Overall Study|Adverse Event|1|||
16407755|NCT03362931|39973312|FG000|Overall Study|Death|2|||
16407756|NCT02141490|39973326|FG000|Overall Study|Screening failures|4|||
16407757|NCT02141490|39973327|FG001|Overall Study|Screening failures|0|||
16407758|NCT02141490|39973328|FG002|Overall Study|Screening failures|0|||
16407759|NCT01149486|39973329|FG000|First Intervention|Adverse Event|0|||
16109942|NCT02484547|38889200|FG002|Placebo-Controlled Period|Adverse Event|20|||
16407760|NCT01149486|39973330|FG001|First Intervention|Adverse Event|1|||
16407761|NCT01655381|39973332|FG000|Overall Study|Investigator Decision|1|||
16407762|NCT01655381|39973332|FG000|Overall Study|Moved to Another City|1|||
16407763|NCT01655381|39973332|FG000|Overall Study|Insufficient Treatment Response|1|||
16407764|NCT04143217|39973333|FG000|Overall Study|Withdrawal by Subject|42|||
16407765|NCT04143217|39973333|FG000|Overall Study|Adverse Event|29|||
16407766|NCT04143217|39973333|FG000|Overall Study|Lost to Follow-up|29|||
16407767|NCT04143217|39973333|FG000|Overall Study|Lack of Efficacy|15|||
16407768|NCT04143217|39973333|FG000|Overall Study|Physician Decision|1|||
16407769|NCT04143217|39973333|FG000|Overall Study|Non-Compliance With Study Drug|6|||
16407770|NCT04143217|39973333|FG000|Overall Study|Other, Multiple Categories|11|||
16407771|NCT01691014|39973334|FG000|Overall Study|Premature Termination|1|||
16109943|NCT02484547|38889201|FG003|Placebo-Controlled Period|Adverse Event|0|||
16109944|NCT02484547|38889202|FG004|Placebo-Controlled Period|Adverse Event|0|||
16109945|NCT02484547|38889203|FG005|Placebo-Controlled Period|Adverse Event|0|||
16109946|NCT02484547|38889204|FG006|Placebo-Controlled Period|Adverse Event|0|||
16109947|NCT02484547|38889198|FG000|Placebo-Controlled Period|Change of Treatment|0|||
16109948|NCT02484547|38889199|FG001|Placebo-Controlled Period|Change of Treatment|0|||
16109949|NCT02484547|38889200|FG002|Placebo-Controlled Period|Change of Treatment|1|||
16109950|NCT02484547|38889201|FG003|Placebo-Controlled Period|Change of Treatment|0|||
16109951|NCT02484547|38889202|FG004|Placebo-Controlled Period|Change of Treatment|0|||
16109952|NCT02484547|38889203|FG005|Placebo-Controlled Period|Change of Treatment|0|||
16109953|NCT02484547|38889204|FG006|Placebo-Controlled Period|Change of Treatment|0|||
16109954|NCT02484547|38889198|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
16109955|NCT02484547|38889199|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
16407772|NCT01691014|39973335|FG001|Overall Study|Premature Termination|6|||
16407773|NCT01691014|39973336|FG002|Overall Study|Premature Termination|0|||
16407774|NCT01691014|39973337|FG003|Overall Study|Premature Termination|3|||
16407775|NCT01691014|39973334|FG000|Overall Study|Other|0|||
16407776|NCT01691014|39973335|FG001|Overall Study|Other|0|||
16407777|NCT01691014|39973336|FG002|Overall Study|Other|2|||
16407778|NCT01691014|39973337|FG003|Overall Study|Other|0|||
16407779|NCT01691014|39973334|FG000|Overall Study|Withdrawal by Subject|0|||
16407780|NCT01691014|39973335|FG001|Overall Study|Withdrawal by Subject|1|||
16407781|NCT01691014|39973336|FG002|Overall Study|Withdrawal by Subject|1|||
16407782|NCT01691014|39973337|FG003|Overall Study|Withdrawal by Subject|1|||
16407783|NCT01691014|39973334|FG000|Overall Study|Adverse Event|0|||
16407784|NCT01691014|39973335|FG001|Overall Study|Adverse Event|5|||
16407785|NCT01691014|39973336|FG002|Overall Study|Adverse Event|1|||
16407786|NCT01691014|39973337|FG003|Overall Study|Adverse Event|1|||
16407787|NCT01691014|39973334|FG000|Overall Study|Lack of Efficacy|2|||
16407788|NCT01691014|39973335|FG001|Overall Study|Lack of Efficacy|3|||
16407789|NCT01691014|39973336|FG002|Overall Study|Lack of Efficacy|7|||
16407790|NCT01691014|39973337|FG003|Overall Study|Lack of Efficacy|0|||
16407791|NCT03554772|39973338|FG000|Overall Study|Lost to Follow-up|0|||
16407792|NCT03554772|39973339|FG001|Overall Study|Lost to Follow-up|0|||
16109956|NCT02484547|38889200|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
16109957|NCT02484547|38889201|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
16109958|NCT02484547|38889202|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
16109959|NCT02484547|38889203|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
16407793|NCT03554772|39973340|FG002|Overall Study|Lost to Follow-up|0|||
16407794|NCT03554772|39973341|FG003|Overall Study|Lost to Follow-up|2|||
16407795|NCT00330928|39973345|FG000|Overall Study|Lost to Follow-up|6|||
16407796|NCT00330928|39973345|FG000|Overall Study|Physician Decision|9|||
16221162|NCT02795182|39290574|FG001|Overall Study|Lost to Follow-up|0|||
16221163|NCT02795182|39290575|FG002|Overall Study|Lost to Follow-up|1|||
16221164|NCT02795182|39290576|FG003|Overall Study|Lost to Follow-up|1|||
16221165|NCT02795182|39290573|FG000|Overall Study|Roll Over to Long Term Extension|3|||
16221166|NCT02795182|39290574|FG001|Overall Study|Roll Over to Long Term Extension|3|||
16221167|NCT02795182|39290575|FG002|Overall Study|Roll Over to Long Term Extension|2|||
16221168|NCT02795182|39290576|FG003|Overall Study|Roll Over to Long Term Extension|5|||
16221169|NCT02795182|39290573|FG000|Overall Study|Progressive Disease|0|||
16221170|NCT02795182|39290574|FG001|Overall Study|Progressive Disease|1|||
16221171|NCT02795182|39290575|FG002|Overall Study|Progressive Disease|0|||
16221172|NCT02795182|39290576|FG003|Overall Study|Progressive Disease|4|||
16407797|NCT00330928|39973345|FG000|Overall Study|Death|1|||
16407798|NCT00330928|39973345|FG000|Overall Study|IVUS could not be performed.|1|||
16407799|NCT00623545|39973346|FG000|Overall Study|Adverse Event|6|||
16407800|NCT00623545|39973346|FG000|Overall Study|Withdrawal by Subject|4|||
16407801|NCT02981407|39973347|FG000|Overall Study|Withdrawal by Subject|2|||
16543747|NCT00944125|40453750|FG001|3 to 6 Months|Withdrawal by Subject|2|||
16543748|NCT00944125|40453749|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
16407802|NCT02981407|39973348|FG001|Overall Study|Withdrawal by Subject|0|||
16407803|NCT00591149|39973360|FG000|Overall Study|Adverse Event|4|||
16407804|NCT00591149|39973360|FG000|Overall Study|Withdrawal by Subject|1|||
16407805|NCT01958021|39973361|FG000|Overall Study|Progressive disease|87|||
16407806|NCT01958021|39973362|FG001|Overall Study|Progressive disease|146|||
16407807|NCT01958021|39973361|FG000|Overall Study|Adverse Event|25|||
16407808|NCT01958021|39973362|FG001|Overall Study|Adverse Event|7|||
16407809|NCT01958021|39973361|FG000|Overall Study|Subject/guardian decision|12|||
16407810|NCT01958021|39973362|FG001|Overall Study|Subject/guardian decision|13|||
16407811|NCT01958021|39973361|FG000|Overall Study|Physician Decision|10|||
16543749|NCT00944125|40453750|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
16543750|NCT03595332|40453751|FG000|Overall Study|Lost to Follow-up|16|||
16543751|NCT03595332|40453752|FG001|Overall Study|Lost to Follow-up|22|||
16543752|NCT03595332|40453751|FG000|Overall Study|Unable to retrieve ID from school|0|||
16543753|NCT03595332|40453752|FG001|Overall Study|Unable to retrieve ID from school|2|||
16543754|NCT02634788|40453755|FG000|Overall Study|Adverse Event|0|||
16543755|NCT02634788|40453756|FG001|Overall Study|Adverse Event|8|||
16543756|NCT02634788|40453757|FG002|Overall Study|Adverse Event|3|||
16543757|NCT02634788|40453758|FG003|Overall Study|Adverse Event|1|||
16543758|NCT02634788|40453755|FG000|Overall Study|Lack of Efficacy|4|||
16543759|NCT02634788|40453756|FG001|Overall Study|Lack of Efficacy|0|||
16543760|NCT02634788|40453757|FG002|Overall Study|Lack of Efficacy|1|||
16543761|NCT02634788|40453758|FG003|Overall Study|Lack of Efficacy|4|||
16543762|NCT02634788|40453755|FG000|Overall Study|Lost to Follow-up|0|||
16543763|NCT02634788|40453756|FG001|Overall Study|Lost to Follow-up|1|||
16543764|NCT02634788|40453757|FG002|Overall Study|Lost to Follow-up|0|||
16543765|NCT02634788|40453758|FG003|Overall Study|Lost to Follow-up|0|||
16543766|NCT02634788|40453755|FG000|Overall Study|Withdrawal by Subject|0|||
16543767|NCT02634788|40453756|FG001|Overall Study|Withdrawal by Subject|1|||
16543768|NCT02634788|40453757|FG002|Overall Study|Withdrawal by Subject|1|||
16543769|NCT02634788|40453758|FG003|Overall Study|Withdrawal by Subject|0|||
16543770|NCT03988634|40453759|FG000|Double-Blind|Adverse Event|4|||
16543771|NCT03988634|40453760|FG001|Double-Blind|Adverse Event|0|||
16543772|NCT03988634|40453761|FG002|Double-Blind|Adverse Event|0|||
16543773|NCT03988634|40453759|FG000|Double-Blind|Death|18|||
16543774|NCT03988634|40453760|FG001|Double-Blind|Death|26|||
16543775|NCT03988634|40453761|FG002|Double-Blind|Death|0|||
16543776|NCT03988634|40453759|FG000|Double-Blind|Lost to Follow-up|6|||
16543777|NCT03988634|40453760|FG001|Double-Blind|Lost to Follow-up|7|||
16543778|NCT03988634|40453761|FG002|Double-Blind|Lost to Follow-up|0|||
16543779|NCT03988634|40453759|FG000|Double-Blind|Physician Decision|9|||
16543780|NCT03988634|40453760|FG001|Double-Blind|Physician Decision|5|||
16543781|NCT03988634|40453761|FG002|Double-Blind|Physician Decision|0|||
16543782|NCT03988634|40453759|FG000|Double-Blind|Subject decision|24|||
16543783|NCT03988634|40453760|FG001|Double-Blind|Subject decision|13|||
16221173|NCT02795182|39290573|FG000|Overall Study|Physician Decision|0|||
16221174|NCT02795182|39290574|FG001|Overall Study|Physician Decision|0|||
16221175|NCT02795182|39290575|FG002|Overall Study|Physician Decision|0|||
16407812|NCT01958021|39973362|FG001|Overall Study|Physician Decision|13|||
16407813|NCT01958021|39973361|FG000|Overall Study|Protocol Violation|3|||
16407814|NCT01958021|39973362|FG001|Overall Study|Protocol Violation|1|||
16543784|NCT03988634|40453761|FG002|Double-Blind|Subject decision|0|||
16543785|NCT03988634|40453759|FG000|Open-Label|Adverse Event|0|||
16543786|NCT03988634|40453760|FG001|Open-Label|Adverse Event|0|||
16543787|NCT03988634|40453761|FG002|Open-Label|Adverse Event|7|||
16543788|NCT03988634|40453759|FG000|Open-Label|Physician Decision|0|||
16109960|NCT02484547|38889204|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
16109961|NCT02484547|38889198|FG000|Placebo-Controlled Period|Death|5|||
16109962|NCT02484547|38889199|FG001|Placebo-Controlled Period|Death|0|||
16109963|NCT02484547|38889200|FG002|Placebo-Controlled Period|Death|6|||
16109964|NCT02484547|38889201|FG003|Placebo-Controlled Period|Death|0|||
16109965|NCT02484547|38889202|FG004|Placebo-Controlled Period|Death|0|||
16109966|NCT02484547|38889203|FG005|Placebo-Controlled Period|Death|0|||
16109967|NCT02484547|38889204|FG006|Placebo-Controlled Period|Death|0|||
16109968|NCT02484547|38889198|FG000|Placebo-Controlled Period|Disease Progression|2|||
16109969|NCT02484547|38889199|FG001|Placebo-Controlled Period|Disease Progression|0|||
16109970|NCT02484547|38889200|FG002|Placebo-Controlled Period|Disease Progression|1|||
16109971|NCT02484547|38889201|FG003|Placebo-Controlled Period|Disease Progression|0|||
16109972|NCT02484547|38889202|FG004|Placebo-Controlled Period|Disease Progression|0|||
16109973|NCT02484547|38889203|FG005|Placebo-Controlled Period|Disease Progression|0|||
16109974|NCT02484547|38889204|FG006|Placebo-Controlled Period|Disease Progression|0|||
16109975|NCT02484547|38889198|FG000|Placebo-Controlled Period|Investigator Decision|2|||
16109976|NCT02484547|38889199|FG001|Placebo-Controlled Period|Investigator Decision|2|||
16109977|NCT02484547|38889200|FG002|Placebo-Controlled Period|Investigator Decision|5|||
16109978|NCT02484547|38889201|FG003|Placebo-Controlled Period|Investigator Decision|0|||
16109979|NCT02484547|38889202|FG004|Placebo-Controlled Period|Investigator Decision|0|||
16109980|NCT02484547|38889203|FG005|Placebo-Controlled Period|Investigator Decision|0|||
16109981|NCT02484547|38889204|FG006|Placebo-Controlled Period|Investigator Decision|0|||
16109982|NCT02484547|38889198|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
16109983|NCT02484547|38889199|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
16109984|NCT02484547|38889200|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
16109985|NCT02484547|38889201|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
16109986|NCT02484547|38889202|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
16109987|NCT02484547|38889203|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
16109988|NCT02484547|38889204|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
16109989|NCT02484547|38889198|FG000|Placebo-Controlled Period|Relocation|1|||
16109990|NCT02484547|38889199|FG001|Placebo-Controlled Period|Relocation|1|||
16109991|NCT02484547|38889200|FG002|Placebo-Controlled Period|Relocation|1|||
16109992|NCT02484547|38889201|FG003|Placebo-Controlled Period|Relocation|0|||
16109993|NCT02484547|38889202|FG004|Placebo-Controlled Period|Relocation|0|||
16109994|NCT02484547|38889203|FG005|Placebo-Controlled Period|Relocation|0|||
16109995|NCT02484547|38889204|FG006|Placebo-Controlled Period|Relocation|0|||
16109996|NCT02484547|38889198|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
16109997|NCT02484547|38889199|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
16109998|NCT02484547|38889200|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
16109999|NCT02484547|38889201|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
16110000|NCT02484547|38889202|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
16110001|NCT02484547|38889203|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
16110002|NCT02484547|38889204|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
16110003|NCT02484547|38889198|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
16110004|NCT02484547|38889199|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
16110005|NCT02484547|38889200|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
16110006|NCT02484547|38889201|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16110007|NCT02484547|38889202|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16110008|NCT02484547|38889203|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16110009|NCT02484547|38889204|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16543789|NCT03988634|40453760|FG001|Open-Label|Physician Decision|0|||
16543790|NCT03988634|40453761|FG002|Open-Label|Physician Decision|1|||
16543791|NCT03988634|40453759|FG000|Open-Label|Technical problems|0|||
16543792|NCT03988634|40453760|FG001|Open-Label|Technical problems|0|||
16543793|NCT03988634|40453761|FG002|Open-Label|Technical problems|1|||
16543794|NCT03576768|40453762|FG000|Overall Study|Lost to Follow-up|3|||
16543795|NCT03576768|40453763|FG001|Overall Study|Lost to Follow-up|3|||
16543796|NCT03576768|40453764|FG002|Overall Study|Lost to Follow-up|0|||
16543797|NCT03576768|40453765|FG003|Overall Study|Lost to Follow-up|0|||
16543798|NCT04074590|40453766|FG000|Overall Study|Adverse Event|1|||
16543799|NCT04074590|40453767|FG001|Overall Study|Adverse Event|0|||
16543800|NCT04074590|40453766|FG000|Overall Study|Physician Decision|1|||
16543801|NCT04074590|40453767|FG001|Overall Study|Physician Decision|0|||
16543802|NCT04074590|40453766|FG000|Overall Study|Withdrawal by Subject|2|||
16543803|NCT04074590|40453767|FG001|Overall Study|Withdrawal by Subject|0|||
16543804|NCT03078816|40453769|FG000|Overall Study|Withdrawal by Subject|1|||
16543805|NCT00420199|40453772|FG000|Overall Study|Participant no longer met study criteria|1|||
16543806|NCT00420199|40453773|FG001|Overall Study|Participant no longer met study criteria|0|||
16543807|NCT04179721|40453774|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
16543808|NCT04179721|40453775|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
16543809|NCT04179721|40453774|FG000|Overall Study|Lost to Follow-up|0|||
16543810|NCT04179721|40453775|FG001|Overall Study|Lost to Follow-up|1|||
16543811|NCT02940574|40453778|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
16543812|NCT02940574|40453779|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
16543813|NCT02940574|40453778|FG000|1-year Follow-up|Lost to Follow-up|3|||
16543814|NCT02940574|40453779|FG001|1-year Follow-up|Lost to Follow-up|4|||
16543815|NCT01875185|40453785|FG000|Overall Study|study was terminated|52|||
16543816|NCT01875185|40453786|FG001|Overall Study|study was terminated|48|||
16543817|NCT01648270|40453787|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
16543818|NCT00985985|40453788|FG000|Overall Study|Adverse Event|4|||
16543819|NCT00985985|40453789|FG001|Overall Study|Adverse Event|2|||
16543820|NCT00985985|40453790|FG002|Overall Study|Adverse Event|2|||
16543821|NCT00985985|40453791|FG003|Overall Study|Adverse Event|2|||
16543822|NCT00985985|40453788|FG000|Overall Study|Lost to Follow-up|4|||
16543823|NCT00985985|40453789|FG001|Overall Study|Lost to Follow-up|11|||
16543824|NCT00985985|40453790|FG002|Overall Study|Lost to Follow-up|2|||
16543825|NCT00985985|40453791|FG003|Overall Study|Lost to Follow-up|3|||
16543826|NCT00985985|40453788|FG000|Overall Study|Protocol Violation|1|||
16543827|NCT00985985|40453789|FG001|Overall Study|Protocol Violation|2|||
16543828|NCT00985985|40453790|FG002|Overall Study|Protocol Violation|0|||
16543829|NCT00985985|40453791|FG003|Overall Study|Protocol Violation|1|||
16407815|NCT01958021|39973361|FG000|Overall Study|Death|2|||
16407816|NCT01958021|39973362|FG001|Overall Study|Death|0|||
16407817|NCT01166958|39973363|FG000|Overall Study|Withdrawal by Subject|1|||
16407818|NCT01166958|39973364|FG001|Overall Study|Withdrawal by Subject|0|||
16407819|NCT01765426|39973365|FG000|Overall Study|Lost to Follow-up|0|||
16407820|NCT01765426|39973366|FG001|Overall Study|Lost to Follow-up|1|||
16407821|NCT01765426|39973367|FG002|Overall Study|Lost to Follow-up|0|||
16407822|NCT01765426|39973368|FG003|Overall Study|Lost to Follow-up|0|||
16407823|NCT01967823|39973373|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
16407824|NCT01669421|39973381|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
16407825|NCT01669421|39973381|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
16407826|NCT00789581|39973382|FG000|AC Therapy|Adverse Event|2|||
16407827|NCT00789581|39973383|FG001|AC Therapy|Adverse Event|3|||
16543830|NCT00985985|40453788|FG000|Overall Study|Lack of Efficacy|5|||
16543831|NCT00985985|40453789|FG001|Overall Study|Lack of Efficacy|6|||
16543832|NCT00985985|40453790|FG002|Overall Study|Lack of Efficacy|1|||
16543833|NCT00985985|40453791|FG003|Overall Study|Lack of Efficacy|3|||
16407828|NCT00789581|39973382|FG000|AC Therapy|Withdrawal by Subject|4|||
16407829|NCT00789581|39973383|FG001|AC Therapy|Withdrawal by Subject|7|||
16407830|NCT00789581|39973382|FG000|AC Therapy|Disease recurrence|3|||
16407831|NCT00789581|39973383|FG001|AC Therapy|Disease recurrence|1|||
16407832|NCT00789581|39973382|FG000|AC Therapy|Intercurrent Illness|1|||
16407833|NCT00789581|39973383|FG001|AC Therapy|Intercurrent Illness|0|||
16407834|NCT00789581|39973382|FG000|AC Therapy|Never Treated|1|||
16407835|NCT00789581|39973383|FG001|AC Therapy|Never Treated|4|||
16407836|NCT00789581|39973382|FG000|AC Therapy|Other|0|||
16407837|NCT00789581|39973383|FG001|AC Therapy|Other|2|||
16543834|NCT00985985|40453788|FG000|Overall Study|Withdrawal by Subject|4|||
16543835|NCT00985985|40453789|FG001|Overall Study|Withdrawal by Subject|2|||
16543836|NCT00985985|40453790|FG002|Overall Study|Withdrawal by Subject|2|||
16407838|NCT00789581|39973382|FG000|Adjuvant Therapy|Never treated|2|||
16407839|NCT00789581|39973383|FG001|Adjuvant Therapy|Never treated|2|||
16407840|NCT00789581|39973382|FG000|Adjuvant Therapy|Adverse Event|20|||
16407841|NCT00789581|39973383|FG001|Adjuvant Therapy|Adverse Event|44|||
16407842|NCT00789581|39973382|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
16407843|NCT00789581|39973383|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
16343602|NCT01371981|39744512|FG004|Overall Study|Physician Decision|14|||
16343603|NCT01371981|39744513|FG005|Overall Study|Physician Decision|3|||
16343604|NCT01371981|39744508|FG000|Overall Study|Withdrawal by Subject|12|||
16343605|NCT01371981|39744509|FG001|Overall Study|Withdrawal by Subject|19|||
16343606|NCT01371981|39744510|FG002|Overall Study|Withdrawal by Subject|1|||
16343607|NCT01371981|39744511|FG003|Overall Study|Withdrawal by Subject|2|||
16343608|NCT01371981|39744512|FG004|Overall Study|Withdrawal by Subject|10|||
16343609|NCT01371981|39744513|FG005|Overall Study|Withdrawal by Subject|3|||
16343610|NCT01371981|39744508|FG000|Overall Study|Ineligible|19|||
16343611|NCT01371981|39744509|FG001|Overall Study|Ineligible|13|||
16343612|NCT01371981|39744510|FG002|Overall Study|Ineligible|0|||
16343613|NCT01371981|39744511|FG003|Overall Study|Ineligible|0|||
16343614|NCT01371981|39744512|FG004|Overall Study|Ineligible|0|||
16343615|NCT01371981|39744513|FG005|Overall Study|Ineligible|4|||
16343616|NCT01371981|39744508|FG000|Overall Study|Did not start treatment|2|||
16343617|NCT01371981|39744509|FG001|Overall Study|Did not start treatment|3|||
16343618|NCT01371981|39744510|FG002|Overall Study|Did not start treatment|0|||
16343619|NCT01371981|39744511|FG003|Overall Study|Did not start treatment|0|||
16343620|NCT01371981|39744512|FG004|Overall Study|Did not start treatment|0|||
16343621|NCT01371981|39744513|FG005|Overall Study|Did not start treatment|2|||
16343622|NCT03060291|39744514|FG000|3-month Follow-up|Declined to respond|8|||
16221176|NCT02795182|39290576|FG003|Overall Study|Physician Decision|1|||
16343623|NCT03060291|39744515|FG001|3-month Follow-up|Declined to respond|10|||
16407844|NCT00789581|39973382|FG000|Adjuvant Therapy|Disease recurrence|2|||
16407845|NCT00789581|39973383|FG001|Adjuvant Therapy|Disease recurrence|1|||
16407846|NCT00789581|39973382|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
16407847|NCT00789581|39973383|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
16407848|NCT00789581|39973382|FG000|Adjuvant Therapy|Protocol Violation|1|||
16407849|NCT00789581|39973383|FG001|Adjuvant Therapy|Protocol Violation|1|||
16407850|NCT00789581|39973382|FG000|Adjuvant Therapy|Other|0|||
16407851|NCT00789581|39973383|FG001|Adjuvant Therapy|Other|1|||
16407852|NCT01371643|39973387|FG000|Overall Study|Withdrawal by Subject|3|||
16407853|NCT01371643|39973388|FG001|Overall Study|Withdrawal by Subject|0|||
16407854|NCT03664674|39973389|FG000|Overall Study|Adverse Event|1|||
16407855|NCT03664674|39973390|FG001|Overall Study|Adverse Event|1|||
16407856|NCT03664674|39973389|FG000|Overall Study|Physician Decision|0|||
16407857|NCT03664674|39973390|FG001|Overall Study|Physician Decision|1|||
16407858|NCT03664674|39973389|FG000|Overall Study|Withdrawal by Subject|2|||
16407859|NCT03664674|39973390|FG001|Overall Study|Withdrawal by Subject|0|||
16407860|NCT04209114|39973402|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
16407861|NCT04209114|39973403|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
16407862|NCT04209114|39973404|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
16407863|NCT04209114|39973402|FG000|Pre-Treatment Phase|Other reasons|0|||
16407864|NCT04209114|39973403|FG001|Pre-Treatment Phase|Other reasons|0|||
16407865|NCT04209114|39973404|FG002|Pre-Treatment Phase|Other reasons|1|||
16407866|NCT04209114|39973402|FG000|Pre-Treatment Phase|Death|0|||
16407867|NCT04209114|39973403|FG001|Pre-Treatment Phase|Death|0|||
16407868|NCT04209114|39973404|FG002|Pre-Treatment Phase|Death|1|||
16407869|NCT04209114|39973402|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
16407870|NCT04209114|39973403|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
16407871|NCT04209114|39973404|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
16407872|NCT04209114|39973402|FG000|Treatment Phase|Other reasons|5|||
16407873|NCT04209114|39973403|FG001|Treatment Phase|Other reasons|3|||
16407874|NCT04209114|39973404|FG002|Treatment Phase|Other reasons|0|||
16407875|NCT04209114|39973402|FG000|Treatment Phase|Lost to Follow-up|1|||
16407876|NCT04209114|39973403|FG001|Treatment Phase|Lost to Follow-up|0|||
16407877|NCT04209114|39973404|FG002|Treatment Phase|Lost to Follow-up|0|||
16407878|NCT04209114|39973402|FG000|Treatment Phase|Participant withdrew consent|1|||
16543837|NCT00985985|40453791|FG003|Overall Study|Withdrawal by Subject|2|||
16543838|NCT00985985|40453788|FG000|Overall Study|Other Reason|6|||
16543839|NCT00985985|40453789|FG001|Overall Study|Other Reason|1|||
16543840|NCT00985985|40453790|FG002|Overall Study|Other Reason|4|||
16543841|NCT00985985|40453791|FG003|Overall Study|Other Reason|2|||
16543842|NCT01287611|40453794|FG000|Overall Study|Lost to Follow-up|29|||
16543843|NCT01287611|40453795|FG001|Overall Study|Lost to Follow-up|16|||
16543844|NCT01287611|40453794|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
16543845|NCT01287611|40453795|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
16543846|NCT03645759|40453800|FG000|Overall Study|Lost to Follow-up|3|||
16543847|NCT03645759|40453801|FG001|Overall Study|Lost to Follow-up|2|||
16407879|NCT04209114|39973403|FG001|Treatment Phase|Participant withdrew consent|0|||
16407880|NCT04209114|39973404|FG002|Treatment Phase|Participant withdrew consent|0|||
16407881|NCT04209114|39973402|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
16407882|NCT04209114|39973403|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
16343624|NCT03060291|39744516|FG002|3-month Follow-up|Declined to respond|2|||
16343625|NCT03060291|39744514|FG000|6-month Follow-up|Declined to respond|7|||
16343626|NCT03060291|39744515|FG001|6-month Follow-up|Declined to respond|13|||
16343627|NCT03060291|39744516|FG002|6-month Follow-up|Declined to respond|4|||
16343628|NCT03060291|39744514|FG000|12-month Follow-up|Declined to respond|7|||
16343629|NCT03060291|39744515|FG001|12-month Follow-up|Declined to respond|16|||
16343630|NCT03060291|39744516|FG002|12-month Follow-up|Declined to respond|6|||
16343631|NCT02942277|39744517|FG000|Year 1|Withdrawal by Subject|0|||
16343632|NCT02942277|39744518|FG001|Year 1|Withdrawal by Subject|0|||
16343633|NCT02942277|39744519|FG002|Year 1|Withdrawal by Subject|0|||
16343634|NCT02942277|39744520|FG003|Year 1|Withdrawal by Subject|0|||
16343635|NCT02942277|39744521|FG004|Year 1|Withdrawal by Subject|1|||
16343636|NCT02942277|39744522|FG005|Year 1|Withdrawal by Subject|3|||
16343637|NCT02942277|39744523|FG006|Year 1|Withdrawal by Subject|0|||
16343638|NCT02942277|39744524|FG007|Year 1|Withdrawal by Subject|1|||
16343639|NCT02942277|39744525|FG008|Year 1|Withdrawal by Subject|0|||
16343640|NCT02942277|39744526|FG009|Year 1|Withdrawal by Subject|0|||
16343641|NCT02942277|39744527|FG010|Year 1|Withdrawal by Subject|3|||
16343642|NCT02942277|39744517|FG000|Year 1|Travel|0|||
16343643|NCT02942277|39744518|FG001|Year 1|Travel|1|||
16343644|NCT02942277|39744519|FG002|Year 1|Travel|0|||
16343645|NCT02942277|39744520|FG003|Year 1|Travel|0|||
16343646|NCT02942277|39744521|FG004|Year 1|Travel|4|||
16343647|NCT02942277|39744522|FG005|Year 1|Travel|5|||
16343648|NCT02942277|39744523|FG006|Year 1|Travel|0|||
16343649|NCT02942277|39744524|FG007|Year 1|Travel|0|||
16343650|NCT02942277|39744525|FG008|Year 1|Travel|0|||
16343651|NCT02942277|39744526|FG009|Year 1|Travel|0|||
16343652|NCT02942277|39744527|FG010|Year 1|Travel|8|||
16343653|NCT02942277|39744517|FG000|Year 1|Joined Army|0|||
16343654|NCT02942277|39744518|FG001|Year 1|Joined Army|1|||
16343655|NCT02942277|39744519|FG002|Year 1|Joined Army|0|||
16343656|NCT02942277|39744520|FG003|Year 1|Joined Army|0|||
16343657|NCT02942277|39744521|FG004|Year 1|Joined Army|0|||
16343658|NCT02942277|39744522|FG005|Year 1|Joined Army|0|||
16343659|NCT02942277|39744523|FG006|Year 1|Joined Army|0|||
16343660|NCT02942277|39744524|FG007|Year 1|Joined Army|0|||
16343661|NCT02942277|39744525|FG008|Year 1|Joined Army|0|||
16343662|NCT02942277|39744526|FG009|Year 1|Joined Army|0|||
16343663|NCT02942277|39744527|FG010|Year 1|Joined Army|0|||
16343664|NCT02942277|39744517|FG000|Year 1|Subject met withdrawal criteria|0|||
16343665|NCT02942277|39744518|FG001|Year 1|Subject met withdrawal criteria|0|||
16343666|NCT02942277|39744519|FG002|Year 1|Subject met withdrawal criteria|0|||
16343667|NCT02942277|39744520|FG003|Year 1|Subject met withdrawal criteria|1|||
16343668|NCT02942277|39744521|FG004|Year 1|Subject met withdrawal criteria|0|||
16343669|NCT02942277|39744522|FG005|Year 1|Subject met withdrawal criteria|0|||
16343670|NCT02942277|39744523|FG006|Year 1|Subject met withdrawal criteria|0|||
16343671|NCT02942277|39744524|FG007|Year 1|Subject met withdrawal criteria|0|||
16343672|NCT02942277|39744525|FG008|Year 1|Subject met withdrawal criteria|0|||
16343673|NCT02942277|39744526|FG009|Year 1|Subject met withdrawal criteria|0|||
16343674|NCT02942277|39744527|FG010|Year 1|Subject met withdrawal criteria|0|||
16343675|NCT02942277|39744517|FG000|Year 1|Lost to Follow-up|0|||
16343676|NCT02942277|39744518|FG001|Year 1|Lost to Follow-up|0|||
16343677|NCT02942277|39744519|FG002|Year 1|Lost to Follow-up|0|||
16343678|NCT02942277|39744520|FG003|Year 1|Lost to Follow-up|0|||
16343679|NCT02942277|39744521|FG004|Year 1|Lost to Follow-up|1|||
16343680|NCT02942277|39744522|FG005|Year 1|Lost to Follow-up|0|||
16343681|NCT02942277|39744523|FG006|Year 1|Lost to Follow-up|0|||
16343682|NCT02942277|39744524|FG007|Year 1|Lost to Follow-up|0|||
16343683|NCT02942277|39744525|FG008|Year 1|Lost to Follow-up|0|||
16343684|NCT02942277|39744526|FG009|Year 1|Lost to Follow-up|0|||
16343685|NCT02942277|39744527|FG010|Year 1|Lost to Follow-up|2|||
16343686|NCT02942277|39744517|FG000|Year 1|Protocol Violation|0|||
16343687|NCT02942277|39744518|FG001|Year 1|Protocol Violation|0|||
16343688|NCT02942277|39744519|FG002|Year 1|Protocol Violation|0|||
16343689|NCT02942277|39744520|FG003|Year 1|Protocol Violation|0|||
16343690|NCT02942277|39744521|FG004|Year 1|Protocol Violation|1|||
16343691|NCT02942277|39744522|FG005|Year 1|Protocol Violation|1|||
16343692|NCT02942277|39744523|FG006|Year 1|Protocol Violation|0|||
16343693|NCT02942277|39744524|FG007|Year 1|Protocol Violation|0|||
16343694|NCT02942277|39744525|FG008|Year 1|Protocol Violation|0|||
16343695|NCT02942277|39744526|FG009|Year 1|Protocol Violation|0|||
16343696|NCT02942277|39744527|FG010|Year 1|Protocol Violation|2|||
16543848|NCT01778556|40453806|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
16543849|NCT01778556|40453807|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
16543850|NCT01778556|40453806|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
16543851|NCT01778556|40453807|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
16543852|NCT01778556|40453806|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
16543853|NCT01778556|40453807|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
16543854|NCT01778556|40453806|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
16543855|NCT01778556|40453807|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
16543856|NCT03303469|40453808|FG000|Overall Study|Lost to Follow-up|2|||
16543857|NCT01125722|40453812|FG000|Overall Study|Withdrawal by Subject|2|||
16543858|NCT01125722|40453813|FG001|Overall Study|Withdrawal by Subject|1|||
16543859|NCT01125722|40453812|FG000|Overall Study|Lost to Follow-up|1|||
16543860|NCT01125722|40453813|FG001|Overall Study|Lost to Follow-up|0|||
16543861|NCT00691938|40453817|FG000|Overall Study|QTc prolongation|1|||
16543862|NCT00691938|40453818|FG001|Overall Study|QTc prolongation|0|||
16543863|NCT00691938|40453819|FG002|Overall Study|QTc prolongation|0|||
16543864|NCT00691938|40453820|FG003|Overall Study|QTc prolongation|0|||
16543865|NCT00691938|40453821|FG004|Overall Study|QTc prolongation|0|||
16543866|NCT00691938|40453822|FG005|Overall Study|QTc prolongation|0|||
16543867|NCT00691938|40453823|FG006|Overall Study|QTc prolongation|0|||
16543868|NCT01436201|40453826|FG000|Overall Study|Adverse Event|2|||
16543869|NCT01436201|40453826|FG000|Overall Study|Withdrawal by Subject|1|||
16543870|NCT01436201|40453826|FG000|Overall Study|Protocol Violation|1|||
16543871|NCT02991482|40453832|FG000|Overall Study|Disease progression|56|||
16543872|NCT02991482|40453833|FG001|Overall Study|Disease progression|47|||
16543873|NCT02991482|40453832|FG000|Overall Study|Death|4|||
16543874|NCT02991482|40453833|FG001|Overall Study|Death|4|||
16543875|NCT02991482|40453832|FG000|Overall Study|Adverse Event|1|||
16543876|NCT02991482|40453833|FG001|Overall Study|Adverse Event|6|||
16543877|NCT02991482|40453832|FG000|Overall Study|Patient decision|1|||
16543878|NCT02991482|40453833|FG001|Overall Study|Patient decision|1|||
16543879|NCT02991482|40453832|FG000|Overall Study|Physician Decision|0|||
16543880|NCT02991482|40453833|FG001|Overall Study|Physician Decision|6|||
16543881|NCT02991482|40453832|FG000|Overall Study|Clinical deterioration|1|||
16543882|NCT02991482|40453833|FG001|Overall Study|Clinical deterioration|0|||
16543883|NCT02991482|40453832|FG000|Overall Study|Patient feeling too unwell|1|||
16543884|NCT02991482|40453833|FG001|Overall Study|Patient feeling too unwell|0|||
16543885|NCT02991482|40453832|FG000|Overall Study|Worsening of performance status|0|||
16543886|NCT02991482|40453833|FG001|Overall Study|Worsening of performance status|1|||
16543887|NCT02991482|40453832|FG000|Overall Study|Death prior to study drug initiation|1|||
16543888|NCT02991482|40453833|FG001|Overall Study|Death prior to study drug initiation|0|||
16543889|NCT02991482|40453832|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
16543890|NCT02991482|40453833|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
16543891|NCT00404495|40453834|FG000|Overall Study|Death|37|||
16543892|NCT00404495|40453835|FG001|Overall Study|Death|11|||
16543893|NCT00404495|40453834|FG000|Overall Study|Lost to Follow-up|5|||
16543894|NCT00404495|40453835|FG001|Overall Study|Lost to Follow-up|0|||
16543895|NCT00404495|40453834|FG000|Overall Study|Other|1|||
16543896|NCT00404495|40453835|FG001|Overall Study|Other|0|||
16543897|NCT00404495|40453834|FG000|Overall Study|Withdrawal by Subject|1|||
16543898|NCT00404495|40453835|FG001|Overall Study|Withdrawal by Subject|0|||
16543899|NCT03040713|40453841|FG000|Overall Study|Positive amyloid scan|3|||
16543900|NCT01489189|40453845|FG000|Overall Study|Withdrawal by Subject|20|||
16543901|NCT01489189|40453846|FG001|Overall Study|Withdrawal by Subject|23|||
16543902|NCT01489189|40453845|FG000|Overall Study|Death|10|||
16543903|NCT01489189|40453846|FG001|Overall Study|Death|8|||
16543904|NCT01489189|40453845|FG000|Overall Study|Missed Visit|1|||
16543905|NCT01489189|40453846|FG001|Overall Study|Missed Visit|4|||
16543906|NCT01127646|40453847|FG000|Overall Study|Entry Criteria Not Met|1|||
16543907|NCT01127646|40453848|FG001|Overall Study|Entry Criteria Not Met|0|||
16543908|NCT01127646|40453847|FG000|Overall Study|Protocol Violation|0|||
16543909|NCT01127646|40453848|FG001|Overall Study|Protocol Violation|1|||
16543910|NCT03108157|40453849|FG000|Overall Study|Protocol Violation|15|||
16543911|NCT03108157|40453850|FG001|Overall Study|Protocol Violation|4|||
16543912|NCT01995539|40453851|FG000|Overall Study|Screening Failure|1|||
16543913|NCT01995539|40453851|FG000|Overall Study|Withdrawal by Investigator|15|||
16543914|NCT01995539|40453851|FG000|Overall Study|Withdrawal by Subject|11|||
16543915|NCT01995539|40453851|FG000|Overall Study|Lost to Follow-up|5|||
16543916|NCT01995539|40453851|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
16543917|NCT04225988|40453852|FG000|Overall Study|Withdrawal by Subject|2|||
16543918|NCT04225988|40453853|FG001|Overall Study|Withdrawal by Subject|0|||
16543919|NCT00215540|40453854|FG000|Overall Study|Withdrew from study medication|1|||
16543920|NCT00215540|40453855|FG001|Overall Study|Withdrew from study medication|0|||
16343697|NCT02942277|39744517|FG000|Year 1|Pregnancy|0|||
16343698|NCT02942277|39744518|FG001|Year 1|Pregnancy|0|||
16343699|NCT02942277|39744519|FG002|Year 1|Pregnancy|0|||
16343700|NCT02942277|39744520|FG003|Year 1|Pregnancy|0|||
16343701|NCT02942277|39744521|FG004|Year 1|Pregnancy|0|||
16343702|NCT02942277|39744522|FG005|Year 1|Pregnancy|1|||
16343703|NCT02942277|39744523|FG006|Year 1|Pregnancy|0|||
16343704|NCT02942277|39744524|FG007|Year 1|Pregnancy|0|||
16221177|NCT01854918|39290577|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
16343705|NCT02942277|39744525|FG008|Year 1|Pregnancy|0|||
16343706|NCT02942277|39744526|FG009|Year 1|Pregnancy|0|||
16343707|NCT02942277|39744527|FG010|Year 1|Pregnancy|0|||
16343708|NCT02942277|39744517|FG000|Year 2|Lost to Follow-up|0|||
16343709|NCT02942277|39744518|FG001|Year 2|Lost to Follow-up|0|||
16343710|NCT02942277|39744519|FG002|Year 2|Lost to Follow-up|0|||
16343711|NCT02942277|39744520|FG003|Year 2|Lost to Follow-up|0|||
16543921|NCT00215540|40453856|FG002|Overall Study|Withdrew from study medication|0|||
16543922|NCT00941798|40453857|FG000|Overall Study|Withdrawal by Subject|72|||
16543923|NCT00941798|40453858|FG001|Overall Study|Withdrawal by Subject|74|||
16543924|NCT00941798|40453857|FG000|Overall Study|Adverse Event|43|||
16543925|NCT00941798|40453858|FG001|Overall Study|Adverse Event|23|||
16543926|NCT00941798|40453857|FG000|Overall Study|Lost to Follow-up|29|||
16543927|NCT00941798|40453858|FG001|Overall Study|Lost to Follow-up|23|||
16543928|NCT00941798|40453857|FG000|Overall Study|Protocol Violation|17|||
16543929|NCT00941798|40453858|FG001|Overall Study|Protocol Violation|20|||
16543930|NCT00941798|40453857|FG000|Overall Study|Administrative problems|13|||
16543931|NCT00941798|40453858|FG001|Overall Study|Administrative problems|23|||
16543932|NCT00941798|40453857|FG000|Overall Study|Lack of Efficacy|10|||
16543933|NCT00941798|40453858|FG001|Overall Study|Lack of Efficacy|17|||
16543934|NCT00941798|40453857|FG000|Overall Study|Patient's inability to use device|6|||
16543935|NCT00941798|40453858|FG001|Overall Study|Patient's inability to use device|1|||
16543936|NCT00941798|40453857|FG000|Overall Study|Abnormal test procedure results|3|||
16343712|NCT02942277|39744521|FG004|Year 2|Lost to Follow-up|2|||
16343713|NCT02942277|39744522|FG005|Year 2|Lost to Follow-up|1|||
16343714|NCT02942277|39744523|FG006|Year 2|Lost to Follow-up|0|||
16343715|NCT02942277|39744524|FG007|Year 2|Lost to Follow-up|0|||
16343716|NCT02942277|39744525|FG008|Year 2|Lost to Follow-up|0|||
16343717|NCT02942277|39744526|FG009|Year 2|Lost to Follow-up|0|||
16343718|NCT02942277|39744527|FG010|Year 2|Lost to Follow-up|0|||
16543937|NCT00941798|40453858|FG001|Overall Study|Abnormal test procedure results|1|||
16343719|NCT02942277|39744517|FG000|Year 2|Did not rescreen|0|||
16343720|NCT02942277|39744518|FG001|Year 2|Did not rescreen|0|||
16343721|NCT02942277|39744519|FG002|Year 2|Did not rescreen|1|||
16343722|NCT02942277|39744520|FG003|Year 2|Did not rescreen|1|||
16343723|NCT02942277|39744521|FG004|Year 2|Did not rescreen|9|||
16343724|NCT02942277|39744522|FG005|Year 2|Did not rescreen|6|||
16343725|NCT02942277|39744523|FG006|Year 2|Did not rescreen|0|||
16343726|NCT02942277|39744524|FG007|Year 2|Did not rescreen|1|||
16343727|NCT02942277|39744525|FG008|Year 2|Did not rescreen|0|||
16343728|NCT02942277|39744526|FG009|Year 2|Did not rescreen|0|||
16343729|NCT02942277|39744527|FG010|Year 2|Did not rescreen|21|||
16343730|NCT02942277|39744517|FG000|Year 2|Met withdrawal criteria|0|||
16343731|NCT02942277|39744518|FG001|Year 2|Met withdrawal criteria|0|||
16343732|NCT02942277|39744519|FG002|Year 2|Met withdrawal criteria|0|||
16343733|NCT02942277|39744520|FG003|Year 2|Met withdrawal criteria|0|||
16343734|NCT02942277|39744521|FG004|Year 2|Met withdrawal criteria|1|||
16343735|NCT02942277|39744522|FG005|Year 2|Met withdrawal criteria|2|||
16343736|NCT02942277|39744523|FG006|Year 2|Met withdrawal criteria|0|||
16343737|NCT02942277|39744524|FG007|Year 2|Met withdrawal criteria|0|||
16343738|NCT02942277|39744525|FG008|Year 2|Met withdrawal criteria|0|||
16343739|NCT02942277|39744526|FG009|Year 2|Met withdrawal criteria|0|||
16343740|NCT02942277|39744527|FG010|Year 2|Met withdrawal criteria|1|||
16343741|NCT02942277|39744517|FG000|Year 2|Travel|0|||
16343742|NCT02942277|39744518|FG001|Year 2|Travel|1|||
16343743|NCT02942277|39744519|FG002|Year 2|Travel|0|||
16343744|NCT02942277|39744520|FG003|Year 2|Travel|0|||
16343745|NCT02942277|39744521|FG004|Year 2|Travel|0|||
16343746|NCT02942277|39744522|FG005|Year 2|Travel|1|||
16343747|NCT02942277|39744523|FG006|Year 2|Travel|0|||
16343748|NCT02942277|39744524|FG007|Year 2|Travel|0|||
16343749|NCT02942277|39744525|FG008|Year 2|Travel|0|||
16343750|NCT02942277|39744526|FG009|Year 2|Travel|1|||
16343751|NCT02942277|39744527|FG010|Year 2|Travel|3|||
16343752|NCT02942277|39744517|FG000|Year 2|Non-compliant|0|||
16343753|NCT02942277|39744518|FG001|Year 2|Non-compliant|0|||
16343754|NCT02942277|39744519|FG002|Year 2|Non-compliant|0|||
16343755|NCT02942277|39744520|FG003|Year 2|Non-compliant|0|||
16343756|NCT02942277|39744521|FG004|Year 2|Non-compliant|1|||
16343757|NCT02942277|39744522|FG005|Year 2|Non-compliant|1|||
16343758|NCT02942277|39744523|FG006|Year 2|Non-compliant|0|||
16343759|NCT02942277|39744524|FG007|Year 2|Non-compliant|0|||
16343760|NCT02942277|39744525|FG008|Year 2|Non-compliant|0|||
16343761|NCT02942277|39744526|FG009|Year 2|Non-compliant|0|||
16343762|NCT02942277|39744527|FG010|Year 2|Non-compliant|0|||
16343763|NCT02942277|39744517|FG000|Year 2|Withdrawal by Subject|0|||
16343764|NCT02942277|39744518|FG001|Year 2|Withdrawal by Subject|0|||
16343765|NCT02942277|39744519|FG002|Year 2|Withdrawal by Subject|0|||
16343766|NCT02942277|39744520|FG003|Year 2|Withdrawal by Subject|0|||
16343767|NCT02942277|39744521|FG004|Year 2|Withdrawal by Subject|0|||
16343768|NCT02942277|39744522|FG005|Year 2|Withdrawal by Subject|0|||
16343769|NCT02942277|39744523|FG006|Year 2|Withdrawal by Subject|1|||
16343770|NCT02942277|39744524|FG007|Year 2|Withdrawal by Subject|0|||
16343771|NCT02942277|39744525|FG008|Year 2|Withdrawal by Subject|0|||
16343772|NCT02942277|39744526|FG009|Year 2|Withdrawal by Subject|0|||
16343773|NCT02942277|39744527|FG010|Year 2|Withdrawal by Subject|0|||
16343774|NCT03076996|39744536|FG000|Overall Study|Withdrawal by Subject|2|||
16343775|NCT03076996|39744536|FG000|Overall Study|Lost to Follow-up|3|||
16343776|NCT03076996|39744536|FG000|Overall Study|Literacy precluded participation|1|||
16343777|NCT00873730|39744538|FG000|Overall Study|Protocol Deviation|5|||
16343778|NCT00873730|39744539|FG001|Overall Study|Protocol Deviation|2|||
16343779|NCT00873730|39744538|FG000|Overall Study|Adverse Event|0|||
16343780|NCT00873730|39744539|FG001|Overall Study|Adverse Event|2|||
16343781|NCT00873730|39744538|FG000|Overall Study|Withdrawal by Subject|0|||
16343782|NCT00873730|39744539|FG001|Overall Study|Withdrawal by Subject|1|||
16343783|NCT00873730|39744538|FG000|Overall Study|Sponsor decision|1|||
16343784|NCT00873730|39744539|FG001|Overall Study|Sponsor decision|0|||
16343785|NCT00960804|39744540|FG000|Overall Study|Adverse Event|1|||
16343786|NCT00960804|39744541|FG001|Overall Study|Adverse Event|0|||
16343787|NCT00960804|39744542|FG002|Overall Study|Adverse Event|0|||
16343788|NCT00960804|39744540|FG000|Overall Study|Withdrawal by Subject|1|||
16343789|NCT00960804|39744541|FG001|Overall Study|Withdrawal by Subject|0|||
16343790|NCT00960804|39744542|FG002|Overall Study|Withdrawal by Subject|0|||
16343791|NCT00960804|39744540|FG000|Overall Study|Study terminated by the sponsor|5|||
16343792|NCT00960804|39744541|FG001|Overall Study|Study terminated by the sponsor|4|||
16343793|NCT00960804|39744542|FG002|Overall Study|Study terminated by the sponsor|10|||
16343794|NCT01081626|39744543|FG000|Overall Study|Dosing error|1|||
16343795|NCT01081626|39744544|FG001|Overall Study|Dosing error|1|||
16343796|NCT01081626|39744543|FG000|Overall Study|Missing Estradiol|25|||
16343797|NCT01081626|39744544|FG001|Overall Study|Missing Estradiol|28|||
16343798|NCT01081626|39744543|FG000|Overall Study|Low antral follicle count|1|||
16343799|NCT01081626|39744544|FG001|Overall Study|Low antral follicle count|0|||
16343800|NCT01081626|39744543|FG000|Overall Study|Overstimulation|0|||
16343801|NCT01081626|39744544|FG001|Overall Study|Overstimulation|1|||
16343802|NCT01081626|39744543|FG000|Overall Study|Lost to Follow-up|0|||
16343803|NCT01081626|39744544|FG001|Overall Study|Lost to Follow-up|1|||
16343804|NCT01081626|39744543|FG000|Overall Study|Other|33|||
16343805|NCT01081626|39744544|FG001|Overall Study|Other|30|||
16343806|NCT04854057|39744550|FG000|Overall Study|Adverse Event|0|||
16343807|NCT04854057|39744551|FG001|Overall Study|Adverse Event|1|||
16343808|NCT01462110|39744555|FG000|Overall Study|Adverse Event|1|||
16343809|NCT01462110|39744556|FG001|Overall Study|Adverse Event|0|||
16343810|NCT04501952|39744557|FG000|Overall Study|Adverse Event|0|||
16343811|NCT04501952|39744558|FG001|Overall Study|Adverse Event|3|||
16343812|NCT04501952|39744557|FG000|Overall Study|Investigator's Discretion|0|||
16343813|NCT04501952|39744558|FG001|Overall Study|Investigator's Discretion|1|||
16343814|NCT04501952|39744557|FG000|Overall Study|Protocol Violation|1|||
16343815|NCT04501952|39744558|FG001|Overall Study|Protocol Violation|1|||
16343816|NCT04501952|39744557|FG000|Overall Study|Withdrew Consent|5|||
16343817|NCT04501952|39744558|FG001|Overall Study|Withdrew Consent|4|||
16343818|NCT04501952|39744557|FG000|Overall Study|Lost to Follow-up|7|||
16343819|NCT04501952|39744558|FG001|Overall Study|Lost to Follow-up|2|||
16343820|NCT04501952|39744557|FG000|Overall Study|Randomized and Never Treated|13|||
16343821|NCT04501952|39744558|FG001|Overall Study|Randomized and Never Treated|9|||
16343822|NCT01381926|39744559|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
16343823|NCT01381926|39744560|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
16343824|NCT01381926|39744559|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
16343825|NCT01381926|39744560|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
16343826|NCT01937884|39744561|FG000|Overall Study|Withdrawal by Subject|1|||
16343827|NCT01937884|39744562|FG001|Overall Study|Withdrawal by Subject|0|||
16343828|NCT01951573|39744563|FG000|Washout Period|Adverse Event|0|||
16343829|NCT01951573|39744564|FG001|Washout Period|Adverse Event|1|||
16343830|NCT02732015|39744565|FG000|Overall Study|Lost to Follow-up|0|||
16343831|NCT02732015|39744566|FG001|Overall Study|Lost to Follow-up|1|||
16343832|NCT02819440|39744567|FG000|Overall Study|Adverse Event|3|||
16343833|NCT02819440|39744568|FG001|Overall Study|Adverse Event|1|||
16343834|NCT02819440|39744567|FG000|Overall Study|Lost to Follow-up|1|||
16343835|NCT02819440|39744568|FG001|Overall Study|Lost to Follow-up|3|||
16343836|NCT02819440|39744567|FG000|Overall Study|Withdrawal by Subject|9|||
16343837|NCT02819440|39744568|FG001|Overall Study|Withdrawal by Subject|8|||
16343838|NCT04888494|39744569|FG000|Overall Study|Lost to Follow-up|2|||
16343839|NCT04888494|39744570|FG001|Overall Study|Lost to Follow-up|3|||
16343840|NCT04888494|39744569|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
16343841|NCT04888494|39744570|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
16343842|NCT01447719|39744571|FG000|Overall Study|Image acquisition failure|2|||
16343843|NCT01447719|39744571|FG000|Overall Study|Invalid image or not imaged|3|||
16343844|NCT01447719|39744571|FG000|Overall Study|Subject still living at end of study|79|||
16543938|NCT00941798|40453857|FG000|Overall Study|Abnormal laboratory values|1|||
16543939|NCT00941798|40453858|FG001|Overall Study|Abnormal laboratory values|2|||
16221178|NCT01854918|39290578|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
16343845|NCT01447719|39744571|FG000|Overall Study|Withdrawal by Subject|2|||
16343846|NCT01447719|39744571|FG000|Overall Study|Family withdrew autopsy consent|7|||
16343847|NCT00199849|39744572|FG000|Overall Study|Unrelated illness or complication|0|||
16343848|NCT00199849|39744573|FG001|Overall Study|Unrelated illness or complication|1|||
16343849|NCT00199849|39744574|FG002|Overall Study|Unrelated illness or complication|0|||
16343850|NCT00199849|39744572|FG000|Overall Study|Progressive disease requiring intervention|0|||
16343851|NCT00199849|39744573|FG001|Overall Study|Progressive disease requiring intervention|0|||
16343852|NCT00199849|39744574|FG002|Overall Study|Progressive disease requiring intervention|1|||
16343853|NCT00199849|39744572|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
16343854|NCT00199849|39744573|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
16343855|NCT00199849|39744574|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
16343856|NCT00255840|39744582|FG000|Overall Study|Lost to Follow-up|10|||
16343857|NCT00255840|39744583|FG001|Overall Study|Lost to Follow-up|14|||
16343858|NCT00255840|39744582|FG000|Overall Study|Discontinued intervention|53|||
16343859|NCT00255840|39744583|FG001|Overall Study|Discontinued intervention|56|||
16343860|NCT00762762|39744584|FG000|Overall Study|Did not return for appointments|6|||
16343861|NCT00762762|39744585|FG001|Overall Study|Did not return for appointments|8|||
16343862|NCT02030119|39744586|FG000|Overall Study|Withdrawal by Subject|3|||
16343863|NCT02030119|39744587|FG001|Overall Study|Withdrawal by Subject|1|||
16343864|NCT02030119|39744588|FG002|Overall Study|Withdrawal by Subject|5|||
16343865|NCT02030119|39744589|FG003|Overall Study|Withdrawal by Subject|3|||
16343866|NCT02030119|39744586|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
16343867|NCT02030119|39744587|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
16343868|NCT02030119|39744588|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
16343869|NCT02030119|39744589|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
16343870|NCT00582426|39744590|FG000|Overall Study|Lost to Follow-up|0|||
16343871|NCT00582426|39744591|FG001|Overall Study|Lost to Follow-up|2|||
16543940|NCT00941798|40453857|FG000|Overall Study|Death|0|||
16343872|NCT00582426|39744590|FG000|Overall Study|Adverse Event|4|||
16343873|NCT00582426|39744591|FG001|Overall Study|Adverse Event|2|||
16343874|NCT00582426|39744590|FG000|Overall Study|Protocol Violation|6|||
16343875|NCT00582426|39744591|FG001|Overall Study|Protocol Violation|2|||
16343876|NCT00582426|39744590|FG000|Overall Study|Death|4|||
16343877|NCT00582426|39744591|FG001|Overall Study|Death|3|||
16343878|NCT00582426|39744590|FG000|Overall Study|Withdrawal by Subject|3|||
16343879|NCT00582426|39744591|FG001|Overall Study|Withdrawal by Subject|2|||
16343880|NCT00582426|39744590|FG000|Overall Study|Disease Progression|2|||
16343881|NCT00582426|39744591|FG001|Overall Study|Disease Progression|2|||
16343882|NCT00582426|39744590|FG000|Overall Study|Use of illicit drugs|1|||
16343883|NCT00582426|39744591|FG001|Overall Study|Use of illicit drugs|0|||
16343884|NCT00493311|39744592|FG000|Overall Study|Need for rescue medication|2|||
16343885|NCT00493311|39744593|FG001|Overall Study|Need for rescue medication|2|||
16343886|NCT01887288|39744596|FG000|Overall Study|The study was terminated and the PI has|16|||
16343887|NCT01639703|39744601|FG000|Overall Study|Withdrawal by Subject|5|||
16407883|NCT04209114|39973404|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
16343888|NCT01639703|39744601|FG000|Overall Study|Other reason|7|||
16343889|NCT02669043|39744602|FG000|Overall Study|Didn't meet I/E criteria|4|||
16343890|NCT01890759|39747442|FG000|Overall Study|Protocol Violation|0|||
16407884|NCT04209114|39973402|FG000|Treatment Phase|Death|4|||
16343891|NCT01890759|39747443|FG001|Overall Study|Protocol Violation|2|||
16343892|NCT01890759|39747442|FG000|Overall Study|Lost to Follow-up|0|||
16343893|NCT01890759|39747443|FG001|Overall Study|Lost to Follow-up|2|||
16343894|NCT01890759|39747442|FG000|Overall Study|Withdrawal by Subject|2|||
16343895|NCT01890759|39747443|FG001|Overall Study|Withdrawal by Subject|8|||
16343896|NCT03519919|39747444|FG000|Overall Study|Withdrawal by Subject|1|||
16343897|NCT03519919|39747444|FG000|Overall Study|Lack of Efficacy|1|||
16407885|NCT04209114|39973403|FG001|Treatment Phase|Death|1|||
16407886|NCT04209114|39973404|FG002|Treatment Phase|Death|0|||
16407887|NCT04209114|39973402|FG000|Treatment Phase|Study drug toxicity|4|||
16407888|NCT04209114|39973403|FG001|Treatment Phase|Study drug toxicity|6|||
16543941|NCT00941798|40453858|FG001|Overall Study|Death|1|||
16543942|NCT02110901|40453859|FG000|Overall Study|Death|6|||
16543943|NCT02110901|40453860|FG001|Overall Study|Death|3|||
16543944|NCT02110901|40453859|FG000|Overall Study|Lost to Follow-up|12|||
16543945|NCT02110901|40453860|FG001|Overall Study|Lost to Follow-up|8|||
16543946|NCT02110901|40453859|FG000|Overall Study|Withdrawal by Subject|7|||
16543947|NCT02110901|40453860|FG001|Overall Study|Withdrawal by Subject|3|||
16543948|NCT02110901|40453859|FG000|Overall Study|received a kidney transplant|5|||
16543949|NCT02110901|40453860|FG001|Overall Study|received a kidney transplant|0|||
16543950|NCT01453348|40453861|FG000|Overall Study|Death|0|||
16543951|NCT01453348|40453862|FG001|Overall Study|Death|0|||
16543952|NCT01453348|40453863|FG002|Overall Study|Death|1|||
16543953|NCT01453348|40453861|FG000|Overall Study|Withdrawal by Subject|0|||
16543954|NCT01453348|40453862|FG001|Overall Study|Withdrawal by Subject|1|||
16543955|NCT01453348|40453863|FG002|Overall Study|Withdrawal by Subject|0|||
16543956|NCT01453348|40453861|FG000|Overall Study|Protocol Violation|1|||
16343898|NCT03519919|39747444|FG000|Overall Study|Screen Failure|1|||
16343899|NCT00656175|39747463|FG000|Overall Study|Adverse Event|1|||
16343900|NCT00656175|39747464|FG001|Overall Study|Adverse Event|0|||
16343901|NCT00656175|39747463|FG000|Overall Study|Transportation issues|0|||
16343902|NCT00656175|39747464|FG001|Overall Study|Transportation issues|1|||
16407889|NCT04209114|39973404|FG002|Treatment Phase|Study drug toxicity|0|||
16407890|NCT04209114|39973402|FG000|Treatment Phase|Disease progression|6|||
16543957|NCT01453348|40453862|FG001|Overall Study|Protocol Violation|0|||
16543958|NCT01453348|40453863|FG002|Overall Study|Protocol Violation|0|||
16543959|NCT00041756|40453875|FG000|Overall Study|Adverse Event|4|||
16543960|NCT00041756|40453876|FG001|Overall Study|Adverse Event|10|||
16343903|NCT01548768|39747465|FG000|Overall Study|Withdrawal by Subject|0|||
16343904|NCT01548768|39747466|FG001|Overall Study|Withdrawal by Subject|2|||
16343905|NCT01548768|39747467|FG002|Overall Study|Withdrawal by Subject|1|||
16343906|NCT01548768|39747468|FG003|Overall Study|Withdrawal by Subject|0|||
16343907|NCT01548768|39747465|FG000|Overall Study|Physician Decision|1|||
16343908|NCT01548768|39747466|FG001|Overall Study|Physician Decision|0|||
16343909|NCT01548768|39747467|FG002|Overall Study|Physician Decision|0|||
16343910|NCT01548768|39747468|FG003|Overall Study|Physician Decision|0|||
16343911|NCT01548768|39747465|FG000|Overall Study|Adverse Event|0|||
16543961|NCT00041756|40453877|FG002|Overall Study|Adverse Event|6|||
16543962|NCT00041756|40453878|FG003|Overall Study|Adverse Event|11|||
16543963|NCT00041756|40453879|FG004|Overall Study|Adverse Event|34|||
16543964|NCT00041756|40453875|FG000|Overall Study|Protocol Violation|1|||
16543965|NCT00041756|40453876|FG001|Overall Study|Protocol Violation|1|||
16543966|NCT00041756|40453877|FG002|Overall Study|Protocol Violation|2|||
16543967|NCT00041756|40453878|FG003|Overall Study|Protocol Violation|2|||
16543968|NCT00041756|40453879|FG004|Overall Study|Protocol Violation|1|||
16221179|NCT01854918|39290577|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
16221180|NCT01854918|39290578|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
16221181|NCT01854918|39290577|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
16221182|NCT01854918|39290578|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
16221183|NCT01854918|39290577|FG000|SOC-controlled Period (Year 1)|Death|5|||
16221184|NCT01854918|39290578|FG001|SOC-controlled Period (Year 1)|Death|5|||
16221185|NCT01854918|39290577|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
16221186|NCT01854918|39290578|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
16221187|NCT01854918|39290577|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
16221188|NCT01854918|39290578|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
16221189|NCT01854918|39290577|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
16221190|NCT01854918|39290578|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
16221191|NCT01854918|39290577|FG000|All-IP Period (Years 2 and 3)|Death|5|||
16221192|NCT01854918|39290578|FG001|All-IP Period (Years 2 and 3)|Death|16|||
16221193|NCT01899729|39290579|FG000|Overall Study|Adverse Event|1|||
16221194|NCT01899729|39290580|FG001|Overall Study|Adverse Event|0|||
16221195|NCT01899729|39290581|FG002|Overall Study|Adverse Event|0|||
16221196|NCT01899729|39290582|FG003|Overall Study|Adverse Event|0|||
16543969|NCT00041756|40453875|FG000|Overall Study|Withdrawal by Subject|3|||
16221197|NCT01899729|39290583|FG004|Overall Study|Adverse Event|1|||
16221198|NCT01899729|39290579|FG000|Overall Study|Withdrawal by Subject|1|||
16221199|NCT01899729|39290580|FG001|Overall Study|Withdrawal by Subject|2|||
16221200|NCT01899729|39290581|FG002|Overall Study|Withdrawal by Subject|0|||
16221201|NCT01899729|39290582|FG003|Overall Study|Withdrawal by Subject|0|||
16221202|NCT01899729|39290583|FG004|Overall Study|Withdrawal by Subject|0|||
16221203|NCT01899729|39290579|FG000|Overall Study|Lack of Efficacy|0|||
16543970|NCT00041756|40453876|FG001|Overall Study|Withdrawal by Subject|3|||
16543971|NCT00041756|40453877|FG002|Overall Study|Withdrawal by Subject|4|||
16543972|NCT00041756|40453878|FG003|Overall Study|Withdrawal by Subject|2|||
16543973|NCT00041756|40453879|FG004|Overall Study|Withdrawal by Subject|3|||
16543974|NCT00041756|40453875|FG000|Overall Study|Lost to Follow-up|0|||
16543975|NCT00041756|40453876|FG001|Overall Study|Lost to Follow-up|1|||
16543976|NCT00041756|40453877|FG002|Overall Study|Lost to Follow-up|0|||
16543977|NCT00041756|40453878|FG003|Overall Study|Lost to Follow-up|1|||
16543978|NCT00041756|40453879|FG004|Overall Study|Lost to Follow-up|0|||
16543979|NCT00041756|40453875|FG000|Overall Study|Unable to meet protocol criteria|0|||
16221204|NCT01899729|39290580|FG001|Overall Study|Lack of Efficacy|0|||
16221205|NCT01899729|39290581|FG002|Overall Study|Lack of Efficacy|2|||
16343912|NCT01548768|39747466|FG001|Overall Study|Adverse Event|0|||
16343913|NCT01548768|39747467|FG002|Overall Study|Adverse Event|0|||
16343914|NCT01548768|39747468|FG003|Overall Study|Adverse Event|1|||
16343915|NCT01548768|39747465|FG000|Overall Study|Non-Compliance|0|||
16221206|NCT01899729|39290582|FG003|Overall Study|Lack of Efficacy|0|||
16221207|NCT01899729|39290583|FG004|Overall Study|Lack of Efficacy|1|||
16221208|NCT02177942|39290584|FG000|Overall Study|Adverse Event|1|||
16343916|NCT01548768|39747466|FG001|Overall Study|Non-Compliance|0|||
16543980|NCT00041756|40453876|FG001|Overall Study|Unable to meet protocol criteria|0|||
16543981|NCT00041756|40453877|FG002|Overall Study|Unable to meet protocol criteria|1|||
16221209|NCT02177942|39290585|FG001|Overall Study|Adverse Event|0|||
16543982|NCT00041756|40453878|FG003|Overall Study|Unable to meet protocol criteria|0|||
16543983|NCT00041756|40453879|FG004|Overall Study|Unable to meet protocol criteria|1|||
16543984|NCT00041756|40453875|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
16221210|NCT02177942|39290584|FG000|Overall Study|Lost to Follow-up|1|||
16221211|NCT02177942|39290585|FG001|Overall Study|Lost to Follow-up|1|||
16221212|NCT02177942|39290584|FG000|Overall Study|Protocol Violation|4|||
16221213|NCT02177942|39290585|FG001|Overall Study|Protocol Violation|6|||
16221214|NCT02177942|39290584|FG000|Overall Study|Withdrawal by Subject|71|||
16221215|NCT02177942|39290585|FG001|Overall Study|Withdrawal by Subject|81|||
16221216|NCT01823991|39290586|FG000|Overall Study|Withdrawal by Subject|8|||
16221217|NCT01823991|39290587|FG001|Overall Study|Withdrawal by Subject|5|||
16221218|NCT02098733|39290588|FG000|Overall Study|Data Not Available|5|||
16221219|NCT02098733|39290588|FG000|Overall Study|Lost to Follow-up|5|||
16221220|NCT02127970|39290593|FG000|Overall Study|Adverse Event|2|||
16221221|NCT02127970|39290594|FG001|Overall Study|Adverse Event|1|||
16543985|NCT00041756|40453876|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
16543986|NCT00041756|40453877|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
16543987|NCT00041756|40453878|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
16543988|NCT00041756|40453879|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
16543989|NCT02090634|40453882|FG000|Overall Study|Lost to Follow-up|0|||
16543990|NCT02090634|40453883|FG001|Overall Study|Lost to Follow-up|1|||
16221222|NCT02127970|39290593|FG000|Overall Study|Death|1|||
16221223|NCT02127970|39290594|FG001|Overall Study|Death|1|||
16221224|NCT02127970|39290593|FG000|Overall Study|Lost to Follow-up|14|||
16407891|NCT04209114|39973403|FG001|Treatment Phase|Disease progression|9|||
16543991|NCT02090634|40453882|FG000|Overall Study|Death|0|||
16543992|NCT02090634|40453883|FG001|Overall Study|Death|1|||
16543993|NCT02090634|40453882|FG000|Overall Study|Protocol Violation|3|||
16543994|NCT02090634|40453883|FG001|Overall Study|Protocol Violation|1|||
16543995|NCT02090634|40453882|FG000|Overall Study|Adverse Event|2|||
16543996|NCT02090634|40453883|FG001|Overall Study|Adverse Event|0|||
16543997|NCT00736489|40453885|FG000|Period 1|Lost to Follow-up|1|||
16543998|NCT00736489|40453886|FG001|Period 1|Lost to Follow-up|0|||
16543999|NCT00736489|40453887|FG002|Period 1|Lost to Follow-up|0|||
16544000|NCT00736489|40453888|FG003|Period 1|Lost to Follow-up|0|||
16544001|NCT00736489|40453889|FG004|Period 1|Lost to Follow-up|0|||
16544002|NCT00736489|40453890|FG005|Period 1|Lost to Follow-up|0|||
16544003|NCT00736489|40453885|FG000|Period 1|Withdrawal by Subject|0|||
16544004|NCT00736489|40453886|FG001|Period 1|Withdrawal by Subject|0|||
16544005|NCT00736489|40453887|FG002|Period 1|Withdrawal by Subject|0|||
16544006|NCT00736489|40453888|FG003|Period 1|Withdrawal by Subject|0|||
16544007|NCT00736489|40453889|FG004|Period 1|Withdrawal by Subject|0|||
16544008|NCT00736489|40453890|FG005|Period 1|Withdrawal by Subject|1|||
16544009|NCT02583425|40456906|FG000|Screening|Did not meet entry criteria|12|||
16544010|NCT02583425|40456906|FG000|Baseline|Did not meet continued criteria|5|||
16544011|NCT02583425|40456906|FG000|Treatment Period|Adverse Event|1|||
16544012|NCT00927355|40456907|FG000|Overall Study|Adverse Event|1|||
16544013|NCT00927355|40456908|FG001|Overall Study|Adverse Event|1|||
16544014|NCT01852058|40456909|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
16544015|NCT01852058|40456910|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16544016|NCT01852058|40456911|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16544017|NCT01852058|40456912|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16221225|NCT02127970|39290594|FG001|Overall Study|Lost to Follow-up|14|||
16221226|NCT02127970|39290593|FG000|Overall Study|Reason not Specified|4|||
16221227|NCT02127970|39290594|FG001|Overall Study|Reason not Specified|7|||
16221228|NCT02127970|39290593|FG000|Overall Study|Pregnancy|0|||
16221229|NCT02127970|39290594|FG001|Overall Study|Pregnancy|1|||
16544018|NCT01852058|40456913|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16544019|NCT01852058|40456914|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16544020|NCT01852058|40456915|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16544021|NCT01852058|40456916|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16544022|NCT01852058|40456917|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16407892|NCT04209114|39973404|FG002|Treatment Phase|Disease progression|0|||
16407893|NCT03305419|39973405|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
16407894|NCT03305419|39973406|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
16407895|NCT03305419|39973407|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
16407896|NCT03305419|39973408|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
16407897|NCT03305419|39973409|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
16407898|NCT03305419|39973410|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
16407899|NCT03305419|39973411|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
16407900|NCT03305419|39973412|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
16407901|NCT03305419|39973405|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
16407902|NCT03305419|39973406|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
16407903|NCT03305419|39973407|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
16407904|NCT03305419|39973408|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
16407905|NCT03305419|39973409|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
16407906|NCT03305419|39973410|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
16407907|NCT03305419|39973411|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
16407908|NCT03305419|39973412|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
16407909|NCT03305419|39973405|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
16407910|NCT03305419|39973406|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
16407911|NCT03305419|39973407|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
16407912|NCT03305419|39973408|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
16407913|NCT03305419|39973409|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
16407914|NCT03305419|39973410|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
16110010|NCT02484547|38889198|FG000|Placebo-Controlled Period|Reason not Specified|216|||
16110011|NCT02484547|38889199|FG001|Placebo-Controlled Period|Reason not Specified|194|||
16110012|NCT02484547|38889200|FG002|Placebo-Controlled Period|Reason not Specified|183|||
16110013|NCT02484547|38889201|FG003|Placebo-Controlled Period|Reason not Specified|0|||
16110014|NCT02484547|38889202|FG004|Placebo-Controlled Period|Reason not Specified|0|||
16110015|NCT02484547|38889203|FG005|Placebo-Controlled Period|Reason not Specified|0|||
16343917|NCT01548768|39747467|FG002|Overall Study|Non-Compliance|0|||
16343918|NCT01548768|39747468|FG003|Overall Study|Non-Compliance|3|||
16343919|NCT00401193|39747469|FG000|Overall Study|Adverse Event|1|||
16343920|NCT00401193|39747470|FG001|Overall Study|Adverse Event|3|||
16343921|NCT00401193|39747471|FG002|Overall Study|Adverse Event|1|||
16343922|NCT00401193|39747469|FG000|Overall Study|Protocol Violation|3|||
16110016|NCT02484547|38889204|FG006|Placebo-Controlled Period|Reason not Specified|0|||
16110017|NCT02484547|38889198|FG000|Long-Term Extension Period|Adverse Event|0|||
16110018|NCT02484547|38889199|FG001|Long-Term Extension Period|Adverse Event|0|||
16110019|NCT02484547|38889200|FG002|Long-Term Extension Period|Adverse Event|0|||
16110020|NCT02484547|38889201|FG003|Long-Term Extension Period|Adverse Event|0|||
16343923|NCT00401193|39747470|FG001|Overall Study|Protocol Violation|1|||
16343924|NCT00401193|39747471|FG002|Overall Study|Protocol Violation|1|||
16343925|NCT00401193|39747469|FG000|Overall Study|Lost to Follow-up|6|||
16343926|NCT00401193|39747470|FG001|Overall Study|Lost to Follow-up|5|||
16343927|NCT00401193|39747471|FG002|Overall Study|Lost to Follow-up|1|||
16343928|NCT00401193|39747469|FG000|Overall Study|Withdrawal by Subject|2|||
16343929|NCT00401193|39747470|FG001|Overall Study|Withdrawal by Subject|0|||
16343930|NCT00401193|39747471|FG002|Overall Study|Withdrawal by Subject|1|||
16221230|NCT02127970|39290593|FG000|Overall Study|Subject Withdrew Consent|5|||
16343931|NCT00401193|39747469|FG000|Overall Study|Other Event|3|||
16343932|NCT00401193|39747470|FG001|Overall Study|Other Event|2|||
16343933|NCT00401193|39747471|FG002|Overall Study|Other Event|2|||
16343934|NCT02308228|39747475|FG000|Overall Study|Adverse Event|3|||
16110021|NCT02484547|38889202|FG004|Long-Term Extension Period|Adverse Event|1|||
16110022|NCT02484547|38889203|FG005|Long-Term Extension Period|Adverse Event|3|||
16110023|NCT02484547|38889204|FG006|Long-Term Extension Period|Adverse Event|2|||
16110024|NCT02484547|38889198|FG000|Long-Term Extension Period|Death|0|||
16110025|NCT02484547|38889199|FG001|Long-Term Extension Period|Death|0|||
16110026|NCT02484547|38889200|FG002|Long-Term Extension Period|Death|0|||
16110027|NCT02484547|38889201|FG003|Long-Term Extension Period|Death|0|||
16110028|NCT02484547|38889202|FG004|Long-Term Extension Period|Death|0|||
16110029|NCT02484547|38889203|FG005|Long-Term Extension Period|Death|3|||
16110030|NCT02484547|38889204|FG006|Long-Term Extension Period|Death|0|||
16544023|NCT01852058|40456918|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16544024|NCT01852058|40456919|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16544025|NCT01852058|40456920|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
16544026|NCT01852058|40456909|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16544027|NCT01852058|40456910|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16110031|NCT02484547|38889198|FG000|Long-Term Extension Period|Disease Progression|0|||
16110032|NCT02484547|38889199|FG001|Long-Term Extension Period|Disease Progression|0|||
16110033|NCT02484547|38889200|FG002|Long-Term Extension Period|Disease Progression|0|||
16110034|NCT02484547|38889201|FG003|Long-Term Extension Period|Disease Progression|0|||
16110035|NCT02484547|38889202|FG004|Long-Term Extension Period|Disease Progression|2|||
16110036|NCT02484547|38889203|FG005|Long-Term Extension Period|Disease Progression|4|||
16110037|NCT02484547|38889204|FG006|Long-Term Extension Period|Disease Progression|0|||
16110038|NCT02484547|38889198|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
16343935|NCT02308228|39747476|FG001|Overall Study|Adverse Event|4|||
16343936|NCT02308228|39747475|FG000|Overall Study|Withdrawal by Subject|5|||
16343937|NCT02308228|39747476|FG001|Overall Study|Withdrawal by Subject|3|||
16343938|NCT01408901|39747477|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
16343939|NCT01408901|39747478|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
16343940|NCT01408901|39747479|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
16343941|NCT01408901|39747480|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
16343942|NCT01408901|39747477|FG000|6-Week Follow-Up|Death|1|||
16343943|NCT01408901|39747478|FG001|6-Week Follow-Up|Death|0|||
16343944|NCT01408901|39747479|FG002|6-Week Follow-Up|Death|0|||
16343945|NCT01408901|39747480|FG003|6-Week Follow-Up|Death|0|||
16343946|NCT01408901|39747477|FG000|6-Week Follow-Up|Cancelled visit|0|||
16343947|NCT01408901|39747478|FG001|6-Week Follow-Up|Cancelled visit|1|||
16343948|NCT01408901|39747479|FG002|6-Week Follow-Up|Cancelled visit|0|||
16343949|NCT01408901|39747480|FG003|6-Week Follow-Up|Cancelled visit|2|||
16343950|NCT01408901|39747477|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
16343951|NCT01408901|39747478|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
16343952|NCT01408901|39747479|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
16343953|NCT01408901|39747480|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
16343954|NCT01408901|39747477|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
16343955|NCT01408901|39747478|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
16343956|NCT01408901|39747479|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
16343957|NCT01408901|39747480|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
16343958|NCT01408901|39747477|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
16343959|NCT01408901|39747478|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
16343960|NCT01408901|39747479|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
16343961|NCT01408901|39747480|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
16343962|NCT01408901|39747477|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
16343963|NCT01408901|39747478|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
16343964|NCT01408901|39747479|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
16343965|NCT01408901|39747480|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
16343966|NCT01408901|39747477|FG000|26-Week Follow-Up|Death|0|||
16343967|NCT01408901|39747478|FG001|26-Week Follow-Up|Death|1|||
16343968|NCT01408901|39747479|FG002|26-Week Follow-Up|Death|0|||
16343969|NCT01408901|39747480|FG003|26-Week Follow-Up|Death|0|||
16110039|NCT02484547|38889199|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
16343970|NCT02112877|39747481|FG000|Overall Study|Withdrawal by Subject|1|||
16343971|NCT02112877|39747482|FG001|Overall Study|Withdrawal by Subject|7|||
16343972|NCT02112877|39747481|FG000|Overall Study|Visit Missed|1|||
16343973|NCT02112877|39747482|FG001|Overall Study|Visit Missed|6|||
16343974|NCT01001520|39747485|FG000|Medication Period 1|Withdrawal by Subject|2|||
16110040|NCT02484547|38889200|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
16110041|NCT02484547|38889201|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
16110042|NCT02484547|38889202|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
16110043|NCT02484547|38889203|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
16110044|NCT02484547|38889204|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
16110045|NCT02484547|38889198|FG000|Long-Term Extension Period|Loss of Capacity|0|||
16343975|NCT01001520|39747486|FG001|Medication Period 1|Withdrawal by Subject|2|||
16343976|NCT01001520|39747485|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
16343977|NCT01001520|39747486|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
16343978|NCT01001520|39747485|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
16343979|NCT01001520|39747486|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
16343980|NCT01001520|39747485|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
16343981|NCT01001520|39747486|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
16343982|NCT01001520|39747485|FG000|Washout Period|Withdrawal by Subject|2|||
16343983|NCT01001520|39747486|FG001|Washout Period|Withdrawal by Subject|1|||
16343984|NCT01001520|39747485|FG000|Medication Period 2|Withdrawal by Subject|0|||
16343985|NCT01001520|39747486|FG001|Medication Period 2|Withdrawal by Subject|3|||
16343986|NCT01344759|39747487|FG000|Overall Study|Patients failed to reach sedation level|0|||
16343987|NCT01344759|39747488|FG001|Overall Study|Patients failed to reach sedation level|2|||
16343988|NCT05279131|39747489|FG000|Overall Study|Lost to Follow-up|1|||
16343989|NCT05279131|39747489|FG000|Overall Study|Death|1|||
16343990|NCT05279131|39747489|FG000|Overall Study|Physician Decision|1|||
16343991|NCT03334188|39747490|FG000|Overall Study|Withdrawal by Subject|0|||
16343992|NCT03334188|39747491|FG001|Overall Study|Withdrawal by Subject|1|||
16343993|NCT03334188|39747490|FG000|Overall Study|Death|1|||
16343994|NCT03334188|39747491|FG001|Overall Study|Death|0|||
16343995|NCT03334188|39747490|FG000|Overall Study|Never had qualifying clinic visit|7|||
16343996|NCT03334188|39747491|FG001|Overall Study|Never had qualifying clinic visit|7|||
16343997|NCT00171158|39747492|FG000|Core Study|Death|27|||
16343998|NCT00171158|39747492|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
16343999|NCT00171158|39747492|FG000|Core Study|Protocol Violation|4|||
16344000|NCT00171158|39747492|FG000|Core Study|Administrative problems|1|||
16344001|NCT00171158|39747492|FG000|Core Study|Adverse event, non-fatal|21|||
16344002|NCT00171158|39747492|FG000|Core Study|Consent withdrawn by subject|6|||
16344003|NCT00171158|39747492|FG000|Core Study|No longer required drug (BMT)|14|||
16344004|NCT00171158|39747492|FG000|Core Study|Abnormal Laboratory Values|2|||
16344005|NCT00171158|39747492|FG000|Core Study|Lost to Follow-up|1|||
16344006|NCT00171158|39747492|FG000|E2 Extension|Other|7|||
16344007|NCT02815267|39747493|FG000|Double-Blind Phase|Adverse Event|0|||
16344008|NCT02815267|39747494|FG001|Double-Blind Phase|Adverse Event|3|||
16344009|NCT02815267|39747493|FG000|Double-Blind Phase|Lost to Follow-up|17|||
16344010|NCT02815267|39747494|FG001|Double-Blind Phase|Lost to Follow-up|9|||
16344011|NCT02815267|39747493|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
16344012|NCT02815267|39747494|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
16344013|NCT02815267|39747493|FG000|Double-Blind Phase|Protocol Violation|3|||
16344014|NCT02815267|39747494|FG001|Double-Blind Phase|Protocol Violation|2|||
16344015|NCT02815267|39747493|FG000|Double-Blind Phase|Site withdrawal|1|||
16344016|NCT02815267|39747494|FG001|Double-Blind Phase|Site withdrawal|6|||
16344017|NCT02815267|39747493|FG000|Double-Blind Phase|Received a disallowed medication|1|||
16344018|NCT02815267|39747494|FG001|Double-Blind Phase|Received a disallowed medication|1|||
16344019|NCT02815267|39747493|FG000|Open-Label Phase|Adverse Event|1|||
16344020|NCT02815267|39747494|FG001|Open-Label Phase|Adverse Event|1|||
16344021|NCT02815267|39747493|FG000|Open-Label Phase|Lost to Follow-up|23|||
16344022|NCT02815267|39747494|FG001|Open-Label Phase|Lost to Follow-up|9|||
16344023|NCT02815267|39747493|FG000|Open-Label Phase|Withdrawal by Subject|24|||
16344024|NCT02815267|39747494|FG001|Open-Label Phase|Withdrawal by Subject|13|||
16344025|NCT02815267|39747493|FG000|Open-Label Phase|Protocol Violation|0|||
16344026|NCT02815267|39747494|FG001|Open-Label Phase|Protocol Violation|1|||
16344027|NCT02815267|39747493|FG000|Open-Label Phase|Administrative|21|||
16344028|NCT02815267|39747494|FG001|Open-Label Phase|Administrative|12|||
16344029|NCT02815267|39747493|FG000|Open-Label Phase|Other|2|||
16344030|NCT02815267|39747494|FG001|Open-Label Phase|Other|5|||
16344031|NCT01990573|39747497|FG000|Overall Study|Physician Decision|0|||
16344032|NCT01990573|39747498|FG001|Overall Study|Physician Decision|0|||
16344033|NCT01990573|39747499|FG002|Overall Study|Physician Decision|1|||
16344034|NCT02329327|39747503|FG000|Overall Study|Death|78|||
16344035|NCT02329327|39747504|FG001|Overall Study|Death|0|||
16344036|NCT02329327|39747503|FG000|Overall Study|Withdrawal by Subject|3|||
16110046|NCT02484547|38889199|FG001|Long-Term Extension Period|Loss of Capacity|0|||
16344037|NCT02329327|39747504|FG001|Overall Study|Withdrawal by Subject|0|||
16344038|NCT02329327|39747503|FG000|Overall Study|Lost to Follow-up|4|||
16344039|NCT02329327|39747504|FG001|Overall Study|Lost to Follow-up|0|||
16344040|NCT03915626|39747505|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
16344041|NCT01733121|39747512|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
16407915|NCT03305419|39973411|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
16407916|NCT03305419|39973412|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
16407917|NCT03305419|39973405|FG000|Part B (14 Days)|Adverse Event|0|||
16407918|NCT03305419|39973406|FG001|Part B (14 Days)|Adverse Event|0|||
16407919|NCT03305419|39973407|FG002|Part B (14 Days)|Adverse Event|0|||
16407920|NCT03305419|39973408|FG003|Part B (14 Days)|Adverse Event|0|||
16407921|NCT03305419|39973409|FG004|Part B (14 Days)|Adverse Event|1|||
16407922|NCT03305419|39973410|FG005|Part B (14 Days)|Adverse Event|2|||
16407923|NCT03305419|39973411|FG006|Part B (14 Days)|Adverse Event|4|||
16407924|NCT03305419|39973412|FG007|Part B (14 Days)|Adverse Event|0|||
16407925|NCT03305419|39973405|FG000|Part B (14 Days)|Physician Decision|0|||
16407926|NCT03305419|39973406|FG001|Part B (14 Days)|Physician Decision|0|||
16407927|NCT03305419|39973407|FG002|Part B (14 Days)|Physician Decision|0|||
16407928|NCT03305419|39973408|FG003|Part B (14 Days)|Physician Decision|0|||
16407929|NCT03305419|39973409|FG004|Part B (14 Days)|Physician Decision|2|||
16407930|NCT03305419|39973410|FG005|Part B (14 Days)|Physician Decision|8|||
16407931|NCT03305419|39973411|FG006|Part B (14 Days)|Physician Decision|1|||
16407932|NCT03305419|39973412|FG007|Part B (14 Days)|Physician Decision|0|||
16407933|NCT02255565|39973413|FG000|Overall Study|Withdrawal by Subject|0|||
16344042|NCT01733121|39747513|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
16407934|NCT02255565|39973414|FG001|Overall Study|Withdrawal by Subject|1|||
16407935|NCT02255565|39973415|FG002|Overall Study|Withdrawal by Subject|0|||
16407936|NCT00794365|39973417|FG000|Overall Study|Lost to Follow-up|38|||
16407937|NCT00794365|39973417|FG000|Overall Study|Other|17|||
16407938|NCT00794365|39973417|FG000|Overall Study|Poor Compliance|11|||
16407939|NCT00794365|39973417|FG000|Overall Study|Adverse Event|10|||
16407940|NCT00794365|39973417|FG000|Overall Study|Lack of Efficacy|3|||
16407941|NCT01666119|39973418|FG000|Overall Study|Adverse Event|6|||
16407942|NCT01666119|39973418|FG000|Overall Study|Withdrawal by Subject|16|||
16407943|NCT01666119|39973418|FG000|Overall Study|Lost to Follow-up|7|||
16407944|NCT01666119|39973418|FG000|Overall Study|non compliance with study medication, pa|18|||
16407945|NCT01666119|39973418|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
16407946|NCT00149994|39973422|FG000|Overall Study|Administrative problems:|1|||
16407947|NCT00149994|39973423|FG001|Overall Study|Administrative problems:|0|||
16407948|NCT00149994|39973422|FG000|Overall Study|Protocol Violation|0|||
16407949|NCT00149994|39973423|FG001|Overall Study|Protocol Violation|1|||
16407950|NCT02312219|39973426|FG000|Overall Study|Withdrawal by Subject|1|||
16407951|NCT02312219|39973427|FG001|Overall Study|Withdrawal by Subject|2|||
16221231|NCT02127970|39290594|FG001|Overall Study|Subject Withdrew Consent|3|||
16221232|NCT00621764|39290598|FG000|Overall Study|Protocol Violation|0|||
16407952|NCT02312219|39973426|FG000|Overall Study|could not schedule imaging in time|0|||
16344043|NCT01733121|39747512|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
16344044|NCT01733121|39747513|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
16344045|NCT01733121|39747512|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
16344046|NCT01733121|39747513|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
16344047|NCT01733121|39747512|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
16344048|NCT01733121|39747513|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
16344049|NCT01435759|39747514|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
16344050|NCT01435759|39747515|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
16344051|NCT01435759|39747516|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
16344052|NCT01435759|39747517|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
16344053|NCT01435759|39747518|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
16344054|NCT01435759|39747519|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
16344055|NCT01435759|39747514|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
16344056|NCT01435759|39747515|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
16407953|NCT02312219|39973427|FG001|Overall Study|could not schedule imaging in time|2|||
16407954|NCT02312219|39973426|FG000|Overall Study|Other|0|||
16407955|NCT02312219|39973427|FG001|Overall Study|Other|1|||
16407956|NCT02312219|39973426|FG000|Overall Study|Not randomized. Ineligible|0|||
16407957|NCT02312219|39973427|FG001|Overall Study|Not randomized. Ineligible|1|||
16221233|NCT00621764|39290599|FG001|Overall Study|Protocol Violation|0|||
16407958|NCT04662073|39973430|FG000|Overall Study|Withdrawal by Subject|1|||
16407959|NCT04662073|39973431|FG001|Overall Study|Withdrawal by Subject|0|||
16407960|NCT03593681|39973435|FG000|Overall Study|Inadequate sample collected|12|||
16407961|NCT03593681|39973435|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
16407962|NCT03593681|39973435|FG000|Overall Study|Protocol Violation|3|||
16407963|NCT03593681|39973435|FG000|Overall Study|Withdrawal by Subject|3|||
16407964|NCT03593681|39973435|FG000|Overall Study|Procedure not attempted|3|||
16407965|NCT03593681|39973435|FG000|Overall Study|Adverse Event|2|||
16407966|NCT03593681|39973435|FG000|Overall Study|Physician Decision|1|||
16407967|NCT01135914|39973436|FG000|Overall Study|Withdrawal by Subject|1|||
16407968|NCT01135914|39973437|FG001|Overall Study|Withdrawal by Subject|3|||
16407969|NCT01135914|39973438|FG002|Overall Study|Withdrawal by Subject|6|||
16407970|NCT01135914|39973436|FG000|Overall Study|Lost to Follow-up|1|||
16407971|NCT01135914|39973437|FG001|Overall Study|Lost to Follow-up|0|||
16407972|NCT01135914|39973438|FG002|Overall Study|Lost to Follow-up|1|||
16407973|NCT01135914|39973436|FG000|Overall Study|Protocol Violation|0|||
16407974|NCT01135914|39973437|FG001|Overall Study|Protocol Violation|0|||
16407975|NCT01135914|39973438|FG002|Overall Study|Protocol Violation|3|||
16407976|NCT01135914|39973436|FG000|Overall Study|Lack of Efficacy|2|||
16407977|NCT01135914|39973437|FG001|Overall Study|Lack of Efficacy|1|||
16407978|NCT01135914|39973438|FG002|Overall Study|Lack of Efficacy|10|||
16407979|NCT01135914|39973436|FG000|Overall Study|Adverse Event|0|||
16407980|NCT01135914|39973437|FG001|Overall Study|Adverse Event|1|||
16407981|NCT01135914|39973438|FG002|Overall Study|Adverse Event|2|||
16407982|NCT01224821|39973439|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
16407983|NCT01224821|39973439|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
16407984|NCT01224821|39973439|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
16407985|NCT01224821|39973439|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
16407986|NCT01224821|39973439|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
16407987|NCT01224821|39973439|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
16407988|NCT01224821|39973439|FG000|Long-Term Follow-Up|Death|2|||
16407989|NCT01224821|39973439|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
16407990|NCT00470093|39973442|FG000|Overall Study|Adverse Event|2|||
16407991|NCT00867087|39973447|FG000|Overall Study|Other|1|||
16407992|NCT00867087|39973447|FG000|Overall Study|Withdrawal by Subject|4|||
16407993|NCT00867087|39973447|FG000|Overall Study|Death|37|||
16407994|NCT03515551|39973450|FG000|Overall Study|Death|4|||
16407995|NCT03515551|39973451|FG001|Overall Study|Death|1|||
16407996|NCT03515551|39973452|FG002|Overall Study|Death|2|||
16407997|NCT03515551|39973453|FG003|Overall Study|Death|2|||
16407998|NCT03515551|39973454|FG004|Overall Study|Death|2|||
16407999|NCT03515551|39973455|FG005|Overall Study|Death|4|||
16408000|NCT03515551|39973456|FG006|Overall Study|Death|1|||
16408001|NCT03515551|39973450|FG000|Overall Study|Lost to Follow-up|0|||
16408002|NCT03515551|39973451|FG001|Overall Study|Lost to Follow-up|0|||
16408003|NCT03515551|39973452|FG002|Overall Study|Lost to Follow-up|1|||
16408004|NCT03515551|39973453|FG003|Overall Study|Lost to Follow-up|0|||
16408005|NCT03515551|39973454|FG004|Overall Study|Lost to Follow-up|0|||
16408006|NCT03515551|39973455|FG005|Overall Study|Lost to Follow-up|0|||
16408007|NCT03515551|39973456|FG006|Overall Study|Lost to Follow-up|0|||
16408008|NCT03515551|39973450|FG000|Overall Study|Withdrawal by Subject|0|||
16408009|NCT03515551|39973451|FG001|Overall Study|Withdrawal by Subject|1|||
16408010|NCT03515551|39973452|FG002|Overall Study|Withdrawal by Subject|0|||
16408011|NCT03515551|39973453|FG003|Overall Study|Withdrawal by Subject|0|||
16408012|NCT03515551|39973454|FG004|Overall Study|Withdrawal by Subject|0|||
16408013|NCT03515551|39973455|FG005|Overall Study|Withdrawal by Subject|0|||
16408014|NCT03515551|39973456|FG006|Overall Study|Withdrawal by Subject|1|||
16408015|NCT03515551|39973450|FG000|Overall Study|Study ended by sponsor|0|||
16408016|NCT03515551|39973451|FG001|Overall Study|Study ended by sponsor|0|||
16408017|NCT03515551|39973452|FG002|Overall Study|Study ended by sponsor|2|||
16408018|NCT03515551|39973453|FG003|Overall Study|Study ended by sponsor|1|||
16408019|NCT03515551|39973454|FG004|Overall Study|Study ended by sponsor|3|||
16408020|NCT03515551|39973455|FG005|Overall Study|Study ended by sponsor|0|||
16408021|NCT03515551|39973456|FG006|Overall Study|Study ended by sponsor|3|||
16408022|NCT03515551|39973450|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
16408023|NCT03515551|39973451|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
16408024|NCT03515551|39973452|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
16408025|NCT03515551|39973453|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
16408026|NCT03515551|39973454|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
16408027|NCT03515551|39973455|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
16408028|NCT03515551|39973456|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
16110047|NCT02484547|38889200|FG002|Long-Term Extension Period|Loss of Capacity|0|||
16110048|NCT02484547|38889201|FG003|Long-Term Extension Period|Loss of Capacity|0|||
16408029|NCT00884039|39973457|FG000|Overall Study|Withdrawal by Subject|0|||
16408030|NCT00884039|39973458|FG001|Overall Study|Withdrawal by Subject|1|||
16408031|NCT00884039|39973457|FG000|Overall Study|Lack of Efficacy|2|||
16408032|NCT00884039|39973458|FG001|Overall Study|Lack of Efficacy|0|||
16408033|NCT04096820|39973459|FG000|Overall Study|Did not return for intervention|2|||
16408034|NCT04096820|39973459|FG000|Overall Study|Death|1|||
16408035|NCT00075946|39973460|FG000|Overall Study|Path ineligible: undetermined histology|0|||
16408036|NCT00075946|39973461|FG001|Overall Study|Path ineligible: undetermined histology|0|||
16408037|NCT00075946|39973462|FG002|Overall Study|Path ineligible: undetermined histology|0|||
16408038|NCT00075946|39973463|FG003|Overall Study|Path ineligible: undetermined histology|0|||
16408039|NCT00075946|39973464|FG004|Overall Study|Path ineligible: undetermined histology|6|||
16408040|NCT00075946|39973460|FG000|Overall Study|Did not achieve response after induction|0|||
16408041|NCT00075946|39973461|FG001|Overall Study|Did not achieve response after induction|0|||
16110049|NCT02484547|38889202|FG004|Long-Term Extension Period|Loss of Capacity|1|||
16110050|NCT02484547|38889203|FG005|Long-Term Extension Period|Loss of Capacity|0|||
16110051|NCT02484547|38889204|FG006|Long-Term Extension Period|Loss of Capacity|0|||
16110052|NCT02484547|38889198|FG000|Long-Term Extension Period|Change of Treatment|0|||
16344057|NCT01435759|39747516|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
16344058|NCT01435759|39747517|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
16408042|NCT00075946|39973462|FG002|Overall Study|Did not achieve response after induction|0|||
16408043|NCT00075946|39973463|FG003|Overall Study|Did not achieve response after induction|0|||
16408044|NCT00075946|39973464|FG004|Overall Study|Did not achieve response after induction|182|||
16408045|NCT00075946|39973460|FG000|Overall Study|Incorrectly randomized (no response)|5|||
16408046|NCT00075946|39973461|FG001|Overall Study|Incorrectly randomized (no response)|5|||
16344059|NCT01435759|39747518|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
16344060|NCT01435759|39747519|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
16344061|NCT01435759|39747514|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
16344062|NCT01435759|39747515|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16344063|NCT01435759|39747516|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16344064|NCT01435759|39747517|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16344065|NCT01435759|39747518|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16344066|NCT01435759|39747519|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16544028|NCT01852058|40456911|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16544029|NCT01852058|40456912|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16110053|NCT02484547|38889199|FG001|Long-Term Extension Period|Change of Treatment|0|||
16110054|NCT02484547|38889200|FG002|Long-Term Extension Period|Change of Treatment|0|||
16110055|NCT02484547|38889201|FG003|Long-Term Extension Period|Change of Treatment|0|||
16110056|NCT02484547|38889202|FG004|Long-Term Extension Period|Change of Treatment|0|||
16221234|NCT00621764|39290600|FG002|Overall Study|Protocol Violation|0|||
16221235|NCT00621764|39290601|FG003|Overall Study|Protocol Violation|1|||
16221236|NCT01314261|39290602|FG000|Overall Study|Adverse Event|1|||
16221237|NCT01314261|39290603|FG001|Overall Study|Adverse Event|0|||
16344067|NCT01435759|39747514|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
16544030|NCT01852058|40456913|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
16544031|NCT01852058|40456914|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16544032|NCT01852058|40456915|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16544033|NCT01852058|40456916|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16544034|NCT01852058|40456917|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16544035|NCT01852058|40456918|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16544036|NCT01852058|40456919|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16544037|NCT01852058|40456920|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
16544038|NCT01852058|40456909|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16544039|NCT01852058|40456910|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16221238|NCT01314261|39290604|FG002|Overall Study|Adverse Event|0|||
16544040|NCT01852058|40456911|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16544041|NCT01852058|40456912|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16544042|NCT01852058|40456913|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
16544043|NCT01852058|40456914|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
16544044|NCT01852058|40456915|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16544045|NCT01852058|40456916|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16544046|NCT01852058|40456917|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16544047|NCT01852058|40456918|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16544048|NCT01852058|40456919|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16544049|NCT01852058|40456920|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
16544050|NCT01852058|40456909|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16544051|NCT01852058|40456910|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16544052|NCT01852058|40456911|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16544053|NCT01852058|40456912|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16544054|NCT01852058|40456913|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
16544055|NCT01852058|40456914|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16544056|NCT01852058|40456915|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16544057|NCT01852058|40456916|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16544058|NCT01852058|40456917|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16110057|NCT02484547|38889203|FG005|Long-Term Extension Period|Change of Treatment|0|||
16110058|NCT02484547|38889204|FG006|Long-Term Extension Period|Change of Treatment|1|||
16110059|NCT02484547|38889198|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
16110060|NCT02484547|38889199|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
16110061|NCT02484547|38889200|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
16110062|NCT02484547|38889201|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
16110063|NCT02484547|38889202|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
16110064|NCT02484547|38889203|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
16110065|NCT02484547|38889204|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
16110066|NCT02484547|38889198|FG000|Long-Term Extension Period|Investigator Decision|0|||
16110067|NCT02484547|38889199|FG001|Long-Term Extension Period|Investigator Decision|0|||
16110068|NCT02484547|38889200|FG002|Long-Term Extension Period|Investigator Decision|0|||
16110069|NCT02484547|38889201|FG003|Long-Term Extension Period|Investigator Decision|2|||
16110070|NCT02484547|38889202|FG004|Long-Term Extension Period|Investigator Decision|1|||
16110071|NCT02484547|38889203|FG005|Long-Term Extension Period|Investigator Decision|0|||
16110072|NCT02484547|38889204|FG006|Long-Term Extension Period|Investigator Decision|1|||
16110073|NCT02484547|38889198|FG000|Long-Term Extension Period|Relocation|0|||
16110074|NCT02484547|38889199|FG001|Long-Term Extension Period|Relocation|0|||
16110075|NCT02484547|38889200|FG002|Long-Term Extension Period|Relocation|0|||
16110076|NCT02484547|38889201|FG003|Long-Term Extension Period|Relocation|1|||
16110077|NCT02484547|38889202|FG004|Long-Term Extension Period|Relocation|1|||
16110078|NCT02484547|38889203|FG005|Long-Term Extension Period|Relocation|0|||
16110079|NCT02484547|38889204|FG006|Long-Term Extension Period|Relocation|0|||
16221239|NCT01314261|39290605|FG003|Overall Study|Adverse Event|0|||
16221240|NCT01314261|39290602|FG000|Overall Study|Withdrawal by Subject|0|||
16110080|NCT02484547|38889198|FG000|Long-Term Extension Period|Study Visit Burden|0|||
16344068|NCT01435759|39747515|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16544059|NCT01852058|40456918|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16544060|NCT01852058|40456919|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16544061|NCT01852058|40456920|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
16544062|NCT01852058|40456909|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16544063|NCT01852058|40456910|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16544064|NCT01852058|40456911|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16544065|NCT01852058|40456912|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16544066|NCT01852058|40456913|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
16544067|NCT01852058|40456914|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
16544068|NCT01852058|40456915|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16544069|NCT01852058|40456916|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16544070|NCT01852058|40456917|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16544071|NCT01852058|40456918|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16544072|NCT01852058|40456919|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16544073|NCT01852058|40456920|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
16544074|NCT01852058|40456909|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16544075|NCT01852058|40456910|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16544076|NCT01852058|40456911|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16110081|NCT02484547|38889199|FG001|Long-Term Extension Period|Study Visit Burden|0|||
16110082|NCT02484547|38889200|FG002|Long-Term Extension Period|Study Visit Burden|0|||
16110083|NCT02484547|38889201|FG003|Long-Term Extension Period|Study Visit Burden|2|||
16110084|NCT02484547|38889202|FG004|Long-Term Extension Period|Study Visit Burden|0|||
16110085|NCT02484547|38889203|FG005|Long-Term Extension Period|Study Visit Burden|0|||
16110086|NCT02484547|38889204|FG006|Long-Term Extension Period|Study Visit Burden|3|||
16344069|NCT01435759|39747516|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16344070|NCT01435759|39747517|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16110087|NCT02484547|38889198|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
16110088|NCT02484547|38889199|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
16110089|NCT02484547|38889200|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
16110090|NCT02484547|38889201|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
16110091|NCT02484547|38889202|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
16110092|NCT02484547|38889203|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
16110093|NCT02484547|38889204|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
16110094|NCT02484547|38889198|FG000|Long-Term Extension Period|Reason not Specified|0|||
16110095|NCT02484547|38889199|FG001|Long-Term Extension Period|Reason not Specified|0|||
16110096|NCT02484547|38889200|FG002|Long-Term Extension Period|Reason not Specified|0|||
16110097|NCT02484547|38889201|FG003|Long-Term Extension Period|Reason not Specified|119|||
16110098|NCT02484547|38889202|FG004|Long-Term Extension Period|Reason not Specified|117|||
16110099|NCT02484547|38889203|FG005|Long-Term Extension Period|Reason not Specified|223|||
16110100|NCT02484547|38889204|FG006|Long-Term Extension Period|Reason not Specified|231|||
16110101|NCT02509312|38889209|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
16110102|NCT02509312|38889210|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
16110103|NCT02509312|38889209|FG000|Overall Study|Obstetrician refusal|0|||
16110104|NCT02509312|38889210|FG001|Overall Study|Obstetrician refusal|1|||
16110105|NCT02509312|38889209|FG000|Overall Study|Patient elected for TOLAC|1|||
16110106|NCT02509312|38889210|FG001|Overall Study|Patient elected for TOLAC|0|||
16110107|NCT02509312|38889209|FG000|Overall Study|Cesarean deemed stat|1|||
16110108|NCT02509312|38889210|FG001|Overall Study|Cesarean deemed stat|0|||
16110109|NCT02509312|38889209|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
16110110|NCT02509312|38889210|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
16110111|NCT00810342|38889211|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
16110112|NCT00810342|38889212|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
16110113|NCT00810342|38889211|FG000|Month 1 Follow-up|Pregnancy|1|||
16110114|NCT00810342|38889212|FG001|Month 1 Follow-up|Pregnancy|0|||
16110115|NCT00810342|38889211|FG000|6-month Follow-up|Lost to Follow-up|18|||
16110116|NCT00810342|38889212|FG001|6-month Follow-up|Lost to Follow-up|6|||
16110117|NCT00810342|38889211|FG000|6-month Follow-up|Pregnancy|6|||
16344071|NCT01435759|39747518|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16344072|NCT01435759|39747519|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16110118|NCT00810342|38889212|FG001|6-month Follow-up|Pregnancy|2|||
16110119|NCT00810342|38889211|FG000|12-month Followup|Pregnancy|9|||
16408047|NCT00075946|39973462|FG002|Overall Study|Incorrectly randomized (no response)|5|||
16544077|NCT01852058|40456912|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
16344073|NCT01435759|39747514|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
16110120|NCT00810342|38889212|FG001|12-month Followup|Pregnancy|10|||
16110121|NCT00810342|38889211|FG000|12-month Followup|Lost to Follow-up|3|||
16110122|NCT00810342|38889212|FG001|12-month Followup|Lost to Follow-up|1|||
16110123|NCT02485899|38889213|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
16344074|NCT01435759|39747515|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16344075|NCT01435759|39747516|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16344076|NCT01435759|39747517|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16344077|NCT01435759|39747518|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16344078|NCT01435759|39747519|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16344079|NCT01435759|39747514|FG000|Antidepressant Lead-in Phase|Other|119|||
16344080|NCT01435759|39747515|FG001|Antidepressant Lead-in Phase|Other|0|||
16344081|NCT01435759|39747516|FG002|Antidepressant Lead-in Phase|Other|0|||
16344082|NCT01435759|39747517|FG003|Antidepressant Lead-in Phase|Other|0|||
16344083|NCT01435759|39747518|FG004|Antidepressant Lead-in Phase|Other|0|||
16344084|NCT01435759|39747519|FG005|Antidepressant Lead-in Phase|Other|0|||
16344085|NCT01435759|39747514|FG000|Double-blind Phase|Adverse Event|7|||
16344086|NCT01435759|39747515|FG001|Double-blind Phase|Adverse Event|0|||
16344087|NCT01435759|39747516|FG002|Double-blind Phase|Adverse Event|1|||
16344088|NCT01435759|39747517|FG003|Double-blind Phase|Adverse Event|1|||
16344089|NCT01435759|39747518|FG004|Double-blind Phase|Adverse Event|1|||
16408048|NCT00075946|39973463|FG003|Overall Study|Incorrectly randomized (no response)|1|||
16408049|NCT00075946|39973464|FG004|Overall Study|Incorrectly randomized (no response)|0|||
16408050|NCT00075946|39973460|FG000|Overall Study|Adverse Event|2|||
16408051|NCT00075946|39973461|FG001|Overall Study|Adverse Event|10|||
16408052|NCT00075946|39973462|FG002|Overall Study|Adverse Event|0|||
16408053|NCT00075946|39973463|FG003|Overall Study|Adverse Event|2|||
16221241|NCT01314261|39290603|FG001|Overall Study|Withdrawal by Subject|3|||
16221242|NCT01314261|39290604|FG002|Overall Study|Withdrawal by Subject|1|||
16221243|NCT01314261|39290605|FG003|Overall Study|Withdrawal by Subject|0|||
16221244|NCT01314261|39290602|FG000|Overall Study|Lost to Follow-up|1|||
16221245|NCT01314261|39290603|FG001|Overall Study|Lost to Follow-up|0|||
16221246|NCT01314261|39290604|FG002|Overall Study|Lost to Follow-up|2|||
16221247|NCT01314261|39290605|FG003|Overall Study|Lost to Follow-up|2|||
16408054|NCT00075946|39973464|FG004|Overall Study|Adverse Event|0|||
16408055|NCT00075946|39973460|FG000|Overall Study|Death|0|||
16408056|NCT00075946|39973461|FG001|Overall Study|Death|1|||
16408057|NCT00075946|39973462|FG002|Overall Study|Death|0|||
16221248|NCT01314261|39290602|FG000|Overall Study|Virologic Failure|0|||
16221249|NCT01314261|39290603|FG001|Overall Study|Virologic Failure|1|||
16221250|NCT01314261|39290604|FG002|Overall Study|Virologic Failure|0|||
16221251|NCT01314261|39290605|FG003|Overall Study|Virologic Failure|1|||
16221252|NCT00413777|39290608|FG000|Fixed-dose Period|Lost to Follow-up|1|||
16221253|NCT00413777|39290609|FG001|Fixed-dose Period|Lost to Follow-up|1|||
16221254|NCT00413777|39290608|FG000|Fixed-dose Period|Adverse Event|2|||
16221255|NCT00413777|39290609|FG001|Fixed-dose Period|Adverse Event|1|||
16221256|NCT00413777|39290608|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
16221257|NCT00413777|39290609|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
16221258|NCT00413777|39290608|FG000|Fixed-dose Period|Withdrew Consent|0|||
16221259|NCT00413777|39290609|FG001|Fixed-dose Period|Withdrew Consent|1|||
16221260|NCT02728804|39290612|FG000|Overall Study|Ineligible|3|||
16221261|NCT02728804|39290612|FG000|Overall Study|Did not complete baseline questionnaire|9|||
16221262|NCT02728804|39290612|FG000|Overall Study|Death|99|||
16221263|NCT02561273|39290613|FG000|Overall Study|Protocol Violation|1|||
16221264|NCT02561273|39290614|FG001|Overall Study|Protocol Violation|0|||
16221265|NCT02505945|39290615|FG000|Overall Study|Withdrawal by Subject|13|||
16221266|NCT02505945|39290616|FG001|Overall Study|Withdrawal by Subject|2|||
16221267|NCT02505945|39290615|FG000|Overall Study|Adverse Event|1|||
16221268|NCT02505945|39290616|FG001|Overall Study|Adverse Event|0|||
16221269|NCT02505945|39290615|FG000|Overall Study|Physician Decision|2|||
16221270|NCT02505945|39290616|FG001|Overall Study|Physician Decision|1|||
16221271|NCT02505945|39290615|FG000|Overall Study|Lost to Follow-up|6|||
16221272|NCT02505945|39290616|FG001|Overall Study|Lost to Follow-up|1|||
16221273|NCT02060903|39290618|FG000|Overall Study|Lost to Follow-up|4|||
16221274|NCT02060903|39290619|FG001|Overall Study|Lost to Follow-up|0|||
16221275|NCT02060903|39290618|FG000|Overall Study|Withdrawal by Subject|0|||
16221276|NCT02060903|39290619|FG001|Overall Study|Withdrawal by Subject|7|||
16221277|NCT00740116|39290620|FG000|Overall Study|Withdrawal by Subject|1|||
16408058|NCT00075946|39973463|FG003|Overall Study|Death|0|||
16408059|NCT00075946|39973464|FG004|Overall Study|Death|0|||
16408060|NCT00075946|39973460|FG000|Overall Study|Withdrawal by Subject|23|||
16408061|NCT00075946|39973461|FG001|Overall Study|Withdrawal by Subject|58|||
16408062|NCT00075946|39973462|FG002|Overall Study|Withdrawal by Subject|4|||
16408063|NCT00075946|39973463|FG003|Overall Study|Withdrawal by Subject|9|||
16221278|NCT00740116|39290621|FG001|Overall Study|Withdrawal by Subject|1|||
16221279|NCT00740116|39290620|FG000|Overall Study|Protocol Violation|1|||
16221280|NCT00740116|39290621|FG001|Overall Study|Protocol Violation|4|||
16221281|NCT00695318|39290622|FG000|Overall Study|Lost to Follow-up|1|||
16221282|NCT00695318|39290623|FG001|Overall Study|Lost to Follow-up|0|||
16221283|NCT00695318|39290622|FG000|Overall Study|Withdrawal by Subject|2|||
16221284|NCT00695318|39290623|FG001|Overall Study|Withdrawal by Subject|0|||
16221285|NCT00695318|39290622|FG000|Overall Study|Death|1|||
16221286|NCT00695318|39290623|FG001|Overall Study|Death|1|||
16221287|NCT00695318|39290622|FG000|Overall Study|Study Terminated|1|||
16344090|NCT01435759|39747519|FG005|Double-blind Phase|Adverse Event|3|||
16344091|NCT01435759|39747514|FG000|Double-blind Phase|Protocol Violation|2|||
16344092|NCT01435759|39747515|FG001|Double-blind Phase|Protocol Violation|0|||
16344093|NCT01435759|39747516|FG002|Double-blind Phase|Protocol Violation|1|||
16344094|NCT01435759|39747517|FG003|Double-blind Phase|Protocol Violation|2|||
16344095|NCT01435759|39747518|FG004|Double-blind Phase|Protocol Violation|0|||
16344096|NCT01435759|39747519|FG005|Double-blind Phase|Protocol Violation|1|||
16344097|NCT01435759|39747514|FG000|Double-blind Phase|Withdrawal by Subject|17|||
16344098|NCT01435759|39747515|FG001|Double-blind Phase|Withdrawal by Subject|4|||
16344099|NCT01435759|39747516|FG002|Double-blind Phase|Withdrawal by Subject|3|||
16344100|NCT01435759|39747517|FG003|Double-blind Phase|Withdrawal by Subject|4|||
16344101|NCT01435759|39747518|FG004|Double-blind Phase|Withdrawal by Subject|2|||
16408064|NCT00075946|39973464|FG004|Overall Study|Withdrawal by Subject|0|||
16408065|NCT00075946|39973460|FG000|Overall Study|Alternative therapy|16|||
16408066|NCT00075946|39973461|FG001|Overall Study|Alternative therapy|2|||
16221288|NCT00695318|39290623|FG001|Overall Study|Study Terminated|0|||
16221289|NCT01842334|39290624|FG000|Overall Study|Withdrawal by Subject|3|||
16221290|NCT01842334|39290625|FG001|Overall Study|Withdrawal by Subject|3|||
16221291|NCT01842334|39290624|FG000|Overall Study|Moved away mid-study|0|||
16221292|NCT01842334|39290625|FG001|Overall Study|Moved away mid-study|1|||
16221293|NCT02757768|39290626|FG000|Overall Study|Randomized Never Received Study Drug|3|||
16544078|NCT01852058|40456913|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16544079|NCT01852058|40456914|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16544080|NCT01852058|40456915|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16544081|NCT01852058|40456916|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16544082|NCT01852058|40456917|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16544083|NCT01852058|40456918|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16544084|NCT01852058|40456919|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16544085|NCT01852058|40456920|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
16544086|NCT01852058|40456909|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16544087|NCT01852058|40456910|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16544088|NCT01852058|40456911|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16544089|NCT01852058|40456912|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16544090|NCT01852058|40456913|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
16544091|NCT01852058|40456914|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
16221294|NCT02757768|39290627|FG001|Overall Study|Randomized Never Received Study Drug|4|||
16344102|NCT01435759|39747519|FG005|Double-blind Phase|Withdrawal by Subject|2|||
16344103|NCT01435759|39747514|FG000|Double-blind Phase|Lost to Follow-up|31|||
16110124|NCT02485899|38889214|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
16110125|NCT02485899|38889213|FG000|Overall Study|Withdrawal by Subject|1|||
16110126|NCT02485899|38889214|FG001|Overall Study|Withdrawal by Subject|0|||
16110127|NCT02485899|38889213|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
16110128|NCT02485899|38889214|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
16110129|NCT01006889|38889215|FG000|Overall Study|Withdrawal by Subject|3|||
16110130|NCT01169636|38889216|FG000|Overall Study|Adverse Event|0|||
16110131|NCT01169636|38889217|FG001|Overall Study|Adverse Event|0|||
16110132|NCT01169636|38889218|FG002|Overall Study|Adverse Event|1|||
16110133|NCT01169636|38889219|FG003|Overall Study|Adverse Event|1|||
16110134|NCT01169636|38889220|FG004|Overall Study|Adverse Event|0|||
16110135|NCT01169636|38889216|FG000|Overall Study|Screen failure|0|||
16110136|NCT01169636|38889217|FG001|Overall Study|Screen failure|0|||
16110137|NCT01169636|38889218|FG002|Overall Study|Screen failure|2|||
16110138|NCT01169636|38889219|FG003|Overall Study|Screen failure|0|||
16221295|NCT02757768|39290626|FG000|Overall Study|Adverse Event|5|||
16344104|NCT01435759|39747515|FG001|Double-blind Phase|Lost to Follow-up|1|||
16344105|NCT01435759|39747516|FG002|Double-blind Phase|Lost to Follow-up|2|||
16344106|NCT01435759|39747517|FG003|Double-blind Phase|Lost to Follow-up|0|||
16344107|NCT01435759|39747518|FG004|Double-blind Phase|Lost to Follow-up|3|||
16344108|NCT01435759|39747519|FG005|Double-blind Phase|Lost to Follow-up|3|||
16344109|NCT01435759|39747514|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
16344110|NCT01435759|39747515|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
16344111|NCT01435759|39747516|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
16344112|NCT01435759|39747517|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
16344113|NCT01435759|39747518|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
16344114|NCT01435759|39747519|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
16344115|NCT01435759|39747514|FG000|Double-blind Phase|Other|8|||
16344116|NCT01435759|39747515|FG001|Double-blind Phase|Other|2|||
16344117|NCT01435759|39747516|FG002|Double-blind Phase|Other|0|||
16344118|NCT01435759|39747517|FG003|Double-blind Phase|Other|2|||
16344119|NCT01435759|39747518|FG004|Double-blind Phase|Other|0|||
16344120|NCT01435759|39747519|FG005|Double-blind Phase|Other|0|||
16344121|NCT00807365|39747520|FG000|Overall Study|Study Terminated|5|||
16408067|NCT00075946|39973462|FG002|Overall Study|Alternative therapy|5|||
16221296|NCT02757768|39290627|FG001|Overall Study|Adverse Event|3|||
16221297|NCT02757768|39290626|FG000|Overall Study|Lack of Efficacy|2|||
16221298|NCT02757768|39290627|FG001|Overall Study|Lack of Efficacy|1|||
16221299|NCT02757768|39290626|FG000|Overall Study|Lost to Follow-up|1|||
16221300|NCT02757768|39290627|FG001|Overall Study|Lost to Follow-up|0|||
16221301|NCT02757768|39290626|FG000|Overall Study|Protocol Deviation|2|||
16221302|NCT02757768|39290627|FG001|Overall Study|Protocol Deviation|9|||
16221303|NCT02757768|39290626|FG000|Overall Study|Withdrawal by Subject|16|||
16221304|NCT02757768|39290627|FG001|Overall Study|Withdrawal by Subject|9|||
16221305|NCT02757768|39290626|FG000|Overall Study|Miscellaneous|4|||
16221306|NCT02757768|39290627|FG001|Overall Study|Miscellaneous|2|||
16221307|NCT02694562|39290628|FG000|Overall Study|Death|8|||
16221308|NCT02694562|39290628|FG000|Overall Study|Protocol Violation|4|||
16221309|NCT02694562|39290628|FG000|Overall Study|Lost to Follow-up|3|||
16221310|NCT02694562|39290628|FG000|Overall Study|Screen Failure|2|||
16221311|NCT02694562|39290628|FG000|Overall Study|Physician Decision|1|||
16221312|NCT02364999|39290635|FG000|Overall Study|Death|136|||
16221313|NCT02364999|39290636|FG001|Overall Study|Death|138|||
16221314|NCT02364999|39290635|FG000|Overall Study|Lost to Follow-up|10|||
16221315|NCT02364999|39290636|FG001|Overall Study|Lost to Follow-up|15|||
16221316|NCT02364999|39290635|FG000|Overall Study|Protocol Violation|3|||
16221317|NCT02364999|39290636|FG001|Overall Study|Protocol Violation|2|||
16221318|NCT02364999|39290635|FG000|Overall Study|Withdrawal by Subject|14|||
16221319|NCT02364999|39290636|FG001|Overall Study|Withdrawal by Subject|14|||
16221320|NCT02364999|39290635|FG000|Overall Study|Other|0|||
16221321|NCT02364999|39290636|FG001|Overall Study|Other|1|||
16221322|NCT02364999|39290635|FG000|Overall Study|Randomized but did not receive treatment|2|||
16221323|NCT02364999|39290636|FG001|Overall Study|Randomized but did not receive treatment|3|||
16221324|NCT03529162|39290637|FG000|Overall Study|Lost to Follow-up|2|||
16221325|NCT03529162|39290638|FG001|Overall Study|Lost to Follow-up|2|||
16221326|NCT00372905|39290649|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
16221327|NCT00372905|39290650|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
16221328|NCT00372905|39290651|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
16221329|NCT00372905|39290652|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
16221330|NCT00372905|39290649|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
16221331|NCT00372905|39290650|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
16221332|NCT00372905|39290651|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
16221333|NCT00372905|39290652|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
16221334|NCT00372905|39290649|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
16221335|NCT00372905|39290650|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
16221336|NCT00372905|39290651|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
16221337|NCT00372905|39290652|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
16344122|NCT01716520|39747521|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
16344123|NCT01716520|39747522|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
16344124|NCT01716520|39747523|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
16344125|NCT01716520|39747524|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
16344126|NCT01716520|39747525|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
16344127|NCT01716520|39747526|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
16344128|NCT01716520|39747521|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
16344129|NCT01716520|39747522|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
16344130|NCT01716520|39747523|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
16344131|NCT01716520|39747524|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
16344132|NCT01716520|39747525|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
16344133|NCT01716520|39747526|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
16408068|NCT00075946|39973463|FG003|Overall Study|Alternative therapy|0|||
16221338|NCT00372905|39290649|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
16221339|NCT00372905|39290650|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
16221340|NCT00372905|39290651|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
16221341|NCT00372905|39290652|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
16221342|NCT00372905|39290649|FG000|Follow up Until Relapse or Progression|Study closed|0|||
16221343|NCT00372905|39290650|FG001|Follow up Until Relapse or Progression|Study closed|0|||
16221344|NCT00372905|39290651|FG002|Follow up Until Relapse or Progression|Study closed|0|||
16221345|NCT00372905|39290652|FG003|Follow up Until Relapse or Progression|Study closed|3|||
16221346|NCT00372905|39290649|FG000|Follow up Until Relapse or Progression|Other|0|||
16221347|NCT00372905|39290650|FG001|Follow up Until Relapse or Progression|Other|1|||
16221348|NCT00372905|39290651|FG002|Follow up Until Relapse or Progression|Other|0|||
16221349|NCT00372905|39290652|FG003|Follow up Until Relapse or Progression|Other|0|||
16221350|NCT00962780|39290653|FG000|Overall Study|Death|0|||
16221351|NCT00962780|39290654|FG001|Overall Study|Death|1|||
16544092|NCT01852058|40456915|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16544093|NCT01852058|40456916|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16544094|NCT01852058|40456917|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16544095|NCT01852058|40456918|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16544096|NCT01852058|40456919|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16544097|NCT01852058|40456920|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
16544098|NCT01852058|40456909|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544099|NCT01852058|40456910|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544100|NCT01852058|40456911|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544101|NCT01852058|40456912|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544102|NCT01852058|40456913|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544103|NCT01852058|40456914|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544104|NCT01852058|40456915|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544105|NCT01852058|40456916|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
16544106|NCT01852058|40456917|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544107|NCT01852058|40456918|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544108|NCT01852058|40456919|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544109|NCT01852058|40456920|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
16544110|NCT01852058|40456909|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544111|NCT01852058|40456910|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544112|NCT01852058|40456911|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544113|NCT01852058|40456912|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544114|NCT01852058|40456913|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544115|NCT01852058|40456914|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544116|NCT01852058|40456915|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544117|NCT01852058|40456916|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544118|NCT01852058|40456917|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
16544119|NCT01852058|40456918|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544120|NCT01852058|40456919|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544121|NCT01852058|40456920|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
16544122|NCT03214367|40456933|FG000|Lead-in Period|Withdrawal by Subject|50|||
16544123|NCT03214367|40456934|FG001|Lead-in Period|Withdrawal by Subject|0|||
16544124|NCT03214367|40456935|FG002|Lead-in Period|Withdrawal by Subject|0|||
16221352|NCT00962780|39290653|FG000|Overall Study|Protocol Violation|9|||
16221353|NCT00962780|39290654|FG001|Overall Study|Protocol Violation|4|||
16221354|NCT00962780|39290653|FG000|Overall Study|Withdrawal by Subject|1|||
16221355|NCT00962780|39290654|FG001|Overall Study|Withdrawal by Subject|8|||
16221356|NCT00962780|39290653|FG000|Overall Study|Other|0|||
16221357|NCT00962780|39290654|FG001|Overall Study|Other|1|||
16221358|NCT01904760|39290659|FG000|Overall Study|Protocol Violation|1|||
16221359|NCT01904760|39290660|FG001|Overall Study|Protocol Violation|0|||
16221360|NCT00579527|39290665|FG000|Overall Study|Death|4|||
16221361|NCT01064622|39290668|FG000|Randomized Phase II|Withdrawal by Subject|2|||
16221362|NCT01064622|39290669|FG001|Randomized Phase II|Withdrawal by Subject|2|||
16221363|NCT01064622|39290668|FG000|Randomized Phase II|Protocol Violation|0|||
16221364|NCT01064622|39290669|FG001|Randomized Phase II|Protocol Violation|1|||
16221365|NCT01222767|39290670|FG000|Overall Study|Progressive disease|13|||
16221366|NCT01222767|39290670|FG000|Overall Study|Adverse Event|2|||
16221367|NCT01222767|39290670|FG000|Overall Study|Surgical resection|1|||
16221368|NCT01222767|39290670|FG000|Overall Study|Never treated|1|||
16221369|NCT00495794|39290671|FG000|Overall Study|Pharmacist did not activate patient|522|||
16221370|NCT00495794|39290672|FG001|Overall Study|Pharmacist did not activate patient|0|||
16221371|NCT04439266|39290673|FG000|Overall Study|Ineligible|1|||
16221372|NCT04439266|39290673|FG000|Overall Study|Adverse Event|1|||
16221373|NCT04439266|39290673|FG000|Overall Study|Death|1|||
16221374|NCT04439266|39290673|FG000|Overall Study|Disease progression|1|||
16221375|NCT04439266|39290673|FG000|Overall Study|Still on treatment|1|||
16544125|NCT03214367|40456936|FG003|Lead-in Period|Withdrawal by Subject|0|||
16544126|NCT03214367|40456937|FG004|Lead-in Period|Withdrawal by Subject|2|||
16544127|NCT03214367|40456938|FG005|Lead-in Period|Withdrawal by Subject|0|||
16544128|NCT03214367|40456939|FG006|Lead-in Period|Withdrawal by Subject|0|||
16544129|NCT03214367|40456940|FG007|Lead-in Period|Withdrawal by Subject|0|||
16544130|NCT03214367|40456933|FG000|Lead-in Period|Adverse Event|3|||
16544131|NCT03214367|40456934|FG001|Lead-in Period|Adverse Event|0|||
16544132|NCT03214367|40456935|FG002|Lead-in Period|Adverse Event|0|||
16544133|NCT03214367|40456936|FG003|Lead-in Period|Adverse Event|0|||
16544134|NCT03214367|40456937|FG004|Lead-in Period|Adverse Event|0|||
16544135|NCT03214367|40456938|FG005|Lead-in Period|Adverse Event|0|||
16544136|NCT03214367|40456939|FG006|Lead-in Period|Adverse Event|0|||
16544137|NCT03214367|40456940|FG007|Lead-in Period|Adverse Event|0|||
16544138|NCT03214367|40456933|FG000|Lead-in Period|Lost to Follow-up|12|||
16544139|NCT03214367|40456934|FG001|Lead-in Period|Lost to Follow-up|0|||
16544140|NCT03214367|40456935|FG002|Lead-in Period|Lost to Follow-up|0|||
16544141|NCT03214367|40456936|FG003|Lead-in Period|Lost to Follow-up|0|||
16544142|NCT03214367|40456937|FG004|Lead-in Period|Lost to Follow-up|0|||
16544143|NCT03214367|40456938|FG005|Lead-in Period|Lost to Follow-up|0|||
16544144|NCT03214367|40456939|FG006|Lead-in Period|Lost to Follow-up|0|||
16544145|NCT03214367|40456940|FG007|Lead-in Period|Lost to Follow-up|0|||
16544146|NCT03214367|40456933|FG000|Lead-in Period|Sponsor Decision|11|||
16544147|NCT03214367|40456934|FG001|Lead-in Period|Sponsor Decision|0|||
16544148|NCT03214367|40456935|FG002|Lead-in Period|Sponsor Decision|0|||
16544149|NCT03214367|40456936|FG003|Lead-in Period|Sponsor Decision|0|||
16544150|NCT03214367|40456937|FG004|Lead-in Period|Sponsor Decision|0|||
16544151|NCT03214367|40456938|FG005|Lead-in Period|Sponsor Decision|0|||
16544152|NCT03214367|40456939|FG006|Lead-in Period|Sponsor Decision|0|||
16544153|NCT03214367|40456940|FG007|Lead-in Period|Sponsor Decision|0|||
16544154|NCT03214367|40456933|FG000|Lead-in Period|Physician Decision|12|||
16544155|NCT03214367|40456934|FG001|Lead-in Period|Physician Decision|0|||
16544156|NCT03214367|40456935|FG002|Lead-in Period|Physician Decision|0|||
16544157|NCT03214367|40456936|FG003|Lead-in Period|Physician Decision|0|||
16544158|NCT03214367|40456937|FG004|Lead-in Period|Physician Decision|0|||
16544159|NCT03214367|40456938|FG005|Lead-in Period|Physician Decision|0|||
16544160|NCT03214367|40456939|FG006|Lead-in Period|Physician Decision|0|||
16544161|NCT03214367|40456940|FG007|Lead-in Period|Physician Decision|0|||
16544162|NCT03214367|40456933|FG000|Lead-in Period|Protocol Violation|5|||
16544163|NCT03214367|40456934|FG001|Lead-in Period|Protocol Violation|0|||
16544164|NCT03214367|40456935|FG002|Lead-in Period|Protocol Violation|0|||
16544165|NCT03214367|40456936|FG003|Lead-in Period|Protocol Violation|0|||
16544166|NCT03214367|40456937|FG004|Lead-in Period|Protocol Violation|0|||
16544167|NCT03214367|40456938|FG005|Lead-in Period|Protocol Violation|0|||
16544168|NCT03214367|40456939|FG006|Lead-in Period|Protocol Violation|0|||
16544169|NCT03214367|40456940|FG007|Lead-in Period|Protocol Violation|0|||
16544170|NCT03214367|40456933|FG000|Lead-in Period|Treatment Interruption|1|||
16544171|NCT03214367|40456934|FG001|Lead-in Period|Treatment Interruption|0|||
16544172|NCT03214367|40456935|FG002|Lead-in Period|Treatment Interruption|0|||
16544173|NCT03214367|40456936|FG003|Lead-in Period|Treatment Interruption|0|||
16544174|NCT03214367|40456937|FG004|Lead-in Period|Treatment Interruption|0|||
16544175|NCT03214367|40456938|FG005|Lead-in Period|Treatment Interruption|0|||
16544176|NCT03214367|40456939|FG006|Lead-in Period|Treatment Interruption|0|||
16544177|NCT03214367|40456940|FG007|Lead-in Period|Treatment Interruption|0|||
16544178|NCT03214367|40456933|FG000|Treatment Period|Adverse Event|0|||
16544179|NCT03214367|40456934|FG001|Treatment Period|Adverse Event|1|||
16344134|NCT01716520|39747521|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16544180|NCT03214367|40456935|FG002|Treatment Period|Adverse Event|4|||
16544181|NCT03214367|40456936|FG003|Treatment Period|Adverse Event|2|||
16544182|NCT03214367|40456937|FG004|Treatment Period|Adverse Event|0|||
16544183|NCT03214367|40456938|FG005|Treatment Period|Adverse Event|0|||
16544184|NCT03214367|40456939|FG006|Treatment Period|Adverse Event|0|||
16544185|NCT03214367|40456940|FG007|Treatment Period|Adverse Event|0|||
16544186|NCT03214367|40456933|FG000|Treatment Period|Death|0|||
16221376|NCT00948389|39290675|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
16110139|NCT01169636|38889220|FG004|Overall Study|Screen failure|0|||
16110140|NCT01169636|38889216|FG000|Overall Study|Withdrawal by Subject|0|||
16110141|NCT01169636|38889217|FG001|Overall Study|Withdrawal by Subject|0|||
16110142|NCT01169636|38889218|FG002|Overall Study|Withdrawal by Subject|0|||
16110143|NCT01169636|38889219|FG003|Overall Study|Withdrawal by Subject|0|||
16110144|NCT01169636|38889220|FG004|Overall Study|Withdrawal by Subject|3|||
16110145|NCT00632021|38889223|FG000|Overall Study|Withdrawal/death|4|||
16110146|NCT00632021|38889224|FG001|Overall Study|Withdrawal/death|7|||
16221377|NCT00948389|39290676|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
16221378|NCT00948389|39290677|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
16221379|NCT00948389|39290678|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
16544187|NCT03214367|40456934|FG001|Treatment Period|Death|1|||
16544188|NCT03214367|40456935|FG002|Treatment Period|Death|1|||
16221380|NCT00948389|39290679|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
16221381|NCT00948389|39290675|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
16221382|NCT00948389|39290676|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
16544189|NCT03214367|40456936|FG003|Treatment Period|Death|1|||
16544190|NCT03214367|40456937|FG004|Treatment Period|Death|0|||
16544191|NCT03214367|40456938|FG005|Treatment Period|Death|0|||
16544192|NCT03214367|40456939|FG006|Treatment Period|Death|0|||
16110147|NCT00590564|38889225|FG000|Overall Study|Withdrawal by Subject|4|||
16110148|NCT00590564|38889225|FG000|Overall Study|Lost to Follow-up|6|||
16110149|NCT00590564|38889225|FG000|Overall Study|Protocol Violation|1|||
16110150|NCT00590564|38889225|FG000|Overall Study|Patient Found to be Ineligible|1|||
16110151|NCT00590564|38889225|FG000|Overall Study|Patient Non-compliance|6|||
16110152|NCT03765164|38889226|FG000|Pre-intervention|Withdrawal by Subject|5|||
16110153|NCT03765164|38889227|FG001|Pre-intervention|Withdrawal by Subject|6|||
16110154|NCT00320398|38889228|FG000|Overall Study|Adverse Event|1|||
16110155|NCT00320398|38889229|FG001|Overall Study|Adverse Event|4|||
16110156|NCT00320398|38889228|FG000|Overall Study|Other|1|||
16110157|NCT00320398|38889229|FG001|Overall Study|Other|0|||
16110158|NCT03569475|38889232|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
16110159|NCT03569475|38889233|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
16110160|NCT03569475|38889234|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
16110161|NCT03569475|38889232|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
16110162|NCT03569475|38889233|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
16221383|NCT00948389|39290677|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
16544193|NCT03214367|40456940|FG007|Treatment Period|Death|0|||
16544194|NCT03214367|40456933|FG000|Treatment Period|Lost to Follow-up|0|||
16544195|NCT03214367|40456934|FG001|Treatment Period|Lost to Follow-up|5|||
16544196|NCT03214367|40456935|FG002|Treatment Period|Lost to Follow-up|3|||
16544197|NCT03214367|40456936|FG003|Treatment Period|Lost to Follow-up|2|||
16544198|NCT03214367|40456937|FG004|Treatment Period|Lost to Follow-up|0|||
16544199|NCT03214367|40456938|FG005|Treatment Period|Lost to Follow-up|2|||
16544200|NCT03214367|40456939|FG006|Treatment Period|Lost to Follow-up|1|||
16544201|NCT03214367|40456940|FG007|Treatment Period|Lost to Follow-up|0|||
16544202|NCT03214367|40456933|FG000|Treatment Period|Sponsor Decision|0|||
16544203|NCT03214367|40456934|FG001|Treatment Period|Sponsor Decision|3|||
16544204|NCT03214367|40456935|FG002|Treatment Period|Sponsor Decision|0|||
16544205|NCT03214367|40456936|FG003|Treatment Period|Sponsor Decision|0|||
16544206|NCT03214367|40456937|FG004|Treatment Period|Sponsor Decision|0|||
16544207|NCT03214367|40456938|FG005|Treatment Period|Sponsor Decision|0|||
16544208|NCT03214367|40456939|FG006|Treatment Period|Sponsor Decision|0|||
16544209|NCT03214367|40456940|FG007|Treatment Period|Sponsor Decision|0|||
16544210|NCT03214367|40456933|FG000|Treatment Period|Physician Decision|0|||
16544211|NCT03214367|40456934|FG001|Treatment Period|Physician Decision|1|||
16544212|NCT03214367|40456935|FG002|Treatment Period|Physician Decision|2|||
16544213|NCT03214367|40456936|FG003|Treatment Period|Physician Decision|0|||
16544214|NCT03214367|40456937|FG004|Treatment Period|Physician Decision|0|||
16544215|NCT03214367|40456938|FG005|Treatment Period|Physician Decision|0|||
16544216|NCT03214367|40456939|FG006|Treatment Period|Physician Decision|0|||
16544217|NCT03214367|40456940|FG007|Treatment Period|Physician Decision|0|||
16544218|NCT03214367|40456933|FG000|Treatment Period|Protocol Violation|0|||
16544219|NCT03214367|40456934|FG001|Treatment Period|Protocol Violation|3|||
16544220|NCT03214367|40456935|FG002|Treatment Period|Protocol Violation|0|||
16544221|NCT03214367|40456936|FG003|Treatment Period|Protocol Violation|0|||
16110163|NCT03569475|38889234|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
16110164|NCT03569475|38889232|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
16110165|NCT03569475|38889233|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
16110166|NCT03569475|38889234|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
16110167|NCT03569475|38889232|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
16110168|NCT03569475|38889233|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
16110169|NCT03569475|38889234|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
16110170|NCT03569475|38889232|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
16110171|NCT03569475|38889233|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
16110172|NCT03569475|38889234|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
16110173|NCT03569475|38889232|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
16110174|NCT03569475|38889233|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
16110175|NCT03569475|38889234|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
16110176|NCT03569475|38889232|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
16110177|NCT03569475|38889233|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
16110178|NCT03569475|38889234|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
16110179|NCT03569475|38889232|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
16110180|NCT03569475|38889233|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
16110181|NCT03569475|38889234|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
16110182|NCT03569475|38889232|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
16221384|NCT00948389|39290678|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
16544222|NCT03214367|40456937|FG004|Treatment Period|Protocol Violation|0|||
16544223|NCT03214367|40456938|FG005|Treatment Period|Protocol Violation|0|||
16544224|NCT03214367|40456939|FG006|Treatment Period|Protocol Violation|0|||
16544225|NCT03214367|40456940|FG007|Treatment Period|Protocol Violation|0|||
16544226|NCT03214367|40456933|FG000|Treatment Period|Withdrawal by Subject|0|||
16544227|NCT03214367|40456934|FG001|Treatment Period|Withdrawal by Subject|20|||
16544228|NCT03214367|40456935|FG002|Treatment Period|Withdrawal by Subject|23|||
16544229|NCT03214367|40456936|FG003|Treatment Period|Withdrawal by Subject|14|||
16544230|NCT03214367|40456937|FG004|Treatment Period|Withdrawal by Subject|0|||
16544231|NCT03214367|40456938|FG005|Treatment Period|Withdrawal by Subject|1|||
16544232|NCT03214367|40456939|FG006|Treatment Period|Withdrawal by Subject|1|||
16544233|NCT03214367|40456940|FG007|Treatment Period|Withdrawal by Subject|1|||
16544234|NCT00855595|40456941|FG000|Overall Study|Withdrawal by Subject|1|||
16544235|NCT00855595|40456942|FG001|Overall Study|Withdrawal by Subject|2|||
16544236|NCT00855595|40456941|FG000|Overall Study|Lost to Follow-up|3|||
16544237|NCT00855595|40456942|FG001|Overall Study|Lost to Follow-up|3|||
16544238|NCT00855595|40456941|FG000|Overall Study|Adverse Event|1|||
16544239|NCT00855595|40456942|FG001|Overall Study|Adverse Event|1|||
16544240|NCT00855595|40456941|FG000|Overall Study|patient moved out of state|1|||
16544241|NCT00855595|40456942|FG001|Overall Study|patient moved out of state|0|||
16544242|NCT00855595|40456941|FG000|Overall Study|patient left country|0|||
16544243|NCT00855595|40456942|FG001|Overall Study|patient left country|1|||
16544244|NCT01352585|40456943|FG000|Overall Study|Adverse Event|2|||
16544245|NCT01352585|40456944|FG001|Overall Study|Adverse Event|1|||
16544246|NCT01352585|40456943|FG000|Overall Study|Lost to Follow-up|1|||
16544247|NCT01352585|40456944|FG001|Overall Study|Lost to Follow-up|0|||
16544248|NCT01352585|40456943|FG000|Overall Study|Other|5|||
16544249|NCT01352585|40456944|FG001|Overall Study|Other|2|||
16544250|NCT00746096|40456945|FG000|Overall Study|Adverse Event|1|||
16544251|NCT00746096|40456946|FG001|Overall Study|Adverse Event|0|||
16544252|NCT00746096|40456945|FG000|Overall Study|Withdrawal by Subject|5|||
16544253|NCT00746096|40456946|FG001|Overall Study|Withdrawal by Subject|1|||
16544254|NCT00746096|40456945|FG000|Overall Study|Lost to Follow-up|2|||
16544255|NCT00746096|40456946|FG001|Overall Study|Lost to Follow-up|1|||
16544256|NCT00746096|40456945|FG000|Overall Study|Protocol Violation|1|||
16544257|NCT00746096|40456946|FG001|Overall Study|Protocol Violation|0|||
16544258|NCT00746096|40456945|FG000|Overall Study|No study drug treatment|1|||
16544259|NCT00746096|40456946|FG001|Overall Study|No study drug treatment|1|||
16544260|NCT04098406|40456947|FG000|Overall Study|Adverse Event|2|||
16544261|NCT04098406|40456948|FG001|Overall Study|Adverse Event|1|||
16544262|NCT04098406|40456947|FG000|Overall Study|Withdrawal by Subject|1|||
16544263|NCT04098406|40456948|FG001|Overall Study|Withdrawal by Subject|0|||
16544264|NCT00885352|40456949|FG000|Overall Study|Adverse Event|2|||
16544265|NCT00885352|40456950|FG001|Overall Study|Adverse Event|3|||
16544266|NCT00885352|40456949|FG000|Overall Study|Lost to Follow-up|2|||
16544267|NCT00885352|40456950|FG001|Overall Study|Lost to Follow-up|2|||
16544268|NCT00885352|40456949|FG000|Overall Study|Physician Decision|0|||
16544269|NCT00885352|40456950|FG001|Overall Study|Physician Decision|3|||
16544270|NCT00885352|40456949|FG000|Overall Study|Protocol Violation|0|||
16544271|NCT00885352|40456950|FG001|Overall Study|Protocol Violation|2|||
16544272|NCT00885352|40456949|FG000|Overall Study|Withdrawal by Subject|1|||
16544273|NCT00885352|40456950|FG001|Overall Study|Withdrawal by Subject|5|||
16110183|NCT03569475|38889233|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
16110184|NCT03569475|38889234|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
16110185|NCT00878553|38889236|FG000|Sleep Study|Withdrawal by Subject|2|||
16110186|NCT00878553|38889237|FG001|Sleep Study|Withdrawal by Subject|0|||
16221385|NCT00948389|39290679|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
16110187|NCT00878553|38889238|FG002|Sleep Study|Withdrawal by Subject|0|||
16110188|NCT00878553|38889239|FG003|Sleep Study|Withdrawal by Subject|0|||
16110189|NCT00878553|38889240|FG004|Sleep Study|Withdrawal by Subject|0|||
16110190|NCT00878553|38889236|FG000|Sleep Study|Lost to Follow-up|1|||
16110191|NCT00878553|38889237|FG001|Sleep Study|Lost to Follow-up|0|||
16408069|NCT00075946|39973464|FG004|Overall Study|Alternative therapy|0|||
16408070|NCT00075946|39973460|FG000|Overall Study|Other complicating disease|7|||
16408071|NCT00075946|39973461|FG001|Overall Study|Other complicating disease|13|||
16408072|NCT00075946|39973462|FG002|Overall Study|Other complicating disease|1|||
16408073|NCT00075946|39973463|FG003|Overall Study|Other complicating disease|4|||
16408074|NCT00075946|39973464|FG004|Overall Study|Other complicating disease|0|||
16408075|NCT00075946|39973460|FG000|Overall Study|No response to retreatment|23|||
16408076|NCT00075946|39973461|FG001|Overall Study|No response to retreatment|0|||
16408077|NCT00075946|39973462|FG002|Overall Study|No response to retreatment|2|||
16408078|NCT00075946|39973463|FG003|Overall Study|No response to retreatment|0|||
16408079|NCT00075946|39973464|FG004|Overall Study|No response to retreatment|0|||
16408080|NCT00075946|39973460|FG000|Overall Study|Time to progression less than 6 months|15|||
16408081|NCT00075946|39973461|FG001|Overall Study|Time to progression less than 6 months|30|||
16544274|NCT00885352|40456949|FG000|Overall Study|Contradiction to study medication|0|||
16544275|NCT00885352|40456950|FG001|Overall Study|Contradiction to study medication|2|||
16544276|NCT00885352|40456949|FG000|Overall Study|Excluded medication|2|||
16544277|NCT00885352|40456950|FG001|Overall Study|Excluded medication|2|||
16544278|NCT00885352|40456949|FG000|Overall Study|Lab abnormalities|1|||
16544279|NCT00885352|40456950|FG001|Overall Study|Lab abnormalities|1|||
16344135|NCT01716520|39747522|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
16344136|NCT01716520|39747523|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16344137|NCT01716520|39747524|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16344138|NCT01716520|39747525|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16110192|NCT00878553|38889238|FG002|Sleep Study|Lost to Follow-up|0|||
16344139|NCT01716520|39747526|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
16544280|NCT03573908|40456953|FG000|Treatment Period|Adverse Event|4|||
16544281|NCT03573908|40456954|FG001|Treatment Period|Adverse Event|9|||
16110193|NCT00878553|38889239|FG003|Sleep Study|Lost to Follow-up|0|||
16110194|NCT00878553|38889240|FG004|Sleep Study|Lost to Follow-up|0|||
16110195|NCT00878553|38889236|FG000|Sleep Study|car accident|1|||
16221386|NCT00948389|39290675|FG000|Overall Study|Both Progression and Toxicity|1|||
16221387|NCT00948389|39290676|FG001|Overall Study|Both Progression and Toxicity|0|||
16544282|NCT03573908|40456955|FG002|Treatment Period|Adverse Event|0|||
16544283|NCT03573908|40456956|FG003|Treatment Period|Adverse Event|0|||
16544284|NCT03573908|40456957|FG004|Treatment Period|Adverse Event|0|||
16544285|NCT03573908|40456953|FG000|Treatment Period|Protocol Violation|1|||
16544286|NCT03573908|40456954|FG001|Treatment Period|Protocol Violation|0|||
16544287|NCT03573908|40456955|FG002|Treatment Period|Protocol Violation|0|||
16544288|NCT03573908|40456956|FG003|Treatment Period|Protocol Violation|0|||
16544289|NCT03573908|40456957|FG004|Treatment Period|Protocol Violation|0|||
16544290|NCT03573908|40456953|FG000|Treatment Period|Withdrawal by Subject|7|||
16544291|NCT03573908|40456954|FG001|Treatment Period|Withdrawal by Subject|5|||
16544292|NCT03573908|40456955|FG002|Treatment Period|Withdrawal by Subject|0|||
16544293|NCT03573908|40456956|FG003|Treatment Period|Withdrawal by Subject|0|||
16221388|NCT00948389|39290677|FG002|Overall Study|Both Progression and Toxicity|0|||
16344140|NCT01716520|39747521|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
16544294|NCT03573908|40456957|FG004|Treatment Period|Withdrawal by Subject|0|||
16544295|NCT03573908|40456953|FG000|Treatment Period|Lost to Follow-up|7|||
16544296|NCT03573908|40456954|FG001|Treatment Period|Lost to Follow-up|6|||
16110196|NCT00878553|38889237|FG001|Sleep Study|car accident|0|||
16110197|NCT00878553|38889238|FG002|Sleep Study|car accident|0|||
16110198|NCT00878553|38889239|FG003|Sleep Study|car accident|0|||
16110199|NCT00878553|38889240|FG004|Sleep Study|car accident|0|||
16110200|NCT00878553|38889236|FG000|Sleep Study|family emergency|1|||
16110201|NCT00878553|38889237|FG001|Sleep Study|family emergency|0|||
16544297|NCT03573908|40456955|FG002|Treatment Period|Lost to Follow-up|0|||
16544298|NCT03573908|40456956|FG003|Treatment Period|Lost to Follow-up|0|||
16110202|NCT00878553|38889238|FG002|Sleep Study|family emergency|0|||
16221389|NCT00948389|39290678|FG003|Overall Study|Both Progression and Toxicity|0|||
16544299|NCT03573908|40456957|FG004|Treatment Period|Lost to Follow-up|0|||
16110203|NCT00878553|38889239|FG003|Sleep Study|family emergency|0|||
16221390|NCT00948389|39290679|FG004|Overall Study|Both Progression and Toxicity|0|||
16544300|NCT03573908|40456953|FG000|Treatment Period|Pregnancy|1|||
16221391|NCT02354690|39290680|FG000|Overall Study|Physician Decision|1|||
16344141|NCT01716520|39747522|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
16344142|NCT01716520|39747523|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
16408082|NCT00075946|39973462|FG002|Overall Study|Time to progression less than 6 months|8|||
16408083|NCT00075946|39973463|FG003|Overall Study|Time to progression less than 6 months|3|||
16408084|NCT00075946|39973464|FG004|Overall Study|Time to progression less than 6 months|0|||
16408085|NCT00075946|39973460|FG000|Overall Study|Other|57|||
16408086|NCT00075946|39973461|FG001|Overall Study|Other|32|||
16408087|NCT00075946|39973462|FG002|Overall Study|Other|3|||
16544301|NCT03573908|40456954|FG001|Treatment Period|Pregnancy|0|||
16544302|NCT03573908|40456955|FG002|Treatment Period|Pregnancy|0|||
16544303|NCT03573908|40456956|FG003|Treatment Period|Pregnancy|0|||
16344143|NCT01716520|39747524|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
16344144|NCT01716520|39747525|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
16344145|NCT01716520|39747526|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
16344146|NCT01716520|39747521|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16344147|NCT01716520|39747522|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16344148|NCT01716520|39747523|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16344149|NCT01716520|39747524|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16344150|NCT01716520|39747525|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
16344151|NCT01716520|39747526|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
16344152|NCT01716520|39747521|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
16344153|NCT01716520|39747522|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
16344154|NCT01716520|39747523|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
16344155|NCT01716520|39747524|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
16344156|NCT01716520|39747525|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
16344157|NCT01716520|39747526|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
16344158|NCT01716520|39747521|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
16544304|NCT03573908|40456957|FG004|Treatment Period|Pregnancy|0|||
16544305|NCT03573908|40456953|FG000|Treatment Period|Other, Not Specified|4|||
16544306|NCT03573908|40456954|FG001|Treatment Period|Other, Not Specified|6|||
16544307|NCT03573908|40456955|FG002|Treatment Period|Other, Not Specified|0|||
16544308|NCT03573908|40456956|FG003|Treatment Period|Other, Not Specified|0|||
16544309|NCT03573908|40456957|FG004|Treatment Period|Other, Not Specified|0|||
16544310|NCT03573908|40456953|FG000|Randomized Withdrawal Period|Adverse Event|0|||
16544311|NCT03573908|40456954|FG001|Randomized Withdrawal Period|Adverse Event|0|||
16544312|NCT03573908|40456955|FG002|Randomized Withdrawal Period|Adverse Event|3|||
16544313|NCT03573908|40456956|FG003|Randomized Withdrawal Period|Adverse Event|0|||
16544314|NCT03573908|40456957|FG004|Randomized Withdrawal Period|Adverse Event|0|||
16544315|NCT03573908|40456953|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16544316|NCT03573908|40456954|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16544317|NCT03573908|40456955|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16544318|NCT03573908|40456956|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16544319|NCT03573908|40456957|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
16544320|NCT03573908|40456953|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
16544321|NCT03573908|40456954|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
16544322|NCT03573908|40456955|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
16544323|NCT03573908|40456956|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
16544324|NCT03573908|40456957|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
16544325|NCT03573908|40456953|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
16544326|NCT03573908|40456954|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
16544327|NCT03573908|40456955|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
16544328|NCT03573908|40456956|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
16544329|NCT03573908|40456957|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
16544330|NCT02234063|40456958|FG000|Overall Study|Lost to Follow-up|235|||
16544331|NCT02234063|40456959|FG001|Overall Study|Lost to Follow-up|42|||
16544332|NCT02234063|40456958|FG000|Overall Study|Withdrawal by Subject|20|||
16544333|NCT02234063|40456959|FG001|Overall Study|Withdrawal by Subject|1|||
16544334|NCT00116272|40456960|FG000|Overall Study|Lost to Follow-up|11|||
16544335|NCT00116272|40456961|FG001|Overall Study|Lost to Follow-up|6|||
16544336|NCT01820559|40456972|FG000|Overall Study|Adverse Event|4|||
16544337|NCT01820559|40456973|FG001|Overall Study|Adverse Event|6|||
16544338|NCT01820559|40456974|FG002|Overall Study|Adverse Event|13|||
16544339|NCT01820559|40456972|FG000|Overall Study|Withdrawal by Subject|1|||
16408088|NCT00075946|39973463|FG003|Overall Study|Other|11|||
16408089|NCT00075946|39973464|FG004|Overall Study|Other|0|||
16408090|NCT00405964|39973465|FG000|Overall Study|Treatment Failure|17|||
16408091|NCT00405964|39973466|FG001|Overall Study|Treatment Failure|45|||
16544340|NCT01820559|40456973|FG001|Overall Study|Withdrawal by Subject|2|||
16544341|NCT01820559|40456974|FG002|Overall Study|Withdrawal by Subject|5|||
16544342|NCT01820559|40456972|FG000|Overall Study|Protocol Violation|2|||
16544343|NCT01820559|40456973|FG001|Overall Study|Protocol Violation|1|||
16110204|NCT00878553|38889240|FG004|Sleep Study|family emergency|0|||
16408092|NCT00405964|39973465|FG000|Overall Study|Adverse Event|7|||
16408093|NCT00405964|39973466|FG001|Overall Study|Adverse Event|16|||
16344159|NCT01716520|39747522|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
16344160|NCT01716520|39747523|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
16344161|NCT01716520|39747524|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
16344162|NCT01716520|39747525|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
16221392|NCT04806334|39290685|FG000|Overall Study|Withdrawal by Subject|1|||
16344163|NCT01716520|39747526|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
16344164|NCT01716520|39747521|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16344165|NCT01716520|39747522|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16344166|NCT01716520|39747523|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16344167|NCT01716520|39747524|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16344168|NCT01716520|39747525|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
16344169|NCT01716520|39747526|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16344170|NCT01716520|39747521|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
16408094|NCT00405964|39973465|FG000|Overall Study|Lost to Follow-up|5|||
16408095|NCT00405964|39973466|FG001|Overall Study|Lost to Follow-up|5|||
16408096|NCT00405964|39973465|FG000|Overall Study|Withdrawal by Subject|19|||
16408097|NCT00405964|39973466|FG001|Overall Study|Withdrawal by Subject|23|||
16408098|NCT00405964|39973465|FG000|Overall Study|Protocol Violation|11|||
16408099|NCT00405964|39973466|FG001|Overall Study|Protocol Violation|6|||
16408100|NCT03816176|39973467|FG000|Overall Study|Miscellaneous|5|||
16408101|NCT03816176|39973467|FG000|Overall Study|Lack of Efficacy|4|||
16408102|NCT03816176|39973467|FG000|Overall Study|Adverse Event|3|||
16408103|NCT03141788|39973477|FG000|Overall Study|Lost to Follow-up|1|||
16408104|NCT03141788|39973477|FG000|Overall Study|Protocol Violation|3|||
16408105|NCT03141788|39973477|FG000|Overall Study|Withdrawal by Subject|4|||
16408106|NCT02914548|39973480|FG000|Overall Study|Adverse Event|15|||
16408107|NCT02914548|39973481|FG001|Overall Study|Adverse Event|7|||
16408108|NCT02914548|39973482|FG002|Overall Study|Adverse Event|15|||
16408109|NCT02914548|39973480|FG000|Overall Study|Physician Decision|2|||
16408110|NCT02914548|39973481|FG001|Overall Study|Physician Decision|2|||
16408111|NCT02914548|39973482|FG002|Overall Study|Physician Decision|0|||
16408112|NCT02914548|39973480|FG000|Overall Study|Protocol Violation|1|||
16408113|NCT02914548|39973481|FG001|Overall Study|Protocol Violation|0|||
16408114|NCT02914548|39973482|FG002|Overall Study|Protocol Violation|0|||
16408115|NCT02914548|39973480|FG000|Overall Study|Withdrawal by Subject|3|||
16408116|NCT02914548|39973481|FG001|Overall Study|Withdrawal by Subject|4|||
16408117|NCT02914548|39973482|FG002|Overall Study|Withdrawal by Subject|4|||
16408118|NCT02914548|39973480|FG000|Overall Study|>40% of body surface area|0|||
16408119|NCT02914548|39973481|FG001|Overall Study|>40% of body surface area|1|||
16408120|NCT02914548|39973482|FG002|Overall Study|>40% of body surface area|1|||
16408121|NCT00983515|39973483|FG000|Ritonavir Alone|liver panel out of range|6|||
16408122|NCT00983515|39973483|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
16408123|NCT02635347|39973484|FG000|Overall Study|Failed screening|20|||
16544344|NCT01820559|40456974|FG002|Overall Study|Protocol Violation|3|||
16544345|NCT01820559|40456972|FG000|Overall Study|Subject's non-compliance|1|||
16544346|NCT01820559|40456973|FG001|Overall Study|Subject's non-compliance|0|||
16544347|NCT01820559|40456974|FG002|Overall Study|Subject's non-compliance|2|||
16544348|NCT01820559|40456972|FG000|Overall Study|Lost to Follow-up|3|||
16544349|NCT01820559|40456973|FG001|Overall Study|Lost to Follow-up|2|||
16544350|NCT01820559|40456974|FG002|Overall Study|Lost to Follow-up|2|||
16544351|NCT01820559|40456972|FG000|Overall Study|At sponsor request|0|||
16544352|NCT01820559|40456973|FG001|Overall Study|At sponsor request|0|||
16408124|NCT02635347|39973485|FG001|Overall Study|Failed screening|7|||
16408125|NCT01514240|39976846|FG000|Overall Study|Adverse Event|4|||
16408126|NCT01514240|39976847|FG001|Overall Study|Adverse Event|4|||
16408127|NCT01514240|39976846|FG000|Overall Study|Subject Decision|2|||
16408128|NCT01514240|39976847|FG001|Overall Study|Subject Decision|7|||
16408129|NCT01338610|39976850|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
16544353|NCT01820559|40456974|FG002|Overall Study|At sponsor request|1|||
16544354|NCT01820559|40456972|FG000|Overall Study|Lack of Efficacy|3|||
16408130|NCT01338610|39976851|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
16544355|NCT01820559|40456973|FG001|Overall Study|Lack of Efficacy|2|||
16544356|NCT01820559|40456974|FG002|Overall Study|Lack of Efficacy|3|||
16544357|NCT04425902|40456976|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
16544358|NCT02404389|40456977|FG000|Overall Study|Adverse Event|1|||
16544359|NCT02404389|40456978|FG001|Overall Study|Adverse Event|0|||
16344171|NCT01716520|39747522|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
16344172|NCT01716520|39747523|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
16344173|NCT01716520|39747524|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
16344174|NCT01716520|39747525|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
16344175|NCT01716520|39747526|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
16344176|NCT01716520|39747521|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
16344177|NCT01716520|39747522|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
16344178|NCT01716520|39747523|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
16344179|NCT01716520|39747524|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
16344180|NCT01716520|39747525|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
16344181|NCT01716520|39747526|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
16344182|NCT01716520|39747521|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
16344183|NCT01716520|39747522|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
16344184|NCT01716520|39747523|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
16344185|NCT01716520|39747524|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
16344186|NCT01716520|39747525|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
16344187|NCT01716520|39747526|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
16344188|NCT01716520|39747521|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
16344189|NCT01716520|39747522|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
16344190|NCT01716520|39747523|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
16344191|NCT01716520|39747524|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
16344192|NCT01716520|39747525|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
16344193|NCT01716520|39747526|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
16344194|NCT01716520|39747521|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
16344195|NCT01716520|39747522|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
16344196|NCT01716520|39747523|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
16344197|NCT01716520|39747524|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
16344198|NCT01716520|39747525|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
16344199|NCT01716520|39747526|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
16344200|NCT01716520|39747521|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16344201|NCT01716520|39747522|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16344202|NCT01716520|39747523|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16344203|NCT01716520|39747524|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16344204|NCT01716520|39747525|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
16344205|NCT01716520|39747526|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
16344206|NCT01716520|39747521|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16344207|NCT01716520|39747522|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16344208|NCT01716520|39747523|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
16344209|NCT01716520|39747524|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16344210|NCT01716520|39747525|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16344211|NCT01716520|39747526|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
16344212|NCT00357877|39747529|FG000|Overall Study|Death|2|||
16344213|NCT00357877|39747530|FG001|Overall Study|Death|1|||
16344214|NCT00357877|39747529|FG000|Overall Study|Lost to Follow-up|20|||
16344215|NCT00357877|39747530|FG001|Overall Study|Lost to Follow-up|23|||
16344216|NCT00357877|39747529|FG000|Overall Study|Withdrawal by Subject|3|||
16344217|NCT00357877|39747530|FG001|Overall Study|Withdrawal by Subject|3|||
16344218|NCT00357877|39747529|FG000|Overall Study|Administrative withdrawal|1|||
16344219|NCT00357877|39747530|FG001|Overall Study|Administrative withdrawal|1|||
16344220|NCT00357877|39747529|FG000|Overall Study|Other|0|||
16344221|NCT00357877|39747530|FG001|Overall Study|Other|2|||
16344222|NCT01307891|39747531|FG000|Overall Study|Progressive Disease|3|||
16344223|NCT01307891|39747532|FG001|Overall Study|Progressive Disease|1|||
16344224|NCT00217581|39747537|FG000|Overall Study|Withdrawal by Subject|1|||
16344225|NCT00391872|39747538|FG000|Overall Study|Protocol Violation|7|||
16544360|NCT02404389|40456979|FG002|Overall Study|Adverse Event|1|||
16544361|NCT02404389|40456980|FG003|Overall Study|Adverse Event|0|||
16408131|NCT01338610|39976852|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
16408132|NCT01338610|39976850|FG000|Overall Study|Protocol Violation|1|||
16408133|NCT01338610|39976851|FG001|Overall Study|Protocol Violation|0|||
16408134|NCT01338610|39976852|FG002|Overall Study|Protocol Violation|1|||
16408135|NCT01338610|39976850|FG000|Overall Study|Adverse Event|3|||
16408136|NCT01338610|39976851|FG001|Overall Study|Adverse Event|0|||
16408137|NCT01338610|39976852|FG002|Overall Study|Adverse Event|0|||
16408138|NCT01133275|39976853|FG000|Overall Study|Withdrawal by Subject|1|||
16408139|NCT01133275|39976853|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
16544362|NCT02404389|40456981|FG004|Overall Study|Adverse Event|2|||
16544363|NCT02404389|40456977|FG000|Overall Study|Subject/guardian decision|1|||
16544364|NCT02404389|40456978|FG001|Overall Study|Subject/guardian decision|0|||
16544365|NCT02404389|40456979|FG002|Overall Study|Subject/guardian decision|0|||
16544366|NCT02404389|40456980|FG003|Overall Study|Subject/guardian decision|1|||
16544367|NCT02404389|40456981|FG004|Overall Study|Subject/guardian decision|1|||
16544368|NCT02567825|40456986|FG000|Overall Study|No follow-up post-randomization|5|||
16408140|NCT00435162|39976854|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
16408141|NCT00435162|39976855|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
16408142|NCT00435162|39976856|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
16408143|NCT00435162|39976857|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
16408144|NCT00435162|39976858|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
16408145|NCT00435162|39976859|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
16544369|NCT02567825|40456987|FG001|Overall Study|No follow-up post-randomization|1|||
16544370|NCT02567825|40456986|FG000|Overall Study|Follow-up less than 23 months|16|||
16544371|NCT02567825|40456987|FG001|Overall Study|Follow-up less than 23 months|20|||
16544372|NCT03299686|40456988|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
16544373|NCT03299686|40456989|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
16544374|NCT03299686|40456988|FG000|Treatment Epoch|Physician Decision|1|||
16544375|NCT03299686|40456989|FG001|Treatment Epoch|Physician Decision|0|||
16544376|NCT03299686|40456988|FG000|Treatment Epoch|Adverse Event|8|||
16544377|NCT03299686|40456989|FG001|Treatment Epoch|Adverse Event|4|||
16544378|NCT03299686|40456988|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
16544379|NCT03299686|40456989|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
16544380|NCT00571701|40456990|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
16544381|NCT00571701|40456991|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
16544382|NCT00571701|40456990|FG000|First Intervention 12 Months|Death|1|||
16344226|NCT00391872|39747539|FG001|Overall Study|Protocol Violation|2|||
16344227|NCT00391872|39747538|FG000|Overall Study|Withdrawal by Subject|296|||
16344228|NCT00391872|39747539|FG001|Overall Study|Withdrawal by Subject|249|||
16344229|NCT00391872|39747538|FG000|Overall Study|Reason unknown|2|||
16344230|NCT00391872|39747539|FG001|Overall Study|Reason unknown|4|||
16344231|NCT00391872|39747538|FG000|Overall Study|Lost to Follow-up|2|||
16344232|NCT00391872|39747539|FG001|Overall Study|Lost to Follow-up|0|||
16344233|NCT00810199|39747542|FG000|Overall Study|Adverse Event|24|||
16344234|NCT00810199|39747543|FG001|Overall Study|Adverse Event|26|||
16344235|NCT00810199|39747542|FG000|Overall Study|Death|4|||
16344236|NCT00810199|39747543|FG001|Overall Study|Death|6|||
16344237|NCT00810199|39747542|FG000|Overall Study|Withdrew consent|9|||
16344238|NCT00810199|39747543|FG001|Overall Study|Withdrew consent|12|||
16344239|NCT00810199|39747542|FG000|Overall Study|Insufficient therapeutic response|5|||
16344240|NCT00810199|39747543|FG001|Overall Study|Insufficient therapeutic response|14|||
16344241|NCT00810199|39747542|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
16344242|NCT00810199|39747543|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
16344243|NCT00810199|39747542|FG000|Overall Study|Administrative/Other|5|||
16344244|NCT00810199|39747543|FG001|Overall Study|Administrative/Other|6|||
16344245|NCT00810199|39747542|FG000|Overall Study|Protocol Violation|2|||
16344246|NCT00810199|39747543|FG001|Overall Study|Protocol Violation|6|||
16344247|NCT00810199|39747542|FG000|Overall Study|Failure to return|1|||
16344248|NCT00810199|39747543|FG001|Overall Study|Failure to return|4|||
16344249|NCT00810199|39747542|FG000|Overall Study|Did not receive study drug|2|||
16344250|NCT00810199|39747543|FG001|Overall Study|Did not receive study drug|1|||
16344251|NCT03512353|39747548|FG000|Overall Study|Sponsor Decision|3|||
16344252|NCT03512353|39747548|FG000|Overall Study|Death|1|||
16344253|NCT00105989|39747553|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
16344254|NCT00105989|39747554|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
16344255|NCT00105989|39747553|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
16344256|NCT00105989|39747554|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
16344257|NCT00105989|39747553|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
16344258|NCT00105989|39747554|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
16344259|NCT00105989|39747553|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
16344260|NCT00105989|39747554|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
16544383|NCT00571701|40456991|FG001|First Intervention 12 Months|Death|0|||
16408146|NCT05427539|39976860|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
16408147|NCT05427539|39976861|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
16408148|NCT05427539|39976860|FG000|Period 1|Withdrawal by Subject|1|||
16544384|NCT00571701|40456990|FG000|Second Intervention 12 Months|Adverse Event|0|||
16544385|NCT00571701|40456991|FG001|Second Intervention 12 Months|Adverse Event|1|||
16544386|NCT00571701|40456990|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
16544387|NCT00571701|40456991|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
16544388|NCT03642938|40456992|FG000|Overall Study|Withdrawal by Subject|0|||
16544389|NCT03642938|40456993|FG001|Overall Study|Withdrawal by Subject|0|||
16544390|NCT03642938|40456994|FG002|Overall Study|Withdrawal by Subject|0|||
16544391|NCT03642938|40456995|FG003|Overall Study|Withdrawal by Subject|1|||
16544392|NCT02710292|40456998|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
16544393|NCT02710292|40456999|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
16544394|NCT02710292|40456998|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
16544395|NCT02710292|40456999|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
16544396|NCT00708435|40457000|FG000|Overall Study|Death / Serious Adverse Event|10|||
16544397|NCT00708435|40457001|FG001|Overall Study|Death / Serious Adverse Event|5|||
16544398|NCT00708435|40457000|FG000|Overall Study|Lost to Follow-up|9|||
16544399|NCT00708435|40457001|FG001|Overall Study|Lost to Follow-up|4|||
16544400|NCT00708435|40457000|FG000|Overall Study|Withdrawal by Subject|3|||
16544401|NCT00708435|40457001|FG001|Overall Study|Withdrawal by Subject|7|||
16544402|NCT00708435|40457000|FG000|Overall Study|Adverse Event|1|||
16544403|NCT00708435|40457001|FG001|Overall Study|Adverse Event|0|||
16344261|NCT00105989|39747553|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
16344262|NCT00105989|39747554|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
16344263|NCT00105989|39747553|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
16344264|NCT00105989|39747554|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
16344265|NCT00105989|39747553|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
16344266|NCT00105989|39747554|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
16344267|NCT00105989|39747553|FG000|Acute - Open Label: Week 0-10|Death|1|||
16344268|NCT00105989|39747554|FG001|Acute - Open Label: Week 0-10|Death|0|||
16344269|NCT00105989|39747553|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
16344270|NCT00105989|39747554|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
16344271|NCT00105989|39747553|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
16344272|NCT00105989|39747554|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
16344273|NCT00105989|39747553|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
16344274|NCT00105989|39747554|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
16344275|NCT00105989|39747553|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
16344276|NCT00105989|39747554|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
16344277|NCT00105989|39747553|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
16344278|NCT00105989|39747554|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
16344279|NCT00105989|39747553|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
16344280|NCT00105989|39747554|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
16344281|NCT00105989|39747553|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
16344282|NCT00105989|39747554|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
16344283|NCT00105989|39747553|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
16344284|NCT00105989|39747554|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
16344285|NCT00105989|39747553|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
16344286|NCT00105989|39747554|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
16344287|NCT00105989|39747553|FG000|Continuation - Open Label:Week 10-34|Death|0|||
16344288|NCT00105989|39747554|FG001|Continuation - Open Label:Week 10-34|Death|0|||
16344289|NCT00105989|39747553|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
16344290|NCT00105989|39747554|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
16344291|NCT00105989|39747553|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
16344292|NCT00105989|39747554|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
16344293|NCT00105989|39747553|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
16344294|NCT00105989|39747554|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
16344295|NCT00105989|39747553|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
16344296|NCT00105989|39747554|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
16344297|NCT00105989|39747553|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
16544404|NCT00708435|40457000|FG000|Overall Study|Protocol Violation|0|||
16544405|NCT00708435|40457001|FG001|Overall Study|Protocol Violation|1|||
16544406|NCT00708435|40457000|FG000|Overall Study|Intervention by primary care physician|1|||
16408149|NCT05427539|39976861|FG001|Period 1|Withdrawal by Subject|0|||
16408150|NCT01891344|39976875|FG000|Overall Study|Ongoing|6|||
16408151|NCT01891344|39976876|FG001|Overall Study|Ongoing|2|||
16408152|NCT01891344|39976877|FG002|Overall Study|Ongoing|0|||
16408153|NCT01891344|39976878|FG003|Overall Study|Ongoing|1|||
16408154|NCT01891344|39976879|FG004|Overall Study|Ongoing|4|||
16408155|NCT01891344|39976880|FG005|Overall Study|Ongoing|1|||
16408156|NCT01891344|39976881|FG006|Overall Study|Ongoing|0|||
16408157|NCT01891344|39976882|FG007|Overall Study|Ongoing|0|||
16408158|NCT00089986|39976892|FG000|Overall Study|Adverse Event|6|||
16408159|NCT00089986|39976893|FG001|Overall Study|Adverse Event|9|||
16408160|NCT00089986|39976894|FG002|Overall Study|Adverse Event|6|||
16408161|NCT00089986|39976892|FG000|Overall Study|Lost to Follow-up|3|||
16408162|NCT00089986|39976893|FG001|Overall Study|Lost to Follow-up|1|||
16408163|NCT00089986|39976894|FG002|Overall Study|Lost to Follow-up|1|||
16408164|NCT00089986|39976892|FG000|Overall Study|Protocol Violation|0|||
16408165|NCT00089986|39976893|FG001|Overall Study|Protocol Violation|1|||
16408166|NCT00089986|39976894|FG002|Overall Study|Protocol Violation|0|||
16408167|NCT00089986|39976892|FG000|Overall Study|Patient transferred to another hospital|2|||
16408168|NCT00089986|39976893|FG001|Overall Study|Patient transferred to another hospital|1|||
16408169|NCT00089986|39976894|FG002|Overall Study|Patient transferred to another hospital|0|||
16408170|NCT00089986|39976892|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
16408171|NCT00089986|39976893|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
16408172|NCT00089986|39976894|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
16408173|NCT00089986|39976892|FG000|Overall Study|Hemohlobin stopping rule|0|||
16344298|NCT00105989|39747554|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
16344299|NCT00105989|39747553|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
16344300|NCT00105989|39747554|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
16344301|NCT00105989|39747553|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
16344302|NCT00105989|39747554|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
16344303|NCT00105989|39747553|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
16344304|NCT00105989|39747554|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
16344305|NCT00105989|39747553|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
16344306|NCT00105989|39747554|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
16344307|NCT00105989|39747553|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
16344308|NCT00105989|39747554|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
16344309|NCT00105989|39747553|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
16344310|NCT00105989|39747554|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
16344311|NCT00105989|39747553|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
16344312|NCT00105989|39747554|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
16344313|NCT04472494|39747555|FG000|Pre-treatment|Other reasons|2|||
16344314|NCT04472494|39747556|FG001|Pre-treatment|Other reasons|0|||
16344315|NCT04472494|39747555|FG000|Treatment|Death|5|||
16544407|NCT00708435|40457001|FG001|Overall Study|Intervention by primary care physician|0|||
16544408|NCT00708435|40457000|FG000|Overall Study|Refused hospitalization|1|||
16544409|NCT00708435|40457001|FG001|Overall Study|Refused hospitalization|0|||
16544410|NCT04067401|40457002|FG000|Overall Study|Withdrawal by Subject|7|||
16544411|NCT04067401|40457003|FG001|Overall Study|Withdrawal by Subject|0|||
16544412|NCT04067401|40457002|FG000|Overall Study|no data provided|1|||
16544413|NCT04067401|40457003|FG001|Overall Study|no data provided|0|||
16408174|NCT00089986|39976893|FG001|Overall Study|Hemohlobin stopping rule|1|||
16408175|NCT00089986|39976894|FG002|Overall Study|Hemohlobin stopping rule|0|||
16408176|NCT00089986|39976892|FG000|Overall Study|Investigator decision to withdrew|0|||
16408177|NCT00089986|39976893|FG001|Overall Study|Investigator decision to withdrew|1|||
16544414|NCT03300570|40457004|FG000|Overall Study|Adverse Event|0|||
16544415|NCT03300570|40457005|FG001|Overall Study|Adverse Event|1|||
16544416|NCT03300570|40457004|FG000|Overall Study|Withdrawal by Subject|1|||
16544417|NCT03300570|40457005|FG001|Overall Study|Withdrawal by Subject|0|||
16544418|NCT03300570|40457004|FG000|Overall Study|Inadequate bowel prep|1|||
16544419|NCT03300570|40457005|FG001|Overall Study|Inadequate bowel prep|0|||
16408178|NCT00089986|39976894|FG002|Overall Study|Investigator decision to withdrew|0|||
16408179|NCT00089986|39976892|FG000|Overall Study|Enrollment in another study|0|||
16408180|NCT00089986|39976893|FG001|Overall Study|Enrollment in another study|1|||
16408181|NCT00089986|39976894|FG002|Overall Study|Enrollment in another study|0|||
16408182|NCT00089986|39976892|FG000|Overall Study|Family decision|0|||
16408183|NCT00089986|39976893|FG001|Overall Study|Family decision|1|||
16408184|NCT00089986|39976894|FG002|Overall Study|Family decision|0|||
16408185|NCT00089986|39976892|FG000|Overall Study|Do not resuscitate (DNR)|0|||
16408186|NCT00089986|39976893|FG001|Overall Study|Do not resuscitate (DNR)|0|||
16408187|NCT00089986|39976894|FG002|Overall Study|Do not resuscitate (DNR)|1|||
16408188|NCT00089986|39976892|FG000|Overall Study|Withdrawal by Subject|3|||
16408189|NCT00089986|39976893|FG001|Overall Study|Withdrawal by Subject|6|||
16408190|NCT00089986|39976894|FG002|Overall Study|Withdrawal by Subject|2|||
16408191|NCT01007123|39976895|FG000|Overall Study|Adverse Event|3|||
16408192|NCT01007123|39976896|FG001|Overall Study|Adverse Event|4|||
16408193|NCT01007123|39976897|FG002|Overall Study|Adverse Event|7|||
16408194|NCT01007123|39976898|FG003|Overall Study|Adverse Event|1|||
16408195|NCT01007123|39976895|FG000|Overall Study|Lack of Efficacy|1|||
16408196|NCT01007123|39976896|FG001|Overall Study|Lack of Efficacy|0|||
16408197|NCT01007123|39976897|FG002|Overall Study|Lack of Efficacy|1|||
16408198|NCT01007123|39976898|FG003|Overall Study|Lack of Efficacy|4|||
16408199|NCT01007123|39976895|FG000|Overall Study|Protocol Violation|1|||
16408200|NCT01007123|39976896|FG001|Overall Study|Protocol Violation|1|||
16408201|NCT01007123|39976897|FG002|Overall Study|Protocol Violation|2|||
16408202|NCT01007123|39976898|FG003|Overall Study|Protocol Violation|1|||
16408203|NCT01007123|39976895|FG000|Overall Study|Withdrawal by Subject|1|||
16408204|NCT01007123|39976896|FG001|Overall Study|Withdrawal by Subject|0|||
16408205|NCT01007123|39976897|FG002|Overall Study|Withdrawal by Subject|1|||
16544420|NCT03541044|40457006|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
16544421|NCT03541044|40457007|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
16544422|NCT03541044|40457006|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
16544423|NCT03541044|40457007|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
16544424|NCT00595504|40457015|FG000|Overall Study|Withdrawal by Subject|1|||
16544425|NCT00595504|40457016|FG001|Overall Study|Withdrawal by Subject|3|||
16544426|NCT00595504|40457015|FG000|Overall Study|Physician Decision|1|||
16544427|NCT00595504|40457016|FG001|Overall Study|Physician Decision|0|||
16544428|NCT01682213|40457017|FG000|Overall Study|Withdrawal by Subject|2|||
16544429|NCT01807156|40457024|FG000|Overall Study|Physician Decision|1|||
16544430|NCT01279343|40457029|FG000|Overall Study|Did not receive treatment|2|||
16544431|NCT01279343|40457030|FG001|Overall Study|Did not receive treatment|6|||
16544432|NCT02552238|40457035|FG000|Overall Study|Withdrawal by Subject|2|||
16544433|NCT02552238|40457035|FG000|Overall Study|Adverse Event|2|||
16408206|NCT01007123|39976898|FG003|Overall Study|Withdrawal by Subject|0|||
16408207|NCT01007123|39976895|FG000|Overall Study|Lost to Follow-up|0|||
16408208|NCT01007123|39976896|FG001|Overall Study|Lost to Follow-up|1|||
16544434|NCT00779779|40457036|FG000|Overall Study|Adverse Event|1|||
16544435|NCT00779779|40457036|FG000|Overall Study|Protocol Violation|14|||
16544436|NCT00779779|40457036|FG000|Overall Study|Withdrawal by Subject|4|||
16544437|NCT00779779|40457036|FG000|Overall Study|Lost to Follow-up|5|||
16544438|NCT01763788|40457039|FG000|Overall Study|Lost to Follow-up|0|||
16408209|NCT01007123|39976897|FG002|Overall Study|Lost to Follow-up|0|||
16408210|NCT01007123|39976898|FG003|Overall Study|Lost to Follow-up|0|||
16408211|NCT05136898|39976899|FG000|Overall Study|Adverse Event|2|||
16408212|NCT03392883|39976904|FG000|Overall Study|Lost to Follow-up|122|||
16544439|NCT01763788|40457040|FG001|Overall Study|Lost to Follow-up|0|||
16544440|NCT01763788|40457041|FG002|Overall Study|Lost to Follow-up|1|||
16544441|NCT01763788|40457042|FG003|Overall Study|Lost to Follow-up|0|||
16544442|NCT01982435|40457043|FG000|Overall Study|Adverse Event|1|||
16544443|NCT01982435|40457044|FG001|Overall Study|Adverse Event|0|||
16544444|NCT01395823|40457046|FG000|Overall Study|Death|4|||
16544445|NCT01395823|40457047|FG001|Overall Study|Death|4|||
16544446|NCT01395823|40457046|FG000|Overall Study|Physician Decision|3|||
16544447|NCT01395823|40457047|FG001|Overall Study|Physician Decision|1|||
16544448|NCT01395823|40457046|FG000|Overall Study|Lost to Follow-up|1|||
16544449|NCT01395823|40457047|FG001|Overall Study|Lost to Follow-up|0|||
16544450|NCT01395823|40457046|FG000|Overall Study|Transplant|1|||
16544451|NCT01395823|40457047|FG001|Overall Study|Transplant|0|||
16544452|NCT01395823|40457046|FG000|Overall Study|GI symptoms|1|||
16544453|NCT01395823|40457047|FG001|Overall Study|GI symptoms|0|||
16110205|NCT00878553|38889236|FG000|PK Study|Withdrawal by Subject|0|||
16544454|NCT01395823|40457046|FG000|Overall Study|Withdrawal by Subject|5|||
16408213|NCT03392883|39976905|FG001|Overall Study|Lost to Follow-up|13|||
16544455|NCT01395823|40457047|FG001|Overall Study|Withdrawal by Subject|4|||
16544456|NCT02010632|40457050|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
16544457|NCT02010632|40457051|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
16110206|NCT00878553|38889237|FG001|PK Study|Withdrawal by Subject|0|||
16221393|NCT01906489|39290687|FG000|Overall Study|Adverse Event|10|||
16221394|NCT01906489|39290688|FG001|Overall Study|Adverse Event|3|||
16544458|NCT00246337|40457052|FG000|Overall Study|Lost to Follow-up|3|||
16544459|NCT00246337|40457053|FG001|Overall Study|Lost to Follow-up|0|||
16221395|NCT01906489|39290687|FG000|Overall Study|Worsening of CKD|6|||
16221396|NCT01906489|39290688|FG001|Overall Study|Worsening of CKD|4|||
16544460|NCT00246337|40457054|FG002|Overall Study|Lost to Follow-up|0|||
16544461|NCT00246337|40457055|FG003|Overall Study|Lost to Follow-up|0|||
16544462|NCT00246337|40457056|FG004|Overall Study|Lost to Follow-up|2|||
16544463|NCT00246337|40457057|FG005|Overall Study|Lost to Follow-up|2|||
16544464|NCT00246337|40457058|FG006|Overall Study|Lost to Follow-up|1|||
16544465|NCT00246337|40457059|FG007|Overall Study|Lost to Follow-up|2|||
16544466|NCT00246337|40457060|FG008|Overall Study|Lost to Follow-up|0|||
16544467|NCT00246337|40457052|FG000|Overall Study|Protocol Violation|1|||
16544468|NCT00246337|40457053|FG001|Overall Study|Protocol Violation|0|||
16544469|NCT00246337|40457054|FG002|Overall Study|Protocol Violation|0|||
16544470|NCT00246337|40457055|FG003|Overall Study|Protocol Violation|0|||
16544471|NCT00246337|40457056|FG004|Overall Study|Protocol Violation|1|||
16544472|NCT00246337|40457057|FG005|Overall Study|Protocol Violation|0|||
16544473|NCT00246337|40457058|FG006|Overall Study|Protocol Violation|1|||
16544474|NCT00246337|40457059|FG007|Overall Study|Protocol Violation|1|||
16544475|NCT00246337|40457060|FG008|Overall Study|Protocol Violation|0|||
16544476|NCT00246337|40457052|FG000|Overall Study|Withdrawal by Subject|2|||
16544477|NCT00246337|40457053|FG001|Overall Study|Withdrawal by Subject|0|||
16544478|NCT00246337|40457054|FG002|Overall Study|Withdrawal by Subject|0|||
16544479|NCT00246337|40457055|FG003|Overall Study|Withdrawal by Subject|0|||
16544480|NCT00246337|40457056|FG004|Overall Study|Withdrawal by Subject|0|||
16544481|NCT00246337|40457057|FG005|Overall Study|Withdrawal by Subject|0|||
16544482|NCT00246337|40457058|FG006|Overall Study|Withdrawal by Subject|1|||
16544483|NCT00246337|40457059|FG007|Overall Study|Withdrawal by Subject|1|||
16544484|NCT00246337|40457060|FG008|Overall Study|Withdrawal by Subject|0|||
16544485|NCT00246337|40457052|FG000|Overall Study|Lack of Qualifying Event|8|||
16544486|NCT00246337|40457053|FG001|Overall Study|Lack of Qualifying Event|2|||
16544487|NCT00246337|40457054|FG002|Overall Study|Lack of Qualifying Event|1|||
16544488|NCT00246337|40457055|FG003|Overall Study|Lack of Qualifying Event|1|||
16544489|NCT00246337|40457056|FG004|Overall Study|Lack of Qualifying Event|1|||
16544490|NCT00246337|40457057|FG005|Overall Study|Lack of Qualifying Event|3|||
16544491|NCT00246337|40457058|FG006|Overall Study|Lack of Qualifying Event|3|||
16544492|NCT00246337|40457059|FG007|Overall Study|Lack of Qualifying Event|2|||
16544493|NCT00246337|40457060|FG008|Overall Study|Lack of Qualifying Event|5|||
16544494|NCT00246337|40457052|FG000|Overall Study|Site Terminated|10|||
16544495|NCT00246337|40457053|FG001|Overall Study|Site Terminated|0|||
16544496|NCT00246337|40457054|FG002|Overall Study|Site Terminated|0|||
16544497|NCT00246337|40457055|FG003|Overall Study|Site Terminated|0|||
16544498|NCT00246337|40457056|FG004|Overall Study|Site Terminated|0|||
16544499|NCT00246337|40457057|FG005|Overall Study|Site Terminated|7|||
16544500|NCT00246337|40457058|FG006|Overall Study|Site Terminated|1|||
16544501|NCT00246337|40457059|FG007|Overall Study|Site Terminated|6|||
16544502|NCT00246337|40457060|FG008|Overall Study|Site Terminated|2|||
16544503|NCT00246337|40457052|FG000|Overall Study|Abnormal baseline lab values|7|||
16544504|NCT00246337|40457053|FG001|Overall Study|Abnormal baseline lab values|0|||
16544505|NCT00246337|40457054|FG002|Overall Study|Abnormal baseline lab values|2|||
16544506|NCT00246337|40457055|FG003|Overall Study|Abnormal baseline lab values|0|||
16544507|NCT00246337|40457056|FG004|Overall Study|Abnormal baseline lab values|0|||
16544508|NCT00246337|40457057|FG005|Overall Study|Abnormal baseline lab values|2|||
16544509|NCT00246337|40457058|FG006|Overall Study|Abnormal baseline lab values|2|||
16544510|NCT00246337|40457059|FG007|Overall Study|Abnormal baseline lab values|0|||
16544511|NCT00246337|40457060|FG008|Overall Study|Abnormal baseline lab values|4|||
16544512|NCT00246337|40457052|FG000|Overall Study|Overwhelmed|0|||
16544513|NCT00246337|40457053|FG001|Overall Study|Overwhelmed|0|||
16544514|NCT00246337|40457054|FG002|Overall Study|Overwhelmed|0|||
16544515|NCT00246337|40457055|FG003|Overall Study|Overwhelmed|0|||
16544516|NCT00246337|40457056|FG004|Overall Study|Overwhelmed|0|||
16110207|NCT00878553|38889238|FG002|PK Study|Withdrawal by Subject|0|||
16110208|NCT00878553|38889239|FG003|PK Study|Withdrawal by Subject|1|||
16221397|NCT01906489|39290687|FG000|Overall Study|Withdrawal by Subject|5|||
16544517|NCT00246337|40457057|FG005|Overall Study|Overwhelmed|1|||
16544518|NCT00246337|40457058|FG006|Overall Study|Overwhelmed|0|||
16544519|NCT00246337|40457059|FG007|Overall Study|Overwhelmed|0|||
16544520|NCT00246337|40457060|FG008|Overall Study|Overwhelmed|0|||
16544521|NCT00246337|40457052|FG000|Overall Study|Protocol Violator|1|||
16544522|NCT00246337|40457053|FG001|Overall Study|Protocol Violator|0|||
16544523|NCT00246337|40457054|FG002|Overall Study|Protocol Violator|0|||
16544524|NCT00246337|40457055|FG003|Overall Study|Protocol Violator|0|||
16544525|NCT00246337|40457056|FG004|Overall Study|Protocol Violator|0|||
16544526|NCT00246337|40457057|FG005|Overall Study|Protocol Violator|0|||
16544527|NCT00246337|40457058|FG006|Overall Study|Protocol Violator|0|||
16544528|NCT00246337|40457059|FG007|Overall Study|Protocol Violator|0|||
16221398|NCT01906489|39290688|FG001|Overall Study|Withdrawal by Subject|0|||
16544529|NCT00246337|40457060|FG008|Overall Study|Protocol Violator|0|||
16544530|NCT00246337|40457052|FG000|Overall Study|Reported as completing trial in error|0|||
16544531|NCT00246337|40457053|FG001|Overall Study|Reported as completing trial in error|0|||
16544532|NCT00246337|40457054|FG002|Overall Study|Reported as completing trial in error|0|||
16544533|NCT00246337|40457055|FG003|Overall Study|Reported as completing trial in error|0|||
16544534|NCT00246337|40457056|FG004|Overall Study|Reported as completing trial in error|0|||
16544535|NCT00246337|40457057|FG005|Overall Study|Reported as completing trial in error|0|||
16544536|NCT00246337|40457058|FG006|Overall Study|Reported as completing trial in error|0|||
16544537|NCT00246337|40457059|FG007|Overall Study|Reported as completing trial in error|1|||
16544538|NCT00246337|40457060|FG008|Overall Study|Reported as completing trial in error|0|||
16544539|NCT00437645|40457062|FG000|Overall Study|Adverse Event|15|||
16544540|NCT00437645|40457063|FG001|Overall Study|Adverse Event|84|||
16544541|NCT00437645|40457062|FG000|Overall Study|Withdrawal by Subject|10|||
16544542|NCT00437645|40457063|FG001|Overall Study|Withdrawal by Subject|22|||
16544543|NCT00437645|40457062|FG000|Overall Study|Protocol Violation|3|||
16544544|NCT00437645|40457063|FG001|Overall Study|Protocol Violation|3|||
16544545|NCT00437645|40457062|FG000|Overall Study|Lost to Follow-up|2|||
16544546|NCT00437645|40457063|FG001|Overall Study|Lost to Follow-up|3|||
16544547|NCT00437645|40457062|FG000|Overall Study|Administrative problems|2|||
16544548|NCT00437645|40457063|FG001|Overall Study|Administrative problems|1|||
16544549|NCT00437645|40457062|FG000|Overall Study|Lack of Efficacy|2|||
16544550|NCT00437645|40457063|FG001|Overall Study|Lack of Efficacy|1|||
16544551|NCT00437645|40457062|FG000|Overall Study|Condition no longer requires study drug|1|||
16544552|NCT00437645|40457063|FG001|Overall Study|Condition no longer requires study drug|1|||
16544553|NCT00429663|40457064|FG000|Overall Study|Lost to Follow-up|24|||
16544554|NCT00429663|40457065|FG001|Overall Study|Lost to Follow-up|31|||
16544555|NCT00429663|40457064|FG000|Overall Study|Physician Decision|6|||
16544556|NCT00429663|40457065|FG001|Overall Study|Physician Decision|3|||
16544557|NCT00429663|40457064|FG000|Overall Study|Withdrawal by Subject|2|||
16544558|NCT00429663|40457065|FG001|Overall Study|Withdrawal by Subject|5|||
16544559|NCT00429663|40457064|FG000|Overall Study|Death|4|||
16544560|NCT00429663|40457065|FG001|Overall Study|Death|0|||
16544561|NCT01966003|40457068|FG000|Overall Study|Death|43|||
16544562|NCT01966003|40457069|FG001|Overall Study|Death|36|||
16544563|NCT01966003|40457068|FG000|Overall Study|Protocol Violation|6|||
16544564|NCT01966003|40457069|FG001|Overall Study|Protocol Violation|4|||
16544565|NCT01966003|40457068|FG000|Overall Study|Lost to Follow-up|4|||
16544566|NCT01966003|40457069|FG001|Overall Study|Lost to Follow-up|3|||
16544567|NCT01966003|40457068|FG000|Overall Study|Physician Decision|12|||
16544568|NCT01966003|40457069|FG001|Overall Study|Physician Decision|13|||
16544569|NCT01966003|40457068|FG000|Overall Study|Withdrawal by Subject|29|||
16544570|NCT01966003|40457069|FG001|Overall Study|Withdrawal by Subject|19|||
16544571|NCT01966003|40457068|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
16544572|NCT01966003|40457069|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
16544573|NCT01966003|40457068|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
16544574|NCT01966003|40457069|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
16544575|NCT01966003|40457068|FG000|Overall Study|Other|1|||
16544576|NCT01966003|40457069|FG001|Overall Study|Other|1|||
16544577|NCT03995784|40457072|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
16544578|NCT02227875|40457073|FG000|Overall Study|Protocol Violation|10|||
16544579|NCT02227875|40457074|FG001|Overall Study|Protocol Violation|7|||
16544580|NCT02227875|40457073|FG000|Overall Study|Other|1|||
16544581|NCT02227875|40457074|FG001|Overall Study|Other|3|||
16544582|NCT02227875|40457073|FG000|Overall Study|Physician Decision|1|||
16110209|NCT00878553|38889240|FG004|PK Study|Withdrawal by Subject|0|||
16544583|NCT02227875|40457074|FG001|Overall Study|Physician Decision|0|||
16544584|NCT02227875|40457073|FG000|Overall Study|Adverse Event|3|||
16544585|NCT02227875|40457074|FG001|Overall Study|Adverse Event|0|||
16544586|NCT02227875|40457073|FG000|Overall Study|Withdrawal by Subject|12|||
16544587|NCT02227875|40457074|FG001|Overall Study|Withdrawal by Subject|13|||
16544588|NCT02227875|40457073|FG000|Overall Study|Lost to Follow-up|10|||
16344316|NCT04472494|39747556|FG001|Treatment|Death|2|||
16344317|NCT04472494|39747555|FG000|Treatment|Hospital discharge|1|||
16344318|NCT04472494|39747556|FG001|Treatment|Hospital discharge|1|||
16344319|NCT02207400|39747557|FG000|Overall Study|Adverse Event|1|||
16344320|NCT02207400|39747558|FG001|Overall Study|Adverse Event|1|||
16344321|NCT02207400|39747557|FG000|Overall Study|Lost to Follow-up|6|||
16344322|NCT02207400|39747558|FG001|Overall Study|Lost to Follow-up|7|||
16344323|NCT02207400|39747557|FG000|Overall Study|Protocol Violation|1|||
16344324|NCT02207400|39747558|FG001|Overall Study|Protocol Violation|1|||
16344325|NCT02207400|39747557|FG000|Overall Study|Withdrawal by Subject|8|||
16344326|NCT02207400|39747558|FG001|Overall Study|Withdrawal by Subject|4|||
16344327|NCT02207400|39747557|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
16344328|NCT02207400|39747558|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
16344329|NCT04613739|39747559|FG000|Overall Study|Lost to Follow-up|6|||
16344330|NCT04613739|39747560|FG001|Overall Study|Lost to Follow-up|9|||
16344331|NCT04613739|39747559|FG000|Overall Study|potentially duplicative/fraudulent|1|||
16344332|NCT04613739|39747560|FG001|Overall Study|potentially duplicative/fraudulent|3|||
16344333|NCT00753675|39747561|FG000|Overall Study|other reason|11|||
16344334|NCT00753675|39747562|FG001|Overall Study|other reason|12|||
16408214|NCT03392883|39976906|FG002|Overall Study|Lost to Follow-up|9|||
16408215|NCT03392883|39976904|FG000|Overall Study|Death|4|||
16408216|NCT03392883|39976905|FG001|Overall Study|Death|0|||
16408217|NCT03392883|39976906|FG002|Overall Study|Death|0|||
16408218|NCT03392883|39976904|FG000|Overall Study|Lack of Efficacy|29|||
16408219|NCT03392883|39976905|FG001|Overall Study|Lack of Efficacy|0|||
16408220|NCT03392883|39976906|FG002|Overall Study|Lack of Efficacy|0|||
16408221|NCT03392883|39976904|FG000|Overall Study|Withdrawal by Subject|180|||
16408222|NCT03392883|39976905|FG001|Overall Study|Withdrawal by Subject|0|||
16408223|NCT03392883|39976906|FG002|Overall Study|Withdrawal by Subject|0|||
16408224|NCT03392883|39976904|FG000|Overall Study|Adverse Event|1|||
16408225|NCT03392883|39976905|FG001|Overall Study|Adverse Event|0|||
16408226|NCT03392883|39976906|FG002|Overall Study|Adverse Event|0|||
16408227|NCT01457950|39976907|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
16408228|NCT01457950|39976908|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
16408229|NCT01457950|39976909|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
16408230|NCT01457950|39976910|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
16408231|NCT01457950|39976907|FG000|Double-Blind Phase|Protocol Violation|2|||
16408232|NCT01457950|39976908|FG001|Double-Blind Phase|Protocol Violation|1|||
16408233|NCT01457950|39976909|FG002|Double-Blind Phase|Protocol Violation|0|||
16408234|NCT01457950|39976910|FG003|Double-Blind Phase|Protocol Violation|0|||
16408235|NCT01457950|39976907|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
16544589|NCT02227875|40457074|FG001|Overall Study|Lost to Follow-up|10|||
16544590|NCT02395133|40457075|FG000|Overall Study|Adverse Event|4|||
16544591|NCT02395133|40457076|FG001|Overall Study|Adverse Event|1|||
16544592|NCT02395133|40457077|FG002|Overall Study|Adverse Event|3|||
16544593|NCT02395133|40457078|FG003|Overall Study|Adverse Event|0|||
16544594|NCT02395133|40457075|FG000|Overall Study|Lack of Efficacy|1|||
16544595|NCT02395133|40457076|FG001|Overall Study|Lack of Efficacy|0|||
16544596|NCT02395133|40457077|FG002|Overall Study|Lack of Efficacy|1|||
16544597|NCT02395133|40457078|FG003|Overall Study|Lack of Efficacy|1|||
16544598|NCT02395133|40457075|FG000|Overall Study|Protocol Violation|1|||
16544599|NCT02395133|40457076|FG001|Overall Study|Protocol Violation|1|||
16544600|NCT02395133|40457077|FG002|Overall Study|Protocol Violation|0|||
16544601|NCT02395133|40457078|FG003|Overall Study|Protocol Violation|3|||
16544602|NCT02395133|40457075|FG000|Overall Study|Lost to Follow-up|0|||
16544603|NCT02395133|40457076|FG001|Overall Study|Lost to Follow-up|1|||
16544604|NCT02395133|40457077|FG002|Overall Study|Lost to Follow-up|1|||
16544605|NCT02395133|40457078|FG003|Overall Study|Lost to Follow-up|0|||
16544606|NCT02395133|40457075|FG000|Overall Study|Pregnancy|0|||
16544607|NCT02395133|40457076|FG001|Overall Study|Pregnancy|0|||
16544608|NCT02395133|40457077|FG002|Overall Study|Pregnancy|3|||
16544609|NCT02395133|40457078|FG003|Overall Study|Pregnancy|0|||
16544610|NCT02395133|40457075|FG000|Overall Study|Consent withdrawn with no reason given|1|||
16544611|NCT02395133|40457076|FG001|Overall Study|Consent withdrawn with no reason given|3|||
16408236|NCT01457950|39976908|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
16408237|NCT01457950|39976909|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
16408238|NCT01457950|39976910|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
16408239|NCT01457950|39976907|FG000|Open-Label Phase|Adverse Event|0|||
16408240|NCT01457950|39976908|FG001|Open-Label Phase|Adverse Event|0|||
16544612|NCT02395133|40457077|FG002|Overall Study|Consent withdrawn with no reason given|0|||
16544613|NCT02395133|40457078|FG003|Overall Study|Consent withdrawn with no reason given|2|||
16544614|NCT02395133|40457075|FG000|Overall Study|Consent withdrawn with personal reason|0|||
16544615|NCT02395133|40457076|FG001|Overall Study|Consent withdrawn with personal reason|1|||
16408241|NCT01457950|39976909|FG002|Open-Label Phase|Adverse Event|0|||
16408242|NCT01457950|39976910|FG003|Open-Label Phase|Adverse Event|1|||
16344335|NCT00753675|39747563|FG002|Overall Study|other reason|13|||
16344336|NCT00753675|39747561|FG000|Overall Study|Death|1|||
16344337|NCT00753675|39747562|FG001|Overall Study|Death|2|||
16544616|NCT02395133|40457077|FG002|Overall Study|Consent withdrawn with personal reason|0|||
16544617|NCT02395133|40457078|FG003|Overall Study|Consent withdrawn with personal reason|3|||
16544618|NCT02395133|40457075|FG000|Overall Study|Sponsor decision|2|||
16544619|NCT02395133|40457076|FG001|Overall Study|Sponsor decision|0|||
16544620|NCT02395133|40457077|FG002|Overall Study|Sponsor decision|0|||
16544621|NCT02395133|40457078|FG003|Overall Study|Sponsor decision|1|||
16544622|NCT02395133|40457075|FG000|Overall Study|Other than specified above|5|||
16544623|NCT02395133|40457076|FG001|Overall Study|Other than specified above|2|||
16544624|NCT02395133|40457077|FG002|Overall Study|Other than specified above|2|||
16544625|NCT02395133|40457078|FG003|Overall Study|Other than specified above|4|||
16544626|NCT00758459|40457081|FG000|Overall Study|Adverse Event|3|||
16544627|NCT00758459|40457082|FG001|Overall Study|Adverse Event|2|||
16544628|NCT00758459|40457081|FG000|Overall Study|Protocol Violation|0|||
16544629|NCT00758459|40457082|FG001|Overall Study|Protocol Violation|1|||
16544630|NCT00758459|40457081|FG000|Overall Study|Withdrawal by Subject|0|||
16544631|NCT00758459|40457082|FG001|Overall Study|Withdrawal by Subject|1|||
16544632|NCT01224925|40457083|FG000|Overall Study|Lost to Follow-up|3|||
16544633|NCT01224925|40457084|FG001|Overall Study|Lost to Follow-up|2|||
16544634|NCT04176939|40457085|FG000|Overall Study|Adverse Event|7|||
16544635|NCT04176939|40457085|FG000|Overall Study|Unspecified reason|2|||
16544636|NCT04176939|40457085|FG000|Overall Study|Migrated/Moved from the study area|1|||
16544637|NCT04176939|40457085|FG000|Overall Study|Withdrawal by Subject|4|||
16544638|NCT04176939|40457085|FG000|Overall Study|In follow-up|54|||
16544639|NCT00652938|40457088|FG000|Overall Study|Adverse Event|1|||
16544640|NCT00652938|40457089|FG001|Overall Study|Adverse Event|0|||
16544641|NCT00652938|40457090|FG002|Overall Study|Adverse Event|2|||
16544642|NCT00652938|40457088|FG000|Overall Study|Withdrawal by Subject|0|||
16544643|NCT00652938|40457089|FG001|Overall Study|Withdrawal by Subject|6|||
16544644|NCT00652938|40457090|FG002|Overall Study|Withdrawal by Subject|1|||
16544645|NCT00652938|40457088|FG000|Overall Study|Lost to Follow-up|0|||
16544646|NCT00652938|40457089|FG001|Overall Study|Lost to Follow-up|0|||
16544647|NCT00652938|40457090|FG002|Overall Study|Lost to Follow-up|2|||
16544648|NCT00652938|40457088|FG000|Overall Study|fear of blood sampling|0|||
16544649|NCT00652938|40457089|FG001|Overall Study|fear of blood sampling|1|||
16544650|NCT00652938|40457090|FG002|Overall Study|fear of blood sampling|0|||
16544651|NCT01830595|40457093|FG000|First Period|Withdrawal by Subject|1|||
16544652|NCT01830595|40457094|FG001|First Period|Withdrawal by Subject|3|||
16544653|NCT01830595|40457093|FG000|Washout|Withdrawal by Subject|2|||
16544654|NCT01830595|40457094|FG001|Washout|Withdrawal by Subject|2|||
16544655|NCT04382924|40457095|FG000|Overall Study|Death|2|||
16544656|NCT04382924|40457096|FG001|Overall Study|Death|5|||
16544657|NCT04382924|40457097|FG002|Overall Study|Death|4|||
16544658|NCT04382924|40457095|FG000|Overall Study|Protocol Violation|0|||
16544659|NCT04382924|40457096|FG001|Overall Study|Protocol Violation|1|||
16544660|NCT04382924|40457097|FG002|Overall Study|Protocol Violation|1|||
16544661|NCT04382924|40457095|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
16544662|NCT04382924|40457096|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
16544663|NCT04382924|40457097|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
16544664|NCT04382924|40457095|FG000|Overall Study|Withdrawal by Subject|6|||
16544665|NCT04382924|40457096|FG001|Overall Study|Withdrawal by Subject|3|||
16544666|NCT04382924|40457097|FG002|Overall Study|Withdrawal by Subject|6|||
16544667|NCT02768662|40457104|FG000|Overall Study|Adverse Event|1|||
16544668|NCT02768662|40457104|FG000|Overall Study|Lost to Follow-up|4|||
16544669|NCT02768662|40457104|FG000|Overall Study|Withdrawal by Subject|3|||
16544670|NCT02768662|40457104|FG000|Overall Study|Study terminated by Sponsor|78|||
16544671|NCT03518125|40457105|FG000|Overall Study|Lost to Follow-up|0|||
16544672|NCT03518125|40457106|FG001|Overall Study|Lost to Follow-up|2|||
16544673|NCT03518125|40457107|FG002|Overall Study|Lost to Follow-up|0|||
16544674|NCT03518125|40457108|FG003|Overall Study|Lost to Follow-up|0|||
16544675|NCT03518125|40457109|FG004|Overall Study|Lost to Follow-up|3|||
16544676|NCT03518125|40457110|FG005|Overall Study|Lost to Follow-up|5|||
16544677|NCT03518125|40457105|FG000|Overall Study|Physician Decision|0|||
16544678|NCT03518125|40457106|FG001|Overall Study|Physician Decision|1|||
16544679|NCT03518125|40457107|FG002|Overall Study|Physician Decision|0|||
16544680|NCT03518125|40457108|FG003|Overall Study|Physician Decision|0|||
16544681|NCT03518125|40457109|FG004|Overall Study|Physician Decision|0|||
16544682|NCT03518125|40457110|FG005|Overall Study|Physician Decision|0|||
16544683|NCT03518125|40457105|FG000|Overall Study|Withdrawal by Subject|1|||
16544684|NCT03518125|40457106|FG001|Overall Study|Withdrawal by Subject|1|||
16344338|NCT00753675|39747563|FG002|Overall Study|Death|4|||
16544685|NCT03518125|40457107|FG002|Overall Study|Withdrawal by Subject|0|||
16544686|NCT03518125|40457108|FG003|Overall Study|Withdrawal by Subject|1|||
16544687|NCT03518125|40457109|FG004|Overall Study|Withdrawal by Subject|1|||
16544688|NCT03518125|40457110|FG005|Overall Study|Withdrawal by Subject|3|||
16544689|NCT03518125|40457105|FG000|Overall Study|Missed Day 394 Visit|1|||
16544690|NCT03518125|40457106|FG001|Overall Study|Missed Day 394 Visit|0|||
16544691|NCT03518125|40457107|FG002|Overall Study|Missed Day 394 Visit|0|||
16544692|NCT03518125|40457108|FG003|Overall Study|Missed Day 394 Visit|0|||
16544693|NCT03518125|40457109|FG004|Overall Study|Missed Day 394 Visit|0|||
16544694|NCT03518125|40457110|FG005|Overall Study|Missed Day 394 Visit|0|||
16544695|NCT01960725|40457111|FG000|Overall Study|Lost to Follow-up|4|||
16544696|NCT01960725|40457112|FG001|Overall Study|Lost to Follow-up|3|||
16544697|NCT01960725|40457111|FG000|Overall Study|Withdrawal by Subject|1|||
16544698|NCT01960725|40457112|FG001|Overall Study|Withdrawal by Subject|0|||
16544699|NCT01960725|40457111|FG000|Overall Study|unable to obtain blood sample|1|||
16544700|NCT01960725|40457112|FG001|Overall Study|unable to obtain blood sample|2|||
16544701|NCT03954743|40457113|FG000|Overall Study|Adverse Event|1|||
16221399|NCT01906489|39290687|FG000|Overall Study|Worsening of Anemia|1|||
16221400|NCT01906489|39290688|FG001|Overall Study|Worsening of Anemia|0|||
16221401|NCT01906489|39290687|FG000|Overall Study|Protocol Violation|0|||
16221402|NCT01906489|39290688|FG001|Overall Study|Protocol Violation|1|||
16221403|NCT01906489|39290687|FG000|Overall Study|Non- Compliance|1|||
16221404|NCT01906489|39290688|FG001|Overall Study|Non- Compliance|0|||
16221405|NCT01906489|39290687|FG000|Overall Study|Sponsor Decision|1|||
16221406|NCT01906489|39290688|FG001|Overall Study|Sponsor Decision|0|||
16221407|NCT01906489|39290687|FG000|Overall Study|Lost to Follow-up|1|||
16221408|NCT01906489|39290688|FG001|Overall Study|Lost to Follow-up|1|||
16221409|NCT01906489|39290687|FG000|Overall Study|Other|1|||
16221410|NCT01906489|39290688|FG001|Overall Study|Other|0|||
16221411|NCT01542632|39290689|FG000|Overall Study|Withdrawal of Consent|0|||
16221412|NCT01542632|39290690|FG001|Overall Study|Withdrawal of Consent|0|||
16221413|NCT01542632|39290691|FG002|Overall Study|Withdrawal of Consent|0|||
16221414|NCT01542632|39290692|FG003|Overall Study|Withdrawal of Consent|2|||
16221415|NCT01542632|39290693|FG004|Overall Study|Withdrawal of Consent|3|||
16221416|NCT01542632|39290694|FG005|Overall Study|Withdrawal of Consent|0|||
16221417|NCT01542632|39290689|FG000|Overall Study|Adverse Event|0|||
16221418|NCT01542632|39290690|FG001|Overall Study|Adverse Event|0|||
16221419|NCT01542632|39290691|FG002|Overall Study|Adverse Event|1|||
16221420|NCT01542632|39290692|FG003|Overall Study|Adverse Event|0|||
16221421|NCT01542632|39290693|FG004|Overall Study|Adverse Event|0|||
16221422|NCT01542632|39290694|FG005|Overall Study|Adverse Event|0|||
16221423|NCT01542632|39290689|FG000|Overall Study|Lost to Follow-up|0|||
16221424|NCT01542632|39290690|FG001|Overall Study|Lost to Follow-up|1|||
16221425|NCT01542632|39290691|FG002|Overall Study|Lost to Follow-up|0|||
16221426|NCT01542632|39290692|FG003|Overall Study|Lost to Follow-up|0|||
16221427|NCT01542632|39290693|FG004|Overall Study|Lost to Follow-up|0|||
16221428|NCT01542632|39290694|FG005|Overall Study|Lost to Follow-up|0|||
16221429|NCT01542632|39290689|FG000|Overall Study|Sponsor/Investigator Decision|0|||
16221430|NCT01542632|39290690|FG001|Overall Study|Sponsor/Investigator Decision|0|||
16544702|NCT03954743|40457114|FG001|Overall Study|Adverse Event|0|||
16221431|NCT01542632|39290691|FG002|Overall Study|Sponsor/Investigator Decision|0|||
16221432|NCT01542632|39290692|FG003|Overall Study|Sponsor/Investigator Decision|0|||
16221433|NCT01542632|39290693|FG004|Overall Study|Sponsor/Investigator Decision|1|||
16221434|NCT01542632|39290694|FG005|Overall Study|Sponsor/Investigator Decision|0|||
16221435|NCT01266876|39290698|FG000|Overall Study|Adverse Event|0|||
16221436|NCT01266876|39290699|FG001|Overall Study|Adverse Event|0|||
16221437|NCT01266876|39290700|FG002|Overall Study|Adverse Event|0|||
16221438|NCT01266876|39290701|FG003|Overall Study|Adverse Event|1|||
16221439|NCT01266876|39290702|FG004|Overall Study|Adverse Event|0|||
16221440|NCT02055976|39290703|FG000|Overall Study|Other|0|||
16221441|NCT02055976|39290704|FG001|Overall Study|Other|0|||
16221442|NCT02055976|39290705|FG002|Overall Study|Other|1|||
16221443|NCT02055976|39290706|FG003|Overall Study|Other|0|||
16221444|NCT02055976|39290707|FG004|Overall Study|Other|0|||
16221445|NCT02055976|39290708|FG005|Overall Study|Other|0|||
16221446|NCT02055976|39290709|FG006|Overall Study|Other|0|||
16221447|NCT02055976|39290710|FG007|Overall Study|Other|0|||
16221448|NCT02055976|39290711|FG008|Overall Study|Other|0|||
16221449|NCT02055976|39290703|FG000|Overall Study|Adverse Event|0|||
16221450|NCT02055976|39290704|FG001|Overall Study|Adverse Event|0|||
16544703|NCT03954743|40457113|FG000|Overall Study|Lost to Follow-up|6|||
16544704|NCT03954743|40457114|FG001|Overall Study|Lost to Follow-up|4|||
16221451|NCT02055976|39290705|FG002|Overall Study|Adverse Event|0|||
16221452|NCT02055976|39290706|FG003|Overall Study|Adverse Event|0|||
16221453|NCT02055976|39290707|FG004|Overall Study|Adverse Event|0|||
16221454|NCT02055976|39290708|FG005|Overall Study|Adverse Event|1|||
16221455|NCT02055976|39290709|FG006|Overall Study|Adverse Event|1|||
16221456|NCT02055976|39290710|FG007|Overall Study|Adverse Event|0|||
16221457|NCT02055976|39290711|FG008|Overall Study|Adverse Event|0|||
16221458|NCT02055976|39290703|FG000|Overall Study|Does not meet entrance criteria|0|||
16221459|NCT02055976|39290704|FG001|Overall Study|Does not meet entrance criteria|0|||
16221460|NCT02055976|39290705|FG002|Overall Study|Does not meet entrance criteria|0|||
16221461|NCT02055976|39290706|FG003|Overall Study|Does not meet entrance criteria|0|||
16221462|NCT02055976|39290707|FG004|Overall Study|Does not meet entrance criteria|0|||
16221463|NCT02055976|39290708|FG005|Overall Study|Does not meet entrance criteria|0|||
16544705|NCT03954743|40457113|FG000|Overall Study|Protocol Violation|1|||
16544706|NCT03954743|40457114|FG001|Overall Study|Protocol Violation|0|||
16544707|NCT03954743|40457113|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
16544708|NCT03954743|40457114|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
16544709|NCT03954743|40457113|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
16544710|NCT03954743|40457114|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16544711|NCT00682643|40457115|FG000|Overall Study|Adverse Event|12|||
16544712|NCT00682643|40457116|FG001|Overall Study|Adverse Event|23|||
16544713|NCT00682643|40457115|FG000|Overall Study|Lack of Efficacy|2|||
16544714|NCT00682643|40457116|FG001|Overall Study|Lack of Efficacy|0|||
16344339|NCT00753675|39747561|FG000|Overall Study|Adverse Event|11|||
16344340|NCT00753675|39747562|FG001|Overall Study|Adverse Event|9|||
16344341|NCT00753675|39747563|FG002|Overall Study|Adverse Event|4|||
16544715|NCT00682643|40457115|FG000|Overall Study|Protocol Violation|38|||
16544716|NCT00682643|40457116|FG001|Overall Study|Protocol Violation|76|||
16544717|NCT00682643|40457115|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
16544718|NCT00682643|40457116|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
16544719|NCT00682643|40457115|FG000|Overall Study|Lost to Follow-up|1|||
16544720|NCT00682643|40457116|FG001|Overall Study|Lost to Follow-up|6|||
16544721|NCT00682643|40457115|FG000|Overall Study|Physician Decision|2|||
16544722|NCT00682643|40457116|FG001|Overall Study|Physician Decision|6|||
16544723|NCT00682643|40457115|FG000|Overall Study|Withdrawal by Subject|19|||
16544724|NCT00682643|40457116|FG001|Overall Study|Withdrawal by Subject|53|||
16544725|NCT00682643|40457115|FG000|Overall Study|Did Not Receive Study Drug|1|||
16544726|NCT00682643|40457116|FG001|Overall Study|Did Not Receive Study Drug|1|||
16544727|NCT00312702|40457119|FG000|Immunization Phase|Lost to Follow-up|0|||
16544728|NCT00312702|40457120|FG001|Immunization Phase|Lost to Follow-up|1|||
16544729|NCT00312702|40457121|FG002|Immunization Phase|Lost to Follow-up|0|||
16544730|NCT00552084|40457122|FG000|Overall Study|Adverse Event|2|||
16544731|NCT00552084|40457123|FG001|Overall Study|Adverse Event|3|||
16544732|NCT00552084|40457122|FG000|Overall Study|Withdrawal by Subject|4|||
16544733|NCT00552084|40457123|FG001|Overall Study|Withdrawal by Subject|5|||
16221464|NCT02055976|39290709|FG006|Overall Study|Does not meet entrance criteria|1|||
16544734|NCT00552084|40457122|FG000|Overall Study|Protocol Violation|1|||
16544735|NCT00552084|40457123|FG001|Overall Study|Protocol Violation|0|||
16544736|NCT00552084|40457122|FG000|Overall Study|change in anti-arrythmic drug|1|||
16544737|NCT00552084|40457123|FG001|Overall Study|change in anti-arrythmic drug|1|||
16544738|NCT01119768|40457124|FG000|Treatment Period|Lack of Efficacy|18|||
16544739|NCT01119768|40457125|FG001|Treatment Period|Lack of Efficacy|25|||
16544740|NCT01666808|40457128|FG000|Overall Study|Lost to Follow-up|9|||
16544741|NCT01666808|40457129|FG001|Overall Study|Lost to Follow-up|15|||
16544742|NCT01666808|40457128|FG000|Overall Study|Withdrawal by Subject|3|||
16544743|NCT01666808|40457129|FG001|Overall Study|Withdrawal by Subject|1|||
16544744|NCT01666808|40457128|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
16544745|NCT01666808|40457129|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
16221465|NCT02055976|39290710|FG007|Overall Study|Does not meet entrance criteria|0|||
16221466|NCT02055976|39290711|FG008|Overall Study|Does not meet entrance criteria|0|||
16221467|NCT02055976|39290703|FG000|Overall Study|Lost to Follow-up|0|||
16221468|NCT02055976|39290704|FG001|Overall Study|Lost to Follow-up|0|||
16221469|NCT02055976|39290705|FG002|Overall Study|Lost to Follow-up|0|||
16221470|NCT02055976|39290706|FG003|Overall Study|Lost to Follow-up|1|||
16221471|NCT02055976|39290707|FG004|Overall Study|Lost to Follow-up|0|||
16221472|NCT02055976|39290708|FG005|Overall Study|Lost to Follow-up|0|||
16221473|NCT02055976|39290709|FG006|Overall Study|Lost to Follow-up|0|||
16221474|NCT02055976|39290710|FG007|Overall Study|Lost to Follow-up|0|||
16221475|NCT02055976|39290711|FG008|Overall Study|Lost to Follow-up|0|||
16221476|NCT04601194|39290713|FG000|Overall Study|Lost to Follow-up|7|||
16221477|NCT01097057|39290717|FG000|Overall Study|Physician Decision|3|||
16221478|NCT04097925|39290719|FG000|Overall Study|Withdrawal by Subject|1|||
16221479|NCT02477215|39290722|FG000|Dose Escalation Phase|Physician Decision|1|||
16221480|NCT02477215|39290723|FG001|Dose Escalation Phase|Physician Decision|2|||
16221481|NCT02477215|39290724|FG002|Dose Escalation Phase|Physician Decision|0|||
16221482|NCT02477215|39290722|FG000|Fixed Dose Phase|Physician Decision|0|||
16221483|NCT02477215|39290723|FG001|Fixed Dose Phase|Physician Decision|7|||
16221484|NCT02477215|39290724|FG002|Fixed Dose Phase|Physician Decision|0|||
16221485|NCT00784836|39290728|FG000|Overall Study|Early Study Termination|3|||
16221486|NCT04604015|39290739|FG000|Overall Study|Incomplete Data Collection|33|||
16221487|NCT01982942|39290743|FG000|Overall Study|Adverse Event|10|||
16221488|NCT01982942|39290744|FG001|Overall Study|Adverse Event|5|||
16544746|NCT02436811|40457131|FG000|Overall Study|Lost to Follow-up|2|||
16544747|NCT02436811|40457132|FG001|Overall Study|Lost to Follow-up|9|||
16344342|NCT00753675|39747561|FG000|Overall Study|Objective progression of disease|35|||
16544748|NCT02436811|40457133|FG002|Overall Study|Lost to Follow-up|7|||
16221489|NCT01982942|39290743|FG000|Overall Study|Lost to Follow-up|4|||
16221490|NCT01982942|39290744|FG001|Overall Study|Lost to Follow-up|3|||
16221491|NCT01982942|39290743|FG000|Overall Study|Multiple sclerosis progression|3|||
16221492|NCT01982942|39290744|FG001|Overall Study|Multiple sclerosis progression|2|||
16344343|NCT00753675|39747562|FG001|Overall Study|Objective progression of disease|35|||
16544749|NCT01521884|40457134|FG000|Overall Study|Non Responders|10|||
16544750|NCT01521884|40457134|FG000|Overall Study|Adverse Event|5|||
16544751|NCT01521884|40457134|FG000|Overall Study|Pregnancy|1|||
16544752|NCT01521884|40457134|FG000|Overall Study|Withdrawal by Subject|1|||
16544753|NCT01521884|40457134|FG000|Overall Study|Physician Decision|2|||
16544754|NCT01521884|40457134|FG000|Overall Study|Protocol Violation|3|||
16544755|NCT01521884|40457134|FG000|Overall Study|Participant non-eligible|1|||
16544756|NCT01521884|40457134|FG000|Overall Study|Lost to Follow-up|4|||
16544757|NCT01525602|40457135|FG000|Overall Study|Adverse Event|1|||
16544758|NCT01525602|40457136|FG001|Overall Study|Adverse Event|0|||
16544759|NCT01525602|40457137|FG002|Overall Study|Adverse Event|1|||
16544760|NCT01525602|40457138|FG003|Overall Study|Adverse Event|1|||
16544761|NCT01525602|40457139|FG004|Overall Study|Adverse Event|3|||
16544762|NCT01525602|40457140|FG005|Overall Study|Adverse Event|3|||
16544763|NCT01525602|40457141|FG006|Overall Study|Adverse Event|0|||
16544764|NCT01525602|40457142|FG007|Overall Study|Adverse Event|1|||
16344344|NCT00753675|39747563|FG002|Overall Study|Objective progression of disease|35|||
16344345|NCT00753675|39747561|FG000|Overall Study|Withdrawal by Subject|0|||
16344346|NCT00753675|39747562|FG001|Overall Study|Withdrawal by Subject|1|||
16344347|NCT00753675|39747563|FG002|Overall Study|Withdrawal by Subject|0|||
16344348|NCT00753675|39747561|FG000|Overall Study|Lost to Follow-up|1|||
16344349|NCT00753675|39747562|FG001|Overall Study|Lost to Follow-up|0|||
16344350|NCT00753675|39747563|FG002|Overall Study|Lost to Follow-up|0|||
16344351|NCT04668209|39747566|FG000|Overall Study|Withdrawal by Subject|2|||
16344352|NCT04668209|39747567|FG001|Overall Study|Withdrawal by Subject|2|||
16344353|NCT04668209|39747566|FG000|Overall Study|Lost to Follow-up|3|||
16344354|NCT04668209|39747567|FG001|Overall Study|Lost to Follow-up|4|||
16344355|NCT04668209|39747566|FG000|Overall Study|Subject Expired|2|||
16344356|NCT04668209|39747567|FG001|Overall Study|Subject Expired|0|||
16344357|NCT04668209|39747566|FG000|Overall Study|Withdrawn from study|0|||
16344358|NCT04668209|39747567|FG001|Overall Study|Withdrawn from study|1|||
16344359|NCT04668209|39747566|FG000|Overall Study|Adverse Event|0|||
16344360|NCT04668209|39747567|FG001|Overall Study|Adverse Event|1|||
16344361|NCT01490840|39747571|FG000|Phase 1|Lost to Follow-up|1|||
16344362|NCT01490840|39747572|FG001|Phase 1|Lost to Follow-up|0|||
16344363|NCT01490840|39747571|FG000|Phase 1|Adverse Event|2|||
16344364|NCT01490840|39747572|FG001|Phase 1|Adverse Event|1|||
16344365|NCT01490840|39747571|FG000|Phase 1|Withdrawal by Subject|6|||
16344366|NCT01490840|39747572|FG001|Phase 1|Withdrawal by Subject|5|||
16544765|NCT01525602|40457135|FG000|Overall Study|Disease progression|6|||
16544766|NCT01525602|40457136|FG001|Overall Study|Disease progression|3|||
16544767|NCT01525602|40457137|FG002|Overall Study|Disease progression|2|||
16544768|NCT01525602|40457138|FG003|Overall Study|Disease progression|5|||
16544769|NCT01525602|40457139|FG004|Overall Study|Disease progression|22|||
16544770|NCT01525602|40457140|FG005|Overall Study|Disease progression|2|||
16544771|NCT01525602|40457141|FG006|Overall Study|Disease progression|3|||
16544772|NCT01525602|40457142|FG007|Overall Study|Disease progression|3|||
16544773|NCT01525602|40457135|FG000|Overall Study|Clinical progression|2|||
16544774|NCT01525602|40457136|FG001|Overall Study|Clinical progression|0|||
16544775|NCT01525602|40457137|FG002|Overall Study|Clinical progression|0|||
16544776|NCT01525602|40457138|FG003|Overall Study|Clinical progression|0|||
16544777|NCT01525602|40457139|FG004|Overall Study|Clinical progression|0|||
16544778|NCT01525602|40457140|FG005|Overall Study|Clinical progression|0|||
16544779|NCT01525602|40457141|FG006|Overall Study|Clinical progression|1|||
16544780|NCT01525602|40457142|FG007|Overall Study|Clinical progression|1|||
16408243|NCT01457950|39976907|FG000|Open-Label Phase|Protocol Violation|0|||
16408244|NCT01457950|39976908|FG001|Open-Label Phase|Protocol Violation|0|||
16408245|NCT01457950|39976909|FG002|Open-Label Phase|Protocol Violation|0|||
16408246|NCT01457950|39976910|FG003|Open-Label Phase|Protocol Violation|1|||
16408247|NCT01457950|39976907|FG000|Open-Label Phase|Withdrawal by Subject|0|||
16408248|NCT01457950|39976908|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16408249|NCT01457950|39976909|FG002|Open-Label Phase|Withdrawal by Subject|2|||
16408250|NCT01457950|39976910|FG003|Open-Label Phase|Withdrawal by Subject|0|||
16544781|NCT01525602|40457135|FG000|Overall Study|Non-compliance|0|||
16544782|NCT01525602|40457136|FG001|Overall Study|Non-compliance|0|||
16544783|NCT01525602|40457137|FG002|Overall Study|Non-compliance|0|||
16544784|NCT01525602|40457138|FG003|Overall Study|Non-compliance|0|||
16344367|NCT01490840|39747571|FG000|Phase 1|Visit 6a omitted|1|||
16544785|NCT01525602|40457139|FG004|Overall Study|Non-compliance|1|||
16544786|NCT01525602|40457140|FG005|Overall Study|Non-compliance|0|||
16544787|NCT01525602|40457141|FG006|Overall Study|Non-compliance|0|||
16544788|NCT01525602|40457142|FG007|Overall Study|Non-compliance|0|||
16544789|NCT01525602|40457135|FG000|Overall Study|Withdrawal by Subject|0|||
16544790|NCT01525602|40457136|FG001|Overall Study|Withdrawal by Subject|0|||
16344368|NCT01490840|39747572|FG001|Phase 1|Visit 6a omitted|0|||
16408251|NCT02118597|39976911|FG000|Overall Study|Sponsor terminated the study|14|||
16544791|NCT01525602|40457137|FG002|Overall Study|Withdrawal by Subject|0|||
16544792|NCT01525602|40457138|FG003|Overall Study|Withdrawal by Subject|0|||
16544793|NCT01525602|40457139|FG004|Overall Study|Withdrawal by Subject|3|||
16544794|NCT01525602|40457140|FG005|Overall Study|Withdrawal by Subject|1|||
16544795|NCT01525602|40457141|FG006|Overall Study|Withdrawal by Subject|0|||
16544796|NCT01525602|40457142|FG007|Overall Study|Withdrawal by Subject|1|||
16408252|NCT02118597|39976911|FG000|Overall Study|Serious Adverse Event|1|||
16408253|NCT02118597|39976911|FG000|Overall Study|Investigator's decision|1|||
16408254|NCT01155466|39976912|FG000|Overall Study|Adverse Event|13|||
16408255|NCT01155466|39976913|FG001|Overall Study|Adverse Event|15|||
16544797|NCT01525602|40457135|FG000|Overall Study|Physician Decision|0|||
16544798|NCT01525602|40457136|FG001|Overall Study|Physician Decision|0|||
16544799|NCT01525602|40457137|FG002|Overall Study|Physician Decision|0|||
16544800|NCT01525602|40457138|FG003|Overall Study|Physician Decision|0|||
16221493|NCT01982942|39290743|FG000|Overall Study|Wanted to try therapy not permitted|1|||
16221494|NCT01982942|39290744|FG001|Overall Study|Wanted to try therapy not permitted|0|||
16221495|NCT01982942|39290743|FG000|Overall Study|Subject declined future visits|0|||
16221496|NCT01982942|39290744|FG001|Overall Study|Subject declined future visits|1|||
16408256|NCT01155466|39976914|FG002|Overall Study|Adverse Event|6|||
16408257|NCT01155466|39976915|FG003|Overall Study|Adverse Event|17|||
16408258|NCT01155466|39976916|FG004|Overall Study|Adverse Event|18|||
16408259|NCT01155466|39976912|FG000|Overall Study|Lost to Follow-up|0|||
16408260|NCT01155466|39976913|FG001|Overall Study|Lost to Follow-up|0|||
16408261|NCT01155466|39976914|FG002|Overall Study|Lost to Follow-up|0|||
16408262|NCT01155466|39976915|FG003|Overall Study|Lost to Follow-up|0|||
16408263|NCT01155466|39976916|FG004|Overall Study|Lost to Follow-up|2|||
16408264|NCT01155466|39976912|FG000|Overall Study|Withdrawal by Subject|7|||
16408265|NCT01155466|39976913|FG001|Overall Study|Withdrawal by Subject|5|||
16408266|NCT01155466|39976914|FG002|Overall Study|Withdrawal by Subject|9|||
16408267|NCT01155466|39976915|FG003|Overall Study|Withdrawal by Subject|4|||
16408268|NCT01155466|39976916|FG004|Overall Study|Withdrawal by Subject|4|||
16408269|NCT01155466|39976912|FG000|Overall Study|Protocol Violation|0|||
16408270|NCT01155466|39976913|FG001|Overall Study|Protocol Violation|0|||
16408271|NCT01155466|39976914|FG002|Overall Study|Protocol Violation|2|||
16408272|NCT01155466|39976915|FG003|Overall Study|Protocol Violation|0|||
16408273|NCT01155466|39976916|FG004|Overall Study|Protocol Violation|1|||
16408274|NCT01155466|39976912|FG000|Overall Study|Administrative|0|||
16408275|NCT01155466|39976913|FG001|Overall Study|Administrative|3|||
16408276|NCT01155466|39976914|FG002|Overall Study|Administrative|0|||
16408277|NCT01155466|39976915|FG003|Overall Study|Administrative|0|||
16408278|NCT01155466|39976916|FG004|Overall Study|Administrative|0|||
16408279|NCT01155466|39976912|FG000|Overall Study|Randomized not treated|2|||
16408280|NCT01155466|39976913|FG001|Overall Study|Randomized not treated|2|||
16408281|NCT01155466|39976914|FG002|Overall Study|Randomized not treated|3|||
16408282|NCT01155466|39976915|FG003|Overall Study|Randomized not treated|0|||
16408283|NCT01155466|39976916|FG004|Overall Study|Randomized not treated|2|||
16408284|NCT03958656|39976917|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
16408285|NCT03958656|39976918|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
16408286|NCT03958656|39976919|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
16408287|NCT03958656|39976920|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
16408288|NCT03958656|39976917|FG000|Overall Study|No longer meets eligibility criteria|0|||
16408289|NCT03958656|39976918|FG001|Overall Study|No longer meets eligibility criteria|0|||
16408290|NCT03958656|39976919|FG002|Overall Study|No longer meets eligibility criteria|1|||
16408291|NCT03958656|39976920|FG003|Overall Study|No longer meets eligibility criteria|0|||
16408292|NCT03958656|39976917|FG000|Overall Study|Started anti-cancer treatment|0|||
16408293|NCT03958656|39976918|FG001|Overall Study|Started anti-cancer treatment|0|||
16408294|NCT03958656|39976919|FG002|Overall Study|Started anti-cancer treatment|1|||
16408295|NCT03958656|39976920|FG003|Overall Study|Started anti-cancer treatment|0|||
16408296|NCT03220581|39976923|FG000|Overall Study|Withdrawal by Subject|0|||
16408297|NCT03220581|39976924|FG001|Overall Study|Withdrawal by Subject|1|||
16408298|NCT03220581|39976923|FG000|Overall Study|Lost to Follow-up|3|||
16408299|NCT03220581|39976924|FG001|Overall Study|Lost to Follow-up|6|||
16408300|NCT01342965|39976925|FG000|Overall Study|Death|58|||
16408301|NCT01342965|39976926|FG001|Overall Study|Death|57|||
16408302|NCT01342965|39976925|FG000|Overall Study|Lost to Follow-up|5|||
16408303|NCT01342965|39976926|FG001|Overall Study|Lost to Follow-up|3|||
16408304|NCT01342965|39976925|FG000|Overall Study|Other Reasons- Unspecified|44|||
16408305|NCT01342965|39976926|FG001|Overall Study|Other Reasons- Unspecified|38|||
16408306|NCT01342965|39976925|FG000|Overall Study|Withdrawal by Subject|2|||
16408307|NCT01342965|39976926|FG001|Overall Study|Withdrawal by Subject|9|||
16408308|NCT01081301|39976929|FG000|Overall Study|Bereaved|3|||
16408309|NCT01081301|39976929|FG000|Overall Study|Too busy|5|||
16544801|NCT01525602|40457139|FG004|Overall Study|Physician Decision|3|||
16221497|NCT01982942|39290743|FG000|Overall Study|Left geographical area|2|||
16408310|NCT01081301|39976929|FG000|Overall Study|Patient too ill|2|||
16408311|NCT01081301|39976929|FG000|Overall Study|Lost to Follow-up|4|||
16408312|NCT02210221|39976947|FG000|Overall Study|Lack of Efficacy|7|||
16544802|NCT01525602|40457140|FG005|Overall Study|Physician Decision|0|||
16221498|NCT01982942|39290744|FG001|Overall Study|Left geographical area|0|||
16221499|NCT01982942|39290743|FG000|Overall Study|Too many pills|1|||
16221500|NCT01982942|39290744|FG001|Overall Study|Too many pills|0|||
16221501|NCT01982942|39290743|FG000|Overall Study|MS Relapse|0|||
16221502|NCT01982942|39290744|FG001|Overall Study|MS Relapse|1|||
16221503|NCT01982942|39290743|FG000|Overall Study|Chose to join a stem cell trial|0|||
16221504|NCT01982942|39290744|FG001|Overall Study|Chose to join a stem cell trial|1|||
16221505|NCT01982942|39290743|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
16221506|NCT01982942|39290744|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
16221507|NCT04554394|39290748|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
16221508|NCT04554394|39290749|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
16221509|NCT04554394|39290748|FG000|Overall Study|Withdrawal by Subject|2|||
16221510|NCT04554394|39290749|FG001|Overall Study|Withdrawal by Subject|2|||
16221511|NCT04554394|39290748|FG000|Overall Study|Lost to Follow-up|2|||
16221512|NCT04554394|39290749|FG001|Overall Study|Lost to Follow-up|2|||
16221513|NCT04554394|39290748|FG000|Overall Study|Physician Decision|1|||
16221514|NCT04554394|39290749|FG001|Overall Study|Physician Decision|1|||
16221515|NCT00474539|39290750|FG000|Infant Series|Withdrawal by Subject|3|||
16221516|NCT00474539|39290751|FG001|Infant Series|Withdrawal by Subject|4|||
16221517|NCT00474539|39290750|FG000|Infant Series|Randomization error|5|||
16221518|NCT00474539|39290751|FG001|Infant Series|Randomization error|0|||
16221519|NCT00474539|39290750|FG000|Infant Series|Lost to Follow-up|2|||
16221520|NCT00474539|39290751|FG001|Infant Series|Lost to Follow-up|1|||
16221521|NCT00474539|39290750|FG000|Infant Series|Protocol Violation|0|||
16221522|NCT00474539|39290751|FG001|Infant Series|Protocol Violation|1|||
16221523|NCT00474539|39290750|FG000|After Infant Series|Lost to Follow-up|3|||
16221524|NCT00474539|39290751|FG001|After Infant Series|Lost to Follow-up|0|||
16221525|NCT00474539|39290750|FG000|After Infant Series|Withdrawal by Subject|1|||
16221526|NCT00474539|39290751|FG001|After Infant Series|Withdrawal by Subject|0|||
16221527|NCT00474539|39290750|FG000|Toddler Dose|Protocol Violation|1|||
16221528|NCT00474539|39290751|FG001|Toddler Dose|Protocol Violation|0|||
16221529|NCT02611037|39290760|FG000|Overall Study|Withdrawal prior to treatment|2|||
16221530|NCT02611037|39290761|FG001|Overall Study|Withdrawal prior to treatment|0|||
16221531|NCT01298661|39290762|FG000|Overall Study|Withdrawal by Subject|2|||
16221532|NCT01298661|39290763|FG001|Overall Study|Withdrawal by Subject|0|||
16221533|NCT01298661|39290764|FG002|Overall Study|Withdrawal by Subject|2|||
16221534|NCT02059174|39290765|FG000|Period 1|Withdrawal by Subject|0|||
16221535|NCT02059174|39290766|FG001|Period 1|Withdrawal by Subject|2|||
16221536|NCT02059174|39290765|FG000|Period 2|Withdrawal by Subject|0|||
16408313|NCT02210221|39976947|FG000|Overall Study|Withdrawal by Subject|43|||
16408314|NCT00847665|39976951|FG000|Overall Study|Withdrawal by Subject|1|||
16408315|NCT00847665|39976952|FG001|Overall Study|Withdrawal by Subject|0|||
16408316|NCT02838901|39976953|FG000|Overall Study|Withdrawal by Subject|1|||
16408317|NCT02838901|39976954|FG001|Overall Study|Withdrawal by Subject|1|||
16408318|NCT02838901|39976953|FG000|Overall Study|Lost to Follow-up|1|||
16408319|NCT02838901|39976954|FG001|Overall Study|Lost to Follow-up|1|||
16408320|NCT02594098|39976955|FG000|Overall Study|Lack of Efficacy|17|||
16408321|NCT02594098|39976956|FG001|Overall Study|Lack of Efficacy|6|||
16408322|NCT02594098|39976955|FG000|Overall Study|Withdrawal by Subject|1|||
16408323|NCT02594098|39976956|FG001|Overall Study|Withdrawal by Subject|3|||
16408324|NCT02594098|39976955|FG000|Overall Study|Terminated participation|6|||
16408325|NCT02594098|39976956|FG001|Overall Study|Terminated participation|2|||
16408326|NCT02594098|39976955|FG000|Overall Study|Seek alternative treatment|2|||
16408327|NCT02594098|39976956|FG001|Overall Study|Seek alternative treatment|1|||
16408328|NCT02594098|39976955|FG000|Overall Study|Other|0|||
16544803|NCT01525602|40457141|FG006|Overall Study|Physician Decision|1|||
16408329|NCT02594098|39976956|FG001|Overall Study|Other|1|||
16544804|NCT01525602|40457142|FG007|Overall Study|Physician Decision|0|||
16544805|NCT01525602|40457135|FG000|Overall Study|Death|0|||
16544806|NCT01525602|40457136|FG001|Overall Study|Death|0|||
16544807|NCT01525602|40457137|FG002|Overall Study|Death|0|||
16544808|NCT01525602|40457138|FG003|Overall Study|Death|0|||
16544809|NCT01525602|40457139|FG004|Overall Study|Death|1|||
16544810|NCT01525602|40457140|FG005|Overall Study|Death|1|||
16544811|NCT01525602|40457141|FG006|Overall Study|Death|0|||
16544812|NCT01525602|40457142|FG007|Overall Study|Death|0|||
16544813|NCT01525602|40457135|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
16544814|NCT01525602|40457136|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
16221537|NCT02059174|39290766|FG001|Period 2|Withdrawal by Subject|2|||
16221538|NCT02059174|39290765|FG000|Period 2|Protocol Violation|1|||
16221539|NCT02059174|39290766|FG001|Period 2|Protocol Violation|0|||
16221540|NCT02059174|39290765|FG000|Period 3|Physician Decision|1|||
16221541|NCT02059174|39290766|FG001|Period 3|Physician Decision|0|||
16221542|NCT00444951|39290769|FG000|Overall Study|Lost to Follow-up|1|||
16221543|NCT00444951|39290770|FG001|Overall Study|Lost to Follow-up|1|||
16221544|NCT00444951|39290771|FG002|Overall Study|Lost to Follow-up|0|||
16221545|NCT00444951|39290769|FG000|Overall Study|Withdrawal by Subject|4|||
16408330|NCT02305849|39976957|FG000|Overall Study|Adverse Event|10|||
16408331|NCT02305849|39976958|FG001|Overall Study|Adverse Event|12|||
16408332|NCT02305849|39976959|FG002|Overall Study|Adverse Event|7|||
16408333|NCT02305849|39976960|FG003|Overall Study|Adverse Event|3|||
16408334|NCT02305849|39976957|FG000|Overall Study|Lack of Efficacy|10|||
16408335|NCT02305849|39976958|FG001|Overall Study|Lack of Efficacy|6|||
16408336|NCT02305849|39976959|FG002|Overall Study|Lack of Efficacy|3|||
16408337|NCT02305849|39976960|FG003|Overall Study|Lack of Efficacy|9|||
16408338|NCT02305849|39976957|FG000|Overall Study|Withdrawal by Subject|2|||
16408339|NCT02305849|39976958|FG001|Overall Study|Withdrawal by Subject|2|||
16408340|NCT02305849|39976959|FG002|Overall Study|Withdrawal by Subject|1|||
16408341|NCT02305849|39976960|FG003|Overall Study|Withdrawal by Subject|4|||
16408342|NCT02305849|39976957|FG000|Overall Study|Lost to Follow-up|0|||
16408343|NCT02305849|39976958|FG001|Overall Study|Lost to Follow-up|2|||
16408344|NCT02305849|39976959|FG002|Overall Study|Lost to Follow-up|0|||
16408345|NCT02305849|39976960|FG003|Overall Study|Lost to Follow-up|0|||
16408346|NCT02305849|39976957|FG000|Overall Study|Protocol Violation|3|||
16408347|NCT02305849|39976958|FG001|Overall Study|Protocol Violation|2|||
16408348|NCT02305849|39976959|FG002|Overall Study|Protocol Violation|1|||
16408349|NCT02305849|39976960|FG003|Overall Study|Protocol Violation|1|||
16408350|NCT02305849|39976957|FG000|Overall Study|Lab data met discontinuation criteria|0|||
16408351|NCT02305849|39976958|FG001|Overall Study|Lab data met discontinuation criteria|1|||
16408352|NCT02305849|39976959|FG002|Overall Study|Lab data met discontinuation criteria|2|||
16408353|NCT02305849|39976960|FG003|Overall Study|Lab data met discontinuation criteria|1|||
16544815|NCT01525602|40457137|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
16544816|NCT01525602|40457138|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
16544817|NCT01525602|40457139|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
16544818|NCT01525602|40457140|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
16544819|NCT01525602|40457141|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
16544820|NCT01525602|40457142|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
16221546|NCT00444951|39290770|FG001|Overall Study|Withdrawal by Subject|5|||
16221547|NCT00444951|39290771|FG002|Overall Study|Withdrawal by Subject|3|||
16221548|NCT02646891|39290772|FG000|Overall Study|Adverse Event|0|||
16221549|NCT02646891|39290773|FG001|Overall Study|Adverse Event|1|||
16221550|NCT02646891|39290774|FG002|Overall Study|Adverse Event|0|||
16221551|NCT02646891|39290775|FG003|Overall Study|Adverse Event|0|||
16221552|NCT02646891|39290776|FG004|Overall Study|Adverse Event|0|||
16221553|NCT02646891|39290777|FG005|Overall Study|Adverse Event|0|||
16221554|NCT02646891|39290778|FG006|Overall Study|Adverse Event|0|||
16221555|NCT02646891|39290779|FG007|Overall Study|Adverse Event|0|||
16221556|NCT02646891|39290780|FG008|Overall Study|Adverse Event|0|||
16221557|NCT02646891|39290781|FG009|Overall Study|Adverse Event|0|||
16221558|NCT02646891|39290772|FG000|Overall Study|Lost to Follow-up|0|||
16221559|NCT02646891|39290773|FG001|Overall Study|Lost to Follow-up|0|||
16221560|NCT02646891|39290774|FG002|Overall Study|Lost to Follow-up|0|||
16221561|NCT02646891|39290775|FG003|Overall Study|Lost to Follow-up|0|||
16221562|NCT02646891|39290776|FG004|Overall Study|Lost to Follow-up|0|||
16221563|NCT02646891|39290777|FG005|Overall Study|Lost to Follow-up|0|||
16221564|NCT02646891|39290778|FG006|Overall Study|Lost to Follow-up|2|||
16408354|NCT02305849|39976957|FG000|Overall Study|Miscellaneous|1|||
16408355|NCT02305849|39976958|FG001|Overall Study|Miscellaneous|2|||
16544821|NCT03745222|40457143|FG000|Overall Study|Withdrawal by Subject|0|||
16544822|NCT03745222|40457144|FG001|Overall Study|Withdrawal by Subject|1|||
16408356|NCT02305849|39976959|FG002|Overall Study|Miscellaneous|4|||
16408357|NCT02305849|39976960|FG003|Overall Study|Miscellaneous|1|||
16544823|NCT03745222|40457145|FG002|Overall Study|Withdrawal by Subject|0|||
16544824|NCT00909428|40457146|FG000|Overall Study|Lost to Follow-up|13|||
16544825|NCT00909428|40457147|FG001|Overall Study|Lost to Follow-up|10|||
16544826|NCT00909428|40457148|FG002|Overall Study|Lost to Follow-up|9|||
16544827|NCT00499863|40457151|FG000|Overall Study|Lack of Efficacy|21|||
16544828|NCT00499863|40457152|FG001|Overall Study|Lack of Efficacy|27|||
16544829|NCT00499863|40457151|FG000|Overall Study|Protocol Violation|12|||
16544830|NCT00499863|40457152|FG001|Overall Study|Protocol Violation|7|||
16544831|NCT00499863|40457151|FG000|Overall Study|Withdrawal by Subject|6|||
16544832|NCT00499863|40457152|FG001|Overall Study|Withdrawal by Subject|4|||
16544833|NCT00499863|40457151|FG000|Overall Study|Adverse Event|8|||
16544834|NCT00499863|40457152|FG001|Overall Study|Adverse Event|2|||
16544835|NCT00499863|40457151|FG000|Overall Study|Sponsor decision|2|||
16544836|NCT00499863|40457152|FG001|Overall Study|Sponsor decision|2|||
16408358|NCT02305849|39976957|FG000|Overall Study|Not fulfill eligibility criteria|1|||
16544837|NCT00499863|40457151|FG000|Overall Study|Lost to Follow-up|1|||
16221565|NCT02646891|39290779|FG007|Overall Study|Lost to Follow-up|2|||
16221566|NCT02646891|39290780|FG008|Overall Study|Lost to Follow-up|2|||
16221567|NCT02646891|39290781|FG009|Overall Study|Lost to Follow-up|2|||
16221568|NCT02646891|39290772|FG000|Overall Study|Protocol Violation|0|||
16221569|NCT02646891|39290773|FG001|Overall Study|Protocol Violation|0|||
16221570|NCT02646891|39290774|FG002|Overall Study|Protocol Violation|0|||
16221571|NCT02646891|39290775|FG003|Overall Study|Protocol Violation|0|||
16408359|NCT02305849|39976958|FG001|Overall Study|Not fulfill eligibility criteria|1|||
16408360|NCT02305849|39976959|FG002|Overall Study|Not fulfill eligibility criteria|0|||
16408361|NCT02305849|39976960|FG003|Overall Study|Not fulfill eligibility criteria|0|||
16408362|NCT02210689|39976968|FG000|Overall Study|Withdrawal by Subject|7|||
16408363|NCT02210689|39976969|FG001|Overall Study|Withdrawal by Subject|4|||
16408364|NCT02210689|39976970|FG002|Overall Study|Withdrawal by Subject|2|||
16408365|NCT02210689|39976968|FG000|Overall Study|Adverse Event|0|||
16408366|NCT02210689|39976969|FG001|Overall Study|Adverse Event|1|||
16408367|NCT02210689|39976970|FG002|Overall Study|Adverse Event|0|||
16110210|NCT03024996|38889241|FG000|Overall Study|Death|57|||
16110211|NCT03024996|38889242|FG001|Overall Study|Death|55|||
16110212|NCT03024996|38889241|FG000|Overall Study|Disease relapse|1|||
16110213|NCT03024996|38889242|FG001|Overall Study|Disease relapse|0|||
16110214|NCT03024996|38889241|FG000|Overall Study|Lost to Follow-up|5|||
16110215|NCT03024996|38889242|FG001|Overall Study|Lost to Follow-up|10|||
16110216|NCT03024996|38889241|FG000|Overall Study|Other|3|||
16110217|NCT03024996|38889242|FG001|Overall Study|Other|3|||
16110218|NCT03024996|38889241|FG000|Overall Study|Physician Decision|0|||
16110219|NCT03024996|38889242|FG001|Overall Study|Physician Decision|1|||
16110220|NCT03024996|38889241|FG000|Overall Study|Study terminated by sponsor|303|||
16221572|NCT02646891|39290776|FG004|Overall Study|Protocol Violation|0|||
16408368|NCT02210689|39976968|FG000|Overall Study|Protocol Violation|1|||
16408369|NCT02210689|39976969|FG001|Overall Study|Protocol Violation|0|||
16408370|NCT02210689|39976970|FG002|Overall Study|Protocol Violation|0|||
16408371|NCT02210689|39976968|FG000|Overall Study|Lost to Follow-up|11|||
16408372|NCT02210689|39976969|FG001|Overall Study|Lost to Follow-up|9|||
16408373|NCT02210689|39976970|FG002|Overall Study|Lost to Follow-up|5|||
16408374|NCT02210689|39976968|FG000|Overall Study|Pregnancy|0|||
16408375|NCT02210689|39976969|FG001|Overall Study|Pregnancy|1|||
16408376|NCT02210689|39976970|FG002|Overall Study|Pregnancy|0|||
16408377|NCT02210689|39976968|FG000|Overall Study|Lack of Efficacy|0|||
16544838|NCT00499863|40457152|FG001|Overall Study|Lost to Follow-up|1|||
16544839|NCT01324271|40457155|FG000|Overall Study|Lost to Follow-up|3|||
16544840|NCT01324271|40457156|FG001|Overall Study|Lost to Follow-up|0|||
16544841|NCT01324271|40457155|FG000|Overall Study|Physician Decision|1|||
16544842|NCT01324271|40457156|FG001|Overall Study|Physician Decision|0|||
16544843|NCT00800202|40457157|FG000|Overall Study|Adverse Event|7|||
16544844|NCT00800202|40457158|FG001|Overall Study|Adverse Event|6|||
16544845|NCT00800202|40457157|FG000|Overall Study|Death|1|||
16544846|NCT00800202|40457158|FG001|Overall Study|Death|0|||
16544847|NCT00800202|40457157|FG000|Overall Study|Other|5|||
16110221|NCT03024996|38889242|FG001|Overall Study|Study terminated by sponsor|283|||
16221573|NCT02646891|39290777|FG005|Overall Study|Protocol Violation|0|||
16221574|NCT02646891|39290778|FG006|Overall Study|Protocol Violation|1|||
16221575|NCT02646891|39290779|FG007|Overall Study|Protocol Violation|1|||
16408378|NCT02210689|39976969|FG001|Overall Study|Lack of Efficacy|1|||
16408379|NCT02210689|39976970|FG002|Overall Study|Lack of Efficacy|5|||
16408380|NCT02210689|39976968|FG000|Overall Study|Prohibited medication|2|||
16408381|NCT02210689|39976969|FG001|Overall Study|Prohibited medication|8|||
16408382|NCT02210689|39976970|FG002|Overall Study|Prohibited medication|1|||
16408383|NCT02210689|39976968|FG000|Overall Study|Negative Nugent score at baseline|6|||
16408384|NCT02210689|39976969|FG001|Overall Study|Negative Nugent score at baseline|2|||
16408385|NCT02210689|39976970|FG002|Overall Study|Negative Nugent score at baseline|2|||
16408386|NCT02210689|39976968|FG000|Overall Study|Other|25|||
16408387|NCT02210689|39976969|FG001|Overall Study|Other|21|||
16408388|NCT02210689|39976970|FG002|Overall Study|Other|8|||
16408389|NCT01510145|39976974|FG000|Overall Study|Adverse Event|6|||
16408390|NCT01510145|39976974|FG000|Overall Study|Lost to Follow-up|5|||
16408391|NCT01510145|39976974|FG000|Overall Study|Withdrawal by Subject|6|||
16408392|NCT01510145|39976974|FG000|Overall Study|Relative reported subject withdrew|1|||
16408393|NCT02229214|39976975|FG000|Overall Study|Adverse Event|2|||
16408394|NCT02229214|39976976|FG001|Overall Study|Adverse Event|0|||
16408395|NCT02229214|39976975|FG000|Overall Study|Withdrawal by Subject|4|||
16408396|NCT02229214|39976976|FG001|Overall Study|Withdrawal by Subject|0|||
16408397|NCT01453946|39976977|FG000|Overall Study|Did not receive drug for the taper phase|1|||
16408398|NCT01453946|39976977|FG000|Overall Study|Protocol Violation|2|||
16408399|NCT01453946|39976977|FG000|Overall Study|Lack of Efficacy|3|||
16408400|NCT01453946|39976977|FG000|Overall Study|Adverse Event|3|||
16110222|NCT03024996|38889241|FG000|Overall Study|Withdrawal by Subject|21|||
16110223|NCT03024996|38889242|FG001|Overall Study|Withdrawal by Subject|36|||
16221576|NCT02646891|39290780|FG008|Overall Study|Protocol Violation|0|||
16408401|NCT02741570|39976979|FG000|Pre-Treatment Period|Other reasons|0|||
16408402|NCT02741570|39976980|FG001|Pre-Treatment Period|Other reasons|3|||
16408403|NCT02741570|39976979|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
16408404|NCT02741570|39976980|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
16544848|NCT00800202|40457158|FG001|Overall Study|Other|0|||
16110224|NCT01151423|38889246|FG000|Overall Study|Study terminated by Sponsor|9|||
16221577|NCT02646891|39290781|FG009|Overall Study|Protocol Violation|0|||
16544849|NCT00800202|40457157|FG000|Overall Study|Disease Progression|54|||
16408405|NCT02741570|39976979|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
16408406|NCT02741570|39976980|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
16408407|NCT02741570|39976979|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
16408408|NCT02741570|39976980|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
16408409|NCT02741570|39976979|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
16408410|NCT02741570|39976980|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
16110225|NCT01151423|38889247|FG001|Overall Study|Study terminated by Sponsor|10|||
16110226|NCT01151423|38889246|FG000|Overall Study|Protocol Violation|0|||
16110227|NCT01151423|38889247|FG001|Overall Study|Protocol Violation|1|||
16221578|NCT02646891|39290772|FG000|Overall Study|Withdrawal by Subject|2|||
16408411|NCT02741570|39976979|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
16408412|NCT02741570|39976980|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
16408413|NCT02741570|39976979|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
16408414|NCT02741570|39976980|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
16408415|NCT02741570|39976979|FG000|Pre-Treatment Period|Death|0|||
16408416|NCT02741570|39976980|FG001|Pre-Treatment Period|Death|1|||
16544850|NCT00800202|40457158|FG001|Overall Study|Disease Progression|18|||
16544851|NCT01337986|40457159|FG000|Overall Study|Adverse Event|2|||
16544852|NCT01337986|40457160|FG001|Overall Study|Adverse Event|2|||
16544853|NCT01337986|40457159|FG000|Overall Study|Lost to Follow-up|1|||
16544854|NCT01337986|40457160|FG001|Overall Study|Lost to Follow-up|0|||
16544855|NCT01337986|40457159|FG000|Overall Study|Protocol Violation|0|||
16544856|NCT01337986|40457160|FG001|Overall Study|Protocol Violation|3|||
16544857|NCT00002558|40457161|FG000|Overall Study|Withdrawal by Subject|0|||
16544858|NCT00002558|40457162|FG001|Overall Study|Withdrawal by Subject|1|||
16544859|NCT00755222|40457172|FG000|Overall Study|Withdrawal by Subject|4|||
16544860|NCT00755222|40457173|FG001|Overall Study|Withdrawal by Subject|2|||
16544861|NCT00755222|40457172|FG000|Overall Study|Adverse Event|2|||
16544862|NCT00755222|40457173|FG001|Overall Study|Adverse Event|0|||
16544863|NCT00755222|40457172|FG000|Overall Study|Protocol Violation|2|||
16544864|NCT00755222|40457173|FG001|Overall Study|Protocol Violation|0|||
16544865|NCT03324880|40457179|FG000|Overall Study|Adverse Event|0|||
16544866|NCT03324880|40457180|FG001|Overall Study|Adverse Event|2|||
16544867|NCT03324880|40457179|FG000|Overall Study|Withdrawal by Subject|2|||
16544868|NCT03324880|40457180|FG001|Overall Study|Withdrawal by Subject|2|||
16544869|NCT03324880|40457179|FG000|Overall Study|Lost to Follow-up|0|||
16544870|NCT03324880|40457180|FG001|Overall Study|Lost to Follow-up|1|||
16544871|NCT03324880|40457179|FG000|Overall Study|Product Recall|0|||
16544872|NCT03324880|40457180|FG001|Overall Study|Product Recall|1|||
16544873|NCT01226511|40457181|FG000|Acute Treatment Period|Adverse Event|7|||
16544874|NCT01226511|40457182|FG001|Acute Treatment Period|Adverse Event|6|||
16544875|NCT01226511|40457181|FG000|Acute Treatment Period|Lack of Efficacy|2|||
16544876|NCT01226511|40457182|FG001|Acute Treatment Period|Lack of Efficacy|1|||
16544877|NCT01226511|40457181|FG000|Acute Treatment Period|Lost to Follow-up|3|||
16544878|NCT01226511|40457182|FG001|Acute Treatment Period|Lost to Follow-up|6|||
16544879|NCT01226511|40457181|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
16544880|NCT01226511|40457182|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
16544881|NCT01226511|40457181|FG000|Acute Treatment Period|Protocol Violation|5|||
16544882|NCT01226511|40457182|FG001|Acute Treatment Period|Protocol Violation|5|||
16544883|NCT01226511|40457181|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
16544884|NCT01226511|40457182|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
16544885|NCT01226511|40457181|FG000|Extension Treatment Period|Adverse Event|8|||
16544886|NCT01226511|40457182|FG001|Extension Treatment Period|Adverse Event|8|||
16544887|NCT01226511|40457181|FG000|Extension Treatment Period|Lack of Efficacy|3|||
16544888|NCT01226511|40457182|FG001|Extension Treatment Period|Lack of Efficacy|2|||
16544889|NCT01226511|40457181|FG000|Extension Treatment Period|Lost to Follow-up|4|||
16544890|NCT01226511|40457182|FG001|Extension Treatment Period|Lost to Follow-up|3|||
16544891|NCT01226511|40457181|FG000|Extension Treatment Period|Protocol Violation|2|||
16544892|NCT01226511|40457182|FG001|Extension Treatment Period|Protocol Violation|2|||
16544893|NCT01226511|40457181|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
16544894|NCT01226511|40457182|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
16544895|NCT01226511|40457181|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
16544896|NCT01226511|40457182|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
16544897|NCT01226511|40457181|FG000|Extension Treatment Period|Sponsor Decision|1|||
16544898|NCT01226511|40457182|FG001|Extension Treatment Period|Sponsor Decision|1|||
16544899|NCT01226511|40457181|FG000|Taper Period|Adverse Event|1|||
16544900|NCT01226511|40457182|FG001|Taper Period|Adverse Event|0|||
16544901|NCT01226511|40457181|FG000|Taper Period|Lost to Follow-up|2|||
16544902|NCT01226511|40457182|FG001|Taper Period|Lost to Follow-up|2|||
16544903|NCT01226511|40457181|FG000|Taper Period|Protocol Violation|1|||
16110228|NCT01151423|38889246|FG000|Overall Study|Physician Decision|1|||
16544904|NCT01226511|40457182|FG001|Taper Period|Protocol Violation|0|||
16110229|NCT01151423|38889247|FG001|Overall Study|Physician Decision|1|||
16544905|NCT01226511|40457181|FG000|Taper Period|Parent/Caregiver Decision|1|||
16544906|NCT01226511|40457182|FG001|Taper Period|Parent/Caregiver Decision|1|||
16408417|NCT02741570|39976979|FG000|Pre-Treatment Period|Disease progression|0|||
16408418|NCT02741570|39976980|FG001|Pre-Treatment Period|Disease progression|1|||
16408419|NCT02741570|39976979|FG000|Treatment Period|Other reasons|47|||
16408420|NCT02741570|39976980|FG001|Treatment Period|Other reasons|12|||
16408421|NCT02741570|39976979|FG000|Treatment Period|Poor/non-compliance|0|||
16408422|NCT02741570|39976980|FG001|Treatment Period|Poor/non-compliance|2|||
16408423|NCT02741570|39976979|FG000|Treatment Period|Maximum clinical benefit|4|||
16408424|NCT02741570|39976980|FG001|Treatment Period|Maximum clinical benefit|6|||
16408425|NCT02741570|39976979|FG000|Treatment Period|Lost to Follow-up|1|||
16408426|NCT02741570|39976980|FG001|Treatment Period|Lost to Follow-up|3|||
16408427|NCT02741570|39976979|FG000|Treatment Period|Participant withdrew consent|9|||
16408428|NCT02741570|39976980|FG001|Treatment Period|Participant withdrew consent|13|||
16408429|NCT02741570|39976979|FG000|Treatment Period|Participant request to discontinue treatment|8|||
16408430|NCT02741570|39976980|FG001|Treatment Period|Participant request to discontinue treatment|23|||
16408431|NCT02741570|39976979|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
16408432|NCT02741570|39976980|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
16408433|NCT02741570|39976979|FG000|Treatment Period|Death|9|||
16408434|NCT02741570|39976980|FG001|Treatment Period|Death|7|||
16544907|NCT01201811|40457183|FG000|Overall Study|Adverse Event|6|||
16544908|NCT01201811|40457183|FG000|Overall Study|Disease progression|3|||
16544909|NCT01201811|40457183|FG000|Overall Study|Withdrawal by Subject|3|||
16544910|NCT01201811|40457183|FG000|Overall Study|Death|4|||
16544911|NCT01201811|40457183|FG000|Overall Study|Treatment Failure|2|||
16544912|NCT01201811|40457183|FG000|Overall Study|Physician Decision|1|||
16544913|NCT01493687|40457184|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
16544914|NCT01493687|40457185|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
16544915|NCT01493687|40457184|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
16544916|NCT01493687|40457185|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
16544917|NCT01493687|40457184|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
16544918|NCT01493687|40457185|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
16544919|NCT01493687|40457184|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
16544920|NCT01493687|40457185|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
16544921|NCT01493687|40457184|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
16544922|NCT01493687|40457185|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
16544923|NCT01493687|40457184|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
16544924|NCT01493687|40457185|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
16544925|NCT01493687|40457184|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
16544926|NCT01493687|40457185|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
16544927|NCT01493687|40457184|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
16544928|NCT01493687|40457185|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
16544929|NCT01493687|40457184|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
16544930|NCT01493687|40457185|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
16544931|NCT01493687|40457184|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
16544932|NCT01493687|40457185|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
16544933|NCT01493687|40457184|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
16544934|NCT01493687|40457185|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
16110230|NCT01151423|38889246|FG000|Overall Study|Pregnancy|0|||
16110231|NCT01151423|38889247|FG001|Overall Study|Pregnancy|1|||
16110232|NCT01151423|38889246|FG000|Overall Study|Death|0|||
16110233|NCT01151423|38889247|FG001|Overall Study|Death|1|||
16110234|NCT01151423|38889246|FG000|Overall Study|Adverse Event|3|||
16110235|NCT01151423|38889247|FG001|Overall Study|Adverse Event|0|||
16110236|NCT01151423|38889246|FG000|Overall Study|Withdrawal by Subject|1|||
16110237|NCT01151423|38889247|FG001|Overall Study|Withdrawal by Subject|3|||
16110238|NCT01151423|38889246|FG000|Overall Study|Lost to Follow-up|1|||
16110239|NCT01151423|38889247|FG001|Overall Study|Lost to Follow-up|0|||
16110240|NCT01151423|38889246|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
16110241|NCT01151423|38889247|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
16110242|NCT01151423|38889246|FG000|Overall Study|Participated in other clinical trial|1|||
16110243|NCT01151423|38889247|FG001|Overall Study|Participated in other clinical trial|0|||
16110244|NCT00934700|38889248|FG000|Overall Study|missing scan|5|||
16110245|NCT00934700|38889249|FG001|Overall Study|missing scan|9|||
16110246|NCT00934700|38889248|FG000|Overall Study|Death|8|||
16110247|NCT00934700|38889249|FG001|Overall Study|Death|3|||
16110248|NCT03004404|38889250|FG000|Period 2|Adverse Event|0|||
16110249|NCT03004404|38889251|FG001|Period 2|Adverse Event|0|||
16110250|NCT03004404|38889252|FG002|Period 2|Adverse Event|0|||
16110251|NCT03004404|38889253|FG003|Period 2|Adverse Event|0|||
16110252|NCT03004404|38889254|FG004|Period 2|Adverse Event|0|||
16110253|NCT03004404|38889255|FG005|Period 2|Adverse Event|0|||
16408435|NCT02741570|39976979|FG000|Treatment Period|Study drug toxicity|55|||
16408436|NCT02741570|39976980|FG001|Treatment Period|Study drug toxicity|47|||
16408437|NCT02741570|39976979|FG000|Treatment Period|Disease progression|294|||
16110254|NCT03004404|38889256|FG006|Period 2|Adverse Event|0|||
16110255|NCT03004404|38889257|FG007|Period 2|Adverse Event|0|||
16110256|NCT03004404|38889258|FG008|Period 2|Adverse Event|1|||
16110257|NCT03004404|38889259|FG009|Period 2|Adverse Event|0|||
16110258|NCT03004404|38889260|FG010|Period 2|Adverse Event|0|||
16110259|NCT03004404|38889261|FG011|Period 2|Adverse Event|0|||
16110260|NCT03004404|38889262|FG012|Period 2|Adverse Event|0|||
16110261|NCT03004404|38889263|FG013|Period 2|Adverse Event|0|||
16110262|NCT03004404|38889264|FG014|Period 2|Adverse Event|0|||
16110263|NCT03004404|38889265|FG015|Period 2|Adverse Event|1|||
16110264|NCT03297398|38892765|FG000|Overall Study|Sponsor's decision|6|||
16110265|NCT03297398|38892766|FG001|Overall Study|Sponsor's decision|9|||
16110266|NCT03297398|38892767|FG002|Overall Study|Sponsor's decision|7|||
16110267|NCT03297398|38892765|FG000|Overall Study|Adverse Event|1|||
16110268|NCT03297398|38892766|FG001|Overall Study|Adverse Event|4|||
16110269|NCT03297398|38892767|FG002|Overall Study|Adverse Event|4|||
16110270|NCT03297398|38892765|FG000|Overall Study|Withdrawal by Subject|1|||
16544935|NCT01493687|40457184|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
16544936|NCT01493687|40457185|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
16544937|NCT01493687|40457184|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
16544938|NCT01493687|40457185|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
16544939|NCT01493687|40457184|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
16544940|NCT01493687|40457185|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
16544941|NCT01493687|40457184|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
16544942|NCT01493687|40457185|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
16110271|NCT03297398|38892766|FG001|Overall Study|Withdrawal by Subject|2|||
16110272|NCT03297398|38892767|FG002|Overall Study|Withdrawal by Subject|2|||
16110273|NCT03297398|38892765|FG000|Overall Study|Protocol Violation|0|||
16110274|NCT03297398|38892766|FG001|Overall Study|Protocol Violation|2|||
16110275|NCT03297398|38892767|FG002|Overall Study|Protocol Violation|0|||
16110276|NCT03297398|38892765|FG000|Overall Study|Physician Decision|0|||
16110277|NCT03297398|38892766|FG001|Overall Study|Physician Decision|0|||
16110278|NCT03297398|38892767|FG002|Overall Study|Physician Decision|1|||
16110279|NCT03297398|38892765|FG000|Overall Study|Lost to Follow-up|0|||
16110280|NCT03297398|38892766|FG001|Overall Study|Lost to Follow-up|0|||
16110281|NCT03297398|38892767|FG002|Overall Study|Lost to Follow-up|1|||
16110282|NCT01057251|38892768|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
16110283|NCT01057251|38892769|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
16110284|NCT01057251|38892768|FG000|Overall Study|Adverse Event|4|||
16110285|NCT01057251|38892769|FG001|Overall Study|Adverse Event|2|||
16110286|NCT01057251|38892768|FG000|Overall Study|Lack of Efficacy|2|||
16110287|NCT01057251|38892769|FG001|Overall Study|Lack of Efficacy|11|||
16110288|NCT01057251|38892768|FG000|Overall Study|Protocol Violation|6|||
16110289|NCT01057251|38892769|FG001|Overall Study|Protocol Violation|2|||
16110290|NCT01057251|38892768|FG000|Overall Study|Withdrawal by Subject|4|||
16110291|NCT01057251|38892769|FG001|Overall Study|Withdrawal by Subject|5|||
16110292|NCT01057251|38892768|FG000|Overall Study|Lost to Follow-up|7|||
16110293|NCT01057251|38892769|FG001|Overall Study|Lost to Follow-up|6|||
16110294|NCT01057251|38892768|FG000|Overall Study|Other Reason|1|||
16110295|NCT01057251|38892769|FG001|Overall Study|Other Reason|1|||
16110296|NCT04156399|38892770|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
16110297|NCT04156399|38892770|FG000|Overall Study|study suspension due to COVID pandemic|3|||
16110298|NCT00460564|38892771|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
16110299|NCT00460564|38892772|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
16110300|NCT00460564|38892773|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
16110301|NCT00460564|38892774|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
16110302|NCT00460564|38892775|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
16110303|NCT00460564|38892776|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
16110304|NCT00460564|38892777|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
16110305|NCT00460564|38892778|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
16110306|NCT00460564|38892771|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
16110307|NCT00460564|38892772|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
16110308|NCT00460564|38892773|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
16110309|NCT00460564|38892774|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
16110310|NCT00460564|38892775|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
16110311|NCT00460564|38892776|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
16344369|NCT01490840|39747571|FG000|Phase 2|Withdrawal by Subject|4|||
16344370|NCT01490840|39747572|FG001|Phase 2|Withdrawal by Subject|3|||
16344371|NCT01490840|39747571|FG000|Phase 2|Permanent interruption of fingolimod|0|||
16544943|NCT00962247|40457188|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
16544944|NCT00962247|40457188|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
16544945|NCT01984684|40457189|FG000|Overall Study|Lost to Follow-up|25|||
16110312|NCT00460564|38892777|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
16110313|NCT00460564|38892778|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
16110314|NCT00460564|38892771|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
16544946|NCT01984684|40457190|FG001|Overall Study|Lost to Follow-up|24|||
16544947|NCT01984684|40457189|FG000|Overall Study|Adverse Event|8|||
16544948|NCT01984684|40457190|FG001|Overall Study|Adverse Event|12|||
16544949|NCT01984684|40457189|FG000|Overall Study|Withdrawal by Subject|9|||
16544950|NCT01984684|40457190|FG001|Overall Study|Withdrawal by Subject|9|||
16544951|NCT01984684|40457189|FG000|Overall Study|Lack of Efficacy|3|||
16544952|NCT01984684|40457190|FG001|Overall Study|Lack of Efficacy|6|||
16544953|NCT01984684|40457189|FG000|Overall Study|Physician Decision|4|||
16544954|NCT01984684|40457190|FG001|Overall Study|Physician Decision|2|||
16544955|NCT01984684|40457189|FG000|Overall Study|Protocol Violation|4|||
16544956|NCT01984684|40457190|FG001|Overall Study|Protocol Violation|2|||
16544957|NCT01984684|40457189|FG000|Overall Study|Death|0|||
16544958|NCT01984684|40457190|FG001|Overall Study|Death|1|||
16544959|NCT01984684|40457189|FG000|Overall Study|Noncompliance with study drug|2|||
16544960|NCT01984684|40457190|FG001|Overall Study|Noncompliance with study drug|1|||
16544961|NCT01984684|40457189|FG000|Overall Study|Subject incarcerated|1|||
16544962|NCT01984684|40457190|FG001|Overall Study|Subject incarcerated|0|||
16544963|NCT01984684|40457189|FG000|Overall Study|Study drug not available at site|1|||
16110315|NCT00460564|38892772|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
16110316|NCT00460564|38892773|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
16110317|NCT00460564|38892774|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
16110318|NCT00460564|38892775|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
16544964|NCT01984684|40457190|FG001|Overall Study|Study drug not available at site|1|||
16544965|NCT01984684|40457189|FG000|Overall Study|Subject had inadequate IV access|0|||
16544966|NCT01984684|40457190|FG001|Overall Study|Subject had inadequate IV access|1|||
16544967|NCT03201445|40457193|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
16544968|NCT03201445|40457194|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
16544969|NCT03201445|40457193|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
16544970|NCT03201445|40457194|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
16544971|NCT03201445|40457193|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
16544972|NCT03201445|40457194|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
16544973|NCT03201445|40457193|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
16544974|NCT03201445|40457194|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
16544975|NCT03201445|40457193|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
16544976|NCT03201445|40457194|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
16544977|NCT03201445|40457193|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
16544978|NCT03201445|40457194|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
16544979|NCT03201445|40457193|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
16544980|NCT03201445|40457194|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
16544981|NCT01641926|40457200|FG000|Overall Study|Adverse Event|5|||
16544982|NCT01641926|40457201|FG001|Overall Study|Adverse Event|2|||
16544983|NCT01641926|40457202|FG002|Overall Study|Adverse Event|3|||
16544984|NCT01641926|40457203|FG003|Overall Study|Adverse Event|1|||
16544985|NCT01641926|40457200|FG000|Overall Study|Lost to Follow-up|2|||
16544986|NCT01641926|40457201|FG001|Overall Study|Lost to Follow-up|2|||
16544987|NCT01641926|40457202|FG002|Overall Study|Lost to Follow-up|1|||
16544988|NCT01641926|40457203|FG003|Overall Study|Lost to Follow-up|0|||
16544989|NCT01641926|40457200|FG000|Overall Study|Physician Decision|6|||
16544990|NCT01641926|40457201|FG001|Overall Study|Physician Decision|5|||
16544991|NCT01641926|40457202|FG002|Overall Study|Physician Decision|0|||
16544992|NCT01641926|40457203|FG003|Overall Study|Physician Decision|1|||
16544993|NCT01641926|40457200|FG000|Overall Study|Protocol Violation|1|||
16544994|NCT01641926|40457201|FG001|Overall Study|Protocol Violation|0|||
16544995|NCT01641926|40457202|FG002|Overall Study|Protocol Violation|0|||
16544996|NCT01641926|40457203|FG003|Overall Study|Protocol Violation|1|||
16544997|NCT01641926|40457200|FG000|Overall Study|Withdrawal by Subject|13|||
16544998|NCT01641926|40457201|FG001|Overall Study|Withdrawal by Subject|5|||
16544999|NCT01641926|40457202|FG002|Overall Study|Withdrawal by Subject|6|||
16545000|NCT01641926|40457203|FG003|Overall Study|Withdrawal by Subject|1|||
16545001|NCT01641926|40457200|FG000|Overall Study|Not Treated|1|||
16545002|NCT01641926|40457201|FG001|Overall Study|Not Treated|1|||
16545003|NCT01641926|40457202|FG002|Overall Study|Not Treated|1|||
16545004|NCT01641926|40457203|FG003|Overall Study|Not Treated|0|||
16545005|NCT04244396|40460579|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
16545006|NCT04244396|40460579|FG000|Overall Study|Withdrawal by Subject|2|||
16110319|NCT00460564|38892776|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
16110320|NCT00460564|38892777|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
16110321|NCT00460564|38892778|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
16545007|NCT04244396|40460579|FG000|Overall Study|Study termination|37|||
16545008|NCT01287520|40460582|FG000|Overall Study|Adverse Event|2|||
16545009|NCT01287520|40460583|FG001|Overall Study|Adverse Event|2|||
16545010|NCT01287520|40460584|FG002|Overall Study|Adverse Event|2|||
16110322|NCT00460564|38892771|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
16110323|NCT00460564|38892772|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
16545011|NCT01287520|40460585|FG003|Overall Study|Adverse Event|1|||
16545012|NCT01287520|40460586|FG004|Overall Study|Adverse Event|1|||
16221579|NCT02646891|39290773|FG001|Overall Study|Withdrawal by Subject|0|||
16221580|NCT02646891|39290774|FG002|Overall Study|Withdrawal by Subject|1|||
16221581|NCT02646891|39290775|FG003|Overall Study|Withdrawal by Subject|0|||
16221582|NCT02646891|39290776|FG004|Overall Study|Withdrawal by Subject|0|||
16221583|NCT02646891|39290777|FG005|Overall Study|Withdrawal by Subject|0|||
16221584|NCT02646891|39290778|FG006|Overall Study|Withdrawal by Subject|5|||
16221585|NCT02646891|39290779|FG007|Overall Study|Withdrawal by Subject|9|||
16221586|NCT02646891|39290780|FG008|Overall Study|Withdrawal by Subject|7|||
16221587|NCT02646891|39290781|FG009|Overall Study|Withdrawal by Subject|3|||
16221588|NCT02646891|39290772|FG000|Overall Study|Death|0|||
16221589|NCT02646891|39290773|FG001|Overall Study|Death|0|||
16221590|NCT02646891|39290774|FG002|Overall Study|Death|0|||
16221591|NCT02646891|39290775|FG003|Overall Study|Death|0|||
16545013|NCT01287520|40460587|FG005|Overall Study|Adverse Event|2|||
16545014|NCT01287520|40460588|FG006|Overall Study|Adverse Event|0|||
16221592|NCT02646891|39290776|FG004|Overall Study|Death|0|||
16221593|NCT02646891|39290777|FG005|Overall Study|Death|0|||
16545015|NCT01287520|40460589|FG007|Overall Study|Adverse Event|2|||
16545016|NCT01287520|40460590|FG008|Overall Study|Adverse Event|0|||
16545017|NCT01287520|40460582|FG000|Overall Study|Physician Decision|1|||
16221594|NCT02646891|39290778|FG006|Overall Study|Death|1|||
16221595|NCT02646891|39290779|FG007|Overall Study|Death|1|||
16221596|NCT02646891|39290780|FG008|Overall Study|Death|1|||
16545018|NCT01287520|40460583|FG001|Overall Study|Physician Decision|1|||
16545019|NCT01287520|40460584|FG002|Overall Study|Physician Decision|2|||
16545020|NCT01287520|40460585|FG003|Overall Study|Physician Decision|0|||
16545021|NCT01287520|40460586|FG004|Overall Study|Physician Decision|1|||
16545022|NCT01287520|40460587|FG005|Overall Study|Physician Decision|1|||
16545023|NCT01287520|40460588|FG006|Overall Study|Physician Decision|0|||
16545024|NCT01287520|40460589|FG007|Overall Study|Physician Decision|1|||
16221597|NCT02646891|39290781|FG009|Overall Study|Death|0|||
16221598|NCT01877655|39290786|FG000|Overall Study|Death|57|||
16221599|NCT01877655|39290787|FG001|Overall Study|Death|52|||
16221600|NCT01877655|39290786|FG000|Overall Study|Withdrawal by Subject|18|||
16221601|NCT01877655|39290787|FG001|Overall Study|Withdrawal by Subject|26|||
16221602|NCT01877655|39290786|FG000|Overall Study|Physician Decision|11|||
16221603|NCT01877655|39290787|FG001|Overall Study|Physician Decision|10|||
16221604|NCT01877655|39290786|FG000|Overall Study|Miscellaneous|4|||
16221605|NCT01877655|39290787|FG001|Overall Study|Miscellaneous|4|||
16221606|NCT01877655|39290786|FG000|Overall Study|Randomized but Never Received Drug|8|||
16221607|NCT01877655|39290787|FG001|Overall Study|Randomized but Never Received Drug|5|||
16221608|NCT01432756|39290790|FG000|Overall Study|Lost to Follow-up|1|||
16221609|NCT01432756|39290791|FG001|Overall Study|Lost to Follow-up|0|||
16221610|NCT01432756|39290792|FG002|Overall Study|Lost to Follow-up|2|||
16221611|NCT01432756|39290793|FG003|Overall Study|Lost to Follow-up|1|||
16221612|NCT02743494|39290794|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
16221613|NCT02743494|39290795|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
16221614|NCT02743494|39290794|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
16221615|NCT02743494|39290795|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
16221616|NCT02743494|39290794|FG000|Treatment Period|Completed treatment|229|||
16221617|NCT02743494|39290795|FG001|Treatment Period|Completed treatment|99|||
16221618|NCT02743494|39290794|FG000|Treatment Period|Disease recurrence|149|||
16221619|NCT02743494|39290795|FG001|Treatment Period|Disease recurrence|113|||
16221620|NCT02743494|39290794|FG000|Treatment Period|Study drug toxicity|57|||
16221621|NCT02743494|39290795|FG001|Treatment Period|Study drug toxicity|8|||
16221622|NCT02743494|39290794|FG000|Treatment Period|Death|1|||
16221623|NCT02743494|39290795|FG001|Treatment Period|Death|0|||
16221624|NCT02743494|39290794|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
16221625|NCT02743494|39290795|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
16221626|NCT02743494|39290794|FG000|Treatment Period|Participant request to discontinue treatment|30|||
16221627|NCT02743494|39290795|FG001|Treatment Period|Participant request to discontinue treatment|5|||
16221628|NCT02743494|39290794|FG000|Treatment Period|Participant withdrew consent|12|||
16344372|NCT01490840|39747572|FG001|Phase 2|Permanent interruption of fingolimod|1|||
16344373|NCT01490840|39747571|FG000|Phase 2|Lost to Follow-up|1|||
16344374|NCT01490840|39747572|FG001|Phase 2|Lost to Follow-up|1|||
16545025|NCT01287520|40460590|FG008|Overall Study|Physician Decision|0|||
16545026|NCT01287520|40460582|FG000|Overall Study|Progressive disease|0|||
16545027|NCT01287520|40460583|FG001|Overall Study|Progressive disease|4|||
16221629|NCT02743494|39290795|FG001|Treatment Period|Participant withdrew consent|4|||
16221630|NCT02743494|39290794|FG000|Treatment Period|Lost to Follow-up|0|||
16221631|NCT02743494|39290795|FG001|Treatment Period|Lost to Follow-up|1|||
16221632|NCT02743494|39290794|FG000|Treatment Period|Poor/Non-compliance|1|||
16221633|NCT02743494|39290795|FG001|Treatment Period|Poor/Non-compliance|0|||
16221634|NCT02743494|39290794|FG000|Treatment Period|Other reasons|7|||
16221635|NCT02743494|39290795|FG001|Treatment Period|Other reasons|2|||
16221636|NCT00591786|39290797|FG000|Overall Study|Withdrawal of Informed Consent|0|||
16344375|NCT01490840|39747571|FG000|Phase 2|Adverse Event|1|||
16221637|NCT00591786|39290798|FG001|Overall Study|Withdrawal of Informed Consent|0|||
16221638|NCT00591786|39290799|FG002|Overall Study|Withdrawal of Informed Consent|1|||
16221639|NCT00591786|39290800|FG003|Overall Study|Withdrawal of Informed Consent|0|||
16221640|NCT00591786|39290801|FG004|Overall Study|Withdrawal of Informed Consent|0|||
16221641|NCT00591786|39290802|FG005|Overall Study|Withdrawal of Informed Consent|0|||
16221642|NCT00591786|39290803|FG006|Overall Study|Withdrawal of Informed Consent|0|||
16221643|NCT00591786|39290804|FG007|Overall Study|Withdrawal of Informed Consent|0|||
16221644|NCT00591786|39290805|FG008|Overall Study|Withdrawal of Informed Consent|0|||
16221645|NCT00591786|39290806|FG009|Overall Study|Withdrawal of Informed Consent|0|||
16221646|NCT01852591|39290807|FG000|Overall Study|Withdrawal by Subject|2|||
16221647|NCT01852591|39290807|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
16221648|NCT00381706|39290808|FG000|Overall Study|Never treated|7|||
16221649|NCT00381706|39290809|FG001|Overall Study|Never treated|2|||
16545028|NCT01287520|40460584|FG002|Overall Study|Progressive disease|1|||
16545029|NCT01287520|40460585|FG003|Overall Study|Progressive disease|6|||
16545030|NCT01287520|40460586|FG004|Overall Study|Progressive disease|1|||
16545031|NCT01287520|40460587|FG005|Overall Study|Progressive disease|0|||
16545032|NCT01287520|40460588|FG006|Overall Study|Progressive disease|2|||
16545033|NCT01287520|40460589|FG007|Overall Study|Progressive disease|2|||
16545034|NCT01287520|40460590|FG008|Overall Study|Progressive disease|4|||
16545035|NCT01287520|40460582|FG000|Overall Study|Withdrawal by Subject|0|||
16545036|NCT01287520|40460583|FG001|Overall Study|Withdrawal by Subject|0|||
16545037|NCT01287520|40460584|FG002|Overall Study|Withdrawal by Subject|0|||
16545038|NCT01287520|40460585|FG003|Overall Study|Withdrawal by Subject|0|||
16545039|NCT01287520|40460586|FG004|Overall Study|Withdrawal by Subject|0|||
16545040|NCT01287520|40460587|FG005|Overall Study|Withdrawal by Subject|1|||
16545041|NCT01287520|40460588|FG006|Overall Study|Withdrawal by Subject|0|||
16545042|NCT01287520|40460589|FG007|Overall Study|Withdrawal by Subject|0|||
16545043|NCT01287520|40460590|FG008|Overall Study|Withdrawal by Subject|1|||
16545044|NCT02799472|40460591|FG000|Overall Study|Withdrawal by Subject|2|||
16545045|NCT02799472|40460592|FG001|Overall Study|Withdrawal by Subject|4|||
16545046|NCT02799472|40460591|FG000|Overall Study|Lack of Efficacy|2|||
16545047|NCT02799472|40460592|FG001|Overall Study|Lack of Efficacy|0|||
16545048|NCT02799472|40460591|FG000|Overall Study|Lost to Follow-up|0|||
16545049|NCT02799472|40460592|FG001|Overall Study|Lost to Follow-up|1|||
16545050|NCT03559218|40460593|FG000|Overall Study|Withdrawal by Subject|1|||
16545051|NCT03559218|40460594|FG001|Overall Study|Withdrawal by Subject|0|||
16545052|NCT00521144|40460595|FG000|Overall Study|Not Treated|0|||
16545053|NCT00521144|40460596|FG001|Overall Study|Not Treated|0|||
16545054|NCT00521144|40460597|FG002|Overall Study|Not Treated|0|||
16545055|NCT00521144|40460598|FG003|Overall Study|Not Treated|1|||
16545056|NCT00521144|40460599|FG004|Overall Study|Not Treated|0|||
16545057|NCT00521144|40460595|FG000|Overall Study|Adverse Event|0|||
16545058|NCT00521144|40460596|FG001|Overall Study|Adverse Event|1|||
16545059|NCT00521144|40460597|FG002|Overall Study|Adverse Event|0|||
16545060|NCT00521144|40460598|FG003|Overall Study|Adverse Event|0|||
16545061|NCT00521144|40460599|FG004|Overall Study|Adverse Event|1|||
16545062|NCT00521144|40460595|FG000|Overall Study|Progressive Disease|4|||
16545063|NCT00521144|40460596|FG001|Overall Study|Progressive Disease|2|||
16545064|NCT00521144|40460597|FG002|Overall Study|Progressive Disease|2|||
16545065|NCT00521144|40460598|FG003|Overall Study|Progressive Disease|0|||
16545066|NCT00521144|40460599|FG004|Overall Study|Progressive Disease|6|||
16545067|NCT04525547|40460610|FG000|Overall Study|Not treated with Ofev|2|||
16545068|NCT04525547|40460610|FG000|Overall Study|Off-label use|2|||
16545069|NCT04525547|40460610|FG000|Overall Study|Lost to Follow-up|1|||
16545070|NCT00110890|40460611|FG000|Overall Study|Adverse Event|30|||
16545071|NCT00110890|40460612|FG001|Overall Study|Adverse Event|7|||
16545072|NCT00110890|40460611|FG000|Overall Study|Death|16|||
16545073|NCT00110890|40460612|FG001|Overall Study|Death|9|||
16545074|NCT00110890|40460611|FG000|Overall Study|Lost to Follow-up|3|||
16545075|NCT00110890|40460612|FG001|Overall Study|Lost to Follow-up|1|||
16545076|NCT00110890|40460611|FG000|Overall Study|Physician Decision|4|||
16545077|NCT00110890|40460612|FG001|Overall Study|Physician Decision|5|||
16545078|NCT00110890|40460611|FG000|Overall Study|Withdrawal by Subject|17|||
16545079|NCT00110890|40460612|FG001|Overall Study|Withdrawal by Subject|5|||
16545080|NCT00110890|40460611|FG000|Overall Study|Protocol Deviation|1|||
16545081|NCT00110890|40460612|FG001|Overall Study|Protocol Deviation|0|||
16545082|NCT00110890|40460611|FG000|Overall Study|Noncompliance|10|||
16545083|NCT00110890|40460612|FG001|Overall Study|Noncompliance|0|||
16545084|NCT00110890|40460611|FG000|Overall Study|Kidney Transplant|16|||
16545085|NCT00110890|40460612|FG001|Overall Study|Kidney Transplant|12|||
16545086|NCT00110890|40460611|FG000|Overall Study|Invest. Product Commercially Available|217|||
16545087|NCT00110890|40460612|FG001|Overall Study|Invest. Product Commercially Available|110|||
16545088|NCT00110890|40460611|FG000|Overall Study|Other|34|||
16545089|NCT00110890|40460612|FG001|Overall Study|Other|23|||
16545090|NCT00110890|40460611|FG000|Overall Study|Ineligibility determined|3|||
16545091|NCT00110890|40460612|FG001|Overall Study|Ineligibility determined|0|||
16221650|NCT00381706|39290810|FG002|Overall Study|Never treated|1|||
16545092|NCT00110890|40460611|FG000|Overall Study|Requirement for alternative therapy|0|||
16545093|NCT00110890|40460612|FG001|Overall Study|Requirement for alternative therapy|1|||
16545094|NCT00110890|40460611|FG000|Overall Study|Disease progression|0|||
16545095|NCT00110890|40460612|FG001|Overall Study|Disease progression|1|||
16545096|NCT00110890|40460611|FG000|Overall Study|Parathyroidectomy|0|||
16545097|NCT00110890|40460612|FG001|Overall Study|Parathyroidectomy|1|||
16545098|NCT00110890|40460611|FG000|Overall Study|Did not enter follow-up phase|10|||
16545099|NCT00110890|40460612|FG001|Overall Study|Did not enter follow-up phase|4|||
16545100|NCT03928028|40460613|FG000|Overall Study|Physician Decision|9|||
16545101|NCT03928028|40460614|FG001|Overall Study|Physician Decision|6|||
16545102|NCT03928028|40460615|FG002|Overall Study|Physician Decision|3|||
16545103|NCT03928028|40460613|FG000|Overall Study|Withdrawal by Subject|12|||
16221651|NCT01077193|39290811|FG000|Overall Study|Lost to Follow-up|1|||
16221652|NCT01077193|39290811|FG000|Overall Study|Withdrawal by Subject|2|||
16221653|NCT01077193|39290811|FG000|Overall Study|Lack of Efficacy|1|||
16545104|NCT03928028|40460614|FG001|Overall Study|Withdrawal by Subject|3|||
16545105|NCT03928028|40460615|FG002|Overall Study|Withdrawal by Subject|3|||
16545106|NCT03333915|40460620|FG000|Overall Study|Lost to Follow-up|0|||
16545107|NCT03333915|40460621|FG001|Overall Study|Lost to Follow-up|0|||
16545108|NCT03333915|40460622|FG002|Overall Study|Lost to Follow-up|1|||
16545109|NCT03333915|40460623|FG003|Overall Study|Lost to Follow-up|0|||
16545110|NCT03333915|40460624|FG004|Overall Study|Lost to Follow-up|0|||
16221654|NCT01077193|39290811|FG000|Overall Study|Study Terminated by Sponsor|40|||
16221655|NCT00686894|39290812|FG000|Overall Study|Relapse|2|||
16221656|NCT00686894|39290812|FG000|Overall Study|Protocol Violation|4|||
16221657|NCT04051944|39290813|FG000|Overall Study|Study ending|1|||
16221658|NCT04051944|39290814|FG001|Overall Study|Study ending|1|||
16221659|NCT04051944|39290813|FG000|Overall Study|Early study termination by participant|1|||
16221660|NCT04051944|39290814|FG001|Overall Study|Early study termination by participant|0|||
16221661|NCT04051944|39290813|FG000|Overall Study|Withdrawal by Subject|2|||
16221662|NCT04051944|39290814|FG001|Overall Study|Withdrawal by Subject|2|||
16221663|NCT04051944|39290813|FG000|Overall Study|Lack of Efficacy|3|||
16221664|NCT04051944|39290814|FG001|Overall Study|Lack of Efficacy|0|||
16221665|NCT04051944|39290813|FG000|Overall Study|Adverse event, non- fatal|1|||
16221666|NCT04051944|39290814|FG001|Overall Study|Adverse event, non- fatal|1|||
16221667|NCT00935701|39290818|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
16221668|NCT01849289|39290819|FG000|Overall Study|Adverse Event|3|||
16221669|NCT01849289|39290820|FG001|Overall Study|Adverse Event|3|||
16221670|NCT01849289|39290819|FG000|Overall Study|Protocol Violation|3|||
16221671|NCT01849289|39290820|FG001|Overall Study|Protocol Violation|3|||
16221672|NCT01849289|39290819|FG000|Overall Study|Withdrawal criteria|1|||
16221673|NCT01849289|39290820|FG001|Overall Study|Withdrawal criteria|0|||
16221674|NCT01849289|39290819|FG000|Overall Study|Unclassified|25|||
16221675|NCT01849289|39290820|FG001|Overall Study|Unclassified|18|||
16221676|NCT01365468|39290821|FG000|Overall Study|Physician Decision|1|||
16221677|NCT01365468|39290822|FG001|Overall Study|Physician Decision|0|||
16221678|NCT01365468|39290821|FG000|Overall Study|Disease progression|1|||
16221679|NCT01365468|39290822|FG001|Overall Study|Disease progression|0|||
16221680|NCT01365468|39290821|FG000|Overall Study|Lost to Follow-up|2|||
16221681|NCT01365468|39290822|FG001|Overall Study|Lost to Follow-up|0|||
16221682|NCT00696774|39290825|FG000|Period II|Adverse Event|0|||
16221683|NCT00696774|39290826|FG001|Period II|Adverse Event|0|||
16221684|NCT00696774|39290827|FG002|Period II|Adverse Event|15|||
16221685|NCT00696774|39290825|FG000|Period II|Lost to Follow-up|0|||
16221686|NCT00696774|39290826|FG001|Period II|Lost to Follow-up|0|||
16221687|NCT00696774|39290827|FG002|Period II|Lost to Follow-up|4|||
16221688|NCT00696774|39290825|FG000|Period II|Protocol Violation|0|||
16221689|NCT00696774|39290826|FG001|Period II|Protocol Violation|0|||
16221690|NCT00696774|39290827|FG002|Period II|Protocol Violation|11|||
16221691|NCT00696774|39290825|FG000|Period II|Withdrawal by Subject|0|||
16221692|NCT00696774|39290826|FG001|Period II|Withdrawal by Subject|0|||
16221693|NCT00696774|39290827|FG002|Period II|Withdrawal by Subject|4|||
16221694|NCT00696774|39290825|FG000|Period II|Sponsor Decision|0|||
16221695|NCT00696774|39290826|FG001|Period II|Sponsor Decision|0|||
16221696|NCT00696774|39290827|FG002|Period II|Sponsor Decision|0|||
16221697|NCT00696774|39290825|FG000|Period II|Lack of Efficacy|0|||
16545111|NCT03333915|40460620|FG000|Overall Study|Disease Progression|0|||
16545112|NCT03333915|40460621|FG001|Overall Study|Disease Progression|1|||
16221698|NCT00696774|39290826|FG001|Period II|Lack of Efficacy|0|||
16221699|NCT00696774|39290827|FG002|Period II|Lack of Efficacy|2|||
16545113|NCT03333915|40460622|FG002|Overall Study|Disease Progression|0|||
16545114|NCT03333915|40460623|FG003|Overall Study|Disease Progression|0|||
16545115|NCT03333915|40460624|FG004|Overall Study|Disease Progression|0|||
16545116|NCT03333915|40460620|FG000|Overall Study|Death|0|||
16545117|NCT03333915|40460621|FG001|Overall Study|Death|0|||
16221700|NCT00696774|39290825|FG000|Period III|Adverse Event|1|||
16221701|NCT00696774|39290826|FG001|Period III|Adverse Event|1|||
16221702|NCT00696774|39290827|FG002|Period III|Adverse Event|0|||
16221703|NCT00696774|39290825|FG000|Period III|Lost to Follow-up|2|||
16221704|NCT00696774|39290826|FG001|Period III|Lost to Follow-up|1|||
16545118|NCT03333915|40460622|FG002|Overall Study|Death|0|||
16545119|NCT03333915|40460623|FG003|Overall Study|Death|37|||
16545120|NCT03333915|40460624|FG004|Overall Study|Death|18|||
16545121|NCT03333915|40460620|FG000|Overall Study|Sponsor's Decision|0|||
16545122|NCT03333915|40460621|FG001|Overall Study|Sponsor's Decision|0|||
16545123|NCT03333915|40460622|FG002|Overall Study|Sponsor's Decision|0|||
16545124|NCT03333915|40460623|FG003|Overall Study|Sponsor's Decision|48|||
16545125|NCT03333915|40460624|FG004|Overall Study|Sponsor's Decision|4|||
16545126|NCT03333915|40460620|FG000|Overall Study|Withdrawal by Subject|0|||
16545127|NCT03333915|40460621|FG001|Overall Study|Withdrawal by Subject|0|||
16545128|NCT03333915|40460622|FG002|Overall Study|Withdrawal by Subject|0|||
16545129|NCT03333915|40460623|FG003|Overall Study|Withdrawal by Subject|5|||
16545130|NCT03333915|40460624|FG004|Overall Study|Withdrawal by Subject|1|||
16545131|NCT00112580|40460625|FG000|Overall Study|Adverse Event|1|||
16545132|NCT00112580|40460626|FG001|Overall Study|Adverse Event|2|||
16545133|NCT00112580|40460625|FG000|Overall Study|Disease progression|5|||
16545134|NCT00112580|40460626|FG001|Overall Study|Disease progression|16|||
16545135|NCT00112580|40460625|FG000|Overall Study|Participant withdrew consent|2|||
16545136|NCT00112580|40460626|FG001|Overall Study|Participant withdrew consent|1|||
16545137|NCT04209855|40460627|FG000|Overall Study|Adverse Event|20|||
16545138|NCT04209855|40460628|FG001|Overall Study|Adverse Event|28|||
16545139|NCT04209855|40460627|FG000|Overall Study|Death|3|||
16545140|NCT04209855|40460628|FG001|Overall Study|Death|1|||
16545141|NCT04209855|40460627|FG000|Overall Study|Principal Investigator (PI) Discretion|4|||
16545142|NCT04209855|40460628|FG001|Overall Study|Principal Investigator (PI) Discretion|9|||
16545143|NCT04209855|40460627|FG000|Overall Study|Participant Withdrew Consent to Treatment|4|||
16545144|NCT04209855|40460628|FG001|Overall Study|Participant Withdrew Consent to Treatment|11|||
16545145|NCT04209855|40460627|FG000|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|4|||
16545146|NCT04209855|40460628|FG001|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|15|||
16545147|NCT04209855|40460627|FG000|Overall Study|Progressive Disease|154|||
16545148|NCT04209855|40460628|FG001|Overall Study|Progressive Disease|145|||
16545149|NCT04209855|40460627|FG000|Overall Study|Protocol Deviation|1|||
16545150|NCT04209855|40460628|FG001|Overall Study|Protocol Deviation|1|||
16545151|NCT04209855|40460627|FG000|Overall Study|Other Than Specified|5|||
16545152|NCT04209855|40460628|FG001|Overall Study|Other Than Specified|10|||
16545153|NCT01861522|40460635|FG000|Overall Study|Adverse Event|1|||
16545154|NCT01861522|40460636|FG001|Overall Study|Adverse Event|0|||
16545155|NCT01861522|40460635|FG000|Overall Study|Withdrawal by Subject|2|||
16545156|NCT01861522|40460636|FG001|Overall Study|Withdrawal by Subject|0|||
16545157|NCT02277990|40460637|FG000|Overall Study|Death|170|||
16545158|NCT02277990|40460638|FG001|Overall Study|Death|188|||
16545159|NCT02277990|40460637|FG000|Overall Study|Withdrawal by Subject|64|||
16545160|NCT02277990|40460638|FG001|Overall Study|Withdrawal by Subject|53|||
16545161|NCT02277990|40460637|FG000|Overall Study|Physician Decision|40|||
16545162|NCT02277990|40460638|FG001|Overall Study|Physician Decision|34|||
16545163|NCT02277990|40460637|FG000|Overall Study|Lost to Follow-up|66|||
16545164|NCT02277990|40460638|FG001|Overall Study|Lost to Follow-up|69|||
16545165|NCT02277990|40460637|FG000|Overall Study|Had other reason|26|||
16545166|NCT02277990|40460638|FG001|Overall Study|Had other reason|32|||
16545167|NCT04810221|40460643|FG000|Overall Study|Physician Decision|3|||
16545168|NCT00895622|40460646|FG000|Overall Study|Protocol Violation|5|||
16545169|NCT00895622|40460647|FG001|Overall Study|Protocol Violation|4|||
16545170|NCT00895622|40460648|FG002|Overall Study|Protocol Violation|4|||
16545171|NCT02613221|40460649|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
16545172|NCT02613221|40460649|FG000|Overall Study|Adverse Event|2|||
16545173|NCT02613221|40460649|FG000|Overall Study|Voluntary Discontinuation|1|||
16545174|NCT02613221|40460649|FG000|Overall Study|Delayed Treatment|1|||
16545175|NCT02613221|40460649|FG000|Overall Study|Enrolled but Not Treated|1|||
16545176|NCT02459093|40460650|FG000|Overall Study|Protocol Violation|6|||
16545177|NCT02459093|40460651|FG001|Overall Study|Protocol Violation|11|||
16545178|NCT02459093|40460650|FG000|Overall Study|Lost to Follow-up|6|||
16545179|NCT02459093|40460651|FG001|Overall Study|Lost to Follow-up|7|||
16545180|NCT01650519|40460652|FG000|Overall Study|Withdrawal by Subject|1|||
16545181|NCT01650519|40460653|FG001|Overall Study|Withdrawal by Subject|0|||
16545182|NCT05597722|40460654|FG000|Overall Study|Study was terminated|6|||
16545183|NCT05597722|40460655|FG001|Overall Study|Study was terminated|1|||
16545184|NCT01164228|40460660|FG000|Overall Study|Progression|24|||
16545185|NCT01164228|40460661|FG001|Overall Study|Progression|25|||
16545186|NCT01164228|40460660|FG000|Overall Study|Adverse Event|13|||
16110324|NCT00460564|38892773|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
16545187|NCT01164228|40460661|FG001|Overall Study|Adverse Event|7|||
16545188|NCT01164228|40460660|FG000|Overall Study|Death|1|||
16545189|NCT01164228|40460661|FG001|Overall Study|Death|1|||
16545190|NCT01164228|40460660|FG000|Overall Study|Withdrawal by Subject|2|||
16545191|NCT01164228|40460661|FG001|Overall Study|Withdrawal by Subject|0|||
16545192|NCT01164228|40460660|FG000|Overall Study|Physician Decision|1|||
16545193|NCT01164228|40460661|FG001|Overall Study|Physician Decision|2|||
16545194|NCT01164228|40460660|FG000|Overall Study|Symptomatic deterioration|1|||
16221705|NCT00696774|39290827|FG002|Period III|Lost to Follow-up|0|||
16221706|NCT00696774|39290825|FG000|Period III|Protocol Violation|1|||
16221707|NCT00696774|39290826|FG001|Period III|Protocol Violation|1|||
16221708|NCT00696774|39290827|FG002|Period III|Protocol Violation|0|||
16221709|NCT00696774|39290825|FG000|Period III|Withdrawal by Subject|1|||
16221710|NCT00696774|39290826|FG001|Period III|Withdrawal by Subject|2|||
16221711|NCT00696774|39290827|FG002|Period III|Withdrawal by Subject|0|||
16221712|NCT00696774|39290825|FG000|Period III|Sponsor Decision|2|||
16221713|NCT00696774|39290826|FG001|Period III|Sponsor Decision|0|||
16221714|NCT00696774|39290827|FG002|Period III|Sponsor Decision|0|||
16221715|NCT00696774|39290825|FG000|Period III|Lack of Efficacy|0|||
16221716|NCT00696774|39290826|FG001|Period III|Lack of Efficacy|2|||
16221717|NCT00696774|39290827|FG002|Period III|Lack of Efficacy|0|||
16221718|NCT04021706|39290828|FG000|Overall Study|Adverse Event|2|||
16221719|NCT04021706|39290829|FG001|Overall Study|Adverse Event|0|||
16221720|NCT04021706|39290828|FG000|Overall Study|Withdrawal by Subject|1|||
16221721|NCT04021706|39290829|FG001|Overall Study|Withdrawal by Subject|2|||
16221722|NCT04021706|39290828|FG000|Overall Study|Physician Decision|1|||
16221723|NCT04021706|39290829|FG001|Overall Study|Physician Decision|0|||
16545195|NCT01164228|40460661|FG001|Overall Study|Symptomatic deterioration|0|||
16545196|NCT01164228|40460660|FG000|Overall Study|Never started treatment|1|||
16545197|NCT01164228|40460661|FG001|Overall Study|Never started treatment|3|||
16545198|NCT01164228|40460660|FG000|Overall Study|Ineligible|1|||
16545199|NCT01164228|40460661|FG001|Overall Study|Ineligible|0|||
16545200|NCT00642902|40460662|FG000|Overall Study|Adverse Event|0|||
16545201|NCT00642902|40460663|FG001|Overall Study|Adverse Event|1|||
16545202|NCT00642902|40460664|FG002|Overall Study|Adverse Event|3|||
16545203|NCT00642902|40460665|FG003|Overall Study|Adverse Event|1|||
16545204|NCT00642902|40460662|FG000|Overall Study|Lost to Follow-up|1|||
16545205|NCT00642902|40460663|FG001|Overall Study|Lost to Follow-up|1|||
16545206|NCT00642902|40460664|FG002|Overall Study|Lost to Follow-up|0|||
16545207|NCT00642902|40460665|FG003|Overall Study|Lost to Follow-up|0|||
16545208|NCT00642902|40460662|FG000|Overall Study|Lack of Efficacy|0|||
16545209|NCT00642902|40460663|FG001|Overall Study|Lack of Efficacy|3|||
16545210|NCT00642902|40460664|FG002|Overall Study|Lack of Efficacy|3|||
16545211|NCT00642902|40460665|FG003|Overall Study|Lack of Efficacy|0|||
16545212|NCT00642902|40460662|FG000|Overall Study|Death|1|||
16545213|NCT00642902|40460663|FG001|Overall Study|Death|0|||
16545214|NCT00642902|40460664|FG002|Overall Study|Death|0|||
16545215|NCT00642902|40460665|FG003|Overall Study|Death|0|||
16221724|NCT01060150|39290834|FG000|Overall Study|Adverse Event|6|||
16221725|NCT01060150|39290834|FG000|Overall Study|Lost to Follow-up|1|||
16221726|NCT01060150|39290834|FG000|Overall Study|Protocol Violation|6|||
16221727|NCT01060150|39290834|FG000|Overall Study|Withdrawal by Subject|8|||
16221728|NCT01060150|39290834|FG000|Overall Study|Enrolled, but not treated|2|||
16545216|NCT00642902|40460662|FG000|Overall Study|Premature termination of clinical trial|37|||
16545217|NCT00642902|40460663|FG001|Overall Study|Premature termination of clinical trial|32|||
16545218|NCT00642902|40460664|FG002|Overall Study|Premature termination of clinical trial|35|||
16545219|NCT00642902|40460665|FG003|Overall Study|Premature termination of clinical trial|35|||
16545220|NCT00642902|40460662|FG000|Overall Study|Randomized, but not treated|0|||
16545221|NCT00642902|40460663|FG001|Overall Study|Randomized, but not treated|0|||
16221729|NCT00983827|39290835|FG000|Overall Study|Withdrawal by Subject|1|||
16545222|NCT00642902|40460664|FG002|Overall Study|Randomized, but not treated|1|||
16545223|NCT00642902|40460665|FG003|Overall Study|Randomized, but not treated|0|||
16545224|NCT00642902|40460662|FG000|Overall Study|Other|1|||
16545225|NCT00642902|40460663|FG001|Overall Study|Other|5|||
16545226|NCT00642902|40460664|FG002|Overall Study|Other|1|||
16545227|NCT00642902|40460665|FG003|Overall Study|Other|4|||
16545228|NCT02832622|40460668|FG000|Overall Study|MPP not programmed|1259|||
16545229|NCT02832622|40460668|FG000|Overall Study|Withdrawal by Subject|123|||
16545230|NCT02832622|40460668|FG000|Overall Study|Death|119|||
16545231|NCT02832622|40460668|FG000|Overall Study|Unsuccessful CRT implant|93|||
16545232|NCT02832622|40460668|FG000|Overall Study|Lost to Follow-up|45|||
16545233|NCT02832622|40460668|FG000|Overall Study|Patient non-compliance|42|||
16545234|NCT02832622|40460668|FG000|Overall Study|Withdrawal by other reasons|25|||
16221730|NCT04794491|39290836|FG000|Overall Study|Adverse Event|1|||
16221731|NCT04794491|39290836|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
16221732|NCT04794491|39290836|FG000|Overall Study|Noncompliance With Study Intervention|1|||
16221733|NCT04794491|39290836|FG000|Overall Study|Withdrawal by Subject|2|||
16221734|NCT00412360|39290845|FG000|Overall Study|Lost to Follow-up|0|||
16221735|NCT00412360|39290846|FG001|Overall Study|Lost to Follow-up|1|||
16221736|NCT00412360|39290845|FG000|Overall Study|Not Transplanted|1|||
16221737|NCT00412360|39290846|FG001|Overall Study|Not Transplanted|2|||
16221738|NCT02608099|39290847|FG000|Overall Study|Ablation procedure not initiated|3|||
16545235|NCT02832622|40460668|FG000|Overall Study|System explant|24|||
16545236|NCT02832622|40460668|FG000|Overall Study|Physician Decision|6|||
16545237|NCT01058304|40460670|FG000|Overall Study|Withdrawal by Subject|8|||
16344376|NCT01490840|39747572|FG001|Phase 2|Adverse Event|1|||
16545238|NCT01058304|40460671|FG001|Overall Study|Withdrawal by Subject|5|||
16545239|NCT01058304|40460670|FG000|Overall Study|Lost to Follow-up|13|||
16545240|NCT01058304|40460671|FG001|Overall Study|Lost to Follow-up|16|||
16545241|NCT01058304|40460670|FG000|Overall Study|Developed exclusion criterion|6|||
16545242|NCT01058304|40460671|FG001|Overall Study|Developed exclusion criterion|12|||
16545243|NCT02110732|40460672|FG000|Overall Study|Physician Decision|5|||
16545244|NCT02110732|40460673|FG001|Overall Study|Physician Decision|2|||
16545245|NCT02110732|40460672|FG000|Overall Study|Lost to Follow-up|1|||
16221739|NCT02608099|39290848|FG001|Overall Study|Ablation procedure not initiated|2|||
16221740|NCT00626795|39290852|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
16221741|NCT00626795|39290853|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
16221742|NCT00626795|39290854|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
16221743|NCT00626795|39290852|FG000|Blinded Treatment|Lack of Efficacy|2|||
16221744|NCT00626795|39290853|FG001|Blinded Treatment|Lack of Efficacy|0|||
16221745|NCT00626795|39290854|FG002|Blinded Treatment|Lack of Efficacy|0|||
16221746|NCT00626795|39290852|FG000|Blinded Treatment|Unacceptable adverse event|0|||
16221747|NCT00626795|39290853|FG001|Blinded Treatment|Unacceptable adverse event|0|||
16221748|NCT00626795|39290854|FG002|Blinded Treatment|Unacceptable adverse event|1|||
16221749|NCT00626795|39290852|FG000|Blinded Treatment|Protocol Violation|0|||
16221750|NCT00626795|39290853|FG001|Blinded Treatment|Protocol Violation|1|||
16221751|NCT00626795|39290854|FG002|Blinded Treatment|Protocol Violation|1|||
16221752|NCT00626795|39290852|FG000|Blinded Treatment|Withdrawal by Subject|1|||
16221753|NCT00626795|39290853|FG001|Blinded Treatment|Withdrawal by Subject|1|||
16221754|NCT00626795|39290854|FG002|Blinded Treatment|Withdrawal by Subject|0|||
16221755|NCT00626795|39290852|FG000|Blinded Treatment|Other reasons|2|||
16221756|NCT00626795|39290853|FG001|Blinded Treatment|Other reasons|0|||
16221757|NCT00626795|39290854|FG002|Blinded Treatment|Other reasons|2|||
16221758|NCT00626795|39290852|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
16221759|NCT00626795|39290853|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
16221760|NCT00626795|39290854|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
16221761|NCT01728454|39290855|FG000|Stage 1 and 2|Pregnancy|1|||
16221762|NCT01728454|39290856|FG001|Stage 1 and 2|Pregnancy|0|||
16221763|NCT01728454|39290857|FG002|Stage 1 and 2|Pregnancy|0|||
16221764|NCT01728454|39290855|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
16221765|NCT01728454|39290856|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
16221766|NCT01728454|39290857|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
16221767|NCT01728454|39290855|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
16221768|NCT01728454|39290856|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
16221769|NCT01728454|39290857|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
16221770|NCT01728454|39290855|FG000|Stage 1 and 2|Lost to Follow-up|1|||
16221771|NCT01728454|39290856|FG001|Stage 1 and 2|Lost to Follow-up|1|||
16221772|NCT01728454|39290857|FG002|Stage 1 and 2|Lost to Follow-up|0|||
16221773|NCT01728454|39290855|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
16221774|NCT01728454|39290856|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
16221775|NCT01728454|39290857|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
16221776|NCT01728454|39290855|FG000|Stage 3|Reason Missing|0|||
16221777|NCT01728454|39290856|FG001|Stage 3|Reason Missing|0|||
16221778|NCT01728454|39290857|FG002|Stage 3|Reason Missing|1|||
16221779|NCT01728454|39290855|FG000|Stage 3|Subject Required Other Treatment|0|||
16221780|NCT01728454|39290856|FG001|Stage 3|Subject Required Other Treatment|1|||
16221781|NCT01728454|39290857|FG002|Stage 3|Subject Required Other Treatment|0|||
16221782|NCT01728454|39290855|FG000|Stage 3|Pregnancy|1|||
16221783|NCT01728454|39290856|FG001|Stage 3|Pregnancy|0|||
16221784|NCT01728454|39290857|FG002|Stage 3|Pregnancy|0|||
16221785|NCT01728454|39290855|FG000|Stage 3|Withdrew Consent|1|||
16221786|NCT01728454|39290856|FG001|Stage 3|Withdrew Consent|0|||
16221787|NCT01728454|39290857|FG002|Stage 3|Withdrew Consent|1|||
16221788|NCT01728454|39290855|FG000|Stage 3|Non-compliance with Protocol|0|||
16221789|NCT01728454|39290856|FG001|Stage 3|Non-compliance with Protocol|0|||
16221790|NCT01728454|39290857|FG002|Stage 3|Non-compliance with Protocol|1|||
16221791|NCT01728454|39290855|FG000|Stage 3|Lost to Follow-up|0|||
16221792|NCT01728454|39290856|FG001|Stage 3|Lost to Follow-up|3|||
16221793|NCT01728454|39290857|FG002|Stage 3|Lost to Follow-up|1|||
16221794|NCT01728454|39290855|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
16221795|NCT01728454|39290856|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
16221796|NCT01728454|39290857|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
16221797|NCT01021553|39290858|FG000|Overall Study|Adverse Event|1|||
16545246|NCT02110732|40460673|FG001|Overall Study|Lost to Follow-up|1|||
16221798|NCT01021553|39290859|FG001|Overall Study|Adverse Event|0|||
16221799|NCT01021553|39290860|FG002|Overall Study|Adverse Event|0|||
16221800|NCT01021553|39290858|FG000|Overall Study|Lack of Efficacy|2|||
16221801|NCT01021553|39290859|FG001|Overall Study|Lack of Efficacy|2|||
16221802|NCT01021553|39290860|FG002|Overall Study|Lack of Efficacy|0|||
16221803|NCT01021553|39290858|FG000|Overall Study|Protocol Violation|0|||
16221804|NCT01021553|39290859|FG001|Overall Study|Protocol Violation|2|||
16344377|NCT03280056|39747573|FG000|Overall Study|Withdrawal by Subject|12|||
16221805|NCT01021553|39290860|FG002|Overall Study|Protocol Violation|2|||
16545247|NCT02778399|40460674|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
16221806|NCT01021553|39290858|FG000|Overall Study|Lost to Follow-up|0|||
16221807|NCT01021553|39290859|FG001|Overall Study|Lost to Follow-up|0|||
16221808|NCT01021553|39290860|FG002|Overall Study|Lost to Follow-up|1|||
16221809|NCT01021553|39290858|FG000|Overall Study|Withdrawal by Subject|1|||
16221810|NCT01021553|39290859|FG001|Overall Study|Withdrawal by Subject|1|||
16221811|NCT01021553|39290860|FG002|Overall Study|Withdrawal by Subject|0|||
16221812|NCT01562327|39290861|FG000|Overall Study|Adverse Event|2|||
16221813|NCT01562327|39290861|FG000|Overall Study|Lack of Efficacy|1|||
16221814|NCT01562327|39290861|FG000|Overall Study|Participant drop-out|1|||
16221815|NCT01562327|39290861|FG000|Overall Study|Infusion not received at 6 month window|4|||
16221816|NCT01066819|39294956|FG000|Overall Study|Adverse Event|18|||
16221817|NCT01066819|39294957|FG001|Overall Study|Adverse Event|1|||
16221818|NCT01066819|39294958|FG002|Overall Study|Adverse Event|6|||
16221819|NCT01066819|39294959|FG003|Overall Study|Adverse Event|0|||
16221820|NCT01066819|39294960|FG004|Overall Study|Adverse Event|0|||
16221821|NCT01066819|39294961|FG005|Overall Study|Adverse Event|0|||
16221822|NCT01066819|39294956|FG000|Overall Study|Death|5|||
16221823|NCT01066819|39294957|FG001|Overall Study|Death|0|||
16221824|NCT01066819|39294958|FG002|Overall Study|Death|1|||
16221825|NCT01066819|39294959|FG003|Overall Study|Death|0|||
16221826|NCT01066819|39294960|FG004|Overall Study|Death|0|||
16221827|NCT01066819|39294961|FG005|Overall Study|Death|0|||
16221828|NCT01066819|39294956|FG000|Overall Study|Lack of Efficacy|22|||
16221829|NCT01066819|39294957|FG001|Overall Study|Lack of Efficacy|1|||
16221830|NCT01066819|39294958|FG002|Overall Study|Lack of Efficacy|2|||
16221831|NCT01066819|39294959|FG003|Overall Study|Lack of Efficacy|1|||
16221832|NCT01066819|39294960|FG004|Overall Study|Lack of Efficacy|0|||
16221833|NCT01066819|39294961|FG005|Overall Study|Lack of Efficacy|0|||
16221834|NCT01066819|39294956|FG000|Overall Study|Physician Decision|6|||
16221835|NCT01066819|39294957|FG001|Overall Study|Physician Decision|2|||
16221836|NCT01066819|39294958|FG002|Overall Study|Physician Decision|3|||
16221837|NCT01066819|39294959|FG003|Overall Study|Physician Decision|0|||
16221838|NCT01066819|39294960|FG004|Overall Study|Physician Decision|0|||
16221839|NCT01066819|39294961|FG005|Overall Study|Physician Decision|0|||
16221840|NCT01066819|39294956|FG000|Overall Study|Protocol Violation|12|||
16221841|NCT01066819|39294957|FG001|Overall Study|Protocol Violation|6|||
16221842|NCT01066819|39294958|FG002|Overall Study|Protocol Violation|0|||
16221843|NCT01066819|39294959|FG003|Overall Study|Protocol Violation|0|||
16221844|NCT01066819|39294960|FG004|Overall Study|Protocol Violation|0|||
16221845|NCT01066819|39294961|FG005|Overall Study|Protocol Violation|0|||
16221846|NCT01066819|39294956|FG000|Overall Study|Withdrawal by Subject|29|||
16221847|NCT01066819|39294957|FG001|Overall Study|Withdrawal by Subject|11|||
16221848|NCT01066819|39294958|FG002|Overall Study|Withdrawal by Subject|6|||
16221849|NCT01066819|39294959|FG003|Overall Study|Withdrawal by Subject|0|||
16221850|NCT01066819|39294960|FG004|Overall Study|Withdrawal by Subject|0|||
16221851|NCT01066819|39294961|FG005|Overall Study|Withdrawal by Subject|0|||
16221852|NCT01066819|39294956|FG000|Overall Study|Administrative|6|||
16221853|NCT01066819|39294957|FG001|Overall Study|Administrative|4|||
16221854|NCT01066819|39294958|FG002|Overall Study|Administrative|2|||
16221855|NCT01066819|39294959|FG003|Overall Study|Administrative|0|||
16221856|NCT01066819|39294960|FG004|Overall Study|Administrative|0|||
16221857|NCT01066819|39294961|FG005|Overall Study|Administrative|0|||
16221858|NCT01066819|39294956|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
16221859|NCT01066819|39294957|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
16221860|NCT01066819|39294958|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
16221861|NCT01066819|39294959|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
16221862|NCT01066819|39294960|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
16221863|NCT01066819|39294961|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
16221864|NCT01066819|39294956|FG000|Overall Study|Early termination|2|||
16221865|NCT01066819|39294957|FG001|Overall Study|Early termination|0|||
16221866|NCT01066819|39294958|FG002|Overall Study|Early termination|0|||
16221867|NCT01066819|39294959|FG003|Overall Study|Early termination|0|||
16221868|NCT01066819|39294960|FG004|Overall Study|Early termination|0|||
16221869|NCT01066819|39294961|FG005|Overall Study|Early termination|0|||
16221870|NCT01066819|39294956|FG000|Overall Study|Failed to return|298|||
16221871|NCT01066819|39294957|FG001|Overall Study|Failed to return|107|||
16221872|NCT01066819|39294958|FG002|Overall Study|Failed to return|68|||
16221873|NCT01066819|39294959|FG003|Overall Study|Failed to return|7|||
16221874|NCT01066819|39294960|FG004|Overall Study|Failed to return|2|||
16221875|NCT01066819|39294961|FG005|Overall Study|Failed to return|3|||
16221876|NCT01066819|39294956|FG000|Overall Study|Lab test not done|9|||
16221877|NCT01066819|39294957|FG001|Overall Study|Lab test not done|0|||
16221878|NCT01066819|39294958|FG002|Overall Study|Lab test not done|2|||
16221879|NCT01066819|39294959|FG003|Overall Study|Lab test not done|1|||
16221880|NCT01066819|39294960|FG004|Overall Study|Lab test not done|0|||
16221881|NCT01066819|39294961|FG005|Overall Study|Lab test not done|0|||
16221882|NCT01066819|39294956|FG000|Overall Study|Miscellaneous|28|||
16221883|NCT01066819|39294957|FG001|Overall Study|Miscellaneous|10|||
16221884|NCT01066819|39294958|FG002|Overall Study|Miscellaneous|18|||
16221885|NCT01066819|39294959|FG003|Overall Study|Miscellaneous|1|||
16221886|NCT01066819|39294960|FG004|Overall Study|Miscellaneous|0|||
16221887|NCT01066819|39294961|FG005|Overall Study|Miscellaneous|0|||
16221888|NCT01066819|39294956|FG000|Overall Study|Non responders|123|||
16221889|NCT01066819|39294957|FG001|Overall Study|Non responders|2|||
16221890|NCT01066819|39294958|FG002|Overall Study|Non responders|7|||
16221891|NCT01066819|39294959|FG003|Overall Study|Non responders|2|||
16221892|NCT01066819|39294960|FG004|Overall Study|Non responders|0|||
16344378|NCT03280056|39747574|FG001|Overall Study|Withdrawal by Subject|14|||
16545248|NCT02778399|40460675|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
16545249|NCT02778399|40460676|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
16545250|NCT02778399|40460677|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
16545251|NCT02778399|40460678|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
16545252|NCT02778399|40460679|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
16545253|NCT02778399|40460674|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
16545254|NCT02778399|40460675|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
16545255|NCT02778399|40460676|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
16545256|NCT02778399|40460677|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
16545257|NCT02778399|40460678|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
16545258|NCT02778399|40460679|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
16545259|NCT02778399|40460674|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
16545260|NCT02778399|40460675|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
16545261|NCT02778399|40460676|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
16545262|NCT02778399|40460677|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
16545263|NCT02778399|40460678|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
16545264|NCT02778399|40460679|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
16545265|NCT02778399|40460674|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
16545266|NCT02778399|40460675|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
16545267|NCT02778399|40460676|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
16545268|NCT02778399|40460677|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
16545269|NCT02778399|40460678|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
16545270|NCT02778399|40460679|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
16545271|NCT02778399|40460674|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
16545272|NCT02778399|40460675|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
16545273|NCT02778399|40460676|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
16545274|NCT02778399|40460677|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
16545275|NCT02778399|40460678|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
16545276|NCT02778399|40460679|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
16545277|NCT02778399|40460674|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
16545278|NCT02778399|40460675|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
16344379|NCT03280056|39747573|FG000|Overall Study|Death|9|||
16344380|NCT03280056|39747574|FG001|Overall Study|Death|2|||
16344381|NCT03280056|39747573|FG000|Overall Study|Adverse Event|1|||
16344382|NCT03280056|39747574|FG001|Overall Study|Adverse Event|3|||
16344383|NCT03280056|39747573|FG000|Overall Study|Lost to Follow-up|1|||
16344384|NCT03280056|39747574|FG001|Overall Study|Lost to Follow-up|1|||
16344385|NCT03280056|39747573|FG000|Overall Study|Physician Decision|0|||
16344386|NCT03280056|39747574|FG001|Overall Study|Physician Decision|1|||
16344387|NCT03280056|39747573|FG000|Overall Study|Early Discontinuation|1|||
16344388|NCT03280056|39747574|FG001|Overall Study|Early Discontinuation|0|||
16344389|NCT03318003|39747575|FG000|Overall Study|Withdrawal by Subject|1|||
16344390|NCT03318003|39747576|FG001|Overall Study|Withdrawal by Subject|1|||
16344391|NCT03318003|39747575|FG000|Overall Study|fetal loss|0|||
16344392|NCT03318003|39747576|FG001|Overall Study|fetal loss|1|||
16344393|NCT02020512|39747577|FG000|Overall Study|Adverse Event|1|||
16344394|NCT02020512|39747577|FG000|Overall Study|Lost to Follow-up|3|||
16545279|NCT02778399|40460676|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
16545280|NCT02778399|40460677|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
16545281|NCT02778399|40460678|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
16545282|NCT02778399|40460679|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
16545283|NCT02778399|40460674|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
16545284|NCT02778399|40460675|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
16545285|NCT02778399|40460676|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
16545286|NCT02778399|40460677|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
16545287|NCT02778399|40460678|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
16545288|NCT02778399|40460679|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
16545289|NCT02778399|40460674|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
16221893|NCT01066819|39294961|FG005|Overall Study|Non responders|1|||
16344395|NCT02020512|39747577|FG000|Overall Study|Protocol Violation|4|||
16221894|NCT01066819|39294956|FG000|Overall Study|Not categorised|9|||
16221895|NCT01066819|39294957|FG001|Overall Study|Not categorised|2|||
16344396|NCT02080364|39747578|FG000|Baseline Period|Protocol Violation|2|||
16545290|NCT02778399|40460675|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
16545291|NCT02778399|40460676|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
16545292|NCT02778399|40460677|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
16545293|NCT02778399|40460678|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
16545294|NCT02778399|40460679|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
16344397|NCT02080364|39747579|FG001|Baseline Period|Protocol Violation|1|||
16344398|NCT02080364|39747580|FG002|Baseline Period|Protocol Violation|0|||
16344399|NCT02080364|39747581|FG003|Baseline Period|Protocol Violation|0|||
16344400|NCT02080364|39747578|FG000|Baseline Period|Other|0|||
16344401|NCT02080364|39747579|FG001|Baseline Period|Other|1|||
16344402|NCT02080364|39747580|FG002|Baseline Period|Other|1|||
16344403|NCT02080364|39747581|FG003|Baseline Period|Other|0|||
16344404|NCT02080364|39747578|FG000|Treatment Period|Adverse Event|10|||
16344405|NCT02080364|39747579|FG001|Treatment Period|Adverse Event|15|||
16344406|NCT02080364|39747580|FG002|Treatment Period|Adverse Event|11|||
16344407|NCT02080364|39747581|FG003|Treatment Period|Adverse Event|14|||
16344408|NCT02080364|39747578|FG000|Treatment Period|Lost to Follow-up|2|||
16344409|NCT02080364|39747579|FG001|Treatment Period|Lost to Follow-up|3|||
16344410|NCT02080364|39747580|FG002|Treatment Period|Lost to Follow-up|5|||
16344411|NCT02080364|39747581|FG003|Treatment Period|Lost to Follow-up|0|||
16344412|NCT02080364|39747578|FG000|Treatment Period|Protocol Violation|5|||
16344413|NCT02080364|39747579|FG001|Treatment Period|Protocol Violation|3|||
16344414|NCT02080364|39747580|FG002|Treatment Period|Protocol Violation|5|||
16344415|NCT02080364|39747581|FG003|Treatment Period|Protocol Violation|1|||
16344416|NCT02080364|39747578|FG000|Treatment Period|Withdrawal by Subject|16|||
16344417|NCT02080364|39747579|FG001|Treatment Period|Withdrawal by Subject|16|||
16344418|NCT02080364|39747580|FG002|Treatment Period|Withdrawal by Subject|15|||
16344419|NCT02080364|39747581|FG003|Treatment Period|Withdrawal by Subject|10|||
16344420|NCT02080364|39747578|FG000|Treatment Period|Study Terminated by Sponsor|0|||
16344421|NCT02080364|39747579|FG001|Treatment Period|Study Terminated by Sponsor|0|||
16344422|NCT02080364|39747580|FG002|Treatment Period|Study Terminated by Sponsor|180|||
16344423|NCT02080364|39747581|FG003|Treatment Period|Study Terminated by Sponsor|183|||
16344424|NCT02080364|39747578|FG000|Treatment Period|Other|14|||
16344425|NCT02080364|39747579|FG001|Treatment Period|Other|12|||
16545295|NCT02778399|40460674|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
16545296|NCT02778399|40460675|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
16545297|NCT02778399|40460676|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
16545298|NCT02778399|40460677|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
16545299|NCT02778399|40460678|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
16545300|NCT02778399|40460679|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
16545301|NCT02778399|40460674|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
16545302|NCT02778399|40460675|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
16545303|NCT02778399|40460676|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
16545304|NCT02778399|40460677|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
16545305|NCT02778399|40460678|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
16545306|NCT02778399|40460679|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
16545307|NCT02778399|40460674|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
16545308|NCT02778399|40460675|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
16545309|NCT02778399|40460676|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
16545310|NCT02778399|40460677|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
16545311|NCT02778399|40460678|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
16545312|NCT02778399|40460679|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
16344426|NCT02080364|39747580|FG002|Treatment Period|Other|21|||
16344427|NCT02080364|39747581|FG003|Treatment Period|Other|16|||
16545313|NCT03315130|40460684|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
16545314|NCT03315130|40460685|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
16545315|NCT03315130|40460686|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
16545316|NCT03315130|40460687|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
16545317|NCT03315130|40460684|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
16545318|NCT03315130|40460685|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
16545319|NCT03315130|40460686|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
16545320|NCT03315130|40460687|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
16545321|NCT03315130|40460684|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
16344428|NCT02609984|39747582|FG000|Overall Study|Death|29|||
16344429|NCT02609984|39747583|FG001|Overall Study|Death|26|||
16545322|NCT03315130|40460685|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
16545323|NCT03315130|40460686|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
16344430|NCT02609984|39747582|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
16344431|NCT02609984|39747583|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
16545324|NCT03315130|40460687|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
16344432|NCT02609984|39747582|FG000|Overall Study|Lost to Follow-up|1|||
16344433|NCT02609984|39747583|FG001|Overall Study|Lost to Follow-up|2|||
16545325|NCT03315130|40460684|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
16545326|NCT03315130|40460685|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
16545327|NCT03315130|40460686|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
16545328|NCT03315130|40460687|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
16545329|NCT03315130|40460684|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
16545330|NCT03315130|40460685|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
16545331|NCT03315130|40460686|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
16545332|NCT03315130|40460687|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
16545333|NCT03315130|40460684|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
16545334|NCT03315130|40460685|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
16545335|NCT03315130|40460686|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
16545336|NCT03315130|40460687|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
16545337|NCT00576732|40460701|FG000|DOUBLE BLIND|Adverse Event|0|||
16545338|NCT00576732|40460702|FG001|DOUBLE BLIND|Adverse Event|0|||
16545339|NCT00576732|40460703|FG002|DOUBLE BLIND|Adverse Event|1|||
16545340|NCT00576732|40460704|FG003|DOUBLE BLIND|Adverse Event|0|||
16545341|NCT00576732|40460705|FG004|DOUBLE BLIND|Adverse Event|0|||
16545342|NCT00576732|40460706|FG005|DOUBLE BLIND|Adverse Event|0|||
16545343|NCT00576732|40460701|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
16545344|NCT00576732|40460702|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
16545345|NCT00576732|40460703|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
16545346|NCT00576732|40460704|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
16545347|NCT00576732|40460705|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
16545348|NCT00576732|40460706|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
16545349|NCT00576732|40460701|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
16545350|NCT00576732|40460702|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
16545351|NCT00576732|40460703|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
16545352|NCT00576732|40460704|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
16545353|NCT00576732|40460705|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
16545354|NCT00576732|40460706|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
16545355|NCT00576732|40460701|FG000|DOUBLE BLIND|OTHER|0|||
16545356|NCT00576732|40460702|FG001|DOUBLE BLIND|OTHER|2|||
16545357|NCT00576732|40460703|FG002|DOUBLE BLIND|OTHER|1|||
16545358|NCT00576732|40460704|FG003|DOUBLE BLIND|OTHER|0|||
16545359|NCT00576732|40460705|FG004|DOUBLE BLIND|OTHER|0|||
16545360|NCT00576732|40460706|FG005|DOUBLE BLIND|OTHER|0|||
16344434|NCT02609984|39747582|FG000|Overall Study|Withdrawal by Subject|0|||
16344435|NCT02609984|39747583|FG001|Overall Study|Withdrawal by Subject|1|||
16344436|NCT02609984|39747582|FG000|Overall Study|Disease Progression|2|||
16344437|NCT02609984|39747583|FG001|Overall Study|Disease Progression|0|||
16344438|NCT02756364|39747588|FG000|Overall Study|Site Terminated by Sponsor|24|||
16344439|NCT02756364|39747589|FG001|Overall Study|Site Terminated by Sponsor|30|||
16344440|NCT02756364|39747590|FG002|Overall Study|Site Terminated by Sponsor|21|||
16344441|NCT02756364|39747588|FG000|Overall Study|Death|20|||
16344442|NCT02756364|39747589|FG001|Overall Study|Death|15|||
16344443|NCT02756364|39747590|FG002|Overall Study|Death|18|||
16344444|NCT02756364|39747588|FG000|Overall Study|Withdrawal by Patient|2|||
16344445|NCT02756364|39747589|FG001|Overall Study|Withdrawal by Patient|1|||
16344446|NCT02756364|39747590|FG002|Overall Study|Withdrawal by Patient|8|||
16344447|NCT02756364|39747588|FG000|Overall Study|Lost to Follow-up|0|||
16344448|NCT02756364|39747589|FG001|Overall Study|Lost to Follow-up|1|||
16344449|NCT02756364|39747590|FG002|Overall Study|Lost to Follow-up|1|||
16344450|NCT00154375|39747593|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
16344451|NCT00154375|39747594|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
16344452|NCT00154375|39747593|FG000|Overall Study|Adverse Event|18|||
16344453|NCT00154375|39747594|FG001|Overall Study|Adverse Event|20|||
16344454|NCT00154375|39747593|FG000|Overall Study|Withdrawal by Subject|14|||
16344455|NCT00154375|39747594|FG001|Overall Study|Withdrawal by Subject|10|||
16344456|NCT00154375|39747593|FG000|Overall Study|Death|5|||
16344457|NCT00154375|39747594|FG001|Overall Study|Death|13|||
16344458|NCT00154375|39747593|FG000|Overall Study|Study drug no longer required|5|||
16545361|NCT00576732|40460701|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
16545362|NCT00576732|40460702|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
16545363|NCT00576732|40460703|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
16545364|NCT00576732|40460704|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
16545365|NCT00576732|40460705|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
16545366|NCT00576732|40460706|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
16545367|NCT00576732|40460701|FG000|DOUBLE BLIND|Protocol Violation|1|||
16545368|NCT00576732|40460702|FG001|DOUBLE BLIND|Protocol Violation|0|||
16545369|NCT00576732|40460703|FG002|DOUBLE BLIND|Protocol Violation|0|||
16545370|NCT00576732|40460704|FG003|DOUBLE BLIND|Protocol Violation|0|||
16545371|NCT00576732|40460705|FG004|DOUBLE BLIND|Protocol Violation|0|||
16545372|NCT00576732|40460706|FG005|DOUBLE BLIND|Protocol Violation|0|||
16545373|NCT00576732|40460701|FG000|OPEN LABEL|Adverse Event|0|||
16110325|NCT00460564|38892774|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
16221896|NCT01066819|39294958|FG002|Overall Study|Not categorised|6|||
16545374|NCT00576732|40460702|FG001|OPEN LABEL|Adverse Event|0|||
16344459|NCT00154375|39747594|FG001|Overall Study|Study drug no longer required|3|||
16344460|NCT00154375|39747593|FG000|Overall Study|Lost to Follow-up|2|||
16344461|NCT00154375|39747594|FG001|Overall Study|Lost to Follow-up|1|||
16344462|NCT00154375|39747593|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16344463|NCT00154375|39747594|FG001|Overall Study|Abnormal laboratory value(s)|2|||
16344464|NCT00154375|39747593|FG000|Overall Study|Protocol Violation|0|||
16545375|NCT00576732|40460703|FG002|OPEN LABEL|Adverse Event|0|||
16545376|NCT00576732|40460704|FG003|OPEN LABEL|Adverse Event|4|||
16545377|NCT00576732|40460705|FG004|OPEN LABEL|Adverse Event|0|||
16545378|NCT00576732|40460706|FG005|OPEN LABEL|Adverse Event|1|||
16545379|NCT00576732|40460701|FG000|OPEN LABEL|Lost to Follow-up|0|||
16545380|NCT00576732|40460702|FG001|OPEN LABEL|Lost to Follow-up|0|||
16545381|NCT00576732|40460703|FG002|OPEN LABEL|Lost to Follow-up|0|||
16545382|NCT00576732|40460704|FG003|OPEN LABEL|Lost to Follow-up|2|||
16545383|NCT00576732|40460705|FG004|OPEN LABEL|Lost to Follow-up|1|||
16545384|NCT00576732|40460706|FG005|OPEN LABEL|Lost to Follow-up|1|||
16344465|NCT00154375|39747594|FG001|Overall Study|Protocol Violation|1|||
16545385|NCT00576732|40460701|FG000|OPEN LABEL|Withdrawal by Subject|0|||
16545386|NCT00576732|40460702|FG001|OPEN LABEL|Withdrawal by Subject|0|||
16545387|NCT00576732|40460703|FG002|OPEN LABEL|Withdrawal by Subject|0|||
16545388|NCT00576732|40460704|FG003|OPEN LABEL|Withdrawal by Subject|1|||
16545389|NCT00576732|40460705|FG004|OPEN LABEL|Withdrawal by Subject|0|||
16545390|NCT00576732|40460706|FG005|OPEN LABEL|Withdrawal by Subject|1|||
16545391|NCT00576732|40460701|FG000|OPEN LABEL|OTHER|0|||
16545392|NCT00576732|40460702|FG001|OPEN LABEL|OTHER|0|||
16545393|NCT00576732|40460703|FG002|OPEN LABEL|OTHER|0|||
16545394|NCT00576732|40460704|FG003|OPEN LABEL|OTHER|0|||
16545395|NCT00576732|40460705|FG004|OPEN LABEL|OTHER|0|||
16545396|NCT00576732|40460706|FG005|OPEN LABEL|OTHER|2|||
16545397|NCT00576732|40460701|FG000|OPEN LABEL|Lack of Efficacy|0|||
16545398|NCT00576732|40460702|FG001|OPEN LABEL|Lack of Efficacy|0|||
16545399|NCT00576732|40460703|FG002|OPEN LABEL|Lack of Efficacy|0|||
16545400|NCT00576732|40460704|FG003|OPEN LABEL|Lack of Efficacy|2|||
16545401|NCT00576732|40460705|FG004|OPEN LABEL|Lack of Efficacy|2|||
16545402|NCT00576732|40460706|FG005|OPEN LABEL|Lack of Efficacy|3|||
16545403|NCT00576732|40460701|FG000|OPEN LABEL|Protocol Violation|0|||
16545404|NCT00576732|40460702|FG001|OPEN LABEL|Protocol Violation|0|||
16545405|NCT00576732|40460703|FG002|OPEN LABEL|Protocol Violation|0|||
16545406|NCT00576732|40460704|FG003|OPEN LABEL|Protocol Violation|2|||
16545407|NCT00576732|40460705|FG004|OPEN LABEL|Protocol Violation|1|||
16545408|NCT00576732|40460706|FG005|OPEN LABEL|Protocol Violation|0|||
16545409|NCT00094328|40460707|FG000|Overall Study|Lost to Follow-up|1|||
16545410|NCT03560245|40460708|FG000|Overall Study|Withdrawal by Subject|3|||
16545411|NCT03560245|40460709|FG001|Overall Study|Withdrawal by Subject|2|||
16545412|NCT03560245|40460708|FG000|Overall Study|Adverse Event|1|||
16545413|NCT03560245|40460709|FG001|Overall Study|Adverse Event|1|||
16545414|NCT03560245|40460708|FG000|Overall Study|Protocol Violation|1|||
16545415|NCT03560245|40460709|FG001|Overall Study|Protocol Violation|0|||
16545416|NCT03560245|40460708|FG000|Overall Study|Death|0|||
16545417|NCT03560245|40460709|FG001|Overall Study|Death|1|||
16545418|NCT03560245|40460708|FG000|Overall Study|Lost to Follow-up|0|||
16545419|NCT03560245|40460709|FG001|Overall Study|Lost to Follow-up|1|||
16545420|NCT03560245|40460708|FG000|Overall Study|Physician Decision|0|||
16545421|NCT03560245|40460709|FG001|Overall Study|Physician Decision|1|||
16545422|NCT03560245|40460708|FG000|Overall Study|Other|0|||
16545423|NCT03560245|40460709|FG001|Overall Study|Other|1|||
16545424|NCT00069784|40460710|FG000|Overall Study|Adverse Event|105|||
16545425|NCT00069784|40460711|FG001|Overall Study|Adverse Event|0|||
16344466|NCT00154375|39747593|FG000|Overall Study|Suspected progression of disease|44|||
16344467|NCT00154375|39747594|FG001|Overall Study|Suspected progression of disease|30|||
16545426|NCT00069784|40460710|FG000|Overall Study|Withdrawal by Subject|1090|||
16545427|NCT00069784|40460711|FG001|Overall Study|Withdrawal by Subject|0|||
16545428|NCT00069784|40460710|FG000|Overall Study|Other|17|||
16545429|NCT00069784|40460711|FG001|Overall Study|Other|0|||
16545430|NCT01780935|40460719|FG000|Overall Study|Admin problems due to early termination|321|||
16344468|NCT02748057|39747595|FG000|Overall Study|Adverse Event|1|||
16344469|NCT02748057|39747596|FG001|Overall Study|Adverse Event|0|||
16545431|NCT01780935|40460720|FG001|Overall Study|Admin problems due to early termination|309|||
16545432|NCT01780935|40460719|FG000|Overall Study|Adverse Event|2|||
16545433|NCT01780935|40460720|FG001|Overall Study|Adverse Event|4|||
16545434|NCT01780935|40460719|FG000|Overall Study|Death|1|||
16545435|NCT01780935|40460720|FG001|Overall Study|Death|6|||
16545436|NCT01780935|40460719|FG000|Overall Study|Lost to Follow-up|2|||
16545437|NCT01780935|40460720|FG001|Overall Study|Lost to Follow-up|6|||
16545438|NCT01780935|40460719|FG000|Overall Study|Physician Decision|1|||
16545439|NCT01780935|40460720|FG001|Overall Study|Physician Decision|1|||
16344470|NCT02748057|39747595|FG000|Overall Study|Physician Decision|0|||
16344471|NCT02748057|39747596|FG001|Overall Study|Physician Decision|1|||
16344472|NCT02748057|39747595|FG000|Overall Study|Protocol Violation|2|||
16344473|NCT02748057|39747596|FG001|Overall Study|Protocol Violation|1|||
16344474|NCT02748057|39747595|FG000|Overall Study|Participant Moved|1|||
16344475|NCT02748057|39747596|FG001|Overall Study|Participant Moved|0|||
16344476|NCT02748057|39747595|FG000|Overall Study|Withdrawal by Subject|1|||
16344477|NCT02748057|39747596|FG001|Overall Study|Withdrawal by Subject|0|||
16344478|NCT01979523|39747597|FG000|Overall Study|Withdrawal by Subject|1|||
16344479|NCT01979523|39747598|FG001|Overall Study|Withdrawal by Subject|0|||
16344480|NCT03442088|39747599|FG000|Overall Study|Adverse Event|1|||
16344481|NCT03442088|39747599|FG000|Overall Study|Lack of Efficacy|2|||
16545440|NCT01780935|40460719|FG000|Overall Study|Protocol deviation|0|||
16545441|NCT01780935|40460720|FG001|Overall Study|Protocol deviation|1|||
16545442|NCT01780935|40460719|FG000|Overall Study|Patient withdrew consent|8|||
16545443|NCT01780935|40460720|FG001|Overall Study|Patient withdrew consent|9|||
16545444|NCT03980184|40460722|FG000|Overall Study|Dropped out before treatment|2|||
16545445|NCT03980184|40460723|FG001|Overall Study|Dropped out before treatment|2|||
16545446|NCT03980184|40460722|FG000|Overall Study|Lost to Follow-up|11|||
16545447|NCT03980184|40460723|FG001|Overall Study|Lost to Follow-up|13|||
16545448|NCT01370525|40460724|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
16545449|NCT01370525|40460725|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
16545450|NCT01370525|40460724|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16545451|NCT01370525|40460725|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16545452|NCT01370525|40460724|FG000|Overall Study|Adverse Event|0|||
16545453|NCT01370525|40460725|FG001|Overall Study|Adverse Event|1|||
16545454|NCT01370525|40460724|FG000|Overall Study|Protocol Violation|2|||
16545455|NCT01370525|40460725|FG001|Overall Study|Protocol Violation|1|||
16545456|NCT01370525|40460724|FG000|Overall Study|Lost to follow up|2|||
16545457|NCT01370525|40460725|FG001|Overall Study|Lost to follow up|6|||
16545458|NCT01161472|40460726|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
16545459|NCT01161472|40460727|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
16545460|NCT01161472|40460728|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
16545461|NCT01161472|40460729|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
16545462|NCT03633929|40460732|FG000|Overall Study|Lost to Follow-up|1|||
16545463|NCT03633929|40460732|FG000|Overall Study|Did not login to software. Did not participate|3|||
16545464|NCT00508404|40460733|FG000|Overall Study|Ongoing at Data Cut-off|12|||
16545465|NCT00508404|40460733|FG000|Overall Study|Adverse Event|2|||
16545466|NCT00508404|40460733|FG000|Overall Study|Death|16|||
16545467|NCT00508404|40460733|FG000|Overall Study|Physician Decision|2|||
16545468|NCT00508404|40460733|FG000|Overall Study|Withdrawal by Subject|3|||
16545469|NCT00508404|40460733|FG000|Overall Study|Protocol-specified Criteria|2|||
16545470|NCT00508404|40460733|FG000|Overall Study|Lost to Follow-up|2|||
16545471|NCT00508404|40460733|FG000|Overall Study|Other - Not Specified|3|||
16545472|NCT02296190|40460735|FG000|Overall Study|Lost to Follow-up|0|||
16545473|NCT02296190|40460736|FG001|Overall Study|Lost to Follow-up|0|||
16545474|NCT02296190|40460737|FG002|Overall Study|Lost to Follow-up|0|||
16545475|NCT02296190|40460738|FG003|Overall Study|Lost to Follow-up|0|||
16545476|NCT02296190|40460739|FG004|Overall Study|Lost to Follow-up|1|||
16545477|NCT02296190|40460740|FG005|Overall Study|Lost to Follow-up|0|||
16545478|NCT02296190|40460735|FG000|Overall Study|Failure to induce PSVT|6|||
16545479|NCT02296190|40460736|FG001|Overall Study|Failure to induce PSVT|10|||
16545480|NCT02296190|40460737|FG002|Overall Study|Failure to induce PSVT|5|||
16545481|NCT02296190|40460738|FG003|Overall Study|Failure to induce PSVT|13|||
16545482|NCT02296190|40460739|FG004|Overall Study|Failure to induce PSVT|8|||
16545483|NCT02296190|40460740|FG005|Overall Study|Failure to induce PSVT|0|||
16545484|NCT02296190|40460735|FG000|Overall Study|Physician Decision|1|||
16545485|NCT02296190|40460736|FG001|Overall Study|Physician Decision|1|||
16545486|NCT02296190|40460737|FG002|Overall Study|Physician Decision|0|||
16344482|NCT03442088|39747599|FG000|Overall Study|Lost to Follow-up|2|||
16344483|NCT00398047|39747600|FG000|Overall Study|all patient progressed before completion|3|||
16545487|NCT02296190|40460738|FG003|Overall Study|Physician Decision|1|||
16545488|NCT02296190|40460739|FG004|Overall Study|Physician Decision|2|||
16545489|NCT02296190|40460740|FG005|Overall Study|Physician Decision|0|||
16545490|NCT02296190|40460735|FG000|Overall Study|Withdrawal by Subject|0|||
16545491|NCT02296190|40460736|FG001|Overall Study|Withdrawal by Subject|1|||
16545492|NCT02296190|40460737|FG002|Overall Study|Withdrawal by Subject|0|||
16545493|NCT02296190|40460738|FG003|Overall Study|Withdrawal by Subject|0|||
16110326|NCT00460564|38892775|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
16110327|NCT00460564|38892776|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
16110328|NCT00460564|38892777|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
16110329|NCT00460564|38892778|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
16110330|NCT00460564|38892771|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
16110331|NCT00460564|38892772|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
16545494|NCT02296190|40460739|FG004|Overall Study|Withdrawal by Subject|0|||
16545495|NCT02296190|40460740|FG005|Overall Study|Withdrawal by Subject|0|||
16545496|NCT02296190|40460735|FG000|Overall Study|PSVT < 5 minutes|5|||
16545497|NCT02296190|40460736|FG001|Overall Study|PSVT < 5 minutes|6|||
16545498|NCT02296190|40460737|FG002|Overall Study|PSVT < 5 minutes|6|||
16545499|NCT02296190|40460738|FG003|Overall Study|PSVT < 5 minutes|6|||
16545500|NCT02296190|40460739|FG004|Overall Study|PSVT < 5 minutes|5|||
16545501|NCT02296190|40460740|FG005|Overall Study|PSVT < 5 minutes|0|||
16545502|NCT02296190|40460735|FG000|Overall Study|Patient was given Propofol|0|||
16110332|NCT00460564|38892773|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
16110333|NCT00460564|38892774|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
16110334|NCT00460564|38892775|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
16221897|NCT01066819|39294959|FG003|Overall Study|Not categorised|1|||
16110335|NCT00460564|38892776|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
16110336|NCT00460564|38892777|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
16110337|NCT00460564|38892778|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
16110338|NCT03713320|38892779|FG000|Randomized Period|Adverse Event|1|||
16110339|NCT03713320|38892780|FG001|Randomized Period|Adverse Event|5|||
16110340|NCT03713320|38892781|FG002|Randomized Period|Adverse Event|0|||
16110341|NCT03713320|38892779|FG000|Randomized Period|Physician Decision|1|||
16110342|NCT03713320|38892780|FG001|Randomized Period|Physician Decision|1|||
16110343|NCT03713320|38892781|FG002|Randomized Period|Physician Decision|0|||
16110344|NCT03713320|38892779|FG000|Randomized Period|Withdrawal by Subject|4|||
16110345|NCT03713320|38892780|FG001|Randomized Period|Withdrawal by Subject|0|||
16110346|NCT03713320|38892781|FG002|Randomized Period|Withdrawal by Subject|0|||
16110347|NCT03713320|38892779|FG000|Randomized Period|Participant decision|3|||
16110348|NCT03713320|38892780|FG001|Randomized Period|Participant decision|1|||
16110349|NCT03713320|38892781|FG002|Randomized Period|Participant decision|0|||
16110350|NCT03713320|38892779|FG000|Randomized Period|Study terminated by sponsor|6|||
16110351|NCT03713320|38892780|FG001|Randomized Period|Study terminated by sponsor|3|||
16110352|NCT03713320|38892781|FG002|Randomized Period|Study terminated by sponsor|0|||
16110353|NCT03713320|38892779|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
16110354|NCT03713320|38892780|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
16110355|NCT03713320|38892781|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
16110356|NCT03713320|38892779|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
16110357|NCT03713320|38892780|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
16110358|NCT03713320|38892781|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
16110359|NCT03482752|38892785|FG000|Overall Study|Withdrawal by Subject|2|||
16110360|NCT03482752|38892785|FG000|Overall Study|Lost to Follow-up|1|||
16110361|NCT03482752|38892785|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
16110362|NCT00224029|38892786|FG000|Overall Study|Lost to Follow-up|1|||
16110363|NCT00224029|38892786|FG000|Overall Study|Withdrawal by Subject|4|||
16110364|NCT00224029|38892786|FG000|Overall Study|Other|1|||
16110365|NCT02654132|38892791|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
16110366|NCT02654132|38892792|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
16110367|NCT02654132|38892791|FG000|Treatment Period|Disease progression|43|||
16110368|NCT02654132|38892792|FG001|Treatment Period|Disease progression|38|||
16110369|NCT02654132|38892791|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
16110370|NCT02654132|38892792|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
16110371|NCT02654132|38892791|FG000|Treatment Period|Other reasons|4|||
16221898|NCT01066819|39294960|FG004|Overall Study|Not categorised|0|||
16110372|NCT02654132|38892792|FG001|Treatment Period|Other reasons|2|||
16110373|NCT02654132|38892791|FG000|Treatment Period|Study drug toxicity|2|||
16110374|NCT02654132|38892792|FG001|Treatment Period|Study drug toxicity|2|||
16110375|NCT02654132|38892791|FG000|Treatment Period|Withdrawal by Subject|2|||
16110376|NCT02654132|38892792|FG001|Treatment Period|Withdrawal by Subject|1|||
16110377|NCT02654132|38892791|FG000|Treatment Period|Maximum Clinical Benefit|0|||
16110378|NCT02654132|38892792|FG001|Treatment Period|Maximum Clinical Benefit|2|||
16110379|NCT02654132|38892791|FG000|Treatment Period|Participant request to discontinue|2|||
16110380|NCT02654132|38892792|FG001|Treatment Period|Participant request to discontinue|0|||
16110381|NCT02654132|38892791|FG000|Treatment Period|Administrative reasons by sponsor|0|||
16110382|NCT02654132|38892792|FG001|Treatment Period|Administrative reasons by sponsor|1|||
16110383|NCT02654132|38892791|FG000|Treatment Period|Death|1|||
16110384|NCT02654132|38892792|FG001|Treatment Period|Death|0|||
16110385|NCT01751165|38892793|FG000|Overall Study|Adverse event, serious fatal|1|||
16110386|NCT01751165|38892794|FG001|Overall Study|Adverse event, serious fatal|0|||
16110387|NCT01751165|38892795|FG002|Overall Study|Adverse event, serious fatal|1|||
16110388|NCT01751165|38892793|FG000|Overall Study|Withdrawal by Subject|0|||
16110389|NCT01751165|38892794|FG001|Overall Study|Withdrawal by Subject|0|||
16110390|NCT01751165|38892795|FG002|Overall Study|Withdrawal by Subject|1|||
16110391|NCT01751165|38892793|FG000|Overall Study|Serious adverse event|0|||
16110392|NCT01751165|38892794|FG001|Overall Study|Serious adverse event|2|||
16110393|NCT01751165|38892795|FG002|Overall Study|Serious adverse event|0|||
16110394|NCT01751165|38892793|FG000|Overall Study|Lost to Follow-up|1|||
16110395|NCT01751165|38892794|FG001|Overall Study|Lost to Follow-up|1|||
16110396|NCT01751165|38892795|FG002|Overall Study|Lost to Follow-up|1|||
16110397|NCT00321685|38892797|FG000|Overall Study|Adverse Event|18|||
16110398|NCT00321685|38892797|FG000|Overall Study|Death|2|||
16110399|NCT00321685|38892797|FG000|Overall Study|Withdrawal by Subject|8|||
16110400|NCT00321685|38892797|FG000|Overall Study|Alternative therapy|1|||
16110401|NCT00321685|38892797|FG000|Overall Study|Complicating disese|1|||
16110402|NCT00321685|38892797|FG000|Overall Study|Other|5|||
16110403|NCT00321685|38892797|FG000|Overall Study|Not start protocol therapy|2|||
16110404|NCT00321685|38892797|FG000|Overall Study|Ineligible|2|||
16110405|NCT01929876|38892798|FG000|Period 2|Non-Compliance|1|||
16110406|NCT00383123|38892799|FG000|Overall Study|Adverse Event|1|||
16110407|NCT00383123|38892800|FG001|Overall Study|Adverse Event|0|||
16110408|NCT00383123|38892799|FG000|Overall Study|Lost to Follow-up|68|||
16110409|NCT00383123|38892800|FG001|Overall Study|Lost to Follow-up|61|||
16110410|NCT00383123|38892799|FG000|Overall Study|Protocol Violation|5|||
16110411|NCT00383123|38892800|FG001|Overall Study|Protocol Violation|1|||
16110412|NCT00383123|38892799|FG000|Overall Study|Withdrawal by Subject|27|||
16110413|NCT00383123|38892800|FG001|Overall Study|Withdrawal by Subject|18|||
16110414|NCT00383123|38892799|FG000|Overall Study|Other reason|10|||
16110415|NCT00383123|38892800|FG001|Overall Study|Other reason|6|||
16110416|NCT02716298|38892801|FG000|First Intervention (1 Month)|Lens discomfort|1|||
16110417|NCT02716298|38892802|FG001|First Intervention (1 Month)|Lens discomfort|1|||
16110418|NCT00745498|38892805|FG000|Overall Study|Lost to Follow-up|1|||
16110419|NCT00745498|38892806|FG001|Overall Study|Lost to Follow-up|1|||
16110420|NCT00745498|38892807|FG002|Overall Study|Lost to Follow-up|3|||
16110421|NCT00745498|38892805|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
16110422|NCT00745498|38892806|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
16110423|NCT00745498|38892807|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
16110424|NCT00745498|38892805|FG000|Overall Study|Non-PDR related VH|0|||
16110425|NCT00745498|38892806|FG001|Overall Study|Non-PDR related VH|1|||
16110426|NCT00745498|38892807|FG002|Overall Study|Non-PDR related VH|1|||
16110427|NCT00745498|38892805|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
16110428|NCT00745498|38892806|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
16110429|NCT00745498|38892807|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
16110430|NCT00732992|38892808|FG000|Overall Study|Adverse Event|1|||
16110431|NCT00732992|38892809|FG001|Overall Study|Adverse Event|1|||
16110432|NCT00732992|38892808|FG000|Overall Study|Objective Progression or Relapse|3|||
16110433|NCT00732992|38892809|FG001|Overall Study|Objective Progression or Relapse|5|||
16110434|NCT00732992|38892808|FG000|Overall Study|Global Deterioration of Health Status|1|||
16110435|NCT00732992|38892809|FG001|Overall Study|Global Deterioration of Health Status|0|||
16110436|NCT00732992|38892808|FG000|Overall Study|Withdrawal by Subject|1|||
16110437|NCT00732992|38892809|FG001|Overall Study|Withdrawal by Subject|0|||
16110438|NCT00443898|38892810|FG000|Overall Study|Adverse Event|0|||
16110439|NCT00443898|38892811|FG001|Overall Study|Adverse Event|0|||
16344484|NCT02489448|39747601|FG000|Overall Study|Death|3|||
16110440|NCT00443898|38892812|FG002|Overall Study|Adverse Event|1|||
16110441|NCT00443898|38892813|FG003|Overall Study|Adverse Event|1|||
16110442|NCT00443898|38892810|FG000|Overall Study|Lack of Efficacy|2|||
16110443|NCT00443898|38892811|FG001|Overall Study|Lack of Efficacy|3|||
16110444|NCT00443898|38892812|FG002|Overall Study|Lack of Efficacy|3|||
16344485|NCT02489448|39747601|FG000|Overall Study|Withdrawal by Subject|2|||
16344486|NCT02716584|39747602|FG000|Overall Study|Lost to Follow-up|8|||
16110445|NCT00443898|38892813|FG003|Overall Study|Lack of Efficacy|1|||
16110446|NCT00443898|38892810|FG000|Overall Study|Protocol Violation|1|||
16110447|NCT00443898|38892811|FG001|Overall Study|Protocol Violation|1|||
16110448|NCT00443898|38892812|FG002|Overall Study|Protocol Violation|1|||
16110449|NCT00443898|38892813|FG003|Overall Study|Protocol Violation|0|||
16110450|NCT00443898|38892810|FG000|Overall Study|Withdrawal by Subject|11|||
16110451|NCT00443898|38892811|FG001|Overall Study|Withdrawal by Subject|10|||
16110452|NCT00443898|38892812|FG002|Overall Study|Withdrawal by Subject|10|||
16110453|NCT00443898|38892813|FG003|Overall Study|Withdrawal by Subject|6|||
16110454|NCT00443898|38892810|FG000|Overall Study|Lost to Follow-up|10|||
16110455|NCT00443898|38892811|FG001|Overall Study|Lost to Follow-up|10|||
16110456|NCT00443898|38892812|FG002|Overall Study|Lost to Follow-up|14|||
16110457|NCT00443898|38892813|FG003|Overall Study|Lost to Follow-up|10|||
16110458|NCT00443898|38892810|FG000|Overall Study|Death|0|||
16110459|NCT00443898|38892811|FG001|Overall Study|Death|1|||
16110460|NCT00443898|38892812|FG002|Overall Study|Death|0|||
16110461|NCT00443898|38892813|FG003|Overall Study|Death|0|||
16110462|NCT01390441|38892814|FG000|Treatment Period|Protocol Violation|0|||
16110463|NCT01390441|38892815|FG001|Treatment Period|Protocol Violation|1|||
16110464|NCT01390441|38892816|FG002|Treatment Period|Protocol Violation|0|||
16110465|NCT01390441|38892817|FG003|Treatment Period|Protocol Violation|0|||
16110466|NCT01390441|38892818|FG004|Treatment Period|Protocol Violation|0|||
16110467|NCT01390441|38892814|FG000|Treatment Period|Physician Decision|0|||
16110468|NCT01390441|38892815|FG001|Treatment Period|Physician Decision|0|||
16110469|NCT01390441|38892816|FG002|Treatment Period|Physician Decision|0|||
16110470|NCT01390441|38892817|FG003|Treatment Period|Physician Decision|1|||
16110471|NCT01390441|38892818|FG004|Treatment Period|Physician Decision|0|||
16110472|NCT01390441|38892814|FG000|Treatment Period|Lack of Efficacy|0|||
16110473|NCT01390441|38892815|FG001|Treatment Period|Lack of Efficacy|0|||
16110474|NCT01390441|38892816|FG002|Treatment Period|Lack of Efficacy|0|||
16110475|NCT01390441|38892817|FG003|Treatment Period|Lack of Efficacy|0|||
16110476|NCT01390441|38892818|FG004|Treatment Period|Lack of Efficacy|1|||
16110477|NCT01390441|38892814|FG000|Treatment Period|Unknown due to early stopping of study|0|||
16110478|NCT01390441|38892815|FG001|Treatment Period|Unknown due to early stopping of study|0|||
16110479|NCT01390441|38892816|FG002|Treatment Period|Unknown due to early stopping of study|8|||
16110480|NCT01390441|38892817|FG003|Treatment Period|Unknown due to early stopping of study|11|||
16110481|NCT01390441|38892818|FG004|Treatment Period|Unknown due to early stopping of study|7|||
16110482|NCT01390441|38892814|FG000|Treatment Period|Adverse Event|0|||
16110483|NCT01390441|38892815|FG001|Treatment Period|Adverse Event|0|||
16110484|NCT01390441|38892816|FG002|Treatment Period|Adverse Event|1|||
16110485|NCT01390441|38892817|FG003|Treatment Period|Adverse Event|1|||
16110486|NCT01390441|38892818|FG004|Treatment Period|Adverse Event|2|||
16110487|NCT01390441|38892814|FG000|Treatment Period|Withdrawal by Subject|0|||
16110488|NCT01390441|38892815|FG001|Treatment Period|Withdrawal by Subject|0|||
16110489|NCT01390441|38892816|FG002|Treatment Period|Withdrawal by Subject|1|||
16110490|NCT01390441|38892817|FG003|Treatment Period|Withdrawal by Subject|0|||
16110491|NCT01390441|38892818|FG004|Treatment Period|Withdrawal by Subject|1|||
16110492|NCT01390441|38892814|FG000|Treatment Period|Lost to Follow-up|1|||
16110493|NCT01390441|38892815|FG001|Treatment Period|Lost to Follow-up|0|||
16110494|NCT01390441|38892816|FG002|Treatment Period|Lost to Follow-up|0|||
16110495|NCT01390441|38892817|FG003|Treatment Period|Lost to Follow-up|0|||
16110496|NCT01390441|38892818|FG004|Treatment Period|Lost to Follow-up|0|||
16110497|NCT01390441|38892814|FG000|Extension Period|Protocol Violation|3|||
16110498|NCT01390441|38892815|FG001|Extension Period|Protocol Violation|1|||
16110499|NCT01390441|38892816|FG002|Extension Period|Protocol Violation|0|||
16110500|NCT01390441|38892817|FG003|Extension Period|Protocol Violation|1|||
16110501|NCT01390441|38892818|FG004|Extension Period|Protocol Violation|0|||
16110502|NCT02284009|38892819|FG000|Overall Study|Adverse Event|3|||
16110503|NCT02284009|38892820|FG001|Overall Study|Adverse Event|0|||
16110504|NCT02284009|38892819|FG000|Overall Study|Lost to Follow-up|1|||
16110505|NCT02284009|38892820|FG001|Overall Study|Lost to Follow-up|3|||
16110506|NCT02284009|38892819|FG000|Overall Study|Physician Decision|0|||
16110507|NCT02284009|38892820|FG001|Overall Study|Physician Decision|2|||
16110508|NCT02284009|38892819|FG000|Overall Study|Withdrawal by Subject|2|||
16110509|NCT02284009|38892820|FG001|Overall Study|Withdrawal by Subject|5|||
16110510|NCT00516139|38892823|FG000|Overall Study|Adverse Event|27|||
16110511|NCT00516139|38892823|FG000|Overall Study|Lost to Follow-up|1|||
16110512|NCT00516139|38892823|FG000|Overall Study|Protocol Violation|1|||
16110513|NCT00516139|38892823|FG000|Overall Study|Withdrawal by Subject|8|||
16110514|NCT00516139|38892823|FG000|Overall Study|Lack of Efficacy|1|||
16110515|NCT00909532|38892824|FG000|Overall Study|Adverse Event|4|||
16110516|NCT00909532|38892825|FG001|Overall Study|Adverse Event|1|||
16110517|NCT00909532|38892824|FG000|Overall Study|Pregnancy|0|||
16110518|NCT00909532|38892825|FG001|Overall Study|Pregnancy|1|||
16110519|NCT00909532|38892824|FG000|Overall Study|Prohibited Medication|2|||
16110520|NCT00909532|38892825|FG001|Overall Study|Prohibited Medication|1|||
16110521|NCT00909532|38892824|FG000|Overall Study|Withdrawal of Consent|1|||
16110522|NCT00909532|38892825|FG001|Overall Study|Withdrawal of Consent|1|||
16110523|NCT00909532|38892824|FG000|Overall Study|Noncompliance with Study Requirements|0|||
16110524|NCT00909532|38892825|FG001|Overall Study|Noncompliance with Study Requirements|2|||
16110525|NCT00909532|38892824|FG000|Overall Study|Physician Decision|1|||
16110526|NCT00909532|38892825|FG001|Overall Study|Physician Decision|0|||
16110527|NCT00909532|38892824|FG000|Overall Study|Wrong Genotype|1|||
16110528|NCT00909532|38892825|FG001|Overall Study|Wrong Genotype|0|||
16110529|NCT00909532|38892824|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
16110530|NCT00909532|38892825|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
16110531|NCT03277352|38892827|FG000|Overall Study|Study Terminated By Sponsor|2|||
16110532|NCT03277352|38892827|FG000|Overall Study|Withdrawal by Subject|4|||
16110533|NCT03277352|38892827|FG000|Overall Study|Death|4|||
16110534|NCT04398368|38892829|FG000|Overall Study|Withdrawal by Subject|2|||
16110535|NCT02312206|38892830|FG000|Overall Study|Adverse Event|3|||
16110536|NCT02312206|38892831|FG001|Overall Study|Adverse Event|6|||
16110537|NCT02312206|38892830|FG000|Overall Study|Withdrawal by Subject|6|||
16110538|NCT02312206|38892831|FG001|Overall Study|Withdrawal by Subject|6|||
16110539|NCT02312206|38892830|FG000|Overall Study|Physician Decision|7|||
16110540|NCT02312206|38892831|FG001|Overall Study|Physician Decision|6|||
16110541|NCT02312206|38892830|FG000|Overall Study|Death|31|||
16110542|NCT02312206|38892831|FG001|Overall Study|Death|36|||
16110543|NCT02312206|38892830|FG000|Overall Study|Study Terminated by Sponsor|81|||
16110544|NCT02312206|38892831|FG001|Overall Study|Study Terminated by Sponsor|74|||
16110545|NCT02312206|38892830|FG000|Overall Study|Patient transferred to hospice|0|||
16110546|NCT02312206|38892831|FG001|Overall Study|Patient transferred to hospice|1|||
16545503|NCT02296190|40460736|FG001|Overall Study|Patient was given Propofol|1|||
16545504|NCT02296190|40460737|FG002|Overall Study|Patient was given Propofol|0|||
16545505|NCT02296190|40460738|FG003|Overall Study|Patient was given Propofol|1|||
16545506|NCT02296190|40460739|FG004|Overall Study|Patient was given Propofol|0|||
16545507|NCT02296190|40460740|FG005|Overall Study|Patient was given Propofol|0|||
16545508|NCT02296190|40460735|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
16545509|NCT02296190|40460736|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
16545510|NCT02296190|40460737|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
16545511|NCT02296190|40460738|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
16545512|NCT02296190|40460739|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
16545513|NCT02296190|40460740|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
16545514|NCT02296190|40460735|FG000|Overall Study|Blood pressure <100 after sedation|0|||
16545515|NCT02296190|40460736|FG001|Overall Study|Blood pressure <100 after sedation|0|||
16545516|NCT02296190|40460737|FG002|Overall Study|Blood pressure <100 after sedation|0|||
16545517|NCT02296190|40460738|FG003|Overall Study|Blood pressure <100 after sedation|1|||
16545518|NCT02296190|40460739|FG004|Overall Study|Blood pressure <100 after sedation|0|||
16545519|NCT02296190|40460740|FG005|Overall Study|Blood pressure <100 after sedation|0|||
16545520|NCT02296190|40460735|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
16545521|NCT02296190|40460736|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
16545522|NCT02296190|40460737|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
16545523|NCT02296190|40460738|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
16545524|NCT02296190|40460739|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
16545525|NCT02296190|40460740|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
16545526|NCT02296190|40460735|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
16545527|NCT02296190|40460736|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
16545528|NCT02296190|40460737|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
16545529|NCT02296190|40460738|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
16545530|NCT02296190|40460739|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
16545531|NCT02296190|40460740|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
16545532|NCT02296190|40460735|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
16545533|NCT02296190|40460736|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
16545534|NCT02296190|40460737|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
16545535|NCT02296190|40460738|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
16545536|NCT02296190|40460739|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
16545537|NCT02296190|40460740|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
16545538|NCT02296190|40460735|FG000|Overall Study|Lab result not available in time|1|||
16110547|NCT02312206|38892830|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
16221899|NCT01066819|39294961|FG005|Overall Study|Not categorised|0|||
16344487|NCT02716584|39747603|FG001|Overall Study|Lost to Follow-up|5|||
16344488|NCT00255164|39747605|FG000|Overall Study|Adverse Event|10|||
16344489|NCT00255164|39747606|FG001|Overall Study|Adverse Event|6|||
16344490|NCT00255164|39747607|FG002|Overall Study|Adverse Event|9|||
16344491|NCT00255164|39747605|FG000|Overall Study|Lost to Follow-up|4|||
16344492|NCT00255164|39747606|FG001|Overall Study|Lost to Follow-up|3|||
16344493|NCT00255164|39747607|FG002|Overall Study|Lost to Follow-up|4|||
16344494|NCT00255164|39747605|FG000|Overall Study|Withdrawal by Subject|18|||
16344495|NCT00255164|39747606|FG001|Overall Study|Withdrawal by Subject|17|||
16344496|NCT00255164|39747607|FG002|Overall Study|Withdrawal by Subject|8|||
16344497|NCT00255164|39747605|FG000|Overall Study|Noncompliance|0|||
16344498|NCT00255164|39747606|FG001|Overall Study|Noncompliance|1|||
16110548|NCT02312206|38892831|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
16110549|NCT02312206|38892830|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
16110550|NCT02312206|38892831|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
16110551|NCT02312206|38892830|FG000|Overall Study|Disease Progression|1|||
16110552|NCT02312206|38892831|FG001|Overall Study|Disease Progression|0|||
16110553|NCT02547441|38892835|FG000|Double-Blind Study Period|Adverse Event|4|||
16110554|NCT02547441|38892836|FG001|Double-Blind Study Period|Adverse Event|9|||
16110555|NCT02547441|38892835|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
16110556|NCT02547441|38892836|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
16408438|NCT02741570|39976980|FG001|Treatment Period|Disease progression|301|||
16408439|NCT02741570|39976979|FG000|Treatment Period|Administrative reason by sponsor|0|||
16408440|NCT02741570|39976980|FG001|Treatment Period|Administrative reason by sponsor|1|||
16408441|NCT02498067|39976982|FG000|Overall Study|Lost to Follow-up|22|||
16408442|NCT02498067|39976982|FG000|Overall Study|Did not meet inclusion criteria|11|||
16408443|NCT01852825|39976987|FG000|Overall Study|Withdrawal by Subject|2|||
16408444|NCT01852825|39976988|FG001|Overall Study|Withdrawal by Subject|0|||
16408445|NCT01852825|39976989|FG002|Overall Study|Withdrawal by Subject|0|||
16408446|NCT02153346|39976993|FG000|Overall Study|Lost to Follow-up|11|||
16408447|NCT03002818|39976994|FG000|Overall Study|Decision of the investigator|1|||
16408448|NCT00953680|39976996|FG000|Period 1|Withdrawal by Subject|0|||
16408449|NCT00953680|39976997|FG001|Period 1|Withdrawal by Subject|1|||
16408450|NCT00871117|39976998|FG000|Overall Study|Lost to Follow-up|5|||
16408451|NCT00871117|39976999|FG001|Overall Study|Lost to Follow-up|6|||
16408452|NCT00871117|39976998|FG000|Overall Study|Other|0|||
16408453|NCT00871117|39976999|FG001|Overall Study|Other|4|||
16408454|NCT01994863|39977002|FG000|Period 1|Adverse Event|4|||
16408455|NCT01994863|39977003|FG001|Period 1|Adverse Event|0|||
16408456|NCT01994863|39977002|FG000|Period 1|Withdrawal by Subject|1|||
16408457|NCT01994863|39977003|FG001|Period 1|Withdrawal by Subject|0|||
16408458|NCT01994863|39977002|FG000|Period 1|Trial stopped by sponsor|1|||
16408459|NCT01994863|39977003|FG001|Period 1|Trial stopped by sponsor|3|||
16408460|NCT01994863|39977002|FG000|Period 1|Lack of Efficacy|1|||
16408461|NCT01994863|39977003|FG001|Period 1|Lack of Efficacy|0|||
16408462|NCT01994863|39977002|FG000|Period 2|Adverse Event|0|||
16408463|NCT01994863|39977003|FG001|Period 2|Adverse Event|1|||
16408464|NCT01994863|39977002|FG000|Period 2|Lack of Efficacy|0|||
16408465|NCT01994863|39977003|FG001|Period 2|Lack of Efficacy|2|||
16408466|NCT01994863|39977002|FG000|Period 2|Withdrawal by Subject|1|||
16408467|NCT01994863|39977003|FG001|Period 2|Withdrawal by Subject|1|||
16408468|NCT02650128|39977008|FG000|Overall Study|Death|2|||
16408469|NCT01089023|39977009|FG000|Overall Study|Lost to Follow-up|3|||
16408470|NCT01089023|39977009|FG000|Overall Study|Adverse Event|1|||
16408471|NCT01089023|39977009|FG000|Overall Study|Withdrawal by Subject|1|||
16408472|NCT01089023|39977009|FG000|Overall Study|Protocol Violation|1|||
16408473|NCT01089023|39977009|FG000|Overall Study|Lack of Efficacy|1|||
16408474|NCT01710527|39977010|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
16408475|NCT01710527|39977011|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
16408476|NCT02590562|39977016|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
16408477|NCT01414205|39977021|FG000|Overall Study|Death|5|||
16408478|NCT01414205|39977022|FG001|Overall Study|Death|1|||
16408479|NCT01414205|39977021|FG000|Overall Study|Lost to Follow-up|1|||
16408480|NCT01414205|39977022|FG001|Overall Study|Lost to Follow-up|4|||
16408481|NCT01414205|39977021|FG000|Overall Study|Physician Decision|0|||
16408482|NCT01414205|39977022|FG001|Overall Study|Physician Decision|1|||
16408483|NCT01414205|39977021|FG000|Overall Study|Randomized but not Treated|1|||
16110557|NCT02547441|38892835|FG000|Double-Blind Study Period|Physician Decision|1|||
16408484|NCT01414205|39977022|FG001|Overall Study|Randomized but not Treated|1|||
16408485|NCT00354107|39977023|FG000|Overall Study|Adverse Event|2|||
16408486|NCT00354107|39977023|FG000|Overall Study|Physician Decision|2|||
16408487|NCT00354107|39977023|FG000|Overall Study|Withdrawal by Subject|1|||
16408488|NCT01703117|39977024|FG000|Overall Study|Adverse Event|4|||
16408489|NCT01703117|39977025|FG001|Overall Study|Adverse Event|3|||
16408490|NCT01703117|39977024|FG000|Overall Study|Withdrawal by Subject|0|||
16408491|NCT01703117|39977025|FG001|Overall Study|Withdrawal by Subject|1|||
16110558|NCT02547441|38892836|FG001|Double-Blind Study Period|Physician Decision|0|||
16110559|NCT02547441|38892835|FG000|Double-Blind Study Period|Protocol Violation|1|||
16110560|NCT02547441|38892836|FG001|Double-Blind Study Period|Protocol Violation|2|||
16110561|NCT02547441|38892835|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
16408492|NCT01286987|39977027|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
16110562|NCT02547441|38892836|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
16408493|NCT01286987|39977028|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
16408494|NCT01286987|39977029|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
16408495|NCT01286987|39977030|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
16408496|NCT01286987|39977031|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
16408497|NCT01286987|39977032|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
16408498|NCT01286987|39977033|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
16408499|NCT01286987|39977034|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
16408500|NCT01286987|39977035|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
16408501|NCT01286987|39977036|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
16408502|NCT01286987|39977037|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
16408503|NCT01286987|39977038|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
16408504|NCT01286987|39977039|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
16408505|NCT01286987|39977040|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
16408506|NCT01286987|39977041|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
16408507|NCT01286987|39977027|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
16408508|NCT01286987|39977028|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
16408509|NCT01286987|39977029|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
16408510|NCT01286987|39977030|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
16408511|NCT01286987|39977031|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
16408512|NCT01286987|39977032|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
16408513|NCT01286987|39977033|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
16408514|NCT01286987|39977034|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
16408515|NCT01286987|39977035|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
16408516|NCT01286987|39977036|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
16408517|NCT01286987|39977037|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
16408518|NCT01286987|39977038|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
16408519|NCT01286987|39977039|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
16408520|NCT01286987|39977040|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
16408521|NCT01286987|39977041|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
16408522|NCT01286987|39977027|FG000|Part 1: Dose Escalation|Physician Decision|0|||
16408523|NCT01286987|39977028|FG001|Part 1: Dose Escalation|Physician Decision|0|||
16408524|NCT01286987|39977029|FG002|Part 1: Dose Escalation|Physician Decision|0|||
16408525|NCT01286987|39977030|FG003|Part 1: Dose Escalation|Physician Decision|0|||
16408526|NCT01286987|39977031|FG004|Part 1: Dose Escalation|Physician Decision|1|||
16408527|NCT01286987|39977032|FG005|Part 1: Dose Escalation|Physician Decision|0|||
16408528|NCT01286987|39977033|FG006|Part 1: Dose Escalation|Physician Decision|0|||
16408529|NCT01286987|39977034|FG007|Part 1: Dose Escalation|Physician Decision|0|||
16408530|NCT01286987|39977035|FG008|Part 1: Dose Escalation|Physician Decision|0|||
16408531|NCT01286987|39977036|FG009|Part 1: Dose Escalation|Physician Decision|0|||
16408532|NCT01286987|39977037|FG010|Part 1: Dose Escalation|Physician Decision|0|||
16408533|NCT01286987|39977038|FG011|Part 1: Dose Escalation|Physician Decision|0|||
16408534|NCT01286987|39977039|FG012|Part 1: Dose Escalation|Physician Decision|0|||
16408535|NCT01286987|39977040|FG013|Part 1: Dose Escalation|Physician Decision|0|||
16408536|NCT01286987|39977041|FG014|Part 1: Dose Escalation|Physician Decision|0|||
16408537|NCT01286987|39977027|FG000|Part 2: Dose Expansion|Death|0|||
16408538|NCT01286987|39977028|FG001|Part 2: Dose Expansion|Death|0|||
16408539|NCT01286987|39977029|FG002|Part 2: Dose Expansion|Death|0|||
16408540|NCT01286987|39977030|FG003|Part 2: Dose Expansion|Death|0|||
16408541|NCT01286987|39977031|FG004|Part 2: Dose Expansion|Death|0|||
16408542|NCT01286987|39977032|FG005|Part 2: Dose Expansion|Death|0|||
16344499|NCT00255164|39747607|FG002|Overall Study|Noncompliance|2|||
16344500|NCT00255164|39747605|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
16344501|NCT00255164|39747606|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
16344502|NCT00255164|39747607|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
16344503|NCT00255164|39747605|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
16344504|NCT00255164|39747606|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
16344505|NCT00255164|39747607|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
16344506|NCT00255164|39747605|FG000|Overall Study|Possible Barrett's Esophagus|1|||
16344507|NCT00255164|39747606|FG001|Overall Study|Possible Barrett's Esophagus|3|||
16344508|NCT00255164|39747607|FG002|Overall Study|Possible Barrett's Esophagus|8|||
16344509|NCT00255164|39747605|FG000|Overall Study|Esophageal Stricture|0|||
16344510|NCT00255164|39747606|FG001|Overall Study|Esophageal Stricture|0|||
16344511|NCT00255164|39747607|FG002|Overall Study|Esophageal Stricture|1|||
16344512|NCT00255164|39747605|FG000|Overall Study|Therapeutic Failure|11|||
16344513|NCT00255164|39747606|FG001|Overall Study|Therapeutic Failure|2|||
16344514|NCT00255164|39747607|FG002|Overall Study|Therapeutic Failure|3|||
16344515|NCT02029274|39747610|FG000|Overall Study|Adverse Event|1|||
16344516|NCT02029274|39747611|FG001|Overall Study|Adverse Event|0|||
16344517|NCT02029274|39747612|FG002|Overall Study|Adverse Event|2|||
16221900|NCT01066819|39294956|FG000|Overall Study|Relapse|16|||
16344518|NCT02029274|39747613|FG003|Overall Study|Adverse Event|2|||
16344519|NCT00320788|39747614|FG000|Overall Study|Adverse Event|0|||
16344520|NCT00320788|39747615|FG001|Overall Study|Adverse Event|0|||
16344521|NCT00320788|39747616|FG002|Overall Study|Adverse Event|0|||
16344522|NCT00320788|39747617|FG003|Overall Study|Adverse Event|1|||
16344523|NCT00320788|39747618|FG004|Overall Study|Adverse Event|0|||
16344524|NCT00320788|39747614|FG000|Overall Study|Death|0|||
16344525|NCT00320788|39747615|FG001|Overall Study|Death|0|||
16344526|NCT00320788|39747616|FG002|Overall Study|Death|1|||
16344527|NCT00320788|39747617|FG003|Overall Study|Death|0|||
16344528|NCT00320788|39747618|FG004|Overall Study|Death|1|||
16344529|NCT00320788|39747614|FG000|Overall Study|Lost to Follow-up|0|||
16344530|NCT00320788|39747615|FG001|Overall Study|Lost to Follow-up|2|||
16344531|NCT00320788|39747616|FG002|Overall Study|Lost to Follow-up|1|||
16344532|NCT00320788|39747617|FG003|Overall Study|Lost to Follow-up|0|||
16344533|NCT00320788|39747618|FG004|Overall Study|Lost to Follow-up|0|||
16344534|NCT00320788|39747614|FG000|Overall Study|Decision by the Sponsor|1|||
16344535|NCT00320788|39747615|FG001|Overall Study|Decision by the Sponsor|1|||
16344536|NCT00320788|39747616|FG002|Overall Study|Decision by the Sponsor|0|||
16344537|NCT00320788|39747617|FG003|Overall Study|Decision by the Sponsor|0|||
16344538|NCT00320788|39747618|FG004|Overall Study|Decision by the Sponsor|1|||
16344539|NCT00320788|39747614|FG000|Overall Study|Other|1|||
16408543|NCT01286987|39977033|FG006|Part 2: Dose Expansion|Death|0|||
16408544|NCT01286987|39977034|FG007|Part 2: Dose Expansion|Death|0|||
16408545|NCT01286987|39977035|FG008|Part 2: Dose Expansion|Death|0|||
16408546|NCT01286987|39977036|FG009|Part 2: Dose Expansion|Death|0|||
16408547|NCT01286987|39977037|FG010|Part 2: Dose Expansion|Death|0|||
16408548|NCT01286987|39977038|FG011|Part 2: Dose Expansion|Death|0|||
16221901|NCT01066819|39294957|FG001|Overall Study|Relapse|4|||
16221902|NCT01066819|39294958|FG002|Overall Study|Relapse|3|||
16221903|NCT01066819|39294959|FG003|Overall Study|Relapse|0|||
16221904|NCT01066819|39294960|FG004|Overall Study|Relapse|0|||
16221905|NCT01066819|39294961|FG005|Overall Study|Relapse|0|||
16221906|NCT01066819|39294956|FG000|Overall Study|Results not available|1|||
16221907|NCT01066819|39294957|FG001|Overall Study|Results not available|0|||
16221908|NCT01066819|39294958|FG002|Overall Study|Results not available|0|||
16221909|NCT01066819|39294959|FG003|Overall Study|Results not available|0|||
16221910|NCT01066819|39294960|FG004|Overall Study|Results not available|0|||
16221911|NCT01066819|39294961|FG005|Overall Study|Results not available|0|||
16221912|NCT01066819|39294956|FG000|Overall Study|Screen failure|1|||
16221913|NCT01066819|39294957|FG001|Overall Study|Screen failure|0|||
16221914|NCT01066819|39294958|FG002|Overall Study|Screen failure|0|||
16221915|NCT01066819|39294959|FG003|Overall Study|Screen failure|0|||
16221916|NCT01066819|39294960|FG004|Overall Study|Screen failure|0|||
16408549|NCT01286987|39977039|FG012|Part 2: Dose Expansion|Death|1|||
16221917|NCT01066819|39294961|FG005|Overall Study|Screen failure|0|||
16221918|NCT01066819|39294956|FG000|Overall Study|Spontaneous cure|1|||
16221919|NCT01066819|39294957|FG001|Overall Study|Spontaneous cure|0|||
16344540|NCT00320788|39747615|FG001|Overall Study|Other|2|||
16344541|NCT00320788|39747616|FG002|Overall Study|Other|1|||
16344542|NCT00320788|39747617|FG003|Overall Study|Other|1|||
16344543|NCT00320788|39747618|FG004|Overall Study|Other|1|||
16344544|NCT00320788|39747614|FG000|Overall Study|Physician Decision|1|||
16344545|NCT00320788|39747615|FG001|Overall Study|Physician Decision|1|||
16344546|NCT00320788|39747616|FG002|Overall Study|Physician Decision|0|||
16344547|NCT00320788|39747617|FG003|Overall Study|Physician Decision|0|||
16344548|NCT00320788|39747618|FG004|Overall Study|Physician Decision|0|||
16344549|NCT00320788|39747614|FG000|Overall Study|Protocol Violation|0|||
16344550|NCT00320788|39747615|FG001|Overall Study|Protocol Violation|0|||
16344551|NCT00320788|39747616|FG002|Overall Study|Protocol Violation|0|||
16344552|NCT00320788|39747617|FG003|Overall Study|Protocol Violation|0|||
16408550|NCT01286987|39977040|FG013|Part 2: Dose Expansion|Death|1|||
16344553|NCT00320788|39747618|FG004|Overall Study|Protocol Violation|1|||
16344554|NCT00320788|39747614|FG000|Overall Study|Withdrawal by Subject|3|||
16344555|NCT00320788|39747615|FG001|Overall Study|Withdrawal by Subject|0|||
16344556|NCT00320788|39747616|FG002|Overall Study|Withdrawal by Subject|0|||
16344557|NCT00320788|39747617|FG003|Overall Study|Withdrawal by Subject|3|||
16344558|NCT00320788|39747618|FG004|Overall Study|Withdrawal by Subject|1|||
16344559|NCT00587795|39747623|FG000|Overall Study|Withdrawal by Subject|1|||
16344560|NCT00587795|39747624|FG001|Overall Study|Withdrawal by Subject|0|||
16344561|NCT02906579|39747627|FG000|Overall Study|Adverse Event|1|||
16344562|NCT02906579|39747627|FG000|Overall Study|Physician Decision|1|||
16344563|NCT04399889|39747628|FG000|Overall Study|Death|5|||
16344564|NCT04399889|39747629|FG001|Overall Study|Death|1|||
16344565|NCT04399889|39747630|FG002|Overall Study|Death|1|||
16344566|NCT00856999|39747631|FG000|Overall Study|Withdrawal by Subject|5|||
16344567|NCT01409915|39747632|FG000|Overall Study|Adverse Event|0|||
16344568|NCT01409915|39747633|FG001|Overall Study|Adverse Event|2|||
16344569|NCT01409915|39747632|FG000|Overall Study|Withdrawal by Subject|0|||
16344570|NCT01409915|39747633|FG001|Overall Study|Withdrawal by Subject|1|||
16344571|NCT01409915|39747632|FG000|Overall Study|Protocol Violation|1|||
16344572|NCT01409915|39747633|FG001|Overall Study|Protocol Violation|0|||
16344573|NCT02098395|39747636|FG000|Overall Study|Protocol Violation|2|||
16344574|NCT02098395|39747637|FG001|Overall Study|Protocol Violation|2|||
16344575|NCT02098395|39747638|FG002|Overall Study|Protocol Violation|0|||
16408551|NCT01286987|39977041|FG014|Part 2: Dose Expansion|Death|0|||
16408552|NCT01286987|39977027|FG000|Part 2: Dose Expansion|Physician Decision|0|||
16408553|NCT01286987|39977028|FG001|Part 2: Dose Expansion|Physician Decision|0|||
16545539|NCT02296190|40460736|FG001|Overall Study|Lab result not available in time|0|||
16545540|NCT02296190|40460737|FG002|Overall Study|Lab result not available in time|0|||
16545541|NCT02296190|40460738|FG003|Overall Study|Lab result not available in time|0|||
16545542|NCT02296190|40460739|FG004|Overall Study|Lab result not available in time|0|||
16545543|NCT02296190|40460740|FG005|Overall Study|Lab result not available in time|0|||
16221920|NCT01066819|39294958|FG002|Overall Study|Spontaneous cure|0|||
16221921|NCT01066819|39294959|FG003|Overall Study|Spontaneous cure|0|||
16221922|NCT01066819|39294960|FG004|Overall Study|Spontaneous cure|0|||
16221923|NCT01066819|39294961|FG005|Overall Study|Spontaneous cure|0|||
16221924|NCT01066819|39294956|FG000|Overall Study|Treatment never started|85|||
16344576|NCT02098395|39747639|FG003|Overall Study|Protocol Violation|7|||
16408554|NCT01286987|39977029|FG002|Part 2: Dose Expansion|Physician Decision|0|||
16545544|NCT02002884|40460742|FG000|Main Period (MP)|Other|0|||
16110563|NCT02547441|38892835|FG000|Double-Blind Study Period|Sponsor Decision|1|||
16110564|NCT02547441|38892836|FG001|Double-Blind Study Period|Sponsor Decision|0|||
16110565|NCT02547441|38892835|FG000|Open-Label Study Period|Adverse Event|10|||
16110566|NCT02547441|38892836|FG001|Open-Label Study Period|Adverse Event|11|||
16110567|NCT02547441|38892835|FG000|Open-Label Study Period|Lack of Efficacy|3|||
16110568|NCT02547441|38892836|FG001|Open-Label Study Period|Lack of Efficacy|2|||
16110569|NCT02547441|38892835|FG000|Open-Label Study Period|Lost to Follow-up|7|||
16110570|NCT02547441|38892836|FG001|Open-Label Study Period|Lost to Follow-up|8|||
16110571|NCT02547441|38892835|FG000|Open-Label Study Period|Physician Decision|1|||
16110572|NCT02547441|38892836|FG001|Open-Label Study Period|Physician Decision|0|||
16110573|NCT02547441|38892835|FG000|Open-Label Study Period|Protocol Violation|2|||
16110574|NCT02547441|38892836|FG001|Open-Label Study Period|Protocol Violation|0|||
16110575|NCT02547441|38892835|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
16110576|NCT02547441|38892836|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
16221925|NCT01066819|39294957|FG001|Overall Study|Treatment never started|19|||
16408555|NCT01286987|39977030|FG003|Part 2: Dose Expansion|Physician Decision|0|||
16408556|NCT01286987|39977031|FG004|Part 2: Dose Expansion|Physician Decision|0|||
16221926|NCT01066819|39294958|FG002|Overall Study|Treatment never started|19|||
16408557|NCT01286987|39977032|FG005|Part 2: Dose Expansion|Physician Decision|0|||
16408558|NCT01286987|39977033|FG006|Part 2: Dose Expansion|Physician Decision|0|||
16408559|NCT01286987|39977034|FG007|Part 2: Dose Expansion|Physician Decision|0|||
16408560|NCT01286987|39977035|FG008|Part 2: Dose Expansion|Physician Decision|0|||
16408561|NCT01286987|39977036|FG009|Part 2: Dose Expansion|Physician Decision|0|||
16408562|NCT01286987|39977037|FG010|Part 2: Dose Expansion|Physician Decision|1|||
16408563|NCT01286987|39977038|FG011|Part 2: Dose Expansion|Physician Decision|1|||
16408564|NCT01286987|39977039|FG012|Part 2: Dose Expansion|Physician Decision|0|||
16408565|NCT01286987|39977040|FG013|Part 2: Dose Expansion|Physician Decision|1|||
16408566|NCT01286987|39977041|FG014|Part 2: Dose Expansion|Physician Decision|0|||
16408567|NCT01286987|39977027|FG000|Part 2: Dose Expansion|Other|0|||
16408568|NCT01286987|39977028|FG001|Part 2: Dose Expansion|Other|0|||
16110577|NCT02547441|38892835|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
16110578|NCT02547441|38892836|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
16110579|NCT01407276|38892837|FG000|Overall Study|Withdrawal by Subject|0|||
16110580|NCT01407276|38892838|FG001|Overall Study|Withdrawal by Subject|0|||
16110581|NCT01407276|38892839|FG002|Overall Study|Withdrawal by Subject|0|||
16110582|NCT01407276|38892840|FG003|Overall Study|Withdrawal by Subject|0|||
16110583|NCT01407276|38892841|FG004|Overall Study|Withdrawal by Subject|0|||
16110584|NCT01407276|38892842|FG005|Overall Study|Withdrawal by Subject|0|||
16110585|NCT01407276|38892843|FG006|Overall Study|Withdrawal by Subject|0|||
16110586|NCT01407276|38892844|FG007|Overall Study|Withdrawal by Subject|1|||
16110587|NCT01649557|38892845|FG000|Overall Study|Lost to Follow-up|5|||
16110588|NCT01649557|38892846|FG001|Overall Study|Lost to Follow-up|0|||
16110589|NCT01649557|38892847|FG002|Overall Study|Lost to Follow-up|3|||
16408569|NCT01286987|39977029|FG002|Part 2: Dose Expansion|Other|0|||
16408570|NCT01286987|39977030|FG003|Part 2: Dose Expansion|Other|0|||
16408571|NCT01286987|39977031|FG004|Part 2: Dose Expansion|Other|0|||
16408572|NCT01286987|39977032|FG005|Part 2: Dose Expansion|Other|0|||
16408573|NCT01286987|39977033|FG006|Part 2: Dose Expansion|Other|0|||
16408574|NCT01286987|39977034|FG007|Part 2: Dose Expansion|Other|0|||
16408575|NCT01286987|39977035|FG008|Part 2: Dose Expansion|Other|0|||
16408576|NCT01286987|39977036|FG009|Part 2: Dose Expansion|Other|0|||
16408577|NCT01286987|39977037|FG010|Part 2: Dose Expansion|Other|0|||
16408578|NCT01286987|39977038|FG011|Part 2: Dose Expansion|Other|0|||
16408579|NCT01286987|39977039|FG012|Part 2: Dose Expansion|Other|0|||
16408580|NCT01286987|39977040|FG013|Part 2: Dose Expansion|Other|1|||
16408581|NCT01286987|39977041|FG014|Part 2: Dose Expansion|Other|0|||
16408582|NCT01286987|39977027|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
16408583|NCT01286987|39977028|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
16408584|NCT01286987|39977029|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
16408585|NCT01286987|39977030|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
16408586|NCT01286987|39977031|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
16408587|NCT01286987|39977032|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
16408588|NCT01286987|39977033|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
16408589|NCT01286987|39977034|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
16408590|NCT01286987|39977035|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
16408591|NCT01286987|39977036|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
16408592|NCT01286987|39977037|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
16408593|NCT01286987|39977038|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
16408594|NCT01286987|39977039|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
16408595|NCT01286987|39977040|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
16408596|NCT01286987|39977041|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
16408597|NCT01286987|39977027|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
16408598|NCT01286987|39977028|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
16408599|NCT01286987|39977029|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
16408600|NCT01286987|39977030|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
16110590|NCT01649557|38892845|FG000|Overall Study|Adverse Event|7|||
16110591|NCT01649557|38892846|FG001|Overall Study|Adverse Event|5|||
16110592|NCT01649557|38892847|FG002|Overall Study|Adverse Event|1|||
16221927|NCT01066819|39294959|FG003|Overall Study|Treatment never started|3|||
16344577|NCT02098395|39747636|FG000|Overall Study|Withdrawal by Subject|10|||
16344578|NCT02098395|39747637|FG001|Overall Study|Withdrawal by Subject|10|||
16344579|NCT02098395|39747638|FG002|Overall Study|Withdrawal by Subject|5|||
16344580|NCT02098395|39747639|FG003|Overall Study|Withdrawal by Subject|13|||
16344581|NCT02098395|39747636|FG000|Overall Study|Adverse Event|12|||
16344582|NCT02098395|39747637|FG001|Overall Study|Adverse Event|19|||
16344583|NCT02098395|39747638|FG002|Overall Study|Adverse Event|34|||
16344584|NCT02098395|39747639|FG003|Overall Study|Adverse Event|2|||
16344585|NCT02098395|39747636|FG000|Overall Study|Lost to Follow-up|2|||
16344586|NCT02098395|39747637|FG001|Overall Study|Lost to Follow-up|1|||
16344587|NCT02098395|39747638|FG002|Overall Study|Lost to Follow-up|0|||
16408601|NCT01286987|39977031|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
16408602|NCT01286987|39977032|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
16545545|NCT02002884|40460743|FG001|Main Period (MP)|Other|3|||
16344588|NCT02098395|39747639|FG003|Overall Study|Lost to Follow-up|3|||
16408603|NCT01286987|39977033|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
16408604|NCT01286987|39977034|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
16408605|NCT01286987|39977035|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
16408606|NCT01286987|39977036|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
16408607|NCT01286987|39977037|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
16408608|NCT01286987|39977038|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
16408609|NCT01286987|39977039|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
16408610|NCT01286987|39977040|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
16408611|NCT01286987|39977041|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
16408612|NCT01286987|39977027|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408613|NCT01286987|39977028|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16344589|NCT02098395|39747636|FG000|Overall Study|Unclassified|0|||
16344590|NCT02098395|39747637|FG001|Overall Study|Unclassified|0|||
16344591|NCT02098395|39747638|FG002|Overall Study|Unclassified|3|||
16344592|NCT02098395|39747639|FG003|Overall Study|Unclassified|2|||
16344593|NCT00878800|39747640|FG000|Overall Study|Adverse Event|0|||
16344594|NCT00878800|39747641|FG001|Overall Study|Adverse Event|0|||
16344595|NCT00878800|39747642|FG002|Overall Study|Adverse Event|2|||
16344596|NCT00878800|39747643|FG003|Overall Study|Adverse Event|0|||
16344597|NCT00878800|39747644|FG004|Overall Study|Adverse Event|1|||
16344598|NCT00878800|39747640|FG000|Overall Study|Progressive disease|1|||
16344599|NCT00878800|39747641|FG001|Overall Study|Progressive disease|5|||
16344600|NCT00878800|39747642|FG002|Overall Study|Progressive disease|6|||
16344601|NCT00878800|39747643|FG003|Overall Study|Progressive disease|5|||
16344602|NCT00878800|39747644|FG004|Overall Study|Progressive disease|13|||
16344603|NCT00878800|39747640|FG000|Overall Study|Withdrew consent|1|||
16344604|NCT00878800|39747641|FG001|Overall Study|Withdrew consent|1|||
16344605|NCT00878800|39747642|FG002|Overall Study|Withdrew consent|0|||
16344606|NCT00878800|39747643|FG003|Overall Study|Withdrew consent|1|||
16344607|NCT00878800|39747644|FG004|Overall Study|Withdrew consent|1|||
16344608|NCT00878800|39747640|FG000|Overall Study|Death|0|||
16344609|NCT00878800|39747641|FG001|Overall Study|Death|0|||
16344610|NCT00878800|39747642|FG002|Overall Study|Death|1|||
16344611|NCT00878800|39747643|FG003|Overall Study|Death|0|||
16344612|NCT00878800|39747644|FG004|Overall Study|Death|0|||
16344613|NCT00878800|39747640|FG000|Overall Study|Other|1|||
16344614|NCT00878800|39747641|FG001|Overall Study|Other|1|||
16344615|NCT00878800|39747642|FG002|Overall Study|Other|0|||
16344616|NCT00878800|39747643|FG003|Overall Study|Other|0|||
16344617|NCT00878800|39747644|FG004|Overall Study|Other|1|||
16344618|NCT00809094|39747645|FG000|Overall Study|Lost to Follow-up|0|||
16344619|NCT00809094|39747646|FG001|Overall Study|Lost to Follow-up|1|||
16344620|NCT05176717|39747647|FG000|Overall Study|Sponsor Decision|1|||
16408614|NCT01286987|39977029|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16344621|NCT05176717|39747648|FG001|Overall Study|Sponsor Decision|2|||
16344622|NCT05176717|39747649|FG002|Overall Study|Sponsor Decision|2|||
16344623|NCT03311841|39747650|FG000|14-day Wash-out|Adverse Event|0|||
16344624|NCT03311841|39747651|FG001|14-day Wash-out|Adverse Event|1|||
16344625|NCT03311841|39747652|FG002|14-day Wash-out|Adverse Event|0|||
16344626|NCT03311841|39747653|FG003|14-day Wash-out|Adverse Event|0|||
16344627|NCT03311841|39747654|FG004|14-day Wash-out|Adverse Event|0|||
16344628|NCT03311841|39747650|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
16344629|NCT03311841|39747651|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
16344630|NCT03311841|39747652|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
16344631|NCT03311841|39747653|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
16344632|NCT03311841|39747654|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
16344633|NCT03630705|39747655|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
16110593|NCT01649557|38892845|FG000|Overall Study|Met withdrawal criteria|4|||
16344634|NCT03630705|39747656|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
16344635|NCT03630705|39747657|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
16344636|NCT03630705|39747658|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
16344637|NCT03630705|39747655|FG000|Overall Study|Lost to Follow-up|1|||
16344638|NCT03630705|39747656|FG001|Overall Study|Lost to Follow-up|2|||
16344639|NCT03630705|39747657|FG002|Overall Study|Lost to Follow-up|0|||
16344640|NCT03630705|39747658|FG003|Overall Study|Lost to Follow-up|0|||
16344641|NCT00992017|39747661|FG000|Overall Study|Lost to Follow-up|2|||
16344642|NCT00992017|39747661|FG000|Overall Study|Withdrawal by Subject|2|||
16344643|NCT00992017|39747661|FG000|Overall Study|Unable to get to clinic|5|||
16344644|NCT00992017|39747661|FG000|Overall Study|Not adhere to study requirements|1|||
16344645|NCT03061188|39747663|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
16344646|NCT03061188|39747664|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
16344647|NCT03061188|39747665|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
16344648|NCT03061188|39747666|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
16344649|NCT03061188|39747663|FG000|On Follow-up for 3 Years|Death|0|||
16344650|NCT03061188|39747664|FG001|On Follow-up for 3 Years|Death|3|||
16110594|NCT01649557|38892846|FG001|Overall Study|Met withdrawal criteria|0|||
16110595|NCT01649557|38892847|FG002|Overall Study|Met withdrawal criteria|0|||
16110596|NCT01649557|38892845|FG000|Overall Study|Physician Decision|8|||
16110597|NCT01649557|38892846|FG001|Overall Study|Physician Decision|2|||
16344651|NCT03061188|39747665|FG002|On Follow-up for 3 Years|Death|5|||
16344652|NCT03061188|39747666|FG003|On Follow-up for 3 Years|Death|4|||
16344653|NCT03061188|39747663|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
16344654|NCT03061188|39747664|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
16344655|NCT03061188|39747665|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
16110598|NCT01649557|38892847|FG002|Overall Study|Physician Decision|1|||
16110599|NCT01649557|38892845|FG000|Overall Study|Withdrawal by Subject|15|||
16221928|NCT01066819|39294960|FG004|Overall Study|Treatment never started|2|||
16110600|NCT01649557|38892846|FG001|Overall Study|Withdrawal by Subject|5|||
16110601|NCT01649557|38892847|FG002|Overall Study|Withdrawal by Subject|4|||
16110602|NCT01649557|38892845|FG000|Overall Study|Protocol deviation|0|||
16110603|NCT01649557|38892846|FG001|Overall Study|Protocol deviation|2|||
16110604|NCT01649557|38892847|FG002|Overall Study|Protocol deviation|0|||
16408615|NCT01286987|39977030|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408616|NCT01286987|39977031|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408617|NCT01286987|39977032|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16110605|NCT01649557|38892845|FG000|Overall Study|Lack of Efficacy|5|||
16344656|NCT03061188|39747666|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
16344657|NCT01093586|39747667|FG000|Overall Study|Failed to engraft|3|||
16344658|NCT01968811|39747670|FG000|Overall Study|Protocol Violation|4|||
16344659|NCT01968811|39747670|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
16344660|NCT00613366|39747672|FG000|Overall Study|Withdrawal by Subject|3|||
16344661|NCT00613366|39747673|FG001|Overall Study|Withdrawal by Subject|2|||
16344662|NCT02609386|39747674|FG000|Overall Study|Withdrawal by Subject|6|||
16221929|NCT01066819|39294961|FG005|Overall Study|Treatment never started|2|||
16221930|NCT01066819|39294956|FG000|Overall Study|Treatment stopped|12|||
16344663|NCT02609386|39747675|FG001|Overall Study|Withdrawal by Subject|1|||
16344664|NCT02609386|39747674|FG000|Overall Study|Lost to Follow-up|3|||
16344665|NCT02609386|39747675|FG001|Overall Study|Lost to Follow-up|5|||
16221931|NCT01066819|39294957|FG001|Overall Study|Treatment stopped|1|||
16344666|NCT02609386|39747674|FG000|Overall Study|Death|19|||
16344667|NCT02609386|39747675|FG001|Overall Study|Death|9|||
16344668|NCT02609386|39747674|FG000|Overall Study|Physician Decision|0|||
16408618|NCT01286987|39977033|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408619|NCT01286987|39977034|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408620|NCT01286987|39977035|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408621|NCT01286987|39977036|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408622|NCT01286987|39977037|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
16408623|NCT01286987|39977038|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408624|NCT01286987|39977039|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408625|NCT01286987|39977040|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408626|NCT01286987|39977041|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
16408627|NCT00853125|39977044|FG000|Overall Study|Study participant's donor was CMV +|1|||
16408628|NCT02725593|39977047|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
16408629|NCT02725593|39977048|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
16408630|NCT02725593|39977047|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
16110606|NCT01649557|38892846|FG001|Overall Study|Lack of Efficacy|0|||
16110607|NCT01649557|38892847|FG002|Overall Study|Lack of Efficacy|0|||
16110608|NCT02402322|38892848|FG000|Pretreatment|Withdrawal by Subject|3|||
16110609|NCT02402322|38892849|FG001|Pretreatment|Withdrawal by Subject|1|||
16110610|NCT02402322|38892850|FG002|Pretreatment|Withdrawal by Subject|1|||
16110611|NCT02402322|38892848|FG000|Follow-up|Withdrawal by Subject|6|||
16110612|NCT02402322|38892849|FG001|Follow-up|Withdrawal by Subject|3|||
16110613|NCT02402322|38892850|FG002|Follow-up|Withdrawal by Subject|24|||
16545546|NCT02002884|40460744|FG002|Main Period (MP)|Other|3|||
16545547|NCT02002884|40460745|FG003|Main Period (MP)|Other|0|||
16110614|NCT01657799|38892851|FG000|Overall Study|Adverse Event Related to progression|6|||
16110615|NCT01657799|38892852|FG001|Overall Study|Adverse Event Related to progression|8|||
16110616|NCT01657799|38892853|FG002|Overall Study|Adverse Event Related to progression|12|||
16110617|NCT01657799|38892851|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
16110618|NCT01657799|38892852|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
16110619|NCT01657799|38892853|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
16110620|NCT01657799|38892851|FG000|Overall Study|Withdrawal by Subject|13|||
16110621|NCT01657799|38892852|FG001|Overall Study|Withdrawal by Subject|10|||
16110622|NCT01657799|38892853|FG002|Overall Study|Withdrawal by Subject|10|||
16110623|NCT01657799|38892851|FG000|Overall Study|Lost to Follow-up|1|||
16110624|NCT01657799|38892852|FG001|Overall Study|Lost to Follow-up|0|||
16110625|NCT01657799|38892853|FG002|Overall Study|Lost to Follow-up|1|||
16110626|NCT01657799|38892851|FG000|Overall Study|Disease Progression|2|||
16110627|NCT01657799|38892852|FG001|Overall Study|Disease Progression|4|||
16110628|NCT01657799|38892853|FG002|Overall Study|Disease Progression|4|||
16110629|NCT01657799|38892851|FG000|Overall Study|Progressive Disease Clinical|7|||
16110630|NCT01657799|38892852|FG001|Overall Study|Progressive Disease Clinical|4|||
16110631|NCT01657799|38892853|FG002|Overall Study|Progressive Disease Clinical|7|||
16110632|NCT01657799|38892851|FG000|Overall Study|Radiographic & Clinical Progression|16|||
16110633|NCT01657799|38892852|FG001|Overall Study|Radiographic & Clinical Progression|11|||
16110634|NCT01657799|38892853|FG002|Overall Study|Radiographic & Clinical Progression|15|||
16110635|NCT01657799|38892851|FG000|Overall Study|Other|52|||
16110636|NCT01657799|38892852|FG001|Overall Study|Other|62|||
16110637|NCT01657799|38892853|FG002|Overall Study|Other|49|||
16110638|NCT01930214|38892854|FG000|Overall Study|Death|4|||
16110639|NCT01930214|38892855|FG001|Overall Study|Death|4|||
16110640|NCT01930214|38892856|FG002|Overall Study|Death|11|||
16110641|NCT01930214|38892854|FG000|Overall Study|Lost to Follow-up|12|||
16110642|NCT01930214|38892855|FG001|Overall Study|Lost to Follow-up|13|||
16110643|NCT01930214|38892856|FG002|Overall Study|Lost to Follow-up|12|||
16110644|NCT01930214|38892854|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
16110645|NCT01930214|38892855|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
16110646|NCT01930214|38892856|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
16110647|NCT01930214|38892854|FG000|Overall Study|Physician Decision|2|||
16110648|NCT01930214|38892855|FG001|Overall Study|Physician Decision|0|||
16110649|NCT01930214|38892856|FG002|Overall Study|Physician Decision|0|||
16110650|NCT00723125|38892857|FG000|Overall Study|Met Dx|1|||
16110651|NCT00723125|38892858|FG001|Overall Study|Met Dx|0|||
16110652|NCT00723125|38892857|FG000|Overall Study|Withdrawal by Subject|15|||
16110653|NCT00723125|38892858|FG001|Overall Study|Withdrawal by Subject|6|||
16110654|NCT00723125|38892857|FG000|Overall Study|Adverse Event|2|||
16110655|NCT00723125|38892858|FG001|Overall Study|Adverse Event|0|||
16110656|NCT01776008|38892866|FG000|Overall Study|ineligible|2|||
16110657|NCT02577003|38892867|FG000|Overall Study|Adverse Event|2|||
16110658|NCT02577003|38892868|FG001|Overall Study|Adverse Event|4|||
16110659|NCT02577003|38892867|FG000|Overall Study|Withdrawal by Subject|0|||
16110660|NCT02577003|38892868|FG001|Overall Study|Withdrawal by Subject|1|||
16221932|NCT01066819|39294958|FG002|Overall Study|Treatment stopped|2|||
16221933|NCT01066819|39294959|FG003|Overall Study|Treatment stopped|1|||
16221934|NCT01066819|39294960|FG004|Overall Study|Treatment stopped|0|||
16221935|NCT01066819|39294961|FG005|Overall Study|Treatment stopped|0|||
16221936|NCT01066819|39294956|FG000|Overall Study|Other|5|||
16221937|NCT01066819|39294957|FG001|Overall Study|Other|1|||
16221938|NCT01066819|39294958|FG002|Overall Study|Other|1|||
16110661|NCT01722045|38892869|FG000|Overall Study|Adverse Event|8|||
16110662|NCT01722045|38892869|FG000|Overall Study|Death|3|||
16110663|NCT01722045|38892869|FG000|Overall Study|Withdrawal by Subject|8|||
16110664|NCT01722045|38892869|FG000|Overall Study|Lost to Follow-up|4|||
16110665|NCT01722045|38892869|FG000|Overall Study|Protocol Deviation|1|||
16110666|NCT01722045|38892869|FG000|Overall Study|Physician Decision|3|||
16110667|NCT01722045|38892869|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
16110668|NCT03325777|38892873|FG000|Overall Study|Lost to Follow-up|9|||
16110669|NCT03325777|38892874|FG001|Overall Study|Lost to Follow-up|12|||
16110670|NCT03596242|38892875|FG000|Overall Study|Lost to Follow-up|2|||
16110671|NCT03596242|38892876|FG001|Overall Study|Lost to Follow-up|2|||
16110672|NCT03616964|38892877|FG000|Overall Study|Adverse Event|15|||
16221939|NCT01066819|39294959|FG003|Overall Study|Other|0|||
16221940|NCT01066819|39294960|FG004|Overall Study|Other|0|||
16221941|NCT01066819|39294961|FG005|Overall Study|Other|0|||
16221942|NCT00972309|39294962|FG000|Overall Study|Switched to alternative treatment|0|||
16221943|NCT00972309|39294963|FG001|Overall Study|Switched to alternative treatment|2|||
16221944|NCT00972309|39294962|FG000|Overall Study|Refused further treatment|0|||
16221945|NCT00972309|39294963|FG001|Overall Study|Refused further treatment|1|||
16221946|NCT00972309|39294962|FG000|Overall Study|Late determination of ineligibility|0|||
16221947|NCT00972309|39294963|FG001|Overall Study|Late determination of ineligibility|1|||
16221948|NCT00972309|39294962|FG000|Overall Study|Second malignancy|1|||
16221949|NCT00972309|39294963|FG001|Overall Study|Second malignancy|1|||
16221950|NCT00972309|39294962|FG000|Overall Study|Visa issues|0|||
16221951|NCT00972309|39294963|FG001|Overall Study|Visa issues|1|||
16408631|NCT02725593|39977048|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
16408632|NCT02725593|39977047|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
16110673|NCT03616964|38892878|FG001|Overall Study|Adverse Event|10|||
16221952|NCT00972309|39294962|FG000|Overall Study|Secondary cancer (SCC)|0|||
16221953|NCT00972309|39294963|FG001|Overall Study|Secondary cancer (SCC)|1|||
16110674|NCT03616964|38892879|FG002|Overall Study|Adverse Event|16|||
16110675|NCT03616964|38892877|FG000|Overall Study|Death|3|||
16110676|NCT03616964|38892878|FG001|Overall Study|Death|0|||
16110677|NCT03616964|38892879|FG002|Overall Study|Death|4|||
16110678|NCT03616964|38892877|FG000|Overall Study|Lack of Efficacy|4|||
16110679|NCT03616964|38892878|FG001|Overall Study|Lack of Efficacy|8|||
16110680|NCT03616964|38892879|FG002|Overall Study|Lack of Efficacy|8|||
16110681|NCT03616964|38892877|FG000|Overall Study|Lost to Follow-up|2|||
16110682|NCT03616964|38892878|FG001|Overall Study|Lost to Follow-up|1|||
16110683|NCT03616964|38892879|FG002|Overall Study|Lost to Follow-up|3|||
16110684|NCT03616964|38892877|FG000|Overall Study|Withdrawal by Subject|18|||
16110685|NCT03616964|38892878|FG001|Overall Study|Withdrawal by Subject|14|||
16110686|NCT03616964|38892879|FG002|Overall Study|Withdrawal by Subject|21|||
16110687|NCT03616964|38892877|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
16110688|NCT03616964|38892878|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
16110689|NCT03616964|38892879|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
16110690|NCT03616964|38892877|FG000|Overall Study|Sponsor's Decision|1|||
16110691|NCT03616964|38892878|FG001|Overall Study|Sponsor's Decision|0|||
16110692|NCT03616964|38892879|FG002|Overall Study|Sponsor's Decision|0|||
16110693|NCT03616964|38892877|FG000|Overall Study|Physician Decision|0|||
16110694|NCT03616964|38892878|FG001|Overall Study|Physician Decision|2|||
16110695|NCT03616964|38892879|FG002|Overall Study|Physician Decision|0|||
16110696|NCT03616964|38892877|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
16110697|NCT03616964|38892878|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
16110698|NCT03616964|38892879|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
16110699|NCT03616964|38892877|FG000|Overall Study|Protocol Violation|0|||
16110700|NCT03616964|38892878|FG001|Overall Study|Protocol Violation|1|||
16110701|NCT03616964|38892879|FG002|Overall Study|Protocol Violation|0|||
16110702|NCT03616964|38892877|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
16110703|NCT03616964|38892878|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
16110704|NCT03616964|38892879|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
16110705|NCT03616964|38892877|FG000|Overall Study|Randomized but Never Treated|1|||
16110706|NCT03616964|38892878|FG001|Overall Study|Randomized but Never Treated|1|||
16110707|NCT03616964|38892879|FG002|Overall Study|Randomized but Never Treated|1|||
16110708|NCT00905034|38892880|FG000|Overall Study|Withdrawal by Subject|1|||
16110709|NCT01458522|38892882|FG000|Overall Study|Withdrawal by Subject|2|||
16110710|NCT01458522|38892883|FG001|Overall Study|Withdrawal by Subject|2|||
16110711|NCT01458522|38892882|FG000|Overall Study|Physician Decision|1|||
16221954|NCT00972309|39294962|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
16221955|NCT00972309|39294963|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
16408633|NCT02725593|39977048|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
16408634|NCT02725593|39977047|FG000|Long Term Extension|Withdrawal by Subject|1|||
16408635|NCT02725593|39977048|FG001|Long Term Extension|Withdrawal by Subject|3|||
16408636|NCT00846040|39977049|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
16408637|NCT00846040|39977050|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
16408638|NCT00846040|39977051|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
16408639|NCT00846040|39977049|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
16408640|NCT00846040|39977050|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
16545548|NCT02002884|40460742|FG000|Main Period (MP)|Adverse Event|0|||
16545549|NCT02002884|40460743|FG001|Main Period (MP)|Adverse Event|1|||
16545550|NCT02002884|40460744|FG002|Main Period (MP)|Adverse Event|1|||
16545551|NCT02002884|40460745|FG003|Main Period (MP)|Adverse Event|0|||
16545552|NCT02002884|40460742|FG000|Main Period (MP)|Withdrawal by Subject|6|||
16545553|NCT02002884|40460743|FG001|Main Period (MP)|Withdrawal by Subject|2|||
16545554|NCT02002884|40460744|FG002|Main Period (MP)|Withdrawal by Subject|2|||
16545555|NCT02002884|40460745|FG003|Main Period (MP)|Withdrawal by Subject|0|||
16545556|NCT02002884|40460742|FG000|Main Period (MP)|Lost to Follow-up|0|||
16545557|NCT02002884|40460743|FG001|Main Period (MP)|Lost to Follow-up|0|||
16545558|NCT02002884|40460744|FG002|Main Period (MP)|Lost to Follow-up|2|||
16545559|NCT02002884|40460745|FG003|Main Period (MP)|Lost to Follow-up|0|||
16545560|NCT02002884|40460742|FG000|Open-Label Extension Period (OLEX)|Other|0|||
16545561|NCT02002884|40460743|FG001|Open-Label Extension Period (OLEX)|Other|0|||
16545562|NCT02002884|40460744|FG002|Open-Label Extension Period (OLEX)|Other|0|||
16545563|NCT02002884|40460745|FG003|Open-Label Extension Period (OLEX)|Other|24|||
16545564|NCT02002884|40460742|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
16545565|NCT02002884|40460743|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
16545566|NCT02002884|40460744|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
16408641|NCT00846040|39977051|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
16408642|NCT01605227|39977053|FG000|Overall Study|Did not receive study treatment|2|||
16408643|NCT01605227|39977054|FG001|Overall Study|Did not receive study treatment|3|||
16408644|NCT01605227|39977053|FG000|Overall Study|Adverse Event|228|||
16408645|NCT01605227|39977054|FG001|Overall Study|Adverse Event|42|||
16408646|NCT01605227|39977053|FG000|Overall Study|Progressive Disease|132|||
16408647|NCT01605227|39977054|FG001|Overall Study|Progressive Disease|128|||
16408648|NCT01605227|39977053|FG000|Overall Study|Clinical Deterioration|227|||
16408649|NCT01605227|39977054|FG001|Overall Study|Clinical Deterioration|133|||
16408650|NCT01605227|39977053|FG000|Overall Study|Lost to Follow-up|1|||
16408651|NCT01605227|39977054|FG001|Overall Study|Lost to Follow-up|0|||
16408652|NCT01605227|39977053|FG000|Overall Study|Protocol Violation|1|||
16408653|NCT01605227|39977054|FG001|Overall Study|Protocol Violation|0|||
16408654|NCT01605227|39977053|FG000|Overall Study|Physician Decision|9|||
16408655|NCT01605227|39977054|FG001|Overall Study|Physician Decision|7|||
16408656|NCT01605227|39977053|FG000|Overall Study|Withdrawal by Subject|18|||
16408657|NCT01605227|39977054|FG001|Overall Study|Withdrawal by Subject|14|||
16408658|NCT01605227|39977053|FG000|Overall Study|Sponsor Decision|2|||
16408659|NCT01605227|39977054|FG001|Overall Study|Sponsor Decision|0|||
16408660|NCT01605227|39977053|FG000|Overall Study|Started New Therapy|1|||
16408661|NCT01605227|39977054|FG001|Overall Study|Started New Therapy|0|||
16408662|NCT01605227|39977053|FG000|Overall Study|Subject Decision|0|||
16408663|NCT01605227|39977054|FG001|Overall Study|Subject Decision|1|||
16408664|NCT01605227|39977053|FG000|Overall Study|Dose Held >6 weeks|0|||
16545567|NCT02002884|40460745|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
16545568|NCT02002884|40460742|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
16545569|NCT02002884|40460743|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
16545570|NCT02002884|40460744|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
16408665|NCT01605227|39977054|FG001|Overall Study|Dose Held >6 weeks|1|||
16408666|NCT00782171|39977055|FG000|Overall Study|Lost to Follow-up|2|||
16408667|NCT00782171|39977056|FG001|Overall Study|Lost to Follow-up|2|||
16408668|NCT00782171|39977055|FG000|Overall Study|Withdrawal by Subject|2|||
16408669|NCT00782171|39977056|FG001|Overall Study|Withdrawal by Subject|1|||
16344669|NCT02609386|39747675|FG001|Overall Study|Physician Decision|2|||
16344670|NCT02144077|39747678|FG000|Overall Study|Withdrawal by Subject|3|||
16344671|NCT02144077|39747679|FG001|Overall Study|Withdrawal by Subject|3|||
16344672|NCT02144077|39747678|FG000|Overall Study|Adverse Event|2|||
16344673|NCT02144077|39747679|FG001|Overall Study|Adverse Event|3|||
16344674|NCT02144077|39747678|FG000|Overall Study|Lost to Follow-up|2|||
16344675|NCT02144077|39747679|FG001|Overall Study|Lost to Follow-up|2|||
16344676|NCT02144077|39747678|FG000|Overall Study|Protocol Violation|1|||
16344677|NCT02144077|39747679|FG001|Overall Study|Protocol Violation|2|||
16344678|NCT02144077|39747678|FG000|Overall Study|Death|0|||
16344679|NCT02144077|39747679|FG001|Overall Study|Death|1|||
16344680|NCT02144077|39747678|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
16344681|NCT02144077|39747679|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
16344682|NCT03563716|39747680|FG000|Overall Study|Death|20|||
16344683|NCT03563716|39747681|FG001|Overall Study|Death|14|||
16344684|NCT03563716|39747680|FG000|Overall Study|Withdrawal by Subject|3|||
16344685|NCT03563716|39747681|FG001|Overall Study|Withdrawal by Subject|3|||
16344686|NCT03563716|39747680|FG000|Overall Study|Still on Study|45|||
16344687|NCT03563716|39747681|FG001|Overall Study|Still on Study|50|||
16344688|NCT01939223|39747682|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
16344689|NCT01939223|39747683|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
16344690|NCT01939223|39747682|FG000|Overall Study|Disease recurrence (radiological)|1|||
16344691|NCT01939223|39747683|FG001|Overall Study|Disease recurrence (radiological)|3|||
16344692|NCT01939223|39747682|FG000|Overall Study|Study stopped by Sponsor|5|||
16344693|NCT01939223|39747683|FG001|Overall Study|Study stopped by Sponsor|7|||
16344694|NCT01939223|39747682|FG000|Overall Study|Withdrawal by Subject|6|||
16344695|NCT01939223|39747683|FG001|Overall Study|Withdrawal by Subject|0|||
16344696|NCT00792909|39747697|FG000|Overall Study|Withdrawal by Subject|0|||
16344697|NCT00792909|39747698|FG001|Overall Study|Withdrawal by Subject|1|||
16344698|NCT00792909|39747699|FG002|Overall Study|Withdrawal by Subject|0|||
16344699|NCT03252145|39747700|FG000|Overall Study|Withdrawal by Subject|1|||
16344700|NCT03252145|39747701|FG001|Overall Study|Withdrawal by Subject|0|||
16344701|NCT03252145|39747700|FG000|Overall Study|Complicating Disease|1|||
16344702|NCT03252145|39747701|FG001|Overall Study|Complicating Disease|2|||
16344703|NCT01135524|39747703|FG000|Overall Study|Withdrawal by Subject|14|||
16344704|NCT01135524|39747703|FG000|Overall Study|Adverse Event|20|||
16344705|NCT01135524|39747703|FG000|Overall Study|Lost to Follow-up|3|||
16344706|NCT01135524|39747703|FG000|Overall Study|Administrative|151|||
16344707|NCT01135524|39747703|FG000|Overall Study|Lack of Efficacy|8|||
16344708|NCT01601496|39747705|FG000|Overall Study|Physician Decision|1|||
16344709|NCT01601496|39747705|FG000|Overall Study|Withdrawal by Subject|1|||
16344710|NCT01601496|39747705|FG000|Overall Study|Lost to Follow-up|6|||
16344711|NCT01601496|39747705|FG000|Overall Study|Death|4|||
16344712|NCT01601496|39747705|FG000|Overall Study|Other: patient refusal to continue|3|||
16344713|NCT03293394|39747715|FG000|Follow-up (6 Months)|Adverse Event|4|||
16344714|NCT03293394|39747716|FG001|Follow-up (6 Months)|Adverse Event|2|||
16344715|NCT03052920|39747717|FG000|Overall Study|Withdrawal by Subject|1|||
16221956|NCT00972309|39294962|FG000|Overall Study|Lost to Follow-up|1|||
16344716|NCT02169505|39747727|FG000|Overall Study|Withdrawal by Subject|1|||
16344717|NCT03253744|39747728|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
16344718|NCT03253744|39747729|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
16344719|NCT03253744|39747730|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
16344720|NCT03253744|39747731|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
16344721|NCT02164318|39747734|FG000|Overall Study|Withdrawal by Subject|0|||
16344722|NCT02164318|39747735|FG001|Overall Study|Withdrawal by Subject|1|||
16344723|NCT02164318|39747736|FG002|Overall Study|Withdrawal by Subject|0|||
16344724|NCT02164318|39747737|FG003|Overall Study|Withdrawal by Subject|1|||
16344725|NCT03117361|39747738|FG000|Overall Study|Progressive disease|5|||
16344726|NCT03117361|39747738|FG000|Overall Study|Death|1|||
16221957|NCT00972309|39294963|FG001|Overall Study|Lost to Follow-up|1|||
16110712|NCT01458522|38892883|FG001|Overall Study|Physician Decision|9|||
16110713|NCT01482429|38892884|FG000|Care Usual|Protocol Violation|0|||
16344727|NCT03117361|39747738|FG000|Overall Study|Physician Decision|2|||
16344728|NCT03117361|39747738|FG000|Overall Study|On study treatment at the end of study|1|||
16110714|NCT01482429|38892885|FG001|Care Usual|Protocol Violation|172|||
16344729|NCT03117361|39747738|FG000|Overall Study|Treatment-related adverse event|1|||
16110715|NCT01482429|38892884|FG000|Care Usual|Lost to Follow-up|0|||
16110716|NCT01482429|38892885|FG001|Care Usual|Lost to Follow-up|1|||
16110717|NCT01482429|38892884|FG000|Protocol|Protocol Violation|275|||
16110718|NCT01482429|38892885|FG001|Protocol|Protocol Violation|0|||
16110719|NCT01948076|38892888|FG000|Overall Study|Withdrawal by Subject|0|||
16110720|NCT01948076|38892889|FG001|Overall Study|Withdrawal by Subject|1|||
16110721|NCT04593823|38892895|FG000|Overall Study|Withdrawal by Subject|1|||
16110722|NCT04593823|38892896|FG001|Overall Study|Withdrawal by Subject|1|||
16110723|NCT04593823|38892895|FG000|Overall Study|Lost to Follow-up|0|||
16110724|NCT04593823|38892896|FG001|Overall Study|Lost to Follow-up|1|||
16110725|NCT01185171|38892897|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
16110726|NCT01185171|38892897|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
16110727|NCT01185171|38892897|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
16110728|NCT01185171|38892897|FG000|Maintenance|Elevated liver transaminases|3|||
16110729|NCT01185171|38892897|FG000|Maintenance|Rush|2|||
16110730|NCT01185171|38892897|FG000|Maintenance|Diarrhea|1|||
16408670|NCT00782171|39977055|FG000|Overall Study|complications|3|||
16408671|NCT00782171|39977056|FG001|Overall Study|complications|1|||
16408672|NCT00782171|39977055|FG000|Overall Study|others|7|||
16408673|NCT00782171|39977056|FG001|Overall Study|others|9|||
16408674|NCT00782171|39977055|FG000|Overall Study|not eligible|8|||
16408675|NCT00782171|39977056|FG001|Overall Study|not eligible|6|||
16408676|NCT00680368|39977057|FG000|Overall Study|not supervised, not eligible|15|||
16408677|NCT00642369|39977058|FG000|Overall Study|Adverse Event|2|||
16408678|NCT00642369|39977059|FG001|Overall Study|Adverse Event|3|||
16408679|NCT00642369|39977058|FG000|Overall Study|Withdrawal by Subject|1|||
16408680|NCT00642369|39977059|FG001|Overall Study|Withdrawal by Subject|0|||
16408681|NCT00642369|39977058|FG000|Overall Study|misdiagnosis|0|||
16408682|NCT00642369|39977059|FG001|Overall Study|misdiagnosis|1|||
16408683|NCT00642369|39977058|FG000|Overall Study|Lack of Efficacy|2|||
16408684|NCT00642369|39977059|FG001|Overall Study|Lack of Efficacy|2|||
16408685|NCT01009346|39977062|FG000|Overall Study|Adverse Event|4|||
16408686|NCT00197145|39977068|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
16408687|NCT00197145|39977069|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
16408688|NCT00197145|39977068|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
16408689|NCT00197145|39977069|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
16408690|NCT00197145|39977068|FG000|Period 1: Randomized Treatment Phase|Other|2|||
16408691|NCT00197145|39977069|FG001|Period 1: Randomized Treatment Phase|Other|2|||
16408692|NCT00197145|39977068|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
16110731|NCT01185171|38892897|FG000|Maintenance|Xerostomia|1|||
16110732|NCT01185171|38892897|FG000|Maintenance|Nausea|1|||
16110733|NCT01185171|38892897|FG000|Maintenance|Comorbid Illness|2|||
16110734|NCT01185171|38892897|FG000|Maintenance|Withdrawal by Subject|1|||
16408693|NCT00197145|39977069|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
16408694|NCT00197145|39977068|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
16110735|NCT01185171|38892897|FG000|Maintenance|Disease Recurrence|1|||
16110736|NCT03418493|38892898|FG000|Overall Study|Adverse Event|1|||
16110737|NCT03418493|38892899|FG001|Overall Study|Adverse Event|0|||
16110738|NCT03418493|38892900|FG002|Overall Study|Adverse Event|0|||
16110739|NCT03418493|38892901|FG003|Overall Study|Adverse Event|0|||
16110740|NCT03418493|38892902|FG004|Overall Study|Adverse Event|0|||
16110741|NCT03418493|38892903|FG005|Overall Study|Adverse Event|0|||
16110742|NCT03418493|38892904|FG006|Overall Study|Adverse Event|0|||
16110743|NCT03418493|38892905|FG007|Overall Study|Adverse Event|0|||
16110744|NCT03418493|38892906|FG008|Overall Study|Adverse Event|0|||
16110745|NCT03418493|38892907|FG009|Overall Study|Adverse Event|0|||
16110746|NCT03418493|38892908|FG010|Overall Study|Adverse Event|0|||
16110747|NCT03418493|38892898|FG000|Overall Study|Protocol Violation|0|||
16110748|NCT03418493|38892899|FG001|Overall Study|Protocol Violation|0|||
16110749|NCT03418493|38892900|FG002|Overall Study|Protocol Violation|0|||
16110750|NCT03418493|38892901|FG003|Overall Study|Protocol Violation|0|||
16110751|NCT03418493|38892902|FG004|Overall Study|Protocol Violation|0|||
16110752|NCT03418493|38892903|FG005|Overall Study|Protocol Violation|0|||
16110753|NCT03418493|38892904|FG006|Overall Study|Protocol Violation|0|||
16110754|NCT03418493|38892905|FG007|Overall Study|Protocol Violation|0|||
16110755|NCT03418493|38892906|FG008|Overall Study|Protocol Violation|0|||
16110756|NCT03418493|38892907|FG009|Overall Study|Protocol Violation|1|||
16110757|NCT03418493|38892908|FG010|Overall Study|Protocol Violation|0|||
16110758|NCT00356759|38892922|FG000|Overall Study|Death|5|||
16110759|NCT00356759|38892923|FG001|Overall Study|Death|2|||
16110760|NCT00356759|38892922|FG000|Overall Study|Withdrawal by Subject|2|||
16110761|NCT00356759|38892923|FG001|Overall Study|Withdrawal by Subject|2|||
16110762|NCT00356759|38892922|FG000|Overall Study|Adverse Event|1|||
16110763|NCT00356759|38892923|FG001|Overall Study|Adverse Event|3|||
16110764|NCT00356759|38892922|FG000|Overall Study|Lost to Follow-up|1|||
16110765|NCT00356759|38892923|FG001|Overall Study|Lost to Follow-up|1|||
16110766|NCT00356759|38892922|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
16110767|NCT00356759|38892923|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
16110768|NCT01438840|38892924|FG000|Core Study|Adverse Event|0|||
16110769|NCT01438840|38892925|FG001|Core Study|Adverse Event|3|||
16110770|NCT01438840|38892926|FG002|Core Study|Adverse Event|0|||
16110771|NCT01438840|38892924|FG000|Core Study|Lack of Efficacy|15|||
16110772|NCT01438840|38892925|FG001|Core Study|Lack of Efficacy|7|||
16110773|NCT01438840|38892926|FG002|Core Study|Lack of Efficacy|0|||
16110774|NCT01438840|38892924|FG000|Core Study|Withdrawal of consent|1|||
16110775|NCT01438840|38892925|FG001|Core Study|Withdrawal of consent|0|||
16110776|NCT01438840|38892926|FG002|Core Study|Withdrawal of consent|0|||
16110777|NCT01438840|38892924|FG000|Extension Phase|Adverse Event|0|||
16110778|NCT01438840|38892925|FG001|Extension Phase|Adverse Event|0|||
16110779|NCT01438840|38892926|FG002|Extension Phase|Adverse Event|3|||
16110780|NCT01438840|38892924|FG000|Extension Phase|Lost to Follow-up|0|||
16110781|NCT01438840|38892925|FG001|Extension Phase|Lost to Follow-up|0|||
16110782|NCT01438840|38892926|FG002|Extension Phase|Lost to Follow-up|1|||
16110783|NCT01438840|38892924|FG000|Extension Phase|Withdrawal by Subject|0|||
16110784|NCT01438840|38892925|FG001|Extension Phase|Withdrawal by Subject|0|||
16110785|NCT01438840|38892926|FG002|Extension Phase|Withdrawal by Subject|3|||
16110786|NCT01438840|38892924|FG000|Extension Phase|Lack of Efficacy|0|||
16110787|NCT01438840|38892925|FG001|Extension Phase|Lack of Efficacy|0|||
16344730|NCT02137226|39747745|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
16110788|NCT01438840|38892926|FG002|Extension Phase|Lack of Efficacy|2|||
16110789|NCT01438840|38892924|FG000|Extension Phase|Other|0|||
16110790|NCT01438840|38892925|FG001|Extension Phase|Other|0|||
16110791|NCT01438840|38892926|FG002|Extension Phase|Other|1|||
16110792|NCT02719743|38892927|FG000|Overall Study|Consent withdrawal|0|||
16110793|NCT02719743|38892928|FG001|Overall Study|Consent withdrawal|2|||
16110794|NCT02719743|38892929|FG002|Overall Study|Consent withdrawal|0|||
16110795|NCT02719743|38892930|FG003|Overall Study|Consent withdrawal|1|||
16110796|NCT02719743|38892931|FG004|Overall Study|Consent withdrawal|0|||
16110797|NCT02719743|38892927|FG000|Overall Study|Migrated/moved from study area|0|||
16110798|NCT02719743|38892928|FG001|Overall Study|Migrated/moved from study area|0|||
16408695|NCT00197145|39977069|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
16408696|NCT00197145|39977068|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
16408697|NCT00197145|39977069|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
16408698|NCT00197145|39977068|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
16408699|NCT00197145|39977069|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
16408700|NCT00197145|39977068|FG000|Period 2 : Open Label Phase|Other|1|||
16408701|NCT00197145|39977069|FG001|Period 2 : Open Label Phase|Other|0|||
16408702|NCT01886690|39977070|FG000|Overall Study|Protocol Violation|0|||
16408703|NCT01886690|39977071|FG001|Overall Study|Protocol Violation|1|||
16408704|NCT01886690|39977070|FG000|Overall Study|Personal Reasons|0|||
16408705|NCT01886690|39977071|FG001|Overall Study|Personal Reasons|1|||
16408706|NCT01484834|39977076|FG000|Overall Study|Lost to Follow-up|5|||
16408707|NCT01484834|39977077|FG001|Overall Study|Lost to Follow-up|8|||
16408708|NCT01484834|39977078|FG002|Overall Study|Lost to Follow-up|1|||
16408709|NCT01484834|39977079|FG003|Overall Study|Lost to Follow-up|4|||
16408710|NCT00316693|39977080|FG000|Overall Study|Adverse Event|6|||
16408711|NCT00316693|39977081|FG001|Overall Study|Adverse Event|1|||
16408712|NCT00316693|39977080|FG000|Overall Study|Protocol Violation|1|||
16408713|NCT00316693|39977081|FG001|Overall Study|Protocol Violation|0|||
16545571|NCT02002884|40460745|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
16545572|NCT02002884|40460742|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
16545573|NCT02002884|40460743|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
16545574|NCT02002884|40460744|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
16545575|NCT02002884|40460745|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
16545576|NCT02002884|40460742|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
16545577|NCT02002884|40460743|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
16545578|NCT02002884|40460744|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
16545579|NCT02002884|40460745|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
16545580|NCT03757234|40460748|FG000|Overall Study|Adverse Event|0|||
16545581|NCT03757234|40460749|FG001|Overall Study|Adverse Event|0|||
16545582|NCT03757234|40460750|FG002|Overall Study|Adverse Event|0|||
16545583|NCT03757234|40460751|FG003|Overall Study|Adverse Event|0|||
16545584|NCT03757234|40460752|FG004|Overall Study|Adverse Event|1|||
16545585|NCT03757234|40460748|FG000|Overall Study|Lost to Follow-up|1|||
16545586|NCT03757234|40460749|FG001|Overall Study|Lost to Follow-up|0|||
16545587|NCT03757234|40460750|FG002|Overall Study|Lost to Follow-up|0|||
16545588|NCT03757234|40460751|FG003|Overall Study|Lost to Follow-up|0|||
16221958|NCT00972309|39294962|FG000|Overall Study|Disease progression on study|10|||
16545589|NCT03757234|40460752|FG004|Overall Study|Lost to Follow-up|1|||
16545590|NCT03757234|40460748|FG000|Overall Study|Withdrawal by Subject|1|||
16545591|NCT03757234|40460749|FG001|Overall Study|Withdrawal by Subject|1|||
16545592|NCT03757234|40460750|FG002|Overall Study|Withdrawal by Subject|0|||
16545593|NCT03757234|40460751|FG003|Overall Study|Withdrawal by Subject|1|||
16545594|NCT03757234|40460752|FG004|Overall Study|Withdrawal by Subject|2|||
16545595|NCT03757234|40460748|FG000|Overall Study|Other|1|||
16545596|NCT03757234|40460749|FG001|Overall Study|Other|1|||
16545597|NCT03757234|40460750|FG002|Overall Study|Other|0|||
16221959|NCT00972309|39294963|FG001|Overall Study|Disease progression on study|4|||
16545598|NCT03757234|40460751|FG003|Overall Study|Other|0|||
16408714|NCT00316693|39977080|FG000|Overall Study|Withdrawal by Subject|6|||
16408715|NCT00316693|39977081|FG001|Overall Study|Withdrawal by Subject|6|||
16545599|NCT03757234|40460752|FG004|Overall Study|Other|0|||
16545600|NCT02739347|40460753|FG000|Overall Study|Adverse Event|3|||
16221960|NCT02358863|39294964|FG000|Overall Study|Physician Decision|3|||
16221961|NCT01108068|39294965|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
16221962|NCT01108068|39294966|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
16221963|NCT00417248|39294970|FG000|Overall Study|Study Terminated|6|||
16221964|NCT00417248|39294970|FG000|Overall Study|Death|1|||
16221965|NCT00417248|39294970|FG000|Overall Study|Lack of Efficacy|1|||
16221966|NCT02087085|39294974|FG000|Overall Study|Adverse Event|10|||
16221967|NCT02087085|39294975|FG001|Overall Study|Adverse Event|14|||
16221968|NCT02087085|39294974|FG000|Overall Study|Lack of Efficacy|4|||
16221969|NCT02087085|39294975|FG001|Overall Study|Lack of Efficacy|3|||
16221970|NCT02087085|39294974|FG000|Overall Study|Lost to Follow-up|6|||
16221971|NCT02087085|39294975|FG001|Overall Study|Lost to Follow-up|4|||
16221972|NCT02087085|39294974|FG000|Overall Study|Withdrawal by Subject|9|||
16221973|NCT02087085|39294975|FG001|Overall Study|Withdrawal by Subject|11|||
16221974|NCT02087085|39294974|FG000|Overall Study|Protocol Violation|1|||
16221975|NCT02087085|39294975|FG001|Overall Study|Protocol Violation|0|||
16221976|NCT02087085|39294974|FG000|Overall Study|Study Terminated by Sponsor|87|||
16221977|NCT02087085|39294975|FG001|Overall Study|Study Terminated by Sponsor|80|||
16221978|NCT02087085|39294974|FG000|Overall Study|Other Miscellaneous Reasons|3|||
16221979|NCT02087085|39294975|FG001|Overall Study|Other Miscellaneous Reasons|4|||
16221980|NCT02698176|39294983|FG000|Overall Study|Progressive disease|4|||
16221981|NCT02698176|39294984|FG001|Overall Study|Progressive disease|3|||
16221982|NCT02698176|39294985|FG002|Overall Study|Progressive disease|1|||
16221983|NCT02698176|39294986|FG003|Overall Study|Progressive disease|0|||
16221984|NCT02698176|39294983|FG000|Overall Study|Adverse Event|2|||
16221985|NCT02698176|39294984|FG001|Overall Study|Adverse Event|0|||
16221986|NCT02698176|39294985|FG002|Overall Study|Adverse Event|0|||
16221987|NCT02698176|39294986|FG003|Overall Study|Adverse Event|0|||
16221988|NCT02698176|39294983|FG000|Overall Study|Clinical progression|3|||
16221989|NCT02698176|39294984|FG001|Overall Study|Clinical progression|0|||
16221990|NCT02698176|39294985|FG002|Overall Study|Clinical progression|0|||
16221991|NCT02698176|39294986|FG003|Overall Study|Clinical progression|0|||
16221992|NCT03145207|39294987|FG000|Overall Study|volunteer started taking allergy shots|1|||
16221993|NCT03145207|39294987|FG000|Overall Study|baseline blood pressure high|1|||
16221994|NCT02168816|39294989|FG000|Overall Study|Lost to Follow-up|2|||
16221995|NCT02168816|39294990|FG001|Overall Study|Lost to Follow-up|2|||
16221996|NCT03143855|39294991|FG000|Overall Study|Withdrawal by Subject|4|||
16221997|NCT03143855|39294992|FG001|Overall Study|Withdrawal by Subject|3|||
16221998|NCT03143855|39294991|FG000|Overall Study|Protocol Violation|1|||
16221999|NCT03143855|39294992|FG001|Overall Study|Protocol Violation|0|||
16222000|NCT03143855|39294991|FG000|Overall Study|Participant experienced withdrawal|0|||
16545601|NCT02739347|40460754|FG001|Overall Study|Adverse Event|0|||
16545602|NCT02739347|40460753|FG000|Overall Study|Protocol Violation|0|||
16545603|NCT02739347|40460754|FG001|Overall Study|Protocol Violation|1|||
16222001|NCT03143855|39294992|FG001|Overall Study|Participant experienced withdrawal|1|||
16222002|NCT00203294|39294998|FG000|Overall Study|Withdrawal by Subject|8|||
16222003|NCT00203294|39294999|FG001|Overall Study|Withdrawal by Subject|13|||
16222004|NCT00911508|39295005|FG000|Overall Study|Lost to Follow-up|27|||
16222005|NCT00911508|39295006|FG001|Overall Study|Lost to Follow-up|18|||
16222006|NCT00911508|39295005|FG000|Overall Study|Withdrawal by Subject|79|||
16222007|NCT00911508|39295006|FG001|Overall Study|Withdrawal by Subject|112|||
16222008|NCT00535236|39295009|FG000|Overall Study|Adverse Event|1|||
16222009|NCT00535236|39295010|FG001|Overall Study|Adverse Event|0|||
16222010|NCT00535236|39295011|FG002|Overall Study|Adverse Event|9|||
16222011|NCT00535236|39295012|FG003|Overall Study|Adverse Event|3|||
16222012|NCT00535236|39295013|FG004|Overall Study|Adverse Event|3|||
16222013|NCT00535236|39295014|FG005|Overall Study|Adverse Event|0|||
16222014|NCT00535236|39295015|FG006|Overall Study|Adverse Event|5|||
16222015|NCT00535236|39295016|FG007|Overall Study|Adverse Event|1|||
16222016|NCT00535236|39295017|FG008|Overall Study|Adverse Event|2|||
16222017|NCT00535236|39295018|FG009|Overall Study|Adverse Event|1|||
16222018|NCT00535236|39295009|FG000|Overall Study|Lost to Follow-up|1|||
16222019|NCT00535236|39295010|FG001|Overall Study|Lost to Follow-up|2|||
16222020|NCT00535236|39295011|FG002|Overall Study|Lost to Follow-up|0|||
16222021|NCT00535236|39295012|FG003|Overall Study|Lost to Follow-up|0|||
16222022|NCT00535236|39295013|FG004|Overall Study|Lost to Follow-up|2|||
16222023|NCT00535236|39295014|FG005|Overall Study|Lost to Follow-up|0|||
16222024|NCT00535236|39295015|FG006|Overall Study|Lost to Follow-up|0|||
16222025|NCT00535236|39295016|FG007|Overall Study|Lost to Follow-up|0|||
16222026|NCT00535236|39295017|FG008|Overall Study|Lost to Follow-up|6|||
16222027|NCT00535236|39295018|FG009|Overall Study|Lost to Follow-up|1|||
16344731|NCT02137226|39747746|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
16222028|NCT00535236|39295009|FG000|Overall Study|Physician Decision|0|||
16222029|NCT00535236|39295010|FG001|Overall Study|Physician Decision|0|||
16222030|NCT00535236|39295011|FG002|Overall Study|Physician Decision|0|||
16344732|NCT02137226|39747747|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
16222031|NCT00535236|39295012|FG003|Overall Study|Physician Decision|0|||
16222032|NCT00535236|39295013|FG004|Overall Study|Physician Decision|1|||
16222033|NCT00535236|39295014|FG005|Overall Study|Physician Decision|0|||
16222034|NCT00535236|39295015|FG006|Overall Study|Physician Decision|1|||
16222035|NCT00535236|39295016|FG007|Overall Study|Physician Decision|0|||
16222036|NCT00535236|39295017|FG008|Overall Study|Physician Decision|0|||
16222037|NCT00535236|39295018|FG009|Overall Study|Physician Decision|0|||
16222038|NCT00535236|39295009|FG000|Overall Study|Protocol Violation|2|||
16222039|NCT00535236|39295010|FG001|Overall Study|Protocol Violation|0|||
16222040|NCT00535236|39295011|FG002|Overall Study|Protocol Violation|1|||
16408716|NCT00316693|39977080|FG000|Overall Study|Lost to Follow-up|26|||
16408717|NCT00316693|39977081|FG001|Overall Study|Lost to Follow-up|34|||
16408718|NCT00316693|39977080|FG000|Overall Study|Other|38|||
16222041|NCT00535236|39295012|FG003|Overall Study|Protocol Violation|0|||
16222042|NCT00535236|39295013|FG004|Overall Study|Protocol Violation|0|||
16222043|NCT00535236|39295014|FG005|Overall Study|Protocol Violation|0|||
16222044|NCT00535236|39295015|FG006|Overall Study|Protocol Violation|0|||
16408719|NCT00316693|39977081|FG001|Overall Study|Other|44|||
16408720|NCT00554619|39977082|FG000|Overall Study|Adverse Event|1|||
16408721|NCT00554619|39977082|FG000|Overall Study|Physician Decision|1|||
16222045|NCT00535236|39295016|FG007|Overall Study|Protocol Violation|0|||
16222046|NCT00535236|39295017|FG008|Overall Study|Protocol Violation|1|||
16222047|NCT00535236|39295018|FG009|Overall Study|Protocol Violation|0|||
16222048|NCT00535236|39295009|FG000|Overall Study|Withdrawal by Subject|3|||
16222049|NCT00535236|39295010|FG001|Overall Study|Withdrawal by Subject|0|||
16222050|NCT00535236|39295011|FG002|Overall Study|Withdrawal by Subject|2|||
16222051|NCT00535236|39295012|FG003|Overall Study|Withdrawal by Subject|1|||
16222052|NCT00535236|39295013|FG004|Overall Study|Withdrawal by Subject|6|||
16222053|NCT00535236|39295014|FG005|Overall Study|Withdrawal by Subject|1|||
16222054|NCT00535236|39295015|FG006|Overall Study|Withdrawal by Subject|5|||
16222055|NCT00535236|39295016|FG007|Overall Study|Withdrawal by Subject|0|||
16222056|NCT00535236|39295017|FG008|Overall Study|Withdrawal by Subject|4|||
16222057|NCT00535236|39295018|FG009|Overall Study|Withdrawal by Subject|2|||
16222058|NCT03037489|39295019|FG000|Overall Study|Adverse Event|4|||
16222059|NCT03037489|39295020|FG001|Overall Study|Adverse Event|0|||
16222060|NCT03037489|39295019|FG000|Overall Study|Withdrawal by Subject|3|||
16222061|NCT03037489|39295020|FG001|Overall Study|Withdrawal by Subject|0|||
16222062|NCT00805194|39295021|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
16222063|NCT00805194|39295022|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
16222064|NCT00805194|39295021|FG000|Overall Study|Worsening or AE of underlying disease|64|||
16222065|NCT00805194|39295022|FG001|Overall Study|Worsening or AE of underlying disease|70|||
16222066|NCT00805194|39295021|FG000|Overall Study|Other AE|84|||
16222067|NCT00805194|39295022|FG001|Overall Study|Other AE|73|||
16222068|NCT00805194|39295021|FG000|Overall Study|Protocol Violation|9|||
16222069|NCT00805194|39295022|FG001|Overall Study|Protocol Violation|9|||
16222070|NCT00805194|39295021|FG000|Overall Study|Lost to Follow-up|5|||
16222071|NCT00805194|39295022|FG001|Overall Study|Lost to Follow-up|5|||
16222072|NCT00805194|39295021|FG000|Overall Study|Withdrawal by Subject|60|||
16222073|NCT00805194|39295022|FG001|Overall Study|Withdrawal by Subject|42|||
16222074|NCT00805194|39295021|FG000|Overall Study|Not treated|3|||
16222075|NCT00805194|39295022|FG001|Overall Study|Not treated|4|||
16222076|NCT00805194|39295021|FG000|Overall Study|Reasons other than stated above|20|||
16222077|NCT00805194|39295022|FG001|Overall Study|Reasons other than stated above|16|||
16222078|NCT03018028|39295023|FG000|Overall Study|Withdrawal by Subject|3|||
16222079|NCT03018028|39295024|FG001|Overall Study|Withdrawal by Subject|0|||
16222080|NCT03018028|39295025|FG002|Overall Study|Withdrawal by Subject|1|||
16222081|NCT03018028|39295026|FG003|Overall Study|Withdrawal by Subject|2|||
16222082|NCT03018028|39295027|FG004|Overall Study|Withdrawal by Subject|0|||
16408722|NCT00554619|39977082|FG000|Overall Study|Liver Function Test Abnormality|1|||
16408723|NCT00546260|39977083|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
16408724|NCT00546260|39977084|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
16408725|NCT01185964|39977086|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
16408726|NCT01185964|39977087|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
16408727|NCT01185964|39977088|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
16408728|NCT01185964|39977089|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
16408729|NCT01185964|39977086|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
16408730|NCT01185964|39977087|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
16222083|NCT01747655|39295029|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
16222084|NCT01747655|39295030|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
16222085|NCT01747655|39295029|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
16222086|NCT01747655|39295030|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
16408731|NCT01185964|39977088|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
16408732|NCT01185964|39977089|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
16222087|NCT01747655|39295029|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
16222088|NCT01747655|39295030|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
16222089|NCT04411472|39295034|FG000|Overall Study|Adverse Event|5|||
16222090|NCT04411472|39295035|FG001|Overall Study|Adverse Event|10|||
16344733|NCT02137226|39747748|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
16344734|NCT02137226|39747749|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
16344735|NCT02137226|39747745|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
16344736|NCT02137226|39747746|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
16344737|NCT02137226|39747747|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
16344738|NCT02137226|39747748|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
16344739|NCT02137226|39747749|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
16344740|NCT02137226|39747745|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
16344741|NCT02137226|39747746|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
16344742|NCT02137226|39747747|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
16344743|NCT02137226|39747748|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
16344744|NCT02137226|39747749|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
16344745|NCT02137226|39747745|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
16344746|NCT02137226|39747746|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
16344747|NCT02137226|39747747|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
16344748|NCT02137226|39747748|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
16344749|NCT02137226|39747749|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
16344750|NCT02137226|39747745|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
16344751|NCT02137226|39747746|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
16344752|NCT02137226|39747747|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
16344753|NCT02137226|39747748|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
16344754|NCT02137226|39747749|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
16344755|NCT02137226|39747745|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
16344756|NCT02137226|39747746|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
16344757|NCT02137226|39747747|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
16344758|NCT02137226|39747748|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
16344759|NCT02137226|39747749|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
16344760|NCT02137226|39747745|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
16344761|NCT02137226|39747746|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
16344762|NCT02137226|39747747|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
16344763|NCT02137226|39747748|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
16344764|NCT02137226|39747749|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
16344765|NCT02137226|39747745|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
16344766|NCT02137226|39747746|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
16344767|NCT02137226|39747747|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
16344768|NCT02137226|39747748|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
16344769|NCT02137226|39747749|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
16344770|NCT02137226|39747745|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
16344771|NCT02137226|39747746|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
16344772|NCT02137226|39747747|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
16344773|NCT02137226|39747748|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
16344774|NCT02137226|39747749|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
16344775|NCT02137226|39747745|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
16344776|NCT02137226|39747746|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
16344777|NCT02137226|39747747|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
16344778|NCT02137226|39747748|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
16344779|NCT02137226|39747749|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
16344780|NCT02137226|39747745|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
16344781|NCT02137226|39747746|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
16344782|NCT02137226|39747747|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
16344783|NCT02137226|39747748|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
16344784|NCT02137226|39747749|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
16344785|NCT02137226|39747745|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
16344786|NCT02137226|39747746|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
16344787|NCT02137226|39747747|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
16344788|NCT02137226|39747748|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
16344789|NCT02137226|39747749|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
16344790|NCT00070564|39747750|FG000|Overall Study|Progression|2|||
16344791|NCT00070564|39747751|FG001|Overall Study|Progression|4|||
16344792|NCT00070564|39747752|FG002|Overall Study|Progression|7|||
16344793|NCT00070564|39747753|FG003|Overall Study|Progression|7|||
16344794|NCT00070564|39747754|FG004|Overall Study|Progression|1|||
16344795|NCT00070564|39747755|FG005|Overall Study|Progression|0|||
16344796|NCT00070564|39747750|FG000|Overall Study|Delinquent|1|||
16344797|NCT00070564|39747751|FG001|Overall Study|Delinquent|4|||
16344798|NCT00070564|39747752|FG002|Overall Study|Delinquent|2|||
16344799|NCT00070564|39747753|FG003|Overall Study|Delinquent|0|||
16344800|NCT00070564|39747754|FG004|Overall Study|Delinquent|0|||
16344801|NCT00070564|39747755|FG005|Overall Study|Delinquent|0|||
16408733|NCT01185964|39977086|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
16545604|NCT02739347|40460753|FG000|Overall Study|Lost to Follow-up|0|||
16408734|NCT01185964|39977087|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
16408735|NCT01185964|39977088|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
16408736|NCT01185964|39977089|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
16408737|NCT01185964|39977086|FG000|Phase 1b and Phase 2|Adverse Event|1|||
16408738|NCT01185964|39977087|FG001|Phase 1b and Phase 2|Adverse Event|0|||
16408739|NCT01185964|39977088|FG002|Phase 1b and Phase 2|Adverse Event|2|||
16408740|NCT01185964|39977089|FG003|Phase 1b and Phase 2|Adverse Event|0|||
16408741|NCT01185964|39977086|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
16408742|NCT01185964|39977087|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
16408743|NCT01185964|39977088|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
16408744|NCT01185964|39977089|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
16408745|NCT01185964|39977086|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
16408746|NCT01185964|39977087|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
16408747|NCT01185964|39977088|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
16408748|NCT01185964|39977089|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
16408749|NCT01185964|39977086|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
16408750|NCT01185964|39977087|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
16408751|NCT01185964|39977088|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
16408752|NCT01185964|39977089|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
16408753|NCT01185964|39977086|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
16408754|NCT01185964|39977087|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
16408755|NCT01185964|39977088|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
16408756|NCT01185964|39977089|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
16408757|NCT04438499|39977091|FG000|Overall Study|Lack of Efficacy|2|||
16408758|NCT02908685|39977094|FG000|Part 1 OLE|Withdrawal by Subject|0|||
16408759|NCT02908685|39977095|FG001|Part 1 OLE|Withdrawal by Subject|0|||
16408760|NCT02908685|39977096|FG002|Part 1 OLE|Withdrawal by Subject|0|||
16408761|NCT02908685|39977097|FG003|Part 1 OLE|Withdrawal by Subject|0|||
16408762|NCT02908685|39977098|FG004|Part 1 OLE|Withdrawal by Subject|0|||
16408763|NCT02908685|39977099|FG005|Part 1 OLE|Withdrawal by Subject|0|||
16408764|NCT02908685|39977100|FG006|Part 1 OLE|Withdrawal by Subject|0|||
16408765|NCT02908685|39977101|FG007|Part 1 OLE|Withdrawal by Subject|0|||
16408766|NCT02908685|39977102|FG008|Part 1 OLE|Withdrawal by Subject|0|||
16408767|NCT02908685|39977103|FG009|Part 1 OLE|Withdrawal by Subject|0|||
16408768|NCT02908685|39977104|FG010|Part 1 OLE|Withdrawal by Subject|2|||
16408769|NCT02908685|39977105|FG011|Part 1 OLE|Withdrawal by Subject|1|||
16344802|NCT00070564|39747750|FG000|Overall Study|Adverse Event|150|||
16344803|NCT00070564|39747751|FG001|Overall Study|Adverse Event|142|||
16344804|NCT00070564|39747752|FG002|Overall Study|Adverse Event|120|||
16344805|NCT00070564|39747753|FG003|Overall Study|Adverse Event|108|||
16344806|NCT00070564|39747754|FG004|Overall Study|Adverse Event|63|||
16344807|NCT00070564|39747755|FG005|Overall Study|Adverse Event|36|||
16344808|NCT00070564|39747750|FG000|Overall Study|Death|4|||
16344809|NCT00070564|39747751|FG001|Overall Study|Death|1|||
16344810|NCT00070564|39747752|FG002|Overall Study|Death|5|||
16344811|NCT00070564|39747753|FG003|Overall Study|Death|3|||
16344812|NCT00070564|39747754|FG004|Overall Study|Death|0|||
16344813|NCT00070564|39747755|FG005|Overall Study|Death|1|||
16344814|NCT00070564|39747750|FG000|Overall Study|Other, not protocol specified|17|||
16344815|NCT00070564|39747751|FG001|Overall Study|Other, not protocol specified|15|||
16344816|NCT00070564|39747752|FG002|Overall Study|Other, not protocol specified|14|||
16344817|NCT00070564|39747753|FG003|Overall Study|Other, not protocol specified|19|||
16344818|NCT00070564|39747754|FG004|Overall Study|Other, not protocol specified|6|||
16344819|NCT00070564|39747755|FG005|Overall Study|Other, not protocol specified|7|||
16344820|NCT00070564|39747750|FG000|Overall Study|Withdrawal by Subject|26|||
16344821|NCT00070564|39747751|FG001|Overall Study|Withdrawal by Subject|37|||
16344822|NCT00070564|39747752|FG002|Overall Study|Withdrawal by Subject|23|||
16344823|NCT00070564|39747753|FG003|Overall Study|Withdrawal by Subject|30|||
16344824|NCT00070564|39747754|FG004|Overall Study|Withdrawal by Subject|8|||
16344825|NCT00070564|39747755|FG005|Overall Study|Withdrawal by Subject|8|||
16344826|NCT00070564|39747750|FG000|Overall Study|Not reported|0|||
16344827|NCT00070564|39747751|FG001|Overall Study|Not reported|0|||
16344828|NCT00070564|39747752|FG002|Overall Study|Not reported|0|||
16408770|NCT02908685|39977106|FG012|Part 1 OLE|Withdrawal by Subject|0|||
16222091|NCT04411472|39295036|FG002|Overall Study|Adverse Event|1|||
16344829|NCT00070564|39747753|FG003|Overall Study|Not reported|0|||
16344830|NCT00070564|39747754|FG004|Overall Study|Not reported|1|||
16344831|NCT00070564|39747755|FG005|Overall Study|Not reported|0|||
16344832|NCT00186485|39747758|FG000|Overall Study|Lost to Follow-up|3|||
16344833|NCT01467271|39751046|FG000|Overall Study|Death|84|||
16408771|NCT02908685|39977107|FG013|Part 1 OLE|Withdrawal by Subject|0|||
16545605|NCT02739347|40460754|FG001|Overall Study|Lost to Follow-up|2|||
16344834|NCT01467271|39751046|FG000|Overall Study|Lost to Follow-up|83|||
16344835|NCT01467271|39751046|FG000|Overall Study|Retraction of patient's consent|21|||
16344836|NCT01467271|39751046|FG000|Overall Study|Other reason|14|||
16344837|NCT02309723|39751047|FG000|Overall Study|Withdrawal by Subject|24|||
16344838|NCT02309723|39751048|FG001|Overall Study|Withdrawal by Subject|23|||
16344839|NCT02309723|39751049|FG002|Overall Study|Withdrawal by Subject|24|||
16344840|NCT01673984|39751050|FG000|Overall Study|Adverse Event|1|||
16344841|NCT01673984|39751051|FG001|Overall Study|Adverse Event|0|||
16344842|NCT01673984|39751050|FG000|Overall Study|Study termination|9|||
16408772|NCT02908685|39977094|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408773|NCT02908685|39977095|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408774|NCT02908685|39977096|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408775|NCT02908685|39977097|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408776|NCT02908685|39977098|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408777|NCT02908685|39977099|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408778|NCT02908685|39977100|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408779|NCT02908685|39977101|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408780|NCT02908685|39977102|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16545606|NCT00946296|40460755|FG000|Overall Study|Physician Decision|3|||
16545607|NCT00946296|40460756|FG001|Overall Study|Physician Decision|0|||
16545608|NCT05044325|40460759|FG000|Part A:Treatment Period 1|Adverse Event|0|||
16545609|NCT05044325|40460760|FG001|Part A:Treatment Period 1|Adverse Event|0|||
16545610|NCT05044325|40460761|FG002|Part A:Treatment Period 1|Adverse Event|0|||
16545611|NCT05044325|40460762|FG003|Part A:Treatment Period 1|Adverse Event|0|||
16545612|NCT05044325|40460763|FG004|Part A:Treatment Period 1|Adverse Event|0|||
16545613|NCT05044325|40460764|FG005|Part A:Treatment Period 1|Adverse Event|1|||
16545614|NCT05044325|40460765|FG006|Part A:Treatment Period 1|Adverse Event|0|||
16545615|NCT05044325|40460766|FG007|Part A:Treatment Period 1|Adverse Event|1|||
16344843|NCT01673984|39751051|FG001|Overall Study|Study termination|6|||
16344844|NCT04530838|39751054|FG000|Overall Study|Other|2|||
16344845|NCT04530838|39751055|FG001|Overall Study|Other|1|||
16344846|NCT04530838|39751056|FG002|Overall Study|Other|0|||
16344847|NCT04530838|39751054|FG000|Overall Study|Physician Decision|0|||
16344848|NCT04530838|39751055|FG001|Overall Study|Physician Decision|0|||
16344849|NCT04530838|39751056|FG002|Overall Study|Physician Decision|1|||
16344850|NCT04530838|39751054|FG000|Overall Study|Death|0|||
16344851|NCT04530838|39751055|FG001|Overall Study|Death|0|||
16344852|NCT04530838|39751056|FG002|Overall Study|Death|1|||
16344853|NCT04530838|39751054|FG000|Overall Study|Adverse Event|0|||
16344854|NCT04530838|39751055|FG001|Overall Study|Adverse Event|1|||
16344855|NCT04530838|39751056|FG002|Overall Study|Adverse Event|0|||
16344856|NCT04530838|39751054|FG000|Overall Study|No longer meets eligibility criteria|1|||
16344857|NCT04530838|39751055|FG001|Overall Study|No longer meets eligibility criteria|0|||
16344858|NCT04530838|39751056|FG002|Overall Study|No longer meets eligibility criteria|2|||
16344859|NCT04530838|39751054|FG000|Overall Study|Withdrawal by parent/guardian|5|||
16344860|NCT04530838|39751055|FG001|Overall Study|Withdrawal by parent/guardian|2|||
16344861|NCT04530838|39751056|FG002|Overall Study|Withdrawal by parent/guardian|2|||
16344862|NCT03046953|39751061|FG000|Overall Study|Relapse/progressive disease|21|||
16344863|NCT03046953|39751061|FG000|Overall Study|Death|2|||
16344864|NCT03046953|39751061|FG000|Overall Study|Withdrawal by Subject|3|||
16344865|NCT00540644|39751064|FG000|Overall Study|Adverse Event|3|||
16344866|NCT00540644|39751065|FG001|Overall Study|Adverse Event|1|||
16344867|NCT00540644|39751064|FG000|Overall Study|Disease Progression|3|||
16545616|NCT05044325|40460767|FG008|Part A:Treatment Period 1|Adverse Event|0|||
16545617|NCT05044325|40460768|FG009|Part A:Treatment Period 1|Adverse Event|0|||
16344868|NCT00540644|39751065|FG001|Overall Study|Disease Progression|1|||
16222092|NCT04411472|39295037|FG003|Overall Study|Adverse Event|0|||
16222093|NCT04411472|39295038|FG004|Overall Study|Adverse Event|0|||
16222094|NCT04411472|39295039|FG005|Overall Study|Adverse Event|0|||
16222095|NCT04411472|39295034|FG000|Overall Study|Protocol Violation|1|||
16222096|NCT04411472|39295035|FG001|Overall Study|Protocol Violation|0|||
16222097|NCT04411472|39295036|FG002|Overall Study|Protocol Violation|0|||
16222098|NCT04411472|39295037|FG003|Overall Study|Protocol Violation|0|||
16222099|NCT04411472|39295038|FG004|Overall Study|Protocol Violation|0|||
16222100|NCT04411472|39295039|FG005|Overall Study|Protocol Violation|0|||
16222101|NCT04411472|39295034|FG000|Overall Study|Withdrawal by Subject|0|||
16222102|NCT04411472|39295035|FG001|Overall Study|Withdrawal by Subject|1|||
16222103|NCT04411472|39295036|FG002|Overall Study|Withdrawal by Subject|0|||
16222104|NCT04411472|39295037|FG003|Overall Study|Withdrawal by Subject|1|||
16222105|NCT04411472|39295038|FG004|Overall Study|Withdrawal by Subject|0|||
16222106|NCT04411472|39295039|FG005|Overall Study|Withdrawal by Subject|0|||
16222107|NCT04411472|39295034|FG000|Overall Study|Physician Decision|1|||
16222108|NCT04411472|39295035|FG001|Overall Study|Physician Decision|0|||
16222109|NCT04411472|39295036|FG002|Overall Study|Physician Decision|0|||
16222110|NCT04411472|39295037|FG003|Overall Study|Physician Decision|0|||
16222111|NCT04411472|39295038|FG004|Overall Study|Physician Decision|0|||
16222112|NCT04411472|39295039|FG005|Overall Study|Physician Decision|0|||
16222113|NCT04411472|39295034|FG000|Overall Study|Study terminated by sponsor|17|||
16222114|NCT04411472|39295035|FG001|Overall Study|Study terminated by sponsor|20|||
16222115|NCT04411472|39295036|FG002|Overall Study|Study terminated by sponsor|3|||
16222116|NCT04411472|39295037|FG003|Overall Study|Study terminated by sponsor|0|||
16222117|NCT04411472|39295038|FG004|Overall Study|Study terminated by sponsor|0|||
16222118|NCT04411472|39295039|FG005|Overall Study|Study terminated by sponsor|0|||
16222119|NCT02624713|39295040|FG000|Overall Study|Lost to Follow-up|14|||
16222120|NCT02624713|39295041|FG001|Overall Study|Lost to Follow-up|0|||
16222121|NCT02612194|39295047|FG000|Overall Study|Death|5|||
16222122|NCT02612194|39295048|FG001|Overall Study|Death|0|||
16222123|NCT02612194|39295049|FG002|Overall Study|Death|2|||
16222124|NCT02612194|39295047|FG000|Overall Study|Early Study Termination|1|||
16545618|NCT05044325|40460759|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
16545619|NCT05044325|40460760|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
16545620|NCT05044325|40460761|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
16545621|NCT05044325|40460762|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
16545622|NCT05044325|40460763|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
16545623|NCT05044325|40460764|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
16545624|NCT05044325|40460765|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
16222125|NCT02612194|39295048|FG001|Overall Study|Early Study Termination|0|||
16222126|NCT02612194|39295049|FG002|Overall Study|Early Study Termination|0|||
16222127|NCT04115293|39295052|FG000|Overall Study|Adverse Event|0|||
16545625|NCT05044325|40460766|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
16545626|NCT05044325|40460767|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
16545627|NCT05044325|40460768|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
16545628|NCT05044325|40460759|FG000|Part A:Treatment Period 1|Physician Decision|0|||
16545629|NCT05044325|40460760|FG001|Part A:Treatment Period 1|Physician Decision|0|||
16545630|NCT05044325|40460761|FG002|Part A:Treatment Period 1|Physician Decision|0|||
16545631|NCT05044325|40460762|FG003|Part A:Treatment Period 1|Physician Decision|0|||
16222128|NCT04115293|39295053|FG001|Overall Study|Adverse Event|2|||
16222129|NCT04115293|39295052|FG000|Overall Study|Withdrawal by Subject|2|||
16222130|NCT04115293|39295053|FG001|Overall Study|Withdrawal by Subject|1|||
16222131|NCT04115293|39295052|FG000|Overall Study|Physician Decision|1|||
16222132|NCT04115293|39295053|FG001|Overall Study|Physician Decision|0|||
16222133|NCT04115293|39295052|FG000|Overall Study|Death|1|||
16222134|NCT04115293|39295053|FG001|Overall Study|Death|1|||
16545632|NCT05044325|40460763|FG004|Part A:Treatment Period 1|Physician Decision|0|||
16545633|NCT05044325|40460764|FG005|Part A:Treatment Period 1|Physician Decision|0|||
16545634|NCT05044325|40460765|FG006|Part A:Treatment Period 1|Physician Decision|1|||
16545635|NCT05044325|40460766|FG007|Part A:Treatment Period 1|Physician Decision|0|||
16344869|NCT00540644|39751064|FG000|Overall Study|Physician Decision|0|||
16344870|NCT00540644|39751065|FG001|Overall Study|Physician Decision|5|||
16344871|NCT00540644|39751064|FG000|Overall Study|Withdrawal by Subject|2|||
16344872|NCT00540644|39751065|FG001|Overall Study|Withdrawal by Subject|2|||
16344873|NCT00540644|39751064|FG000|Overall Study|Noncomplilance|1|||
16344874|NCT00540644|39751065|FG001|Overall Study|Noncomplilance|0|||
16344875|NCT00045734|39751076|FG000|Overall Study|Protocol Violation|1|||
16344876|NCT02499120|39751077|FG000|Overall Study|Death|52|||
16344877|NCT02499120|39751078|FG001|Overall Study|Death|43|||
16344878|NCT02499120|39751077|FG000|Overall Study|Lost to Follow-up|1|||
16344879|NCT02499120|39751078|FG001|Overall Study|Lost to Follow-up|2|||
16545636|NCT05044325|40460767|FG008|Part A:Treatment Period 1|Physician Decision|0|||
16545637|NCT05044325|40460768|FG009|Part A:Treatment Period 1|Physician Decision|0|||
16545638|NCT05044325|40460759|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
16545639|NCT05044325|40460760|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
16545640|NCT05044325|40460761|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
16545641|NCT05044325|40460762|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
16545642|NCT05044325|40460763|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
16545643|NCT05044325|40460764|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
16545644|NCT05044325|40460765|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
16545645|NCT05044325|40460766|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
16545646|NCT05044325|40460767|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
16545647|NCT05044325|40460768|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
16545648|NCT05044325|40460759|FG000|Part A:Treatment Period 2|Adverse Event|0|||
16344880|NCT02499120|39751077|FG000|Overall Study|Participant refused further follow-up|1|||
16545649|NCT05044325|40460760|FG001|Part A:Treatment Period 2|Adverse Event|1|||
16545650|NCT05044325|40460761|FG002|Part A:Treatment Period 2|Adverse Event|0|||
16222135|NCT01087944|39295056|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
16222136|NCT01087944|39295057|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
16222137|NCT01087944|39295056|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
16222138|NCT01087944|39295057|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
16222139|NCT00951912|39295058|FG000|Overall Study|Lack of Efficacy|1|||
16222140|NCT00951912|39295059|FG001|Overall Study|Lack of Efficacy|0|||
16222141|NCT00951912|39295060|FG002|Overall Study|Lack of Efficacy|0|||
16222142|NCT00951912|39295058|FG000|Overall Study|Adverse Event|0|||
16222143|NCT00951912|39295059|FG001|Overall Study|Adverse Event|1|||
16222144|NCT00951912|39295060|FG002|Overall Study|Adverse Event|1|||
16344881|NCT02499120|39751078|FG001|Overall Study|Participant refused further follow-up|0|||
16344882|NCT02499120|39751077|FG000|Overall Study|Withdrawal by Subject|2|||
16344883|NCT02499120|39751078|FG001|Overall Study|Withdrawal by Subject|5|||
16344884|NCT02499120|39751077|FG000|Overall Study|Other|9|||
16344885|NCT02499120|39751078|FG001|Overall Study|Other|10|||
16344886|NCT00460239|39751080|FG000|Overall Study|Physician Decision|0|||
16344887|NCT00460239|39751081|FG001|Overall Study|Physician Decision|1|||
16344888|NCT00460239|39751082|FG002|Overall Study|Physician Decision|0|||
16344889|NCT00460239|39751083|FG003|Overall Study|Physician Decision|0|||
16344890|NCT00460239|39751084|FG004|Overall Study|Physician Decision|0|||
16344891|NCT00460239|39751085|FG005|Overall Study|Physician Decision|2|||
16344892|NCT00460239|39751086|FG006|Overall Study|Physician Decision|0|||
16344893|NCT00460239|39751087|FG007|Overall Study|Physician Decision|0|||
16344894|NCT00460239|39751088|FG008|Overall Study|Physician Decision|0|||
16344895|NCT00460239|39751080|FG000|Overall Study|Withdrawal by Subject|0|||
16344896|NCT00460239|39751081|FG001|Overall Study|Withdrawal by Subject|0|||
16344897|NCT00460239|39751082|FG002|Overall Study|Withdrawal by Subject|0|||
16344898|NCT00460239|39751083|FG003|Overall Study|Withdrawal by Subject|0|||
16344899|NCT00460239|39751084|FG004|Overall Study|Withdrawal by Subject|0|||
16344900|NCT00460239|39751085|FG005|Overall Study|Withdrawal by Subject|1|||
16344901|NCT00460239|39751086|FG006|Overall Study|Withdrawal by Subject|0|||
16344902|NCT00460239|39751087|FG007|Overall Study|Withdrawal by Subject|0|||
16344903|NCT00460239|39751088|FG008|Overall Study|Withdrawal by Subject|0|||
16222145|NCT00951912|39295058|FG000|Overall Study|Lost to Follow-up|2|||
16222146|NCT00951912|39295059|FG001|Overall Study|Lost to Follow-up|2|||
16222147|NCT00951912|39295060|FG002|Overall Study|Lost to Follow-up|0|||
16222148|NCT00951912|39295058|FG000|Overall Study|Physician Decision|1|||
16222149|NCT00951912|39295059|FG001|Overall Study|Physician Decision|0|||
16222150|NCT00951912|39295060|FG002|Overall Study|Physician Decision|1|||
16222151|NCT00951912|39295058|FG000|Overall Study|Withdrawal by Subject|1|||
16222152|NCT00951912|39295059|FG001|Overall Study|Withdrawal by Subject|1|||
16222153|NCT00951912|39295060|FG002|Overall Study|Withdrawal by Subject|0|||
16222154|NCT00951912|39295058|FG000|Overall Study|Other:Depression|1|||
16222155|NCT00951912|39295059|FG001|Overall Study|Other:Depression|0|||
16222156|NCT00951912|39295060|FG002|Overall Study|Other:Depression|0|||
16222157|NCT00951912|39295058|FG000|Overall Study|Other: Colon cancer|1|||
16222158|NCT00951912|39295059|FG001|Overall Study|Other: Colon cancer|0|||
16222159|NCT00951912|39295060|FG002|Overall Study|Other: Colon cancer|0|||
16222160|NCT00951912|39295058|FG000|Overall Study|Other: Stroke|0|||
16222161|NCT00951912|39295059|FG001|Overall Study|Other: Stroke|1|||
16222162|NCT00951912|39295060|FG002|Overall Study|Other: Stroke|0|||
16344904|NCT00187278|39751089|FG000|Overall Study|Protocol Violation|10|||
16344905|NCT00187278|39751090|FG001|Overall Study|Protocol Violation|13|||
16344906|NCT01957579|39751091|FG000|Overall Study|Withdrawal of concent|0|||
16344907|NCT01957579|39751092|FG001|Overall Study|Withdrawal of concent|1|||
16344908|NCT01957579|39751093|FG002|Overall Study|Withdrawal of concent|0|||
16344909|NCT01957579|39751094|FG003|Overall Study|Withdrawal of concent|0|||
16344910|NCT01957579|39751091|FG000|Overall Study|Death|0|||
16344911|NCT01957579|39751092|FG001|Overall Study|Death|0|||
16344912|NCT01957579|39751093|FG002|Overall Study|Death|2|||
16545651|NCT05044325|40460762|FG003|Part A:Treatment Period 2|Adverse Event|0|||
16545652|NCT05044325|40460763|FG004|Part A:Treatment Period 2|Adverse Event|1|||
16545653|NCT05044325|40460764|FG005|Part A:Treatment Period 2|Adverse Event|1|||
16110799|NCT02719743|38892929|FG002|Overall Study|Migrated/moved from study area|0|||
16545654|NCT05044325|40460765|FG006|Part A:Treatment Period 2|Adverse Event|0|||
16110800|NCT02719743|38892930|FG003|Overall Study|Migrated/moved from study area|0|||
16110801|NCT02719743|38892931|FG004|Overall Study|Migrated/moved from study area|2|||
16110802|NCT02719743|38892927|FG000|Overall Study|Lost to Follow-up|1|||
16110803|NCT02719743|38892928|FG001|Overall Study|Lost to Follow-up|1|||
16110804|NCT02719743|38892929|FG002|Overall Study|Lost to Follow-up|0|||
16110805|NCT02719743|38892930|FG003|Overall Study|Lost to Follow-up|0|||
16110806|NCT02719743|38892931|FG004|Overall Study|Lost to Follow-up|0|||
16110807|NCT04014790|38892932|FG000|Overall Study|Death|4|||
16222163|NCT01791543|39295063|FG000|Overall Study|Lost to Follow-up|1|||
16344913|NCT01957579|39751094|FG003|Overall Study|Death|0|||
16344914|NCT03012841|39751095|FG000|Overall Study|Protocol Violation|0|||
16344915|NCT03012841|39751096|FG001|Overall Study|Protocol Violation|10|||
16344916|NCT03012841|39751095|FG000|Overall Study|Lost to Follow-up|6|||
16545655|NCT05044325|40460766|FG007|Part A:Treatment Period 2|Adverse Event|0|||
16545656|NCT05044325|40460767|FG008|Part A:Treatment Period 2|Adverse Event|0|||
16545657|NCT05044325|40460768|FG009|Part A:Treatment Period 2|Adverse Event|0|||
16545658|NCT05044325|40460759|FG000|Part A:Treatment Period 2|Physician Decision|0|||
16545659|NCT05044325|40460760|FG001|Part A:Treatment Period 2|Physician Decision|0|||
16545660|NCT05044325|40460761|FG002|Part A:Treatment Period 2|Physician Decision|0|||
16545661|NCT05044325|40460762|FG003|Part A:Treatment Period 2|Physician Decision|0|||
16545662|NCT05044325|40460763|FG004|Part A:Treatment Period 2|Physician Decision|0|||
16545663|NCT05044325|40460764|FG005|Part A:Treatment Period 2|Physician Decision|1|||
16545664|NCT05044325|40460765|FG006|Part A:Treatment Period 2|Physician Decision|0|||
16545665|NCT05044325|40460766|FG007|Part A:Treatment Period 2|Physician Decision|0|||
16545666|NCT05044325|40460767|FG008|Part A:Treatment Period 2|Physician Decision|0|||
16545667|NCT05044325|40460768|FG009|Part A:Treatment Period 2|Physician Decision|0|||
16545668|NCT05044325|40460759|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
16545669|NCT05044325|40460760|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
16545670|NCT05044325|40460761|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
16545671|NCT05044325|40460762|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
16545672|NCT05044325|40460763|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
16545673|NCT05044325|40460764|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
16545674|NCT05044325|40460765|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
16545675|NCT05044325|40460766|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
16545676|NCT05044325|40460767|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
16545677|NCT05044325|40460768|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
16110808|NCT04014790|38892932|FG000|Overall Study|Adverse Event|1|||
16222164|NCT01791543|39295063|FG000|Overall Study|Adverse Event|1|||
16222165|NCT01207427|39295068|FG000|Double-blind Treatment Period|Adverse Event|0|||
16545678|NCT01755702|40460769|FG000|Wash Out Period I|Other Reason|3|||
16545679|NCT01755702|40460769|FG000|Washout Period II|Other Reason|5|||
16222166|NCT01207427|39295069|FG001|Double-blind Treatment Period|Adverse Event|1|||
16222167|NCT01207427|39295070|FG002|Double-blind Treatment Period|Adverse Event|0|||
16222168|NCT01207427|39295068|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16344917|NCT03012841|39751096|FG001|Overall Study|Lost to Follow-up|1|||
16222169|NCT01207427|39295069|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
16545680|NCT03138733|40460772|FG000|Overall Study|Death|17|||
16545681|NCT03138733|40460773|FG001|Overall Study|Death|18|||
16110809|NCT04014790|38892932|FG000|Overall Study|Withdrawal by Subject|1|||
16110810|NCT00643617|38892933|FG000|Overall Study|Death|6|||
16110811|NCT00643617|38892934|FG001|Overall Study|Death|9|||
16110812|NCT00643617|38892933|FG000|Overall Study|Lost to Follow-up|42|||
16110813|NCT00643617|38892934|FG001|Overall Study|Lost to Follow-up|51|||
16110814|NCT03783689|38892935|FG000|Overall Study|Adverse Event|2|||
16344918|NCT03012841|39751095|FG000|Overall Study|Withdrawal by Subject|6|||
16110815|NCT03783689|38892936|FG001|Overall Study|Adverse Event|0|||
16110816|NCT03783689|38892935|FG000|Overall Study|Lost to Follow-up|2|||
16344919|NCT03012841|39751096|FG001|Overall Study|Withdrawal by Subject|0|||
16344920|NCT03012841|39751095|FG000|Overall Study|Unable to complete 12 month visit|6|||
16344921|NCT03012841|39751096|FG001|Overall Study|Unable to complete 12 month visit|0|||
16344922|NCT03012841|39751095|FG000|Overall Study|Subject relocation|1|||
16344923|NCT03012841|39751096|FG001|Overall Study|Subject relocation|0|||
16344924|NCT03012841|39751095|FG000|Overall Study|Seasonal winter travel|1|||
16344925|NCT03012841|39751096|FG001|Overall Study|Seasonal winter travel|0|||
16344926|NCT03012841|39751095|FG000|Overall Study|Physician Decision|0|||
16344927|NCT03012841|39751096|FG001|Overall Study|Physician Decision|2|||
16344928|NCT03012841|39751095|FG000|Overall Study|No ablation performed|0|||
16408781|NCT02908685|39977103|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408782|NCT02908685|39977104|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408783|NCT02908685|39977105|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
16408784|NCT02908685|39977106|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
16408785|NCT02908685|39977107|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
16545682|NCT03138733|40460772|FG000|Overall Study|Withdrawal by Subject|11|||
16545683|NCT03138733|40460773|FG001|Overall Study|Withdrawal by Subject|6|||
16545684|NCT03138733|40460772|FG000|Overall Study|Lost to Follow-up|3|||
16545685|NCT03138733|40460773|FG001|Overall Study|Lost to Follow-up|2|||
16545686|NCT03138733|40460772|FG000|Overall Study|Adverse Event|1|||
16344929|NCT03012841|39751096|FG001|Overall Study|No ablation performed|2|||
16344930|NCT03012841|39751095|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
16344931|NCT03012841|39751096|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
16344932|NCT03012841|39751095|FG000|Overall Study|Insurance change|0|||
16408786|NCT02908685|39977094|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408787|NCT02908685|39977095|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408788|NCT02908685|39977096|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408789|NCT02908685|39977097|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408790|NCT02908685|39977098|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408791|NCT02908685|39977099|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408792|NCT02908685|39977100|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408793|NCT02908685|39977101|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408794|NCT02908685|39977102|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408795|NCT02908685|39977103|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16545687|NCT03138733|40460773|FG001|Overall Study|Adverse Event|0|||
16545688|NCT03138733|40460772|FG000|Overall Study|Protocol Violation|1|||
16545689|NCT03138733|40460773|FG001|Overall Study|Protocol Violation|3|||
16545690|NCT03138733|40460772|FG000|Overall Study|Administrative or logistical reason|1|||
16545691|NCT03138733|40460773|FG001|Overall Study|Administrative or logistical reason|0|||
16408796|NCT02908685|39977104|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408797|NCT02908685|39977105|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408798|NCT02908685|39977106|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
16408799|NCT02908685|39977107|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
16408800|NCT02908685|39977094|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16545692|NCT03138733|40460772|FG000|Overall Study|The patient was transferred to another hospital|1|||
16344933|NCT03012841|39751096|FG001|Overall Study|Insurance change|1|||
16344934|NCT01223937|39751097|FG000|Overall Study|Withdrawal by Subject|3|||
16344935|NCT01223937|39751098|FG001|Overall Study|Withdrawal by Subject|2|||
16222170|NCT01207427|39295070|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
16222171|NCT01207427|39295068|FG000|Double-blind Treatment Period|Protocol Violation|2|||
16222172|NCT01207427|39295069|FG001|Double-blind Treatment Period|Protocol Violation|1|||
16222173|NCT01207427|39295070|FG002|Double-blind Treatment Period|Protocol Violation|1|||
16222174|NCT01207427|39295068|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
16222175|NCT01207427|39295069|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
16222176|NCT01207427|39295070|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16222177|NCT01383317|39295074|FG000|Overall Study|Lost to Follow-up|2|||
16222178|NCT01383317|39295075|FG001|Overall Study|Lost to Follow-up|1|||
16222179|NCT01383317|39295074|FG000|Overall Study|Death|1|||
16222180|NCT01383317|39295075|FG001|Overall Study|Death|0|||
16222181|NCT01383317|39295074|FG000|Overall Study|Adverse Event|0|||
16222182|NCT01383317|39295075|FG001|Overall Study|Adverse Event|1|||
16222183|NCT00565721|39295076|FG000|Overall Study|Screen Failure|2|||
16222184|NCT00565721|39295076|FG000|Overall Study|Lost to Follow-up|6|||
16222185|NCT00565721|39295076|FG000|Overall Study|Technical Problems|1|||
16222186|NCT00565721|39295076|FG000|Overall Study|Physician Decision|2|||
16222187|NCT00565721|39295076|FG000|Overall Study|Other reasons|6|||
16222188|NCT00286156|39295079|FG000|Overall Study|Missed 12 month visit|0|||
16222189|NCT00286156|39295080|FG001|Overall Study|Missed 12 month visit|0|||
16222190|NCT00286156|39295081|FG002|Overall Study|Missed 12 month visit|1|||
16222191|NCT00286156|39295079|FG000|Overall Study|AE: pulmonary embolus|0|||
16222192|NCT00286156|39295080|FG001|Overall Study|AE: pulmonary embolus|1|||
16222193|NCT00286156|39295081|FG002|Overall Study|AE: pulmonary embolus|0|||
16222194|NCT00286156|39295079|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
16222195|NCT00286156|39295080|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
16222196|NCT00286156|39295081|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
16222197|NCT00286156|39295079|FG000|Overall Study|AE: pneumonia|1|||
16222198|NCT00286156|39295080|FG001|Overall Study|AE: pneumonia|0|||
16222199|NCT00286156|39295081|FG002|Overall Study|AE: pneumonia|0|||
16222200|NCT00426842|39295085|FG000|Overall Study|Lost to Follow-up|1|||
16222201|NCT04298229|39295086|FG000|Overall Study|Physician Decision|1|||
16222202|NCT04298229|39295087|FG001|Overall Study|Physician Decision|1|||
16222203|NCT04298229|39295086|FG000|Overall Study|Withdrawal by Subject|1|||
16222204|NCT04298229|39295087|FG001|Overall Study|Withdrawal by Subject|1|||
16222205|NCT04298229|39295086|FG000|Overall Study|Did not receive IV loop diuretics|2|||
16222206|NCT04298229|39295087|FG001|Overall Study|Did not receive IV loop diuretics|0|||
16222207|NCT03696576|39295090|FG000|Overall Study|Soreness of throat after therapy|1|||
16222208|NCT03696576|39295091|FG001|Overall Study|Soreness of throat after therapy|1|||
16222209|NCT03696576|39295090|FG000|Overall Study|Lost to Follow-up|2|||
16222210|NCT03696576|39295091|FG001|Overall Study|Lost to Follow-up|4|||
16222211|NCT01454531|39295092|FG000|Overall Study|Adverse Event|14|||
16222212|NCT01454531|39295092|FG000|Overall Study|Withdrawal by Subject|5|||
16222213|NCT01454531|39295092|FG000|Overall Study|Lost to Follow-up|1|||
16222214|NCT01454531|39295092|FG000|Overall Study|Physician Decision|1|||
16222215|NCT01454531|39295092|FG000|Overall Study|Delay in IMP administration|1|||
16222216|NCT01454531|39295092|FG000|Overall Study|Other|1|||
16222217|NCT02475564|39295095|FG000|Overall Study|Withdrawal by Subject|1|||
16222218|NCT02475564|39295096|FG001|Overall Study|Withdrawal by Subject|0|||
16222219|NCT02475564|39295095|FG000|Overall Study|Lost to Follow-up|2|||
16222220|NCT02475564|39295096|FG001|Overall Study|Lost to Follow-up|1|||
16222221|NCT02475564|39295095|FG000|Overall Study|Intense Menstrual bleeding|1|||
16344936|NCT01223937|39751097|FG000|Overall Study|Lost to Follow-up|1|||
16344937|NCT01223937|39751098|FG001|Overall Study|Lost to Follow-up|4|||
16344938|NCT01223937|39751097|FG000|Overall Study|Adverse Event|1|||
16344939|NCT01223937|39751098|FG001|Overall Study|Adverse Event|4|||
16344940|NCT01223937|39751097|FG000|Overall Study|Protocol Violation|8|||
16344941|NCT01223937|39751098|FG001|Overall Study|Protocol Violation|7|||
16344942|NCT01223937|39751097|FG000|Overall Study|Other|4|||
16344943|NCT01223937|39751098|FG001|Overall Study|Other|1|||
16344944|NCT00613821|39751101|FG000|Overall Study|Withdrawal by Subject|1|||
16344945|NCT00613821|39751102|FG001|Overall Study|Withdrawal by Subject|0|||
16344946|NCT00613821|39751101|FG000|Overall Study|Physician Decision|1|||
16344947|NCT00613821|39751102|FG001|Overall Study|Physician Decision|1|||
16222222|NCT02475564|39295096|FG001|Overall Study|Intense Menstrual bleeding|0|||
16222223|NCT03137433|39295099|FG000|Overall Study|Withdrawal by Subject|11|||
16222224|NCT03137433|39295100|FG001|Overall Study|Withdrawal by Subject|11|||
16222225|NCT03137433|39295099|FG000|Overall Study|Lost to Follow-up|5|||
16222226|NCT03137433|39295100|FG001|Overall Study|Lost to Follow-up|6|||
16222227|NCT03137433|39295099|FG000|Overall Study|Physician Decision|2|||
16344948|NCT02757352|39751103|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
16344949|NCT02757352|39751104|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
16344950|NCT02757352|39751105|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
16222228|NCT03137433|39295100|FG001|Overall Study|Physician Decision|0|||
16222229|NCT03137433|39295099|FG000|Overall Study|Moved out of study area|1|||
16222230|NCT03137433|39295100|FG001|Overall Study|Moved out of study area|0|||
16222231|NCT03137433|39295099|FG000|Overall Study|Too far out of window due to COVID|0|||
16110817|NCT03783689|38892936|FG001|Overall Study|Lost to Follow-up|1|||
16110818|NCT03783689|38892935|FG000|Overall Study|Physician Decision|2|||
16110819|NCT03783689|38892936|FG001|Overall Study|Physician Decision|1|||
16110820|NCT03783689|38892935|FG000|Overall Study|Withdrawal by Subject|3|||
16110821|NCT03783689|38892936|FG001|Overall Study|Withdrawal by Subject|3|||
16110822|NCT03188536|38892937|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
16110823|NCT03188536|38892937|FG000|Overall Study|Not participated/met inclusion criteria|1|||
16110824|NCT01947517|38892938|FG000|Overall Study|Withdrawal by Subject|1|||
16110825|NCT01947517|38892939|FG001|Overall Study|Withdrawal by Subject|1|||
16110826|NCT04081389|38892942|FG000|Overall Study|Withdrawal by Subject|0|||
16110827|NCT04081389|38892943|FG001|Overall Study|Withdrawal by Subject|0|||
16110828|NCT04081389|38892944|FG002|Overall Study|Withdrawal by Subject|1|||
16110829|NCT04081389|38892945|FG003|Overall Study|Withdrawal by Subject|0|||
16110830|NCT00475228|38892946|FG000|Overall Study|Lost to Follow-up|17|||
16110831|NCT00475228|38892947|FG001|Overall Study|Lost to Follow-up|17|||
16110832|NCT01814072|38892948|FG000|Overall Study|Lost to Follow-up|2|||
16110833|NCT01814072|38892949|FG001|Overall Study|Lost to Follow-up|2|||
16110834|NCT01814072|38892950|FG002|Overall Study|Lost to Follow-up|2|||
16110835|NCT01814072|38892951|FG003|Overall Study|Lost to Follow-up|0|||
16110836|NCT01814072|38892952|FG004|Overall Study|Lost to Follow-up|2|||
16110837|NCT01814072|38892953|FG005|Overall Study|Lost to Follow-up|3|||
16110838|NCT01814072|38892954|FG006|Overall Study|Lost to Follow-up|3|||
16110839|NCT01814072|38892955|FG007|Overall Study|Lost to Follow-up|1|||
16110840|NCT01814072|38892956|FG008|Overall Study|Lost to Follow-up|2|||
16110841|NCT01814072|38892957|FG009|Overall Study|Lost to Follow-up|3|||
16110842|NCT01814072|38892958|FG010|Overall Study|Lost to Follow-up|1|||
16110843|NCT01814072|38892959|FG011|Overall Study|Lost to Follow-up|2|||
16110844|NCT01814072|38892960|FG012|Overall Study|Lost to Follow-up|2|||
16110845|NCT01814072|38892961|FG013|Overall Study|Lost to Follow-up|1|||
16110846|NCT01814072|38892962|FG014|Overall Study|Lost to Follow-up|2|||
16110847|NCT01814072|38892963|FG015|Overall Study|Lost to Follow-up|1|||
16110848|NCT01814072|38892964|FG016|Overall Study|Lost to Follow-up|3|||
16110849|NCT01814072|38892965|FG017|Overall Study|Lost to Follow-up|1|||
16110850|NCT01814072|38892966|FG018|Overall Study|Lost to Follow-up|3|||
16110851|NCT01814072|38892967|FG019|Overall Study|Lost to Follow-up|3|||
16110852|NCT01814072|38892968|FG020|Overall Study|Lost to Follow-up|2|||
16110853|NCT01814072|38892969|FG021|Overall Study|Lost to Follow-up|1|||
16110854|NCT01814072|38892970|FG022|Overall Study|Lost to Follow-up|3|||
16110855|NCT01814072|38892971|FG023|Overall Study|Lost to Follow-up|1|||
16110856|NCT01814072|38892972|FG024|Overall Study|Lost to Follow-up|4|||
16110857|NCT01814072|38892973|FG025|Overall Study|Lost to Follow-up|1|||
16110858|NCT01814072|38892974|FG026|Overall Study|Lost to Follow-up|1|||
16110859|NCT01814072|38892975|FG027|Overall Study|Lost to Follow-up|2|||
16110860|NCT01814072|38892976|FG028|Overall Study|Lost to Follow-up|3|||
16110861|NCT01814072|38892977|FG029|Overall Study|Lost to Follow-up|3|||
16110862|NCT01814072|38892978|FG030|Overall Study|Lost to Follow-up|2|||
16110863|NCT01814072|38892979|FG031|Overall Study|Lost to Follow-up|0|||
16110864|NCT01814072|38892948|FG000|Overall Study|Withdrawal by Subject|2|||
16110865|NCT01814072|38892949|FG001|Overall Study|Withdrawal by Subject|0|||
16110866|NCT01814072|38892950|FG002|Overall Study|Withdrawal by Subject|1|||
16110867|NCT01814072|38892951|FG003|Overall Study|Withdrawal by Subject|0|||
16110868|NCT01814072|38892952|FG004|Overall Study|Withdrawal by Subject|2|||
16110869|NCT01814072|38892953|FG005|Overall Study|Withdrawal by Subject|3|||
16110870|NCT01814072|38892954|FG006|Overall Study|Withdrawal by Subject|1|||
16110871|NCT01814072|38892955|FG007|Overall Study|Withdrawal by Subject|0|||
16110872|NCT01814072|38892956|FG008|Overall Study|Withdrawal by Subject|1|||
16110873|NCT01814072|38892957|FG009|Overall Study|Withdrawal by Subject|2|||
16110874|NCT01814072|38892958|FG010|Overall Study|Withdrawal by Subject|0|||
16110875|NCT01814072|38892959|FG011|Overall Study|Withdrawal by Subject|0|||
16110876|NCT01814072|38892960|FG012|Overall Study|Withdrawal by Subject|1|||
16110877|NCT01814072|38892961|FG013|Overall Study|Withdrawal by Subject|1|||
16110878|NCT01814072|38892962|FG014|Overall Study|Withdrawal by Subject|1|||
16110879|NCT01814072|38892963|FG015|Overall Study|Withdrawal by Subject|1|||
16110880|NCT01814072|38892964|FG016|Overall Study|Withdrawal by Subject|0|||
16110881|NCT01814072|38892965|FG017|Overall Study|Withdrawal by Subject|0|||
16110882|NCT01814072|38892966|FG018|Overall Study|Withdrawal by Subject|0|||
16222232|NCT03137433|39295100|FG001|Overall Study|Too far out of window due to COVID|1|||
16222233|NCT00634933|39295101|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
16222234|NCT00634933|39295102|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
16222235|NCT00634933|39295103|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
16222236|NCT00634933|39295104|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
16222237|NCT00634933|39295105|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
16222238|NCT00634933|39295101|FG000|Part A: Baseline to Week 24|Death|1|||
16222239|NCT00634933|39295102|FG001|Part A: Baseline to Week 24|Death|0|||
16222240|NCT00634933|39295103|FG002|Part A: Baseline to Week 24|Death|0|||
16222241|NCT00634933|39295104|FG003|Part A: Baseline to Week 24|Death|0|||
16222242|NCT00634933|39295105|FG004|Part A: Baseline to Week 24|Death|0|||
16222243|NCT00634933|39295101|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
16222244|NCT00634933|39295102|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
16222245|NCT00634933|39295103|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
16222246|NCT00634933|39295104|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
16222247|NCT00634933|39295105|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
16222248|NCT00634933|39295101|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
16222249|NCT00634933|39295102|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
16222250|NCT00634933|39295103|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
16222251|NCT00634933|39295104|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
16222252|NCT00634933|39295105|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
16222253|NCT00634933|39295101|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
16222254|NCT00634933|39295102|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
16222255|NCT00634933|39295103|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
16222256|NCT00634933|39295104|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
16222257|NCT00634933|39295105|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
16222258|NCT00634933|39295101|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
16222259|NCT00634933|39295102|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
16222260|NCT00634933|39295103|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
16222261|NCT00634933|39295104|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
16222262|NCT00634933|39295105|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
16222263|NCT00634933|39295101|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
16222264|NCT00634933|39295102|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
16222265|NCT00634933|39295103|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
16222266|NCT00634933|39295104|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
16222267|NCT00634933|39295105|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
16344951|NCT02757352|39751106|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
16344952|NCT02757352|39751107|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
16344953|NCT02757352|39751108|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
16344954|NCT02757352|39751109|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
16344955|NCT02757352|39751110|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
16344956|NCT02757352|39751111|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
16344957|NCT02757352|39751112|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
16344958|NCT02757352|39751103|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
16344959|NCT02757352|39751104|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
16344960|NCT02757352|39751105|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
16344961|NCT02757352|39751106|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
16344962|NCT02757352|39751107|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
16344963|NCT02757352|39751108|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
16344964|NCT02757352|39751109|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
16344965|NCT02757352|39751110|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
16344966|NCT02757352|39751111|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
16344967|NCT02757352|39751112|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
16344968|NCT02757352|39751103|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
16408801|NCT02908685|39977095|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16408802|NCT02908685|39977096|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16344969|NCT02757352|39751104|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
16344970|NCT02757352|39751105|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
16344971|NCT02757352|39751106|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
16344972|NCT02757352|39751107|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
16344973|NCT02757352|39751108|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
16344974|NCT02757352|39751109|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
16344975|NCT02757352|39751110|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
16408803|NCT02908685|39977097|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16408804|NCT02908685|39977098|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16222268|NCT00634933|39295101|FG000|Part A: Baseline to Week 24|Other|1|||
16222269|NCT00634933|39295102|FG001|Part A: Baseline to Week 24|Other|8|||
16222270|NCT00634933|39295103|FG002|Part A: Baseline to Week 24|Other|5|||
16344976|NCT02757352|39751111|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
16344977|NCT02757352|39751112|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
16344978|NCT02757352|39751103|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
16344979|NCT02757352|39751104|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
16344980|NCT02757352|39751105|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
16344981|NCT02757352|39751106|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
16344982|NCT02757352|39751107|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
16344983|NCT02757352|39751108|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
16344984|NCT02757352|39751109|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
16344985|NCT02757352|39751110|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
16344986|NCT02757352|39751111|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
16344987|NCT02757352|39751112|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
16344988|NCT02757352|39751103|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16344989|NCT02757352|39751104|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
16344990|NCT02757352|39751105|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16344991|NCT02757352|39751106|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16344992|NCT02757352|39751107|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16344993|NCT02757352|39751108|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16344994|NCT02757352|39751109|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16344995|NCT02757352|39751110|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16344996|NCT02757352|39751111|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16344997|NCT02757352|39751112|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16344998|NCT02757352|39751103|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
16344999|NCT02757352|39751104|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
16345000|NCT02757352|39751105|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
16345001|NCT02757352|39751106|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345002|NCT02757352|39751107|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345003|NCT02757352|39751108|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345004|NCT02757352|39751109|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345005|NCT02757352|39751110|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345006|NCT02757352|39751111|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345007|NCT02757352|39751112|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345008|NCT02757352|39751103|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
16345009|NCT02757352|39751104|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
16345010|NCT02757352|39751105|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
16345011|NCT02757352|39751106|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
16345012|NCT02757352|39751107|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
16345013|NCT02757352|39751108|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
16345014|NCT02757352|39751109|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
16345015|NCT02757352|39751110|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
16345016|NCT02757352|39751111|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
16345017|NCT02757352|39751112|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
16345018|NCT02757352|39751103|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
16345019|NCT02757352|39751104|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
16345020|NCT02757352|39751105|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
16345021|NCT02757352|39751106|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
16345022|NCT02757352|39751107|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
16345023|NCT02757352|39751108|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
16345024|NCT02757352|39751109|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
16345025|NCT02757352|39751110|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
16345026|NCT02757352|39751111|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
16345027|NCT02757352|39751112|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
16345028|NCT02757352|39751103|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16345029|NCT02757352|39751104|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16345030|NCT02757352|39751105|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16345031|NCT02757352|39751106|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
16345032|NCT02757352|39751107|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
16408805|NCT02908685|39977099|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16408806|NCT02908685|39977100|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16222271|NCT00634933|39295104|FG003|Part A: Baseline to Week 24|Other|0|||
16110883|NCT01814072|38892967|FG019|Overall Study|Withdrawal by Subject|2|||
16110884|NCT01814072|38892968|FG020|Overall Study|Withdrawal by Subject|0|||
16110885|NCT01814072|38892969|FG021|Overall Study|Withdrawal by Subject|0|||
16345033|NCT02757352|39751108|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
16345034|NCT02757352|39751109|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16345035|NCT02757352|39751110|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16345036|NCT02757352|39751111|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16345037|NCT02757352|39751112|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
16345038|NCT02757352|39751103|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
16345039|NCT02757352|39751104|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
16345040|NCT02757352|39751105|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
16345041|NCT02757352|39751106|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
16345042|NCT02757352|39751107|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
16345043|NCT02757352|39751108|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
16345044|NCT02757352|39751109|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
16345045|NCT02757352|39751110|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
16345046|NCT02757352|39751111|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
16345047|NCT02757352|39751112|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
16345048|NCT02757352|39751103|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
16110886|NCT01814072|38892970|FG022|Overall Study|Withdrawal by Subject|1|||
16110887|NCT01814072|38892971|FG023|Overall Study|Withdrawal by Subject|0|||
16110888|NCT01814072|38892972|FG024|Overall Study|Withdrawal by Subject|2|||
16110889|NCT01814072|38892973|FG025|Overall Study|Withdrawal by Subject|1|||
16110890|NCT01814072|38892974|FG026|Overall Study|Withdrawal by Subject|1|||
16110891|NCT01814072|38892975|FG027|Overall Study|Withdrawal by Subject|2|||
16110892|NCT01814072|38892976|FG028|Overall Study|Withdrawal by Subject|1|||
16110893|NCT01814072|38892977|FG029|Overall Study|Withdrawal by Subject|0|||
16110894|NCT01814072|38892978|FG030|Overall Study|Withdrawal by Subject|0|||
16110895|NCT01814072|38892979|FG031|Overall Study|Withdrawal by Subject|0|||
16110896|NCT01402063|38892984|FG000|Overall Study|Withdrawal by Subject|3|||
16110897|NCT01402063|38892985|FG001|Overall Study|Withdrawal by Subject|3|||
16110898|NCT03517111|38892988|FG000|Enrolled|Withdrawal by Subject|0|||
16110899|NCT03517111|38892989|FG001|Enrolled|Withdrawal by Subject|1|||
16110900|NCT03517111|38892990|FG002|Enrolled|Withdrawal by Subject|0|||
16110901|NCT03517111|38892988|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
16110902|NCT03517111|38892989|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
16110903|NCT03517111|38892990|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
16110904|NCT03517111|38892988|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
16110905|NCT03517111|38892989|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
16110906|NCT03517111|38892990|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
16110907|NCT03517111|38892988|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
16110908|NCT03517111|38892989|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
16110909|NCT03517111|38892990|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
16110910|NCT03517111|38892988|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
16222272|NCT00634933|39295105|FG004|Part A: Baseline to Week 24|Other|0|||
16110911|NCT03517111|38892989|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
16110912|NCT03517111|38892990|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
16110913|NCT02818998|38892993|FG000|Overall Study|Adverse Event|3|||
16110914|NCT02818998|38892994|FG001|Overall Study|Adverse Event|2|||
16110915|NCT02818998|38892995|FG002|Overall Study|Adverse Event|1|||
16110916|NCT02818998|38892993|FG000|Overall Study|Lost to Follow-up|4|||
16110917|NCT02818998|38892994|FG001|Overall Study|Lost to Follow-up|1|||
16222273|NCT00634933|39295101|FG000|Between Part A and Part B|Physician Decision|0|||
16222274|NCT00634933|39295102|FG001|Between Part A and Part B|Physician Decision|1|||
16222275|NCT00634933|39295103|FG002|Between Part A and Part B|Physician Decision|0|||
16222276|NCT00634933|39295104|FG003|Between Part A and Part B|Physician Decision|0|||
16222277|NCT00634933|39295105|FG004|Between Part A and Part B|Physician Decision|0|||
16222278|NCT00634933|39295101|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
16222279|NCT00634933|39295102|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
16222280|NCT00634933|39295103|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
16222281|NCT00634933|39295104|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
16110918|NCT02818998|38892995|FG002|Overall Study|Lost to Follow-up|2|||
16110919|NCT02818998|38892993|FG000|Overall Study|Withdrawal by sponsor|0|||
16110920|NCT02818998|38892994|FG001|Overall Study|Withdrawal by sponsor|1|||
16110921|NCT02818998|38892995|FG002|Overall Study|Withdrawal by sponsor|1|||
16110922|NCT02818998|38892993|FG000|Overall Study|Death|3|||
16110923|NCT02818998|38892994|FG001|Overall Study|Death|6|||
16110924|NCT02818998|38892995|FG002|Overall Study|Death|8|||
16110925|NCT02818998|38892993|FG000|Overall Study|Withdrawal by Subject|7|||
16110926|NCT02818998|38892994|FG001|Overall Study|Withdrawal by Subject|6|||
16110927|NCT02818998|38892995|FG002|Overall Study|Withdrawal by Subject|6|||
16110928|NCT02818998|38892993|FG000|Overall Study|Physician Decision|1|||
16110929|NCT02818998|38892994|FG001|Overall Study|Physician Decision|0|||
16110930|NCT02818998|38892995|FG002|Overall Study|Physician Decision|0|||
16110931|NCT04120376|38892996|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
16110932|NCT04120376|38892997|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
16110933|NCT00612352|38892998|FG000|Overall Study|Adverse Event|1|||
16110934|NCT00612352|38892999|FG001|Overall Study|Adverse Event|0|||
16110935|NCT00612352|38892998|FG000|Overall Study|Withdrawal by Subject|3|||
16110936|NCT00612352|38892999|FG001|Overall Study|Withdrawal by Subject|5|||
16110937|NCT00612352|38892998|FG000|Overall Study|moved out of state|1|||
16110938|NCT00612352|38892999|FG001|Overall Study|moved out of state|0|||
16110939|NCT00612352|38892998|FG000|Overall Study|didn't return calls/show up on test date|4|||
16110940|NCT00612352|38892999|FG001|Overall Study|didn't return calls/show up on test date|1|||
16110941|NCT01190644|38893002|FG000|Overall Study|Death|2|||
16110942|NCT01190644|38893002|FG000|Overall Study|Disease progression|1|||
16110943|NCT01266161|38893004|FG000|Overall Study|Ineligible|1|||
16110944|NCT01266161|38893005|FG001|Overall Study|Ineligible|0|||
16110945|NCT01266161|38893004|FG000|Overall Study|Lack of Efficacy|0|||
16110946|NCT01266161|38893005|FG001|Overall Study|Lack of Efficacy|1|||
16110947|NCT01266161|38893004|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
16110948|NCT01266161|38893005|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
16110949|NCT00217022|38893014|FG000|Overall Study|Withdrawal by Subject|1|||
16110950|NCT00217022|38893015|FG001|Overall Study|Withdrawal by Subject|1|||
16110951|NCT02615509|38893022|FG000|Overall Study|Lost to Follow-up|134|||
16110952|NCT02615509|38893022|FG000|Overall Study|Death|4|||
16110953|NCT02615509|38893022|FG000|Overall Study|Withdrawal by Subject|8|||
16110954|NCT02635386|38893026|FG000|Overall Study|Pregnancy|2|||
16110955|NCT02635386|38893027|FG001|Overall Study|Pregnancy|0|||
16110956|NCT02635386|38893028|FG002|Overall Study|Pregnancy|0|||
16110957|NCT02635386|38893029|FG003|Overall Study|Pregnancy|0|||
16110958|NCT02635386|38893030|FG004|Overall Study|Pregnancy|2|||
16110959|NCT02635386|38893026|FG000|Overall Study|Withdrawal by Subject|1|||
16110960|NCT02635386|38893027|FG001|Overall Study|Withdrawal by Subject|1|||
16110961|NCT02635386|38893028|FG002|Overall Study|Withdrawal by Subject|0|||
16110962|NCT02635386|38893029|FG003|Overall Study|Withdrawal by Subject|1|||
16110963|NCT02635386|38893030|FG004|Overall Study|Withdrawal by Subject|0|||
16110964|NCT02635386|38893026|FG000|Overall Study|Physician Decision|0|||
16110965|NCT02635386|38893027|FG001|Overall Study|Physician Decision|1|||
16110966|NCT02635386|38893028|FG002|Overall Study|Physician Decision|0|||
16110967|NCT02635386|38893029|FG003|Overall Study|Physician Decision|0|||
16110968|NCT02635386|38893030|FG004|Overall Study|Physician Decision|0|||
16408807|NCT02908685|39977101|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16408808|NCT02908685|39977102|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16408809|NCT02908685|39977103|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16110969|NCT02635386|38893026|FG000|Overall Study|Moved Out of State|0|||
16408810|NCT02908685|39977104|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16110970|NCT02635386|38893027|FG001|Overall Study|Moved Out of State|1|||
16110971|NCT02635386|38893028|FG002|Overall Study|Moved Out of State|0|||
16110972|NCT02635386|38893029|FG003|Overall Study|Moved Out of State|0|||
16110973|NCT02635386|38893030|FG004|Overall Study|Moved Out of State|0|||
16110974|NCT02635386|38893026|FG000|Overall Study|Noncompliant|0|||
16110975|NCT02635386|38893027|FG001|Overall Study|Noncompliant|2|||
16110976|NCT02635386|38893028|FG002|Overall Study|Noncompliant|1|||
16110977|NCT02635386|38893029|FG003|Overall Study|Noncompliant|1|||
16110978|NCT02635386|38893030|FG004|Overall Study|Noncompliant|1|||
16110979|NCT02635386|38893026|FG000|Overall Study|side effects|0|||
16110980|NCT02635386|38893027|FG001|Overall Study|side effects|0|||
16222282|NCT00634933|39295105|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
16408811|NCT02908685|39977105|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16408812|NCT02908685|39977106|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
16408813|NCT02908685|39977107|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
16408814|NCT02908685|39977094|FG000|Part 2 OLE: > Month 24|Death|0|||
16408815|NCT02908685|39977095|FG001|Part 2 OLE: > Month 24|Death|0|||
16408816|NCT02908685|39977096|FG002|Part 2 OLE: > Month 24|Death|0|||
16408817|NCT02908685|39977097|FG003|Part 2 OLE: > Month 24|Death|0|||
16408818|NCT02908685|39977098|FG004|Part 2 OLE: > Month 24|Death|0|||
16408819|NCT02908685|39977099|FG005|Part 2 OLE: > Month 24|Death|0|||
16408820|NCT02908685|39977100|FG006|Part 2 OLE: > Month 24|Death|0|||
16408821|NCT02908685|39977101|FG007|Part 2 OLE: > Month 24|Death|0|||
16408822|NCT02908685|39977102|FG008|Part 2 OLE: > Month 24|Death|0|||
16408823|NCT02908685|39977103|FG009|Part 2 OLE: > Month 24|Death|0|||
16408824|NCT02908685|39977104|FG010|Part 2 OLE: > Month 24|Death|0|||
16408825|NCT02908685|39977105|FG011|Part 2 OLE: > Month 24|Death|0|||
16408826|NCT02908685|39977106|FG012|Part 2 OLE: > Month 24|Death|1|||
16408827|NCT02908685|39977107|FG013|Part 2 OLE: > Month 24|Death|0|||
16408828|NCT02908685|39977094|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
16408829|NCT02908685|39977095|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
16408830|NCT02908685|39977096|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
16408831|NCT02908685|39977097|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
16408832|NCT02908685|39977098|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
16408833|NCT02908685|39977099|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
16408834|NCT02908685|39977100|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
16408835|NCT02908685|39977101|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
16408836|NCT02908685|39977102|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
16408837|NCT02908685|39977103|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
16408838|NCT02908685|39977104|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
16408839|NCT02908685|39977105|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
16408840|NCT02908685|39977106|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
16408841|NCT02908685|39977107|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
16408842|NCT02908685|39977094|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16408843|NCT02908685|39977095|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16408844|NCT02908685|39977096|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16408845|NCT02908685|39977097|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16110981|NCT02635386|38893028|FG002|Overall Study|side effects|1|||
16110982|NCT02635386|38893029|FG003|Overall Study|side effects|4|||
16110983|NCT02635386|38893030|FG004|Overall Study|side effects|6|||
16110984|NCT02635386|38893026|FG000|Overall Study|needed other major surgery|0|||
16110985|NCT02635386|38893027|FG001|Overall Study|needed other major surgery|1|||
16110986|NCT02635386|38893028|FG002|Overall Study|needed other major surgery|0|||
16110987|NCT02635386|38893029|FG003|Overall Study|needed other major surgery|0|||
16110988|NCT02635386|38893030|FG004|Overall Study|needed other major surgery|0|||
16110989|NCT02635386|38893026|FG000|Overall Study|Other medical problems not drug related|0|||
16110990|NCT02635386|38893027|FG001|Overall Study|Other medical problems not drug related|0|||
16110991|NCT02635386|38893028|FG002|Overall Study|Other medical problems not drug related|0|||
16110992|NCT02635386|38893029|FG003|Overall Study|Other medical problems not drug related|1|||
16345049|NCT02757352|39751104|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
16345050|NCT02757352|39751105|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
16345051|NCT02757352|39751106|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
16345052|NCT02757352|39751107|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
16345053|NCT02757352|39751108|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
16345054|NCT02757352|39751109|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
16408846|NCT02908685|39977098|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16408847|NCT02908685|39977099|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16545693|NCT03138733|40460773|FG001|Overall Study|The patient was transferred to another hospital|0|||
16545694|NCT04899245|40460779|FG000|Overall Study|Withdrawal by Subject|3|||
16545695|NCT04899245|40460780|FG001|Overall Study|Withdrawal by Subject|5|||
16545696|NCT04899245|40460781|FG002|Overall Study|Withdrawal by Subject|2|||
16545697|NCT04899245|40460779|FG000|Overall Study|No longer eligible - Left staff position|0|||
16545698|NCT04899245|40460780|FG001|Overall Study|No longer eligible - Left staff position|0|||
16545699|NCT04899245|40460781|FG002|Overall Study|No longer eligible - Left staff position|1|||
16545700|NCT04899245|40460779|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
16545701|NCT04899245|40460780|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
16545702|NCT04899245|40460781|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
16545703|NCT04899245|40460779|FG000|Overall Study|No longer eligible - Moved away from area|2|||
16545704|NCT04899245|40460780|FG001|Overall Study|No longer eligible - Moved away from area|2|||
16545705|NCT04899245|40460781|FG002|Overall Study|No longer eligible - Moved away from area|0|||
16110993|NCT02635386|38893030|FG004|Overall Study|Other medical problems not drug related|0|||
16110994|NCT00958711|38893031|FG000|Overall Study|Withdrawal by Subject|0|||
16110995|NCT00958711|38893032|FG001|Overall Study|Withdrawal by Subject|4|||
16110996|NCT00958711|38893031|FG000|Overall Study|Physician Decision|5|||
16110997|NCT00958711|38893032|FG001|Overall Study|Physician Decision|7|||
16110998|NCT00958711|38893031|FG000|Overall Study|Lost to Follow-up|4|||
16345055|NCT02757352|39751110|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
16345056|NCT02757352|39751111|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
16110999|NCT00958711|38893032|FG001|Overall Study|Lost to Follow-up|1|||
16111000|NCT00958711|38893031|FG000|Overall Study|Other|2|||
16111001|NCT00958711|38893032|FG001|Overall Study|Other|5|||
16345057|NCT02757352|39751112|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
16345058|NCT02757352|39751103|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345059|NCT02757352|39751104|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345060|NCT02757352|39751105|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345061|NCT02757352|39751106|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
16345062|NCT02757352|39751107|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
16345063|NCT02757352|39751108|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
16345064|NCT02757352|39751109|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345065|NCT02757352|39751110|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345066|NCT02757352|39751111|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345067|NCT02757352|39751112|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
16345068|NCT02757352|39751103|FG000|Follow-Up Period|Adverse Event|0|||
16345069|NCT02757352|39751104|FG001|Follow-Up Period|Adverse Event|0|||
16345070|NCT02757352|39751105|FG002|Follow-Up Period|Adverse Event|0|||
16545706|NCT00754338|40460782|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
16545707|NCT00754338|40460783|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
16545708|NCT00754338|40460784|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
16545709|NCT00754338|40460785|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
16545710|NCT00754338|40460782|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
16545711|NCT00754338|40460783|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
16545712|NCT00754338|40460784|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
16545713|NCT00754338|40460785|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
16545714|NCT00615264|40460786|FG000|Overall Study|Withdrawal by Subject|17|||
16545715|NCT00615264|40460787|FG001|Overall Study|Withdrawal by Subject|19|||
16545716|NCT00615264|40460786|FG000|Overall Study|Lost to Follow-up|6|||
16545717|NCT00615264|40460787|FG001|Overall Study|Lost to Follow-up|13|||
16545718|NCT00615264|40460786|FG000|Overall Study|Adverse Event|8|||
16545719|NCT00615264|40460787|FG001|Overall Study|Adverse Event|5|||
16545720|NCT00615264|40460786|FG000|Overall Study|Death|1|||
16545721|NCT00615264|40460787|FG001|Overall Study|Death|1|||
16545722|NCT00615264|40460786|FG000|Overall Study|Protocol Violation|11|||
16545723|NCT00615264|40460787|FG001|Overall Study|Protocol Violation|7|||
16545724|NCT00615264|40460786|FG000|Overall Study|Not defined|7|||
16545725|NCT00615264|40460787|FG001|Overall Study|Not defined|4|||
16545726|NCT00615264|40460786|FG000|Overall Study|Dermal Hypersensitivity|0|||
16545727|NCT00615264|40460787|FG001|Overall Study|Dermal Hypersensitivity|3|||
16545728|NCT01782742|40460797|FG000|Double-blind Treatment Phase|Adverse Event|1|||
16545729|NCT01782742|40460798|FG001|Double-blind Treatment Phase|Adverse Event|0|||
16545730|NCT01892345|40460799|FG000|Overall Study|Adverse Event|0|||
16545731|NCT01892345|40460800|FG001|Overall Study|Adverse Event|2|||
16545732|NCT01892345|40460799|FG000|Overall Study|Death|1|||
16111002|NCT00958711|38893031|FG000|Overall Study|Death|1|||
16111003|NCT00958711|38893032|FG001|Overall Study|Death|2|||
16111004|NCT00958711|38893031|FG000|Overall Study|Adverse Event|1|||
16111005|NCT00958711|38893032|FG001|Overall Study|Adverse Event|2|||
16111006|NCT02575950|38893033|FG000|Overall Study|Withdrawal by Subject|0|||
16111007|NCT02575950|38893034|FG001|Overall Study|Withdrawal by Subject|0|||
16111008|NCT02575950|38893035|FG002|Overall Study|Withdrawal by Subject|0|||
16111009|NCT02575950|38893036|FG003|Overall Study|Withdrawal by Subject|2|||
16111010|NCT02575950|38893033|FG000|Overall Study|Lost to Follow-up|0|||
16111011|NCT02575950|38893034|FG001|Overall Study|Lost to Follow-up|1|||
16111012|NCT02575950|38893035|FG002|Overall Study|Lost to Follow-up|0|||
16111013|NCT02575950|38893036|FG003|Overall Study|Lost to Follow-up|3|||
16111014|NCT00967005|38893037|FG000|Overall Study|Lost to Follow-up|7|||
16111015|NCT00967005|38893038|FG001|Overall Study|Lost to Follow-up|10|||
16111016|NCT00416598|38893039|FG000|Induction & Intensification|Adverse Event|38|||
16111017|NCT00416598|38893039|FG000|Induction & Intensification|Death|32|||
16111018|NCT00416598|38893039|FG000|Induction & Intensification|Withdrawal by Subject|46|||
16111019|NCT00416598|38893039|FG000|Induction & Intensification|Alternative Treatment|135|||
16111020|NCT00416598|38893039|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
16111021|NCT00416598|38893039|FG000|Induction & Intensification|Relapse/progression|29|||
16111022|NCT00416598|38893039|FG000|Induction & Intensification|Failed induction|87|||
16111023|NCT00416598|38893039|FG000|Decitabine Maintenance|Adverse Event|5|||
16111024|NCT00416598|38893039|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
16111025|NCT00416598|38893039|FG000|Decitabine Maintenance|Progression/relapse|38|||
16111026|NCT00416598|38893039|FG000|Decitabine Maintenance|Alternative treatment|2|||
16111027|NCT00416598|38893039|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
16111028|NCT04016272|38893040|FG000|Overall Study|Withdrawal by Subject|1|||
16111029|NCT04016272|38893041|FG001|Overall Study|Withdrawal by Subject|2|||
16111030|NCT01322009|38893042|FG000|Overall Study|Death|0|||
16111031|NCT01322009|38893043|FG001|Overall Study|Death|1|||
16222283|NCT00634933|39295101|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
16222284|NCT00634933|39295102|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
16222285|NCT00634933|39295103|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
16222286|NCT00634933|39295104|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
16222287|NCT00634933|39295105|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
16222288|NCT00634933|39295101|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
16222289|NCT00634933|39295102|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
16222290|NCT00634933|39295103|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
16222291|NCT00634933|39295104|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
16222292|NCT00634933|39295105|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
16111032|NCT01322009|38893042|FG000|Overall Study|Adverse Event|0|||
16345071|NCT02757352|39751106|FG003|Follow-Up Period|Adverse Event|0|||
16222293|NCT00634933|39295101|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
16222294|NCT00634933|39295102|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
16222295|NCT00634933|39295103|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
16222296|NCT00634933|39295104|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
16222297|NCT00634933|39295105|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
16222298|NCT00634933|39295101|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
16222299|NCT00634933|39295102|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
16222300|NCT00634933|39295103|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
16222301|NCT00634933|39295104|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
16222302|NCT00634933|39295105|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
16222303|NCT00634933|39295101|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
16222304|NCT00634933|39295102|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
16222305|NCT00634933|39295103|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
16222306|NCT00634933|39295104|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
16222307|NCT00634933|39295105|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
16222308|NCT00634933|39295101|FG000|Part B: Week 24 to Week 52|Other|0|||
16222309|NCT00634933|39295102|FG001|Part B: Week 24 to Week 52|Other|0|||
16222310|NCT00634933|39295103|FG002|Part B: Week 24 to Week 52|Other|5|||
16222311|NCT00634933|39295104|FG003|Part B: Week 24 to Week 52|Other|0|||
16222312|NCT00634933|39295105|FG004|Part B: Week 24 to Week 52|Other|1|||
16222313|NCT00931515|39295106|FG000|Overall Study|Lost to Follow-up|2|||
16222314|NCT00931515|39295107|FG001|Overall Study|Lost to Follow-up|5|||
16222315|NCT03055806|39295108|FG000|Overall Study|Adverse Event|0|||
16222316|NCT03055806|39295109|FG001|Overall Study|Adverse Event|0|||
16222317|NCT03055806|39295110|FG002|Overall Study|Adverse Event|1|||
16222318|NCT03055806|39295111|FG003|Overall Study|Adverse Event|1|||
16222319|NCT03055806|39295108|FG000|Overall Study|Lost to Follow-up|0|||
16222320|NCT03055806|39295109|FG001|Overall Study|Lost to Follow-up|3|||
16222321|NCT03055806|39295110|FG002|Overall Study|Lost to Follow-up|6|||
16222322|NCT03055806|39295111|FG003|Overall Study|Lost to Follow-up|7|||
16222323|NCT03055806|39295108|FG000|Overall Study|Physician Decision|1|||
16222324|NCT03055806|39295109|FG001|Overall Study|Physician Decision|0|||
16222325|NCT03055806|39295110|FG002|Overall Study|Physician Decision|0|||
16222326|NCT03055806|39295111|FG003|Overall Study|Physician Decision|1|||
16222327|NCT03055806|39295108|FG000|Overall Study|Protocol Violation|1|||
16222328|NCT03055806|39295109|FG001|Overall Study|Protocol Violation|0|||
16222329|NCT03055806|39295110|FG002|Overall Study|Protocol Violation|0|||
16222330|NCT03055806|39295111|FG003|Overall Study|Protocol Violation|0|||
16222331|NCT03055806|39295108|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
16222332|NCT03055806|39295109|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
16222333|NCT03055806|39295110|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
16222334|NCT03055806|39295111|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
16222335|NCT03055806|39295108|FG000|Overall Study|Withdrawal of consent to continue study|2|||
16222336|NCT03055806|39295109|FG001|Overall Study|Withdrawal of consent to continue study|3|||
16222337|NCT03055806|39295110|FG002|Overall Study|Withdrawal of consent to continue study|4|||
16222338|NCT03055806|39295111|FG003|Overall Study|Withdrawal of consent to continue study|6|||
16222339|NCT03055806|39295108|FG000|Overall Study|Partner not willing to try intercourse|1|||
16222340|NCT03055806|39295109|FG001|Overall Study|Partner not willing to try intercourse|0|||
16222341|NCT03055806|39295110|FG002|Overall Study|Partner not willing to try intercourse|0|||
16222342|NCT03055806|39295111|FG003|Overall Study|Partner not willing to try intercourse|0|||
16222343|NCT01990339|39295121|FG000|Overall Study|Data Not Available|49|||
16222344|NCT01990339|39295121|FG000|Overall Study|Voluntary Withdrawal|1402|||
16222345|NCT01990339|39295121|FG000|Overall Study|Lost to Follow-up|861|||
16222346|NCT00141297|39295122|FG000|Overall Study|Adverse Event|0|||
16222347|NCT00141297|39295123|FG001|Overall Study|Adverse Event|0|||
16222348|NCT00141297|39295124|FG002|Overall Study|Adverse Event|1|||
16222349|NCT00141297|39295125|FG003|Overall Study|Adverse Event|0|||
16222350|NCT00141297|39295126|FG004|Overall Study|Adverse Event|1|||
16222351|NCT00141297|39295127|FG005|Overall Study|Adverse Event|1|||
16222352|NCT00141297|39295128|FG006|Overall Study|Adverse Event|0|||
16222353|NCT00141297|39295129|FG007|Overall Study|Adverse Event|1|||
16222354|NCT00141297|39295130|FG008|Overall Study|Adverse Event|1|||
16222355|NCT00141297|39295131|FG009|Overall Study|Adverse Event|0|||
16222356|NCT00141297|39295122|FG000|Overall Study|Death|1|||
16222357|NCT00141297|39295123|FG001|Overall Study|Death|0|||
16222358|NCT00141297|39295124|FG002|Overall Study|Death|0|||
16222359|NCT00141297|39295125|FG003|Overall Study|Death|0|||
16222360|NCT00141297|39295126|FG004|Overall Study|Death|0|||
16222361|NCT00141297|39295127|FG005|Overall Study|Death|0|||
16222362|NCT00141297|39295128|FG006|Overall Study|Death|0|||
16222363|NCT00141297|39295129|FG007|Overall Study|Death|0|||
16222364|NCT00141297|39295130|FG008|Overall Study|Death|1|||
16222365|NCT00141297|39295131|FG009|Overall Study|Death|0|||
16222366|NCT00141297|39295122|FG000|Overall Study|Withdrawal by Subject|0|||
16222367|NCT00141297|39295123|FG001|Overall Study|Withdrawal by Subject|0|||
16222368|NCT00141297|39295124|FG002|Overall Study|Withdrawal by Subject|0|||
16222369|NCT00141297|39295125|FG003|Overall Study|Withdrawal by Subject|0|||
16222370|NCT00141297|39295126|FG004|Overall Study|Withdrawal by Subject|0|||
16222371|NCT00141297|39295127|FG005|Overall Study|Withdrawal by Subject|0|||
16222372|NCT00141297|39295128|FG006|Overall Study|Withdrawal by Subject|0|||
16222373|NCT00141297|39295129|FG007|Overall Study|Withdrawal by Subject|0|||
16222374|NCT00141297|39295130|FG008|Overall Study|Withdrawal by Subject|1|||
16222375|NCT00141297|39295131|FG009|Overall Study|Withdrawal by Subject|0|||
16222376|NCT00141297|39295122|FG000|Overall Study|Other|0|||
16222377|NCT00141297|39295123|FG001|Overall Study|Other|0|||
16222378|NCT00141297|39295124|FG002|Overall Study|Other|0|||
16222379|NCT00141297|39295125|FG003|Overall Study|Other|1|||
16222380|NCT00141297|39295126|FG004|Overall Study|Other|5|||
16222381|NCT00141297|39295127|FG005|Overall Study|Other|0|||
16222382|NCT00141297|39295128|FG006|Overall Study|Other|0|||
16222383|NCT00141297|39295129|FG007|Overall Study|Other|0|||
16222384|NCT00141297|39295130|FG008|Overall Study|Other|2|||
16222385|NCT00141297|39295131|FG009|Overall Study|Other|0|||
16222386|NCT00141297|39295122|FG000|Overall Study|Progressive Disease|2|||
16222387|NCT00141297|39295123|FG001|Overall Study|Progressive Disease|3|||
16222388|NCT00141297|39295124|FG002|Overall Study|Progressive Disease|6|||
16222389|NCT00141297|39295125|FG003|Overall Study|Progressive Disease|2|||
16222390|NCT00141297|39295126|FG004|Overall Study|Progressive Disease|15|||
16222391|NCT00141297|39295127|FG005|Overall Study|Progressive Disease|2|||
16222392|NCT00141297|39295128|FG006|Overall Study|Progressive Disease|3|||
16222393|NCT00141297|39295129|FG007|Overall Study|Progressive Disease|3|||
16222394|NCT00141297|39295130|FG008|Overall Study|Progressive Disease|15|||
16222395|NCT00141297|39295131|FG009|Overall Study|Progressive Disease|6|||
16222396|NCT00141297|39295122|FG000|Overall Study|Transitioned|0|||
16222397|NCT00141297|39295123|FG001|Overall Study|Transitioned|0|||
16222398|NCT00141297|39295124|FG002|Overall Study|Transitioned|0|||
16222399|NCT00141297|39295125|FG003|Overall Study|Transitioned|0|||
16111033|NCT01322009|38893043|FG001|Overall Study|Adverse Event|1|||
16222400|NCT00141297|39295126|FG004|Overall Study|Transitioned|1|||
16222401|NCT00141297|39295127|FG005|Overall Study|Transitioned|0|||
16222402|NCT00141297|39295128|FG006|Overall Study|Transitioned|0|||
16222403|NCT00141297|39295129|FG007|Overall Study|Transitioned|0|||
16222404|NCT00141297|39295130|FG008|Overall Study|Transitioned|0|||
16222405|NCT00141297|39295131|FG009|Overall Study|Transitioned|0|||
16408848|NCT02908685|39977100|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16408849|NCT02908685|39977101|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16408850|NCT02908685|39977102|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16408851|NCT02908685|39977103|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16408852|NCT02908685|39977104|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16408853|NCT02908685|39977105|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
16408854|NCT02908685|39977106|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
16408855|NCT02908685|39977107|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
16408856|NCT02226198|39977108|FG000|Lead-in Phase|Protocol Violation|1|||
16408857|NCT02226198|39977109|FG001|Lead-in Phase|Protocol Violation|0|||
16408858|NCT02226198|39977110|FG002|Lead-in Phase|Protocol Violation|0|||
16408859|NCT02226198|39977108|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
16408860|NCT02226198|39977109|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
16408861|NCT02226198|39977110|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
16408862|NCT03349645|39977111|FG000|Overall Study|Sponsor Terminated Study|75|||
16408863|NCT03349645|39977111|FG000|Overall Study|Withdrawal by Subject|4|||
16408864|NCT03349645|39977111|FG000|Overall Study|Protocol Violation|1|||
16408865|NCT03349645|39977111|FG000|Overall Study|Other|2|||
16408866|NCT01767493|39977120|FG000|Overall Study|screen failures|3|||
16408867|NCT00869050|39977121|FG000|Overall Study|Screen Failure|3|||
16408868|NCT02275117|39977122|FG000|Overall Study|Adverse Event|0|||
16408869|NCT02275117|39977123|FG001|Overall Study|Adverse Event|0|||
16408870|NCT02275117|39977124|FG002|Overall Study|Adverse Event|0|||
16408871|NCT02275117|39977125|FG003|Overall Study|Adverse Event|0|||
16408872|NCT02275117|39977126|FG004|Overall Study|Adverse Event|1|||
16408873|NCT02275117|39977122|FG000|Overall Study|Lack of Efficacy|6|||
16408874|NCT02275117|39977123|FG001|Overall Study|Lack of Efficacy|7|||
16408875|NCT02275117|39977124|FG002|Overall Study|Lack of Efficacy|5|||
16408876|NCT02275117|39977125|FG003|Overall Study|Lack of Efficacy|2|||
16408877|NCT02275117|39977126|FG004|Overall Study|Lack of Efficacy|10|||
16408878|NCT02275117|39977122|FG000|Overall Study|Lost to Follow-up|11|||
16408879|NCT02275117|39977123|FG001|Overall Study|Lost to Follow-up|16|||
16408880|NCT02275117|39977124|FG002|Overall Study|Lost to Follow-up|15|||
16408881|NCT02275117|39977125|FG003|Overall Study|Lost to Follow-up|16|||
16408882|NCT02275117|39977126|FG004|Overall Study|Lost to Follow-up|8|||
16408883|NCT02275117|39977122|FG000|Overall Study|Physician Decision|0|||
16408884|NCT02275117|39977123|FG001|Overall Study|Physician Decision|1|||
16408885|NCT02275117|39977124|FG002|Overall Study|Physician Decision|1|||
16408886|NCT02275117|39977125|FG003|Overall Study|Physician Decision|0|||
16408887|NCT02275117|39977126|FG004|Overall Study|Physician Decision|1|||
16408888|NCT02275117|39977122|FG000|Overall Study|Protocol Violation|1|||
16408889|NCT02275117|39977123|FG001|Overall Study|Protocol Violation|0|||
16408890|NCT02275117|39977124|FG002|Overall Study|Protocol Violation|1|||
16408891|NCT02275117|39977125|FG003|Overall Study|Protocol Violation|1|||
16408892|NCT02275117|39977126|FG004|Overall Study|Protocol Violation|0|||
16408893|NCT02275117|39977122|FG000|Overall Study|Withdrawal by Subject|6|||
16408894|NCT02275117|39977123|FG001|Overall Study|Withdrawal by Subject|4|||
16408895|NCT02275117|39977124|FG002|Overall Study|Withdrawal by Subject|7|||
16408896|NCT02275117|39977125|FG003|Overall Study|Withdrawal by Subject|3|||
16408897|NCT02275117|39977126|FG004|Overall Study|Withdrawal by Subject|3|||
16408898|NCT02275117|39977122|FG000|Overall Study|Terminated by Sponsor|4|||
16408899|NCT02275117|39977123|FG001|Overall Study|Terminated by Sponsor|4|||
16408900|NCT02275117|39977124|FG002|Overall Study|Terminated by Sponsor|4|||
16408901|NCT02275117|39977125|FG003|Overall Study|Terminated by Sponsor|6|||
16408902|NCT02275117|39977126|FG004|Overall Study|Terminated by Sponsor|4|||
16408903|NCT02275117|39977122|FG000|Overall Study|Worsening of Study Indication|0|||
16222406|NCT02994927|39295134|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16408904|NCT02275117|39977123|FG001|Overall Study|Worsening of Study Indication|1|||
16408905|NCT02275117|39977124|FG002|Overall Study|Worsening of Study Indication|2|||
16408906|NCT02275117|39977125|FG003|Overall Study|Worsening of Study Indication|0|||
16408907|NCT02275117|39977126|FG004|Overall Study|Worsening of Study Indication|0|||
16408908|NCT02275117|39977122|FG000|Overall Study|Study Burden|5|||
16408909|NCT02275117|39977123|FG001|Overall Study|Study Burden|4|||
16408910|NCT02275117|39977124|FG002|Overall Study|Study Burden|7|||
16408911|NCT02275117|39977125|FG003|Overall Study|Study Burden|5|||
16408912|NCT02275117|39977126|FG004|Overall Study|Study Burden|7|||
16408913|NCT02275117|39977122|FG000|Overall Study|Other|1|||
16222407|NCT02994927|39295135|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16222408|NCT02994927|39295134|FG000|Overall Study|Did not meet eligibility criteria|0|||
16222409|NCT02994927|39295135|FG001|Overall Study|Did not meet eligibility criteria|1|||
16408914|NCT02275117|39977123|FG001|Overall Study|Other|0|||
16408915|NCT02275117|39977124|FG002|Overall Study|Other|0|||
16408916|NCT02275117|39977125|FG003|Overall Study|Other|0|||
16222410|NCT02994927|39295134|FG000|Overall Study|Physician Decision|4|||
16408917|NCT02275117|39977126|FG004|Overall Study|Other|2|||
16408918|NCT00159913|39977127|FG000|Overall Study|Adverse Event|1|||
16408919|NCT00159913|39977128|FG001|Overall Study|Adverse Event|0|||
16345072|NCT02757352|39751107|FG004|Follow-Up Period|Adverse Event|0|||
16345073|NCT02757352|39751108|FG005|Follow-Up Period|Adverse Event|0|||
16345074|NCT02757352|39751109|FG006|Follow-Up Period|Adverse Event|1|||
16345075|NCT02757352|39751110|FG007|Follow-Up Period|Adverse Event|0|||
16345076|NCT02757352|39751111|FG008|Follow-Up Period|Adverse Event|2|||
16345077|NCT02757352|39751112|FG009|Follow-Up Period|Adverse Event|0|||
16345078|NCT02757352|39751103|FG000|Follow-Up Period|Lost to Follow-up|0|||
16408920|NCT00159913|39977129|FG002|Overall Study|Adverse Event|1|||
16408921|NCT00159913|39977130|FG003|Overall Study|Adverse Event|0|||
16408922|NCT00159913|39977127|FG000|Overall Study|Withdrawal by Subject|0|||
16408923|NCT00159913|39977128|FG001|Overall Study|Withdrawal by Subject|0|||
16408924|NCT00159913|39977129|FG002|Overall Study|Withdrawal by Subject|0|||
16408925|NCT00159913|39977130|FG003|Overall Study|Withdrawal by Subject|1|||
16408926|NCT00159913|39977127|FG000|Overall Study|Lost to Follow-up|0|||
16408927|NCT00159913|39977128|FG001|Overall Study|Lost to Follow-up|0|||
16408928|NCT00159913|39977129|FG002|Overall Study|Lost to Follow-up|0|||
16408929|NCT00159913|39977130|FG003|Overall Study|Lost to Follow-up|1|||
16408930|NCT00159913|39977127|FG000|Overall Study|Protocol Violation|1|||
16408931|NCT00159913|39977128|FG001|Overall Study|Protocol Violation|0|||
16408932|NCT00159913|39977129|FG002|Overall Study|Protocol Violation|1|||
16408933|NCT00159913|39977130|FG003|Overall Study|Protocol Violation|0|||
16408934|NCT00511433|39977131|FG000|Overall Study|Adverse Event|5|||
16408935|NCT00511433|39977132|FG001|Overall Study|Adverse Event|0|||
16408936|NCT00511433|39977131|FG000|Overall Study|Other Reason|1|||
16408937|NCT00511433|39977132|FG001|Overall Study|Other Reason|1|||
16545733|NCT01892345|40460800|FG001|Overall Study|Death|0|||
16545734|NCT01892345|40460799|FG000|Overall Study|Lost to Follow-up|3|||
16545735|NCT01892345|40460800|FG001|Overall Study|Lost to Follow-up|0|||
16545736|NCT01892345|40460799|FG000|Overall Study|Withdrawal by Subject|12|||
16545737|NCT01892345|40460800|FG001|Overall Study|Withdrawal by Subject|1|||
16545738|NCT02312856|40460801|FG000|Overall Study|Death|1|||
16545739|NCT02312856|40460801|FG000|Overall Study|Lost to Follow-up|3|||
16545740|NCT02801669|40460802|FG000|Overall Study|Death|66|||
16345079|NCT02757352|39751104|FG001|Follow-Up Period|Lost to Follow-up|0|||
16345080|NCT02757352|39751105|FG002|Follow-Up Period|Lost to Follow-up|0|||
16345081|NCT02757352|39751106|FG003|Follow-Up Period|Lost to Follow-up|0|||
16345082|NCT02757352|39751107|FG004|Follow-Up Period|Lost to Follow-up|0|||
16408938|NCT01360398|39977133|FG000|Overall Study|Withdrawal by Subject|14|||
16408939|NCT01360398|39977133|FG000|Overall Study|Other|7|||
16545741|NCT02801669|40460803|FG001|Overall Study|Death|69|||
16545742|NCT02801669|40460802|FG000|Overall Study|Withdrawal by Subject|81|||
16545743|NCT02801669|40460803|FG001|Overall Study|Withdrawal by Subject|77|||
16545744|NCT02801669|40460802|FG000|Overall Study|Other|4|||
16545745|NCT02801669|40460803|FG001|Overall Study|Other|6|||
16545746|NCT04524598|40460805|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
16545747|NCT04524598|40460806|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
16545748|NCT04524598|40460807|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
16545749|NCT04524598|40460808|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
16222411|NCT02994927|39295135|FG001|Overall Study|Physician Decision|3|||
16222412|NCT02994927|39295134|FG000|Overall Study|Death|4|||
16222413|NCT02994927|39295135|FG001|Overall Study|Death|2|||
16222414|NCT02994927|39295134|FG000|Overall Study|Adverse Event|2|||
16222415|NCT02994927|39295135|FG001|Overall Study|Adverse Event|1|||
16222416|NCT02994927|39295134|FG000|Overall Study|Withdrawal by Subject|3|||
16222417|NCT02994927|39295135|FG001|Overall Study|Withdrawal by Subject|6|||
16545750|NCT04524598|40460809|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
16222418|NCT02994927|39295134|FG000|Overall Study|Lost to Follow-up|2|||
16222419|NCT02994927|39295135|FG001|Overall Study|Lost to Follow-up|1|||
16408940|NCT01360398|39977133|FG000|Overall Study|Migrated/moved from study area|1|||
16345083|NCT02757352|39751108|FG005|Follow-Up Period|Lost to Follow-up|0|||
16345084|NCT02757352|39751109|FG006|Follow-Up Period|Lost to Follow-up|0|||
16408941|NCT01442064|39977138|FG000|Overall Study|Adverse Event|2|||
16408942|NCT01442064|39977139|FG001|Overall Study|Adverse Event|2|||
16408943|NCT01442064|39977140|FG002|Overall Study|Adverse Event|2|||
16408944|NCT01442064|39977141|FG003|Overall Study|Adverse Event|1|||
16408945|NCT01442064|39977142|FG004|Overall Study|Adverse Event|2|||
16408946|NCT01442064|39977143|FG005|Overall Study|Adverse Event|0|||
16408947|NCT01442064|39977138|FG000|Overall Study|Death|0|||
16545751|NCT04524598|40460805|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
16408948|NCT01442064|39977139|FG001|Overall Study|Death|1|||
16408949|NCT01442064|39977140|FG002|Overall Study|Death|3|||
16408950|NCT01442064|39977141|FG003|Overall Study|Death|3|||
16408951|NCT01442064|39977142|FG004|Overall Study|Death|1|||
16408952|NCT01442064|39977143|FG005|Overall Study|Death|3|||
16222420|NCT00352027|39295137|FG000|Overall Study|Progressive disease|3|||
16222421|NCT01024946|39295144|FG000|Overall Study|Screen Failure|3|||
16222422|NCT01024946|39295144|FG000|Overall Study|Withdrawal by Subject|1|||
16222423|NCT01024946|39295144|FG000|Overall Study|Adverse Event|1|||
16222424|NCT02185040|39295145|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
16222425|NCT02185040|39295146|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
16408953|NCT01442064|39977138|FG000|Overall Study|Lost to Follow-up|5|||
16408954|NCT01442064|39977139|FG001|Overall Study|Lost to Follow-up|5|||
16408955|NCT01442064|39977140|FG002|Overall Study|Lost to Follow-up|1|||
16345085|NCT02757352|39751110|FG007|Follow-Up Period|Lost to Follow-up|0|||
16345086|NCT02757352|39751111|FG008|Follow-Up Period|Lost to Follow-up|1|||
16345087|NCT02757352|39751112|FG009|Follow-Up Period|Lost to Follow-up|0|||
16345088|NCT02757352|39751103|FG000|Follow-Up Period|Lack of Efficacy|0|||
16345089|NCT02757352|39751104|FG001|Follow-Up Period|Lack of Efficacy|0|||
16345090|NCT02757352|39751105|FG002|Follow-Up Period|Lack of Efficacy|0|||
16345091|NCT02757352|39751106|FG003|Follow-Up Period|Lack of Efficacy|0|||
16345092|NCT02757352|39751107|FG004|Follow-Up Period|Lack of Efficacy|0|||
16345093|NCT02757352|39751108|FG005|Follow-Up Period|Lack of Efficacy|0|||
16345094|NCT02757352|39751109|FG006|Follow-Up Period|Lack of Efficacy|0|||
16345095|NCT02757352|39751110|FG007|Follow-Up Period|Lack of Efficacy|0|||
16345096|NCT02757352|39751111|FG008|Follow-Up Period|Lack of Efficacy|1|||
16345097|NCT02757352|39751112|FG009|Follow-Up Period|Lack of Efficacy|1|||
16345098|NCT02757352|39751103|FG000|Follow-Up Period|Withdrawal by Subject|0|||
16345099|NCT02757352|39751104|FG001|Follow-Up Period|Withdrawal by Subject|0|||
16408956|NCT01442064|39977141|FG003|Overall Study|Lost to Follow-up|1|||
16408957|NCT01442064|39977142|FG004|Overall Study|Lost to Follow-up|3|||
16408958|NCT01442064|39977143|FG005|Overall Study|Lost to Follow-up|3|||
16408959|NCT01442064|39977138|FG000|Overall Study|Physician Decision|1|||
16408960|NCT01442064|39977139|FG001|Overall Study|Physician Decision|1|||
16408961|NCT01442064|39977140|FG002|Overall Study|Physician Decision|2|||
16408962|NCT01442064|39977141|FG003|Overall Study|Physician Decision|3|||
16408963|NCT01442064|39977142|FG004|Overall Study|Physician Decision|3|||
16408964|NCT01442064|39977143|FG005|Overall Study|Physician Decision|1|||
16408965|NCT01442064|39977138|FG000|Overall Study|Withdrawal by Subject|6|||
16408966|NCT01442064|39977139|FG001|Overall Study|Withdrawal by Subject|3|||
16408967|NCT01442064|39977140|FG002|Overall Study|Withdrawal by Subject|2|||
16408968|NCT01442064|39977141|FG003|Overall Study|Withdrawal by Subject|2|||
16408969|NCT01442064|39977142|FG004|Overall Study|Withdrawal by Subject|2|||
16408970|NCT01442064|39977143|FG005|Overall Study|Withdrawal by Subject|1|||
16408971|NCT01442064|39977138|FG000|Overall Study|Sponsor decision|82|||
16408972|NCT01442064|39977139|FG001|Overall Study|Sponsor decision|88|||
16408973|NCT01442064|39977140|FG002|Overall Study|Sponsor decision|92|||
16408974|NCT01442064|39977141|FG003|Overall Study|Sponsor decision|88|||
16408975|NCT01442064|39977142|FG004|Overall Study|Sponsor decision|95|||
16408976|NCT01442064|39977143|FG005|Overall Study|Sponsor decision|87|||
16408977|NCT01442064|39977138|FG000|Overall Study|Subject non-compliance|0|||
16408978|NCT01442064|39977139|FG001|Overall Study|Subject non-compliance|0|||
16408979|NCT01442064|39977140|FG002|Overall Study|Subject non-compliance|0|||
16408980|NCT01442064|39977141|FG003|Overall Study|Subject non-compliance|0|||
16408981|NCT01442064|39977142|FG004|Overall Study|Subject non-compliance|0|||
16408982|NCT01442064|39977143|FG005|Overall Study|Subject non-compliance|2|||
16408983|NCT01442064|39977138|FG000|Overall Study|Condition mandated other intervention|1|||
16408984|NCT01442064|39977139|FG001|Overall Study|Condition mandated other intervention|1|||
16222426|NCT02185040|39295147|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
16345100|NCT02757352|39751105|FG002|Follow-Up Period|Withdrawal by Subject|0|||
16345101|NCT02757352|39751106|FG003|Follow-Up Period|Withdrawal by Subject|0|||
16345102|NCT02757352|39751107|FG004|Follow-Up Period|Withdrawal by Subject|0|||
16345103|NCT02757352|39751108|FG005|Follow-Up Period|Withdrawal by Subject|0|||
16408985|NCT01442064|39977140|FG002|Overall Study|Condition mandated other intervention|2|||
16408986|NCT01442064|39977141|FG003|Overall Study|Condition mandated other intervention|0|||
16408987|NCT01442064|39977142|FG004|Overall Study|Condition mandated other intervention|0|||
16408988|NCT01442064|39977143|FG005|Overall Study|Condition mandated other intervention|2|||
16408989|NCT03089944|39977144|FG000|Overall Study|Lost to Follow-up|8|||
16408990|NCT03089944|39977144|FG000|Overall Study|Withdrew Consent|2|||
16408991|NCT03089944|39977144|FG000|Overall Study|Adverse Event|1|||
16408992|NCT03089944|39977144|FG000|Overall Study|Other|1|||
16408993|NCT01352741|39977146|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
16408994|NCT01352741|39977147|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
16408995|NCT01352741|39977146|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
16408996|NCT01352741|39977147|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
16408997|NCT01352741|39977146|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
16408998|NCT01352741|39977147|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
16408999|NCT01352741|39977146|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
16409000|NCT01352741|39977147|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
16409001|NCT01352741|39977146|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
16409002|NCT01352741|39977147|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
16345104|NCT02757352|39751109|FG006|Follow-Up Period|Withdrawal by Subject|0|||
16409003|NCT01352741|39977146|FG000|Open-label Tapentadol Titration Period|Other|4|||
16409004|NCT01352741|39977147|FG001|Open-label Tapentadol Titration Period|Other|0|||
16409005|NCT01352741|39977146|FG000|Double-blind Comparative Period|Protocol Violation|2|||
16409006|NCT01352741|39977147|FG001|Double-blind Comparative Period|Protocol Violation|0|||
16409007|NCT01352741|39977146|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
16345105|NCT02757352|39751110|FG007|Follow-Up Period|Withdrawal by Subject|1|||
16345106|NCT02757352|39751111|FG008|Follow-Up Period|Withdrawal by Subject|6|||
16345107|NCT02757352|39751112|FG009|Follow-Up Period|Withdrawal by Subject|2|||
16345108|NCT03335813|39751118|FG000|Overall Study|Withdrawal by Subject|1|||
16345109|NCT00339833|39751122|FG000|Overall Study|Withdrawal by Subject|1|||
16345110|NCT00339833|39751123|FG001|Overall Study|Withdrawal by Subject|2|||
16345111|NCT00339833|39751122|FG000|Overall Study|toothache|0|||
16345112|NCT00339833|39751123|FG001|Overall Study|toothache|1|||
16345113|NCT00339833|39751122|FG000|Overall Study|indigestion|0|||
16345114|NCT00339833|39751123|FG001|Overall Study|indigestion|1|||
16345115|NCT00339833|39751122|FG000|Overall Study|Chest pain|0|||
16222427|NCT02185040|39295148|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
16345116|NCT00339833|39751123|FG001|Overall Study|Chest pain|1|||
16345117|NCT00339833|39751122|FG000|Overall Study|minor infection|0|||
16345118|NCT00339833|39751123|FG001|Overall Study|minor infection|1|||
16345119|NCT00339833|39751122|FG000|Overall Study|Poor venous access|2|||
16345120|NCT00339833|39751123|FG001|Overall Study|Poor venous access|2|||
16345121|NCT00339833|39751122|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
16345122|NCT00339833|39751123|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
16345123|NCT00339833|39751122|FG000|Overall Study|Error in data records|1|||
16345124|NCT00339833|39751123|FG001|Overall Study|Error in data records|0|||
16111034|NCT01322009|38893042|FG000|Overall Study|ng tube discontinued|0|||
16111035|NCT01322009|38893043|FG001|Overall Study|ng tube discontinued|1|||
16111036|NCT00464945|38893044|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
16111037|NCT00464945|38893045|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
16111038|NCT00464945|38893044|FG000|Infant Series|Protocol Violation|1|||
16111039|NCT00464945|38893045|FG001|Infant Series|Protocol Violation|0|||
16111040|NCT00464945|38893044|FG000|Infant Series|Lost to Follow-up|1|||
16111041|NCT00464945|38893045|FG001|Infant Series|Lost to Follow-up|0|||
16111042|NCT00464945|38893044|FG000|After Infant Series|Withdrawal by Subject|0|||
16409008|NCT01352741|39977147|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
16409009|NCT01352741|39977146|FG000|Double-blind Comparative Period|Adverse Event|16|||
16409010|NCT01352741|39977147|FG001|Double-blind Comparative Period|Adverse Event|17|||
16409011|NCT01352741|39977146|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
16409012|NCT01352741|39977147|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
16409013|NCT01352741|39977146|FG000|Double-blind Comparative Period|Death|0|||
16409014|NCT01352741|39977147|FG001|Double-blind Comparative Period|Death|1|||
16409015|NCT01352741|39977146|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
16409016|NCT01352741|39977147|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
16222428|NCT02185040|39295149|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
16222429|NCT02185040|39295150|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
16222430|NCT02185040|39295151|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
16222431|NCT02185040|39295145|FG000|Part 1 Treatment Phase|Adverse Event|1|||
16222432|NCT02185040|39295146|FG001|Part 1 Treatment Phase|Adverse Event|0|||
16345125|NCT04625413|39751126|FG000|Overall Study|Hospice|2|||
16345126|NCT04625413|39751126|FG000|Overall Study|Distress|1|||
16345127|NCT04625413|39751126|FG000|Overall Study|Not feeling well|1|||
16345128|NCT01540981|39751129|FG000|Overall Study|Withdrawal by Subject|1|||
16345129|NCT01540981|39751130|FG001|Overall Study|Withdrawal by Subject|0|||
16345130|NCT02250300|39751137|FG000|Expansion Phase|Death|6|||
16345131|NCT02250300|39751138|FG001|Expansion Phase|Death|7|||
16409017|NCT01352741|39977146|FG000|Double-blind Comparative Period|Other|1|||
16222433|NCT02185040|39295147|FG002|Part 1 Treatment Phase|Adverse Event|0|||
16345132|NCT02250300|39751139|FG002|Expansion Phase|Death|0|||
16345133|NCT02250300|39751140|FG003|Expansion Phase|Death|0|||
16345134|NCT01051557|39751141|FG000|Overall Study|Physician Decision|1|||
16345135|NCT01051557|39751142|FG001|Overall Study|Physician Decision|0|||
16345136|NCT01051557|39751143|FG002|Overall Study|Physician Decision|0|||
16345137|NCT01051557|39751144|FG003|Overall Study|Physician Decision|0|||
16345138|NCT01051557|39751145|FG004|Overall Study|Physician Decision|0|||
16345139|NCT01051557|39751146|FG005|Overall Study|Physician Decision|0|||
16345140|NCT01051557|39751147|FG006|Overall Study|Physician Decision|0|||
16345141|NCT01051557|39751141|FG000|Overall Study|disease progression|3|||
16345142|NCT01051557|39751142|FG001|Overall Study|disease progression|3|||
16345143|NCT01051557|39751143|FG002|Overall Study|disease progression|5|||
16345144|NCT01051557|39751144|FG003|Overall Study|disease progression|2|||
16345145|NCT01051557|39751145|FG004|Overall Study|disease progression|4|||
16345146|NCT01051557|39751146|FG005|Overall Study|disease progression|3|||
16345147|NCT01051557|39751147|FG006|Overall Study|disease progression|1|||
16345148|NCT01051557|39751141|FG000|Overall Study|Withdrawal by Subject|0|||
16345149|NCT01051557|39751142|FG001|Overall Study|Withdrawal by Subject|0|||
16345150|NCT01051557|39751143|FG002|Overall Study|Withdrawal by Subject|1|||
16345151|NCT01051557|39751144|FG003|Overall Study|Withdrawal by Subject|0|||
16345152|NCT01051557|39751145|FG004|Overall Study|Withdrawal by Subject|2|||
16345153|NCT01051557|39751146|FG005|Overall Study|Withdrawal by Subject|0|||
16345154|NCT01051557|39751147|FG006|Overall Study|Withdrawal by Subject|1|||
16345155|NCT01051557|39751141|FG000|Overall Study|Adverse Event|0|||
16345156|NCT01051557|39751142|FG001|Overall Study|Adverse Event|0|||
16345157|NCT01051557|39751143|FG002|Overall Study|Adverse Event|0|||
16345158|NCT01051557|39751144|FG003|Overall Study|Adverse Event|1|||
16345159|NCT01051557|39751145|FG004|Overall Study|Adverse Event|1|||
16345160|NCT01051557|39751146|FG005|Overall Study|Adverse Event|3|||
16345161|NCT01051557|39751147|FG006|Overall Study|Adverse Event|4|||
16345162|NCT01720524|39751150|FG000|Part A|Insufficient Clinical Response|2|||
16345163|NCT01720524|39751151|FG001|Part A|Insufficient Clinical Response|4|||
16345164|NCT01720524|39751150|FG000|Part A|Adverse Event|2|||
16345165|NCT01720524|39751151|FG001|Part A|Adverse Event|2|||
16345166|NCT01720524|39751150|FG000|Part A|Death|2|||
16345167|NCT01720524|39751151|FG001|Part A|Death|1|||
16345168|NCT01720524|39751150|FG000|Part A|Lost to Follow-up|0|||
16345169|NCT01720524|39751151|FG001|Part A|Lost to Follow-up|1|||
16345170|NCT01720524|39751150|FG000|Part A|Missed 28 day follow-up visit|1|||
16345171|NCT01720524|39751151|FG001|Part A|Missed 28 day follow-up visit|1|||
16345172|NCT01720524|39751150|FG000|Part A|Withdrawal by Subject|0|||
16345173|NCT01720524|39751151|FG001|Part A|Withdrawal by Subject|1|||
16345174|NCT01720524|39751150|FG000|Part A|Other|0|||
16345175|NCT01720524|39751151|FG001|Part A|Other|1|||
16345176|NCT01720524|39751150|FG000|Part A|Lost to Follow-up|0|||
16345177|NCT01720524|39751151|FG001|Part A|Lost to Follow-up|1|||
16345178|NCT01720524|39751150|FG000|Part B|No longer willing to participate in study|1|||
16345179|NCT01720524|39751151|FG001|Part B|No longer willing to participate in study|4|||
16345180|NCT01720524|39751150|FG000|Part B|Other|2|||
16345181|NCT01720524|39751151|FG001|Part B|Other|0|||
16345182|NCT01720524|39751150|FG000|Part B|Lost to Follow-up|2|||
16345183|NCT01720524|39751151|FG001|Part B|Lost to Follow-up|3|||
16345184|NCT01720524|39751150|FG000|Part B|Death|0|||
16345185|NCT01720524|39751151|FG001|Part B|Death|2|||
16345186|NCT02020889|39751161|FG000|Overall Study|Adverse Event|0|||
16345187|NCT02020889|39751162|FG001|Overall Study|Adverse Event|1|||
16345188|NCT02020889|39751161|FG000|Overall Study|Lack of Efficacy|1|||
16345189|NCT02020889|39751162|FG001|Overall Study|Lack of Efficacy|0|||
16345190|NCT02020889|39751161|FG000|Overall Study|Lost to Follow-up|1|||
16345191|NCT02020889|39751162|FG001|Overall Study|Lost to Follow-up|0|||
16345192|NCT02020889|39751161|FG000|Overall Study|Physician Decision|2|||
16345193|NCT02020889|39751162|FG001|Overall Study|Physician Decision|0|||
16345194|NCT02020889|39751161|FG000|Overall Study|Withdrawal by Subject|3|||
16409018|NCT01352741|39977147|FG001|Double-blind Comparative Period|Other|2|||
16409019|NCT01352741|39977146|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
16409020|NCT01352741|39977147|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
16409021|NCT01352741|39977146|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
16345195|NCT02020889|39751162|FG001|Overall Study|Withdrawal by Subject|2|||
16345196|NCT02600923|39751163|FG000|Overall Study|Death|10|||
16345197|NCT02600923|39751163|FG000|Overall Study|Adverse Event|3|||
16345198|NCT02600923|39751163|FG000|Overall Study|Global deterioration of health status|2|||
16345199|NCT02600923|39751163|FG000|Overall Study|Insufficient clinical response|6|||
16345200|NCT02600923|39751163|FG000|Overall Study|Lost to Follow-up|1|||
16345201|NCT02600923|39751163|FG000|Overall Study|Withdrawal by Subject|5|||
16409022|NCT01352741|39977147|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
16409023|NCT01352741|39977146|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
16345202|NCT02600923|39751163|FG000|Overall Study|Objective progression or relapse|50|||
16345203|NCT02600923|39751163|FG000|Overall Study|Study terminated by Sponsor|53|||
16345204|NCT02600923|39751163|FG000|Overall Study|Not treated|1|||
16345205|NCT00805129|39751171|FG000|Overall Study|Not treated|1|||
16345206|NCT01877668|39751174|FG000|Overall Study|Death|0|||
16345207|NCT01877668|39751175|FG001|Overall Study|Death|0|||
16345208|NCT01877668|39751176|FG002|Overall Study|Death|0|||
16345209|NCT01877668|39751177|FG003|Overall Study|Death|1|||
16345210|NCT01877668|39751178|FG004|Overall Study|Death|0|||
16345211|NCT01877668|39751174|FG000|Overall Study|No longer met study criteria|1|||
16345212|NCT01877668|39751175|FG001|Overall Study|No longer met study criteria|0|||
16345213|NCT01877668|39751176|FG002|Overall Study|No longer met study criteria|1|||
16345214|NCT01877668|39751177|FG003|Overall Study|No longer met study criteria|0|||
16345215|NCT01877668|39751178|FG004|Overall Study|No longer met study criteria|0|||
16345216|NCT01877668|39751174|FG000|Overall Study|Insufficient clinical response|0|||
16345217|NCT01877668|39751175|FG001|Overall Study|Insufficient clinical response|1|||
16345218|NCT01877668|39751176|FG002|Overall Study|Insufficient clinical response|2|||
16345219|NCT01877668|39751177|FG003|Overall Study|Insufficient clinical response|2|||
16345220|NCT01877668|39751178|FG004|Overall Study|Insufficient clinical response|0|||
16345221|NCT01877668|39751174|FG000|Overall Study|Lost to Follow-up|0|||
16345222|NCT01877668|39751175|FG001|Overall Study|Lost to Follow-up|2|||
16345223|NCT01877668|39751176|FG002|Overall Study|Lost to Follow-up|1|||
16345224|NCT01877668|39751177|FG003|Overall Study|Lost to Follow-up|0|||
16345225|NCT01877668|39751178|FG004|Overall Study|Lost to Follow-up|0|||
16345226|NCT01877668|39751174|FG000|Overall Study|Withdrawal by Subject|2|||
16345227|NCT01877668|39751175|FG001|Overall Study|Withdrawal by Subject|0|||
16345228|NCT01877668|39751176|FG002|Overall Study|Withdrawal by Subject|3|||
16111043|NCT00464945|38893045|FG001|After Infant Series|Withdrawal by Subject|2|||
16111044|NCT00464945|38893044|FG000|Toddler Dose|Lost to Follow-up|0|||
16111045|NCT00464945|38893045|FG001|Toddler Dose|Lost to Follow-up|1|||
16111046|NCT00825305|38893048|FG000|Overall Study|Adverse Event|1|||
16111047|NCT00825305|38893049|FG001|Overall Study|Adverse Event|1|||
16111048|NCT00825305|38893048|FG000|Overall Study|Withdrawal by Subject|6|||
16111049|NCT00825305|38893049|FG001|Overall Study|Withdrawal by Subject|12|||
16111050|NCT00825305|38893048|FG000|Overall Study|Inappropriate inclusion|1|||
16111051|NCT00825305|38893049|FG001|Overall Study|Inappropriate inclusion|0|||
16111052|NCT00825305|38893048|FG000|Overall Study|Protocol Violation|9|||
16111053|NCT00825305|38893049|FG001|Overall Study|Protocol Violation|9|||
16111054|NCT00825305|38893048|FG000|Overall Study|Can not be classified|0|||
16111055|NCT00825305|38893049|FG001|Overall Study|Can not be classified|1|||
16111056|NCT01917006|38893052|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
16111057|NCT01917006|38893053|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
16409024|NCT01352741|39977147|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
16409025|NCT01352741|39977146|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
16409026|NCT01352741|39977147|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
16409027|NCT04941807|39977150|FG000|Overall Study|Lost to Follow-up|1|||
16409028|NCT04941807|39977151|FG001|Overall Study|Lost to Follow-up|1|||
16409029|NCT02174523|39977158|FG000|Overall Study|Withdrawal by Subject|1|||
16409030|NCT02174523|39977159|FG001|Overall Study|Withdrawal by Subject|0|||
16409031|NCT02573246|39977160|FG000|Overall Study|Lost to Follow-up|2|||
16409032|NCT02573246|39977161|FG001|Overall Study|Lost to Follow-up|0|||
16409033|NCT02573246|39977162|FG002|Overall Study|Lost to Follow-up|0|||
16409034|NCT02573246|39977163|FG003|Overall Study|Lost to Follow-up|0|||
16409035|NCT02573246|39977164|FG004|Overall Study|Lost to Follow-up|1|||
16409036|NCT02573246|39977160|FG000|Overall Study|Withdrawal by Subject|0|||
16409037|NCT02573246|39977161|FG001|Overall Study|Withdrawal by Subject|0|||
16409038|NCT02573246|39977162|FG002|Overall Study|Withdrawal by Subject|0|||
16409039|NCT02573246|39977163|FG003|Overall Study|Withdrawal by Subject|0|||
16409040|NCT02573246|39977164|FG004|Overall Study|Withdrawal by Subject|1|||
16409041|NCT02573246|39977160|FG000|Overall Study|Physician Decision|1|||
16409042|NCT02573246|39977161|FG001|Overall Study|Physician Decision|1|||
16409043|NCT02573246|39977162|FG002|Overall Study|Physician Decision|3|||
16409044|NCT02573246|39977163|FG003|Overall Study|Physician Decision|2|||
16409045|NCT02573246|39977164|FG004|Overall Study|Physician Decision|2|||
16409046|NCT00477269|39977167|FG000|Core Study|Adverse Event|6|||
16409047|NCT00477269|39977168|FG001|Core Study|Adverse Event|4|||
16409048|NCT00477269|39977169|FG002|Core Study|Adverse Event|0|||
16409049|NCT00477269|39977167|FG000|Core Study|Death|3|||
16409050|NCT00477269|39977168|FG001|Core Study|Death|3|||
16409051|NCT00477269|39977169|FG002|Core Study|Death|0|||
16409052|NCT00477269|39977167|FG000|Core Study|Withdrawn Consent|0|||
16409053|NCT00477269|39977168|FG001|Core Study|Withdrawn Consent|1|||
16409054|NCT00477269|39977169|FG002|Core Study|Withdrawn Consent|0|||
16409055|NCT00477269|39977167|FG000|Open Label Extension|Adverse Event|0|||
16111058|NCT01917006|38893054|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
16111059|NCT01917006|38893055|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
16345229|NCT01877668|39751177|FG003|Overall Study|Withdrawal by Subject|2|||
16345230|NCT01877668|39751178|FG004|Overall Study|Withdrawal by Subject|2|||
16345231|NCT01877668|39751174|FG000|Overall Study|Other|1|||
16345232|NCT01877668|39751175|FG001|Overall Study|Other|1|||
16345233|NCT01877668|39751176|FG002|Overall Study|Other|1|||
16409056|NCT00477269|39977168|FG001|Open Label Extension|Adverse Event|0|||
16409057|NCT00477269|39977169|FG002|Open Label Extension|Adverse Event|4|||
16409058|NCT00477269|39977167|FG000|Open Label Extension|Abnormal laboratory values|0|||
16409059|NCT00477269|39977168|FG001|Open Label Extension|Abnormal laboratory values|0|||
16409060|NCT00477269|39977169|FG002|Open Label Extension|Abnormal laboratory values|1|||
16409061|NCT00477269|39977167|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
16345234|NCT01877668|39751177|FG003|Overall Study|Other|1|||
16345235|NCT01877668|39751178|FG004|Overall Study|Other|3|||
16345236|NCT01877668|39751174|FG000|Overall Study|Protocol Violation|1|||
16345237|NCT01877668|39751175|FG001|Overall Study|Protocol Violation|1|||
16345238|NCT01877668|39751176|FG002|Overall Study|Protocol Violation|0|||
16345239|NCT01877668|39751177|FG003|Overall Study|Protocol Violation|0|||
16345240|NCT01877668|39751178|FG004|Overall Study|Protocol Violation|3|||
16345241|NCT01877668|39751174|FG000|Overall Study|Adverse event related to study drug|2|||
16345242|NCT01877668|39751175|FG001|Overall Study|Adverse event related to study drug|2|||
16345243|NCT01877668|39751176|FG002|Overall Study|Adverse event related to study drug|2|||
16345244|NCT01877668|39751177|FG003|Overall Study|Adverse event related to study drug|2|||
16345245|NCT01877668|39751178|FG004|Overall Study|Adverse event related to study drug|1|||
16345246|NCT01877668|39751174|FG000|Overall Study|Adverse event unrelated to study drug|4|||
16345247|NCT01877668|39751175|FG001|Overall Study|Adverse event unrelated to study drug|1|||
16345248|NCT01877668|39751176|FG002|Overall Study|Adverse event unrelated to study drug|2|||
16345249|NCT01877668|39751177|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16345250|NCT01877668|39751178|FG004|Overall Study|Adverse event unrelated to study drug|1|||
16345251|NCT00426764|39751179|FG000|Overall Study|Protocol Violation|1|||
16345252|NCT00426764|39751179|FG000|Overall Study|Withdrawal by Subject|4|||
16345253|NCT00426764|39751179|FG000|Overall Study|Physician Decision|6|||
16345254|NCT00426764|39751179|FG000|Overall Study|Compassionate Use|1|||
16345255|NCT00426764|39751179|FG000|Overall Study|Progressive Disease|83|||
16345256|NCT00426764|39751179|FG000|Overall Study|Adverse Event|24|||
16345257|NCT00426764|39751179|FG000|Overall Study|Other|1|||
16345258|NCT00426764|39751179|FG000|Overall Study|Death|1|||
16345259|NCT00426764|39751179|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
16345260|NCT05027815|39751180|FG000|Overall Study|Death|2|||
16345261|NCT05027815|39751181|FG001|Overall Study|Death|1|||
16345262|NCT00996034|39751186|FG000|Overall Study|Lost to Follow-up|2|||
16345263|NCT00996034|39751186|FG000|Overall Study|withdrawn by PI|1|||
16345264|NCT02989402|39751189|FG000|Overall Study|Adverse event, or serious adverse event|4|||
16345265|NCT02989402|39751189|FG000|Overall Study|Death|2|||
16345266|NCT02989402|39751189|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
16345267|NCT02989402|39751189|FG000|Overall Study|Lost to Follow-up|8|||
16345268|NCT02989402|39751189|FG000|Overall Study|Patient no longer on monotherapy|1|||
16345269|NCT02989402|39751189|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
16345270|NCT02989402|39751189|FG000|Overall Study|Withdrawal by Subject|7|||
16345271|NCT02989402|39751189|FG000|Overall Study|Other|2|||
16345272|NCT01212094|39751190|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
16345273|NCT01212094|39751191|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
16345274|NCT01212094|39751192|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
16345275|NCT01212094|39751190|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
16345276|NCT01212094|39751191|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
16345277|NCT01212094|39751192|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
16345278|NCT01212094|39751190|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
16345279|NCT01212094|39751191|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
16345280|NCT01212094|39751192|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
16345281|NCT01212094|39751190|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
16345282|NCT01212094|39751191|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
16345283|NCT01212094|39751192|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
16345284|NCT01212094|39751190|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
16345285|NCT01212094|39751191|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
16345286|NCT01212094|39751192|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
16345287|NCT01212094|39751190|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
16345288|NCT01212094|39751191|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
16345289|NCT01212094|39751192|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
16345290|NCT02035553|39751195|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
16345291|NCT02035553|39751196|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
16345292|NCT02035553|39751195|FG000|Overall Study|Adverse Event|10|||
16345293|NCT02035553|39751196|FG001|Overall Study|Adverse Event|6|||
16345294|NCT02035553|39751195|FG000|Overall Study|Physician Decision|3|||
16111060|NCT01917006|38893056|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
16111061|NCT01917006|38893057|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
16111062|NCT01917006|38893058|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
16111063|NCT01917006|38893059|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
16111064|NCT01917006|38893052|FG000|Randomized-treatment Period|Personal Reasons|0|||
16111065|NCT01917006|38893053|FG001|Randomized-treatment Period|Personal Reasons|0|||
16345295|NCT02035553|39751196|FG001|Overall Study|Physician Decision|2|||
16345296|NCT02035553|39751195|FG000|Overall Study|Lack of Efficacy|1|||
16345297|NCT02035553|39751196|FG001|Overall Study|Lack of Efficacy|1|||
16345298|NCT02035553|39751195|FG000|Overall Study|Withdrawal by Subject|4|||
16345299|NCT02035553|39751196|FG001|Overall Study|Withdrawal by Subject|7|||
16345300|NCT02035553|39751195|FG000|Overall Study|Non-compliance with Study Drug|0|||
16345301|NCT02035553|39751196|FG001|Overall Study|Non-compliance with Study Drug|1|||
16345302|NCT02035553|39751195|FG000|Overall Study|Lost to Follow-up|0|||
16345303|NCT02035553|39751196|FG001|Overall Study|Lost to Follow-up|1|||
16345304|NCT02035553|39751195|FG000|Overall Study|Other Reason|0|||
16345305|NCT02035553|39751196|FG001|Overall Study|Other Reason|4|||
16345306|NCT01909804|39751198|FG000|Overall Study|Randomized but Never Treated|0|||
16345307|NCT01909804|39751199|FG001|Overall Study|Randomized but Never Treated|0|||
16345308|NCT01909804|39751200|FG002|Overall Study|Randomized but Never Treated|0|||
16345309|NCT01909804|39751201|FG003|Overall Study|Randomized but Never Treated|0|||
16345310|NCT01909804|39751202|FG004|Overall Study|Randomized but Never Treated|0|||
16345311|NCT01909804|39751203|FG005|Overall Study|Randomized but Never Treated|0|||
16111066|NCT01917006|38893054|FG002|Randomized-treatment Period|Personal Reasons|0|||
16111067|NCT01917006|38893055|FG003|Randomized-treatment Period|Personal Reasons|0|||
16111068|NCT01917006|38893056|FG004|Randomized-treatment Period|Personal Reasons|0|||
16111069|NCT01917006|38893057|FG005|Randomized-treatment Period|Personal Reasons|1|||
16111070|NCT01917006|38893058|FG006|Randomized-treatment Period|Personal Reasons|0|||
16111071|NCT01917006|38893059|FG007|Randomized-treatment Period|Personal Reasons|0|||
16345312|NCT01909804|39751204|FG006|Overall Study|Randomized but Never Treated|1|||
16345313|NCT01909804|39751205|FG007|Overall Study|Randomized but Never Treated|0|||
16345314|NCT01909804|39751206|FG008|Overall Study|Randomized but Never Treated|0|||
16345315|NCT01909804|39751207|FG009|Overall Study|Randomized but Never Treated|0|||
16345316|NCT01909804|39751208|FG010|Overall Study|Randomized but Never Treated|0|||
16345317|NCT01909804|39751209|FG011|Overall Study|Randomized but Never Treated|1|||
16345318|NCT01909804|39751198|FG000|Overall Study|Death|0|||
16111072|NCT01917006|38893052|FG000|Randomized-treatment Period|Protocol Violation|1|||
16111073|NCT01917006|38893053|FG001|Randomized-treatment Period|Protocol Violation|0|||
16409062|NCT00477269|39977168|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
16409063|NCT00477269|39977169|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
16409064|NCT00477269|39977167|FG000|Open Label Extension|Adminiatrative problems|0|||
16409065|NCT00477269|39977168|FG001|Open Label Extension|Adminiatrative problems|0|||
16409066|NCT00477269|39977169|FG002|Open Label Extension|Adminiatrative problems|2|||
16409067|NCT00477269|39977167|FG000|Open Label Extension|Death|0|||
16345319|NCT01909804|39751199|FG001|Overall Study|Death|0|||
16345320|NCT01909804|39751200|FG002|Overall Study|Death|0|||
16345321|NCT01909804|39751201|FG003|Overall Study|Death|0|||
16345322|NCT01909804|39751202|FG004|Overall Study|Death|0|||
16345323|NCT01909804|39751203|FG005|Overall Study|Death|0|||
16345324|NCT01909804|39751204|FG006|Overall Study|Death|0|||
16345325|NCT01909804|39751205|FG007|Overall Study|Death|0|||
16345326|NCT01909804|39751206|FG008|Overall Study|Death|0|||
16345327|NCT01909804|39751207|FG009|Overall Study|Death|0|||
16409068|NCT00477269|39977168|FG001|Open Label Extension|Death|0|||
16409069|NCT00477269|39977169|FG002|Open Label Extension|Death|4|||
16409070|NCT01156389|39977170|FG000|Overall Study|Elevated liver enzymes|4|||
16409071|NCT01156389|39977171|FG001|Overall Study|Elevated liver enzymes|0|||
16409072|NCT01156389|39977170|FG000|Overall Study|Vomiting|0|||
16345328|NCT01909804|39751208|FG010|Overall Study|Death|1|||
16345329|NCT01909804|39751209|FG011|Overall Study|Death|0|||
16345330|NCT01909804|39751198|FG000|Overall Study|Lack of Efficacy|4|||
16345331|NCT01909804|39751199|FG001|Overall Study|Lack of Efficacy|1|||
16345332|NCT01909804|39751200|FG002|Overall Study|Lack of Efficacy|0|||
16345333|NCT01909804|39751201|FG003|Overall Study|Lack of Efficacy|0|||
16345334|NCT01909804|39751202|FG004|Overall Study|Lack of Efficacy|7|||
16345335|NCT01909804|39751203|FG005|Overall Study|Lack of Efficacy|3|||
16345336|NCT01909804|39751204|FG006|Overall Study|Lack of Efficacy|1|||
16345337|NCT01909804|39751205|FG007|Overall Study|Lack of Efficacy|1|||
16345338|NCT01909804|39751206|FG008|Overall Study|Lack of Efficacy|0|||
16345339|NCT01909804|39751207|FG009|Overall Study|Lack of Efficacy|1|||
16345340|NCT01909804|39751208|FG010|Overall Study|Lack of Efficacy|0|||
16345341|NCT01909804|39751209|FG011|Overall Study|Lack of Efficacy|1|||
16345342|NCT01909804|39751198|FG000|Overall Study|Withdrew Consent|0|||
16345343|NCT01909804|39751199|FG001|Overall Study|Withdrew Consent|0|||
16345344|NCT01909804|39751200|FG002|Overall Study|Withdrew Consent|0|||
16345345|NCT01909804|39751201|FG003|Overall Study|Withdrew Consent|0|||
16345346|NCT01909804|39751202|FG004|Overall Study|Withdrew Consent|1|||
16345347|NCT01909804|39751203|FG005|Overall Study|Withdrew Consent|1|||
16345348|NCT01909804|39751204|FG006|Overall Study|Withdrew Consent|0|||
16345349|NCT01909804|39751205|FG007|Overall Study|Withdrew Consent|0|||
16345350|NCT01909804|39751206|FG008|Overall Study|Withdrew Consent|0|||
16409073|NCT01156389|39977171|FG001|Overall Study|Vomiting|1|||
16409074|NCT00966719|39977173|FG000|Overall Study|Lost to Follow-up|6|||
16345351|NCT01909804|39751207|FG009|Overall Study|Withdrew Consent|0|||
16345352|NCT01909804|39751208|FG010|Overall Study|Withdrew Consent|0|||
16345353|NCT01909804|39751209|FG011|Overall Study|Withdrew Consent|0|||
16409075|NCT00966719|39977174|FG001|Overall Study|Lost to Follow-up|11|||
16345354|NCT01909804|39751198|FG000|Overall Study|Protocol Violation|0|||
16345355|NCT01909804|39751199|FG001|Overall Study|Protocol Violation|0|||
16345356|NCT01909804|39751200|FG002|Overall Study|Protocol Violation|0|||
16345357|NCT01909804|39751201|FG003|Overall Study|Protocol Violation|0|||
16345358|NCT01909804|39751202|FG004|Overall Study|Protocol Violation|0|||
16345359|NCT01909804|39751203|FG005|Overall Study|Protocol Violation|0|||
16345360|NCT01909804|39751204|FG006|Overall Study|Protocol Violation|0|||
16345361|NCT01909804|39751205|FG007|Overall Study|Protocol Violation|0|||
16345362|NCT01909804|39751206|FG008|Overall Study|Protocol Violation|0|||
16409076|NCT00687609|39981540|FG000|Overall Study|Physician Decision|1|||
16222434|NCT02185040|39295148|FG003|Part 1 Treatment Phase|Adverse Event|2|||
16409077|NCT00687609|39981540|FG000|Overall Study|Withdrawal by Subject|2|||
16409078|NCT00495521|39981541|FG000|Overall Study|Physician Decision|0|||
16409079|NCT00495521|39981542|FG001|Overall Study|Physician Decision|1|||
16409080|NCT03356977|39981543|FG000|Overall Study|Lost to Follow-up|3|||
16409081|NCT03356977|39981543|FG000|Overall Study|Withdrawal by parent/guardian|2|||
16409082|NCT03968159|39981558|FG000|Overall Study|Adverse Event|4|||
16409083|NCT03968159|39981559|FG001|Overall Study|Adverse Event|4|||
16409084|NCT03968159|39981558|FG000|Overall Study|Lost to Follow-up|1|||
16409085|NCT03968159|39981559|FG001|Overall Study|Lost to Follow-up|1|||
16409086|NCT03968159|39981558|FG000|Overall Study|Use of prohibited medication|0|||
16409087|NCT03968159|39981559|FG001|Overall Study|Use of prohibited medication|1|||
16409088|NCT03968159|39981558|FG000|Overall Study|Protocol Violation|2|||
16409089|NCT03968159|39981559|FG001|Overall Study|Protocol Violation|2|||
16409090|NCT03968159|39981558|FG000|Overall Study|Withdrawal by Subject|4|||
16409091|NCT03968159|39981559|FG001|Overall Study|Withdrawal by Subject|6|||
16409092|NCT03968159|39981558|FG000|Overall Study|Lack of Efficacy|0|||
16545752|NCT04524598|40460806|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
16545753|NCT04524598|40460807|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
16545754|NCT04524598|40460808|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
16545755|NCT04524598|40460809|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
16545756|NCT04524598|40460805|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
16111074|NCT01917006|38893054|FG002|Randomized-treatment Period|Protocol Violation|0|||
16111075|NCT01917006|38893055|FG003|Randomized-treatment Period|Protocol Violation|0|||
16111076|NCT01917006|38893056|FG004|Randomized-treatment Period|Protocol Violation|0|||
16111077|NCT01917006|38893057|FG005|Randomized-treatment Period|Protocol Violation|0|||
16111078|NCT01917006|38893058|FG006|Randomized-treatment Period|Protocol Violation|0|||
16111079|NCT01917006|38893059|FG007|Randomized-treatment Period|Protocol Violation|0|||
16111080|NCT01917006|38893052|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16111081|NCT01917006|38893053|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16111082|NCT01917006|38893054|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16111083|NCT01917006|38893055|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16111084|NCT01917006|38893056|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16111085|NCT01917006|38893057|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16111086|NCT01917006|38893058|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
16111087|NCT01917006|38893059|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
16111088|NCT01917006|38893052|FG000|Open-label Period|Adverse Event|0|||
16111089|NCT01917006|38893053|FG001|Open-label Period|Adverse Event|0|||
16111090|NCT01917006|38893054|FG002|Open-label Period|Adverse Event|0|||
16111091|NCT01917006|38893055|FG003|Open-label Period|Adverse Event|0|||
16111092|NCT01917006|38893056|FG004|Open-label Period|Adverse Event|0|||
16111093|NCT01917006|38893057|FG005|Open-label Period|Adverse Event|0|||
16111094|NCT01917006|38893058|FG006|Open-label Period|Adverse Event|0|||
16545757|NCT04524598|40460806|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
16545758|NCT04524598|40460807|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
16545759|NCT04524598|40460808|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
16409093|NCT03968159|39981559|FG001|Overall Study|Lack of Efficacy|1|||
16409094|NCT03968159|39981558|FG000|Overall Study|Not further specified|2|||
16409095|NCT03968159|39981559|FG001|Overall Study|Not further specified|0|||
16409096|NCT04422561|39981560|FG000|Overall Study|Lost to Follow-up|25|||
16409097|NCT04422561|39981561|FG001|Overall Study|Lost to Follow-up|11|||
16409098|NCT01129882|39981564|FG000|Overall Study|Adverse Event|39|||
16409099|NCT01129882|39981564|FG000|Overall Study|Death|6|||
16409100|NCT01129882|39981564|FG000|Overall Study|Lack of Efficacy|5|||
16409101|NCT01129882|39981564|FG000|Overall Study|Lost to Follow-up|13|||
16409102|NCT01129882|39981564|FG000|Overall Study|Physician Decision|27|||
16409103|NCT01129882|39981564|FG000|Overall Study|Protocol Deviation|3|||
16409104|NCT01129882|39981564|FG000|Overall Study|Withdrawal Criteria Met|19|||
16409105|NCT01129882|39981564|FG000|Overall Study|Trial Termination by Sponsor|6|||
16409106|NCT01129882|39981564|FG000|Overall Study|Withdrawal by Subject|160|||
16409107|NCT03770728|39981565|FG000|Overall Study|Adverse Event|1|||
16409108|NCT03770728|39981566|FG001|Overall Study|Adverse Event|0|||
16409109|NCT03770728|39981567|FG002|Overall Study|Adverse Event|1|||
16409110|NCT03770728|39981568|FG003|Overall Study|Adverse Event|0|||
16409111|NCT03770728|39981565|FG000|Overall Study|Poor compliance to protocol|0|||
16409112|NCT03770728|39981566|FG001|Overall Study|Poor compliance to protocol|0|||
16409113|NCT03770728|39981567|FG002|Overall Study|Poor compliance to protocol|1|||
16409114|NCT03770728|39981568|FG003|Overall Study|Poor compliance to protocol|0|||
16409115|NCT03770728|39981565|FG000|Overall Study|Withdrawal by Subject|13|||
16409116|NCT03770728|39981566|FG001|Overall Study|Withdrawal by Subject|8|||
16409117|NCT03770728|39981567|FG002|Overall Study|Withdrawal by Subject|9|||
16409118|NCT03770728|39981568|FG003|Overall Study|Withdrawal by Subject|13|||
16409119|NCT03770728|39981565|FG000|Overall Study|Other than specified|24|||
16409120|NCT03770728|39981566|FG001|Overall Study|Other than specified|23|||
16222435|NCT02185040|39295149|FG004|Part 1 Treatment Phase|Adverse Event|3|||
16222436|NCT02185040|39295150|FG005|Part 1 Treatment Phase|Adverse Event|0|||
16222437|NCT02185040|39295151|FG006|Part 1 Treatment Phase|Adverse Event|0|||
16345363|NCT01909804|39751207|FG009|Overall Study|Protocol Violation|0|||
16345364|NCT01909804|39751208|FG010|Overall Study|Protocol Violation|0|||
16345365|NCT01909804|39751209|FG011|Overall Study|Protocol Violation|1|||
16345366|NCT04001803|39751210|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
16345367|NCT04001803|39751210|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
16345368|NCT04001803|39751210|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
16345369|NCT04001803|39751210|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
16345370|NCT04001803|39751210|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
16345371|NCT04001803|39751210|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
16345372|NCT04001803|39751210|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
16345373|NCT04001803|39751210|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
16345374|NCT04001803|39751210|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
16345375|NCT04001803|39751210|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
16345376|NCT00004088|39751214|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
16345377|NCT00004088|39751214|FG000|Overall Study|Withdrawal by Subject|1|||
16345378|NCT00004088|39751214|FG000|Overall Study|Protocol Violation|3|||
16345379|NCT00004088|39751214|FG000|Overall Study|Physician Decision|1|||
16345380|NCT03746405|39751215|FG000|Overall Study|Withdrawal by Subject|3|||
16345381|NCT03746405|39751216|FG001|Overall Study|Withdrawal by Subject|0|||
16345382|NCT03746405|39751215|FG000|Overall Study|technical difficulties|0|||
16345383|NCT03746405|39751216|FG001|Overall Study|technical difficulties|2|||
16345384|NCT01843803|39751217|FG000|Overall Study|not a Veteran, did not see provider|1|||
16345385|NCT01843803|39751218|FG001|Overall Study|not a Veteran, did not see provider|3|||
16345386|NCT02532283|39751229|FG000|Overall Study|Adverse Event|0|||
16345387|NCT02532283|39751230|FG001|Overall Study|Adverse Event|1|||
16345388|NCT02532283|39751229|FG000|Overall Study|Death|1|||
16345389|NCT02532283|39751230|FG001|Overall Study|Death|0|||
16345390|NCT02532283|39751229|FG000|Overall Study|Lost to Follow-up|0|||
16345391|NCT02532283|39751230|FG001|Overall Study|Lost to Follow-up|1|||
16345392|NCT02532283|39751229|FG000|Overall Study|Withdrawal by Subject|8|||
16345393|NCT02532283|39751230|FG001|Overall Study|Withdrawal by Subject|3|||
16345394|NCT00991289|39751232|FG000|Overall Study|Adverse Event|1|||
16345395|NCT00991289|39751232|FG000|Overall Study|Physician Decision|2|||
16345396|NCT00991289|39751232|FG000|Overall Study|Withdrawal by Subject|3|||
16345397|NCT00991289|39751232|FG000|Overall Study|Lost to Follow-up|4|||
16345398|NCT00991289|39751232|FG000|Overall Study|Protocol Violation|2|||
16345399|NCT01021332|39751233|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
16345400|NCT01021332|39751233|FG000|Overall Study|Adverse Event|43|||
16345401|NCT01021332|39751233|FG000|Overall Study|Lack of Efficacy|19|||
16345402|NCT01021332|39751233|FG000|Overall Study|Withdrawal of Consent|23|||
16345403|NCT01021332|39751233|FG000|Overall Study|Lost to Follow-up|4|||
16345404|NCT01021332|39751233|FG000|Overall Study|Protocol Violation|9|||
16345405|NCT01021332|39751233|FG000|Overall Study|Miscellaneous|3|||
16345406|NCT02793947|39751234|FG000|Overall Study|Death|1|||
16345407|NCT02793947|39751235|FG001|Overall Study|Death|0|||
16345408|NCT02793947|39751234|FG000|Overall Study|Physician Decision|1|||
16345409|NCT02793947|39751235|FG001|Overall Study|Physician Decision|5|||
16345410|NCT00943592|39751236|FG000|Overall Study|Death|3|||
16345411|NCT02149264|39751238|FG000|Overall Study|Withdrawal by Subject|9|||
16345412|NCT02149264|39751238|FG000|Overall Study|Adverse Event|7|||
16345413|NCT02149264|39751238|FG000|Overall Study|Physician Decision|3|||
16345414|NCT02149264|39751238|FG000|Overall Study|Protocol Violation|1|||
16345415|NCT00905632|39751241|FG000|Overall Study|Adverse Event|0|||
16345416|NCT00905632|39751242|FG001|Overall Study|Adverse Event|0|||
16345417|NCT00905632|39751243|FG002|Overall Study|Adverse Event|0|||
16345418|NCT00905632|39751244|FG003|Overall Study|Adverse Event|0|||
16345419|NCT00905632|39751245|FG004|Overall Study|Adverse Event|0|||
16345420|NCT00905632|39751246|FG005|Overall Study|Adverse Event|1|||
16345421|NCT00905632|39751247|FG006|Overall Study|Adverse Event|4|||
16345422|NCT01768559|39751248|FG000|Overall Study|Randomized but not treated|0|||
16345423|NCT01768559|39751249|FG001|Overall Study|Randomized but not treated|0|||
16345424|NCT01768559|39751250|FG002|Overall Study|Randomized but not treated|1|||
16345425|NCT01768559|39751248|FG000|Overall Study|Adverse Event|15|||
16345426|NCT01768559|39751249|FG001|Overall Study|Adverse Event|2|||
16345427|NCT01768559|39751250|FG002|Overall Study|Adverse Event|5|||
16545760|NCT04524598|40460809|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
16545761|NCT04524598|40460805|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
16545762|NCT04524598|40460806|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
16545763|NCT04524598|40460807|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
16545764|NCT04524598|40460808|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
16545765|NCT04524598|40460809|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
16545766|NCT04524598|40460805|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
16545767|NCT04524598|40460806|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
16345428|NCT01768559|39751248|FG000|Overall Study|Lack of Efficacy|6|||
16345429|NCT01768559|39751249|FG001|Overall Study|Lack of Efficacy|4|||
16345430|NCT01768559|39751250|FG002|Overall Study|Lack of Efficacy|0|||
16345431|NCT01768559|39751248|FG000|Overall Study|Poor compliance to protocol|0|||
16345432|NCT01768559|39751249|FG001|Overall Study|Poor compliance to protocol|3|||
16345433|NCT01768559|39751250|FG002|Overall Study|Poor compliance to protocol|2|||
16345434|NCT01768559|39751248|FG000|Overall Study|Other than specified|9|||
16345435|NCT01768559|39751249|FG001|Overall Study|Other than specified|8|||
16345436|NCT01768559|39751250|FG002|Overall Study|Other than specified|5|||
16345437|NCT03536663|39751252|FG000|Endexo|Protocol Violation|1|||
16345438|NCT01497067|39751255|FG000|Overall Study|Lost to Follow-up|56|||
16345439|NCT01497067|39751255|FG000|Overall Study|Adverse Event|3|||
16345440|NCT01497067|39751255|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
16345441|NCT01497067|39751255|FG000|Overall Study|Other|13|||
16345442|NCT01091246|39751257|FG000|Overall Study|Lost to Follow-up|23|||
16345443|NCT01091246|39751258|FG001|Overall Study|Lost to Follow-up|11|||
16345444|NCT01091246|39751259|FG002|Overall Study|Lost to Follow-up|7|||
16345445|NCT01091246|39751257|FG000|Overall Study|Adverse Event|1|||
16345446|NCT01091246|39751258|FG001|Overall Study|Adverse Event|0|||
16345447|NCT01091246|39751259|FG002|Overall Study|Adverse Event|1|||
16345448|NCT01091246|39751257|FG000|Overall Study|Withdrawal by Subject|9|||
16345449|NCT01091246|39751258|FG001|Overall Study|Withdrawal by Subject|5|||
16345450|NCT01091246|39751259|FG002|Overall Study|Withdrawal by Subject|4|||
16345451|NCT01091246|39751257|FG000|Overall Study|Subject not dosed|2|||
16345452|NCT01091246|39751258|FG001|Overall Study|Subject not dosed|0|||
16111095|NCT01917006|38893059|FG007|Open-label Period|Adverse Event|1|||
16111096|NCT01917006|38893052|FG000|Open-label Period|Lost to Follow-up|0|||
16111097|NCT01917006|38893053|FG001|Open-label Period|Lost to Follow-up|0|||
16111098|NCT01917006|38893054|FG002|Open-label Period|Lost to Follow-up|0|||
16111099|NCT01917006|38893055|FG003|Open-label Period|Lost to Follow-up|0|||
16111100|NCT01917006|38893056|FG004|Open-label Period|Lost to Follow-up|0|||
16111101|NCT01917006|38893057|FG005|Open-label Period|Lost to Follow-up|0|||
16111102|NCT01917006|38893058|FG006|Open-label Period|Lost to Follow-up|0|||
16111103|NCT01917006|38893059|FG007|Open-label Period|Lost to Follow-up|1|||
16345453|NCT01091246|39751259|FG002|Overall Study|Subject not dosed|1|||
16345454|NCT00686335|39751272|FG000|Run-in Period|Adverse Event|1|||
16345455|NCT00686335|39751272|FG000|Run-in Period|asthma exacerbation|1|||
16345456|NCT00686335|39751272|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
16345457|NCT00158262|39751273|FG000|Overall Study|Lost to Follow-up|1|||
16345458|NCT00158262|39751274|FG001|Overall Study|Lost to Follow-up|1|||
16345459|NCT04826484|39751275|FG000|Overall Study|Lost to Follow-up|2|||
16345460|NCT04826484|39751276|FG001|Overall Study|Lost to Follow-up|0|||
16345461|NCT02072941|39751277|FG000|Overall Study|Withdrawal by Subject|29|||
16345462|NCT02072941|39751278|FG001|Overall Study|Withdrawal by Subject|21|||
16345463|NCT02072941|39751277|FG000|Overall Study|Lost to Follow-up|4|||
16345464|NCT02072941|39751278|FG001|Overall Study|Lost to Follow-up|4|||
16345465|NCT02072941|39751277|FG000|Overall Study|Death|3|||
16345466|NCT02072941|39751278|FG001|Overall Study|Death|2|||
16345467|NCT02072941|39751277|FG000|Overall Study|Removed by Study Staff|2|||
16345468|NCT02072941|39751278|FG001|Overall Study|Removed by Study Staff|2|||
16345469|NCT02335346|39751279|FG000|Overall Study|Adverse Event|11|||
16345470|NCT02335346|39751279|FG000|Overall Study|Withdrawal by Subject|1|||
16345471|NCT03203850|39751280|FG000|Overall Study|Subject/guardian decision|4|||
16345472|NCT03203850|39751281|FG001|Overall Study|Subject/guardian decision|3|||
16222438|NCT02185040|39295145|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16345473|NCT03203850|39751280|FG000|Overall Study|Adverse Event|3|||
16345474|NCT03203850|39751281|FG001|Overall Study|Adverse Event|0|||
16345475|NCT03203850|39751280|FG000|Overall Study|Death|1|||
16345476|NCT03203850|39751281|FG001|Overall Study|Death|0|||
16409121|NCT03770728|39981567|FG002|Overall Study|Other than specified|21|||
16345477|NCT01556997|39751282|FG000|Overall Study|Adverse Event|10|||
16345478|NCT01556997|39751283|FG001|Overall Study|Adverse Event|12|||
16111104|NCT00917462|38893063|FG000|Overall Study|Clinical Deterioration|1|||
16345479|NCT01556997|39751284|FG002|Overall Study|Adverse Event|12|||
16345480|NCT01556997|39751282|FG000|Overall Study|Lost to Follow-up|6|||
16345481|NCT01556997|39751283|FG001|Overall Study|Lost to Follow-up|6|||
16345482|NCT01556997|39751284|FG002|Overall Study|Lost to Follow-up|4|||
16111105|NCT00805285|38893064|FG000|Overall Study|Lack of Efficacy|1|||
16345483|NCT01556997|39751282|FG000|Overall Study|Physician Decision|1|||
16345484|NCT01556997|39751283|FG001|Overall Study|Physician Decision|1|||
16345485|NCT01556997|39751284|FG002|Overall Study|Physician Decision|1|||
16345486|NCT01556997|39751282|FG000|Overall Study|Withdrawal by Subject|7|||
16345487|NCT01556997|39751283|FG001|Overall Study|Withdrawal by Subject|6|||
16345488|NCT01556997|39751284|FG002|Overall Study|Withdrawal by Subject|8|||
16345489|NCT01556997|39751282|FG000|Overall Study|Other|2|||
16345490|NCT01556997|39751283|FG001|Overall Study|Other|3|||
16345491|NCT01556997|39751284|FG002|Overall Study|Other|7|||
16345492|NCT01845597|39751288|FG000|Overall Study|Death|8|||
16345493|NCT01845597|39751288|FG000|Overall Study|Lost to Follow-up|22|||
16345494|NCT01826981|39751289|FG000|Overall Study|Lack of Efficacy|0|||
16345495|NCT01826981|39751290|FG001|Overall Study|Lack of Efficacy|1|||
16345496|NCT01826981|39751291|FG002|Overall Study|Lack of Efficacy|0|||
16345497|NCT01826981|39751292|FG003|Overall Study|Lack of Efficacy|0|||
16345498|NCT01826981|39751293|FG004|Overall Study|Lack of Efficacy|5|||
16345499|NCT01826981|39751294|FG005|Overall Study|Lack of Efficacy|0|||
16345500|NCT01826981|39751295|FG006|Overall Study|Lack of Efficacy|0|||
16345501|NCT01826981|39751296|FG007|Overall Study|Lack of Efficacy|8|||
16345502|NCT01826981|39751297|FG008|Overall Study|Lack of Efficacy|7|||
16345503|NCT01826981|39751298|FG009|Overall Study|Lack of Efficacy|0|||
16409122|NCT03770728|39981568|FG003|Overall Study|Other than specified|22|||
16409123|NCT00996801|39981569|FG000|Overall Study|Adverse Event|6|||
16409124|NCT00996801|39981570|FG001|Overall Study|Adverse Event|4|||
16409125|NCT00996801|39981571|FG002|Overall Study|Adverse Event|12|||
16409126|NCT00996801|39981572|FG003|Overall Study|Adverse Event|17|||
16409127|NCT00996801|39981573|FG004|Overall Study|Adverse Event|31|||
16345504|NCT01826981|39751299|FG010|Overall Study|Lack of Efficacy|1|||
16345505|NCT01826981|39751300|FG011|Overall Study|Lack of Efficacy|0|||
16345506|NCT01826981|39751301|FG012|Overall Study|Lack of Efficacy|0|||
16345507|NCT01826981|39751302|FG013|Overall Study|Lack of Efficacy|3|||
16345508|NCT01826981|39751303|FG014|Overall Study|Lack of Efficacy|0|||
16409128|NCT00996801|39981574|FG005|Overall Study|Adverse Event|3|||
16409129|NCT00996801|39981569|FG000|Overall Study|Lack of Efficacy|3|||
16409130|NCT00996801|39981570|FG001|Overall Study|Lack of Efficacy|0|||
16409131|NCT00996801|39981571|FG002|Overall Study|Lack of Efficacy|1|||
16409132|NCT00996801|39981572|FG003|Overall Study|Lack of Efficacy|3|||
16409133|NCT00996801|39981573|FG004|Overall Study|Lack of Efficacy|0|||
16409134|NCT00996801|39981574|FG005|Overall Study|Lack of Efficacy|1|||
16409135|NCT00996801|39981569|FG000|Overall Study|Lost to Follow-up|0|||
16545768|NCT04524598|40460807|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
16545769|NCT04524598|40460808|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
16545770|NCT04524598|40460809|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
16545771|NCT04524598|40460805|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
16545772|NCT04524598|40460806|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
16545773|NCT04524598|40460807|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
16545774|NCT04524598|40460808|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
16545775|NCT04524598|40460809|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
16545776|NCT04524598|40460805|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
16545777|NCT04524598|40460806|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
16545778|NCT04524598|40460807|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
16545779|NCT04524598|40460808|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
16545780|NCT04524598|40460809|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
16545781|NCT01480596|40460810|FG000|Overall Study|Adverse Event|3|||
16545782|NCT01480596|40460811|FG001|Overall Study|Adverse Event|0|||
16545783|NCT01480596|40460810|FG000|Overall Study|MG exacerbation or change in medication|2|||
16545784|NCT01480596|40460811|FG001|Overall Study|MG exacerbation or change in medication|2|||
16545785|NCT05178121|40460812|FG000|Overall Study|Other|4|||
16545786|NCT05178121|40460812|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
16545787|NCT00510458|40460813|FG000|Overall Study|5 year not evaluable/missed|21|||
16545788|NCT00510458|40460813|FG000|Overall Study|Death|1|||
16545789|NCT00510458|40460813|FG000|Overall Study|Terminated|14|||
16545790|NCT00510458|40460813|FG000|Overall Study|Lost to Follow-up|6|||
16345509|NCT01826981|39751289|FG000|Overall Study|Lost to Follow-up|0|||
16345510|NCT01826981|39751290|FG001|Overall Study|Lost to Follow-up|0|||
16345511|NCT01826981|39751291|FG002|Overall Study|Lost to Follow-up|0|||
16345512|NCT01826981|39751292|FG003|Overall Study|Lost to Follow-up|0|||
16345513|NCT01826981|39751293|FG004|Overall Study|Lost to Follow-up|1|||
16345514|NCT01826981|39751294|FG005|Overall Study|Lost to Follow-up|1|||
16345515|NCT01826981|39751295|FG006|Overall Study|Lost to Follow-up|0|||
16345516|NCT01826981|39751296|FG007|Overall Study|Lost to Follow-up|1|||
16409136|NCT00996801|39981570|FG001|Overall Study|Lost to Follow-up|0|||
16409137|NCT00996801|39981571|FG002|Overall Study|Lost to Follow-up|0|||
16409138|NCT00996801|39981572|FG003|Overall Study|Lost to Follow-up|3|||
16409139|NCT00996801|39981573|FG004|Overall Study|Lost to Follow-up|3|||
16409140|NCT00996801|39981574|FG005|Overall Study|Lost to Follow-up|2|||
16409141|NCT00996801|39981569|FG000|Overall Study|Physician Decision|0|||
16409142|NCT00996801|39981570|FG001|Overall Study|Physician Decision|0|||
16409143|NCT00996801|39981571|FG002|Overall Study|Physician Decision|0|||
16409144|NCT00996801|39981572|FG003|Overall Study|Physician Decision|1|||
16409145|NCT00996801|39981573|FG004|Overall Study|Physician Decision|0|||
16409146|NCT00996801|39981574|FG005|Overall Study|Physician Decision|0|||
16409147|NCT00996801|39981569|FG000|Overall Study|Progressive Disease|0|||
16409148|NCT00996801|39981570|FG001|Overall Study|Progressive Disease|1|||
16409149|NCT00996801|39981571|FG002|Overall Study|Progressive Disease|0|||
16409150|NCT00996801|39981572|FG003|Overall Study|Progressive Disease|0|||
16409151|NCT00996801|39981573|FG004|Overall Study|Progressive Disease|0|||
16409152|NCT00996801|39981574|FG005|Overall Study|Progressive Disease|0|||
16409153|NCT00996801|39981569|FG000|Overall Study|Protocol Violation|3|||
16409154|NCT00996801|39981570|FG001|Overall Study|Protocol Violation|4|||
16409155|NCT00996801|39981571|FG002|Overall Study|Protocol Violation|1|||
16409156|NCT00996801|39981572|FG003|Overall Study|Protocol Violation|2|||
16409157|NCT00996801|39981573|FG004|Overall Study|Protocol Violation|3|||
16345517|NCT01826981|39751297|FG008|Overall Study|Lost to Follow-up|0|||
16345518|NCT01826981|39751298|FG009|Overall Study|Lost to Follow-up|1|||
16345519|NCT01826981|39751299|FG010|Overall Study|Lost to Follow-up|1|||
16345520|NCT01826981|39751300|FG011|Overall Study|Lost to Follow-up|1|||
16409158|NCT00996801|39981574|FG005|Overall Study|Protocol Violation|4|||
16345521|NCT01826981|39751301|FG012|Overall Study|Lost to Follow-up|1|||
16345522|NCT01826981|39751302|FG013|Overall Study|Lost to Follow-up|0|||
16345523|NCT01826981|39751303|FG014|Overall Study|Lost to Follow-up|0|||
16345524|NCT01826981|39751289|FG000|Overall Study|Withdrew Consent|0|||
16345525|NCT01826981|39751290|FG001|Overall Study|Withdrew Consent|0|||
16345526|NCT01826981|39751291|FG002|Overall Study|Withdrew Consent|0|||
16345527|NCT01826981|39751292|FG003|Overall Study|Withdrew Consent|0|||
16345528|NCT01826981|39751293|FG004|Overall Study|Withdrew Consent|0|||
16345529|NCT01826981|39751294|FG005|Overall Study|Withdrew Consent|0|||
16345530|NCT01826981|39751295|FG006|Overall Study|Withdrew Consent|1|||
16345531|NCT01826981|39751296|FG007|Overall Study|Withdrew Consent|1|||
16345532|NCT01826981|39751297|FG008|Overall Study|Withdrew Consent|0|||
16345533|NCT01826981|39751298|FG009|Overall Study|Withdrew Consent|0|||
16345534|NCT01826981|39751299|FG010|Overall Study|Withdrew Consent|0|||
16345535|NCT01826981|39751300|FG011|Overall Study|Withdrew Consent|1|||
16345536|NCT01826981|39751301|FG012|Overall Study|Withdrew Consent|0|||
16345537|NCT01826981|39751302|FG013|Overall Study|Withdrew Consent|1|||
16345538|NCT01826981|39751303|FG014|Overall Study|Withdrew Consent|0|||
16345539|NCT01826981|39751289|FG000|Overall Study|Adverse Event|0|||
16345540|NCT01826981|39751290|FG001|Overall Study|Adverse Event|0|||
16345541|NCT01826981|39751291|FG002|Overall Study|Adverse Event|0|||
16345542|NCT01826981|39751292|FG003|Overall Study|Adverse Event|0|||
16345543|NCT01826981|39751293|FG004|Overall Study|Adverse Event|1|||
16345544|NCT01826981|39751294|FG005|Overall Study|Adverse Event|0|||
16345545|NCT01826981|39751295|FG006|Overall Study|Adverse Event|0|||
16345546|NCT01826981|39751296|FG007|Overall Study|Adverse Event|0|||
16345547|NCT01826981|39751297|FG008|Overall Study|Adverse Event|0|||
16345548|NCT01826981|39751298|FG009|Overall Study|Adverse Event|0|||
16345549|NCT01826981|39751299|FG010|Overall Study|Adverse Event|0|||
16345550|NCT01826981|39751300|FG011|Overall Study|Adverse Event|0|||
16345551|NCT01826981|39751301|FG012|Overall Study|Adverse Event|0|||
16345552|NCT01826981|39751302|FG013|Overall Study|Adverse Event|0|||
16345553|NCT01826981|39751303|FG014|Overall Study|Adverse Event|0|||
16345554|NCT01826981|39751289|FG000|Overall Study|Upper G-I Haemorrhage|0|||
16345555|NCT01826981|39751290|FG001|Overall Study|Upper G-I Haemorrhage|0|||
16345556|NCT01826981|39751291|FG002|Overall Study|Upper G-I Haemorrhage|0|||
16345557|NCT01826981|39751292|FG003|Overall Study|Upper G-I Haemorrhage|0|||
16345558|NCT01826981|39751293|FG004|Overall Study|Upper G-I Haemorrhage|0|||
16345559|NCT01826981|39751294|FG005|Overall Study|Upper G-I Haemorrhage|0|||
16345560|NCT01826981|39751295|FG006|Overall Study|Upper G-I Haemorrhage|0|||
16345561|NCT01826981|39751296|FG007|Overall Study|Upper G-I Haemorrhage|0|||
16345562|NCT01826981|39751297|FG008|Overall Study|Upper G-I Haemorrhage|0|||
16345563|NCT01826981|39751298|FG009|Overall Study|Upper G-I Haemorrhage|0|||
16345564|NCT01826981|39751299|FG010|Overall Study|Upper G-I Haemorrhage|0|||
16345565|NCT01826981|39751300|FG011|Overall Study|Upper G-I Haemorrhage|0|||
16345566|NCT01826981|39751301|FG012|Overall Study|Upper G-I Haemorrhage|0|||
16409159|NCT00996801|39981569|FG000|Overall Study|Study Terminated by Sponsor|0|||
16409160|NCT00996801|39981570|FG001|Overall Study|Study Terminated by Sponsor|1|||
16409161|NCT00996801|39981571|FG002|Overall Study|Study Terminated by Sponsor|0|||
16409162|NCT00996801|39981572|FG003|Overall Study|Study Terminated by Sponsor|0|||
16409163|NCT00996801|39981573|FG004|Overall Study|Study Terminated by Sponsor|46|||
16409164|NCT00996801|39981574|FG005|Overall Study|Study Terminated by Sponsor|0|||
16409165|NCT00996801|39981569|FG000|Overall Study|Withdrawal by Subject|8|||
16409166|NCT00996801|39981570|FG001|Overall Study|Withdrawal by Subject|6|||
16111106|NCT01242371|38893065|FG000|Overall Study|Withdrawal by Subject|2|||
16111107|NCT01242371|38893066|FG001|Overall Study|Withdrawal by Subject|2|||
16111108|NCT01242371|38893065|FG000|Overall Study|Protocol Violation|0|||
16345567|NCT01826981|39751302|FG013|Overall Study|Upper G-I Haemorrhage|1|||
16345568|NCT01826981|39751303|FG014|Overall Study|Upper G-I Haemorrhage|0|||
16345569|NCT01826981|39751289|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345570|NCT01826981|39751290|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345571|NCT01826981|39751291|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345572|NCT01826981|39751292|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345573|NCT01826981|39751293|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345574|NCT01826981|39751294|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345575|NCT01826981|39751295|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345576|NCT01826981|39751296|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
16345577|NCT01826981|39751297|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345578|NCT01826981|39751298|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345579|NCT01826981|39751299|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345580|NCT01826981|39751300|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345581|NCT01826981|39751301|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345582|NCT01826981|39751302|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345583|NCT01826981|39751303|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
16345584|NCT03374488|39751308|FG000|Overall Study|Death|13|||
16345585|NCT03374488|39751309|FG001|Overall Study|Death|13|||
16345586|NCT03374488|39751308|FG000|Overall Study|Withdrawal by Subject|3|||
16345587|NCT03374488|39751309|FG001|Overall Study|Withdrawal by Subject|1|||
16345588|NCT03374488|39751308|FG000|Overall Study|Physician Decision|3|||
16345589|NCT03374488|39751309|FG001|Overall Study|Physician Decision|0|||
16345590|NCT02221648|39751310|FG000|Overall Study|Withdrawal by Subject|3|||
16345591|NCT02221648|39751311|FG001|Overall Study|Withdrawal by Subject|3|||
16345592|NCT00110357|39751315|FG000|Overall Study|Deterioration without progression|2|||
16345593|NCT00110357|39751316|FG001|Overall Study|Deterioration without progression|0|||
16345594|NCT00110357|39751315|FG000|Overall Study|Disease progression/relapse|20|||
16345595|NCT00110357|39751316|FG001|Overall Study|Disease progression/relapse|15|||
16345596|NCT00110357|39751315|FG000|Overall Study|Study Closure|1|||
16345597|NCT00110357|39751316|FG001|Overall Study|Study Closure|0|||
16345598|NCT00110357|39751315|FG000|Overall Study|Study Drug Toxicity|1|||
16345599|NCT00110357|39751316|FG001|Overall Study|Study Drug Toxicity|3|||
16345600|NCT00110357|39751315|FG000|Overall Study|Withdrawal by Subject|3|||
16345601|NCT00110357|39751316|FG001|Overall Study|Withdrawal by Subject|1|||
16345602|NCT00524771|39751317|FG000|Overall Study|Protocol Violation|220|||
16345603|NCT00524771|39751318|FG001|Overall Study|Protocol Violation|585|||
16345604|NCT04017832|39751323|FG000|Overall Study|Withdrawal by Subject|13|||
16345605|NCT04017832|39751324|FG001|Overall Study|Withdrawal by Subject|12|||
16409167|NCT00996801|39981571|FG002|Overall Study|Withdrawal by Subject|9|||
16409168|NCT00996801|39981572|FG003|Overall Study|Withdrawal by Subject|5|||
16111109|NCT01242371|38893066|FG001|Overall Study|Protocol Violation|3|||
16111110|NCT01606319|38893067|FG000|Overall Study|Lost to Follow-up|17|||
16111111|NCT01606319|38893068|FG001|Overall Study|Lost to Follow-up|14|||
16111112|NCT01606319|38893067|FG000|Overall Study|Withdrawal by Subject|9|||
16111113|NCT01606319|38893068|FG001|Overall Study|Withdrawal by Subject|12|||
16111114|NCT01606319|38893067|FG000|Overall Study|Physician Decision|1|||
16111115|NCT01606319|38893068|FG001|Overall Study|Physician Decision|2|||
16345606|NCT04017832|39751325|FG002|Overall Study|Withdrawal by Subject|21|||
16345607|NCT04017832|39751326|FG003|Overall Study|Withdrawal by Subject|7|||
16111116|NCT01606319|38893067|FG000|Overall Study|Lack of Efficacy|6|||
16345608|NCT04017832|39751323|FG000|Overall Study|Lost to Follow-up|0|||
16111117|NCT01606319|38893068|FG001|Overall Study|Lack of Efficacy|8|||
16111118|NCT01606319|38893067|FG000|Overall Study|Adverse Event|1|||
16111119|NCT01606319|38893068|FG001|Overall Study|Adverse Event|4|||
16111120|NCT04042077|38893069|FG000|Overall Study|Adverse Event|0|||
16111121|NCT04042077|38893070|FG001|Overall Study|Adverse Event|1|||
16111122|NCT04042077|38893069|FG000|Overall Study|Death|2|||
16111123|NCT04042077|38893070|FG001|Overall Study|Death|1|||
16111124|NCT04042077|38893069|FG000|Overall Study|Physician Decision|2|||
16409169|NCT00996801|39981573|FG004|Overall Study|Withdrawal by Subject|5|||
16409170|NCT00996801|39981574|FG005|Overall Study|Withdrawal by Subject|9|||
16409171|NCT01460719|39981580|FG000|Overall Study|Adverse Event|1|||
16409172|NCT01460719|39981580|FG000|Overall Study|Withdrawal by Subject|1|||
16409173|NCT00989235|39981581|FG000|Overall Study|Death|0|||
16409174|NCT00989235|39981582|FG001|Overall Study|Death|1|||
16409175|NCT00989235|39981581|FG000|Overall Study|Adverse Event|0|||
16409176|NCT00989235|39981582|FG001|Overall Study|Adverse Event|1|||
16409177|NCT00989235|39981581|FG000|Overall Study|Lack of Efficacy|1|||
16409178|NCT00989235|39981582|FG001|Overall Study|Lack of Efficacy|0|||
16409179|NCT00989235|39981581|FG000|Overall Study|Withdrawal of Consent|1|||
16409180|NCT00989235|39981582|FG001|Overall Study|Withdrawal of Consent|1|||
16409181|NCT00989235|39981581|FG000|Overall Study|Desire to Become Pregnant|1|||
16409182|NCT00989235|39981582|FG001|Overall Study|Desire to Become Pregnant|0|||
16409183|NCT00989235|39981581|FG000|Overall Study|Randomized by Mistake|0|||
16409184|NCT00989235|39981582|FG001|Overall Study|Randomized by Mistake|2|||
16409185|NCT00989235|39981581|FG000|Overall Study|Lost to Follow-up|0|||
16409186|NCT00989235|39981582|FG001|Overall Study|Lost to Follow-up|1|||
16409187|NCT00033540|39981583|FG000|Overall Study|Adverse Event|14|||
16409188|NCT00033540|39981583|FG000|Overall Study|Death|1|||
16409189|NCT00033540|39981583|FG000|Overall Study|Progression|26|||
16409190|NCT00033540|39981583|FG000|Overall Study|Withdrawal by Subject|6|||
16409191|NCT00033540|39981583|FG000|Overall Study|Other|5|||
16409192|NCT00033540|39981583|FG000|Overall Study|Ineligible|3|||
16409193|NCT00033540|39981583|FG000|Overall Study|Never received treatment|2|||
16409194|NCT02836873|39981584|FG000|Overall Study|Protocol Violation|0|||
16111125|NCT04042077|38893070|FG001|Overall Study|Physician Decision|0|||
16409195|NCT02836873|39981585|FG001|Overall Study|Protocol Violation|1|||
16409196|NCT02836873|39981584|FG000|Overall Study|Adverse Event|1|||
16409197|NCT02836873|39981585|FG001|Overall Study|Adverse Event|4|||
16409198|NCT02836873|39981584|FG000|Overall Study|Withdrawal by Subject|2|||
16409199|NCT02836873|39981585|FG001|Overall Study|Withdrawal by Subject|2|||
16409200|NCT02836873|39981584|FG000|Overall Study|Lost to Follow-up|1|||
16409201|NCT02836873|39981585|FG001|Overall Study|Lost to Follow-up|3|||
16409202|NCT02836873|39981584|FG000|Overall Study|Physician Decision|0|||
16409203|NCT02836873|39981585|FG001|Overall Study|Physician Decision|1|||
16409204|NCT02836873|39981584|FG000|Overall Study|Other|1|||
16409205|NCT02836873|39981585|FG001|Overall Study|Other|0|||
16409206|NCT04070326|39981586|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
16409207|NCT04070326|39981587|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
16409208|NCT03618628|39981591|FG000|Overall Study|Death|1|||
16409209|NCT03618628|39981591|FG000|Overall Study|Lost to Follow-up|1|||
16409210|NCT00823212|39981592|FG000|Overall Study|Death|8|||
16409211|NCT00823212|39981593|FG001|Overall Study|Death|10|||
16409212|NCT00823212|39981592|FG000|Overall Study|Withdrawal by Subject|6|||
16409213|NCT00823212|39981593|FG001|Overall Study|Withdrawal by Subject|1|||
16409214|NCT00823212|39981592|FG000|Overall Study|Incarcerated|0|||
16409215|NCT00823212|39981593|FG001|Overall Study|Incarcerated|1|||
16409216|NCT00823212|39981592|FG000|Overall Study|Missed 12-month visit|21|||
16111126|NCT04042077|38893069|FG000|Overall Study|Withdrawal by Subject|3|||
16111127|NCT04042077|38893070|FG001|Overall Study|Withdrawal by Subject|2|||
16111128|NCT04042077|38893069|FG000|Overall Study|Lack of Efficacy|0|||
16111129|NCT04042077|38893070|FG001|Overall Study|Lack of Efficacy|1|||
16111130|NCT01712061|38893074|FG000|Overall Study|Adverse Event|4|||
16409217|NCT00823212|39981593|FG001|Overall Study|Missed 12-month visit|21|||
16409218|NCT00106691|39981594|FG000|Overall Study|Adverse Event|60|||
16409219|NCT00106691|39981595|FG001|Overall Study|Adverse Event|64|||
16409220|NCT00106691|39981594|FG000|Overall Study|Lost to Follow-up|23|||
16409221|NCT00106691|39981595|FG001|Overall Study|Lost to Follow-up|18|||
16409222|NCT00106691|39981594|FG000|Overall Study|Physician Decision|18|||
16409223|NCT00106691|39981595|FG001|Overall Study|Physician Decision|21|||
16409224|NCT00106691|39981594|FG000|Overall Study|Protocol Violation|13|||
16409225|NCT00106691|39981595|FG001|Overall Study|Protocol Violation|18|||
16345609|NCT04017832|39751324|FG001|Overall Study|Lost to Follow-up|3|||
16111131|NCT01712061|38893075|FG001|Overall Study|Adverse Event|9|||
16111132|NCT01712061|38893076|FG002|Overall Study|Adverse Event|5|||
16111133|NCT01712061|38893074|FG000|Overall Study|Death|0|||
16111134|NCT01712061|38893075|FG001|Overall Study|Death|0|||
16111135|NCT01712061|38893076|FG002|Overall Study|Death|1|||
16111136|NCT01712061|38893074|FG000|Overall Study|Lost to Follow-up|1|||
16111137|NCT01712061|38893075|FG001|Overall Study|Lost to Follow-up|0|||
16111138|NCT01712061|38893076|FG002|Overall Study|Lost to Follow-up|1|||
16111139|NCT01712061|38893074|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
16111140|NCT01712061|38893075|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
16111141|NCT01712061|38893076|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
16111142|NCT01712061|38893074|FG000|Overall Study|Medication Error Without Associated AE|0|||
16111143|NCT01712061|38893075|FG001|Overall Study|Medication Error Without Associated AE|1|||
16222439|NCT02185040|39295146|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
16222440|NCT02185040|39295147|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16222441|NCT02185040|39295148|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16222442|NCT02185040|39295149|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16222443|NCT02185040|39295150|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16222444|NCT02185040|39295151|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
16222445|NCT02185040|39295145|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
16222446|NCT02185040|39295146|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
16222447|NCT02185040|39295147|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
16222448|NCT02185040|39295148|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
16222449|NCT02185040|39295149|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
16222450|NCT02185040|39295150|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
16222451|NCT02185040|39295151|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
16222452|NCT02185040|39295145|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
16222453|NCT02185040|39295146|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
16222454|NCT02185040|39295147|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
16222455|NCT02185040|39295148|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
16222456|NCT02185040|39295149|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
16222457|NCT02185040|39295150|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
16222458|NCT02185040|39295151|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
16222459|NCT02185040|39295145|FG000|Active Treatment Extension Phase|Adverse Event|0|||
16222460|NCT02185040|39295146|FG001|Active Treatment Extension Phase|Adverse Event|0|||
16222461|NCT02185040|39295147|FG002|Active Treatment Extension Phase|Adverse Event|0|||
16222462|NCT02185040|39295148|FG003|Active Treatment Extension Phase|Adverse Event|0|||
16222463|NCT02185040|39295149|FG004|Active Treatment Extension Phase|Adverse Event|0|||
16222464|NCT02185040|39295150|FG005|Active Treatment Extension Phase|Adverse Event|1|||
16111144|NCT01712061|38893076|FG002|Overall Study|Medication Error Without Associated AE|0|||
16222465|NCT02185040|39295151|FG006|Active Treatment Extension Phase|Adverse Event|4|||
16222466|NCT02185040|39295145|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
16222467|NCT02185040|39295146|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
16222468|NCT02185040|39295147|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
16222469|NCT02185040|39295148|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
16222470|NCT02185040|39295149|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
16222471|NCT02185040|39295150|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
16222472|NCT02185040|39295151|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
16222473|NCT02185040|39295145|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
16222474|NCT02185040|39295146|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
16222475|NCT02185040|39295147|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
16222476|NCT02185040|39295148|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
16222477|NCT02185040|39295149|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
16222478|NCT02185040|39295150|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
16222479|NCT02185040|39295151|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
16222480|NCT04335929|39295152|FG000|Overall Study|Lost to Follow-up|10|||
16222481|NCT00760994|39295153|FG000|Overall Study|Lost to Follow-up|4|||
16222482|NCT00760994|39295154|FG001|Overall Study|Lost to Follow-up|4|||
16222483|NCT00760994|39295155|FG002|Overall Study|Lost to Follow-up|3|||
16222484|NCT02709889|39295160|FG000|Overall Study|Withdrawal by Subject|11|||
16222485|NCT02709889|39295161|FG001|Overall Study|Withdrawal by Subject|10|||
16222486|NCT02709889|39295162|FG002|Overall Study|Withdrawal by Subject|2|||
16222487|NCT02709889|39295163|FG003|Overall Study|Withdrawal by Subject|12|||
16222488|NCT02709889|39295160|FG000|Overall Study|Death|25|||
16222489|NCT02709889|39295161|FG001|Overall Study|Death|38|||
16222490|NCT02709889|39295162|FG002|Overall Study|Death|4|||
16222491|NCT02709889|39295163|FG003|Overall Study|Death|44|||
16222492|NCT02709889|39295160|FG000|Overall Study|Physician Decision|1|||
16222493|NCT02709889|39295161|FG001|Overall Study|Physician Decision|2|||
16222494|NCT02709889|39295162|FG002|Overall Study|Physician Decision|3|||
16222495|NCT02709889|39295163|FG003|Overall Study|Physician Decision|5|||
16222496|NCT02709889|39295160|FG000|Overall Study|Lost to Follow-up|2|||
16345610|NCT04017832|39751325|FG002|Overall Study|Lost to Follow-up|3|||
16222497|NCT02709889|39295161|FG001|Overall Study|Lost to Follow-up|0|||
16222498|NCT02709889|39295162|FG002|Overall Study|Lost to Follow-up|0|||
16222499|NCT02709889|39295163|FG003|Overall Study|Lost to Follow-up|4|||
16222500|NCT02709889|39295160|FG000|Overall Study|Study Terminated by Sponsor|4|||
16222501|NCT02709889|39295161|FG001|Overall Study|Study Terminated by Sponsor|6|||
16345611|NCT04017832|39751326|FG003|Overall Study|Lost to Follow-up|1|||
16345612|NCT04017832|39751323|FG000|Overall Study|Physician Decision|1|||
16222502|NCT02709889|39295162|FG002|Overall Study|Study Terminated by Sponsor|2|||
16222503|NCT02709889|39295163|FG003|Overall Study|Study Terminated by Sponsor|17|||
16222504|NCT02709889|39295160|FG000|Overall Study|Other, Not Specified|0|||
16222505|NCT02709889|39295161|FG001|Overall Study|Other, Not Specified|1|||
16222506|NCT02709889|39295162|FG002|Overall Study|Other, Not Specified|1|||
16222507|NCT02709889|39295163|FG003|Overall Study|Other, Not Specified|6|||
16222508|NCT00570492|39295164|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
16222509|NCT00570492|39295165|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
16222510|NCT00570492|39295166|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
16222511|NCT00570492|39295164|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
16222512|NCT00570492|39295165|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
16222513|NCT00570492|39295166|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
16222514|NCT00570492|39295164|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
16222515|NCT00570492|39295165|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
16222516|NCT00570492|39295166|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
16222517|NCT00570492|39295164|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
16222518|NCT00570492|39295165|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
16222519|NCT00570492|39295166|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
16222520|NCT00570492|39295164|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
16222521|NCT00570492|39295165|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
16222522|NCT00570492|39295166|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
16222523|NCT00570492|39295164|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
16222524|NCT00570492|39295165|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
16222525|NCT00570492|39295166|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
16222526|NCT00570492|39295164|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
16222527|NCT00570492|39295165|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
16222528|NCT00570492|39295166|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
16222529|NCT00570492|39295164|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16222530|NCT00570492|39295165|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
16222531|NCT00570492|39295166|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
16222532|NCT00570492|39295164|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
16222533|NCT00570492|39295165|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
16222534|NCT00570492|39295166|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
16222535|NCT00570492|39295164|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
16222536|NCT00570492|39295165|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
16222537|NCT00570492|39295166|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
16222538|NCT00570492|39295164|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
16222539|NCT00570492|39295165|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
16222540|NCT00570492|39295166|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
16222541|NCT00570492|39295164|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
16222542|NCT00570492|39295165|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
16222543|NCT00570492|39295166|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
16222544|NCT00570492|39295164|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
16222545|NCT00570492|39295165|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
16222546|NCT00570492|39295166|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
16222547|NCT00570492|39295164|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
16222548|NCT00570492|39295165|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
16222549|NCT00570492|39295166|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
16222550|NCT00554229|39295170|FG000|Overall Study|Lost to Follow-up|3|||
16222551|NCT00554229|39295171|FG001|Overall Study|Lost to Follow-up|6|||
16222552|NCT00554229|39295170|FG000|Overall Study|Withdrawal by Subject|29|||
16222553|NCT00554229|39295171|FG001|Overall Study|Withdrawal by Subject|37|||
16222554|NCT00554229|39295170|FG000|Overall Study|Adverse Event|71|||
16222555|NCT00554229|39295171|FG001|Overall Study|Adverse Event|39|||
16222556|NCT00554229|39295170|FG000|Overall Study|Protocol Violation|3|||
16222557|NCT00554229|39295171|FG001|Overall Study|Protocol Violation|3|||
16222558|NCT00554229|39295170|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
16222559|NCT00554229|39295171|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
16222560|NCT00554229|39295170|FG000|Overall Study|Randomised but no treatment received|1|||
16222561|NCT00554229|39295171|FG001|Overall Study|Randomised but no treatment received|0|||
16345613|NCT04017832|39751324|FG001|Overall Study|Physician Decision|1|||
16345614|NCT04017832|39751325|FG002|Overall Study|Physician Decision|1|||
16111145|NCT01712061|38893074|FG000|Overall Study|Withdrawal by Subject|1|||
16111146|NCT01712061|38893075|FG001|Overall Study|Withdrawal by Subject|7|||
16111147|NCT01712061|38893076|FG002|Overall Study|Withdrawal by Subject|1|||
16111148|NCT01712061|38893074|FG000|Overall Study|Other|0|||
16111149|NCT01712061|38893075|FG001|Overall Study|Other|3|||
16111150|NCT01712061|38893076|FG002|Overall Study|Other|0|||
16111151|NCT02201901|38893079|FG000|Overall Study|Randomized but never treated|0|||
16111152|NCT02201901|38893080|FG001|Overall Study|Randomized but never treated|1|||
16111153|NCT02201901|38893081|FG002|Overall Study|Randomized but never treated|0|||
16111154|NCT02201901|38893079|FG000|Overall Study|Lack of Efficacy|7|||
16111155|NCT02201901|38893080|FG001|Overall Study|Lack of Efficacy|1|||
16111156|NCT02201901|38893081|FG002|Overall Study|Lack of Efficacy|6|||
16111157|NCT02201901|38893079|FG000|Overall Study|Death|3|||
16111158|NCT02201901|38893080|FG001|Overall Study|Death|3|||
16111159|NCT02201901|38893081|FG002|Overall Study|Death|3|||
16111160|NCT02201901|38893079|FG000|Overall Study|Lost to Follow-up|2|||
16111161|NCT02201901|38893080|FG001|Overall Study|Lost to Follow-up|3|||
16111162|NCT02201901|38893081|FG002|Overall Study|Lost to Follow-up|2|||
16111163|NCT02201901|38893079|FG000|Overall Study|Withdrew Consent|2|||
16111164|NCT02201901|38893080|FG001|Overall Study|Withdrew Consent|0|||
16111165|NCT02201901|38893081|FG002|Overall Study|Withdrew Consent|2|||
16111166|NCT02201901|38893079|FG000|Overall Study|Adverse Event|1|||
16111167|NCT02201901|38893080|FG001|Overall Study|Adverse Event|1|||
16111168|NCT02201901|38893081|FG002|Overall Study|Adverse Event|0|||
16111169|NCT00559377|38893084|FG000|Overall Study|Withdrawal by Subject|9|||
16111170|NCT01124838|38893087|FG000|Overall Study|Miscellaneous|4|||
16111171|NCT01124838|38893088|FG001|Overall Study|Miscellaneous|2|||
16111172|NCT01124838|38893087|FG000|Overall Study|Adverse Event|7|||
16111173|NCT01124838|38893088|FG001|Overall Study|Adverse Event|11|||
16111174|NCT01124838|38893087|FG000|Overall Study|Lack of Efficacy|2|||
16111175|NCT01124838|38893088|FG001|Overall Study|Lack of Efficacy|0|||
16111176|NCT01124838|38893087|FG000|Overall Study|Withdrawal by Subject|3|||
16111177|NCT01124838|38893088|FG001|Overall Study|Withdrawal by Subject|2|||
16111178|NCT01124838|38893087|FG000|Overall Study|Lost to Follow-up|2|||
16111179|NCT01124838|38893088|FG001|Overall Study|Lost to Follow-up|0|||
16111180|NCT00936598|38893089|FG000|Overall Study|Withdrawal by Subject|1|||
16111181|NCT00936598|38893090|FG001|Overall Study|Withdrawal by Subject|0|||
16111182|NCT00936598|38893089|FG000|Overall Study|Ineligible after consent|1|||
16111183|NCT00936598|38893090|FG001|Overall Study|Ineligible after consent|0|||
16111184|NCT02520310|38893091|FG000|At 6 Months Clinical Follow-up|Death|1|||
16111185|NCT02520310|38893091|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
16111186|NCT02520310|38893091|FG000|AT 3 Year Clinical Follow-up|Death|2|||
16111187|NCT02520310|38893091|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
16111188|NCT02520310|38893091|FG000|AT 4 Year Clinical Follow-up|Death|1|||
16111189|NCT02520310|38893091|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
16111190|NCT03448536|38893092|FG000|Overall Study|Protocol Violation|2|||
16111191|NCT03448536|38893093|FG001|Overall Study|Protocol Violation|0|||
16111192|NCT03448536|38893092|FG000|Overall Study|Pregnancy|1|||
16111193|NCT03448536|38893093|FG001|Overall Study|Pregnancy|0|||
16111194|NCT03448536|38893092|FG000|Overall Study|Withdrawal by Subject|1|||
16222562|NCT00106626|39295172|FG000|Overall Study|Adverse Event|5|||
16345615|NCT04017832|39751326|FG003|Overall Study|Physician Decision|1|||
16111195|NCT03448536|38893093|FG001|Overall Study|Withdrawal by Subject|2|||
16111196|NCT03448536|38893092|FG000|Overall Study|Lost to Follow-up|3|||
16111197|NCT03448536|38893093|FG001|Overall Study|Lost to Follow-up|2|||
16111198|NCT03448536|38893092|FG000|Overall Study|Inadequate pain reporter|1|||
16111199|NCT03448536|38893093|FG001|Overall Study|Inadequate pain reporter|0|||
16111200|NCT03448536|38893092|FG000|Overall Study|Other|3|||
16111201|NCT03448536|38893093|FG001|Overall Study|Other|0|||
16111202|NCT03448536|38893092|FG000|Overall Study|Physician Decision|1|||
16111203|NCT03448536|38893093|FG001|Overall Study|Physician Decision|0|||
16111204|NCT01447576|38893094|FG000|Overall Study|Lost to Follow-up|52|||
16111205|NCT01447576|38893094|FG000|Overall Study|Adverse Event|127|||
16111206|NCT01447576|38893094|FG000|Overall Study|Participant met withdrawal criteria|40|||
16111207|NCT01447576|38893094|FG000|Overall Study|Withdrawal by Subject|100|||
16345616|NCT04017832|39751323|FG000|Overall Study|Death|2|||
16111208|NCT01447576|38893094|FG000|Overall Study|Protocol deviation|83|||
16111209|NCT01447576|38893094|FG000|Overall Study|Lack of Efficacy|68|||
16111210|NCT01447576|38893094|FG000|Overall Study|Physician Decision|6|||
16111211|NCT02670122|38893095|FG000|Overall Study|Lost to Follow-up|4|||
16111212|NCT00516906|38893096|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
16111213|NCT00516906|38893097|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
16345617|NCT04017832|39751324|FG001|Overall Study|Death|2|||
16345618|NCT04017832|39751325|FG002|Overall Study|Death|1|||
16111214|NCT00030823|38893098|FG000|Overall Study|Withdrawal by Subject|1|||
16111215|NCT02392104|38893101|FG000|Overall Study|discontinuation of warfarin|3|||
16111216|NCT02392104|38893101|FG000|Overall Study|bleeding event|1|||
16111217|NCT02392104|38893101|FG000|Overall Study|transferred care to another doctor|2|||
16111218|NCT02392104|38893101|FG000|Overall Study|INR goal range changed|1|||
16111219|NCT02392104|38893101|FG000|Overall Study|admitted to skilled nursing facility|3|||
16111220|NCT02392104|38893101|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
16111221|NCT00394589|38893102|FG000|Overall Study|Adverse Event|2|||
16111222|NCT00394589|38893103|FG001|Overall Study|Adverse Event|1|||
16111223|NCT00394589|38893104|FG002|Overall Study|Adverse Event|2|||
16111224|NCT00394589|38893102|FG000|Overall Study|Lack of Efficacy|2|||
16111225|NCT00394589|38893103|FG001|Overall Study|Lack of Efficacy|2|||
16111226|NCT00394589|38893104|FG002|Overall Study|Lack of Efficacy|3|||
16111227|NCT00394589|38893102|FG000|Overall Study|Protocol Violation|4|||
16111228|NCT00394589|38893103|FG001|Overall Study|Protocol Violation|0|||
16111229|NCT00394589|38893104|FG002|Overall Study|Protocol Violation|2|||
16111230|NCT00952848|38893106|FG000|Overall Study|Withdrawal by Subject|4|||
16111231|NCT03443414|38893107|FG000|Overall Study|Adverse Event|6|||
16111232|NCT03443414|38893108|FG001|Overall Study|Adverse Event|0|||
16111233|NCT03443414|38893109|FG002|Overall Study|Adverse Event|4|||
16345619|NCT04017832|39751326|FG003|Overall Study|Death|0|||
16222563|NCT00106626|39295173|FG001|Overall Study|Adverse Event|4|||
16111234|NCT03443414|38893110|FG003|Overall Study|Adverse Event|2|||
16345620|NCT03077607|39751327|FG000|Period 1 (15 Days)|Adverse Event|1|||
16111235|NCT03443414|38893111|FG004|Overall Study|Adverse Event|3|||
16111236|NCT03443414|38893107|FG000|Overall Study|Withdrawal by Subject|3|||
16111237|NCT03443414|38893108|FG001|Overall Study|Withdrawal by Subject|2|||
16111238|NCT03443414|38893109|FG002|Overall Study|Withdrawal by Subject|2|||
16345621|NCT03077607|39751328|FG001|Period 1 (15 Days)|Adverse Event|0|||
16345622|NCT03077607|39751327|FG000|Period 1 (15 Days)|Death|1|||
16345623|NCT03077607|39751328|FG001|Period 1 (15 Days)|Death|0|||
16345624|NCT03077607|39751327|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
16345625|NCT03077607|39751328|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
16345626|NCT03077607|39751327|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
16345627|NCT03077607|39751328|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
16345628|NCT02003144|39751336|FG000|Open Label Maintenance Phase|Other than specified|2|||
16345629|NCT02003144|39751337|FG001|Open Label Maintenance Phase|Other than specified|4|||
16345630|NCT02003144|39751336|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
16345631|NCT02003144|39751337|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
16345632|NCT02003144|39751336|FG000|Open Label Maintenance Phase|Pregnancy|0|||
16345633|NCT02003144|39751337|FG001|Open Label Maintenance Phase|Pregnancy|2|||
16345634|NCT02003144|39751336|FG000|Open Label Maintenance Phase|Physician Decision|1|||
16345635|NCT02003144|39751337|FG001|Open Label Maintenance Phase|Physician Decision|1|||
16345636|NCT02003144|39751336|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
16345637|NCT02003144|39751337|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
16345638|NCT02003144|39751336|FG000|Open Label Maintenance Phase|Adverse Event|2|||
16345639|NCT02003144|39751337|FG001|Open Label Maintenance Phase|Adverse Event|1|||
16345640|NCT01909973|39751338|FG000|Overall Study|Lost to Follow-up|1|||
16345641|NCT01909973|39751339|FG001|Overall Study|Lost to Follow-up|0|||
16346441|NCT00758498|39757158|FG001|Overall Study|Subject legally detained out of state|0|||
16346442|NCT00758498|39757159|FG002|Overall Study|Subject legally detained out of state|0|||
16346443|NCT00758498|39757157|FG000|Overall Study|Withdrawal by Subject|0|||
16409226|NCT00106691|39981594|FG000|Overall Study|Withdrawal by Subject|75|||
16409227|NCT00106691|39981595|FG001|Overall Study|Withdrawal by Subject|70|||
16409228|NCT00106691|39981594|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
16409229|NCT00106691|39981595|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
16409230|NCT00106691|39981594|FG000|Overall Study|QTc>480|3|||
16409231|NCT00106691|39981595|FG001|Overall Study|QTc>480|1|||
16409232|NCT00106691|39981594|FG000|Overall Study|mililtary deployment|2|||
16409233|NCT00106691|39981595|FG001|Overall Study|mililtary deployment|0|||
16409234|NCT00106691|39981594|FG000|Overall Study|Study Site Closing/PI Moved|1|||
16409235|NCT00106691|39981595|FG001|Overall Study|Study Site Closing/PI Moved|2|||
16409236|NCT00106691|39981594|FG000|Overall Study|Cardiologist recommendation|1|||
16409237|NCT00106691|39981595|FG001|Overall Study|Cardiologist recommendation|0|||
16409238|NCT00106691|39981594|FG000|Overall Study|Pt. moved to another state|1|||
16111239|NCT03443414|38893110|FG003|Overall Study|Withdrawal by Subject|2|||
16111240|NCT03443414|38893111|FG004|Overall Study|Withdrawal by Subject|1|||
16111241|NCT03443414|38893107|FG000|Overall Study|Death|0|||
16111242|NCT03443414|38893108|FG001|Overall Study|Death|1|||
16111243|NCT03443414|38893109|FG002|Overall Study|Death|0|||
16111244|NCT03443414|38893110|FG003|Overall Study|Death|1|||
16111245|NCT03443414|38893111|FG004|Overall Study|Death|0|||
16111246|NCT03443414|38893107|FG000|Overall Study|Reason not specified|2|||
16111247|NCT03443414|38893108|FG001|Overall Study|Reason not specified|0|||
16111248|NCT03443414|38893109|FG002|Overall Study|Reason not specified|0|||
16111249|NCT03443414|38893110|FG003|Overall Study|Reason not specified|0|||
16111250|NCT03443414|38893111|FG004|Overall Study|Reason not specified|1|||
16111251|NCT00823836|38893112|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
16111252|NCT00823836|38893113|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
16111253|NCT00823836|38893112|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
16111254|NCT00823836|38893113|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
16409239|NCT00106691|39981595|FG001|Overall Study|Pt. moved to another state|0|||
16409240|NCT00106691|39981594|FG000|Overall Study|Taking exclusionary avodart|1|||
16409241|NCT00106691|39981595|FG001|Overall Study|Taking exclusionary avodart|0|||
16409242|NCT00106691|39981594|FG000|Overall Study|Not able to discontinue plavix|0|||
16222564|NCT00106626|39295174|FG002|Overall Study|Adverse Event|3|||
16345642|NCT04265261|39753133|FG000|Overall Study|Adverse Event|2|||
16345643|NCT04265261|39753134|FG001|Overall Study|Adverse Event|0|||
16345644|NCT04265261|39753135|FG002|Overall Study|Adverse Event|0|||
16345645|NCT04265261|39753133|FG000|Overall Study|Death|1|||
16345646|NCT04265261|39753134|FG001|Overall Study|Death|0|||
16345647|NCT04265261|39753135|FG002|Overall Study|Death|0|||
16345648|NCT04265261|39753133|FG000|Overall Study|Lost to Follow-up|4|||
16345649|NCT04265261|39753134|FG001|Overall Study|Lost to Follow-up|1|||
16345650|NCT04265261|39753135|FG002|Overall Study|Lost to Follow-up|3|||
16345651|NCT04265261|39753133|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16345652|NCT04265261|39753134|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16345653|NCT04265261|39753135|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16345654|NCT04265261|39753133|FG000|Overall Study|Physician Decision|0|||
16345655|NCT04265261|39753134|FG001|Overall Study|Physician Decision|0|||
16345656|NCT04265261|39753135|FG002|Overall Study|Physician Decision|1|||
16345657|NCT04265261|39753133|FG000|Overall Study|Protocol Deviation|0|||
16345658|NCT04265261|39753134|FG001|Overall Study|Protocol Deviation|2|||
16345659|NCT04265261|39753135|FG002|Overall Study|Protocol Deviation|0|||
16345660|NCT04265261|39753133|FG000|Overall Study|Withdrawal by Subject|2|||
16345661|NCT04265261|39753134|FG001|Overall Study|Withdrawal by Subject|1|||
16345662|NCT04265261|39753135|FG002|Overall Study|Withdrawal by Subject|4|||
16345663|NCT01950390|39753136|FG000|Overall Study|Never started treatment|3|||
16345664|NCT01950390|39753137|FG001|Overall Study|Never started treatment|2|||
16345665|NCT01950390|39753136|FG000|Overall Study|Disease progression|45|||
16409243|NCT00106691|39981595|FG001|Overall Study|Not able to discontinue plavix|1|||
16409244|NCT00385723|39981596|FG000|Overall Study|Lost to Follow-up|1|||
16409245|NCT00385723|39981597|FG001|Overall Study|Lost to Follow-up|1|||
16409246|NCT00385723|39981598|FG002|Overall Study|Lost to Follow-up|0|||
16409247|NCT00385723|39981596|FG000|Overall Study|Withdrawal by Subject|1|||
16222565|NCT00106626|39295175|FG003|Overall Study|Adverse Event|3|||
16222566|NCT00106626|39295172|FG000|Overall Study|Progressive Disease|4|||
16345666|NCT01950390|39753137|FG001|Overall Study|Disease progression|52|||
16345667|NCT01950390|39753136|FG000|Overall Study|Adverse Event|22|||
16345668|NCT01950390|39753137|FG001|Overall Study|Adverse Event|16|||
16345669|NCT01950390|39753136|FG000|Overall Study|Death|5|||
16345670|NCT01950390|39753137|FG001|Overall Study|Death|3|||
16345671|NCT01950390|39753136|FG000|Overall Study|Withdrawal by Subject|5|||
16409248|NCT00385723|39981597|FG001|Overall Study|Withdrawal by Subject|0|||
16111255|NCT00823836|38893112|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
16111256|NCT00823836|38893113|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
16111257|NCT00823836|38893112|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
16111258|NCT00823836|38893113|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
16111259|NCT00823836|38893112|FG000|Long-term Phase|Adverse Event|3|||
16111260|NCT00823836|38893113|FG001|Long-term Phase|Adverse Event|2|||
16111261|NCT00823836|38893112|FG000|Long-term Phase|Physician Decision|1|||
16111262|NCT00823836|38893113|FG001|Long-term Phase|Physician Decision|2|||
16111263|NCT00823836|38893112|FG000|Long-term Phase|Withdrawal by Subject|1|||
16111264|NCT00823836|38893113|FG001|Long-term Phase|Withdrawal by Subject|1|||
16111265|NCT01437423|38893114|FG000|Overall Study|Lost to Follow-up|12|||
16111266|NCT01437423|38893114|FG000|Overall Study|Off label usage|3|||
16111267|NCT03672175|38893115|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
16111268|NCT03672175|38893116|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
16111269|NCT03672175|38893117|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
16111270|NCT03672175|38893115|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
16111271|NCT03672175|38893116|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
16111272|NCT03672175|38893117|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
16111273|NCT03672175|38893115|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
16111274|NCT03672175|38893116|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
16111275|NCT03672175|38893117|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
16111276|NCT03672175|38893115|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
16111277|NCT03672175|38893116|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
16111278|NCT03672175|38893117|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
16111279|NCT03672175|38893115|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
16111280|NCT03672175|38893116|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
16111281|NCT03672175|38893117|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
16111282|NCT03672175|38893115|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
16111283|NCT03672175|38893116|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
16111284|NCT03672175|38893117|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
16111285|NCT03672175|38893115|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
16111286|NCT03672175|38893116|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
16111287|NCT03672175|38893117|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
16111288|NCT03672175|38893115|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
16111289|NCT03672175|38893116|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
16545791|NCT00510458|40460813|FG000|Overall Study|Withdrawal by Subject|3|||
16545792|NCT00510458|40460813|FG000|Overall Study|Revision|2|||
16545793|NCT00782496|40460814|FG000|Overall Study|Lost to Follow-up|14|||
16545794|NCT00782496|40460815|FG001|Overall Study|Lost to Follow-up|15|||
16545795|NCT00847405|40460816|FG000|First Intervention|Adverse Event|0|||
16545796|NCT00847405|40460817|FG001|First Intervention|Adverse Event|1|||
16545797|NCT00847405|40460816|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16545798|NCT00847405|40460817|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16545799|NCT02966002|40460818|FG000|Overall Study|Withdrawal by Subject|2|||
16545800|NCT02966002|40460818|FG000|Overall Study|Adverse Event|1|||
16545801|NCT02966002|40460818|FG000|Overall Study|Lost to Follow-up|1|||
16545802|NCT04277455|40460819|FG000|Overall Study|Lost to Follow-up|1|||
16545803|NCT02287584|40460820|FG000|the Double-blind Phase|Adverse Event|17|||
16545804|NCT02287584|40460821|FG001|the Double-blind Phase|Adverse Event|17|||
16545805|NCT02287584|40460822|FG002|the Double-blind Phase|Adverse Event|12|||
16545806|NCT02287584|40460823|FG003|the Double-blind Phase|Adverse Event|0|||
16545807|NCT02287584|40460824|FG004|the Double-blind Phase|Adverse Event|0|||
16545808|NCT02287584|40460825|FG005|the Double-blind Phase|Adverse Event|0|||
16545809|NCT02287584|40460820|FG000|the Double-blind Phase|Lack of Efficacy|18|||
16545810|NCT02287584|40460821|FG001|the Double-blind Phase|Lack of Efficacy|8|||
16545811|NCT02287584|40460822|FG002|the Double-blind Phase|Lack of Efficacy|8|||
16545812|NCT02287584|40460823|FG003|the Double-blind Phase|Lack of Efficacy|0|||
16545813|NCT02287584|40460824|FG004|the Double-blind Phase|Lack of Efficacy|0|||
16545814|NCT02287584|40460825|FG005|the Double-blind Phase|Lack of Efficacy|0|||
16545815|NCT02287584|40460820|FG000|the Double-blind Phase|Lost to Follow-up|0|||
16545816|NCT02287584|40460821|FG001|the Double-blind Phase|Lost to Follow-up|1|||
16545817|NCT02287584|40460822|FG002|the Double-blind Phase|Lost to Follow-up|1|||
16545818|NCT02287584|40460823|FG003|the Double-blind Phase|Lost to Follow-up|0|||
16545819|NCT02287584|40460824|FG004|the Double-blind Phase|Lost to Follow-up|0|||
16545820|NCT02287584|40460825|FG005|the Double-blind Phase|Lost to Follow-up|0|||
16545821|NCT02287584|40460820|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
16545822|NCT02287584|40460821|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
16545823|NCT02287584|40460822|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
16222567|NCT00106626|39295173|FG001|Overall Study|Progressive Disease|1|||
16222568|NCT00106626|39295174|FG002|Overall Study|Progressive Disease|9|||
16222569|NCT00106626|39295175|FG003|Overall Study|Progressive Disease|10|||
16222570|NCT00106626|39295172|FG000|Overall Study|Received radiation on new therapy|1|||
16222571|NCT00106626|39295173|FG001|Overall Study|Received radiation on new therapy|0|||
16222572|NCT00106626|39295174|FG002|Overall Study|Received radiation on new therapy|0|||
16222573|NCT00106626|39295175|FG003|Overall Study|Received radiation on new therapy|0|||
16222574|NCT00106626|39295172|FG000|Overall Study|> 14 day delay in therapy start|0|||
16409249|NCT00385723|39981598|FG002|Overall Study|Withdrawal by Subject|2|||
16545824|NCT02287584|40460823|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
16545825|NCT02287584|40460824|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
16545826|NCT02287584|40460825|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
16345672|NCT01950390|39753137|FG001|Overall Study|Withdrawal by Subject|1|||
16345673|NCT01950390|39753136|FG000|Overall Study|Alternative therapy|0|||
16222575|NCT00106626|39295173|FG001|Overall Study|> 14 day delay in therapy start|1|||
16222576|NCT00106626|39295174|FG002|Overall Study|> 14 day delay in therapy start|0|||
16222577|NCT00106626|39295175|FG003|Overall Study|> 14 day delay in therapy start|0|||
16222578|NCT01004159|39295176|FG000|Overall Study|Adverse Event|2|||
16222579|NCT01004159|39295176|FG000|Overall Study|Disease Progression|18|||
16222580|NCT00465894|39295177|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
16222581|NCT00465894|39295178|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
16222582|NCT00465894|39295177|FG000|Treatment For 12 Weeks|Family Issues|1|||
16222583|NCT00465894|39295178|FG001|Treatment For 12 Weeks|Family Issues|1|||
16222584|NCT00465894|39295177|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
16222585|NCT00465894|39295178|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
16222586|NCT04880642|39295179|FG000|Randomization|Withdrawal by Subject|2|||
16222587|NCT04880642|39295180|FG001|Randomization|Withdrawal by Subject|3|||
16222588|NCT04880642|39295179|FG000|Treatment Period|Adverse Event|0|||
16222589|NCT04880642|39295180|FG001|Treatment Period|Adverse Event|1|||
16545827|NCT02287584|40460820|FG000|the Double-blind Phase|Pregnancy|0|||
16545828|NCT02287584|40460821|FG001|the Double-blind Phase|Pregnancy|1|||
16222590|NCT04880642|39295179|FG000|Treatment Period|Death|6|||
16222591|NCT04880642|39295180|FG001|Treatment Period|Death|6|||
16222592|NCT04880642|39295179|FG000|Treatment Period|Lost to Follow-up|1|||
16345674|NCT01950390|39753137|FG001|Overall Study|Alternative therapy|3|||
16345675|NCT01950390|39753136|FG000|Overall Study|Complicating disease|1|||
16345676|NCT01950390|39753137|FG001|Overall Study|Complicating disease|0|||
16345677|NCT01950390|39753136|FG000|Overall Study|On treatment|1|||
16345678|NCT01950390|39753137|FG001|Overall Study|On treatment|0|||
16345679|NCT01950390|39753136|FG000|Overall Study|Symptomatic deterioration|2|||
16409250|NCT00431951|39981599|FG000|Overall Study|Inability to follow study procedures|1|||
16409251|NCT00431951|39981600|FG001|Overall Study|Inability to follow study procedures|0|||
16545829|NCT02287584|40460822|FG002|the Double-blind Phase|Pregnancy|0|||
16545830|NCT02287584|40460823|FG003|the Double-blind Phase|Pregnancy|0|||
16545831|NCT02287584|40460824|FG004|the Double-blind Phase|Pregnancy|0|||
16545832|NCT02287584|40460825|FG005|the Double-blind Phase|Pregnancy|0|||
16545833|NCT02287584|40460820|FG000|the Double-blind Phase|Protocol Violation|0|||
16545834|NCT02287584|40460821|FG001|the Double-blind Phase|Protocol Violation|3|||
16545835|NCT02287584|40460822|FG002|the Double-blind Phase|Protocol Violation|0|||
16545836|NCT02287584|40460823|FG003|the Double-blind Phase|Protocol Violation|0|||
16545837|NCT02287584|40460824|FG004|the Double-blind Phase|Protocol Violation|0|||
16545838|NCT02287584|40460825|FG005|the Double-blind Phase|Protocol Violation|0|||
16222593|NCT04880642|39295180|FG001|Treatment Period|Lost to Follow-up|0|||
16345680|NCT01950390|39753137|FG001|Overall Study|Symptomatic deterioration|1|||
16345681|NCT01950390|39753136|FG000|Overall Study|Physician Decision|0|||
16545839|NCT02287584|40460820|FG000|the Double-blind Phase|other reasons|0|||
16409252|NCT00431951|39981601|FG002|Overall Study|Inability to follow study procedures|1|||
16222594|NCT04880642|39295179|FG000|Treatment Period|Protocol Violation|0|||
16222595|NCT04880642|39295180|FG001|Treatment Period|Protocol Violation|1|||
16222596|NCT04880642|39295179|FG000|Treatment Period|Withdrawal by Subject|5|||
16222597|NCT04880642|39295180|FG001|Treatment Period|Withdrawal by Subject|3|||
16222598|NCT04880642|39295179|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
16222599|NCT04880642|39295180|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
16222600|NCT04880642|39295179|FG000|Follow-up|Death|4|||
16222601|NCT04880642|39295180|FG001|Follow-up|Death|3|||
16222602|NCT04880642|39295179|FG000|Follow-up|Withdrawal by Subject|1|||
16222603|NCT04880642|39295180|FG001|Follow-up|Withdrawal by Subject|0|||
16222604|NCT04382066|39295181|FG000|Overall Study|Adverse Event|1|||
16222605|NCT04382066|39295182|FG001|Overall Study|Adverse Event|0|||
16222606|NCT04382066|39295183|FG002|Overall Study|Adverse Event|0|||
16222607|NCT04382066|39295181|FG000|Overall Study|Death|1|||
16222608|NCT04382066|39295182|FG001|Overall Study|Death|0|||
16222609|NCT04382066|39295183|FG002|Overall Study|Death|1|||
16222610|NCT03961529|39295184|FG000|Overall Study|Adverse Event|13|||
16222611|NCT03961529|39295185|FG001|Overall Study|Adverse Event|5|||
16222612|NCT03961529|39295186|FG002|Overall Study|Adverse Event|2|||
16222613|NCT03961529|39295184|FG000|Overall Study|Withdrawal by Subject|17|||
16222614|NCT03961529|39295185|FG001|Overall Study|Withdrawal by Subject|2|||
16222615|NCT03961529|39295186|FG002|Overall Study|Withdrawal by Subject|1|||
16222616|NCT03961529|39295184|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16222617|NCT03961529|39295185|FG001|Overall Study|Withdrawal by parent/guardian|7|||
16222618|NCT03961529|39295186|FG002|Overall Study|Withdrawal by parent/guardian|0|||
16222619|NCT03961529|39295184|FG000|Overall Study|Physician Decision|2|||
16222620|NCT03961529|39295185|FG001|Overall Study|Physician Decision|1|||
16222621|NCT03961529|39295186|FG002|Overall Study|Physician Decision|1|||
16222622|NCT03961529|39295184|FG000|Overall Study|Lost to Follow-up|2|||
16222623|NCT03961529|39295185|FG001|Overall Study|Lost to Follow-up|1|||
16222624|NCT03961529|39295186|FG002|Overall Study|Lost to Follow-up|0|||
16222625|NCT03961529|39295184|FG000|Overall Study|Lack of Efficacy|2|||
16222626|NCT03961529|39295185|FG001|Overall Study|Lack of Efficacy|0|||
16222627|NCT03961529|39295186|FG002|Overall Study|Lack of Efficacy|1|||
16222628|NCT03961529|39295184|FG000|Overall Study|Other|6|||
16222629|NCT03961529|39295185|FG001|Overall Study|Other|1|||
16222630|NCT03961529|39295186|FG002|Overall Study|Other|0|||
16222631|NCT04118127|39295187|FG000|Overall Study|Trial terminated by sponsor|0|||
16222632|NCT04118127|39295188|FG001|Overall Study|Trial terminated by sponsor|12|||
16222633|NCT04118127|39295187|FG000|Overall Study|Adverse Event|1|||
16222634|NCT04118127|39295188|FG001|Overall Study|Adverse Event|2|||
16222635|NCT04118127|39295187|FG000|Overall Study|Physician Decision|0|||
16222636|NCT04118127|39295188|FG001|Overall Study|Physician Decision|1|||
16222637|NCT04118127|39295187|FG000|Overall Study|Withdrawal by Subject|2|||
16222638|NCT04118127|39295188|FG001|Overall Study|Withdrawal by Subject|1|||
16222639|NCT00129220|39295196|FG000|Study Period II|Adverse Event|9|||
16222640|NCT00129220|39295197|FG001|Study Period II|Adverse Event|5|||
16222641|NCT00129220|39295198|FG002|Study Period II|Adverse Event|7|||
16222642|NCT00129220|39295196|FG000|Study Period II|Lack of Efficacy|15|||
16222643|NCT00129220|39295197|FG001|Study Period II|Lack of Efficacy|1|||
16222644|NCT00129220|39295198|FG002|Study Period II|Lack of Efficacy|28|||
16222645|NCT00129220|39295196|FG000|Study Period II|Entry Criteria Not Met|2|||
16222646|NCT00129220|39295197|FG001|Study Period II|Entry Criteria Not Met|0|||
16222647|NCT00129220|39295198|FG002|Study Period II|Entry Criteria Not Met|2|||
16222648|NCT00129220|39295196|FG000|Study Period II|Protocol Violation|4|||
16222649|NCT00129220|39295197|FG001|Study Period II|Protocol Violation|2|||
16222650|NCT00129220|39295198|FG002|Study Period II|Protocol Violation|1|||
16222651|NCT00129220|39295196|FG000|Study Period II|Physician Decision|0|||
16222652|NCT00129220|39295197|FG001|Study Period II|Physician Decision|1|||
16222653|NCT00129220|39295198|FG002|Study Period II|Physician Decision|0|||
16222654|NCT00129220|39295196|FG000|Study Period II|Withdrawal by Subject|1|||
16222655|NCT00129220|39295197|FG001|Study Period II|Withdrawal by Subject|3|||
16222656|NCT00129220|39295198|FG002|Study Period II|Withdrawal by Subject|4|||
16222657|NCT00129220|39295196|FG000|Study Period II|Reason Not Specified|2|||
16222658|NCT00129220|39295197|FG001|Study Period II|Reason Not Specified|0|||
16222659|NCT00129220|39295198|FG002|Study Period II|Reason Not Specified|5|||
16222660|NCT00129220|39295196|FG000|Study Period III|Adverse Event|1|||
16222661|NCT00129220|39295197|FG001|Study Period III|Adverse Event|0|||
16222662|NCT00129220|39295198|FG002|Study Period III|Adverse Event|3|||
16222663|NCT00129220|39295196|FG000|Study Period III|Protocol Violation|1|||
16222664|NCT00129220|39295197|FG001|Study Period III|Protocol Violation|1|||
16222665|NCT00129220|39295198|FG002|Study Period III|Protocol Violation|2|||
16222666|NCT00129220|39295196|FG000|Study Period III|Withdrawal by Subject|1|||
16222667|NCT00129220|39295197|FG001|Study Period III|Withdrawal by Subject|0|||
16222668|NCT00129220|39295198|FG002|Study Period III|Withdrawal by Subject|3|||
16222669|NCT00129220|39295196|FG000|Study Period III|Sponsor Decision|1|||
16222670|NCT00129220|39295197|FG001|Study Period III|Sponsor Decision|0|||
16222671|NCT00129220|39295198|FG002|Study Period III|Sponsor Decision|0|||
16222672|NCT00129220|39295196|FG000|Study Period III|Reason Not Specified|9|||
16222673|NCT00129220|39295197|FG001|Study Period III|Reason Not Specified|0|||
16222674|NCT00129220|39295198|FG002|Study Period III|Reason Not Specified|2|||
16222675|NCT03323385|39295199|FG000|Overall Study|Withdrawal by Subject|1|||
16222676|NCT03323385|39295200|FG001|Overall Study|Withdrawal by Subject|2|||
16222677|NCT03323385|39295199|FG000|Overall Study|Noncompliance|0|||
16222678|NCT03323385|39295200|FG001|Overall Study|Noncompliance|1|||
16222679|NCT04657003|39295205|FG000|Overall Study|Adverse Event|5|||
16222680|NCT04657003|39295206|FG001|Overall Study|Adverse Event|1|||
16222681|NCT04657003|39295207|FG002|Overall Study|Adverse Event|5|||
16222682|NCT04657003|39295205|FG000|Overall Study|Death|0|||
16222683|NCT04657003|39295206|FG001|Overall Study|Death|2|||
16222684|NCT04657003|39295207|FG002|Overall Study|Death|0|||
16222685|NCT04657003|39295205|FG000|Overall Study|Lost to Follow-up|8|||
16222686|NCT04657003|39295206|FG001|Overall Study|Lost to Follow-up|4|||
16222687|NCT04657003|39295207|FG002|Overall Study|Lost to Follow-up|10|||
16222688|NCT04657003|39295205|FG000|Overall Study|Other - As Reported by Investigator|3|||
16222689|NCT04657003|39295206|FG001|Overall Study|Other - As Reported by Investigator|2|||
16222690|NCT04657003|39295207|FG002|Overall Study|Other - As Reported by Investigator|2|||
16222691|NCT04657003|39295205|FG000|Overall Study|Pregnancy|2|||
16222692|NCT04657003|39295206|FG001|Overall Study|Pregnancy|0|||
16222693|NCT04657003|39295207|FG002|Overall Study|Pregnancy|2|||
16222694|NCT04657003|39295205|FG000|Overall Study|Withdrawal by Subject|16|||
16222695|NCT04657003|39295206|FG001|Overall Study|Withdrawal by Subject|7|||
16222696|NCT04657003|39295207|FG002|Overall Study|Withdrawal by Subject|10|||
16222697|NCT01412333|39295208|FG000|Overall Study|Adverse Event|40|||
16222698|NCT01412333|39295209|FG001|Overall Study|Adverse Event|42|||
16222699|NCT01412333|39295208|FG000|Overall Study|Death|5|||
16222700|NCT01412333|39295209|FG001|Overall Study|Death|6|||
16222701|NCT01412333|39295208|FG000|Overall Study|Lack of Efficacy|22|||
16222702|NCT01412333|39295209|FG001|Overall Study|Lack of Efficacy|10|||
16222703|NCT01412333|39295208|FG000|Overall Study|Lost to Follow-up|15|||
16222704|NCT01412333|39295209|FG001|Overall Study|Lost to Follow-up|12|||
16222705|NCT01412333|39295208|FG000|Overall Study|Non-Compliance|3|||
16222706|NCT01412333|39295209|FG001|Overall Study|Non-Compliance|7|||
16409253|NCT00431951|39981602|FG003|Overall Study|Inability to follow study procedures|2|||
16409254|NCT00431951|39981599|FG000|Overall Study|Lost to Follow-up|0|||
16409255|NCT00431951|39981600|FG001|Overall Study|Lost to Follow-up|1|||
16409256|NCT00431951|39981601|FG002|Overall Study|Lost to Follow-up|0|||
16409257|NCT00431951|39981602|FG003|Overall Study|Lost to Follow-up|0|||
16222707|NCT01412333|39295208|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16222708|NCT01412333|39295209|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16222709|NCT01412333|39295208|FG000|Overall Study|Other|30|||
16222710|NCT01412333|39295209|FG001|Overall Study|Other|33|||
16222711|NCT01412333|39295208|FG000|Overall Study|Physician Decision|11|||
16222712|NCT01412333|39295209|FG001|Overall Study|Physician Decision|16|||
16222713|NCT01412333|39295208|FG000|Overall Study|Pregnancy|6|||
16222714|NCT01412333|39295209|FG001|Overall Study|Pregnancy|4|||
16222715|NCT01412333|39295208|FG000|Overall Study|Protocol Violation|1|||
16345682|NCT01950390|39753137|FG001|Overall Study|Physician Decision|4|||
16345683|NCT01950390|39753136|FG000|Overall Study|Lack of clinical benefit|0|||
16345684|NCT01950390|39753137|FG001|Overall Study|Lack of clinical benefit|1|||
16345685|NCT01950390|39753136|FG000|Overall Study|Maintained PR and moved to observation only|0|||
16345686|NCT01950390|39753137|FG001|Overall Study|Maintained PR and moved to observation only|1|||
16345687|NCT01853748|39753143|FG000|Allocation|Withdrawal by Subject|1|||
16345688|NCT01853748|39753144|FG001|Allocation|Withdrawal by Subject|13|||
16345689|NCT01853748|39753143|FG000|Allocation|not sufficient to receive intervention|0|||
16345690|NCT01853748|39753144|FG001|Allocation|not sufficient to receive intervention|1|||
16345691|NCT01853748|39753143|FG000|Follow-Up|Withdrawal by Subject|7|||
16345692|NCT01853748|39753144|FG001|Follow-Up|Withdrawal by Subject|6|||
16345693|NCT01853748|39753143|FG000|Follow-Up|Adverse Event|67|||
16345694|NCT01853748|39753144|FG001|Follow-Up|Adverse Event|7|||
16345695|NCT01853748|39753143|FG000|Follow-Up|not available for data collection|16|||
16345696|NCT01853748|39753144|FG001|Follow-Up|not available for data collection|4|||
16345697|NCT03455855|39753145|FG000|Overall Study|Lost to Follow-up|4|||
16345698|NCT03455855|39753146|FG001|Overall Study|Lost to Follow-up|2|||
16222716|NCT01412333|39295209|FG001|Overall Study|Protocol Violation|2|||
16222717|NCT01412333|39295208|FG000|Overall Study|Study Terminated By Sponsor|3|||
16409258|NCT00431951|39981599|FG000|Overall Study|Withdrawal by Subject|0|||
16222718|NCT01412333|39295209|FG001|Overall Study|Study Terminated By Sponsor|2|||
16222719|NCT01412333|39295208|FG000|Overall Study|Withdrawal by Subject|51|||
16222720|NCT01412333|39295209|FG001|Overall Study|Withdrawal by Subject|54|||
16222721|NCT01412333|39295208|FG000|Overall Study|Missing|1|||
16222722|NCT01412333|39295209|FG001|Overall Study|Missing|3|||
16222723|NCT00758394|39295210|FG000|2nd Intervention Order|Lost to Follow-up|0|||
16222724|NCT00758394|39295211|FG001|2nd Intervention Order|Lost to Follow-up|1|||
16222725|NCT00758394|39295212|FG002|2nd Intervention Order|Lost to Follow-up|0|||
16222726|NCT00758394|39295213|FG003|2nd Intervention Order|Lost to Follow-up|0|||
16222727|NCT00758394|39295210|FG000|3rd Intervention|Lost to Follow-up|1|||
16222728|NCT00758394|39295211|FG001|3rd Intervention|Lost to Follow-up|0|||
16222729|NCT00758394|39295212|FG002|3rd Intervention|Lost to Follow-up|0|||
16222730|NCT00758394|39295213|FG003|3rd Intervention|Lost to Follow-up|1|||
16222731|NCT00764322|39295220|FG000|Overall Study|Withdrawal by Subject|11|||
16222732|NCT00764322|39295220|FG000|Overall Study|No CYP2D6 genotyping|9|||
16222733|NCT04511533|39295221|FG000|Treatment|Other|2|||
16222734|NCT04511533|39295221|FG000|Treatment|Withdrawal by Subject|11|||
16222735|NCT04511533|39295221|FG000|Treatment|Death|5|||
16222736|NCT04511533|39295221|FG000|Treatment|Physician Decision|1|||
16222737|NCT04511533|39295221|FG000|Treatment|Progressive Disease|61|||
16222738|NCT04511533|39295221|FG000|Follow-Up|Other|7|||
16222739|NCT04511533|39295221|FG000|Follow-Up|Withdrawal by Subject|5|||
16222740|NCT04511533|39295221|FG000|Follow-Up|Lost to Follow-up|2|||
16222741|NCT04511533|39295221|FG000|Follow-Up|Death|4|||
16409259|NCT00431951|39981600|FG001|Overall Study|Withdrawal by Subject|1|||
16409260|NCT00431951|39981601|FG002|Overall Study|Withdrawal by Subject|0|||
16409261|NCT00431951|39981602|FG003|Overall Study|Withdrawal by Subject|0|||
16409262|NCT00431951|39981599|FG000|Overall Study|Adverse Event|0|||
16409263|NCT00431951|39981600|FG001|Overall Study|Adverse Event|0|||
16409264|NCT00431951|39981601|FG002|Overall Study|Adverse Event|1|||
16409265|NCT00431951|39981602|FG003|Overall Study|Adverse Event|0|||
16409266|NCT02847858|39981603|FG000|Overall Study|Lost to Follow-up|401|||
16409267|NCT02847858|39981604|FG001|Overall Study|Lost to Follow-up|269|||
16409268|NCT01146288|39981605|FG000|First Intervention(1 Day)|Adverse Event|0|||
16222742|NCT00361504|39295225|FG000|Overall Study|Withdrawal by Subject|94|||
16222743|NCT00361504|39295226|FG001|Overall Study|Withdrawal by Subject|31|||
16222744|NCT00361504|39295225|FG000|Overall Study|Lost to Follow-up|40|||
16222745|NCT00361504|39295226|FG001|Overall Study|Lost to Follow-up|7|||
16409269|NCT01146288|39981606|FG001|First Intervention(1 Day)|Adverse Event|1|||
16409270|NCT03421743|39981607|FG000|Overall Study|Lack of Efficacy|1|||
16222746|NCT00361504|39295225|FG000|Overall Study|Adverse Event|203|||
16222747|NCT00361504|39295226|FG001|Overall Study|Adverse Event|82|||
16409271|NCT03421743|39981608|FG001|Overall Study|Lack of Efficacy|0|||
16409272|NCT03421743|39981607|FG000|Overall Study|Adverse Event|2|||
16409273|NCT03421743|39981608|FG001|Overall Study|Adverse Event|1|||
16409274|NCT03421743|39981607|FG000|Overall Study|Withdrawal by Subject|0|||
16409275|NCT03421743|39981608|FG001|Overall Study|Withdrawal by Subject|1|||
16409276|NCT02525939|39981609|FG000|Overall Study|Lost to Follow-up|27|||
16409277|NCT02525939|39981610|FG001|Overall Study|Lost to Follow-up|24|||
16409278|NCT02525939|39981609|FG000|Overall Study|Physician Decision|0|||
16409279|NCT02525939|39981610|FG001|Overall Study|Physician Decision|1|||
16409280|NCT02525939|39981609|FG000|Overall Study|Withdrawal by Subject|24|||
16409281|NCT02525939|39981610|FG001|Overall Study|Withdrawal by Subject|39|||
16409282|NCT02525939|39981609|FG000|Overall Study|Death|180|||
16409283|NCT02525939|39981610|FG001|Overall Study|Death|179|||
16111290|NCT03672175|38893117|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
16409284|NCT04258995|39981615|FG000|Overall Study|Lost to Follow-up|1|||
16409285|NCT04258995|39981616|FG001|Overall Study|Lost to Follow-up|1|||
16409286|NCT00837876|39981619|FG000|Overall Study|Death|2|||
16409287|NCT00837876|39981619|FG000|Overall Study|Adverse Event|7|||
16409288|NCT00837876|39981619|FG000|Overall Study|Physician Decision|1|||
16409289|NCT00837876|39981619|FG000|Overall Study|Withdrawal by Subject|3|||
16409290|NCT00837876|39981619|FG000|Overall Study|disease progression|24|||
16409291|NCT02744612|39981620|FG000|Overall Study|Withdrawal by Subject|0|||
16409292|NCT02744612|39981621|FG001|Overall Study|Withdrawal by Subject|2|||
16409293|NCT02370641|39981626|FG000|Overall Study|dropped study|4|||
16545840|NCT02287584|40460821|FG001|the Double-blind Phase|other reasons|0|||
16545841|NCT02287584|40460822|FG002|the Double-blind Phase|other reasons|1|||
16545842|NCT02287584|40460823|FG003|the Double-blind Phase|other reasons|0|||
16545843|NCT02287584|40460824|FG004|the Double-blind Phase|other reasons|0|||
16545844|NCT02287584|40460825|FG005|the Double-blind Phase|other reasons|0|||
16545845|NCT02287584|40460820|FG000|the Open-label Phase|Did not receive drug|0|||
16545846|NCT02287584|40460821|FG001|the Open-label Phase|Did not receive drug|0|||
16111291|NCT03672175|38893115|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
16111292|NCT03672175|38893116|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
16409294|NCT02370641|39981627|FG001|Overall Study|dropped study|2|||
16545847|NCT02287584|40460822|FG002|the Open-label Phase|Did not receive drug|0|||
16111293|NCT03672175|38893117|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
16111294|NCT03672175|38893115|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
16111295|NCT03672175|38893116|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
16111296|NCT03672175|38893117|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
16222748|NCT00361504|39295225|FG000|Overall Study|Lack of Efficacy|72|||
16222749|NCT00361504|39295226|FG001|Overall Study|Lack of Efficacy|7|||
16222750|NCT00361504|39295225|FG000|Overall Study|Resolution of Pain|2|||
16409295|NCT00545532|39981628|FG000|Overall Study|Withdrawal by Subject|1|||
16409296|NCT00545532|39981629|FG001|Overall Study|Withdrawal by Subject|3|||
16409297|NCT00545532|39981628|FG000|Overall Study|Lost to Follow-up|5|||
16409298|NCT00545532|39981629|FG001|Overall Study|Lost to Follow-up|6|||
16409299|NCT00545532|39981628|FG000|Overall Study|Death|0|||
16409300|NCT00545532|39981629|FG001|Overall Study|Death|1|||
16409301|NCT01344629|39981630|FG000|Crossover Period 2|Withdrawal by Subject|0|||
16111297|NCT03672175|38893115|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
16111298|NCT03672175|38893116|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
16409302|NCT01344629|39981631|FG001|Crossover Period 2|Withdrawal by Subject|1|||
16409303|NCT05028517|39981632|FG000|Overall Study|Lost to Follow-up|13|||
16409304|NCT05028517|39981633|FG001|Overall Study|Lost to Follow-up|20|||
16409305|NCT05028517|39981634|FG002|Overall Study|Lost to Follow-up|12|||
16409306|NCT05028517|39981632|FG000|Overall Study|Withdrawal by Subject|0|||
16409307|NCT05028517|39981633|FG001|Overall Study|Withdrawal by Subject|0|||
16409308|NCT05028517|39981634|FG002|Overall Study|Withdrawal by Subject|1|||
16409309|NCT01688921|39981635|FG000|Overall Study|Lost to Follow-up|7|||
16409310|NCT01688921|39981636|FG001|Overall Study|Lost to Follow-up|13|||
16409311|NCT01688921|39981635|FG000|Overall Study|Physician Decision|6|||
16409312|NCT01688921|39981636|FG001|Overall Study|Physician Decision|1|||
16409313|NCT01688921|39981635|FG000|Overall Study|Protocol Violation|0|||
16409314|NCT01688921|39981636|FG001|Overall Study|Protocol Violation|1|||
16409315|NCT01688921|39981635|FG000|Overall Study|informed consent|3|||
16409316|NCT01688921|39981636|FG001|Overall Study|informed consent|0|||
16409317|NCT02608450|39981642|FG000|Overall Study|Lost to Follow-up|39|||
16222751|NCT00361504|39295226|FG001|Overall Study|Resolution of Pain|0|||
16222752|NCT00361504|39295225|FG000|Overall Study|Study medication non compliant|42|||
16545848|NCT02287584|40460823|FG003|the Open-label Phase|Did not receive drug|7|||
16545849|NCT02287584|40460824|FG004|the Open-label Phase|Did not receive drug|6|||
16545850|NCT02287584|40460825|FG005|the Open-label Phase|Did not receive drug|4|||
16545851|NCT02287584|40460820|FG000|the Open-label Phase|Adverse Event|0|||
16545852|NCT02287584|40460821|FG001|the Open-label Phase|Adverse Event|0|||
16545853|NCT02287584|40460822|FG002|the Open-label Phase|Adverse Event|0|||
16545854|NCT02287584|40460823|FG003|the Open-label Phase|Adverse Event|15|||
16545855|NCT02287584|40460824|FG004|the Open-label Phase|Adverse Event|12|||
16545856|NCT02287584|40460825|FG005|the Open-label Phase|Adverse Event|16|||
16545857|NCT02287584|40460820|FG000|the Open-label Phase|Lack of Efficacy|0|||
16545858|NCT02287584|40460821|FG001|the Open-label Phase|Lack of Efficacy|0|||
16545859|NCT02287584|40460822|FG002|the Open-label Phase|Lack of Efficacy|0|||
16545860|NCT02287584|40460823|FG003|the Open-label Phase|Lack of Efficacy|8|||
16545861|NCT02287584|40460824|FG004|the Open-label Phase|Lack of Efficacy|3|||
16545862|NCT02287584|40460825|FG005|the Open-label Phase|Lack of Efficacy|7|||
16345769|NCT04999085|39753155|FG000|Overall Study|Death|1|||
16345770|NCT02532257|39753158|FG000|Overall Study|Adverse Event|2|||
16345771|NCT02532257|39753158|FG000|Overall Study|Physician Decision|4|||
16345772|NCT02532257|39753158|FG000|Overall Study|Withdrawal by Subject|3|||
16345773|NCT02532257|39753158|FG000|Overall Study|Progressive Disease|10|||
16345774|NCT05285787|39753160|FG000|Overall Study|Withdrawal by Subject|1|||
16345775|NCT02506153|39753163|FG000|Overall Study|Adverse Event|359|||
16345776|NCT02506153|39753164|FG001|Overall Study|Adverse Event|114|||
16345777|NCT02506153|39753163|FG000|Overall Study|Refused unrelated to adverse event|127|||
16345778|NCT02506153|39753164|FG001|Overall Study|Refused unrelated to adverse event|18|||
16345779|NCT02506153|39753163|FG000|Overall Study|Progression/relapse|91|||
16345780|NCT02506153|39753164|FG001|Overall Study|Progression/relapse|136|||
16345781|NCT02506153|39753163|FG000|Overall Study|Death|2|||
16345782|NCT02506153|39753164|FG001|Overall Study|Death|1|||
16345783|NCT02506153|39753163|FG000|Overall Study|Other - not protocol specified|23|||
16345784|NCT02506153|39753164|FG001|Overall Study|Other - not protocol specified|12|||
16345785|NCT04754542|39753165|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
16345786|NCT04754542|39753166|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
16345802|NCT03713619|39753170|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
16345803|NCT03713619|39753171|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
16345804|NCT03713619|39753172|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
16345805|NCT03713619|39753173|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
16345806|NCT03713619|39753174|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
16345807|NCT03713619|39753170|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
16345808|NCT03713619|39753171|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
16345809|NCT03713619|39753172|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
16345810|NCT03713619|39753173|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
16345811|NCT03713619|39753174|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
16345812|NCT03713619|39753170|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
16345813|NCT03713619|39753171|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
16345814|NCT03713619|39753172|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
16345815|NCT03713619|39753173|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
16345816|NCT03713619|39753174|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
16345817|NCT03713619|39753170|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
16545863|NCT02287584|40460820|FG000|the Open-label Phase|Lost to Follow-up|0|||
16345818|NCT03713619|39753171|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
16345819|NCT03713619|39753172|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
16345820|NCT03713619|39753173|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
16345821|NCT03713619|39753174|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
16345822|NCT03713619|39753170|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
16345823|NCT03713619|39753171|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
16345824|NCT03713619|39753172|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
16345825|NCT03713619|39753173|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
16345826|NCT03713619|39753174|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
16345827|NCT03713619|39753170|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
16345828|NCT03713619|39753171|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
16345829|NCT03713619|39753172|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
16345830|NCT03713619|39753173|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
16345831|NCT03713619|39753174|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
16345832|NCT03713619|39753170|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
16345833|NCT03713619|39753171|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
16345834|NCT03713619|39753172|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
16345835|NCT03713619|39753173|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
16345836|NCT03713619|39753174|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
16345837|NCT03713619|39753170|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
16345838|NCT03713619|39753171|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
16345839|NCT03713619|39753172|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
16345840|NCT03713619|39753173|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
16409318|NCT02608450|39981643|FG001|Overall Study|Lost to Follow-up|32|||
16409319|NCT02608450|39981642|FG000|Overall Study|Withdrawal by Subject|21|||
16409320|NCT02608450|39981643|FG001|Overall Study|Withdrawal by Subject|15|||
16409321|NCT02608450|39981642|FG000|Overall Study|Adverse Event|3|||
16409322|NCT02608450|39981643|FG001|Overall Study|Adverse Event|6|||
16409323|NCT02608450|39981642|FG000|Overall Study|Withdrawal by parent|2|||
16409324|NCT02608450|39981643|FG001|Overall Study|Withdrawal by parent|3|||
16409325|NCT02608450|39981642|FG000|Overall Study|Lack of Efficacy|0|||
16409326|NCT02608450|39981643|FG001|Overall Study|Lack of Efficacy|3|||
16409327|NCT02608450|39981642|FG000|Overall Study|Noncompliance with study drug|0|||
16409328|NCT02608450|39981643|FG001|Overall Study|Noncompliance with study drug|2|||
16409329|NCT02608450|39981642|FG000|Overall Study|Physician Decision|0|||
16409330|NCT02608450|39981643|FG001|Overall Study|Physician Decision|1|||
16409331|NCT02608450|39981642|FG000|Overall Study|Pregnancy|0|||
16409332|NCT02608450|39981643|FG001|Overall Study|Pregnancy|1|||
16409333|NCT02608450|39981642|FG000|Overall Study|Progressive disease|1|||
16409334|NCT02608450|39981643|FG001|Overall Study|Progressive disease|0|||
16409335|NCT02608450|39981642|FG000|Overall Study|Multiple reasons|0|||
16409336|NCT02608450|39981643|FG001|Overall Study|Multiple reasons|2|||
16409337|NCT01510184|39981646|FG000|Overall Study|Sponsor discretion|28|||
16409338|NCT01510184|39981647|FG001|Overall Study|Sponsor discretion|28|||
16409339|NCT01510184|39981646|FG000|Overall Study|Death|1|||
16409340|NCT01510184|39981647|FG001|Overall Study|Death|2|||
16409341|NCT01510184|39981646|FG000|Overall Study|Withdrawal by Subject|1|||
16409342|NCT01510184|39981647|FG001|Overall Study|Withdrawal by Subject|4|||
16409343|NCT01510184|39981646|FG000|Overall Study|Other|0|||
16409344|NCT01510184|39981647|FG001|Overall Study|Other|1|||
16409345|NCT01902888|39981651|FG000|Overall Study|Study Terminated|3|||
16409346|NCT02485925|39981652|FG000|Overall Study|Withdrawal by Subject|3|||
16409347|NCT02485925|39981652|FG000|Overall Study|Death|1|||
16345841|NCT03713619|39753174|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
16345842|NCT03713619|39753170|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
16345843|NCT03713619|39753171|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
16345844|NCT03713619|39753172|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
16345845|NCT03713619|39753173|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
16345846|NCT03713619|39753174|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
16345847|NCT03713619|39753170|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
16345848|NCT03713619|39753171|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
16345849|NCT03713619|39753172|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
16345850|NCT03713619|39753173|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
16345851|NCT03713619|39753174|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
16345852|NCT03713619|39753170|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
16345853|NCT03713619|39753171|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
16345854|NCT03713619|39753172|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
16345855|NCT03713619|39753173|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
16345856|NCT03713619|39753174|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
16345857|NCT03713619|39753170|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
16409348|NCT02485925|39981652|FG000|Overall Study|Lost to Follow-up|11|||
16545864|NCT02287584|40460821|FG001|the Open-label Phase|Lost to Follow-up|0|||
16545865|NCT02287584|40460822|FG002|the Open-label Phase|Lost to Follow-up|0|||
16545866|NCT02287584|40460823|FG003|the Open-label Phase|Lost to Follow-up|4|||
16545867|NCT02287584|40460824|FG004|the Open-label Phase|Lost to Follow-up|1|||
16545868|NCT02287584|40460825|FG005|the Open-label Phase|Lost to Follow-up|2|||
16545869|NCT02287584|40460820|FG000|the Open-label Phase|Withdrawal by Subject|0|||
16545870|NCT02287584|40460821|FG001|the Open-label Phase|Withdrawal by Subject|0|||
16545871|NCT02287584|40460822|FG002|the Open-label Phase|Withdrawal by Subject|0|||
16545872|NCT02287584|40460823|FG003|the Open-label Phase|Withdrawal by Subject|18|||
16545873|NCT02287584|40460824|FG004|the Open-label Phase|Withdrawal by Subject|29|||
16545874|NCT02287584|40460825|FG005|the Open-label Phase|Withdrawal by Subject|21|||
16545875|NCT02287584|40460820|FG000|the Open-label Phase|non-compliance|0|||
16545876|NCT02287584|40460821|FG001|the Open-label Phase|non-compliance|0|||
16545877|NCT02287584|40460822|FG002|the Open-label Phase|non-compliance|0|||
16545878|NCT02287584|40460823|FG003|the Open-label Phase|non-compliance|2|||
16545879|NCT02287584|40460824|FG004|the Open-label Phase|non-compliance|5|||
16545880|NCT02287584|40460825|FG005|the Open-label Phase|non-compliance|1|||
16545881|NCT02287584|40460820|FG000|the Open-label Phase|other reasons|0|||
16545882|NCT02287584|40460821|FG001|the Open-label Phase|other reasons|0|||
16545883|NCT02287584|40460822|FG002|the Open-label Phase|other reasons|0|||
16545884|NCT02287584|40460823|FG003|the Open-label Phase|other reasons|3|||
16545885|NCT02287584|40460824|FG004|the Open-label Phase|other reasons|6|||
16545886|NCT02287584|40460825|FG005|the Open-label Phase|other reasons|6|||
16545887|NCT00603265|40460833|FG000|Overall Study|Adverse Event|2|||
16545888|NCT00603265|40460834|FG001|Overall Study|Adverse Event|11|||
16545889|NCT00603265|40460835|FG002|Overall Study|Adverse Event|1|||
16545890|NCT00603265|40460833|FG000|Overall Study|Withdrawal by Subject|1|||
16545891|NCT00603265|40460834|FG001|Overall Study|Withdrawal by Subject|2|||
16545892|NCT00603265|40460835|FG002|Overall Study|Withdrawal by Subject|1|||
16545893|NCT00603265|40460833|FG000|Overall Study|Lack of Efficacy|3|||
16545894|NCT00603265|40460834|FG001|Overall Study|Lack of Efficacy|0|||
16545895|NCT00603265|40460835|FG002|Overall Study|Lack of Efficacy|3|||
16545896|NCT00603265|40460833|FG000|Overall Study|Lost to Follow-up|0|||
16545897|NCT00603265|40460834|FG001|Overall Study|Lost to Follow-up|1|||
16545898|NCT00603265|40460835|FG002|Overall Study|Lost to Follow-up|0|||
16545899|NCT00603265|40460833|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
16545900|NCT00603265|40460834|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
16545901|NCT00603265|40460835|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
16409349|NCT03353922|39981653|FG000|Overall Study|Withdrawal by Subject|1|||
16409350|NCT03353922|39981654|FG001|Overall Study|Withdrawal by Subject|0|||
16409351|NCT03353922|39981655|FG002|Overall Study|Withdrawal by Subject|1|||
16409352|NCT03353922|39981656|FG003|Overall Study|Withdrawal by Subject|1|||
16409353|NCT03353922|39981657|FG004|Overall Study|Withdrawal by Subject|0|||
16409354|NCT03353922|39981658|FG005|Overall Study|Withdrawal by Subject|0|||
16409355|NCT03353922|39981653|FG000|Overall Study|Adverse Event|0|||
16409356|NCT03353922|39981654|FG001|Overall Study|Adverse Event|1|||
16409357|NCT03353922|39981655|FG002|Overall Study|Adverse Event|0|||
16409358|NCT03353922|39981656|FG003|Overall Study|Adverse Event|0|||
16409359|NCT03353922|39981657|FG004|Overall Study|Adverse Event|0|||
16409360|NCT03353922|39981658|FG005|Overall Study|Adverse Event|0|||
16409361|NCT00355342|39981660|FG000|Overall Study|Adverse Event|13|||
16409362|NCT00355342|39981661|FG001|Overall Study|Adverse Event|15|||
16409363|NCT00355342|39981660|FG000|Overall Study|Lost to Follow-up|4|||
16409364|NCT00355342|39981661|FG001|Overall Study|Lost to Follow-up|2|||
16345858|NCT03713619|39753171|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
16345859|NCT03713619|39753172|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
16345860|NCT03713619|39753173|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
16345861|NCT03713619|39753174|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
16345862|NCT03713619|39753170|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
16345863|NCT03713619|39753171|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
16345864|NCT03713619|39753172|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
16345865|NCT03713619|39753173|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
16345866|NCT03713619|39753174|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
16345867|NCT00807612|39753175|FG000|Overall Study|Death|8|||
16345868|NCT00807612|39753175|FG000|Overall Study|Study early termination|5|||
16345869|NCT00807612|39753175|FG000|Overall Study|Withdrawal by Subject|1|||
16345870|NCT05359952|39753176|FG000|Overall Study|Lost to Follow-up|1|||
16345871|NCT05359952|39753177|FG001|Overall Study|Lost to Follow-up|0|||
16345872|NCT01314118|39753178|FG000|Overall Study|Adverse Event|9|||
16345873|NCT01314118|39753178|FG000|Overall Study|Progressive disease|27|||
16345874|NCT01314118|39753178|FG000|Overall Study|Physician Decision|11|||
16345875|NCT01314118|39753178|FG000|Overall Study|Death|4|||
16345876|NCT01314118|39753178|FG000|Overall Study|Protocol Violation|5|||
16345877|NCT01314118|39753178|FG000|Overall Study|Withdrawal by Subject|11|||
16345878|NCT01314118|39753178|FG000|Overall Study|Other|2|||
16345879|NCT01314118|39753178|FG000|Overall Study|Ongoing|62|||
16345880|NCT02768792|39753179|FG000|Overall Study|Adverse Event|1|||
16409365|NCT00355342|39981660|FG000|Overall Study|Withdrawal by Subject|14|||
16409366|NCT00355342|39981661|FG001|Overall Study|Withdrawal by Subject|11|||
16409367|NCT00355342|39981660|FG000|Overall Study|Sponsor terminated study|2|||
16409368|NCT00355342|39981661|FG001|Overall Study|Sponsor terminated study|2|||
16409369|NCT00355342|39981660|FG000|Overall Study|Overcompliant-PI discretion|1|||
16409370|NCT00355342|39981661|FG001|Overall Study|Overcompliant-PI discretion|0|||
16409371|NCT00355342|39981660|FG000|Overall Study|Use of prohibited medication|1|||
16409372|NCT00355342|39981661|FG001|Overall Study|Use of prohibited medication|0|||
16409373|NCT00355342|39981660|FG000|Overall Study|COPD exacerbation|1|||
16409374|NCT00355342|39981661|FG001|Overall Study|COPD exacerbation|1|||
16409375|NCT00355342|39981660|FG000|Overall Study|Dispensed wrong study drug kit|1|||
16409376|NCT00355342|39981661|FG001|Overall Study|Dispensed wrong study drug kit|0|||
16409377|NCT00355342|39981660|FG000|Overall Study|Non-compliance with Dexa scans|1|||
16409378|NCT00355342|39981661|FG001|Overall Study|Non-compliance with Dexa scans|0|||
16409379|NCT00355342|39981660|FG000|Overall Study|Withdrawal by participant and physician|1|||
16409380|NCT00355342|39981661|FG001|Overall Study|Withdrawal by participant and physician|0|||
16409381|NCT00355342|39981660|FG000|Overall Study|Participant relocated|0|||
16409382|NCT00355342|39981661|FG001|Overall Study|Participant relocated|1|||
16409383|NCT00355342|39981660|FG000|Overall Study|Participant discontinued study drug|0|||
16345881|NCT02281955|39753181|FG000|Overall Study|Death|1|||
16345882|NCT02028507|39753182|FG000|Overall Study|Progressive Disease|122|||
16345883|NCT02028507|39753183|FG001|Overall Study|Progressive Disease|90|||
16345884|NCT02028507|39753184|FG002|Overall Study|Progressive Disease|102|||
16345885|NCT02028507|39753185|FG003|Overall Study|Progressive Disease|89|||
16409384|NCT00355342|39981661|FG001|Overall Study|Participant discontinued study drug|1|||
16409385|NCT00355342|39981660|FG000|Overall Study|Study management|0|||
16409386|NCT00355342|39981661|FG001|Overall Study|Study management|1|||
16409387|NCT00355342|39981660|FG000|Overall Study|Protocol Violation|0|||
16409388|NCT00355342|39981661|FG001|Overall Study|Protocol Violation|1|||
16409389|NCT00355342|39981660|FG000|Overall Study|Use of protocol excluded medication|0|||
16409390|NCT00355342|39981661|FG001|Overall Study|Use of protocol excluded medication|1|||
16409391|NCT01667562|39981662|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
16345886|NCT02028507|39753182|FG000|Overall Study|Adverse Event|8|||
16345887|NCT02028507|39753183|FG001|Overall Study|Adverse Event|25|||
16345888|NCT02028507|39753184|FG002|Overall Study|Adverse Event|3|||
16345889|NCT02028507|39753185|FG003|Overall Study|Adverse Event|16|||
16345890|NCT02028507|39753182|FG000|Overall Study|Withdrawal by Subject|6|||
16345891|NCT02028507|39753183|FG001|Overall Study|Withdrawal by Subject|8|||
16345892|NCT02028507|39753184|FG002|Overall Study|Withdrawal by Subject|5|||
16345893|NCT02028507|39753185|FG003|Overall Study|Withdrawal by Subject|9|||
16345894|NCT02028507|39753182|FG000|Overall Study|Protocol Violation|2|||
16345895|NCT02028507|39753183|FG001|Overall Study|Protocol Violation|4|||
16345896|NCT02028507|39753184|FG002|Overall Study|Protocol Violation|1|||
16345897|NCT02028507|39753185|FG003|Overall Study|Protocol Violation|3|||
16345898|NCT02028507|39753182|FG000|Overall Study|Physician Decision|0|||
16345899|NCT02028507|39753183|FG001|Overall Study|Physician Decision|4|||
16345900|NCT02028507|39753184|FG002|Overall Study|Physician Decision|0|||
16345901|NCT02028507|39753185|FG003|Overall Study|Physician Decision|0|||
16345902|NCT02028507|39753182|FG000|Overall Study|Death|1|||
16345903|NCT02028507|39753183|FG001|Overall Study|Death|0|||
16345904|NCT02028507|39753184|FG002|Overall Study|Death|1|||
16345905|NCT02028507|39753185|FG003|Overall Study|Death|3|||
16345906|NCT02028507|39753182|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
16345907|NCT02028507|39753183|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
16345908|NCT02028507|39753184|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
16111299|NCT03672175|38893117|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
16111300|NCT03672175|38893115|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
16111301|NCT03672175|38893116|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
16111302|NCT03672175|38893117|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
16111303|NCT02872012|38893118|FG000|Overall Study|Withdrawal by Subject|1|||
16111304|NCT02872012|38893119|FG001|Overall Study|Withdrawal by Subject|0|||
16111305|NCT02872012|38893120|FG002|Overall Study|Withdrawal by Subject|0|||
16111306|NCT02872012|38893121|FG003|Overall Study|Withdrawal by Subject|0|||
16111307|NCT02872012|38893122|FG004|Overall Study|Withdrawal by Subject|0|||
16111308|NCT00664105|38893123|FG000|Overall Study|Death|3|||
16111309|NCT00664105|38893123|FG000|Overall Study|Withdrawal by Subject|5|||
16111310|NCT00664105|38893123|FG000|Overall Study|Adverse Event|9|||
16111311|NCT00664105|38893123|FG000|Overall Study|Disease progression|7|||
16111312|NCT02573493|38897224|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
16111313|NCT02573493|38897225|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
16111314|NCT02573493|38897226|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
16111315|NCT02573493|38897227|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
16111316|NCT01772823|38897228|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
16111317|NCT01772823|38897229|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
16111318|NCT01772823|38897228|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
16111319|NCT01772823|38897229|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
16345909|NCT02028507|39753185|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
16345910|NCT02028507|39753182|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
16111320|NCT01772823|38897228|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
16111321|NCT01772823|38897229|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
16111322|NCT01772823|38897228|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
16111323|NCT01772823|38897229|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
16111324|NCT01772823|38897228|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
16111325|NCT01772823|38897229|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
16111326|NCT01772823|38897228|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
16111327|NCT01772823|38897229|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
16111328|NCT01772823|38897228|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
16111329|NCT01772823|38897229|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
16111330|NCT01772823|38897228|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
16222753|NCT00361504|39295226|FG001|Overall Study|Study medication non compliant|15|||
16345911|NCT02028507|39753183|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
16345912|NCT02028507|39753184|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
16345913|NCT02028507|39753185|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
16345914|NCT02028507|39753182|FG000|Overall Study|Randomized But Not Treated|3|||
16345915|NCT02028507|39753183|FG001|Overall Study|Randomized But Not Treated|6|||
16345916|NCT02028507|39753184|FG002|Overall Study|Randomized But Not Treated|0|||
16345917|NCT02028507|39753185|FG003|Overall Study|Randomized But Not Treated|4|||
16345918|NCT02028507|39753182|FG000|Overall Study|Enzyme defect|0|||
16345919|NCT02028507|39753183|FG001|Overall Study|Enzyme defect|0|||
16345920|NCT02028507|39753184|FG002|Overall Study|Enzyme defect|0|||
16345921|NCT02028507|39753185|FG003|Overall Study|Enzyme defect|1|||
16345922|NCT02028507|39753182|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
16345923|NCT02028507|39753183|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
16345924|NCT02028507|39753184|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
16345925|NCT02028507|39753185|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
16345926|NCT02028507|39753182|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
16345927|NCT02028507|39753183|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
16345928|NCT02028507|39753184|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
16345929|NCT02028507|39753185|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
16345930|NCT02258659|39753186|FG000|Overall Study|Withdrawal by Subject|1|||
16345931|NCT02076009|39753189|FG000|Overall Study|Death|172|||
16345932|NCT02076009|39753190|FG001|Overall Study|Death|153|||
16345933|NCT02076009|39753189|FG000|Overall Study|Withdrawal by Subject|16|||
16345934|NCT02076009|39753190|FG001|Overall Study|Withdrawal by Subject|12|||
16345935|NCT02076009|39753189|FG000|Overall Study|Lost to Follow-up|4|||
16345936|NCT02076009|39753190|FG001|Overall Study|Lost to Follow-up|2|||
16345937|NCT02076009|39753189|FG000|Overall Study|Progressive Disease|1|||
16345938|NCT02076009|39753190|FG001|Overall Study|Progressive Disease|0|||
16345939|NCT02076009|39753189|FG000|Overall Study|Physician Decision|0|||
16545902|NCT00603265|40460833|FG000|Overall Study|Participant Left Country, No Responses|0|||
16545903|NCT00603265|40460834|FG001|Overall Study|Participant Left Country, No Responses|1|||
16545904|NCT00603265|40460835|FG002|Overall Study|Participant Left Country, No Responses|0|||
16545905|NCT00603265|40460833|FG000|Overall Study|Protocol Violation|1|||
16545906|NCT00603265|40460834|FG001|Overall Study|Protocol Violation|0|||
16545907|NCT00603265|40460835|FG002|Overall Study|Protocol Violation|0|||
16545908|NCT02755597|40460836|FG000|Overall Study|Withdrew consent|27|||
16545909|NCT02755597|40460837|FG001|Overall Study|Withdrew consent|11|||
16545910|NCT02755597|40460836|FG000|Overall Study|Lost to Follow-up|1|||
16545911|NCT02755597|40460837|FG001|Overall Study|Lost to Follow-up|0|||
16545912|NCT02755597|40460836|FG000|Overall Study|Death|78|||
16545913|NCT02755597|40460837|FG001|Overall Study|Death|36|||
16545914|NCT02755597|40460836|FG000|Overall Study|Study terminated by Sponsor|67|||
16545915|NCT02755597|40460837|FG001|Overall Study|Study terminated by Sponsor|47|||
16545916|NCT02755597|40460836|FG000|Overall Study|Other, not specified|20|||
16545917|NCT02755597|40460837|FG001|Overall Study|Other, not specified|3|||
16545918|NCT02755597|40460836|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
16545919|NCT02755597|40460837|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
16545920|NCT01520402|40460838|FG000|Overall Study|Withdrawal by Subject|2|||
16545921|NCT01520402|40460838|FG000|Overall Study|Physician Decision|3|||
16545922|NCT02799784|40460843|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
16545923|NCT02799784|40460844|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
16545924|NCT02799784|40460843|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
16545925|NCT02799784|40460844|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
16545926|NCT02799784|40460843|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
16545927|NCT02799784|40460844|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
16545928|NCT02799784|40460843|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
16545929|NCT02799784|40460844|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
16545930|NCT02799784|40460843|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
16545931|NCT02799784|40460844|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
16545932|NCT02799784|40460843|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
16545933|NCT02799784|40460844|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
16545934|NCT03012061|40460847|FG000|Overall Study|Withdrawal by Subject|1|||
16545935|NCT03012061|40460848|FG001|Overall Study|Withdrawal by Subject|5|||
16545936|NCT03012061|40460849|FG002|Overall Study|Withdrawal by Subject|4|||
16345940|NCT02076009|39753190|FG001|Overall Study|Physician Decision|1|||
16345941|NCT02076009|39753189|FG000|Overall Study|End of data collection|90|||
16345942|NCT02076009|39753190|FG001|Overall Study|End of data collection|118|||
16545937|NCT03012061|40460847|FG000|Overall Study|Investigator Site Closed|1|||
16545938|NCT03012061|40460848|FG001|Overall Study|Investigator Site Closed|2|||
16545939|NCT03012061|40460849|FG002|Overall Study|Investigator Site Closed|0|||
16545940|NCT03012061|40460847|FG000|Overall Study|Lost to Follow-up|2|||
16545941|NCT03012061|40460848|FG001|Overall Study|Lost to Follow-up|1|||
16545942|NCT03012061|40460849|FG002|Overall Study|Lost to Follow-up|0|||
16545943|NCT03012061|40460847|FG000|Overall Study|Study closed/ Terminated|0|||
16545944|NCT03012061|40460848|FG001|Overall Study|Study closed/ Terminated|0|||
16545945|NCT03012061|40460849|FG002|Overall Study|Study closed/ Terminated|1|||
16545946|NCT03012061|40460847|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
16545947|NCT03012061|40460848|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
16545948|NCT03012061|40460849|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
16545949|NCT03012061|40460847|FG000|Overall Study|Protocol Violation|0|||
16545950|NCT03012061|40460848|FG001|Overall Study|Protocol Violation|0|||
16545951|NCT03012061|40460849|FG002|Overall Study|Protocol Violation|2|||
16545952|NCT03012061|40460847|FG000|Overall Study|Lack of Efficacy|0|||
16545953|NCT03012061|40460848|FG001|Overall Study|Lack of Efficacy|1|||
16545954|NCT03012061|40460849|FG002|Overall Study|Lack of Efficacy|0|||
16545955|NCT03012061|40460847|FG000|Overall Study|Adverse Event|2|||
16545956|NCT03012061|40460848|FG001|Overall Study|Adverse Event|0|||
16545957|NCT03012061|40460849|FG002|Overall Study|Adverse Event|0|||
16545958|NCT01965938|40460850|FG000|Overall Study|Withdrawal by Subject|1|||
16545959|NCT01965938|40460851|FG001|Overall Study|Withdrawal by Subject|0|||
16545960|NCT01644734|40460852|FG000|Overall Study|Adverse Event|4|||
16545961|NCT01644734|40460852|FG000|Overall Study|Lost to Follow-up|17|||
16545962|NCT01644734|40460852|FG000|Overall Study|Reasons other than stated above|7|||
16545963|NCT01644734|40460852|FG000|Overall Study|Missing documentation|238|||
16545964|NCT01392300|40460853|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
16545965|NCT01392300|40460854|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
16545966|NCT01392300|40460855|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
16545967|NCT01392300|40460853|FG000|Main Period (MP)|Withdrawal by Subject|5|||
16545968|NCT01392300|40460854|FG001|Main Period (MP)|Withdrawal by Subject|1|||
16545969|NCT01392300|40460855|FG002|Main Period (MP)|Withdrawal by Subject|0|||
16545970|NCT01392300|40460853|FG000|Main Period (MP)|Lost to Follow-up|3|||
16545971|NCT01392300|40460854|FG001|Main Period (MP)|Lost to Follow-up|3|||
16545972|NCT01392300|40460855|FG002|Main Period (MP)|Lost to Follow-up|0|||
16545973|NCT01392300|40460853|FG000|Main Period (MP)|Non-compliance|1|||
16545974|NCT01392300|40460854|FG001|Main Period (MP)|Non-compliance|0|||
16545975|NCT01392300|40460855|FG002|Main Period (MP)|Non-compliance|0|||
16545976|NCT01392300|40460853|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
16545977|NCT01392300|40460854|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
16545978|NCT01392300|40460855|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
16545979|NCT01392300|40460853|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
16545980|NCT01392300|40460854|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
16545981|NCT01392300|40460855|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
16545982|NCT01392300|40460853|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
16545983|NCT01392300|40460854|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
16545984|NCT01392300|40460855|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
16545985|NCT01392300|40460853|FG000|Open Label Extension (OLEX) Period|Death|0|||
16545986|NCT01392300|40460854|FG001|Open Label Extension (OLEX) Period|Death|0|||
16545987|NCT01392300|40460855|FG002|Open Label Extension (OLEX) Period|Death|4|||
16409392|NCT01667562|39981663|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
16545988|NCT01392300|40460853|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
16545989|NCT01392300|40460854|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
16409393|NCT01667562|39981662|FG000|Erlotinib Phase|Lost to Follow-up|0|||
16409394|NCT01667562|39981663|FG001|Erlotinib Phase|Lost to Follow-up|1|||
16409395|NCT01667562|39981662|FG000|Erlotinib Phase|Adverse Event|0|||
16409396|NCT01667562|39981663|FG001|Erlotinib Phase|Adverse Event|1|||
16409397|NCT01667562|39981662|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
16409398|NCT01667562|39981663|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
16222754|NCT00361504|39295225|FG000|Overall Study|All other|28|||
16222755|NCT00361504|39295226|FG001|Overall Study|All other|3|||
16222756|NCT01354964|39295232|FG000|Overall Study|Lost to Follow-up|2|||
16222757|NCT01354964|39295233|FG001|Overall Study|Lost to Follow-up|0|||
16222758|NCT01354964|39295232|FG000|Overall Study|IV access issues|1|||
16222759|NCT01354964|39295233|FG001|Overall Study|IV access issues|1|||
16345967|NCT02714036|39753195|FG000|Overall Study|Adverse Event|9|||
16345968|NCT02714036|39753196|FG001|Overall Study|Adverse Event|2|||
16222760|NCT01354964|39295232|FG000|Overall Study|Physician Decision|1|||
16222761|NCT01354964|39295233|FG001|Overall Study|Physician Decision|0|||
16222762|NCT00242658|39295239|FG000|Overall Study|Lost to Follow-up|22|||
16222763|NCT00242658|39295240|FG001|Overall Study|Lost to Follow-up|19|||
16222764|NCT01049360|39295241|FG000|Period 1|Adverse Event|0|||
16222765|NCT01049360|39295242|FG001|Period 1|Adverse Event|1|||
16222766|NCT01049360|39295243|FG002|Period 1|Adverse Event|0|||
16222767|NCT01049360|39295244|FG003|Period 1|Adverse Event|1|||
16222768|NCT01049360|39295245|FG004|Period 1|Adverse Event|0|||
16222769|NCT01049360|39295246|FG005|Period 1|Adverse Event|0|||
16222770|NCT01049360|39295247|FG006|Period 1|Adverse Event|0|||
16222771|NCT01049360|39295248|FG007|Period 1|Adverse Event|1|||
16222772|NCT01049360|39295249|FG008|Period 1|Adverse Event|0|||
16222773|NCT01049360|39295250|FG009|Period 1|Adverse Event|0|||
16222774|NCT01049360|39295251|FG010|Period 1|Adverse Event|0|||
16222775|NCT01049360|39295252|FG011|Period 1|Adverse Event|0|||
16222776|NCT01049360|39295253|FG012|Period 1|Adverse Event|1|||
16222777|NCT01049360|39295254|FG013|Period 1|Adverse Event|1|||
16545990|NCT01392300|40460855|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
16222778|NCT01049360|39295255|FG014|Period 1|Adverse Event|0|||
16222779|NCT01049360|39295256|FG015|Period 1|Adverse Event|0|||
16222780|NCT01049360|39295257|FG016|Period 1|Adverse Event|1|||
16222781|NCT01049360|39295258|FG017|Period 1|Adverse Event|0|||
16222782|NCT01049360|39295259|FG018|Period 1|Adverse Event|1|||
16222783|NCT01049360|39295260|FG019|Period 1|Adverse Event|0|||
16222784|NCT01049360|39295241|FG000|Period 1|Did not meet inc/exc criteria|0|||
16222785|NCT01049360|39295242|FG001|Period 1|Did not meet inc/exc criteria|0|||
16222786|NCT01049360|39295243|FG002|Period 1|Did not meet inc/exc criteria|0|||
16222787|NCT01049360|39295244|FG003|Period 1|Did not meet inc/exc criteria|0|||
16345969|NCT02714036|39753195|FG000|Overall Study|Withdrawal by Subject|3|||
16345970|NCT02714036|39753196|FG001|Overall Study|Withdrawal by Subject|2|||
16345971|NCT01509664|39753200|FG000|Overall Study|Lost to Follow-up|15|||
16545991|NCT01392300|40460853|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
16545992|NCT01392300|40460854|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
16545993|NCT01392300|40460855|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
16545994|NCT01392300|40460853|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
16545995|NCT01392300|40460854|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
16545996|NCT01392300|40460855|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
16545997|NCT02066402|40460856|FG000|Overall Study|Adverse Event|1|||
16545998|NCT02066402|40460857|FG001|Overall Study|Adverse Event|2|||
16545999|NCT02066402|40460856|FG000|Overall Study|Lost to Follow-up|11|||
16546000|NCT02066402|40460857|FG001|Overall Study|Lost to Follow-up|8|||
16546001|NCT02066402|40460856|FG000|Overall Study|Withdrawal by Subject|14|||
16546002|NCT02066402|40460857|FG001|Overall Study|Withdrawal by Subject|11|||
16546003|NCT02066402|40460856|FG000|Overall Study|Progressive disease-clinical progression|0|||
16546004|NCT02066402|40460857|FG001|Overall Study|Progressive disease-clinical progression|1|||
16546005|NCT02066402|40460856|FG000|Overall Study|Protocol driven decision point|0|||
16546006|NCT02066402|40460857|FG001|Overall Study|Protocol driven decision point|1|||
16546007|NCT00365378|40460858|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
16546008|NCT00365378|40460859|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
16546009|NCT00365378|40460860|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
16546010|NCT00365378|40460858|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
16546011|NCT00365378|40460859|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
16546012|NCT00365378|40460860|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
16546013|NCT00365378|40460858|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
16546014|NCT00365378|40460859|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
16222788|NCT01049360|39295245|FG004|Period 1|Did not meet inc/exc criteria|0|||
16222789|NCT01049360|39295246|FG005|Period 1|Did not meet inc/exc criteria|0|||
16222790|NCT01049360|39295247|FG006|Period 1|Did not meet inc/exc criteria|0|||
16222791|NCT01049360|39295248|FG007|Period 1|Did not meet inc/exc criteria|1|||
16222792|NCT01049360|39295249|FG008|Period 1|Did not meet inc/exc criteria|1|||
16222793|NCT01049360|39295250|FG009|Period 1|Did not meet inc/exc criteria|0|||
16222794|NCT01049360|39295251|FG010|Period 1|Did not meet inc/exc criteria|0|||
16222795|NCT01049360|39295252|FG011|Period 1|Did not meet inc/exc criteria|0|||
16222796|NCT01049360|39295253|FG012|Period 1|Did not meet inc/exc criteria|0|||
16222797|NCT01049360|39295254|FG013|Period 1|Did not meet inc/exc criteria|0|||
16222798|NCT01049360|39295255|FG014|Period 1|Did not meet inc/exc criteria|0|||
16345972|NCT01509664|39753201|FG001|Overall Study|Lost to Follow-up|21|||
16222799|NCT01049360|39295256|FG015|Period 1|Did not meet inc/exc criteria|0|||
16222800|NCT01049360|39295257|FG016|Period 1|Did not meet inc/exc criteria|0|||
16222801|NCT01049360|39295258|FG017|Period 1|Did not meet inc/exc criteria|0|||
16222802|NCT01049360|39295259|FG018|Period 1|Did not meet inc/exc criteria|0|||
16222803|NCT01049360|39295260|FG019|Period 1|Did not meet inc/exc criteria|0|||
16222804|NCT01049360|39295241|FG000|Period 1|Withdrawal by Subject|0|||
16222805|NCT01049360|39295242|FG001|Period 1|Withdrawal by Subject|0|||
16222806|NCT01049360|39295243|FG002|Period 1|Withdrawal by Subject|0|||
16222807|NCT01049360|39295244|FG003|Period 1|Withdrawal by Subject|0|||
16222808|NCT01049360|39295245|FG004|Period 1|Withdrawal by Subject|0|||
16222809|NCT01049360|39295246|FG005|Period 1|Withdrawal by Subject|0|||
16222810|NCT01049360|39295247|FG006|Period 1|Withdrawal by Subject|0|||
16222811|NCT01049360|39295248|FG007|Period 1|Withdrawal by Subject|0|||
16222812|NCT01049360|39295249|FG008|Period 1|Withdrawal by Subject|1|||
16222813|NCT01049360|39295250|FG009|Period 1|Withdrawal by Subject|0|||
16222814|NCT01049360|39295251|FG010|Period 1|Withdrawal by Subject|1|||
16222815|NCT01049360|39295252|FG011|Period 1|Withdrawal by Subject|0|||
16222816|NCT01049360|39295253|FG012|Period 1|Withdrawal by Subject|1|||
16222817|NCT01049360|39295254|FG013|Period 1|Withdrawal by Subject|0|||
16222818|NCT01049360|39295255|FG014|Period 1|Withdrawal by Subject|0|||
16222819|NCT01049360|39295256|FG015|Period 1|Withdrawal by Subject|0|||
16222820|NCT01049360|39295257|FG016|Period 1|Withdrawal by Subject|0|||
16222821|NCT01049360|39295258|FG017|Period 1|Withdrawal by Subject|0|||
16222822|NCT01049360|39295259|FG018|Period 1|Withdrawal by Subject|0|||
16222823|NCT01049360|39295260|FG019|Period 1|Withdrawal by Subject|0|||
16222824|NCT01049360|39295241|FG000|Period 2|Protocol Violation|0|||
16222825|NCT01049360|39295242|FG001|Period 2|Protocol Violation|0|||
16222826|NCT01049360|39295243|FG002|Period 2|Protocol Violation|0|||
16222827|NCT01049360|39295244|FG003|Period 2|Protocol Violation|1|||
16222828|NCT01049360|39295245|FG004|Period 2|Protocol Violation|0|||
16222829|NCT01049360|39295246|FG005|Period 2|Protocol Violation|0|||
16222830|NCT01049360|39295247|FG006|Period 2|Protocol Violation|0|||
16222831|NCT01049360|39295248|FG007|Period 2|Protocol Violation|0|||
16222832|NCT01049360|39295249|FG008|Period 2|Protocol Violation|0|||
16222833|NCT01049360|39295250|FG009|Period 2|Protocol Violation|0|||
16222834|NCT01049360|39295251|FG010|Period 2|Protocol Violation|0|||
16222835|NCT01049360|39295252|FG011|Period 2|Protocol Violation|0|||
16222836|NCT01049360|39295253|FG012|Period 2|Protocol Violation|0|||
16222837|NCT01049360|39295254|FG013|Period 2|Protocol Violation|0|||
16222838|NCT01049360|39295255|FG014|Period 2|Protocol Violation|1|||
16222839|NCT01049360|39295256|FG015|Period 2|Protocol Violation|1|||
16222840|NCT01049360|39295257|FG016|Period 2|Protocol Violation|0|||
16222841|NCT01049360|39295258|FG017|Period 2|Protocol Violation|0|||
16222842|NCT01049360|39295259|FG018|Period 2|Protocol Violation|0|||
16222843|NCT01049360|39295260|FG019|Period 2|Protocol Violation|0|||
16222844|NCT01049360|39295241|FG000|Period 2|Adverse Event|0|||
16222845|NCT01049360|39295242|FG001|Period 2|Adverse Event|1|||
16222846|NCT01049360|39295243|FG002|Period 2|Adverse Event|0|||
16222847|NCT01049360|39295244|FG003|Period 2|Adverse Event|0|||
16222848|NCT01049360|39295245|FG004|Period 2|Adverse Event|0|||
16222849|NCT01049360|39295246|FG005|Period 2|Adverse Event|0|||
16222850|NCT01049360|39295247|FG006|Period 2|Adverse Event|0|||
16222851|NCT01049360|39295248|FG007|Period 2|Adverse Event|0|||
16222852|NCT01049360|39295249|FG008|Period 2|Adverse Event|1|||
16222853|NCT01049360|39295250|FG009|Period 2|Adverse Event|0|||
16222854|NCT01049360|39295251|FG010|Period 2|Adverse Event|0|||
16222855|NCT01049360|39295252|FG011|Period 2|Adverse Event|0|||
16222856|NCT01049360|39295253|FG012|Period 2|Adverse Event|0|||
16222857|NCT01049360|39295254|FG013|Period 2|Adverse Event|0|||
16222858|NCT01049360|39295255|FG014|Period 2|Adverse Event|0|||
16222859|NCT01049360|39295256|FG015|Period 2|Adverse Event|0|||
16222860|NCT01049360|39295257|FG016|Period 2|Adverse Event|0|||
16222861|NCT01049360|39295258|FG017|Period 2|Adverse Event|0|||
16222862|NCT01049360|39295259|FG018|Period 2|Adverse Event|0|||
16222863|NCT01049360|39295260|FG019|Period 2|Adverse Event|1|||
16222864|NCT01049360|39295241|FG000|Period 2|Withdrawal by Subject|0|||
16222865|NCT01049360|39295242|FG001|Period 2|Withdrawal by Subject|0|||
16222866|NCT01049360|39295243|FG002|Period 2|Withdrawal by Subject|0|||
16222867|NCT01049360|39295244|FG003|Period 2|Withdrawal by Subject|1|||
16222868|NCT01049360|39295245|FG004|Period 2|Withdrawal by Subject|0|||
16222869|NCT01049360|39295246|FG005|Period 2|Withdrawal by Subject|0|||
16222870|NCT01049360|39295247|FG006|Period 2|Withdrawal by Subject|0|||
16222871|NCT01049360|39295248|FG007|Period 2|Withdrawal by Subject|0|||
16222872|NCT01049360|39295249|FG008|Period 2|Withdrawal by Subject|0|||
16222873|NCT01049360|39295250|FG009|Period 2|Withdrawal by Subject|0|||
16222874|NCT01049360|39295251|FG010|Period 2|Withdrawal by Subject|0|||
16222875|NCT01049360|39295252|FG011|Period 2|Withdrawal by Subject|0|||
16222876|NCT01049360|39295253|FG012|Period 2|Withdrawal by Subject|0|||
16222877|NCT01049360|39295254|FG013|Period 2|Withdrawal by Subject|0|||
16222878|NCT01049360|39295255|FG014|Period 2|Withdrawal by Subject|1|||
16222879|NCT01049360|39295256|FG015|Period 2|Withdrawal by Subject|0|||
16222880|NCT01049360|39295257|FG016|Period 2|Withdrawal by Subject|0|||
16222881|NCT01049360|39295258|FG017|Period 2|Withdrawal by Subject|0|||
16222882|NCT01049360|39295259|FG018|Period 2|Withdrawal by Subject|0|||
16222883|NCT01049360|39295260|FG019|Period 2|Withdrawal by Subject|1|||
16222884|NCT01049360|39295241|FG000|Period 2|Lack of Efficacy|0|||
16222885|NCT01049360|39295242|FG001|Period 2|Lack of Efficacy|0|||
16222886|NCT01049360|39295243|FG002|Period 2|Lack of Efficacy|0|||
16222887|NCT01049360|39295244|FG003|Period 2|Lack of Efficacy|0|||
16222888|NCT01049360|39295245|FG004|Period 2|Lack of Efficacy|0|||
16222889|NCT01049360|39295246|FG005|Period 2|Lack of Efficacy|1|||
16222890|NCT01049360|39295247|FG006|Period 2|Lack of Efficacy|0|||
16222891|NCT01049360|39295248|FG007|Period 2|Lack of Efficacy|0|||
16222892|NCT01049360|39295249|FG008|Period 2|Lack of Efficacy|0|||
16222893|NCT01049360|39295250|FG009|Period 2|Lack of Efficacy|0|||
16222894|NCT01049360|39295251|FG010|Period 2|Lack of Efficacy|0|||
16222895|NCT01049360|39295252|FG011|Period 2|Lack of Efficacy|0|||
16222896|NCT01049360|39295253|FG012|Period 2|Lack of Efficacy|0|||
16222897|NCT01049360|39295254|FG013|Period 2|Lack of Efficacy|0|||
16222898|NCT01049360|39295255|FG014|Period 2|Lack of Efficacy|0|||
16222899|NCT01049360|39295256|FG015|Period 2|Lack of Efficacy|0|||
16222900|NCT01049360|39295257|FG016|Period 2|Lack of Efficacy|0|||
16222901|NCT01049360|39295258|FG017|Period 2|Lack of Efficacy|0|||
16222902|NCT01049360|39295259|FG018|Period 2|Lack of Efficacy|0|||
16222903|NCT01049360|39295260|FG019|Period 2|Lack of Efficacy|0|||
16222904|NCT01049360|39295241|FG000|Period 4|Protocol Violation|0|||
16222905|NCT01049360|39295242|FG001|Period 4|Protocol Violation|0|||
16222906|NCT01049360|39295243|FG002|Period 4|Protocol Violation|0|||
16222907|NCT01049360|39295244|FG003|Period 4|Protocol Violation|0|||
16222908|NCT01049360|39295245|FG004|Period 4|Protocol Violation|0|||
16222909|NCT01049360|39295246|FG005|Period 4|Protocol Violation|0|||
16222910|NCT01049360|39295247|FG006|Period 4|Protocol Violation|0|||
16222911|NCT01049360|39295248|FG007|Period 4|Protocol Violation|0|||
16222912|NCT01049360|39295249|FG008|Period 4|Protocol Violation|0|||
16222913|NCT01049360|39295250|FG009|Period 4|Protocol Violation|0|||
16222914|NCT01049360|39295251|FG010|Period 4|Protocol Violation|0|||
16222915|NCT01049360|39295252|FG011|Period 4|Protocol Violation|0|||
16222916|NCT01049360|39295253|FG012|Period 4|Protocol Violation|0|||
16222917|NCT01049360|39295254|FG013|Period 4|Protocol Violation|0|||
16222918|NCT01049360|39295255|FG014|Period 4|Protocol Violation|0|||
16222919|NCT01049360|39295256|FG015|Period 4|Protocol Violation|0|||
16222920|NCT01049360|39295257|FG016|Period 4|Protocol Violation|0|||
16222921|NCT01049360|39295258|FG017|Period 4|Protocol Violation|1|||
16222922|NCT01049360|39295259|FG018|Period 4|Protocol Violation|0|||
16222923|NCT01049360|39295260|FG019|Period 4|Protocol Violation|0|||
16409399|NCT03761394|39981664|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
16222924|NCT01049360|39295241|FG000|Period 4|Withdrawal by Subject|0|||
16222925|NCT01049360|39295242|FG001|Period 4|Withdrawal by Subject|0|||
16222926|NCT01049360|39295243|FG002|Period 4|Withdrawal by Subject|0|||
16222927|NCT01049360|39295244|FG003|Period 4|Withdrawal by Subject|1|||
16222928|NCT01049360|39295245|FG004|Period 4|Withdrawal by Subject|0|||
16222929|NCT01049360|39295246|FG005|Period 4|Withdrawal by Subject|0|||
16222930|NCT01049360|39295247|FG006|Period 4|Withdrawal by Subject|0|||
16222931|NCT01049360|39295248|FG007|Period 4|Withdrawal by Subject|0|||
16222932|NCT01049360|39295249|FG008|Period 4|Withdrawal by Subject|0|||
16222933|NCT01049360|39295250|FG009|Period 4|Withdrawal by Subject|0|||
16409400|NCT03761394|39981665|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
16409401|NCT03761394|39981666|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
16222934|NCT01049360|39295251|FG010|Period 4|Withdrawal by Subject|0|||
16222935|NCT01049360|39295252|FG011|Period 4|Withdrawal by Subject|0|||
16222936|NCT01049360|39295253|FG012|Period 4|Withdrawal by Subject|0|||
16222937|NCT01049360|39295254|FG013|Period 4|Withdrawal by Subject|0|||
16222938|NCT01049360|39295255|FG014|Period 4|Withdrawal by Subject|0|||
16222939|NCT01049360|39295256|FG015|Period 4|Withdrawal by Subject|0|||
16222940|NCT01049360|39295257|FG016|Period 4|Withdrawal by Subject|0|||
16222941|NCT01049360|39295258|FG017|Period 4|Withdrawal by Subject|0|||
16222942|NCT01049360|39295259|FG018|Period 4|Withdrawal by Subject|0|||
16222943|NCT01049360|39295260|FG019|Period 4|Withdrawal by Subject|0|||
16222944|NCT03575975|39295261|FG000|Overall Study|Lost to Follow-up|1|||
16222945|NCT03575975|39295262|FG001|Overall Study|Lost to Follow-up|0|||
16222946|NCT03575975|39295263|FG002|Overall Study|Lost to Follow-up|0|||
16222947|NCT03524664|39295271|FG000|Overall Study|Withdrawal by Subject|1|||
16222948|NCT03524664|39295272|FG001|Overall Study|Withdrawal by Subject|2|||
16222949|NCT03524664|39295271|FG000|Overall Study|Lost to Follow-up|4|||
16222950|NCT03524664|39295272|FG001|Overall Study|Lost to Follow-up|13|||
16222951|NCT00805142|39295273|FG000|Titration Period|Adverse Event|3|||
16222952|NCT00805142|39295274|FG001|Titration Period|Adverse Event|3|||
16222953|NCT00805142|39295273|FG000|Titration Period|Lack of Efficacy|1|||
16409402|NCT03761394|39981667|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
16409403|NCT03761394|39981664|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
16409404|NCT03761394|39981665|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
16409405|NCT03761394|39981666|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
16409406|NCT03761394|39981667|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
16409407|NCT03761394|39981664|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
16409408|NCT03761394|39981665|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
16409409|NCT03761394|39981666|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
16409410|NCT03761394|39981667|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
16409411|NCT03761394|39981664|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
16409412|NCT03761394|39981665|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
16409413|NCT03761394|39981666|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
16409414|NCT03761394|39981667|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
16409415|NCT00953524|39981676|FG000|Overall Study|Adverse Event|2|||
16409416|NCT00953524|39981677|FG001|Overall Study|Adverse Event|0|||
16409417|NCT00953524|39981678|FG002|Overall Study|Adverse Event|1|||
16409418|NCT00953524|39981679|FG003|Overall Study|Adverse Event|2|||
16409419|NCT00953524|39981676|FG000|Overall Study|Protocol Violation|18|||
16409420|NCT00953524|39981677|FG001|Overall Study|Protocol Violation|10|||
16409421|NCT00953524|39981678|FG002|Overall Study|Protocol Violation|11|||
16409422|NCT00953524|39981679|FG003|Overall Study|Protocol Violation|6|||
16409423|NCT00953524|39981676|FG000|Overall Study|Lost to Follow-up|0|||
16409424|NCT00953524|39981677|FG001|Overall Study|Lost to Follow-up|1|||
16409425|NCT00953524|39981678|FG002|Overall Study|Lost to Follow-up|1|||
16409426|NCT00953524|39981679|FG003|Overall Study|Lost to Follow-up|0|||
16409427|NCT00953524|39981676|FG000|Overall Study|Withdrawal by Subject|2|||
16409428|NCT00953524|39981677|FG001|Overall Study|Withdrawal by Subject|4|||
16409429|NCT00953524|39981678|FG002|Overall Study|Withdrawal by Subject|1|||
16409430|NCT00953524|39981679|FG003|Overall Study|Withdrawal by Subject|0|||
16409431|NCT01328041|39981680|FG000|Overall Study|Adverse Event|7|||
16222954|NCT00805142|39295274|FG001|Titration Period|Lack of Efficacy|1|||
16222955|NCT00805142|39295273|FG000|Titration Period|Lost to Follow-up|0|||
16222956|NCT00805142|39295274|FG001|Titration Period|Lost to Follow-up|1|||
16222957|NCT00805142|39295273|FG000|Titration Period|Disease Progression|2|||
16222958|NCT00805142|39295274|FG001|Titration Period|Disease Progression|1|||
16222959|NCT00805142|39295273|FG000|Titration Period|Withdrawal of consent|0|||
16222960|NCT00805142|39295274|FG001|Titration Period|Withdrawal of consent|1|||
16222961|NCT00805142|39295273|FG000|Titration Period|Other|0|||
16222962|NCT00805142|39295274|FG001|Titration Period|Other|3|||
16222963|NCT00805142|39295273|FG000|Maintenance Period|Adverse Event|0|||
16222964|NCT00805142|39295274|FG001|Maintenance Period|Adverse Event|1|||
16222965|NCT00805142|39295273|FG000|Maintenance Period|Other|0|||
16222966|NCT00805142|39295274|FG001|Maintenance Period|Other|1|||
16222967|NCT01234337|39295277|FG000|Overall Study|Adverse Event|58|||
16222968|NCT01234337|39295278|FG001|Overall Study|Adverse Event|21|||
16222969|NCT01234337|39295277|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
16222970|NCT01234337|39295278|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
16222971|NCT01234337|39295277|FG000|Overall Study|Investi. decision not protocol driven|5|||
16222972|NCT01234337|39295278|FG001|Overall Study|Investi. decision not protocol driven|6|||
16222973|NCT01234337|39295277|FG000|Overall Study|Non-compliant with study medication|3|||
16222974|NCT01234337|39295278|FG001|Overall Study|Non-compliant with study medication|2|||
16222975|NCT01234337|39295277|FG000|Overall Study|Randomized but not treated|6|||
16222976|NCT01234337|39295278|FG001|Overall Study|Randomized but not treated|4|||
16222977|NCT01234337|39295277|FG000|Overall Study|Lost to Follow-up|0|||
16222978|NCT01234337|39295278|FG001|Overall Study|Lost to Follow-up|1|||
16222979|NCT01234337|39295277|FG000|Overall Study|Protocol Violation|2|||
16222980|NCT01234337|39295278|FG001|Overall Study|Protocol Violation|3|||
16222981|NCT01234337|39295277|FG000|Overall Study|Withdrawal by Subject|11|||
16222982|NCT01234337|39295278|FG001|Overall Study|Withdrawal by Subject|9|||
16222983|NCT01234337|39295277|FG000|Overall Study|Death|0|||
16409432|NCT01328041|39981680|FG000|Overall Study|Lack of Efficacy|27|||
16409433|NCT01328041|39981680|FG000|Overall Study|Protocol Violation|7|||
16409434|NCT01328041|39981680|FG000|Overall Study|Lost to Follow-up|7|||
16409435|NCT01328041|39981680|FG000|Overall Study|Physician Decision|2|||
16409436|NCT01328041|39981680|FG000|Overall Study|Withdrawal by Subject|7|||
16409437|NCT01294462|39981681|FG000|Overall Study|Lost to Follow-up|1|||
16222984|NCT01234337|39295278|FG001|Overall Study|Death|1|||
16222985|NCT01234337|39295277|FG000|Overall Study|Switch to commercial drug|0|||
16345987|NCT02658669|39753206|FG000|Overall Study|Lost to Follow-up|7|||
16345988|NCT02658669|39753207|FG001|Overall Study|Lost to Follow-up|5|||
16345989|NCT05227118|39753210|FG000|Overall Study|Adverse Event|0|||
16345990|NCT05227118|39753211|FG001|Overall Study|Adverse Event|0|||
16345991|NCT05227118|39753212|FG002|Overall Study|Adverse Event|1|||
16345992|NCT05227118|39753213|FG003|Overall Study|Adverse Event|0|||
16345993|NCT05227118|39753210|FG000|Overall Study|Withdrawal by Subject|0|||
16345994|NCT05227118|39753211|FG001|Overall Study|Withdrawal by Subject|0|||
16345995|NCT05227118|39753212|FG002|Overall Study|Withdrawal by Subject|2|||
16345996|NCT05227118|39753213|FG003|Overall Study|Withdrawal by Subject|0|||
16345997|NCT03839394|39753217|FG000|Overall Study|Lost to Follow-up|6|||
16345998|NCT03839394|39753218|FG001|Overall Study|Lost to Follow-up|8|||
16345999|NCT03839394|39753217|FG000|Overall Study|Withdrawal by Subject|0|||
16346000|NCT03839394|39753218|FG001|Overall Study|Withdrawal by Subject|2|||
16346001|NCT05464420|39753219|FG000|Overall Study|Death|0|||
16346002|NCT05464420|39753220|FG001|Overall Study|Death|0|||
16346003|NCT05464420|39753221|FG002|Overall Study|Death|0|||
16346004|NCT05464420|39753222|FG003|Overall Study|Death|1|||
16346005|NCT05464420|39753219|FG000|Overall Study|Lost to Follow-up|16|||
16346006|NCT05464420|39753220|FG001|Overall Study|Lost to Follow-up|11|||
16346007|NCT05464420|39753221|FG002|Overall Study|Lost to Follow-up|11|||
16346008|NCT05464420|39753222|FG003|Overall Study|Lost to Follow-up|11|||
16346009|NCT05464420|39753219|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
16346010|NCT05464420|39753220|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
16346011|NCT05464420|39753221|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
16346012|NCT05464420|39753222|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
16346013|NCT05464420|39753219|FG000|Overall Study|Withdrawal by Subject|4|||
16409438|NCT01294462|39981682|FG001|Overall Study|Lost to Follow-up|0|||
16346014|NCT05464420|39753220|FG001|Overall Study|Withdrawal by Subject|8|||
16346015|NCT05464420|39753221|FG002|Overall Study|Withdrawal by Subject|3|||
16409439|NCT01294462|39981681|FG000|Overall Study|Withdrawal by Subject|65|||
16409440|NCT01294462|39981682|FG001|Overall Study|Withdrawal by Subject|63|||
16409441|NCT00293709|39981684|FG000|Overall Study|Other|47|||
16409442|NCT00747344|39981686|FG000|Controlled Period|Adverse Event|3|||
16409443|NCT00747344|39981687|FG001|Controlled Period|Adverse Event|0|||
16409444|NCT00747344|39981688|FG002|Controlled Period|Adverse Event|0|||
16409445|NCT00747344|39981689|FG003|Controlled Period|Adverse Event|0|||
16409446|NCT00747344|39981686|FG000|Controlled Period|Lack of Efficacy|2|||
16409447|NCT00747344|39981687|FG001|Controlled Period|Lack of Efficacy|1|||
16409448|NCT00747344|39981688|FG002|Controlled Period|Lack of Efficacy|0|||
16409449|NCT00747344|39981689|FG003|Controlled Period|Lack of Efficacy|0|||
16409450|NCT00747344|39981686|FG000|Controlled Period|Other|0|||
16409451|NCT00747344|39981687|FG001|Controlled Period|Other|3|||
16409452|NCT00747344|39981688|FG002|Controlled Period|Other|0|||
16409453|NCT00747344|39981689|FG003|Controlled Period|Other|0|||
16409454|NCT00747344|39981686|FG000|After Controlled Period|Adverse Event|0|||
16409455|NCT00747344|39981687|FG001|After Controlled Period|Adverse Event|0|||
16409456|NCT00747344|39981688|FG002|After Controlled Period|Adverse Event|0|||
16409457|NCT00747344|39981689|FG003|After Controlled Period|Adverse Event|1|||
16409458|NCT00168103|39981690|FG000|Overall Study|Withdrawal by Subject|1|||
16409459|NCT00168103|39981691|FG001|Overall Study|Withdrawal by Subject|2|||
16409460|NCT00168103|39981692|FG002|Overall Study|Withdrawal by Subject|1|||
16409461|NCT00168103|39981693|FG003|Overall Study|Withdrawal by Subject|0|||
16409462|NCT00168103|39981690|FG000|Overall Study|Lost to Follow-up|1|||
16409463|NCT00168103|39981691|FG001|Overall Study|Lost to Follow-up|3|||
16409464|NCT00168103|39981692|FG002|Overall Study|Lost to Follow-up|0|||
16409465|NCT00168103|39981693|FG003|Overall Study|Lost to Follow-up|0|||
16409466|NCT00717522|39981694|FG000|Overall Study|Disease Progression|5|||
16409467|NCT00717522|39981694|FG000|Overall Study|Adverse Event|1|||
16409468|NCT00717522|39981694|FG000|Overall Study|Death|1|||
16409469|NCT00394901|39981700|FG000|Baseline Phase|Protocol Violation|0|||
16409470|NCT00394901|39981701|FG001|Baseline Phase|Protocol Violation|0|||
16409471|NCT00394901|39981702|FG002|Baseline Phase|Protocol Violation|1|||
16409472|NCT00394901|39981703|FG003|Baseline Phase|Protocol Violation|0|||
16409473|NCT00394901|39981700|FG000|Double-blind Phase|Adverse Event|5|||
16409474|NCT00394901|39981701|FG001|Double-blind Phase|Adverse Event|7|||
16546015|NCT00365378|40460860|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
16546016|NCT00365378|40460858|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
16546017|NCT00365378|40460859|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
16546018|NCT00365378|40460860|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
16546019|NCT00365378|40460858|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
16546020|NCT00365378|40460859|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
16546021|NCT00365378|40460860|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
16546022|NCT00365378|40460858|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
16222986|NCT01234337|39295278|FG001|Overall Study|Switch to commercial drug|1|||
16222987|NCT00942422|39295279|FG000|Overall Study|Withdrawal by Subject|1|||
16222988|NCT00942422|39295279|FG000|Overall Study|Death|1|||
16222989|NCT00942422|39295279|FG000|Overall Study|Progressive diease|1|||
16222990|NCT01539720|39295280|FG000|Overall Study|Screen Fail|15|||
16222991|NCT01539720|39295281|FG001|Overall Study|Screen Fail|3|||
16222992|NCT01539720|39295280|FG000|Overall Study|Lost to Follow-up|14|||
16222993|NCT01539720|39295281|FG001|Overall Study|Lost to Follow-up|7|||
16222994|NCT02993731|39295282|FG000|Overall Study|Study Termination|101|||
16222995|NCT02993731|39295283|FG001|Overall Study|Study Termination|105|||
16222996|NCT00337935|39295290|FG000|Overall Study|Adverse Event|2|||
16222997|NCT00337935|39295291|FG001|Overall Study|Adverse Event|5|||
16222998|NCT00337935|39295290|FG000|Overall Study|Death|2|||
16222999|NCT00337935|39295291|FG001|Overall Study|Death|8|||
16223000|NCT00337935|39295290|FG000|Overall Study|Physician Decision|1|||
16223001|NCT00337935|39295291|FG001|Overall Study|Physician Decision|1|||
16223002|NCT00337935|39295290|FG000|Overall Study|Lost to Follow-up|0|||
16223003|NCT00337935|39295291|FG001|Overall Study|Lost to Follow-up|1|||
16223004|NCT00337935|39295290|FG000|Overall Study|Protocol Violation|4|||
16223005|NCT00337935|39295291|FG001|Overall Study|Protocol Violation|3|||
16223006|NCT00337935|39295290|FG000|Overall Study|Withdrawal by Subject|1|||
16223007|NCT00337935|39295291|FG001|Overall Study|Withdrawal by Subject|7|||
16223008|NCT00337935|39295290|FG000|Overall Study|Other|0|||
16223009|NCT00337935|39295291|FG001|Overall Study|Other|1|||
16223010|NCT00337935|39295290|FG000|Overall Study|Lack of Efficacy|0|||
16223011|NCT00337935|39295291|FG001|Overall Study|Lack of Efficacy|1|||
16409475|NCT00394901|39981702|FG002|Double-blind Phase|Adverse Event|16|||
16409476|NCT00394901|39981703|FG003|Double-blind Phase|Adverse Event|20|||
16409477|NCT00394901|39981700|FG000|Double-blind Phase|Lack of Efficacy|6|||
16409478|NCT00394901|39981701|FG001|Double-blind Phase|Lack of Efficacy|4|||
16409479|NCT00394901|39981702|FG002|Double-blind Phase|Lack of Efficacy|1|||
16409480|NCT00394901|39981703|FG003|Double-blind Phase|Lack of Efficacy|3|||
16409481|NCT00394901|39981700|FG000|Double-blind Phase|Withdrawal by Subject|2|||
16409482|NCT00394901|39981701|FG001|Double-blind Phase|Withdrawal by Subject|0|||
16223012|NCT02390362|39295292|FG000|Overall Study|Withdrawal by Subject|0|||
16223013|NCT02390362|39295293|FG001|Overall Study|Withdrawal by Subject|1|||
16223014|NCT01397409|39295294|FG000|Stage 2|Adverse Event|0|||
16223015|NCT01397409|39295295|FG001|Stage 2|Adverse Event|0|||
16111331|NCT01772823|38897229|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
16223016|NCT01397409|39295296|FG002|Stage 2|Adverse Event|0|||
16223017|NCT01397409|39295297|FG003|Stage 2|Adverse Event|0|||
16223018|NCT01397409|39295298|FG004|Stage 2|Adverse Event|6|||
16223019|NCT01397409|39295299|FG005|Stage 2|Adverse Event|3|||
16223020|NCT01397409|39295300|FG006|Stage 2|Adverse Event|0|||
16223021|NCT01397409|39295301|FG007|Stage 2|Adverse Event|0|||
16223022|NCT01397409|39295302|FG008|Stage 2|Adverse Event|0|||
16223023|NCT01397409|39295303|FG009|Stage 2|Adverse Event|0|||
16223024|NCT01397409|39295294|FG000|Stage 2|Personal Reasons|0|||
16223025|NCT01397409|39295295|FG001|Stage 2|Personal Reasons|0|||
16223026|NCT01397409|39295296|FG002|Stage 2|Personal Reasons|0|||
16223027|NCT01397409|39295297|FG003|Stage 2|Personal Reasons|0|||
16223028|NCT01397409|39295298|FG004|Stage 2|Personal Reasons|1|||
16223029|NCT01397409|39295299|FG005|Stage 2|Personal Reasons|0|||
16223030|NCT01397409|39295300|FG006|Stage 2|Personal Reasons|0|||
16223031|NCT01397409|39295301|FG007|Stage 2|Personal Reasons|0|||
16223032|NCT01397409|39295302|FG008|Stage 2|Personal Reasons|0|||
16223033|NCT01397409|39295303|FG009|Stage 2|Personal Reasons|0|||
16223034|NCT01397409|39295294|FG000|Stage 2|Other Miscellaneous Reasons|0|||
16223035|NCT01397409|39295295|FG001|Stage 2|Other Miscellaneous Reasons|0|||
16223036|NCT01397409|39295296|FG002|Stage 2|Other Miscellaneous Reasons|0|||
16223037|NCT01397409|39295297|FG003|Stage 2|Other Miscellaneous Reasons|0|||
16223038|NCT01397409|39295298|FG004|Stage 2|Other Miscellaneous Reasons|1|||
16223039|NCT01397409|39295299|FG005|Stage 2|Other Miscellaneous Reasons|1|||
16223040|NCT01397409|39295300|FG006|Stage 2|Other Miscellaneous Reasons|0|||
16223041|NCT01397409|39295301|FG007|Stage 2|Other Miscellaneous Reasons|0|||
16223042|NCT01397409|39295302|FG008|Stage 2|Other Miscellaneous Reasons|0|||
16409483|NCT00394901|39981702|FG002|Double-blind Phase|Withdrawal by Subject|0|||
16409484|NCT00394901|39981703|FG003|Double-blind Phase|Withdrawal by Subject|0|||
16409485|NCT00394901|39981700|FG000|Double-blind Phase|Lost to Follow-up|0|||
16409486|NCT00394901|39981701|FG001|Double-blind Phase|Lost to Follow-up|0|||
16409487|NCT00394901|39981702|FG002|Double-blind Phase|Lost to Follow-up|0|||
16409488|NCT00394901|39981703|FG003|Double-blind Phase|Lost to Follow-up|1|||
16409489|NCT00394901|39981700|FG000|Double-blind Phase|Protocol Violation|0|||
16409490|NCT00394901|39981701|FG001|Double-blind Phase|Protocol Violation|0|||
16409491|NCT00394901|39981702|FG002|Double-blind Phase|Protocol Violation|0|||
16409492|NCT00394901|39981703|FG003|Double-blind Phase|Protocol Violation|1|||
16409493|NCT00394901|39981700|FG000|Double-blind Phase|Death|1|||
16409494|NCT00394901|39981701|FG001|Double-blind Phase|Death|0|||
16409495|NCT00394901|39981702|FG002|Double-blind Phase|Death|0|||
16409496|NCT00394901|39981703|FG003|Double-blind Phase|Death|0|||
16409497|NCT00394901|39981700|FG000|Double-blind Phase|Subject's Personal Reason|1|||
16409498|NCT00394901|39981701|FG001|Double-blind Phase|Subject's Personal Reason|0|||
16409499|NCT00394901|39981702|FG002|Double-blind Phase|Subject's Personal Reason|0|||
16409500|NCT00394901|39981703|FG003|Double-blind Phase|Subject's Personal Reason|1|||
16409501|NCT00394901|39981700|FG000|Double-blind Phase|Lack of Compliance|0|||
16409502|NCT00394901|39981701|FG001|Double-blind Phase|Lack of Compliance|3|||
16409503|NCT00394901|39981702|FG002|Double-blind Phase|Lack of Compliance|0|||
16409504|NCT00394901|39981703|FG003|Double-blind Phase|Lack of Compliance|0|||
16409505|NCT00394901|39981700|FG000|Double-blind Phase|Entry into another study was found|0|||
16409506|NCT00394901|39981701|FG001|Double-blind Phase|Entry into another study was found|0|||
16409507|NCT00394901|39981702|FG002|Double-blind Phase|Entry into another study was found|1|||
16409508|NCT00394901|39981703|FG003|Double-blind Phase|Entry into another study was found|0|||
16409509|NCT00394901|39981700|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
16223043|NCT01397409|39295303|FG009|Stage 2|Other Miscellaneous Reasons|0|||
16223044|NCT01397409|39295294|FG000|Stage 3|Adverse Event|0|||
16223045|NCT01397409|39295295|FG001|Stage 3|Adverse Event|0|||
16223046|NCT01397409|39295296|FG002|Stage 3|Adverse Event|0|||
16223047|NCT01397409|39295297|FG003|Stage 3|Adverse Event|0|||
16223048|NCT01397409|39295298|FG004|Stage 3|Adverse Event|0|||
16223049|NCT01397409|39295299|FG005|Stage 3|Adverse Event|0|||
16223050|NCT01397409|39295300|FG006|Stage 3|Adverse Event|0|||
16223051|NCT01397409|39295301|FG007|Stage 3|Adverse Event|1|||
16223052|NCT01397409|39295302|FG008|Stage 3|Adverse Event|0|||
16409510|NCT00394901|39981701|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
16409511|NCT00394901|39981702|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
16409512|NCT00394901|39981703|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
16223053|NCT01397409|39295303|FG009|Stage 3|Adverse Event|0|||
16223054|NCT01397409|39295294|FG000|Stage 3|Other Miscellaneous Reasons|0|||
16223055|NCT01397409|39295295|FG001|Stage 3|Other Miscellaneous Reasons|0|||
16223056|NCT01397409|39295296|FG002|Stage 3|Other Miscellaneous Reasons|0|||
16409513|NCT04676867|39981704|FG000|Overall Study|Screen failure|0|||
16409514|NCT04676867|39981705|FG001|Overall Study|Screen failure|0|||
16409515|NCT04676867|39981706|FG002|Overall Study|Screen failure|6|||
16409516|NCT04676867|39981707|FG003|Overall Study|Screen failure|2|||
16409517|NCT04676867|39981704|FG000|Overall Study|Death|0|||
16409518|NCT04676867|39981705|FG001|Overall Study|Death|0|||
16409519|NCT04676867|39981706|FG002|Overall Study|Death|1|||
16409520|NCT04676867|39981707|FG003|Overall Study|Death|0|||
16409521|NCT04676867|39981704|FG000|Overall Study|Withdrawal by Subject|2|||
16409522|NCT04676867|39981705|FG001|Overall Study|Withdrawal by Subject|2|||
16409523|NCT04676867|39981706|FG002|Overall Study|Withdrawal by Subject|4|||
16409524|NCT04676867|39981707|FG003|Overall Study|Withdrawal by Subject|4|||
16409525|NCT04676867|39981704|FG000|Overall Study|Lost to Follow-up|1|||
16409526|NCT04676867|39981705|FG001|Overall Study|Lost to Follow-up|0|||
16409527|NCT04676867|39981706|FG002|Overall Study|Lost to Follow-up|0|||
16409528|NCT04676867|39981707|FG003|Overall Study|Lost to Follow-up|0|||
16409529|NCT03187834|39981709|FG000|Overall Study|Lost to Follow-up|0|||
16409530|NCT03187834|39981710|FG001|Overall Study|Lost to Follow-up|1|||
16409531|NCT03187834|39981711|FG002|Overall Study|Lost to Follow-up|2|||
16409532|NCT03187834|39981712|FG003|Overall Study|Lost to Follow-up|2|||
16409533|NCT03187834|39981709|FG000|Overall Study|Had invalid anthropometric measurements|5|||
16409534|NCT03187834|39981710|FG001|Overall Study|Had invalid anthropometric measurements|3|||
16409535|NCT03187834|39981711|FG002|Overall Study|Had invalid anthropometric measurements|4|||
16409536|NCT03187834|39981712|FG003|Overall Study|Had invalid anthropometric measurements|2|||
16409537|NCT02370095|39981713|FG000|Overall Study|Withdrawal by Subject|0|||
16409538|NCT02370095|39981714|FG001|Overall Study|Withdrawal by Subject|1|||
16409539|NCT01231321|39981718|FG000|Overall Study|Adverse Event|3|||
16409540|NCT01231321|39981718|FG000|Overall Study|Lack of Efficacy|2|||
16409541|NCT02827500|39981719|FG000|Overall Study|Death|7|||
16409542|NCT02827500|39981720|FG001|Overall Study|Death|3|||
16409543|NCT02827500|39981719|FG000|Overall Study|Lost to Follow-up|1|||
16409544|NCT02827500|39981720|FG001|Overall Study|Lost to Follow-up|1|||
16409545|NCT02827500|39981719|FG000|Overall Study|Withdrawal by Subject|3|||
16409546|NCT02827500|39981720|FG001|Overall Study|Withdrawal by Subject|1|||
16409547|NCT02827500|39981719|FG000|Overall Study|Missing primary endpoint data|3|||
16409548|NCT02827500|39981720|FG001|Overall Study|Missing primary endpoint data|1|||
16409549|NCT02827500|39981719|FG000|Overall Study|Other|5|||
16409550|NCT02827500|39981720|FG001|Overall Study|Other|1|||
16409551|NCT00520013|39981721|FG000|Overall Study|Withdrawal by Subject|0|||
16409552|NCT00520013|39981722|FG001|Overall Study|Withdrawal by Subject|0|||
16409553|NCT00520013|39981723|FG002|Overall Study|Withdrawal by Subject|1|||
16409554|NCT00520013|39981721|FG000|Overall Study|Adverse Event|2|||
16409555|NCT00520013|39981722|FG001|Overall Study|Adverse Event|10|||
16409556|NCT00520013|39981723|FG002|Overall Study|Adverse Event|7|||
16409557|NCT00520013|39981721|FG000|Overall Study|Progressive Disease|7|||
16409558|NCT00520013|39981722|FG001|Overall Study|Progressive Disease|3|||
16409559|NCT00520013|39981723|FG002|Overall Study|Progressive Disease|0|||
16409560|NCT00520013|39981721|FG000|Overall Study|Clinical Progression|3|||
16409561|NCT00520013|39981722|FG001|Overall Study|Clinical Progression|1|||
16409562|NCT00520013|39981723|FG002|Overall Study|Clinical Progression|0|||
16409563|NCT00520013|39981721|FG000|Overall Study|Death|0|||
16409564|NCT00520013|39981722|FG001|Overall Study|Death|1|||
16409565|NCT00520013|39981723|FG002|Overall Study|Death|0|||
16409566|NCT00520013|39981721|FG000|Overall Study|Physician Decision|0|||
16409567|NCT00520013|39981722|FG001|Overall Study|Physician Decision|0|||
16409568|NCT00520013|39981723|FG002|Overall Study|Physician Decision|3|||
16409569|NCT01740089|39981724|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
16409570|NCT01740089|39981725|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
16409571|NCT01740089|39981726|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
16409572|NCT01740089|39981724|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
16409573|NCT01740089|39981725|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
16409574|NCT01740089|39981726|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
16409575|NCT01740089|39981724|FG000|After 12 Weeks|Lack of Efficacy|3|||
16409576|NCT01740089|39981725|FG001|After 12 Weeks|Lack of Efficacy|1|||
16409577|NCT01740089|39981726|FG002|After 12 Weeks|Lack of Efficacy|4|||
16409578|NCT01740089|39981724|FG000|After 12 Weeks|Adverse Event|2|||
16409579|NCT01740089|39981725|FG001|After 12 Weeks|Adverse Event|0|||
16409580|NCT01740089|39981726|FG002|After 12 Weeks|Adverse Event|5|||
16409581|NCT01740089|39981724|FG000|After 12 Weeks|Protocol Violation|1|||
16409582|NCT01740089|39981725|FG001|After 12 Weeks|Protocol Violation|1|||
16409583|NCT01740089|39981726|FG002|After 12 Weeks|Protocol Violation|1|||
16409584|NCT01740089|39981724|FG000|After 12 Weeks|Withdrawal by Subject|1|||
16409585|NCT01740089|39981725|FG001|After 12 Weeks|Withdrawal by Subject|1|||
16409586|NCT01740089|39981726|FG002|After 12 Weeks|Withdrawal by Subject|1|||
16409587|NCT02279719|39981727|FG000|Overall Study|Patients randomized but never treated|0|||
16409588|NCT02279719|39981728|FG001|Overall Study|Patients randomized but never treated|0|||
16409589|NCT02279719|39981729|FG002|Overall Study|Patients randomized but never treated|0|||
16409590|NCT02279719|39981730|FG003|Overall Study|Patients randomized but never treated|0|||
16409591|NCT02279719|39981731|FG004|Overall Study|Patients randomized but never treated|3|||
16409592|NCT02279719|39981732|FG005|Overall Study|Patients randomized but never treated|0|||
16409593|NCT02279719|39981733|FG006|Overall Study|Patients randomized but never treated|3|||
16409594|NCT00652899|39981734|FG000|Overall Study|Death|1|||
16409595|NCT00652899|39981734|FG000|Overall Study|Treating physician decision|1|||
16409596|NCT01697462|39981735|FG000|Overall Study|Disease Progression|1|||
16409597|NCT01697462|39981735|FG000|Overall Study|Adverse Event|6|||
16409598|NCT01697462|39981735|FG000|Overall Study|Lost to Follow-up|21|||
16409599|NCT01697462|39981735|FG000|Overall Study|Withdrawal by Subject|12|||
16409600|NCT01697462|39981735|FG000|Overall Study|Investigator Decision|21|||
16409601|NCT01697462|39981735|FG000|Overall Study|Death|1|||
16409602|NCT01697462|39981735|FG000|Overall Study|Other|10|||
16409603|NCT01697462|39981735|FG000|Overall Study|Missing|5|||
16409604|NCT01920152|39981736|FG000|Overall Study|Withdrawal by Subject|1|||
16409605|NCT01920152|39981737|FG001|Overall Study|Withdrawal by Subject|2|||
16409606|NCT00711113|39981738|FG000|Overall Study|Lost to Follow-up|9|||
16409607|NCT00711113|39981738|FG000|Overall Study|Implant lost|2|||
16409608|NCT00624780|39981740|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
16409609|NCT00624780|39981741|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
16409610|NCT00624780|39981742|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
16409611|NCT00624780|39981743|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
16409612|NCT00624780|39981744|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
16409613|NCT00624780|39981745|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
16409614|NCT00624780|39981740|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
16409615|NCT00624780|39981741|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
16409616|NCT00624780|39981742|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
16409617|NCT00624780|39981743|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
16409618|NCT00624780|39981744|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
16409619|NCT00624780|39981745|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
16409620|NCT00624780|39981740|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
16409621|NCT00624780|39981741|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
16409622|NCT00624780|39981742|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
16111332|NCT01772823|38897228|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
16409623|NCT00624780|39981743|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
16409624|NCT00624780|39981744|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
16546023|NCT00365378|40460859|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
16111333|NCT01772823|38897229|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
16111334|NCT01772823|38897228|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
16111335|NCT01772823|38897229|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
16111336|NCT01772823|38897228|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
16111337|NCT01772823|38897229|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
16111338|NCT01772823|38897228|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
16223057|NCT01397409|39295297|FG003|Stage 3|Other Miscellaneous Reasons|0|||
16223058|NCT01397409|39295298|FG004|Stage 3|Other Miscellaneous Reasons|0|||
16223059|NCT01397409|39295299|FG005|Stage 3|Other Miscellaneous Reasons|0|||
16223060|NCT01397409|39295300|FG006|Stage 3|Other Miscellaneous Reasons|0|||
16223061|NCT01397409|39295301|FG007|Stage 3|Other Miscellaneous Reasons|1|||
16223062|NCT01397409|39295302|FG008|Stage 3|Other Miscellaneous Reasons|0|||
16223063|NCT01397409|39295303|FG009|Stage 3|Other Miscellaneous Reasons|0|||
16223064|NCT00082628|39295308|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
16223065|NCT00082628|39295309|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
16223066|NCT00082628|39295310|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
16223067|NCT00082628|39295311|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
16223068|NCT00082628|39295312|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
16223069|NCT00082628|39295308|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
16223070|NCT00082628|39295309|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
16223071|NCT00082628|39295310|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
16223072|NCT00082628|39295311|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
16223073|NCT00082628|39295312|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
16223074|NCT00082628|39295308|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
16223075|NCT00082628|39295309|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
16223076|NCT00082628|39295310|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
16223077|NCT00082628|39295311|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
16223078|NCT00082628|39295312|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
16409625|NCT00624780|39981745|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
16546024|NCT00365378|40460860|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
16546025|NCT00365378|40460858|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
16546026|NCT00365378|40460859|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
16546027|NCT00365378|40460860|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
16546028|NCT00365378|40460858|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
16546029|NCT00365378|40460859|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
16546030|NCT00365378|40460860|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
16546031|NCT00365378|40460858|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
16546032|NCT00365378|40460859|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
16546033|NCT00365378|40460860|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
16546034|NCT00365378|40460858|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
16546035|NCT00365378|40460859|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
16546036|NCT00365378|40460860|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
16546037|NCT00365378|40460858|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
16546038|NCT00365378|40460859|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
16546039|NCT00365378|40460860|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
16546040|NCT00365378|40460858|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
16546041|NCT00365378|40460859|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
16546042|NCT00365378|40460860|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
16111339|NCT01772823|38897229|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
16111340|NCT01772823|38897228|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
16111341|NCT01772823|38897229|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
16111342|NCT01772823|38897228|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
16111343|NCT01772823|38897229|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
16111344|NCT01772823|38897228|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
16111345|NCT01772823|38897229|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
16111346|NCT01772823|38897228|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
16111347|NCT01772823|38897229|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
16111348|NCT00573651|38897235|FG000|Overall Study|Lost to Follow-up|3|||
16111349|NCT00573651|38897235|FG000|Overall Study|Withdrawal by Subject|1|||
16111350|NCT00778921|38897236|FG000|Overall Study|Adverse Event|9|||
16111351|NCT00778921|38897237|FG001|Overall Study|Adverse Event|10|||
16346016|NCT05464420|39753222|FG003|Overall Study|Withdrawal by Subject|1|||
16346017|NCT05464420|39753219|FG000|Overall Study|Protocol Violation|0|||
16546043|NCT00365378|40460858|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
16346018|NCT05464420|39753220|FG001|Overall Study|Protocol Violation|0|||
16546044|NCT00365378|40460859|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
16546045|NCT00365378|40460860|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
16546046|NCT00365378|40460858|FG000|Extension|Adverse Event|0|||
16546047|NCT00365378|40460859|FG001|Extension|Adverse Event|0|||
16546048|NCT00365378|40460860|FG002|Extension|Adverse Event|1|||
16546049|NCT00365378|40460858|FG000|Extension|Moved|0|||
16546050|NCT00365378|40460859|FG001|Extension|Moved|0|||
16546051|NCT00365378|40460860|FG002|Extension|Moved|8|||
16546052|NCT00365378|40460858|FG000|Extension|Lost to Follow-up|0|||
16546053|NCT00365378|40460859|FG001|Extension|Lost to Follow-up|0|||
16546054|NCT00365378|40460860|FG002|Extension|Lost to Follow-up|57|||
16546055|NCT00365378|40460858|FG000|Extension|Protocol Violation|0|||
16546056|NCT00365378|40460859|FG001|Extension|Protocol Violation|0|||
16546057|NCT00365378|40460860|FG002|Extension|Protocol Violation|2|||
16546058|NCT00365378|40460858|FG000|Extension|Withdrawal by Subject|0|||
16546059|NCT00365378|40460859|FG001|Extension|Withdrawal by Subject|0|||
16546060|NCT00365378|40460860|FG002|Extension|Withdrawal by Subject|98|||
16546061|NCT00365378|40460858|FG000|Extension|Other|0|||
16546062|NCT00365378|40460859|FG001|Extension|Other|0|||
16546063|NCT00365378|40460860|FG002|Extension|Other|31|||
16546064|NCT03205371|40460863|FG000|Overall Study|Withdrawal by Subject|4|||
16546065|NCT03205371|40460864|FG001|Overall Study|Withdrawal by Subject|1|||
16546066|NCT03205371|40460865|FG002|Overall Study|Withdrawal by Subject|0|||
16546067|NCT03205371|40460866|FG003|Overall Study|Withdrawal by Subject|0|||
16546068|NCT03205371|40460867|FG004|Overall Study|Withdrawal by Subject|0|||
16546069|NCT03205371|40460868|FG005|Overall Study|Withdrawal by Subject|0|||
16546070|NCT03205371|40460869|FG006|Overall Study|Withdrawal by Subject|4|||
16546071|NCT03205371|40460870|FG007|Overall Study|Withdrawal by Subject|0|||
16546072|NCT03205371|40460871|FG008|Overall Study|Withdrawal by Subject|2|||
16546073|NCT03205371|40460872|FG009|Overall Study|Withdrawal by Subject|0|||
16546074|NCT03205371|40460873|FG010|Overall Study|Withdrawal by Subject|0|||
16546075|NCT03205371|40460874|FG011|Overall Study|Withdrawal by Subject|1|||
16546076|NCT03205371|40460863|FG000|Overall Study|Lost to Follow-up|0|||
16546077|NCT03205371|40460864|FG001|Overall Study|Lost to Follow-up|0|||
16546078|NCT03205371|40460865|FG002|Overall Study|Lost to Follow-up|0|||
16546079|NCT03205371|40460866|FG003|Overall Study|Lost to Follow-up|0|||
16546080|NCT03205371|40460867|FG004|Overall Study|Lost to Follow-up|0|||
16546081|NCT03205371|40460868|FG005|Overall Study|Lost to Follow-up|0|||
16546082|NCT03205371|40460869|FG006|Overall Study|Lost to Follow-up|5|||
16546083|NCT03205371|40460870|FG007|Overall Study|Lost to Follow-up|2|||
16546084|NCT03205371|40460871|FG008|Overall Study|Lost to Follow-up|3|||
16546085|NCT03205371|40460872|FG009|Overall Study|Lost to Follow-up|0|||
16546086|NCT03205371|40460873|FG010|Overall Study|Lost to Follow-up|0|||
16546087|NCT03205371|40460874|FG011|Overall Study|Lost to Follow-up|0|||
16546088|NCT03205371|40460863|FG000|Overall Study|Protocol Violation|0|||
16546089|NCT03205371|40460864|FG001|Overall Study|Protocol Violation|0|||
16546090|NCT03205371|40460865|FG002|Overall Study|Protocol Violation|0|||
16546091|NCT03205371|40460866|FG003|Overall Study|Protocol Violation|0|||
16546092|NCT03205371|40460867|FG004|Overall Study|Protocol Violation|0|||
16546093|NCT03205371|40460868|FG005|Overall Study|Protocol Violation|0|||
16546094|NCT03205371|40460869|FG006|Overall Study|Protocol Violation|1|||
16546095|NCT03205371|40460870|FG007|Overall Study|Protocol Violation|0|||
16546096|NCT03205371|40460871|FG008|Overall Study|Protocol Violation|0|||
16546097|NCT03205371|40460872|FG009|Overall Study|Protocol Violation|0|||
16546098|NCT03205371|40460873|FG010|Overall Study|Protocol Violation|0|||
16546099|NCT03205371|40460874|FG011|Overall Study|Protocol Violation|0|||
16546100|NCT03205371|40460863|FG000|Overall Study|Adverse Event|0|||
16111352|NCT00778921|38897238|FG002|Overall Study|Adverse Event|14|||
16111353|NCT00778921|38897236|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
16111354|NCT00778921|38897237|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
16111355|NCT00778921|38897238|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
16111356|NCT00778921|38897236|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
16111357|NCT00778921|38897237|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
16111358|NCT00778921|38897238|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
16111359|NCT00778921|38897236|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
16111360|NCT00778921|38897237|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
16111361|NCT00778921|38897238|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
16111362|NCT00778921|38897236|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
16111363|NCT00778921|38897237|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
16111364|NCT00778921|38897238|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
16111365|NCT00778921|38897236|FG000|Overall Study|Patient withdrew request|3|||
16111366|NCT00778921|38897237|FG001|Overall Study|Patient withdrew request|1|||
16111367|NCT00778921|38897238|FG002|Overall Study|Patient withdrew request|6|||
16111368|NCT00778921|38897236|FG000|Overall Study|Lost to Follow-up|0|||
16111369|NCT00778921|38897237|FG001|Overall Study|Lost to Follow-up|2|||
16111370|NCT00778921|38897238|FG002|Overall Study|Lost to Follow-up|1|||
16111371|NCT00778921|38897236|FG000|Overall Study|Administrative Problems|1|||
16111372|NCT00778921|38897237|FG001|Overall Study|Administrative Problems|2|||
16111373|NCT00778921|38897238|FG002|Overall Study|Administrative Problems|0|||
16111374|NCT00778921|38897236|FG000|Overall Study|Protocol Violation|3|||
16111375|NCT00778921|38897237|FG001|Overall Study|Protocol Violation|0|||
16111376|NCT00778921|38897238|FG002|Overall Study|Protocol Violation|2|||
16111377|NCT00778921|38897236|FG000|Overall Study|Not treated|0|||
16111378|NCT00778921|38897237|FG001|Overall Study|Not treated|2|||
16111379|NCT00778921|38897238|FG002|Overall Study|Not treated|2|||
16111380|NCT01036165|38897241|FG000|Overall Study|Adverse Event|6|||
16111381|NCT01036165|38897241|FG000|Overall Study|Lost to Follow-up|2|||
16111382|NCT01036165|38897241|FG000|Overall Study|Withdrawal by Subject|3|||
16111383|NCT01036165|38897241|FG000|Overall Study|Device Related Issues|3|||
16111384|NCT01036165|38897241|FG000|Overall Study|Problems finding proper area to inject|1|||
16111385|NCT01434680|38897245|FG000|Overall Study|Withdrawal by Subject|1|||
16111386|NCT01434680|38897246|FG001|Overall Study|Withdrawal by Subject|0|||
16111387|NCT01434680|38897247|FG002|Overall Study|Withdrawal by Subject|2|||
16111388|NCT01434680|38897248|FG003|Overall Study|Withdrawal by Subject|0|||
16223079|NCT00082628|39295308|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
16223080|NCT00082628|39295309|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
16223081|NCT00082628|39295310|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
16223082|NCT00082628|39295311|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
16223083|NCT00082628|39295312|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
16223084|NCT00082628|39295308|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
16223085|NCT00082628|39295309|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
16223086|NCT00082628|39295310|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
16223087|NCT00082628|39295311|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
16223088|NCT00082628|39295312|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
16223089|NCT00082628|39295308|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
16223090|NCT00082628|39295309|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
16223091|NCT00082628|39295310|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
16223092|NCT00082628|39295311|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
16223093|NCT00082628|39295312|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
16223094|NCT00082628|39295308|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
16223095|NCT00082628|39295309|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
16223096|NCT00082628|39295310|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
16223097|NCT00082628|39295311|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
16223098|NCT00082628|39295312|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
16223099|NCT00121485|39298555|FG000|Overall Study|Not implanted|1|||
16223100|NCT00121485|39298556|FG001|Overall Study|Not implanted|5|||
16223101|NCT00121485|39298555|FG000|Overall Study|Crossover|0|||
16223102|NCT00121485|39298556|FG001|Overall Study|Crossover|2|||
16223103|NCT00504595|39298557|FG000|Overall Study|Lack of Efficacy|1|||
16111389|NCT01434680|38897245|FG000|Overall Study|Lost to Follow-up|1|||
16223104|NCT00504595|39298558|FG001|Overall Study|Lack of Efficacy|0|||
16111390|NCT01434680|38897246|FG001|Overall Study|Lost to Follow-up|1|||
16111391|NCT01434680|38897247|FG002|Overall Study|Lost to Follow-up|0|||
16111392|NCT01434680|38897248|FG003|Overall Study|Lost to Follow-up|0|||
16111393|NCT01434680|38897245|FG000|Overall Study|Protocol Violation|1|||
16111394|NCT01434680|38897246|FG001|Overall Study|Protocol Violation|1|||
16111395|NCT01434680|38897247|FG002|Overall Study|Protocol Violation|0|||
16111396|NCT01434680|38897248|FG003|Overall Study|Protocol Violation|0|||
16111397|NCT01130168|38897251|FG000|Period 1|Withdrawal by Subject|0|||
16111398|NCT01130168|38897252|FG001|Period 1|Withdrawal by Subject|1|||
16111399|NCT01130168|38897253|FG002|Period 1|Withdrawal by Subject|0|||
16111400|NCT01130168|38897254|FG003|Period 1|Withdrawal by Subject|1|||
16111401|NCT01130168|38897255|FG004|Period 1|Withdrawal by Subject|0|||
16111402|NCT01130168|38897256|FG005|Period 1|Withdrawal by Subject|0|||
16111403|NCT01130168|38897251|FG000|Period 1|Discontinued For Other Reason|0|||
16111404|NCT01130168|38897252|FG001|Period 1|Discontinued For Other Reason|0|||
16111405|NCT01130168|38897253|FG002|Period 1|Discontinued For Other Reason|1|||
16111406|NCT01130168|38897254|FG003|Period 1|Discontinued For Other Reason|1|||
16111407|NCT01130168|38897255|FG004|Period 1|Discontinued For Other Reason|0|||
16546101|NCT03205371|40460864|FG001|Overall Study|Adverse Event|0|||
16546102|NCT03205371|40460865|FG002|Overall Study|Adverse Event|0|||
16546103|NCT03205371|40460866|FG003|Overall Study|Adverse Event|0|||
16546104|NCT03205371|40460867|FG004|Overall Study|Adverse Event|0|||
16546105|NCT03205371|40460868|FG005|Overall Study|Adverse Event|0|||
16546106|NCT03205371|40460869|FG006|Overall Study|Adverse Event|0|||
16546107|NCT03205371|40460870|FG007|Overall Study|Adverse Event|1|||
16546108|NCT03205371|40460871|FG008|Overall Study|Adverse Event|0|||
16546109|NCT03205371|40460872|FG009|Overall Study|Adverse Event|0|||
16546110|NCT03205371|40460873|FG010|Overall Study|Adverse Event|0|||
16546111|NCT03205371|40460874|FG011|Overall Study|Adverse Event|0|||
16546112|NCT02946918|40460879|FG000|Overall Study|Patient unblinded himself|1|||
16546113|NCT02946918|40460880|FG001|Overall Study|Patient unblinded himself|0|||
16546114|NCT02946918|40460879|FG000|Overall Study|Physician Decision|0|||
16546115|NCT02946918|40460880|FG001|Overall Study|Physician Decision|2|||
16546116|NCT02946918|40460879|FG000|Overall Study|Ran out of study medication|0|||
16546117|NCT02946918|40460880|FG001|Overall Study|Ran out of study medication|1|||
16546118|NCT01933880|40460881|FG000|Overall Study|Withdrawal by Subject|5|||
16546119|NCT01933880|40460882|FG001|Overall Study|Withdrawal by Subject|0|||
16546120|NCT01933880|40460881|FG000|Overall Study|Lack of Efficacy|1|||
16546121|NCT01933880|40460882|FG001|Overall Study|Lack of Efficacy|0|||
16546122|NCT01933880|40460881|FG000|Overall Study|Concomitant medication Interference|0|||
16546123|NCT01933880|40460882|FG001|Overall Study|Concomitant medication Interference|1|||
16546124|NCT01933880|40460881|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
16546125|NCT01933880|40460882|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
16546126|NCT01933880|40460881|FG000|Overall Study|Other|4|||
16546127|NCT01933880|40460882|FG001|Overall Study|Other|0|||
16546128|NCT01933880|40460881|FG000|Overall Study|Protocol Violation|1|||
16546129|NCT01933880|40460882|FG001|Overall Study|Protocol Violation|0|||
16546130|NCT01191840|40460885|FG000|Overall Study|withdrew consent|2|||
16546131|NCT01191840|40460886|FG001|Overall Study|withdrew consent|1|||
16546132|NCT01191840|40460885|FG000|Overall Study|Subject discontinued treatment|1|||
16546133|NCT01191840|40460886|FG001|Overall Study|Subject discontinued treatment|2|||
16546134|NCT01191840|40460885|FG000|Overall Study|Lost to Follow-up|4|||
16546135|NCT01191840|40460886|FG001|Overall Study|Lost to Follow-up|6|||
16546136|NCT01191840|40460885|FG000|Overall Study|Non Staph Infection|4|||
16546137|NCT01191840|40460886|FG001|Overall Study|Non Staph Infection|3|||
16546138|NCT01191840|40460885|FG000|Overall Study|ineligible at enrollment|1|||
16546139|NCT01191840|40460886|FG001|Overall Study|ineligible at enrollment|0|||
16546140|NCT01191840|40460885|FG000|Overall Study|IRB approval lapse|0|||
16546141|NCT01191840|40460886|FG001|Overall Study|IRB approval lapse|2|||
16546142|NCT01191840|40460885|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
16546143|NCT01191840|40460886|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
16546144|NCT01191840|40460885|FG000|Overall Study|Withdrawal by Subject|2|||
16546145|NCT01191840|40460886|FG001|Overall Study|Withdrawal by Subject|0|||
16546146|NCT00638235|40460887|FG000|Overall Study|Lost to Follow-up|31|||
16546147|NCT00638235|40460888|FG001|Overall Study|Lost to Follow-up|3|||
16546148|NCT00638235|40460889|FG002|Overall Study|Lost to Follow-up|18|||
16546149|NCT00638235|40460890|FG003|Overall Study|Lost to Follow-up|10|||
16346019|NCT05464420|39753221|FG002|Overall Study|Protocol Violation|1|||
16346020|NCT05464420|39753222|FG003|Overall Study|Protocol Violation|1|||
16546150|NCT00638235|40460891|FG004|Overall Study|Lost to Follow-up|13|||
16546151|NCT00638235|40460892|FG005|Overall Study|Lost to Follow-up|26|||
16546152|NCT00638235|40460893|FG006|Overall Study|Lost to Follow-up|0|||
16546153|NCT00638235|40460894|FG007|Overall Study|Lost to Follow-up|1|||
16111408|NCT01130168|38897256|FG005|Period 1|Discontinued For Other Reason|0|||
16111409|NCT01130168|38897251|FG000|Period 1|Adverse Event|0|||
16111410|NCT01130168|38897252|FG001|Period 1|Adverse Event|0|||
16346021|NCT05464420|39753219|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
16346022|NCT05464420|39753220|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
16346023|NCT05464420|39753221|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
16346024|NCT05464420|39753222|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
16546154|NCT00638235|40460895|FG008|Overall Study|Lost to Follow-up|18|||
16546155|NCT02696902|40460896|FG000|Overall Study|Lost to Follow-up|0|||
16546156|NCT02696902|40460897|FG001|Overall Study|Lost to Follow-up|1|||
16546157|NCT02696902|40460898|FG002|Overall Study|Lost to Follow-up|1|||
16546158|NCT02696902|40460896|FG000|Overall Study|Withdrawal by Subject|0|||
16409626|NCT00624780|39981740|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
16409627|NCT00624780|39981741|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
16409628|NCT00624780|39981742|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
16409629|NCT00624780|39981743|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
16409630|NCT00624780|39981744|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
16409631|NCT00624780|39981745|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
16111411|NCT01130168|38897253|FG002|Period 1|Adverse Event|0|||
16223105|NCT00504595|39298559|FG002|Overall Study|Lack of Efficacy|0|||
16223106|NCT00504595|39298560|FG003|Overall Study|Lack of Efficacy|0|||
16223107|NCT00504595|39298557|FG000|Overall Study|Other|0|||
16346025|NCT03315455|39753223|FG000|Overall Study|Ongoing in the Study|13|||
16346026|NCT03315455|39753224|FG001|Overall Study|Ongoing in the Study|24|||
16346027|NCT03315455|39753225|FG002|Overall Study|Ongoing in the Study|17|||
16346028|NCT03315455|39753226|FG003|Overall Study|Ongoing in the Study|15|||
16346029|NCT03315455|39753223|FG000|Overall Study|Withdrawal by Subject|0|||
16346030|NCT03315455|39753224|FG001|Overall Study|Withdrawal by Subject|1|||
16346031|NCT03315455|39753225|FG002|Overall Study|Withdrawal by Subject|0|||
16346032|NCT03315455|39753226|FG003|Overall Study|Withdrawal by Subject|0|||
16346033|NCT03975647|39753227|FG000|Overall Study|Death|71|||
16346034|NCT03975647|39753228|FG001|Overall Study|Death|63|||
16346035|NCT03975647|39753227|FG000|Overall Study|Lost to Follow-up|2|||
16346036|NCT03975647|39753228|FG001|Overall Study|Lost to Follow-up|2|||
16409632|NCT00624780|39981740|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
16409633|NCT00624780|39981741|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
16409634|NCT00624780|39981742|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
16409635|NCT00624780|39981743|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
16409636|NCT00624780|39981744|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
16409637|NCT00624780|39981745|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
16409638|NCT00624780|39981740|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
16409639|NCT00624780|39981741|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
16409640|NCT00624780|39981742|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
16409641|NCT00624780|39981743|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
16409642|NCT00624780|39981744|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
16409643|NCT00624780|39981745|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
16409644|NCT00624780|39981740|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
16409645|NCT00624780|39981741|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
16409646|NCT00624780|39981742|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
16546159|NCT02696902|40460897|FG001|Overall Study|Withdrawal by Subject|0|||
16546160|NCT02696902|40460898|FG002|Overall Study|Withdrawal by Subject|1|||
16546161|NCT02696902|40460896|FG000|Overall Study|Death|19|||
16546162|NCT02696902|40460897|FG001|Overall Study|Death|3|||
16546163|NCT02696902|40460898|FG002|Overall Study|Death|24|||
16546164|NCT02696902|40460896|FG000|Overall Study|Participant not fit post-randomization|0|||
16546165|NCT02696902|40460897|FG001|Overall Study|Participant not fit post-randomization|0|||
16546166|NCT02696902|40460898|FG002|Overall Study|Participant not fit post-randomization|1|||
16546167|NCT02696902|40460896|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
16546168|NCT02696902|40460897|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
16546169|NCT02696902|40460898|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
16546170|NCT02696902|40460896|FG000|Overall Study|Principal investigator's decision|1|||
16546171|NCT02696902|40460897|FG001|Overall Study|Principal investigator's decision|0|||
16546172|NCT02696902|40460898|FG002|Overall Study|Principal investigator's decision|0|||
16546173|NCT02696902|40460896|FG000|Overall Study|Sponsor's decision|1|||
16546174|NCT02696902|40460897|FG001|Overall Study|Sponsor's decision|0|||
16546175|NCT02696902|40460898|FG002|Overall Study|Sponsor's decision|0|||
16546176|NCT02696902|40460896|FG000|Overall Study|Transferred to other hospital|1|||
16546177|NCT02696902|40460897|FG001|Overall Study|Transferred to other hospital|0|||
16546178|NCT02696902|40460898|FG002|Overall Study|Transferred to other hospital|0|||
16546179|NCT02180438|40460899|FG000|Overall Study|Lost to Follow-up|1|||
16546180|NCT01555164|40460900|FG000|Overall Study|Adverse Event|5|||
16546181|NCT01555164|40460901|FG001|Overall Study|Adverse Event|7|||
16546182|NCT01555164|40460900|FG000|Overall Study|Hyperglycemia|0|||
16546183|NCT01555164|40460901|FG001|Overall Study|Hyperglycemia|1|||
16546184|NCT01555164|40460900|FG000|Overall Study|Investigator's Discretion|2|||
16546185|NCT01555164|40460901|FG001|Overall Study|Investigator's Discretion|2|||
16546186|NCT01555164|40460900|FG000|Overall Study|Lost to Follow-up|4|||
16546187|NCT01555164|40460901|FG001|Overall Study|Lost to Follow-up|3|||
16546188|NCT01555164|40460900|FG000|Overall Study|Protocol Violation|9|||
16546189|NCT01555164|40460901|FG001|Overall Study|Protocol Violation|5|||
16546190|NCT01555164|40460900|FG000|Overall Study|Subject Non-compliance|14|||
16546191|NCT01555164|40460901|FG001|Overall Study|Subject Non-compliance|6|||
16111412|NCT01130168|38897254|FG003|Period 1|Adverse Event|1|||
16346037|NCT03975647|39753227|FG000|Overall Study|Subject withdrawal of consent|7|||
16346038|NCT03975647|39753228|FG001|Overall Study|Subject withdrawal of consent|11|||
16346039|NCT04978337|39753229|FG000|Overall Study|Withdrawal by Subject|0|||
16346040|NCT04978337|39753230|FG001|Overall Study|Withdrawal by Subject|1|||
16346044|NCT05259163|39753234|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
16409647|NCT00624780|39981743|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
16409648|NCT00624780|39981744|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
16409649|NCT00624780|39981745|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
16409650|NCT00624780|39981740|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
16409651|NCT00624780|39981741|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
16409652|NCT00624780|39981742|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
16409653|NCT00624780|39981743|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
16409654|NCT00624780|39981744|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
16346045|NCT05259163|39753235|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
16346046|NCT04877990|39753236|FG000|Treatment|Other reasons|3|||
16346047|NCT04877990|39753237|FG001|Treatment|Other reasons|1|||
16346048|NCT04877990|39753236|FG000|Treatment|Administrative reasons by sponsor|17|||
16346049|NCT04877990|39753237|FG001|Treatment|Administrative reasons by sponsor|33|||
16346050|NCT04877990|39753236|FG000|Treatment|Withdrawal by Subject|2|||
16346051|NCT04877990|39753237|FG001|Treatment|Withdrawal by Subject|6|||
16346052|NCT04877990|39753236|FG000|Treatment|Adverse Event|2|||
16346053|NCT04877990|39753237|FG001|Treatment|Adverse Event|1|||
16346054|NCT02903420|39753238|FG000|Overall Study|Death|3|||
16346055|NCT04529538|39753239|FG000|Overall Study|Lost to Follow-up|3|||
16346056|NCT04529538|39753240|FG001|Overall Study|Lost to Follow-up|2|||
16346057|NCT04529538|39753241|FG002|Overall Study|Lost to Follow-up|1|||
16346058|NCT04529538|39753242|FG003|Overall Study|Lost to Follow-up|0|||
16346059|NCT04529538|39753243|FG004|Overall Study|Lost to Follow-up|1|||
16346060|NCT04529538|39753244|FG005|Overall Study|Lost to Follow-up|1|||
16346061|NCT04529538|39753245|FG006|Overall Study|Lost to Follow-up|2|||
16346062|NCT04529538|39753246|FG007|Overall Study|Lost to Follow-up|0|||
16346063|NCT04529538|39753239|FG000|Overall Study|Not eligible at enrollment|0|||
16346064|NCT04529538|39753240|FG001|Overall Study|Not eligible at enrollment|1|||
16111413|NCT01130168|38897255|FG004|Period 1|Adverse Event|0|||
16346065|NCT04529538|39753241|FG002|Overall Study|Not eligible at enrollment|2|||
16346066|NCT04529538|39753242|FG003|Overall Study|Not eligible at enrollment|1|||
16346067|NCT04529538|39753243|FG004|Overall Study|Not eligible at enrollment|0|||
16409655|NCT00624780|39981745|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
16409656|NCT00624780|39981740|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
16409657|NCT00624780|39981741|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
16409658|NCT00624780|39981742|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
16409659|NCT00624780|39981743|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
16409660|NCT00624780|39981744|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
16409661|NCT00624780|39981745|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
16409662|NCT00624780|39981740|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
16409663|NCT00624780|39981741|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
16409664|NCT00624780|39981742|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
16409665|NCT00624780|39981743|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
16409666|NCT00624780|39981744|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
16409667|NCT00624780|39981745|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
16409668|NCT00624780|39981740|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
16409669|NCT00624780|39981741|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
16409670|NCT00624780|39981742|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
16409671|NCT00624780|39981743|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
16409672|NCT00624780|39981744|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
16409673|NCT00624780|39981745|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
16409674|NCT00624780|39981740|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
16409675|NCT00624780|39981741|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
16409676|NCT00624780|39981742|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
16409677|NCT00624780|39981743|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
16409678|NCT00624780|39981744|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
16409679|NCT00624780|39981745|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
16409680|NCT00624780|39981740|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
16409681|NCT00624780|39981741|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
16409682|NCT00624780|39981742|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
16409683|NCT00624780|39981743|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
16409684|NCT00624780|39981744|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
16409685|NCT00624780|39981745|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
16409686|NCT00624780|39981740|FG000|Follow-up (Week 26)|Death|0|||
16409687|NCT00624780|39981741|FG001|Follow-up (Week 26)|Death|0|||
16409688|NCT00624780|39981742|FG002|Follow-up (Week 26)|Death|1|||
16409689|NCT00624780|39981743|FG003|Follow-up (Week 26)|Death|0|||
16409690|NCT00624780|39981744|FG004|Follow-up (Week 26)|Death|0|||
16409691|NCT00624780|39981745|FG005|Follow-up (Week 26)|Death|0|||
16409692|NCT00624780|39981740|FG000|Follow-up (Week 26)|Adverse Event|0|||
16409693|NCT00624780|39981741|FG001|Follow-up (Week 26)|Adverse Event|0|||
16409694|NCT00624780|39981742|FG002|Follow-up (Week 26)|Adverse Event|0|||
16409695|NCT00624780|39981743|FG003|Follow-up (Week 26)|Adverse Event|0|||
16409696|NCT00624780|39981744|FG004|Follow-up (Week 26)|Adverse Event|1|||
16409697|NCT00624780|39981745|FG005|Follow-up (Week 26)|Adverse Event|0|||
16409698|NCT00624780|39981740|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
16409699|NCT00624780|39981741|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
16409700|NCT00624780|39981742|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
16409701|NCT00624780|39981743|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
16409702|NCT00624780|39981744|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
16409703|NCT00624780|39981745|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
16409704|NCT00624780|39981740|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
16409705|NCT00624780|39981741|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
16409706|NCT00624780|39981742|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
16409707|NCT00624780|39981743|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
16409708|NCT00624780|39981744|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
16409709|NCT00624780|39981745|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
16409710|NCT00624780|39981740|FG000|Follow-up (Week 26)|Other|1|||
16409711|NCT00624780|39981741|FG001|Follow-up (Week 26)|Other|1|||
16409712|NCT00624780|39981742|FG002|Follow-up (Week 26)|Other|0|||
16409713|NCT00624780|39981743|FG003|Follow-up (Week 26)|Other|0|||
16409714|NCT00624780|39981744|FG004|Follow-up (Week 26)|Other|0|||
16409715|NCT00624780|39981745|FG005|Follow-up (Week 26)|Other|0|||
16409716|NCT00824005|39981748|FG000|Overall Study|Death|0|||
16409717|NCT00824005|39981749|FG001|Overall Study|Death|1|||
16409718|NCT00824005|39981748|FG000|Overall Study|Lost to Follow-up|0|||
16409719|NCT00824005|39981749|FG001|Overall Study|Lost to Follow-up|1|||
16409720|NCT00900146|39981750|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
16409721|NCT00900146|39981751|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
16409722|NCT00900146|39981752|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
16409723|NCT00900146|39981753|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
16409724|NCT00900146|39981754|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
16409725|NCT00900146|39981750|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
16409726|NCT00900146|39981751|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
16409727|NCT00900146|39981752|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
16409728|NCT00900146|39981753|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
16409729|NCT00900146|39981754|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
16409730|NCT00900146|39981750|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
16409731|NCT00900146|39981751|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
16409732|NCT00900146|39981752|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
16409733|NCT00900146|39981753|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
16409734|NCT00900146|39981754|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
16409735|NCT00900146|39981750|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
16409736|NCT00900146|39981751|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
16409737|NCT00900146|39981752|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
16409738|NCT00900146|39981753|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
16409739|NCT00900146|39981754|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
16409740|NCT00900146|39981750|FG000|Intermediate: Period III|Lost to Follow-up|2|||
16409741|NCT00900146|39981751|FG001|Intermediate: Period III|Lost to Follow-up|0|||
16409742|NCT00900146|39981752|FG002|Intermediate: Period III|Lost to Follow-up|0|||
16409743|NCT00900146|39981753|FG003|Intermediate: Period III|Lost to Follow-up|0|||
16546192|NCT01555164|40460900|FG000|Overall Study|Subject Withdrew Consent|6|||
16546193|NCT01555164|40460901|FG001|Overall Study|Subject Withdrew Consent|11|||
16546194|NCT03122119|40460906|FG000|Overall Study|Did not meet eligibility critria|1|||
16546195|NCT04766086|40460907|FG000|Overall Study|Lost to Follow-up|3|||
16546196|NCT04766086|40460908|FG001|Overall Study|Lost to Follow-up|5|||
16546197|NCT04766086|40460909|FG002|Overall Study|Lost to Follow-up|3|||
16546198|NCT04766086|40460907|FG000|Overall Study|Withdrawal by Subject|1|||
16546199|NCT04766086|40460908|FG001|Overall Study|Withdrawal by Subject|1|||
16546200|NCT04766086|40460909|FG002|Overall Study|Withdrawal by Subject|2|||
16546201|NCT04766086|40460907|FG000|Overall Study|Other|0|||
16346068|NCT04529538|39753244|FG005|Overall Study|Not eligible at enrollment|0|||
16346069|NCT04529538|39753245|FG006|Overall Study|Not eligible at enrollment|0|||
16346070|NCT04529538|39753246|FG007|Overall Study|Not eligible at enrollment|1|||
16346071|NCT04529538|39753239|FG000|Overall Study|Withdrawal by Subject|0|||
16346072|NCT04529538|39753240|FG001|Overall Study|Withdrawal by Subject|1|||
16346073|NCT04529538|39753241|FG002|Overall Study|Withdrawal by Subject|1|||
16346074|NCT04529538|39753242|FG003|Overall Study|Withdrawal by Subject|2|||
16346075|NCT04529538|39753243|FG004|Overall Study|Withdrawal by Subject|0|||
16346076|NCT04529538|39753244|FG005|Overall Study|Withdrawal by Subject|2|||
16346077|NCT04529538|39753245|FG006|Overall Study|Withdrawal by Subject|3|||
16346078|NCT04529538|39753246|FG007|Overall Study|Withdrawal by Subject|0|||
16346079|NCT04529538|39753239|FG000|Overall Study|Other|0|||
16346080|NCT04529538|39753240|FG001|Overall Study|Other|1|||
16346081|NCT04529538|39753241|FG002|Overall Study|Other|0|||
16346082|NCT04529538|39753242|FG003|Overall Study|Other|0|||
16346083|NCT04529538|39753243|FG004|Overall Study|Other|0|||
16346084|NCT04529538|39753244|FG005|Overall Study|Other|0|||
16346085|NCT04529538|39753245|FG006|Overall Study|Other|0|||
16346086|NCT04529538|39753246|FG007|Overall Study|Other|0|||
16346087|NCT04529538|39753239|FG000|Overall Study|Adverse Event|0|||
16346088|NCT04529538|39753240|FG001|Overall Study|Adverse Event|0|||
16346089|NCT04529538|39753241|FG002|Overall Study|Adverse Event|0|||
16223108|NCT00504595|39298558|FG001|Overall Study|Other|0|||
16223109|NCT00504595|39298559|FG002|Overall Study|Other|2|||
16223110|NCT00504595|39298560|FG003|Overall Study|Other|0|||
16223111|NCT02972658|39298561|FG000|Overall Study|Adverse Event|0|||
16346090|NCT04529538|39753242|FG003|Overall Study|Adverse Event|1|||
16346091|NCT04529538|39753243|FG004|Overall Study|Adverse Event|0|||
16346092|NCT04529538|39753244|FG005|Overall Study|Adverse Event|0|||
16346093|NCT04529538|39753245|FG006|Overall Study|Adverse Event|0|||
16346094|NCT04529538|39753246|FG007|Overall Study|Adverse Event|0|||
16346095|NCT04529538|39753239|FG000|Overall Study|Protocol Deviation|0|||
16346096|NCT04529538|39753240|FG001|Overall Study|Protocol Deviation|0|||
16346097|NCT04529538|39753241|FG002|Overall Study|Protocol Deviation|0|||
16346098|NCT04529538|39753242|FG003|Overall Study|Protocol Deviation|1|||
16346099|NCT04529538|39753243|FG004|Overall Study|Protocol Deviation|0|||
16346100|NCT04529538|39753244|FG005|Overall Study|Protocol Deviation|0|||
16346101|NCT04529538|39753245|FG006|Overall Study|Protocol Deviation|0|||
16346102|NCT04529538|39753246|FG007|Overall Study|Protocol Deviation|0|||
16346103|NCT04529538|39753239|FG000|Overall Study|Physician Decision|0|||
16346104|NCT04529538|39753240|FG001|Overall Study|Physician Decision|0|||
16346105|NCT04529538|39753241|FG002|Overall Study|Physician Decision|0|||
16346106|NCT04529538|39753242|FG003|Overall Study|Physician Decision|0|||
16346107|NCT04529538|39753243|FG004|Overall Study|Physician Decision|0|||
16346108|NCT04529538|39753244|FG005|Overall Study|Physician Decision|1|||
16223112|NCT02972658|39298562|FG001|Overall Study|Adverse Event|3|||
16346109|NCT04529538|39753245|FG006|Overall Study|Physician Decision|0|||
16346110|NCT04529538|39753246|FG007|Overall Study|Physician Decision|1|||
16346111|NCT02365467|39753247|FG000|Overall Study|Death|3|||
16409744|NCT00900146|39981754|FG004|Intermediate: Period III|Lost to Follow-up|1|||
16409745|NCT00900146|39981750|FG000|Intermediate: Period III|Administrative problems|85|||
16409746|NCT00900146|39981751|FG001|Intermediate: Period III|Administrative problems|92|||
16409747|NCT00900146|39981752|FG002|Intermediate: Period III|Administrative problems|84|||
16409748|NCT00900146|39981753|FG003|Intermediate: Period III|Administrative problems|90|||
16409749|NCT00900146|39981754|FG004|Intermediate: Period III|Administrative problems|163|||
16409750|NCT01635764|39981755|FG000|Overall Study|Adverse Event|46|||
16409751|NCT01635764|39981755|FG000|Overall Study|Lack of Efficacy|76|||
16409752|NCT01635764|39981755|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
16409753|NCT01635764|39981755|FG000|Overall Study|Protocol Deviation|1|||
16409754|NCT01635764|39981755|FG000|Overall Study|Withdrew Consent|67|||
16409755|NCT01635764|39981755|FG000|Overall Study|Lost to Follow-up|53|||
16409756|NCT01635764|39981755|FG000|Overall Study|Other|28|||
16223113|NCT02972658|39298563|FG002|Overall Study|Adverse Event|0|||
16223114|NCT02972658|39298564|FG003|Overall Study|Adverse Event|2|||
16223115|NCT02972658|39298561|FG000|Overall Study|Other-determined by Investigator|1|||
16223116|NCT02972658|39298562|FG001|Overall Study|Other-determined by Investigator|1|||
16223117|NCT02972658|39298563|FG002|Overall Study|Other-determined by Investigator|0|||
16223118|NCT02972658|39298564|FG003|Overall Study|Other-determined by Investigator|0|||
16223119|NCT02972658|39298561|FG000|Overall Study|Death|0|||
16223120|NCT02972658|39298562|FG001|Overall Study|Death|0|||
16223121|NCT02972658|39298563|FG002|Overall Study|Death|0|||
16223122|NCT02972658|39298564|FG003|Overall Study|Death|1|||
16223123|NCT02972658|39298561|FG000|Overall Study|Lost to Follow-up|0|||
16223124|NCT02972658|39298562|FG001|Overall Study|Lost to Follow-up|1|||
16223125|NCT02972658|39298563|FG002|Overall Study|Lost to Follow-up|1|||
16223126|NCT02972658|39298564|FG003|Overall Study|Lost to Follow-up|2|||
16223127|NCT02972658|39298561|FG000|Overall Study|Progressive Disease|0|||
16223128|NCT02972658|39298562|FG001|Overall Study|Progressive Disease|1|||
16223129|NCT02972658|39298563|FG002|Overall Study|Progressive Disease|0|||
16223130|NCT02972658|39298564|FG003|Overall Study|Progressive Disease|1|||
16223131|NCT02972658|39298561|FG000|Overall Study|Withdrawal by Subject|4|||
16546202|NCT04766086|40460908|FG001|Overall Study|Other|0|||
16546203|NCT04766086|40460909|FG002|Overall Study|Other|1|||
16546204|NCT03386032|40460910|FG000|Overall Study|Lack of Efficacy|6|||
16546205|NCT03386032|40460911|FG001|Overall Study|Lack of Efficacy|2|||
16409757|NCT02456636|39981760|FG000|Overall Study|Death|0|||
16409758|NCT02456636|39981761|FG001|Overall Study|Death|3|||
16409759|NCT02456636|39981762|FG002|Overall Study|Death|0|||
16409760|NCT02456636|39981760|FG000|Overall Study|Pregnancy|1|||
16223132|NCT02972658|39298562|FG001|Overall Study|Withdrawal by Subject|4|||
16223133|NCT02972658|39298563|FG002|Overall Study|Withdrawal by Subject|1|||
16223134|NCT02972658|39298564|FG003|Overall Study|Withdrawal by Subject|6|||
16409761|NCT02456636|39981761|FG001|Overall Study|Pregnancy|3|||
16409762|NCT02456636|39981762|FG002|Overall Study|Pregnancy|5|||
16409763|NCT02456636|39981760|FG000|Overall Study|Physician Decision|4|||
16409764|NCT02456636|39981761|FG001|Overall Study|Physician Decision|5|||
16409765|NCT02456636|39981762|FG002|Overall Study|Physician Decision|4|||
16409766|NCT02456636|39981760|FG000|Overall Study|Withdrawal by Subject|13|||
16409767|NCT02456636|39981761|FG001|Overall Study|Withdrawal by Subject|14|||
16409768|NCT02456636|39981762|FG002|Overall Study|Withdrawal by Subject|16|||
16409769|NCT02456636|39981760|FG000|Overall Study|Lost to Follow-up|50|||
16546206|NCT03386032|40460912|FG002|Overall Study|Lack of Efficacy|0|||
16546207|NCT03386032|40460910|FG000|Overall Study|Adverse Event|2|||
16546208|NCT03386032|40460911|FG001|Overall Study|Adverse Event|2|||
16546209|NCT03386032|40460912|FG002|Overall Study|Adverse Event|0|||
16546210|NCT03386032|40460910|FG000|Overall Study|Withdrawal by Subject|1|||
16546211|NCT03386032|40460911|FG001|Overall Study|Withdrawal by Subject|0|||
16546212|NCT03386032|40460912|FG002|Overall Study|Withdrawal by Subject|0|||
16546213|NCT03386032|40460910|FG000|Overall Study|Lost to Follow-up|9|||
16546214|NCT03386032|40460911|FG001|Overall Study|Lost to Follow-up|3|||
16546215|NCT03386032|40460912|FG002|Overall Study|Lost to Follow-up|0|||
16546216|NCT05822921|40460913|FG000|Overall Study|Lost to Follow-up|1|||
16546217|NCT05822921|40460914|FG001|Overall Study|Lost to Follow-up|1|||
16546218|NCT01036022|40460915|FG000|Overall Study|Adverse Event|1|||
16546219|NCT01036022|40460916|FG001|Overall Study|Adverse Event|3|||
16223135|NCT02972658|39298561|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
16223136|NCT02972658|39298562|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
16223137|NCT02972658|39298563|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
16223138|NCT02972658|39298564|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
16409770|NCT02456636|39981761|FG001|Overall Study|Lost to Follow-up|44|||
16409771|NCT02456636|39981762|FG002|Overall Study|Lost to Follow-up|50|||
16409772|NCT03344640|39981763|FG000|Overall Study|Adverse Event|1|||
16409773|NCT03344640|39981764|FG001|Overall Study|Adverse Event|0|||
16409774|NCT03344640|39981763|FG000|Overall Study|Physician Decision|1|||
16409775|NCT03344640|39981764|FG001|Overall Study|Physician Decision|1|||
16223139|NCT02972658|39298561|FG000|Overall Study|Sponsor Decision|70|||
16223140|NCT02972658|39298562|FG001|Overall Study|Sponsor Decision|127|||
16223141|NCT02972658|39298563|FG002|Overall Study|Sponsor Decision|72|||
16223142|NCT02972658|39298564|FG003|Overall Study|Sponsor Decision|119|||
16223143|NCT01513460|39298565|FG000|Overall Study|Death|0|||
16223144|NCT01513460|39298566|FG001|Overall Study|Death|0|||
16223145|NCT01513460|39298567|FG002|Overall Study|Death|1|||
16223146|NCT01513460|39298565|FG000|Overall Study|Lost to Follow-up|0|||
16223147|NCT01513460|39298566|FG001|Overall Study|Lost to Follow-up|0|||
16223148|NCT01513460|39298567|FG002|Overall Study|Lost to Follow-up|2|||
16223149|NCT01513460|39298565|FG000|Overall Study|Abnormal laboratory value|1|||
16223150|NCT01513460|39298566|FG001|Overall Study|Abnormal laboratory value|0|||
16223151|NCT01513460|39298567|FG002|Overall Study|Abnormal laboratory value|1|||
16223152|NCT01513460|39298565|FG000|Overall Study|Lack of Efficacy|1|||
16223153|NCT01513460|39298566|FG001|Overall Study|Lack of Efficacy|2|||
16223154|NCT01513460|39298567|FG002|Overall Study|Lack of Efficacy|5|||
16223155|NCT01513460|39298565|FG000|Overall Study|Protocol deviations|3|||
16223156|NCT01513460|39298566|FG001|Overall Study|Protocol deviations|4|||
16223157|NCT01513460|39298567|FG002|Overall Study|Protocol deviations|3|||
16223158|NCT01513460|39298565|FG000|Overall Study|Withdrawal by Subject|7|||
16223159|NCT01513460|39298566|FG001|Overall Study|Withdrawal by Subject|8|||
16223160|NCT01513460|39298567|FG002|Overall Study|Withdrawal by Subject|21|||
16409776|NCT03344640|39981763|FG000|Overall Study|Withdrawal by Subject|1|||
16409777|NCT03344640|39981764|FG001|Overall Study|Withdrawal by Subject|2|||
16409778|NCT03344640|39981763|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
16409779|NCT03344640|39981764|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
16223161|NCT01513460|39298565|FG000|Overall Study|Adverse Event|16|||
16223162|NCT01513460|39298566|FG001|Overall Study|Adverse Event|18|||
16223163|NCT01513460|39298567|FG002|Overall Study|Adverse Event|23|||
16223164|NCT01513460|39298565|FG000|Overall Study|Abnormal test procedure|1|||
16223165|NCT01513460|39298566|FG001|Overall Study|Abnormal test procedure|0|||
16223166|NCT01513460|39298567|FG002|Overall Study|Abnormal test procedure|0|||
16223167|NCT00174460|39298568|FG000|Overall Study|Withdrawal by Subject|0|||
16223168|NCT00174460|39298569|FG001|Overall Study|Withdrawal by Subject|1|||
16409780|NCT00554099|39981765|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
16409781|NCT00554099|39981766|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
16409782|NCT00554099|39981767|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
16409783|NCT00554099|39981765|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
16409784|NCT00554099|39981766|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
16409785|NCT00554099|39981767|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
16546220|NCT01036022|40460917|FG002|Overall Study|Adverse Event|2|||
16546221|NCT01036022|40460918|FG003|Overall Study|Adverse Event|1|||
16546222|NCT01036022|40460919|FG004|Overall Study|Adverse Event|0|||
16546223|NCT01036022|40460920|FG005|Overall Study|Adverse Event|2|||
16546224|NCT01036022|40460915|FG000|Overall Study|Lack of Efficacy|1|||
16546225|NCT01036022|40460916|FG001|Overall Study|Lack of Efficacy|1|||
16546226|NCT01036022|40460917|FG002|Overall Study|Lack of Efficacy|1|||
16546227|NCT01036022|40460918|FG003|Overall Study|Lack of Efficacy|0|||
16546228|NCT01036022|40460919|FG004|Overall Study|Lack of Efficacy|1|||
16546229|NCT01036022|40460920|FG005|Overall Study|Lack of Efficacy|1|||
16546230|NCT01036022|40460915|FG000|Overall Study|Physician Decision|0|||
16546231|NCT01036022|40460916|FG001|Overall Study|Physician Decision|0|||
16546232|NCT01036022|40460917|FG002|Overall Study|Physician Decision|1|||
16546233|NCT01036022|40460918|FG003|Overall Study|Physician Decision|0|||
16546234|NCT01036022|40460919|FG004|Overall Study|Physician Decision|0|||
16546235|NCT01036022|40460920|FG005|Overall Study|Physician Decision|0|||
16546236|NCT01036022|40460915|FG000|Overall Study|Withdrawal by Subject|0|||
16546237|NCT01036022|40460916|FG001|Overall Study|Withdrawal by Subject|0|||
16546238|NCT01036022|40460917|FG002|Overall Study|Withdrawal by Subject|0|||
16546239|NCT01036022|40460918|FG003|Overall Study|Withdrawal by Subject|1|||
16546240|NCT01036022|40460919|FG004|Overall Study|Withdrawal by Subject|2|||
16546241|NCT01036022|40460920|FG005|Overall Study|Withdrawal by Subject|0|||
16546242|NCT00591864|40460921|FG000|Overall Study|Incomplete Imaging|5|||
16546243|NCT01800201|40460925|FG000|Overall Study|Withdrawal by Subject|2|||
16546244|NCT01800201|40460926|FG001|Overall Study|Withdrawal by Subject|0|||
16546245|NCT01800201|40460925|FG000|Overall Study|patient privacy concerns|1|||
16546246|NCT01800201|40460926|FG001|Overall Study|patient privacy concerns|1|||
16546247|NCT01800201|40460925|FG000|Overall Study|did not want to use device|0|||
16223169|NCT00422942|39298571|FG000|Overall Study|Study terminated by Sponsor|3|||
16223170|NCT02708524|39298591|FG000|Overall Study|Adverse Event|0|||
16223171|NCT02708524|39298592|FG001|Overall Study|Adverse Event|1|||
16409786|NCT00554099|39981765|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
16409787|NCT00554099|39981766|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
16409788|NCT00554099|39981767|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
16409789|NCT00554099|39981765|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
16111414|NCT01130168|38897256|FG005|Period 1|Adverse Event|0|||
16223172|NCT02708524|39298593|FG002|Overall Study|Adverse Event|0|||
16223173|NCT02708524|39298594|FG003|Overall Study|Adverse Event|0|||
16223174|NCT02708524|39298591|FG000|Overall Study|Lens Discomfort|1|||
16223175|NCT02708524|39298592|FG001|Overall Study|Lens Discomfort|0|||
16409790|NCT00554099|39981766|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
16223176|NCT02708524|39298593|FG002|Overall Study|Lens Discomfort|1|||
16409791|NCT00554099|39981767|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
16546248|NCT01800201|40460926|FG001|Overall Study|did not want to use device|1|||
16546249|NCT01800201|40460925|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
16546250|NCT01800201|40460926|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
16546383|NCT01662063|40464797|FG001|Overall Study|Withdrawal by Subject|4|||
16546384|NCT01662063|40464798|FG002|Overall Study|Withdrawal by Subject|1|||
16546385|NCT01662063|40464796|FG000|Overall Study|Physician Decision|0|||
16546386|NCT01662063|40464797|FG001|Overall Study|Physician Decision|2|||
16546387|NCT01662063|40464798|FG002|Overall Study|Physician Decision|0|||
16546388|NCT01662063|40464796|FG000|Overall Study|Other|0|||
16546389|NCT01662063|40464797|FG001|Overall Study|Other|1|||
16546390|NCT01662063|40464798|FG002|Overall Study|Other|0|||
16546391|NCT00514943|40464799|FG000|Stage 1|Progressive disease|4|||
16546392|NCT00514943|40464800|FG001|Stage 1|Progressive disease|8|||
16546393|NCT00514943|40464799|FG000|Stage 1|Other Adverse Event|16|||
16546394|NCT00514943|40464800|FG001|Stage 1|Other Adverse Event|6|||
16546395|NCT00514943|40464799|FG000|Stage 1|Not treated|1|||
16546396|NCT00514943|40464800|FG001|Stage 1|Not treated|2|||
16546397|NCT00514943|40464799|FG000|Stage 1|Patient refused to continue study meds|8|||
16546398|NCT00514943|40464800|FG001|Stage 1|Patient refused to continue study meds|3|||
16546399|NCT00514943|40464799|FG000|Stage 1|Other than stated above|1|||
16546400|NCT00514943|40464800|FG001|Stage 1|Other than stated above|7|||
16546401|NCT00514943|40464799|FG000|Stage 2|Progressive disease|27|||
16546402|NCT00514943|40464800|FG001|Stage 2|Progressive disease|24|||
16546403|NCT00514943|40464799|FG000|Stage 2|Other Adverse Event|3|||
16546404|NCT00514943|40464800|FG001|Stage 2|Other Adverse Event|10|||
16546405|NCT00514943|40464799|FG000|Stage 2|Patient refused to continue study meds|2|||
16546406|NCT00514943|40464800|FG001|Stage 2|Patient refused to continue study meds|0|||
16546407|NCT00514943|40464799|FG000|Stage 2|Other than stated above|0|||
16546408|NCT00514943|40464800|FG001|Stage 2|Other than stated above|2|||
16546409|NCT04043962|40464801|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
16546410|NCT04043962|40464801|FG000|Post-Treatment|Withdrawal by Subject|5|||
16546411|NCT04043962|40464801|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
16546412|NCT05340751|40464802|FG000|Overall Study|Physician Decision|3|||
16546413|NCT02978443|40464803|FG000|Overall Study|Withdrawal by Subject|1|||
16546414|NCT02978443|40464803|FG000|Overall Study|Adverse Event|3|||
16546415|NCT02978443|40464803|FG000|Overall Study|Disease Progression on study|6|||
16546416|NCT02978443|40464803|FG000|Overall Study|Death|1|||
16546417|NCT02978443|40464803|FG000|Overall Study|Physician Decision|1|||
16546418|NCT02978443|40464803|FG000|Overall Study|Switch to alternative therapy|1|||
16546419|NCT02978443|40464803|FG000|Overall Study|Refused further treatment|1|||
16546420|NCT01686581|40464804|FG000|Overall Study|Side-effects or Health Problems|15|||
16546421|NCT01686581|40464804|FG000|Overall Study|Lack of Efficacy|90|||
16546422|NCT01686581|40464804|FG000|Overall Study|Participant Concerned about Risks|6|||
16546423|NCT01686581|40464804|FG000|Overall Study|Thinks Injections Too Painful|8|||
16546424|NCT01686581|40464804|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
16546425|NCT01686581|40464804|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
16546426|NCT01686581|40464804|FG000|Overall Study|Thinks it is Inconvenient|17|||
16546427|NCT01686581|40464804|FG000|Overall Study|Other Miscellaneous Reasons|36|||
16546428|NCT01686581|40464804|FG000|Overall Study|Reason Missing|1|||
16546429|NCT04704154|40464805|FG000|Overall Study|Adverse Event|2|||
16546430|NCT04704154|40464806|FG001|Overall Study|Adverse Event|1|||
16546431|NCT04704154|40464807|FG002|Overall Study|Adverse Event|3|||
16546432|NCT04704154|40464808|FG003|Overall Study|Adverse Event|2|||
16546433|NCT04704154|40464809|FG004|Overall Study|Adverse Event|3|||
16546434|NCT04704154|40464810|FG005|Overall Study|Adverse Event|0|||
16546435|NCT04704154|40464805|FG000|Overall Study|Death|3|||
16546436|NCT04704154|40464806|FG001|Overall Study|Death|0|||
16546437|NCT04704154|40464807|FG002|Overall Study|Death|0|||
16546438|NCT04704154|40464808|FG003|Overall Study|Death|0|||
16546439|NCT04704154|40464809|FG004|Overall Study|Death|3|||
16546440|NCT04704154|40464810|FG005|Overall Study|Death|0|||
16546441|NCT04704154|40464805|FG000|Overall Study|Physician Decision|1|||
16546442|NCT04704154|40464806|FG001|Overall Study|Physician Decision|0|||
16546443|NCT04704154|40464807|FG002|Overall Study|Physician Decision|0|||
16546444|NCT04704154|40464808|FG003|Overall Study|Physician Decision|0|||
16111415|NCT01536171|38897257|FG000|Overall Study|Withdrawal by Subject|1|||
16111416|NCT01466790|38897258|FG000|Overall Study|Adverse Event|1|||
16111417|NCT01466790|38897259|FG001|Overall Study|Adverse Event|0|||
16111418|NCT01466790|38897260|FG002|Overall Study|Adverse Event|0|||
16111419|NCT01466790|38897261|FG003|Overall Study|Adverse Event|0|||
16111420|NCT01466790|38897262|FG004|Overall Study|Adverse Event|2|||
16111421|NCT01466790|38897263|FG005|Overall Study|Adverse Event|0|||
16111422|NCT01466790|38897264|FG006|Overall Study|Adverse Event|0|||
16111423|NCT01466790|38897265|FG007|Overall Study|Adverse Event|0|||
16111424|NCT01466790|38897258|FG000|Overall Study|Lost to Follow-up|2|||
16111425|NCT01466790|38897259|FG001|Overall Study|Lost to Follow-up|0|||
16111426|NCT01466790|38897260|FG002|Overall Study|Lost to Follow-up|0|||
16409792|NCT00554099|39981765|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
16409793|NCT00554099|39981766|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
16409794|NCT00554099|39981767|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
16409795|NCT00554099|39981765|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
16409796|NCT00554099|39981766|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
16409797|NCT00554099|39981767|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
16409798|NCT00554099|39981765|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
16409799|NCT00554099|39981766|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
16409800|NCT00554099|39981767|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
16409801|NCT00554099|39981765|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
16409802|NCT00554099|39981766|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
16409803|NCT00554099|39981767|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
16409804|NCT00554099|39981765|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
16409805|NCT00554099|39981766|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
16409806|NCT00554099|39981767|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
16409807|NCT02266875|39981768|FG000|Overall Study|Withdrawal by Subject|9|||
16409808|NCT02266875|39981769|FG001|Overall Study|Withdrawal by Subject|0|||
16409809|NCT02266875|39981768|FG000|Overall Study|Lost to Follow-up|2|||
16409810|NCT02266875|39981769|FG001|Overall Study|Lost to Follow-up|0|||
16409811|NCT01100567|39981778|FG000|Overall Study|Withdrawal by Subject|5|||
16409812|NCT01100567|39981779|FG001|Overall Study|Withdrawal by Subject|8|||
16409813|NCT01100567|39981778|FG000|Overall Study|Early Hospital Discharge|6|||
16409814|NCT01100567|39981779|FG001|Overall Study|Early Hospital Discharge|4|||
16409815|NCT01100567|39981778|FG000|Overall Study|Lost to Follow-up|1|||
16409816|NCT01100567|39981779|FG001|Overall Study|Lost to Follow-up|2|||
16409817|NCT01100567|39981778|FG000|Overall Study|Physician Decision|0|||
16409818|NCT01100567|39981779|FG001|Overall Study|Physician Decision|1|||
16409819|NCT01100567|39981778|FG000|Overall Study|Deemed ineligible after consent|0|||
16409820|NCT01100567|39981779|FG001|Overall Study|Deemed ineligible after consent|1|||
16111427|NCT01466790|38897261|FG003|Overall Study|Lost to Follow-up|0|||
16111428|NCT01466790|38897262|FG004|Overall Study|Lost to Follow-up|0|||
16111429|NCT01466790|38897263|FG005|Overall Study|Lost to Follow-up|0|||
16111430|NCT01466790|38897264|FG006|Overall Study|Lost to Follow-up|0|||
16111431|NCT01466790|38897265|FG007|Overall Study|Lost to Follow-up|0|||
16409821|NCT00186537|39981780|FG000|Overall Study|Withdrawal by Subject|4|||
16409822|NCT00186537|39981781|FG001|Overall Study|Withdrawal by Subject|0|||
16409823|NCT00186537|39981782|FG002|Overall Study|Withdrawal by Subject|3|||
16409824|NCT00186537|39981780|FG000|Overall Study|ALT > 1.5 x ULN|3|||
16409825|NCT00186537|39981781|FG001|Overall Study|ALT > 1.5 x ULN|0|||
16409826|NCT00186537|39981782|FG002|Overall Study|ALT > 1.5 x ULN|0|||
16346132|NCT04633226|39753254|FG000|Overall Study|Withdrawal by parent/guardian|4|||
16346133|NCT04633226|39753254|FG000|Overall Study|Randomized by mistake without study treatment|1|||
16346134|NCT04058028|39753255|FG000|Overall Study|Withdrawal of Consent from Study|12|||
16346135|NCT04058028|39753256|FG001|Overall Study|Withdrawal of Consent from Study|8|||
16346136|NCT04058028|39753257|FG002|Overall Study|Withdrawal of Consent from Study|6|||
16346137|NCT04058028|39753258|FG003|Overall Study|Withdrawal of Consent from Study|7|||
16346138|NCT04058028|39753255|FG000|Overall Study|Decision by Sponsor|13|||
16346139|NCT04058028|39753256|FG001|Overall Study|Decision by Sponsor|4|||
16346140|NCT04058028|39753257|FG002|Overall Study|Decision by Sponsor|1|||
16346141|NCT04058028|39753258|FG003|Overall Study|Decision by Sponsor|35|||
16346142|NCT04058028|39753255|FG000|Overall Study|Lost to Follow-up|1|||
16346143|NCT04058028|39753256|FG001|Overall Study|Lost to Follow-up|1|||
16346144|NCT04058028|39753257|FG002|Overall Study|Lost to Follow-up|1|||
16346145|NCT04058028|39753258|FG003|Overall Study|Lost to Follow-up|0|||
16346146|NCT04058028|39753255|FG000|Overall Study|Death|0|||
16346147|NCT04058028|39753256|FG001|Overall Study|Death|1|||
16111432|NCT01466790|38897258|FG000|Overall Study|Withdrawal by Subject|1|||
16111433|NCT01466790|38897259|FG001|Overall Study|Withdrawal by Subject|1|||
16111434|NCT01466790|38897260|FG002|Overall Study|Withdrawal by Subject|0|||
16111435|NCT01466790|38897261|FG003|Overall Study|Withdrawal by Subject|0|||
16111436|NCT01466790|38897262|FG004|Overall Study|Withdrawal by Subject|1|||
16111437|NCT01466790|38897263|FG005|Overall Study|Withdrawal by Subject|0|||
16223177|NCT02708524|39298594|FG003|Overall Study|Lens Discomfort|0|||
16223178|NCT02708524|39298591|FG000|Overall Study|Lost to Follow-up|1|||
16223179|NCT02708524|39298592|FG001|Overall Study|Lost to Follow-up|1|||
16223180|NCT02708524|39298593|FG002|Overall Study|Lost to Follow-up|1|||
16223181|NCT02708524|39298594|FG003|Overall Study|Lost to Follow-up|0|||
16223182|NCT02708524|39298591|FG000|Overall Study|Protocol Violation|0|||
16223183|NCT02708524|39298592|FG001|Overall Study|Protocol Violation|1|||
16223184|NCT02708524|39298593|FG002|Overall Study|Protocol Violation|0|||
16223185|NCT02708524|39298594|FG003|Overall Study|Protocol Violation|0|||
16223186|NCT02708524|39298591|FG000|Overall Study|Withdrawal by Subject|1|||
16223187|NCT02708524|39298592|FG001|Overall Study|Withdrawal by Subject|1|||
16223188|NCT02708524|39298593|FG002|Overall Study|Withdrawal by Subject|0|||
16223189|NCT02708524|39298594|FG003|Overall Study|Withdrawal by Subject|0|||
16223190|NCT02708524|39298591|FG000|Overall Study|Dispensed incorrect study lens|0|||
16223191|NCT02708524|39298592|FG001|Overall Study|Dispensed incorrect study lens|1|||
16223192|NCT02708524|39298593|FG002|Overall Study|Dispensed incorrect study lens|1|||
16223193|NCT02708524|39298594|FG003|Overall Study|Dispensed incorrect study lens|0|||
16223194|NCT02708524|39298591|FG000|Overall Study|Did not wear lens at final visit|0|||
16223195|NCT02708524|39298592|FG001|Overall Study|Did not wear lens at final visit|1|||
16223196|NCT02708524|39298593|FG002|Overall Study|Did not wear lens at final visit|0|||
16223197|NCT02708524|39298594|FG003|Overall Study|Did not wear lens at final visit|0|||
16223198|NCT02708524|39298591|FG000|Overall Study|Subject lost study lens|1|||
16223199|NCT02708524|39298592|FG001|Overall Study|Subject lost study lens|0|||
16223200|NCT02708524|39298593|FG002|Overall Study|Subject lost study lens|0|||
16223201|NCT02708524|39298594|FG003|Overall Study|Subject lost study lens|0|||
16223202|NCT01654224|39298595|FG000|Overall Study|Lost to Follow-up|2|||
16223203|NCT01654224|39298596|FG001|Overall Study|Lost to Follow-up|2|||
16223204|NCT01654224|39298595|FG000|Overall Study|Did not receive allocation|1|||
16223205|NCT01654224|39298596|FG001|Overall Study|Did not receive allocation|8|||
16223206|NCT01654224|39298595|FG000|Overall Study|Insufficient blood sample|3|||
16223207|NCT01654224|39298596|FG001|Overall Study|Insufficient blood sample|2|||
16223208|NCT01398176|39298597|FG000|Overall Study|Lost to Follow-up|1|||
16223209|NCT01398176|39298598|FG001|Overall Study|Lost to Follow-up|3|||
16223210|NCT01398176|39298597|FG000|Overall Study|Physician Decision|2|||
16223211|NCT01398176|39298598|FG001|Overall Study|Physician Decision|3|||
16223212|NCT02132312|39298599|FG000|Overall Study|Adverse Event|2|||
16223213|NCT02132312|39298600|FG001|Overall Study|Adverse Event|0|||
16223214|NCT02132312|39298599|FG000|Overall Study|Physician Decision|1|||
16223215|NCT02132312|39298600|FG001|Overall Study|Physician Decision|1|||
16223216|NCT02132312|39298599|FG000|Overall Study|Protocol Violation|0|||
16223217|NCT02132312|39298600|FG001|Overall Study|Protocol Violation|1|||
16111438|NCT01466790|38897264|FG006|Overall Study|Withdrawal by Subject|1|||
16111439|NCT01466790|38897265|FG007|Overall Study|Withdrawal by Subject|1|||
16223218|NCT02132312|39298599|FG000|Overall Study|Withdrawal by Subject|1|||
16223219|NCT02132312|39298600|FG001|Overall Study|Withdrawal by Subject|0|||
16223220|NCT02132312|39298599|FG000|Overall Study|Lost to Follow-up|2|||
16223221|NCT02132312|39298600|FG001|Overall Study|Lost to Follow-up|1|||
16223222|NCT00984009|39298610|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
16223223|NCT02127931|39298611|FG000|Overall Study|Glitch in Game|1|||
16223224|NCT01944462|39298614|FG000|PPPP Educational Program|Lost to Follow-up|60|||
16223225|NCT01393444|39298618|FG000|Overall Study|Withdrawal by Subject|1|||
16223226|NCT01393444|39298618|FG000|Overall Study|Determined ineligible during screening.|2|||
16111440|NCT02650466|38897268|FG000|Overall Study|Physician Decision|1|||
16111441|NCT02650466|38897268|FG000|Overall Study|Withdrawal by Subject|5|||
16111442|NCT02650466|38897268|FG000|Overall Study|Lost to Follow-up|1|||
16111443|NCT02367352|38897269|FG000|Overall Study|Progressive disease|7|||
16111444|NCT02367352|38897270|FG001|Overall Study|Progressive disease|0|||
16111445|NCT02367352|38897271|FG002|Overall Study|Progressive disease|0|||
16223227|NCT01373294|39298619|FG000|Overall Study|Adverse Event|1|||
16223228|NCT01373294|39298620|FG001|Overall Study|Adverse Event|0|||
16346148|NCT04058028|39753257|FG002|Overall Study|Death|0|||
16346149|NCT04058028|39753258|FG003|Overall Study|Death|0|||
16111446|NCT02367352|38897269|FG000|Overall Study|Participant Received Alternative Therapy|1|||
16111447|NCT02367352|38897270|FG001|Overall Study|Participant Received Alternative Therapy|0|||
16223229|NCT02400281|39298622|FG000|Overall Study|Adverse Event|0|||
16223230|NCT02400281|39298623|FG001|Overall Study|Adverse Event|0|||
16223231|NCT02400281|39298624|FG002|Overall Study|Adverse Event|1|||
16223232|NCT02400281|39298625|FG003|Overall Study|Adverse Event|0|||
16223233|NCT02400281|39298626|FG004|Overall Study|Adverse Event|1|||
16223234|NCT02400281|39298627|FG005|Overall Study|Adverse Event|0|||
16223235|NCT02400281|39298622|FG000|Overall Study|Physician Decision|0|||
16223236|NCT02400281|39298623|FG001|Overall Study|Physician Decision|0|||
16223237|NCT02400281|39298624|FG002|Overall Study|Physician Decision|1|||
16223238|NCT02400281|39298625|FG003|Overall Study|Physician Decision|0|||
16223239|NCT02400281|39298626|FG004|Overall Study|Physician Decision|0|||
16223240|NCT02400281|39298627|FG005|Overall Study|Physician Decision|0|||
16223241|NCT01952041|39298628|FG000|Overall Study|Lost to Follow-up|9|||
16223242|NCT01952041|39298629|FG001|Overall Study|Lost to Follow-up|16|||
16223243|NCT01952041|39298628|FG000|Overall Study|Withdrawal by Subject|7|||
16223244|NCT01952041|39298629|FG001|Overall Study|Withdrawal by Subject|5|||
16223245|NCT01952041|39298628|FG000|Overall Study|Death|1|||
16223246|NCT01952041|39298629|FG001|Overall Study|Death|0|||
16223247|NCT02987205|39298630|FG000|Overall Study|Adverse Event|1|||
16223248|NCT02987205|39298630|FG000|Overall Study|Withdrawal by Subject|3|||
16223249|NCT01475214|39298631|FG000|Overall Study|Lost to Follow-up|1|||
16223250|NCT01475214|39298632|FG001|Overall Study|Lost to Follow-up|0|||
16223251|NCT01475214|39298633|FG002|Overall Study|Lost to Follow-up|1|||
16223252|NCT01475214|39298631|FG000|Overall Study|Physician Decision|2|||
16223253|NCT01475214|39298632|FG001|Overall Study|Physician Decision|0|||
16223254|NCT01475214|39298633|FG002|Overall Study|Physician Decision|0|||
16223255|NCT01475214|39298631|FG000|Overall Study|Withdrawal by Subject|2|||
16223256|NCT01475214|39298632|FG001|Overall Study|Withdrawal by Subject|4|||
16223257|NCT01475214|39298633|FG002|Overall Study|Withdrawal by Subject|1|||
16223258|NCT02908841|39298641|FG000|Overall Study|Physician Decision|4|||
16223259|NCT02908841|39298642|FG001|Overall Study|Physician Decision|0|||
16223260|NCT00568399|39298647|FG000|Overall Study|Death|2|||
16223261|NCT00568399|39298647|FG000|Overall Study|Adverse Event|5|||
16223262|NCT00568399|39298647|FG000|Overall Study|Withdrawal by Subject|8|||
16223263|NCT03287089|39298648|FG000|Overall Study|Lost to Follow-up|0|||
16223264|NCT03287089|39298649|FG001|Overall Study|Lost to Follow-up|2|||
16223265|NCT03287089|39298648|FG000|Overall Study|Physician Decision|0|||
16223266|NCT03287089|39298649|FG001|Overall Study|Physician Decision|2|||
16223267|NCT03287089|39298648|FG000|Overall Study|Withdrawal by Subject|0|||
16223268|NCT03287089|39298649|FG001|Overall Study|Withdrawal by Subject|2|||
16223269|NCT01371721|39298650|FG000|Overall Study|Adverse Event|5|||
16223270|NCT01371721|39298651|FG001|Overall Study|Adverse Event|4|||
16223271|NCT01371721|39298652|FG002|Overall Study|Adverse Event|5|||
16223272|NCT01371721|39298650|FG000|Overall Study|Protocol Violation|6|||
16223273|NCT01371721|39298651|FG001|Overall Study|Protocol Violation|4|||
16223274|NCT01371721|39298652|FG002|Overall Study|Protocol Violation|5|||
16223275|NCT01371721|39298650|FG000|Overall Study|Lost to Follow-up|8|||
16223276|NCT01371721|39298651|FG001|Overall Study|Lost to Follow-up|2|||
16223277|NCT01371721|39298652|FG002|Overall Study|Lost to Follow-up|6|||
16223278|NCT01371721|39298650|FG000|Overall Study|Withdrawal by Subject|5|||
16223279|NCT01371721|39298651|FG001|Overall Study|Withdrawal by Subject|7|||
16223280|NCT01371721|39298652|FG002|Overall Study|Withdrawal by Subject|11|||
16223281|NCT01371721|39298650|FG000|Overall Study|Other|2|||
16223282|NCT01371721|39298651|FG001|Overall Study|Other|3|||
16223283|NCT01371721|39298652|FG002|Overall Study|Other|0|||
16223284|NCT01371721|39298650|FG000|Overall Study|Lack of Efficacy|2|||
16223285|NCT01371721|39298651|FG001|Overall Study|Lack of Efficacy|4|||
16223286|NCT01371721|39298652|FG002|Overall Study|Lack of Efficacy|3|||
16223287|NCT01371721|39298650|FG000|Overall Study|Randomized but not treated|1|||
16223288|NCT01371721|39298651|FG001|Overall Study|Randomized but not treated|0|||
16223289|NCT01371721|39298652|FG002|Overall Study|Randomized but not treated|0|||
16223290|NCT00134563|39298653|FG000|Overall Study|Not treated due to protocol violation|0|||
16223291|NCT00134563|39298654|FG001|Overall Study|Not treated due to protocol violation|1|||
16409827|NCT01028716|39981783|FG000|Overall Study|Physician Decision|1|||
16409828|NCT00259298|39981784|FG000|Overall Study|Withdrawal by Subject|1|||
16223292|NCT00134563|39298655|FG002|Overall Study|Not treated due to protocol violation|1|||
16223293|NCT00134563|39298653|FG000|Overall Study|Adverse Event|29|||
16223294|NCT00134563|39298654|FG001|Overall Study|Adverse Event|37|||
16223295|NCT00134563|39298655|FG002|Overall Study|Adverse Event|38|||
16223296|NCT00134563|39298653|FG000|Overall Study|Lack of Efficacy|24|||
16223297|NCT00134563|39298654|FG001|Overall Study|Lack of Efficacy|14|||
16223298|NCT00134563|39298655|FG002|Overall Study|Lack of Efficacy|17|||
16223299|NCT00134563|39298653|FG000|Overall Study|Protocol Violation|3|||
16223300|NCT00134563|39298654|FG001|Overall Study|Protocol Violation|2|||
16223301|NCT00134563|39298655|FG002|Overall Study|Protocol Violation|5|||
16223302|NCT00134563|39298653|FG000|Overall Study|Lost to Follow-up|4|||
16223303|NCT00134563|39298654|FG001|Overall Study|Lost to Follow-up|0|||
16223304|NCT00134563|39298655|FG002|Overall Study|Lost to Follow-up|2|||
16223305|NCT00134563|39298653|FG000|Overall Study|progressive disease|11|||
16223306|NCT00134563|39298654|FG001|Overall Study|progressive disease|4|||
16409829|NCT00259298|39981784|FG000|Overall Study|Physician Decision|2|||
16223307|NCT00134563|39298655|FG002|Overall Study|progressive disease|2|||
16223308|NCT00134563|39298653|FG000|Overall Study|did not wish to continue|33|||
16223309|NCT00134563|39298654|FG001|Overall Study|did not wish to continue|32|||
16223310|NCT00134563|39298655|FG002|Overall Study|did not wish to continue|26|||
16223311|NCT00134563|39298653|FG000|Overall Study|Reason other than above|0|||
16223312|NCT00134563|39298654|FG001|Overall Study|Reason other than above|2|||
16223313|NCT00134563|39298655|FG002|Overall Study|Reason other than above|5|||
16223314|NCT00829010|39298656|FG000|Overall Study|Adverse Event|1|||
16223315|NCT00829010|39298657|FG001|Overall Study|Adverse Event|0|||
16409830|NCT01628367|39981785|FG000|Overall Study|Adverse Event|1|||
16409831|NCT01628367|39981786|FG001|Overall Study|Adverse Event|0|||
16111448|NCT02367352|38897271|FG002|Overall Study|Participant Received Alternative Therapy|0|||
16111449|NCT02367352|38897269|FG000|Overall Study|Adverse Event|1|||
16111450|NCT02367352|38897270|FG001|Overall Study|Adverse Event|0|||
16111451|NCT02367352|38897271|FG002|Overall Study|Adverse Event|0|||
16111452|NCT00827775|38897272|FG000|Overall Study|Withdrawal by Subject|0|||
16223316|NCT00829010|39298658|FG002|Overall Study|Adverse Event|0|||
16223317|NCT00829010|39298659|FG003|Overall Study|Adverse Event|0|||
16223318|NCT00829010|39298660|FG004|Overall Study|Adverse Event|0|||
16223319|NCT00829010|39298656|FG000|Overall Study|Withdrawal by Subject|0|||
16223320|NCT00829010|39298657|FG001|Overall Study|Withdrawal by Subject|1|||
16223321|NCT00829010|39298658|FG002|Overall Study|Withdrawal by Subject|1|||
16223322|NCT00829010|39298659|FG003|Overall Study|Withdrawal by Subject|0|||
16223323|NCT00829010|39298660|FG004|Overall Study|Withdrawal by Subject|2|||
16223324|NCT00829010|39298656|FG000|Overall Study|Lost to Follow-up|1|||
16223325|NCT00829010|39298657|FG001|Overall Study|Lost to Follow-up|0|||
16223326|NCT00829010|39298658|FG002|Overall Study|Lost to Follow-up|2|||
16223327|NCT00829010|39298659|FG003|Overall Study|Lost to Follow-up|0|||
16223328|NCT00829010|39298660|FG004|Overall Study|Lost to Follow-up|0|||
16223329|NCT00829010|39298656|FG000|Overall Study|Fatality|5|||
16223330|NCT00829010|39298657|FG001|Overall Study|Fatality|4|||
16223331|NCT00829010|39298658|FG002|Overall Study|Fatality|0|||
16223332|NCT00829010|39298659|FG003|Overall Study|Fatality|3|||
16223333|NCT00829010|39298660|FG004|Overall Study|Fatality|0|||
16223334|NCT00829010|39298656|FG000|Overall Study|Migrated/Moved from study area|3|||
16223335|NCT00829010|39298657|FG001|Overall Study|Migrated/Moved from study area|4|||
16223336|NCT00829010|39298658|FG002|Overall Study|Migrated/Moved from study area|0|||
16223337|NCT00829010|39298659|FG003|Overall Study|Migrated/Moved from study area|5|||
16223338|NCT00829010|39298660|FG004|Overall Study|Migrated/Moved from study area|0|||
16223339|NCT04594213|39298661|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
16223340|NCT04594213|39298662|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
16223341|NCT04594213|39298663|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
16223342|NCT04594213|39298664|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
16223343|NCT04594213|39298665|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
16223344|NCT04594213|39298666|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
16223345|NCT04594213|39298661|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
16223346|NCT04594213|39298662|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
16223347|NCT04594213|39298663|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
16223348|NCT04594213|39298664|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
16223349|NCT04594213|39298665|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
16223350|NCT04594213|39298666|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
16223351|NCT04594213|39298661|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
16223352|NCT04594213|39298662|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
16223353|NCT04594213|39298663|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
16223354|NCT04594213|39298664|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
16223355|NCT04594213|39298665|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
16223356|NCT04594213|39298666|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
16223357|NCT04594213|39298661|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
16409832|NCT01969500|39981787|FG000|Overall Study|Death|0|||
16409833|NCT01969500|39981788|FG001|Overall Study|Death|1|||
16409834|NCT01969500|39981787|FG000|Overall Study|extended hospitalization|1|||
16111453|NCT00827775|38897273|FG001|Overall Study|Withdrawal by Subject|5|||
16111454|NCT00760747|38897274|FG000|Study Period II|Adverse Event|3|||
16111455|NCT00760747|38897275|FG001|Study Period II|Adverse Event|4|||
16223358|NCT04594213|39298662|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
16223359|NCT04594213|39298663|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
16223360|NCT04594213|39298664|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
16223361|NCT04594213|39298665|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
16223362|NCT04594213|39298666|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
16223363|NCT04594213|39298661|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
16223364|NCT04594213|39298662|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
16223365|NCT04594213|39298663|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
16546251|NCT01538472|40464753|FG000|Overall Study|Disease Progression|3|||
16111456|NCT00760747|38897274|FG000|Study Period II|Lack of Efficacy|0|||
16111457|NCT00760747|38897275|FG001|Study Period II|Lack of Efficacy|6|||
16223366|NCT04594213|39298664|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
16223367|NCT04594213|39298665|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
16223368|NCT04594213|39298666|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
16409835|NCT01969500|39981788|FG001|Overall Study|extended hospitalization|1|||
16409836|NCT02142283|39981789|FG000|Overall Study|Death|20|||
16546252|NCT01538472|40464753|FG000|Overall Study|Death|1|||
16546253|NCT00058422|40464754|FG000|Overall Study|Not treated|2|||
16409837|NCT02142283|39981790|FG001|Overall Study|Death|18|||
16409838|NCT02142283|39981789|FG000|Overall Study|Withdrawal by Subject|1|||
16409839|NCT02142283|39981790|FG001|Overall Study|Withdrawal by Subject|3|||
16409840|NCT03023826|39981791|FG000|Period 1|Withdrawal by Subject|0|||
16409841|NCT03023826|39981792|FG001|Period 1|Withdrawal by Subject|0|||
16409842|NCT03023826|39981793|FG002|Period 1|Withdrawal by Subject|0|||
16409843|NCT03023826|39981794|FG003|Period 1|Withdrawal by Subject|0|||
16409844|NCT03023826|39981795|FG004|Period 1|Withdrawal by Subject|1|||
16409845|NCT03023826|39981796|FG005|Period 1|Withdrawal by Subject|0|||
16409846|NCT02981524|39981803|FG000|Overall Study|Progressive Disease|14|||
16409847|NCT02981524|39981803|FG000|Overall Study|Death (unrelated)|1|||
16409848|NCT02981524|39981803|FG000|Overall Study|Treatment Related Toxicity|1|||
16409849|NCT02981524|39981803|FG000|Overall Study|Withdrawal by Subject|1|||
16409850|NCT00882908|39981805|FG000|Overall Study|Adverse Event|0|||
16409851|NCT00882908|39981806|FG001|Overall Study|Adverse Event|0|||
16409852|NCT00882908|39981807|FG002|Overall Study|Adverse Event|1|||
16409853|NCT00882908|39981808|FG003|Overall Study|Adverse Event|0|||
16409854|NCT00882908|39981809|FG004|Overall Study|Adverse Event|1|||
16409855|NCT00882908|39981805|FG000|Overall Study|Lost to Follow-up|3|||
16409856|NCT00882908|39981806|FG001|Overall Study|Lost to Follow-up|5|||
16409857|NCT00882908|39981807|FG002|Overall Study|Lost to Follow-up|3|||
16409858|NCT00882908|39981808|FG003|Overall Study|Lost to Follow-up|1|||
16409859|NCT00882908|39981809|FG004|Overall Study|Lost to Follow-up|2|||
16409860|NCT00882908|39981805|FG000|Overall Study|Protocol Violation|0|||
16409861|NCT00882908|39981806|FG001|Overall Study|Protocol Violation|1|||
16409862|NCT00882908|39981807|FG002|Overall Study|Protocol Violation|0|||
16409863|NCT00882908|39981808|FG003|Overall Study|Protocol Violation|0|||
16409864|NCT00882908|39981809|FG004|Overall Study|Protocol Violation|0|||
16409865|NCT00882908|39981805|FG000|Overall Study|Withdrawal by Subject|0|||
16409866|NCT00882908|39981806|FG001|Overall Study|Withdrawal by Subject|0|||
16409867|NCT00882908|39981807|FG002|Overall Study|Withdrawal by Subject|3|||
16409868|NCT00882908|39981808|FG003|Overall Study|Withdrawal by Subject|5|||
16409869|NCT00882908|39981809|FG004|Overall Study|Withdrawal by Subject|2|||
16409870|NCT00882908|39981805|FG000|Overall Study|Subject reached a virologic endpoint|0|||
16409871|NCT00882908|39981806|FG001|Overall Study|Subject reached a virologic endpoint|0|||
16409872|NCT00882908|39981807|FG002|Overall Study|Subject reached a virologic endpoint|0|||
16409873|NCT00882908|39981808|FG003|Overall Study|Subject reached a virologic endpoint|0|||
16409874|NCT00882908|39981809|FG004|Overall Study|Subject reached a virologic endpoint|1|||
16223369|NCT04594213|39298661|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
16223370|NCT04594213|39298662|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
16223371|NCT04594213|39298663|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
16223372|NCT04594213|39298664|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
16223373|NCT04594213|39298665|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
16223374|NCT04594213|39298666|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
16223375|NCT04594213|39298661|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
16223376|NCT04594213|39298662|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
16409875|NCT00882908|39981805|FG000|Overall Study|Study terminated in error|0|||
16409876|NCT00882908|39981806|FG001|Overall Study|Study terminated in error|0|||
16409877|NCT00882908|39981807|FG002|Overall Study|Study terminated in error|0|||
16409878|NCT00882908|39981808|FG003|Overall Study|Study terminated in error|1|||
16546254|NCT04887948|40464756|FG000|Overall Study|Death|1|||
16546255|NCT04887948|40464757|FG001|Overall Study|Death|0|||
16546256|NCT04887948|40464758|FG002|Overall Study|Death|0|||
16546257|NCT04887948|40464756|FG000|Overall Study|Lost to Follow-up|1|||
16546258|NCT04887948|40464757|FG001|Overall Study|Lost to Follow-up|0|||
16546259|NCT04887948|40464758|FG002|Overall Study|Lost to Follow-up|3|||
16546260|NCT04887948|40464756|FG000|Overall Study|Physician Decision|0|||
16546261|NCT04887948|40464757|FG001|Overall Study|Physician Decision|4|||
16546262|NCT04887948|40464758|FG002|Overall Study|Physician Decision|1|||
16546263|NCT04887948|40464756|FG000|Overall Study|Protocol Violation|1|||
16546264|NCT04887948|40464757|FG001|Overall Study|Protocol Violation|1|||
16546265|NCT04887948|40464758|FG002|Overall Study|Protocol Violation|0|||
16546266|NCT04887948|40464756|FG000|Overall Study|Withdrawal by Subject|0|||
16409879|NCT00882908|39981809|FG004|Overall Study|Study terminated in error|0|||
16409880|NCT01174004|39981810|FG000|Overall Study|Adverse Event|2|||
16409881|NCT01174004|39981811|FG001|Overall Study|Adverse Event|10|||
16409882|NCT01174004|39981810|FG000|Overall Study|Withdrawal by Subject|2|||
16409883|NCT01174004|39981811|FG001|Overall Study|Withdrawal by Subject|3|||
16409884|NCT01174004|39981810|FG000|Overall Study|At Discretion of Sponsor|2|||
16546267|NCT04887948|40464757|FG001|Overall Study|Withdrawal by Subject|6|||
16409885|NCT01174004|39981811|FG001|Overall Study|At Discretion of Sponsor|2|||
16409886|NCT01174004|39981810|FG000|Overall Study|Protocol Violation|0|||
16409887|NCT01174004|39981811|FG001|Overall Study|Protocol Violation|1|||
16409888|NCT01174004|39981810|FG000|Overall Study|Physician Decision|1|||
16409889|NCT01174004|39981811|FG001|Overall Study|Physician Decision|0|||
16409890|NCT01143051|39981812|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
16409891|NCT01143051|39981813|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
16409892|NCT01143051|39981814|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
16546268|NCT04887948|40464758|FG002|Overall Study|Withdrawal by Subject|1|||
16546269|NCT04887948|40464756|FG000|Overall Study|No longer met eligibility criteria|1|||
16546270|NCT04887948|40464757|FG001|Overall Study|No longer met eligibility criteria|2|||
16546271|NCT04887948|40464758|FG002|Overall Study|No longer met eligibility criteria|1|||
16546272|NCT04887948|40464756|FG000|Overall Study|Other|2|||
16546273|NCT04887948|40464757|FG001|Overall Study|Other|1|||
16546274|NCT04887948|40464758|FG002|Overall Study|Other|1|||
16546275|NCT02036645|40464759|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546276|NCT02036645|40464760|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546277|NCT02036645|40464761|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546278|NCT02036645|40464762|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546279|NCT02036645|40464763|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546280|NCT02036645|40464764|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546281|NCT02036645|40464765|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
16546282|NCT02036645|40464766|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546283|NCT02036645|40464767|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546284|NCT02036645|40464768|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546285|NCT02036645|40464769|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546286|NCT02036645|40464770|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
16546287|NCT02036645|40464759|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546288|NCT02036645|40464760|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546289|NCT02036645|40464761|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546290|NCT02036645|40464762|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
16546291|NCT02036645|40464763|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546292|NCT02036645|40464764|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546293|NCT02036645|40464765|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546294|NCT02036645|40464766|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546295|NCT02036645|40464767|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546296|NCT02036645|40464768|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546297|NCT02036645|40464769|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546298|NCT02036645|40464770|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
16546299|NCT02237508|40464773|FG000|Overall Study|Withdrawal by Subject|0|||
16546300|NCT02237508|40464774|FG001|Overall Study|Withdrawal by Subject|2|||
16546301|NCT02237508|40464775|FG002|Overall Study|Withdrawal by Subject|0|||
16409893|NCT01143051|39981815|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
16409894|NCT01143051|39981816|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
16546447|NCT04704154|40464805|FG000|Overall Study|Participant Decision|1|||
16546448|NCT04704154|40464806|FG001|Overall Study|Participant Decision|1|||
16546449|NCT04704154|40464807|FG002|Overall Study|Participant Decision|0|||
16546450|NCT04704154|40464808|FG003|Overall Study|Participant Decision|0|||
16546451|NCT04704154|40464809|FG004|Overall Study|Participant Decision|0|||
16546452|NCT04704154|40464810|FG005|Overall Study|Participant Decision|0|||
16546453|NCT04704154|40464805|FG000|Overall Study|Progressive Disease|16|||
16223465|NCT02275780|39298682|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
16223466|NCT02275780|39298683|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
16223467|NCT02275780|39298682|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
16223468|NCT02275780|39298683|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
16223469|NCT02275780|39298682|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
16223470|NCT02275780|39298683|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
16223471|NCT02275780|39298682|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
16223472|NCT02275780|39298683|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
16223473|NCT02275780|39298682|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
16223474|NCT02275780|39298683|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
16223475|NCT02275780|39298682|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
16223476|NCT02275780|39298683|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
16223477|NCT02275780|39298682|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
16223478|NCT02275780|39298683|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
16223479|NCT02275780|39298682|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
16223480|NCT02275780|39298683|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
16223481|NCT02275780|39298682|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
16223482|NCT02275780|39298683|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
16223483|NCT02275780|39298682|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
16223484|NCT02275780|39298683|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
16223485|NCT02275780|39298682|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
16223486|NCT02275780|39298683|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
16223487|NCT02275780|39298682|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
16223488|NCT02275780|39298683|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
16223489|NCT02198040|39298685|FG000|Overall Study|Work reasons|0|||
16223490|NCT02198040|39298686|FG001|Overall Study|Work reasons|1|||
16223491|NCT02198040|39298687|FG002|Overall Study|Work reasons|0|||
16223492|NCT02198040|39298685|FG000|Overall Study|Withdrawal by Subject|0|||
16223493|NCT02198040|39298686|FG001|Overall Study|Withdrawal by Subject|0|||
16223494|NCT02198040|39298687|FG002|Overall Study|Withdrawal by Subject|1|||
16223495|NCT02679222|39298695|FG000|Overall Study|No time for project|1|||
16223496|NCT01220024|39298696|FG000|Overall Study|Lost to Follow-up|1|||
16546454|NCT04704154|40464806|FG001|Overall Study|Progressive Disease|17|||
16111470|NCT00760747|38897274|FG000|Study Period III|Parent/Caregiver Decision|0|||
16111471|NCT00760747|38897275|FG001|Study Period III|Parent/Caregiver Decision|1|||
16111472|NCT00760747|38897274|FG000|Study Period III|Protocol Violation|1|||
16223497|NCT01220024|39298697|FG001|Overall Study|Lost to Follow-up|1|||
16223498|NCT00211536|39298698|FG000|Overall Study|Withdrawal by Subject|2|||
16223499|NCT00211536|39298699|FG001|Overall Study|Withdrawal by Subject|2|||
16223500|NCT00211536|39298698|FG000|Overall Study|Physician Decision|0|||
16223501|NCT00211536|39298699|FG001|Overall Study|Physician Decision|5|||
16223502|NCT00211536|39298698|FG000|Overall Study|Adverse Event|2|||
16223503|NCT00211536|39298699|FG001|Overall Study|Adverse Event|0|||
16223504|NCT00724243|39298703|FG000|Overall Study|Lack of Efficacy|10|||
16223505|NCT00724243|39298703|FG000|Overall Study|Adverse Event|5|||
16223506|NCT03907072|39298704|FG000|Overall Study|Study Terminated by Sponsor|2|||
16223507|NCT03907072|39298705|FG001|Overall Study|Study Terminated by Sponsor|2|||
16223508|NCT03907072|39298706|FG002|Overall Study|Study Terminated by Sponsor|2|||
16223509|NCT00104299|39298714|FG000|Overall Study|Adverse Event|3|||
16223510|NCT00104299|39298715|FG001|Overall Study|Adverse Event|1|||
16223511|NCT00104299|39298714|FG000|Overall Study|Death|2|||
16223512|NCT00104299|39298715|FG001|Overall Study|Death|2|||
16223513|NCT00104299|39298714|FG000|Overall Study|Withdrawal by Subject|2|||
16223514|NCT00104299|39298715|FG001|Overall Study|Withdrawal by Subject|6|||
16223515|NCT00104299|39298714|FG000|Overall Study|Physician Decision|1|||
16223516|NCT00104299|39298715|FG001|Overall Study|Physician Decision|1|||
16223517|NCT00104299|39298714|FG000|Overall Study|To have renal transplant|1|||
16223518|NCT00104299|39298715|FG001|Overall Study|To have renal transplant|0|||
16223519|NCT00508001|39298719|FG000|Overall Study|Adverse Event|2|||
16223520|NCT00508001|39298720|FG001|Overall Study|Adverse Event|0|||
16223521|NCT00508001|39298721|FG002|Overall Study|Adverse Event|4|||
16223522|NCT00508001|39298719|FG000|Overall Study|condition under investigation worsened|13|||
16223523|NCT00508001|39298720|FG001|Overall Study|condition under investigation worsened|7|||
16223524|NCT00508001|39298721|FG002|Overall Study|condition under investigation worsened|1|||
16223525|NCT00508001|39298719|FG000|Overall Study|Death|0|||
16223526|NCT00508001|39298720|FG001|Overall Study|Death|1|||
16223527|NCT00508001|39298721|FG002|Overall Study|Death|1|||
16223528|NCT00508001|39298719|FG000|Overall Study|Withdrawal by Subject|4|||
16223529|NCT00508001|39298720|FG001|Overall Study|Withdrawal by Subject|4|||
16223530|NCT00508001|39298721|FG002|Overall Study|Withdrawal by Subject|1|||
16223531|NCT02269709|39298722|FG000|Time of Enrollment|Withdrawal by Subject|3|||
16223532|NCT02269709|39298722|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
16223533|NCT02269709|39298722|FG000|Six Month Follow-up|Lost to Follow-up|12|||
16223534|NCT02519777|39298726|FG000|Overall Study|Death|1|||
16223535|NCT02519777|39298727|FG001|Overall Study|Death|0|||
16223536|NCT02519777|39298728|FG002|Overall Study|Death|0|||
16223537|NCT02519777|39298726|FG000|Overall Study|Lost to Follow-up|0|||
16223538|NCT02519777|39298727|FG001|Overall Study|Lost to Follow-up|4|||
16223539|NCT02519777|39298728|FG002|Overall Study|Lost to Follow-up|2|||
16223540|NCT02519777|39298726|FG000|Overall Study|Withdrawal by Subject|3|||
16223541|NCT02519777|39298727|FG001|Overall Study|Withdrawal by Subject|1|||
16223542|NCT02519777|39298728|FG002|Overall Study|Withdrawal by Subject|0|||
16223543|NCT02519777|39298726|FG000|Overall Study|Severe Debilitation|1|||
16223544|NCT02519777|39298727|FG001|Overall Study|Severe Debilitation|1|||
16223545|NCT02519777|39298728|FG002|Overall Study|Severe Debilitation|1|||
16223546|NCT02519777|39298726|FG000|Overall Study|Not able to get to clinic|1|||
16223547|NCT02519777|39298727|FG001|Overall Study|Not able to get to clinic|2|||
16223548|NCT02519777|39298728|FG002|Overall Study|Not able to get to clinic|1|||
16111473|NCT00760747|38897275|FG001|Study Period III|Protocol Violation|1|||
16223549|NCT01632345|39298733|FG000|Treatment: Part I|Adverse Event|1|||
16223550|NCT01632345|39298734|FG001|Treatment: Part I|Adverse Event|4|||
16223551|NCT01632345|39298735|FG002|Treatment: Part I|Adverse Event|2|||
16223552|NCT01632345|39298736|FG003|Treatment: Part I|Adverse Event|1|||
16223553|NCT01632345|39298737|FG004|Treatment: Part I|Adverse Event|3|||
16223554|NCT01632345|39298738|FG005|Treatment: Part I|Adverse Event|0|||
16223555|NCT01632345|39298739|FG006|Treatment: Part I|Adverse Event|0|||
16223556|NCT01632345|39298733|FG000|Treatment: Part I|Lack of Efficacy|0|||
16223557|NCT01632345|39298734|FG001|Treatment: Part I|Lack of Efficacy|1|||
16223558|NCT01632345|39298735|FG002|Treatment: Part I|Lack of Efficacy|0|||
16223559|NCT01632345|39298736|FG003|Treatment: Part I|Lack of Efficacy|1|||
16223560|NCT01632345|39298737|FG004|Treatment: Part I|Lack of Efficacy|1|||
16409990|NCT02536300|39981854|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
16409991|NCT02536300|39981855|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
16409992|NCT02536300|39981856|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
16409993|NCT02536300|39981854|FG000|Overall Study|Enrolled but Never Treated|0|||
16409994|NCT02536300|39981855|FG001|Overall Study|Enrolled but Never Treated|0|||
16111474|NCT00760747|38897274|FG000|Study Period III|Physician Decision|0|||
16111475|NCT00760747|38897275|FG001|Study Period III|Physician Decision|1|||
16223561|NCT01632345|39298738|FG005|Treatment: Part I|Lack of Efficacy|0|||
16223562|NCT01632345|39298739|FG006|Treatment: Part I|Lack of Efficacy|0|||
16223563|NCT01632345|39298733|FG000|Treatment: Part I|Lost to Follow-up|3|||
16223564|NCT01632345|39298734|FG001|Treatment: Part I|Lost to Follow-up|2|||
16111476|NCT02725567|38897276|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
16111477|NCT02725567|38897277|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
16111478|NCT02725567|38897276|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
16111479|NCT02725567|38897277|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
16111480|NCT02725567|38897276|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
16111481|NCT02725567|38897277|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
16111482|NCT00583947|38897278|FG000|Cross-over Period|Adverse Event|2|||
16111483|NCT00583947|38897279|FG001|Cross-over Period|Adverse Event|0|||
16111484|NCT00583947|38897278|FG000|Cross-over Period|Withdrawal by Subject|2|||
16111485|NCT00583947|38897279|FG001|Cross-over Period|Withdrawal by Subject|0|||
16223565|NCT01632345|39298735|FG002|Treatment: Part I|Lost to Follow-up|1|||
16111486|NCT00583947|38897278|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
16111487|NCT00583947|38897279|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
16111488|NCT00583947|38897278|FG000|Cross-over Period|Other|1|||
16111489|NCT00583947|38897279|FG001|Cross-over Period|Other|1|||
16111490|NCT04411186|38897285|FG000|Overall Study|Withdrawn due to protocol violation|0|||
16111491|NCT04411186|38897286|FG001|Overall Study|Withdrawn due to protocol violation|1|||
16111492|NCT00943722|38897293|FG000|Base Study|Adverse Event|0|||
16111493|NCT00943722|38897294|FG001|Base Study|Adverse Event|0|||
16111494|NCT00943722|38897295|FG002|Base Study|Adverse Event|0|||
16111495|NCT00943722|38897296|FG003|Base Study|Adverse Event|1|||
16111496|NCT00943722|38897297|FG004|Base Study|Adverse Event|0|||
16111497|NCT00943722|38897298|FG005|Base Study|Adverse Event|0|||
16223566|NCT01632345|39298736|FG003|Treatment: Part I|Lost to Follow-up|3|||
16223567|NCT01632345|39298737|FG004|Treatment: Part I|Lost to Follow-up|4|||
16223568|NCT01632345|39298738|FG005|Treatment: Part I|Lost to Follow-up|0|||
16223569|NCT01632345|39298739|FG006|Treatment: Part I|Lost to Follow-up|0|||
16223570|NCT01632345|39298733|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
16223571|NCT01632345|39298734|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
16223572|NCT01632345|39298735|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
16223573|NCT01632345|39298736|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
16223574|NCT01632345|39298737|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
16223575|NCT01632345|39298738|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
16223576|NCT01632345|39298739|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
16223577|NCT01632345|39298733|FG000|Treatment: Part I|Physician Decision|2|||
16223578|NCT01632345|39298734|FG001|Treatment: Part I|Physician Decision|1|||
16223579|NCT01632345|39298735|FG002|Treatment: Part I|Physician Decision|0|||
16111498|NCT00943722|38897299|FG006|Base Study|Adverse Event|0|||
16111499|NCT00943722|38897293|FG000|Base Study|Lost to Follow-up|12|||
16111500|NCT00943722|38897294|FG001|Base Study|Lost to Follow-up|8|||
16111501|NCT00943722|38897295|FG002|Base Study|Lost to Follow-up|10|||
16111502|NCT00943722|38897296|FG003|Base Study|Lost to Follow-up|8|||
16111503|NCT00943722|38897297|FG004|Base Study|Lost to Follow-up|11|||
16111504|NCT00943722|38897298|FG005|Base Study|Lost to Follow-up|0|||
16111505|NCT00943722|38897299|FG006|Base Study|Lost to Follow-up|0|||
16223580|NCT01632345|39298736|FG003|Treatment: Part I|Physician Decision|0|||
16223581|NCT01632345|39298737|FG004|Treatment: Part I|Physician Decision|1|||
16223582|NCT01632345|39298738|FG005|Treatment: Part I|Physician Decision|0|||
16223583|NCT01632345|39298739|FG006|Treatment: Part I|Physician Decision|0|||
16223584|NCT01632345|39298733|FG000|Treatment: Part I|Pregnancy|0|||
16223585|NCT01632345|39298734|FG001|Treatment: Part I|Pregnancy|1|||
16223586|NCT01632345|39298735|FG002|Treatment: Part I|Pregnancy|0|||
16223587|NCT01632345|39298736|FG003|Treatment: Part I|Pregnancy|0|||
16223588|NCT01632345|39298737|FG004|Treatment: Part I|Pregnancy|0|||
16223589|NCT01632345|39298738|FG005|Treatment: Part I|Pregnancy|0|||
16223590|NCT01632345|39298739|FG006|Treatment: Part I|Pregnancy|0|||
16223591|NCT01632345|39298733|FG000|Treatment: Part I|Protocol Deviation|0|||
16223592|NCT01632345|39298734|FG001|Treatment: Part I|Protocol Deviation|0|||
16223593|NCT01632345|39298735|FG002|Treatment: Part I|Protocol Deviation|1|||
16223594|NCT01632345|39298736|FG003|Treatment: Part I|Protocol Deviation|1|||
16223595|NCT01632345|39298737|FG004|Treatment: Part I|Protocol Deviation|0|||
16223596|NCT01632345|39298738|FG005|Treatment: Part I|Protocol Deviation|0|||
16223597|NCT01632345|39298739|FG006|Treatment: Part I|Protocol Deviation|0|||
16223598|NCT01632345|39298733|FG000|Treatment: Part I|Withdrawal by Subject|3|||
16111506|NCT00943722|38897293|FG000|Base Study|Physician Decision|1|||
16111507|NCT00943722|38897294|FG001|Base Study|Physician Decision|0|||
16111508|NCT00943722|38897295|FG002|Base Study|Physician Decision|0|||
16223599|NCT01632345|39298734|FG001|Treatment: Part I|Withdrawal by Subject|4|||
16223600|NCT01632345|39298735|FG002|Treatment: Part I|Withdrawal by Subject|4|||
16223601|NCT01632345|39298736|FG003|Treatment: Part I|Withdrawal by Subject|1|||
16223602|NCT01632345|39298737|FG004|Treatment: Part I|Withdrawal by Subject|4|||
16223603|NCT01632345|39298738|FG005|Treatment: Part I|Withdrawal by Subject|0|||
16223604|NCT01632345|39298739|FG006|Treatment: Part I|Withdrawal by Subject|0|||
16223605|NCT01632345|39298733|FG000|Treatment: Part II|Adverse Event|0|||
16223606|NCT01632345|39298734|FG001|Treatment: Part II|Adverse Event|0|||
16223607|NCT01632345|39298735|FG002|Treatment: Part II|Adverse Event|0|||
16223608|NCT01632345|39298736|FG003|Treatment: Part II|Adverse Event|0|||
16223609|NCT01632345|39298737|FG004|Treatment: Part II|Adverse Event|0|||
16223610|NCT01632345|39298738|FG005|Treatment: Part II|Adverse Event|3|||
16223611|NCT01632345|39298739|FG006|Treatment: Part II|Adverse Event|8|||
16223612|NCT01632345|39298733|FG000|Treatment: Part II|Lost to Follow-up|0|||
16223613|NCT01632345|39298734|FG001|Treatment: Part II|Lost to Follow-up|0|||
16223614|NCT01632345|39298735|FG002|Treatment: Part II|Lost to Follow-up|0|||
16223615|NCT01632345|39298736|FG003|Treatment: Part II|Lost to Follow-up|0|||
16223616|NCT01632345|39298737|FG004|Treatment: Part II|Lost to Follow-up|0|||
16223617|NCT01632345|39298738|FG005|Treatment: Part II|Lost to Follow-up|3|||
16223618|NCT01632345|39298739|FG006|Treatment: Part II|Lost to Follow-up|1|||
16223619|NCT01632345|39298733|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
16223620|NCT01632345|39298734|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
16223621|NCT01632345|39298735|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
16223622|NCT01632345|39298736|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
16223623|NCT01632345|39298737|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
16223624|NCT01632345|39298738|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
16223625|NCT01632345|39298739|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
16223626|NCT01632345|39298733|FG000|Treatment: Part II|Withdrawal by Subject|0|||
16223627|NCT01632345|39298734|FG001|Treatment: Part II|Withdrawal by Subject|0|||
16223628|NCT01632345|39298735|FG002|Treatment: Part II|Withdrawal by Subject|0|||
16223629|NCT01632345|39298736|FG003|Treatment: Part II|Withdrawal by Subject|0|||
16223630|NCT01632345|39298737|FG004|Treatment: Part II|Withdrawal by Subject|0|||
16223631|NCT01632345|39298738|FG005|Treatment: Part II|Withdrawal by Subject|2|||
16223632|NCT01632345|39298739|FG006|Treatment: Part II|Withdrawal by Subject|2|||
16223633|NCT01599585|39298743|FG000|Overall Study|Withdrawal by Subject|16|||
16223634|NCT01599585|39298744|FG001|Overall Study|Withdrawal by Subject|9|||
16223635|NCT01599585|39298743|FG000|Overall Study|Lost to Follow-up|3|||
16223636|NCT01599585|39298744|FG001|Overall Study|Lost to Follow-up|5|||
16223637|NCT01599585|39298743|FG000|Overall Study|randomized did not start treatment|3|||
16223638|NCT01599585|39298744|FG001|Overall Study|randomized did not start treatment|3|||
16223639|NCT04419558|39298751|FG000|DB Period (48 Weeks)|Adverse Event|6|||
16223640|NCT04419558|39298752|FG001|DB Period (48 Weeks)|Adverse Event|6|||
16223641|NCT04419558|39298751|FG000|DB Period (48 Weeks)|Death|14|||
16223642|NCT04419558|39298752|FG001|DB Period (48 Weeks)|Death|11|||
16223643|NCT04419558|39298751|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
16223644|NCT04419558|39298752|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
16223645|NCT04419558|39298751|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
16223646|NCT04419558|39298752|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
16409995|NCT02536300|39981856|FG002|Overall Study|Enrolled but Never Treated|1|||
16111509|NCT00943722|38897296|FG003|Base Study|Physician Decision|0|||
16223647|NCT04419558|39298751|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
16223648|NCT04419558|39298752|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
16223649|NCT04419558|39298751|FG000|DB Period (48 Weeks)|Disease Progression|1|||
16223650|NCT04419558|39298752|FG001|DB Period (48 Weeks)|Disease Progression|0|||
16223651|NCT04419558|39298751|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
16223652|NCT04419558|39298752|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
16223653|NCT04419558|39298751|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
16223654|NCT04419558|39298752|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
16409996|NCT02536300|39981854|FG000|Overall Study|Non-compliance With Study Drug|1|||
16546455|NCT04704154|40464807|FG002|Overall Study|Progressive Disease|20|||
16223655|NCT04419558|39298751|FG000|DB Period (48 Weeks)|Participant Decision|4|||
16223656|NCT04419558|39298752|FG001|DB Period (48 Weeks)|Participant Decision|3|||
16223657|NCT04419558|39298751|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
16223658|NCT04419558|39298752|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
16223659|NCT04419558|39298751|FG000|OLE Period (48 Weeks)|Death|4|||
16223660|NCT04419558|39298752|FG001|OLE Period (48 Weeks)|Death|6|||
16223661|NCT04419558|39298751|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
16223662|NCT04419558|39298752|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
16223663|NCT04419558|39298751|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
16223664|NCT04419558|39298752|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
16223665|NCT02555722|39298753|FG000|Week 2|Adverse Event|0|||
16223666|NCT02555722|39298754|FG001|Week 2|Adverse Event|1|||
16223667|NCT02555722|39298753|FG000|Week 2|Withdrawal by Subject|1|||
16223668|NCT02555722|39298754|FG001|Week 2|Withdrawal by Subject|0|||
16223669|NCT02555722|39298753|FG000|Month 1|Lens Discomfort|1|||
16223670|NCT02555722|39298754|FG001|Month 1|Lens Discomfort|0|||
16223671|NCT02555722|39298753|FG000|Month 2|Withdrawal by Subject|3|||
16223672|NCT02555722|39298754|FG001|Month 2|Withdrawal by Subject|0|||
16223673|NCT02555722|39298753|FG000|Month 2|Lost to Follow-up|1|||
16223674|NCT02555722|39298754|FG001|Month 2|Lost to Follow-up|0|||
16223675|NCT03795233|39298755|FG000|Overall Study|Withdrawal by Subject|2|||
16223676|NCT03795233|39298756|FG001|Overall Study|Withdrawal by Subject|1|||
16223677|NCT03795233|39298755|FG000|Overall Study|Lost to Follow-up|1|||
16223678|NCT03795233|39298756|FG001|Overall Study|Lost to Follow-up|0|||
16546456|NCT04704154|40464808|FG003|Overall Study|Progressive Disease|18|||
16546457|NCT04704154|40464809|FG004|Overall Study|Progressive Disease|36|||
16546458|NCT04704154|40464810|FG005|Overall Study|Progressive Disease|30|||
16546459|NCT04704154|40464805|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
16546460|NCT04704154|40464806|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
16546461|NCT04704154|40464807|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
16546462|NCT04704154|40464808|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
16223679|NCT03795233|39298755|FG000|Overall Study|Death|1|||
16223680|NCT03795233|39298756|FG001|Overall Study|Death|0|||
16223681|NCT03417102|39298758|FG000|Overall Study|Adverse Event|0|||
16223682|NCT03417102|39298759|FG001|Overall Study|Adverse Event|1|||
16223683|NCT03417102|39298758|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
16223684|NCT03417102|39298759|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
16223685|NCT03417102|39298758|FG000|Overall Study|Other|0|||
16223686|NCT03417102|39298759|FG001|Overall Study|Other|1|||
16223687|NCT01883362|39298760|FG000|Treatment|Adverse Event|1|||
16223688|NCT01883362|39298761|FG001|Treatment|Adverse Event|8|||
16223689|NCT01883362|39298760|FG000|Treatment|Withdrawal by Subject|6|||
16223690|NCT01883362|39298761|FG001|Treatment|Withdrawal by Subject|2|||
16223691|NCT01883362|39298760|FG000|Treatment|Administrative problems|4|||
16223692|NCT01883362|39298761|FG001|Treatment|Administrative problems|1|||
16223693|NCT01883362|39298760|FG000|Treatment|Relapse|4|||
16223694|NCT01883362|39298761|FG001|Treatment|Relapse|2|||
16223695|NCT01883362|39298760|FG000|Treatment|Randomized, not treated|1|||
16223696|NCT01883362|39298761|FG001|Treatment|Randomized, not treated|1|||
16223697|NCT01883362|39298760|FG000|Post Treatment Follow-up|Protocol Violation|0|||
16223698|NCT01883362|39298761|FG001|Post Treatment Follow-up|Protocol Violation|1|||
16223699|NCT01883362|39298760|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
16223700|NCT01883362|39298761|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
16223701|NCT01883362|39298760|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
16223702|NCT01883362|39298761|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
16223703|NCT01883362|39298760|FG000|Post Treatment Follow-up|Administrative problems|2|||
16223704|NCT01883362|39298761|FG001|Post Treatment Follow-up|Administrative problems|0|||
16223705|NCT01883362|39298760|FG000|Post Treatment Follow-up|Death|8|||
16223706|NCT01883362|39298761|FG001|Post Treatment Follow-up|Death|4|||
16223707|NCT01883362|39298760|FG000|Post Treatment Follow-up|Relapse|1|||
16223708|NCT01883362|39298761|FG001|Post Treatment Follow-up|Relapse|2|||
16223709|NCT00682539|39298762|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
16223710|NCT00682539|39298763|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
16223711|NCT00682539|39298764|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
16223712|NCT00682539|39298762|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
16223713|NCT00682539|39298763|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
16223714|NCT00682539|39298764|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
16223715|NCT02062385|39298765|FG000|Overall Study|Adverse Event|19|||
16223716|NCT02062385|39298766|FG001|Overall Study|Adverse Event|13|||
16223717|NCT02062385|39298767|FG002|Overall Study|Adverse Event|1|||
16223718|NCT02062385|39298768|FG003|Overall Study|Adverse Event|0|||
16223719|NCT02062385|39298765|FG000|Overall Study|Protocol Violation|1|||
16223720|NCT02062385|39298766|FG001|Overall Study|Protocol Violation|0|||
16223721|NCT02062385|39298767|FG002|Overall Study|Protocol Violation|0|||
16223722|NCT02062385|39298768|FG003|Overall Study|Protocol Violation|0|||
16223723|NCT02062385|39298765|FG000|Overall Study|Incomplete EPI by database lock|2|||
16223724|NCT02062385|39298766|FG001|Overall Study|Incomplete EPI by database lock|0|||
16223725|NCT02062385|39298767|FG002|Overall Study|Incomplete EPI by database lock|0|||
16223726|NCT02062385|39298768|FG003|Overall Study|Incomplete EPI by database lock|0|||
16223727|NCT02062385|39298765|FG000|Overall Study|Moved|10|||
16223728|NCT02062385|39298766|FG001|Overall Study|Moved|11|||
16223729|NCT02062385|39298767|FG002|Overall Study|Moved|1|||
16223730|NCT02062385|39298768|FG003|Overall Study|Moved|0|||
16223731|NCT02062385|39298765|FG000|Overall Study|Withdrawn by parent/guardian|46|||
16223732|NCT02062385|39298766|FG001|Overall Study|Withdrawn by parent/guardian|41|||
16223733|NCT02062385|39298767|FG002|Overall Study|Withdrawn by parent/guardian|9|||
16223734|NCT02062385|39298768|FG003|Overall Study|Withdrawn by parent/guardian|8|||
16223735|NCT02062385|39298765|FG000|Overall Study|Death|0|||
16223736|NCT02062385|39298766|FG001|Overall Study|Death|0|||
16223737|NCT02062385|39298767|FG002|Overall Study|Death|0|||
16223738|NCT02062385|39298768|FG003|Overall Study|Death|1|||
16223739|NCT02062385|39298765|FG000|Overall Study|Lost to Follow-up|0|||
16223740|NCT02062385|39298766|FG001|Overall Study|Lost to Follow-up|0|||
16223741|NCT02062385|39298767|FG002|Overall Study|Lost to Follow-up|1|||
16223742|NCT02062385|39298768|FG003|Overall Study|Lost to Follow-up|0|||
16223743|NCT02499172|39298769|FG000|Overall Study|Financial reason|0|||
16223744|NCT02499172|39298770|FG001|Overall Study|Financial reason|0|||
16223745|NCT02499172|39298771|FG002|Overall Study|Financial reason|523|||
16111510|NCT00943722|38897297|FG004|Base Study|Physician Decision|1|||
16111511|NCT00943722|38897298|FG005|Base Study|Physician Decision|0|||
16111512|NCT00943722|38897299|FG006|Base Study|Physician Decision|0|||
16111513|NCT00943722|38897293|FG000|Base Study|Pregnancy|0|||
16111514|NCT00943722|38897294|FG001|Base Study|Pregnancy|0|||
16111515|NCT00943722|38897295|FG002|Base Study|Pregnancy|1|||
16111516|NCT00943722|38897296|FG003|Base Study|Pregnancy|0|||
16111517|NCT00943722|38897297|FG004|Base Study|Pregnancy|2|||
16111518|NCT00943722|38897298|FG005|Base Study|Pregnancy|0|||
16111519|NCT00943722|38897299|FG006|Base Study|Pregnancy|0|||
16111520|NCT00943722|38897293|FG000|Base Study|Protocol Violation|0|||
16111521|NCT00943722|38897294|FG001|Base Study|Protocol Violation|1|||
16111522|NCT00943722|38897295|FG002|Base Study|Protocol Violation|0|||
16111523|NCT00943722|38897296|FG003|Base Study|Protocol Violation|0|||
16111524|NCT00943722|38897297|FG004|Base Study|Protocol Violation|2|||
16111525|NCT00943722|38897298|FG005|Base Study|Protocol Violation|0|||
16111526|NCT00943722|38897299|FG006|Base Study|Protocol Violation|0|||
16111527|NCT00943722|38897293|FG000|Base Study|Withdrawal by Subject|12|||
16111528|NCT00943722|38897294|FG001|Base Study|Withdrawal by Subject|13|||
16111529|NCT00943722|38897295|FG002|Base Study|Withdrawal by Subject|2|||
16111530|NCT00943722|38897296|FG003|Base Study|Withdrawal by Subject|13|||
16111531|NCT00943722|38897297|FG004|Base Study|Withdrawal by Subject|8|||
16111532|NCT00943722|38897298|FG005|Base Study|Withdrawal by Subject|0|||
16111533|NCT00943722|38897299|FG006|Base Study|Withdrawal by Subject|0|||
16111534|NCT00943722|38897293|FG000|Base Study|Month 12 visit not completed|0|||
16111535|NCT00943722|38897294|FG001|Base Study|Month 12 visit not completed|0|||
16111536|NCT00943722|38897295|FG002|Base Study|Month 12 visit not completed|0|||
16111537|NCT00943722|38897296|FG003|Base Study|Month 12 visit not completed|0|||
16111538|NCT00943722|38897297|FG004|Base Study|Month 12 visit not completed|2|||
16111539|NCT00943722|38897298|FG005|Base Study|Month 12 visit not completed|0|||
16111540|NCT00943722|38897299|FG006|Base Study|Month 12 visit not completed|0|||
16111541|NCT00943722|38897293|FG000|First Extension Study: EXT 1|Adverse Event|0|||
16111542|NCT00943722|38897294|FG001|First Extension Study: EXT 1|Adverse Event|0|||
16111543|NCT00943722|38897295|FG002|First Extension Study: EXT 1|Adverse Event|0|||
16111544|NCT00943722|38897296|FG003|First Extension Study: EXT 1|Adverse Event|0|||
16111545|NCT00943722|38897297|FG004|First Extension Study: EXT 1|Adverse Event|0|||
16111546|NCT00943722|38897298|FG005|First Extension Study: EXT 1|Adverse Event|1|||
16111547|NCT00943722|38897299|FG006|First Extension Study: EXT 1|Adverse Event|0|||
16111548|NCT00943722|38897293|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
16111549|NCT00943722|38897294|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
16111550|NCT00943722|38897295|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
16111551|NCT00943722|38897296|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
16111552|NCT00943722|38897297|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
16111553|NCT00943722|38897298|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
16111554|NCT00943722|38897299|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
16111555|NCT00943722|38897293|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
16111556|NCT00943722|38897294|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
16111557|NCT00943722|38897295|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
16111558|NCT00943722|38897296|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
16111559|NCT00943722|38897297|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
16111560|NCT00943722|38897298|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
16111561|NCT00943722|38897299|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
16111562|NCT00943722|38897293|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
16111563|NCT00943722|38897294|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
16111564|NCT00943722|38897295|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
16111565|NCT00943722|38897296|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
16111566|NCT00943722|38897297|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
16111567|NCT00943722|38897298|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
16111568|NCT00943722|38897299|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
16111569|NCT00943722|38897293|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
16111570|NCT00943722|38897294|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
16111571|NCT00943722|38897295|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
16111572|NCT00943722|38897296|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
16346444|NCT00758498|39757158|FG001|Overall Study|Withdrawal by Subject|0|||
16346445|NCT00758498|39757159|FG002|Overall Study|Withdrawal by Subject|1|||
16346446|NCT00758498|39757157|FG000|Overall Study|Noncompliance to study procedures|0|||
16223746|NCT02499172|39298772|FG003|Overall Study|Financial reason|436|||
16223747|NCT02499172|39298769|FG000|Overall Study|Lost to Follow-up|65|||
16223748|NCT02499172|39298770|FG001|Overall Study|Lost to Follow-up|64|||
16223749|NCT02499172|39298771|FG002|Overall Study|Lost to Follow-up|0|||
16223750|NCT02499172|39298772|FG003|Overall Study|Lost to Follow-up|0|||
16223751|NCT03417999|39298773|FG000|Overall Study|Withdrawal by Subject|1|||
16223752|NCT03417999|39298774|FG001|Overall Study|Withdrawal by Subject|0|||
16223753|NCT03417999|39298775|FG002|Overall Study|Withdrawal by Subject|0|||
16223754|NCT03417999|39298773|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
16223755|NCT03417999|39298774|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
16223756|NCT03417999|39298775|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
16223757|NCT03417999|39298773|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
16223758|NCT03417999|39298774|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
16223759|NCT03417999|39298775|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
16223760|NCT03417999|39298773|FG000|Overall Study|Inadequate study staff available to process samples|0|||
16223761|NCT03417999|39298774|FG001|Overall Study|Inadequate study staff available to process samples|0|||
16223762|NCT03417999|39298775|FG002|Overall Study|Inadequate study staff available to process samples|1|||
16223763|NCT03490734|39298776|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
16223764|NCT03490734|39298777|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
16223765|NCT03490734|39298778|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
16223766|NCT03490734|39298779|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
16223767|NCT03490734|39298776|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
16223768|NCT03490734|39298777|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
16223769|NCT03490734|39298778|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
16223770|NCT03490734|39298779|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
16223771|NCT03490734|39298776|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
16346447|NCT00758498|39757158|FG001|Overall Study|Noncompliance to study procedures|0|||
16346448|NCT00758498|39757159|FG002|Overall Study|Noncompliance to study procedures|1|||
16346449|NCT03518086|39757167|FG000|Overall Study|Adverse Event|23|||
16346450|NCT03518086|39757168|FG001|Overall Study|Adverse Event|15|||
16346451|NCT03518086|39757169|FG002|Overall Study|Adverse Event|0|||
16346452|NCT03518086|39757170|FG003|Overall Study|Adverse Event|0|||
16346453|NCT03518086|39757167|FG000|Overall Study|Withdrawal by Subject|8|||
16346454|NCT03518086|39757168|FG001|Overall Study|Withdrawal by Subject|5|||
16346455|NCT03518086|39757169|FG002|Overall Study|Withdrawal by Subject|0|||
16346456|NCT03518086|39757170|FG003|Overall Study|Withdrawal by Subject|0|||
16346457|NCT03518086|39757167|FG000|Overall Study|Lack of Efficacy|5|||
16346458|NCT03518086|39757168|FG001|Overall Study|Lack of Efficacy|5|||
16346459|NCT03518086|39757169|FG002|Overall Study|Lack of Efficacy|0|||
16346460|NCT03518086|39757170|FG003|Overall Study|Lack of Efficacy|0|||
16346461|NCT03518086|39757167|FG000|Overall Study|Protocol Violation|1|||
16346462|NCT03518086|39757168|FG001|Overall Study|Protocol Violation|5|||
16346463|NCT03518086|39757169|FG002|Overall Study|Protocol Violation|0|||
16346464|NCT03518086|39757170|FG003|Overall Study|Protocol Violation|0|||
16346465|NCT03518086|39757167|FG000|Overall Study|Lost to Follow-up|0|||
16346466|NCT03518086|39757168|FG001|Overall Study|Lost to Follow-up|3|||
16346467|NCT03518086|39757169|FG002|Overall Study|Lost to Follow-up|0|||
16346468|NCT03518086|39757170|FG003|Overall Study|Lost to Follow-up|0|||
16346469|NCT03518086|39757167|FG000|Overall Study|Insufficient Diary Data|0|||
16346470|NCT03518086|39757168|FG001|Overall Study|Insufficient Diary Data|2|||
16346471|NCT03518086|39757169|FG002|Overall Study|Insufficient Diary Data|0|||
16346472|NCT03518086|39757170|FG003|Overall Study|Insufficient Diary Data|0|||
16346473|NCT03518086|39757167|FG000|Overall Study|Non- compliance to Protocol|0|||
16346474|NCT03518086|39757168|FG001|Overall Study|Non- compliance to Protocol|1|||
16346475|NCT03518086|39757169|FG002|Overall Study|Non- compliance to Protocol|0|||
16346476|NCT03518086|39757170|FG003|Overall Study|Non- compliance to Protocol|0|||
16346477|NCT03518086|39757167|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
16346478|NCT03518086|39757168|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
16346479|NCT03518086|39757169|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
16346480|NCT03518086|39757170|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
16346481|NCT03518086|39757167|FG000|Overall Study|Site Terminated by Sponsor|0|||
16346482|NCT03518086|39757168|FG001|Overall Study|Site Terminated by Sponsor|1|||
16111573|NCT00943722|38897297|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
16111574|NCT00943722|38897298|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
16111575|NCT00943722|38897299|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
16111576|NCT00943722|38897293|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
16111577|NCT00943722|38897294|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
16111578|NCT00943722|38897295|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
16111579|NCT00943722|38897296|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
16111580|NCT00943722|38897297|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
16111581|NCT00943722|38897298|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
16111582|NCT00943722|38897299|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
16111583|NCT00943722|38897293|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
16111584|NCT00943722|38897294|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
16111585|NCT00943722|38897295|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
16111586|NCT00943722|38897296|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
16111587|NCT00943722|38897297|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
16111588|NCT00943722|38897298|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
16111589|NCT00943722|38897299|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
16111590|NCT00943722|38897293|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
16111591|NCT00943722|38897294|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
16111592|NCT00943722|38897295|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
16111593|NCT00943722|38897296|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
16111594|NCT00943722|38897297|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
16111595|NCT00943722|38897298|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
16111596|NCT00943722|38897299|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
16111597|NCT00943722|38897293|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
16111598|NCT00943722|38897294|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
16111599|NCT00943722|38897295|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
16111600|NCT00943722|38897296|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
16111601|NCT00943722|38897297|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
16111602|NCT00943722|38897298|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
16111603|NCT00943722|38897299|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
16111604|NCT00174447|38897314|FG000|Overall Study|Adverse Event|19|||
16111605|NCT00174447|38897314|FG000|Overall Study|Withdrawal by Subject|15|||
16111606|NCT00174447|38897314|FG000|Overall Study|Protocol Violation|1|||
16111607|NCT00174447|38897314|FG000|Overall Study|Lack of Efficacy|1|||
16111608|NCT00174447|38897314|FG000|Overall Study|Administrative reason/Other|2|||
16111609|NCT01375751|38897315|FG000|Overall Study|Other|0|||
16111610|NCT01375751|38897316|FG001|Overall Study|Other|1|||
16111611|NCT01375751|38897317|FG002|Overall Study|Other|0|||
16111612|NCT02601209|38897318|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
16111613|NCT02601209|38897319|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
16111614|NCT02601209|38897320|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
16111615|NCT02601209|38897321|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16111616|NCT02601209|38897322|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16111617|NCT02601209|38897323|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16111618|NCT02601209|38897324|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16111619|NCT02601209|38897325|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16111620|NCT02601209|38897326|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
16111621|NCT02601209|38897318|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16111622|NCT02601209|38897319|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16111623|NCT02601209|38897320|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16111624|NCT02601209|38897321|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16111625|NCT02601209|38897322|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
16111626|NCT02601209|38897323|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
16111627|NCT02601209|38897324|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
16111628|NCT02601209|38897325|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16111629|NCT02601209|38897326|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
16111630|NCT00784147|38897327|FG000|Overall Study|Lost to Follow-up|2|||
16111631|NCT00784147|38897328|FG001|Overall Study|Lost to Follow-up|4|||
16111632|NCT00784147|38897327|FG000|Overall Study|Withdrawal by Subject|1|||
16111633|NCT00784147|38897328|FG001|Overall Study|Withdrawal by Subject|3|||
16111634|NCT00784147|38897327|FG000|Overall Study|Physician Decision|2|||
16111635|NCT00784147|38897328|FG001|Overall Study|Physician Decision|1|||
16111636|NCT00784147|38897327|FG000|Overall Study|Protocol Violation|1|||
16111637|NCT00784147|38897328|FG001|Overall Study|Protocol Violation|1|||
16111638|NCT00784147|38897327|FG000|Overall Study|Death|2|||
16111639|NCT00784147|38897328|FG001|Overall Study|Death|0|||
16111640|NCT00458393|38897333|FG000|Overall Study|Withdrawal by Subject|67|||
16111641|NCT00458393|38897334|FG001|Overall Study|Withdrawal by Subject|80|||
16223772|NCT03490734|39298777|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
16223773|NCT03490734|39298778|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
16223774|NCT03490734|39298779|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
16223775|NCT03490734|39298776|FG000|Post-intervention Scan Visit|Adverse Event|2|||
16223776|NCT03490734|39298777|FG001|Post-intervention Scan Visit|Adverse Event|0|||
16223777|NCT03490734|39298778|FG002|Post-intervention Scan Visit|Adverse Event|0|||
16223778|NCT03490734|39298779|FG003|Post-intervention Scan Visit|Adverse Event|0|||
16223779|NCT03490734|39298776|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
16223780|NCT03490734|39298777|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
16223781|NCT03490734|39298778|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
16223782|NCT03490734|39298779|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
16223783|NCT03490734|39298776|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
16223784|NCT03490734|39298777|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
16223785|NCT03490734|39298778|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
16223786|NCT03490734|39298779|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
16223787|NCT00508820|39298783|FG000|Overall Study|Adverse Event|6|||
16223788|NCT00508820|39298784|FG001|Overall Study|Adverse Event|10|||
16223789|NCT00508820|39298783|FG000|Overall Study|Death|6|||
16223790|NCT00508820|39298784|FG001|Overall Study|Death|8|||
16223791|NCT00508820|39298783|FG000|Overall Study|Lost to Follow-up|1|||
16223792|NCT00508820|39298784|FG001|Overall Study|Lost to Follow-up|1|||
16223793|NCT00508820|39298783|FG000|Overall Study|Physician Decision|8|||
16223794|NCT00508820|39298784|FG001|Overall Study|Physician Decision|2|||
16223795|NCT00508820|39298783|FG000|Overall Study|Pregnancy|0|||
16223796|NCT00508820|39298784|FG001|Overall Study|Pregnancy|2|||
16223797|NCT00508820|39298783|FG000|Overall Study|Protocol Violation|2|||
16223798|NCT00508820|39298784|FG001|Overall Study|Protocol Violation|0|||
16223799|NCT00508820|39298783|FG000|Overall Study|Withdrawal by Subject|10|||
16223800|NCT00508820|39298784|FG001|Overall Study|Withdrawal by Subject|12|||
16223801|NCT00508820|39298783|FG000|Overall Study|Other|11|||
16223802|NCT00508820|39298784|FG001|Overall Study|Other|2|||
16223803|NCT00508820|39298783|FG000|Overall Study|Noncompliance|1|||
16223804|NCT00508820|39298784|FG001|Overall Study|Noncompliance|0|||
16223805|NCT00508820|39298783|FG000|Overall Study|Requirement for alternative therapy|7|||
16223806|NCT00508820|39298784|FG001|Overall Study|Requirement for alternative therapy|15|||
16223807|NCT00508820|39298783|FG000|Overall Study|Protocol-specified Criteria|3|||
16223808|NCT00508820|39298784|FG001|Overall Study|Protocol-specified Criteria|12|||
16223809|NCT00669240|39298785|FG000|Overall Study|Lack of Efficacy|33|||
16223810|NCT00669240|39298785|FG000|Overall Study|Withdrawal by Subject|42|||
16223811|NCT00669240|39298785|FG000|Overall Study|Lost to Follow-up|34|||
16223812|NCT00669240|39298785|FG000|Overall Study|Adverse Event|21|||
16223813|NCT00669240|39298785|FG000|Overall Study|Other|19|||
16223814|NCT00669240|39298785|FG000|Overall Study|Enrolled but not treated|15|||
16223815|NCT00669240|39298785|FG000|Overall Study|Enrolled but no dosing record|1|||
16546463|NCT04704154|40464809|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
16546464|NCT04704154|40464810|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
16223816|NCT01592773|39298796|FG000|Overall Study|Study Terminated by Sponsor|582|||
16223817|NCT01592773|39298796|FG000|Overall Study|Withdrawal by Subject|35|||
16223818|NCT01592773|39298796|FG000|Overall Study|Lost to Follow-up|19|||
16223819|NCT01592773|39298796|FG000|Overall Study|Adverse Event|17|||
16223820|NCT01592773|39298796|FG000|Overall Study|Lack of Efficacy|9|||
16223821|NCT01592773|39298796|FG000|Overall Study|Protocol Violation|2|||
16223822|NCT01592773|39298796|FG000|Overall Study|Inclusion/exclusion not meet|1|||
16223823|NCT01592773|39298796|FG000|Overall Study|Other Reason|1|||
16223824|NCT01736176|39298797|FG000|Overall Study|Adverse Event|3|||
16223825|NCT01736176|39298797|FG000|Overall Study|Withdrawal by Subject|4|||
16223826|NCT01736176|39298797|FG000|Overall Study|Lack of Efficacy|3|||
16223827|NCT01736176|39298797|FG000|Overall Study|Unable to Complete PEG Placement|1|||
16223828|NCT01948791|39298800|FG000|Overall Study|Adverse Event|12|||
16223829|NCT01948791|39298800|FG000|Overall Study|Lack of Efficacy|3|||
16223830|NCT01948791|39298800|FG000|Overall Study|Protocol Violation|2|||
16223831|NCT01948791|39298800|FG000|Overall Study|Withdrawal by Subject|5|||
16346483|NCT03518086|39757169|FG002|Overall Study|Site Terminated by Sponsor|0|||
16546465|NCT02087501|40464811|FG000|Overall Study|Death|7|||
16546466|NCT02087501|40464811|FG000|Overall Study|Open repair of aneurysm|1|||
16546467|NCT02087501|40464811|FG000|Overall Study|Lost to Follow-up|2|||
16546468|NCT04534114|40464816|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
16546469|NCT04534114|40464817|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
16546470|NCT04534114|40464818|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
16223832|NCT01948791|39298800|FG000|Overall Study|Lost to Follow-up|6|||
16223833|NCT01948791|39298800|FG000|Overall Study|Management issues|1|||
16223834|NCT01948791|39298800|FG000|Overall Study|Others|7|||
16223835|NCT01948791|39298800|FG000|Overall Study|Screening failure|35|||
16346484|NCT03518086|39757170|FG003|Overall Study|Site Terminated by Sponsor|0|||
16346485|NCT03066830|39757171|FG000|Overall Study|At the Participant's own Request|16|||
16346486|NCT03066830|39757172|FG001|Overall Study|At the Participant's own Request|17|||
16409997|NCT02536300|39981855|FG001|Overall Study|Non-compliance With Study Drug|0|||
16409998|NCT02536300|39981856|FG002|Overall Study|Non-compliance With Study Drug|0|||
16409999|NCT02536300|39981854|FG000|Overall Study|Protocol Violation|0|||
16410000|NCT02536300|39981855|FG001|Overall Study|Protocol Violation|1|||
16410001|NCT02536300|39981856|FG002|Overall Study|Protocol Violation|0|||
16410002|NCT04493684|39981858|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
16410003|NCT04493684|39981859|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410004|NCT04493684|39981860|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
16410005|NCT04493684|39981861|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410006|NCT04493684|39981862|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410007|NCT04493684|39981863|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
16410008|NCT04493684|39981864|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410009|NCT04493684|39981865|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410010|NCT04493684|39981866|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410011|NCT04493684|39981867|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410012|NCT04493684|39981868|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410013|NCT04493684|39981869|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410014|NCT04493684|39981870|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410015|NCT04493684|39981871|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410016|NCT04493684|39981872|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410017|NCT04493684|39981873|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410018|NCT04493684|39981874|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
16410019|NCT04493684|39981858|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
16410020|NCT04493684|39981859|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410021|NCT04493684|39981860|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410022|NCT04493684|39981861|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410023|NCT04493684|39981862|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410024|NCT04493684|39981863|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410025|NCT04493684|39981864|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410026|NCT04493684|39981865|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410027|NCT04493684|39981866|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410028|NCT04493684|39981867|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410029|NCT04493684|39981868|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410030|NCT04493684|39981869|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16223836|NCT01667731|39298801|FG000|Overall Study|Enrolled but not treated|0|||
16223837|NCT01667731|39298802|FG001|Overall Study|Enrolled but not treated|0|||
16223838|NCT01667731|39298803|FG002|Overall Study|Enrolled but not treated|0|||
16223839|NCT01667731|39298804|FG003|Overall Study|Enrolled but not treated|0|||
16223840|NCT01667731|39298805|FG004|Overall Study|Enrolled but not treated|1|||
16223841|NCT01667731|39298801|FG000|Overall Study|Efficacy Failure|1|||
16223842|NCT01667731|39298802|FG001|Overall Study|Efficacy Failure|12|||
16346487|NCT03066830|39757171|FG000|Overall Study|Other|3|||
16346488|NCT03066830|39757172|FG001|Overall Study|Other|0|||
16346489|NCT03066830|39757171|FG000|Overall Study|Poor Compliance to Protocol|1|||
16346490|NCT03066830|39757172|FG001|Overall Study|Poor Compliance to Protocol|0|||
16346491|NCT03066830|39757171|FG000|Overall Study|Adverse Event|2|||
16346492|NCT03066830|39757172|FG001|Overall Study|Adverse Event|2|||
16346493|NCT03066830|39757171|FG000|Overall Study|Lost to Follow-up|11|||
16346494|NCT03066830|39757172|FG001|Overall Study|Lost to Follow-up|3|||
16346495|NCT01535443|39757173|FG000|Overall Study|Physician Decision|3|||
16346496|NCT00527826|39757174|FG000|Overall Study|Adverse Event|10|||
16346497|NCT00527826|39757175|FG001|Overall Study|Adverse Event|10|||
16346498|NCT00527826|39757174|FG000|Overall Study|Lost to Follow-up|3|||
16346499|NCT00527826|39757175|FG001|Overall Study|Lost to Follow-up|2|||
16346500|NCT00527826|39757174|FG000|Overall Study|Withdrawal by Subject|5|||
16346501|NCT00527826|39757175|FG001|Overall Study|Withdrawal by Subject|8|||
16346502|NCT00527826|39757174|FG000|Overall Study|Inclusion Criteria Not Met|3|||
16346503|NCT00527826|39757175|FG001|Overall Study|Inclusion Criteria Not Met|3|||
16346504|NCT00527826|39757174|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
16346505|NCT00527826|39757175|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
16346506|NCT00527826|39757174|FG000|Overall Study|Additional Intake of Viani forte|0|||
16346507|NCT00527826|39757175|FG001|Overall Study|Additional Intake of Viani forte|1|||
16346508|NCT00527826|39757174|FG000|Overall Study|Participant moved away|0|||
16346509|NCT00527826|39757175|FG001|Overall Study|Participant moved away|1|||
16346510|NCT02864407|39757178|FG000|Overall Study|Protocol Violation|3|||
16346511|NCT02864407|39757178|FG000|Overall Study|Lost to Follow-up|115|||
16346512|NCT02864407|39757178|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
16410031|NCT04493684|39981870|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410032|NCT04493684|39981871|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410033|NCT04493684|39981872|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410034|NCT04493684|39981873|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410035|NCT04493684|39981874|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
16410036|NCT04493684|39981858|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410037|NCT04493684|39981859|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410038|NCT04493684|39981860|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410039|NCT04493684|39981861|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410040|NCT04493684|39981862|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410041|NCT04493684|39981863|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410042|NCT04493684|39981864|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
16410043|NCT04493684|39981865|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410044|NCT04493684|39981866|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410045|NCT04493684|39981867|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16223843|NCT01667731|39298803|FG002|Overall Study|Efficacy Failure|0|||
16223844|NCT01667731|39298804|FG003|Overall Study|Efficacy Failure|1|||
16410046|NCT04493684|39981868|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16111642|NCT00458393|38897333|FG000|Overall Study|Physician Decision|31|||
16111643|NCT00458393|38897334|FG001|Overall Study|Physician Decision|22|||
16111644|NCT00458393|38897333|FG000|Overall Study|Relocated|77|||
16111645|NCT00458393|38897334|FG001|Overall Study|Relocated|81|||
16111646|NCT00458393|38897333|FG000|Overall Study|Lost to Follow-up|115|||
16111647|NCT00458393|38897334|FG001|Overall Study|Lost to Follow-up|92|||
16111648|NCT00458393|38897333|FG000|Overall Study|Sites marked other on the form.|19|||
16111649|NCT00458393|38897334|FG001|Overall Study|Sites marked other on the form.|20|||
16111650|NCT01318876|38897335|FG000|Day 8 Survey|email address invalid|96|||
16111651|NCT01318876|38897335|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
16111652|NCT01318876|38897335|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
16111653|NCT00208325|38897340|FG000|Overall Study|Death|18|||
16111654|NCT00208325|38897341|FG001|Overall Study|Death|19|||
16111655|NCT00208325|38897342|FG002|Overall Study|Death|7|||
16111656|NCT00208325|38897343|FG003|Overall Study|Death|5|||
16111657|NCT00208325|38897340|FG000|Overall Study|Withdrawal by Subject|0|||
16111658|NCT00208325|38897341|FG001|Overall Study|Withdrawal by Subject|1|||
16111659|NCT00208325|38897342|FG002|Overall Study|Withdrawal by Subject|0|||
16111660|NCT00208325|38897343|FG003|Overall Study|Withdrawal by Subject|0|||
16111661|NCT00208325|38897340|FG000|Overall Study|Revision|4|||
16111662|NCT00208325|38897341|FG001|Overall Study|Revision|1|||
16111663|NCT00208325|38897342|FG002|Overall Study|Revision|0|||
16111664|NCT00208325|38897343|FG003|Overall Study|Revision|4|||
16111665|NCT00208325|38897340|FG000|Overall Study|Lost to Follow-up|1|||
16111666|NCT00208325|38897341|FG001|Overall Study|Lost to Follow-up|0|||
16111667|NCT00208325|38897342|FG002|Overall Study|Lost to Follow-up|2|||
16111668|NCT00208325|38897343|FG003|Overall Study|Lost to Follow-up|0|||
16111669|NCT00208325|38897340|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
16111670|NCT00208325|38897341|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
16111671|NCT00208325|38897342|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
16111672|NCT00208325|38897343|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
16111673|NCT00208325|38897340|FG000|Overall Study|Does not wish to Continue in Study|5|||
16111674|NCT00208325|38897341|FG001|Overall Study|Does not wish to Continue in Study|8|||
16111675|NCT00208325|38897342|FG002|Overall Study|Does not wish to Continue in Study|3|||
16111676|NCT00208325|38897343|FG003|Overall Study|Does not wish to Continue in Study|2|||
16111677|NCT00208325|38897340|FG000|Overall Study|Other|2|||
16111678|NCT00208325|38897341|FG001|Overall Study|Other|1|||
16111679|NCT00208325|38897342|FG002|Overall Study|Other|1|||
16111680|NCT00208325|38897343|FG003|Overall Study|Other|0|||
16111681|NCT00208325|38897340|FG000|Overall Study|Mis-Randomized|17|||
16111682|NCT00208325|38897341|FG001|Overall Study|Mis-Randomized|20|||
16111683|NCT00208325|38897342|FG002|Overall Study|Mis-Randomized|0|||
16111684|NCT00208325|38897343|FG003|Overall Study|Mis-Randomized|0|||
16111685|NCT02153905|38897344|FG000|Overall Study|Death|1|||
16111686|NCT02153905|38897345|FG001|Overall Study|Death|0|||
16111687|NCT00585078|38897347|FG000|Overall Study|Withdrawal by Subject|4|||
16111688|NCT00585078|38897347|FG000|Overall Study|Poor performance status|1|||
16111689|NCT00585078|38897347|FG000|Overall Study|Disease Progression|24|||
16111690|NCT00585078|38897347|FG000|Overall Study|Adverse Event|10|||
16111691|NCT00585078|38897347|FG000|Overall Study|Death|1|||
16111692|NCT03636373|38897348|FG000|Overall Study|Study closure due to Covid-19|1|||
16111693|NCT03636373|38897349|FG001|Overall Study|Study closure due to Covid-19|0|||
16111694|NCT02872311|38897350|FG000|Overall Study|Death|2|||
16111695|NCT02872311|38897351|FG001|Overall Study|Death|0|||
16111696|NCT02872311|38897352|FG002|Overall Study|Death|0|||
16111697|NCT02872311|38897353|FG003|Overall Study|Death|0|||
16111698|NCT02872311|38897354|FG004|Overall Study|Death|0|||
16111699|NCT02872311|38897350|FG000|Overall Study|Lost to Follow-up|2|||
16111700|NCT02872311|38897351|FG001|Overall Study|Lost to Follow-up|0|||
16111701|NCT02872311|38897352|FG002|Overall Study|Lost to Follow-up|0|||
16111702|NCT02872311|38897353|FG003|Overall Study|Lost to Follow-up|0|||
16111703|NCT02872311|38897354|FG004|Overall Study|Lost to Follow-up|0|||
16223845|NCT01667731|39298805|FG004|Overall Study|Efficacy Failure|24|||
16111704|NCT02872311|38897350|FG000|Overall Study|Protocol Violation|0|||
16111705|NCT02872311|38897351|FG001|Overall Study|Protocol Violation|2|||
16111706|NCT02872311|38897352|FG002|Overall Study|Protocol Violation|1|||
16111707|NCT02872311|38897353|FG003|Overall Study|Protocol Violation|0|||
16111708|NCT02872311|38897354|FG004|Overall Study|Protocol Violation|0|||
16111709|NCT02881047|38897355|FG000|Overall Study|Adverse Event|1|||
16111710|NCT02881047|38897355|FG000|Overall Study|Withdrawal by Subject|1|||
16111711|NCT01807182|38897356|FG000|Overall Study|Death|1|||
16223846|NCT01667731|39298801|FG000|Overall Study|Lost to Follow-up|2|||
16346513|NCT02864407|39757178|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
16111712|NCT01807182|38897356|FG000|Overall Study|New therapy|1|||
16111713|NCT01807182|38897356|FG000|Overall Study|Moved to hospice care|1|||
16111714|NCT01667549|38897363|FG000|Overall Study|Withdrawal by Subject|3|||
16111715|NCT01667549|38897364|FG001|Overall Study|Withdrawal by Subject|5|||
16111716|NCT01667549|38897365|FG002|Overall Study|Withdrawal by Subject|7|||
16111717|NCT01667549|38897366|FG003|Overall Study|Withdrawal by Subject|6|||
16111718|NCT01667549|38897367|FG004|Overall Study|Withdrawal by Subject|1|||
16111719|NCT04544865|38897368|FG000|Overall Study|Death|0|||
16111720|NCT04544865|38897369|FG001|Overall Study|Death|2|||
16111721|NCT04544865|38897368|FG000|Overall Study|Lost to Follow-up|11|||
16111722|NCT04544865|38897369|FG001|Overall Study|Lost to Follow-up|7|||
16111723|NCT04544865|38897368|FG000|Overall Study|Withdrawal by Subject|0|||
16111724|NCT04544865|38897369|FG001|Overall Study|Withdrawal by Subject|1|||
16111725|NCT04544865|38897368|FG000|Overall Study|Other|0|||
16111726|NCT04544865|38897369|FG001|Overall Study|Other|1|||
16111727|NCT02548078|38897370|FG000|Overall Study|Serious adverse event/Adverse event|1|||
16111728|NCT02548078|38897371|FG001|Overall Study|Serious adverse event/Adverse event|0|||
16111729|NCT02548078|38897370|FG000|Overall Study|Moved from study area|3|||
16111730|NCT02548078|38897371|FG001|Overall Study|Moved from study area|3|||
16111731|NCT02548078|38897370|FG000|Overall Study|Lost to Follow-up|1|||
16111732|NCT02548078|38897371|FG001|Overall Study|Lost to Follow-up|3|||
16111733|NCT02460562|38897372|FG000|Overall Study|Lost to Follow-up|15|||
16111734|NCT02460562|38897373|FG001|Overall Study|Lost to Follow-up|16|||
16111735|NCT04354168|38897374|FG000|Overall Study|Lost to Follow-up|22|||
16111736|NCT04160988|38897375|FG000|Overall Study|poor image quality|28|||
16111737|NCT03113383|38897376|FG000|Overall Study|Death|4|||
16111738|NCT03113383|38897377|FG001|Overall Study|Death|0|||
16111739|NCT01310699|38897381|FG000|Overall Study|Patients did not complete tandem.|4|||
16111740|NCT01310699|38897382|FG001|Overall Study|Patients did not complete tandem.|6|||
16111741|NCT01013961|38897383|FG000|Overall Study|Adverse Event|2|||
16111742|NCT01013961|38897384|FG001|Overall Study|Adverse Event|2|||
16111743|NCT01013961|38897383|FG000|Overall Study|Withdrawal by Subject|1|||
16111744|NCT01013961|38897384|FG001|Overall Study|Withdrawal by Subject|0|||
16111745|NCT01013961|38897383|FG000|Overall Study|Physician Decision|0|||
16111746|NCT01013961|38897384|FG001|Overall Study|Physician Decision|1|||
16111747|NCT00085566|38897388|FG000|Overall Study|Adverse Event|0|||
16111748|NCT00085566|38897389|FG001|Overall Study|Adverse Event|0|||
16111749|NCT00085566|38897390|FG002|Overall Study|Adverse Event|10|||
16111750|NCT00085566|38897388|FG000|Overall Study|Patient Not treated|0|||
16111751|NCT00085566|38897389|FG001|Overall Study|Patient Not treated|0|||
16111752|NCT00085566|38897390|FG002|Overall Study|Patient Not treated|3|||
16111753|NCT00085566|38897388|FG000|Overall Study|Clinical progression|0|||
16111754|NCT00085566|38897389|FG001|Overall Study|Clinical progression|0|||
16111755|NCT00085566|38897390|FG002|Overall Study|Clinical progression|1|||
16111756|NCT03080493|38897391|FG000|Overall Study|Did not provide NRS pain results|1|||
16111757|NCT03080493|38897392|FG001|Overall Study|Did not provide NRS pain results|0|||
16111758|NCT03080493|38897391|FG000|Overall Study|Adverse Event|0|||
16111759|NCT03080493|38897392|FG001|Overall Study|Adverse Event|1|||
16111760|NCT03080493|38897391|FG000|Overall Study|Randomization error (parity group)|0|||
16111761|NCT03080493|38897392|FG001|Overall Study|Randomization error (parity group)|1|||
16111762|NCT01263054|38897394|FG000|Overall Study|Death|1|||
16111763|NCT01263054|38897395|FG001|Overall Study|Death|0|||
16111764|NCT01263054|38897394|FG000|Overall Study|Lost to Follow-up|2|||
16111765|NCT01263054|38897395|FG001|Overall Study|Lost to Follow-up|2|||
16111766|NCT01263054|38897394|FG000|Overall Study|Withdrawal by Subject|1|||
16111767|NCT01263054|38897395|FG001|Overall Study|Withdrawal by Subject|3|||
16111768|NCT01263054|38897394|FG000|Overall Study|Qualification Violation|1|||
16111769|NCT01263054|38897395|FG001|Overall Study|Qualification Violation|0|||
16111770|NCT01263054|38897394|FG000|Overall Study|Other|0|||
16111771|NCT01263054|38897395|FG001|Overall Study|Other|1|||
16111772|NCT00025662|38897396|FG000|Overall Study|Withdrawal by Subject|2|||
16111773|NCT00025662|38897396|FG000|Overall Study|Technical failure of manipulation|1|||
16111774|NCT01639742|38897400|FG000|Overall Study|Study Ongoing|17|||
16111775|NCT01639742|38897400|FG000|Overall Study|Lost to Follow-up|1|||
16111776|NCT02419417|38897401|FG000|Overall Study|Disease progression|5|||
16111777|NCT02419417|38897402|FG001|Overall Study|Disease progression|4|||
16111778|NCT02419417|38897403|FG002|Overall Study|Disease progression|13|||
16111779|NCT02419417|38897404|FG003|Overall Study|Disease progression|10|||
16111780|NCT02419417|38897405|FG004|Overall Study|Disease progression|10|||
16111781|NCT02419417|38897406|FG005|Overall Study|Disease progression|3|||
16111782|NCT02419417|38897407|FG006|Overall Study|Disease progression|4|||
16111783|NCT02419417|38897408|FG007|Overall Study|Disease progression|5|||
16111784|NCT02419417|38897409|FG008|Overall Study|Disease progression|13|||
16111785|NCT02419417|38897410|FG009|Overall Study|Disease progression|9|||
16111786|NCT02419417|38897411|FG010|Overall Study|Disease progression|0|||
16111787|NCT02419417|38897401|FG000|Overall Study|Study drug toxicity|0|||
16111788|NCT02419417|38897402|FG001|Overall Study|Study drug toxicity|0|||
16111789|NCT02419417|38897403|FG002|Overall Study|Study drug toxicity|0|||
16111790|NCT02419417|38897404|FG003|Overall Study|Study drug toxicity|0|||
16111791|NCT02419417|38897405|FG004|Overall Study|Study drug toxicity|1|||
16111792|NCT02419417|38897406|FG005|Overall Study|Study drug toxicity|0|||
16111793|NCT02419417|38897407|FG006|Overall Study|Study drug toxicity|0|||
16111794|NCT02419417|38897408|FG007|Overall Study|Study drug toxicity|0|||
16111795|NCT02419417|38897409|FG008|Overall Study|Study drug toxicity|0|||
16111796|NCT02419417|38897410|FG009|Overall Study|Study drug toxicity|0|||
16111797|NCT02419417|38897411|FG010|Overall Study|Study drug toxicity|0|||
16111798|NCT02419417|38897401|FG000|Overall Study|Adverse event unrelated to study drug|0|||
16111799|NCT02419417|38897402|FG001|Overall Study|Adverse event unrelated to study drug|0|||
16111800|NCT02419417|38897403|FG002|Overall Study|Adverse event unrelated to study drug|0|||
16111801|NCT02419417|38897404|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16111802|NCT02419417|38897405|FG004|Overall Study|Adverse event unrelated to study drug|2|||
16111803|NCT02419417|38897406|FG005|Overall Study|Adverse event unrelated to study drug|1|||
16111804|NCT02419417|38897407|FG006|Overall Study|Adverse event unrelated to study drug|0|||
16111805|NCT02419417|38897408|FG007|Overall Study|Adverse event unrelated to study drug|1|||
16111806|NCT02419417|38897409|FG008|Overall Study|Adverse event unrelated to study drug|0|||
16111807|NCT02419417|38897410|FG009|Overall Study|Adverse event unrelated to study drug|0|||
16111808|NCT02419417|38897411|FG010|Overall Study|Adverse event unrelated to study drug|0|||
16111809|NCT02419417|38897401|FG000|Overall Study|Participant request to discontinue|0|||
16111810|NCT02419417|38897402|FG001|Overall Study|Participant request to discontinue|0|||
16111811|NCT02419417|38897403|FG002|Overall Study|Participant request to discontinue|0|||
16111812|NCT02419417|38897404|FG003|Overall Study|Participant request to discontinue|0|||
16111813|NCT02419417|38897405|FG004|Overall Study|Participant request to discontinue|0|||
16111814|NCT02419417|38897406|FG005|Overall Study|Participant request to discontinue|0|||
16111815|NCT02419417|38897407|FG006|Overall Study|Participant request to discontinue|0|||
16111816|NCT02419417|38897408|FG007|Overall Study|Participant request to discontinue|0|||
16111817|NCT02419417|38897409|FG008|Overall Study|Participant request to discontinue|0|||
16111818|NCT02419417|38897410|FG009|Overall Study|Participant request to discontinue|1|||
16111819|NCT02419417|38897411|FG010|Overall Study|Participant request to discontinue|0|||
16111820|NCT02419417|38897401|FG000|Overall Study|Withdrawal by Subject|0|||
16111821|NCT02419417|38897402|FG001|Overall Study|Withdrawal by Subject|0|||
16111822|NCT02419417|38897403|FG002|Overall Study|Withdrawal by Subject|0|||
16111823|NCT02419417|38897404|FG003|Overall Study|Withdrawal by Subject|0|||
16111824|NCT02419417|38897405|FG004|Overall Study|Withdrawal by Subject|0|||
16111825|NCT02419417|38897406|FG005|Overall Study|Withdrawal by Subject|0|||
16111826|NCT02419417|38897407|FG006|Overall Study|Withdrawal by Subject|0|||
16111827|NCT02419417|38897408|FG007|Overall Study|Withdrawal by Subject|0|||
16111828|NCT02419417|38897409|FG008|Overall Study|Withdrawal by Subject|0|||
16111829|NCT02419417|38897410|FG009|Overall Study|Withdrawal by Subject|0|||
16111830|NCT02419417|38897411|FG010|Overall Study|Withdrawal by Subject|1|||
16111831|NCT04140266|38897418|FG000|Overall Study|Physician Decision|2|||
16111832|NCT04140266|38897419|FG001|Overall Study|Physician Decision|0|||
16111833|NCT04140266|38897418|FG000|Overall Study|Withdrawal by Subject|4|||
16111834|NCT04140266|38897419|FG001|Overall Study|Withdrawal by Subject|2|||
16111835|NCT02062645|38897422|FG000|Overall Study|Adverse Event|2|||
16111836|NCT02062645|38897422|FG000|Overall Study|Protocol Violation|8|||
16111837|NCT02062645|38897422|FG000|Overall Study|Lost to Follow-up|5|||
16111838|NCT01436305|38897425|FG000|Overall Study|Death|1|||
16111839|NCT01436305|38897426|FG001|Overall Study|Death|0|||
16111840|NCT01436305|38897427|FG002|Overall Study|Death|0|||
16111841|NCT01436305|38897425|FG000|Overall Study|Lost to Follow-up|0|||
16111842|NCT01436305|38897426|FG001|Overall Study|Lost to Follow-up|1|||
16111843|NCT01436305|38897427|FG002|Overall Study|Lost to Follow-up|0|||
16111844|NCT01436305|38897425|FG000|Overall Study|Withdrawal by Subject|1|||
16111845|NCT01436305|38897426|FG001|Overall Study|Withdrawal by Subject|3|||
16111846|NCT01436305|38897427|FG002|Overall Study|Withdrawal by Subject|0|||
16111847|NCT01628692|38897428|FG000|Overall Study|Lack of Efficacy|4|||
16111848|NCT01628692|38897429|FG001|Overall Study|Lack of Efficacy|4|||
16111849|NCT01628692|38897430|FG002|Overall Study|Lack of Efficacy|5|||
16111850|NCT01628692|38897431|FG003|Overall Study|Lack of Efficacy|1|||
16111851|NCT01628692|38897432|FG004|Overall Study|Lack of Efficacy|4|||
16111852|NCT01628692|38897433|FG005|Overall Study|Lack of Efficacy|7|||
16111853|NCT01628692|38897428|FG000|Overall Study|Adverse Event|2|||
16111854|NCT01628692|38897429|FG001|Overall Study|Adverse Event|0|||
16111855|NCT01628692|38897430|FG002|Overall Study|Adverse Event|2|||
16111856|NCT01628692|38897431|FG003|Overall Study|Adverse Event|0|||
16111857|NCT01628692|38897432|FG004|Overall Study|Adverse Event|0|||
16111858|NCT01628692|38897433|FG005|Overall Study|Adverse Event|0|||
16111859|NCT01628692|38897428|FG000|Overall Study|Withdrawal by Subject|0|||
16111860|NCT01628692|38897429|FG001|Overall Study|Withdrawal by Subject|1|||
16111861|NCT01628692|38897430|FG002|Overall Study|Withdrawal by Subject|1|||
16111862|NCT01628692|38897431|FG003|Overall Study|Withdrawal by Subject|0|||
16111863|NCT01628692|38897432|FG004|Overall Study|Withdrawal by Subject|0|||
16111864|NCT01628692|38897433|FG005|Overall Study|Withdrawal by Subject|0|||
16111865|NCT01628692|38897428|FG000|Overall Study|Death|0|||
16111866|NCT01628692|38897429|FG001|Overall Study|Death|1|||
16111867|NCT01628692|38897430|FG002|Overall Study|Death|0|||
16111868|NCT01628692|38897431|FG003|Overall Study|Death|0|||
16111869|NCT01628692|38897432|FG004|Overall Study|Death|0|||
16111870|NCT01628692|38897433|FG005|Overall Study|Death|0|||
16111871|NCT01628692|38897428|FG000|Overall Study|Poor compliance/noncompliance|1|||
16111872|NCT01628692|38897429|FG001|Overall Study|Poor compliance/noncompliance|0|||
16111873|NCT01628692|38897430|FG002|Overall Study|Poor compliance/noncompliance|0|||
16111874|NCT01628692|38897431|FG003|Overall Study|Poor compliance/noncompliance|0|||
16111875|NCT01628692|38897432|FG004|Overall Study|Poor compliance/noncompliance|0|||
16111876|NCT01628692|38897433|FG005|Overall Study|Poor compliance/noncompliance|0|||
16111877|NCT01628692|38897428|FG000|Overall Study|Administrative reason by sponsor|0|||
16111878|NCT01628692|38897429|FG001|Overall Study|Administrative reason by sponsor|0|||
16111879|NCT01628692|38897430|FG002|Overall Study|Administrative reason by sponsor|0|||
16111880|NCT01628692|38897431|FG003|Overall Study|Administrative reason by sponsor|0|||
16111881|NCT01628692|38897432|FG004|Overall Study|Administrative reason by sponsor|0|||
16111882|NCT01628692|38897433|FG005|Overall Study|Administrative reason by sponsor|1|||
16111883|NCT01628692|38897428|FG000|Overall Study|Completed 12 Week only|0|||
16223847|NCT01667731|39298802|FG001|Overall Study|Lost to Follow-up|3|||
16223848|NCT01667731|39298803|FG002|Overall Study|Lost to Follow-up|1|||
16223849|NCT01667731|39298804|FG003|Overall Study|Lost to Follow-up|1|||
16346514|NCT02864407|39757178|FG000|Overall Study|Consent prior to the contract date|1|||
16546471|NCT04534114|40464819|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
16546472|NCT04534114|40464816|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
16546473|NCT04534114|40464817|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
16546474|NCT04534114|40464818|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
16546475|NCT04534114|40464819|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
16546476|NCT04534114|40464816|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
16546477|NCT04534114|40464817|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
16546478|NCT04534114|40464818|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
16546479|NCT04534114|40464819|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
16546480|NCT04534114|40464816|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
16546481|NCT04534114|40464817|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
16546482|NCT04534114|40464818|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
16546483|NCT04534114|40464819|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
16546484|NCT04534114|40464816|FG000|Main Treatment Period|Physician Decision|0|||
16546485|NCT04534114|40464817|FG001|Main Treatment Period|Physician Decision|0|||
16546486|NCT04534114|40464818|FG002|Main Treatment Period|Physician Decision|0|||
16546487|NCT04534114|40464819|FG003|Main Treatment Period|Physician Decision|1|||
16546488|NCT04534114|40464816|FG000|Main Treatment Period|Death|1|||
16546489|NCT04534114|40464817|FG001|Main Treatment Period|Death|0|||
16546490|NCT04534114|40464818|FG002|Main Treatment Period|Death|0|||
16546491|NCT04534114|40464819|FG003|Main Treatment Period|Death|1|||
16546492|NCT04534114|40464816|FG000|Main Treatment Period|Other reason|1|||
16546493|NCT04534114|40464817|FG001|Main Treatment Period|Other reason|1|||
16546494|NCT04534114|40464818|FG002|Main Treatment Period|Other reason|0|||
16546495|NCT04534114|40464819|FG003|Main Treatment Period|Other reason|0|||
16546496|NCT04534114|40464816|FG000|Main Treatment Period|Participant decision|1|||
16546497|NCT04534114|40464817|FG001|Main Treatment Period|Participant decision|3|||
16546498|NCT04534114|40464818|FG002|Main Treatment Period|Participant decision|3|||
16546499|NCT04534114|40464819|FG003|Main Treatment Period|Participant decision|1|||
16546500|NCT04534114|40464816|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
16346515|NCT00905424|39757179|FG000|Overall Study|Lost to Follow-up|3|||
16346516|NCT00905424|39757180|FG001|Overall Study|Lost to Follow-up|3|||
16346517|NCT00905424|39757179|FG000|Overall Study|Withdrawal by Subject|1|||
16346518|NCT00905424|39757180|FG001|Overall Study|Withdrawal by Subject|2|||
16346519|NCT00905424|39757179|FG000|Overall Study|Adverse Event|4|||
16346520|NCT00905424|39757180|FG001|Overall Study|Adverse Event|2|||
16346521|NCT00905424|39757179|FG000|Overall Study|Non-compliance with study medication|2|||
16346522|NCT00905424|39757180|FG001|Overall Study|Non-compliance with study medication|0|||
16346523|NCT00905424|39757179|FG000|Overall Study|Sponsor decision|1|||
16346524|NCT00905424|39757180|FG001|Overall Study|Sponsor decision|0|||
16346525|NCT00905424|39757179|FG000|Overall Study|Positive urine drug screen|0|||
16346526|NCT00905424|39757180|FG001|Overall Study|Positive urine drug screen|1|||
16346527|NCT00905424|39757179|FG000|Overall Study|Non-adherence to visit schedule|0|||
16346528|NCT00905424|39757180|FG001|Overall Study|Non-adherence to visit schedule|1|||
16346529|NCT02256839|39757184|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
16346530|NCT02256839|39757185|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
16346531|NCT04878055|39757186|FG000|Overall Study|Patient transferred in another department|0|||
16346532|NCT04878055|39757187|FG001|Overall Study|Patient transferred in another department|2|||
16346533|NCT04878055|39757186|FG000|Overall Study|Physician Decision|1|||
16346534|NCT04878055|39757187|FG001|Overall Study|Physician Decision|1|||
16346535|NCT04878055|39757186|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
16346536|NCT04878055|39757187|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
16346537|NCT04878055|39757186|FG000|Overall Study|Adverse Event|12|||
16346538|NCT04878055|39757187|FG001|Overall Study|Adverse Event|7|||
16346539|NCT04878055|39757186|FG000|Overall Study|Other|5|||
16346540|NCT04878055|39757187|FG001|Overall Study|Other|0|||
16346541|NCT04878055|39757186|FG000|Overall Study|Withdrawal by Subject|7|||
16111884|NCT01628692|38897429|FG001|Overall Study|Completed 12 Week only|0|||
16111885|NCT01628692|38897430|FG002|Overall Study|Completed 12 Week only|0|||
16111886|NCT01628692|38897431|FG003|Overall Study|Completed 12 Week only|0|||
16111887|NCT01628692|38897432|FG004|Overall Study|Completed 12 Week only|0|||
16111888|NCT01628692|38897433|FG005|Overall Study|Completed 12 Week only|1|||
16111889|NCT01163474|38897434|FG000|Overall Study|Withdrawal by Subject|1|||
16111890|NCT01163474|38897434|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
16111891|NCT01163474|38897434|FG000|Overall Study|Lost to Follow-up|3|||
16111892|NCT01077128|38897435|FG000|Overall Study|Adverse Event|8|||
16111893|NCT01077128|38897435|FG000|Overall Study|Lack of Efficacy|1|||
16111894|NCT01077128|38897435|FG000|Overall Study|Disease exacerbation|1|||
16111895|NCT01077128|38897435|FG000|Overall Study|Adverse event and consent withdrawal|1|||
16111896|NCT01077128|38897435|FG000|Overall Study|Adverse event and disease exacerbation|1|||
16111897|NCT01077128|38897435|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
16111898|NCT01077128|38897435|FG000|Overall Study|Other|54|||
16111899|NCT02844777|38897436|FG000|Overall Study|Withdrawal by Subject|2|||
16111900|NCT02844777|38897437|FG001|Overall Study|Withdrawal by Subject|0|||
16111901|NCT02844777|38897438|FG002|Overall Study|Withdrawal by Subject|0|||
16111902|NCT02684123|38897440|FG000|Phase 1|Lack of Efficacy|5|||
16111903|NCT02684123|38897441|FG001|Phase 1|Lack of Efficacy|0|||
16111904|NCT02684123|38897440|FG000|Phase 1|Adverse Event|3|||
16111905|NCT02684123|38897441|FG001|Phase 1|Adverse Event|0|||
16111906|NCT02684123|38897440|FG000|Phase 1|Lost to Follow-up|0|||
16111907|NCT02684123|38897441|FG001|Phase 1|Lost to Follow-up|1|||
16111908|NCT02684123|38897440|FG000|Phase 2|Lack of Efficacy|1|||
16111909|NCT02684123|38897441|FG001|Phase 2|Lack of Efficacy|8|||
16111910|NCT02296892|38897442|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
16111911|NCT02296892|38897443|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
16111912|NCT02296892|38897444|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
16111913|NCT02296892|38897442|FG000|Overall Study|Lost to Follow-up|5|||
16111914|NCT02296892|38897443|FG001|Overall Study|Lost to Follow-up|0|||
16111915|NCT02296892|38897444|FG002|Overall Study|Lost to Follow-up|1|||
16111916|NCT03358238|38897445|FG000|Overall Study|Withdrawal by Subject|0|||
16111917|NCT03358238|38897446|FG001|Overall Study|Withdrawal by Subject|1|||
16111918|NCT03432390|38897450|FG000|Apnea Period|Protocol Violation|2|||
16111919|NCT03432390|38897451|FG001|Apnea Period|Protocol Violation|2|||
16111920|NCT00781937|38897452|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
16111921|NCT00781937|38897453|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
16111922|NCT00781937|38897452|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
16111923|NCT00781937|38897453|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
16111924|NCT00781937|38897452|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
16111925|NCT00781937|38897453|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
16111926|NCT00781937|38897452|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
16111927|NCT00781937|38897453|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
16111928|NCT00781937|38897452|FG000|Main Trial Period Through Week 56|Unclassified|10|||
16111929|NCT00781937|38897453|FG001|Main Trial Period Through Week 56|Unclassified|15|||
16111930|NCT00781937|38897452|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
16111931|NCT00781937|38897453|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
16111932|NCT00781937|38897452|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
16111933|NCT00781937|38897453|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
16111934|NCT00863798|38897466|FG000|Overall Study|Adverse Event|5|||
16111935|NCT00863798|38897467|FG001|Overall Study|Adverse Event|2|||
16111936|NCT00863798|38897468|FG002|Overall Study|Adverse Event|4|||
16111937|NCT00863798|38897466|FG000|Overall Study|Participant failed to return|2|||
16111938|NCT00863798|38897467|FG001|Overall Study|Participant failed to return|1|||
16111939|NCT00863798|38897468|FG002|Overall Study|Participant failed to return|0|||
16111940|NCT00863798|38897466|FG000|Overall Study|Investigator request|1|||
16111941|NCT00863798|38897467|FG001|Overall Study|Investigator request|2|||
16111942|NCT00863798|38897468|FG002|Overall Study|Investigator request|1|||
16111943|NCT00863798|38897466|FG000|Overall Study|Lack of Efficacy|4|||
16111944|NCT00863798|38897467|FG001|Overall Study|Lack of Efficacy|3|||
16111945|NCT00863798|38897468|FG002|Overall Study|Lack of Efficacy|6|||
16111946|NCT00863798|38897466|FG000|Overall Study|Lost to Follow-up|6|||
16111947|NCT00863798|38897467|FG001|Overall Study|Lost to Follow-up|9|||
16111948|NCT00863798|38897468|FG002|Overall Study|Lost to Follow-up|5|||
16111949|NCT00863798|38897466|FG000|Overall Study|Other|2|||
16111950|NCT00863798|38897467|FG001|Overall Study|Other|3|||
16111951|NCT00863798|38897468|FG002|Overall Study|Other|1|||
16111952|NCT00863798|38897466|FG000|Overall Study|Protocol Violation|0|||
16111953|NCT00863798|38897467|FG001|Overall Study|Protocol Violation|1|||
16111954|NCT00863798|38897468|FG002|Overall Study|Protocol Violation|1|||
16111955|NCT00863798|38897466|FG000|Overall Study|Withdrawal by Subject|8|||
16111956|NCT00863798|38897467|FG001|Overall Study|Withdrawal by Subject|7|||
16111957|NCT00863798|38897468|FG002|Overall Study|Withdrawal by Subject|4|||
16111958|NCT00863798|38897466|FG000|Overall Study|Randomized not treated|4|||
16111959|NCT00863798|38897467|FG001|Overall Study|Randomized not treated|2|||
16111960|NCT00863798|38897468|FG002|Overall Study|Randomized not treated|3|||
16111961|NCT00511836|38897469|FG000|Double-blind Period|Lost to Follow-up|1|||
16111962|NCT00511836|38897470|FG001|Double-blind Period|Lost to Follow-up|0|||
16111963|NCT02058836|38897473|FG000|Overall Study|Withdrawal by Subject|1|||
16111964|NCT02058836|38897474|FG001|Overall Study|Withdrawal by Subject|1|||
16111965|NCT01304498|38897475|FG000|Overall Study|Adverse Event|1|||
16111966|NCT01304498|38897476|FG001|Overall Study|Adverse Event|1|||
16111967|NCT01304498|38897475|FG000|Overall Study|Withdrawal by Subject|2|||
16111968|NCT01304498|38897476|FG001|Overall Study|Withdrawal by Subject|3|||
16111969|NCT01304498|38897475|FG000|Overall Study|Protocol Violation|1|||
16111970|NCT01304498|38897476|FG001|Overall Study|Protocol Violation|0|||
16111971|NCT01304498|38897475|FG000|Overall Study|Lost to Follow-up|2|||
16111972|NCT01304498|38897476|FG001|Overall Study|Lost to Follow-up|1|||
16111973|NCT05071313|38897488|FG000|Overall Study|Lost to Follow-up|17|||
16111974|NCT05071313|38897489|FG001|Overall Study|Lost to Follow-up|10|||
16111975|NCT05071313|38897488|FG000|Overall Study|Physician Decision|1|||
16111976|NCT05071313|38897489|FG001|Overall Study|Physician Decision|6|||
16111977|NCT05071313|38897488|FG000|Overall Study|Death|1|||
16111978|NCT05071313|38897489|FG001|Overall Study|Death|0|||
16111979|NCT05071313|38897488|FG000|Overall Study|Withdrawal by Subject|10|||
16111980|NCT05071313|38897489|FG001|Overall Study|Withdrawal by Subject|15|||
16111981|NCT05071313|38897488|FG000|Overall Study|Other|1|||
16111982|NCT05071313|38897489|FG001|Overall Study|Other|0|||
16111983|NCT05071313|38897488|FG000|Overall Study|Randomized but not vaccinated|4|||
16111984|NCT05071313|38897489|FG001|Overall Study|Randomized but not vaccinated|2|||
16223850|NCT01667731|39298805|FG004|Overall Study|Lost to Follow-up|2|||
16223851|NCT01667731|39298801|FG000|Overall Study|Subject Withdrew Consent|2|||
16111985|NCT00760513|38897490|FG000|Overall Study|Withdrawal by Subject|5|||
16111986|NCT00760513|38897491|FG001|Overall Study|Withdrawal by Subject|7|||
16111987|NCT00913523|38897492|FG000|Overall Study|Withdrawal by Subject|3|||
16111988|NCT00913523|38897493|FG001|Overall Study|Withdrawal by Subject|2|||
16111989|NCT00913523|38897494|FG002|Overall Study|Withdrawal by Subject|2|||
16111990|NCT00913523|38897492|FG000|Overall Study|Lost to Follow-up|1|||
16111991|NCT00913523|38897493|FG001|Overall Study|Lost to Follow-up|1|||
16111992|NCT00913523|38897494|FG002|Overall Study|Lost to Follow-up|1|||
16111993|NCT00913523|38897492|FG000|Overall Study|Adverse Event|1|||
16111994|NCT00913523|38897493|FG001|Overall Study|Adverse Event|0|||
16111995|NCT00913523|38897494|FG002|Overall Study|Adverse Event|0|||
16111996|NCT00913523|38897492|FG000|Overall Study|Protocol Violation|5|||
16111997|NCT00913523|38897493|FG001|Overall Study|Protocol Violation|8|||
16111998|NCT00913523|38897494|FG002|Overall Study|Protocol Violation|8|||
16111999|NCT00913523|38897492|FG000|Overall Study|Pregnancy|1|||
16112000|NCT00913523|38897493|FG001|Overall Study|Pregnancy|3|||
16112001|NCT00913523|38897494|FG002|Overall Study|Pregnancy|0|||
16112002|NCT00913523|38897492|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
16112003|NCT00913523|38897493|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
16112004|NCT00913523|38897494|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
16112005|NCT01896726|38897495|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
16112006|NCT01896726|38897495|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
16112007|NCT00490945|38897498|FG000|Overall Study|Adverse Event|0|||
16112008|NCT00490945|38897499|FG001|Overall Study|Adverse Event|1|||
16112009|NCT00490945|38897500|FG002|Overall Study|Adverse Event|0|||
16112010|NCT00490945|38897501|FG003|Overall Study|Adverse Event|0|||
16112011|NCT00490945|38897502|FG004|Overall Study|Adverse Event|0|||
16112012|NCT00992992|38897503|FG000|Overall Study|Lost to Follow-up|3|||
16112013|NCT00992992|38897503|FG000|Overall Study|Death|16|||
16112014|NCT00992992|38897503|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
16112015|NCT00992992|38897503|FG000|Overall Study|Sponsor Closed the Study|4|||
16112016|NCT01333111|38897504|FG000|Overall Study|patient undergoing major surgery|0|||
16112017|NCT01333111|38897505|FG001|Overall Study|patient undergoing major surgery|2|||
16112018|NCT01333111|38897506|FG002|Overall Study|patient undergoing major surgery|0|||
16112019|NCT01333111|38897504|FG000|Overall Study|personal reasons|0|||
16112020|NCT01333111|38897505|FG001|Overall Study|personal reasons|0|||
16112021|NCT01333111|38897506|FG002|Overall Study|personal reasons|1|||
16112022|NCT01333111|38897504|FG000|Overall Study|unclassified|1|||
16112023|NCT01333111|38897505|FG001|Overall Study|unclassified|0|||
16112024|NCT01333111|38897506|FG002|Overall Study|unclassified|0|||
16112025|NCT01333111|38897504|FG000|Overall Study|withdrawal criteria|0|||
16112026|NCT01333111|38897505|FG001|Overall Study|withdrawal criteria|1|||
16112027|NCT01333111|38897506|FG002|Overall Study|withdrawal criteria|0|||
16112028|NCT01333111|38897504|FG000|Overall Study|Non-compliance|1|||
16112029|NCT01333111|38897505|FG001|Overall Study|Non-compliance|0|||
16112030|NCT01333111|38897506|FG002|Overall Study|Non-compliance|0|||
16112031|NCT01333111|38897504|FG000|Overall Study|Ineffective therapy|0|||
16112032|NCT01333111|38897505|FG001|Overall Study|Ineffective therapy|0|||
16112033|NCT01333111|38897506|FG002|Overall Study|Ineffective therapy|1|||
16112034|NCT02172911|38897507|FG000|Overall Study|Serious Adverse Event|0|||
16112035|NCT02172911|38897508|FG001|Overall Study|Serious Adverse Event|1|||
16112036|NCT02172911|38897507|FG000|Overall Study|Progression of Disease|0|||
16112037|NCT02172911|38897508|FG001|Overall Study|Progression of Disease|1|||
16112038|NCT02172911|38897507|FG000|Overall Study|Loss of insurance coverage|1|||
16112039|NCT02172911|38897508|FG001|Overall Study|Loss of insurance coverage|0|||
16112040|NCT02980523|38897509|FG000|Overall Study|Lost to Follow-up|1|||
16112041|NCT02980523|38897510|FG001|Overall Study|Lost to Follow-up|4|||
16112042|NCT02980523|38897511|FG002|Overall Study|Lost to Follow-up|1|||
16112043|NCT02980523|38897512|FG003|Overall Study|Lost to Follow-up|2|||
16112044|NCT02980523|38897513|FG004|Overall Study|Lost to Follow-up|1|||
16112045|NCT02980523|38897509|FG000|Overall Study|Excluded from analysis|1|||
16112046|NCT02980523|38897510|FG001|Overall Study|Excluded from analysis|3|||
16112047|NCT02980523|38897511|FG002|Overall Study|Excluded from analysis|1|||
16112048|NCT02980523|38897512|FG003|Overall Study|Excluded from analysis|1|||
16112049|NCT02980523|38897513|FG004|Overall Study|Excluded from analysis|1|||
16112050|NCT02980523|38897509|FG000|Overall Study|Lack of Efficacy|1|||
16112051|NCT02980523|38897510|FG001|Overall Study|Lack of Efficacy|4|||
16112052|NCT02980523|38897511|FG002|Overall Study|Lack of Efficacy|4|||
16112053|NCT02980523|38897512|FG003|Overall Study|Lack of Efficacy|5|||
16112054|NCT02980523|38897513|FG004|Overall Study|Lack of Efficacy|8|||
16346542|NCT04878055|39757187|FG001|Overall Study|Withdrawal by Subject|3|||
16346543|NCT04878055|39757186|FG000|Overall Study|Lost to Follow-up|10|||
16112055|NCT02980523|38897509|FG000|Overall Study|Did not receive intervention|0|||
16112056|NCT02980523|38897510|FG001|Overall Study|Did not receive intervention|0|||
16112057|NCT02980523|38897511|FG002|Overall Study|Did not receive intervention|0|||
16112058|NCT02980523|38897512|FG003|Overall Study|Did not receive intervention|1|||
16112059|NCT02980523|38897513|FG004|Overall Study|Did not receive intervention|0|||
16410047|NCT04493684|39981869|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16112060|NCT00623363|38897514|FG000|Overall Study|Adverse Event|2|||
16112061|NCT00623363|38897515|FG001|Overall Study|Adverse Event|2|||
16112062|NCT01078922|38897518|FG000|Overall Study|Adverse Event|1|||
16112063|NCT01200290|38897519|FG000|Treatment Period|Adverse Event|1|||
16112064|NCT01200290|38897519|FG000|Post-Treatment Follow-Up Period|Death|2|||
16112065|NCT01114672|38897522|FG000|Overall Study|Death|0|||
16112066|NCT01114672|38897523|FG001|Overall Study|Death|1|||
16112067|NCT01114672|38897522|FG000|Overall Study|Withdrawal by Subject|2|||
16112068|NCT01114672|38897523|FG001|Overall Study|Withdrawal by Subject|1|||
16112069|NCT01114672|38897522|FG000|Overall Study|Lost to Follow-up|1|||
16112070|NCT01114672|38897523|FG001|Overall Study|Lost to Follow-up|0|||
16112071|NCT01114672|38897522|FG000|Overall Study|transplanted|1|||
16112072|NCT01114672|38897523|FG001|Overall Study|transplanted|0|||
16112073|NCT04927364|38897524|FG000|Overall Study|Withdrawal by Subject|3|||
16112074|NCT04927364|38897524|FG000|Overall Study|Unable to complete preassessment MRI|1|||
16112075|NCT02559310|38897525|FG000|Overall Study|Death|4|||
16112076|NCT02559310|38897526|FG001|Overall Study|Death|3|||
16112077|NCT02559310|38897525|FG000|Overall Study|Lost to Follow-up|5|||
16112078|NCT02559310|38897526|FG001|Overall Study|Lost to Follow-up|3|||
16112079|NCT02559310|38897525|FG000|Overall Study|Physician Decision|2|||
16112080|NCT02559310|38897526|FG001|Overall Study|Physician Decision|1|||
16112081|NCT02559310|38897525|FG000|Overall Study|Withdrawal by Subject|13|||
16112082|NCT02559310|38897526|FG001|Overall Study|Withdrawal by Subject|9|||
16112083|NCT02559310|38897525|FG000|Overall Study|Sponsor Decision|0|||
16112084|NCT02559310|38897526|FG001|Overall Study|Sponsor Decision|1|||
16112085|NCT02559310|38897525|FG000|Overall Study|Randomized but not treated|3|||
16112086|NCT02559310|38897526|FG001|Overall Study|Randomized but not treated|2|||
16112087|NCT00356811|38897527|FG000|Overall Study|Death|35|||
16112088|NCT00356811|38897527|FG000|Overall Study|Lost to Follow-up|2|||
16112089|NCT00356811|38897527|FG000|Overall Study|Withdrawal by Subject|6|||
16112090|NCT00356811|38897527|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
16112091|NCT00356811|38897527|FG000|Overall Study|Study Is Terminating|3|||
16112092|NCT00356811|38897527|FG000|Overall Study|Site Closed during Follow-up|2|||
16112093|NCT00966979|38897528|FG000|Overall Study|Death|1|||
16112094|NCT00966979|38897528|FG000|Overall Study|Lost to Follow-up|6|||
16112095|NCT00966979|38897528|FG000|Overall Study|Withdrawal by Subject|14|||
16112096|NCT00966979|38897528|FG000|Overall Study|Adverse Event|5|||
16112097|NCT00966979|38897528|FG000|Overall Study|Sponsor terminated early|49|||
16112098|NCT00966979|38897528|FG000|Overall Study|Censored because surgery not done|2|||
16112099|NCT00966979|38897528|FG000|Overall Study|Censored because study device was not implanted|14|||
16112100|NCT00966979|38897528|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
16112101|NCT03229486|38897531|FG000|Overall Study|Protocol Violation|0|||
16112102|NCT03229486|38897532|FG001|Overall Study|Protocol Violation|1|||
16112103|NCT04468230|38897533|FG000|Overall Study|Adverse Event|2|||
16112104|NCT02165826|38897535|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
16112105|NCT02165826|38897536|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
16112106|NCT02165826|38897537|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
16112107|NCT02165826|38897535|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
16112108|NCT02165826|38897536|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
16112109|NCT02165826|38897537|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
16112110|NCT02165826|38897535|FG000|Main Treatment Period|Lost to Follow-up|4|||
16112111|NCT02165826|38897536|FG001|Main Treatment Period|Lost to Follow-up|2|||
16112112|NCT02165826|38897537|FG002|Main Treatment Period|Lost to Follow-up|1|||
16112113|NCT02165826|38897535|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
16112114|NCT02165826|38897536|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
16112115|NCT02165826|38897537|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
16112116|NCT02165826|38897535|FG000|Main Treatment Period|Lack of Efficacy|2|||
16112117|NCT02165826|38897536|FG001|Main Treatment Period|Lack of Efficacy|0|||
16112118|NCT02165826|38897537|FG002|Main Treatment Period|Lack of Efficacy|0|||
16112119|NCT02165826|38897535|FG000|Main Treatment Period|Reason Not Specified|8|||
16112120|NCT02165826|38897536|FG001|Main Treatment Period|Reason Not Specified|5|||
16112121|NCT02165826|38897537|FG002|Main Treatment Period|Reason Not Specified|16|||
16112122|NCT02165826|38897535|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
16112123|NCT02165826|38897536|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
16112124|NCT02165826|38897537|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
16112125|NCT02165826|38897535|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
16112126|NCT02165826|38897536|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
16112127|NCT02165826|38897537|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
16112128|NCT02165826|38897535|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
16112129|NCT02165826|38897536|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
16112130|NCT02165826|38897537|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
16112131|NCT02165826|38897535|FG000|Down-Titration Period|Reason Not Specified|1|||
16112132|NCT02165826|38897536|FG001|Down-Titration Period|Reason Not Specified|0|||
16112133|NCT02165826|38897537|FG002|Down-Titration Period|Reason Not Specified|2|||
16112134|NCT00150618|38897539|FG000|Overall Study|Adverse Event|2|||
16112135|NCT00150618|38897540|FG001|Overall Study|Adverse Event|2|||
16112136|NCT00150618|38897541|FG002|Overall Study|Adverse Event|6|||
16112137|NCT00150618|38897542|FG003|Overall Study|Adverse Event|9|||
16112138|NCT00150618|38897543|FG004|Overall Study|Adverse Event|5|||
16112139|NCT00150618|38897539|FG000|Overall Study|Withdrawal by Subject|6|||
16112140|NCT00150618|38897540|FG001|Overall Study|Withdrawal by Subject|8|||
16112141|NCT00150618|38897541|FG002|Overall Study|Withdrawal by Subject|8|||
16112142|NCT00150618|38897542|FG003|Overall Study|Withdrawal by Subject|4|||
16112143|NCT00150618|38897543|FG004|Overall Study|Withdrawal by Subject|5|||
16112144|NCT00150618|38897539|FG000|Overall Study|Lost to Follow-up|4|||
16112145|NCT00150618|38897540|FG001|Overall Study|Lost to Follow-up|1|||
16112146|NCT00150618|38897541|FG002|Overall Study|Lost to Follow-up|5|||
16112147|NCT00150618|38897542|FG003|Overall Study|Lost to Follow-up|8|||
16112148|NCT00150618|38897543|FG004|Overall Study|Lost to Follow-up|4|||
16112149|NCT00150618|38897539|FG000|Overall Study|Protocol Violation|1|||
16112150|NCT00150618|38897540|FG001|Overall Study|Protocol Violation|0|||
16112151|NCT00150618|38897541|FG002|Overall Study|Protocol Violation|0|||
16112152|NCT00150618|38897542|FG003|Overall Study|Protocol Violation|0|||
16112153|NCT00150618|38897543|FG004|Overall Study|Protocol Violation|1|||
16112154|NCT00150618|38897539|FG000|Overall Study|Lack of Efficacy|1|||
16112155|NCT00150618|38897540|FG001|Overall Study|Lack of Efficacy|4|||
16112156|NCT00150618|38897541|FG002|Overall Study|Lack of Efficacy|7|||
16112157|NCT00150618|38897542|FG003|Overall Study|Lack of Efficacy|4|||
16112158|NCT00150618|38897543|FG004|Overall Study|Lack of Efficacy|6|||
16112159|NCT00150618|38897539|FG000|Overall Study|No study meds|0|||
16112160|NCT00150618|38897540|FG001|Overall Study|No study meds|0|||
16112161|NCT00150618|38897541|FG002|Overall Study|No study meds|0|||
16112162|NCT00150618|38897542|FG003|Overall Study|No study meds|0|||
16112163|NCT00150618|38897543|FG004|Overall Study|No study meds|2|||
16112164|NCT00150618|38897539|FG000|Overall Study|Physician Decision|0|||
16112165|NCT00150618|38897540|FG001|Overall Study|Physician Decision|2|||
16112166|NCT00150618|38897541|FG002|Overall Study|Physician Decision|0|||
16112167|NCT00150618|38897542|FG003|Overall Study|Physician Decision|0|||
16112168|NCT00150618|38897543|FG004|Overall Study|Physician Decision|1|||
16112169|NCT00150618|38897539|FG000|Overall Study|Lack of compliance|2|||
16112170|NCT00150618|38897540|FG001|Overall Study|Lack of compliance|1|||
16112171|NCT00150618|38897541|FG002|Overall Study|Lack of compliance|1|||
16112172|NCT00150618|38897542|FG003|Overall Study|Lack of compliance|0|||
16112173|NCT00150618|38897543|FG004|Overall Study|Lack of compliance|1|||
16112174|NCT00150618|38897539|FG000|Overall Study|Abnormal ECG|1|||
16112175|NCT00150618|38897540|FG001|Overall Study|Abnormal ECG|0|||
16112176|NCT00150618|38897541|FG002|Overall Study|Abnormal ECG|0|||
16112177|NCT00150618|38897542|FG003|Overall Study|Abnormal ECG|0|||
16112178|NCT00150618|38897543|FG004|Overall Study|Abnormal ECG|0|||
16112179|NCT00150618|38897539|FG000|Overall Study|Sponsor's decision|0|||
16112180|NCT00150618|38897540|FG001|Overall Study|Sponsor's decision|0|||
16112181|NCT00150618|38897541|FG002|Overall Study|Sponsor's decision|0|||
16112182|NCT00150618|38897542|FG003|Overall Study|Sponsor's decision|1|||
16112183|NCT00150618|38897543|FG004|Overall Study|Sponsor's decision|0|||
16112184|NCT01124097|38897544|FG000|Overall Study|Withdrawal by Subject|4|||
16112185|NCT01124097|38897545|FG001|Overall Study|Withdrawal by Subject|3|||
16112186|NCT01124097|38897546|FG002|Overall Study|Withdrawal by Subject|2|||
16112187|NCT01124097|38897547|FG003|Overall Study|Withdrawal by Subject|3|||
16112188|NCT01124097|38897544|FG000|Overall Study|Lack of Efficacy|2|||
16112189|NCT01124097|38897545|FG001|Overall Study|Lack of Efficacy|3|||
16112190|NCT01124097|38897546|FG002|Overall Study|Lack of Efficacy|1|||
16112191|NCT01124097|38897547|FG003|Overall Study|Lack of Efficacy|3|||
16112192|NCT01124097|38897544|FG000|Overall Study|Adverse Event|24|||
16112193|NCT01124097|38897545|FG001|Overall Study|Adverse Event|15|||
16112194|NCT01124097|38897546|FG002|Overall Study|Adverse Event|15|||
16112195|NCT01124097|38897547|FG003|Overall Study|Adverse Event|7|||
16112196|NCT01124097|38897544|FG000|Overall Study|Protocol Violation|2|||
16112197|NCT01124097|38897545|FG001|Overall Study|Protocol Violation|0|||
16112198|NCT01124097|38897546|FG002|Overall Study|Protocol Violation|2|||
16112199|NCT01124097|38897547|FG003|Overall Study|Protocol Violation|1|||
16112200|NCT01124097|38897544|FG000|Overall Study|Physician Decision|2|||
16223852|NCT01667731|39298802|FG001|Overall Study|Subject Withdrew Consent|0|||
16112201|NCT01124097|38897545|FG001|Overall Study|Physician Decision|1|||
16112202|NCT01124097|38897546|FG002|Overall Study|Physician Decision|0|||
16112203|NCT01124097|38897547|FG003|Overall Study|Physician Decision|0|||
16112204|NCT02242643|38897549|FG000|Overall Study|Protocol Violation|1|||
16112205|NCT02242643|38897550|FG001|Overall Study|Protocol Violation|2|||
16112206|NCT02242643|38897549|FG000|Overall Study|Withdrawal by Subject|15|||
16112207|NCT02242643|38897550|FG001|Overall Study|Withdrawal by Subject|10|||
16112208|NCT02242643|38897549|FG000|Overall Study|Migrated/moved from study area|1|||
16112209|NCT02242643|38897550|FG001|Overall Study|Migrated/moved from study area|3|||
16273123|NCT02694536|39484413|FG000|Overall Study|Death|8|||
16223853|NCT01667731|39298803|FG002|Overall Study|Subject Withdrew Consent|1|||
16223854|NCT01667731|39298804|FG003|Overall Study|Subject Withdrew Consent|0|||
16223855|NCT01667731|39298805|FG004|Overall Study|Subject Withdrew Consent|1|||
16223856|NCT01667731|39298801|FG000|Overall Study|Death|0|||
16223857|NCT01667731|39298802|FG001|Overall Study|Death|1|||
16410048|NCT04493684|39981870|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410049|NCT04493684|39981871|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410050|NCT04493684|39981872|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410051|NCT04493684|39981873|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410052|NCT04493684|39981874|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
16410053|NCT04493684|39981858|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
16410054|NCT04493684|39981859|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410055|NCT04493684|39981860|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410056|NCT04493684|39981861|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410057|NCT04493684|39981862|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410058|NCT04493684|39981863|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410059|NCT04493684|39981864|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410060|NCT04493684|39981865|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410061|NCT04493684|39981866|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410062|NCT04493684|39981867|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410063|NCT04493684|39981868|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410064|NCT04493684|39981869|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410065|NCT04493684|39981870|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16546501|NCT04534114|40464817|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
16546502|NCT04534114|40464818|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
16546503|NCT04534114|40464819|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
16546504|NCT04534114|40464816|FG000|Main Treatment Period|Adverse Event|4|||
16410066|NCT04493684|39981871|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410067|NCT04493684|39981872|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410068|NCT04493684|39981873|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410069|NCT04493684|39981874|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
16410070|NCT04493684|39981858|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410071|NCT04493684|39981859|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410072|NCT04493684|39981860|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410073|NCT04493684|39981861|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410074|NCT04493684|39981862|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410075|NCT04493684|39981863|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
16410076|NCT04493684|39981864|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410077|NCT04493684|39981865|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410078|NCT04493684|39981866|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410079|NCT04493684|39981867|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410080|NCT04493684|39981868|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410081|NCT04493684|39981869|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410082|NCT04493684|39981870|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410083|NCT04493684|39981871|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410084|NCT04493684|39981872|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410085|NCT04493684|39981873|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410086|NCT04493684|39981874|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
16410087|NCT04493684|39981858|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410088|NCT04493684|39981859|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410089|NCT04493684|39981860|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410090|NCT04493684|39981861|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410091|NCT04493684|39981862|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410092|NCT04493684|39981863|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410093|NCT04493684|39981864|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410094|NCT04493684|39981865|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410095|NCT04493684|39981866|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410096|NCT04493684|39981867|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410097|NCT04493684|39981868|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410098|NCT04493684|39981869|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
16410099|NCT04493684|39981870|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16223858|NCT01667731|39298803|FG002|Overall Study|Death|0|||
16223859|NCT01667731|39298804|FG003|Overall Study|Death|0|||
16223860|NCT01667731|39298805|FG004|Overall Study|Death|0|||
16112210|NCT02242643|38897549|FG000|Overall Study|Lost to Follow-up|54|||
16112211|NCT02242643|38897550|FG001|Overall Study|Lost to Follow-up|61|||
16112212|NCT02242643|38897549|FG000|Overall Study|Child placed in foster care by family|0|||
16112213|NCT02242643|38897550|FG001|Overall Study|Child placed in foster care by family|1|||
16112214|NCT02242643|38897549|FG000|Overall Study|Non-compliance|1|||
16112215|NCT02242643|38897550|FG001|Overall Study|Non-compliance|0|||
16112216|NCT02242643|38897549|FG000|Overall Study|Consent withdrawal by parent|1|||
16112217|NCT02242643|38897550|FG001|Overall Study|Consent withdrawal by parent|0|||
16112218|NCT02242643|38897549|FG000|Overall Study|Protocol requirements not followed|1|||
16112219|NCT02242643|38897550|FG001|Overall Study|Protocol requirements not followed|0|||
16112220|NCT02242643|38897549|FG000|Overall Study|Language barrier|1|||
16112221|NCT02242643|38897550|FG001|Overall Study|Language barrier|0|||
16112222|NCT02242643|38897549|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
16112223|NCT02242643|38897550|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
16112224|NCT00832000|38897551|FG000|Overall Study|Adverse Event|2|||
16112225|NCT00832000|38897552|FG001|Overall Study|Adverse Event|0|||
16112226|NCT00832000|38897551|FG000|Overall Study|Withdrawal by Subject|1|||
16112227|NCT00832000|38897552|FG001|Overall Study|Withdrawal by Subject|0|||
16112228|NCT00832000|38897551|FG000|Overall Study|No calls to IVR in either period|1|||
16112229|NCT00832000|38897552|FG001|Overall Study|No calls to IVR in either period|1|||
16112230|NCT00832000|38897551|FG000|Overall Study|No calls to IVR in period 2|2|||
16112231|NCT00832000|38897552|FG001|Overall Study|No calls to IVR in period 2|0|||
16112232|NCT01547598|38897553|FG000|Overall Study|Withdrew consent|1|||
16112233|NCT01547598|38897554|FG001|Overall Study|Withdrew consent|1|||
16112234|NCT01547598|38897553|FG000|Overall Study|Lost to Follow-up|1|||
16112235|NCT01547598|38897554|FG001|Overall Study|Lost to Follow-up|1|||
16112236|NCT01547598|38897553|FG000|Overall Study|Adverse Event|1|||
16112237|NCT01547598|38897554|FG001|Overall Study|Adverse Event|1|||
16112238|NCT01547598|38897553|FG000|Overall Study|Protocol Violation|1|||
16112239|NCT01547598|38897554|FG001|Overall Study|Protocol Violation|1|||
16112240|NCT01547598|38897553|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16112241|NCT01547598|38897554|FG001|Overall Study|Other Miscellaneous Reasons|1|||
16112242|NCT00307164|38897555|FG000|Overall Study|Death|1|||
16112243|NCT00307164|38897556|FG001|Overall Study|Death|0|||
16112244|NCT00307164|38897555|FG000|Overall Study|Severe debilitation, unable to continue|1|||
16112245|NCT00307164|38897556|FG001|Overall Study|Severe debilitation, unable to continue|0|||
16112246|NCT00307164|38897555|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
16112247|NCT00307164|38897556|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
16112248|NCT00307164|38897555|FG000|Overall Study|Withdrawal by Subject|1|||
16112249|NCT00307164|38897556|FG001|Overall Study|Withdrawal by Subject|8|||
16112250|NCT00307164|38897555|FG000|Overall Study|Not compliant with requirements|4|||
16112251|NCT00307164|38897556|FG001|Overall Study|Not compliant with requirements|4|||
16112252|NCT00307164|38897555|FG000|Overall Study|Lost to Follow-up|6|||
16112253|NCT00307164|38897556|FG001|Overall Study|Lost to Follow-up|1|||
16112254|NCT01774305|38897557|FG000|Overall Study|Physician Decision|1|||
16112255|NCT01774305|38897558|FG001|Overall Study|Physician Decision|0|||
16112256|NCT02825251|38897559|FG000|Overall Study|Adverse Event|0|||
16112257|NCT02825251|38897560|FG001|Overall Study|Adverse Event|1|||
16112258|NCT02825251|38897559|FG000|Overall Study|Lost to Follow-up|0|||
16112259|NCT02825251|38897560|FG001|Overall Study|Lost to Follow-up|1|||
16112260|NCT02825251|38897559|FG000|Overall Study|Withdrawal by Subject|1|||
16112261|NCT02825251|38897560|FG001|Overall Study|Withdrawal by Subject|4|||
16112262|NCT02825251|38897559|FG000|Overall Study|Unclassified|2|||
16112263|NCT02825251|38897560|FG001|Overall Study|Unclassified|0|||
16112264|NCT01174264|38897561|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
16112265|NCT01174264|38897562|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
16112266|NCT01174264|38897563|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
16112267|NCT01174264|38897561|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
16112268|NCT01174264|38897562|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
16112269|NCT01174264|38897563|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
16112270|NCT01174264|38897561|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
16112271|NCT01174264|38897562|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
16112272|NCT01174264|38897563|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
16112273|NCT02895360|38897564|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
16112274|NCT02895360|38897565|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
16112275|NCT02895360|38897566|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
16112276|NCT02895360|38897567|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
16112277|NCT02895360|38897568|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
16112278|NCT02895360|38897569|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
16112279|NCT02895360|38897564|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
16112280|NCT02895360|38897565|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
16112281|NCT02895360|38897566|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
16112282|NCT02895360|38897567|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
16112283|NCT02895360|38897568|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
16112284|NCT02895360|38897569|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
16112285|NCT02895360|38897564|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
16112286|NCT02895360|38897565|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
16112287|NCT02895360|38897566|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
16112288|NCT02895360|38897567|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
16112289|NCT02895360|38897568|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
16112290|NCT02895360|38897569|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
16112291|NCT02895360|38897564|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
16112292|NCT02895360|38897565|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
16112293|NCT02895360|38897566|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
16112294|NCT02895360|38897567|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
16112295|NCT02895360|38897568|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
16112296|NCT02895360|38897569|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
16112297|NCT02895360|38897564|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
16112298|NCT02895360|38897565|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
16112299|NCT02895360|38897566|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
16112300|NCT02895360|38897567|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
16112301|NCT02895360|38897568|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
16112302|NCT02895360|38897569|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
16112303|NCT02895360|38897564|FG000|Phase 2a|Adverse Event|0|||
16112304|NCT02895360|38897565|FG001|Phase 2a|Adverse Event|0|||
16112305|NCT02895360|38897566|FG002|Phase 2a|Adverse Event|0|||
16112306|NCT02895360|38897567|FG003|Phase 2a|Adverse Event|0|||
16112307|NCT02895360|38897568|FG004|Phase 2a|Adverse Event|0|||
16112308|NCT02895360|38897569|FG005|Phase 2a|Adverse Event|1|||
16112309|NCT02895360|38897564|FG000|Phase 2a|Progressive disease|0|||
16112310|NCT02895360|38897565|FG001|Phase 2a|Progressive disease|0|||
16112311|NCT02895360|38897566|FG002|Phase 2a|Progressive disease|0|||
16112312|NCT02895360|38897567|FG003|Phase 2a|Progressive disease|0|||
16112313|NCT02895360|38897568|FG004|Phase 2a|Progressive disease|11|||
16112314|NCT02895360|38897569|FG005|Phase 2a|Progressive disease|11|||
16112315|NCT04698915|38901734|FG000|Overall Study|Adverse Event|2|||
16112316|NCT04698915|38901735|FG001|Overall Study|Adverse Event|0|||
16112317|NCT04698915|38901734|FG000|Overall Study|Death|23|||
16112318|NCT04698915|38901735|FG001|Overall Study|Death|20|||
16112319|NCT04698915|38901734|FG000|Overall Study|Physician Decision|1|||
16112320|NCT04698915|38901735|FG001|Overall Study|Physician Decision|1|||
16112321|NCT04698915|38901734|FG000|Overall Study|Lost to Follow-up|1|||
16112322|NCT04698915|38901735|FG001|Overall Study|Lost to Follow-up|0|||
16112323|NCT04698915|38901734|FG000|Overall Study|Study Terminated by Sponsor|55|||
16112324|NCT04698915|38901735|FG001|Overall Study|Study Terminated by Sponsor|60|||
16112325|NCT04698915|38901734|FG000|Overall Study|Withdrawal by Subject|2|||
16112326|NCT04698915|38901735|FG001|Overall Study|Withdrawal by Subject|3|||
16112327|NCT01150045|38901736|FG000|Overall Study|Protocol Violation|0|||
16112328|NCT01150045|38901737|FG001|Overall Study|Protocol Violation|1|||
16112329|NCT01150045|38901738|FG002|Overall Study|Protocol Violation|0|||
16112330|NCT01150045|38901739|FG003|Overall Study|Protocol Violation|1|||
16112331|NCT04547023|38901740|FG000|Overall Study|Did Not Receive Intervention|3|||
16112332|NCT04547023|38901741|FG001|Overall Study|Did Not Receive Intervention|2|||
16112333|NCT04547023|38901740|FG000|Overall Study|Lost to Follow-up|1|||
16112334|NCT04547023|38901741|FG001|Overall Study|Lost to Follow-up|1|||
16112335|NCT01099917|38901742|FG000|Overall Study|Adverse Event|3|||
16112336|NCT01099917|38901742|FG000|Overall Study|Not Treated|24|||
16112337|NCT02132117|38901743|FG000|Overall Study|Adverse Event|6|||
16112338|NCT02132117|38901744|FG001|Overall Study|Adverse Event|1|||
16223861|NCT01218477|39298806|FG000|Overall Study|Disease progression|2|||
16223862|NCT01218477|39298807|FG001|Overall Study|Disease progression|3|||
16223863|NCT01218477|39298808|FG002|Overall Study|Disease progression|6|||
16112339|NCT02132117|38901743|FG000|Overall Study|Lost to Follow-up|2|||
16112340|NCT02132117|38901744|FG001|Overall Study|Lost to Follow-up|2|||
16112341|NCT02132117|38901743|FG000|Overall Study|Personal Reasons|1|||
16112342|NCT02132117|38901744|FG001|Overall Study|Personal Reasons|2|||
16112343|NCT02132117|38901743|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16112344|NCT02132117|38901744|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16112345|NCT04333147|38901745|FG000|Overall Study|Adverse Event|43|||
16112346|NCT04333147|38901746|FG001|Overall Study|Adverse Event|40|||
16112347|NCT04333147|38901745|FG000|Overall Study|Lack of Efficacy|49|||
16112348|NCT04333147|38901746|FG001|Overall Study|Lack of Efficacy|48|||
16112349|NCT04333147|38901745|FG000|Overall Study|Lost to Follow-up|19|||
16112350|NCT04333147|38901746|FG001|Overall Study|Lost to Follow-up|16|||
16112351|NCT04333147|38901745|FG000|Overall Study|Physician Decision|17|||
16112352|NCT04333147|38901746|FG001|Overall Study|Physician Decision|20|||
16112353|NCT04333147|38901745|FG000|Overall Study|Withdrawal by Subject|65|||
16112354|NCT04333147|38901746|FG001|Overall Study|Withdrawal by Subject|68|||
16112355|NCT04333147|38901745|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
16112356|NCT04333147|38901746|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
16112357|NCT04333147|38901745|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
16223864|NCT01218477|39298809|FG003|Overall Study|Disease progression|2|||
16112358|NCT04333147|38901746|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
16112359|NCT04333147|38901745|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
16112360|NCT04333147|38901746|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
16112361|NCT01015677|38901752|FG000|Overall Study|Adverse Event|0|||
16112362|NCT01015677|38901753|FG001|Overall Study|Adverse Event|1|||
16112363|NCT01015677|38901754|FG002|Overall Study|Adverse Event|0|||
16112364|NCT01015677|38901752|FG000|Overall Study|Lack of Efficacy|0|||
16112365|NCT01015677|38901753|FG001|Overall Study|Lack of Efficacy|1|||
16112366|NCT01015677|38901754|FG002|Overall Study|Lack of Efficacy|0|||
16112367|NCT01015677|38901752|FG000|Overall Study|Protocol Violation|0|||
16112368|NCT01015677|38901753|FG001|Overall Study|Protocol Violation|1|||
16112369|NCT01015677|38901754|FG002|Overall Study|Protocol Violation|0|||
16112370|NCT01015677|38901752|FG000|Overall Study|Withdrawal by Subject|1|||
16112371|NCT01015677|38901753|FG001|Overall Study|Withdrawal by Subject|1|||
16112372|NCT01015677|38901754|FG002|Overall Study|Withdrawal by Subject|0|||
16112373|NCT00475644|38901758|FG000|Overall Study|Protocol Violation|13|||
16112374|NCT01010204|38901759|FG000|Overall Study|Lost to Follow-up|2|||
16112375|NCT01010204|38901760|FG001|Overall Study|Lost to Follow-up|2|||
16112376|NCT01010204|38901759|FG000|Overall Study|Adverse Event|1|||
16112377|NCT01010204|38901760|FG001|Overall Study|Adverse Event|3|||
16112378|NCT01010204|38901759|FG000|Overall Study|Withdrawal by Subject|2|||
16112379|NCT01010204|38901760|FG001|Overall Study|Withdrawal by Subject|3|||
16112380|NCT01010204|38901759|FG000|Overall Study|psychiatric hospitalization|2|||
16112381|NCT01010204|38901760|FG001|Overall Study|psychiatric hospitalization|1|||
16112382|NCT00195442|38901761|FG000|Overall Study|Less than expected therapeutic effect|38|||
16112383|NCT00195442|38901761|FG000|Overall Study|Lost to Follow-up|27|||
16112384|NCT00195442|38901761|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
16112385|NCT00195442|38901761|FG000|Overall Study|Intermittent product shortage|21|||
16112386|NCT00195442|38901761|FG000|Overall Study|Death|7|||
16112387|NCT00195442|38901761|FG000|Overall Study|No reason specified|4|||
16112388|NCT00195442|38901761|FG000|Overall Study|Poor cooperation|2|||
16112389|NCT00195442|38901761|FG000|Overall Study|Other|14|||
16112390|NCT03933462|38901762|FG000|Overall Study|Adverse Event|2|||
16112391|NCT03933462|38901763|FG001|Overall Study|Adverse Event|0|||
16112392|NCT01781832|38901768|FG000|Overall Study|Withdrawal by Subject|1|||
16112393|NCT02725528|38901769|FG000|Overall Study|Lost to Follow-up|1|||
16112394|NCT02725528|38901770|FG001|Overall Study|Lost to Follow-up|4|||
16112395|NCT02725528|38901769|FG000|Overall Study|Withdrawal by Subject|0|||
16112396|NCT02725528|38901770|FG001|Overall Study|Withdrawal by Subject|1|||
16112397|NCT01986114|38901775|FG000|Overall Study|Adverse Event|59|||
16112398|NCT01986114|38901775|FG000|Overall Study|Lack of Efficacy|23|||
16112399|NCT01986114|38901775|FG000|Overall Study|Withdrawal by Subject|58|||
16112400|NCT01986114|38901775|FG000|Overall Study|Noncompliance|3|||
16112401|NCT01986114|38901775|FG000|Overall Study|Protocol Violation|1|||
16112402|NCT01986114|38901775|FG000|Overall Study|Lost to Follow-up|5|||
16112403|NCT01986114|38901775|FG000|Overall Study|Other reason|7|||
16112404|NCT00478205|38901776|FG000|Overall Study|Adverse Event|182|||
16112405|NCT00478205|38901777|FG001|Overall Study|Adverse Event|39|||
16112406|NCT00478205|38901776|FG000|Overall Study|Medication Non-compliance|9|||
16112407|NCT00478205|38901777|FG001|Overall Study|Medication Non-compliance|4|||
16112408|NCT00478205|38901776|FG000|Overall Study|Protocol Violation|15|||
16112409|NCT00478205|38901777|FG001|Overall Study|Protocol Violation|5|||
16223865|NCT01218477|39298806|FG000|Overall Study|Study drug toxicity|0|||
16223866|NCT01218477|39298807|FG001|Overall Study|Study drug toxicity|2|||
16223867|NCT01218477|39298808|FG002|Overall Study|Study drug toxicity|5|||
16112410|NCT00478205|38901776|FG000|Overall Study|Request of Investigator or Sponsor|4|||
16112411|NCT00478205|38901777|FG001|Overall Study|Request of Investigator or Sponsor|5|||
16112412|NCT00478205|38901776|FG000|Overall Study|Withdrawal by Subject|61|||
16112413|NCT00478205|38901777|FG001|Overall Study|Withdrawal by Subject|22|||
16112414|NCT00478205|38901776|FG000|Overall Study|Lack of Efficacy|1|||
16112415|NCT00478205|38901777|FG001|Overall Study|Lack of Efficacy|0|||
16112416|NCT00478205|38901776|FG000|Overall Study|Other|24|||
16112417|NCT00478205|38901777|FG001|Overall Study|Other|12|||
16112418|NCT02229578|38901780|FG000|Overall Study|Withdrawal by Subject|1|||
16112419|NCT02229578|38901781|FG001|Overall Study|Withdrawal by Subject|3|||
16112420|NCT02229578|38901780|FG000|Overall Study|Protocol Violation|2|||
16112421|NCT02229578|38901781|FG001|Overall Study|Protocol Violation|0|||
16112422|NCT02386839|38901784|FG000|Overall Study|Death|1|||
16112423|NCT02386839|38901785|FG001|Overall Study|Death|0|||
16112424|NCT02386839|38901784|FG000|Overall Study|Withdrawal by Subject|9|||
16112425|NCT02386839|38901785|FG001|Overall Study|Withdrawal by Subject|10|||
16112426|NCT02386839|38901784|FG000|Overall Study|Lost to Follow-up|4|||
16112427|NCT02386839|38901785|FG001|Overall Study|Lost to Follow-up|4|||
16112428|NCT02386839|38901784|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
16112429|NCT02386839|38901785|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
16112430|NCT02386839|38901784|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
16112431|NCT02386839|38901785|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
16112432|NCT02386839|38901784|FG000|Overall Study|Other (unspecified)|1|||
16112433|NCT02386839|38901785|FG001|Overall Study|Other (unspecified)|0|||
16112434|NCT01200485|38901786|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
16112435|NCT01200485|38901787|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
16112436|NCT01200485|38901788|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
16112437|NCT01200485|38901786|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
16112438|NCT01200485|38901787|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
16112439|NCT01200485|38901788|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
16112440|NCT02990468|38901794|FG000|Phase 2: MTD|Change in treatment|0|||
16112441|NCT02990468|38901795|FG001|Phase 2: MTD|Change in treatment|0|||
16112442|NCT02990468|38901796|FG002|Phase 2: MTD|Change in treatment|1|||
16112443|NCT01262092|38901797|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
16112444|NCT01262092|38901798|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
16112445|NCT01262092|38901797|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
16112446|NCT01262092|38901798|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
16112447|NCT01262092|38901797|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
16112448|NCT01262092|38901798|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
16112449|NCT01262092|38901797|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
16112450|NCT01262092|38901798|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
16112451|NCT02586415|38901801|FG000|Overall Study|Death|13|||
16112452|NCT02586415|38901802|FG001|Overall Study|Death|23|||
16112453|NCT02586415|38901801|FG000|Overall Study|Lost to Follow-up|1|||
16112454|NCT02586415|38901802|FG001|Overall Study|Lost to Follow-up|2|||
16112455|NCT01031628|38901803|FG000|Overall Study|Study terminated early|0|||
16112456|NCT01031628|38901804|FG001|Overall Study|Study terminated early|1|||
16112457|NCT01031628|38901805|FG002|Overall Study|Study terminated early|3|||
16112458|NCT01031628|38901806|FG003|Overall Study|Study terminated early|0|||
16112459|NCT01209598|38901807|FG000|Overall Study|Withdrawal by Subject|1|||
16112460|NCT01209598|38901808|FG001|Overall Study|Withdrawal by Subject|0|||
16112461|NCT01755546|38901809|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
16112462|NCT01755546|38901809|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
16112463|NCT01755546|38901809|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
16112464|NCT01755546|38901809|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
16112465|NCT01755546|38901809|FG000|Titration Phase|Adverse Event|11|||
16112466|NCT01755546|38901809|FG000|Titration Phase|Lack of Efficacy|18|||
16112467|NCT01755546|38901809|FG000|Titration Phase|Protocol Violation|9|||
16112468|NCT01755546|38901809|FG000|Titration Phase|Lost to Follow-up|2|||
16112469|NCT01755546|38901809|FG000|Titration Phase|Other and Continuing|22|||
16112470|NCT01755546|38901809|FG000|Titration Phase|Withdrawal by Subject|8|||
16112471|NCT01755546|38901809|FG000|Long Term Treatment|Adverse Event|12|||
16112472|NCT01755546|38901809|FG000|Long Term Treatment|Lack of Efficacy|6|||
16112473|NCT01755546|38901809|FG000|Long Term Treatment|Protocol Violation|10|||
16112474|NCT01755546|38901809|FG000|Long Term Treatment|Withdrawal by Subject|35|||
16112475|NCT01755546|38901809|FG000|Long Term Treatment|Lost to Follow-up|17|||
16112476|NCT01755546|38901809|FG000|Long Term Treatment|other and ongoing|41|||
16112477|NCT04092452|38901812|FG000|Overall Study|Adverse Event|1|||
16112478|NCT04092452|38901813|FG001|Overall Study|Adverse Event|3|||
16112479|NCT04092452|38901814|FG002|Overall Study|Adverse Event|3|||
16112480|NCT04092452|38901815|FG003|Overall Study|Adverse Event|7|||
16112481|NCT04092452|38901812|FG000|Overall Study|Lack of Efficacy|1|||
16112482|NCT04092452|38901813|FG001|Overall Study|Lack of Efficacy|1|||
16112483|NCT04092452|38901814|FG002|Overall Study|Lack of Efficacy|1|||
16112484|NCT04092452|38901815|FG003|Overall Study|Lack of Efficacy|0|||
16112485|NCT04092452|38901812|FG000|Overall Study|Lost to Follow-up|4|||
16112486|NCT04092452|38901813|FG001|Overall Study|Lost to Follow-up|3|||
16112487|NCT04092452|38901814|FG002|Overall Study|Lost to Follow-up|5|||
16112488|NCT04092452|38901815|FG003|Overall Study|Lost to Follow-up|1|||
16112489|NCT04092452|38901812|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16112490|NCT04092452|38901813|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16112491|NCT04092452|38901814|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16112492|NCT04092452|38901815|FG003|Overall Study|Non-Compliance With Study Drug|1|||
16112493|NCT04092452|38901812|FG000|Overall Study|Physician Decision|1|||
16112494|NCT04092452|38901813|FG001|Overall Study|Physician Decision|0|||
16112495|NCT04092452|38901814|FG002|Overall Study|Physician Decision|1|||
16112496|NCT04092452|38901815|FG003|Overall Study|Physician Decision|0|||
16112497|NCT04092452|38901812|FG000|Overall Study|Pregnancy|2|||
16112498|NCT04092452|38901813|FG001|Overall Study|Pregnancy|0|||
16112499|NCT04092452|38901814|FG002|Overall Study|Pregnancy|0|||
16112500|NCT04092452|38901815|FG003|Overall Study|Pregnancy|0|||
16112501|NCT04092452|38901812|FG000|Overall Study|Protocol Deviation|1|||
16112502|NCT04092452|38901813|FG001|Overall Study|Protocol Deviation|0|||
16112503|NCT04092452|38901814|FG002|Overall Study|Protocol Deviation|0|||
16112504|NCT04092452|38901815|FG003|Overall Study|Protocol Deviation|0|||
16112505|NCT04092452|38901812|FG000|Overall Study|Withdrawal by Subject|3|||
16112506|NCT04092452|38901813|FG001|Overall Study|Withdrawal by Subject|10|||
16223868|NCT01218477|39298809|FG003|Overall Study|Study drug toxicity|0|||
16112507|NCT04092452|38901814|FG002|Overall Study|Withdrawal by Subject|3|||
16112508|NCT04092452|38901815|FG003|Overall Study|Withdrawal by Subject|5|||
16112509|NCT04092452|38901812|FG000|Overall Study|Other|0|||
16112510|NCT04092452|38901813|FG001|Overall Study|Other|0|||
16112511|NCT04092452|38901814|FG002|Overall Study|Other|1|||
16112512|NCT04092452|38901815|FG003|Overall Study|Other|2|||
16112513|NCT00975676|38901819|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
16112514|NCT00975676|38901820|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
16112515|NCT03126110|38901828|FG000|Phase 1|Death|2|||
16112516|NCT03126110|38901829|FG001|Phase 1|Death|2|||
16112517|NCT03126110|38901830|FG002|Phase 1|Death|4|||
16112518|NCT03126110|38901831|FG003|Phase 1|Death|3|||
16112519|NCT03126110|38901832|FG004|Phase 1|Death|4|||
16112520|NCT03126110|38901833|FG005|Phase 1|Death|4|||
16112521|NCT03126110|38901834|FG006|Phase 1|Death|3|||
16112522|NCT03126110|38901835|FG007|Phase 1|Death|4|||
16112523|NCT03126110|38901836|FG008|Phase 1|Death|5|||
16112524|NCT03126110|38901837|FG009|Phase 1|Death|2|||
16112525|NCT03126110|38901838|FG010|Phase 1|Death|6|||
16112526|NCT03126110|38901839|FG011|Phase 1|Death|0|||
16112527|NCT03126110|38901840|FG012|Phase 1|Death|0|||
16112528|NCT03126110|38901841|FG013|Phase 1|Death|0|||
16112529|NCT03126110|38901842|FG014|Phase 1|Death|0|||
16112530|NCT03126110|38901843|FG015|Phase 1|Death|0|||
16112531|NCT03126110|38901844|FG016|Phase 1|Death|0|||
16112532|NCT03126110|38901828|FG000|Phase 1|Lost to Follow-up|0|||
16112533|NCT03126110|38901829|FG001|Phase 1|Lost to Follow-up|1|||
16112534|NCT03126110|38901830|FG002|Phase 1|Lost to Follow-up|0|||
16112535|NCT03126110|38901831|FG003|Phase 1|Lost to Follow-up|0|||
16112536|NCT03126110|38901832|FG004|Phase 1|Lost to Follow-up|0|||
16112537|NCT03126110|38901833|FG005|Phase 1|Lost to Follow-up|0|||
16112538|NCT03126110|38901834|FG006|Phase 1|Lost to Follow-up|0|||
16112539|NCT03126110|38901835|FG007|Phase 1|Lost to Follow-up|0|||
16112540|NCT03126110|38901836|FG008|Phase 1|Lost to Follow-up|1|||
16112541|NCT03126110|38901837|FG009|Phase 1|Lost to Follow-up|0|||
16112542|NCT03126110|38901838|FG010|Phase 1|Lost to Follow-up|0|||
16112543|NCT03126110|38901839|FG011|Phase 1|Lost to Follow-up|0|||
16112544|NCT03126110|38901840|FG012|Phase 1|Lost to Follow-up|0|||
16112545|NCT03126110|38901841|FG013|Phase 1|Lost to Follow-up|0|||
16112546|NCT03126110|38901842|FG014|Phase 1|Lost to Follow-up|0|||
16112547|NCT03126110|38901843|FG015|Phase 1|Lost to Follow-up|0|||
16112548|NCT03126110|38901844|FG016|Phase 1|Lost to Follow-up|0|||
16112549|NCT03126110|38901828|FG000|Phase 1|Withdrawal by Subject|1|||
16112550|NCT03126110|38901829|FG001|Phase 1|Withdrawal by Subject|0|||
16223869|NCT01218477|39298806|FG000|Overall Study|No longer meets study criteria|1|||
16223870|NCT01218477|39298807|FG001|Overall Study|No longer meets study criteria|0|||
16223871|NCT01218477|39298808|FG002|Overall Study|No longer meets study criteria|0|||
16223872|NCT01218477|39298809|FG003|Overall Study|No longer meets study criteria|0|||
16223873|NCT01218477|39298806|FG000|Overall Study|Withdrawal by Subject|0|||
16223874|NCT01218477|39298807|FG001|Overall Study|Withdrawal by Subject|0|||
16223875|NCT01218477|39298808|FG002|Overall Study|Withdrawal by Subject|1|||
16223876|NCT01218477|39298809|FG003|Overall Study|Withdrawal by Subject|0|||
16223877|NCT01218477|39298806|FG000|Overall Study|Prepared for cell transplantation|0|||
16223878|NCT01218477|39298807|FG001|Overall Study|Prepared for cell transplantation|1|||
16223879|NCT01218477|39298808|FG002|Overall Study|Prepared for cell transplantation|1|||
16223880|NCT01218477|39298809|FG003|Overall Study|Prepared for cell transplantation|0|||
16223881|NCT01218477|39298806|FG000|Overall Study|Administrative reason by sponsor|0|||
16223882|NCT01218477|39298807|FG001|Overall Study|Administrative reason by sponsor|0|||
16223883|NCT01218477|39298808|FG002|Overall Study|Administrative reason by sponsor|1|||
16223884|NCT01218477|39298809|FG003|Overall Study|Administrative reason by sponsor|0|||
16223885|NCT01218477|39298806|FG000|Overall Study|Maximum clinical benefit|0|||
16223886|NCT01218477|39298807|FG001|Overall Study|Maximum clinical benefit|2|||
16223887|NCT01218477|39298808|FG002|Overall Study|Maximum clinical benefit|0|||
16223888|NCT01218477|39298809|FG003|Overall Study|Maximum clinical benefit|0|||
16223889|NCT00960323|39298810|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
16112551|NCT03126110|38901830|FG002|Phase 1|Withdrawal by Subject|0|||
16112552|NCT03126110|38901831|FG003|Phase 1|Withdrawal by Subject|1|||
16112553|NCT03126110|38901832|FG004|Phase 1|Withdrawal by Subject|1|||
16112554|NCT03126110|38901833|FG005|Phase 1|Withdrawal by Subject|0|||
16112555|NCT03126110|38901834|FG006|Phase 1|Withdrawal by Subject|0|||
16112556|NCT03126110|38901835|FG007|Phase 1|Withdrawal by Subject|0|||
16112557|NCT03126110|38901836|FG008|Phase 1|Withdrawal by Subject|2|||
16112558|NCT03126110|38901837|FG009|Phase 1|Withdrawal by Subject|1|||
16112559|NCT03126110|38901838|FG010|Phase 1|Withdrawal by Subject|0|||
16112560|NCT03126110|38901839|FG011|Phase 1|Withdrawal by Subject|0|||
16112561|NCT03126110|38901840|FG012|Phase 1|Withdrawal by Subject|0|||
16112562|NCT03126110|38901841|FG013|Phase 1|Withdrawal by Subject|0|||
16112563|NCT03126110|38901842|FG014|Phase 1|Withdrawal by Subject|0|||
16112564|NCT03126110|38901843|FG015|Phase 1|Withdrawal by Subject|0|||
16112565|NCT03126110|38901844|FG016|Phase 1|Withdrawal by Subject|0|||
16112566|NCT03126110|38901828|FG000|Phase 1|Safety follow-up no longer necessary|1|||
16223890|NCT00298766|39298811|FG000|Overall Study|Adverse Event|18|||
16223891|NCT00298766|39298811|FG000|Overall Study|Death|2|||
16223892|NCT00298766|39298811|FG000|Overall Study|Withdrawal by Subject|9|||
16112567|NCT03126110|38901829|FG001|Phase 1|Safety follow-up no longer necessary|0|||
16223893|NCT00298766|39298811|FG000|Overall Study|Treatment ongoing|4|||
16223894|NCT00298766|39298811|FG000|Overall Study|Progression of amyloid markers|4|||
16223895|NCT00298766|39298811|FG000|Overall Study|Deterioration in KPS and organ function|1|||
16223896|NCT00298766|39298811|FG000|Overall Study|Subjects overall condition deterioration|4|||
16223897|NCT00298766|39298811|FG000|Overall Study|Other|4|||
16223898|NCT02506101|39298812|FG000|Overall Study|Transportation issues|1|||
16223899|NCT02506101|39298813|FG001|Overall Study|Transportation issues|0|||
16223900|NCT02506101|39298812|FG000|Overall Study|No enrollment and staff unavailability|1|||
16223901|NCT02506101|39298813|FG001|Overall Study|No enrollment and staff unavailability|0|||
16223902|NCT04249076|39298816|FG000|Overall Study|Adverse Event|1|||
16223903|NCT04249076|39298817|FG001|Overall Study|Adverse Event|1|||
16223904|NCT04249076|39298816|FG000|Overall Study|Protocol Violation|1|||
16223905|NCT04249076|39298817|FG001|Overall Study|Protocol Violation|2|||
16223906|NCT04249076|39298816|FG000|Overall Study|Lack of Efficacy|0|||
16223907|NCT04249076|39298817|FG001|Overall Study|Lack of Efficacy|1|||
16223908|NCT04249076|39298816|FG000|Overall Study|Withdrawal by Subject|0|||
16223909|NCT04249076|39298817|FG001|Overall Study|Withdrawal by Subject|1|||
16223910|NCT02630459|39298818|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
16223911|NCT02630459|39298819|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
16223912|NCT02630459|39298820|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
16112568|NCT03126110|38901830|FG002|Phase 1|Safety follow-up no longer necessary|0|||
16112569|NCT03126110|38901831|FG003|Phase 1|Safety follow-up no longer necessary|0|||
16112570|NCT03126110|38901832|FG004|Phase 1|Safety follow-up no longer necessary|0|||
16112571|NCT03126110|38901833|FG005|Phase 1|Safety follow-up no longer necessary|0|||
16112572|NCT03126110|38901834|FG006|Phase 1|Safety follow-up no longer necessary|0|||
16112573|NCT03126110|38901835|FG007|Phase 1|Safety follow-up no longer necessary|0|||
16112574|NCT03126110|38901836|FG008|Phase 1|Safety follow-up no longer necessary|0|||
16112575|NCT03126110|38901837|FG009|Phase 1|Safety follow-up no longer necessary|0|||
16112576|NCT03126110|38901838|FG010|Phase 1|Safety follow-up no longer necessary|0|||
16112577|NCT03126110|38901839|FG011|Phase 1|Safety follow-up no longer necessary|0|||
16112578|NCT03126110|38901840|FG012|Phase 1|Safety follow-up no longer necessary|0|||
16112579|NCT03126110|38901841|FG013|Phase 1|Safety follow-up no longer necessary|0|||
16223913|NCT02630459|39298821|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
16223914|NCT02630459|39298822|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
16223915|NCT02630459|39298823|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
16546505|NCT04534114|40464817|FG001|Main Treatment Period|Adverse Event|2|||
16546506|NCT04534114|40464818|FG002|Main Treatment Period|Adverse Event|1|||
16546507|NCT04534114|40464819|FG003|Main Treatment Period|Adverse Event|2|||
16546508|NCT04534114|40464816|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
16546509|NCT04534114|40464817|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
16546510|NCT04534114|40464818|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
16546511|NCT04534114|40464819|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
16546512|NCT04534114|40464816|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
16546513|NCT04534114|40464817|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
16546514|NCT04534114|40464818|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
16546515|NCT04534114|40464819|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
16546516|NCT04534114|40464816|FG000|Extension Treatment Period|Other reason|0|||
16546517|NCT04534114|40464817|FG001|Extension Treatment Period|Other reason|1|||
16546518|NCT04534114|40464818|FG002|Extension Treatment Period|Other reason|0|||
16546519|NCT04534114|40464819|FG003|Extension Treatment Period|Other reason|0|||
16546520|NCT04534114|40464816|FG000|Extension Treatment Period|Death|0|||
16546521|NCT04534114|40464817|FG001|Extension Treatment Period|Death|0|||
16546522|NCT04534114|40464818|FG002|Extension Treatment Period|Death|1|||
16546523|NCT04534114|40464819|FG003|Extension Treatment Period|Death|2|||
16546524|NCT04534114|40464816|FG000|Extension Treatment Period|Adverse Event|0|||
16223916|NCT02630459|39298824|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
16223917|NCT02630459|39298825|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
16223918|NCT02630459|39298818|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
16223919|NCT02630459|39298819|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
16223920|NCT02630459|39298820|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
16546525|NCT04534114|40464817|FG001|Extension Treatment Period|Adverse Event|1|||
16112580|NCT03126110|38901842|FG014|Phase 1|Safety follow-up no longer necessary|0|||
16112581|NCT03126110|38901843|FG015|Phase 1|Safety follow-up no longer necessary|0|||
16112582|NCT03126110|38901844|FG016|Phase 1|Safety follow-up no longer necessary|0|||
16112583|NCT03126110|38901828|FG000|Phase 1|Survival follow-up no longer necessary|0|||
16112584|NCT03126110|38901829|FG001|Phase 1|Survival follow-up no longer necessary|0|||
16223921|NCT02630459|39298821|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
16223922|NCT02630459|39298822|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
16223923|NCT02630459|39298823|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
16223924|NCT02630459|39298824|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
16223925|NCT02630459|39298825|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
16223926|NCT02630459|39298818|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
16223927|NCT02630459|39298819|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
16223928|NCT02630459|39298820|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
16223929|NCT02630459|39298821|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
16223930|NCT02630459|39298822|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
16223931|NCT02630459|39298823|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
16223932|NCT02630459|39298824|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
16223933|NCT02630459|39298825|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
16223934|NCT02630459|39298818|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
16223935|NCT02630459|39298819|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
16223936|NCT02630459|39298820|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
16223937|NCT02630459|39298821|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
16223938|NCT02630459|39298822|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
16112585|NCT03126110|38901830|FG002|Phase 1|Survival follow-up no longer necessary|1|||
16112586|NCT03126110|38901831|FG003|Phase 1|Survival follow-up no longer necessary|0|||
16112587|NCT03126110|38901832|FG004|Phase 1|Survival follow-up no longer necessary|0|||
16112588|NCT03126110|38901833|FG005|Phase 1|Survival follow-up no longer necessary|0|||
16223939|NCT02630459|39298823|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
16223940|NCT02630459|39298824|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
16223941|NCT02630459|39298825|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
16546526|NCT04534114|40464818|FG002|Extension Treatment Period|Adverse Event|0|||
16112589|NCT03126110|38901834|FG006|Phase 1|Survival follow-up no longer necessary|0|||
16223942|NCT02630459|39298818|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
16223943|NCT02630459|39298819|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
16223944|NCT02630459|39298820|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
16273124|NCT02694536|39484413|FG000|Overall Study|Other|22|||
16546527|NCT04534114|40464819|FG003|Extension Treatment Period|Adverse Event|1|||
16546528|NCT04534114|40464816|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
16546529|NCT04534114|40464817|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
16546530|NCT04534114|40464818|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
16546531|NCT04534114|40464819|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
16546532|NCT03188120|40464820|FG000|Overall Study|Adverse Event|4|||
16546533|NCT03188120|40464820|FG000|Overall Study|Insufficient Effectiveness|8|||
16546534|NCT03188120|40464820|FG000|Overall Study|Improved|12|||
16546535|NCT03188120|40464820|FG000|Overall Study|Lost to Follow-up|7|||
16546536|NCT03188120|40464820|FG000|Overall Study|Other than specified|3|||
16546537|NCT03188120|40464820|FG000|Overall Study|No visit after the first visit|13|||
16546538|NCT00550550|40464822|FG000|Overall Study|Adverse Event|13|||
16112590|NCT03126110|38901835|FG007|Phase 1|Survival follow-up no longer necessary|0|||
16112591|NCT03126110|38901836|FG008|Phase 1|Survival follow-up no longer necessary|0|||
16112592|NCT03126110|38901837|FG009|Phase 1|Survival follow-up no longer necessary|0|||
16112593|NCT03126110|38901838|FG010|Phase 1|Survival follow-up no longer necessary|0|||
16112594|NCT03126110|38901839|FG011|Phase 1|Survival follow-up no longer necessary|0|||
16112595|NCT03126110|38901840|FG012|Phase 1|Survival follow-up no longer necessary|0|||
16112596|NCT03126110|38901841|FG013|Phase 1|Survival follow-up no longer necessary|0|||
16112597|NCT03126110|38901842|FG014|Phase 1|Survival follow-up no longer necessary|0|||
16112598|NCT03126110|38901843|FG015|Phase 1|Survival follow-up no longer necessary|0|||
16112599|NCT03126110|38901844|FG016|Phase 1|Survival follow-up no longer necessary|0|||
16112600|NCT03126110|38901828|FG000|Phase 2|Study terminated by the sponsor|0|||
16410100|NCT04493684|39981871|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410101|NCT04493684|39981872|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410102|NCT04493684|39981873|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16410103|NCT04493684|39981874|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
16546539|NCT00550550|40464823|FG001|Overall Study|Adverse Event|5|||
16112601|NCT03126110|38901829|FG001|Phase 2|Study terminated by the sponsor|0|||
16112602|NCT03126110|38901830|FG002|Phase 2|Study terminated by the sponsor|0|||
16112603|NCT03126110|38901831|FG003|Phase 2|Study terminated by the sponsor|0|||
16112604|NCT03126110|38901832|FG004|Phase 2|Study terminated by the sponsor|0|||
16112605|NCT03126110|38901833|FG005|Phase 2|Study terminated by the sponsor|0|||
16112606|NCT03126110|38901834|FG006|Phase 2|Study terminated by the sponsor|0|||
16112607|NCT03126110|38901835|FG007|Phase 2|Study terminated by the sponsor|0|||
16112608|NCT03126110|38901836|FG008|Phase 2|Study terminated by the sponsor|0|||
16112609|NCT03126110|38901837|FG009|Phase 2|Study terminated by the sponsor|0|||
16112610|NCT03126110|38901838|FG010|Phase 2|Study terminated by the sponsor|0|||
16112611|NCT03126110|38901839|FG011|Phase 2|Study terminated by the sponsor|0|||
16112612|NCT03126110|38901840|FG012|Phase 2|Study terminated by the sponsor|0|||
16112613|NCT03126110|38901841|FG013|Phase 2|Study terminated by the sponsor|4|||
16112614|NCT03126110|38901842|FG014|Phase 2|Study terminated by the sponsor|0|||
16112615|NCT03126110|38901843|FG015|Phase 2|Study terminated by the sponsor|0|||
16112616|NCT03126110|38901844|FG016|Phase 2|Study terminated by the sponsor|0|||
16112617|NCT03126110|38901828|FG000|Phase 2|Withdrawal by Subject|0|||
16112618|NCT03126110|38901829|FG001|Phase 2|Withdrawal by Subject|0|||
16112619|NCT03126110|38901830|FG002|Phase 2|Withdrawal by Subject|0|||
16112620|NCT03126110|38901831|FG003|Phase 2|Withdrawal by Subject|0|||
16112621|NCT03126110|38901832|FG004|Phase 2|Withdrawal by Subject|0|||
16112622|NCT03126110|38901833|FG005|Phase 2|Withdrawal by Subject|0|||
16112623|NCT03126110|38901834|FG006|Phase 2|Withdrawal by Subject|0|||
16346544|NCT04878055|39757187|FG001|Overall Study|Lost to Follow-up|1|||
16346545|NCT02753816|39757193|FG000|Overall Study|Protocol Violation|0|||
16346546|NCT02753816|39757194|FG001|Overall Study|Protocol Violation|1|||
16346547|NCT02753816|39757195|FG002|Overall Study|Protocol Violation|0|||
16346548|NCT00762034|39757196|FG000|Induction Period|Protocol Violation|1|||
16346549|NCT00762034|39757197|FG001|Induction Period|Protocol Violation|2|||
16346550|NCT00762034|39757196|FG000|Induction Period|Entry Criterion Not Met|12|||
16346551|NCT00762034|39757197|FG001|Induction Period|Entry Criterion Not Met|11|||
16346552|NCT00762034|39757196|FG000|Induction Period|Adverse Event|27|||
16346553|NCT00762034|39757197|FG001|Induction Period|Adverse Event|38|||
16346554|NCT00762034|39757196|FG000|Induction Period|Lost to Follow-up|1|||
16346555|NCT00762034|39757197|FG001|Induction Period|Lost to Follow-up|1|||
16346556|NCT00762034|39757196|FG000|Induction Period|Progressive Disease|73|||
16346557|NCT00762034|39757197|FG001|Induction Period|Progressive Disease|55|||
16346558|NCT00762034|39757196|FG000|Induction Period|Physician Decision|21|||
16346559|NCT00762034|39757197|FG001|Induction Period|Physician Decision|20|||
16346560|NCT00762034|39757196|FG000|Induction Period|Withdrawal by Subject|15|||
16346561|NCT00762034|39757197|FG001|Induction Period|Withdrawal by Subject|19|||
16346562|NCT00762034|39757196|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
16346563|NCT00762034|39757197|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
16346564|NCT00762034|39757196|FG000|Induction Period|Deaths Due to Study Disease|9|||
16410104|NCT04493684|39981858|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16546540|NCT00550550|40464822|FG000|Overall Study|Treatment Failure|0|||
16112624|NCT03126110|38901835|FG007|Phase 2|Withdrawal by Subject|0|||
16112625|NCT03126110|38901836|FG008|Phase 2|Withdrawal by Subject|0|||
16112626|NCT03126110|38901837|FG009|Phase 2|Withdrawal by Subject|0|||
16112627|NCT03126110|38901838|FG010|Phase 2|Withdrawal by Subject|0|||
16112628|NCT03126110|38901839|FG011|Phase 2|Withdrawal by Subject|1|||
16112629|NCT03126110|38901840|FG012|Phase 2|Withdrawal by Subject|3|||
16112630|NCT03126110|38901841|FG013|Phase 2|Withdrawal by Subject|3|||
16112631|NCT03126110|38901842|FG014|Phase 2|Withdrawal by Subject|2|||
16112632|NCT03126110|38901843|FG015|Phase 2|Withdrawal by Subject|1|||
16112633|NCT03126110|38901844|FG016|Phase 2|Withdrawal by Subject|0|||
16346565|NCT00762034|39757197|FG001|Induction Period|Deaths Due to Study Disease|9|||
16346566|NCT00762034|39757196|FG000|Maintenance Period|Protocol Violation|1|||
16346567|NCT00762034|39757197|FG001|Maintenance Period|Protocol Violation|3|||
16112634|NCT03126110|38901828|FG000|Phase 2|Lost to Follow-up|0|||
16112635|NCT03126110|38901829|FG001|Phase 2|Lost to Follow-up|0|||
16112636|NCT03126110|38901830|FG002|Phase 2|Lost to Follow-up|0|||
16112637|NCT03126110|38901831|FG003|Phase 2|Lost to Follow-up|0|||
16112638|NCT03126110|38901832|FG004|Phase 2|Lost to Follow-up|0|||
16112639|NCT03126110|38901833|FG005|Phase 2|Lost to Follow-up|0|||
16112640|NCT03126110|38901834|FG006|Phase 2|Lost to Follow-up|0|||
16112641|NCT03126110|38901835|FG007|Phase 2|Lost to Follow-up|0|||
16112642|NCT03126110|38901836|FG008|Phase 2|Lost to Follow-up|0|||
16112643|NCT03126110|38901837|FG009|Phase 2|Lost to Follow-up|0|||
16112644|NCT03126110|38901838|FG010|Phase 2|Lost to Follow-up|0|||
16112645|NCT03126110|38901839|FG011|Phase 2|Lost to Follow-up|1|||
16112646|NCT03126110|38901840|FG012|Phase 2|Lost to Follow-up|1|||
16112647|NCT03126110|38901841|FG013|Phase 2|Lost to Follow-up|1|||
16112648|NCT03126110|38901842|FG014|Phase 2|Lost to Follow-up|2|||
16112649|NCT03126110|38901843|FG015|Phase 2|Lost to Follow-up|0|||
16112650|NCT03126110|38901844|FG016|Phase 2|Lost to Follow-up|0|||
16112651|NCT03126110|38901828|FG000|Phase 2|Death|0|||
16112652|NCT03126110|38901829|FG001|Phase 2|Death|0|||
16112653|NCT03126110|38901830|FG002|Phase 2|Death|0|||
16112654|NCT03126110|38901831|FG003|Phase 2|Death|0|||
16112655|NCT03126110|38901832|FG004|Phase 2|Death|0|||
16112656|NCT03126110|38901833|FG005|Phase 2|Death|0|||
16112657|NCT03126110|38901834|FG006|Phase 2|Death|0|||
16112658|NCT03126110|38901835|FG007|Phase 2|Death|0|||
16112659|NCT03126110|38901836|FG008|Phase 2|Death|0|||
16112660|NCT03126110|38901837|FG009|Phase 2|Death|0|||
16112661|NCT03126110|38901838|FG010|Phase 2|Death|0|||
16112662|NCT03126110|38901839|FG011|Phase 2|Death|6|||
16112663|NCT03126110|38901840|FG012|Phase 2|Death|12|||
16112664|NCT03126110|38901841|FG013|Phase 2|Death|25|||
16112665|NCT03126110|38901842|FG014|Phase 2|Death|11|||
16112666|NCT03126110|38901843|FG015|Phase 2|Death|3|||
16112667|NCT03126110|38901844|FG016|Phase 2|Death|2|||
16112668|NCT03126110|38901828|FG000|Phase 2|Progressive Disease|0|||
16112669|NCT03126110|38901829|FG001|Phase 2|Progressive Disease|0|||
16112670|NCT03126110|38901830|FG002|Phase 2|Progressive Disease|0|||
16112671|NCT03126110|38901831|FG003|Phase 2|Progressive Disease|0|||
16112672|NCT03126110|38901832|FG004|Phase 2|Progressive Disease|0|||
16112673|NCT03126110|38901833|FG005|Phase 2|Progressive Disease|0|||
16112674|NCT03126110|38901834|FG006|Phase 2|Progressive Disease|0|||
16112675|NCT03126110|38901835|FG007|Phase 2|Progressive Disease|0|||
16112676|NCT03126110|38901836|FG008|Phase 2|Progressive Disease|0|||
16410105|NCT04493684|39981859|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410106|NCT04493684|39981860|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16346568|NCT00762034|39757196|FG000|Maintenance Period|Entry Criterion Not Met|0|||
16346569|NCT00762034|39757197|FG001|Maintenance Period|Entry Criterion Not Met|2|||
16346570|NCT00762034|39757196|FG000|Maintenance Period|Adverse Event|42|||
16346571|NCT00762034|39757197|FG001|Maintenance Period|Adverse Event|26|||
16346572|NCT00762034|39757196|FG000|Maintenance Period|Progressive Disease|186|||
16346573|NCT00762034|39757197|FG001|Maintenance Period|Progressive Disease|224|||
16346574|NCT00762034|39757196|FG000|Maintenance Period|Physician Decision|25|||
16546541|NCT00550550|40464823|FG001|Overall Study|Treatment Failure|1|||
16112677|NCT03126110|38901837|FG009|Phase 2|Progressive Disease|0|||
16112678|NCT03126110|38901838|FG010|Phase 2|Progressive Disease|0|||
16112679|NCT03126110|38901839|FG011|Phase 2|Progressive Disease|0|||
16112680|NCT03126110|38901840|FG012|Phase 2|Progressive Disease|0|||
16112681|NCT03126110|38901841|FG013|Phase 2|Progressive Disease|1|||
16112682|NCT03126110|38901842|FG014|Phase 2|Progressive Disease|0|||
16112683|NCT03126110|38901843|FG015|Phase 2|Progressive Disease|0|||
16112684|NCT03126110|38901844|FG016|Phase 2|Progressive Disease|0|||
16112685|NCT03126110|38901828|FG000|Phase 2|Started new treatment|0|||
16112686|NCT03126110|38901829|FG001|Phase 2|Started new treatment|0|||
16112687|NCT03126110|38901830|FG002|Phase 2|Started new treatment|0|||
16112688|NCT03126110|38901831|FG003|Phase 2|Started new treatment|0|||
16112689|NCT03126110|38901832|FG004|Phase 2|Started new treatment|0|||
16112690|NCT03126110|38901833|FG005|Phase 2|Started new treatment|0|||
16112691|NCT03126110|38901834|FG006|Phase 2|Started new treatment|0|||
16346575|NCT00762034|39757197|FG001|Maintenance Period|Physician Decision|20|||
16112692|NCT03126110|38901835|FG007|Phase 2|Started new treatment|0|||
16112693|NCT03126110|38901836|FG008|Phase 2|Started new treatment|0|||
16112694|NCT03126110|38901837|FG009|Phase 2|Started new treatment|0|||
16112695|NCT03126110|38901838|FG010|Phase 2|Started new treatment|0|||
16112696|NCT03126110|38901839|FG011|Phase 2|Started new treatment|0|||
16112697|NCT03126110|38901840|FG012|Phase 2|Started new treatment|0|||
16112698|NCT03126110|38901841|FG013|Phase 2|Started new treatment|0|||
16112699|NCT03126110|38901842|FG014|Phase 2|Started new treatment|1|||
16112700|NCT03126110|38901843|FG015|Phase 2|Started new treatment|0|||
16112701|NCT03126110|38901844|FG016|Phase 2|Started new treatment|0|||
16112702|NCT02270671|38901847|FG000|Overall Study|Withdrawal by Subject|1|||
16112703|NCT02270671|38901848|FG001|Overall Study|Withdrawal by Subject|1|||
16112704|NCT02270671|38901847|FG000|Overall Study|Protocol Violation|0|||
16112705|NCT02270671|38901848|FG001|Overall Study|Protocol Violation|1|||
16112706|NCT02270671|38901847|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
16112707|NCT02270671|38901848|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
16112708|NCT02270671|38901847|FG000|Overall Study|Lost to Follow-up|2|||
16112709|NCT02270671|38901848|FG001|Overall Study|Lost to Follow-up|1|||
16112710|NCT01439867|38901849|FG000|Overall Study|Non-compliance|0|||
16112711|NCT01439867|38901850|FG001|Overall Study|Non-compliance|1|||
16112712|NCT01439867|38901849|FG000|Overall Study|Withdrawal by Subject|1|||
16112713|NCT01439867|38901850|FG001|Overall Study|Withdrawal by Subject|2|||
16223945|NCT02630459|39298821|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
16223946|NCT02630459|39298822|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
16546542|NCT00550550|40464822|FG000|Overall Study|Lost to Follow-up|4|||
16546543|NCT00550550|40464823|FG001|Overall Study|Lost to Follow-up|0|||
16546544|NCT00550550|40464822|FG000|Overall Study|Withdrawal by Subject|10|||
16546545|NCT00550550|40464823|FG001|Overall Study|Withdrawal by Subject|8|||
16546546|NCT00550550|40464822|FG000|Overall Study|Protocol Violation|5|||
16546547|NCT00550550|40464823|FG001|Overall Study|Protocol Violation|14|||
16546548|NCT00550550|40464822|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
16546549|NCT00550550|40464823|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
16546550|NCT00550550|40464822|FG000|Overall Study|Randomized But Not Treated|1|||
16546551|NCT00550550|40464823|FG001|Overall Study|Randomized But Not Treated|0|||
16546552|NCT03502616|40464824|FG000|Up to Week 16|Withdrawal by Subject|1|||
16546553|NCT03502616|40464825|FG001|Up to Week 16|Withdrawal by Subject|2|||
16546554|NCT03502616|40464824|FG000|Up to Week 16|Lost to Follow-up|0|||
16223947|NCT02630459|39298823|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
16223948|NCT02630459|39298824|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
16223949|NCT02630459|39298825|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
16223950|NCT02630459|39298818|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
16223951|NCT02630459|39298819|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
16223952|NCT02630459|39298820|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
16223953|NCT02630459|39298821|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
16223954|NCT02630459|39298822|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
16223955|NCT02630459|39298823|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
16223956|NCT02630459|39298824|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
16223957|NCT02630459|39298825|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
16410107|NCT04493684|39981861|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410108|NCT04493684|39981862|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16546555|NCT03502616|40464825|FG001|Up to Week 16|Lost to Follow-up|1|||
16546556|NCT03502616|40464824|FG000|Up to Week 16|Randomized, but not treated|1|||
16546557|NCT03502616|40464825|FG001|Up to Week 16|Randomized, but not treated|0|||
16546558|NCT03502616|40464824|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
16546559|NCT03502616|40464825|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
16546560|NCT03502616|40464824|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
16546561|NCT03502616|40464825|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
16546562|NCT00553501|40464832|FG000|Overall Study|Adverse Event|2|||
16546563|NCT00553501|40464832|FG000|Overall Study|Death|1|||
16546564|NCT00553501|40464832|FG000|Overall Study|Progression|1|||
16546565|NCT03682705|40464836|FG000|Overall Study|Adverse Event|1|||
16546566|NCT03682705|40464837|FG001|Overall Study|Adverse Event|1|||
16546567|NCT03682705|40464838|FG002|Overall Study|Adverse Event|1|||
16546568|NCT03682705|40464839|FG003|Overall Study|Adverse Event|0|||
16546569|NCT03682705|40464840|FG004|Overall Study|Adverse Event|1|||
16112714|NCT01439867|38901849|FG000|Overall Study|Administrative Decision|4|||
16112715|NCT01439867|38901850|FG001|Overall Study|Administrative Decision|5|||
16112716|NCT01439867|38901849|FG000|Overall Study|Protocol-specified Criteria|1|||
16546570|NCT03682705|40464841|FG005|Overall Study|Adverse Event|1|||
16546571|NCT03682705|40464836|FG000|Overall Study|Withdrawal by Subject|1|||
16546572|NCT03682705|40464837|FG001|Overall Study|Withdrawal by Subject|3|||
16546573|NCT03682705|40464838|FG002|Overall Study|Withdrawal by Subject|2|||
16546574|NCT03682705|40464839|FG003|Overall Study|Withdrawal by Subject|4|||
16546575|NCT03682705|40464840|FG004|Overall Study|Withdrawal by Subject|0|||
16546576|NCT03682705|40464841|FG005|Overall Study|Withdrawal by Subject|1|||
16546577|NCT03682705|40464836|FG000|Overall Study|Other, not specified|0|||
16112717|NCT01439867|38901850|FG001|Overall Study|Protocol-specified Criteria|0|||
16112718|NCT03589300|38901852|FG000|Overall Study|Adverse Event|2|||
16112719|NCT03589300|38901852|FG000|Overall Study|Death|4|||
16112720|NCT03589300|38901852|FG000|Overall Study|Lost to Follow-up|12|||
16112721|NCT03589300|38901852|FG000|Overall Study|Withdrawal by Subject|5|||
16112722|NCT02522728|38901855|FG000|Overall Study|Withdrawal by Subject|6|||
16112723|NCT02522728|38901856|FG001|Overall Study|Withdrawal by Subject|6|||
16112724|NCT02522728|38901855|FG000|Overall Study|Death|4|||
16112725|NCT02522728|38901856|FG001|Overall Study|Death|3|||
16112726|NCT02522728|38901855|FG000|Overall Study|Adverse Event|2|||
16112727|NCT02522728|38901856|FG001|Overall Study|Adverse Event|1|||
16112728|NCT02522728|38901855|FG000|Overall Study|Did not receive randomized study device|0|||
16112729|NCT02522728|38901856|FG001|Overall Study|Did not receive randomized study device|1|||
16112730|NCT03178045|38901857|FG000|Overall Study|Withdrawal by Subject|5|||
16112731|NCT03178045|38901858|FG001|Overall Study|Withdrawal by Subject|7|||
16112732|NCT03178045|38901857|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
16112733|NCT03178045|38901858|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
16112734|NCT03178045|38901857|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
16112735|NCT03178045|38901858|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
16112736|NCT00003477|38901859|FG000|Overall Study|Not evalauable|4|||
16112737|NCT03566979|38901860|FG000|Overall Study|Withdrawal by Subject|2|||
16112738|NCT03566979|38901861|FG001|Overall Study|Withdrawal by Subject|0|||
16112739|NCT03566979|38901862|FG002|Overall Study|Withdrawal by Subject|1|||
16112740|NCT03566979|38901863|FG003|Overall Study|Withdrawal by Subject|1|||
16112741|NCT03566979|38901860|FG000|Overall Study|Lost to Follow-up|2|||
16112742|NCT03566979|38901861|FG001|Overall Study|Lost to Follow-up|7|||
16112743|NCT03566979|38901862|FG002|Overall Study|Lost to Follow-up|9|||
16112744|NCT03566979|38901863|FG003|Overall Study|Lost to Follow-up|5|||
16112745|NCT03566979|38901860|FG000|Overall Study|Adverse Event|1|||
16112746|NCT03566979|38901861|FG001|Overall Study|Adverse Event|0|||
16112747|NCT03566979|38901862|FG002|Overall Study|Adverse Event|0|||
16112748|NCT03566979|38901863|FG003|Overall Study|Adverse Event|0|||
16112749|NCT01256671|38901864|FG000|Overall Study|Adverse Event|29|||
16112750|NCT01256671|38901864|FG000|Overall Study|Lost to Follow-up|16|||
16112751|NCT01256671|38901864|FG000|Overall Study|Withdrawal by Subject|31|||
16112752|NCT01256671|38901864|FG000|Overall Study|Physician Decision|3|||
16112753|NCT01256671|38901864|FG000|Overall Study|Lack of Efficacy|4|||
16112754|NCT01256671|38901864|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
16112755|NCT00882115|38901865|FG000|Overall Study|Withdrawal by Subject|3|||
16112756|NCT00882115|38901865|FG000|Overall Study|did not respond to DEP challe|6|||
16112757|NCT00490698|38901866|FG000|Overall Study|Withdrawal by Subject|1|||
16112758|NCT00490698|38901866|FG000|Overall Study|Disease Progression|7|||
16112759|NCT00490698|38901866|FG000|Overall Study|Physician Decision|2|||
16112760|NCT02804399|38901867|FG000|Period 2|Adverse Event|0|||
16112761|NCT02804399|38901868|FG001|Period 2|Adverse Event|1|||
16112762|NCT00639769|38901869|FG000|Overall Study|Death|2|||
16112763|NCT00639769|38901869|FG000|Overall Study|Adverse Event|7|||
16112764|NCT00639769|38901869|FG000|Overall Study|Lack of Efficacy|1|||
16112765|NCT00639769|38901869|FG000|Overall Study|Disease progression|26|||
16112766|NCT00639769|38901869|FG000|Overall Study|Withdrawal by Subject|4|||
16112767|NCT00844597|38901870|FG000|Overall Study|Adverse Event|0|||
16112768|NCT00844597|38901871|FG001|Overall Study|Adverse Event|0|||
16112769|NCT00844597|38901872|FG002|Overall Study|Adverse Event|0|||
16112770|NCT00844597|38901873|FG003|Overall Study|Adverse Event|1|||
16112771|NCT00844597|38901874|FG004|Overall Study|Adverse Event|0|||
16112772|NCT00844597|38901875|FG005|Overall Study|Adverse Event|0|||
16112773|NCT02466243|38901877|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
16112774|NCT02466243|38901878|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
16112775|NCT02466243|38901877|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
16112776|NCT02466243|38901878|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
16112777|NCT02466243|38901877|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
16112778|NCT02466243|38901878|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
16546578|NCT03682705|40464837|FG001|Overall Study|Other, not specified|0|||
16112779|NCT02466243|38901877|FG000|Part B Open-label Treatment Period|Missing|2|||
16112780|NCT02466243|38901878|FG001|Part B Open-label Treatment Period|Missing|2|||
16112781|NCT00079339|38901879|FG000|Overall Study|Adverse Event|1|||
16112782|NCT00079339|38901880|FG001|Overall Study|Adverse Event|7|||
16112783|NCT00079339|38901881|FG002|Overall Study|Adverse Event|2|||
16112784|NCT00079339|38901879|FG000|Overall Study|Death|1|||
16112785|NCT00079339|38901880|FG001|Overall Study|Death|0|||
16112786|NCT00079339|38901881|FG002|Overall Study|Death|0|||
16112787|NCT00079339|38901879|FG000|Overall Study|Non-compliance|0|||
16112788|NCT00079339|38901880|FG001|Overall Study|Non-compliance|0|||
16112789|NCT00079339|38901881|FG002|Overall Study|Non-compliance|1|||
16112790|NCT00079339|38901879|FG000|Overall Study|Withdrawal by Subject|0|||
16112791|NCT00079339|38901880|FG001|Overall Study|Withdrawal by Subject|4|||
16112792|NCT00079339|38901881|FG002|Overall Study|Withdrawal by Subject|1|||
16112793|NCT00079339|38901879|FG000|Overall Study|Disease progression|3|||
16112794|NCT00079339|38901880|FG001|Overall Study|Disease progression|28|||
16112795|NCT00079339|38901881|FG002|Overall Study|Disease progression|2|||
16112796|NCT00664534|38901890|FG000|Overall Study|Adverse Event|2|||
16112797|NCT00664534|38901891|FG001|Overall Study|Adverse Event|3|||
16112798|NCT00664534|38901890|FG000|Overall Study|Lost to Follow-up|6|||
16112799|NCT00664534|38901891|FG001|Overall Study|Lost to Follow-up|10|||
16112800|NCT00664534|38901890|FG000|Overall Study|Protocol Violation|10|||
16112801|NCT00664534|38901891|FG001|Overall Study|Protocol Violation|8|||
16112802|NCT00664534|38901890|FG000|Overall Study|Withdrawal by Subject|7|||
16112803|NCT00664534|38901891|FG001|Overall Study|Withdrawal by Subject|6|||
16112804|NCT00664534|38901890|FG000|Overall Study|Physician Decision|8|||
16112805|NCT00664534|38901891|FG001|Overall Study|Physician Decision|0|||
16112806|NCT00664534|38901890|FG000|Overall Study|Sponsor decision|8|||
16112807|NCT00664534|38901891|FG001|Overall Study|Sponsor decision|6|||
16112808|NCT01250509|38901894|FG000|Overall Study|Lost to Follow-up|5|||
16112809|NCT01250509|38901895|FG001|Overall Study|Lost to Follow-up|2|||
16112810|NCT02366143|38901901|FG000|Overall Study|Death|307|||
16112811|NCT02366143|38901902|FG001|Overall Study|Death|278|||
16112812|NCT02366143|38901903|FG002|Overall Study|Death|280|||
16112813|NCT02366143|38901901|FG000|Overall Study|Lost to Follow-up|2|||
16112814|NCT02366143|38901902|FG001|Overall Study|Lost to Follow-up|4|||
16112815|NCT02366143|38901903|FG002|Overall Study|Lost to Follow-up|2|||
16112816|NCT02366143|38901901|FG000|Overall Study|Physician Decision|1|||
16112817|NCT02366143|38901902|FG001|Overall Study|Physician Decision|2|||
16112818|NCT02366143|38901903|FG002|Overall Study|Physician Decision|1|||
16112819|NCT02366143|38901901|FG000|Overall Study|Protocol Violation|0|||
16112820|NCT02366143|38901902|FG001|Overall Study|Protocol Violation|0|||
16112821|NCT02366143|38901903|FG002|Overall Study|Protocol Violation|2|||
16112822|NCT02366143|38901901|FG000|Overall Study|Withdrawal by Subject|16|||
16112823|NCT02366143|38901902|FG001|Overall Study|Withdrawal by Subject|17|||
16112824|NCT02366143|38901903|FG002|Overall Study|Withdrawal by Subject|22|||
16112825|NCT02366143|38901901|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
16410109|NCT04493684|39981863|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410110|NCT04493684|39981864|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410111|NCT04493684|39981865|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410112|NCT04493684|39981866|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410113|NCT04493684|39981867|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410114|NCT04493684|39981868|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410115|NCT04493684|39981869|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410116|NCT04493684|39981870|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410117|NCT04493684|39981871|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410118|NCT04493684|39981872|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410119|NCT04493684|39981873|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
16410120|NCT04493684|39981874|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
16410121|NCT04493684|39981858|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410122|NCT04493684|39981859|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410123|NCT04493684|39981860|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410124|NCT04493684|39981861|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410125|NCT04493684|39981862|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16546579|NCT03682705|40464838|FG002|Overall Study|Other, not specified|0|||
16410126|NCT04493684|39981863|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410127|NCT04493684|39981864|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410128|NCT04493684|39981865|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410129|NCT04493684|39981866|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410130|NCT04493684|39981867|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16546580|NCT03682705|40464839|FG003|Overall Study|Other, not specified|1|||
16546581|NCT03682705|40464840|FG004|Overall Study|Other, not specified|2|||
16546582|NCT03682705|40464841|FG005|Overall Study|Other, not specified|0|||
16546583|NCT03682705|40464836|FG000|Overall Study|Lost to Follow-up|0|||
16546584|NCT03682705|40464837|FG001|Overall Study|Lost to Follow-up|0|||
16546585|NCT03682705|40464838|FG002|Overall Study|Lost to Follow-up|0|||
16546586|NCT03682705|40464839|FG003|Overall Study|Lost to Follow-up|0|||
16546587|NCT03682705|40464840|FG004|Overall Study|Lost to Follow-up|3|||
16546588|NCT03682705|40464841|FG005|Overall Study|Lost to Follow-up|0|||
16546589|NCT02322814|40464842|FG000|Overall Study|Death|7|||
16546590|NCT02322814|40464843|FG001|Overall Study|Death|29|||
16546591|NCT02322814|40464844|FG002|Overall Study|Death|32|||
16546592|NCT02322814|40464845|FG003|Overall Study|Death|23|||
16546593|NCT02322814|40464846|FG004|Overall Study|Death|14|||
16546594|NCT02322814|40464842|FG000|Overall Study|Lost to Follow-up|1|||
16546595|NCT02322814|40464843|FG001|Overall Study|Lost to Follow-up|3|||
16112826|NCT02366143|38901902|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
16112827|NCT02366143|38901903|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
16112828|NCT02366143|38901901|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
16223958|NCT02630459|39298818|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
16223959|NCT02630459|39298819|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
16223960|NCT02630459|39298820|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
16223961|NCT02630459|39298821|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
16223962|NCT02630459|39298822|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
16112829|NCT02366143|38901902|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
16112830|NCT02366143|38901903|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
16112831|NCT02366143|38901901|FG000|Overall Study|Randomization Error|1|||
16112832|NCT02366143|38901902|FG001|Overall Study|Randomization Error|0|||
16112833|NCT02366143|38901903|FG002|Overall Study|Randomization Error|0|||
16112834|NCT02366143|38901901|FG000|Overall Study|PI Move and Site Closure|1|||
16112835|NCT02366143|38901902|FG001|Overall Study|PI Move and Site Closure|0|||
16223963|NCT02630459|39298823|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
16223964|NCT02630459|39298824|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
16223965|NCT02630459|39298825|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
16223966|NCT02711306|39298828|FG000|Overall Study|Withdrawal by Subject|2|||
16223967|NCT02711306|39298829|FG001|Overall Study|Withdrawal by Subject|2|||
16223968|NCT00665002|39298830|FG000|Overall Study|Progression/relapse during treatment|11|||
16223969|NCT00665002|39298830|FG000|Overall Study|Cytogenetic resistance|1|||
16223970|NCT02911285|39298831|FG000|Overall Study|Lost to Follow-up|8|||
16223971|NCT02911285|39298832|FG001|Overall Study|Lost to Follow-up|5|||
16223972|NCT02911285|39298831|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
16223973|NCT02911285|39298832|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
16223974|NCT05047601|39298834|FG000|Overall Study|Lost to Follow-up|9|||
16346576|NCT00762034|39757196|FG000|Maintenance Period|Withdrawal by Subject|34|||
16346577|NCT00762034|39757197|FG001|Maintenance Period|Withdrawal by Subject|14|||
16346578|NCT00762034|39757196|FG000|Maintenance Period|Death not due to study disease|2|||
16346579|NCT00762034|39757197|FG001|Maintenance Period|Death not due to study disease|5|||
16112836|NCT02366143|38901903|FG002|Overall Study|PI Move and Site Closure|1|||
16112837|NCT02366143|38901901|FG000|Overall Study|Study Terminated By Sponsor|0|||
16112838|NCT02366143|38901902|FG001|Overall Study|Study Terminated By Sponsor|0|||
16112839|NCT02366143|38901903|FG002|Overall Study|Study Terminated By Sponsor|2|||
16112840|NCT02366143|38901901|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
16112841|NCT02366143|38901902|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
16112842|NCT02366143|38901903|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
16112843|NCT02366143|38901901|FG000|Overall Study|Patient moved to roll-over study|1|||
16112844|NCT02366143|38901902|FG001|Overall Study|Patient moved to roll-over study|19|||
16112845|NCT02366143|38901903|FG002|Overall Study|Patient moved to roll-over study|28|||
16112846|NCT02366143|38901901|FG000|Overall Study|Patient moved to commercial stock|0|||
16112847|NCT02366143|38901902|FG001|Overall Study|Patient moved to commercial stock|0|||
16346580|NCT00762034|39757196|FG000|Maintenance Period|Death due to study disease|3|||
16346581|NCT00762034|39757197|FG001|Maintenance Period|Death due to study disease|3|||
16346582|NCT00762034|39757196|FG000|Maintenance Period|Other|1|||
16346583|NCT00762034|39757197|FG001|Maintenance Period|Other|1|||
16112848|NCT02366143|38901903|FG002|Overall Study|Patient moved to commercial stock|1|||
16112849|NCT02366143|38901901|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
16112850|NCT02366143|38901902|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
16112851|NCT02366143|38901903|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
16112852|NCT02366143|38901901|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
16112853|NCT02366143|38901902|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
16112854|NCT02366143|38901903|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
16112855|NCT02366143|38901901|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
16223975|NCT05047601|39298835|FG001|Overall Study|Lost to Follow-up|11|||
16223976|NCT05047601|39298836|FG002|Overall Study|Lost to Follow-up|7|||
16223977|NCT05047601|39298834|FG000|Overall Study|Withdrawal by Subject|25|||
16346584|NCT00707057|39757198|FG000|Overall Study|Withdrawal by Subject|8|||
16346585|NCT00707057|39757199|FG001|Overall Study|Withdrawal by Subject|3|||
16346586|NCT00707057|39757198|FG000|Overall Study|Dosed incorrectly|0|||
16346587|NCT00707057|39757199|FG001|Overall Study|Dosed incorrectly|1|||
16346588|NCT02302846|39757201|FG000|Overall Study|Withdrawal by Subject|1|||
16346589|NCT01395810|39757202|FG000|Overall Study|Adverse Event|0|||
16546596|NCT02322814|40464844|FG002|Overall Study|Lost to Follow-up|3|||
16223978|NCT05047601|39298835|FG001|Overall Study|Withdrawal by Subject|36|||
16223979|NCT05047601|39298836|FG002|Overall Study|Withdrawal by Subject|23|||
16346590|NCT01395810|39757203|FG001|Overall Study|Adverse Event|1|||
16346591|NCT01395810|39757204|FG002|Overall Study|Adverse Event|0|||
16346592|NCT01395810|39757205|FG003|Overall Study|Adverse Event|0|||
16546597|NCT02322814|40464845|FG003|Overall Study|Lost to Follow-up|1|||
16546598|NCT02322814|40464846|FG004|Overall Study|Lost to Follow-up|0|||
16546599|NCT02322814|40464842|FG000|Overall Study|Various Reasons|2|||
16546600|NCT02322814|40464843|FG001|Overall Study|Various Reasons|0|||
16223980|NCT05047601|39298834|FG000|Overall Study|Other|10|||
16223981|NCT05047601|39298835|FG001|Overall Study|Other|6|||
16223982|NCT05047601|39298836|FG002|Overall Study|Other|5|||
16223983|NCT00598442|39298838|FG000|Overall Study|Adverse Event|3|||
16223984|NCT00598442|39298839|FG001|Overall Study|Adverse Event|0|||
16223985|NCT00598442|39298840|FG002|Overall Study|Adverse Event|0|||
16223986|NCT00598442|39298838|FG000|Overall Study|Death|19|||
16223987|NCT00598442|39298839|FG001|Overall Study|Death|11|||
16223988|NCT00598442|39298840|FG002|Overall Study|Death|11|||
16223989|NCT00598442|39298838|FG000|Overall Study|Lost to Follow-up|4|||
16223990|NCT00598442|39298839|FG001|Overall Study|Lost to Follow-up|3|||
16223991|NCT00598442|39298840|FG002|Overall Study|Lost to Follow-up|3|||
16223992|NCT00598442|39298838|FG000|Overall Study|Physician Decision|2|||
16223993|NCT00598442|39298839|FG001|Overall Study|Physician Decision|1|||
16223994|NCT00598442|39298840|FG002|Overall Study|Physician Decision|1|||
16223995|NCT00598442|39298838|FG000|Overall Study|Withdrawal by Subject|8|||
16223996|NCT00598442|39298839|FG001|Overall Study|Withdrawal by Subject|16|||
16223997|NCT00598442|39298840|FG002|Overall Study|Withdrawal by Subject|6|||
16223998|NCT00598442|39298838|FG000|Overall Study|Noncompliance|0|||
16223999|NCT00598442|39298839|FG001|Overall Study|Noncompliance|2|||
16224000|NCT00598442|39298840|FG002|Overall Study|Noncompliance|1|||
16224001|NCT00598442|39298838|FG000|Overall Study|Relocation|1|||
16224002|NCT00598442|39298839|FG001|Overall Study|Relocation|4|||
16224003|NCT00598442|39298840|FG002|Overall Study|Relocation|0|||
16224004|NCT00598442|39298838|FG000|Overall Study|Renal transplant|0|||
16224005|NCT00598442|39298839|FG001|Overall Study|Renal transplant|0|||
16224006|NCT00598442|39298840|FG002|Overall Study|Renal transplant|1|||
16224007|NCT00598442|39298838|FG000|Overall Study|Site closed by sponsor|5|||
16224008|NCT00598442|39298839|FG001|Overall Study|Site closed by sponsor|2|||
16224009|NCT00598442|39298840|FG002|Overall Study|Site closed by sponsor|1|||
16224010|NCT00598442|39298838|FG000|Overall Study|Started dialysis|1|||
16224011|NCT00598442|39298839|FG001|Overall Study|Started dialysis|0|||
16224012|NCT00598442|39298840|FG002|Overall Study|Started dialysis|0|||
16224013|NCT00303602|39298845|FG000|Overall Study|Adverse Event|2|||
16224014|NCT00303602|39298846|FG001|Overall Study|Adverse Event|2|||
16224015|NCT00303602|39298845|FG000|Overall Study|Withdrawal by Subject|5|||
16224016|NCT00303602|39298846|FG001|Overall Study|Withdrawal by Subject|6|||
16224017|NCT00303602|39298845|FG000|Overall Study|Lost to Follow-up|5|||
16224018|NCT00303602|39298846|FG001|Overall Study|Lost to Follow-up|2|||
16224019|NCT00303602|39298845|FG000|Overall Study|Protocol entry criteria not met|2|||
16224020|NCT00303602|39298846|FG001|Overall Study|Protocol entry criteria not met|2|||
16224021|NCT00303602|39298845|FG000|Overall Study|Physician Decision|2|||
16224022|NCT00303602|39298846|FG001|Overall Study|Physician Decision|1|||
16224023|NCT00303602|39298845|FG000|Overall Study|Noncompliance|2|||
16224024|NCT00303602|39298846|FG001|Overall Study|Noncompliance|2|||
16224025|NCT00303602|39298845|FG000|Overall Study|Protocol Violation|1|||
16224026|NCT00303602|39298846|FG001|Overall Study|Protocol Violation|0|||
16224027|NCT00660829|39298847|FG000|Overall Study|Adverse Event|3|||
16224028|NCT00660829|39298848|FG001|Overall Study|Adverse Event|4|||
16224029|NCT00660829|39298847|FG000|Overall Study|Lack of Efficacy|2|||
16224030|NCT00660829|39298848|FG001|Overall Study|Lack of Efficacy|3|||
16224031|NCT00660829|39298847|FG000|Overall Study|Non-Compliance|0|||
16224032|NCT00660829|39298848|FG001|Overall Study|Non-Compliance|4|||
16224033|NCT00660829|39298847|FG000|Overall Study|Withdrawal by Subject|1|||
16224034|NCT00660829|39298848|FG001|Overall Study|Withdrawal by Subject|2|||
16224035|NCT00660829|39298847|FG000|Overall Study|Lost to Follow-up|3|||
16224036|NCT00660829|39298848|FG001|Overall Study|Lost to Follow-up|2|||
16224037|NCT00660829|39298847|FG000|Overall Study|Other|9|||
16224038|NCT00660829|39298848|FG001|Overall Study|Other|4|||
16224039|NCT02828982|39298849|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16224040|NCT02828982|39298850|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16224041|NCT02074059|39298851|FG000|Overall Study|Death|0|||
16224042|NCT02074059|39298852|FG001|Overall Study|Death|0|||
16224043|NCT02074059|39298853|FG002|Overall Study|Death|0|||
16224044|NCT02074059|39298854|FG003|Overall Study|Death|0|||
16224045|NCT02074059|39298855|FG004|Overall Study|Death|1|||
16224046|NCT02074059|39298856|FG005|Overall Study|Death|1|||
16224047|NCT04524507|39298857|FG000|Overall Study|Lost to Follow-up|2|||
16224048|NCT04524507|39298858|FG001|Overall Study|Lost to Follow-up|4|||
16224049|NCT04524507|39298857|FG000|Overall Study|Withdrawal by Subject|2|||
16224050|NCT04524507|39298858|FG001|Overall Study|Withdrawal by Subject|9|||
16224051|NCT04524507|39298857|FG000|Overall Study|Death|2|||
16224052|NCT04524507|39298858|FG001|Overall Study|Death|10|||
16224053|NCT00087594|39298859|FG000|Overall Study|Adverse Event|2|||
16224054|NCT00087594|39298860|FG001|Overall Study|Adverse Event|3|||
16224055|NCT00087594|39298859|FG000|Overall Study|Lost to Follow-up|0|||
16224056|NCT00087594|39298860|FG001|Overall Study|Lost to Follow-up|2|||
16224057|NCT00087594|39298859|FG000|Overall Study|Withdrawal by Subject|4|||
16224058|NCT00087594|39298860|FG001|Overall Study|Withdrawal by Subject|2|||
16224059|NCT00087594|39298859|FG000|Overall Study|Lack of Efficacy|2|||
16224060|NCT00087594|39298860|FG001|Overall Study|Lack of Efficacy|5|||
16224061|NCT02554721|39298862|FG000|Overall Study|Adverse Event|1|||
16224062|NCT02554721|39298863|FG001|Overall Study|Adverse Event|0|||
16224063|NCT02554721|39298864|FG002|Overall Study|Adverse Event|0|||
16224064|NCT02554721|39298865|FG003|Overall Study|Adverse Event|0|||
16224065|NCT02554721|39298866|FG004|Overall Study|Adverse Event|1|||
16224066|NCT02554721|39298862|FG000|Overall Study|Noncompliance|0|||
16224067|NCT02554721|39298863|FG001|Overall Study|Noncompliance|0|||
16410131|NCT04493684|39981868|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410132|NCT04493684|39981869|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410133|NCT04493684|39981870|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410134|NCT04493684|39981871|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410135|NCT04493684|39981872|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410136|NCT04493684|39981873|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
16410137|NCT04493684|39981874|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
16410138|NCT03383783|39981881|FG000|Overall Study|Withdrawal by Subject|2|||
16224068|NCT02554721|39298864|FG002|Overall Study|Noncompliance|0|||
16224069|NCT02554721|39298865|FG003|Overall Study|Noncompliance|0|||
16224070|NCT02554721|39298866|FG004|Overall Study|Noncompliance|1|||
16224071|NCT01716585|39298867|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
16224072|NCT01716585|39298868|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
16224073|NCT01716585|39298867|FG000|Double-blind Treatment|Adverse Event|2|||
16224074|NCT01716585|39298868|FG001|Double-blind Treatment|Adverse Event|1|||
16224075|NCT01716585|39298867|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
16224076|NCT01716585|39298868|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
16224077|NCT01716585|39298867|FG000|Double-blind Treatment|Lost to Follow-up|2|||
16224078|NCT01716585|39298868|FG001|Double-blind Treatment|Lost to Follow-up|0|||
16224079|NCT01716585|39298867|FG000|Double-blind Treatment|Subject Noncompliant|1|||
16224080|NCT01716585|39298868|FG001|Double-blind Treatment|Subject Noncompliant|0|||
16224081|NCT01716585|39298867|FG000|Double-blind Treatment|Other|1|||
16224082|NCT01716585|39298868|FG001|Double-blind Treatment|Other|0|||
16224083|NCT01716585|39298867|FG000|Open-label Treatment|Adverse Event|0|||
16224084|NCT01716585|39298868|FG001|Open-label Treatment|Adverse Event|2|||
16224085|NCT01716585|39298867|FG000|Open-label Treatment|Virologic Failure|0|||
16224086|NCT01716585|39298868|FG001|Open-label Treatment|Virologic Failure|2|||
16224087|NCT01716585|39298867|FG000|Open-label Treatment|Withdrawal by Subject|0|||
16224088|NCT01716585|39298868|FG001|Open-label Treatment|Withdrawal by Subject|3|||
16224089|NCT02561572|39298869|FG000|Overall Study|Inadequate time before surgery|2|||
16224090|NCT02561572|39298870|FG001|Overall Study|Inadequate time before surgery|1|||
16224091|NCT02561572|39298869|FG000|Overall Study|Protocol Violation|0|||
16224092|NCT02561572|39298870|FG001|Overall Study|Protocol Violation|1|||
16224093|NCT00626327|39298877|FG000|Overall Study|Withdrawal by Subject|21|||
16224094|NCT00626327|39298878|FG001|Overall Study|Withdrawal by Subject|29|||
16224095|NCT00626327|39298879|FG002|Overall Study|Withdrawal by Subject|30|||
16224096|NCT00626327|39298877|FG000|Overall Study|Adverse Event|1|||
16224097|NCT00626327|39298878|FG001|Overall Study|Adverse Event|0|||
16224098|NCT00626327|39298879|FG002|Overall Study|Adverse Event|0|||
16224099|NCT00626327|39298877|FG000|Overall Study|Lost to Follow-up|24|||
16224100|NCT00626327|39298878|FG001|Overall Study|Lost to Follow-up|21|||
16224101|NCT00626327|39298879|FG002|Overall Study|Lost to Follow-up|23|||
16224102|NCT00626327|39298877|FG000|Overall Study|Inappropriate enrollment|4|||
16224103|NCT00626327|39298878|FG001|Overall Study|Inappropriate enrollment|5|||
16224104|NCT00626327|39298879|FG002|Overall Study|Inappropriate enrollment|3|||
16224105|NCT00626327|39298877|FG000|Overall Study|Administrative Reason|2|||
16224106|NCT00626327|39298878|FG001|Overall Study|Administrative Reason|0|||
16224107|NCT00626327|39298879|FG002|Overall Study|Administrative Reason|6|||
16224108|NCT00626327|39298877|FG000|Overall Study|Protocol Violation|26|||
16224109|NCT00626327|39298878|FG001|Overall Study|Protocol Violation|4|||
16224110|NCT00626327|39298879|FG002|Overall Study|Protocol Violation|26|||
16224111|NCT02759939|39298880|FG000|Overall Study|Missing data on first outcome assessed|11|||
16224112|NCT02759939|39298881|FG001|Overall Study|Missing data on first outcome assessed|2|||
16224113|NCT02759939|39298882|FG002|Overall Study|Missing data on first outcome assessed|5|||
16224114|NCT02759939|39298883|FG003|Overall Study|Missing data on first outcome assessed|2|||
16224115|NCT02759939|39298880|FG000|Overall Study|Ineligible for T2 and T3|310|||
16224116|NCT02759939|39298881|FG001|Overall Study|Ineligible for T2 and T3|179|||
16224117|NCT02759939|39298882|FG002|Overall Study|Ineligible for T2 and T3|366|||
16224118|NCT02759939|39298883|FG003|Overall Study|Ineligible for T2 and T3|391|||
16224119|NCT02759939|39298880|FG000|Overall Study|Lost to Follow-up|735|||
16224120|NCT02759939|39298881|FG001|Overall Study|Lost to Follow-up|791|||
16224121|NCT02759939|39298882|FG002|Overall Study|Lost to Follow-up|783|||
16224122|NCT02759939|39298883|FG003|Overall Study|Lost to Follow-up|650|||
16224123|NCT00967343|39298884|FG000|Overall Study|Study termination by sponsor|12|||
16224124|NCT00967343|39298884|FG000|Overall Study|Death|24|||
16224125|NCT00967343|39298884|FG000|Overall Study|Relapse|1|||
16224126|NCT00967343|39298884|FG000|Overall Study|Lost to Follow-up|1|||
16224127|NCT01474993|39302326|FG000|Overall Study|Lost to Follow-up|1|||
16224128|NCT01474993|39302327|FG001|Overall Study|Lost to Follow-up|2|||
16224129|NCT01474993|39302326|FG000|Overall Study|Adverse Event|0|||
16224130|NCT01474993|39302327|FG001|Overall Study|Adverse Event|1|||
16224131|NCT02406586|39302328|FG000|Overall Study|Lost to Follow-up|0|||
16224132|NCT02406586|39302329|FG001|Overall Study|Lost to Follow-up|4|||
16224133|NCT02406586|39302330|FG002|Overall Study|Lost to Follow-up|2|||
16224134|NCT02406586|39302328|FG000|Overall Study|Withdrawal by Subject|1|||
16224135|NCT02406586|39302329|FG001|Overall Study|Withdrawal by Subject|0|||
16112856|NCT02366143|38901902|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
16112857|NCT02366143|38901903|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
16112858|NCT02366143|38901901|FG000|Overall Study|Requester's instructions|1|||
16112859|NCT02366143|38901902|FG001|Overall Study|Requester's instructions|1|||
16112860|NCT02366143|38901903|FG002|Overall Study|Requester's instructions|1|||
16112861|NCT02366143|38901901|FG000|Overall Study|Uneligible|0|||
16112862|NCT02366143|38901902|FG001|Overall Study|Uneligible|1|||
16112863|NCT02366143|38901903|FG002|Overall Study|Uneligible|0|||
16112864|NCT02366143|38901901|FG000|Overall Study|Post Trial Migration|0|||
16112865|NCT02366143|38901902|FG001|Overall Study|Post Trial Migration|1|||
16112866|NCT02366143|38901903|FG002|Overall Study|Post Trial Migration|0|||
16112867|NCT02366143|38901901|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
16112868|NCT02366143|38901902|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
16224136|NCT02406586|39302330|FG002|Overall Study|Withdrawal by Subject|0|||
16224137|NCT03737812|39302331|FG000|Overall Study|Withdrawal by Subject|1|||
16224138|NCT03737812|39302332|FG001|Overall Study|Withdrawal by Subject|2|||
16224139|NCT03737812|39302333|FG002|Overall Study|Withdrawal by Subject|1|||
16224140|NCT03737812|39302331|FG000|Overall Study|Sponsor Discontinued the Study|4|||
16410139|NCT02680574|39981882|FG000|Overall Study|Death|137|||
16224141|NCT03737812|39302332|FG001|Overall Study|Sponsor Discontinued the Study|3|||
16224142|NCT03737812|39302333|FG002|Overall Study|Sponsor Discontinued the Study|2|||
16224143|NCT03737812|39302331|FG000|Overall Study|Adverse Event|0|||
16224144|NCT03737812|39302332|FG001|Overall Study|Adverse Event|1|||
16224145|NCT03737812|39302333|FG002|Overall Study|Adverse Event|0|||
16224146|NCT03737812|39302331|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
16224147|NCT03737812|39302332|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
16224148|NCT03737812|39302333|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
16112869|NCT02366143|38901903|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
16112870|NCT02366143|38901901|FG000|Overall Study|Patient switched to PTAP|0|||
16112871|NCT02366143|38901902|FG001|Overall Study|Patient switched to PTAP|1|||
16112872|NCT02366143|38901903|FG002|Overall Study|Patient switched to PTAP|0|||
16112873|NCT02366143|38901901|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
16112874|NCT02366143|38901902|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
16112875|NCT02366143|38901903|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
16112876|NCT00856245|38901907|FG000|Overall Study|Was not transplanted|5|||
16112877|NCT01012947|38901912|FG000|Overall Study|Lost to Follow-up|131|||
16112878|NCT01012947|38901913|FG001|Overall Study|Lost to Follow-up|135|||
16112879|NCT01012947|38901914|FG002|Overall Study|Lost to Follow-up|130|||
16112880|NCT01012947|38901915|FG003|Overall Study|Lost to Follow-up|118|||
16112881|NCT01012947|38901916|FG004|Overall Study|Lost to Follow-up|142|||
16112882|NCT02344342|38901917|FG000|Overall Study|Industry partner dropped out|11|||
16112883|NCT02344342|38901918|FG001|Overall Study|Industry partner dropped out|9|||
16112884|NCT02344342|38901919|FG002|Overall Study|Industry partner dropped out|14|||
16112885|NCT02344342|38901920|FG003|Overall Study|Industry partner dropped out|10|||
16112886|NCT03575065|38901921|FG000|Overall Study|Death|31|||
16112887|NCT03575065|38901922|FG001|Overall Study|Death|12|||
16112888|NCT03575065|38901921|FG000|Overall Study|Sponsor's Decision|28|||
16112889|NCT03575065|38901922|FG001|Overall Study|Sponsor's Decision|13|||
16112890|NCT03575065|38901921|FG000|Overall Study|Withdrawal by Subject|2|||
16112891|NCT03575065|38901922|FG001|Overall Study|Withdrawal by Subject|1|||
16112892|NCT03575065|38901921|FG000|Overall Study|Lost to Follow-up|1|||
16112893|NCT03575065|38901922|FG001|Overall Study|Lost to Follow-up|0|||
16112894|NCT01288209|38901923|FG000|Overall Study|Withdrawal by Subject|1|||
16112895|NCT01288209|38901924|FG001|Overall Study|Withdrawal by Subject|3|||
16112896|NCT01288209|38901923|FG000|Overall Study|Other|1|||
16112897|NCT01288209|38901924|FG001|Overall Study|Other|0|||
16112898|NCT00839956|38901925|FG000|Overall Study|Adverse Event|2|||
16112899|NCT00839956|38901925|FG000|Overall Study|Lack of Efficacy|6|||
16112900|NCT00839956|38901925|FG000|Overall Study|Physician Decision|1|||
16112901|NCT00839956|38901925|FG000|Overall Study|Withdrawal by Subject|3|||
16112902|NCT03638258|38901926|FG000|Overall Study|Adverse Event|1|||
16112903|NCT03638258|38901927|FG001|Overall Study|Adverse Event|0|||
16112904|NCT03638258|38901928|FG002|Overall Study|Adverse Event|2|||
16112905|NCT03638258|38901926|FG000|Overall Study|Lost to Follow-up|2|||
16112906|NCT03638258|38901927|FG001|Overall Study|Lost to Follow-up|4|||
16112907|NCT03638258|38901928|FG002|Overall Study|Lost to Follow-up|5|||
16112908|NCT03638258|38901926|FG000|Overall Study|Pregnancy|0|||
16112909|NCT03638258|38901927|FG001|Overall Study|Pregnancy|0|||
16112910|NCT03638258|38901928|FG002|Overall Study|Pregnancy|1|||
16112911|NCT03638258|38901926|FG000|Overall Study|Protocol Violation|0|||
16112912|NCT03638258|38901927|FG001|Overall Study|Protocol Violation|0|||
16112913|NCT03638258|38901928|FG002|Overall Study|Protocol Violation|1|||
16112914|NCT03638258|38901926|FG000|Overall Study|Withdrawal by Subject|4|||
16112915|NCT03638258|38901927|FG001|Overall Study|Withdrawal by Subject|5|||
16112916|NCT03638258|38901928|FG002|Overall Study|Withdrawal by Subject|12|||
16112917|NCT03638258|38901926|FG000|Overall Study|Lack of Efficacy|0|||
16112918|NCT03638258|38901927|FG001|Overall Study|Lack of Efficacy|0|||
16112919|NCT03638258|38901928|FG002|Overall Study|Lack of Efficacy|2|||
16112920|NCT01736189|38901929|FG000|Overall Study|Violation of registration criteria|41|||
16112921|NCT01736189|38901929|FG000|Overall Study|Protocol Violation|4|||
16224149|NCT03763942|39302334|FG000|Overall Study|Lost to Follow-up|114|||
16410140|NCT02680574|39981883|FG001|Overall Study|Death|137|||
16410141|NCT02680574|39981882|FG000|Overall Study|Withdrawal by Subject|17|||
16410142|NCT02680574|39981883|FG001|Overall Study|Withdrawal by Subject|9|||
16410143|NCT02680574|39981882|FG000|Overall Study|Lost to Follow-up|4|||
16410144|NCT02680574|39981883|FG001|Overall Study|Lost to Follow-up|6|||
16410145|NCT02776033|39981884|FG000|Overall Study|Withdrawal by Subject|0|||
16410146|NCT02776033|39981885|FG001|Overall Study|Withdrawal by Subject|0|||
16410147|NCT02776033|39981886|FG002|Overall Study|Withdrawal by Subject|2|||
16410148|NCT02776033|39981884|FG000|Overall Study|Physician Decision|2|||
16410149|NCT02776033|39981885|FG001|Overall Study|Physician Decision|0|||
16410150|NCT02776033|39981886|FG002|Overall Study|Physician Decision|0|||
16410151|NCT02776033|39981884|FG000|Overall Study|Lost to Follow-up|1|||
16410152|NCT02776033|39981885|FG001|Overall Study|Lost to Follow-up|0|||
16410153|NCT02776033|39981886|FG002|Overall Study|Lost to Follow-up|0|||
16410154|NCT02776033|39981884|FG000|Overall Study|Adverse Event|1|||
16410155|NCT02776033|39981885|FG001|Overall Study|Adverse Event|2|||
16112922|NCT01736189|38901929|FG000|Overall Study|Criteria and protocol violations|1|||
16410156|NCT02776033|39981886|FG002|Overall Study|Adverse Event|0|||
16410157|NCT00791557|39985373|FG000|Overall Study|Adverse Event|1|||
16410158|NCT00585546|39985374|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
16410159|NCT00585546|39985374|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
16112923|NCT02209181|38901930|FG000|Overall Study|Adverse Event|1|||
16112924|NCT02209181|38901931|FG001|Overall Study|Adverse Event|0|||
16112925|NCT02209181|38901932|FG002|Overall Study|Adverse Event|1|||
16112926|NCT02209181|38901933|FG003|Overall Study|Adverse Event|0|||
16112927|NCT02209181|38901930|FG000|Overall Study|Withdrawal by Subject|0|||
16112928|NCT02209181|38901931|FG001|Overall Study|Withdrawal by Subject|1|||
16112929|NCT02209181|38901932|FG002|Overall Study|Withdrawal by Subject|0|||
16112930|NCT02209181|38901933|FG003|Overall Study|Withdrawal by Subject|0|||
16112931|NCT02498236|38901938|FG000|Overall Study|Did not show for testing|1|||
16112932|NCT02498236|38901939|FG001|Overall Study|Did not show for testing|0|||
16112933|NCT02498236|38901940|FG002|Overall Study|Did not show for testing|0|||
16112934|NCT02498236|38901941|FG003|Overall Study|Did not show for testing|0|||
16112935|NCT02498236|38901942|FG004|Overall Study|Did not show for testing|0|||
16112936|NCT02498236|38901943|FG005|Overall Study|Did not show for testing|0|||
16112937|NCT02498236|38901944|FG006|Overall Study|Did not show for testing|0|||
16224150|NCT03763942|39302335|FG001|Overall Study|Lost to Follow-up|54|||
16112938|NCT02498236|38901945|FG007|Overall Study|Did not show for testing|1|||
16112939|NCT02498236|38901938|FG000|Overall Study|Equipment failure|0|||
16112940|NCT02498236|38901939|FG001|Overall Study|Equipment failure|0|||
16224151|NCT03763942|39302334|FG000|Overall Study|Protocol Violation|1|||
16112941|NCT02498236|38901940|FG002|Overall Study|Equipment failure|0|||
16112942|NCT02498236|38901941|FG003|Overall Study|Equipment failure|0|||
16112943|NCT02498236|38901942|FG004|Overall Study|Equipment failure|0|||
16112944|NCT02498236|38901943|FG005|Overall Study|Equipment failure|0|||
16112945|NCT02498236|38901944|FG006|Overall Study|Equipment failure|1|||
16112946|NCT02498236|38901945|FG007|Overall Study|Equipment failure|0|||
16112947|NCT02498236|38901938|FG000|Overall Study|Withdrawal by Subject|0|||
16112948|NCT02498236|38901939|FG001|Overall Study|Withdrawal by Subject|0|||
16112949|NCT02498236|38901940|FG002|Overall Study|Withdrawal by Subject|0|||
16112950|NCT02498236|38901941|FG003|Overall Study|Withdrawal by Subject|0|||
16112951|NCT02498236|38901942|FG004|Overall Study|Withdrawal by Subject|1|||
16112952|NCT02498236|38901943|FG005|Overall Study|Withdrawal by Subject|0|||
16112953|NCT02498236|38901944|FG006|Overall Study|Withdrawal by Subject|0|||
16112954|NCT02498236|38901945|FG007|Overall Study|Withdrawal by Subject|0|||
16112955|NCT01889069|38901946|FG000|Overall Study|Death|18|||
16112956|NCT01889069|38901946|FG000|Overall Study|Progression of Disease|14|||
16112957|NCT01889069|38901946|FG000|Overall Study|Lost to Follow-up|6|||
16112958|NCT01889069|38901946|FG000|Overall Study|Other|4|||
16112959|NCT01889069|38901946|FG000|Overall Study|Consent Withdrawal|3|||
16112960|NCT03707977|38901950|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
16112961|NCT03707977|38901951|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
16224152|NCT03763942|39302335|FG001|Overall Study|Protocol Violation|0|||
16410160|NCT01219933|39985378|FG000|Overall Study|Adverse Event|8|||
16410161|NCT01219933|39985378|FG000|Overall Study|No LDA reached|5|||
16410162|NCT01219933|39985378|FG000|Overall Study|No LDA maintained|7|||
16410163|NCT01219933|39985378|FG000|Overall Study|Lost to Follow-up|3|||
16410164|NCT01219933|39985378|FG000|Overall Study|GC free|1|||
16410165|NCT01219933|39985378|FG000|Overall Study|Withdrawal by Subject|5|||
16410166|NCT01219933|39985378|FG000|Overall Study|Protocol Violation|8|||
16410167|NCT01219933|39985378|FG000|Overall Study|Lack of Efficacy|1|||
16546601|NCT02322814|40464844|FG002|Overall Study|Various Reasons|1|||
16224153|NCT03763942|39302334|FG000|Overall Study|Withdrawal by Subject|2|||
16224154|NCT03763942|39302335|FG001|Overall Study|Withdrawal by Subject|0|||
16410168|NCT02689076|39985379|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
16546602|NCT02322814|40464845|FG003|Overall Study|Various Reasons|1|||
16546603|NCT02322814|40464846|FG004|Overall Study|Various Reasons|0|||
16546604|NCT02322814|40464842|FG000|Overall Study|Progressive Disease|0|||
16546605|NCT02322814|40464843|FG001|Overall Study|Progressive Disease|0|||
16546606|NCT02322814|40464844|FG002|Overall Study|Progressive Disease|0|||
16546607|NCT02322814|40464845|FG003|Overall Study|Progressive Disease|1|||
16546608|NCT02322814|40464846|FG004|Overall Study|Progressive Disease|1|||
16546609|NCT02322814|40464842|FG000|Overall Study|Protocol Violation|1|||
16546610|NCT02322814|40464843|FG001|Overall Study|Protocol Violation|0|||
16546611|NCT02322814|40464844|FG002|Overall Study|Protocol Violation|0|||
16546612|NCT02322814|40464845|FG003|Overall Study|Protocol Violation|0|||
16112962|NCT03707977|38901952|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
16112963|NCT03707977|38901950|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
16112964|NCT03707977|38901951|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
16112965|NCT03707977|38901952|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
16112966|NCT04947436|38901953|FG000|Overall Study|Lost to Follow-up|3|||
16224155|NCT03763942|39302334|FG000|Overall Study|Other|2|||
16224156|NCT03763942|39302335|FG001|Overall Study|Other|3|||
16112967|NCT04947436|38901954|FG001|Overall Study|Lost to Follow-up|7|||
16112968|NCT04947436|38901955|FG002|Overall Study|Lost to Follow-up|5|||
16112969|NCT04947436|38901953|FG000|Overall Study|Death|1|||
16112970|NCT04947436|38901954|FG001|Overall Study|Death|1|||
16112971|NCT04947436|38901955|FG002|Overall Study|Death|1|||
16112972|NCT03546816|38901956|FG000|Overall Study|Adverse Event|5|||
16112973|NCT03546816|38901957|FG001|Overall Study|Adverse Event|3|||
16112974|NCT03546816|38901956|FG000|Overall Study|Lack of Efficacy|2|||
16112975|NCT03546816|38901957|FG001|Overall Study|Lack of Efficacy|4|||
16112976|NCT03546816|38901956|FG000|Overall Study|Pregnancy|1|||
16112977|NCT03546816|38901957|FG001|Overall Study|Pregnancy|0|||
16112978|NCT03546816|38901956|FG000|Overall Study|Physician Decision|2|||
16112979|NCT03546816|38901957|FG001|Overall Study|Physician Decision|0|||
16112980|NCT03546816|38901956|FG000|Overall Study|Withdrawal by Subject|8|||
16112981|NCT03546816|38901957|FG001|Overall Study|Withdrawal by Subject|10|||
16112982|NCT03546816|38901956|FG000|Overall Study|Lost to Follow-up|3|||
16112983|NCT03546816|38901957|FG001|Overall Study|Lost to Follow-up|2|||
16112984|NCT00730015|38901958|FG000|Overall Study|Adverse Event|11|||
16112985|NCT00730015|38901959|FG001|Overall Study|Adverse Event|10|||
16112986|NCT00730015|38901960|FG002|Overall Study|Adverse Event|8|||
16112987|NCT00730015|38901958|FG000|Overall Study|Protocol Violation|2|||
16112988|NCT00730015|38901959|FG001|Overall Study|Protocol Violation|6|||
16112989|NCT00730015|38901960|FG002|Overall Study|Protocol Violation|4|||
16112990|NCT00730015|38901958|FG000|Overall Study|Withdrawal by Subject|12|||
16112991|NCT00730015|38901959|FG001|Overall Study|Withdrawal by Subject|12|||
16112992|NCT00730015|38901960|FG002|Overall Study|Withdrawal by Subject|8|||
16112993|NCT00730015|38901958|FG000|Overall Study|Lost to Follow-up|4|||
16112994|NCT00730015|38901959|FG001|Overall Study|Lost to Follow-up|10|||
16112995|NCT00730015|38901960|FG002|Overall Study|Lost to Follow-up|3|||
16112996|NCT00730015|38901958|FG000|Overall Study|Lack of Efficacy|1|||
16112997|NCT00730015|38901959|FG001|Overall Study|Lack of Efficacy|2|||
16112998|NCT00730015|38901960|FG002|Overall Study|Lack of Efficacy|8|||
16112999|NCT00730015|38901958|FG000|Overall Study|Other Reason|1|||
16113000|NCT00730015|38901959|FG001|Overall Study|Other Reason|0|||
16113001|NCT00730015|38901960|FG002|Overall Study|Other Reason|1|||
16113002|NCT01496365|38901961|FG000|Overall Study|Adverse Event|2|||
16113003|NCT01496365|38901962|FG001|Overall Study|Adverse Event|3|||
16113004|NCT01496365|38901963|FG002|Overall Study|Adverse Event|3|||
16113005|NCT01496365|38901964|FG003|Overall Study|Adverse Event|2|||
16113006|NCT01496365|38901965|FG004|Overall Study|Adverse Event|5|||
16113007|NCT01496365|38901966|FG005|Overall Study|Adverse Event|6|||
16113008|NCT01496365|38901967|FG006|Overall Study|Adverse Event|4|||
16113009|NCT01496365|38901961|FG000|Overall Study|Withdrawal by Subject|6|||
16113010|NCT01496365|38901962|FG001|Overall Study|Withdrawal by Subject|6|||
16113011|NCT01496365|38901963|FG002|Overall Study|Withdrawal by Subject|0|||
16113012|NCT01496365|38901964|FG003|Overall Study|Withdrawal by Subject|1|||
16113013|NCT01496365|38901965|FG004|Overall Study|Withdrawal by Subject|3|||
16113014|NCT01496365|38901966|FG005|Overall Study|Withdrawal by Subject|2|||
16113015|NCT01496365|38901967|FG006|Overall Study|Withdrawal by Subject|1|||
16113016|NCT01496365|38901961|FG000|Overall Study|Protocol Violation|2|||
16113017|NCT01496365|38901962|FG001|Overall Study|Protocol Violation|1|||
16113018|NCT01496365|38901963|FG002|Overall Study|Protocol Violation|1|||
16113019|NCT01496365|38901964|FG003|Overall Study|Protocol Violation|0|||
16113020|NCT01496365|38901965|FG004|Overall Study|Protocol Violation|0|||
16113021|NCT01496365|38901966|FG005|Overall Study|Protocol Violation|1|||
16113022|NCT01496365|38901967|FG006|Overall Study|Protocol Violation|0|||
16113023|NCT01496365|38901961|FG000|Overall Study|Lack of Efficacy|1|||
16113024|NCT01496365|38901962|FG001|Overall Study|Lack of Efficacy|0|||
16113025|NCT01496365|38901963|FG002|Overall Study|Lack of Efficacy|0|||
16113026|NCT01496365|38901964|FG003|Overall Study|Lack of Efficacy|0|||
16113027|NCT01496365|38901965|FG004|Overall Study|Lack of Efficacy|0|||
16113028|NCT01496365|38901966|FG005|Overall Study|Lack of Efficacy|1|||
16113029|NCT01496365|38901967|FG006|Overall Study|Lack of Efficacy|0|||
16113030|NCT01496365|38901961|FG000|Overall Study|Lost to Follow-up|0|||
16113031|NCT01496365|38901962|FG001|Overall Study|Lost to Follow-up|1|||
16113032|NCT01496365|38901963|FG002|Overall Study|Lost to Follow-up|0|||
16113033|NCT01496365|38901964|FG003|Overall Study|Lost to Follow-up|0|||
16113034|NCT01496365|38901965|FG004|Overall Study|Lost to Follow-up|2|||
16113035|NCT01496365|38901966|FG005|Overall Study|Lost to Follow-up|0|||
16113036|NCT01496365|38901967|FG006|Overall Study|Lost to Follow-up|0|||
16113037|NCT01496365|38901961|FG000|Overall Study|Other|4|||
16113038|NCT01496365|38901962|FG001|Overall Study|Other|4|||
16113039|NCT01496365|38901963|FG002|Overall Study|Other|2|||
16113040|NCT01496365|38901964|FG003|Overall Study|Other|1|||
16113041|NCT01496365|38901965|FG004|Overall Study|Other|3|||
16113042|NCT01496365|38901966|FG005|Overall Study|Other|0|||
16113043|NCT01496365|38901967|FG006|Overall Study|Other|1|||
16113044|NCT02641587|38901968|FG000|Confinement Period|Adverse Event|1|||
16113045|NCT02641587|38901969|FG001|Confinement Period|Adverse Event|0|||
16113046|NCT02641587|38901968|FG000|Confinement Period|Withdrawal by Subject|2|||
16113047|NCT02641587|38901969|FG001|Confinement Period|Withdrawal by Subject|1|||
16113048|NCT02641587|38901968|FG000|Ambulatory Period|Withdrawal by Subject|1|||
16113049|NCT02641587|38901969|FG001|Ambulatory Period|Withdrawal by Subject|0|||
16113050|NCT01791413|38901972|FG000|Overall Study|Lost to Follow-up|5|||
16113051|NCT01791413|38901973|FG001|Overall Study|Lost to Follow-up|1|||
16113052|NCT01056263|38901974|FG000|Overall Study|Adverse Event|12|||
16113053|NCT01056263|38901974|FG000|Overall Study|Death|1|||
16113054|NCT01056263|38901974|FG000|Overall Study|Withdrawal by Subject|1|||
16113055|NCT01056263|38901974|FG000|Overall Study|Lack of Efficacy|29|||
16113056|NCT01056263|38901974|FG000|Overall Study|Progressive disease|2|||
16113057|NCT01056263|38901974|FG000|Overall Study|Neoplasm progression|1|||
16113058|NCT01056263|38901974|FG000|Overall Study|Objective progression or relapse|1|||
16113059|NCT01056263|38901974|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
16113060|NCT02706847|38901977|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
16113061|NCT02706847|38901978|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
16113062|NCT02706847|38901979|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
16113063|NCT02706847|38901980|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
16113064|NCT02706847|38901977|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
16113065|NCT02706847|38901978|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
16113066|NCT02706847|38901979|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
16113067|NCT02706847|38901980|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
16113068|NCT02706847|38901977|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
16113069|NCT02706847|38901978|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
16113070|NCT02706847|38901979|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
16113071|NCT02706847|38901980|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
16113072|NCT02706847|38901977|FG000|Period 1: Day 1 to Week 12|Other|4|||
16113073|NCT02706847|38901978|FG001|Period 1: Day 1 to Week 12|Other|4|||
16113074|NCT02706847|38901979|FG002|Period 1: Day 1 to Week 12|Other|2|||
16113075|NCT02706847|38901980|FG003|Period 1: Day 1 to Week 12|Other|2|||
16113076|NCT02706847|38901977|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
16113077|NCT02706847|38901978|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
16113078|NCT02706847|38901979|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
16113079|NCT02706847|38901980|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
16113080|NCT02706847|38901977|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
16113081|NCT02706847|38901978|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
16113082|NCT02706847|38901979|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
16113083|NCT02706847|38901980|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
16113084|NCT02706847|38901977|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
16113085|NCT02706847|38901978|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
16113086|NCT02706847|38901979|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
16113087|NCT02706847|38901980|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
16113088|NCT02706847|38901977|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
16113089|NCT02706847|38901978|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
16113090|NCT02706847|38901979|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
16224157|NCT01265511|39302336|FG000|Overall Study|Lack of Efficacy|2|||
16113091|NCT02706847|38901980|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
16113092|NCT02706847|38901977|FG000|Period 1: Week 12 to Week 24|Other|1|||
16113093|NCT02706847|38901978|FG001|Period 1: Week 12 to Week 24|Other|0|||
16113094|NCT02706847|38901979|FG002|Period 1: Week 12 to Week 24|Other|1|||
16113095|NCT02706847|38901980|FG003|Period 1: Week 12 to Week 24|Other|4|||
16113096|NCT02706847|38901977|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
16113097|NCT02706847|38901978|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
16113098|NCT02706847|38901979|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
16113099|NCT02706847|38901980|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
16113100|NCT02706847|38901977|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
16113101|NCT02706847|38901978|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
16113102|NCT02706847|38901979|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
16113103|NCT02706847|38901980|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
16113104|NCT02706847|38901977|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
16113105|NCT02706847|38901978|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
16546613|NCT02322814|40464846|FG004|Overall Study|Protocol Violation|0|||
16546614|NCT02322814|40464842|FG000|Overall Study|Study Terminated by Sponsor|0|||
16546615|NCT02322814|40464843|FG001|Overall Study|Study Terminated by Sponsor|7|||
16546616|NCT02322814|40464844|FG002|Overall Study|Study Terminated by Sponsor|9|||
16546617|NCT02322814|40464845|FG003|Overall Study|Study Terminated by Sponsor|5|||
16546618|NCT02322814|40464846|FG004|Overall Study|Study Terminated by Sponsor|13|||
16546619|NCT02322814|40464842|FG000|Overall Study|Withdrawal by Subject|5|||
16410169|NCT02689076|39985380|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
16546620|NCT02322814|40464843|FG001|Overall Study|Withdrawal by Subject|4|||
16224158|NCT01265511|39302337|FG001|Overall Study|Lack of Efficacy|1|||
16224159|NCT01265511|39302336|FG000|Overall Study|Met stopping rules|0|||
16224160|NCT01265511|39302337|FG001|Overall Study|Met stopping rules|2|||
16224161|NCT00950755|39302338|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
16224162|NCT00950755|39302338|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
16224163|NCT00950755|39302338|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
16224164|NCT00950755|39302338|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
16224165|NCT00950755|39302338|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
16113106|NCT02706847|38901979|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
16113107|NCT02706847|38901980|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
16113108|NCT02706847|38901977|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
16113109|NCT02706847|38901978|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
16113110|NCT02706847|38901979|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
16113111|NCT02706847|38901980|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
16113112|NCT02706847|38901977|FG000|Period 2: Week 24 to Week 260|Other|8|||
16113113|NCT02706847|38901978|FG001|Period 2: Week 24 to Week 260|Other|5|||
16113114|NCT02706847|38901979|FG002|Period 2: Week 24 to Week 260|Other|15|||
16113115|NCT02706847|38901980|FG003|Period 2: Week 24 to Week 260|Other|15|||
16113116|NCT05382039|38901981|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
16113117|NCT05382039|38901982|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
16113118|NCT05382039|38901983|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
16113119|NCT05382039|38901981|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
16113120|NCT05382039|38901982|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
16113121|NCT05382039|38901983|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
16224166|NCT00950755|39302338|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
16224167|NCT00950755|39302338|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
16546621|NCT02322814|40464844|FG002|Overall Study|Withdrawal by Subject|2|||
16546622|NCT02322814|40464845|FG003|Overall Study|Withdrawal by Subject|1|||
16546623|NCT02322814|40464846|FG004|Overall Study|Withdrawal by Subject|3|||
16546624|NCT05061537|40464848|FG000|Treatment Phase|Progressive disease|0|||
16546625|NCT05061537|40464849|FG001|Treatment Phase|Progressive disease|1|||
16546626|NCT05061537|40464850|FG002|Treatment Phase|Progressive disease|2|||
16546627|NCT05061537|40464851|FG003|Treatment Phase|Progressive disease|0|||
16546628|NCT05061537|40464852|FG004|Treatment Phase|Progressive disease|0|||
16546629|NCT05061537|40464848|FG000|Treatment Phase|Adverse Event|0|||
16546630|NCT05061537|40464849|FG001|Treatment Phase|Adverse Event|0|||
16546631|NCT05061537|40464850|FG002|Treatment Phase|Adverse Event|2|||
16546632|NCT05061537|40464851|FG003|Treatment Phase|Adverse Event|0|||
16546633|NCT05061537|40464852|FG004|Treatment Phase|Adverse Event|0|||
16546634|NCT05061537|40464848|FG000|Treatment Phase|Global deterioration of health status|0|||
16224168|NCT00950755|39302338|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
16224169|NCT00950755|39302338|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
16224170|NCT00950755|39302338|FG000|Long-Term Follow-Up|Death|8|||
16546635|NCT05061537|40464849|FG001|Treatment Phase|Global deterioration of health status|1|||
16113122|NCT05382039|38901981|FG000|Overall Study|waiting for confirmation|0|||
16113123|NCT05382039|38901982|FG001|Overall Study|waiting for confirmation|0|||
16113124|NCT05382039|38901983|FG002|Overall Study|waiting for confirmation|1|||
16113125|NCT00891046|38901989|FG000|Overall Study|Protocol Violation|1|||
16113126|NCT00891046|38901990|FG001|Overall Study|Protocol Violation|1|||
16113127|NCT00891046|38901991|FG002|Overall Study|Protocol Violation|0|||
16113128|NCT00891046|38901992|FG003|Overall Study|Protocol Violation|0|||
16113129|NCT00891046|38901993|FG004|Overall Study|Protocol Violation|1|||
16113130|NCT00891046|38901989|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
16113131|NCT00891046|38901990|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16113132|NCT00891046|38901991|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
16113133|NCT00891046|38901992|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
16113134|NCT00891046|38901993|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
16113135|NCT00891046|38901989|FG000|Overall Study|Administrative problems|0|||
16113136|NCT00891046|38901990|FG001|Overall Study|Administrative problems|0|||
16113137|NCT00891046|38901991|FG002|Overall Study|Administrative problems|0|||
16113138|NCT00891046|38901992|FG003|Overall Study|Administrative problems|0|||
16113139|NCT00891046|38901993|FG004|Overall Study|Administrative problems|1|||
16113140|NCT00891046|38901989|FG000|Overall Study|Participant no longer required drug|0|||
16113141|NCT00891046|38901990|FG001|Overall Study|Participant no longer required drug|2|||
16113142|NCT00891046|38901991|FG002|Overall Study|Participant no longer required drug|0|||
16113143|NCT00891046|38901992|FG003|Overall Study|Participant no longer required drug|0|||
16113144|NCT00891046|38901993|FG004|Overall Study|Participant no longer required drug|1|||
16113145|NCT00891046|38901989|FG000|Overall Study|Adverse Event|4|||
16113146|NCT00891046|38901990|FG001|Overall Study|Adverse Event|3|||
16113147|NCT00891046|38901991|FG002|Overall Study|Adverse Event|2|||
16113148|NCT00891046|38901992|FG003|Overall Study|Adverse Event|0|||
16113149|NCT00891046|38901993|FG004|Overall Study|Adverse Event|14|||
16113150|NCT00891046|38901989|FG000|Overall Study|Withdrawal by Subject|2|||
16113151|NCT00891046|38901990|FG001|Overall Study|Withdrawal by Subject|1|||
16113152|NCT00891046|38901991|FG002|Overall Study|Withdrawal by Subject|2|||
16113153|NCT00891046|38901992|FG003|Overall Study|Withdrawal by Subject|1|||
16113154|NCT00891046|38901993|FG004|Overall Study|Withdrawal by Subject|1|||
16113155|NCT00891046|38901989|FG000|Overall Study|Lost to Follow-up|0|||
16113156|NCT00891046|38901990|FG001|Overall Study|Lost to Follow-up|0|||
16113157|NCT00891046|38901991|FG002|Overall Study|Lost to Follow-up|0|||
16113158|NCT00891046|38901992|FG003|Overall Study|Lost to Follow-up|0|||
16113159|NCT00891046|38901993|FG004|Overall Study|Lost to Follow-up|1|||
16113160|NCT03865953|38901994|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
16113161|NCT03865953|38901995|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
16113162|NCT03865953|38901994|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
16113163|NCT03865953|38901995|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
16113164|NCT03865953|38901994|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
16113165|NCT03865953|38901995|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
16113166|NCT01740154|38901996|FG000|Overall Study|Adverse Event|1|||
16113167|NCT00847626|38901999|FG000|Overall Study|Adverse Event|10|||
16113168|NCT00847626|38902000|FG001|Overall Study|Adverse Event|10|||
16113169|NCT00847626|38902001|FG002|Overall Study|Adverse Event|6|||
16113170|NCT00847626|38902002|FG003|Overall Study|Adverse Event|19|||
16113171|NCT00847626|38902003|FG004|Overall Study|Adverse Event|11|||
16113172|NCT00847626|38902004|FG005|Overall Study|Adverse Event|22|||
16113173|NCT00847626|38902005|FG006|Overall Study|Adverse Event|4|||
16113174|NCT00847626|38902006|FG007|Overall Study|Adverse Event|6|||
16113175|NCT00847626|38902007|FG008|Overall Study|Adverse Event|3|||
16113176|NCT00847626|38902008|FG009|Overall Study|Adverse Event|6|||
16113177|NCT00847626|38902009|FG010|Overall Study|Adverse Event|6|||
16224171|NCT01101321|39302345|FG000|Period 1|Withdrawal by Subject|1|||
16113178|NCT00847626|38901999|FG000|Overall Study|Protocol Violation|2|||
16113179|NCT00847626|38902000|FG001|Overall Study|Protocol Violation|1|||
16113180|NCT00847626|38902001|FG002|Overall Study|Protocol Violation|2|||
16113181|NCT00847626|38902002|FG003|Overall Study|Protocol Violation|1|||
16113182|NCT00847626|38902003|FG004|Overall Study|Protocol Violation|1|||
16113183|NCT00847626|38902004|FG005|Overall Study|Protocol Violation|1|||
16113184|NCT00847626|38902005|FG006|Overall Study|Protocol Violation|1|||
16113185|NCT00847626|38902006|FG007|Overall Study|Protocol Violation|1|||
16113186|NCT00847626|38902007|FG008|Overall Study|Protocol Violation|0|||
16113187|NCT00847626|38902008|FG009|Overall Study|Protocol Violation|1|||
16113188|NCT00847626|38902009|FG010|Overall Study|Protocol Violation|1|||
16113189|NCT00847626|38901999|FG000|Overall Study|Lost to Follow-up|0|||
16113190|NCT00847626|38902000|FG001|Overall Study|Lost to Follow-up|1|||
16113191|NCT00847626|38902001|FG002|Overall Study|Lost to Follow-up|1|||
16113192|NCT00847626|38902002|FG003|Overall Study|Lost to Follow-up|1|||
16113193|NCT00847626|38902003|FG004|Overall Study|Lost to Follow-up|0|||
16113194|NCT00847626|38902004|FG005|Overall Study|Lost to Follow-up|3|||
16113195|NCT00847626|38902005|FG006|Overall Study|Lost to Follow-up|1|||
16113196|NCT00847626|38902006|FG007|Overall Study|Lost to Follow-up|3|||
16113197|NCT00847626|38902007|FG008|Overall Study|Lost to Follow-up|1|||
16113198|NCT00847626|38902008|FG009|Overall Study|Lost to Follow-up|0|||
16224172|NCT01101321|39302346|FG001|Period 1|Withdrawal by Subject|1|||
16113199|NCT00847626|38902009|FG010|Overall Study|Lost to Follow-up|1|||
16113200|NCT00847626|38901999|FG000|Overall Study|Withdrawal by Subject|5|||
16113201|NCT00847626|38902000|FG001|Overall Study|Withdrawal by Subject|5|||
16113202|NCT00847626|38902001|FG002|Overall Study|Withdrawal by Subject|3|||
16113203|NCT00847626|38902002|FG003|Overall Study|Withdrawal by Subject|8|||
16113204|NCT00847626|38902003|FG004|Overall Study|Withdrawal by Subject|12|||
16113205|NCT00847626|38902004|FG005|Overall Study|Withdrawal by Subject|9|||
16113206|NCT00847626|38902005|FG006|Overall Study|Withdrawal by Subject|8|||
16113207|NCT00847626|38902006|FG007|Overall Study|Withdrawal by Subject|4|||
16113208|NCT00847626|38902007|FG008|Overall Study|Withdrawal by Subject|4|||
16113209|NCT00847626|38902008|FG009|Overall Study|Withdrawal by Subject|5|||
16113210|NCT00847626|38902009|FG010|Overall Study|Withdrawal by Subject|2|||
16113211|NCT00847626|38901999|FG000|Overall Study|Lack of Efficacy|3|||
16113212|NCT00847626|38902000|FG001|Overall Study|Lack of Efficacy|1|||
16113213|NCT00847626|38902001|FG002|Overall Study|Lack of Efficacy|0|||
16113214|NCT00847626|38902002|FG003|Overall Study|Lack of Efficacy|1|||
16113215|NCT00847626|38902003|FG004|Overall Study|Lack of Efficacy|2|||
16113216|NCT00847626|38902004|FG005|Overall Study|Lack of Efficacy|0|||
16113217|NCT00847626|38902005|FG006|Overall Study|Lack of Efficacy|6|||
16113218|NCT00847626|38902006|FG007|Overall Study|Lack of Efficacy|2|||
16113219|NCT00847626|38902007|FG008|Overall Study|Lack of Efficacy|5|||
16113220|NCT00847626|38902008|FG009|Overall Study|Lack of Efficacy|1|||
16113221|NCT00847626|38902009|FG010|Overall Study|Lack of Efficacy|7|||
16113222|NCT00847626|38901999|FG000|Overall Study|Other|1|||
16113223|NCT00847626|38902000|FG001|Overall Study|Other|5|||
16113224|NCT00847626|38902001|FG002|Overall Study|Other|4|||
16113225|NCT00847626|38902002|FG003|Overall Study|Other|1|||
16113226|NCT00847626|38902003|FG004|Overall Study|Other|2|||
16113227|NCT00847626|38902004|FG005|Overall Study|Other|2|||
16113228|NCT00847626|38902005|FG006|Overall Study|Other|2|||
16113229|NCT00847626|38902006|FG007|Overall Study|Other|3|||
16113230|NCT00847626|38902007|FG008|Overall Study|Other|1|||
16113231|NCT00847626|38902008|FG009|Overall Study|Other|1|||
16113232|NCT00847626|38902009|FG010|Overall Study|Other|3|||
16113233|NCT01266018|38902010|FG000|Overall Study|Physician Decision|1|||
16113234|NCT01266018|38902011|FG001|Overall Study|Physician Decision|0|||
16113235|NCT01266018|38902010|FG000|Overall Study|Progressive disease|0|||
16113236|NCT01266018|38902011|FG001|Overall Study|Progressive disease|1|||
16113237|NCT04887506|38902012|FG000|Overall Study|Death|1|||
16113238|NCT04887506|38902013|FG001|Overall Study|Death|1|||
16113239|NCT04887506|38902012|FG000|Overall Study|Withdrawal by Subject|0|||
16113240|NCT04887506|38902013|FG001|Overall Study|Withdrawal by Subject|3|||
16113241|NCT04887506|38902012|FG000|Overall Study|Adverse Event|4|||
16113242|NCT04887506|38902013|FG001|Overall Study|Adverse Event|3|||
16113243|NCT04887506|38902012|FG000|Overall Study|Other - Not Reported|1|||
16113244|NCT04887506|38902013|FG001|Overall Study|Other - Not Reported|1|||
16113245|NCT03021551|38902015|FG000|Overall Study|Equipment Issues|2|||
16113246|NCT03021551|38902015|FG000|Overall Study|Protocol Violation|1|||
16113247|NCT02643628|38902016|FG000|Overall Study|Lost to Follow-up|1|||
16113248|NCT02643628|38902017|FG001|Overall Study|Lost to Follow-up|4|||
16113249|NCT02643628|38902016|FG000|Overall Study|Withdrawal by Subject|0|||
16113250|NCT02643628|38902017|FG001|Overall Study|Withdrawal by Subject|1|||
16113251|NCT02643628|38902016|FG000|Overall Study|Relocated out of state|0|||
16113252|NCT02643628|38902017|FG001|Overall Study|Relocated out of state|1|||
16113253|NCT01426347|38902018|FG000|Overall Study|Lost to Follow-up|0|||
16113254|NCT01426347|38902019|FG001|Overall Study|Lost to Follow-up|3|||
16113255|NCT01426347|38902018|FG000|Overall Study|Protocol Violation|2|||
16113256|NCT01426347|38902019|FG001|Overall Study|Protocol Violation|0|||
16113257|NCT01426347|38902018|FG000|Overall Study|Withdrawal by Subject|5|||
16113258|NCT01426347|38902019|FG001|Overall Study|Withdrawal by Subject|0|||
16113259|NCT02581059|38902024|FG000|Study Treatment|Disease Progression|1|||
16113260|NCT02581059|38902025|FG001|Study Treatment|Disease Progression|1|||
16113261|NCT02581059|38902024|FG000|Study Treatment|Adverse Event|2|||
16113262|NCT02581059|38902025|FG001|Study Treatment|Adverse Event|1|||
16224173|NCT01101321|39302345|FG000|Period 1|Adverse Event|3|||
16224174|NCT01101321|39302346|FG001|Period 1|Adverse Event|3|||
16224175|NCT02192190|39302347|FG000|Overall Study|Adverse Event|1|||
16224176|NCT02192190|39302348|FG001|Overall Study|Adverse Event|1|||
16113263|NCT02581059|38902024|FG000|Study Treatment|Death|1|||
16113264|NCT02581059|38902025|FG001|Study Treatment|Death|1|||
16113265|NCT02581059|38902024|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
16113266|NCT02581059|38902025|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
16113267|NCT02581059|38902024|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
16113268|NCT02581059|38902025|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
16113269|NCT02581059|38902024|FG000|Follow up|Death|1|||
16113270|NCT02581059|38902025|FG001|Follow up|Death|3|||
16113271|NCT02581059|38902024|FG000|Follow up|study terminated|1|||
16113272|NCT02581059|38902025|FG001|Follow up|study terminated|1|||
16224177|NCT02192190|39302349|FG002|Overall Study|Adverse Event|0|||
16113273|NCT02581059|38902024|FG000|Follow up|screen failure|0|||
16113274|NCT02581059|38902025|FG001|Follow up|screen failure|1|||
16113275|NCT02581059|38902024|FG000|Follow up|Patient started new clinical trial|1|||
16224178|NCT02192190|39302350|FG003|Overall Study|Adverse Event|0|||
16224179|NCT02192190|39302351|FG004|Overall Study|Adverse Event|0|||
16224180|NCT02192190|39302352|FG005|Overall Study|Adverse Event|0|||
16224181|NCT02192190|39302347|FG000|Overall Study|Lost to Follow-up|3|||
16224182|NCT02192190|39302348|FG001|Overall Study|Lost to Follow-up|3|||
16224183|NCT02192190|39302349|FG002|Overall Study|Lost to Follow-up|2|||
16224184|NCT02192190|39302350|FG003|Overall Study|Lost to Follow-up|1|||
16224185|NCT02192190|39302351|FG004|Overall Study|Lost to Follow-up|4|||
16113276|NCT02581059|38902025|FG001|Follow up|Patient started new clinical trial|0|||
16113277|NCT02161406|38902026|FG000|Overall Study|Death|2|||
16113278|NCT02161406|38902027|FG001|Overall Study|Death|1|||
16113279|NCT02161406|38902026|FG000|Overall Study|Lost to Follow-up|2|||
16113280|NCT02161406|38902027|FG001|Overall Study|Lost to Follow-up|1|||
16113281|NCT02161406|38902026|FG000|Overall Study|Withdrawal by Subject|2|||
16113282|NCT02161406|38902027|FG001|Overall Study|Withdrawal by Subject|4|||
16113283|NCT02161406|38902026|FG000|Overall Study|investigator withdrew subject|3|||
16113284|NCT02161406|38902027|FG001|Overall Study|investigator withdrew subject|1|||
16113285|NCT02161406|38902026|FG000|Overall Study|Lack of Efficacy|1|||
16113286|NCT02161406|38902027|FG001|Overall Study|Lack of Efficacy|1|||
16113287|NCT02161406|38902026|FG000|Overall Study|relocation|0|||
16113288|NCT02161406|38902027|FG001|Overall Study|relocation|1|||
16113289|NCT02659098|38902028|FG000|Overall Study|Withdrawal by Subject|7|||
16113290|NCT01240551|38902029|FG000|Overall Study|Refused further treatment|3|||
16113291|NCT01240551|38902030|FG001|Overall Study|Refused further treatment|2|||
16113292|NCT01240551|38902029|FG000|Overall Study|Lost to Follow-up|1|||
16113293|NCT01240551|38902030|FG001|Overall Study|Lost to Follow-up|1|||
16113294|NCT00263211|38902031|FG000|Overall Study|Death|1|||
16113295|NCT00263211|38902032|FG001|Overall Study|Death|0|||
16113296|NCT00263211|38902031|FG000|Overall Study|Withdrawal by Subject|3|||
16113297|NCT00263211|38902032|FG001|Overall Study|Withdrawal by Subject|0|||
16113298|NCT00263211|38902031|FG000|Overall Study|Protocol Violation|1|||
16113299|NCT00263211|38902032|FG001|Overall Study|Protocol Violation|0|||
16113300|NCT00263211|38902031|FG000|Overall Study|Disease Progression|0|||
16224186|NCT02192190|39302352|FG005|Overall Study|Lost to Follow-up|3|||
16224187|NCT02192190|39302347|FG000|Overall Study|Physician Decision|2|||
16224188|NCT02192190|39302348|FG001|Overall Study|Physician Decision|0|||
16224189|NCT02192190|39302349|FG002|Overall Study|Physician Decision|0|||
16224190|NCT02192190|39302350|FG003|Overall Study|Physician Decision|0|||
16224191|NCT02192190|39302351|FG004|Overall Study|Physician Decision|0|||
16224192|NCT02192190|39302352|FG005|Overall Study|Physician Decision|0|||
16224193|NCT02192190|39302347|FG000|Overall Study|Terminated by Sponsor|43|||
16224194|NCT02192190|39302348|FG001|Overall Study|Terminated by Sponsor|23|||
16224195|NCT02192190|39302349|FG002|Overall Study|Terminated by Sponsor|20|||
16224196|NCT02192190|39302350|FG003|Overall Study|Terminated by Sponsor|23|||
16224197|NCT02192190|39302351|FG004|Overall Study|Terminated by Sponsor|21|||
16224198|NCT02192190|39302352|FG005|Overall Study|Terminated by Sponsor|23|||
16224199|NCT02192190|39302347|FG000|Overall Study|Withdrawal by Subject|4|||
16224200|NCT02192190|39302348|FG001|Overall Study|Withdrawal by Subject|1|||
16224201|NCT02192190|39302349|FG002|Overall Study|Withdrawal by Subject|2|||
16224202|NCT02192190|39302350|FG003|Overall Study|Withdrawal by Subject|1|||
16224203|NCT02192190|39302351|FG004|Overall Study|Withdrawal by Subject|5|||
16224204|NCT02192190|39302352|FG005|Overall Study|Withdrawal by Subject|3|||
16224205|NCT02192190|39302347|FG000|Overall Study|Could not Keep Visit Schedule|1|||
16224206|NCT02192190|39302348|FG001|Overall Study|Could not Keep Visit Schedule|0|||
16224207|NCT02192190|39302349|FG002|Overall Study|Could not Keep Visit Schedule|0|||
16224208|NCT02192190|39302350|FG003|Overall Study|Could not Keep Visit Schedule|0|||
16224209|NCT02192190|39302351|FG004|Overall Study|Could not Keep Visit Schedule|0|||
16224210|NCT02192190|39302352|FG005|Overall Study|Could not Keep Visit Schedule|0|||
16224211|NCT02192190|39302347|FG000|Overall Study|Positive Drug Screen|0|||
16224212|NCT02192190|39302348|FG001|Overall Study|Positive Drug Screen|0|||
16224213|NCT02192190|39302349|FG002|Overall Study|Positive Drug Screen|0|||
16224214|NCT02192190|39302350|FG003|Overall Study|Positive Drug Screen|1|||
16224215|NCT02192190|39302351|FG004|Overall Study|Positive Drug Screen|0|||
16113301|NCT00263211|38902032|FG001|Overall Study|Disease Progression|1|||
16113302|NCT03513068|38902033|FG000|Overall Study|Death|1|||
16224216|NCT02192190|39302352|FG005|Overall Study|Positive Drug Screen|0|||
16224217|NCT02192190|39302347|FG000|Overall Study|Inadequate Pain Relief|0|||
16113303|NCT03513068|38902034|FG001|Overall Study|Death|0|||
16113304|NCT03513068|38902033|FG000|Overall Study|Withdrawal by Subject|4|||
16113305|NCT03513068|38902034|FG001|Overall Study|Withdrawal by Subject|6|||
16113306|NCT00798304|38902035|FG000|Overall Study|Adverse Event|0|||
16113307|NCT00798304|38902036|FG001|Overall Study|Adverse Event|1|||
16224218|NCT02192190|39302348|FG001|Overall Study|Inadequate Pain Relief|1|||
16224219|NCT02192190|39302349|FG002|Overall Study|Inadequate Pain Relief|1|||
16224220|NCT02192190|39302350|FG003|Overall Study|Inadequate Pain Relief|0|||
16224221|NCT02192190|39302351|FG004|Overall Study|Inadequate Pain Relief|0|||
16224222|NCT02192190|39302352|FG005|Overall Study|Inadequate Pain Relief|0|||
16224223|NCT04354870|39302353|FG000|Overall Study|Lost to Follow-up|32|||
16224224|NCT04354870|39302354|FG001|Overall Study|Lost to Follow-up|12|||
16224225|NCT04354870|39302353|FG000|Overall Study|Withdrawal by Subject|10|||
16224226|NCT04354870|39302354|FG001|Overall Study|Withdrawal by Subject|16|||
16224227|NCT04354870|39302353|FG000|Overall Study|Did not complete all study visits|6|||
16224228|NCT04354870|39302354|FG001|Overall Study|Did not complete all study visits|5|||
16224229|NCT02036476|39302356|FG000|Overall Study|Withdrawal by Subject|2|||
16224230|NCT02036476|39302356|FG000|Overall Study|Progressive Disease|4|||
16224231|NCT02036476|39302356|FG000|Overall Study|Unacceptable Toxicity|2|||
16224232|NCT01078389|39302357|FG000|Overall Study|Adverse Event|10|||
16224233|NCT01078389|39302358|FG001|Overall Study|Adverse Event|6|||
16224234|NCT01078389|39302357|FG000|Overall Study|Major Protocol Deviation|2|||
16224235|NCT01078389|39302358|FG001|Overall Study|Major Protocol Deviation|0|||
16224236|NCT01078389|39302357|FG000|Overall Study|Lost to Follow-up|23|||
16224237|NCT01078389|39302358|FG001|Overall Study|Lost to Follow-up|23|||
16224238|NCT01078389|39302357|FG000|Overall Study|Voluntary Withdrawal|20|||
16224239|NCT01078389|39302358|FG001|Overall Study|Voluntary Withdrawal|36|||
16224240|NCT01078389|39302357|FG000|Overall Study|Other|9|||
16224241|NCT01078389|39302358|FG001|Overall Study|Other|2|||
16224242|NCT01233284|39302362|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
16224243|NCT01233284|39302363|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16224244|NCT01233284|39302364|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16224245|NCT01233284|39302365|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16224246|NCT01233284|39302366|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
16224247|NCT01233284|39302362|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16224248|NCT01233284|39302363|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
16224249|NCT01233284|39302364|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16224250|NCT01233284|39302365|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16224251|NCT01233284|39302366|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16224252|NCT01233284|39302362|FG000|Period 1 (4 Weeks)|Other|0|||
16224253|NCT01233284|39302363|FG001|Period 1 (4 Weeks)|Other|0|||
16224254|NCT01233284|39302364|FG002|Period 1 (4 Weeks)|Other|1|||
16224255|NCT01233284|39302365|FG003|Period 1 (4 Weeks)|Other|0|||
16224256|NCT01233284|39302366|FG004|Period 1 (4 Weeks)|Other|0|||
16224257|NCT01233284|39302362|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16224258|NCT01233284|39302363|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16224259|NCT01233284|39302364|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
16224260|NCT01233284|39302365|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16224261|NCT01233284|39302366|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
16224262|NCT01233284|39302362|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16224263|NCT01233284|39302363|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16224264|NCT01233284|39302364|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
16224265|NCT01233284|39302365|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16224266|NCT01233284|39302366|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
16224267|NCT01233284|39302362|FG000|Period 3 (4 Weeks)|Other|0|||
16224268|NCT01233284|39302363|FG001|Period 3 (4 Weeks)|Other|0|||
16224269|NCT01233284|39302364|FG002|Period 3 (4 Weeks)|Other|0|||
16224270|NCT01233284|39302365|FG003|Period 3 (4 Weeks)|Other|1|||
16224271|NCT01233284|39302366|FG004|Period 3 (4 Weeks)|Other|0|||
16224272|NCT01233284|39302362|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
16224273|NCT01233284|39302363|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
16224274|NCT01233284|39302364|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
16224275|NCT01233284|39302365|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
16224276|NCT01233284|39302366|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
16224277|NCT01233284|39302362|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
16224278|NCT01233284|39302363|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
16224279|NCT01233284|39302364|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
16224280|NCT01233284|39302365|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
16224281|NCT01233284|39302366|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
16224282|NCT01370499|39302367|FG000|Overall Study|Adverse Event|38|||
16224283|NCT01370499|39302368|FG001|Overall Study|Adverse Event|12|||
16224284|NCT01370499|39302367|FG000|Overall Study|Lack of Efficacy|4|||
16224285|NCT01370499|39302368|FG001|Overall Study|Lack of Efficacy|2|||
16224286|NCT01370499|39302367|FG000|Overall Study|Lost to Follow-up|2|||
16224287|NCT01370499|39302368|FG001|Overall Study|Lost to Follow-up|1|||
16224288|NCT01370499|39302367|FG000|Overall Study|Physician Decision|3|||
16224289|NCT01370499|39302368|FG001|Overall Study|Physician Decision|3|||
16224290|NCT01370499|39302367|FG000|Overall Study|Protocol Violation|5|||
16224291|NCT01370499|39302368|FG001|Overall Study|Protocol Violation|4|||
16224292|NCT01370499|39302367|FG000|Overall Study|Withdrawal by Subject|18|||
16224293|NCT01370499|39302368|FG001|Overall Study|Withdrawal by Subject|7|||
16224294|NCT01370499|39302367|FG000|Overall Study|Sponsor Decision|41|||
16224295|NCT01370499|39302368|FG001|Overall Study|Sponsor Decision|15|||
16224296|NCT01855919|39302369|FG000|Overall Study|Adverse Event|16|||
16224297|NCT01855919|39302370|FG001|Overall Study|Adverse Event|8|||
16224298|NCT01855919|39302369|FG000|Overall Study|Lack of Efficacy|1|||
16224299|NCT01855919|39302370|FG001|Overall Study|Lack of Efficacy|3|||
16224300|NCT01855919|39302369|FG000|Overall Study|Withdrawal by Subject|4|||
16224301|NCT01855919|39302370|FG001|Overall Study|Withdrawal by Subject|10|||
16224302|NCT01855919|39302369|FG000|Overall Study|Entry Criteria Not Met|1|||
16224303|NCT01855919|39302370|FG001|Overall Study|Entry Criteria Not Met|1|||
16224304|NCT01855919|39302369|FG000|Overall Study|Protocol Violation|1|||
16224305|NCT01855919|39302370|FG001|Overall Study|Protocol Violation|4|||
16224306|NCT00765726|39302371|FG000|Overall Study|Withdrawal by Subject|1|||
16224307|NCT00765726|39302371|FG000|Overall Study|Discontinuation of study by sponsor|8|||
16224308|NCT02545504|39302372|FG000|Overall Study|Death|174|||
16224309|NCT02545504|39302373|FG001|Overall Study|Death|168|||
16224310|NCT02545504|39302372|FG000|Overall Study|Unknown reason|30|||
16224311|NCT02545504|39302373|FG001|Overall Study|Unknown reason|32|||
16224312|NCT02545504|39302372|FG000|Overall Study|Withdrew consent|9|||
16224313|NCT02545504|39302373|FG001|Overall Study|Withdrew consent|11|||
16224314|NCT02545504|39302372|FG000|Overall Study|Investigator's discretion|3|||
16224315|NCT02545504|39302373|FG001|Overall Study|Investigator's discretion|1|||
16224316|NCT02545504|39302372|FG000|Overall Study|Lost to Follow-up|2|||
16224317|NCT02545504|39302373|FG001|Overall Study|Lost to Follow-up|2|||
16224318|NCT00285857|39302376|FG000|Overall Study|Withdrawal by Subject|2|||
16224319|NCT00285857|39302376|FG000|Overall Study|Inadequate initial breast cytology|1|||
16224320|NCT00285857|39302376|FG000|Overall Study|Adverse Event|1|||
16224321|NCT02718131|39302377|FG000|Overall Study|Withdrawal by Subject|1|||
16224322|NCT02718131|39302378|FG001|Overall Study|Withdrawal by Subject|0|||
16224323|NCT02718131|39302377|FG000|Overall Study|Adverse Event|1|||
16224324|NCT02718131|39302378|FG001|Overall Study|Adverse Event|0|||
16224325|NCT02718131|39302377|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
16224326|NCT02718131|39302378|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
16224327|NCT02785588|39302390|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
16224328|NCT02785588|39302390|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
16224329|NCT00768040|39302391|FG000|Overall Study|Adverse Event|3|||
16224330|NCT00768040|39302392|FG001|Overall Study|Adverse Event|2|||
16224331|NCT00768040|39302391|FG000|Overall Study|Abnormal laboratory value|1|||
16224332|NCT00768040|39302392|FG001|Overall Study|Abnormal laboratory value|1|||
16224333|NCT00302731|39302401|FG000|Overall Study|Lost to Follow-up|1|||
16224334|NCT00302731|39302402|FG001|Overall Study|Lost to Follow-up|2|||
16224335|NCT00302731|39302403|FG002|Overall Study|Lost to Follow-up|0|||
16224336|NCT00302731|39302404|FG003|Overall Study|Lost to Follow-up|0|||
16224337|NCT00302731|39302401|FG000|Overall Study|Adverse Event|0|||
16224338|NCT00302731|39302402|FG001|Overall Study|Adverse Event|2|||
16224339|NCT00302731|39302403|FG002|Overall Study|Adverse Event|2|||
16224340|NCT00302731|39302404|FG003|Overall Study|Adverse Event|0|||
16224341|NCT00302731|39302401|FG000|Overall Study|Withdrawal by Subject|1|||
16224342|NCT00302731|39302402|FG001|Overall Study|Withdrawal by Subject|1|||
16224343|NCT00302731|39302403|FG002|Overall Study|Withdrawal by Subject|0|||
16224344|NCT00302731|39302404|FG003|Overall Study|Withdrawal by Subject|0|||
16224345|NCT00302731|39302401|FG000|Overall Study|Protocol Violation|1|||
16224346|NCT00302731|39302402|FG001|Overall Study|Protocol Violation|0|||
16224347|NCT00302731|39302403|FG002|Overall Study|Protocol Violation|0|||
16224348|NCT00302731|39302404|FG003|Overall Study|Protocol Violation|0|||
16224349|NCT00302731|39302401|FG000|Overall Study|cancer unrelated to study discovered|1|||
16224350|NCT00302731|39302402|FG001|Overall Study|cancer unrelated to study discovered|0|||
16224351|NCT00302731|39302403|FG002|Overall Study|cancer unrelated to study discovered|1|||
16224352|NCT00302731|39302404|FG003|Overall Study|cancer unrelated to study discovered|0|||
16224353|NCT00963820|39302406|FG000|Dose Escalation Phase|Progressive Disease|3|||
16224354|NCT00963820|39302407|FG001|Dose Escalation Phase|Progressive Disease|3|||
16224355|NCT00963820|39302408|FG002|Dose Escalation Phase|Progressive Disease|3|||
16224356|NCT00963820|39302409|FG003|Dose Escalation Phase|Progressive Disease|3|||
16224357|NCT00963820|39302410|FG004|Dose Escalation Phase|Progressive Disease|4|||
16224358|NCT00963820|39302411|FG005|Dose Escalation Phase|Progressive Disease|3|||
16224359|NCT00963820|39302412|FG006|Dose Escalation Phase|Progressive Disease|3|||
16224360|NCT00963820|39302413|FG007|Dose Escalation Phase|Progressive Disease|2|||
16224361|NCT00963820|39302414|FG008|Dose Escalation Phase|Progressive Disease|0|||
16224362|NCT00963820|39302415|FG009|Dose Escalation Phase|Progressive Disease|0|||
16224363|NCT00963820|39302416|FG010|Dose Escalation Phase|Progressive Disease|0|||
16224364|NCT00963820|39302417|FG011|Dose Escalation Phase|Progressive Disease|0|||
16224365|NCT00963820|39302406|FG000|Dose Escalation Phase|Adverse Event|0|||
16224366|NCT00963820|39302407|FG001|Dose Escalation Phase|Adverse Event|0|||
16224367|NCT00963820|39302408|FG002|Dose Escalation Phase|Adverse Event|0|||
16224368|NCT00963820|39302409|FG003|Dose Escalation Phase|Adverse Event|0|||
16224369|NCT00963820|39302410|FG004|Dose Escalation Phase|Adverse Event|0|||
16224370|NCT00963820|39302411|FG005|Dose Escalation Phase|Adverse Event|0|||
16224371|NCT00963820|39302412|FG006|Dose Escalation Phase|Adverse Event|3|||
16224372|NCT00963820|39302413|FG007|Dose Escalation Phase|Adverse Event|1|||
16224373|NCT00963820|39302414|FG008|Dose Escalation Phase|Adverse Event|0|||
16224374|NCT00963820|39302415|FG009|Dose Escalation Phase|Adverse Event|0|||
16224375|NCT00963820|39302416|FG010|Dose Escalation Phase|Adverse Event|0|||
16224376|NCT00963820|39302417|FG011|Dose Escalation Phase|Adverse Event|0|||
16224377|NCT00963820|39302406|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
16224378|NCT00963820|39302407|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
16224379|NCT00963820|39302408|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
16224380|NCT00963820|39302409|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16224381|NCT00963820|39302410|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
16224382|NCT00963820|39302411|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
16224383|NCT00963820|39302412|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
16224384|NCT00963820|39302413|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
16224385|NCT00963820|39302414|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
16224386|NCT00963820|39302415|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
16224387|NCT00963820|39302416|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
16224388|NCT00963820|39302417|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
16224389|NCT00963820|39302406|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224390|NCT00963820|39302407|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224391|NCT00963820|39302408|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224392|NCT00963820|39302409|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224393|NCT00963820|39302410|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224394|NCT00963820|39302411|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224395|NCT00963820|39302412|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
16224396|NCT00963820|39302413|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224397|NCT00963820|39302414|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224398|NCT00963820|39302415|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224399|NCT00963820|39302416|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224400|NCT00963820|39302417|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16224401|NCT00963820|39302406|FG000|Expansion Phase|Progressive Disease|0|||
16224402|NCT00963820|39302407|FG001|Expansion Phase|Progressive Disease|0|||
16224403|NCT00963820|39302408|FG002|Expansion Phase|Progressive Disease|0|||
16224404|NCT00963820|39302409|FG003|Expansion Phase|Progressive Disease|0|||
16224405|NCT00963820|39302410|FG004|Expansion Phase|Progressive Disease|0|||
16224406|NCT00963820|39302411|FG005|Expansion Phase|Progressive Disease|0|||
16113308|NCT00798304|38902037|FG002|Overall Study|Adverse Event|1|||
16113309|NCT00798304|38902035|FG000|Overall Study|Discontinuation by Sponsor|14|||
16113310|NCT00798304|38902036|FG001|Overall Study|Discontinuation by Sponsor|21|||
16113311|NCT00798304|38902037|FG002|Overall Study|Discontinuation by Sponsor|9|||
16113312|NCT00132678|38902038|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
16113313|NCT00132678|38902039|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
16113314|NCT00132678|38902040|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
16113315|NCT00132678|38902038|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
16113316|NCT00132678|38902039|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
16113317|NCT00132678|38902040|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
16113318|NCT00132678|38902038|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
16113319|NCT00132678|38902039|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
16113320|NCT00132678|38902040|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
16113321|NCT00132678|38902038|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
16113322|NCT00132678|38902039|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
16113323|NCT00132678|38902040|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
16113324|NCT00132678|38902038|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
16113325|NCT00132678|38902039|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
16113326|NCT00132678|38902040|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
16113327|NCT00132678|38902038|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
16113328|NCT00132678|38902039|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
16113329|NCT00132678|38902040|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
16224407|NCT00963820|39302412|FG006|Expansion Phase|Progressive Disease|0|||
16224408|NCT00963820|39302413|FG007|Expansion Phase|Progressive Disease|0|||
16224409|NCT00963820|39302414|FG008|Expansion Phase|Progressive Disease|8|||
16224410|NCT00963820|39302415|FG009|Expansion Phase|Progressive Disease|6|||
16224411|NCT00963820|39302416|FG010|Expansion Phase|Progressive Disease|4|||
16224412|NCT00963820|39302417|FG011|Expansion Phase|Progressive Disease|2|||
16224413|NCT00963820|39302406|FG000|Expansion Phase|Adverse Event|0|||
16224414|NCT00963820|39302407|FG001|Expansion Phase|Adverse Event|0|||
16224415|NCT00963820|39302408|FG002|Expansion Phase|Adverse Event|0|||
16224416|NCT00963820|39302409|FG003|Expansion Phase|Adverse Event|0|||
16224417|NCT00963820|39302410|FG004|Expansion Phase|Adverse Event|0|||
16224418|NCT00963820|39302411|FG005|Expansion Phase|Adverse Event|0|||
16224419|NCT00963820|39302412|FG006|Expansion Phase|Adverse Event|0|||
16224420|NCT00963820|39302413|FG007|Expansion Phase|Adverse Event|0|||
16224421|NCT00963820|39302414|FG008|Expansion Phase|Adverse Event|1|||
16224422|NCT00963820|39302415|FG009|Expansion Phase|Adverse Event|3|||
16224423|NCT00963820|39302416|FG010|Expansion Phase|Adverse Event|0|||
16224424|NCT00963820|39302417|FG011|Expansion Phase|Adverse Event|0|||
16224425|NCT00963820|39302406|FG000|Expansion Phase|Withdrawal by Subject|0|||
16224426|NCT00963820|39302407|FG001|Expansion Phase|Withdrawal by Subject|0|||
16224427|NCT00963820|39302408|FG002|Expansion Phase|Withdrawal by Subject|0|||
16224428|NCT00963820|39302409|FG003|Expansion Phase|Withdrawal by Subject|0|||
16224429|NCT00963820|39302410|FG004|Expansion Phase|Withdrawal by Subject|0|||
16224430|NCT00963820|39302411|FG005|Expansion Phase|Withdrawal by Subject|0|||
16224431|NCT00963820|39302412|FG006|Expansion Phase|Withdrawal by Subject|0|||
16224432|NCT00963820|39302413|FG007|Expansion Phase|Withdrawal by Subject|0|||
16224433|NCT00963820|39302414|FG008|Expansion Phase|Withdrawal by Subject|1|||
16224434|NCT00963820|39302415|FG009|Expansion Phase|Withdrawal by Subject|0|||
16224435|NCT00963820|39302416|FG010|Expansion Phase|Withdrawal by Subject|1|||
16224436|NCT00963820|39302417|FG011|Expansion Phase|Withdrawal by Subject|1|||
16224437|NCT00963820|39302406|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16224438|NCT00963820|39302407|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16224439|NCT00963820|39302408|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16224440|NCT00963820|39302409|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16224441|NCT00963820|39302410|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16224442|NCT00963820|39302411|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16224443|NCT00963820|39302412|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16224444|NCT00963820|39302413|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16224445|NCT00963820|39302414|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16346593|NCT01395810|39757202|FG000|Overall Study|Lack of Efficacy|0|||
16224446|NCT00963820|39302415|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16224447|NCT00963820|39302416|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16224448|NCT00963820|39302417|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
16224449|NCT01724021|39302418|FG000|Overall Study|Adverse Event|11|||
16224450|NCT01724021|39302419|FG001|Overall Study|Adverse Event|6|||
16224451|NCT01724021|39302418|FG000|Overall Study|Death|46|||
16224452|NCT01724021|39302419|FG001|Overall Study|Death|58|||
16224453|NCT01724021|39302418|FG000|Overall Study|Participant request/ Withdrew consent|18|||
16224454|NCT01724021|39302419|FG001|Overall Study|Participant request/ Withdrew consent|14|||
16224455|NCT01724021|39302418|FG000|Overall Study|Lost to Follow-up|15|||
16224456|NCT01724021|39302419|FG001|Overall Study|Lost to Follow-up|15|||
16224457|NCT01724021|39302418|FG000|Overall Study|Reason Not Specified|36|||
16224458|NCT01724021|39302419|FG001|Overall Study|Reason Not Specified|39|||
16224459|NCT01724021|39302418|FG000|Overall Study|Missing|1|||
16224460|NCT01724021|39302419|FG001|Overall Study|Missing|1|||
16546636|NCT05061537|40464850|FG002|Treatment Phase|Global deterioration of health status|0|||
16546637|NCT05061537|40464851|FG003|Treatment Phase|Global deterioration of health status|0|||
16546638|NCT05061537|40464852|FG004|Treatment Phase|Global deterioration of health status|0|||
16546639|NCT05061537|40464848|FG000|Follow up|Other|2|||
16546640|NCT05061537|40464849|FG001|Follow up|Other|0|||
16546641|NCT05061537|40464850|FG002|Follow up|Other|2|||
16224461|NCT02207413|39302420|FG000|Overall Study|Withdrawal by Subject|1|||
16546642|NCT05061537|40464851|FG003|Follow up|Other|0|||
16546643|NCT05061537|40464852|FG004|Follow up|Other|0|||
16546644|NCT05061537|40464848|FG000|Follow up|Study terminated by sponsor|0|||
16546645|NCT05061537|40464849|FG001|Follow up|Study terminated by sponsor|0|||
16546646|NCT05061537|40464850|FG002|Follow up|Study terminated by sponsor|2|||
16546647|NCT05061537|40464851|FG003|Follow up|Study terminated by sponsor|0|||
16546648|NCT05061537|40464852|FG004|Follow up|Study terminated by sponsor|0|||
16546649|NCT05061537|40464848|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
16546650|NCT05061537|40464849|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
16546651|NCT05061537|40464850|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
16546652|NCT05061537|40464851|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
16546653|NCT05061537|40464852|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
16546654|NCT05061537|40464848|FG000|Long-term Follow-up|Death|0|||
16546655|NCT05061537|40464849|FG001|Long-term Follow-up|Death|1|||
16546656|NCT05061537|40464850|FG002|Long-term Follow-up|Death|0|||
16546657|NCT05061537|40464851|FG003|Long-term Follow-up|Death|0|||
16546658|NCT05061537|40464852|FG004|Long-term Follow-up|Death|0|||
16546659|NCT03321006|40464853|FG000|Overall Study|Death|1|||
16546660|NCT03321006|40464854|FG001|Overall Study|Death|0|||
16546661|NCT03321006|40464853|FG000|Overall Study|Lack of Efficacy|1|||
16546662|NCT03321006|40464854|FG001|Overall Study|Lack of Efficacy|0|||
16546663|NCT01959347|40464855|FG000|Overall Study|Protocol Violation|9|||
16546664|NCT01959347|40464856|FG001|Overall Study|Protocol Violation|7|||
16546665|NCT01364922|40464861|FG000|Open-label (OL) Period|Adverse Event|7|||
16546666|NCT01364922|40464862|FG001|Open-label (OL) Period|Adverse Event|0|||
16546667|NCT01364922|40464863|FG002|Open-label (OL) Period|Adverse Event|0|||
16546668|NCT01364922|40464861|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
16546669|NCT01364922|40464862|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
16546670|NCT01364922|40464863|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
16546671|NCT01364922|40464861|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
16546672|NCT01364922|40464862|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
16546673|NCT01364922|40464863|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
16224462|NCT02207413|39302421|FG001|Overall Study|Withdrawal by Subject|0|||
16546674|NCT01364922|40464861|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
16546675|NCT01364922|40464862|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
16546676|NCT01364922|40464863|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
16546677|NCT01364922|40464861|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
16546678|NCT01364922|40464862|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
16546679|NCT01364922|40464863|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
16546680|NCT01364922|40464861|FG000|Open-label (OL) Period|Other, Unspecified|1|||
16546681|NCT01364922|40464862|FG001|Open-label (OL) Period|Other, Unspecified|0|||
16546682|NCT01364922|40464863|FG002|Open-label (OL) Period|Other, Unspecified|0|||
16546683|NCT01364922|40464861|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
16546684|NCT01364922|40464862|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
16546685|NCT01364922|40464863|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
16546686|NCT01364922|40464861|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
16546687|NCT01364922|40464862|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
16546688|NCT01364922|40464863|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
16546689|NCT01364922|40464861|FG000|Double-Blind (DB) Period|Adverse Event|0|||
16546690|NCT01364922|40464862|FG001|Double-Blind (DB) Period|Adverse Event|0|||
16546691|NCT01364922|40464863|FG002|Double-Blind (DB) Period|Adverse Event|1|||
16546692|NCT01364922|40464861|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
16546693|NCT01364922|40464862|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
16546694|NCT01364922|40464863|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
16546695|NCT00611858|40464868|FG000|Overall Study|Adverse Event|2|||
16546696|NCT00611858|40464868|FG000|Overall Study|Withdrawal by Subject|2|||
16546697|NCT01621880|40464869|FG000|Overall Study|Adverse Event|5|||
16346594|NCT01395810|39757203|FG001|Overall Study|Lack of Efficacy|1|||
16346595|NCT01395810|39757204|FG002|Overall Study|Lack of Efficacy|0|||
16346596|NCT01395810|39757205|FG003|Overall Study|Lack of Efficacy|0|||
16346597|NCT01395810|39757202|FG000|Overall Study|Withdrawal criteria|0|||
16346598|NCT01395810|39757203|FG001|Overall Study|Withdrawal criteria|2|||
16346599|NCT01395810|39757204|FG002|Overall Study|Withdrawal criteria|0|||
16346600|NCT01395810|39757205|FG003|Overall Study|Withdrawal criteria|0|||
16346601|NCT01395810|39757202|FG000|Overall Study|Unclassified|2|||
16346602|NCT01395810|39757203|FG001|Overall Study|Unclassified|0|||
16346603|NCT01395810|39757204|FG002|Overall Study|Unclassified|0|||
16346604|NCT01395810|39757205|FG003|Overall Study|Unclassified|0|||
16546698|NCT01621880|40464870|FG001|Overall Study|Adverse Event|1|||
16346605|NCT03300050|39757206|FG000|Overall Study|Lost to Follow-up|2|||
16346606|NCT03300050|39757207|FG001|Overall Study|Lost to Follow-up|1|||
16546699|NCT01621880|40464869|FG000|Overall Study|Withdrawal by Subject|5|||
16546700|NCT01621880|40464870|FG001|Overall Study|Withdrawal by Subject|4|||
16546701|NCT03237858|40464873|FG000|Overall Study|Death|19|||
16546702|NCT03237858|40464873|FG000|Overall Study|Withdrawal by Subject|37|||
16546703|NCT02013388|40464874|FG000|Overall Study|work emergency|1|||
16546704|NCT02013388|40464875|FG001|Overall Study|work emergency|0|||
16546705|NCT02013388|40464876|FG002|Overall Study|work emergency|0|||
16546706|NCT02013388|40464877|FG003|Overall Study|work emergency|0|||
16546707|NCT02013388|40464878|FG004|Overall Study|work emergency|1|||
16546708|NCT02013388|40464879|FG005|Overall Study|work emergency|0|||
16546709|NCT02013388|40464880|FG006|Overall Study|work emergency|0|||
16546710|NCT02013388|40464881|FG007|Overall Study|work emergency|0|||
16546711|NCT02120664|40464884|FG000|Overall Study|Withdrawal by Subject|0|||
16546712|NCT02120664|40464885|FG001|Overall Study|Withdrawal by Subject|0|||
16546713|NCT02120664|40464886|FG002|Overall Study|Withdrawal by Subject|0|||
16546714|NCT02120664|40464887|FG003|Overall Study|Withdrawal by Subject|1|||
16546715|NCT02120664|40464888|FG004|Overall Study|Withdrawal by Subject|0|||
16546716|NCT03092375|40464889|FG000|Overall Study|Lack of Efficacy|0|||
16546717|NCT03092375|40464890|FG001|Overall Study|Lack of Efficacy|1|||
16546718|NCT03092375|40464891|FG002|Overall Study|Lack of Efficacy|1|||
16546719|NCT03092375|40464892|FG003|Overall Study|Lack of Efficacy|0|||
16546720|NCT03066622|40464893|FG000|Overall Study|Lost to Follow-up|24|||
16546721|NCT03066622|40464894|FG001|Overall Study|Lost to Follow-up|25|||
16546722|NCT03066622|40464893|FG000|Overall Study|Withdrawal by Subject|2|||
16546723|NCT03066622|40464894|FG001|Overall Study|Withdrawal by Subject|1|||
16546724|NCT02460263|40464895|FG000|Transition Period|Withdrawal by Subject|1|||
16546725|NCT02460263|40464895|FG000|Transition Period|Death|1|||
16546726|NCT01492686|40464898|FG000|Double-blind Phase|Adverse Event|0|||
16546727|NCT01492686|40464899|FG001|Double-blind Phase|Adverse Event|2|||
16546728|NCT01492686|40464898|FG000|Double-blind Phase|Physician Decision|0|||
16546729|NCT01492686|40464899|FG001|Double-blind Phase|Physician Decision|1|||
16546730|NCT01492686|40464898|FG000|Double-blind Phase|Withdrawal by Subject|0|||
16546731|NCT01492686|40464899|FG001|Double-blind Phase|Withdrawal by Subject|2|||
16546732|NCT01492686|40464898|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
16546733|NCT01492686|40464899|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
16546734|NCT01492686|40464898|FG000|Open-label Phase|Adverse Event|1|||
16546735|NCT01492686|40464899|FG001|Open-label Phase|Adverse Event|2|||
16546736|NCT01492686|40464898|FG000|Open-label Phase|Physician Decision|1|||
16546737|NCT01492686|40464899|FG001|Open-label Phase|Physician Decision|0|||
16546738|NCT01492686|40464898|FG000|Open-label Phase|Withdrawal by Subject|6|||
16546739|NCT01492686|40464899|FG001|Open-label Phase|Withdrawal by Subject|7|||
16346607|NCT03300050|39757208|FG002|Overall Study|Lost to Follow-up|0|||
16346608|NCT03300050|39757209|FG003|Overall Study|Lost to Follow-up|0|||
16546740|NCT01492686|40464898|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
16546741|NCT01492686|40464899|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
16546742|NCT02228967|40464900|FG000|Overall Study|Lost to Follow-up|146|||
16546743|NCT02228967|40464901|FG001|Overall Study|Lost to Follow-up|142|||
16546744|NCT02228967|40464900|FG000|Overall Study|Withdrawal by Subject|13|||
16546745|NCT02228967|40464901|FG001|Overall Study|Withdrawal by Subject|18|||
16546746|NCT04860518|40464906|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
16546747|NCT04860518|40464907|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
16546748|NCT03916744|40464908|FG000|Overall Study|Withdrawal by Subject|0|||
16346609|NCT03300050|39757210|FG004|Overall Study|Lost to Follow-up|1|||
16346610|NCT03300050|39757206|FG000|Overall Study|Withdrawal by Subject|1|||
16346611|NCT03300050|39757207|FG001|Overall Study|Withdrawal by Subject|1|||
16346612|NCT03300050|39757208|FG002|Overall Study|Withdrawal by Subject|1|||
16346613|NCT03300050|39757209|FG003|Overall Study|Withdrawal by Subject|0|||
16346614|NCT03300050|39757210|FG004|Overall Study|Withdrawal by Subject|0|||
16346615|NCT03300050|39757206|FG000|Overall Study|Death|0|||
16346616|NCT03300050|39757207|FG001|Overall Study|Death|0|||
16346617|NCT03300050|39757208|FG002|Overall Study|Death|1|||
16346618|NCT03300050|39757209|FG003|Overall Study|Death|0|||
16546749|NCT03916744|40464909|FG001|Overall Study|Withdrawal by Subject|1|||
16546750|NCT03916744|40464910|FG002|Overall Study|Withdrawal by Subject|2|||
16546751|NCT01949870|40464912|FG000|Overall Study|Lack of Efficacy|2|||
16546752|NCT01949870|40464912|FG000|Overall Study|Adverse Event|1|||
16113330|NCT00132678|38902038|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
16113331|NCT00132678|38902039|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
16346619|NCT03300050|39757210|FG004|Overall Study|Death|0|||
16346620|NCT03300050|39757206|FG000|Overall Study|Not Eligible at Randomization|0|||
16546753|NCT01949870|40464912|FG000|Overall Study|Study termination|1|||
16546754|NCT01949870|40464912|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
16546755|NCT01728792|40464918|FG000|Overall Study|Withdrawal of Consent|1|||
16546756|NCT01728792|40464919|FG001|Overall Study|Withdrawal of Consent|1|||
16546757|NCT01728792|40464920|FG002|Overall Study|Withdrawal of Consent|0|||
16546758|NCT01728792|40464921|FG003|Overall Study|Withdrawal of Consent|1|||
16546759|NCT01728792|40464922|FG004|Overall Study|Withdrawal of Consent|0|||
16546760|NCT01728792|40464918|FG000|Overall Study|Lost to Follow-up|2|||
16546761|NCT01728792|40464919|FG001|Overall Study|Lost to Follow-up|1|||
16546762|NCT01728792|40464920|FG002|Overall Study|Lost to Follow-up|4|||
16546763|NCT01728792|40464921|FG003|Overall Study|Lost to Follow-up|2|||
16546764|NCT01728792|40464922|FG004|Overall Study|Lost to Follow-up|0|||
16113332|NCT00132678|38902040|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
16346621|NCT03300050|39757207|FG001|Overall Study|Not Eligible at Randomization|0|||
16346622|NCT03300050|39757208|FG002|Overall Study|Not Eligible at Randomization|1|||
16346623|NCT03300050|39757209|FG003|Overall Study|Not Eligible at Randomization|1|||
16346624|NCT03300050|39757210|FG004|Overall Study|Not Eligible at Randomization|0|||
16346625|NCT01128400|39757216|FG000|Overall Study|Lost to Follow-up|1|||
16346626|NCT01128400|39757217|FG001|Overall Study|Lost to Follow-up|0|||
16346627|NCT01128400|39757218|FG002|Overall Study|Lost to Follow-up|1|||
16346628|NCT01128400|39757216|FG000|Overall Study|Screening failure|1|||
16346629|NCT01128400|39757217|FG001|Overall Study|Screening failure|0|||
16346630|NCT01128400|39757218|FG002|Overall Study|Screening failure|0|||
16346631|NCT01128400|39757216|FG000|Overall Study|were not invited to participate on taste|0|||
16346632|NCT01128400|39757217|FG001|Overall Study|were not invited to participate on taste|0|||
16346633|NCT01128400|39757218|FG002|Overall Study|were not invited to participate on taste|15|||
16346634|NCT01128400|39757216|FG000|Overall Study|Excluded due to sinus problems|0|||
16346635|NCT01128400|39757217|FG001|Overall Study|Excluded due to sinus problems|1|||
16346636|NCT01128400|39757218|FG002|Overall Study|Excluded due to sinus problems|0|||
16346637|NCT00227539|39757222|FG000|Overall Study|Protocol Violation|1|||
16346638|NCT04086121|39757228|FG000|Overall Study|Other than listed|8|||
16346639|NCT04086121|39757228|FG000|Overall Study|Withdrawal by Subject|3|||
16346640|NCT04086121|39757228|FG000|Overall Study|Lost to Follow-up|2|||
16346641|NCT04086121|39757228|FG000|Overall Study|Adverse Event|1|||
16346642|NCT02504320|39757229|FG000|Treatment Period 1|Positive Drug Screen|0|||
16346643|NCT02504320|39757230|FG001|Treatment Period 1|Positive Drug Screen|0|||
16113333|NCT00132678|38902038|FG000|Period III (Open-Label Stabilization)|Death|2|||
16410170|NCT02689076|39985381|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
16113334|NCT00132678|38902039|FG001|Period III (Open-Label Stabilization)|Death|0|||
16113335|NCT00132678|38902040|FG002|Period III (Open-Label Stabilization)|Death|0|||
16113336|NCT00132678|38902038|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
16113337|NCT00132678|38902039|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
16113338|NCT00132678|38902040|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
16113339|NCT00132678|38902038|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
16113340|NCT00132678|38902039|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
16113341|NCT00132678|38902040|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
16113342|NCT00132678|38902038|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
16113343|NCT00132678|38902039|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
16113344|NCT00132678|38902040|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
16113345|NCT00132678|38902038|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
16113346|NCT00132678|38902039|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
16113347|NCT00132678|38902040|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
16113348|NCT00132678|38902038|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
16113349|NCT00132678|38902039|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
16113350|NCT00132678|38902040|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
16113351|NCT00132678|38902038|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
16113352|NCT00132678|38902039|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
16113353|NCT00132678|38902040|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
16113354|NCT00132678|38902038|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
16113355|NCT00132678|38902039|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
16113356|NCT00132678|38902040|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
16113357|NCT00132678|38902038|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
16113358|NCT00132678|38902039|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
16346644|NCT02504320|39757231|FG002|Treatment Period 1|Positive Drug Screen|1|||
16346645|NCT02504320|39757232|FG003|Treatment Period 1|Positive Drug Screen|0|||
16346646|NCT02504320|39757229|FG000|Treatment Period 2|Positive Drug Screen|0|||
16346647|NCT02504320|39757230|FG001|Treatment Period 2|Positive Drug Screen|1|||
16346648|NCT02504320|39757231|FG002|Treatment Period 2|Positive Drug Screen|0|||
16546765|NCT03391765|40464923|FG000|Overall Study|Adverse Event|2|||
16546766|NCT03391765|40464924|FG001|Overall Study|Adverse Event|0|||
16113359|NCT00132678|38902040|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
16113360|NCT00132678|38902038|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
16113361|NCT00132678|38902039|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
16113362|NCT00132678|38902040|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
16113363|NCT00132678|38902038|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
16113364|NCT00132678|38902039|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
16113365|NCT00132678|38902040|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
16113366|NCT00132678|38902038|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
16113367|NCT00132678|38902039|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
16113368|NCT00132678|38902040|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
16113369|NCT00132678|38902038|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
16113370|NCT00132678|38902039|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
16113371|NCT00132678|38902040|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
16113372|NCT00132678|38902038|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
16113373|NCT00132678|38902039|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
16113374|NCT00132678|38902040|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
16113375|NCT00132678|38902038|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
16113376|NCT00132678|38902039|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
16113377|NCT00132678|38902040|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
16113378|NCT00132678|38902038|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
16113379|NCT00132678|38902039|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
16113380|NCT00132678|38902040|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
16113381|NCT02287233|38902043|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
16113382|NCT02287233|38902044|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
16113383|NCT02287233|38902045|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
16113384|NCT02287233|38902043|FG000|Overall Study|Adverse Event Related to Progression|0|||
16113385|NCT02287233|38902044|FG001|Overall Study|Adverse Event Related to Progression|2|||
16113386|NCT02287233|38902045|FG002|Overall Study|Adverse Event Related to Progression|8|||
16113387|NCT02287233|38902043|FG000|Overall Study|Physician Decision|1|||
16113388|NCT02287233|38902044|FG001|Overall Study|Physician Decision|2|||
16113389|NCT02287233|38902045|FG002|Overall Study|Physician Decision|4|||
16113390|NCT02287233|38902043|FG000|Overall Study|Progressive Disease with Death|0|||
16113391|NCT02287233|38902044|FG001|Overall Study|Progressive Disease with Death|0|||
16113392|NCT02287233|38902045|FG002|Overall Study|Progressive Disease with Death|10|||
16113393|NCT02287233|38902043|FG000|Overall Study|Progressive Disease Without Death|2|||
16113394|NCT02287233|38902044|FG001|Overall Study|Progressive Disease Without Death|3|||
16113395|NCT02287233|38902045|FG002|Overall Study|Progressive Disease Without Death|20|||
16113396|NCT02287233|38902043|FG000|Overall Study|Withdrawal by Subject|1|||
16113397|NCT02287233|38902044|FG001|Overall Study|Withdrawal by Subject|1|||
16113398|NCT02287233|38902045|FG002|Overall Study|Withdrawal by Subject|7|||
16113399|NCT02287233|38902043|FG000|Overall Study|Other|3|||
16113400|NCT02287233|38902044|FG001|Overall Study|Other|0|||
16113401|NCT02287233|38902045|FG002|Overall Study|Other|15|||
16113402|NCT02287233|38902043|FG000|Overall Study|Did Not Receive Treatment|0|||
16113403|NCT02287233|38902044|FG001|Overall Study|Did Not Receive Treatment|0|||
16113404|NCT02287233|38902045|FG002|Overall Study|Did Not Receive Treatment|2|||
16113405|NCT00926575|38902051|FG000|Overall Study|Adverse Event|1|||
16113406|NCT00926575|38902052|FG001|Overall Study|Adverse Event|1|||
16113407|NCT00926575|38902051|FG000|Overall Study|Death|4|||
16113408|NCT00926575|38902052|FG001|Overall Study|Death|4|||
16113409|NCT00926575|38902051|FG000|Overall Study|Lost to Follow-up|1|||
16546767|NCT03391765|40464925|FG002|Overall Study|Adverse Event|0|||
16546768|NCT03391765|40464926|FG003|Overall Study|Adverse Event|2|||
16546769|NCT03391765|40464923|FG000|Overall Study|Withdrew consent|5|||
16546770|NCT03391765|40464924|FG001|Overall Study|Withdrew consent|7|||
16546771|NCT03391765|40464925|FG002|Overall Study|Withdrew consent|2|||
16546772|NCT03391765|40464926|FG003|Overall Study|Withdrew consent|5|||
16546773|NCT03391765|40464923|FG000|Overall Study|Other, not specified|44|||
16546774|NCT03391765|40464924|FG001|Overall Study|Other, not specified|38|||
16546775|NCT03391765|40464925|FG002|Overall Study|Other, not specified|21|||
16546776|NCT03391765|40464926|FG003|Overall Study|Other, not specified|16|||
16546777|NCT01987817|40464927|FG000|Overall Study|Adverse Event|4|||
16546778|NCT01987817|40464928|FG001|Overall Study|Adverse Event|0|||
16546779|NCT01987817|40464927|FG000|Overall Study|Withdrawal by Subject|1|||
16546780|NCT01987817|40464928|FG001|Overall Study|Withdrawal by Subject|1|||
16546781|NCT01987817|40464927|FG000|Overall Study|Physician Decision|1|||
16546782|NCT01987817|40464928|FG001|Overall Study|Physician Decision|0|||
16546783|NCT04338269|40464933|FG000|Overall Study|Death|86|||
16546784|NCT04338269|40464934|FG001|Overall Study|Death|89|||
16546785|NCT04338269|40464933|FG000|Overall Study|Lost to Follow-up|1|||
16546786|NCT04338269|40464934|FG001|Overall Study|Lost to Follow-up|2|||
16546787|NCT04338269|40464933|FG000|Overall Study|Physician Decision|1|||
16546788|NCT04338269|40464934|FG001|Overall Study|Physician Decision|0|||
16546789|NCT04338269|40464933|FG000|Overall Study|Withdrawal by Subject|14|||
16546790|NCT04338269|40464934|FG001|Overall Study|Withdrawal by Subject|11|||
16546791|NCT00717314|40464935|FG000|Overall Study|Adverse Event|3|||
16546792|NCT00717314|40464936|FG001|Overall Study|Adverse Event|2|||
16546793|NCT00717314|40464935|FG000|Overall Study|Protocol Violation|1|||
16546794|NCT00717314|40464936|FG001|Overall Study|Protocol Violation|0|||
16546795|NCT00717314|40464935|FG000|Overall Study|Lost to Follow-up|1|||
16546796|NCT00717314|40464936|FG001|Overall Study|Lost to Follow-up|5|||
16546797|NCT00717314|40464935|FG000|Overall Study|Withdrawal by Subject|1|||
16546798|NCT00717314|40464936|FG001|Overall Study|Withdrawal by Subject|3|||
16224463|NCT02207413|39302422|FG002|Overall Study|Withdrawal by Subject|0|||
16546799|NCT00106184|40464937|FG000|Overall Study|Withdrawal by Subject|3|||
16546800|NCT00106184|40464938|FG001|Overall Study|Withdrawal by Subject|2|||
16546801|NCT02923739|40464939|FG000|Overall Study|Withdrawal by Subject|2|||
16546802|NCT02923739|40464940|FG001|Overall Study|Withdrawal by Subject|0|||
16546803|NCT02923739|40464941|FG002|Overall Study|Withdrawal by Subject|0|||
16546804|NCT02923739|40464942|FG003|Overall Study|Withdrawal by Subject|0|||
16546805|NCT02923739|40464939|FG000|Overall Study|Failed Screening|3|||
16546806|NCT02923739|40464940|FG001|Overall Study|Failed Screening|0|||
16546807|NCT02923739|40464941|FG002|Overall Study|Failed Screening|0|||
16546808|NCT02923739|40464942|FG003|Overall Study|Failed Screening|0|||
16546809|NCT03124199|40464945|FG000|Overall Study|Lost to Follow-up|4|||
16546810|NCT00768430|40464948|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
16546811|NCT00768430|40464949|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
16546812|NCT02073097|40464950|FG000|Overall Study|Adverse Event|0|||
16546813|NCT02073097|40464951|FG001|Overall Study|Adverse Event|0|||
16546814|NCT02073097|40464952|FG002|Overall Study|Adverse Event|0|||
16546815|NCT02073097|40464953|FG003|Overall Study|Adverse Event|0|||
16546816|NCT02073097|40464954|FG004|Overall Study|Adverse Event|0|||
16546817|NCT02073097|40464955|FG005|Overall Study|Adverse Event|0|||
16546818|NCT02073097|40464956|FG006|Overall Study|Adverse Event|0|||
16546819|NCT02073097|40464957|FG007|Overall Study|Adverse Event|2|||
16546820|NCT02073097|40464950|FG000|Overall Study|Withdrawal by Subject|0|||
16546821|NCT02073097|40464951|FG001|Overall Study|Withdrawal by Subject|0|||
16546822|NCT02073097|40464952|FG002|Overall Study|Withdrawal by Subject|0|||
16546823|NCT02073097|40464953|FG003|Overall Study|Withdrawal by Subject|0|||
16546824|NCT02073097|40464954|FG004|Overall Study|Withdrawal by Subject|0|||
16546825|NCT02073097|40464955|FG005|Overall Study|Withdrawal by Subject|0|||
16546826|NCT02073097|40464956|FG006|Overall Study|Withdrawal by Subject|0|||
16546827|NCT02073097|40464957|FG007|Overall Study|Withdrawal by Subject|2|||
16546828|NCT02073097|40464950|FG000|Overall Study|Death|0|||
16546829|NCT02073097|40464951|FG001|Overall Study|Death|0|||
16113410|NCT00926575|38902052|FG001|Overall Study|Lost to Follow-up|1|||
16224464|NCT02207413|39302423|FG003|Overall Study|Withdrawal by Subject|0|||
16224465|NCT02207413|39302424|FG004|Overall Study|Withdrawal by Subject|3|||
16546830|NCT02073097|40464952|FG002|Overall Study|Death|0|||
16224466|NCT02207413|39302425|FG005|Overall Study|Withdrawal by Subject|7|||
16546831|NCT02073097|40464953|FG003|Overall Study|Death|0|||
16546832|NCT02073097|40464954|FG004|Overall Study|Death|0|||
16546833|NCT02073097|40464955|FG005|Overall Study|Death|0|||
16546834|NCT02073097|40464956|FG006|Overall Study|Death|0|||
16546835|NCT02073097|40464957|FG007|Overall Study|Death|1|||
16546836|NCT02073097|40464950|FG000|Overall Study|Physician Decision|0|||
16546837|NCT02073097|40464951|FG001|Overall Study|Physician Decision|0|||
16546838|NCT02073097|40464952|FG002|Overall Study|Physician Decision|0|||
16546839|NCT02073097|40464953|FG003|Overall Study|Physician Decision|0|||
16546840|NCT02073097|40464954|FG004|Overall Study|Physician Decision|0|||
16546841|NCT02073097|40464955|FG005|Overall Study|Physician Decision|0|||
16546842|NCT02073097|40464956|FG006|Overall Study|Physician Decision|0|||
16546843|NCT02073097|40464957|FG007|Overall Study|Physician Decision|1|||
16546844|NCT00085202|40464959|FG000|Overall Study|Still on therapy|2|||
16546845|NCT00085202|40464960|FG001|Overall Study|Still on therapy|0|||
16546846|NCT00085202|40464959|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
16546847|NCT00085202|40464960|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
16546848|NCT00085202|40464959|FG000|Overall Study|Excessive toxicity|6|||
16546849|NCT00085202|40464960|FG001|Overall Study|Excessive toxicity|5|||
16546850|NCT00085202|40464959|FG000|Overall Study|Non-specified|3|||
16546851|NCT00085202|40464960|FG001|Overall Study|Non-specified|5|||
16546852|NCT00085202|40464959|FG000|Overall Study|Withdrawal by Subject|2|||
16546853|NCT00085202|40464960|FG001|Overall Study|Withdrawal by Subject|1|||
16546854|NCT00085202|40464959|FG000|Overall Study|Physician Decision|4|||
16546855|NCT00085202|40464960|FG001|Overall Study|Physician Decision|1|||
16546856|NCT00085202|40464959|FG000|Overall Study|Progressive disease|1|||
16546857|NCT00085202|40464960|FG001|Overall Study|Progressive disease|11|||
16546858|NCT00255346|40464961|FG000|Overall Study|Adverse Event|1|||
16546859|NCT00255346|40464962|FG001|Overall Study|Adverse Event|0|||
16224467|NCT02207413|39302420|FG000|Overall Study|Lost to Follow-up|0|||
16224468|NCT02207413|39302421|FG001|Overall Study|Lost to Follow-up|0|||
16224469|NCT02207413|39302422|FG002|Overall Study|Lost to Follow-up|0|||
16224470|NCT02207413|39302423|FG003|Overall Study|Lost to Follow-up|1|||
16546860|NCT00255346|40464963|FG002|Overall Study|Adverse Event|0|||
16546861|NCT00255346|40464964|FG003|Overall Study|Adverse Event|0|||
16546862|NCT00255346|40464965|FG004|Overall Study|Adverse Event|0|||
16546863|NCT00770432|40464968|FG000|Overall Study|Other|4|||
16546864|NCT00770432|40464969|FG001|Overall Study|Other|6|||
16546865|NCT00770432|40464968|FG000|Overall Study|Non-compliance|0|||
16546866|NCT00770432|40464969|FG001|Overall Study|Non-compliance|1|||
16224471|NCT02207413|39302424|FG004|Overall Study|Lost to Follow-up|1|||
16224472|NCT02207413|39302425|FG005|Overall Study|Lost to Follow-up|5|||
16224473|NCT02207413|39302420|FG000|Overall Study|Adverse Event|0|||
16224474|NCT02207413|39302421|FG001|Overall Study|Adverse Event|0|||
16224475|NCT02207413|39302422|FG002|Overall Study|Adverse Event|0|||
16224476|NCT02207413|39302423|FG003|Overall Study|Adverse Event|0|||
16224477|NCT02207413|39302424|FG004|Overall Study|Adverse Event|2|||
16224478|NCT02207413|39302425|FG005|Overall Study|Adverse Event|1|||
16224479|NCT02207413|39302420|FG000|Overall Study|Migrated/moved from study area|0|||
16224480|NCT02207413|39302421|FG001|Overall Study|Migrated/moved from study area|0|||
16224481|NCT02207413|39302422|FG002|Overall Study|Migrated/moved from study area|0|||
16224482|NCT02207413|39302423|FG003|Overall Study|Migrated/moved from study area|0|||
16546867|NCT04006925|40464980|FG000|Overall Study|Side effects|2|||
16224483|NCT02207413|39302424|FG004|Overall Study|Migrated/moved from study area|1|||
16224484|NCT02207413|39302425|FG005|Overall Study|Migrated/moved from study area|0|||
16224485|NCT01856920|39302426|FG000|Overall Study|Disease Progression On Study|3|||
16224486|NCT01856920|39302427|FG001|Overall Study|Disease Progression On Study|4|||
16224487|NCT01856920|39302426|FG000|Overall Study|Disease Progression before Treatment|1|||
16224488|NCT01856920|39302427|FG001|Overall Study|Disease Progression before Treatment|0|||
16224489|NCT01856920|39302426|FG000|Overall Study|Ineligible|0|||
16224490|NCT01856920|39302427|FG001|Overall Study|Ineligible|1|||
16224491|NCT01856920|39302426|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
16224492|NCT01856920|39302427|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
16224493|NCT01856920|39302426|FG000|Overall Study|Refused further Treatment|5|||
16224494|NCT01856920|39302427|FG001|Overall Study|Refused further Treatment|1|||
16224495|NCT01856920|39302426|FG000|Overall Study|Other Reasons|0|||
16224496|NCT01856920|39302427|FG001|Overall Study|Other Reasons|1|||
16224497|NCT01856920|39302426|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
16224498|NCT01856920|39302427|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
16224499|NCT01453439|39302428|FG000|Treatment Phase|Withdrawal by Subject|13|||
16113411|NCT00926575|38902051|FG000|Overall Study|Physician Decision|1|||
16224500|NCT01453439|39302429|FG001|Treatment Phase|Withdrawal by Subject|10|||
16224501|NCT01453439|39302428|FG000|Treatment Phase|Suicidal Ideation|2|||
16224502|NCT01453439|39302429|FG001|Treatment Phase|Suicidal Ideation|0|||
16546868|NCT04006925|40464981|FG001|Overall Study|Side effects|0|||
16546869|NCT02759185|40464988|FG000|Stage 1|Adverse Event|0|||
16546870|NCT02759185|40464989|FG001|Stage 1|Adverse Event|1|||
16546871|NCT02759185|40464990|FG002|Stage 1|Adverse Event|3|||
16546872|NCT02759185|40464991|FG003|Stage 1|Adverse Event|0|||
16546873|NCT02759185|40464992|FG004|Stage 1|Adverse Event|0|||
16546874|NCT02759185|40464993|FG005|Stage 1|Adverse Event|0|||
16546875|NCT02759185|40464994|FG006|Stage 1|Adverse Event|0|||
16546876|NCT02759185|40464988|FG000|Stage 1|Withdrawal by Subject|1|||
16546877|NCT02759185|40464989|FG001|Stage 1|Withdrawal by Subject|0|||
16546878|NCT02759185|40464990|FG002|Stage 1|Withdrawal by Subject|0|||
16546879|NCT02759185|40464991|FG003|Stage 1|Withdrawal by Subject|0|||
16546880|NCT02759185|40464992|FG004|Stage 1|Withdrawal by Subject|0|||
16224503|NCT01453439|39302428|FG000|Treatment Phase|Need for higher level of care|1|||
16224504|NCT01453439|39302429|FG001|Treatment Phase|Need for higher level of care|1|||
16224505|NCT01453439|39302428|FG000|Treatment Phase|Therapist conflict of interest|1|||
16224506|NCT01453439|39302429|FG001|Treatment Phase|Therapist conflict of interest|0|||
16346649|NCT02504320|39757232|FG003|Treatment Period 2|Positive Drug Screen|0|||
16346650|NCT02504320|39757229|FG000|Treatment Period 3|Positive Drug Screen|0|||
16346651|NCT02504320|39757230|FG001|Treatment Period 3|Positive Drug Screen|0|||
16224507|NCT01453439|39302428|FG000|Follow-up|Withdrawal by Subject|0|||
16224508|NCT01453439|39302429|FG001|Follow-up|Withdrawal by Subject|1|||
16224509|NCT01453439|39302428|FG000|Follow-up|Lost to Follow-up|5|||
16224510|NCT01453439|39302429|FG001|Follow-up|Lost to Follow-up|10|||
16224511|NCT03911401|39302436|FG000|Overall Study|Adverse Event|1|||
16546881|NCT02759185|40464993|FG005|Stage 1|Withdrawal by Subject|0|||
16224512|NCT03911401|39302437|FG001|Overall Study|Adverse Event|2|||
16224513|NCT03911401|39302438|FG002|Overall Study|Adverse Event|5|||
16224514|NCT03911401|39302436|FG000|Overall Study|Lack of Efficacy|1|||
16224515|NCT03911401|39302437|FG001|Overall Study|Lack of Efficacy|1|||
16224516|NCT03911401|39302438|FG002|Overall Study|Lack of Efficacy|8|||
16224517|NCT03911401|39302436|FG000|Overall Study|Physician Decision|0|||
16224518|NCT03911401|39302437|FG001|Overall Study|Physician Decision|0|||
16224519|NCT03911401|39302438|FG002|Overall Study|Physician Decision|1|||
16224520|NCT03911401|39302436|FG000|Overall Study|Withdrawal by Subject|1|||
16224521|NCT03911401|39302437|FG001|Overall Study|Withdrawal by Subject|2|||
16224522|NCT03911401|39302438|FG002|Overall Study|Withdrawal by Subject|0|||
16224523|NCT03911401|39302436|FG000|Overall Study|Withdrawal by parent/guardian|4|||
16224524|NCT03911401|39302437|FG001|Overall Study|Withdrawal by parent/guardian|4|||
16224525|NCT03911401|39302438|FG002|Overall Study|Withdrawal by parent/guardian|11|||
16224526|NCT02577107|39302442|FG000|Overall Study|Protocol deviation|0|||
16224527|NCT02577107|39302443|FG001|Overall Study|Protocol deviation|1|||
16224528|NCT01293123|39302449|FG000|Overall Study|Lost to Follow-up|0|||
16224529|NCT01293123|39302450|FG001|Overall Study|Lost to Follow-up|1|||
16224530|NCT03982069|39302455|FG000|Overall Study|Lost to Follow-up|5|||
16224531|NCT03982069|39302456|FG001|Overall Study|Lost to Follow-up|5|||
16224532|NCT03982069|39302457|FG002|Overall Study|Lost to Follow-up|3|||
16224533|NCT03982069|39302458|FG003|Overall Study|Lost to Follow-up|5|||
16224534|NCT03982069|39302455|FG000|Overall Study|Physician Decision|0|||
16546882|NCT02759185|40464994|FG006|Stage 1|Withdrawal by Subject|0|||
16546883|NCT02759185|40464988|FG000|Stage 2|Adverse Event|0|||
16546884|NCT02759185|40464989|FG001|Stage 2|Adverse Event|0|||
16546885|NCT02759185|40464990|FG002|Stage 2|Adverse Event|0|||
16546886|NCT02759185|40464991|FG003|Stage 2|Adverse Event|0|||
16546887|NCT02759185|40464992|FG004|Stage 2|Adverse Event|1|||
16546888|NCT02759185|40464993|FG005|Stage 2|Adverse Event|2|||
16224535|NCT03982069|39302456|FG001|Overall Study|Physician Decision|1|||
16224536|NCT03982069|39302457|FG002|Overall Study|Physician Decision|0|||
16224537|NCT03982069|39302458|FG003|Overall Study|Physician Decision|0|||
16224538|NCT03982069|39302455|FG000|Overall Study|Withdrawal by Subject|2|||
16224539|NCT03982069|39302456|FG001|Overall Study|Withdrawal by Subject|1|||
16224540|NCT03982069|39302457|FG002|Overall Study|Withdrawal by Subject|5|||
16224541|NCT03982069|39302458|FG003|Overall Study|Withdrawal by Subject|2|||
16224542|NCT03982069|39302455|FG000|Overall Study|Specimen loss|3|||
16224543|NCT03982069|39302456|FG001|Overall Study|Specimen loss|3|||
16224544|NCT03982069|39302457|FG002|Overall Study|Specimen loss|1|||
16224545|NCT03982069|39302458|FG003|Overall Study|Specimen loss|1|||
16224546|NCT01955005|39302465|FG000|Overall Study|Withdrawal by Subject|3|||
16224547|NCT01955005|39302466|FG001|Overall Study|Withdrawal by Subject|5|||
16224548|NCT00027846|39302467|FG000|Overall Study|Lost to Follow-up|0|||
16224549|NCT00027846|39302468|FG001|Overall Study|Lost to Follow-up|41|||
16224550|NCT00027846|39302469|FG002|Overall Study|Lost to Follow-up|9|||
16224551|NCT00027846|39302467|FG000|Overall Study|Withdrawal by Subject|0|||
16224552|NCT00027846|39302468|FG001|Overall Study|Withdrawal by Subject|14|||
16346652|NCT02504320|39757231|FG002|Treatment Period 3|Positive Drug Screen|0|||
16346653|NCT02504320|39757232|FG003|Treatment Period 3|Positive Drug Screen|1|||
16224553|NCT00027846|39302469|FG002|Overall Study|Withdrawal by Subject|7|||
16224554|NCT00027846|39302467|FG000|Overall Study|Ineligible for study|2|||
16224555|NCT00027846|39302468|FG001|Overall Study|Ineligible for study|6|||
16546889|NCT02759185|40464994|FG006|Stage 2|Adverse Event|0|||
16546890|NCT02759185|40464988|FG000|Stage 2|Withdrawal by Subject|0|||
16546891|NCT02759185|40464989|FG001|Stage 2|Withdrawal by Subject|0|||
16113412|NCT00926575|38902052|FG001|Overall Study|Physician Decision|2|||
16224556|NCT00027846|39302469|FG002|Overall Study|Ineligible for study|14|||
16224557|NCT00027846|39302467|FG000|Overall Study|Entry into another COG therapeutic study|0|||
16346654|NCT02504320|39757229|FG000|Treatment Period 3|Adverse Event|0|||
16546892|NCT02759185|40464990|FG002|Stage 2|Withdrawal by Subject|0|||
16346655|NCT02504320|39757230|FG001|Treatment Period 3|Adverse Event|0|||
16346656|NCT02504320|39757231|FG002|Treatment Period 3|Adverse Event|1|||
16546893|NCT02759185|40464991|FG003|Stage 2|Withdrawal by Subject|0|||
16546894|NCT02759185|40464992|FG004|Stage 2|Withdrawal by Subject|1|||
16546895|NCT02759185|40464993|FG005|Stage 2|Withdrawal by Subject|1|||
16224558|NCT00027846|39302468|FG001|Overall Study|Entry into another COG therapeutic study|5|||
16224559|NCT00027846|39302469|FG002|Overall Study|Entry into another COG therapeutic study|2|||
16224560|NCT00027846|39302467|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
16224561|NCT00027846|39302468|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
16224562|NCT00027846|39302469|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
16224563|NCT01552408|39302470|FG000|Overall Study|Lost to Follow-up|2|||
16224564|NCT01552408|39302471|FG001|Overall Study|Lost to Follow-up|0|||
16224565|NCT01552408|39302470|FG000|Overall Study|Relocation|0|||
16224566|NCT01552408|39302471|FG001|Overall Study|Relocation|1|||
16224567|NCT01552408|39302470|FG000|Overall Study|Withdrawal by Subject|2|||
16224568|NCT01552408|39302471|FG001|Overall Study|Withdrawal by Subject|1|||
16224569|NCT01711359|39302472|FG000|Treatment Period|Withdrawal by Subject|18|||
16224570|NCT01711359|39302473|FG001|Treatment Period|Withdrawal by Subject|7|||
16224571|NCT01711359|39302474|FG002|Treatment Period|Withdrawal by Subject|13|||
16224572|NCT01711359|39302472|FG000|Treatment Period|Lack of Efficacy|13|||
16224573|NCT01711359|39302473|FG001|Treatment Period|Lack of Efficacy|2|||
16224574|NCT01711359|39302474|FG002|Treatment Period|Lack of Efficacy|2|||
16224575|NCT01711359|39302472|FG000|Treatment Period|Adverse Event|8|||
16346657|NCT02504320|39757232|FG003|Treatment Period 3|Adverse Event|0|||
16346658|NCT03786380|39757236|FG000|Overall Study|Adverse Event|1|||
16546896|NCT02759185|40464994|FG006|Stage 2|Withdrawal by Subject|1|||
16546897|NCT03243422|40464998|FG000|Overall Study|Death|20|||
16546898|NCT03243422|40464999|FG001|Overall Study|Death|21|||
16546899|NCT03243422|40464998|FG000|Overall Study|Lost to Follow-up|9|||
16546900|NCT03243422|40464999|FG001|Overall Study|Lost to Follow-up|21|||
16546901|NCT03243422|40464998|FG000|Overall Study|Withdrawal by Subject|22|||
16546902|NCT03243422|40464999|FG001|Overall Study|Withdrawal by Subject|8|||
16546903|NCT00462670|40465003|FG000|Overall Study|Adverse Event|3|||
16546904|NCT00462670|40465004|FG001|Overall Study|Adverse Event|5|||
16546905|NCT00462670|40465003|FG000|Overall Study|Lack of Efficacy|1|||
16546906|NCT00462670|40465004|FG001|Overall Study|Lack of Efficacy|0|||
16546907|NCT00462670|40465003|FG000|Overall Study|Protocol Violation|1|||
16546908|NCT00462670|40465004|FG001|Overall Study|Protocol Violation|0|||
16546909|NCT00462670|40465003|FG000|Overall Study|Resolution of signs and symptoms|0|||
16546910|NCT00462670|40465004|FG001|Overall Study|Resolution of signs and symptoms|2|||
16546911|NCT00405639|40465005|FG000|Overall Study|Withdrawal by Subject|1|||
16546912|NCT00405639|40465006|FG001|Overall Study|Withdrawal by Subject|0|||
16546913|NCT00405639|40465005|FG000|Overall Study|Adverse Event|1|||
16546914|NCT00405639|40465006|FG001|Overall Study|Adverse Event|0|||
16546915|NCT00405639|40465005|FG000|Overall Study|Seizure prior to receiving BNP|1|||
16546916|NCT00405639|40465006|FG001|Overall Study|Seizure prior to receiving BNP|0|||
16546917|NCT05096208|40465007|FG000|Overall Study|Lost to Follow-up|3|||
16546918|NCT05096208|40465008|FG001|Overall Study|Lost to Follow-up|5|||
16113413|NCT00926575|38902051|FG000|Overall Study|Protocol Violation|1|||
16113414|NCT00926575|38902052|FG001|Overall Study|Protocol Violation|0|||
16113415|NCT00926575|38902051|FG000|Overall Study|Withdrawal by Subject|8|||
16113416|NCT00926575|38902052|FG001|Overall Study|Withdrawal by Subject|9|||
16113417|NCT01234883|38902056|FG000|Overall Study|Early treatment release|8|||
16113418|NCT01234883|38902057|FG001|Overall Study|Early treatment release|10|||
16113419|NCT01234883|38902056|FG000|Overall Study|Parent/guardian withdrew consent|1|||
16113420|NCT01234883|38902057|FG001|Overall Study|Parent/guardian withdrew consent|2|||
16113421|NCT01234883|38902056|FG000|Overall Study|Technical difficulties with IV infusion|0|||
16113422|NCT01234883|38902057|FG001|Overall Study|Technical difficulties with IV infusion|1|||
16113423|NCT01234883|38902056|FG000|Overall Study|Inclusion/exclusion failure|1|||
16113424|NCT01234883|38902057|FG001|Overall Study|Inclusion/exclusion failure|0|||
16113425|NCT03062449|38902061|FG000|Overall Study|Withdrawal by Subject|7|||
16113426|NCT03062449|38902062|FG001|Overall Study|Withdrawal by Subject|1|||
16113427|NCT00425607|38902065|FG000|Overall Study|Death|1|||
16113428|NCT00425607|38902065|FG000|Overall Study|Withdrawal by Subject|1|||
16113429|NCT02397447|38902066|FG000|Overall Study|Lost to Follow-up|2|||
16113430|NCT02397447|38902067|FG001|Overall Study|Lost to Follow-up|2|||
16113431|NCT00013611|38902068|FG000|Overall Study|Lost to Follow-up|91|||
16113432|NCT00013611|38902069|FG001|Overall Study|Lost to Follow-up|100|||
16113433|NCT00681668|38905891|FG000|Overall Study|Protocol Violation|1|||
16113434|NCT00681668|38905891|FG000|Overall Study|Withdrawal by Subject|1|||
16113435|NCT00250432|38905892|FG000|Overall Study|Adverse Event|25|||
16113436|NCT00250432|38905893|FG001|Overall Study|Adverse Event|29|||
16113437|NCT00250432|38905892|FG000|Overall Study|Lack of Efficacy|2|||
16113438|NCT00250432|38905893|FG001|Overall Study|Lack of Efficacy|1|||
16113439|NCT00250432|38905892|FG000|Overall Study|Lost to Follow-up|6|||
16113440|NCT00250432|38905893|FG001|Overall Study|Lost to Follow-up|5|||
16346659|NCT03786380|39757237|FG001|Overall Study|Adverse Event|0|||
16346660|NCT03786380|39757238|FG002|Overall Study|Adverse Event|0|||
16346661|NCT03786380|39757239|FG003|Overall Study|Adverse Event|3|||
16346662|NCT03786380|39757240|FG004|Overall Study|Adverse Event|1|||
16346663|NCT03786380|39757236|FG000|Overall Study|Lack of Efficacy|0|||
16346664|NCT03786380|39757237|FG001|Overall Study|Lack of Efficacy|0|||
16346665|NCT03786380|39757238|FG002|Overall Study|Lack of Efficacy|0|||
16346666|NCT03786380|39757239|FG003|Overall Study|Lack of Efficacy|0|||
16346667|NCT03786380|39757240|FG004|Overall Study|Lack of Efficacy|1|||
16346668|NCT03786380|39757236|FG000|Overall Study|Withdrawal by Subject|1|||
16410171|NCT02689076|39985379|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
16410172|NCT02689076|39985380|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
16224576|NCT01711359|39302473|FG001|Treatment Period|Adverse Event|10|||
16224577|NCT01711359|39302474|FG002|Treatment Period|Adverse Event|24|||
16224578|NCT01711359|39302472|FG000|Treatment Period|Physician Decision|4|||
16224579|NCT01711359|39302473|FG001|Treatment Period|Physician Decision|3|||
16410173|NCT02689076|39985381|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
16410174|NCT02689076|39985379|FG000|Overall Study|Did not have an HIE match|2|||
16410175|NCT02689076|39985380|FG001|Overall Study|Did not have an HIE match|0|||
16410176|NCT02689076|39985381|FG002|Overall Study|Did not have an HIE match|0|||
16346669|NCT03786380|39757237|FG001|Overall Study|Withdrawal by Subject|2|||
16346670|NCT03786380|39757238|FG002|Overall Study|Withdrawal by Subject|2|||
16346671|NCT03786380|39757239|FG003|Overall Study|Withdrawal by Subject|1|||
16346672|NCT03786380|39757240|FG004|Overall Study|Withdrawal by Subject|2|||
16346673|NCT03786380|39757236|FG000|Overall Study|Lost to Follow-up|3|||
16346674|NCT03786380|39757237|FG001|Overall Study|Lost to Follow-up|0|||
16346675|NCT03786380|39757238|FG002|Overall Study|Lost to Follow-up|1|||
16410177|NCT02689076|39985379|FG000|Overall Study|Death during non-VA encounter|2|||
16410178|NCT02689076|39985380|FG001|Overall Study|Death during non-VA encounter|5|||
16410179|NCT02689076|39985381|FG002|Overall Study|Death during non-VA encounter|0|||
16410180|NCT02689076|39985379|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
16410181|NCT02689076|39985380|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
16410182|NCT02689076|39985381|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
16410183|NCT02689076|39985379|FG000|Overall Study|Participant no longer active in VA system|1|||
16410184|NCT02689076|39985380|FG001|Overall Study|Participant no longer active in VA system|0|||
16410185|NCT02689076|39985381|FG002|Overall Study|Participant no longer active in VA system|0|||
16224580|NCT01711359|39302474|FG002|Treatment Period|Physician Decision|2|||
16410186|NCT02689076|39985379|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
16410187|NCT02689076|39985380|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
16410188|NCT02689076|39985381|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
16546919|NCT05096208|40465009|FG002|Overall Study|Lost to Follow-up|5|||
16224581|NCT01711359|39302472|FG000|Treatment Period|Death|3|||
16224582|NCT01711359|39302473|FG001|Treatment Period|Death|0|||
16224583|NCT01711359|39302474|FG002|Treatment Period|Death|0|||
16224584|NCT01711359|39302472|FG000|Treatment Period|Entry Criteria Not Met|1|||
16224585|NCT01711359|39302473|FG001|Treatment Period|Entry Criteria Not Met|0|||
16346676|NCT03786380|39757239|FG003|Overall Study|Lost to Follow-up|2|||
16546920|NCT05096208|40465010|FG003|Overall Study|Lost to Follow-up|2|||
16546921|NCT05096208|40465007|FG000|Overall Study|Withdrawal by Subject|0|||
16546922|NCT05096208|40465008|FG001|Overall Study|Withdrawal by Subject|1|||
16546923|NCT05096208|40465009|FG002|Overall Study|Withdrawal by Subject|2|||
16546924|NCT05096208|40465010|FG003|Overall Study|Withdrawal by Subject|3|||
16546925|NCT05096208|40465007|FG000|Overall Study|No longer met eligibility criteria|1|||
16546926|NCT05096208|40465008|FG001|Overall Study|No longer met eligibility criteria|0|||
16546927|NCT05096208|40465009|FG002|Overall Study|No longer met eligibility criteria|0|||
16546928|NCT05096208|40465010|FG003|Overall Study|No longer met eligibility criteria|0|||
16546929|NCT05096208|40465007|FG000|Overall Study|Other|0|||
16546930|NCT05096208|40465008|FG001|Overall Study|Other|0|||
16546931|NCT05096208|40465009|FG002|Overall Study|Other|1|||
16546932|NCT05096208|40465010|FG003|Overall Study|Other|0|||
16546933|NCT03474549|40465011|FG000|Overall Study|Death|31|||
16546934|NCT03474549|40465011|FG000|Overall Study|Lost to Follow-up|4|||
16346677|NCT03786380|39757240|FG004|Overall Study|Lost to Follow-up|0|||
16546935|NCT03474549|40465011|FG000|Overall Study|Withdrawal by Subject|2|||
16546936|NCT00691132|40465014|FG000|Overall Study|Adverse Event|2|||
16546937|NCT00691132|40465015|FG001|Overall Study|Adverse Event|3|||
16546938|NCT00691132|40465014|FG000|Overall Study|Withdrawal by Subject|10|||
16546939|NCT00691132|40465015|FG001|Overall Study|Withdrawal by Subject|10|||
16410209|NCT01754194|39985390|FG000|Overall Study|Lost to Follow-up|39|||
16410210|NCT01754194|39985391|FG001|Overall Study|Lost to Follow-up|14|||
16410211|NCT01754194|39985390|FG000|Overall Study|Withdrawal by Subject|4|||
16410212|NCT01754194|39985391|FG001|Overall Study|Withdrawal by Subject|5|||
16410213|NCT01754194|39985390|FG000|Overall Study|Other|9|||
16410214|NCT01754194|39985391|FG001|Overall Study|Other|8|||
16410215|NCT04962230|39985392|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
16410216|NCT04962230|39985392|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
16410217|NCT01479595|39985399|FG000|Overall Study|Protocol deviation|0|||
16410218|NCT01479595|39985400|FG001|Overall Study|Protocol deviation|1|||
16410219|NCT01479595|39985399|FG000|Overall Study|Adverse Event|2|||
16410220|NCT01479595|39985400|FG001|Overall Study|Adverse Event|1|||
16410221|NCT01636713|39985404|FG000|Overall Study|Adverse Event|16|||
16546940|NCT04207840|40465016|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
16546941|NCT04207840|40465017|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
16546942|NCT04207840|40465018|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
16546943|NCT04207840|40465016|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
16546944|NCT04207840|40465017|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
16546945|NCT04207840|40465018|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
16546946|NCT00263328|40465019|FG000|Overall Study|Death|0|||
16546947|NCT00263328|40465020|FG001|Overall Study|Death|0|||
16546948|NCT00263328|40465021|FG002|Overall Study|Death|1|||
16546949|NCT00263328|40465019|FG000|Overall Study|Lost to Follow-up|1|||
16546950|NCT00263328|40465020|FG001|Overall Study|Lost to Follow-up|1|||
16546951|NCT00263328|40465021|FG002|Overall Study|Lost to Follow-up|0|||
16546952|NCT00263328|40465019|FG000|Overall Study|Withdrawal by Subject|3|||
16546953|NCT00263328|40465020|FG001|Overall Study|Withdrawal by Subject|0|||
16546954|NCT00263328|40465021|FG002|Overall Study|Withdrawal by Subject|1|||
16546955|NCT00263328|40465019|FG000|Overall Study|Other|3|||
16546956|NCT00263328|40465020|FG001|Overall Study|Other|0|||
16546957|NCT00263328|40465021|FG002|Overall Study|Other|1|||
16546958|NCT00263328|40465019|FG000|Overall Study|Adverse Event|1|||
16546959|NCT00263328|40465020|FG001|Overall Study|Adverse Event|1|||
16546960|NCT00263328|40465021|FG002|Overall Study|Adverse Event|4|||
16546961|NCT05076149|40465022|FG000|Overall Study|Adverse Event|3|||
16546962|NCT05076149|40465023|FG001|Overall Study|Adverse Event|9|||
16546963|NCT05076149|40465022|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
16546964|NCT05076149|40465023|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
16546965|NCT05076149|40465022|FG000|Overall Study|Lost to Follow-up|0|||
16546966|NCT05076149|40465023|FG001|Overall Study|Lost to Follow-up|1|||
16546967|NCT05076149|40465022|FG000|Overall Study|Commercial drug is available for participant|0|||
16546968|NCT05076149|40465023|FG001|Overall Study|Commercial drug is available for participant|1|||
16546969|NCT05076149|40465022|FG000|Overall Study|Other non compliance|1|||
16546970|NCT05076149|40465023|FG001|Overall Study|Other non compliance|1|||
16546971|NCT05076149|40465022|FG000|Overall Study|Physician Decision|0|||
16546972|NCT05076149|40465023|FG001|Overall Study|Physician Decision|1|||
16546973|NCT05076149|40465022|FG000|Overall Study|Other|5|||
16546974|NCT05076149|40465023|FG001|Overall Study|Other|4|||
16546975|NCT01106430|40465024|FG000|Overall Study|Adverse Event|8|||
16546976|NCT01106430|40465025|FG001|Overall Study|Adverse Event|10|||
16546977|NCT01106430|40465024|FG000|Overall Study|Lack of Efficacy|2|||
16410222|NCT01636713|39985405|FG001|Overall Study|Adverse Event|16|||
16410223|NCT01636713|39985406|FG002|Overall Study|Adverse Event|7|||
16410224|NCT01636713|39985404|FG000|Overall Study|Lack of Efficacy|6|||
16410225|NCT01636713|39985405|FG001|Overall Study|Lack of Efficacy|6|||
16546978|NCT01106430|40465025|FG001|Overall Study|Lack of Efficacy|13|||
16546979|NCT01106430|40465024|FG000|Overall Study|Lost to Follow-up|5|||
16546980|NCT01106430|40465025|FG001|Overall Study|Lost to Follow-up|1|||
16410226|NCT01636713|39985406|FG002|Overall Study|Lack of Efficacy|2|||
16410227|NCT01636713|39985404|FG000|Overall Study|Protocol Violation|3|||
16410228|NCT01636713|39985405|FG001|Overall Study|Protocol Violation|0|||
16546981|NCT01106430|40465024|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
16546982|NCT01106430|40465025|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
16410229|NCT01636713|39985406|FG002|Overall Study|Protocol Violation|1|||
16410230|NCT01636713|39985404|FG000|Overall Study|Lost to Follow-up|0|||
16346678|NCT03786380|39757236|FG000|Overall Study|Physician Decision|0|||
16410231|NCT01636713|39985405|FG001|Overall Study|Lost to Follow-up|0|||
16410232|NCT01636713|39985406|FG002|Overall Study|Lost to Follow-up|1|||
16410233|NCT01636713|39985404|FG000|Overall Study|Withdrawal by Subject|5|||
16410234|NCT01636713|39985405|FG001|Overall Study|Withdrawal by Subject|4|||
16410235|NCT01636713|39985406|FG002|Overall Study|Withdrawal by Subject|8|||
16410236|NCT01636713|39985404|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
16410237|NCT01636713|39985405|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
16410238|NCT01636713|39985406|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
16410239|NCT02743780|39985407|FG000|Part 3 (7 Days)|Adverse Event|0|||
16410240|NCT02743780|39985408|FG001|Part 3 (7 Days)|Adverse Event|0|||
16410241|NCT02743780|39985409|FG002|Part 3 (7 Days)|Adverse Event|1|||
16410242|NCT02743780|39985410|FG003|Part 3 (7 Days)|Adverse Event|0|||
16410243|NCT02743780|39985411|FG004|Part 3 (7 Days)|Adverse Event|0|||
16410244|NCT02788201|39985416|FG000|Overall Study|Death|1|||
16410245|NCT02788201|39985417|FG001|Overall Study|Death|1|||
16410246|NCT02788201|39985418|FG002|Overall Study|Death|1|||
16410247|NCT02788201|39985419|FG003|Overall Study|Death|1|||
16410248|NCT02788201|39985420|FG004|Overall Study|Death|0|||
16346679|NCT03786380|39757237|FG001|Overall Study|Physician Decision|0|||
16346680|NCT03786380|39757238|FG002|Overall Study|Physician Decision|1|||
16410249|NCT02788201|39985421|FG005|Overall Study|Death|1|||
16410250|NCT02788201|39985416|FG000|Overall Study|Ineligible|0|||
16410251|NCT02788201|39985417|FG001|Overall Study|Ineligible|0|||
16410252|NCT02788201|39985418|FG002|Overall Study|Ineligible|0|||
16410253|NCT02788201|39985419|FG003|Overall Study|Ineligible|0|||
16410254|NCT02788201|39985420|FG004|Overall Study|Ineligible|0|||
16410255|NCT02788201|39985421|FG005|Overall Study|Ineligible|1|||
16410256|NCT02788201|39985416|FG000|Overall Study|Withdrawal by Subject|0|||
16410257|NCT02788201|39985417|FG001|Overall Study|Withdrawal by Subject|0|||
16410258|NCT02788201|39985418|FG002|Overall Study|Withdrawal by Subject|0|||
16410259|NCT02788201|39985419|FG003|Overall Study|Withdrawal by Subject|0|||
16410260|NCT02788201|39985420|FG004|Overall Study|Withdrawal by Subject|0|||
16410261|NCT02788201|39985421|FG005|Overall Study|Withdrawal by Subject|1|||
16546983|NCT01106430|40465024|FG000|Overall Study|Moved Out Of State|0|||
16546984|NCT01106430|40465025|FG001|Overall Study|Moved Out Of State|1|||
16546985|NCT01106430|40465024|FG000|Overall Study|Refused To Take Medication|0|||
16546986|NCT01106430|40465025|FG001|Overall Study|Refused To Take Medication|1|||
16546987|NCT01106430|40465024|FG000|Overall Study|Noncompliance|0|||
16546988|NCT01106430|40465025|FG001|Overall Study|Noncompliance|1|||
16546989|NCT01106430|40465024|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
16546990|NCT01106430|40465025|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
16546991|NCT01106430|40465024|FG000|Overall Study|Previous Use Of Marijuana|1|||
16346681|NCT03786380|39757239|FG003|Overall Study|Physician Decision|0|||
16410262|NCT02677844|39985422|FG000|Period 3|Withdrawal by Subject|0|||
16346682|NCT03786380|39757240|FG004|Overall Study|Physician Decision|0|||
16346683|NCT03786380|39757236|FG000|Overall Study|Study Terminated by the Sponsor|30|||
16346684|NCT03786380|39757237|FG001|Overall Study|Study Terminated by the Sponsor|20|||
16410263|NCT02677844|39985423|FG001|Period 3|Withdrawal by Subject|0|||
16410264|NCT02677844|39985424|FG002|Period 3|Withdrawal by Subject|0|||
16410265|NCT02677844|39985425|FG003|Period 3|Withdrawal by Subject|1|||
16410266|NCT02677844|39985426|FG004|Period 3|Withdrawal by Subject|0|||
16346685|NCT03786380|39757238|FG002|Overall Study|Study Terminated by the Sponsor|50|||
16346686|NCT03786380|39757239|FG003|Overall Study|Study Terminated by the Sponsor|57|||
16410267|NCT02677844|39985427|FG005|Period 3|Withdrawal by Subject|0|||
16410268|NCT02677844|39985428|FG006|Period 3|Withdrawal by Subject|0|||
16410269|NCT00493636|39985429|FG000|Overall Study|Withdrawal by Subject|1|||
16410270|NCT00493636|39985430|FG001|Overall Study|Withdrawal by Subject|0|||
16410271|NCT00493636|39985429|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
16410272|NCT00493636|39985430|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
16546992|NCT01106430|40465025|FG001|Overall Study|Previous Use Of Marijuana|0|||
16113441|NCT00250432|38905892|FG000|Overall Study|Patient Moved|0|||
16410273|NCT00493636|39985429|FG000|Overall Study|Mis-randomization|1|||
16410274|NCT00493636|39985430|FG001|Overall Study|Mis-randomization|1|||
16410275|NCT01287221|39985432|FG000|Overall Study|Lack of Perceived Benefit|1|||
16410276|NCT01287221|39985433|FG001|Overall Study|Lack of Perceived Benefit|1|||
16410277|NCT01287221|39985432|FG000|Overall Study|Adverse Event|3|||
16410278|NCT01287221|39985433|FG001|Overall Study|Adverse Event|3|||
16410279|NCT01287221|39985432|FG000|Overall Study|Withdrawal by Subject|0|||
16410280|NCT01287221|39985433|FG001|Overall Study|Withdrawal by Subject|1|||
16410281|NCT02961790|39985436|FG000|Overall Study|Canceled|4|||
16410282|NCT02961790|39985437|FG001|Overall Study|Canceled|5|||
16410283|NCT02961790|39985438|FG002|Overall Study|Canceled|1|||
16410284|NCT02961790|39985439|FG003|Overall Study|Canceled|4|||
16224586|NCT01711359|39302474|FG002|Treatment Period|Entry Criteria Not Met|0|||
16224587|NCT01711359|39302472|FG000|Treatment Period|Sponsor Decision|1|||
16224588|NCT01711359|39302473|FG001|Treatment Period|Sponsor Decision|0|||
16224589|NCT01711359|39302474|FG002|Treatment Period|Sponsor Decision|0|||
16224590|NCT01711359|39302472|FG000|Treatment Period|Lost to Follow-up|1|||
16224591|NCT01711359|39302473|FG001|Treatment Period|Lost to Follow-up|1|||
16224592|NCT01711359|39302474|FG002|Treatment Period|Lost to Follow-up|1|||
16224593|NCT01711359|39302472|FG000|Treatment Period|Randomized, Not Treated|3|||
16224594|NCT01711359|39302473|FG001|Treatment Period|Randomized, Not Treated|1|||
16224595|NCT01711359|39302474|FG002|Treatment Period|Randomized, Not Treated|0|||
16224596|NCT03172026|39302475|FG000|Overall Study|Withdrawal by Subject|1|||
16224597|NCT03172026|39302476|FG001|Overall Study|Withdrawal by Subject|0|||
16224598|NCT03172026|39302475|FG000|Overall Study|COVID restrictions|1|||
16224599|NCT03172026|39302476|FG001|Overall Study|COVID restrictions|0|||
16224600|NCT00699582|39302477|FG000|Overall Study|Adverse Event|4|||
16224601|NCT00699582|39302478|FG001|Overall Study|Adverse Event|11|||
16224602|NCT00699582|39302479|FG002|Overall Study|Adverse Event|23|||
16224603|NCT00699582|39302477|FG000|Overall Study|Withdrawal by Subject|6|||
16224604|NCT00699582|39302478|FG001|Overall Study|Withdrawal by Subject|7|||
16224605|NCT00699582|39302479|FG002|Overall Study|Withdrawal by Subject|4|||
16224606|NCT00699582|39302477|FG000|Overall Study|Lack of Efficacy|1|||
16224607|NCT00699582|39302478|FG001|Overall Study|Lack of Efficacy|0|||
16224608|NCT00699582|39302479|FG002|Overall Study|Lack of Efficacy|1|||
16224609|NCT00699582|39302477|FG000|Overall Study|Progressive Disease|1|||
16224610|NCT00699582|39302478|FG001|Overall Study|Progressive Disease|0|||
16224611|NCT00699582|39302479|FG002|Overall Study|Progressive Disease|0|||
16224612|NCT00699582|39302477|FG000|Overall Study|Administrative/Other|4|||
16224613|NCT00699582|39302478|FG001|Overall Study|Administrative/Other|3|||
16224614|NCT00699582|39302479|FG002|Overall Study|Administrative/Other|0|||
16224615|NCT00699582|39302477|FG000|Overall Study|Randomized, Not Treated|2|||
16224616|NCT00699582|39302478|FG001|Overall Study|Randomized, Not Treated|1|||
16224617|NCT00699582|39302479|FG002|Overall Study|Randomized, Not Treated|0|||
16224618|NCT00523744|39302480|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
16224619|NCT00523744|39302480|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
16224620|NCT00523744|39302480|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
16224621|NCT00523744|39302480|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
16224622|NCT00523744|39302480|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
16224623|NCT00523744|39302480|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
16224624|NCT01616173|39302481|FG000|Overall Study|Lost to Follow-up|0|||
16224625|NCT01616173|39302482|FG001|Overall Study|Lost to Follow-up|2|||
16224626|NCT01616173|39302483|FG002|Overall Study|Lost to Follow-up|0|||
16410285|NCT02961790|39985436|FG000|Overall Study|without baseline data|4|||
16410286|NCT02961790|39985437|FG001|Overall Study|without baseline data|0|||
16546993|NCT01106430|40465024|FG000|Overall Study|Protocol Violation|7|||
16546994|NCT01106430|40465025|FG001|Overall Study|Protocol Violation|2|||
16546995|NCT01106430|40465024|FG000|Overall Study|Withdrawal by Subject|8|||
16546996|NCT01106430|40465025|FG001|Overall Study|Withdrawal by Subject|4|||
16546997|NCT01889186|40465034|FG000|Overall Study|Adverse event- not related to progression|18|||
16546998|NCT01889186|40465035|FG001|Overall Study|Adverse event- not related to progression|5|||
16546999|NCT01889186|40465034|FG000|Overall Study|Adverse event- related to progression|7|||
16547000|NCT01889186|40465035|FG001|Overall Study|Adverse event- related to progression|2|||
16547001|NCT01889186|40465034|FG000|Overall Study|COVID-19 logistical restrictions|1|||
16547002|NCT01889186|40465035|FG001|Overall Study|COVID-19 logistical restrictions|0|||
16547003|NCT01889186|40465034|FG000|Overall Study|Investigator request|1|||
16547004|NCT01889186|40465035|FG001|Overall Study|Investigator request|1|||
16547005|NCT01889186|40465034|FG000|Overall Study|Progressive disease- Richter's|12|||
16547006|NCT01889186|40465035|FG001|Overall Study|Progressive disease- Richter's|7|||
16547007|NCT01889186|40465034|FG000|Overall Study|Progressive disease per protocol|46|||
16547008|NCT01889186|40465035|FG001|Overall Study|Progressive disease per protocol|17|||
16547009|NCT01889186|40465034|FG000|Overall Study|Stem cell transplant|2|||
16547010|NCT01889186|40465035|FG001|Overall Study|Stem cell transplant|1|||
16547011|NCT01889186|40465034|FG000|Overall Study|Withdrew consent|2|||
16547012|NCT01889186|40465035|FG001|Overall Study|Withdrew consent|3|||
16547013|NCT01889186|40465034|FG000|Overall Study|Other, not specified|18|||
16113442|NCT00250432|38905893|FG001|Overall Study|Patient Moved|1|||
16113443|NCT00250432|38905892|FG000|Overall Study|Protocol Violation|0|||
16113444|NCT00250432|38905893|FG001|Overall Study|Protocol Violation|3|||
16113445|NCT00250432|38905892|FG000|Overall Study|Withdrawal by Subject|6|||
16113446|NCT00250432|38905893|FG001|Overall Study|Withdrawal by Subject|2|||
16113447|NCT00250432|38905892|FG000|Overall Study|Pt died out of posttherapy report period|6|||
16113448|NCT00250432|38905893|FG001|Overall Study|Pt died out of posttherapy report period|5|||
16113449|NCT00250432|38905892|FG000|Overall Study|Pt was considered untreatable|0|||
16113450|NCT00250432|38905893|FG001|Overall Study|Pt was considered untreatable|1|||
16113451|NCT00943787|38905894|FG000|Overall Study|Physician Decision|4|||
16410287|NCT02961790|39985438|FG002|Overall Study|without baseline data|1|||
16410288|NCT02961790|39985439|FG003|Overall Study|without baseline data|0|||
16410289|NCT02961790|39985436|FG000|Overall Study|without post baseline data|7|||
16410290|NCT02961790|39985437|FG001|Overall Study|without post baseline data|6|||
16346687|NCT03786380|39757240|FG004|Overall Study|Study Terminated by the Sponsor|23|||
16346688|NCT03786380|39757236|FG000|Overall Study|Reason Not Specified|0|||
16346689|NCT03786380|39757237|FG001|Overall Study|Reason Not Specified|0|||
16346690|NCT03786380|39757238|FG002|Overall Study|Reason Not Specified|0|||
16346691|NCT03786380|39757239|FG003|Overall Study|Reason Not Specified|0|||
16346692|NCT03786380|39757240|FG004|Overall Study|Reason Not Specified|1|||
16346693|NCT04613518|39757241|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
16346694|NCT04613518|39757242|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
16346695|NCT04613518|39757243|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
16113452|NCT00943787|38905894|FG000|Overall Study|Withdrawal by Subject|3|||
16346696|NCT04613518|39757241|FG000|Double-Blind Treatment Period|Adverse Event|2|||
16113453|NCT03019640|38905898|FG000|Overall Study|Screen Failures|4|||
16410291|NCT02961790|39985438|FG002|Overall Study|without post baseline data|4|||
16346697|NCT04613518|39757242|FG001|Double-Blind Treatment Period|Adverse Event|0|||
16113454|NCT03019640|38905898|FG000|Overall Study|Adverse Event|3|||
16113455|NCT03019640|38905898|FG000|Overall Study|Participant Relapsed|1|||
16113456|NCT00412880|38905899|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
16113457|NCT00412880|38905899|FG000|Overall Study|Consent withdrawn|1|||
16113458|NCT00412880|38905899|FG000|Overall Study|Adverse Event|1|||
16113459|NCT00412880|38905899|FG000|Overall Study|Progressive disease|20|||
16113460|NCT00113269|38905900|FG000|Overall Study|Not transplanted, donor issues|4|||
16113461|NCT00113269|38905901|FG001|Overall Study|Not transplanted, donor issues|0|||
16113462|NCT00113269|38905902|FG002|Overall Study|Not transplanted, donor issues|2|||
16113463|NCT00113269|38905903|FG003|Overall Study|Not transplanted, donor issues|2|||
16113464|NCT00113269|38905900|FG000|Overall Study|Not transplanted, recipient issues|2|||
16113465|NCT00113269|38905901|FG001|Overall Study|Not transplanted, recipient issues|1|||
16113466|NCT00113269|38905902|FG002|Overall Study|Not transplanted, recipient issues|7|||
16113467|NCT00113269|38905903|FG003|Overall Study|Not transplanted, recipient issues|4|||
16113468|NCT00113269|38905900|FG000|Overall Study|Early graft loss, technical|0|||
16113469|NCT00113269|38905901|FG001|Overall Study|Early graft loss, technical|0|||
16113470|NCT00113269|38905902|FG002|Overall Study|Early graft loss, technical|2|||
16113471|NCT00113269|38905903|FG003|Overall Study|Early graft loss, technical|0|||
16113472|NCT00113269|38905900|FG000|Overall Study|Death in operating room|0|||
16113473|NCT00113269|38905901|FG001|Overall Study|Death in operating room|0|||
16113474|NCT00113269|38905902|FG002|Overall Study|Death in operating room|0|||
16113475|NCT00113269|38905903|FG003|Overall Study|Death in operating room|1|||
16113476|NCT00113269|38905900|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
16113477|NCT00113269|38905901|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
16113478|NCT00113269|38905902|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
16113479|NCT00113269|38905903|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
16113480|NCT00113269|38905900|FG000|Overall Study|Adverse Event|2|||
16113481|NCT00113269|38905901|FG001|Overall Study|Adverse Event|7|||
16113482|NCT00113269|38905902|FG002|Overall Study|Adverse Event|11|||
16113483|NCT00113269|38905903|FG003|Overall Study|Adverse Event|7|||
16113484|NCT00113269|38905900|FG000|Overall Study|Withdrawal by Subject|4|||
16113485|NCT00113269|38905901|FG001|Overall Study|Withdrawal by Subject|3|||
16113486|NCT00113269|38905902|FG002|Overall Study|Withdrawal by Subject|4|||
16113487|NCT00113269|38905903|FG003|Overall Study|Withdrawal by Subject|2|||
16113488|NCT00113269|38905900|FG000|Overall Study|Graft loss|6|||
16113489|NCT00113269|38905901|FG001|Overall Study|Graft loss|6|||
16113490|NCT00113269|38905902|FG002|Overall Study|Graft loss|4|||
16113491|NCT00113269|38905903|FG003|Overall Study|Graft loss|9|||
16113492|NCT00113269|38905900|FG000|Overall Study|Protocol Violation|1|||
16113493|NCT00113269|38905901|FG001|Overall Study|Protocol Violation|0|||
16113494|NCT00113269|38905902|FG002|Overall Study|Protocol Violation|4|||
16113495|NCT00113269|38905903|FG003|Overall Study|Protocol Violation|2|||
16113496|NCT00113269|38905900|FG000|Overall Study|Lost to Follow-up|2|||
16113497|NCT00113269|38905901|FG001|Overall Study|Lost to Follow-up|3|||
16113498|NCT00113269|38905902|FG002|Overall Study|Lost to Follow-up|6|||
16113499|NCT00113269|38905903|FG003|Overall Study|Lost to Follow-up|3|||
16113500|NCT00113269|38905900|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
16113501|NCT00113269|38905901|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
16113502|NCT00113269|38905902|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
16113503|NCT00113269|38905903|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
16113504|NCT00113269|38905900|FG000|Overall Study|Discontinued due to rejection|0|||
16113505|NCT00113269|38905901|FG001|Overall Study|Discontinued due to rejection|0|||
16113506|NCT00113269|38905902|FG002|Overall Study|Discontinued due to rejection|1|||
16113507|NCT00113269|38905903|FG003|Overall Study|Discontinued due to rejection|0|||
16224627|NCT03604159|39302487|FG000|Overall Study|Lost to Follow-up|6|||
16224628|NCT03604159|39302488|FG001|Overall Study|Lost to Follow-up|7|||
16224629|NCT02371980|39302489|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
16224630|NCT02371980|39302490|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
16224631|NCT02371980|39302491|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
16224632|NCT02371980|39302492|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
16224633|NCT02371980|39302493|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
16224634|NCT02371980|39302489|FG000|Open-label Period|Significant Protocol Deviation|19|||
16113508|NCT00113269|38905900|FG000|Overall Study|Moved|0|||
16113509|NCT00113269|38905901|FG001|Overall Study|Moved|1|||
16113510|NCT00113269|38905902|FG002|Overall Study|Moved|0|||
16113511|NCT00113269|38905903|FG003|Overall Study|Moved|3|||
16113512|NCT00113269|38905900|FG000|Overall Study|Received pancreas transplant|0|||
16113513|NCT00113269|38905901|FG001|Overall Study|Received pancreas transplant|0|||
16113514|NCT00113269|38905902|FG002|Overall Study|Received pancreas transplant|0|||
16113515|NCT00113269|38905903|FG003|Overall Study|Received pancreas transplant|2|||
16113516|NCT00113269|38905900|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
16113517|NCT00113269|38905901|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
16113518|NCT00113269|38905902|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
16224635|NCT02371980|39302490|FG001|Open-label Period|Significant Protocol Deviation|0|||
16224636|NCT02371980|39302491|FG002|Open-label Period|Significant Protocol Deviation|0|||
16224637|NCT02371980|39302492|FG003|Open-label Period|Significant Protocol Deviation|0|||
16113519|NCT00113269|38905903|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
16113520|NCT00113269|38905900|FG000|Overall Study|Did not meet eligibility criteria|1|||
16113521|NCT00113269|38905901|FG001|Overall Study|Did not meet eligibility criteria|0|||
16113522|NCT00113269|38905902|FG002|Overall Study|Did not meet eligibility criteria|0|||
16113523|NCT00113269|38905903|FG003|Overall Study|Did not meet eligibility criteria|1|||
16113524|NCT00113269|38905900|FG000|Overall Study|Unable to return for follow up|2|||
16113525|NCT00113269|38905901|FG001|Overall Study|Unable to return for follow up|1|||
16113526|NCT00113269|38905902|FG002|Overall Study|Unable to return for follow up|0|||
16113527|NCT00113269|38905903|FG003|Overall Study|Unable to return for follow up|0|||
16113528|NCT01080300|38905904|FG000|Overall Study|Adverse Event|49|||
16113529|NCT01080300|38905905|FG001|Overall Study|Adverse Event|35|||
16113530|NCT01080300|38905904|FG000|Overall Study|Lack of Efficacy|12|||
16113531|NCT01080300|38905905|FG001|Overall Study|Lack of Efficacy|15|||
16113532|NCT01080300|38905904|FG000|Overall Study|Protocol Violation|7|||
16113533|NCT01080300|38905905|FG001|Overall Study|Protocol Violation|13|||
16113534|NCT01080300|38905904|FG000|Overall Study|Lost to Follow-up|10|||
16113535|NCT01080300|38905905|FG001|Overall Study|Lost to Follow-up|6|||
16113536|NCT01080300|38905904|FG000|Overall Study|Death|0|||
16113537|NCT01080300|38905905|FG001|Overall Study|Death|1|||
16113538|NCT01080300|38905904|FG000|Overall Study|Withdrawal by Subject|12|||
16113539|NCT01080300|38905905|FG001|Overall Study|Withdrawal by Subject|28|||
16113540|NCT01080300|38905904|FG000|Overall Study|Reasons not specified|4|||
16113541|NCT01080300|38905905|FG001|Overall Study|Reasons not specified|6|||
16113542|NCT00916305|38905907|FG000|Overall Study|Lost to Follow-up|21|||
16113543|NCT00916305|38905908|FG001|Overall Study|Lost to Follow-up|27|||
16113544|NCT00916305|38905907|FG000|Overall Study|Withdrawal by Subject|0|||
16113545|NCT00916305|38905908|FG001|Overall Study|Withdrawal by Subject|1|||
16113546|NCT03334253|38905911|FG000|Overall Study|Withdrawal by Subject|1|||
16113547|NCT03334253|38905912|FG001|Overall Study|Withdrawal by Subject|0|||
16113548|NCT03334253|38905911|FG000|Overall Study|Lost to Follow-up|4|||
16113549|NCT03334253|38905912|FG001|Overall Study|Lost to Follow-up|3|||
16113550|NCT03334253|38905911|FG000|Overall Study|Moved residence|2|||
16113551|NCT03334253|38905912|FG001|Overall Study|Moved residence|2|||
16113552|NCT00706654|38905913|FG000|Conversion Phase|Lost to Follow-up|4|||
16113553|NCT00706654|38905914|FG001|Conversion Phase|Lost to Follow-up|0|||
16113554|NCT00706654|38905915|FG002|Conversion Phase|Lost to Follow-up|0|||
16113555|NCT00706654|38905916|FG003|Conversion Phase|Lost to Follow-up|0|||
16113556|NCT00706654|38905913|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
16113557|NCT00706654|38905914|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
16113558|NCT00706654|38905915|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
16113559|NCT00706654|38905916|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
16113560|NCT00706654|38905913|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
16113561|NCT00706654|38905914|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
16113562|NCT00706654|38905915|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
16113563|NCT00706654|38905916|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
16113564|NCT00706654|38905913|FG000|Conversion Phase|Withdrawn by Investigator|14|||
16113565|NCT00706654|38905914|FG001|Conversion Phase|Withdrawn by Investigator|0|||
16113566|NCT00706654|38905915|FG002|Conversion Phase|Withdrawn by Investigator|0|||
16113567|NCT00706654|38905916|FG003|Conversion Phase|Withdrawn by Investigator|0|||
16113568|NCT00706654|38905913|FG000|Conversion Phase|Withdrew Consent|38|||
16113569|NCT00706654|38905914|FG001|Conversion Phase|Withdrew Consent|0|||
16113570|NCT00706654|38905915|FG002|Conversion Phase|Withdrew Consent|0|||
16113571|NCT00706654|38905916|FG003|Conversion Phase|Withdrew Consent|0|||
16113572|NCT00706654|38905913|FG000|Conversion Phase|Adverse Event|18|||
16113573|NCT00706654|38905914|FG001|Conversion Phase|Adverse Event|0|||
16113574|NCT00706654|38905915|FG002|Conversion Phase|Adverse Event|0|||
16113575|NCT00706654|38905916|FG003|Conversion Phase|Adverse Event|0|||
16113576|NCT00706654|38905913|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
16113577|NCT00706654|38905914|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
16113578|NCT00706654|38905915|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
16113579|NCT00706654|38905916|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
16113580|NCT00706654|38905913|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
16113581|NCT00706654|38905914|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
16113582|NCT00706654|38905915|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
16113583|NCT00706654|38905916|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
16113584|NCT00706654|38905913|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
16113585|NCT00706654|38905914|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
16113586|NCT00706654|38905915|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
16113587|NCT00706654|38905916|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
16113588|NCT00706654|38905913|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
16224638|NCT02371980|39302493|FG004|Open-label Period|Significant Protocol Deviation|0|||
16113589|NCT00706654|38905914|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
16113590|NCT00706654|38905915|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
16113591|NCT00706654|38905916|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
16113592|NCT00706654|38905913|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
16113593|NCT00706654|38905914|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
16113594|NCT00706654|38905915|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
16113595|NCT00706654|38905916|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
16113596|NCT00706654|38905913|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
16113597|NCT00706654|38905914|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
16113598|NCT00706654|38905915|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
16113599|NCT00706654|38905916|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
16113600|NCT00706654|38905913|FG000|Oral Stabilization Phase|Withdrew consent|55|||
16113601|NCT00706654|38905914|FG001|Oral Stabilization Phase|Withdrew consent|0|||
16113602|NCT00706654|38905915|FG002|Oral Stabilization Phase|Withdrew consent|0|||
16113603|NCT00706654|38905916|FG003|Oral Stabilization Phase|Withdrew consent|0|||
16113604|NCT00706654|38905913|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
16113605|NCT00706654|38905914|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
16113606|NCT00706654|38905915|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
16113607|NCT00706654|38905916|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
16113608|NCT00706654|38905913|FG000|Oral Stabilization Phase|Adverse Event|21|||
16113609|NCT00706654|38905914|FG001|Oral Stabilization Phase|Adverse Event|0|||
16113610|NCT00706654|38905915|FG002|Oral Stabilization Phase|Adverse Event|0|||
16113611|NCT00706654|38905916|FG003|Oral Stabilization Phase|Adverse Event|0|||
16113612|NCT00706654|38905913|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
16113613|NCT00706654|38905914|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
16113614|NCT00706654|38905915|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
16113615|NCT00706654|38905916|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
16113616|NCT00706654|38905913|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
16113617|NCT00706654|38905914|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
16113618|NCT00706654|38905915|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
16113619|NCT00706654|38905916|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
16113620|NCT00706654|38905913|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
16113621|NCT00706654|38905914|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
16113622|NCT00706654|38905915|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
16113623|NCT00706654|38905916|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
16113624|NCT00706654|38905913|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
16113625|NCT00706654|38905914|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
16113626|NCT00706654|38905915|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
16113627|NCT00706654|38905916|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
16113628|NCT00706654|38905913|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
16113629|NCT00706654|38905914|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
16113630|NCT00706654|38905915|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
16113631|NCT00706654|38905916|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
16113632|NCT00706654|38905913|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
16113633|NCT00706654|38905914|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
16113634|NCT00706654|38905915|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
16113635|NCT00706654|38905916|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
16113636|NCT00706654|38905913|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
16113637|NCT00706654|38905914|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
16113638|NCT00706654|38905915|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
16113639|NCT00706654|38905916|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
16113640|NCT00706654|38905913|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
16113641|NCT00706654|38905914|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
16113642|NCT00706654|38905915|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
16113643|NCT00706654|38905916|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
16113644|NCT00706654|38905913|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
16113645|NCT00706654|38905914|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
16113646|NCT00706654|38905915|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
16113647|NCT00706654|38905916|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
16113648|NCT00706654|38905913|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
16113649|NCT00706654|38905914|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
16113650|NCT00706654|38905915|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
16113651|NCT00706654|38905916|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
16113652|NCT00543062|38905917|FG000|Overall Study|Withdrawal by Subject|1|||
16113653|NCT00543062|38905918|FG001|Overall Study|Withdrawal by Subject|0|||
16113654|NCT00543062|38905919|FG002|Overall Study|Withdrawal by Subject|2|||
16113655|NCT00543062|38905920|FG003|Overall Study|Withdrawal by Subject|0|||
16113656|NCT00543062|38905917|FG000|Overall Study|Adverse Event|0|||
16113657|NCT00543062|38905918|FG001|Overall Study|Adverse Event|1|||
16113658|NCT00543062|38905919|FG002|Overall Study|Adverse Event|1|||
16113659|NCT00543062|38905920|FG003|Overall Study|Adverse Event|1|||
16113660|NCT00543062|38905917|FG000|Overall Study|Protocol Violation|1|||
16113661|NCT00543062|38905918|FG001|Overall Study|Protocol Violation|0|||
16113662|NCT00543062|38905919|FG002|Overall Study|Protocol Violation|0|||
16113663|NCT00543062|38905920|FG003|Overall Study|Protocol Violation|0|||
16113664|NCT00848484|38905922|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
16113665|NCT00848484|38905923|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
16113666|NCT00848484|38905922|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
16113667|NCT00848484|38905923|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
16113668|NCT00848484|38905922|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
16113669|NCT00848484|38905923|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
16113670|NCT00848484|38905922|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
16113671|NCT00848484|38905923|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
16113672|NCT00848484|38905922|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
16113673|NCT00848484|38905923|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
16113674|NCT04594733|38905924|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
16113675|NCT04594733|38905925|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
16113676|NCT04594733|38905924|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
16113677|NCT04594733|38905925|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
16113678|NCT04594733|38905924|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
16113679|NCT04594733|38905925|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
16113680|NCT00350727|38905930|FG000|Phase I: Dose Escalation|Adverse Event|4|||
16113681|NCT00350727|38905931|FG001|Phase I: Dose Escalation|Adverse Event|0|||
16113682|NCT00350727|38905932|FG002|Phase I: Dose Escalation|Adverse Event|0|||
16113683|NCT00350727|38905930|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
16113684|NCT00350727|38905931|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
16113685|NCT00350727|38905932|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
16113686|NCT00350727|38905930|FG000|Phase I: Dose Escalation|Death|1|||
16113687|NCT00350727|38905931|FG001|Phase I: Dose Escalation|Death|0|||
16113688|NCT00350727|38905932|FG002|Phase I: Dose Escalation|Death|0|||
16113689|NCT00350727|38905930|FG000|Phase I: Dose Escalation|Physician Decision|1|||
16113690|NCT00350727|38905931|FG001|Phase I: Dose Escalation|Physician Decision|0|||
16113691|NCT00350727|38905932|FG002|Phase I: Dose Escalation|Physician Decision|0|||
16113692|NCT00350727|38905930|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
16113693|NCT00350727|38905931|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
16113694|NCT00350727|38905932|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
16113695|NCT00350727|38905930|FG000|Phase II|Disease Progression|0|||
16113696|NCT00350727|38905931|FG001|Phase II|Disease Progression|15|||
16113697|NCT00350727|38905932|FG002|Phase II|Disease Progression|16|||
16113698|NCT00350727|38905930|FG000|Phase II|Clinical Deterioration|0|||
16113699|NCT00350727|38905931|FG001|Phase II|Clinical Deterioration|1|||
16113700|NCT00350727|38905932|FG002|Phase II|Clinical Deterioration|0|||
16113701|NCT00350727|38905930|FG000|Phase II|Withdrawal by Subject|0|||
16113702|NCT00350727|38905931|FG001|Phase II|Withdrawal by Subject|2|||
16113703|NCT00350727|38905932|FG002|Phase II|Withdrawal by Subject|1|||
16113704|NCT00350727|38905930|FG000|Phase II|Adverse Event|0|||
16113705|NCT00350727|38905931|FG001|Phase II|Adverse Event|1|||
16113706|NCT00350727|38905932|FG002|Phase II|Adverse Event|1|||
16113707|NCT00350727|38905930|FG000|Phase II|Death|0|||
16113708|NCT00350727|38905931|FG001|Phase II|Death|0|||
16113709|NCT00350727|38905932|FG002|Phase II|Death|2|||
16113710|NCT00350727|38905930|FG000|Phase II|Sponsor Terminated Study|0|||
16113711|NCT00350727|38905931|FG001|Phase II|Sponsor Terminated Study|0|||
16346698|NCT04613518|39757243|FG002|Double-Blind Treatment Period|Adverse Event|1|||
16346699|NCT04613518|39757241|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
16346700|NCT04613518|39757242|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
16346701|NCT04613518|39757243|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
16346702|NCT04613518|39757241|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
16346703|NCT04613518|39757242|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
16346704|NCT04613518|39757243|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
16346705|NCT04613518|39757241|FG000|Double-Blind Treatment Period|Other Reasons|2|||
16346706|NCT04613518|39757242|FG001|Double-Blind Treatment Period|Other Reasons|0|||
16346707|NCT04613518|39757243|FG002|Double-Blind Treatment Period|Other Reasons|0|||
16346708|NCT04613518|39757241|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
16346709|NCT04613518|39757242|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
16410292|NCT02961790|39985439|FG003|Overall Study|without post baseline data|1|||
16410293|NCT00054691|39985444|FG000|Overall Study|Unmeasurable Disease|2|||
16410294|NCT00054691|39985444|FG000|Overall Study|Noncompliant|1|||
16410295|NCT00357656|39985448|FG000|Overall Study|Other, No surgery performed|0|||
16113712|NCT00350727|38905932|FG002|Phase II|Sponsor Terminated Study|1|||
16113713|NCT00350727|38905930|FG000|Phase II|Enrolled in Rollover Study|0|||
16113714|NCT00350727|38905931|FG001|Phase II|Enrolled in Rollover Study|0|||
16113715|NCT00350727|38905932|FG002|Phase II|Enrolled in Rollover Study|1|||
16346710|NCT04613518|39757243|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
16346711|NCT04613518|39757241|FG000|Open-Label Treatment Period|Adverse Event|1|||
16346712|NCT04613518|39757242|FG001|Open-Label Treatment Period|Adverse Event|0|||
16346713|NCT04613518|39757243|FG002|Open-Label Treatment Period|Adverse Event|3|||
16346714|NCT04613518|39757241|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
16346715|NCT04613518|39757242|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
16346716|NCT04613518|39757243|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
16346717|NCT04613518|39757241|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
16346718|NCT04613518|39757242|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
16346719|NCT04613518|39757243|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
16346720|NCT04613518|39757241|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
16346721|NCT04613518|39757242|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
16346722|NCT04613518|39757243|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
16346723|NCT04613518|39757241|FG000|Open-Label Treatment Period|Other reasons|1|||
16346724|NCT04613518|39757242|FG001|Open-Label Treatment Period|Other reasons|0|||
16346725|NCT04613518|39757243|FG002|Open-Label Treatment Period|Other reasons|0|||
16346726|NCT03382418|39757244|FG000|Overall Study|Withdrawal by Subject|1|||
16346727|NCT03382418|39757245|FG001|Overall Study|Withdrawal by Subject|0|||
16346728|NCT03382418|39757246|FG002|Overall Study|Withdrawal by Subject|0|||
16346729|NCT03382418|39757244|FG000|Overall Study|Lost to Follow-up|2|||
16346730|NCT03382418|39757245|FG001|Overall Study|Lost to Follow-up|3|||
16346731|NCT03382418|39757246|FG002|Overall Study|Lost to Follow-up|0|||
16346732|NCT00412932|39757247|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
16346733|NCT00412932|39757247|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
16346734|NCT00412932|39757247|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
16346735|NCT00412932|39757247|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
16346736|NCT00412932|39757247|FG000|Olmesartan (Olm) 20 mg|Other|1|||
16346737|NCT00412932|39757247|FG000|Olmesartan 40 mg|Adverse Event|4|||
16346738|NCT00412932|39757247|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
16346739|NCT00412932|39757247|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
16346740|NCT00412932|39757247|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
16346741|NCT00412932|39757247|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
16346742|NCT00412932|39757247|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
16346743|NCT00412932|39757247|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
16346744|NCT00715299|39757248|FG000|Overall Study|Withdrawal by Subject|1|||
16346745|NCT00715299|39757248|FG000|Overall Study|Adverse Event|3|||
16346746|NCT00715299|39757248|FG000|Overall Study|failed the pre-screen exercise test|2|||
16346747|NCT00463801|39757253|FG000|Overall Study|Protocol Violation|1|||
16346748|NCT00463801|39757253|FG000|Overall Study|Lack of Efficacy|2|||
16410296|NCT00357656|39985449|FG001|Overall Study|Other, No surgery performed|3|||
16410297|NCT03461406|39985450|FG000|Overall Study|Death|1|||
16410298|NCT03461406|39985451|FG001|Overall Study|Death|2|||
16410299|NCT03461406|39985450|FG000|Overall Study|Consent Withdrawn by Participant|0|||
16410300|NCT03461406|39985451|FG001|Overall Study|Consent Withdrawn by Participant|1|||
16410301|NCT03461406|39985450|FG000|Overall Study|Screen Failure|3|||
16410302|NCT03461406|39985451|FG001|Overall Study|Screen Failure|1|||
16410303|NCT03461406|39985450|FG000|Overall Study|Reason not Specified|1|||
16410304|NCT03461406|39985451|FG001|Overall Study|Reason not Specified|3|||
16410305|NCT03461406|39985450|FG000|Overall Study|Lost to Follow-up|3|||
16410306|NCT03461406|39985451|FG001|Overall Study|Lost to Follow-up|0|||
16410307|NCT01632241|39985452|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
16410308|NCT01632241|39985453|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
16410309|NCT01632241|39985452|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
16410310|NCT01632241|39985453|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
16410311|NCT01632241|39985452|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
16410312|NCT01632241|39985453|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
16410313|NCT01632241|39985452|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
16410314|NCT01632241|39985453|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
16113716|NCT01840410|38905935|FG000|Overall Study|Physician Decision|1|||
16113717|NCT01840410|38905936|FG001|Overall Study|Physician Decision|2|||
16113718|NCT01840410|38905935|FG000|Overall Study|Pregnancy|1|||
16113719|NCT01840410|38905936|FG001|Overall Study|Pregnancy|0|||
16113720|NCT01840410|38905935|FG000|Overall Study|Protocol deviation|1|||
16113721|NCT01840410|38905936|FG001|Overall Study|Protocol deviation|0|||
16113722|NCT01840410|38905935|FG000|Overall Study|Lost to Follow-up|1|||
16113723|NCT01840410|38905936|FG001|Overall Study|Lost to Follow-up|0|||
16113724|NCT01840410|38905935|FG000|Overall Study|Withdrawal by Subject|2|||
16113725|NCT01840410|38905936|FG001|Overall Study|Withdrawal by Subject|1|||
16113726|NCT01840410|38905935|FG000|Overall Study|Adverse Event|1|||
16113727|NCT01840410|38905936|FG001|Overall Study|Adverse Event|1|||
16113728|NCT02138786|38905937|FG000|Overall Study|Adverse Event|0|||
16113729|NCT02138786|38905938|FG001|Overall Study|Adverse Event|2|||
16113730|NCT02138786|38905939|FG002|Overall Study|Adverse Event|1|||
16113731|NCT02138786|38905937|FG000|Overall Study|Death|1|||
16113732|NCT02138786|38905938|FG001|Overall Study|Death|7|||
16113733|NCT02138786|38905939|FG002|Overall Study|Death|2|||
16113734|NCT02138786|38905937|FG000|Overall Study|Disease Progression|1|||
16113735|NCT02138786|38905938|FG001|Overall Study|Disease Progression|1|||
16113736|NCT02138786|38905939|FG002|Overall Study|Disease Progression|3|||
16113737|NCT02138786|38905937|FG000|Overall Study|Withdrawal by Subject|1|||
16113738|NCT02138786|38905938|FG001|Overall Study|Withdrawal by Subject|2|||
16113739|NCT02138786|38905939|FG002|Overall Study|Withdrawal by Subject|0|||
16113740|NCT02138786|38905937|FG000|Overall Study|Patient's Wish|0|||
16113741|NCT02138786|38905938|FG001|Overall Study|Patient's Wish|2|||
16113742|NCT02138786|38905939|FG002|Overall Study|Patient's Wish|0|||
16113743|NCT02138786|38905937|FG000|Overall Study|Sponsor Terminated Study|0|||
16113744|NCT02138786|38905938|FG001|Overall Study|Sponsor Terminated Study|1|||
16113745|NCT02138786|38905939|FG002|Overall Study|Sponsor Terminated Study|1|||
16113746|NCT02138786|38905937|FG000|Overall Study|Non-Compliance|0|||
16113747|NCT02138786|38905938|FG001|Overall Study|Non-Compliance|0|||
16113748|NCT02138786|38905939|FG002|Overall Study|Non-Compliance|1|||
16113749|NCT01327846|38905940|FG000|Core Phase|Subject decision (vital status: missing)|1|||
16113750|NCT01327846|38905941|FG001|Core Phase|Subject decision (vital status: missing)|2|||
16113751|NCT01327846|38905942|FG002|Core Phase|Subject decision (vital status: missing)|2|||
16113752|NCT01327846|38905943|FG003|Core Phase|Subject decision (vital status: missing)|1|||
16113753|NCT01327846|38905940|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
16113754|NCT01327846|38905941|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
16113755|NCT01327846|38905942|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
16113756|NCT01327846|38905943|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
16113757|NCT01327846|38905940|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
16113758|NCT01327846|38905941|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
16113759|NCT01327846|38905942|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
16113760|NCT01327846|38905943|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
16113761|NCT01327846|38905940|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
16113762|NCT01327846|38905941|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
16113763|NCT01327846|38905942|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
16113764|NCT01327846|38905943|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
16113765|NCT01327846|38905940|FG000|Core Phase|Lost to Follow-up|3|||
16113766|NCT01327846|38905941|FG001|Core Phase|Lost to Follow-up|3|||
16113767|NCT01327846|38905942|FG002|Core Phase|Lost to Follow-up|4|||
16113768|NCT01327846|38905943|FG003|Core Phase|Lost to Follow-up|5|||
16113769|NCT01327846|38905940|FG000|Extension Phase|Study terminated by sponsor|1073|||
16113770|NCT01327846|38905941|FG001|Extension Phase|Study terminated by sponsor|1124|||
16113771|NCT01327846|38905942|FG002|Extension Phase|Study terminated by sponsor|1067|||
16113772|NCT01327846|38905943|FG003|Extension Phase|Study terminated by sponsor|1660|||
16113773|NCT01327846|38905940|FG000|Extension Phase|Withdrawal by Subject|20|||
16113774|NCT01327846|38905941|FG001|Extension Phase|Withdrawal by Subject|13|||
16113775|NCT01327846|38905942|FG002|Extension Phase|Withdrawal by Subject|19|||
16113776|NCT01327846|38905943|FG003|Extension Phase|Withdrawal by Subject|37|||
16113777|NCT01327846|38905940|FG000|Extension Phase|Lost to Follow-up|4|||
16113778|NCT01327846|38905941|FG001|Extension Phase|Lost to Follow-up|3|||
16113779|NCT01327846|38905942|FG002|Extension Phase|Lost to Follow-up|4|||
16113780|NCT01327846|38905943|FG003|Extension Phase|Lost to Follow-up|7|||
16113781|NCT01327846|38905940|FG000|Extension Phase|Technical Problems|2|||
16113782|NCT01327846|38905941|FG001|Extension Phase|Technical Problems|4|||
16113783|NCT01327846|38905942|FG002|Extension Phase|Technical Problems|2|||
16113784|NCT01327846|38905943|FG003|Extension Phase|Technical Problems|2|||
16113785|NCT01888874|38905944|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
16113786|NCT01888874|38905945|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
16113787|NCT01888874|38905946|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
16113788|NCT01888874|38905947|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
16113789|NCT01888874|38905948|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
16224639|NCT02371980|39302489|FG000|Open-label Period|Noncompliance with Study Drug|10|||
16113790|NCT01888874|38905949|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
16113791|NCT01888874|38905950|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
16113792|NCT01888874|38905944|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
16113793|NCT01888874|38905945|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
16113794|NCT01888874|38905946|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
16113795|NCT01888874|38905947|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
16113796|NCT01888874|38905948|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
16113797|NCT01888874|38905949|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
16113798|NCT01888874|38905950|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
16113799|NCT01888874|38905944|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16113800|NCT01888874|38905945|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16113801|NCT01888874|38905946|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16113802|NCT01888874|38905947|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16113803|NCT01888874|38905948|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16113804|NCT01888874|38905949|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
16113805|NCT01888874|38905950|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
16113806|NCT01888874|38905944|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
16113807|NCT01888874|38905945|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
16113808|NCT01888874|38905946|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
16113809|NCT01888874|38905947|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
16113810|NCT01888874|38905948|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
16113811|NCT01888874|38905949|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
16113812|NCT01888874|38905950|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
16113813|NCT01888874|38905944|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16113814|NCT01888874|38905945|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16113815|NCT01888874|38905946|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16113816|NCT01888874|38905947|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16113817|NCT01888874|38905948|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
16113818|NCT01888874|38905949|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16113819|NCT01888874|38905950|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
16113820|NCT01888874|38905944|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16113821|NCT01888874|38905945|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
16113822|NCT01888874|38905946|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16113823|NCT01888874|38905947|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16113824|NCT01888874|38905948|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16113825|NCT01888874|38905949|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16113826|NCT01888874|38905950|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
16113827|NCT01888874|38905944|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
16113828|NCT01888874|38905945|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
16113829|NCT01888874|38905946|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
16113830|NCT01888874|38905947|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
16113831|NCT01888874|38905948|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
16113832|NCT01888874|38905949|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
16113833|NCT01888874|38905950|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
16113834|NCT01888874|38905944|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
16113835|NCT01888874|38905945|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
16113836|NCT01888874|38905946|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
16113837|NCT01888874|38905947|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16113838|NCT01888874|38905948|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
16113839|NCT01888874|38905949|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16113840|NCT01888874|38905950|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
16113841|NCT01888874|38905944|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16113842|NCT01888874|38905945|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16113843|NCT01888874|38905946|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16113844|NCT01888874|38905947|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16113845|NCT01888874|38905948|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
16113846|NCT01888874|38905949|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16113847|NCT01888874|38905950|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
16113848|NCT01888874|38905944|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
16113849|NCT01888874|38905945|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
16113850|NCT01888874|38905946|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
16113851|NCT01888874|38905947|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
16346749|NCT00463801|39757253|FG000|Overall Study|Adverse Event|4|||
16346750|NCT00463801|39757253|FG000|Overall Study|Lost to Follow-up|5|||
16113852|NCT01888874|38905948|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
16113853|NCT01888874|38905949|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
16113854|NCT01888874|38905950|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
16113855|NCT01888874|38905944|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16113856|NCT01888874|38905945|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16113857|NCT01888874|38905946|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
16113858|NCT01888874|38905947|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16113859|NCT01888874|38905948|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16113860|NCT01888874|38905949|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16113861|NCT01888874|38905950|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
16113862|NCT01888874|38905944|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
16113863|NCT01888874|38905945|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
16113864|NCT01888874|38905946|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
16113865|NCT01888874|38905947|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
16113866|NCT01888874|38905948|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
16113867|NCT01888874|38905949|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
16113868|NCT01888874|38905950|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
16113869|NCT01888874|38905944|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
16113870|NCT01888874|38905945|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
16113871|NCT01888874|38905946|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
16113872|NCT01888874|38905947|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
16113873|NCT01888874|38905948|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
16113874|NCT01888874|38905949|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
16113875|NCT01888874|38905950|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
16113876|NCT00193479|38905955|FG000|Induction Chemotherapy|Adverse Event|2|||
16113877|NCT00193479|38905955|FG000|Induction Chemotherapy|Disease Progression|1|||
16113878|NCT00193479|38905955|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
16113879|NCT00193479|38905955|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
16113880|NCT01931098|38905956|FG000|Overall Study|Withdrawal by Subject|0|||
16113881|NCT01931098|38905957|FG001|Overall Study|Withdrawal by Subject|1|||
16113882|NCT01931098|38905956|FG000|Overall Study|Enrolled in different protocol|0|||
16113883|NCT01931098|38905957|FG001|Overall Study|Enrolled in different protocol|1|||
16113884|NCT01931098|38905956|FG000|Overall Study|Unable to begin trmt:active infection|0|||
16113885|NCT01931098|38905957|FG001|Overall Study|Unable to begin trmt:active infection|1|||
16113886|NCT01931098|38905956|FG000|Overall Study|Refused further treatment|0|||
16113887|NCT01931098|38905957|FG001|Overall Study|Refused further treatment|1|||
16113888|NCT04949802|38905964|FG000|Overall Study|Lost to Follow-up|3|||
16113889|NCT02567708|38905970|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
16113890|NCT02567708|38905971|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
16113891|NCT02567708|38905970|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
16113892|NCT02567708|38905971|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
16113893|NCT02567708|38905970|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
16113894|NCT02567708|38905971|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
16113895|NCT02567708|38905970|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
16224640|NCT02371980|39302490|FG001|Open-label Period|Noncompliance with Study Drug|0|||
16224641|NCT02371980|39302491|FG002|Open-label Period|Noncompliance with Study Drug|0|||
16224642|NCT02371980|39302492|FG003|Open-label Period|Noncompliance with Study Drug|0|||
16224643|NCT02371980|39302493|FG004|Open-label Period|Noncompliance with Study Drug|0|||
16224644|NCT02371980|39302489|FG000|Open-label Period|Lost to Follow-up|55|||
16224645|NCT02371980|39302490|FG001|Open-label Period|Lost to Follow-up|0|||
16224646|NCT02371980|39302491|FG002|Open-label Period|Lost to Follow-up|0|||
16224647|NCT02371980|39302492|FG003|Open-label Period|Lost to Follow-up|0|||
16224648|NCT02371980|39302493|FG004|Open-label Period|Lost to Follow-up|0|||
16224649|NCT02371980|39302489|FG000|Open-label Period|Voluntary Withdrawal|91|||
16224650|NCT02371980|39302490|FG001|Open-label Period|Voluntary Withdrawal|0|||
16224651|NCT02371980|39302491|FG002|Open-label Period|Voluntary Withdrawal|0|||
16224652|NCT02371980|39302492|FG003|Open-label Period|Voluntary Withdrawal|0|||
16224653|NCT02371980|39302493|FG004|Open-label Period|Voluntary Withdrawal|0|||
16224654|NCT02371980|39302489|FG000|Open-label Period|Pregnancy|1|||
16224655|NCT02371980|39302490|FG001|Open-label Period|Pregnancy|0|||
16224656|NCT02371980|39302491|FG002|Open-label Period|Pregnancy|0|||
16113896|NCT02567708|38905971|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
16113897|NCT01217437|38905972|FG000|Overall Study|Adverse Event|0|||
16113898|NCT01217437|38905973|FG001|Overall Study|Adverse Event|8|||
16113899|NCT01217437|38905972|FG000|Overall Study|Death|5|||
16113900|NCT01217437|38905973|FG001|Overall Study|Death|0|||
16113901|NCT01217437|38905972|FG000|Overall Study|Lack of Efficacy|29|||
16113902|NCT01217437|38905973|FG001|Overall Study|Lack of Efficacy|25|||
16113903|NCT01217437|38905972|FG000|Overall Study|Physician Decision|8|||
16224657|NCT02371980|39302492|FG003|Open-label Period|Pregnancy|0|||
16224658|NCT02371980|39302493|FG004|Open-label Period|Pregnancy|0|||
16113904|NCT01217437|38905973|FG001|Overall Study|Physician Decision|5|||
16113905|NCT01217437|38905972|FG000|Overall Study|Withdrawal by Subject|0|||
16113906|NCT01217437|38905973|FG001|Overall Study|Withdrawal by Subject|2|||
16113907|NCT01217437|38905972|FG000|Overall Study|Ineligible|1|||
16113908|NCT01217437|38905973|FG001|Overall Study|Ineligible|1|||
16113909|NCT02536742|38905974|FG000|Overall Study|Did not start protocol therapy|1|||
16113910|NCT02536742|38905974|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
16113911|NCT02034162|38905975|FG000|Double-blind|Lost to Follow-up|3|||
16113912|NCT02034162|38905976|FG001|Double-blind|Lost to Follow-up|0|||
16113913|NCT02034162|38905977|FG002|Double-blind|Lost to Follow-up|0|||
16113914|NCT02034162|38905975|FG000|Double-blind|Physician Decision|1|||
16113915|NCT02034162|38905976|FG001|Double-blind|Physician Decision|0|||
16113916|NCT02034162|38905977|FG002|Double-blind|Physician Decision|0|||
16113917|NCT02034162|38905975|FG000|Double-blind|Protocol Violation|0|||
16113918|NCT02034162|38905976|FG001|Double-blind|Protocol Violation|1|||
16113919|NCT02034162|38905977|FG002|Double-blind|Protocol Violation|0|||
16113920|NCT02034162|38905975|FG000|Double-blind|Withdrawal by Subject|5|||
16113921|NCT02034162|38905976|FG001|Double-blind|Withdrawal by Subject|7|||
16113922|NCT02034162|38905977|FG002|Double-blind|Withdrawal by Subject|0|||
16113923|NCT01183390|38905982|FG000|First Intervention|Adverse Event|0|||
16113924|NCT01183390|38905983|FG001|First Intervention|Adverse Event|1|||
16113925|NCT02763215|38905984|FG000|Overall Study|Participants withdrew from study|3|||
16113926|NCT02763215|38905984|FG000|Overall Study|Missed visit|1|||
16113927|NCT02763215|38905984|FG000|Overall Study|Visit outside visit-window|1|||
16113928|NCT02763215|38905984|FG000|Overall Study|Death|1|||
16113929|NCT02763215|38905984|FG000|Overall Study|Lost to Follow-up|1|||
16113930|NCT02820597|38905987|FG000|Overall Study|Lost to Follow-up|12|||
16113931|NCT01443923|38905989|FG000|Overall Study|Adverse Event|1|||
16113932|NCT01443923|38905990|FG001|Overall Study|Adverse Event|0|||
16113933|NCT05262751|38905991|FG000|Washout Period 2|Adverse Event|1|||
16113934|NCT05262751|38905992|FG001|Washout Period 2|Adverse Event|0|||
16113935|NCT05262751|38905993|FG002|Washout Period 2|Adverse Event|0|||
16113936|NCT05262751|38905994|FG003|Washout Period 2|Adverse Event|0|||
16113937|NCT05262751|38905995|FG004|Washout Period 2|Adverse Event|0|||
16113938|NCT05262751|38905996|FG005|Washout Period 2|Adverse Event|0|||
16113939|NCT05262751|38905991|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
16113940|NCT05262751|38905992|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
16113941|NCT05262751|38905993|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
16113942|NCT05262751|38905994|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
16113943|NCT05262751|38905995|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
16113944|NCT05262751|38905996|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
16113945|NCT04292470|38906003|FG000|Overall Study|Withdrawal by Subject|0|||
16113946|NCT04292470|38906004|FG001|Overall Study|Withdrawal by Subject|1|||
16410315|NCT01632241|39985452|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
16410316|NCT01632241|39985453|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
16410317|NCT01632241|39985452|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
16113951|NCT01470599|38906013|FG000|Overall Study|Did not meet entrance criteria|1|||
16113952|NCT01470599|38906014|FG001|Overall Study|Did not meet entrance criteria|0|||
16113953|NCT01470599|38906013|FG000|Overall Study|Lost to Follow-up|2|||
16113954|NCT01470599|38906014|FG001|Overall Study|Lost to Follow-up|1|||
16113955|NCT01470599|38906013|FG000|Overall Study|Withdrawal by Subject|3|||
16113956|NCT01470599|38906014|FG001|Overall Study|Withdrawal by Subject|4|||
16113957|NCT01470599|38906013|FG000|Overall Study|Other|1|||
16113958|NCT01470599|38906014|FG001|Overall Study|Other|0|||
16113959|NCT01470599|38906013|FG000|Overall Study|Protocol Violation|3|||
16113960|NCT01470599|38906014|FG001|Overall Study|Protocol Violation|1|||
16113961|NCT01470599|38906013|FG000|Overall Study|Adverse event related to study drug|2|||
16113962|NCT01470599|38906014|FG001|Overall Study|Adverse event related to study drug|5|||
16113963|NCT01470599|38906013|FG000|Overall Study|Insufficient clinical response|6|||
16113964|NCT01470599|38906014|FG001|Overall Study|Insufficient clinical response|27|||
16113965|NCT01470599|38906013|FG000|Overall Study|Adverse event not related to study drug|1|||
16113966|NCT01470599|38906014|FG001|Overall Study|Adverse event not related to study drug|5|||
16113967|NCT00694109|38906015|FG000|Overall Study|Physician Decision|3|||
16113968|NCT00694109|38906015|FG000|Overall Study|Adverse Event|74|||
16113969|NCT00694109|38906015|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
16113970|NCT00694109|38906015|FG000|Overall Study|Lack of Efficacy|2|||
16113971|NCT00694109|38906015|FG000|Overall Study|Withdrawal by Subject|13|||
16113972|NCT00694109|38906015|FG000|Overall Study|Pregnancy|1|||
16113973|NCT00694109|38906015|FG000|Overall Study|Enrolled but not treated|1|||
16113974|NCT00694109|38906015|FG000|Overall Study|Other|2|||
16113975|NCT00694109|38906015|FG000|Overall Study|Consented but no additional treatment|3|||
16113976|NCT04210843|38906018|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
16113977|NCT04210843|38906019|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
16113978|NCT04210843|38906018|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
16113979|NCT04210843|38906019|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
16113980|NCT04210843|38906018|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
16113981|NCT04210843|38906019|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
16113982|NCT04210843|38906018|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
16113983|NCT04210843|38906019|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
16113984|NCT04210843|38906018|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
16113985|NCT04210843|38906019|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
16113986|NCT04210843|38906018|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
16113987|NCT04210843|38906019|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
16113988|NCT04210843|38906018|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
16113989|NCT04210843|38906019|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
16113990|NCT04210843|38906018|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
16113991|NCT04210843|38906019|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
16113992|NCT04210843|38906018|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
16113993|NCT04210843|38906019|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
16113994|NCT04210843|38906018|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
16113995|NCT04210843|38906019|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
16113996|NCT04210843|38906018|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
16113997|NCT04210843|38906019|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
16113998|NCT04210843|38906018|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
16113999|NCT04210843|38906019|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
16114000|NCT04210843|38906018|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
16114001|NCT04210843|38906019|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
16114002|NCT04210843|38906018|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
16114003|NCT04210843|38906019|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
16114004|NCT04210843|38906018|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
16114005|NCT04210843|38906019|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
16114006|NCT04210843|38906018|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
16114007|NCT04210843|38906019|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
16114008|NCT04210843|38906018|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
16114009|NCT04210843|38906019|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
16114010|NCT04210843|38906018|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
16114011|NCT04210843|38906019|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
16114012|NCT04210843|38906018|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
16114013|NCT04210843|38906019|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
16114014|NCT04210843|38906018|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
16114015|NCT04210843|38906019|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
16114016|NCT04210843|38906018|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
16114017|NCT04210843|38906019|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
16114018|NCT04210843|38906018|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
16114019|NCT04210843|38906019|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
16114020|NCT04210843|38906018|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
16114021|NCT04210843|38906019|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
16114022|NCT04210843|38906018|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
16114023|NCT04210843|38906019|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
16114024|NCT03768336|38906020|FG000|Overall Study|Lost to Follow-up|3|||
16114025|NCT03768336|38906021|FG001|Overall Study|Lost to Follow-up|2|||
16114026|NCT03768336|38906020|FG000|Overall Study|Became Ineligible|2|||
16114027|NCT03768336|38906021|FG001|Overall Study|Became Ineligible|0|||
16547014|NCT01889186|40465035|FG001|Overall Study|Other, not specified|15|||
16547015|NCT00245102|40465036|FG000|Overall Study|Not Treated|1|||
16547016|NCT00245102|40465037|FG001|Overall Study|Not Treated|0|||
16547017|NCT00245102|40465038|FG002|Overall Study|Not Treated|1|||
16547018|NCT00245102|40465039|FG003|Overall Study|Not Treated|0|||
16547019|NCT00245102|40465040|FG004|Overall Study|Not Treated|0|||
16547020|NCT00245102|40465041|FG005|Overall Study|Not Treated|0|||
16547021|NCT00245102|40465036|FG000|Overall Study|Protocol Violation|1|||
16547022|NCT00245102|40465037|FG001|Overall Study|Protocol Violation|0|||
16547023|NCT00245102|40465038|FG002|Overall Study|Protocol Violation|0|||
16547024|NCT00245102|40465039|FG003|Overall Study|Protocol Violation|0|||
16547025|NCT00245102|40465040|FG004|Overall Study|Protocol Violation|0|||
16547026|NCT00245102|40465041|FG005|Overall Study|Protocol Violation|0|||
16547027|NCT00245102|40465036|FG000|Overall Study|Death|0|||
16547028|NCT00245102|40465037|FG001|Overall Study|Death|0|||
16547029|NCT00245102|40465038|FG002|Overall Study|Death|0|||
16547030|NCT00245102|40465039|FG003|Overall Study|Death|1|||
16547031|NCT00245102|40465040|FG004|Overall Study|Death|0|||
16547032|NCT00245102|40465041|FG005|Overall Study|Death|0|||
16547033|NCT00245102|40465036|FG000|Overall Study|Adverse Event|4|||
16224659|NCT02371980|39302489|FG000|Open-label Period|Lack of Efficacy|116|||
16224660|NCT02371980|39302490|FG001|Open-label Period|Lack of Efficacy|0|||
16224661|NCT02371980|39302491|FG002|Open-label Period|Lack of Efficacy|0|||
16224662|NCT02371980|39302492|FG003|Open-label Period|Lack of Efficacy|0|||
16114028|NCT03768336|38906020|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
16114029|NCT03768336|38906021|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
16114030|NCT03768336|38906020|FG000|Overall Study|Missed final survey (post-treatment|0|||
16114031|NCT03768336|38906021|FG001|Overall Study|Missed final survey (post-treatment|1|||
16114032|NCT00940875|38906022|FG000|Treatment Phase|Adverse Event|9|||
16224663|NCT02371980|39302493|FG004|Open-label Period|Lack of Efficacy|0|||
16114033|NCT00940875|38906023|FG001|Treatment Phase|Adverse Event|3|||
16114034|NCT00940875|38906022|FG000|Treatment Phase|Death|3|||
16114035|NCT00940875|38906023|FG001|Treatment Phase|Death|5|||
16114036|NCT00940875|38906022|FG000|Treatment Phase|Lack of Efficacy|1|||
16114037|NCT00940875|38906023|FG001|Treatment Phase|Lack of Efficacy|0|||
16114038|NCT00940875|38906022|FG000|Treatment Phase|Withdrawal by Subject|3|||
16114039|NCT00940875|38906023|FG001|Treatment Phase|Withdrawal by Subject|0|||
16114040|NCT00940875|38906022|FG000|Treatment Phase|Disease progression|9|||
16114041|NCT00940875|38906023|FG001|Treatment Phase|Disease progression|11|||
16114042|NCT00940875|38906022|FG000|Treatment Phase|Physician Decision|1|||
16114043|NCT00940875|38906023|FG001|Treatment Phase|Physician Decision|0|||
16224664|NCT02371980|39302489|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
16224665|NCT02371980|39302490|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
16224666|NCT02371980|39302491|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
16224667|NCT02371980|39302492|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
16224668|NCT02371980|39302493|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
16224669|NCT02371980|39302489|FG000|Open-label Period|Reason not Specified|9|||
16224670|NCT02371980|39302490|FG001|Open-label Period|Reason not Specified|0|||
16224671|NCT02371980|39302491|FG002|Open-label Period|Reason not Specified|0|||
16224672|NCT02371980|39302492|FG003|Open-label Period|Reason not Specified|0|||
16224673|NCT02371980|39302493|FG004|Open-label Period|Reason not Specified|0|||
16224674|NCT02371980|39302489|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
16224675|NCT02371980|39302490|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
16224676|NCT02371980|39302491|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
16224677|NCT02371980|39302492|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
16224678|NCT02371980|39302493|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
16224679|NCT02371980|39302489|FG000|Double-blind Period|Significant Protocol Deviation|0|||
16224680|NCT02371980|39302490|FG001|Double-blind Period|Significant Protocol Deviation|2|||
16224681|NCT02371980|39302491|FG002|Double-blind Period|Significant Protocol Deviation|7|||
16224682|NCT02371980|39302492|FG003|Double-blind Period|Significant Protocol Deviation|3|||
16224683|NCT02371980|39302493|FG004|Double-blind Period|Significant Protocol Deviation|3|||
16224684|NCT02371980|39302489|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
16224685|NCT02371980|39302490|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
16114044|NCT00940875|38906022|FG000|Post-Study Treatment|Death|0|||
16114045|NCT00940875|38906023|FG001|Post-Study Treatment|Death|1|||
16114046|NCT00940875|38906022|FG000|Post-Study Treatment|Disease Progression|0|||
16224686|NCT02371980|39302491|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
16224687|NCT02371980|39302492|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
16224688|NCT02371980|39302493|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
16224689|NCT02371980|39302489|FG000|Double-blind Period|Lost to Follow-up|0|||
16410318|NCT01632241|39985453|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
16410319|NCT01632241|39985452|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
16410320|NCT01632241|39985453|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
16410321|NCT01632241|39985452|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
16410322|NCT01632241|39985453|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
16410323|NCT01632241|39985452|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
16410324|NCT01632241|39985453|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
16410325|NCT01632241|39985452|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
16410326|NCT01632241|39985453|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
16224690|NCT02371980|39302490|FG001|Double-blind Period|Lost to Follow-up|8|||
16224691|NCT02371980|39302491|FG002|Double-blind Period|Lost to Follow-up|8|||
16224692|NCT02371980|39302492|FG003|Double-blind Period|Lost to Follow-up|6|||
16224693|NCT02371980|39302493|FG004|Double-blind Period|Lost to Follow-up|5|||
16224694|NCT02371980|39302489|FG000|Double-blind Period|Voluntary Withdrawal|0|||
16224695|NCT02371980|39302490|FG001|Double-blind Period|Voluntary Withdrawal|12|||
16224696|NCT02371980|39302491|FG002|Double-blind Period|Voluntary Withdrawal|8|||
16224697|NCT02371980|39302492|FG003|Double-blind Period|Voluntary Withdrawal|9|||
16224698|NCT02371980|39302493|FG004|Double-blind Period|Voluntary Withdrawal|11|||
16224699|NCT02371980|39302489|FG000|Double-blind Period|Relapse|0|||
16224700|NCT02371980|39302490|FG001|Double-blind Period|Relapse|50|||
16224701|NCT02371980|39302491|FG002|Double-blind Period|Relapse|25|||
16224702|NCT02371980|39302492|FG003|Double-blind Period|Relapse|25|||
16224703|NCT02371980|39302493|FG004|Double-blind Period|Relapse|26|||
16224704|NCT02371980|39302489|FG000|Double-blind Period|Reason not Specified|0|||
16224705|NCT02371980|39302490|FG001|Double-blind Period|Reason not Specified|3|||
16224706|NCT02371980|39302491|FG002|Double-blind Period|Reason not Specified|3|||
16224707|NCT02371980|39302492|FG003|Double-blind Period|Reason not Specified|2|||
16224708|NCT02371980|39302493|FG004|Double-blind Period|Reason not Specified|1|||
16224709|NCT02371980|39302489|FG000|Double-blind Period|Missing|0|||
16224710|NCT02371980|39302490|FG001|Double-blind Period|Missing|1|||
16224711|NCT02371980|39302491|FG002|Double-blind Period|Missing|0|||
16224712|NCT02371980|39302492|FG003|Double-blind Period|Missing|0|||
16224713|NCT02371980|39302493|FG004|Double-blind Period|Missing|0|||
16224714|NCT00166504|39302498|FG000|Overall Study|Adverse Event|3|||
16224715|NCT00166504|39302499|FG001|Overall Study|Adverse Event|3|||
16224716|NCT00166504|39302498|FG000|Overall Study|Lost to Follow-up|1|||
16224717|NCT00166504|39302499|FG001|Overall Study|Lost to Follow-up|1|||
16224718|NCT00166504|39302498|FG000|Overall Study|Withdrawal by Subject|1|||
16224719|NCT00166504|39302499|FG001|Overall Study|Withdrawal by Subject|0|||
16224720|NCT01377194|39302500|FG000|Overall Study|Adverse Event|3|||
16224721|NCT01377194|39302501|FG001|Overall Study|Adverse Event|12|||
16224722|NCT01377194|39302502|FG002|Overall Study|Adverse Event|19|||
16224723|NCT01377194|39302500|FG000|Overall Study|Lack of Efficacy|3|||
16224724|NCT01377194|39302501|FG001|Overall Study|Lack of Efficacy|3|||
16224725|NCT01377194|39302502|FG002|Overall Study|Lack of Efficacy|3|||
16224726|NCT01377194|39302500|FG000|Overall Study|Protocol Violation|4|||
16224727|NCT01377194|39302501|FG001|Overall Study|Protocol Violation|10|||
16224728|NCT01377194|39302502|FG002|Overall Study|Protocol Violation|6|||
16224729|NCT01377194|39302500|FG000|Overall Study|Withdrawal by Subject|8|||
16224730|NCT01377194|39302501|FG001|Overall Study|Withdrawal by Subject|10|||
16224731|NCT01377194|39302502|FG002|Overall Study|Withdrawal by Subject|7|||
16224732|NCT01377194|39302500|FG000|Overall Study|Lost to Follow-up|14|||
16224733|NCT01377194|39302501|FG001|Overall Study|Lost to Follow-up|8|||
16224734|NCT01377194|39302502|FG002|Overall Study|Lost to Follow-up|11|||
16224735|NCT01287403|39302506|FG000|1st Intervention (1 Day)|Adverse Event|1|||
16224736|NCT02155712|39302507|FG000|Overall Study|Death|12|||
16224737|NCT02155712|39302508|FG001|Overall Study|Death|0|||
16224738|NCT02155712|39302507|FG000|Overall Study|Lost to Follow-up|37|||
16547034|NCT00245102|40465037|FG001|Overall Study|Adverse Event|2|||
16547035|NCT00245102|40465038|FG002|Overall Study|Adverse Event|5|||
16547036|NCT00245102|40465039|FG003|Overall Study|Adverse Event|1|||
16547037|NCT00245102|40465040|FG004|Overall Study|Adverse Event|0|||
16547038|NCT00245102|40465041|FG005|Overall Study|Adverse Event|2|||
16547039|NCT00245102|40465036|FG000|Overall Study|Decline in performance|0|||
16547040|NCT00245102|40465037|FG001|Overall Study|Decline in performance|2|||
16547041|NCT00245102|40465038|FG002|Overall Study|Decline in performance|0|||
16547042|NCT00245102|40465039|FG003|Overall Study|Decline in performance|1|||
16547043|NCT00245102|40465040|FG004|Overall Study|Decline in performance|0|||
16547044|NCT00245102|40465041|FG005|Overall Study|Decline in performance|2|||
16547045|NCT00245102|40465036|FG000|Overall Study|Participant needed surgery|0|||
16224739|NCT02155712|39302508|FG001|Overall Study|Lost to Follow-up|22|||
16224740|NCT02155712|39302507|FG000|Overall Study|Revision of device|4|||
16224741|NCT02155712|39302508|FG001|Overall Study|Revision of device|3|||
16224742|NCT02155712|39302507|FG000|Overall Study|Withdrawal by Subject|39|||
16224743|NCT02155712|39302508|FG001|Overall Study|Withdrawal by Subject|21|||
16224744|NCT02155712|39302507|FG000|Overall Study|Site termination|77|||
16224745|NCT02155712|39302508|FG001|Overall Study|Site termination|19|||
16224746|NCT02155712|39302507|FG000|Overall Study|Sponsor terminated study early|150|||
16224747|NCT02155712|39302508|FG001|Overall Study|Sponsor terminated study early|0|||
16224748|NCT02155712|39302507|FG000|Overall Study|Missed final 5-year protocol visit|0|||
16547046|NCT00245102|40465037|FG001|Overall Study|Participant needed surgery|0|||
16547047|NCT00245102|40465038|FG002|Overall Study|Participant needed surgery|1|||
16224749|NCT02155712|39302508|FG001|Overall Study|Missed final 5-year protocol visit|32|||
16224750|NCT02155712|39302507|FG000|Overall Study|Censored because surgery cancelled|6|||
16224751|NCT02155712|39302508|FG001|Overall Study|Censored because surgery cancelled|10|||
16224752|NCT02155712|39302507|FG000|Overall Study|Censored because study device was not implanted|61|||
16224753|NCT02155712|39302508|FG001|Overall Study|Censored because study device was not implanted|66|||
16346751|NCT00463801|39757253|FG000|Overall Study|No longer require therapy|1|||
16346752|NCT03365934|39757258|FG000|Overall Study|Adverse Event|1|||
16346753|NCT03365934|39757258|FG000|Overall Study|Withdrawal by Subject|1|||
16346754|NCT02964338|39757259|FG000|Overall Study|Sponsor terminated study for futility|12|||
16346755|NCT02964338|39757260|FG001|Overall Study|Sponsor terminated study for futility|15|||
16346756|NCT02964338|39757261|FG002|Overall Study|Sponsor terminated study for futility|14|||
16346757|NCT02964338|39757259|FG000|Overall Study|Lack of Efficacy|0|||
16346758|NCT02964338|39757260|FG001|Overall Study|Lack of Efficacy|3|||
16346759|NCT02964338|39757261|FG002|Overall Study|Lack of Efficacy|0|||
16346760|NCT02964338|39757259|FG000|Overall Study|Lost to Follow-up|1|||
16346761|NCT02964338|39757260|FG001|Overall Study|Lost to Follow-up|0|||
16346762|NCT02964338|39757261|FG002|Overall Study|Lost to Follow-up|3|||
16346763|NCT02964338|39757259|FG000|Overall Study|Protocol Violation|0|||
16346764|NCT02964338|39757260|FG001|Overall Study|Protocol Violation|1|||
16346765|NCT02964338|39757261|FG002|Overall Study|Protocol Violation|0|||
16346766|NCT02964338|39757259|FG000|Overall Study|Withdrawal by Subject|1|||
16346767|NCT02964338|39757260|FG001|Overall Study|Withdrawal by Subject|3|||
16346768|NCT02964338|39757261|FG002|Overall Study|Withdrawal by Subject|1|||
16346769|NCT02964338|39757259|FG000|Overall Study|Adverse Event|2|||
16346770|NCT02964338|39757260|FG001|Overall Study|Adverse Event|1|||
16346771|NCT02964338|39757261|FG002|Overall Study|Adverse Event|1|||
16346772|NCT02964338|39757259|FG000|Overall Study|Non-compliant with e-diary|0|||
16346773|NCT02964338|39757260|FG001|Overall Study|Non-compliant with e-diary|1|||
16346774|NCT02964338|39757261|FG002|Overall Study|Non-compliant with e-diary|0|||
16346775|NCT02964338|39757259|FG000|Overall Study|Did not meet criteria|1|||
16346776|NCT02964338|39757260|FG001|Overall Study|Did not meet criteria|0|||
16346777|NCT02964338|39757261|FG002|Overall Study|Did not meet criteria|0|||
16346778|NCT01691378|39757262|FG000|Overall Study|Withdrawal by Subject|2|||
16346779|NCT01691378|39757263|FG001|Overall Study|Withdrawal by Subject|0|||
16346780|NCT01691378|39757262|FG000|Overall Study|Lost to Follow-up|5|||
16346781|NCT01691378|39757263|FG001|Overall Study|Lost to Follow-up|2|||
16346782|NCT04157088|39757264|FG000|Overall Study|Study terminated by sponsor|23|||
16346783|NCT04157088|39757264|FG000|Overall Study|Withdrawal by Subject|4|||
16346784|NCT04157088|39757264|FG000|Overall Study|Lost to Follow-up|2|||
16346785|NCT04157088|39757264|FG000|Overall Study|Death|1|||
16346786|NCT02291029|39757265|FG000|Overall Study|Withdrawal by Subject|0|||
16346787|NCT02291029|39757266|FG001|Overall Study|Withdrawal by Subject|0|||
16346788|NCT02291029|39757267|FG002|Overall Study|Withdrawal by Subject|1|||
16346789|NCT02291029|39757268|FG003|Overall Study|Withdrawal by Subject|0|||
16346790|NCT02291029|39757269|FG004|Overall Study|Withdrawal by Subject|0|||
16346791|NCT02291029|39757270|FG005|Overall Study|Withdrawal by Subject|0|||
16346792|NCT02291029|39757265|FG000|Overall Study|Adverse Event|0|||
16346793|NCT02291029|39757266|FG001|Overall Study|Adverse Event|1|||
16346794|NCT02291029|39757267|FG002|Overall Study|Adverse Event|0|||
16346795|NCT02291029|39757268|FG003|Overall Study|Adverse Event|0|||
16346796|NCT02291029|39757269|FG004|Overall Study|Adverse Event|0|||
16346797|NCT02291029|39757270|FG005|Overall Study|Adverse Event|0|||
16346798|NCT01639144|39757271|FG000|Overall Study|Withdrawal by Subject|4|||
16346799|NCT01639144|39757272|FG001|Overall Study|Withdrawal by Subject|2|||
16346800|NCT01639144|39757271|FG000|Overall Study|Physician Decision|2|||
16346801|NCT01639144|39757272|FG001|Overall Study|Physician Decision|0|||
16346802|NCT01639144|39757271|FG000|Overall Study|Met postoperative exclusion criteria|4|||
16346803|NCT01639144|39757272|FG001|Overall Study|Met postoperative exclusion criteria|3|||
16346804|NCT00571662|39757273|FG000|Overall Study|Withdrawal by Subject|2|||
16346805|NCT00571662|39757273|FG000|Overall Study|psychiatric instability|1|||
16346806|NCT00571662|39757273|FG000|Overall Study|Adverse Event|5|||
16346807|NCT02306850|39757276|FG000|Overall Study|Lack of Efficacy|2|||
16346808|NCT00096538|39757277|FG000|Overall Study|Withdrawal by Subject|1|||
16346809|NCT00534248|39757291|FG000|Overall Study|Adverse Event|19|||
16346810|NCT00534248|39757292|FG001|Overall Study|Adverse Event|29|||
16346811|NCT00534248|39757291|FG000|Overall Study|Lost to Follow-up|353|||
16346812|NCT00534248|39757292|FG001|Overall Study|Lost to Follow-up|375|||
16346813|NCT00534248|39757291|FG000|Overall Study|Other protocol specified criteria|13|||
16114047|NCT00940875|38906023|FG001|Post-Study Treatment|Disease Progression|2|||
16346814|NCT00534248|39757292|FG001|Overall Study|Other protocol specified criteria|3|||
16346815|NCT00534248|39757291|FG000|Overall Study|Physician Decision|10|||
16224754|NCT02155712|39302507|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
16224755|NCT02155712|39302508|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
16224756|NCT02576951|39302512|FG000|Overall Study|Lost to Follow-up|0|||
16224757|NCT02576951|39302513|FG001|Overall Study|Lost to Follow-up|0|||
16224758|NCT02576951|39302514|FG002|Overall Study|Lost to Follow-up|2|||
16224759|NCT02576951|39302515|FG003|Overall Study|Lost to Follow-up|2|||
16224760|NCT02576951|39302512|FG000|Overall Study|Withdrawal by Subject|1|||
16224761|NCT02576951|39302513|FG001|Overall Study|Withdrawal by Subject|0|||
16224762|NCT02576951|39302514|FG002|Overall Study|Withdrawal by Subject|0|||
16547048|NCT00245102|40465039|FG003|Overall Study|Participant needed surgery|0|||
16547049|NCT00245102|40465040|FG004|Overall Study|Participant needed surgery|0|||
16547050|NCT00245102|40465041|FG005|Overall Study|Participant needed surgery|0|||
16547051|NCT00245102|40465036|FG000|Overall Study|Clinical progression|1|||
16547052|NCT00245102|40465037|FG001|Overall Study|Clinical progression|0|||
16547053|NCT00245102|40465038|FG002|Overall Study|Clinical progression|0|||
16547054|NCT00245102|40465039|FG003|Overall Study|Clinical progression|0|||
16547055|NCT00245102|40465040|FG004|Overall Study|Clinical progression|0|||
16547056|NCT00245102|40465041|FG005|Overall Study|Clinical progression|0|||
16547057|NCT02716038|40465042|FG000|Overall Study|Not evaluable|1|||
16224763|NCT02576951|39302515|FG003|Overall Study|Withdrawal by Subject|2|||
16224764|NCT02576951|39302512|FG000|Overall Study|Protocol Violation|0|||
16114048|NCT02166476|38906024|FG000|Overall Study|Withdrawal by Subject|5|||
16114049|NCT02166476|38906025|FG001|Overall Study|Withdrawal by Subject|7|||
16224765|NCT02576951|39302513|FG001|Overall Study|Protocol Violation|0|||
16224766|NCT02576951|39302514|FG002|Overall Study|Protocol Violation|0|||
16346816|NCT00534248|39757292|FG001|Overall Study|Physician Decision|7|||
16346817|NCT00534248|39757291|FG000|Overall Study|Protocol Violation|3|||
16346818|NCT00534248|39757292|FG001|Overall Study|Protocol Violation|4|||
16346819|NCT00534248|39757291|FG000|Overall Study|Withdrawal by Subject|263|||
16346820|NCT00534248|39757292|FG001|Overall Study|Withdrawal by Subject|255|||
16346821|NCT00807885|39757293|FG000|Overall Study|Lost to Follow-up|0|||
16346822|NCT00807885|39757294|FG001|Overall Study|Lost to Follow-up|0|||
16346823|NCT00807885|39757295|FG002|Overall Study|Lost to Follow-up|0|||
16346824|NCT00807885|39757296|FG003|Overall Study|Lost to Follow-up|0|||
16346825|NCT00807885|39757297|FG004|Overall Study|Lost to Follow-up|0|||
16346826|NCT00807885|39757298|FG005|Overall Study|Lost to Follow-up|1|||
16346827|NCT00807885|39757299|FG006|Overall Study|Lost to Follow-up|0|||
16346828|NCT00807885|39757300|FG007|Overall Study|Lost to Follow-up|0|||
16346829|NCT00807885|39757301|FG008|Overall Study|Lost to Follow-up|0|||
16346830|NCT01025284|39757302|FG000|Overall Study|Investigator Decision|0|||
16346831|NCT01025284|39757303|FG001|Overall Study|Investigator Decision|1|||
16346832|NCT01025284|39757304|FG002|Overall Study|Investigator Decision|0|||
16346833|NCT01025284|39757302|FG000|Overall Study|Withdrawal by Subject|0|||
16346834|NCT01025284|39757303|FG001|Overall Study|Withdrawal by Subject|1|||
16346835|NCT01025284|39757304|FG002|Overall Study|Withdrawal by Subject|0|||
16346836|NCT01450813|39757305|FG000|Overall Study|Physician Decision|1|||
16346837|NCT01450813|39757306|FG001|Overall Study|Physician Decision|1|||
16346838|NCT01450813|39757307|FG002|Overall Study|Physician Decision|0|||
16346839|NCT01450813|39757308|FG003|Overall Study|Physician Decision|3|||
16547058|NCT02716038|40465042|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
16547059|NCT02716038|40465042|FG000|Overall Study|Unresectable|3|||
16547060|NCT04539821|40465046|FG000|Overall Study|Withdrawal by Subject|2|||
16547061|NCT04539821|40465046|FG000|Overall Study|continued care with their physician|20|||
16547062|NCT04539821|40465046|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
16547063|NCT00185640|40465048|FG000|Overall Study|Not Eligible|4|||
16547064|NCT00185640|40465048|FG000|Overall Study|Withdrawal by Subject|3|||
16547065|NCT00185640|40465048|FG000|Overall Study|Death|138|||
16547066|NCT00384059|40465059|FG000|Infant Series|Not consented|2|||
16547067|NCT00384059|40465060|FG001|Infant Series|Not consented|6|||
16547068|NCT00384059|40465059|FG000|Infant Series|Withdrawal by Subject|2|||
16547069|NCT00384059|40465060|FG001|Infant Series|Withdrawal by Subject|2|||
16224767|NCT02576951|39302515|FG003|Overall Study|Protocol Violation|1|||
16224768|NCT00656136|39302516|FG000|Overall Study|Progressive disease|177|||
16346840|NCT02322749|39757310|FG000|Period 2|Adverse Event|0|||
16346841|NCT02322749|39757311|FG001|Period 2|Adverse Event|0|||
16346842|NCT02322749|39757312|FG002|Period 2|Adverse Event|0|||
16224769|NCT00656136|39302517|FG001|Overall Study|Progressive disease|322|||
16547070|NCT00384059|40465059|FG000|Infant Series|Adverse Event|1|||
16547071|NCT00384059|40465060|FG001|Infant Series|Adverse Event|2|||
16547072|NCT00384059|40465059|FG000|Infant Series|Protocol Violation|1|||
16547073|NCT00384059|40465060|FG001|Infant Series|Protocol Violation|2|||
16547074|NCT00384059|40465059|FG000|Infant Series|Lost to Follow-up|0|||
16547075|NCT00384059|40465060|FG001|Infant Series|Lost to Follow-up|1|||
16547076|NCT00384059|40465059|FG000|After Infant Series|Protocol Violation|2|||
16547077|NCT00384059|40465060|FG001|After Infant Series|Protocol Violation|3|||
16547078|NCT00384059|40465059|FG000|After Infant Series|Withdrawal by Subject|2|||
16547079|NCT00384059|40465060|FG001|After Infant Series|Withdrawal by Subject|2|||
16547080|NCT00384059|40465059|FG000|After Infant Series|Failed to Return|0|||
16547081|NCT00384059|40465060|FG001|After Infant Series|Failed to Return|2|||
16410327|NCT01632241|39985452|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
16410328|NCT01632241|39985453|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
16410329|NCT01632241|39985452|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
16410330|NCT01632241|39985453|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
16410331|NCT01632241|39985452|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
16410332|NCT01632241|39985453|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
16410333|NCT01632241|39985452|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
16410334|NCT01632241|39985453|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
16410335|NCT01170598|39985454|FG000|Overall Study|Withdrawal by Subject|1|||
16410336|NCT01170598|39985454|FG000|Overall Study|Death|3|||
16410337|NCT01170598|39985454|FG000|Overall Study|Lost to Follow-up|1|||
16410338|NCT01170598|39985454|FG000|Overall Study|Refused|1|||
16410339|NCT03283098|39985455|FG000|Overall Study|Withdrawal by Subject|0|||
16410340|NCT03283098|39985456|FG001|Overall Study|Withdrawal by Subject|1|||
16410341|NCT00664560|39985457|FG000|Overall Study|Adverse Event|19|||
16410342|NCT00664560|39985458|FG001|Overall Study|Adverse Event|16|||
16547082|NCT00384059|40465059|FG000|After Infant Series|Adverse Event|0|||
16547083|NCT00384059|40465060|FG001|After Infant Series|Adverse Event|1|||
16547084|NCT00384059|40465059|FG000|After Infant Series|Physician Decision|0|||
16547085|NCT00384059|40465060|FG001|After Infant Series|Physician Decision|1|||
16547086|NCT00384059|40465059|FG000|After Infant Series|Lost to Follow-up|0|||
16547087|NCT00384059|40465060|FG001|After Infant Series|Lost to Follow-up|1|||
16547088|NCT00384059|40465059|FG000|Toddler Dose|Lost to Follow-up|1|||
16547089|NCT00384059|40465060|FG001|Toddler Dose|Lost to Follow-up|1|||
16547090|NCT00384059|40465059|FG000|Toddler Dose|Failed to return|0|||
16547091|NCT00384059|40465060|FG001|Toddler Dose|Failed to return|1|||
16547092|NCT00949715|40465061|FG000|Overall Study|Physician Decision|1|||
16547093|NCT00949715|40465062|FG001|Overall Study|Physician Decision|0|||
16547094|NCT00949715|40465061|FG000|Overall Study|Lost to Follow-up|1|||
16410343|NCT00664560|39985459|FG002|Overall Study|Adverse Event|7|||
16410344|NCT00664560|39985457|FG000|Overall Study|Withdrawal by Subject|9|||
16410345|NCT00664560|39985458|FG001|Overall Study|Withdrawal by Subject|13|||
16410346|NCT00664560|39985459|FG002|Overall Study|Withdrawal by Subject|7|||
16410347|NCT00664560|39985457|FG000|Overall Study|Lost to Follow-up|0|||
16410348|NCT00664560|39985458|FG001|Overall Study|Lost to Follow-up|2|||
16410349|NCT00664560|39985459|FG002|Overall Study|Lost to Follow-up|0|||
16410350|NCT00664560|39985457|FG000|Overall Study|Other|11|||
16410351|NCT00664560|39985458|FG001|Overall Study|Other|4|||
16410352|NCT00664560|39985459|FG002|Overall Study|Other|5|||
16410353|NCT01561755|39985460|FG000|Overall Study|Lost to Follow-up|0|||
16410354|NCT01561755|39985461|FG001|Overall Study|Lost to Follow-up|1|||
16410355|NCT00260065|39985462|FG000|Overall Study|Progressive Disease|22|||
16410356|NCT00260065|39985462|FG000|Overall Study|Adverse Event|17|||
16410357|NCT00260065|39985462|FG000|Overall Study|Death|13|||
16410358|NCT00260065|39985462|FG000|Overall Study|Withdrawal by Subject|13|||
16410359|NCT00260065|39985462|FG000|Overall Study|Physician Decision|19|||
16410360|NCT00260065|39985462|FG000|Overall Study|Not otherwise specified|8|||
16410361|NCT00260065|39985462|FG000|Overall Study|Medication Noncompliance|1|||
16410362|NCT02075632|39985463|FG000|Overall Study|Adverse Event|1|||
16410363|NCT02075632|39985464|FG001|Overall Study|Adverse Event|1|||
16410364|NCT02075632|39985463|FG000|Overall Study|Lost to Follow-up|0|||
16547095|NCT00949715|40465062|FG001|Overall Study|Lost to Follow-up|0|||
16547096|NCT00949715|40465061|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
16410365|NCT02075632|39985464|FG001|Overall Study|Lost to Follow-up|3|||
16410366|NCT02075632|39985463|FG000|Overall Study|Withdrawal by Subject|0|||
16410367|NCT02075632|39985464|FG001|Overall Study|Withdrawal by Subject|1|||
16547097|NCT00949715|40465062|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
16547098|NCT02127372|40465063|FG000|Overall Study|Withdrawal by Subject|1|||
16547099|NCT02127372|40465064|FG001|Overall Study|Withdrawal by Subject|0|||
16547100|NCT01787097|40465065|FG000|Overall Study|Withdrawal by Subject|1|||
16410368|NCT01688739|39985465|FG000|Overall Study|Administrative Decision|1|||
16410369|NCT01688739|39985466|FG001|Overall Study|Administrative Decision|0|||
16410370|NCT01688739|39985467|FG002|Overall Study|Administrative Decision|0|||
16410371|NCT01688739|39985468|FG003|Overall Study|Administrative Decision|0|||
16410372|NCT01688739|39985469|FG004|Overall Study|Administrative Decision|0|||
16410373|NCT01688739|39985470|FG005|Overall Study|Administrative Decision|0|||
16410374|NCT01688739|39985471|FG006|Overall Study|Administrative Decision|0|||
16410375|NCT01688739|39985472|FG007|Overall Study|Administrative Decision|0|||
16410376|NCT01688739|39985473|FG008|Overall Study|Administrative Decision|0|||
16410377|NCT01688739|39985474|FG009|Overall Study|Administrative Decision|0|||
16410378|NCT01998893|39985475|FG000|Overall Study|Adverse Event|2|||
16410379|NCT01998893|39985475|FG000|Overall Study|Death|1|||
16410380|NCT01998893|39985475|FG000|Overall Study|Lost to Follow-up|8|||
16410381|NCT01998893|39985475|FG000|Overall Study|Physician Decision|2|||
16410382|NCT01998893|39985475|FG000|Overall Study|Protocol Violation|2|||
16410383|NCT01998893|39985475|FG000|Overall Study|Withdrawal by Subject|1|||
16410384|NCT01998893|39985475|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
16547101|NCT01787097|40465066|FG001|Overall Study|Withdrawal by Subject|0|||
16547102|NCT01787097|40465067|FG002|Overall Study|Withdrawal by Subject|0|||
16547103|NCT01787097|40465068|FG003|Overall Study|Withdrawal by Subject|0|||
16547104|NCT00612534|40465070|FG000|Overall Study|Adverse Event|0|||
16547105|NCT00612534|40465071|FG001|Overall Study|Adverse Event|4|||
16547106|NCT00612534|40465072|FG002|Overall Study|Adverse Event|2|||
16547107|NCT00612534|40465073|FG003|Overall Study|Adverse Event|1|||
16114050|NCT02166476|38906024|FG000|Overall Study|Adverse Event|3|||
16410385|NCT02842086|39985478|FG000|Overall Study|Randomized but Never Treated|6|||
16410386|NCT02842086|39985479|FG001|Overall Study|Randomized but Never Treated|6|||
16410387|NCT02842086|39985478|FG000|Overall Study|Still in Double-Blind Phase|7|||
16547108|NCT00612534|40465070|FG000|Overall Study|Lack of Efficacy|13|||
16547109|NCT00612534|40465071|FG001|Overall Study|Lack of Efficacy|12|||
16547110|NCT00612534|40465072|FG002|Overall Study|Lack of Efficacy|5|||
16547111|NCT00612534|40465073|FG003|Overall Study|Lack of Efficacy|16|||
16547112|NCT00612534|40465070|FG000|Overall Study|Other Reason|0|||
16547113|NCT00612534|40465071|FG001|Overall Study|Other Reason|1|||
16547114|NCT00612534|40465072|FG002|Overall Study|Other Reason|0|||
16547115|NCT00612534|40465073|FG003|Overall Study|Other Reason|0|||
16547116|NCT02293395|40465074|FG000|Overall Study|Lost to Follow-up|1|||
16547117|NCT02293395|40465075|FG001|Overall Study|Lost to Follow-up|0|||
16547118|NCT02293395|40465074|FG000|Overall Study|Withdrawal by Subject|8|||
16547119|NCT02293395|40465075|FG001|Overall Study|Withdrawal by Subject|7|||
16547120|NCT02364180|40465078|FG000|Overall Study|Screen Fail|1|||
16547121|NCT02093663|40467484|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
16547122|NCT02093663|40467485|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
16547123|NCT02093663|40467486|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
16547124|NCT02093663|40467487|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
16547125|NCT02093663|40467488|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
16547126|NCT02093663|40467484|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
16547127|NCT02093663|40467485|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16547128|NCT02093663|40467486|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16547129|NCT02093663|40467487|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16547130|NCT02093663|40467488|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16547131|NCT02093663|40467484|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
16547132|NCT02093663|40467485|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
16547133|NCT02093663|40467486|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
16547134|NCT02093663|40467487|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
16547135|NCT02093663|40467488|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
16547136|NCT02093663|40467484|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
16547137|NCT02093663|40467485|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
16547138|NCT02093663|40467486|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
16547139|NCT02093663|40467487|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
16547140|NCT02093663|40467488|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
16547141|NCT02093663|40467484|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16547142|NCT02093663|40467485|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16547143|NCT02093663|40467486|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
16410388|NCT02842086|39985479|FG001|Overall Study|Still in Double-Blind Phase|3|||
16114051|NCT02166476|38906025|FG001|Overall Study|Adverse Event|3|||
16114052|NCT02166476|38906024|FG000|Overall Study|Lost to Follow-up|5|||
16114053|NCT02166476|38906025|FG001|Overall Study|Lost to Follow-up|10|||
16114054|NCT02166476|38906024|FG000|Overall Study|Physician Decision|1|||
16114055|NCT02166476|38906025|FG001|Overall Study|Physician Decision|0|||
16114056|NCT02166476|38906024|FG000|Overall Study|Unable to Come for Visit|0|||
16114057|NCT02166476|38906025|FG001|Overall Study|Unable to Come for Visit|3|||
16114058|NCT01844726|38906028|FG000|Overall Study|Withdrawal by Subject|0|||
16114059|NCT01844726|38906029|FG001|Overall Study|Withdrawal by Subject|1|||
16114060|NCT01844726|38906028|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
16114061|NCT01844726|38906029|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
16114062|NCT04147195|38906030|FG000|Overall Study|Adverse Event|0|||
16114063|NCT04147195|38906031|FG001|Overall Study|Adverse Event|3|||
16114064|NCT04147195|38906030|FG000|Overall Study|Study Terminated by Sponsor|4|||
16114065|NCT04147195|38906031|FG001|Overall Study|Study Terminated by Sponsor|2|||
16114066|NCT04147195|38906030|FG000|Overall Study|Withdrawal by Subject|0|||
16114067|NCT04147195|38906031|FG001|Overall Study|Withdrawal by Subject|1|||
16114068|NCT04463680|38906032|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
16114069|NCT04463680|38906032|FG000|Overall Study|Not eligible due to implant duration of use|1|||
16114070|NCT04463680|38906032|FG000|Overall Study|Withdrawal by Subject|3|||
16114071|NCT05144945|38906038|FG000|Overall Study|Withdrawal by Subject|1|||
16114072|NCT05144945|38906039|FG001|Overall Study|Withdrawal by Subject|0|||
16114073|NCT01236352|38906040|FG000|Overall Study|Death|0|||
16114074|NCT01236352|38906041|FG001|Overall Study|Death|0|||
16114075|NCT01236352|38906042|FG002|Overall Study|Death|0|||
16114076|NCT01236352|38906043|FG003|Overall Study|Death|0|||
16114077|NCT01236352|38906044|FG004|Overall Study|Death|0|||
16114078|NCT01236352|38906045|FG005|Overall Study|Death|0|||
16114079|NCT01236352|38906046|FG006|Overall Study|Death|0|||
16114080|NCT01236352|38906047|FG007|Overall Study|Death|1|||
16114081|NCT01236352|38906048|FG008|Overall Study|Death|0|||
16114082|NCT01236352|38906049|FG009|Overall Study|Death|0|||
16114083|NCT01236352|38906050|FG010|Overall Study|Death|0|||
16114084|NCT01236352|38906040|FG000|Overall Study|Withdrawal by Subject|0|||
16114085|NCT01236352|38906041|FG001|Overall Study|Withdrawal by Subject|0|||
16114086|NCT01236352|38906042|FG002|Overall Study|Withdrawal by Subject|0|||
16114087|NCT01236352|38906043|FG003|Overall Study|Withdrawal by Subject|0|||
16114088|NCT01236352|38906044|FG004|Overall Study|Withdrawal by Subject|0|||
16114089|NCT01236352|38906045|FG005|Overall Study|Withdrawal by Subject|0|||
16114090|NCT01236352|38906046|FG006|Overall Study|Withdrawal by Subject|0|||
16547144|NCT02093663|40467487|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16547145|NCT02093663|40467488|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
16114091|NCT01236352|38906047|FG007|Overall Study|Withdrawal by Subject|0|||
16114092|NCT01236352|38906048|FG008|Overall Study|Withdrawal by Subject|0|||
16224770|NCT00656136|39302516|FG000|Overall Study|Other Adverse Event|5|||
16410389|NCT02842086|39985478|FG000|Overall Study|Adverse Event|18|||
16114093|NCT01236352|38906049|FG009|Overall Study|Withdrawal by Subject|2|||
16114094|NCT01236352|38906050|FG010|Overall Study|Withdrawal by Subject|1|||
16224771|NCT00656136|39302517|FG001|Overall Study|Other Adverse Event|51|||
16410390|NCT02842086|39985479|FG001|Overall Study|Adverse Event|20|||
16410391|NCT02842086|39985478|FG000|Overall Study|Death|3|||
16410392|NCT02842086|39985479|FG001|Overall Study|Death|3|||
16410393|NCT02842086|39985478|FG000|Overall Study|Investigator's Discretion|9|||
16410394|NCT02842086|39985479|FG001|Overall Study|Investigator's Discretion|13|||
16410395|NCT02842086|39985478|FG000|Overall Study|Non-Compliance with Study Drug|9|||
16410396|NCT02842086|39985479|FG001|Overall Study|Non-Compliance with Study Drug|8|||
16410397|NCT02842086|39985478|FG000|Overall Study|Protocol Violation|8|||
16410398|NCT02842086|39985479|FG001|Overall Study|Protocol Violation|4|||
16410399|NCT02842086|39985478|FG000|Overall Study|Withdrew Consent|205|||
16410400|NCT02842086|39985479|FG001|Overall Study|Withdrew Consent|194|||
16114095|NCT01236352|38906040|FG000|Overall Study|Adverse Event|0|||
16410401|NCT02842086|39985478|FG000|Overall Study|Lost to Follow-up|274|||
16114096|NCT01236352|38906041|FG001|Overall Study|Adverse Event|0|||
16114097|NCT01236352|38906042|FG002|Overall Study|Adverse Event|0|||
16114098|NCT01236352|38906043|FG003|Overall Study|Adverse Event|0|||
16224772|NCT00656136|39302516|FG000|Overall Study|Protocol Violation|2|||
16224773|NCT00656136|39302517|FG001|Overall Study|Protocol Violation|3|||
16224774|NCT00656136|39302516|FG000|Overall Study|Patient refused to take study medication|7|||
16224775|NCT00656136|39302517|FG001|Overall Study|Patient refused to take study medication|10|||
16224776|NCT00656136|39302516|FG000|Overall Study|Unknown and others|4|||
16224777|NCT00656136|39302517|FG001|Overall Study|Unknown and others|4|||
16224778|NCT00702949|39302518|FG000|Overall Study|Refusal|3|||
16224779|NCT00702949|39302519|FG001|Overall Study|Refusal|2|||
16224780|NCT00702949|39302520|FG002|Overall Study|Refusal|2|||
16224781|NCT00702949|39302518|FG000|Overall Study|Adverse Event|1|||
16224782|NCT00702949|39302519|FG001|Overall Study|Adverse Event|6|||
16224783|NCT00702949|39302520|FG002|Overall Study|Adverse Event|3|||
16224784|NCT00702949|39302518|FG000|Overall Study|Other Medical Reason/unknown|1|||
16224785|NCT00702949|39302519|FG001|Overall Study|Other Medical Reason/unknown|1|||
16224786|NCT00702949|39302520|FG002|Overall Study|Other Medical Reason/unknown|3|||
16224787|NCT00475657|39302525|FG000|Overall Study|Death|1|||
16224788|NCT00475657|39302525|FG000|Overall Study|Sponsor's Decision|3|||
16224789|NCT00851721|39302528|FG000|Overall Study|planned surgery|1|||
16224790|NCT00851721|39302529|FG001|Overall Study|planned surgery|0|||
16224791|NCT00851721|39302528|FG000|Overall Study|Death|1|||
16224792|NCT00851721|39302529|FG001|Overall Study|Death|0|||
16224793|NCT00851721|39302528|FG000|Overall Study|Adverse Event|0|||
16224794|NCT00851721|39302529|FG001|Overall Study|Adverse Event|1|||
16224795|NCT04863898|39302532|FG000|Overall Study|Away from study clinic during intervention training period|2|||
16224796|NCT04863898|39302532|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
16224797|NCT04863898|39302532|FG000|Overall Study|Lost to Follow-up|3|||
16224798|NCT04863898|39302532|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
16224799|NCT04863898|39302532|FG000|Overall Study|No longer employed at clinic|3|||
16224800|NCT02712008|39302533|FG000|Baseline (Day 1) up to Week 12|Death|3|||
16224801|NCT02712008|39302534|FG001|Baseline (Day 1) up to Week 12|Death|0|||
16410402|NCT02842086|39985479|FG001|Overall Study|Lost to Follow-up|236|||
16410403|NCT02842086|39985478|FG000|Overall Study|HIV-1 Infection|5|||
16410404|NCT02842086|39985479|FG001|Overall Study|HIV-1 Infection|6|||
16410405|NCT03215706|39985481|FG000|Randomization|Adverse Event unrelated to study drug|1|||
16410406|NCT03215706|39985482|FG001|Randomization|Adverse Event unrelated to study drug|0|||
16410407|NCT03215706|39985481|FG000|Randomization|participant withdrew consent|1|||
16410408|NCT03215706|39985482|FG001|Randomization|participant withdrew consent|3|||
16410409|NCT03215706|39985481|FG000|Randomization|no longer meets study criteria|1|||
16410410|NCT03215706|39985482|FG001|Randomization|no longer meets study criteria|4|||
16410411|NCT03215706|39985481|FG000|Randomization|other reasons|0|||
16410412|NCT03215706|39985482|FG001|Randomization|other reasons|2|||
16410413|NCT03215706|39985481|FG000|Treatment Period|Disease Progression|150|||
16410414|NCT03215706|39985482|FG001|Treatment Period|Disease Progression|142|||
16410415|NCT03215706|39985481|FG000|Treatment Period|Study Drug Toxicity|53|||
16410416|NCT03215706|39985482|FG001|Treatment Period|Study Drug Toxicity|21|||
16410417|NCT03215706|39985481|FG000|Treatment Period|Death|2|||
16410418|NCT03215706|39985482|FG001|Treatment Period|Death|1|||
16410419|NCT03215706|39985481|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
16410420|NCT03215706|39985482|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
16410421|NCT03215706|39985481|FG000|Treatment Period|Request to D/C treatment|1|||
16410422|NCT03215706|39985482|FG001|Treatment Period|Request to D/C treatment|6|||
16410423|NCT03215706|39985481|FG000|Treatment Period|Participant withdrew consent|3|||
16410424|NCT03215706|39985482|FG001|Treatment Period|Participant withdrew consent|4|||
16410425|NCT03215706|39985481|FG000|Treatment Period|Lost to Follow-up|0|||
16410426|NCT03215706|39985482|FG001|Treatment Period|Lost to Follow-up|1|||
16410427|NCT03215706|39985481|FG000|Treatment Period|Other Reasons|4|||
16410428|NCT03215706|39985482|FG001|Treatment Period|Other Reasons|5|||
16410429|NCT03215706|39985481|FG000|Treatment Period|Ongoing in the treatment period|105|||
16410430|NCT03215706|39985482|FG001|Treatment Period|Ongoing in the treatment period|43|||
16410431|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
16410432|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
16410433|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
16410434|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
16410435|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
16410436|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
16410437|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
16224802|NCT02712008|39302535|FG002|Baseline (Day 1) up to Week 12|Death|0|||
16224803|NCT02712008|39302536|FG003|Baseline (Day 1) up to Week 12|Death|0|||
16224804|NCT02712008|39302537|FG004|Baseline (Day 1) up to Week 12|Death|0|||
16224805|NCT02712008|39302538|FG005|Baseline (Day 1) up to Week 12|Death|0|||
16224806|NCT02712008|39302539|FG006|Baseline (Day 1) up to Week 12|Death|0|||
16224807|NCT02712008|39302540|FG007|Baseline (Day 1) up to Week 12|Death|0|||
16224808|NCT02712008|39302533|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16224809|NCT02712008|39302534|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
16114099|NCT01236352|38906044|FG004|Overall Study|Adverse Event|0|||
16114100|NCT01236352|38906045|FG005|Overall Study|Adverse Event|0|||
16114101|NCT01236352|38906046|FG006|Overall Study|Adverse Event|2|||
16114102|NCT01236352|38906047|FG007|Overall Study|Adverse Event|0|||
16114103|NCT01236352|38906048|FG008|Overall Study|Adverse Event|0|||
16114104|NCT01236352|38906049|FG009|Overall Study|Adverse Event|4|||
16114105|NCT01236352|38906050|FG010|Overall Study|Adverse Event|1|||
16114106|NCT01236352|38906040|FG000|Overall Study|Study drug toxicity|0|||
16114107|NCT01236352|38906041|FG001|Overall Study|Study drug toxicity|0|||
16114108|NCT01236352|38906042|FG002|Overall Study|Study drug toxicity|0|||
16114109|NCT01236352|38906043|FG003|Overall Study|Study drug toxicity|0|||
16114110|NCT01236352|38906044|FG004|Overall Study|Study drug toxicity|0|||
16114111|NCT01236352|38906045|FG005|Overall Study|Study drug toxicity|1|||
16114112|NCT01236352|38906046|FG006|Overall Study|Study drug toxicity|1|||
16114113|NCT01236352|38906047|FG007|Overall Study|Study drug toxicity|0|||
16114114|NCT01236352|38906048|FG008|Overall Study|Study drug toxicity|0|||
16114115|NCT01236352|38906049|FG009|Overall Study|Study drug toxicity|2|||
16114116|NCT01236352|38906050|FG010|Overall Study|Study drug toxicity|2|||
16114117|NCT01236352|38906040|FG000|Overall Study|Disease progression|1|||
16114118|NCT01236352|38906041|FG001|Overall Study|Disease progression|2|||
16114119|NCT01236352|38906042|FG002|Overall Study|Disease progression|1|||
16114120|NCT01236352|38906043|FG003|Overall Study|Disease progression|2|||
16114121|NCT01236352|38906044|FG004|Overall Study|Disease progression|2|||
16114122|NCT01236352|38906045|FG005|Overall Study|Disease progression|2|||
16114123|NCT01236352|38906046|FG006|Overall Study|Disease progression|1|||
16114124|NCT01236352|38906047|FG007|Overall Study|Disease progression|3|||
16114125|NCT01236352|38906048|FG008|Overall Study|Disease progression|2|||
16114126|NCT01236352|38906049|FG009|Overall Study|Disease progression|2|||
16114127|NCT01236352|38906050|FG010|Overall Study|Disease progression|2|||
16114128|NCT01236352|38906040|FG000|Overall Study|Poor/Non-compliance|1|||
16114129|NCT01236352|38906041|FG001|Overall Study|Poor/Non-compliance|0|||
16114130|NCT01236352|38906042|FG002|Overall Study|Poor/Non-compliance|0|||
16114131|NCT01236352|38906043|FG003|Overall Study|Poor/Non-compliance|0|||
16114132|NCT01236352|38906044|FG004|Overall Study|Poor/Non-compliance|0|||
16114133|NCT01236352|38906045|FG005|Overall Study|Poor/Non-compliance|0|||
16114134|NCT01236352|38906046|FG006|Overall Study|Poor/Non-compliance|0|||
16114135|NCT01236352|38906047|FG007|Overall Study|Poor/Non-compliance|0|||
16114136|NCT01236352|38906048|FG008|Overall Study|Poor/Non-compliance|0|||
16114137|NCT01236352|38906049|FG009|Overall Study|Poor/Non-compliance|0|||
16114138|NCT01236352|38906050|FG010|Overall Study|Poor/Non-compliance|0|||
16114139|NCT01236352|38906040|FG000|Overall Study|Maximum clinical benefit|1|||
16114140|NCT01236352|38906041|FG001|Overall Study|Maximum clinical benefit|1|||
16114141|NCT01236352|38906042|FG002|Overall Study|Maximum clinical benefit|1|||
16114142|NCT01236352|38906043|FG003|Overall Study|Maximum clinical benefit|0|||
16114143|NCT01236352|38906044|FG004|Overall Study|Maximum clinical benefit|2|||
16114144|NCT01236352|38906045|FG005|Overall Study|Maximum clinical benefit|0|||
16114145|NCT01236352|38906046|FG006|Overall Study|Maximum clinical benefit|3|||
16114146|NCT01236352|38906047|FG007|Overall Study|Maximum clinical benefit|1|||
16114147|NCT01236352|38906048|FG008|Overall Study|Maximum clinical benefit|1|||
16114148|NCT01236352|38906049|FG009|Overall Study|Maximum clinical benefit|4|||
16114149|NCT01236352|38906050|FG010|Overall Study|Maximum clinical benefit|2|||
16114150|NCT01236352|38906040|FG000|Overall Study|Subject request to discontinue treatment|0|||
16114151|NCT01236352|38906041|FG001|Overall Study|Subject request to discontinue treatment|0|||
16114152|NCT01236352|38906042|FG002|Overall Study|Subject request to discontinue treatment|1|||
16114153|NCT01236352|38906043|FG003|Overall Study|Subject request to discontinue treatment|1|||
16114154|NCT01236352|38906044|FG004|Overall Study|Subject request to discontinue treatment|0|||
16114155|NCT01236352|38906045|FG005|Overall Study|Subject request to discontinue treatment|1|||
16114156|NCT01236352|38906046|FG006|Overall Study|Subject request to discontinue treatment|0|||
16114157|NCT01236352|38906047|FG007|Overall Study|Subject request to discontinue treatment|0|||
16114158|NCT01236352|38906048|FG008|Overall Study|Subject request to discontinue treatment|0|||
16114159|NCT01236352|38906049|FG009|Overall Study|Subject request to discontinue treatment|1|||
16224810|NCT02712008|39302535|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
16224811|NCT02712008|39302536|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16224812|NCT02712008|39302537|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16224813|NCT02712008|39302538|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16224814|NCT02712008|39302539|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16346843|NCT02322749|39757313|FG003|Period 2|Adverse Event|1|||
16114160|NCT01236352|38906050|FG010|Overall Study|Subject request to discontinue treatment|4|||
16114161|NCT01236352|38906040|FG000|Overall Study|Subject to receive drug via EAP|1|||
16114162|NCT01236352|38906041|FG001|Overall Study|Subject to receive drug via EAP|1|||
16114163|NCT01236352|38906042|FG002|Overall Study|Subject to receive drug via EAP|1|||
16114164|NCT01236352|38906043|FG003|Overall Study|Subject to receive drug via EAP|0|||
16114165|NCT01236352|38906044|FG004|Overall Study|Subject to receive drug via EAP|0|||
16114166|NCT01236352|38906045|FG005|Overall Study|Subject to receive drug via EAP|0|||
16114167|NCT01236352|38906046|FG006|Overall Study|Subject to receive drug via EAP|0|||
16346844|NCT02322749|39757314|FG004|Period 2|Adverse Event|0|||
16114168|NCT01236352|38906047|FG007|Overall Study|Subject to receive drug via EAP|2|||
16114169|NCT01236352|38906048|FG008|Overall Study|Subject to receive drug via EAP|0|||
16114170|NCT01236352|38906049|FG009|Overall Study|Subject to receive drug via EAP|4|||
16114171|NCT01236352|38906050|FG010|Overall Study|Subject to receive drug via EAP|0|||
16114172|NCT01236352|38906040|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
16114173|NCT01236352|38906041|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
16114174|NCT01236352|38906042|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
16114175|NCT01236352|38906043|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
16114176|NCT01236352|38906044|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
16114177|NCT01236352|38906045|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
16114178|NCT01236352|38906046|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
16114179|NCT01236352|38906047|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
16114180|NCT01236352|38906048|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
16114181|NCT01236352|38906049|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
16114182|NCT01236352|38906050|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
16114183|NCT01236352|38906040|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16114184|NCT01236352|38906041|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16114185|NCT01236352|38906042|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16114186|NCT01236352|38906043|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16114187|NCT01236352|38906044|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16114188|NCT01236352|38906045|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16114189|NCT01236352|38906046|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16224815|NCT02712008|39302540|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
16224816|NCT02712008|39302533|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
16224817|NCT02712008|39302534|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16224818|NCT02712008|39302535|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
16224819|NCT02712008|39302536|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16224820|NCT02712008|39302537|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16224821|NCT02712008|39302538|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16224822|NCT02712008|39302539|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16224823|NCT02712008|39302540|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
16224824|NCT02712008|39302533|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
16224825|NCT02712008|39302534|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
16224826|NCT02712008|39302535|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
16224827|NCT02712008|39302536|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
16547146|NCT02093663|40467484|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
16547147|NCT02093663|40467485|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
16547148|NCT02093663|40467486|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
16547149|NCT02093663|40467487|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
16547150|NCT02093663|40467488|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
16547151|NCT02093663|40467484|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
16547152|NCT02093663|40467485|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
16547153|NCT02093663|40467486|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
16547154|NCT02093663|40467487|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
16547155|NCT02093663|40467488|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
16547156|NCT02093663|40467484|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
16547157|NCT02093663|40467485|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
16547158|NCT02093663|40467486|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
16547159|NCT02093663|40467487|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
16114190|NCT01236352|38906047|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16114191|NCT01236352|38906048|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16114192|NCT01236352|38906049|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
16114193|NCT01236352|38906050|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
16224828|NCT02712008|39302537|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
16224829|NCT02712008|39302538|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
16224830|NCT02712008|39302539|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
16224831|NCT02712008|39302540|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
16224832|NCT02712008|39302533|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
16224833|NCT02712008|39302534|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
16224834|NCT02712008|39302535|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
16224835|NCT02712008|39302536|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
16224836|NCT02712008|39302537|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
16224837|NCT02712008|39302538|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
16547160|NCT02093663|40467488|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
16547161|NCT02093663|40467484|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
16547162|NCT02093663|40467485|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
16547163|NCT02093663|40467486|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
16547164|NCT02093663|40467487|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
16547165|NCT02093663|40467488|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
16547166|NCT01691521|40467494|FG000|Overall Study|Adverse Event|4|||
16547167|NCT01691521|40467495|FG001|Overall Study|Adverse Event|0|||
16547168|NCT01691521|40467496|FG002|Overall Study|Adverse Event|1|||
16547169|NCT01691521|40467494|FG000|Overall Study|Lack of Efficacy|1|||
16547170|NCT01691521|40467495|FG001|Overall Study|Lack of Efficacy|1|||
16547171|NCT01691521|40467496|FG002|Overall Study|Lack of Efficacy|2|||
16547172|NCT01691521|40467494|FG000|Overall Study|Protocol Violation|0|||
16547173|NCT01691521|40467495|FG001|Overall Study|Protocol Violation|3|||
16224838|NCT02712008|39302539|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
16224839|NCT02712008|39302540|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
16224840|NCT02712008|39302533|FG000|From Week 12 up to Week 36|Adverse Event|0|||
16224841|NCT02712008|39302534|FG001|From Week 12 up to Week 36|Adverse Event|0|||
16224842|NCT02712008|39302535|FG002|From Week 12 up to Week 36|Adverse Event|0|||
16224843|NCT02712008|39302536|FG003|From Week 12 up to Week 36|Adverse Event|0|||
16224844|NCT02712008|39302537|FG004|From Week 12 up to Week 36|Adverse Event|1|||
16224845|NCT02712008|39302538|FG005|From Week 12 up to Week 36|Adverse Event|0|||
16224846|NCT02712008|39302539|FG006|From Week 12 up to Week 36|Adverse Event|0|||
16224847|NCT02712008|39302540|FG007|From Week 12 up to Week 36|Adverse Event|2|||
16224848|NCT02712008|39302533|FG000|From Week 12 up to Week 36|Death|1|||
16224849|NCT02712008|39302534|FG001|From Week 12 up to Week 36|Death|0|||
16547174|NCT01691521|40467496|FG002|Overall Study|Protocol Violation|0|||
16547175|NCT01691521|40467494|FG000|Overall Study|Lost to Follow-up|0|||
16547176|NCT01691521|40467495|FG001|Overall Study|Lost to Follow-up|2|||
16114194|NCT01236352|38906040|FG000|Overall Study|Lack of response to drug|0|||
16114195|NCT01236352|38906041|FG001|Overall Study|Lack of response to drug|0|||
16114196|NCT01236352|38906042|FG002|Overall Study|Lack of response to drug|0|||
16114197|NCT01236352|38906043|FG003|Overall Study|Lack of response to drug|0|||
16114198|NCT01236352|38906044|FG004|Overall Study|Lack of response to drug|0|||
16114199|NCT01236352|38906045|FG005|Overall Study|Lack of response to drug|0|||
16114200|NCT01236352|38906046|FG006|Overall Study|Lack of response to drug|0|||
16114201|NCT01236352|38906047|FG007|Overall Study|Lack of response to drug|0|||
16114202|NCT01236352|38906048|FG008|Overall Study|Lack of response to drug|0|||
16114203|NCT01236352|38906049|FG009|Overall Study|Lack of response to drug|1|||
16114204|NCT01236352|38906050|FG010|Overall Study|Lack of response to drug|1|||
16114205|NCT01236352|38906040|FG000|Overall Study|Patient transferred to IST|0|||
16114206|NCT01236352|38906041|FG001|Overall Study|Patient transferred to IST|0|||
16114207|NCT01236352|38906042|FG002|Overall Study|Patient transferred to IST|0|||
16114208|NCT01236352|38906043|FG003|Overall Study|Patient transferred to IST|0|||
16114209|NCT01236352|38906044|FG004|Overall Study|Patient transferred to IST|0|||
16114210|NCT01236352|38906045|FG005|Overall Study|Patient transferred to IST|0|||
16114211|NCT01236352|38906046|FG006|Overall Study|Patient transferred to IST|0|||
16114212|NCT01236352|38906047|FG007|Overall Study|Patient transferred to IST|0|||
16114213|NCT01236352|38906048|FG008|Overall Study|Patient transferred to IST|0|||
16114214|NCT01236352|38906049|FG009|Overall Study|Patient transferred to IST|2|||
16114215|NCT01236352|38906050|FG010|Overall Study|Patient transferred to IST|6|||
16114216|NCT04650698|38906051|FG000|Overall Study|Protocol Violation|2|||
16114217|NCT04650698|38906052|FG001|Overall Study|Protocol Violation|1|||
16114218|NCT04650698|38906051|FG000|Overall Study|Withdrawal by Subject|0|||
16114219|NCT04650698|38906052|FG001|Overall Study|Withdrawal by Subject|1|||
16114220|NCT00872001|38906054|FG000|Overall Study|Adverse Event|34|||
16114221|NCT00872001|38906055|FG001|Overall Study|Adverse Event|23|||
16114222|NCT00872001|38906054|FG000|Overall Study|Protocol Defined Clinical Event|5|||
16114223|NCT00872001|38906055|FG001|Overall Study|Protocol Defined Clinical Event|7|||
16114224|NCT00872001|38906054|FG000|Overall Study|Lost to Follow-up|13|||
16114225|NCT00872001|38906055|FG001|Overall Study|Lost to Follow-up|12|||
16114226|NCT00872001|38906054|FG000|Overall Study|Withdrawal by Subject|18|||
16114227|NCT00872001|38906055|FG001|Overall Study|Withdrawal by Subject|30|||
16114228|NCT00872001|38906054|FG000|Overall Study|Protocol Violation|5|||
16114229|NCT00872001|38906055|FG001|Overall Study|Protocol Violation|8|||
16114230|NCT00872001|38906054|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
16114231|NCT00872001|38906055|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
16114232|NCT00872001|38906054|FG000|Overall Study|Administrative|23|||
16114233|NCT00872001|38906055|FG001|Overall Study|Administrative|15|||
16114234|NCT01432626|38906056|FG000|Overall Study|LV function recovered|2|||
16114235|NCT01432626|38906056|FG000|Overall Study|Withdrawal by Subject|2|||
16114236|NCT01432626|38906056|FG000|Overall Study|Only 1 image competed|2|||
16224850|NCT02712008|39302535|FG002|From Week 12 up to Week 36|Death|0|||
16114237|NCT01432626|38906056|FG000|Overall Study|Imaging agent not available|1|||
16114238|NCT00903760|38906057|FG000|Overall Study|Disease Progression/Death|8|||
16114239|NCT00903760|38906058|FG001|Overall Study|Disease Progression/Death|6|||
16114240|NCT00903760|38906057|FG000|Overall Study|Stem Cell Transplant|8|||
16114241|NCT00903760|38906058|FG001|Overall Study|Stem Cell Transplant|4|||
16114242|NCT00903760|38906057|FG000|Overall Study|Physician Decision|1|||
16224851|NCT02712008|39302536|FG003|From Week 12 up to Week 36|Death|0|||
16224852|NCT02712008|39302537|FG004|From Week 12 up to Week 36|Death|0|||
16224853|NCT02712008|39302538|FG005|From Week 12 up to Week 36|Death|0|||
16224854|NCT02712008|39302539|FG006|From Week 12 up to Week 36|Death|1|||
16224855|NCT02712008|39302540|FG007|From Week 12 up to Week 36|Death|0|||
16224856|NCT02712008|39302533|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
16224857|NCT02712008|39302534|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
16224858|NCT02712008|39302535|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
16224859|NCT02712008|39302536|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
16224860|NCT02712008|39302537|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
16224861|NCT02712008|39302538|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
16224862|NCT02712008|39302539|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
16224863|NCT02712008|39302540|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
16224864|NCT02712008|39302533|FG000|From Week 12 up to Week 36|Physician Decision|0|||
16224865|NCT02712008|39302534|FG001|From Week 12 up to Week 36|Physician Decision|0|||
16224866|NCT02712008|39302535|FG002|From Week 12 up to Week 36|Physician Decision|0|||
16224867|NCT02712008|39302536|FG003|From Week 12 up to Week 36|Physician Decision|1|||
16114243|NCT00903760|38906058|FG001|Overall Study|Physician Decision|2|||
16114244|NCT00903760|38906057|FG000|Overall Study|Death|0|||
16114245|NCT00903760|38906058|FG001|Overall Study|Death|1|||
16114246|NCT00903760|38906057|FG000|Overall Study|Lost to Follow-up|1|||
16114247|NCT00903760|38906058|FG001|Overall Study|Lost to Follow-up|0|||
16114248|NCT00903760|38906057|FG000|Overall Study|Withdrawal by Subject|1|||
16224868|NCT02712008|39302537|FG004|From Week 12 up to Week 36|Physician Decision|1|||
16224869|NCT02712008|39302538|FG005|From Week 12 up to Week 36|Physician Decision|0|||
16224870|NCT02712008|39302539|FG006|From Week 12 up to Week 36|Physician Decision|0|||
16224871|NCT02712008|39302540|FG007|From Week 12 up to Week 36|Physician Decision|0|||
16224872|NCT02712008|39302533|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
16224873|NCT02712008|39302534|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
16224874|NCT02712008|39302535|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
16224875|NCT02712008|39302536|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
16224876|NCT02712008|39302537|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
16224877|NCT02712008|39302538|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
16224878|NCT02712008|39302539|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
16224879|NCT02712008|39302540|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
16224880|NCT02906644|39302541|FG000|First 2 Weeks|Withdrawal by Subject|0|||
16224881|NCT02906644|39302542|FG001|First 2 Weeks|Withdrawal by Subject|2|||
16224882|NCT02906644|39302541|FG000|First 2 Weeks|Physician Decision|1|||
16224883|NCT02906644|39302542|FG001|First 2 Weeks|Physician Decision|1|||
16224884|NCT02906644|39302541|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
16224885|NCT02906644|39302542|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
16224886|NCT02906644|39302541|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
16547177|NCT01691521|40467496|FG002|Overall Study|Lost to Follow-up|2|||
16547178|NCT01691521|40467494|FG000|Overall Study|Physician Decision|2|||
16547179|NCT01691521|40467495|FG001|Overall Study|Physician Decision|1|||
16547180|NCT01691521|40467496|FG002|Overall Study|Physician Decision|0|||
16547181|NCT01691521|40467494|FG000|Overall Study|Withdrawal by Subject|5|||
16547182|NCT01691521|40467495|FG001|Overall Study|Withdrawal by Subject|9|||
16547183|NCT01691521|40467496|FG002|Overall Study|Withdrawal by Subject|4|||
16547184|NCT00622180|40467502|FG000|Overall Study|Lost to Follow-up|1|||
16547185|NCT00622180|40467503|FG001|Overall Study|Lost to Follow-up|2|||
16547186|NCT02696564|40467508|FG000|Overall Study|Death|1|||
16547187|NCT02696564|40467509|FG001|Overall Study|Death|2|||
16547188|NCT02696564|40467508|FG000|Overall Study|Withdrawal by Subject|3|||
16547189|NCT02696564|40467509|FG001|Overall Study|Withdrawal by Subject|2|||
16547190|NCT02696564|40467508|FG000|Overall Study|Lost to Follow-up|3|||
16547191|NCT02696564|40467509|FG001|Overall Study|Lost to Follow-up|3|||
16547192|NCT02696564|40467508|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
16547193|NCT02696564|40467509|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
16547194|NCT02696564|40467508|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
16547195|NCT02696564|40467509|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
16547196|NCT02696564|40467508|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
16547197|NCT02696564|40467509|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
16547198|NCT02696564|40467508|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
16547199|NCT02696564|40467509|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
16547200|NCT02696564|40467508|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
16547201|NCT02696564|40467509|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
16547202|NCT01396395|40467510|FG000|Overall Study|Withdrawal by Subject|10|||
16547203|NCT01396395|40467511|FG001|Overall Study|Withdrawal by Subject|12|||
16547204|NCT01396395|40467510|FG000|Overall Study|Protocol Violation|3|||
16547205|NCT01396395|40467511|FG001|Overall Study|Protocol Violation|1|||
16547206|NCT01396395|40467510|FG000|Overall Study|Adverse Event|10|||
16547207|NCT01396395|40467511|FG001|Overall Study|Adverse Event|2|||
16547208|NCT01396395|40467510|FG000|Overall Study|Lost to Follow-up|17|||
16547209|NCT01396395|40467511|FG001|Overall Study|Lost to Follow-up|11|||
16547210|NCT01396395|40467510|FG000|Overall Study|Other|0|||
16547211|NCT01396395|40467511|FG001|Overall Study|Other|1|||
16547212|NCT02316769|40467515|FG000|Overall Study|Physician Decision|1|||
16547213|NCT02316769|40467516|FG001|Overall Study|Physician Decision|0|||
16547214|NCT02316769|40467515|FG000|Overall Study|Withdrawal by Subject|1|||
16547215|NCT02316769|40467516|FG001|Overall Study|Withdrawal by Subject|0|||
16547216|NCT03287414|40467518|FG000|Treatment Epoch|Adverse Event|0|||
16547217|NCT03287414|40467519|FG001|Treatment Epoch|Adverse Event|1|||
16547218|NCT03287414|40467518|FG000|Treatment Epoch|Study terminated by sponsor|2|||
16547219|NCT03287414|40467519|FG001|Treatment Epoch|Study terminated by sponsor|2|||
16547220|NCT03287414|40467518|FG000|Treatment Epoch|Subject/Guardian decision|4|||
16547221|NCT03287414|40467519|FG001|Treatment Epoch|Subject/Guardian decision|0|||
16547222|NCT03287414|40467518|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
16547223|NCT03287414|40467519|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
16547224|NCT03287414|40467518|FG000|Treatment Epoch|Withdrawal by Subject|1|||
16547225|NCT03287414|40467519|FG001|Treatment Epoch|Withdrawal by Subject|0|||
16547226|NCT03287414|40467518|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
16224887|NCT02906644|39302542|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
16224888|NCT01757821|39302547|FG000|Overall Study|Adverse Event|1|||
16224889|NCT02194699|39302555|FG000|Randomised|Did not receive treatment|1|||
16346845|NCT02322749|39757315|FG005|Period 2|Adverse Event|0|||
16224890|NCT02194699|39302556|FG001|Randomised|Did not receive treatment|5|||
16224891|NCT02194699|39302555|FG000|Randomised|Without potential for 52 weeks of IP|5|||
16224892|NCT02194699|39302556|FG001|Randomised|Without potential for 52 weeks of IP|5|||
16224893|NCT02194699|39302555|FG000|Randomised|Duplicate patient|2|||
16224894|NCT02194699|39302556|FG001|Randomised|Duplicate patient|1|||
16224895|NCT02194699|39302555|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
16224896|NCT02194699|39302556|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
16224897|NCT02194699|39302555|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
16224898|NCT02194699|39302556|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
16224899|NCT02194699|39302555|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
16224900|NCT02194699|39302556|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
16224901|NCT02194699|39302555|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
16224902|NCT02194699|39302556|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
16224903|NCT02194699|39302555|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
16224904|NCT02194699|39302556|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
16224905|NCT02194699|39302555|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
16224906|NCT02194699|39302556|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
16224907|NCT02335411|39302557|FG000|Overall Study|Death|223|||
16224908|NCT02335411|39302558|FG001|Overall Study|Death|22|||
16224909|NCT02335411|39302559|FG002|Overall Study|Death|26|||
16224910|NCT02335411|39302557|FG000|Overall Study|Physician Decision|3|||
16224911|NCT02335411|39302558|FG001|Overall Study|Physician Decision|0|||
16224912|NCT02335411|39302559|FG002|Overall Study|Physician Decision|0|||
16224913|NCT02335411|39302557|FG000|Overall Study|Protocol Violation|1|||
16224914|NCT02335411|39302558|FG001|Overall Study|Protocol Violation|0|||
16224915|NCT02335411|39302559|FG002|Overall Study|Protocol Violation|0|||
16224916|NCT02335411|39302557|FG000|Overall Study|Withdrawal by Subject|11|||
16224917|NCT02335411|39302558|FG001|Overall Study|Withdrawal by Subject|0|||
16224918|NCT02335411|39302559|FG002|Overall Study|Withdrawal by Subject|3|||
16224919|NCT02335411|39302557|FG000|Overall Study|Sponsor Decision|12|||
16224920|NCT02335411|39302558|FG001|Overall Study|Sponsor Decision|3|||
16224921|NCT02335411|39302559|FG002|Overall Study|Sponsor Decision|2|||
16224922|NCT02335411|39302557|FG000|Overall Study|Adverse Event|9|||
16224923|NCT02335411|39302558|FG001|Overall Study|Adverse Event|0|||
16224924|NCT02335411|39302559|FG002|Overall Study|Adverse Event|0|||
16224925|NCT02493712|39302560|FG000|Overall Study|Withdrawal by Subject|1|||
16224926|NCT02493712|39302561|FG001|Overall Study|Withdrawal by Subject|0|||
16224927|NCT02493712|39302562|FG002|Overall Study|Withdrawal by Subject|2|||
16224928|NCT02493712|39302560|FG000|Overall Study|Protocol Violation|0|||
16224929|NCT02493712|39302561|FG001|Overall Study|Protocol Violation|0|||
16224930|NCT02493712|39302562|FG002|Overall Study|Protocol Violation|1|||
16224931|NCT02493712|39302560|FG000|Overall Study|Lost to Follow-up|1|||
16224932|NCT02493712|39302561|FG001|Overall Study|Lost to Follow-up|0|||
16224933|NCT02493712|39302562|FG002|Overall Study|Lost to Follow-up|0|||
16224934|NCT02493712|39302560|FG000|Overall Study|Physician Decision|0|||
16224935|NCT02493712|39302561|FG001|Overall Study|Physician Decision|1|||
16224936|NCT02493712|39302562|FG002|Overall Study|Physician Decision|0|||
16224937|NCT02493712|39302560|FG000|Overall Study|Lack of Efficacy|0|||
16224938|NCT02493712|39302561|FG001|Overall Study|Lack of Efficacy|5|||
16224939|NCT02493712|39302562|FG002|Overall Study|Lack of Efficacy|3|||
16224940|NCT04034225|39302563|FG000|Overall Study|Death|3|||
16224941|NCT04034225|39302563|FG000|Overall Study|Withdrawal by Subject|2|||
16224942|NCT04034225|39302563|FG000|Overall Study|Study termination by Sponsor|18|||
16224943|NCT04034225|39302563|FG000|Overall Study|Physician Decision|1|||
16224944|NCT04034225|39302563|FG000|Overall Study|Lack of Efficacy|1|||
16224945|NCT01224171|39302568|FG000|Overall Study|Adverse Event|8|||
16224946|NCT01224171|39302569|FG001|Overall Study|Adverse Event|4|||
16224947|NCT01224171|39302568|FG000|Overall Study|Protocol Violation|0|||
16224948|NCT01224171|39302569|FG001|Overall Study|Protocol Violation|1|||
16224949|NCT01224171|39302568|FG000|Overall Study|Lack of Efficacy|5|||
16224950|NCT01224171|39302569|FG001|Overall Study|Lack of Efficacy|1|||
16224951|NCT01224171|39302568|FG000|Overall Study|Withdrawal of Consent|2|||
16224952|NCT01224171|39302569|FG001|Overall Study|Withdrawal of Consent|4|||
16224953|NCT01224171|39302568|FG000|Overall Study|Lost to Follow-up|0|||
16224954|NCT01224171|39302569|FG001|Overall Study|Lost to Follow-up|3|||
16224955|NCT04369742|39302576|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
16224956|NCT04369742|39302577|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
16224957|NCT04369742|39302576|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
16224958|NCT04369742|39302577|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
16224959|NCT00612456|39302578|FG000|Overall Study|Adverse Event|1|||
16547227|NCT03287414|40467519|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
16224960|NCT00612456|39302579|FG001|Overall Study|Adverse Event|0|||
16224961|NCT00612456|39302580|FG002|Overall Study|Adverse Event|0|||
16224962|NCT00612456|39302578|FG000|Overall Study|Lack of Efficacy|1|||
16224963|NCT00612456|39302579|FG001|Overall Study|Lack of Efficacy|1|||
16224964|NCT00612456|39302580|FG002|Overall Study|Lack of Efficacy|0|||
16547228|NCT03287414|40467518|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
16224965|NCT00612456|39302578|FG000|Overall Study|Withdrawal by Subject|0|||
16224966|NCT00612456|39302579|FG001|Overall Study|Withdrawal by Subject|1|||
16224967|NCT00612456|39302580|FG002|Overall Study|Withdrawal by Subject|0|||
16224968|NCT01249404|39302583|FG000|Overall Study|Study treatment not received|0|||
16224969|NCT01249404|39302584|FG001|Overall Study|Study treatment not received|1|||
16224970|NCT01249404|39302585|FG002|Overall Study|Study treatment not received|2|||
16224971|NCT01249404|39302583|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
16224972|NCT01249404|39302584|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
16224973|NCT01249404|39302585|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
16224974|NCT01249404|39302583|FG000|Overall Study|Adverse Event|2|||
16224975|NCT01249404|39302584|FG001|Overall Study|Adverse Event|2|||
16224976|NCT01249404|39302585|FG002|Overall Study|Adverse Event|2|||
16224977|NCT01249404|39302583|FG000|Overall Study|Withdrawal by Subject|2|||
16224978|NCT01249404|39302584|FG001|Overall Study|Withdrawal by Subject|2|||
16224979|NCT01249404|39302585|FG002|Overall Study|Withdrawal by Subject|0|||
16224980|NCT01249404|39302583|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
16224981|NCT01249404|39302584|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
16224982|NCT01249404|39302585|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
16224983|NCT01249404|39302583|FG000|Overall Study|Non compliance to visit schedule|0|||
16224984|NCT01249404|39302584|FG001|Overall Study|Non compliance to visit schedule|1|||
16224985|NCT01249404|39302585|FG002|Overall Study|Non compliance to visit schedule|0|||
16547229|NCT03287414|40467519|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
16547230|NCT02343003|40467520|FG000|Overall Study|Withdrawal by Subject|9|||
16547231|NCT02343003|40467521|FG001|Overall Study|Withdrawal by Subject|4|||
16547232|NCT02343003|40467520|FG000|Overall Study|Lost to Follow-up|5|||
16547233|NCT02343003|40467521|FG001|Overall Study|Lost to Follow-up|1|||
16547234|NCT02343003|40467520|FG000|Overall Study|Protocol Violation|1|||
16547235|NCT02343003|40467521|FG001|Overall Study|Protocol Violation|0|||
16547236|NCT02343003|40467520|FG000|Overall Study|Death|0|||
16547237|NCT02343003|40467521|FG001|Overall Study|Death|1|||
16547238|NCT02343003|40467520|FG000|Overall Study|exclusion criteria met|1|||
16547239|NCT02343003|40467521|FG001|Overall Study|exclusion criteria met|1|||
16547240|NCT02343003|40467520|FG000|Overall Study|terminated by sponsor|2|||
16547241|NCT02343003|40467521|FG001|Overall Study|terminated by sponsor|0|||
16547242|NCT02944656|40467528|FG000|Overall Study|No longer eligible|3|||
16224986|NCT01681004|39302586|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
16224987|NCT01681004|39302587|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
16224988|NCT01681004|39302586|FG000|Study Completion|Lost to Follow-up|8|||
16224989|NCT01681004|39302587|FG001|Study Completion|Lost to Follow-up|3|||
16224990|NCT01681004|39302586|FG000|Study Completion|Physician Decision|1|||
16224991|NCT01681004|39302587|FG001|Study Completion|Physician Decision|3|||
16224992|NCT01681004|39302586|FG000|Study Completion|Site Termination|2|||
16224993|NCT01681004|39302587|FG001|Study Completion|Site Termination|1|||
16224994|NCT01681004|39302586|FG000|Study Completion|Death|1|||
16224995|NCT01681004|39302587|FG001|Study Completion|Death|1|||
16224996|NCT01231620|39302588|FG000|Overall Study|Physician Decision|3|||
16224997|NCT01231620|39302589|FG001|Overall Study|Physician Decision|5|||
16224998|NCT01231620|39302590|FG002|Overall Study|Physician Decision|10|||
16224999|NCT01231620|39302588|FG000|Overall Study|Death|12|||
16225000|NCT01231620|39302589|FG001|Overall Study|Death|14|||
16225001|NCT01231620|39302590|FG002|Overall Study|Death|11|||
16225002|NCT01231620|39302588|FG000|Overall Study|Adverse Event|2|||
16225003|NCT01231620|39302589|FG001|Overall Study|Adverse Event|2|||
16225004|NCT01231620|39302590|FG002|Overall Study|Adverse Event|1|||
16547243|NCT02944656|40467529|FG001|Overall Study|No longer eligible|0|||
16547244|NCT02944656|40467528|FG000|Overall Study|Lost to Follow-up|7|||
16225005|NCT01231620|39302588|FG000|Overall Study|Withdrawal by Subject|6|||
16225006|NCT01231620|39302589|FG001|Overall Study|Withdrawal by Subject|6|||
16225007|NCT01231620|39302590|FG002|Overall Study|Withdrawal by Subject|8|||
16225008|NCT01231620|39302588|FG000|Overall Study|Lost to Follow-up|3|||
16547245|NCT02944656|40467529|FG001|Overall Study|Lost to Follow-up|10|||
16547246|NCT02323646|40467534|FG000|Treatment Course 1|Adverse Event|1|||
16225009|NCT01231620|39302589|FG001|Overall Study|Lost to Follow-up|4|||
16225010|NCT01231620|39302590|FG002|Overall Study|Lost to Follow-up|9|||
16225011|NCT02173158|39302592|FG000|Efficacy Phase|Adverse Event|1|||
16225012|NCT00364351|39302593|FG000|Overall Study|Adverse Event|90|||
16225013|NCT00364351|39302594|FG001|Overall Study|Adverse Event|44|||
16225014|NCT00364351|39302593|FG000|Overall Study|Condition under investigation worsened|469|||
16225015|NCT00364351|39302594|FG001|Overall Study|Condition under investigation worsened|497|||
16225016|NCT00364351|39302593|FG000|Overall Study|Prohibited concomitant medication|0|||
16225017|NCT00364351|39302594|FG001|Overall Study|Prohibited concomitant medication|2|||
16225018|NCT00364351|39302593|FG000|Overall Study|Lost to Follow-up|1|||
16225019|NCT00364351|39302594|FG001|Overall Study|Lost to Follow-up|1|||
16225020|NCT00364351|39302593|FG000|Overall Study|Withdrawal by Subject|30|||
16225021|NCT00364351|39302594|FG001|Overall Study|Withdrawal by Subject|29|||
16225022|NCT00364351|39302593|FG000|Overall Study|Incorrect enrollment|1|||
16225023|NCT00364351|39302594|FG001|Overall Study|Incorrect enrollment|1|||
16225024|NCT00364351|39302593|FG000|Overall Study|Sponsor decision|1|||
16225025|NCT00364351|39302594|FG001|Overall Study|Sponsor decision|0|||
16225026|NCT00364351|39302593|FG000|Overall Study|Poor treatment compliance|0|||
16225027|NCT00364351|39302594|FG001|Overall Study|Poor treatment compliance|3|||
16225028|NCT00364351|39302593|FG000|Overall Study|Investigator error|0|||
16225029|NCT00364351|39302594|FG001|Overall Study|Investigator error|2|||
16225030|NCT00364351|39302593|FG000|Overall Study|Patient could not travel to site|0|||
16225031|NCT00364351|39302594|FG001|Overall Study|Patient could not travel to site|1|||
16225032|NCT00364351|39302593|FG000|Overall Study|Randomised treatment not started|0|||
16225033|NCT00364351|39302594|FG001|Overall Study|Randomised treatment not started|3|||
16225034|NCT01177943|39302599|FG000|First Intervention|Withdrawal by Subject|2|||
16225035|NCT01177943|39302600|FG001|First Intervention|Withdrawal by Subject|0|||
16225036|NCT01611558|39302601|FG000|Induction Phase|Study drug toxicity|15|||
16225037|NCT01611558|39302601|FG000|Induction Phase|Disease progression|18|||
16225038|NCT01611558|39302601|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
16225039|NCT01611558|39302601|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
16225040|NCT01611558|39302601|FG000|Induction Phase|Death|1|||
16225041|NCT01611558|39302601|FG000|Maintenance Phase|Withdrawal by Subject|1|||
16225042|NCT01611558|39302601|FG000|Maintenance Phase|Elevated Uric acid|1|||
16225043|NCT00421928|39302617|FG000|Overall Study|Adverse Event|61|||
16225044|NCT00421928|39302618|FG001|Overall Study|Adverse Event|140|||
16225045|NCT00421928|39302619|FG002|Overall Study|Adverse Event|22|||
16225046|NCT00421928|39302617|FG000|Overall Study|Lost to Follow-up|5|||
16225047|NCT00421928|39302618|FG001|Overall Study|Lost to Follow-up|0|||
16225048|NCT00421928|39302619|FG002|Overall Study|Lost to Follow-up|3|||
16225049|NCT00421928|39302617|FG000|Overall Study|Withdrawal by Subject|50|||
16225050|NCT00421928|39302618|FG001|Overall Study|Withdrawal by Subject|48|||
16225051|NCT00421928|39302619|FG002|Overall Study|Withdrawal by Subject|43|||
16225052|NCT00421928|39302617|FG000|Overall Study|Lack of Efficacy|15|||
16225053|NCT00421928|39302618|FG001|Overall Study|Lack of Efficacy|7|||
16225054|NCT00421928|39302619|FG002|Overall Study|Lack of Efficacy|35|||
16225055|NCT00421928|39302617|FG000|Overall Study|Study drug non-compliant|6|||
16225056|NCT00421928|39302618|FG001|Overall Study|Study drug non-compliant|7|||
16225057|NCT00421928|39302619|FG002|Overall Study|Study drug non-compliant|4|||
16225058|NCT00421928|39302617|FG000|Overall Study|All other|26|||
16225059|NCT00421928|39302618|FG001|Overall Study|All other|21|||
16225060|NCT00421928|39302619|FG002|Overall Study|All other|27|||
16225061|NCT00421928|39302617|FG000|Overall Study|Death|0|||
16225062|NCT00421928|39302618|FG001|Overall Study|Death|1|||
16225063|NCT00421928|39302619|FG002|Overall Study|Death|0|||
16225064|NCT03039699|39302620|FG000|Overall Study|Incorrect inclusion|5|||
16225065|NCT03039699|39302621|FG001|Overall Study|Incorrect inclusion|4|||
16225066|NCT03039699|39302620|FG000|Overall Study|Lack of data to assess study endpoint|5|||
16225067|NCT03039699|39302621|FG001|Overall Study|Lack of data to assess study endpoint|3|||
16225068|NCT03039699|39302620|FG000|Overall Study|Bacterial infection|12|||
16225069|NCT03039699|39302621|FG001|Overall Study|Bacterial infection|28|||
16225070|NCT02418000|39302623|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
16225071|NCT02418000|39302624|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
16225072|NCT02418000|39302625|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
16225073|NCT02418000|39302626|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
16225074|NCT02418000|39302627|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
16225075|NCT02418000|39302623|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
16225076|NCT02418000|39302624|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
16225077|NCT02418000|39302625|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
16225078|NCT02418000|39302626|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
16225079|NCT02418000|39302627|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
16225080|NCT02418000|39302623|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
16225081|NCT02418000|39302624|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
16225082|NCT02418000|39302625|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
16225083|NCT02418000|39302626|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
16225084|NCT02418000|39302627|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
16225085|NCT02418000|39302623|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
16225086|NCT02418000|39302624|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
16225087|NCT02418000|39302625|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
16225088|NCT02418000|39302626|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
16225089|NCT02418000|39302627|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
16225090|NCT02418000|39302623|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
16225091|NCT02418000|39302624|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
16225092|NCT02418000|39302625|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
16225093|NCT02418000|39302626|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
16225094|NCT02418000|39302627|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
16225095|NCT02418000|39302623|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225096|NCT02418000|39302624|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225097|NCT02418000|39302625|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
16225098|NCT02418000|39302626|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225099|NCT02418000|39302627|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225100|NCT02418000|39302623|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225101|NCT02418000|39302624|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225102|NCT02418000|39302625|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225103|NCT02418000|39302626|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
16225104|NCT02418000|39302627|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225105|NCT02418000|39302623|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
16225106|NCT02418000|39302624|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
16225107|NCT02418000|39302625|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
16225108|NCT02418000|39302626|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
16225109|NCT02418000|39302627|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
16225110|NCT02418000|39302623|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225111|NCT02418000|39302624|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225112|NCT02418000|39302625|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225113|NCT02418000|39302626|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
16225114|NCT02418000|39302627|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
16225115|NCT01385098|39302628|FG000|Overall Study|Adverse Event|10|||
16225116|NCT01385098|39302628|FG000|Overall Study|Lost to Follow-up|4|||
16225117|NCT01673373|39302631|FG000|Overall Study|Death|2|||
16225118|NCT02610231|39302632|FG000|Overall Study|Withdrawal by Subject|27|||
16225119|NCT02610231|39302632|FG000|Overall Study|Adverse Event|20|||
16225120|NCT02610231|39302632|FG000|Overall Study|Death|5|||
16225121|NCT02610231|39302632|FG000|Overall Study|Surgery|2|||
16225122|NCT02610231|39302632|FG000|Overall Study|Physician Decision|1|||
16225123|NCT02610231|39302632|FG000|Overall Study|Non Compliance|2|||
16225124|NCT02610231|39302632|FG000|Overall Study|Other|3|||
16225125|NCT02528331|39302645|FG000|Overall Study|Withdrawal by Subject|2|||
16225126|NCT03759340|39302649|FG000|Overall Study|Adverse Event|2|||
16225127|NCT03759340|39302649|FG000|Overall Study|Lost to Follow-up|1|||
16225128|NCT03759340|39302649|FG000|Overall Study|Withdrawal by Subject|15|||
16225129|NCT03759340|39302649|FG000|Overall Study|Study Terminated by Sponsor|38|||
16225130|NCT01684930|39302650|FG000|Overall Study|Withdrawal by Subject|3|||
16225131|NCT01684930|39302651|FG001|Overall Study|Withdrawal by Subject|1|||
16225132|NCT01731951|39302653|FG000|Overall Study|Documented Disease Progression|1|||
16225133|NCT01731951|39302654|FG001|Overall Study|Documented Disease Progression|0|||
16225134|NCT01731951|39302655|FG002|Overall Study|Documented Disease Progression|0|||
16225135|NCT01731951|39302656|FG003|Overall Study|Documented Disease Progression|0|||
16225136|NCT01731951|39302657|FG004|Overall Study|Documented Disease Progression|0|||
16225137|NCT01731951|39302658|FG005|Overall Study|Documented Disease Progression|0|||
16225138|NCT01731951|39302653|FG000|Overall Study|Lost to Follow-up|2|||
16225139|NCT01731951|39302654|FG001|Overall Study|Lost to Follow-up|0|||
16225140|NCT01731951|39302655|FG002|Overall Study|Lost to Follow-up|0|||
16225141|NCT01731951|39302656|FG003|Overall Study|Lost to Follow-up|1|||
16225142|NCT01731951|39302657|FG004|Overall Study|Lost to Follow-up|3|||
16225143|NCT01731951|39302658|FG005|Overall Study|Lost to Follow-up|1|||
16225144|NCT01731951|39302653|FG000|Overall Study|Withdrawal of Consent|1|||
16225145|NCT01731951|39302654|FG001|Overall Study|Withdrawal of Consent|0|||
16225146|NCT01731951|39302655|FG002|Overall Study|Withdrawal of Consent|0|||
16225147|NCT01731951|39302656|FG003|Overall Study|Withdrawal of Consent|0|||
16225148|NCT01731951|39302657|FG004|Overall Study|Withdrawal of Consent|0|||
16225149|NCT01731951|39302658|FG005|Overall Study|Withdrawal of Consent|2|||
16225150|NCT01731951|39302653|FG000|Overall Study|Death|13|||
16225151|NCT01731951|39302654|FG001|Overall Study|Death|15|||
16225152|NCT01731951|39302655|FG002|Overall Study|Death|9|||
16225153|NCT01731951|39302656|FG003|Overall Study|Death|8|||
16225154|NCT01731951|39302657|FG004|Overall Study|Death|9|||
16225155|NCT01731951|39302658|FG005|Overall Study|Death|6|||
16225156|NCT02713490|39302659|FG000|Overall Study|Withdrawal by Subject|2|||
16225157|NCT02713490|39302660|FG001|Overall Study|Withdrawal by Subject|1|||
16225158|NCT02713490|39302659|FG000|Overall Study|Did not receive study drug|1|||
16225159|NCT02713490|39302660|FG001|Overall Study|Did not receive study drug|0|||
16225160|NCT02713490|39302659|FG000|Overall Study|Met exclusion criteria|0|||
16225161|NCT02713490|39302660|FG001|Overall Study|Met exclusion criteria|1|||
16225162|NCT02583399|39302661|FG000|Overall Study|Able to be discharged|3|||
16225163|NCT02583399|39302661|FG000|Overall Study|Wanted to use a restricted medication|3|||
16225164|NCT01345162|39302662|FG000|Overall Study|Protocol Violation|2|||
16225165|NCT01345162|39302663|FG001|Overall Study|Protocol Violation|4|||
16225166|NCT01365182|39302664|FG000|Overall Study|Withdrawal by Subject|10|||
16225167|NCT01365182|39302665|FG001|Overall Study|Withdrawal by Subject|13|||
16225168|NCT01365182|39302666|FG002|Overall Study|Withdrawal by Subject|12|||
16225169|NCT02390167|39306023|FG000|Overall Study|Lost to Follow-up|1|||
16225170|NCT01710709|39306024|FG000|Overall Study|Lost to Follow-up|29|||
16225171|NCT01710709|39306024|FG000|Overall Study|Adverse Event|48|||
16225172|NCT01710709|39306024|FG000|Overall Study|Participant met withdrawal criteria|33|||
16225173|NCT01710709|39306024|FG000|Overall Study|Participant withdrawn by investigator|2|||
16225174|NCT01710709|39306024|FG000|Overall Study|Withdrawal by Subject|53|||
16225175|NCT01710709|39306024|FG000|Overall Study|Protocol Violation|5|||
16225176|NCT01710709|39306024|FG000|Overall Study|Lack of Efficacy|3|||
16225177|NCT00039377|39306026|FG000|Initial Registration|Adverse Event|2|||
16225178|NCT00039377|39306027|FG001|Initial Registration|Adverse Event|0|||
16225179|NCT00039377|39306028|FG002|Initial Registration|Adverse Event|0|||
16225180|NCT00039377|39306029|FG003|Initial Registration|Adverse Event|0|||
16225181|NCT00039377|39306026|FG000|Initial Registration|Relapsed|6|||
16225182|NCT00039377|39306027|FG001|Initial Registration|Relapsed|0|||
16225183|NCT00039377|39306028|FG002|Initial Registration|Relapsed|0|||
16225184|NCT00039377|39306029|FG003|Initial Registration|Relapsed|0|||
16225185|NCT00039377|39306026|FG000|Initial Registration|Received non-protocol therapy|11|||
16225186|NCT00039377|39306027|FG001|Initial Registration|Received non-protocol therapy|0|||
16225187|NCT00039377|39306028|FG002|Initial Registration|Received non-protocol therapy|0|||
16225188|NCT00039377|39306029|FG003|Initial Registration|Received non-protocol therapy|0|||
16225189|NCT00039377|39306026|FG000|Initial Registration|Withdrawal by Subject|3|||
16225190|NCT00039377|39306027|FG001|Initial Registration|Withdrawal by Subject|0|||
16225191|NCT00039377|39306028|FG002|Initial Registration|Withdrawal by Subject|0|||
16225192|NCT00039377|39306029|FG003|Initial Registration|Withdrawal by Subject|0|||
16225193|NCT02546193|39306032|FG000|Overall Study|Withdrawal by Subject|2|||
16225194|NCT02546193|39306033|FG001|Overall Study|Withdrawal by Subject|0|||
16225195|NCT02546193|39306034|FG002|Overall Study|Withdrawal by Subject|1|||
16225196|NCT02546193|39306035|FG003|Overall Study|Withdrawal by Subject|0|||
16225197|NCT02546193|39306032|FG000|Overall Study|Not eligible at time of induction|4|||
16225198|NCT02546193|39306033|FG001|Overall Study|Not eligible at time of induction|6|||
16225199|NCT02546193|39306034|FG002|Overall Study|Not eligible at time of induction|1|||
16225200|NCT02546193|39306035|FG003|Overall Study|Not eligible at time of induction|0|||
16225201|NCT02463097|39306036|FG000|Overall Study|Withdrawal by Subject|1|||
16225202|NCT03044730|39306037|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
16225203|NCT03044730|39306037|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
16225204|NCT03044730|39306037|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
16225205|NCT03044730|39306037|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
16225206|NCT03044730|39306037|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
16225207|NCT03044730|39306037|FG000|Cycles 4 and Beyond|Adverse Event|1|||
16225208|NCT03044730|39306037|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
16225209|NCT03044730|39306037|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
16225210|NCT03044730|39306037|FG000|On Follow-up for 2 Years|Death|17|||
16225211|NCT01977573|39306038|FG000|Overall Study|Adverse Event|7|||
16225212|NCT01977573|39306039|FG001|Overall Study|Adverse Event|0|||
16225213|NCT01977573|39306040|FG002|Overall Study|Adverse Event|2|||
16225214|NCT01977573|39306041|FG003|Overall Study|Adverse Event|1|||
16225215|NCT01977573|39306038|FG000|Overall Study|Lost to Follow-up|1|||
16225216|NCT01977573|39306039|FG001|Overall Study|Lost to Follow-up|0|||
16225217|NCT01977573|39306040|FG002|Overall Study|Lost to Follow-up|0|||
16225218|NCT01977573|39306041|FG003|Overall Study|Lost to Follow-up|1|||
16225219|NCT01977573|39306038|FG000|Overall Study|Physician Decision|1|||
16225220|NCT01977573|39306039|FG001|Overall Study|Physician Decision|0|||
16225221|NCT01977573|39306040|FG002|Overall Study|Physician Decision|0|||
16225222|NCT01977573|39306041|FG003|Overall Study|Physician Decision|0|||
16225223|NCT01977573|39306038|FG000|Overall Study|Protocol Violation|3|||
16225224|NCT01977573|39306039|FG001|Overall Study|Protocol Violation|1|||
16225225|NCT01977573|39306040|FG002|Overall Study|Protocol Violation|0|||
16225226|NCT01977573|39306041|FG003|Overall Study|Protocol Violation|0|||
16225227|NCT01977573|39306038|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
16225228|NCT01977573|39306039|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
16225229|NCT01977573|39306040|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
16225230|NCT01977573|39306041|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
16225231|NCT01977573|39306038|FG000|Overall Study|Withdrawal by Subject|6|||
16225232|NCT01977573|39306039|FG001|Overall Study|Withdrawal by Subject|1|||
16225233|NCT01977573|39306040|FG002|Overall Study|Withdrawal by Subject|1|||
16225234|NCT01977573|39306041|FG003|Overall Study|Withdrawal by Subject|1|||
16547247|NCT02323646|40467535|FG001|Treatment Course 1|Adverse Event|0|||
16547248|NCT02323646|40467536|FG002|Treatment Course 1|Adverse Event|1|||
16547249|NCT02323646|40467534|FG000|Treatment Course 1|Heavy Bleeding|1|||
16547250|NCT02323646|40467535|FG001|Treatment Course 1|Heavy Bleeding|1|||
16547251|NCT02323646|40467536|FG002|Treatment Course 1|Heavy Bleeding|0|||
16547252|NCT02323646|40467534|FG000|Treatment Course 1|Lost to Follow-up|1|||
16225235|NCT00283062|39306042|FG000|Overall Study|Did not receive any study medication|5|||
16225236|NCT00283062|39306043|FG001|Overall Study|Did not receive any study medication|4|||
16225237|NCT00283062|39306044|FG002|Overall Study|Did not receive any study medication|36|||
16225238|NCT00283062|39306045|FG003|Overall Study|Did not receive any study medication|45|||
16225239|NCT00283062|39306042|FG000|Overall Study|Adverse Event|2|||
16225240|NCT00283062|39306043|FG001|Overall Study|Adverse Event|0|||
16225241|NCT00283062|39306044|FG002|Overall Study|Adverse Event|1|||
16225242|NCT00283062|39306045|FG003|Overall Study|Adverse Event|0|||
16225243|NCT00283062|39306042|FG000|Overall Study|Lost to Follow-up|1|||
16225244|NCT00283062|39306043|FG001|Overall Study|Lost to Follow-up|0|||
16225245|NCT00283062|39306044|FG002|Overall Study|Lost to Follow-up|1|||
16225246|NCT00283062|39306045|FG003|Overall Study|Lost to Follow-up|0|||
16225247|NCT00283062|39306042|FG000|Overall Study|Progressive disease|0|||
16225248|NCT00283062|39306043|FG001|Overall Study|Progressive disease|0|||
16225249|NCT00283062|39306044|FG002|Overall Study|Progressive disease|1|||
16225250|NCT00283062|39306045|FG003|Overall Study|Progressive disease|0|||
16225251|NCT00283062|39306042|FG000|Overall Study|Participant did not wish to continue|3|||
16225252|NCT00283062|39306043|FG001|Overall Study|Participant did not wish to continue|2|||
16225253|NCT00283062|39306044|FG002|Overall Study|Participant did not wish to continue|1|||
16225254|NCT00283062|39306045|FG003|Overall Study|Participant did not wish to continue|0|||
16225255|NCT00283062|39306042|FG000|Overall Study|Undefined|0|||
16225256|NCT00283062|39306043|FG001|Overall Study|Undefined|1|||
16225257|NCT00283062|39306044|FG002|Overall Study|Undefined|1|||
16225258|NCT00283062|39306045|FG003|Overall Study|Undefined|4|||
16547253|NCT02323646|40467535|FG001|Treatment Course 1|Lost to Follow-up|0|||
16547254|NCT02323646|40467536|FG002|Treatment Course 1|Lost to Follow-up|2|||
16547255|NCT02323646|40467534|FG000|Treatment Course 1|Withdrawal by Subject|0|||
16547256|NCT02323646|40467535|FG001|Treatment Course 1|Withdrawal by Subject|2|||
16225259|NCT00283062|39306042|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
16225260|NCT00283062|39306043|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
16225261|NCT00283062|39306044|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
16410438|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
16547257|NCT02323646|40467536|FG002|Treatment Course 1|Withdrawal by Subject|0|||
16547258|NCT02323646|40467534|FG000|Treatment Course 2|Adverse Event|1|||
16547259|NCT02323646|40467535|FG001|Treatment Course 2|Adverse Event|0|||
16547260|NCT02323646|40467536|FG002|Treatment Course 2|Adverse Event|1|||
16547261|NCT02323646|40467534|FG000|Treatment Course 2|Lost to Follow-up|0|||
16547262|NCT02323646|40467535|FG001|Treatment Course 2|Lost to Follow-up|0|||
16547263|NCT02323646|40467536|FG002|Treatment Course 2|Lost to Follow-up|1|||
16547264|NCT02323646|40467534|FG000|Treatment Course 2|Non-compliance|0|||
16547265|NCT02323646|40467535|FG001|Treatment Course 2|Non-compliance|1|||
16547266|NCT02323646|40467536|FG002|Treatment Course 2|Non-compliance|1|||
16547267|NCT04399551|40467537|FG000|Overall Study|Adverse Event|15|||
16547268|NCT04399551|40467537|FG000|Overall Study|Withdrawal by Subject|6|||
16547269|NCT04399551|40467537|FG000|Overall Study|Physician Decision|3|||
16547270|NCT04399551|40467537|FG000|Overall Study|Lost to Follow-up|2|||
16547271|NCT04399551|40467537|FG000|Overall Study|Protocol Deviation|2|||
16547272|NCT03176238|40467538|FG000|Overall Study|Unacceptable AEs|15|||
16410439|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
16547273|NCT03176238|40467539|FG001|Overall Study|Unacceptable AEs|8|||
16547274|NCT03176238|40467538|FG000|Overall Study|Abnormal lab value(s)|2|||
16547275|NCT03176238|40467539|FG001|Overall Study|Abnormal lab value(s)|0|||
16547276|NCT03176238|40467538|FG000|Overall Study|Inter-current illness|0|||
16547277|NCT03176238|40467539|FG001|Overall Study|Inter-current illness|1|||
16547278|NCT03176238|40467538|FG000|Overall Study|Consent withdrawal|14|||
16547279|NCT03176238|40467539|FG001|Overall Study|Consent withdrawal|2|||
16114249|NCT00903760|38906058|FG001|Overall Study|Withdrawal by Subject|2|||
16114250|NCT00903760|38906057|FG000|Overall Study|Off treatment for long period|0|||
16225262|NCT00283062|39306045|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
16225263|NCT00422227|39306046|FG000|Overall Study|Adverse Event|3|||
16225264|NCT00422227|39306047|FG001|Overall Study|Adverse Event|8|||
16547280|NCT03176238|40467538|FG000|Overall Study|Lost to Follow-up|3|||
16547281|NCT03176238|40467539|FG001|Overall Study|Lost to Follow-up|0|||
16547282|NCT03176238|40467538|FG000|Overall Study|Administrative problems|1|||
16547283|NCT03176238|40467539|FG001|Overall Study|Administrative problems|0|||
16547284|NCT03176238|40467538|FG000|Overall Study|Death|3|||
16547285|NCT03176238|40467539|FG001|Overall Study|Death|0|||
16547286|NCT03176238|40467538|FG000|Overall Study|Disease Progression|133|||
16547287|NCT03176238|40467539|FG001|Overall Study|Disease Progression|22|||
16547288|NCT03176238|40467538|FG000|Overall Study|Tx duration completed per EAP|0|||
16547289|NCT03176238|40467539|FG001|Overall Study|Tx duration completed per EAP|1|||
16547290|NCT03176238|40467538|FG000|Overall Study|Patient is switched to commercial drug|16|||
16225265|NCT00422227|39306046|FG000|Overall Study|Lost to Follow-up|1|||
16225266|NCT00422227|39306047|FG001|Overall Study|Lost to Follow-up|3|||
16225267|NCT00422227|39306046|FG000|Overall Study|Withdrawal by Subject|0|||
16225268|NCT00422227|39306047|FG001|Overall Study|Withdrawal by Subject|4|||
16225269|NCT00723489|39306048|FG000|Overall Study|Physician Decision|0|||
16225270|NCT00723489|39306049|FG001|Overall Study|Physician Decision|1|||
16225271|NCT00723489|39306050|FG002|Overall Study|Physician Decision|0|||
16225272|NCT00723489|39306051|FG003|Overall Study|Physician Decision|0|||
16225273|NCT00723489|39306048|FG000|Overall Study|Pregnancy|0|||
16225274|NCT00723489|39306049|FG001|Overall Study|Pregnancy|0|||
16225275|NCT00723489|39306050|FG002|Overall Study|Pregnancy|0|||
16225276|NCT00723489|39306051|FG003|Overall Study|Pregnancy|1|||
16225277|NCT00723489|39306048|FG000|Overall Study|Withdrawal by Subject|0|||
16225278|NCT00723489|39306049|FG001|Overall Study|Withdrawal by Subject|0|||
16225279|NCT00723489|39306050|FG002|Overall Study|Withdrawal by Subject|0|||
16225280|NCT00723489|39306051|FG003|Overall Study|Withdrawal by Subject|1|||
16225281|NCT00723489|39306048|FG000|Overall Study|Seropositive at baseline|1|||
16225282|NCT00723489|39306049|FG001|Overall Study|Seropositive at baseline|0|||
16225283|NCT00723489|39306050|FG002|Overall Study|Seropositive at baseline|0|||
16225284|NCT00723489|39306051|FG003|Overall Study|Seropositive at baseline|0|||
16225285|NCT00723489|39306048|FG000|Overall Study|Prohibited Medication|0|||
16225286|NCT00723489|39306049|FG001|Overall Study|Prohibited Medication|0|||
16225287|NCT00723489|39306050|FG002|Overall Study|Prohibited Medication|0|||
16225288|NCT00723489|39306051|FG003|Overall Study|Prohibited Medication|1|||
16225289|NCT00723489|39306048|FG000|Overall Study|Samples Collected Out of Window|0|||
16225290|NCT00723489|39306049|FG001|Overall Study|Samples Collected Out of Window|3|||
16225291|NCT00723489|39306050|FG002|Overall Study|Samples Collected Out of Window|0|||
16225292|NCT00723489|39306051|FG003|Overall Study|Samples Collected Out of Window|0|||
16225293|NCT00405756|39306053|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
16225294|NCT00405756|39306054|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
16225295|NCT00405756|39306055|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
16225296|NCT00405756|39306053|FG000|Double-blind Treatment|Adverse Event|31|||
16225297|NCT00405756|39306054|FG001|Double-blind Treatment|Adverse Event|27|||
16225298|NCT00405756|39306055|FG002|Double-blind Treatment|Adverse Event|12|||
16225299|NCT00405756|39306053|FG000|Double-blind Treatment|Disease Progression|47|||
16225300|NCT00405756|39306054|FG001|Double-blind Treatment|Disease Progression|81|||
16225301|NCT00405756|39306055|FG002|Double-blind Treatment|Disease Progression|102|||
16225302|NCT00405756|39306053|FG000|Double-blind Treatment|Lack of Efficacy|1|||
16225303|NCT00405756|39306054|FG001|Double-blind Treatment|Lack of Efficacy|4|||
16225304|NCT00405756|39306055|FG002|Double-blind Treatment|Lack of Efficacy|2|||
16225305|NCT00405756|39306053|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
16225306|NCT00405756|39306054|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
16225307|NCT00405756|39306055|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
16225308|NCT00405756|39306053|FG000|Double-blind Treatment|Lost to Follow-up|1|||
16225309|NCT00405756|39306054|FG001|Double-blind Treatment|Lost to Follow-up|0|||
16225310|NCT00405756|39306055|FG002|Double-blind Treatment|Lost to Follow-up|0|||
16225311|NCT00405756|39306053|FG000|Double-blind Treatment|Death|4|||
16225312|NCT00405756|39306054|FG001|Double-blind Treatment|Death|4|||
16225313|NCT00405756|39306055|FG002|Double-blind Treatment|Death|4|||
16225314|NCT00405756|39306053|FG000|Double-blind Treatment|Protocol Violation|1|||
16225315|NCT00405756|39306054|FG001|Double-blind Treatment|Protocol Violation|0|||
16225316|NCT00405756|39306055|FG002|Double-blind Treatment|Protocol Violation|2|||
16225317|NCT00405756|39306053|FG000|Double-blind Treatment|Other|7|||
16225318|NCT00405756|39306054|FG001|Double-blind Treatment|Other|4|||
16225319|NCT00405756|39306055|FG002|Double-blind Treatment|Other|4|||
16225320|NCT00405756|39306053|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
16225321|NCT00405756|39306054|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
16225322|NCT00405756|39306055|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
16225323|NCT00405756|39306053|FG000|Open-label Extension|Adverse Event|1|||
16225324|NCT00405756|39306054|FG001|Open-label Extension|Adverse Event|3|||
16225325|NCT00405756|39306055|FG002|Open-label Extension|Adverse Event|7|||
16225326|NCT00405756|39306053|FG000|Open-label Extension|Disease Progression|8|||
16225327|NCT00405756|39306054|FG001|Open-label Extension|Disease Progression|23|||
16225328|NCT00405756|39306055|FG002|Open-label Extension|Disease Progression|26|||
16225329|NCT00405756|39306053|FG000|Open-label Extension|Withdrawal by Subject|2|||
16225330|NCT00405756|39306054|FG001|Open-label Extension|Withdrawal by Subject|3|||
16225331|NCT00405756|39306055|FG002|Open-label Extension|Withdrawal by Subject|3|||
16225332|NCT00405756|39306053|FG000|Open-label Extension|Death|1|||
16225333|NCT00405756|39306054|FG001|Open-label Extension|Death|2|||
16225334|NCT00405756|39306055|FG002|Open-label Extension|Death|4|||
16346846|NCT02322749|39757310|FG000|Period 2|Withdrawal by Subject|0|||
16410440|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
16410441|NCT03906656|39985483|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
16410442|NCT03906656|39985484|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
16410443|NCT03906656|39985483|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
16410444|NCT03906656|39985484|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
16410445|NCT03906656|39985483|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
16410446|NCT03906656|39985484|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
16410447|NCT03906656|39985483|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
16410448|NCT03906656|39985484|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
16410449|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
16410450|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
16410451|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
16410452|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
16410453|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
16410454|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
16410455|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
16410456|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
16410457|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
16410458|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
16410459|NCT03906656|39985483|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
16410460|NCT03906656|39985484|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
16410461|NCT03906656|39985483|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
16410462|NCT03906656|39985484|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
16410463|NCT03906656|39985483|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
16410464|NCT03906656|39985484|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
16410465|NCT03906656|39985483|FG000|Home Use 2 (3 Months)|Death|2|||
16410466|NCT03906656|39985484|FG001|Home Use 2 (3 Months)|Death|0|||
16410467|NCT03906656|39985483|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
16410468|NCT03906656|39985484|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
16410469|NCT03906656|39985483|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
16410470|NCT03906656|39985484|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
16410471|NCT03423979|39985485|FG000|Overall Study|Death|1|||
16410472|NCT05590000|39985488|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
16410473|NCT01145053|39985489|FG000|Overall Study|Adverse Event|22|||
16410474|NCT01145053|39985489|FG000|Overall Study|Lost to Follow-up|28|||
16410475|NCT01145053|39985489|FG000|Overall Study|Withdrawal by Subject|25|||
16410476|NCT01145053|39985489|FG000|Overall Study|Other|18|||
16410477|NCT03630302|39985490|FG000|Surgery|hardware issue prevented LFP recordings|1|||
16225335|NCT00405756|39306053|FG000|Open-label Extension|Other|0|||
16225336|NCT00405756|39306054|FG001|Open-label Extension|Other|1|||
16225337|NCT00405756|39306055|FG002|Open-label Extension|Other|7|||
16225338|NCT00405756|39306053|FG000|Follow-up|Ongoing in Follow-up Period|52|||
16225339|NCT00405756|39306054|FG001|Follow-up|Ongoing in Follow-up Period|51|||
16225340|NCT00405756|39306055|FG002|Follow-up|Ongoing in Follow-up Period|60|||
16225341|NCT00405756|39306053|FG000|Follow-up|Death|21|||
16225342|NCT00405756|39306054|FG001|Follow-up|Death|31|||
16225343|NCT00405756|39306055|FG002|Follow-up|Death|24|||
16225344|NCT00405756|39306053|FG000|Follow-up|Lost to Follow-up|2|||
16225345|NCT00405756|39306054|FG001|Follow-up|Lost to Follow-up|8|||
16225346|NCT00405756|39306055|FG002|Follow-up|Lost to Follow-up|4|||
16225347|NCT03650387|39306056|FG000|Overall Study|Withdrawal by Subject|13|||
16225348|NCT03650387|39306056|FG000|Overall Study|Lost to Follow-up|12|||
16225349|NCT03650387|39306056|FG000|Overall Study|Adverse Event (Not related)|1|||
16225350|NCT03650387|39306056|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
16225351|NCT02145429|39306060|FG000|Overall Study|Death|4|||
16225352|NCT02145429|39306061|FG001|Overall Study|Death|5|||
16225353|NCT02145429|39306060|FG000|Overall Study|Lost to Follow-up|4|||
16225354|NCT02145429|39306061|FG001|Overall Study|Lost to Follow-up|3|||
16225355|NCT02145429|39306060|FG000|Overall Study|Withdrawal by Subject|8|||
16225356|NCT02145429|39306061|FG001|Overall Study|Withdrawal by Subject|3|||
16225357|NCT01189201|39306062|FG000|Overall Study|Adverse Event|1|||
16225358|NCT03691831|39306063|FG000|Overall Study|Lost to Follow-up|16|||
16225359|NCT03691831|39306064|FG001|Overall Study|Lost to Follow-up|12|||
16225360|NCT03691831|39306063|FG000|Overall Study|Withdrawal by Subject|9|||
16225361|NCT03691831|39306064|FG001|Overall Study|Withdrawal by Subject|17|||
16225362|NCT03691831|39306063|FG000|Overall Study|Investigator Decision|2|||
16225363|NCT03691831|39306064|FG001|Overall Study|Investigator Decision|2|||
16410478|NCT03630302|39985490|FG000|3 Month Visit|Adverse Event|2|||
16225364|NCT01219959|39306073|FG000|Overall Study|Adverse Event|6|||
16225365|NCT01219959|39306074|FG001|Overall Study|Adverse Event|14|||
16225366|NCT01219959|39306073|FG000|Overall Study|Physician Decision|0|||
16225367|NCT01219959|39306074|FG001|Overall Study|Physician Decision|4|||
16225368|NCT01219959|39306073|FG000|Overall Study|Withdrawal by Subject|0|||
16225369|NCT01219959|39306074|FG001|Overall Study|Withdrawal by Subject|2|||
16225370|NCT01219959|39306073|FG000|Overall Study|Renal Transplantation|0|||
16225371|NCT01219959|39306074|FG001|Overall Study|Renal Transplantation|3|||
16225372|NCT01219959|39306073|FG000|Overall Study|Other|1|||
16225373|NCT01219959|39306074|FG001|Overall Study|Other|0|||
16225374|NCT01266967|39306075|FG000|Overall Study|Death|69|||
16225375|NCT01266967|39306076|FG001|Overall Study|Death|61|||
16225376|NCT01266967|39306075|FG000|Overall Study|Study Closed/Terminated|15|||
16225377|NCT01266967|39306076|FG001|Overall Study|Study Closed/Terminated|17|||
16225378|NCT01266967|39306075|FG000|Overall Study|Lost to Follow-up|2|||
16225379|NCT01266967|39306076|FG001|Overall Study|Lost to Follow-up|1|||
16225380|NCT01266967|39306075|FG000|Overall Study|Physician Decision|0|||
16225381|NCT01266967|39306076|FG001|Overall Study|Physician Decision|1|||
16225382|NCT01266967|39306075|FG000|Overall Study|Withdrawal by Subject|3|||
16346847|NCT02322749|39757311|FG001|Period 2|Withdrawal by Subject|0|||
16114251|NCT00903760|38906058|FG001|Overall Study|Off treatment for long period|1|||
16114252|NCT01667926|38906071|FG000|Overall Study|Withdrawal by Subject|1|||
16225383|NCT01266967|39306076|FG001|Overall Study|Withdrawal by Subject|3|||
16225384|NCT02930889|39306077|FG000|Overall Study|Lost to Follow-up|2|||
16346848|NCT02322749|39757312|FG002|Period 2|Withdrawal by Subject|0|||
16346849|NCT02322749|39757313|FG003|Period 2|Withdrawal by Subject|1|||
16547291|NCT03176238|40467539|FG001|Overall Study|Patient is switched to commercial drug|1|||
16547292|NCT03176238|40467538|FG000|Overall Study|Protocol Violation|1|||
16547293|NCT03176238|40467539|FG001|Overall Study|Protocol Violation|0|||
16547294|NCT03176238|40467538|FG000|Overall Study|Changes in the patient's condition|2|||
16547295|NCT03176238|40467539|FG001|Overall Study|Changes in the patient's condition|1|||
16547296|NCT03176238|40467538|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
16547297|NCT03176238|40467539|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
16547298|NCT02259517|40467544|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
16547299|NCT02259517|40467545|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
16547300|NCT02259517|40467546|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
16547301|NCT02259517|40467544|FG000|Overall Study|Withdrawal by Subject|0|||
16547302|NCT02259517|40467545|FG001|Overall Study|Withdrawal by Subject|0|||
16547303|NCT02259517|40467546|FG002|Overall Study|Withdrawal by Subject|3|||
16547304|NCT04737109|40467551|FG000|Study Treatment|Disease Progression|5|||
16547305|NCT04737109|40467552|FG001|Study Treatment|Disease Progression|0|||
16547306|NCT04737109|40467553|FG002|Study Treatment|Disease Progression|0|||
16547307|NCT04737109|40467554|FG003|Study Treatment|Disease Progression|0|||
16547308|NCT04737109|40467551|FG000|Study Treatment|Death on study|1|||
16547309|NCT04737109|40467552|FG001|Study Treatment|Death on study|0|||
16547310|NCT04737109|40467553|FG002|Study Treatment|Death on study|0|||
16547311|NCT04737109|40467554|FG003|Study Treatment|Death on study|0|||
16547312|NCT01547299|40467570|FG000|Overall Study|Withdrawal by Subject|2|||
16547313|NCT01547299|40467571|FG001|Overall Study|Withdrawal by Subject|2|||
16547314|NCT00117156|40467572|FG000|Overall Study|Adverse Event|9|||
16547315|NCT00117156|40467572|FG000|Overall Study|Physician Decision|1|||
16547316|NCT00117156|40467572|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
16346850|NCT02322749|39757314|FG004|Period 2|Withdrawal by Subject|0|||
16346851|NCT02322749|39757315|FG005|Period 2|Withdrawal by Subject|0|||
16547317|NCT00067990|40467576|FG000|Overall Study|Death|5|||
16547318|NCT00067990|40467577|FG001|Overall Study|Death|7|||
16547319|NCT00067990|40467576|FG000|Overall Study|ESRD, Non IF/TA|1|||
16547320|NCT00067990|40467577|FG001|Overall Study|ESRD, Non IF/TA|3|||
16114253|NCT01667926|38906072|FG001|Overall Study|Withdrawal by Subject|2|||
16114254|NCT01667926|38906073|FG002|Overall Study|Withdrawal by Subject|2|||
16114255|NCT01667926|38906071|FG000|Overall Study|Physician Decision|0|||
16114256|NCT01667926|38906072|FG001|Overall Study|Physician Decision|0|||
16114257|NCT01667926|38906073|FG002|Overall Study|Physician Decision|1|||
16114258|NCT01667926|38906071|FG000|Overall Study|Time committment|0|||
16114259|NCT01667926|38906072|FG001|Overall Study|Time committment|0|||
16114260|NCT01667926|38906073|FG002|Overall Study|Time committment|2|||
16114261|NCT01667926|38906071|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
16114262|NCT01667926|38906072|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
16114263|NCT01667926|38906073|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
16114264|NCT01667926|38906071|FG000|Overall Study|Lost to Follow-up|1|||
16114265|NCT01667926|38906072|FG001|Overall Study|Lost to Follow-up|2|||
16114266|NCT01667926|38906073|FG002|Overall Study|Lost to Follow-up|1|||
16114267|NCT01667926|38906071|FG000|Overall Study|Side effects|3|||
16114268|NCT01667926|38906072|FG001|Overall Study|Side effects|0|||
16114269|NCT01667926|38906073|FG002|Overall Study|Side effects|0|||
16114270|NCT01263509|38906074|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
16114271|NCT01263509|38906075|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
16346852|NCT02322749|39757310|FG000|Period 3|Withdrawal by Subject|0|||
16346853|NCT02322749|39757311|FG001|Period 3|Withdrawal by Subject|0|||
16346854|NCT02322749|39757312|FG002|Period 3|Withdrawal by Subject|1|||
16346855|NCT02322749|39757313|FG003|Period 3|Withdrawal by Subject|0|||
16346856|NCT02322749|39757314|FG004|Period 3|Withdrawal by Subject|0|||
16346857|NCT02322749|39757315|FG005|Period 3|Withdrawal by Subject|0|||
16346858|NCT03193047|39757323|FG000|Overall Study|Physician Decision|1|||
16346859|NCT03193047|39757324|FG001|Overall Study|Physician Decision|0|||
16346860|NCT03193047|39757323|FG000|Overall Study|Participant Left State|1|||
16346861|NCT03193047|39757324|FG001|Overall Study|Participant Left State|0|||
16346862|NCT01188668|39757325|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
16346863|NCT01188668|39757325|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
16346864|NCT01188668|39757325|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
16346865|NCT02907463|39757327|FG000|Overall Study|Lost to Follow-up|17|||
16346866|NCT02907463|39757327|FG000|Overall Study|Death|10|||
16346867|NCT02907463|39757327|FG000|Overall Study|Withdrawal by Subject|4|||
16346868|NCT02907463|39757327|FG000|Overall Study|MIS Approach was not used|2|||
16346869|NCT02907463|39757327|FG000|Overall Study|Not Implanted with Study Device|2|||
16346870|NCT02907463|39757327|FG000|Overall Study|Device Explanted|1|||
16346871|NCT02907463|39757327|FG000|Overall Study|Missing Exit Form|1|||
16346872|NCT00972283|39757329|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
16346873|NCT00972283|39757330|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
16346874|NCT00972283|39757329|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
16346875|NCT00972283|39757330|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
16346876|NCT00972283|39757329|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
16346877|NCT00972283|39757330|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
16346878|NCT00972283|39757329|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
16346879|NCT00972283|39757330|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
16114272|NCT01263509|38906076|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
16346880|NCT00972283|39757329|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
16346881|NCT00972283|39757330|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
16346882|NCT00972283|39757329|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
16346883|NCT00972283|39757330|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
16114273|NCT01263509|38906077|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
16114274|NCT01263509|38906074|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
16114275|NCT01263509|38906075|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
16547321|NCT00067990|40467576|FG000|Overall Study|Withdrawal by Subject|4|||
16547322|NCT00067990|40467577|FG001|Overall Study|Withdrawal by Subject|12|||
16114276|NCT01263509|38906076|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
16114277|NCT01263509|38906077|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
16114278|NCT01263509|38906074|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16114279|NCT01263509|38906075|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16547323|NCT00659984|40467578|FG000|Overall Study|Adverse Event|1|||
16547324|NCT02961881|40467579|FG000|Overall Study|Adverse Event|1|||
16547325|NCT02961881|40467580|FG001|Overall Study|Adverse Event|2|||
16547326|NCT02961881|40467581|FG002|Overall Study|Adverse Event|2|||
16547327|NCT02961881|40467582|FG003|Overall Study|Adverse Event|0|||
16547328|NCT02961881|40467583|FG004|Overall Study|Adverse Event|1|||
16547329|NCT02961881|40467579|FG000|Overall Study|Participant request|0|||
16114280|NCT01263509|38906076|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
16114281|NCT01263509|38906077|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
16114282|NCT01263509|38906074|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
16225385|NCT02930889|39306077|FG000|Overall Study|Withdrawal by Subject|6|||
16225386|NCT02930889|39306077|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
16114283|NCT01263509|38906075|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
16346884|NCT00972283|39757329|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
16114284|NCT01263509|38906076|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16547330|NCT02961881|40467580|FG001|Overall Study|Participant request|2|||
16547331|NCT02961881|40467581|FG002|Overall Study|Participant request|0|||
16114285|NCT01263509|38906077|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
16114286|NCT01263509|38906074|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
16114287|NCT01263509|38906075|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
16114288|NCT01263509|38906076|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
16114289|NCT01263509|38906077|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
16114290|NCT00379769|38906079|FG000|Main Study|Death|57|||
16114291|NCT00379769|38906080|FG001|Main Study|Death|67|||
16114292|NCT00379769|38906081|FG002|Main Study|Death|54|||
16547332|NCT02961881|40467582|FG003|Overall Study|Participant request|0|||
16547333|NCT02961881|40467583|FG004|Overall Study|Participant request|0|||
16547334|NCT02961881|40467579|FG000|Overall Study|Disease progression|1|||
16547335|NCT02961881|40467580|FG001|Overall Study|Disease progression|0|||
16547336|NCT02961881|40467581|FG002|Overall Study|Disease progression|1|||
16547337|NCT02961881|40467582|FG003|Overall Study|Disease progression|0|||
16547338|NCT02961881|40467583|FG004|Overall Study|Disease progression|0|||
16114293|NCT00379769|38906082|FG003|Main Study|Death|72|||
16114294|NCT00379769|38906083|FG004|Main Study|Death|0|||
16114295|NCT00379769|38906084|FG005|Main Study|Death|0|||
16114296|NCT00379769|38906079|FG000|Main Study|Adverse Event|5|||
16114297|NCT00379769|38906080|FG001|Main Study|Adverse Event|8|||
16114298|NCT00379769|38906081|FG002|Main Study|Adverse Event|10|||
16114299|NCT00379769|38906082|FG003|Main Study|Adverse Event|11|||
16114300|NCT00379769|38906083|FG004|Main Study|Adverse Event|0|||
16114301|NCT00379769|38906084|FG005|Main Study|Adverse Event|0|||
16114302|NCT00379769|38906079|FG000|Main Study|Lost to Follow-up|29|||
16114303|NCT00379769|38906080|FG001|Main Study|Lost to Follow-up|29|||
16114304|NCT00379769|38906081|FG002|Main Study|Lost to Follow-up|25|||
16114305|NCT00379769|38906082|FG003|Main Study|Lost to Follow-up|26|||
16114306|NCT00379769|38906083|FG004|Main Study|Lost to Follow-up|0|||
16114307|NCT00379769|38906084|FG005|Main Study|Lost to Follow-up|0|||
16114308|NCT00379769|38906079|FG000|Main Study|Withdrawal by Subject|46|||
16114309|NCT00379769|38906080|FG001|Main Study|Withdrawal by Subject|56|||
16114310|NCT00379769|38906081|FG002|Main Study|Withdrawal by Subject|72|||
16547339|NCT01498822|40467584|FG000|Overall Study|Protocol Violation|8|||
16114311|NCT00379769|38906082|FG003|Main Study|Withdrawal by Subject|70|||
16114312|NCT00379769|38906083|FG004|Main Study|Withdrawal by Subject|0|||
16114313|NCT00379769|38906084|FG005|Main Study|Withdrawal by Subject|0|||
16346885|NCT00972283|39757330|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
16547340|NCT01498822|40467585|FG001|Overall Study|Protocol Violation|4|||
16547341|NCT01498822|40467584|FG000|Overall Study|Other Reason|5|||
16547342|NCT01498822|40467585|FG001|Overall Study|Other Reason|2|||
16547343|NCT01498822|40467584|FG000|Overall Study|Lack of Efficacy|7|||
16547344|NCT01498822|40467585|FG001|Overall Study|Lack of Efficacy|2|||
16547345|NCT01498822|40467584|FG000|Overall Study|AE, non-serious non-fatal|8|||
16547346|NCT01498822|40467585|FG001|Overall Study|AE, non-serious non-fatal|17|||
16547347|NCT01498822|40467584|FG000|Overall Study|SAE, non-fatal|2|||
16547348|NCT01498822|40467585|FG001|Overall Study|SAE, non-fatal|2|||
16114314|NCT00379769|38906079|FG000|Main Study|Moved to survival status follow-up only|27|||
16114315|NCT00379769|38906080|FG001|Main Study|Moved to survival status follow-up only|25|||
16114316|NCT00379769|38906081|FG002|Main Study|Moved to survival status follow-up only|32|||
16114317|NCT00379769|38906082|FG003|Main Study|Moved to survival status follow-up only|36|||
16114318|NCT00379769|38906083|FG004|Main Study|Moved to survival status follow-up only|0|||
16114319|NCT00379769|38906084|FG005|Main Study|Moved to survival status follow-up only|0|||
16114320|NCT00379769|38906079|FG000|Main Study|Participant moved|3|||
16114321|NCT00379769|38906080|FG001|Main Study|Participant moved|2|||
16114322|NCT00379769|38906081|FG002|Main Study|Participant moved|3|||
16114323|NCT00379769|38906082|FG003|Main Study|Participant moved|3|||
16114324|NCT00379769|38906083|FG004|Main Study|Participant moved|0|||
16114325|NCT00379769|38906084|FG005|Main Study|Participant moved|0|||
16114326|NCT00379769|38906079|FG000|Main Study|Poor compliance|3|||
16114327|NCT00379769|38906080|FG001|Main Study|Poor compliance|2|||
16114328|NCT00379769|38906081|FG002|Main Study|Poor compliance|2|||
16114329|NCT00379769|38906082|FG003|Main Study|Poor compliance|1|||
16114330|NCT00379769|38906083|FG004|Main Study|Poor compliance|0|||
16114331|NCT00379769|38906084|FG005|Main Study|Poor compliance|0|||
16114332|NCT00379769|38906079|FG000|Main Study|Prohibited glucose lowering medication|0|||
16114333|NCT00379769|38906080|FG001|Main Study|Prohibited glucose lowering medication|3|||
16114334|NCT00379769|38906081|FG002|Main Study|Prohibited glucose lowering medication|0|||
16114335|NCT00379769|38906082|FG003|Main Study|Prohibited glucose lowering medication|1|||
16114336|NCT00379769|38906083|FG004|Main Study|Prohibited glucose lowering medication|0|||
16114337|NCT00379769|38906084|FG005|Main Study|Prohibited glucose lowering medication|0|||
16114338|NCT00379769|38906079|FG000|Main Study|Site closed|4|||
16114339|NCT00379769|38906080|FG001|Main Study|Site closed|4|||
16114340|NCT00379769|38906081|FG002|Main Study|Site closed|4|||
16114341|NCT00379769|38906082|FG003|Main Study|Site closed|8|||
16114342|NCT00379769|38906083|FG004|Main Study|Site closed|0|||
16114343|NCT00379769|38906084|FG005|Main Study|Site closed|0|||
16547349|NCT01498822|40467584|FG000|Overall Study|Adverse Event, serious fatal|1|||
16547350|NCT01498822|40467585|FG001|Overall Study|Adverse Event, serious fatal|1|||
16547351|NCT01498822|40467584|FG000|Overall Study|Withdrawal by Subject|15|||
16547352|NCT01498822|40467585|FG001|Overall Study|Withdrawal by Subject|25|||
16547353|NCT01498822|40467584|FG000|Overall Study|Lost to Follow-up|8|||
16547354|NCT01498822|40467585|FG001|Overall Study|Lost to Follow-up|3|||
16547355|NCT01919970|40467586|FG000|Overall Study|Withdrawal by Subject|3|||
16547356|NCT01919970|40467587|FG001|Overall Study|Withdrawal by Subject|0|||
16547357|NCT03311230|40467590|FG000|Overall Study|Withdrawal by Subject|1|||
16547358|NCT03311230|40467591|FG001|Overall Study|Withdrawal by Subject|4|||
16547359|NCT03311230|40467592|FG002|Overall Study|Withdrawal by Subject|2|||
16547360|NCT03311230|40467593|FG003|Overall Study|Withdrawal by Subject|7|||
16547361|NCT03311230|40467590|FG000|Overall Study|Unrelated injury|0|||
16547362|NCT03311230|40467591|FG001|Overall Study|Unrelated injury|1|||
16547363|NCT03311230|40467592|FG002|Overall Study|Unrelated injury|0|||
16547364|NCT03311230|40467593|FG003|Overall Study|Unrelated injury|0|||
16547365|NCT02223754|40467596|FG000|Period 1|Adverse Event|1|||
16114344|NCT00379769|38906079|FG000|Main Study|Entry criteria violation|0|||
16114345|NCT00379769|38906080|FG001|Main Study|Entry criteria violation|0|||
16114346|NCT00379769|38906081|FG002|Main Study|Entry criteria violation|1|||
16114347|NCT00379769|38906082|FG003|Main Study|Entry criteria violation|1|||
16114348|NCT00379769|38906083|FG004|Main Study|Entry criteria violation|0|||
16114349|NCT00379769|38906084|FG005|Main Study|Entry criteria violation|0|||
16114350|NCT00379769|38906079|FG000|Main Study|Participant did not take study drug|0|||
16114351|NCT00379769|38906080|FG001|Main Study|Participant did not take study drug|0|||
16114352|NCT00379769|38906081|FG002|Main Study|Participant did not take study drug|1|||
16114353|NCT00379769|38906082|FG003|Main Study|Participant did not take study drug|0|||
16114354|NCT00379769|38906083|FG004|Main Study|Participant did not take study drug|0|||
16114355|NCT00379769|38906084|FG005|Main Study|Participant did not take study drug|0|||
16114356|NCT00379769|38906079|FG000|Main Study|Physician Decision|2|||
16114357|NCT00379769|38906080|FG001|Main Study|Physician Decision|2|||
16114358|NCT00379769|38906081|FG002|Main Study|Physician Decision|1|||
16114359|NCT00379769|38906082|FG003|Main Study|Physician Decision|1|||
16114360|NCT00379769|38906083|FG004|Main Study|Physician Decision|0|||
16114361|NCT00379769|38906084|FG005|Main Study|Physician Decision|0|||
16114362|NCT00379769|38906079|FG000|Main Study|Participant completed study at visit 27|1|||
16114363|NCT00379769|38906080|FG001|Main Study|Participant completed study at visit 27|0|||
16114364|NCT00379769|38906081|FG002|Main Study|Participant completed study at visit 27|0|||
16114365|NCT00379769|38906082|FG003|Main Study|Participant completed study at visit 27|0|||
16114366|NCT00379769|38906083|FG004|Main Study|Participant completed study at visit 27|0|||
16114367|NCT00379769|38906084|FG005|Main Study|Participant completed study at visit 27|0|||
16114368|NCT00379769|38906079|FG000|Main Study|Personal reasons|1|||
16114369|NCT00379769|38906080|FG001|Main Study|Personal reasons|0|||
16114370|NCT00379769|38906081|FG002|Main Study|Personal reasons|0|||
16114371|NCT00379769|38906082|FG003|Main Study|Personal reasons|0|||
16114372|NCT00379769|38906083|FG004|Main Study|Personal reasons|0|||
16114373|NCT00379769|38906084|FG005|Main Study|Personal reasons|0|||
16114374|NCT00379769|38906079|FG000|Main Study|Risk of heart failure|0|||
16114375|NCT00379769|38906080|FG001|Main Study|Risk of heart failure|1|||
16114376|NCT00379769|38906081|FG002|Main Study|Risk of heart failure|0|||
16114377|NCT00379769|38906082|FG003|Main Study|Risk of heart failure|0|||
16114378|NCT00379769|38906083|FG004|Main Study|Risk of heart failure|0|||
16114379|NCT00379769|38906084|FG005|Main Study|Risk of heart failure|0|||
16114380|NCT00379769|38906079|FG000|Main Study|Investigator refused to log temperature|0|||
16114381|NCT00379769|38906080|FG001|Main Study|Investigator refused to log temperature|0|||
16114382|NCT00379769|38906081|FG002|Main Study|Investigator refused to log temperature|1|||
16114383|NCT00379769|38906082|FG003|Main Study|Investigator refused to log temperature|0|||
16114384|NCT00379769|38906083|FG004|Main Study|Investigator refused to log temperature|0|||
16114385|NCT00379769|38906084|FG005|Main Study|Investigator refused to log temperature|0|||
16114386|NCT00379769|38906079|FG000|Main Study|Reason unspecified|0|||
16114387|NCT00379769|38906080|FG001|Main Study|Reason unspecified|0|||
16114388|NCT00379769|38906081|FG002|Main Study|Reason unspecified|1|||
16114389|NCT00379769|38906082|FG003|Main Study|Reason unspecified|0|||
16114390|NCT00379769|38906083|FG004|Main Study|Reason unspecified|0|||
16114391|NCT00379769|38906084|FG005|Main Study|Reason unspecified|0|||
16114392|NCT00379769|38906079|FG000|Observational Follow-up|Death|0|||
16114393|NCT00379769|38906080|FG001|Observational Follow-up|Death|0|||
16114394|NCT00379769|38906081|FG002|Observational Follow-up|Death|0|||
16114395|NCT00379769|38906082|FG003|Observational Follow-up|Death|0|||
16114396|NCT00379769|38906083|FG004|Observational Follow-up|Death|78|||
16114397|NCT00379769|38906084|FG005|Observational Follow-up|Death|70|||
16114398|NCT00379769|38906079|FG000|Observational Follow-up|Adverse Event|0|||
16225387|NCT00689299|39306080|FG000|Overall Study|Adverse Event|2|||
16410479|NCT03630302|39985490|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
16410480|NCT02084238|39985491|FG000|Overall Study|Lost to Follow-up|2|||
16410481|NCT00868530|39985492|FG000|Overall Study|Adverse Event|3|||
16410482|NCT00868530|39985492|FG000|Overall Study|Lost to Follow-up|1|||
16410483|NCT01703065|39985493|FG000|Overall Study|Lack of Efficacy|1|||
16410484|NCT01703065|39985494|FG001|Overall Study|Lack of Efficacy|0|||
16547366|NCT02223754|40467597|FG001|Period 1|Adverse Event|0|||
16547367|NCT02223754|40467596|FG000|Period 1|Lost to Follow-up|0|||
16547368|NCT02223754|40467597|FG001|Period 1|Lost to Follow-up|1|||
16225388|NCT00689299|39306081|FG001|Overall Study|Adverse Event|1|||
16547369|NCT02223754|40467596|FG000|Period 1|Protocol Violation|2|||
16547370|NCT02223754|40467597|FG001|Period 1|Protocol Violation|4|||
16547371|NCT02223754|40467596|FG000|Period 1|Withdrawal by Subject|0|||
16547372|NCT02223754|40467597|FG001|Period 1|Withdrawal by Subject|4|||
16547373|NCT02223754|40467596|FG000|Period 1|Test Article No Longer Available|1|||
16547374|NCT02223754|40467597|FG001|Period 1|Test Article No Longer Available|5|||
16225389|NCT00689299|39306082|FG002|Overall Study|Adverse Event|1|||
16225390|NCT00689299|39306080|FG000|Overall Study|Lost to Follow-up|0|||
16225391|NCT00689299|39306081|FG001|Overall Study|Lost to Follow-up|1|||
16225392|NCT00689299|39306082|FG002|Overall Study|Lost to Follow-up|1|||
16225393|NCT00689299|39306080|FG000|Overall Study|Withdrawal by Subject|4|||
16225394|NCT00689299|39306081|FG001|Overall Study|Withdrawal by Subject|1|||
16225395|NCT00689299|39306082|FG002|Overall Study|Withdrawal by Subject|3|||
16225396|NCT00689299|39306080|FG000|Overall Study|Protocol Violation|1|||
16225397|NCT00689299|39306081|FG001|Overall Study|Protocol Violation|0|||
16225398|NCT00689299|39306082|FG002|Overall Study|Protocol Violation|0|||
16225399|NCT03655951|39306083|FG000|Overall Study|Lost to Follow-up|39|||
16225400|NCT03655951|39306084|FG001|Overall Study|Lost to Follow-up|20|||
16225401|NCT03655951|39306083|FG000|Overall Study|Withdrawal by Subject|0|||
16225402|NCT03655951|39306084|FG001|Overall Study|Withdrawal by Subject|1|||
16225403|NCT00848965|39306099|FG000|Overall Study|Adverse Event|1|||
16225404|NCT00848965|39306099|FG000|Overall Study|Withdrawal by Subject|1|||
16225405|NCT02370173|39306101|FG000|Overall Study|Protocol Violation|1|||
16225406|NCT02370173|39306102|FG001|Overall Study|Protocol Violation|1|||
16225407|NCT02370173|39306101|FG000|Overall Study|Withdrawal by Subject|2|||
16225408|NCT02370173|39306102|FG001|Overall Study|Withdrawal by Subject|2|||
16225409|NCT03382639|39306103|FG000|Overall Study|Adverse Event|2|||
16225410|NCT03382639|39306104|FG001|Overall Study|Adverse Event|0|||
16225411|NCT03382639|39306105|FG002|Overall Study|Adverse Event|1|||
16225412|NCT03382639|39306106|FG003|Overall Study|Adverse Event|1|||
16225413|NCT03382639|39306103|FG000|Overall Study|Lost to Follow-up|1|||
16225414|NCT03382639|39306104|FG001|Overall Study|Lost to Follow-up|0|||
16225415|NCT03382639|39306105|FG002|Overall Study|Lost to Follow-up|0|||
16225416|NCT03382639|39306106|FG003|Overall Study|Lost to Follow-up|0|||
16225417|NCT03382639|39306103|FG000|Overall Study|Withdrawal by Subject|4|||
16225418|NCT03382639|39306104|FG001|Overall Study|Withdrawal by Subject|3|||
16225419|NCT03382639|39306105|FG002|Overall Study|Withdrawal by Subject|2|||
16225420|NCT03382639|39306106|FG003|Overall Study|Withdrawal by Subject|3|||
16225421|NCT03382639|39306103|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
16225422|NCT03382639|39306104|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
16225423|NCT03382639|39306105|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
16225424|NCT03382639|39306106|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
16225425|NCT03382639|39306103|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
16225426|NCT03382639|39306104|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
16225427|NCT03382639|39306105|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
16225428|NCT03382639|39306106|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
16225429|NCT03382639|39306103|FG000|Overall Study|Other|2|||
16225430|NCT03382639|39306104|FG001|Overall Study|Other|0|||
16225431|NCT03382639|39306105|FG002|Overall Study|Other|0|||
16225432|NCT03382639|39306106|FG003|Overall Study|Other|3|||
16225433|NCT03339999|39306109|FG000|Overall Study|Adverse Event|1|||
16225434|NCT03339999|39306110|FG001|Overall Study|Adverse Event|2|||
16225435|NCT03339999|39306111|FG002|Overall Study|Adverse Event|2|||
16225436|NCT03339999|39306112|FG003|Overall Study|Adverse Event|1|||
16225437|NCT03339999|39306109|FG000|Overall Study|Lack of Efficacy|0|||
16225438|NCT03339999|39306110|FG001|Overall Study|Lack of Efficacy|1|||
16225439|NCT03339999|39306111|FG002|Overall Study|Lack of Efficacy|0|||
16225440|NCT03339999|39306112|FG003|Overall Study|Lack of Efficacy|0|||
16225441|NCT03339999|39306109|FG000|Overall Study|Lost to Follow-up|0|||
16225442|NCT03339999|39306110|FG001|Overall Study|Lost to Follow-up|0|||
16410485|NCT00864851|39985495|FG000|Overall Study|Withdrawal by Subject|0|||
16410486|NCT00864851|39985496|FG001|Overall Study|Withdrawal by Subject|1|||
16547375|NCT02223754|40467596|FG000|Period 1|Unsatisfactory Visual Response|0|||
16547376|NCT02223754|40467597|FG001|Period 1|Unsatisfactory Visual Response|1|||
16225443|NCT03339999|39306111|FG002|Overall Study|Lost to Follow-up|0|||
16225444|NCT03339999|39306112|FG003|Overall Study|Lost to Follow-up|1|||
16225445|NCT03339999|39306109|FG000|Overall Study|Study Terminated by Sponsor|6|||
16225446|NCT03339999|39306110|FG001|Overall Study|Study Terminated by Sponsor|3|||
16225447|NCT03339999|39306111|FG002|Overall Study|Study Terminated by Sponsor|4|||
16225448|NCT03339999|39306112|FG003|Overall Study|Study Terminated by Sponsor|3|||
16547377|NCT02223754|40467596|FG000|Period 2|Adverse Event|0|||
16225449|NCT01928758|39306113|FG000|Overall Study|Lost to Follow-up|14|||
16225450|NCT01928758|39306114|FG001|Overall Study|Lost to Follow-up|9|||
16225451|NCT01928758|39306113|FG000|Overall Study|Withdrawal by Subject|5|||
16225452|NCT01928758|39306114|FG001|Overall Study|Withdrawal by Subject|2|||
16225453|NCT01928758|39306113|FG000|Overall Study|Adverse Event|3|||
16225454|NCT01928758|39306114|FG001|Overall Study|Adverse Event|5|||
16225455|NCT01928758|39306113|FG000|Overall Study|Protocol Violation|3|||
16225456|NCT01928758|39306114|FG001|Overall Study|Protocol Violation|4|||
16225457|NCT04115488|39306115|FG000|Overall Study|Adverse Event|8|||
16225458|NCT04115488|39306116|FG001|Overall Study|Adverse Event|4|||
16225459|NCT04115488|39306115|FG000|Overall Study|Withdrawal by Subject|3|||
16225460|NCT04115488|39306116|FG001|Overall Study|Withdrawal by Subject|6|||
16225461|NCT04115488|39306115|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
16225462|NCT04115488|39306116|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
16225463|NCT04115488|39306115|FG000|Overall Study|Patient 's location change|1|||
16225464|NCT04115488|39306116|FG001|Overall Study|Patient 's location change|0|||
16225465|NCT04115488|39306115|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
16225466|NCT04115488|39306116|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
16225467|NCT03053180|39306121|FG000|Overall Study|Failure to Return|1|||
16547378|NCT02223754|40467597|FG001|Period 2|Adverse Event|1|||
16547379|NCT02223754|40467596|FG000|Period 2|Protocol Violation|1|||
16547380|NCT02223754|40467597|FG001|Period 2|Protocol Violation|0|||
16547381|NCT02223754|40467596|FG000|Period 2|Lens Discomfort|1|||
16547382|NCT02223754|40467597|FG001|Period 2|Lens Discomfort|1|||
16547383|NCT02223754|40467596|FG000|Period 2|Lost to Follow-up|1|||
16547384|NCT02223754|40467597|FG001|Period 2|Lost to Follow-up|0|||
16547385|NCT02223754|40467596|FG000|Period 2|Test Article No Longer Available|0|||
16547386|NCT02223754|40467597|FG001|Period 2|Test Article No Longer Available|1|||
16547387|NCT02835339|40467598|FG000|Overall Study|Did not receive allocated intervention|13|||
16547388|NCT02835339|40467599|FG001|Overall Study|Did not receive allocated intervention|16|||
16547389|NCT01540565|40467600|FG000|Overall Study|Ineligible|2|||
16225468|NCT02028182|39306122|FG000|Overall Study|Protocol Violation|2|||
16225469|NCT04225026|39306123|FG000|Overall Study|Withdrawal by Subject|4|||
16225470|NCT04225026|39306123|FG000|Overall Study|Adverse Event|1|||
16547390|NCT04555096|40467603|FG000|Overall Study|Death|4|||
16547391|NCT04555096|40467604|FG001|Overall Study|Death|4|||
16547392|NCT04555096|40467603|FG000|Overall Study|Withdrawal by Subject|1|||
16547393|NCT04555096|40467604|FG001|Overall Study|Withdrawal by Subject|0|||
16547394|NCT04555096|40467603|FG000|Overall Study|Other|0|||
16547395|NCT04555096|40467604|FG001|Overall Study|Other|1|||
16547396|NCT02178059|40467605|FG000|Washout|Physician Decision|1|||
16547397|NCT02178059|40467606|FG001|Washout|Physician Decision|0|||
16547398|NCT04108000|40467610|FG000|Overall Study|Death of patient|1|||
16547399|NCT04108000|40467611|FG001|Overall Study|Death of patient|0|||
16547400|NCT04108000|40467612|FG002|Overall Study|Death of patient|1|||
16547401|NCT04108000|40467613|FG003|Overall Study|Death of patient|0|||
16547402|NCT04108000|40467610|FG000|Overall Study|Withdrawal by Subject|2|||
16547403|NCT04108000|40467611|FG001|Overall Study|Withdrawal by Subject|2|||
16547404|NCT04108000|40467612|FG002|Overall Study|Withdrawal by Subject|0|||
16547405|NCT04108000|40467613|FG003|Overall Study|Withdrawal by Subject|0|||
16547406|NCT04108000|40467610|FG000|Overall Study|Death of surrogate partner|0|||
16547407|NCT04108000|40467611|FG001|Overall Study|Death of surrogate partner|1|||
16547408|NCT04108000|40467612|FG002|Overall Study|Death of surrogate partner|0|||
16114399|NCT00379769|38906080|FG001|Observational Follow-up|Adverse Event|0|||
16114400|NCT00379769|38906081|FG002|Observational Follow-up|Adverse Event|0|||
16114401|NCT00379769|38906082|FG003|Observational Follow-up|Adverse Event|0|||
16114402|NCT00379769|38906083|FG004|Observational Follow-up|Adverse Event|1|||
16114403|NCT00379769|38906084|FG005|Observational Follow-up|Adverse Event|0|||
16225471|NCT04225026|39306123|FG000|Overall Study|Other|1|||
16225472|NCT04225026|39306123|FG000|Overall Study|Death|11|||
16225473|NCT04225026|39306123|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
16225474|NCT00732199|39306127|FG000|Overall Study|Withdrawal by Subject|25|||
16225475|NCT00732199|39306128|FG001|Overall Study|Withdrawal by Subject|18|||
16225476|NCT00732199|39306127|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
16225477|NCT00732199|39306128|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
16225478|NCT01004861|39306136|FG000|Overall Study|Disease progression|3|||
16225479|NCT01004861|39306137|FG001|Overall Study|Disease progression|4|||
16225480|NCT01004861|39306138|FG002|Overall Study|Disease progression|5|||
16225481|NCT01004861|39306139|FG003|Overall Study|Disease progression|4|||
16225482|NCT01004861|39306140|FG004|Overall Study|Disease progression|4|||
16225483|NCT01004861|39306141|FG005|Overall Study|Disease progression|4|||
16225484|NCT01004861|39306142|FG006|Overall Study|Disease progression|5|||
16225485|NCT01004861|39306143|FG007|Overall Study|Disease progression|1|||
16225486|NCT01004861|39306144|FG008|Overall Study|Disease progression|4|||
16225487|NCT01004861|39306145|FG009|Overall Study|Disease progression|7|||
16547409|NCT04108000|40467613|FG003|Overall Study|Death of surrogate partner|1|||
16547410|NCT01483937|40467614|FG000|Overall Study|Withdrawal by Subject|4|||
16547411|NCT01483937|40467615|FG001|Overall Study|Withdrawal by Subject|3|||
16547412|NCT01859793|40467618|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
16547413|NCT01859793|40467619|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
16547414|NCT01859793|40467618|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
16547415|NCT01859793|40467619|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
16547416|NCT01859793|40467618|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
16547417|NCT01859793|40467619|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
16547418|NCT01859793|40467618|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
16547419|NCT01859793|40467619|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
16547420|NCT00695786|40467620|FG000|Overall Study|Adverse Event|0|||
16547421|NCT00695786|40467621|FG001|Overall Study|Adverse Event|3|||
16547422|NCT00695786|40467622|FG002|Overall Study|Adverse Event|4|||
16547423|NCT00695786|40467623|FG003|Overall Study|Adverse Event|2|||
16547424|NCT00695786|40467620|FG000|Overall Study|Lost to Follow-up|0|||
16547425|NCT00695786|40467621|FG001|Overall Study|Lost to Follow-up|5|||
16547426|NCT00695786|40467622|FG002|Overall Study|Lost to Follow-up|1|||
16547427|NCT00695786|40467623|FG003|Overall Study|Lost to Follow-up|1|||
16114404|NCT00379769|38906079|FG000|Observational Follow-up|Lost to Follow-up|0|||
16114405|NCT00379769|38906080|FG001|Observational Follow-up|Lost to Follow-up|0|||
16114406|NCT00379769|38906081|FG002|Observational Follow-up|Lost to Follow-up|0|||
16114407|NCT00379769|38906082|FG003|Observational Follow-up|Lost to Follow-up|0|||
16547428|NCT00695786|40467620|FG000|Overall Study|Withdrawal by Subject|0|||
16547429|NCT00695786|40467621|FG001|Overall Study|Withdrawal by Subject|4|||
16547430|NCT00695786|40467622|FG002|Overall Study|Withdrawal by Subject|3|||
16547431|NCT00695786|40467623|FG003|Overall Study|Withdrawal by Subject|1|||
16547432|NCT00695786|40467620|FG000|Overall Study|Deemed Ineligible|1|||
16547433|NCT00695786|40467621|FG001|Overall Study|Deemed Ineligible|0|||
16114408|NCT00379769|38906083|FG004|Observational Follow-up|Lost to Follow-up|25|||
16225488|NCT01004861|39306146|FG010|Overall Study|Disease progression|6|||
16547434|NCT00695786|40467622|FG002|Overall Study|Deemed Ineligible|0|||
16547435|NCT00695786|40467623|FG003|Overall Study|Deemed Ineligible|0|||
16547436|NCT00695786|40467620|FG000|Overall Study|Lack of Efficacy|0|||
16547437|NCT00695786|40467621|FG001|Overall Study|Lack of Efficacy|0|||
16547438|NCT00695786|40467622|FG002|Overall Study|Lack of Efficacy|0|||
16410487|NCT00864851|39985497|FG002|Overall Study|Withdrawal by Subject|0|||
16410488|NCT00864851|39985495|FG000|Overall Study|Physician Decision|1|||
16410489|NCT00864851|39985496|FG001|Overall Study|Physician Decision|0|||
16410490|NCT00864851|39985497|FG002|Overall Study|Physician Decision|0|||
16410491|NCT00864851|39985495|FG000|Overall Study|Death|1|||
16410492|NCT00864851|39985496|FG001|Overall Study|Death|0|||
16410493|NCT00864851|39985497|FG002|Overall Study|Death|0|||
16410494|NCT00864851|39985495|FG000|Overall Study|Patient uncooperative|1|||
16410495|NCT00864851|39985496|FG001|Overall Study|Patient uncooperative|0|||
16410496|NCT00864851|39985497|FG002|Overall Study|Patient uncooperative|0|||
16410497|NCT01728077|39985499|FG000|Overall Study|Lack of Efficacy|3|||
16410498|NCT01728077|39985500|FG001|Overall Study|Lack of Efficacy|1|||
16410499|NCT01728077|39985499|FG000|Overall Study|Lost to Follow-up|1|||
16410500|NCT01728077|39985500|FG001|Overall Study|Lost to Follow-up|0|||
16410501|NCT01728077|39985499|FG000|Overall Study|Subject choice|2|||
16410502|NCT01728077|39985500|FG001|Overall Study|Subject choice|3|||
16410503|NCT01728077|39985499|FG000|Overall Study|Death|0|||
16410504|NCT01728077|39985500|FG001|Overall Study|Death|1|||
16410505|NCT01728077|39985499|FG000|Overall Study|Patient moving|1|||
16410506|NCT01728077|39985500|FG001|Overall Study|Patient moving|0|||
16410507|NCT01728077|39985499|FG000|Overall Study|Non compliance|1|||
16410508|NCT01728077|39985500|FG001|Overall Study|Non compliance|0|||
16410509|NCT02130986|39985501|FG000|Overall Study|Withdrawal by Subject|4|||
16410510|NCT02130986|39985502|FG001|Overall Study|Withdrawal by Subject|4|||
16410511|NCT02130986|39985501|FG000|Overall Study|Lost to Follow-up|151|||
16410512|NCT02130986|39985502|FG001|Overall Study|Lost to Follow-up|160|||
16410513|NCT00496197|39985503|FG000|Overall Study|Discontinued study due to death|43|||
16410514|NCT00496197|39985503|FG000|Overall Study|Adverse Event|13|||
16410515|NCT00496197|39985503|FG000|Overall Study|Does not meet entrance criteria|5|||
16410516|NCT00496197|39985503|FG000|Overall Study|Insufficient clinical response|3|||
16410517|NCT00496197|39985503|FG000|Overall Study|Insufficient bacteriological response|10|||
16410518|NCT00496197|39985503|FG000|Overall Study|Lost to Follow-up|11|||
16410519|NCT00496197|39985503|FG000|Overall Study|Withdrawal by Subject|11|||
16410520|NCT00496197|39985503|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
16410521|NCT00496197|39985503|FG000|Overall Study|Other|14|||
16410522|NCT00496197|39985503|FG000|Overall Study|Protocol Violation|8|||
16410523|NCT01448824|39985505|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16410524|NCT01448824|39985506|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16410525|NCT01448824|39985507|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16410526|NCT01448824|39985508|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16410527|NCT01448824|39985509|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16410528|NCT01448824|39985510|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16410529|NCT01448824|39985511|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
16410530|NCT01448824|39985512|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
16410531|NCT01448824|39985505|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
16410532|NCT01448824|39985506|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
16410533|NCT01448824|39985507|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
16410534|NCT01448824|39985508|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
16410535|NCT01448824|39985509|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
16410536|NCT01448824|39985510|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
16410537|NCT01448824|39985511|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
16410538|NCT01448824|39985512|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
16410539|NCT01448824|39985505|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16410540|NCT01448824|39985506|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16410541|NCT01448824|39985507|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16410542|NCT01448824|39985508|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16410543|NCT01448824|39985509|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16410544|NCT01448824|39985510|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
16410545|NCT01448824|39985511|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16410546|NCT01448824|39985512|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
16410547|NCT01448824|39985505|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
16547439|NCT00695786|40467623|FG003|Overall Study|Lack of Efficacy|4|||
16547440|NCT01785563|40467624|FG000|Overall Study|Physician Decision|10|||
16547441|NCT01785563|40467624|FG000|Overall Study|Withdrawal by Subject|1|||
16547442|NCT01785563|40467624|FG000|Overall Study|Protocol Violation|2|||
16410548|NCT01448824|39985506|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
16410549|NCT01448824|39985507|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
16547443|NCT01203930|40467627|FG000|Overall Study|Disease Progression|0|||
16547444|NCT01203930|40467628|FG001|Overall Study|Disease Progression|4|||
16547445|NCT01203930|40467627|FG000|Overall Study|Death|3|||
16547446|NCT01203930|40467628|FG001|Overall Study|Death|1|||
16547447|NCT01203930|40467627|FG000|Overall Study|Withdrew Consent|1|||
16547448|NCT01203930|40467628|FG001|Overall Study|Withdrew Consent|10|||
16547449|NCT01203930|40467627|FG000|Overall Study|Investigator Request|0|||
16547450|NCT01203930|40467628|FG001|Overall Study|Investigator Request|8|||
16547451|NCT01203930|40467627|FG000|Overall Study|Study Terminated by Sponsor|0|||
16547452|NCT01203930|40467628|FG001|Overall Study|Study Terminated by Sponsor|12|||
16547453|NCT01203930|40467627|FG000|Overall Study|Poor tolerance of study drug|0|||
16547454|NCT01203930|40467628|FG001|Overall Study|Poor tolerance of study drug|1|||
16547455|NCT01203930|40467627|FG000|Overall Study|Adverse Event|17|||
16547456|NCT01203930|40467628|FG001|Overall Study|Adverse Event|5|||
16547457|NCT03882801|40467629|FG000|Period 1|Adverse Event|0|||
16547458|NCT03882801|40467630|FG001|Period 1|Adverse Event|1|||
16547459|NCT03882801|40467629|FG000|Period 1|Non-compliance with study drug|1|||
16547460|NCT03882801|40467630|FG001|Period 1|Non-compliance with study drug|1|||
16547461|NCT03882801|40467629|FG000|Period 1|Never treated with study drug|1|||
16547462|NCT03882801|40467630|FG001|Period 1|Never treated with study drug|0|||
16547463|NCT03882801|40467629|FG000|Washout Period|Physician Decision|0|||
16547464|NCT03882801|40467630|FG001|Washout Period|Physician Decision|1|||
16547465|NCT03882801|40467629|FG000|Period 2|Non-compliance with study drug|0|||
16547466|NCT03882801|40467630|FG001|Period 2|Non-compliance with study drug|1|||
16547467|NCT02301156|40467631|FG000|Overall Study|Adverse Event|13|||
16547468|NCT02301156|40467632|FG001|Overall Study|Adverse Event|14|||
16547469|NCT02301156|40467631|FG000|Overall Study|Death|1|||
16547470|NCT02301156|40467632|FG001|Overall Study|Death|5|||
16547471|NCT02301156|40467631|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
16547472|NCT02301156|40467632|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
16547473|NCT02301156|40467631|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
16547474|NCT02301156|40467632|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
16547475|NCT02301156|40467631|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
16547476|NCT02301156|40467632|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
16547477|NCT02301156|40467631|FG000|Overall Study|Reason not Specified|6|||
16547478|NCT02301156|40467632|FG001|Overall Study|Reason not Specified|3|||
16547479|NCT00313911|40467637|FG000|Overall Study|Serious adverse event|6|||
16547480|NCT00313911|40467638|FG001|Overall Study|Serious adverse event|1|||
16547481|NCT00313911|40467637|FG000|Overall Study|Adverse Event|2|||
16114409|NCT00379769|38906084|FG005|Observational Follow-up|Lost to Follow-up|27|||
16114410|NCT00379769|38906079|FG000|Observational Follow-up|Withdrawal by Subject|0|||
16225489|NCT01004861|39306147|FG011|Overall Study|Disease progression|3|||
16547482|NCT00313911|40467638|FG001|Overall Study|Adverse Event|3|||
16547483|NCT00313911|40467637|FG000|Overall Study|Protocol Violation|19|||
16547484|NCT00313911|40467638|FG001|Overall Study|Protocol Violation|10|||
16547485|NCT00313911|40467637|FG000|Overall Study|Lost to Follow-up|27|||
16547486|NCT00313911|40467638|FG001|Overall Study|Lost to Follow-up|14|||
16547487|NCT00313911|40467637|FG000|Overall Study|Withdrawal by Subject|39|||
16547488|NCT00313911|40467638|FG001|Overall Study|Withdrawal by Subject|12|||
16547489|NCT00313911|40467637|FG000|Overall Study|Did not meet age criteria|1|||
16547490|NCT00313911|40467638|FG001|Overall Study|Did not meet age criteria|1|||
16547491|NCT03131960|40467641|FG000|Overall Study|Adverse Event|0|||
16547492|NCT03131960|40467642|FG001|Overall Study|Adverse Event|1|||
16547493|NCT01576367|40467646|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16547494|NCT01576367|40467646|FG000|Overall Study|Moved to commercial use after 6 months|1|||
16547495|NCT02669095|40467647|FG000|Overall Study|Adverse Event|1|||
16547496|NCT02669095|40467648|FG001|Overall Study|Adverse Event|0|||
16547497|NCT02669095|40467647|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
16547498|NCT02669095|40467648|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
16547499|NCT02669095|40467647|FG000|Overall Study|Torn Lens|0|||
16547500|NCT02669095|40467648|FG001|Overall Study|Torn Lens|1|||
16547501|NCT02669095|40467647|FG000|Overall Study|Visit 5 assessments not completed|0|||
16547502|NCT02669095|40467648|FG001|Overall Study|Visit 5 assessments not completed|1|||
16547503|NCT01518946|40467650|FG000|Open-label Phase|Other|4|||
16547504|NCT01518946|40467651|FG001|Open-label Phase|Other|0|||
16547505|NCT01518946|40467652|FG002|Open-label Phase|Other|0|||
16547506|NCT01518946|40467650|FG000|Randomized Phase (First Intervention)|Other|0|||
16547507|NCT01518946|40467651|FG001|Randomized Phase (First Intervention)|Other|1|||
16547508|NCT01518946|40467652|FG002|Randomized Phase (First Intervention)|Other|0|||
16547509|NCT00879996|40467653|FG000|Overall Study|Lost to Follow-up|7|||
16547510|NCT00879996|40467654|FG001|Overall Study|Lost to Follow-up|6|||
16225490|NCT01004861|39306148|FG012|Overall Study|Disease progression|8|||
16346886|NCT00972283|39757329|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
16547511|NCT00879996|40467653|FG000|Overall Study|non-compliance|6|||
16547512|NCT00879996|40467654|FG001|Overall Study|non-compliance|4|||
16547513|NCT00879996|40467653|FG000|Overall Study|Physician Decision|1|||
16547514|NCT00879996|40467654|FG001|Overall Study|Physician Decision|2|||
16547515|NCT00879996|40467653|FG000|Overall Study|psychiatric problem|0|||
16547516|NCT00879996|40467654|FG001|Overall Study|psychiatric problem|1|||
16547517|NCT00879996|40467653|FG000|Overall Study|put on parole|1|||
16547518|NCT00879996|40467654|FG001|Overall Study|put on parole|0|||
16547519|NCT00886639|40467659|FG000|Overall Study|acute exacerbation|14|||
16547520|NCT00886639|40467659|FG000|Overall Study|non-compliance|2|||
16547521|NCT00738101|40467660|FG000|Overall Study|Physician Decision|5|||
16547522|NCT00738101|40467660|FG000|Overall Study|Death|1|||
16547523|NCT00738101|40467660|FG000|Overall Study|Repeat enrollment|1|||
16547524|NCT02924389|40467663|FG000|Overall Study|Lost to Follow-up|1|||
16547525|NCT02924389|40467664|FG001|Overall Study|Lost to Follow-up|0|||
16547526|NCT02924389|40467663|FG000|Overall Study|Physician Decision|2|||
16547527|NCT02924389|40467664|FG001|Overall Study|Physician Decision|0|||
16547528|NCT02924389|40467663|FG000|Overall Study|Withdrawal by Subject|3|||
16114411|NCT00379769|38906080|FG001|Observational Follow-up|Withdrawal by Subject|0|||
16114412|NCT00379769|38906081|FG002|Observational Follow-up|Withdrawal by Subject|0|||
16114413|NCT00379769|38906082|FG003|Observational Follow-up|Withdrawal by Subject|0|||
16114414|NCT00379769|38906083|FG004|Observational Follow-up|Withdrawal by Subject|12|||
16114415|NCT00379769|38906084|FG005|Observational Follow-up|Withdrawal by Subject|12|||
16114416|NCT00379769|38906079|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
16114417|NCT00379769|38906080|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
16114418|NCT00379769|38906081|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
16114419|NCT00379769|38906082|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
16114420|NCT00379769|38906083|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
16114421|NCT00379769|38906084|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
16114422|NCT00379769|38906079|FG000|Observational Follow-up|Physician Decision|0|||
16114423|NCT00379769|38906080|FG001|Observational Follow-up|Physician Decision|0|||
16114424|NCT00379769|38906081|FG002|Observational Follow-up|Physician Decision|0|||
16114425|NCT00379769|38906082|FG003|Observational Follow-up|Physician Decision|0|||
16114426|NCT00379769|38906083|FG004|Observational Follow-up|Physician Decision|8|||
16547529|NCT02924389|40467664|FG001|Overall Study|Withdrawal by Subject|0|||
16547530|NCT02924389|40467663|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
16547531|NCT02924389|40467664|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
16547532|NCT04858802|40467673|FG000|Overall Study|Lost to Follow-up|1|||
16114427|NCT00379769|38906084|FG005|Observational Follow-up|Physician Decision|8|||
16114428|NCT00379769|38906079|FG000|Observational Follow-up|Site Closed Early|0|||
16114429|NCT00379769|38906080|FG001|Observational Follow-up|Site Closed Early|0|||
16114430|NCT00379769|38906081|FG002|Observational Follow-up|Site Closed Early|0|||
16114431|NCT00379769|38906082|FG003|Observational Follow-up|Site Closed Early|0|||
16114432|NCT00379769|38906083|FG004|Observational Follow-up|Site Closed Early|6|||
16114433|NCT00379769|38906084|FG005|Observational Follow-up|Site Closed Early|7|||
16114434|NCT00379769|38906079|FG000|Observational Follow-up|Participant Moved|0|||
16114435|NCT00379769|38906080|FG001|Observational Follow-up|Participant Moved|0|||
16114436|NCT00379769|38906081|FG002|Observational Follow-up|Participant Moved|0|||
16114437|NCT00379769|38906082|FG003|Observational Follow-up|Participant Moved|0|||
16114438|NCT00379769|38906083|FG004|Observational Follow-up|Participant Moved|0|||
16114439|NCT00379769|38906084|FG005|Observational Follow-up|Participant Moved|1|||
16114440|NCT00379769|38906079|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
16114441|NCT00379769|38906080|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
16114442|NCT00379769|38906081|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
16114443|NCT00379769|38906082|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
16114444|NCT00379769|38906083|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
16114445|NCT00379769|38906084|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
16114446|NCT01821937|38906088|FG000|Overall Study|Adverse Event|0|||
16114447|NCT01821937|38906089|FG001|Overall Study|Adverse Event|3|||
16114448|NCT02906020|38906090|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
16114449|NCT02906020|38906091|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
16114450|NCT02906020|38906092|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
16114451|NCT02906020|38906093|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
16114452|NCT02906020|38906094|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
16114453|NCT02906020|38906095|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
16114454|NCT02906020|38906096|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
16114455|NCT02906020|38906097|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
16114456|NCT02906020|38906098|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
16114457|NCT02906020|38906099|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
16114458|NCT02906020|38906100|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
16114459|NCT02906020|38906101|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
16114460|NCT02906020|38906102|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
16114461|NCT02906020|38906103|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
16547533|NCT04858802|40467674|FG001|Overall Study|Lost to Follow-up|1|||
16547534|NCT04858802|40467673|FG000|Overall Study|Withdrawal by Subject|1|||
16547535|NCT04858802|40467674|FG001|Overall Study|Withdrawal by Subject|1|||
16114462|NCT02906020|38906104|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
16114463|NCT02906020|38906105|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
16114464|NCT02906020|38906090|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114465|NCT02906020|38906091|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114466|NCT02906020|38906092|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114467|NCT02906020|38906093|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114468|NCT02906020|38906094|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114469|NCT02906020|38906095|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114470|NCT02906020|38906096|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114471|NCT02906020|38906097|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114472|NCT02906020|38906098|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
16114473|NCT02906020|38906099|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
16114474|NCT02906020|38906100|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114475|NCT02906020|38906101|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114476|NCT02906020|38906102|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114477|NCT02906020|38906103|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114478|NCT02906020|38906104|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114479|NCT02906020|38906105|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
16114480|NCT02906020|38906090|FG000|Part 2: Double-blind Treatment Period|Other|0|||
16114481|NCT02906020|38906091|FG001|Part 2: Double-blind Treatment Period|Other|0|||
16114482|NCT02906020|38906092|FG002|Part 2: Double-blind Treatment Period|Other|0|||
16114483|NCT02906020|38906093|FG003|Part 2: Double-blind Treatment Period|Other|0|||
16114484|NCT02906020|38906094|FG004|Part 2: Double-blind Treatment Period|Other|0|||
16114485|NCT02906020|38906095|FG005|Part 2: Double-blind Treatment Period|Other|0|||
16114486|NCT02906020|38906096|FG006|Part 2: Double-blind Treatment Period|Other|0|||
16114487|NCT02906020|38906097|FG007|Part 2: Double-blind Treatment Period|Other|0|||
16114488|NCT02906020|38906098|FG008|Part 2: Double-blind Treatment Period|Other|6|||
16114489|NCT02906020|38906099|FG009|Part 2: Double-blind Treatment Period|Other|10|||
16114490|NCT02906020|38906100|FG010|Part 2: Double-blind Treatment Period|Other|0|||
16114491|NCT02906020|38906101|FG011|Part 2: Double-blind Treatment Period|Other|0|||
16114492|NCT02906020|38906102|FG012|Part 2: Double-blind Treatment Period|Other|0|||
16114493|NCT02906020|38906103|FG013|Part 2: Double-blind Treatment Period|Other|0|||
16114494|NCT02906020|38906104|FG014|Part 2: Double-blind Treatment Period|Other|0|||
16114495|NCT02906020|38906105|FG015|Part 2: Double-blind Treatment Period|Other|0|||
16114496|NCT02906020|38906090|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114497|NCT02906020|38906091|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114498|NCT02906020|38906092|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114499|NCT02906020|38906093|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114500|NCT02906020|38906094|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114501|NCT02906020|38906095|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114502|NCT02906020|38906096|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114503|NCT02906020|38906097|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114504|NCT02906020|38906098|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114505|NCT02906020|38906099|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114506|NCT02906020|38906100|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114507|NCT02906020|38906101|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114508|NCT02906020|38906102|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
16114509|NCT02906020|38906103|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
16114510|NCT02906020|38906104|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114511|NCT02906020|38906105|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
16114512|NCT02906020|38906090|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114513|NCT02906020|38906091|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114514|NCT02906020|38906092|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114515|NCT02906020|38906093|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114516|NCT02906020|38906094|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114517|NCT02906020|38906095|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114518|NCT02906020|38906096|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114519|NCT02906020|38906097|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114520|NCT02906020|38906098|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114521|NCT02906020|38906099|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114522|NCT02906020|38906100|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114523|NCT02906020|38906101|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114524|NCT02906020|38906102|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
16114525|NCT02906020|38906103|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
16225491|NCT01004861|39306136|FG000|Overall Study|Physician Decision|0|||
16225492|NCT01004861|39306137|FG001|Overall Study|Physician Decision|2|||
16225493|NCT01004861|39306138|FG002|Overall Study|Physician Decision|1|||
16114526|NCT02906020|38906104|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
16114527|NCT02906020|38906105|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
16114528|NCT02906020|38906090|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114529|NCT02906020|38906091|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114530|NCT02906020|38906092|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114531|NCT02906020|38906093|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114532|NCT02906020|38906094|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114533|NCT02906020|38906095|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114534|NCT02906020|38906096|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114535|NCT02906020|38906097|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114536|NCT02906020|38906098|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114537|NCT02906020|38906099|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114538|NCT02906020|38906100|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114539|NCT02906020|38906101|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114540|NCT02906020|38906102|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
16114541|NCT02906020|38906103|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
16114542|NCT02906020|38906104|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114543|NCT02906020|38906105|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
16114544|NCT02906020|38906090|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114545|NCT02906020|38906091|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114546|NCT02906020|38906092|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114547|NCT02906020|38906093|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114548|NCT02906020|38906094|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16225494|NCT01004861|39306139|FG003|Overall Study|Physician Decision|1|||
16225495|NCT01004861|39306140|FG004|Overall Study|Physician Decision|1|||
16225496|NCT01004861|39306141|FG005|Overall Study|Physician Decision|0|||
16225497|NCT01004861|39306142|FG006|Overall Study|Physician Decision|0|||
16225498|NCT01004861|39306143|FG007|Overall Study|Physician Decision|1|||
16547536|NCT01077544|40467675|FG000|Overall Study|New Cancer Therapy|3|||
16547537|NCT01077544|40467676|FG001|Overall Study|New Cancer Therapy|3|||
16547538|NCT01077544|40467675|FG000|Overall Study|Adverse Event|0|||
16547539|NCT01077544|40467676|FG001|Overall Study|Adverse Event|1|||
16547540|NCT01077544|40467675|FG000|Overall Study|Disease Progression|0|||
16547541|NCT01077544|40467676|FG001|Overall Study|Disease Progression|1|||
16547542|NCT02202434|40467677|FG000|Overall Study|Death|70|||
16547543|NCT02202434|40467678|FG001|Overall Study|Death|39|||
16547544|NCT02202434|40467679|FG002|Overall Study|Death|13|||
16547545|NCT02202434|40467680|FG003|Overall Study|Death|27|||
16547546|NCT02202434|40467677|FG000|Overall Study|Lost to Follow-up|1|||
16547547|NCT02202434|40467678|FG001|Overall Study|Lost to Follow-up|1|||
16547548|NCT02202434|40467679|FG002|Overall Study|Lost to Follow-up|1|||
16547549|NCT02202434|40467680|FG003|Overall Study|Lost to Follow-up|0|||
16547550|NCT02202434|40467677|FG000|Overall Study|Physician Decision|2|||
16547551|NCT02202434|40467678|FG001|Overall Study|Physician Decision|3|||
16547552|NCT02202434|40467679|FG002|Overall Study|Physician Decision|0|||
16547553|NCT02202434|40467680|FG003|Overall Study|Physician Decision|0|||
16547554|NCT02202434|40467677|FG000|Overall Study|Withdrawal by Subject|13|||
16547555|NCT02202434|40467678|FG001|Overall Study|Withdrawal by Subject|14|||
16547556|NCT02202434|40467679|FG002|Overall Study|Withdrawal by Subject|1|||
16547557|NCT02202434|40467680|FG003|Overall Study|Withdrawal by Subject|4|||
16547558|NCT02202434|40467677|FG000|Overall Study|Completed Study|1|||
16225499|NCT01004861|39306144|FG008|Overall Study|Physician Decision|0|||
16225500|NCT01004861|39306145|FG009|Overall Study|Physician Decision|0|||
16225501|NCT01004861|39306146|FG010|Overall Study|Physician Decision|0|||
16225502|NCT01004861|39306147|FG011|Overall Study|Physician Decision|0|||
16225503|NCT01004861|39306148|FG012|Overall Study|Physician Decision|3|||
16225504|NCT01004861|39306136|FG000|Overall Study|Adverse Event|0|||
16225505|NCT01004861|39306137|FG001|Overall Study|Adverse Event|0|||
16225506|NCT01004861|39306138|FG002|Overall Study|Adverse Event|0|||
16225507|NCT01004861|39306139|FG003|Overall Study|Adverse Event|1|||
16225508|NCT01004861|39306140|FG004|Overall Study|Adverse Event|0|||
16225509|NCT01004861|39306141|FG005|Overall Study|Adverse Event|2|||
16225510|NCT01004861|39306142|FG006|Overall Study|Adverse Event|1|||
16225511|NCT01004861|39306143|FG007|Overall Study|Adverse Event|1|||
16225512|NCT01004861|39306144|FG008|Overall Study|Adverse Event|13|||
16225513|NCT01004861|39306145|FG009|Overall Study|Adverse Event|1|||
16225514|NCT01004861|39306146|FG010|Overall Study|Adverse Event|1|||
16225515|NCT01004861|39306147|FG011|Overall Study|Adverse Event|0|||
16225516|NCT01004861|39306148|FG012|Overall Study|Adverse Event|2|||
16225517|NCT01004861|39306136|FG000|Overall Study|Protocol Violation|0|||
16547559|NCT02202434|40467678|FG001|Overall Study|Completed Study|0|||
16547560|NCT02202434|40467679|FG002|Overall Study|Completed Study|0|||
16547561|NCT02202434|40467680|FG003|Overall Study|Completed Study|0|||
16547562|NCT02202434|40467677|FG000|Overall Study|Visit Missed|21|||
16547563|NCT02202434|40467678|FG001|Overall Study|Visit Missed|12|||
16547564|NCT02202434|40467679|FG002|Overall Study|Visit Missed|0|||
16547565|NCT02202434|40467680|FG003|Overall Study|Visit Missed|5|||
16225518|NCT01004861|39306137|FG001|Overall Study|Protocol Violation|0|||
16225519|NCT01004861|39306138|FG002|Overall Study|Protocol Violation|0|||
16225520|NCT01004861|39306139|FG003|Overall Study|Protocol Violation|0|||
16225521|NCT01004861|39306140|FG004|Overall Study|Protocol Violation|1|||
16225522|NCT01004861|39306141|FG005|Overall Study|Protocol Violation|0|||
16225523|NCT01004861|39306142|FG006|Overall Study|Protocol Violation|0|||
16225524|NCT01004861|39306143|FG007|Overall Study|Protocol Violation|0|||
16225525|NCT01004861|39306144|FG008|Overall Study|Protocol Violation|0|||
16225526|NCT01004861|39306145|FG009|Overall Study|Protocol Violation|0|||
16225527|NCT01004861|39306146|FG010|Overall Study|Protocol Violation|0|||
16225528|NCT01004861|39306147|FG011|Overall Study|Protocol Violation|0|||
16225529|NCT01004861|39306148|FG012|Overall Study|Protocol Violation|0|||
16225530|NCT01004861|39306136|FG000|Overall Study|Lost to Follow-up|0|||
16225531|NCT01004861|39306137|FG001|Overall Study|Lost to Follow-up|0|||
16225532|NCT01004861|39306138|FG002|Overall Study|Lost to Follow-up|0|||
16410550|NCT01448824|39985508|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
16410551|NCT01448824|39985509|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
16225533|NCT01004861|39306139|FG003|Overall Study|Lost to Follow-up|0|||
16225534|NCT01004861|39306140|FG004|Overall Study|Lost to Follow-up|0|||
16225535|NCT01004861|39306141|FG005|Overall Study|Lost to Follow-up|0|||
16225536|NCT01004861|39306142|FG006|Overall Study|Lost to Follow-up|0|||
16225537|NCT01004861|39306143|FG007|Overall Study|Lost to Follow-up|1|||
16225538|NCT01004861|39306144|FG008|Overall Study|Lost to Follow-up|3|||
16225539|NCT01004861|39306145|FG009|Overall Study|Lost to Follow-up|0|||
16225540|NCT01004861|39306146|FG010|Overall Study|Lost to Follow-up|0|||
16225541|NCT01004861|39306147|FG011|Overall Study|Lost to Follow-up|1|||
16225542|NCT01004861|39306148|FG012|Overall Study|Lost to Follow-up|0|||
16225543|NCT01004861|39306136|FG000|Overall Study|Non-compliance|0|||
16225544|NCT01004861|39306137|FG001|Overall Study|Non-compliance|0|||
16225545|NCT01004861|39306138|FG002|Overall Study|Non-compliance|0|||
16225546|NCT01004861|39306139|FG003|Overall Study|Non-compliance|0|||
16225547|NCT01004861|39306140|FG004|Overall Study|Non-compliance|0|||
16225548|NCT01004861|39306141|FG005|Overall Study|Non-compliance|0|||
16225549|NCT01004861|39306142|FG006|Overall Study|Non-compliance|0|||
16225550|NCT01004861|39306143|FG007|Overall Study|Non-compliance|0|||
16114549|NCT02906020|38906095|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16225551|NCT01004861|39306144|FG008|Overall Study|Non-compliance|5|||
16225552|NCT01004861|39306145|FG009|Overall Study|Non-compliance|0|||
16225553|NCT01004861|39306146|FG010|Overall Study|Non-compliance|0|||
16225554|NCT01004861|39306147|FG011|Overall Study|Non-compliance|0|||
16225555|NCT01004861|39306148|FG012|Overall Study|Non-compliance|1|||
16225556|NCT01004861|39306136|FG000|Overall Study|Other|0|||
16225557|NCT01004861|39306137|FG001|Overall Study|Other|0|||
16225558|NCT01004861|39306138|FG002|Overall Study|Other|0|||
16225559|NCT01004861|39306139|FG003|Overall Study|Other|0|||
16225560|NCT01004861|39306140|FG004|Overall Study|Other|0|||
16346887|NCT00972283|39757330|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
16346888|NCT00972283|39757329|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
16346889|NCT00972283|39757330|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
16346890|NCT00972283|39757329|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
16346891|NCT00972283|39757330|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
16346892|NCT00715559|39757335|FG000|Overall Study|medication not tolerated - nausea|1|||
16346893|NCT01383018|39757336|FG000|Overall Study|Adverse Event|14|||
16346894|NCT01383018|39757336|FG000|Overall Study|Death|10|||
16346895|NCT01383018|39757336|FG000|Overall Study|Lost to Follow-up|5|||
16346896|NCT01383018|39757336|FG000|Overall Study|Physician Decision|5|||
16346897|NCT01383018|39757336|FG000|Overall Study|Withdrawal by Subject|9|||
16346898|NCT01383018|39757336|FG000|Overall Study|Subject not implanted|76|||
16346899|NCT01383018|39757336|FG000|Overall Study|Missed Visit|247|||
16346900|NCT01383018|39757336|FG000|Overall Study|Site closed early-not compliance related|7|||
16346901|NCT01383018|39757336|FG000|Overall Study|Patient moved away from site|1|||
16346902|NCT01383018|39757336|FG000|Overall Study|Subject Incarcerated|1|||
16346903|NCT00954122|39757337|FG000|Overall Study|Withdrawal by Subject|5|||
16346904|NCT00954122|39757337|FG000|Overall Study|Adverse Event|1|||
16346905|NCT00954122|39757337|FG000|Overall Study|Safety Reason|1|||
16346906|NCT00482170|39757338|FG000|Overall Study|Adverse Event|5|||
16346907|NCT00482170|39757339|FG001|Overall Study|Adverse Event|14|||
16346908|NCT00482170|39757338|FG000|Overall Study|Withdrawal by Subject|6|||
16346909|NCT00482170|39757339|FG001|Overall Study|Withdrawal by Subject|1|||
16346910|NCT00482170|39757338|FG000|Overall Study|Protocol Violation|2|||
16346911|NCT00482170|39757339|FG001|Overall Study|Protocol Violation|3|||
16346912|NCT00482170|39757338|FG000|Overall Study|Lost to Follow-up|2|||
16346913|NCT00482170|39757339|FG001|Overall Study|Lost to Follow-up|0|||
16225561|NCT01004861|39306141|FG005|Overall Study|Other|0|||
16225562|NCT01004861|39306142|FG006|Overall Study|Other|0|||
16225563|NCT01004861|39306143|FG007|Overall Study|Other|0|||
16225564|NCT01004861|39306144|FG008|Overall Study|Other|0|||
16225565|NCT01004861|39306145|FG009|Overall Study|Other|2|||
16225566|NCT01004861|39306146|FG010|Overall Study|Other|1|||
16225567|NCT01004861|39306147|FG011|Overall Study|Other|2|||
16225568|NCT01004861|39306148|FG012|Overall Study|Other|3|||
16225569|NCT01004861|39306136|FG000|Overall Study|Patient decision|0|||
16225570|NCT01004861|39306137|FG001|Overall Study|Patient decision|0|||
16225571|NCT01004861|39306138|FG002|Overall Study|Patient decision|0|||
16225572|NCT01004861|39306139|FG003|Overall Study|Patient decision|0|||
16225573|NCT01004861|39306140|FG004|Overall Study|Patient decision|1|||
16225574|NCT01004861|39306141|FG005|Overall Study|Patient decision|0|||
16225575|NCT01004861|39306142|FG006|Overall Study|Patient decision|1|||
16225576|NCT01004861|39306143|FG007|Overall Study|Patient decision|0|||
16225577|NCT01004861|39306144|FG008|Overall Study|Patient decision|7|||
16225578|NCT01004861|39306145|FG009|Overall Study|Patient decision|1|||
16225579|NCT01004861|39306146|FG010|Overall Study|Patient decision|1|||
16225580|NCT01004861|39306147|FG011|Overall Study|Patient decision|2|||
16225581|NCT01004861|39306148|FG012|Overall Study|Patient decision|3|||
16225582|NCT01004861|39306136|FG000|Overall Study|Transitioned to Phase 4 study|0|||
16225583|NCT01004861|39306137|FG001|Overall Study|Transitioned to Phase 4 study|0|||
16225584|NCT01004861|39306138|FG002|Overall Study|Transitioned to Phase 4 study|0|||
16225585|NCT01004861|39306139|FG003|Overall Study|Transitioned to Phase 4 study|0|||
16225586|NCT01004861|39306140|FG004|Overall Study|Transitioned to Phase 4 study|0|||
16225587|NCT01004861|39306141|FG005|Overall Study|Transitioned to Phase 4 study|0|||
16225588|NCT01004861|39306142|FG006|Overall Study|Transitioned to Phase 4 study|0|||
16225589|NCT01004861|39306143|FG007|Overall Study|Transitioned to Phase 4 study|0|||
16225590|NCT01004861|39306144|FG008|Overall Study|Transitioned to Phase 4 study|2|||
16225591|NCT01004861|39306145|FG009|Overall Study|Transitioned to Phase 4 study|0|||
16225592|NCT01004861|39306146|FG010|Overall Study|Transitioned to Phase 4 study|0|||
16225593|NCT01004861|39306147|FG011|Overall Study|Transitioned to Phase 4 study|0|||
16225594|NCT01004861|39306148|FG012|Overall Study|Transitioned to Phase 4 study|0|||
16225595|NCT01004861|39306136|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225596|NCT01004861|39306137|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225597|NCT01004861|39306138|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225598|NCT01004861|39306139|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225599|NCT01004861|39306140|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225600|NCT01004861|39306141|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225601|NCT01004861|39306142|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225602|NCT01004861|39306143|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225603|NCT01004861|39306144|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
16225604|NCT01004861|39306145|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225605|NCT01004861|39306146|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225606|NCT01004861|39306147|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225607|NCT01004861|39306148|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
16225608|NCT01004861|39306136|FG000|Overall Study|Patient withdrew|0|||
16225609|NCT01004861|39306137|FG001|Overall Study|Patient withdrew|0|||
16225610|NCT01004861|39306138|FG002|Overall Study|Patient withdrew|0|||
16225611|NCT01004861|39306139|FG003|Overall Study|Patient withdrew|0|||
16225612|NCT01004861|39306140|FG004|Overall Study|Patient withdrew|0|||
16225613|NCT01004861|39306141|FG005|Overall Study|Patient withdrew|0|||
16225614|NCT01004861|39306142|FG006|Overall Study|Patient withdrew|0|||
16225615|NCT01004861|39306143|FG007|Overall Study|Patient withdrew|0|||
16225616|NCT01004861|39306144|FG008|Overall Study|Patient withdrew|1|||
16225617|NCT01004861|39306145|FG009|Overall Study|Patient withdrew|0|||
16225618|NCT01004861|39306146|FG010|Overall Study|Patient withdrew|0|||
16225619|NCT01004861|39306147|FG011|Overall Study|Patient withdrew|0|||
16225620|NCT01004861|39306148|FG012|Overall Study|Patient withdrew|0|||
16225621|NCT01004861|39306136|FG000|Overall Study|Surgical resection|0|||
16225622|NCT01004861|39306137|FG001|Overall Study|Surgical resection|0|||
16225623|NCT01004861|39306138|FG002|Overall Study|Surgical resection|0|||
16225624|NCT01004861|39306139|FG003|Overall Study|Surgical resection|0|||
16225625|NCT01004861|39306140|FG004|Overall Study|Surgical resection|0|||
16225626|NCT01004861|39306141|FG005|Overall Study|Surgical resection|0|||
16225627|NCT01004861|39306142|FG006|Overall Study|Surgical resection|0|||
16225628|NCT01004861|39306143|FG007|Overall Study|Surgical resection|0|||
16225629|NCT01004861|39306144|FG008|Overall Study|Surgical resection|1|||
16225630|NCT01004861|39306145|FG009|Overall Study|Surgical resection|0|||
16225631|NCT01004861|39306146|FG010|Overall Study|Surgical resection|0|||
16225632|NCT01004861|39306147|FG011|Overall Study|Surgical resection|0|||
16225633|NCT01004861|39306148|FG012|Overall Study|Surgical resection|0|||
16346914|NCT00482170|39757338|FG000|Overall Study|Unspecified reason|0|||
16346915|NCT00482170|39757339|FG001|Overall Study|Unspecified reason|2|||
16346916|NCT04110314|39757340|FG000|Overall Study|Did not meet inclusion criteria|35255|||
16346917|NCT04110314|39757341|FG001|Overall Study|Did not meet inclusion criteria|35104|||
16225634|NCT01004861|39306136|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16225635|NCT01004861|39306137|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16225636|NCT01004861|39306138|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16225637|NCT01004861|39306139|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16410552|NCT01448824|39985510|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
16410553|NCT01448824|39985511|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
16410554|NCT01448824|39985512|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
16410555|NCT01448824|39985505|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16410556|NCT01448824|39985506|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16410557|NCT01448824|39985507|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16547566|NCT02202434|40467677|FG000|Overall Study|Other|1|||
16225638|NCT01004861|39306140|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16346918|NCT04110314|39757342|FG002|Overall Study|Did not meet inclusion criteria|35636|||
16346919|NCT04110314|39757343|FG003|Overall Study|Did not meet inclusion criteria|35135|||
16346920|NCT04110314|39757344|FG004|Overall Study|Did not meet inclusion criteria|35247|||
16346921|NCT04110314|39757345|FG005|Overall Study|Did not meet inclusion criteria|35727|||
16346922|NCT00130689|39757348|FG000|Overall Study|Progressive Disease|29|||
16225639|NCT01004861|39306141|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16225640|NCT01004861|39306142|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16225641|NCT01004861|39306143|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16346923|NCT00130689|39757348|FG000|Overall Study|Death|1|||
16346924|NCT00130689|39757348|FG000|Overall Study|Clinical Deterioration|4|||
16346925|NCT00130689|39757348|FG000|Overall Study|Withdrawal by Subject|3|||
16225642|NCT01004861|39306144|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
16225643|NCT01004861|39306145|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16225644|NCT01004861|39306146|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16225645|NCT01004861|39306147|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16225646|NCT01004861|39306148|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
16225647|NCT01004861|39306136|FG000|Overall Study|Study termination by Sponsor|0|||
16225648|NCT01004861|39306137|FG001|Overall Study|Study termination by Sponsor|0|||
16225649|NCT01004861|39306138|FG002|Overall Study|Study termination by Sponsor|0|||
16225650|NCT01004861|39306139|FG003|Overall Study|Study termination by Sponsor|0|||
16225651|NCT01004861|39306140|FG004|Overall Study|Study termination by Sponsor|0|||
16225652|NCT01004861|39306141|FG005|Overall Study|Study termination by Sponsor|0|||
16225653|NCT01004861|39306142|FG006|Overall Study|Study termination by Sponsor|0|||
16225654|NCT01004861|39306143|FG007|Overall Study|Study termination by Sponsor|0|||
16225655|NCT01004861|39306144|FG008|Overall Study|Study termination by Sponsor|1|||
16225656|NCT01004861|39306145|FG009|Overall Study|Study termination by Sponsor|0|||
16225657|NCT01004861|39306146|FG010|Overall Study|Study termination by Sponsor|0|||
16225658|NCT01004861|39306147|FG011|Overall Study|Study termination by Sponsor|0|||
16225659|NCT01004861|39306148|FG012|Overall Study|Study termination by Sponsor|0|||
16225660|NCT02500901|39306151|FG000|Overall Study|Disease ProgressionDD|2|||
16225661|NCT00265109|39306152|FG000|Overall Study|Withdrawal by Subject|5|||
16225662|NCT00265109|39306152|FG000|Overall Study|Adverse Event|1|||
16225663|NCT01453296|39306157|FG000|Treatment Period 1|Adverse Event|0|||
16225664|NCT01453296|39306158|FG001|Treatment Period 1|Adverse Event|1|||
16225665|NCT01453296|39306157|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
16225666|NCT01453296|39306158|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
16225667|NCT01453296|39306157|FG000|Treatment Period 2|Adverse Event|1|||
16225668|NCT01453296|39306158|FG001|Treatment Period 2|Adverse Event|0|||
16225669|NCT01453296|39306157|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16225670|NCT01453296|39306158|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16225671|NCT00795717|39306159|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
16225672|NCT00795717|39306160|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
16225673|NCT00795717|39306159|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
16225674|NCT00795717|39306160|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
16410558|NCT01448824|39985508|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16547567|NCT02202434|40467678|FG001|Overall Study|Other|0|||
16547568|NCT02202434|40467679|FG002|Overall Study|Other|0|||
16547569|NCT02202434|40467680|FG003|Overall Study|Other|1|||
16547570|NCT02313909|40467682|FG000|Overall Study|Consent withdrawn by participant|33|||
16547571|NCT02313909|40467683|FG001|Overall Study|Consent withdrawn by participant|33|||
16547572|NCT02313909|40467682|FG000|Overall Study|Lost to Follow-up|24|||
16547573|NCT02313909|40467683|FG001|Overall Study|Lost to Follow-up|17|||
16547574|NCT01364597|40467684|FG000|Overall Study|Adverse Event|4|||
16225675|NCT00795717|39306159|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
16225676|NCT00795717|39306160|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
16225677|NCT00795717|39306159|FG000|Phase II|too busy|0|||
16225678|NCT00795717|39306160|FG001|Phase II|too busy|1|||
16346926|NCT00130689|39757348|FG000|Overall Study|Ineligible|6|||
16346927|NCT02937740|39757349|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
16346928|NCT02937740|39757350|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
16346929|NCT02937740|39757349|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
16346930|NCT02937740|39757350|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
16346931|NCT02937740|39757349|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
16346932|NCT02937740|39757350|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
16346933|NCT02937740|39757349|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
16346934|NCT02937740|39757350|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
16346935|NCT02937740|39757349|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
16346936|NCT02937740|39757350|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
16346937|NCT02937740|39757349|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
16346938|NCT02937740|39757350|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
16346939|NCT00621257|39757351|FG000|Overall Study|Lost to Follow-up|4|||
16346940|NCT00621257|39757352|FG001|Overall Study|Lost to Follow-up|0|||
16346941|NCT00621257|39757353|FG002|Overall Study|Lost to Follow-up|2|||
16346942|NCT00621257|39757354|FG003|Overall Study|Lost to Follow-up|4|||
16346943|NCT00621257|39757355|FG004|Overall Study|Lost to Follow-up|7|||
16346944|NCT00621257|39757351|FG000|Overall Study|Adverse Event|0|||
16346945|NCT00621257|39757352|FG001|Overall Study|Adverse Event|1|||
16346946|NCT00621257|39757353|FG002|Overall Study|Adverse Event|1|||
16346947|NCT00621257|39757354|FG003|Overall Study|Adverse Event|0|||
16346948|NCT00621257|39757355|FG004|Overall Study|Adverse Event|0|||
16225679|NCT00383292|39306162|FG000|Overall Study|Adverse Event|4|||
16225680|NCT00383292|39306163|FG001|Overall Study|Adverse Event|1|||
16225681|NCT00383292|39306164|FG002|Overall Study|Adverse Event|2|||
16225682|NCT00383292|39306162|FG000|Overall Study|Death|3|||
16225683|NCT00383292|39306163|FG001|Overall Study|Death|3|||
16225684|NCT00383292|39306164|FG002|Overall Study|Death|3|||
16225685|NCT00383292|39306162|FG000|Overall Study|Physician Decision|4|||
16225686|NCT00383292|39306163|FG001|Overall Study|Physician Decision|0|||
16225687|NCT00383292|39306164|FG002|Overall Study|Physician Decision|1|||
16225688|NCT00383292|39306162|FG000|Overall Study|Withdrawal by Subject|3|||
16225689|NCT00383292|39306163|FG001|Overall Study|Withdrawal by Subject|2|||
16225690|NCT00383292|39306164|FG002|Overall Study|Withdrawal by Subject|2|||
16225691|NCT00383292|39306162|FG000|Overall Study|Other|1|||
16225692|NCT00383292|39306163|FG001|Overall Study|Other|0|||
16225693|NCT00383292|39306164|FG002|Overall Study|Other|0|||
16225694|NCT02584660|39306165|FG000|Overall Study|Adverse Event|4|||
16225695|NCT02584660|39306166|FG001|Overall Study|Adverse Event|0|||
16225696|NCT02584660|39306165|FG000|Overall Study|Lost to Follow-up|3|||
16225697|NCT02584660|39306166|FG001|Overall Study|Lost to Follow-up|4|||
16225698|NCT02584660|39306165|FG000|Overall Study|Protocol Violation|0|||
16225699|NCT02584660|39306166|FG001|Overall Study|Protocol Violation|1|||
16225700|NCT02584660|39306165|FG000|Overall Study|Withdrawal by Subject|0|||
16225701|NCT02584660|39306166|FG001|Overall Study|Withdrawal by Subject|2|||
16225702|NCT02584660|39306165|FG000|Overall Study|Other|0|||
16225703|NCT02584660|39306166|FG001|Overall Study|Other|1|||
16225704|NCT00706901|39306167|FG000|Overall Study|Lost to Follow-up|2|||
16225705|NCT00706901|39306168|FG001|Overall Study|Lost to Follow-up|3|||
16225706|NCT00706901|39306169|FG002|Overall Study|Lost to Follow-up|2|||
16225707|NCT00706901|39306167|FG000|Overall Study|Withdrawal by Subject|4|||
16225708|NCT00706901|39306168|FG001|Overall Study|Withdrawal by Subject|2|||
16225709|NCT00706901|39306169|FG002|Overall Study|Withdrawal by Subject|5|||
16225710|NCT00706901|39306167|FG000|Overall Study|In Jail|1|||
16225711|NCT00706901|39306168|FG001|Overall Study|In Jail|0|||
16225712|NCT00706901|39306169|FG002|Overall Study|In Jail|1|||
16225713|NCT00706901|39306167|FG000|Overall Study|Death|1|||
16225714|NCT00706901|39306168|FG001|Overall Study|Death|0|||
16225715|NCT00706901|39306169|FG002|Overall Study|Death|0|||
16225716|NCT03487549|39306170|FG000|Overall Study|Protocol Violation|0|||
16225717|NCT03487549|39306171|FG001|Overall Study|Protocol Violation|1|||
16225718|NCT03487549|39306170|FG000|Overall Study|Lost to Follow-up|2|||
16225719|NCT03487549|39306171|FG001|Overall Study|Lost to Follow-up|1|||
16225720|NCT03487549|39306170|FG000|Overall Study|Withdrawal by Subject|2|||
16225721|NCT03487549|39306171|FG001|Overall Study|Withdrawal by Subject|0|||
16225722|NCT00223990|39306177|FG000|Overall Study|Moved from area|2|||
16225723|NCT00223990|39306178|FG001|Overall Study|Moved from area|1|||
16225724|NCT00223990|39306177|FG000|Overall Study|Withdrawal by Subject|4|||
16225725|NCT00223990|39306178|FG001|Overall Study|Withdrawal by Subject|8|||
16225726|NCT00223990|39306177|FG000|Overall Study|Lost to Follow-up|1|||
16225727|NCT00223990|39306178|FG001|Overall Study|Lost to Follow-up|0|||
16346949|NCT00621257|39757351|FG000|Overall Study|Physician Decision|0|||
16346950|NCT00621257|39757352|FG001|Overall Study|Physician Decision|2|||
16225728|NCT01605370|39306179|FG000|Overall Study|Adverse Event|1|||
16225729|NCT01605370|39306180|FG001|Overall Study|Adverse Event|0|||
16225730|NCT03258710|39306181|FG000|Overall Study|Adverse Event|1|||
16346951|NCT00621257|39757353|FG002|Overall Study|Physician Decision|0|||
16346952|NCT00621257|39757354|FG003|Overall Study|Physician Decision|1|||
16346953|NCT00621257|39757355|FG004|Overall Study|Physician Decision|1|||
16346954|NCT00621257|39757351|FG000|Overall Study|Withdrawal by Subject|0|||
16346955|NCT00621257|39757352|FG001|Overall Study|Withdrawal by Subject|0|||
16346956|NCT00621257|39757353|FG002|Overall Study|Withdrawal by Subject|0|||
16346957|NCT00621257|39757354|FG003|Overall Study|Withdrawal by Subject|1|||
16346958|NCT00621257|39757355|FG004|Overall Study|Withdrawal by Subject|1|||
16346959|NCT00397189|39757356|FG000|3 Weeks Period|Lost to Follow-up|5|||
16346960|NCT00397189|39757357|FG001|3 Weeks Period|Lost to Follow-up|4|||
16410559|NCT01448824|39985509|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16410560|NCT01448824|39985510|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16410561|NCT01448824|39985511|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
16225731|NCT03258710|39306181|FG000|Overall Study|Protocol-defined stopping criteria|1|||
16225732|NCT03258710|39306181|FG000|Overall Study|Physician Decision|1|||
16410562|NCT01448824|39985512|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
16410563|NCT01448824|39985505|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16410564|NCT01448824|39985506|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16410565|NCT01448824|39985507|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16410566|NCT01448824|39985508|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16410567|NCT01448824|39985509|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16410568|NCT01448824|39985510|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16410569|NCT01448824|39985511|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
16410570|NCT01448824|39985512|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
16410571|NCT01448824|39985505|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16410572|NCT01448824|39985506|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16410573|NCT01448824|39985507|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16410574|NCT01448824|39985508|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16410575|NCT01448824|39985509|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16410576|NCT01448824|39985510|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16410577|NCT01448824|39985511|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
16410578|NCT01448824|39985512|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
16410579|NCT01448824|39985505|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16410580|NCT01448824|39985506|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16410581|NCT01448824|39985507|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16410582|NCT01448824|39985508|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16410583|NCT01448824|39985509|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16410584|NCT01448824|39985510|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16410585|NCT01448824|39985511|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
16410586|NCT01448824|39985512|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
16410587|NCT01300351|39985516|FG000|Overall Study|Did not receive treatment|2|||
16410588|NCT01300351|39985517|FG001|Overall Study|Did not receive treatment|0|||
16410589|NCT01300351|39985516|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
16410590|NCT01300351|39985517|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
16410591|NCT01300351|39985516|FG000|Overall Study|Lost to Follow-up|0|||
16410592|NCT01300351|39985517|FG001|Overall Study|Lost to Follow-up|1|||
16410593|NCT01300351|39985516|FG000|Overall Study|Adverse Event|0|||
16410594|NCT01300351|39985517|FG001|Overall Study|Adverse Event|4|||
16410595|NCT01300351|39985516|FG000|Overall Study|Withdrawal by Subject|7|||
16410596|NCT01300351|39985517|FG001|Overall Study|Withdrawal by Subject|10|||
16410597|NCT01011933|39985520|FG000|Overall Study|Wrong cell type|1|||
16410598|NCT01011933|39985520|FG000|Overall Study|Improper pre-protocol Rx|1|||
16410599|NCT01011933|39985520|FG000|Overall Study|Inadequate pathology|1|||
16410600|NCT01011933|39985520|FG000|Overall Study|Never treated|1|||
16410601|NCT00583791|39985521|FG000|Overall Study|Other|67|||
16410602|NCT00583791|39985521|FG000|Overall Study|Death|6|||
16410603|NCT03093974|39985522|FG000|Overall Study|Withdrawal by Subject|32|||
16410604|NCT03093974|39985523|FG001|Overall Study|Withdrawal by Subject|27|||
16410605|NCT03093974|39985522|FG000|Overall Study|Adverse Event|17|||
16410606|NCT03093974|39985523|FG001|Overall Study|Adverse Event|24|||
16410607|NCT03093974|39985522|FG000|Overall Study|Death|0|||
16410608|NCT03093974|39985523|FG001|Overall Study|Death|1|||
16410609|NCT03093974|39985522|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16410610|NCT03093974|39985523|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16410611|NCT03093974|39985522|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
16410612|NCT03093974|39985523|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
16225733|NCT02058940|39306182|FG000|Overall Study|Discharged from Critical Care Unit|1|||
16346961|NCT00397189|39757356|FG000|3 Weeks Period|Adverse Event|3|||
16410613|NCT03093974|39985522|FG000|Overall Study|Lost to Follow-up|0|||
16410614|NCT03093974|39985523|FG001|Overall Study|Lost to Follow-up|1|||
16410615|NCT03093974|39985522|FG000|Overall Study|Other|1|||
16410616|NCT03093974|39985523|FG001|Overall Study|Other|2|||
16225734|NCT02039687|39306185|FG000|Overall Study|Adverse Event|0|||
16114550|NCT02906020|38906096|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114551|NCT02906020|38906097|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114552|NCT02906020|38906098|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114553|NCT02906020|38906099|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114554|NCT02906020|38906100|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114555|NCT02906020|38906101|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114556|NCT02906020|38906102|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
16114557|NCT02906020|38906103|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
16114558|NCT02906020|38906104|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114559|NCT02906020|38906105|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
16114560|NCT02906020|38906090|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114561|NCT02906020|38906091|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114562|NCT02906020|38906092|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114563|NCT02906020|38906093|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114564|NCT02906020|38906094|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114565|NCT02906020|38906095|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114566|NCT02906020|38906096|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114567|NCT02906020|38906097|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114568|NCT02906020|38906098|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114569|NCT02906020|38906099|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114570|NCT02906020|38906100|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16114571|NCT02906020|38906101|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
16346962|NCT00397189|39757357|FG001|3 Weeks Period|Adverse Event|2|||
16346963|NCT00397189|39757356|FG000|3 Weeks Period|Withdrawal by Subject|13|||
16346964|NCT00397189|39757357|FG001|3 Weeks Period|Withdrawal by Subject|9|||
16346965|NCT00397189|39757356|FG000|3 Weeks Period|Physician Decision|0|||
16346966|NCT00397189|39757357|FG001|3 Weeks Period|Physician Decision|2|||
16346967|NCT00397189|39757356|FG000|3 Weeks Period|Protocol Violation|0|||
16346968|NCT00397189|39757357|FG001|3 Weeks Period|Protocol Violation|3|||
16346969|NCT00397189|39757356|FG000|3 Weeks Period|Other|0|||
16346970|NCT00397189|39757357|FG001|3 Weeks Period|Other|2|||
16346971|NCT04577794|39757358|FG000|Overall Study|Adverse Event|1|||
16346972|NCT04577794|39757359|FG001|Overall Study|Adverse Event|1|||
16346973|NCT01819727|39757360|FG000|Overall Study|Adverse Event|8|||
16346974|NCT01819727|39757361|FG001|Overall Study|Adverse Event|9|||
16346975|NCT01819727|39757360|FG000|Overall Study|Death|1|||
16346976|NCT01819727|39757361|FG001|Overall Study|Death|0|||
16346977|NCT01819727|39757360|FG000|Overall Study|Lost to Follow-up|1|||
16346978|NCT01819727|39757361|FG001|Overall Study|Lost to Follow-up|1|||
16346979|NCT01819727|39757360|FG000|Overall Study|Physician Decision|3|||
16346980|NCT01819727|39757361|FG001|Overall Study|Physician Decision|2|||
16346981|NCT01819727|39757360|FG000|Overall Study|Pregnancy|1|||
16346982|NCT01819727|39757361|FG001|Overall Study|Pregnancy|0|||
16346983|NCT01819727|39757360|FG000|Overall Study|Protocol Violation|0|||
16346984|NCT01819727|39757361|FG001|Overall Study|Protocol Violation|2|||
16346985|NCT01819727|39757360|FG000|Overall Study|Study Terminated by Sponsor|0|||
16346986|NCT01819727|39757361|FG001|Overall Study|Study Terminated by Sponsor|1|||
16346987|NCT01819727|39757360|FG000|Overall Study|Withdrawal by Subject|6|||
16346988|NCT01819727|39757361|FG001|Overall Study|Withdrawal by Subject|11|||
16346989|NCT01819727|39757360|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
16346990|NCT01819727|39757361|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
16114572|NCT02906020|38906102|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
16114573|NCT02906020|38906103|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
16114574|NCT02906020|38906104|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
16346991|NCT01819727|39757360|FG000|Overall Study|Quit due to lack of health benifits|0|||
16346992|NCT01819727|39757361|FG001|Overall Study|Quit due to lack of health benifits|1|||
16346993|NCT00169104|39757366|FG000|Overall Study|Withdrawal by Subject|2|||
16346994|NCT00169104|39757367|FG001|Overall Study|Withdrawal by Subject|0|||
16346995|NCT00169104|39757366|FG000|Overall Study|Protocol Violation|0|||
16346996|NCT00169104|39757367|FG001|Overall Study|Protocol Violation|1|||
16346997|NCT00169104|39757366|FG000|Overall Study|Physician Decision|0|||
16346998|NCT00169104|39757367|FG001|Overall Study|Physician Decision|1|||
16346999|NCT02155309|39757369|FG000|Overall Study|Protocol Violation|0|||
16347000|NCT02155309|39757370|FG001|Overall Study|Protocol Violation|0|||
16347001|NCT02155309|39757371|FG002|Overall Study|Protocol Violation|1|||
16347002|NCT00905567|39757372|FG000|Washout|Withdrawal by Subject|0|||
16347003|NCT00905567|39757373|FG001|Washout|Withdrawal by Subject|1|||
16347004|NCT00490919|39757375|FG000|Open-label Run-in Period|Adverse Event|239|||
16114575|NCT02906020|38906105|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
16347005|NCT00490919|39757376|FG001|Open-label Run-in Period|Adverse Event|0|||
16347006|NCT00490919|39757377|FG002|Open-label Run-in Period|Adverse Event|0|||
16347007|NCT00490919|39757375|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
16410617|NCT00810901|39985524|FG000|Overall Study|Lost to Follow-up|88|||
16410618|NCT00810901|39985525|FG001|Overall Study|Lost to Follow-up|58|||
16410619|NCT00815191|39985526|FG000|Overall Study|Protocol Violation|1|||
16410620|NCT00815191|39985527|FG001|Overall Study|Protocol Violation|1|||
16410621|NCT00490139|39985534|FG000|Overall Study|Death|106|||
16547575|NCT01364597|40467685|FG001|Overall Study|Adverse Event|5|||
16547576|NCT01364597|40467686|FG002|Overall Study|Adverse Event|16|||
16547577|NCT01364597|40467687|FG003|Overall Study|Adverse Event|7|||
16547578|NCT01364597|40467684|FG000|Overall Study|Lack of Efficacy|4|||
16547579|NCT01364597|40467685|FG001|Overall Study|Lack of Efficacy|4|||
16114576|NCT02906020|38906090|FG000|Part 2: Long-term Follow-up Period|Other|0|||
16114577|NCT02906020|38906091|FG001|Part 2: Long-term Follow-up Period|Other|0|||
16114578|NCT02906020|38906092|FG002|Part 2: Long-term Follow-up Period|Other|0|||
16114579|NCT02906020|38906093|FG003|Part 2: Long-term Follow-up Period|Other|0|||
16114580|NCT02906020|38906094|FG004|Part 2: Long-term Follow-up Period|Other|0|||
16114581|NCT02906020|38906095|FG005|Part 2: Long-term Follow-up Period|Other|0|||
16114582|NCT02906020|38906096|FG006|Part 2: Long-term Follow-up Period|Other|0|||
16114583|NCT02906020|38906097|FG007|Part 2: Long-term Follow-up Period|Other|0|||
16114584|NCT02906020|38906098|FG008|Part 2: Long-term Follow-up Period|Other|0|||
16114585|NCT02906020|38906099|FG009|Part 2: Long-term Follow-up Period|Other|0|||
16114586|NCT02906020|38906100|FG010|Part 2: Long-term Follow-up Period|Other|0|||
16114587|NCT02906020|38906101|FG011|Part 2: Long-term Follow-up Period|Other|0|||
16114588|NCT02906020|38906102|FG012|Part 2: Long-term Follow-up Period|Other|13|||
16114589|NCT02906020|38906103|FG013|Part 2: Long-term Follow-up Period|Other|8|||
16114590|NCT02906020|38906104|FG014|Part 2: Long-term Follow-up Period|Other|3|||
16114591|NCT02906020|38906105|FG015|Part 2: Long-term Follow-up Period|Other|2|||
16114592|NCT01663506|38906106|FG000|Overall Study|Lack of Efficacy|3|||
16114593|NCT01663506|38906106|FG000|Overall Study|Consent Withdrawal by Subject|1|||
16114594|NCT01663506|38906106|FG000|Overall Study|Lost to Follow-up|1|||
16114595|NCT01663506|38906106|FG000|Overall Study|Adverse Event|1|||
16114596|NCT01663506|38906106|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
16114597|NCT02232399|38906109|FG000|Overall Study|Adverse Event|1|||
16114598|NCT02232399|38906110|FG001|Overall Study|Adverse Event|0|||
16114599|NCT02232399|38906109|FG000|Overall Study|Withdrawal by Subject|0|||
16114600|NCT02232399|38906110|FG001|Overall Study|Withdrawal by Subject|1|||
16114601|NCT03054337|38906113|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
16114602|NCT03054337|38906114|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
16114603|NCT03054337|38906115|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
16114604|NCT03054337|38906116|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
16114605|NCT03054337|38906117|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
16114606|NCT03054337|38906118|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
16114607|NCT02762903|38906119|FG000|Overall Study|Lost to Follow-up|0|||
16114608|NCT02762903|38906120|FG001|Overall Study|Lost to Follow-up|1|||
16114609|NCT02689453|38906123|FG000|Overall Study|Progressive disease|0|||
16114610|NCT02689453|38906124|FG001|Overall Study|Progressive disease|1|||
16114611|NCT02689453|38906125|FG002|Overall Study|Progressive disease|1|||
16114612|NCT03210519|38906126|FG000|Overall Study|Adverse Event|2|||
16114613|NCT03210519|38906127|FG001|Overall Study|Adverse Event|0|||
16114614|NCT02080403|38906128|FG000|Overall Study|Adverse Event|5|||
16114615|NCT02080403|38906129|FG001|Overall Study|Adverse Event|1|||
16114616|NCT02080403|38906128|FG000|Overall Study|Death|0|||
16114617|NCT02080403|38906129|FG001|Overall Study|Death|2|||
16114618|NCT02080403|38906128|FG000|Overall Study|Lost to Follow-up|2|||
16114619|NCT02080403|38906129|FG001|Overall Study|Lost to Follow-up|0|||
16114620|NCT02080403|38906128|FG000|Overall Study|Pregnancy|0|||
16114621|NCT02080403|38906129|FG001|Overall Study|Pregnancy|1|||
16114622|NCT02080403|38906128|FG000|Overall Study|Protocol Violation|3|||
16114623|NCT02080403|38906129|FG001|Overall Study|Protocol Violation|7|||
16114624|NCT02080403|38906128|FG000|Overall Study|Withdrawal by Subject|5|||
16114625|NCT02080403|38906129|FG001|Overall Study|Withdrawal by Subject|1|||
16114626|NCT00267098|38906133|FG000|Overall Study|Death|0|||
16114627|NCT00267098|38906134|FG001|Overall Study|Death|0|||
16114628|NCT00267098|38906135|FG002|Overall Study|Death|57|||
16114629|NCT00267098|38906136|FG003|Overall Study|Death|66|||
16114630|NCT00267098|38906137|FG004|Overall Study|Death|14|||
16114631|NCT00267098|38906138|FG005|Overall Study|Death|23|||
16114632|NCT00267098|38906139|FG006|Overall Study|Death|28|||
16114633|NCT00267098|38906140|FG007|Overall Study|Death|9|||
16114634|NCT00267098|38906133|FG000|Overall Study|Lost to Follow-up|0|||
16114635|NCT00267098|38906134|FG001|Overall Study|Lost to Follow-up|0|||
16114636|NCT00267098|38906135|FG002|Overall Study|Lost to Follow-up|6|||
16114637|NCT00267098|38906136|FG003|Overall Study|Lost to Follow-up|5|||
16114638|NCT00267098|38906137|FG004|Overall Study|Lost to Follow-up|2|||
16410622|NCT00490139|39985535|FG001|Overall Study|Death|119|||
16114639|NCT00267098|38906138|FG005|Overall Study|Lost to Follow-up|3|||
16114640|NCT00267098|38906139|FG006|Overall Study|Lost to Follow-up|1|||
16114641|NCT00267098|38906140|FG007|Overall Study|Lost to Follow-up|1|||
16547580|NCT01364597|40467686|FG002|Overall Study|Lack of Efficacy|23|||
16547581|NCT01364597|40467687|FG003|Overall Study|Lack of Efficacy|8|||
16347008|NCT00490919|39757376|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
16347009|NCT00490919|39757377|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
16347010|NCT00490919|39757375|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
16347011|NCT00490919|39757376|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
16347012|NCT00490919|39757377|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
16347013|NCT00490919|39757375|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
16347014|NCT00490919|39757376|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
16347015|NCT00490919|39757377|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
16347016|NCT00490919|39757375|FG000|Open-label Run-in Period|Administrative|40|||
16547582|NCT01364597|40467684|FG000|Overall Study|Protocol Violation|0|||
16547583|NCT01364597|40467685|FG001|Overall Study|Protocol Violation|0|||
16547584|NCT01364597|40467686|FG002|Overall Study|Protocol Violation|2|||
16547585|NCT01364597|40467687|FG003|Overall Study|Protocol Violation|0|||
16547586|NCT01364597|40467684|FG000|Overall Study|Lost to Follow-up|0|||
16547587|NCT01364597|40467685|FG001|Overall Study|Lost to Follow-up|0|||
16547588|NCT01364597|40467686|FG002|Overall Study|Lost to Follow-up|5|||
16547589|NCT01364597|40467687|FG003|Overall Study|Lost to Follow-up|3|||
16114642|NCT00267098|38906133|FG000|Overall Study|Withdrawal by Subject|8|||
16114643|NCT00267098|38906134|FG001|Overall Study|Withdrawal by Subject|0|||
16114644|NCT00267098|38906135|FG002|Overall Study|Withdrawal by Subject|24|||
16225735|NCT02039687|39306186|FG001|Overall Study|Adverse Event|0|||
16225736|NCT02039687|39306187|FG002|Overall Study|Adverse Event|1|||
16225737|NCT02039687|39306188|FG003|Overall Study|Adverse Event|0|||
16225738|NCT02039687|39306185|FG000|Overall Study|Withdrawal by Subject|0|||
16225739|NCT02039687|39306186|FG001|Overall Study|Withdrawal by Subject|1|||
16225740|NCT02039687|39306187|FG002|Overall Study|Withdrawal by Subject|0|||
16225741|NCT02039687|39306188|FG003|Overall Study|Withdrawal by Subject|0|||
16225742|NCT02039687|39306185|FG000|Overall Study|treatment assignment could not be confir|0|||
16225743|NCT02039687|39306186|FG001|Overall Study|treatment assignment could not be confir|0|||
16225744|NCT02039687|39306187|FG002|Overall Study|treatment assignment could not be confir|2|||
16114645|NCT00267098|38906136|FG003|Overall Study|Withdrawal by Subject|21|||
16114646|NCT00267098|38906137|FG004|Overall Study|Withdrawal by Subject|12|||
16114647|NCT00267098|38906138|FG005|Overall Study|Withdrawal by Subject|9|||
16114648|NCT00267098|38906139|FG006|Overall Study|Withdrawal by Subject|12|||
16114649|NCT00267098|38906140|FG007|Overall Study|Withdrawal by Subject|5|||
16114650|NCT00267098|38906133|FG000|Overall Study|Physician Decision|5|||
16114651|NCT00267098|38906134|FG001|Overall Study|Physician Decision|0|||
16114652|NCT00267098|38906135|FG002|Overall Study|Physician Decision|7|||
16114653|NCT00267098|38906136|FG003|Overall Study|Physician Decision|11|||
16114654|NCT00267098|38906137|FG004|Overall Study|Physician Decision|5|||
16114655|NCT00267098|38906138|FG005|Overall Study|Physician Decision|4|||
16114656|NCT00267098|38906139|FG006|Overall Study|Physician Decision|3|||
16114657|NCT00267098|38906140|FG007|Overall Study|Physician Decision|0|||
16114658|NCT00267098|38906133|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
16114659|NCT00267098|38906134|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16114660|NCT00267098|38906135|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16114661|NCT00267098|38906136|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16114662|NCT00267098|38906137|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
16114663|NCT00267098|38906138|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16114664|NCT00267098|38906139|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16114665|NCT00267098|38906140|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16114666|NCT00267098|38906133|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
16114667|NCT00267098|38906134|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
16114668|NCT00267098|38906135|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
16114669|NCT00267098|38906136|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
16114670|NCT00267098|38906137|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
16114671|NCT00267098|38906138|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
16114672|NCT00267098|38906139|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
16114673|NCT00267098|38906140|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
16114674|NCT00267098|38906133|FG000|Overall Study|Site closure|0|||
16114675|NCT00267098|38906134|FG001|Overall Study|Site closure|0|||
16114676|NCT00267098|38906135|FG002|Overall Study|Site closure|0|||
16114677|NCT00267098|38906136|FG003|Overall Study|Site closure|1|||
16114678|NCT00267098|38906137|FG004|Overall Study|Site closure|0|||
16114679|NCT00267098|38906138|FG005|Overall Study|Site closure|1|||
16114680|NCT00267098|38906139|FG006|Overall Study|Site closure|1|||
16114681|NCT00267098|38906140|FG007|Overall Study|Site closure|0|||
16114682|NCT00267098|38906133|FG000|Overall Study|Explanted Medtronic device|0|||
16225745|NCT02039687|39306188|FG003|Overall Study|treatment assignment could not be confir|0|||
16225746|NCT05102734|39306189|FG000|Overall Study|Did not require vasopressors|1|||
16547590|NCT01364597|40467684|FG000|Overall Study|Withdrawal by Subject|4|||
16547591|NCT01364597|40467685|FG001|Overall Study|Withdrawal by Subject|1|||
16547592|NCT01364597|40467686|FG002|Overall Study|Withdrawal by Subject|18|||
16114683|NCT00267098|38906134|FG001|Overall Study|Explanted Medtronic device|0|||
16114684|NCT00267098|38906135|FG002|Overall Study|Explanted Medtronic device|0|||
16114685|NCT00267098|38906136|FG003|Overall Study|Explanted Medtronic device|1|||
16114686|NCT00267098|38906137|FG004|Overall Study|Explanted Medtronic device|0|||
16114687|NCT00267098|38906138|FG005|Overall Study|Explanted Medtronic device|0|||
16114688|NCT00267098|38906139|FG006|Overall Study|Explanted Medtronic device|0|||
16114689|NCT00267098|38906140|FG007|Overall Study|Explanted Medtronic device|0|||
16114690|NCT00267098|38906133|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
16114691|NCT00267098|38906134|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
16114692|NCT00267098|38906135|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
16114693|NCT00267098|38906136|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
16114694|NCT00267098|38906137|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
16114695|NCT00267098|38906138|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
16114696|NCT00267098|38906139|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
16114697|NCT00267098|38906140|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
16114698|NCT00267098|38906133|FG000|Overall Study|Subject listed for heart transplant|0|||
16114699|NCT00267098|38906134|FG001|Overall Study|Subject listed for heart transplant|0|||
16114700|NCT00267098|38906135|FG002|Overall Study|Subject listed for heart transplant|0|||
16114701|NCT00267098|38906136|FG003|Overall Study|Subject listed for heart transplant|0|||
16114702|NCT00267098|38906137|FG004|Overall Study|Subject listed for heart transplant|0|||
16114703|NCT00267098|38906138|FG005|Overall Study|Subject listed for heart transplant|0|||
16114704|NCT00267098|38906139|FG006|Overall Study|Subject listed for heart transplant|1|||
16114705|NCT00267098|38906140|FG007|Overall Study|Subject listed for heart transplant|0|||
16114706|NCT00267098|38906133|FG000|Overall Study|Sponsor withdrew subject|0|||
16114707|NCT00267098|38906134|FG001|Overall Study|Sponsor withdrew subject|0|||
16114708|NCT00267098|38906135|FG002|Overall Study|Sponsor withdrew subject|0|||
16114709|NCT00267098|38906136|FG003|Overall Study|Sponsor withdrew subject|1|||
16114710|NCT00267098|38906137|FG004|Overall Study|Sponsor withdrew subject|0|||
16114711|NCT00267098|38906138|FG005|Overall Study|Sponsor withdrew subject|0|||
16114712|NCT00267098|38906139|FG006|Overall Study|Sponsor withdrew subject|0|||
16114713|NCT00267098|38906140|FG007|Overall Study|Sponsor withdrew subject|0|||
16114714|NCT04936685|38906141|FG000|Overall Study|Protocol Violation|1|||
16114715|NCT04936685|38906142|FG001|Overall Study|Protocol Violation|0|||
16114716|NCT00847132|38906147|FG000|Overall Study|Death|1|||
16114717|NCT00847132|38906148|FG001|Overall Study|Death|1|||
16114718|NCT03784820|38906150|FG000|Overall Study|Lost to Follow-up|5|||
16114719|NCT03784820|38906151|FG001|Overall Study|Lost to Follow-up|5|||
16114720|NCT03784820|38906152|FG002|Overall Study|Lost to Follow-up|3|||
16114721|NCT03784820|38906153|FG003|Overall Study|Lost to Follow-up|3|||
16114722|NCT01867047|38906156|FG000|Overall Study|Lost to Follow-up|3|||
16114723|NCT01867047|38906157|FG001|Overall Study|Lost to Follow-up|3|||
16114724|NCT01867047|38906156|FG000|Overall Study|Withdrawal by Subject|2|||
16114725|NCT01867047|38906157|FG001|Overall Study|Withdrawal by Subject|0|||
16114726|NCT01867047|38906156|FG000|Overall Study|Physician Decision|2|||
16114727|NCT01867047|38906157|FG001|Overall Study|Physician Decision|0|||
16347017|NCT00490919|39757376|FG001|Open-label Run-in Period|Administrative|0|||
16347018|NCT00490919|39757377|FG002|Open-label Run-in Period|Administrative|0|||
16347019|NCT00490919|39757375|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
16347020|NCT00490919|39757376|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
16347021|NCT00490919|39757377|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
16347022|NCT00490919|39757375|FG000|Double-blind Phase|Adverse Event|0|||
16114728|NCT01867047|38906156|FG000|Overall Study|surgery not indicated in protocol|1|||
16114729|NCT01867047|38906157|FG001|Overall Study|surgery not indicated in protocol|2|||
16225747|NCT05102734|39306190|FG001|Overall Study|Did not require vasopressors|0|||
16114730|NCT00979953|38906158|FG000|Overall Study|Adverse Event|5|||
16225748|NCT05102734|39306189|FG000|Overall Study|Did not have functioning PA catheter|1|||
16114731|NCT00979953|38906159|FG001|Overall Study|Adverse Event|2|||
16114732|NCT00979953|38906160|FG002|Overall Study|Adverse Event|17|||
16114733|NCT00979953|38906161|FG003|Overall Study|Adverse Event|4|||
16114734|NCT00979953|38906158|FG000|Overall Study|Lack of Efficacy|1|||
16114735|NCT00979953|38906159|FG001|Overall Study|Lack of Efficacy|2|||
16114736|NCT00979953|38906160|FG002|Overall Study|Lack of Efficacy|0|||
16114737|NCT00979953|38906161|FG003|Overall Study|Lack of Efficacy|0|||
16114738|NCT00979953|38906158|FG000|Overall Study|Lost to Follow-up|1|||
16114739|NCT00979953|38906159|FG001|Overall Study|Lost to Follow-up|1|||
16114740|NCT00979953|38906160|FG002|Overall Study|Lost to Follow-up|1|||
16114741|NCT00979953|38906161|FG003|Overall Study|Lost to Follow-up|0|||
16114742|NCT00979953|38906158|FG000|Overall Study|Withdrawal by Subject|0|||
16114743|NCT00979953|38906159|FG001|Overall Study|Withdrawal by Subject|0|||
16114744|NCT00979953|38906160|FG002|Overall Study|Withdrawal by Subject|2|||
16114745|NCT00979953|38906161|FG003|Overall Study|Withdrawal by Subject|1|||
16114746|NCT00979953|38906158|FG000|Overall Study|Protocol Violation|1|||
16114747|NCT00979953|38906159|FG001|Overall Study|Protocol Violation|0|||
16114748|NCT00979953|38906160|FG002|Overall Study|Protocol Violation|2|||
16114749|NCT00979953|38906161|FG003|Overall Study|Protocol Violation|2|||
16114750|NCT02786004|38906162|FG000|Overall Study|Withdrawal by Subject|0|||
16114751|NCT02786004|38906163|FG001|Overall Study|Withdrawal by Subject|1|||
16114752|NCT01485120|38906164|FG000|Overall Study|Withdrawal by Subject|2|||
16114753|NCT01999972|38906169|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
16114754|NCT01999972|38906170|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
16114755|NCT01999972|38906171|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
16114756|NCT01999972|38906172|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
16114757|NCT01999972|38906173|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
16114758|NCT01999972|38906174|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
16114759|NCT01999972|38906169|FG000|Dose Escalation Part|Death|0|||
16114760|NCT01999972|38906170|FG001|Dose Escalation Part|Death|1|||
16114761|NCT01999972|38906171|FG002|Dose Escalation Part|Death|0|||
16547593|NCT01364597|40467687|FG003|Overall Study|Withdrawal by Subject|6|||
16547594|NCT01364597|40467684|FG000|Overall Study|Non compliance|1|||
16547595|NCT01364597|40467685|FG001|Overall Study|Non compliance|0|||
16547596|NCT01364597|40467686|FG002|Overall Study|Non compliance|1|||
16547597|NCT01364597|40467687|FG003|Overall Study|Non compliance|0|||
16547598|NCT01364597|40467684|FG000|Overall Study|Lack of compliance|1|||
16547599|NCT01364597|40467685|FG001|Overall Study|Lack of compliance|0|||
16547600|NCT01364597|40467686|FG002|Overall Study|Lack of compliance|0|||
16547601|NCT01364597|40467687|FG003|Overall Study|Lack of compliance|0|||
16547602|NCT01364597|40467684|FG000|Overall Study|End of treatment epilepsy|1|||
16547603|NCT01364597|40467685|FG001|Overall Study|End of treatment epilepsy|0|||
16547604|NCT01364597|40467686|FG002|Overall Study|End of treatment epilepsy|0|||
16547605|NCT01364597|40467687|FG003|Overall Study|End of treatment epilepsy|0|||
16547606|NCT01364597|40467684|FG000|Overall Study|No Seizures|1|||
16547607|NCT01364597|40467685|FG001|Overall Study|No Seizures|0|||
16547608|NCT01364597|40467686|FG002|Overall Study|No Seizures|0|||
16547609|NCT01364597|40467687|FG003|Overall Study|No Seizures|0|||
16547610|NCT01364597|40467684|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
16547611|NCT01364597|40467685|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
16547612|NCT01364597|40467686|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
16547613|NCT01364597|40467687|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
16547614|NCT01364597|40467684|FG000|Overall Study|Cure|1|||
16547615|NCT01364597|40467685|FG001|Overall Study|Cure|0|||
16547616|NCT01364597|40467686|FG002|Overall Study|Cure|0|||
16547617|NCT01364597|40467687|FG003|Overall Study|Cure|0|||
16547618|NCT01364597|40467684|FG000|Overall Study|Patient was moving|0|||
16547619|NCT01364597|40467685|FG001|Overall Study|Patient was moving|1|||
16547620|NCT01364597|40467686|FG002|Overall Study|Patient was moving|0|||
16547621|NCT01364597|40467687|FG003|Overall Study|Patient was moving|0|||
16547622|NCT01364597|40467684|FG000|Overall Study|Seizures resolved|0|||
16547623|NCT01364597|40467685|FG001|Overall Study|Seizures resolved|0|||
16547624|NCT01364597|40467686|FG002|Overall Study|Seizures resolved|1|||
16547625|NCT01364597|40467687|FG003|Overall Study|Seizures resolved|0|||
16547626|NCT01364597|40467684|FG000|Overall Study|Patient became seizure-free after surgery|0|||
16114762|NCT01999972|38906172|FG003|Dose Escalation Part|Death|0|||
16225749|NCT05102734|39306190|FG001|Overall Study|Did not have functioning PA catheter|0|||
16114763|NCT01999972|38906173|FG004|Dose Escalation Part|Death|0|||
16114764|NCT01999972|38906174|FG005|Dose Escalation Part|Death|0|||
16114765|NCT01999972|38906169|FG000|Dose Escalation Part|Enrolled but not treated|0|||
16114766|NCT01999972|38906170|FG001|Dose Escalation Part|Enrolled but not treated|0|||
16547627|NCT01364597|40467685|FG001|Overall Study|Patient became seizure-free after surgery|0|||
16547628|NCT01364597|40467686|FG002|Overall Study|Patient became seizure-free after surgery|1|||
16547629|NCT01364597|40467687|FG003|Overall Study|Patient became seizure-free after surgery|0|||
16547630|NCT01364597|40467684|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
16547631|NCT01364597|40467685|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
16114767|NCT01999972|38906171|FG002|Dose Escalation Part|Enrolled but not treated|1|||
16114768|NCT01999972|38906172|FG003|Dose Escalation Part|Enrolled but not treated|1|||
16114769|NCT01999972|38906173|FG004|Dose Escalation Part|Enrolled but not treated|0|||
16114770|NCT01999972|38906174|FG005|Dose Escalation Part|Enrolled but not treated|0|||
16114771|NCT01999972|38906169|FG000|Dose Escalation Part|Disease progression|3|||
16114772|NCT01999972|38906170|FG001|Dose Escalation Part|Disease progression|2|||
16114773|NCT01999972|38906171|FG002|Dose Escalation Part|Disease progression|3|||
16114774|NCT01999972|38906172|FG003|Dose Escalation Part|Disease progression|6|||
16114775|NCT01999972|38906173|FG004|Dose Escalation Part|Disease progression|0|||
16114776|NCT01999972|38906174|FG005|Dose Escalation Part|Disease progression|0|||
16114777|NCT01999972|38906169|FG000|Dose Escalation Part|Adverse Event|0|||
16114778|NCT01999972|38906170|FG001|Dose Escalation Part|Adverse Event|0|||
16114779|NCT01999972|38906171|FG002|Dose Escalation Part|Adverse Event|0|||
16114780|NCT01999972|38906172|FG003|Dose Escalation Part|Adverse Event|2|||
16114781|NCT01999972|38906173|FG004|Dose Escalation Part|Adverse Event|0|||
16114782|NCT01999972|38906174|FG005|Dose Escalation Part|Adverse Event|0|||
16114783|NCT01999972|38906169|FG000|Dose Escalation Part|Global deterioration of health status|1|||
16114784|NCT01999972|38906170|FG001|Dose Escalation Part|Global deterioration of health status|0|||
16410623|NCT00490139|39985536|FG002|Overall Study|Death|168|||
16410624|NCT00490139|39985537|FG003|Overall Study|Death|135|||
16114785|NCT01999972|38906171|FG002|Dose Escalation Part|Global deterioration of health status|0|||
16114786|NCT01999972|38906172|FG003|Dose Escalation Part|Global deterioration of health status|1|||
16114787|NCT01999972|38906173|FG004|Dose Escalation Part|Global deterioration of health status|0|||
16114788|NCT01999972|38906174|FG005|Dose Escalation Part|Global deterioration of health status|0|||
16114789|NCT01999972|38906169|FG000|Dose Expansion Part|Death|0|||
16114790|NCT01999972|38906170|FG001|Dose Expansion Part|Death|0|||
16114791|NCT01999972|38906171|FG002|Dose Expansion Part|Death|0|||
16114792|NCT01999972|38906172|FG003|Dose Expansion Part|Death|0|||
16114793|NCT01999972|38906173|FG004|Dose Expansion Part|Death|2|||
16114794|NCT01999972|38906174|FG005|Dose Expansion Part|Death|1|||
16114795|NCT01999972|38906169|FG000|Dose Expansion Part|Disease progression|0|||
16114796|NCT01999972|38906170|FG001|Dose Expansion Part|Disease progression|0|||
16114797|NCT01999972|38906171|FG002|Dose Expansion Part|Disease progression|0|||
16114798|NCT01999972|38906172|FG003|Dose Expansion Part|Disease progression|0|||
16114799|NCT01999972|38906173|FG004|Dose Expansion Part|Disease progression|9|||
16114800|NCT01999972|38906174|FG005|Dose Expansion Part|Disease progression|3|||
16114801|NCT01999972|38906169|FG000|Dose Expansion Part|Sponsor decision|0|||
16114802|NCT01999972|38906170|FG001|Dose Expansion Part|Sponsor decision|0|||
16114803|NCT01999972|38906171|FG002|Dose Expansion Part|Sponsor decision|0|||
16114804|NCT01999972|38906172|FG003|Dose Expansion Part|Sponsor decision|0|||
16114805|NCT01999972|38906173|FG004|Dose Expansion Part|Sponsor decision|1|||
16114806|NCT01999972|38906174|FG005|Dose Expansion Part|Sponsor decision|0|||
16114807|NCT01999972|38906169|FG000|Dose Expansion Part|Adverse Event|0|||
16114808|NCT01999972|38906170|FG001|Dose Expansion Part|Adverse Event|0|||
16114809|NCT01999972|38906171|FG002|Dose Expansion Part|Adverse Event|0|||
16114810|NCT01999972|38906172|FG003|Dose Expansion Part|Adverse Event|0|||
16114811|NCT01999972|38906173|FG004|Dose Expansion Part|Adverse Event|4|||
16114812|NCT01999972|38906174|FG005|Dose Expansion Part|Adverse Event|2|||
16114813|NCT01999972|38906169|FG000|Dose Expansion Part|Participant's non-compliance|0|||
16114814|NCT01999972|38906170|FG001|Dose Expansion Part|Participant's non-compliance|0|||
16114815|NCT01999972|38906171|FG002|Dose Expansion Part|Participant's non-compliance|0|||
16225750|NCT05102734|39306189|FG000|Overall Study|Inadequate video quality|2|||
16225751|NCT05102734|39306190|FG001|Overall Study|Inadequate video quality|0|||
16225752|NCT00736840|39306191|FG000|Overall Study|Lost to Follow-up|13|||
16225753|NCT00955682|39306194|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
16225754|NCT00955682|39306195|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
16225755|NCT00424463|39306196|FG000|Overall Study|Adverse Event|2|||
16225756|NCT00424463|39306197|FG001|Overall Study|Adverse Event|3|||
16225757|NCT00424463|39306198|FG002|Overall Study|Adverse Event|2|||
16225758|NCT00424463|39306196|FG000|Overall Study|Physician Decision|0|||
16225759|NCT00424463|39306197|FG001|Overall Study|Physician Decision|2|||
16225760|NCT00424463|39306198|FG002|Overall Study|Physician Decision|2|||
16225761|NCT00424463|39306196|FG000|Overall Study|Withdrawal by Subject|4|||
16225762|NCT00424463|39306197|FG001|Overall Study|Withdrawal by Subject|2|||
16225763|NCT00424463|39306198|FG002|Overall Study|Withdrawal by Subject|5|||
16225764|NCT00424463|39306196|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
16225765|NCT00424463|39306197|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
16114816|NCT01999972|38906172|FG003|Dose Expansion Part|Participant's non-compliance|0|||
16225766|NCT00424463|39306198|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
16114817|NCT01999972|38906173|FG004|Dose Expansion Part|Participant's non-compliance|0|||
16225767|NCT00424463|39306196|FG000|Overall Study|Patient's convenience|0|||
16114818|NCT01999972|38906174|FG005|Dose Expansion Part|Participant's non-compliance|1|||
16225768|NCT00424463|39306197|FG001|Overall Study|Patient's convenience|0|||
16225769|NCT00424463|39306198|FG002|Overall Study|Patient's convenience|1|||
16225770|NCT01140646|39306200|FG000|Overall Study|Adverse Event|4|||
16114819|NCT01999972|38906169|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
16114820|NCT01999972|38906170|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
16114821|NCT01999972|38906171|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
16114822|NCT01999972|38906172|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
16114823|NCT01999972|38906173|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
16114824|NCT01999972|38906174|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
16114825|NCT01999972|38906169|FG000|Dose Expansion Part|Changed to standard of care|0|||
16114826|NCT01999972|38906170|FG001|Dose Expansion Part|Changed to standard of care|0|||
16114827|NCT01999972|38906171|FG002|Dose Expansion Part|Changed to standard of care|0|||
16114828|NCT01999972|38906172|FG003|Dose Expansion Part|Changed to standard of care|0|||
16114829|NCT01999972|38906173|FG004|Dose Expansion Part|Changed to standard of care|1|||
16114830|NCT01999972|38906174|FG005|Dose Expansion Part|Changed to standard of care|0|||
16114831|NCT01677299|38906175|FG000|Overall Study|Adverse Event|0|||
16114832|NCT01677299|38906176|FG001|Overall Study|Adverse Event|2|||
16114833|NCT01677299|38906177|FG002|Overall Study|Adverse Event|1|||
16114834|NCT01677299|38906178|FG003|Overall Study|Adverse Event|0|||
16114835|NCT01677299|38906175|FG000|Overall Study|Withdrawal by Subject|0|||
16114836|NCT01677299|38906176|FG001|Overall Study|Withdrawal by Subject|1|||
16114837|NCT01677299|38906177|FG002|Overall Study|Withdrawal by Subject|0|||
16114838|NCT01677299|38906178|FG003|Overall Study|Withdrawal by Subject|1|||
16114839|NCT01371708|38906179|FG000|Overall Study|Insufficient clinical response|3|||
16114840|NCT01371708|38906180|FG001|Overall Study|Insufficient clinical response|2|||
16114841|NCT01371708|38906181|FG002|Overall Study|Insufficient clinical response|0|||
16114842|NCT01371708|38906179|FG000|Overall Study|Lost to Follow-up|5|||
16114843|NCT01371708|38906180|FG001|Overall Study|Lost to Follow-up|9|||
16114844|NCT01371708|38906181|FG002|Overall Study|Lost to Follow-up|7|||
16114845|NCT01371708|38906179|FG000|Overall Study|Protocol Violation|2|||
16114846|NCT01371708|38906180|FG001|Overall Study|Protocol Violation|1|||
16114847|NCT01371708|38906181|FG002|Overall Study|Protocol Violation|2|||
16114848|NCT01371708|38906179|FG000|Overall Study|No longer willing to participate|7|||
16114849|NCT01371708|38906180|FG001|Overall Study|No longer willing to participate|7|||
16114850|NCT01371708|38906181|FG002|Overall Study|No longer willing to participate|13|||
16114851|NCT01371708|38906179|FG000|Overall Study|Medication error/not related to AE|0|||
16114852|NCT01371708|38906180|FG001|Overall Study|Medication error/not related to AE|1|||
16225771|NCT01140646|39306200|FG000|Overall Study|Refused Further Treatment|5|||
16225772|NCT02983305|39306202|FG000|Overall Study|incomplete data|2|||
16410625|NCT00490139|39985534|FG000|Overall Study|Lost to Follow-up|56|||
16114853|NCT01371708|38906181|FG002|Overall Study|Medication error/not related to AE|0|||
16114854|NCT01371708|38906179|FG000|Overall Study|Other|3|||
16114855|NCT01371708|38906180|FG001|Overall Study|Other|2|||
16347023|NCT00490919|39757376|FG001|Double-blind Phase|Adverse Event|40|||
16547632|NCT01364597|40467686|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
16547633|NCT01364597|40467687|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
16547634|NCT01364597|40467684|FG000|Overall Study|Patient cured from Epilepsy|0|||
16547635|NCT01364597|40467685|FG001|Overall Study|Patient cured from Epilepsy|0|||
16547636|NCT01364597|40467686|FG002|Overall Study|Patient cured from Epilepsy|1|||
16547637|NCT01364597|40467687|FG003|Overall Study|Patient cured from Epilepsy|0|||
16547638|NCT01364597|40467684|FG000|Overall Study|Investigator decision|0|||
16547639|NCT01364597|40467685|FG001|Overall Study|Investigator decision|0|||
16114856|NCT01371708|38906181|FG002|Overall Study|Other|4|||
16114857|NCT01371708|38906179|FG000|Overall Study|Adverse Event|5|||
16114858|NCT01371708|38906180|FG001|Overall Study|Adverse Event|8|||
16114859|NCT01371708|38906181|FG002|Overall Study|Adverse Event|12|||
16114860|NCT01371708|38906179|FG000|Overall Study|Started but did not receive treatment|1|||
16114861|NCT01371708|38906180|FG001|Overall Study|Started but did not receive treatment|0|||
16114862|NCT01371708|38906181|FG002|Overall Study|Started but did not receive treatment|1|||
16114863|NCT00477464|38906183|FG000|Overall Study|Lost to Follow-up|1|||
16114864|NCT00477464|38906183|FG000|Overall Study|Death|36|||
16547640|NCT01364597|40467686|FG002|Overall Study|Investigator decision|1|||
16547641|NCT01364597|40467687|FG003|Overall Study|Investigator decision|0|||
16547642|NCT01364597|40467684|FG000|Overall Study|Sponsor recommended discontinuation|0|||
16114865|NCT00477464|38906183|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
16114866|NCT00658606|38906184|FG000|Overall Study|Adverse Event|2|||
16114867|NCT00658606|38906185|FG001|Overall Study|Adverse Event|1|||
16114868|NCT00658606|38906184|FG000|Overall Study|Lack of Efficacy|6|||
16114869|NCT00658606|38906185|FG001|Overall Study|Lack of Efficacy|3|||
16114870|NCT00658606|38906184|FG000|Overall Study|Lost to Follow-up|1|||
16114871|NCT00658606|38906185|FG001|Overall Study|Lost to Follow-up|0|||
16114872|NCT00658606|38906184|FG000|Overall Study|Withdrawal by Subject|7|||
16347024|NCT00490919|39757377|FG002|Double-blind Phase|Adverse Event|20|||
16347025|NCT00490919|39757375|FG000|Double-blind Phase|Withdrawal by Subject|0|||
16547643|NCT01364597|40467685|FG001|Overall Study|Sponsor recommended discontinuation|0|||
16114873|NCT00658606|38906185|FG001|Overall Study|Withdrawal by Subject|16|||
16114874|NCT00658606|38906184|FG000|Overall Study|Lack of Compliance|0|||
16114875|NCT00658606|38906185|FG001|Overall Study|Lack of Compliance|3|||
16114876|NCT01090011|38906186|FG000|Overall Study|Progressive disease|128|||
16114877|NCT01090011|38906186|FG000|Overall Study|Adverse Event|32|||
16114878|NCT01090011|38906186|FG000|Overall Study|Protocol Violation|1|||
16114879|NCT01090011|38906186|FG000|Overall Study|Refusal to start/continue medication|5|||
16114880|NCT01090011|38906186|FG000|Overall Study|Other reason not defined above|5|||
16114881|NCT03192462|38906193|FG000|Overall Study|Death|13|||
16114882|NCT03192462|38906194|FG001|Overall Study|Death|11|||
16114883|NCT03192462|38906195|FG002|Overall Study|Death|9|||
16114884|NCT03192462|38906193|FG000|Overall Study|Lost to Follow-up|0|||
16114885|NCT03192462|38906194|FG001|Overall Study|Lost to Follow-up|1|||
16114886|NCT03192462|38906195|FG002|Overall Study|Lost to Follow-up|0|||
16114887|NCT03192462|38906193|FG000|Overall Study|On follow up|0|||
16114888|NCT03192462|38906194|FG001|Overall Study|On follow up|0|||
16114889|NCT03192462|38906195|FG002|Overall Study|On follow up|3|||
16114890|NCT01228175|38906198|FG000|Overall Study|Lost to Follow-up|64|||
16114891|NCT01228175|38906199|FG001|Overall Study|Lost to Follow-up|50|||
16114892|NCT01228175|38906198|FG000|Overall Study|Withdrawal by Subject|1|||
16114893|NCT01228175|38906199|FG001|Overall Study|Withdrawal by Subject|2|||
16114894|NCT01228175|38906198|FG000|Overall Study|Physician Decision|1|||
16114895|NCT01228175|38906199|FG001|Overall Study|Physician Decision|1|||
16114896|NCT02035696|38906200|FG000|Overall Study|Lost to Follow-up|0|||
16114897|NCT02035696|38906201|FG001|Overall Study|Lost to Follow-up|3|||
16114898|NCT02035696|38906202|FG002|Overall Study|Lost to Follow-up|1|||
16114899|NCT02035696|38906203|FG003|Overall Study|Lost to Follow-up|2|||
16114900|NCT02035696|38906200|FG000|Overall Study|Withdrawal by Subject|3|||
16114901|NCT02035696|38906201|FG001|Overall Study|Withdrawal by Subject|0|||
16114902|NCT02035696|38906202|FG002|Overall Study|Withdrawal by Subject|2|||
16114903|NCT02035696|38906203|FG003|Overall Study|Withdrawal by Subject|1|||
16114904|NCT02375347|38906204|FG000|Overall Study|Protocol Violation|1|||
16114905|NCT01441583|38906208|FG000|Overall Study|Withdrawal by Subject|1|||
16114906|NCT01441583|38906209|FG001|Overall Study|Withdrawal by Subject|1|||
16114907|NCT01441583|38906210|FG002|Overall Study|Withdrawal by Subject|1|||
16114908|NCT01441583|38906208|FG000|Overall Study|Death|1|||
16114909|NCT01441583|38906209|FG001|Overall Study|Death|0|||
16114910|NCT01441583|38906210|FG002|Overall Study|Death|4|||
16114911|NCT01441583|38906208|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
16114912|NCT01441583|38906209|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
16114913|NCT01441583|38906210|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
16114914|NCT00307047|38906211|FG000|Overall Study|Lost to Follow-up|35|||
16114915|NCT00307047|38906212|FG001|Overall Study|Lost to Follow-up|24|||
16114916|NCT00307047|38906211|FG000|Overall Study|Withdrawal by Subject|6|||
16114917|NCT00307047|38906212|FG001|Overall Study|Withdrawal by Subject|6|||
16114918|NCT00307047|38906211|FG000|Overall Study|Physician Decision|1|||
16114919|NCT00307047|38906212|FG001|Overall Study|Physician Decision|2|||
16114920|NCT00307047|38906211|FG000|Overall Study|Lost to follow-up for other reasons|0|||
16114921|NCT00307047|38906212|FG001|Overall Study|Lost to follow-up for other reasons|1|||
16114922|NCT00307047|38906211|FG000|Overall Study|All death, all MI, all Revascularization|27|||
16114923|NCT00307047|38906212|FG001|Overall Study|All death, all MI, all Revascularization|16|||
16114924|NCT01519778|38906213|FG000|Overall Study|Withdrawal by Subject|3|||
16114925|NCT01519778|38906213|FG000|Overall Study|Lost to Follow-up|10|||
16114926|NCT01519778|38906213|FG000|Overall Study|Physician Decision|1|||
16114927|NCT03301155|38906214|FG000|Overall Study|Сompliance with exclusion criteria|8|||
16114928|NCT03301155|38906215|FG001|Overall Study|Сompliance with exclusion criteria|7|||
16114929|NCT03065933|38906216|FG000|Overall Study|study terminated|5|||
16114930|NCT01453023|38906217|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
16114931|NCT01453023|38906218|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
16225773|NCT02983305|39306203|FG001|Overall Study|incomplete data|0|||
16347026|NCT00490919|39757376|FG001|Double-blind Phase|Withdrawal by Subject|10|||
16347027|NCT00490919|39757377|FG002|Double-blind Phase|Withdrawal by Subject|11|||
16347028|NCT00490919|39757375|FG000|Double-blind Phase|Lost to Follow-up|0|||
16547644|NCT01364597|40467686|FG002|Overall Study|Sponsor recommended discontinuation|0|||
16547645|NCT01364597|40467687|FG003|Overall Study|Sponsor recommended discontinuation|1|||
16547646|NCT01364597|40467684|FG000|Overall Study|Parents went abroad with the patient|0|||
16547647|NCT01364597|40467685|FG001|Overall Study|Parents went abroad with the patient|0|||
16547648|NCT01364597|40467686|FG002|Overall Study|Parents went abroad with the patient|1|||
16547649|NCT01364597|40467687|FG003|Overall Study|Parents went abroad with the patient|0|||
16547650|NCT01364597|40467684|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
16547651|NCT01364597|40467685|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
16547652|NCT01364597|40467686|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
16547653|NCT01364597|40467687|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
16547654|NCT01364597|40467684|FG000|Overall Study|BRV administration dropout|0|||
16547655|NCT01364597|40467685|FG001|Overall Study|BRV administration dropout|0|||
16547656|NCT01364597|40467686|FG002|Overall Study|BRV administration dropout|1|||
16547657|NCT01364597|40467687|FG003|Overall Study|BRV administration dropout|0|||
16547658|NCT01364597|40467684|FG000|Overall Study|Dropout|0|||
16547659|NCT01364597|40467685|FG001|Overall Study|Dropout|0|||
16547660|NCT01364597|40467686|FG002|Overall Study|Dropout|3|||
16547661|NCT01364597|40467687|FG003|Overall Study|Dropout|1|||
16547662|NCT01364597|40467684|FG000|Overall Study|Unreliable subject|0|||
16547663|NCT01364597|40467685|FG001|Overall Study|Unreliable subject|0|||
16547664|NCT01364597|40467686|FG002|Overall Study|Unreliable subject|0|||
16547665|NCT01364597|40467687|FG003|Overall Study|Unreliable subject|1|||
16547666|NCT01364597|40467684|FG000|Overall Study|Other|0|||
16547667|NCT01364597|40467685|FG001|Overall Study|Other|0|||
16547668|NCT01364597|40467686|FG002|Overall Study|Other|0|||
16547669|NCT01364597|40467687|FG003|Overall Study|Other|1|||
16547670|NCT00744263|40467690|FG000|Overall Study|Death|3006|||
16547671|NCT00744263|40467691|FG001|Overall Study|Death|3005|||
16547672|NCT00744263|40467690|FG000|Overall Study|Lost to Follow-up|2038|||
16547673|NCT00744263|40467691|FG001|Overall Study|Lost to Follow-up|2135|||
16547674|NCT00744263|40467690|FG000|Overall Study|Withdrawal by Subject|166|||
16547675|NCT00744263|40467691|FG001|Overall Study|Withdrawal by Subject|150|||
16547676|NCT00744263|40467690|FG000|Overall Study|Physician Decision|20|||
16547677|NCT00744263|40467691|FG001|Overall Study|Physician Decision|23|||
16547678|NCT00744263|40467690|FG000|Overall Study|Protocol Violation|3|||
16547679|NCT00744263|40467691|FG001|Overall Study|Protocol Violation|5|||
16547680|NCT00744263|40467690|FG000|Overall Study|Adverse Event|1|||
16547681|NCT00744263|40467691|FG001|Overall Study|Adverse Event|0|||
16547682|NCT00744263|40467690|FG000|Overall Study|Other|2|||
16547683|NCT00744263|40467691|FG001|Overall Study|Other|2|||
16547684|NCT00856661|40467692|FG000|Overall Study|Death|15|||
16547685|NCT00856661|40467693|FG001|Overall Study|Death|18|||
16547686|NCT00856661|40467692|FG000|Overall Study|Protocol Violation|2|||
16547687|NCT00856661|40467693|FG001|Overall Study|Protocol Violation|1|||
16547688|NCT00856661|40467692|FG000|Overall Study|Withdrawal by Subject|1|||
16547689|NCT00856661|40467693|FG001|Overall Study|Withdrawal by Subject|2|||
16547690|NCT00856661|40467692|FG000|Overall Study|Lost to Follow-up|1|||
16547691|NCT00856661|40467693|FG001|Overall Study|Lost to Follow-up|3|||
16547692|NCT00856661|40467692|FG000|Overall Study|Physician Judgement|8|||
16547693|NCT00856661|40467693|FG001|Overall Study|Physician Judgement|5|||
16547694|NCT04836858|40467694|FG000|Overall Study|Adverse Event|0|||
16547695|NCT04836858|40467695|FG001|Overall Study|Adverse Event|0|||
16547696|NCT04836858|40467696|FG002|Overall Study|Adverse Event|0|||
16547697|NCT04836858|40467697|FG003|Overall Study|Adverse Event|1|||
16547698|NCT04836858|40467694|FG000|Overall Study|Lost to Follow-up|1|||
16547699|NCT04836858|40467695|FG001|Overall Study|Lost to Follow-up|0|||
16547700|NCT04836858|40467696|FG002|Overall Study|Lost to Follow-up|0|||
16547701|NCT04836858|40467697|FG003|Overall Study|Lost to Follow-up|0|||
16547702|NCT04836858|40467694|FG000|Overall Study|Subject/Guardian decision|3|||
16547703|NCT04836858|40467695|FG001|Overall Study|Subject/Guardian decision|0|||
16547704|NCT04836858|40467696|FG002|Overall Study|Subject/Guardian decision|0|||
16225774|NCT03057054|39306210|FG000|Overall Study|Death|4|||
16547705|NCT04836858|40467697|FG003|Overall Study|Subject/Guardian decision|1|||
16547706|NCT04836858|40467694|FG000|Overall Study|Randomized but not treated|4|||
16547707|NCT04836858|40467695|FG001|Overall Study|Randomized but not treated|0|||
16547708|NCT04836858|40467696|FG002|Overall Study|Randomized but not treated|0|||
16225775|NCT03057054|39306211|FG001|Overall Study|Death|4|||
16225776|NCT03057054|39306210|FG000|Overall Study|Withdrawal by Subject|6|||
16225777|NCT03057054|39306211|FG001|Overall Study|Withdrawal by Subject|3|||
16225778|NCT03057054|39306210|FG000|Overall Study|Ineligible|1|||
16225779|NCT03057054|39306211|FG001|Overall Study|Ineligible|1|||
16225780|NCT02743117|39306214|FG000|Overall Study|Lost to Follow-up|0|||
16225781|NCT02743117|39306215|FG001|Overall Study|Lost to Follow-up|1|||
16225782|NCT02743117|39306214|FG000|Overall Study|Other|1|||
16225783|NCT02743117|39306215|FG001|Overall Study|Other|0|||
16225784|NCT03418727|39306221|FG000|Overall Study|Adverse Event|1|||
16225785|NCT03418727|39306222|FG001|Overall Study|Adverse Event|2|||
16225786|NCT03418727|39306223|FG002|Overall Study|Adverse Event|0|||
16547709|NCT04836858|40467697|FG003|Overall Study|Randomized but not treated|0|||
16547710|NCT00990340|40467709|FG000|First 14-day Treatment|Not Compliant|2|||
16547711|NCT00990340|40467710|FG001|First 14-day Treatment|Not Compliant|1|||
16547712|NCT00990340|40467709|FG000|First 14-day Treatment|Lost to Follow-up|2|||
16547713|NCT00990340|40467710|FG001|First 14-day Treatment|Lost to Follow-up|1|||
16547714|NCT00990340|40467709|FG000|First 14-day Treatment|Protocol Violation|2|||
16547715|NCT00990340|40467710|FG001|First 14-day Treatment|Protocol Violation|2|||
16547716|NCT02914184|40467715|FG000|Overall Study|Lost to Follow-up|7|||
16547717|NCT02914184|40467716|FG001|Overall Study|Lost to Follow-up|10|||
16547718|NCT02914184|40467717|FG002|Overall Study|Lost to Follow-up|8|||
16547719|NCT02914184|40467718|FG003|Overall Study|Lost to Follow-up|7|||
16114932|NCT01453023|38906217|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
16114933|NCT01453023|38906218|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
16225787|NCT03418727|39306221|FG000|Overall Study|Withdrawal by Subject|0|||
16225788|NCT03418727|39306222|FG001|Overall Study|Withdrawal by Subject|0|||
16225789|NCT03418727|39306223|FG002|Overall Study|Withdrawal by Subject|2|||
16225790|NCT00423137|39306224|FG000|Overall Study|Lost to Follow-up|0|||
16225791|NCT00423137|39306225|FG001|Overall Study|Lost to Follow-up|0|||
16225792|NCT00423137|39306226|FG002|Overall Study|Lost to Follow-up|1|||
16225793|NCT00423137|39306227|FG003|Overall Study|Lost to Follow-up|0|||
16547720|NCT02914184|40467715|FG000|Overall Study|Withdrawal by Subject|4|||
16547721|NCT02914184|40467716|FG001|Overall Study|Withdrawal by Subject|2|||
16225794|NCT00423137|39306224|FG000|Overall Study|Protocol Violation|0|||
16225795|NCT00423137|39306225|FG001|Overall Study|Protocol Violation|0|||
16225796|NCT00423137|39306226|FG002|Overall Study|Protocol Violation|0|||
16225797|NCT00423137|39306227|FG003|Overall Study|Protocol Violation|1|||
16225798|NCT00423137|39306224|FG000|Overall Study|Adverse Event Study disease worse|1|||
16225799|NCT00423137|39306225|FG001|Overall Study|Adverse Event Study disease worse|0|||
16225800|NCT00423137|39306226|FG002|Overall Study|Adverse Event Study disease worse|3|||
16225801|NCT00423137|39306227|FG003|Overall Study|Adverse Event Study disease worse|1|||
16225802|NCT00423137|39306224|FG000|Overall Study|Adverse Event Other|0|||
16225803|NCT00423137|39306225|FG001|Overall Study|Adverse Event Other|0|||
16225804|NCT00423137|39306226|FG002|Overall Study|Adverse Event Other|2|||
16225805|NCT00423137|39306227|FG003|Overall Study|Adverse Event Other|0|||
16225806|NCT02569398|39306232|FG000|Overall Study|Adverse Event|0|||
16225807|NCT02569398|39306233|FG001|Overall Study|Adverse Event|1|||
16225808|NCT02569398|39306234|FG002|Overall Study|Adverse Event|6|||
16225809|NCT02569398|39306232|FG000|Overall Study|Withdrawal by Subject|43|||
16225810|NCT02569398|39306233|FG001|Overall Study|Withdrawal by Subject|43|||
16225811|NCT02569398|39306234|FG002|Overall Study|Withdrawal by Subject|30|||
16225812|NCT02569398|39306232|FG000|Overall Study|Study terminated by sponsor|130|||
16225813|NCT02569398|39306233|FG001|Overall Study|Study terminated by sponsor|131|||
16225814|NCT02569398|39306234|FG002|Overall Study|Study terminated by sponsor|134|||
16225815|NCT02569398|39306232|FG000|Overall Study|Other|12|||
16225816|NCT02569398|39306233|FG001|Overall Study|Other|14|||
16225817|NCT02569398|39306234|FG002|Overall Study|Other|13|||
16225818|NCT03558503|39306235|FG000|Overall Study|Adverse Event|1|||
16225819|NCT03558503|39306235|FG000|Overall Study|Death|1|||
16225820|NCT03558503|39306235|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
16225821|NCT00348686|39306236|FG000|Overall Study|Withdrawal by Subject|45|||
16225822|NCT00348686|39306236|FG000|Overall Study|Adverse Event|5|||
16225823|NCT00348686|39306236|FG000|Overall Study|Protocol Violation|6|||
16225824|NCT00348686|39306236|FG000|Overall Study|Lost to Follow-up|2|||
16225825|NCT00348686|39306236|FG000|Overall Study|Multiple Reasons|8|||
16225826|NCT00103207|39306240|FG000|Overall Study|Adverse Event|3|||
16225827|NCT00103207|39306240|FG000|Overall Study|Death|1|||
16225828|NCT00103207|39306240|FG000|Overall Study|Withdrawal by Subject|2|||
16225829|NCT00103207|39306240|FG000|Overall Study|Other complicating disease|1|||
16225830|NCT00103207|39306240|FG000|Overall Study|Ineligible|4|||
16225831|NCT00103207|39306240|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
16225832|NCT02452320|39306241|FG000|Overall Study|Adverse Event|0|||
16225833|NCT02452320|39306242|FG001|Overall Study|Adverse Event|1|||
16225834|NCT03764813|39306249|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
16225835|NCT03764813|39306250|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
16225836|NCT03764813|39306251|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
16225837|NCT03764813|39306252|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
16225838|NCT02200510|39306253|FG000|Overall Study|Death|1|||
16225839|NCT02200510|39306254|FG001|Overall Study|Death|1|||
16225840|NCT02200510|39306253|FG000|Overall Study|Protocol Violation|0|||
16225841|NCT02200510|39306254|FG001|Overall Study|Protocol Violation|1|||
16225842|NCT02200510|39306253|FG000|Overall Study|Lost to Follow-up|7|||
16225843|NCT02200510|39306254|FG001|Overall Study|Lost to Follow-up|1|||
16225844|NCT02200510|39306253|FG000|Overall Study|potential COI - joined study team|1|||
16225845|NCT02200510|39306254|FG001|Overall Study|potential COI - joined study team|0|||
16225846|NCT04585789|39306255|FG000|Overall Study|Withdrawal by Subject|1|||
16225847|NCT04585789|39306256|FG001|Overall Study|Withdrawal by Subject|0|||
16225848|NCT04585789|39306255|FG000|Overall Study|Ongoing|9|||
16225849|NCT04585789|39306256|FG001|Overall Study|Ongoing|10|||
16225850|NCT04557189|39306257|FG000|Overall Study|Adverse Event|0|||
16225851|NCT04557189|39306258|FG001|Overall Study|Adverse Event|1|||
16225852|NCT04557189|39306257|FG000|Overall Study|Lost to Follow-up|1|||
16225853|NCT04557189|39306258|FG001|Overall Study|Lost to Follow-up|1|||
16225854|NCT04557189|39306257|FG000|Overall Study|Withdrawal by Subject|2|||
16225855|NCT04557189|39306258|FG001|Overall Study|Withdrawal by Subject|1|||
16225856|NCT04557189|39306257|FG000|Overall Study|Reason not Specified|3|||
16225857|NCT04557189|39306258|FG001|Overall Study|Reason not Specified|6|||
16225858|NCT02329834|39306261|FG000|Overall Study|Physician Decision|1|||
16225859|NCT02329834|39306262|FG001|Overall Study|Physician Decision|0|||
16225860|NCT00003389|39306263|FG000|Overall Study|Disease progression|6|||
16225861|NCT00003389|39306264|FG001|Overall Study|Disease progression|1|||
16225862|NCT00003389|39306263|FG000|Overall Study|Adverse Event|13|||
16225863|NCT00003389|39306264|FG001|Overall Study|Adverse Event|2|||
16225864|NCT00003389|39306263|FG000|Overall Study|Death|0|||
16225865|NCT00003389|39306264|FG001|Overall Study|Death|3|||
16225866|NCT00003389|39306263|FG000|Overall Study|Withdrawal by Subject|12|||
16225867|NCT00003389|39306264|FG001|Overall Study|Withdrawal by Subject|5|||
16225868|NCT00003389|39306263|FG000|Overall Study|Alternative therapy|2|||
16225869|NCT00003389|39306264|FG001|Overall Study|Alternative therapy|1|||
16225870|NCT00003389|39306263|FG000|Overall Study|Complicating disease|1|||
16225871|NCT00003389|39306264|FG001|Overall Study|Complicating disease|0|||
16225872|NCT00003389|39306263|FG000|Overall Study|Off-treatment reason missing|31|||
16225873|NCT00003389|39306264|FG001|Overall Study|Off-treatment reason missing|21|||
16225874|NCT00003389|39306263|FG000|Overall Study|Ineligible|33|||
16225875|NCT00003389|39306264|FG001|Overall Study|Ineligible|27|||
16225876|NCT01270139|39306265|FG000|Overall Study|Adverse Event|8|||
16225877|NCT01270139|39306266|FG001|Overall Study|Adverse Event|17|||
16225878|NCT01270139|39306267|FG002|Overall Study|Adverse Event|18|||
16225879|NCT01270139|39306265|FG000|Overall Study|Lost to Follow-up|10|||
16225880|NCT01270139|39306266|FG001|Overall Study|Lost to Follow-up|9|||
16410626|NCT00490139|39985535|FG001|Overall Study|Lost to Follow-up|46|||
16410627|NCT00490139|39985536|FG002|Overall Study|Lost to Follow-up|58|||
16410628|NCT00490139|39985537|FG003|Overall Study|Lost to Follow-up|56|||
16410629|NCT00490139|39985534|FG000|Overall Study|Participant Withdrew Consent|146|||
16410630|NCT00490139|39985535|FG001|Overall Study|Participant Withdrew Consent|110|||
16410631|NCT00490139|39985536|FG002|Overall Study|Participant Withdrew Consent|208|||
16410632|NCT00490139|39985537|FG003|Overall Study|Participant Withdrew Consent|116|||
16410633|NCT04191135|39985538|FG000|Induction Treatment|Not Treated|2|||
16114934|NCT01453023|38906217|FG000|Treatment Period 2|Protocol Violation|0|||
16114935|NCT01453023|38906218|FG001|Treatment Period 2|Protocol Violation|1|||
16114936|NCT01536587|38906222|FG000|Overall Study|Adverse Event|2|||
16114937|NCT01053247|38906223|FG000|Overall Study|Withdrawal by Subject|9|||
16114938|NCT01053247|38906224|FG001|Overall Study|Withdrawal by Subject|4|||
16114939|NCT01053247|38906225|FG002|Overall Study|Withdrawal by Subject|15|||
16225881|NCT01270139|39306267|FG002|Overall Study|Lost to Follow-up|2|||
16410634|NCT04191135|39985539|FG001|Induction Treatment|Not Treated|0|||
16410635|NCT04191135|39985540|FG002|Induction Treatment|Not Treated|0|||
16410636|NCT04191135|39985538|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
16410637|NCT04191135|39985539|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
16410638|NCT04191135|39985540|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
16410639|NCT04191135|39985538|FG000|Induction Treatment|Adverse Event|25|||
16410640|NCT04191135|39985539|FG001|Induction Treatment|Adverse Event|0|||
16410641|NCT04191135|39985540|FG002|Induction Treatment|Adverse Event|0|||
16410642|NCT04191135|39985538|FG000|Induction Treatment|Clinical Progression|8|||
16547722|NCT02914184|40467717|FG002|Overall Study|Withdrawal by Subject|7|||
16547723|NCT02914184|40467718|FG003|Overall Study|Withdrawal by Subject|3|||
16547724|NCT02914184|40467715|FG000|Overall Study|Other|1|||
16547725|NCT02914184|40467716|FG001|Overall Study|Other|0|||
16547726|NCT02914184|40467717|FG002|Overall Study|Other|0|||
16547727|NCT02914184|40467718|FG003|Overall Study|Other|0|||
16547728|NCT02914184|40467715|FG000|Overall Study|Migrated/moved from the study area|2|||
16547729|NCT02914184|40467716|FG001|Overall Study|Migrated/moved from the study area|1|||
16547730|NCT02914184|40467717|FG002|Overall Study|Migrated/moved from the study area|2|||
16547731|NCT02914184|40467718|FG003|Overall Study|Migrated/moved from the study area|1|||
16547732|NCT02026232|40467719|FG000|Overall Study|incomplete visit/missing data|3|||
16547733|NCT02026232|40467720|FG001|Overall Study|incomplete visit/missing data|2|||
16547734|NCT01301274|40467721|FG000|Overall Study|Physician Decision|2|||
16547735|NCT01301274|40467722|FG001|Overall Study|Physician Decision|1|||
16547736|NCT00224770|40467737|FG000|Overall Study|Lost to Follow-up|4|||
16547737|NCT00224770|40467738|FG001|Overall Study|Lost to Follow-up|2|||
16547738|NCT00224770|40467739|FG002|Overall Study|Lost to Follow-up|0|||
16547739|NCT00998400|40467740|FG000|Overall Study|Lack of interest/motivation|1|||
16114940|NCT01053247|38906223|FG000|Overall Study|Lack of Efficacy|1|||
16114941|NCT01053247|38906224|FG001|Overall Study|Lack of Efficacy|0|||
16225882|NCT00247962|39306268|FG000|Overall Study|Adverse Event|15|||
16225883|NCT00247962|39306269|FG001|Overall Study|Adverse Event|12|||
16547740|NCT00998400|40467741|FG001|Overall Study|Lack of interest/motivation|2|||
16547741|NCT00998400|40467740|FG000|Overall Study|Logistical problems|1|||
16225884|NCT00247962|39306268|FG000|Overall Study|Lost to Follow-up|3|||
16410643|NCT04191135|39985539|FG001|Induction Treatment|Clinical Progression|0|||
16410644|NCT04191135|39985540|FG002|Induction Treatment|Clinical Progression|0|||
16547742|NCT00998400|40467741|FG001|Overall Study|Logistical problems|0|||
16347029|NCT00490919|39757376|FG001|Double-blind Phase|Lost to Follow-up|8|||
16347030|NCT00490919|39757377|FG002|Double-blind Phase|Lost to Follow-up|11|||
16347031|NCT00490919|39757375|FG000|Double-blind Phase|Lack of Efficacy|0|||
16347032|NCT00490919|39757376|FG001|Double-blind Phase|Lack of Efficacy|22|||
16347033|NCT00490919|39757377|FG002|Double-blind Phase|Lack of Efficacy|36|||
16347034|NCT00490919|39757375|FG000|Double-blind Phase|Administrative|0|||
16347035|NCT00490919|39757376|FG001|Double-blind Phase|Administrative|6|||
16347036|NCT00490919|39757377|FG002|Double-blind Phase|Administrative|6|||
16410645|NCT04191135|39985538|FG000|Induction Treatment|Excluded Medication|1|||
16410646|NCT04191135|39985539|FG001|Induction Treatment|Excluded Medication|0|||
16410647|NCT04191135|39985540|FG002|Induction Treatment|Excluded Medication|0|||
16410648|NCT04191135|39985538|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
16410649|NCT04191135|39985539|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
16410650|NCT04191135|39985540|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
16410651|NCT04191135|39985538|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
16410652|NCT04191135|39985539|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
16410653|NCT04191135|39985540|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
16410654|NCT04191135|39985538|FG000|Induction Treatment|Physician Decision|2|||
16410655|NCT04191135|39985539|FG001|Induction Treatment|Physician Decision|0|||
16410656|NCT04191135|39985540|FG002|Induction Treatment|Physician Decision|0|||
16410657|NCT04191135|39985538|FG000|Induction Treatment|Progressive Disease|135|||
16410658|NCT04191135|39985539|FG001|Induction Treatment|Progressive Disease|0|||
16410659|NCT04191135|39985540|FG002|Induction Treatment|Progressive Disease|0|||
16410660|NCT04191135|39985538|FG000|Induction Treatment|Protocol Violation|10|||
16225885|NCT00247962|39306269|FG001|Overall Study|Lost to Follow-up|1|||
16225886|NCT00247962|39306268|FG000|Overall Study|Physician Decision|0|||
16410661|NCT04191135|39985539|FG001|Induction Treatment|Protocol Violation|0|||
16410662|NCT04191135|39985540|FG002|Induction Treatment|Protocol Violation|0|||
16410663|NCT04191135|39985538|FG000|Induction Treatment|Withdrawal by Subject|4|||
16410664|NCT04191135|39985539|FG001|Induction Treatment|Withdrawal by Subject|0|||
16410665|NCT04191135|39985540|FG002|Induction Treatment|Withdrawal by Subject|0|||
16410666|NCT04191135|39985538|FG000|Randomized Treatment|Death|0|||
16410667|NCT04191135|39985539|FG001|Randomized Treatment|Death|50|||
16410668|NCT04191135|39985540|FG002|Randomized Treatment|Death|54|||
16410669|NCT04191135|39985538|FG000|Randomized Treatment|Lost to Follow-up|0|||
16410670|NCT04191135|39985539|FG001|Randomized Treatment|Lost to Follow-up|0|||
16410671|NCT04191135|39985540|FG002|Randomized Treatment|Lost to Follow-up|1|||
16410672|NCT04191135|39985538|FG000|Randomized Treatment|Withdrawal by Subject|0|||
16410673|NCT04191135|39985539|FG001|Randomized Treatment|Withdrawal by Subject|2|||
16410674|NCT04191135|39985540|FG002|Randomized Treatment|Withdrawal by Subject|0|||
16410675|NCT04191135|39985538|FG000|Randomized Treatment|Ongoing in Trial|0|||
16410676|NCT04191135|39985539|FG001|Randomized Treatment|Ongoing in Trial|83|||
16410677|NCT04191135|39985540|FG002|Randomized Treatment|Ongoing in Trial|81|||
16410678|NCT04912895|39985541|FG000|Overall Study|Unable to provide specimen|2|||
16410679|NCT04912895|39985542|FG001|Overall Study|Unable to provide specimen|0|||
16410680|NCT04912895|39985543|FG002|Overall Study|Unable to provide specimen|0|||
16410681|NCT01515475|39985544|FG000|Overall Study|Lost to Follow-up|20|||
16410682|NCT01515475|39985545|FG001|Overall Study|Lost to Follow-up|15|||
16410683|NCT01515475|39985546|FG002|Overall Study|Lost to Follow-up|12|||
16410684|NCT01515475|39985547|FG003|Overall Study|Lost to Follow-up|12|||
16410685|NCT03730012|39985551|FG000|Overall Study|Adverse Event|0|||
16410686|NCT03730012|39985552|FG001|Overall Study|Adverse Event|1|||
16410687|NCT03730012|39985551|FG000|Overall Study|Lack of Efficacy|1|||
16410688|NCT03730012|39985552|FG001|Overall Study|Lack of Efficacy|5|||
16225887|NCT00247962|39306269|FG001|Overall Study|Physician Decision|1|||
16225888|NCT00247962|39306268|FG000|Overall Study|Protocol Violation|1|||
16225889|NCT00247962|39306269|FG001|Overall Study|Protocol Violation|1|||
16225890|NCT00247962|39306268|FG000|Overall Study|Withdrawal by Subject|3|||
16225891|NCT00247962|39306269|FG001|Overall Study|Withdrawal by Subject|2|||
16225892|NCT00247962|39306268|FG000|Overall Study|Lack of Efficacy|4|||
16225893|NCT00247962|39306269|FG001|Overall Study|Lack of Efficacy|2|||
16225894|NCT00553319|39306274|FG000|Overall Study|Lost to Follow-up|10|||
16225895|NCT00553319|39306275|FG001|Overall Study|Lost to Follow-up|9|||
16225896|NCT00553319|39306276|FG002|Overall Study|Lost to Follow-up|5|||
16225897|NCT00553319|39306274|FG000|Overall Study|wanted treatment elsewhere|2|||
16225898|NCT00553319|39306275|FG001|Overall Study|wanted treatment elsewhere|1|||
16225899|NCT00553319|39306276|FG002|Overall Study|wanted treatment elsewhere|1|||
16225900|NCT00553319|39306274|FG000|Overall Study|non-compliance|0|||
16225901|NCT00553319|39306275|FG001|Overall Study|non-compliance|0|||
16225902|NCT00553319|39306276|FG002|Overall Study|non-compliance|2|||
16225903|NCT00553319|39306274|FG000|Overall Study|incarceration|1|||
16410689|NCT03730012|39985551|FG000|Overall Study|Withdrawal by Subject|0|||
16410690|NCT03730012|39985552|FG001|Overall Study|Withdrawal by Subject|1|||
16225904|NCT00553319|39306275|FG001|Overall Study|incarceration|0|||
16347037|NCT01310127|39757381|FG000|Overall Study|Protocol Violation|1|||
16410691|NCT03730012|39985551|FG000|Overall Study|Miscellaneous|2|||
16410692|NCT03730012|39985552|FG001|Overall Study|Miscellaneous|1|||
16410693|NCT03684304|39985559|FG000|Overall Study|Lost to Follow-up|19|||
16410694|NCT03684304|39985560|FG001|Overall Study|Lost to Follow-up|17|||
16547743|NCT01121484|40467742|FG000|Overall Study|Adverse Event|12|||
16547744|NCT01121484|40467743|FG001|Overall Study|Adverse Event|5|||
16547745|NCT01121484|40467742|FG000|Overall Study|Lack of Efficacy|3|||
16547746|NCT01121484|40467743|FG001|Overall Study|Lack of Efficacy|11|||
16547747|NCT01121484|40467742|FG000|Overall Study|Lost to Follow-up|5|||
16547748|NCT01121484|40467743|FG001|Overall Study|Lost to Follow-up|9|||
16547749|NCT01121484|40467742|FG000|Overall Study|Physician Decision|0|||
16547750|NCT01121484|40467743|FG001|Overall Study|Physician Decision|3|||
16547751|NCT01121484|40467742|FG000|Overall Study|Protocol Violation|1|||
16547752|NCT01121484|40467743|FG001|Overall Study|Protocol Violation|0|||
16547753|NCT01121484|40467742|FG000|Overall Study|Withdrawal by Subject|8|||
16547754|NCT01121484|40467743|FG001|Overall Study|Withdrawal by Subject|7|||
16547755|NCT01121484|40467742|FG000|Overall Study|Discontinuation of study by sponsor|0|||
16547756|NCT01121484|40467743|FG001|Overall Study|Discontinuation of study by sponsor|1|||
16547757|NCT01121484|40467742|FG000|Overall Study|Other|3|||
16547758|NCT01121484|40467743|FG001|Overall Study|Other|3|||
16547759|NCT01121484|40467742|FG000|Overall Study|Randomized, not treated|1|||
16114942|NCT01053247|38906225|FG002|Overall Study|Lack of Efficacy|1|||
16225905|NCT00553319|39306276|FG002|Overall Study|incarceration|0|||
16347038|NCT01310127|39757382|FG001|Overall Study|Protocol Violation|1|||
16347039|NCT01310127|39757381|FG000|Overall Study|advanced psc cataract outlier|1|||
16347040|NCT01310127|39757382|FG001|Overall Study|advanced psc cataract outlier|0|||
16347041|NCT01004978|39757383|FG000|Overall Study|Disease progression|31|||
16347042|NCT01004978|39757384|FG001|Overall Study|Disease progression|48|||
16347043|NCT01004978|39757383|FG000|Overall Study|Adverse Event|42|||
16347044|NCT01004978|39757384|FG001|Overall Study|Adverse Event|22|||
16347045|NCT01004978|39757383|FG000|Overall Study|Death|3|||
16347046|NCT01004978|39757384|FG001|Overall Study|Death|2|||
16347047|NCT01004978|39757383|FG000|Overall Study|Withdrawal by Subject|16|||
16347048|NCT01004978|39757384|FG001|Overall Study|Withdrawal by Subject|16|||
16347049|NCT01004978|39757383|FG000|Overall Study|Alternative therapy|4|||
16347050|NCT01004978|39757384|FG001|Overall Study|Alternative therapy|8|||
16347051|NCT01004978|39757383|FG000|Overall Study|Physician Decision|6|||
16347052|NCT01004978|39757384|FG001|Overall Study|Physician Decision|3|||
16347053|NCT01004978|39757383|FG000|Overall Study|Other complicating disease|2|||
16347054|NCT01004978|39757384|FG001|Overall Study|Other complicating disease|2|||
16347055|NCT01004978|39757383|FG000|Overall Study|Protocol Violation|2|||
16347056|NCT01004978|39757384|FG001|Overall Study|Protocol Violation|3|||
16347057|NCT01004978|39757383|FG000|Overall Study|Non-compliance|3|||
16347058|NCT01004978|39757384|FG001|Overall Study|Non-compliance|2|||
16347059|NCT01004978|39757383|FG000|Overall Study|Ineligible|1|||
16410695|NCT00590824|39985561|FG000|Overall Study|Disease could not be resected|0|||
16410696|NCT00590824|39985562|FG001|Overall Study|Disease could not be resected|2|||
16347060|NCT01004978|39757384|FG001|Overall Study|Ineligible|0|||
16410697|NCT00590824|39985563|FG002|Overall Study|Disease could not be resected|1|||
16547760|NCT01121484|40467743|FG001|Overall Study|Randomized, not treated|4|||
16547761|NCT03342053|40467744|FG000|Overall Study|Adverse Event|2|||
16547762|NCT03342053|40467745|FG001|Overall Study|Adverse Event|0|||
16347061|NCT01004978|39757383|FG000|Overall Study|Unblinded|0|||
16347062|NCT01004978|39757384|FG001|Overall Study|Unblinded|1|||
16347063|NCT01004978|39757383|FG000|Overall Study|Performance status worsening|0|||
16347064|NCT01004978|39757384|FG001|Overall Study|Performance status worsening|1|||
16347065|NCT01004978|39757383|FG000|Overall Study|Never started treatment|8|||
16347066|NCT01004978|39757384|FG001|Overall Study|Never started treatment|9|||
16347067|NCT01421641|39757387|FG000|Overall Study|Protocol Violation|2|||
16347068|NCT01421641|39757388|FG001|Overall Study|Protocol Violation|2|||
16347069|NCT01951417|39757392|FG000|Overall Study|Withdrawal by Subject|1|||
16347070|NCT01951417|39757392|FG000|Overall Study|Protocol Violation|2|||
16347071|NCT01951417|39757392|FG000|Overall Study|Lost to Follow-up|6|||
16347072|NCT01249417|39757394|FG000|Randomised Population|Study treatment not received|0|||
16347073|NCT01249417|39757395|FG001|Randomised Population|Study treatment not received|0|||
16347074|NCT01249417|39757396|FG002|Randomised Population|Study treatment not received|2|||
16347075|NCT01249417|39757394|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
16347076|NCT01249417|39757395|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
16347077|NCT01249417|39757396|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
16347078|NCT01249417|39757394|FG000|Treatment Phase - ITT Population|Other|0|||
16347079|NCT01249417|39757395|FG001|Treatment Phase - ITT Population|Other|0|||
16347080|NCT01249417|39757396|FG002|Treatment Phase - ITT Population|Other|1|||
16347081|NCT01249417|39757394|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
16347082|NCT01249417|39757395|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
16347083|NCT01249417|39757396|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
16347084|NCT01249417|39757394|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
16347085|NCT01249417|39757395|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
16347086|NCT01249417|39757396|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
16347087|NCT01249417|39757394|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
16347088|NCT01249417|39757395|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
16347089|NCT01249417|39757396|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
16347090|NCT05225389|39757400|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
16347091|NCT02581488|39757403|FG000|Overall Study|Adverse Event|6|||
16347092|NCT02581488|39757404|FG001|Overall Study|Adverse Event|7|||
16347093|NCT02581488|39757403|FG000|Overall Study|Lost to Follow-up|1|||
16347094|NCT02581488|39757404|FG001|Overall Study|Lost to Follow-up|0|||
16347095|NCT02581488|39757403|FG000|Overall Study|Withdrawal by Subject|1|||
16347096|NCT02581488|39757404|FG001|Overall Study|Withdrawal by Subject|0|||
16347097|NCT02581488|39757403|FG000|Overall Study|Non-Compliance|1|||
16347098|NCT02581488|39757404|FG001|Overall Study|Non-Compliance|0|||
16347099|NCT02581488|39757403|FG000|Overall Study|Protocol Violation|0|||
16347100|NCT02581488|39757404|FG001|Overall Study|Protocol Violation|4|||
16347101|NCT01854697|39757405|FG000|Overall Study|Adverse Event|1|||
16347102|NCT01854697|39757406|FG001|Overall Study|Adverse Event|0|||
16347103|NCT01854697|39757407|FG002|Overall Study|Adverse Event|0|||
16347104|NCT01854697|39757408|FG003|Overall Study|Adverse Event|0|||
16347105|NCT01854697|39757409|FG004|Overall Study|Adverse Event|1|||
16347106|NCT01854697|39757405|FG000|Overall Study|Lost to Follow-up|4|||
16347107|NCT01854697|39757406|FG001|Overall Study|Lost to Follow-up|1|||
16347108|NCT01854697|39757407|FG002|Overall Study|Lost to Follow-up|1|||
16347109|NCT01854697|39757408|FG003|Overall Study|Lost to Follow-up|2|||
16347110|NCT01854697|39757409|FG004|Overall Study|Lost to Follow-up|0|||
16347111|NCT01854697|39757405|FG000|Overall Study|To enter another AbbVie study|1|||
16347112|NCT01854697|39757406|FG001|Overall Study|To enter another AbbVie study|0|||
16347113|NCT01854697|39757407|FG002|Overall Study|To enter another AbbVie study|0|||
16347114|NCT01854697|39757408|FG003|Overall Study|To enter another AbbVie study|0|||
16347115|NCT01854697|39757409|FG004|Overall Study|To enter another AbbVie study|1|||
16347116|NCT01854697|39757405|FG000|Overall Study|Withdrew Consent|0|||
16347117|NCT01854697|39757406|FG001|Overall Study|Withdrew Consent|1|||
16347118|NCT01854697|39757407|FG002|Overall Study|Withdrew Consent|0|||
16347119|NCT01854697|39757408|FG003|Overall Study|Withdrew Consent|1|||
16347120|NCT01854697|39757409|FG004|Overall Study|Withdrew Consent|0|||
16347121|NCT01854697|39757405|FG000|Overall Study|Other|0|||
16347122|NCT01854697|39757406|FG001|Overall Study|Other|1|||
16347123|NCT01854697|39757407|FG002|Overall Study|Other|1|||
16347124|NCT01854697|39757408|FG003|Overall Study|Other|0|||
16347125|NCT01854697|39757409|FG004|Overall Study|Other|0|||
16347126|NCT00385918|39757410|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
16347127|NCT00385918|39757411|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
16347128|NCT00385918|39757412|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
16347129|NCT00385918|39757410|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
16347130|NCT00385918|39757411|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
16547763|NCT03342053|40467744|FG000|Overall Study|Withdrawal by Subject|0|||
16347131|NCT00385918|39757412|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
16347132|NCT00385918|39757410|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
16347133|NCT00385918|39757411|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
16347134|NCT00385918|39757412|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
16347135|NCT00385918|39757410|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
16347136|NCT00385918|39757411|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
16347137|NCT00385918|39757412|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
16347138|NCT00385918|39757410|FG000|Intervention Phase After Randomization|Physician Decision|1|||
16347139|NCT00385918|39757411|FG001|Intervention Phase After Randomization|Physician Decision|0|||
16347140|NCT00385918|39757412|FG002|Intervention Phase After Randomization|Physician Decision|0|||
16347141|NCT00385918|39757410|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
16347142|NCT00385918|39757411|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
16347143|NCT00385918|39757412|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
16347144|NCT03479008|39757413|FG000|Overall Study|Withdrawal by Subject|3|||
16347145|NCT00618826|39757415|FG000|Overall Study|Adverse Event|1|||
16347146|NCT02630563|39757416|FG000|Overall Study|Administrative|1|||
16347147|NCT03339713|39757417|FG000|Overall Study|Lost to Follow-up|2|||
16347148|NCT03339713|39757418|FG001|Overall Study|Lost to Follow-up|1|||
16347149|NCT03339713|39757417|FG000|Overall Study|Protocol Violation|1|||
16347150|NCT03339713|39757418|FG001|Overall Study|Protocol Violation|0|||
16347151|NCT03339713|39757417|FG000|Overall Study|Withdrawal by Subject|1|||
16347152|NCT03339713|39757418|FG001|Overall Study|Withdrawal by Subject|1|||
16347153|NCT03654729|39757419|FG000|Overall Study|Death|9|||
16347154|NCT03654729|39757420|FG001|Overall Study|Death|9|||
16347155|NCT03654729|39757421|FG002|Overall Study|Death|16|||
16347156|NCT03654729|39757419|FG000|Overall Study|Withdrawal by Subject|8|||
16347157|NCT03654729|39757420|FG001|Overall Study|Withdrawal by Subject|6|||
16347158|NCT03654729|39757421|FG002|Overall Study|Withdrawal by Subject|4|||
16347159|NCT03654729|39757419|FG000|Overall Study|Study terminated by Sponsor|3|||
16347160|NCT03654729|39757420|FG001|Overall Study|Study terminated by Sponsor|5|||
16347161|NCT03654729|39757421|FG002|Overall Study|Study terminated by Sponsor|4|||
16347162|NCT03654729|39757419|FG000|Overall Study|Not reported|2|||
16347163|NCT03654729|39757420|FG001|Overall Study|Not reported|4|||
16347164|NCT03654729|39757421|FG002|Overall Study|Not reported|5|||
16347165|NCT03654729|39757419|FG000|Overall Study|Progressive disease|3|||
16347166|NCT03654729|39757420|FG001|Overall Study|Progressive disease|0|||
16347167|NCT03654729|39757421|FG002|Overall Study|Progressive disease|0|||
16347168|NCT03654729|39757419|FG000|Overall Study|Lost to Follow-up|2|||
16347169|NCT03654729|39757420|FG001|Overall Study|Lost to Follow-up|0|||
16347170|NCT03654729|39757421|FG002|Overall Study|Lost to Follow-up|0|||
16347171|NCT03654729|39757419|FG000|Overall Study|Physician Decision|2|||
16347172|NCT03654729|39757420|FG001|Overall Study|Physician Decision|0|||
16347173|NCT03654729|39757421|FG002|Overall Study|Physician Decision|0|||
16347174|NCT03654729|39757419|FG000|Overall Study|Protocol Violation|1|||
16347175|NCT03654729|39757420|FG001|Overall Study|Protocol Violation|1|||
16347176|NCT03654729|39757421|FG002|Overall Study|Protocol Violation|0|||
16347177|NCT03654729|39757419|FG000|Overall Study|Non-compliance with study drug|0|||
16347178|NCT03654729|39757420|FG001|Overall Study|Non-compliance with study drug|1|||
16347179|NCT03654729|39757421|FG002|Overall Study|Non-compliance with study drug|0|||
16347180|NCT03654729|39757419|FG000|Overall Study|Site terminated by Sponsor|1|||
16347181|NCT03654729|39757420|FG001|Overall Study|Site terminated by Sponsor|0|||
16347182|NCT03654729|39757421|FG002|Overall Study|Site terminated by Sponsor|0|||
16347183|NCT02090283|39757422|FG000|Overall Study|Withdrawal by Subject|6|||
16347184|NCT02090283|39757423|FG001|Overall Study|Withdrawal by Subject|6|||
16347185|NCT02090283|39757424|FG002|Overall Study|Withdrawal by Subject|6|||
16347186|NCT02090283|39757422|FG000|Overall Study|Sponsor Terminated Study|6|||
16347187|NCT02090283|39757423|FG001|Overall Study|Sponsor Terminated Study|6|||
16347188|NCT02090283|39757424|FG002|Overall Study|Sponsor Terminated Study|1|||
16347189|NCT02090283|39757422|FG000|Overall Study|Lost to Follow-up|2|||
16347190|NCT02090283|39757423|FG001|Overall Study|Lost to Follow-up|2|||
16410698|NCT00590824|39985564|FG003|Overall Study|Disease could not be resected|0|||
16410699|NCT00590824|39985561|FG000|Overall Study|Adverse Event|0|||
16410700|NCT00590824|39985562|FG001|Overall Study|Adverse Event|0|||
16410701|NCT00590824|39985563|FG002|Overall Study|Adverse Event|0|||
16410702|NCT00590824|39985564|FG003|Overall Study|Adverse Event|1|||
16347191|NCT02090283|39757424|FG002|Overall Study|Lost to Follow-up|3|||
16347192|NCT02090283|39757422|FG000|Overall Study|Adverse Event|1|||
16347193|NCT02090283|39757423|FG001|Overall Study|Adverse Event|1|||
16347194|NCT02090283|39757424|FG002|Overall Study|Adverse Event|0|||
16347195|NCT02090283|39757422|FG000|Overall Study|Protocol Violation|2|||
16347196|NCT02090283|39757423|FG001|Overall Study|Protocol Violation|0|||
16347197|NCT02090283|39757424|FG002|Overall Study|Protocol Violation|0|||
16347198|NCT01254656|39757425|FG000|Overall Study|Discontinued due to termination of study|40|||
16347199|NCT01254656|39757426|FG001|Overall Study|Discontinued due to termination of study|39|||
16347200|NCT01254656|39757427|FG002|Overall Study|Discontinued due to termination of study|13|||
16347201|NCT01254656|39757425|FG000|Overall Study|Lack of Efficacy|3|||
16347202|NCT01254656|39757426|FG001|Overall Study|Lack of Efficacy|0|||
16410703|NCT03987932|39985565|FG000|Overall Study|Lost to Follow-up|2|||
16347203|NCT01254656|39757427|FG002|Overall Study|Lack of Efficacy|0|||
16547764|NCT03342053|40467745|FG001|Overall Study|Withdrawal by Subject|1|||
16547765|NCT03704584|40467748|FG000|Overall Study|Withdrawal by Subject|1|||
16410704|NCT03987932|39985566|FG001|Overall Study|Lost to Follow-up|1|||
16410705|NCT03987932|39985567|FG002|Overall Study|Lost to Follow-up|1|||
16410706|NCT03987932|39985565|FG000|Overall Study|Non-study related elective surgery|0|||
16410707|NCT03987932|39985566|FG001|Overall Study|Non-study related elective surgery|0|||
16347204|NCT01254656|39757425|FG000|Overall Study|Lost to Follow-up|1|||
16347205|NCT01254656|39757426|FG001|Overall Study|Lost to Follow-up|0|||
16410708|NCT03987932|39985567|FG002|Overall Study|Non-study related elective surgery|1|||
16410709|NCT02982018|39985568|FG000|Overall Study|Incorrect Lens Dispensed|1|||
16410710|NCT02982018|39985569|FG001|Overall Study|Incorrect Lens Dispensed|0|||
16410711|NCT02982018|39985568|FG000|Overall Study|Protocol Violation|1|||
16410712|NCT02982018|39985569|FG001|Overall Study|Protocol Violation|1|||
16410713|NCT02982018|39985568|FG000|Overall Study|Adverse Event|1|||
16410714|NCT02982018|39985569|FG001|Overall Study|Adverse Event|1|||
16410715|NCT02982018|39985568|FG000|Overall Study|Lens Discomfort|2|||
16410716|NCT02982018|39985569|FG001|Overall Study|Lens Discomfort|0|||
16410717|NCT02982018|39985568|FG000|Overall Study|Withdrawal by Subject|0|||
16410718|NCT02982018|39985569|FG001|Overall Study|Withdrawal by Subject|1|||
16410719|NCT02066415|39985570|FG000|Overall Study|Decision by Sponsor|5|||
16410720|NCT02066415|39985571|FG001|Overall Study|Decision by Sponsor|4|||
16410721|NCT02066415|39985572|FG002|Overall Study|Decision by Sponsor|2|||
16410722|NCT02066415|39985570|FG000|Overall Study|Withdrawal by Subject|9|||
16410723|NCT02066415|39985571|FG001|Overall Study|Withdrawal by Subject|1|||
16410724|NCT02066415|39985572|FG002|Overall Study|Withdrawal by Subject|4|||
16547766|NCT03704584|40467749|FG001|Overall Study|Withdrawal by Subject|0|||
16114943|NCT01053247|38906223|FG000|Overall Study|Protocol Violation|2|||
16114944|NCT01053247|38906224|FG001|Overall Study|Protocol Violation|1|||
16114945|NCT01053247|38906225|FG002|Overall Study|Protocol Violation|2|||
16347206|NCT01254656|39757427|FG002|Overall Study|Lost to Follow-up|2|||
16347207|NCT01254656|39757425|FG000|Overall Study|Withdrawal by Subject|2|||
16347208|NCT01254656|39757426|FG001|Overall Study|Withdrawal by Subject|2|||
16347209|NCT01254656|39757427|FG002|Overall Study|Withdrawal by Subject|1|||
16347210|NCT01254656|39757425|FG000|Overall Study|Pregnancy|0|||
16347211|NCT01254656|39757426|FG001|Overall Study|Pregnancy|0|||
16347212|NCT01254656|39757427|FG002|Overall Study|Pregnancy|2|||
16347213|NCT01254656|39757425|FG000|Overall Study|Adverse Event|1|||
16347214|NCT01254656|39757426|FG001|Overall Study|Adverse Event|1|||
16347215|NCT01254656|39757427|FG002|Overall Study|Adverse Event|0|||
16347216|NCT01254656|39757425|FG000|Overall Study|Death|0|||
16347217|NCT01254656|39757426|FG001|Overall Study|Death|1|||
16347218|NCT01254656|39757427|FG002|Overall Study|Death|0|||
16347219|NCT02227784|39757428|FG000|Double-Blind Phase|Adverse Event|3|||
16347220|NCT02227784|39757429|FG001|Double-Blind Phase|Adverse Event|2|||
16347221|NCT02227784|39757430|FG002|Double-Blind Phase|Adverse Event|1|||
16347222|NCT02227784|39757431|FG003|Double-Blind Phase|Adverse Event|3|||
16347223|NCT02227784|39757432|FG004|Double-Blind Phase|Adverse Event|0|||
16347224|NCT02227784|39757428|FG000|Double-Blind Phase|Physician Decision|1|||
16347225|NCT02227784|39757429|FG001|Double-Blind Phase|Physician Decision|0|||
16347226|NCT02227784|39757430|FG002|Double-Blind Phase|Physician Decision|0|||
16347227|NCT02227784|39757431|FG003|Double-Blind Phase|Physician Decision|1|||
16347228|NCT02227784|39757432|FG004|Double-Blind Phase|Physician Decision|0|||
16347229|NCT02227784|39757428|FG000|Double-Blind Phase|Protocol Violation|0|||
16347230|NCT02227784|39757429|FG001|Double-Blind Phase|Protocol Violation|0|||
16347231|NCT02227784|39757430|FG002|Double-Blind Phase|Protocol Violation|1|||
16347232|NCT02227784|39757431|FG003|Double-Blind Phase|Protocol Violation|1|||
16347233|NCT02227784|39757432|FG004|Double-Blind Phase|Protocol Violation|0|||
16347234|NCT02227784|39757428|FG000|Double-Blind Phase|Sponsor Decision|34|||
16347235|NCT02227784|39757429|FG001|Double-Blind Phase|Sponsor Decision|15|||
16347236|NCT02227784|39757430|FG002|Double-Blind Phase|Sponsor Decision|14|||
16347237|NCT02227784|39757431|FG003|Double-Blind Phase|Sponsor Decision|32|||
16347238|NCT02227784|39757432|FG004|Double-Blind Phase|Sponsor Decision|0|||
16347239|NCT02227784|39757428|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
16114946|NCT01053247|38906223|FG000|Overall Study|Lost to Follow-up|8|||
16347240|NCT02227784|39757429|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
16347241|NCT02227784|39757430|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
16347242|NCT02227784|39757431|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
16410725|NCT02066415|39985570|FG000|Overall Study|Lost to Follow-up|7|||
16410726|NCT02066415|39985571|FG001|Overall Study|Lost to Follow-up|2|||
16547767|NCT03406702|40470775|FG000|Overall Study|Missed Day 27 Dosing|1|||
16347243|NCT02227784|39757432|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
16347244|NCT02227784|39757428|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
16347245|NCT02227784|39757429|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
16347246|NCT02227784|39757430|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
16347247|NCT02227784|39757431|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
16410727|NCT02066415|39985572|FG002|Overall Study|Lost to Follow-up|2|||
16347248|NCT02227784|39757432|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
16347249|NCT02227784|39757428|FG000|Open-Label Extension Phase (OLE)|Death|0|||
16347250|NCT02227784|39757429|FG001|Open-Label Extension Phase (OLE)|Death|0|||
16347251|NCT02227784|39757430|FG002|Open-Label Extension Phase (OLE)|Death|0|||
16347252|NCT02227784|39757431|FG003|Open-Label Extension Phase (OLE)|Death|0|||
16347253|NCT02227784|39757432|FG004|Open-Label Extension Phase (OLE)|Death|1|||
16347254|NCT02227784|39757428|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
16347255|NCT02227784|39757429|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
16347256|NCT02227784|39757430|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
16347257|NCT02227784|39757431|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
16347258|NCT02227784|39757432|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
16347259|NCT02227784|39757428|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
16347260|NCT02227784|39757429|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
16347261|NCT02227784|39757430|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
16347262|NCT02227784|39757431|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
16347263|NCT02227784|39757432|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
16347264|NCT04235504|39757436|FG000|Study Phase|Withdrawal by Subject|5|||
16347265|NCT04235504|39757437|FG001|Study Phase|Withdrawal by Subject|2|||
16347266|NCT04235504|39757438|FG002|Study Phase|Withdrawal by Subject|0|||
16347267|NCT04235504|39757439|FG003|Study Phase|Withdrawal by Subject|0|||
16347268|NCT04235504|39757436|FG000|Continuation Phase|Withdrawal by Subject|0|||
16347269|NCT04235504|39757437|FG001|Continuation Phase|Withdrawal by Subject|4|||
16347270|NCT04235504|39757438|FG002|Continuation Phase|Withdrawal by Subject|0|||
16347271|NCT04235504|39757439|FG003|Continuation Phase|Withdrawal by Subject|0|||
16347272|NCT04235504|39757436|FG000|Continuation Phase|Adverse Event|0|||
16347273|NCT04235504|39757437|FG001|Continuation Phase|Adverse Event|1|||
16347274|NCT04235504|39757438|FG002|Continuation Phase|Adverse Event|0|||
16347275|NCT04235504|39757439|FG003|Continuation Phase|Adverse Event|0|||
16347276|NCT04235504|39757436|FG000|Continuation Phase|Physician Decision|1|||
16114947|NCT01053247|38906224|FG001|Overall Study|Lost to Follow-up|5|||
16114948|NCT01053247|38906225|FG002|Overall Study|Lost to Follow-up|7|||
16347277|NCT04235504|39757437|FG001|Continuation Phase|Physician Decision|2|||
16347278|NCT04235504|39757438|FG002|Continuation Phase|Physician Decision|1|||
16347279|NCT04235504|39757439|FG003|Continuation Phase|Physician Decision|0|||
16347280|NCT00784719|39757440|FG000|Overall Study|Adverse Event|0|||
16347281|NCT00784719|39757441|FG001|Overall Study|Adverse Event|2|||
16347282|NCT00784719|39757442|FG002|Overall Study|Adverse Event|0|||
16347283|NCT00784719|39757443|FG003|Overall Study|Adverse Event|0|||
16347284|NCT00784719|39757444|FG004|Overall Study|Adverse Event|1|||
16347285|NCT00784719|39757445|FG005|Overall Study|Adverse Event|1|||
16347286|NCT00784719|39757446|FG006|Overall Study|Adverse Event|1|||
16347287|NCT00784719|39757440|FG000|Overall Study|Lost to Follow-up|0|||
16347288|NCT00784719|39757441|FG001|Overall Study|Lost to Follow-up|0|||
16347289|NCT00784719|39757442|FG002|Overall Study|Lost to Follow-up|0|||
16347290|NCT00784719|39757443|FG003|Overall Study|Lost to Follow-up|0|||
16347291|NCT00784719|39757444|FG004|Overall Study|Lost to Follow-up|1|||
16347292|NCT00784719|39757445|FG005|Overall Study|Lost to Follow-up|1|||
16347293|NCT00784719|39757446|FG006|Overall Study|Lost to Follow-up|0|||
16347294|NCT00784719|39757440|FG000|Overall Study|Other|2|||
16347295|NCT00784719|39757441|FG001|Overall Study|Other|1|||
16347296|NCT00784719|39757442|FG002|Overall Study|Other|1|||
16347297|NCT00784719|39757443|FG003|Overall Study|Other|0|||
16347298|NCT00784719|39757444|FG004|Overall Study|Other|2|||
16347299|NCT00784719|39757445|FG005|Overall Study|Other|1|||
16347300|NCT00784719|39757446|FG006|Overall Study|Other|3|||
16347301|NCT00784719|39757440|FG000|Overall Study|Withdrawal by Subject|1|||
16347302|NCT00784719|39757441|FG001|Overall Study|Withdrawal by Subject|0|||
16347303|NCT00784719|39757442|FG002|Overall Study|Withdrawal by Subject|0|||
16347304|NCT00784719|39757443|FG003|Overall Study|Withdrawal by Subject|0|||
16347305|NCT00784719|39757444|FG004|Overall Study|Withdrawal by Subject|2|||
16347306|NCT00784719|39757445|FG005|Overall Study|Withdrawal by Subject|0|||
16347307|NCT00784719|39757446|FG006|Overall Study|Withdrawal by Subject|1|||
16347308|NCT00588146|39757447|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
16347309|NCT00588146|39757448|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
16347310|NCT01166750|39757449|FG000|Overall Study|Lost to Follow-up|1|||
16347311|NCT01166750|39757450|FG001|Overall Study|Lost to Follow-up|0|||
16347312|NCT02420119|39757453|FG000|Overall Study|insufficient laboratory data|5|||
16347313|NCT00770913|39757454|FG000|Overall Study|Adverse Event|1|||
16347314|NCT00770913|39757455|FG001|Overall Study|Adverse Event|3|||
16347315|NCT00770913|39757456|FG002|Overall Study|Adverse Event|6|||
16347316|NCT00770913|39757454|FG000|Overall Study|Refusal to continue participation|6|||
16347317|NCT00770913|39757455|FG001|Overall Study|Refusal to continue participation|4|||
16347318|NCT00770913|39757456|FG002|Overall Study|Refusal to continue participation|5|||
16347319|NCT00770913|39757454|FG000|Overall Study|Physician Decision|0|||
16347320|NCT00770913|39757455|FG001|Overall Study|Physician Decision|1|||
16347321|NCT00770913|39757456|FG002|Overall Study|Physician Decision|1|||
16410728|NCT01369680|39985575|FG000|Overall Study|Lost to Follow-up|0|||
16347322|NCT00770913|39757454|FG000|Overall Study|Protocol Violation|3|||
16347323|NCT00770913|39757455|FG001|Overall Study|Protocol Violation|0|||
16347324|NCT00770913|39757456|FG002|Overall Study|Protocol Violation|1|||
16347325|NCT00770913|39757454|FG000|Overall Study|Incorrect drug was allocated|1|||
16347326|NCT00770913|39757455|FG001|Overall Study|Incorrect drug was allocated|0|||
16347327|NCT00770913|39757456|FG002|Overall Study|Incorrect drug was allocated|0|||
16347328|NCT03283930|39757457|FG000|Overall Study|Scheduling conflict|8|||
16347329|NCT03283930|39757458|FG001|Overall Study|Scheduling conflict|10|||
16347330|NCT03283930|39757457|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
16347331|NCT03283930|39757458|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
16347332|NCT03283930|39757457|FG000|Overall Study|Technical software issue|2|||
16347333|NCT03283930|39757458|FG001|Overall Study|Technical software issue|2|||
16347334|NCT02998151|39757461|FG000|Overall Study|Withdrawal by Subject|3|||
16347335|NCT02998151|39757461|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
16347336|NCT02998151|39757461|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
16347337|NCT04966741|39757464|FG000|Overall Study|Lost to Follow-up|1|||
16347338|NCT04966741|39757465|FG001|Overall Study|Lost to Follow-up|0|||
16347339|NCT00196105|39757466|FG000|Overall Study|Lost to Follow-up|4|||
16347340|NCT00196105|39757467|FG001|Overall Study|Lost to Follow-up|5|||
16347341|NCT00196105|39757468|FG002|Overall Study|Lost to Follow-up|7|||
16347342|NCT00369343|39757469|FG000|Double-blind Phase|Adverse Event|19|||
16114949|NCT01053247|38906223|FG000|Overall Study|Adverse Event|0|||
16114950|NCT01053247|38906224|FG001|Overall Study|Adverse Event|9|||
16114951|NCT01053247|38906225|FG002|Overall Study|Adverse Event|3|||
16114952|NCT01399918|38906226|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
16114953|NCT02563548|38909522|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
16114954|NCT02563548|38909523|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
16114955|NCT02563548|38909524|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
16114956|NCT02563548|38909525|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
16114957|NCT02563548|38909526|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
16114958|NCT02563548|38909527|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
16114959|NCT02563548|38909522|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
16114960|NCT02563548|38909523|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
16114961|NCT02563548|38909524|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
16114962|NCT02563548|38909525|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
16114963|NCT02563548|38909526|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
16114964|NCT02563548|38909527|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
16114965|NCT02563548|38909522|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
16114966|NCT02563548|38909523|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
16114967|NCT02563548|38909524|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
16114968|NCT02563548|38909525|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
16225906|NCT00553319|39306274|FG000|Overall Study|moved|1|||
16347343|NCT00369343|39757470|FG001|Double-blind Phase|Adverse Event|4|||
16347344|NCT00369343|39757469|FG000|Double-blind Phase|Failed to return|2|||
16347345|NCT00369343|39757470|FG001|Double-blind Phase|Failed to return|0|||
16347346|NCT00369343|39757469|FG000|Double-blind Phase|Lost to Follow-up|9|||
16347347|NCT00369343|39757470|FG001|Double-blind Phase|Lost to Follow-up|2|||
16347348|NCT00369343|39757469|FG000|Double-blind Phase|Protocol Violation|2|||
16347349|NCT00369343|39757470|FG001|Double-blind Phase|Protocol Violation|0|||
16347350|NCT00369343|39757469|FG000|Double-blind Phase|Withdrawal by Subject|8|||
16347351|NCT00369343|39757470|FG001|Double-blind Phase|Withdrawal by Subject|6|||
16347352|NCT00369343|39757469|FG000|Double-blind Phase|Lack of Efficacy|0|||
16347353|NCT00369343|39757470|FG001|Double-blind Phase|Lack of Efficacy|4|||
16347354|NCT00369343|39757469|FG000|Double-blind Phase|Protocol deviation|4|||
16347355|NCT00369343|39757470|FG001|Double-blind Phase|Protocol deviation|0|||
16347356|NCT00369343|39757469|FG000|Open-label Phase|Adverse Event|19|||
16347357|NCT00369343|39757470|FG001|Open-label Phase|Adverse Event|7|||
16347358|NCT00369343|39757469|FG000|Open-label Phase|Failed to return|4|||
16347359|NCT00369343|39757470|FG001|Open-label Phase|Failed to return|0|||
16347360|NCT00369343|39757469|FG000|Open-label Phase|Physician Decision|2|||
16347361|NCT00369343|39757470|FG001|Open-label Phase|Physician Decision|0|||
16347362|NCT00369343|39757469|FG000|Open-label Phase|Lost to Follow-up|5|||
16347363|NCT00369343|39757470|FG001|Open-label Phase|Lost to Follow-up|3|||
16347364|NCT00369343|39757469|FG000|Open-label Phase|inadvertently reported study completers|3|||
16347365|NCT00369343|39757470|FG001|Open-label Phase|inadvertently reported study completers|2|||
16347366|NCT00369343|39757469|FG000|Open-label Phase|Protocol Violation|1|||
16347367|NCT00369343|39757470|FG001|Open-label Phase|Protocol Violation|3|||
16347368|NCT00369343|39757469|FG000|Open-label Phase|Withdrawal by Subject|15|||
16347369|NCT00369343|39757470|FG001|Open-label Phase|Withdrawal by Subject|6|||
16347370|NCT00369343|39757469|FG000|Open-label Phase|Lack of Efficacy|4|||
16347371|NCT00369343|39757470|FG001|Open-label Phase|Lack of Efficacy|3|||
16347372|NCT00369343|39757469|FG000|Open-label Phase|Lack of continuance tolerability|3|||
16347373|NCT00369343|39757470|FG001|Open-label Phase|Lack of continuance tolerability|4|||
16410729|NCT01369680|39985576|FG001|Overall Study|Lost to Follow-up|0|||
16410730|NCT01369680|39985577|FG002|Overall Study|Lost to Follow-up|1|||
16410731|NCT01369680|39985578|FG003|Overall Study|Lost to Follow-up|2|||
16410732|NCT02513823|39985579|FG000|Overall Study|Lost to Follow-up|4|||
16410733|NCT02513823|39985579|FG000|Overall Study|Physician Decision|1|||
16410734|NCT03285958|39985580|FG000|Overall Study|Lost to Follow-up|1|||
16410735|NCT03285958|39985581|FG001|Overall Study|Lost to Follow-up|1|||
16410736|NCT03285958|39985580|FG000|Overall Study|Withdrawal by Subject|1|||
16410737|NCT03285958|39985581|FG001|Overall Study|Withdrawal by Subject|0|||
16410738|NCT03285958|39985580|FG000|Overall Study|Not able to attend required orientation|3|||
16410739|NCT03285958|39985581|FG001|Overall Study|Not able to attend required orientation|0|||
16410740|NCT03662659|39985582|FG000|Pre-treatment|Participant no longer met study criteria|1|||
16410741|NCT03662659|39985583|FG001|Pre-treatment|Participant no longer met study criteria|1|||
16410742|NCT03662659|39985582|FG000|Pre-treatment|Other reasons|1|||
16410743|NCT03662659|39985583|FG001|Pre-treatment|Other reasons|0|||
16410744|NCT03662659|39985582|FG000|Treatment|Completed Treatment|0|||
16410745|NCT03662659|39985583|FG001|Treatment|Completed Treatment|3|||
16410746|NCT03662659|39985582|FG000|Treatment|Disease Progression|69|||
16410747|NCT03662659|39985583|FG001|Treatment|Disease Progression|78|||
16410748|NCT03662659|39985582|FG000|Treatment|Study Drug Toxicity|18|||
16410749|NCT03662659|39985583|FG001|Treatment|Study Drug Toxicity|8|||
16410750|NCT03662659|39985582|FG000|Treatment|Death|12|||
16410751|NCT03662659|39985583|FG001|Treatment|Death|7|||
16410752|NCT03662659|39985582|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
16410753|NCT03662659|39985583|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
16410754|NCT03662659|39985582|FG000|Treatment|Withdrawal by Subject|1|||
16410755|NCT03662659|39985583|FG001|Treatment|Withdrawal by Subject|1|||
16410756|NCT03662659|39985582|FG000|Treatment|Poor/Non-compliance|1|||
16410757|NCT03662659|39985583|FG001|Treatment|Poor/Non-compliance|0|||
16410758|NCT03662659|39985582|FG000|Treatment|Participant no longer meets study criteria|1|||
16410759|NCT03662659|39985583|FG001|Treatment|Participant no longer meets study criteria|0|||
16410760|NCT03662659|39985582|FG000|Treatment|Other reasons|6|||
16410761|NCT03662659|39985583|FG001|Treatment|Other reasons|5|||
16410762|NCT00445939|39985584|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
16410763|NCT00445939|39985585|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
16410764|NCT00445939|39985586|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
16410765|NCT00445939|39985587|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
16410766|NCT00445939|39985584|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
16410767|NCT00445939|39985585|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
16410768|NCT00445939|39985586|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
16410769|NCT00445939|39985587|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
16410770|NCT02421601|39985588|FG000|Overall Study|Adverse Event|4|||
16410771|NCT02421601|39985588|FG000|Overall Study|Lack of Efficacy|5|||
16410772|NCT02421601|39985588|FG000|Overall Study|Physician Decision|1|||
16410773|NCT02421601|39985588|FG000|Overall Study|Withdrawal by Subject|31|||
16410774|NCT02421601|39985588|FG000|Overall Study|Others|41|||
16410775|NCT02966795|39985589|FG000|Overall Study|Patient Left the Country|0|||
16410776|NCT02966795|39985590|FG001|Overall Study|Patient Left the Country|1|||
16410777|NCT02699450|39985593|FG000|Overall Study|Death|2|||
16410778|NCT02699450|39985594|FG001|Overall Study|Death|1|||
16410779|NCT02699450|39985595|FG002|Overall Study|Death|2|||
16410780|NCT02699450|39985593|FG000|Overall Study|Met Criteria for Study Exit|0|||
16410781|NCT02699450|39985594|FG001|Overall Study|Met Criteria for Study Exit|0|||
16410782|NCT02699450|39985595|FG002|Overall Study|Met Criteria for Study Exit|1|||
16410783|NCT02699450|39985593|FG000|Overall Study|Protocol Violation|4|||
16410784|NCT02699450|39985594|FG001|Overall Study|Protocol Violation|3|||
16410785|NCT02699450|39985595|FG002|Overall Study|Protocol Violation|5|||
16410786|NCT02699450|39985593|FG000|Overall Study|Lost to Follow-up|3|||
16410787|NCT02699450|39985594|FG001|Overall Study|Lost to Follow-up|0|||
16410788|NCT02699450|39985595|FG002|Overall Study|Lost to Follow-up|5|||
16410789|NCT02699450|39985593|FG000|Overall Study|Physician Decision|2|||
16410790|NCT02699450|39985594|FG001|Overall Study|Physician Decision|0|||
16410791|NCT02699450|39985595|FG002|Overall Study|Physician Decision|0|||
16410792|NCT02699450|39985593|FG000|Overall Study|Withdrawal by Subject|3|||
16410793|NCT02699450|39985594|FG001|Overall Study|Withdrawal by Subject|1|||
16410794|NCT02699450|39985595|FG002|Overall Study|Withdrawal by Subject|2|||
16410795|NCT02699450|39985593|FG000|Overall Study|Adverse Event|1|||
16547768|NCT01672853|40470776|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
16547769|NCT01672853|40470777|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
16547770|NCT01672853|40470778|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
16410796|NCT02699450|39985594|FG001|Overall Study|Adverse Event|0|||
16410797|NCT02699450|39985595|FG002|Overall Study|Adverse Event|0|||
16410798|NCT01253265|39985598|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
16410799|NCT01253265|39985599|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
16410800|NCT01253265|39985600|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
16410801|NCT01253265|39985601|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
16410802|NCT01253265|39985602|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
16114969|NCT02563548|38909526|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
16114970|NCT02563548|38909527|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
16114971|NCT02563548|38909522|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
16114972|NCT02563548|38909523|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
16114973|NCT02563548|38909524|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
16114974|NCT02563548|38909525|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
16114975|NCT02563548|38909526|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
16114976|NCT02563548|38909527|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
16114977|NCT02563548|38909522|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
16114978|NCT02563548|38909523|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
16114979|NCT02563548|38909524|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
16114980|NCT02563548|38909525|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
16114981|NCT02563548|38909526|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
16114982|NCT02563548|38909527|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
16114983|NCT02563548|38909522|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
16114984|NCT02563548|38909523|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
16114985|NCT02563548|38909524|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
16114986|NCT02563548|38909525|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
16114987|NCT02563548|38909526|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
16114988|NCT02563548|38909527|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
16114989|NCT02563548|38909522|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
16114990|NCT02563548|38909523|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
16114991|NCT02563548|38909524|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
16114992|NCT02563548|38909525|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
16114993|NCT02563548|38909526|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
16114994|NCT02563548|38909527|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
16114995|NCT02563548|38909522|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
16114996|NCT02563548|38909523|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
16114997|NCT02563548|38909524|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
16114998|NCT02563548|38909525|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
16114999|NCT02563548|38909526|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
16115000|NCT02563548|38909527|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
16115001|NCT02563548|38909522|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
16115002|NCT02563548|38909523|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
16115003|NCT02563548|38909524|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
16115004|NCT02563548|38909525|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
16115005|NCT02563548|38909526|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
16115006|NCT02563548|38909527|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
16115007|NCT02563548|38909522|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
16115008|NCT02563548|38909523|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
16115009|NCT02563548|38909524|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
16115010|NCT02563548|38909525|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
16115011|NCT02563548|38909526|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
16115012|NCT02563548|38909527|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
16115013|NCT02563548|38909522|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
16115014|NCT02563548|38909523|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
16115015|NCT02563548|38909524|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
16115016|NCT02563548|38909525|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
16115017|NCT02563548|38909526|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
16115018|NCT02563548|38909527|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
16115019|NCT02563548|38909522|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
16115020|NCT02563548|38909523|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
16115021|NCT02563548|38909524|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
16115022|NCT02563548|38909525|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
16115023|NCT02563548|38909526|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
16115024|NCT02563548|38909527|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
16115025|NCT00455741|38909528|FG000|Overall Study|Physician Decision|0|||
16115026|NCT00455741|38909529|FG001|Overall Study|Physician Decision|1|||
16115027|NCT01721954|38909530|FG000|Overall Study|Death|58|||
16115028|NCT01721954|38909531|FG001|Overall Study|Death|64|||
16115029|NCT01721954|38909530|FG000|Overall Study|Withdrawal by Subject|8|||
16115030|NCT01721954|38909531|FG001|Overall Study|Withdrawal by Subject|4|||
16115031|NCT01721954|38909530|FG000|Overall Study|Adverse Event|2|||
16115032|NCT01721954|38909531|FG001|Overall Study|Adverse Event|0|||
16115033|NCT01721954|38909530|FG000|Overall Study|Lost to Follow-up|2|||
16115034|NCT01721954|38909531|FG001|Overall Study|Lost to Follow-up|1|||
16115035|NCT00340704|38909532|FG000|PK Study|Adverse Event|0|||
16225907|NCT00553319|39306275|FG001|Overall Study|moved|0|||
16410803|NCT01253265|39985598|FG000|Overall Study|Withdrawal by Subject|0|||
16547771|NCT01672853|40470776|FG000|Overall Study|Pregnancy|0|||
16547772|NCT01672853|40470777|FG001|Overall Study|Pregnancy|1|||
16547773|NCT01672853|40470778|FG002|Overall Study|Pregnancy|0|||
16547774|NCT01672853|40470776|FG000|Overall Study|Investigator's Discretion|1|||
16547775|NCT01672853|40470777|FG001|Overall Study|Investigator's Discretion|0|||
16547776|NCT01672853|40470778|FG002|Overall Study|Investigator's Discretion|0|||
16547777|NCT01672853|40470776|FG000|Overall Study|Withdrew Consent|5|||
16547778|NCT01672853|40470777|FG001|Overall Study|Withdrew Consent|5|||
16547779|NCT01672853|40470778|FG002|Overall Study|Withdrew Consent|5|||
16547780|NCT01672853|40470776|FG000|Overall Study|Adverse Event|4|||
16547781|NCT01672853|40470777|FG001|Overall Study|Adverse Event|6|||
16547782|NCT01672853|40470778|FG002|Overall Study|Adverse Event|8|||
16547783|NCT01672853|40470776|FG000|Overall Study|Lost to Follow-up|0|||
16547784|NCT01672853|40470777|FG001|Overall Study|Lost to Follow-up|1|||
16547785|NCT01672853|40470778|FG002|Overall Study|Lost to Follow-up|0|||
16547786|NCT01672853|40470776|FG000|Overall Study|Randomized but Never Treated|0|||
16547787|NCT01672853|40470777|FG001|Overall Study|Randomized but Never Treated|0|||
16547788|NCT01672853|40470778|FG002|Overall Study|Randomized but Never Treated|1|||
16547789|NCT00744328|40470783|FG000|Overall Study|Lost to Follow-up|2|||
16547790|NCT00744328|40470784|FG001|Overall Study|Lost to Follow-up|5|||
16225908|NCT00553319|39306276|FG002|Overall Study|moved|1|||
16547791|NCT00744328|40470785|FG002|Overall Study|Lost to Follow-up|3|||
16547792|NCT00744328|40470783|FG000|Overall Study|Withdrawal by Subject|5|||
16547793|NCT00744328|40470784|FG001|Overall Study|Withdrawal by Subject|3|||
16547794|NCT00744328|40470785|FG002|Overall Study|Withdrawal by Subject|4|||
16547795|NCT00744328|40470783|FG000|Overall Study|Found ineligible after randomization|0|||
16225909|NCT05604781|39306277|FG000|Overall Study|Lost to Follow-up|3|||
16225910|NCT05604781|39306277|FG000|Overall Study|Adverse Event|1|||
16225911|NCT02079077|39306278|FG000|Overall Study|Lost to Follow-up|5|||
16225912|NCT02079077|39306279|FG001|Overall Study|Lost to Follow-up|7|||
16225913|NCT02079077|39306278|FG000|Overall Study|Became STIs Positive|1|||
16225914|NCT02079077|39306279|FG001|Overall Study|Became STIs Positive|2|||
16225915|NCT00985114|39306281|FG000|Overall Study|Adverse Event|1|||
16225916|NCT00985114|39306282|FG001|Overall Study|Adverse Event|0|||
16225917|NCT00985114|39306281|FG000|Overall Study|Withdrawal by Subject|0|||
16225918|NCT00985114|39306282|FG001|Overall Study|Withdrawal by Subject|2|||
16225919|NCT03480360|39306283|FG000|Overall Study|Death|2|||
16225920|NCT00186121|39306286|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
16225921|NCT00186121|39306286|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
16225922|NCT00186121|39306286|FG000|Overall Study|Not eligible (no treatment)|1|||
16225923|NCT03370133|39306287|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
16225924|NCT03370133|39306288|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
16225925|NCT03370133|39306289|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
16225926|NCT03370133|39306290|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
16225927|NCT03370133|39306291|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
16225928|NCT03370133|39306292|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
16225929|NCT03370133|39306287|FG000|Initial Treatment Period (WK 16)|Death|1|||
16225930|NCT03370133|39306288|FG001|Initial Treatment Period (WK 16)|Death|1|||
16547796|NCT00744328|40470784|FG001|Overall Study|Found ineligible after randomization|0|||
16547797|NCT00744328|40470785|FG002|Overall Study|Found ineligible after randomization|1|||
16547798|NCT04741802|40470791|FG000|Overall Study|Death|1|||
16547799|NCT04741802|40470791|FG000|Overall Study|Lost to Follow-up|11|||
16547800|NCT01153269|40470793|FG000|Overall Study|Withdrawal by Subject|1|||
16547801|NCT01153269|40470793|FG000|Overall Study|Antiretroviral therapy break|1|||
16547802|NCT04503096|40470799|FG000|Overall Study|Withdrawal by Subject|3|||
16547803|NCT00988221|40470801|FG000|Part I|Adverse Event|0|||
16547804|NCT00988221|40470802|FG001|Part I|Adverse Event|1|||
16547805|NCT00988221|40470803|FG002|Part I|Adverse Event|2|||
16115036|NCT00340704|38909533|FG001|PK Study|Adverse Event|1|||
16115037|NCT00340704|38909534|FG002|PK Study|Adverse Event|0|||
16115038|NCT00340704|38909535|FG003|PK Study|Adverse Event|0|||
16115039|NCT00340704|38909536|FG004|PK Study|Adverse Event|0|||
16115040|NCT00340704|38909537|FG005|PK Study|Adverse Event|0|||
16115041|NCT00340704|38909538|FG006|PK Study|Adverse Event|0|||
16115042|NCT00340704|38909539|FG007|PK Study|Adverse Event|0|||
16115043|NCT00340704|38909540|FG008|PK Study|Adverse Event|0|||
16115044|NCT00340704|38909532|FG000|PK Study|Not treated|0|||
16115045|NCT00340704|38909533|FG001|PK Study|Not treated|0|||
16115046|NCT00340704|38909534|FG002|PK Study|Not treated|1|||
16115047|NCT00340704|38909535|FG003|PK Study|Not treated|0|||
16115048|NCT00340704|38909536|FG004|PK Study|Not treated|0|||
16115049|NCT00340704|38909537|FG005|PK Study|Not treated|0|||
16115050|NCT00340704|38909538|FG006|PK Study|Not treated|0|||
16115051|NCT00340704|38909539|FG007|PK Study|Not treated|0|||
16115052|NCT00340704|38909540|FG008|PK Study|Not treated|0|||
16115053|NCT00340704|38909532|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
16115054|NCT00340704|38909533|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
16115055|NCT00340704|38909534|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
16115056|NCT00340704|38909535|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
16115057|NCT00340704|38909536|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
16115058|NCT00340704|38909537|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
16115059|NCT00340704|38909538|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
16115060|NCT00340704|38909539|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
16115061|NCT00340704|38909540|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
16115062|NCT00340704|38909532|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
16115063|NCT00340704|38909533|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
16115064|NCT00340704|38909534|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
16115065|NCT00340704|38909535|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
16115066|NCT00340704|38909536|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
16115067|NCT00340704|38909537|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
16115068|NCT00340704|38909538|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
16115069|NCT00340704|38909539|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
16115070|NCT00340704|38909540|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
16115071|NCT00340704|38909532|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
16115072|NCT00340704|38909533|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
16115073|NCT00340704|38909534|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
16115074|NCT00340704|38909535|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
16115075|NCT00340704|38909536|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
16115076|NCT00340704|38909537|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
16115077|NCT00340704|38909538|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
16547806|NCT00988221|40470804|FG003|Part I|Adverse Event|0|||
16547807|NCT00988221|40470801|FG000|Part I|Insufficient Therapeutic Response|4|||
16115078|NCT00340704|38909539|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
16115079|NCT00340704|38909540|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
16115080|NCT00340704|38909532|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
16173179|NCT00214461|39111106|FG001|Overall Study|Withdrawal by Subject|0|||
16173180|NCT00214461|39111107|FG002|Overall Study|Withdrawal by Subject|1|||
16173181|NCT00214461|39111108|FG003|Overall Study|Withdrawal by Subject|0|||
16173182|NCT03542682|39111115|FG000|Overall Study|COVID-19 Protocol|0|||
16173183|NCT03542682|39111116|FG001|Overall Study|COVID-19 Protocol|1|||
16547808|NCT00988221|40470802|FG001|Part I|Insufficient Therapeutic Response|6|||
16547809|NCT00988221|40470803|FG002|Part I|Insufficient Therapeutic Response|5|||
16547810|NCT00988221|40470804|FG003|Part I|Insufficient Therapeutic Response|0|||
16547811|NCT00988221|40470801|FG000|Part I|Refused Treatment|0|||
16547812|NCT00988221|40470802|FG001|Part I|Refused Treatment|2|||
16547813|NCT00988221|40470803|FG002|Part I|Refused Treatment|1|||
16547814|NCT00988221|40470804|FG003|Part I|Refused Treatment|0|||
16547815|NCT00988221|40470801|FG000|Part I|Lost to Follow-up|0|||
16547816|NCT00988221|40470802|FG001|Part I|Lost to Follow-up|1|||
16547817|NCT00988221|40470803|FG002|Part I|Lost to Follow-up|0|||
16547818|NCT00988221|40470804|FG003|Part I|Lost to Follow-up|0|||
16547819|NCT00988221|40470801|FG000|Part II|Adverse Event|1|||
16547820|NCT00988221|40470802|FG001|Part II|Adverse Event|0|||
16547821|NCT00988221|40470803|FG002|Part II|Adverse Event|0|||
16547822|NCT00988221|40470804|FG003|Part II|Adverse Event|1|||
16547823|NCT00988221|40470801|FG000|Part II|Withdrawal by Subject|0|||
16547824|NCT00988221|40470802|FG001|Part II|Withdrawal by Subject|0|||
16547825|NCT00988221|40470803|FG002|Part II|Withdrawal by Subject|2|||
16547826|NCT00988221|40470804|FG003|Part II|Withdrawal by Subject|2|||
16547827|NCT00988221|40470801|FG000|Part II|Reason not Specified|0|||
16547828|NCT00988221|40470802|FG001|Part II|Reason not Specified|0|||
16173184|NCT02203149|39111117|FG000|Part 1|Adverse Event|0|||
16173185|NCT02203149|39111118|FG001|Part 1|Adverse Event|1|||
16173186|NCT02203149|39111119|FG002|Part 1|Adverse Event|0|||
16173187|NCT02203149|39111120|FG003|Part 1|Adverse Event|0|||
16173188|NCT02203149|39111121|FG004|Part 1|Adverse Event|0|||
16173189|NCT02203149|39111117|FG000|Part 2|Death|0|||
16173190|NCT02203149|39111118|FG001|Part 2|Death|0|||
16173191|NCT02203149|39111119|FG002|Part 2|Death|1|||
16173192|NCT02203149|39111120|FG003|Part 2|Death|1|||
16173193|NCT02203149|39111121|FG004|Part 2|Death|0|||
16115081|NCT00340704|38909533|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
16115082|NCT00340704|38909534|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
16115083|NCT00340704|38909535|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
16115084|NCT00340704|38909536|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
16115085|NCT00340704|38909537|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
16115086|NCT00340704|38909538|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
16115087|NCT00340704|38909539|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
16115088|NCT00340704|38909540|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
16115089|NCT01592045|38909545|FG000|Overall Study|Disease Progression|1|||
16115090|NCT01592045|38909546|FG001|Overall Study|Disease Progression|1|||
16115091|NCT01592045|38909545|FG000|Overall Study|Adverse Event|1|||
16115092|NCT01592045|38909546|FG001|Overall Study|Adverse Event|1|||
16115093|NCT01592045|38909545|FG000|Overall Study|Withdrawal by Subject|1|||
16115094|NCT01592045|38909546|FG001|Overall Study|Withdrawal by Subject|0|||
16115095|NCT01592045|38909545|FG000|Overall Study|Moved out of country|2|||
16225931|NCT03370133|39306289|FG002|Initial Treatment Period (WK 16)|Death|1|||
16225932|NCT03370133|39306290|FG003|Initial Treatment Period (WK 16)|Death|0|||
16225933|NCT03370133|39306291|FG004|Initial Treatment Period (WK 16)|Death|0|||
16225934|NCT03370133|39306292|FG005|Initial Treatment Period (WK 16)|Death|0|||
16225935|NCT03370133|39306287|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
16225936|NCT03370133|39306288|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
16410804|NCT01253265|39985599|FG001|Overall Study|Withdrawal by Subject|0|||
16410805|NCT01253265|39985600|FG002|Overall Study|Withdrawal by Subject|0|||
16410806|NCT01253265|39985601|FG003|Overall Study|Withdrawal by Subject|0|||
16410807|NCT01253265|39985602|FG004|Overall Study|Withdrawal by Subject|1|||
16410808|NCT01140568|39985603|FG000|Overall Study|disease progression|31|||
16410809|NCT01140568|39985603|FG000|Overall Study|Withdrawal by Subject|1|||
16410810|NCT01140568|39985603|FG000|Overall Study|Screen Fail|4|||
16410811|NCT00428220|39985604|FG000|Overall Study|Participant died|8|||
16410812|NCT00428220|39985604|FG000|Overall Study|Global deterioration of health status|7|||
16410813|NCT00428220|39985604|FG000|Overall Study|Lost to Follow-up|4|||
16410814|NCT00428220|39985604|FG000|Overall Study|Objective progression or relapse|123|||
16410815|NCT00428220|39985604|FG000|Overall Study|Participant refused continued treatment|7|||
16410816|NCT00428220|39985604|FG000|Overall Study|Adverse Event|51|||
16547829|NCT00988221|40470803|FG002|Part II|Reason not Specified|1|||
16115096|NCT01592045|38909546|FG001|Overall Study|Moved out of country|0|||
16225937|NCT03370133|39306289|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
16225938|NCT03370133|39306290|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
16225939|NCT03370133|39306291|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
16225940|NCT03370133|39306292|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
16225941|NCT03370133|39306287|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
16225942|NCT03370133|39306288|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
16225943|NCT03370133|39306289|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
16225944|NCT03370133|39306290|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
16225945|NCT03370133|39306291|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
16225946|NCT03370133|39306292|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
16225947|NCT03370133|39306287|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
16225948|NCT03370133|39306288|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
16225949|NCT03370133|39306289|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
16225950|NCT03370133|39306290|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
16225951|NCT03370133|39306291|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
16225952|NCT03370133|39306292|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
16225953|NCT03370133|39306287|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
16225954|NCT03370133|39306288|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
16225955|NCT03370133|39306289|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
16225956|NCT03370133|39306290|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
16225957|NCT03370133|39306291|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
16225958|NCT03370133|39306292|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
16225959|NCT03370133|39306287|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
16225960|NCT03370133|39306288|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
16225961|NCT03370133|39306289|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
16225962|NCT03370133|39306290|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
16225963|NCT03370133|39306291|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
16225964|NCT03370133|39306292|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
16225965|NCT03370133|39306287|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
16225966|NCT03370133|39306288|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
16225967|NCT03370133|39306289|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
16410817|NCT00428220|39985604|FG000|Overall Study|Other|23|||
16410818|NCT00289198|39985610|FG000|Overall Study|Adverse Event|0|||
16410819|NCT00289198|39985611|FG001|Overall Study|Adverse Event|2|||
16547830|NCT00988221|40470804|FG003|Part II|Reason not Specified|0|||
16547831|NCT00988221|40470801|FG000|Part III|Adverse Event|1|||
16547832|NCT00988221|40470802|FG001|Part III|Adverse Event|0|||
16547833|NCT00988221|40470803|FG002|Part III|Adverse Event|1|||
16547834|NCT00988221|40470804|FG003|Part III|Adverse Event|0|||
16547835|NCT00988221|40470801|FG000|Part III|Insufficient Therapeutic Response|0|||
16547836|NCT00988221|40470802|FG001|Part III|Insufficient Therapeutic Response|1|||
16547837|NCT00988221|40470803|FG002|Part III|Insufficient Therapeutic Response|1|||
16547838|NCT00988221|40470804|FG003|Part III|Insufficient Therapeutic Response|0|||
16547839|NCT00988221|40470801|FG000|Part III|Refused Treatment|0|||
16547840|NCT00988221|40470802|FG001|Part III|Refused Treatment|0|||
16547841|NCT00988221|40470803|FG002|Part III|Refused Treatment|1|||
16547842|NCT00988221|40470804|FG003|Part III|Refused Treatment|0|||
16547843|NCT04615182|40470805|FG000|Overall Study|Re-transplanted|2|||
16547844|NCT04615182|40470805|FG000|Overall Study|Protocol Violation|6|||
16547845|NCT04615182|40470805|FG000|Overall Study|Death|6|||
16547846|NCT04615182|40470805|FG000|Overall Study|Death and protocol violation|1|||
16547847|NCT01282801|40470808|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
16547848|NCT01282801|40470809|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
16547849|NCT02243202|40470819|FG000|Overall Study|Adverse Event|5|||
16547850|NCT02243202|40470820|FG001|Overall Study|Adverse Event|6|||
16115097|NCT02229227|38909547|FG000|Overall Study|Adverse Event|14|||
16115098|NCT02229227|38909548|FG001|Overall Study|Adverse Event|9|||
16115099|NCT02229227|38909547|FG000|Overall Study|Lack of Efficacy|3|||
16115100|NCT02229227|38909548|FG001|Overall Study|Lack of Efficacy|3|||
16115101|NCT02229227|38909547|FG000|Overall Study|Protocol Violation|6|||
16410820|NCT00289198|39985610|FG000|Overall Study|Protocol Violation|2|||
16410821|NCT00289198|39985611|FG001|Overall Study|Protocol Violation|1|||
16410822|NCT00289198|39985610|FG000|Overall Study|Withdrawal by Subject|4|||
16410823|NCT00289198|39985611|FG001|Overall Study|Withdrawal by Subject|1|||
16410824|NCT00289198|39985610|FG000|Overall Study|Lack of Efficacy|2|||
16410825|NCT00289198|39985611|FG001|Overall Study|Lack of Efficacy|0|||
16410826|NCT00289198|39985610|FG000|Overall Study|Other: Low compliance|0|||
16410827|NCT00289198|39985611|FG001|Overall Study|Other: Low compliance|1|||
16410828|NCT00289198|39985610|FG000|Overall Study|Other: Physician's decision|0|||
16410829|NCT00289198|39985611|FG001|Overall Study|Other: Physician's decision|1|||
16410830|NCT00289198|39985610|FG000|Overall Study|Other: Unable to attend on schedule|2|||
16410831|NCT00289198|39985611|FG001|Overall Study|Other: Unable to attend on schedule|1|||
16410832|NCT00289198|39985610|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
16410833|NCT00289198|39985611|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
16410834|NCT00289198|39985610|FG000|Overall Study|Other: Impossible to come on visit|0|||
16410835|NCT00289198|39985611|FG001|Overall Study|Other: Impossible to come on visit|1|||
16547851|NCT02243202|40470821|FG002|Overall Study|Adverse Event|10|||
16547852|NCT02243202|40470822|FG003|Overall Study|Adverse Event|4|||
16547853|NCT02243202|40470819|FG000|Overall Study|Lost to Follow-up|9|||
16115102|NCT02229227|38909548|FG001|Overall Study|Protocol Violation|8|||
16115103|NCT02229227|38909547|FG000|Overall Study|Protocol defined stopping criteria|1|||
16115104|NCT02229227|38909548|FG001|Overall Study|Protocol defined stopping criteria|3|||
16115105|NCT02229227|38909547|FG000|Overall Study|Lost to Follow-up|3|||
16115106|NCT02229227|38909548|FG001|Overall Study|Lost to Follow-up|3|||
16115107|NCT02229227|38909547|FG000|Overall Study|Study terminated by sponsor|11|||
16115108|NCT02229227|38909548|FG001|Overall Study|Study terminated by sponsor|11|||
16115109|NCT02229227|38909547|FG000|Overall Study|Withdrawal by Subject|8|||
16115110|NCT02229227|38909548|FG001|Overall Study|Withdrawal by Subject|12|||
16115111|NCT02229227|38909547|FG000|Overall Study|Other|0|||
16115112|NCT02229227|38909548|FG001|Overall Study|Other|1|||
16115113|NCT02229227|38909547|FG000|Overall Study|Physician Decision|5|||
16115114|NCT02229227|38909548|FG001|Overall Study|Physician Decision|12|||
16115115|NCT01660256|38909549|FG000|Overall Study|Adverse Event|4|||
16115116|NCT01660256|38909550|FG001|Overall Study|Adverse Event|0|||
16115117|NCT01660256|38909551|FG002|Overall Study|Adverse Event|2|||
16547854|NCT02243202|40470820|FG001|Overall Study|Lost to Follow-up|9|||
16547855|NCT02243202|40470821|FG002|Overall Study|Lost to Follow-up|14|||
16115118|NCT01660256|38909549|FG000|Overall Study|Withdrawal by Subject|1|||
16115119|NCT01660256|38909550|FG001|Overall Study|Withdrawal by Subject|0|||
16115120|NCT01660256|38909551|FG002|Overall Study|Withdrawal by Subject|2|||
16410836|NCT02642965|39985612|FG000|Overall Study|Lack of Efficacy|4|||
16547856|NCT02243202|40470822|FG003|Overall Study|Lost to Follow-up|11|||
16410837|NCT02642965|39985612|FG000|Overall Study|Physician Decision|9|||
16410838|NCT02653495|39985622|FG000|Overall Study|Lost to Follow-up|2|||
16410839|NCT02653495|39985623|FG001|Overall Study|Lost to Follow-up|0|||
16410840|NCT02653495|39985622|FG000|Overall Study|Screening Failure|10|||
16410841|NCT02653495|39985623|FG001|Overall Study|Screening Failure|0|||
16410842|NCT03002623|39985624|FG000|Overall Study|Lost to Follow-up|1|||
16410843|NCT03002623|39985625|FG001|Overall Study|Lost to Follow-up|0|||
16410844|NCT03002623|39985624|FG000|Overall Study|Physician Decision|1|||
16410845|NCT03002623|39985625|FG001|Overall Study|Physician Decision|1|||
16410846|NCT02761694|39985626|FG000|Overall Study|Lack of Efficacy|0|||
16410847|NCT02761694|39985627|FG001|Overall Study|Lack of Efficacy|0|||
16410848|NCT02761694|39985628|FG002|Overall Study|Lack of Efficacy|0|||
16410849|NCT02761694|39985629|FG003|Overall Study|Lack of Efficacy|0|||
16347374|NCT00369343|39757469|FG000|Open-label Phase|did not take study drug|1|||
16347375|NCT00369343|39757470|FG001|Open-label Phase|did not take study drug|2|||
16347376|NCT01211145|39757473|FG000|Overall Study|Reason not specified|3|||
16347377|NCT01211145|39757474|FG001|Overall Study|Reason not specified|2|||
16347378|NCT01211145|39757475|FG002|Overall Study|Reason not specified|2|||
16347379|NCT01211145|39757476|FG003|Overall Study|Reason not specified|1|||
16347380|NCT01211145|39757473|FG000|Overall Study|Lost to Follow-up|3|||
16347381|NCT01211145|39757474|FG001|Overall Study|Lost to Follow-up|2|||
16347382|NCT01211145|39757475|FG002|Overall Study|Lost to Follow-up|1|||
16347383|NCT01211145|39757476|FG003|Overall Study|Lost to Follow-up|2|||
16347384|NCT01211145|39757473|FG000|Overall Study|Study-specific withdrawal criteria|1|||
16347385|NCT01211145|39757474|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16347386|NCT01211145|39757475|FG002|Overall Study|Study-specific withdrawal criteria|0|||
16347387|NCT01211145|39757476|FG003|Overall Study|Study-specific withdrawal criteria|0|||
16347388|NCT01211145|39757473|FG000|Overall Study|Severe noncompliance to protocol|1|||
16347389|NCT01211145|39757474|FG001|Overall Study|Severe noncompliance to protocol|0|||
16347390|NCT01211145|39757475|FG002|Overall Study|Severe noncompliance to protocol|0|||
16347391|NCT01211145|39757476|FG003|Overall Study|Severe noncompliance to protocol|0|||
16347392|NCT01211145|39757473|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
16347393|NCT01211145|39757474|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
16347394|NCT01211145|39757475|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
16347395|NCT01211145|39757476|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
16347396|NCT01211145|39757473|FG000|Overall Study|Patient decision|2|||
16347397|NCT01211145|39757474|FG001|Overall Study|Patient decision|1|||
16347398|NCT01211145|39757475|FG002|Overall Study|Patient decision|0|||
16347399|NCT01211145|39757476|FG003|Overall Study|Patient decision|2|||
16347400|NCT00707980|39757477|FG000|Overall Study|Adverse Event|49|||
16347401|NCT00707980|39757477|FG000|Overall Study|Lack of Efficacy|35|||
16347402|NCT00707980|39757477|FG000|Overall Study|Non-Compliance with Study Drug|28|||
16347403|NCT00707980|39757477|FG000|Overall Study|Protocol Deviations|19|||
16347404|NCT00707980|39757477|FG000|Overall Study|Withdrawal of Consent|81|||
16347405|NCT00707980|39757477|FG000|Overall Study|Lost to Follow-up|59|||
16347406|NCT00707980|39757477|FG000|Overall Study|Other|39|||
16347407|NCT02277028|39757478|FG000|Overall Study|Lost to Follow-up|1|||
16347408|NCT02277028|39757479|FG001|Overall Study|Lost to Follow-up|0|||
16347409|NCT02277028|39757478|FG000|Overall Study|Withdrawal by Subject|0|||
16410850|NCT02761694|39985630|FG004|Overall Study|Lack of Efficacy|0|||
16410851|NCT02761694|39985631|FG005|Overall Study|Lack of Efficacy|0|||
16410852|NCT02761694|39985632|FG006|Overall Study|Lack of Efficacy|6|||
16410853|NCT02761694|39985633|FG007|Overall Study|Lack of Efficacy|0|||
16410854|NCT02761694|39985634|FG008|Overall Study|Lack of Efficacy|0|||
16410855|NCT02761694|39985635|FG009|Overall Study|Lack of Efficacy|1|||
16410856|NCT02761694|39985636|FG010|Overall Study|Lack of Efficacy|1|||
16410857|NCT02761694|39985637|FG011|Overall Study|Lack of Efficacy|4|||
16410858|NCT02761694|39985626|FG000|Overall Study|Death|0|||
16410859|NCT02761694|39985627|FG001|Overall Study|Death|0|||
16410860|NCT02761694|39985628|FG002|Overall Study|Death|0|||
16410861|NCT02761694|39985629|FG003|Overall Study|Death|0|||
16410862|NCT02761694|39985630|FG004|Overall Study|Death|0|||
16410863|NCT02761694|39985631|FG005|Overall Study|Death|0|||
16410864|NCT02761694|39985632|FG006|Overall Study|Death|2|||
16410865|NCT02761694|39985633|FG007|Overall Study|Death|0|||
16410866|NCT02761694|39985634|FG008|Overall Study|Death|2|||
16410867|NCT02761694|39985635|FG009|Overall Study|Death|2|||
16410868|NCT02761694|39985636|FG010|Overall Study|Death|1|||
16410869|NCT02761694|39985637|FG011|Overall Study|Death|0|||
16410870|NCT02761694|39985626|FG000|Overall Study|Physician Decision|0|||
16410871|NCT02761694|39985627|FG001|Overall Study|Physician Decision|0|||
16410872|NCT02761694|39985628|FG002|Overall Study|Physician Decision|0|||
16410873|NCT02761694|39985629|FG003|Overall Study|Physician Decision|0|||
16410874|NCT02761694|39985630|FG004|Overall Study|Physician Decision|0|||
16410875|NCT02761694|39985631|FG005|Overall Study|Physician Decision|0|||
16410876|NCT02761694|39985632|FG006|Overall Study|Physician Decision|1|||
16410877|NCT02761694|39985633|FG007|Overall Study|Physician Decision|0|||
16410878|NCT02761694|39985634|FG008|Overall Study|Physician Decision|0|||
16410879|NCT02761694|39985635|FG009|Overall Study|Physician Decision|0|||
16410880|NCT02761694|39985636|FG010|Overall Study|Physician Decision|0|||
16410881|NCT02761694|39985637|FG011|Overall Study|Physician Decision|0|||
16410882|NCT02761694|39985626|FG000|Overall Study|Withdrawal by Subject|0|||
16410883|NCT02761694|39985627|FG001|Overall Study|Withdrawal by Subject|0|||
16410884|NCT02761694|39985628|FG002|Overall Study|Withdrawal by Subject|0|||
16410885|NCT02761694|39985629|FG003|Overall Study|Withdrawal by Subject|1|||
16410886|NCT02761694|39985630|FG004|Overall Study|Withdrawal by Subject|0|||
16410887|NCT02761694|39985631|FG005|Overall Study|Withdrawal by Subject|0|||
16410888|NCT02761694|39985632|FG006|Overall Study|Withdrawal by Subject|4|||
16410889|NCT02761694|39985633|FG007|Overall Study|Withdrawal by Subject|0|||
16410890|NCT02761694|39985634|FG008|Overall Study|Withdrawal by Subject|2|||
16410891|NCT02761694|39985635|FG009|Overall Study|Withdrawal by Subject|1|||
16410892|NCT02761694|39985636|FG010|Overall Study|Withdrawal by Subject|0|||
16410893|NCT02761694|39985637|FG011|Overall Study|Withdrawal by Subject|0|||
16410894|NCT02761694|39985626|FG000|Overall Study|Lost to Follow-up|0|||
16410895|NCT02761694|39985627|FG001|Overall Study|Lost to Follow-up|0|||
16410896|NCT02761694|39985628|FG002|Overall Study|Lost to Follow-up|0|||
16410897|NCT02761694|39985629|FG003|Overall Study|Lost to Follow-up|0|||
16410898|NCT02761694|39985630|FG004|Overall Study|Lost to Follow-up|0|||
16410899|NCT02761694|39985631|FG005|Overall Study|Lost to Follow-up|0|||
16410900|NCT02761694|39985632|FG006|Overall Study|Lost to Follow-up|1|||
16410901|NCT02761694|39985633|FG007|Overall Study|Lost to Follow-up|0|||
16410902|NCT02761694|39985634|FG008|Overall Study|Lost to Follow-up|0|||
16410903|NCT02761694|39985635|FG009|Overall Study|Lost to Follow-up|0|||
16410904|NCT02761694|39985636|FG010|Overall Study|Lost to Follow-up|0|||
16410905|NCT02761694|39985637|FG011|Overall Study|Lost to Follow-up|1|||
16410906|NCT02761694|39985626|FG000|Overall Study|Adverse Event|0|||
16547857|NCT02243202|40470819|FG000|Overall Study|Protocol Violation|3|||
16547858|NCT02243202|40470820|FG001|Overall Study|Protocol Violation|1|||
16547859|NCT02243202|40470821|FG002|Overall Study|Protocol Violation|2|||
16547860|NCT02243202|40470822|FG003|Overall Study|Protocol Violation|1|||
16547861|NCT02243202|40470819|FG000|Overall Study|Withdrawal by Subject|7|||
16547862|NCT02243202|40470820|FG001|Overall Study|Withdrawal by Subject|6|||
16547863|NCT02243202|40470821|FG002|Overall Study|Withdrawal by Subject|4|||
16547864|NCT02243202|40470822|FG003|Overall Study|Withdrawal by Subject|4|||
16547865|NCT02243202|40470819|FG000|Overall Study|Other|1|||
16547866|NCT02243202|40470820|FG001|Overall Study|Other|3|||
16547867|NCT02243202|40470821|FG002|Overall Study|Other|1|||
16410907|NCT02761694|39985627|FG001|Overall Study|Adverse Event|0|||
16410908|NCT02761694|39985628|FG002|Overall Study|Adverse Event|0|||
16547868|NCT02243202|40470822|FG003|Overall Study|Other|2|||
16547869|NCT02243202|40470819|FG000|Overall Study|Randomized but not received treatment|0|||
16410909|NCT02761694|39985629|FG003|Overall Study|Adverse Event|0|||
16410910|NCT02761694|39985630|FG004|Overall Study|Adverse Event|0|||
16410911|NCT02761694|39985631|FG005|Overall Study|Adverse Event|0|||
16410912|NCT02761694|39985632|FG006|Overall Study|Adverse Event|1|||
16410913|NCT02761694|39985633|FG007|Overall Study|Adverse Event|0|||
16410914|NCT02761694|39985634|FG008|Overall Study|Adverse Event|1|||
16410915|NCT02761694|39985635|FG009|Overall Study|Adverse Event|0|||
16410916|NCT02761694|39985636|FG010|Overall Study|Adverse Event|0|||
16410917|NCT02761694|39985637|FG011|Overall Study|Adverse Event|1|||
16225968|NCT03370133|39306290|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
16225969|NCT03370133|39306291|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
16225970|NCT03370133|39306292|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
16225971|NCT03370133|39306287|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
16225972|NCT03370133|39306288|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
16225973|NCT03370133|39306289|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
16225974|NCT03370133|39306290|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
16225975|NCT03370133|39306291|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
16225976|NCT03370133|39306292|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
16225977|NCT03370133|39306287|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
16225978|NCT03370133|39306288|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
16225979|NCT03370133|39306289|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
16225980|NCT03370133|39306290|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
16225981|NCT03370133|39306291|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
16225982|NCT03370133|39306292|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
16225983|NCT03370133|39306287|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
16225984|NCT03370133|39306288|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
16225985|NCT03370133|39306289|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
16225986|NCT03370133|39306290|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
16225987|NCT03370133|39306291|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
16225988|NCT03370133|39306292|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
16225989|NCT03370133|39306287|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
16225990|NCT03370133|39306288|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
16410918|NCT02761694|39985626|FG000|Overall Study|Other|4|||
16410919|NCT02761694|39985627|FG001|Overall Study|Other|4|||
16410920|NCT02761694|39985628|FG002|Overall Study|Other|1|||
16410921|NCT02761694|39985629|FG003|Overall Study|Other|2|||
16410922|NCT02761694|39985630|FG004|Overall Study|Other|3|||
16410923|NCT02761694|39985631|FG005|Overall Study|Other|3|||
16410924|NCT02761694|39985632|FG006|Overall Study|Other|18|||
16547870|NCT02243202|40470820|FG001|Overall Study|Randomized but not received treatment|0|||
16547871|NCT02243202|40470821|FG002|Overall Study|Randomized but not received treatment|0|||
16547872|NCT02243202|40470822|FG003|Overall Study|Randomized but not received treatment|1|||
16547873|NCT02508532|40470828|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
16547874|NCT02508532|40470829|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
16547875|NCT02508532|40470830|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
16547876|NCT02508532|40470831|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
16410925|NCT02761694|39985633|FG007|Overall Study|Other|8|||
16410926|NCT02761694|39985634|FG008|Overall Study|Other|0|||
16410927|NCT02761694|39985635|FG009|Overall Study|Other|1|||
16410928|NCT02761694|39985636|FG010|Overall Study|Other|1|||
16410929|NCT02761694|39985637|FG011|Overall Study|Other|0|||
16410930|NCT01460407|39985638|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
16410931|NCT01460407|39985639|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
16410932|NCT00276094|39985640|FG000|Overall Study|Adverse Event|15|||
16410933|NCT00276094|39985641|FG001|Overall Study|Adverse Event|13|||
16410934|NCT00276094|39985642|FG002|Overall Study|Adverse Event|11|||
16410935|NCT00276094|39985640|FG000|Overall Study|Withdrawal by Subject|14|||
16410936|NCT00276094|39985641|FG001|Overall Study|Withdrawal by Subject|14|||
16410937|NCT00276094|39985642|FG002|Overall Study|Withdrawal by Subject|12|||
16410938|NCT00276094|39985640|FG000|Overall Study|Protocol Violation|16|||
16410939|NCT00276094|39985641|FG001|Overall Study|Protocol Violation|7|||
16410940|NCT00276094|39985642|FG002|Overall Study|Protocol Violation|10|||
16410941|NCT00276094|39985640|FG000|Overall Study|Lost to Follow-up|8|||
16410942|NCT00276094|39985641|FG001|Overall Study|Lost to Follow-up|6|||
16410943|NCT00276094|39985642|FG002|Overall Study|Lost to Follow-up|4|||
16410944|NCT00276094|39985640|FG000|Overall Study|Other-Subject moved out of country|1|||
16410945|NCT00276094|39985641|FG001|Overall Study|Other-Subject moved out of country|0|||
16410946|NCT00276094|39985642|FG002|Overall Study|Other-Subject moved out of country|0|||
16410947|NCT00276094|39985640|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
16410948|NCT00276094|39985641|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
16410949|NCT00276094|39985642|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
16410950|NCT00276094|39985640|FG000|Overall Study|Other-Lack of efficacy|1|||
16410951|NCT00276094|39985641|FG001|Overall Study|Other-Lack of efficacy|0|||
16410952|NCT00276094|39985642|FG002|Overall Study|Other-Lack of efficacy|0|||
16410953|NCT00276094|39985640|FG000|Overall Study|Other-Refused follow-up visit|1|||
16410954|NCT00276094|39985641|FG001|Overall Study|Other-Refused follow-up visit|0|||
16410955|NCT00276094|39985642|FG002|Overall Study|Other-Refused follow-up visit|0|||
16410956|NCT00276094|39985640|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
16410957|NCT00276094|39985641|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
16410958|NCT00276094|39985642|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
16410959|NCT00276094|39985640|FG000|Overall Study|Other-Relocation|0|||
16410960|NCT00276094|39985641|FG001|Overall Study|Other-Relocation|1|||
16410961|NCT00276094|39985642|FG002|Overall Study|Other-Relocation|0|||
16410962|NCT00276094|39985640|FG000|Overall Study|Other-Study medication lost|0|||
16410963|NCT00276094|39985641|FG001|Overall Study|Other-Study medication lost|0|||
16410964|NCT00276094|39985642|FG002|Overall Study|Other-Study medication lost|1|||
16410965|NCT00240110|39985643|FG000|Overall Study|Lost to Follow-up|6|||
16547877|NCT02508532|40470832|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
16547878|NCT02508532|40470833|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
16547879|NCT02508532|40470834|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
16547880|NCT02508532|40470835|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
16547881|NCT02508532|40470836|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
16410966|NCT00240110|39985644|FG001|Overall Study|Lost to Follow-up|7|||
16410967|NCT00908115|39985645|FG000|Overall Study|Other|14|||
16410968|NCT00661388|39985646|FG000|Overall Study|Adverse Event|14|||
16410969|NCT00661388|39985646|FG000|Overall Study|Protocol Violation|7|||
16410970|NCT00661388|39985646|FG000|Overall Study|Renal transplantation|1|||
16410971|NCT00661388|39985646|FG000|Overall Study|Dialysis initiation|1|||
16410972|NCT00661388|39985646|FG000|Overall Study|Administrative reasons|1|||
16410973|NCT03323736|39985647|FG000|Overall Study|Screen Failure|14|||
16410974|NCT03323736|39985648|FG001|Overall Study|Screen Failure|9|||
16410975|NCT03323736|39985649|FG002|Overall Study|Screen Failure|1|||
16115121|NCT01907906|38909553|FG000|Overall Study|Withdrawal by Subject|1|||
16115122|NCT01907906|38909554|FG001|Overall Study|Withdrawal by Subject|0|||
16115123|NCT01907906|38909553|FG000|Overall Study|Physician Decision|3|||
16115124|NCT01907906|38909554|FG001|Overall Study|Physician Decision|1|||
16115125|NCT04351269|38909555|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
16115126|NCT04351269|38909556|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
16115127|NCT04351269|38909557|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
16115128|NCT04351269|38909555|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
16115129|NCT04351269|38909556|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
16115130|NCT04351269|38909557|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
16115131|NCT04351269|38909555|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
16115132|NCT04351269|38909556|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
16115133|NCT04351269|38909557|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
16115134|NCT04351269|38909555|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
16115135|NCT04351269|38909556|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
16115136|NCT04351269|38909557|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
16115137|NCT04351269|38909555|FG000|Overall Study|Lost to Follow-up|1|||
16115138|NCT04351269|38909556|FG001|Overall Study|Lost to Follow-up|3|||
16115139|NCT04351269|38909557|FG002|Overall Study|Lost to Follow-up|0|||
16115140|NCT02706951|38909560|FG000|Period 1|Adverse Event|1|||
16115141|NCT02706951|38909561|FG001|Period 1|Adverse Event|5|||
16115142|NCT02706951|38909562|FG002|Period 1|Adverse Event|3|||
16115143|NCT02706951|38909563|FG003|Period 1|Adverse Event|0|||
16115144|NCT02706951|38909564|FG004|Period 1|Adverse Event|0|||
16115145|NCT02706951|38909560|FG000|Period 1|Withdrawal by Subject|10|||
16115146|NCT02706951|38909561|FG001|Period 1|Withdrawal by Subject|6|||
16115147|NCT02706951|38909562|FG002|Period 1|Withdrawal by Subject|6|||
16115148|NCT02706951|38909563|FG003|Period 1|Withdrawal by Subject|0|||
16115149|NCT02706951|38909564|FG004|Period 1|Withdrawal by Subject|0|||
16115150|NCT02706951|38909560|FG000|Period 1|Lost to Follow-up|0|||
16115151|NCT02706951|38909561|FG001|Period 1|Lost to Follow-up|4|||
16115152|NCT02706951|38909562|FG002|Period 1|Lost to Follow-up|1|||
16115153|NCT02706951|38909563|FG003|Period 1|Lost to Follow-up|0|||
16115154|NCT02706951|38909564|FG004|Period 1|Lost to Follow-up|0|||
16115155|NCT02706951|38909560|FG000|Period 1|Other|2|||
16115156|NCT02706951|38909561|FG001|Period 1|Other|1|||
16115157|NCT02706951|38909562|FG002|Period 1|Other|0|||
16115158|NCT02706951|38909563|FG003|Period 1|Other|0|||
16115159|NCT02706951|38909564|FG004|Period 1|Other|0|||
16115160|NCT02706951|38909560|FG000|Period 2|Adverse Event|0|||
16115161|NCT02706951|38909561|FG001|Period 2|Adverse Event|0|||
16115162|NCT02706951|38909562|FG002|Period 2|Adverse Event|0|||
16115163|NCT02706951|38909563|FG003|Period 2|Adverse Event|25|||
16115164|NCT02706951|38909564|FG004|Period 2|Adverse Event|34|||
16115165|NCT02706951|38909560|FG000|Period 2|Withdrawal by Subject|0|||
16115166|NCT02706951|38909561|FG001|Period 2|Withdrawal by Subject|0|||
16115167|NCT02706951|38909562|FG002|Period 2|Withdrawal by Subject|0|||
16115168|NCT02706951|38909563|FG003|Period 2|Withdrawal by Subject|38|||
16115169|NCT02706951|38909564|FG004|Period 2|Withdrawal by Subject|44|||
16115170|NCT02706951|38909560|FG000|Period 2|Lost to Follow-up|0|||
16115171|NCT02706951|38909561|FG001|Period 2|Lost to Follow-up|0|||
16115172|NCT02706951|38909562|FG002|Period 2|Lost to Follow-up|0|||
16115173|NCT02706951|38909563|FG003|Period 2|Lost to Follow-up|17|||
16115174|NCT02706951|38909564|FG004|Period 2|Lost to Follow-up|9|||
16115175|NCT02706951|38909560|FG000|Period 2|COVID-19 Related|0|||
16115176|NCT02706951|38909561|FG001|Period 2|COVID-19 Related|0|||
16115177|NCT02706951|38909562|FG002|Period 2|COVID-19 Related|0|||
16115178|NCT02706951|38909563|FG003|Period 2|COVID-19 Related|1|||
16115179|NCT02706951|38909564|FG004|Period 2|COVID-19 Related|2|||
16115180|NCT02706951|38909560|FG000|Period 2|Other|0|||
16115181|NCT02706951|38909561|FG001|Period 2|Other|0|||
16115182|NCT02706951|38909562|FG002|Period 2|Other|0|||
16115183|NCT02706951|38909563|FG003|Period 2|Other|37|||
16115184|NCT02706951|38909564|FG004|Period 2|Other|31|||
16115185|NCT03690427|38909567|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
16115186|NCT03690427|38909568|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
16115187|NCT02579772|38909571|FG000|Overall Study|Withdrawal by Subject|0|||
16115188|NCT02579772|38909572|FG001|Overall Study|Withdrawal by Subject|1|||
16115189|NCT02579772|38909571|FG000|Overall Study|Usage of additional antioxidants|1|||
16115190|NCT02579772|38909572|FG001|Overall Study|Usage of additional antioxidants|0|||
16115191|NCT02579772|38909571|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
16115192|NCT02579772|38909572|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
16115193|NCT03057847|38909574|FG000|Overall Study|Lost to Follow-up|16|||
16547882|NCT02508532|40470828|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
16547883|NCT02508532|40470829|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
16547884|NCT02508532|40470830|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
16547885|NCT02508532|40470831|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
16115194|NCT00798434|38909575|FG000|Double-Blind|Adverse Event|22|||
16115195|NCT00798434|38909576|FG001|Double-Blind|Adverse Event|46|||
16115196|NCT00798434|38909575|FG000|Double-Blind|Death|0|||
16115197|NCT00798434|38909576|FG001|Double-Blind|Death|1|||
16115198|NCT00798434|38909575|FG000|Double-Blind|Lost to Follow-up|1|||
16115199|NCT00798434|38909576|FG001|Double-Blind|Lost to Follow-up|0|||
16115200|NCT00798434|38909575|FG000|Double-Blind|Lack of Efficacy|8|||
16115201|NCT00798434|38909576|FG001|Double-Blind|Lack of Efficacy|12|||
16115202|NCT00798434|38909575|FG000|Double-Blind|Withdrawal by Subject|17|||
16115203|NCT00798434|38909576|FG001|Double-Blind|Withdrawal by Subject|14|||
16115204|NCT00798434|38909575|FG000|Double-Blind|Protocol Violation|1|||
16115205|NCT00798434|38909576|FG001|Double-Blind|Protocol Violation|4|||
16547886|NCT02508532|40470832|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
16115206|NCT00798434|38909575|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
16115207|NCT00798434|38909576|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
16115208|NCT00798434|38909575|FG000|Double-Blind|Other|1|||
16115209|NCT00798434|38909576|FG001|Double-Blind|Other|0|||
16115210|NCT00798434|38909575|FG000|Double-Blind|Not Treated|3|||
16115211|NCT00798434|38909576|FG001|Double-Blind|Not Treated|6|||
16115212|NCT00798434|38909575|FG000|Open-Label|Adverse Event|33|||
16115213|NCT00798434|38909576|FG001|Open-Label|Adverse Event|11|||
16115214|NCT00798434|38909575|FG000|Open-Label|Lack of Efficacy|5|||
16115215|NCT00798434|38909576|FG001|Open-Label|Lack of Efficacy|11|||
16115216|NCT00798434|38909575|FG000|Open-Label|Withdrawal by Subject|2|||
16115217|NCT00798434|38909576|FG001|Open-Label|Withdrawal by Subject|7|||
16115218|NCT00798434|38909575|FG000|Open-Label|Protocol Violation|1|||
16115219|NCT00798434|38909576|FG001|Open-Label|Protocol Violation|0|||
16115220|NCT00798434|38909575|FG000|Open-Label|Other|1|||
16115221|NCT00798434|38909576|FG001|Open-Label|Other|2|||
16115222|NCT00798434|38909575|FG000|Open-Label|Not Treated|0|||
16115223|NCT00798434|38909576|FG001|Open-Label|Not Treated|1|||
16115224|NCT04148651|38909577|FG000|Overall Study|Lost to Follow-up|2|||
16115225|NCT00334542|38909580|FG000|Overall Study|Adverse Event|3|||
16115226|NCT00334542|38909580|FG000|Overall Study|Withdrawal by Subject|1|||
16115227|NCT00334542|38909580|FG000|Overall Study|New cancer diagnosis|1|||
16115228|NCT02614183|38909581|FG000|Double Blind Treatment Phase|Adverse Event|10|||
16115229|NCT02614183|38909582|FG001|Double Blind Treatment Phase|Adverse Event|9|||
16115230|NCT02614183|38909583|FG002|Double Blind Treatment Phase|Adverse Event|7|||
16115231|NCT02614183|38909581|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
16115232|NCT02614183|38909582|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
16115233|NCT02614183|38909583|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
16115234|NCT02614183|38909581|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
16547887|NCT02508532|40470833|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
16115235|NCT02614183|38909582|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
16115236|NCT02614183|38909583|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
16115237|NCT02614183|38909581|FG000|Double Blind Treatment Phase|Physician Decision|7|||
16115238|NCT02614183|38909582|FG001|Double Blind Treatment Phase|Physician Decision|3|||
16115239|NCT02614183|38909583|FG002|Double Blind Treatment Phase|Physician Decision|2|||
16115240|NCT02614183|38909581|FG000|Double Blind Treatment Phase|Pregnancy|2|||
16115241|NCT02614183|38909582|FG001|Double Blind Treatment Phase|Pregnancy|1|||
16115242|NCT02614183|38909583|FG002|Double Blind Treatment Phase|Pregnancy|3|||
16115243|NCT02614183|38909581|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
16115244|NCT02614183|38909582|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
16115245|NCT02614183|38909583|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
16115246|NCT02614183|38909581|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
16115247|NCT02614183|38909582|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
16115248|NCT02614183|38909583|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
16115249|NCT02614183|38909581|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
16115250|NCT02614183|38909582|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
16115251|NCT02614183|38909583|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
16115252|NCT02614183|38909581|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
16115253|NCT02614183|38909582|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
16115254|NCT02614183|38909583|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
16115255|NCT02614183|38909581|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
16115256|NCT02614183|38909582|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
16115257|NCT02614183|38909583|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
16115258|NCT02614183|38909581|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
16115259|NCT02614183|38909582|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
16115260|NCT02614183|38909583|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
16115261|NCT02614183|38909581|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
16115262|NCT02614183|38909582|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
16115263|NCT02614183|38909583|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
16115264|NCT00884650|38909584|FG000|Overall Study|Did not return complete pain diaries|7|||
16547888|NCT02508532|40470834|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
16547889|NCT02508532|40470835|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
16547890|NCT02508532|40470836|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
16547891|NCT02508532|40470828|FG000|Part 2 - Treatment|Disease Progression|0|||
16547892|NCT02508532|40470829|FG001|Part 2 - Treatment|Disease Progression|0|||
16547893|NCT02508532|40470830|FG002|Part 2 - Treatment|Disease Progression|0|||
16547894|NCT02508532|40470831|FG003|Part 2 - Treatment|Disease Progression|0|||
16547895|NCT02508532|40470832|FG004|Part 2 - Treatment|Disease Progression|0|||
16547896|NCT02508532|40470833|FG005|Part 2 - Treatment|Disease Progression|0|||
16547897|NCT02508532|40470834|FG006|Part 2 - Treatment|Disease Progression|0|||
16547898|NCT02508532|40470835|FG007|Part 2 - Treatment|Disease Progression|0|||
16547899|NCT02508532|40470836|FG008|Part 2 - Treatment|Disease Progression|118|||
16547900|NCT02508532|40470828|FG000|Part 2 - Treatment|Adverse Event|0|||
16547901|NCT02508532|40470829|FG001|Part 2 - Treatment|Adverse Event|0|||
16547902|NCT02508532|40470830|FG002|Part 2 - Treatment|Adverse Event|0|||
16547903|NCT02508532|40470831|FG003|Part 2 - Treatment|Adverse Event|0|||
16547904|NCT02508532|40470832|FG004|Part 2 - Treatment|Adverse Event|0|||
16547905|NCT02508532|40470833|FG005|Part 2 - Treatment|Adverse Event|0|||
16547906|NCT02508532|40470834|FG006|Part 2 - Treatment|Adverse Event|0|||
16547907|NCT02508532|40470835|FG007|Part 2 - Treatment|Adverse Event|0|||
16547908|NCT02508532|40470836|FG008|Part 2 - Treatment|Adverse Event|49|||
16547909|NCT02508532|40470828|FG000|Part 2 - Treatment|Physician Decision|0|||
16547910|NCT02508532|40470829|FG001|Part 2 - Treatment|Physician Decision|0|||
16547911|NCT02508532|40470830|FG002|Part 2 - Treatment|Physician Decision|0|||
16547912|NCT02508532|40470831|FG003|Part 2 - Treatment|Physician Decision|0|||
16547913|NCT02508532|40470832|FG004|Part 2 - Treatment|Physician Decision|0|||
16547914|NCT02508532|40470833|FG005|Part 2 - Treatment|Physician Decision|0|||
16547915|NCT02508532|40470834|FG006|Part 2 - Treatment|Physician Decision|0|||
16547916|NCT02508532|40470835|FG007|Part 2 - Treatment|Physician Decision|0|||
16547917|NCT02508532|40470836|FG008|Part 2 - Treatment|Physician Decision|12|||
16547918|NCT02508532|40470828|FG000|Part 2 - Treatment|Administrative|0|||
16547919|NCT02508532|40470829|FG001|Part 2 - Treatment|Administrative|0|||
16547920|NCT02508532|40470830|FG002|Part 2 - Treatment|Administrative|0|||
16547921|NCT02508532|40470831|FG003|Part 2 - Treatment|Administrative|0|||
16547922|NCT02508532|40470832|FG004|Part 2 - Treatment|Administrative|0|||
16115265|NCT00884650|38909585|FG001|Overall Study|Did not return complete pain diaries|7|||
16115266|NCT00884650|38909584|FG000|Overall Study|Admitted Post-Op|1|||
16115267|NCT00884650|38909585|FG001|Overall Study|Admitted Post-Op|0|||
16225991|NCT03370133|39306289|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
16225992|NCT03370133|39306290|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
16225993|NCT03370133|39306291|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
16225994|NCT03370133|39306292|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
16225995|NCT03370133|39306287|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
16547923|NCT02508532|40470833|FG005|Part 2 - Treatment|Administrative|0|||
16547924|NCT02508532|40470834|FG006|Part 2 - Treatment|Administrative|0|||
16547925|NCT02508532|40470835|FG007|Part 2 - Treatment|Administrative|0|||
16547926|NCT02508532|40470836|FG008|Part 2 - Treatment|Administrative|3|||
16547927|NCT02508532|40470828|FG000|Part 2 - Treatment|Sponsor Decision|0|||
16547928|NCT02508532|40470829|FG001|Part 2 - Treatment|Sponsor Decision|0|||
16547929|NCT02508532|40470830|FG002|Part 2 - Treatment|Sponsor Decision|0|||
16547930|NCT02508532|40470831|FG003|Part 2 - Treatment|Sponsor Decision|0|||
16547931|NCT02508532|40470832|FG004|Part 2 - Treatment|Sponsor Decision|0|||
16547932|NCT02508532|40470833|FG005|Part 2 - Treatment|Sponsor Decision|0|||
16547933|NCT02508532|40470834|FG006|Part 2 - Treatment|Sponsor Decision|0|||
16547934|NCT02508532|40470835|FG007|Part 2 - Treatment|Sponsor Decision|0|||
16547935|NCT02508532|40470836|FG008|Part 2 - Treatment|Sponsor Decision|28|||
16547936|NCT02508532|40470828|FG000|Part 2 - Treatment|Death|0|||
16547937|NCT02508532|40470829|FG001|Part 2 - Treatment|Death|0|||
16115268|NCT00884650|38909584|FG000|Overall Study|Femoral Stress Fracture|1|||
16115269|NCT00884650|38909585|FG001|Overall Study|Femoral Stress Fracture|0|||
16115270|NCT00884650|38909584|FG000|Overall Study|Pain Pump Complication|0|||
16115271|NCT00884650|38909585|FG001|Overall Study|Pain Pump Complication|1|||
16115272|NCT00879775|38909586|FG000|Overall Study|Lost to Follow-up|2|||
16115273|NCT00879775|38909587|FG001|Overall Study|Lost to Follow-up|1|||
16115274|NCT00281320|38909588|FG000|Overall Study|Adverse Event|12|||
16115275|NCT00281320|38909589|FG001|Overall Study|Adverse Event|9|||
16115276|NCT00281320|38909588|FG000|Overall Study|Lack of Efficacy|4|||
16115277|NCT00281320|38909589|FG001|Overall Study|Lack of Efficacy|3|||
16115278|NCT00281320|38909588|FG000|Overall Study|Withdrawal by Subject|5|||
16115279|NCT00281320|38909589|FG001|Overall Study|Withdrawal by Subject|6|||
16115280|NCT00281320|38909588|FG000|Overall Study|Lost to Follow-up|1|||
16115281|NCT00281320|38909589|FG001|Overall Study|Lost to Follow-up|2|||
16115282|NCT00281320|38909588|FG000|Overall Study|Other|3|||
16115283|NCT00281320|38909589|FG001|Overall Study|Other|1|||
16115284|NCT01210651|38909594|FG000|Overall Study|Lost to Follow-up|1|||
16115285|NCT01210651|38909595|FG001|Overall Study|Lost to Follow-up|1|||
16115286|NCT01210651|38909594|FG000|Overall Study|schedule conflicts|1|||
16115287|NCT01210651|38909595|FG001|Overall Study|schedule conflicts|5|||
16115288|NCT01210651|38909594|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
16115289|NCT01210651|38909595|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
16115290|NCT01210651|38909594|FG000|Overall Study|Withdrawal by Subject|1|||
16115291|NCT01210651|38909595|FG001|Overall Study|Withdrawal by Subject|1|||
16115292|NCT01210651|38909594|FG000|Overall Study|Injury outside study|2|||
16115293|NCT01210651|38909595|FG001|Overall Study|Injury outside study|0|||
16115294|NCT00121667|38909600|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
16115295|NCT00121667|38909601|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
16115296|NCT00121667|38909602|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
16115297|NCT00121667|38909603|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
16115298|NCT00121667|38909600|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
16115299|NCT00121667|38909601|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
16115300|NCT00121667|38909602|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
16115301|NCT00121667|38909603|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
16347410|NCT02277028|39757479|FG001|Overall Study|Withdrawal by Subject|1|||
16547938|NCT02508532|40470830|FG002|Part 2 - Treatment|Death|0|||
16547939|NCT02508532|40470831|FG003|Part 2 - Treatment|Death|0|||
16547940|NCT02508532|40470832|FG004|Part 2 - Treatment|Death|0|||
16547941|NCT02508532|40470833|FG005|Part 2 - Treatment|Death|0|||
16547942|NCT02508532|40470834|FG006|Part 2 - Treatment|Death|0|||
16547943|NCT02508532|40470835|FG007|Part 2 - Treatment|Death|0|||
16547944|NCT02508532|40470836|FG008|Part 2 - Treatment|Death|1|||
16547945|NCT02508532|40470828|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
16347411|NCT01827592|39757480|FG000|Overall Study|Adverse Event|11|||
16547946|NCT02508532|40470829|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
16547947|NCT02508532|40470830|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
16547948|NCT02508532|40470831|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
16547949|NCT02508532|40470832|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
16547950|NCT02508532|40470833|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
16547951|NCT02508532|40470834|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
16547952|NCT02508532|40470835|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
16547953|NCT02508532|40470836|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
16547954|NCT02508532|40470828|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
16547955|NCT02508532|40470829|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
16547956|NCT02508532|40470830|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
16547957|NCT02508532|40470831|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
16547958|NCT02508532|40470832|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
16547959|NCT02508532|40470833|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
16547960|NCT02508532|40470834|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
16547961|NCT02508532|40470835|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
16547962|NCT02508532|40470836|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
16547963|NCT02508532|40470828|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
16547964|NCT02508532|40470829|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
16547965|NCT02508532|40470830|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
16115302|NCT00121667|38909600|FG000|Short Term (ST) Period|Adverse Event|5|||
16115303|NCT00121667|38909601|FG001|Short Term (ST) Period|Adverse Event|6|||
16115304|NCT00121667|38909602|FG002|Short Term (ST) Period|Adverse Event|5|||
16115305|NCT00121667|38909603|FG003|Short Term (ST) Period|Adverse Event|3|||
16115306|NCT00121667|38909600|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
16173194|NCT02203149|39111117|FG000|Part 2|Withdrawal by Subject|0|||
16547966|NCT02508532|40470831|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
16547967|NCT02508532|40470832|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
16547968|NCT02508532|40470833|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
16547969|NCT02508532|40470834|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
16547970|NCT02508532|40470835|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
16547971|NCT02508532|40470836|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
16547972|NCT02508532|40470828|FG000|Part 1 and Part 2 End of Study|Death|0|||
16547973|NCT02508532|40470829|FG001|Part 1 and Part 2 End of Study|Death|4|||
16547974|NCT02508532|40470830|FG002|Part 1 and Part 2 End of Study|Death|2|||
16547975|NCT02508532|40470831|FG003|Part 1 and Part 2 End of Study|Death|4|||
16547976|NCT02508532|40470832|FG004|Part 1 and Part 2 End of Study|Death|3|||
16547977|NCT02508532|40470833|FG005|Part 1 and Part 2 End of Study|Death|0|||
16547978|NCT02508532|40470834|FG006|Part 1 and Part 2 End of Study|Death|0|||
16225996|NCT03370133|39306288|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
16225997|NCT03370133|39306289|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
16225998|NCT03370133|39306290|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
16225999|NCT03370133|39306291|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
16226000|NCT03370133|39306292|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
16226001|NCT03370133|39306287|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
16226002|NCT03370133|39306288|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
16226003|NCT03370133|39306289|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
16226004|NCT03370133|39306290|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
16226005|NCT03370133|39306291|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
16226006|NCT03370133|39306292|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
16226007|NCT03370133|39306287|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
16226008|NCT03370133|39306288|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
16226009|NCT03370133|39306289|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
16226010|NCT03370133|39306290|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
16226011|NCT03370133|39306291|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
16226012|NCT03370133|39306292|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
16226013|NCT02033369|39306293|FG000|Overall Study|Physician Decision|1|||
16226014|NCT02033369|39306294|FG001|Overall Study|Physician Decision|2|||
16226015|NCT02033369|39306293|FG000|Overall Study|Not a good demographic match|0|||
16226016|NCT02033369|39306294|FG001|Overall Study|Not a good demographic match|2|||
16226017|NCT02033369|39306293|FG000|Overall Study|Withdrawal by Subject|1|||
16226018|NCT02033369|39306294|FG001|Overall Study|Withdrawal by Subject|1|||
16226019|NCT02033369|39306293|FG000|Overall Study|Lost to Follow-up|1|||
16226020|NCT02033369|39306294|FG001|Overall Study|Lost to Follow-up|0|||
16347412|NCT01827592|39757481|FG001|Overall Study|Adverse Event|9|||
16547979|NCT02508532|40470835|FG007|Part 1 and Part 2 End of Study|Death|1|||
16547980|NCT02508532|40470836|FG008|Part 1 and Part 2 End of Study|Death|111|||
16547981|NCT02508532|40470828|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
16547982|NCT02508532|40470829|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
16547983|NCT02508532|40470830|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
16547984|NCT02508532|40470831|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
16547985|NCT02508532|40470832|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
16547986|NCT02508532|40470833|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
16547987|NCT02508532|40470834|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
16547988|NCT02508532|40470835|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
16547989|NCT02508532|40470836|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
16547990|NCT02508532|40470828|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
16547991|NCT02508532|40470829|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
16547992|NCT02508532|40470830|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
16547993|NCT02508532|40470831|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
16547994|NCT02508532|40470832|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
16547995|NCT02508532|40470833|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
16547996|NCT02508532|40470834|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
16547997|NCT02508532|40470835|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
16547998|NCT02508532|40470836|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
16547999|NCT02508532|40470828|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
16548000|NCT02508532|40470829|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
16548001|NCT02508532|40470830|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
16548002|NCT02508532|40470831|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
16548003|NCT02508532|40470832|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
16548004|NCT02508532|40470833|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
16548005|NCT02508532|40470834|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
16548006|NCT02508532|40470835|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
16548007|NCT02508532|40470836|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
16548008|NCT02508532|40470828|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
16548009|NCT02508532|40470829|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
16548010|NCT02508532|40470830|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
16548011|NCT02508532|40470831|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
16548012|NCT02508532|40470832|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
16548013|NCT02508532|40470833|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
16548014|NCT02508532|40470834|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
16548015|NCT02508532|40470835|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
16548016|NCT02508532|40470836|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
16548017|NCT02508532|40470828|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
16548018|NCT02508532|40470829|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
16548019|NCT02508532|40470830|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
16410976|NCT03323736|39985647|FG000|Overall Study|Withdrawal Before Treatment|3|||
16410977|NCT03323736|39985648|FG001|Overall Study|Withdrawal Before Treatment|1|||
16410978|NCT03323736|39985649|FG002|Overall Study|Withdrawal Before Treatment|1|||
16410979|NCT03323736|39985647|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
16410980|NCT03323736|39985648|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
16410981|NCT03323736|39985649|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
16410982|NCT00526110|39985650|FG000|Overall Study|Adverse Event|2|||
16410983|NCT00526110|39985651|FG001|Overall Study|Adverse Event|9|||
16410984|NCT00526110|39985650|FG000|Overall Study|Disease Progression|0|||
16410985|NCT00526110|39985651|FG001|Overall Study|Disease Progression|19|||
16410986|NCT00526110|39985650|FG000|Overall Study|Maximal Response|0|||
16410987|NCT00526110|39985651|FG001|Overall Study|Maximal Response|6|||
16410988|NCT00526110|39985650|FG000|Overall Study|Withdrawal by Subject|0|||
16410989|NCT00526110|39985651|FG001|Overall Study|Withdrawal by Subject|2|||
16410990|NCT00526110|39985650|FG000|Overall Study|Poor Tolerance|0|||
16410991|NCT00526110|39985651|FG001|Overall Study|Poor Tolerance|5|||
16410992|NCT00930969|39985654|FG000|Overall Study|Death|5|||
16410993|NCT00930969|39985654|FG000|Overall Study|Lost to Follow-up|1|||
16410994|NCT00930969|39985654|FG000|Overall Study|Physician Decision|13|||
16410995|NCT00930969|39985654|FG000|Overall Study|Withdrawal by Subject|19|||
16410996|NCT03352453|39985655|FG000|Overall Study|Miscellaneous Reasons|1|||
16410997|NCT03352453|39985656|FG001|Overall Study|Miscellaneous Reasons|2|||
16410998|NCT03352453|39985655|FG000|Overall Study|Lack of Efficacy|1|||
16410999|NCT03352453|39985656|FG001|Overall Study|Lack of Efficacy|0|||
16411000|NCT03352453|39985655|FG000|Overall Study|Withdrawal by Subject|8|||
16411001|NCT03352453|39985656|FG001|Overall Study|Withdrawal by Subject|14|||
16411002|NCT03352453|39985655|FG000|Overall Study|Study Terminated by Sponsor|2|||
16411003|NCT03352453|39985656|FG001|Overall Study|Study Terminated by Sponsor|1|||
16411004|NCT03352453|39985655|FG000|Overall Study|Protocol Deviation|1|||
16411005|NCT03352453|39985656|FG001|Overall Study|Protocol Deviation|0|||
16411006|NCT03352453|39985655|FG000|Overall Study|Lost to Follow-up|7|||
16411007|NCT03352453|39985656|FG001|Overall Study|Lost to Follow-up|6|||
16411008|NCT03352453|39985655|FG000|Overall Study|Adverse Event|2|||
16411009|NCT03352453|39985656|FG001|Overall Study|Adverse Event|9|||
16411010|NCT01463111|39985658|FG000|Overall Study|Withdrawal by Subject|2|||
16548020|NCT02508532|40470831|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
16548021|NCT02508532|40470832|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
16548022|NCT02508532|40470833|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
16548023|NCT02508532|40470834|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
16548024|NCT02508532|40470835|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
16548025|NCT02508532|40470836|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
16548026|NCT02091739|40470837|FG000|MP: 16 Weeks|Adverse Event|1|||
16548027|NCT02091739|40470838|FG001|MP: 16 Weeks|Adverse Event|1|||
16548028|NCT02091739|40470839|FG002|MP: 16 Weeks|Adverse Event|1|||
16548029|NCT02091739|40470840|FG003|MP: 16 Weeks|Adverse Event|0|||
16548030|NCT02091739|40470841|FG004|MP: 16 Weeks|Adverse Event|0|||
16548031|NCT02091739|40470837|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
16548032|NCT02091739|40470838|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
16548033|NCT02091739|40470839|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
16548034|NCT02091739|40470840|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
16548035|NCT02091739|40470841|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
16548036|NCT02091739|40470837|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
16548037|NCT02091739|40470838|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
16548038|NCT02091739|40470839|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
16548039|NCT02091739|40470840|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
16548040|NCT02091739|40470841|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
16548041|NCT02091739|40470837|FG000|EP: 48 Weeks|Other|0|||
16548042|NCT02091739|40470838|FG001|EP: 48 Weeks|Other|0|||
16548043|NCT02091739|40470839|FG002|EP: 48 Weeks|Other|0|||
16411011|NCT01463111|39985658|FG000|Overall Study|Lost to Follow-up|5|||
16548044|NCT02091739|40470840|FG003|EP: 48 Weeks|Other|1|||
16548045|NCT02091739|40470841|FG004|EP: 48 Weeks|Other|0|||
16548046|NCT02091739|40470837|FG000|EP: 48 Weeks|Death|0|||
16548047|NCT02091739|40470838|FG001|EP: 48 Weeks|Death|0|||
16548048|NCT02091739|40470839|FG002|EP: 48 Weeks|Death|0|||
16548049|NCT02091739|40470840|FG003|EP: 48 Weeks|Death|3|||
16548050|NCT02091739|40470841|FG004|EP: 48 Weeks|Death|2|||
16548051|NCT02091739|40470837|FG000|EP: 48 Weeks|Adverse Event|0|||
16548052|NCT02091739|40470838|FG001|EP: 48 Weeks|Adverse Event|0|||
16226021|NCT02033369|39306293|FG000|Overall Study|Protocol Violation|2|||
16548053|NCT02091739|40470839|FG002|EP: 48 Weeks|Adverse Event|0|||
16548054|NCT02091739|40470840|FG003|EP: 48 Weeks|Adverse Event|2|||
16548055|NCT02091739|40470841|FG004|EP: 48 Weeks|Adverse Event|6|||
16548056|NCT02091739|40470837|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
16548057|NCT02091739|40470838|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
16548058|NCT02091739|40470839|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
16548059|NCT02091739|40470840|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
16548060|NCT02091739|40470841|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
16548061|NCT01964521|40470842|FG000|Overall Study|Lost to Follow-up|4|||
16115307|NCT00121667|38909601|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
16115308|NCT00121667|38909602|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
16115309|NCT00121667|38909603|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
16115310|NCT00121667|38909600|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
16115311|NCT00121667|38909601|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
16115312|NCT00121667|38909602|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
16115313|NCT00121667|38909603|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
16115314|NCT00121667|38909600|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
16115315|NCT00121667|38909601|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
16115316|NCT00121667|38909602|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
16115317|NCT00121667|38909603|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
16115318|NCT00121667|38909600|FG000|Short Term (ST) Period|Other Reason|3|||
16115319|NCT00121667|38909601|FG001|Short Term (ST) Period|Other Reason|0|||
16115320|NCT00121667|38909602|FG002|Short Term (ST) Period|Other Reason|0|||
16115321|NCT00121667|38909603|FG003|Short Term (ST) Period|Other Reason|0|||
16115322|NCT00121667|38909600|FG000|Short Term (ST) Period|Death|0|||
16115323|NCT00121667|38909601|FG001|Short Term (ST) Period|Death|0|||
16115324|NCT00121667|38909602|FG002|Short Term (ST) Period|Death|0|||
16115325|NCT00121667|38909603|FG003|Short Term (ST) Period|Death|1|||
16115326|NCT00121667|38909600|FG000|Short Term (ST) Period|Pregnancy|0|||
16411012|NCT01463111|39985658|FG000|Overall Study|Physician Decision|2|||
16411013|NCT00536874|39985659|FG000|Overall Study|Adverse Event|1|||
16411014|NCT00536874|39985659|FG000|Overall Study|Death|2|||
16115327|NCT00121667|38909601|FG001|Short Term (ST) Period|Pregnancy|0|||
16115328|NCT00121667|38909602|FG002|Short Term (ST) Period|Pregnancy|0|||
16115329|NCT00121667|38909603|FG003|Short Term (ST) Period|Pregnancy|1|||
16115330|NCT00121667|38909600|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
16115331|NCT00121667|38909601|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
16548062|NCT03072238|40470843|FG000|Overall Study|Withdrawal by Subject|30|||
16548063|NCT03072238|40470844|FG001|Overall Study|Withdrawal by Subject|51|||
16548064|NCT03072238|40470843|FG000|Overall Study|Lost to Follow-up|7|||
16548065|NCT03072238|40470844|FG001|Overall Study|Lost to Follow-up|4|||
16548066|NCT03072238|40470843|FG000|Overall Study|Physician Decision|1|||
16548067|NCT03072238|40470844|FG001|Overall Study|Physician Decision|3|||
16115332|NCT00121667|38909602|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
16115333|NCT00121667|38909603|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
16115334|NCT00121667|38909600|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
16115335|NCT00121667|38909601|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
16115336|NCT00121667|38909602|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
16115337|NCT00121667|38909603|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
16115338|NCT00121667|38909600|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
16115339|NCT00121667|38909601|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
16115340|NCT00121667|38909602|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
16115341|NCT00121667|38909603|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
16115342|NCT00121667|38909600|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
16115343|NCT00121667|38909601|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
16115344|NCT00121667|38909602|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
16115345|NCT00121667|38909603|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
16548068|NCT03072238|40470843|FG000|Overall Study|Death|139|||
16548069|NCT03072238|40470844|FG001|Overall Study|Death|121|||
16548070|NCT03072238|40470843|FG000|Overall Study|Other|0|||
16548071|NCT03072238|40470844|FG001|Overall Study|Other|1|||
16548072|NCT03072238|40470843|FG000|Overall Study|Ongoing on study|377|||
16548073|NCT03072238|40470844|FG001|Overall Study|Ongoing on study|367|||
16548074|NCT01350505|40470849|FG000|Overall Study|Lost to Follow-up|4|||
16548075|NCT01306201|40470853|FG000|Overall Study|Arrhythmia|4|||
16548076|NCT01306201|40470853|FG000|Overall Study|Files could not be processed|3|||
16548077|NCT01306201|40470853|FG000|Overall Study|Files unreadable|3|||
16548078|NCT00847301|40470854|FG000|Overall Study|Adverse Event|35|||
16548079|NCT00847301|40470854|FG000|Overall Study|Switch to other anticoagulants|16|||
16548080|NCT00847301|40470854|FG000|Overall Study|Lost to Follow-up|1|||
16548081|NCT00847301|40470854|FG000|Overall Study|No prescription after hospital discharge|1|||
16548082|NCT00847301|40470854|FG000|Overall Study|Other reason not defined above|1|||
16548083|NCT00105586|40470856|FG000|Overall Study|Adverse Event|4|||
16548084|NCT00105586|40470857|FG001|Overall Study|Adverse Event|3|||
16548085|NCT00105586|40470856|FG000|Overall Study|Physician Decision|13|||
16548086|NCT00105586|40470857|FG001|Overall Study|Physician Decision|13|||
16548087|NCT02228395|40470859|FG000|First Intervention Period|No longer willing to participate|1|||
16548088|NCT02228395|40470860|FG001|First Intervention Period|No longer willing to participate|0|||
16548089|NCT02228395|40470861|FG002|First Intervention Period|No longer willing to participate|0|||
16411015|NCT00536874|39985659|FG000|Overall Study|Withdrawal by Subject|1|||
16411016|NCT00806442|39985660|FG000|Overall Study|Lost to Follow-up|3|||
16411017|NCT00806442|39985661|FG001|Overall Study|Lost to Follow-up|2|||
16548090|NCT02228395|40470859|FG000|First Intervention Period|Unable to comply with study dates|0|||
16548091|NCT02228395|40470860|FG001|First Intervention Period|Unable to comply with study dates|1|||
16548092|NCT02228395|40470861|FG002|First Intervention Period|Unable to comply with study dates|1|||
16115346|NCT00121667|38909600|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
16115347|NCT00121667|38909601|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
16115348|NCT00121667|38909602|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
16115349|NCT00121667|38909603|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
16115350|NCT00121667|38909600|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
16115351|NCT00121667|38909601|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
16115352|NCT00121667|38909602|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
16115353|NCT00121667|38909603|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
16115354|NCT00121667|38909600|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
16115355|NCT00121667|38909601|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
16115356|NCT00121667|38909602|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
16115357|NCT00121667|38909603|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
16115358|NCT00121667|38909600|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
16115359|NCT00121667|38909601|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
16115360|NCT00121667|38909602|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
16115361|NCT00121667|38909603|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
16115362|NCT00121667|38909600|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
16115363|NCT00121667|38909601|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
16115364|NCT00121667|38909602|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
16115365|NCT00121667|38909603|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
16115366|NCT02394665|38909604|FG000|Overall Study|Physician Decision|1|||
16115367|NCT02394665|38909605|FG001|Overall Study|Physician Decision|0|||
16115368|NCT02394665|38909606|FG002|Overall Study|Physician Decision|0|||
16115369|NCT01646385|38909607|FG000|Overall Study|Death|202|||
16115370|NCT01646385|38909608|FG001|Overall Study|Death|222|||
16548093|NCT00944658|40470862|FG000|Treatment 12 Weeks|Adverse Event|0|||
16548094|NCT00944658|40470863|FG001|Treatment 12 Weeks|Adverse Event|2|||
16115371|NCT01646385|38909607|FG000|Overall Study|Switched to alternate biologic|636|||
16115372|NCT01646385|38909608|FG001|Overall Study|Switched to alternate biologic|649|||
16226022|NCT02033369|39306294|FG001|Overall Study|Protocol Violation|0|||
16411018|NCT00806442|39985660|FG000|Overall Study|Withdrawal by Subject|1|||
16548095|NCT01370005|40470868|FG000|Overall Study|Not treated|1|||
16411019|NCT00806442|39985661|FG001|Overall Study|Withdrawal by Subject|5|||
16411020|NCT02753127|39985664|FG000|Overall Study|Lost to Follow-up|13|||
16115373|NCT02094898|38909609|FG000|Overall Study|Clinical Worsening|2|||
16115374|NCT02094898|38909609|FG000|Overall Study|Adverse Event|2|||
16115375|NCT02094898|38909609|FG000|Overall Study|Lack of Efficacy|1|||
16115376|NCT01081886|38909612|FG000|Overall Study|Study termination|11|||
16115377|NCT01081886|38909613|FG001|Overall Study|Study termination|13|||
16115378|NCT02031536|38909614|FG000|Overall Study|ineligible|1|||
16115379|NCT02031536|38909615|FG001|Overall Study|ineligible|0|||
16115380|NCT00634842|38909619|FG000|Overall Study|Adverse Event|2|||
16115381|NCT00634842|38909620|FG001|Overall Study|Adverse Event|3|||
16115382|NCT00634842|38909619|FG000|Overall Study|Protocol Violation|8|||
16115383|NCT00634842|38909620|FG001|Overall Study|Protocol Violation|4|||
16115384|NCT00634842|38909619|FG000|Overall Study|Move to another state|1|||
16115385|NCT00634842|38909620|FG001|Overall Study|Move to another state|0|||
16115386|NCT00634842|38909619|FG000|Overall Study|Inclusion criteria were not met|1|||
16115387|NCT00634842|38909620|FG001|Overall Study|Inclusion criteria were not met|0|||
16115388|NCT00634842|38909619|FG000|Overall Study|Lost to Follow-up|1|||
16115389|NCT00634842|38909620|FG001|Overall Study|Lost to Follow-up|2|||
16115390|NCT00634842|38909619|FG000|Overall Study|Physician Decision|1|||
16115391|NCT00634842|38909620|FG001|Overall Study|Physician Decision|0|||
16548096|NCT01370005|40470869|FG001|Overall Study|Not treated|0|||
16548097|NCT01370005|40470870|FG002|Overall Study|Not treated|0|||
16548098|NCT01370005|40470868|FG000|Overall Study|Adverse Event|5|||
16548099|NCT01370005|40470869|FG001|Overall Study|Adverse Event|5|||
16548100|NCT01370005|40470870|FG002|Overall Study|Adverse Event|6|||
16548101|NCT01370005|40470868|FG000|Overall Study|Lack of Efficacy|1|||
16548102|NCT01370005|40470869|FG001|Overall Study|Lack of Efficacy|0|||
16548103|NCT01370005|40470870|FG002|Overall Study|Lack of Efficacy|0|||
16548104|NCT01370005|40470868|FG000|Overall Study|Non compliant with protocol|0|||
16548105|NCT01370005|40470869|FG001|Overall Study|Non compliant with protocol|1|||
16115392|NCT00634842|38909619|FG000|Overall Study|Withdrawal by Subject|1|||
16115393|NCT00634842|38909620|FG001|Overall Study|Withdrawal by Subject|3|||
16115394|NCT00634842|38909619|FG000|Overall Study|Lack of time and intolerance to drug|0|||
16115395|NCT00634842|38909620|FG001|Overall Study|Lack of time and intolerance to drug|1|||
16226023|NCT02924129|39306299|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
16226024|NCT02924129|39306300|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
16226025|NCT02924129|39306299|FG000|Overall Study|Withdrawal by Subject|2|||
16226026|NCT02924129|39306300|FG001|Overall Study|Withdrawal by Subject|2|||
16226027|NCT02924129|39306299|FG000|Overall Study|Physician Decision|1|||
16226028|NCT02924129|39306300|FG001|Overall Study|Physician Decision|0|||
16226029|NCT02924129|39306299|FG000|Overall Study|Missed Visit|0|||
16226030|NCT02924129|39306300|FG001|Overall Study|Missed Visit|1|||
16226031|NCT03328325|39306301|FG000|Overall Study|Lost to Follow-up|4|||
16226032|NCT03328325|39306301|FG000|Overall Study|Physician Decision|1|||
16226033|NCT03328325|39306301|FG000|Overall Study|Withdrawal by Subject|3|||
16226034|NCT03328325|39306301|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
16226035|NCT00280059|39306302|FG000|Efficacy Assessment Phase|Death|2|||
16226036|NCT00280059|39306303|FG001|Efficacy Assessment Phase|Death|0|||
16226037|NCT00280059|39306302|FG000|Efficacy Assessment Phase|Adverse Event|33|||
16226038|NCT00280059|39306303|FG001|Efficacy Assessment Phase|Adverse Event|31|||
16226039|NCT00280059|39306302|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
16226040|NCT00280059|39306303|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
16226041|NCT00280059|39306302|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
16226042|NCT00280059|39306303|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
16226043|NCT00280059|39306302|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
16226044|NCT00280059|39306303|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
16226045|NCT00280059|39306302|FG000|Efficacy Assessment Phase|Other|7|||
16226046|NCT00280059|39306303|FG001|Efficacy Assessment Phase|Other|8|||
16226047|NCT00280059|39306302|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
16226048|NCT00280059|39306303|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
16226049|NCT03799198|39306304|FG000|Overall Study|Lost to Follow-up|4|||
16411021|NCT02753127|39985665|FG001|Overall Study|Lost to Follow-up|11|||
16411022|NCT02753127|39985664|FG000|Overall Study|Withdrawal by Subject|37|||
16411023|NCT02753127|39985665|FG001|Overall Study|Withdrawal by Subject|47|||
16411024|NCT02753127|39985664|FG000|Overall Study|Other|3|||
16411025|NCT02753127|39985665|FG001|Overall Study|Other|8|||
16411026|NCT02753127|39985664|FG000|Overall Study|Hospice|0|||
16411027|NCT02753127|39985665|FG001|Overall Study|Hospice|2|||
16411028|NCT02317809|39985666|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
16226050|NCT03799198|39306305|FG001|Overall Study|Lost to Follow-up|8|||
16226051|NCT03799198|39306304|FG000|Overall Study|Death|0|||
16226052|NCT03799198|39306305|FG001|Overall Study|Death|1|||
16226053|NCT03287960|39306309|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
16226054|NCT03287960|39306309|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
16226055|NCT00489216|39306310|FG000|Overall Study|Adverse Event|1|||
16226056|NCT00643006|39309853|FG000|Overall Study|Lost to Follow-up|5|||
16226057|NCT00643006|39309854|FG001|Overall Study|Lost to Follow-up|4|||
16226058|NCT03781167|39309855|FG000|Overall Study|Adverse Event|23|||
16226059|NCT03781167|39309856|FG001|Overall Study|Adverse Event|25|||
16226060|NCT03781167|39309855|FG000|Overall Study|Withdrew consent|16|||
16226061|NCT03781167|39309856|FG001|Overall Study|Withdrew consent|12|||
16226062|NCT03781167|39309855|FG000|Overall Study|Lost to Follow-up|0|||
16226063|NCT03781167|39309856|FG001|Overall Study|Lost to Follow-up|1|||
16226064|NCT03781167|39309855|FG000|Overall Study|Lack of Efficacy|4|||
16226065|NCT03781167|39309856|FG001|Overall Study|Lack of Efficacy|5|||
16226066|NCT03781167|39309855|FG000|Overall Study|Difficulty with drug delivery system|2|||
16226067|NCT03781167|39309856|FG001|Overall Study|Difficulty with drug delivery system|3|||
16226068|NCT03781167|39309855|FG000|Overall Study|Other, not specified|2|||
16226069|NCT03781167|39309856|FG001|Overall Study|Other, not specified|2|||
16226070|NCT02612129|39309857|FG000|Single Dose Treatment Period|Screening Failure|1|||
16226071|NCT02612129|39309858|FG001|Single Dose Treatment Period|Screening Failure|0|||
16411029|NCT02317809|39985667|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
16411030|NCT02317809|39985666|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
16411031|NCT02317809|39985667|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
16548106|NCT01370005|40470870|FG002|Overall Study|Non compliant with protocol|2|||
16548107|NCT01370005|40470868|FG000|Overall Study|Lost to Follow-up|1|||
16548108|NCT01370005|40470869|FG001|Overall Study|Lost to Follow-up|1|||
16548109|NCT01370005|40470870|FG002|Overall Study|Lost to Follow-up|1|||
16548110|NCT01370005|40470868|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
16548111|NCT01370005|40470869|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
16548112|NCT01370005|40470870|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
16226072|NCT02612129|39309859|FG002|Single Dose Treatment Period|Screening Failure|0|||
16226073|NCT02612129|39309857|FG000|Continuous Treatment Period|Early Escape|0|||
16226074|NCT02612129|39309858|FG001|Continuous Treatment Period|Early Escape|2|||
16226075|NCT02612129|39309859|FG002|Continuous Treatment Period|Early Escape|0|||
16226076|NCT02612129|39309857|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
16226077|NCT02612129|39309858|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
16115396|NCT00634842|38909619|FG000|Overall Study|Discontinued due to injection|0|||
16115397|NCT00634842|38909620|FG001|Overall Study|Discontinued due to injection|2|||
16115398|NCT00634842|38909619|FG000|Overall Study|No need of study drug to treat diabetes|0|||
16115399|NCT00634842|38909620|FG001|Overall Study|No need of study drug to treat diabetes|1|||
16115400|NCT00634842|38909619|FG000|Overall Study|No wish to keep taking Avandia|0|||
16115401|NCT00634842|38909620|FG001|Overall Study|No wish to keep taking Avandia|1|||
16115402|NCT00634842|38909619|FG000|Overall Study|Subject off study drug for too long|0|||
16115403|NCT00634842|38909620|FG001|Overall Study|Subject off study drug for too long|1|||
16115404|NCT01575873|38909621|FG000|Overall Study|Withdrawal by Subject|15|||
16115405|NCT01575873|38909622|FG001|Overall Study|Withdrawal by Subject|20|||
16115406|NCT01575873|38909623|FG002|Overall Study|Withdrawal by Subject|34|||
16115407|NCT01575873|38909624|FG003|Overall Study|Withdrawal by Subject|34|||
16115408|NCT01575873|38909621|FG000|Overall Study|Adverse Event|7|||
16115409|NCT01575873|38909622|FG001|Overall Study|Adverse Event|7|||
16115410|NCT01575873|38909623|FG002|Overall Study|Adverse Event|9|||
16115411|NCT01575873|38909624|FG003|Overall Study|Adverse Event|12|||
16115412|NCT01575873|38909621|FG000|Overall Study|Lost to Follow-up|1|||
16226078|NCT02612129|39309859|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
16226079|NCT02612129|39309857|FG000|Continuous Treatment Period|Safety Reasons|0|||
16226080|NCT02612129|39309858|FG001|Continuous Treatment Period|Safety Reasons|3|||
16226081|NCT02612129|39309859|FG002|Continuous Treatment Period|Safety Reasons|0|||
16226082|NCT02612129|39309857|FG000|Continuous Treatment Period|Death|0|||
16226083|NCT02612129|39309858|FG001|Continuous Treatment Period|Death|1|||
16226084|NCT02612129|39309859|FG002|Continuous Treatment Period|Death|0|||
16226085|NCT02612129|39309857|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
16226086|NCT02612129|39309858|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
16226087|NCT02612129|39309859|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
16226088|NCT03198559|39309860|FG000|Overall Study|Adverse Event|2|||
16226089|NCT02452034|39309861|FG000|Overall Study|Adverse Event|0|||
16226090|NCT02452034|39309862|FG001|Overall Study|Adverse Event|0|||
16226091|NCT02452034|39309863|FG002|Overall Study|Adverse Event|0|||
16226092|NCT02452034|39309864|FG003|Overall Study|Adverse Event|0|||
16226093|NCT02452034|39309865|FG004|Overall Study|Adverse Event|0|||
16226094|NCT02452034|39309866|FG005|Overall Study|Adverse Event|1|||
16226095|NCT02452034|39309861|FG000|Overall Study|Death|0|||
16226096|NCT02452034|39309862|FG001|Overall Study|Death|0|||
16226097|NCT02452034|39309863|FG002|Overall Study|Death|0|||
16226098|NCT02452034|39309864|FG003|Overall Study|Death|0|||
16226099|NCT02452034|39309865|FG004|Overall Study|Death|1|||
16226100|NCT02452034|39309866|FG005|Overall Study|Death|1|||
16226101|NCT02452034|39309861|FG000|Overall Study|Physician Decision|0|||
16226102|NCT02452034|39309862|FG001|Overall Study|Physician Decision|1|||
16226103|NCT02452034|39309863|FG002|Overall Study|Physician Decision|1|||
16226104|NCT02452034|39309864|FG003|Overall Study|Physician Decision|0|||
16226105|NCT02452034|39309865|FG004|Overall Study|Physician Decision|0|||
16226106|NCT02452034|39309866|FG005|Overall Study|Physician Decision|0|||
16226107|NCT02452034|39309861|FG000|Overall Study|Protocol Violation|0|||
16226108|NCT02452034|39309862|FG001|Overall Study|Protocol Violation|0|||
16347413|NCT01827592|39757482|FG002|Overall Study|Adverse Event|2|||
16347414|NCT01827592|39757480|FG000|Overall Study|Physician Decision|0|||
16226109|NCT02452034|39309863|FG002|Overall Study|Protocol Violation|0|||
16226110|NCT02452034|39309864|FG003|Overall Study|Protocol Violation|0|||
16226111|NCT02452034|39309865|FG004|Overall Study|Protocol Violation|0|||
16226112|NCT02452034|39309866|FG005|Overall Study|Protocol Violation|1|||
16226113|NCT02452034|39309861|FG000|Overall Study|Screen Failure|1|||
16226114|NCT02452034|39309862|FG001|Overall Study|Screen Failure|0|||
16226115|NCT02452034|39309863|FG002|Overall Study|Screen Failure|0|||
16226116|NCT02452034|39309864|FG003|Overall Study|Screen Failure|1|||
16226117|NCT02452034|39309865|FG004|Overall Study|Screen Failure|0|||
16226118|NCT02452034|39309866|FG005|Overall Study|Screen Failure|0|||
16226119|NCT02452034|39309861|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
16226120|NCT02452034|39309862|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
16226121|NCT02452034|39309863|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
16226122|NCT02452034|39309864|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
16226123|NCT02452034|39309865|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
16226124|NCT02452034|39309866|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
16226125|NCT01215968|39309867|FG000|Overall Study|Adverse Event|0|||
16226126|NCT01215968|39309868|FG001|Overall Study|Adverse Event|2|||
16226127|NCT01215968|39309867|FG000|Overall Study|Protocol Violation|2|||
16226128|NCT01215968|39309868|FG001|Overall Study|Protocol Violation|4|||
16226129|NCT01215968|39309867|FG000|Overall Study|Not received study drug|0|||
16226130|NCT01215968|39309868|FG001|Overall Study|Not received study drug|1|||
16226131|NCT00976989|39309869|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
16226132|NCT00976989|39309870|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
16226133|NCT00976989|39309871|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
16226134|NCT00976989|39309869|FG000|Overall Study|Death|5|||
16226135|NCT00976989|39309870|FG001|Overall Study|Death|7|||
16226136|NCT00976989|39309871|FG002|Overall Study|Death|10|||
16226137|NCT00976989|39309869|FG000|Overall Study|Refused Treatment|4|||
16226138|NCT00976989|39309870|FG001|Overall Study|Refused Treatment|3|||
16226139|NCT00976989|39309871|FG002|Overall Study|Refused Treatment|5|||
16226140|NCT00976989|39309869|FG000|Overall Study|Failure to Return|2|||
16226141|NCT00976989|39309870|FG001|Overall Study|Failure to Return|1|||
16226142|NCT00976989|39309871|FG002|Overall Study|Failure to Return|0|||
16226143|NCT00976989|39309869|FG000|Overall Study|Recurrence of Disease|0|||
16226144|NCT00976989|39309870|FG001|Overall Study|Recurrence of Disease|1|||
16226145|NCT00976989|39309871|FG002|Overall Study|Recurrence of Disease|0|||
16226146|NCT00976989|39309869|FG000|Overall Study|Other|1|||
16226147|NCT00976989|39309870|FG001|Overall Study|Other|0|||
16226148|NCT00976989|39309871|FG002|Overall Study|Other|1|||
16226149|NCT01569568|39309872|FG000|Overall Study|Physician Decision|0|||
16226150|NCT01569568|39309873|FG001|Overall Study|Physician Decision|2|||
16226151|NCT02135848|39309874|FG000|Overall Study|Adverse Event|2|||
16226152|NCT02135848|39309875|FG001|Overall Study|Adverse Event|0|||
16226153|NCT02135848|39309874|FG000|Overall Study|Withdrawal by Subject|1|||
16226154|NCT02135848|39309875|FG001|Overall Study|Withdrawal by Subject|1|||
16226155|NCT00125138|39309876|FG000|Overall Study|Adverse Event|1|||
16226156|NCT00125138|39309877|FG001|Overall Study|Adverse Event|0|||
16226157|NCT00125138|39309878|FG002|Overall Study|Adverse Event|3|||
16226158|NCT00125138|39309879|FG003|Overall Study|Adverse Event|2|||
16226159|NCT00125138|39309876|FG000|Overall Study|Withdrawal by Subject|2|||
16226160|NCT00125138|39309877|FG001|Overall Study|Withdrawal by Subject|3|||
16226161|NCT00125138|39309878|FG002|Overall Study|Withdrawal by Subject|1|||
16226162|NCT00125138|39309879|FG003|Overall Study|Withdrawal by Subject|1|||
16226163|NCT00125138|39309876|FG000|Overall Study|Lack of Efficacy|0|||
16226164|NCT00125138|39309877|FG001|Overall Study|Lack of Efficacy|0|||
16226165|NCT00125138|39309878|FG002|Overall Study|Lack of Efficacy|0|||
16226166|NCT00125138|39309879|FG003|Overall Study|Lack of Efficacy|1|||
16226167|NCT00125138|39309876|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
16226168|NCT00125138|39309877|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
16226169|NCT00125138|39309878|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
16226170|NCT00125138|39309879|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
16226171|NCT04533204|39309880|FG000|Overall Study|Unable to understand training instructions|1|||
16226172|NCT04533204|39309881|FG001|Overall Study|Unable to understand training instructions|1|||
16226173|NCT00933543|39309882|FG000|Overall Study|Adverse Event|2|||
16226174|NCT00933543|39309883|FG001|Overall Study|Adverse Event|1|||
16226175|NCT00933543|39309882|FG000|Overall Study|Lost to Follow-up|0|||
16226176|NCT00933543|39309883|FG001|Overall Study|Lost to Follow-up|1|||
16548113|NCT01370005|40470868|FG000|Overall Study|Other reason not defined above|3|||
16548114|NCT01370005|40470869|FG001|Overall Study|Other reason not defined above|0|||
16548115|NCT01370005|40470870|FG002|Overall Study|Other reason not defined above|2|||
16548116|NCT01338012|40470872|FG000|Overall Study|Death|4|||
16548117|NCT01338012|40470872|FG000|Overall Study|Study terminated|4|||
16548118|NCT03749447|40470873|FG000|Overall Study|Adverse Event|11|||
16548119|NCT03749447|40470874|FG001|Overall Study|Adverse Event|3|||
16548120|NCT03749447|40470873|FG000|Overall Study|Death|1|||
16548121|NCT03749447|40470874|FG001|Overall Study|Death|1|||
16548122|NCT03749447|40470873|FG000|Overall Study|Lost to Follow-up|2|||
16548123|NCT03749447|40470874|FG001|Overall Study|Lost to Follow-up|2|||
16548124|NCT03749447|40470873|FG000|Overall Study|Reason Not Specified|0|||
16548125|NCT03749447|40470874|FG001|Overall Study|Reason Not Specified|3|||
16548126|NCT03749447|40470873|FG000|Overall Study|Physician Decision|4|||
16548127|NCT03749447|40470874|FG001|Overall Study|Physician Decision|3|||
16548128|NCT03749447|40470873|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
16548129|NCT03749447|40470874|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
16548130|NCT03749447|40470873|FG000|Overall Study|Study Terminated By Sponsor|112|||
16548131|NCT03749447|40470874|FG001|Overall Study|Study Terminated By Sponsor|105|||
16548132|NCT03749447|40470873|FG000|Overall Study|Withdrawal by Subject|12|||
16548133|NCT03749447|40470874|FG001|Overall Study|Withdrawal by Subject|6|||
16548134|NCT03749447|40470873|FG000|Overall Study|Non-compliance With Study Drug|0|||
16548135|NCT03749447|40470874|FG001|Overall Study|Non-compliance With Study Drug|1|||
16548136|NCT01871558|40470877|FG000|Overall Study|Other reason|0|||
16548137|NCT01871558|40470878|FG001|Overall Study|Other reason|1|||
16548138|NCT01871558|40470877|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
16548139|NCT01871558|40470878|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
16548140|NCT01871558|40470877|FG000|Overall Study|Withdrawal by Subject|2|||
16548141|NCT01871558|40470878|FG001|Overall Study|Withdrawal by Subject|0|||
16548142|NCT03713021|40470883|FG000|Overall Study|Did not have CT sim scan available|6|||
16548143|NCT03713021|40470883|FG000|Overall Study|Not eligible|4|||
16548144|NCT03713021|40470883|FG000|Overall Study|Issues with TraceIT markers|5|||
16548145|NCT02569437|40470885|FG000|Overall Study|Lost to Follow-up|12|||
16548146|NCT02569437|40470886|FG001|Overall Study|Lost to Follow-up|14|||
16548147|NCT01289418|40470887|FG000|Day 8 Survey|email address invalid|283|||
16548148|NCT01289418|40470887|FG000|Day 8 Survey|participants did not complete the survey|1935|||
16548149|NCT01289418|40470887|FG000|Day 29 Survey|email address invalid|283|||
16548150|NCT01289418|40470887|FG000|Day 29 Survey|participants did not complete the survey|2185|||
16548151|NCT02387216|40470888|FG000|Overall Study|Progressive disease|2|||
16548152|NCT02387216|40470889|FG001|Overall Study|Progressive disease|0|||
16548153|NCT02387216|40470888|FG000|Overall Study|Withdrawal by Subject|3|||
16548154|NCT02387216|40470889|FG001|Overall Study|Withdrawal by Subject|5|||
16548155|NCT02387216|40470888|FG000|Overall Study|Physician Decision|2|||
16115413|NCT01575873|38909622|FG001|Overall Study|Lost to Follow-up|3|||
16226177|NCT00933543|39309882|FG000|Overall Study|Withdrawal by Subject|0|||
16226178|NCT00933543|39309883|FG001|Overall Study|Withdrawal by Subject|1|||
16226179|NCT00933543|39309882|FG000|Overall Study|Lack of Efficacy|0|||
16226180|NCT00933543|39309883|FG001|Overall Study|Lack of Efficacy|3|||
16347415|NCT01827592|39757481|FG001|Overall Study|Physician Decision|2|||
16226181|NCT00933543|39309882|FG000|Overall Study|Other|1|||
16548156|NCT02387216|40470889|FG001|Overall Study|Physician Decision|0|||
16548157|NCT02387216|40470888|FG000|Overall Study|Sponsor Decision|28|||
16548158|NCT02387216|40470889|FG001|Overall Study|Sponsor Decision|12|||
16548159|NCT02387216|40470888|FG000|Overall Study|Death|60|||
16548160|NCT02387216|40470889|FG001|Overall Study|Death|23|||
16548161|NCT02387216|40470888|FG000|Overall Study|Other|5|||
16548162|NCT02387216|40470889|FG001|Overall Study|Other|4|||
16548163|NCT02387216|40470888|FG000|Overall Study|Lost to Follow-up|0|||
16548164|NCT02387216|40470889|FG001|Overall Study|Lost to Follow-up|3|||
16548165|NCT01396317|40470890|FG000|Overall Study|Adverse Event|1|||
16548166|NCT01396317|40470891|FG001|Overall Study|Adverse Event|0|||
16548167|NCT02118896|40470895|FG000|Overall Study|Death|4|||
16548168|NCT02118896|40470896|FG001|Overall Study|Death|0|||
16548169|NCT02118896|40470897|FG002|Overall Study|Death|4|||
16548170|NCT02118896|40470898|FG003|Overall Study|Death|6|||
16548171|NCT02118896|40470899|FG004|Overall Study|Death|3|||
16548172|NCT02118896|40470900|FG005|Overall Study|Death|1|||
16548173|NCT02118896|40470901|FG006|Overall Study|Death|0|||
16548174|NCT02118896|40470902|FG007|Overall Study|Death|0|||
16548175|NCT02118896|40470903|FG008|Overall Study|Death|0|||
16548176|NCT02118896|40470904|FG009|Overall Study|Death|0|||
16548177|NCT02118896|40470895|FG000|Overall Study|Adverse Event|5|||
16548178|NCT02118896|40470896|FG001|Overall Study|Adverse Event|4|||
16548179|NCT02118896|40470897|FG002|Overall Study|Adverse Event|4|||
16548180|NCT02118896|40470898|FG003|Overall Study|Adverse Event|5|||
16548181|NCT02118896|40470899|FG004|Overall Study|Adverse Event|5|||
16548182|NCT02118896|40470900|FG005|Overall Study|Adverse Event|9|||
16548183|NCT02118896|40470901|FG006|Overall Study|Adverse Event|1|||
16226182|NCT00933543|39309883|FG001|Overall Study|Other|1|||
16226183|NCT02361307|39309884|FG000|Overall Study|Unstable medical condition.|0|||
16226184|NCT02361307|39309885|FG001|Overall Study|Unstable medical condition.|1|||
16226185|NCT02643420|39309887|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
16226186|NCT02643420|39309888|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
16226187|NCT02643420|39309887|FG000|Overall Study|Withdrawal by Subject|25|||
16226188|NCT02643420|39309888|FG001|Overall Study|Withdrawal by Subject|19|||
16226189|NCT02643420|39309887|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
16226190|NCT02643420|39309888|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
16226191|NCT02643420|39309887|FG000|Overall Study|Lost to Follow-up|6|||
16226192|NCT02643420|39309888|FG001|Overall Study|Lost to Follow-up|10|||
16226193|NCT02643420|39309887|FG000|Overall Study|Investigator Decision|2|||
16226194|NCT02643420|39309888|FG001|Overall Study|Investigator Decision|4|||
16226195|NCT02643420|39309887|FG000|Overall Study|Sponsor decision|1|||
16226196|NCT02643420|39309888|FG001|Overall Study|Sponsor decision|1|||
16226197|NCT02643420|39309887|FG000|Overall Study|Death|0|||
16226198|NCT02643420|39309888|FG001|Overall Study|Death|2|||
16226199|NCT02643420|39309887|FG000|Overall Study|Reason not Specified|8|||
16226200|NCT02643420|39309888|FG001|Overall Study|Reason not Specified|7|||
16226201|NCT02304484|39309889|FG000|Overall Study|Death|9|||
16226202|NCT02304484|39309889|FG000|Overall Study|Withdrawal by Subject|14|||
16226203|NCT02304484|39309889|FG000|Overall Study|Lost to Follow-up|2|||
16226204|NCT02898662|39309893|FG000|Overall Study|Adverse Event|1|||
16226205|NCT02898662|39309894|FG001|Overall Study|Adverse Event|0|||
16226206|NCT02898662|39309893|FG000|Overall Study|Loss of asthma control|23|||
16226207|NCT02898662|39309894|FG001|Overall Study|Loss of asthma control|24|||
16226208|NCT02898662|39309893|FG000|Overall Study|Withdrawal by Subject|4|||
16226209|NCT02898662|39309894|FG001|Overall Study|Withdrawal by Subject|1|||
16226210|NCT02898662|39309893|FG000|Overall Study|Technical issue|0|||
16226211|NCT02898662|39309894|FG001|Overall Study|Technical issue|1|||
16226212|NCT02898662|39309893|FG000|Overall Study|Randomized in error|0|||
16226213|NCT02898662|39309894|FG001|Overall Study|Randomized in error|1|||
16226214|NCT02898662|39309893|FG000|Overall Study|Subject decision|1|||
16226215|NCT02898662|39309894|FG001|Overall Study|Subject decision|0|||
16226216|NCT02898662|39309893|FG000|Overall Study|Other|0|||
16226217|NCT02898662|39309894|FG001|Overall Study|Other|1|||
16347416|NCT01827592|39757482|FG002|Overall Study|Physician Decision|1|||
16347417|NCT01827592|39757480|FG000|Overall Study|Protocol Violation|2|||
16347418|NCT01827592|39757481|FG001|Overall Study|Protocol Violation|1|||
16548184|NCT02118896|40470902|FG007|Overall Study|Adverse Event|1|||
16226218|NCT00451191|39309898|FG000|Overall Study|withdrawal or received alternate tx|15|||
16226219|NCT00451191|39309899|FG001|Overall Study|withdrawal or received alternate tx|11|||
16226220|NCT00594958|39309908|FG000|Overall Study|Withdrawal by Subject|1|||
16226221|NCT00594958|39309909|FG001|Overall Study|Withdrawal by Subject|0|||
16226222|NCT00594958|39309910|FG002|Overall Study|Withdrawal by Subject|1|||
16226223|NCT00594958|39309908|FG000|Overall Study|Adverse Event|4|||
16548185|NCT02118896|40470903|FG008|Overall Study|Adverse Event|4|||
16548186|NCT02118896|40470904|FG009|Overall Study|Adverse Event|0|||
16226224|NCT00594958|39309909|FG001|Overall Study|Adverse Event|1|||
16226225|NCT00594958|39309910|FG002|Overall Study|Adverse Event|2|||
16347419|NCT01827592|39757482|FG002|Overall Study|Protocol Violation|0|||
16548187|NCT02118896|40470895|FG000|Overall Study|Consent withdrawn|2|||
16226226|NCT00594958|39309908|FG000|Overall Study|Pregnancy|0|||
16226227|NCT00594958|39309909|FG001|Overall Study|Pregnancy|2|||
16226228|NCT00594958|39309910|FG002|Overall Study|Pregnancy|0|||
16226229|NCT00594958|39309908|FG000|Overall Study|Protocol Violation|1|||
16226230|NCT00594958|39309909|FG001|Overall Study|Protocol Violation|0|||
16226231|NCT00594958|39309910|FG002|Overall Study|Protocol Violation|2|||
16226232|NCT00594958|39309908|FG000|Overall Study|Lost to Follow-up|5|||
16411032|NCT02639338|39985668|FG000|Overall Study|Lost to Follow-up|2|||
16411033|NCT02639338|39985669|FG001|Overall Study|Lost to Follow-up|2|||
16411034|NCT02639338|39985668|FG000|Overall Study|Withdrew Consent|1|||
16411035|NCT02639338|39985669|FG001|Overall Study|Withdrew Consent|2|||
16411036|NCT02639338|39985668|FG000|Overall Study|Death|1|||
16411037|NCT02639338|39985669|FG001|Overall Study|Death|0|||
16548188|NCT02118896|40470896|FG001|Overall Study|Consent withdrawn|0|||
16548189|NCT02118896|40470897|FG002|Overall Study|Consent withdrawn|3|||
16548190|NCT02118896|40470898|FG003|Overall Study|Consent withdrawn|4|||
16548191|NCT02118896|40470899|FG004|Overall Study|Consent withdrawn|1|||
16548192|NCT02118896|40470900|FG005|Overall Study|Consent withdrawn|4|||
16548193|NCT02118896|40470901|FG006|Overall Study|Consent withdrawn|0|||
16548194|NCT02118896|40470902|FG007|Overall Study|Consent withdrawn|0|||
16548195|NCT02118896|40470903|FG008|Overall Study|Consent withdrawn|0|||
16548196|NCT02118896|40470904|FG009|Overall Study|Consent withdrawn|0|||
16548197|NCT02118896|40470895|FG000|Overall Study|Non-compliance|2|||
16548198|NCT02118896|40470896|FG001|Overall Study|Non-compliance|1|||
16548199|NCT02118896|40470897|FG002|Overall Study|Non-compliance|1|||
16548200|NCT02118896|40470898|FG003|Overall Study|Non-compliance|5|||
16548201|NCT02118896|40470899|FG004|Overall Study|Non-compliance|0|||
16548202|NCT02118896|40470900|FG005|Overall Study|Non-compliance|1|||
16548203|NCT02118896|40470901|FG006|Overall Study|Non-compliance|0|||
16548204|NCT02118896|40470902|FG007|Overall Study|Non-compliance|1|||
16115414|NCT01575873|38909623|FG002|Overall Study|Lost to Follow-up|13|||
16115415|NCT01575873|38909624|FG003|Overall Study|Lost to Follow-up|5|||
16115416|NCT01575873|38909621|FG000|Overall Study|Death|3|||
16115417|NCT01575873|38909622|FG001|Overall Study|Death|2|||
16115418|NCT01575873|38909623|FG002|Overall Study|Death|8|||
16115419|NCT01575873|38909624|FG003|Overall Study|Death|9|||
16115420|NCT01575873|38909621|FG000|Overall Study|Noncompliance|1|||
16115421|NCT01575873|38909622|FG001|Overall Study|Noncompliance|2|||
16115422|NCT01575873|38909623|FG002|Overall Study|Noncompliance|4|||
16115423|NCT01575873|38909624|FG003|Overall Study|Noncompliance|3|||
16115424|NCT01575873|38909621|FG000|Overall Study|Administrative decision|1|||
16115425|NCT01575873|38909622|FG001|Overall Study|Administrative decision|1|||
16115426|NCT01575873|38909623|FG002|Overall Study|Administrative decision|1|||
16115427|NCT01575873|38909624|FG003|Overall Study|Administrative decision|0|||
16115428|NCT01575873|38909621|FG000|Overall Study|Protocol deviation|0|||
16115429|NCT01575873|38909622|FG001|Overall Study|Protocol deviation|1|||
16115430|NCT01575873|38909623|FG002|Overall Study|Protocol deviation|0|||
16115431|NCT01575873|38909624|FG003|Overall Study|Protocol deviation|1|||
16115432|NCT01575873|38909621|FG000|Overall Study|Requirement for Alternative Therapy|0|||
16115433|NCT01575873|38909622|FG001|Overall Study|Requirement for Alternative Therapy|0|||
16115434|NCT01575873|38909623|FG002|Overall Study|Requirement for Alternative Therapy|1|||
16115435|NCT01575873|38909624|FG003|Overall Study|Requirement for Alternative Therapy|1|||
16115436|NCT01575873|38909621|FG000|Overall Study|Other|0|||
16115437|NCT01575873|38909622|FG001|Overall Study|Other|0|||
16115438|NCT01575873|38909623|FG002|Overall Study|Other|4|||
16115439|NCT01575873|38909624|FG003|Overall Study|Other|2|||
16115440|NCT02493946|38909625|FG000|DB Period|Withdrawal by Subject|8|||
16115441|NCT02493946|38909626|FG001|DB Period|Withdrawal by Subject|5|||
16115442|NCT02493946|38909627|FG002|DB Period|Withdrawal by Subject|0|||
16115443|NCT02493946|38909625|FG000|Open Label Period|Withdrawal by Subject|0|||
16115444|NCT02493946|38909626|FG001|Open Label Period|Withdrawal by Subject|0|||
16115445|NCT02493946|38909627|FG002|Open Label Period|Withdrawal by Subject|74|||
16115446|NCT02493946|38909625|FG000|Open Label Period|Adverse Event|0|||
16115447|NCT02493946|38909626|FG001|Open Label Period|Adverse Event|0|||
16115448|NCT02493946|38909627|FG002|Open Label Period|Adverse Event|4|||
16115449|NCT02493946|38909625|FG000|Open Label Period|Lost to Follow-up|0|||
16115450|NCT02493946|38909626|FG001|Open Label Period|Lost to Follow-up|0|||
16548205|NCT02118896|40470903|FG008|Overall Study|Non-compliance|0|||
16115451|NCT02493946|38909627|FG002|Open Label Period|Lost to Follow-up|1|||
16226233|NCT00594958|39309909|FG001|Overall Study|Lost to Follow-up|0|||
16115452|NCT02493946|38909625|FG000|Open Label Period|Investigator decision, non-compliance|0|||
16115453|NCT02493946|38909626|FG001|Open Label Period|Investigator decision, non-compliance|0|||
16115454|NCT02493946|38909627|FG002|Open Label Period|Investigator decision, non-compliance|2|||
16115455|NCT02493946|38909625|FG000|Open Label Period|Investigator decision, non-availability|0|||
16115456|NCT02493946|38909626|FG001|Open Label Period|Investigator decision, non-availability|0|||
16226234|NCT00594958|39309910|FG002|Overall Study|Lost to Follow-up|3|||
16548206|NCT02118896|40470904|FG009|Overall Study|Non-compliance|0|||
16226235|NCT00594958|39309908|FG000|Overall Study|administrative|3|||
16411038|NCT02639338|39985668|FG000|Overall Study|Randomized but Not Treated|0|||
16548207|NCT02118896|40470895|FG000|Overall Study|Pregnancy|1|||
16226236|NCT00594958|39309909|FG001|Overall Study|administrative|0|||
16226237|NCT00594958|39309910|FG002|Overall Study|administrative|2|||
16226238|NCT01482598|39309911|FG000|Overall Study|Death|7|||
16226239|NCT01482598|39309912|FG001|Overall Study|Death|10|||
16173195|NCT02203149|39111118|FG001|Part 2|Withdrawal by Subject|0|||
16226240|NCT01482598|39309911|FG000|Overall Study|Physician Decision|0|||
16226241|NCT01482598|39309912|FG001|Overall Study|Physician Decision|3|||
16226242|NCT01482598|39309911|FG000|Overall Study|Withdrawal by Subject|4|||
16226243|NCT01482598|39309912|FG001|Overall Study|Withdrawal by Subject|5|||
16226244|NCT01482598|39309911|FG000|Overall Study|Lost to Follow-up|5|||
16226245|NCT01482598|39309912|FG001|Overall Study|Lost to Follow-up|4|||
16226246|NCT01920061|39309913|FG000|Overall Study|Death|1|||
16226247|NCT01920061|39309914|FG001|Overall Study|Death|1|||
16226248|NCT01920061|39309915|FG002|Overall Study|Death|0|||
16226249|NCT01920061|39309916|FG003|Overall Study|Death|1|||
16226250|NCT01920061|39309917|FG004|Overall Study|Death|1|||
16226251|NCT01920061|39309918|FG005|Overall Study|Death|0|||
16226252|NCT01920061|39309919|FG006|Overall Study|Death|0|||
16226253|NCT01920061|39309920|FG007|Overall Study|Death|1|||
16226254|NCT01920061|39309921|FG008|Overall Study|Death|0|||
16226255|NCT01920061|39309922|FG009|Overall Study|Death|1|||
16226256|NCT01920061|39309923|FG010|Overall Study|Death|0|||
16226257|NCT01920061|39309924|FG011|Overall Study|Death|1|||
16226258|NCT01920061|39309925|FG012|Overall Study|Death|0|||
16226259|NCT01920061|39309926|FG013|Overall Study|Death|2|||
16226260|NCT01920061|39309927|FG014|Overall Study|Death|0|||
16226261|NCT01920061|39309928|FG015|Overall Study|Death|0|||
16226262|NCT01920061|39309929|FG016|Overall Study|Death|0|||
16226263|NCT01920061|39309930|FG017|Overall Study|Death|0|||
16226264|NCT01920061|39309931|FG018|Overall Study|Death|1|||
16226265|NCT01920061|39309932|FG019|Overall Study|Death|0|||
16226266|NCT01920061|39309913|FG000|Overall Study|Lost to Follow-up|0|||
16226267|NCT01920061|39309914|FG001|Overall Study|Lost to Follow-up|2|||
16226268|NCT01920061|39309915|FG002|Overall Study|Lost to Follow-up|0|||
16226269|NCT01920061|39309916|FG003|Overall Study|Lost to Follow-up|0|||
16226270|NCT01920061|39309917|FG004|Overall Study|Lost to Follow-up|0|||
16226271|NCT01920061|39309918|FG005|Overall Study|Lost to Follow-up|0|||
16226272|NCT01920061|39309919|FG006|Overall Study|Lost to Follow-up|1|||
16226273|NCT01920061|39309920|FG007|Overall Study|Lost to Follow-up|0|||
16226274|NCT01920061|39309921|FG008|Overall Study|Lost to Follow-up|0|||
16226275|NCT01920061|39309922|FG009|Overall Study|Lost to Follow-up|0|||
16226276|NCT01920061|39309923|FG010|Overall Study|Lost to Follow-up|3|||
16226277|NCT01920061|39309924|FG011|Overall Study|Lost to Follow-up|0|||
16226278|NCT01920061|39309925|FG012|Overall Study|Lost to Follow-up|0|||
16226279|NCT01920061|39309926|FG013|Overall Study|Lost to Follow-up|0|||
16226280|NCT01920061|39309927|FG014|Overall Study|Lost to Follow-up|0|||
16226281|NCT01920061|39309928|FG015|Overall Study|Lost to Follow-up|0|||
16226282|NCT01920061|39309929|FG016|Overall Study|Lost to Follow-up|0|||
16226283|NCT01920061|39309930|FG017|Overall Study|Lost to Follow-up|1|||
16226284|NCT01920061|39309931|FG018|Overall Study|Lost to Follow-up|4|||
16226285|NCT01920061|39309932|FG019|Overall Study|Lost to Follow-up|3|||
16226286|NCT01920061|39309913|FG000|Overall Study|Other|1|||
16226287|NCT01920061|39309914|FG001|Overall Study|Other|1|||
16226288|NCT01920061|39309915|FG002|Overall Study|Other|2|||
16548208|NCT02118896|40470896|FG001|Overall Study|Pregnancy|1|||
16548209|NCT02118896|40470897|FG002|Overall Study|Pregnancy|0|||
16548210|NCT02118896|40470898|FG003|Overall Study|Pregnancy|0|||
16548211|NCT02118896|40470899|FG004|Overall Study|Pregnancy|1|||
16548212|NCT02118896|40470900|FG005|Overall Study|Pregnancy|3|||
16548213|NCT02118896|40470901|FG006|Overall Study|Pregnancy|1|||
16548214|NCT02118896|40470902|FG007|Overall Study|Pregnancy|0|||
16548215|NCT02118896|40470903|FG008|Overall Study|Pregnancy|0|||
16548216|NCT02118896|40470904|FG009|Overall Study|Pregnancy|0|||
16226289|NCT01920061|39309916|FG003|Overall Study|Other|1|||
16226290|NCT01920061|39309917|FG004|Overall Study|Other|0|||
16226291|NCT01920061|39309918|FG005|Overall Study|Other|1|||
16226292|NCT01920061|39309919|FG006|Overall Study|Other|0|||
16226293|NCT01920061|39309920|FG007|Overall Study|Other|0|||
16226294|NCT01920061|39309921|FG008|Overall Study|Other|0|||
16226295|NCT01920061|39309922|FG009|Overall Study|Other|1|||
16226296|NCT01920061|39309923|FG010|Overall Study|Other|1|||
16226297|NCT01920061|39309924|FG011|Overall Study|Other|2|||
16226298|NCT01920061|39309925|FG012|Overall Study|Other|1|||
16226299|NCT01920061|39309926|FG013|Overall Study|Other|4|||
16548217|NCT02118896|40470895|FG000|Overall Study|Lost to Follow-up|1|||
16173196|NCT02203149|39111119|FG002|Part 2|Withdrawal by Subject|0|||
16173197|NCT02203149|39111120|FG003|Part 2|Withdrawal by Subject|1|||
16173198|NCT02203149|39111121|FG004|Part 2|Withdrawal by Subject|0|||
16173199|NCT02203149|39111117|FG000|Part 2|Adverse Event|0|||
16173200|NCT02203149|39111118|FG001|Part 2|Adverse Event|0|||
16173201|NCT02203149|39111119|FG002|Part 2|Adverse Event|0|||
16173202|NCT02203149|39111120|FG003|Part 2|Adverse Event|1|||
16173203|NCT02203149|39111121|FG004|Part 2|Adverse Event|1|||
16226300|NCT01920061|39309927|FG014|Overall Study|Other|0|||
16548218|NCT02118896|40470896|FG001|Overall Study|Lost to Follow-up|2|||
16226301|NCT01920061|39309928|FG015|Overall Study|Other|1|||
16226302|NCT01920061|39309929|FG016|Overall Study|Other|1|||
16226303|NCT01920061|39309930|FG017|Overall Study|Other|0|||
16226304|NCT01920061|39309931|FG018|Overall Study|Other|1|||
16226305|NCT01920061|39309932|FG019|Overall Study|Other|1|||
16226306|NCT01920061|39309913|FG000|Overall Study|Participant refused further follow-up|0|||
16226307|NCT01920061|39309914|FG001|Overall Study|Participant refused further follow-up|0|||
16226308|NCT01920061|39309915|FG002|Overall Study|Participant refused further follow-up|0|||
16226309|NCT01920061|39309916|FG003|Overall Study|Participant refused further follow-up|0|||
16226310|NCT01920061|39309917|FG004|Overall Study|Participant refused further follow-up|1|||
16226311|NCT01920061|39309918|FG005|Overall Study|Participant refused further follow-up|1|||
16226312|NCT01920061|39309919|FG006|Overall Study|Participant refused further follow-up|0|||
16226313|NCT01920061|39309920|FG007|Overall Study|Participant refused further follow-up|0|||
16226314|NCT01920061|39309921|FG008|Overall Study|Participant refused further follow-up|1|||
16226315|NCT01920061|39309922|FG009|Overall Study|Participant refused further follow-up|0|||
16226316|NCT01920061|39309923|FG010|Overall Study|Participant refused further follow-up|1|||
16226317|NCT01920061|39309924|FG011|Overall Study|Participant refused further follow-up|0|||
16226318|NCT01920061|39309925|FG012|Overall Study|Participant refused further follow-up|1|||
16226319|NCT01920061|39309926|FG013|Overall Study|Participant refused further follow-up|0|||
16548219|NCT02118896|40470897|FG002|Overall Study|Lost to Follow-up|1|||
16548220|NCT02118896|40470898|FG003|Overall Study|Lost to Follow-up|0|||
16548221|NCT02118896|40470899|FG004|Overall Study|Lost to Follow-up|2|||
16548222|NCT02118896|40470900|FG005|Overall Study|Lost to Follow-up|1|||
16548223|NCT02118896|40470901|FG006|Overall Study|Lost to Follow-up|0|||
16548224|NCT02118896|40470902|FG007|Overall Study|Lost to Follow-up|0|||
16548225|NCT02118896|40470903|FG008|Overall Study|Lost to Follow-up|0|||
16548226|NCT02118896|40470904|FG009|Overall Study|Lost to Follow-up|0|||
16548227|NCT02118896|40470895|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
16548228|NCT02118896|40470896|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
16548229|NCT02118896|40470897|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
16548230|NCT02118896|40470898|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
16226320|NCT01920061|39309927|FG014|Overall Study|Participant refused further follow-up|1|||
16548231|NCT02118896|40470899|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
16548232|NCT02118896|40470900|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
16548233|NCT02118896|40470901|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
16548234|NCT02118896|40470902|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
16548235|NCT02118896|40470903|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
16548236|NCT02118896|40470904|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
16548237|NCT02118896|40470895|FG000|Overall Study|Prohibited medication|0|||
16548238|NCT02118896|40470896|FG001|Overall Study|Prohibited medication|0|||
16548239|NCT02118896|40470897|FG002|Overall Study|Prohibited medication|0|||
16226321|NCT01920061|39309928|FG015|Overall Study|Participant refused further follow-up|2|||
16226322|NCT01920061|39309929|FG016|Overall Study|Participant refused further follow-up|1|||
16226323|NCT01920061|39309930|FG017|Overall Study|Participant refused further follow-up|1|||
16226324|NCT01920061|39309931|FG018|Overall Study|Participant refused further follow-up|0|||
16226325|NCT01920061|39309932|FG019|Overall Study|Participant refused further follow-up|0|||
16226326|NCT01884675|39309933|FG000|Overall Study|Study closed/terminated|3|||
16226327|NCT01884675|39309934|FG001|Overall Study|Study closed/terminated|2|||
16226328|NCT00787527|39309935|FG000|Overall Study|Toxicity|3|||
16226329|NCT03007472|39309936|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
16226330|NCT03007472|39309936|FG000|Overall Study|Death|2|||
16226331|NCT03007472|39309936|FG000|Overall Study|Loss to Follow Up|1|||
16226332|NCT00561795|39309942|FG000|Overall Study|Adverse Event|3|||
16226333|NCT00561795|39309943|FG001|Overall Study|Adverse Event|3|||
16226334|NCT00561795|39309944|FG002|Overall Study|Adverse Event|0|||
16226335|NCT00561795|39309945|FG003|Overall Study|Adverse Event|0|||
16226336|NCT00561795|39309942|FG000|Overall Study|Study Closed/Terminated|0|||
16226337|NCT00561795|39309943|FG001|Overall Study|Study Closed/Terminated|3|||
16226338|NCT00561795|39309944|FG002|Overall Study|Study Closed/Terminated|0|||
16226339|NCT00561795|39309945|FG003|Overall Study|Study Closed/Terminated|0|||
16226340|NCT00561795|39309942|FG000|Overall Study|Physician Decision|1|||
16347420|NCT01827592|39757480|FG000|Overall Study|Lost to Follow-up|1|||
16548240|NCT02118896|40470898|FG003|Overall Study|Prohibited medication|0|||
16548241|NCT02118896|40470899|FG004|Overall Study|Prohibited medication|1|||
16548242|NCT02118896|40470900|FG005|Overall Study|Prohibited medication|3|||
16548243|NCT02118896|40470901|FG006|Overall Study|Prohibited medication|0|||
16548244|NCT02118896|40470902|FG007|Overall Study|Prohibited medication|0|||
16226341|NCT00561795|39309943|FG001|Overall Study|Physician Decision|0|||
16347421|NCT01827592|39757481|FG001|Overall Study|Lost to Follow-up|2|||
16226342|NCT00561795|39309944|FG002|Overall Study|Physician Decision|0|||
16226343|NCT00561795|39309945|FG003|Overall Study|Physician Decision|0|||
16226344|NCT01098266|39309948|FG000|Overall Study|Physician Decision|1|||
16226345|NCT01098266|39309949|FG001|Overall Study|Physician Decision|0|||
16226346|NCT01098266|39309948|FG000|Overall Study|Death|3|||
16226347|NCT01098266|39309949|FG001|Overall Study|Death|2|||
16226348|NCT01098266|39309948|FG000|Overall Study|Withdrawal by Subject|3|||
16226349|NCT01098266|39309949|FG001|Overall Study|Withdrawal by Subject|5|||
16226350|NCT01083121|39309950|FG000|Overall Study|Use of Humira outside the approved label|81|||
16226351|NCT03890731|39309951|FG000|Overall Study|Progressive disease|1|||
16226352|NCT03890731|39309951|FG000|Overall Study|Patient's decision|1|||
16226353|NCT03890731|39309951|FG000|Overall Study|Adverse Event|4|||
16548245|NCT02118896|40470903|FG008|Overall Study|Prohibited medication|0|||
16548246|NCT02118896|40470904|FG009|Overall Study|Prohibited medication|0|||
16548247|NCT02118896|40470895|FG000|Overall Study|Miscellaneous|1|||
16548248|NCT02118896|40470896|FG001|Overall Study|Miscellaneous|2|||
16548249|NCT02118896|40470897|FG002|Overall Study|Miscellaneous|0|||
16548250|NCT02118896|40470898|FG003|Overall Study|Miscellaneous|2|||
16548251|NCT02118896|40470899|FG004|Overall Study|Miscellaneous|0|||
16548252|NCT02118896|40470900|FG005|Overall Study|Miscellaneous|4|||
16548253|NCT02118896|40470901|FG006|Overall Study|Miscellaneous|0|||
16548254|NCT02118896|40470902|FG007|Overall Study|Miscellaneous|0|||
16548255|NCT02118896|40470903|FG008|Overall Study|Miscellaneous|0|||
16548256|NCT02118896|40470904|FG009|Overall Study|Miscellaneous|0|||
16548257|NCT00661661|40470905|FG000|Overall Study|Adverse Event|99|||
16226354|NCT00711009|39309965|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
16226355|NCT00711009|39309966|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
16226356|NCT00711009|39309965|FG000|Overall Study|Withdrawal by Subject|4|||
16226357|NCT00711009|39309966|FG001|Overall Study|Withdrawal by Subject|2|||
16226358|NCT00711009|39309965|FG000|Overall Study|Lost to Follow-up|3|||
16226359|NCT00711009|39309966|FG001|Overall Study|Lost to Follow-up|9|||
16226360|NCT00711009|39309965|FG000|Overall Study|Participant Noncompliant|0|||
16226361|NCT00711009|39309966|FG001|Overall Study|Participant Noncompliant|1|||
16226362|NCT00711009|39309965|FG000|Overall Study|Virologic Failure|2|||
16226363|NCT00711009|39309966|FG001|Overall Study|Virologic Failure|1|||
16226364|NCT00711009|39309965|FG000|Overall Study|Pregnancy|1|||
16226365|NCT00711009|39309966|FG001|Overall Study|Pregnancy|0|||
16226366|NCT00711009|39309965|FG000|Overall Study|Site closing|0|||
16226367|NCT00711009|39309966|FG001|Overall Study|Site closing|1|||
16226368|NCT00711009|39309965|FG000|Overall Study|Dose adjustment|1|||
16226369|NCT00711009|39309966|FG001|Overall Study|Dose adjustment|0|||
16226370|NCT00453349|39309967|FG000|Randomized|Adverse Event|12|||
16226371|NCT00453349|39309968|FG001|Randomized|Adverse Event|11|||
16226372|NCT00453349|39309967|FG000|Randomized|Lack of Efficacy|2|||
16226373|NCT00453349|39309968|FG001|Randomized|Lack of Efficacy|1|||
16226374|NCT00453349|39309967|FG000|Randomized|Lost to Follow-up|7|||
16226375|NCT00453349|39309968|FG001|Randomized|Lost to Follow-up|5|||
16226376|NCT00453349|39309967|FG000|Randomized|Protocol Violation|1|||
16226377|NCT00453349|39309968|FG001|Randomized|Protocol Violation|1|||
16226378|NCT00453349|39309967|FG000|Randomized|Withdrawal by Subject|3|||
16226379|NCT00453349|39309968|FG001|Randomized|Withdrawal by Subject|5|||
16226380|NCT00453349|39309967|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
16226381|NCT00453349|39309968|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
16226382|NCT00453349|39309967|FG000|Completed Study|Adverse Event|12|||
16226383|NCT00453349|39309968|FG001|Completed Study|Adverse Event|11|||
16226384|NCT00453349|39309967|FG000|Completed Study|Lack of Efficacy|2|||
16226385|NCT00453349|39309968|FG001|Completed Study|Lack of Efficacy|1|||
16226386|NCT00453349|39309967|FG000|Completed Study|Lost to Follow-up|7|||
16226387|NCT00453349|39309968|FG001|Completed Study|Lost to Follow-up|5|||
16226388|NCT00453349|39309967|FG000|Completed Study|Protocol Violation|1|||
16226389|NCT00453349|39309968|FG001|Completed Study|Protocol Violation|1|||
16226390|NCT00453349|39309967|FG000|Completed Study|Withdrawal by Subject|3|||
16226391|NCT00453349|39309968|FG001|Completed Study|Withdrawal by Subject|5|||
16226392|NCT00453349|39309967|FG000|Completed Study|Lost to follow up after study treatment|2|||
16226393|NCT00453349|39309968|FG001|Completed Study|Lost to follow up after study treatment|11|||
16226394|NCT02442284|39309970|FG000|Overall Study|Adverse Event|1|||
16226395|NCT02442284|39309970|FG000|Overall Study|Withdrew Consent|2|||
16226396|NCT02442284|39309970|FG000|Overall Study|Lost to Follow-up|3|||
16548258|NCT00661661|40470906|FG001|Overall Study|Adverse Event|24|||
16226397|NCT02442284|39309970|FG000|Overall Study|Other|1|||
16548259|NCT00661661|40470905|FG000|Overall Study|Lack of Efficacy|3|||
16548260|NCT00661661|40470906|FG001|Overall Study|Lack of Efficacy|2|||
16548261|NCT00661661|40470905|FG000|Overall Study|Lost to Follow-up|0|||
16548262|NCT00661661|40470906|FG001|Overall Study|Lost to Follow-up|1|||
16226398|NCT04391894|39309971|FG000|Overall Study|Adverse Event|1|||
16226399|NCT04391894|39309972|FG001|Overall Study|Adverse Event|1|||
16226400|NCT04391894|39309973|FG002|Overall Study|Adverse Event|1|||
16226401|NCT04391894|39309974|FG003|Overall Study|Adverse Event|1|||
16226402|NCT04391894|39309975|FG004|Overall Study|Adverse Event|1|||
16226403|NCT04391894|39309971|FG000|Overall Study|Lost to Follow-up|1|||
16226404|NCT04391894|39309972|FG001|Overall Study|Lost to Follow-up|0|||
16226405|NCT04391894|39309973|FG002|Overall Study|Lost to Follow-up|0|||
16226406|NCT04391894|39309974|FG003|Overall Study|Lost to Follow-up|0|||
16226407|NCT04391894|39309975|FG004|Overall Study|Lost to Follow-up|0|||
16226408|NCT04391894|39309971|FG000|Overall Study|Protocol Violation|0|||
16226409|NCT04391894|39309972|FG001|Overall Study|Protocol Violation|0|||
16226410|NCT04391894|39309973|FG002|Overall Study|Protocol Violation|0|||
16226411|NCT04391894|39309974|FG003|Overall Study|Protocol Violation|1|||
16226412|NCT04391894|39309975|FG004|Overall Study|Protocol Violation|0|||
16226413|NCT04391894|39309971|FG000|Overall Study|Withdrawal by Subject|2|||
16226414|NCT04391894|39309972|FG001|Overall Study|Withdrawal by Subject|0|||
16226415|NCT04391894|39309973|FG002|Overall Study|Withdrawal by Subject|3|||
16226416|NCT04391894|39309974|FG003|Overall Study|Withdrawal by Subject|0|||
16226417|NCT04391894|39309975|FG004|Overall Study|Withdrawal by Subject|1|||
16226418|NCT04391894|39309971|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
16226419|NCT04391894|39309972|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
16226420|NCT04391894|39309973|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
16226421|NCT04391894|39309974|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
16226422|NCT04391894|39309975|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
16226423|NCT03922945|39309976|FG000|Overall Study|Adverse Event|1|||
16226424|NCT03922945|39309977|FG001|Overall Study|Adverse Event|1|||
16226425|NCT03922945|39309978|FG002|Overall Study|Adverse Event|2|||
16226426|NCT03922945|39309976|FG000|Overall Study|Lost to Follow-up|13|||
16226427|NCT03922945|39309977|FG001|Overall Study|Lost to Follow-up|9|||
16226428|NCT03922945|39309978|FG002|Overall Study|Lost to Follow-up|20|||
16226429|NCT03922945|39309976|FG000|Overall Study|Lack of Efficacy|2|||
16226430|NCT03922945|39309977|FG001|Overall Study|Lack of Efficacy|0|||
16226431|NCT03922945|39309978|FG002|Overall Study|Lack of Efficacy|1|||
16226432|NCT03922945|39309976|FG000|Overall Study|Protocol Non-Compliance|0|||
16226433|NCT03922945|39309977|FG001|Overall Study|Protocol Non-Compliance|0|||
16226434|NCT03922945|39309978|FG002|Overall Study|Protocol Non-Compliance|1|||
16226435|NCT03922945|39309976|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
16226436|NCT03922945|39309977|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
16226437|NCT03922945|39309978|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
16226438|NCT03922945|39309976|FG000|Overall Study|All Other Personal Reasons|1|||
16226439|NCT03922945|39309977|FG001|Overall Study|All Other Personal Reasons|1|||
16226440|NCT03922945|39309978|FG002|Overall Study|All Other Personal Reasons|2|||
16226441|NCT00965562|39309983|FG000|Overall Study|Lost to Follow-up|1|||
16226442|NCT00965562|39309984|FG001|Overall Study|Lost to Follow-up|2|||
16226443|NCT00965562|39309985|FG002|Overall Study|Lost to Follow-up|3|||
16226444|NCT00965562|39309983|FG000|Overall Study|Withdrawal by Subject|2|||
16226445|NCT00965562|39309984|FG001|Overall Study|Withdrawal by Subject|2|||
16226446|NCT00965562|39309985|FG002|Overall Study|Withdrawal by Subject|0|||
16226447|NCT00561912|39309990|FG000|Overall Study|ineligible|1|||
16226448|NCT02539160|39309991|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
16226449|NCT02539160|39309992|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
16226450|NCT02539160|39309993|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
16226451|NCT02539160|39309994|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
16226452|NCT02539160|39309991|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
16226453|NCT02539160|39309992|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
16226454|NCT02539160|39309993|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
16226455|NCT02539160|39309994|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
16226456|NCT02539160|39309991|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
16226457|NCT02539160|39309992|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
16226458|NCT02539160|39309993|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
16226459|NCT02539160|39309994|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
16226460|NCT00496782|39309995|FG000|Overall Study|Protocol Violation|1|||
16226461|NCT00496782|39309996|FG001|Overall Study|Protocol Violation|2|||
16226462|NCT00374452|39309997|FG000|Overall Study|Left clinic before intervention started|4|||
16226463|NCT00374452|39309998|FG001|Overall Study|Left clinic before intervention started|1|||
16226464|NCT00374452|39309997|FG000|Overall Study|Change in job role before intervention|0|||
16226465|NCT00374452|39309998|FG001|Overall Study|Change in job role before intervention|1|||
16226466|NCT00374452|39309997|FG000|Overall Study|Left clinic after intervention started|1|||
16226467|NCT00374452|39309998|FG001|Overall Study|Left clinic after intervention started|1|||
16226468|NCT00374452|39309997|FG000|Overall Study|Withdrawal by Subject|0|||
16226469|NCT00374452|39309998|FG001|Overall Study|Withdrawal by Subject|2|||
16226470|NCT00450814|39309999|FG000|Overall Study|Failed to complete the initial therapy|0|||
16226471|NCT00450814|39310000|FG001|Overall Study|Failed to complete the initial therapy|0|||
16226472|NCT00450814|39310001|FG002|Overall Study|Failed to complete the initial therapy|0|||
16226473|NCT00450814|39310002|FG003|Overall Study|Failed to complete the initial therapy|1|||
16226474|NCT00450814|39310003|FG004|Overall Study|Failed to complete the initial therapy|1|||
16226475|NCT00450814|39310004|FG005|Overall Study|Failed to complete the initial therapy|1|||
16411039|NCT02639338|39985669|FG001|Overall Study|Randomized but Not Treated|1|||
16226476|NCT00450814|39310005|FG006|Overall Study|Failed to complete the initial therapy|0|||
16226477|NCT00450814|39310006|FG007|Overall Study|Failed to complete the initial therapy|0|||
16226478|NCT00450814|39310007|FG008|Overall Study|Failed to complete the initial therapy|0|||
16226479|NCT00450814|39310008|FG009|Overall Study|Failed to complete the initial therapy|0|||
16226480|NCT00450814|39310009|FG010|Overall Study|Failed to complete the initial therapy|0|||
16226481|NCT00450814|39309999|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
16226482|NCT00450814|39310000|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
16226483|NCT00450814|39310001|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
16226484|NCT00450814|39310002|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
16226485|NCT00450814|39310003|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
16226486|NCT00450814|39310004|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
16226487|NCT00450814|39310005|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
16226488|NCT00450814|39310006|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
16226489|NCT00450814|39310007|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
16226490|NCT00450814|39310008|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
16226491|NCT00450814|39310009|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
16226492|NCT01821391|39310014|FG000|Overall Study|Adverse Event|1|||
16226493|NCT01821391|39310015|FG001|Overall Study|Adverse Event|0|||
16226494|NCT02500732|39310016|FG000|Overall Study|Physician Decision|0|||
16226495|NCT02500732|39310017|FG001|Overall Study|Physician Decision|1|||
16226496|NCT01038609|39310018|FG000|Overall Study|Adverse Event|0|||
16226497|NCT01038609|39310019|FG001|Overall Study|Adverse Event|0|||
16226498|NCT01038609|39310020|FG002|Overall Study|Adverse Event|1|||
16226499|NCT01038609|39310021|FG003|Overall Study|Adverse Event|0|||
16226500|NCT01038609|39310022|FG004|Overall Study|Adverse Event|0|||
16226501|NCT01038609|39310018|FG000|Overall Study|Dosing Error|0|||
16226502|NCT01038609|39310019|FG001|Overall Study|Dosing Error|0|||
16226503|NCT01038609|39310020|FG002|Overall Study|Dosing Error|0|||
16226504|NCT01038609|39310021|FG003|Overall Study|Dosing Error|1|||
16226505|NCT01038609|39310022|FG004|Overall Study|Dosing Error|1|||
16226506|NCT01038609|39310018|FG000|Overall Study|Death in the Family|1|||
16226507|NCT01038609|39310019|FG001|Overall Study|Death in the Family|0|||
16226508|NCT01038609|39310020|FG002|Overall Study|Death in the Family|0|||
16226509|NCT01038609|39310021|FG003|Overall Study|Death in the Family|0|||
16226510|NCT01038609|39310022|FG004|Overall Study|Death in the Family|0|||
16226511|NCT01038609|39310018|FG000|Overall Study|Refusal of Blood Draws|0|||
16226512|NCT01038609|39310019|FG001|Overall Study|Refusal of Blood Draws|1|||
16226513|NCT01038609|39310020|FG002|Overall Study|Refusal of Blood Draws|0|||
16226514|NCT01038609|39310021|FG003|Overall Study|Refusal of Blood Draws|0|||
16226515|NCT01038609|39310022|FG004|Overall Study|Refusal of Blood Draws|0|||
16226516|NCT00808665|39310023|FG000|Overall Study|Withdrawal by Subject|1|||
16226517|NCT00808665|39310024|FG001|Overall Study|Withdrawal by Subject|0|||
16226518|NCT00808665|39310023|FG000|Overall Study|only required minimally invasive surgery|1|||
16226519|NCT00808665|39310024|FG001|Overall Study|only required minimally invasive surgery|0|||
16226520|NCT00808665|39310023|FG000|Overall Study|surgery cancelled|1|||
16226521|NCT00808665|39310024|FG001|Overall Study|surgery cancelled|0|||
16226522|NCT00808665|39310023|FG000|Overall Study|required an additional procedure|0|||
16226523|NCT00808665|39310024|FG001|Overall Study|required an additional procedure|1|||
16226524|NCT00808665|39310023|FG000|Overall Study|Physician Decision|3|||
16226525|NCT00808665|39310024|FG001|Overall Study|Physician Decision|1|||
16226526|NCT00808665|39310023|FG000|Overall Study|Medication stopped by resident|0|||
16226527|NCT00808665|39310024|FG001|Overall Study|Medication stopped by resident|1|||
16226528|NCT00877929|39310025|FG000|Overall Study|Adverse Event|11|||
16226529|NCT00877929|39310026|FG001|Overall Study|Adverse Event|20|||
16226530|NCT00877929|39310025|FG000|Overall Study|Protocol Violation|3|||
16226531|NCT00877929|39310026|FG001|Overall Study|Protocol Violation|3|||
16226532|NCT00877929|39310025|FG000|Overall Study|Lost to Follow-up|0|||
16226533|NCT00877929|39310026|FG001|Overall Study|Lost to Follow-up|1|||
16226534|NCT00877929|39310025|FG000|Overall Study|Withdrawal by Subject|4|||
16226535|NCT00877929|39310026|FG001|Overall Study|Withdrawal by Subject|4|||
16226536|NCT00877929|39310025|FG000|Overall Study|Lack of Efficacy|0|||
16226537|NCT00877929|39310026|FG001|Overall Study|Lack of Efficacy|1|||
16226538|NCT00877929|39310025|FG000|Overall Study|Other reason (not specified)|2|||
16226539|NCT00877929|39310026|FG001|Overall Study|Other reason (not specified)|6|||
16226540|NCT04576702|39310027|FG000|Overall Study|Death|1|||
16226541|NCT04576702|39310028|FG001|Overall Study|Death|0|||
16226542|NCT04576702|39310029|FG002|Overall Study|Death|0|||
16226543|NCT04576702|39310030|FG003|Overall Study|Death|0|||
16226544|NCT04576702|39310027|FG000|Overall Study|Withdrawal by Subject|0|||
16226545|NCT04576702|39310028|FG001|Overall Study|Withdrawal by Subject|2|||
16226546|NCT04576702|39310029|FG002|Overall Study|Withdrawal by Subject|1|||
16226547|NCT04576702|39310030|FG003|Overall Study|Withdrawal by Subject|0|||
16226548|NCT04576702|39310027|FG000|Overall Study|Lost to Follow-up|3|||
16226549|NCT04576702|39310028|FG001|Overall Study|Lost to Follow-up|3|||
16226550|NCT04576702|39310029|FG002|Overall Study|Lost to Follow-up|3|||
16226551|NCT04576702|39310030|FG003|Overall Study|Lost to Follow-up|4|||
16226552|NCT01003691|39310031|FG000|Overall Study|Adverse Event|0|||
16226553|NCT01003691|39310032|FG001|Overall Study|Adverse Event|0|||
16226554|NCT01003691|39310033|FG002|Overall Study|Adverse Event|0|||
16226555|NCT01003691|39310034|FG003|Overall Study|Adverse Event|1|||
16226556|NCT01349816|39310037|FG000|Overall Study|Withdrawal by Subject|4|||
16226557|NCT01349816|39310037|FG000|Overall Study|Physician Decision|1|||
16226558|NCT01349816|39310037|FG000|Overall Study|Adverse Event|14|||
16226559|NCT01349816|39310037|FG000|Overall Study|Lost to Follow-up|2|||
16226560|NCT01349816|39310037|FG000|Overall Study|Protocol Violation|1|||
16226561|NCT01349816|39310037|FG000|Overall Study|Protocol-specified criteria|8|||
16226562|NCT01233076|39310040|FG000|Period 2, One Week|Lost to Follow-up|1|||
16226563|NCT01233076|39310041|FG001|Period 2, One Week|Lost to Follow-up|0|||
16226564|NCT01317199|39310052|FG000|Dose-escalation Phase 1|Physician Decision|5|||
16226565|NCT01317199|39310053|FG001|Dose-escalation Phase 1|Physician Decision|0|||
16226566|NCT01317199|39310054|FG002|Dose-escalation Phase 1|Physician Decision|0|||
16226567|NCT01317199|39310055|FG003|Dose-escalation Phase 1|Physician Decision|0|||
16226568|NCT01317199|39310052|FG000|Dose-escalation Phase 1|Disease progression|1|||
16226569|NCT01317199|39310053|FG001|Dose-escalation Phase 1|Disease progression|0|||
16226570|NCT01317199|39310054|FG002|Dose-escalation Phase 1|Disease progression|0|||
16226571|NCT01317199|39310055|FG003|Dose-escalation Phase 1|Disease progression|0|||
16226572|NCT01317199|39310052|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
16226573|NCT01317199|39310053|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
16226574|NCT01317199|39310054|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
16226575|NCT01317199|39310055|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
16226576|NCT01317199|39310052|FG000|Randomized Phase 2|Disease progression|0|||
16226577|NCT01317199|39310053|FG001|Randomized Phase 2|Disease progression|3|||
16226578|NCT01317199|39310054|FG002|Randomized Phase 2|Disease progression|7|||
16226579|NCT01317199|39310055|FG003|Randomized Phase 2|Disease progression|5|||
16226580|NCT01317199|39310052|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
16226581|NCT01317199|39310053|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
16226582|NCT01317199|39310054|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
16226583|NCT01317199|39310055|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
16226584|NCT01317199|39310052|FG000|Randomized Phase 2|Adverse Event|0|||
16226585|NCT01317199|39310053|FG001|Randomized Phase 2|Adverse Event|0|||
16226586|NCT01317199|39310054|FG002|Randomized Phase 2|Adverse Event|0|||
16226587|NCT01317199|39310055|FG003|Randomized Phase 2|Adverse Event|1|||
16226588|NCT01317199|39310052|FG000|Randomized Phase 2|Comorbidities|0|||
16226589|NCT01317199|39310053|FG001|Randomized Phase 2|Comorbidities|2|||
16226590|NCT01317199|39310054|FG002|Randomized Phase 2|Comorbidities|2|||
16226591|NCT01317199|39310055|FG003|Randomized Phase 2|Comorbidities|2|||
16226592|NCT01317199|39310052|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
16226593|NCT01317199|39310053|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
16226594|NCT01317199|39310054|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
16226595|NCT01317199|39310055|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
16226596|NCT01317199|39310052|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
16226597|NCT01317199|39310053|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
16226598|NCT01317199|39310054|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
16226599|NCT01317199|39310055|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
16226600|NCT01317199|39310052|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
16226601|NCT01317199|39310053|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
16226602|NCT01317199|39310054|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
16226603|NCT01317199|39310055|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
16226604|NCT01317199|39310052|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
16226605|NCT01317199|39310053|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
16347422|NCT01827592|39757482|FG002|Overall Study|Lost to Follow-up|2|||
16347423|NCT01827592|39757480|FG000|Overall Study|Withdrawal by Subject|12|||
16226606|NCT01317199|39310054|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
16226607|NCT01317199|39310055|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
16226608|NCT03556202|39310056|FG000|Extension Treatment Period|Adverse Event|18|||
16226609|NCT03556202|39310057|FG001|Extension Treatment Period|Adverse Event|14|||
16226610|NCT03556202|39310058|FG002|Extension Treatment Period|Adverse Event|9|||
16226611|NCT03556202|39310056|FG000|Extension Treatment Period|Death|2|||
16226612|NCT03556202|39310057|FG001|Extension Treatment Period|Death|6|||
16226613|NCT03556202|39310058|FG002|Extension Treatment Period|Death|0|||
16226614|NCT03556202|39310056|FG000|Extension Treatment Period|Lack of Efficacy|5|||
16226615|NCT03556202|39310057|FG001|Extension Treatment Period|Lack of Efficacy|12|||
16226616|NCT03556202|39310058|FG002|Extension Treatment Period|Lack of Efficacy|18|||
16226617|NCT03556202|39310056|FG000|Extension Treatment Period|Lost to Follow-up|9|||
16226618|NCT03556202|39310057|FG001|Extension Treatment Period|Lost to Follow-up|20|||
16226619|NCT03556202|39310058|FG002|Extension Treatment Period|Lost to Follow-up|2|||
16226620|NCT03556202|39310056|FG000|Extension Treatment Period|Pregnancy|2|||
16226621|NCT03556202|39310057|FG001|Extension Treatment Period|Pregnancy|4|||
16226622|NCT03556202|39310058|FG002|Extension Treatment Period|Pregnancy|3|||
16226623|NCT03556202|39310056|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
16226624|NCT03556202|39310057|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
16226625|NCT03556202|39310058|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
16226626|NCT03556202|39310056|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
16226627|NCT03556202|39310057|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
16226628|NCT03556202|39310058|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
16226629|NCT03556202|39310056|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
16226630|NCT03556202|39310057|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
16226631|NCT03556202|39310058|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
16226632|NCT03556202|39310056|FG000|Extension Treatment Period|Physician Decision|0|||
16226633|NCT03556202|39310057|FG001|Extension Treatment Period|Physician Decision|8|||
16226634|NCT03556202|39310058|FG002|Extension Treatment Period|Physician Decision|2|||
16226635|NCT03556202|39310056|FG000|Extension Treatment Period|Protocol Violation|0|||
16226636|NCT03556202|39310057|FG001|Extension Treatment Period|Protocol Violation|1|||
16226637|NCT03556202|39310058|FG002|Extension Treatment Period|Protocol Violation|1|||
16226638|NCT03556202|39310056|FG000|Extension Treatment Period|Sponsor Decision|0|||
16226639|NCT03556202|39310057|FG001|Extension Treatment Period|Sponsor Decision|1|||
16226640|NCT03556202|39310058|FG002|Extension Treatment Period|Sponsor Decision|0|||
16226641|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
16226642|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
16226643|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
16226644|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Death|1|||
16226645|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Death|0|||
16226646|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Death|0|||
16226647|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
16226648|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
16226649|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
16226650|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
16226651|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
16226652|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
16226653|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
16226654|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
16226655|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
16226656|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
16226657|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
16226658|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
16226659|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
16226660|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
16226661|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
16226662|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
16226663|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
16226664|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
16226665|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
16226666|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
16226667|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
16226668|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
16226669|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
16226670|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
16226671|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
16226672|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
16226673|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
16226674|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
16226675|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
16226676|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
16226677|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
16226678|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
16226679|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
16226680|NCT03556202|39310056|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
16226681|NCT03556202|39310057|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
16226682|NCT03556202|39310058|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
16226683|NCT02534324|39310060|FG000|Overall Study|Protocol Violation|4|||
16226684|NCT02534324|39310061|FG001|Overall Study|Protocol Violation|1|||
16226685|NCT02534324|39310060|FG000|Overall Study|Lost to Follow-up|20|||
16226686|NCT02534324|39310061|FG001|Overall Study|Lost to Follow-up|7|||
16226687|NCT02534324|39310060|FG000|Overall Study|Adverse Event|1|||
16226688|NCT02534324|39310061|FG001|Overall Study|Adverse Event|0|||
16226689|NCT04996797|39310062|FG000|Overall Study|Adverse Event|0|||
16226690|NCT04996797|39310063|FG001|Overall Study|Adverse Event|2|||
16226691|NCT04996797|39310064|FG002|Overall Study|Adverse Event|0|||
16226692|NCT04996797|39310065|FG003|Overall Study|Adverse Event|1|||
16226693|NCT04996797|39310062|FG000|Overall Study|Lack of Efficacy|0|||
16226694|NCT04996797|39310063|FG001|Overall Study|Lack of Efficacy|2|||
16226695|NCT04996797|39310064|FG002|Overall Study|Lack of Efficacy|0|||
16226696|NCT04996797|39310065|FG003|Overall Study|Lack of Efficacy|0|||
16226697|NCT04996797|39310062|FG000|Overall Study|Prohibited Medication|0|||
16226698|NCT04996797|39310063|FG001|Overall Study|Prohibited Medication|1|||
16226699|NCT04996797|39310064|FG002|Overall Study|Prohibited Medication|0|||
16226700|NCT04996797|39310065|FG003|Overall Study|Prohibited Medication|0|||
16226701|NCT04996797|39310062|FG000|Overall Study|Ongoing|68|||
16226702|NCT04996797|39310063|FG001|Overall Study|Ongoing|60|||
16226703|NCT04996797|39310064|FG002|Overall Study|Ongoing|22|||
16226704|NCT04996797|39310065|FG003|Overall Study|Ongoing|20|||
16226705|NCT04996797|39310062|FG000|Overall Study|Withdrawal by Subject|0|||
16226706|NCT04996797|39310063|FG001|Overall Study|Withdrawal by Subject|2|||
16226707|NCT04996797|39310064|FG002|Overall Study|Withdrawal by Subject|0|||
16226708|NCT04996797|39310065|FG003|Overall Study|Withdrawal by Subject|0|||
16226709|NCT02275052|39310066|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16226710|NCT02275052|39310067|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
16226711|NCT02275052|39310068|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16226712|NCT02275052|39310069|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16226713|NCT02275052|39310066|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
16226714|NCT02275052|39310067|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
16226715|NCT02275052|39310068|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
16226716|NCT02275052|39310069|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
16226717|NCT02275052|39310066|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
16226718|NCT02275052|39310067|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
16226719|NCT02275052|39310068|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16226720|NCT02275052|39310069|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16226721|NCT02275052|39310066|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
16226722|NCT02275052|39310067|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
16226723|NCT02275052|39310068|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
16226724|NCT02275052|39310069|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
16226725|NCT02275052|39310066|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
16226726|NCT02275052|39310067|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
16226727|NCT02275052|39310068|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
16226728|NCT02275052|39310069|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
16226729|NCT02275052|39310066|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
16226730|NCT02275052|39310067|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
16226731|NCT02275052|39310068|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
16226732|NCT02275052|39310069|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
16226733|NCT02275052|39310066|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
16226734|NCT02275052|39310067|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
16226735|NCT02275052|39310068|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
16226736|NCT02275052|39310069|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
16226737|NCT02275052|39310066|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
16226738|NCT02275052|39310067|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
16226739|NCT02275052|39310068|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
16226740|NCT02275052|39310069|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
16548263|NCT00661661|40470905|FG000|Overall Study|Withdrawal by Subject|15|||
16115457|NCT02493946|38909627|FG002|Open Label Period|Investigator decision, non-availability|1|||
16226741|NCT02275052|39310066|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16226742|NCT02275052|39310067|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16226743|NCT02275052|39310068|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16226744|NCT02275052|39310069|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
16226745|NCT02275052|39310066|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
16226746|NCT02275052|39310067|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
16226747|NCT02275052|39310068|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
16226748|NCT02275052|39310069|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
16226749|NCT02275052|39310066|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16226750|NCT02275052|39310067|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16226751|NCT02275052|39310068|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16226752|NCT02275052|39310069|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
16226753|NCT01130831|39310070|FG000|Overall Study|Withdrawal by Subject|7|||
16226754|NCT01130831|39310070|FG000|Overall Study|Death|4|||
16226755|NCT01130831|39310070|FG000|Overall Study|Information was missing|3|||
16226756|NCT00752895|39310073|FG000|Overall Study|Withdrawal by Subject|8|||
16226757|NCT00752895|39310074|FG001|Overall Study|Withdrawal by Subject|3|||
16411040|NCT02654236|39985670|FG000|Overall Study|Withdrawal by Subject|0|||
16411041|NCT02654236|39985671|FG001|Overall Study|Withdrawal by Subject|0|||
16411042|NCT02654236|39985672|FG002|Overall Study|Withdrawal by Subject|2|||
16411043|NCT00740714|39985674|FG000|Overall Study|Withdrawal by Subject|17|||
16411044|NCT00740714|39985675|FG001|Overall Study|Withdrawal by Subject|19|||
16411045|NCT00740714|39985676|FG002|Overall Study|Withdrawal by Subject|29|||
16226758|NCT03726320|39310076|FG000|Overall Study|Lost to Follow-up|2|||
16226759|NCT03726320|39310077|FG001|Overall Study|Lost to Follow-up|4|||
16226760|NCT03726320|39310078|FG002|Overall Study|Lost to Follow-up|0|||
16226761|NCT03726320|39310076|FG000|Overall Study|Time Constraints|4|||
16226762|NCT03726320|39310077|FG001|Overall Study|Time Constraints|1|||
16226763|NCT03726320|39310078|FG002|Overall Study|Time Constraints|0|||
16226764|NCT03726320|39310076|FG000|Overall Study|Ineligible after enrollment|3|||
16226765|NCT03726320|39310077|FG001|Overall Study|Ineligible after enrollment|3|||
16226766|NCT03726320|39310078|FG002|Overall Study|Ineligible after enrollment|0|||
16226767|NCT03726320|39310076|FG000|Overall Study|Clinic / insurance issue|2|||
16226768|NCT03726320|39310077|FG001|Overall Study|Clinic / insurance issue|0|||
16226769|NCT03726320|39310078|FG002|Overall Study|Clinic / insurance issue|0|||
16226770|NCT03726320|39310076|FG000|Overall Study|Language barrier|1|||
16226771|NCT03726320|39310077|FG001|Overall Study|Language barrier|0|||
16226772|NCT03726320|39310078|FG002|Overall Study|Language barrier|0|||
16226773|NCT03726320|39310076|FG000|Overall Study|Provider left the clinic|0|||
16226774|NCT03726320|39310077|FG001|Overall Study|Provider left the clinic|0|||
16226775|NCT03726320|39310078|FG002|Overall Study|Provider left the clinic|1|||
16226776|NCT03633461|39310081|FG000|Overall Study|Lost to Follow-up|0|||
16226777|NCT03633461|39310082|FG001|Overall Study|Lost to Follow-up|1|||
16411046|NCT01646203|39985685|FG000|Overall Study|Adverse Event|2|||
16411047|NCT01646203|39985686|FG001|Overall Study|Adverse Event|0|||
16411048|NCT01646203|39985687|FG002|Overall Study|Adverse Event|1|||
16411049|NCT01646203|39985685|FG000|Overall Study|Withdrawal by Subject|0|||
16411050|NCT01646203|39985686|FG001|Overall Study|Withdrawal by Subject|1|||
16411051|NCT01646203|39985687|FG002|Overall Study|Withdrawal by Subject|0|||
16548264|NCT00661661|40470906|FG001|Overall Study|Withdrawal by Subject|5|||
16548265|NCT00661661|40470905|FG000|Overall Study|Other|22|||
16548266|NCT00661661|40470906|FG001|Overall Study|Other|7|||
16548267|NCT00661661|40470905|FG000|Overall Study|Not assigned treatment|1|||
16548268|NCT00661661|40470906|FG001|Overall Study|Not assigned treatment|0|||
16548269|NCT02917941|40470907|FG000|Treatment Period|Adverse Event|11|||
16548270|NCT02917941|40470907|FG000|Treatment Period|Progressive Disease|11|||
16548271|NCT02917941|40470907|FG000|Treatment Period|Reason not Specified|2|||
16548272|NCT02917941|40470907|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
16548273|NCT02917941|40470907|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
16548274|NCT01802437|40470919|FG000|Overall Study|Lost to Follow-up|1|||
16548275|NCT01802437|40470920|FG001|Overall Study|Lost to Follow-up|0|||
16548276|NCT01802437|40470919|FG000|Overall Study|Withdrawal by Subject|3|||
16548277|NCT01802437|40470920|FG001|Overall Study|Withdrawal by Subject|4|||
16548278|NCT00882921|40470921|FG000|Overall Study|Death|2|||
16548279|NCT00882921|40470921|FG000|Overall Study|Other|3|||
16548280|NCT00882921|40470921|FG000|Overall Study|Lost to Follow-up|2|||
16548281|NCT00882921|40470921|FG000|Overall Study|Termination By Investigator|3|||
16548282|NCT00882921|40470921|FG000|Overall Study|Withdrawal Of Consent|1|||
16226778|NCT03798366|39310085|FG000|Overall Study|Lost to Follow-up|0|||
16226779|NCT03798366|39310086|FG001|Overall Study|Lost to Follow-up|1|||
16226780|NCT02706327|39310087|FG000|Overall Study|Lost to Follow-up|1|||
16226781|NCT02706327|39310088|FG001|Overall Study|Lost to Follow-up|1|||
16226782|NCT02706327|39310089|FG002|Overall Study|Lost to Follow-up|2|||
16226783|NCT00401726|39310090|FG000|Overall Study|Adverse Event|34|||
16226784|NCT00401726|39310091|FG001|Overall Study|Adverse Event|45|||
16411052|NCT01646203|39985685|FG000|Overall Study|Physician's Decision|0|||
16548283|NCT02401308|40470922|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
16548284|NCT02401308|40470923|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
16548285|NCT02281760|40470925|FG000|Overall Study|Withdrawal by Subject|1|||
16548286|NCT01642602|40470929|FG000|Overall Study|Adverse Event|2|||
16548287|NCT00301080|40470934|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
16548288|NCT00301080|40470935|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
16411053|NCT01646203|39985686|FG001|Overall Study|Physician's Decision|1|||
16411054|NCT01646203|39985687|FG002|Overall Study|Physician's Decision|0|||
16411055|NCT01036529|39985690|FG000|Overall Study|Adverse Event|0|||
16411056|NCT01036529|39985691|FG001|Overall Study|Adverse Event|1|||
16411057|NCT01036529|39985690|FG000|Overall Study|Lost to Follow-up|0|||
16411058|NCT01036529|39985691|FG001|Overall Study|Lost to Follow-up|1|||
16411059|NCT01036529|39985690|FG000|Overall Study|Physician Decision|1|||
16411060|NCT01036529|39985691|FG001|Overall Study|Physician Decision|0|||
16411061|NCT01036529|39985690|FG000|Overall Study|Withdrawal by Subject|1|||
16411062|NCT01036529|39985691|FG001|Overall Study|Withdrawal by Subject|1|||
16411063|NCT01036529|39985690|FG000|Overall Study|Sponsor study termination|11|||
16411064|NCT01036529|39985691|FG001|Overall Study|Sponsor study termination|12|||
16411065|NCT00993499|39985694|FG000|Run-in Period (8 Days)|Adverse Event|0|||
16411066|NCT00993499|39985695|FG001|Run-in Period (8 Days)|Adverse Event|1|||
16548289|NCT00301080|40470936|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
16548290|NCT00301080|40470937|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
16548291|NCT00301080|40470938|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
16548292|NCT02635724|40470940|FG000|Overall Study|Withdrawal by Subject|0|||
16226785|NCT00401726|39310090|FG000|Overall Study|Death|0|||
16548293|NCT02635724|40470941|FG001|Overall Study|Withdrawal by Subject|1|||
16548294|NCT02635724|40470942|FG002|Overall Study|Withdrawal by Subject|0|||
16548295|NCT01014975|40470943|FG000|Overall Study|Withdrawal by Subject|1|||
16548296|NCT01014975|40470944|FG001|Overall Study|Withdrawal by Subject|0|||
16226786|NCT00401726|39310091|FG001|Overall Study|Death|3|||
16226787|NCT00401726|39310090|FG000|Overall Study|Sponsor Request|0|||
16226788|NCT00401726|39310091|FG001|Overall Study|Sponsor Request|1|||
16226789|NCT00401726|39310090|FG000|Overall Study|Physician Decision|3|||
16226790|NCT00401726|39310091|FG001|Overall Study|Physician Decision|6|||
16226791|NCT00401726|39310090|FG000|Overall Study|Lost to Follow-up|23|||
16226792|NCT00401726|39310091|FG001|Overall Study|Lost to Follow-up|20|||
16226793|NCT00401726|39310090|FG000|Overall Study|Protocol Violation|6|||
16226794|NCT00401726|39310091|FG001|Overall Study|Protocol Violation|3|||
16226795|NCT00401726|39310090|FG000|Overall Study|Withdrawal by Subject|18|||
16226796|NCT00401726|39310091|FG001|Overall Study|Withdrawal by Subject|24|||
16226797|NCT00401726|39310090|FG000|Overall Study|Lack of Efficacy|4|||
16226798|NCT00401726|39310091|FG001|Overall Study|Lack of Efficacy|6|||
16226799|NCT00401726|39310090|FG000|Overall Study|Protocol Deviation|9|||
16226800|NCT00401726|39310091|FG001|Overall Study|Protocol Deviation|4|||
16226801|NCT00960869|39310093|FG000|Overall Study|Adverse Event|17|||
16226802|NCT00960869|39310094|FG001|Overall Study|Adverse Event|26|||
16226803|NCT00960869|39310093|FG000|Overall Study|Withdrawal by Subject|16|||
16226804|NCT00960869|39310094|FG001|Overall Study|Withdrawal by Subject|14|||
16226805|NCT00960869|39310093|FG000|Overall Study|Lost to Follow-up|1|||
16226806|NCT00960869|39310094|FG001|Overall Study|Lost to Follow-up|4|||
16226807|NCT00960869|39310093|FG000|Overall Study|Misc|19|||
16226808|NCT00960869|39310094|FG001|Overall Study|Misc|18|||
16226809|NCT04212221|39310095|FG000|Overall Study|Remained on Treatment|0|||
16226810|NCT04212221|39310096|FG001|Overall Study|Remained on Treatment|0|||
16226811|NCT04212221|39310097|FG002|Overall Study|Remained on Treatment|0|||
16226812|NCT04212221|39310098|FG003|Overall Study|Remained on Treatment|1|||
16226813|NCT04212221|39310099|FG004|Overall Study|Remained on Treatment|0|||
16226814|NCT04212221|39310100|FG005|Overall Study|Remained on Treatment|0|||
16226815|NCT04212221|39310101|FG006|Overall Study|Remained on Treatment|3|||
16226816|NCT04212221|39310102|FG007|Overall Study|Remained on Treatment|9|||
16226817|NCT04212221|39310095|FG000|Overall Study|Adverse Event|0|||
16226818|NCT04212221|39310096|FG001|Overall Study|Adverse Event|0|||
16226819|NCT04212221|39310097|FG002|Overall Study|Adverse Event|0|||
16226820|NCT04212221|39310098|FG003|Overall Study|Adverse Event|0|||
16226821|NCT04212221|39310099|FG004|Overall Study|Adverse Event|0|||
16548297|NCT01014975|40470945|FG002|Overall Study|Withdrawal by Subject|1|||
16115458|NCT02493946|38909625|FG000|Open Label Period|Pregnancy|0|||
16226822|NCT04212221|39310100|FG005|Overall Study|Adverse Event|0|||
16226823|NCT04212221|39310101|FG006|Overall Study|Adverse Event|2|||
16411067|NCT00993499|39985696|FG002|Run-in Period (8 Days)|Adverse Event|0|||
16226824|NCT04212221|39310102|FG007|Overall Study|Adverse Event|3|||
16226825|NCT04212221|39310095|FG000|Overall Study|Death|0|||
16226826|NCT04212221|39310096|FG001|Overall Study|Death|0|||
16226827|NCT04212221|39310097|FG002|Overall Study|Death|0|||
16226828|NCT04212221|39310098|FG003|Overall Study|Death|0|||
16226829|NCT04212221|39310099|FG004|Overall Study|Death|0|||
16226830|NCT04212221|39310100|FG005|Overall Study|Death|0|||
16226831|NCT04212221|39310101|FG006|Overall Study|Death|0|||
16226832|NCT04212221|39310102|FG007|Overall Study|Death|2|||
16226833|NCT04212221|39310095|FG000|Overall Study|Disease progression according to irRECIST|1|||
16226834|NCT04212221|39310096|FG001|Overall Study|Disease progression according to irRECIST|2|||
16226835|NCT04212221|39310097|FG002|Overall Study|Disease progression according to irRECIST|3|||
16226836|NCT04212221|39310098|FG003|Overall Study|Disease progression according to irRECIST|3|||
16226837|NCT04212221|39310099|FG004|Overall Study|Disease progression according to irRECIST|2|||
16226838|NCT04212221|39310100|FG005|Overall Study|Disease progression according to irRECIST|2|||
16226839|NCT04212221|39310101|FG006|Overall Study|Disease progression according to irRECIST|21|||
16548298|NCT01014975|40470943|FG000|Overall Study|Death|3|||
16548299|NCT01014975|40470944|FG001|Overall Study|Death|3|||
16548300|NCT01014975|40470945|FG002|Overall Study|Death|4|||
16548301|NCT01014975|40470943|FG000|Overall Study|Lost to Follow-up|0|||
16548302|NCT01014975|40470944|FG001|Overall Study|Lost to Follow-up|0|||
16548303|NCT01014975|40470945|FG002|Overall Study|Lost to Follow-up|1|||
16548304|NCT00926003|40470946|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
16226840|NCT04212221|39310102|FG007|Overall Study|Disease progression according to irRECIST|17|||
16226841|NCT04212221|39310095|FG000|Overall Study|Global Deterioration of Health Status|0|||
16226842|NCT04212221|39310096|FG001|Overall Study|Global Deterioration of Health Status|0|||
16226843|NCT04212221|39310097|FG002|Overall Study|Global Deterioration of Health Status|0|||
16226844|NCT04212221|39310098|FG003|Overall Study|Global Deterioration of Health Status|0|||
16226845|NCT04212221|39310099|FG004|Overall Study|Global Deterioration of Health Status|0|||
16226846|NCT04212221|39310100|FG005|Overall Study|Global Deterioration of Health Status|0|||
16226847|NCT04212221|39310101|FG006|Overall Study|Global Deterioration of Health Status|0|||
16226848|NCT04212221|39310102|FG007|Overall Study|Global Deterioration of Health Status|2|||
16226849|NCT04212221|39310095|FG000|Overall Study|Investigator's Decision|0|||
16226850|NCT04212221|39310096|FG001|Overall Study|Investigator's Decision|0|||
16226851|NCT04212221|39310097|FG002|Overall Study|Investigator's Decision|0|||
16226852|NCT04212221|39310098|FG003|Overall Study|Investigator's Decision|1|||
16226853|NCT04212221|39310099|FG004|Overall Study|Investigator's Decision|0|||
16226854|NCT04212221|39310100|FG005|Overall Study|Investigator's Decision|0|||
16226855|NCT04212221|39310101|FG006|Overall Study|Investigator's Decision|3|||
16226856|NCT04212221|39310102|FG007|Overall Study|Investigator's Decision|0|||
16226857|NCT04212221|39310095|FG000|Overall Study|Participant refused to continue treatment|0|||
16226858|NCT04212221|39310096|FG001|Overall Study|Participant refused to continue treatment|1|||
16226859|NCT04212221|39310097|FG002|Overall Study|Participant refused to continue treatment|0|||
16226860|NCT04212221|39310098|FG003|Overall Study|Participant refused to continue treatment|1|||
16226861|NCT04212221|39310099|FG004|Overall Study|Participant refused to continue treatment|1|||
16226862|NCT04212221|39310100|FG005|Overall Study|Participant refused to continue treatment|2|||
16226863|NCT04212221|39310101|FG006|Overall Study|Participant refused to continue treatment|4|||
16226864|NCT04212221|39310102|FG007|Overall Study|Participant refused to continue treatment|2|||
16226865|NCT04212221|39310095|FG000|Overall Study|Protocol Violation|0|||
16226866|NCT04212221|39310096|FG001|Overall Study|Protocol Violation|0|||
16226867|NCT04212221|39310097|FG002|Overall Study|Protocol Violation|0|||
16226868|NCT04212221|39310098|FG003|Overall Study|Protocol Violation|0|||
16226869|NCT04212221|39310099|FG004|Overall Study|Protocol Violation|0|||
16226870|NCT04212221|39310100|FG005|Overall Study|Protocol Violation|0|||
16226871|NCT04212221|39310101|FG006|Overall Study|Protocol Violation|0|||
16226872|NCT04212221|39310102|FG007|Overall Study|Protocol Violation|1|||
16226873|NCT01005966|39310103|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
16226874|NCT01005966|39310104|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
16226875|NCT01005966|39310105|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
16226876|NCT01005966|39310106|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
16226877|NCT01005966|39310107|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
16226878|NCT01005966|39310103|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
16226879|NCT01005966|39310104|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
16226880|NCT01005966|39310105|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
16548305|NCT00926003|40470947|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
16548306|NCT00926003|40470948|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
16548307|NCT00926003|40470946|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
16548308|NCT00926003|40470947|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
16548309|NCT00926003|40470948|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
16548310|NCT01446796|40470949|FG000|Overall Study|Withdrawal by Subject|1|||
16548311|NCT01446796|40470950|FG001|Overall Study|Withdrawal by Subject|0|||
16548312|NCT02588261|40470951|FG000|Overall Study|Study Terminated by Sponsor|157|||
16226881|NCT01005966|39310106|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
16226882|NCT01005966|39310107|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
16548313|NCT02588261|40470952|FG001|Overall Study|Study Terminated by Sponsor|142|||
16548314|NCT02588261|40470951|FG000|Overall Study|Protocol Deviation|1|||
16548315|NCT02588261|40470952|FG001|Overall Study|Protocol Deviation|0|||
16548316|NCT02588261|40470951|FG000|Overall Study|Death|1|||
16548317|NCT02588261|40470952|FG001|Overall Study|Death|2|||
16548318|NCT02588261|40470951|FG000|Overall Study|Withdrawal by Subject|12|||
16548319|NCT02588261|40470952|FG001|Overall Study|Withdrawal by Subject|8|||
16411068|NCT00993499|39985697|FG003|Run-in Period (8 Days)|Adverse Event|0|||
16411069|NCT00993499|39985698|FG004|Run-in Period (8 Days)|Adverse Event|0|||
16411070|NCT00993499|39985699|FG005|Run-in Period (8 Days)|Adverse Event|0|||
16411071|NCT00993499|39985694|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
16411072|NCT00993499|39985695|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
16548320|NCT02588261|40470951|FG000|Overall Study|Noncompliance with Study Drug|0|||
16548321|NCT02588261|40470952|FG001|Overall Study|Noncompliance with Study Drug|1|||
16548322|NCT02588261|40470951|FG000|Overall Study|Miscellaneous|5|||
16226883|NCT01005966|39310103|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
16226884|NCT01005966|39310104|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
16115459|NCT02493946|38909626|FG001|Open Label Period|Pregnancy|0|||
16115460|NCT02493946|38909627|FG002|Open Label Period|Pregnancy|3|||
16115461|NCT02493946|38909625|FG000|Open Label Period|Site error|0|||
16115462|NCT02493946|38909626|FG001|Open Label Period|Site error|0|||
16115463|NCT02493946|38909627|FG002|Open Label Period|Site error|1|||
16115464|NCT03712449|38909628|FG000|Overall Study|Withdraw Consent|0|||
16115465|NCT03712449|38909629|FG001|Overall Study|Withdraw Consent|1|||
16115466|NCT03392168|38909630|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
16115467|NCT03392168|38909631|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
16115468|NCT03392168|38909632|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
16115469|NCT03392168|38909633|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
16115470|NCT03392168|38909630|FG000|Period 2: Cohort 2|Other|0|||
16115471|NCT03392168|38909631|FG001|Period 2: Cohort 2|Other|1|||
16115472|NCT03392168|38909632|FG002|Period 2: Cohort 2|Other|0|||
16115473|NCT03392168|38909633|FG003|Period 2: Cohort 2|Other|0|||
16115474|NCT02127125|38909634|FG000|Overall Study|Lost to Follow-up|0|||
16115475|NCT02127125|38909635|FG001|Overall Study|Lost to Follow-up|0|||
16115476|NCT02127125|38909636|FG002|Overall Study|Lost to Follow-up|0|||
16115477|NCT02127125|38909637|FG003|Overall Study|Lost to Follow-up|0|||
16115478|NCT02127125|38909638|FG004|Overall Study|Lost to Follow-up|2|||
16548323|NCT02588261|40470952|FG001|Overall Study|Miscellaneous|4|||
16115479|NCT02127125|38909639|FG005|Overall Study|Lost to Follow-up|1|||
16115480|NCT02127125|38909640|FG006|Overall Study|Lost to Follow-up|0|||
16115481|NCT02127125|38909641|FG007|Overall Study|Lost to Follow-up|0|||
16115482|NCT02127125|38909642|FG008|Overall Study|Lost to Follow-up|0|||
16115483|NCT02127125|38909634|FG000|Overall Study|Withdrawal by Subject|0|||
16548324|NCT02588261|40470951|FG000|Overall Study|Progressive Disease|61|||
16115484|NCT02127125|38909635|FG001|Overall Study|Withdrawal by Subject|0|||
16548325|NCT02588261|40470952|FG001|Overall Study|Progressive Disease|82|||
16548326|NCT02588261|40470951|FG000|Overall Study|Adverse Event|29|||
16115485|NCT02127125|38909636|FG002|Overall Study|Withdrawal by Subject|0|||
16115486|NCT02127125|38909637|FG003|Overall Study|Withdrawal by Subject|1|||
16115487|NCT02127125|38909638|FG004|Overall Study|Withdrawal by Subject|0|||
16115488|NCT02127125|38909639|FG005|Overall Study|Withdrawal by Subject|0|||
16115489|NCT02127125|38909640|FG006|Overall Study|Withdrawal by Subject|0|||
16115490|NCT02127125|38909641|FG007|Overall Study|Withdrawal by Subject|0|||
16115491|NCT02127125|38909642|FG008|Overall Study|Withdrawal by Subject|0|||
16115492|NCT02127125|38909634|FG000|Overall Study|Physician Decision|0|||
16115493|NCT02127125|38909635|FG001|Overall Study|Physician Decision|0|||
16115494|NCT02127125|38909636|FG002|Overall Study|Physician Decision|1|||
16115495|NCT02127125|38909637|FG003|Overall Study|Physician Decision|0|||
16115496|NCT02127125|38909638|FG004|Overall Study|Physician Decision|1|||
16115497|NCT02127125|38909639|FG005|Overall Study|Physician Decision|2|||
16115498|NCT02127125|38909640|FG006|Overall Study|Physician Decision|0|||
16115499|NCT02127125|38909641|FG007|Overall Study|Physician Decision|0|||
16115500|NCT02127125|38909642|FG008|Overall Study|Physician Decision|0|||
16115501|NCT00351377|38909643|FG000|Overall Study|Adverse Event|5|||
16115502|NCT00351377|38909643|FG000|Overall Study|Death|1|||
16115503|NCT00351377|38909643|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16115504|NCT00203047|38909644|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
16115505|NCT00203047|38909645|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
16115506|NCT00203047|38909644|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
16115507|NCT00203047|38909645|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
16115508|NCT00203047|38909644|FG000|Overall Study|Withdrawal by Subject|13|||
16115509|NCT00203047|38909645|FG001|Overall Study|Withdrawal by Subject|47|||
16115510|NCT00203047|38909644|FG000|Overall Study|Teva requested participant withdrawal|1|||
16115511|NCT00203047|38909645|FG001|Overall Study|Teva requested participant withdrawal|1|||
16115512|NCT00203047|38909644|FG000|Overall Study|Physician Decision|8|||
16115513|NCT00203047|38909645|FG001|Overall Study|Physician Decision|7|||
16115514|NCT00203047|38909644|FG000|Overall Study|Non-compliance|4|||
16115515|NCT00203047|38909645|FG001|Overall Study|Non-compliance|8|||
16115516|NCT00203047|38909644|FG000|Overall Study|Protocol Violation|1|||
16115517|NCT00203047|38909645|FG001|Overall Study|Protocol Violation|0|||
16115518|NCT00203047|38909644|FG000|Overall Study|Lost to Follow-up|11|||
16115519|NCT00203047|38909645|FG001|Overall Study|Lost to Follow-up|5|||
16548327|NCT02588261|40470952|FG001|Overall Study|Adverse Event|24|||
16548328|NCT02588261|40470951|FG000|Overall Study|Lost to Follow-up|1|||
16548329|NCT02588261|40470952|FG001|Overall Study|Lost to Follow-up|0|||
16548330|NCT00861614|40470957|FG000|Overall Study|Disease Progression|182|||
16548331|NCT00861614|40470958|FG001|Overall Study|Disease Progression|263|||
16548332|NCT00861614|40470957|FG000|Overall Study|Study Drug Toxicity|79|||
16548333|NCT00861614|40470958|FG001|Overall Study|Study Drug Toxicity|6|||
16548334|NCT00861614|40470957|FG000|Overall Study|Death|32|||
16548335|NCT00861614|40470958|FG001|Overall Study|Death|19|||
16548336|NCT00861614|40470957|FG000|Overall Study|Adverse Event|27|||
16548337|NCT00861614|40470958|FG001|Overall Study|Adverse Event|23|||
16548338|NCT00861614|40470957|FG000|Overall Study|Withdrawal by Subject|34|||
16548339|NCT00861614|40470958|FG001|Overall Study|Withdrawal by Subject|35|||
16548340|NCT00861614|40470957|FG000|Overall Study|Other|17|||
16548341|NCT00861614|40470958|FG001|Overall Study|Other|22|||
16548342|NCT01054573|40470959|FG000|Overall Study|Adverse Event|1|||
16548343|NCT01054573|40470960|FG001|Overall Study|Adverse Event|0|||
16548344|NCT01054573|40470961|FG002|Overall Study|Adverse Event|1|||
16548345|NCT01054573|40470962|FG003|Overall Study|Adverse Event|1|||
16548346|NCT01054573|40470959|FG000|Overall Study|Lost to Follow-up|0|||
16548347|NCT01054573|40470960|FG001|Overall Study|Lost to Follow-up|2|||
16548348|NCT01054573|40470961|FG002|Overall Study|Lost to Follow-up|0|||
16115520|NCT00203047|38909644|FG000|Overall Study|Adverse Event|8|||
16115521|NCT00203047|38909645|FG001|Overall Study|Adverse Event|18|||
16548349|NCT01054573|40470962|FG003|Overall Study|Lost to Follow-up|0|||
16115522|NCT00203047|38909644|FG000|Overall Study|Death|1|||
16548350|NCT01054573|40470959|FG000|Overall Study|Withdrawal by Subject|0|||
16548351|NCT01054573|40470960|FG001|Overall Study|Withdrawal by Subject|2|||
16548352|NCT01054573|40470961|FG002|Overall Study|Withdrawal by Subject|2|||
16548353|NCT01054573|40470962|FG003|Overall Study|Withdrawal by Subject|1|||
16115523|NCT00203047|38909645|FG001|Overall Study|Death|2|||
16115524|NCT00203047|38909644|FG000|Overall Study|Pregnancy|3|||
16548354|NCT01529008|40470963|FG000|Bone Marrow Harvesting|Physician Decision|1|||
16548355|NCT01529008|40470964|FG001|Bone Marrow Harvesting|Physician Decision|1|||
16548356|NCT01529008|40470963|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
16548357|NCT01529008|40470964|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
16548358|NCT01529008|40470963|FG000|Treatment|Adverse Event|6|||
16115525|NCT00203047|38909645|FG001|Overall Study|Pregnancy|0|||
16115526|NCT00203047|38909644|FG000|Overall Study|Other|5|||
16115527|NCT00203047|38909645|FG001|Overall Study|Other|5|||
16115528|NCT01594827|38909646|FG000|Overall Study|Adverse Event|1|||
16115529|NCT01594827|38909647|FG001|Overall Study|Adverse Event|0|||
16115530|NCT01594827|38909646|FG000|Overall Study|Physician Decision|3|||
16115531|NCT01594827|38909647|FG001|Overall Study|Physician Decision|0|||
16115532|NCT02552147|38909651|FG000|First Intervention (7 Days)|Protocol Violation|1|||
16115533|NCT02552147|38909652|FG001|First Intervention (7 Days)|Protocol Violation|0|||
16115534|NCT02552147|38909651|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
16115535|NCT02552147|38909652|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
16115536|NCT00895895|38909653|FG000|Period 1|Adverse Event|7|||
16115537|NCT00895895|38909654|FG001|Period 1|Adverse Event|6|||
16115538|NCT00895895|38909655|FG002|Period 1|Adverse Event|4|||
16115539|NCT00895895|38909656|FG003|Period 1|Adverse Event|6|||
16115540|NCT00895895|38909657|FG004|Period 1|Adverse Event|7|||
16115541|NCT00895895|38909653|FG000|Period 1|Death|0|||
16115542|NCT00895895|38909654|FG001|Period 1|Death|0|||
16115543|NCT00895895|38909655|FG002|Period 1|Death|0|||
16115544|NCT00895895|38909656|FG003|Period 1|Death|0|||
16115545|NCT00895895|38909657|FG004|Period 1|Death|1|||
16115546|NCT00895895|38909653|FG000|Period 1|discontinued by sponsor|2|||
16115547|NCT00895895|38909654|FG001|Period 1|discontinued by sponsor|1|||
16115548|NCT00895895|38909655|FG002|Period 1|discontinued by sponsor|2|||
16115549|NCT00895895|38909656|FG003|Period 1|discontinued by sponsor|1|||
16115550|NCT00895895|38909657|FG004|Period 1|discontinued by sponsor|1|||
16115551|NCT00895895|38909653|FG000|Period 1|failed to return|0|||
16115552|NCT00895895|38909654|FG001|Period 1|failed to return|0|||
16115553|NCT00895895|38909655|FG002|Period 1|failed to return|1|||
16115554|NCT00895895|38909656|FG003|Period 1|failed to return|0|||
16226885|NCT01005966|39310105|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
16226886|NCT01005966|39310106|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
16548359|NCT01529008|40470964|FG001|Treatment|Adverse Event|0|||
16548360|NCT01529008|40470963|FG000|Treatment|Other|3|||
16548361|NCT01529008|40470964|FG001|Treatment|Other|1|||
16548362|NCT01529008|40470963|FG000|Efficacy Analysis|Protocol Violation|2|||
16548363|NCT01529008|40470964|FG001|Efficacy Analysis|Protocol Violation|0|||
16548364|NCT01529008|40470963|FG000|Efficacy Analysis|Physician Decision|0|||
16548365|NCT01529008|40470964|FG001|Efficacy Analysis|Physician Decision|1|||
16548366|NCT01529008|40470963|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
16548367|NCT01529008|40470964|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
16548368|NCT03351738|40470979|FG000|Overall Study|Withdrawal by Subject|0|||
16548369|NCT03351738|40470980|FG001|Overall Study|Withdrawal by Subject|1|||
16548370|NCT03351738|40470981|FG002|Overall Study|Withdrawal by Subject|0|||
16548371|NCT03351738|40470982|FG003|Overall Study|Withdrawal by Subject|1|||
16548372|NCT03351738|40470983|FG004|Overall Study|Withdrawal by Subject|0|||
16548373|NCT03351738|40470984|FG005|Overall Study|Withdrawal by Subject|0|||
16548374|NCT02496767|40470985|FG000|Open-label Lead-in Phase|Adverse Event|176|||
16548375|NCT02496767|40470986|FG001|Open-label Lead-in Phase|Adverse Event|0|||
16548376|NCT02496767|40470987|FG002|Open-label Lead-in Phase|Adverse Event|0|||
16548377|NCT02496767|40470988|FG003|Open-label Lead-in Phase|Adverse Event|0|||
16548378|NCT02496767|40470989|FG004|Open-label Lead-in Phase|Adverse Event|0|||
16115555|NCT00895895|38909657|FG004|Period 1|failed to return|1|||
16115556|NCT00895895|38909653|FG000|Period 1|investigator request|0|||
16115557|NCT00895895|38909654|FG001|Period 1|investigator request|1|||
16115558|NCT00895895|38909655|FG002|Period 1|investigator request|0|||
16115559|NCT00895895|38909656|FG003|Period 1|investigator request|0|||
16115560|NCT00895895|38909657|FG004|Period 1|investigator request|0|||
16115561|NCT00895895|38909653|FG000|Period 1|Lost to Follow-up|2|||
16115562|NCT00895895|38909654|FG001|Period 1|Lost to Follow-up|1|||
16115563|NCT00895895|38909655|FG002|Period 1|Lost to Follow-up|3|||
16115564|NCT00895895|38909656|FG003|Period 1|Lost to Follow-up|2|||
16548379|NCT02496767|40470990|FG005|Open-label Lead-in Phase|Adverse Event|0|||
16115565|NCT00895895|38909657|FG004|Period 1|Lost to Follow-up|3|||
16548380|NCT02496767|40470991|FG006|Open-label Lead-in Phase|Adverse Event|0|||
16548381|NCT02496767|40470992|FG007|Open-label Lead-in Phase|Adverse Event|0|||
16548382|NCT02496767|40470985|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
16548383|NCT02496767|40470986|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
16548384|NCT02496767|40470987|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
16548385|NCT02496767|40470988|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
16548386|NCT02496767|40470989|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
16548387|NCT02496767|40470990|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
16548388|NCT02496767|40470991|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
16548389|NCT02496767|40470992|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
16548390|NCT02496767|40470985|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
16548391|NCT02496767|40470986|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
16548392|NCT02496767|40470987|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
16548393|NCT02496767|40470988|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
16548394|NCT02496767|40470989|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
16548395|NCT02496767|40470990|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
16548396|NCT02496767|40470991|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
16548397|NCT02496767|40470992|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
16548398|NCT02496767|40470985|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
16548399|NCT02496767|40470986|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
16548400|NCT02496767|40470987|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
16548401|NCT02496767|40470988|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
16115566|NCT00895895|38909653|FG000|Period 1|Other|1|||
16115567|NCT00895895|38909654|FG001|Period 1|Other|2|||
16115568|NCT00895895|38909655|FG002|Period 1|Other|1|||
16115569|NCT00895895|38909656|FG003|Period 1|Other|1|||
16115570|NCT00895895|38909657|FG004|Period 1|Other|1|||
16548402|NCT02496767|40470989|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
16548403|NCT02496767|40470990|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
16548404|NCT02496767|40470991|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
16548405|NCT02496767|40470992|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
16548406|NCT02496767|40470985|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
16548407|NCT02496767|40470986|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
16115571|NCT00895895|38909653|FG000|Period 1|Protocol Violation|0|||
16115572|NCT00895895|38909654|FG001|Period 1|Protocol Violation|1|||
16115573|NCT00895895|38909655|FG002|Period 1|Protocol Violation|0|||
16115574|NCT00895895|38909656|FG003|Period 1|Protocol Violation|0|||
16115575|NCT00895895|38909657|FG004|Period 1|Protocol Violation|0|||
16115576|NCT00895895|38909653|FG000|Period 1|Withdrawal by Subject|6|||
16115577|NCT00895895|38909654|FG001|Period 1|Withdrawal by Subject|6|||
16115578|NCT00895895|38909655|FG002|Period 1|Withdrawal by Subject|8|||
16548408|NCT02496767|40470987|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
16548409|NCT02496767|40470988|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
16548410|NCT02496767|40470989|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
16548411|NCT02496767|40470990|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
16548412|NCT02496767|40470991|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
16548413|NCT02496767|40470992|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
16548414|NCT02496767|40470985|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
16548415|NCT02496767|40470986|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
16548416|NCT02496767|40470987|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
16548417|NCT02496767|40470988|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
16548418|NCT02496767|40470989|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
16548419|NCT02496767|40470990|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
16548420|NCT02496767|40470991|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
16548421|NCT02496767|40470992|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
16548422|NCT02496767|40470985|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
16548423|NCT02496767|40470986|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
16548424|NCT02496767|40470987|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
16548425|NCT02496767|40470988|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
16548426|NCT02496767|40470989|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
16548427|NCT02496767|40470990|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
16548428|NCT02496767|40470991|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
16548429|NCT02496767|40470992|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
16548430|NCT02496767|40470985|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16115579|NCT00895895|38909656|FG003|Period 1|Withdrawal by Subject|2|||
16115580|NCT00895895|38909657|FG004|Period 1|Withdrawal by Subject|4|||
16115581|NCT00895895|38909653|FG000|Period 1|unsatisfactory response-efficacy|2|||
16115582|NCT00895895|38909654|FG001|Period 1|unsatisfactory response-efficacy|0|||
16548431|NCT02496767|40470986|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
16548432|NCT02496767|40470987|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
16548433|NCT02496767|40470988|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
16548434|NCT02496767|40470989|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
16548435|NCT02496767|40470990|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16548436|NCT02496767|40470991|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16548437|NCT02496767|40470992|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16548438|NCT02496767|40470985|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16548439|NCT02496767|40470986|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
16115583|NCT00895895|38909655|FG002|Period 1|unsatisfactory response-efficacy|0|||
16115584|NCT00895895|38909656|FG003|Period 1|unsatisfactory response-efficacy|0|||
16115585|NCT00895895|38909657|FG004|Period 1|unsatisfactory response-efficacy|0|||
16115586|NCT00895895|38909653|FG000|Period 1|randomized and not treated|1|||
16115587|NCT00895895|38909654|FG001|Period 1|randomized and not treated|3|||
16115588|NCT00895895|38909655|FG002|Period 1|randomized and not treated|1|||
16115589|NCT00895895|38909656|FG003|Period 1|randomized and not treated|1|||
16115590|NCT00895895|38909657|FG004|Period 1|randomized and not treated|2|||
16115591|NCT00895895|38909653|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
16115592|NCT00895895|38909654|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
16115593|NCT00895895|38909655|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
16115594|NCT00895895|38909656|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
16115595|NCT00895895|38909657|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
16115596|NCT00895895|38909653|FG000|After Period 1, Prior to Period 2|Other|0|||
16115597|NCT00895895|38909654|FG001|After Period 1, Prior to Period 2|Other|0|||
16115598|NCT00895895|38909655|FG002|After Period 1, Prior to Period 2|Other|1|||
16115599|NCT00895895|38909656|FG003|After Period 1, Prior to Period 2|Other|0|||
16115600|NCT00895895|38909657|FG004|After Period 1, Prior to Period 2|Other|0|||
16548440|NCT02496767|40470987|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
16548441|NCT02496767|40470988|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16548442|NCT02496767|40470989|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16548443|NCT02496767|40470990|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16548444|NCT02496767|40470991|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16548445|NCT02496767|40470992|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16548446|NCT02496767|40470985|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16548447|NCT02496767|40470986|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
16115601|NCT00895895|38909653|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
16115602|NCT00895895|38909654|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
16115603|NCT00895895|38909655|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
16115604|NCT00895895|38909656|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
16115605|NCT00895895|38909657|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
16115606|NCT00895895|38909653|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
16115607|NCT00895895|38909654|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
16115608|NCT00895895|38909655|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
16115609|NCT00895895|38909656|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
16115610|NCT00895895|38909657|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
16115611|NCT00895895|38909653|FG000|Period 2|Adverse Event|3|||
16115612|NCT00895895|38909654|FG001|Period 2|Adverse Event|3|||
16115613|NCT00895895|38909655|FG002|Period 2|Adverse Event|5|||
16115614|NCT00895895|38909656|FG003|Period 2|Adverse Event|2|||
16115615|NCT00895895|38909657|FG004|Period 2|Adverse Event|5|||
16115616|NCT00895895|38909653|FG000|Period 2|Death|0|||
16115617|NCT00895895|38909654|FG001|Period 2|Death|0|||
16115618|NCT00895895|38909655|FG002|Period 2|Death|1|||
16115619|NCT00895895|38909656|FG003|Period 2|Death|0|||
16115620|NCT00895895|38909657|FG004|Period 2|Death|0|||
16115621|NCT00895895|38909653|FG000|Period 2|discontinued by sponsor|44|||
16115622|NCT00895895|38909654|FG001|Period 2|discontinued by sponsor|44|||
16115623|NCT00895895|38909655|FG002|Period 2|discontinued by sponsor|38|||
16115624|NCT00895895|38909656|FG003|Period 2|discontinued by sponsor|46|||
16115625|NCT00895895|38909657|FG004|Period 2|discontinued by sponsor|37|||
16115626|NCT00895895|38909653|FG000|Period 2|failed to return|2|||
16115627|NCT00895895|38909654|FG001|Period 2|failed to return|0|||
16115628|NCT00895895|38909655|FG002|Period 2|failed to return|0|||
16115629|NCT00895895|38909656|FG003|Period 2|failed to return|0|||
16115630|NCT00895895|38909657|FG004|Period 2|failed to return|0|||
16115631|NCT00895895|38909653|FG000|Period 2|investigator request|2|||
16115632|NCT00895895|38909654|FG001|Period 2|investigator request|0|||
16115633|NCT00895895|38909655|FG002|Period 2|investigator request|0|||
16115634|NCT00895895|38909656|FG003|Period 2|investigator request|0|||
16115635|NCT00895895|38909657|FG004|Period 2|investigator request|0|||
16411073|NCT00993499|39985696|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
16411074|NCT00993499|39985697|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
16115636|NCT00895895|38909653|FG000|Period 2|Lost to Follow-up|1|||
16115637|NCT00895895|38909654|FG001|Period 2|Lost to Follow-up|2|||
16115638|NCT00895895|38909655|FG002|Period 2|Lost to Follow-up|1|||
16115639|NCT00895895|38909656|FG003|Period 2|Lost to Follow-up|1|||
16115640|NCT00895895|38909657|FG004|Period 2|Lost to Follow-up|0|||
16548448|NCT02496767|40470987|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16548449|NCT02496767|40470988|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
16548450|NCT02496767|40470989|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
16548451|NCT02496767|40470990|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16548452|NCT02496767|40470991|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16548453|NCT02496767|40470992|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16548454|NCT02496767|40470985|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16548455|NCT02496767|40470986|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
16548456|NCT02496767|40470987|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16548457|NCT02496767|40470988|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16548458|NCT02496767|40470989|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16115641|NCT00895895|38909653|FG000|Period 2|Other|1|||
16115642|NCT00895895|38909654|FG001|Period 2|Other|1|||
16115643|NCT00895895|38909655|FG002|Period 2|Other|3|||
16115644|NCT00895895|38909656|FG003|Period 2|Other|1|||
16548459|NCT02496767|40470990|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16548460|NCT02496767|40470991|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16115645|NCT00895895|38909657|FG004|Period 2|Other|1|||
16115646|NCT00895895|38909653|FG000|Period 2|Protocol Violation|1|||
16411075|NCT00993499|39985698|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
16548461|NCT02496767|40470992|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
16548462|NCT02496767|40470985|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
16115647|NCT00895895|38909654|FG001|Period 2|Protocol Violation|0|||
16548463|NCT02496767|40470986|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
16548464|NCT02496767|40470987|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
16548465|NCT02496767|40470988|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
16115648|NCT00895895|38909655|FG002|Period 2|Protocol Violation|1|||
16115649|NCT00895895|38909656|FG003|Period 2|Protocol Violation|1|||
16115650|NCT00895895|38909657|FG004|Period 2|Protocol Violation|1|||
16115651|NCT00895895|38909653|FG000|Period 2|Withdrawal by Subject|0|||
16115652|NCT00895895|38909654|FG001|Period 2|Withdrawal by Subject|2|||
16115653|NCT00895895|38909655|FG002|Period 2|Withdrawal by Subject|0|||
16115654|NCT00895895|38909656|FG003|Period 2|Withdrawal by Subject|3|||
16226887|NCT01005966|39310107|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
16226888|NCT01005966|39310103|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
16226889|NCT01005966|39310104|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
16226890|NCT01005966|39310105|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
16226891|NCT01005966|39310106|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
16226892|NCT01005966|39310107|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
16226893|NCT01005966|39310103|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16226894|NCT01005966|39310104|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16226895|NCT01005966|39310105|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16226896|NCT01005966|39310106|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
16226897|NCT01005966|39310107|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
16226898|NCT01005966|39310103|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16226899|NCT01005966|39310104|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16226900|NCT01005966|39310105|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
16226901|NCT01005966|39310106|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16226902|NCT01005966|39310107|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
16226903|NCT01005966|39310103|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
16226904|NCT01005966|39310104|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
16226905|NCT01005966|39310105|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
16226906|NCT01005966|39310106|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
16226907|NCT01005966|39310107|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
16226908|NCT01005966|39310103|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
16226909|NCT01005966|39310104|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
16226910|NCT01005966|39310105|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
16226911|NCT01005966|39310106|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
16226912|NCT01005966|39310107|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
16226913|NCT01005966|39310103|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
16226914|NCT01005966|39310104|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
16226915|NCT01005966|39310105|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
16226916|NCT01005966|39310106|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
16226917|NCT01005966|39310107|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
16226918|NCT01230827|39310114|FG000|Overall Study|Lost to Follow-up|0|||
16226919|NCT01230827|39310115|FG001|Overall Study|Lost to Follow-up|0|||
16226920|NCT01230827|39310116|FG002|Overall Study|Lost to Follow-up|1|||
16226921|NCT01230827|39310117|FG003|Overall Study|Lost to Follow-up|3|||
16226922|NCT01230827|39310114|FG000|Overall Study|Withdrawal by Subject|1|||
16226923|NCT01230827|39310115|FG001|Overall Study|Withdrawal by Subject|0|||
16226924|NCT01230827|39310116|FG002|Overall Study|Withdrawal by Subject|3|||
16226925|NCT01230827|39310117|FG003|Overall Study|Withdrawal by Subject|2|||
16226926|NCT01230827|39310114|FG000|Overall Study|Lack of Efficacy|14|||
16226927|NCT01230827|39310115|FG001|Overall Study|Lack of Efficacy|1|||
16226928|NCT01230827|39310116|FG002|Overall Study|Lack of Efficacy|2|||
16226929|NCT01230827|39310117|FG003|Overall Study|Lack of Efficacy|3|||
16226930|NCT01230827|39310114|FG000|Overall Study|Adverse Event|4|||
16226931|NCT01230827|39310115|FG001|Overall Study|Adverse Event|2|||
16115655|NCT00895895|38909657|FG004|Period 2|Withdrawal by Subject|5|||
16115656|NCT00895895|38909653|FG000|Period 2|unsatisfactory response-efficacy|2|||
16115657|NCT00895895|38909654|FG001|Period 2|unsatisfactory response-efficacy|1|||
16115658|NCT00895895|38909655|FG002|Period 2|unsatisfactory response-efficacy|0|||
16115659|NCT00895895|38909656|FG003|Period 2|unsatisfactory response-efficacy|0|||
16115660|NCT00895895|38909657|FG004|Period 2|unsatisfactory response-efficacy|0|||
16115661|NCT00513708|38909658|FG000|Overall Study|Lost to Follow-up|4|||
16115662|NCT00513708|38909659|FG001|Overall Study|Lost to Follow-up|4|||
16115663|NCT00513708|38909660|FG002|Overall Study|Lost to Follow-up|4|||
16115664|NCT01908829|38909663|FG000|Overall Study|Adverse Event|13|||
16115665|NCT01908829|38909664|FG001|Overall Study|Adverse Event|11|||
16115666|NCT01908829|38909665|FG002|Overall Study|Adverse Event|13|||
16115667|NCT01908829|38909663|FG000|Overall Study|Lost to Follow-up|4|||
16226932|NCT01230827|39310116|FG002|Overall Study|Adverse Event|3|||
16226933|NCT01230827|39310117|FG003|Overall Study|Adverse Event|7|||
16226934|NCT01230827|39310114|FG000|Overall Study|Recovery|0|||
16226935|NCT01230827|39310115|FG001|Overall Study|Recovery|6|||
16226936|NCT01230827|39310116|FG002|Overall Study|Recovery|0|||
16226937|NCT01230827|39310117|FG003|Overall Study|Recovery|0|||
16226938|NCT01230827|39310114|FG000|Overall Study|Study terminated by Sponsor|0|||
16226939|NCT01230827|39310115|FG001|Overall Study|Study terminated by Sponsor|2|||
16226940|NCT01230827|39310116|FG002|Overall Study|Study terminated by Sponsor|56|||
16226941|NCT01230827|39310117|FG003|Overall Study|Study terminated by Sponsor|63|||
16226942|NCT02719028|39310118|FG000|Overall Study|Adverse Event|2|||
16226943|NCT02719028|39310119|FG001|Overall Study|Adverse Event|1|||
16226944|NCT02719028|39310120|FG002|Overall Study|Adverse Event|4|||
16115668|NCT01908829|38909664|FG001|Overall Study|Lost to Follow-up|2|||
16115669|NCT01908829|38909665|FG002|Overall Study|Lost to Follow-up|1|||
16115670|NCT01908829|38909663|FG000|Overall Study|Randomized no double-blind drug received|1|||
16226945|NCT02719028|39310121|FG003|Overall Study|Adverse Event|8|||
16226946|NCT02719028|39310118|FG000|Overall Study|Physician Decision|0|||
16226947|NCT02719028|39310119|FG001|Overall Study|Physician Decision|1|||
16226948|NCT02719028|39310120|FG002|Overall Study|Physician Decision|1|||
16226949|NCT02719028|39310121|FG003|Overall Study|Physician Decision|1|||
16226950|NCT02719028|39310118|FG000|Overall Study|Use of prohibited medication|0|||
16226951|NCT02719028|39310119|FG001|Overall Study|Use of prohibited medication|0|||
16226952|NCT02719028|39310120|FG002|Overall Study|Use of prohibited medication|1|||
16226953|NCT02719028|39310121|FG003|Overall Study|Use of prohibited medication|0|||
16226954|NCT02719028|39310118|FG000|Overall Study|Protocol Violation|0|||
16226955|NCT02719028|39310119|FG001|Overall Study|Protocol Violation|0|||
16226956|NCT02719028|39310120|FG002|Overall Study|Protocol Violation|0|||
16226957|NCT02719028|39310121|FG003|Overall Study|Protocol Violation|1|||
16226958|NCT01801475|39310122|FG000|Overall Study|Withdrawal by Subject|0|||
16226959|NCT01801475|39310123|FG001|Overall Study|Withdrawal by Subject|0|||
16226960|NCT01801475|39310124|FG002|Overall Study|Withdrawal by Subject|0|||
16226961|NCT01801475|39310125|FG003|Overall Study|Withdrawal by Subject|0|||
16226962|NCT01801475|39310126|FG004|Overall Study|Withdrawal by Subject|1|||
16226963|NCT00689611|39310128|FG000|Overall Study|Death|6|||
16226964|NCT00689611|39310129|FG001|Overall Study|Death|9|||
16226965|NCT00689611|39310128|FG000|Overall Study|Withdrawal by Subject|8|||
16226966|NCT00689611|39310129|FG001|Overall Study|Withdrawal by Subject|9|||
16226967|NCT00689611|39310128|FG000|Overall Study|Lost to Follow-up|27|||
16226968|NCT00689611|39310129|FG001|Overall Study|Lost to Follow-up|28|||
16411076|NCT00993499|39985699|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
16411077|NCT00993499|39985694|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
16411078|NCT00993499|39985695|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
16411079|NCT00993499|39985696|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
16411080|NCT00993499|39985697|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
16226969|NCT04052425|39310130|FG000|24-Week Double-blind Period|Adverse Event|0|||
16226970|NCT04052425|39310131|FG001|24-Week Double-blind Period|Adverse Event|1|||
16226971|NCT04052425|39310132|FG002|24-Week Double-blind Period|Adverse Event|0|||
16226972|NCT04052425|39310133|FG003|24-Week Double-blind Period|Adverse Event|0|||
16411081|NCT00993499|39985698|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
16411082|NCT00993499|39985699|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
16411083|NCT00993499|39985694|FG000|Run-in Period (8 Days)|Progressive disease|0|||
16411084|NCT00993499|39985695|FG001|Run-in Period (8 Days)|Progressive disease|1|||
16411085|NCT00993499|39985696|FG002|Run-in Period (8 Days)|Progressive disease|1|||
16411086|NCT00993499|39985697|FG003|Run-in Period (8 Days)|Progressive disease|0|||
16411087|NCT00993499|39985698|FG004|Run-in Period (8 Days)|Progressive disease|0|||
16411088|NCT00993499|39985699|FG005|Run-in Period (8 Days)|Progressive disease|0|||
16411089|NCT00993499|39985694|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
16411090|NCT00993499|39985695|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
16411091|NCT00993499|39985696|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
16411092|NCT00993499|39985697|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
16411093|NCT00993499|39985698|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
16411094|NCT00993499|39985699|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
16411095|NCT00993499|39985694|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
16411096|NCT00993499|39985695|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
16411097|NCT00993499|39985696|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
16411098|NCT00993499|39985697|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
16411099|NCT00993499|39985698|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
16411100|NCT00993499|39985699|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
16411101|NCT00993499|39985694|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
16411102|NCT00993499|39985695|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
16411103|NCT00993499|39985696|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
16411104|NCT00993499|39985697|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
16226973|NCT04052425|39310130|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
16226974|NCT04052425|39310131|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
16226975|NCT04052425|39310132|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
16226976|NCT04052425|39310133|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
16226977|NCT04052425|39310130|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
16226978|NCT04052425|39310131|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
16226979|NCT04052425|39310132|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
16226980|NCT04052425|39310133|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
16411105|NCT00993499|39985698|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
16411106|NCT00993499|39985699|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
16226981|NCT04052425|39310130|FG000|24-Week Double-blind Period|Physician Decision|1|||
16226982|NCT04052425|39310131|FG001|24-Week Double-blind Period|Physician Decision|0|||
16226983|NCT04052425|39310132|FG002|24-Week Double-blind Period|Physician Decision|0|||
16226984|NCT04052425|39310133|FG003|24-Week Double-blind Period|Physician Decision|0|||
16226985|NCT04052425|39310130|FG000|24-Week Double-blind Period|Protocol Violation|1|||
16226986|NCT04052425|39310131|FG001|24-Week Double-blind Period|Protocol Violation|0|||
16226987|NCT04052425|39310132|FG002|24-Week Double-blind Period|Protocol Violation|0|||
16226988|NCT04052425|39310133|FG003|24-Week Double-blind Period|Protocol Violation|0|||
16226989|NCT04052425|39310130|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
16226990|NCT04052425|39310131|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
16226991|NCT04052425|39310132|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
16226992|NCT04052425|39310133|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
16226993|NCT04052425|39310130|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
16226994|NCT04052425|39310131|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
16226995|NCT04052425|39310132|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
16226996|NCT04052425|39310133|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
16226997|NCT04052425|39310130|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
16226998|NCT04052425|39310131|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
16115671|NCT01908829|38909664|FG001|Overall Study|Randomized no double-blind drug received|0|||
16115672|NCT01908829|38909665|FG002|Overall Study|Randomized no double-blind drug received|1|||
16115673|NCT01908829|38909663|FG000|Overall Study|Discontinued (no EoT page)|2|||
16115674|NCT01908829|38909664|FG001|Overall Study|Discontinued (no EoT page)|0|||
16115675|NCT01908829|38909665|FG002|Overall Study|Discontinued (no EoT page)|0|||
16115676|NCT01908829|38909663|FG000|Overall Study|Miscellaneous|0|||
16115677|NCT01908829|38909664|FG001|Overall Study|Miscellaneous|2|||
16115678|NCT01908829|38909665|FG002|Overall Study|Miscellaneous|0|||
16115679|NCT01908829|38909663|FG000|Overall Study|Protocol Violation|2|||
16115680|NCT01908829|38909664|FG001|Overall Study|Protocol Violation|2|||
16115681|NCT01908829|38909665|FG002|Overall Study|Protocol Violation|0|||
16115682|NCT01908829|38909663|FG000|Overall Study|Lack of Efficacy|1|||
16115683|NCT01908829|38909664|FG001|Overall Study|Lack of Efficacy|3|||
16115684|NCT01908829|38909665|FG002|Overall Study|Lack of Efficacy|2|||
16115685|NCT01908829|38909663|FG000|Overall Study|Withdrawal by Subject|26|||
16115686|NCT01908829|38909664|FG001|Overall Study|Withdrawal by Subject|29|||
16115687|NCT01908829|38909665|FG002|Overall Study|Withdrawal by Subject|22|||
16115688|NCT02473965|38909666|FG000|Overall Study|Adverse Event|6|||
16115689|NCT02473965|38909667|FG001|Overall Study|Adverse Event|4|||
16115690|NCT02473965|38909666|FG000|Overall Study|MG worsening|4|||
16115691|NCT02473965|38909667|FG001|Overall Study|MG worsening|1|||
16115692|NCT02473965|38909666|FG000|Overall Study|Withdrawal by Subject|2|||
16115693|NCT02473965|38909667|FG001|Overall Study|Withdrawal by Subject|3|||
16115694|NCT02473965|38909666|FG000|Overall Study|Physician Decision|0|||
16115695|NCT02473965|38909667|FG001|Overall Study|Physician Decision|2|||
16115696|NCT01107899|38909668|FG000|Overall Study|Physician Decision|5|||
16115697|NCT01107899|38909669|FG001|Overall Study|Physician Decision|0|||
16115698|NCT01107899|38909670|FG002|Overall Study|Physician Decision|3|||
16115699|NCT01107899|38909668|FG000|Overall Study|Withdrawal by Subject|0|||
16115700|NCT01107899|38909669|FG001|Overall Study|Withdrawal by Subject|0|||
16115701|NCT01107899|38909670|FG002|Overall Study|Withdrawal by Subject|1|||
16115702|NCT00633945|38909671|FG000|Overall Study|Physician Decision|2|||
16115703|NCT01011868|38909673|FG000|After Week 18 Follow-up|Adverse Event|8|||
16115704|NCT01011868|38909674|FG001|After Week 18 Follow-up|Adverse Event|6|||
16115705|NCT01011868|38909675|FG002|After Week 18 Follow-up|Adverse Event|13|||
16115706|NCT01011868|38909673|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
16115707|NCT01011868|38909674|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
16115708|NCT01011868|38909675|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
16115709|NCT01011868|38909673|FG000|After Week 18 Follow-up|Protocol Violation|1|||
16115710|NCT01011868|38909674|FG001|After Week 18 Follow-up|Protocol Violation|1|||
16115711|NCT01011868|38909675|FG002|After Week 18 Follow-up|Protocol Violation|1|||
16115712|NCT01011868|38909673|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
16115713|NCT01011868|38909674|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
16115714|NCT01011868|38909675|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
16115715|NCT01011868|38909673|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
16115716|NCT01011868|38909674|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
16115717|NCT01011868|38909675|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
16115718|NCT01011868|38909673|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
16115719|NCT01011868|38909674|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
16115720|NCT01011868|38909675|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
16115721|NCT01011868|38909673|FG000|After Week 78 Follow-up|Adverse Event|14|||
16115722|NCT01011868|38909674|FG001|After Week 78 Follow-up|Adverse Event|18|||
16226999|NCT04052425|39310132|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
16227000|NCT04052425|39310133|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
16347424|NCT01827592|39757481|FG001|Overall Study|Withdrawal by Subject|11|||
16347425|NCT01827592|39757482|FG002|Overall Study|Withdrawal by Subject|11|||
16115723|NCT01011868|38909675|FG002|After Week 78 Follow-up|Adverse Event|21|||
16115724|NCT01011868|38909673|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
16227001|NCT04052425|39310130|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
16227002|NCT04052425|39310131|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
16227003|NCT04052425|39310132|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
16227004|NCT04052425|39310133|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
16411107|NCT00993499|39985694|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
16411108|NCT00993499|39985695|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
16411109|NCT00993499|39985696|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
16411110|NCT00993499|39985697|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
16115725|NCT01011868|38909674|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
16227005|NCT04052425|39310130|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
16227006|NCT04052425|39310131|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
16227007|NCT04052425|39310132|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
16227008|NCT04052425|39310133|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
16227009|NCT04052425|39310130|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
16227010|NCT04052425|39310131|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
16227011|NCT04052425|39310132|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
16227012|NCT04052425|39310133|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
16227013|NCT04052425|39310130|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
16227014|NCT04052425|39310131|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
16227015|NCT04052425|39310132|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
16227016|NCT04052425|39310133|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
16227017|NCT04052425|39310130|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
16227018|NCT04052425|39310131|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
16227019|NCT04052425|39310132|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
16227020|NCT04052425|39310133|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
16227021|NCT04052425|39310130|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
16227022|NCT04052425|39310131|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
16227023|NCT04052425|39310132|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
16227024|NCT04052425|39310133|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
16227025|NCT00229931|39310134|FG000|Overall Study|Death|1|||
16227026|NCT00229931|39310135|FG001|Overall Study|Death|0|||
16227027|NCT00229931|39310134|FG000|Overall Study|Lost to Follow-up|3|||
16227028|NCT00229931|39310135|FG001|Overall Study|Lost to Follow-up|2|||
16227029|NCT00310440|39310141|FG000|Overall Study|Lost to Follow-up|17|||
16227030|NCT00310440|39310142|FG001|Overall Study|Lost to Follow-up|8|||
16227031|NCT00310440|39310141|FG000|Overall Study|Withdrawal by Subject|2|||
16227032|NCT00310440|39310142|FG001|Overall Study|Withdrawal by Subject|1|||
16227033|NCT00310440|39310141|FG000|Overall Study|Missed 12 Month Visit|7|||
16227034|NCT00310440|39310142|FG001|Overall Study|Missed 12 Month Visit|4|||
16227035|NCT04246996|39310146|FG000|Overall Study|Physician Decision|1|||
16227036|NCT04246996|39310147|FG001|Overall Study|Physician Decision|1|||
16227037|NCT04246996|39310146|FG000|Overall Study|Did not meet eligibility criteria|1|||
16227038|NCT04246996|39310147|FG001|Overall Study|Did not meet eligibility criteria|4|||
16227039|NCT02985541|39310152|FG000|Overall Study|Withdrawal by Subject|33|||
16227040|NCT02985541|39310152|FG000|Overall Study|Lost to Follow-up|26|||
16227041|NCT02985541|39310152|FG000|Overall Study|Adverse Event|27|||
16227042|NCT02985541|39310152|FG000|Overall Study|Physician Decision|2|||
16227043|NCT02985541|39310152|FG000|Overall Study|Pregnancy|2|||
16227044|NCT02985541|39310152|FG000|Overall Study|Wish for pregnancy|44|||
16227045|NCT02985541|39310152|FG000|Overall Study|Other reason|5|||
16227046|NCT02985541|39310152|FG000|Overall Study|Not valid for analysis|2|||
16227047|NCT01756846|39310153|FG000|Overall Study|Lost to Follow-up|5|||
16227048|NCT01756846|39310154|FG001|Overall Study|Lost to Follow-up|10|||
16227049|NCT01756846|39310153|FG000|Overall Study|Withdrawal by Subject|1|||
16227050|NCT01756846|39310154|FG001|Overall Study|Withdrawal by Subject|2|||
16227051|NCT00027027|39310157|FG000|Overall Study|Adverse Event|0|||
16227052|NCT00027027|39310158|FG001|Overall Study|Adverse Event|0|||
16227053|NCT00027027|39310159|FG002|Overall Study|Adverse Event|1|||
16227054|NCT00027027|39310160|FG003|Overall Study|Adverse Event|0|||
16227055|NCT00027027|39310161|FG004|Overall Study|Adverse Event|1|||
16227056|NCT00027027|39310157|FG000|Overall Study|Admitted for Signs of PD|0|||
16227057|NCT00027027|39310158|FG001|Overall Study|Admitted for Signs of PD|0|||
16227058|NCT00027027|39310159|FG002|Overall Study|Admitted for Signs of PD|0|||
16227059|NCT00027027|39310160|FG003|Overall Study|Admitted for Signs of PD|0|||
16227060|NCT00027027|39310161|FG004|Overall Study|Admitted for Signs of PD|1|||
16115726|NCT01011868|38909675|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
16227061|NCT00027027|39310157|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
16227062|NCT00027027|39310158|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
16227063|NCT00027027|39310159|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
16227064|NCT00027027|39310160|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
16227065|NCT00027027|39310161|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
16227066|NCT00027027|39310157|FG000|Overall Study|PD Requiring Surgery|0|||
16227067|NCT00027027|39310158|FG001|Overall Study|PD Requiring Surgery|0|||
16227068|NCT00027027|39310159|FG002|Overall Study|PD Requiring Surgery|1|||
16227069|NCT00027027|39310160|FG003|Overall Study|PD Requiring Surgery|0|||
16227070|NCT00027027|39310161|FG004|Overall Study|PD Requiring Surgery|0|||
16227071|NCT00027027|39310157|FG000|Overall Study|Physician Decision Due To PD|2|||
16227072|NCT00027027|39310158|FG001|Overall Study|Physician Decision Due To PD|3|||
16227073|NCT00027027|39310159|FG002|Overall Study|Physician Decision Due To PD|2|||
16227074|NCT00027027|39310160|FG003|Overall Study|Physician Decision Due To PD|3|||
16227075|NCT00027027|39310161|FG004|Overall Study|Physician Decision Due To PD|5|||
16227076|NCT00027027|39310157|FG000|Overall Study|Withdrawal by Subject|0|||
16227077|NCT00027027|39310158|FG001|Overall Study|Withdrawal by Subject|0|||
16227078|NCT00027027|39310159|FG002|Overall Study|Withdrawal by Subject|0|||
16227079|NCT00027027|39310160|FG003|Overall Study|Withdrawal by Subject|0|||
16227080|NCT00027027|39310161|FG004|Overall Study|Withdrawal by Subject|1|||
16227081|NCT00508872|39313409|FG000|Overall Study|Lost to Follow-up|1|||
16227082|NCT00508872|39313409|FG000|Overall Study|Physician Decision|1|||
16227083|NCT00608426|39313410|FG000|Overall Study|Death|32|||
16227084|NCT00608426|39313411|FG001|Overall Study|Death|36|||
16227085|NCT00608426|39313410|FG000|Overall Study|Lost to Follow-up|485|||
16227086|NCT00608426|39313411|FG001|Overall Study|Lost to Follow-up|521|||
16115727|NCT01011868|38909673|FG000|After Week 78 Follow-up|Protocol Violation|9|||
16115728|NCT01011868|38909674|FG001|After Week 78 Follow-up|Protocol Violation|1|||
16115729|NCT01011868|38909675|FG002|After Week 78 Follow-up|Protocol Violation|2|||
16115730|NCT01011868|38909673|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
16115731|NCT01011868|38909674|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
16115732|NCT01011868|38909675|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
16227087|NCT00608426|39313410|FG000|Overall Study|refused, health issues, wrong address|319|||
16411111|NCT00993499|39985698|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
16411112|NCT00993499|39985699|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
16411113|NCT00993499|39985694|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
16411114|NCT00993499|39985695|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
16411115|NCT00993499|39985696|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
16411116|NCT00993499|39985697|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
16548466|NCT02496767|40470989|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
16227088|NCT00608426|39313411|FG001|Overall Study|refused, health issues, wrong address|348|||
16548467|NCT02496767|40470990|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
16548468|NCT02496767|40470991|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
16548469|NCT02496767|40470992|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
16227089|NCT01430559|39313412|FG000|Overall Study|Adverse Event|7|||
16227090|NCT01430559|39313413|FG001|Overall Study|Adverse Event|3|||
16227091|NCT01430559|39313412|FG000|Overall Study|Entry criteria not met|1|||
16227092|NCT01430559|39313413|FG001|Overall Study|Entry criteria not met|1|||
16227093|NCT01430559|39313412|FG000|Overall Study|Lost to Follow-up|1|||
16227094|NCT01430559|39313413|FG001|Overall Study|Lost to Follow-up|0|||
16227095|NCT01430559|39313412|FG000|Overall Study|Medication error|1|||
16347426|NCT01827592|39757480|FG000|Overall Study|Patient's substantial non-compliance|1|||
16548470|NCT02496767|40470985|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
16548471|NCT02496767|40470986|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
16548472|NCT02496767|40470987|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
16227096|NCT01430559|39313413|FG001|Overall Study|Medication error|0|||
16227097|NCT01430559|39313412|FG000|Overall Study|Withdrawal by Subject|3|||
16227098|NCT01430559|39313413|FG001|Overall Study|Withdrawal by Subject|2|||
16227099|NCT01430559|39313412|FG000|Overall Study|Protocol Violation|1|||
16347427|NCT01827592|39757481|FG001|Overall Study|Patient's substantial non-compliance|1|||
16347428|NCT01827592|39757482|FG002|Overall Study|Patient's substantial non-compliance|6|||
16347429|NCT01827592|39757480|FG000|Overall Study|Trial terminated by Sponsor|47|||
16347430|NCT01827592|39757481|FG001|Overall Study|Trial terminated by Sponsor|53|||
16347431|NCT01827592|39757482|FG002|Overall Study|Trial terminated by Sponsor|51|||
16347432|NCT01827592|39757480|FG000|Overall Study|Others|0|||
16347433|NCT01827592|39757481|FG001|Overall Study|Others|1|||
16347434|NCT01827592|39757482|FG002|Overall Study|Others|3|||
16347435|NCT01098162|39757485|FG000|Overall Study|Adverse Event|37|||
16347436|NCT01098162|39757485|FG000|Overall Study|Lack of Efficacy|4|||
16347437|NCT01098162|39757485|FG000|Overall Study|Wish of Patient|7|||
16347438|NCT01098162|39757485|FG000|Overall Study|Lost to Follow-up|9|||
16347439|NCT01098162|39757485|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
16347440|NCT01098162|39757485|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
16347441|NCT01098162|39757485|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
16347442|NCT01098162|39757485|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
16347443|NCT01098162|39757485|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
16347444|NCT01098162|39757485|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
16347445|NCT01098162|39757485|FG000|Overall Study|Other Reason|1|||
16227100|NCT01430559|39313413|FG001|Overall Study|Protocol Violation|0|||
16227101|NCT01430559|39313412|FG000|Overall Study|Other|3|||
16227102|NCT01430559|39313413|FG001|Overall Study|Other|3|||
16227103|NCT01430559|39313412|FG000|Overall Study|Randomized, Not Treated|3|||
16227104|NCT01430559|39313413|FG001|Overall Study|Randomized, Not Treated|3|||
16227105|NCT00399542|39313414|FG000|Overall Study|Adverse Event|18|||
16227106|NCT00399542|39313415|FG001|Overall Study|Adverse Event|15|||
16227107|NCT00399542|39313414|FG000|Overall Study|Protocol Violation|13|||
16227108|NCT00399542|39313415|FG001|Overall Study|Protocol Violation|3|||
16227109|NCT00399542|39313414|FG000|Overall Study|Withdrawal by Subject|28|||
16227110|NCT00399542|39313415|FG001|Overall Study|Withdrawal by Subject|10|||
16227111|NCT00399542|39313414|FG000|Overall Study|Lack of Efficacy|18|||
16227112|NCT00399542|39313415|FG001|Overall Study|Lack of Efficacy|8|||
16227113|NCT00399542|39313414|FG000|Overall Study|Lost to Follow-up|6|||
16227114|NCT00399542|39313415|FG001|Overall Study|Lost to Follow-up|6|||
16227115|NCT00399542|39313414|FG000|Overall Study|Other|1|||
16411117|NCT00993499|39985698|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
16411118|NCT00993499|39985699|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
16411119|NCT00993499|39985694|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
16411120|NCT00993499|39985695|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
16411121|NCT00993499|39985696|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
16411122|NCT00993499|39985697|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
16411123|NCT00993499|39985698|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
16411124|NCT00993499|39985699|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
16411125|NCT00993499|39985694|FG000|Discontinued After Starting Course 3|DLT|1|||
16411126|NCT00993499|39985695|FG001|Discontinued After Starting Course 3|DLT|0|||
16411127|NCT00993499|39985696|FG002|Discontinued After Starting Course 3|DLT|2|||
16411128|NCT00993499|39985697|FG003|Discontinued After Starting Course 3|DLT|1|||
16411129|NCT00993499|39985698|FG004|Discontinued After Starting Course 3|DLT|0|||
16411130|NCT00993499|39985699|FG005|Discontinued After Starting Course 3|DLT|0|||
16411131|NCT00993499|39985694|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
16411132|NCT00993499|39985695|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
16411133|NCT00993499|39985696|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
16411134|NCT00993499|39985697|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
16411135|NCT00993499|39985698|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
16411136|NCT00993499|39985699|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
16411137|NCT01444027|39985702|FG000|Overall Study|Withdrawal by Subject|4|||
16411138|NCT01444027|39985703|FG001|Overall Study|Withdrawal by Subject|10|||
16411139|NCT01444027|39985704|FG002|Overall Study|Withdrawal by Subject|24|||
16411140|NCT01444027|39985702|FG000|Overall Study|Lost to Follow-up|26|||
16411141|NCT01444027|39985703|FG001|Overall Study|Lost to Follow-up|20|||
16411142|NCT01444027|39985704|FG002|Overall Study|Lost to Follow-up|14|||
16411143|NCT02956850|39985705|FG000|Overall Study|Withdrawal by Subject|0|||
16411144|NCT02956850|39985706|FG001|Overall Study|Withdrawal by Subject|0|||
16411145|NCT02956850|39985707|FG002|Overall Study|Withdrawal by Subject|0|||
16411146|NCT02956850|39985708|FG003|Overall Study|Withdrawal by Subject|0|||
16548473|NCT02496767|40470988|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
16548474|NCT02496767|40470989|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
16548475|NCT02496767|40470990|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
16548476|NCT02496767|40470991|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
16548477|NCT02496767|40470992|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
16548478|NCT02496767|40470985|FG000|Double-blind, Withdrawal Phase|Death|0|||
16548479|NCT02496767|40470986|FG001|Double-blind, Withdrawal Phase|Death|0|||
16548480|NCT02496767|40470987|FG002|Double-blind, Withdrawal Phase|Death|0|||
16548481|NCT02496767|40470988|FG003|Double-blind, Withdrawal Phase|Death|0|||
16548482|NCT02496767|40470989|FG004|Double-blind, Withdrawal Phase|Death|0|||
16548483|NCT02496767|40470990|FG005|Double-blind, Withdrawal Phase|Death|0|||
16548484|NCT02496767|40470991|FG006|Double-blind, Withdrawal Phase|Death|1|||
16548485|NCT02496767|40470992|FG007|Double-blind, Withdrawal Phase|Death|2|||
16548486|NCT02496767|40470985|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
16548487|NCT02496767|40470986|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
16548488|NCT02496767|40470987|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
16548489|NCT02496767|40470988|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
16548490|NCT02496767|40470989|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
16548491|NCT02496767|40470990|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
16548492|NCT02496767|40470991|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
16548493|NCT02496767|40470992|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
16548494|NCT03097861|40470993|FG000|Overall Study|Adverse Event|3|||
16227116|NCT00399542|39313415|FG001|Overall Study|Other|0|||
16227117|NCT00399542|39313414|FG000|Overall Study|Physician Decision|0|||
16227118|NCT00399542|39313415|FG001|Overall Study|Physician Decision|1|||
16227119|NCT00887822|39313416|FG000|Overall Study|Insufficient therapeutic response|53|||
16411147|NCT02956850|39985709|FG004|Overall Study|Withdrawal by Subject|0|||
16227120|NCT00887822|39313417|FG001|Overall Study|Insufficient therapeutic response|55|||
16227121|NCT00887822|39313416|FG000|Overall Study|Adverse Event|14|||
16227122|NCT00887822|39313417|FG001|Overall Study|Adverse Event|17|||
16227123|NCT00887822|39313416|FG000|Overall Study|Failure to return|11|||
16227124|NCT00887822|39313417|FG001|Overall Study|Failure to return|11|||
16227125|NCT00887822|39313416|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
16411148|NCT02956850|39985710|FG005|Overall Study|Withdrawal by Subject|0|||
16411149|NCT02956850|39985711|FG006|Overall Study|Withdrawal by Subject|0|||
16411150|NCT02956850|39985712|FG007|Overall Study|Withdrawal by Subject|0|||
16411151|NCT02956850|39985713|FG008|Overall Study|Withdrawal by Subject|0|||
16411152|NCT02956850|39985714|FG009|Overall Study|Withdrawal by Subject|0|||
16411153|NCT02956850|39985715|FG010|Overall Study|Withdrawal by Subject|0|||
16411154|NCT02956850|39985716|FG011|Overall Study|Withdrawal by Subject|0|||
16411155|NCT02956850|39985717|FG012|Overall Study|Withdrawal by Subject|0|||
16411156|NCT02956850|39985718|FG013|Overall Study|Withdrawal by Subject|0|||
16411157|NCT02956850|39985719|FG014|Overall Study|Withdrawal by Subject|0|||
16411158|NCT02956850|39985720|FG015|Overall Study|Withdrawal by Subject|0|||
16411159|NCT02956850|39985721|FG016|Overall Study|Withdrawal by Subject|0|||
16548495|NCT03097861|40470994|FG001|Overall Study|Adverse Event|8|||
16548496|NCT03097861|40470995|FG002|Overall Study|Adverse Event|4|||
16548497|NCT03097861|40470993|FG000|Overall Study|Investigator Decision|0|||
16548498|NCT03097861|40470994|FG001|Overall Study|Investigator Decision|1|||
16548499|NCT03097861|40470995|FG002|Overall Study|Investigator Decision|0|||
16548500|NCT03097861|40470993|FG000|Overall Study|Lost to Follow-up|0|||
16548501|NCT03097861|40470994|FG001|Overall Study|Lost to Follow-up|7|||
16411160|NCT02956850|39985722|FG017|Overall Study|Withdrawal by Subject|1|||
16411161|NCT00303446|39985723|FG000|Overall Study|Withdrawal by Subject|2|||
16411162|NCT00303446|39985724|FG001|Overall Study|Withdrawal by Subject|2|||
16411163|NCT00303446|39985723|FG000|Overall Study|Death|0|||
16411164|NCT00303446|39985724|FG001|Overall Study|Death|1|||
16411165|NCT00303446|39985723|FG000|Overall Study|Physician Decision|0|||
16411166|NCT00303446|39985724|FG001|Overall Study|Physician Decision|1|||
16548502|NCT03097861|40470995|FG002|Overall Study|Lost to Follow-up|1|||
16227126|NCT00887822|39313417|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
16227127|NCT00887822|39313416|FG000|Overall Study|Administrative/Other than specified|5|||
16411167|NCT00543296|39985725|FG000|Overall Study|Physician Decision|7|||
16411168|NCT00886119|39985730|FG000|Period 1|Did not meet inclusion criteria|1|||
16115733|NCT01011868|38909673|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
16115734|NCT01011868|38909674|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
16115735|NCT01011868|38909675|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
16115736|NCT01011868|38909673|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
16115737|NCT01011868|38909674|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
16115738|NCT01011868|38909675|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
16115739|NCT00983749|38909681|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
16115740|NCT00983749|38909682|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
16115741|NCT01602510|38909683|FG000|Open Label Phase|Adverse Event|46|||
16115742|NCT01602510|38909684|FG001|Open Label Phase|Adverse Event|0|||
16115743|NCT01602510|38909685|FG002|Open Label Phase|Adverse Event|0|||
16115744|NCT01602510|38909683|FG000|Open Label Phase|Lack of Efficacy|22|||
16115745|NCT01602510|38909684|FG001|Open Label Phase|Lack of Efficacy|0|||
16115746|NCT01602510|38909685|FG002|Open Label Phase|Lack of Efficacy|0|||
16227128|NCT00887822|39313417|FG001|Overall Study|Administrative/Other than specified|4|||
16227129|NCT00887822|39313416|FG000|Overall Study|Death|2|||
16115747|NCT01602510|38909683|FG000|Open Label Phase|Protocol Violation|15|||
16411169|NCT00886119|39985731|FG001|Period 1|Did not meet inclusion criteria|0|||
16411170|NCT02723006|39985733|FG000|Overall Study|Withdrawal by Subject|0|||
16411171|NCT02723006|39985734|FG001|Overall Study|Withdrawal by Subject|1|||
16227130|NCT00887822|39313417|FG001|Overall Study|Death|3|||
16227131|NCT00887822|39313416|FG000|Overall Study|Protocol Violation|0|||
16227132|NCT00887822|39313417|FG001|Overall Study|Protocol Violation|1|||
16411172|NCT02723006|39985735|FG002|Overall Study|Withdrawal by Subject|1|||
16411173|NCT02723006|39985733|FG000|Overall Study|Study Terminated by Sponsor|1|||
16411174|NCT02723006|39985734|FG001|Overall Study|Study Terminated by Sponsor|6|||
16411175|NCT02723006|39985735|FG002|Overall Study|Study Terminated by Sponsor|6|||
16411176|NCT00598078|39988506|FG000|Period 2 (Day 2)|Adverse Event|1|||
16411177|NCT00598078|39988507|FG001|Period 2 (Day 2)|Adverse Event|0|||
16548503|NCT03097861|40470993|FG000|Overall Study|Withdrawal by Subject|1|||
16548504|NCT03097861|40470994|FG001|Overall Study|Withdrawal by Subject|5|||
16548505|NCT03097861|40470995|FG002|Overall Study|Withdrawal by Subject|3|||
16548506|NCT03097861|40470993|FG000|Overall Study|Reason not provided|3|||
16548507|NCT03097861|40470994|FG001|Overall Study|Reason not provided|1|||
16548508|NCT03097861|40470995|FG002|Overall Study|Reason not provided|1|||
16548509|NCT04399356|40470997|FG000|Overall Study|Lost to Follow-up|1|||
16548510|NCT04399356|40470998|FG001|Overall Study|Lost to Follow-up|1|||
16548511|NCT04399356|40470997|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
16548512|NCT04399356|40470998|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
16548513|NCT04399356|40470997|FG000|Overall Study|Withdrawal by Subject|1|||
16411178|NCT03538444|39988508|FG000|Overall Study|opioid withdrawal|1|||
16411179|NCT03538444|39988509|FG001|Overall Study|opioid withdrawal|0|||
16115748|NCT01602510|38909684|FG001|Open Label Phase|Protocol Violation|0|||
16115749|NCT01602510|38909685|FG002|Open Label Phase|Protocol Violation|0|||
16115750|NCT01602510|38909683|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
16115751|NCT01602510|38909684|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
16115752|NCT01602510|38909685|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
16115753|NCT01602510|38909683|FG000|Open Label Phase|Lost to Follow-up|22|||
16115754|NCT01602510|38909684|FG001|Open Label Phase|Lost to Follow-up|0|||
16115755|NCT01602510|38909685|FG002|Open Label Phase|Lost to Follow-up|0|||
16411180|NCT01537081|39988515|FG000|Overall Study|Adverse Event|5|||
16411181|NCT01537081|39988516|FG001|Overall Study|Adverse Event|2|||
16548514|NCT04399356|40470998|FG001|Overall Study|Withdrawal by Subject|0|||
16548515|NCT02254421|40470999|FG000|Overall Study|Randomized but Not Treated|1|||
16115756|NCT01602510|38909683|FG000|Open Label Phase|Physician Decision|19|||
16115757|NCT01602510|38909684|FG001|Open Label Phase|Physician Decision|0|||
16115758|NCT01602510|38909685|FG002|Open Label Phase|Physician Decision|0|||
16115759|NCT01602510|38909683|FG000|Open Label Phase|Withdrawal by Subject|57|||
16115760|NCT01602510|38909684|FG001|Open Label Phase|Withdrawal by Subject|0|||
16115761|NCT01602510|38909685|FG002|Open Label Phase|Withdrawal by Subject|0|||
16115762|NCT01602510|38909683|FG000|Randomized Phase|Adverse Event|0|||
16115763|NCT01602510|38909684|FG001|Randomized Phase|Adverse Event|2|||
16115764|NCT01602510|38909685|FG002|Randomized Phase|Adverse Event|6|||
16115765|NCT01602510|38909683|FG000|Randomized Phase|Lack of Efficacy|0|||
16115766|NCT01602510|38909684|FG001|Randomized Phase|Lack of Efficacy|4|||
16115767|NCT01602510|38909685|FG002|Randomized Phase|Lack of Efficacy|4|||
16115768|NCT01602510|38909683|FG000|Randomized Phase|Protocol Violation|0|||
16115769|NCT01602510|38909684|FG001|Randomized Phase|Protocol Violation|3|||
16115770|NCT01602510|38909685|FG002|Randomized Phase|Protocol Violation|3|||
16115771|NCT01602510|38909683|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
16115772|NCT01602510|38909684|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
16115773|NCT01602510|38909685|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
16115774|NCT01602510|38909683|FG000|Randomized Phase|Lost to Follow-up|0|||
16115775|NCT01602510|38909684|FG001|Randomized Phase|Lost to Follow-up|1|||
16115776|NCT01602510|38909685|FG002|Randomized Phase|Lost to Follow-up|3|||
16115777|NCT01602510|38909683|FG000|Randomized Phase|Physician Decision|0|||
16115778|NCT01602510|38909684|FG001|Randomized Phase|Physician Decision|0|||
16115779|NCT01602510|38909685|FG002|Randomized Phase|Physician Decision|2|||
16115780|NCT01602510|38909683|FG000|Randomized Phase|Withdrawal by Subject|0|||
16115781|NCT01602510|38909684|FG001|Randomized Phase|Withdrawal by Subject|6|||
16115782|NCT01602510|38909685|FG002|Randomized Phase|Withdrawal by Subject|7|||
16115783|NCT00935532|38909686|FG000|Overall Study|Adverse Event|11|||
16115784|NCT00935532|38909687|FG001|Overall Study|Adverse Event|6|||
16115785|NCT00935532|38909686|FG000|Overall Study|Death|1|||
16115786|NCT00935532|38909687|FG001|Overall Study|Death|0|||
16115787|NCT00935532|38909686|FG000|Overall Study|Lost to Follow-up|1|||
16115788|NCT00935532|38909687|FG001|Overall Study|Lost to Follow-up|0|||
16548516|NCT02254421|40471000|FG001|Overall Study|Randomized but Not Treated|0|||
16115789|NCT00935532|38909686|FG000|Overall Study|Physician Decision|1|||
16115790|NCT00935532|38909687|FG001|Overall Study|Physician Decision|2|||
16115791|NCT00935532|38909686|FG000|Overall Study|Protocol Violation|2|||
16115792|NCT00935532|38909687|FG001|Overall Study|Protocol Violation|1|||
16115793|NCT00935532|38909686|FG000|Overall Study|Subject Decision|2|||
16115794|NCT00935532|38909687|FG001|Overall Study|Subject Decision|1|||
16115795|NCT00935532|38909686|FG000|Overall Study|Sponsor Decision|0|||
16227133|NCT00887822|39313416|FG000|Overall Study|Randomized but not treated|0|||
16548517|NCT02254421|40470999|FG000|Overall Study|Death|0|||
16548518|NCT02254421|40471000|FG001|Overall Study|Death|2|||
16548519|NCT02254421|40470999|FG000|Overall Study|Withdrew Consent|1|||
16548520|NCT02254421|40471000|FG001|Overall Study|Withdrew Consent|1|||
16548521|NCT03565068|40471016|FG000|Overall Study|Protocol Violation|0|||
16548522|NCT03565068|40471017|FG001|Overall Study|Protocol Violation|0|||
16548523|NCT03565068|40471018|FG002|Overall Study|Protocol Violation|0|||
16548524|NCT03565068|40471019|FG003|Overall Study|Protocol Violation|0|||
16548525|NCT03565068|40471020|FG004|Overall Study|Protocol Violation|1|||
16548526|NCT03565068|40471021|FG005|Overall Study|Protocol Violation|0|||
16548527|NCT03565068|40471022|FG006|Overall Study|Protocol Violation|0|||
16115796|NCT00935532|38909687|FG001|Overall Study|Sponsor Decision|1|||
16115797|NCT00935532|38909686|FG000|Overall Study|Loss Glucose Control|4|||
16115798|NCT00935532|38909687|FG001|Overall Study|Loss Glucose Control|0|||
16115799|NCT00572533|38909688|FG000|Overall Study|Death|4|||
16115800|NCT00572533|38909689|FG001|Overall Study|Death|1|||
16115801|NCT00572533|38909688|FG000|Overall Study|Received Kidney Transplant|2|||
16115802|NCT00572533|38909689|FG001|Overall Study|Received Kidney Transplant|1|||
16115803|NCT00572533|38909688|FG000|Overall Study|Social Issues|1|||
16115804|NCT00572533|38909689|FG001|Overall Study|Social Issues|0|||
16115805|NCT00572533|38909688|FG000|Overall Study|Transfer out of Facility|0|||
16411182|NCT01537081|39988517|FG002|Overall Study|Adverse Event|2|||
16548528|NCT03565068|40471023|FG007|Overall Study|Protocol Violation|1|||
16548529|NCT03565068|40471024|FG008|Overall Study|Protocol Violation|0|||
16115806|NCT00572533|38909689|FG001|Overall Study|Transfer out of Facility|1|||
16115807|NCT02994784|38909691|FG000|6 Months Follow-up|Lost to Follow-up|3|||
16115808|NCT00422734|38909692|FG000|Overall Study|Physician Decision|1|||
16115809|NCT00422734|38909693|FG001|Overall Study|Physician Decision|1|||
16115810|NCT00422734|38909692|FG000|Overall Study|Protocol Violation|1|||
16115811|NCT00422734|38909693|FG001|Overall Study|Protocol Violation|6|||
16115812|NCT00422734|38909692|FG000|Overall Study|Withdrawal by Subject|12|||
16115813|NCT00422734|38909693|FG001|Overall Study|Withdrawal by Subject|8|||
16115814|NCT00422734|38909692|FG000|Overall Study|Adverse Event|0|||
16115815|NCT00422734|38909693|FG001|Overall Study|Adverse Event|3|||
16115816|NCT00422734|38909692|FG000|Overall Study|Partner Decision|0|||
16115817|NCT00422734|38909693|FG001|Overall Study|Partner Decision|3|||
16115818|NCT01732549|38909694|FG000|Overall Study|Adverse Event|13|||
16115819|NCT01732549|38909695|FG001|Overall Study|Adverse Event|3|||
16115820|NCT01732549|38909694|FG000|Overall Study|Consent withdrawn|13|||
16115821|NCT01732549|38909695|FG001|Overall Study|Consent withdrawn|6|||
16115822|NCT01732549|38909694|FG000|Overall Study|Disease progression|37|||
16115823|NCT01732549|38909695|FG001|Overall Study|Disease progression|50|||
16115824|NCT01732549|38909694|FG000|Overall Study|Other|8|||
16115825|NCT01732549|38909695|FG001|Overall Study|Other|14|||
16115826|NCT00108745|38909696|FG000|Overall Study|Withdrawal by Subject|19|||
16115827|NCT00108745|38909697|FG001|Overall Study|Withdrawal by Subject|12|||
16115828|NCT00108745|38909698|FG002|Overall Study|Withdrawal by Subject|12|||
16115829|NCT00108745|38909696|FG000|Overall Study|Never Treated|8|||
16115830|NCT00108745|38909697|FG001|Overall Study|Never Treated|10|||
16115831|NCT00108745|38909698|FG002|Overall Study|Never Treated|12|||
16115832|NCT00108745|38909696|FG000|Overall Study|Ineligible|7|||
16115833|NCT00108745|38909697|FG001|Overall Study|Ineligible|13|||
16115834|NCT00108745|38909698|FG002|Overall Study|Ineligible|13|||
16115835|NCT03682185|38909699|FG000|Overall Study|Lost to Follow-up|4|||
16115836|NCT03682185|38909700|FG001|Overall Study|Lost to Follow-up|7|||
16115837|NCT03682185|38909701|FG002|Overall Study|Lost to Follow-up|4|||
16115838|NCT03682185|38909702|FG003|Overall Study|Lost to Follow-up|7|||
16115839|NCT03682185|38909703|FG004|Overall Study|Lost to Follow-up|1|||
16115840|NCT03682185|38909699|FG000|Overall Study|Withdrawal by Subject|7|||
16115841|NCT03682185|38909700|FG001|Overall Study|Withdrawal by Subject|3|||
16115842|NCT03682185|38909701|FG002|Overall Study|Withdrawal by Subject|7|||
16115843|NCT03682185|38909702|FG003|Overall Study|Withdrawal by Subject|3|||
16115844|NCT03682185|38909703|FG004|Overall Study|Withdrawal by Subject|0|||
16115845|NCT00575042|38909704|FG000|Overall Study|Adverse Event|2|||
16115846|NCT00575042|38909704|FG000|Overall Study|Lost to Follow-up|1|||
16115847|NCT02053610|38909707|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
16115848|NCT02053610|38909708|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
16115849|NCT02053610|38909707|FG000|Overall Study|Withdrew Consent|2|||
16115850|NCT02053610|38909708|FG001|Overall Study|Withdrew Consent|9|||
16115851|NCT02053610|38909707|FG000|Overall Study|Death|5|||
16115852|NCT02053610|38909708|FG001|Overall Study|Death|5|||
16115853|NCT02053610|38909707|FG000|Overall Study|Administrative/Other|1|||
16115854|NCT02053610|38909708|FG001|Overall Study|Administrative/Other|1|||
16115855|NCT02053610|38909707|FG000|Overall Study|Disease Progression|2|||
16115856|NCT02053610|38909708|FG001|Overall Study|Disease Progression|3|||
16115857|NCT02053610|38909707|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
16115858|NCT02053610|38909708|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
16115859|NCT02053610|38909707|FG000|Overall Study|Did not Receive Treatment|4|||
16115860|NCT02053610|38909708|FG001|Overall Study|Did not Receive Treatment|2|||
16115861|NCT02053610|38909707|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16115862|NCT02053610|38909708|FG001|Overall Study|Insufficient Therapeutic Response|1|||
16115863|NCT02053610|38909707|FG000|Overall Study|Violation of Selection Criteria|1|||
16115864|NCT02053610|38909708|FG001|Overall Study|Violation of Selection Criteria|0|||
16115865|NCT01261247|38909710|FG000|Overall Study|Ineligible|2|||
16115866|NCT03274453|38909716|FG000|Overall Study|Lost to Follow-up|2|||
16115867|NCT03274453|38909717|FG001|Overall Study|Lost to Follow-up|5|||
16115868|NCT03274453|38909718|FG002|Overall Study|Lost to Follow-up|4|||
16548530|NCT03565068|40471016|FG000|Overall Study|Sponsor decision|0|||
16115869|NCT03274453|38909719|FG003|Overall Study|Lost to Follow-up|1|||
16115870|NCT03274453|38909716|FG000|Overall Study|Physician Decision|2|||
16115871|NCT03274453|38909717|FG001|Overall Study|Physician Decision|0|||
16115872|NCT03274453|38909718|FG002|Overall Study|Physician Decision|0|||
16115873|NCT03274453|38909719|FG003|Overall Study|Physician Decision|3|||
16115874|NCT03274453|38909716|FG000|Overall Study|Surgery Cancelled|0|||
16115875|NCT03274453|38909717|FG001|Overall Study|Surgery Cancelled|1|||
16115876|NCT03274453|38909718|FG002|Overall Study|Surgery Cancelled|0|||
16115877|NCT03274453|38909719|FG003|Overall Study|Surgery Cancelled|0|||
16115878|NCT00497874|38909720|FG000|Overall Study|Withdrawal by Subject|48|||
16115879|NCT00497874|38909721|FG001|Overall Study|Withdrawal by Subject|17|||
16115880|NCT00497874|38909720|FG000|Overall Study|Illness|8|||
16115881|NCT00497874|38909721|FG001|Overall Study|Illness|4|||
16115882|NCT00497874|38909720|FG000|Overall Study|Death|2|||
16115883|NCT00497874|38909721|FG001|Overall Study|Death|4|||
16115884|NCT00497874|38909720|FG000|Overall Study|Unable to contact|52|||
16115885|NCT00497874|38909721|FG001|Overall Study|Unable to contact|67|||
16115886|NCT00497874|38909720|FG000|Overall Study|Unable to schedule|37|||
16115887|NCT00497874|38909721|FG001|Overall Study|Unable to schedule|24|||
16115888|NCT02593123|38909723|FG000|Overall Study|Physician Decision|2|||
16115889|NCT02593123|38909724|FG001|Overall Study|Physician Decision|1|||
16115890|NCT02593123|38909723|FG000|Overall Study|Relapse|1|||
16115891|NCT02593123|38909724|FG001|Overall Study|Relapse|1|||
16115892|NCT04071301|38909725|FG000|Overall Study|Withdrawal by Subject|6|||
16115893|NCT04071301|38909725|FG000|Overall Study|Death|1|||
16115894|NCT01294397|38909739|FG000|Overall Study|Withdrawal by Subject|1|||
16115895|NCT01294397|38909739|FG000|Overall Study|Administrative Decision|1|||
16115896|NCT00911768|38909745|FG000|Overall Study|Protocol Violation|5|||
16115897|NCT00911768|38909746|FG001|Overall Study|Protocol Violation|4|||
16115898|NCT00911768|38909745|FG000|Overall Study|Withdrawal by Subject|1|||
16173204|NCT04672083|39111122|FG000|Overall Study|Lost to Follow-up|1|||
16115899|NCT00911768|38909746|FG001|Overall Study|Withdrawal by Subject|0|||
16115900|NCT00725712|38909747|FG000|Overall Study|Withdrawal by Subject|2|||
16411183|NCT01537081|39988515|FG000|Overall Study|Lack of Efficacy|2|||
16411184|NCT01537081|39988516|FG001|Overall Study|Lack of Efficacy|1|||
16411185|NCT01537081|39988517|FG002|Overall Study|Lack of Efficacy|0|||
16411186|NCT01537081|39988515|FG000|Overall Study|Lost to Follow-up|17|||
16411187|NCT01537081|39988516|FG001|Overall Study|Lost to Follow-up|15|||
16411188|NCT01537081|39988517|FG002|Overall Study|Lost to Follow-up|9|||
16548531|NCT03565068|40471017|FG001|Overall Study|Sponsor decision|0|||
16115901|NCT00725712|38909748|FG001|Overall Study|Withdrawal by Subject|1|||
16115902|NCT00725712|38909747|FG000|Overall Study|Protocol Violation|1|||
16115903|NCT00725712|38909748|FG001|Overall Study|Protocol Violation|0|||
16115904|NCT00725712|38909747|FG000|Overall Study|Progressive disease|37|||
16115905|NCT00725712|38909748|FG001|Overall Study|Progressive disease|16|||
16115906|NCT00725712|38909747|FG000|Overall Study|Clinical progression not based on RECIST|0|||
16115907|NCT00725712|38909748|FG001|Overall Study|Clinical progression not based on RECIST|3|||
16115908|NCT00725712|38909747|FG000|Overall Study|Adverse Event|5|||
16115909|NCT00725712|38909748|FG001|Overall Study|Adverse Event|5|||
16115910|NCT00725712|38909747|FG000|Overall Study|Death|2|||
16115911|NCT00725712|38909748|FG001|Overall Study|Death|0|||
16115912|NCT00725712|38909747|FG000|Overall Study|Other: Death|1|||
16115913|NCT00725712|38909748|FG001|Overall Study|Other: Death|0|||
16115914|NCT00725712|38909747|FG000|Overall Study|Hospitalized, unable to continue|0|||
16115915|NCT00725712|38909748|FG001|Overall Study|Hospitalized, unable to continue|1|||
16115916|NCT02963090|38909749|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
16548532|NCT03565068|40471018|FG002|Overall Study|Sponsor decision|0|||
16548533|NCT03565068|40471019|FG003|Overall Study|Sponsor decision|0|||
16548534|NCT03565068|40471020|FG004|Overall Study|Sponsor decision|1|||
16548535|NCT03565068|40471021|FG005|Overall Study|Sponsor decision|1|||
16548536|NCT03565068|40471022|FG006|Overall Study|Sponsor decision|0|||
16548537|NCT03565068|40471023|FG007|Overall Study|Sponsor decision|0|||
16548538|NCT03565068|40471024|FG008|Overall Study|Sponsor decision|0|||
16115917|NCT02963090|38909750|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
16115918|NCT00520845|38909756|FG000|Overall Study|Death|3|||
16115919|NCT00520845|38909756|FG000|Overall Study|Adverse Event|4|||
16115920|NCT00520845|38909756|FG000|Overall Study|Disease Progression, relapse|13|||
16115921|NCT00520845|38909756|FG000|Overall Study|Withdrawal by Subject|1|||
16115922|NCT00520845|38909756|FG000|Overall Study|Alternative Therapy|1|||
16115923|NCT00971997|38909757|FG000|Overall Study|Adverse Event|2|||
16115924|NCT00971997|38909757|FG000|Overall Study|Death|1|||
16115925|NCT00971997|38909757|FG000|Overall Study|Protocol Violation|4|||
16115926|NCT00971997|38909757|FG000|Overall Study|Withdrawal by Subject|5|||
16115927|NCT00971997|38909757|FG000|Overall Study|Physician Decision|7|||
16115928|NCT02227992|38909759|FG000|Overall Study|Lost to Follow-up|1|||
16115929|NCT02227992|38909760|FG001|Overall Study|Lost to Follow-up|1|||
16115930|NCT03614676|38909765|FG000|Overall Study|Delivery before planned visit|2|||
16347446|NCT01098162|39757485|FG000|Overall Study|Reason Unknown|26|||
16548539|NCT03565068|40471016|FG000|Overall Study|Withdrawal by Subject|0|||
16115931|NCT03614676|38909766|FG001|Overall Study|Delivery before planned visit|0|||
16173205|NCT04672083|39111123|FG001|Overall Study|Lost to Follow-up|0|||
16347447|NCT02372383|39757486|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
16347448|NCT02372383|39757487|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
16347449|NCT02372383|39757488|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
16347450|NCT02824627|39757491|FG000|Overall Study|Adverse Event|1|||
16347451|NCT02824627|39757492|FG001|Overall Study|Adverse Event|2|||
16347452|NCT02824627|39757491|FG000|Overall Study|Lost to Follow-up|2|||
16347453|NCT02824627|39757492|FG001|Overall Study|Lost to Follow-up|1|||
16347454|NCT00672633|39757495|FG000|Overall Study|Withdrawal by Subject|0|||
16411189|NCT01537081|39988515|FG000|Overall Study|Protocol Violation|3|||
16548540|NCT03565068|40471017|FG001|Overall Study|Withdrawal by Subject|0|||
16411190|NCT01537081|39988516|FG001|Overall Study|Protocol Violation|2|||
16411191|NCT01537081|39988517|FG002|Overall Study|Protocol Violation|2|||
16411192|NCT01537081|39988515|FG000|Overall Study|Withdrawal by Subject|6|||
16411193|NCT01537081|39988516|FG001|Overall Study|Withdrawal by Subject|11|||
16411194|NCT01537081|39988517|FG002|Overall Study|Withdrawal by Subject|3|||
16411195|NCT01537081|39988515|FG000|Overall Study|Physician Decision|5|||
16411196|NCT01537081|39988516|FG001|Overall Study|Physician Decision|6|||
16411197|NCT01537081|39988517|FG002|Overall Study|Physician Decision|0|||
16411198|NCT01537081|39988515|FG000|Overall Study|Sponsor decision|0|||
16411199|NCT01537081|39988516|FG001|Overall Study|Sponsor decision|1|||
16411200|NCT01537081|39988517|FG002|Overall Study|Sponsor decision|0|||
16411201|NCT01537081|39988515|FG000|Overall Study|Assigned but never dosed|1|||
16411202|NCT01537081|39988516|FG001|Overall Study|Assigned but never dosed|0|||
16411203|NCT01537081|39988517|FG002|Overall Study|Assigned but never dosed|0|||
16411204|NCT00787930|39988518|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
16411205|NCT03458702|39988524|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
16411206|NCT03458702|39988525|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
16411207|NCT03458702|39988524|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
16411208|NCT03458702|39988525|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
16411209|NCT00748709|39988526|FG000|Overall Study|Progressive disease|15|||
16411210|NCT00748709|39988526|FG000|Overall Study|Drug reducing Toxity|2|||
16411211|NCT00748709|39988526|FG000|Overall Study|Other Adverse Event|1|||
16411212|NCT00748709|39988526|FG000|Overall Study|Withdrawal by Subject|1|||
16411213|NCT00748709|39988526|FG000|Overall Study|Other Reasons|1|||
16411214|NCT00283868|39988530|FG000|Overall Study|Lost to Follow-up|7|||
16411215|NCT00283868|39988531|FG001|Overall Study|Lost to Follow-up|8|||
16411216|NCT02818036|39988533|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
16411217|NCT02818036|39988534|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
16411218|NCT02818036|39988533|FG000|Overall Study|Withdrawal by Subject|1|||
16411219|NCT02818036|39988534|FG001|Overall Study|Withdrawal by Subject|0|||
16411220|NCT01400243|39988537|FG000|Overall Study|Protocol Violation|8|||
16548541|NCT03565068|40471018|FG002|Overall Study|Withdrawal by Subject|1|||
16548542|NCT03565068|40471019|FG003|Overall Study|Withdrawal by Subject|0|||
16548543|NCT03565068|40471020|FG004|Overall Study|Withdrawal by Subject|2|||
16548544|NCT03565068|40471021|FG005|Overall Study|Withdrawal by Subject|0|||
16548545|NCT03565068|40471022|FG006|Overall Study|Withdrawal by Subject|1|||
16548546|NCT03565068|40471023|FG007|Overall Study|Withdrawal by Subject|5|||
16548547|NCT03565068|40471024|FG008|Overall Study|Withdrawal by Subject|1|||
16548548|NCT03565068|40471016|FG000|Overall Study|Physician Decision|0|||
16548549|NCT03565068|40471017|FG001|Overall Study|Physician Decision|0|||
16548550|NCT03565068|40471018|FG002|Overall Study|Physician Decision|0|||
16548551|NCT03565068|40471019|FG003|Overall Study|Physician Decision|0|||
16548552|NCT03565068|40471020|FG004|Overall Study|Physician Decision|0|||
16548553|NCT03565068|40471021|FG005|Overall Study|Physician Decision|0|||
16548554|NCT03565068|40471022|FG006|Overall Study|Physician Decision|0|||
16548555|NCT03565068|40471023|FG007|Overall Study|Physician Decision|1|||
16548556|NCT03565068|40471024|FG008|Overall Study|Physician Decision|0|||
16548557|NCT03565068|40471016|FG000|Overall Study|Lost to Follow-up|0|||
16548558|NCT03565068|40471017|FG001|Overall Study|Lost to Follow-up|0|||
16173206|NCT04672083|39111124|FG002|Overall Study|Lost to Follow-up|0|||
16411221|NCT01400243|39988538|FG001|Overall Study|Protocol Violation|11|||
16411222|NCT03080883|39988539|FG000|Overall Study|Withdrawal by Subject|11|||
16411223|NCT03080883|39988540|FG001|Overall Study|Withdrawal by Subject|15|||
16411224|NCT03080883|39988539|FG000|Overall Study|Adverse Event|22|||
16548559|NCT03565068|40471018|FG002|Overall Study|Lost to Follow-up|0|||
16548560|NCT03565068|40471019|FG003|Overall Study|Lost to Follow-up|0|||
16548561|NCT03565068|40471020|FG004|Overall Study|Lost to Follow-up|0|||
16548562|NCT03565068|40471021|FG005|Overall Study|Lost to Follow-up|0|||
16548563|NCT03565068|40471022|FG006|Overall Study|Lost to Follow-up|0|||
16548564|NCT03565068|40471023|FG007|Overall Study|Lost to Follow-up|1|||
16548565|NCT03565068|40471024|FG008|Overall Study|Lost to Follow-up|0|||
16548566|NCT01857622|40471036|FG000|Overall Study|Adverse Event|5|||
16548567|NCT01857622|40471037|FG001|Overall Study|Adverse Event|0|||
16548568|NCT01857622|40471038|FG002|Overall Study|Adverse Event|2|||
16548569|NCT01857622|40471036|FG000|Overall Study|Physician Decision|1|||
16548570|NCT01857622|40471037|FG001|Overall Study|Physician Decision|0|||
16548571|NCT01857622|40471038|FG002|Overall Study|Physician Decision|0|||
16548572|NCT01857622|40471036|FG000|Overall Study|Protocol Violation|4|||
16411225|NCT03080883|39988540|FG001|Overall Study|Adverse Event|22|||
16411226|NCT03080883|39988539|FG000|Overall Study|Alternative Therapy|0|||
16411227|NCT03080883|39988540|FG001|Overall Study|Alternative Therapy|3|||
16411228|NCT03080883|39988539|FG000|Overall Study|Other Complicating Disease|9|||
16115932|NCT03614676|38909765|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
16115933|NCT03614676|38909766|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
16115934|NCT03614676|38909765|FG000|Overall Study|Migrated / moved from the study area|30|||
16115935|NCT03614676|38909766|FG001|Overall Study|Migrated / moved from the study area|22|||
16115936|NCT03614676|38909765|FG000|Overall Study|Lost to Follow-up|17|||
16115937|NCT03614676|38909766|FG001|Overall Study|Lost to Follow-up|42|||
16115938|NCT03614676|38909765|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
16115939|NCT03614676|38909766|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
16115940|NCT03614676|38909765|FG000|Overall Study|Other|16|||
16115941|NCT03614676|38909766|FG001|Overall Study|Other|47|||
16115942|NCT03614676|38909765|FG000|Overall Study|Protocol Violation|0|||
16115943|NCT03614676|38909766|FG001|Overall Study|Protocol Violation|2|||
16115944|NCT03614676|38909765|FG000|Overall Study|Neonatal event of interest|0|||
16115945|NCT03614676|38909766|FG001|Overall Study|Neonatal event of interest|6|||
16115946|NCT03614676|38909765|FG000|Overall Study|Death in infant greater than 28 days old|0|||
16115947|NCT03614676|38909766|FG001|Overall Study|Death in infant greater than 28 days old|12|||
16115948|NCT03614676|38909765|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
16115949|NCT03614676|38909766|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
16115950|NCT03994731|38909769|FG000|Pegloticase + IMM Period|Death|2|||
16115951|NCT03994731|38909770|FG001|Pegloticase + IMM Period|Death|0|||
16115952|NCT03994731|38909769|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
16115953|NCT03994731|38909770|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
16115954|NCT03994731|38909769|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
16115955|NCT03994731|38909770|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
16115956|NCT02638103|38909773|FG000|Overall Study|Adverse Event|13|||
16115957|NCT02638103|38909774|FG001|Overall Study|Adverse Event|12|||
16115958|NCT02638103|38909775|FG002|Overall Study|Adverse Event|19|||
16115959|NCT02638103|38909776|FG003|Overall Study|Adverse Event|12|||
16115960|NCT02638103|38909773|FG000|Overall Study|Withdrawal by Subject|43|||
16115961|NCT02638103|38909774|FG001|Overall Study|Withdrawal by Subject|53|||
16411229|NCT03080883|39988540|FG001|Overall Study|Other Complicating Disease|5|||
16411230|NCT03080883|39988539|FG000|Overall Study|Death|21|||
16548573|NCT01857622|40471037|FG001|Overall Study|Protocol Violation|1|||
16115962|NCT02638103|38909775|FG002|Overall Study|Withdrawal by Subject|30|||
16115963|NCT02638103|38909776|FG003|Overall Study|Withdrawal by Subject|61|||
16115964|NCT02638103|38909773|FG000|Overall Study|Protocol Violation|1|||
16115965|NCT02638103|38909774|FG001|Overall Study|Protocol Violation|2|||
16115966|NCT02638103|38909775|FG002|Overall Study|Protocol Violation|1|||
16115967|NCT02638103|38909776|FG003|Overall Study|Protocol Violation|4|||
16115968|NCT02638103|38909773|FG000|Overall Study|Pregnancy|2|||
16115969|NCT02638103|38909774|FG001|Overall Study|Pregnancy|3|||
16115970|NCT02638103|38909775|FG002|Overall Study|Pregnancy|0|||
16115971|NCT02638103|38909776|FG003|Overall Study|Pregnancy|1|||
16115972|NCT02638103|38909773|FG000|Overall Study|Non-compliance to Study Procedures|2|||
16115973|NCT02638103|38909774|FG001|Overall Study|Non-compliance to Study Procedures|1|||
16115974|NCT02638103|38909775|FG002|Overall Study|Non-compliance to Study Procedures|1|||
16115975|NCT02638103|38909776|FG003|Overall Study|Non-compliance to Study Procedures|1|||
16115976|NCT02638103|38909773|FG000|Overall Study|Lost to Follow-up|26|||
16115977|NCT02638103|38909774|FG001|Overall Study|Lost to Follow-up|33|||
16115978|NCT02638103|38909775|FG002|Overall Study|Lost to Follow-up|20|||
16115979|NCT02638103|38909776|FG003|Overall Study|Lost to Follow-up|37|||
16115980|NCT02638103|38909773|FG000|Overall Study|Lack of Efficacy|14|||
16115981|NCT02638103|38909774|FG001|Overall Study|Lack of Efficacy|10|||
16115982|NCT02638103|38909775|FG002|Overall Study|Lack of Efficacy|12|||
16115983|NCT02638103|38909776|FG003|Overall Study|Lack of Efficacy|22|||
16115984|NCT02638103|38909773|FG000|Overall Study|Other than specified|5|||
16115985|NCT02638103|38909774|FG001|Overall Study|Other than specified|4|||
16115986|NCT02638103|38909775|FG002|Overall Study|Other than specified|2|||
16115987|NCT02638103|38909776|FG003|Overall Study|Other than specified|4|||
16115988|NCT03898700|38909777|FG000|Overall Study|Withdrawal by Subject|2|||
16115989|NCT00126659|38909780|FG000|Overall Study|Adverse Event|0|||
16115990|NCT00126659|38909781|FG001|Overall Study|Adverse Event|0|||
16115991|NCT00126659|38909782|FG002|Overall Study|Adverse Event|2|||
16115992|NCT01246999|38909783|FG000|Overall Study|Lost to Follow-up|0|||
16115993|NCT01246999|38909784|FG001|Overall Study|Lost to Follow-up|1|||
16115994|NCT01246999|38909785|FG002|Overall Study|Lost to Follow-up|0|||
16115995|NCT01246999|38909786|FG003|Overall Study|Lost to Follow-up|0|||
16115996|NCT01246999|38909783|FG000|Overall Study|Withdrawal by Subject|0|||
16115997|NCT01246999|38909784|FG001|Overall Study|Withdrawal by Subject|0|||
16115998|NCT01246999|38909785|FG002|Overall Study|Withdrawal by Subject|0|||
16115999|NCT01246999|38909786|FG003|Overall Study|Withdrawal by Subject|2|||
16116000|NCT00447590|38909789|FG000|Overall Study|Withdrawal by Subject|26|||
16227134|NCT00887822|39313417|FG001|Overall Study|Randomized but not treated|1|||
16227135|NCT00701064|39313418|FG000|Overall Study|Protocol Violation|1|||
16227136|NCT00701064|39313419|FG001|Overall Study|Protocol Violation|1|||
16227137|NCT00701064|39313418|FG000|Overall Study|Withdrawal by Subject|1|||
16227138|NCT00701064|39313419|FG001|Overall Study|Withdrawal by Subject|1|||
16227139|NCT00701064|39313418|FG000|Overall Study|initiated other PTSD treatment|2|||
16227140|NCT00701064|39313419|FG001|Overall Study|initiated other PTSD treatment|2|||
16227141|NCT04409262|39313422|FG000|Overall Study|Adverse Event|0|||
16227142|NCT04409262|39313423|FG001|Overall Study|Adverse Event|2|||
16227143|NCT04409262|39313422|FG000|Overall Study|Death|55|||
16227144|NCT04409262|39313423|FG001|Overall Study|Death|97|||
16227145|NCT04409262|39313422|FG000|Overall Study|Lost to Follow-up|12|||
16227146|NCT04409262|39313423|FG001|Overall Study|Lost to Follow-up|23|||
16227147|NCT04409262|39313422|FG000|Overall Study|Lack of Staff|0|||
16227148|NCT04409262|39313423|FG001|Overall Study|Lack of Staff|1|||
16227149|NCT04409262|39313422|FG000|Overall Study|Protocol Violation|3|||
16227150|NCT04409262|39313423|FG001|Overall Study|Protocol Violation|1|||
16227151|NCT04409262|39313422|FG000|Overall Study|Withdrawal by Subject|5|||
16227152|NCT04409262|39313423|FG001|Overall Study|Withdrawal by Subject|10|||
16227153|NCT02491463|39313426|FG000|Overall Study|Withdrawal by Subject|1|||
16227154|NCT02491463|39313427|FG001|Overall Study|Withdrawal by Subject|2|||
16227155|NCT02491463|39313428|FG002|Overall Study|Withdrawal by Subject|0|||
16347455|NCT00672633|39757496|FG001|Overall Study|Withdrawal by Subject|1|||
16347456|NCT00048035|39761913|FG000|Core Period|Early Withdrawals|4|||
16116001|NCT00447590|38909789|FG000|Overall Study|Lost to Follow-up|24|||
16116002|NCT00447590|38909789|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
16116003|NCT03149549|38909791|FG000|Study Discontinuation--Treatment Period|Death|0|||
16116004|NCT03149549|38909792|FG001|Study Discontinuation--Treatment Period|Death|0|||
16116005|NCT03149549|38909793|FG002|Study Discontinuation--Treatment Period|Death|0|||
16116006|NCT03149549|38909794|FG003|Study Discontinuation--Treatment Period|Death|1|||
16116007|NCT03149549|38909795|FG004|Study Discontinuation--Treatment Period|Death|2|||
16116008|NCT03149549|38909796|FG005|Study Discontinuation--Treatment Period|Death|1|||
16227156|NCT02491463|39313429|FG003|Overall Study|Withdrawal by Subject|0|||
16227157|NCT02491463|39313426|FG000|Overall Study|Migrated/moved from study area|1|||
16347457|NCT00048035|39761914|FG001|Core Period|Early Withdrawals|2|||
16116009|NCT03149549|38909797|FG006|Study Discontinuation--Treatment Period|Death|1|||
16116010|NCT03149549|38909798|FG007|Study Discontinuation--Treatment Period|Death|2|||
16116011|NCT03149549|38909799|FG008|Study Discontinuation--Treatment Period|Death|4|||
16116012|NCT03149549|38909800|FG009|Study Discontinuation--Treatment Period|Death|1|||
16116013|NCT03149549|38909801|FG010|Study Discontinuation--Treatment Period|Death|0|||
16116014|NCT03149549|38909802|FG011|Study Discontinuation--Treatment Period|Death|0|||
16116015|NCT03149549|38909803|FG012|Study Discontinuation--Treatment Period|Death|1|||
16116016|NCT03149549|38909791|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16116017|NCT03149549|38909792|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16116018|NCT03149549|38909793|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16116019|NCT03149549|38909794|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16227158|NCT02491463|39313427|FG001|Overall Study|Migrated/moved from study area|5|||
16227159|NCT02491463|39313428|FG002|Overall Study|Migrated/moved from study area|1|||
16227160|NCT02491463|39313429|FG003|Overall Study|Migrated/moved from study area|1|||
16227161|NCT02491463|39313426|FG000|Overall Study|Lost to Follow-up|0|||
16227162|NCT02491463|39313427|FG001|Overall Study|Lost to Follow-up|3|||
16227163|NCT02491463|39313428|FG002|Overall Study|Lost to Follow-up|3|||
16227164|NCT02491463|39313429|FG003|Overall Study|Lost to Follow-up|0|||
16227165|NCT00598585|39313434|FG000|Overall Study|Lost to Follow-up|1|||
16227166|NCT00598585|39313435|FG001|Overall Study|Lost to Follow-up|0|||
16227167|NCT01021423|39313438|FG000|Overall Study|Study terminated|4|||
16227168|NCT01021423|39313439|FG001|Overall Study|Study terminated|5|||
16227169|NCT01072175|39313440|FG000|Part A (Drug-Drug Interaction)|Death|1|||
16227170|NCT01072175|39313441|FG001|Part A (Drug-Drug Interaction)|Death|0|||
16227171|NCT01072175|39313442|FG002|Part A (Drug-Drug Interaction)|Death|0|||
16227172|NCT01072175|39313443|FG003|Part A (Drug-Drug Interaction)|Death|0|||
16227173|NCT01072175|39313444|FG004|Part A (Drug-Drug Interaction)|Death|0|||
16227174|NCT01072175|39313445|FG005|Part A (Drug-Drug Interaction)|Death|0|||
16227175|NCT01072175|39313446|FG006|Part A (Drug-Drug Interaction)|Death|0|||
16227176|NCT01072175|39313447|FG007|Part A (Drug-Drug Interaction)|Death|0|||
16227177|NCT01072175|39313448|FG008|Part A (Drug-Drug Interaction)|Death|0|||
16227178|NCT01072175|39313449|FG009|Part A (Drug-Drug Interaction)|Death|0|||
16227179|NCT01072175|39313450|FG010|Part A (Drug-Drug Interaction)|Death|0|||
16227180|NCT01072175|39313451|FG011|Part A (Drug-Drug Interaction)|Death|0|||
16227181|NCT01072175|39313452|FG012|Part A (Drug-Drug Interaction)|Death|0|||
16227182|NCT01072175|39313440|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
16227183|NCT01072175|39313441|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227184|NCT01072175|39313442|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227185|NCT01072175|39313443|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227186|NCT01072175|39313444|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227187|NCT01072175|39313445|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227188|NCT01072175|39313446|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227189|NCT01072175|39313447|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227190|NCT01072175|39313448|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227191|NCT01072175|39313449|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227192|NCT01072175|39313450|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227193|NCT01072175|39313451|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227194|NCT01072175|39313452|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
16227195|NCT01072175|39313440|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
16227196|NCT01072175|39313441|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227197|NCT01072175|39313442|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227198|NCT01072175|39313443|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227199|NCT01072175|39313444|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227200|NCT01072175|39313445|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227201|NCT01072175|39313446|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227202|NCT01072175|39313447|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227203|NCT01072175|39313448|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227204|NCT01072175|39313449|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227205|NCT01072175|39313450|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227206|NCT01072175|39313451|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227207|NCT01072175|39313452|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
16227208|NCT01072175|39313440|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
16227209|NCT01072175|39313441|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
16227210|NCT01072175|39313442|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
16227211|NCT01072175|39313443|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
16227212|NCT01072175|39313444|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
16227213|NCT01072175|39313445|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
16227214|NCT01072175|39313446|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
16227215|NCT01072175|39313447|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
16227216|NCT01072175|39313448|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
16227217|NCT01072175|39313449|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
16227218|NCT01072175|39313450|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
16227219|NCT01072175|39313451|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
16347458|NCT00048035|39761915|FG002|Core Period|Early Withdrawals|1|||
16116020|NCT03149549|38909795|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16116021|NCT03149549|38909796|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16116022|NCT03149549|38909797|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16116023|NCT03149549|38909798|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
16116024|NCT03149549|38909799|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16116025|NCT03149549|38909800|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16116026|NCT03149549|38909801|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16116027|NCT03149549|38909802|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
16116028|NCT03149549|38909803|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
16116029|NCT03149549|38909791|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
16116030|NCT03149549|38909792|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
16116031|NCT03149549|38909793|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
16116032|NCT03149549|38909794|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
16116033|NCT03149549|38909795|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
16116034|NCT03149549|38909796|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
16116035|NCT03149549|38909797|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
16116036|NCT03149549|38909798|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
16116037|NCT03149549|38909799|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
16116038|NCT03149549|38909800|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
16116039|NCT03149549|38909801|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
16116040|NCT03149549|38909802|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
16116041|NCT03149549|38909803|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
16116042|NCT03149549|38909791|FG000|Study Discontinuation--Treatment Period|Other|0|||
16116043|NCT03149549|38909792|FG001|Study Discontinuation--Treatment Period|Other|0|||
16411231|NCT03080883|39988540|FG001|Overall Study|Death|16|||
16411232|NCT03080883|39988539|FG000|Overall Study|Physician Decision|2|||
16411233|NCT03080883|39988540|FG001|Overall Study|Physician Decision|2|||
16411234|NCT03080883|39988539|FG000|Overall Study|Disease Progression|2|||
16411235|NCT03080883|39988540|FG001|Overall Study|Disease Progression|8|||
16411236|NCT03080883|39988539|FG000|Overall Study|Lost to Follow-up|1|||
16411237|NCT03080883|39988540|FG001|Overall Study|Lost to Follow-up|1|||
16411238|NCT02250664|39988541|FG000|Overall Study|Lost to Follow-up|18|||
16411239|NCT02250664|39988542|FG001|Overall Study|Lost to Follow-up|28|||
16411240|NCT02250664|39988543|FG002|Overall Study|Lost to Follow-up|33|||
16411241|NCT02250664|39988541|FG000|Overall Study|Personal Reasons|7|||
16411242|NCT02250664|39988542|FG001|Overall Study|Personal Reasons|8|||
16411243|NCT02250664|39988543|FG002|Overall Study|Personal Reasons|14|||
16411244|NCT02250664|39988541|FG000|Overall Study|Adverse Event|6|||
16411245|NCT02250664|39988542|FG001|Overall Study|Adverse Event|3|||
16411246|NCT02250664|39988543|FG002|Overall Study|Adverse Event|8|||
16411247|NCT02250664|39988541|FG000|Overall Study|Incarcerated|2|||
16411248|NCT02250664|39988542|FG001|Overall Study|Incarcerated|1|||
16411249|NCT02250664|39988543|FG002|Overall Study|Incarcerated|2|||
16411250|NCT02250664|39988541|FG000|Overall Study|Withdrawal by Subject|0|||
16411251|NCT02250664|39988542|FG001|Overall Study|Withdrawal by Subject|1|||
16411252|NCT02250664|39988543|FG002|Overall Study|Withdrawal by Subject|2|||
16411253|NCT02250664|39988541|FG000|Overall Study|Death|0|||
16411254|NCT02250664|39988542|FG001|Overall Study|Death|1|||
16411255|NCT02250664|39988543|FG002|Overall Study|Death|1|||
16411256|NCT02250664|39988541|FG000|Overall Study|Physician Decision|1|||
16411257|NCT02250664|39988542|FG001|Overall Study|Physician Decision|3|||
16411258|NCT02250664|39988543|FG002|Overall Study|Physician Decision|1|||
16411259|NCT02250664|39988541|FG000|Overall Study|Protocol Violation|1|||
16411260|NCT02250664|39988542|FG001|Overall Study|Protocol Violation|0|||
16227220|NCT01072175|39313452|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
16227221|NCT01072175|39313440|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227222|NCT01072175|39313441|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227223|NCT01072175|39313442|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
16548574|NCT01857622|40471038|FG002|Overall Study|Protocol Violation|0|||
16548575|NCT01857622|40471036|FG000|Overall Study|Withdrawal by Subject|1|||
16116044|NCT03149549|38909793|FG002|Study Discontinuation--Treatment Period|Other|0|||
16116045|NCT03149549|38909794|FG003|Study Discontinuation--Treatment Period|Other|0|||
16116046|NCT03149549|38909795|FG004|Study Discontinuation--Treatment Period|Other|0|||
16116047|NCT03149549|38909796|FG005|Study Discontinuation--Treatment Period|Other|0|||
16116048|NCT03149549|38909797|FG006|Study Discontinuation--Treatment Period|Other|0|||
16116049|NCT03149549|38909798|FG007|Study Discontinuation--Treatment Period|Other|1|||
16116050|NCT03149549|38909799|FG008|Study Discontinuation--Treatment Period|Other|0|||
16116051|NCT03149549|38909800|FG009|Study Discontinuation--Treatment Period|Other|1|||
16116052|NCT03149549|38909801|FG010|Study Discontinuation--Treatment Period|Other|0|||
16116053|NCT03149549|38909802|FG011|Study Discontinuation--Treatment Period|Other|0|||
16116054|NCT03149549|38909803|FG012|Study Discontinuation--Treatment Period|Other|0|||
16116055|NCT03149549|38909791|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
16116056|NCT03149549|38909792|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
16116057|NCT03149549|38909793|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
16116058|NCT03149549|38909794|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
16116059|NCT03149549|38909795|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
16116060|NCT03149549|38909796|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
16116061|NCT03149549|38909797|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
16116062|NCT03149549|38909798|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
16116063|NCT03149549|38909799|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
16116064|NCT03149549|38909800|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
16116065|NCT03149549|38909801|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
16116066|NCT03149549|38909802|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
16116067|NCT03149549|38909803|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
16116068|NCT03149549|38909791|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
16116069|NCT03149549|38909792|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
16116070|NCT03149549|38909793|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
16116071|NCT03149549|38909794|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
16116072|NCT03149549|38909795|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
16116073|NCT03149549|38909796|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
16116074|NCT03149549|38909797|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
16116075|NCT03149549|38909798|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
16116076|NCT03149549|38909799|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
16116077|NCT03149549|38909800|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
16116078|NCT03149549|38909801|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
16116079|NCT03149549|38909802|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
16116080|NCT03149549|38909803|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
16116081|NCT03149549|38909791|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
16116082|NCT03149549|38909792|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
16116083|NCT03149549|38909793|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
16116084|NCT03149549|38909794|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
16116085|NCT03149549|38909795|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
16116086|NCT03149549|38909796|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
16116087|NCT03149549|38909797|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
16116088|NCT03149549|38909798|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
16116089|NCT03149549|38909799|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
16116090|NCT03149549|38909800|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
16116091|NCT03149549|38909801|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
16116092|NCT03149549|38909802|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
16116093|NCT03149549|38909803|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
16116094|NCT03149549|38909791|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
16116095|NCT03149549|38909792|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
16116096|NCT03149549|38909793|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
16116097|NCT03149549|38909794|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
16116098|NCT03149549|38909795|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
16116099|NCT03149549|38909796|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
16116100|NCT03149549|38909797|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
16116101|NCT03149549|38909798|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
16116102|NCT03149549|38909799|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
16548576|NCT01857622|40471037|FG001|Overall Study|Withdrawal by Subject|0|||
16548577|NCT01857622|40471038|FG002|Overall Study|Withdrawal by Subject|0|||
16548578|NCT01160484|40471039|FG000|Overall Study|Lack of Efficacy|9|||
16548579|NCT01160484|40471039|FG000|Overall Study|Adverse Event|6|||
16548580|NCT01160484|40471039|FG000|Overall Study|Withdrawal by Subject|2|||
16116103|NCT03149549|38909800|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
16548581|NCT01160484|40471039|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
16548582|NCT01659658|40471042|FG000|Overall Study|Withdrawal by Patient|18|||
16548583|NCT01659658|40471043|FG001|Overall Study|Withdrawal by Patient|4|||
16548584|NCT01659658|40471044|FG002|Overall Study|Withdrawal by Patient|2|||
16548585|NCT01659658|40471045|FG003|Overall Study|Withdrawal by Patient|0|||
16548586|NCT01659658|40471046|FG004|Overall Study|Withdrawal by Patient|11|||
16548587|NCT01659658|40471042|FG000|Overall Study|Study Terminated by Sponsor|9|||
16548588|NCT01659658|40471043|FG001|Overall Study|Study Terminated by Sponsor|7|||
16548589|NCT01659658|40471044|FG002|Overall Study|Study Terminated by Sponsor|0|||
16548590|NCT01659658|40471045|FG003|Overall Study|Study Terminated by Sponsor|1|||
16548591|NCT01659658|40471046|FG004|Overall Study|Study Terminated by Sponsor|4|||
16548592|NCT01659658|40471042|FG000|Overall Study|Reason not Specified|61|||
16548593|NCT01659658|40471043|FG001|Overall Study|Reason not Specified|15|||
16548594|NCT01659658|40471044|FG002|Overall Study|Reason not Specified|8|||
16548595|NCT01659658|40471045|FG003|Overall Study|Reason not Specified|1|||
16116104|NCT03149549|38909801|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
16116105|NCT03149549|38909802|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
16116106|NCT03149549|38909803|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
16116107|NCT03149549|38909791|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
16116108|NCT03149549|38909792|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
16116109|NCT03149549|38909793|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
16116110|NCT03149549|38909794|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
16116111|NCT03149549|38909795|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
16116112|NCT03149549|38909796|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
16116113|NCT03149549|38909797|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
16116114|NCT03149549|38909798|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
16116115|NCT03149549|38909799|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
16116116|NCT03149549|38909800|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
16116117|NCT03149549|38909801|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
16116118|NCT03149549|38909802|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
16116119|NCT03149549|38909803|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
16116120|NCT01516749|38909804|FG000|Active Therapy|Lost to Follow-up|1|||
16116121|NCT01516749|38909804|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
16116122|NCT03194867|38909805|FG000|Overall Study|Incorrect completion of end of study form|0|||
16116123|NCT03194867|38909806|FG001|Overall Study|Incorrect completion of end of study form|0|||
16116124|NCT03194867|38909807|FG002|Overall Study|Incorrect completion of end of study form|1|||
16116125|NCT03194867|38909808|FG003|Overall Study|Incorrect completion of end of study form|0|||
16116126|NCT01468077|38909809|FG000|Overall Study|Adverse Event|2|||
16116127|NCT01468077|38909810|FG001|Overall Study|Adverse Event|2|||
16116128|NCT01468077|38909809|FG000|Overall Study|Lack of Efficacy|1|||
16116129|NCT01468077|38909810|FG001|Overall Study|Lack of Efficacy|1|||
16116130|NCT01468077|38909809|FG000|Overall Study|Physician Decision|1|||
16116131|NCT01468077|38909810|FG001|Overall Study|Physician Decision|0|||
16116132|NCT01681992|38909811|FG000|Overall Study|Adverse Event|3|||
16116133|NCT01681992|38909812|FG001|Overall Study|Adverse Event|2|||
16116134|NCT01681992|38909813|FG002|Overall Study|Adverse Event|3|||
16116135|NCT01681992|38909811|FG000|Overall Study|Lost to Follow-up|36|||
16116136|NCT01681992|38909812|FG001|Overall Study|Lost to Follow-up|38|||
16116137|NCT01681992|38909813|FG002|Overall Study|Lost to Follow-up|53|||
16116138|NCT01681992|38909811|FG000|Overall Study|As Per Sponsor Decision|0|||
16116139|NCT01681992|38909812|FG001|Overall Study|As Per Sponsor Decision|0|||
16116140|NCT01681992|38909813|FG002|Overall Study|As Per Sponsor Decision|1|||
16116141|NCT01681992|38909811|FG000|Overall Study|Protocol Violation|0|||
16548596|NCT01659658|40471046|FG004|Overall Study|Reason not Specified|34|||
16548597|NCT01659658|40471042|FG000|Overall Study|Lost to Follow-up|2|||
16548598|NCT01659658|40471043|FG001|Overall Study|Lost to Follow-up|0|||
16227224|NCT01072175|39313443|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227225|NCT01072175|39313444|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
16227226|NCT01072175|39313445|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227227|NCT01072175|39313446|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227228|NCT01072175|39313447|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227229|NCT01072175|39313448|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227230|NCT01072175|39313449|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227231|NCT01072175|39313450|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227232|NCT01072175|39313451|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227233|NCT01072175|39313452|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
16227234|NCT01072175|39313440|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16227235|NCT01072175|39313441|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
16227236|NCT01072175|39313442|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16227237|NCT01072175|39313443|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
16227238|NCT01072175|39313444|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
16227239|NCT01072175|39313445|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16227240|NCT01072175|39313446|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16227241|NCT01072175|39313447|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16227242|NCT01072175|39313448|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16227243|NCT01072175|39313449|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16227244|NCT01072175|39313450|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16227245|NCT01072175|39313451|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16227246|NCT01072175|39313452|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
16227247|NCT01072175|39313440|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16227248|NCT01072175|39313441|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16227249|NCT01072175|39313442|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
16227250|NCT01072175|39313443|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
16227251|NCT01072175|39313444|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
16227252|NCT01072175|39313445|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16227253|NCT01072175|39313446|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16227254|NCT01072175|39313447|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16227255|NCT01072175|39313448|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16227256|NCT01072175|39313449|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16227257|NCT01072175|39313450|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16227258|NCT01072175|39313451|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16227259|NCT01072175|39313452|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
16227260|NCT01072175|39313440|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16227261|NCT01072175|39313441|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
16227262|NCT01072175|39313442|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16227263|NCT01072175|39313443|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
16227264|NCT01072175|39313444|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
16227265|NCT01072175|39313445|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16227266|NCT01072175|39313446|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16227267|NCT01072175|39313447|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16227268|NCT01072175|39313448|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16227269|NCT01072175|39313449|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16227270|NCT01072175|39313450|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16227271|NCT01072175|39313451|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16227272|NCT01072175|39313452|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
16227273|NCT01072175|39313440|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
16227274|NCT01072175|39313441|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
16227275|NCT01072175|39313442|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
16227276|NCT01072175|39313443|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
16116142|NCT01681992|38909812|FG001|Overall Study|Protocol Violation|0|||
16411261|NCT02250664|39988543|FG002|Overall Study|Protocol Violation|1|||
16411262|NCT02250664|39988541|FG000|Overall Study|Reason unknown|1|||
16411263|NCT02250664|39988542|FG001|Overall Study|Reason unknown|0|||
16411264|NCT02250664|39988543|FG002|Overall Study|Reason unknown|0|||
16411265|NCT03780959|39988557|FG000|Part 1|Adverse Event|1|||
16411266|NCT03780959|39988558|FG001|Part 1|Adverse Event|0|||
16411267|NCT03780959|39988559|FG002|Part 1|Adverse Event|0|||
16411268|NCT03780959|39988557|FG000|Part 1|Withdrawal by Subject|1|||
16411269|NCT03780959|39988558|FG001|Part 1|Withdrawal by Subject|0|||
16411270|NCT03780959|39988559|FG002|Part 1|Withdrawal by Subject|0|||
16411271|NCT03780959|39988557|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
16411272|NCT03780959|39988558|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
16411273|NCT03780959|39988559|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
16411274|NCT03780959|39988557|FG000|Part 1|Response Status|2|||
16411275|NCT03780959|39988558|FG001|Part 1|Response Status|0|||
16411276|NCT03780959|39988559|FG002|Part 1|Response Status|0|||
16411277|NCT03780959|39988557|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
16411278|NCT03780959|39988558|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
16411279|NCT03780959|39988559|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
16411280|NCT03780959|39988557|FG000|Part 2|Response Status|0|||
16411281|NCT03780959|39988558|FG001|Part 2|Response Status|18|||
16411282|NCT03780959|39988559|FG002|Part 2|Response Status|6|||
16548599|NCT01659658|40471044|FG002|Overall Study|Lost to Follow-up|0|||
16227277|NCT01072175|39313444|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
16411283|NCT01300819|39988560|FG000|Overall Study|Adverse Event|9|||
16548600|NCT01659658|40471045|FG003|Overall Study|Lost to Follow-up|0|||
16548601|NCT01659658|40471046|FG004|Overall Study|Lost to Follow-up|0|||
16548602|NCT01821898|40471048|FG000|Overall Study|Withdrawal by Subject|2|||
16548603|NCT01821898|40471049|FG001|Overall Study|Withdrawal by Subject|1|||
16548604|NCT01460160|40471050|FG000|Treatment Phase|Lack of Efficacy|3|||
16548605|NCT01460160|40471050|FG000|Treatment Phase|Study Drug Toxicity|2|||
16548606|NCT01460160|40471050|FG000|Treatment Phase|Adverse Event|8|||
16548607|NCT01460160|40471050|FG000|Treatment Phase|Withdrawal by Subject|4|||
16548608|NCT01460160|40471050|FG000|Treatment Phase|Death|2|||
16548609|NCT01460160|40471050|FG000|Treatment Phase|Other reasons|9|||
16548610|NCT01460160|40471050|FG000|Follow-up Phase|Withdrawal by Subject|4|||
16548611|NCT01460160|40471050|FG000|Follow-up Phase|Death|14|||
16548612|NCT01460160|40471050|FG000|Follow-up Phase|Lost to Follow-up|7|||
16548613|NCT01460160|40471050|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
16548614|NCT01460160|40471050|FG000|Follow-up Phase|Other and not reported reasons|5|||
16548615|NCT02821819|40471051|FG000|Overall Study|Protocol Violation|1|||
16548616|NCT00337662|40471052|FG000|Study Period II|Lost to Follow-up|0|||
16548617|NCT00337662|40471053|FG001|Study Period II|Lost to Follow-up|0|||
16548618|NCT00337662|40471054|FG002|Study Period II|Lost to Follow-up|0|||
16548619|NCT00337662|40471055|FG003|Study Period II|Lost to Follow-up|35|||
16548620|NCT00337662|40471052|FG000|Study Period II|Withdrawal by Subject|0|||
16548621|NCT00337662|40471053|FG001|Study Period II|Withdrawal by Subject|0|||
16411284|NCT01300819|39988561|FG001|Overall Study|Adverse Event|27|||
16411285|NCT01300819|39988560|FG000|Overall Study|Lack of Efficacy|2|||
16411286|NCT01300819|39988561|FG001|Overall Study|Lack of Efficacy|1|||
16548622|NCT00337662|40471054|FG002|Study Period II|Withdrawal by Subject|0|||
16548623|NCT00337662|40471055|FG003|Study Period II|Withdrawal by Subject|20|||
16548624|NCT00337662|40471052|FG000|Study Period II|Adverse Event|0|||
16548625|NCT00337662|40471053|FG001|Study Period II|Adverse Event|0|||
16548626|NCT00337662|40471054|FG002|Study Period II|Adverse Event|0|||
16411287|NCT01300819|39988560|FG000|Overall Study|Withdrawal by Subject|10|||
16548627|NCT00337662|40471055|FG003|Study Period II|Adverse Event|16|||
16548628|NCT00337662|40471052|FG000|Study Period II|Physician Decision|0|||
16548629|NCT00337662|40471053|FG001|Study Period II|Physician Decision|0|||
16548630|NCT00337662|40471054|FG002|Study Period II|Physician Decision|0|||
16548631|NCT00337662|40471055|FG003|Study Period II|Physician Decision|13|||
16548632|NCT00337662|40471052|FG000|Study Period II|Entry Criteria Not Met|0|||
16548633|NCT00337662|40471053|FG001|Study Period II|Entry Criteria Not Met|0|||
16548634|NCT00337662|40471054|FG002|Study Period II|Entry Criteria Not Met|0|||
16548635|NCT00337662|40471055|FG003|Study Period II|Entry Criteria Not Met|6|||
16548636|NCT00337662|40471052|FG000|Study Period II|Protocol Violation|0|||
16548637|NCT00337662|40471053|FG001|Study Period II|Protocol Violation|0|||
16548638|NCT00337662|40471054|FG002|Study Period II|Protocol Violation|0|||
16347459|NCT00048035|39761916|FG003|Core Period|Early Withdrawals|1|||
16347460|NCT00048035|39761917|FG004|Core Period|Early Withdrawals|1|||
16347461|NCT00048035|39761918|FG005|Core Period|Early Withdrawals|1|||
16347462|NCT00048035|39761919|FG006|Core Period|Early Withdrawals|0|||
16347463|NCT00048035|39761920|FG007|Core Period|Early Withdrawals|0|||
16347464|NCT00048035|39761913|FG000|Extension Year 1|Early Withdrawals|0|||
16347465|NCT00048035|39761914|FG001|Extension Year 1|Early Withdrawals|0|||
16347466|NCT00048035|39761915|FG002|Extension Year 1|Early Withdrawals|0|||
16347467|NCT00048035|39761916|FG003|Extension Year 1|Early Withdrawals|0|||
16347468|NCT00048035|39761917|FG004|Extension Year 1|Early Withdrawals|0|||
16347469|NCT00048035|39761918|FG005|Extension Year 1|Early Withdrawals|0|||
16347470|NCT00048035|39761919|FG006|Extension Year 1|Early Withdrawals|11|||
16347471|NCT00048035|39761920|FG007|Extension Year 1|Early Withdrawals|11|||
16347472|NCT00048035|39761913|FG000|Extension Year 2|Early Withdrawals|0|||
16347473|NCT00048035|39761914|FG001|Extension Year 2|Early Withdrawals|0|||
16347474|NCT00048035|39761915|FG002|Extension Year 2|Early Withdrawals|0|||
16347475|NCT00048035|39761916|FG003|Extension Year 2|Early Withdrawals|0|||
16347476|NCT00048035|39761917|FG004|Extension Year 2|Early Withdrawals|0|||
16347477|NCT00048035|39761918|FG005|Extension Year 2|Early Withdrawals|0|||
16347478|NCT00048035|39761919|FG006|Extension Year 2|Early Withdrawals|3|||
16347479|NCT00048035|39761920|FG007|Extension Year 2|Early Withdrawals|3|||
16347480|NCT00685360|39761921|FG000|Overall Study|Lost to Follow-up|0|||
16347481|NCT00685360|39761922|FG001|Overall Study|Lost to Follow-up|1|||
16347482|NCT00685360|39761923|FG002|Overall Study|Lost to Follow-up|2|||
16347483|NCT00685360|39761921|FG000|Overall Study|Adverse Event|4|||
16347484|NCT00685360|39761922|FG001|Overall Study|Adverse Event|6|||
16347485|NCT00685360|39761923|FG002|Overall Study|Adverse Event|4|||
16347486|NCT00685360|39761921|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
16347487|NCT00685360|39761922|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
16347488|NCT00685360|39761923|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
16347489|NCT00685360|39761921|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
16347490|NCT00685360|39761922|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
16347491|NCT00685360|39761923|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
16347492|NCT00685360|39761921|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
16347493|NCT00685360|39761922|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
16347494|NCT00685360|39761923|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
16347495|NCT00685360|39761921|FG000|Overall Study|Protocol Deviation|0|||
16347496|NCT00685360|39761922|FG001|Overall Study|Protocol Deviation|1|||
16347497|NCT00685360|39761923|FG002|Overall Study|Protocol Deviation|1|||
16347498|NCT00943397|39761924|FG000|Overall Study|Adverse Event|0|||
16347499|NCT00943397|39761925|FG001|Overall Study|Adverse Event|6|||
16347500|NCT00943397|39761924|FG000|Overall Study|Lost to Follow-up|0|||
16347501|NCT00943397|39761925|FG001|Overall Study|Lost to Follow-up|4|||
16347502|NCT00943397|39761924|FG000|Overall Study|Protocol Violation|2|||
16347503|NCT00943397|39761925|FG001|Overall Study|Protocol Violation|5|||
16347504|NCT00943397|39761924|FG000|Overall Study|Withdrawal by Subject|1|||
16347505|NCT00943397|39761925|FG001|Overall Study|Withdrawal by Subject|1|||
16347506|NCT00943397|39761924|FG000|Overall Study|Site terminated and other|12|||
16347507|NCT00943397|39761925|FG001|Overall Study|Site terminated and other|56|||
16347508|NCT02699996|39761926|FG000|Overall Study|Withdrawal by Subject|5|||
16347509|NCT02699996|39761927|FG001|Overall Study|Withdrawal by Subject|2|||
16347510|NCT02105285|39761931|FG000|Overall Study|Adverse Event|1|||
16347511|NCT02105285|39761932|FG001|Overall Study|Adverse Event|1|||
16347512|NCT02105285|39761933|FG002|Overall Study|Adverse Event|0|||
16347513|NCT02105285|39761931|FG000|Overall Study|Protocol Violation|0|||
16347514|NCT02105285|39761932|FG001|Overall Study|Protocol Violation|1|||
16347515|NCT02105285|39761933|FG002|Overall Study|Protocol Violation|0|||
16347516|NCT02105285|39761931|FG000|Overall Study|Withdrawal by Subject|1|||
16347517|NCT02105285|39761932|FG001|Overall Study|Withdrawal by Subject|0|||
16347518|NCT02105285|39761933|FG002|Overall Study|Withdrawal by Subject|0|||
16347519|NCT01239394|39761934|FG000|Overall Study|Adverse Event|1|||
16548639|NCT00337662|40471055|FG003|Study Period II|Protocol Violation|6|||
16411288|NCT01300819|39988561|FG001|Overall Study|Withdrawal by Subject|12|||
16411289|NCT01300819|39988560|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
16411290|NCT01300819|39988561|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
16411291|NCT01300819|39988560|FG000|Overall Study|Refusal to down titrate study drug|0|||
16411292|NCT01300819|39988561|FG001|Overall Study|Refusal to down titrate study drug|1|||
16411293|NCT01300819|39988560|FG000|Overall Study|Administrative reason|0|||
16411294|NCT01300819|39988561|FG001|Overall Study|Administrative reason|1|||
16411295|NCT01300819|39988560|FG000|Overall Study|Safety follow up not done by mistake|0|||
16411296|NCT01300819|39988561|FG001|Overall Study|Safety follow up not done by mistake|1|||
16411297|NCT01300819|39988560|FG000|Overall Study|Follow up call was not done|1|||
16411298|NCT01300819|39988561|FG001|Overall Study|Follow up call was not done|0|||
16411299|NCT00434759|39988562|FG000|Overall Study|Lack of Efficacy|5|||
16411300|NCT00434759|39988563|FG001|Overall Study|Lack of Efficacy|4|||
16411301|NCT00434759|39988562|FG000|Overall Study|Withdrawal by Subject|17|||
16116143|NCT01681992|38909813|FG002|Overall Study|Protocol Violation|1|||
16116144|NCT01681992|38909811|FG000|Overall Study|Withdrawal by Subject|27|||
16116145|NCT01681992|38909812|FG001|Overall Study|Withdrawal by Subject|30|||
16116146|NCT01681992|38909813|FG002|Overall Study|Withdrawal by Subject|25|||
16116147|NCT02353468|38909814|FG000|Overall Study|Study terminated|3|||
16116148|NCT00486252|38909818|FG000|Overall Study|Adverse Event|7|||
16116149|NCT00486252|38909818|FG000|Overall Study|Lack of Efficacy|9|||
16116150|NCT00486252|38909818|FG000|Overall Study|Lost to Follow-up|24|||
16116151|NCT00486252|38909818|FG000|Overall Study|Other|18|||
16116152|NCT03721705|38909819|FG000|Overall Study|Adverse Event|2|||
16116153|NCT03721705|38909820|FG001|Overall Study|Adverse Event|0|||
16116154|NCT03721705|38909819|FG000|Overall Study|Withdrawal by Subject|4|||
16116155|NCT03721705|38909820|FG001|Overall Study|Withdrawal by Subject|10|||
16116156|NCT03721705|38909819|FG000|Overall Study|No Suitable Study Partner|1|||
16116157|NCT03721705|38909820|FG001|Overall Study|No Suitable Study Partner|0|||
16116158|NCT03721705|38909819|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
16116159|NCT03721705|38909820|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
16116160|NCT03721705|38909819|FG000|Overall Study|Death|0|||
16116161|NCT03721705|38909820|FG001|Overall Study|Death|1|||
16116162|NCT01790295|38909822|FG000|Overall Study|Adverse Event|1|||
16116163|NCT01790295|38909822|FG000|Overall Study|Death|4|||
16116164|NCT01790295|38909822|FG000|Overall Study|Lack of Efficacy|2|||
16116165|NCT01790295|38909822|FG000|Overall Study|Study closure|4|||
16116166|NCT01607476|38909827|FG000|Overall Study|Withdrawal by Subject|1|||
16116167|NCT01607476|38909828|FG001|Overall Study|Withdrawal by Subject|0|||
16116168|NCT01607476|38909829|FG002|Overall Study|Withdrawal by Subject|1|||
16116169|NCT01607476|38909827|FG000|Overall Study|Lost to Follow-up|0|||
16116170|NCT01607476|38909828|FG001|Overall Study|Lost to Follow-up|0|||
16116171|NCT01607476|38909829|FG002|Overall Study|Lost to Follow-up|2|||
16116172|NCT01454739|38909834|FG000|Overall Study|Protocol Violation|2|||
16116173|NCT01454739|38909835|FG001|Overall Study|Protocol Violation|3|||
16411302|NCT00434759|39988563|FG001|Overall Study|Withdrawal by Subject|1|||
16116174|NCT01454739|38909834|FG000|Overall Study|Withdrawal by Subject|2|||
16116175|NCT01454739|38909835|FG001|Overall Study|Withdrawal by Subject|6|||
16116176|NCT01454739|38909834|FG000|Overall Study|Other|3|||
16116177|NCT01454739|38909835|FG001|Overall Study|Other|5|||
16116178|NCT01454739|38909834|FG000|Overall Study|Physician Decision|0|||
16116179|NCT01454739|38909835|FG001|Overall Study|Physician Decision|5|||
16116180|NCT01454739|38909834|FG000|Overall Study|Lost to Follow-up|0|||
16116181|NCT01454739|38909835|FG001|Overall Study|Lost to Follow-up|1|||
16116182|NCT01454739|38909834|FG000|Overall Study|Adverse Event|0|||
16116183|NCT01454739|38909835|FG001|Overall Study|Adverse Event|1|||
16116184|NCT00762476|38909836|FG000|Overall Study|Adverse Event|7|||
16116185|NCT00762476|38909837|FG001|Overall Study|Adverse Event|1|||
16116186|NCT00762476|38909836|FG000|Overall Study|Lost to Follow-up|2|||
16116187|NCT00762476|38909837|FG001|Overall Study|Lost to Follow-up|0|||
16116188|NCT00762476|38909836|FG000|Overall Study|Protocol Violation|5|||
16116189|NCT00762476|38909837|FG001|Overall Study|Protocol Violation|6|||
16116190|NCT00762476|38909836|FG000|Overall Study|Physician Decision|2|||
16116191|NCT00762476|38909837|FG001|Overall Study|Physician Decision|14|||
16116192|NCT00762476|38909836|FG000|Overall Study|Withdrawal by Subject|6|||
16116193|NCT00762476|38909837|FG001|Overall Study|Withdrawal by Subject|12|||
16116194|NCT00762476|38909836|FG000|Overall Study|antibiotic use|0|||
16116195|NCT00762476|38909837|FG001|Overall Study|antibiotic use|1|||
16116196|NCT00762476|38909836|FG000|Overall Study|non-compliance with study visits|0|||
16116197|NCT00762476|38909837|FG001|Overall Study|non-compliance with study visits|2|||
16116198|NCT00762476|38909836|FG000|Overall Study|Seasonal allergies|1|||
16116199|NCT00762476|38909837|FG001|Overall Study|Seasonal allergies|0|||
16411303|NCT00434759|39988562|FG000|Overall Study|family affairs|2|||
16411304|NCT00434759|39988563|FG001|Overall Study|family affairs|0|||
16411305|NCT00541099|39988566|FG000|Overall Study|Ineligible|3|||
16411306|NCT02360293|39988567|FG000|Overall Study|Lost to Follow-up|73|||
16411307|NCT02360293|39988568|FG001|Overall Study|Lost to Follow-up|95|||
16411308|NCT02360293|39988567|FG000|Overall Study|Withdrawal by Subject|2|||
16411309|NCT02360293|39988568|FG001|Overall Study|Withdrawal by Subject|1|||
16411310|NCT02360293|39988567|FG000|Overall Study|Excluded|1|||
16116208|NCT01367847|38909856|FG000|Overall Study|Withdrawal by Subject|2|||
16116209|NCT01367847|38909857|FG001|Overall Study|Withdrawal by Subject|2|||
16116210|NCT04211389|38912271|FG000|Overall Study|Adverse Event|1|||
16116211|NCT04211389|38912272|FG001|Overall Study|Adverse Event|2|||
16116212|NCT04211389|38912271|FG000|Overall Study|Lost to Follow-up|15|||
16116213|NCT04211389|38912272|FG001|Overall Study|Lost to Follow-up|7|||
16116214|NCT04211389|38912271|FG000|Overall Study|Protocol Violation|0|||
16116215|NCT04211389|38912272|FG001|Overall Study|Protocol Violation|1|||
16116216|NCT04211389|38912271|FG000|Overall Study|Withdrawal by Subject|10|||
16116217|NCT04211389|38912272|FG001|Overall Study|Withdrawal by Subject|11|||
16116218|NCT00402051|38912273|FG000|Overall Study|Progressive Disease|13|||
16116219|NCT00402051|38912274|FG001|Overall Study|Progressive Disease|20|||
16116220|NCT00402051|38912273|FG000|Overall Study|Adverse Event|11|||
16116221|NCT00402051|38912274|FG001|Overall Study|Adverse Event|4|||
16116222|NCT00402051|38912273|FG000|Overall Study|Physician Decision|7|||
16116223|NCT00402051|38912274|FG001|Overall Study|Physician Decision|3|||
16116224|NCT00402051|38912273|FG000|Overall Study|Withdrawal by Subject|3|||
16116225|NCT00402051|38912274|FG001|Overall Study|Withdrawal by Subject|3|||
16116226|NCT00402051|38912273|FG000|Overall Study|Death - Related to Study Drug|1|||
16116227|NCT00402051|38912274|FG001|Overall Study|Death - Related to Study Drug|2|||
16116228|NCT00402051|38912273|FG000|Overall Study|Death Due to Study Disease|2|||
16116229|NCT00402051|38912274|FG001|Overall Study|Death Due to Study Disease|1|||
16116230|NCT00402051|38912273|FG000|Overall Study|Death Due to Adverse Event|0|||
16116231|NCT00402051|38912274|FG001|Overall Study|Death Due to Adverse Event|2|||
16116232|NCT00402051|38912273|FG000|Overall Study|Lost to Follow-up|1|||
16116233|NCT00402051|38912274|FG001|Overall Study|Lost to Follow-up|0|||
16116234|NCT01271504|38912281|FG000|Overall Study|Death|7|||
16116235|NCT01271504|38912282|FG001|Overall Study|Death|6|||
16116236|NCT01271504|38912283|FG002|Overall Study|Death|32|||
16116237|NCT01271504|38912284|FG003|Overall Study|Death|32|||
16116238|NCT01271504|38912281|FG000|Overall Study|Lost to Follow-up|0|||
16116239|NCT01271504|38912282|FG001|Overall Study|Lost to Follow-up|1|||
16116240|NCT01271504|38912283|FG002|Overall Study|Lost to Follow-up|3|||
16116241|NCT01271504|38912284|FG003|Overall Study|Lost to Follow-up|1|||
16116242|NCT01271504|38912281|FG000|Overall Study|Protocol Violation|0|||
16116243|NCT01271504|38912282|FG001|Overall Study|Protocol Violation|0|||
16116244|NCT01271504|38912283|FG002|Overall Study|Protocol Violation|0|||
16116245|NCT01271504|38912284|FG003|Overall Study|Protocol Violation|2|||
16116246|NCT01271504|38912281|FG000|Overall Study|Administrative Reasons|0|||
16116247|NCT01271504|38912282|FG001|Overall Study|Administrative Reasons|0|||
16116248|NCT01271504|38912283|FG002|Overall Study|Administrative Reasons|6|||
16116249|NCT01271504|38912284|FG003|Overall Study|Administrative Reasons|5|||
16116250|NCT01271504|38912281|FG000|Overall Study|Withdrawal by Subject|0|||
16116251|NCT01271504|38912282|FG001|Overall Study|Withdrawal by Subject|0|||
16116252|NCT01271504|38912283|FG002|Overall Study|Withdrawal by Subject|1|||
16116253|NCT01271504|38912284|FG003|Overall Study|Withdrawal by Subject|3|||
16116254|NCT01271504|38912281|FG000|Overall Study|Other|0|||
16116255|NCT01271504|38912282|FG001|Overall Study|Other|1|||
16116256|NCT01271504|38912283|FG002|Overall Study|Other|2|||
16116257|NCT01271504|38912284|FG003|Overall Study|Other|0|||
16116258|NCT04343976|38912285|FG000|Overall Study|Withdrawal by Subject|0|||
16116259|NCT04343976|38912286|FG001|Overall Study|Withdrawal by Subject|1|||
16116260|NCT00594880|38912289|FG000|Overall Study|Withdrawal by Subject|1|||
16116261|NCT00594880|38912290|FG001|Overall Study|Withdrawal by Subject|1|||
16116262|NCT00594880|38912289|FG000|Overall Study|Lost to Follow-up|1|||
16116263|NCT00594880|38912290|FG001|Overall Study|Lost to Follow-up|0|||
16116264|NCT01245374|38912295|FG000|Overall Study|Protocol Violation|1|||
16116265|NCT01245374|38912295|FG000|Overall Study|Withdrawal by Subject|3|||
16116266|NCT01040169|38912296|FG000|Overall Study|Lost to Follow-up|3|||
16116267|NCT01040169|38912297|FG001|Overall Study|Lost to Follow-up|8|||
16116268|NCT00362375|38912300|FG000|Overall Study|Lost to Follow-up|40|||
16116269|NCT00362375|38912301|FG001|Overall Study|Lost to Follow-up|35|||
16116270|NCT02666664|38912303|FG000|Overall Study|Physician Decision|0|||
16116271|NCT02666664|38912304|FG001|Overall Study|Physician Decision|1|||
16116272|NCT02666664|38912303|FG000|Overall Study|Protocol Violation|0|||
16116273|NCT02666664|38912304|FG001|Overall Study|Protocol Violation|2|||
16116274|NCT02666664|38912303|FG000|Overall Study|Other|0|||
16116275|NCT02666664|38912304|FG001|Overall Study|Other|1|||
16116276|NCT02666664|38912303|FG000|Overall Study|Adverse Event|12|||
16116277|NCT02666664|38912304|FG001|Overall Study|Adverse Event|37|||
16116278|NCT02666664|38912303|FG000|Overall Study|Withdrawal by participant|23|||
16116279|NCT02666664|38912304|FG001|Overall Study|Withdrawal by participant|40|||
16116280|NCT02666664|38912303|FG000|Overall Study|Sponsor decision|0|||
16116281|NCT02666664|38912304|FG001|Overall Study|Sponsor decision|1|||
16116282|NCT02666664|38912303|FG000|Overall Study|Lost to Follow-up|1|||
16116283|NCT02666664|38912304|FG001|Overall Study|Lost to Follow-up|2|||
16116284|NCT02630706|38912305|FG000|Overall Study|Adverse Event|2|||
16116285|NCT02630706|38912306|FG001|Overall Study|Adverse Event|1|||
16116286|NCT02630706|38912307|FG002|Overall Study|Adverse Event|1|||
16116287|NCT02630706|38912305|FG000|Overall Study|Lost to Follow-up|0|||
16116288|NCT02630706|38912306|FG001|Overall Study|Lost to Follow-up|1|||
16116289|NCT02630706|38912307|FG002|Overall Study|Lost to Follow-up|2|||
16116290|NCT02630706|38912305|FG000|Overall Study|Physician Decision|1|||
16548640|NCT00337662|40471052|FG000|Study Period II|Lack of Efficacy|0|||
16548641|NCT00337662|40471053|FG001|Study Period II|Lack of Efficacy|0|||
16116291|NCT02630706|38912306|FG001|Overall Study|Physician Decision|1|||
16116292|NCT02630706|38912307|FG002|Overall Study|Physician Decision|0|||
16116293|NCT02630706|38912305|FG000|Overall Study|Pregnancy|0|||
16116294|NCT02630706|38912306|FG001|Overall Study|Pregnancy|1|||
16116295|NCT02630706|38912307|FG002|Overall Study|Pregnancy|0|||
16116296|NCT02630706|38912305|FG000|Overall Study|Withdrawal by Subject|4|||
16116297|NCT02630706|38912306|FG001|Overall Study|Withdrawal by Subject|5|||
16116298|NCT02630706|38912307|FG002|Overall Study|Withdrawal by Subject|7|||
16116299|NCT00358644|38912308|FG000|Overall Study|Progressive Disease|21|||
16116300|NCT00358644|38912308|FG000|Overall Study|Adverse Event|7|||
16116301|NCT00358644|38912308|FG000|Overall Study|Death|11|||
16227278|NCT01072175|39313445|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
16411311|NCT02360293|39988568|FG001|Overall Study|Excluded|0|||
16411312|NCT00609791|39988569|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
16411313|NCT00875056|39988570|FG000|Overall Study|Adverse Event|6|||
16411314|NCT00875056|39988571|FG001|Overall Study|Adverse Event|1|||
16411315|NCT00875056|39988572|FG002|Overall Study|Adverse Event|2|||
16411316|NCT00875056|39988570|FG000|Overall Study|Progressive Disease|14|||
16411317|NCT00875056|39988571|FG001|Overall Study|Progressive Disease|8|||
16411318|NCT00875056|39988572|FG002|Overall Study|Progressive Disease|3|||
16411319|NCT00875056|39988570|FG000|Overall Study|Withdrawal by Subject|3|||
16411320|NCT00875056|39988571|FG001|Overall Study|Withdrawal by Subject|0|||
16411321|NCT00875056|39988572|FG002|Overall Study|Withdrawal by Subject|1|||
16411322|NCT01299571|39988573|FG000|Overall Study|Protocol Violation|107|||
16411323|NCT00787202|39988579|FG000|Overall Study|Adverse Event|3|||
16411324|NCT00787202|39988580|FG001|Overall Study|Adverse Event|2|||
16411325|NCT00787202|39988581|FG002|Overall Study|Adverse Event|0|||
16411326|NCT00787202|39988582|FG003|Overall Study|Adverse Event|0|||
16411327|NCT00787202|39988583|FG004|Overall Study|Adverse Event|2|||
16411328|NCT00787202|39988579|FG000|Overall Study|Lack of Efficacy|5|||
16411329|NCT00787202|39988580|FG001|Overall Study|Lack of Efficacy|6|||
16411330|NCT00787202|39988581|FG002|Overall Study|Lack of Efficacy|5|||
16411331|NCT00787202|39988582|FG003|Overall Study|Lack of Efficacy|2|||
16411332|NCT00787202|39988583|FG004|Overall Study|Lack of Efficacy|1|||
16411333|NCT00787202|39988579|FG000|Overall Study|Lost to Follow-up|1|||
16411334|NCT00787202|39988580|FG001|Overall Study|Lost to Follow-up|0|||
16411335|NCT00787202|39988581|FG002|Overall Study|Lost to Follow-up|0|||
16411336|NCT00787202|39988582|FG003|Overall Study|Lost to Follow-up|0|||
16116302|NCT00358644|38912308|FG000|Overall Study|Withdrawal by Subject|4|||
16411337|NCT00787202|39988583|FG004|Overall Study|Lost to Follow-up|0|||
16411338|NCT00787202|39988579|FG000|Overall Study|Withdrawal by Subject|2|||
16411339|NCT00787202|39988580|FG001|Overall Study|Withdrawal by Subject|2|||
16411340|NCT00787202|39988581|FG002|Overall Study|Withdrawal by Subject|2|||
16116303|NCT00358644|38912308|FG000|Overall Study|Physician Decision|6|||
16116304|NCT00358644|38912308|FG000|Overall Study|Patient not eligible for study|1|||
16116305|NCT00570908|38912309|FG000|Overall Study|Adverse Event|5|||
16116306|NCT00570908|38912309|FG000|Overall Study|Withdrawal by Subject|2|||
16116307|NCT01327612|38912310|FG000|Overall Study|Withdrawal by Subject|0|||
16548642|NCT00337662|40471054|FG002|Study Period II|Lack of Efficacy|0|||
16411341|NCT00787202|39988582|FG003|Overall Study|Withdrawal by Subject|0|||
16411342|NCT00787202|39988583|FG004|Overall Study|Withdrawal by Subject|0|||
16411343|NCT00787202|39988579|FG000|Overall Study|Protocol Violation|2|||
16411344|NCT00787202|39988580|FG001|Overall Study|Protocol Violation|1|||
16411345|NCT00787202|39988581|FG002|Overall Study|Protocol Violation|0|||
16411346|NCT00787202|39988582|FG003|Overall Study|Protocol Violation|0|||
16411347|NCT00787202|39988583|FG004|Overall Study|Protocol Violation|1|||
16411348|NCT00787202|39988579|FG000|Overall Study|Randomized, not treated|1|||
16411349|NCT00787202|39988580|FG001|Overall Study|Randomized, not treated|0|||
16411350|NCT00787202|39988581|FG002|Overall Study|Randomized, not treated|0|||
16411351|NCT00787202|39988582|FG003|Overall Study|Randomized, not treated|0|||
16411352|NCT00787202|39988583|FG004|Overall Study|Randomized, not treated|0|||
16411353|NCT01420627|39988586|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
16411354|NCT01143896|39988587|FG000|Overall Study|Did not complete Baseline Interview|5|||
16411355|NCT01143896|39988588|FG001|Overall Study|Did not complete Baseline Interview|4|||
16411356|NCT01143896|39988587|FG000|Overall Study|Lost to Follow-up|18|||
16411357|NCT01143896|39988588|FG001|Overall Study|Lost to Follow-up|13|||
16411358|NCT01143896|39988587|FG000|Overall Study|Withdrawal by Subject|13|||
16411359|NCT01143896|39988588|FG001|Overall Study|Withdrawal by Subject|5|||
16411360|NCT01143896|39988587|FG000|Overall Study|Death|6|||
16411361|NCT01143896|39988588|FG001|Overall Study|Death|3|||
16411362|NCT00392808|39988589|FG000|Overall Study|Lost to Follow-up|3|||
16411363|NCT00392808|39988590|FG001|Overall Study|Lost to Follow-up|2|||
16411364|NCT00392808|39988591|FG002|Overall Study|Lost to Follow-up|1|||
16411365|NCT00392808|39988592|FG003|Overall Study|Lost to Follow-up|2|||
16411366|NCT00392808|39988589|FG000|Overall Study|Unable to withdraw blood|3|||
16411367|NCT00392808|39988590|FG001|Overall Study|Unable to withdraw blood|1|||
16116308|NCT01327612|38912311|FG001|Overall Study|Withdrawal by Subject|0|||
16116309|NCT01327612|38912312|FG002|Overall Study|Withdrawal by Subject|0|||
16116310|NCT01327612|38912313|FG003|Overall Study|Withdrawal by Subject|0|||
16411368|NCT00392808|39988591|FG002|Overall Study|Unable to withdraw blood|1|||
16116311|NCT01327612|38912314|FG004|Overall Study|Withdrawal by Subject|0|||
16116312|NCT01327612|38912315|FG005|Overall Study|Withdrawal by Subject|1|||
16116313|NCT01327612|38912316|FG006|Overall Study|Withdrawal by Subject|0|||
16116314|NCT01327612|38912310|FG000|Overall Study|Disease Progression|1|||
16116315|NCT01327612|38912311|FG001|Overall Study|Disease Progression|1|||
16116316|NCT01327612|38912312|FG002|Overall Study|Disease Progression|1|||
16116317|NCT01327612|38912313|FG003|Overall Study|Disease Progression|0|||
16116318|NCT01327612|38912314|FG004|Overall Study|Disease Progression|1|||
16116319|NCT01327612|38912315|FG005|Overall Study|Disease Progression|2|||
16116320|NCT01327612|38912316|FG006|Overall Study|Disease Progression|2|||
16411369|NCT00392808|39988592|FG003|Overall Study|Unable to withdraw blood|2|||
16411370|NCT02391961|39988598|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
16116321|NCT01327612|38912310|FG000|Overall Study|Administrative Decision|0|||
16116322|NCT01327612|38912311|FG001|Overall Study|Administrative Decision|0|||
16116323|NCT01327612|38912312|FG002|Overall Study|Administrative Decision|0|||
16116324|NCT01327612|38912313|FG003|Overall Study|Administrative Decision|1|||
16116325|NCT01327612|38912314|FG004|Overall Study|Administrative Decision|0|||
16116326|NCT01327612|38912315|FG005|Overall Study|Administrative Decision|0|||
16116327|NCT01327612|38912316|FG006|Overall Study|Administrative Decision|0|||
16116328|NCT01327612|38912310|FG000|Overall Study|Death|0|||
16116329|NCT01327612|38912311|FG001|Overall Study|Death|0|||
16116330|NCT01327612|38912312|FG002|Overall Study|Death|0|||
16116331|NCT01327612|38912313|FG003|Overall Study|Death|0|||
16116332|NCT01327612|38912314|FG004|Overall Study|Death|1|||
16116333|NCT01327612|38912315|FG005|Overall Study|Death|0|||
16116334|NCT01327612|38912316|FG006|Overall Study|Death|0|||
16411371|NCT02391961|39988599|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
16411372|NCT02391961|39988598|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
16411373|NCT02391961|39988599|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
16116335|NCT00127842|38912324|FG000|Overall Study|Adverse Event|15|||
16116336|NCT00127842|38912324|FG000|Overall Study|Withdrawal by Subject|3|||
16411374|NCT02391961|39988598|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16411375|NCT02391961|39988599|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16116337|NCT00127842|38912324|FG000|Overall Study|Lost to Follow-up|1|||
16116338|NCT00127842|38912324|FG000|Overall Study|Lack of Efficacy|12|||
16116339|NCT00127842|38912324|FG000|Overall Study|Noncompliance|2|||
16411376|NCT00657371|39988600|FG000|Overall Study|Poor bowel preparation|15|||
16116340|NCT00127842|38912324|FG000|Overall Study|Protocol Violation|1|||
16116341|NCT00127842|38912324|FG000|Overall Study|Other|5|||
16116342|NCT00420784|38912325|FG000|Overall Study|Adverse Event|11|||
16116343|NCT00420784|38912326|FG001|Overall Study|Adverse Event|29|||
16116344|NCT00420784|38912327|FG002|Overall Study|Adverse Event|10|||
16116345|NCT00420784|38912328|FG003|Overall Study|Adverse Event|5|||
16116346|NCT00420784|38912325|FG000|Overall Study|Withdrawal by Subject|0|||
16116347|NCT00420784|38912326|FG001|Overall Study|Withdrawal by Subject|1|||
16116348|NCT00420784|38912327|FG002|Overall Study|Withdrawal by Subject|0|||
16116349|NCT00420784|38912328|FG003|Overall Study|Withdrawal by Subject|0|||
16116350|NCT00420784|38912325|FG000|Overall Study|Lost to Follow-up|0|||
16116351|NCT00420784|38912326|FG001|Overall Study|Lost to Follow-up|0|||
16116352|NCT00420784|38912327|FG002|Overall Study|Lost to Follow-up|2|||
16116353|NCT00420784|38912328|FG003|Overall Study|Lost to Follow-up|1|||
16116354|NCT00420784|38912325|FG000|Overall Study|Virologic Stopping Rule|17|||
16116355|NCT00420784|38912326|FG001|Overall Study|Virologic Stopping Rule|26|||
16116356|NCT00420784|38912327|FG002|Overall Study|Virologic Stopping Rule|41|||
16116357|NCT00420784|38912328|FG003|Overall Study|Virologic Stopping Rule|67|||
16116358|NCT00420784|38912325|FG000|Overall Study|Other|1|||
16116359|NCT00420784|38912326|FG001|Overall Study|Other|2|||
16116360|NCT00420784|38912327|FG002|Overall Study|Other|0|||
16116361|NCT00420784|38912328|FG003|Overall Study|Other|5|||
16116362|NCT01647542|38912329|FG000|Overall Study|Major Protocol Deviation|1|||
16116363|NCT01647542|38912330|FG001|Overall Study|Major Protocol Deviation|0|||
16116364|NCT01647542|38912331|FG002|Overall Study|Major Protocol Deviation|0|||
16116365|NCT01647542|38912329|FG000|Overall Study|Adverse Event|4|||
16116366|NCT01647542|38912330|FG001|Overall Study|Adverse Event|5|||
16116367|NCT01647542|38912331|FG002|Overall Study|Adverse Event|4|||
16116368|NCT01647542|38912329|FG000|Overall Study|Lost to Follow-up|0|||
16116369|NCT01647542|38912330|FG001|Overall Study|Lost to Follow-up|2|||
16116370|NCT01647542|38912331|FG002|Overall Study|Lost to Follow-up|2|||
16116371|NCT01647542|38912329|FG000|Overall Study|Withdrawal by Subject|6|||
16116372|NCT01647542|38912330|FG001|Overall Study|Withdrawal by Subject|4|||
16116373|NCT01647542|38912331|FG002|Overall Study|Withdrawal by Subject|0|||
16116374|NCT01647542|38912329|FG000|Overall Study|Study Termination|64|||
16116375|NCT01647542|38912330|FG001|Overall Study|Study Termination|61|||
16116376|NCT01647542|38912331|FG002|Overall Study|Study Termination|65|||
16116377|NCT01647542|38912329|FG000|Overall Study|Lack of Efficacy|1|||
16116378|NCT01647542|38912330|FG001|Overall Study|Lack of Efficacy|1|||
16116379|NCT01647542|38912331|FG002|Overall Study|Lack of Efficacy|0|||
16116380|NCT01647542|38912329|FG000|Overall Study|Death|0|||
16116381|NCT01647542|38912330|FG001|Overall Study|Death|0|||
16116382|NCT01647542|38912331|FG002|Overall Study|Death|1|||
16116383|NCT04732871|38912332|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
16116384|NCT04732871|38912333|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
16116385|NCT04732871|38912334|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
16116386|NCT04732871|38912332|FG000|Overall Study|Lost to Follow-up|7|||
16116387|NCT04732871|38912333|FG001|Overall Study|Lost to Follow-up|4|||
16116388|NCT04732871|38912334|FG002|Overall Study|Lost to Follow-up|3|||
16116389|NCT04732871|38912332|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
16116390|NCT04732871|38912333|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
16116391|NCT04732871|38912334|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
16116392|NCT04732871|38912332|FG000|Overall Study|Migrated / moved from the study area|5|||
16116393|NCT04732871|38912333|FG001|Overall Study|Migrated / moved from the study area|0|||
16116394|NCT04732871|38912334|FG002|Overall Study|Migrated / moved from the study area|0|||
16116395|NCT04732871|38912332|FG000|Overall Study|Other|1|||
16116396|NCT04732871|38912333|FG001|Overall Study|Other|0|||
16116397|NCT04732871|38912334|FG002|Overall Study|Other|1|||
16116398|NCT04732871|38912332|FG000|Overall Study|Ongoing|6|||
16116399|NCT04732871|38912333|FG001|Overall Study|Ongoing|0|||
16116400|NCT04732871|38912334|FG002|Overall Study|Ongoing|1|||
16116401|NCT04732871|38912332|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
16116402|NCT04732871|38912333|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
16116403|NCT04732871|38912334|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
16116404|NCT00966264|38912335|FG000|Overall Study|Lost to Follow-up|4|||
16116405|NCT00966264|38912336|FG001|Overall Study|Lost to Follow-up|3|||
16116406|NCT02595372|38912337|FG000|Overall Study|Adverse Event|6|||
16116407|NCT02595372|38912337|FG000|Overall Study|Physician Decision|2|||
16116408|NCT02595372|38912337|FG000|Overall Study|Disease Progression|1|||
16116409|NCT05186311|38912341|FG000|Part A: Serum|Withdrawal by Subject|1|||
16116410|NCT01441635|38912344|FG000|Overall Study|Adverse Event|4|||
16116411|NCT01441635|38912345|FG001|Overall Study|Adverse Event|3|||
16116412|NCT01441635|38912346|FG002|Overall Study|Adverse Event|1|||
16116413|NCT01441635|38912347|FG003|Overall Study|Adverse Event|5|||
16116414|NCT01441635|38912348|FG004|Overall Study|Adverse Event|1|||
16116415|NCT01441635|38912349|FG005|Overall Study|Adverse Event|2|||
16116416|NCT01441635|38912350|FG006|Overall Study|Adverse Event|2|||
16116417|NCT01441635|38912351|FG007|Overall Study|Adverse Event|2|||
16116418|NCT01441635|38912352|FG008|Overall Study|Adverse Event|1|||
16116419|NCT01441635|38912353|FG009|Overall Study|Adverse Event|0|||
16116420|NCT01441635|38912344|FG000|Overall Study|Withdrawal by Subject|1|||
16116421|NCT01441635|38912345|FG001|Overall Study|Withdrawal by Subject|1|||
16116422|NCT01441635|38912346|FG002|Overall Study|Withdrawal by Subject|0|||
16116423|NCT01441635|38912347|FG003|Overall Study|Withdrawal by Subject|1|||
16116424|NCT01441635|38912348|FG004|Overall Study|Withdrawal by Subject|0|||
16116425|NCT01441635|38912349|FG005|Overall Study|Withdrawal by Subject|0|||
16116426|NCT01441635|38912350|FG006|Overall Study|Withdrawal by Subject|2|||
16116427|NCT01441635|38912351|FG007|Overall Study|Withdrawal by Subject|0|||
16116428|NCT01441635|38912352|FG008|Overall Study|Withdrawal by Subject|1|||
16116429|NCT01441635|38912353|FG009|Overall Study|Withdrawal by Subject|1|||
16116430|NCT01441635|38912344|FG000|Overall Study|Lost to Follow-up|0|||
16116431|NCT01441635|38912345|FG001|Overall Study|Lost to Follow-up|1|||
16116432|NCT01441635|38912346|FG002|Overall Study|Lost to Follow-up|1|||
16116433|NCT01441635|38912347|FG003|Overall Study|Lost to Follow-up|1|||
16116434|NCT01441635|38912348|FG004|Overall Study|Lost to Follow-up|1|||
16116435|NCT01441635|38912349|FG005|Overall Study|Lost to Follow-up|3|||
16116436|NCT01441635|38912350|FG006|Overall Study|Lost to Follow-up|1|||
16116437|NCT01441635|38912351|FG007|Overall Study|Lost to Follow-up|1|||
16116438|NCT01441635|38912352|FG008|Overall Study|Lost to Follow-up|0|||
16116439|NCT01441635|38912353|FG009|Overall Study|Lost to Follow-up|1|||
16116440|NCT01441635|38912344|FG000|Overall Study|Noncompliance|0|||
16116441|NCT01441635|38912345|FG001|Overall Study|Noncompliance|1|||
16116442|NCT01441635|38912346|FG002|Overall Study|Noncompliance|0|||
16116443|NCT01441635|38912347|FG003|Overall Study|Noncompliance|0|||
16116444|NCT01441635|38912348|FG004|Overall Study|Noncompliance|0|||
16116445|NCT01441635|38912349|FG005|Overall Study|Noncompliance|0|||
16116446|NCT01441635|38912350|FG006|Overall Study|Noncompliance|1|||
16116447|NCT01441635|38912351|FG007|Overall Study|Noncompliance|0|||
16116448|NCT01441635|38912352|FG008|Overall Study|Noncompliance|0|||
16116449|NCT01441635|38912353|FG009|Overall Study|Noncompliance|0|||
16116450|NCT01441635|38912344|FG000|Overall Study|Surgery or Invasive Intervention|0|||
16116451|NCT01441635|38912345|FG001|Overall Study|Surgery or Invasive Intervention|0|||
16116452|NCT01441635|38912346|FG002|Overall Study|Surgery or Invasive Intervention|1|||
16116453|NCT01441635|38912347|FG003|Overall Study|Surgery or Invasive Intervention|0|||
16116454|NCT01441635|38912348|FG004|Overall Study|Surgery or Invasive Intervention|0|||
16116455|NCT01441635|38912349|FG005|Overall Study|Surgery or Invasive Intervention|0|||
16116456|NCT01441635|38912350|FG006|Overall Study|Surgery or Invasive Intervention|0|||
16116457|NCT01441635|38912351|FG007|Overall Study|Surgery or Invasive Intervention|0|||
16116458|NCT01441635|38912352|FG008|Overall Study|Surgery or Invasive Intervention|0|||
16116459|NCT01441635|38912353|FG009|Overall Study|Surgery or Invasive Intervention|0|||
16116460|NCT01441635|38912344|FG000|Overall Study|Received Exclusionary Medication|1|||
16116461|NCT01441635|38912345|FG001|Overall Study|Received Exclusionary Medication|0|||
16116462|NCT01441635|38912346|FG002|Overall Study|Received Exclusionary Medication|0|||
16116463|NCT01441635|38912347|FG003|Overall Study|Received Exclusionary Medication|0|||
16116464|NCT01441635|38912348|FG004|Overall Study|Received Exclusionary Medication|0|||
16116465|NCT01441635|38912349|FG005|Overall Study|Received Exclusionary Medication|0|||
16116466|NCT01441635|38912350|FG006|Overall Study|Received Exclusionary Medication|0|||
16116467|NCT01441635|38912351|FG007|Overall Study|Received Exclusionary Medication|0|||
16116468|NCT01441635|38912352|FG008|Overall Study|Received Exclusionary Medication|0|||
16116469|NCT01441635|38912353|FG009|Overall Study|Received Exclusionary Medication|0|||
16116470|NCT01441635|38912344|FG000|Overall Study|Other|0|||
16116471|NCT01441635|38912345|FG001|Overall Study|Other|0|||
16116472|NCT01441635|38912346|FG002|Overall Study|Other|0|||
16116473|NCT01441635|38912347|FG003|Overall Study|Other|0|||
16116474|NCT01441635|38912348|FG004|Overall Study|Other|0|||
16116475|NCT01441635|38912349|FG005|Overall Study|Other|0|||
16116476|NCT01441635|38912350|FG006|Overall Study|Other|0|||
16116477|NCT01441635|38912351|FG007|Overall Study|Other|1|||
16116478|NCT01441635|38912352|FG008|Overall Study|Other|0|||
16116479|NCT01441635|38912353|FG009|Overall Study|Other|0|||
16116480|NCT01967069|38912356|FG000|Overall Study|Adverse Event|2|||
16116481|NCT01967069|38912357|FG001|Overall Study|Adverse Event|2|||
16116482|NCT01967069|38912356|FG000|Overall Study|Lost to Follow-up|5|||
16116483|NCT01967069|38912357|FG001|Overall Study|Lost to Follow-up|2|||
16116484|NCT01967069|38912356|FG000|Overall Study|Withdrawal by Subject|1|||
16116485|NCT01967069|38912357|FG001|Overall Study|Withdrawal by Subject|3|||
16227279|NCT01072175|39313446|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
16227280|NCT01072175|39313447|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
16227281|NCT01072175|39313448|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
16227282|NCT01072175|39313449|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
16227283|NCT01072175|39313450|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
16548643|NCT00337662|40471055|FG003|Study Period II|Lack of Efficacy|7|||
16548644|NCT00337662|40471052|FG000|Study Period II|Sponsor Decision|0|||
16548645|NCT00337662|40471053|FG001|Study Period II|Sponsor Decision|0|||
16548646|NCT00337662|40471054|FG002|Study Period II|Sponsor Decision|0|||
16548647|NCT00337662|40471055|FG003|Study Period II|Sponsor Decision|2|||
16548648|NCT00337662|40471052|FG000|Study Period II|Parent/Caregiver Decision|0|||
16548649|NCT00337662|40471053|FG001|Study Period II|Parent/Caregiver Decision|0|||
16548650|NCT00337662|40471054|FG002|Study Period II|Parent/Caregiver Decision|0|||
16548651|NCT00337662|40471055|FG003|Study Period II|Parent/Caregiver Decision|1|||
16548652|NCT00337662|40471052|FG000|Study Period III|Lost to Follow-up|14|||
16548653|NCT00337662|40471053|FG001|Study Period III|Lost to Follow-up|16|||
16548654|NCT00337662|40471054|FG002|Study Period III|Lost to Follow-up|14|||
16548655|NCT00337662|40471055|FG003|Study Period III|Lost to Follow-up|0|||
16548656|NCT00337662|40471052|FG000|Study Period III|Withdrawal by Subject|18|||
16548657|NCT00337662|40471053|FG001|Study Period III|Withdrawal by Subject|14|||
16548658|NCT00337662|40471054|FG002|Study Period III|Withdrawal by Subject|12|||
16548659|NCT00337662|40471055|FG003|Study Period III|Withdrawal by Subject|0|||
16548660|NCT00337662|40471052|FG000|Study Period III|Adverse Event|9|||
16548661|NCT00337662|40471053|FG001|Study Period III|Adverse Event|10|||
16548662|NCT00337662|40471054|FG002|Study Period III|Adverse Event|8|||
16548663|NCT00337662|40471055|FG003|Study Period III|Adverse Event|0|||
16548664|NCT00337662|40471052|FG000|Study Period III|Protocol Violation|3|||
16548665|NCT00337662|40471053|FG001|Study Period III|Protocol Violation|8|||
16548666|NCT00337662|40471054|FG002|Study Period III|Protocol Violation|2|||
16548667|NCT00337662|40471055|FG003|Study Period III|Protocol Violation|0|||
16548668|NCT00337662|40471052|FG000|Study Period III|Physician Decision|6|||
16548669|NCT00337662|40471053|FG001|Study Period III|Physician Decision|5|||
16548670|NCT00337662|40471054|FG002|Study Period III|Physician Decision|0|||
16548671|NCT00337662|40471055|FG003|Study Period III|Physician Decision|0|||
16548672|NCT00337662|40471052|FG000|Study Period III|Entry Criteria Not Met|4|||
16548673|NCT00337662|40471053|FG001|Study Period III|Entry Criteria Not Met|1|||
16548674|NCT00337662|40471054|FG002|Study Period III|Entry Criteria Not Met|3|||
16227284|NCT01072175|39313451|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
16227285|NCT01072175|39313452|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
16227286|NCT01072175|39313440|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16227287|NCT01072175|39313441|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16227288|NCT01072175|39313442|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16227289|NCT01072175|39313443|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16227290|NCT01072175|39313444|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16227291|NCT01072175|39313445|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
16227292|NCT01072175|39313446|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
16227293|NCT01072175|39313447|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
16227294|NCT01072175|39313448|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16227295|NCT01072175|39313449|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16227296|NCT01072175|39313450|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16227297|NCT01072175|39313451|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16227298|NCT01072175|39313452|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
16227299|NCT01072175|39313440|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16411377|NCT00657371|39988600|FG000|Overall Study|Unable to intubate the cecum|5|||
16411378|NCT00657371|39988600|FG000|Overall Study|Protocol Violation|2|||
16411379|NCT00657371|39988600|FG000|Overall Study|Device- related reasons|13|||
16411380|NCT00657371|39988600|FG000|Overall Study|Pre-existing medical condition|4|||
16411381|NCT02436408|39988601|FG000|Overall Study|Death|1|||
16411382|NCT02876328|39988602|FG000|Overall Study|Death|2|||
16411383|NCT02876328|39988603|FG001|Overall Study|Death|1|||
16411384|NCT02876328|39988604|FG002|Overall Study|Death|3|||
16411385|NCT02876328|39988605|FG003|Overall Study|Death|0|||
16411386|NCT02876328|39988606|FG004|Overall Study|Death|0|||
16411387|NCT02876328|39988607|FG005|Overall Study|Death|0|||
16411388|NCT02876328|39988608|FG006|Overall Study|Death|1|||
16411389|NCT02876328|39988609|FG007|Overall Study|Death|3|||
16411390|NCT02876328|39988610|FG008|Overall Study|Death|0|||
16411391|NCT02876328|39988611|FG009|Overall Study|Death|1|||
16411392|NCT02876328|39988612|FG010|Overall Study|Death|1|||
16227300|NCT01072175|39313441|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16227301|NCT01072175|39313442|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16227302|NCT01072175|39313443|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16227303|NCT01072175|39313444|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16227304|NCT01072175|39313445|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16227305|NCT01072175|39313446|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
16227306|NCT01072175|39313447|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
16227307|NCT01072175|39313448|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16227308|NCT01072175|39313449|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16227309|NCT01072175|39313450|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16227310|NCT01072175|39313451|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16227311|NCT01072175|39313452|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
16227312|NCT01072175|39313440|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16227313|NCT01072175|39313441|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16227314|NCT01072175|39313442|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16227315|NCT01072175|39313443|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16227316|NCT01072175|39313444|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16227317|NCT01072175|39313445|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
16227318|NCT01072175|39313446|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
16227319|NCT01072175|39313447|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
16227320|NCT01072175|39313448|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16227321|NCT01072175|39313449|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16227322|NCT01072175|39313450|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16227323|NCT01072175|39313451|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16227324|NCT01072175|39313452|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
16227325|NCT01072175|39313440|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227326|NCT01072175|39313441|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227327|NCT01072175|39313442|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227328|NCT01072175|39313443|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227329|NCT01072175|39313444|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227330|NCT01072175|39313445|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
16227331|NCT01072175|39313446|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
16227332|NCT01072175|39313447|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227333|NCT01072175|39313448|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227334|NCT01072175|39313449|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227335|NCT01072175|39313450|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227336|NCT01072175|39313451|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227337|NCT01072175|39313452|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
16227338|NCT01072175|39313440|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16347520|NCT01922258|39761935|FG000|Overall Study|Lost to Follow-up|1|||
16347521|NCT01922258|39761936|FG001|Overall Study|Lost to Follow-up|1|||
16116486|NCT01967069|38912356|FG000|Overall Study|Lack of Efficacy|0|||
16116487|NCT01967069|38912357|FG001|Overall Study|Lack of Efficacy|1|||
16116488|NCT02388347|38912358|FG000|Overall Study|Withdrawal by Subject|0|||
16116489|NCT02388347|38912359|FG001|Overall Study|Withdrawal by Subject|0|||
16116490|NCT02388347|38912360|FG002|Overall Study|Withdrawal by Subject|1|||
16116491|NCT02388347|38912361|FG003|Overall Study|Withdrawal by Subject|0|||
16227339|NCT01072175|39313441|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227340|NCT01072175|39313442|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227341|NCT01072175|39313443|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227342|NCT01072175|39313444|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227343|NCT01072175|39313445|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227344|NCT01072175|39313446|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227345|NCT01072175|39313447|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227346|NCT01072175|39313448|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
16227347|NCT01072175|39313449|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227348|NCT01072175|39313450|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227349|NCT01072175|39313451|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227350|NCT01072175|39313452|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
16227351|NCT01072175|39313440|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227352|NCT01072175|39313441|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227353|NCT01072175|39313442|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227354|NCT01072175|39313443|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227355|NCT01072175|39313444|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227356|NCT01072175|39313445|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227357|NCT01072175|39313446|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227358|NCT01072175|39313447|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227359|NCT01072175|39313448|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
16227360|NCT01072175|39313449|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227361|NCT01072175|39313450|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227362|NCT01072175|39313451|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227363|NCT01072175|39313452|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
16227364|NCT01072175|39313440|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227365|NCT01072175|39313441|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227366|NCT01072175|39313442|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227367|NCT01072175|39313443|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227368|NCT01072175|39313444|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227369|NCT01072175|39313445|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227370|NCT01072175|39313446|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227371|NCT01072175|39313447|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227372|NCT01072175|39313448|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
16227373|NCT01072175|39313449|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227374|NCT01072175|39313450|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227375|NCT01072175|39313451|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227376|NCT01072175|39313452|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
16227377|NCT01072175|39313440|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227378|NCT01072175|39313441|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227379|NCT01072175|39313442|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227380|NCT01072175|39313443|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227381|NCT01072175|39313444|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227382|NCT01072175|39313445|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16116492|NCT02388347|38912362|FG004|Overall Study|Withdrawal by Subject|0|||
16116493|NCT00978562|38912363|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
16227383|NCT01072175|39313446|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227384|NCT01072175|39313447|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227385|NCT01072175|39313448|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
16227386|NCT01072175|39313449|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227387|NCT01072175|39313450|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227388|NCT01072175|39313451|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227389|NCT01072175|39313452|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
16227390|NCT01072175|39313440|FG000|Part D (HPMC Capsules)|Death|0|||
16227391|NCT01072175|39313441|FG001|Part D (HPMC Capsules)|Death|0|||
16227392|NCT01072175|39313442|FG002|Part D (HPMC Capsules)|Death|0|||
16227393|NCT01072175|39313443|FG003|Part D (HPMC Capsules)|Death|0|||
16227394|NCT01072175|39313444|FG004|Part D (HPMC Capsules)|Death|0|||
16227395|NCT01072175|39313445|FG005|Part D (HPMC Capsules)|Death|0|||
16227396|NCT01072175|39313446|FG006|Part D (HPMC Capsules)|Death|0|||
16227397|NCT01072175|39313447|FG007|Part D (HPMC Capsules)|Death|0|||
16227398|NCT01072175|39313448|FG008|Part D (HPMC Capsules)|Death|0|||
16227399|NCT01072175|39313449|FG009|Part D (HPMC Capsules)|Death|10|||
16227400|NCT01072175|39313450|FG010|Part D (HPMC Capsules)|Death|12|||
16227401|NCT01072175|39313451|FG011|Part D (HPMC Capsules)|Death|28|||
16227402|NCT01072175|39313452|FG012|Part D (HPMC Capsules)|Death|26|||
16227403|NCT01072175|39313440|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
16227404|NCT01072175|39313441|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
16227405|NCT01072175|39313442|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
16227406|NCT01072175|39313443|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
16227407|NCT01072175|39313444|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
16227408|NCT01072175|39313445|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
16227409|NCT01072175|39313446|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
16227410|NCT01072175|39313447|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
16227411|NCT01072175|39313448|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
16227412|NCT01072175|39313449|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
16227413|NCT01072175|39313450|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
16227414|NCT01072175|39313451|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
16227415|NCT01072175|39313452|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
16227416|NCT01072175|39313440|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16227417|NCT01072175|39313441|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16227418|NCT01072175|39313442|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16227419|NCT01072175|39313443|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16227420|NCT01072175|39313444|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16227421|NCT01072175|39313445|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16227422|NCT01072175|39313446|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16227423|NCT01072175|39313447|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16227424|NCT01072175|39313448|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16227425|NCT01072175|39313449|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
16227426|NCT01072175|39313450|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
16227427|NCT01072175|39313451|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
16227428|NCT01072175|39313452|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
16227429|NCT01072175|39313440|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
16227430|NCT01072175|39313441|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
16227431|NCT01072175|39313442|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
16227432|NCT01072175|39313443|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
16227433|NCT01072175|39313444|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
16227434|NCT01072175|39313445|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
16227435|NCT01072175|39313446|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
16227436|NCT01072175|39313447|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
16227437|NCT01072175|39313448|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
16227438|NCT01072175|39313449|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
16227439|NCT01072175|39313450|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
16227440|NCT01072175|39313451|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
16227441|NCT01072175|39313452|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
16227442|NCT01072175|39313440|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227443|NCT01072175|39313441|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227444|NCT01072175|39313442|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227445|NCT01072175|39313443|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227446|NCT01072175|39313444|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227447|NCT01072175|39313445|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227448|NCT01072175|39313446|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227449|NCT01072175|39313447|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227450|NCT01072175|39313448|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227451|NCT01072175|39313449|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227452|NCT01072175|39313450|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
16227453|NCT01072175|39313451|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
16227454|NCT01072175|39313452|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
16227455|NCT03831282|39313453|FG000|Overall Study|Could not place sensor|1|||
16227456|NCT00386152|39313454|FG000|Overall Study|Adverse Event|6|||
16227457|NCT00386152|39313455|FG001|Overall Study|Adverse Event|5|||
16227458|NCT00386152|39313456|FG002|Overall Study|Adverse Event|4|||
16227459|NCT00386152|39313454|FG000|Overall Study|Chang from original chemo stratification|4|||
16227460|NCT00386152|39313455|FG001|Overall Study|Chang from original chemo stratification|5|||
16227461|NCT00386152|39313456|FG002|Overall Study|Chang from original chemo stratification|6|||
16227462|NCT00386152|39313454|FG000|Overall Study|Death|3|||
16227463|NCT00386152|39313455|FG001|Overall Study|Death|0|||
16227464|NCT00386152|39313456|FG002|Overall Study|Death|1|||
16227465|NCT00386152|39313454|FG000|Overall Study|Disease progression|7|||
16227466|NCT00386152|39313455|FG001|Overall Study|Disease progression|4|||
16227467|NCT00386152|39313456|FG002|Overall Study|Disease progression|5|||
16227468|NCT00386152|39313454|FG000|Overall Study|Physician Decision|13|||
16227469|NCT00386152|39313455|FG001|Overall Study|Physician Decision|10|||
16227470|NCT00386152|39313456|FG002|Overall Study|Physician Decision|4|||
16227471|NCT00386152|39313454|FG000|Overall Study|Lost to Follow-up|1|||
16227472|NCT00386152|39313455|FG001|Overall Study|Lost to Follow-up|0|||
16227473|NCT00386152|39313456|FG002|Overall Study|Lost to Follow-up|0|||
16347522|NCT01922258|39761935|FG000|Overall Study|Adverse Event|9|||
16347523|NCT01922258|39761936|FG001|Overall Study|Adverse Event|2|||
16347524|NCT01922258|39761935|FG000|Overall Study|Met Withdrawal Criteria|0|||
16347525|NCT01922258|39761936|FG001|Overall Study|Met Withdrawal Criteria|4|||
16347526|NCT01922258|39761935|FG000|Overall Study|Withdrawn by the Investigator|1|||
16347527|NCT01922258|39761936|FG001|Overall Study|Withdrawn by the Investigator|4|||
16347528|NCT01922258|39761935|FG000|Overall Study|Withdrawal by participant|5|||
16347529|NCT01922258|39761936|FG001|Overall Study|Withdrawal by participant|5|||
16347530|NCT00803712|39761939|FG000|Overall Study|Noncompliance|3|||
16347531|NCT00803712|39761940|FG001|Overall Study|Noncompliance|0|||
16347532|NCT00803712|39761939|FG000|Overall Study|Adverse Event|5|||
16347533|NCT00803712|39761940|FG001|Overall Study|Adverse Event|0|||
16347534|NCT00803712|39761939|FG000|Overall Study|Death|8|||
16347535|NCT00803712|39761940|FG001|Overall Study|Death|7|||
16347536|NCT00803712|39761939|FG000|Overall Study|Lost to Follow-up|3|||
16347537|NCT00803712|39761940|FG001|Overall Study|Lost to Follow-up|1|||
16347538|NCT00803712|39761939|FG000|Overall Study|Withdrawal by Subject|2|||
16347539|NCT00803712|39761940|FG001|Overall Study|Withdrawal by Subject|4|||
16347540|NCT00803712|39761939|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
16347541|NCT00803712|39761940|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
16347542|NCT00803712|39761939|FG000|Overall Study|Protocol criteria (other)|0|||
16347543|NCT00803712|39761940|FG001|Overall Study|Protocol criteria (other)|2|||
16347544|NCT00803712|39761939|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
16347545|NCT00803712|39761940|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
16347546|NCT00803712|39761939|FG000|Overall Study|Administrative decision|2|||
16347547|NCT00803712|39761940|FG001|Overall Study|Administrative decision|3|||
16227474|NCT00386152|39313454|FG000|Overall Study|Completed chemotherapy|4|||
16227475|NCT00386152|39313455|FG001|Overall Study|Completed chemotherapy|5|||
16227476|NCT00386152|39313456|FG002|Overall Study|Completed chemotherapy|1|||
16347548|NCT00803712|39761939|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
16347549|NCT00803712|39761940|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
16347550|NCT01302418|39761941|FG000|Overall Study|Protocol Violation|9|||
16411393|NCT02876328|39988613|FG011|Overall Study|Death|0|||
16411394|NCT02876328|39988614|FG012|Overall Study|Death|0|||
16411395|NCT02876328|39988615|FG013|Overall Study|Death|0|||
16411396|NCT02876328|39988616|FG014|Overall Study|Death|0|||
16411397|NCT02876328|39988617|FG015|Overall Study|Death|0|||
16411398|NCT02876328|39988618|FG016|Overall Study|Death|1|||
16411399|NCT02876328|39988619|FG017|Overall Study|Death|1|||
16411400|NCT02876328|39988620|FG018|Overall Study|Death|0|||
16411401|NCT02876328|39988621|FG019|Overall Study|Death|0|||
16411402|NCT02876328|39988622|FG020|Overall Study|Death|0|||
16411403|NCT02876328|39988623|FG021|Overall Study|Death|1|||
16411404|NCT02876328|39988624|FG022|Overall Study|Death|0|||
16411405|NCT02876328|39988625|FG023|Overall Study|Death|0|||
16411406|NCT02876328|39988602|FG000|Overall Study|Withdrawal by Subject|0|||
16411407|NCT02876328|39988603|FG001|Overall Study|Withdrawal by Subject|2|||
16411408|NCT02876328|39988604|FG002|Overall Study|Withdrawal by Subject|3|||
16411409|NCT02876328|39988605|FG003|Overall Study|Withdrawal by Subject|3|||
16411410|NCT02876328|39988606|FG004|Overall Study|Withdrawal by Subject|0|||
16411411|NCT02876328|39988607|FG005|Overall Study|Withdrawal by Subject|1|||
16411412|NCT02876328|39988608|FG006|Overall Study|Withdrawal by Subject|0|||
16411413|NCT02876328|39988609|FG007|Overall Study|Withdrawal by Subject|1|||
16411414|NCT02876328|39988610|FG008|Overall Study|Withdrawal by Subject|1|||
16411415|NCT02876328|39988611|FG009|Overall Study|Withdrawal by Subject|2|||
16411416|NCT02876328|39988612|FG010|Overall Study|Withdrawal by Subject|0|||
16411417|NCT02876328|39988613|FG011|Overall Study|Withdrawal by Subject|0|||
16411418|NCT02876328|39988614|FG012|Overall Study|Withdrawal by Subject|0|||
16411419|NCT02876328|39988615|FG013|Overall Study|Withdrawal by Subject|0|||
16411420|NCT02876328|39988616|FG014|Overall Study|Withdrawal by Subject|0|||
16411421|NCT02876328|39988617|FG015|Overall Study|Withdrawal by Subject|0|||
16411422|NCT02876328|39988618|FG016|Overall Study|Withdrawal by Subject|1|||
16411423|NCT02876328|39988619|FG017|Overall Study|Withdrawal by Subject|3|||
16411424|NCT02876328|39988620|FG018|Overall Study|Withdrawal by Subject|0|||
16411425|NCT02876328|39988621|FG019|Overall Study|Withdrawal by Subject|0|||
16411426|NCT02876328|39988622|FG020|Overall Study|Withdrawal by Subject|1|||
16411427|NCT02876328|39988623|FG021|Overall Study|Withdrawal by Subject|0|||
16411428|NCT02876328|39988624|FG022|Overall Study|Withdrawal by Subject|0|||
16411429|NCT02876328|39988625|FG023|Overall Study|Withdrawal by Subject|0|||
16411430|NCT02876328|39988602|FG000|Overall Study|Missed 12 Month Visit|15|||
16411431|NCT02876328|39988603|FG001|Overall Study|Missed 12 Month Visit|10|||
16411432|NCT02876328|39988604|FG002|Overall Study|Missed 12 Month Visit|11|||
16411433|NCT02876328|39988605|FG003|Overall Study|Missed 12 Month Visit|6|||
16411434|NCT02876328|39988606|FG004|Overall Study|Missed 12 Month Visit|10|||
16411435|NCT02876328|39988607|FG005|Overall Study|Missed 12 Month Visit|14|||
16411436|NCT02876328|39988608|FG006|Overall Study|Missed 12 Month Visit|3|||
16411437|NCT02876328|39988609|FG007|Overall Study|Missed 12 Month Visit|8|||
16411438|NCT02876328|39988610|FG008|Overall Study|Missed 12 Month Visit|9|||
16411439|NCT02876328|39988611|FG009|Overall Study|Missed 12 Month Visit|5|||
16411440|NCT02876328|39988612|FG010|Overall Study|Missed 12 Month Visit|4|||
16411441|NCT02876328|39988613|FG011|Overall Study|Missed 12 Month Visit|1|||
16411442|NCT02876328|39988614|FG012|Overall Study|Missed 12 Month Visit|5|||
16411443|NCT02876328|39988615|FG013|Overall Study|Missed 12 Month Visit|4|||
16411444|NCT02876328|39988616|FG014|Overall Study|Missed 12 Month Visit|4|||
16411445|NCT02876328|39988617|FG015|Overall Study|Missed 12 Month Visit|4|||
16411446|NCT02876328|39988618|FG016|Overall Study|Missed 12 Month Visit|3|||
16411447|NCT02876328|39988619|FG017|Overall Study|Missed 12 Month Visit|6|||
16411448|NCT02876328|39988620|FG018|Overall Study|Missed 12 Month Visit|2|||
16411449|NCT02876328|39988621|FG019|Overall Study|Missed 12 Month Visit|2|||
16411450|NCT02876328|39988622|FG020|Overall Study|Missed 12 Month Visit|11|||
16411451|NCT02876328|39988623|FG021|Overall Study|Missed 12 Month Visit|7|||
16548675|NCT00337662|40471055|FG003|Study Period III|Entry Criteria Not Met|0|||
16548676|NCT00337662|40471052|FG000|Study Period III|Lack of Efficacy|4|||
16548677|NCT00337662|40471053|FG001|Study Period III|Lack of Efficacy|4|||
16548678|NCT00337662|40471054|FG002|Study Period III|Lack of Efficacy|2|||
16548679|NCT00337662|40471055|FG003|Study Period III|Lack of Efficacy|0|||
16548680|NCT00337662|40471052|FG000|Study Period III|Parent/Caregiver Decision|0|||
16548681|NCT00337662|40471053|FG001|Study Period III|Parent/Caregiver Decision|0|||
16411452|NCT02876328|39988624|FG022|Overall Study|Missed 12 Month Visit|1|||
16411453|NCT02876328|39988625|FG023|Overall Study|Missed 12 Month Visit|0|||
16411454|NCT02046070|39988626|FG000|Overall Study|Progressive Disease|18|||
16411455|NCT02046070|39988627|FG001|Overall Study|Progressive Disease|11|||
16411456|NCT02046070|39988628|FG002|Overall Study|Progressive Disease|40|||
16411457|NCT02046070|39988626|FG000|Overall Study|Adverse Event|8|||
16411458|NCT02046070|39988627|FG001|Overall Study|Adverse Event|10|||
16411459|NCT02046070|39988628|FG002|Overall Study|Adverse Event|17|||
16411460|NCT02046070|39988626|FG000|Overall Study|Withdrawal by Subject|1|||
16411461|NCT02046070|39988627|FG001|Overall Study|Withdrawal by Subject|2|||
16548682|NCT00337662|40471054|FG002|Study Period III|Parent/Caregiver Decision|2|||
16548683|NCT00337662|40471055|FG003|Study Period III|Parent/Caregiver Decision|0|||
16548684|NCT00337662|40471052|FG000|Study Period III|Sponsor Decision|1|||
16548685|NCT00337662|40471053|FG001|Study Period III|Sponsor Decision|0|||
16548686|NCT00337662|40471054|FG002|Study Period III|Sponsor Decision|1|||
16548687|NCT00337662|40471055|FG003|Study Period III|Sponsor Decision|0|||
16548688|NCT00337662|40471052|FG000|Study Period III|Clinical Relapse|1|||
16548689|NCT00337662|40471053|FG001|Study Period III|Clinical Relapse|0|||
16548690|NCT00337662|40471054|FG002|Study Period III|Clinical Relapse|0|||
16548691|NCT00337662|40471055|FG003|Study Period III|Clinical Relapse|0|||
16548692|NCT02118337|40471056|FG000|Overall Study|Other|1|||
16548693|NCT02118337|40471057|FG001|Overall Study|Other|0|||
16548694|NCT02118337|40471058|FG002|Overall Study|Other|0|||
16548695|NCT02118337|40471059|FG003|Overall Study|Other|0|||
16548696|NCT02118337|40471060|FG004|Overall Study|Other|2|||
16548697|NCT02118337|40471061|FG005|Overall Study|Other|3|||
16548698|NCT02118337|40471062|FG006|Overall Study|Other|1|||
16548699|NCT02118337|40471063|FG007|Overall Study|Other|28|||
16548700|NCT02118337|40471064|FG008|Overall Study|Other|15|||
16548701|NCT02118337|40471056|FG000|Overall Study|Lost to Follow-up|0|||
16548702|NCT02118337|40471057|FG001|Overall Study|Lost to Follow-up|0|||
16548703|NCT02118337|40471058|FG002|Overall Study|Lost to Follow-up|0|||
16548704|NCT02118337|40471059|FG003|Overall Study|Lost to Follow-up|0|||
16548705|NCT02118337|40471060|FG004|Overall Study|Lost to Follow-up|0|||
16548706|NCT02118337|40471061|FG005|Overall Study|Lost to Follow-up|0|||
16548707|NCT02118337|40471062|FG006|Overall Study|Lost to Follow-up|0|||
16548708|NCT02118337|40471063|FG007|Overall Study|Lost to Follow-up|1|||
16548709|NCT02118337|40471064|FG008|Overall Study|Lost to Follow-up|0|||
16548710|NCT02118337|40471056|FG000|Overall Study|Withdrawal by Subject|1|||
16548711|NCT02118337|40471057|FG001|Overall Study|Withdrawal by Subject|3|||
16548712|NCT02118337|40471058|FG002|Overall Study|Withdrawal by Subject|2|||
16548713|NCT02118337|40471059|FG003|Overall Study|Withdrawal by Subject|1|||
16548714|NCT02118337|40471060|FG004|Overall Study|Withdrawal by Subject|2|||
16548715|NCT02118337|40471061|FG005|Overall Study|Withdrawal by Subject|2|||
16548716|NCT02118337|40471062|FG006|Overall Study|Withdrawal by Subject|1|||
16548717|NCT02118337|40471063|FG007|Overall Study|Withdrawal by Subject|4|||
16548718|NCT02118337|40471064|FG008|Overall Study|Withdrawal by Subject|2|||
16548719|NCT02118337|40471056|FG000|Overall Study|Death|2|||
16548720|NCT02118337|40471057|FG001|Overall Study|Death|2|||
16548721|NCT02118337|40471058|FG002|Overall Study|Death|1|||
16116494|NCT01777334|38912364|FG000|Overall Study|Adverse Event|18|||
16227477|NCT00386152|39313454|FG000|Overall Study|Protocol Violation|3|||
16411462|NCT02046070|39988628|FG002|Overall Study|Withdrawal by Subject|6|||
16548722|NCT02118337|40471059|FG003|Overall Study|Death|2|||
16548723|NCT02118337|40471060|FG004|Overall Study|Death|5|||
16548724|NCT02118337|40471061|FG005|Overall Study|Death|1|||
16548725|NCT02118337|40471062|FG006|Overall Study|Death|2|||
16548726|NCT02118337|40471063|FG007|Overall Study|Death|9|||
16548727|NCT02118337|40471064|FG008|Overall Study|Death|4|||
16548728|NCT03203694|40471065|FG000|Overall Study|Withdrawal by Subject|2|||
16548729|NCT03203694|40471066|FG001|Overall Study|Withdrawal by Subject|0|||
16548730|NCT03203694|40471067|FG002|Overall Study|Withdrawal by Subject|0|||
16548731|NCT03203694|40471068|FG003|Overall Study|Withdrawal by Subject|0|||
16548732|NCT03203694|40471069|FG004|Overall Study|Withdrawal by Subject|0|||
16116495|NCT01777334|38912365|FG001|Overall Study|Adverse Event|14|||
16116496|NCT01777334|38912364|FG000|Overall Study|Lack of Efficacy|15|||
16116497|NCT01777334|38912365|FG001|Overall Study|Lack of Efficacy|29|||
16116498|NCT01777334|38912364|FG000|Overall Study|Protocol Violation|3|||
16116499|NCT01777334|38912365|FG001|Overall Study|Protocol Violation|7|||
16116500|NCT01777334|38912364|FG000|Overall Study|Lost to Follow-up|3|||
16116501|NCT01777334|38912365|FG001|Overall Study|Lost to Follow-up|2|||
16116502|NCT01777334|38912364|FG000|Overall Study|Withdrawal by Subject|14|||
16116503|NCT01777334|38912365|FG001|Overall Study|Withdrawal by Subject|11|||
16116504|NCT01375673|38912369|FG000|Overall Study|Withdrawal by Subject|0|||
16116505|NCT01375673|38912370|FG001|Overall Study|Withdrawal by Subject|1|||
16116506|NCT04829747|38912373|FG000|Overall Study|Protocol Violation|1|||
16411463|NCT02046070|39988626|FG000|Overall Study|Study Terminated by Sponsor|1|||
16548733|NCT03203694|40471070|FG005|Overall Study|Withdrawal by Subject|0|||
16548734|NCT02421666|40471071|FG000|6-month Follow-up|Lost to Follow-up|8|||
16548735|NCT02421666|40471072|FG001|6-month Follow-up|Lost to Follow-up|7|||
16548736|NCT02421666|40471071|FG000|6-month Follow-up|Withdrawal by Subject|5|||
16548737|NCT02421666|40471072|FG001|6-month Follow-up|Withdrawal by Subject|6|||
16548738|NCT02421666|40471071|FG000|12-month Follow-up|Lost to Follow-up|5|||
16548739|NCT02421666|40471072|FG001|12-month Follow-up|Lost to Follow-up|5|||
16548740|NCT02421666|40471071|FG000|12-month Follow-up|Withdrawal by Subject|6|||
16548741|NCT02421666|40471072|FG001|12-month Follow-up|Withdrawal by Subject|11|||
16548742|NCT00633932|40471073|FG000|Overall Study|Adverse Event|1|||
16411464|NCT02046070|39988627|FG001|Overall Study|Study Terminated by Sponsor|1|||
16411465|NCT02046070|39988628|FG002|Overall Study|Study Terminated by Sponsor|1|||
16411466|NCT02046070|39988626|FG000|Overall Study|Reason not Specified|4|||
16411467|NCT02046070|39988627|FG001|Overall Study|Reason not Specified|4|||
16411468|NCT02046070|39988628|FG002|Overall Study|Reason not Specified|6|||
16411469|NCT03883113|39988631|FG000|Overall Study|Physician Decision|4|||
16411470|NCT03883113|39988632|FG001|Overall Study|Physician Decision|2|||
16411471|NCT03883113|39988631|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
16411472|NCT03883113|39988632|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
16411473|NCT03883113|39988631|FG000|Overall Study|Pregnancy|1|||
16116507|NCT03819634|38912374|FG000|Overall Study|Physician Decision|2|||
16411474|NCT03883113|39988632|FG001|Overall Study|Pregnancy|0|||
16411475|NCT03883113|39988631|FG000|Overall Study|Adverse Event|0|||
16411476|NCT03883113|39988632|FG001|Overall Study|Adverse Event|1|||
16411477|NCT03883113|39988631|FG000|Overall Study|Withdrawal by Subject|1|||
16411478|NCT03883113|39988632|FG001|Overall Study|Withdrawal by Subject|2|||
16411479|NCT03883113|39988631|FG000|Overall Study|Lost to Follow-up|1|||
16411480|NCT03883113|39988632|FG001|Overall Study|Lost to Follow-up|0|||
16411481|NCT04316741|39988633|FG000|Baseline Enrollment|Lost to Follow-up|1|||
16411482|NCT04316741|39988634|FG001|Baseline Enrollment|Lost to Follow-up|1|||
16411483|NCT04316741|39988633|FG000|Immediate Post-Test|Lost to Follow-up|5|||
16411484|NCT04316741|39988634|FG001|Immediate Post-Test|Lost to Follow-up|1|||
16411485|NCT04316741|39988633|FG000|1-month Post-test|Lost to Follow-up|7|||
16411486|NCT04316741|39988634|FG001|1-month Post-test|Lost to Follow-up|2|||
16411487|NCT04316741|39988633|FG000|3-month Follow-up|Lost to Follow-up|10|||
16411488|NCT04316741|39988634|FG001|3-month Follow-up|Lost to Follow-up|2|||
16411489|NCT01318070|39988637|FG000|Overall Study|Adverse Event|1|||
16411490|NCT01318070|39988638|FG001|Overall Study|Adverse Event|1|||
16411491|NCT01318070|39988639|FG002|Overall Study|Adverse Event|5|||
16116508|NCT01989169|38912375|FG000|Period 2|Adverse Event|0|||
16116509|NCT01989169|38912376|FG001|Period 2|Adverse Event|1|||
16411492|NCT01318070|39988637|FG000|Overall Study|Withdrawal by Subject|0|||
16411493|NCT01318070|39988638|FG001|Overall Study|Withdrawal by Subject|1|||
16411494|NCT01318070|39988639|FG002|Overall Study|Withdrawal by Subject|1|||
16411495|NCT01318070|39988637|FG000|Overall Study|Lack of Efficacy|0|||
16411496|NCT01318070|39988638|FG001|Overall Study|Lack of Efficacy|0|||
16411497|NCT01318070|39988639|FG002|Overall Study|Lack of Efficacy|1|||
16548743|NCT00633932|40471074|FG001|Overall Study|Adverse Event|3|||
16548744|NCT00633932|40471075|FG002|Overall Study|Adverse Event|4|||
16227478|NCT00386152|39313455|FG001|Overall Study|Protocol Violation|5|||
16227479|NCT00386152|39313456|FG002|Overall Study|Protocol Violation|2|||
16227480|NCT00386152|39313454|FG000|Overall Study|Withdrawal by Subject|3|||
16227481|NCT00386152|39313455|FG001|Overall Study|Withdrawal by Subject|6|||
16548745|NCT00633932|40471073|FG000|Overall Study|Withdrawal by Subject|3|||
16548746|NCT00633932|40471074|FG001|Overall Study|Withdrawal by Subject|9|||
16548747|NCT00633932|40471075|FG002|Overall Study|Withdrawal by Subject|1|||
16548748|NCT00633932|40471073|FG000|Overall Study|Lost to Follow-up|1|||
16548749|NCT00633932|40471074|FG001|Overall Study|Lost to Follow-up|0|||
16548750|NCT00633932|40471075|FG002|Overall Study|Lost to Follow-up|2|||
16548751|NCT00633932|40471073|FG000|Overall Study|Protocol Violation|5|||
16548752|NCT00633932|40471074|FG001|Overall Study|Protocol Violation|2|||
16548753|NCT00633932|40471075|FG002|Overall Study|Protocol Violation|3|||
16548754|NCT00633932|40471073|FG000|Overall Study|Physician Decision|0|||
16548755|NCT00633932|40471074|FG001|Overall Study|Physician Decision|0|||
16548756|NCT00633932|40471075|FG002|Overall Study|Physician Decision|1|||
16548757|NCT00633932|40471073|FG000|Overall Study|Doctor's judgement|1|||
16548758|NCT00633932|40471074|FG001|Overall Study|Doctor's judgement|0|||
16227482|NCT00386152|39313456|FG002|Overall Study|Withdrawal by Subject|10|||
16227483|NCT01200758|39313459|FG000|Stage I|Death|0|||
16227484|NCT01200758|39313460|FG001|Stage I|Death|1|||
16227485|NCT01200758|39313461|FG002|Stage I|Death|0|||
16227486|NCT01200758|39313462|FG003|Stage I|Death|0|||
16411498|NCT01318070|39988637|FG000|Overall Study|Principal Investigator Discretion|1|||
16411499|NCT01318070|39988638|FG001|Overall Study|Principal Investigator Discretion|0|||
16411500|NCT01318070|39988639|FG002|Overall Study|Principal Investigator Discretion|0|||
16411501|NCT04584346|39988640|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
16411502|NCT04584346|39988641|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
16411503|NCT03374202|39988642|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
16411504|NCT03374202|39988643|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
16411505|NCT03374202|39988644|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
16411506|NCT03374202|39988642|FG000|Five Year Long Term Follow Up|Death|0|||
16411507|NCT03374202|39988643|FG001|Five Year Long Term Follow Up|Death|1|||
16411508|NCT03374202|39988644|FG002|Five Year Long Term Follow Up|Death|0|||
16411509|NCT00857948|39988646|FG000|Overall Study|Withdrawal by Subject|2|||
16411510|NCT00857948|39988647|FG001|Overall Study|Withdrawal by Subject|0|||
16411511|NCT00857948|39988648|FG002|Overall Study|Withdrawal by Subject|0|||
16411512|NCT00857948|39988649|FG003|Overall Study|Withdrawal by Subject|0|||
16411513|NCT00857948|39988646|FG000|Overall Study|Protocol Violation|1|||
16411514|NCT00857948|39988647|FG001|Overall Study|Protocol Violation|0|||
16411515|NCT00857948|39988648|FG002|Overall Study|Protocol Violation|1|||
16411516|NCT00857948|39988649|FG003|Overall Study|Protocol Violation|0|||
16411517|NCT04342689|39988650|FG000|Overall Study|Withdrawal by Subject|32|||
16411518|NCT04342689|39988651|FG001|Overall Study|Withdrawal by Subject|33|||
16411519|NCT04342689|39988650|FG000|Overall Study|Lost to Follow-up|10|||
16411520|NCT04342689|39988651|FG001|Overall Study|Lost to Follow-up|12|||
16411521|NCT03779503|39988653|FG000|First Intervention|Adverse Event|0|||
16411522|NCT03779503|39988654|FG001|First Intervention|Adverse Event|1|||
16411523|NCT03779503|39988653|FG000|First Intervention|Withdrawal by Subject|1|||
16411524|NCT03779503|39988654|FG001|First Intervention|Withdrawal by Subject|0|||
16411525|NCT01439074|39988657|FG000|Overall Study|Lost to Follow-up|3|||
16411526|NCT01439074|39988658|FG001|Overall Study|Lost to Follow-up|4|||
16411527|NCT01439074|39988657|FG000|Overall Study|Subject shedding|1|||
16411528|NCT01439074|39988658|FG001|Overall Study|Subject shedding|0|||
16411529|NCT01439074|39988657|FG000|Overall Study|Withdrawal by Subject|1|||
16411530|NCT01439074|39988658|FG001|Overall Study|Withdrawal by Subject|5|||
16411531|NCT01439074|39988657|FG000|Overall Study|Other|4|||
16411532|NCT01439074|39988658|FG001|Overall Study|Other|4|||
16411533|NCT04035564|39988659|FG000|Overall Study|Protocol Violation|1|||
16411534|NCT04035564|39988660|FG001|Overall Study|Protocol Violation|2|||
16411535|NCT04035564|39988659|FG000|Overall Study|No laboratory available|2|||
16411536|NCT04035564|39988660|FG001|Overall Study|No laboratory available|2|||
16411537|NCT04035564|39988659|FG000|Overall Study|Guardian declined consent|1|||
16411538|NCT04035564|39988660|FG001|Overall Study|Guardian declined consent|2|||
16411539|NCT00524589|39988661|FG000|Overall Study|Withdrawal by Subject|2|||
16411540|NCT00524589|39988661|FG000|Overall Study|Disease Progression|16|||
16411541|NCT00160199|39988662|FG000|Overall Study|Adverse Event|5|||
16411542|NCT00160199|39988663|FG001|Overall Study|Adverse Event|14|||
16411543|NCT00160199|39988662|FG000|Overall Study|Lack of Efficacy|0|||
16411544|NCT00160199|39988663|FG001|Overall Study|Lack of Efficacy|1|||
16411545|NCT00160199|39988662|FG000|Overall Study|Lost to Follow-up|7|||
16411546|NCT00160199|39988663|FG001|Overall Study|Lost to Follow-up|7|||
16411547|NCT00160199|39988662|FG000|Overall Study|Withdrawal by Subject|4|||
16411548|NCT00160199|39988663|FG001|Overall Study|Withdrawal by Subject|6|||
16548759|NCT00633932|40471075|FG002|Overall Study|Doctor's judgement|0|||
16548760|NCT00633932|40471073|FG000|Overall Study|Moved Away|1|||
16548761|NCT00633932|40471074|FG001|Overall Study|Moved Away|0|||
16548762|NCT00633932|40471075|FG002|Overall Study|Moved Away|0|||
16548763|NCT04152343|40471076|FG000|Overall Study|Transplanted|5|||
16548764|NCT04152343|40471076|FG000|Overall Study|Death|20|||
16548765|NCT04152343|40471076|FG000|Overall Study|Lost to Follow-up|3|||
16548766|NCT00265330|40471077|FG000|Overall Study|Adverse Event|41|||
16548767|NCT00265330|40471077|FG000|Overall Study|Lost to Follow-up|8|||
16548768|NCT00265330|40471077|FG000|Overall Study|Withdrawal by Subject|34|||
16548769|NCT00265330|40471077|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
16116510|NCT00504075|38912377|FG000|Overall Study|Adverse Event|1|||
16548770|NCT00265330|40471077|FG000|Overall Study|Lack of Efficacy|4|||
16548771|NCT00265330|40471077|FG000|Overall Study|Family Scheduling Conflicts|1|||
16548772|NCT00265330|40471077|FG000|Overall Study|Began Taking Formulary Geodon|1|||
16411549|NCT00160199|39988662|FG000|Overall Study|Administrative|0|||
16411550|NCT00160199|39988663|FG001|Overall Study|Administrative|1|||
16411551|NCT00160199|39988662|FG000|Overall Study|Protocol Violation|8|||
16411552|NCT00160199|39988663|FG001|Overall Study|Protocol Violation|8|||
16411553|NCT00509093|39988664|FG000|Overall Study|Adverse Event|10|||
16411554|NCT00509093|39988664|FG000|Overall Study|Disease Progression|9|||
16411555|NCT00509093|39988664|FG000|Overall Study|Transformed into MDS|1|||
16411556|NCT00509093|39988664|FG000|Overall Study|Withdrawal by Subject|3|||
16411557|NCT00509093|39988664|FG000|Overall Study|Physician Decision|1|||
16411558|NCT00700102|39988665|FG000|Overall Study|Died|394|||
16411559|NCT00700102|39988666|FG001|Overall Study|Died|385|||
16411560|NCT00700102|39988665|FG000|Overall Study|Lost to Follow-up|8|||
16411561|NCT00700102|39988666|FG001|Overall Study|Lost to Follow-up|10|||
16411562|NCT01610596|39988667|FG000|Overall Study|Lost to Follow-up|0|||
16411563|NCT01610596|39988668|FG001|Overall Study|Lost to Follow-up|1|||
16411564|NCT01066780|39988672|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
16411565|NCT01066780|39988673|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
16411566|NCT00162266|39988674|FG000|Double-Blind Period|Adverse Event|5|||
16411567|NCT00162266|39988675|FG001|Double-Blind Period|Adverse Event|9|||
16411568|NCT00162266|39988676|FG002|Double-Blind Period|Adverse Event|11|||
16411569|NCT00162266|39988677|FG003|Double-Blind Period|Adverse Event|0|||
16411570|NCT00162266|39988674|FG000|Double-Blind Period|Death|0|||
16411571|NCT00162266|39988675|FG001|Double-Blind Period|Death|1|||
16411572|NCT00162266|39988676|FG002|Double-Blind Period|Death|0|||
16411573|NCT00162266|39988677|FG003|Double-Blind Period|Death|0|||
16411574|NCT00162266|39988674|FG000|Double-Blind Period|Lost to Follow-up|1|||
16411575|NCT00162266|39988675|FG001|Double-Blind Period|Lost to Follow-up|2|||
16411576|NCT00162266|39988676|FG002|Double-Blind Period|Lost to Follow-up|0|||
16411577|NCT00162266|39988677|FG003|Double-Blind Period|Lost to Follow-up|0|||
16411578|NCT00162266|39988674|FG000|Double-Blind Period|Other Reason|1|||
16411579|NCT00162266|39988675|FG001|Double-Blind Period|Other Reason|0|||
16411580|NCT00162266|39988676|FG002|Double-Blind Period|Other Reason|1|||
16411581|NCT00162266|39988677|FG003|Double-Blind Period|Other Reason|0|||
16411582|NCT00162266|39988674|FG000|Double-Blind Period|Lack of Efficacy|13|||
16411583|NCT00162266|39988675|FG001|Double-Blind Period|Lack of Efficacy|17|||
16116511|NCT00504075|38912377|FG000|Overall Study|Lost to Follow-up|5|||
16411584|NCT00162266|39988676|FG002|Double-Blind Period|Lack of Efficacy|30|||
16411585|NCT00162266|39988677|FG003|Double-Blind Period|Lack of Efficacy|0|||
16411586|NCT00162266|39988674|FG000|Double-Blind Period|Withdrawal by Subject|5|||
16411587|NCT00162266|39988675|FG001|Double-Blind Period|Withdrawal by Subject|2|||
16411588|NCT00162266|39988676|FG002|Double-Blind Period|Withdrawal by Subject|6|||
16411589|NCT00162266|39988677|FG003|Double-Blind Period|Withdrawal by Subject|0|||
16411590|NCT00162266|39988674|FG000|Open-Label Period|Death|0|||
16411591|NCT00162266|39988675|FG001|Open-Label Period|Death|0|||
16411592|NCT00162266|39988676|FG002|Open-Label Period|Death|0|||
16411593|NCT00162266|39988677|FG003|Open-Label Period|Death|7|||
16411594|NCT00162266|39988674|FG000|Open-Label Period|Adverse Event|0|||
16411595|NCT00162266|39988675|FG001|Open-Label Period|Adverse Event|0|||
16411596|NCT00162266|39988676|FG002|Open-Label Period|Adverse Event|0|||
16411597|NCT00162266|39988677|FG003|Open-Label Period|Adverse Event|46|||
16411598|NCT00162266|39988674|FG000|Open-Label Period|Lack of Efficacy|0|||
16411599|NCT00162266|39988675|FG001|Open-Label Period|Lack of Efficacy|0|||
16411600|NCT00162266|39988676|FG002|Open-Label Period|Lack of Efficacy|0|||
16411601|NCT00162266|39988677|FG003|Open-Label Period|Lack of Efficacy|26|||
16227487|NCT01200758|39313459|FG000|Stage I|Physician Decision|1|||
16411602|NCT00162266|39988674|FG000|Open-Label Period|Lost to Follow-up|0|||
16411603|NCT00162266|39988675|FG001|Open-Label Period|Lost to Follow-up|0|||
16411604|NCT00162266|39988676|FG002|Open-Label Period|Lost to Follow-up|0|||
16411605|NCT00162266|39988677|FG003|Open-Label Period|Lost to Follow-up|3|||
16411606|NCT00162266|39988674|FG000|Open-Label Period|Withdrawal by Subject|0|||
16411607|NCT00162266|39988675|FG001|Open-Label Period|Withdrawal by Subject|0|||
16411608|NCT00162266|39988676|FG002|Open-Label Period|Withdrawal by Subject|0|||
16411609|NCT00162266|39988677|FG003|Open-Label Period|Withdrawal by Subject|31|||
16411610|NCT00162266|39988674|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
16411611|NCT00162266|39988675|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
16411612|NCT00162266|39988676|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
16411613|NCT00162266|39988677|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
16548773|NCT00265330|40471077|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
16548774|NCT00265330|40471077|FG000|Overall Study|Site Closed by Sponsor|1|||
16548775|NCT00265330|40471077|FG000|Overall Study|Principal Investigators Request|1|||
16548776|NCT00265330|40471077|FG000|Overall Study|Withdrew Consent|1|||
16548777|NCT00265330|40471077|FG000|Overall Study|Protocol Violation|1|||
16548778|NCT00100932|40471080|FG000|Overall Study|Adverse Event|11|||
16548779|NCT00100932|40471081|FG001|Overall Study|Adverse Event|2|||
16548780|NCT00100932|40471080|FG000|Overall Study|Withdrawal by Subject|6|||
16116512|NCT00504075|38912377|FG000|Overall Study|Withdrawal by Subject|1|||
16116513|NCT00504075|38912377|FG000|Overall Study|Required other therapeutic intervention|1|||
16116514|NCT04129580|38912378|FG000|Overall Study|Lost to Follow-up|14|||
16116515|NCT04129580|38912379|FG001|Overall Study|Lost to Follow-up|25|||
16548781|NCT00100932|40471081|FG001|Overall Study|Withdrawal by Subject|0|||
16548782|NCT00100932|40471080|FG000|Overall Study|Progressive Disease|44|||
16548783|NCT00100932|40471081|FG001|Overall Study|Progressive Disease|18|||
16411614|NCT00162266|39988674|FG000|Open-Label Period|Other Reasons|0|||
16411615|NCT00162266|39988675|FG001|Open-Label Period|Other Reasons|0|||
16411616|NCT00162266|39988676|FG002|Open-Label Period|Other Reasons|0|||
16411617|NCT00162266|39988677|FG003|Open-Label Period|Other Reasons|15|||
16411618|NCT04384107|39988679|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
16548784|NCT00100932|40471080|FG000|Overall Study|Physician Decision|7|||
16548785|NCT00100932|40471081|FG001|Overall Study|Physician Decision|5|||
16548786|NCT00100932|40471080|FG000|Overall Study|Other|5|||
16548787|NCT00100932|40471081|FG001|Overall Study|Other|2|||
16548788|NCT00874432|40471082|FG000|Overall Study|Withdrawal by Subject|1|||
16548789|NCT00874432|40471083|FG001|Overall Study|Withdrawal by Subject|0|||
16548790|NCT00874432|40471084|FG002|Overall Study|Withdrawal by Subject|0|||
16548791|NCT00874432|40471085|FG003|Overall Study|Withdrawal by Subject|0|||
16116516|NCT03017742|38912380|FG000|Overall Study|Protocol Violation|36|||
16116517|NCT03017742|38912380|FG000|Overall Study|Withdrawal by Subject|37|||
16116518|NCT02088957|38912381|FG000|Overall Study|Lack of Efficacy|1|||
16116519|NCT02088957|38912382|FG001|Overall Study|Lack of Efficacy|0|||
16116520|NCT01747551|38912386|FG000|Overall Study|Progressive Disease|24|||
16116521|NCT01747551|38912387|FG001|Overall Study|Progressive Disease|17|||
16116522|NCT01747551|38912386|FG000|Overall Study|Death|3|||
16116523|NCT01747551|38912387|FG001|Overall Study|Death|1|||
16116524|NCT01747551|38912386|FG000|Overall Study|Adverse Event|7|||
16116525|NCT01747551|38912387|FG001|Overall Study|Adverse Event|1|||
16116526|NCT01747551|38912386|FG000|Overall Study|Prolonged Treatment Delay|2|||
16116527|NCT01747551|38912387|FG001|Overall Study|Prolonged Treatment Delay|0|||
16116528|NCT01747551|38912386|FG000|Overall Study|Withdrawal by Subject|3|||
16116529|NCT01747551|38912387|FG001|Overall Study|Withdrawal by Subject|1|||
16116530|NCT01747551|38912386|FG000|Overall Study|Physician Decision|2|||
16116531|NCT01747551|38912387|FG001|Overall Study|Physician Decision|1|||
16116532|NCT01747551|38912386|FG000|Overall Study|Other|2|||
16116533|NCT01747551|38912387|FG001|Overall Study|Other|0|||
16116534|NCT01509547|38912390|FG000|Overall Study|Lost to Follow-up|24|||
16116535|NCT01509547|38912391|FG001|Overall Study|Lost to Follow-up|14|||
16116536|NCT01509547|38912390|FG000|Overall Study|Withdrawal by Subject|11|||
16116537|NCT01509547|38912391|FG001|Overall Study|Withdrawal by Subject|24|||
16116538|NCT01509547|38912390|FG000|Overall Study|Physician Decision|0|||
16116539|NCT01509547|38912391|FG001|Overall Study|Physician Decision|1|||
16116540|NCT03631407|38912396|FG000|Overall Study|Withdrawal by Subject|3|||
16116541|NCT03631407|38912397|FG001|Overall Study|Withdrawal by Subject|2|||
16116542|NCT03631407|38912396|FG000|Overall Study|Sponsor Decision|0|||
16116543|NCT03631407|38912397|FG001|Overall Study|Sponsor Decision|2|||
16116544|NCT03631407|38912396|FG000|Overall Study|Death|16|||
16411619|NCT04384107|39988680|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
16411620|NCT04384107|39988679|FG000|Overall Study|Lost to Follow-up|1|||
16548792|NCT00874432|40471082|FG000|Overall Study|Physician Decision|1|||
16116545|NCT03631407|38912397|FG001|Overall Study|Death|16|||
16116546|NCT03631407|38912396|FG000|Overall Study|Randomized by mistake without study treatment|1|||
16411621|NCT04384107|39988680|FG001|Overall Study|Lost to Follow-up|0|||
16411622|NCT02616393|39988681|FG000|Overall Study|Death|5|||
16548793|NCT00874432|40471083|FG001|Overall Study|Physician Decision|0|||
16548794|NCT00874432|40471084|FG002|Overall Study|Physician Decision|0|||
16227488|NCT01200758|39313460|FG001|Stage I|Physician Decision|1|||
16116547|NCT03631407|38912397|FG001|Overall Study|Randomized by mistake without study treatment|0|||
16116548|NCT00731133|38912398|FG000|Overall Study|Withdrawal by Subject|10|||
16116549|NCT01371825|38912403|FG000|Overall Study|Death|4|||
16116550|NCT04147858|38912409|FG000|Overall Study|Adverse Event|6|||
16116551|NCT04147858|38912410|FG001|Overall Study|Adverse Event|6|||
16116552|NCT04147858|38912411|FG002|Overall Study|Adverse Event|6|||
16116553|NCT04147858|38912409|FG000|Overall Study|Lack of Efficacy|3|||
16116554|NCT04147858|38912410|FG001|Overall Study|Lack of Efficacy|3|||
16116555|NCT04147858|38912411|FG002|Overall Study|Lack of Efficacy|1|||
16116556|NCT04147858|38912409|FG000|Overall Study|Lost to Follow-up|1|||
16116557|NCT04147858|38912410|FG001|Overall Study|Lost to Follow-up|6|||
16116558|NCT04147858|38912411|FG002|Overall Study|Lost to Follow-up|2|||
16116559|NCT04147858|38912409|FG000|Overall Study|Withdrawal by Subject|3|||
16116560|NCT04147858|38912410|FG001|Overall Study|Withdrawal by Subject|4|||
16116561|NCT04147858|38912411|FG002|Overall Study|Withdrawal by Subject|10|||
16116562|NCT04147858|38912409|FG000|Overall Study|Subject Noncompliance, Other|4|||
16116563|NCT04147858|38912410|FG001|Overall Study|Subject Noncompliance, Other|3|||
16116564|NCT04147858|38912411|FG002|Overall Study|Subject Noncompliance, Other|1|||
16116565|NCT01843777|38912422|FG000|Overall Study|Withdrawal by Subject|1|||
16116566|NCT01843777|38912423|FG001|Overall Study|Withdrawal by Subject|0|||
16116567|NCT01896557|38912424|FG000|Clopidogrel Alone|Adverse Event|1|||
16116568|NCT01896557|38912425|FG001|Clopidogrel Alone|Adverse Event|0|||
16116569|NCT01896557|38912424|FG000|Clopidogrel + GI Protector|low adherence|1|||
16116570|NCT01896557|38912425|FG001|Clopidogrel + GI Protector|low adherence|1|||
16116571|NCT01896557|38912424|FG000|Clopidogrel + GI Protector|Reading error|1|||
16116572|NCT01896557|38912425|FG001|Clopidogrel + GI Protector|Reading error|3|||
16116573|NCT02125279|38912427|FG000|Overall Study|Lack of Efficacy|2|||
16116574|NCT02125279|38912427|FG000|Overall Study|Withdrawal by Subject|6|||
16116575|NCT02125279|38912427|FG000|Overall Study|Protocol Violation|1|||
16116576|NCT02125279|38912427|FG000|Overall Study|Lost to Follow-up|4|||
16116577|NCT00335140|38912431|FG000|Overall Study|Ineligible|1|||
16116578|NCT01850030|38912432|FG000|Overall Study|Adverse Event|64|||
16116579|NCT01850030|38912433|FG001|Overall Study|Adverse Event|82|||
16116580|NCT01850030|38912432|FG000|Overall Study|Lack of Efficacy|3|||
16116581|NCT01850030|38912433|FG001|Overall Study|Lack of Efficacy|1|||
16116582|NCT01850030|38912432|FG000|Overall Study|Lost to Follow-up|5|||
16116583|NCT01850030|38912433|FG001|Overall Study|Lost to Follow-up|5|||
16116584|NCT01850030|38912432|FG000|Overall Study|Withdrawal by Subject|3|||
16116585|NCT01850030|38912433|FG001|Overall Study|Withdrawal by Subject|4|||
16116586|NCT01850030|38912432|FG000|Overall Study|Protocol Violation|24|||
16116587|NCT01850030|38912433|FG001|Overall Study|Protocol Violation|28|||
16116588|NCT01850030|38912432|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
16116589|NCT01850030|38912433|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
16116590|NCT02975102|38912437|FG000|Overall Study|Adverse Event|2|||
16116591|NCT02975102|38912438|FG001|Overall Study|Adverse Event|1|||
16116592|NCT02370251|38912441|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
16116593|NCT02370251|38912441|FG000|Overall Study|Death|4|||
16116594|NCT00862836|38912442|FG000|Overall Study|Withdrawal by Subject|1|||
16116595|NCT00487825|38912443|FG000|Overall Study|Adverse Event|2|||
16116596|NCT00487825|38912444|FG001|Overall Study|Adverse Event|2|||
16116597|NCT00487825|38912443|FG000|Overall Study|Lack of Efficacy|1|||
16116598|NCT00487825|38912444|FG001|Overall Study|Lack of Efficacy|1|||
16116599|NCT00487825|38912443|FG000|Overall Study|Other|3|||
16116600|NCT00487825|38912444|FG001|Overall Study|Other|2|||
16116601|NCT01661205|38912449|FG000|Overall Study|Physician Decision|2|||
16116602|NCT02838134|38912453|FG000|Overall Study|Lost to Follow-up|1|||
16116603|NCT02838134|38912454|FG001|Overall Study|Lost to Follow-up|2|||
16116604|NCT02838134|38912453|FG000|Overall Study|logistic problems|1|||
16227489|NCT01200758|39313461|FG002|Stage I|Physician Decision|0|||
16227490|NCT01200758|39313462|FG003|Stage I|Physician Decision|0|||
16227491|NCT01200758|39313459|FG000|Stage I|Lack of Efficacy|2|||
16227492|NCT01200758|39313460|FG001|Stage I|Lack of Efficacy|1|||
16227493|NCT01200758|39313461|FG002|Stage I|Lack of Efficacy|0|||
16227494|NCT01200758|39313462|FG003|Stage I|Lack of Efficacy|0|||
16116605|NCT02838134|38912454|FG001|Overall Study|logistic problems|1|||
16116606|NCT03445533|38912459|FG000|Overall Study|Progressive Disease|48|||
16116607|NCT03445533|38912460|FG001|Overall Study|Progressive Disease|81|||
16116608|NCT03445533|38912459|FG000|Overall Study|Adverse Event|60|||
16116609|NCT03445533|38912460|FG001|Overall Study|Adverse Event|64|||
16116610|NCT03445533|38912459|FG000|Overall Study|Death|9|||
16116611|NCT03445533|38912460|FG001|Overall Study|Death|19|||
16116612|NCT03445533|38912459|FG000|Overall Study|Miscellaneous|0|||
16116613|NCT03445533|38912460|FG001|Overall Study|Miscellaneous|16|||
16116614|NCT03445533|38912459|FG000|Overall Study|Withdrawal by Subject|3|||
16116615|NCT03445533|38912460|FG001|Overall Study|Withdrawal by Subject|4|||
16116616|NCT03445533|38912459|FG000|Overall Study|Physician Decision|1|||
16116617|NCT03445533|38912460|FG001|Overall Study|Physician Decision|3|||
16116618|NCT03445533|38912459|FG000|Overall Study|Sponsor Decision|0|||
16227495|NCT01200758|39313459|FG000|Stage I|Adverse Event|5|||
16116619|NCT03445533|38912460|FG001|Overall Study|Sponsor Decision|1|||
16548795|NCT00874432|40471085|FG003|Overall Study|Physician Decision|0|||
16548796|NCT00874432|40471082|FG000|Overall Study|Other|1|||
16548797|NCT00874432|40471083|FG001|Overall Study|Other|2|||
16116620|NCT03445533|38912459|FG000|Overall Study|Lost to Follow-up|0|||
16116621|NCT03445533|38912460|FG001|Overall Study|Lost to Follow-up|1|||
16116622|NCT03445533|38912459|FG000|Overall Study|Never Received any Study Treatment|7|||
16116623|NCT03445533|38912460|FG001|Overall Study|Never Received any Study Treatment|4|||
16116624|NCT04978090|38912461|FG000|Overall Study|unable to adequately fit device|2|||
16116625|NCT01358331|38912462|FG000|Overall Study|Lost to Follow-up|0|||
16116626|NCT01358331|38912463|FG001|Overall Study|Lost to Follow-up|0|||
16116627|NCT01358331|38912464|FG002|Overall Study|Lost to Follow-up|0|||
16116628|NCT01358331|38912465|FG003|Overall Study|Lost to Follow-up|1|||
16116629|NCT01358331|38912466|FG004|Overall Study|Lost to Follow-up|0|||
16116630|NCT01358331|38912467|FG005|Overall Study|Lost to Follow-up|0|||
16116631|NCT01358331|38912462|FG000|Overall Study|Withdrawal by Subject|0|||
16116632|NCT01358331|38912463|FG001|Overall Study|Withdrawal by Subject|0|||
16116633|NCT01358331|38912464|FG002|Overall Study|Withdrawal by Subject|0|||
16116634|NCT01358331|38912465|FG003|Overall Study|Withdrawal by Subject|1|||
16116635|NCT01358331|38912466|FG004|Overall Study|Withdrawal by Subject|1|||
16116636|NCT01358331|38912467|FG005|Overall Study|Withdrawal by Subject|1|||
16116637|NCT01358331|38912462|FG000|Overall Study|Adverse Events|1|||
16116638|NCT01358331|38912463|FG001|Overall Study|Adverse Events|1|||
16116639|NCT01358331|38912464|FG002|Overall Study|Adverse Events|1|||
16116640|NCT01358331|38912465|FG003|Overall Study|Adverse Events|0|||
16116641|NCT01358331|38912466|FG004|Overall Study|Adverse Events|1|||
16116642|NCT01358331|38912467|FG005|Overall Study|Adverse Events|5|||
16116643|NCT01358331|38912462|FG000|Overall Study|Symptomatic Deterioration|0|||
16116644|NCT01358331|38912463|FG001|Overall Study|Symptomatic Deterioration|0|||
16116645|NCT01358331|38912464|FG002|Overall Study|Symptomatic Deterioration|0|||
16116646|NCT01358331|38912465|FG003|Overall Study|Symptomatic Deterioration|0|||
16116647|NCT01358331|38912466|FG004|Overall Study|Symptomatic Deterioration|1|||
16116648|NCT01358331|38912467|FG005|Overall Study|Symptomatic Deterioration|0|||
16116649|NCT01358331|38912462|FG000|Overall Study|Participants did not wish to continue|0|||
16116650|NCT01358331|38912463|FG001|Overall Study|Participants did not wish to continue|0|||
16116651|NCT01358331|38912464|FG002|Overall Study|Participants did not wish to continue|0|||
16116652|NCT01358331|38912465|FG003|Overall Study|Participants did not wish to continue|0|||
16116653|NCT01358331|38912466|FG004|Overall Study|Participants did not wish to continue|1|||
16116654|NCT01358331|38912467|FG005|Overall Study|Participants did not wish to continue|0|||
16116655|NCT01358331|38912462|FG000|Overall Study|Progress of disease under investigation|1|||
16116656|NCT01358331|38912463|FG001|Overall Study|Progress of disease under investigation|2|||
16116657|NCT01358331|38912464|FG002|Overall Study|Progress of disease under investigation|3|||
16116658|NCT01358331|38912465|FG003|Overall Study|Progress of disease under investigation|1|||
16116659|NCT01358331|38912466|FG004|Overall Study|Progress of disease under investigation|3|||
16116660|NCT01358331|38912467|FG005|Overall Study|Progress of disease under investigation|0|||
16116661|NCT01001390|38912475|FG000|Overall Study|Failure to wear AFO device|2|||
16116662|NCT01001390|38912476|FG001|Overall Study|Failure to wear AFO device|0|||
16116663|NCT01131104|38912477|FG000|Overall Study|Withdrawal by Subject|3|||
16116664|NCT01131104|38912477|FG000|Overall Study|Physician Decision|4|||
16116665|NCT01131104|38912477|FG000|Overall Study|Information Not Available|5|||
16116666|NCT01131104|38912477|FG000|Overall Study|No Information on Index Date of Onset|1|||
16116667|NCT03926195|38912479|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
16116668|NCT03926195|38912480|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
16116669|NCT03926195|38912479|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
16116670|NCT03926195|38912480|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
16116671|NCT03926195|38912479|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
16116672|NCT03926195|38912480|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
16116673|NCT03926195|38912479|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
16116674|NCT03926195|38912480|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
16116675|NCT03926195|38912479|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
16116676|NCT03926195|38912480|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
16116677|NCT03926195|38912479|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
16116678|NCT03926195|38912480|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
16116679|NCT03838731|38912481|FG000|Overall Study|Pregnancy|0|||
16116680|NCT03838731|38912482|FG001|Overall Study|Pregnancy|1|||
16116681|NCT03838731|38912481|FG000|Overall Study|Withdrawal of consent|1|||
16116682|NCT03838731|38912482|FG001|Overall Study|Withdrawal of consent|0|||
16116683|NCT02833077|38912483|FG000|Overall Study|Adverse Event|1|||
16116684|NCT02833077|38912484|FG001|Overall Study|Adverse Event|2|||
16116685|NCT02833077|38912483|FG000|Overall Study|Lost to Follow-up|10|||
16116686|NCT02833077|38912484|FG001|Overall Study|Lost to Follow-up|1|||
16548798|NCT00874432|40471084|FG002|Overall Study|Other|8|||
16116687|NCT02833077|38912483|FG000|Overall Study|Personal Reasons|6|||
16548799|NCT00874432|40471085|FG003|Overall Study|Other|3|||
16227496|NCT01200758|39313460|FG001|Stage I|Adverse Event|5|||
16227497|NCT01200758|39313461|FG002|Stage I|Adverse Event|0|||
16227498|NCT01200758|39313462|FG003|Stage I|Adverse Event|0|||
16227499|NCT01200758|39313459|FG000|Stage I|Withdrawal by Subject|1|||
16227500|NCT01200758|39313460|FG001|Stage I|Withdrawal by Subject|2|||
16227501|NCT01200758|39313461|FG002|Stage I|Withdrawal by Subject|0|||
16227502|NCT01200758|39313462|FG003|Stage I|Withdrawal by Subject|0|||
16227503|NCT01200758|39313459|FG000|Stage I|Disease Progression|9|||
16227504|NCT01200758|39313460|FG001|Stage I|Disease Progression|7|||
16227505|NCT01200758|39313461|FG002|Stage I|Disease Progression|0|||
16227506|NCT01200758|39313462|FG003|Stage I|Disease Progression|0|||
16227507|NCT01200758|39313459|FG000|Stage 2|Disease Progression|0|||
16227508|NCT01200758|39313460|FG001|Stage 2|Disease Progression|0|||
16227509|NCT01200758|39313461|FG002|Stage 2|Disease Progression|16|||
16227510|NCT01200758|39313462|FG003|Stage 2|Disease Progression|21|||
16227511|NCT01200758|39313459|FG000|Stage 2|Lack of Efficacy|0|||
16227512|NCT01200758|39313460|FG001|Stage 2|Lack of Efficacy|0|||
16227513|NCT01200758|39313461|FG002|Stage 2|Lack of Efficacy|4|||
16227514|NCT01200758|39313462|FG003|Stage 2|Lack of Efficacy|2|||
16227515|NCT01200758|39313459|FG000|Stage 2|Physician Decision|0|||
16227516|NCT01200758|39313460|FG001|Stage 2|Physician Decision|0|||
16227517|NCT01200758|39313461|FG002|Stage 2|Physician Decision|5|||
16227518|NCT01200758|39313462|FG003|Stage 2|Physician Decision|7|||
16227519|NCT01200758|39313459|FG000|Stage 2|Adverse Event|0|||
16227520|NCT01200758|39313460|FG001|Stage 2|Adverse Event|0|||
16227521|NCT01200758|39313461|FG002|Stage 2|Adverse Event|5|||
16227522|NCT01200758|39313462|FG003|Stage 2|Adverse Event|9|||
16227523|NCT01200758|39313459|FG000|Stage 2|Withdrawal by Subject|0|||
16227524|NCT01200758|39313460|FG001|Stage 2|Withdrawal by Subject|0|||
16227525|NCT01200758|39313461|FG002|Stage 2|Withdrawal by Subject|4|||
16227526|NCT01200758|39313462|FG003|Stage 2|Withdrawal by Subject|1|||
16227527|NCT01200758|39313459|FG000|Stage 2|Lost to Follow-up|0|||
16227528|NCT01200758|39313460|FG001|Stage 2|Lost to Follow-up|0|||
16227529|NCT01200758|39313461|FG002|Stage 2|Lost to Follow-up|3|||
16227530|NCT01200758|39313462|FG003|Stage 2|Lost to Follow-up|1|||
16227531|NCT01200758|39313459|FG000|Stage 2|Protocol Violation|0|||
16227532|NCT01200758|39313460|FG001|Stage 2|Protocol Violation|0|||
16227533|NCT01200758|39313461|FG002|Stage 2|Protocol Violation|1|||
16227534|NCT01200758|39313462|FG003|Stage 2|Protocol Violation|4|||
16227535|NCT01200758|39313459|FG000|Stage 2|Death|0|||
16227536|NCT01200758|39313460|FG001|Stage 2|Death|0|||
16227537|NCT01200758|39313461|FG002|Stage 2|Death|3|||
16227538|NCT01200758|39313462|FG003|Stage 2|Death|5|||
16227539|NCT01640353|39313463|FG000|Overall Study|Withdrew prior to treatment|10|||
16227540|NCT01640353|39313463|FG000|Overall Study|Withdrawn from analysis at term site|12|||
16227541|NCT01640353|39313463|FG000|Overall Study|Withdrawal by Subject|5|||
16227542|NCT01640353|39313463|FG000|Overall Study|Death|2|||
16227543|NCT01640353|39313463|FG000|Overall Study|Early site termination|3|||
16227544|NCT01640353|39313463|FG000|Overall Study|Lost to Follow-up|12|||
16227545|NCT01640353|39313463|FG000|Overall Study|Physician Decision|1|||
16227546|NCT00579059|39313464|FG000|Overall Study|Study Canceled at 1 Year|21|||
16227547|NCT00579059|39313465|FG001|Overall Study|Study Canceled at 1 Year|10|||
16227548|NCT02756182|39313466|FG000|Overall Study|StudyTechnical Difficulties|4|||
16227549|NCT02452892|39313467|FG000|Week 1 Initial Randommization|Adverse Event|1|||
16227550|NCT02452892|39313468|FG001|Week 1 Initial Randommization|Adverse Event|0|||
16227551|NCT02452892|39313469|FG002|Week 1 Initial Randommization|Adverse Event|0|||
16227552|NCT02452892|39313470|FG003|Week 1 Initial Randommization|Adverse Event|0|||
16227553|NCT02452892|39313467|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
16227554|NCT02452892|39313468|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
16227555|NCT02452892|39313469|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
16227556|NCT02452892|39313470|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
16227557|NCT02452892|39313467|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
16227558|NCT02452892|39313468|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
16227559|NCT02452892|39313469|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
16227560|NCT02452892|39313470|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
16227561|NCT02452892|39313467|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
16227562|NCT02452892|39313468|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
16347551|NCT01302418|39761941|FG000|Overall Study|Non-evaluable|9|||
16347552|NCT01738919|39761942|FG000|Overall Study|Lost to Follow-up|1|||
16347553|NCT01738919|39761943|FG001|Overall Study|Lost to Follow-up|0|||
16347554|NCT01738919|39761942|FG000|Overall Study|Immigrated|0|||
16347555|NCT01738919|39761943|FG001|Overall Study|Immigrated|1|||
16347556|NCT01738919|39761942|FG000|Overall Study|Withdrawal by Subject|0|||
16347557|NCT01738919|39761943|FG001|Overall Study|Withdrawal by Subject|1|||
16347558|NCT01738919|39761942|FG000|Overall Study|Not treated in accordance to guidelines|0|||
16347559|NCT01738919|39761943|FG001|Overall Study|Not treated in accordance to guidelines|1|||
16347560|NCT01465230|39761944|FG000|Overall Study|Withdrawal by Subject|2|||
16347561|NCT02948829|39761946|FG000|Overall Study|Lost to Follow-up|2|||
16227563|NCT02452892|39313469|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
16227564|NCT02452892|39313470|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
16227565|NCT02452892|39313467|FG000|Follow-up|Withdrawal by Subject|0|||
16227566|NCT02452892|39313468|FG001|Follow-up|Withdrawal by Subject|0|||
16227567|NCT02452892|39313469|FG002|Follow-up|Withdrawal by Subject|0|||
16227568|NCT02452892|39313470|FG003|Follow-up|Withdrawal by Subject|1|||
16227569|NCT02452892|39313467|FG000|Follow-up|Subject left town on Day 42|1|||
16227570|NCT02452892|39313468|FG001|Follow-up|Subject left town on Day 42|0|||
16227571|NCT02452892|39313469|FG002|Follow-up|Subject left town on Day 42|0|||
16227572|NCT02452892|39313470|FG003|Follow-up|Subject left town on Day 42|0|||
16227573|NCT02331680|39313471|FG000|Overall Study|Adverse Event|3|||
16227574|NCT02331680|39313472|FG001|Overall Study|Adverse Event|0|||
16227575|NCT02331680|39313473|FG002|Overall Study|Adverse Event|2|||
16227576|NCT02331680|39313471|FG000|Overall Study|Physician Decision|1|||
16227577|NCT02331680|39313472|FG001|Overall Study|Physician Decision|1|||
16227578|NCT02331680|39313473|FG002|Overall Study|Physician Decision|2|||
16227579|NCT02331680|39313471|FG000|Overall Study|Withdrawal by Subject|0|||
16227580|NCT02331680|39313472|FG001|Overall Study|Withdrawal by Subject|1|||
16227581|NCT02331680|39313473|FG002|Overall Study|Withdrawal by Subject|2|||
16227582|NCT02331680|39313471|FG000|Overall Study|Met withdrawal criteria|2|||
16227583|NCT02331680|39313472|FG001|Overall Study|Met withdrawal criteria|2|||
16227584|NCT02331680|39313473|FG002|Overall Study|Met withdrawal criteria|5|||
16227585|NCT02331680|39313471|FG000|Overall Study|Non-compliance with study drug|0|||
16227586|NCT02331680|39313472|FG001|Overall Study|Non-compliance with study drug|0|||
16227587|NCT02331680|39313473|FG002|Overall Study|Non-compliance with study drug|1|||
16227588|NCT02331680|39313471|FG000|Overall Study|Protocol Violation|0|||
16227589|NCT02331680|39313472|FG001|Overall Study|Protocol Violation|0|||
16227590|NCT02331680|39313473|FG002|Overall Study|Protocol Violation|3|||
16227591|NCT01308476|39313474|FG000|Overall Study|Lost to Follow-up|2|||
16227592|NCT01308476|39313475|FG001|Overall Study|Lost to Follow-up|2|||
16227593|NCT01308476|39313474|FG000|Overall Study|Other|1|||
16227594|NCT01308476|39313475|FG001|Overall Study|Other|0|||
16227595|NCT01020812|39313476|FG000|Overall Study|Physician Decision|1|||
16227596|NCT01020812|39313476|FG000|Overall Study|Withdrawal by Subject|1|||
16227597|NCT01020812|39313476|FG000|Overall Study|Protocol Violation|1|||
16227598|NCT02569996|39313478|FG000|Overall Study|Adverse Event|6|||
16227599|NCT02569996|39313478|FG000|Overall Study|Physician Decision|3|||
16227600|NCT02569996|39313478|FG000|Overall Study|Progression of the disease|18|||
16227601|NCT02569996|39313478|FG000|Overall Study|New anti-lymphoma treatment|1|||
16227602|NCT02569996|39313478|FG000|Overall Study|Non-compliance|9|||
16227603|NCT02569996|39313478|FG000|Overall Study|Withdrawal by Subject|5|||
16227604|NCT02569996|39313478|FG000|Overall Study|Lost to Follow-up|5|||
16227605|NCT02569996|39313478|FG000|Overall Study|Complete remission|7|||
16227606|NCT02569996|39313478|FG000|Overall Study|Unknown reason|1|||
16227607|NCT04524663|39313479|FG000|Overall Study|Withdrawal by Subject|0|||
16227608|NCT04524663|39313480|FG001|Overall Study|Withdrawal by Subject|2|||
16227609|NCT01876901|39313483|FG000|Overall Study|Protocol Violation|10|||
16227610|NCT01876901|39313484|FG001|Overall Study|Protocol Violation|2|||
16227611|NCT01876901|39313483|FG000|Overall Study|No or other surgical intervention|7|||
16227612|NCT01876901|39313484|FG001|Overall Study|No or other surgical intervention|5|||
16227613|NCT04563845|39313485|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227614|NCT04563845|39313486|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227615|NCT04563845|39313487|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227616|NCT04563845|39313488|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227617|NCT04563845|39313489|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227618|NCT04563845|39313490|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227619|NCT04563845|39313491|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227620|NCT04563845|39313492|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
16227621|NCT04563845|39313493|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227622|NCT04563845|39313494|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227623|NCT04563845|39313495|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227624|NCT04563845|39313496|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16548800|NCT01616771|40471086|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
16548801|NCT00909480|40471087|FG000|Overall Study|Adverse Event|5|||
16227625|NCT04563845|39313497|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227626|NCT04563845|39313498|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
16227627|NCT04563845|39313485|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227628|NCT04563845|39313486|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227629|NCT04563845|39313487|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227630|NCT04563845|39313488|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227631|NCT04563845|39313489|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
16411623|NCT02616393|39988682|FG001|Overall Study|Death|12|||
16411624|NCT02616393|39988683|FG002|Overall Study|Death|1|||
16548802|NCT00909480|40471088|FG001|Overall Study|Adverse Event|3|||
16548803|NCT00909480|40471087|FG000|Overall Study|Protocol Violation|6|||
16548804|NCT00909480|40471088|FG001|Overall Study|Protocol Violation|8|||
16548805|NCT00909480|40471087|FG000|Overall Study|Withdrawal criteria|9|||
16548806|NCT00909480|40471088|FG001|Overall Study|Withdrawal criteria|11|||
16548807|NCT00909480|40471087|FG000|Overall Study|Unclassified|18|||
16548808|NCT00909480|40471088|FG001|Overall Study|Unclassified|19|||
16548809|NCT02213328|40471090|FG000|Overall Study|Withdrawal by Subject|10|||
16548810|NCT02213328|40471090|FG000|Overall Study|Physician Decision|2|||
16116688|NCT02833077|38912484|FG001|Overall Study|Personal Reasons|4|||
16116689|NCT02833077|38912483|FG000|Overall Study|Protocol Deviation|0|||
16116690|NCT02833077|38912484|FG001|Overall Study|Protocol Deviation|1|||
16116691|NCT02636608|38912487|FG000|Overall Study|Failure to Return|4|||
16116692|NCT02636608|38912487|FG000|Overall Study|Insufficient Virological Response|1|||
16116693|NCT02636608|38912487|FG000|Overall Study|Death|3|||
16116694|NCT02636608|38912487|FG000|Overall Study|Other|2|||
16116695|NCT02636608|38912487|FG000|Overall Study|Did Not Receive Treatment|1|||
16116696|NCT00943852|38912491|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16173207|NCT04672083|39111125|FG003|Overall Study|Lost to Follow-up|0|||
16173208|NCT04672083|39111126|FG004|Overall Study|Lost to Follow-up|0|||
16173209|NCT00712348|39111127|FG000|Overall Study|Withdrawal by Subject|1|||
16173210|NCT01511445|39111128|FG000|Overall Study|Lost to Follow-up|3|||
16173211|NCT01511445|39111129|FG001|Overall Study|Lost to Follow-up|1|||
16173212|NCT01511445|39111128|FG000|Overall Study|Protocol Violation|1|||
16173213|NCT01511445|39111129|FG001|Overall Study|Protocol Violation|3|||
16173214|NCT01511445|39111128|FG000|Overall Study|Protocol Violation|1|||
16173215|NCT01511445|39111129|FG001|Overall Study|Protocol Violation|0|||
16173216|NCT02928952|39111135|FG000|Overall Study|Lost to Follow-up|5|||
16173217|NCT02928952|39111136|FG001|Overall Study|Lost to Follow-up|5|||
16173218|NCT02928952|39111135|FG000|Overall Study|Withdrawal by Subject|5|||
16173219|NCT02928952|39111136|FG001|Overall Study|Withdrawal by Subject|1|||
16173220|NCT02928952|39111135|FG000|Overall Study|Physician Decision|0|||
16173221|NCT02928952|39111136|FG001|Overall Study|Physician Decision|1|||
16173222|NCT01276821|39111137|FG000|Overall Study|Protocol Violation|0|||
16173223|NCT01276821|39111138|FG001|Overall Study|Protocol Violation|1|||
16173224|NCT00943683|39111139|FG000|Overall Study|Adverse Event|3|||
16173225|NCT00943683|39111140|FG001|Overall Study|Adverse Event|3|||
16173226|NCT00943683|39111139|FG000|Overall Study|Lost to Follow-up|1|||
16173227|NCT00943683|39111140|FG001|Overall Study|Lost to Follow-up|1|||
16173228|NCT00943683|39111139|FG000|Overall Study|Protocol Violation|1|||
16173229|NCT00943683|39111140|FG001|Overall Study|Protocol Violation|2|||
16173230|NCT00943683|39111139|FG000|Overall Study|Withdrawal by Subject|1|||
16173231|NCT00943683|39111140|FG001|Overall Study|Withdrawal by Subject|0|||
16173232|NCT00943683|39111139|FG000|Overall Study|Patient Moved|1|||
16173233|NCT00943683|39111140|FG001|Overall Study|Patient Moved|0|||
16173234|NCT03244059|39111150|FG000|Specific Aim 1|Physician Decision|1|||
16173235|NCT03244059|39111151|FG001|Specific Aim 1|Physician Decision|0|||
16173236|NCT03244059|39111150|FG000|Specific Aim 2|Physician Decision|1|||
16173237|NCT03244059|39111151|FG001|Specific Aim 2|Physician Decision|0|||
16173238|NCT00977470|39111153|FG000|Overall Study|Lack of Efficacy|32|||
16173239|NCT00977470|39111154|FG001|Overall Study|Lack of Efficacy|30|||
16173240|NCT00977470|39111153|FG000|Overall Study|Physician Decision|2|||
16173241|NCT00977470|39111154|FG001|Overall Study|Physician Decision|0|||
16173242|NCT00977470|39111153|FG000|Overall Study|Adverse Event|1|||
16227632|NCT04563845|39313490|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227633|NCT04563845|39313491|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227634|NCT04563845|39313492|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227635|NCT04563845|39313493|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16411625|NCT02616393|39988681|FG000|Overall Study|Termination by Sponsor|4|||
16411626|NCT02616393|39988682|FG001|Overall Study|Termination by Sponsor|5|||
16411627|NCT02616393|39988683|FG002|Overall Study|Termination by Sponsor|2|||
16227636|NCT04563845|39313494|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227637|NCT04563845|39313495|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16411628|NCT02616393|39988681|FG000|Overall Study|Other|3|||
16548811|NCT02213328|40471090|FG000|Overall Study|Lost to Follow-up|16|||
16548812|NCT03966053|40474646|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
16548813|NCT00960752|40474647|FG000|Overall Study|Adverse Event|0|||
16548814|NCT00960752|40474648|FG001|Overall Study|Adverse Event|0|||
16548815|NCT00960752|40474649|FG002|Overall Study|Adverse Event|1|||
16548816|NCT00960752|40474647|FG000|Overall Study|Progression|0|||
16548817|NCT00960752|40474648|FG001|Overall Study|Progression|0|||
16548818|NCT00960752|40474649|FG002|Overall Study|Progression|1|||
16548819|NCT03185832|40474650|FG000|Overall Study|Death|9|||
16548820|NCT03185832|40474651|FG001|Overall Study|Death|14|||
16548821|NCT03185832|40474652|FG002|Overall Study|Death|9|||
16548822|NCT03185832|40474653|FG003|Overall Study|Death|7|||
16548823|NCT03185832|40474650|FG000|Overall Study|Withdrawn - vital status available|0|||
16548824|NCT03185832|40474651|FG001|Overall Study|Withdrawn - vital status available|1|||
16548825|NCT03185832|40474652|FG002|Overall Study|Withdrawn - vital status available|1|||
16548826|NCT03185832|40474653|FG003|Overall Study|Withdrawn - vital status available|4|||
16548827|NCT04035200|40474654|FG000|Overall Study|Lost to Follow-up|0|||
16548828|NCT04035200|40474655|FG001|Overall Study|Lost to Follow-up|1|||
16548829|NCT04035200|40474656|FG002|Overall Study|Lost to Follow-up|0|||
16548830|NCT04035200|40474654|FG000|Overall Study|Withdrawal by Subject|1|||
16548831|NCT04035200|40474655|FG001|Overall Study|Withdrawal by Subject|4|||
16548832|NCT04035200|40474656|FG002|Overall Study|Withdrawal by Subject|4|||
16548833|NCT04035200|40474654|FG000|Overall Study|COVID-19|1|||
16548834|NCT04035200|40474655|FG001|Overall Study|COVID-19|0|||
16548835|NCT04035200|40474656|FG002|Overall Study|COVID-19|0|||
16548836|NCT04035200|40474654|FG000|Overall Study|Early Termination|0|||
16548837|NCT04035200|40474655|FG001|Overall Study|Early Termination|1|||
16548838|NCT04035200|40474656|FG002|Overall Study|Early Termination|0|||
16548839|NCT04035200|40474654|FG000|Overall Study|Non-compliance|0|||
16548840|NCT04035200|40474655|FG001|Overall Study|Non-compliance|1|||
16548841|NCT04035200|40474656|FG002|Overall Study|Non-compliance|0|||
16548842|NCT01512745|40474659|FG000|Overall Study|Adverse Event|22|||
16548843|NCT01512745|40474660|FG001|Overall Study|Adverse Event|3|||
16411629|NCT02616393|39988682|FG001|Overall Study|Other|0|||
16548844|NCT01512745|40474659|FG000|Overall Study|Death|9|||
16548845|NCT01512745|40474660|FG001|Overall Study|Death|13|||
16548846|NCT01512745|40474659|FG000|Overall Study|Withdrawal by Subject|2|||
16548847|NCT01512745|40474660|FG001|Overall Study|Withdrawal by Subject|2|||
16548848|NCT01512745|40474659|FG000|Overall Study|Lost to Follow-up|4|||
16548849|NCT01512745|40474660|FG001|Overall Study|Lost to Follow-up|0|||
16548850|NCT01512745|40474659|FG000|Overall Study|Lack of Efficacy|2|||
16548851|NCT01512745|40474660|FG001|Overall Study|Lack of Efficacy|2|||
16548852|NCT01512745|40474659|FG000|Overall Study|Protocol Violation|1|||
16548853|NCT01512745|40474660|FG001|Overall Study|Protocol Violation|0|||
16548854|NCT00482274|40474661|FG000|Overall Study|Adverse Event|1|||
16548855|NCT03528174|40474665|FG000|Overall Study|Adverse Event|1|||
16548856|NCT03528174|40474665|FG000|Overall Study|sensors dislodged|1|||
16548857|NCT03724396|40474666|FG000|Overall Study|Lost to Follow-up|1|||
16548858|NCT03724396|40474667|FG001|Overall Study|Lost to Follow-up|1|||
16548859|NCT03724396|40474666|FG000|Overall Study|Withdrawal by Subject|1|||
16548860|NCT03724396|40474667|FG001|Overall Study|Withdrawal by Subject|0|||
16347562|NCT02948829|39761946|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
16347563|NCT02948829|39761946|FG000|Overall Study|Pregnancy|1|||
16347564|NCT02948829|39761946|FG000|Overall Study|Other: Reason not Specified|8|||
16347565|NCT03732820|39761947|FG000|Overall Study|Death|168|||
16173243|NCT00977470|39111154|FG001|Overall Study|Adverse Event|2|||
16347566|NCT03732820|39761948|FG001|Overall Study|Death|203|||
16347567|NCT03732820|39761947|FG000|Overall Study|Other|2|||
16347568|NCT03732820|39761948|FG001|Overall Study|Other|2|||
16548861|NCT02200939|40474668|FG000|Overall Study|Participant withdrew consent|0|||
16548862|NCT02200939|40474669|FG001|Overall Study|Participant withdrew consent|1|||
16548863|NCT02200939|40474668|FG000|Overall Study|Lost to Follow-up|2|||
16548864|NCT02200939|40474669|FG001|Overall Study|Lost to Follow-up|9|||
16548865|NCT02200939|40474668|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
16548866|NCT02200939|40474669|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
16548867|NCT03008122|40474676|FG000|Overall Study|Physician Decision|3|||
16548868|NCT03008122|40474677|FG001|Overall Study|Physician Decision|2|||
16548869|NCT03008122|40474678|FG002|Overall Study|Physician Decision|0|||
16548870|NCT03008122|40474676|FG000|Overall Study|Withdrawal by Subject|1|||
16548871|NCT03008122|40474677|FG001|Overall Study|Withdrawal by Subject|3|||
16548872|NCT03008122|40474678|FG002|Overall Study|Withdrawal by Subject|0|||
16548873|NCT03008122|40474676|FG000|Overall Study|Lost to Follow-up|4|||
16548874|NCT03008122|40474677|FG001|Overall Study|Lost to Follow-up|8|||
16548875|NCT03008122|40474678|FG002|Overall Study|Lost to Follow-up|3|||
16548876|NCT03008122|40474676|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
16548877|NCT03008122|40474677|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
16548878|NCT03008122|40474678|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
16548879|NCT03008122|40474676|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
16548880|NCT03008122|40474677|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
16548881|NCT03008122|40474678|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
16548882|NCT03008122|40474676|FG000|Overall Study|Death|0|||
16548883|NCT03008122|40474677|FG001|Overall Study|Death|0|||
16548884|NCT03008122|40474678|FG002|Overall Study|Death|1|||
16548885|NCT04707196|40474679|FG000|Overall Study|Withdrawal by Subject|9|||
16548886|NCT04707196|40474680|FG001|Overall Study|Withdrawal by Subject|6|||
16548887|NCT04707196|40474679|FG000|Overall Study|Lost to Follow-up|1|||
16548888|NCT04707196|40474680|FG001|Overall Study|Lost to Follow-up|0|||
16548889|NCT04707196|40474679|FG000|Overall Study|Protocol Violation|4|||
16548890|NCT04707196|40474680|FG001|Overall Study|Protocol Violation|1|||
16227638|NCT04563845|39313496|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227639|NCT04563845|39313497|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227640|NCT04563845|39313498|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
16227641|NCT01016912|39313501|FG000|End of Treatment Period|Lack of Efficacy|0|||
16227642|NCT01016912|39313502|FG001|End of Treatment Period|Lack of Efficacy|1|||
16227643|NCT01016912|39313503|FG002|End of Treatment Period|Lack of Efficacy|0|||
16227644|NCT01016912|39313504|FG003|End of Treatment Period|Lack of Efficacy|4|||
16227645|NCT01016912|39313505|FG004|End of Treatment Period|Lack of Efficacy|4|||
16227646|NCT01016912|39313501|FG000|End of Treatment Period|Adverse Event|0|||
16227647|NCT01016912|39313502|FG001|End of Treatment Period|Adverse Event|1|||
16227648|NCT01016912|39313503|FG002|End of Treatment Period|Adverse Event|1|||
16227649|NCT01016912|39313504|FG003|End of Treatment Period|Adverse Event|0|||
16227650|NCT01016912|39313505|FG004|End of Treatment Period|Adverse Event|0|||
16227651|NCT01016912|39313501|FG000|End of Treatment Period|Completed double-blind period only|0|||
16227652|NCT01016912|39313502|FG001|End of Treatment Period|Completed double-blind period only|1|||
16227653|NCT01016912|39313503|FG002|End of Treatment Period|Completed double-blind period only|0|||
16227654|NCT01016912|39313504|FG003|End of Treatment Period|Completed double-blind period only|0|||
16227655|NCT01016912|39313505|FG004|End of Treatment Period|Completed double-blind period only|0|||
16227656|NCT01016912|39313501|FG000|Follow-up Period|Other reason|0|||
16227657|NCT01016912|39313502|FG001|Follow-up Period|Other reason|0|||
16227658|NCT01016912|39313503|FG002|Follow-up Period|Other reason|1|||
16227659|NCT01016912|39313504|FG003|Follow-up Period|Other reason|1|||
16227660|NCT01016912|39313505|FG004|Follow-up Period|Other reason|0|||
16227661|NCT00934661|39313508|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
16227662|NCT00934661|39313509|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
16227663|NCT04145531|39313512|FG000|Part A|Adverse Event|2|||
16227664|NCT04145531|39313513|FG001|Part A|Adverse Event|12|||
16227665|NCT04145531|39313514|FG002|Part A|Adverse Event|6|||
16227666|NCT04145531|39313515|FG003|Part A|Adverse Event|0|||
16227667|NCT04145531|39313512|FG000|Part A|Death|1|||
16227668|NCT04145531|39313513|FG001|Part A|Death|2|||
16227669|NCT04145531|39313514|FG002|Part A|Death|0|||
16227670|NCT04145531|39313515|FG003|Part A|Death|0|||
16227671|NCT04145531|39313512|FG000|Part A|Physician Decision|2|||
16227672|NCT04145531|39313513|FG001|Part A|Physician Decision|5|||
16227673|NCT04145531|39313514|FG002|Part A|Physician Decision|2|||
16227674|NCT04145531|39313515|FG003|Part A|Physician Decision|0|||
16227675|NCT04145531|39313512|FG000|Part A|Progressive disease|0|||
16227676|NCT04145531|39313513|FG001|Part A|Progressive disease|2|||
16227677|NCT04145531|39313514|FG002|Part A|Progressive disease|1|||
16227678|NCT04145531|39313515|FG003|Part A|Progressive disease|0|||
16227679|NCT04145531|39313512|FG000|Part A|Protocol deviation|0|||
16227680|NCT04145531|39313513|FG001|Part A|Protocol deviation|0|||
16227681|NCT04145531|39313514|FG002|Part A|Protocol deviation|1|||
16227682|NCT04145531|39313515|FG003|Part A|Protocol deviation|0|||
16347569|NCT03732820|39761947|FG000|Overall Study|Failure to meet randomisation criteria|1|||
16548891|NCT04707196|40474679|FG000|Overall Study|Adverse Event|2|||
16548892|NCT04707196|40474680|FG001|Overall Study|Adverse Event|2|||
16548893|NCT04707196|40474679|FG000|Overall Study|Death|3|||
16548894|NCT04707196|40474680|FG001|Overall Study|Death|1|||
16548895|NCT04707196|40474679|FG000|Overall Study|Non-compliance with study drug|1|||
16548896|NCT04707196|40474680|FG001|Overall Study|Non-compliance with study drug|0|||
16548897|NCT04707196|40474679|FG000|Overall Study|Progressive disease|9|||
16548898|NCT04707196|40474680|FG001|Overall Study|Progressive disease|10|||
16548899|NCT02041923|40474681|FG000|Overall Study|Lost to Follow-up|26|||
16548900|NCT02041923|40474682|FG001|Overall Study|Lost to Follow-up|30|||
16548901|NCT03556358|40474683|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
16548902|NCT03556358|40474684|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
16548903|NCT03556358|40474683|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
16548904|NCT03556358|40474684|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
16548905|NCT03556358|40474683|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
16548906|NCT03556358|40474684|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
16548907|NCT03556358|40474683|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
16548908|NCT03556358|40474684|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
16548909|NCT03556358|40474683|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
16548910|NCT03556358|40474684|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
16548911|NCT03556358|40474683|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
16548912|NCT03556358|40474684|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
16227683|NCT04145531|39313512|FG000|Part A|Withdrawal by parent or guardian|1|||
16548913|NCT03556358|40474683|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
16227684|NCT04145531|39313513|FG001|Part A|Withdrawal by parent or guardian|0|||
16227685|NCT04145531|39313514|FG002|Part A|Withdrawal by parent or guardian|0|||
16227686|NCT04145531|39313515|FG003|Part A|Withdrawal by parent or guardian|0|||
16548914|NCT03556358|40474684|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
16116697|NCT00943852|38912492|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16116698|NCT00943852|38912493|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16116699|NCT00943852|38912494|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
16116700|NCT00943852|38912495|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16116701|NCT00943852|38912496|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16116702|NCT00943852|38912497|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16116703|NCT00943852|38912498|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16116704|NCT00943852|38912499|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16548915|NCT02306265|40474685|FG000|Overall Study|Withdrawal by Subject|1|||
16116705|NCT00943852|38912500|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
16116706|NCT00943852|38912491|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16116707|NCT00943852|38912492|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16116708|NCT00943852|38912493|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16116709|NCT00943852|38912494|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16116710|NCT00943852|38912495|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16116711|NCT00943852|38912496|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
16116712|NCT00943852|38912497|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16347570|NCT03732820|39761948|FG001|Overall Study|Failure to meet randomisation criteria|1|||
16347571|NCT03732820|39761947|FG000|Overall Study|Patient decision|14|||
16548916|NCT02500979|40474686|FG000|Period 1|Hyperglycemia|1|||
16548917|NCT02500979|40474687|FG001|Period 1|Hyperglycemia|0|||
16548918|NCT02500979|40474686|FG000|Period 1|Severe non-compliance to protocol|0|||
16548919|NCT02500979|40474687|FG001|Period 1|Severe non-compliance to protocol|1|||
16548920|NCT02500979|40474686|FG000|Period 1|Adverse Event|1|||
16548921|NCT02500979|40474687|FG001|Period 1|Adverse Event|0|||
16548922|NCT02500979|40474686|FG000|Period 1|Subject decision|2|||
16548923|NCT02500979|40474687|FG001|Period 1|Subject decision|0|||
16548924|NCT02500979|40474686|FG000|Period 2|Change in risk|1|||
16548925|NCT02500979|40474687|FG001|Period 2|Change in risk|0|||
16548926|NCT01291225|40474688|FG000|Overall Study|Lost to Follow-up|85|||
16548927|NCT01291225|40474689|FG001|Overall Study|Lost to Follow-up|39|||
16548928|NCT00954733|40474690|FG000|Overall Study|blood gas machine did not work|1|||
16548929|NCT02309112|40474691|FG000|Overall Study|Withdrawal by Subject|1|||
16548930|NCT02309112|40474692|FG001|Overall Study|Withdrawal by Subject|0|||
16548931|NCT02309112|40474693|FG002|Overall Study|Withdrawal by Subject|1|||
16548932|NCT02309112|40474691|FG000|Overall Study|Lost to Follow-up|0|||
16548933|NCT02309112|40474692|FG001|Overall Study|Lost to Follow-up|1|||
16548934|NCT02309112|40474693|FG002|Overall Study|Lost to Follow-up|0|||
16548935|NCT03101241|40474695|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
16548936|NCT03101241|40474696|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
16548937|NCT03101241|40474695|FG000|Overall Study|Participant withdrew consent|3|||
16548938|NCT03101241|40474696|FG001|Overall Study|Participant withdrew consent|1|||
16548939|NCT03101241|40474695|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
16548940|NCT03101241|40474696|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
16548941|NCT03101241|40474695|FG000|Overall Study|Lost to Follow-up|2|||
16548942|NCT03101241|40474696|FG001|Overall Study|Lost to Follow-up|0|||
16548943|NCT03101241|40474695|FG000|Overall Study|Lack of Efficacy|0|||
16548944|NCT03101241|40474696|FG001|Overall Study|Lack of Efficacy|1|||
16548945|NCT03101241|40474695|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
16548946|NCT03101241|40474696|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
16548947|NCT01265823|40474708|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
16548948|NCT01265823|40474708|FG000|Overall Study|Failure to Return|4|||
16548949|NCT01265823|40474708|FG000|Overall Study|Protocol Violation|1|||
16548950|NCT01265823|40474708|FG000|Overall Study|Participant Request|1|||
16548951|NCT01463293|40474709|FG000|Overall Study|Lost to Follow-up|1|||
16548952|NCT01463293|40474710|FG001|Overall Study|Lost to Follow-up|4|||
16548953|NCT01463293|40474711|FG002|Overall Study|Lost to Follow-up|5|||
16548954|NCT01463293|40474709|FG000|Overall Study|Adverse Event|1|||
16548955|NCT01463293|40474710|FG001|Overall Study|Adverse Event|2|||
16548956|NCT01463293|40474711|FG002|Overall Study|Adverse Event|0|||
16548957|NCT01463293|40474709|FG000|Overall Study|Withdrawal by Subject|4|||
16548958|NCT01463293|40474710|FG001|Overall Study|Withdrawal by Subject|10|||
16548959|NCT01463293|40474711|FG002|Overall Study|Withdrawal by Subject|5|||
16347572|NCT03732820|39761948|FG001|Overall Study|Patient decision|10|||
16548960|NCT01463293|40474709|FG000|Overall Study|Other|0|||
16548961|NCT01463293|40474710|FG001|Overall Study|Other|0|||
16548962|NCT01463293|40474711|FG002|Overall Study|Other|2|||
16548963|NCT00674323|40474713|FG000|Overall Study|Adverse Event|0|||
16548964|NCT00674323|40474714|FG001|Overall Study|Adverse Event|1|||
16548965|NCT00674323|40474715|FG002|Overall Study|Adverse Event|0|||
16116713|NCT00943852|38912498|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16116714|NCT00943852|38912499|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16116715|NCT00943852|38912500|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
16116716|NCT00943852|38912491|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16116717|NCT00943852|38912492|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16116718|NCT00943852|38912493|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16116719|NCT00943852|38912494|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16116720|NCT00943852|38912495|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16116721|NCT00943852|38912496|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16116722|NCT00943852|38912497|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
16116723|NCT00943852|38912498|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16116724|NCT00943852|38912499|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16116725|NCT00943852|38912500|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
16116726|NCT00943852|38912491|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16116727|NCT00943852|38912492|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16116728|NCT00943852|38912493|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16116729|NCT00943852|38912494|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16116730|NCT00943852|38912495|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16116731|NCT00943852|38912496|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16116732|NCT00943852|38912497|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16116733|NCT00943852|38912498|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
16116734|NCT00943852|38912499|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16116735|NCT00943852|38912500|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
16116736|NCT00943852|38912491|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
16116737|NCT00943852|38912492|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16116738|NCT00943852|38912493|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
16116739|NCT00943852|38912494|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
16116740|NCT00943852|38912495|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16116741|NCT00943852|38912496|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16227687|NCT04145531|39313512|FG000|Part A|Withdrawal by participant|0|||
16227688|NCT04145531|39313513|FG001|Part A|Withdrawal by participant|0|||
16227689|NCT04145531|39313514|FG002|Part A|Withdrawal by participant|1|||
16411630|NCT02616393|39988683|FG002|Overall Study|Other|0|||
16411631|NCT02616393|39988681|FG000|Overall Study|Withdrawal by Subject|1|||
16411632|NCT02616393|39988682|FG001|Overall Study|Withdrawal by Subject|1|||
16411633|NCT02616393|39988683|FG002|Overall Study|Withdrawal by Subject|0|||
16411634|NCT02616393|39988681|FG000|Overall Study|Lost to Follow-up|0|||
16173244|NCT00977470|39111153|FG000|Overall Study|Protocol Violation|1|||
16173245|NCT00977470|39111154|FG001|Overall Study|Protocol Violation|0|||
16173246|NCT00977470|39111153|FG000|Overall Study|Withdrawal by Subject|0|||
16173247|NCT00977470|39111154|FG001|Overall Study|Withdrawal by Subject|2|||
16173248|NCT00977470|39111153|FG000|Overall Study|Death|0|||
16173249|NCT00977470|39111154|FG001|Overall Study|Death|2|||
16173250|NCT00977470|39111153|FG000|Overall Study|clinical decline|0|||
16173251|NCT00977470|39111154|FG001|Overall Study|clinical decline|1|||
16173252|NCT00977470|39111153|FG000|Overall Study|prolonged recovery post-surgery|0|||
16173253|NCT00977470|39111154|FG001|Overall Study|prolonged recovery post-surgery|1|||
16173254|NCT00977470|39111153|FG000|Overall Study|Still on-study|2|||
16173255|NCT00977470|39111154|FG001|Overall Study|Still on-study|0|||
16173256|NCT00355264|39111155|FG000|Extension (Variable Duration)|Adverse Event|1|||
16173257|NCT00355264|39111155|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
16173258|NCT05300087|39111158|FG000|Overall Study|Withdrawal by Subject|0|||
16173259|NCT05300087|39111159|FG001|Overall Study|Withdrawal by Subject|1|||
16173260|NCT00461175|39111161|FG000|Overall Study|Protocol Violation|522|||
16173261|NCT00461175|39111162|FG001|Overall Study|Protocol Violation|365|||
16173262|NCT04041375|39111163|FG000|Intervention Phase|Withdrawal by Subject|2|||
16173263|NCT04041375|39111164|FG001|Intervention Phase|Withdrawal by Subject|2|||
16173264|NCT04041375|39111163|FG000|Follow-up Phase|Death|2|||
16173265|NCT04041375|39111164|FG001|Follow-up Phase|Death|0|||
16173266|NCT04041375|39111163|FG000|Follow-up Phase|Lost to Follow-up|2|||
16173267|NCT04041375|39111164|FG001|Follow-up Phase|Lost to Follow-up|1|||
16173268|NCT04041375|39111163|FG000|Follow-up Phase|Too ill|3|||
16173269|NCT04041375|39111164|FG001|Follow-up Phase|Too ill|0|||
16173270|NCT03832387|39111165|FG000|Overall Study|Protocol Violation|2|||
16173271|NCT03832387|39111166|FG001|Overall Study|Protocol Violation|6|||
16173272|NCT03832387|39111165|FG000|Overall Study|EXCLUSION CRITERIA|3|||
16173273|NCT03832387|39111166|FG001|Overall Study|EXCLUSION CRITERIA|1|||
16173274|NCT01097044|39111167|FG000|Overall Study|Withdrawal by Subject|4|||
16173275|NCT01097044|39111168|FG001|Overall Study|Withdrawal by Subject|4|||
16173276|NCT01097044|39111167|FG000|Overall Study|Lost to Follow-up|1|||
16173277|NCT01097044|39111168|FG001|Overall Study|Lost to Follow-up|0|||
16173278|NCT01097044|39111167|FG000|Overall Study|Withdrawal by Sponsor|0|||
16173279|NCT01097044|39111168|FG001|Overall Study|Withdrawal by Sponsor|1|||
16173280|NCT01445535|39111169|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
16173281|NCT01445535|39111170|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
16173282|NCT01445535|39111171|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
16173283|NCT01445535|39111172|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
16173284|NCT01445535|39111169|FG000|Overall Study|Disease progression|1|||
16173285|NCT01445535|39111170|FG001|Overall Study|Disease progression|0|||
16173286|NCT01445535|39111171|FG002|Overall Study|Disease progression|1|||
16173287|NCT01445535|39111172|FG003|Overall Study|Disease progression|0|||
16173288|NCT01445535|39111169|FG000|Overall Study|PI discretion|0|||
16173289|NCT01445535|39111170|FG001|Overall Study|PI discretion|0|||
16173290|NCT01445535|39111171|FG002|Overall Study|PI discretion|0|||
16173291|NCT01445535|39111172|FG003|Overall Study|PI discretion|1|||
16173292|NCT01227967|39111173|FG000|Overall Study|Protocol Violation|3|||
16173293|NCT01227967|39111174|FG001|Overall Study|Protocol Violation|1|||
16173294|NCT01227967|39111173|FG000|Overall Study|Death|0|||
16173295|NCT01227967|39111174|FG001|Overall Study|Death|1|||
16173296|NCT01227967|39111173|FG000|Overall Study|Lost to Follow-up|8|||
16173297|NCT01227967|39111174|FG001|Overall Study|Lost to Follow-up|3|||
16173298|NCT01227967|39111173|FG000|Overall Study|Withdrawal by Subject|4|||
16173299|NCT01227967|39111174|FG001|Overall Study|Withdrawal by Subject|3|||
16173300|NCT01227967|39111173|FG000|Overall Study|Physician Decision|0|||
16173301|NCT01227967|39111174|FG001|Overall Study|Physician Decision|1|||
16173302|NCT01227967|39111173|FG000|Overall Study|Never Started Treatment|0|||
16173303|NCT01227967|39111174|FG001|Overall Study|Never Started Treatment|4|||
16173304|NCT01227967|39111173|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
16173305|NCT01227967|39111174|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
16116742|NCT00943852|38912497|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
16116743|NCT00943852|38912498|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16116744|NCT00943852|38912499|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16116745|NCT00943852|38912500|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
16116746|NCT01435772|38912501|FG000|Overall Study|Adverse Event|1|||
16116747|NCT01435772|38912502|FG001|Overall Study|Adverse Event|0|||
16116748|NCT01435772|38912503|FG002|Overall Study|Adverse Event|2|||
16116749|NCT01435772|38912501|FG000|Overall Study|Withdrawal by Subject|0|||
16116750|NCT01435772|38912502|FG001|Overall Study|Withdrawal by Subject|1|||
16116751|NCT01435772|38912503|FG002|Overall Study|Withdrawal by Subject|3|||
16116752|NCT01435772|38912501|FG000|Overall Study|Other - study termination|2|||
16116753|NCT01435772|38912502|FG001|Overall Study|Other - study termination|2|||
16116754|NCT01435772|38912503|FG002|Overall Study|Other - study termination|10|||
16116755|NCT02417441|38912504|FG000|Overall Study|Inconclusive due to missing data|52|||
16116756|NCT02417441|38912505|FG001|Overall Study|Inconclusive due to missing data|19|||
16116757|NCT02807883|38912506|FG000|Overall Study|Withdrawal by Subject|2|||
16116758|NCT03834519|38912507|FG000|Overall Study|Ongoing|234|||
16116759|NCT03834519|38912508|FG001|Overall Study|Ongoing|111|||
16116760|NCT03834519|38912507|FG000|Overall Study|Withdrawal by Subject|4|||
16116761|NCT03834519|38912508|FG001|Overall Study|Withdrawal by Subject|7|||
16116762|NCT03834519|38912507|FG000|Overall Study|Death|291|||
16116763|NCT03834519|38912508|FG001|Overall Study|Death|146|||
16116764|NCT02106195|38912509|FG000|Overall Study|Adverse Event|2|||
16116765|NCT02106195|38912509|FG000|Overall Study|Protocol Violation|1|||
16116766|NCT01381575|38912510|FG000|Overall Study|Serious Adverse Event|1|||
16116767|NCT01381575|38912511|FG001|Overall Study|Serious Adverse Event|0|||
16116768|NCT01381575|38912512|FG002|Overall Study|Serious Adverse Event|0|||
16116769|NCT01381575|38912510|FG000|Overall Study|Non-Serious Adverse Event|0|||
16116770|NCT01381575|38912511|FG001|Overall Study|Non-Serious Adverse Event|0|||
16116771|NCT01381575|38912512|FG002|Overall Study|Non-Serious Adverse Event|1|||
16116772|NCT01381575|38912510|FG000|Overall Study|Protocol Violation|0|||
16116773|NCT01381575|38912511|FG001|Overall Study|Protocol Violation|1|||
16116774|NCT01381575|38912512|FG002|Overall Study|Protocol Violation|1|||
16116775|NCT01381575|38912510|FG000|Overall Study|Withdrawal by Subject|15|||
16116776|NCT01381575|38912511|FG001|Overall Study|Withdrawal by Subject|9|||
16116777|NCT01381575|38912512|FG002|Overall Study|Withdrawal by Subject|7|||
16116778|NCT01381575|38912510|FG000|Overall Study|Migrated/moved from study area|2|||
16116779|NCT01381575|38912511|FG001|Overall Study|Migrated/moved from study area|12|||
16116780|NCT01381575|38912512|FG002|Overall Study|Migrated/moved from study area|2|||
16116781|NCT01381575|38912510|FG000|Overall Study|Lost to Follow-up|8|||
16116782|NCT01381575|38912511|FG001|Overall Study|Lost to Follow-up|17|||
16116783|NCT01381575|38912512|FG002|Overall Study|Lost to Follow-up|9|||
16116784|NCT00874731|38912514|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
16116785|NCT00874731|38912515|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
16116786|NCT00874731|38912516|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
16116787|NCT00874731|38912514|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
16116788|NCT00874731|38912515|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
16548966|NCT00674323|40474713|FG000|Overall Study|Protocol Violation|1|||
16116789|NCT00874731|38912516|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
16116790|NCT00874731|38912514|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
16116791|NCT00874731|38912515|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
16116792|NCT00874731|38912516|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
16548967|NCT00674323|40474714|FG001|Overall Study|Protocol Violation|0|||
16548968|NCT00674323|40474715|FG002|Overall Study|Protocol Violation|0|||
16548969|NCT01782872|40474716|FG000|Overall Study|Protocol Violation|0|||
16548970|NCT01782872|40474717|FG001|Overall Study|Protocol Violation|0|||
16116793|NCT03510455|38912517|FG000|Overall Study|Physician Decision|1|||
16116794|NCT03327831|38912518|FG000|Overall Study|Lost to Follow-up|2|||
16116795|NCT00794924|38916140|FG000|Overall Study|Lost to Follow-up|6|||
16116796|NCT00794924|38916141|FG001|Overall Study|Lost to Follow-up|8|||
16116797|NCT00794924|38916140|FG000|Overall Study|Withdrawal by Subject|48|||
16116798|NCT00794924|38916141|FG001|Overall Study|Withdrawal by Subject|60|||
16116799|NCT00794924|38916140|FG000|Overall Study|Adverse Event|6|||
16116800|NCT00794924|38916141|FG001|Overall Study|Adverse Event|2|||
16116801|NCT02412735|38916144|FG000|Overall Study|Adverse Event|0|||
16116802|NCT02412735|38916145|FG001|Overall Study|Adverse Event|1|||
16116803|NCT02412735|38916146|FG002|Overall Study|Adverse Event|2|||
16116804|NCT02412735|38916144|FG000|Overall Study|Withdrawal by Subject|23|||
16116805|NCT02412735|38916145|FG001|Overall Study|Withdrawal by Subject|27|||
16116806|NCT02412735|38916146|FG002|Overall Study|Withdrawal by Subject|22|||
16116807|NCT02412735|38916144|FG000|Overall Study|Investigator Decision|3|||
16116808|NCT02412735|38916145|FG001|Overall Study|Investigator Decision|3|||
16116809|NCT02412735|38916146|FG002|Overall Study|Investigator Decision|2|||
16116810|NCT02412735|38916144|FG000|Overall Study|Lost to Follow-up|17|||
16116811|NCT02412735|38916145|FG001|Overall Study|Lost to Follow-up|11|||
16548971|NCT01782872|40474718|FG002|Overall Study|Protocol Violation|0|||
16116812|NCT02412735|38916146|FG002|Overall Study|Lost to Follow-up|18|||
16116813|NCT02412735|38916144|FG000|Overall Study|Reason not Specified|3|||
16116814|NCT02412735|38916145|FG001|Overall Study|Reason not Specified|2|||
16116815|NCT02412735|38916146|FG002|Overall Study|Reason not Specified|2|||
16116816|NCT01730950|38916147|FG000|Overall Study|Protocol Violation|6|||
16116817|NCT01730950|38916148|FG001|Overall Study|Protocol Violation|6|||
16116818|NCT00504777|38916149|FG000|Overall Study|Adverse Event|1|||
16116819|NCT02591953|38916153|FG000|Overall Study|Lost to Follow-up|6|||
16116820|NCT02591953|38916154|FG001|Overall Study|Lost to Follow-up|6|||
16116821|NCT00996606|38916158|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
16116822|NCT00996606|38916158|FG000|Overall Study|Insufficient Therapeutic Response|2|||
16116823|NCT00996606|38916158|FG000|Overall Study|Protocol Violation|1|||
16116824|NCT00996606|38916158|FG000|Overall Study|Withdrawal by Subject|3|||
16116825|NCT01681277|38916159|FG000|Overall Study|Adverse Event|1|||
16116826|NCT01681277|38916160|FG001|Overall Study|Adverse Event|0|||
16116827|NCT01681277|38916161|FG002|Overall Study|Adverse Event|0|||
16116828|NCT01681277|38916162|FG003|Overall Study|Adverse Event|0|||
16116829|NCT01681277|38916163|FG004|Overall Study|Adverse Event|0|||
16116830|NCT02091206|38916164|FG000|Treatment Period|Adverse Event|0|||
16116831|NCT02091206|38916165|FG001|Treatment Period|Adverse Event|1|||
16116832|NCT02091206|38916166|FG002|Treatment Period|Adverse Event|0|||
16116833|NCT02091206|38916167|FG003|Treatment Period|Adverse Event|0|||
16116834|NCT02091206|38916164|FG000|Treatment Period|Met withdrawal criteria|0|||
16116835|NCT02091206|38916165|FG001|Treatment Period|Met withdrawal criteria|0|||
16116836|NCT02091206|38916166|FG002|Treatment Period|Met withdrawal criteria|1|||
16116837|NCT02091206|38916167|FG003|Treatment Period|Met withdrawal criteria|0|||
16116838|NCT02091206|38916164|FG000|Taper Period|Participant refused study drug|1|||
16116839|NCT02091206|38916165|FG001|Taper Period|Participant refused study drug|0|||
16116840|NCT02091206|38916166|FG002|Taper Period|Participant refused study drug|0|||
16116841|NCT02091206|38916167|FG003|Taper Period|Participant refused study drug|1|||
16116842|NCT02091206|38916164|FG000|Taper Period|Lost to Follow-up|0|||
16116843|NCT02091206|38916165|FG001|Taper Period|Lost to Follow-up|0|||
16116844|NCT02091206|38916166|FG002|Taper Period|Lost to Follow-up|0|||
16116845|NCT02091206|38916167|FG003|Taper Period|Lost to Follow-up|1|||
16116846|NCT00567567|38916168|FG000|Overall Study|Adverse Event|0|||
16116847|NCT00567567|38916169|FG001|Overall Study|Adverse Event|2|||
16116848|NCT00567567|38916170|FG002|Overall Study|Adverse Event|5|||
16116849|NCT00567567|38916168|FG000|Overall Study|Death|8|||
16116850|NCT00567567|38916169|FG001|Overall Study|Death|1|||
16116851|NCT00567567|38916170|FG002|Overall Study|Death|5|||
16116852|NCT00567567|38916168|FG000|Overall Study|Lack of Efficacy|16|||
16116853|NCT00567567|38916169|FG001|Overall Study|Lack of Efficacy|17|||
16116854|NCT00567567|38916170|FG002|Overall Study|Lack of Efficacy|48|||
16116855|NCT00567567|38916168|FG000|Overall Study|Lost to Follow-up|0|||
16116856|NCT00567567|38916169|FG001|Overall Study|Lost to Follow-up|0|||
16116857|NCT00567567|38916170|FG002|Overall Study|Lost to Follow-up|1|||
16116858|NCT00567567|38916168|FG000|Overall Study|Physician Decision|16|||
16116859|NCT00567567|38916169|FG001|Overall Study|Physician Decision|18|||
16116860|NCT00567567|38916170|FG002|Overall Study|Physician Decision|84|||
16116861|NCT00567567|38916168|FG000|Overall Study|Withdrawal by Subject|0|||
16116862|NCT00567567|38916169|FG001|Overall Study|Withdrawal by Subject|0|||
16116863|NCT00567567|38916170|FG002|Overall Study|Withdrawal by Subject|2|||
16116864|NCT00567567|38916168|FG000|Overall Study|Ineligible|4|||
16116865|NCT00567567|38916169|FG001|Overall Study|Ineligible|0|||
16116866|NCT00567567|38916170|FG002|Overall Study|Ineligible|9|||
16116867|NCT00567567|38916168|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
16116868|NCT00567567|38916169|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
16116869|NCT00567567|38916170|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
16116870|NCT00567567|38916168|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
16116871|NCT00567567|38916169|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
16116872|NCT00567567|38916170|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
16116873|NCT00567567|38916168|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
16116874|NCT00567567|38916169|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
16116875|NCT00567567|38916170|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
16116876|NCT03809039|38916171|FG000|Part 1|Withdrawal by Subject|1|||
16116877|NCT03809039|38916172|FG001|Part 1|Withdrawal by Subject|0|||
16116878|NCT03809039|38916173|FG002|Part 1|Withdrawal by Subject|0|||
16116879|NCT03809039|38916174|FG003|Part 1|Withdrawal by Subject|1|||
16116880|NCT03809039|38916175|FG004|Part 1|Withdrawal by Subject|0|||
16116881|NCT03809039|38916176|FG005|Part 1|Withdrawal by Subject|0|||
16116882|NCT03809039|38916177|FG006|Part 1|Withdrawal by Subject|0|||
16116883|NCT03809039|38916178|FG007|Part 1|Withdrawal by Subject|0|||
16116884|NCT03809039|38916179|FG008|Part 1|Withdrawal by Subject|0|||
16116885|NCT03809039|38916171|FG000|Part 3|Withdrawn by study termination|0|||
16116886|NCT03809039|38916172|FG001|Part 3|Withdrawn by study termination|0|||
16116887|NCT03809039|38916173|FG002|Part 3|Withdrawn by study termination|0|||
16116888|NCT03809039|38916174|FG003|Part 3|Withdrawn by study termination|0|||
16116889|NCT03809039|38916175|FG004|Part 3|Withdrawn by study termination|0|||
16548972|NCT01782872|40474719|FG003|Overall Study|Protocol Violation|1|||
16548973|NCT01782872|40474716|FG000|Overall Study|Withdrawal by Subject|0|||
16548974|NCT01782872|40474717|FG001|Overall Study|Withdrawal by Subject|1|||
16548975|NCT01782872|40474718|FG002|Overall Study|Withdrawal by Subject|0|||
16548976|NCT01782872|40474719|FG003|Overall Study|Withdrawal by Subject|0|||
16116890|NCT03809039|38916176|FG005|Part 3|Withdrawn by study termination|0|||
16116891|NCT03809039|38916177|FG006|Part 3|Withdrawn by study termination|0|||
16116892|NCT03809039|38916178|FG007|Part 3|Withdrawn by study termination|2|||
16116893|NCT03809039|38916179|FG008|Part 3|Withdrawn by study termination|6|||
16116894|NCT03238963|38916180|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
16116895|NCT03238963|38916181|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
16116896|NCT03238963|38916180|FG000|Overall Study|Withdrawal by Subject|1|||
16116897|NCT03238963|38916181|FG001|Overall Study|Withdrawal by Subject|1|||
16116898|NCT03238963|38916180|FG000|Overall Study|Lost to Follow-up|1|||
16116899|NCT03238963|38916181|FG001|Overall Study|Lost to Follow-up|0|||
16548977|NCT02294474|40474722|FG000|Overall Study|Adverse Event|7|||
16548978|NCT02294474|40474723|FG001|Overall Study|Adverse Event|7|||
16116900|NCT03238963|38916180|FG000|Overall Study|Protocol Violation|1|||
16116901|NCT03238963|38916181|FG001|Overall Study|Protocol Violation|1|||
16116902|NCT03238963|38916180|FG000|Overall Study|Adverse Event|1|||
16116903|NCT03238963|38916181|FG001|Overall Study|Adverse Event|0|||
16116904|NCT01475461|38916182|FG000|Run-in Period|Not meet eligibility criteria|16|||
16116905|NCT01475461|38916183|FG001|Run-in Period|Not meet eligibility criteria|0|||
16548979|NCT02294474|40474722|FG000|Overall Study|Lack of Efficacy|2|||
16548980|NCT02294474|40474723|FG001|Overall Study|Lack of Efficacy|1|||
16548981|NCT02294474|40474722|FG000|Overall Study|Protocol Violation|4|||
16548982|NCT02294474|40474723|FG001|Overall Study|Protocol Violation|2|||
16116906|NCT01475461|38916184|FG002|Run-in Period|Not meet eligibility criteria|0|||
16116907|NCT01475461|38916185|FG003|Run-in Period|Not meet eligibility criteria|0|||
16116908|NCT01475461|38916186|FG004|Run-in Period|Not meet eligibility criteria|0|||
16116909|NCT01475461|38916187|FG005|Run-in Period|Not meet eligibility criteria|0|||
16116910|NCT01475461|38916188|FG006|Run-in Period|Not meet eligibility criteria|0|||
16116911|NCT01475461|38916182|FG000|Run-in Period|Lost to Follow-up|7|||
16116912|NCT01475461|38916183|FG001|Run-in Period|Lost to Follow-up|0|||
16116913|NCT01475461|38916184|FG002|Run-in Period|Lost to Follow-up|0|||
16116914|NCT01475461|38916185|FG003|Run-in Period|Lost to Follow-up|0|||
16116915|NCT01475461|38916186|FG004|Run-in Period|Lost to Follow-up|0|||
16116916|NCT01475461|38916187|FG005|Run-in Period|Lost to Follow-up|0|||
16116917|NCT01475461|38916188|FG006|Run-in Period|Lost to Follow-up|0|||
16548983|NCT02294474|40474722|FG000|Overall Study|Other than specified above|12|||
16548984|NCT02294474|40474723|FG001|Overall Study|Other than specified above|12|||
16548985|NCT03002038|40474726|FG000|Overall Study|Adverse Event|3|||
16548986|NCT03002038|40474727|FG001|Overall Study|Adverse Event|1|||
16548987|NCT03002038|40474726|FG000|Overall Study|Withdrawal by Subject|8|||
16548988|NCT03002038|40474727|FG001|Overall Study|Withdrawal by Subject|4|||
16548989|NCT03002038|40474726|FG000|Overall Study|Immigration to another region|0|||
16548990|NCT03002038|40474727|FG001|Overall Study|Immigration to another region|2|||
16548991|NCT02712398|40474728|FG000|Overall Study|Withdrawal by Subject|6|||
16548992|NCT02712398|40474728|FG000|Overall Study|Lost to Follow-up|6|||
16116918|NCT01475461|38916182|FG000|Run-in Period|Withdrawal by Subject|11|||
16116919|NCT01475461|38916183|FG001|Run-in Period|Withdrawal by Subject|0|||
16116920|NCT01475461|38916184|FG002|Run-in Period|Withdrawal by Subject|0|||
16116921|NCT01475461|38916185|FG003|Run-in Period|Withdrawal by Subject|0|||
16548993|NCT02712398|40474728|FG000|Overall Study|Sponsor Decision|1|||
16548994|NCT02712398|40474728|FG000|Overall Study|Physician Decision|1|||
16548995|NCT02712398|40474728|FG000|Overall Study|Death|2|||
16548996|NCT02712398|40474728|FG000|Overall Study|Re-operation|21|||
16116922|NCT01475461|38916186|FG004|Run-in Period|Withdrawal by Subject|0|||
16116923|NCT01475461|38916187|FG005|Run-in Period|Withdrawal by Subject|0|||
16116924|NCT01475461|38916188|FG006|Run-in Period|Withdrawal by Subject|0|||
16116925|NCT01475461|38916182|FG000|Run-in Period|Other|3|||
16116926|NCT01475461|38916183|FG001|Run-in Period|Other|0|||
16116927|NCT01475461|38916184|FG002|Run-in Period|Other|0|||
16116928|NCT01475461|38916185|FG003|Run-in Period|Other|0|||
16116929|NCT01475461|38916186|FG004|Run-in Period|Other|0|||
16548997|NCT02668016|40474730|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
16548998|NCT02668016|40474730|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
16548999|NCT02668016|40474730|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
16549000|NCT02668016|40474730|FG000|Month 4|Withdrawal due to severe symptoms|1|||
16549001|NCT02668016|40474730|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
16549002|NCT02668016|40474730|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
16549003|NCT02668016|40474730|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
16549004|NCT02668016|40474730|FG000|Month 6|Withdrawal due to severe symptoms|2|||
16549005|NCT02668016|40474730|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
16549006|NCT02668016|40474730|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
16549007|NCT02668016|40474730|FG000|Month 8|Withdrawal due to severe symptoms|1|||
16549008|NCT02668016|40474730|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
16549009|NCT02668016|40474730|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
16549010|NCT02668016|40474730|FG000|Month 10|Withdrawal due to severe symptoms|1|||
16116930|NCT01475461|38916187|FG005|Run-in Period|Other|0|||
16116931|NCT01475461|38916188|FG006|Run-in Period|Other|0|||
16116932|NCT01475461|38916182|FG000|Run-in Period|Protocol Violation|4|||
16116933|NCT01475461|38916183|FG001|Run-in Period|Protocol Violation|0|||
16116934|NCT01475461|38916184|FG002|Run-in Period|Protocol Violation|0|||
16116935|NCT01475461|38916185|FG003|Run-in Period|Protocol Violation|0|||
16116936|NCT01475461|38916186|FG004|Run-in Period|Protocol Violation|0|||
16116937|NCT01475461|38916187|FG005|Run-in Period|Protocol Violation|0|||
16116938|NCT01475461|38916188|FG006|Run-in Period|Protocol Violation|0|||
16549011|NCT02668016|40474730|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
16549012|NCT01965158|40474733|FG000|Overall Study|Adverse Event|14|||
16549013|NCT01965158|40474734|FG001|Overall Study|Adverse Event|5|||
16549014|NCT01965158|40474733|FG000|Overall Study|Withdrawal by Subject|16|||
16549015|NCT01965158|40474734|FG001|Overall Study|Withdrawal by Subject|24|||
16549016|NCT01965158|40474733|FG000|Overall Study|Lost to Follow-up|7|||
16549017|NCT01965158|40474734|FG001|Overall Study|Lost to Follow-up|5|||
16549018|NCT01965158|40474733|FG000|Overall Study|Protocol Violation|1|||
16549019|NCT01965158|40474734|FG001|Overall Study|Protocol Violation|1|||
16549020|NCT01965158|40474733|FG000|Overall Study|Other - Miscellaneous|3|||
16549021|NCT01965158|40474734|FG001|Overall Study|Other - Miscellaneous|0|||
16549022|NCT02736968|40474735|FG000|Overall Study|Lost to Follow-up|0|||
16549023|NCT02736968|40474736|FG001|Overall Study|Lost to Follow-up|0|||
16549024|NCT02736968|40474737|FG002|Overall Study|Lost to Follow-up|0|||
16549025|NCT02736968|40474738|FG003|Overall Study|Lost to Follow-up|0|||
16549026|NCT02736968|40474739|FG004|Overall Study|Lost to Follow-up|0|||
16549027|NCT02736968|40474740|FG005|Overall Study|Lost to Follow-up|0|||
16549028|NCT02736968|40474741|FG006|Overall Study|Lost to Follow-up|5|||
16549029|NCT02736968|40474742|FG007|Overall Study|Lost to Follow-up|2|||
16549030|NCT02736968|40474735|FG000|Overall Study|COVID-19 Pandemic|0|||
16549031|NCT02736968|40474736|FG001|Overall Study|COVID-19 Pandemic|0|||
16549032|NCT02736968|40474737|FG002|Overall Study|COVID-19 Pandemic|0|||
16549033|NCT02736968|40474738|FG003|Overall Study|COVID-19 Pandemic|0|||
16549034|NCT02736968|40474739|FG004|Overall Study|COVID-19 Pandemic|0|||
16549035|NCT02736968|40474740|FG005|Overall Study|COVID-19 Pandemic|0|||
16549036|NCT02736968|40474741|FG006|Overall Study|COVID-19 Pandemic|2|||
16549037|NCT02736968|40474742|FG007|Overall Study|COVID-19 Pandemic|0|||
16549038|NCT02736968|40474735|FG000|Overall Study|Withdrawal by Subject|0|||
16549039|NCT02736968|40474736|FG001|Overall Study|Withdrawal by Subject|0|||
16549040|NCT02736968|40474737|FG002|Overall Study|Withdrawal by Subject|0|||
16549041|NCT02736968|40474738|FG003|Overall Study|Withdrawal by Subject|0|||
16549042|NCT02736968|40474739|FG004|Overall Study|Withdrawal by Subject|0|||
16549043|NCT02736968|40474740|FG005|Overall Study|Withdrawal by Subject|0|||
16549044|NCT02736968|40474741|FG006|Overall Study|Withdrawal by Subject|1|||
16549045|NCT02736968|40474742|FG007|Overall Study|Withdrawal by Subject|0|||
16549046|NCT00920621|40474747|FG000|Overall Study|Lost to Follow-up|16|||
16549047|NCT00920621|40474748|FG001|Overall Study|Lost to Follow-up|17|||
16549048|NCT00920621|40474749|FG002|Overall Study|Lost to Follow-up|19|||
16549049|NCT00920621|40474750|FG003|Overall Study|Lost to Follow-up|21|||
16549050|NCT00920621|40474747|FG000|Overall Study|Fetal/neonatal deaths|16|||
16549051|NCT00920621|40474748|FG001|Overall Study|Fetal/neonatal deaths|14|||
16549052|NCT00920621|40474749|FG002|Overall Study|Fetal/neonatal deaths|16|||
16549053|NCT00920621|40474750|FG003|Overall Study|Fetal/neonatal deaths|14|||
16549054|NCT00920621|40474747|FG000|Overall Study|Blood sample not collected|22|||
16549055|NCT00920621|40474748|FG001|Overall Study|Blood sample not collected|14|||
16549056|NCT00920621|40474749|FG002|Overall Study|Blood sample not collected|0|||
16549057|NCT00920621|40474750|FG003|Overall Study|Blood sample not collected|0|||
16116939|NCT01475461|38916182|FG000|Treatment Period|Death|0|||
16116940|NCT01475461|38916183|FG001|Treatment Period|Death|0|||
16116941|NCT01475461|38916184|FG002|Treatment Period|Death|0|||
16116942|NCT01475461|38916185|FG003|Treatment Period|Death|1|||
16549058|NCT01255592|40474751|FG000|Overall Study|Adverse Event|5|||
16549059|NCT01255592|40474752|FG001|Overall Study|Adverse Event|0|||
16549060|NCT01255592|40474751|FG000|Overall Study|Withdrawal by Subject|1|||
16549061|NCT01255592|40474752|FG001|Overall Study|Withdrawal by Subject|0|||
16549062|NCT01255592|40474751|FG000|Overall Study|Other|0|||
16549063|NCT01255592|40474752|FG001|Overall Study|Other|1|||
16549064|NCT02798211|40474753|FG000|Period 1|Adverse Event|1|||
16549065|NCT02798211|40474754|FG001|Period 1|Adverse Event|1|||
16549066|NCT02798211|40474755|FG002|Period 1|Adverse Event|0|||
16549067|NCT02798211|40474756|FG003|Period 1|Adverse Event|0|||
16116943|NCT01475461|38916186|FG004|Treatment Period|Death|0|||
16116944|NCT01475461|38916187|FG005|Treatment Period|Death|0|||
16549068|NCT02798211|40474757|FG004|Period 1|Adverse Event|0|||
16549069|NCT02798211|40474758|FG005|Period 1|Adverse Event|0|||
16549070|NCT02798211|40474753|FG000|Period 1|Lost to Follow-up|2|||
16549071|NCT02798211|40474754|FG001|Period 1|Lost to Follow-up|1|||
16549072|NCT02798211|40474755|FG002|Period 1|Lost to Follow-up|0|||
16549073|NCT02798211|40474756|FG003|Period 1|Lost to Follow-up|0|||
16549074|NCT02798211|40474757|FG004|Period 1|Lost to Follow-up|0|||
16549075|NCT02798211|40474758|FG005|Period 1|Lost to Follow-up|0|||
16549076|NCT02798211|40474753|FG000|Period 1|Protocol Violation|0|||
16549077|NCT02798211|40474754|FG001|Period 1|Protocol Violation|0|||
16549078|NCT02798211|40474755|FG002|Period 1|Protocol Violation|2|||
16549079|NCT02798211|40474756|FG003|Period 1|Protocol Violation|0|||
16227690|NCT04145531|39313515|FG003|Part A|Withdrawal by participant|0|||
16227691|NCT04145531|39313512|FG000|Part A|Other|0|||
16227692|NCT04145531|39313513|FG001|Part A|Other|0|||
16227693|NCT04145531|39313514|FG002|Part A|Other|1|||
16227694|NCT04145531|39313515|FG003|Part A|Other|0|||
16227695|NCT04145531|39313512|FG000|Part B|Adverse Event|0|||
16116945|NCT01475461|38916188|FG006|Treatment Period|Death|0|||
16116946|NCT01475461|38916182|FG000|Treatment Period|Lost to Follow-up|0|||
16116947|NCT01475461|38916183|FG001|Treatment Period|Lost to Follow-up|3|||
16116948|NCT01475461|38916184|FG002|Treatment Period|Lost to Follow-up|2|||
16116949|NCT01475461|38916185|FG003|Treatment Period|Lost to Follow-up|3|||
16116950|NCT01475461|38916186|FG004|Treatment Period|Lost to Follow-up|1|||
16116951|NCT01475461|38916187|FG005|Treatment Period|Lost to Follow-up|2|||
16116952|NCT01475461|38916188|FG006|Treatment Period|Lost to Follow-up|1|||
16116953|NCT01475461|38916182|FG000|Treatment Period|Withdrawal by Subject|0|||
16116954|NCT01475461|38916183|FG001|Treatment Period|Withdrawal by Subject|2|||
16227696|NCT04145531|39313513|FG001|Part B|Adverse Event|0|||
16549080|NCT02798211|40474757|FG004|Period 1|Protocol Violation|0|||
16116955|NCT01475461|38916184|FG002|Treatment Period|Withdrawal by Subject|2|||
16116956|NCT01475461|38916185|FG003|Treatment Period|Withdrawal by Subject|0|||
16116957|NCT01475461|38916186|FG004|Treatment Period|Withdrawal by Subject|2|||
16116958|NCT01475461|38916187|FG005|Treatment Period|Withdrawal by Subject|2|||
16116959|NCT01475461|38916188|FG006|Treatment Period|Withdrawal by Subject|0|||
16116960|NCT01475461|38916182|FG000|Treatment Period|Other|0|||
16116961|NCT01475461|38916183|FG001|Treatment Period|Other|1|||
16549081|NCT02798211|40474758|FG005|Period 1|Protocol Violation|0|||
16549082|NCT02798211|40474753|FG000|Period 1|Withdrawal by Subject|1|||
16549083|NCT02798211|40474754|FG001|Period 1|Withdrawal by Subject|1|||
16116962|NCT01475461|38916184|FG002|Treatment Period|Other|0|||
16227697|NCT04145531|39313514|FG002|Part B|Adverse Event|0|||
16549084|NCT02798211|40474755|FG002|Period 1|Withdrawal by Subject|0|||
16116963|NCT01475461|38916185|FG003|Treatment Period|Other|0|||
16227698|NCT04145531|39313515|FG003|Part B|Adverse Event|21|||
16227699|NCT04145531|39313512|FG000|Part B|Physician Decision|0|||
16549085|NCT02798211|40474756|FG003|Period 1|Withdrawal by Subject|0|||
16549086|NCT02798211|40474757|FG004|Period 1|Withdrawal by Subject|0|||
16116964|NCT01475461|38916186|FG004|Treatment Period|Other|0|||
16116965|NCT01475461|38916187|FG005|Treatment Period|Other|0|||
16116966|NCT01475461|38916188|FG006|Treatment Period|Other|0|||
16116967|NCT01475461|38916182|FG000|Treatment Period|Protocol Violation|0|||
16116968|NCT01475461|38916183|FG001|Treatment Period|Protocol Violation|1|||
16116969|NCT01475461|38916184|FG002|Treatment Period|Protocol Violation|0|||
16227700|NCT04145531|39313513|FG001|Part B|Physician Decision|0|||
16227701|NCT04145531|39313514|FG002|Part B|Physician Decision|0|||
16227702|NCT04145531|39313515|FG003|Part B|Physician Decision|7|||
16227703|NCT04145531|39313512|FG000|Part B|Progressive disease|0|||
16227704|NCT04145531|39313513|FG001|Part B|Progressive disease|0|||
16227705|NCT04145531|39313514|FG002|Part B|Progressive disease|0|||
16227706|NCT04145531|39313515|FG003|Part B|Progressive disease|1|||
16227707|NCT04145531|39313512|FG000|Part B|Recurrent disease|0|||
16227708|NCT04145531|39313513|FG001|Part B|Recurrent disease|0|||
16227709|NCT04145531|39313514|FG002|Part B|Recurrent disease|0|||
16227710|NCT04145531|39313515|FG003|Part B|Recurrent disease|1|||
16227711|NCT04145531|39313512|FG000|Part B|Withdrawal by parent or guardian|0|||
16227712|NCT04145531|39313513|FG001|Part B|Withdrawal by parent or guardian|0|||
16227713|NCT04145531|39313514|FG002|Part B|Withdrawal by parent or guardian|0|||
16227714|NCT04145531|39313515|FG003|Part B|Withdrawal by parent or guardian|3|||
16227715|NCT04145531|39313512|FG000|Part B|Withdrawal by participant|0|||
16227716|NCT04145531|39313513|FG001|Part B|Withdrawal by participant|0|||
16227717|NCT04145531|39313514|FG002|Part B|Withdrawal by participant|0|||
16227718|NCT04145531|39313515|FG003|Part B|Withdrawal by participant|1|||
16227719|NCT04145531|39313512|FG000|Part B|Other|0|||
16227720|NCT04145531|39313513|FG001|Part B|Other|0|||
16227721|NCT04145531|39313514|FG002|Part B|Other|0|||
16227722|NCT04145531|39313515|FG003|Part B|Other|1|||
16227723|NCT00689728|39313517|FG000|Double-Blind Treatment|Adverse Event|1|||
16227724|NCT00689728|39313518|FG001|Double-Blind Treatment|Adverse Event|0|||
16227725|NCT00689728|39313519|FG002|Double-Blind Treatment|Adverse Event|0|||
16227726|NCT00689728|39313517|FG000|Double-Blind Treatment|Protocol Violation|0|||
16227727|NCT00689728|39313518|FG001|Double-Blind Treatment|Protocol Violation|0|||
16227728|NCT00689728|39313519|FG002|Double-Blind Treatment|Protocol Violation|1|||
16227729|NCT00689728|39313517|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
16227730|NCT00689728|39313518|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
16227731|NCT00689728|39313519|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
16227732|NCT00689728|39313517|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
16227733|NCT00689728|39313518|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
16227734|NCT00689728|39313519|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
16549087|NCT02798211|40474758|FG005|Period 1|Withdrawal by Subject|0|||
16549088|NCT02798211|40474753|FG000|Period 1|Death|0|||
16549089|NCT02798211|40474754|FG001|Period 1|Death|0|||
16549090|NCT02798211|40474755|FG002|Period 1|Death|1|||
16549091|NCT02798211|40474756|FG003|Period 1|Death|0|||
16549092|NCT02798211|40474757|FG004|Period 1|Death|0|||
16549093|NCT02798211|40474758|FG005|Period 1|Death|0|||
16549094|NCT02798211|40474753|FG000|Period 1|Withdrawal of Informed Consent|2|||
16549095|NCT02798211|40474754|FG001|Period 1|Withdrawal of Informed Consent|7|||
16549096|NCT02798211|40474755|FG002|Period 1|Withdrawal of Informed Consent|3|||
16549097|NCT02798211|40474756|FG003|Period 1|Withdrawal of Informed Consent|0|||
16549098|NCT02798211|40474757|FG004|Period 1|Withdrawal of Informed Consent|0|||
16227735|NCT00689728|39313517|FG000|Rescue|Adverse Event|0|||
16227736|NCT00689728|39313518|FG001|Rescue|Adverse Event|1|||
16227737|NCT00689728|39313519|FG002|Rescue|Adverse Event|0|||
16227738|NCT00689728|39313517|FG000|Rescue|Withdrawal by Subject|1|||
16227739|NCT00689728|39313518|FG001|Rescue|Withdrawal by Subject|1|||
16227740|NCT00689728|39313519|FG002|Rescue|Withdrawal by Subject|1|||
16549099|NCT02798211|40474758|FG005|Period 1|Withdrawal of Informed Consent|0|||
16116970|NCT01475461|38916185|FG003|Treatment Period|Protocol Violation|0|||
16116971|NCT01475461|38916186|FG004|Treatment Period|Protocol Violation|0|||
16116972|NCT01475461|38916187|FG005|Treatment Period|Protocol Violation|0|||
16116973|NCT01475461|38916188|FG006|Treatment Period|Protocol Violation|1|||
16116974|NCT01475461|38916182|FG000|Treatment Period|Lack of Efficacy|0|||
16116975|NCT01475461|38916183|FG001|Treatment Period|Lack of Efficacy|2|||
16116976|NCT01475461|38916184|FG002|Treatment Period|Lack of Efficacy|0|||
16116977|NCT01475461|38916185|FG003|Treatment Period|Lack of Efficacy|2|||
16116978|NCT01475461|38916186|FG004|Treatment Period|Lack of Efficacy|1|||
16116979|NCT01475461|38916187|FG005|Treatment Period|Lack of Efficacy|1|||
16116980|NCT01475461|38916188|FG006|Treatment Period|Lack of Efficacy|0|||
16227741|NCT00689728|39313517|FG000|Optional Follow-Up|Adverse Event|1|||
16227742|NCT00689728|39313518|FG001|Optional Follow-Up|Adverse Event|0|||
16227743|NCT00689728|39313519|FG002|Optional Follow-Up|Adverse Event|0|||
16227744|NCT00689728|39313517|FG000|Optional Follow-Up|Lack of Efficacy|0|||
16227745|NCT00689728|39313518|FG001|Optional Follow-Up|Lack of Efficacy|1|||
16227746|NCT00689728|39313519|FG002|Optional Follow-Up|Lack of Efficacy|1|||
16227747|NCT00689728|39313517|FG000|Optional Follow-Up|Lost to Follow-up|0|||
16227748|NCT00689728|39313518|FG001|Optional Follow-Up|Lost to Follow-up|1|||
16549100|NCT02798211|40474753|FG000|Period 2|Withdrawal by Subject|2|||
16549101|NCT02798211|40474754|FG001|Period 2|Withdrawal by Subject|0|||
16227749|NCT00689728|39313519|FG002|Optional Follow-Up|Lost to Follow-up|1|||
16227750|NCT00689728|39313517|FG000|Optional Follow-Up|Protocol Violation|0|||
16227751|NCT00689728|39313518|FG001|Optional Follow-Up|Protocol Violation|0|||
16227752|NCT00689728|39313519|FG002|Optional Follow-Up|Protocol Violation|1|||
16227753|NCT00689728|39313517|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
16227754|NCT00689728|39313518|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
16227755|NCT00689728|39313519|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
16411635|NCT02616393|39988682|FG001|Overall Study|Lost to Follow-up|2|||
16549102|NCT02798211|40474755|FG002|Period 2|Withdrawal by Subject|0|||
16549103|NCT02798211|40474756|FG003|Period 2|Withdrawal by Subject|0|||
16549104|NCT02798211|40474757|FG004|Period 2|Withdrawal by Subject|2|||
16549105|NCT02798211|40474758|FG005|Period 2|Withdrawal by Subject|2|||
16116981|NCT01475461|38916182|FG000|Treatment Period|Medication Error|0|||
16116982|NCT01475461|38916183|FG001|Treatment Period|Medication Error|0|||
16116983|NCT01475461|38916184|FG002|Treatment Period|Medication Error|0|||
16116984|NCT01475461|38916185|FG003|Treatment Period|Medication Error|1|||
16116985|NCT01475461|38916186|FG004|Treatment Period|Medication Error|0|||
16116986|NCT01475461|38916187|FG005|Treatment Period|Medication Error|0|||
16116987|NCT01475461|38916188|FG006|Treatment Period|Medication Error|0|||
16116988|NCT01475461|38916182|FG000|Treatment Period|Adverse Event|0|||
16549106|NCT02798211|40474753|FG000|Period 2|Adverse Event|5|||
16549107|NCT02798211|40474754|FG001|Period 2|Adverse Event|0|||
16549108|NCT02798211|40474755|FG002|Period 2|Adverse Event|0|||
16549109|NCT02798211|40474756|FG003|Period 2|Adverse Event|0|||
16549110|NCT02798211|40474757|FG004|Period 2|Adverse Event|1|||
16549111|NCT02798211|40474758|FG005|Period 2|Adverse Event|0|||
16549112|NCT02798211|40474753|FG000|Period 2|Lack of Efficacy|1|||
16549113|NCT02798211|40474754|FG001|Period 2|Lack of Efficacy|0|||
16549114|NCT02798211|40474755|FG002|Period 2|Lack of Efficacy|0|||
16549115|NCT02798211|40474756|FG003|Period 2|Lack of Efficacy|1|||
16549116|NCT02798211|40474757|FG004|Period 2|Lack of Efficacy|0|||
16549117|NCT02798211|40474758|FG005|Period 2|Lack of Efficacy|1|||
16411636|NCT02616393|39988683|FG002|Overall Study|Lost to Follow-up|0|||
16411637|NCT03559699|39988684|FG000|Overall Study|Withdrawal by Subject|6|||
16411638|NCT03559699|39988684|FG000|Overall Study|Lost to Follow-up|1|||
16411639|NCT00613080|39988685|FG000|Overall Study|Ineligible / no protocol treatment|11|||
16411640|NCT00657150|39988688|FG000|Overall Study|Adverse Event|19|||
16411641|NCT00657150|39988689|FG001|Overall Study|Adverse Event|10|||
16411642|NCT00657150|39988688|FG000|Overall Study|Non-compliant with protocol|5|||
16411643|NCT00657150|39988689|FG001|Overall Study|Non-compliant with protocol|9|||
16411644|NCT00657150|39988688|FG000|Overall Study|Lost to Follow-up|2|||
16411645|NCT00657150|39988689|FG001|Overall Study|Lost to Follow-up|0|||
16411646|NCT00657150|39988688|FG000|Overall Study|Withdrawal by Subject|51|||
16411647|NCT00657150|39988689|FG001|Overall Study|Withdrawal by Subject|36|||
16411648|NCT00657150|39988688|FG000|Overall Study|Other|38|||
16411649|NCT00657150|39988689|FG001|Overall Study|Other|38|||
16411650|NCT00657150|39988688|FG000|Treatment|Adverse Event|60|||
16411651|NCT00657150|39988689|FG001|Treatment|Adverse Event|53|||
16411652|NCT00657150|39988688|FG000|Treatment|Non-compliant with protocol|10|||
16411653|NCT00657150|39988689|FG001|Treatment|Non-compliant with protocol|9|||
16411654|NCT00657150|39988688|FG000|Treatment|Lost to Follow-up|1|||
16411655|NCT00657150|39988689|FG001|Treatment|Lost to Follow-up|0|||
16411656|NCT00657150|39988688|FG000|Treatment|Withdrawal by Subject|23|||
16411657|NCT00657150|39988689|FG001|Treatment|Withdrawal by Subject|20|||
16411658|NCT00657150|39988688|FG000|Treatment|Other|13|||
16411659|NCT00657150|39988689|FG001|Treatment|Other|15|||
16116989|NCT01475461|38916183|FG001|Treatment Period|Adverse Event|0|||
16227756|NCT00379639|39313522|FG000|Overall Study|Disease Progression|3|||
16411660|NCT02812966|39988690|FG000|Overall Study|Death|1|||
16411661|NCT02812966|39988691|FG001|Overall Study|Death|0|||
16411662|NCT00587847|39988692|FG000|Overall Study|Lack of Efficacy|5|||
16549118|NCT02798211|40474753|FG000|Period 2|Lost to Follow-up|3|||
16549119|NCT02798211|40474754|FG001|Period 2|Lost to Follow-up|0|||
16549120|NCT02798211|40474755|FG002|Period 2|Lost to Follow-up|0|||
16116990|NCT01475461|38916184|FG002|Treatment Period|Adverse Event|0|||
16227757|NCT00379639|39313523|FG001|Overall Study|Disease Progression|3|||
16411663|NCT00587847|39988692|FG000|Overall Study|Adverse Event|2|||
16411664|NCT03724981|39988694|FG000|First Device|Protocol Violation|1|||
16411665|NCT03724981|39988695|FG001|First Device|Protocol Violation|1|||
16411666|NCT04032080|39988697|FG000|Overall Study|Death|6|||
16347573|NCT03732820|39761947|FG000|Overall Study|Screen failure|0|||
16116991|NCT01475461|38916185|FG003|Treatment Period|Adverse Event|1|||
16116992|NCT01475461|38916186|FG004|Treatment Period|Adverse Event|0|||
16116993|NCT01475461|38916187|FG005|Treatment Period|Adverse Event|0|||
16116994|NCT01475461|38916188|FG006|Treatment Period|Adverse Event|0|||
16116995|NCT04367480|38916189|FG000|Overall Study|Adverse Event|1|||
16116996|NCT04367480|38916190|FG001|Overall Study|Adverse Event|1|||
16116997|NCT04367480|38916189|FG000|Overall Study|Death|1|||
16116998|NCT04367480|38916190|FG001|Overall Study|Death|0|||
16116999|NCT04367480|38916189|FG000|Overall Study|Lost to Follow-up|1|||
16117000|NCT04367480|38916190|FG001|Overall Study|Lost to Follow-up|1|||
16117001|NCT04367480|38916189|FG000|Overall Study|Withdrawal by Subject|0|||
16117002|NCT04367480|38916190|FG001|Overall Study|Withdrawal by Subject|3|||
16117003|NCT04367480|38916189|FG000|Overall Study|App glitch during the study|1|||
16117004|NCT04367480|38916190|FG001|Overall Study|App glitch during the study|0|||
16117005|NCT04367480|38916189|FG000|Overall Study|Device Distribution Error|0|||
16117006|NCT04367480|38916190|FG001|Overall Study|Device Distribution Error|2|||
16117007|NCT04367480|38916189|FG000|Overall Study|Ineligible after Randomization|0|||
16117008|NCT04367480|38916190|FG001|Overall Study|Ineligible after Randomization|1|||
16117009|NCT04367480|38916189|FG000|Overall Study|Other Medical Reasons|0|||
16117010|NCT04367480|38916190|FG001|Overall Study|Other Medical Reasons|2|||
16117011|NCT02737826|38916191|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
16117012|NCT02737826|38916192|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
16117013|NCT02737826|38916193|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
16117014|NCT00701909|38916194|FG000|Overall Study|Withdrawal by Subject|0|||
16117015|NCT00701909|38916195|FG001|Overall Study|Withdrawal by Subject|1|||
16117016|NCT01572740|38916196|FG000|Overall Study|Adverse Event|1|||
16117017|NCT01572740|38916197|FG001|Overall Study|Adverse Event|1|||
16117018|NCT01572740|38916196|FG000|Overall Study|Withdrawal by Subject|1|||
16117019|NCT01572740|38916197|FG001|Overall Study|Withdrawal by Subject|1|||
16117020|NCT01572740|38916196|FG000|Overall Study|unclassified|4|||
16117021|NCT01572740|38916197|FG001|Overall Study|unclassified|3|||
16117022|NCT03041792|38916200|FG000|Overall Study|Adverse Event|4|||
16117023|NCT03041792|38916201|FG001|Overall Study|Adverse Event|0|||
16117024|NCT03041792|38916200|FG000|Overall Study|Death in the family|0|||
16117025|NCT03041792|38916201|FG001|Overall Study|Death in the family|2|||
16117026|NCT03041792|38916200|FG000|Overall Study|Randomized but not treated|0|||
16117027|NCT03041792|38916201|FG001|Overall Study|Randomized but not treated|1|||
16117028|NCT02514551|38916202|FG000|Overall Study|Lost to Follow-up|0|||
16117029|NCT02514551|38916203|FG001|Overall Study|Lost to Follow-up|1|||
16117030|NCT02514551|38916202|FG000|Overall Study|Participant Never Treated|0|||
16117031|NCT02514551|38916203|FG001|Overall Study|Participant Never Treated|2|||
16117032|NCT01932762|38916204|FG000|Overall Study|Withdrawal by Subject|1|||
16117033|NCT01932762|38916205|FG001|Overall Study|Withdrawal by Subject|2|||
16117034|NCT01932762|38916206|FG002|Overall Study|Withdrawal by Subject|0|||
16117035|NCT01932762|38916207|FG003|Overall Study|Withdrawal by Subject|0|||
16117036|NCT01932762|38916204|FG000|Overall Study|Lost to Follow-up|4|||
16117037|NCT01932762|38916205|FG001|Overall Study|Lost to Follow-up|0|||
16117038|NCT01932762|38916206|FG002|Overall Study|Lost to Follow-up|0|||
16117039|NCT01932762|38916207|FG003|Overall Study|Lost to Follow-up|1|||
16117040|NCT01932762|38916204|FG000|Overall Study|Physician Decision|1|||
16117041|NCT01932762|38916205|FG001|Overall Study|Physician Decision|0|||
16117042|NCT01932762|38916206|FG002|Overall Study|Physician Decision|0|||
16117043|NCT01932762|38916207|FG003|Overall Study|Physician Decision|0|||
16117044|NCT00953147|38916212|FG000|Overall Study|Adverse Event|8|||
16117045|NCT00953147|38916213|FG001|Overall Study|Adverse Event|16|||
16117046|NCT00953147|38916214|FG002|Overall Study|Adverse Event|6|||
16117047|NCT00953147|38916212|FG000|Overall Study|Protocol Violation|2|||
16117048|NCT00953147|38916213|FG001|Overall Study|Protocol Violation|8|||
16117049|NCT00953147|38916214|FG002|Overall Study|Protocol Violation|4|||
16117050|NCT00953147|38916212|FG000|Overall Study|Withdrawal by Subject|13|||
16117051|NCT00953147|38916213|FG001|Overall Study|Withdrawal by Subject|15|||
16117052|NCT00953147|38916214|FG002|Overall Study|Withdrawal by Subject|12|||
16117053|NCT00953147|38916212|FG000|Overall Study|Lost to Follow-up|8|||
16549121|NCT02798211|40474756|FG003|Period 2|Lost to Follow-up|0|||
16549122|NCT02798211|40474757|FG004|Period 2|Lost to Follow-up|2|||
16549123|NCT02798211|40474758|FG005|Period 2|Lost to Follow-up|0|||
16549124|NCT02798211|40474753|FG000|Period 2|Physician Decision|1|||
16549125|NCT02798211|40474754|FG001|Period 2|Physician Decision|0|||
16549126|NCT02798211|40474755|FG002|Period 2|Physician Decision|0|||
16549127|NCT02798211|40474756|FG003|Period 2|Physician Decision|1|||
16549128|NCT02798211|40474757|FG004|Period 2|Physician Decision|1|||
16549129|NCT02798211|40474758|FG005|Period 2|Physician Decision|0|||
16549130|NCT02798211|40474753|FG000|Period 2|Pregnancy|0|||
16549131|NCT02798211|40474754|FG001|Period 2|Pregnancy|0|||
16549132|NCT02798211|40474755|FG002|Period 2|Pregnancy|0|||
16549133|NCT02798211|40474756|FG003|Period 2|Pregnancy|2|||
16549134|NCT02798211|40474757|FG004|Period 2|Pregnancy|0|||
16549135|NCT02798211|40474758|FG005|Period 2|Pregnancy|0|||
16549136|NCT02798211|40474753|FG000|Period 2|Technical problems|1|||
16549137|NCT02798211|40474754|FG001|Period 2|Technical problems|0|||
16549138|NCT02798211|40474755|FG002|Period 2|Technical problems|0|||
16549139|NCT02798211|40474756|FG003|Period 2|Technical problems|1|||
16549140|NCT02798211|40474757|FG004|Period 2|Technical problems|0|||
16549141|NCT02798211|40474758|FG005|Period 2|Technical problems|0|||
16549142|NCT02798211|40474753|FG000|Period 2|Withdrawal of Informed Consent|1|||
16549143|NCT02798211|40474754|FG001|Period 2|Withdrawal of Informed Consent|0|||
16549144|NCT02798211|40474755|FG002|Period 2|Withdrawal of Informed Consent|0|||
16549145|NCT02798211|40474756|FG003|Period 2|Withdrawal of Informed Consent|2|||
16549146|NCT02798211|40474757|FG004|Period 2|Withdrawal of Informed Consent|2|||
16549147|NCT02798211|40474758|FG005|Period 2|Withdrawal of Informed Consent|3|||
16549148|NCT00708305|40474759|FG000|Period 1|Protocol Violation|1|||
16549149|NCT00708305|40474760|FG001|Period 1|Protocol Violation|0|||
16549150|NCT00708305|40474761|FG002|Period 1|Protocol Violation|1|||
16549151|NCT00708305|40474762|FG003|Period 1|Protocol Violation|0|||
16549152|NCT00708305|40474759|FG000|Period 1|Other Reason|0|||
16549153|NCT00708305|40474760|FG001|Period 1|Other Reason|0|||
16549154|NCT00708305|40474761|FG002|Period 1|Other Reason|0|||
16549155|NCT00708305|40474762|FG003|Period 1|Other Reason|2|||
16549156|NCT00708305|40474759|FG000|Period 2|Lost to Follow-up|0|||
16549157|NCT00708305|40474760|FG001|Period 2|Lost to Follow-up|1|||
16549158|NCT00708305|40474761|FG002|Period 2|Lost to Follow-up|0|||
16549159|NCT00708305|40474762|FG003|Period 2|Lost to Follow-up|0|||
16549160|NCT00708305|40474759|FG000|Period 2|Protocol Violation|0|||
16549161|NCT00708305|40474760|FG001|Period 2|Protocol Violation|1|||
16549162|NCT00708305|40474761|FG002|Period 2|Protocol Violation|0|||
16549163|NCT00708305|40474762|FG003|Period 2|Protocol Violation|0|||
16549164|NCT00708305|40474759|FG000|Period 2|Other Reason|1|||
16549165|NCT00708305|40474760|FG001|Period 2|Other Reason|0|||
16549166|NCT00708305|40474761|FG002|Period 2|Other Reason|0|||
16549167|NCT00708305|40474762|FG003|Period 2|Other Reason|1|||
16549168|NCT00708305|40474759|FG000|Period 3|Protocol Violation|0|||
16549169|NCT00708305|40474760|FG001|Period 3|Protocol Violation|2|||
16549170|NCT00708305|40474761|FG002|Period 3|Protocol Violation|0|||
16549171|NCT00708305|40474762|FG003|Period 3|Protocol Violation|0|||
16549172|NCT00708305|40474759|FG000|Period 3|Other Reason|1|||
16549173|NCT00708305|40474760|FG001|Period 3|Other Reason|0|||
16549174|NCT00708305|40474761|FG002|Period 3|Other Reason|0|||
16549175|NCT00708305|40474762|FG003|Period 3|Other Reason|0|||
16549176|NCT01953003|40474766|FG000|Overall Study|Not treated|0|||
16549177|NCT01953003|40474767|FG001|Overall Study|Not treated|1|||
16549178|NCT01953003|40474766|FG000|Overall Study|Progressive disease|35|||
16549179|NCT01953003|40474767|FG001|Overall Study|Progressive disease|45|||
16549180|NCT01953003|40474766|FG000|Overall Study|Related Adverse events|7|||
16549181|NCT01953003|40474767|FG001|Overall Study|Related Adverse events|2|||
16549182|NCT01953003|40474766|FG000|Overall Study|Non-related adverse events|0|||
16549183|NCT01953003|40474767|FG001|Overall Study|Non-related adverse events|2|||
16549184|NCT01953003|40474766|FG000|Overall Study|Protocol Violation|0|||
16549185|NCT01953003|40474767|FG001|Overall Study|Protocol Violation|1|||
16549186|NCT01953003|40474766|FG000|Overall Study|Withdrawal by Subject|14|||
16549187|NCT01953003|40474767|FG001|Overall Study|Withdrawal by Subject|4|||
16549188|NCT01008475|40474768|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
16549189|NCT01008475|40474769|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
16549190|NCT01008475|40474770|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
16549191|NCT01008475|40474771|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
16549192|NCT01008475|40474772|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
16549193|NCT01008475|40474773|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
16549194|NCT01008475|40474774|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
16549195|NCT00871403|40474775|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
16549196|NCT00871403|40474776|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
16549197|NCT00871403|40474777|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
16549198|NCT00871403|40474775|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
16549199|NCT00871403|40474776|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
16549200|NCT00871403|40474777|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
16549201|NCT00871403|40474775|FG000|Combination Treatment Phase|Adverse Event|0|||
16549202|NCT00871403|40474776|FG001|Combination Treatment Phase|Adverse Event|17|||
16549203|NCT00871403|40474777|FG002|Combination Treatment Phase|Adverse Event|2|||
16549204|NCT00871403|40474775|FG000|Combination Treatment Phase|Disease Progression|0|||
16549205|NCT00871403|40474776|FG001|Combination Treatment Phase|Disease Progression|8|||
16549206|NCT00871403|40474777|FG002|Combination Treatment Phase|Disease Progression|5|||
16549207|NCT00871403|40474775|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
16549208|NCT00871403|40474776|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
16549209|NCT00871403|40474777|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
16117054|NCT00953147|38916213|FG001|Overall Study|Lost to Follow-up|9|||
16117055|NCT00953147|38916214|FG002|Overall Study|Lost to Follow-up|4|||
16117056|NCT00953147|38916212|FG000|Overall Study|Physician Decision|2|||
16117057|NCT00953147|38916213|FG001|Overall Study|Physician Decision|7|||
16117058|NCT00953147|38916214|FG002|Overall Study|Physician Decision|3|||
16117059|NCT00953147|38916212|FG000|Overall Study|Other|4|||
16117060|NCT00953147|38916213|FG001|Overall Study|Other|11|||
16117061|NCT00953147|38916214|FG002|Overall Study|Other|13|||
16117062|NCT00955708|38916217|FG000|Overall Study|Death|269|||
16117063|NCT00955708|38916217|FG000|Overall Study|Lost to Follow-up|72|||
16117064|NCT00955708|38916217|FG000|Overall Study|Physician Decision|36|||
16117065|NCT00955708|38916217|FG000|Overall Study|Protocol Violation|134|||
16117066|NCT00955708|38916217|FG000|Overall Study|Registry Conclusion|186|||
16117067|NCT00955708|38916217|FG000|Overall Study|Product removed from service|94|||
16117068|NCT00955708|38916217|FG000|Overall Study|Patient Refused to participate further|116|||
16117069|NCT00955708|38916217|FG000|Overall Study|Closure of study location|60|||
16117070|NCT00955708|38916217|FG000|Overall Study|Patient changed care provider/moved|91|||
16117071|NCT02956837|38916218|FG000|Overall Study|Serious Adverse Events|0|||
16117072|NCT02956837|38916219|FG001|Overall Study|Serious Adverse Events|1|||
16117073|NCT02956837|38916220|FG002|Overall Study|Serious Adverse Events|0|||
16117074|NCT02956837|38916221|FG003|Overall Study|Serious Adverse Events|0|||
16117075|NCT02956837|38916218|FG000|Overall Study|Withdrawal by Subject|0|||
16117076|NCT02956837|38916219|FG001|Overall Study|Withdrawal by Subject|1|||
16117077|NCT02956837|38916220|FG002|Overall Study|Withdrawal by Subject|0|||
16549210|NCT00871403|40474775|FG000|Combination Treatment Phase|Physician Decision|0|||
16549211|NCT00871403|40474776|FG001|Combination Treatment Phase|Physician Decision|1|||
16549212|NCT00871403|40474777|FG002|Combination Treatment Phase|Physician Decision|3|||
16117078|NCT02956837|38916221|FG003|Overall Study|Withdrawal by Subject|3|||
16117079|NCT02956837|38916218|FG000|Overall Study|Lost to Follow-up|0|||
16347574|NCT03732820|39761948|FG001|Overall Study|Screen failure|1|||
16117080|NCT02956837|38916219|FG001|Overall Study|Lost to Follow-up|1|||
16117081|NCT02956837|38916220|FG002|Overall Study|Lost to Follow-up|2|||
16117082|NCT02956837|38916221|FG003|Overall Study|Lost to Follow-up|0|||
16117083|NCT01261000|38916230|FG000|Overall Study|Screen failure|1|||
16347575|NCT03732820|39761947|FG000|Overall Study|Patients ongoing study at data cut off|210|||
16347576|NCT03732820|39761948|FG001|Overall Study|Patients ongoing study at data cut off|178|||
16347577|NCT03732820|39761947|FG000|Overall Study|Lost to Follow-up|4|||
16347578|NCT03732820|39761948|FG001|Overall Study|Lost to Follow-up|2|||
16347579|NCT00497146|39761949|FG000|Treatment Period|Adverse Event|6|||
16347580|NCT00497146|39761950|FG001|Treatment Period|Adverse Event|2|||
16347581|NCT00497146|39761949|FG000|Treatment Period|Withdrawal by Subject|5|||
16549213|NCT00871403|40474775|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
16549214|NCT00871403|40474776|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
16549215|NCT00871403|40474777|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
16549216|NCT00871403|40474775|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
16549217|NCT00871403|40474776|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
16549218|NCT00871403|40474777|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
16549219|NCT02006121|40474778|FG000|Double Blind Phase|Adverse Event|6|||
16549220|NCT02006121|40474779|FG001|Double Blind Phase|Adverse Event|0|||
16549221|NCT02006121|40474778|FG000|Double Blind Phase|Lack of Efficacy|1|||
16549222|NCT02006121|40474779|FG001|Double Blind Phase|Lack of Efficacy|16|||
16549223|NCT02006121|40474778|FG000|Double Blind Phase|Withdrawal by Subject|3|||
16549224|NCT02006121|40474779|FG001|Double Blind Phase|Withdrawal by Subject|4|||
16549225|NCT02006121|40474778|FG000|Double Blind Phase|Non-compliance with study drug|1|||
16549226|NCT02006121|40474779|FG001|Double Blind Phase|Non-compliance with study drug|3|||
16549227|NCT02006121|40474778|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
16549228|NCT02006121|40474779|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
16549229|NCT02006121|40474778|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
16549230|NCT02006121|40474779|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
16549231|NCT02006121|40474778|FG000|Open Label Phase|Adverse Event|15|||
16549232|NCT02006121|40474779|FG001|Open Label Phase|Adverse Event|0|||
16549233|NCT02006121|40474778|FG000|Open Label Phase|Lack of Efficacy|2|||
16549234|NCT02006121|40474779|FG001|Open Label Phase|Lack of Efficacy|0|||
16549235|NCT02006121|40474778|FG000|Open Label Phase|Protocol Violation|2|||
16549236|NCT02006121|40474779|FG001|Open Label Phase|Protocol Violation|0|||
16549237|NCT02006121|40474778|FG000|Open Label Phase|Withdrawal by Subject|3|||
16549238|NCT02006121|40474779|FG001|Open Label Phase|Withdrawal by Subject|0|||
16549239|NCT02006121|40474778|FG000|Open Label Phase|Non-compliance with study drug|3|||
16549240|NCT02006121|40474779|FG001|Open Label Phase|Non-compliance with study drug|0|||
16549241|NCT01725386|40474780|FG000|Overall Study|Death|84|||
16549242|NCT01725386|40474781|FG001|Overall Study|Death|40|||
16549243|NCT01725386|40474780|FG000|Overall Study|Lost to Follow-up|81|||
16549244|NCT01725386|40474781|FG001|Overall Study|Lost to Follow-up|6|||
16549245|NCT01725386|40474780|FG000|Overall Study|Withdrawal by Subject|10|||
16549246|NCT01725386|40474781|FG001|Overall Study|Withdrawal by Subject|0|||
16549247|NCT01679301|40474782|FG000|Screening Period|screen failure|3|||
16549248|NCT01679301|40474783|FG001|Screening Period|screen failure|0|||
16549249|NCT01679301|40474784|FG002|Screening Period|screen failure|0|||
16549250|NCT03015116|40474785|FG000|Overall Study|Lost to Follow-up|3|||
16549251|NCT03015116|40474786|FG001|Overall Study|Lost to Follow-up|0|||
16549252|NCT03015116|40474787|FG002|Overall Study|Lost to Follow-up|2|||
16549253|NCT03015116|40474785|FG000|Overall Study|Withdrawal by Subject|3|||
16549254|NCT03015116|40474786|FG001|Overall Study|Withdrawal by Subject|1|||
16549255|NCT03015116|40474787|FG002|Overall Study|Withdrawal by Subject|0|||
16549256|NCT03015116|40474785|FG000|Overall Study|Subject has New Medical Status|1|||
16549257|NCT03015116|40474786|FG001|Overall Study|Subject has New Medical Status|0|||
16549258|NCT03015116|40474787|FG002|Overall Study|Subject has New Medical Status|0|||
16549259|NCT03015116|40474785|FG000|Overall Study|Physician Decision|0|||
16549260|NCT03015116|40474786|FG001|Overall Study|Physician Decision|1|||
16549261|NCT03015116|40474787|FG002|Overall Study|Physician Decision|0|||
16549262|NCT03430063|40474789|FG000|Overall Study|Adverse Event|0|||
16549263|NCT03430063|40474790|FG001|Overall Study|Adverse Event|1|||
16549264|NCT03430063|40474791|FG002|Overall Study|Adverse Event|0|||
16549265|NCT03430063|40474789|FG000|Overall Study|Death|3|||
16549266|NCT03430063|40474790|FG001|Overall Study|Death|2|||
16549267|NCT03430063|40474791|FG002|Overall Study|Death|3|||
16549268|NCT03430063|40474789|FG000|Overall Study|Lost to Follow-up|0|||
16549269|NCT03430063|40474790|FG001|Overall Study|Lost to Follow-up|1|||
16549270|NCT03430063|40474791|FG002|Overall Study|Lost to Follow-up|0|||
16549271|NCT03430063|40474789|FG000|Overall Study|Withdrawal by Subject|0|||
16549272|NCT03430063|40474790|FG001|Overall Study|Withdrawal by Subject|0|||
16549273|NCT03430063|40474791|FG002|Overall Study|Withdrawal by Subject|1|||
16549274|NCT03430063|40474789|FG000|Overall Study|Withdrawal of consent|3|||
16117084|NCT00632502|38916231|FG000|Overall Study|Adverse Event|0|||
16117085|NCT00632502|38916232|FG001|Overall Study|Adverse Event|1|||
16117086|NCT00632502|38916231|FG000|Overall Study|Randomized not treated|3|||
16117087|NCT00632502|38916232|FG001|Overall Study|Randomized not treated|0|||
16117088|NCT03909971|38916234|FG000|Overall Study|Other Reasons Not Specified|0|||
16117089|NCT03909971|38916235|FG001|Overall Study|Other Reasons Not Specified|1|||
16117090|NCT03909971|38916234|FG000|Overall Study|Global Deterioration of Health Status|2|||
16411667|NCT00610441|39988698|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
16411668|NCT00610441|39988699|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
16411669|NCT00610441|39988700|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
16411670|NCT00610441|39988701|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
16411671|NCT00610441|39988698|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
16411672|NCT00610441|39988699|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
16411673|NCT00610441|39988700|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
16411674|NCT00610441|39988701|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
16411675|NCT00610441|39988698|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
16411676|NCT00610441|39988699|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
16411677|NCT00610441|39988700|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
16411678|NCT00610441|39988701|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
16411679|NCT00610441|39988698|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
16411680|NCT00610441|39988699|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
16411681|NCT00610441|39988700|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
16411682|NCT00610441|39988701|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
16411683|NCT00610441|39988698|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
16411684|NCT00610441|39988699|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
16411685|NCT00610441|39988700|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
16411686|NCT00610441|39988701|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
16411687|NCT00610441|39988698|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
16411688|NCT00610441|39988699|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
16411689|NCT00610441|39988700|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
16411690|NCT00610441|39988701|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
16411691|NCT00610441|39988698|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
16411692|NCT00610441|39988699|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
16411693|NCT00610441|39988700|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
16411694|NCT00610441|39988701|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
16549275|NCT03430063|40474790|FG001|Overall Study|Withdrawal of consent|1|||
16549276|NCT03430063|40474791|FG002|Overall Study|Withdrawal of consent|2|||
16549277|NCT03430063|40474789|FG000|Overall Study|Progressive disease|1|||
16549278|NCT03430063|40474790|FG001|Overall Study|Progressive disease|2|||
16549279|NCT03430063|40474791|FG002|Overall Study|Progressive disease|1|||
16549280|NCT03430063|40474789|FG000|Overall Study|Other un-specified|1|||
16549281|NCT03430063|40474790|FG001|Overall Study|Other un-specified|1|||
16549282|NCT03430063|40474791|FG002|Overall Study|Other un-specified|0|||
16411695|NCT00610441|39988698|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
16411696|NCT00610441|39988699|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
16411697|NCT00610441|39988700|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
16411698|NCT00610441|39988701|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
16411699|NCT00610441|39988698|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
16411700|NCT00610441|39988699|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
16411701|NCT00610441|39988700|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
16411702|NCT00610441|39988701|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
16411703|NCT02927262|39988704|FG000|Overall Study|Adverse Event|7|||
16411704|NCT02927262|39988705|FG001|Overall Study|Adverse Event|1|||
16411705|NCT02927262|39988704|FG000|Overall Study|Death|1|||
16411706|NCT02927262|39988705|FG001|Overall Study|Death|0|||
16411707|NCT02927262|39988704|FG000|Overall Study|Withdrawal by Subject|3|||
16411708|NCT02927262|39988705|FG001|Overall Study|Withdrawal by Subject|0|||
16549283|NCT03430063|40474789|FG000|Overall Study|Randomized, but never treated|0|||
16549284|NCT03430063|40474790|FG001|Overall Study|Randomized, but never treated|0|||
16549285|NCT03430063|40474791|FG002|Overall Study|Randomized, but never treated|1|||
16117091|NCT03909971|38916235|FG001|Overall Study|Global Deterioration of Health Status|1|||
16117092|NCT03909971|38916234|FG000|Overall Study|Progressive Disease|6|||
16117093|NCT03909971|38916235|FG001|Overall Study|Progressive Disease|14|||
16411709|NCT02927262|39988704|FG000|Overall Study|Disease Relapse|23|||
16549286|NCT03592277|40474796|FG000|Overall Study|Withdrawal by Subject|6|||
16117094|NCT03909971|38916234|FG000|Overall Study|Death|2|||
16411710|NCT02927262|39988705|FG001|Overall Study|Disease Relapse|18|||
16411711|NCT02927262|39988704|FG000|Overall Study|Miscellaneous|5|||
16411712|NCT02927262|39988705|FG001|Overall Study|Miscellaneous|4|||
16411713|NCT02927262|39988704|FG000|Overall Study|Ongoing|4|||
16411714|NCT02927262|39988705|FG001|Overall Study|Ongoing|0|||
16411715|NCT01440517|39988706|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
16411716|NCT00086502|39988709|FG000|Overall Study|Adverse Event|11|||
16411717|NCT00086502|39988710|FG001|Overall Study|Adverse Event|2|||
16549287|NCT03592277|40474797|FG001|Overall Study|Withdrawal by Subject|8|||
16227758|NCT00379639|39313524|FG002|Overall Study|Disease Progression|3|||
16227759|NCT00379639|39313525|FG003|Overall Study|Disease Progression|4|||
16227760|NCT00379639|39313526|FG004|Overall Study|Disease Progression|4|||
16227761|NCT00379639|39313522|FG000|Overall Study|Physician Decision|0|||
16227762|NCT00379639|39313523|FG001|Overall Study|Physician Decision|2|||
16227763|NCT00379639|39313524|FG002|Overall Study|Physician Decision|1|||
16227764|NCT00379639|39313525|FG003|Overall Study|Physician Decision|1|||
16227765|NCT00379639|39313526|FG004|Overall Study|Physician Decision|0|||
16227766|NCT00379639|39313522|FG000|Overall Study|Symptomatic Deterioration|0|||
16227767|NCT00379639|39313523|FG001|Overall Study|Symptomatic Deterioration|0|||
16227768|NCT00379639|39313524|FG002|Overall Study|Symptomatic Deterioration|1|||
16347582|NCT00497146|39761950|FG001|Treatment Period|Withdrawal by Subject|9|||
16549288|NCT01302938|40474802|FG000|Overall Study|Withdrawal by Subject|1|||
16549289|NCT01302938|40474803|FG001|Overall Study|Withdrawal by Subject|0|||
16549290|NCT01302938|40474802|FG000|Overall Study|Adverse Event|1|||
16549291|NCT01302938|40474803|FG001|Overall Study|Adverse Event|0|||
16549292|NCT00860067|40474804|FG000|Overall Study|Lost to Follow-up|46|||
16549293|NCT00860067|40474805|FG001|Overall Study|Lost to Follow-up|9|||
16549294|NCT00860067|40474806|FG002|Overall Study|Lost to Follow-up|9|||
16549295|NCT00860067|40474804|FG000|Overall Study|Withdrawal by Subject|4|||
16549296|NCT00860067|40474805|FG001|Overall Study|Withdrawal by Subject|0|||
16549297|NCT00860067|40474806|FG002|Overall Study|Withdrawal by Subject|0|||
16411718|NCT00086502|39988709|FG000|Overall Study|Lack of Efficacy|0|||
16411719|NCT00086502|39988710|FG001|Overall Study|Lack of Efficacy|2|||
16411720|NCT00086502|39988709|FG000|Overall Study|Lost to Follow-up|3|||
16411721|NCT00086502|39988710|FG001|Overall Study|Lost to Follow-up|1|||
16411722|NCT00086502|39988709|FG000|Overall Study|Physician Decision|1|||
16411723|NCT00086502|39988710|FG001|Overall Study|Physician Decision|1|||
16411724|NCT00086502|39988709|FG000|Overall Study|Pregnancy|0|||
16411725|NCT00086502|39988710|FG001|Overall Study|Pregnancy|1|||
16411726|NCT00086502|39988709|FG000|Overall Study|Protocol Violation|3|||
16411727|NCT00086502|39988710|FG001|Overall Study|Protocol Violation|3|||
16411728|NCT00086502|39988709|FG000|Overall Study|Withdrawal by Subject|5|||
16411729|NCT00086502|39988710|FG001|Overall Study|Withdrawal by Subject|6|||
16347583|NCT00497146|39761949|FG000|Treatment Period|Lost to Follow-up|1|||
16347584|NCT00497146|39761950|FG001|Treatment Period|Lost to Follow-up|3|||
16411730|NCT00086502|39988709|FG000|Overall Study|Patient Moved|1|||
16411731|NCT00086502|39988710|FG001|Overall Study|Patient Moved|1|||
16411732|NCT00086502|39988709|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
16411733|NCT00086502|39988710|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
16411734|NCT00086502|39988709|FG000|Overall Study|Patient Accidentally Unblinded|1|||
16411735|NCT00086502|39988710|FG001|Overall Study|Patient Accidentally Unblinded|0|||
16227769|NCT00379639|39313525|FG003|Overall Study|Symptomatic Deterioration|0|||
16347585|NCT00497146|39761949|FG000|Treatment Period|Required dialysis|4|||
16347586|NCT00497146|39761950|FG001|Treatment Period|Required dialysis|1|||
16347587|NCT00497146|39761949|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
16347588|NCT00497146|39761950|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
16347589|NCT00497146|39761949|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
16347590|NCT00497146|39761950|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
16347591|NCT00497146|39761949|FG000|Treatment Period|Other Reason|2|||
16347592|NCT00497146|39761950|FG001|Treatment Period|Other Reason|3|||
16347593|NCT00497146|39761949|FG000|Long-term Follow-up Period|Adverse Event|2|||
16411736|NCT01591863|39988711|FG000|Overall Study|Adverse Event|3|||
16411737|NCT01591863|39988711|FG000|Overall Study|Withdrawal by Subject|1|||
16411738|NCT01591863|39988711|FG000|Overall Study|recurrence|9|||
16549298|NCT00860067|40474804|FG000|Overall Study|Pregnancy|1|||
16227770|NCT00379639|39313526|FG004|Overall Study|Symptomatic Deterioration|1|||
16411739|NCT01591863|39988711|FG000|Overall Study|Lack of Efficacy|1|||
16411740|NCT02463032|39988712|FG000|Overall Study|Lack of Efficacy|61|||
16549299|NCT00860067|40474805|FG001|Overall Study|Pregnancy|0|||
16549300|NCT00860067|40474806|FG002|Overall Study|Pregnancy|0|||
16549301|NCT01719224|40474839|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
16549302|NCT01719224|40474840|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
16549303|NCT02392611|40474841|FG000|Overall Study|Adverse Event|0|||
16549304|NCT02392611|40474842|FG001|Overall Study|Adverse Event|0|||
16549305|NCT02392611|40474843|FG002|Overall Study|Adverse Event|0|||
16549306|NCT02392611|40474844|FG003|Overall Study|Adverse Event|1|||
16549307|NCT02392611|40474845|FG004|Overall Study|Adverse Event|0|||
16549308|NCT02392611|40474846|FG005|Overall Study|Adverse Event|0|||
16549309|NCT02392611|40474847|FG006|Overall Study|Adverse Event|0|||
16549310|NCT02392611|40474848|FG007|Overall Study|Adverse Event|0|||
16549311|NCT02392611|40474849|FG008|Overall Study|Adverse Event|0|||
16549312|NCT02392611|40474841|FG000|Overall Study|Progressive disease|0|||
16549313|NCT02392611|40474842|FG001|Overall Study|Progressive disease|0|||
16549314|NCT02392611|40474843|FG002|Overall Study|Progressive disease|0|||
16549315|NCT02392611|40474844|FG003|Overall Study|Progressive disease|2|||
16549316|NCT02392611|40474845|FG004|Overall Study|Progressive disease|1|||
16549317|NCT02392611|40474846|FG005|Overall Study|Progressive disease|0|||
16549318|NCT02392611|40474847|FG006|Overall Study|Progressive disease|0|||
16549319|NCT02392611|40474848|FG007|Overall Study|Progressive disease|0|||
16549320|NCT02392611|40474849|FG008|Overall Study|Progressive disease|0|||
16549321|NCT02392611|40474841|FG000|Overall Study|Death|1|||
16549322|NCT02392611|40474842|FG001|Overall Study|Death|0|||
16549323|NCT02392611|40474843|FG002|Overall Study|Death|0|||
16549324|NCT02392611|40474844|FG003|Overall Study|Death|0|||
16549325|NCT02392611|40474845|FG004|Overall Study|Death|0|||
16549326|NCT02392611|40474846|FG005|Overall Study|Death|1|||
16549327|NCT02392611|40474847|FG006|Overall Study|Death|0|||
16549328|NCT02392611|40474848|FG007|Overall Study|Death|0|||
16549329|NCT02392611|40474849|FG008|Overall Study|Death|0|||
16549330|NCT02392611|40474841|FG000|Overall Study|Withdrawal by Subject|0|||
16549331|NCT02392611|40474842|FG001|Overall Study|Withdrawal by Subject|0|||
16549332|NCT02392611|40474843|FG002|Overall Study|Withdrawal by Subject|0|||
16549333|NCT02392611|40474844|FG003|Overall Study|Withdrawal by Subject|1|||
16549334|NCT02392611|40474845|FG004|Overall Study|Withdrawal by Subject|0|||
16227771|NCT00379639|39313522|FG000|Overall Study|Adverse Event|0|||
16227772|NCT00379639|39313523|FG001|Overall Study|Adverse Event|0|||
16227773|NCT00379639|39313524|FG002|Overall Study|Adverse Event|1|||
16227774|NCT00379639|39313525|FG003|Overall Study|Adverse Event|0|||
16227775|NCT00379639|39313526|FG004|Overall Study|Adverse Event|1|||
16227776|NCT00379639|39313522|FG000|Overall Study|Lost to Follow-up|0|||
16117095|NCT03909971|38916235|FG001|Overall Study|Death|6|||
16117096|NCT00246090|38916236|FG000|Overall Study|Adverse Event|25|||
16117097|NCT00246090|38916236|FG000|Overall Study|Withdrawal by Subject|7|||
16117098|NCT00246090|38916236|FG000|Overall Study|Progressive Disease|212|||
16117099|NCT00246090|38916236|FG000|Overall Study|Clinical Progression|30|||
16117100|NCT00246090|38916236|FG000|Overall Study|Physician Decision|11|||
16117101|NCT00246090|38916236|FG000|Overall Study|Not Otherwise Specified|10|||
16227777|NCT00379639|39313523|FG001|Overall Study|Lost to Follow-up|0|||
16227778|NCT00379639|39313524|FG002|Overall Study|Lost to Follow-up|0|||
16227779|NCT00379639|39313525|FG003|Overall Study|Lost to Follow-up|1|||
16549335|NCT02392611|40474846|FG005|Overall Study|Withdrawal by Subject|0|||
16227780|NCT00379639|39313526|FG004|Overall Study|Lost to Follow-up|0|||
16227781|NCT00379639|39313522|FG000|Overall Study|Other|0|||
16227782|NCT00379639|39313523|FG001|Overall Study|Other|0|||
16227783|NCT00379639|39313524|FG002|Overall Study|Other|3|||
16227784|NCT00379639|39313525|FG003|Overall Study|Other|0|||
16227785|NCT00379639|39313526|FG004|Overall Study|Other|0|||
16227786|NCT04491591|39313528|FG000|Overall Study|Accidently randomized|3|||
16227787|NCT04491591|39313529|FG001|Overall Study|Accidently randomized|1|||
16227788|NCT04491591|39313530|FG002|Overall Study|Accidently randomized|0|||
16227789|NCT04491591|39313528|FG000|Overall Study|Did not complete survey|28|||
16411741|NCT02463032|39988713|FG001|Overall Study|Lack of Efficacy|50|||
16411742|NCT02463032|39988712|FG000|Overall Study|Death|8|||
16411743|NCT02463032|39988713|FG001|Overall Study|Death|8|||
16549336|NCT02392611|40474847|FG006|Overall Study|Withdrawal by Subject|0|||
16549337|NCT02392611|40474848|FG007|Overall Study|Withdrawal by Subject|0|||
16549338|NCT02392611|40474849|FG008|Overall Study|Withdrawal by Subject|0|||
16549339|NCT02392611|40474841|FG000|Overall Study|Lost to Follow-up|0|||
16117102|NCT03816761|38916237|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
16117103|NCT03816761|38916238|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
16227790|NCT04491591|39313529|FG001|Overall Study|Did not complete survey|20|||
16227791|NCT04491591|39313530|FG002|Overall Study|Did not complete survey|3|||
16227792|NCT01161173|39313532|FG000|Overall Study|Protocol Violation|13|||
16227793|NCT01161173|39313532|FG000|Overall Study|Lost to Follow-up|7|||
16227794|NCT01161173|39313532|FG000|Overall Study|Progressive Disease|82|||
16411744|NCT02463032|39988712|FG000|Overall Study|Adverse Event|2|||
16549340|NCT02392611|40474842|FG001|Overall Study|Lost to Follow-up|0|||
16549341|NCT02392611|40474843|FG002|Overall Study|Lost to Follow-up|0|||
16549342|NCT02392611|40474844|FG003|Overall Study|Lost to Follow-up|0|||
16227795|NCT01161173|39313532|FG000|Overall Study|Withdrawal of Consent|5|||
16227796|NCT01161173|39313532|FG000|Overall Study|Unacceptable Toxicity|21|||
16227797|NCT01161173|39313532|FG000|Overall Study|Death|194|||
16227798|NCT01161173|39313532|FG000|Overall Study|End of Study|2|||
16227799|NCT01161173|39313532|FG000|Overall Study|Reasons Not Specified|23|||
16227800|NCT00761462|39313542|FG000|Treatment|Subjects never received study medication|23|||
16227801|NCT00761462|39313543|FG001|Treatment|Subjects never received study medication|12|||
16227802|NCT00761462|39313542|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
16227803|NCT00761462|39313543|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
16227804|NCT00761462|39313542|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
16227805|NCT00761462|39313543|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
16549343|NCT02392611|40474845|FG004|Overall Study|Lost to Follow-up|0|||
16549344|NCT02392611|40474846|FG005|Overall Study|Lost to Follow-up|0|||
16549345|NCT02392611|40474847|FG006|Overall Study|Lost to Follow-up|1|||
16549346|NCT02392611|40474848|FG007|Overall Study|Lost to Follow-up|0|||
16549347|NCT02392611|40474849|FG008|Overall Study|Lost to Follow-up|0|||
16549348|NCT02392611|40474841|FG000|Overall Study|Enrolled, not treated|0|||
16549349|NCT02392611|40474842|FG001|Overall Study|Enrolled, not treated|0|||
16549350|NCT02392611|40474843|FG002|Overall Study|Enrolled, not treated|0|||
16549351|NCT02392611|40474844|FG003|Overall Study|Enrolled, not treated|2|||
16549352|NCT02392611|40474845|FG004|Overall Study|Enrolled, not treated|0|||
16549353|NCT02392611|40474846|FG005|Overall Study|Enrolled, not treated|0|||
16549354|NCT02392611|40474847|FG006|Overall Study|Enrolled, not treated|0|||
16549355|NCT02392611|40474848|FG007|Overall Study|Enrolled, not treated|0|||
16227806|NCT00761462|39313542|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
16227807|NCT00761462|39313543|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
16227808|NCT00545584|39313544|FG000|Overall Study|Only one reason for discontinuation|62|||
16227809|NCT00545584|39313545|FG001|Overall Study|Only one reason for discontinuation|61|||
16227810|NCT00545584|39313546|FG002|Overall Study|Only one reason for discontinuation|48|||
16227811|NCT00545584|39313544|FG000|Overall Study|Two or more reasons for discontinuation|17|||
16227812|NCT00545584|39313545|FG001|Overall Study|Two or more reasons for discontinuation|19|||
16227813|NCT00545584|39313546|FG002|Overall Study|Two or more reasons for discontinuation|8|||
16227814|NCT00408408|39313547|FG000|Overall Study|No follow up data|2|||
16227815|NCT00408408|39313548|FG001|Overall Study|No follow up data|3|||
16227816|NCT00408408|39313549|FG002|Overall Study|No follow up data|0|||
16227817|NCT00408408|39313550|FG003|Overall Study|No follow up data|7|||
16227818|NCT00408408|39313551|FG004|Overall Study|No follow up data|5|||
16227819|NCT00408408|39313552|FG005|Overall Study|No follow up data|3|||
16227820|NCT01711736|39313553|FG000|Overall Study|Lost to Follow-up|4|||
16227821|NCT01711736|39313554|FG001|Overall Study|Lost to Follow-up|1|||
16227822|NCT01711736|39313553|FG000|Overall Study|Withdrawal by Subject|6|||
16227823|NCT01711736|39313554|FG001|Overall Study|Withdrawal by Subject|6|||
16227824|NCT01711736|39313553|FG000|Overall Study|Migrated/moved from study area|2|||
16227825|NCT01711736|39313554|FG001|Overall Study|Migrated/moved from study area|1|||
16227826|NCT01858701|39313555|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
16227827|NCT01858701|39313556|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
16227828|NCT01858701|39313555|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
16549356|NCT02392611|40474849|FG008|Overall Study|Enrolled, not treated|0|||
16227829|NCT01858701|39313556|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
16227830|NCT01858701|39313555|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
16227831|NCT01858701|39313556|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
16227832|NCT01858701|39313555|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
16227833|NCT01858701|39313556|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
16227834|NCT02147132|39313578|FG000|Overall Study|Lost to Follow-up|1|||
16227835|NCT02147132|39313579|FG001|Overall Study|Lost to Follow-up|0|||
16227836|NCT02147132|39313580|FG002|Overall Study|Lost to Follow-up|0|||
16227837|NCT02147132|39313581|FG003|Overall Study|Lost to Follow-up|0|||
16227838|NCT03219372|39313582|FG000|Overall Study|Withdrawal by Subject|1|||
16227839|NCT03219372|39313583|FG001|Overall Study|Withdrawal by Subject|0|||
16227840|NCT01474291|39313584|FG000|Overall Study|Not Evaluable for Efficacy|26|||
16411745|NCT02463032|39988713|FG001|Overall Study|Adverse Event|6|||
16411746|NCT01241760|39988714|FG000|Overall Study|Adverse Event|1|||
16411747|NCT01241760|39988715|FG001|Overall Study|Adverse Event|0|||
16411748|NCT01241760|39988714|FG000|Overall Study|Lost to Follow-up|18|||
16411749|NCT01241760|39988715|FG001|Overall Study|Lost to Follow-up|22|||
16411750|NCT01241760|39988714|FG000|Overall Study|Withdrawal by Subject|13|||
16411751|NCT01241760|39988715|FG001|Overall Study|Withdrawal by Subject|13|||
16411752|NCT01241760|39988714|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
16411753|NCT01241760|39988715|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
16411754|NCT01241760|39988714|FG000|Overall Study|Other|1|||
16411755|NCT01241760|39988715|FG001|Overall Study|Other|1|||
16411756|NCT02120365|39988716|FG000|Overall Study|Withdrawal by Subject|0|||
16411757|NCT02120365|39988717|FG001|Overall Study|Withdrawal by Subject|0|||
16411758|NCT02120365|39988718|FG002|Overall Study|Withdrawal by Subject|2|||
16549357|NCT00114634|40474850|FG000|Overall Study|failure to return forms|3|||
16549358|NCT00003511|40474854|FG000|Overall Study|Not evaluable|4|||
16549359|NCT02387996|40474855|FG000|Overall Study|Disease Progression|167|||
16549360|NCT02387996|40474855|FG000|Overall Study|Study Drug Toxicity|31|||
16549361|NCT02387996|40474855|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
16549362|NCT02387996|40474855|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
16549363|NCT02387996|40474855|FG000|Overall Study|Subject Withdrew Consent|5|||
16117104|NCT03816761|38916239|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
16117105|NCT03816761|38916240|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
16117106|NCT03816761|38916241|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
16117107|NCT03816761|38916242|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
16117108|NCT03816761|38916237|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
16117109|NCT03816761|38916238|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
16117110|NCT03816761|38916239|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
16117111|NCT03816761|38916240|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
16117112|NCT03816761|38916241|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
16117113|NCT03816761|38916242|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
16117114|NCT02609672|38916243|FG000|Overall Study|Lost to Follow-up|3|||
16117115|NCT02609672|38916244|FG001|Overall Study|Lost to Follow-up|1|||
16117116|NCT01605019|38916245|FG000|Overall Study|pt did not meet transplant endpoint|3|||
16117117|NCT01605019|38916246|FG001|Overall Study|pt did not meet transplant endpoint|0|||
16117118|NCT04843579|38916247|FG000|Overall Study|Adverse Event|1|||
16117119|NCT04843579|38916247|FG000|Overall Study|Disease Progression|1|||
16117120|NCT00951015|38916248|FG000|Randomization Phase 96 Week|Adverse Event|1|||
16117121|NCT00951015|38916249|FG001|Randomization Phase 96 Week|Adverse Event|1|||
16117122|NCT00951015|38916250|FG002|Randomization Phase 96 Week|Adverse Event|2|||
16117123|NCT00951015|38916251|FG003|Randomization Phase 96 Week|Adverse Event|5|||
16117124|NCT00951015|38916252|FG004|Randomization Phase 96 Week|Adverse Event|0|||
16117125|NCT00951015|38916248|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
16117126|NCT00951015|38916249|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
16117127|NCT00951015|38916250|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
16117128|NCT00951015|38916251|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
16117129|NCT00951015|38916252|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
16117130|NCT00951015|38916248|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
16117131|NCT00951015|38916249|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
16117132|NCT00951015|38916250|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
16117133|NCT00951015|38916251|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
16117134|NCT00951015|38916252|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
16117135|NCT00951015|38916248|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
16117136|NCT00951015|38916249|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
16117137|NCT00951015|38916250|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
16117138|NCT00951015|38916251|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
16117139|NCT00951015|38916252|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
16117140|NCT00951015|38916248|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
16117141|NCT00951015|38916249|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
16117142|NCT00951015|38916250|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
16117143|NCT00951015|38916251|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
16117144|NCT00951015|38916252|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
16117145|NCT00951015|38916248|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
16117146|NCT00951015|38916249|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
16117147|NCT00951015|38916250|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
16117148|NCT00951015|38916251|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
16117149|NCT00951015|38916252|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
16117150|NCT00951015|38916248|FG000|Open-label Phase|Adverse Event|0|||
16117151|NCT00951015|38916249|FG001|Open-label Phase|Adverse Event|0|||
16117152|NCT00951015|38916250|FG002|Open-label Phase|Adverse Event|0|||
16117153|NCT00951015|38916251|FG003|Open-label Phase|Adverse Event|0|||
16117154|NCT00951015|38916252|FG004|Open-label Phase|Adverse Event|3|||
16117155|NCT00951015|38916248|FG000|Open-label Phase|Lack of Efficacy|0|||
16117156|NCT00951015|38916249|FG001|Open-label Phase|Lack of Efficacy|0|||
16117157|NCT00951015|38916250|FG002|Open-label Phase|Lack of Efficacy|0|||
16117158|NCT00951015|38916251|FG003|Open-label Phase|Lack of Efficacy|0|||
16117159|NCT00951015|38916252|FG004|Open-label Phase|Lack of Efficacy|1|||
16117160|NCT00951015|38916248|FG000|Open-label Phase|Protocol Violation|0|||
16117161|NCT00951015|38916249|FG001|Open-label Phase|Protocol Violation|0|||
16117162|NCT00951015|38916250|FG002|Open-label Phase|Protocol Violation|0|||
16117163|NCT00951015|38916251|FG003|Open-label Phase|Protocol Violation|0|||
16117164|NCT00951015|38916252|FG004|Open-label Phase|Protocol Violation|12|||
16117165|NCT00951015|38916248|FG000|Open-label Phase|Lost to Follow-up|0|||
16117166|NCT00951015|38916249|FG001|Open-label Phase|Lost to Follow-up|0|||
16117167|NCT00951015|38916250|FG002|Open-label Phase|Lost to Follow-up|0|||
16549364|NCT02387996|40474855|FG000|Overall Study|Lost to Follow-up|1|||
16227841|NCT01474291|39313584|FG000|Overall Study|Lack of Treatment Efficacy|88|||
16227842|NCT01474291|39313584|FG000|Overall Study|Adverse Event|53|||
16227843|NCT01474291|39313584|FG000|Overall Study|Lost to Follow-up|29|||
16227844|NCT01474291|39313584|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
16227845|NCT01474291|39313584|FG000|Overall Study|No Reason Reported|10|||
16227846|NCT01474291|39313584|FG000|Overall Study|Death|2|||
16227847|NCT05403502|39313585|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
16227848|NCT05403502|39313585|FG000|Humalog Lead-In Period|Physician Decision|2|||
16227849|NCT05403502|39313585|FG000|Humalog Lead-In Period|Protocol Violation|1|||
16227850|NCT05403502|39313585|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
16227851|NCT05403502|39313585|FG000|Lyumjev Treatment Period|Physician Decision|2|||
16227852|NCT02408016|39313586|FG000|Overall Study|Death|6|||
16227853|NCT02408016|39313587|FG001|Overall Study|Death|1|||
16227854|NCT02408016|39313588|FG002|Overall Study|Death|0|||
16227855|NCT02408016|39313586|FG000|Overall Study|Physician Decision|0|||
16227856|NCT02408016|39313587|FG001|Overall Study|Physician Decision|2|||
16227857|NCT02408016|39313588|FG002|Overall Study|Physician Decision|0|||
16227858|NCT02195531|39313589|FG000|Overall Study|Withdrawal by Subject|1|||
16227859|NCT02195531|39313590|FG001|Overall Study|Withdrawal by Subject|1|||
16227860|NCT02195531|39313591|FG002|Overall Study|Withdrawal by Subject|1|||
16227861|NCT01425268|39313592|FG000|Overall Study|Withdrawal by Subject|2|||
16227862|NCT01425268|39313593|FG001|Overall Study|Withdrawal by Subject|0|||
16227863|NCT01425268|39313592|FG000|Overall Study|Sponsor Decision|5|||
16227864|NCT01425268|39313593|FG001|Overall Study|Sponsor Decision|0|||
16227865|NCT01425268|39313592|FG000|Overall Study|Physician Decision|1|||
16227866|NCT01425268|39313593|FG001|Overall Study|Physician Decision|0|||
16227867|NCT00596466|39313595|FG000|Overall Study|Lack of Efficacy|5|||
16227868|NCT00596466|39313595|FG000|Overall Study|Adverse Event|4|||
16227869|NCT00596466|39313595|FG000|Overall Study|Withdrawal by Subject|2|||
16227870|NCT00596466|39313595|FG000|Overall Study|Protocol Violation|2|||
16227871|NCT00596466|39313595|FG000|Overall Study|Unpecified|2|||
16227872|NCT00596466|39313595|FG000|Overall Study|Enrolled, not treated|2|||
16227873|NCT01638546|39313600|FG000|Overall Study|Adverse Event|1|||
16227874|NCT01638546|39313601|FG001|Overall Study|Adverse Event|3|||
16227875|NCT02988115|39313610|FG000|Overall Study|Adverse Event|6|||
16227876|NCT02988115|39313611|FG001|Overall Study|Adverse Event|1|||
16227877|NCT02988115|39313610|FG000|Overall Study|Sponsor Decision|5|||
16227878|NCT02988115|39313611|FG001|Overall Study|Sponsor Decision|2|||
16227879|NCT02988115|39313610|FG000|Overall Study|Withdrawal by Subject|1|||
16227880|NCT02988115|39313611|FG001|Overall Study|Withdrawal by Subject|1|||
16227881|NCT02988115|39313610|FG000|Overall Study|Withdrawn by Mistake|1|||
16227882|NCT02988115|39313611|FG001|Overall Study|Withdrawn by Mistake|0|||
16227883|NCT02988115|39313610|FG000|Overall Study|Lost to Follow-up|1|||
16227884|NCT02988115|39313611|FG001|Overall Study|Lost to Follow-up|0|||
16227885|NCT02985996|39313612|FG000|Overall Study|Withdrawal by Subject|0|||
16227886|NCT02985996|39313613|FG001|Overall Study|Withdrawal by Subject|0|||
16227887|NCT02985996|39313614|FG002|Overall Study|Withdrawal by Subject|1|||
16227888|NCT02985996|39313615|FG003|Overall Study|Withdrawal by Subject|0|||
16227889|NCT02985996|39313616|FG004|Overall Study|Withdrawal by Subject|0|||
16227890|NCT02985996|39313612|FG000|Overall Study|Protocol Violation|0|||
16227891|NCT02985996|39313613|FG001|Overall Study|Protocol Violation|1|||
16227892|NCT02985996|39313614|FG002|Overall Study|Protocol Violation|0|||
16227893|NCT02985996|39313615|FG003|Overall Study|Protocol Violation|0|||
16227894|NCT02985996|39313616|FG004|Overall Study|Protocol Violation|0|||
16227895|NCT02431559|39313619|FG000|Overall Study|Adverse Event|0|||
16227896|NCT02431559|39313620|FG001|Overall Study|Adverse Event|1|||
16227897|NCT02431559|39313621|FG002|Overall Study|Adverse Event|0|||
16227898|NCT02431559|39313622|FG003|Overall Study|Adverse Event|4|||
16227899|NCT02431559|39313619|FG000|Overall Study|Progressive disease|2|||
16227900|NCT02431559|39313620|FG001|Overall Study|Progressive disease|1|||
16227901|NCT02431559|39313621|FG002|Overall Study|Progressive disease|4|||
16227902|NCT02431559|39313622|FG003|Overall Study|Progressive disease|22|||
16227903|NCT02431559|39313619|FG000|Overall Study|Withdrawal by Subject|0|||
16227904|NCT02431559|39313620|FG001|Overall Study|Withdrawal by Subject|1|||
16227905|NCT02431559|39313621|FG002|Overall Study|Withdrawal by Subject|0|||
16227906|NCT02431559|39313622|FG003|Overall Study|Withdrawal by Subject|4|||
16227907|NCT02431559|39313619|FG000|Overall Study|Physician Decision|0|||
16227908|NCT02431559|39313620|FG001|Overall Study|Physician Decision|0|||
16227909|NCT02431559|39313621|FG002|Overall Study|Physician Decision|0|||
16227910|NCT02431559|39313622|FG003|Overall Study|Physician Decision|1|||
16227911|NCT02889861|39313623|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
16227912|NCT01066546|39313624|FG000|Overall Study|Study terminated by sponsor|5|||
16227913|NCT03384316|39313625|FG000|Overall Study|Screen failure|0|||
16227914|NCT03384316|39313626|FG001|Overall Study|Screen failure|1|||
16227915|NCT03159455|39313628|FG000|Overall Study|Adverse Event|0|||
16227916|NCT03159455|39313629|FG001|Overall Study|Adverse Event|0|||
16227917|NCT03159455|39313630|FG002|Overall Study|Adverse Event|0|||
16227918|NCT03159455|39313631|FG003|Overall Study|Adverse Event|0|||
16227919|NCT03159455|39313632|FG004|Overall Study|Adverse Event|0|||
16227920|NCT03159455|39313633|FG005|Overall Study|Adverse Event|1|||
16227921|NCT01012765|39313634|FG000|Treatment Period 1|Adverse Event|1|||
16227922|NCT01012765|39313635|FG001|Treatment Period 1|Adverse Event|0|||
16227923|NCT01012765|39313636|FG002|Treatment Period 1|Adverse Event|1|||
16227924|NCT01012765|39313637|FG003|Treatment Period 1|Adverse Event|0|||
16227925|NCT01012765|39313638|FG004|Treatment Period 1|Adverse Event|0|||
16227926|NCT01012765|39313639|FG005|Treatment Period 1|Adverse Event|0|||
16227927|NCT01012765|39313634|FG000|Treatment Period 1|Withdrawal by Subject|2|||
16227928|NCT01012765|39313635|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16227929|NCT01012765|39313636|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16227930|NCT01012765|39313637|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16227931|NCT01012765|39313638|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16227932|NCT01012765|39313639|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16227933|NCT01012765|39313634|FG000|Treatment Period 1|Administrative problems|0|||
16227934|NCT01012765|39313635|FG001|Treatment Period 1|Administrative problems|0|||
16227935|NCT01012765|39313636|FG002|Treatment Period 1|Administrative problems|1|||
16227936|NCT01012765|39313637|FG003|Treatment Period 1|Administrative problems|1|||
16227937|NCT01012765|39313638|FG004|Treatment Period 1|Administrative problems|1|||
16227938|NCT01012765|39313639|FG005|Treatment Period 1|Administrative problems|0|||
16227939|NCT01012765|39313634|FG000|Treatment Period 1|Protocol Violation|0|||
16227940|NCT01012765|39313635|FG001|Treatment Period 1|Protocol Violation|0|||
16227941|NCT01012765|39313636|FG002|Treatment Period 1|Protocol Violation|0|||
16227942|NCT01012765|39313637|FG003|Treatment Period 1|Protocol Violation|2|||
16227943|NCT01012765|39313638|FG004|Treatment Period 1|Protocol Violation|1|||
16227944|NCT01012765|39313639|FG005|Treatment Period 1|Protocol Violation|0|||
16227945|NCT01012765|39313634|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
16227946|NCT01012765|39313635|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
16227947|NCT01012765|39313636|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
16227948|NCT01012765|39313637|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
16227949|NCT01012765|39313638|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
16227950|NCT01012765|39313639|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
16227951|NCT01012765|39313634|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16227952|NCT01012765|39313635|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16227953|NCT01012765|39313636|FG002|Treatment Period 2|Withdrawal by Subject|1|||
16227954|NCT01012765|39313637|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16227955|NCT01012765|39313638|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16227956|NCT01012765|39313639|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16227957|NCT01012765|39313634|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
16227958|NCT01012765|39313635|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
16227959|NCT01012765|39313636|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
16227960|NCT01012765|39313637|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
16227961|NCT01012765|39313638|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
16227962|NCT01012765|39313639|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
16227963|NCT01012765|39313634|FG000|Treatment Period 2|Adverse Event|0|||
16227964|NCT01012765|39313635|FG001|Treatment Period 2|Adverse Event|1|||
16227965|NCT01012765|39313636|FG002|Treatment Period 2|Adverse Event|1|||
16227966|NCT01012765|39313637|FG003|Treatment Period 2|Adverse Event|0|||
16227967|NCT01012765|39313638|FG004|Treatment Period 2|Adverse Event|0|||
16227968|NCT01012765|39313639|FG005|Treatment Period 2|Adverse Event|0|||
16227969|NCT01012765|39313634|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
16227970|NCT01012765|39313635|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
16227971|NCT01012765|39313636|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
16227972|NCT01012765|39313637|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
16227973|NCT01012765|39313638|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
16227974|NCT01012765|39313639|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
16227975|NCT00267202|39313640|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
16227976|NCT00267202|39313641|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
16227977|NCT00267202|39313640|FG000|Overall Study|Withdrawal by Subject|12|||
16227978|NCT00267202|39313641|FG001|Overall Study|Withdrawal by Subject|15|||
16227979|NCT00267202|39313640|FG000|Overall Study|Adverse Event|13|||
16227980|NCT00267202|39313641|FG001|Overall Study|Adverse Event|7|||
16227981|NCT00267202|39313640|FG000|Overall Study|Protocol Violation|2|||
16227982|NCT00267202|39313641|FG001|Overall Study|Protocol Violation|3|||
16549365|NCT02387996|40474855|FG000|Overall Study|Poor/Non-Compliance|1|||
16549366|NCT02387996|40474855|FG000|Overall Study|Other Reasons|5|||
16227983|NCT00267202|39313640|FG000|Overall Study|Administrative problems|2|||
16549367|NCT02387996|40474855|FG000|Overall Study|Death|1|||
16549368|NCT04359771|40474861|FG000|Overall Study|Lack of Efficacy|2|||
16227984|NCT00267202|39313641|FG001|Overall Study|Administrative problems|1|||
16227985|NCT00267202|39313640|FG000|Overall Study|Lost to Follow-up|3|||
16227986|NCT00267202|39313641|FG001|Overall Study|Lost to Follow-up|0|||
16227987|NCT01258803|39313642|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
16227988|NCT01258803|39313643|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
16549369|NCT04359771|40474862|FG001|Overall Study|Lack of Efficacy|2|||
16227989|NCT01258803|39313644|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
16227990|NCT01258803|39313645|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
16227991|NCT01258803|39313646|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
16227992|NCT01258803|39313647|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
16227993|NCT01258803|39313642|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
16227994|NCT01258803|39313643|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
16227995|NCT01258803|39313644|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
16227996|NCT01258803|39313645|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
16227997|NCT01258803|39313646|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
16227998|NCT01258803|39313647|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
16227999|NCT01258803|39313642|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
16228000|NCT01258803|39313643|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
16228001|NCT01258803|39313644|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
16228002|NCT01258803|39313645|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
16228003|NCT01258803|39313646|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
16228004|NCT01258803|39313647|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
16228005|NCT01265719|39313648|FG000|Overall Study|Does not meet entrance criteria|0|||
16228006|NCT01265719|39313649|FG001|Overall Study|Does not meet entrance criteria|3|||
16228007|NCT01265719|39313648|FG000|Overall Study|Other reasons|2|||
16228008|NCT01265719|39313649|FG001|Overall Study|Other reasons|0|||
16228009|NCT01265719|39313648|FG000|Overall Study|Withdrawal by Subject|8|||
16228010|NCT01265719|39313649|FG001|Overall Study|Withdrawal by Subject|3|||
16228011|NCT01265719|39313648|FG000|Overall Study|Lost to Follow-up|2|||
16228012|NCT01265719|39313649|FG001|Overall Study|Lost to Follow-up|7|||
16228013|NCT01265719|39313648|FG000|Overall Study|Adverse Event|2|||
16228014|NCT01265719|39313649|FG001|Overall Study|Adverse Event|0|||
16228015|NCT00033514|39313654|FG000|Overall Study|Lost to Follow-up|1|||
16228016|NCT00033514|39313655|FG001|Overall Study|Lost to Follow-up|1|||
16228017|NCT00033514|39313654|FG000|Overall Study|Withdrawal by Subject|0|||
16228018|NCT00033514|39313655|FG001|Overall Study|Withdrawal by Subject|3|||
16228019|NCT02213666|39313656|FG000|Overall Study|Withdrawal by Subject|1|||
16228020|NCT00764465|39313661|FG000|Overall Study|Adverse Event|2|||
16228021|NCT00764465|39313662|FG001|Overall Study|Adverse Event|0|||
16228022|NCT00764465|39313663|FG002|Overall Study|Adverse Event|0|||
16228023|NCT00764465|39313664|FG003|Overall Study|Adverse Event|1|||
16228024|NCT00764465|39313665|FG004|Overall Study|Adverse Event|1|||
16228025|NCT00764465|39313666|FG005|Overall Study|Adverse Event|1|||
16228026|NCT00764465|39313661|FG000|Overall Study|Withdrawal by Subject|0|||
16228027|NCT00764465|39313662|FG001|Overall Study|Withdrawal by Subject|1|||
16228028|NCT00764465|39313663|FG002|Overall Study|Withdrawal by Subject|1|||
16228029|NCT00764465|39313664|FG003|Overall Study|Withdrawal by Subject|0|||
16228030|NCT00764465|39313665|FG004|Overall Study|Withdrawal by Subject|0|||
16228031|NCT00764465|39313666|FG005|Overall Study|Withdrawal by Subject|0|||
16228032|NCT02354599|39313667|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16228033|NCT02354599|39313668|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
16228034|NCT02354599|39313669|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16228035|NCT02354599|39313670|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
16228036|NCT02354599|39313671|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
16228037|NCT02354599|39313672|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
16228038|NCT02354599|39313667|FG000|Overall Study|Withdrawal by Subject|1|||
16228039|NCT02354599|39313668|FG001|Overall Study|Withdrawal by Subject|1|||
16228040|NCT02354599|39313669|FG002|Overall Study|Withdrawal by Subject|0|||
16228041|NCT02354599|39313670|FG003|Overall Study|Withdrawal by Subject|0|||
16228042|NCT02354599|39313671|FG004|Overall Study|Withdrawal by Subject|0|||
16228043|NCT02354599|39313672|FG005|Overall Study|Withdrawal by Subject|0|||
16228044|NCT01399619|39313677|FG000|Overall Study|Adverse Event|10|||
16228045|NCT01399619|39313678|FG001|Overall Study|Adverse Event|0|||
16228046|NCT01399619|39313679|FG002|Overall Study|Adverse Event|4|||
16228047|NCT01399619|39313680|FG003|Overall Study|Adverse Event|10|||
16228048|NCT01399619|39313677|FG000|Overall Study|Lack of Efficacy|9|||
16228049|NCT01399619|39313678|FG001|Overall Study|Lack of Efficacy|0|||
16228050|NCT01399619|39313679|FG002|Overall Study|Lack of Efficacy|5|||
16228051|NCT01399619|39313680|FG003|Overall Study|Lack of Efficacy|0|||
16228052|NCT01399619|39313677|FG000|Overall Study|Withdrawal by Subject|6|||
16228053|NCT01399619|39313678|FG001|Overall Study|Withdrawal by Subject|0|||
16228054|NCT01399619|39313679|FG002|Overall Study|Withdrawal by Subject|3|||
16228055|NCT01399619|39313680|FG003|Overall Study|Withdrawal by Subject|4|||
16228056|NCT01399619|39313677|FG000|Overall Study|Protocol Violation|0|||
16228057|NCT01399619|39313678|FG001|Overall Study|Protocol Violation|0|||
16228058|NCT01399619|39313679|FG002|Overall Study|Protocol Violation|0|||
16228059|NCT01399619|39313680|FG003|Overall Study|Protocol Violation|1|||
16228060|NCT01399619|39313677|FG000|Overall Study|Not treated|0|||
16228061|NCT01399619|39313678|FG001|Overall Study|Not treated|0|||
16549370|NCT02086552|40474867|FG000|Overall Study|Withdrawal by Subject|1|||
16549371|NCT00709059|40474870|FG000|Overall Study|Lost to Follow-up|34|||
16228062|NCT01399619|39313679|FG002|Overall Study|Not treated|0|||
16228063|NCT01399619|39313680|FG003|Overall Study|Not treated|2|||
16228064|NCT01748162|39313681|FG000|Overall Study|no additional croup episodes to evaluate|2|||
16228065|NCT01748162|39313682|FG001|Overall Study|no additional croup episodes to evaluate|2|||
16228066|NCT01748162|39313681|FG000|Overall Study|participant consented but did not begin|0|||
16228067|NCT01748162|39313682|FG001|Overall Study|participant consented but did not begin|1|||
16228068|NCT01748162|39313681|FG000|Overall Study|reasons not available|3|||
16228069|NCT01748162|39313682|FG001|Overall Study|reasons not available|2|||
16228070|NCT00198107|39313685|FG000|Double-Blind Period|Adverse Event|1|||
16228071|NCT00198107|39313686|FG001|Double-Blind Period|Adverse Event|1|||
16228072|NCT00198107|39313687|FG002|Double-Blind Period|Adverse Event|0|||
16228073|NCT00198107|39313685|FG000|Double-Blind Period|Lack of Efficacy|2|||
16228074|NCT00198107|39313686|FG001|Double-Blind Period|Lack of Efficacy|0|||
16228075|NCT00198107|39313687|FG002|Double-Blind Period|Lack of Efficacy|0|||
16228076|NCT00198107|39313685|FG000|Double-Blind Period|Lost to Follow-up|2|||
16228077|NCT00198107|39313686|FG001|Double-Blind Period|Lost to Follow-up|1|||
16549372|NCT00709059|40474870|FG000|Overall Study|Withdrawal by Subject|19|||
16549373|NCT00709059|40474870|FG000|Overall Study|Physician Decision|7|||
16549374|NCT00709059|40474870|FG000|Overall Study|Disease complication|3|||
16549375|NCT00709059|40474870|FG000|Overall Study|Side effects|20|||
16549376|NCT00709059|40474870|FG000|Overall Study|Serious side effects|11|||
16549377|NCT01975220|40474873|FG000|Test Period 1|Not treated|0|||
16549378|NCT01975220|40474874|FG001|Test Period 1|Not treated|1|||
16549379|NCT01975220|40474875|FG002|Test Period 1|Not treated|0|||
16549380|NCT01975220|40474876|FG003|Test Period 1|Not treated|0|||
16549381|NCT01975220|40474877|FG004|Test Period 1|Not treated|0|||
16549382|NCT01975220|40474878|FG005|Test Period 1|Not treated|0|||
16549383|NCT02058290|40474879|FG000|Overall Study|Protocol Violation|2|||
16549384|NCT02058290|40474880|FG001|Overall Study|Protocol Violation|1|||
16549385|NCT02058290|40474879|FG000|Overall Study|Physician Decision|1|||
16549386|NCT02058290|40474880|FG001|Overall Study|Physician Decision|0|||
16549387|NCT02058290|40474879|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
16549388|NCT02058290|40474880|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
16549389|NCT02058290|40474879|FG000|Overall Study|Withdrawal by Subject|0|||
16228078|NCT00198107|39313687|FG002|Double-Blind Period|Lost to Follow-up|0|||
16228079|NCT00198107|39313685|FG000|Double-Blind Period|Physician Decision|1|||
16228080|NCT00198107|39313686|FG001|Double-Blind Period|Physician Decision|0|||
16228081|NCT00198107|39313687|FG002|Double-Blind Period|Physician Decision|0|||
16228082|NCT00198107|39313685|FG000|Double-Blind Period|Withdrawal by Subject|0|||
16549390|NCT02058290|40474880|FG001|Overall Study|Withdrawal by Subject|1|||
16549391|NCT01336621|40474884|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
16228083|NCT00198107|39313686|FG001|Double-Blind Period|Withdrawal by Subject|1|||
16228084|NCT00198107|39313687|FG002|Double-Blind Period|Withdrawal by Subject|0|||
16228085|NCT00198107|39313685|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
16228086|NCT00198107|39313686|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
16228087|NCT00198107|39313687|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
16228088|NCT00505765|39313688|FG000|Overall Study|Withdrawal by Subject|1|||
16228089|NCT00505765|39313689|FG001|Overall Study|Withdrawal by Subject|0|||
16228090|NCT00505765|39313690|FG002|Overall Study|Withdrawal by Subject|0|||
16228091|NCT00505765|39313688|FG000|Overall Study|Adverse Event|1|||
16228092|NCT00505765|39313689|FG001|Overall Study|Adverse Event|2|||
16228093|NCT00505765|39313690|FG002|Overall Study|Adverse Event|0|||
16228094|NCT00505765|39313688|FG000|Overall Study|Noncompliance|0|||
16228095|NCT00505765|39313689|FG001|Overall Study|Noncompliance|1|||
16228096|NCT00505765|39313690|FG002|Overall Study|Noncompliance|3|||
16228097|NCT02543918|39313691|FG000|Overall Study|Never treated|0|||
16228098|NCT02543918|39313692|FG001|Overall Study|Never treated|1|||
16228099|NCT02543918|39313691|FG000|Overall Study|Lost to Follow-up|1|||
16228100|NCT02543918|39313692|FG001|Overall Study|Lost to Follow-up|1|||
16228101|NCT02543918|39313691|FG000|Overall Study|Withdrawal by Subject|1|||
16228102|NCT02543918|39313692|FG001|Overall Study|Withdrawal by Subject|1|||
16228103|NCT02543918|39313691|FG000|Overall Study|Adverse Event|1|||
16228104|NCT02543918|39313692|FG001|Overall Study|Adverse Event|1|||
16228105|NCT01348828|39313693|FG000|Overall Study|Death|20|||
16228106|NCT01348828|39313693|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
16228107|NCT01348828|39313693|FG000|Overall Study|Conversion|2|||
16228108|NCT01348828|39313693|FG000|Overall Study|missed visit|1|||
16228109|NCT00690612|39313696|FG000|Overall Study|Adverse Event|1|||
16228110|NCT00690612|39313696|FG000|Overall Study|Withdrawal by Subject|2|||
16411759|NCT02120365|39988719|FG003|Overall Study|Withdrawal by Subject|4|||
16549392|NCT01336621|40474884|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
16411760|NCT02120365|39988720|FG004|Overall Study|Withdrawal by Subject|0|||
16549393|NCT01336621|40474884|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
16549394|NCT01336621|40474884|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
16549395|NCT01336621|40474884|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
16411761|NCT02120365|39988721|FG005|Overall Study|Withdrawal by Subject|2|||
16228111|NCT01054443|39313699|FG000|Overall Study|Withdrawal by Subject|0|||
16228112|NCT01054443|39313700|FG001|Overall Study|Withdrawal by Subject|0|||
16228113|NCT01054443|39313701|FG002|Overall Study|Withdrawal by Subject|0|||
16228114|NCT01054443|39313702|FG003|Overall Study|Withdrawal by Subject|1|||
16228115|NCT02030067|39313703|FG000|Overall Study|Disease Progression|1|||
16228116|NCT02030067|39313704|FG001|Overall Study|Disease Progression|1|||
16228117|NCT02030067|39313705|FG002|Overall Study|Disease Progression|2|||
16228118|NCT02030067|39313706|FG003|Overall Study|Disease Progression|2|||
16228119|NCT02030067|39313707|FG004|Overall Study|Disease Progression|3|||
16228120|NCT02030067|39313708|FG005|Overall Study|Disease Progression|2|||
16228121|NCT02030067|39313709|FG006|Overall Study|Disease Progression|3|||
16228122|NCT02030067|39313710|FG007|Overall Study|Disease Progression|3|||
16228123|NCT02030067|39313711|FG008|Overall Study|Disease Progression|4|||
16228124|NCT02030067|39313712|FG009|Overall Study|Disease Progression|3|||
16117168|NCT00951015|38916251|FG003|Open-label Phase|Lost to Follow-up|0|||
16117169|NCT00951015|38916252|FG004|Open-label Phase|Lost to Follow-up|12|||
16117170|NCT00951015|38916248|FG000|Open-label Phase|Withdrawal by Subject|0|||
16117171|NCT00951015|38916249|FG001|Open-label Phase|Withdrawal by Subject|0|||
16117172|NCT00951015|38916250|FG002|Open-label Phase|Withdrawal by Subject|0|||
16117173|NCT00951015|38916251|FG003|Open-label Phase|Withdrawal by Subject|0|||
16117174|NCT00951015|38916252|FG004|Open-label Phase|Withdrawal by Subject|14|||
16411762|NCT02649855|39988722|FG000|Overall Study|Refused further treatment|2|||
16411763|NCT02649855|39988723|FG001|Overall Study|Refused further treatment|1|||
16411764|NCT02649855|39988724|FG002|Overall Study|Refused further treatment|1|||
16411765|NCT02649855|39988722|FG000|Overall Study|Withdrew consent|0|||
16411766|NCT02649855|39988723|FG001|Overall Study|Withdrew consent|1|||
16411767|NCT02649855|39988724|FG002|Overall Study|Withdrew consent|0|||
16411768|NCT02649855|39988722|FG000|Overall Study|Switched to alternative treatment|0|||
16411769|NCT02649855|39988723|FG001|Overall Study|Switched to alternative treatment|1|||
16411770|NCT02649855|39988724|FG002|Overall Study|Switched to alternative treatment|1|||
16411771|NCT02649855|39988722|FG000|Overall Study|Principal investigator discretion|0|||
16411772|NCT02649855|39988723|FG001|Overall Study|Principal investigator discretion|1|||
16411773|NCT02649855|39988724|FG002|Overall Study|Principal investigator discretion|1|||
16411774|NCT02649855|39988722|FG000|Overall Study|No treatment, per protocol|1|||
16411775|NCT02649855|39988723|FG001|Overall Study|No treatment, per protocol|0|||
16411776|NCT02649855|39988724|FG002|Overall Study|No treatment, per protocol|0|||
16411777|NCT02649855|39988722|FG000|Overall Study|Initiate new treatment|1|||
16411778|NCT02649855|39988723|FG001|Overall Study|Initiate new treatment|0|||
16411779|NCT02649855|39988724|FG002|Overall Study|Initiate new treatment|0|||
16411780|NCT00787137|39988725|FG000|Overall Study|Study Termination|0|||
16411781|NCT00787137|39988726|FG001|Overall Study|Study Termination|0|||
16411782|NCT00787137|39988727|FG002|Overall Study|Study Termination|1|||
16411783|NCT02576860|39988728|FG000|Overall Study|Adverse Event|6|||
16411784|NCT02576860|39988729|FG001|Overall Study|Adverse Event|6|||
16411785|NCT02576860|39988728|FG000|Overall Study|Lost to Follow-up|5|||
16411786|NCT02576860|39988729|FG001|Overall Study|Lost to Follow-up|7|||
16411787|NCT02576860|39988728|FG000|Overall Study|Physician Decision|0|||
16411788|NCT02576860|39988729|FG001|Overall Study|Physician Decision|1|||
16411789|NCT02576860|39988728|FG000|Overall Study|Protocol Violation|0|||
16549396|NCT01336621|40474884|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
16549397|NCT01336621|40474884|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
16549398|NCT01336621|40474884|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
16549399|NCT01336621|40474884|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
16549400|NCT01336621|40474884|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
16549401|NCT01336621|40474884|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
16549402|NCT01336621|40474884|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
16549403|NCT01336621|40474884|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
16549404|NCT01336621|40474884|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
16549405|NCT02948959|40474891|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
16549406|NCT02948959|40474892|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
16549407|NCT02948959|40474891|FG000|52 Weeks Treatment Period|Adverse Event|2|||
16549408|NCT02948959|40474892|FG001|52 Weeks Treatment Period|Adverse Event|5|||
16549409|NCT02948959|40474891|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
16549410|NCT02948959|40474892|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
16549411|NCT02948959|40474891|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
16549412|NCT02948959|40474892|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
16549413|NCT02948959|40474891|FG000|52 Weeks Treatment Period|Randomized by error|0|||
16549414|NCT02948959|40474892|FG001|52 Weeks Treatment Period|Randomized by error|5|||
16549415|NCT02948959|40474891|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
16549416|NCT02948959|40474892|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
16549417|NCT02948959|40474891|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
16549418|NCT02948959|40474892|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
16549419|NCT02948959|40474891|FG000|52 Weeks Treatment Period|Change of residence location|0|||
16549420|NCT02948959|40474892|FG001|52 Weeks Treatment Period|Change of residence location|1|||
16549421|NCT02948959|40474891|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
16549422|NCT02948959|40474892|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
16549423|NCT02948959|40474891|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
16549424|NCT02948959|40474892|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
16411790|NCT02576860|39988729|FG001|Overall Study|Protocol Violation|2|||
16411791|NCT02576860|39988728|FG000|Overall Study|Withdrawal by Subject|13|||
16411792|NCT02576860|39988729|FG001|Overall Study|Withdrawal by Subject|8|||
16411793|NCT02576860|39988728|FG000|Overall Study|Disallowed medication|1|||
16411794|NCT02576860|39988729|FG001|Overall Study|Disallowed medication|0|||
16549425|NCT02948959|40474891|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
16411795|NCT00849875|39988731|FG000|Overall Study|Death|28|||
16411796|NCT00849875|39988731|FG000|Overall Study|Ongoing (unknown completion status)|11|||
16411797|NCT00849875|39988731|FG000|Overall Study|Others|6|||
16411798|NCT00849875|39988731|FG000|Overall Study|Lost to Follow-up|2|||
16411799|NCT02278614|39988732|FG000|Overall Study|Withdrawal by Subject|3|||
16411800|NCT02278614|39988733|FG001|Overall Study|Withdrawal by Subject|5|||
16117175|NCT00951015|38916248|FG000|Open-label Phase|Physician Decision|0|||
16117176|NCT00951015|38916249|FG001|Open-label Phase|Physician Decision|0|||
16117177|NCT00951015|38916250|FG002|Open-label Phase|Physician Decision|0|||
16117178|NCT00951015|38916251|FG003|Open-label Phase|Physician Decision|0|||
16117179|NCT00951015|38916252|FG004|Open-label Phase|Physician Decision|8|||
16117180|NCT01810939|38916253|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
16117181|NCT01810939|38916254|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
16117182|NCT01810939|38916255|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
16228125|NCT02030067|39313713|FG010|Overall Study|Disease Progression|7|||
16228126|NCT02030067|39313714|FG011|Overall Study|Disease Progression|2|||
16228127|NCT02030067|39313715|FG012|Overall Study|Disease Progression|59|||
16228128|NCT02030067|39313703|FG000|Overall Study|Withdrawal by Subject|0|||
16228129|NCT02030067|39313704|FG001|Overall Study|Withdrawal by Subject|0|||
16228130|NCT02030067|39313705|FG002|Overall Study|Withdrawal by Subject|0|||
16228131|NCT02030067|39313706|FG003|Overall Study|Withdrawal by Subject|1|||
16228132|NCT02030067|39313707|FG004|Overall Study|Withdrawal by Subject|0|||
16411801|NCT02278614|39988732|FG000|Overall Study|Adverse Event|1|||
16411802|NCT02278614|39988733|FG001|Overall Study|Adverse Event|0|||
16411803|NCT02278614|39988732|FG000|Overall Study|left eye was not eligible|1|||
16411804|NCT02278614|39988733|FG001|Overall Study|left eye was not eligible|0|||
16411805|NCT02356887|39988734|FG000|Overall Study|poor compliance|2|||
16411806|NCT01064687|39988735|FG000|Overall Study|Adverse Event|9|||
16411807|NCT01064687|39988736|FG001|Overall Study|Adverse Event|4|||
16411808|NCT01064687|39988737|FG002|Overall Study|Adverse Event|10|||
16411809|NCT01064687|39988738|FG003|Overall Study|Adverse Event|3|||
16411810|NCT01064687|39988735|FG000|Overall Study|Death|1|||
16411811|NCT01064687|39988736|FG001|Overall Study|Death|1|||
16411812|NCT01064687|39988737|FG002|Overall Study|Death|0|||
16411813|NCT01064687|39988738|FG003|Overall Study|Death|0|||
16411814|NCT01064687|39988735|FG000|Overall Study|Entry Criteria Not Met|3|||
16411815|NCT01064687|39988736|FG001|Overall Study|Entry Criteria Not Met|0|||
16411816|NCT01064687|39988737|FG002|Overall Study|Entry Criteria Not Met|0|||
16411817|NCT01064687|39988738|FG003|Overall Study|Entry Criteria Not Met|0|||
16411818|NCT01064687|39988735|FG000|Overall Study|Lack of Efficacy|1|||
16411819|NCT01064687|39988736|FG001|Overall Study|Lack of Efficacy|0|||
16411820|NCT01064687|39988737|FG002|Overall Study|Lack of Efficacy|2|||
16411821|NCT01064687|39988738|FG003|Overall Study|Lack of Efficacy|3|||
16411822|NCT01064687|39988735|FG000|Overall Study|Lost to Follow-up|7|||
16411823|NCT01064687|39988736|FG001|Overall Study|Lost to Follow-up|10|||
16549426|NCT02948959|40474892|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
16411824|NCT01064687|39988737|FG002|Overall Study|Lost to Follow-up|13|||
16411825|NCT01064687|39988738|FG003|Overall Study|Lost to Follow-up|5|||
16411826|NCT01064687|39988735|FG000|Overall Study|Physician Decision|2|||
16411827|NCT01064687|39988736|FG001|Overall Study|Physician Decision|2|||
16411828|NCT01064687|39988737|FG002|Overall Study|Physician Decision|0|||
16411829|NCT01064687|39988738|FG003|Overall Study|Physician Decision|0|||
16411830|NCT01064687|39988735|FG000|Overall Study|Protocol Violation|1|||
16411831|NCT01064687|39988736|FG001|Overall Study|Protocol Violation|1|||
16411832|NCT01064687|39988737|FG002|Overall Study|Protocol Violation|0|||
16549427|NCT02948959|40474891|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
16549428|NCT02948959|40474892|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
16549429|NCT02948959|40474891|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
16549430|NCT02948959|40474892|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
16549431|NCT02948959|40474891|FG000|12 Weeks Follow-up Period|Study site closure|1|||
16549432|NCT02948959|40474892|FG001|12 Weeks Follow-up Period|Study site closure|0|||
16549433|NCT01336634|40474893|FG000|Overall Study|Study closed/terminated|5|||
16549434|NCT01336634|40474894|FG001|Overall Study|Study closed/terminated|6|||
16549435|NCT01336634|40474895|FG002|Overall Study|Study closed/terminated|6|||
16549436|NCT01336634|40474893|FG000|Overall Study|Lost to Follow-up|2|||
16549437|NCT01336634|40474894|FG001|Overall Study|Lost to Follow-up|1|||
16549438|NCT01336634|40474895|FG002|Overall Study|Lost to Follow-up|1|||
16549439|NCT01336634|40474893|FG000|Overall Study|Physician Decision|1|||
16549440|NCT01336634|40474894|FG001|Overall Study|Physician Decision|1|||
16549441|NCT01336634|40474895|FG002|Overall Study|Physician Decision|0|||
16549442|NCT01336634|40474893|FG000|Overall Study|Withdrawal by Subject|6|||
16549443|NCT01336634|40474894|FG001|Overall Study|Withdrawal by Subject|0|||
16549444|NCT01336634|40474895|FG002|Overall Study|Withdrawal by Subject|2|||
16549445|NCT03214081|40474896|FG000|Overall Study|Case Report Forms Uncollected|9|||
16549446|NCT03214081|40474896|FG000|Overall Study|Protocol Deviation|54|||
16549447|NCT01862796|40474897|FG000|Overall Study|Prohibited medications|0|||
16549448|NCT01862796|40474898|FG001|Overall Study|Prohibited medications|0|||
16549449|NCT01862796|40474899|FG002|Overall Study|Prohibited medications|1|||
16549450|NCT03035032|40474905|FG000|Overall Study|Adverse Event|2|||
16549451|NCT03035032|40474905|FG000|Overall Study|Death|9|||
16549452|NCT03035032|40474905|FG000|Overall Study|Lost to Follow-up|1|||
16549453|NCT03035032|40474905|FG000|Overall Study|Progressive Disease|22|||
16549454|NCT03035032|40474905|FG000|Overall Study|Protocol Violation|2|||
16228133|NCT02030067|39313708|FG005|Overall Study|Withdrawal by Subject|0|||
16228134|NCT02030067|39313709|FG006|Overall Study|Withdrawal by Subject|0|||
16228135|NCT02030067|39313710|FG007|Overall Study|Withdrawal by Subject|1|||
16228136|NCT02030067|39313711|FG008|Overall Study|Withdrawal by Subject|0|||
16228137|NCT02030067|39313712|FG009|Overall Study|Withdrawal by Subject|0|||
16228138|NCT02030067|39313713|FG010|Overall Study|Withdrawal by Subject|3|||
16228139|NCT02030067|39313714|FG011|Overall Study|Withdrawal by Subject|0|||
16228140|NCT02030067|39313715|FG012|Overall Study|Withdrawal by Subject|6|||
16228141|NCT02030067|39313703|FG000|Overall Study|Physician Decision|0|||
16228142|NCT02030067|39313704|FG001|Overall Study|Physician Decision|0|||
16228143|NCT02030067|39313705|FG002|Overall Study|Physician Decision|0|||
16228144|NCT02030067|39313706|FG003|Overall Study|Physician Decision|0|||
16228145|NCT02030067|39313707|FG004|Overall Study|Physician Decision|0|||
16228146|NCT02030067|39313708|FG005|Overall Study|Physician Decision|0|||
16228147|NCT02030067|39313709|FG006|Overall Study|Physician Decision|0|||
16228148|NCT02030067|39313710|FG007|Overall Study|Physician Decision|0|||
16228149|NCT02030067|39313711|FG008|Overall Study|Physician Decision|0|||
16228150|NCT02030067|39313712|FG009|Overall Study|Physician Decision|0|||
16411833|NCT01064687|39988738|FG003|Overall Study|Protocol Violation|1|||
16411834|NCT01064687|39988735|FG000|Overall Study|Sponsor Decision|0|||
16411835|NCT01064687|39988736|FG001|Overall Study|Sponsor Decision|0|||
16411836|NCT01064687|39988737|FG002|Overall Study|Sponsor Decision|3|||
16411837|NCT01064687|39988738|FG003|Overall Study|Sponsor Decision|0|||
16411838|NCT01064687|39988735|FG000|Overall Study|Withdrawal by Subject|9|||
16411839|NCT01064687|39988736|FG001|Overall Study|Withdrawal by Subject|7|||
16411840|NCT01064687|39988737|FG002|Overall Study|Withdrawal by Subject|12|||
16411841|NCT01064687|39988738|FG003|Overall Study|Withdrawal by Subject|5|||
16411842|NCT01064687|39988735|FG000|Overall Study|Treatment Noncompliance|1|||
16411843|NCT01064687|39988736|FG001|Overall Study|Treatment Noncompliance|1|||
16411844|NCT01064687|39988737|FG002|Overall Study|Treatment Noncompliance|1|||
16411845|NCT01064687|39988738|FG003|Overall Study|Treatment Noncompliance|0|||
16411846|NCT03242252|39988748|FG000|Overall Study|At the Participant's own Request|18|||
16411847|NCT03242252|39988749|FG001|Overall Study|At the Participant's own Request|10|||
16117183|NCT01810939|38916253|FG000|Part A Treatment Period|Protocol Violation|2|||
16117184|NCT01810939|38916254|FG001|Part A Treatment Period|Protocol Violation|0|||
16117185|NCT01810939|38916255|FG002|Part A Treatment Period|Protocol Violation|0|||
16117186|NCT01810939|38916253|FG000|Part A Treatment Period|Adverse Event|10|||
16117187|NCT01810939|38916254|FG001|Part A Treatment Period|Adverse Event|0|||
16117188|NCT01810939|38916255|FG002|Part A Treatment Period|Adverse Event|0|||
16117189|NCT01810939|38916253|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
16117190|NCT01810939|38916254|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
16117191|NCT01810939|38916255|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
16117192|NCT01810939|38916253|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
16117193|NCT01810939|38916254|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
16117194|NCT01810939|38916255|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
16117195|NCT01810939|38916253|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
16117196|NCT01810939|38916254|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
16117197|NCT01810939|38916255|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
16117198|NCT01810939|38916253|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
16117199|NCT01810939|38916254|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
16117200|NCT01810939|38916255|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
16117201|NCT01810939|38916253|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
16117202|NCT01810939|38916254|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
16117203|NCT01810939|38916255|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
16117204|NCT01810939|38916253|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
16117205|NCT01810939|38916254|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
16117206|NCT01810939|38916255|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
16117207|NCT01810939|38916253|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
16117208|NCT01810939|38916254|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
16117209|NCT01810939|38916255|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
16117210|NCT01810939|38916253|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
16117211|NCT01810939|38916254|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
16117212|NCT01810939|38916255|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
16117213|NCT01810939|38916253|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
16117214|NCT01810939|38916254|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
16228151|NCT02030067|39313713|FG010|Overall Study|Physician Decision|1|||
16228152|NCT02030067|39313714|FG011|Overall Study|Physician Decision|0|||
16228153|NCT02030067|39313715|FG012|Overall Study|Physician Decision|3|||
16228154|NCT02030067|39313703|FG000|Overall Study|other reasons|0|||
16411848|NCT03242252|39988750|FG002|Overall Study|At the Participant's own Request|15|||
16411849|NCT03242252|39988748|FG000|Overall Study|Adverse Event|8|||
16549455|NCT03035032|40474905|FG000|Overall Study|Withdrawal by Subject|2|||
16117215|NCT01810939|38916255|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
16117216|NCT01810939|38916253|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
16117217|NCT01810939|38916254|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
16117218|NCT01810939|38916255|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
16117219|NCT01810939|38916253|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
16117220|NCT01810939|38916254|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
16117221|NCT01810939|38916255|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
16117222|NCT01810939|38916253|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
16117223|NCT01810939|38916254|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
16117224|NCT01810939|38916255|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
16117225|NCT01810939|38916253|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
16117226|NCT01810939|38916254|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
16117227|NCT01810939|38916255|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
16117228|NCT01810939|38916253|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
16117229|NCT01810939|38916254|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
16117230|NCT01810939|38916255|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
16117231|NCT03361605|38916261|FG000|Overall Study|Analyzable data not available|3|||
16117232|NCT00738283|38916262|FG000|Overall Study|Death|1|||
16117233|NCT00738283|38916262|FG000|Overall Study|Transfer to another facility|2|||
16117234|NCT00738283|38916262|FG000|Overall Study|Discharge home prior to end of study|1|||
16117235|NCT02683785|38916263|FG000|Overall Study|Withdrawal by Subject|1|||
16117236|NCT02683785|38916264|FG001|Overall Study|Withdrawal by Subject|1|||
16117237|NCT02683785|38916263|FG000|Overall Study|Lost to Follow-up|0|||
16117238|NCT02683785|38916264|FG001|Overall Study|Lost to Follow-up|1|||
16117239|NCT02683785|38916263|FG000|Overall Study|Adverse Event|0|||
16117240|NCT02683785|38916264|FG001|Overall Study|Adverse Event|2|||
16117241|NCT01208103|38916267|FG000|Overall Study|Adverse Event|1|||
16117242|NCT01208103|38916267|FG000|Overall Study|Withdrawal by Subject|1|||
16117243|NCT01289210|38916268|FG000|Overall Study|Adverse Event|1|||
16117244|NCT00965497|38916269|FG000|Overall Study|Physician Decision|1|||
16117245|NCT00581893|38916270|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
16117246|NCT00581893|38916271|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
16117247|NCT00790400|38916272|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
16117248|NCT00790400|38916273|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
16117249|NCT00790400|38916272|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
16117250|NCT00790400|38916273|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
16228155|NCT02030067|39313704|FG001|Overall Study|other reasons|0|||
16228156|NCT02030067|39313705|FG002|Overall Study|other reasons|0|||
16228157|NCT02030067|39313706|FG003|Overall Study|other reasons|0|||
16228158|NCT02030067|39313707|FG004|Overall Study|other reasons|0|||
16411850|NCT03242252|39988749|FG001|Overall Study|Adverse Event|6|||
16411851|NCT03242252|39988750|FG002|Overall Study|Adverse Event|9|||
16411852|NCT03242252|39988748|FG000|Overall Study|Poor Compliance to Protocol|0|||
16228159|NCT02030067|39313708|FG005|Overall Study|other reasons|1|||
16228160|NCT02030067|39313709|FG006|Overall Study|other reasons|0|||
16228161|NCT02030067|39313710|FG007|Overall Study|other reasons|0|||
16228162|NCT02030067|39313711|FG008|Overall Study|other reasons|2|||
16228163|NCT02030067|39313712|FG009|Overall Study|other reasons|0|||
16228164|NCT02030067|39313713|FG010|Overall Study|other reasons|0|||
16228165|NCT02030067|39313714|FG011|Overall Study|other reasons|0|||
16228166|NCT02030067|39313715|FG012|Overall Study|other reasons|4|||
16228167|NCT02030067|39313703|FG000|Overall Study|Adverse Event|0|||
16228168|NCT02030067|39313704|FG001|Overall Study|Adverse Event|0|||
16228169|NCT02030067|39313705|FG002|Overall Study|Adverse Event|0|||
16228170|NCT02030067|39313706|FG003|Overall Study|Adverse Event|0|||
16411853|NCT03242252|39988749|FG001|Overall Study|Poor Compliance to Protocol|2|||
16228171|NCT02030067|39313707|FG004|Overall Study|Adverse Event|0|||
16411854|NCT03242252|39988750|FG002|Overall Study|Poor Compliance to Protocol|3|||
16117251|NCT00790400|38916272|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
16117252|NCT00790400|38916273|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
16117253|NCT00790400|38916272|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
16117254|NCT00790400|38916273|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
16117255|NCT00790400|38916272|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
16117256|NCT00790400|38916273|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
16117257|NCT00790400|38916272|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
16117258|NCT00790400|38916273|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
16117259|NCT00790400|38916272|FG000|Double-blind Period (Core Phase)|Death|1|||
16117260|NCT00790400|38916273|FG001|Double-blind Period (Core Phase)|Death|0|||
16117261|NCT00790400|38916272|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
16117262|NCT00790400|38916273|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
16117263|NCT00790400|38916272|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
16117264|NCT00790400|38916273|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
16117265|NCT00790400|38916272|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
16117266|NCT00790400|38916273|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
16117267|NCT00790400|38916272|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
16117268|NCT00790400|38916273|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
16117269|NCT00790400|38916272|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
16117270|NCT00790400|38916273|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
16117271|NCT00790400|38916272|FG000|Everolimus Period (Core or Extension)|Death|1|||
16117272|NCT00790400|38916273|FG001|Everolimus Period (Core or Extension)|Death|0|||
16117273|NCT00790400|38916272|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
16117274|NCT00790400|38916273|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
16117275|NCT00790400|38916272|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
16117276|NCT00790400|38916273|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
16117277|NCT00790400|38916272|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
16117278|NCT00790400|38916273|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
16117279|NCT00527787|38916274|FG000|Overall Study|Adverse Event|14|||
16117280|NCT00527787|38916275|FG001|Overall Study|Adverse Event|24|||
16117281|NCT00527787|38916274|FG000|Overall Study|Withdrawal by Subject|13|||
16117282|NCT00527787|38916275|FG001|Overall Study|Withdrawal by Subject|25|||
16117283|NCT00527787|38916274|FG000|Overall Study|Lost to Follow-up|5|||
16117284|NCT00527787|38916275|FG001|Overall Study|Lost to Follow-up|2|||
16117285|NCT00527787|38916274|FG000|Overall Study|Duodenal Ulcer|1|||
16117286|NCT00527787|38916275|FG001|Overall Study|Duodenal Ulcer|10|||
16117287|NCT00527787|38916274|FG000|Overall Study|misc|5|||
16347594|NCT00497146|39761950|FG001|Long-term Follow-up Period|Adverse Event|2|||
16347595|NCT00497146|39761949|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
16411855|NCT03242252|39988748|FG000|Overall Study|Study Terminated by Sponsor|1|||
16411856|NCT03242252|39988749|FG001|Overall Study|Study Terminated by Sponsor|0|||
16411857|NCT03242252|39988750|FG002|Overall Study|Study Terminated by Sponsor|0|||
16411858|NCT03242252|39988748|FG000|Overall Study|Reason not Specified|4|||
16411859|NCT03242252|39988749|FG001|Overall Study|Reason not Specified|4|||
16411860|NCT03242252|39988750|FG002|Overall Study|Reason not Specified|1|||
16411861|NCT03242252|39988748|FG000|Overall Study|Lost to Follow-up|5|||
16411862|NCT03242252|39988749|FG001|Overall Study|Lost to Follow-up|1|||
16411863|NCT03242252|39988750|FG002|Overall Study|Lost to Follow-up|4|||
16411864|NCT05239221|39988751|FG000|Overall Study|Adverse Event|0|||
16117288|NCT00527787|38916275|FG001|Overall Study|misc|2|||
16117289|NCT01254747|38916285|FG000|Overall Study|Unacceptable subjective vision|0|||
16117290|NCT01254747|38916286|FG001|Overall Study|Unacceptable subjective vision|0|||
16117291|NCT01254747|38916287|FG002|Overall Study|Unacceptable subjective vision|0|||
16117292|NCT01254747|38916288|FG003|Overall Study|Unacceptable subjective vision|2|||
16347596|NCT00497146|39761950|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
16347597|NCT00497146|39761949|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
16347598|NCT00497146|39761950|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
16347599|NCT00497146|39761949|FG000|Long-term Follow-up Period|Other|0|||
16347600|NCT00497146|39761950|FG001|Long-term Follow-up Period|Other|1|||
16347601|NCT00184002|39761961|FG000|Overall Study|Adverse Event|9|||
16347602|NCT00184002|39761961|FG000|Overall Study|Death|3|||
16347603|NCT00184002|39761961|FG000|Overall Study|Physician Decision|1|||
16347604|NCT00184002|39761961|FG000|Overall Study|Withdrawal by Subject|4|||
16347605|NCT01214668|39761965|FG000|Overall Study|Adverse Event|0|||
16347606|NCT01214668|39761966|FG001|Overall Study|Adverse Event|1|||
16347607|NCT01214668|39761967|FG002|Overall Study|Adverse Event|0|||
16347608|NCT01214668|39761968|FG003|Overall Study|Adverse Event|2|||
16347609|NCT01214668|39761969|FG004|Overall Study|Adverse Event|1|||
16347610|NCT01214668|39761970|FG005|Overall Study|Adverse Event|1|||
16347611|NCT01214668|39761965|FG000|Overall Study|Death|0|||
16347612|NCT01214668|39761966|FG001|Overall Study|Death|0|||
16347613|NCT01214668|39761967|FG002|Overall Study|Death|1|||
16347614|NCT01214668|39761968|FG003|Overall Study|Death|0|||
16411865|NCT05239221|39988752|FG001|Overall Study|Adverse Event|0|||
16411866|NCT05239221|39988753|FG002|Overall Study|Adverse Event|0|||
16411867|NCT05239221|39988754|FG003|Overall Study|Adverse Event|0|||
16411868|NCT05239221|39988755|FG004|Overall Study|Adverse Event|0|||
16411869|NCT05239221|39988756|FG005|Overall Study|Adverse Event|0|||
16411870|NCT05239221|39988757|FG006|Overall Study|Adverse Event|1|||
16411871|NCT05239221|39988758|FG007|Overall Study|Adverse Event|0|||
16411872|NCT05239221|39988759|FG008|Overall Study|Adverse Event|0|||
16411873|NCT05239221|39988760|FG009|Overall Study|Adverse Event|0|||
16411874|NCT05239221|39988761|FG010|Overall Study|Adverse Event|1|||
16411875|NCT05239221|39988762|FG011|Overall Study|Adverse Event|1|||
16117293|NCT01254747|38916285|FG000|Overall Study|Difficult removal handling|0|||
16117294|NCT01254747|38916286|FG001|Overall Study|Difficult removal handling|0|||
16117295|NCT01254747|38916287|FG002|Overall Study|Difficult removal handling|1|||
16117296|NCT01254747|38916288|FG003|Overall Study|Difficult removal handling|0|||
16117297|NCT01254747|38916285|FG000|Overall Study|Symptoms and problems|0|||
16117298|NCT01254747|38916286|FG001|Overall Study|Symptoms and problems|2|||
16117299|NCT01254747|38916287|FG002|Overall Study|Symptoms and problems|1|||
16117300|NCT01254747|38916288|FG003|Overall Study|Symptoms and problems|0|||
16117301|NCT01254747|38916285|FG000|Overall Study|Lost to Follow-up|0|||
16117302|NCT01254747|38916286|FG001|Overall Study|Lost to Follow-up|0|||
16117303|NCT01254747|38916287|FG002|Overall Study|Lost to Follow-up|1|||
16117304|NCT01254747|38916288|FG003|Overall Study|Lost to Follow-up|0|||
16117305|NCT01254747|38916285|FG000|Overall Study|Biomicroscopy|0|||
16117306|NCT01254747|38916286|FG001|Overall Study|Biomicroscopy|0|||
16117307|NCT01254747|38916287|FG002|Overall Study|Biomicroscopy|1|||
16117308|NCT01254747|38916288|FG003|Overall Study|Biomicroscopy|0|||
16117309|NCT01254747|38916285|FG000|Overall Study|Discomfort|0|||
16117310|NCT01254747|38916286|FG001|Overall Study|Discomfort|4|||
16117311|NCT01254747|38916287|FG002|Overall Study|Discomfort|0|||
16117312|NCT01254747|38916288|FG003|Overall Study|Discomfort|0|||
16117313|NCT02879383|38916289|FG000|First 24 Weeks|Physician Decision|0|||
16117314|NCT02879383|38916290|FG001|First 24 Weeks|Physician Decision|1|||
16347615|NCT01214668|39761969|FG004|Overall Study|Death|0|||
16347616|NCT01214668|39761970|FG005|Overall Study|Death|0|||
16347617|NCT01214668|39761965|FG000|Overall Study|Progressive Disease|4|||
16347618|NCT01214668|39761966|FG001|Overall Study|Progressive Disease|2|||
16347619|NCT01214668|39761967|FG002|Overall Study|Progressive Disease|5|||
16347620|NCT01214668|39761968|FG003|Overall Study|Progressive Disease|4|||
16347621|NCT01214668|39761969|FG004|Overall Study|Progressive Disease|4|||
16347622|NCT01214668|39761970|FG005|Overall Study|Progressive Disease|5|||
16347623|NCT01214668|39761965|FG000|Overall Study|Withdrawal by Subject|0|||
16347624|NCT01214668|39761966|FG001|Overall Study|Withdrawal by Subject|0|||
16347625|NCT01214668|39761967|FG002|Overall Study|Withdrawal by Subject|0|||
16347626|NCT01214668|39761968|FG003|Overall Study|Withdrawal by Subject|0|||
16347627|NCT01214668|39761969|FG004|Overall Study|Withdrawal by Subject|1|||
16347628|NCT01214668|39761970|FG005|Overall Study|Withdrawal by Subject|0|||
16117315|NCT02879383|38916291|FG002|First 24 Weeks|Physician Decision|0|||
16117316|NCT02879383|38916292|FG003|First 24 Weeks|Physician Decision|0|||
16117317|NCT03197766|38916295|FG000|Overall Study|Withdrawal by Subject|2|||
16117318|NCT03197766|38916296|FG001|Overall Study|Withdrawal by Subject|0|||
16411876|NCT05239221|39988763|FG012|Overall Study|Adverse Event|0|||
16411877|NCT05239221|39988764|FG013|Overall Study|Adverse Event|0|||
16411878|NCT05239221|39988765|FG014|Overall Study|Adverse Event|0|||
16117319|NCT01939353|38916299|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
16117320|NCT01939353|38916299|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
16347629|NCT00369915|39761971|FG000|Overall Study|expected side effects|2|||
16347630|NCT00369915|39761972|FG001|Overall Study|expected side effects|1|||
16411879|NCT05239221|39988766|FG015|Overall Study|Adverse Event|0|||
16411880|NCT05239221|39988751|FG000|Overall Study|Withdrawal by Subject|0|||
16117321|NCT01939353|38916299|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
16117322|NCT01939353|38916299|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
16117323|NCT01939353|38916299|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
16117324|NCT00964886|38916300|FG000|Overall Study|Lost to Follow-up|2|||
16117325|NCT00964886|38916301|FG001|Overall Study|Lost to Follow-up|2|||
16228172|NCT02030067|39313708|FG005|Overall Study|Adverse Event|0|||
16347631|NCT00369915|39761971|FG000|Overall Study|Withdrawal by Subject|4|||
16347632|NCT00369915|39761972|FG001|Overall Study|Withdrawal by Subject|1|||
16347633|NCT00369915|39761971|FG000|Overall Study|W/drawl by investigators|0|||
16347634|NCT00369915|39761972|FG001|Overall Study|W/drawl by investigators|1|||
16347635|NCT02735980|39761983|FG000|Overall Study|Adverse Event|0|||
16347636|NCT02735980|39761984|FG001|Overall Study|Adverse Event|4|||
16347637|NCT02735980|39761985|FG002|Overall Study|Adverse Event|1|||
16347638|NCT02735980|39761983|FG000|Overall Study|Death|5|||
16347639|NCT02735980|39761984|FG001|Overall Study|Death|4|||
16411881|NCT05239221|39988752|FG001|Overall Study|Withdrawal by Subject|0|||
16411882|NCT05239221|39988753|FG002|Overall Study|Withdrawal by Subject|0|||
16347640|NCT02735980|39761985|FG002|Overall Study|Death|0|||
16347641|NCT02735980|39761983|FG000|Overall Study|Physician Decision|3|||
16347642|NCT02735980|39761984|FG001|Overall Study|Physician Decision|1|||
16347643|NCT02735980|39761985|FG002|Overall Study|Physician Decision|0|||
16347644|NCT02735980|39761983|FG000|Overall Study|Screen failure|1|||
16347645|NCT02735980|39761984|FG001|Overall Study|Screen failure|0|||
16347646|NCT02735980|39761985|FG002|Overall Study|Screen failure|0|||
16347647|NCT02735980|39761983|FG000|Overall Study|Withdrawal by Subject|1|||
16347648|NCT02735980|39761984|FG001|Overall Study|Withdrawal by Subject|2|||
16347649|NCT02735980|39761985|FG002|Overall Study|Withdrawal by Subject|0|||
16347650|NCT01441973|39761990|FG000|Overall Study|Disease progression|8|||
16347651|NCT01441973|39761991|FG001|Overall Study|Disease progression|6|||
16347652|NCT01441973|39761990|FG000|Overall Study|Adverse event unrelated to study drug|3|||
16347653|NCT01441973|39761991|FG001|Overall Study|Adverse event unrelated to study drug|2|||
16411883|NCT05239221|39988754|FG003|Overall Study|Withdrawal by Subject|0|||
16411884|NCT05239221|39988755|FG004|Overall Study|Withdrawal by Subject|0|||
16411885|NCT05239221|39988756|FG005|Overall Study|Withdrawal by Subject|0|||
16411886|NCT05239221|39988757|FG006|Overall Study|Withdrawal by Subject|0|||
16411887|NCT05239221|39988758|FG007|Overall Study|Withdrawal by Subject|0|||
16411888|NCT05239221|39988759|FG008|Overall Study|Withdrawal by Subject|0|||
16411889|NCT05239221|39988760|FG009|Overall Study|Withdrawal by Subject|0|||
16347654|NCT01441973|39761990|FG000|Overall Study|Participant request to discontinue|1|||
16347655|NCT01441973|39761991|FG001|Overall Study|Participant request to discontinue|1|||
16411890|NCT05239221|39988761|FG010|Overall Study|Withdrawal by Subject|1|||
16411891|NCT05239221|39988762|FG011|Overall Study|Withdrawal by Subject|0|||
16549456|NCT03035032|40474905|FG000|Overall Study|Physician Decision|5|||
16549457|NCT03560258|40474909|FG000|Overall Study|Lost to Follow-up|3|||
16549458|NCT03560258|40474910|FG001|Overall Study|Lost to Follow-up|0|||
16549459|NCT03560258|40474911|FG002|Overall Study|Lost to Follow-up|0|||
16549460|NCT03560258|40474909|FG000|Overall Study|Protocol Violation|0|||
16549461|NCT03560258|40474910|FG001|Overall Study|Protocol Violation|1|||
16549462|NCT03560258|40474911|FG002|Overall Study|Protocol Violation|0|||
16549463|NCT03560258|40474909|FG000|Overall Study|Withdrawal by Subject|0|||
16549464|NCT03560258|40474910|FG001|Overall Study|Withdrawal by Subject|0|||
16549465|NCT03560258|40474911|FG002|Overall Study|Withdrawal by Subject|1|||
16549466|NCT02176421|40474928|FG000|Overall Study|Lost to Follow-up|4|||
16549467|NCT02176421|40474928|FG000|Overall Study|Adverse Event|1|||
16549468|NCT00949884|40474929|FG000|Overall Study|Adverse Event|14|||
16549469|NCT00949884|40474930|FG001|Overall Study|Adverse Event|3|||
16549470|NCT00949884|40474931|FG002|Overall Study|Adverse Event|12|||
16549471|NCT00949884|40474929|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
16549472|NCT00949884|40474930|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
16549473|NCT00949884|40474931|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
16549474|NCT00949884|40474929|FG000|Overall Study|Lost to Follow-up|7|||
16549475|NCT00949884|40474930|FG001|Overall Study|Lost to Follow-up|5|||
16549476|NCT00949884|40474931|FG002|Overall Study|Lost to Follow-up|5|||
16549477|NCT00949884|40474929|FG000|Overall Study|Physician Decision|5|||
16549478|NCT00949884|40474930|FG001|Overall Study|Physician Decision|0|||
16549479|NCT00949884|40474931|FG002|Overall Study|Physician Decision|6|||
16549480|NCT00949884|40474929|FG000|Overall Study|Treatment non-compliance|5|||
16549481|NCT00949884|40474930|FG001|Overall Study|Treatment non-compliance|0|||
16549482|NCT00949884|40474931|FG002|Overall Study|Treatment non-compliance|8|||
16549483|NCT00949884|40474929|FG000|Overall Study|Withdrawal by Subject|13|||
16549484|NCT00949884|40474930|FG001|Overall Study|Withdrawal by Subject|4|||
16549485|NCT00949884|40474931|FG002|Overall Study|Withdrawal by Subject|16|||
16549486|NCT00949884|40474929|FG000|Overall Study|Lack of Efficacy|4|||
16549487|NCT00949884|40474930|FG001|Overall Study|Lack of Efficacy|2|||
16549488|NCT00949884|40474931|FG002|Overall Study|Lack of Efficacy|7|||
16549489|NCT00949884|40474929|FG000|Overall Study|Study terminated by sponsor|0|||
16549490|NCT00949884|40474930|FG001|Overall Study|Study terminated by sponsor|0|||
16549491|NCT00949884|40474931|FG002|Overall Study|Study terminated by sponsor|1|||
16549492|NCT02424591|40474932|FG000|Overall Study|Protocol Violation|2|||
16549493|NCT02424591|40474933|FG001|Overall Study|Protocol Violation|3|||
16549494|NCT00544544|40474936|FG000|Overall Study|Withdrawal by Subject|1|||
16549495|NCT00544544|40474936|FG000|Overall Study|Adverse Event|1|||
16549496|NCT00544544|40474936|FG000|Overall Study|Lost to Follow-up|1|||
16549497|NCT01267253|40474937|FG000|Overall Study|Ineligible - required test not done|1|||
16549498|NCT01267253|40474937|FG000|Overall Study|Inevaluable-never received study treatme|2|||
16549499|NCT01215357|40474938|FG000|Overall Study|Withdrawal by Subject|3|||
16549500|NCT01215357|40474938|FG000|Overall Study|Protocol Violation|9|||
16549501|NCT02276066|40474939|FG000|Overall Study|Lost to Follow-up|21|||
16549502|NCT02276066|40474940|FG001|Overall Study|Lost to Follow-up|11|||
16549503|NCT02936037|40474941|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
16549504|NCT02936037|40474942|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
16549505|NCT02936037|40474941|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
16549506|NCT02936037|40474942|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
16549507|NCT02936037|40474941|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
16549508|NCT02936037|40474942|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
16549509|NCT02936037|40474941|FG000|Double-Blind Treatment Period|Death|0|||
16549510|NCT02936037|40474942|FG001|Double-Blind Treatment Period|Death|1|||
16549511|NCT02936037|40474941|FG000|Double-Blind Treatment Period|Adverse Event|11|||
16549512|NCT02936037|40474942|FG001|Double-Blind Treatment Period|Adverse Event|11|||
16549513|NCT02936037|40474941|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
16549514|NCT02936037|40474942|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
16549515|NCT02936037|40474941|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16549516|NCT02936037|40474942|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
16117326|NCT00964886|38916302|FG002|Overall Study|Lost to Follow-up|6|||
16117327|NCT00964886|38916303|FG003|Overall Study|Lost to Follow-up|4|||
16117328|NCT00964886|38916300|FG000|Overall Study|Withdrawal by Subject|6|||
16117329|NCT00964886|38916301|FG001|Overall Study|Withdrawal by Subject|2|||
16117330|NCT00964886|38916302|FG002|Overall Study|Withdrawal by Subject|5|||
16117331|NCT00964886|38916303|FG003|Overall Study|Withdrawal by Subject|3|||
16117332|NCT00964886|38916300|FG000|Overall Study|Adverse Event|3|||
16117333|NCT00964886|38916301|FG001|Overall Study|Adverse Event|1|||
16117334|NCT00964886|38916302|FG002|Overall Study|Adverse Event|5|||
16117335|NCT00964886|38916303|FG003|Overall Study|Adverse Event|2|||
16117336|NCT00964886|38916300|FG000|Overall Study|Protocol Violation|0|||
16117337|NCT00964886|38916301|FG001|Overall Study|Protocol Violation|2|||
16117338|NCT00964886|38916302|FG002|Overall Study|Protocol Violation|0|||
16117339|NCT00964886|38916303|FG003|Overall Study|Protocol Violation|0|||
16117340|NCT02878603|38916304|FG000|Overall Study|Lost to Follow-up|4|||
16228173|NCT02030067|39313709|FG006|Overall Study|Adverse Event|0|||
16228174|NCT02030067|39313710|FG007|Overall Study|Adverse Event|0|||
16228175|NCT02030067|39313711|FG008|Overall Study|Adverse Event|0|||
16228176|NCT02030067|39313712|FG009|Overall Study|Adverse Event|0|||
16228177|NCT02030067|39313713|FG010|Overall Study|Adverse Event|0|||
16228178|NCT02030067|39313714|FG011|Overall Study|Adverse Event|1|||
16228179|NCT02030067|39313715|FG012|Overall Study|Adverse Event|8|||
16347656|NCT01441973|39761990|FG000|Overall Study|Poor compliance/noncompliance|0|||
16347657|NCT01441973|39761991|FG001|Overall Study|Poor compliance/noncompliance|1|||
16347658|NCT01441973|39761990|FG000|Overall Study|Administrative reason by sponsor|3|||
16347659|NCT01441973|39761991|FG001|Overall Study|Administrative reason by sponsor|5|||
16347660|NCT01441973|39761990|FG000|Overall Study|Participant withdrew consent|0|||
16347661|NCT01441973|39761991|FG001|Overall Study|Participant withdrew consent|1|||
16347662|NCT02058589|39761992|FG000|Overall Study|Serious Adverse Event|1|||
16347663|NCT02058589|39761993|FG001|Overall Study|Serious Adverse Event|1|||
16347664|NCT02058589|39761992|FG000|Overall Study|Non-Serious Adverse Event|1|||
16347665|NCT02058589|39761993|FG001|Overall Study|Non-Serious Adverse Event|0|||
16347666|NCT02058589|39761992|FG000|Overall Study|Withdrawal by Subject|0|||
16347667|NCT02058589|39761993|FG001|Overall Study|Withdrawal by Subject|1|||
16347668|NCT00549549|39761997|FG000|Overall Study|Adverse Event|5|||
16347669|NCT00549549|39761998|FG001|Overall Study|Adverse Event|3|||
16411892|NCT05239221|39988763|FG012|Overall Study|Withdrawal by Subject|0|||
16411893|NCT05239221|39988764|FG013|Overall Study|Withdrawal by Subject|0|||
16411894|NCT05239221|39988765|FG014|Overall Study|Withdrawal by Subject|0|||
16411895|NCT05239221|39988766|FG015|Overall Study|Withdrawal by Subject|1|||
16411896|NCT01304329|39988767|FG000|Third Intervention (3 Days)|Adverse Event|0|||
16411897|NCT01304329|39988768|FG001|Third Intervention (3 Days)|Adverse Event|1|||
16411898|NCT01304329|39988769|FG002|Third Intervention (3 Days)|Adverse Event|0|||
16411899|NCT01304329|39988770|FG003|Third Intervention (3 Days)|Adverse Event|0|||
16411900|NCT01304329|39988771|FG004|Third Intervention (3 Days)|Adverse Event|0|||
16411901|NCT01304329|39988772|FG005|Third Intervention (3 Days)|Adverse Event|0|||
16411902|NCT00673881|39988773|FG000|Overall Study|Withdrawal by Subject|1|||
16411903|NCT00042432|39988778|FG000|Overall Study|Adverse Event|4|||
16411904|NCT00042432|39988779|FG001|Overall Study|Adverse Event|1|||
16411905|NCT00042432|39988778|FG000|Overall Study|Withdrawal by Subject|1|||
16411906|NCT00042432|39988779|FG001|Overall Study|Withdrawal by Subject|3|||
16411907|NCT00042432|39988778|FG000|Overall Study|Death|0|||
16411908|NCT00042432|39988779|FG001|Overall Study|Death|2|||
16117341|NCT02878603|38916305|FG001|Overall Study|Lost to Follow-up|1|||
16117342|NCT02878603|38916304|FG000|Overall Study|Withdrawal by Subject|1|||
16117343|NCT02878603|38916305|FG001|Overall Study|Withdrawal by Subject|1|||
16228180|NCT03077646|39313716|FG000|Overall Study|Lost to Follow-up|29|||
16411909|NCT00042432|39988778|FG000|Overall Study|Ineligibility determined|1|||
16411910|NCT00042432|39988779|FG001|Overall Study|Ineligibility determined|0|||
16411911|NCT00042432|39988778|FG000|Overall Study|Initiation of maintenance dialysis|1|||
16411912|NCT00042432|39988779|FG001|Overall Study|Initiation of maintenance dialysis|1|||
16411913|NCT00042432|39988778|FG000|Overall Study|Other|2|||
16549517|NCT02936037|40474941|FG000|Open Label Extension|Adverse Event|0|||
16228181|NCT03077646|39313717|FG001|Overall Study|Lost to Follow-up|30|||
16549518|NCT02936037|40474942|FG001|Open Label Extension|Adverse Event|3|||
16549519|NCT02936037|40474941|FG000|Open Label Extension|Other|0|||
16549520|NCT02936037|40474942|FG001|Open Label Extension|Other|3|||
16549521|NCT02936037|40474941|FG000|Open Label Extension|Withdrawal by Subject|0|||
16549522|NCT02936037|40474942|FG001|Open Label Extension|Withdrawal by Subject|4|||
16549523|NCT04146896|40474946|FG000|Overall Study|Adverse Event|5|||
16549524|NCT04146896|40474947|FG001|Overall Study|Adverse Event|8|||
16549525|NCT04146896|40474946|FG000|Overall Study|Lack of Efficacy|3|||
16549526|NCT04146896|40474947|FG001|Overall Study|Lack of Efficacy|2|||
16549527|NCT04146896|40474946|FG000|Overall Study|Lost to Follow-up|0|||
16549528|NCT04146896|40474947|FG001|Overall Study|Lost to Follow-up|1|||
16549529|NCT04146896|40474946|FG000|Overall Study|Non-compliance|5|||
16549530|NCT04146896|40474947|FG001|Overall Study|Non-compliance|4|||
16549531|NCT04146896|40474946|FG000|Overall Study|Withdrawal by Subject|3|||
16549532|NCT04146896|40474947|FG001|Overall Study|Withdrawal by Subject|5|||
16549533|NCT04146896|40474946|FG000|Overall Study|Randomized in error|1|||
16549534|NCT04146896|40474947|FG001|Overall Study|Randomized in error|2|||
16549535|NCT04395183|40474948|FG000|Overall Study|Withdrawal by Subject|1|||
16549536|NCT04395183|40474949|FG001|Overall Study|Withdrawal by Subject|0|||
16549537|NCT04395183|40474950|FG002|Overall Study|Withdrawal by Subject|2|||
16411914|NCT00042432|39988779|FG001|Overall Study|Other|0|||
16117344|NCT02878603|38916304|FG000|Overall Study|Death|1|||
16117345|NCT02878603|38916305|FG001|Overall Study|Death|0|||
16117346|NCT02878603|38916304|FG000|Overall Study|Physician Decision|0|||
16117347|NCT02878603|38916305|FG001|Overall Study|Physician Decision|3|||
16117348|NCT01154140|38916306|FG000|Overall Study|Death|71|||
16117349|NCT01154140|38916307|FG001|Overall Study|Death|81|||
16117350|NCT01154140|38916306|FG000|Overall Study|Lost to Follow-up|4|||
16117351|NCT01154140|38916307|FG001|Overall Study|Lost to Follow-up|5|||
16117352|NCT01154140|38916306|FG000|Overall Study|Withdrawal by Subject|12|||
16117353|NCT01154140|38916307|FG001|Overall Study|Withdrawal by Subject|13|||
16117354|NCT01154140|38916306|FG000|Overall Study|Other|3|||
16117355|NCT01154140|38916307|FG001|Overall Study|Other|1|||
16117356|NCT01154140|38916306|FG000|Overall Study|Randomized but not treated|1|||
16117357|NCT01154140|38916307|FG001|Overall Study|Randomized but not treated|2|||
16117358|NCT00968526|38916308|FG000|Overall Study|Adverse Event|2|||
16117359|NCT00968526|38916309|FG001|Overall Study|Adverse Event|0|||
16117360|NCT00968526|38916308|FG000|Overall Study|Migrated/moved from study area|1|||
16117361|NCT00968526|38916309|FG001|Overall Study|Migrated/moved from study area|0|||
16117362|NCT01147536|38916310|FG000|Overall Study|Administrative study close|2|||
16117363|NCT01147536|38916310|FG000|Overall Study|Death|1|||
16117364|NCT00747227|38916311|FG000|Overall Study|Death|3|||
16117365|NCT00747227|38916312|FG001|Overall Study|Death|1|||
16117366|NCT00747227|38916311|FG000|Overall Study|Withdrawal by Subject|1|||
16117367|NCT00747227|38916312|FG001|Overall Study|Withdrawal by Subject|0|||
16117368|NCT00747227|38916311|FG000|Overall Study|Lost to Follow-up|1|||
16117369|NCT00747227|38916312|FG001|Overall Study|Lost to Follow-up|2|||
16117370|NCT00747227|38916311|FG000|Overall Study|Illness|1|||
16117371|NCT00747227|38916312|FG001|Overall Study|Illness|1|||
16117372|NCT00609947|38916313|FG000|Overall Study|Death|1|||
16117373|NCT02568397|38916314|FG000|Period 2|Withdrawal by Subject|0|||
16117374|NCT02568397|38916315|FG001|Period 2|Withdrawal by Subject|1|||
16117375|NCT02568397|38916314|FG000|Period 2|Physician Decision|0|||
16117376|NCT02568397|38916315|FG001|Period 2|Physician Decision|1|||
16117377|NCT01156376|38916316|FG000|Overall Study|Adverse Event|1|||
16117378|NCT01156376|38916317|FG001|Overall Study|Adverse Event|0|||
16117379|NCT01156376|38916318|FG002|Overall Study|Adverse Event|1|||
16117380|NCT01156376|38916316|FG000|Overall Study|Withdrawal by Subject|0|||
16117381|NCT01156376|38916317|FG001|Overall Study|Withdrawal by Subject|0|||
16117382|NCT01156376|38916318|FG002|Overall Study|Withdrawal by Subject|3|||
16117383|NCT01730378|38916319|FG000|Overall Study|Lost to Follow-up|1|||
16117384|NCT01730378|38916320|FG001|Overall Study|Lost to Follow-up|0|||
16117385|NCT02808975|38916322|FG000|Overall Study|Adverse Event|3|||
16117386|NCT02808975|38916323|FG001|Overall Study|Adverse Event|4|||
16117387|NCT02808975|38916322|FG000|Overall Study|Withdrew consent|9|||
16411915|NCT02726880|39988780|FG000|Overall Study|Withdrawal by Subject|2|||
16411916|NCT02726880|39988781|FG001|Overall Study|Withdrawal by Subject|0|||
16117388|NCT02808975|38916323|FG001|Overall Study|Withdrew consent|8|||
16117389|NCT02808975|38916322|FG000|Overall Study|Lost to Follow-up|4|||
16117390|NCT02808975|38916323|FG001|Overall Study|Lost to Follow-up|6|||
16117391|NCT02808975|38916322|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
16549538|NCT04395183|40474951|FG003|Overall Study|Withdrawal by Subject|2|||
16549539|NCT00979602|40474952|FG000|Overall Study|Serious Adverse Event|5|||
16549540|NCT00979602|40474953|FG001|Overall Study|Serious Adverse Event|3|||
16117392|NCT02808975|38916323|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
16117393|NCT02808975|38916322|FG000|Overall Study|Other, not specified|5|||
16117394|NCT02808975|38916323|FG001|Overall Study|Other, not specified|1|||
16117395|NCT03023722|38916324|FG000|Overall Study|No follow-up assessment|4|||
16549541|NCT00979602|40474952|FG000|Overall Study|Protocol Violation|3|||
16228182|NCT03077646|39313718|FG002|Overall Study|Lost to Follow-up|31|||
16228183|NCT03525613|39313719|FG000|Overall Study|Adverse Event|11|||
16228184|NCT03525613|39313720|FG001|Overall Study|Adverse Event|8|||
16228185|NCT03525613|39313721|FG002|Overall Study|Adverse Event|3|||
16228186|NCT03525613|39313722|FG003|Overall Study|Adverse Event|3|||
16228187|NCT03525613|39313719|FG000|Overall Study|Lost to Follow-up|4|||
16228188|NCT03525613|39313720|FG001|Overall Study|Lost to Follow-up|5|||
16228189|NCT03525613|39313721|FG002|Overall Study|Lost to Follow-up|3|||
16228190|NCT03525613|39313722|FG003|Overall Study|Lost to Follow-up|2|||
16228191|NCT03525613|39313719|FG000|Overall Study|Physician Decision|0|||
16228192|NCT03525613|39313720|FG001|Overall Study|Physician Decision|1|||
16228193|NCT03525613|39313721|FG002|Overall Study|Physician Decision|0|||
16228194|NCT03525613|39313722|FG003|Overall Study|Physician Decision|1|||
16228195|NCT03525613|39313719|FG000|Overall Study|Consent Withdrawal|25|||
16228196|NCT03525613|39313720|FG001|Overall Study|Consent Withdrawal|16|||
16228197|NCT03525613|39313721|FG002|Overall Study|Consent Withdrawal|12|||
16228198|NCT03525613|39313722|FG003|Overall Study|Consent Withdrawal|9|||
16228199|NCT03525613|39313719|FG000|Overall Study|Death|20|||
16228200|NCT03525613|39313720|FG001|Overall Study|Death|9|||
16228201|NCT03525613|39313721|FG002|Overall Study|Death|7|||
16228202|NCT03525613|39313722|FG003|Overall Study|Death|1|||
16228203|NCT03525613|39313719|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
16117396|NCT01736540|38916325|FG000|Overall Study|Did not complete scan within 45 days|2|||
16117397|NCT01736540|38916325|FG000|Overall Study|Death|1|||
16117398|NCT01736540|38916325|FG000|Overall Study|Abnormal test procedure|1|||
16117399|NCT01736540|38916325|FG000|Overall Study|Withdrawal by Subject|5|||
16117400|NCT01736540|38916325|FG000|Overall Study|Protocol Violation|1|||
16117401|NCT01736540|38916325|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
16117402|NCT01736540|38916325|FG000|Overall Study|No show for MRI appointment|1|||
16117403|NCT01736540|38916325|FG000|Overall Study|Unable to make MRI appointment|3|||
16117404|NCT00547534|38916326|FG000|Overall Study|Adverse Event|7|||
16117405|NCT00547534|38916326|FG000|Overall Study|Disease Progression|4|||
16117406|NCT02354651|38916328|FG000|Overall Study|Withdrawal by Subject|2|||
16117407|NCT02354651|38916328|FG000|Overall Study|Physician Decision|1|||
16228204|NCT03525613|39313720|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
16228205|NCT03525613|39313721|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
16228206|NCT03525613|39313722|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
16228207|NCT02283411|39316883|FG000|Overall Study|Withdrawal by Subject|3|||
16228208|NCT02283411|39316883|FG000|Overall Study|Screen Failed|28|||
16228209|NCT01495793|39316902|FG000|Overall Study|Lost to Follow-up|1|||
16228210|NCT01495793|39316902|FG000|Overall Study|Violation of inclusion criteria|1|||
16228211|NCT01002573|39316903|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
16228212|NCT01002573|39316904|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
16228213|NCT00227591|39316909|FG000|Overall Study|Withdrawal by Subject|1|||
16228214|NCT01041027|39316910|FG000|Overall Study|Withdrawal by Subject|2|||
16228215|NCT01041027|39316910|FG000|Overall Study|Protocol Violation|1|||
16228216|NCT01041027|39316910|FG000|Overall Study|Delayed Radiation Therapy|1|||
16228217|NCT01041027|39316910|FG000|Overall Study|Adverse Event|4|||
16228218|NCT04983589|39316911|FG000|Overall Study|Withdrawal by Subject|0|||
16228219|NCT04983589|39316912|FG001|Overall Study|Withdrawal by Subject|3|||
16228220|NCT04983589|39316911|FG000|Overall Study|COVID-19 Infection|1|||
16228221|NCT04983589|39316912|FG001|Overall Study|COVID-19 Infection|0|||
16228222|NCT04983589|39316911|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
16228223|NCT04983589|39316912|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
16228224|NCT02180659|39316913|FG000|Overall Study|Adverse Event|1|||
16228225|NCT02180659|39316914|FG001|Overall Study|Adverse Event|0|||
16228226|NCT02180659|39316913|FG000|Overall Study|Lost to Follow-up|4|||
16228227|NCT02180659|39316914|FG001|Overall Study|Lost to Follow-up|2|||
16228228|NCT02180659|39316913|FG000|Overall Study|Subject incarcerated during conduct|1|||
16228229|NCT02180659|39316914|FG001|Overall Study|Subject incarcerated during conduct|0|||
16228230|NCT02180659|39316913|FG000|Overall Study|Withdrawal by Subject|0|||
16228231|NCT02180659|39316914|FG001|Overall Study|Withdrawal by Subject|2|||
16228232|NCT02180659|39316913|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
16228233|NCT02180659|39316914|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
16228234|NCT00483119|39316918|FG000|Overall Study|Adverse Event|0|||
16117408|NCT04206085|38916329|FG000|Overall Study|Lost to Follow-up|0|||
16228235|NCT00483119|39316919|FG001|Overall Study|Adverse Event|1|||
16228236|NCT00483119|39316918|FG000|Overall Study|Physician Decision|1|||
16228237|NCT00483119|39316919|FG001|Overall Study|Physician Decision|0|||
16228238|NCT00772031|39316922|FG000|Overall Study|Early termination of trial|12|||
16228239|NCT00772031|39316923|FG001|Overall Study|Early termination of trial|10|||
16228240|NCT00772031|39316922|FG000|Overall Study|Lost to Follow-up|20|||
16228241|NCT00772031|39316923|FG001|Overall Study|Lost to Follow-up|33|||
16228242|NCT04678557|39316924|FG000|Overall Study|Withdrawal by Subject|1|||
16228243|NCT04678557|39316925|FG001|Overall Study|Withdrawal by Subject|0|||
16228244|NCT04678557|39316924|FG000|Overall Study|Lack of Efficacy|0|||
16228245|NCT04678557|39316925|FG001|Overall Study|Lack of Efficacy|13|||
16228246|NCT04678557|39316924|FG000|Overall Study|Safety Evaluation|0|||
16228247|NCT04678557|39316925|FG001|Overall Study|Safety Evaluation|1|||
16228248|NCT04822701|39316926|FG000|Overall Study|Not treated|2|||
16228249|NCT04822701|39316927|FG001|Overall Study|Not treated|0|||
16228250|NCT04822701|39316926|FG000|Overall Study|Lost to Follow-up|1|||
16228251|NCT04822701|39316927|FG001|Overall Study|Lost to Follow-up|0|||
16228252|NCT04822701|39316926|FG000|Overall Study|Withdrawal by Subject|1|||
16228253|NCT04822701|39316927|FG001|Overall Study|Withdrawal by Subject|0|||
16228254|NCT04409509|39316928|FG000|Overall Study|Failure to meet randomization requirement|1|||
16228255|NCT04409509|39316929|FG001|Overall Study|Failure to meet randomization requirement|0|||
16228256|NCT04409509|39316928|FG000|Overall Study|Adverse Event|0|||
16228257|NCT04409509|39316929|FG001|Overall Study|Adverse Event|1|||
16228258|NCT04409509|39316928|FG000|Overall Study|Death|11|||
16228259|NCT04409509|39316929|FG001|Overall Study|Death|10|||
16228260|NCT04409509|39316928|FG000|Overall Study|Non-compliance with study drug|0|||
16228261|NCT04409509|39316929|FG001|Overall Study|Non-compliance with study drug|1|||
16228262|NCT04409509|39316928|FG000|Overall Study|Lost to Follow-up|0|||
16228263|NCT04409509|39316929|FG001|Overall Study|Lost to Follow-up|3|||
16228264|NCT04409509|39316928|FG000|Overall Study|Withdrawal by Subject|0|||
16228265|NCT04409509|39316929|FG001|Overall Study|Withdrawal by Subject|3|||
16228266|NCT04409509|39316928|FG000|Overall Study|Randomized by mistake|0|||
16228267|NCT04409509|39316929|FG001|Overall Study|Randomized by mistake|1|||
16228268|NCT04409509|39316928|FG000|Overall Study|Other|1|||
16228269|NCT04409509|39316929|FG001|Overall Study|Other|1|||
16228270|NCT00727246|39316930|FG000|Overall Study|could not complete MRI|0|||
16228271|NCT00727246|39316931|FG001|Overall Study|could not complete MRI|1|||
16228272|NCT00727246|39316932|FG002|Overall Study|could not complete MRI|0|||
16228273|NCT00727246|39316933|FG003|Overall Study|could not complete MRI|1|||
16228274|NCT00727246|39316930|FG000|Overall Study|incidental finding|0|||
16228275|NCT00727246|39316931|FG001|Overall Study|incidental finding|0|||
16228276|NCT00727246|39316932|FG002|Overall Study|incidental finding|0|||
16228277|NCT00727246|39316933|FG003|Overall Study|incidental finding|1|||
16228278|NCT00727246|39316930|FG000|Overall Study|withdrawn|0|||
16228279|NCT00727246|39316931|FG001|Overall Study|withdrawn|0|||
16228280|NCT00727246|39316932|FG002|Overall Study|withdrawn|1|||
16228281|NCT00727246|39316933|FG003|Overall Study|withdrawn|0|||
16228282|NCT03841331|39316938|FG000|Overall Study|Withdrawal by Subject|4|||
16228283|NCT03841331|39316939|FG001|Overall Study|Withdrawal by Subject|9|||
16228284|NCT03841331|39316938|FG000|Overall Study|Lost to Follow-up|5|||
16228285|NCT03841331|39316939|FG001|Overall Study|Lost to Follow-up|1|||
16228286|NCT01241591|39316942|FG000|Overall Study|Lack of Efficacy|5|||
16228287|NCT01241591|39316943|FG001|Overall Study|Lack of Efficacy|2|||
16228288|NCT01241591|39316944|FG002|Overall Study|Lack of Efficacy|2|||
16228289|NCT01241591|39316945|FG003|Overall Study|Lack of Efficacy|3|||
16228290|NCT01241591|39316942|FG000|Overall Study|Protocol Violation|5|||
16228291|NCT01241591|39316943|FG001|Overall Study|Protocol Violation|2|||
16228292|NCT01241591|39316944|FG002|Overall Study|Protocol Violation|3|||
16228293|NCT01241591|39316945|FG003|Overall Study|Protocol Violation|0|||
16228294|NCT01241591|39316942|FG000|Overall Study|Lost to Follow-up|1|||
16228295|NCT01241591|39316943|FG001|Overall Study|Lost to Follow-up|2|||
16228296|NCT01241591|39316944|FG002|Overall Study|Lost to Follow-up|2|||
16228297|NCT01241591|39316945|FG003|Overall Study|Lost to Follow-up|2|||
16549542|NCT00979602|40474953|FG001|Overall Study|Protocol Violation|0|||
16549543|NCT00979602|40474952|FG000|Overall Study|Withdrawal by Subject|31|||
16228298|NCT01241591|39316942|FG000|Overall Study|Screen Failure|3|||
16228299|NCT01241591|39316943|FG001|Overall Study|Screen Failure|2|||
16228300|NCT01241591|39316944|FG002|Overall Study|Screen Failure|1|||
16228301|NCT01241591|39316945|FG003|Overall Study|Screen Failure|0|||
16228302|NCT01241591|39316942|FG000|Overall Study|Withdrawal by Subject|6|||
16347670|NCT00549549|39761999|FG002|Overall Study|Adverse Event|1|||
16549544|NCT00979602|40474953|FG001|Overall Study|Withdrawal by Subject|25|||
16549545|NCT00979602|40474952|FG000|Overall Study|Lost to Follow-up|100|||
16549546|NCT00979602|40474953|FG001|Overall Study|Lost to Follow-up|96|||
16549547|NCT00979602|40474952|FG000|Overall Study|Migrated/moved from study area|3|||
16549548|NCT00979602|40474953|FG001|Overall Study|Migrated/moved from study area|6|||
16549549|NCT00979602|40474952|FG000|Overall Study|Others|3|||
16549550|NCT00979602|40474953|FG001|Overall Study|Others|3|||
16549551|NCT00803101|40474956|FG000|Overall Study|Death / Serious Adverse Event|4|||
16549552|NCT00803101|40474957|FG001|Overall Study|Death / Serious Adverse Event|6|||
16549553|NCT00803101|40474956|FG000|Overall Study|Withdrawal by Subject|6|||
16228303|NCT01241591|39316943|FG001|Overall Study|Withdrawal by Subject|4|||
16228304|NCT01241591|39316944|FG002|Overall Study|Withdrawal by Subject|2|||
16228305|NCT01241591|39316945|FG003|Overall Study|Withdrawal by Subject|2|||
16228306|NCT01241591|39316942|FG000|Overall Study|Other|0|||
16228307|NCT01241591|39316943|FG001|Overall Study|Other|1|||
16228308|NCT01241591|39316944|FG002|Overall Study|Other|0|||
16228309|NCT01241591|39316945|FG003|Overall Study|Other|1|||
16228310|NCT01241591|39316942|FG000|Overall Study|Adverse Event|3|||
16228311|NCT01241591|39316943|FG001|Overall Study|Adverse Event|11|||
16228312|NCT01241591|39316944|FG002|Overall Study|Adverse Event|12|||
16228313|NCT01241591|39316945|FG003|Overall Study|Adverse Event|4|||
16228314|NCT02058849|39316946|FG000|Overall Study|Hospitalization|1|||
16228315|NCT02058849|39316947|FG001|Overall Study|Hospitalization|1|||
16228316|NCT02058849|39316946|FG000|Overall Study|Death|1|||
16228317|NCT02058849|39316947|FG001|Overall Study|Death|0|||
16228318|NCT02058849|39316946|FG000|Overall Study|Lost to Follow-up|1|||
16347671|NCT00549549|39762000|FG003|Overall Study|Adverse Event|9|||
16347672|NCT00549549|39761997|FG000|Overall Study|Lack of Efficacy|9|||
16347673|NCT00549549|39761998|FG001|Overall Study|Lack of Efficacy|6|||
16347674|NCT00549549|39761999|FG002|Overall Study|Lack of Efficacy|4|||
16347675|NCT00549549|39762000|FG003|Overall Study|Lack of Efficacy|2|||
16549554|NCT00803101|40474957|FG001|Overall Study|Withdrawal by Subject|4|||
16549555|NCT00803101|40474956|FG000|Overall Study|Lost to Follow-up|2|||
16549556|NCT00803101|40474957|FG001|Overall Study|Lost to Follow-up|2|||
16549557|NCT00803101|40474956|FG000|Overall Study|Protocol Violation|1|||
16549558|NCT00803101|40474957|FG001|Overall Study|Protocol Violation|7|||
16549559|NCT00803101|40474956|FG000|Overall Study|Surgery finished outside protocol window|1|||
16549560|NCT00803101|40474957|FG001|Overall Study|Surgery finished outside protocol window|1|||
16549561|NCT00803101|40474956|FG000|Overall Study|Patient died outside SAE report period|1|||
16228319|NCT02058849|39316947|FG001|Overall Study|Lost to Follow-up|0|||
16228320|NCT02058849|39316946|FG000|Overall Study|Withdrawal by Subject|4|||
16347676|NCT00549549|39761997|FG000|Overall Study|Lost to Follow-up|1|||
16347677|NCT00549549|39761998|FG001|Overall Study|Lost to Follow-up|0|||
16347678|NCT00549549|39761999|FG002|Overall Study|Lost to Follow-up|1|||
16347679|NCT00549549|39762000|FG003|Overall Study|Lost to Follow-up|2|||
16347680|NCT00549549|39761997|FG000|Overall Study|Withdrawal by Subject|0|||
16347681|NCT00549549|39761998|FG001|Overall Study|Withdrawal by Subject|4|||
16228321|NCT02058849|39316947|FG001|Overall Study|Withdrawal by Subject|0|||
16347682|NCT00549549|39761999|FG002|Overall Study|Withdrawal by Subject|1|||
16411917|NCT02726880|39988780|FG000|Overall Study|Lost to Follow-up|1|||
16549562|NCT00803101|40474957|FG001|Overall Study|Patient died outside SAE report period|0|||
16549563|NCT00803101|40474956|FG000|Overall Study|Patient did not attend scheduled visit|2|||
16228322|NCT01159665|39316954|FG000|Overall Study|Withdrawal by Subject|0|||
16549564|NCT00803101|40474957|FG001|Overall Study|Patient did not attend scheduled visit|1|||
16549565|NCT00803101|40474956|FG000|Overall Study|Patient did not have surgery|1|||
16549566|NCT00803101|40474957|FG001|Overall Study|Patient did not have surgery|1|||
16549567|NCT01872910|40474960|FG000|Overall Study|Lost to Follow-up|2|||
16549568|NCT01872910|40474961|FG001|Overall Study|Lost to Follow-up|0|||
16549569|NCT01872910|40474962|FG002|Overall Study|Lost to Follow-up|2|||
16549570|NCT01872910|40474963|FG003|Overall Study|Lost to Follow-up|0|||
16549571|NCT01872910|40474964|FG004|Overall Study|Lost to Follow-up|0|||
16549572|NCT01872910|40474965|FG005|Overall Study|Lost to Follow-up|0|||
16549573|NCT04161807|40474970|FG000|Overall Study|Withdrawal by Subject|2|||
16549574|NCT04161807|40474970|FG000|Overall Study|Performed only 1 treatment|2|||
16549575|NCT03193801|40474980|FG000|Overall Study|Physician Decision|2|||
16549576|NCT03193801|40474980|FG000|Overall Study|Withdrawal by Subject|1|||
16549577|NCT03893825|40474981|FG000|Overall Study|Death|2|||
16549578|NCT03893825|40474982|FG001|Overall Study|Death|1|||
16549579|NCT03893825|40474981|FG000|Overall Study|Adverse Event|0|||
16549580|NCT03893825|40474982|FG001|Overall Study|Adverse Event|2|||
16549581|NCT03893825|40474981|FG000|Overall Study|Withdrawal by Subject|19|||
16549582|NCT03893825|40474982|FG001|Overall Study|Withdrawal by Subject|21|||
16549583|NCT03893825|40474981|FG000|Overall Study|Protocol deviation|1|||
16549584|NCT03893825|40474982|FG001|Overall Study|Protocol deviation|0|||
16228323|NCT01159665|39316955|FG001|Overall Study|Withdrawal by Subject|1|||
16549585|NCT03893825|40474981|FG000|Overall Study|Lost to Follow-up|10|||
16549586|NCT03893825|40474982|FG001|Overall Study|Lost to Follow-up|10|||
16549587|NCT03893825|40474981|FG000|Overall Study|Other than specified|7|||
16549588|NCT03893825|40474982|FG001|Overall Study|Other than specified|6|||
16117409|NCT04206085|38916330|FG001|Overall Study|Lost to Follow-up|1|||
16117410|NCT04206085|38916331|FG002|Overall Study|Lost to Follow-up|0|||
16117411|NCT04206085|38916329|FG000|Overall Study|Lost to Follow-up|0|||
16117412|NCT04206085|38916330|FG001|Overall Study|Lost to Follow-up|0|||
16117413|NCT04206085|38916331|FG002|Overall Study|Lost to Follow-up|1|||
16117414|NCT01195623|38916332|FG000|Overall Study|Lost to Follow-up|35|||
16117415|NCT01195623|38916333|FG001|Overall Study|Lost to Follow-up|37|||
16117416|NCT03853551|38916336|FG000|Overall Study|Death|2|||
16117417|NCT03853551|38916336|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
16117418|NCT02489968|38916337|FG000|Open-label Treatment Period|Adverse Event|14|||
16117419|NCT02489968|38916338|FG001|Open-label Treatment Period|Adverse Event|7|||
16117420|NCT02489968|38916339|FG002|Open-label Treatment Period|Adverse Event|0|||
16117421|NCT02489968|38916340|FG003|Open-label Treatment Period|Adverse Event|0|||
16117422|NCT02489968|38916341|FG004|Open-label Treatment Period|Adverse Event|0|||
16117423|NCT02489968|38916342|FG005|Open-label Treatment Period|Adverse Event|0|||
16117424|NCT02489968|38916337|FG000|Open-label Treatment Period|Protocol Violation|2|||
16117425|NCT02489968|38916338|FG001|Open-label Treatment Period|Protocol Violation|2|||
16117426|NCT02489968|38916339|FG002|Open-label Treatment Period|Protocol Violation|0|||
16117427|NCT02489968|38916340|FG003|Open-label Treatment Period|Protocol Violation|0|||
16117428|NCT02489968|38916341|FG004|Open-label Treatment Period|Protocol Violation|0|||
16117429|NCT02489968|38916342|FG005|Open-label Treatment Period|Protocol Violation|0|||
16117430|NCT02489968|38916337|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
16117431|NCT02489968|38916338|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
16117432|NCT02489968|38916339|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
16117433|NCT02489968|38916340|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
16117434|NCT02489968|38916341|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
16117435|NCT02489968|38916342|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
16117436|NCT02489968|38916337|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
16117437|NCT02489968|38916338|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
16117438|NCT02489968|38916339|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
16117439|NCT02489968|38916340|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
16117440|NCT02489968|38916341|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
16117441|NCT02489968|38916342|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
16117442|NCT02489968|38916337|FG000|Open-label Treatment Period|Other than specified above|204|||
16117443|NCT02489968|38916338|FG001|Open-label Treatment Period|Other than specified above|189|||
16117444|NCT02489968|38916339|FG002|Open-label Treatment Period|Other than specified above|0|||
16117445|NCT02489968|38916340|FG003|Open-label Treatment Period|Other than specified above|0|||
16117446|NCT02489968|38916341|FG004|Open-label Treatment Period|Other than specified above|0|||
16117447|NCT02489968|38916342|FG005|Open-label Treatment Period|Other than specified above|0|||
16117448|NCT02489968|38916337|FG000|Double-blind Treatment Period|Adverse Event|0|||
16117449|NCT02489968|38916338|FG001|Double-blind Treatment Period|Adverse Event|0|||
16117450|NCT02489968|38916339|FG002|Double-blind Treatment Period|Adverse Event|2|||
16117451|NCT02489968|38916340|FG003|Double-blind Treatment Period|Adverse Event|6|||
16117452|NCT02489968|38916341|FG004|Double-blind Treatment Period|Adverse Event|4|||
16117453|NCT02489968|38916342|FG005|Double-blind Treatment Period|Adverse Event|5|||
16117454|NCT02489968|38916337|FG000|Double-blind Treatment Period|Protocol Violation|0|||
16117455|NCT02489968|38916338|FG001|Double-blind Treatment Period|Protocol Violation|0|||
16117456|NCT02489968|38916339|FG002|Double-blind Treatment Period|Protocol Violation|0|||
16117457|NCT02489968|38916340|FG003|Double-blind Treatment Period|Protocol Violation|0|||
16549589|NCT04318093|40474983|FG000|Overall Study|Adverse Event|2|||
16549590|NCT04318093|40474984|FG001|Overall Study|Adverse Event|2|||
16549591|NCT04318093|40474983|FG000|Overall Study|Participant withdrew consent|1|||
16549592|NCT04318093|40474984|FG001|Overall Study|Participant withdrew consent|0|||
16117458|NCT02489968|38916341|FG004|Double-blind Treatment Period|Protocol Violation|1|||
16117459|NCT02489968|38916342|FG005|Double-blind Treatment Period|Protocol Violation|1|||
16117460|NCT02489968|38916337|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
16117461|NCT02489968|38916338|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
16117462|NCT02489968|38916339|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16117463|NCT02489968|38916340|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
16117464|NCT02489968|38916341|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
16117465|NCT02489968|38916342|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
16117466|NCT02489968|38916337|FG000|Double-blind Treatment Period|Other than specified above|0|||
16117467|NCT02489968|38916338|FG001|Double-blind Treatment Period|Other than specified above|0|||
16117468|NCT02489968|38916339|FG002|Double-blind Treatment Period|Other than specified above|0|||
16117469|NCT02489968|38916340|FG003|Double-blind Treatment Period|Other than specified above|0|||
16228324|NCT01159665|39316956|FG002|Overall Study|Withdrawal by Subject|0|||
16228325|NCT01159665|39316957|FG003|Overall Study|Withdrawal by Subject|0|||
16228326|NCT01159665|39316958|FG004|Overall Study|Withdrawal by Subject|0|||
16228327|NCT01159665|39316959|FG005|Overall Study|Withdrawal by Subject|0|||
16228328|NCT01911546|39316960|FG000|Overall Study|Lost to Follow-up|1|||
16549593|NCT04318093|40474983|FG000|Overall Study|Other reasons|0|||
16117470|NCT02489968|38916341|FG004|Double-blind Treatment Period|Other than specified above|1|||
16117471|NCT02489968|38916342|FG005|Double-blind Treatment Period|Other than specified above|0|||
16117472|NCT01377389|38916343|FG000|Overall Study|Withdrawal by Subject|1|||
16117473|NCT01377389|38916343|FG000|Overall Study|Screen failure|2|||
16117474|NCT01594970|38916344|FG000|Overall Study|Non-Adverse Event Related|4|||
16117475|NCT01594970|38916345|FG001|Overall Study|Non-Adverse Event Related|5|||
16117476|NCT01594970|38916346|FG002|Overall Study|Non-Adverse Event Related|6|||
16117477|NCT01594970|38916344|FG000|Overall Study|Adverse Event|17|||
16117478|NCT01594970|38916345|FG001|Overall Study|Adverse Event|23|||
16117479|NCT01594970|38916346|FG002|Overall Study|Adverse Event|23|||
16117480|NCT01594970|38916344|FG000|Overall Study|Lost to Follow-up|54|||
16117481|NCT01594970|38916345|FG001|Overall Study|Lost to Follow-up|54|||
16117482|NCT01594970|38916346|FG002|Overall Study|Lost to Follow-up|37|||
16117483|NCT03721172|38916348|FG000|Placebo-controlled Phase|Adverse Event|7|||
16117484|NCT03721172|38916349|FG001|Placebo-controlled Phase|Adverse Event|7|||
16117485|NCT03721172|38916350|FG002|Placebo-controlled Phase|Adverse Event|0|||
16117486|NCT03721172|38916348|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
16117487|NCT03721172|38916349|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
16117488|NCT03721172|38916350|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
16117489|NCT03721172|38916348|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
16117490|NCT03721172|38916349|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
16117491|NCT03721172|38916350|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
16117492|NCT03721172|38916348|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
16228329|NCT01911546|39316960|FG000|Overall Study|Everolimus was discontinued|5|||
16228330|NCT00148109|39316961|FG000|Overall Study|Lack of Efficacy|10|||
16117493|NCT03721172|38916349|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
16117494|NCT03721172|38916350|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
16228331|NCT00148109|39316962|FG001|Overall Study|Lack of Efficacy|18|||
16228332|NCT00148109|39316961|FG000|Overall Study|Adverse Event|0|||
16228333|NCT00148109|39316962|FG001|Overall Study|Adverse Event|2|||
16228334|NCT00148109|39316961|FG000|Overall Study|Withdrawal by Subject|2|||
16228335|NCT00148109|39316962|FG001|Overall Study|Withdrawal by Subject|0|||
16228336|NCT01654666|39316963|FG000|Overall Study|Protocol Violation|7|||
16228337|NCT01654666|39316964|FG001|Overall Study|Protocol Violation|4|||
16228338|NCT01654666|39316965|FG002|Overall Study|Protocol Violation|8|||
16228339|NCT01654666|39316963|FG000|Overall Study|Lost to Follow-up|4|||
16228340|NCT01654666|39316964|FG001|Overall Study|Lost to Follow-up|5|||
16228341|NCT01654666|39316965|FG002|Overall Study|Lost to Follow-up|5|||
16228342|NCT01654666|39316963|FG000|Overall Study|Withdrawal by Subject|4|||
16228343|NCT01654666|39316964|FG001|Overall Study|Withdrawal by Subject|4|||
16228344|NCT01654666|39316965|FG002|Overall Study|Withdrawal by Subject|1|||
16228345|NCT00461552|39316968|FG000|Overall Study|Drug Dispensing error|0|||
16228346|NCT00461552|39316969|FG001|Overall Study|Drug Dispensing error|2|||
16228347|NCT00438815|39316970|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
16228348|NCT00438815|39316970|FG000|Overall Study|3-month follow-up no longer required|12|||
16228349|NCT00438815|39316970|FG000|Overall Study|Noncompliance with protocol requirements|9|||
16228350|NCT00438815|39316970|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
16228351|NCT00438815|39316970|FG000|Overall Study|Lost to Follow-up|6|||
16228352|NCT00438815|39316970|FG000|Overall Study|Withdrawal by Subject|6|||
16228353|NCT00438815|39316970|FG000|Overall Study|Death|1|||
16228354|NCT03672006|39316971|FG000|Overall Study|exclusion criteria met|0|||
16228355|NCT03672006|39316972|FG001|Overall Study|exclusion criteria met|1|||
16549594|NCT04318093|40474984|FG001|Overall Study|Other reasons|1|||
16549595|NCT01598298|40474985|FG000|Overall Study|Not eligible|5|||
16549596|NCT01598298|40474986|FG001|Overall Study|Not eligible|5|||
16549597|NCT01598298|40474985|FG000|Overall Study|Adverse Event|21|||
16549598|NCT01598298|40474986|FG001|Overall Study|Adverse Event|19|||
16549599|NCT01598298|40474985|FG000|Overall Study|Progression/relapse|0|||
16228356|NCT01589185|39316974|FG000|Overall Study|Death|1|||
16228357|NCT01589185|39316975|FG001|Overall Study|Death|2|||
16228358|NCT01589185|39316976|FG002|Overall Study|Death|2|||
16549600|NCT01598298|40474986|FG001|Overall Study|Progression/relapse|2|||
16549601|NCT01598298|40474985|FG000|Overall Study|Withdrawal by Subject|10|||
16549602|NCT01598298|40474986|FG001|Overall Study|Withdrawal by Subject|15|||
16549603|NCT01598298|40474985|FG000|Overall Study|Other reason (not protocol specified)|4|||
16549604|NCT01598298|40474986|FG001|Overall Study|Other reason (not protocol specified)|0|||
16549605|NCT02305381|40474987|FG000|Overall Study|Unclassified|5|||
16549606|NCT02305381|40474988|FG001|Overall Study|Unclassified|5|||
16117495|NCT03721172|38916348|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
16228359|NCT01589185|39316977|FG003|Overall Study|Death|0|||
16117496|NCT03721172|38916349|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
16117497|NCT03721172|38916350|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
16228360|NCT01589185|39316978|FG004|Overall Study|Death|1|||
16228361|NCT01589185|39316974|FG000|Overall Study|Lost to Follow-up|1|||
16228362|NCT01589185|39316975|FG001|Overall Study|Lost to Follow-up|0|||
16228363|NCT01589185|39316976|FG002|Overall Study|Lost to Follow-up|2|||
16117498|NCT03721172|38916348|FG000|Placebo-controlled Phase|Other|3|||
16117499|NCT03721172|38916349|FG001|Placebo-controlled Phase|Other|0|||
16117500|NCT03721172|38916350|FG002|Placebo-controlled Phase|Other|0|||
16117501|NCT03721172|38916348|FG000|Apremilast Extension Phase|Adverse Event|0|||
16117502|NCT03721172|38916349|FG001|Apremilast Extension Phase|Adverse Event|0|||
16117503|NCT03721172|38916350|FG002|Apremilast Extension Phase|Adverse Event|10|||
16117504|NCT03721172|38916348|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
16117505|NCT03721172|38916349|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
16117506|NCT03721172|38916350|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
16117507|NCT03721172|38916348|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
16117508|NCT03721172|38916349|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
16117509|NCT03721172|38916350|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
16117510|NCT03721172|38916348|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
16117511|NCT03721172|38916349|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
16117512|NCT03721172|38916350|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
16117513|NCT03721172|38916348|FG000|Apremilast Extension Phase|Protocol Violation|0|||
16117514|NCT03721172|38916349|FG001|Apremilast Extension Phase|Protocol Violation|0|||
16117515|NCT03721172|38916350|FG002|Apremilast Extension Phase|Protocol Violation|1|||
16117516|NCT03721172|38916348|FG000|Apremilast Extension Phase|Physician Decision|0|||
16117517|NCT03721172|38916349|FG001|Apremilast Extension Phase|Physician Decision|0|||
16117518|NCT03721172|38916350|FG002|Apremilast Extension Phase|Physician Decision|1|||
16117519|NCT03721172|38916348|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
16117520|NCT03721172|38916349|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
16117521|NCT03721172|38916350|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
16117522|NCT03721172|38916348|FG000|Apremilast Extension Phase|Other|0|||
16117523|NCT03721172|38916349|FG001|Apremilast Extension Phase|Other|0|||
16117524|NCT03721172|38916350|FG002|Apremilast Extension Phase|Other|3|||
16117525|NCT03721172|38916348|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
16117526|NCT03721172|38916349|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
16117527|NCT03721172|38916350|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
16117528|NCT03519204|38916351|FG000|Overall Study|Lost to Follow-up|3|||
16117529|NCT03519204|38916352|FG001|Overall Study|Lost to Follow-up|8|||
16117530|NCT03519204|38916351|FG000|Overall Study|Withdrawal by Subject|9|||
16117531|NCT03519204|38916352|FG001|Overall Study|Withdrawal by Subject|7|||
16117532|NCT03519204|38916351|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16117533|NCT03519204|38916352|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16117534|NCT00078377|38916353|FG000|Overall Study|Adverse Event|2|||
16117535|NCT00078377|38916354|FG001|Overall Study|Adverse Event|5|||
16117536|NCT00078377|38916355|FG002|Overall Study|Adverse Event|1|||
16117537|NCT00078377|38916353|FG000|Overall Study|Lack of Efficacy|2|||
16117538|NCT00078377|38916354|FG001|Overall Study|Lack of Efficacy|0|||
16117539|NCT00078377|38916355|FG002|Overall Study|Lack of Efficacy|2|||
16117540|NCT00078377|38916353|FG000|Overall Study|Lost to Follow-up|0|||
16117541|NCT00078377|38916354|FG001|Overall Study|Lost to Follow-up|1|||
16117542|NCT00078377|38916355|FG002|Overall Study|Lost to Follow-up|1|||
16117543|NCT00078377|38916353|FG000|Overall Study|Physician Decision|2|||
16117544|NCT00078377|38916354|FG001|Overall Study|Physician Decision|0|||
16117545|NCT00078377|38916355|FG002|Overall Study|Physician Decision|0|||
16117546|NCT00078377|38916353|FG000|Overall Study|Withdrawal by Subject|3|||
16117547|NCT00078377|38916354|FG001|Overall Study|Withdrawal by Subject|4|||
16117548|NCT00078377|38916355|FG002|Overall Study|Withdrawal by Subject|4|||
16117549|NCT00078377|38916353|FG000|Overall Study|Miscellaneous|2|||
16117550|NCT00078377|38916354|FG001|Overall Study|Miscellaneous|6|||
16117551|NCT00078377|38916355|FG002|Overall Study|Miscellaneous|1|||
16117552|NCT00953615|38916356|FG000|Overall Study|Adverse Event|1|||
16117553|NCT01912404|38916357|FG000|Overall Study|Due to personal reasons|1|||
16117554|NCT01912404|38916358|FG001|Overall Study|Due to personal reasons|0|||
16117555|NCT01305408|38916359|FG000|Overall Study|Adverse Event|10|||
16117556|NCT01305408|38916360|FG001|Overall Study|Adverse Event|7|||
16117557|NCT01305408|38916359|FG000|Overall Study|Lack of Efficacy|3|||
16117558|NCT01305408|38916360|FG001|Overall Study|Lack of Efficacy|4|||
16117559|NCT01305408|38916359|FG000|Overall Study|Withdrawal by Subject|9|||
16117560|NCT01305408|38916360|FG001|Overall Study|Withdrawal by Subject|9|||
16117561|NCT01305408|38916359|FG000|Overall Study|Protocol Violation|4|||
16117562|NCT01305408|38916360|FG001|Overall Study|Protocol Violation|6|||
16117563|NCT01305408|38916359|FG000|Overall Study|Lost to Follow-up|5|||
16117564|NCT01305408|38916360|FG001|Overall Study|Lost to Follow-up|3|||
16117565|NCT01305408|38916359|FG000|Overall Study|Noncompliance with study medication|0|||
16117566|NCT01305408|38916360|FG001|Overall Study|Noncompliance with study medication|1|||
16117567|NCT01305408|38916359|FG000|Overall Study|Noncompliance with study procedures|0|||
16117568|NCT01305408|38916360|FG001|Overall Study|Noncompliance with study procedures|1|||
16117569|NCT01305408|38916359|FG000|Overall Study|Other|1|||
16117570|NCT01305408|38916360|FG001|Overall Study|Other|0|||
16117571|NCT01199068|38916371|FG000|Overall Study|Unacceptable toxicity|0|||
16117572|NCT01199068|38916372|FG001|Overall Study|Unacceptable toxicity|0|||
16117573|NCT01199068|38916373|FG002|Overall Study|Unacceptable toxicity|2|||
16117574|NCT01199068|38916371|FG000|Overall Study|Progressive disease|3|||
16117575|NCT01199068|38916372|FG001|Overall Study|Progressive disease|3|||
16117576|NCT01199068|38916373|FG002|Overall Study|Progressive disease|6|||
16117577|NCT01199068|38916371|FG000|Overall Study|Withdrawal by Subject|0|||
16117578|NCT01199068|38916372|FG001|Overall Study|Withdrawal by Subject|0|||
16117579|NCT01199068|38916373|FG002|Overall Study|Withdrawal by Subject|1|||
16117580|NCT00392925|38916376|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
16117581|NCT00392925|38916377|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
16117582|NCT00392925|38916378|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
16117583|NCT00392925|38916379|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
16117584|NCT00392925|38916376|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
16117585|NCT00392925|38916377|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
16117586|NCT00392925|38916378|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
16117587|NCT00392925|38916379|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
16117588|NCT00392925|38916376|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
16117589|NCT00392925|38916377|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
16117590|NCT00392925|38916378|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
16117591|NCT00392925|38916379|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
16117592|NCT00392925|38916376|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
16117593|NCT00392925|38916377|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
16117594|NCT00392925|38916378|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
16117595|NCT00392925|38916379|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
16117596|NCT00392925|38916376|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
16117597|NCT00392925|38916377|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
16117598|NCT00392925|38916378|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
16228364|NCT01589185|39316977|FG003|Overall Study|Lost to Follow-up|3|||
16228365|NCT01589185|39316978|FG004|Overall Study|Lost to Follow-up|0|||
16228366|NCT03868059|39316979|FG000|Overall Study|Adverse Event|3|||
16228367|NCT03868059|39316979|FG000|Overall Study|Lost to Follow-up|3|||
16228368|NCT03868059|39316979|FG000|Overall Study|Withdrawal by Subject|6|||
16228369|NCT01641952|39316984|FG000|Overall Study|Lost to Follow-up|28|||
16228370|NCT01641952|39316984|FG000|Overall Study|Adverse Event|6|||
16228371|NCT03433482|39316990|FG000|Overall Study|Lost to Follow-up|1|||
16228372|NCT03433482|39316991|FG001|Overall Study|Lost to Follow-up|0|||
16549607|NCT02305381|40474989|FG002|Overall Study|Unclassified|7|||
16549608|NCT01372605|40474993|FG000|Overall Study|Death|1|||
16549609|NCT01372605|40474994|FG001|Overall Study|Death|2|||
16549610|NCT01372605|40474993|FG000|Overall Study|Lost to Follow-up|2|||
16549611|NCT01372605|40474994|FG001|Overall Study|Lost to Follow-up|1|||
16549612|NCT01372605|40474993|FG000|Overall Study|Withdrawal by Subject|4|||
16549613|NCT01372605|40474994|FG001|Overall Study|Withdrawal by Subject|7|||
16549614|NCT01372605|40474993|FG000|Overall Study|Moved|3|||
16228373|NCT03433482|39316992|FG002|Overall Study|Lost to Follow-up|1|||
16228374|NCT03433482|39316993|FG003|Overall Study|Lost to Follow-up|1|||
16411918|NCT02726880|39988781|FG001|Overall Study|Lost to Follow-up|3|||
16117599|NCT00392925|38916379|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
16117600|NCT00392925|38916376|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
16117601|NCT00392925|38916377|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
16117602|NCT00392925|38916378|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
16228375|NCT03433482|39316990|FG000|Overall Study|Withdrawal by Subject|0|||
16347683|NCT00549549|39762000|FG003|Overall Study|Withdrawal by Subject|0|||
16347684|NCT00549549|39761997|FG000|Overall Study|Other|9|||
16347685|NCT00549549|39761998|FG001|Overall Study|Other|9|||
16347686|NCT00549549|39761999|FG002|Overall Study|Other|9|||
16347687|NCT00549549|39762000|FG003|Overall Study|Other|11|||
16347688|NCT00549549|39761997|FG000|Overall Study|Randomized but not treated|0|||
16347689|NCT00549549|39761998|FG001|Overall Study|Randomized but not treated|0|||
16347690|NCT00549549|39761999|FG002|Overall Study|Randomized but not treated|1|||
16347691|NCT00549549|39762000|FG003|Overall Study|Randomized but not treated|1|||
16347692|NCT04131712|39762001|FG000|Overall Study|COVID related|0|||
16347693|NCT04131712|39762002|FG001|Overall Study|COVID related|0|||
16347694|NCT04131712|39762003|FG002|Overall Study|COVID related|2|||
16347695|NCT04131712|39762004|FG003|Overall Study|COVID related|0|||
16347696|NCT04131712|39762001|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
16347697|NCT04131712|39762002|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
16347698|NCT04131712|39762003|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
16347699|NCT04131712|39762004|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
16347700|NCT01697800|39762005|FG000|Overall Study|Death|0|||
16347701|NCT01697800|39762006|FG001|Overall Study|Death|1|||
16347702|NCT02171429|39762009|FG000|Overall Study|Other|0|||
16347703|NCT02171429|39762010|FG001|Overall Study|Other|1|||
16347704|NCT02171429|39762011|FG002|Overall Study|Other|1|||
16347705|NCT02171429|39762009|FG000|Overall Study|Non-Compliance|0|||
16347706|NCT02171429|39762010|FG001|Overall Study|Non-Compliance|0|||
16347707|NCT02171429|39762011|FG002|Overall Study|Non-Compliance|1|||
16347708|NCT02171429|39762009|FG000|Overall Study|Physician Decision|0|||
16347709|NCT02171429|39762010|FG001|Overall Study|Physician Decision|0|||
16347710|NCT02171429|39762011|FG002|Overall Study|Physician Decision|1|||
16347711|NCT02171429|39762009|FG000|Overall Study|Withdrawal by Subject|1|||
16347712|NCT02171429|39762010|FG001|Overall Study|Withdrawal by Subject|1|||
16228376|NCT03433482|39316991|FG001|Overall Study|Withdrawal by Subject|0|||
16347713|NCT02171429|39762011|FG002|Overall Study|Withdrawal by Subject|1|||
16347714|NCT02171429|39762009|FG000|Overall Study|Lost to Follow-up|0|||
16347715|NCT02171429|39762010|FG001|Overall Study|Lost to Follow-up|1|||
16347716|NCT02171429|39762011|FG002|Overall Study|Lost to Follow-up|0|||
16347717|NCT02171429|39762009|FG000|Overall Study|Death|0|||
16347718|NCT02171429|39762010|FG001|Overall Study|Death|0|||
16347719|NCT02171429|39762011|FG002|Overall Study|Death|1|||
16347720|NCT05502302|39762012|FG000|Overall Study|Lost to Follow-up|6|||
16347721|NCT05502302|39762012|FG000|Overall Study|Death|2|||
16347722|NCT03101150|39762013|FG000|Overall Study|Lost to Follow-up|2|||
16347723|NCT03101150|39762014|FG001|Overall Study|Lost to Follow-up|4|||
16347724|NCT03101150|39762013|FG000|Overall Study|Miscarriage|3|||
16347725|NCT03101150|39762014|FG001|Overall Study|Miscarriage|6|||
16347726|NCT01266824|39762015|FG000|Overall Study|Study terminated prior to completion|2|||
16347727|NCT01266824|39762016|FG001|Overall Study|Study terminated prior to completion|3|||
16347728|NCT01473940|39762017|FG000|Induction Therapy|Death|0|||
16411919|NCT04063787|39988782|FG000|Overall Study|Inadequate Doppler data|4|||
16411920|NCT04063787|39988782|FG000|Overall Study|Lost to Follow-up|2|||
16228377|NCT03433482|39316992|FG002|Overall Study|Withdrawal by Subject|1|||
16228378|NCT03433482|39316993|FG003|Overall Study|Withdrawal by Subject|0|||
16117603|NCT00392925|38916379|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
16117604|NCT00392925|38916376|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
16117605|NCT00392925|38916377|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
16117606|NCT00392925|38916378|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
16117607|NCT00392925|38916379|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
16228379|NCT03433482|39316990|FG000|Overall Study|Unknown reason|0|||
16549615|NCT01372605|40474994|FG001|Overall Study|Moved|0|||
16347729|NCT01473940|39762018|FG001|Induction Therapy|Death|0|||
16411921|NCT04063787|39988782|FG000|Overall Study|Death|3|||
16411922|NCT02068118|39988783|FG000|18-month Comparative Study Period|Death|90|||
16411923|NCT02068118|39988784|FG001|18-month Comparative Study Period|Death|97|||
16411924|NCT02068118|39988783|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
16549616|NCT01372605|40474993|FG000|Overall Study|Changed medical home|2|||
16549617|NCT01372605|40474994|FG001|Overall Study|Changed medical home|0|||
16549618|NCT00332332|40474995|FG000|Overall Study|Adverse Event|13|||
16549619|NCT00332332|40474995|FG000|Overall Study|Death|1|||
16549620|NCT00332332|40474995|FG000|Overall Study|Withdrawal by Subject|8|||
16549621|NCT00332332|40474995|FG000|Overall Study|Physician Decision|1|||
16549622|NCT00332332|40474995|FG000|Overall Study|Lost to Follow-up|3|||
16549623|NCT00332332|40474995|FG000|Overall Study|Protocol deviation|4|||
16549624|NCT00332332|40474995|FG000|Overall Study|Noncompliance|2|||
16549625|NCT00332332|40474995|FG000|Overall Study|Disease progression|2|||
16549626|NCT00332332|40474995|FG000|Overall Study|Other|18|||
16549627|NCT00332332|40474995|FG000|Overall Study|Did not receive study treatment|16|||
16549628|NCT01834222|40474998|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
16549629|NCT02001974|40474999|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
16549630|NCT02001974|40475000|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
16549631|NCT02001974|40475001|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
16549632|NCT02001974|40474999|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
16549633|NCT02001974|40475000|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
16549634|NCT02001974|40475001|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
16549635|NCT02001974|40474999|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
16549636|NCT02001974|40475000|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
16549637|NCT02001974|40475001|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
16549638|NCT02001974|40474999|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
16549639|NCT02001974|40475000|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
16549640|NCT02001974|40475001|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
16549641|NCT01032044|40475004|FG000|Overall Study|Protocol Violation|14|||
16549642|NCT01032044|40475005|FG001|Overall Study|Protocol Violation|8|||
16411925|NCT02068118|39988784|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
16347730|NCT01473940|39762019|FG002|Induction Therapy|Death|1|||
16347731|NCT01473940|39762020|FG003|Induction Therapy|Death|1|||
16347732|NCT01473940|39762017|FG000|Induction Therapy|Progressive Disease|0|||
16347733|NCT01473940|39762018|FG001|Induction Therapy|Progressive Disease|1|||
16347734|NCT01473940|39762019|FG002|Induction Therapy|Progressive Disease|1|||
16347735|NCT01473940|39762020|FG003|Induction Therapy|Progressive Disease|0|||
16347736|NCT01473940|39762017|FG000|Maintenance Therapy|Progressive Disease|1|||
16347737|NCT01473940|39762018|FG001|Maintenance Therapy|Progressive Disease|2|||
16347738|NCT01473940|39762019|FG002|Maintenance Therapy|Progressive Disease|1|||
16347739|NCT01473940|39762020|FG003|Maintenance Therapy|Progressive Disease|4|||
16347740|NCT03810456|39762021|FG000|Treatment|Urgent Family Matters|3|||
16347741|NCT03810456|39762022|FG001|Treatment|Urgent Family Matters|0|||
16347742|NCT03810456|39762023|FG002|Treatment|Urgent Family Matters|0|||
16347743|NCT03810456|39762021|FG000|Treatment|Scheduling Conflicts|0|||
16347744|NCT03810456|39762022|FG001|Treatment|Scheduling Conflicts|11|||
16347745|NCT03810456|39762023|FG002|Treatment|Scheduling Conflicts|0|||
16347746|NCT03810456|39762021|FG000|Treatment|No Longer Interested|0|||
16347747|NCT03810456|39762022|FG001|Treatment|No Longer Interested|12|||
16347748|NCT03810456|39762023|FG002|Treatment|No Longer Interested|0|||
16347749|NCT03810456|39762021|FG000|Treatment|Transportation Issues|0|||
16347750|NCT03810456|39762022|FG001|Treatment|Transportation Issues|1|||
16347751|NCT03810456|39762023|FG002|Treatment|Transportation Issues|0|||
16347752|NCT03810456|39762021|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
16347753|NCT03810456|39762022|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
16347754|NCT03810456|39762023|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
16347755|NCT03810456|39762021|FG000|1 Month Follow-Up|Relocated to Different State|1|||
16347756|NCT03810456|39762022|FG001|1 Month Follow-Up|Relocated to Different State|0|||
16347757|NCT03810456|39762023|FG002|1 Month Follow-Up|Relocated to Different State|1|||
16347758|NCT03810456|39762021|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
16347759|NCT03810456|39762022|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
16347760|NCT03810456|39762023|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
16347761|NCT03810456|39762021|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
16347762|NCT03810456|39762022|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
16347763|NCT03810456|39762023|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
16347764|NCT03810456|39762021|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
16347765|NCT03810456|39762022|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
16347766|NCT03810456|39762023|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
16347767|NCT03810456|39762021|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
16347768|NCT03810456|39762022|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
16347769|NCT03810456|39762023|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
16347770|NCT03810456|39762021|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
16347771|NCT03810456|39762022|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
16347772|NCT03810456|39762023|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
16347773|NCT00547248|39762024|FG000|Overall Study|Protocol Violation|0|||
16347774|NCT00547248|39762025|FG001|Overall Study|Protocol Violation|0|||
16347775|NCT00547248|39762026|FG002|Overall Study|Protocol Violation|1|||
16347776|NCT00547248|39762027|FG003|Overall Study|Protocol Violation|1|||
16347777|NCT00547248|39762024|FG000|Overall Study|Migrated/moved from study area|0|||
16347778|NCT00547248|39762025|FG001|Overall Study|Migrated/moved from study area|0|||
16347779|NCT00547248|39762026|FG002|Overall Study|Migrated/moved from study area|2|||
16347780|NCT00547248|39762027|FG003|Overall Study|Migrated/moved from study area|0|||
16347781|NCT00547248|39762024|FG000|Overall Study|Withdrawal by Subject|0|||
16347782|NCT00547248|39762025|FG001|Overall Study|Withdrawal by Subject|0|||
16347783|NCT00547248|39762026|FG002|Overall Study|Withdrawal by Subject|7|||
16347784|NCT00547248|39762027|FG003|Overall Study|Withdrawal by Subject|1|||
16347785|NCT00325819|39762028|FG000|Overall Study|Study product lost in mail|2|||
16347786|NCT00325819|39762029|FG001|Overall Study|Study product lost in mail|1|||
16347787|NCT00325819|39762028|FG000|Overall Study|Did not take a dose of study product|4|||
16347788|NCT00325819|39762029|FG001|Overall Study|Did not take a dose of study product|9|||
16347789|NCT00325819|39762028|FG000|Overall Study|Lost to Follow-up|3|||
16347790|NCT00325819|39762029|FG001|Overall Study|Lost to Follow-up|3|||
16411926|NCT02068118|39988783|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
16549643|NCT01032044|40475004|FG000|Overall Study|Adverse Event|0|||
16228380|NCT03433482|39316991|FG001|Overall Study|Unknown reason|0|||
16347791|NCT02155985|39762030|FG000|Overall Study|Withdrawal by Subject|0|||
16347792|NCT02155985|39762031|FG001|Overall Study|Withdrawal by Subject|0|||
16347793|NCT02155985|39762032|FG002|Overall Study|Withdrawal by Subject|1|||
16347794|NCT02155985|39762030|FG000|Overall Study|Lost to Follow-up|1|||
16347795|NCT02155985|39762031|FG001|Overall Study|Lost to Follow-up|0|||
16347796|NCT02155985|39762032|FG002|Overall Study|Lost to Follow-up|0|||
16347797|NCT03560869|39762033|FG000|Overall Study|Withdrawal by Subject|3|||
16347798|NCT03560869|39762034|FG001|Overall Study|Withdrawal by Subject|4|||
16347799|NCT03560869|39762033|FG000|Overall Study|Screening failure|4|||
16347800|NCT03560869|39762034|FG001|Overall Study|Screening failure|4|||
16347801|NCT03560869|39762033|FG000|Overall Study|Withdrawal by PI|0|||
16347802|NCT03560869|39762034|FG001|Overall Study|Withdrawal by PI|1|||
16347803|NCT04004260|39762035|FG000|Overall Study|Withdrawal by Subject|7|||
16347804|NCT04004260|39762036|FG001|Overall Study|Withdrawal by Subject|3|||
16347805|NCT04004260|39762035|FG000|Overall Study|Lost to Follow-up|22|||
16347806|NCT04004260|39762036|FG001|Overall Study|Lost to Follow-up|12|||
16347807|NCT04004260|39762035|FG000|Overall Study|Did not engage in intervention|13|||
16347808|NCT04004260|39762036|FG001|Overall Study|Did not engage in intervention|17|||
16347809|NCT00447902|39762037|FG000|Overall Study|Adverse Event|0|||
16228381|NCT03433482|39316992|FG002|Overall Study|Unknown reason|2|||
16228382|NCT03433482|39316993|FG003|Overall Study|Unknown reason|0|||
16228383|NCT00914940|39316996|FG000|D0 to D100 Post-transplant|Death|2|||
16228384|NCT00914940|39316996|FG000|D101 to 2 Years Post-transplant|Death|8|||
16228385|NCT00914940|39316996|FG000|2 Years to 5 Years Post-transplant|Death|3|||
16228386|NCT03359811|39316999|FG000|Overall Study|Protocol Violation|2|||
16228387|NCT03359811|39317000|FG001|Overall Study|Protocol Violation|0|||
16228388|NCT03000075|39317001|FG000|Part A|Adverse Event|4|||
16228389|NCT03000075|39317002|FG001|Part A|Adverse Event|0|||
16228390|NCT03000075|39317003|FG002|Part A|Adverse Event|0|||
16228391|NCT03000075|39317004|FG003|Part A|Adverse Event|0|||
16228392|NCT03000075|39317005|FG004|Part A|Adverse Event|0|||
16228393|NCT03000075|39317006|FG005|Part A|Adverse Event|0|||
16228394|NCT03000075|39317007|FG006|Part A|Adverse Event|0|||
16228395|NCT03000075|39317001|FG000|Part B|Not dosed due to AE|0|||
16228396|NCT03000075|39317002|FG001|Part B|Not dosed due to AE|0|||
16228397|NCT03000075|39317003|FG002|Part B|Not dosed due to AE|0|||
16228398|NCT03000075|39317004|FG003|Part B|Not dosed due to AE|0|||
16228399|NCT03000075|39317005|FG004|Part B|Not dosed due to AE|0|||
16228400|NCT03000075|39317006|FG005|Part B|Not dosed due to AE|2|||
16228401|NCT03000075|39317007|FG006|Part B|Not dosed due to AE|1|||
16228402|NCT03000075|39317001|FG000|Part B|Adverse Event|0|||
16228403|NCT03000075|39317002|FG001|Part B|Adverse Event|0|||
16228404|NCT03000075|39317003|FG002|Part B|Adverse Event|0|||
16228405|NCT03000075|39317004|FG003|Part B|Adverse Event|0|||
16228406|NCT03000075|39317005|FG004|Part B|Adverse Event|1|||
16228407|NCT03000075|39317006|FG005|Part B|Adverse Event|0|||
16228408|NCT03000075|39317007|FG006|Part B|Adverse Event|0|||
16228409|NCT00368069|39317008|FG000|Overall Study|Adverse Event|5|||
16228410|NCT00368069|39317009|FG001|Overall Study|Adverse Event|2|||
16228411|NCT00368069|39317008|FG000|Overall Study|Lack of Efficacy|0|||
16228412|NCT00368069|39317009|FG001|Overall Study|Lack of Efficacy|1|||
16228413|NCT00368069|39317008|FG000|Overall Study|Lost to Follow-up|1|||
16228414|NCT00368069|39317009|FG001|Overall Study|Lost to Follow-up|0|||
16228415|NCT00368069|39317008|FG000|Overall Study|Protocol Violation|0|||
16228416|NCT00368069|39317009|FG001|Overall Study|Protocol Violation|2|||
16228417|NCT00368069|39317008|FG000|Overall Study|Withdrawal of Consent|2|||
16228418|NCT00368069|39317009|FG001|Overall Study|Withdrawal of Consent|1|||
16228419|NCT00368069|39317008|FG000|Overall Study|no blood sampling possible|0|||
16228420|NCT00368069|39317009|FG001|Overall Study|no blood sampling possible|1|||
16228421|NCT03710824|39317010|FG000|Overall Study|Withdrawal by Subject|1|||
16228422|NCT03710824|39317010|FG000|Overall Study|Lost to Follow-up|3|||
16228423|NCT03710824|39317010|FG000|Overall Study|Adverse Event|25|||
16228424|NCT03710824|39317010|FG000|Overall Study|Treatment discontinuation|2|||
16228425|NCT03288987|39317012|FG000|Overall Study|Protocol Violation|10|||
16228426|NCT03288987|39317013|FG001|Overall Study|Protocol Violation|4|||
16228427|NCT01000311|39317014|FG000|Overall Study|Adverse Event|2|||
16228428|NCT01000311|39317015|FG001|Overall Study|Adverse Event|5|||
16228429|NCT01000311|39317014|FG000|Overall Study|Withdrawal by Subject|16|||
16228430|NCT01000311|39317015|FG001|Overall Study|Withdrawal by Subject|24|||
16228431|NCT01000311|39317014|FG000|Overall Study|Lost to Follow-up|15|||
16228432|NCT01000311|39317015|FG001|Overall Study|Lost to Follow-up|24|||
16228433|NCT01000311|39317014|FG000|Overall Study|Protocol Violation|1|||
16228434|NCT01000311|39317015|FG001|Overall Study|Protocol Violation|2|||
16228435|NCT01000311|39317014|FG000|Overall Study|Inappropriate enrollment|2|||
16228436|NCT01000311|39317015|FG001|Overall Study|Inappropriate enrollment|0|||
16228437|NCT01000311|39317014|FG000|Overall Study|Administrative reason|9|||
16347810|NCT00447902|39762038|FG001|Overall Study|Adverse Event|3|||
16347811|NCT00447902|39762037|FG000|Overall Study|Protocol Violation|1|||
16347812|NCT00447902|39762038|FG001|Overall Study|Protocol Violation|0|||
16347813|NCT00447902|39762037|FG000|Overall Study|Withdrawal by Subject|0|||
16347814|NCT00447902|39762038|FG001|Overall Study|Withdrawal by Subject|1|||
16347815|NCT00447902|39762037|FG000|Overall Study|included patients who discontinued|1|||
16228438|NCT01000311|39317015|FG001|Overall Study|Administrative reason|15|||
16228439|NCT04366258|39317020|FG000|Baseline Assessments|Screen Failure|21|||
16228440|NCT04366258|39317020|FG000|Baseline Assessments|Early Termination|3|||
16228441|NCT04621227|39317021|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
16228442|NCT04621227|39317021|FG000|Period 3 (29 Days)|Adverse Event|1|||
16228443|NCT04621227|39317021|FG000|Period 8 (2 Days)|Adverse Event|1|||
16228444|NCT01119118|39317022|FG000|Overall Study|Adverse Event|1|||
16228445|NCT01682876|39317023|FG000|Overall Study|Administrative reason|4|||
16228446|NCT01682876|39317024|FG001|Overall Study|Administrative reason|4|||
16228447|NCT01682876|39317025|FG002|Overall Study|Administrative reason|0|||
16228448|NCT01682876|39317026|FG003|Overall Study|Administrative reason|3|||
16549644|NCT01032044|40475005|FG001|Overall Study|Adverse Event|1|||
16228449|NCT01682876|39317023|FG000|Overall Study|Adverse Event|0|||
16228450|NCT01682876|39317024|FG001|Overall Study|Adverse Event|0|||
16228451|NCT01682876|39317025|FG002|Overall Study|Adverse Event|0|||
16228452|NCT01682876|39317026|FG003|Overall Study|Adverse Event|1|||
16228453|NCT01682876|39317023|FG000|Overall Study|Lost to Follow-up|11|||
16228454|NCT01682876|39317024|FG001|Overall Study|Lost to Follow-up|15|||
16228455|NCT01682876|39317025|FG002|Overall Study|Lost to Follow-up|9|||
16228456|NCT01682876|39317026|FG003|Overall Study|Lost to Follow-up|11|||
16228457|NCT01682876|39317023|FG000|Overall Study|Protocol Violation|1|||
16228458|NCT01682876|39317024|FG001|Overall Study|Protocol Violation|1|||
16228459|NCT01682876|39317025|FG002|Overall Study|Protocol Violation|1|||
16228460|NCT01682876|39317026|FG003|Overall Study|Protocol Violation|1|||
16228461|NCT01682876|39317023|FG000|Overall Study|Withdrawal by Subject|4|||
16228462|NCT01682876|39317024|FG001|Overall Study|Withdrawal by Subject|0|||
16228463|NCT01682876|39317025|FG002|Overall Study|Withdrawal by Subject|0|||
16228464|NCT01682876|39317026|FG003|Overall Study|Withdrawal by Subject|2|||
16228465|NCT01682876|39317023|FG000|Overall Study|Other|1|||
16228466|NCT01682876|39317024|FG001|Overall Study|Other|0|||
16228467|NCT01682876|39317025|FG002|Overall Study|Other|1|||
16228468|NCT01682876|39317026|FG003|Overall Study|Other|1|||
16228469|NCT04640168|39317027|FG000|Overall Study|Withdrawal by Subject|8|||
16228470|NCT04640168|39317028|FG001|Overall Study|Withdrawal by Subject|7|||
16228471|NCT04640168|39317027|FG000|Overall Study|Lost to Follow-up|1|||
16228472|NCT04640168|39317028|FG001|Overall Study|Lost to Follow-up|0|||
16228473|NCT04640168|39317027|FG000|Overall Study|Enrolled but not treated|12|||
16228474|NCT04640168|39317028|FG001|Overall Study|Enrolled but not treated|12|||
16228475|NCT00486720|39317032|FG000|Overall Study|Adverse Event|1|||
16228476|NCT00486720|39317033|FG001|Overall Study|Adverse Event|2|||
16228477|NCT00486720|39317032|FG000|Overall Study|Lack of Efficacy|4|||
16228478|NCT00486720|39317033|FG001|Overall Study|Lack of Efficacy|6|||
16228479|NCT00486720|39317032|FG000|Overall Study|Physician Decision|1|||
16228480|NCT00486720|39317033|FG001|Overall Study|Physician Decision|2|||
16228481|NCT00486720|39317032|FG000|Overall Study|Protocol Violation|1|||
16228482|NCT00486720|39317033|FG001|Overall Study|Protocol Violation|0|||
16228483|NCT00486720|39317032|FG000|Overall Study|Withdrawal by Subject|3|||
16228484|NCT00486720|39317033|FG001|Overall Study|Withdrawal by Subject|1|||
16228485|NCT00486720|39317032|FG000|Overall Study|Progressive Disease|0|||
16228486|NCT00486720|39317033|FG001|Overall Study|Progressive Disease|1|||
16228487|NCT00077766|39317034|FG000|Overall Study|Adverse Event|1|||
16228488|NCT00077766|39317035|FG001|Overall Study|Adverse Event|1|||
16228489|NCT00077766|39317034|FG000|Overall Study|Withdrawal by Subject|4|||
16228490|NCT00077766|39317035|FG001|Overall Study|Withdrawal by Subject|3|||
16228491|NCT00077766|39317034|FG000|Overall Study|Death|12|||
16228492|NCT00077766|39317035|FG001|Overall Study|Death|10|||
16228493|NCT00077766|39317034|FG000|Overall Study|Lost to Follow-up|2|||
16228494|NCT00077766|39317035|FG001|Overall Study|Lost to Follow-up|0|||
16228495|NCT00077766|39317034|FG000|Overall Study|Protocol Violation|1|||
16228496|NCT00077766|39317035|FG001|Overall Study|Protocol Violation|0|||
16228497|NCT00077766|39317034|FG000|Overall Study|Kidney Transplantation|9|||
16228498|NCT00077766|39317035|FG001|Overall Study|Kidney Transplantation|5|||
16228499|NCT00077766|39317034|FG000|Overall Study|Transplantation|5|||
16228500|NCT00077766|39317035|FG001|Overall Study|Transplantation|1|||
16228501|NCT00077766|39317034|FG000|Overall Study|Investigators Discretion|1|||
16228502|NCT00077766|39317035|FG001|Overall Study|Investigators Discretion|0|||
16228503|NCT00077766|39317034|FG000|Overall Study|Participant's decision|1|||
16228504|NCT00077766|39317035|FG001|Overall Study|Participant's decision|0|||
16228505|NCT00077766|39317034|FG000|Overall Study|Dialysis Discontinued|1|||
16228506|NCT00077766|39317035|FG001|Overall Study|Dialysis Discontinued|0|||
16228507|NCT00077766|39317034|FG000|Overall Study|Dialysis|0|||
16228508|NCT00077766|39317035|FG001|Overall Study|Dialysis|1|||
16228509|NCT00077766|39317034|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
16228510|NCT00077766|39317035|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
16228511|NCT00077766|39317034|FG000|Overall Study|Started Nocturnal Dialysis|0|||
16228512|NCT00077766|39317035|FG001|Overall Study|Started Nocturnal Dialysis|1|||
16228513|NCT00077766|39317034|FG000|Overall Study|Stop Dialysis|0|||
16228514|NCT00077766|39317035|FG001|Overall Study|Stop Dialysis|1|||
16228515|NCT00077766|39317034|FG000|Overall Study|Participants Vacation|2|||
16228516|NCT00077766|39317035|FG001|Overall Study|Participants Vacation|1|||
16228517|NCT01302366|39317037|FG000|Overall Study|patient choice or noncompliance|5|||
16228518|NCT03769753|39317038|FG000|Overall Study|Not Treated|6|||
16228519|NCT03769753|39317038|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
16228520|NCT01283282|39317039|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
16228521|NCT01283282|39317040|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
16228522|NCT01283282|39317039|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
16228523|NCT01283282|39317040|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
16228524|NCT01283282|39317039|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
16228525|NCT01283282|39317040|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
16228526|NCT04823494|39317051|FG000|Overall Study|Programming software malfunction.|1|||
16228527|NCT04823494|39317052|FG001|Overall Study|Programming software malfunction.|0|||
16228528|NCT04823494|39317051|FG000|Overall Study|Withdrawal by Subject|1|||
16228529|NCT04823494|39317052|FG001|Overall Study|Withdrawal by Subject|0|||
16228530|NCT04823494|39317051|FG000|Overall Study|Devices lost|0|||
16228531|NCT04823494|39317052|FG001|Overall Study|Devices lost|1|||
16228532|NCT01258738|39317055|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
16228533|NCT01258738|39317056|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
16228534|NCT01258738|39317055|FG000|Double-blind Period|Withdrawal by Subject|2|||
16228535|NCT01258738|39317056|FG001|Double-blind Period|Withdrawal by Subject|2|||
16228536|NCT01258738|39317055|FG000|Double-blind Period|Protocol Violation|1|||
16228537|NCT01258738|39317056|FG001|Double-blind Period|Protocol Violation|1|||
16228538|NCT01258738|39317055|FG000|Double-blind Period|Adverse Event|3|||
16228539|NCT01258738|39317056|FG001|Double-blind Period|Adverse Event|1|||
16228540|NCT01258738|39317055|FG000|Open-label Period|Did not meet inclusion criteria|0|||
16228541|NCT01258738|39317056|FG001|Open-label Period|Did not meet inclusion criteria|1|||
16228542|NCT01258738|39317055|FG000|Open-label Period|Insufficient clinical response|5|||
16228543|NCT01258738|39317056|FG001|Open-label Period|Insufficient clinical response|3|||
16228544|NCT01258738|39317055|FG000|Open-label Period|Lost to Follow-up|0|||
16228545|NCT01258738|39317056|FG001|Open-label Period|Lost to Follow-up|2|||
16228546|NCT01258738|39317055|FG000|Open-label Period|Withdrawal by Subject|5|||
16228547|NCT01258738|39317056|FG001|Open-label Period|Withdrawal by Subject|6|||
16228548|NCT01258738|39317055|FG000|Open-label Period|Protocol Violation|2|||
16228549|NCT01258738|39317056|FG001|Open-label Period|Protocol Violation|2|||
16228550|NCT01258738|39317055|FG000|Open-label Period|Adverse Event|4|||
16228551|NCT01258738|39317056|FG001|Open-label Period|Adverse Event|5|||
16228552|NCT01258738|39317055|FG000|Open-label Period|Other Reasons|0|||
16228553|NCT01258738|39317056|FG001|Open-label Period|Other Reasons|1|||
16228554|NCT01258738|39317055|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
16228555|NCT01258738|39317056|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
16228556|NCT02059265|39317057|FG000|Overall Study|Ineligible|4|||
16228557|NCT00690573|39317059|FG000|Overall Study|Lack of Efficacy|8|||
16228558|NCT00690573|39317059|FG000|Overall Study|Withdrawal by Subject|1|||
16228559|NCT02383966|39317062|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
16228560|NCT02383966|39317063|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
16228561|NCT02383966|39317062|FG000|Overall Study|Randomized, but not treated|1|||
16228562|NCT02383966|39317063|FG001|Overall Study|Randomized, but not treated|3|||
16228563|NCT01471197|39317064|FG000|Overall Study|Disease Progression|4|||
16228564|NCT01471197|39317065|FG001|Overall Study|Disease Progression|2|||
16228565|NCT01471197|39317064|FG000|Overall Study|Death|1|||
16228566|NCT01471197|39317065|FG001|Overall Study|Death|0|||
16228567|NCT01471197|39317064|FG000|Overall Study|Study Drug Toxicity|1|||
16228568|NCT01471197|39317065|FG001|Overall Study|Study Drug Toxicity|0|||
16228569|NCT02613910|39317066|FG000|Overall Study|Termination of study|1|||
16228570|NCT00726882|39317067|FG000|Overall Study|Withdrawal by Subject|5|||
16228571|NCT00726882|39317067|FG000|Overall Study|Lost to Follow-up|7|||
16228572|NCT00726882|39317067|FG000|Overall Study|Other|10|||
16228573|NCT03783026|39317070|FG000|Treatment Phase|Adverse Event|15|||
16228574|NCT03783026|39317070|FG000|Treatment Phase|Lack of Efficacy|11|||
16228575|NCT03783026|39317070|FG000|Treatment Phase|Withdrawal by Subject|6|||
16228576|NCT03783026|39317070|FG000|Treatment Phase|Lost to Follow-up|2|||
16228577|NCT03783026|39317070|FG000|Treatment Phase|Protocol Deviation|8|||
16228578|NCT03783026|39317070|FG000|Treatment Phase|Did Not Receive Treatment|1|||
16228579|NCT03783026|39317070|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
16228580|NCT00471237|39317071|FG000|Overall Study|Adverse Event|6|||
16411927|NCT02068118|39988784|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
16411928|NCT02068118|39988783|FG000|18-month Comparative Study Period|Heart transplant|9|||
16411929|NCT02068118|39988784|FG001|18-month Comparative Study Period|Heart transplant|15|||
16411930|NCT02068118|39988783|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
16411931|NCT02068118|39988784|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
16411932|NCT02068118|39988783|FG000|18-month Comparative Study Period|Hemiplegia|0|||
16411933|NCT02068118|39988784|FG001|18-month Comparative Study Period|Hemiplegia|1|||
16411934|NCT02068118|39988783|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
16411935|NCT02068118|39988784|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
16411936|NCT02068118|39988783|FG000|18-month Comparative Study Period|Move|0|||
16411937|NCT02068118|39988784|FG001|18-month Comparative Study Period|Move|1|||
16411938|NCT02068118|39988783|FG000|18-month Comparative Study Period|Hearing loss|0|||
16411939|NCT02068118|39988784|FG001|18-month Comparative Study Period|Hearing loss|1|||
16411940|NCT02068118|39988783|FG000|Extension Period|Death|0|||
16411941|NCT02068118|39988784|FG001|Extension Period|Death|2|||
16411942|NCT02068118|39988783|FG000|Extension Period|Withdrawal by Subject|1|||
16411943|NCT02068118|39988784|FG001|Extension Period|Withdrawal by Subject|0|||
16411944|NCT02068118|39988783|FG000|Extension Period|Heart transplant|1|||
16228581|NCT00471237|39317072|FG001|Overall Study|Adverse Event|5|||
16228582|NCT00471237|39317073|FG002|Overall Study|Adverse Event|4|||
16228583|NCT00471237|39317074|FG003|Overall Study|Adverse Event|8|||
16411945|NCT02068118|39988784|FG001|Extension Period|Heart transplant|0|||
16228584|NCT00471237|39317075|FG004|Overall Study|Adverse Event|7|||
16228585|NCT00471237|39317076|FG005|Overall Study|Adverse Event|5|||
16228586|NCT00471237|39317077|FG006|Overall Study|Adverse Event|0|||
16228587|NCT00471237|39317071|FG000|Overall Study|Lost to Follow-up|1|||
16228588|NCT00471237|39317072|FG001|Overall Study|Lost to Follow-up|1|||
16228589|NCT00471237|39317073|FG002|Overall Study|Lost to Follow-up|0|||
16228590|NCT00471237|39317074|FG003|Overall Study|Lost to Follow-up|2|||
16228591|NCT00471237|39317075|FG004|Overall Study|Lost to Follow-up|3|||
16228592|NCT00471237|39317076|FG005|Overall Study|Lost to Follow-up|0|||
16228593|NCT00471237|39317077|FG006|Overall Study|Lost to Follow-up|0|||
16347816|NCT00447902|39762038|FG001|Overall Study|included patients who discontinued|1|||
16347817|NCT00447902|39762037|FG000|Overall Study|Lack of Efficacy|2|||
16347818|NCT00447902|39762038|FG001|Overall Study|Lack of Efficacy|1|||
16347819|NCT02324361|39762039|FG000|Overall Study|Lost to Follow-up|5|||
16347820|NCT02324361|39762040|FG001|Overall Study|Lost to Follow-up|2|||
16347821|NCT00181883|39762041|FG000|Overall Study|Lack of Efficacy|2|||
16347822|NCT00181883|39762041|FG000|Overall Study|Treatment Limiting AEs|3|||
16347823|NCT00181883|39762041|FG000|Overall Study|Withdrawal by Subject|4|||
16347824|NCT00181883|39762041|FG000|Overall Study|Lost to Follow-up|1|||
16347825|NCT03589807|39762042|FG000|Overall Study|Lost to Follow-up|0|||
16347826|NCT03589807|39762043|FG001|Overall Study|Lost to Follow-up|2|||
16347827|NCT03589807|39762044|FG002|Overall Study|Lost to Follow-up|2|||
16347828|NCT03589807|39762045|FG003|Overall Study|Lost to Follow-up|3|||
16347829|NCT03589807|39762046|FG004|Overall Study|Lost to Follow-up|1|||
16347830|NCT03589807|39762047|FG005|Overall Study|Lost to Follow-up|1|||
16347831|NCT03589807|39762042|FG000|Overall Study|Withdrawal by Subject|0|||
16347832|NCT03589807|39762043|FG001|Overall Study|Withdrawal by Subject|5|||
16347833|NCT03589807|39762044|FG002|Overall Study|Withdrawal by Subject|0|||
16347834|NCT03589807|39762045|FG003|Overall Study|Withdrawal by Subject|0|||
16347835|NCT03589807|39762046|FG004|Overall Study|Withdrawal by Subject|0|||
16347836|NCT03589807|39762047|FG005|Overall Study|Withdrawal by Subject|0|||
16347837|NCT03589807|39762042|FG000|Overall Study|Protocol Violation|0|||
16347838|NCT03589807|39762043|FG001|Overall Study|Protocol Violation|0|||
16347839|NCT03589807|39762044|FG002|Overall Study|Protocol Violation|0|||
16347840|NCT03589807|39762045|FG003|Overall Study|Protocol Violation|1|||
16347841|NCT03589807|39762046|FG004|Overall Study|Protocol Violation|0|||
16347842|NCT03589807|39762047|FG005|Overall Study|Protocol Violation|0|||
16347843|NCT03589807|39762042|FG000|Overall Study|Enrolled but treatment not administered|0|||
16411946|NCT02068118|39988783|FG000|Extension Period|Wrong device use|0|||
16411947|NCT02068118|39988784|FG001|Extension Period|Wrong device use|1|||
16228594|NCT00471237|39317071|FG000|Overall Study|Protocol Violation|3|||
16228595|NCT00471237|39317072|FG001|Overall Study|Protocol Violation|6|||
16347844|NCT03589807|39762043|FG001|Overall Study|Enrolled but treatment not administered|0|||
16347845|NCT03589807|39762044|FG002|Overall Study|Enrolled but treatment not administered|0|||
16347846|NCT03589807|39762045|FG003|Overall Study|Enrolled but treatment not administered|0|||
16228596|NCT00471237|39317073|FG002|Overall Study|Protocol Violation|3|||
16228597|NCT00471237|39317074|FG003|Overall Study|Protocol Violation|2|||
16347847|NCT03589807|39762046|FG004|Overall Study|Enrolled but treatment not administered|1|||
16347848|NCT03589807|39762047|FG005|Overall Study|Enrolled but treatment not administered|0|||
16347849|NCT02895347|39762048|FG000|Overall Study|Withdrawal by Subject|3|||
16347850|NCT02895347|39762049|FG001|Overall Study|Withdrawal by Subject|1|||
16347851|NCT01921517|39762055|FG000|Overall Study|Lost to Follow-up|5|||
16347852|NCT01921517|39762056|FG001|Overall Study|Lost to Follow-up|0|||
16347853|NCT01921517|39762055|FG000|Overall Study|Newly diagnosed health concern|2|||
16347854|NCT01921517|39762056|FG001|Overall Study|Newly diagnosed health concern|0|||
16347855|NCT01921517|39762055|FG000|Overall Study|Physician Decision|0|||
16228598|NCT00471237|39317075|FG004|Overall Study|Protocol Violation|2|||
16228599|NCT00471237|39317076|FG005|Overall Study|Protocol Violation|4|||
16228600|NCT00471237|39317077|FG006|Overall Study|Protocol Violation|1|||
16411948|NCT02640625|39988785|FG000|Overall Study|Adverse Event|1|||
16228601|NCT00471237|39317071|FG000|Overall Study|Withdrawal by Subject|8|||
16228602|NCT00471237|39317072|FG001|Overall Study|Withdrawal by Subject|6|||
16228603|NCT00471237|39317073|FG002|Overall Study|Withdrawal by Subject|5|||
16228604|NCT00471237|39317074|FG003|Overall Study|Withdrawal by Subject|8|||
16228605|NCT00471237|39317075|FG004|Overall Study|Withdrawal by Subject|7|||
16228606|NCT00471237|39317076|FG005|Overall Study|Withdrawal by Subject|4|||
16228607|NCT00471237|39317077|FG006|Overall Study|Withdrawal by Subject|2|||
16228608|NCT00471237|39317071|FG000|Overall Study|Sponsor terminated study|20|||
16228609|NCT00471237|39317072|FG001|Overall Study|Sponsor terminated study|23|||
16228610|NCT00471237|39317073|FG002|Overall Study|Sponsor terminated study|19|||
16228611|NCT00471237|39317074|FG003|Overall Study|Sponsor terminated study|22|||
16228612|NCT00471237|39317075|FG004|Overall Study|Sponsor terminated study|18|||
16228613|NCT00471237|39317076|FG005|Overall Study|Sponsor terminated study|24|||
16228614|NCT00471237|39317077|FG006|Overall Study|Sponsor terminated study|0|||
16228615|NCT00471237|39317071|FG000|Overall Study|Non-compliance|0|||
16228616|NCT00471237|39317072|FG001|Overall Study|Non-compliance|1|||
16228617|NCT00471237|39317073|FG002|Overall Study|Non-compliance|0|||
16228618|NCT00471237|39317074|FG003|Overall Study|Non-compliance|1|||
16228619|NCT00471237|39317075|FG004|Overall Study|Non-compliance|0|||
16228620|NCT00471237|39317076|FG005|Overall Study|Non-compliance|0|||
16228621|NCT00471237|39317077|FG006|Overall Study|Non-compliance|0|||
16228622|NCT00471237|39317071|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
16228623|NCT00471237|39317072|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
16228624|NCT00471237|39317073|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
16228625|NCT00471237|39317074|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
16228626|NCT00471237|39317075|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
16228627|NCT00471237|39317076|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
16228628|NCT00471237|39317077|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
16347856|NCT01921517|39762056|FG001|Overall Study|Physician Decision|2|||
16347857|NCT01921517|39762055|FG000|Overall Study|Withdrawal by Subject|7|||
16347858|NCT01921517|39762056|FG001|Overall Study|Withdrawal by Subject|3|||
16228629|NCT00471237|39317071|FG000|Overall Study|Early stopping due to non-efficacy|1|||
16228630|NCT00471237|39317072|FG001|Overall Study|Early stopping due to non-efficacy|0|||
16228631|NCT00471237|39317073|FG002|Overall Study|Early stopping due to non-efficacy|0|||
16228632|NCT00471237|39317074|FG003|Overall Study|Early stopping due to non-efficacy|0|||
16228633|NCT00471237|39317075|FG004|Overall Study|Early stopping due to non-efficacy|1|||
16228634|NCT00471237|39317076|FG005|Overall Study|Early stopping due to non-efficacy|0|||
16228635|NCT00471237|39317077|FG006|Overall Study|Early stopping due to non-efficacy|0|||
16228636|NCT00471237|39317071|FG000|Overall Study|Participant planned to travel to abraod|1|||
16228637|NCT00471237|39317072|FG001|Overall Study|Participant planned to travel to abraod|0|||
16228638|NCT00471237|39317073|FG002|Overall Study|Participant planned to travel to abraod|0|||
16228639|NCT00471237|39317074|FG003|Overall Study|Participant planned to travel to abraod|0|||
16228640|NCT00471237|39317075|FG004|Overall Study|Participant planned to travel to abraod|0|||
16228641|NCT00471237|39317076|FG005|Overall Study|Participant planned to travel to abraod|1|||
16228642|NCT00471237|39317077|FG006|Overall Study|Participant planned to travel to abraod|0|||
16117608|NCT00392925|38916376|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
16117609|NCT00392925|38916377|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
16117610|NCT00392925|38916378|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
16117611|NCT00392925|38916379|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
16117612|NCT00392925|38916376|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
16117613|NCT00392925|38916377|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
16117614|NCT00392925|38916378|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
16117615|NCT00392925|38916379|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
16347859|NCT01921517|39762055|FG000|Overall Study|Subject missed final imaging|1|||
16347860|NCT01921517|39762056|FG001|Overall Study|Subject missed final imaging|4|||
16347861|NCT02421419|39762057|FG000|Overall Study|Physician Decision|0|||
16347862|NCT02421419|39762058|FG001|Overall Study|Physician Decision|0|||
16347863|NCT02421419|39762059|FG002|Overall Study|Physician Decision|1|||
16228643|NCT00471237|39317071|FG000|Overall Study|High parathyroid hormone|0|||
16228644|NCT00471237|39317072|FG001|Overall Study|High parathyroid hormone|0|||
16228645|NCT00471237|39317073|FG002|Overall Study|High parathyroid hormone|1|||
16228646|NCT00471237|39317074|FG003|Overall Study|High parathyroid hormone|0|||
16228647|NCT00471237|39317075|FG004|Overall Study|High parathyroid hormone|0|||
16228648|NCT00471237|39317076|FG005|Overall Study|High parathyroid hormone|0|||
16228649|NCT00471237|39317077|FG006|Overall Study|High parathyroid hormone|0|||
16228650|NCT00471237|39317071|FG000|Overall Study|Participant lost medication|0|||
16228651|NCT00471237|39317072|FG001|Overall Study|Participant lost medication|0|||
16228652|NCT00471237|39317073|FG002|Overall Study|Participant lost medication|0|||
16228653|NCT00471237|39317074|FG003|Overall Study|Participant lost medication|0|||
16228654|NCT00471237|39317075|FG004|Overall Study|Participant lost medication|1|||
16228655|NCT00471237|39317076|FG005|Overall Study|Participant lost medication|0|||
16228656|NCT00471237|39317077|FG006|Overall Study|Participant lost medication|0|||
16228657|NCT00471237|39317071|FG000|Overall Study|Administration of prohibited medicine|0|||
16228658|NCT00471237|39317072|FG001|Overall Study|Administration of prohibited medicine|0|||
16117616|NCT01144377|38916380|FG000|52 Week Treatment Period|Adverse Event|0|||
16117617|NCT01144377|38916381|FG001|52 Week Treatment Period|Adverse Event|0|||
16117618|NCT01144377|38916382|FG002|52 Week Treatment Period|Adverse Event|3|||
16117619|NCT01144377|38916383|FG003|52 Week Treatment Period|Adverse Event|2|||
16117620|NCT01144377|38916384|FG004|52 Week Treatment Period|Adverse Event|1|||
16117621|NCT01144377|38916380|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
16228659|NCT00471237|39317073|FG002|Overall Study|Administration of prohibited medicine|0|||
16228660|NCT00471237|39317074|FG003|Overall Study|Administration of prohibited medicine|0|||
16228661|NCT00471237|39317075|FG004|Overall Study|Administration of prohibited medicine|1|||
16228662|NCT00471237|39317076|FG005|Overall Study|Administration of prohibited medicine|0|||
16228663|NCT00471237|39317077|FG006|Overall Study|Administration of prohibited medicine|0|||
16228664|NCT00471237|39317071|FG000|Overall Study|Participant shifted residence|0|||
16228665|NCT00471237|39317072|FG001|Overall Study|Participant shifted residence|0|||
16347864|NCT02849080|39762060|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
16347865|NCT02849080|39762061|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
16347866|NCT02849080|39762062|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
16228666|NCT00471237|39317073|FG002|Overall Study|Participant shifted residence|0|||
16117622|NCT01144377|38916381|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
16347867|NCT02849080|39762063|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
16347868|NCT02849080|39762060|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
16347869|NCT02849080|39762061|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
16347870|NCT02849080|39762062|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
16117623|NCT01144377|38916382|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
16117624|NCT01144377|38916383|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
16117625|NCT01144377|38916384|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
16117626|NCT01144377|38916380|FG000|52 Week Treatment Period|Protocol Violation|0|||
16117627|NCT01144377|38916381|FG001|52 Week Treatment Period|Protocol Violation|0|||
16117628|NCT01144377|38916382|FG002|52 Week Treatment Period|Protocol Violation|0|||
16117629|NCT01144377|38916383|FG003|52 Week Treatment Period|Protocol Violation|0|||
16117630|NCT01144377|38916384|FG004|52 Week Treatment Period|Protocol Violation|1|||
16347871|NCT02849080|39762063|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
16347872|NCT02849080|39762060|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
16347873|NCT02849080|39762061|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
16347874|NCT02849080|39762062|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
16347875|NCT02849080|39762063|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
16347876|NCT02849080|39762060|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
16347877|NCT02849080|39762061|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
16347878|NCT02849080|39762062|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
16347879|NCT02849080|39762063|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
16347880|NCT02849080|39762060|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
16347881|NCT02849080|39762061|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
16347882|NCT02849080|39762062|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
16347883|NCT02849080|39762063|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
16347884|NCT02849080|39762060|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
16347885|NCT02849080|39762061|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
16347886|NCT02849080|39762062|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
16347887|NCT02849080|39762063|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
16347888|NCT02007720|39762064|FG000|Overall Study|Withdrawal by Subject|9|||
16347889|NCT02007720|39762065|FG001|Overall Study|Withdrawal by Subject|11|||
16347890|NCT02007720|39762064|FG000|Overall Study|study terminated by sponsor|58|||
16347891|NCT02007720|39762065|FG001|Overall Study|study terminated by sponsor|54|||
16347892|NCT02007720|39762064|FG000|Overall Study|technical problem|4|||
16347893|NCT02007720|39762065|FG001|Overall Study|technical problem|2|||
16347894|NCT02007720|39762064|FG000|Overall Study|patient followd less than 165 days|11|||
16347895|NCT02007720|39762065|FG001|Overall Study|patient followd less than 165 days|5|||
16347896|NCT03421379|39762066|FG000|Period 1|Withdrawal by Subject|0|||
16347897|NCT03421379|39762067|FG001|Period 1|Withdrawal by Subject|1|||
16347898|NCT03421379|39762066|FG000|Period 1|Physician Decision|1|||
16347899|NCT03421379|39762067|FG001|Period 1|Physician Decision|1|||
16347900|NCT03421379|39762066|FG000|Period 1|Did not receive treatment|1|||
16347901|NCT03421379|39762067|FG001|Period 1|Did not receive treatment|2|||
16347902|NCT00872521|39762069|FG000|Completed PAD Induction|Patient choice|0|||
16347903|NCT00872521|39762070|FG001|Completed PAD Induction|Patient choice|1|||
16347904|NCT00872521|39762071|FG002|Completed PAD Induction|Patient choice|0|||
16117631|NCT01144377|38916380|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
16347905|NCT00872521|39762069|FG000|Completed PAD Induction|Disease progression|0|||
16549645|NCT01032044|40475004|FG000|Overall Study|Lost to Follow-up|11|||
16117632|NCT01144377|38916381|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
16347906|NCT00872521|39762070|FG001|Completed PAD Induction|Disease progression|2|||
16347907|NCT00872521|39762071|FG002|Completed PAD Induction|Disease progression|0|||
16347908|NCT00872521|39762069|FG000|Completed PAD Induction|Adverse Event|4|||
16347909|NCT00872521|39762070|FG001|Completed PAD Induction|Adverse Event|0|||
16117633|NCT01144377|38916382|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
16117634|NCT01144377|38916383|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
16117635|NCT01144377|38916384|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
16117636|NCT01144377|38916380|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
16117637|NCT01144377|38916381|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
16117638|NCT01144377|38916382|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
16117639|NCT01144377|38916383|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
16117640|NCT01144377|38916384|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
16228667|NCT00471237|39317074|FG003|Overall Study|Participant shifted residence|0|||
16228668|NCT00471237|39317075|FG004|Overall Study|Participant shifted residence|1|||
16411949|NCT03550404|39988786|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
16411950|NCT03550404|39988787|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
16411951|NCT03550404|39988788|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
16411952|NCT03550404|39988786|FG000|Phase 2|Vacated position|1|||
16411953|NCT03550404|39988787|FG001|Phase 2|Vacated position|0|||
16411954|NCT03550404|39988788|FG002|Phase 2|Vacated position|0|||
16411955|NCT02358044|39988789|FG000|Overall Study|Adverse Event|0|||
16411956|NCT02358044|39988790|FG001|Overall Study|Adverse Event|1|||
16411957|NCT02358044|39988789|FG000|Overall Study|Lost to Follow-up|2|||
16411958|NCT02358044|39988790|FG001|Overall Study|Lost to Follow-up|1|||
16411959|NCT02358044|39988789|FG000|Overall Study|Physician Decision|0|||
16411960|NCT02358044|39988790|FG001|Overall Study|Physician Decision|1|||
16411961|NCT02358044|39988789|FG000|Overall Study|Withdrawal by Subject|0|||
16411962|NCT02358044|39988790|FG001|Overall Study|Withdrawal by Subject|4|||
16411963|NCT00475865|39988791|FG000|Overall Study|Adverse Event|0|||
16411964|NCT00475865|39988792|FG001|Overall Study|Adverse Event|3|||
16411965|NCT00475865|39988793|FG002|Overall Study|Adverse Event|4|||
16411966|NCT00475865|39988791|FG000|Overall Study|Lack of Efficacy|1|||
16411967|NCT00475865|39988792|FG001|Overall Study|Lack of Efficacy|0|||
16411968|NCT00475865|39988793|FG002|Overall Study|Lack of Efficacy|0|||
16411969|NCT00475865|39988791|FG000|Overall Study|Progressive disease|0|||
16411970|NCT00475865|39988792|FG001|Overall Study|Progressive disease|1|||
16411971|NCT00475865|39988793|FG002|Overall Study|Progressive disease|2|||
16411972|NCT00475865|39988791|FG000|Overall Study|Participant did not wish to continue|1|||
16411973|NCT00475865|39988792|FG001|Overall Study|Participant did not wish to continue|0|||
16411974|NCT00475865|39988793|FG002|Overall Study|Participant did not wish to continue|0|||
16411975|NCT00475865|39988791|FG000|Overall Study|Other than above|0|||
16411976|NCT00475865|39988792|FG001|Overall Study|Other than above|1|||
16411977|NCT00475865|39988793|FG002|Overall Study|Other than above|0|||
16411978|NCT04047420|39988794|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
16411979|NCT04047420|39988794|FG000|Washout Period|Refused Participation|2|||
16411980|NCT01974752|39988797|FG000|Overall Study|Death|33|||
16411981|NCT01974752|39988798|FG001|Overall Study|Death|11|||
16411982|NCT01974752|39988797|FG000|Overall Study|Lost to Follow-up|2|||
16411983|NCT01974752|39988798|FG001|Overall Study|Lost to Follow-up|0|||
16411984|NCT01974752|39988797|FG000|Overall Study|Withdrawal by Subject|2|||
16411985|NCT01974752|39988798|FG001|Overall Study|Withdrawal by Subject|3|||
16411986|NCT01974752|39988797|FG000|Overall Study|Other Eligibility Criteria|0|||
16411987|NCT01974752|39988798|FG001|Overall Study|Other Eligibility Criteria|1|||
16411988|NCT01439126|39988800|FG000|Overall Study|Adverse Event|2|||
16411989|NCT01439126|39988801|FG001|Overall Study|Adverse Event|0|||
16411990|NCT01439126|39988800|FG000|Overall Study|Withdrawal by Subject|5|||
16411991|NCT01439126|39988801|FG001|Overall Study|Withdrawal by Subject|21|||
16411992|NCT01439126|39988800|FG000|Overall Study|Protocol Violation|6|||
16411993|NCT01439126|39988801|FG001|Overall Study|Protocol Violation|4|||
16411994|NCT01439126|39988800|FG000|Overall Study|Lost to Follow-up|6|||
16411995|NCT01439126|39988801|FG001|Overall Study|Lost to Follow-up|3|||
16411996|NCT01439126|39988800|FG000|Overall Study|Other-Use of prohibited treatment|0|||
16411997|NCT01439126|39988801|FG001|Overall Study|Other-Use of prohibited treatment|2|||
16411998|NCT01439126|39988800|FG000|Overall Study|Other-Miscellaneous|12|||
16411999|NCT01439126|39988801|FG001|Overall Study|Other-Miscellaneous|12|||
16412000|NCT00933244|39991992|FG000|Overall Study|Withdrawal by Subject|5|||
16412001|NCT00933244|39991993|FG001|Overall Study|Withdrawal by Subject|1|||
16228669|NCT00471237|39317076|FG005|Overall Study|Participant shifted residence|0|||
16412002|NCT00933244|39991994|FG002|Overall Study|Withdrawal by Subject|3|||
16412003|NCT02410824|39991995|FG000|First Intervention (One Week)|Headache|0|||
16412004|NCT02410824|39991996|FG001|First Intervention (One Week)|Headache|1|||
16412005|NCT03899064|39992002|FG000|Overall Study|Lost to Follow-up|1|||
16412006|NCT03899064|39992002|FG000|Overall Study|Protocol Violation|2|||
16412007|NCT03899064|39992002|FG000|Overall Study|Withdrawal by Subject|2|||
16412008|NCT03899064|39992002|FG000|Overall Study|Other|2|||
16412009|NCT00353873|39992003|FG000|Overall Study|Protocol Violation|1|||
16412010|NCT00353873|39992004|FG001|Overall Study|Protocol Violation|2|||
16412011|NCT00353873|39992003|FG000|Overall Study|Exacerbation|1|||
16412012|NCT00353873|39992004|FG001|Overall Study|Exacerbation|0|||
16412013|NCT00353873|39992003|FG000|Overall Study|Adverse Event|1|||
16347910|NCT00872521|39762071|FG002|Completed PAD Induction|Adverse Event|0|||
16347911|NCT00872521|39762069|FG000|Completed PAD Induction|Death|1|||
16347912|NCT00872521|39762070|FG001|Completed PAD Induction|Death|1|||
16347913|NCT00872521|39762071|FG002|Completed PAD Induction|Death|0|||
16347914|NCT00872521|39762069|FG000|Primary Endpoint Analysis|Other|1|||
16347915|NCT00872521|39762070|FG001|Primary Endpoint Analysis|Other|2|||
16347916|NCT00872521|39762071|FG002|Primary Endpoint Analysis|Other|0|||
16347917|NCT00872521|39762069|FG000|Primary Endpoint Analysis|Patient choice|0|||
16347918|NCT00872521|39762070|FG001|Primary Endpoint Analysis|Patient choice|1|||
16347919|NCT00872521|39762071|FG002|Primary Endpoint Analysis|Patient choice|0|||
16347920|NCT00872521|39762069|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
16347921|NCT00872521|39762070|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
16347922|NCT00872521|39762071|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
16412014|NCT00353873|39992004|FG001|Overall Study|Adverse Event|0|||
16549646|NCT01032044|40475005|FG001|Overall Study|Lost to Follow-up|11|||
16117641|NCT01144377|38916380|FG000|52 Week Treatment Period|Sponsor Decision|0|||
16117642|NCT01144377|38916381|FG001|52 Week Treatment Period|Sponsor Decision|0|||
16117643|NCT01144377|38916382|FG002|52 Week Treatment Period|Sponsor Decision|0|||
16117644|NCT01144377|38916383|FG003|52 Week Treatment Period|Sponsor Decision|0|||
16117645|NCT01144377|38916384|FG004|52 Week Treatment Period|Sponsor Decision|1|||
16117646|NCT01144377|38916380|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
16117647|NCT01144377|38916381|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
16117648|NCT01144377|38916382|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
16117649|NCT01144377|38916383|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
16117650|NCT01144377|38916384|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
16117651|NCT01144377|38916380|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
16117652|NCT01144377|38916381|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
16117653|NCT01144377|38916382|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
16117654|NCT01144377|38916383|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
16549647|NCT01108458|40475006|FG000|Overall Study|Withdrawal by Subject|1|||
16549648|NCT03714022|40475007|FG000|Overall Study|Adverse Event|1|||
16549649|NCT03714022|40475008|FG001|Overall Study|Adverse Event|0|||
16549650|NCT03714022|40475007|FG000|Overall Study|Consent withdrawal|0|||
16549651|NCT03714022|40475008|FG001|Overall Study|Consent withdrawal|1|||
16549652|NCT03714022|40475007|FG000|Overall Study|Lost to Follow-up|3|||
16549653|NCT03714022|40475008|FG001|Overall Study|Lost to Follow-up|2|||
16549654|NCT01126060|40475009|FG000|Overall Study|Protocol Violation|0|||
16549655|NCT01126060|40475010|FG001|Overall Study|Protocol Violation|2|||
16549656|NCT01464021|40475013|FG000|Overall Study|Withdrawal by Subject|13|||
16549657|NCT01464021|40475013|FG000|Overall Study|Lost to Follow-up|1|||
16549658|NCT01464021|40475013|FG000|Overall Study|Lack of Efficacy|1|||
16549659|NCT01464021|40475013|FG000|Overall Study|various|11|||
16549660|NCT01973491|40478404|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
16549661|NCT01973491|40478404|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
16549662|NCT01973491|40478404|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
16549663|NCT01130883|40478405|FG000|Overall Study|Patient Noncompliance|6|||
16549664|NCT01130883|40478405|FG000|Overall Study|Reason Unknown|1|||
16549665|NCT01130883|40478405|FG000|Overall Study|Adverse Event|3|||
16549666|NCT02875834|40478407|FG000|Open-label Phase|Withdrawal by Subject|3|||
16549667|NCT02875834|40478408|FG001|Open-label Phase|Withdrawal by Subject|0|||
16549668|NCT02875834|40478409|FG002|Open-label Phase|Withdrawal by Subject|0|||
16549669|NCT02875834|40478410|FG003|Open-label Phase|Withdrawal by Subject|0|||
16549670|NCT02875834|40478407|FG000|Open-label Phase|(Not collected)|4|||
16549671|NCT02875834|40478408|FG001|Open-label Phase|(Not collected)|0|||
16549672|NCT02875834|40478409|FG002|Open-label Phase|(Not collected)|0|||
16549673|NCT02875834|40478410|FG003|Open-label Phase|(Not collected)|0|||
16549674|NCT02875834|40478407|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
16549675|NCT02875834|40478408|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
16549676|NCT02875834|40478409|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
16549677|NCT02875834|40478410|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
16549678|NCT02875834|40478407|FG000|Randomized Treatment Phase|Protocol Violation|0|||
16549679|NCT02875834|40478408|FG001|Randomized Treatment Phase|Protocol Violation|2|||
16117655|NCT01144377|38916384|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
16347923|NCT00872521|39762069|FG000|Primary Endpoint Analysis|Patient response missing|0|||
16549680|NCT02875834|40478409|FG002|Randomized Treatment Phase|Protocol Violation|0|||
16549681|NCT02875834|40478410|FG003|Randomized Treatment Phase|Protocol Violation|0|||
16549682|NCT02875834|40478407|FG000|Randomized Treatment Phase|(Not collected)|0|||
16549683|NCT02875834|40478408|FG001|Randomized Treatment Phase|(Not collected)|9|||
16347924|NCT00872521|39762070|FG001|Primary Endpoint Analysis|Patient response missing|0|||
16412015|NCT00353873|39992003|FG000|Overall Study|Physician Decision|2|||
16412016|NCT00353873|39992004|FG001|Overall Study|Physician Decision|0|||
16117656|NCT01144377|38916380|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
16117657|NCT01144377|38916381|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
16549684|NCT02875834|40478409|FG002|Randomized Treatment Phase|(Not collected)|10|||
16549685|NCT02875834|40478410|FG003|Randomized Treatment Phase|(Not collected)|9|||
16549686|NCT04498247|40478414|FG000|Overall Study|Lost to Follow-up|0|||
16549687|NCT04498247|40478415|FG001|Overall Study|Lost to Follow-up|0|||
16549688|NCT04498247|40478416|FG002|Overall Study|Lost to Follow-up|0|||
16549689|NCT04498247|40478417|FG003|Overall Study|Lost to Follow-up|1|||
16549690|NCT04498247|40478418|FG004|Overall Study|Lost to Follow-up|0|||
16549691|NCT04498247|40478419|FG005|Overall Study|Lost to Follow-up|0|||
16549692|NCT04498247|40478420|FG006|Overall Study|Lost to Follow-up|0|||
16549693|NCT04498247|40478421|FG007|Overall Study|Lost to Follow-up|0|||
16549694|NCT04498247|40478414|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
16549695|NCT04498247|40478415|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
16549696|NCT04498247|40478416|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
16549697|NCT04498247|40478417|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
16549698|NCT04498247|40478418|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
16549699|NCT04498247|40478419|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
16549700|NCT04498247|40478420|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
16549701|NCT04498247|40478421|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
16549702|NCT04498247|40478414|FG000|Overall Study|Withdrawal by Subject|0|||
16549703|NCT04498247|40478415|FG001|Overall Study|Withdrawal by Subject|8|||
16549704|NCT04498247|40478416|FG002|Overall Study|Withdrawal by Subject|0|||
16549705|NCT04498247|40478417|FG003|Overall Study|Withdrawal by Subject|7|||
16549706|NCT04498247|40478418|FG004|Overall Study|Withdrawal by Subject|0|||
16549707|NCT04498247|40478419|FG005|Overall Study|Withdrawal by Subject|0|||
16549708|NCT04498247|40478420|FG006|Overall Study|Withdrawal by Subject|1|||
16549709|NCT04498247|40478421|FG007|Overall Study|Withdrawal by Subject|0|||
16549710|NCT04498247|40478414|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
16549711|NCT04498247|40478415|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
16549712|NCT04498247|40478416|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
16549713|NCT04498247|40478417|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
16549714|NCT04498247|40478418|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
16549715|NCT04498247|40478419|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
16549716|NCT04498247|40478420|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
16549717|NCT04498247|40478421|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
16549718|NCT01024959|40478422|FG000|Overall Study|ineligible|12|||
16549719|NCT01024959|40478422|FG000|Overall Study|results not evaluable|12|||
16347925|NCT00872521|39762071|FG002|Primary Endpoint Analysis|Patient response missing|1|||
16347926|NCT00872521|39762069|FG000|Completed 3-month Follow up|Other|0|||
16549720|NCT01024959|40478422|FG000|Overall Study|missing results required for analysis|17|||
16117658|NCT01144377|38916382|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
16117659|NCT01144377|38916383|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
16117660|NCT01144377|38916384|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
16117661|NCT00129935|38916385|FG000|Overall Study|Adverse Event|18|||
16117662|NCT00129935|38916386|FG001|Overall Study|Adverse Event|56|||
16117663|NCT00129935|38916385|FG000|Overall Study|Death|1|||
16117664|NCT00129935|38916386|FG001|Overall Study|Death|1|||
16117665|NCT00129935|38916385|FG000|Overall Study|Withdrawal by Subject|7|||
16117666|NCT00129935|38916386|FG001|Overall Study|Withdrawal by Subject|20|||
16117667|NCT00129935|38916385|FG000|Overall Study|Protocol Violation|0|||
16117668|NCT00129935|38916386|FG001|Overall Study|Protocol Violation|4|||
16117669|NCT00129935|38916385|FG000|Overall Study|Physician Decision|3|||
16347927|NCT00872521|39762070|FG001|Completed 3-month Follow up|Other|2|||
16347928|NCT00872521|39762071|FG002|Completed 3-month Follow up|Other|0|||
16549721|NCT01576718|40478423|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
16549722|NCT01576718|40478424|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16549723|NCT01576718|40478425|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16117670|NCT00129935|38916386|FG001|Overall Study|Physician Decision|4|||
16549724|NCT01576718|40478426|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16549725|NCT01576718|40478427|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16549726|NCT01576718|40478428|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16549727|NCT01576718|40478429|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
16549728|NCT01576718|40478423|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
16549729|NCT01576718|40478424|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16549730|NCT01576718|40478425|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16549731|NCT01576718|40478426|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16549732|NCT01576718|40478427|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16549733|NCT01576718|40478428|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16549734|NCT01576718|40478429|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
16549735|NCT01576718|40478423|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
16549736|NCT01576718|40478424|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16549737|NCT01576718|40478425|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16549738|NCT01576718|40478426|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16549739|NCT01576718|40478427|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16549740|NCT01576718|40478428|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16549741|NCT01576718|40478429|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
16549742|NCT01576718|40478423|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
16549743|NCT01576718|40478424|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16549744|NCT01576718|40478425|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16549745|NCT01576718|40478426|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16549746|NCT01576718|40478427|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16117671|NCT00129935|38916385|FG000|Overall Study|Recurrence|1|||
16549747|NCT01576718|40478428|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16549748|NCT01576718|40478429|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
16549749|NCT01576718|40478423|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
16549750|NCT01576718|40478424|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16549751|NCT01576718|40478425|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16549752|NCT01576718|40478426|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16549753|NCT01576718|40478427|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16549754|NCT01576718|40478428|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16549755|NCT01576718|40478429|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
16549756|NCT01576718|40478423|FG000|Treatment Period|Adverse Event|0|||
16549757|NCT01576718|40478424|FG001|Treatment Period|Adverse Event|1|||
16549758|NCT01576718|40478425|FG002|Treatment Period|Adverse Event|1|||
16549759|NCT01576718|40478426|FG003|Treatment Period|Adverse Event|1|||
16549760|NCT01576718|40478427|FG004|Treatment Period|Adverse Event|1|||
16549761|NCT01576718|40478428|FG005|Treatment Period|Adverse Event|1|||
16549762|NCT01576718|40478429|FG006|Treatment Period|Adverse Event|0|||
16549763|NCT01576718|40478423|FG000|Treatment Period|Withdrawal by Subject|0|||
16549764|NCT01576718|40478424|FG001|Treatment Period|Withdrawal by Subject|1|||
16549765|NCT01576718|40478425|FG002|Treatment Period|Withdrawal by Subject|1|||
16549766|NCT01576718|40478426|FG003|Treatment Period|Withdrawal by Subject|0|||
16549767|NCT01576718|40478427|FG004|Treatment Period|Withdrawal by Subject|2|||
16549768|NCT01576718|40478428|FG005|Treatment Period|Withdrawal by Subject|4|||
16549769|NCT01576718|40478429|FG006|Treatment Period|Withdrawal by Subject|2|||
16549770|NCT01576718|40478423|FG000|Treatment Period|Physician Decision|0|||
16549771|NCT01576718|40478424|FG001|Treatment Period|Physician Decision|1|||
16549772|NCT01576718|40478425|FG002|Treatment Period|Physician Decision|1|||
16549773|NCT01576718|40478426|FG003|Treatment Period|Physician Decision|1|||
16549774|NCT01576718|40478427|FG004|Treatment Period|Physician Decision|1|||
16549775|NCT01576718|40478428|FG005|Treatment Period|Physician Decision|0|||
16549776|NCT01576718|40478429|FG006|Treatment Period|Physician Decision|0|||
16549777|NCT01576718|40478423|FG000|Treatment Period|Protocol Violation|0|||
16549778|NCT01576718|40478424|FG001|Treatment Period|Protocol Violation|5|||
16549779|NCT01576718|40478425|FG002|Treatment Period|Protocol Violation|4|||
16549780|NCT01576718|40478426|FG003|Treatment Period|Protocol Violation|10|||
16549781|NCT01576718|40478427|FG004|Treatment Period|Protocol Violation|6|||
16549782|NCT01576718|40478428|FG005|Treatment Period|Protocol Violation|8|||
16549783|NCT01576718|40478429|FG006|Treatment Period|Protocol Violation|12|||
16549784|NCT01576718|40478423|FG000|Treatment Period|Sponsor request|0|||
16549785|NCT01576718|40478424|FG001|Treatment Period|Sponsor request|1|||
16549786|NCT01576718|40478425|FG002|Treatment Period|Sponsor request|0|||
16549787|NCT01576718|40478426|FG003|Treatment Period|Sponsor request|0|||
16549788|NCT01576718|40478427|FG004|Treatment Period|Sponsor request|0|||
16549789|NCT01576718|40478428|FG005|Treatment Period|Sponsor request|1|||
16549790|NCT01576718|40478429|FG006|Treatment Period|Sponsor request|0|||
16549791|NCT01576718|40478423|FG000|Treatment Period|Met stopping criteria|0|||
16549792|NCT01576718|40478424|FG001|Treatment Period|Met stopping criteria|16|||
16549793|NCT01576718|40478425|FG002|Treatment Period|Met stopping criteria|13|||
16549794|NCT01576718|40478426|FG003|Treatment Period|Met stopping criteria|19|||
16549795|NCT01576718|40478427|FG004|Treatment Period|Met stopping criteria|16|||
16549796|NCT01576718|40478428|FG005|Treatment Period|Met stopping criteria|33|||
16549797|NCT01576718|40478429|FG006|Treatment Period|Met stopping criteria|15|||
16549798|NCT01576718|40478423|FG000|Treatment Period|Lost to Follow-up|0|||
16549799|NCT01576718|40478424|FG001|Treatment Period|Lost to Follow-up|0|||
16549800|NCT01576718|40478425|FG002|Treatment Period|Lost to Follow-up|0|||
16117672|NCT00129935|38916386|FG001|Overall Study|Recurrence|3|||
16117673|NCT00129935|38916385|FG000|Overall Study|Second primary|0|||
16228670|NCT00471237|39317077|FG006|Overall Study|Participant shifted residence|0|||
16549801|NCT01576718|40478426|FG003|Treatment Period|Lost to Follow-up|0|||
16549802|NCT01576718|40478427|FG004|Treatment Period|Lost to Follow-up|1|||
16549803|NCT01576718|40478428|FG005|Treatment Period|Lost to Follow-up|0|||
16549804|NCT01576718|40478429|FG006|Treatment Period|Lost to Follow-up|0|||
16549805|NCT01576718|40478423|FG000|Treatment Period|Noncompliance to study medication|0|||
16549806|NCT01576718|40478424|FG001|Treatment Period|Noncompliance to study medication|0|||
16549807|NCT01576718|40478425|FG002|Treatment Period|Noncompliance to study medication|0|||
16549808|NCT01576718|40478426|FG003|Treatment Period|Noncompliance to study medication|0|||
16549809|NCT01576718|40478427|FG004|Treatment Period|Noncompliance to study medication|0|||
16549810|NCT01576718|40478428|FG005|Treatment Period|Noncompliance to study medication|1|||
16549811|NCT01576718|40478429|FG006|Treatment Period|Noncompliance to study medication|1|||
16549812|NCT02904902|40478431|FG000|Overall Study|Withdrawal by Subject|1|||
16549813|NCT01155661|40478432|FG000|Overall Study|Adverse Event|101|||
16549814|NCT01155661|40478432|FG000|Overall Study|Death|1|||
16549815|NCT01155661|40478432|FG000|Overall Study|Lack of Efficacy|32|||
16549816|NCT01155661|40478432|FG000|Overall Study|Lost to Follow-up|22|||
16549817|NCT01155661|40478432|FG000|Overall Study|Physician Decision|3|||
16549818|NCT01155661|40478432|FG000|Overall Study|Protocol Violation|35|||
16549819|NCT01155661|40478432|FG000|Overall Study|Withdrawal by Subject|73|||
16549820|NCT01155661|40478432|FG000|Overall Study|Sponsor Decision|13|||
16549821|NCT02254408|40478433|FG000|Overall Study|Randomized But Not Treated|1|||
16549822|NCT02254408|40478434|FG001|Overall Study|Randomized But Not Treated|3|||
16549823|NCT02254408|40478433|FG000|Overall Study|Adverse Event|1|||
16549824|NCT02254408|40478434|FG001|Overall Study|Adverse Event|0|||
16549825|NCT02254408|40478433|FG000|Overall Study|Death|2|||
16549826|NCT02254408|40478434|FG001|Overall Study|Death|3|||
16549827|NCT02254408|40478433|FG000|Overall Study|Investigator's Discretion|0|||
16549828|NCT02254408|40478434|FG001|Overall Study|Investigator's Discretion|1|||
16549829|NCT02254408|40478433|FG000|Overall Study|Withdrawal by Subject|3|||
16549830|NCT02254408|40478434|FG001|Overall Study|Withdrawal by Subject|3|||
16549831|NCT02254408|40478433|FG000|Overall Study|Lost to Follow-up|1|||
16549832|NCT02254408|40478434|FG001|Overall Study|Lost to Follow-up|0|||
16549833|NCT01709305|40478435|FG000|Phase 1|Clinical Adverse Event|80|||
16549834|NCT01709305|40478436|FG001|Phase 1|Clinical Adverse Event|0|||
16549835|NCT01709305|40478437|FG002|Phase 1|Clinical Adverse Event|0|||
16549836|NCT01709305|40478438|FG003|Phase 1|Clinical Adverse Event|0|||
16549837|NCT01709305|40478439|FG004|Phase 1|Clinical Adverse Event|0|||
16549838|NCT01709305|40478435|FG000|Phase 1|Death|2|||
16549839|NCT01709305|40478436|FG001|Phase 1|Death|0|||
16549840|NCT01709305|40478437|FG002|Phase 1|Death|0|||
16549841|NCT01709305|40478438|FG003|Phase 1|Death|0|||
16549842|NCT01709305|40478439|FG004|Phase 1|Death|0|||
16549843|NCT01709305|40478435|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
16549844|NCT01709305|40478436|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
16549845|NCT01709305|40478437|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
16549846|NCT01709305|40478438|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
16549847|NCT01709305|40478439|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
16549848|NCT01709305|40478435|FG000|Phase 1|Laboratory Adverse Event|16|||
16549849|NCT01709305|40478436|FG001|Phase 1|Laboratory Adverse Event|0|||
16549850|NCT01709305|40478437|FG002|Phase 1|Laboratory Adverse Event|0|||
16549851|NCT01709305|40478438|FG003|Phase 1|Laboratory Adverse Event|0|||
16549852|NCT01709305|40478439|FG004|Phase 1|Laboratory Adverse Event|0|||
16549853|NCT01709305|40478435|FG000|Phase 1|Lost to Follow-up|147|||
16549854|NCT01709305|40478436|FG001|Phase 1|Lost to Follow-up|0|||
16549855|NCT01709305|40478437|FG002|Phase 1|Lost to Follow-up|0|||
16549856|NCT01709305|40478438|FG003|Phase 1|Lost to Follow-up|0|||
16549857|NCT01709305|40478439|FG004|Phase 1|Lost to Follow-up|0|||
16549858|NCT01709305|40478435|FG000|Phase 1|Travel, moving, etc.|30|||
16549859|NCT01709305|40478436|FG001|Phase 1|Travel, moving, etc.|0|||
16549860|NCT01709305|40478437|FG002|Phase 1|Travel, moving, etc.|0|||
16549861|NCT01709305|40478438|FG003|Phase 1|Travel, moving, etc.|0|||
16549862|NCT01709305|40478439|FG004|Phase 1|Travel, moving, etc.|0|||
16549863|NCT01709305|40478435|FG000|Phase 1|Physician Decision|13|||
16549864|NCT01709305|40478436|FG001|Phase 1|Physician Decision|0|||
16549865|NCT01709305|40478437|FG002|Phase 1|Physician Decision|0|||
16549866|NCT01709305|40478438|FG003|Phase 1|Physician Decision|0|||
16549867|NCT01709305|40478439|FG004|Phase 1|Physician Decision|0|||
16549868|NCT01709305|40478435|FG000|Phase 1|Protocol Violation|118|||
16549869|NCT01709305|40478436|FG001|Phase 1|Protocol Violation|0|||
16549870|NCT01709305|40478437|FG002|Phase 1|Protocol Violation|0|||
16549871|NCT01709305|40478438|FG003|Phase 1|Protocol Violation|0|||
16549872|NCT01709305|40478439|FG004|Phase 1|Protocol Violation|0|||
16549873|NCT01709305|40478435|FG000|Phase 1|Withdrawal by Subject|218|||
16549874|NCT01709305|40478436|FG001|Phase 1|Withdrawal by Subject|0|||
16549875|NCT01709305|40478437|FG002|Phase 1|Withdrawal by Subject|0|||
16549876|NCT01709305|40478438|FG003|Phase 1|Withdrawal by Subject|0|||
16549877|NCT01709305|40478439|FG004|Phase 1|Withdrawal by Subject|0|||
16549878|NCT01709305|40478435|FG000|Phase 2|Clinical Adverse Event|0|||
16549879|NCT01709305|40478436|FG001|Phase 2|Clinical Adverse Event|10|||
16228671|NCT00471237|39317071|FG000|Overall Study|Participant's decision|0|||
16228672|NCT00471237|39317072|FG001|Overall Study|Participant's decision|0|||
16228673|NCT00471237|39317073|FG002|Overall Study|Participant's decision|0|||
16549880|NCT01709305|40478437|FG002|Phase 2|Clinical Adverse Event|10|||
16549881|NCT01709305|40478438|FG003|Phase 2|Clinical Adverse Event|6|||
16549882|NCT01709305|40478439|FG004|Phase 2|Clinical Adverse Event|11|||
16549883|NCT01709305|40478435|FG000|Phase 2|Death|0|||
16549884|NCT01709305|40478436|FG001|Phase 2|Death|0|||
16549885|NCT01709305|40478437|FG002|Phase 2|Death|1|||
16549886|NCT01709305|40478438|FG003|Phase 2|Death|0|||
16549887|NCT01709305|40478439|FG004|Phase 2|Death|0|||
16549888|NCT01709305|40478435|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
16228674|NCT00471237|39317074|FG003|Overall Study|Participant's decision|0|||
16549889|NCT01709305|40478436|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
16549890|NCT01709305|40478437|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
16549891|NCT01709305|40478438|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
16549892|NCT01709305|40478439|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
16549893|NCT01709305|40478435|FG000|Phase 2|Laboratory Adverse Event|0|||
16549894|NCT01709305|40478436|FG001|Phase 2|Laboratory Adverse Event|1|||
16549895|NCT01709305|40478437|FG002|Phase 2|Laboratory Adverse Event|0|||
16549896|NCT01709305|40478438|FG003|Phase 2|Laboratory Adverse Event|1|||
16549897|NCT01709305|40478439|FG004|Phase 2|Laboratory Adverse Event|1|||
16549898|NCT01709305|40478435|FG000|Phase 2|Lost to Follow-up|0|||
16549899|NCT01709305|40478436|FG001|Phase 2|Lost to Follow-up|10|||
16549900|NCT01709305|40478437|FG002|Phase 2|Lost to Follow-up|6|||
16549901|NCT01709305|40478438|FG003|Phase 2|Lost to Follow-up|9|||
16549902|NCT01709305|40478439|FG004|Phase 2|Lost to Follow-up|5|||
16549903|NCT01709305|40478435|FG000|Phase 2|Travel, moving, etc.|0|||
16228675|NCT00471237|39317075|FG004|Overall Study|Participant's decision|0|||
16228676|NCT00471237|39317076|FG005|Overall Study|Participant's decision|1|||
16228677|NCT00471237|39317077|FG006|Overall Study|Participant's decision|0|||
16228678|NCT01967134|39317078|FG000|Overall Study|Lost to Follow-up|0|||
16228679|NCT01967134|39317079|FG001|Overall Study|Lost to Follow-up|1|||
16228680|NCT01967134|39317080|FG002|Overall Study|Lost to Follow-up|0|||
16228681|NCT00660816|39317081|FG000|Overall Study|Adverse Event|1|||
16228682|NCT00660816|39317082|FG001|Overall Study|Adverse Event|2|||
16228683|NCT00660816|39317081|FG000|Overall Study|Withdrawal by Subject|1|||
16228684|NCT00660816|39317082|FG001|Overall Study|Withdrawal by Subject|0|||
16228685|NCT00660816|39317081|FG000|Overall Study|Death|0|||
16228686|NCT00660816|39317082|FG001|Overall Study|Death|2|||
16228687|NCT00660816|39317081|FG000|Overall Study|Lack of Efficacy|1|||
16228688|NCT00660816|39317082|FG001|Overall Study|Lack of Efficacy|0|||
16228689|NCT00660816|39317081|FG000|Overall Study|Physician Decision|0|||
16228690|NCT00660816|39317082|FG001|Overall Study|Physician Decision|2|||
16228691|NCT00660816|39317081|FG000|Overall Study|Protocol Violation|1|||
16228692|NCT00660816|39317082|FG001|Overall Study|Protocol Violation|0|||
16228693|NCT00660816|39317081|FG000|Overall Study|Disease Progression|16|||
16228694|NCT00660816|39317082|FG001|Overall Study|Disease Progression|12|||
16228695|NCT00660816|39317081|FG000|Overall Study|Complicating Disease|0|||
16228696|NCT00660816|39317082|FG001|Overall Study|Complicating Disease|1|||
16228697|NCT03246152|39317085|FG000|Overall Study|Lost to Follow-up|2|||
16228698|NCT03246152|39317085|FG000|Overall Study|Protocol Violation|1|||
16228699|NCT02451137|39317086|FG000|Overall Study|Randomized but not treated|19|||
16228700|NCT02451137|39317087|FG001|Overall Study|Randomized but not treated|27|||
16228701|NCT02451137|39317086|FG000|Overall Study|Adverse Event|43|||
16228702|NCT02451137|39317087|FG001|Overall Study|Adverse Event|42|||
16228703|NCT02451137|39317086|FG000|Overall Study|Lack of Efficacy|4|||
16228704|NCT02451137|39317087|FG001|Overall Study|Lack of Efficacy|9|||
16228705|NCT02451137|39317086|FG000|Overall Study|Participant decision:discontinue insulin|41|||
16228706|NCT02451137|39317087|FG001|Overall Study|Participant decision:discontinue insulin|43|||
16228707|NCT02451137|39317086|FG000|Overall Study|Hypoglycemia|2|||
16228708|NCT02451137|39317087|FG001|Overall Study|Hypoglycemia|1|||
16228709|NCT02451137|39317086|FG000|Overall Study|Investigator's decision|23|||
16228710|NCT02451137|39317087|FG001|Overall Study|Investigator's decision|19|||
16228711|NCT02451137|39317086|FG000|Overall Study|Lost to Follow-up|53|||
16228712|NCT02451137|39317087|FG001|Overall Study|Lost to Follow-up|61|||
16228713|NCT02451137|39317086|FG000|Overall Study|Physician Decision|6|||
16228714|NCT02451137|39317087|FG001|Overall Study|Physician Decision|5|||
16228715|NCT02451137|39317086|FG000|Overall Study|Sponsor decision|13|||
16228716|NCT02451137|39317087|FG001|Overall Study|Sponsor decision|25|||
16228717|NCT02451137|39317086|FG000|Overall Study|Withdrawal by Subject|40|||
16228718|NCT02451137|39317087|FG001|Overall Study|Withdrawal by Subject|63|||
16228719|NCT02451137|39317086|FG000|Overall Study|Other than specified above|2|||
16228720|NCT02451137|39317087|FG001|Overall Study|Other than specified above|3|||
16228721|NCT03358407|39317090|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
16228722|NCT03358407|39317091|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
16228723|NCT03358407|39317092|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
16228724|NCT03358407|39317093|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
16228725|NCT03358407|39317094|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
16228726|NCT03358407|39317095|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
16228727|NCT03358407|39317096|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
16228728|NCT03358407|39317097|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
16228729|NCT03358407|39317098|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
16228730|NCT03358407|39317099|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
16228731|NCT03358407|39317090|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228732|NCT03358407|39317091|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228733|NCT03358407|39317092|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228734|NCT03358407|39317093|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16549904|NCT01709305|40478436|FG001|Phase 2|Travel, moving, etc.|2|||
16549905|NCT01709305|40478437|FG002|Phase 2|Travel, moving, etc.|3|||
16549906|NCT01709305|40478438|FG003|Phase 2|Travel, moving, etc.|3|||
16228735|NCT03358407|39317094|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
16228736|NCT03358407|39317095|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228737|NCT03358407|39317096|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228738|NCT03358407|39317097|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16549907|NCT01709305|40478439|FG004|Phase 2|Travel, moving, etc.|5|||
16228739|NCT03358407|39317098|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228740|NCT03358407|39317099|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16549908|NCT01709305|40478435|FG000|Phase 2|Physician Decision|0|||
16549909|NCT01709305|40478436|FG001|Phase 2|Physician Decision|2|||
16228741|NCT03358407|39317090|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
16228742|NCT03358407|39317091|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
16228743|NCT03358407|39317092|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
16228744|NCT03358407|39317093|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
16228745|NCT03358407|39317094|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
16228746|NCT03358407|39317095|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
16228747|NCT03358407|39317096|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
16549910|NCT01709305|40478437|FG002|Phase 2|Physician Decision|0|||
16549911|NCT01709305|40478438|FG003|Phase 2|Physician Decision|1|||
16549912|NCT01709305|40478439|FG004|Phase 2|Physician Decision|2|||
16549913|NCT01709305|40478435|FG000|Phase 2|Protocol Violation|0|||
16549914|NCT01709305|40478436|FG001|Phase 2|Protocol Violation|19|||
16549915|NCT01709305|40478437|FG002|Phase 2|Protocol Violation|19|||
16549916|NCT01709305|40478438|FG003|Phase 2|Protocol Violation|13|||
16549917|NCT01709305|40478439|FG004|Phase 2|Protocol Violation|9|||
16549918|NCT01709305|40478435|FG000|Phase 2|Withdrawal by Subject|0|||
16549919|NCT01709305|40478436|FG001|Phase 2|Withdrawal by Subject|8|||
16549920|NCT01709305|40478437|FG002|Phase 2|Withdrawal by Subject|6|||
16549921|NCT01709305|40478438|FG003|Phase 2|Withdrawal by Subject|15|||
16549922|NCT01709305|40478439|FG004|Phase 2|Withdrawal by Subject|12|||
16228748|NCT03358407|39317097|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
16228749|NCT03358407|39317098|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
16228750|NCT03358407|39317099|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
16228751|NCT03358407|39317090|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
16228752|NCT03358407|39317091|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
16228753|NCT03358407|39317092|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
16228754|NCT03358407|39317093|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
16228755|NCT03358407|39317094|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
16228756|NCT03358407|39317095|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
16228757|NCT03358407|39317096|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
16228758|NCT03358407|39317097|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
16228759|NCT03358407|39317098|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
16228760|NCT03358407|39317099|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
16228761|NCT03358407|39317090|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228762|NCT03358407|39317091|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228763|NCT03358407|39317092|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228764|NCT03358407|39317093|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228765|NCT03358407|39317094|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228766|NCT03358407|39317095|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
16228767|NCT03358407|39317096|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
16228768|NCT03358407|39317097|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228769|NCT03358407|39317098|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228770|NCT03358407|39317099|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
16228771|NCT03358407|39317090|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
16228772|NCT03358407|39317091|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
16228773|NCT03358407|39317092|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
16228774|NCT03358407|39317093|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
16228775|NCT03358407|39317094|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
16228776|NCT03358407|39317095|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
16228777|NCT03358407|39317096|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
16228778|NCT03358407|39317097|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
16412017|NCT00353873|39992003|FG000|Overall Study|Withdrawal by Subject|1|||
16412018|NCT00353873|39992004|FG001|Overall Study|Withdrawal by Subject|1|||
16549923|NCT02035332|40478444|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
16549924|NCT00192023|40478448|FG000|Period III - Double-Blind|Adverse Event|3|||
16549925|NCT00192023|40478449|FG001|Period III - Double-Blind|Adverse Event|0|||
16549926|NCT00192023|40478448|FG000|Period III - Double-Blind|Physician Decision|2|||
16549927|NCT00192023|40478449|FG001|Period III - Double-Blind|Physician Decision|0|||
16228779|NCT03358407|39317098|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
16228780|NCT03358407|39317099|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
16228781|NCT02438787|39317100|FG000|Overall Study|Adverse Event|1|||
16228782|NCT02438787|39317101|FG001|Overall Study|Adverse Event|0|||
16228783|NCT02438787|39317102|FG002|Overall Study|Adverse Event|2|||
16228784|NCT02438787|39317100|FG000|Overall Study|Lack of Efficacy|1|||
16228785|NCT02438787|39317101|FG001|Overall Study|Lack of Efficacy|2|||
16228786|NCT02438787|39317102|FG002|Overall Study|Lack of Efficacy|0|||
16228787|NCT02438787|39317100|FG000|Overall Study|Lost to Follow-up|0|||
16228788|NCT02438787|39317101|FG001|Overall Study|Lost to Follow-up|1|||
16228789|NCT02438787|39317102|FG002|Overall Study|Lost to Follow-up|0|||
16228790|NCT02438787|39317100|FG000|Overall Study|Protocol Violation|0|||
16228791|NCT02438787|39317101|FG001|Overall Study|Protocol Violation|0|||
16228792|NCT02438787|39317102|FG002|Overall Study|Protocol Violation|1|||
16228793|NCT02438787|39317100|FG000|Overall Study|Withdrawal by Subject|15|||
16228794|NCT02438787|39317101|FG001|Overall Study|Withdrawal by Subject|7|||
16228795|NCT02438787|39317102|FG002|Overall Study|Withdrawal by Subject|10|||
16228796|NCT02438787|39317100|FG000|Overall Study|Study discontinued by sponsor|64|||
16228797|NCT02438787|39317101|FG001|Overall Study|Study discontinued by sponsor|72|||
16228798|NCT02438787|39317102|FG002|Overall Study|Study discontinued by sponsor|69|||
16228799|NCT02438787|39317100|FG000|Overall Study|Other|0|||
16228800|NCT02438787|39317101|FG001|Overall Study|Other|1|||
16228801|NCT02438787|39317102|FG002|Overall Study|Other|0|||
16228802|NCT02438787|39317100|FG000|Overall Study|Site terminated by sponsor|0|||
16228803|NCT02438787|39317101|FG001|Overall Study|Site terminated by sponsor|0|||
16228804|NCT02438787|39317102|FG002|Overall Study|Site terminated by sponsor|1|||
16228805|NCT04196023|39317103|FG000|Overall Study|Withdrawal by Subject|0|||
16228806|NCT04196023|39317104|FG001|Overall Study|Withdrawal by Subject|1|||
16228807|NCT04196023|39317103|FG000|Overall Study|Adverse Event|3|||
16228808|NCT04196023|39317104|FG001|Overall Study|Adverse Event|1|||
16228809|NCT04196023|39317103|FG000|Overall Study|Lost to Follow-up|0|||
16228810|NCT04196023|39317104|FG001|Overall Study|Lost to Follow-up|1|||
16228811|NCT03938857|39317107|FG000|Overall Study|Physician Decision|1|||
16228812|NCT03938857|39317108|FG001|Overall Study|Physician Decision|0|||
16228813|NCT03938857|39317109|FG002|Overall Study|Physician Decision|0|||
16228814|NCT03938857|39317110|FG003|Overall Study|Physician Decision|0|||
16228815|NCT03193996|39317117|FG000|Overall Study|Withdrawal by Subject|4|||
16228816|NCT03193996|39317117|FG000|Overall Study|Lost to Follow-up|4|||
16228817|NCT03193996|39317117|FG000|Overall Study|Physician Decision|2|||
16228818|NCT03193996|39317117|FG000|Overall Study|Pregnancy|1|||
16228819|NCT03193996|39317117|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
16228820|NCT03193996|39317117|FG000|Overall Study|Complicating disease|1|||
16228821|NCT02260804|39317118|FG000|Induction Study Period|Protocol Violation|2|||
16228822|NCT02260804|39317119|FG001|Induction Study Period|Protocol Violation|0|||
16228823|NCT02260804|39317118|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
16228824|NCT02260804|39317119|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
16549928|NCT00192023|40478448|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
16228825|NCT02260804|39317118|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
16549929|NCT00192023|40478449|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
16549930|NCT00192023|40478448|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
16549931|NCT00192023|40478449|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
16549932|NCT00192023|40478448|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
16228826|NCT02260804|39317119|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
16228827|NCT02260804|39317118|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
16228828|NCT02260804|39317119|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
16228829|NCT02260804|39317118|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
16228830|NCT02260804|39317119|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
16228831|NCT02260804|39317118|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
16228832|NCT02260804|39317119|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
16228833|NCT02260804|39317118|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
16228834|NCT02260804|39317119|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
16228835|NCT02260804|39317118|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
16228836|NCT02260804|39317119|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
16228837|NCT02260804|39317118|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
16228838|NCT02260804|39317119|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
16228839|NCT02260804|39317118|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
16228840|NCT02260804|39317119|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
16228841|NCT02260804|39317118|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
16228842|NCT02260804|39317119|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
16228843|NCT01874288|39317120|FG000|Overall Study|Withdrawal by Subject|1|||
16228844|NCT01874288|39317121|FG001|Overall Study|Withdrawal by Subject|0|||
16228845|NCT01874288|39317122|FG002|Overall Study|Withdrawal by Subject|2|||
16228846|NCT01874288|39317123|FG003|Overall Study|Withdrawal by Subject|1|||
16228847|NCT01874288|39317124|FG004|Overall Study|Withdrawal by Subject|1|||
16549933|NCT00192023|40478449|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
16549934|NCT00192023|40478448|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
16549935|NCT00192023|40478449|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
16549936|NCT00192023|40478448|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
16549937|NCT00192023|40478449|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
16549938|NCT00192023|40478448|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
16549939|NCT00192023|40478449|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
16549940|NCT00192023|40478448|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
16549941|NCT00192023|40478449|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
16549942|NCT00192023|40478448|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
16549943|NCT00192023|40478449|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
16549944|NCT01216163|40478454|FG000|Overall Study|Withdrawal by Subject|1|||
16549945|NCT01216163|40478455|FG001|Overall Study|Withdrawal by Subject|1|||
16549946|NCT01216163|40478456|FG002|Overall Study|Withdrawal by Subject|0|||
16549947|NCT02357810|40478457|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
16549948|NCT02357810|40478457|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
16549949|NCT02357810|40478457|FG000|Reached 12 Weeks Response|Adverse Event|5|||
16549950|NCT02357810|40478457|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
16549951|NCT02357810|40478457|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
16549952|NCT02357810|40478457|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
16549953|NCT02357810|40478457|FG000|Reached 12 Weeks Response|Death|1|||
16549954|NCT02357810|40478457|FG000|Reached 12 Weeks Response|Physician Decision|1|||
16549955|NCT02357810|40478457|FG000|Reached 12 Weeks Response|Other|1|||
16549956|NCT02357810|40478457|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
16549957|NCT02357810|40478457|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
16549958|NCT02357810|40478457|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
16549959|NCT02357810|40478457|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
16549960|NCT02357810|40478457|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
16549961|NCT02357810|40478457|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
16549962|NCT01062763|40478458|FG000|Overall Study|Adverse Event|3|||
16549963|NCT01062763|40478459|FG001|Overall Study|Adverse Event|4|||
16549964|NCT00669903|40478464|FG000|Overall Study|Adverse Event|0|||
16549965|NCT00669903|40478465|FG001|Overall Study|Adverse Event|1|||
16549966|NCT00669903|40478466|FG002|Overall Study|Adverse Event|3|||
16549967|NCT00669903|40478467|FG003|Overall Study|Adverse Event|1|||
16549968|NCT00669903|40478464|FG000|Overall Study|Withdrawal by Subject|0|||
16549969|NCT00669903|40478465|FG001|Overall Study|Withdrawal by Subject|2|||
16549970|NCT00669903|40478466|FG002|Overall Study|Withdrawal by Subject|2|||
16549971|NCT00669903|40478467|FG003|Overall Study|Withdrawal by Subject|2|||
16549972|NCT00669903|40478464|FG000|Overall Study|Lost to Follow-up|1|||
16549973|NCT00669903|40478465|FG001|Overall Study|Lost to Follow-up|1|||
16549974|NCT00669903|40478466|FG002|Overall Study|Lost to Follow-up|0|||
16549975|NCT00669903|40478467|FG003|Overall Study|Lost to Follow-up|1|||
16549976|NCT00669903|40478464|FG000|Overall Study|Protocol Violation|0|||
16549977|NCT00669903|40478465|FG001|Overall Study|Protocol Violation|1|||
16549978|NCT00669903|40478466|FG002|Overall Study|Protocol Violation|0|||
16549979|NCT00669903|40478467|FG003|Overall Study|Protocol Violation|0|||
16549980|NCT02614066|40478468|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
16549981|NCT02614066|40478469|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
16549982|NCT02614066|40478470|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
16549983|NCT02614066|40478471|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
16228848|NCT01874288|39317120|FG000|Overall Study|Physician Decision|0|||
16228849|NCT01874288|39317121|FG001|Overall Study|Physician Decision|0|||
16228850|NCT01874288|39317122|FG002|Overall Study|Physician Decision|0|||
16228851|NCT01874288|39317123|FG003|Overall Study|Physician Decision|1|||
16228852|NCT01874288|39317124|FG004|Overall Study|Physician Decision|0|||
16228853|NCT01874288|39317120|FG000|Overall Study|Progressive disease|2|||
16228854|NCT01874288|39317121|FG001|Overall Study|Progressive disease|0|||
16228855|NCT01874288|39317122|FG002|Overall Study|Progressive disease|3|||
16228856|NCT01874288|39317123|FG003|Overall Study|Progressive disease|5|||
16228857|NCT01874288|39317124|FG004|Overall Study|Progressive disease|1|||
16228858|NCT02734290|39317141|FG000|Overall Study|Adverse Event|1|||
16228859|NCT02734290|39317142|FG001|Overall Study|Adverse Event|0|||
16549984|NCT02614066|40478468|FG000|Overall Study|Full Consent Withdrawn|0|||
16549985|NCT02614066|40478469|FG001|Overall Study|Full Consent Withdrawn|1|||
16549986|NCT02614066|40478470|FG002|Overall Study|Full Consent Withdrawn|0|||
16549987|NCT02614066|40478471|FG003|Overall Study|Full Consent Withdrawn|3|||
16549988|NCT02614066|40478468|FG000|Overall Study|Lost to Follow-up|0|||
16117674|NCT00129935|38916386|FG001|Overall Study|Second primary|1|||
16228860|NCT02734290|39317141|FG000|Overall Study|Death|1|||
16228861|NCT02734290|39317142|FG001|Overall Study|Death|0|||
16228862|NCT03099096|39317143|FG000|Overall Study|Adverse Event|1|||
16228863|NCT03099096|39317143|FG000|Overall Study|Physician Decision|1|||
16228864|NCT00649220|39317145|FG000|Overall Study|Adverse Event|2|||
16228865|NCT00649220|39317145|FG000|Overall Study|Withdrawal by Subject|1|||
16228866|NCT01610752|39317146|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
16347929|NCT00872521|39762069|FG000|Completed 3-month Follow up|Physician Decision|0|||
16549989|NCT02614066|40478469|FG001|Overall Study|Lost to Follow-up|1|||
16549990|NCT02614066|40478470|FG002|Overall Study|Lost to Follow-up|0|||
16549991|NCT02614066|40478471|FG003|Overall Study|Lost to Follow-up|0|||
16549992|NCT02614066|40478468|FG000|Overall Study|Still on-study|1|||
16549993|NCT02614066|40478469|FG001|Overall Study|Still on-study|9|||
16549994|NCT02614066|40478470|FG002|Overall Study|Still on-study|5|||
16549995|NCT02614066|40478471|FG003|Overall Study|Still on-study|32|||
16549996|NCT02614066|40478468|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
16549997|NCT02614066|40478469|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
16549998|NCT02614066|40478470|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
16549999|NCT02614066|40478471|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
16550000|NCT01118455|40478478|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
16550001|NCT01118455|40478479|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
16550002|NCT02998021|40478485|FG000|Overall Study|Withdrawal by Subject|3|||
16550003|NCT02998021|40478486|FG001|Overall Study|Withdrawal by Subject|1|||
16550004|NCT02998021|40478485|FG000|Overall Study|unsafe home|0|||
16550005|NCT02998021|40478486|FG001|Overall Study|unsafe home|1|||
16550006|NCT00993317|40478487|FG000|Overall Study|Adverse Event|2|||
16550007|NCT00993317|40478488|FG001|Overall Study|Adverse Event|4|||
16228867|NCT01610752|39317147|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
16347930|NCT00872521|39762070|FG001|Completed 3-month Follow up|Physician Decision|1|||
16347931|NCT00872521|39762071|FG002|Completed 3-month Follow up|Physician Decision|0|||
16347932|NCT00872521|39762069|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
16347933|NCT00872521|39762070|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
16347934|NCT00872521|39762071|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
16347935|NCT01683604|39762073|FG000|Overall Study|Adverse Event|2|||
16550008|NCT00993317|40478487|FG000|Overall Study|Lack of Efficacy|18|||
16550009|NCT00993317|40478488|FG001|Overall Study|Lack of Efficacy|18|||
16228868|NCT01610752|39317148|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
16347936|NCT01683604|39762073|FG000|Overall Study|Lack of Efficacy|1|||
16550010|NCT00993317|40478487|FG000|Overall Study|Withdrawal by Subject|0|||
16550011|NCT00993317|40478488|FG001|Overall Study|Withdrawal by Subject|2|||
16228869|NCT00265382|39317152|FG000|Overall Study|Adverse Event|21|||
16228870|NCT00265382|39317152|FG000|Overall Study|Laboratory Abnormality|1|||
16228871|NCT00265382|39317152|FG000|Overall Study|Lost to Follow-up|3|||
16228872|NCT00265382|39317152|FG000|Overall Study|Lack of Efficacy|6|||
16228873|NCT00265382|39317152|FG000|Overall Study|Miscellaneous|6|||
16228874|NCT00265382|39317152|FG000|Overall Study|Withdrawal by Subject|13|||
16228875|NCT00265382|39317152|FG000|Overall Study|Study terminated by sponsor|94|||
16228876|NCT00265382|39317152|FG000|Overall Study|Death|1|||
16228877|NCT00672490|39317153|FG000|Overall Study|Withdrawal by Subject|8|||
16228878|NCT00672490|39317154|FG001|Overall Study|Withdrawal by Subject|8|||
16228879|NCT00672490|39317153|FG000|Overall Study|Lack of Compliance|2|||
16228880|NCT00672490|39317154|FG001|Overall Study|Lack of Compliance|7|||
16550012|NCT00993317|40478487|FG000|Overall Study|Investigator's opinion|0|||
16550013|NCT00993317|40478488|FG001|Overall Study|Investigator's opinion|1|||
16228881|NCT00672490|39317153|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
16228882|NCT00672490|39317154|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
16228883|NCT00672490|39317153|FG000|Overall Study|Adverse Event|5|||
16228884|NCT00672490|39317154|FG001|Overall Study|Adverse Event|8|||
16228885|NCT00672490|39317153|FG000|Overall Study|Violation of Concomitant Medicine|1|||
16228886|NCT00672490|39317154|FG001|Overall Study|Violation of Concomitant Medicine|0|||
16228887|NCT00672490|39317153|FG000|Overall Study|Intolerance|0|||
16228888|NCT00672490|39317154|FG001|Overall Study|Intolerance|2|||
16228889|NCT00672490|39317153|FG000|Overall Study|Lost to Follow-up|1|||
16228890|NCT00672490|39317154|FG001|Overall Study|Lost to Follow-up|5|||
16228891|NCT00672490|39317153|FG000|Overall Study|No reason was provided|6|||
16228892|NCT00672490|39317154|FG001|Overall Study|No reason was provided|2|||
16228893|NCT00313716|39317155|FG000|Overall Study|Death|3|||
16228894|NCT00313716|39317156|FG001|Overall Study|Death|2|||
16228895|NCT00313716|39317157|FG002|Overall Study|Death|9|||
16228896|NCT00313716|39317158|FG003|Overall Study|Death|3|||
16228897|NCT00313716|39317159|FG004|Overall Study|Death|5|||
16228898|NCT00313716|39317160|FG005|Overall Study|Death|9|||
16550014|NCT00993317|40478487|FG000|Overall Study|Early study termination at the site|1|||
16550015|NCT00993317|40478488|FG001|Overall Study|Early study termination at the site|0|||
16550016|NCT00675506|40478489|FG000|Overall Study|Lost to Follow-up|1|||
16550017|NCT00675506|40478490|FG001|Overall Study|Lost to Follow-up|5|||
16550018|NCT00675506|40478489|FG000|Overall Study|Lost interest|3|||
16550019|NCT00675506|40478490|FG001|Overall Study|Lost interest|5|||
16550020|NCT00675506|40478489|FG000|Overall Study|Elevated fasting glucose|2|||
16550021|NCT00675506|40478490|FG001|Overall Study|Elevated fasting glucose|1|||
16228899|NCT00313716|39317155|FG000|Overall Study|Lost to Follow-up|2|||
16228900|NCT00313716|39317156|FG001|Overall Study|Lost to Follow-up|5|||
16228901|NCT00313716|39317157|FG002|Overall Study|Lost to Follow-up|2|||
16228902|NCT00313716|39317158|FG003|Overall Study|Lost to Follow-up|1|||
16228903|NCT00313716|39317159|FG004|Overall Study|Lost to Follow-up|0|||
16228904|NCT00313716|39317160|FG005|Overall Study|Lost to Follow-up|4|||
16228905|NCT00313716|39317155|FG000|Overall Study|Withdrawal by Subject|0|||
16228906|NCT00313716|39317156|FG001|Overall Study|Withdrawal by Subject|1|||
16228907|NCT00313716|39317157|FG002|Overall Study|Withdrawal by Subject|1|||
16228908|NCT00313716|39317158|FG003|Overall Study|Withdrawal by Subject|0|||
16228909|NCT00313716|39317159|FG004|Overall Study|Withdrawal by Subject|1|||
16228910|NCT00313716|39317160|FG005|Overall Study|Withdrawal by Subject|0|||
16228911|NCT00344968|39317169|FG000|Overall Study|Adverse Event|5|||
16228912|NCT00344968|39317170|FG001|Overall Study|Adverse Event|4|||
16228913|NCT00344968|39317171|FG002|Overall Study|Adverse Event|15|||
16228914|NCT00344968|39317169|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16228915|NCT00344968|39317170|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16228916|NCT00344968|39317171|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
16228917|NCT00344968|39317169|FG000|Overall Study|Protocol Violation|2|||
16228918|NCT00344968|39317170|FG001|Overall Study|Protocol Violation|2|||
16228919|NCT00344968|39317171|FG002|Overall Study|Protocol Violation|5|||
16228920|NCT00344968|39317169|FG000|Overall Study|Withdrawal by Subject|14|||
16228921|NCT00344968|39317170|FG001|Overall Study|Withdrawal by Subject|31|||
16228922|NCT00344968|39317171|FG002|Overall Study|Withdrawal by Subject|27|||
16228923|NCT00344968|39317169|FG000|Overall Study|Lost to Follow-up|24|||
16228924|NCT00344968|39317170|FG001|Overall Study|Lost to Follow-up|37|||
16228925|NCT00344968|39317171|FG002|Overall Study|Lost to Follow-up|37|||
16228926|NCT00344968|39317169|FG000|Overall Study|Death|11|||
16550022|NCT00675506|40478489|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
16228927|NCT00344968|39317170|FG001|Overall Study|Death|27|||
16228928|NCT00344968|39317171|FG002|Overall Study|Death|31|||
16228929|NCT00344968|39317169|FG000|Overall Study|Other|0|||
16228930|NCT00344968|39317170|FG001|Overall Study|Other|1|||
16228931|NCT00344968|39317171|FG002|Overall Study|Other|0|||
16228932|NCT02815670|39317174|FG000|Overall Study|Prematurely discontinued of the trial|1|||
16228933|NCT02369874|39317175|FG000|Overall Study|Lost to Follow-up|2|||
16228934|NCT02369874|39317176|FG001|Overall Study|Lost to Follow-up|2|||
16550023|NCT00675506|40478490|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
16550024|NCT00675506|40478489|FG000|Overall Study|Elevated IGF-1|2|||
16228935|NCT02369874|39317177|FG002|Overall Study|Lost to Follow-up|2|||
16228936|NCT02369874|39317175|FG000|Overall Study|Withdrawal by Subject|7|||
16228937|NCT02369874|39317176|FG001|Overall Study|Withdrawal by Subject|9|||
16228938|NCT02369874|39317177|FG002|Overall Study|Withdrawal by Subject|27|||
16228939|NCT02369874|39317175|FG000|Overall Study|Miscellaneous|1|||
16228940|NCT02369874|39317176|FG001|Overall Study|Miscellaneous|1|||
16228941|NCT02369874|39317177|FG002|Overall Study|Miscellaneous|0|||
16228942|NCT02369874|39317175|FG000|Overall Study|On Treatment/Off Study|34|||
16228943|NCT02369874|39317176|FG001|Overall Study|On Treatment/Off Study|45|||
16228944|NCT02369874|39317177|FG002|Overall Study|On Treatment/Off Study|32|||
16228945|NCT01298362|39320247|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
16228946|NCT01298362|39320248|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
16228947|NCT01646268|39320249|FG000|Overall Study|Adverse Event|6|||
16228948|NCT01646268|39320250|FG001|Overall Study|Adverse Event|7|||
16228949|NCT01646268|39320249|FG000|Overall Study|Lack of Efficacy|1|||
16228950|NCT01646268|39320250|FG001|Overall Study|Lack of Efficacy|3|||
16228951|NCT01646268|39320249|FG000|Overall Study|Protocol Violation|0|||
16228952|NCT01646268|39320250|FG001|Overall Study|Protocol Violation|1|||
16228953|NCT01646268|39320249|FG000|Overall Study|Withdrawal by Subject|2|||
16228954|NCT01646268|39320250|FG001|Overall Study|Withdrawal by Subject|5|||
16228955|NCT01646268|39320249|FG000|Overall Study|Other|2|||
16228956|NCT01646268|39320250|FG001|Overall Study|Other|0|||
16228965|NCT00883896|39320253|FG000|Overall Study|Lost to Follow-up|0|||
16228966|NCT00883896|39320254|FG001|Overall Study|Lost to Follow-up|0|||
16228967|NCT00883896|39320255|FG002|Overall Study|Lost to Follow-up|0|||
16228968|NCT00883896|39320256|FG003|Overall Study|Lost to Follow-up|2|||
16228969|NCT00883896|39320253|FG000|Overall Study|Withdrawal by Subject|5|||
16228970|NCT00883896|39320254|FG001|Overall Study|Withdrawal by Subject|0|||
16228971|NCT00883896|39320255|FG002|Overall Study|Withdrawal by Subject|1|||
16228972|NCT00883896|39320256|FG003|Overall Study|Withdrawal by Subject|3|||
16228973|NCT00883896|39320253|FG000|Overall Study|Lack of Efficacy|0|||
16228974|NCT00883896|39320254|FG001|Overall Study|Lack of Efficacy|0|||
16228975|NCT00883896|39320255|FG002|Overall Study|Lack of Efficacy|0|||
16228976|NCT00883896|39320256|FG003|Overall Study|Lack of Efficacy|2|||
16228977|NCT00883896|39320253|FG000|Overall Study|Other|1|||
16228978|NCT00883896|39320254|FG001|Overall Study|Other|0|||
16228979|NCT00883896|39320255|FG002|Overall Study|Other|0|||
16228980|NCT00883896|39320256|FG003|Overall Study|Other|0|||
16228981|NCT01361308|39320257|FG000|Overall Study|Withdrawal by Subject|9|||
16228982|NCT01361308|39320258|FG001|Overall Study|Withdrawal by Subject|13|||
16550025|NCT00675506|40478490|FG001|Overall Study|Elevated IGF-1|0|||
16550026|NCT00675506|40478489|FG000|Overall Study|Hypersensitivity Reaction|1|||
16550027|NCT00675506|40478490|FG001|Overall Study|Hypersensitivity Reaction|0|||
16550028|NCT00675506|40478489|FG000|Overall Study|Disclosed history of cancer|1|||
16550029|NCT00675506|40478490|FG001|Overall Study|Disclosed history of cancer|0|||
16550030|NCT00675506|40478489|FG000|Overall Study|Declined participation|1|||
16550031|NCT00675506|40478490|FG001|Overall Study|Declined participation|0|||
16550032|NCT00675506|40478489|FG000|Overall Study|Schedule conflict|0|||
16550033|NCT00675506|40478490|FG001|Overall Study|Schedule conflict|1|||
16550034|NCT01844115|40478493|FG000|Overall Study|Adverse Event|4|||
16228983|NCT01361308|39320257|FG000|Overall Study|Physician Decision|3|||
16228984|NCT01361308|39320258|FG001|Overall Study|Physician Decision|3|||
16117675|NCT00129935|38916385|FG000|Overall Study|Other|3|||
16117676|NCT00129935|38916386|FG001|Overall Study|Other|2|||
16228985|NCT01361308|39320257|FG000|Overall Study|Lack of Efficacy|2|||
16228986|NCT01361308|39320258|FG001|Overall Study|Lack of Efficacy|0|||
16228987|NCT01361308|39320257|FG000|Overall Study|Protocol Violation|1|||
16347937|NCT01683604|39762073|FG000|Overall Study|Other|2|||
16347938|NCT01051817|39762076|FG000|Overall Study|Adverse Event|0|||
16550035|NCT01844115|40478494|FG001|Overall Study|Adverse Event|22|||
16550036|NCT01844115|40478493|FG000|Overall Study|Lack of Efficacy|1|||
16228988|NCT01361308|39320258|FG001|Overall Study|Protocol Violation|0|||
16228989|NCT01361308|39320257|FG000|Overall Study|Lost to Follow-up|5|||
16228990|NCT01361308|39320258|FG001|Overall Study|Lost to Follow-up|4|||
16228991|NCT01361308|39320257|FG000|Overall Study|Adverse Event|8|||
16228992|NCT01361308|39320258|FG001|Overall Study|Adverse Event|4|||
16228993|NCT01361308|39320257|FG000|Overall Study|Eligibility Criteria Not Met|2|||
16228994|NCT01361308|39320258|FG001|Overall Study|Eligibility Criteria Not Met|3|||
16117677|NCT00129935|38916385|FG000|Overall Study|Crossed to the other arm|2|||
16228995|NCT01361308|39320257|FG000|Overall Study|Failed C-SSRS|5|||
16228996|NCT01361308|39320258|FG001|Overall Study|Failed C-SSRS|2|||
16228997|NCT01361308|39320257|FG000|Overall Study|Other|0|||
16228998|NCT01361308|39320258|FG001|Overall Study|Other|1|||
16228999|NCT02950831|39320259|FG000|Overall Study|Lost to Follow-up|1|||
16229000|NCT02950831|39320259|FG000|Overall Study|Withdrawal by Subject|3|||
16229001|NCT02950831|39320259|FG000|Overall Study|stimulation trail failure|5|||
16229002|NCT02842736|39320260|FG000|Overall Study|Lost to Follow-up|13|||
16229003|NCT02842736|39320260|FG000|Overall Study|Intervention for menstrual bleeding|17|||
16229004|NCT02842736|39320260|FG000|Overall Study|Withdrawal by Subject|4|||
16229005|NCT02842736|39320260|FG000|Overall Study|Pregnancy|3|||
16229006|NCT02842736|39320260|FG000|Overall Study|Hysterectomy for fibroids|2|||
16229007|NCT02842736|39320260|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
16229008|NCT02842736|39320260|FG000|Overall Study|IUD: Mirena|1|||
16229009|NCT05056311|39320261|FG000|Overall Study|Lost to Follow-up|14|||
16229010|NCT05056311|39320261|FG000|Overall Study|Withdrawal by Subject|1|||
16229011|NCT05056311|39320261|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
16229012|NCT00334893|39320262|FG000|Overall Study|Not Treated|1|||
16229013|NCT00334893|39320263|FG001|Overall Study|Not Treated|0|||
16229014|NCT00718809|39320264|FG000|Overall Study|Disease progression|9|||
16229015|NCT00718809|39320265|FG001|Overall Study|Disease progression|7|||
16229016|NCT00718809|39320264|FG000|Overall Study|Adverse Event|1|||
16229017|NCT00718809|39320265|FG001|Overall Study|Adverse Event|1|||
16229018|NCT00718809|39320264|FG000|Overall Study|Withdrawal by Subject|0|||
16229019|NCT00718809|39320265|FG001|Overall Study|Withdrawal by Subject|1|||
16229020|NCT00718809|39320264|FG000|Overall Study|Lost to Follow-up|1|||
16229021|NCT00718809|39320265|FG001|Overall Study|Lost to Follow-up|0|||
16229022|NCT00718809|39320264|FG000|Overall Study|Noncompliance|1|||
16229023|NCT00718809|39320265|FG001|Overall Study|Noncompliance|0|||
16229024|NCT00938366|39320266|FG000|Overall Study|Withdrawal by Subject|1|||
16229025|NCT00938366|39320267|FG001|Overall Study|Withdrawal by Subject|0|||
16229026|NCT04235959|39320268|FG000|Overall Study|Protocol Violation|0|||
16229027|NCT04235959|39320269|FG001|Overall Study|Protocol Violation|1|||
16229028|NCT04235959|39320270|FG002|Overall Study|Protocol Violation|0|||
16229029|NCT04235959|39320268|FG000|Overall Study|Adverse Event|1|||
16229030|NCT04235959|39320269|FG001|Overall Study|Adverse Event|0|||
16229031|NCT04235959|39320270|FG002|Overall Study|Adverse Event|0|||
16229032|NCT00924820|39320271|FG000|Overall Study|Death|2|||
16229033|NCT00924820|39320271|FG000|Overall Study|Ineligible, Screen Failure|5|||
16229034|NCT01013207|39320272|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
16229035|NCT00750061|39320276|FG000|Overall Study|Adverse Event|2|||
16229036|NCT00750061|39320277|FG001|Overall Study|Adverse Event|0|||
16229037|NCT00750061|39320276|FG000|Overall Study|Withdrawal by Subject|0|||
16229038|NCT00750061|39320277|FG001|Overall Study|Withdrawal by Subject|1|||
16229039|NCT00750061|39320276|FG000|Overall Study|Physician Decision|0|||
16229040|NCT00750061|39320277|FG001|Overall Study|Physician Decision|1|||
16229041|NCT00422058|39320280|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
16229042|NCT00422058|39320281|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
16229043|NCT00422058|39320282|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
16229044|NCT00422058|39320283|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
16229045|NCT00422058|39320284|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
16229046|NCT00422058|39320285|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
16229047|NCT00422058|39320280|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
16229048|NCT00422058|39320281|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
16229049|NCT00422058|39320282|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
16229050|NCT00422058|39320283|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
16229051|NCT00422058|39320284|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
16229052|NCT00422058|39320285|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
16229053|NCT00422058|39320280|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
16229054|NCT00422058|39320281|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
16229055|NCT00422058|39320282|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
16229056|NCT00422058|39320283|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
16229057|NCT00422058|39320284|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
16229058|NCT00422058|39320285|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
16229059|NCT00422058|39320280|FG000|Double-Blind, Week 0-20|Other|11|||
16229060|NCT00422058|39320281|FG001|Double-Blind, Week 0-20|Other|3|||
16229061|NCT00422058|39320282|FG002|Double-Blind, Week 0-20|Other|8|||
16229062|NCT00422058|39320283|FG003|Double-Blind, Week 0-20|Other|8|||
16229063|NCT00422058|39320284|FG004|Double-Blind, Week 0-20|Other|4|||
16229064|NCT00422058|39320285|FG005|Double-Blind, Week 0-20|Other|10|||
16229065|NCT00422058|39320280|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
16229066|NCT00422058|39320281|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
16229067|NCT00422058|39320282|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
16229068|NCT00422058|39320283|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
16229069|NCT00422058|39320284|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
16229070|NCT00422058|39320285|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
16229071|NCT00422058|39320280|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
16229072|NCT00422058|39320281|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
16229073|NCT00422058|39320282|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
16229074|NCT00422058|39320283|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
16229075|NCT00422058|39320284|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
16229076|NCT00422058|39320285|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
16229077|NCT00422058|39320280|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
16229078|NCT00422058|39320281|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
16229079|NCT00422058|39320282|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
16229080|NCT00422058|39320283|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
16229081|NCT00422058|39320284|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
16229082|NCT00422058|39320285|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
16229083|NCT00422058|39320280|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
16229084|NCT00422058|39320281|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
16229085|NCT00422058|39320282|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
16229086|NCT00422058|39320283|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
16229087|NCT00422058|39320284|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
16229088|NCT00422058|39320285|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
16229089|NCT00422058|39320280|FG000|Open-Label Extension, Week 20-104|Other|13|||
16229090|NCT00422058|39320281|FG001|Open-Label Extension, Week 20-104|Other|14|||
16229091|NCT00422058|39320282|FG002|Open-Label Extension, Week 20-104|Other|6|||
16229092|NCT00422058|39320283|FG003|Open-Label Extension, Week 20-104|Other|13|||
16229093|NCT00422058|39320284|FG004|Open-Label Extension, Week 20-104|Other|16|||
16229094|NCT00422058|39320285|FG005|Open-Label Extension, Week 20-104|Other|18|||
16229095|NCT01656850|39320286|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
16229096|NCT01656850|39320287|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
16229097|NCT02777554|39320288|FG000|Overall Study|Adverse Event|4|||
16229098|NCT02777554|39320289|FG001|Overall Study|Adverse Event|4|||
16229099|NCT02777554|39320290|FG002|Overall Study|Adverse Event|0|||
16229100|NCT02777554|39320291|FG003|Overall Study|Adverse Event|1|||
16229101|NCT02777554|39320292|FG004|Overall Study|Adverse Event|0|||
16229102|NCT02777554|39320293|FG005|Overall Study|Adverse Event|0|||
16229103|NCT02777554|39320288|FG000|Overall Study|Withdrawal by Subject|3|||
16229104|NCT02777554|39320289|FG001|Overall Study|Withdrawal by Subject|1|||
16229105|NCT02777554|39320290|FG002|Overall Study|Withdrawal by Subject|1|||
16229106|NCT02777554|39320291|FG003|Overall Study|Withdrawal by Subject|0|||
16347939|NCT01051817|39762077|FG001|Overall Study|Adverse Event|2|||
16347940|NCT01051817|39762076|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
16347941|NCT01051817|39762077|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
16347942|NCT01051817|39762076|FG000|Overall Study|Withdrawal by Subject|3|||
16347943|NCT01051817|39762077|FG001|Overall Study|Withdrawal by Subject|5|||
16347944|NCT01051817|39762076|FG000|Overall Study|Protocol Violation|0|||
16347945|NCT01051817|39762077|FG001|Overall Study|Protocol Violation|1|||
16347946|NCT00215644|39762088|FG000|Overall Study|Disease Progression|28|||
16347947|NCT00215644|39762089|FG001|Overall Study|Disease Progression|10|||
16347948|NCT00215644|39762088|FG000|Overall Study|Adverse Event|2|||
16347949|NCT00215644|39762089|FG001|Overall Study|Adverse Event|9|||
16347950|NCT00215644|39762088|FG000|Overall Study|Death|1|||
16347951|NCT00215644|39762089|FG001|Overall Study|Death|2|||
16347952|NCT00215644|39762088|FG000|Overall Study|Withdrawal by Subject|1|||
16347953|NCT00215644|39762089|FG001|Overall Study|Withdrawal by Subject|0|||
16347954|NCT00215644|39762088|FG000|Overall Study|Other|3|||
16347955|NCT00215644|39762089|FG001|Overall Study|Other|15|||
16347956|NCT00215644|39762088|FG000|Overall Study|Randomized but Not Treated|1|||
16347957|NCT00215644|39762089|FG001|Overall Study|Randomized but Not Treated|0|||
16347958|NCT00379899|39762094|FG000|Overall Study|Adverse Event|7|||
16347959|NCT00379899|39762095|FG001|Overall Study|Adverse Event|3|||
16347960|NCT00379899|39762094|FG000|Overall Study|Death|10|||
16347961|NCT00379899|39762095|FG001|Overall Study|Death|10|||
16347962|NCT00379899|39762094|FG000|Overall Study|Lost to Follow-up|2|||
16347963|NCT00379899|39762095|FG001|Overall Study|Lost to Follow-up|4|||
16347964|NCT00379899|39762094|FG000|Overall Study|Physician Decision|3|||
16347965|NCT00379899|39762095|FG001|Overall Study|Physician Decision|4|||
16347966|NCT00379899|39762094|FG000|Overall Study|Withdrawal by Subject|5|||
16347967|NCT00379899|39762095|FG001|Overall Study|Withdrawal by Subject|5|||
16347968|NCT00379899|39762094|FG000|Overall Study|Ineligibility determined|0|||
16347969|NCT00379899|39762095|FG001|Overall Study|Ineligibility determined|1|||
16347970|NCT00379899|39762094|FG000|Overall Study|Noncompliance|1|||
16347971|NCT00379899|39762095|FG001|Overall Study|Noncompliance|1|||
16347972|NCT00379899|39762094|FG000|Overall Study|Parathyroidectomy|0|||
16347973|NCT00379899|39762095|FG001|Overall Study|Parathyroidectomy|2|||
16347974|NCT00379899|39762094|FG000|Overall Study|Renal transplantation|5|||
16229107|NCT02777554|39320292|FG004|Overall Study|Withdrawal by Subject|0|||
16229108|NCT02777554|39320293|FG005|Overall Study|Withdrawal by Subject|0|||
16229109|NCT02777554|39320288|FG000|Overall Study|Discharged early due to hurricane|22|||
16229110|NCT02777554|39320289|FG001|Overall Study|Discharged early due to hurricane|20|||
16229111|NCT02777554|39320290|FG002|Overall Study|Discharged early due to hurricane|0|||
16229112|NCT02777554|39320291|FG003|Overall Study|Discharged early due to hurricane|0|||
16229113|NCT02777554|39320292|FG004|Overall Study|Discharged early due to hurricane|0|||
16229114|NCT02777554|39320293|FG005|Overall Study|Discharged early due to hurricane|0|||
16229115|NCT02777554|39320288|FG000|Overall Study|Other - Miscellaneous|1|||
16229116|NCT02777554|39320289|FG001|Overall Study|Other - Miscellaneous|0|||
16229117|NCT02777554|39320290|FG002|Overall Study|Other - Miscellaneous|0|||
16229118|NCT02777554|39320291|FG003|Overall Study|Other - Miscellaneous|0|||
16229119|NCT02777554|39320292|FG004|Overall Study|Other - Miscellaneous|0|||
16412019|NCT04135859|39992005|FG000|Overall Study|Withdrawal by Subject|1|||
16412020|NCT04135859|39992006|FG001|Overall Study|Withdrawal by Subject|0|||
16412021|NCT04135859|39992005|FG000|Overall Study|Withdrawal due to screening failure|1|||
16412022|NCT04135859|39992006|FG001|Overall Study|Withdrawal due to screening failure|2|||
16412023|NCT04135859|39992005|FG000|Overall Study|Did not complete stress test|3|||
16412024|NCT04135859|39992006|FG001|Overall Study|Did not complete stress test|3|||
16412025|NCT04135859|39992005|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
16412026|NCT04135859|39992006|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
16412027|NCT00654004|39992013|FG000|Overall Study|Lost to Follow-up|1|||
16412028|NCT00654004|39992014|FG001|Overall Study|Lost to Follow-up|0|||
16412029|NCT01154283|39992015|FG000|0-6 Weeks|Withdrawal by Subject|7|||
16412030|NCT01154283|39992016|FG001|0-6 Weeks|Withdrawal by Subject|2|||
16412031|NCT01154283|39992015|FG000|0-6 Weeks|Death|0|||
16412032|NCT01154283|39992016|FG001|0-6 Weeks|Death|1|||
16412033|NCT01154283|39992015|FG000|7-12 Weeks|Death|1|||
16412034|NCT01154283|39992016|FG001|7-12 Weeks|Death|0|||
16412035|NCT01154283|39992015|FG000|7-12 Weeks|Withdrawal by Subject|0|||
16412036|NCT01154283|39992016|FG001|7-12 Weeks|Withdrawal by Subject|1|||
16412037|NCT00973102|39992019|FG000|Overall Study|Protocol Violation|1|||
16412038|NCT00973102|39992020|FG001|Overall Study|Protocol Violation|0|||
16412039|NCT00973102|39992019|FG000|Overall Study|Prisoner|0|||
16412040|NCT00973102|39992020|FG001|Overall Study|Prisoner|1|||
16412041|NCT03541187|39992021|FG000|Overall Study|Lost to Follow-up|2|||
16412042|NCT03541187|39992022|FG001|Overall Study|Lost to Follow-up|6|||
16412043|NCT03541187|39992021|FG000|Overall Study|Pregnancy|0|||
16412044|NCT03541187|39992022|FG001|Overall Study|Pregnancy|1|||
16412045|NCT03541187|39992021|FG000|Overall Study|Withdrawal by Subject|6|||
16412046|NCT03541187|39992022|FG001|Overall Study|Withdrawal by Subject|2|||
16412047|NCT03541187|39992021|FG000|Overall Study|Moved out of town|1|||
16412048|NCT03541187|39992022|FG001|Overall Study|Moved out of town|0|||
16412049|NCT03541187|39992021|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
16412050|NCT03541187|39992022|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
16412051|NCT03541187|39992021|FG000|Overall Study|Did not meet randomization criteria|1|||
16412052|NCT03541187|39992022|FG001|Overall Study|Did not meet randomization criteria|1|||
16412053|NCT03541187|39992021|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
16412054|NCT03541187|39992022|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
16412055|NCT03541187|39992021|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
16412056|NCT03541187|39992022|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
16550037|NCT01844115|40478494|FG001|Overall Study|Lack of Efficacy|4|||
16550038|NCT01844115|40478493|FG000|Overall Study|Protocol Violation|12|||
16550039|NCT01844115|40478494|FG001|Overall Study|Protocol Violation|10|||
16550040|NCT01844115|40478493|FG000|Overall Study|Withdrawal by Subject|11|||
16550041|NCT01844115|40478494|FG001|Overall Study|Withdrawal by Subject|11|||
16550042|NCT01844115|40478493|FG000|Overall Study|Lost to Follow-up|11|||
16550043|NCT01844115|40478494|FG001|Overall Study|Lost to Follow-up|10|||
16550044|NCT01844115|40478493|FG000|Overall Study|Pregnancy|0|||
16550045|NCT01844115|40478494|FG001|Overall Study|Pregnancy|1|||
16550046|NCT00622713|40478495|FG000|Overall Study|Adverse Event|35|||
16550047|NCT00622713|40478495|FG000|Overall Study|Administrative problems|4|||
16550048|NCT00622713|40478495|FG000|Overall Study|Withdrawal by Subject|11|||
16550049|NCT00622713|40478495|FG000|Overall Study|Lost to Follow-up|5|||
16229120|NCT02777554|39320293|FG005|Overall Study|Other - Miscellaneous|0|||
16229121|NCT01636076|39320294|FG000|Overall Study|Terminated by sponsor|1|||
16229122|NCT01636076|39320295|FG001|Overall Study|Terminated by sponsor|1|||
16412057|NCT03529110|39992023|FG000|Overall Study|Progressive Disease|66|||
16412058|NCT03529110|39992024|FG001|Overall Study|Progressive Disease|158|||
16412059|NCT03529110|39992023|FG000|Overall Study|Clinical Progression|4|||
16412060|NCT03529110|39992024|FG001|Overall Study|Clinical Progression|12|||
16550050|NCT00622713|40478495|FG000|Overall Study|Death|2|||
16550051|NCT00622713|40478495|FG000|Overall Study|Subject no longer required study drug|1|||
16550052|NCT00622713|40478495|FG000|Overall Study|Did not meet eligibility criteria|1|||
16550053|NCT02086162|40478497|FG000|Overall Study|Withdrawal by Subject|4|||
16117678|NCT00129935|38916386|FG001|Overall Study|Crossed to the other arm|1|||
16117679|NCT00129935|38916385|FG000|Overall Study|Incorrect study treatment|1|||
16117680|NCT00129935|38916386|FG001|Overall Study|Incorrect study treatment|0|||
16117681|NCT02980042|38916387|FG000|Overall Study|Lost to Follow-up|5|||
16550054|NCT02086162|40478498|FG001|Overall Study|Withdrawal by Subject|4|||
16550055|NCT02086162|40478497|FG000|Overall Study|moved|1|||
16550056|NCT02086162|40478498|FG001|Overall Study|moved|1|||
16550057|NCT02086162|40478497|FG000|Overall Study|Lost to Follow-up|4|||
16117682|NCT02980042|38916388|FG001|Overall Study|Lost to Follow-up|0|||
16117683|NCT02980042|38916387|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
16117684|NCT02980042|38916388|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
16117685|NCT00983853|38916389|FG000|Overall Study|Lost to Follow-up|1|||
16117686|NCT00983853|38916390|FG001|Overall Study|Lost to Follow-up|1|||
16117687|NCT00983853|38916391|FG002|Overall Study|Lost to Follow-up|2|||
16117688|NCT00983853|38916392|FG003|Overall Study|Lost to Follow-up|2|||
16117689|NCT00983853|38916393|FG004|Overall Study|Lost to Follow-up|2|||
16117690|NCT00983853|38916394|FG005|Overall Study|Lost to Follow-up|1|||
16117691|NCT00983853|38916389|FG000|Overall Study|Withdrawal by Subject|0|||
16117692|NCT00983853|38916390|FG001|Overall Study|Withdrawal by Subject|0|||
16117693|NCT00983853|38916391|FG002|Overall Study|Withdrawal by Subject|1|||
16117694|NCT00983853|38916392|FG003|Overall Study|Withdrawal by Subject|0|||
16117695|NCT00983853|38916393|FG004|Overall Study|Withdrawal by Subject|1|||
16117696|NCT00983853|38916394|FG005|Overall Study|Withdrawal by Subject|0|||
16117697|NCT00983853|38916389|FG000|Overall Study|Unable to come to study follow-up visits|0|||
16412061|NCT03529110|39992023|FG000|Overall Study|Adverse Event|35|||
16412062|NCT03529110|39992024|FG001|Overall Study|Adverse Event|17|||
16550058|NCT02086162|40478498|FG001|Overall Study|Lost to Follow-up|2|||
16550059|NCT02086162|40478497|FG000|Overall Study|Death|1|||
16550060|NCT02086162|40478498|FG001|Overall Study|Death|0|||
16550061|NCT01536145|40478499|FG000|Overall Study|Progressive disease|3|||
16550062|NCT01536145|40478500|FG001|Overall Study|Progressive disease|4|||
16550063|NCT01536145|40478501|FG002|Overall Study|Progressive disease|1|||
16550064|NCT01536145|40478502|FG003|Overall Study|Progressive disease|2|||
16550065|NCT01536145|40478503|FG004|Overall Study|Progressive disease|1|||
16550066|NCT01536145|40478504|FG005|Overall Study|Progressive disease|2|||
16550067|NCT01536145|40478505|FG006|Overall Study|Progressive disease|1|||
16550068|NCT01536145|40478506|FG007|Overall Study|Progressive disease|2|||
16550069|NCT01536145|40478507|FG008|Overall Study|Progressive disease|1|||
16550070|NCT01536145|40478508|FG009|Overall Study|Progressive disease|3|||
16550071|NCT01536145|40478509|FG010|Overall Study|Progressive disease|3|||
16550072|NCT01536145|40478499|FG000|Overall Study|Withdrawal by Subject|0|||
16550073|NCT01536145|40478500|FG001|Overall Study|Withdrawal by Subject|0|||
16550074|NCT01536145|40478501|FG002|Overall Study|Withdrawal by Subject|1|||
16550075|NCT01536145|40478502|FG003|Overall Study|Withdrawal by Subject|0|||
16550076|NCT01536145|40478503|FG004|Overall Study|Withdrawal by Subject|0|||
16550077|NCT01536145|40478504|FG005|Overall Study|Withdrawal by Subject|1|||
16550078|NCT01536145|40478505|FG006|Overall Study|Withdrawal by Subject|0|||
16550079|NCT01536145|40478506|FG007|Overall Study|Withdrawal by Subject|0|||
16550080|NCT01536145|40478507|FG008|Overall Study|Withdrawal by Subject|2|||
16550081|NCT01536145|40478508|FG009|Overall Study|Withdrawal by Subject|0|||
16550082|NCT01536145|40478509|FG010|Overall Study|Withdrawal by Subject|2|||
16550083|NCT01536145|40478499|FG000|Overall Study|Other|0|||
16550084|NCT01536145|40478500|FG001|Overall Study|Other|0|||
16550085|NCT01536145|40478501|FG002|Overall Study|Other|0|||
16550086|NCT01536145|40478502|FG003|Overall Study|Other|0|||
16550087|NCT01536145|40478503|FG004|Overall Study|Other|1|||
16550088|NCT01536145|40478504|FG005|Overall Study|Other|0|||
16550089|NCT01536145|40478505|FG006|Overall Study|Other|0|||
16550090|NCT01536145|40478506|FG007|Overall Study|Other|0|||
16550091|NCT01536145|40478507|FG008|Overall Study|Other|0|||
16550092|NCT01536145|40478508|FG009|Overall Study|Other|3|||
16550093|NCT01536145|40478509|FG010|Overall Study|Other|2|||
16550094|NCT01536145|40478499|FG000|Overall Study|Death|0|||
16117698|NCT00983853|38916390|FG001|Overall Study|Unable to come to study follow-up visits|1|||
16117699|NCT00983853|38916391|FG002|Overall Study|Unable to come to study follow-up visits|0|||
16117700|NCT00983853|38916392|FG003|Overall Study|Unable to come to study follow-up visits|0|||
16550095|NCT01536145|40478500|FG001|Overall Study|Death|0|||
16550096|NCT01536145|40478501|FG002|Overall Study|Death|0|||
16550097|NCT01536145|40478502|FG003|Overall Study|Death|0|||
16550098|NCT01536145|40478503|FG004|Overall Study|Death|0|||
16550099|NCT01536145|40478504|FG005|Overall Study|Death|0|||
16550100|NCT01536145|40478505|FG006|Overall Study|Death|1|||
16347975|NCT00379899|39762095|FG001|Overall Study|Renal transplantation|4|||
16347976|NCT00379899|39762094|FG000|Overall Study|Coronary artery bypass graft|1|||
16347977|NCT00379899|39762095|FG001|Overall Study|Coronary artery bypass graft|1|||
16347978|NCT00379899|39762094|FG000|Overall Study|Other protocol-specified criteria|3|||
16347979|NCT00379899|39762095|FG001|Overall Study|Other protocol-specified criteria|4|||
16347980|NCT00379899|39762094|FG000|Overall Study|Other|3|||
16347981|NCT00379899|39762095|FG001|Overall Study|Other|1|||
16347982|NCT00149396|39762096|FG000|Overall Study|Death|15|||
16347983|NCT00149396|39762096|FG000|Overall Study|Withdrawal by Subject|1|||
16347984|NCT00149396|39762096|FG000|Overall Study|Subject noncompliance|2|||
16347985|NCT00149396|39762096|FG000|Overall Study|other treatment|5|||
16347986|NCT01676012|39762097|FG000|Overall Study|Adverse Event|2|||
16347987|NCT01676012|39762097|FG000|Overall Study|incomplete set of videos|1|||
16347988|NCT01265394|39762100|FG000|Overall Study|Subjects withdrawn|37|||
16347989|NCT01675492|39762101|FG000|Overall Study|study completed early - product approval|42|||
16347990|NCT03284853|39762102|FG000|Overall Study|Adverse Event|40|||
16347991|NCT03284853|39762103|FG001|Overall Study|Adverse Event|4|||
16550101|NCT01536145|40478506|FG007|Overall Study|Death|0|||
16550102|NCT01536145|40478507|FG008|Overall Study|Death|0|||
16550103|NCT01536145|40478508|FG009|Overall Study|Death|0|||
16550104|NCT01536145|40478509|FG010|Overall Study|Death|0|||
16550105|NCT01536145|40478499|FG000|Overall Study|Adverse Event|0|||
16550106|NCT01536145|40478500|FG001|Overall Study|Adverse Event|0|||
16550107|NCT01536145|40478501|FG002|Overall Study|Adverse Event|0|||
16550108|NCT01536145|40478502|FG003|Overall Study|Adverse Event|0|||
16550109|NCT01536145|40478503|FG004|Overall Study|Adverse Event|0|||
16550110|NCT01536145|40478504|FG005|Overall Study|Adverse Event|0|||
16550111|NCT01536145|40478505|FG006|Overall Study|Adverse Event|0|||
16550112|NCT01536145|40478506|FG007|Overall Study|Adverse Event|2|||
16550113|NCT01536145|40478507|FG008|Overall Study|Adverse Event|0|||
16550114|NCT01536145|40478508|FG009|Overall Study|Adverse Event|0|||
16550115|NCT01536145|40478509|FG010|Overall Study|Adverse Event|3|||
16550116|NCT01674621|40478513|FG000|Overall Study|Adverse Event|3|||
16550117|NCT01674621|40478514|FG001|Overall Study|Adverse Event|2|||
16550118|NCT01674621|40478515|FG002|Overall Study|Adverse Event|5|||
16550119|NCT01674621|40478516|FG003|Overall Study|Adverse Event|5|||
16550120|NCT01674621|40478517|FG004|Overall Study|Adverse Event|1|||
16550121|NCT01674621|40478513|FG000|Overall Study|Inability to Complete Study Procedures|0|||
16550122|NCT01674621|40478514|FG001|Overall Study|Inability to Complete Study Procedures|0|||
16550123|NCT01674621|40478515|FG002|Overall Study|Inability to Complete Study Procedures|0|||
16550124|NCT01674621|40478516|FG003|Overall Study|Inability to Complete Study Procedures|0|||
16550125|NCT01674621|40478517|FG004|Overall Study|Inability to Complete Study Procedures|2|||
16550126|NCT01674621|40478513|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
16550127|NCT01674621|40478514|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
16550128|NCT01674621|40478515|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
16550129|NCT01674621|40478516|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
16550130|NCT01674621|40478517|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
16550131|NCT01674621|40478513|FG000|Overall Study|Withdrawal by Subject|2|||
16117701|NCT00983853|38916393|FG004|Overall Study|Unable to come to study follow-up visits|0|||
16550132|NCT01674621|40478514|FG001|Overall Study|Withdrawal by Subject|5|||
16117702|NCT00983853|38916394|FG005|Overall Study|Unable to come to study follow-up visits|0|||
16347992|NCT03284853|39762102|FG000|Overall Study|Withdrawal by Subject|5|||
16347993|NCT03284853|39762103|FG001|Overall Study|Withdrawal by Subject|1|||
16550133|NCT01674621|40478515|FG002|Overall Study|Withdrawal by Subject|2|||
16550134|NCT01674621|40478516|FG003|Overall Study|Withdrawal by Subject|0|||
16550135|NCT01674621|40478517|FG004|Overall Study|Withdrawal by Subject|1|||
16550136|NCT01674621|40478513|FG000|Overall Study|Other than specified|0|||
16550137|NCT01674621|40478514|FG001|Overall Study|Other than specified|1|||
16347994|NCT03284853|39762102|FG000|Overall Study|Lost to Follow-up|1|||
16117703|NCT04531098|38916395|FG000|Stage I|Adverse Event|0|||
16117704|NCT04531098|38916396|FG001|Stage I|Adverse Event|0|||
16117705|NCT04531098|38916397|FG002|Stage I|Adverse Event|3|||
16117706|NCT04531098|38916395|FG000|Stage I|Protocol Violation|0|||
16117707|NCT04531098|38916396|FG001|Stage I|Protocol Violation|0|||
16117708|NCT04531098|38916397|FG002|Stage I|Protocol Violation|5|||
16117709|NCT04531098|38916395|FG000|Stage I|Withdrawal by Subject|0|||
16117710|NCT04531098|38916396|FG001|Stage I|Withdrawal by Subject|5|||
16347995|NCT03284853|39762103|FG001|Overall Study|Lost to Follow-up|0|||
16347996|NCT03284853|39762102|FG000|Overall Study|Lack of Efficacy|1|||
16347997|NCT03284853|39762103|FG001|Overall Study|Lack of Efficacy|0|||
16347998|NCT03284853|39762102|FG000|Overall Study|Disallowed Concurrent Medication|1|||
16347999|NCT03284853|39762103|FG001|Overall Study|Disallowed Concurrent Medication|1|||
16348000|NCT03284853|39762102|FG000|Overall Study|Protocol Violation|3|||
16117711|NCT04531098|38916397|FG002|Stage I|Withdrawal by Subject|10|||
16117712|NCT04531098|38916395|FG000|Stage II|Adverse Event|1|||
16117713|NCT04531098|38916396|FG001|Stage II|Adverse Event|2|||
16117714|NCT04531098|38916397|FG002|Stage II|Adverse Event|0|||
16117715|NCT04531098|38916395|FG000|Stage II|Protocol Violation|1|||
16117716|NCT04531098|38916396|FG001|Stage II|Protocol Violation|2|||
16117717|NCT04531098|38916397|FG002|Stage II|Protocol Violation|0|||
16117718|NCT04531098|38916395|FG000|Stage II|Withdrawal by Subject|3|||
16117719|NCT04531098|38916396|FG001|Stage II|Withdrawal by Subject|1|||
16117720|NCT04531098|38916397|FG002|Stage II|Withdrawal by Subject|0|||
16550138|NCT01674621|40478515|FG002|Overall Study|Other than specified|0|||
16550139|NCT01674621|40478516|FG003|Overall Study|Other than specified|0|||
16550140|NCT01674621|40478517|FG004|Overall Study|Other than specified|2|||
16550141|NCT01913639|40478518|FG000|Overall Study|Not Eligible|3|||
16550142|NCT00152971|40478521|FG000|Overall Study|Adverse Event|12|||
16550143|NCT00152971|40478522|FG001|Overall Study|Adverse Event|10|||
16550144|NCT00152971|40478523|FG002|Overall Study|Adverse Event|9|||
16550145|NCT00152971|40478521|FG000|Overall Study|Protocol Violation|10|||
16550146|NCT00152971|40478522|FG001|Overall Study|Protocol Violation|11|||
16550147|NCT00152971|40478523|FG002|Overall Study|Protocol Violation|8|||
16117721|NCT04531098|38916395|FG000|Stage II|Moved from study area|8|||
16117722|NCT04531098|38916396|FG001|Stage II|Moved from study area|5|||
16117723|NCT04531098|38916397|FG002|Stage II|Moved from study area|0|||
16117724|NCT02807272|38916399|FG000|Overall Study|Death|9|||
16117725|NCT02807272|38916400|FG001|Overall Study|Death|5|||
16117726|NCT02807272|38916401|FG002|Overall Study|Death|2|||
16117727|NCT02807272|38916402|FG003|Overall Study|Death|0|||
16117728|NCT02807272|38916403|FG004|Overall Study|Death|1|||
16117729|NCT02807272|38916399|FG000|Overall Study|Lost to Follow-up|1|||
16117730|NCT02807272|38916400|FG001|Overall Study|Lost to Follow-up|0|||
16117731|NCT02807272|38916401|FG002|Overall Study|Lost to Follow-up|0|||
16117732|NCT02807272|38916402|FG003|Overall Study|Lost to Follow-up|0|||
16117733|NCT02807272|38916403|FG004|Overall Study|Lost to Follow-up|0|||
16117734|NCT02807272|38916399|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
16117735|NCT02807272|38916400|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
16117736|NCT02807272|38916401|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
16117737|NCT02807272|38916402|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
16348001|NCT03284853|39762103|FG001|Overall Study|Protocol Violation|3|||
16348002|NCT03284853|39762102|FG000|Overall Study|Death|0|||
16348003|NCT03284853|39762103|FG001|Overall Study|Death|1|||
16348004|NCT03284853|39762102|FG000|Overall Study|Other - Reason not reported in CSR|4|||
16348005|NCT03284853|39762103|FG001|Overall Study|Other - Reason not reported in CSR|3|||
16348006|NCT01038687|39762110|FG000|Overall Study|Adverse Event|0|||
16550148|NCT00152971|40478521|FG000|Overall Study|Lost to Follow-up|17|||
16550149|NCT00152971|40478522|FG001|Overall Study|Lost to Follow-up|14|||
16550150|NCT00152971|40478523|FG002|Overall Study|Lost to Follow-up|13|||
16550151|NCT00152971|40478521|FG000|Overall Study|Withdrawal by Subject|9|||
16550152|NCT00152971|40478522|FG001|Overall Study|Withdrawal by Subject|8|||
16550153|NCT00152971|40478523|FG002|Overall Study|Withdrawal by Subject|14|||
16550154|NCT00152971|40478521|FG000|Overall Study|Other|3|||
16550155|NCT00152971|40478522|FG001|Overall Study|Other|5|||
16550156|NCT00152971|40478523|FG002|Overall Study|Other|5|||
16348007|NCT01038687|39762111|FG001|Overall Study|Adverse Event|2|||
16117738|NCT02807272|38916403|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
16117739|NCT02807272|38916399|FG000|Overall Study|Protocol-defined Disease Progression|0|||
16117740|NCT02807272|38916400|FG001|Overall Study|Protocol-defined Disease Progression|1|||
16117741|NCT02807272|38916401|FG002|Overall Study|Protocol-defined Disease Progression|0|||
16117742|NCT02807272|38916402|FG003|Overall Study|Protocol-defined Disease Progression|0|||
16117743|NCT02807272|38916403|FG004|Overall Study|Protocol-defined Disease Progression|1|||
16117744|NCT02807272|38916399|FG000|Overall Study|Study Terminated by Sponsor|1|||
16348008|NCT01038687|39762112|FG002|Overall Study|Adverse Event|1|||
16550157|NCT00152971|40478521|FG000|Treatment|Adverse Event|49|||
16550158|NCT00152971|40478522|FG001|Treatment|Adverse Event|40|||
16550159|NCT00152971|40478523|FG002|Treatment|Adverse Event|54|||
16550160|NCT00152971|40478521|FG000|Treatment|Protocol Violation|8|||
16550161|NCT00152971|40478522|FG001|Treatment|Protocol Violation|6|||
16550162|NCT00152971|40478523|FG002|Treatment|Protocol Violation|10|||
16550163|NCT00152971|40478521|FG000|Treatment|Lost to Follow-up|1|||
16550164|NCT00152971|40478522|FG001|Treatment|Lost to Follow-up|2|||
16550165|NCT00152971|40478523|FG002|Treatment|Lost to Follow-up|1|||
16550166|NCT00152971|40478521|FG000|Treatment|Withdrawal by Subject|4|||
16550167|NCT00152971|40478522|FG001|Treatment|Withdrawal by Subject|4|||
16550168|NCT00152971|40478523|FG002|Treatment|Withdrawal by Subject|5|||
16550169|NCT00152971|40478521|FG000|Treatment|Other|9|||
16550170|NCT00152971|40478522|FG001|Treatment|Other|11|||
16550171|NCT00152971|40478523|FG002|Treatment|Other|10|||
16550172|NCT00113360|40478526|FG000|Overall Study|Adverse Event|3|||
16550173|NCT00113360|40478526|FG000|Overall Study|Subject required surgery|1|||
16550174|NCT00113360|40478526|FG000|Overall Study|Did not meet eligibility criteria|3|||
16550175|NCT02762981|40478528|FG000|Overall Study|Adverse Event|2|||
16550176|NCT02762981|40478529|FG001|Overall Study|Adverse Event|3|||
16550177|NCT02762981|40478530|FG002|Overall Study|Adverse Event|1|||
16550178|NCT02762981|40478531|FG003|Overall Study|Adverse Event|1|||
16550179|NCT02762981|40478532|FG004|Overall Study|Adverse Event|3|||
16550180|NCT02762981|40478528|FG000|Overall Study|Physician Decision|0|||
16550181|NCT02762981|40478529|FG001|Overall Study|Physician Decision|1|||
16550182|NCT02762981|40478530|FG002|Overall Study|Physician Decision|0|||
16550183|NCT02762981|40478531|FG003|Overall Study|Physician Decision|0|||
16550184|NCT02762981|40478532|FG004|Overall Study|Physician Decision|1|||
16550185|NCT02762981|40478528|FG000|Overall Study|Disease progression|11|||
16550186|NCT02762981|40478529|FG001|Overall Study|Disease progression|23|||
16550187|NCT02762981|40478530|FG002|Overall Study|Disease progression|4|||
16550188|NCT02762981|40478531|FG003|Overall Study|Disease progression|10|||
16550189|NCT02762981|40478532|FG004|Overall Study|Disease progression|1|||
16550190|NCT02762981|40478528|FG000|Overall Study|Enrolled not treated|1|||
16550191|NCT02762981|40478529|FG001|Overall Study|Enrolled not treated|5|||
16550192|NCT02762981|40478530|FG002|Overall Study|Enrolled not treated|0|||
16550193|NCT02762981|40478531|FG003|Overall Study|Enrolled not treated|2|||
16550194|NCT02762981|40478532|FG004|Overall Study|Enrolled not treated|0|||
16550195|NCT02762981|40478528|FG000|Overall Study|Other|2|||
16550196|NCT02762981|40478529|FG001|Overall Study|Other|3|||
16550197|NCT02762981|40478530|FG002|Overall Study|Other|1|||
16550198|NCT02762981|40478531|FG003|Overall Study|Other|0|||
16550199|NCT02762981|40478532|FG004|Overall Study|Other|0|||
16550200|NCT02762981|40478528|FG000|Overall Study|Missing|1|||
16550201|NCT02762981|40478529|FG001|Overall Study|Missing|0|||
16550202|NCT02762981|40478530|FG002|Overall Study|Missing|0|||
16550203|NCT02762981|40478531|FG003|Overall Study|Missing|0|||
16117745|NCT02807272|38916400|FG001|Overall Study|Study Terminated by Sponsor|0|||
16117746|NCT02807272|38916401|FG002|Overall Study|Study Terminated by Sponsor|0|||
16117747|NCT02807272|38916402|FG003|Overall Study|Study Terminated by Sponsor|1|||
16117748|NCT02807272|38916403|FG004|Overall Study|Study Terminated by Sponsor|0|||
16117749|NCT02807272|38916399|FG000|Overall Study|Other|1|||
16117750|NCT02807272|38916400|FG001|Overall Study|Other|0|||
16117751|NCT02807272|38916401|FG002|Overall Study|Other|0|||
16117752|NCT02807272|38916402|FG003|Overall Study|Other|0|||
16117753|NCT02807272|38916403|FG004|Overall Study|Other|1|||
16117754|NCT02271984|38916404|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16117755|NCT02271984|38916405|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16117756|NCT02271984|38916406|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16117757|NCT02271984|38916407|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16117758|NCT02271984|38916408|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16117759|NCT02271984|38916409|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
16117760|NCT02271984|38916410|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16117761|NCT02271984|38916411|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
16117762|NCT02271984|38916412|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16117763|NCT02271984|38916413|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16117764|NCT02271984|38916414|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16117765|NCT02271984|38916415|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
16117766|NCT01151215|38916416|FG000|Overall Study|Worsening of condition under study|1|||
16117767|NCT01151215|38916417|FG001|Overall Study|Worsening of condition under study|1|||
16229123|NCT01636076|39320294|FG000|Overall Study|Lack of Efficacy|0|||
16229124|NCT01636076|39320295|FG001|Overall Study|Lack of Efficacy|1|||
16550204|NCT02762981|40478532|FG004|Overall Study|Missing|0|||
16550205|NCT02762981|40478528|FG000|Overall Study|Withdrawal by Subject|0|||
16348009|NCT03146741|39762114|FG000|Overall Study|Txp with non-HCV+ heart|4|||
16348010|NCT03146741|39762114|FG000|Overall Study|Listeted for MOT|2|||
16348011|NCT03146741|39762114|FG000|Overall Study|Physician Decision|2|||
16229125|NCT01636076|39320294|FG000|Overall Study|Lost to Follow-up|1|||
16229126|NCT01636076|39320295|FG001|Overall Study|Lost to Follow-up|0|||
16229127|NCT01636076|39320294|FG000|Overall Study|Physician Decision|1|||
16229128|NCT01636076|39320295|FG001|Overall Study|Physician Decision|1|||
16229129|NCT01636076|39320294|FG000|Overall Study|Non-compliance with study treatment|1|||
16229130|NCT01636076|39320295|FG001|Overall Study|Non-compliance with study treatment|1|||
16229131|NCT01636076|39320294|FG000|Overall Study|Adverse Event|6|||
16229132|NCT01636076|39320295|FG001|Overall Study|Adverse Event|11|||
16229133|NCT01636076|39320294|FG000|Overall Study|Withdrawal by Subject|7|||
16229134|NCT01636076|39320295|FG001|Overall Study|Withdrawal by Subject|10|||
16229135|NCT01786707|39320300|FG000|Overall Study|Lost to Follow-up|1|||
16229136|NCT01786707|39320301|FG001|Overall Study|Lost to Follow-up|1|||
16229137|NCT04398030|39320302|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
16229138|NCT04398030|39320303|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
16229139|NCT04398030|39320302|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
16229140|NCT04398030|39320303|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
16550206|NCT02762981|40478529|FG001|Overall Study|Withdrawal by Subject|5|||
16550207|NCT02762981|40478530|FG002|Overall Study|Withdrawal by Subject|1|||
16229141|NCT01151085|39320304|FG000|Overall Study|Lost to Follow-up|31|||
16348012|NCT03146741|39762114|FG000|Overall Study|Awaiting txp|2|||
16348013|NCT04346199|39762122|FG000|Overall Study|Death|8|||
16348014|NCT04346199|39762123|FG001|Overall Study|Death|9|||
16348015|NCT04346199|39762122|FG000|Overall Study|Lost to Follow-up|0|||
16348016|NCT04346199|39762123|FG001|Overall Study|Lost to Follow-up|1|||
16348017|NCT04346199|39762122|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
16348018|NCT04346199|39762123|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
16348019|NCT04346199|39762122|FG000|Overall Study|Withdrawal by Subject|5|||
16348020|NCT04346199|39762123|FG001|Overall Study|Withdrawal by Subject|1|||
16348021|NCT04378569|39762124|FG000|Overall Study|Adverse Event|0|||
16348022|NCT04378569|39762125|FG001|Overall Study|Adverse Event|0|||
16550208|NCT02762981|40478531|FG003|Overall Study|Withdrawal by Subject|3|||
16550209|NCT02762981|40478532|FG004|Overall Study|Withdrawal by Subject|0|||
16550210|NCT01932294|40478534|FG000|Overall Study|Death|43|||
16550211|NCT01932294|40478534|FG000|Overall Study|Lost to Follow-up|8|||
16550212|NCT01932294|40478534|FG000|Overall Study|VAD Implantation|20|||
16550213|NCT01932294|40478534|FG000|Overall Study|Heart Transplantation|16|||
16550214|NCT01932294|40478534|FG000|Overall Study|Transferred to other hospitals|12|||
16550215|NCT00758160|40478535|FG000|Overall Study|No Longer Requires Study Medication|4|||
16117768|NCT01151215|38916418|FG002|Overall Study|Worsening of condition under study|1|||
16348023|NCT04378569|39762126|FG002|Overall Study|Adverse Event|2|||
16550216|NCT00758160|40478535|FG000|Overall Study|Administration Problems|3|||
16117769|NCT01151215|38916416|FG000|Overall Study|Death|16|||
16117770|NCT01151215|38916417|FG001|Overall Study|Death|20|||
16117771|NCT01151215|38916418|FG002|Overall Study|Death|11|||
16229142|NCT01151085|39320304|FG000|Overall Study|Protocol Violation|25|||
16550217|NCT00758160|40478535|FG000|Overall Study|Adverse Event|15|||
16229143|NCT03319368|39320308|FG000|Overall Study|Discharge swabs not collected from resident|57|||
16229144|NCT03319368|39320309|FG001|Overall Study|Discharge swabs not collected from resident|46|||
16229145|NCT02061293|39320310|FG000|Overall Study|Elevated Blood Pressure|1|||
16229146|NCT02061293|39320311|FG001|Overall Study|Elevated Blood Pressure|1|||
16229147|NCT01096017|39320312|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
16229148|NCT01096017|39320313|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
16229149|NCT00003526|39320314|FG000|Overall Study|Not evaluable|6|||
16229150|NCT04988035|39320323|FG000|Overall Study|Death|19|||
16229151|NCT04988035|39320324|FG001|Overall Study|Death|13|||
16229152|NCT04988035|39320323|FG000|Overall Study|Lost to Follow-up|12|||
16229153|NCT04988035|39320324|FG001|Overall Study|Lost to Follow-up|6|||
16229154|NCT04988035|39320323|FG000|Overall Study|Protocol Violation|0|||
16229155|NCT04988035|39320324|FG001|Overall Study|Protocol Violation|1|||
16229156|NCT04988035|39320323|FG000|Overall Study|Withdrawal by Subject|2|||
16229157|NCT04988035|39320324|FG001|Overall Study|Withdrawal by Subject|4|||
16229158|NCT04988035|39320323|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
16229159|NCT04988035|39320324|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
16229160|NCT02545270|39320328|FG000|Overall Study|technical difficulties|0|||
16229161|NCT02545270|39320329|FG001|Overall Study|technical difficulties|1|||
16229162|NCT02545270|39320330|FG002|Overall Study|technical difficulties|0|||
16229163|NCT02545270|39320328|FG000|Overall Study|Videos being too similar to other|0|||
16229164|NCT02545270|39320329|FG001|Overall Study|Videos being too similar to other|0|||
16229165|NCT02545270|39320330|FG002|Overall Study|Videos being too similar to other|2|||
16229166|NCT00083226|39320333|FG000|Overall Study|Lack of Efficacy|19|||
16229167|NCT00083226|39320333|FG000|Overall Study|Adverse Event|9|||
16229168|NCT00083226|39320333|FG000|Overall Study|Death|4|||
16229169|NCT00083226|39320333|FG000|Overall Study|Withdrawal by Subject|4|||
16229170|NCT00083226|39320333|FG000|Overall Study|Other|2|||
16229171|NCT00083226|39320333|FG000|Overall Study|ineligible or not receiving treatment|4|||
16229172|NCT01060007|39320334|FG000|Overall Study|Withdrawal by Subject|1|||
16229173|NCT01060007|39320334|FG000|Overall Study|Inevaluable for response at surgery|3|||
16229174|NCT00532441|39320335|FG000|Overall Study|Death|1|||
16229175|NCT00532441|39320336|FG001|Overall Study|Death|0|||
16550218|NCT00758160|40478535|FG000|Overall Study|Lack of Efficacy|10|||
16550219|NCT00758160|40478535|FG000|Overall Study|Lost to Follow-up|14|||
16550220|NCT00758160|40478535|FG000|Overall Study|Protocol Violation|12|||
16550221|NCT00758160|40478535|FG000|Overall Study|Withdrawal by Subject|8|||
16117772|NCT01151215|38916416|FG000|Overall Study|Lost to Follow-up|0|||
16117773|NCT01151215|38916417|FG001|Overall Study|Lost to Follow-up|0|||
16117774|NCT01151215|38916418|FG002|Overall Study|Lost to Follow-up|3|||
16117775|NCT01151215|38916416|FG000|Overall Study|Withdrawal by Subject|3|||
16117776|NCT01151215|38916417|FG001|Overall Study|Withdrawal by Subject|1|||
16117777|NCT01151215|38916418|FG002|Overall Study|Withdrawal by Subject|2|||
16117778|NCT01151215|38916416|FG000|Overall Study|Disease progression|0|||
16117779|NCT01151215|38916417|FG001|Overall Study|Disease progression|1|||
16117780|NCT01151215|38916418|FG002|Overall Study|Disease progression|1|||
16117781|NCT01151215|38916416|FG000|Overall Study|Safety as judged by the investigator|0|||
16550222|NCT02396537|40478536|FG000|Overall Study|Protocol Violation|0|||
16550223|NCT02396537|40478537|FG001|Overall Study|Protocol Violation|1|||
16550224|NCT02153359|40478543|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
16550225|NCT02153359|40478544|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
16117782|NCT01151215|38916417|FG001|Overall Study|Safety as judged by the investigator|0|||
16117783|NCT01151215|38916418|FG002|Overall Study|Safety as judged by the investigator|1|||
16117784|NCT03406078|38916420|FG000|Overall Study|Death|1|||
16117785|NCT03406078|38916421|FG001|Overall Study|Death|0|||
16117786|NCT03406078|38916420|FG000|Overall Study|Lost to Follow-up|0|||
16117787|NCT03406078|38916421|FG001|Overall Study|Lost to Follow-up|1|||
16117788|NCT03406078|38916420|FG000|Overall Study|Withdrawal by Subject|5|||
16117789|NCT03406078|38916421|FG001|Overall Study|Withdrawal by Subject|2|||
16229176|NCT00777920|39320337|FG000|Overall Study|Adverse Event|39|||
16229177|NCT00777920|39320337|FG000|Overall Study|Withdrawal of Consent|4|||
16550226|NCT00845871|40478545|FG000|Assessment Period|Adverse Event|2|||
16550227|NCT00845871|40478545|FG000|Assessment Period|Abnormal laboratory values|1|||
16550228|NCT00845871|40478545|FG000|Assessment Period|Abnormal test procedure results|1|||
16550229|NCT00845871|40478545|FG000|Assessment Period|Patient withdrew consent|3|||
16550230|NCT01893827|40478546|FG000|Overall Study|Lost to Follow-up|19|||
16229178|NCT00777920|39320337|FG000|Overall Study|Lost to Follow-up|1|||
16229179|NCT00777920|39320337|FG000|Overall Study|Investigator's discretion|1|||
16348024|NCT04378569|39762127|FG003|Overall Study|Adverse Event|0|||
16550231|NCT01893827|40478547|FG001|Overall Study|Lost to Follow-up|26|||
16550232|NCT01083641|40478550|FG000|Overall Study|Withdrawal by Subject|2|||
16117790|NCT01250925|38916426|FG000|Overall Study|Lost to Follow-up|1|||
16117791|NCT01250925|38916427|FG001|Overall Study|Lost to Follow-up|1|||
16117792|NCT01250925|38916428|FG002|Overall Study|Lost to Follow-up|0|||
16117793|NCT01250925|38916426|FG000|Overall Study|Withdrawal by Subject|2|||
16229180|NCT00777920|39320337|FG000|Overall Study|Clinical status did not improve|1|||
16229181|NCT00777920|39320337|FG000|Overall Study|Other, not specified|4|||
16229182|NCT04221373|39320341|FG000|Overall Study|Physician Decision|4|||
16229183|NCT04221373|39320342|FG001|Overall Study|Physician Decision|0|||
16229184|NCT02992743|39320343|FG000|Overall Study|Withdrawal by Subject|1|||
16229185|NCT02992743|39320344|FG001|Overall Study|Withdrawal by Subject|1|||
16229186|NCT02992743|39320343|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
16229187|NCT02992743|39320344|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
16229188|NCT02992743|39320343|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
16229189|NCT02992743|39320344|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
16229190|NCT02992743|39320343|FG000|Overall Study|No measurable disease|1|||
16229191|NCT02992743|39320344|FG001|Overall Study|No measurable disease|0|||
16229192|NCT02992743|39320343|FG000|Overall Study|Lost to Follow-up|0|||
16229193|NCT02992743|39320344|FG001|Overall Study|Lost to Follow-up|1|||
16229194|NCT01326312|39320355|FG000|Overall Study|Adverse Event|11|||
16229195|NCT01326312|39320356|FG001|Overall Study|Adverse Event|11|||
16229196|NCT01326312|39320357|FG002|Overall Study|Adverse Event|1|||
16229197|NCT01326312|39320355|FG000|Overall Study|Withdrawal by Subject|1|||
16229198|NCT01326312|39320356|FG001|Overall Study|Withdrawal by Subject|2|||
16229199|NCT01326312|39320357|FG002|Overall Study|Withdrawal by Subject|1|||
16229200|NCT01326312|39320355|FG000|Overall Study|Protocol Violation|0|||
16229201|NCT01326312|39320356|FG001|Overall Study|Protocol Violation|1|||
16348025|NCT04378569|39762128|FG004|Overall Study|Adverse Event|3|||
16348026|NCT04378569|39762129|FG005|Overall Study|Adverse Event|3|||
16348027|NCT04378569|39762124|FG000|Overall Study|Lost to Follow-up|0|||
16348028|NCT04378569|39762125|FG001|Overall Study|Lost to Follow-up|3|||
16348029|NCT04378569|39762126|FG002|Overall Study|Lost to Follow-up|1|||
16348030|NCT04378569|39762127|FG003|Overall Study|Lost to Follow-up|0|||
16348031|NCT04378569|39762128|FG004|Overall Study|Lost to Follow-up|1|||
16348032|NCT04378569|39762129|FG005|Overall Study|Lost to Follow-up|1|||
16348033|NCT04378569|39762124|FG000|Overall Study|Protocol Violation|0|||
16348034|NCT04378569|39762125|FG001|Overall Study|Protocol Violation|0|||
16550233|NCT00779584|40478551|FG000|Overall Study|Protocol Violation|0|||
16550234|NCT00779584|40478552|FG001|Overall Study|Protocol Violation|0|||
16550235|NCT00779584|40478553|FG002|Overall Study|Protocol Violation|0|||
16550236|NCT00779584|40478554|FG003|Overall Study|Protocol Violation|0|||
16348035|NCT04378569|39762126|FG002|Overall Study|Protocol Violation|0|||
16550237|NCT00779584|40478555|FG004|Overall Study|Protocol Violation|0|||
16550238|NCT00779584|40478556|FG005|Overall Study|Protocol Violation|1|||
16550239|NCT00779584|40478557|FG006|Overall Study|Protocol Violation|0|||
16550240|NCT00779584|40478558|FG007|Overall Study|Protocol Violation|0|||
16550241|NCT00779584|40478559|FG008|Overall Study|Protocol Violation|0|||
16550242|NCT00779584|40478551|FG000|Overall Study|Withdrawal by Subject|1|||
16550243|NCT00779584|40478552|FG001|Overall Study|Withdrawal by Subject|1|||
16550244|NCT00779584|40478553|FG002|Overall Study|Withdrawal by Subject|2|||
16550245|NCT00779584|40478554|FG003|Overall Study|Withdrawal by Subject|0|||
16550246|NCT00779584|40478555|FG004|Overall Study|Withdrawal by Subject|0|||
16550247|NCT00779584|40478556|FG005|Overall Study|Withdrawal by Subject|2|||
16550248|NCT00779584|40478557|FG006|Overall Study|Withdrawal by Subject|1|||
16550249|NCT00779584|40478558|FG007|Overall Study|Withdrawal by Subject|0|||
16550250|NCT00779584|40478559|FG008|Overall Study|Withdrawal by Subject|0|||
16550251|NCT00779584|40478551|FG000|Overall Study|Lost to Follow-up|0|||
16550252|NCT00779584|40478552|FG001|Overall Study|Lost to Follow-up|0|||
16550253|NCT00779584|40478553|FG002|Overall Study|Lost to Follow-up|0|||
16550254|NCT00779584|40478554|FG003|Overall Study|Lost to Follow-up|0|||
16550255|NCT00779584|40478555|FG004|Overall Study|Lost to Follow-up|1|||
16550256|NCT00779584|40478556|FG005|Overall Study|Lost to Follow-up|0|||
16550257|NCT00779584|40478557|FG006|Overall Study|Lost to Follow-up|0|||
16550258|NCT00779584|40478558|FG007|Overall Study|Lost to Follow-up|0|||
16550259|NCT00779584|40478559|FG008|Overall Study|Lost to Follow-up|0|||
16550260|NCT00779584|40478551|FG000|Overall Study|Progression of Disease|0|||
16550261|NCT00779584|40478552|FG001|Overall Study|Progression of Disease|1|||
16550262|NCT00779584|40478553|FG002|Overall Study|Progression of Disease|2|||
16550263|NCT00779584|40478554|FG003|Overall Study|Progression of Disease|6|||
16550264|NCT00779584|40478555|FG004|Overall Study|Progression of Disease|5|||
16550265|NCT00779584|40478556|FG005|Overall Study|Progression of Disease|1|||
16550266|NCT00779584|40478557|FG006|Overall Study|Progression of Disease|4|||
16229202|NCT01326312|39320357|FG002|Overall Study|Protocol Violation|0|||
16229203|NCT01326312|39320355|FG000|Overall Study|Lack of Efficacy|13|||
16229204|NCT01326312|39320356|FG001|Overall Study|Lack of Efficacy|7|||
16348036|NCT04378569|39762127|FG003|Overall Study|Protocol Violation|0|||
16348037|NCT04378569|39762128|FG004|Overall Study|Protocol Violation|0|||
16348038|NCT04378569|39762129|FG005|Overall Study|Protocol Violation|1|||
16229205|NCT01326312|39320357|FG002|Overall Study|Lack of Efficacy|1|||
16229206|NCT01326312|39320355|FG000|Overall Study|Death|1|||
16348039|NCT04378569|39762124|FG000|Overall Study|Withdrawal by Subject|0|||
16348040|NCT04378569|39762125|FG001|Overall Study|Withdrawal by Subject|6|||
16550267|NCT00779584|40478558|FG007|Overall Study|Progression of Disease|2|||
16550268|NCT00779584|40478559|FG008|Overall Study|Progression of Disease|1|||
16550269|NCT00779584|40478551|FG000|Overall Study|Adverse Event|1|||
16550270|NCT00779584|40478552|FG001|Overall Study|Adverse Event|0|||
16550271|NCT00779584|40478553|FG002|Overall Study|Adverse Event|2|||
16550272|NCT00779584|40478554|FG003|Overall Study|Adverse Event|0|||
16229207|NCT01326312|39320356|FG001|Overall Study|Death|0|||
16229208|NCT01326312|39320357|FG002|Overall Study|Death|1|||
16229209|NCT01326312|39320355|FG000|Overall Study|progressive disease|0|||
16412063|NCT03529110|39992023|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
16412064|NCT03529110|39992024|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
16412065|NCT03529110|39992023|FG000|Overall Study|Lack of Efficacy|3|||
16550273|NCT00779584|40478555|FG004|Overall Study|Adverse Event|0|||
16550274|NCT00779584|40478556|FG005|Overall Study|Adverse Event|0|||
16550275|NCT00779584|40478557|FG006|Overall Study|Adverse Event|2|||
16550276|NCT00779584|40478558|FG007|Overall Study|Adverse Event|1|||
16550277|NCT00779584|40478559|FG008|Overall Study|Adverse Event|1|||
16550278|NCT00779584|40478551|FG000|Overall Study|Symptomatic Deterioration|1|||
16550279|NCT00779584|40478552|FG001|Overall Study|Symptomatic Deterioration|1|||
16550280|NCT00779584|40478553|FG002|Overall Study|Symptomatic Deterioration|1|||
16550281|NCT00779584|40478554|FG003|Overall Study|Symptomatic Deterioration|0|||
16550282|NCT00779584|40478555|FG004|Overall Study|Symptomatic Deterioration|0|||
16550283|NCT00779584|40478556|FG005|Overall Study|Symptomatic Deterioration|1|||
16550284|NCT00779584|40478557|FG006|Overall Study|Symptomatic Deterioration|1|||
16550285|NCT00779584|40478558|FG007|Overall Study|Symptomatic Deterioration|0|||
16550286|NCT00779584|40478559|FG008|Overall Study|Symptomatic Deterioration|0|||
16550287|NCT00779584|40478551|FG000|Overall Study|Ongoing in Study|0|||
16550288|NCT00779584|40478552|FG001|Overall Study|Ongoing in Study|0|||
16550289|NCT00779584|40478553|FG002|Overall Study|Ongoing in Study|0|||
16550290|NCT00779584|40478554|FG003|Overall Study|Ongoing in Study|0|||
16550291|NCT00779584|40478555|FG004|Overall Study|Ongoing in Study|1|||
16550292|NCT00779584|40478556|FG005|Overall Study|Ongoing in Study|1|||
16550293|NCT00779584|40478557|FG006|Overall Study|Ongoing in Study|0|||
16550294|NCT00779584|40478558|FG007|Overall Study|Ongoing in Study|0|||
16550295|NCT00779584|40478559|FG008|Overall Study|Ongoing in Study|0|||
16550296|NCT00154310|40478560|FG000|Overall Study|Adverse Event|19|||
16550297|NCT00154310|40478561|FG001|Overall Study|Adverse Event|9|||
16550298|NCT00154310|40478560|FG000|Overall Study|Lack of Efficacy|5|||
16550299|NCT00154310|40478561|FG001|Overall Study|Lack of Efficacy|4|||
16550300|NCT00154310|40478560|FG000|Overall Study|Protocol Violation|4|||
16550301|NCT00154310|40478561|FG001|Overall Study|Protocol Violation|2|||
16550302|NCT00154310|40478560|FG000|Overall Study|Withdrawal by Subject|9|||
16550303|NCT00154310|40478561|FG001|Overall Study|Withdrawal by Subject|3|||
16550304|NCT00154310|40478560|FG000|Overall Study|Lost to Follow-up|0|||
16550305|NCT00154310|40478561|FG001|Overall Study|Lost to Follow-up|8|||
16550306|NCT00154310|40478560|FG000|Overall Study|Administrative problems|0|||
16550307|NCT00154310|40478561|FG001|Overall Study|Administrative problems|1|||
16550308|NCT00154310|40478560|FG000|Overall Study|Death|0|||
16550309|NCT00154310|40478561|FG001|Overall Study|Death|1|||
16412066|NCT03529110|39992024|FG001|Overall Study|Lack of Efficacy|3|||
16412067|NCT03529110|39992023|FG000|Overall Study|Physician Decision|2|||
16412068|NCT03529110|39992024|FG001|Overall Study|Physician Decision|8|||
16412069|NCT03529110|39992023|FG000|Overall Study|Miscellaneous|2|||
16412070|NCT03529110|39992024|FG001|Overall Study|Miscellaneous|5|||
16412071|NCT00780273|39992028|FG000|Overall Study|Death|1|||
16412072|NCT00780273|39992028|FG000|Overall Study|Lost to Follow-up|1|||
16412073|NCT00671437|39992029|FG000|Overall Study|Progressive disease before C1 week 8|8|||
16550310|NCT02906202|40478564|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
16550311|NCT03439189|40478565|FG000|Overall Study|Protocol Violation|19|||
16550312|NCT03439189|40478565|FG000|Overall Study|Lack of Efficacy|63|||
16550313|NCT02693834|40478570|FG000|Baseline Measurement|Withdrawal by Subject|1|||
16550314|NCT02693834|40478571|FG001|Baseline Measurement|Withdrawal by Subject|0|||
16229210|NCT01326312|39320356|FG001|Overall Study|progressive disease|1|||
16412074|NCT00671437|39992029|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
16412075|NCT00671437|39992029|FG000|Overall Study|Adverse Event|3|||
16550315|NCT02693834|40478570|FG000|Baseline Measurement|Adverse Event|1|||
16550316|NCT02693834|40478571|FG001|Baseline Measurement|Adverse Event|0|||
16550317|NCT02693834|40478570|FG000|Week 2 Practice|Adverse Event|0|||
16550318|NCT02693834|40478571|FG001|Week 2 Practice|Adverse Event|1|||
16412076|NCT00671437|39992029|FG000|Overall Study|Ineligible post-hoc|1|||
16412077|NCT02449018|39992030|FG000|Overall Study|Abnormal laboratory value|0|||
16412078|NCT02449018|39992031|FG001|Overall Study|Abnormal laboratory value|1|||
16412079|NCT02449018|39992030|FG000|Overall Study|Administrative problems|1|||
16412080|NCT02449018|39992031|FG001|Overall Study|Administrative problems|0|||
16412081|NCT02449018|39992030|FG000|Overall Study|Adverse Event|5|||
16412082|NCT02449018|39992031|FG001|Overall Study|Adverse Event|1|||
16412083|NCT02449018|39992030|FG000|Overall Study|Protocol deviation|4|||
16412084|NCT02449018|39992031|FG001|Overall Study|Protocol deviation|0|||
16412085|NCT02449018|39992030|FG000|Overall Study|Patient decision|2|||
16412086|NCT02449018|39992031|FG001|Overall Study|Patient decision|0|||
16412087|NCT02256267|39992032|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
16412088|NCT02256267|39992032|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
16412089|NCT01822535|39992033|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
16412090|NCT01822535|39992034|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
16412091|NCT01822535|39992033|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
16412092|NCT01822535|39992034|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
16412093|NCT01822535|39992033|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
16412094|NCT01822535|39992034|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
16412095|NCT02809053|39992035|FG000|Overall Study|Death|0|||
16412096|NCT02809053|39992036|FG001|Overall Study|Death|1|||
16412097|NCT02809053|39992035|FG000|Overall Study|Lost to Follow-up|3|||
16412098|NCT02809053|39992036|FG001|Overall Study|Lost to Follow-up|1|||
16412099|NCT02809053|39992035|FG000|Overall Study|Withdrawal by Subject|2|||
16412100|NCT02809053|39992036|FG001|Overall Study|Withdrawal by Subject|3|||
16412101|NCT02809053|39992035|FG000|Overall Study|Disease Progression|2|||
16412102|NCT02809053|39992036|FG001|Overall Study|Disease Progression|1|||
16412103|NCT02226549|39992037|FG000|Overall Study|Randomized but Never Treated|1|||
16550319|NCT03661996|40478572|FG000|Overall Study|Adverse Event|0|||
16550320|NCT03661996|40478573|FG001|Overall Study|Adverse Event|0|||
16550321|NCT03661996|40478574|FG002|Overall Study|Adverse Event|1|||
16550322|NCT03661996|40478575|FG003|Overall Study|Adverse Event|1|||
16550323|NCT03661996|40478576|FG004|Overall Study|Adverse Event|0|||
16550324|NCT03661996|40478572|FG000|Overall Study|Lost to Follow-up|5|||
16550325|NCT03661996|40478573|FG001|Overall Study|Lost to Follow-up|1|||
16550326|NCT03661996|40478574|FG002|Overall Study|Lost to Follow-up|2|||
16550327|NCT03661996|40478575|FG003|Overall Study|Lost to Follow-up|2|||
16550328|NCT03661996|40478576|FG004|Overall Study|Lost to Follow-up|6|||
16550329|NCT03661996|40478572|FG000|Overall Study|Physician Decision|1|||
16550330|NCT03661996|40478573|FG001|Overall Study|Physician Decision|1|||
16550331|NCT03661996|40478574|FG002|Overall Study|Physician Decision|1|||
16550332|NCT03661996|40478575|FG003|Overall Study|Physician Decision|2|||
16550333|NCT03661996|40478576|FG004|Overall Study|Physician Decision|0|||
16550334|NCT03661996|40478572|FG000|Overall Study|Protocol Violation|0|||
16550335|NCT03661996|40478573|FG001|Overall Study|Protocol Violation|0|||
16550336|NCT03661996|40478574|FG002|Overall Study|Protocol Violation|0|||
16550337|NCT03661996|40478575|FG003|Overall Study|Protocol Violation|0|||
16550338|NCT03661996|40478576|FG004|Overall Study|Protocol Violation|1|||
16550339|NCT03661996|40478572|FG000|Overall Study|Withdrawal by Subject|3|||
16550340|NCT03661996|40478573|FG001|Overall Study|Withdrawal by Subject|5|||
16550341|NCT03661996|40478574|FG002|Overall Study|Withdrawal by Subject|1|||
16550342|NCT03661996|40478575|FG003|Overall Study|Withdrawal by Subject|7|||
16550343|NCT03661996|40478576|FG004|Overall Study|Withdrawal by Subject|7|||
16550344|NCT03661996|40478572|FG000|Overall Study|Sponsors Decision|2|||
16550345|NCT03661996|40478573|FG001|Overall Study|Sponsors Decision|0|||
16550346|NCT03661996|40478574|FG002|Overall Study|Sponsors Decision|0|||
16550347|NCT03661996|40478575|FG003|Overall Study|Sponsors Decision|0|||
16550348|NCT03661996|40478576|FG004|Overall Study|Sponsors Decision|0|||
16550349|NCT03661996|40478572|FG000|Overall Study|Other|1|||
16550350|NCT03661996|40478573|FG001|Overall Study|Other|1|||
16412104|NCT02226549|39992038|FG001|Overall Study|Randomized but Never Treated|0|||
16412105|NCT02226549|39992037|FG000|Overall Study|Lost to Follow-up|0|||
16412106|NCT02226549|39992038|FG001|Overall Study|Lost to Follow-up|1|||
16412107|NCT00582738|39992050|FG000|Overall Study|Administrative Problems|7|||
16412108|NCT00582738|39992051|FG001|Overall Study|Administrative Problems|8|||
16412109|NCT00582738|39992050|FG000|Overall Study|Adverse Event|0|||
16550351|NCT03661996|40478574|FG002|Overall Study|Other|1|||
16550352|NCT03661996|40478575|FG003|Overall Study|Other|1|||
16550353|NCT03661996|40478576|FG004|Overall Study|Other|0|||
16550354|NCT02802319|40478586|FG000|Overall Study|Physician Decision|2|||
16550355|NCT02802319|40478587|FG001|Overall Study|Physician Decision|1|||
16550356|NCT02802319|40478586|FG000|Overall Study|Lost to Follow-up|0|||
16550357|NCT02802319|40478587|FG001|Overall Study|Lost to Follow-up|4|||
16550358|NCT04844918|40478588|FG000|Overall Study|Adverse Event|7|||
16550359|NCT04844918|40478589|FG001|Overall Study|Adverse Event|8|||
16550360|NCT04844918|40478590|FG002|Overall Study|Adverse Event|5|||
16550361|NCT04844918|40478588|FG000|Overall Study|Physician Decision|0|||
16550362|NCT04844918|40478589|FG001|Overall Study|Physician Decision|1|||
16550363|NCT04844918|40478590|FG002|Overall Study|Physician Decision|0|||
16550364|NCT04844918|40478588|FG000|Overall Study|Withdrawal by Subject|6|||
16550365|NCT04844918|40478589|FG001|Overall Study|Withdrawal by Subject|3|||
16550366|NCT04844918|40478590|FG002|Overall Study|Withdrawal by Subject|3|||
16550367|NCT04844918|40478588|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
16412110|NCT00582738|39992051|FG001|Overall Study|Adverse Event|5|||
16412111|NCT00582738|39992050|FG000|Overall Study|Graft Lost|0|||
16412112|NCT00582738|39992051|FG001|Overall Study|Graft Lost|1|||
16412113|NCT00582738|39992050|FG000|Overall Study|Other|1|||
16412114|NCT00582738|39992051|FG001|Overall Study|Other|0|||
16412115|NCT00582738|39992050|FG000|Overall Study|Protocol Violation|1|||
16412116|NCT00582738|39992051|FG001|Overall Study|Protocol Violation|1|||
16412117|NCT00582738|39992050|FG000|Overall Study|Withdrawal by Subject|0|||
16412118|NCT00582738|39992051|FG001|Overall Study|Withdrawal by Subject|3|||
16412119|NCT01527383|39992053|FG000|Overall Study|Adverse Event|5|||
16412120|NCT01527383|39992054|FG001|Overall Study|Adverse Event|0|||
16412121|NCT01527383|39992053|FG000|Overall Study|Lost to Follow-up|3|||
16412122|NCT01527383|39992054|FG001|Overall Study|Lost to Follow-up|0|||
16412123|NCT01527383|39992053|FG000|Overall Study|Physician Decision|2|||
16412124|NCT01527383|39992054|FG001|Overall Study|Physician Decision|0|||
16412125|NCT01527383|39992053|FG000|Overall Study|Pregnancy|1|||
16412126|NCT01527383|39992054|FG001|Overall Study|Pregnancy|0|||
16412127|NCT01527383|39992053|FG000|Overall Study|Protocol Violation|1|||
16412128|NCT01527383|39992054|FG001|Overall Study|Protocol Violation|0|||
16412129|NCT01527383|39992053|FG000|Overall Study|Screen failure|1|||
16412130|NCT01527383|39992054|FG001|Overall Study|Screen failure|0|||
16412131|NCT01527383|39992053|FG000|Overall Study|Participant moved|0|||
16412132|NCT01527383|39992054|FG001|Overall Study|Participant moved|1|||
16412133|NCT01527383|39992053|FG000|Overall Study|Withdrawal by Subject|2|||
16412134|NCT01527383|39992054|FG001|Overall Study|Withdrawal by Subject|3|||
16412135|NCT00316888|39992061|FG000|Overall Study|Adverse Event|4|||
16412136|NCT00316888|39992062|FG001|Overall Study|Adverse Event|5|||
16412137|NCT00316888|39992061|FG000|Overall Study|Withdrawal by Subject|2|||
16412138|NCT00316888|39992062|FG001|Overall Study|Withdrawal by Subject|2|||
16412139|NCT00316888|39992061|FG000|Overall Study|Not start protocol therapy|0|||
16412140|NCT00316888|39992062|FG001|Overall Study|Not start protocol therapy|1|||
16412141|NCT02613169|39992063|FG000|Overall Study|Withdrawal by Subject|4|||
16412142|NCT02613169|39992064|FG001|Overall Study|Withdrawal by Subject|1|||
16412143|NCT02613169|39992063|FG000|Overall Study|Lost to Follow-up|0|||
16412144|NCT02613169|39992064|FG001|Overall Study|Lost to Follow-up|5|||
16412145|NCT02613169|39992063|FG000|Overall Study|HIV|0|||
16412146|NCT02613169|39992064|FG001|Overall Study|HIV|2|||
16412147|NCT02613169|39992063|FG000|Overall Study|No TB infection endpoint|14|||
16412148|NCT02613169|39992064|FG001|Overall Study|No TB infection endpoint|9|||
16412149|NCT03077698|39992068|FG000|Progestin Monotherapy|Stable Disease|8|||
16412150|NCT03077698|39992069|FG001|Progestin Monotherapy|Stable Disease|0|||
16412151|NCT03077698|39992068|FG000|Progestin Monotherapy|Adverse Event|1|||
16550368|NCT04844918|40478589|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
16550369|NCT04844918|40478590|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
16550370|NCT00545363|40478591|FG000|Overall Study|Adverse Event|6|||
16412152|NCT03077698|39992069|FG001|Progestin Monotherapy|Adverse Event|0|||
16412153|NCT03077698|39992068|FG000|Progestin Monotherapy|Death|1|||
16412154|NCT03077698|39992069|FG001|Progestin Monotherapy|Death|0|||
16412155|NCT03077698|39992068|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
16412156|NCT03077698|39992069|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
16412157|NCT03077698|39992068|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
16412158|NCT03077698|39992069|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
16550371|NCT00545363|40478592|FG001|Overall Study|Adverse Event|7|||
16550372|NCT00545363|40478591|FG000|Overall Study|Withdrawal by Subject|6|||
16550373|NCT00545363|40478592|FG001|Overall Study|Withdrawal by Subject|5|||
16550374|NCT00545363|40478591|FG000|Overall Study|Non-compliance|3|||
16550375|NCT00545363|40478592|FG001|Overall Study|Non-compliance|1|||
16117794|NCT01250925|38916427|FG001|Overall Study|Withdrawal by Subject|0|||
16117795|NCT01250925|38916428|FG002|Overall Study|Withdrawal by Subject|0|||
16117796|NCT01250925|38916426|FG000|Overall Study|Protocol Violation|2|||
16117797|NCT01250925|38916427|FG001|Overall Study|Protocol Violation|0|||
16117798|NCT01250925|38916428|FG002|Overall Study|Protocol Violation|0|||
16117799|NCT01250925|38916426|FG000|Overall Study|Physician Decision|0|||
16117800|NCT01250925|38916427|FG001|Overall Study|Physician Decision|2|||
16117801|NCT01250925|38916428|FG002|Overall Study|Physician Decision|1|||
16117802|NCT01250925|38916426|FG000|Overall Study|Adverse Event|0|||
16117803|NCT01250925|38916427|FG001|Overall Study|Adverse Event|0|||
16117804|NCT01250925|38916428|FG002|Overall Study|Adverse Event|1|||
16117805|NCT02358668|38916429|FG000|Overall Study|Adverse Event|2|||
16117806|NCT02358668|38916430|FG001|Overall Study|Adverse Event|0|||
16117807|NCT02358668|38916431|FG002|Overall Study|Adverse Event|0|||
16117808|NCT02358668|38916429|FG000|Overall Study|Withdrawal by Subject|0|||
16117809|NCT02358668|38916430|FG001|Overall Study|Withdrawal by Subject|1|||
16117810|NCT02358668|38916431|FG002|Overall Study|Withdrawal by Subject|0|||
16117811|NCT00203268|38916432|FG000|Early Treatment|only treated one headache|2|||
16117812|NCT00203268|38916432|FG000|Early Treatment|Lost to Follow-up|1|||
16117813|NCT00203268|38916432|FG000|Early Treatment|Withdrawal by Subject|1|||
16117814|NCT01401153|38916433|FG000|First Test Day|Learning disabilities; illness|1|||
16117815|NCT01401153|38916434|FG001|First Test Day|Learning disabilities; illness|10|||
16117816|NCT01401153|38916433|FG000|Second Test Day|illness|0|||
16117817|NCT01401153|38916434|FG001|Second Test Day|illness|5|||
16117818|NCT00600613|38916435|FG000|Overall Study|Protocol Deviation|1|||
16117819|NCT00479882|38916436|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
16117820|NCT00479882|38916437|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
16117821|NCT00479882|38916438|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
16229211|NCT01326312|39320357|FG002|Overall Study|progressive disease|1|||
16229212|NCT01326312|39320355|FG000|Overall Study|Study terminated by Sponsor|8|||
16550376|NCT00545363|40478591|FG000|Overall Study|Did not meet entry criteria|1|||
16550377|NCT00545363|40478592|FG001|Overall Study|Did not meet entry criteria|1|||
16550378|NCT00545363|40478591|FG000|Overall Study|Lost to Follow-up|2|||
16550379|NCT00545363|40478592|FG001|Overall Study|Lost to Follow-up|0|||
16550380|NCT00545363|40478591|FG000|Overall Study|Other|1|||
16550381|NCT00545363|40478592|FG001|Overall Study|Other|1|||
16550382|NCT00785707|40478594|FG000|Overall Study|Lost to Follow-up|7|||
16550383|NCT01678820|40478595|FG000|Overall Study|Study Terminated by Sponsor|45|||
16550384|NCT01678820|40478596|FG001|Overall Study|Study Terminated by Sponsor|43|||
16550385|NCT01678820|40478597|FG002|Overall Study|Study Terminated by Sponsor|43|||
16550386|NCT01678820|40478595|FG000|Overall Study|Withdrawal by Subject|2|||
16550387|NCT01678820|40478596|FG001|Overall Study|Withdrawal by Subject|5|||
16550388|NCT01678820|40478597|FG002|Overall Study|Withdrawal by Subject|2|||
16550389|NCT01678820|40478595|FG000|Overall Study|Protocol Specified Criteria|2|||
16550390|NCT01678820|40478596|FG001|Overall Study|Protocol Specified Criteria|3|||
16550391|NCT01678820|40478597|FG002|Overall Study|Protocol Specified Criteria|1|||
16550392|NCT01678820|40478595|FG000|Overall Study|Adverse Event|2|||
16550393|NCT01678820|40478596|FG001|Overall Study|Adverse Event|2|||
16550394|NCT01678820|40478597|FG002|Overall Study|Adverse Event|2|||
16550395|NCT01678820|40478595|FG000|Overall Study|Lost to Follow-up|7|||
16550396|NCT01678820|40478596|FG001|Overall Study|Lost to Follow-up|2|||
16550397|NCT01678820|40478597|FG002|Overall Study|Lost to Follow-up|2|||
16550398|NCT01678820|40478595|FG000|Overall Study|Non-compliance with study drug|0|||
16550399|NCT01678820|40478596|FG001|Overall Study|Non-compliance with study drug|1|||
16117822|NCT00479882|38916439|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
16117823|NCT00479882|38916436|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
16117824|NCT00479882|38916437|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
16117825|NCT00479882|38916438|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
16117826|NCT00479882|38916439|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
16550400|NCT01678820|40478597|FG002|Overall Study|Non-compliance with study drug|0|||
16550401|NCT01678820|40478595|FG000|Overall Study|Physician Decision|0|||
16550402|NCT01678820|40478596|FG001|Overall Study|Physician Decision|0|||
16550403|NCT01678820|40478597|FG002|Overall Study|Physician Decision|1|||
16117827|NCT00479882|38916436|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
16117828|NCT00479882|38916437|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
16117829|NCT00479882|38916438|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
16117830|NCT00479882|38916439|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
16117831|NCT00479882|38916436|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
16117832|NCT00479882|38916437|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
16117833|NCT00479882|38916438|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
16117834|NCT00479882|38916439|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
16117835|NCT00479882|38916436|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
16117836|NCT00479882|38916437|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
16117837|NCT00479882|38916438|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
16117838|NCT00479882|38916439|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
16117839|NCT00479882|38916436|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
16117840|NCT00479882|38916437|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
16117841|NCT00479882|38916438|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
16117842|NCT00479882|38916439|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
16117843|NCT00479882|38916436|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
16117844|NCT00479882|38916437|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
16117845|NCT00479882|38916438|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
16117846|NCT00479882|38916439|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
16117847|NCT00479882|38916436|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
16117848|NCT00479882|38916437|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
16117849|NCT00479882|38916438|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
16117850|NCT00479882|38916439|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
16117851|NCT00479882|38916436|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
16117852|NCT00479882|38916437|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
16117853|NCT00479882|38916438|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
16117854|NCT00479882|38916439|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
16117855|NCT00479882|38916436|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
16117856|NCT00479882|38916437|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
16117857|NCT00479882|38916438|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
16117858|NCT00479882|38916439|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
16117859|NCT00479882|38916436|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
16117860|NCT00479882|38916437|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
16117861|NCT00479882|38916438|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
16117862|NCT00479882|38916439|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
16117863|NCT00479882|38916436|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
16117864|NCT00479882|38916437|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
16117865|NCT00479882|38916438|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
16117866|NCT00479882|38916439|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
16117867|NCT00479882|38916436|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
16117868|NCT00479882|38916437|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
16117869|NCT00479882|38916438|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
16117870|NCT00479882|38916439|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
16117871|NCT00479882|38916436|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
16117872|NCT00479882|38916437|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
16117873|NCT00479882|38916438|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
16117874|NCT00479882|38916439|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
16117875|NCT02336451|38916443|FG000|Overall Study|Adverse Event|1|||
16117876|NCT02336451|38916444|FG001|Overall Study|Adverse Event|2|||
16117877|NCT02336451|38916445|FG002|Overall Study|Adverse Event|0|||
16117878|NCT02336451|38916446|FG003|Overall Study|Adverse Event|6|||
16117879|NCT02336451|38916447|FG004|Overall Study|Adverse Event|4|||
16117880|NCT02336451|38916443|FG000|Overall Study|Death|6|||
16117881|NCT02336451|38916444|FG001|Overall Study|Death|2|||
16117882|NCT02336451|38916445|FG002|Overall Study|Death|3|||
16117883|NCT02336451|38916446|FG003|Overall Study|Death|6|||
16117884|NCT02336451|38916447|FG004|Overall Study|Death|6|||
16117885|NCT02336451|38916443|FG000|Overall Study|Physician Decision|9|||
16117886|NCT02336451|38916444|FG001|Overall Study|Physician Decision|6|||
16117887|NCT02336451|38916445|FG002|Overall Study|Physician Decision|7|||
16117888|NCT02336451|38916446|FG003|Overall Study|Physician Decision|16|||
16117889|NCT02336451|38916447|FG004|Overall Study|Physician Decision|3|||
16117890|NCT02336451|38916443|FG000|Overall Study|Progressive disease|23|||
16550404|NCT01678820|40478595|FG000|Overall Study|Protocol Violation|4|||
16117891|NCT02336451|38916444|FG001|Overall Study|Progressive disease|26|||
16117892|NCT02336451|38916445|FG002|Overall Study|Progressive disease|2|||
16117893|NCT02336451|38916446|FG003|Overall Study|Progressive disease|14|||
16117894|NCT02336451|38916447|FG004|Overall Study|Progressive disease|4|||
16117895|NCT02336451|38916443|FG000|Overall Study|Protocol Violation|1|||
16117896|NCT02336451|38916444|FG001|Overall Study|Protocol Violation|0|||
16117897|NCT02336451|38916445|FG002|Overall Study|Protocol Violation|0|||
16117898|NCT02336451|38916446|FG003|Overall Study|Protocol Violation|0|||
16117899|NCT02336451|38916447|FG004|Overall Study|Protocol Violation|0|||
16117900|NCT02336451|38916443|FG000|Overall Study|Patient/guardian decision|2|||
16117901|NCT02336451|38916444|FG001|Overall Study|Patient/guardian decision|4|||
16117902|NCT02336451|38916445|FG002|Overall Study|Patient/guardian decision|0|||
16117903|NCT02336451|38916446|FG003|Overall Study|Patient/guardian decision|2|||
16117904|NCT02336451|38916447|FG004|Overall Study|Patient/guardian decision|1|||
16117905|NCT01417104|38919879|FG000|Overall Study|Withdrawal by Subject|5|||
16117906|NCT01417104|38919880|FG001|Overall Study|Withdrawal by Subject|1|||
16117907|NCT01417104|38919879|FG000|Overall Study|Failure to make contact|0|||
16117908|NCT01417104|38919880|FG001|Overall Study|Failure to make contact|1|||
16117909|NCT01417104|38919879|FG000|Overall Study|Adverse Event|1|||
16117910|NCT01417104|38919880|FG001|Overall Study|Adverse Event|0|||
16117911|NCT03559062|38919881|FG000|Overall Study|Other|0|||
16117912|NCT03559062|38919882|FG001|Overall Study|Other|1|||
16117913|NCT03559062|38919883|FG002|Overall Study|Other|0|||
16117914|NCT01825577|38919889|FG000|Overall Study|Physician Decision|2|||
16117915|NCT01825577|38919889|FG000|Overall Study|Withdrawal by Subject|1|||
16117916|NCT01825577|38919889|FG000|Overall Study|Withdrawn by family members|2|||
16117917|NCT01825577|38919889|FG000|Overall Study|Lack of Efficacy|3|||
16117918|NCT00384397|38919890|FG000|Overall Study|Adverse Event|0|||
16117919|NCT00384397|38919891|FG001|Overall Study|Adverse Event|1|||
16229213|NCT01326312|39320356|FG001|Overall Study|Study terminated by Sponsor|32|||
16550405|NCT01678820|40478596|FG001|Overall Study|Protocol Violation|5|||
16550406|NCT01678820|40478597|FG002|Overall Study|Protocol Violation|4|||
16550407|NCT01678820|40478595|FG000|Overall Study|Not treated with double-blind study drug|0|||
16550408|NCT01678820|40478596|FG001|Overall Study|Not treated with double-blind study drug|2|||
16550409|NCT01678820|40478597|FG002|Overall Study|Not treated with double-blind study drug|2|||
16550410|NCT04128293|40478600|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
16229214|NCT01326312|39320357|FG002|Overall Study|Study terminated by Sponsor|46|||
16412159|NCT03077698|39992068|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
16550411|NCT04128293|40478601|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
16550412|NCT04128293|40478602|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
16550413|NCT04128293|40478603|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
16550414|NCT02344537|40478604|FG000|Overall Study|Protocol Violation|1|||
16550415|NCT02344537|40478605|FG001|Overall Study|Protocol Violation|1|||
16550416|NCT02344537|40478604|FG000|Overall Study|Subject started another treatment after wk 6|1|||
16550417|NCT02344537|40478605|FG001|Overall Study|Subject started another treatment after wk 6|0|||
16550418|NCT02344537|40478604|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
16550419|NCT02344537|40478605|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
16550420|NCT03239873|40478606|FG000|Overall Study|Lost to Follow-up|15|||
16550421|NCT03239873|40478607|FG001|Overall Study|Lost to Follow-up|16|||
16550422|NCT03239873|40478606|FG000|Overall Study|Physician Decision|1|||
16550423|NCT03239873|40478607|FG001|Overall Study|Physician Decision|0|||
16550424|NCT03239873|40478606|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
16550425|NCT03239873|40478607|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
16550426|NCT03239873|40478606|FG000|Overall Study|Withdrawal by Subject|2|||
16550427|NCT03239873|40478607|FG001|Overall Study|Withdrawal by Subject|0|||
16550428|NCT03239873|40478606|FG000|Overall Study|Contraindication to study medication|1|||
16412160|NCT03077698|39992069|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
16412161|NCT03077698|39992068|FG000|Safety Follow Up|Withdrawal by Subject|2|||
16412162|NCT03077698|39992069|FG001|Safety Follow Up|Withdrawal by Subject|1|||
16412163|NCT03077698|39992068|FG000|Safety Follow Up|Transfer of care to hospice|1|||
16412164|NCT03077698|39992069|FG001|Safety Follow Up|Transfer of care to hospice|0|||
16412165|NCT00443781|39992079|FG000|Overall Study|Lost to Follow-up|10|||
16412166|NCT00443781|39992079|FG000|Overall Study|Physician Decision|2|||
16412167|NCT00443781|39992079|FG000|Overall Study|Protocol Violation|1|||
16412168|NCT00443781|39992079|FG000|Overall Study|Withdrawal by Subject|6|||
16412169|NCT00443781|39992079|FG000|Overall Study|Unable to comply with study follow up|2|||
16412170|NCT00443781|39992079|FG000|Overall Study|Investigator terminated participation|1|||
16412171|NCT00443781|39992079|FG000|Overall Study|Insurance not covered|2|||
16412172|NCT00443781|39992079|FG000|Overall Study|PD/FAD not done|1|||
16412173|NCT00514020|39992080|FG000|Overall Study|Adverse Event|6|||
16412174|NCT00514020|39992080|FG000|Overall Study|Withdrawal by Subject|3|||
16412175|NCT00514020|39992080|FG000|Overall Study|Physician Decision|1|||
16412176|NCT00514020|39992080|FG000|Overall Study|disease progression|9|||
16117920|NCT00384397|38919892|FG002|Overall Study|Adverse Event|2|||
16117921|NCT00384397|38919890|FG000|Overall Study|Protocol Violation|7|||
16117922|NCT00384397|38919891|FG001|Overall Study|Protocol Violation|15|||
16117923|NCT00384397|38919892|FG002|Overall Study|Protocol Violation|13|||
16117924|NCT00384397|38919890|FG000|Overall Study|Lost to Follow-up|11|||
16117925|NCT00384397|38919891|FG001|Overall Study|Lost to Follow-up|13|||
16117926|NCT00384397|38919892|FG002|Overall Study|Lost to Follow-up|3|||
16117927|NCT00384397|38919890|FG000|Overall Study|Withdrawal by Subject|14|||
16117928|NCT00384397|38919891|FG001|Overall Study|Withdrawal by Subject|17|||
16117929|NCT00384397|38919892|FG002|Overall Study|Withdrawal by Subject|15|||
16412177|NCT00514020|39992080|FG000|Overall Study|other complicating disease|2|||
16412178|NCT00514020|39992080|FG000|Overall Study|patient went to radiation treatment|1|||
16412179|NCT00514020|39992080|FG000|Overall Study|"patients moved to the no tx group"|6|||
16412180|NCT00203021|39992081|FG000|Overall Study|Death|4|||
16229215|NCT01326312|39320355|FG000|Overall Study|Treatment arm terminated|19|||
16229216|NCT01326312|39320356|FG001|Overall Study|Treatment arm terminated|0|||
16229217|NCT01326312|39320357|FG002|Overall Study|Treatment arm terminated|0|||
16229218|NCT01326312|39320355|FG000|Overall Study|QTc > 500|0|||
16229219|NCT01326312|39320356|FG001|Overall Study|QTc > 500|1|||
16229220|NCT01326312|39320357|FG002|Overall Study|QTc > 500|0|||
16229221|NCT01339273|39320358|FG000|Overall Study|Lost to Follow-up|8|||
16229222|NCT01339273|39320359|FG001|Overall Study|Lost to Follow-up|8|||
16229223|NCT01473602|39320360|FG000|Overall Study|Adverse Event|1|||
16229224|NCT01473602|39320361|FG001|Overall Study|Adverse Event|2|||
16229225|NCT01473602|39320360|FG000|Overall Study|Death|0|||
16229226|NCT01473602|39320361|FG001|Overall Study|Death|1|||
16229227|NCT01473602|39320360|FG000|Overall Study|Lost to Follow-up|1|||
16229228|NCT01473602|39320361|FG001|Overall Study|Lost to Follow-up|1|||
16229229|NCT01473602|39320360|FG000|Overall Study|Withdrawal by Subject|5|||
16229230|NCT01473602|39320361|FG001|Overall Study|Withdrawal by Subject|4|||
16229231|NCT01473602|39320360|FG000|Overall Study|Physician Decision|1|||
16229232|NCT01473602|39320361|FG001|Overall Study|Physician Decision|0|||
16229233|NCT04308668|39320362|FG000|Overall Study|Lost to Follow-up|32|||
16229234|NCT04308668|39320363|FG001|Overall Study|Lost to Follow-up|38|||
16229235|NCT04308668|39320362|FG000|Overall Study|Withdrawal by Subject|4|||
16229236|NCT04308668|39320363|FG001|Overall Study|Withdrawal by Subject|4|||
16229237|NCT01303159|39320366|FG000|Overall Study|Death|16|||
16229238|NCT01303159|39320366|FG000|Overall Study|Study Termination|7|||
16229239|NCT01396434|39320367|FG000|Overall Study|Lost to Follow-up|1|||
16229240|NCT01396434|39320368|FG001|Overall Study|Lost to Follow-up|0|||
16229241|NCT01396434|39320369|FG002|Overall Study|Lost to Follow-up|0|||
16229242|NCT01396434|39320367|FG000|Overall Study|Other|10|||
16412181|NCT00203021|39992082|FG001|Overall Study|Death|1|||
16117930|NCT04954326|38919893|FG000|Overall Study|Protocol Violation|0|||
16412182|NCT00203021|39992081|FG000|Overall Study|Adverse Event|10|||
16412183|NCT00203021|39992082|FG001|Overall Study|Adverse Event|5|||
16412184|NCT00203021|39992081|FG000|Overall Study|Withdrawal by Subject|45|||
16412185|NCT00203021|39992082|FG001|Overall Study|Withdrawal by Subject|48|||
16412186|NCT00203021|39992081|FG000|Overall Study|Lost to Follow-up|9|||
16412187|NCT00203021|39992082|FG001|Overall Study|Lost to Follow-up|7|||
16412188|NCT00203021|39992081|FG000|Overall Study|Other than specified|11|||
16412189|NCT00203021|39992082|FG001|Overall Study|Other than specified|16|||
16117931|NCT04954326|38919894|FG001|Overall Study|Protocol Violation|1|||
16117932|NCT04954326|38919893|FG000|Overall Study|Death|0|||
16117933|NCT04954326|38919894|FG001|Overall Study|Death|2|||
16117934|NCT04954326|38919893|FG000|Overall Study|Physician Decision|0|||
16229243|NCT01396434|39320368|FG001|Overall Study|Other|0|||
16229244|NCT01396434|39320369|FG002|Overall Study|Other|0|||
16229245|NCT00525499|39320370|FG000|Overall Study|Lost to Follow-up|2|||
16229246|NCT00525499|39320371|FG001|Overall Study|Lost to Follow-up|4|||
16229247|NCT00525499|39320372|FG002|Overall Study|Lost to Follow-up|1|||
16229248|NCT00525499|39320373|FG003|Overall Study|Lost to Follow-up|4|||
16229249|NCT00525499|39320370|FG000|Overall Study|Adverse Event|0|||
16412190|NCT02395055|39992083|FG000|Overall Study|Withdrawal by Subject|7|||
16412191|NCT02395055|39992084|FG001|Overall Study|Withdrawal by Subject|3|||
16229250|NCT00525499|39320371|FG001|Overall Study|Adverse Event|1|||
16229251|NCT00525499|39320372|FG002|Overall Study|Adverse Event|0|||
16117935|NCT04954326|38919894|FG001|Overall Study|Physician Decision|1|||
16117936|NCT01825798|38919895|FG000|Overall Study|Adverse Event|1|||
16117937|NCT01825798|38919896|FG001|Overall Study|Adverse Event|5|||
16229252|NCT00525499|39320373|FG003|Overall Study|Adverse Event|1|||
16117938|NCT01825798|38919895|FG000|Overall Study|Lost to Follow-up|1|||
16550429|NCT03239873|40478607|FG001|Overall Study|Contraindication to study medication|0|||
16550430|NCT03239873|40478606|FG000|Overall Study|Protocol Violation|1|||
16550431|NCT03239873|40478607|FG001|Overall Study|Protocol Violation|0|||
16117939|NCT01825798|38919896|FG001|Overall Study|Lost to Follow-up|0|||
16229253|NCT00525499|39320370|FG000|Overall Study|Withdrawal by Subject|5|||
16117940|NCT02406248|38919901|FG000|Overall Study|Death|7|||
16117941|NCT02406248|38919901|FG000|Overall Study|Withdrawal by Subject|2|||
16117942|NCT01727505|38919904|FG000|First 24 Hours|Adverse Event|0|||
16117943|NCT01727505|38919905|FG001|First 24 Hours|Adverse Event|1|||
16117944|NCT01727505|38919904|FG000|Second 24 Hours|Missing data|0|||
16117945|NCT01727505|38919905|FG001|Second 24 Hours|Missing data|1|||
16117946|NCT01162486|38919906|FG000|Overall Study|low ANC|1|||
16229254|NCT00525499|39320371|FG001|Overall Study|Withdrawal by Subject|1|||
16229255|NCT00525499|39320372|FG002|Overall Study|Withdrawal by Subject|5|||
16229256|NCT00525499|39320373|FG003|Overall Study|Withdrawal by Subject|2|||
16229257|NCT00525499|39320370|FG000|Overall Study|Protocol Violation|0|||
16229258|NCT00525499|39320371|FG001|Overall Study|Protocol Violation|1|||
16229259|NCT00525499|39320372|FG002|Overall Study|Protocol Violation|1|||
16117947|NCT01162486|38919907|FG001|Overall Study|low ANC|0|||
16117948|NCT01162486|38919908|FG002|Overall Study|low ANC|0|||
16117949|NCT01162486|38919909|FG003|Overall Study|low ANC|0|||
16117950|NCT01162486|38919910|FG004|Overall Study|low ANC|0|||
16117951|NCT01162486|38919906|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
16117952|NCT01162486|38919907|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
16117953|NCT01162486|38919908|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
16117954|NCT01162486|38919909|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
16117955|NCT01162486|38919910|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
16117956|NCT01162486|38919906|FG000|Overall Study|elevated LFTs|0|||
16117957|NCT01162486|38919907|FG001|Overall Study|elevated LFTs|0|||
16117958|NCT01162486|38919908|FG002|Overall Study|elevated LFTs|1|||
16117959|NCT01162486|38919909|FG003|Overall Study|elevated LFTs|0|||
16117960|NCT01162486|38919910|FG004|Overall Study|elevated LFTs|0|||
16117961|NCT01162486|38919906|FG000|Overall Study|Pregnancy|0|||
16117962|NCT01162486|38919907|FG001|Overall Study|Pregnancy|0|||
16117963|NCT01162486|38919908|FG002|Overall Study|Pregnancy|0|||
16117964|NCT01162486|38919909|FG003|Overall Study|Pregnancy|1|||
16117965|NCT01162486|38919910|FG004|Overall Study|Pregnancy|0|||
16117966|NCT04458922|38919911|FG000|Overall Study|Withdrawal by Subject|1|||
16117967|NCT04458922|38919912|FG001|Overall Study|Withdrawal by Subject|0|||
16117968|NCT04458922|38919913|FG002|Overall Study|Withdrawal by Subject|2|||
16117969|NCT04458922|38919911|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
16117970|NCT04458922|38919912|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
16117971|NCT04458922|38919913|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
16117972|NCT04458922|38919911|FG000|Overall Study|Adverse Event|1|||
16117973|NCT04458922|38919912|FG001|Overall Study|Adverse Event|0|||
16117974|NCT04458922|38919913|FG002|Overall Study|Adverse Event|0|||
16117975|NCT04458922|38919911|FG000|Overall Study|Started new study|0|||
16117976|NCT04458922|38919912|FG001|Overall Study|Started new study|0|||
16117977|NCT04458922|38919913|FG002|Overall Study|Started new study|1|||
16117978|NCT04458922|38919911|FG000|Overall Study|Progressive disease|6|||
16117979|NCT04458922|38919912|FG001|Overall Study|Progressive disease|8|||
16117980|NCT04458922|38919913|FG002|Overall Study|Progressive disease|2|||
16117981|NCT04458922|38919911|FG000|Overall Study|Death|1|||
16117982|NCT04458922|38919912|FG001|Overall Study|Death|0|||
16117983|NCT04458922|38919913|FG002|Overall Study|Death|2|||
16117984|NCT04458922|38919911|FG000|Overall Study|Participant started chemotherapy|0|||
16117985|NCT04458922|38919912|FG001|Overall Study|Participant started chemotherapy|1|||
16229260|NCT00525499|39320373|FG003|Overall Study|Protocol Violation|0|||
16229261|NCT03480243|39320375|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
16229262|NCT03480243|39320375|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
16550432|NCT00728962|40478610|FG000|Implant Placement Surgery|Adverse Event|8|||
16550433|NCT00728962|40478610|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
16550434|NCT00728962|40478610|FG000|Implant Placement Surgery|Protocol Violation|1|||
16550435|NCT00728962|40478610|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
16117986|NCT04458922|38919913|FG002|Overall Study|Participant started chemotherapy|0|||
16117987|NCT01165177|38919915|FG000|Overall Study|Serious Adverse Event|227|||
16117988|NCT01165177|38919916|FG001|Overall Study|Serious Adverse Event|235|||
16117989|NCT01165177|38919915|FG000|Overall Study|Withdrawal by Subject|368|||
16117990|NCT01165177|38919916|FG001|Overall Study|Withdrawal by Subject|354|||
16117991|NCT01165177|38919915|FG000|Overall Study|Protocol Violation|19|||
16117992|NCT01165177|38919916|FG001|Overall Study|Protocol Violation|21|||
16117993|NCT01165177|38919915|FG000|Overall Study|Non-serious adverse event|30|||
16117994|NCT01165177|38919916|FG001|Overall Study|Non-serious adverse event|18|||
16117995|NCT01165177|38919915|FG000|Overall Study|Other unspecified reasons|47|||
16117996|NCT01165177|38919916|FG001|Overall Study|Other unspecified reasons|35|||
16117997|NCT01165177|38919915|FG000|Overall Study|Suspected HZ episode|0|||
16117998|NCT01165177|38919916|FG001|Overall Study|Suspected HZ episode|2|||
16117999|NCT01165177|38919915|FG000|Overall Study|Lost to Follow-up|183|||
16118000|NCT01165177|38919916|FG001|Overall Study|Lost to Follow-up|194|||
16118001|NCT01165177|38919915|FG000|Overall Study|Migrated/ moved from study area|48|||
16118002|NCT01165177|38919916|FG001|Overall Study|Migrated/ moved from study area|43|||
16118003|NCT00565773|38919922|FG000|Overall Study|Withdrawal by Subject|1|||
16118004|NCT00565773|38919922|FG000|Overall Study|Physician Decision|1|||
16118005|NCT01934790|38919923|FG000|Treatment|Adverse Event|3|||
16118006|NCT01934790|38919923|FG000|Treatment|Clinical progression|6|||
16118007|NCT01934790|38919923|FG000|Treatment|Radiological progression|4|||
16118008|NCT01934790|38919923|FG000|Treatment|Withdrawal by Subject|2|||
16118009|NCT01934790|38919923|FG000|Treatment|Study drug never administered|1|||
16118010|NCT01934790|38919923|FG000|Active Follow up|Death|20|||
16118011|NCT01934790|38919923|FG000|Active Follow up|Physician Decision|2|||
16118012|NCT01934790|38919923|FG000|Active Follow up|Progressive disease|1|||
16118013|NCT01934790|38919923|FG000|Active Follow up|Other reason|1|||
16118014|NCT01411241|38919924|FG000|Overall Study|Protocol Violation|0|||
16118015|NCT01411241|38919925|FG001|Overall Study|Protocol Violation|5|||
16118016|NCT01411241|38919924|FG000|Overall Study|Withdrawal by Subject|9|||
16118017|NCT01411241|38919925|FG001|Overall Study|Withdrawal by Subject|10|||
16118018|NCT01411241|38919924|FG000|Overall Study|Serious Adverse Event|0|||
16118019|NCT01411241|38919925|FG001|Overall Study|Serious Adverse Event|3|||
16118020|NCT01411241|38919924|FG000|Overall Study|Lost to Follow-up|2|||
16118021|NCT01411241|38919925|FG001|Overall Study|Lost to Follow-up|4|||
16118022|NCT02325739|38919932|FG000|Phase I Part|Adverse Event|1|||
16118023|NCT02325739|38919933|FG001|Phase I Part|Adverse Event|0|||
16118024|NCT02325739|38919934|FG002|Phase I Part|Adverse Event|1|||
16118025|NCT02325739|38919935|FG003|Phase I Part|Adverse Event|2|||
16118026|NCT02325739|38919936|FG004|Phase I Part|Adverse Event|3|||
16118027|NCT02325739|38919937|FG005|Phase I Part|Adverse Event|1|||
16118028|NCT02325739|38919938|FG006|Phase I Part|Adverse Event|0|||
16118029|NCT02325739|38919939|FG007|Phase I Part|Adverse Event|2|||
16118030|NCT02325739|38919940|FG008|Phase I Part|Adverse Event|0|||
16118031|NCT02325739|38919941|FG009|Phase I Part|Adverse Event|0|||
16118032|NCT02325739|38919942|FG010|Phase I Part|Adverse Event|0|||
16118033|NCT02325739|38919932|FG000|Phase I Part|Progressive disease|9|||
16118034|NCT02325739|38919933|FG001|Phase I Part|Progressive disease|6|||
16118035|NCT02325739|38919934|FG002|Phase I Part|Progressive disease|3|||
16118036|NCT02325739|38919935|FG003|Phase I Part|Progressive disease|23|||
16118037|NCT02325739|38919936|FG004|Phase I Part|Progressive disease|14|||
16118038|NCT02325739|38919937|FG005|Phase I Part|Progressive disease|6|||
16118039|NCT02325739|38919938|FG006|Phase I Part|Progressive disease|6|||
16118040|NCT02325739|38919939|FG007|Phase I Part|Progressive disease|3|||
16118041|NCT02325739|38919940|FG008|Phase I Part|Progressive disease|0|||
16118042|NCT02325739|38919941|FG009|Phase I Part|Progressive disease|0|||
16118043|NCT02325739|38919942|FG010|Phase I Part|Progressive disease|0|||
16229263|NCT00663208|39320376|FG000|Treatment Period|Lost to Follow-up|0|||
16229264|NCT00663208|39320377|FG001|Treatment Period|Lost to Follow-up|1|||
16229265|NCT00663208|39320378|FG002|Treatment Period|Lost to Follow-up|0|||
16229266|NCT00663208|39320379|FG003|Treatment Period|Lost to Follow-up|0|||
16229267|NCT00663208|39320380|FG004|Treatment Period|Lost to Follow-up|0|||
16229268|NCT00663208|39320381|FG005|Treatment Period|Lost to Follow-up|0|||
16229269|NCT00663208|39320382|FG006|Treatment Period|Lost to Follow-up|0|||
16229270|NCT00663208|39320376|FG000|Follow-up Period|Lost to Follow-up|2|||
16229271|NCT00663208|39320377|FG001|Follow-up Period|Lost to Follow-up|0|||
16229272|NCT00663208|39320378|FG002|Follow-up Period|Lost to Follow-up|3|||
16229273|NCT00663208|39320379|FG003|Follow-up Period|Lost to Follow-up|2|||
16229274|NCT00663208|39320380|FG004|Follow-up Period|Lost to Follow-up|0|||
16229275|NCT00663208|39320381|FG005|Follow-up Period|Lost to Follow-up|0|||
16229276|NCT00663208|39320382|FG006|Follow-up Period|Lost to Follow-up|0|||
16118044|NCT02325739|38919932|FG000|Phase I Part|Subject/guardian decision|1|||
16118045|NCT02325739|38919933|FG001|Phase I Part|Subject/guardian decision|0|||
16118046|NCT02325739|38919934|FG002|Phase I Part|Subject/guardian decision|1|||
16118047|NCT02325739|38919935|FG003|Phase I Part|Subject/guardian decision|1|||
16118048|NCT02325739|38919936|FG004|Phase I Part|Subject/guardian decision|0|||
16118049|NCT02325739|38919937|FG005|Phase I Part|Subject/guardian decision|0|||
16118050|NCT02325739|38919938|FG006|Phase I Part|Subject/guardian decision|0|||
16118051|NCT02325739|38919939|FG007|Phase I Part|Subject/guardian decision|1|||
16118052|NCT02325739|38919940|FG008|Phase I Part|Subject/guardian decision|0|||
16118053|NCT02325739|38919941|FG009|Phase I Part|Subject/guardian decision|0|||
16118054|NCT02325739|38919942|FG010|Phase I Part|Subject/guardian decision|0|||
16118055|NCT02325739|38919932|FG000|Phase I Part|Death|0|||
16118056|NCT02325739|38919933|FG001|Phase I Part|Death|0|||
16118057|NCT02325739|38919934|FG002|Phase I Part|Death|0|||
16118058|NCT02325739|38919935|FG003|Phase I Part|Death|0|||
16118059|NCT02325739|38919936|FG004|Phase I Part|Death|2|||
16118060|NCT02325739|38919937|FG005|Phase I Part|Death|0|||
16118061|NCT02325739|38919938|FG006|Phase I Part|Death|0|||
16118062|NCT02325739|38919939|FG007|Phase I Part|Death|0|||
16229277|NCT00663208|39320376|FG000|Follow-up Period|Other reason|1|||
16229278|NCT00663208|39320377|FG001|Follow-up Period|Other reason|0|||
16229279|NCT00663208|39320378|FG002|Follow-up Period|Other reason|0|||
16229280|NCT00663208|39320379|FG003|Follow-up Period|Other reason|0|||
16229281|NCT00663208|39320380|FG004|Follow-up Period|Other reason|0|||
16229282|NCT00663208|39320381|FG005|Follow-up Period|Other reason|0|||
16229283|NCT00663208|39320382|FG006|Follow-up Period|Other reason|1|||
16229284|NCT00625846|39320383|FG000|Overall Study|Withdrawal by Subject|2|||
16229285|NCT00625846|39320384|FG001|Overall Study|Withdrawal by Subject|0|||
16229286|NCT00625846|39320385|FG002|Overall Study|Withdrawal by Subject|1|||
16229287|NCT00625846|39320386|FG003|Overall Study|Withdrawal by Subject|2|||
16229288|NCT01459016|39320387|FG000|Overall Study|Withdrawal by Subject|11|||
16229289|NCT01459016|39320387|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
16229290|NCT03557775|39320390|FG000|Overall Study|Withdrawal by Subject|1|||
16229291|NCT03557775|39320391|FG001|Overall Study|Withdrawal by Subject|2|||
16229292|NCT03557775|39320392|FG002|Overall Study|Withdrawal by Subject|4|||
16229293|NCT03557775|39320390|FG000|Overall Study|Physician Decision|0|||
16229294|NCT03557775|39320391|FG001|Overall Study|Physician Decision|1|||
16229295|NCT03557775|39320392|FG002|Overall Study|Physician Decision|0|||
16229296|NCT02967055|39320394|FG000|Overall Study|Excluded|40|||
16229297|NCT02967055|39320394|FG000|Overall Study|Screen fail|3|||
16229298|NCT02967055|39320394|FG000|Overall Study|Lost to Follow-up|2|||
16229299|NCT02967055|39320394|FG000|Overall Study|Stopped due to side effects|3|||
16229300|NCT02967055|39320394|FG000|Overall Study|Stopped due to drug cost|1|||
16229301|NCT00096031|39320395|FG000|Overall Study|Adverse Event|3|||
16229302|NCT00096031|39320395|FG000|Overall Study|Lack of Efficacy|42|||
16229303|NCT00096031|39320395|FG000|Overall Study|Death|4|||
16229304|NCT00096031|39320395|FG000|Overall Study|Withdrawal by Subject|1|||
16229305|NCT00096031|39320395|FG000|Overall Study|Ineligible|8|||
16229306|NCT00096031|39320395|FG000|Overall Study|Not protocol specified|5|||
16229307|NCT02684370|39320397|FG000|Part A|Adverse Event|2|||
16229308|NCT02684370|39320398|FG001|Part A|Adverse Event|0|||
16229309|NCT02684370|39320399|FG002|Part A|Adverse Event|1|||
16229310|NCT02684370|39320400|FG003|Part A|Adverse Event|0|||
16229311|NCT02684370|39320401|FG004|Part A|Adverse Event|0|||
16229312|NCT02684370|39320402|FG005|Part A|Adverse Event|0|||
16229313|NCT02684370|39320397|FG000|Part A|Lost to Follow-up|1|||
16229314|NCT02684370|39320398|FG001|Part A|Lost to Follow-up|1|||
16229315|NCT02684370|39320399|FG002|Part A|Lost to Follow-up|0|||
16229316|NCT02684370|39320400|FG003|Part A|Lost to Follow-up|0|||
16229317|NCT02684370|39320401|FG004|Part A|Lost to Follow-up|0|||
16229318|NCT02684370|39320402|FG005|Part A|Lost to Follow-up|0|||
16229319|NCT02684370|39320397|FG000|Part A|Subject Withdrawal|1|||
16229320|NCT02684370|39320398|FG001|Part A|Subject Withdrawal|0|||
16229321|NCT02684370|39320399|FG002|Part A|Subject Withdrawal|3|||
16229322|NCT02684370|39320400|FG003|Part A|Subject Withdrawal|0|||
16229323|NCT02684370|39320401|FG004|Part A|Subject Withdrawal|0|||
16229324|NCT02684370|39320402|FG005|Part A|Subject Withdrawal|0|||
16229325|NCT02684370|39320397|FG000|Part A|Other|0|||
16229326|NCT02684370|39320398|FG001|Part A|Other|0|||
16229327|NCT02684370|39320399|FG002|Part A|Other|1|||
16229328|NCT02684370|39320400|FG003|Part A|Other|0|||
16229329|NCT02684370|39320401|FG004|Part A|Other|0|||
16229330|NCT02684370|39320402|FG005|Part A|Other|0|||
16229331|NCT02684370|39320397|FG000|Part B|Adverse Event|0|||
16229332|NCT02684370|39320398|FG001|Part B|Adverse Event|0|||
16229333|NCT02684370|39320399|FG002|Part B|Adverse Event|0|||
16229334|NCT02684370|39320400|FG003|Part B|Adverse Event|0|||
16229335|NCT02684370|39320401|FG004|Part B|Adverse Event|2|||
16229336|NCT02684370|39320402|FG005|Part B|Adverse Event|1|||
16229337|NCT02684370|39320397|FG000|Part B|Lost to Follow-up|0|||
16229338|NCT02684370|39320398|FG001|Part B|Lost to Follow-up|0|||
16229339|NCT02684370|39320399|FG002|Part B|Lost to Follow-up|0|||
16229340|NCT02684370|39320400|FG003|Part B|Lost to Follow-up|1|||
16550436|NCT00728962|40478610|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
16550437|NCT01848834|40478611|FG000|Overall Study|Adverse Event|3|||
16229341|NCT02684370|39320401|FG004|Part B|Lost to Follow-up|2|||
16229342|NCT02684370|39320402|FG005|Part B|Lost to Follow-up|5|||
16229343|NCT02684370|39320397|FG000|Part B|Subject Withdrawal|0|||
16229344|NCT02684370|39320398|FG001|Part B|Subject Withdrawal|0|||
16229345|NCT02684370|39320399|FG002|Part B|Subject Withdrawal|0|||
16229346|NCT02684370|39320400|FG003|Part B|Subject Withdrawal|1|||
16229347|NCT02684370|39320401|FG004|Part B|Subject Withdrawal|1|||
16229348|NCT02684370|39320402|FG005|Part B|Subject Withdrawal|2|||
16229349|NCT00779857|39320403|FG000|Overall Study|Death|1|||
16229350|NCT00779857|39320403|FG000|Overall Study|Withdrawal by Subject|3|||
16229351|NCT00779857|39320403|FG000|Overall Study|Missed Visit|2|||
16229352|NCT02312934|39320405|FG000|Overall Study|Lost to Follow-up|1|||
16229353|NCT02312934|39320406|FG001|Overall Study|Lost to Follow-up|0|||
16229354|NCT02312934|39320405|FG000|Overall Study|Physician Decision|1|||
16229355|NCT02312934|39320406|FG001|Overall Study|Physician Decision|0|||
16229356|NCT00593385|39320407|FG000|Overall Study|Death|14|||
16229357|NCT00593385|39320407|FG000|Overall Study|Lost to Follow-up|17|||
16229358|NCT00593385|39320407|FG000|Overall Study|Withdrawal by Subject|9|||
16229359|NCT02120456|39320409|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16229360|NCT02120456|39320410|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16229361|NCT02120456|39320411|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16229362|NCT02120456|39320412|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16229363|NCT02120456|39320413|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16229364|NCT02120456|39320414|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16229365|NCT02120456|39320415|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
16229366|NCT02120456|39320416|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16229367|NCT02120456|39320417|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
16229368|NCT02120456|39320409|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16229369|NCT02120456|39320410|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16229370|NCT02120456|39320411|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16229371|NCT02120456|39320412|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16229372|NCT02120456|39320413|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16229373|NCT02120456|39320414|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16229374|NCT02120456|39320415|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
16229375|NCT02120456|39320416|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16229376|NCT02120456|39320417|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
16229377|NCT02120456|39320409|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16229378|NCT02120456|39320410|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16229379|NCT02120456|39320411|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16229380|NCT02120456|39320412|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16229381|NCT02120456|39320413|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16229382|NCT02120456|39320414|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16229383|NCT02120456|39320415|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16229384|NCT02120456|39320416|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
16229385|NCT02120456|39320417|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
16229386|NCT02221882|39320418|FG000|Overall Study|Withdrawal by Subject|0|||
16229387|NCT02221882|39320419|FG001|Overall Study|Withdrawal by Subject|0|||
16229388|NCT02221882|39320420|FG002|Overall Study|Withdrawal by Subject|4|||
16229389|NCT02221882|39320421|FG003|Overall Study|Withdrawal by Subject|2|||
16229390|NCT02221882|39320422|FG004|Overall Study|Withdrawal by Subject|2|||
16229391|NCT02221882|39320423|FG005|Overall Study|Withdrawal by Subject|2|||
16229392|NCT02221882|39320418|FG000|Overall Study|Death|0|||
16229393|NCT02221882|39320419|FG001|Overall Study|Death|1|||
16229394|NCT02221882|39320420|FG002|Overall Study|Death|0|||
16412192|NCT04957758|39992085|FG000|Overall Study|Adverse Event|1|||
16550438|NCT01848834|40478612|FG001|Overall Study|Adverse Event|11|||
16550439|NCT01848834|40478613|FG002|Overall Study|Adverse Event|3|||
16550440|NCT01848834|40478614|FG003|Overall Study|Adverse Event|5|||
16550441|NCT01848834|40478615|FG004|Overall Study|Adverse Event|9|||
16550442|NCT01848834|40478611|FG000|Overall Study|Death|2|||
16550443|NCT01848834|40478612|FG001|Overall Study|Death|11|||
16550444|NCT01848834|40478613|FG002|Overall Study|Death|1|||
16550445|NCT01848834|40478614|FG003|Overall Study|Death|8|||
16550446|NCT01848834|40478615|FG004|Overall Study|Death|27|||
16550447|NCT01848834|40478611|FG000|Overall Study|Excluded Medication|5|||
16550448|NCT01848834|40478612|FG001|Overall Study|Excluded Medication|4|||
16550449|NCT01848834|40478613|FG002|Overall Study|Excluded Medication|3|||
16550450|NCT01848834|40478614|FG003|Overall Study|Excluded Medication|6|||
16550451|NCT01848834|40478615|FG004|Overall Study|Excluded Medication|6|||
16550452|NCT01848834|40478611|FG000|Overall Study|Lost to Follow-up|5|||
16550453|NCT01848834|40478612|FG001|Overall Study|Lost to Follow-up|5|||
16550454|NCT01848834|40478613|FG002|Overall Study|Lost to Follow-up|3|||
16550455|NCT01848834|40478614|FG003|Overall Study|Lost to Follow-up|0|||
16550456|NCT01848834|40478615|FG004|Overall Study|Lost to Follow-up|3|||
16550457|NCT01848834|40478611|FG000|Overall Study|Physician Decision|1|||
16550458|NCT01848834|40478612|FG001|Overall Study|Physician Decision|3|||
16550459|NCT01848834|40478613|FG002|Overall Study|Physician Decision|4|||
16550460|NCT01848834|40478614|FG003|Overall Study|Physician Decision|0|||
16550461|NCT01848834|40478615|FG004|Overall Study|Physician Decision|11|||
16550462|NCT01848834|40478611|FG000|Overall Study|Protocol Violation|0|||
16550463|NCT01848834|40478612|FG001|Overall Study|Protocol Violation|0|||
16550464|NCT01848834|40478613|FG002|Overall Study|Protocol Violation|0|||
16550465|NCT01848834|40478614|FG003|Overall Study|Protocol Violation|0|||
16550466|NCT01848834|40478615|FG004|Overall Study|Protocol Violation|1|||
16550467|NCT01848834|40478611|FG000|Overall Study|Sponsor Decision|1|||
16229395|NCT02221882|39320421|FG003|Overall Study|Death|0|||
16229396|NCT02221882|39320422|FG004|Overall Study|Death|0|||
16229397|NCT02221882|39320423|FG005|Overall Study|Death|0|||
16229398|NCT01190839|39320424|FG000|Overall Study|Adverse Event|32|||
16229399|NCT01190839|39320425|FG001|Overall Study|Adverse Event|41|||
16550468|NCT01848834|40478612|FG001|Overall Study|Sponsor Decision|1|||
16550469|NCT01848834|40478613|FG002|Overall Study|Sponsor Decision|0|||
16550470|NCT01848834|40478614|FG003|Overall Study|Sponsor Decision|1|||
16550471|NCT01848834|40478615|FG004|Overall Study|Sponsor Decision|1|||
16229400|NCT01190839|39320424|FG000|Overall Study|Protocol Violation|2|||
16229401|NCT01190839|39320425|FG001|Overall Study|Protocol Violation|2|||
16229402|NCT01190839|39320424|FG000|Overall Study|Lost to Follow-up|7|||
16229403|NCT01190839|39320425|FG001|Overall Study|Lost to Follow-up|1|||
16229404|NCT01190839|39320424|FG000|Overall Study|Death|1|||
16229405|NCT01190839|39320425|FG001|Overall Study|Death|0|||
16229406|NCT01190839|39320424|FG000|Overall Study|Trial stopped by Sponsor|71|||
16229407|NCT01190839|39320425|FG001|Overall Study|Trial stopped by Sponsor|68|||
16229408|NCT01190839|39320424|FG000|Overall Study|Undefined|35|||
16229409|NCT01190839|39320425|FG001|Overall Study|Undefined|31|||
16229410|NCT01190839|39320424|FG000|Overall Study|Randomized but not treated|2|||
16229411|NCT01190839|39320425|FG001|Overall Study|Randomized but not treated|4|||
16229412|NCT00953576|39320431|FG000|Overall Study|Adverse Event|0|||
16229413|NCT00953576|39320432|FG001|Overall Study|Adverse Event|1|||
16229414|NCT00953576|39320431|FG000|Overall Study|Ineligible after Consent|2|||
16229415|NCT00953576|39320432|FG001|Overall Study|Ineligible after Consent|0|||
16229416|NCT00135694|39320433|FG000|Overall Study|Adverse Event|17|||
16229417|NCT00135694|39320434|FG001|Overall Study|Adverse Event|4|||
16229418|NCT00135694|39320435|FG002|Overall Study|Adverse Event|0|||
16229419|NCT00135694|39320433|FG000|Overall Study|Death|14|||
16229420|NCT00135694|39320434|FG001|Overall Study|Death|1|||
16229421|NCT00135694|39320435|FG002|Overall Study|Death|2|||
16229422|NCT00135694|39320433|FG000|Overall Study|Lost to Follow-up|8|||
16229423|NCT00135694|39320434|FG001|Overall Study|Lost to Follow-up|7|||
16229424|NCT00135694|39320435|FG002|Overall Study|Lost to Follow-up|1|||
16229425|NCT00135694|39320433|FG000|Overall Study|Withdrawal by Subject|41|||
16229426|NCT00135694|39320434|FG001|Overall Study|Withdrawal by Subject|7|||
16229427|NCT00135694|39320435|FG002|Overall Study|Withdrawal by Subject|4|||
16229428|NCT00135694|39320433|FG000|Overall Study|Protocol Violation|19|||
16229429|NCT00135694|39320434|FG001|Overall Study|Protocol Violation|1|||
16229430|NCT00135694|39320435|FG002|Overall Study|Protocol Violation|0|||
16229431|NCT00135694|39320433|FG000|Overall Study|Hepatitis C related reasons|39|||
16229432|NCT00135694|39320434|FG001|Overall Study|Hepatitis C related reasons|1|||
16229433|NCT00135694|39320435|FG002|Overall Study|Hepatitis C related reasons|0|||
16412193|NCT04957758|39992086|FG001|Overall Study|Adverse Event|0|||
16412194|NCT04957758|39992085|FG000|Overall Study|Lost to Follow-up|0|||
16229434|NCT00135694|39320433|FG000|Overall Study|Ineligible for Random assignment|42|||
16229435|NCT00135694|39320434|FG001|Overall Study|Ineligible for Random assignment|0|||
16229436|NCT00135694|39320435|FG002|Overall Study|Ineligible for Random assignment|0|||
16229437|NCT01012609|39320439|FG000|Overall Study|Withdrawal by Subject|1|||
16229438|NCT01012609|39320440|FG001|Overall Study|Withdrawal by Subject|1|||
16229439|NCT00796367|39320443|FG000|Overall Study|Adverse Event|6|||
16229440|NCT00796367|39320444|FG001|Overall Study|Adverse Event|4|||
16229441|NCT00796367|39320445|FG002|Overall Study|Adverse Event|7|||
16229442|NCT00796367|39320443|FG000|Overall Study|Lost to Follow-up|5|||
16229443|NCT00796367|39320444|FG001|Overall Study|Lost to Follow-up|4|||
16229444|NCT00796367|39320445|FG002|Overall Study|Lost to Follow-up|21|||
16229445|NCT00796367|39320443|FG000|Overall Study|Withdrawal by Subject|9|||
16229446|NCT00796367|39320444|FG001|Overall Study|Withdrawal by Subject|11|||
16229447|NCT00796367|39320445|FG002|Overall Study|Withdrawal by Subject|12|||
16229448|NCT00796367|39320443|FG000|Overall Study|Lack of Efficacy|2|||
16229449|NCT00796367|39320444|FG001|Overall Study|Lack of Efficacy|1|||
16229450|NCT00796367|39320445|FG002|Overall Study|Lack of Efficacy|0|||
16229451|NCT00796367|39320443|FG000|Overall Study|non compliance|3|||
16229452|NCT00796367|39320444|FG001|Overall Study|non compliance|1|||
16229453|NCT00796367|39320445|FG002|Overall Study|non compliance|1|||
16229454|NCT00796367|39320443|FG000|Overall Study|Pregnancy|1|||
16229455|NCT00796367|39320444|FG001|Overall Study|Pregnancy|0|||
16229456|NCT00796367|39320445|FG002|Overall Study|Pregnancy|1|||
16229457|NCT00796367|39320443|FG000|Overall Study|Requirement for restricted medication|2|||
16229458|NCT00796367|39320444|FG001|Overall Study|Requirement for restricted medication|0|||
16412195|NCT04957758|39992086|FG001|Overall Study|Lost to Follow-up|2|||
16550472|NCT01848834|40478611|FG000|Overall Study|Withdrawal by Subject|2|||
16229459|NCT00796367|39320445|FG002|Overall Study|Requirement for restricted medication|2|||
16229460|NCT00796367|39320443|FG000|Overall Study|other|2|||
16229461|NCT00796367|39320444|FG001|Overall Study|other|4|||
16229462|NCT00796367|39320445|FG002|Overall Study|other|3|||
16229463|NCT02184988|39320446|FG000|Overall Study|Pregnancy|2|||
16229464|NCT02184988|39320446|FG000|Overall Study|Adverse Event|2|||
16229465|NCT02184988|39320446|FG000|Overall Study|moving away/travelling/unable to complet|6|||
16229466|NCT02184988|39320446|FG000|Overall Study|work scheduling issues|4|||
16229467|NCT02184988|39320446|FG000|Overall Study|various other reasons|9|||
16229468|NCT02184988|39320446|FG000|Overall Study|Lost to Follow-up|32|||
16229469|NCT01450631|39320447|FG000|Overall Study|Lost to Follow-up|2|||
16229470|NCT01450631|39320448|FG001|Overall Study|Lost to Follow-up|4|||
16229471|NCT01450631|39320447|FG000|Overall Study|Withdrawal by Subject|1|||
16229472|NCT01450631|39320448|FG001|Overall Study|Withdrawal by Subject|0|||
16412196|NCT04957758|39992085|FG000|Overall Study|Withdrawal by Subject|4|||
16412197|NCT04957758|39992086|FG001|Overall Study|Withdrawal by Subject|2|||
16412198|NCT04957758|39992085|FG000|Overall Study|Protocol Violation|0|||
16412199|NCT04957758|39992086|FG001|Overall Study|Protocol Violation|1|||
16118063|NCT02325739|38919940|FG008|Phase I Part|Death|0|||
16118064|NCT02325739|38919941|FG009|Phase I Part|Death|0|||
16118065|NCT02325739|38919942|FG010|Phase I Part|Death|0|||
16118066|NCT02325739|38919932|FG000|Phase II Part|Adverse Event|0|||
16118067|NCT02325739|38919933|FG001|Phase II Part|Adverse Event|0|||
16118068|NCT02325739|38919934|FG002|Phase II Part|Adverse Event|0|||
16118069|NCT02325739|38919935|FG003|Phase II Part|Adverse Event|0|||
16412200|NCT02782325|39992087|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
16412201|NCT02782325|39992088|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
16412202|NCT02782325|39992089|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
16412203|NCT02782325|39992087|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
16412204|NCT02782325|39992088|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
16118070|NCT02325739|38919936|FG004|Phase II Part|Adverse Event|0|||
16118071|NCT02325739|38919937|FG005|Phase II Part|Adverse Event|0|||
16118072|NCT02325739|38919938|FG006|Phase II Part|Adverse Event|0|||
16118073|NCT02325739|38919939|FG007|Phase II Part|Adverse Event|0|||
16118074|NCT02325739|38919940|FG008|Phase II Part|Adverse Event|4|||
16118075|NCT02325739|38919941|FG009|Phase II Part|Adverse Event|5|||
16118076|NCT02325739|38919942|FG010|Phase II Part|Adverse Event|1|||
16118077|NCT02325739|38919932|FG000|Phase II Part|Physician Decision|0|||
16118078|NCT02325739|38919933|FG001|Phase II Part|Physician Decision|0|||
16118079|NCT02325739|38919934|FG002|Phase II Part|Physician Decision|0|||
16118080|NCT02325739|38919935|FG003|Phase II Part|Physician Decision|0|||
16229473|NCT00535262|39320451|FG000|Overall Study|No funding|3|||
16229474|NCT00822237|39320456|FG000|Dose 1 Vaccination|Not vaccinated|3|||
16229475|NCT00822237|39320457|FG001|Dose 1 Vaccination|Not vaccinated|0|||
16229476|NCT00822237|39320456|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
16412205|NCT02782325|39992089|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
16412206|NCT00276614|39992090|FG000|Overall Study|Progression of disease under study|3|||
16412207|NCT01595581|39992091|FG000|Overall Study|Withdrawal by Subject|1|||
16412208|NCT01595581|39992092|FG001|Overall Study|Withdrawal by Subject|0|||
16412209|NCT00490022|39992095|FG000|Overall Study|Adverse Event|0|||
16412210|NCT00490022|39992096|FG001|Overall Study|Adverse Event|2|||
16412211|NCT00490022|39992095|FG000|Overall Study|Withdrawal by Subject|1|||
16412212|NCT00490022|39992096|FG001|Overall Study|Withdrawal by Subject|0|||
16412213|NCT00490022|39992095|FG000|Overall Study|Subject failed to disclose concommitant|0|||
16412214|NCT00490022|39992096|FG001|Overall Study|Subject failed to disclose concommitant|1|||
16412215|NCT01048866|39992097|FG000|Overall Study|Adverse Event|1|||
16412216|NCT01048866|39992098|FG001|Overall Study|Adverse Event|0|||
16412217|NCT01048866|39992097|FG000|Overall Study|Protocol Violation|1|||
16412218|NCT01048866|39992098|FG001|Overall Study|Protocol Violation|0|||
16412219|NCT01048866|39992097|FG000|Overall Study|Physician Decision|1|||
16550473|NCT01848834|40478612|FG001|Overall Study|Withdrawal by Subject|13|||
16550474|NCT01848834|40478613|FG002|Overall Study|Withdrawal by Subject|10|||
16550475|NCT01848834|40478614|FG003|Overall Study|Withdrawal by Subject|6|||
16550476|NCT01848834|40478615|FG004|Overall Study|Withdrawal by Subject|36|||
16550477|NCT00369681|40478618|FG000|Overall Study|Death|1|||
16550478|NCT00562978|40478619|FG000|Overall Study|Patient had imaging dose only|1|||
16229477|NCT00822237|39320457|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
16229478|NCT00822237|39320456|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
16550479|NCT00562978|40478620|FG001|Overall Study|Patient had imaging dose only|11|||
16229479|NCT00822237|39320457|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
16229480|NCT00822237|39320456|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
16412220|NCT01048866|39992098|FG001|Overall Study|Physician Decision|0|||
16412221|NCT01048866|39992097|FG000|Overall Study|Withdrawal by Subject|0|||
16412222|NCT01048866|39992098|FG001|Overall Study|Withdrawal by Subject|2|||
16550480|NCT01216293|40478621|FG000|Main Study|Adverse Event|1|||
16550481|NCT01216293|40478622|FG001|Main Study|Adverse Event|4|||
16412223|NCT01048866|39992097|FG000|Overall Study|Lost to Follow-up|0|||
16412224|NCT01048866|39992098|FG001|Overall Study|Lost to Follow-up|2|||
16412225|NCT01048866|39992097|FG000|Overall Study|Other|1|||
16412226|NCT01048866|39992098|FG001|Overall Study|Other|1|||
16550482|NCT01216293|40478623|FG002|Main Study|Adverse Event|2|||
16550483|NCT01216293|40478621|FG000|Main Study|Major Protocol Deviation|1|||
16118081|NCT02325739|38919936|FG004|Phase II Part|Physician Decision|0|||
16118082|NCT02325739|38919937|FG005|Phase II Part|Physician Decision|0|||
16118083|NCT02325739|38919938|FG006|Phase II Part|Physician Decision|0|||
16118084|NCT02325739|38919939|FG007|Phase II Part|Physician Decision|0|||
16118085|NCT02325739|38919940|FG008|Phase II Part|Physician Decision|0|||
16118086|NCT02325739|38919941|FG009|Phase II Part|Physician Decision|1|||
16118087|NCT02325739|38919942|FG010|Phase II Part|Physician Decision|0|||
16229481|NCT00822237|39320457|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
16229482|NCT00822237|39320456|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
16118088|NCT02325739|38919932|FG000|Phase II Part|Progressive disease|0|||
16118089|NCT02325739|38919933|FG001|Phase II Part|Progressive disease|0|||
16118090|NCT02325739|38919934|FG002|Phase II Part|Progressive disease|0|||
16118091|NCT02325739|38919935|FG003|Phase II Part|Progressive disease|0|||
16118092|NCT02325739|38919936|FG004|Phase II Part|Progressive disease|0|||
16118093|NCT02325739|38919937|FG005|Phase II Part|Progressive disease|0|||
16118094|NCT02325739|38919938|FG006|Phase II Part|Progressive disease|0|||
16118095|NCT02325739|38919939|FG007|Phase II Part|Progressive disease|0|||
16229483|NCT00822237|39320457|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
16348041|NCT04378569|39762126|FG002|Overall Study|Withdrawal by Subject|7|||
16412227|NCT01657760|39992099|FG000|Overall Study|Withdrawal by Subject|0|||
16412228|NCT01657760|39992100|FG001|Overall Study|Withdrawal by Subject|0|||
16412229|NCT01657760|39992101|FG002|Overall Study|Withdrawal by Subject|0|||
16412230|NCT01657760|39992102|FG003|Overall Study|Withdrawal by Subject|1|||
16348042|NCT04378569|39762127|FG003|Overall Study|Withdrawal by Subject|4|||
16348043|NCT04378569|39762128|FG004|Overall Study|Withdrawal by Subject|5|||
16348044|NCT04378569|39762129|FG005|Overall Study|Withdrawal by Subject|4|||
16348045|NCT04378569|39762124|FG000|Overall Study|Lack of response|0|||
16348046|NCT04378569|39762125|FG001|Overall Study|Lack of response|0|||
16348047|NCT04378569|39762126|FG002|Overall Study|Lack of response|1|||
16348048|NCT04378569|39762127|FG003|Overall Study|Lack of response|0|||
16348049|NCT04378569|39762128|FG004|Overall Study|Lack of response|1|||
16348050|NCT04378569|39762129|FG005|Overall Study|Lack of response|1|||
16348051|NCT02175121|39762139|FG000|Overall Study|Lack of Efficacy|1|||
16550484|NCT01216293|40478622|FG001|Main Study|Major Protocol Deviation|0|||
16348052|NCT02175121|39762140|FG001|Overall Study|Lack of Efficacy|0|||
16348053|NCT02175121|39762141|FG002|Overall Study|Lack of Efficacy|0|||
16348054|NCT02175121|39762142|FG003|Overall Study|Lack of Efficacy|0|||
16348055|NCT02175121|39762143|FG004|Overall Study|Lack of Efficacy|0|||
16348056|NCT02175121|39762139|FG000|Overall Study|Lost to Follow-up|0|||
16412231|NCT01657760|39992099|FG000|Overall Study|Physician Decision|1|||
16412232|NCT01657760|39992100|FG001|Overall Study|Physician Decision|1|||
16412233|NCT01657760|39992101|FG002|Overall Study|Physician Decision|1|||
16412234|NCT01657760|39992102|FG003|Overall Study|Physician Decision|2|||
16412235|NCT01873729|39992103|FG000|Overall Study|Withdrawal by Subject|1|||
16412236|NCT00530920|39992111|FG000|Overall Study|Randomized but not treated|0|||
16348057|NCT02175121|39762140|FG001|Overall Study|Lost to Follow-up|1|||
16348058|NCT02175121|39762141|FG002|Overall Study|Lost to Follow-up|0|||
16412237|NCT00530920|39992112|FG001|Overall Study|Randomized but not treated|2|||
16412238|NCT00530920|39992113|FG002|Overall Study|Randomized but not treated|0|||
16412239|NCT00530920|39992111|FG000|Overall Study|Adverse Event|0|||
16412240|NCT00530920|39992112|FG001|Overall Study|Adverse Event|0|||
16412241|NCT00530920|39992113|FG002|Overall Study|Adverse Event|3|||
16412242|NCT00530920|39992111|FG000|Overall Study|Withdrawal by Subject|0|||
16412243|NCT00530920|39992112|FG001|Overall Study|Withdrawal by Subject|0|||
16412244|NCT00530920|39992113|FG002|Overall Study|Withdrawal by Subject|1|||
16412245|NCT00430937|39992115|FG000|Overall Study|Adverse Event|3|||
16412246|NCT00430937|39992116|FG001|Overall Study|Adverse Event|8|||
16412247|NCT00430937|39992115|FG000|Overall Study|Death|0|||
16412248|NCT00430937|39992116|FG001|Overall Study|Death|1|||
16412249|NCT00430937|39992115|FG000|Overall Study|Lost to Follow-up|6|||
16412250|NCT00430937|39992116|FG001|Overall Study|Lost to Follow-up|6|||
16550485|NCT01216293|40478623|FG002|Main Study|Major Protocol Deviation|1|||
16550486|NCT01216293|40478621|FG000|Main Study|Lost to Follow-up|3|||
16550487|NCT01216293|40478622|FG001|Main Study|Lost to Follow-up|1|||
16550488|NCT01216293|40478623|FG002|Main Study|Lost to Follow-up|0|||
16550489|NCT01216293|40478621|FG000|Main Study|Voluntary Withdrawal|2|||
16550490|NCT01216293|40478622|FG001|Main Study|Voluntary Withdrawal|2|||
16550491|NCT01216293|40478623|FG002|Main Study|Voluntary Withdrawal|2|||
16550492|NCT01216293|40478621|FG000|Main Study|Other Reason Not Specified|0|||
16550493|NCT01216293|40478622|FG001|Main Study|Other Reason Not Specified|1|||
16550494|NCT01216293|40478623|FG002|Main Study|Other Reason Not Specified|1|||
16550495|NCT01216293|40478621|FG000|Main Study|Randomized, Not Treated|1|||
16550496|NCT01216293|40478622|FG001|Main Study|Randomized, Not Treated|0|||
16550497|NCT01216293|40478623|FG002|Main Study|Randomized, Not Treated|0|||
16550498|NCT01216293|40478621|FG000|Calcium Absorption Substudy|Adverse Event|0|||
16550499|NCT01216293|40478622|FG001|Calcium Absorption Substudy|Adverse Event|2|||
16550500|NCT01216293|40478623|FG002|Calcium Absorption Substudy|Adverse Event|0|||
16550501|NCT01216293|40478621|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
16550502|NCT01216293|40478622|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
16550503|NCT01216293|40478623|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
16550504|NCT01216293|40478621|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
16118096|NCT02325739|38919940|FG008|Phase II Part|Progressive disease|22|||
16412251|NCT00430937|39992115|FG000|Overall Study|Withdrawal by Subject|5|||
16118097|NCT02325739|38919941|FG009|Phase II Part|Progressive disease|29|||
16118098|NCT02325739|38919942|FG010|Phase II Part|Progressive disease|18|||
16348059|NCT02175121|39762142|FG003|Overall Study|Lost to Follow-up|1|||
16412252|NCT00430937|39992116|FG001|Overall Study|Withdrawal by Subject|2|||
16412253|NCT00430937|39992115|FG000|Overall Study|Protocol Violation|3|||
16412254|NCT00430937|39992116|FG001|Overall Study|Protocol Violation|2|||
16412255|NCT00430937|39992115|FG000|Overall Study|Lack of Efficacy|6|||
16412256|NCT00430937|39992116|FG001|Overall Study|Lack of Efficacy|5|||
16412257|NCT00430937|39992115|FG000|Overall Study|Inappropriate enrollment|2|||
16412258|NCT00430937|39992116|FG001|Overall Study|Inappropriate enrollment|1|||
16412259|NCT00430937|39992115|FG000|Overall Study|Administrative reasons|1|||
16550505|NCT01216293|40478622|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
16550506|NCT01216293|40478623|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
16550507|NCT01112514|40478625|FG000|Overall Study|Lost to Follow-up|1|||
16550508|NCT00672958|40478626|FG000|Overall Study|Adverse Event|11|||
16550509|NCT00672958|40478627|FG001|Overall Study|Adverse Event|9|||
16550510|NCT00672958|40478626|FG000|Overall Study|Lack of Efficacy|6|||
16550511|NCT00672958|40478627|FG001|Overall Study|Lack of Efficacy|11|||
16229484|NCT00489411|39320458|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
16229485|NCT00489411|39320459|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
16229486|NCT00489411|39320458|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
16229487|NCT00489411|39320459|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
16229488|NCT00489411|39320458|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
16229489|NCT00489411|39320459|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
16229490|NCT00489411|39320458|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
16550512|NCT00672958|40478626|FG000|Overall Study|Non-compliance with study drug|2|||
16550513|NCT00672958|40478627|FG001|Overall Study|Non-compliance with study drug|3|||
16550514|NCT00672958|40478626|FG000|Overall Study|Protocol deviations|11|||
16118099|NCT02325739|38919932|FG000|Phase II Part|Subject/guardian decision|0|||
16118100|NCT02325739|38919933|FG001|Phase II Part|Subject/guardian decision|0|||
16118101|NCT02325739|38919934|FG002|Phase II Part|Subject/guardian decision|0|||
16229491|NCT00489411|39320459|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
16229492|NCT00489411|39320458|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
16229493|NCT00489411|39320459|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
16412260|NCT00430937|39992116|FG001|Overall Study|Administrative reasons|0|||
16412261|NCT00430937|39992115|FG000|Overall Study|Protocol discontinuation criteria met|1|||
16412262|NCT00430937|39992116|FG001|Overall Study|Protocol discontinuation criteria met|2|||
16412263|NCT00430937|39992115|FG000|Overall Study|Unable to classify|0|||
16412264|NCT00430937|39992116|FG001|Overall Study|Unable to classify|1|||
16412265|NCT03262116|39992118|FG000|Overall Study|Physician Decision|0|||
16412266|NCT03262116|39992119|FG001|Overall Study|Physician Decision|2|||
16412267|NCT03262116|39992120|FG002|Overall Study|Physician Decision|1|||
16412268|NCT03262116|39992121|FG003|Overall Study|Physician Decision|1|||
16412269|NCT03262116|39992122|FG004|Overall Study|Physician Decision|1|||
16412270|NCT03262116|39992123|FG005|Overall Study|Physician Decision|2|||
16412271|NCT00199888|39992124|FG000|Overall Study|Lost to Follow-up|1|||
16550515|NCT00672958|40478627|FG001|Overall Study|Protocol deviations|5|||
16550516|NCT00672958|40478626|FG000|Overall Study|Voluntary withdrawal|12|||
16412272|NCT01533922|39992125|FG000|Overall Study|Adverse Event|5|||
16412273|NCT01533922|39992126|FG001|Overall Study|Adverse Event|8|||
16550517|NCT00672958|40478627|FG001|Overall Study|Voluntary withdrawal|8|||
16118102|NCT02325739|38919935|FG003|Phase II Part|Subject/guardian decision|0|||
16118103|NCT02325739|38919936|FG004|Phase II Part|Subject/guardian decision|0|||
16118104|NCT02325739|38919937|FG005|Phase II Part|Subject/guardian decision|0|||
16118105|NCT02325739|38919938|FG006|Phase II Part|Subject/guardian decision|0|||
16118106|NCT02325739|38919939|FG007|Phase II Part|Subject/guardian decision|0|||
16118107|NCT02325739|38919940|FG008|Phase II Part|Subject/guardian decision|4|||
16118108|NCT02325739|38919941|FG009|Phase II Part|Subject/guardian decision|1|||
16118109|NCT02325739|38919942|FG010|Phase II Part|Subject/guardian decision|1|||
16118110|NCT01943851|38919943|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118111|NCT01943851|38919944|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118112|NCT01943851|38919945|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118113|NCT01943851|38919946|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
16118114|NCT01943851|38919947|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118115|NCT01943851|38919948|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118116|NCT01943851|38919949|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
16118117|NCT01943851|38919950|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
16118118|NCT01943851|38919951|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
16118119|NCT01943851|38919952|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118120|NCT01943851|38919953|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118121|NCT01943851|38919954|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118122|NCT01943851|38919955|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118123|NCT01943851|38919956|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118124|NCT01943851|38919957|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118125|NCT01943851|38919958|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118126|NCT01943851|38919959|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118127|NCT01943851|38919960|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
16118128|NCT01943851|38919943|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16550518|NCT00672958|40478626|FG000|Overall Study|Lost to Follow-up|22|||
16550519|NCT00672958|40478627|FG001|Overall Study|Lost to Follow-up|17|||
16550520|NCT00672958|40478626|FG000|Overall Study|Reason not specified|0|||
16550521|NCT00672958|40478627|FG001|Overall Study|Reason not specified|3|||
16550522|NCT00399763|40478628|FG000|Overall Study|Lost to Follow-up|2|||
16550523|NCT00399763|40478629|FG001|Overall Study|Lost to Follow-up|3|||
16550524|NCT03469349|40478636|FG000|Overall Study|Withdrawal by Subject|1|||
16550525|NCT03469349|40478637|FG001|Overall Study|Withdrawal by Subject|3|||
16550526|NCT03469349|40478636|FG000|Overall Study|Progressive Disease|0|||
16118129|NCT01943851|38919944|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118130|NCT01943851|38919945|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118131|NCT01943851|38919946|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118132|NCT01943851|38919947|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
16118133|NCT01943851|38919948|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16348060|NCT02175121|39762143|FG004|Overall Study|Lost to Follow-up|0|||
16348061|NCT02175121|39762139|FG000|Overall Study|Personal emergency|0|||
16348062|NCT02175121|39762140|FG001|Overall Study|Personal emergency|0|||
16550527|NCT03469349|40478637|FG001|Overall Study|Progressive Disease|1|||
16550528|NCT03469349|40478636|FG000|Overall Study|Lost to Follow-up|2|||
16550529|NCT03469349|40478637|FG001|Overall Study|Lost to Follow-up|2|||
16550530|NCT03469349|40478636|FG000|Overall Study|Adverse Event|2|||
16550531|NCT03469349|40478637|FG001|Overall Study|Adverse Event|4|||
16550532|NCT01984424|40478643|FG000|Overall Study|Withdrawal by Subject|3|||
16348063|NCT02175121|39762141|FG002|Overall Study|Personal emergency|0|||
16348064|NCT02175121|39762142|FG003|Overall Study|Personal emergency|0|||
16348065|NCT02175121|39762143|FG004|Overall Study|Personal emergency|1|||
16412274|NCT01533922|39992127|FG002|Overall Study|Adverse Event|6|||
16412275|NCT01533922|39992128|FG003|Overall Study|Adverse Event|3|||
16412276|NCT01533922|39992129|FG004|Overall Study|Adverse Event|4|||
16412277|NCT01533922|39992125|FG000|Overall Study|Lack of Efficacy|0|||
16412278|NCT01533922|39992126|FG001|Overall Study|Lack of Efficacy|0|||
16550533|NCT01984424|40478644|FG001|Overall Study|Withdrawal by Subject|5|||
16348066|NCT02175121|39762139|FG000|Overall Study|Schedule conflict|0|||
16348067|NCT02175121|39762140|FG001|Overall Study|Schedule conflict|0|||
16348068|NCT02175121|39762141|FG002|Overall Study|Schedule conflict|1|||
16412279|NCT01533922|39992127|FG002|Overall Study|Lack of Efficacy|1|||
16550534|NCT01984424|40478643|FG000|Overall Study|Sponsor Decision|0|||
16550535|NCT01984424|40478644|FG001|Overall Study|Sponsor Decision|1|||
16118134|NCT01943851|38919949|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118135|NCT01943851|38919950|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
16118136|NCT01943851|38919951|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118137|NCT01943851|38919952|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118138|NCT01943851|38919953|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118139|NCT01943851|38919954|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118140|NCT01943851|38919955|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118141|NCT01943851|38919956|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16412280|NCT01533922|39992128|FG003|Overall Study|Lack of Efficacy|0|||
16550536|NCT01984424|40478643|FG000|Overall Study|Lost to Follow-up|0|||
16118142|NCT01943851|38919957|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118143|NCT01943851|38919958|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118144|NCT01943851|38919959|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118145|NCT01943851|38919960|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
16118146|NCT01943851|38919943|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118147|NCT01943851|38919944|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118148|NCT01943851|38919945|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118149|NCT01943851|38919946|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118150|NCT01943851|38919947|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118151|NCT01943851|38919948|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118152|NCT01943851|38919949|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118153|NCT01943851|38919950|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118154|NCT01943851|38919951|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118155|NCT01943851|38919952|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118156|NCT01943851|38919953|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118157|NCT01943851|38919954|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118158|NCT01943851|38919955|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118159|NCT01943851|38919956|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
16118160|NCT01943851|38919957|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118161|NCT01943851|38919958|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118162|NCT01943851|38919959|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118163|NCT01943851|38919960|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
16118164|NCT01943851|38919943|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118165|NCT01943851|38919944|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118166|NCT01943851|38919945|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118167|NCT01943851|38919946|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118168|NCT01943851|38919947|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118169|NCT01943851|38919948|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118170|NCT01943851|38919949|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118171|NCT01943851|38919950|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118172|NCT01943851|38919951|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118173|NCT01943851|38919952|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118174|NCT01943851|38919953|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118175|NCT01943851|38919954|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118176|NCT01943851|38919955|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118177|NCT01943851|38919956|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118178|NCT01943851|38919957|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118179|NCT01943851|38919958|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
16118180|NCT01943851|38919959|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118181|NCT01943851|38919960|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
16118182|NCT01943851|38919943|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118183|NCT01943851|38919944|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118184|NCT01943851|38919945|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118185|NCT01943851|38919946|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118186|NCT01943851|38919947|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118187|NCT01943851|38919948|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16229494|NCT01243762|39320465|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
16229495|NCT01243762|39320466|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
16229496|NCT01243762|39320467|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
16229497|NCT01243762|39320468|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
16229498|NCT01243762|39320469|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
16229499|NCT01243762|39320470|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
16229500|NCT01243762|39320471|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
16229501|NCT01243762|39320465|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
16229502|NCT01243762|39320466|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
16229503|NCT01243762|39320467|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
16229504|NCT01243762|39320468|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
16229505|NCT01243762|39320469|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
16229506|NCT01243762|39320470|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
16118188|NCT01943851|38919949|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118189|NCT01943851|38919950|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118190|NCT01943851|38919951|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118191|NCT01943851|38919952|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118192|NCT01943851|38919953|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118193|NCT01943851|38919954|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118194|NCT01943851|38919955|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118195|NCT01943851|38919956|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118196|NCT01943851|38919957|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
16118197|NCT01943851|38919958|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
16229507|NCT01243762|39320471|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
16118198|NCT01943851|38919959|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
16118199|NCT01943851|38919960|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
16118200|NCT00604825|38919963|FG000|Overall Study|Adverse Event|2|||
16118201|NCT00604825|38919964|FG001|Overall Study|Adverse Event|6|||
16118202|NCT00604825|38919965|FG002|Overall Study|Adverse Event|7|||
16118203|NCT00604825|38919966|FG003|Overall Study|Adverse Event|4|||
16118204|NCT00604825|38919963|FG000|Overall Study|Lost to Follow-up|0|||
16118205|NCT00604825|38919964|FG001|Overall Study|Lost to Follow-up|3|||
16118206|NCT00604825|38919965|FG002|Overall Study|Lost to Follow-up|1|||
16118207|NCT00604825|38919966|FG003|Overall Study|Lost to Follow-up|0|||
16118208|NCT00604825|38919963|FG000|Overall Study|Protocol Violation|0|||
16118209|NCT00604825|38919964|FG001|Overall Study|Protocol Violation|1|||
16118210|NCT00604825|38919965|FG002|Overall Study|Protocol Violation|0|||
16118211|NCT00604825|38919966|FG003|Overall Study|Protocol Violation|0|||
16118212|NCT00604825|38919963|FG000|Overall Study|Withdrawal by Subject|4|||
16118213|NCT00604825|38919964|FG001|Overall Study|Withdrawal by Subject|3|||
16118214|NCT00604825|38919965|FG002|Overall Study|Withdrawal by Subject|5|||
16118215|NCT00604825|38919966|FG003|Overall Study|Withdrawal by Subject|5|||
16118216|NCT00604825|38919963|FG000|Overall Study|Lack of Efficacy|3|||
16118217|NCT00604825|38919964|FG001|Overall Study|Lack of Efficacy|2|||
16118218|NCT00604825|38919965|FG002|Overall Study|Lack of Efficacy|1|||
16118219|NCT00604825|38919966|FG003|Overall Study|Lack of Efficacy|0|||
16118220|NCT00604825|38919963|FG000|Overall Study|Did not meet eligibility criteria|0|||
16118221|NCT00604825|38919964|FG001|Overall Study|Did not meet eligibility criteria|0|||
16118222|NCT00604825|38919965|FG002|Overall Study|Did not meet eligibility criteria|2|||
16118223|NCT00604825|38919966|FG003|Overall Study|Did not meet eligibility criteria|0|||
16118224|NCT00604825|38919963|FG000|Overall Study|Physician Decision|0|||
16118225|NCT00604825|38919964|FG001|Overall Study|Physician Decision|0|||
16118226|NCT00604825|38919965|FG002|Overall Study|Physician Decision|0|||
16118227|NCT00604825|38919966|FG003|Overall Study|Physician Decision|1|||
16118228|NCT00604825|38919963|FG000|Overall Study|Exclusion criterion met|0|||
16118229|NCT00604825|38919964|FG001|Overall Study|Exclusion criterion met|0|||
16118230|NCT00604825|38919965|FG002|Overall Study|Exclusion criterion met|0|||
16118231|NCT00604825|38919966|FG003|Overall Study|Exclusion criterion met|1|||
16118232|NCT01133418|38919967|FG000|Overall Study|Lost to Follow-up|5|||
16118233|NCT01133418|38919968|FG001|Overall Study|Lost to Follow-up|6|||
16118234|NCT00737698|38919969|FG000|Overall Study|Withdrawal by Subject|6|||
16118235|NCT00737698|38919970|FG001|Overall Study|Withdrawal by Subject|5|||
16118236|NCT00737698|38919971|FG002|Overall Study|Withdrawal by Subject|3|||
16118237|NCT00737698|38919969|FG000|Overall Study|Death|0|||
16118238|NCT00737698|38919970|FG001|Overall Study|Death|0|||
16118239|NCT00737698|38919971|FG002|Overall Study|Death|1|||
16118240|NCT02406677|38919972|FG000|Overall Study|Death|16|||
16118241|NCT02406677|38919973|FG001|Overall Study|Death|8|||
16118242|NCT02406677|38919972|FG000|Overall Study|Discharged without P2Y12|1|||
16118243|NCT02406677|38919973|FG001|Overall Study|Discharged without P2Y12|3|||
16118244|NCT02406677|38919972|FG000|Overall Study|Discharged on prasugrel|283|||
16118245|NCT02406677|38919973|FG001|Overall Study|Discharged on prasugrel|587|||
16118246|NCT02406677|38919972|FG000|Overall Study|Withdrawal by Subject|1|||
16118247|NCT02406677|38919973|FG001|Overall Study|Withdrawal by Subject|0|||
16118248|NCT00245960|38919976|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
16118249|NCT00245960|38919977|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
16118250|NCT00245960|38919976|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
16118251|NCT00245960|38919977|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
16118252|NCT00245960|38919976|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
16118253|NCT00245960|38919977|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
16118254|NCT00245960|38919976|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
16118255|NCT00245960|38919977|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
16118256|NCT00245960|38919976|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
16229508|NCT01243762|39320465|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
16229509|NCT01243762|39320466|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
16229510|NCT01243762|39320467|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
16550537|NCT01984424|40478644|FG001|Overall Study|Lost to Follow-up|1|||
16550538|NCT01233609|40478645|FG000|Overall Study|Death|1|||
16550539|NCT01233609|40478646|FG001|Overall Study|Death|0|||
16550540|NCT01233609|40478645|FG000|Overall Study|Lost to Follow-up|3|||
16550541|NCT01233609|40478646|FG001|Overall Study|Lost to Follow-up|1|||
16550542|NCT01233609|40478645|FG000|Overall Study|Adverse Event|2|||
16118257|NCT00245960|38919977|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
16118258|NCT00245960|38919976|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
16118259|NCT00245960|38919977|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
16118260|NCT00245960|38919976|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
16118261|NCT00245960|38919977|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
16118262|NCT00245960|38919976|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
16173306|NCT04134494|39111175|FG000|Overall Study|Lost to Follow-up|2|||
16550543|NCT01233609|40478646|FG001|Overall Study|Adverse Event|1|||
16550544|NCT01233609|40478645|FG000|Overall Study|Withdrawal by Subject|3|||
16118263|NCT00245960|38919977|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
16118264|NCT00245960|38919976|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
16118265|NCT00245960|38919977|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
16118266|NCT00245960|38919976|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
16118267|NCT00245960|38919977|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
16118268|NCT00245960|38919976|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
16118269|NCT00245960|38919977|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
16118270|NCT00245960|38919976|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
16118271|NCT00245960|38919977|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
16118272|NCT01754753|38919978|FG000|Overall Study|Study close|43|||
16118273|NCT01754753|38919979|FG001|Overall Study|Study close|44|||
16118274|NCT01754753|38919978|FG000|Overall Study|Lost to Follow-up|9|||
16118275|NCT01754753|38919979|FG001|Overall Study|Lost to Follow-up|5|||
16118276|NCT00401258|38919987|FG000|Overall Study|Adverse Event|7|||
16118277|NCT03548220|38919988|FG000|Overall Study|Lost to Follow-up|1|||
16118278|NCT03548220|38919989|FG001|Overall Study|Lost to Follow-up|0|||
16118279|NCT03548220|38919990|FG002|Overall Study|Lost to Follow-up|0|||
16550545|NCT01233609|40478646|FG001|Overall Study|Withdrawal by Subject|0|||
16118280|NCT03548220|38919991|FG003|Overall Study|Lost to Follow-up|0|||
16118281|NCT00243074|38919998|FG000|Overall Study|Ineligible|6|||
16118282|NCT00243074|38919998|FG000|Overall Study|Adverse Event|6|||
16118283|NCT00243074|38919998|FG000|Overall Study|Withdrawal by Subject|2|||
16118284|NCT00243074|38919998|FG000|Overall Study|Lack of Efficacy|36|||
16118285|NCT00243074|38919998|FG000|Overall Study|Death|2|||
16550546|NCT00579982|40478648|FG000|Overall Study|Adverse Event|4|||
16550547|NCT00579982|40478648|FG000|Overall Study|Protocol Violation|4|||
16550548|NCT01263106|40478649|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
16550549|NCT01263106|40478650|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
16118286|NCT00243074|38919998|FG000|Overall Study|not protocol specified|1|||
16118287|NCT00243074|38919998|FG000|Overall Study|Did not receive any treatment|1|||
16118288|NCT01920477|38919999|FG000|Overall Study|Adverse Event|0|||
16118289|NCT01920477|38920000|FG001|Overall Study|Adverse Event|1|||
16118290|NCT01920477|38919999|FG000|Overall Study|Lack of Efficacy|1|||
16118291|NCT01920477|38920000|FG001|Overall Study|Lack of Efficacy|0|||
16118292|NCT01920477|38919999|FG000|Overall Study|Study closed/terminated|14|||
16118293|NCT01920477|38920000|FG001|Overall Study|Study closed/terminated|15|||
16118294|NCT01920477|38919999|FG000|Overall Study|Withdrawal by Subject|0|||
16118295|NCT01920477|38920000|FG001|Overall Study|Withdrawal by Subject|1|||
16118296|NCT03338296|38920005|FG000|Overall Study|Adverse Event|0|||
16550550|NCT00171873|40478652|FG000|Overall Study|Withdrawal by Subject|4|||
16550551|NCT00171873|40478653|FG001|Overall Study|Withdrawal by Subject|2|||
16550552|NCT00171873|40478652|FG000|Overall Study|Adverse Event|5|||
16550553|NCT00171873|40478653|FG001|Overall Study|Adverse Event|0|||
16550554|NCT00171873|40478652|FG000|Overall Study|Switched to Octreotide|0|||
16550555|NCT00171873|40478653|FG001|Overall Study|Switched to Octreotide|1|||
16118297|NCT03338296|38920006|FG001|Overall Study|Adverse Event|1|||
16118298|NCT03338296|38920005|FG000|Overall Study|Withdrawal by Subject|14|||
16118299|NCT03338296|38920006|FG001|Overall Study|Withdrawal by Subject|13|||
16118300|NCT03338296|38920005|FG000|Overall Study|Lost to Follow-up|10|||
16118301|NCT03338296|38920006|FG001|Overall Study|Lost to Follow-up|10|||
16118302|NCT03338296|38920005|FG000|Overall Study|Study Terminated by Sponsor|77|||
16550556|NCT01719237|40478655|FG000|Overall Study|Physician Decision|0|||
16118303|NCT03338296|38920006|FG001|Overall Study|Study Terminated by Sponsor|76|||
16550557|NCT01719237|40478656|FG001|Overall Study|Physician Decision|1|||
16550558|NCT02756832|40478657|FG000|Overall Study|Lost for Observation after Baseline|6|||
16550559|NCT02756832|40478657|FG000|Overall Study|Lost for Observation|13|||
16550560|NCT02756832|40478657|FG000|Overall Study|Patient's Unwillingness|12|||
16550561|NCT02756832|40478657|FG000|Overall Study|Insufficient Efficacy|2|||
16118304|NCT03338296|38920005|FG000|Overall Study|Other|2|||
16118305|NCT03338296|38920006|FG001|Overall Study|Other|7|||
16118306|NCT03338296|38920005|FG000|Overall Study|Missing|0|||
16118307|NCT03338296|38920006|FG001|Overall Study|Missing|1|||
16348069|NCT02175121|39762142|FG003|Overall Study|Schedule conflict|0|||
16550562|NCT02756832|40478657|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
16550563|NCT02756832|40478657|FG000|Overall Study|Reason not Specified|9|||
16118308|NCT00702962|38920007|FG000|Overall Study|Progressive disease|0|||
16118309|NCT00702962|38920008|FG001|Overall Study|Progressive disease|1|||
16118310|NCT00702962|38920007|FG000|Overall Study|Hospitalized for other health disorder|1|||
16118311|NCT00702962|38920008|FG001|Overall Study|Hospitalized for other health disorder|0|||
16118312|NCT02071290|38920009|FG000|Overall Study|Death|1|||
16118313|NCT02071290|38920010|FG001|Overall Study|Death|0|||
16118314|NCT02071290|38920009|FG000|Overall Study|Withdrawal by Subject|0|||
16118315|NCT02071290|38920010|FG001|Overall Study|Withdrawal by Subject|1|||
16118316|NCT02071290|38920009|FG000|Overall Study|Protocol Violation|3|||
16348070|NCT02175121|39762143|FG004|Overall Study|Schedule conflict|0|||
16550564|NCT02756832|40478657|FG000|Overall Study|Protocol Deviation|10|||
16550565|NCT03579290|40478658|FG000|Overall Study|Lost to Follow-up|9|||
16550566|NCT00423293|40478659|FG000|Overall Study|Ineligible / No protocol treatment|11|||
16550567|NCT01781390|40478667|FG000|Overall Study|Withdrawal of Consent|0|||
16550568|NCT01781390|40478668|FG001|Overall Study|Withdrawal of Consent|3|||
16550569|NCT01781390|40478669|FG002|Overall Study|Withdrawal of Consent|1|||
16550570|NCT01781390|40478667|FG000|Overall Study|Lost to Follow-up|1|||
16550571|NCT01781390|40478668|FG001|Overall Study|Lost to Follow-up|1|||
16550572|NCT01781390|40478669|FG002|Overall Study|Lost to Follow-up|1|||
16550573|NCT01781390|40478667|FG000|Overall Study|Adverse Event|1|||
16550574|NCT01781390|40478668|FG001|Overall Study|Adverse Event|2|||
16550575|NCT01781390|40478669|FG002|Overall Study|Adverse Event|1|||
16550576|NCT01781390|40478667|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
16550577|NCT01781390|40478668|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
16550578|NCT01781390|40478669|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
16550579|NCT03285295|40478670|FG000|Alinity s HBsAg|Protocol Violation|11|||
16550580|NCT03285295|40478671|FG001|Alinity s HBsAg|Protocol Violation|0|||
16550581|NCT03285295|40478672|FG002|Alinity s HBsAg|Protocol Violation|0|||
16550582|NCT03285295|40478673|FG003|Alinity s HBsAg|Protocol Violation|0|||
16550583|NCT03285295|40478674|FG004|Alinity s HBsAg|Protocol Violation|0|||
16550584|NCT03285295|40478670|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
16550585|NCT03285295|40478671|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
16550586|NCT03285295|40478672|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
16550587|NCT03285295|40478673|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
16550588|NCT03285295|40478674|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
16550589|NCT03285295|40478670|FG000|Alinity s HBsAg|No Results Generated|74|||
16550590|NCT03285295|40478671|FG001|Alinity s HBsAg|No Results Generated|6|||
16550591|NCT03285295|40478672|FG002|Alinity s HBsAg|No Results Generated|0|||
16550592|NCT03285295|40478673|FG003|Alinity s HBsAg|No Results Generated|0|||
16550593|NCT03285295|40478674|FG004|Alinity s HBsAg|No Results Generated|0|||
16550594|NCT03285295|40478670|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
16550595|NCT03285295|40478671|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
16550596|NCT03285295|40478672|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
16550597|NCT03285295|40478673|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
16550598|NCT03285295|40478674|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
16550599|NCT03285295|40478670|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
16550600|NCT03285295|40478671|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
16550601|NCT03285295|40478672|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
16550602|NCT03285295|40478673|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
16550603|NCT03285295|40478674|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
16550604|NCT03285295|40478670|FG000|Alinity s HTLV I/II|No Results Generated|70|||
16550605|NCT03285295|40478671|FG001|Alinity s HTLV I/II|No Results Generated|0|||
16550606|NCT03285295|40478672|FG002|Alinity s HTLV I/II|No Results Generated|0|||
16550607|NCT03285295|40478673|FG003|Alinity s HTLV I/II|No Results Generated|0|||
16550608|NCT03285295|40478674|FG004|Alinity s HTLV I/II|No Results Generated|0|||
16550609|NCT03285295|40478670|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
16550610|NCT03285295|40478671|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
16550611|NCT03285295|40478672|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
16550612|NCT03285295|40478673|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
16550613|NCT03285295|40478674|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
16550614|NCT03285295|40478670|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
16550615|NCT03285295|40478671|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
16550616|NCT03285295|40478672|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
16550617|NCT03285295|40478673|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
16550618|NCT03285295|40478674|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
16550619|NCT03285295|40478670|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
16550620|NCT03285295|40478671|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
16550621|NCT03285295|40478672|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
16550622|NCT03285295|40478673|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
16550623|NCT03285295|40478674|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
16550624|NCT03285295|40478670|FG000|Alinity s Anti-HCV|No Results Generated|71|||
16550625|NCT03285295|40478671|FG001|Alinity s Anti-HCV|No Results Generated|0|||
16550626|NCT03285295|40478672|FG002|Alinity s Anti-HCV|No Results Generated|0|||
16550627|NCT03285295|40478673|FG003|Alinity s Anti-HCV|No Results Generated|0|||
16550628|NCT03285295|40478674|FG004|Alinity s Anti-HCV|No Results Generated|0|||
16550629|NCT03285295|40478670|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
16550630|NCT03285295|40478671|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
16550631|NCT03285295|40478672|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
16550632|NCT03285295|40478673|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
16550633|NCT03285295|40478674|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
16550634|NCT03285295|40478670|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
16550635|NCT03285295|40478671|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
16550636|NCT03285295|40478672|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
16550637|NCT03285295|40478673|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
16550638|NCT03285295|40478674|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
16550639|NCT03285295|40478670|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
16550640|NCT03285295|40478671|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
16550641|NCT03285295|40478672|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
16550642|NCT03285295|40478673|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
16550643|NCT03285295|40478674|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
16550644|NCT03285295|40478670|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
16550645|NCT03285295|40478671|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
16550646|NCT03285295|40478672|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
16550647|NCT03285295|40478673|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
16550648|NCT03285295|40478674|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
16550649|NCT03285295|40478670|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
16550650|NCT03285295|40478671|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
16550651|NCT03285295|40478672|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
16550652|NCT03285295|40478673|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
16550653|NCT03285295|40478674|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
16550654|NCT03285295|40478670|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
16550655|NCT03285295|40478671|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
16550656|NCT03285295|40478672|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
16550657|NCT03285295|40478673|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
16550658|NCT03285295|40478674|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
16550659|NCT03285295|40478670|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
16550660|NCT03285295|40478671|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
16550661|NCT03285295|40478672|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
16550662|NCT03285295|40478673|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
16550663|NCT03285295|40478674|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
16550664|NCT03285295|40478670|FG000|Alinity s Anti-HBc|No Results Generated|70|||
16550665|NCT03285295|40478671|FG001|Alinity s Anti-HBc|No Results Generated|0|||
16550666|NCT03285295|40478672|FG002|Alinity s Anti-HBc|No Results Generated|0|||
16550667|NCT03285295|40478673|FG003|Alinity s Anti-HBc|No Results Generated|0|||
16550668|NCT03285295|40478674|FG004|Alinity s Anti-HBc|No Results Generated|0|||
16550669|NCT03285295|40478670|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
16550670|NCT03285295|40478671|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
16550671|NCT03285295|40478672|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
16550672|NCT03285295|40478673|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
16550673|NCT03285295|40478674|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
16550674|NCT03285295|40478670|FG000|Alinity s Chagas|Protocol Violation|76|||
16550675|NCT03285295|40478671|FG001|Alinity s Chagas|Protocol Violation|0|||
16550676|NCT03285295|40478672|FG002|Alinity s Chagas|Protocol Violation|0|||
16118317|NCT02071290|38920010|FG001|Overall Study|Protocol Violation|5|||
16118318|NCT02071290|38920009|FG000|Overall Study|Physician Decision|0|||
16118319|NCT02071290|38920010|FG001|Overall Study|Physician Decision|1|||
16118320|NCT01793129|38920011|FG000|Overall Study|Lost to Follow-up|3|||
16118321|NCT01793129|38920012|FG001|Overall Study|Lost to Follow-up|7|||
16118322|NCT01793129|38920011|FG000|Overall Study|Withdrawal by Subject|0|||
16118323|NCT01793129|38920012|FG001|Overall Study|Withdrawal by Subject|2|||
16118324|NCT00416195|38920014|FG000|Overall Study|Adverse Event|1|||
16118325|NCT00416195|38920015|FG001|Overall Study|Adverse Event|2|||
16118326|NCT00416195|38920014|FG000|Overall Study|Protocol Violation|1|||
16229511|NCT01243762|39320468|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
16229512|NCT01243762|39320469|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
16229513|NCT01243762|39320470|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
16229514|NCT01243762|39320471|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
16229515|NCT01243762|39320465|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16229516|NCT01243762|39320466|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
16229517|NCT01243762|39320467|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16229518|NCT01243762|39320468|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16229519|NCT01243762|39320469|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16229520|NCT01243762|39320470|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16229521|NCT01243762|39320471|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
16229522|NCT01243762|39320465|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
16229523|NCT01243762|39320466|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
16229524|NCT01243762|39320467|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
16229525|NCT01243762|39320468|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
16229526|NCT01243762|39320469|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
16229527|NCT01243762|39320470|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
16229528|NCT01243762|39320471|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
16229529|NCT01243762|39320465|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
16229530|NCT01243762|39320466|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
16229531|NCT01243762|39320467|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
16229532|NCT01243762|39320468|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
16229533|NCT01243762|39320469|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
16229534|NCT01243762|39320470|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
16229535|NCT01243762|39320471|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
16229536|NCT01243762|39320465|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
16229537|NCT01243762|39320466|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
16229538|NCT01243762|39320467|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
16229539|NCT01243762|39320468|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
16229540|NCT01243762|39320469|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
16229541|NCT01243762|39320470|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
16229542|NCT01243762|39320471|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
16229543|NCT01243762|39320465|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
16229544|NCT01243762|39320466|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
16229545|NCT01243762|39320467|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
16229546|NCT01243762|39320468|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
16229547|NCT01243762|39320469|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
16229548|NCT01243762|39320470|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
16229549|NCT01243762|39320471|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
16229550|NCT02600559|39320472|FG000|Overall Study|Withdrawal by Subject|3|||
16229551|NCT02600559|39320472|FG000|Overall Study|Lost to Follow-up|20|||
16229552|NCT01381068|39320477|FG000|Overall Study|Death|1|||
16229553|NCT01381068|39320478|FG001|Overall Study|Death|0|||
16229554|NCT00494234|39320479|FG000|Overall Study|Withdrawal by Subject|1|||
16229555|NCT00494234|39320480|FG001|Overall Study|Withdrawal by Subject|0|||
16229556|NCT00494234|39320479|FG000|Overall Study|Disease progression|11|||
16229557|NCT00494234|39320480|FG001|Overall Study|Disease progression|8|||
16229558|NCT00494234|39320479|FG000|Overall Study|Death|2|||
16229559|NCT00494234|39320480|FG001|Overall Study|Death|1|||
16229560|NCT03380091|39320483|FG000|Overall Study|Withdrawal by Subject|2|||
16229561|NCT03380091|39320484|FG001|Overall Study|Withdrawal by Subject|1|||
16229562|NCT01945034|39320485|FG000|Overall Study|Medication Error|0|||
16229563|NCT01945034|39320486|FG001|Overall Study|Medication Error|1|||
16229564|NCT01945034|39320487|FG002|Overall Study|Medication Error|0|||
16229565|NCT01945034|39320485|FG000|Overall Study|Withdrawal by Subject|0|||
16229566|NCT01945034|39320486|FG001|Overall Study|Withdrawal by Subject|3|||
16229567|NCT01945034|39320487|FG002|Overall Study|Withdrawal by Subject|1|||
16229568|NCT01945034|39320485|FG000|Overall Study|Other|0|||
16229569|NCT01945034|39320486|FG001|Overall Study|Other|1|||
16229570|NCT01945034|39320487|FG002|Overall Study|Other|3|||
16229571|NCT01945034|39320485|FG000|Overall Study|Lost to Follow-up|0|||
16229572|NCT01945034|39320486|FG001|Overall Study|Lost to Follow-up|0|||
16229573|NCT01945034|39320487|FG002|Overall Study|Lost to Follow-up|2|||
16229574|NCT01945034|39320485|FG000|Overall Study|Protocol Violation|1|||
16229575|NCT01945034|39320486|FG001|Overall Study|Protocol Violation|0|||
16229576|NCT01945034|39320487|FG002|Overall Study|Protocol Violation|1|||
16229577|NCT03772574|39320490|FG000|Overall Study|Protocol Violation|2|||
16229578|NCT03772574|39320491|FG001|Overall Study|Protocol Violation|0|||
16229579|NCT03772574|39320492|FG002|Overall Study|Protocol Violation|0|||
16229580|NCT03772574|39320490|FG000|Overall Study|Discomfort|0|||
16229581|NCT03772574|39320491|FG001|Overall Study|Discomfort|5|||
16229582|NCT03772574|39320492|FG002|Overall Study|Discomfort|4|||
16229583|NCT00620776|39320496|FG000|Overall Study|Did not receive treatment|3|||
16229584|NCT00620776|39320497|FG001|Overall Study|Did not receive treatment|5|||
16229585|NCT00620776|39320496|FG000|Overall Study|Adverse Event|2|||
16229586|NCT00620776|39320497|FG001|Overall Study|Adverse Event|3|||
16229587|NCT00620776|39320496|FG000|Overall Study|Lack of Efficacy|2|||
16229588|NCT00620776|39320497|FG001|Overall Study|Lack of Efficacy|1|||
16229589|NCT00620776|39320496|FG000|Overall Study|Lost to Follow-up|2|||
16229590|NCT00620776|39320497|FG001|Overall Study|Lost to Follow-up|5|||
16229591|NCT00620776|39320496|FG000|Overall Study|Withdrawal by Subject|3|||
16229592|NCT00620776|39320497|FG001|Overall Study|Withdrawal by Subject|2|||
16229593|NCT00752206|39320498|FG000|Overall Study|Disease progression|8|||
16229594|NCT00752206|39320499|FG001|Overall Study|Disease progression|11|||
16229595|NCT00752206|39320498|FG000|Overall Study|Pregnancy|1|||
16229596|NCT00752206|39320499|FG001|Overall Study|Pregnancy|0|||
16229597|NCT00219349|39320500|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
16229598|NCT00219349|39320500|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
16229599|NCT00219349|39320500|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
16229600|NCT00219349|39320500|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
16229601|NCT00429026|39320501|FG000|Overall Study|Inevaluable for response.|40|||
16229602|NCT04652245|39320502|FG000|Wash-Out Period|Adverse Event|0|||
16229603|NCT04652245|39320503|FG001|Wash-Out Period|Adverse Event|2|||
16229604|NCT04652245|39320502|FG000|Wash-Out Period|Withdrawal by Subject|0|||
16229605|NCT04652245|39320503|FG001|Wash-Out Period|Withdrawal by Subject|2|||
16229606|NCT03778021|39320506|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
16229607|NCT03778021|39320507|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
16229608|NCT01340794|39320510|FG000|Overall Study|Withdrawal by Subject|0|||
16229609|NCT01340794|39320511|FG001|Overall Study|Withdrawal by Subject|1|||
16229610|NCT01519700|39320512|FG000|Overall Study|Death|1|||
16229611|NCT01519700|39320513|FG001|Overall Study|Death|0|||
16229612|NCT01519700|39320514|FG002|Overall Study|Death|0|||
16229613|NCT01519700|39320515|FG003|Overall Study|Death|0|||
16229614|NCT01519700|39320512|FG000|Overall Study|Lost to Follow-up|0|||
16229615|NCT01519700|39320513|FG001|Overall Study|Lost to Follow-up|0|||
16229616|NCT01519700|39320514|FG002|Overall Study|Lost to Follow-up|1|||
16229617|NCT01519700|39320515|FG003|Overall Study|Lost to Follow-up|1|||
16229618|NCT01519700|39320512|FG000|Overall Study|Physician Decision|1|||
16229619|NCT01519700|39320513|FG001|Overall Study|Physician Decision|1|||
16229620|NCT01519700|39320514|FG002|Overall Study|Physician Decision|3|||
16229621|NCT01519700|39320515|FG003|Overall Study|Physician Decision|0|||
16229622|NCT01519700|39320512|FG000|Overall Study|Withdrawal by Subject|5|||
16229623|NCT01519700|39320513|FG001|Overall Study|Withdrawal by Subject|3|||
16229624|NCT01519700|39320514|FG002|Overall Study|Withdrawal by Subject|3|||
16229625|NCT01519700|39320515|FG003|Overall Study|Withdrawal by Subject|2|||
16550677|NCT03285295|40478673|FG003|Alinity s Chagas|Protocol Violation|0|||
16229626|NCT01519700|39320512|FG000|Overall Study|Other Reason|2|||
16229627|NCT01519700|39320513|FG001|Overall Study|Other Reason|2|||
16229628|NCT01519700|39320514|FG002|Overall Study|Other Reason|0|||
16229629|NCT01519700|39320515|FG003|Overall Study|Other Reason|4|||
16229630|NCT03532048|39320520|FG000|Overall Study|Lost to Follow-up|12|||
16229631|NCT03532048|39320521|FG001|Overall Study|Lost to Follow-up|17|||
16229632|NCT03532048|39320520|FG000|Overall Study|Withdrawal by Subject|7|||
16229633|NCT03532048|39320521|FG001|Overall Study|Withdrawal by Subject|0|||
16229634|NCT02158949|39320522|FG000|Overall Study|Withdrawal by Subject|1|||
16229635|NCT02158949|39320523|FG001|Overall Study|Withdrawal by Subject|0|||
16229636|NCT02158949|39320522|FG000|Overall Study|Lost to Follow-up|5|||
16229637|NCT02158949|39320523|FG001|Overall Study|Lost to Follow-up|11|||
16229638|NCT01846442|39320524|FG000|Overall Study|Adverse Event|2|||
16229639|NCT01846442|39320525|FG001|Overall Study|Adverse Event|4|||
16229640|NCT01846442|39320526|FG002|Overall Study|Adverse Event|2|||
16229641|NCT01846442|39320527|FG003|Overall Study|Adverse Event|1|||
16229642|NCT01846442|39320524|FG000|Overall Study|Lost to Follow-up|0|||
16229643|NCT01846442|39320525|FG001|Overall Study|Lost to Follow-up|0|||
16229644|NCT01846442|39320526|FG002|Overall Study|Lost to Follow-up|1|||
16229645|NCT01846442|39320527|FG003|Overall Study|Lost to Follow-up|0|||
16229646|NCT01846442|39320524|FG000|Overall Study|Withdrawal by Subject|3|||
16229647|NCT01846442|39320525|FG001|Overall Study|Withdrawal by Subject|2|||
16229648|NCT01846442|39320526|FG002|Overall Study|Withdrawal by Subject|0|||
16229649|NCT01846442|39320527|FG003|Overall Study|Withdrawal by Subject|1|||
16229650|NCT01846442|39320524|FG000|Overall Study|Left the city/Lost medication|1|||
16229651|NCT01846442|39320525|FG001|Overall Study|Left the city/Lost medication|0|||
16348071|NCT02175121|39762139|FG000|Overall Study|Time issues|0|||
16229652|NCT01846442|39320526|FG002|Overall Study|Left the city/Lost medication|1|||
16229653|NCT01846442|39320527|FG003|Overall Study|Left the city/Lost medication|1|||
16229654|NCT02322866|39320528|FG000|Overall Study|Adverse Event|6|||
16229655|NCT02322866|39320529|FG001|Overall Study|Adverse Event|11|||
16229656|NCT02322866|39320528|FG000|Overall Study|Withdrawal of Consent|16|||
16229657|NCT02322866|39320529|FG001|Overall Study|Withdrawal of Consent|25|||
16229658|NCT02322866|39320528|FG000|Overall Study|Lost to Follow-up|36|||
16229659|NCT02322866|39320529|FG001|Overall Study|Lost to Follow-up|39|||
16229660|NCT02322866|39320528|FG000|Overall Study|Protocol Violation|1|||
16229661|NCT02322866|39320529|FG001|Overall Study|Protocol Violation|0|||
16229662|NCT02322866|39320528|FG000|Overall Study|Noncompliance with Treatment|3|||
16229663|NCT02322866|39320529|FG001|Overall Study|Noncompliance with Treatment|4|||
16229664|NCT02322866|39320528|FG000|Overall Study|Lack of Efficacy|3|||
16229665|NCT02322866|39320529|FG001|Overall Study|Lack of Efficacy|1|||
16229666|NCT02322866|39320528|FG000|Overall Study|Other Miscellaneous Reasons|6|||
16229667|NCT02322866|39320529|FG001|Overall Study|Other Miscellaneous Reasons|6|||
16229668|NCT01871870|39320532|FG000|Overall Study|Hardware issues|7|||
16229669|NCT01871870|39320532|FG000|Overall Study|hyperglycemia|2|||
16229670|NCT01319422|39324216|FG000|Overall Study|Withdrawal by Subject|1|||
16229671|NCT01319422|39324217|FG001|Overall Study|Withdrawal by Subject|0|||
16229672|NCT01886105|39324218|FG000|Overall Study|Lack of Efficacy|3|||
16229673|NCT00627094|39324221|FG000|Overall Study|Adverse Event|8|||
16229674|NCT00627094|39324222|FG001|Overall Study|Adverse Event|7|||
16229675|NCT00627094|39324221|FG000|Overall Study|Lost to Follow-up|1|||
16229676|NCT00627094|39324222|FG001|Overall Study|Lost to Follow-up|0|||
16229677|NCT00627094|39324221|FG000|Overall Study|Withdrawal by Subject|1|||
16229678|NCT00627094|39324222|FG001|Overall Study|Withdrawal by Subject|1|||
16229679|NCT00627094|39324221|FG000|Overall Study|ulcer healed|1|||
16229680|NCT00627094|39324222|FG001|Overall Study|ulcer healed|7|||
16229681|NCT00627094|39324221|FG000|Overall Study|Other reason|1|||
16229682|NCT00627094|39324222|FG001|Overall Study|Other reason|0|||
16229683|NCT00700115|39324225|FG000|Overall Study|Withdrawal by Subject|1|||
16229684|NCT00700115|39324226|FG001|Overall Study|Withdrawal by Subject|0|||
16229685|NCT00700115|39324225|FG000|Overall Study|Lost to Follow-up|0|||
16229686|NCT00700115|39324226|FG001|Overall Study|Lost to Follow-up|1|||
16229687|NCT00812968|39324229|FG000|Overall Study|Relapse after erythroid response|6|||
16229688|NCT00812968|39324229|FG000|Overall Study|Disease progression|1|||
16229689|NCT00812968|39324229|FG000|Overall Study|No further treatment required|1|||
16229690|NCT00812968|39324229|FG000|Overall Study|Study closed due to marketing approval|3|||
16229691|NCT00467051|39324230|FG000|Overall Study|Adverse Event|2|||
16229692|NCT01269346|39324231|FG000|Treatment Phase|Disease progression|3|||
16229693|NCT01269346|39324231|FG000|Treatment Phase|Adverse Event|3|||
16229694|NCT01269346|39324231|FG000|Treatment Phase|Withdrawal by Subject|1|||
16229695|NCT01269346|39324231|FG000|Treatment Phase|Other|2|||
16229696|NCT01269346|39324231|FG000|Extension Phase|Adverse Event|6|||
16229697|NCT01269346|39324231|FG000|Extension Phase|Withdrawal by Subject|4|||
16229698|NCT01269346|39324231|FG000|Extension Phase|Disease progression|22|||
16229699|NCT01269346|39324231|FG000|Extension Phase|Physician decision or participant choice|9|||
16229700|NCT01269346|39324231|FG000|Extension Phase|Clinical progression|1|||
16229701|NCT01269346|39324231|FG000|Extension Phase|Started a prohibited con med|1|||
16229702|NCT00348348|39324240|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
16229703|NCT00348348|39324241|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
16229704|NCT00348348|39324240|FG000|Overall Study|Lack of Efficacy|1|||
16229705|NCT00348348|39324241|FG001|Overall Study|Lack of Efficacy|1|||
16229706|NCT00348348|39324240|FG000|Overall Study|Lost to Follow-up|8|||
16229707|NCT00348348|39324241|FG001|Overall Study|Lost to Follow-up|10|||
16229708|NCT00348348|39324240|FG000|Overall Study|Withdrawal by Subject|4|||
16550678|NCT03285295|40478674|FG004|Alinity s Chagas|Protocol Violation|0|||
16550679|NCT03285295|40478670|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
16550680|NCT03285295|40478671|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
16550681|NCT03285295|40478672|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
16550682|NCT03285295|40478673|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
16550683|NCT03285295|40478674|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
16550684|NCT03285295|40478670|FG000|Alinity s Chagas|No Results Generated|105|||
16550685|NCT03285295|40478671|FG001|Alinity s Chagas|No Results Generated|0|||
16550686|NCT03285295|40478672|FG002|Alinity s Chagas|No Results Generated|0|||
16550687|NCT03285295|40478673|FG003|Alinity s Chagas|No Results Generated|0|||
16550688|NCT03285295|40478674|FG004|Alinity s Chagas|No Results Generated|0|||
16550689|NCT03285295|40478670|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
16229709|NCT00348348|39324241|FG001|Overall Study|Withdrawal by Subject|1|||
16229710|NCT00348348|39324240|FG000|Overall Study|Other|7|||
16550690|NCT03285295|40478671|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
16229711|NCT00348348|39324241|FG001|Overall Study|Other|4|||
16229712|NCT00348348|39324240|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
16229713|NCT00348348|39324241|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
16229714|NCT00348348|39324240|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
16229715|NCT00348348|39324241|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
16229716|NCT00348348|39324240|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
16229717|NCT00348348|39324241|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
16229718|NCT00348348|39324240|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
16229719|NCT00348348|39324241|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
16229720|NCT00348348|39324240|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
16229721|NCT00348348|39324241|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
16229722|NCT00348348|39324240|FG000|Overall Study|Adverse event probably related to study|1|||
16229723|NCT00348348|39324241|FG001|Overall Study|Adverse event probably related to study|0|||
16229724|NCT00877799|39324243|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
16229725|NCT00877799|39324244|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
16229726|NCT00877799|39324245|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
16229727|NCT00877799|39324246|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
16229728|NCT00877799|39324247|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
16229729|NCT00877799|39324243|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
16229730|NCT00877799|39324244|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
16229731|NCT00877799|39324245|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
16229732|NCT00877799|39324246|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
16229733|NCT00877799|39324247|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
16229734|NCT00877799|39324243|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
16229735|NCT00877799|39324244|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
16229736|NCT00877799|39324245|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
16229737|NCT00877799|39324246|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
16229738|NCT00877799|39324247|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
16229739|NCT00877799|39324243|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
16229740|NCT00877799|39324244|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
16229741|NCT00877799|39324245|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
16229742|NCT00877799|39324246|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
16229743|NCT00877799|39324247|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
16229744|NCT00877799|39324243|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
16229745|NCT00877799|39324244|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
16229746|NCT00877799|39324245|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
16229747|NCT00877799|39324246|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
16229748|NCT00877799|39324247|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
16229749|NCT00462501|39324248|FG000|Overall Study|Not treated|3|||
16229750|NCT00462501|39324248|FG000|Overall Study|Adverse Event|2|||
16229751|NCT00633217|39324249|FG000|Overall Study|Adverse Event|5|||
16229752|NCT00633217|39324250|FG001|Overall Study|Adverse Event|9|||
16229753|NCT00633217|39324249|FG000|Overall Study|Lack of Efficacy|0|||
16229754|NCT00633217|39324250|FG001|Overall Study|Lack of Efficacy|2|||
16229755|NCT00633217|39324249|FG000|Overall Study|Protocol Violation|3|||
16229756|NCT00633217|39324250|FG001|Overall Study|Protocol Violation|7|||
16229757|NCT00633217|39324249|FG000|Overall Study|Lost to Follow-up|2|||
16229758|NCT00633217|39324250|FG001|Overall Study|Lost to Follow-up|2|||
16229759|NCT00633217|39324249|FG000|Overall Study|Investigator Discretion|2|||
16229760|NCT00633217|39324250|FG001|Overall Study|Investigator Discretion|0|||
16229761|NCT00633217|39324249|FG000|Overall Study|Withdrew Consent|3|||
16229762|NCT00633217|39324250|FG001|Overall Study|Withdrew Consent|3|||
16229763|NCT04753606|39324251|FG000|Overall Study|Adverse Event|1|||
16229764|NCT04753606|39324252|FG001|Overall Study|Adverse Event|0|||
16229765|NCT04753606|39324253|FG002|Overall Study|Adverse Event|0|||
16229766|NCT02551874|39324254|FG000|Overall Study|Lost to Follow-up|0|||
16229767|NCT02551874|39324255|FG001|Overall Study|Lost to Follow-up|2|||
16229768|NCT02551874|39324254|FG000|Overall Study|Pregnancy|0|||
16229769|NCT02551874|39324255|FG001|Overall Study|Pregnancy|1|||
16229770|NCT02551874|39324254|FG000|Overall Study|Reason not reported|10|||
16229771|NCT02551874|39324255|FG001|Overall Study|Reason not reported|4|||
16229772|NCT02551874|39324254|FG000|Overall Study|Did not receive randomized treatment|0|||
16229773|NCT02551874|39324255|FG001|Overall Study|Did not receive randomized treatment|7|||
16229774|NCT02551874|39324254|FG000|Overall Study|Did not enter long-term study|18|||
16229775|NCT02551874|39324255|FG001|Overall Study|Did not enter long-term study|25|||
16229776|NCT00234533|39324256|FG000|Overall Study|Withdrawal by Subject|6|||
16229777|NCT00234533|39324256|FG000|Overall Study|Adverse Event|2|||
16229778|NCT00234533|39324256|FG000|Overall Study|Enrolled but not treated|3|||
16229779|NCT01976104|39324257|FG000|Overall Study|Adverse Event|0|||
16229780|NCT01976104|39324258|FG001|Overall Study|Adverse Event|0|||
16229781|NCT01976104|39324259|FG002|Overall Study|Adverse Event|1|||
16229782|NCT01976104|39324260|FG003|Overall Study|Adverse Event|0|||
16229783|NCT01976104|39324257|FG000|Overall Study|Lost to Follow-up|3|||
16229784|NCT01976104|39324258|FG001|Overall Study|Lost to Follow-up|0|||
16229785|NCT01976104|39324259|FG002|Overall Study|Lost to Follow-up|1|||
16229786|NCT01976104|39324260|FG003|Overall Study|Lost to Follow-up|1|||
16229787|NCT01976104|39324257|FG000|Overall Study|Subject Choice|0|||
16229788|NCT01976104|39324258|FG001|Overall Study|Subject Choice|1|||
16229789|NCT01976104|39324259|FG002|Overall Study|Subject Choice|0|||
16229790|NCT01976104|39324260|FG003|Overall Study|Subject Choice|1|||
16229791|NCT01976104|39324257|FG000|Overall Study|Withdrawal by Subject|3|||
16229792|NCT01976104|39324258|FG001|Overall Study|Withdrawal by Subject|0|||
16229793|NCT01976104|39324259|FG002|Overall Study|Withdrawal by Subject|0|||
16229794|NCT01976104|39324260|FG003|Overall Study|Withdrawal by Subject|1|||
16229795|NCT01976104|39324257|FG000|Overall Study|Other|0|||
16229796|NCT01976104|39324258|FG001|Overall Study|Other|1|||
16229797|NCT01976104|39324259|FG002|Overall Study|Other|0|||
16229798|NCT01976104|39324260|FG003|Overall Study|Other|0|||
16229799|NCT02764229|39324264|FG000|Overall Study|Withdrawal by Subject|15|||
16229800|NCT02764229|39324264|FG000|Overall Study|Adverse Event|9|||
16229801|NCT02764229|39324264|FG000|Overall Study|Physician Decision|5|||
16229802|NCT02764229|39324264|FG000|Overall Study|Lost to Follow-up|3|||
16229803|NCT02764229|39324264|FG000|Overall Study|Lack of Efficacy|1|||
16229804|NCT02764229|39324264|FG000|Overall Study|Study Stopped by Sponsor|69|||
16229805|NCT02422186|39324277|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
16229806|NCT02422186|39324278|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
16550691|NCT03285295|40478672|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
16550692|NCT03285295|40478673|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
16229807|NCT02422186|39324277|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
16229808|NCT02422186|39324278|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
16229809|NCT02422186|39324277|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
16229810|NCT02422186|39324278|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
16229811|NCT02422186|39324277|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
16229812|NCT02422186|39324278|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
16229813|NCT02422186|39324277|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
16229814|NCT02422186|39324278|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
16229815|NCT02422186|39324277|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
16229816|NCT02422186|39324278|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
16229817|NCT02422186|39324277|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
16229818|NCT02422186|39324278|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
16229819|NCT02422186|39324277|FG000|Follow-up Phase (2 Weeks)|Other|3|||
16229820|NCT02422186|39324278|FG001|Follow-up Phase (2 Weeks)|Other|0|||
16229821|NCT02064231|39324279|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
16229822|NCT02064231|39324280|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
16229823|NCT02064231|39324281|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
16550693|NCT03285295|40478674|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
16550694|NCT00951509|40478675|FG000|Overall Study|Withdrawal by Subject|2|||
16550695|NCT02002182|40478679|FG000|Overall Study|Withdraw from study|3|||
16550696|NCT02002182|40478680|FG001|Overall Study|Withdraw from study|1|||
16550697|NCT02002182|40478679|FG000|Overall Study|Health Reasons|1|||
16550698|NCT02002182|40478680|FG001|Overall Study|Health Reasons|0|||
16550699|NCT02002182|40478679|FG000|Overall Study|Death|1|||
16550700|NCT02002182|40478680|FG001|Overall Study|Death|0|||
16550701|NCT03077620|40478681|FG000|Overall Study|Unable to place lumbar catheter|1|||
16550702|NCT03077620|40478682|FG001|Overall Study|Unable to place lumbar catheter|0|||
16550703|NCT03077620|40478683|FG002|Overall Study|Unable to place lumbar catheter|1|||
16550704|NCT03077620|40478684|FG003|Overall Study|Unable to place lumbar catheter|0|||
16550705|NCT03077620|40478681|FG000|Overall Study|Withdrawal by Subject|0|||
16550706|NCT03077620|40478682|FG001|Overall Study|Withdrawal by Subject|1|||
16550707|NCT03077620|40478683|FG002|Overall Study|Withdrawal by Subject|0|||
16550708|NCT03077620|40478684|FG003|Overall Study|Withdrawal by Subject|0|||
16550709|NCT03077620|40478681|FG000|Overall Study|Physician Decision|0|||
16550710|NCT03077620|40478682|FG001|Overall Study|Physician Decision|0|||
16550711|NCT03077620|40478683|FG002|Overall Study|Physician Decision|1|||
16550712|NCT03077620|40478684|FG003|Overall Study|Physician Decision|0|||
16550713|NCT02468934|40478685|FG000|Overall Study|Withdrawal by Subject|4|||
16550714|NCT02468934|40478685|FG000|Overall Study|Screen Failure|3|||
16550715|NCT01862991|40478686|FG000|Overall Study|Lost to Follow-up|2|||
16550716|NCT01862991|40478687|FG001|Overall Study|Lost to Follow-up|1|||
16550717|NCT01862991|40478688|FG002|Overall Study|Lost to Follow-up|1|||
16550718|NCT01862991|40478686|FG000|Overall Study|Protocol Violation|1|||
16550719|NCT01862991|40478687|FG001|Overall Study|Protocol Violation|0|||
16550720|NCT01862991|40478688|FG002|Overall Study|Protocol Violation|0|||
16550721|NCT01722162|40478689|FG000|Overall Study|Withdrawal by Subject|1|||
16229824|NCT02064231|39324282|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
16550722|NCT01722162|40478690|FG001|Overall Study|Withdrawal by Subject|1|||
16550723|NCT01722162|40478689|FG000|Overall Study|Found ineligible|1|||
16229825|NCT02064231|39324279|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
16348072|NCT02175121|39762140|FG001|Overall Study|Time issues|0|||
16229826|NCT02064231|39324280|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
16229827|NCT02064231|39324281|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
16229828|NCT02064231|39324282|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
16229829|NCT02064231|39324279|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
16229830|NCT02064231|39324280|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
16229831|NCT02064231|39324281|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
16229832|NCT02064231|39324282|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
16229833|NCT02064231|39324279|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
16229834|NCT02064231|39324280|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
16229835|NCT02064231|39324281|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
16229836|NCT02064231|39324282|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
16229837|NCT00650806|39324283|FG000|Overall Study|Adverse Event|0|||
16229838|NCT00650806|39324284|FG001|Overall Study|Adverse Event|5|||
16229839|NCT00650806|39324285|FG002|Overall Study|Adverse Event|3|||
16229840|NCT00650806|39324286|FG003|Overall Study|Adverse Event|4|||
16229841|NCT00650806|39324283|FG000|Overall Study|Lost to Follow-up|7|||
16229842|NCT00650806|39324284|FG001|Overall Study|Lost to Follow-up|6|||
16229843|NCT00650806|39324285|FG002|Overall Study|Lost to Follow-up|11|||
16229844|NCT00650806|39324286|FG003|Overall Study|Lost to Follow-up|10|||
16229845|NCT00650806|39324283|FG000|Overall Study|Protocol Violation|0|||
16229846|NCT00650806|39324284|FG001|Overall Study|Protocol Violation|0|||
16229847|NCT00650806|39324285|FG002|Overall Study|Protocol Violation|0|||
16229848|NCT00650806|39324286|FG003|Overall Study|Protocol Violation|1|||
16229849|NCT00650806|39324283|FG000|Overall Study|Pregnancy|0|||
16229850|NCT00650806|39324284|FG001|Overall Study|Pregnancy|0|||
16229851|NCT00650806|39324285|FG002|Overall Study|Pregnancy|0|||
16229852|NCT00650806|39324286|FG003|Overall Study|Pregnancy|1|||
16229853|NCT00650806|39324283|FG000|Overall Study|Withdrawal by Subject|7|||
16229854|NCT00650806|39324284|FG001|Overall Study|Withdrawal by Subject|5|||
16229855|NCT00650806|39324285|FG002|Overall Study|Withdrawal by Subject|8|||
16229856|NCT00650806|39324286|FG003|Overall Study|Withdrawal by Subject|6|||
16229857|NCT00650806|39324283|FG000|Overall Study|Noncompliance with study drug regimen|1|||
16229858|NCT00650806|39324284|FG001|Overall Study|Noncompliance with study drug regimen|1|||
16229859|NCT00650806|39324285|FG002|Overall Study|Noncompliance with study drug regimen|0|||
16412281|NCT01533922|39992129|FG004|Overall Study|Lack of Efficacy|0|||
16412282|NCT01533922|39992125|FG000|Overall Study|Protocol Violation|0|||
16412283|NCT01533922|39992126|FG001|Overall Study|Protocol Violation|3|||
16412284|NCT01533922|39992127|FG002|Overall Study|Protocol Violation|0|||
16412285|NCT01533922|39992128|FG003|Overall Study|Protocol Violation|0|||
16412286|NCT01533922|39992129|FG004|Overall Study|Protocol Violation|1|||
16412287|NCT01533922|39992125|FG000|Overall Study|Withdrawal by Subject|3|||
16412288|NCT01533922|39992126|FG001|Overall Study|Withdrawal by Subject|1|||
16412289|NCT01533922|39992127|FG002|Overall Study|Withdrawal by Subject|2|||
16550724|NCT01722162|40478690|FG001|Overall Study|Found ineligible|0|||
16550725|NCT01722162|40478689|FG000|Overall Study|Unrelated to study adverse event|2|||
16550726|NCT01722162|40478690|FG001|Overall Study|Unrelated to study adverse event|2|||
16550727|NCT01722162|40478689|FG000|Overall Study|Adverse Event|1|||
16412290|NCT01533922|39992128|FG003|Overall Study|Withdrawal by Subject|2|||
16412291|NCT01533922|39992129|FG004|Overall Study|Withdrawal by Subject|1|||
16412292|NCT01533922|39992125|FG000|Overall Study|Other reason not defined above|2|||
16412293|NCT01533922|39992126|FG001|Overall Study|Other reason not defined above|0|||
16412294|NCT01533922|39992127|FG002|Overall Study|Other reason not defined above|1|||
16412295|NCT01533922|39992128|FG003|Overall Study|Other reason not defined above|0|||
16412296|NCT01533922|39992129|FG004|Overall Study|Other reason not defined above|0|||
16412297|NCT01842581|39992130|FG000|Overall Study|Adverse Event|6|||
16550728|NCT01722162|40478690|FG001|Overall Study|Adverse Event|1|||
16550729|NCT01722162|40478689|FG000|Overall Study|Insurance denial post enrollment|0|||
16550730|NCT01722162|40478690|FG001|Overall Study|Insurance denial post enrollment|1|||
16550731|NCT01722162|40478689|FG000|Overall Study|Noncompliance|0|||
16550732|NCT01722162|40478690|FG001|Overall Study|Noncompliance|1|||
16550733|NCT03292146|40478691|FG000|Baseline to 12 Months|Relocation|1|||
16550734|NCT03292146|40478692|FG001|Baseline to 12 Months|Relocation|0|||
16550735|NCT03292146|40478691|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
16550736|NCT03292146|40478692|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
16550737|NCT03292146|40478691|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
16229860|NCT00650806|39324286|FG003|Overall Study|Noncompliance with study drug regimen|0|||
16229861|NCT00650806|39324283|FG000|Overall Study|Study terminated by sponsor|2|||
16229862|NCT00650806|39324284|FG001|Overall Study|Study terminated by sponsor|3|||
16229863|NCT00650806|39324285|FG002|Overall Study|Study terminated by sponsor|5|||
16229864|NCT00650806|39324286|FG003|Overall Study|Study terminated by sponsor|4|||
16229865|NCT00650806|39324283|FG000|Overall Study|Other|1|||
16412298|NCT01842581|39992131|FG001|Overall Study|Adverse Event|4|||
16412299|NCT01842581|39992130|FG000|Overall Study|HE breakthrough|26|||
16412300|NCT01842581|39992131|FG001|Overall Study|HE breakthrough|13|||
16550738|NCT03292146|40478692|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
16550739|NCT03292146|40478691|FG000|12 Months to 24 Months|Planning pregnancy|2|||
16550740|NCT03292146|40478692|FG001|12 Months to 24 Months|Planning pregnancy|2|||
16550741|NCT03292146|40478691|FG000|12 Months to 24 Months|Personal reasons|1|||
16550742|NCT03292146|40478692|FG001|12 Months to 24 Months|Personal reasons|0|||
16550743|NCT03292146|40478691|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
16550744|NCT03292146|40478692|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
16550745|NCT03151395|40478693|FG000|Overall Study|Adverse Event|2|||
16550746|NCT03151395|40478693|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
16550747|NCT03151395|40478693|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
16550748|NCT03151395|40478693|FG000|Overall Study|Unspecified reason|4|||
16550749|NCT04772053|40478694|FG000|Overall Study|Physician Decision|2|||
16550750|NCT04772053|40478694|FG000|Overall Study|Withdrawal by Subject|3|||
16550751|NCT04772053|40478694|FG000|Overall Study|Study Terminated by Sponsor|1|||
16550752|NCT02914314|40478695|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
16550753|NCT02914314|40478696|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
16550754|NCT02914314|40478697|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
16550755|NCT02914314|40478698|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
16550756|NCT02914314|40478695|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
16550757|NCT02914314|40478696|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
16550758|NCT02914314|40478697|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
16550759|NCT02914314|40478698|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
16229866|NCT00650806|39324284|FG001|Overall Study|Other|1|||
16229867|NCT00650806|39324285|FG002|Overall Study|Other|2|||
16229868|NCT00650806|39324286|FG003|Overall Study|Other|0|||
16550760|NCT02914314|40478695|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
16550761|NCT02914314|40478696|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
16550762|NCT02914314|40478697|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
16550763|NCT02914314|40478698|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
16550764|NCT02914314|40478695|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
16550765|NCT02914314|40478696|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
16550766|NCT02914314|40478697|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
16550767|NCT02914314|40478698|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
16550768|NCT02914314|40478695|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
16550769|NCT02914314|40478696|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
16550770|NCT02914314|40478697|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
16550771|NCT02914314|40478698|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
16550772|NCT03820323|40478699|FG000|Overall Study|Lost to Follow-up|2|||
16550773|NCT03820323|40478700|FG001|Overall Study|Lost to Follow-up|1|||
16550774|NCT03820323|40478699|FG000|Overall Study|Missed 12-month visit|22|||
16550775|NCT03820323|40478700|FG001|Overall Study|Missed 12-month visit|14|||
16550776|NCT03820323|40478699|FG000|Overall Study|Death|2|||
16550777|NCT03820323|40478700|FG001|Overall Study|Death|1|||
16550778|NCT03820323|40478699|FG000|Overall Study|Transferred out|13|||
16550779|NCT03820323|40478700|FG001|Overall Study|Transferred out|11|||
16550780|NCT03820323|40478699|FG000|Overall Study|Terminated|0|||
16550781|NCT03820323|40478700|FG001|Overall Study|Terminated|3|||
16550782|NCT03820323|40478699|FG000|Overall Study|Withdrawal by Subject|1|||
16550783|NCT03820323|40478700|FG001|Overall Study|Withdrawal by Subject|6|||
16550784|NCT00787319|40478712|FG000|Overall Study|Lost to Follow-up|2|||
16550785|NCT00787319|40478712|FG000|Overall Study|Withdrawal by Subject|15|||
16550786|NCT00787319|40478712|FG000|Overall Study|Adverse Event|3|||
16550787|NCT00787319|40478712|FG000|Overall Study|Objective progression or relapse|30|||
16550788|NCT00787319|40478712|FG000|Overall Study|Lack of Efficacy|1|||
16550789|NCT00787319|40478712|FG000|Overall Study|Budget exhausted/exceeded|1|||
16550790|NCT00787319|40478712|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
16550791|NCT00787319|40478712|FG000|Overall Study|No health insurance reimbursement|2|||
16550792|NCT00787319|40478712|FG000|Overall Study|Stabilized disease findings|3|||
16550793|NCT00787319|40478712|FG000|Overall Study|Inactive disease|5|||
16412301|NCT01842581|39992130|FG000|Overall Study|Liver transplant|2|||
16412302|NCT01842581|39992131|FG001|Overall Study|Liver transplant|0|||
16412303|NCT01842581|39992130|FG000|Overall Study|Lost to Follow-up|2|||
16412304|NCT01842581|39992131|FG001|Overall Study|Lost to Follow-up|5|||
16550794|NCT00147225|40481335|FG000|Overall Study|Withdrawal by Subject|1|||
16118327|NCT00416195|38920015|FG001|Overall Study|Protocol Violation|1|||
16412305|NCT01842581|39992130|FG000|Overall Study|Withdrawal by Subject|5|||
16412306|NCT01842581|39992131|FG001|Overall Study|Withdrawal by Subject|7|||
16550795|NCT00147225|40481336|FG001|Overall Study|Withdrawal by Subject|0|||
16550796|NCT00147225|40481337|FG002|Overall Study|Withdrawal by Subject|1|||
16550797|NCT00147225|40481338|FG003|Overall Study|Withdrawal by Subject|0|||
16550798|NCT00147225|40481339|FG004|Overall Study|Withdrawal by Subject|0|||
16550799|NCT00147225|40481340|FG005|Overall Study|Withdrawal by Subject|1|||
16118328|NCT00416195|38920014|FG000|Overall Study|Other|0|||
16412307|NCT01842581|39992130|FG000|Overall Study|Other than specified|3|||
16412308|NCT01842581|39992131|FG001|Overall Study|Other than specified|1|||
16412309|NCT05291936|39992132|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
16348073|NCT02175121|39762141|FG002|Overall Study|Time issues|1|||
16550800|NCT00147225|40481335|FG000|Overall Study|Adverse Event|0|||
16550801|NCT00147225|40481336|FG001|Overall Study|Adverse Event|0|||
16550802|NCT00147225|40481337|FG002|Overall Study|Adverse Event|1|||
16550803|NCT00147225|40481338|FG003|Overall Study|Adverse Event|1|||
16550804|NCT00147225|40481339|FG004|Overall Study|Adverse Event|0|||
16550805|NCT00147225|40481340|FG005|Overall Study|Adverse Event|0|||
16550806|NCT00147225|40481335|FG000|Overall Study|Screen Failure|0|||
16550807|NCT00147225|40481336|FG001|Overall Study|Screen Failure|0|||
16550808|NCT00147225|40481337|FG002|Overall Study|Screen Failure|0|||
16550809|NCT00147225|40481338|FG003|Overall Study|Screen Failure|0|||
16550810|NCT00147225|40481339|FG004|Overall Study|Screen Failure|1|||
16550811|NCT00147225|40481340|FG005|Overall Study|Screen Failure|0|||
16550812|NCT00147225|40481335|FG000|Overall Study|Chemotherapy Changed|0|||
16550813|NCT00147225|40481336|FG001|Overall Study|Chemotherapy Changed|0|||
16550814|NCT00147225|40481337|FG002|Overall Study|Chemotherapy Changed|0|||
16550815|NCT00147225|40481338|FG003|Overall Study|Chemotherapy Changed|0|||
16550816|NCT00147225|40481339|FG004|Overall Study|Chemotherapy Changed|0|||
16550817|NCT00147225|40481340|FG005|Overall Study|Chemotherapy Changed|1|||
16118329|NCT00416195|38920015|FG001|Overall Study|Other|1|||
16118330|NCT00667459|38920016|FG000|Overall Study|Death|0|||
16118331|NCT00667459|38920017|FG001|Overall Study|Death|2|||
16118332|NCT00667459|38920016|FG000|Overall Study|Lost to Follow-up|8|||
16348074|NCT02175121|39762142|FG003|Overall Study|Time issues|0|||
16348075|NCT02175121|39762143|FG004|Overall Study|Time issues|0|||
16348076|NCT01178125|39762144|FG000|Overall Study|Lost to Follow-up|397|||
16348077|NCT01178125|39762144|FG000|Overall Study|Adverse Event|244|||
16348078|NCT01178125|39762144|FG000|Overall Study|Withdrawal by Subject|209|||
16348079|NCT01178125|39762144|FG000|Overall Study|Noncompliance|184|||
16348080|NCT01178125|39762144|FG000|Overall Study|Pregnancy|55|||
16348081|NCT01178125|39762144|FG000|Overall Study|Other Reason|39|||
16348082|NCT01178125|39762144|FG000|Overall Study|Sponsor Decision|28|||
16412310|NCT05291936|39992133|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
16412311|NCT05291936|39992132|FG000|Period 1|Withdrew Consent during study|1|||
16412312|NCT05291936|39992133|FG001|Period 1|Withdrew Consent during study|0|||
16550818|NCT00692406|40481341|FG000|Overall Study|PI dropped, bad data|57|||
16550819|NCT02285595|40481344|FG000|Overall Study|Lost to Follow-up|14|||
16550820|NCT02285595|40481344|FG000|Overall Study|Withdrawal by Subject|1|||
16550821|NCT01375205|40481345|FG000|Overall Study|Lost to Follow-up|15|||
16550822|NCT01375205|40481346|FG001|Overall Study|Lost to Follow-up|12|||
16550823|NCT01375205|40481345|FG000|Overall Study|Withdrawal by Subject|6|||
16550824|NCT01375205|40481346|FG001|Overall Study|Withdrawal by Subject|1|||
16118333|NCT00667459|38920017|FG001|Overall Study|Lost to Follow-up|43|||
16118334|NCT04707664|38920018|FG000|Overall Study|Adverse Event|2|||
16118335|NCT04707664|38920019|FG001|Overall Study|Adverse Event|0|||
16118336|NCT04707664|38920018|FG000|Overall Study|Death|1|||
16118337|NCT04707664|38920019|FG001|Overall Study|Death|2|||
16118338|NCT04707664|38920018|FG000|Overall Study|Withdrawal by Subject|13|||
16118339|NCT04707664|38920019|FG001|Overall Study|Withdrawal by Subject|21|||
16118340|NCT04707664|38920018|FG000|Overall Study|Lost to Follow-up|11|||
16118341|NCT04707664|38920019|FG001|Overall Study|Lost to Follow-up|13|||
16118342|NCT04707664|38920018|FG000|Overall Study|Not treated|2|||
16118343|NCT04707664|38920019|FG001|Overall Study|Not treated|0|||
16118344|NCT01020877|38920020|FG000|Second Intervention|Withdrawal by Subject|1|||
16118345|NCT01020877|38920021|FG001|Second Intervention|Withdrawal by Subject|0|||
16118346|NCT02597712|38920022|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
16118347|NCT02597712|38920023|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
16348083|NCT01178125|39762144|FG000|Overall Study|Protocol Violation|17|||
16348084|NCT01178125|39762144|FG000|Overall Study|Investigator Decision|5|||
16348085|NCT01000974|39762145|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
16348086|NCT01000974|39762146|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
16412313|NCT05291936|39992132|FG000|Period 2|Adverse Event|0|||
16550825|NCT01735396|40481350|FG000|Overall Study|not evaluable|1|||
16550826|NCT02291432|40481351|FG000|Overall Study|Withdrawal by Subject|2|||
16550827|NCT00904150|40481352|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
16550828|NCT00904150|40481353|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
16550829|NCT00904150|40481352|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
16550830|NCT00904150|40481353|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
16550831|NCT02714868|40481354|FG000|Overall Study|Withdrawal by Subject|3|||
16118348|NCT02597712|38920022|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
16118349|NCT02597712|38920023|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
16118350|NCT02597712|38920022|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
16118351|NCT02597712|38920023|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
16412314|NCT05291936|39992133|FG001|Period 2|Adverse Event|1|||
16118352|NCT00412607|38920024|FG000|Overall Study|Withdrawal by Subject|9|||
16118353|NCT00412607|38920024|FG000|Overall Study|Lost to Follow-up|19|||
16118354|NCT00412607|38920024|FG000|Overall Study|Death|61|||
16118355|NCT00412607|38920024|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
16118356|NCT01067846|38920025|FG000|Overall Study|Lost to Follow-up|17|||
16118357|NCT01067846|38920026|FG001|Overall Study|Lost to Follow-up|19|||
16118358|NCT01067846|38920025|FG000|Overall Study|Withdrawal by Subject|1|||
16118359|NCT01067846|38920026|FG001|Overall Study|Withdrawal by Subject|0|||
16118360|NCT01067846|38920025|FG000|Overall Study|participation in other tx study|1|||
16118361|NCT01067846|38920026|FG001|Overall Study|participation in other tx study|0|||
16118362|NCT01252355|38920027|FG000|Overall Study|Adverse Event|9|||
16118363|NCT01252355|38920028|FG001|Overall Study|Adverse Event|17|||
16118364|NCT01252355|38920029|FG002|Overall Study|Adverse Event|22|||
16118365|NCT01252355|38920027|FG000|Overall Study|Lack of Efficacy|6|||
16118366|NCT01252355|38920028|FG001|Overall Study|Lack of Efficacy|4|||
16118367|NCT01252355|38920029|FG002|Overall Study|Lack of Efficacy|2|||
16118368|NCT01252355|38920027|FG000|Overall Study|Lost to Follow-up|0|||
16118369|NCT01252355|38920028|FG001|Overall Study|Lost to Follow-up|0|||
16118370|NCT01252355|38920029|FG002|Overall Study|Lost to Follow-up|1|||
16118371|NCT01252355|38920027|FG000|Overall Study|Poor Compliance to Protocol|1|||
16118372|NCT01252355|38920028|FG001|Overall Study|Poor Compliance to Protocol|1|||
16118373|NCT01252355|38920029|FG002|Overall Study|Poor Compliance to Protocol|1|||
16412315|NCT05291936|39992132|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
16412316|NCT05291936|39992133|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
16412317|NCT00693472|39992135|FG000|Part 1|Adverse Event|1|||
16412318|NCT00693472|39992136|FG001|Part 1|Adverse Event|1|||
16412319|NCT00693472|39992137|FG002|Part 1|Adverse Event|0|||
16412320|NCT00693472|39992138|FG003|Part 1|Adverse Event|0|||
16412321|NCT00693472|39992135|FG000|Part 1|Lost to Follow-up|0|||
16412322|NCT00693472|39992136|FG001|Part 1|Lost to Follow-up|1|||
16412323|NCT00693472|39992137|FG002|Part 1|Lost to Follow-up|0|||
16412324|NCT00693472|39992138|FG003|Part 1|Lost to Follow-up|0|||
16550832|NCT02714868|40481355|FG001|Overall Study|Withdrawal by Subject|0|||
16118374|NCT01252355|38920027|FG000|Overall Study|Progressive Disease|2|||
16412325|NCT00693472|39992135|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
16412326|NCT00693472|39992136|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
16412327|NCT00693472|39992137|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
16550833|NCT02714868|40481354|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
16550834|NCT02714868|40481355|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
16550835|NCT02714868|40481354|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
16550836|NCT02714868|40481355|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
16412328|NCT00693472|39992138|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
16412329|NCT00693472|39992135|FG000|Part 2|Adverse Event|0|||
16412330|NCT00693472|39992136|FG001|Part 2|Adverse Event|0|||
16412331|NCT00693472|39992137|FG002|Part 2|Adverse Event|1|||
16412332|NCT00693472|39992138|FG003|Part 2|Adverse Event|0|||
16412333|NCT00693472|39992135|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
16412334|NCT00693472|39992136|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
16412335|NCT00693472|39992137|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
16412336|NCT00693472|39992138|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
16412337|NCT02989805|39992140|FG000|Overall Study|invalid consent|6|||
16412338|NCT02989805|39992141|FG001|Overall Study|invalid consent|4|||
16412339|NCT01565564|39992142|FG000|Overall Study|Lost to Follow-up|5|||
16412340|NCT01565564|39992143|FG001|Overall Study|Lost to Follow-up|1|||
16412341|NCT02017522|39992156|FG000|Overall Study|Withdrawal by Subject|1|||
16412342|NCT03149003|39992157|FG000|Overall Study|Randomized but not treated|0|||
16412343|NCT03149003|39992158|FG001|Overall Study|Randomized but not treated|1|||
16412344|NCT03149003|39992159|FG002|Overall Study|Randomized but not treated|18|||
16412345|NCT00468845|39992166|FG000|Overall Study|Adverse Event|9|||
16412346|NCT00468845|39992167|FG001|Overall Study|Adverse Event|14|||
16412347|NCT00468845|39992168|FG002|Overall Study|Adverse Event|11|||
16412348|NCT00468845|39992166|FG000|Overall Study|Lost to Follow-up|2|||
16412349|NCT00468845|39992167|FG001|Overall Study|Lost to Follow-up|1|||
16412350|NCT00468845|39992168|FG002|Overall Study|Lost to Follow-up|2|||
16412351|NCT00468845|39992166|FG000|Overall Study|Other|4|||
16412352|NCT00468845|39992167|FG001|Overall Study|Other|9|||
16412353|NCT00468845|39992168|FG002|Overall Study|Other|5|||
16412354|NCT00468845|39992166|FG000|Overall Study|No longer willing to participate|5|||
16412355|NCT00468845|39992167|FG001|Overall Study|No longer willing to participate|6|||
16412356|NCT00468845|39992168|FG002|Overall Study|No longer willing to participate|10|||
16118375|NCT01252355|38920028|FG001|Overall Study|Progressive Disease|0|||
16118376|NCT01252355|38920029|FG002|Overall Study|Progressive Disease|0|||
16118377|NCT01252355|38920027|FG000|Overall Study|Sponsor Early Termination of Study|149|||
16118378|NCT01252355|38920028|FG001|Overall Study|Sponsor Early Termination of Study|149|||
16118379|NCT01252355|38920029|FG002|Overall Study|Sponsor Early Termination of Study|146|||
16118380|NCT01252355|38920027|FG000|Overall Study|Randomized but not Treated|2|||
16412357|NCT00468845|39992166|FG000|Overall Study|Randomized, not treated|1|||
16118381|NCT01252355|38920028|FG001|Overall Study|Randomized but not Treated|0|||
16118382|NCT01252355|38920029|FG002|Overall Study|Randomized but not Treated|0|||
16118383|NCT01252355|38920027|FG000|Overall Study|Other Than Above|8|||
16118384|NCT01252355|38920028|FG001|Overall Study|Other Than Above|7|||
16118385|NCT01252355|38920029|FG002|Overall Study|Other Than Above|7|||
16118386|NCT02592876|38920030|FG000|Overall Study|Withdrawal by Subject|3|||
16118387|NCT02592876|38920031|FG001|Overall Study|Withdrawal by Subject|3|||
16118388|NCT02592876|38920030|FG000|Overall Study|Study Termination by Sponsor|32|||
16118389|NCT02592876|38920031|FG001|Overall Study|Study Termination by Sponsor|27|||
16118390|NCT02592876|38920030|FG000|Overall Study|Lost to Follow-up|0|||
16118391|NCT02592876|38920031|FG001|Overall Study|Lost to Follow-up|1|||
16118392|NCT02592876|38920030|FG000|Overall Study|Death|6|||
16118393|NCT02592876|38920031|FG001|Overall Study|Death|9|||
16118394|NCT02637323|38920036|FG000|Overall Study|Lost to Follow-up|2|||
16118395|NCT02637323|38920037|FG001|Overall Study|Lost to Follow-up|0|||
16118396|NCT02637323|38920036|FG000|Overall Study|Protocol Violation|0|||
16118397|NCT02637323|38920037|FG001|Overall Study|Protocol Violation|1|||
16118398|NCT01241604|38920041|FG000|Screening Period|Screen Failure|3|||
16118399|NCT01241604|38920042|FG001|Screening Period|Screen Failure|0|||
16118400|NCT01241604|38920043|FG002|Screening Period|Screen Failure|0|||
16118401|NCT01125514|38920044|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
16118402|NCT01125514|38920044|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
16118403|NCT01125514|38920044|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
16118404|NCT01125514|38920044|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
16118405|NCT01125514|38920044|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
16118406|NCT01125514|38920044|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
16118407|NCT00552929|38920045|FG000|Overall Study|Lost to Follow-up|0|||
16118408|NCT00552929|38920046|FG001|Overall Study|Lost to Follow-up|0|||
16118409|NCT00552929|38920047|FG002|Overall Study|Lost to Follow-up|0|||
16118410|NCT00552929|38920048|FG003|Overall Study|Lost to Follow-up|0|||
16118411|NCT00552929|38920049|FG004|Overall Study|Lost to Follow-up|0|||
16118412|NCT00552929|38920050|FG005|Overall Study|Lost to Follow-up|0|||
16118413|NCT00552929|38920051|FG006|Overall Study|Lost to Follow-up|0|||
16550837|NCT00068380|40481356|FG000|Overall Study|Withdrawal by Subject|3|||
16550838|NCT00068380|40481356|FG000|Overall Study|Adverse Event|2|||
16550839|NCT02306122|40481359|FG000|Initial Physician Randomization|Physician Decision|0|||
16550840|NCT02306122|40481360|FG001|Initial Physician Randomization|Physician Decision|0|||
16550841|NCT02306122|40481361|FG002|Initial Physician Randomization|Physician Decision|0|||
16550842|NCT02306122|40481362|FG003|Initial Physician Randomization|Physician Decision|0|||
16550843|NCT02306122|40481363|FG004|Initial Physician Randomization|Physician Decision|0|||
16550844|NCT02306122|40481364|FG005|Initial Physician Randomization|Physician Decision|0|||
16550845|NCT02306122|40481365|FG006|Initial Physician Randomization|Physician Decision|0|||
16550846|NCT02306122|40481366|FG007|Initial Physician Randomization|Physician Decision|0|||
16550847|NCT02306122|40481367|FG008|Initial Physician Randomization|Physician Decision|1|||
16550848|NCT02306122|40481368|FG009|Initial Physician Randomization|Physician Decision|0|||
16118414|NCT00552929|38920052|FG007|Overall Study|Lost to Follow-up|0|||
16118415|NCT00552929|38920053|FG008|Overall Study|Lost to Follow-up|1|||
16118416|NCT00552929|38920054|FG009|Overall Study|Lost to Follow-up|0|||
16118417|NCT00552929|38920045|FG000|Overall Study|Not Eligible|0|||
16118418|NCT00552929|38920046|FG001|Overall Study|Not Eligible|0|||
16118419|NCT00552929|38920047|FG002|Overall Study|Not Eligible|0|||
16118420|NCT00552929|38920048|FG003|Overall Study|Not Eligible|0|||
16348087|NCT01000974|39762147|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
16550849|NCT02306122|40481369|FG010|Initial Physician Randomization|Physician Decision|0|||
16550850|NCT00251927|40481370|FG000|Overall Study|Adverse Event|3|||
16118421|NCT00552929|38920049|FG004|Overall Study|Not Eligible|0|||
16118422|NCT00552929|38920050|FG005|Overall Study|Not Eligible|1|||
16118423|NCT00552929|38920051|FG006|Overall Study|Not Eligible|0|||
16118424|NCT00552929|38920052|FG007|Overall Study|Not Eligible|0|||
16118425|NCT00552929|38920053|FG008|Overall Study|Not Eligible|0|||
16118426|NCT00552929|38920054|FG009|Overall Study|Not Eligible|0|||
16118427|NCT00699153|38920055|FG000|Overall Study|Lost to Follow-up|1|||
16118428|NCT00699153|38920056|FG001|Overall Study|Lost to Follow-up|0|||
16118429|NCT00699153|38920055|FG000|Overall Study|Adverse Event|0|||
16118430|NCT00699153|38920056|FG001|Overall Study|Adverse Event|2|||
16118431|NCT00699153|38920055|FG000|Overall Study|Protocol Violation|1|||
16118432|NCT00699153|38920056|FG001|Overall Study|Protocol Violation|0|||
16118433|NCT00699153|38920055|FG000|Overall Study|Travel Problem|1|||
16118434|NCT00699153|38920056|FG001|Overall Study|Travel Problem|0|||
16118435|NCT00277095|38920057|FG000|Overall Study|Death|2|||
16118436|NCT00277095|38920057|FG000|Overall Study|Explanted|7|||
16118437|NCT00277095|38920057|FG000|Overall Study|Lost to Follow-up|2|||
16118438|NCT00277095|38920057|FG000|Overall Study|Missed Follow-up|9|||
16229869|NCT01411917|39324289|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
16550851|NCT00251927|40481371|FG001|Overall Study|Adverse Event|15|||
16550852|NCT00251927|40481370|FG000|Overall Study|Lack of Efficacy|22|||
16550853|NCT00251927|40481371|FG001|Overall Study|Lack of Efficacy|16|||
16550854|NCT00251927|40481370|FG000|Overall Study|Lost to Follow-up|22|||
16550855|NCT00251927|40481371|FG001|Overall Study|Lost to Follow-up|8|||
16550856|NCT00251927|40481370|FG000|Overall Study|Protocol Violation|1|||
16550857|NCT00251927|40481371|FG001|Overall Study|Protocol Violation|2|||
16550858|NCT00251927|40481370|FG000|Overall Study|Pregnancy|2|||
16550859|NCT00251927|40481371|FG001|Overall Study|Pregnancy|0|||
16550860|NCT00251927|40481370|FG000|Overall Study|Withdrawal by Subject|40|||
16550861|NCT00251927|40481371|FG001|Overall Study|Withdrawal by Subject|25|||
16550862|NCT00251927|40481370|FG000|Overall Study|Study-specific discont. achieved|13|||
16550863|NCT00251927|40481371|FG001|Overall Study|Study-specific discont. achieved|2|||
16550864|NCT00251927|40481370|FG000|Overall Study|Study procedure non-compliance|5|||
16550865|NCT00251927|40481371|FG001|Overall Study|Study procedure non-compliance|6|||
16550866|NCT01380990|40481372|FG000|Overall Study|Treatment Failure|1|||
16118439|NCT00277095|38920057|FG000|Overall Study|Physician Decision|1|||
16118440|NCT01216072|38920058|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
16118441|NCT01216072|38920059|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
16118442|NCT01216072|38920058|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
16118443|NCT01216072|38920059|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
16118444|NCT01216072|38920058|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
16118445|NCT01216072|38920059|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
16118446|NCT01216072|38920058|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
16118447|NCT01216072|38920059|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
16118448|NCT01216072|38920058|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
16118449|NCT01216072|38920059|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
16118450|NCT01216072|38920058|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
16118451|NCT01216072|38920059|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
16118452|NCT01216072|38920058|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
16118453|NCT01216072|38920059|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
16118454|NCT01216072|38920058|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
16118455|NCT01216072|38920059|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
16118456|NCT01216072|38920058|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
16118457|NCT01216072|38920059|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
16118458|NCT01216072|38920058|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
16118459|NCT01216072|38920059|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
16118460|NCT03603639|38920060|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
16118461|NCT03603639|38920061|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
16118462|NCT03603639|38920062|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
16118463|NCT03603639|38920063|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
16118464|NCT03603639|38920064|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
16118465|NCT03603639|38920065|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
16118466|NCT03603639|38920060|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
16118467|NCT03603639|38920061|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
16118468|NCT03603639|38920062|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
16118469|NCT03603639|38920063|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
16118470|NCT03603639|38920064|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
16118471|NCT03603639|38920065|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
16118472|NCT04942366|38920066|FG000|Overall Study|Withdrawal by Subject|5|||
16118473|NCT04942366|38920067|FG001|Overall Study|Withdrawal by Subject|5|||
16118474|NCT01865747|38920070|FG000|Overall Study (ITT)|Adverse Event|32|||
16118475|NCT01865747|38920071|FG001|Overall Study (ITT)|Adverse Event|31|||
16118476|NCT01865747|38920070|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
16118477|NCT01865747|38920071|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
16118478|NCT01865747|38920070|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
16118479|NCT01865747|38920071|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
16118480|NCT01865747|38920070|FG000|Overall Study (ITT)|Protocol Violation|1|||
16118481|NCT01865747|38920071|FG001|Overall Study (ITT)|Protocol Violation|1|||
16118482|NCT01865747|38920070|FG000|Overall Study (ITT)|Physician Decision|5|||
16118483|NCT01865747|38920071|FG001|Overall Study (ITT)|Physician Decision|2|||
16118484|NCT01865747|38920070|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
16118485|NCT01865747|38920071|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
16118486|NCT01865747|38920070|FG000|Overall Study (ITT)|Sponsor Decision|0|||
16118487|NCT01865747|38920071|FG001|Overall Study (ITT)|Sponsor Decision|1|||
16118488|NCT01865747|38920070|FG000|Overall Study (ITT)|Progressive Disease|122|||
16118489|NCT01865747|38920071|FG001|Overall Study (ITT)|Progressive Disease|158|||
16118490|NCT01865747|38920070|FG000|Overall Study (ITT)|Reason Not Provided|0|||
16118491|NCT01865747|38920071|FG001|Overall Study (ITT)|Reason Not Provided|1|||
16118492|NCT01865747|38920070|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
16118493|NCT01865747|38920071|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
16118494|NCT01865747|38920070|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
16118495|NCT01865747|38920071|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
16118496|NCT01865747|38920070|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
16118497|NCT01865747|38920071|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
16118498|NCT01865747|38920070|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
16118499|NCT01865747|38920071|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
16118500|NCT01865747|38920070|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
16118501|NCT01865747|38920071|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
16118502|NCT01865747|38920070|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
16118503|NCT01865747|38920071|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
16118504|NCT01865747|38920070|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
16118505|NCT01865747|38920071|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
16118506|NCT01865747|38920070|FG000|Primary Intent to Treat (PITT)|Other|0|||
16118507|NCT01865747|38920071|FG001|Primary Intent to Treat (PITT)|Other|1|||
16118508|NCT00757627|38920076|FG000|Overall Study|Adverse Event|15|||
16118509|NCT00757627|38920076|FG000|Overall Study|Lack of Efficacy|10|||
16118510|NCT00757627|38920076|FG000|Overall Study|Lost to Follow-up|28|||
16118511|NCT00757627|38920076|FG000|Overall Study|Withdrawal by Subject|27|||
16118512|NCT00757627|38920076|FG000|Overall Study|Other|1|||
16118513|NCT00666198|38920077|FG000|Overall Study|Protocol Violation|10|||
16550867|NCT01380990|40481373|FG001|Overall Study|Treatment Failure|0|||
16550868|NCT01380990|40481372|FG000|Overall Study|Death|0|||
16550869|NCT01380990|40481373|FG001|Overall Study|Death|1|||
16550870|NCT05593211|40481376|FG000|Overall Study|Withdrawal by Subject|1|||
16550871|NCT02823964|40481377|FG000|Overall Study|Adverse Event|2|||
16550872|NCT02823964|40481377|FG000|Overall Study|Physician Decision|1|||
16550873|NCT02823964|40481377|FG000|Overall Study|Lack of Efficacy|1|||
16550874|NCT02823964|40481377|FG000|Overall Study|Withdrawal by Subject|1|||
16550875|NCT00553202|40481380|FG000|Overall Study|Death|16|||
16550876|NCT00553202|40481380|FG000|Overall Study|Lost to Follow-up|1|||
16550877|NCT00553202|40481380|FG000|Overall Study|Physician Decision|28|||
16550878|NCT00553202|40481380|FG000|Overall Study|Withdrawal by Subject|1|||
16118514|NCT00666198|38920077|FG000|Overall Study|No Visit After First Day of Treatment|13|||
16118515|NCT00666198|38920077|FG000|Overall Study|Safety Not Assessable|6|||
16118516|NCT00666198|38920077|FG000|Overall Study|No Drug Administration|4|||
16118517|NCT01174446|38920079|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
16118518|NCT01174446|38920080|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
16118519|NCT01174446|38920081|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
16118520|NCT01174446|38920082|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
16118521|NCT01174446|38920079|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
16118522|NCT01174446|38920080|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
16118523|NCT01174446|38920081|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
16118524|NCT01174446|38920082|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
16118525|NCT01174446|38920079|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
16118526|NCT01174446|38920080|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
16118527|NCT01174446|38920081|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
16118528|NCT01174446|38920082|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
16118529|NCT01174446|38920079|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
16118530|NCT01174446|38920080|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
16118531|NCT01174446|38920081|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
16118532|NCT01174446|38920082|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
16118533|NCT01658020|38920083|FG000|Overall Study|Adverse Event|3|||
16118534|NCT01658020|38920084|FG001|Overall Study|Adverse Event|3|||
16118535|NCT01658020|38920083|FG000|Overall Study|Lost to Follow-up|1|||
16118536|NCT01658020|38920084|FG001|Overall Study|Lost to Follow-up|0|||
16118537|NCT01658020|38920083|FG000|Overall Study|Withdrawal by Subject|4|||
16550879|NCT00553202|40481380|FG000|Overall Study|No donor identified|16|||
16550880|NCT00553202|40481380|FG000|Overall Study|Fails to meet organ function|6|||
16550881|NCT00936221|40481381|FG000|Overall Study|Withdrawal by Subject|1|||
16550882|NCT00936221|40481382|FG001|Overall Study|Withdrawal by Subject|1|||
16550883|NCT01993017|40481386|FG000|Overall Study|Death|23|||
16550884|NCT01993017|40481387|FG001|Overall Study|Death|26|||
16550885|NCT01993017|40481388|FG002|Overall Study|Death|18|||
16550886|NCT01993017|40481386|FG000|Overall Study|Could not be contacted|43|||
16550887|NCT01993017|40481387|FG001|Overall Study|Could not be contacted|42|||
16550888|NCT01993017|40481388|FG002|Overall Study|Could not be contacted|38|||
16550889|NCT01993017|40481386|FG000|Overall Study|Dropped out|19|||
16550890|NCT01993017|40481387|FG001|Overall Study|Dropped out|6|||
16550891|NCT01993017|40481388|FG002|Overall Study|Dropped out|11|||
16550892|NCT01993017|40481386|FG000|Overall Study|Other reasons|17|||
16550893|NCT01993017|40481387|FG001|Overall Study|Other reasons|11|||
16550894|NCT01993017|40481388|FG002|Overall Study|Other reasons|7|||
16550895|NCT01993017|40481386|FG000|Overall Study|Ineligible after randomization|4|||
16550896|NCT01993017|40481387|FG001|Overall Study|Ineligible after randomization|5|||
16550897|NCT01993017|40481388|FG002|Overall Study|Ineligible after randomization|5|||
16550898|NCT01794117|40481389|FG000|Overall Study|Adverse Event|1|||
16550899|NCT01794117|40481390|FG001|Overall Study|Adverse Event|0|||
16550900|NCT01794117|40481391|FG002|Overall Study|Adverse Event|0|||
16550901|NCT01794117|40481392|FG003|Overall Study|Adverse Event|0|||
16550902|NCT01794117|40481389|FG000|Overall Study|Participant noncompliance|0|||
16550903|NCT01794117|40481390|FG001|Overall Study|Participant noncompliance|1|||
16550904|NCT01794117|40481391|FG002|Overall Study|Participant noncompliance|0|||
16550905|NCT01794117|40481392|FG003|Overall Study|Participant noncompliance|0|||
16550906|NCT01794117|40481389|FG000|Overall Study|Refused further treatment|0|||
16550907|NCT01794117|40481390|FG001|Overall Study|Refused further treatment|2|||
16550908|NCT01794117|40481391|FG002|Overall Study|Refused further treatment|0|||
16550909|NCT01794117|40481392|FG003|Overall Study|Refused further treatment|0|||
16550910|NCT04404478|40481393|FG000|Overall Study|Withdrawal by Subject|1|||
16550911|NCT04404478|40481394|FG001|Overall Study|Withdrawal by Subject|3|||
16550912|NCT03447730|40481395|FG000|Overall Study|Adverse Event|0|||
16550913|NCT03447730|40481396|FG001|Overall Study|Adverse Event|2|||
16550914|NCT03447730|40481397|FG002|Overall Study|Adverse Event|0|||
16550915|NCT04599101|40481399|FG000|Overall Study|Lost to Follow-up|5|||
16550916|NCT04599101|40481400|FG001|Overall Study|Lost to Follow-up|5|||
16550917|NCT04651114|40481401|FG000|Overall Study|Withdrawal by Subject|8|||
16550918|NCT01863043|40481402|FG000|Overall Study|Death|6|||
16550919|NCT01863043|40481403|FG001|Overall Study|Death|1|||
16229870|NCT01411917|39324290|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
16229871|NCT04177862|39324293|FG000|Overall Study|Protocol Violation|2|||
16229872|NCT04177862|39324294|FG001|Overall Study|Protocol Violation|7|||
16229873|NCT02210559|39324302|FG000|Overall Study|Progressive Disease|3|||
16229874|NCT02210559|39324303|FG001|Overall Study|Progressive Disease|2|||
16229875|NCT02210559|39324302|FG000|Overall Study|Adverse Event|2|||
16229876|NCT02210559|39324303|FG001|Overall Study|Adverse Event|2|||
16229877|NCT02210559|39324302|FG000|Overall Study|Physician Decision|1|||
16229878|NCT02210559|39324303|FG001|Overall Study|Physician Decision|0|||
16229879|NCT02210559|39324302|FG000|Overall Study|Withdrawal by Subject|0|||
16229880|NCT02210559|39324303|FG001|Overall Study|Withdrawal by Subject|1|||
16229881|NCT02210559|39324302|FG000|Overall Study|Other than specified|0|||
16229882|NCT02210559|39324303|FG001|Overall Study|Other than specified|1|||
16229883|NCT03237325|39324305|FG000|Overall Study|Lost to Follow-up|3|||
16229884|NCT03237325|39324306|FG001|Overall Study|Lost to Follow-up|5|||
16229885|NCT03237325|39324305|FG000|Overall Study|Physician Decision|2|||
16229886|NCT03237325|39324306|FG001|Overall Study|Physician Decision|4|||
16229887|NCT03237325|39324305|FG000|Overall Study|Withdrawal by Subject|9|||
16229888|NCT03237325|39324306|FG001|Overall Study|Withdrawal by Subject|12|||
16229889|NCT03237325|39324305|FG000|Overall Study|Noncompliance with Study Procedures|1|||
16229890|NCT03237325|39324306|FG001|Overall Study|Noncompliance with Study Procedures|1|||
16229891|NCT03237325|39324305|FG000|Overall Study|Termination by Sponsor|0|||
16229892|NCT03237325|39324306|FG001|Overall Study|Termination by Sponsor|1|||
16229893|NCT03237325|39324305|FG000|Overall Study|Reason other than described|0|||
16229894|NCT03237325|39324306|FG001|Overall Study|Reason other than described|2|||
16229895|NCT00066573|39324307|FG000|Overall Study|Did not received protocol treatment|28|||
16229896|NCT00066573|39324308|FG001|Overall Study|Did not received protocol treatment|28|||
16229897|NCT03878108|39324309|FG000|Overall Study|Adverse Event|1|||
16229898|NCT03878108|39324310|FG001|Overall Study|Adverse Event|0|||
16229899|NCT02341482|39324314|FG000|Overall Study|Adverse Event|1|||
16229900|NCT04144140|39324315|FG000|Overall Study|Other|0|||
16229901|NCT04144140|39324316|FG001|Overall Study|Other|0|||
16229902|NCT04144140|39324317|FG002|Overall Study|Other|0|||
16348088|NCT01000974|39762145|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
16348089|NCT01000974|39762146|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
16348090|NCT01000974|39762147|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
16348091|NCT01000974|39762145|FG000|Primary Vaccination Phase|Protocol Violation|40|||
16348092|NCT01000974|39762146|FG001|Primary Vaccination Phase|Protocol Violation|3|||
16348093|NCT01000974|39762147|FG002|Primary Vaccination Phase|Protocol Violation|2|||
16348094|NCT01000974|39762145|FG000|Primary Vaccination Phase|Adverse Event|14|||
16348095|NCT01000974|39762146|FG001|Primary Vaccination Phase|Adverse Event|2|||
16348096|NCT01000974|39762147|FG002|Primary Vaccination Phase|Adverse Event|2|||
16348097|NCT01000974|39762145|FG000|Primary Vaccination Phase|Other|4|||
16348098|NCT01000974|39762146|FG001|Primary Vaccination Phase|Other|9|||
16229903|NCT04144140|39324318|FG003|Overall Study|Other|0|||
16348099|NCT01000974|39762147|FG002|Primary Vaccination Phase|Other|12|||
16348100|NCT01000974|39762145|FG000|Booster Vaccination Phase|Protocol Violation|0|||
16348101|NCT01000974|39762146|FG001|Booster Vaccination Phase|Protocol Violation|0|||
16229904|NCT04144140|39324319|FG004|Overall Study|Other|0|||
16550920|NCT01863043|40481402|FG000|Overall Study|Withdrawal by Subject|0|||
16550921|NCT01863043|40481403|FG001|Overall Study|Withdrawal by Subject|2|||
16550922|NCT01863043|40481402|FG000|Overall Study|Adverse Event|7|||
16550923|NCT01863043|40481403|FG001|Overall Study|Adverse Event|8|||
16229905|NCT04144140|39324320|FG005|Overall Study|Other|1|||
16229906|NCT04144140|39324321|FG006|Overall Study|Other|0|||
16229907|NCT02687815|39324322|FG000|Overall Study|Lost to Follow-up|2|||
16229908|NCT02687815|39324323|FG001|Overall Study|Lost to Follow-up|4|||
16229909|NCT02687815|39324322|FG000|Overall Study|Withdrawal by Subject|2|||
16229910|NCT02687815|39324323|FG001|Overall Study|Withdrawal by Subject|4|||
16229911|NCT00948896|39324324|FG000|Randomization to 24 Months of Age|Death|1|||
16229912|NCT00948896|39324325|FG001|Randomization to 24 Months of Age|Death|0|||
16229913|NCT00948896|39324326|FG002|Randomization to 24 Months of Age|Death|0|||
16229914|NCT00948896|39324327|FG003|Randomization to 24 Months of Age|Death|0|||
16229915|NCT00948896|39324328|FG004|Randomization to 24 Months of Age|Death|2|||
16229916|NCT00948896|39324329|FG005|Randomization to 24 Months of Age|Death|1|||
16229917|NCT00948896|39324330|FG006|Randomization to 24 Months of Age|Death|2|||
16229918|NCT00948896|39324331|FG007|Randomization to 24 Months of Age|Death|1|||
16229919|NCT00948896|39324324|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
16229920|NCT00948896|39324325|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
16229921|NCT00948896|39324326|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
16229922|NCT00948896|39324327|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
16229923|NCT00948896|39324328|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
16229924|NCT00948896|39324329|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
16229925|NCT00948896|39324330|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
16229926|NCT00948896|39324331|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
16229927|NCT00948896|39324324|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
16229928|NCT00948896|39324325|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
16229929|NCT00948896|39324326|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
16229930|NCT00948896|39324327|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
16229931|NCT00948896|39324328|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
16229932|NCT00948896|39324329|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
16229933|NCT00948896|39324330|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
16229934|NCT00948896|39324331|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
16229935|NCT00948896|39324324|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
16229936|NCT00948896|39324325|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
16229937|NCT00948896|39324326|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
16229938|NCT00948896|39324327|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
16229939|NCT00948896|39324328|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
16229940|NCT00948896|39324329|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
16229941|NCT00948896|39324330|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
16229942|NCT00948896|39324331|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
16229943|NCT00948896|39324324|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
16229944|NCT00948896|39324325|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
16229945|NCT00948896|39324326|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
16229946|NCT00948896|39324327|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
16229947|NCT00948896|39324328|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
16229948|NCT00948896|39324329|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
16229949|NCT00948896|39324330|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
16229950|NCT00948896|39324331|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
16229951|NCT00948896|39324324|FG000|24 Months of Age to 36 Months of Age|Death|0|||
16229952|NCT00948896|39324325|FG001|24 Months of Age to 36 Months of Age|Death|2|||
16229953|NCT00948896|39324326|FG002|24 Months of Age to 36 Months of Age|Death|2|||
16229954|NCT00948896|39324327|FG003|24 Months of Age to 36 Months of Age|Death|0|||
16229955|NCT00948896|39324328|FG004|24 Months of Age to 36 Months of Age|Death|0|||
16229956|NCT00948896|39324329|FG005|24 Months of Age to 36 Months of Age|Death|1|||
16229957|NCT00948896|39324330|FG006|24 Months of Age to 36 Months of Age|Death|0|||
16229958|NCT00948896|39324331|FG007|24 Months of Age to 36 Months of Age|Death|0|||
16229959|NCT00948896|39324324|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
16229960|NCT00948896|39324325|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
16229961|NCT00948896|39324326|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
16229962|NCT00948896|39324327|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
16229963|NCT00948896|39324328|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
16229964|NCT00948896|39324329|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
16229965|NCT00948896|39324330|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
16229966|NCT00948896|39324331|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
16229967|NCT00948896|39324324|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
16229968|NCT00948896|39324325|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
16229969|NCT00948896|39324326|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
16229970|NCT00948896|39324327|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
16229971|NCT00948896|39324328|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
16229972|NCT00948896|39324329|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
16229973|NCT00948896|39324330|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
16229974|NCT00948896|39324331|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
16229975|NCT00948896|39324324|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16229976|NCT00948896|39324325|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16229977|NCT00948896|39324326|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
16118538|NCT01658020|38920084|FG001|Overall Study|Withdrawal by Subject|5|||
16118539|NCT01658020|38920083|FG000|Overall Study|Protocol Violation|0|||
16118540|NCT01658020|38920084|FG001|Overall Study|Protocol Violation|1|||
16118541|NCT01191008|38920085|FG000|Overall Study|Protocol Violation|7|||
16118542|NCT01191008|38920085|FG000|Overall Study|Lost to Follow-up|8|||
16118543|NCT00972322|38920086|FG000|Overall Study|Adverse Event|2|||
16118544|NCT00972322|38920087|FG001|Overall Study|Adverse Event|1|||
16118545|NCT00972322|38920086|FG000|Overall Study|Positive drug screen|0|||
16118546|NCT00972322|38920087|FG001|Overall Study|Positive drug screen|1|||
16229978|NCT00948896|39324327|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16229979|NCT00948896|39324328|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16229980|NCT00948896|39324329|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
16229981|NCT00948896|39324330|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16229982|NCT00948896|39324331|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
16229983|NCT00948896|39324324|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16229984|NCT00948896|39324325|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16229985|NCT00948896|39324326|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16229986|NCT00948896|39324327|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
16229987|NCT00948896|39324328|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16229988|NCT00948896|39324329|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16229989|NCT00948896|39324330|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16229990|NCT00948896|39324331|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
16229991|NCT00442572|39324338|FG000|Overall Study|Relapse|8|||
16229992|NCT00442572|39324339|FG001|Overall Study|Relapse|1|||
16229993|NCT00442572|39324338|FG000|Overall Study|Lost to Follow-up|0|||
16229994|NCT00442572|39324339|FG001|Overall Study|Lost to Follow-up|1|||
16229995|NCT00442572|39324338|FG000|Overall Study|Withdrawal by Subject|0|||
16229996|NCT00442572|39324339|FG001|Overall Study|Withdrawal by Subject|1|||
16229997|NCT02441517|39324340|FG000|Overall Study|Lost to Follow-up|1|||
16229998|NCT02441517|39324340|FG000|Overall Study|Withdrawal by Subject|2|||
16229999|NCT02441517|39324340|FG000|Overall Study|Study Terminated by Sponsor|1|||
16230000|NCT03457701|39324345|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
16230001|NCT03457701|39324346|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
16230002|NCT03457701|39324345|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
16230003|NCT03457701|39324346|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
16230004|NCT01539512|39324347|FG000|Overall Study|Adverse Event|9|||
16230005|NCT01539512|39324348|FG001|Overall Study|Adverse Event|7|||
16230006|NCT01539512|39324347|FG000|Overall Study|Physician Decision|1|||
16230007|NCT01539512|39324348|FG001|Overall Study|Physician Decision|1|||
16230008|NCT01539512|39324347|FG000|Overall Study|Withdrawal by Subject|12|||
16230009|NCT01539512|39324348|FG001|Overall Study|Withdrawal by Subject|5|||
16230010|NCT01539512|39324347|FG000|Overall Study|Richter's Transformation|1|||
16230011|NCT01539512|39324348|FG001|Overall Study|Richter's Transformation|0|||
16230012|NCT01590628|39324349|FG000|Overall Study|Death|2|||
16230013|NCT01590628|39324350|FG001|Overall Study|Death|0|||
16230014|NCT01491802|39324351|FG000|Overall Study|Adverse Event|1|||
16230015|NCT01491802|39324352|FG001|Overall Study|Adverse Event|1|||
16230016|NCT01491802|39324351|FG000|Overall Study|Withdrawal by Subject|0|||
16230017|NCT01491802|39324352|FG001|Overall Study|Withdrawal by Subject|1|||
16230018|NCT00465101|39324353|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
16230019|NCT00465101|39324353|FG000|Overall Study|Change in health precluded follow up|4|||
16230020|NCT00465101|39324353|FG000|Overall Study|Did not meet study criteria|4|||
16230021|NCT00465101|39324353|FG000|Overall Study|Lost to Follow-up|5|||
16230022|NCT00465101|39324353|FG000|Overall Study|Other|6|||
16230023|NCT00465101|39324353|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
16230024|NCT00465101|39324353|FG000|Overall Study|Patient postponed procedure|1|||
16230025|NCT00465101|39324353|FG000|Overall Study|Site closed due to IRB expiration|1|||
16230026|NCT00465101|39324353|FG000|Overall Study|Unable to obtain IRB approval|1|||
16230027|NCT00465101|39324353|FG000|Overall Study|Death|3|||
16230028|NCT00465101|39324353|FG000|Overall Study|Withdrawal by Subject|25|||
16230029|NCT00465101|39324353|FG000|Overall Study|Physician Decision|1|||
16230030|NCT00465101|39324353|FG000|Overall Study|Withdrew consent prior to procedure|3|||
16230031|NCT00903357|39324354|FG000|First Intervention|Withdrawal by Subject|5|||
16230032|NCT00903357|39324355|FG001|First Intervention|Withdrawal by Subject|3|||
16230033|NCT00903357|39324354|FG000|First Intervention|Flu|0|||
16230034|NCT00903357|39324355|FG001|First Intervention|Flu|1|||
16230035|NCT00903357|39324354|FG000|Wash Out Period of 2 Weeks|Flu|0|||
16230036|NCT00903357|39324355|FG001|Wash Out Period of 2 Weeks|Flu|1|||
16118547|NCT00972322|38920086|FG000|Overall Study|Lost to Follow-up|0|||
16118548|NCT00972322|38920087|FG001|Overall Study|Lost to Follow-up|1|||
16118549|NCT00972322|38920086|FG000|Overall Study|Consistently high glucose values|1|||
16118550|NCT00972322|38920087|FG001|Overall Study|Consistently high glucose values|0|||
16118551|NCT00589303|38920089|FG000|Overall Study|Withdrawal by Subject|2|||
16118552|NCT00589303|38920090|FG001|Overall Study|Withdrawal by Subject|1|||
16118553|NCT01443403|38920098|FG000|Overall Study|Adverse Event|1|||
16118554|NCT01443403|38920099|FG001|Overall Study|Adverse Event|1|||
16118555|NCT01443403|38920100|FG002|Overall Study|Adverse Event|4|||
16118556|NCT01443403|38920101|FG003|Overall Study|Adverse Event|5|||
16118557|NCT01443403|38920098|FG000|Overall Study|Withdrawal by Subject|0|||
16118558|NCT01443403|38920099|FG001|Overall Study|Withdrawal by Subject|1|||
16230037|NCT00903357|39324354|FG000|Second Intervention|Lost to Follow-up|1|||
16230038|NCT00903357|39324355|FG001|Second Intervention|Lost to Follow-up|0|||
16412358|NCT00468845|39992167|FG001|Overall Study|Randomized, not treated|4|||
16412359|NCT00468845|39992168|FG002|Overall Study|Randomized, not treated|2|||
16412360|NCT01945775|39992170|FG000|Overall Study|Death|214|||
16412361|NCT01945775|39992171|FG001|Overall Study|Death|98|||
16412362|NCT01945775|39992170|FG000|Overall Study|Lost to Follow-up|12|||
16412363|NCT01945775|39992171|FG001|Overall Study|Lost to Follow-up|7|||
16412364|NCT01945775|39992170|FG000|Overall Study|Withdrawal by Subject|11|||
16412365|NCT01945775|39992171|FG001|Overall Study|Withdrawal by Subject|21|||
16412366|NCT01945775|39992170|FG000|Overall Study|Other|50|||
16412367|NCT01945775|39992171|FG001|Overall Study|Other|18|||
16412368|NCT03959982|39992172|FG000|Overall Study|Withdrawal by Subject|1|||
16412369|NCT03959982|39992173|FG001|Overall Study|Withdrawal by Subject|0|||
16412370|NCT03959982|39992172|FG000|Overall Study|Physician Decision|2|||
16412371|NCT03959982|39992173|FG001|Overall Study|Physician Decision|0|||
16230039|NCT01333501|39324356|FG000|Overall Study|Adverse Event|3|||
16230040|NCT01333501|39324357|FG001|Overall Study|Adverse Event|1|||
16230041|NCT01333501|39324356|FG000|Overall Study|Abnormal laboratory value|2|||
16230042|NCT01333501|39324357|FG001|Overall Study|Abnormal laboratory value|1|||
16230043|NCT01333501|39324356|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16230044|NCT01333501|39324357|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
16230045|NCT01333501|39324356|FG000|Overall Study|Withdrawn consent|3|||
16230046|NCT01333501|39324357|FG001|Overall Study|Withdrawn consent|12|||
16230047|NCT01465958|39324359|FG000|Run-in Phase|Protocol Violation|1|||
16230048|NCT01465958|39324360|FG001|Run-in Phase|Protocol Violation|0|||
16230049|NCT01465958|39324359|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
16230050|NCT01465958|39324360|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
16230051|NCT01422876|39324361|FG000|Week 24|Lost to Follow-up|1|||
16230052|NCT01422876|39324362|FG001|Week 24|Lost to Follow-up|1|||
16230053|NCT01422876|39324363|FG002|Week 24|Lost to Follow-up|2|||
16230054|NCT01422876|39324364|FG003|Week 24|Lost to Follow-up|4|||
16230055|NCT01422876|39324365|FG004|Week 24|Lost to Follow-up|2|||
16230056|NCT01422876|39324366|FG005|Week 24|Lost to Follow-up|0|||
16230057|NCT01422876|39324367|FG006|Week 24|Lost to Follow-up|1|||
16230058|NCT01422876|39324368|FG007|Week 24|Lost to Follow-up|3|||
16230059|NCT01422876|39324369|FG008|Week 24|Lost to Follow-up|3|||
16230060|NCT01422876|39324370|FG009|Week 24|Lost to Follow-up|4|||
16230061|NCT01422876|39324361|FG000|Week 24|Consent withdrawn|5|||
16230062|NCT01422876|39324362|FG001|Week 24|Consent withdrawn|1|||
16230063|NCT01422876|39324363|FG002|Week 24|Consent withdrawn|3|||
16230064|NCT01422876|39324364|FG003|Week 24|Consent withdrawn|4|||
16230065|NCT01422876|39324365|FG004|Week 24|Consent withdrawn|5|||
16230066|NCT01422876|39324366|FG005|Week 24|Consent withdrawn|6|||
16230067|NCT01422876|39324367|FG006|Week 24|Consent withdrawn|5|||
16230068|NCT01422876|39324368|FG007|Week 24|Consent withdrawn|4|||
16230069|NCT01422876|39324369|FG008|Week 24|Consent withdrawn|3|||
16230070|NCT01422876|39324370|FG009|Week 24|Consent withdrawn|6|||
16230071|NCT01422876|39324361|FG000|Week 24|Death|0|||
16230072|NCT01422876|39324362|FG001|Week 24|Death|1|||
16230073|NCT01422876|39324363|FG002|Week 24|Death|0|||
16230074|NCT01422876|39324364|FG003|Week 24|Death|0|||
16230075|NCT01422876|39324365|FG004|Week 24|Death|0|||
16230076|NCT01422876|39324366|FG005|Week 24|Death|0|||
16230077|NCT01422876|39324367|FG006|Week 24|Death|0|||
16230078|NCT01422876|39324368|FG007|Week 24|Death|0|||
16230079|NCT01422876|39324369|FG008|Week 24|Death|0|||
16230080|NCT01422876|39324370|FG009|Week 24|Death|0|||
16230081|NCT01422876|39324361|FG000|Week 52|Lost to Follow-up|3|||
16230082|NCT01422876|39324362|FG001|Week 52|Lost to Follow-up|5|||
16230083|NCT01422876|39324363|FG002|Week 52|Lost to Follow-up|7|||
16230084|NCT01422876|39324364|FG003|Week 52|Lost to Follow-up|5|||
16230085|NCT01422876|39324365|FG004|Week 52|Lost to Follow-up|8|||
16230086|NCT01422876|39324366|FG005|Week 52|Lost to Follow-up|5|||
16230087|NCT01422876|39324367|FG006|Week 52|Lost to Follow-up|5|||
16230088|NCT01422876|39324368|FG007|Week 52|Lost to Follow-up|8|||
16230089|NCT01422876|39324369|FG008|Week 52|Lost to Follow-up|7|||
16230090|NCT01422876|39324370|FG009|Week 52|Lost to Follow-up|8|||
16412372|NCT03959982|39992172|FG000|Overall Study|Lost to Follow-up|1|||
16412373|NCT03959982|39992173|FG001|Overall Study|Lost to Follow-up|0|||
16550924|NCT01863043|40481402|FG000|Overall Study|exclusion criteria found after enrollment|0|||
16550925|NCT01863043|40481403|FG001|Overall Study|exclusion criteria found after enrollment|1|||
16412374|NCT00831701|39992174|FG000|Overall Study|Withdrawal by Subject|2|||
16230091|NCT01422876|39324361|FG000|Week 52|Consent withdrawn|9|||
16230092|NCT01422876|39324362|FG001|Week 52|Consent withdrawn|4|||
16230093|NCT01422876|39324363|FG002|Week 52|Consent withdrawn|6|||
16230094|NCT01422876|39324364|FG003|Week 52|Consent withdrawn|12|||
16230095|NCT01422876|39324365|FG004|Week 52|Consent withdrawn|7|||
16230096|NCT01422876|39324366|FG005|Week 52|Consent withdrawn|12|||
16230097|NCT01422876|39324367|FG006|Week 52|Consent withdrawn|10|||
16230098|NCT01422876|39324368|FG007|Week 52|Consent withdrawn|12|||
16230099|NCT01422876|39324369|FG008|Week 52|Consent withdrawn|13|||
16230100|NCT01422876|39324370|FG009|Week 52|Consent withdrawn|9|||
16230101|NCT01422876|39324361|FG000|Week 52|Death|0|||
16412375|NCT00831701|39992175|FG001|Overall Study|Withdrawal by Subject|0|||
16230102|NCT01422876|39324362|FG001|Week 52|Death|1|||
16230103|NCT01422876|39324363|FG002|Week 52|Death|0|||
16230104|NCT01422876|39324364|FG003|Week 52|Death|1|||
16230105|NCT01422876|39324365|FG004|Week 52|Death|0|||
16230106|NCT01422876|39324366|FG005|Week 52|Death|0|||
16230107|NCT01422876|39324367|FG006|Week 52|Death|1|||
16348102|NCT01000974|39762147|FG002|Booster Vaccination Phase|Protocol Violation|2|||
16550926|NCT01190215|40481404|FG000|Up to Month 6|Lost to Follow-up|2|||
16348103|NCT01000974|39762145|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
16348104|NCT01000974|39762146|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
16348105|NCT01000974|39762147|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
16348106|NCT01000974|39762145|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
16348107|NCT01000974|39762146|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
16348108|NCT01000974|39762147|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
16348109|NCT01000974|39762145|FG000|Booster Vaccination Phase|Other|24|||
16348110|NCT01000974|39762146|FG001|Booster Vaccination Phase|Other|6|||
16550927|NCT01190215|40481405|FG001|Up to Month 6|Lost to Follow-up|0|||
16550928|NCT00519896|40481406|FG000|Overall Study|Protocol Violation|1|||
16550929|NCT00519896|40481406|FG000|Overall Study|Adverse Event|1|||
16550930|NCT02009696|40481407|FG000|Overall Study|Withdrawal by Subject|2|||
16550931|NCT00734214|40481411|FG000|Overall Study|Withdrawal by Subject|3|||
16550932|NCT00734214|40481412|FG001|Overall Study|Withdrawal by Subject|4|||
16550933|NCT00734214|40481411|FG000|Overall Study|MD withdrawal|1|||
16550934|NCT00734214|40481412|FG001|Overall Study|MD withdrawal|0|||
16550935|NCT03086018|40481413|FG000|Final Testing for End of Trial|Adverse Event|1|||
16550936|NCT03086018|40481413|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
16550937|NCT00064025|40481414|FG000|Overall Study|Ineligible|4|||
16550938|NCT00064025|40481414|FG000|Overall Study|Inevaluable|3|||
16550939|NCT04170686|40481415|FG000|Screening|Physician Decision|12|||
16550940|NCT04170686|40481416|FG001|Screening|Physician Decision|13|||
16550941|NCT04170686|40481415|FG000|Randomization and Treatment|Lost to Follow-up|26|||
16550942|NCT04170686|40481416|FG001|Randomization and Treatment|Lost to Follow-up|15|||
16550943|NCT00393523|40481422|FG000|Overall Study|Lost to Follow-up|0|||
16550944|NCT00393523|40481423|FG001|Overall Study|Lost to Follow-up|0|||
16550945|NCT00393523|40481424|FG002|Overall Study|Lost to Follow-up|0|||
16550946|NCT00393523|40481425|FG003|Overall Study|Lost to Follow-up|2|||
16550947|NCT00393523|40481426|FG004|Overall Study|Lost to Follow-up|1|||
16550948|NCT00393523|40481422|FG000|Overall Study|Protocol Violation|6|||
16550949|NCT00393523|40481423|FG001|Overall Study|Protocol Violation|2|||
16550950|NCT00393523|40481424|FG002|Overall Study|Protocol Violation|0|||
16550951|NCT00393523|40481425|FG003|Overall Study|Protocol Violation|1|||
16550952|NCT00393523|40481426|FG004|Overall Study|Protocol Violation|0|||
16550953|NCT00393523|40481422|FG000|Overall Study|Withdrawal by Subject|6|||
16550954|NCT00393523|40481423|FG001|Overall Study|Withdrawal by Subject|7|||
16550955|NCT00393523|40481424|FG002|Overall Study|Withdrawal by Subject|2|||
16550956|NCT00393523|40481425|FG003|Overall Study|Withdrawal by Subject|3|||
16550957|NCT00393523|40481426|FG004|Overall Study|Withdrawal by Subject|0|||
16550958|NCT00393523|40481422|FG000|Overall Study|Difficulties in specimen collection|0|||
16550959|NCT00393523|40481423|FG001|Overall Study|Difficulties in specimen collection|0|||
16550960|NCT00393523|40481424|FG002|Overall Study|Difficulties in specimen collection|1|||
16550961|NCT00393523|40481425|FG003|Overall Study|Difficulties in specimen collection|0|||
16550962|NCT00393523|40481426|FG004|Overall Study|Difficulties in specimen collection|0|||
16550963|NCT00393523|40481422|FG000|Overall Study|Vaccine supply issue|0|||
16550964|NCT00393523|40481423|FG001|Overall Study|Vaccine supply issue|0|||
16550965|NCT00393523|40481424|FG002|Overall Study|Vaccine supply issue|1|||
16550966|NCT00393523|40481425|FG003|Overall Study|Vaccine supply issue|0|||
16550967|NCT00393523|40481426|FG004|Overall Study|Vaccine supply issue|0|||
16550968|NCT02247804|40481431|FG000|Treatment Period 1|Adverse Event|9|||
16550969|NCT02247804|40481432|FG001|Treatment Period 1|Adverse Event|2|||
16550970|NCT02247804|40481433|FG002|Treatment Period 1|Adverse Event|0|||
16550971|NCT02247804|40481431|FG000|Treatment Period 1|Lack of Efficacy|0|||
16550972|NCT02247804|40481432|FG001|Treatment Period 1|Lack of Efficacy|0|||
16550973|NCT02247804|40481433|FG002|Treatment Period 1|Lack of Efficacy|2|||
16550974|NCT02247804|40481431|FG000|Treatment Period 1|Lost to Follow-up|1|||
16550975|NCT02247804|40481432|FG001|Treatment Period 1|Lost to Follow-up|0|||
16550976|NCT02247804|40481433|FG002|Treatment Period 1|Lost to Follow-up|2|||
16550977|NCT02247804|40481431|FG000|Treatment Period 1|Personal Reasons|7|||
16550978|NCT02247804|40481432|FG001|Treatment Period 1|Personal Reasons|1|||
16550979|NCT02247804|40481433|FG002|Treatment Period 1|Personal Reasons|2|||
16550980|NCT02247804|40481431|FG000|Treatment Period 1|Protocol Deviation|0|||
16550981|NCT02247804|40481432|FG001|Treatment Period 1|Protocol Deviation|0|||
16550982|NCT02247804|40481433|FG002|Treatment Period 1|Protocol Deviation|1|||
16550983|NCT02247804|40481431|FG000|Treatment Period 1|Randomized but not Treated|5|||
16550984|NCT02247804|40481432|FG001|Treatment Period 1|Randomized but not Treated|1|||
16550985|NCT02247804|40481433|FG002|Treatment Period 1|Randomized but not Treated|1|||
16230108|NCT01422876|39324368|FG007|Week 52|Death|3|||
16230109|NCT01422876|39324369|FG008|Week 52|Death|1|||
16230110|NCT01422876|39324370|FG009|Week 52|Death|0|||
16412376|NCT00831701|39992174|FG000|Overall Study|Stone expulsion before first medication|2|||
16412377|NCT00831701|39992175|FG001|Overall Study|Stone expulsion before first medication|2|||
16412378|NCT00831701|39992174|FG000|Overall Study|Lost to Follow-up|1|||
16412379|NCT00831701|39992175|FG001|Overall Study|Lost to Follow-up|3|||
16412380|NCT03266172|39992179|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
16412381|NCT03266172|39992180|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
16412382|NCT03266172|39992181|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
16412383|NCT03266172|39992179|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
16412384|NCT03266172|39992180|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
16412385|NCT03266172|39992181|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
16412386|NCT03266172|39992179|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
16412387|NCT03266172|39992180|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
16412388|NCT03266172|39992181|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
16412389|NCT03266172|39992179|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
16412390|NCT03266172|39992180|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
16412391|NCT03266172|39992181|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
16412392|NCT03266172|39992179|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
16412393|NCT03266172|39992180|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
16412394|NCT03266172|39992181|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
16412395|NCT03266172|39992179|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
16412396|NCT03266172|39992180|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
16550986|NCT02247804|40481431|FG000|Treatment Period 2|Adverse Event|6|||
16550987|NCT02247804|40481432|FG001|Treatment Period 2|Adverse Event|3|||
16550988|NCT02247804|40481433|FG002|Treatment Period 2|Adverse Event|3|||
16550989|NCT02247804|40481431|FG000|Treatment Period 2|Lack of Efficacy|0|||
16550990|NCT02247804|40481432|FG001|Treatment Period 2|Lack of Efficacy|0|||
16550991|NCT02247804|40481433|FG002|Treatment Period 2|Lack of Efficacy|1|||
16550992|NCT02247804|40481431|FG000|Treatment Period 2|Lost to Follow-up|0|||
16550993|NCT02247804|40481432|FG001|Treatment Period 2|Lost to Follow-up|1|||
16550994|NCT02247804|40481433|FG002|Treatment Period 2|Lost to Follow-up|1|||
16550995|NCT02247804|40481431|FG000|Treatment Period 2|Personal Reasons|2|||
16550996|NCT02247804|40481432|FG001|Treatment Period 2|Personal Reasons|1|||
16550997|NCT02247804|40481433|FG002|Treatment Period 2|Personal Reasons|1|||
16550998|NCT02247804|40481431|FG000|Treatment Period 2|Reason not Specified|0|||
16550999|NCT02247804|40481432|FG001|Treatment Period 2|Reason not Specified|0|||
16118559|NCT01443403|38920100|FG002|Overall Study|Withdrawal by Subject|2|||
16118560|NCT01443403|38920101|FG003|Overall Study|Withdrawal by Subject|1|||
16118561|NCT01443403|38920098|FG000|Overall Study|Lost to Follow-up|0|||
16118562|NCT01443403|38920099|FG001|Overall Study|Lost to Follow-up|0|||
16118563|NCT01443403|38920100|FG002|Overall Study|Lost to Follow-up|0|||
16118564|NCT01443403|38920101|FG003|Overall Study|Lost to Follow-up|1|||
16118565|NCT01443403|38920098|FG000|Overall Study|Protocol Violation|2|||
16412397|NCT03266172|39992181|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
16412398|NCT03697993|39992182|FG000|Overall Study|Became Ineligible after Enrollment|1|||
16412399|NCT03697993|39992183|FG001|Overall Study|Became Ineligible after Enrollment|3|||
16412400|NCT03697993|39992182|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
16412401|NCT03697993|39992183|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
16412402|NCT03697993|39992182|FG000|Overall Study|Lost to Follow-up|3|||
16412403|NCT03697993|39992183|FG001|Overall Study|Lost to Follow-up|0|||
16412404|NCT03697993|39992182|FG000|Overall Study|Physician Decision|4|||
16412405|NCT03697993|39992183|FG001|Overall Study|Physician Decision|0|||
16412406|NCT03697993|39992182|FG000|Overall Study|Initial Urine Culture Negative|0|||
16551000|NCT02247804|40481433|FG002|Treatment Period 2|Reason not Specified|2|||
16551001|NCT02247804|40481431|FG000|Treatment Period 3|Adverse Event|4|||
16551002|NCT02247804|40481432|FG001|Treatment Period 3|Adverse Event|3|||
16551003|NCT02247804|40481433|FG002|Treatment Period 3|Adverse Event|3|||
16551004|NCT02247804|40481431|FG000|Treatment Period 3|Lack of Efficacy|0|||
16551005|NCT02247804|40481432|FG001|Treatment Period 3|Lack of Efficacy|1|||
16551006|NCT02247804|40481433|FG002|Treatment Period 3|Lack of Efficacy|0|||
16118566|NCT01443403|38920099|FG001|Overall Study|Protocol Violation|1|||
16118567|NCT01443403|38920100|FG002|Overall Study|Protocol Violation|1|||
16551007|NCT02247804|40481431|FG000|Treatment Period 3|Lost to Follow-up|1|||
16551008|NCT02247804|40481432|FG001|Treatment Period 3|Lost to Follow-up|2|||
16551009|NCT02247804|40481433|FG002|Treatment Period 3|Lost to Follow-up|2|||
16551010|NCT02247804|40481431|FG000|Treatment Period 3|Personal Reasons|4|||
16551011|NCT02247804|40481432|FG001|Treatment Period 3|Personal Reasons|3|||
16551012|NCT02247804|40481433|FG002|Treatment Period 3|Personal Reasons|2|||
16118568|NCT01443403|38920101|FG003|Overall Study|Protocol Violation|1|||
16118569|NCT01443403|38920098|FG000|Overall Study|Use of Prohibited Treatment|2|||
16118570|NCT01443403|38920099|FG001|Overall Study|Use of Prohibited Treatment|3|||
16118571|NCT01443403|38920100|FG002|Overall Study|Use of Prohibited Treatment|0|||
16118572|NCT01443403|38920101|FG003|Overall Study|Use of Prohibited Treatment|0|||
16118573|NCT01443403|38920098|FG000|Overall Study|Other - Miscellaneous|1|||
16118574|NCT01443403|38920099|FG001|Overall Study|Other - Miscellaneous|0|||
16118575|NCT01443403|38920100|FG002|Overall Study|Other - Miscellaneous|0|||
16118576|NCT01443403|38920101|FG003|Overall Study|Other - Miscellaneous|1|||
16118577|NCT03846453|38920102|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
16118578|NCT03846453|38920103|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
16348111|NCT01000974|39762147|FG002|Booster Vaccination Phase|Other|4|||
16348112|NCT03084302|39762148|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
16348113|NCT03084302|39762148|FG000|Overall Study|No valid objective monitor data|6|||
16348114|NCT01073163|39762149|FG000|Overall Study|Adverse Event|1|||
16348115|NCT01073163|39762149|FG000|Overall Study|Disease Progression|1|||
16348116|NCT01073163|39762149|FG000|Overall Study|Early termination|1|||
16348117|NCT03771963|39762150|FG000|Overall Study|Lost to Follow-up|22|||
16348118|NCT03771963|39762150|FG000|Overall Study|Withdrawal of Consent|10|||
16551013|NCT02247804|40481431|FG000|Treatment Period 3|Reason not Specified|2|||
16551014|NCT02247804|40481432|FG001|Treatment Period 3|Reason not Specified|1|||
16230111|NCT01569074|39324371|FG000|Overall Study|Study stopped|6|||
16551015|NCT02247804|40481433|FG002|Treatment Period 3|Reason not Specified|3|||
16118579|NCT03846453|38920104|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
16118580|NCT03846453|38920102|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
16118581|NCT03846453|38920103|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
16118582|NCT03846453|38920104|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
16118583|NCT03846453|38920102|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
16118584|NCT03846453|38920103|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
16118585|NCT03846453|38920104|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
16118586|NCT03846453|38920102|FG000|Placebo Run-in (14 Days)|Other|2|||
16118587|NCT03846453|38920103|FG001|Placebo Run-in (14 Days)|Other|0|||
16118588|NCT03846453|38920104|FG002|Placebo Run-in (14 Days)|Other|0|||
16118589|NCT03846453|38920102|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
16118590|NCT03846453|38920103|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
16118591|NCT03846453|38920104|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
16118592|NCT03846453|38920102|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
16118593|NCT03846453|38920103|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
16118594|NCT03846453|38920104|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
16118595|NCT03846453|38920102|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
16412407|NCT03697993|39992183|FG001|Overall Study|Initial Urine Culture Negative|1|||
16412408|NCT00413010|39992189|FG000|Overall Study|Adverse Event|8|||
16412409|NCT00413010|39992190|FG001|Overall Study|Adverse Event|4|||
16412410|NCT00413010|39992189|FG000|Overall Study|Laboratory abnormality|0|||
16412411|NCT00413010|39992190|FG001|Overall Study|Laboratory abnormality|2|||
16412412|NCT00413010|39992189|FG000|Overall Study|Lack of Efficacy|0|||
16412413|NCT00413010|39992190|FG001|Overall Study|Lack of Efficacy|3|||
16412414|NCT00413010|39992189|FG000|Overall Study|Lost to Follow-up|3|||
16412415|NCT00413010|39992190|FG001|Overall Study|Lost to Follow-up|0|||
16412416|NCT00413010|39992189|FG000|Overall Study|Withdrawal by Subject|7|||
16412417|NCT00413010|39992190|FG001|Overall Study|Withdrawal by Subject|2|||
16412418|NCT00413010|39992189|FG000|Overall Study|Due to termination of the study|54|||
16412419|NCT00413010|39992190|FG001|Overall Study|Due to termination of the study|52|||
16412420|NCT02124772|39992192|FG000|Overall Study|Lack of Efficacy|2|||
16412421|NCT02124772|39992193|FG001|Overall Study|Lack of Efficacy|0|||
16412422|NCT02124772|39992194|FG002|Overall Study|Lack of Efficacy|0|||
16412423|NCT02124772|39992195|FG003|Overall Study|Lack of Efficacy|1|||
16412424|NCT02124772|39992196|FG004|Overall Study|Lack of Efficacy|2|||
16412425|NCT02124772|39992197|FG005|Overall Study|Lack of Efficacy|3|||
16412426|NCT02124772|39992198|FG006|Overall Study|Lack of Efficacy|0|||
16412427|NCT02124772|39992199|FG007|Overall Study|Lack of Efficacy|2|||
16412428|NCT02124772|39992200|FG008|Overall Study|Lack of Efficacy|0|||
16412429|NCT02124772|39992201|FG009|Overall Study|Lack of Efficacy|1|||
16412430|NCT02124772|39992202|FG010|Overall Study|Lack of Efficacy|0|||
16412431|NCT02124772|39992203|FG011|Overall Study|Lack of Efficacy|0|||
16412432|NCT02124772|39992204|FG012|Overall Study|Lack of Efficacy|1|||
16412433|NCT02124772|39992192|FG000|Overall Study|Adverse Event|1|||
16412434|NCT02124772|39992193|FG001|Overall Study|Adverse Event|4|||
16412435|NCT02124772|39992194|FG002|Overall Study|Adverse Event|1|||
16412436|NCT02124772|39992195|FG003|Overall Study|Adverse Event|5|||
16412437|NCT02124772|39992196|FG004|Overall Study|Adverse Event|2|||
16412438|NCT02124772|39992197|FG005|Overall Study|Adverse Event|1|||
16412439|NCT02124772|39992198|FG006|Overall Study|Adverse Event|1|||
16412440|NCT02124772|39992199|FG007|Overall Study|Adverse Event|5|||
16412441|NCT02124772|39992200|FG008|Overall Study|Adverse Event|0|||
16412442|NCT02124772|39992201|FG009|Overall Study|Adverse Event|3|||
16412443|NCT02124772|39992202|FG010|Overall Study|Adverse Event|1|||
16412444|NCT02124772|39992203|FG011|Overall Study|Adverse Event|3|||
16412445|NCT02124772|39992204|FG012|Overall Study|Adverse Event|1|||
16412446|NCT02124772|39992192|FG000|Overall Study|Withdrawal consent|0|||
16412447|NCT02124772|39992193|FG001|Overall Study|Withdrawal consent|1|||
16412448|NCT02124772|39992194|FG002|Overall Study|Withdrawal consent|1|||
16412449|NCT02124772|39992195|FG003|Overall Study|Withdrawal consent|1|||
16412450|NCT02124772|39992196|FG004|Overall Study|Withdrawal consent|0|||
16412451|NCT02124772|39992197|FG005|Overall Study|Withdrawal consent|1|||
16551016|NCT02584855|40481434|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
16118596|NCT03846453|38920103|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
16412452|NCT02124772|39992198|FG006|Overall Study|Withdrawal consent|1|||
16412453|NCT02124772|39992199|FG007|Overall Study|Withdrawal consent|0|||
16412454|NCT02124772|39992200|FG008|Overall Study|Withdrawal consent|0|||
16412455|NCT02124772|39992201|FG009|Overall Study|Withdrawal consent|1|||
16412456|NCT02124772|39992202|FG010|Overall Study|Withdrawal consent|0|||
16412457|NCT02124772|39992203|FG011|Overall Study|Withdrawal consent|1|||
16118597|NCT03846453|38920104|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
16412458|NCT02124772|39992204|FG012|Overall Study|Withdrawal consent|0|||
16412459|NCT02124772|39992192|FG000|Overall Study|Investigator discretion|0|||
16412460|NCT02124772|39992193|FG001|Overall Study|Investigator discretion|2|||
16412461|NCT02124772|39992194|FG002|Overall Study|Investigator discretion|2|||
16412462|NCT02124772|39992195|FG003|Overall Study|Investigator discretion|1|||
16412463|NCT02124772|39992196|FG004|Overall Study|Investigator discretion|1|||
16412464|NCT02124772|39992197|FG005|Overall Study|Investigator discretion|0|||
16412465|NCT02124772|39992198|FG006|Overall Study|Investigator discretion|1|||
16412466|NCT02124772|39992199|FG007|Overall Study|Investigator discretion|0|||
16412467|NCT02124772|39992200|FG008|Overall Study|Investigator discretion|0|||
16412468|NCT02124772|39992201|FG009|Overall Study|Investigator discretion|1|||
16412469|NCT02124772|39992202|FG010|Overall Study|Investigator discretion|0|||
16412470|NCT02124772|39992203|FG011|Overall Study|Investigator discretion|1|||
16412471|NCT02124772|39992204|FG012|Overall Study|Investigator discretion|0|||
16412472|NCT02124772|39992192|FG000|Overall Study|Progressive disease|0|||
16412473|NCT02124772|39992193|FG001|Overall Study|Progressive disease|0|||
16412474|NCT02124772|39992194|FG002|Overall Study|Progressive disease|0|||
16412475|NCT02124772|39992195|FG003|Overall Study|Progressive disease|0|||
16412476|NCT02124772|39992196|FG004|Overall Study|Progressive disease|0|||
16412477|NCT02124772|39992197|FG005|Overall Study|Progressive disease|0|||
16412478|NCT02124772|39992198|FG006|Overall Study|Progressive disease|1|||
16412479|NCT02124772|39992199|FG007|Overall Study|Progressive disease|1|||
16412480|NCT02124772|39992200|FG008|Overall Study|Progressive disease|0|||
16412481|NCT02124772|39992201|FG009|Overall Study|Progressive disease|0|||
16412482|NCT02124772|39992202|FG010|Overall Study|Progressive disease|0|||
16412483|NCT02124772|39992203|FG011|Overall Study|Progressive disease|0|||
16412484|NCT02124772|39992204|FG012|Overall Study|Progressive disease|0|||
16412485|NCT02124772|39992192|FG000|Overall Study|Other|0|||
16412486|NCT02124772|39992193|FG001|Overall Study|Other|7|||
16412487|NCT02124772|39992194|FG002|Overall Study|Other|2|||
16412488|NCT02124772|39992195|FG003|Overall Study|Other|5|||
16412489|NCT02124772|39992196|FG004|Overall Study|Other|4|||
16412490|NCT02124772|39992197|FG005|Overall Study|Other|3|||
16412491|NCT02124772|39992198|FG006|Overall Study|Other|4|||
16412492|NCT02124772|39992199|FG007|Overall Study|Other|1|||
16412493|NCT02124772|39992200|FG008|Overall Study|Other|1|||
16412494|NCT02124772|39992201|FG009|Overall Study|Other|1|||
16412495|NCT02124772|39992202|FG010|Overall Study|Other|1|||
16412496|NCT02124772|39992203|FG011|Overall Study|Other|1|||
16412497|NCT02124772|39992204|FG012|Overall Study|Other|0|||
16412498|NCT00413374|39992205|FG000|Overall Study|Ineligible due to screening criteria.|3|||
16412499|NCT00413374|39992206|FG001|Overall Study|Ineligible due to screening criteria.|0|||
16412500|NCT00413374|39992205|FG000|Overall Study|Adverse Event|1|||
16412501|NCT00413374|39992206|FG001|Overall Study|Adverse Event|0|||
16412502|NCT00413374|39992205|FG000|Overall Study|Lost to Follow-up|1|||
16412503|NCT00413374|39992206|FG001|Overall Study|Lost to Follow-up|0|||
16412504|NCT00413374|39992205|FG000|Overall Study|Surgery|1|||
16412505|NCT00413374|39992206|FG001|Overall Study|Surgery|0|||
16412506|NCT02193087|39992209|FG000|Overall Study|Adverse Event|2|||
16412507|NCT02193087|39992210|FG001|Overall Study|Adverse Event|0|||
16412508|NCT02193087|39992211|FG002|Overall Study|Adverse Event|0|||
16412509|NCT02193087|39992212|FG003|Overall Study|Adverse Event|11|||
16412510|NCT02193087|39992209|FG000|Overall Study|Lost to Follow-up|14|||
16412511|NCT02193087|39992210|FG001|Overall Study|Lost to Follow-up|6|||
16551017|NCT02584855|40481435|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
16551018|NCT02584855|40481436|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
16551019|NCT02584855|40481437|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
16230112|NCT01569074|39324372|FG001|Overall Study|Study stopped|6|||
16348119|NCT02689804|39762153|FG000|Overall Study|Withdrawal by Subject|2|||
16348120|NCT02689804|39762154|FG001|Overall Study|Withdrawal by Subject|0|||
16348121|NCT01673178|39762155|FG000|Overall Study|Lost to Follow-up|0|||
16348122|NCT01673178|39762156|FG001|Overall Study|Lost to Follow-up|1|||
16348123|NCT01673178|39762157|FG002|Overall Study|Lost to Follow-up|0|||
16348124|NCT01673178|39762158|FG003|Overall Study|Lost to Follow-up|0|||
16348125|NCT01673178|39762159|FG004|Overall Study|Lost to Follow-up|0|||
16348126|NCT01673178|39762155|FG000|Overall Study|Withdrawal by Subject|0|||
16348127|NCT01673178|39762156|FG001|Overall Study|Withdrawal by Subject|0|||
16348128|NCT01673178|39762157|FG002|Overall Study|Withdrawal by Subject|1|||
16348129|NCT01673178|39762158|FG003|Overall Study|Withdrawal by Subject|4|||
16348130|NCT01673178|39762159|FG004|Overall Study|Withdrawal by Subject|2|||
16348131|NCT01673178|39762155|FG000|Overall Study|Protocol Violation|1|||
16348132|NCT01673178|39762156|FG001|Overall Study|Protocol Violation|1|||
16412512|NCT02193087|39992211|FG002|Overall Study|Lost to Follow-up|4|||
16412513|NCT02193087|39992212|FG003|Overall Study|Lost to Follow-up|37|||
16412514|NCT02193087|39992209|FG000|Overall Study|Protocol Violation|2|||
16412515|NCT02193087|39992210|FG001|Overall Study|Protocol Violation|0|||
16412516|NCT02193087|39992211|FG002|Overall Study|Protocol Violation|1|||
16412517|NCT02193087|39992212|FG003|Overall Study|Protocol Violation|2|||
16348133|NCT01673178|39762157|FG002|Overall Study|Protocol Violation|0|||
16412518|NCT02193087|39992209|FG000|Overall Study|Withdrawal by Subject|10|||
16412519|NCT02193087|39992210|FG001|Overall Study|Withdrawal by Subject|3|||
16412520|NCT02193087|39992211|FG002|Overall Study|Withdrawal by Subject|1|||
16412521|NCT02193087|39992212|FG003|Overall Study|Withdrawal by Subject|19|||
16412522|NCT02193087|39992209|FG000|Overall Study|Other Reason Not Specified|7|||
16412523|NCT02193087|39992210|FG001|Overall Study|Other Reason Not Specified|2|||
16348134|NCT01673178|39762158|FG003|Overall Study|Protocol Violation|1|||
16348135|NCT01673178|39762159|FG004|Overall Study|Protocol Violation|0|||
16348136|NCT01673178|39762155|FG000|Overall Study|Adverse Event|1|||
16348137|NCT01673178|39762156|FG001|Overall Study|Adverse Event|0|||
16348138|NCT01673178|39762157|FG002|Overall Study|Adverse Event|0|||
16348139|NCT01673178|39762158|FG003|Overall Study|Adverse Event|2|||
16348140|NCT01673178|39762159|FG004|Overall Study|Adverse Event|0|||
16348141|NCT01673178|39762155|FG000|Overall Study|Other|1|||
16348142|NCT01673178|39762156|FG001|Overall Study|Other|0|||
16412524|NCT02193087|39992211|FG002|Overall Study|Other Reason Not Specified|1|||
16412525|NCT02193087|39992212|FG003|Overall Study|Other Reason Not Specified|9|||
16412526|NCT02193087|39992209|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
16412527|NCT02193087|39992210|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
16412528|NCT02193087|39992211|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
16412529|NCT02193087|39992212|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
16412530|NCT01443130|39992214|FG000|Overall Study|Lost to Follow-up|44|||
16412531|NCT01443130|39992215|FG001|Overall Study|Lost to Follow-up|42|||
16412532|NCT01443130|39992216|FG002|Overall Study|Lost to Follow-up|50|||
16412533|NCT01443130|39992217|FG003|Overall Study|Lost to Follow-up|23|||
16412534|NCT01443130|39992218|FG004|Overall Study|Lost to Follow-up|25|||
16412535|NCT01443130|39992219|FG005|Overall Study|Lost to Follow-up|21|||
16412536|NCT01443130|39992214|FG000|Overall Study|Death|0|||
16412537|NCT01443130|39992215|FG001|Overall Study|Death|1|||
16412538|NCT01443130|39992216|FG002|Overall Study|Death|0|||
16412539|NCT01443130|39992217|FG003|Overall Study|Death|7|||
16412540|NCT01443130|39992218|FG004|Overall Study|Death|10|||
16412541|NCT01443130|39992219|FG005|Overall Study|Death|8|||
16412542|NCT01443130|39992214|FG000|Overall Study|Adverse Event|2|||
16412543|NCT01443130|39992215|FG001|Overall Study|Adverse Event|1|||
16412544|NCT01443130|39992216|FG002|Overall Study|Adverse Event|1|||
16412545|NCT01443130|39992217|FG003|Overall Study|Adverse Event|0|||
16412546|NCT01443130|39992218|FG004|Overall Study|Adverse Event|0|||
16412547|NCT01443130|39992219|FG005|Overall Study|Adverse Event|0|||
16412548|NCT01443130|39992214|FG000|Overall Study|Protocol Violation|2|||
16412549|NCT01443130|39992215|FG001|Overall Study|Protocol Violation|1|||
16412550|NCT01443130|39992216|FG002|Overall Study|Protocol Violation|3|||
16412551|NCT01443130|39992217|FG003|Overall Study|Protocol Violation|2|||
16412552|NCT01443130|39992218|FG004|Overall Study|Protocol Violation|2|||
16412553|NCT01443130|39992219|FG005|Overall Study|Protocol Violation|3|||
16412554|NCT01443130|39992214|FG000|Overall Study|Withdrawal by Subject|15|||
16412555|NCT01443130|39992215|FG001|Overall Study|Withdrawal by Subject|14|||
16412556|NCT01443130|39992216|FG002|Overall Study|Withdrawal by Subject|12|||
16412557|NCT01443130|39992217|FG003|Overall Study|Withdrawal by Subject|7|||
16412558|NCT01443130|39992218|FG004|Overall Study|Withdrawal by Subject|7|||
16412559|NCT01443130|39992219|FG005|Overall Study|Withdrawal by Subject|2|||
16412560|NCT01443130|39992214|FG000|Overall Study|Death of Subject's Infant|5|||
16412561|NCT01443130|39992215|FG001|Overall Study|Death of Subject's Infant|10|||
16412562|NCT01443130|39992216|FG002|Overall Study|Death of Subject's Infant|11|||
16412563|NCT01443130|39992217|FG003|Overall Study|Death of Subject's Infant|0|||
16412564|NCT01443130|39992218|FG004|Overall Study|Death of Subject's Infant|0|||
16412565|NCT01443130|39992219|FG005|Overall Study|Death of Subject's Infant|0|||
16412566|NCT00798317|39992220|FG000|Overall Study|Physician Decision|0|||
16412567|NCT00798317|39992221|FG001|Overall Study|Physician Decision|1|||
16412568|NCT00798317|39992220|FG000|Overall Study|Withdrawal by Subject|5|||
16118598|NCT03846453|38920102|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
16412569|NCT00798317|39992221|FG001|Overall Study|Withdrawal by Subject|4|||
16348143|NCT01673178|39762157|FG002|Overall Study|Other|2|||
16412570|NCT00798317|39992220|FG000|Overall Study|Lost to Follow-up|2|||
16412571|NCT00798317|39992221|FG001|Overall Study|Lost to Follow-up|2|||
16412572|NCT00798317|39992220|FG000|Overall Study|Adverse Event|2|||
16412573|NCT00798317|39992221|FG001|Overall Study|Adverse Event|0|||
16551020|NCT02584855|40481438|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
16348144|NCT01673178|39762158|FG003|Overall Study|Other|1|||
16348145|NCT01673178|39762159|FG004|Overall Study|Other|0|||
16551021|NCT02584855|40481439|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
16230113|NCT01569074|39324373|FG002|Overall Study|Study stopped|8|||
16412574|NCT00798317|39992220|FG000|Overall Study|Death|1|||
16412575|NCT00798317|39992221|FG001|Overall Study|Death|0|||
16412576|NCT02198794|39992224|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
16412577|NCT02198794|39992225|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
16412578|NCT02198794|39992226|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
16412579|NCT02198794|39992227|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
16412580|NCT02198794|39992224|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
16348146|NCT01419535|39762160|FG000|Overall Study|could not maintain iv line|1|||
16348147|NCT01419535|39762161|FG001|Overall Study|could not maintain iv line|1|||
16348148|NCT01419535|39762160|FG000|Overall Study|Withdrawal by Subject|0|||
16412581|NCT02198794|39992225|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
16412582|NCT02198794|39992226|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
16118599|NCT03846453|38920103|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
16551022|NCT02584855|40481434|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
16551023|NCT02584855|40481435|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
16551024|NCT02584855|40481436|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
16551025|NCT02584855|40481437|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
16551026|NCT02584855|40481438|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
16551027|NCT02584855|40481439|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
16551028|NCT02584855|40481434|FG000|Open-Label Treatment Period|Adverse Event|14|||
16551029|NCT02584855|40481435|FG001|Open-Label Treatment Period|Adverse Event|0|||
16551030|NCT02584855|40481436|FG002|Open-Label Treatment Period|Adverse Event|0|||
16551031|NCT02584855|40481437|FG003|Open-Label Treatment Period|Adverse Event|0|||
16551032|NCT02584855|40481438|FG004|Open-Label Treatment Period|Adverse Event|0|||
16551033|NCT02584855|40481439|FG005|Open-Label Treatment Period|Adverse Event|0|||
16551034|NCT02584855|40481434|FG000|Open-Label Treatment Period|Death|2|||
16551035|NCT02584855|40481435|FG001|Open-Label Treatment Period|Death|0|||
16551036|NCT02584855|40481436|FG002|Open-Label Treatment Period|Death|0|||
16551037|NCT02584855|40481437|FG003|Open-Label Treatment Period|Death|0|||
16551038|NCT02584855|40481438|FG004|Open-Label Treatment Period|Death|0|||
16551039|NCT02584855|40481439|FG005|Open-Label Treatment Period|Death|0|||
16551040|NCT02584855|40481434|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
16118600|NCT03846453|38920104|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
16118601|NCT03846453|38920102|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
16118602|NCT03846453|38920103|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
16118603|NCT03846453|38920104|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
16118604|NCT00623805|38920108|FG000|Overall Study|Adverse Event|9|||
16118605|NCT00623805|38920109|FG001|Overall Study|Adverse Event|6|||
16118606|NCT00623805|38920108|FG000|Overall Study|Death|2|||
16118607|NCT00623805|38920109|FG001|Overall Study|Death|0|||
16118608|NCT00623805|38920108|FG000|Overall Study|Lack of Efficacy|3|||
16230114|NCT01569074|39324374|FG003|Overall Study|Study stopped|7|||
16551041|NCT02584855|40481435|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
16551042|NCT02584855|40481436|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
16551043|NCT02584855|40481437|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
16551044|NCT02584855|40481438|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
16551045|NCT02584855|40481439|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
16551046|NCT02584855|40481434|FG000|Open-Label Treatment Period|Protocol Violation|1|||
16118609|NCT00623805|38920109|FG001|Overall Study|Lack of Efficacy|7|||
16118610|NCT00623805|38920108|FG000|Overall Study|Lost to Follow-up|2|||
16118611|NCT00623805|38920109|FG001|Overall Study|Lost to Follow-up|2|||
16230115|NCT01569074|39324375|FG004|Overall Study|Study stopped|7|||
16118612|NCT00623805|38920108|FG000|Overall Study|Protocol Violation|1|||
16118613|NCT00623805|38920109|FG001|Overall Study|Protocol Violation|1|||
16118614|NCT00623805|38920108|FG000|Overall Study|Reason not Specified|3|||
16118615|NCT00623805|38920109|FG001|Overall Study|Reason not Specified|6|||
16118616|NCT04577001|38920110|FG000|Overall Study|Subject became ineligible|0|||
16118617|NCT04577001|38920111|FG001|Overall Study|Subject became ineligible|1|||
16118618|NCT01711853|38920112|FG000|Overall Study|Not treated|3|||
16118619|NCT01638390|38920114|FG000|Overall Study|screening failures|21|||
16118620|NCT00214019|38920116|FG000|Overall Study|Lost to Follow-up|11|||
16118621|NCT00214019|38920116|FG000|Overall Study|Withdrawal by Subject|2|||
16118622|NCT00214019|38920116|FG000|Overall Study|Screen Failed prior to randomization|17|||
16118623|NCT02569476|38920117|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
16118624|NCT02569476|38920117|FG000|Overall Study|Death|33|||
16118625|NCT02569476|38920117|FG000|Overall Study|Withdrawal by Subject|9|||
16118626|NCT02569476|38920117|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
16118627|NCT02569476|38920117|FG000|Overall Study|Palliative care|1|||
16118628|NCT02569476|38920117|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
16118629|NCT02569476|38920117|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
16118630|NCT03149042|38920118|FG000|Overall Study|Invasive FFR not performed|21|||
16118631|NCT03149042|38920118|FG000|Overall Study|Poor CT Image Quality|1|||
16118632|NCT03149042|38920118|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
16118633|NCT01696955|38920128|FG000|Main Study|Protocol Violation|1|||
16118634|NCT01696955|38920129|FG001|Main Study|Protocol Violation|0|||
16118635|NCT01696955|38920128|FG000|Main Study|Withdrawal by Subject|1|||
16118636|NCT01696955|38920129|FG001|Main Study|Withdrawal by Subject|1|||
16118637|NCT01483144|38920130|FG000|Overall Study|Adverse Event|9|||
16118638|NCT01483144|38920131|FG001|Overall Study|Adverse Event|4|||
16118639|NCT01483144|38920132|FG002|Overall Study|Adverse Event|6|||
16118640|NCT01483144|38920130|FG000|Overall Study|Withdrawal by Subject|0|||
16118641|NCT01483144|38920131|FG001|Overall Study|Withdrawal by Subject|2|||
16118642|NCT01483144|38920132|FG002|Overall Study|Withdrawal by Subject|5|||
16118643|NCT01483144|38920130|FG000|Overall Study|Physician Decision|1|||
16118644|NCT01483144|38920131|FG001|Overall Study|Physician Decision|0|||
16118645|NCT01483144|38920132|FG002|Overall Study|Physician Decision|0|||
16118646|NCT01483144|38920130|FG000|Overall Study|Lost to Follow-up|2|||
16118647|NCT01483144|38920131|FG001|Overall Study|Lost to Follow-up|4|||
16118648|NCT01483144|38920132|FG002|Overall Study|Lost to Follow-up|1|||
16118649|NCT01483144|38920130|FG000|Overall Study|Protocol Violation|3|||
16118650|NCT01483144|38920131|FG001|Overall Study|Protocol Violation|3|||
16118651|NCT01483144|38920132|FG002|Overall Study|Protocol Violation|3|||
16118652|NCT01677767|38920135|FG000|Overall Study|Adverse Event|1|||
16118653|NCT01677767|38920135|FG000|Overall Study|Death|4|||
16118654|NCT01677767|38920135|FG000|Overall Study|Protocol Violation|4|||
16551047|NCT02584855|40481435|FG001|Open-Label Treatment Period|Protocol Violation|0|||
16551048|NCT02584855|40481436|FG002|Open-Label Treatment Period|Protocol Violation|0|||
16551049|NCT02584855|40481437|FG003|Open-Label Treatment Period|Protocol Violation|0|||
16551050|NCT02584855|40481438|FG004|Open-Label Treatment Period|Protocol Violation|0|||
16551051|NCT02584855|40481439|FG005|Open-Label Treatment Period|Protocol Violation|0|||
16551052|NCT02584855|40481434|FG000|Open-Label Treatment Period|No PI Available|2|||
16551053|NCT02584855|40481435|FG001|Open-Label Treatment Period|No PI Available|0|||
16551054|NCT02584855|40481436|FG002|Open-Label Treatment Period|No PI Available|0|||
16118655|NCT01677767|38920135|FG000|Overall Study|Withdrawal by Subject|10|||
16551055|NCT02584855|40481437|FG003|Open-Label Treatment Period|No PI Available|0|||
16551056|NCT02584855|40481438|FG004|Open-Label Treatment Period|No PI Available|0|||
16551057|NCT02584855|40481439|FG005|Open-Label Treatment Period|No PI Available|0|||
16551058|NCT02584855|40481434|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
16551059|NCT02584855|40481435|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
16118656|NCT01677767|38920135|FG000|Overall Study|Non-compliance by the participants|3|||
16118657|NCT01784523|38920136|FG000|Overall Study|Study closed early|7|||
16118658|NCT01784523|38920137|FG001|Overall Study|Study closed early|4|||
16118659|NCT00611975|38920138|FG000|Overall Study|Withdrawal by Subject|3|||
16118660|NCT00611975|38920139|FG001|Overall Study|Withdrawal by Subject|7|||
16118661|NCT00611975|38920138|FG000|Overall Study|Pregnancy|2|||
16348149|NCT01419535|39762161|FG001|Overall Study|Withdrawal by Subject|1|||
16348150|NCT02346877|39762162|FG000|Overall Study|Adverse Event|1|||
16348151|NCT02346877|39762163|FG001|Overall Study|Adverse Event|0|||
16348152|NCT02346877|39762162|FG000|Overall Study|Administrative Decision|1|||
16348153|NCT02346877|39762163|FG001|Overall Study|Administrative Decision|0|||
16348154|NCT02346877|39762162|FG000|Overall Study|Sponsor Decision|12|||
16348155|NCT02346877|39762163|FG001|Overall Study|Sponsor Decision|0|||
16348156|NCT02346877|39762162|FG000|Overall Study|Missing|5|||
16348157|NCT02346877|39762163|FG001|Overall Study|Missing|0|||
16348158|NCT00327717|39762171|FG000|Overall Study|Adverse Event|6|||
16348159|NCT00327717|39762172|FG001|Overall Study|Adverse Event|6|||
16348160|NCT00327717|39762171|FG000|Overall Study|Lack of Efficacy|0|||
16348161|NCT00327717|39762172|FG001|Overall Study|Lack of Efficacy|1|||
16348162|NCT00327717|39762171|FG000|Overall Study|Withdrawal by Subject|3|||
16348163|NCT00327717|39762172|FG001|Overall Study|Withdrawal by Subject|7|||
16348164|NCT00766597|39762185|FG000|Overall Study|Unexpected closure of study|4|||
16348165|NCT00766597|39762185|FG000|Overall Study|Without CCR5-tropic virus|5|||
16348166|NCT00917124|39762187|FG000|Overall Study|Protocol Violation|4|||
16348167|NCT00917124|39762188|FG001|Overall Study|Protocol Violation|6|||
16348168|NCT01938846|39762189|FG000|Overall Study|Progressive disease|26|||
16348169|NCT01938846|39762190|FG001|Overall Study|Progressive disease|18|||
16348170|NCT01938846|39762191|FG002|Overall Study|Progressive disease|16|||
16348171|NCT01938846|39762189|FG000|Overall Study|Adverse Event|8|||
16348172|NCT01938846|39762190|FG001|Overall Study|Adverse Event|4|||
16348173|NCT01938846|39762191|FG002|Overall Study|Adverse Event|3|||
16348174|NCT01938846|39762189|FG000|Overall Study|Withdrawal by Subject|2|||
16348175|NCT01938846|39762190|FG001|Overall Study|Withdrawal by Subject|2|||
16348176|NCT01938846|39762191|FG002|Overall Study|Withdrawal by Subject|1|||
16348177|NCT01938846|39762189|FG000|Overall Study|Other than listed|5|||
16348178|NCT01938846|39762190|FG001|Overall Study|Other than listed|1|||
16348179|NCT01938846|39762191|FG002|Overall Study|Other than listed|4|||
16348180|NCT02542397|39762196|FG000|Overall Study|Death|2|||
16348181|NCT02542397|39762196|FG000|Overall Study|Physician Decision|6|||
16348182|NCT02542397|39762196|FG000|Overall Study|Withdrawal by Subject|6|||
16348183|NCT02542397|39762196|FG000|Overall Study|Lost to Follow-up|2|||
16348184|NCT04069715|39762200|FG000|Overall Study|Lost to Follow-up|1|||
16348185|NCT04069715|39762201|FG001|Overall Study|Lost to Follow-up|1|||
16348186|NCT04069715|39762200|FG000|Overall Study|Physician Decision|1|||
16348187|NCT04069715|39762201|FG001|Overall Study|Physician Decision|1|||
16348188|NCT04069715|39762200|FG000|Overall Study|Withdrawal by Subject|3|||
16348189|NCT04069715|39762201|FG001|Overall Study|Withdrawal by Subject|3|||
16348190|NCT02317991|39762202|FG000|Overall Study|Adverse Event|12|||
16348191|NCT02317991|39762202|FG000|Overall Study|Death|4|||
16348192|NCT02317991|39762202|FG000|Overall Study|Withdrawal by Subject|8|||
16348193|NCT02317991|39762202|FG000|Overall Study|Progressive Disease|41|||
16348194|NCT00547157|39762208|FG000|Overall Study|Other|1|||
16348195|NCT00547157|39762209|FG001|Overall Study|Other|0|||
16348196|NCT00547157|39762208|FG000|Overall Study|Death|38|||
16348197|NCT00547157|39762209|FG001|Overall Study|Death|18|||
16348198|NCT00547157|39762208|FG000|Overall Study|Withdrawal by Subject|3|||
16348199|NCT00547157|39762209|FG001|Overall Study|Withdrawal by Subject|1|||
16348200|NCT00547157|39762208|FG000|Overall Study|Administrative decision|3|||
16348201|NCT00547157|39762209|FG001|Overall Study|Administrative decision|2|||
16348202|NCT00547157|39762208|FG000|Overall Study|Lost to Follow-up|4|||
16348203|NCT00547157|39762209|FG001|Overall Study|Lost to Follow-up|2|||
16348204|NCT02213380|39762210|FG000|Underwent Randomization|Withdrawal by Subject|2|||
16348205|NCT02213380|39762211|FG001|Underwent Randomization|Withdrawal by Subject|0|||
16348206|NCT02213380|39762210|FG000|Underwent Randomization|Not treated|3|||
16348207|NCT02213380|39762211|FG001|Underwent Randomization|Not treated|3|||
16348208|NCT02213380|39762210|FG000|Per-protocol Analysis|Protocol Violation|32|||
16348209|NCT02213380|39762211|FG001|Per-protocol Analysis|Protocol Violation|36|||
16551060|NCT02584855|40481436|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
16551061|NCT02584855|40481437|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
16551062|NCT02584855|40481438|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
16551063|NCT02584855|40481439|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
16551064|NCT02584855|40481434|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
16551065|NCT02584855|40481435|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
16551066|NCT02584855|40481436|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
16551067|NCT02584855|40481437|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
16551068|NCT02584855|40481438|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
16551069|NCT02584855|40481439|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
16551070|NCT02584855|40481434|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
16551071|NCT02584855|40481435|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
16551072|NCT02584855|40481436|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
16551073|NCT02584855|40481437|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
16551074|NCT02584855|40481438|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
16551075|NCT02584855|40481439|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
16551076|NCT02584855|40481434|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
16551077|NCT02584855|40481435|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
16551078|NCT02584855|40481436|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
16551079|NCT02584855|40481437|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
16551080|NCT02584855|40481438|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
16551081|NCT02584855|40481439|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
16551082|NCT02584855|40481434|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
16551083|NCT02584855|40481435|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
16551084|NCT02584855|40481436|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
16551085|NCT02584855|40481437|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
16551086|NCT02584855|40481438|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
16551087|NCT02584855|40481439|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
16551088|NCT02584855|40481434|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16551089|NCT02584855|40481435|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16551090|NCT02584855|40481436|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16551091|NCT02584855|40481437|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16551092|NCT02584855|40481438|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
16551093|NCT02584855|40481439|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16551094|NCT02584855|40481434|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
16551095|NCT02584855|40481435|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
16551096|NCT02584855|40481436|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
16118662|NCT00611975|38920139|FG001|Overall Study|Pregnancy|1|||
16118663|NCT00635661|38920145|FG000|Overall Study|Withdrawal by Subject|4|||
16118664|NCT02175641|38923228|FG000|Overall Study|Death|3|||
16118665|NCT02175641|38923229|FG001|Overall Study|Death|4|||
16551097|NCT02584855|40481437|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
16551098|NCT02584855|40481438|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
16551099|NCT02584855|40481439|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
16118666|NCT02175641|38923228|FG000|Overall Study|Lost to Follow-up|4|||
16118667|NCT02175641|38923229|FG001|Overall Study|Lost to Follow-up|4|||
16118668|NCT02175641|38923228|FG000|Overall Study|Withdrawal by Subject|7|||
16118669|NCT02175641|38923229|FG001|Overall Study|Withdrawal by Subject|4|||
16118670|NCT02175641|38923228|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
16118671|NCT02175641|38923229|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
16118672|NCT02175641|38923228|FG000|Overall Study|Developed Contraindicated Condition|8|||
16348210|NCT02259400|39762213|FG000|Overall Study|Death|0|||
16348211|NCT02259400|39762214|FG001|Overall Study|Death|2|||
16118673|NCT02175641|38923229|FG001|Overall Study|Developed Contraindicated Condition|0|||
16118674|NCT01068665|38923230|FG000|Overall Study|Adverse Event|5|||
16118675|NCT01068665|38923231|FG001|Overall Study|Adverse Event|4|||
16118676|NCT01068665|38923230|FG000|Overall Study|Lack of Efficacy|0|||
16118677|NCT01068665|38923231|FG001|Overall Study|Lack of Efficacy|2|||
16118678|NCT01068665|38923230|FG000|Overall Study|Protocol Violation|5|||
16118679|NCT01068665|38923231|FG001|Overall Study|Protocol Violation|2|||
16118680|NCT01068665|38923230|FG000|Overall Study|Withdrawal Criteria|3|||
16118681|NCT01068665|38923231|FG001|Overall Study|Withdrawal Criteria|9|||
16118682|NCT01068665|38923230|FG000|Overall Study|Other|17|||
16118683|NCT01068665|38923231|FG001|Overall Study|Other|12|||
16118684|NCT01564277|38923233|FG000|Overall Study|Protocol Violation|0|||
16118685|NCT01564277|38923234|FG001|Overall Study|Protocol Violation|1|||
16118686|NCT01564277|38923233|FG000|Overall Study|Physician Decision|1|||
16118687|NCT01564277|38923234|FG001|Overall Study|Physician Decision|0|||
16118688|NCT00633880|38923243|FG000|Open Label Titration|Lack of Efficacy|1|||
16551100|NCT01027364|40481447|FG000|Overall Study|Adverse Event|1|||
16551101|NCT01027364|40481448|FG001|Overall Study|Adverse Event|0|||
16551102|NCT01027364|40481449|FG002|Overall Study|Adverse Event|1|||
16551103|NCT01027364|40481450|FG003|Overall Study|Adverse Event|0|||
16551104|NCT01027364|40481447|FG000|Overall Study|Lost to Follow-up|1|||
16551105|NCT01027364|40481448|FG001|Overall Study|Lost to Follow-up|0|||
16551106|NCT01027364|40481449|FG002|Overall Study|Lost to Follow-up|0|||
16551107|NCT01027364|40481450|FG003|Overall Study|Lost to Follow-up|0|||
16551108|NCT01027364|40481447|FG000|Overall Study|Protocol Violation|1|||
16551109|NCT01027364|40481448|FG001|Overall Study|Protocol Violation|0|||
16551110|NCT01027364|40481449|FG002|Overall Study|Protocol Violation|0|||
16551111|NCT01027364|40481450|FG003|Overall Study|Protocol Violation|1|||
16551112|NCT01027364|40481447|FG000|Overall Study|Withdrawal by Subject|1|||
16551113|NCT01027364|40481448|FG001|Overall Study|Withdrawal by Subject|2|||
16551114|NCT01027364|40481449|FG002|Overall Study|Withdrawal by Subject|0|||
16551115|NCT01027364|40481450|FG003|Overall Study|Withdrawal by Subject|0|||
16551116|NCT00720902|40481451|FG000|Overall Study|Withdrawal by Subject|1|||
16551117|NCT00720902|40481452|FG001|Overall Study|Withdrawal by Subject|0|||
16551118|NCT00720902|40481451|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
16551119|NCT00720902|40481452|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
16551120|NCT03734991|40481454|FG000|Overall Study|Adverse Event|4|||
16551121|NCT03734991|40481455|FG001|Overall Study|Adverse Event|0|||
16118689|NCT00633880|38923244|FG001|Open Label Titration|Lack of Efficacy|0|||
16118690|NCT00633880|38923245|FG002|Open Label Titration|Lack of Efficacy|0|||
16412583|NCT02198794|39992227|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
16118691|NCT00633880|38923243|FG000|Open Label Titration|Adverse Event|13|||
16118692|NCT00633880|38923244|FG001|Open Label Titration|Adverse Event|0|||
16118693|NCT00633880|38923245|FG002|Open Label Titration|Adverse Event|0|||
16118694|NCT00633880|38923243|FG000|Open Label Titration|Treatment Failure|55|||
16118695|NCT00633880|38923244|FG001|Open Label Titration|Treatment Failure|0|||
16118696|NCT00633880|38923245|FG002|Open Label Titration|Treatment Failure|0|||
16118697|NCT00633880|38923243|FG000|Open Label Titration|Protocol Violation|6|||
16230116|NCT01569074|39324371|FG000|Overall Study|Study-specific discontinuation criteria|0|||
16412584|NCT02198794|39992224|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
16551122|NCT03734991|40481454|FG000|Overall Study|Lost to Follow-up|4|||
16118698|NCT00633880|38923244|FG001|Open Label Titration|Protocol Violation|0|||
16230117|NCT01569074|39324372|FG001|Overall Study|Study-specific discontinuation criteria|1|||
16230118|NCT01569074|39324373|FG002|Overall Study|Study-specific discontinuation criteria|0|||
16230119|NCT01569074|39324374|FG003|Overall Study|Study-specific discontinuation criteria|0|||
16230120|NCT01569074|39324375|FG004|Overall Study|Study-specific discontinuation criteria|0|||
16230121|NCT01569074|39324371|FG000|Overall Study|Severe non-compliance to protocol|0|||
16230122|NCT01569074|39324372|FG001|Overall Study|Severe non-compliance to protocol|0|||
16230123|NCT01569074|39324373|FG002|Overall Study|Severe non-compliance to protocol|1|||
16230124|NCT01569074|39324374|FG003|Overall Study|Severe non-compliance to protocol|0|||
16230125|NCT01569074|39324375|FG004|Overall Study|Severe non-compliance to protocol|0|||
16230126|NCT01569074|39324371|FG000|Overall Study|eg change in circumstances|0|||
16230127|NCT01569074|39324372|FG001|Overall Study|eg change in circumstances|2|||
16230128|NCT01569074|39324373|FG002|Overall Study|eg change in circumstances|0|||
16230129|NCT01569074|39324374|FG003|Overall Study|eg change in circumstances|1|||
16230130|NCT01569074|39324375|FG004|Overall Study|eg change in circumstances|1|||
16230131|NCT01569074|39324371|FG000|Overall Study|Adverse Event|1|||
16230132|NCT01569074|39324372|FG001|Overall Study|Adverse Event|0|||
16230133|NCT01569074|39324373|FG002|Overall Study|Adverse Event|3|||
16230134|NCT01569074|39324374|FG003|Overall Study|Adverse Event|0|||
16348212|NCT02019550|39762215|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16348213|NCT02019550|39762216|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
16348214|NCT00248651|39762217|FG000|Overall Study|Withdrawal by Subject|28|||
16348215|NCT00248651|39762218|FG001|Overall Study|Withdrawal by Subject|40|||
16348216|NCT00248651|39762219|FG002|Overall Study|Withdrawal by Subject|32|||
16551123|NCT03734991|40481455|FG001|Overall Study|Lost to Follow-up|0|||
16551124|NCT03734991|40481454|FG000|Overall Study|Physician Decision|0|||
16551125|NCT03734991|40481455|FG001|Overall Study|Physician Decision|1|||
16551126|NCT03734991|40481454|FG000|Overall Study|Pregnancy|1|||
16551127|NCT03734991|40481455|FG001|Overall Study|Pregnancy|0|||
16551128|NCT03734991|40481454|FG000|Overall Study|Withdrawal by Subject|6|||
16551129|NCT03734991|40481455|FG001|Overall Study|Withdrawal by Subject|3|||
16551130|NCT03734991|40481454|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
16551131|NCT03734991|40481455|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
16551132|NCT03734991|40481454|FG000|Overall Study|Other|2|||
16551133|NCT03734991|40481455|FG001|Overall Study|Other|2|||
16551134|NCT02145078|40481456|FG000|Overall Study|Death|1|||
16551135|NCT02145078|40481456|FG000|Overall Study|Reason not given|3|||
16551136|NCT01350141|40481467|FG000|Overall Study|Lost to Follow-up|1|||
16551137|NCT01350141|40481468|FG001|Overall Study|Lost to Follow-up|0|||
16551138|NCT01350141|40481469|FG002|Overall Study|Lost to Follow-up|1|||
16551139|NCT01350141|40481467|FG000|Overall Study|Withdrawal by Subject|1|||
16551140|NCT01350141|40481468|FG001|Overall Study|Withdrawal by Subject|0|||
16551141|NCT01350141|40481469|FG002|Overall Study|Withdrawal by Subject|0|||
16551142|NCT01350141|40481467|FG000|Overall Study|Randomized but not treated|1|||
16551143|NCT01350141|40481468|FG001|Overall Study|Randomized but not treated|0|||
16551144|NCT01350141|40481469|FG002|Overall Study|Randomized but not treated|0|||
16551145|NCT04422639|40481470|FG000|Overall Study|Death|1|||
16348217|NCT00398216|39762222|FG000|Overall Study|Adverse Event|4|||
16348218|NCT00398216|39762223|FG001|Overall Study|Adverse Event|2|||
16348219|NCT00398216|39762224|FG002|Overall Study|Adverse Event|5|||
16348220|NCT00398216|39762225|FG003|Overall Study|Adverse Event|7|||
16348221|NCT00398216|39762226|FG004|Overall Study|Adverse Event|2|||
16348222|NCT00398216|39762222|FG000|Overall Study|Protocol Violation|2|||
16348223|NCT00398216|39762223|FG001|Overall Study|Protocol Violation|4|||
16348224|NCT00398216|39762224|FG002|Overall Study|Protocol Violation|5|||
16348225|NCT00398216|39762225|FG003|Overall Study|Protocol Violation|7|||
16348226|NCT00398216|39762226|FG004|Overall Study|Protocol Violation|5|||
16348227|NCT00398216|39762222|FG000|Overall Study|Lost to Follow-up|1|||
16348228|NCT00398216|39762223|FG001|Overall Study|Lost to Follow-up|6|||
16348229|NCT00398216|39762224|FG002|Overall Study|Lost to Follow-up|4|||
16348230|NCT00398216|39762225|FG003|Overall Study|Lost to Follow-up|4|||
16348231|NCT00398216|39762226|FG004|Overall Study|Lost to Follow-up|1|||
16348232|NCT00398216|39762222|FG000|Overall Study|Death|0|||
16348233|NCT00398216|39762223|FG001|Overall Study|Death|3|||
16348234|NCT00398216|39762224|FG002|Overall Study|Death|0|||
16348235|NCT00398216|39762225|FG003|Overall Study|Death|0|||
16551146|NCT04422639|40481471|FG001|Overall Study|Death|0|||
16551147|NCT04422639|40481470|FG000|Overall Study|study closed prior to completion of FU visits|0|||
16551148|NCT04422639|40481471|FG001|Overall Study|study closed prior to completion of FU visits|2|||
16551149|NCT01680458|40481472|FG000|Overall Study|Protocol Violation|3|||
16551150|NCT00474929|40481474|FG000|Overall Study|Withdrawal by Subject|0|||
16230135|NCT01569074|39324375|FG004|Overall Study|Adverse Event|0|||
16230136|NCT01608321|39324376|FG000|Overall Study|Withdrawal by Subject|1|||
16230137|NCT01608321|39324377|FG001|Overall Study|Withdrawal by Subject|0|||
16230138|NCT02046993|39324379|FG000|Overall Study|Withdrawal by Subject|2|||
16230139|NCT02046993|39324380|FG001|Overall Study|Withdrawal by Subject|10|||
16230140|NCT02046993|39324379|FG000|Overall Study|Lost to Follow-up|1|||
16348236|NCT00398216|39762226|FG004|Overall Study|Death|0|||
16551151|NCT00474929|40481475|FG001|Overall Study|Withdrawal by Subject|1|||
16551152|NCT00474929|40481476|FG002|Overall Study|Withdrawal by Subject|0|||
16551153|NCT00474929|40481477|FG003|Overall Study|Withdrawal by Subject|0|||
16551154|NCT00474929|40481478|FG004|Overall Study|Withdrawal by Subject|0|||
16551155|NCT00474929|40481474|FG000|Overall Study|Unrelated medical condition|0|||
16551156|NCT00474929|40481475|FG001|Overall Study|Unrelated medical condition|0|||
16230141|NCT02046993|39324380|FG001|Overall Study|Lost to Follow-up|1|||
16230142|NCT00834366|39324381|FG000|Treatment Period 1|Adverse Event|1|||
16230143|NCT00834366|39324382|FG001|Treatment Period 1|Adverse Event|1|||
16230144|NCT04668066|39324383|FG000|Part 1: Treatment Phase|Adverse Event|0|||
16230145|NCT04668066|39324384|FG001|Part 1: Treatment Phase|Adverse Event|0|||
16230146|NCT04668066|39324385|FG002|Part 1: Treatment Phase|Adverse Event|0|||
16230147|NCT04668066|39324386|FG003|Part 1: Treatment Phase|Adverse Event|0|||
16230148|NCT04668066|39324387|FG004|Part 1: Treatment Phase|Adverse Event|0|||
16230149|NCT04668066|39324388|FG005|Part 1: Treatment Phase|Adverse Event|0|||
16230150|NCT04668066|39324389|FG006|Part 1: Treatment Phase|Adverse Event|0|||
16230151|NCT04668066|39324390|FG007|Part 1: Treatment Phase|Adverse Event|0|||
16230152|NCT04668066|39324391|FG008|Part 1: Treatment Phase|Adverse Event|0|||
16230153|NCT04668066|39324392|FG009|Part 1: Treatment Phase|Adverse Event|0|||
16230154|NCT04668066|39324393|FG010|Part 1: Treatment Phase|Adverse Event|0|||
16230155|NCT04668066|39324394|FG011|Part 1: Treatment Phase|Adverse Event|1|||
16230156|NCT04668066|39324395|FG012|Part 1: Treatment Phase|Adverse Event|1|||
16230157|NCT04668066|39324396|FG013|Part 1: Treatment Phase|Adverse Event|0|||
16230158|NCT04668066|39324397|FG014|Part 1: Treatment Phase|Adverse Event|0|||
16118699|NCT00633880|38923245|FG002|Open Label Titration|Protocol Violation|0|||
16118700|NCT00633880|38923243|FG000|Open Label Titration|Physician Decision|1|||
16118701|NCT00633880|38923244|FG001|Open Label Titration|Physician Decision|0|||
16118702|NCT00633880|38923245|FG002|Open Label Titration|Physician Decision|0|||
16118703|NCT00633880|38923243|FG000|Open Label Titration|Withdrawal by Subject|4|||
16118704|NCT00633880|38923244|FG001|Open Label Titration|Withdrawal by Subject|0|||
16118705|NCT00633880|38923245|FG002|Open Label Titration|Withdrawal by Subject|0|||
16118706|NCT03232931|38923246|FG000|Overall Study|Physician Decision|1|||
16118707|NCT03232931|38923247|FG001|Overall Study|Physician Decision|1|||
16118708|NCT03232931|38923246|FG000|Overall Study|Withdrawal by Subject|6|||
16118709|NCT03232931|38923247|FG001|Overall Study|Withdrawal by Subject|0|||
16118710|NCT03232931|38923246|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
16118711|NCT03232931|38923247|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
16118712|NCT03232931|38923246|FG000|Overall Study|Parent did not record voice|1|||
16118713|NCT03232931|38923247|FG001|Overall Study|Parent did not record voice|2|||
16118714|NCT03232931|38923246|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
16118715|NCT03232931|38923247|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
16118716|NCT00523640|38923248|FG000|Overall Study|Death|1|||
16118717|NCT04596995|38923253|FG000|Overall Study|Lack of Efficacy|8|||
16118718|NCT04596995|38923253|FG000|Overall Study|Lost to Follow-up|3|||
16118719|NCT04596995|38923253|FG000|Overall Study|Withdrawal by Subject|12|||
16118720|NCT04596995|38923253|FG000|Overall Study|Sponsor decision|3|||
16118721|NCT04596995|38923253|FG000|Overall Study|Enrolled in managed access program|3|||
16118722|NCT02473289|38923254|FG000|Overall Study|Adverse Event|2|||
16118723|NCT02473289|38923255|FG001|Overall Study|Adverse Event|3|||
16118724|NCT02473289|38923254|FG000|Overall Study|Lost to Follow-up|1|||
16118725|NCT02473289|38923255|FG001|Overall Study|Lost to Follow-up|1|||
16118726|NCT02473289|38923254|FG000|Overall Study|Protocol Violation|0|||
16118727|NCT02473289|38923255|FG001|Overall Study|Protocol Violation|1|||
16118728|NCT02473289|38923254|FG000|Overall Study|Withdrawal of consent|6|||
16118729|NCT02473289|38923255|FG001|Overall Study|Withdrawal of consent|7|||
16118730|NCT02473289|38923254|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
16118731|NCT02473289|38923255|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
16118732|NCT02473289|38923254|FG000|Overall Study|Other|2|||
16118733|NCT02473289|38923255|FG001|Overall Study|Other|0|||
16118734|NCT02817906|38923256|FG000|Overall Study|Adverse Event|3|||
16230159|NCT04668066|39324398|FG015|Part 1: Treatment Phase|Adverse Event|0|||
16230160|NCT04668066|39324399|FG016|Part 1: Treatment Phase|Adverse Event|0|||
16230161|NCT04668066|39324400|FG017|Part 1: Treatment Phase|Adverse Event|0|||
16551157|NCT00474929|40481476|FG002|Overall Study|Unrelated medical condition|1|||
16551158|NCT00474929|40481477|FG003|Overall Study|Unrelated medical condition|0|||
16118735|NCT02817906|38923257|FG001|Overall Study|Adverse Event|0|||
16118736|NCT02817906|38923256|FG000|Overall Study|Lack of Efficacy|1|||
16118737|NCT02817906|38923257|FG001|Overall Study|Lack of Efficacy|0|||
16118738|NCT02817906|38923256|FG000|Overall Study|Protocol Violation|1|||
16118739|NCT02817906|38923257|FG001|Overall Study|Protocol Violation|1|||
16118740|NCT02817906|38923256|FG000|Overall Study|Study Terminated by Sponsor|2|||
16230162|NCT04668066|39324401|FG018|Part 1: Treatment Phase|Adverse Event|0|||
16230163|NCT04668066|39324383|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230164|NCT04668066|39324384|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230165|NCT04668066|39324385|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
16230166|NCT04668066|39324386|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230167|NCT04668066|39324387|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230168|NCT04668066|39324388|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230169|NCT04668066|39324389|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230170|NCT04668066|39324390|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230171|NCT04668066|39324391|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230172|NCT04668066|39324392|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230173|NCT04668066|39324393|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230174|NCT04668066|39324394|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230175|NCT04668066|39324395|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230176|NCT04668066|39324396|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230177|NCT04668066|39324397|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230178|NCT04668066|39324398|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230179|NCT04668066|39324399|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230180|NCT04668066|39324400|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230181|NCT04668066|39324401|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
16230182|NCT04668066|39324383|FG000|Part 1: Treatment Phase|Other|0|||
16230183|NCT04668066|39324384|FG001|Part 1: Treatment Phase|Other|0|||
16230184|NCT04668066|39324385|FG002|Part 1: Treatment Phase|Other|0|||
16230185|NCT04668066|39324386|FG003|Part 1: Treatment Phase|Other|0|||
16230186|NCT04668066|39324387|FG004|Part 1: Treatment Phase|Other|0|||
16230187|NCT04668066|39324388|FG005|Part 1: Treatment Phase|Other|0|||
16230188|NCT04668066|39324389|FG006|Part 1: Treatment Phase|Other|0|||
16230189|NCT04668066|39324390|FG007|Part 1: Treatment Phase|Other|0|||
16230190|NCT04668066|39324391|FG008|Part 1: Treatment Phase|Other|0|||
16230191|NCT04668066|39324392|FG009|Part 1: Treatment Phase|Other|0|||
16230192|NCT04668066|39324393|FG010|Part 1: Treatment Phase|Other|0|||
16230193|NCT04668066|39324394|FG011|Part 1: Treatment Phase|Other|1|||
16230194|NCT04668066|39324395|FG012|Part 1: Treatment Phase|Other|0|||
16230195|NCT04668066|39324396|FG013|Part 1: Treatment Phase|Other|0|||
16230196|NCT04668066|39324397|FG014|Part 1: Treatment Phase|Other|0|||
16230197|NCT04668066|39324398|FG015|Part 1: Treatment Phase|Other|0|||
16230198|NCT04668066|39324399|FG016|Part 1: Treatment Phase|Other|0|||
16230199|NCT04668066|39324400|FG017|Part 1: Treatment Phase|Other|0|||
16230200|NCT04668066|39324401|FG018|Part 1: Treatment Phase|Other|0|||
16230201|NCT04668066|39324383|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230202|NCT04668066|39324384|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230203|NCT04668066|39324385|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230204|NCT04668066|39324386|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230205|NCT04668066|39324387|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230206|NCT04668066|39324388|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230207|NCT04668066|39324389|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16118741|NCT02817906|38923257|FG001|Overall Study|Study Terminated by Sponsor|2|||
16118742|NCT02817906|38923256|FG000|Overall Study|Withdrawal by Subject|7|||
16230208|NCT04668066|39324390|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16551159|NCT00474929|40481478|FG004|Overall Study|Unrelated medical condition|0|||
16551160|NCT00474929|40481474|FG000|Overall Study|Physician Decision|0|||
16551161|NCT00474929|40481475|FG001|Overall Study|Physician Decision|0|||
16551162|NCT00474929|40481476|FG002|Overall Study|Physician Decision|1|||
16551163|NCT00474929|40481477|FG003|Overall Study|Physician Decision|2|||
16230209|NCT04668066|39324391|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230210|NCT04668066|39324392|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230211|NCT04668066|39324393|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16348237|NCT00398216|39762222|FG000|Overall Study|Withdrawal by Subject|1|||
16348238|NCT00398216|39762223|FG001|Overall Study|Withdrawal by Subject|0|||
16551164|NCT00474929|40481478|FG004|Overall Study|Physician Decision|0|||
16551165|NCT04397523|40481484|FG000|Overall Study|Lost to Follow-up|3|||
16551166|NCT04397523|40481484|FG000|Overall Study|Transfer from/to other hospital|8|||
16551167|NCT01777321|40481490|FG000|Overall Study|Withdrawal by Subject|0|||
16551168|NCT01777321|40481491|FG001|Overall Study|Withdrawal by Subject|1|||
16551169|NCT01535274|40481492|FG000|Overall Study|Determined to be ineligible|0|||
16551170|NCT01535274|40481493|FG001|Overall Study|Determined to be ineligible|1|||
16230212|NCT04668066|39324394|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230213|NCT04668066|39324395|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
16230214|NCT04668066|39324396|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230215|NCT04668066|39324397|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230216|NCT04668066|39324398|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
16230217|NCT04668066|39324399|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16348239|NCT00398216|39762224|FG002|Overall Study|Withdrawal by Subject|3|||
16348240|NCT00398216|39762225|FG003|Overall Study|Withdrawal by Subject|1|||
16348241|NCT00398216|39762226|FG004|Overall Study|Withdrawal by Subject|2|||
16348242|NCT00398216|39762222|FG000|Overall Study|administrative reasons|3|||
16348243|NCT00398216|39762223|FG001|Overall Study|administrative reasons|4|||
16348244|NCT00398216|39762224|FG002|Overall Study|administrative reasons|4|||
16230218|NCT04668066|39324400|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230219|NCT04668066|39324401|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
16230220|NCT04668066|39324383|FG000|Part 1: Follow-Up|Adverse Event|0|||
16230221|NCT04668066|39324384|FG001|Part 1: Follow-Up|Adverse Event|0|||
16551171|NCT01535274|40481492|FG000|Overall Study|Misallocated to propofol intervention|0|||
16551172|NCT01535274|40481493|FG001|Overall Study|Misallocated to propofol intervention|1|||
16551173|NCT01148862|40481494|FG000|Second Intervention|Withdrawal by Subject|0|||
16551174|NCT01148862|40481495|FG001|Second Intervention|Withdrawal by Subject|2|||
16551175|NCT01806740|40481496|FG000|Overall Study|Withdrawal by Subject|4|||
16551176|NCT01806740|40481496|FG000|Overall Study|Physician Decision|1|||
16551177|NCT01806740|40481496|FG000|Overall Study|Patient's refusal of treatment|1|||
16551178|NCT00514046|40481497|FG000|Overall Study|transferred to another protocol|2|||
16551179|NCT00514046|40481498|FG001|Overall Study|transferred to another protocol|1|||
16230222|NCT04668066|39324385|FG002|Part 1: Follow-Up|Adverse Event|0|||
16230223|NCT04668066|39324386|FG003|Part 1: Follow-Up|Adverse Event|0|||
16230224|NCT04668066|39324387|FG004|Part 1: Follow-Up|Adverse Event|0|||
16230225|NCT04668066|39324388|FG005|Part 1: Follow-Up|Adverse Event|0|||
16230226|NCT04668066|39324389|FG006|Part 1: Follow-Up|Adverse Event|0|||
16230227|NCT04668066|39324390|FG007|Part 1: Follow-Up|Adverse Event|0|||
16230228|NCT04668066|39324391|FG008|Part 1: Follow-Up|Adverse Event|0|||
16230229|NCT04668066|39324392|FG009|Part 1: Follow-Up|Adverse Event|0|||
16230230|NCT04668066|39324393|FG010|Part 1: Follow-Up|Adverse Event|0|||
16230231|NCT04668066|39324394|FG011|Part 1: Follow-Up|Adverse Event|1|||
16230232|NCT04668066|39324395|FG012|Part 1: Follow-Up|Adverse Event|0|||
16230233|NCT04668066|39324396|FG013|Part 1: Follow-Up|Adverse Event|0|||
16230234|NCT04668066|39324397|FG014|Part 1: Follow-Up|Adverse Event|0|||
16230235|NCT04668066|39324398|FG015|Part 1: Follow-Up|Adverse Event|0|||
16230236|NCT04668066|39324399|FG016|Part 1: Follow-Up|Adverse Event|0|||
16230237|NCT04668066|39324400|FG017|Part 1: Follow-Up|Adverse Event|0|||
16230238|NCT04668066|39324401|FG018|Part 1: Follow-Up|Adverse Event|0|||
16230239|NCT04668066|39324383|FG000|Part 1: Follow-Up|Other|0|||
16348245|NCT00398216|39762225|FG003|Overall Study|administrative reasons|3|||
16348246|NCT00398216|39762226|FG004|Overall Study|administrative reasons|3|||
16348247|NCT00398216|39762222|FG000|Overall Study|entrance criteria|0|||
16348248|NCT00398216|39762223|FG001|Overall Study|entrance criteria|0|||
16348249|NCT00398216|39762224|FG002|Overall Study|entrance criteria|0|||
16348250|NCT00398216|39762225|FG003|Overall Study|entrance criteria|0|||
16348251|NCT00398216|39762226|FG004|Overall Study|entrance criteria|2|||
16348252|NCT00673257|39762227|FG000|Overall Study|Withdrawal by Subject|4|||
16348253|NCT00673257|39762227|FG000|Overall Study|Unable to obtain specimen|1|||
16348254|NCT05401565|39762228|FG000|Overall Study|Lost to Follow-up|1|||
16348255|NCT05401565|39762229|FG001|Overall Study|Lost to Follow-up|0|||
16348256|NCT05401565|39762228|FG000|Overall Study|Adverse Event|2|||
16348257|NCT05401565|39762229|FG001|Overall Study|Adverse Event|0|||
16551180|NCT00514046|40481499|FG002|Overall Study|transferred to another protocol|3|||
16230240|NCT04668066|39324384|FG001|Part 1: Follow-Up|Other|0|||
16230241|NCT04668066|39324385|FG002|Part 1: Follow-Up|Other|0|||
16230242|NCT04668066|39324386|FG003|Part 1: Follow-Up|Other|0|||
16230243|NCT04668066|39324387|FG004|Part 1: Follow-Up|Other|0|||
16230244|NCT04668066|39324388|FG005|Part 1: Follow-Up|Other|0|||
16230245|NCT04668066|39324389|FG006|Part 1: Follow-Up|Other|0|||
16230246|NCT04668066|39324390|FG007|Part 1: Follow-Up|Other|0|||
16230247|NCT04668066|39324391|FG008|Part 1: Follow-Up|Other|0|||
16348258|NCT00697593|39762230|FG000|Overall Study|Adverse Event|3|||
16412585|NCT02198794|39992225|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
16118743|NCT02817906|38923257|FG001|Overall Study|Withdrawal by Subject|0|||
16118744|NCT02817906|38923256|FG000|Overall Study|Other|2|||
16118745|NCT02817906|38923257|FG001|Overall Study|Other|2|||
16118746|NCT00700778|38923258|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
16118747|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
16118748|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
16118749|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
16118750|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Death|4|||
16118751|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Death|2|||
16118752|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Death|3|||
16118753|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
16118754|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
16118755|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
16118756|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
16412586|NCT02198794|39992226|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
16412587|NCT02198794|39992227|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
16412588|NCT02198794|39992224|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
16412589|NCT02198794|39992225|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
16412590|NCT02198794|39992226|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
16412591|NCT02198794|39992227|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
16412592|NCT02198794|39992224|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
16412593|NCT02198794|39992225|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
16412594|NCT02198794|39992226|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
16412595|NCT02198794|39992227|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
16118757|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
16118758|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
16118759|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
16412596|NCT02198794|39992224|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
16412597|NCT02198794|39992225|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
16412598|NCT02198794|39992226|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
16412599|NCT02198794|39992227|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
16412600|NCT02198794|39992224|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
16412601|NCT02198794|39992225|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
16412602|NCT02198794|39992226|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
16412603|NCT02198794|39992227|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
16230248|NCT04668066|39324392|FG009|Part 1: Follow-Up|Other|0|||
16118760|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
16118761|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
16118762|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
16118763|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
16118764|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
16118765|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
16118766|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
16118767|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
16118768|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
16118769|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
16118770|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
16118771|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
16118772|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
16551181|NCT00514046|40481500|FG003|Overall Study|transferred to another protocol|0|||
16551182|NCT00514046|40481501|FG004|Overall Study|transferred to another protocol|1|||
16551183|NCT00514046|40481502|FG005|Overall Study|transferred to another protocol|0|||
16551184|NCT00514046|40481503|FG006|Overall Study|transferred to another protocol|0|||
16551185|NCT00514046|40481504|FG007|Overall Study|transferred to another protocol|0|||
16551186|NCT00514046|40481505|FG008|Overall Study|transferred to another protocol|0|||
16551187|NCT00514046|40481497|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
16551188|NCT00514046|40481498|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
16551189|NCT00514046|40481499|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
16551190|NCT00514046|40481500|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
16551191|NCT00514046|40481501|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
16551192|NCT00514046|40481502|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
16551193|NCT00514046|40481503|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
16551194|NCT00514046|40481504|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
16118773|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
16118774|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
16118775|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
16118776|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
16118777|NCT02783573|38923259|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
16118778|NCT02783573|38923260|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
16118779|NCT02783573|38923261|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
16118780|NCT02783573|38923259|FG000|Delayed-Start Period|Sponsor Decision|0|||
16118781|NCT02783573|38923260|FG001|Delayed-Start Period|Sponsor Decision|17|||
16118782|NCT02783573|38923261|FG002|Delayed-Start Period|Sponsor Decision|12|||
16118783|NCT01525238|38923263|FG000|Overall Study|Withdrawal by Subject|1|||
16118784|NCT01525238|38923264|FG001|Overall Study|Withdrawal by Subject|0|||
16118785|NCT01525238|38923265|FG002|Overall Study|Withdrawal by Subject|0|||
16118786|NCT00842244|38923267|FG000|Overall Study|Death|3|||
16118787|NCT00842244|38923267|FG000|Overall Study|Withdrawal by Subject|1|||
16118788|NCT00842244|38923267|FG000|Overall Study|Other|17|||
16118789|NCT00846807|38923270|FG000|Overall Study|Adverse Event|270|||
16118790|NCT00846807|38923270|FG000|Overall Study|Lost to Follow-up|94|||
16118791|NCT00846807|38923270|FG000|Overall Study|Withdrawal by Subject|56|||
16118792|NCT00846807|38923270|FG000|Overall Study|Non compliant with European label|7|||
16118793|NCT00846807|38923270|FG000|Overall Study|Switch to other anticoagulants|89|||
16118794|NCT00846807|38923270|FG000|Overall Study|No prescription after hospital discharge|56|||
16118795|NCT00846807|38923270|FG000|Overall Study|Other|60|||
16118796|NCT05383508|38923271|FG000|Overall Study|Withdrawal by Subject|1|||
16118797|NCT05383508|38923272|FG001|Overall Study|Withdrawal by Subject|0|||
16118798|NCT05383508|38923273|FG002|Overall Study|Withdrawal by Subject|1|||
16118799|NCT05383508|38923274|FG003|Overall Study|Withdrawal by Subject|1|||
16118800|NCT05383508|38923275|FG004|Overall Study|Withdrawal by Subject|2|||
16118801|NCT05383508|38923276|FG005|Overall Study|Withdrawal by Subject|0|||
16118802|NCT04674189|38923279|FG000|Overall Study|Adverse Event|0|||
16118803|NCT04674189|38923280|FG001|Overall Study|Adverse Event|0|||
16118804|NCT04674189|38923281|FG002|Overall Study|Adverse Event|1|||
16118805|NCT04674189|38923279|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
16118806|NCT04674189|38923280|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
16118807|NCT04674189|38923281|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
16118808|NCT04674189|38923279|FG000|Overall Study|Physician Decision|1|||
16118809|NCT04674189|38923280|FG001|Overall Study|Physician Decision|0|||
16118810|NCT04674189|38923281|FG002|Overall Study|Physician Decision|0|||
16118811|NCT04674189|38923279|FG000|Overall Study|Withdrawal by Participant|83|||
16118812|NCT04674189|38923280|FG001|Overall Study|Withdrawal by Participant|71|||
16118813|NCT04674189|38923281|FG002|Overall Study|Withdrawal by Participant|142|||
16118814|NCT04674189|38923279|FG000|Overall Study|Lost to Follow-up|55|||
16118815|NCT04674189|38923280|FG001|Overall Study|Lost to Follow-up|53|||
16118816|NCT04674189|38923281|FG002|Overall Study|Lost to Follow-up|44|||
16118817|NCT04674189|38923279|FG000|Overall Study|Miscellaneous|27|||
16348259|NCT00697593|39762230|FG000|Overall Study|Protocol Violation|1|||
16348260|NCT00697593|39762230|FG000|Overall Study|Lack of Efficacy|3|||
16348261|NCT00697593|39762230|FG000|Overall Study|Suspension of the study by sponsor|12|||
16348262|NCT01429298|39762233|FG000|Overall Study|Protocol Violation|4|||
16348263|NCT01429298|39762234|FG001|Overall Study|Protocol Violation|6|||
16348264|NCT00490971|39762235|FG000|Acute/Continuation|Adverse Event|62|||
16348265|NCT00490971|39762236|FG001|Acute/Continuation|Adverse Event|13|||
16118818|NCT04674189|38923280|FG001|Overall Study|Miscellaneous|23|||
16118819|NCT04674189|38923281|FG002|Overall Study|Miscellaneous|207|||
16118820|NCT04674189|38923279|FG000|Overall Study|Did Not Receive Treatment|3|||
16118821|NCT04674189|38923280|FG001|Overall Study|Did Not Receive Treatment|1|||
16118822|NCT04674189|38923281|FG002|Overall Study|Did Not Receive Treatment|2|||
16118823|NCT00299494|38923284|FG000|Overall Study|Withdrawal by Subject|0|||
16118824|NCT00299494|38923285|FG001|Overall Study|Withdrawal by Subject|0|||
16118825|NCT00299494|38923286|FG002|Overall Study|Withdrawal by Subject|0|||
16118826|NCT00299494|38923287|FG003|Overall Study|Withdrawal by Subject|3|||
16348266|NCT00490971|39762237|FG002|Acute/Continuation|Adverse Event|0|||
16118827|NCT00299494|38923288|FG004|Overall Study|Withdrawal by Subject|1|||
16118828|NCT00299494|38923289|FG005|Overall Study|Withdrawal by Subject|4|||
16118829|NCT00299494|38923284|FG000|Overall Study|Physician Decision|0|||
16348267|NCT00490971|39762238|FG003|Acute/Continuation|Adverse Event|0|||
16118830|NCT00299494|38923285|FG001|Overall Study|Physician Decision|0|||
16118831|NCT00299494|38923286|FG002|Overall Study|Physician Decision|0|||
16118832|NCT00299494|38923287|FG003|Overall Study|Physician Decision|0|||
16118833|NCT00299494|38923288|FG004|Overall Study|Physician Decision|1|||
16118834|NCT00299494|38923289|FG005|Overall Study|Physician Decision|0|||
16118835|NCT00299494|38923284|FG000|Overall Study|Death|3|||
16118836|NCT00299494|38923285|FG001|Overall Study|Death|1|||
16118837|NCT00299494|38923286|FG002|Overall Study|Death|4|||
16118838|NCT00299494|38923287|FG003|Overall Study|Death|6|||
16118839|NCT00299494|38923288|FG004|Overall Study|Death|18|||
16118840|NCT00299494|38923289|FG005|Overall Study|Death|19|||
16118841|NCT00299494|38923284|FG000|Overall Study|Lost to Follow-up|0|||
16118842|NCT00299494|38923285|FG001|Overall Study|Lost to Follow-up|0|||
16118843|NCT00299494|38923286|FG002|Overall Study|Lost to Follow-up|0|||
16118844|NCT00299494|38923287|FG003|Overall Study|Lost to Follow-up|0|||
16118845|NCT00299494|38923288|FG004|Overall Study|Lost to Follow-up|3|||
16118846|NCT00299494|38923289|FG005|Overall Study|Lost to Follow-up|1|||
16118847|NCT00299494|38923284|FG000|Overall Study|Other - Unspecified|0|||
16118848|NCT00299494|38923285|FG001|Overall Study|Other - Unspecified|0|||
16118849|NCT00299494|38923286|FG002|Overall Study|Other - Unspecified|0|||
16118850|NCT00299494|38923287|FG003|Overall Study|Other - Unspecified|0|||
16118851|NCT00299494|38923288|FG004|Overall Study|Other - Unspecified|3|||
16118852|NCT00299494|38923289|FG005|Overall Study|Other - Unspecified|1|||
16118853|NCT00299494|38923284|FG000|Overall Study|Other - site closure|0|||
16118854|NCT00299494|38923285|FG001|Overall Study|Other - site closure|0|||
16118855|NCT00299494|38923286|FG002|Overall Study|Other - site closure|0|||
16118856|NCT00299494|38923287|FG003|Overall Study|Other - site closure|1|||
16118857|NCT00299494|38923288|FG004|Overall Study|Other - site closure|1|||
16118858|NCT00299494|38923289|FG005|Overall Study|Other - site closure|1|||
16118859|NCT02206061|38923290|FG000|Overall Study|Withdrawal by Subject|4|||
16118860|NCT02206061|38923291|FG001|Overall Study|Withdrawal by Subject|7|||
16118861|NCT02206061|38923292|FG002|Overall Study|Withdrawal by Subject|1|||
16118862|NCT02206061|38923290|FG000|Overall Study|Lost to Follow-up|14|||
16118863|NCT02206061|38923291|FG001|Overall Study|Lost to Follow-up|7|||
16118864|NCT02206061|38923292|FG002|Overall Study|Lost to Follow-up|20|||
16118865|NCT00918879|38923293|FG000|Overall Study|Withdrawal by Subject|4|||
16118866|NCT00918879|38923294|FG001|Overall Study|Withdrawal by Subject|4|||
16118867|NCT00918879|38923293|FG000|Overall Study|Lost to Follow-up|1|||
16118868|NCT00918879|38923294|FG001|Overall Study|Lost to Follow-up|1|||
16118869|NCT00918879|38923293|FG000|Overall Study|Severe non-compliance to protocol|1|||
16118870|NCT00918879|38923294|FG001|Overall Study|Severe non-compliance to protocol|1|||
16118871|NCT01123070|38923295|FG000|Part B Double Blind Period|Protocol Violation|0|||
16118872|NCT01123070|38923296|FG001|Part B Double Blind Period|Protocol Violation|0|||
16118873|NCT01123070|38923297|FG002|Part B Double Blind Period|Protocol Violation|0|||
16118874|NCT01123070|38923298|FG003|Part B Double Blind Period|Protocol Violation|1|||
16118875|NCT01123070|38923295|FG000|Part B Double Blind Period|Adverse Event|0|||
16118876|NCT01123070|38923296|FG001|Part B Double Blind Period|Adverse Event|0|||
16118877|NCT01123070|38923297|FG002|Part B Double Blind Period|Adverse Event|2|||
16118878|NCT01123070|38923298|FG003|Part B Double Blind Period|Adverse Event|0|||
16118879|NCT01123070|38923295|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
16118880|NCT01123070|38923296|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
16230249|NCT04668066|39324393|FG010|Part 1: Follow-Up|Other|0|||
16230250|NCT04668066|39324394|FG011|Part 1: Follow-Up|Other|1|||
16230251|NCT04668066|39324395|FG012|Part 1: Follow-Up|Other|1|||
16551195|NCT00514046|40481505|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
16551196|NCT00514046|40481497|FG000|Overall Study|Disease progression on study|0|||
16551197|NCT00514046|40481498|FG001|Overall Study|Disease progression on study|0|||
16551198|NCT00514046|40481499|FG002|Overall Study|Disease progression on study|2|||
16551199|NCT00514046|40481500|FG003|Overall Study|Disease progression on study|0|||
16551200|NCT00514046|40481501|FG004|Overall Study|Disease progression on study|0|||
16551201|NCT00514046|40481502|FG005|Overall Study|Disease progression on study|1|||
16551202|NCT00514046|40481503|FG006|Overall Study|Disease progression on study|0|||
16551203|NCT00514046|40481504|FG007|Overall Study|Disease progression on study|0|||
16551204|NCT00514046|40481505|FG008|Overall Study|Disease progression on study|0|||
16551205|NCT01960790|40481512|FG000|Overall Study|Survey forms could not be recovered|3|||
16551206|NCT01960790|40481512|FG000|Overall Study|Treat with Humira outside survey period|3|||
16551207|NCT01960790|40481512|FG000|Overall Study|Transferred to another hospital|4|||
16230252|NCT04668066|39324396|FG013|Part 1: Follow-Up|Other|0|||
16118881|NCT01123070|38923297|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
16118882|NCT01123070|38923298|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
16230253|NCT04668066|39324397|FG014|Part 1: Follow-Up|Other|0|||
16230254|NCT04668066|39324398|FG015|Part 1: Follow-Up|Other|0|||
16118883|NCT01385748|38923300|FG000|Overall Study|Withdrawal by Subject|7|||
16118884|NCT01385748|38923301|FG001|Overall Study|Withdrawal by Subject|4|||
16118885|NCT01385748|38923302|FG002|Overall Study|Withdrawal by Subject|5|||
16230255|NCT04668066|39324399|FG016|Part 1: Follow-Up|Other|0|||
16551208|NCT01960790|40481512|FG000|Overall Study|Unevaluable for safety|1|||
16118886|NCT01385748|38923300|FG000|Overall Study|Noncompliance|3|||
16118887|NCT01385748|38923301|FG001|Overall Study|Noncompliance|1|||
16118888|NCT01385748|38923302|FG002|Overall Study|Noncompliance|6|||
16118889|NCT01385748|38923300|FG000|Overall Study|Other|1|||
16118890|NCT01385748|38923301|FG001|Overall Study|Other|7|||
16118891|NCT01385748|38923302|FG002|Overall Study|Other|1|||
16118892|NCT01385748|38923300|FG000|Overall Study|Adverse Event|4|||
16118893|NCT01385748|38923301|FG001|Overall Study|Adverse Event|2|||
16118894|NCT01385748|38923302|FG002|Overall Study|Adverse Event|1|||
16118895|NCT01142115|38923303|FG000|First Intervention|Lack of Efficacy|1|||
16118896|NCT01142115|38923304|FG001|First Intervention|Lack of Efficacy|1|||
16118897|NCT01142115|38923303|FG000|First Intervention|Adverse Event|1|||
16118898|NCT01142115|38923304|FG001|First Intervention|Adverse Event|0|||
16118899|NCT02476175|38923305|FG000|Overall Study|Adverse Event|2|||
16118900|NCT04491877|38923306|FG000|Overall Study|Protocol Deviation|1|||
16118901|NCT04491877|38923307|FG001|Overall Study|Protocol Deviation|0|||
16118902|NCT04491877|38923308|FG002|Overall Study|Protocol Deviation|2|||
16118903|NCT04491877|38923309|FG003|Overall Study|Protocol Deviation|0|||
16118904|NCT04491877|38923310|FG004|Overall Study|Protocol Deviation|0|||
16118905|NCT04491877|38923311|FG005|Overall Study|Protocol Deviation|0|||
16118906|NCT04491877|38923312|FG006|Overall Study|Protocol Deviation|1|||
16118907|NCT04491877|38923313|FG007|Overall Study|Protocol Deviation|1|||
16118908|NCT04491877|38923314|FG008|Overall Study|Protocol Deviation|0|||
16118909|NCT04491877|38923306|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16118910|NCT04491877|38923307|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16118911|NCT04491877|38923308|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16118912|NCT04491877|38923309|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
16118913|NCT04491877|38923310|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
16118914|NCT04491877|38923311|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
16118915|NCT04491877|38923312|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
16118916|NCT04491877|38923313|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
16118917|NCT04491877|38923314|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
16118918|NCT04491877|38923306|FG000|Overall Study|Lost to Follow-up|0|||
16118919|NCT04491877|38923307|FG001|Overall Study|Lost to Follow-up|2|||
16118920|NCT04491877|38923308|FG002|Overall Study|Lost to Follow-up|0|||
16230256|NCT04668066|39324400|FG017|Part 1: Follow-Up|Other|0|||
16230257|NCT04668066|39324401|FG018|Part 1: Follow-Up|Other|0|||
16230258|NCT04668066|39324383|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230259|NCT04668066|39324384|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
16118921|NCT04491877|38923309|FG003|Overall Study|Lost to Follow-up|0|||
16118922|NCT04491877|38923310|FG004|Overall Study|Lost to Follow-up|0|||
16118923|NCT04491877|38923311|FG005|Overall Study|Lost to Follow-up|0|||
16230260|NCT04668066|39324385|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
16118924|NCT04491877|38923312|FG006|Overall Study|Lost to Follow-up|2|||
16118925|NCT04491877|38923313|FG007|Overall Study|Lost to Follow-up|1|||
16118926|NCT04491877|38923314|FG008|Overall Study|Lost to Follow-up|1|||
16118927|NCT04497389|38923315|FG000|Overall Study|Withdrawal by Subject|1|||
16118928|NCT04497389|38923316|FG001|Overall Study|Withdrawal by Subject|0|||
16118929|NCT00945672|38923319|FG000|Overall Study|Withdrawal by Subject|0|||
16118930|NCT00945672|38923320|FG001|Overall Study|Withdrawal by Subject|0|||
16118931|NCT00945672|38923321|FG002|Overall Study|Withdrawal by Subject|0|||
16118932|NCT00945672|38923322|FG003|Overall Study|Withdrawal by Subject|1|||
16118933|NCT01689857|38923323|FG000|Overall Study|Lost to Follow-up|5|||
16118934|NCT01689857|38923324|FG001|Overall Study|Lost to Follow-up|2|||
16118935|NCT00581477|38923327|FG000|Overall Study|Physician Decision|2|||
16551209|NCT00258440|40481513|FG000|Overall Study|Withdrawal by Subject|0|||
16551210|NCT00258440|40481514|FG001|Overall Study|Withdrawal by Subject|0|||
16551211|NCT00258440|40481515|FG002|Overall Study|Withdrawal by Subject|1|||
16551212|NCT01588990|40481517|FG000|Phase A|Withdrawal by Subject|5|||
16551213|NCT01588990|40481517|FG000|Phase A|Physician Decision|11|||
16551214|NCT01588990|40481517|FG000|Phase A|Other|14|||
16551215|NCT01588990|40481517|FG000|Phase A|Lost to Follow-up|1|||
16551216|NCT01588990|40481517|FG000|Phase A|Death|5|||
16551217|NCT01588990|40481517|FG000|Phase A|Adverse Event|28|||
16118936|NCT01850589|38923328|FG000|Overall Study|Withdrawal by Subject|8|||
16118937|NCT01850589|38923329|FG001|Overall Study|Withdrawal by Subject|0|||
16118938|NCT00607724|38923330|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
16118939|NCT00607724|38923331|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
16118940|NCT00607724|38923332|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
16118941|NCT00607724|38923333|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
16118942|NCT00607724|38923334|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
16118943|NCT00607724|38923335|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
16118944|NCT00607724|38923336|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
16118945|NCT00607724|38923330|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
16118946|NCT00607724|38923331|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
16118947|NCT00607724|38923332|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
16118948|NCT00607724|38923333|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
16118949|NCT00607724|38923334|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
16118950|NCT00607724|38923335|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
16118951|NCT00607724|38923336|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
16118952|NCT00607724|38923330|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
16118953|NCT00607724|38923331|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
16118954|NCT00607724|38923332|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
16118955|NCT00607724|38923333|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
16118956|NCT00607724|38923334|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
16118957|NCT00607724|38923335|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
16118958|NCT00607724|38923336|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
16118959|NCT00607724|38923330|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
16118960|NCT00607724|38923331|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
16118961|NCT00607724|38923332|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
16118962|NCT00607724|38923333|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
16118963|NCT00607724|38923334|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
16118964|NCT00607724|38923335|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
16118965|NCT00607724|38923336|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
16118966|NCT00607724|38923330|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
16118967|NCT00607724|38923331|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
16118968|NCT00607724|38923332|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
16118969|NCT00607724|38923333|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
16118970|NCT00607724|38923334|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
16118971|NCT00607724|38923335|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
16118972|NCT00607724|38923336|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
16118973|NCT02631577|38923337|FG000|Overall Study|Death|1|||
16118974|NCT02631577|38923338|FG001|Overall Study|Death|7|||
16118975|NCT02631577|38923337|FG000|Overall Study|Withdrawal by Subject|0|||
16118976|NCT02631577|38923338|FG001|Overall Study|Withdrawal by Subject|3|||
16348268|NCT00490971|39762239|FG004|Acute/Continuation|Adverse Event|0|||
16551218|NCT01588990|40481517|FG000|Phase A|Still on therapy at end of study|6|||
16118977|NCT01365481|38923339|FG000|Overall Study|Adverse Event|6|||
16118978|NCT01365481|38923340|FG001|Overall Study|Adverse Event|9|||
16118979|NCT01365481|38923341|FG002|Overall Study|Adverse Event|0|||
16118980|NCT01365481|38923342|FG003|Overall Study|Adverse Event|2|||
16118981|NCT01365481|38923339|FG000|Overall Study|Withdrawal by Subject|0|||
16118982|NCT01365481|38923340|FG001|Overall Study|Withdrawal by Subject|2|||
16118983|NCT01365481|38923341|FG002|Overall Study|Withdrawal by Subject|1|||
16118984|NCT01365481|38923342|FG003|Overall Study|Withdrawal by Subject|1|||
16551219|NCT01588990|40481517|FG000|Phase B|Adverse Event|2|||
16551220|NCT01588990|40481517|FG000|Phase B|Still on therapy at end of study|5|||
16118985|NCT01365481|38923339|FG000|Overall Study|Lost to Follow-up|1|||
16118986|NCT01365481|38923340|FG001|Overall Study|Lost to Follow-up|1|||
16118987|NCT01365481|38923341|FG002|Overall Study|Lost to Follow-up|2|||
16118988|NCT01365481|38923342|FG003|Overall Study|Lost to Follow-up|3|||
16118989|NCT01365481|38923339|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16118990|NCT01365481|38923340|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16118991|NCT01365481|38923341|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16230261|NCT04668066|39324386|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230262|NCT04668066|39324387|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230263|NCT04668066|39324388|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230264|NCT04668066|39324389|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230265|NCT04668066|39324390|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230266|NCT04668066|39324391|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230267|NCT04668066|39324392|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230268|NCT04668066|39324393|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230269|NCT04668066|39324394|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230270|NCT04668066|39324395|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
16230271|NCT04668066|39324396|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230272|NCT04668066|39324397|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230273|NCT04668066|39324398|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
16230274|NCT04668066|39324399|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230275|NCT04668066|39324400|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230276|NCT04668066|39324401|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
16230277|NCT04668066|39324383|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230278|NCT04668066|39324384|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230279|NCT04668066|39324385|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230280|NCT04668066|39324386|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230281|NCT04668066|39324387|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230282|NCT04668066|39324388|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230283|NCT04668066|39324389|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230284|NCT04668066|39324390|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230285|NCT04668066|39324391|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230286|NCT04668066|39324392|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16551221|NCT01588990|40481517|FG000|Phase B|Withdrawal by Subject|3|||
16551222|NCT01588990|40481517|FG000|Phase B|Physician Decision|4|||
16551223|NCT01588990|40481517|FG000|Phase B|Other|2|||
16551224|NCT01737996|40481518|FG000|Overall Study|Adverse Event|0|||
16551225|NCT01737996|40481519|FG001|Overall Study|Adverse Event|1|||
16551226|NCT01737996|40481520|FG002|Overall Study|Adverse Event|1|||
16230287|NCT04668066|39324393|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230288|NCT04668066|39324394|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230289|NCT04668066|39324395|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230290|NCT04668066|39324396|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230291|NCT04668066|39324397|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230292|NCT04668066|39324398|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230293|NCT04668066|39324399|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16348269|NCT00490971|39762235|FG000|Acute/Continuation|Death|2|||
16551227|NCT01737996|40481518|FG000|Overall Study|Withdrawal by Subject|0|||
16551228|NCT01737996|40481519|FG001|Overall Study|Withdrawal by Subject|0|||
16551229|NCT01737996|40481520|FG002|Overall Study|Withdrawal by Subject|1|||
16551230|NCT00980005|40481523|FG000|Overall Study|Withdrawal by Subject|6|||
16551231|NCT00980005|40481524|FG001|Overall Study|Withdrawal by Subject|17|||
16551232|NCT00980005|40481523|FG000|Overall Study|Lost to Follow-up|37|||
16551233|NCT00980005|40481524|FG001|Overall Study|Lost to Follow-up|43|||
16551234|NCT00980005|40481523|FG000|Overall Study|Other|4|||
16551235|NCT00980005|40481524|FG001|Overall Study|Other|3|||
16551236|NCT00409786|40481525|FG000|Overall Study|Withdrawal by Subject|3|||
16551237|NCT00876460|40481526|FG000|Combination Therapy Phase|Progressive disease|2|||
16551238|NCT00876460|40481527|FG001|Combination Therapy Phase|Progressive disease|3|||
16551239|NCT00876460|40481528|FG002|Combination Therapy Phase|Progressive disease|3|||
16551240|NCT00876460|40481529|FG003|Combination Therapy Phase|Progressive disease|3|||
16551241|NCT00876460|40481530|FG004|Combination Therapy Phase|Progressive disease|3|||
16551242|NCT00876460|40481531|FG005|Combination Therapy Phase|Progressive disease|1|||
16551243|NCT00876460|40481532|FG006|Combination Therapy Phase|Progressive disease|1|||
16551244|NCT00876460|40481533|FG007|Combination Therapy Phase|Progressive disease|1|||
16551245|NCT00876460|40481526|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
16551246|NCT00876460|40481527|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
16551247|NCT00876460|40481528|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
16348270|NCT00490971|39762236|FG001|Acute/Continuation|Death|0|||
16551248|NCT00876460|40481529|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
16551249|NCT00876460|40481530|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
16118992|NCT01365481|38923342|FG003|Overall Study|Abnormal laboratory value(s)|0|||
16230294|NCT04668066|39324400|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
16230295|NCT04668066|39324401|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
16230296|NCT04668066|39324383|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230297|NCT04668066|39324384|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230298|NCT04668066|39324385|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230299|NCT04668066|39324386|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230300|NCT04668066|39324387|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230301|NCT04668066|39324388|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230302|NCT04668066|39324389|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230303|NCT04668066|39324390|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230304|NCT04668066|39324391|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230305|NCT04668066|39324392|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230306|NCT04668066|39324393|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230307|NCT04668066|39324394|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230308|NCT04668066|39324395|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230309|NCT04668066|39324396|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230310|NCT04668066|39324397|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230311|NCT04668066|39324398|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230312|NCT04668066|39324399|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230313|NCT04668066|39324400|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
16230314|NCT04668066|39324401|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
16230315|NCT04668066|39324383|FG000|Part 2: Treatment Phase|Other|0|||
16230316|NCT04668066|39324384|FG001|Part 2: Treatment Phase|Other|0|||
16230317|NCT04668066|39324385|FG002|Part 2: Treatment Phase|Other|0|||
16230318|NCT04668066|39324386|FG003|Part 2: Treatment Phase|Other|0|||
16230319|NCT04668066|39324387|FG004|Part 2: Treatment Phase|Other|0|||
16230320|NCT04668066|39324388|FG005|Part 2: Treatment Phase|Other|0|||
16230321|NCT04668066|39324389|FG006|Part 2: Treatment Phase|Other|0|||
16230322|NCT04668066|39324390|FG007|Part 2: Treatment Phase|Other|0|||
16230323|NCT04668066|39324391|FG008|Part 2: Treatment Phase|Other|0|||
16230324|NCT04668066|39324392|FG009|Part 2: Treatment Phase|Other|0|||
16230325|NCT04668066|39324393|FG010|Part 2: Treatment Phase|Other|0|||
16230326|NCT04668066|39324394|FG011|Part 2: Treatment Phase|Other|0|||
16230327|NCT04668066|39324395|FG012|Part 2: Treatment Phase|Other|0|||
16230328|NCT04668066|39324396|FG013|Part 2: Treatment Phase|Other|0|||
16230329|NCT04668066|39324397|FG014|Part 2: Treatment Phase|Other|0|||
16230330|NCT04668066|39324398|FG015|Part 2: Treatment Phase|Other|0|||
16230331|NCT04668066|39324399|FG016|Part 2: Treatment Phase|Other|0|||
16551250|NCT00876460|40481531|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
16551251|NCT00876460|40481532|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
16551252|NCT00876460|40481533|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
16551253|NCT00876460|40481526|FG000|Combination Therapy Phase|Adverse Event|0|||
16551254|NCT00876460|40481527|FG001|Combination Therapy Phase|Adverse Event|2|||
16551255|NCT00876460|40481528|FG002|Combination Therapy Phase|Adverse Event|0|||
16551256|NCT00876460|40481529|FG003|Combination Therapy Phase|Adverse Event|2|||
16551257|NCT00876460|40481530|FG004|Combination Therapy Phase|Adverse Event|2|||
16230332|NCT04668066|39324400|FG017|Part 2: Treatment Phase|Other|0|||
16230333|NCT04668066|39324401|FG018|Part 2: Treatment Phase|Other|1|||
16230334|NCT04668066|39324383|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230335|NCT04668066|39324384|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230336|NCT04668066|39324385|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230337|NCT04668066|39324386|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230338|NCT04668066|39324387|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230339|NCT04668066|39324388|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230340|NCT04668066|39324389|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230341|NCT04668066|39324390|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230342|NCT04668066|39324391|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230343|NCT04668066|39324392|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230344|NCT04668066|39324393|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230345|NCT04668066|39324394|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230346|NCT04668066|39324395|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230347|NCT04668066|39324396|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230348|NCT04668066|39324397|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230349|NCT04668066|39324398|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230350|NCT04668066|39324399|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230351|NCT04668066|39324400|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
16230352|NCT04668066|39324401|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
16230353|NCT02985515|39324407|FG000|Olfaction Testing|Lost to Follow-up|0|||
16230354|NCT02985515|39324408|FG001|Olfaction Testing|Lost to Follow-up|5|||
16230355|NCT02985515|39324407|FG000|Olfaction Testing|Protocol Violation|0|||
16230356|NCT02985515|39324408|FG001|Olfaction Testing|Protocol Violation|3|||
16230357|NCT01160770|39324409|FG000|Overall Study|Adverse Event|10|||
16230358|NCT01160770|39324409|FG000|Overall Study|Protocol Violation|2|||
16230359|NCT01160770|39324409|FG000|Overall Study|Subject/parent/caregiver request|33|||
16230360|NCT01160770|39324409|FG000|Overall Study|Physician Decision|1|||
16230361|NCT01160770|39324409|FG000|Overall Study|Lost to Follow-up|7|||
16230362|NCT01160770|39324409|FG000|Overall Study|Study termination or sponsor request|1|||
16230363|NCT01160770|39324409|FG000|Overall Study|Death|9|||
16230364|NCT01160770|39324409|FG000|Overall Study|Lack of Efficacy|15|||
16230365|NCT01160770|39324409|FG000|Overall Study|Other Reasons|1|||
16230366|NCT02268214|39324410|FG000|Overall Study|Subject no longer meets study criteria|0|||
16230367|NCT02268214|39324411|FG001|Overall Study|Subject no longer meets study criteria|2|||
16230368|NCT02268214|39324412|FG002|Overall Study|Subject no longer meets study criteria|0|||
16230369|NCT02268214|39324410|FG000|Overall Study|Pregnancy|2|||
16230370|NCT02268214|39324411|FG001|Overall Study|Pregnancy|2|||
16230371|NCT02268214|39324412|FG002|Overall Study|Pregnancy|1|||
16230372|NCT02268214|39324410|FG000|Overall Study|Lost to Follow-up|3|||
16230373|NCT02268214|39324411|FG001|Overall Study|Lost to Follow-up|3|||
16230374|NCT02268214|39324412|FG002|Overall Study|Lost to Follow-up|4|||
16230375|NCT02268214|39324410|FG000|Overall Study|Lack of Efficacy|1|||
16230376|NCT02268214|39324411|FG001|Overall Study|Lack of Efficacy|0|||
16230377|NCT02268214|39324412|FG002|Overall Study|Lack of Efficacy|2|||
16230378|NCT02268214|39324410|FG000|Overall Study|Adverse Event|11|||
16230379|NCT02268214|39324411|FG001|Overall Study|Adverse Event|14|||
16230380|NCT02268214|39324412|FG002|Overall Study|Adverse Event|9|||
16230381|NCT02268214|39324410|FG000|Overall Study|Withdrawal by Subject|4|||
16230382|NCT02268214|39324411|FG001|Overall Study|Withdrawal by Subject|5|||
16230383|NCT02268214|39324412|FG002|Overall Study|Withdrawal by Subject|10|||
16230384|NCT02268214|39324410|FG000|Overall Study|Subject request to discontinue treatment|10|||
16230385|NCT02268214|39324411|FG001|Overall Study|Subject request to discontinue treatment|8|||
16230386|NCT02268214|39324412|FG002|Overall Study|Subject request to discontinue treatment|6|||
16230387|NCT02268214|39324410|FG000|Overall Study|Poor/non-compliance|2|||
16230388|NCT02268214|39324411|FG001|Overall Study|Poor/non-compliance|1|||
16230389|NCT02268214|39324412|FG002|Overall Study|Poor/non-compliance|2|||
16230390|NCT02268214|39324410|FG000|Overall Study|Other reasons|7|||
16230391|NCT02268214|39324411|FG001|Overall Study|Other reasons|3|||
16230392|NCT02268214|39324412|FG002|Overall Study|Other reasons|3|||
16230393|NCT02268214|39324410|FG000|Overall Study|Not entering long-term period|2|||
16230394|NCT02268214|39324411|FG001|Overall Study|Not entering long-term period|3|||
16230395|NCT02268214|39324412|FG002|Overall Study|Not entering long-term period|5|||
16230396|NCT00253747|39324419|FG000|Overall Study|Lost to Follow-up|13|||
16230397|NCT00253747|39324420|FG001|Overall Study|Lost to Follow-up|14|||
16230398|NCT00253747|39324419|FG000|Overall Study|Withdrawal by Subject|10|||
16230399|NCT00253747|39324420|FG001|Overall Study|Withdrawal by Subject|11|||
16230400|NCT00253747|39324419|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
16230401|NCT00253747|39324420|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
16230402|NCT02696382|39324421|FG000|Overall Study|Death|7|||
16230403|NCT02696382|39324422|FG001|Overall Study|Death|2|||
16230404|NCT02696382|39324421|FG000|Overall Study|Withdrawal by Subject|5|||
16230405|NCT02696382|39324422|FG001|Overall Study|Withdrawal by Subject|12|||
16230406|NCT02696382|39324421|FG000|Overall Study|Lost to Follow-up|4|||
16230407|NCT02696382|39324422|FG001|Overall Study|Lost to Follow-up|7|||
16230408|NCT04516291|39324425|FG000|Treatment Period (24 Weeks)|Other|1|||
16230409|NCT04516291|39324426|FG001|Treatment Period (24 Weeks)|Other|0|||
16230410|NCT04516291|39324427|FG002|Treatment Period (24 Weeks)|Other|0|||
16230411|NCT04516291|39324428|FG003|Treatment Period (24 Weeks)|Other|2|||
16230412|NCT04516291|39324429|FG004|Treatment Period (24 Weeks)|Other|2|||
16230413|NCT04516291|39324430|FG005|Treatment Period (24 Weeks)|Other|4|||
16230414|NCT04516291|39324431|FG006|Treatment Period (24 Weeks)|Other|2|||
16230415|NCT04516291|39324432|FG007|Treatment Period (24 Weeks)|Other|0|||
16230416|NCT04516291|39324425|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16230417|NCT04516291|39324426|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
16230418|NCT04516291|39324427|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
16230419|NCT04516291|39324428|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16230420|NCT04516291|39324429|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
16230421|NCT04516291|39324430|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16230422|NCT04516291|39324431|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16230423|NCT04516291|39324432|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16230424|NCT04516291|39324425|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
16230425|NCT04516291|39324426|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
16230426|NCT04516291|39324427|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
16230427|NCT04516291|39324428|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
16230428|NCT04516291|39324429|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
16230429|NCT04516291|39324430|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
16348271|NCT00490971|39762237|FG002|Acute/Continuation|Death|0|||
16230430|NCT04516291|39324431|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
16230431|NCT04516291|39324432|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
16230432|NCT04516291|39324425|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16230433|NCT04516291|39324426|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
16230434|NCT04516291|39324427|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16230435|NCT04516291|39324428|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16230436|NCT04516291|39324429|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16230437|NCT04516291|39324430|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16230438|NCT04516291|39324431|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16230439|NCT04516291|39324432|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16230440|NCT04516291|39324425|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
16230441|NCT04516291|39324426|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
16230442|NCT04516291|39324427|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
16230443|NCT04516291|39324428|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
16230444|NCT04516291|39324429|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
16230445|NCT04516291|39324430|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
16230446|NCT04516291|39324431|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
16230447|NCT04516291|39324432|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
16230448|NCT04516291|39324425|FG000|Follow-up Period (12 Weeks)|Other|0|||
16230449|NCT04516291|39324426|FG001|Follow-up Period (12 Weeks)|Other|1|||
16230450|NCT04516291|39324427|FG002|Follow-up Period (12 Weeks)|Other|0|||
16230451|NCT04516291|39324428|FG003|Follow-up Period (12 Weeks)|Other|2|||
16230452|NCT04516291|39324429|FG004|Follow-up Period (12 Weeks)|Other|0|||
16230453|NCT04516291|39324430|FG005|Follow-up Period (12 Weeks)|Other|0|||
16230454|NCT04516291|39324431|FG006|Follow-up Period (12 Weeks)|Other|0|||
16230455|NCT04516291|39324432|FG007|Follow-up Period (12 Weeks)|Other|0|||
16230456|NCT04516291|39324425|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16230457|NCT04516291|39324426|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16230458|NCT04516291|39324427|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16551258|NCT00876460|40481531|FG005|Combination Therapy Phase|Adverse Event|0|||
16551259|NCT00876460|40481532|FG006|Combination Therapy Phase|Adverse Event|3|||
16551260|NCT00876460|40481533|FG007|Combination Therapy Phase|Adverse Event|2|||
16551261|NCT00876460|40481526|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
16551262|NCT00876460|40481527|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
16551263|NCT00876460|40481528|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
16551264|NCT00876460|40481529|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
16551265|NCT00876460|40481530|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
16551266|NCT00876460|40481531|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
16551267|NCT00876460|40481532|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
16551268|NCT00876460|40481533|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
16551269|NCT00876460|40481526|FG000|Combination Therapy Phase|Other reason not defined above|0|||
16230459|NCT04516291|39324428|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16230460|NCT04516291|39324429|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
16230461|NCT04516291|39324430|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16230462|NCT04516291|39324431|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16230463|NCT04516291|39324432|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
16230464|NCT04516291|39324425|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
16230465|NCT04516291|39324426|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
16230466|NCT04516291|39324427|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
16230467|NCT04516291|39324428|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
16551270|NCT00876460|40481527|FG001|Combination Therapy Phase|Other reason not defined above|0|||
16551271|NCT00876460|40481528|FG002|Combination Therapy Phase|Other reason not defined above|0|||
16551272|NCT00876460|40481529|FG003|Combination Therapy Phase|Other reason not defined above|0|||
16230468|NCT04516291|39324429|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
16230469|NCT04516291|39324430|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
16230470|NCT04516291|39324431|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
16230471|NCT04516291|39324432|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
16230472|NCT01479777|39324433|FG000|Overall Study|Physician Decision|2|||
16230473|NCT02503215|39324434|FG000|Overall Study|Unable to wear compression stockings|1|||
16230474|NCT02503215|39324434|FG000|Overall Study|Unable to use positive airway pressure|2|||
16230475|NCT01714726|39324435|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
16230476|NCT01714726|39324436|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
16230477|NCT01714726|39324437|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
16230478|NCT01714726|39324438|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
16230479|NCT01714726|39324435|FG000|Double-Blinded Induction Period|Adverse Event|0|||
16230480|NCT01714726|39324436|FG001|Double-Blinded Induction Period|Adverse Event|1|||
16230481|NCT01714726|39324437|FG002|Double-Blinded Induction Period|Adverse Event|0|||
16230482|NCT01714726|39324438|FG003|Double-Blinded Induction Period|Adverse Event|0|||
16230483|NCT01714726|39324435|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
16230484|NCT01714726|39324436|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
16230485|NCT01714726|39324437|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
16230486|NCT01714726|39324438|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
16230487|NCT01714726|39324435|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
16230488|NCT01714726|39324436|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
16230489|NCT01714726|39324437|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
16230490|NCT01714726|39324438|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
16230491|NCT01714726|39324435|FG000|Open-Label Period|Other|0|||
16230492|NCT01714726|39324436|FG001|Open-Label Period|Other|0|||
16230493|NCT01714726|39324437|FG002|Open-Label Period|Other|1|||
16230494|NCT01714726|39324438|FG003|Open-Label Period|Other|3|||
16230495|NCT01714726|39324435|FG000|Open-Label Period|Adverse Event|0|||
16230496|NCT01714726|39324436|FG001|Open-Label Period|Adverse Event|0|||
16230497|NCT01714726|39324437|FG002|Open-Label Period|Adverse Event|1|||
16230498|NCT01714726|39324438|FG003|Open-Label Period|Adverse Event|0|||
16551273|NCT00876460|40481530|FG004|Combination Therapy Phase|Other reason not defined above|0|||
16551274|NCT00876460|40481531|FG005|Combination Therapy Phase|Other reason not defined above|0|||
16551275|NCT00876460|40481532|FG006|Combination Therapy Phase|Other reason not defined above|1|||
16551276|NCT00876460|40481533|FG007|Combination Therapy Phase|Other reason not defined above|2|||
16551277|NCT00876460|40481526|FG000|Combination Therapy Phase|Not treated|0|||
16551278|NCT00876460|40481527|FG001|Combination Therapy Phase|Not treated|0|||
16551279|NCT00876460|40481528|FG002|Combination Therapy Phase|Not treated|0|||
16551280|NCT00876460|40481529|FG003|Combination Therapy Phase|Not treated|0|||
16551281|NCT00876460|40481530|FG004|Combination Therapy Phase|Not treated|0|||
16551282|NCT00876460|40481531|FG005|Combination Therapy Phase|Not treated|0|||
16551283|NCT00876460|40481532|FG006|Combination Therapy Phase|Not treated|1|||
16551284|NCT00876460|40481533|FG007|Combination Therapy Phase|Not treated|0|||
16551285|NCT00876460|40481526|FG000|Mono Therapy Phase|Progressive disease|0|||
16551286|NCT00876460|40481527|FG001|Mono Therapy Phase|Progressive disease|0|||
16551287|NCT00876460|40481528|FG002|Mono Therapy Phase|Progressive disease|0|||
16551288|NCT00876460|40481529|FG003|Mono Therapy Phase|Progressive disease|0|||
16551289|NCT00876460|40481530|FG004|Mono Therapy Phase|Progressive disease|2|||
16551290|NCT00876460|40481531|FG005|Mono Therapy Phase|Progressive disease|0|||
16551291|NCT00876460|40481532|FG006|Mono Therapy Phase|Progressive disease|1|||
16551292|NCT00876460|40481533|FG007|Mono Therapy Phase|Progressive disease|3|||
16551293|NCT00876460|40481526|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
16551294|NCT00876460|40481527|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
16551295|NCT00876460|40481528|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
16551296|NCT00876460|40481529|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
16551297|NCT00876460|40481530|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
16551298|NCT00876460|40481531|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
16551299|NCT00876460|40481532|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
16551300|NCT00876460|40481533|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
16551301|NCT00876460|40481526|FG000|Mono Therapy Phase|Adverse Event|0|||
16551302|NCT00876460|40481527|FG001|Mono Therapy Phase|Adverse Event|0|||
16551303|NCT00876460|40481528|FG002|Mono Therapy Phase|Adverse Event|0|||
16551304|NCT00876460|40481529|FG003|Mono Therapy Phase|Adverse Event|1|||
16551305|NCT00876460|40481530|FG004|Mono Therapy Phase|Adverse Event|0|||
16551306|NCT00876460|40481531|FG005|Mono Therapy Phase|Adverse Event|0|||
16551307|NCT00876460|40481532|FG006|Mono Therapy Phase|Adverse Event|0|||
16230499|NCT01714726|39324435|FG000|Open-Label Period|Withdrawal by Subject|0|||
16230500|NCT01714726|39324436|FG001|Open-Label Period|Withdrawal by Subject|0|||
16230501|NCT01714726|39324437|FG002|Open-Label Period|Withdrawal by Subject|9|||
16230502|NCT01714726|39324438|FG003|Open-Label Period|Withdrawal by Subject|19|||
16230503|NCT01714726|39324435|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
16230504|NCT01714726|39324436|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
16230505|NCT01714726|39324437|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
16348272|NCT00490971|39762238|FG003|Acute/Continuation|Death|0|||
16551308|NCT00876460|40481533|FG007|Mono Therapy Phase|Adverse Event|0|||
16551309|NCT03321513|40481534|FG000|Overall Study|Death|11|||
16551310|NCT03321513|40481535|FG001|Overall Study|Death|5|||
16551311|NCT03321513|40481534|FG000|Overall Study|Withdrawal by Subject|5|||
16551312|NCT03321513|40481535|FG001|Overall Study|Withdrawal by Subject|10|||
16551313|NCT03321513|40481534|FG000|Overall Study|Lost to Follow-up|10|||
16551314|NCT03321513|40481535|FG001|Overall Study|Lost to Follow-up|11|||
16551315|NCT04488003|40481536|FG000|Assessed for Eligibility|Screen Failure|24|||
16551316|NCT04488003|40481537|FG001|Assessed for Eligibility|Screen Failure|0|||
16551317|NCT04488003|40481538|FG002|Assessed for Eligibility|Screen Failure|0|||
16551318|NCT04488003|40481536|FG000|Assessed for Eligibility|Adverse Event|1|||
16551319|NCT04488003|40481537|FG001|Assessed for Eligibility|Adverse Event|0|||
16551320|NCT04488003|40481538|FG002|Assessed for Eligibility|Adverse Event|0|||
16551321|NCT04488003|40481536|FG000|Assessed for Eligibility|Death|1|||
16551322|NCT04488003|40481537|FG001|Assessed for Eligibility|Death|0|||
16551323|NCT04488003|40481538|FG002|Assessed for Eligibility|Death|0|||
16551324|NCT04488003|40481536|FG000|Assessed for Eligibility|Physician Decision|1|||
16551325|NCT04488003|40481537|FG001|Assessed for Eligibility|Physician Decision|0|||
16230506|NCT01714726|39324438|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
16230507|NCT01714726|39324435|FG000|Open-Label Period|Lost to Follow-up|0|||
16230508|NCT01714726|39324436|FG001|Open-Label Period|Lost to Follow-up|0|||
16230509|NCT01714726|39324437|FG002|Open-Label Period|Lost to Follow-up|3|||
16348273|NCT00490971|39762239|FG004|Acute/Continuation|Death|0|||
16551326|NCT04488003|40481538|FG002|Assessed for Eligibility|Physician Decision|0|||
16551327|NCT04488003|40481536|FG000|Allocated to Treatment|Progressive Disease|51|||
16551328|NCT04488003|40481537|FG001|Allocated to Treatment|Progressive Disease|0|||
16551329|NCT04488003|40481538|FG002|Allocated to Treatment|Progressive Disease|0|||
16230510|NCT01714726|39324438|FG003|Open-Label Period|Lost to Follow-up|4|||
16230511|NCT00678652|39324440|FG000|Overall Study|Protocol Violation|2|||
16551330|NCT04488003|40481536|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
16551331|NCT04488003|40481537|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
16551332|NCT04488003|40481538|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
16551333|NCT04488003|40481536|FG000|Allocated to Treatment|Adverse Event|6|||
16551334|NCT04488003|40481537|FG001|Allocated to Treatment|Adverse Event|0|||
16551335|NCT04488003|40481538|FG002|Allocated to Treatment|Adverse Event|0|||
16551336|NCT04488003|40481536|FG000|Allocated to Treatment|Other|5|||
16551337|NCT04488003|40481537|FG001|Allocated to Treatment|Other|0|||
16551338|NCT04488003|40481538|FG002|Allocated to Treatment|Other|0|||
16230512|NCT00678652|39324441|FG001|Overall Study|Protocol Violation|0|||
16230513|NCT00678652|39324442|FG002|Overall Study|Protocol Violation|0|||
16230514|NCT00678652|39324443|FG003|Overall Study|Protocol Violation|0|||
16230515|NCT00678652|39324440|FG000|Overall Study|Pregnancy|0|||
16230516|NCT00678652|39324441|FG001|Overall Study|Pregnancy|0|||
16230517|NCT00678652|39324442|FG002|Overall Study|Pregnancy|1|||
16230518|NCT00678652|39324443|FG003|Overall Study|Pregnancy|0|||
16230519|NCT00678652|39324440|FG000|Overall Study|Relocation|1|||
16230520|NCT00678652|39324441|FG001|Overall Study|Relocation|0|||
16230521|NCT00678652|39324442|FG002|Overall Study|Relocation|0|||
16230522|NCT00678652|39324443|FG003|Overall Study|Relocation|0|||
16230523|NCT03426995|39324456|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230524|NCT03426995|39324457|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230525|NCT03426995|39324458|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
16230526|NCT03426995|39324459|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230527|NCT03426995|39324460|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230528|NCT03426995|39324461|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230529|NCT03426995|39324462|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230530|NCT03426995|39324463|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230531|NCT03426995|39324464|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230532|NCT03426995|39324465|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16348274|NCT00490971|39762235|FG000|Acute/Continuation|Lack of Efficacy|106|||
16230533|NCT03426995|39324466|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16348275|NCT00490971|39762236|FG001|Acute/Continuation|Lack of Efficacy|12|||
16551339|NCT04488003|40481536|FG000|Allocated to Treatment|Physician Decision|4|||
16551340|NCT04488003|40481537|FG001|Allocated to Treatment|Physician Decision|0|||
16230534|NCT03426995|39324467|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230535|NCT03426995|39324468|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230536|NCT03426995|39324469|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230537|NCT03426995|39324470|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230538|NCT03426995|39324471|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230539|NCT03426995|39324472|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230540|NCT03426995|39324473|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230541|NCT03426995|39324474|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
16230542|NCT03426995|39324456|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230543|NCT03426995|39324457|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230544|NCT03426995|39324458|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230545|NCT03426995|39324459|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230546|NCT03426995|39324460|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230547|NCT03426995|39324461|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
16230548|NCT03426995|39324462|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230549|NCT03426995|39324463|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230550|NCT03426995|39324464|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230551|NCT03426995|39324465|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230552|NCT03426995|39324466|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230553|NCT03426995|39324467|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230554|NCT03426995|39324468|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230555|NCT03426995|39324469|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230556|NCT03426995|39324470|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230557|NCT03426995|39324471|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230558|NCT03426995|39324472|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230559|NCT03426995|39324473|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230560|NCT03426995|39324474|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
16230561|NCT03426995|39324456|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230562|NCT03426995|39324457|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230563|NCT03426995|39324458|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230564|NCT03426995|39324459|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230565|NCT03426995|39324460|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
16230566|NCT03426995|39324461|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
16230567|NCT03426995|39324462|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230568|NCT03426995|39324463|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230569|NCT03426995|39324464|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230570|NCT03426995|39324465|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230571|NCT03426995|39324466|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230572|NCT03426995|39324467|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230573|NCT03426995|39324468|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230574|NCT03426995|39324469|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230575|NCT03426995|39324470|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230576|NCT03426995|39324471|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230577|NCT03426995|39324472|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230578|NCT03426995|39324473|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230579|NCT03426995|39324474|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
16230580|NCT03426995|39324456|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230581|NCT03426995|39324457|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230582|NCT03426995|39324458|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230583|NCT03426995|39324459|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230584|NCT03426995|39324460|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230585|NCT03426995|39324461|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230586|NCT03426995|39324462|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230587|NCT03426995|39324463|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230588|NCT03426995|39324464|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230589|NCT03426995|39324465|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230590|NCT03426995|39324466|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
16551341|NCT04488003|40481538|FG002|Allocated to Treatment|Physician Decision|0|||
16551342|NCT04488003|40481536|FG000|Allocated to Treatment|Death|4|||
16551343|NCT04488003|40481537|FG001|Allocated to Treatment|Death|0|||
16551344|NCT04488003|40481538|FG002|Allocated to Treatment|Death|0|||
16551345|NCT01868035|40481547|FG000|Overall Study|Lost to Follow-up|3|||
16551346|NCT01868035|40481547|FG000|Overall Study|Withdrawal by Subject|1|||
16551347|NCT01868035|40481547|FG000|Overall Study|Progressive Disease|2|||
16551348|NCT01868035|40481547|FG000|Overall Study|Non-compliance|1|||
16551349|NCT00366301|40481548|FG000|Overall Study|Lost to Follow-up|4|||
16551350|NCT00366301|40481549|FG001|Overall Study|Lost to Follow-up|4|||
16551351|NCT00366301|40481550|FG002|Overall Study|Lost to Follow-up|3|||
16551352|NCT00366301|40481551|FG003|Overall Study|Lost to Follow-up|7|||
16551353|NCT00366301|40481548|FG000|Overall Study|Withdrawal by Subject|4|||
16551354|NCT00366301|40481549|FG001|Overall Study|Withdrawal by Subject|2|||
16230591|NCT03426995|39324467|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230592|NCT03426995|39324468|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230593|NCT03426995|39324469|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230594|NCT03426995|39324470|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230595|NCT03426995|39324471|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16118993|NCT01365481|38923339|FG000|Overall Study|Administrative problems|0|||
16118994|NCT01365481|38923340|FG001|Overall Study|Administrative problems|1|||
16118995|NCT01365481|38923341|FG002|Overall Study|Administrative problems|0|||
16348276|NCT00490971|39762237|FG002|Acute/Continuation|Lack of Efficacy|0|||
16348277|NCT00490971|39762238|FG003|Acute/Continuation|Lack of Efficacy|0|||
16551355|NCT00366301|40481550|FG002|Overall Study|Withdrawal by Subject|1|||
16551356|NCT00366301|40481551|FG003|Overall Study|Withdrawal by Subject|1|||
16551357|NCT02796963|40481554|FG000|Overall Study|Lost to Follow-up|89|||
16551358|NCT02796963|40481555|FG001|Overall Study|Lost to Follow-up|76|||
16551359|NCT02796963|40481556|FG002|Overall Study|Lost to Follow-up|69|||
16551360|NCT02796963|40481557|FG003|Overall Study|Lost to Follow-up|72|||
16551361|NCT04041440|40481558|FG000|Overall Study|Withdrawal by Subject|0|||
16551362|NCT04041440|40481559|FG001|Overall Study|Withdrawal by Subject|1|||
16551363|NCT04041440|40481558|FG000|Overall Study|Lost to Follow-up|0|||
16551364|NCT04041440|40481559|FG001|Overall Study|Lost to Follow-up|1|||
16348278|NCT00490971|39762239|FG004|Acute/Continuation|Lack of Efficacy|0|||
16348279|NCT00490971|39762235|FG000|Acute/Continuation|Lost to Follow-up|23|||
16348280|NCT00490971|39762236|FG001|Acute/Continuation|Lost to Follow-up|7|||
16348281|NCT00490971|39762237|FG002|Acute/Continuation|Lost to Follow-up|0|||
16348282|NCT00490971|39762238|FG003|Acute/Continuation|Lost to Follow-up|0|||
16348283|NCT00490971|39762239|FG004|Acute/Continuation|Lost to Follow-up|0|||
16348284|NCT00490971|39762235|FG000|Acute/Continuation|Protocol Violation|10|||
16348285|NCT00490971|39762236|FG001|Acute/Continuation|Protocol Violation|2|||
16348286|NCT00490971|39762237|FG002|Acute/Continuation|Protocol Violation|0|||
16348287|NCT00490971|39762238|FG003|Acute/Continuation|Protocol Violation|0|||
16348288|NCT00490971|39762239|FG004|Acute/Continuation|Protocol Violation|0|||
16348289|NCT00490971|39762235|FG000|Acute/Continuation|Withdrawal by Subject|92|||
16348290|NCT00490971|39762236|FG001|Acute/Continuation|Withdrawal by Subject|24|||
16348291|NCT00490971|39762237|FG002|Acute/Continuation|Withdrawal by Subject|0|||
16348292|NCT00490971|39762238|FG003|Acute/Continuation|Withdrawal by Subject|0|||
16348293|NCT00490971|39762239|FG004|Acute/Continuation|Withdrawal by Subject|0|||
16348294|NCT00490971|39762235|FG000|Acute/Continuation|Other|11|||
16348295|NCT00490971|39762236|FG001|Acute/Continuation|Other|4|||
16348296|NCT00490971|39762237|FG002|Acute/Continuation|Other|0|||
16412604|NCT02198794|39992224|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
16412605|NCT02198794|39992225|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
16551365|NCT01103960|40481560|FG000|Overall Study|Adverse Event|2|||
16551366|NCT01103960|40481561|FG001|Overall Study|Adverse Event|1|||
16551367|NCT01103960|40481560|FG000|Overall Study|Withdrawal by Subject|2|||
16118996|NCT01365481|38923342|FG003|Overall Study|Administrative problems|0|||
16118997|NCT01365481|38923339|FG000|Overall Study|Protocol deviation|0|||
16118998|NCT01365481|38923340|FG001|Overall Study|Protocol deviation|1|||
16118999|NCT01365481|38923341|FG002|Overall Study|Protocol deviation|0|||
16119000|NCT01365481|38923342|FG003|Overall Study|Protocol deviation|1|||
16119001|NCT01365481|38923339|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16119002|NCT01365481|38923340|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16119003|NCT01365481|38923341|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
16119004|NCT01365481|38923342|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
16119005|NCT00863512|38923343|FG000|Overall Study|Adverse Event|2|||
16119006|NCT00863512|38923344|FG001|Overall Study|Adverse Event|0|||
16119007|NCT00863512|38923343|FG000|Overall Study|Withdrawal by Subject|11|||
16119008|NCT00863512|38923344|FG001|Overall Study|Withdrawal by Subject|0|||
16230596|NCT03426995|39324472|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16348297|NCT00490971|39762238|FG003|Acute/Continuation|Other|0|||
16348298|NCT00490971|39762239|FG004|Acute/Continuation|Other|0|||
16348299|NCT00490971|39762235|FG000|Maintenance|Adverse Event|0|||
16348300|NCT00490971|39762236|FG001|Maintenance|Adverse Event|0|||
16348301|NCT00490971|39762237|FG002|Maintenance|Adverse Event|4|||
16348302|NCT00490971|39762238|FG003|Maintenance|Adverse Event|5|||
16348303|NCT00490971|39762239|FG004|Maintenance|Adverse Event|7|||
16348304|NCT00490971|39762235|FG000|Maintenance|Death|0|||
16348305|NCT00490971|39762236|FG001|Maintenance|Death|0|||
16348306|NCT00490971|39762237|FG002|Maintenance|Death|0|||
16348307|NCT00490971|39762238|FG003|Maintenance|Death|2|||
16348308|NCT00490971|39762239|FG004|Maintenance|Death|0|||
16348309|NCT00490971|39762235|FG000|Maintenance|Lost to Follow-up|0|||
16348310|NCT00490971|39762236|FG001|Maintenance|Lost to Follow-up|0|||
16119009|NCT00863512|38923343|FG000|Overall Study|Physician Decision|1|||
16119010|NCT00863512|38923344|FG001|Overall Study|Physician Decision|0|||
16119011|NCT01706705|38923346|FG000|Overall Study|Death|1|||
16348311|NCT00490971|39762237|FG002|Maintenance|Lost to Follow-up|5|||
16348312|NCT00490971|39762238|FG003|Maintenance|Lost to Follow-up|8|||
16348313|NCT00490971|39762239|FG004|Maintenance|Lost to Follow-up|10|||
16348314|NCT00490971|39762235|FG000|Maintenance|Pregnancy|0|||
16119012|NCT01706705|38923346|FG000|Overall Study|Lack of Efficacy|13|||
16348315|NCT00490971|39762236|FG001|Maintenance|Pregnancy|0|||
16348316|NCT00490971|39762237|FG002|Maintenance|Pregnancy|1|||
16348317|NCT00490971|39762238|FG003|Maintenance|Pregnancy|0|||
16412606|NCT02198794|39992226|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
16412607|NCT02198794|39992227|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
16412608|NCT02198794|39992224|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
16412609|NCT02198794|39992225|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
16412610|NCT02198794|39992226|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
16412611|NCT02198794|39992227|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
16412612|NCT02198794|39992224|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
16412613|NCT02198794|39992225|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
16412614|NCT02198794|39992226|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
16412615|NCT02198794|39992227|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
16412616|NCT02198794|39992224|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
16412617|NCT02198794|39992225|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
16412618|NCT02198794|39992226|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
16412619|NCT02198794|39992227|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
16412620|NCT02198794|39992224|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
16412621|NCT02198794|39992225|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
16412622|NCT02198794|39992226|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
16412623|NCT02198794|39992227|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
16412624|NCT02198794|39992224|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
16412625|NCT02198794|39992225|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
16412626|NCT02198794|39992226|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
16412627|NCT02198794|39992227|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
16412628|NCT02198794|39992224|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
16412629|NCT02198794|39992225|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
16412630|NCT02198794|39992226|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
16412631|NCT02198794|39992227|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
16412632|NCT02198794|39992224|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
16412633|NCT02198794|39992225|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
16412634|NCT02198794|39992226|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
16412635|NCT02198794|39992227|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
16412636|NCT00711802|39992228|FG000|Overall Study|Not treated (no further detail)|2|||
16412637|NCT00711802|39992229|FG001|Overall Study|Not treated (no further detail)|1|||
16412638|NCT00711802|39992230|FG002|Overall Study|Not treated (no further detail)|2|||
16412639|NCT00711802|39992231|FG003|Overall Study|Not treated (no further detail)|0|||
16412640|NCT00711802|39992232|FG004|Overall Study|Not treated (no further detail)|2|||
16412641|NCT00711802|39992233|FG005|Overall Study|Not treated (no further detail)|0|||
16412642|NCT00711802|39992234|FG006|Overall Study|Not treated (no further detail)|0|||
16412643|NCT00711802|39992235|FG007|Overall Study|Not treated (no further detail)|0|||
16412644|NCT00711802|39992228|FG000|Overall Study|Adverse Event|0|||
16119013|NCT01706705|38923346|FG000|Overall Study|Non-clinical|6|||
16119014|NCT03812029|38923350|FG000|Overall Study|Protocol Violation|1|||
16119015|NCT03812029|38923351|FG001|Overall Study|Protocol Violation|0|||
16119016|NCT03812029|38923352|FG002|Overall Study|Protocol Violation|0|||
16119017|NCT03812029|38923353|FG003|Overall Study|Protocol Violation|1|||
16119018|NCT03812029|38923354|FG004|Overall Study|Protocol Violation|0|||
16119019|NCT03812029|38923350|FG000|Overall Study|Withdrawal by Subject|1|||
16119020|NCT03812029|38923351|FG001|Overall Study|Withdrawal by Subject|0|||
16119021|NCT03812029|38923352|FG002|Overall Study|Withdrawal by Subject|0|||
16119022|NCT03812029|38923353|FG003|Overall Study|Withdrawal by Subject|2|||
16119023|NCT03812029|38923354|FG004|Overall Study|Withdrawal by Subject|2|||
16119024|NCT03812029|38923350|FG000|Overall Study|Stopping rules|0|||
16119025|NCT03812029|38923351|FG001|Overall Study|Stopping rules|1|||
16412645|NCT00711802|39992229|FG001|Overall Study|Adverse Event|0|||
16412646|NCT00711802|39992230|FG002|Overall Study|Adverse Event|0|||
16412647|NCT00711802|39992231|FG003|Overall Study|Adverse Event|0|||
16412648|NCT00711802|39992232|FG004|Overall Study|Adverse Event|1|||
16412649|NCT00711802|39992233|FG005|Overall Study|Adverse Event|1|||
16412650|NCT00711802|39992234|FG006|Overall Study|Adverse Event|0|||
16412651|NCT00711802|39992235|FG007|Overall Study|Adverse Event|0|||
16412652|NCT00711802|39992228|FG000|Overall Study|Microbiological failure|0|||
16412653|NCT00711802|39992229|FG001|Overall Study|Microbiological failure|1|||
16551368|NCT01103960|40481561|FG001|Overall Study|Withdrawal by Subject|1|||
16551369|NCT01103960|40481560|FG000|Overall Study|Other|1|||
16551370|NCT01103960|40481561|FG001|Overall Study|Other|0|||
16551371|NCT01381874|40481562|FG000|Overall Study|Lost to Follow-up|1|||
16551372|NCT01381874|40481563|FG001|Overall Study|Lost to Follow-up|1|||
16551373|NCT01381874|40481564|FG002|Overall Study|Lost to Follow-up|0|||
16551374|NCT01381874|40481562|FG000|Overall Study|Withdrawal by Subject|9|||
16551375|NCT01381874|40481563|FG001|Overall Study|Withdrawal by Subject|10|||
16551376|NCT01381874|40481564|FG002|Overall Study|Withdrawal by Subject|9|||
16119026|NCT03812029|38923352|FG002|Overall Study|Stopping rules|0|||
16119027|NCT03812029|38923353|FG003|Overall Study|Stopping rules|0|||
16551377|NCT01381874|40481562|FG000|Overall Study|Other|67|||
16412654|NCT00711802|39992230|FG002|Overall Study|Microbiological failure|0|||
16412655|NCT00711802|39992231|FG003|Overall Study|Microbiological failure|0|||
16412656|NCT00711802|39992232|FG004|Overall Study|Microbiological failure|0|||
16412657|NCT00711802|39992233|FG005|Overall Study|Microbiological failure|1|||
16412658|NCT00711802|39992234|FG006|Overall Study|Microbiological failure|0|||
16412659|NCT00711802|39992235|FG007|Overall Study|Microbiological failure|0|||
16412660|NCT00711802|39992228|FG000|Overall Study|Protocol Violation|0|||
16551378|NCT01381874|40481563|FG001|Overall Study|Other|52|||
16551379|NCT01381874|40481564|FG002|Overall Study|Other|67|||
16551380|NCT01462162|40481565|FG000|Overall Study|Adverse Event|5|||
16551381|NCT01462162|40481565|FG000|Overall Study|Lack of Efficacy|4|||
16551382|NCT01462162|40481565|FG000|Overall Study|Abnormal laboratory parameters|1|||
16119028|NCT03812029|38923354|FG004|Overall Study|Stopping rules|0|||
16119029|NCT03812029|38923350|FG000|Overall Study|Adverse Event|0|||
16119030|NCT03812029|38923351|FG001|Overall Study|Adverse Event|9|||
16119031|NCT03812029|38923352|FG002|Overall Study|Adverse Event|0|||
16119032|NCT03812029|38923353|FG003|Overall Study|Adverse Event|3|||
16119033|NCT03812029|38923354|FG004|Overall Study|Adverse Event|5|||
16119034|NCT03812029|38923350|FG000|Overall Study|Lost to Follow-up|0|||
16119035|NCT03812029|38923351|FG001|Overall Study|Lost to Follow-up|0|||
16119036|NCT03812029|38923352|FG002|Overall Study|Lost to Follow-up|0|||
16412661|NCT00711802|39992229|FG001|Overall Study|Protocol Violation|0|||
16412662|NCT00711802|39992230|FG002|Overall Study|Protocol Violation|0|||
16412663|NCT00711802|39992231|FG003|Overall Study|Protocol Violation|1|||
16412664|NCT00711802|39992232|FG004|Overall Study|Protocol Violation|0|||
16551383|NCT01462162|40481565|FG000|Overall Study|Other|2|||
16551384|NCT01567865|40481566|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
16551385|NCT01567865|40481567|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
16551386|NCT01567865|40481568|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
16551387|NCT01567865|40481569|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
16551388|NCT01567865|40481566|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
16551389|NCT01567865|40481567|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
16551390|NCT01567865|40481568|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
16551391|NCT01567865|40481569|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
16551392|NCT04581200|40481571|FG000|Overall Study|Lost to Follow-up|6|||
16551393|NCT04581200|40481572|FG001|Overall Study|Lost to Follow-up|5|||
16551394|NCT02494921|40481577|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
16551395|NCT02494921|40481578|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
16551396|NCT02494921|40481579|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
16551397|NCT02494921|40481580|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
16551398|NCT02494921|40481581|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
16551399|NCT02494921|40481577|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
16551400|NCT02494921|40481578|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
16551401|NCT02494921|40481579|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
16551402|NCT02494921|40481580|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
16551403|NCT02494921|40481581|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
16551404|NCT02494921|40481577|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
16551405|NCT02494921|40481578|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
16551406|NCT02494921|40481579|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
16551407|NCT02494921|40481580|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
16551408|NCT02494921|40481581|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
16412665|NCT00711802|39992233|FG005|Overall Study|Protocol Violation|0|||
16412666|NCT00711802|39992234|FG006|Overall Study|Protocol Violation|0|||
16412667|NCT00711802|39992235|FG007|Overall Study|Protocol Violation|0|||
16551409|NCT03691948|40481582|FG000|Overall Study|Lost to Follow-up|1|||
16551410|NCT03691948|40481583|FG001|Overall Study|Lost to Follow-up|3|||
16551411|NCT00077636|40481584|FG000|Overall Study|Refused Treatment|9|||
16119037|NCT03812029|38923353|FG003|Overall Study|Lost to Follow-up|0|||
16119038|NCT03812029|38923354|FG004|Overall Study|Lost to Follow-up|3|||
16551412|NCT00077636|40481585|FG001|Overall Study|Refused Treatment|31|||
16119039|NCT03106753|38923355|FG000|Overall Study|Withdrawal by Subject|0|||
16119040|NCT03106753|38923356|FG001|Overall Study|Withdrawal by Subject|1|||
16119041|NCT02770612|38923357|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
16119042|NCT03738423|38923358|FG000|Overall Study|Withdrawal by Subject|9|||
16119043|NCT03738423|38923359|FG001|Overall Study|Withdrawal by Subject|12|||
16119044|NCT03738423|38923360|FG002|Overall Study|Withdrawal by Subject|9|||
16119045|NCT03738423|38923361|FG003|Overall Study|Withdrawal by Subject|12|||
16119046|NCT03738423|38923362|FG004|Overall Study|Withdrawal by Subject|10|||
16119047|NCT03738423|38923358|FG000|Overall Study|Lack of Efficacy|3|||
16119048|NCT03738423|38923359|FG001|Overall Study|Lack of Efficacy|1|||
16119049|NCT03738423|38923360|FG002|Overall Study|Lack of Efficacy|1|||
16348318|NCT00490971|39762239|FG004|Maintenance|Pregnancy|0|||
16348319|NCT00490971|39762235|FG000|Maintenance|Protocol Violation|0|||
16551413|NCT00077636|40481584|FG000|Overall Study|Admin|3|||
16551414|NCT00077636|40481585|FG001|Overall Study|Admin|3|||
16551415|NCT00077636|40481584|FG000|Overall Study|Withdrawal by Subject|2|||
16551416|NCT00077636|40481585|FG001|Overall Study|Withdrawal by Subject|2|||
16551417|NCT00077636|40481584|FG000|Overall Study|Adverse Event|17|||
16551418|NCT00077636|40481585|FG001|Overall Study|Adverse Event|34|||
16551419|NCT00077636|40481584|FG000|Overall Study|Protocol Violation|0|||
16551420|NCT00077636|40481585|FG001|Overall Study|Protocol Violation|2|||
16551421|NCT00077636|40481584|FG000|Overall Study|Lost to Follow-up|10|||
16551422|NCT00077636|40481585|FG001|Overall Study|Lost to Follow-up|18|||
16551423|NCT00077636|40481584|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
16551424|NCT00077636|40481585|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
16551425|NCT04105972|40481588|FG000|Overall Study|Adverse Event|2|||
16551426|NCT04105972|40481589|FG001|Overall Study|Adverse Event|1|||
16551427|NCT03029247|40481590|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
16551428|NCT03029247|40481591|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
16551429|NCT03029247|40481590|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
16551430|NCT03029247|40481591|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
16119050|NCT03738423|38923361|FG003|Overall Study|Lack of Efficacy|1|||
16119051|NCT03738423|38923362|FG004|Overall Study|Lack of Efficacy|2|||
16230597|NCT03426995|39324473|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230598|NCT03426995|39324474|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
16230599|NCT03426995|39324456|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230600|NCT03426995|39324457|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230601|NCT03426995|39324458|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16348320|NCT00490971|39762236|FG001|Maintenance|Protocol Violation|0|||
16230602|NCT03426995|39324459|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230603|NCT03426995|39324460|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230604|NCT03426995|39324461|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230605|NCT03426995|39324462|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230606|NCT03426995|39324463|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
16230607|NCT03426995|39324464|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230608|NCT03426995|39324465|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16119052|NCT03738423|38923358|FG000|Overall Study|Lost to Follow-up|1|||
16119053|NCT03738423|38923359|FG001|Overall Study|Lost to Follow-up|0|||
16119054|NCT03738423|38923360|FG002|Overall Study|Lost to Follow-up|1|||
16119055|NCT03738423|38923361|FG003|Overall Study|Lost to Follow-up|1|||
16119056|NCT03738423|38923362|FG004|Overall Study|Lost to Follow-up|0|||
16119057|NCT03738423|38923358|FG000|Overall Study|Protocol Violation|1|||
16119058|NCT03738423|38923359|FG001|Overall Study|Protocol Violation|0|||
16119059|NCT03738423|38923360|FG002|Overall Study|Protocol Violation|0|||
16119060|NCT03738423|38923361|FG003|Overall Study|Protocol Violation|0|||
16119061|NCT03738423|38923362|FG004|Overall Study|Protocol Violation|1|||
16119062|NCT03738423|38923358|FG000|Overall Study|Physician Decision|0|||
16119063|NCT03738423|38923359|FG001|Overall Study|Physician Decision|0|||
16119064|NCT03738423|38923360|FG002|Overall Study|Physician Decision|1|||
16119065|NCT03738423|38923361|FG003|Overall Study|Physician Decision|0|||
16119066|NCT03738423|38923362|FG004|Overall Study|Physician Decision|1|||
16119067|NCT03738423|38923358|FG000|Overall Study|Death|0|||
16119068|NCT03738423|38923359|FG001|Overall Study|Death|0|||
16119069|NCT03738423|38923360|FG002|Overall Study|Death|0|||
16119070|NCT03738423|38923361|FG003|Overall Study|Death|0|||
16119071|NCT03738423|38923362|FG004|Overall Study|Death|1|||
16119072|NCT03738423|38923358|FG000|Overall Study|Randomized but never treated|0|||
16119073|NCT03738423|38923359|FG001|Overall Study|Randomized but never treated|0|||
16119074|NCT03738423|38923360|FG002|Overall Study|Randomized but never treated|1|||
16119075|NCT03738423|38923361|FG003|Overall Study|Randomized but never treated|1|||
16119076|NCT03738423|38923362|FG004|Overall Study|Randomized but never treated|0|||
16119077|NCT01088984|38923363|FG000|Phase 1|Death|2|||
16119078|NCT01088984|38923364|FG001|Phase 1|Death|1|||
16119079|NCT01088984|38923363|FG000|Phase 1|Disease Progression|2|||
16119080|NCT01088984|38923364|FG001|Phase 1|Disease Progression|4|||
16119081|NCT01088984|38923363|FG000|Phase 1|Other|1|||
16119082|NCT01088984|38923364|FG001|Phase 1|Other|1|||
16119083|NCT01088984|38923363|FG000|Phase 2|Death|0|||
16119084|NCT01088984|38923364|FG001|Phase 2|Death|5|||
16119085|NCT01088984|38923363|FG000|Phase 2|Withdrawal by Subject|0|||
16119086|NCT01088984|38923364|FG001|Phase 2|Withdrawal by Subject|1|||
16119087|NCT01088984|38923363|FG000|Phase 2|DIsease Progression|0|||
16119088|NCT01088984|38923364|FG001|Phase 2|DIsease Progression|25|||
16119089|NCT01088984|38923363|FG000|Phase 2|Other|0|||
16119090|NCT01088984|38923364|FG001|Phase 2|Other|1|||
16119091|NCT02688530|38923367|FG000|Overall Study|Withdrawal by Subject|0|||
16119092|NCT02688530|38923368|FG001|Overall Study|Withdrawal by Subject|1|||
16119093|NCT02688530|38923369|FG002|Overall Study|Withdrawal by Subject|0|||
16119094|NCT02688530|38923370|FG003|Overall Study|Withdrawal by Subject|0|||
16119095|NCT02688530|38923367|FG000|Overall Study|Lost to Follow-up|0|||
16119096|NCT02688530|38923368|FG001|Overall Study|Lost to Follow-up|0|||
16119097|NCT02688530|38923369|FG002|Overall Study|Lost to Follow-up|2|||
16119098|NCT02688530|38923370|FG003|Overall Study|Lost to Follow-up|0|||
16119099|NCT03015129|38923373|FG000|Overall Study|Death|2|||
16119100|NCT03015129|38923374|FG001|Overall Study|Death|2|||
16119101|NCT03015129|38923373|FG000|Overall Study|Lost to Follow-up|0|||
16119102|NCT03015129|38923374|FG001|Overall Study|Lost to Follow-up|1|||
16119103|NCT03015129|38923373|FG000|Overall Study|Progression of disease|38|||
16119104|NCT03015129|38923374|FG001|Overall Study|Progression of disease|33|||
16119105|NCT03015129|38923373|FG000|Overall Study|Adverse Event|0|||
16119106|NCT03015129|38923374|FG001|Overall Study|Adverse Event|4|||
16230609|NCT03426995|39324466|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16119107|NCT04276051|38923386|FG000|Overall Study|Lost to Follow-up|0|||
16119108|NCT04276051|38923387|FG001|Overall Study|Lost to Follow-up|1|||
16119109|NCT04276051|38923386|FG000|Overall Study|Physician Decision|0|||
16119110|NCT04276051|38923387|FG001|Overall Study|Physician Decision|1|||
16119111|NCT04276051|38923386|FG000|Overall Study|Withdrawal by Subject|1|||
16119112|NCT04276051|38923387|FG001|Overall Study|Withdrawal by Subject|1|||
16119113|NCT03274895|38923388|FG000|Overall Study|Lack of Efficacy|1|||
16119114|NCT03274895|38923389|FG001|Overall Study|Lack of Efficacy|0|||
16119115|NCT03274895|38923388|FG000|Overall Study|Adverse Event|8|||
16230610|NCT03426995|39324467|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230611|NCT03426995|39324468|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16119116|NCT03274895|38923389|FG001|Overall Study|Adverse Event|7|||
16119117|NCT03274895|38923388|FG000|Overall Study|Lost to Follow-up|1|||
16119118|NCT03274895|38923389|FG001|Overall Study|Lost to Follow-up|0|||
16119119|NCT03274895|38923388|FG000|Overall Study|Diagnosis not confirmed|3|||
16119120|NCT03274895|38923389|FG001|Overall Study|Diagnosis not confirmed|4|||
16119121|NCT00368875|38923390|FG000|Overall Study|Adverse Event|0|||
16119122|NCT00368875|38923391|FG001|Overall Study|Adverse Event|12|||
16119123|NCT00368875|38923390|FG000|Overall Study|Progressive disease|3|||
16119124|NCT00368875|38923391|FG001|Overall Study|Progressive disease|27|||
16119125|NCT00368875|38923390|FG000|Overall Study|Withdrawal by Subject|2|||
16119126|NCT00368875|38923391|FG001|Overall Study|Withdrawal by Subject|6|||
16119127|NCT00368875|38923390|FG000|Overall Study|Other Reason|0|||
16119128|NCT00368875|38923391|FG001|Overall Study|Other Reason|2|||
16119129|NCT00368875|38923390|FG000|Overall Study|Alternative Therapy|1|||
16119130|NCT00368875|38923391|FG001|Overall Study|Alternative Therapy|1|||
16119131|NCT01132820|38923392|FG000|Overall Study|Ineligible: wrong cell type|1|||
16119132|NCT01132820|38923392|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
16119133|NCT01132820|38923392|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
16119134|NCT01132820|38923392|FG000|Overall Study|Never treated|1|||
16119135|NCT01132820|38923392|FG000|Overall Study|Inadequate data|1|||
16119136|NCT02690077|38923397|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
16119137|NCT02690077|38923398|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
16119138|NCT02690077|38923397|FG000|Overall Study|Withdrawal by Subject|0|||
16119139|NCT02690077|38923398|FG001|Overall Study|Withdrawal by Subject|5|||
16119140|NCT02690077|38923397|FG000|Overall Study|Excluded by IRB|0|||
16119141|NCT02690077|38923398|FG001|Overall Study|Excluded by IRB|2|||
16119142|NCT02336425|38923399|FG000|Overall Study|Study terminated.|2|||
16119143|NCT02336425|38923400|FG001|Overall Study|Study terminated.|2|||
16119144|NCT02336425|38923401|FG002|Overall Study|Study terminated.|3|||
16119145|NCT02336425|38923402|FG003|Overall Study|Study terminated.|3|||
16119146|NCT03043313|38923403|FG000|Overall Study|Withdrawal by Subject|4|||
16119147|NCT03043313|38923404|FG001|Overall Study|Withdrawal by Subject|1|||
16119148|NCT03043313|38923405|FG002|Overall Study|Withdrawal by Subject|1|||
16119149|NCT03043313|38923403|FG000|Overall Study|Lost to Follow-up|1|||
16119150|NCT03043313|38923404|FG001|Overall Study|Lost to Follow-up|0|||
16119151|NCT03043313|38923405|FG002|Overall Study|Lost to Follow-up|0|||
16119152|NCT03043313|38923403|FG000|Overall Study|Death|26|||
16119153|NCT03043313|38923404|FG001|Overall Study|Death|13|||
16119154|NCT03043313|38923405|FG002|Overall Study|Death|8|||
16119155|NCT03043313|38923403|FG000|Overall Study|On Treatment|7|||
16119156|NCT03043313|38923404|FG001|Overall Study|On Treatment|12|||
16230612|NCT03426995|39324469|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230613|NCT03426995|39324470|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230614|NCT03426995|39324471|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16412668|NCT00711802|39992228|FG000|Overall Study|Physician Decision|0|||
16119157|NCT03043313|38923405|FG002|Overall Study|On Treatment|11|||
16119158|NCT03043313|38923403|FG000|Overall Study|In follow up|7|||
16119159|NCT03043313|38923404|FG001|Overall Study|In follow up|15|||
16119160|NCT03043313|38923405|FG002|Overall Study|In follow up|11|||
16119161|NCT00387426|38923411|FG000|Overall Study|Lack of Response|7|||
16119162|NCT00387426|38923411|FG000|Overall Study|Toxicities|4|||
16119163|NCT00387426|38923411|FG000|Overall Study|Disease Progression|3|||
16119164|NCT02920970|38923412|FG000|First Intervention|Protocol Violation|0|||
16119165|NCT02920970|38923413|FG001|First Intervention|Protocol Violation|1|||
16119166|NCT02920970|38923412|FG000|First Intervention|Adverse Event|0|||
16119167|NCT02920970|38923413|FG001|First Intervention|Adverse Event|1|||
16119168|NCT02920970|38923412|FG000|Second Intervention|Poor Lens Fit|1|||
16119169|NCT02920970|38923413|FG001|Second Intervention|Poor Lens Fit|0|||
16119170|NCT01987895|38923414|FG000|Overall Study|Withdrawal by Subject|12|||
16119171|NCT01987895|38923415|FG001|Overall Study|Withdrawal by Subject|7|||
16119172|NCT01987895|38923414|FG000|Overall Study|Physician Decision|8|||
16119173|NCT01987895|38923415|FG001|Overall Study|Physician Decision|10|||
16119174|NCT01987895|38923414|FG000|Overall Study|Death|7|||
16119175|NCT01987895|38923415|FG001|Overall Study|Death|7|||
16119176|NCT01987895|38923414|FG000|Overall Study|Lost to Follow-up|3|||
16119177|NCT01987895|38923415|FG001|Overall Study|Lost to Follow-up|5|||
16119178|NCT01987895|38923414|FG000|Overall Study|randomized before giving IC|0|||
16119179|NCT01987895|38923415|FG001|Overall Study|randomized before giving IC|1|||
16119180|NCT01818531|38923416|FG000|Overall Study|Withdrawn for case delay after block|1|||
16119181|NCT01818531|38923417|FG001|Overall Study|Withdrawn for case delay after block|0|||
16119182|NCT01818531|38923416|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
16412669|NCT00711802|39992229|FG001|Overall Study|Physician Decision|2|||
16551431|NCT03029247|40481590|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
16551432|NCT03029247|40481591|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
16551433|NCT03029247|40481590|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
16551434|NCT03029247|40481591|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
16551435|NCT00152009|40481592|FG000|Overall Study|Adverse Event|9|||
16551436|NCT00152009|40481593|FG001|Overall Study|Adverse Event|13|||
16551437|NCT00152009|40481594|FG002|Overall Study|Adverse Event|20|||
16551438|NCT00152009|40481595|FG003|Overall Study|Adverse Event|1|||
16551439|NCT00152009|40481592|FG000|Overall Study|Protocol Violation|3|||
16551440|NCT00152009|40481593|FG001|Overall Study|Protocol Violation|0|||
16551441|NCT00152009|40481594|FG002|Overall Study|Protocol Violation|0|||
16551442|NCT00152009|40481595|FG003|Overall Study|Protocol Violation|1|||
16551443|NCT00152009|40481592|FG000|Overall Study|Withdrawal by Subject|2|||
16551444|NCT00152009|40481593|FG001|Overall Study|Withdrawal by Subject|3|||
16551445|NCT00152009|40481594|FG002|Overall Study|Withdrawal by Subject|4|||
16119183|NCT01818531|38923417|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
16119184|NCT01818531|38923416|FG000|Overall Study|Withdrawn for failure to place block|0|||
16348321|NCT00490971|39762237|FG002|Maintenance|Protocol Violation|4|||
16348322|NCT00490971|39762238|FG003|Maintenance|Protocol Violation|1|||
16348323|NCT00490971|39762239|FG004|Maintenance|Protocol Violation|1|||
16348324|NCT00490971|39762235|FG000|Maintenance|Withdrawal by Subject|0|||
16348325|NCT00490971|39762236|FG001|Maintenance|Withdrawal by Subject|0|||
16348326|NCT00490971|39762237|FG002|Maintenance|Withdrawal by Subject|26|||
16348327|NCT00490971|39762238|FG003|Maintenance|Withdrawal by Subject|28|||
16348328|NCT00490971|39762239|FG004|Maintenance|Withdrawal by Subject|18|||
16348329|NCT00490971|39762235|FG000|Maintenance|Other|0|||
16348330|NCT00490971|39762236|FG001|Maintenance|Other|0|||
16348331|NCT00490971|39762237|FG002|Maintenance|Other|11|||
16348332|NCT00490971|39762238|FG003|Maintenance|Other|9|||
16348333|NCT00490971|39762239|FG004|Maintenance|Other|3|||
16348334|NCT00436826|39762241|FG000|Double Blind Period (DBP)|Adverse Event|2|||
16348335|NCT00436826|39762242|FG001|Double Blind Period (DBP)|Adverse Event|0|||
16348336|NCT00436826|39762243|FG002|Double Blind Period (DBP)|Adverse Event|0|||
16348337|NCT00436826|39762244|FG003|Double Blind Period (DBP)|Adverse Event|0|||
16348338|NCT00436826|39762245|FG004|Double Blind Period (DBP)|Adverse Event|0|||
16348339|NCT00436826|39762246|FG005|Double Blind Period (DBP)|Adverse Event|0|||
16348340|NCT00436826|39762241|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
16348341|NCT00436826|39762242|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
16348342|NCT00436826|39762243|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
16348343|NCT00436826|39762244|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
16348344|NCT00436826|39762245|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
16348345|NCT00436826|39762246|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
16348346|NCT00436826|39762241|FG000|Double Blind Period (DBP)|Other|10|||
16348347|NCT00436826|39762242|FG001|Double Blind Period (DBP)|Other|11|||
16348348|NCT00436826|39762243|FG002|Double Blind Period (DBP)|Other|0|||
16348349|NCT00436826|39762244|FG003|Double Blind Period (DBP)|Other|0|||
16348350|NCT00436826|39762245|FG004|Double Blind Period (DBP)|Other|0|||
16348351|NCT00436826|39762246|FG005|Double Blind Period (DBP)|Other|0|||
16348352|NCT00436826|39762241|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
16348353|NCT00436826|39762242|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
16119185|NCT01818531|38923417|FG001|Overall Study|Withdrawn for failure to place block|1|||
16119186|NCT02037477|38923418|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
16119187|NCT02037477|38923419|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
16119188|NCT02037477|38923420|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
16119189|NCT02037477|38923421|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
16119190|NCT02687035|38923422|FG000|Overall Study|Withdrawal by Subject|1|||
16119191|NCT02687035|38923422|FG000|Overall Study|Death|87|||
16119192|NCT02687035|38923422|FG000|Overall Study|Lost to Follow-up|1|||
16119193|NCT02687035|38923422|FG000|Overall Study|Missed Visit|87|||
16119194|NCT02687035|38923422|FG000|Overall Study|Did not receive Study Device|8|||
16119195|NCT00709228|38923423|FG000|Overall Study|Not treated|14|||
16119196|NCT00709228|38923423|FG000|Overall Study|Eligibility criteria not met|281|||
16119197|NCT00709228|38923423|FG000|Overall Study|Adverse events|2|||
16119198|NCT00709228|38923423|FG000|Overall Study|Discontinued treatment|14|||
16119199|NCT00709228|38923423|FG000|Overall Study|Did not enter follow-up|4|||
16119200|NCT00709228|38923423|FG000|Overall Study|Discontinued follow-up|5|||
16119201|NCT00709228|38923423|FG000|Overall Study|Disease progression|1|||
16119202|NCT00709228|38923423|FG000|Overall Study|Lost to Follow-up|6|||
16119203|NCT00709228|38923423|FG000|Overall Study|Non-compliance|5|||
16119204|NCT00037830|38923426|FG000|Overall Study|Adverse Event|2|||
16230615|NCT03426995|39324472|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16230616|NCT03426995|39324473|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16551446|NCT00152009|40481595|FG003|Overall Study|Withdrawal by Subject|9|||
16551447|NCT00152009|40481592|FG000|Overall Study|Lost to Follow-up|2|||
16551448|NCT00152009|40481593|FG001|Overall Study|Lost to Follow-up|4|||
16551449|NCT00152009|40481594|FG002|Overall Study|Lost to Follow-up|3|||
16551450|NCT00152009|40481595|FG003|Overall Study|Lost to Follow-up|3|||
16551451|NCT00152009|40481592|FG000|Overall Study|Lack of Efficacy|8|||
16551452|NCT00152009|40481593|FG001|Overall Study|Lack of Efficacy|6|||
16551453|NCT00152009|40481594|FG002|Overall Study|Lack of Efficacy|7|||
16551454|NCT00152009|40481595|FG003|Overall Study|Lack of Efficacy|15|||
16551455|NCT00152009|40481592|FG000|Overall Study|ECG abnormalities|2|||
16551456|NCT00152009|40481593|FG001|Overall Study|ECG abnormalities|2|||
16551457|NCT00152009|40481594|FG002|Overall Study|ECG abnormalities|2|||
16551458|NCT00152009|40481595|FG003|Overall Study|ECG abnormalities|1|||
16119205|NCT00037830|38923427|FG001|Overall Study|Adverse Event|0|||
16412670|NCT00711802|39992230|FG002|Overall Study|Physician Decision|0|||
16551459|NCT00152009|40481592|FG000|Overall Study|Sponsor's decision|3|||
16551460|NCT00152009|40481593|FG001|Overall Study|Sponsor's decision|3|||
16551461|NCT00152009|40481594|FG002|Overall Study|Sponsor's decision|1|||
16119206|NCT00037830|38923428|FG002|Overall Study|Adverse Event|0|||
16119207|NCT00037830|38923426|FG000|Overall Study|Withdrawal by Subject|4|||
16119208|NCT00037830|38923427|FG001|Overall Study|Withdrawal by Subject|5|||
16119209|NCT00037830|38923428|FG002|Overall Study|Withdrawal by Subject|1|||
16551462|NCT00152009|40481595|FG003|Overall Study|Sponsor's decision|3|||
16551463|NCT00655551|40481596|FG000|All Periods Combined|Adverse Event|0|||
16551464|NCT00655551|40481597|FG001|All Periods Combined|Adverse Event|3|||
16551465|NCT00655551|40481598|FG002|All Periods Combined|Adverse Event|4|||
16119210|NCT00037830|38923426|FG000|Overall Study|Protocol Violation|2|||
16119211|NCT00037830|38923427|FG001|Overall Study|Protocol Violation|2|||
16119212|NCT00037830|38923428|FG002|Overall Study|Protocol Violation|0|||
16119213|NCT00037830|38923426|FG000|Overall Study|Unrelated Medical Problem|2|||
16119214|NCT00037830|38923427|FG001|Overall Study|Unrelated Medical Problem|0|||
16119215|NCT00037830|38923428|FG002|Overall Study|Unrelated Medical Problem|0|||
16119216|NCT03332784|38923430|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119217|NCT03332784|38923431|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
16119218|NCT03332784|38923432|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16230617|NCT03426995|39324474|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
16412671|NCT00711802|39992231|FG003|Overall Study|Physician Decision|0|||
16551466|NCT00655551|40481596|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
16551467|NCT00655551|40481597|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
16551468|NCT00655551|40481598|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
16551469|NCT00655551|40481596|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
16551470|NCT00655551|40481597|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
16551471|NCT00655551|40481598|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
16551472|NCT00655551|40481596|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
16551473|NCT00655551|40481597|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
16551474|NCT00655551|40481598|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
16551475|NCT00857805|40481605|FG000|Overall Study|Withdrawal by Subject|1|||
16551476|NCT00857805|40481606|FG001|Overall Study|Withdrawal by Subject|1|||
16551477|NCT03125941|40481607|FG000|Overall Study|did not receive intervention|1|||
16551478|NCT03125941|40481608|FG001|Overall Study|did not receive intervention|2|||
16551479|NCT00119262|40481614|FG000|Overall Study|Lack of Efficacy|0|||
16551480|NCT00119262|40481615|FG001|Overall Study|Lack of Efficacy|3|||
16551481|NCT00119262|40481614|FG000|Overall Study|Withdrawal by Subject|12|||
16551482|NCT00119262|40481615|FG001|Overall Study|Withdrawal by Subject|11|||
16551483|NCT00119262|40481614|FG000|Overall Study|Adverse Event|33|||
16551484|NCT00119262|40481615|FG001|Overall Study|Adverse Event|35|||
16551485|NCT00119262|40481614|FG000|Overall Study|other disease|0|||
16551486|NCT00119262|40481615|FG001|Overall Study|other disease|2|||
16551487|NCT00119262|40481614|FG000|Overall Study|ineligble|1|||
16551488|NCT00119262|40481615|FG001|Overall Study|ineligble|2|||
16551489|NCT00119262|40481614|FG000|Overall Study|others|0|||
16551490|NCT00119262|40481615|FG001|Overall Study|others|5|||
16551491|NCT01597505|40481616|FG000|Overall Study|Physician Decision|5|||
16551492|NCT01597505|40481617|FG001|Overall Study|Physician Decision|0|||
16551493|NCT01597505|40481616|FG000|Overall Study|Adverse Event|19|||
16551494|NCT01597505|40481617|FG001|Overall Study|Adverse Event|7|||
16551495|NCT01597505|40481616|FG000|Overall Study|Lost to Follow-up|4|||
16551496|NCT01597505|40481617|FG001|Overall Study|Lost to Follow-up|2|||
16551497|NCT01597505|40481616|FG000|Overall Study|Withdrawal by Subject|10|||
16551498|NCT01597505|40481617|FG001|Overall Study|Withdrawal by Subject|18|||
16551499|NCT01597505|40481616|FG000|Overall Study|Other|5|||
16551500|NCT01597505|40481617|FG001|Overall Study|Other|6|||
16551501|NCT01597505|40481616|FG000|Overall Study|Missing|1|||
16551502|NCT01597505|40481617|FG001|Overall Study|Missing|0|||
16551503|NCT01155388|40481618|FG000|Overall Study|Adverse Event|1|||
16551504|NCT01155388|40481619|FG001|Overall Study|Adverse Event|0|||
16551505|NCT04170296|40481620|FG000|Overall Study|Adverse Event|1|||
16551506|NCT04170296|40481621|FG001|Overall Study|Adverse Event|0|||
16119219|NCT03332784|38923433|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16412672|NCT00711802|39992232|FG004|Overall Study|Physician Decision|0|||
16551507|NCT04170296|40481620|FG000|Overall Study|Withdrawal by Subject|3|||
16551508|NCT04170296|40481621|FG001|Overall Study|Withdrawal by Subject|2|||
16119220|NCT03332784|38923434|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119221|NCT03332784|38923435|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119222|NCT03332784|38923436|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119223|NCT03332784|38923437|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119224|NCT03332784|38923438|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119225|NCT03332784|38923439|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119226|NCT03332784|38923440|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119227|NCT03332784|38923441|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119228|NCT03332784|38923442|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119229|NCT03332784|38923443|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119230|NCT03332784|38923444|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
16119231|NCT03332784|38923445|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119232|NCT03332784|38923446|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119233|NCT03332784|38923447|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119234|NCT03332784|38923448|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119235|NCT03332784|38923449|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
16119236|NCT03635099|38923450|FG000|Period 1|Adverse Event|1|||
16119237|NCT03635099|38923451|FG001|Period 1|Adverse Event|0|||
16119238|NCT03635099|38923452|FG002|Period 1|Adverse Event|0|||
16119239|NCT03635099|38923453|FG003|Period 1|Adverse Event|1|||
16119240|NCT03635099|38923454|FG004|Period 1|Adverse Event|0|||
16119241|NCT03635099|38923455|FG005|Period 1|Adverse Event|0|||
16119242|NCT03635099|38923456|FG006|Period 1|Adverse Event|0|||
16119243|NCT03635099|38923457|FG007|Period 1|Adverse Event|0|||
16119244|NCT03635099|38923450|FG000|Period 1|Protocol Violation|0|||
16119245|NCT03635099|38923451|FG001|Period 1|Protocol Violation|0|||
16119246|NCT03635099|38923452|FG002|Period 1|Protocol Violation|1|||
16119247|NCT03635099|38923453|FG003|Period 1|Protocol Violation|0|||
16119248|NCT03635099|38923454|FG004|Period 1|Protocol Violation|0|||
16119249|NCT03635099|38923455|FG005|Period 1|Protocol Violation|0|||
16119250|NCT03635099|38923456|FG006|Period 1|Protocol Violation|0|||
16119251|NCT03635099|38923457|FG007|Period 1|Protocol Violation|0|||
16119252|NCT03635099|38923450|FG000|Period 1|Lost to Follow-up|0|||
16119253|NCT03635099|38923451|FG001|Period 1|Lost to Follow-up|0|||
16119254|NCT03635099|38923452|FG002|Period 1|Lost to Follow-up|1|||
16119255|NCT03635099|38923453|FG003|Period 1|Lost to Follow-up|2|||
16119256|NCT03635099|38923454|FG004|Period 1|Lost to Follow-up|1|||
16119257|NCT03635099|38923455|FG005|Period 1|Lost to Follow-up|0|||
16119258|NCT03635099|38923456|FG006|Period 1|Lost to Follow-up|1|||
16119259|NCT03635099|38923457|FG007|Period 1|Lost to Follow-up|2|||
16119260|NCT03635099|38923450|FG000|Period 1|Withdrawal by Subject|3|||
16119261|NCT03635099|38923451|FG001|Period 1|Withdrawal by Subject|3|||
16119262|NCT03635099|38923452|FG002|Period 1|Withdrawal by Subject|5|||
16119263|NCT03635099|38923453|FG003|Period 1|Withdrawal by Subject|2|||
16119264|NCT03635099|38923454|FG004|Period 1|Withdrawal by Subject|2|||
16119265|NCT03635099|38923455|FG005|Period 1|Withdrawal by Subject|0|||
16119266|NCT03635099|38923456|FG006|Period 1|Withdrawal by Subject|3|||
16119267|NCT03635099|38923457|FG007|Period 1|Withdrawal by Subject|0|||
16119268|NCT03635099|38923450|FG000|Period 1|History of suicidal ideation|0|||
16119269|NCT03635099|38923451|FG001|Period 1|History of suicidal ideation|0|||
16119270|NCT03635099|38923452|FG002|Period 1|History of suicidal ideation|1|||
16119271|NCT03635099|38923453|FG003|Period 1|History of suicidal ideation|0|||
16119272|NCT03635099|38923454|FG004|Period 1|History of suicidal ideation|0|||
16119273|NCT03635099|38923455|FG005|Period 1|History of suicidal ideation|0|||
16119274|NCT03635099|38923456|FG006|Period 1|History of suicidal ideation|0|||
16119275|NCT03635099|38923457|FG007|Period 1|History of suicidal ideation|0|||
16119276|NCT03635099|38923450|FG000|Period 1|pursue other treatment options|0|||
16119277|NCT03635099|38923451|FG001|Period 1|pursue other treatment options|0|||
16119278|NCT03635099|38923452|FG002|Period 1|pursue other treatment options|0|||
16119279|NCT03635099|38923453|FG003|Period 1|pursue other treatment options|0|||
16119280|NCT03635099|38923454|FG004|Period 1|pursue other treatment options|0|||
16119281|NCT03635099|38923455|FG005|Period 1|pursue other treatment options|1|||
16119282|NCT03635099|38923456|FG006|Period 1|pursue other treatment options|0|||
16119283|NCT03635099|38923457|FG007|Period 1|pursue other treatment options|0|||
16119284|NCT03635099|38923450|FG000|Not Eligible for Period 2|Pregnancy|0|||
16119285|NCT03635099|38923451|FG001|Not Eligible for Period 2|Pregnancy|0|||
16119286|NCT03635099|38923452|FG002|Not Eligible for Period 2|Pregnancy|0|||
16119287|NCT03635099|38923453|FG003|Not Eligible for Period 2|Pregnancy|1|||
16119288|NCT03635099|38923454|FG004|Not Eligible for Period 2|Pregnancy|0|||
16119289|NCT03635099|38923455|FG005|Not Eligible for Period 2|Pregnancy|0|||
16119290|NCT03635099|38923456|FG006|Not Eligible for Period 2|Pregnancy|0|||
16119291|NCT03635099|38923457|FG007|Not Eligible for Period 2|Pregnancy|0|||
16119292|NCT03635099|38923450|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
16119293|NCT03635099|38923451|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
16119294|NCT03635099|38923452|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
16119295|NCT03635099|38923453|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
16119296|NCT03635099|38923454|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
16119297|NCT03635099|38923455|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
16119298|NCT03635099|38923456|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
16119299|NCT03635099|38923457|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
16119300|NCT03635099|38923450|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
16119301|NCT03635099|38923451|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
16119302|NCT03635099|38923452|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
16119303|NCT03635099|38923453|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
16119304|NCT03635099|38923454|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
16119305|NCT03635099|38923455|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
16119306|NCT03635099|38923456|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
16119307|NCT03635099|38923457|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
16119308|NCT03635099|38923450|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
16119309|NCT03635099|38923451|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
16119310|NCT03635099|38923452|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
16119311|NCT03635099|38923453|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
16119312|NCT03635099|38923454|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
16119313|NCT03635099|38923455|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
16119314|NCT03635099|38923456|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
16119315|NCT03635099|38923457|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
16119316|NCT03635099|38923450|FG000|Period 2|Adverse Event|0|||
16119317|NCT03635099|38923451|FG001|Period 2|Adverse Event|0|||
16119318|NCT03635099|38923452|FG002|Period 2|Adverse Event|1|||
16119319|NCT03635099|38923453|FG003|Period 2|Adverse Event|0|||
16119320|NCT03635099|38923454|FG004|Period 2|Adverse Event|1|||
16119321|NCT03635099|38923455|FG005|Period 2|Adverse Event|0|||
16119322|NCT03635099|38923456|FG006|Period 2|Adverse Event|0|||
16119323|NCT03635099|38923457|FG007|Period 2|Adverse Event|0|||
16119324|NCT03635099|38923450|FG000|Period 2|Lost to Follow-up|0|||
16119325|NCT03635099|38923451|FG001|Period 2|Lost to Follow-up|0|||
16119326|NCT03635099|38923452|FG002|Period 2|Lost to Follow-up|1|||
16119327|NCT03635099|38923453|FG003|Period 2|Lost to Follow-up|0|||
16119328|NCT03635099|38923454|FG004|Period 2|Lost to Follow-up|4|||
16119329|NCT03635099|38923455|FG005|Period 2|Lost to Follow-up|0|||
16119330|NCT03635099|38923456|FG006|Period 2|Lost to Follow-up|0|||
16119331|NCT03635099|38923457|FG007|Period 2|Lost to Follow-up|0|||
16119332|NCT03635099|38923450|FG000|Period 2|Withdrawal by Subject|0|||
16119333|NCT03635099|38923451|FG001|Period 2|Withdrawal by Subject|0|||
16119334|NCT03635099|38923452|FG002|Period 2|Withdrawal by Subject|7|||
16119335|NCT03635099|38923453|FG003|Period 2|Withdrawal by Subject|4|||
16119336|NCT03635099|38923454|FG004|Period 2|Withdrawal by Subject|7|||
16119337|NCT03635099|38923455|FG005|Period 2|Withdrawal by Subject|0|||
16119338|NCT03635099|38923456|FG006|Period 2|Withdrawal by Subject|0|||
16119339|NCT03635099|38923457|FG007|Period 2|Withdrawal by Subject|0|||
16119340|NCT03381339|38923458|FG000|Overall Study|Protocol Violation|4|||
16119341|NCT03381339|38923459|FG001|Overall Study|Protocol Violation|3|||
16119342|NCT03381339|38923458|FG000|Overall Study|Lost to Follow-up|0|||
16119343|NCT03381339|38923459|FG001|Overall Study|Lost to Follow-up|1|||
16119344|NCT03101462|38923461|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
16119345|NCT03101462|38923462|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
16119346|NCT01461811|38923463|FG000|Overall Study|Adverse Event|2|||
16119347|NCT01461811|38923464|FG001|Overall Study|Adverse Event|1|||
16119348|NCT01461811|38923463|FG000|Overall Study|Subject decision unrelated to an AE|1|||
16119349|NCT01461811|38923464|FG001|Overall Study|Subject decision unrelated to an AE|1|||
16119350|NCT01461811|38923463|FG000|Overall Study|Noncompliance|1|||
16119351|NCT01461811|38923464|FG001|Overall Study|Noncompliance|1|||
16119352|NCT02755818|38923465|FG000|Overall Study|Withdrawal by Subject|0|||
16119353|NCT02755818|38923466|FG001|Overall Study|Withdrawal by Subject|0|||
16119354|NCT02755818|38923467|FG002|Overall Study|Withdrawal by Subject|0|||
16119355|NCT02755818|38923468|FG003|Overall Study|Withdrawal by Subject|2|||
16119356|NCT02755818|38923465|FG000|Overall Study|withdrawal by PI|0|||
16119357|NCT02755818|38923466|FG001|Overall Study|withdrawal by PI|0|||
16119358|NCT02755818|38923467|FG002|Overall Study|withdrawal by PI|1|||
16119359|NCT02755818|38923468|FG003|Overall Study|withdrawal by PI|1|||
16119360|NCT00677534|38923469|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
16119361|NCT00677534|38923469|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
16119362|NCT00677534|38923469|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
16119363|NCT01214642|38923472|FG000|Overall Study|Progressive Disease|3|||
16119364|NCT01214642|38923473|FG001|Overall Study|Progressive Disease|2|||
16119365|NCT01214642|38923474|FG002|Overall Study|Progressive Disease|3|||
16119366|NCT01214642|38923475|FG003|Overall Study|Progressive Disease|5|||
16119367|NCT01214642|38923476|FG004|Overall Study|Progressive Disease|5|||
16119368|NCT01214642|38923477|FG005|Overall Study|Progressive Disease|3|||
16119369|NCT01214642|38923478|FG006|Overall Study|Progressive Disease|5|||
16119370|NCT01214642|38923479|FG007|Overall Study|Progressive Disease|3|||
16119371|NCT01214642|38923480|FG008|Overall Study|Progressive Disease|10|||
16119372|NCT01214642|38923481|FG009|Overall Study|Progressive Disease|2|||
16119373|NCT01214642|38923482|FG010|Overall Study|Progressive Disease|1|||
16119374|NCT01214642|38923483|FG011|Overall Study|Progressive Disease|4|||
16119375|NCT01214642|38923472|FG000|Overall Study|Adverse Event|0|||
16119376|NCT01214642|38923473|FG001|Overall Study|Adverse Event|1|||
16119377|NCT01214642|38923474|FG002|Overall Study|Adverse Event|0|||
16119378|NCT01214642|38923475|FG003|Overall Study|Adverse Event|0|||
16119379|NCT01214642|38923476|FG004|Overall Study|Adverse Event|0|||
16119380|NCT01214642|38923477|FG005|Overall Study|Adverse Event|0|||
16119381|NCT01214642|38923478|FG006|Overall Study|Adverse Event|1|||
16119382|NCT01214642|38923479|FG007|Overall Study|Adverse Event|0|||
16119383|NCT01214642|38923480|FG008|Overall Study|Adverse Event|0|||
16119384|NCT01214642|38923481|FG009|Overall Study|Adverse Event|1|||
16230618|NCT03426995|39324456|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230619|NCT03426995|39324457|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16119385|NCT01214642|38923482|FG010|Overall Study|Adverse Event|1|||
16119386|NCT01214642|38923483|FG011|Overall Study|Adverse Event|0|||
16119387|NCT01214642|38923472|FG000|Overall Study|Death|0|||
16119388|NCT01214642|38923473|FG001|Overall Study|Death|0|||
16119389|NCT01214642|38923474|FG002|Overall Study|Death|1|||
16119390|NCT01214642|38923475|FG003|Overall Study|Death|0|||
16119391|NCT01214642|38923476|FG004|Overall Study|Death|0|||
16551509|NCT04170296|40481620|FG000|Overall Study|Lost to Follow-up|4|||
16551510|NCT04170296|40481621|FG001|Overall Study|Lost to Follow-up|2|||
16551511|NCT00406419|40481622|FG000|Overall Study|Death|3|||
16551512|NCT00406419|40481623|FG001|Overall Study|Death|1|||
16551513|NCT00406419|40481624|FG002|Overall Study|Death|4|||
16551514|NCT00406419|40481622|FG000|Overall Study|Protocol Violation|6|||
16551515|NCT00406419|40481623|FG001|Overall Study|Protocol Violation|2|||
16551516|NCT00406419|40481624|FG002|Overall Study|Protocol Violation|5|||
16551517|NCT00406419|40481622|FG000|Overall Study|Study Terminated by Sponsor|260|||
16119392|NCT01214642|38923477|FG005|Overall Study|Death|0|||
16119393|NCT01214642|38923478|FG006|Overall Study|Death|0|||
16119394|NCT01214642|38923479|FG007|Overall Study|Death|0|||
16119395|NCT01214642|38923480|FG008|Overall Study|Death|0|||
16119396|NCT01214642|38923481|FG009|Overall Study|Death|0|||
16119397|NCT01214642|38923482|FG010|Overall Study|Death|1|||
16119398|NCT01214642|38923483|FG011|Overall Study|Death|0|||
16119399|NCT01214642|38923472|FG000|Overall Study|Withdrawal by Subject|0|||
16119400|NCT01214642|38923473|FG001|Overall Study|Withdrawal by Subject|0|||
16119401|NCT01214642|38923474|FG002|Overall Study|Withdrawal by Subject|1|||
16119402|NCT01214642|38923475|FG003|Overall Study|Withdrawal by Subject|0|||
16119403|NCT01214642|38923476|FG004|Overall Study|Withdrawal by Subject|0|||
16119404|NCT01214642|38923477|FG005|Overall Study|Withdrawal by Subject|0|||
16119405|NCT01214642|38923478|FG006|Overall Study|Withdrawal by Subject|0|||
16412673|NCT00711802|39992233|FG005|Overall Study|Physician Decision|0|||
16551518|NCT00406419|40481623|FG001|Overall Study|Study Terminated by Sponsor|288|||
16551519|NCT00406419|40481624|FG002|Overall Study|Study Terminated by Sponsor|282|||
16551520|NCT00406419|40481622|FG000|Overall Study|Withdrawal by Subject|17|||
16119406|NCT01214642|38923479|FG007|Overall Study|Withdrawal by Subject|0|||
16119407|NCT01214642|38923480|FG008|Overall Study|Withdrawal by Subject|3|||
16119408|NCT01214642|38923481|FG009|Overall Study|Withdrawal by Subject|1|||
16119409|NCT01214642|38923482|FG010|Overall Study|Withdrawal by Subject|1|||
16119410|NCT01214642|38923483|FG011|Overall Study|Withdrawal by Subject|0|||
16119411|NCT01214642|38923472|FG000|Overall Study|Physician Decision|0|||
16119412|NCT01214642|38923473|FG001|Overall Study|Physician Decision|0|||
16119413|NCT01214642|38923474|FG002|Overall Study|Physician Decision|1|||
16119414|NCT01214642|38923475|FG003|Overall Study|Physician Decision|1|||
16119415|NCT01214642|38923476|FG004|Overall Study|Physician Decision|1|||
16119416|NCT01214642|38923477|FG005|Overall Study|Physician Decision|0|||
16119417|NCT01214642|38923478|FG006|Overall Study|Physician Decision|0|||
16119418|NCT01214642|38923479|FG007|Overall Study|Physician Decision|0|||
16119419|NCT01214642|38923480|FG008|Overall Study|Physician Decision|0|||
16119420|NCT01214642|38923481|FG009|Overall Study|Physician Decision|0|||
16119421|NCT01214642|38923482|FG010|Overall Study|Physician Decision|0|||
16119422|NCT01214642|38923483|FG011|Overall Study|Physician Decision|2|||
16119423|NCT01923467|38923491|FG000|Overall Study|Lost to Follow-up|62|||
16119424|NCT01923467|38923491|FG000|Overall Study|Subject non-interest|479|||
16119425|NCT00426127|38923492|FG000|Overall Study|Adverse Event|1|||
16119426|NCT00426127|38923492|FG000|Overall Study|Removed due to disease progression|1|||
16119427|NCT01637077|38923494|FG000|Overall Study|Cancel|1|||
16119428|NCT01637077|38923495|FG001|Overall Study|Cancel|1|||
16119429|NCT01637077|38923494|FG000|Overall Study|Withdrawal by Subject|1|||
16119430|NCT01637077|38923495|FG001|Overall Study|Withdrawal by Subject|0|||
16119431|NCT01637077|38923494|FG000|Overall Study|No cycle 1 questionnaire data|2|||
16119432|NCT01637077|38923495|FG001|Overall Study|No cycle 1 questionnaire data|0|||
16119433|NCT02440425|38923496|FG000|Overall Study|Death likely due to disease progression|1|||
16119434|NCT02440425|38923496|FG000|Overall Study|Withdrawal by Subject|2|||
16119435|NCT02440425|38923496|FG000|Overall Study|Adverse Event|1|||
16119436|NCT02440425|38923496|FG000|Overall Study|Adverse Event/Ineligible|1|||
16119437|NCT01370655|38923497|FG000|Period 1|Adverse Event|2|||
16119438|NCT01370655|38923498|FG001|Period 1|Adverse Event|0|||
16119439|NCT01370655|38923499|FG002|Period 1|Adverse Event|0|||
16119440|NCT01370655|38923500|FG003|Period 1|Adverse Event|0|||
16119441|NCT01370655|38923501|FG004|Period 1|Adverse Event|0|||
16230620|NCT03426995|39324458|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230621|NCT03426995|39324459|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230622|NCT03426995|39324460|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16551521|NCT00406419|40481623|FG001|Overall Study|Withdrawal by Subject|24|||
16551522|NCT00406419|40481624|FG002|Overall Study|Withdrawal by Subject|26|||
16551523|NCT00406419|40481622|FG000|Overall Study|Lack of Efficacy|12|||
16551524|NCT00406419|40481623|FG001|Overall Study|Lack of Efficacy|1|||
16551525|NCT00406419|40481624|FG002|Overall Study|Lack of Efficacy|6|||
16551526|NCT00406419|40481622|FG000|Overall Study|Non-Compliance with Study Drug|5|||
16551527|NCT00406419|40481623|FG001|Overall Study|Non-Compliance with Study Drug|6|||
16551528|NCT00406419|40481624|FG002|Overall Study|Non-Compliance with Study Drug|3|||
16551529|NCT00406419|40481622|FG000|Overall Study|Adverse Event|10|||
16551530|NCT00406419|40481623|FG001|Overall Study|Adverse Event|12|||
16119442|NCT01370655|38923502|FG005|Period 1|Adverse Event|0|||
16119443|NCT01370655|38923503|FG006|Period 1|Adverse Event|1|||
16119444|NCT01370655|38923504|FG007|Period 1|Adverse Event|0|||
16119445|NCT01370655|38923505|FG008|Period 1|Adverse Event|0|||
16119446|NCT01370655|38923506|FG009|Period 1|Adverse Event|0|||
16119447|NCT01370655|38923507|FG010|Period 1|Adverse Event|0|||
16119448|NCT01370655|38923508|FG011|Period 1|Adverse Event|0|||
16119449|NCT01370655|38923497|FG000|Period 2|Adverse Event|0|||
16119450|NCT01370655|38923498|FG001|Period 2|Adverse Event|0|||
16119451|NCT01370655|38923499|FG002|Period 2|Adverse Event|1|||
16119452|NCT01370655|38923500|FG003|Period 2|Adverse Event|0|||
16119453|NCT01370655|38923501|FG004|Period 2|Adverse Event|1|||
16119454|NCT01370655|38923502|FG005|Period 2|Adverse Event|0|||
16119455|NCT01370655|38923503|FG006|Period 2|Adverse Event|0|||
16119456|NCT01370655|38923504|FG007|Period 2|Adverse Event|1|||
16119457|NCT01370655|38923505|FG008|Period 2|Adverse Event|0|||
16119458|NCT01370655|38923506|FG009|Period 2|Adverse Event|0|||
16119459|NCT01370655|38923507|FG010|Period 2|Adverse Event|0|||
16119460|NCT01370655|38923508|FG011|Period 2|Adverse Event|0|||
16119461|NCT01370655|38923497|FG000|Period 2|met protocol specified stopping criteria|0|||
16551531|NCT00406419|40481624|FG002|Overall Study|Adverse Event|16|||
16551532|NCT00406419|40481622|FG000|Overall Study|Lost to Follow-up|11|||
16551533|NCT00406419|40481623|FG001|Overall Study|Lost to Follow-up|10|||
16119462|NCT01370655|38923498|FG001|Period 2|met protocol specified stopping criteria|0|||
16119463|NCT01370655|38923499|FG002|Period 2|met protocol specified stopping criteria|1|||
16119464|NCT01370655|38923500|FG003|Period 2|met protocol specified stopping criteria|0|||
16119465|NCT01370655|38923501|FG004|Period 2|met protocol specified stopping criteria|0|||
16551534|NCT00406419|40481624|FG002|Overall Study|Lost to Follow-up|5|||
16551535|NCT00572624|40481628|FG000|Overall Study|Lost to Follow-up|10|||
16551536|NCT00572624|40481629|FG001|Overall Study|Lost to Follow-up|4|||
16119466|NCT01370655|38923502|FG005|Period 2|met protocol specified stopping criteria|0|||
16119467|NCT01370655|38923503|FG006|Period 2|met protocol specified stopping criteria|1|||
16119468|NCT01370655|38923504|FG007|Period 2|met protocol specified stopping criteria|0|||
16119469|NCT01370655|38923505|FG008|Period 2|met protocol specified stopping criteria|1|||
16119470|NCT01370655|38923506|FG009|Period 2|met protocol specified stopping criteria|0|||
16119471|NCT01370655|38923507|FG010|Period 2|met protocol specified stopping criteria|1|||
16119472|NCT01370655|38923508|FG011|Period 2|met protocol specified stopping criteria|0|||
16119473|NCT01370655|38923497|FG000|Period 2|Withdrawal by Subject|0|||
16119474|NCT01370655|38923498|FG001|Period 2|Withdrawal by Subject|0|||
16119475|NCT01370655|38923499|FG002|Period 2|Withdrawal by Subject|0|||
16119476|NCT01370655|38923500|FG003|Period 2|Withdrawal by Subject|0|||
16119477|NCT01370655|38923501|FG004|Period 2|Withdrawal by Subject|0|||
16119478|NCT01370655|38923502|FG005|Period 2|Withdrawal by Subject|0|||
16551537|NCT00572624|40481628|FG000|Overall Study|Wanted to do a different diet program|1|||
16551538|NCT00572624|40481629|FG001|Overall Study|Wanted to do a different diet program|0|||
16551539|NCT00572624|40481628|FG000|Overall Study|Medication change|1|||
16551540|NCT00572624|40481629|FG001|Overall Study|Medication change|0|||
16551541|NCT00572624|40481628|FG000|Overall Study|Started a new job-- no time for study|1|||
16119479|NCT01370655|38923503|FG006|Period 2|Withdrawal by Subject|0|||
16119480|NCT01370655|38923504|FG007|Period 2|Withdrawal by Subject|0|||
16119481|NCT01370655|38923505|FG008|Period 2|Withdrawal by Subject|1|||
16119482|NCT01370655|38923506|FG009|Period 2|Withdrawal by Subject|0|||
16119483|NCT01370655|38923507|FG010|Period 2|Withdrawal by Subject|0|||
16551542|NCT00572624|40481629|FG001|Overall Study|Started a new job-- no time for study|0|||
16551543|NCT00572624|40481628|FG000|Overall Study|Admitted to being a smoker|1|||
16119484|NCT01370655|38923508|FG011|Period 2|Withdrawal by Subject|0|||
16119485|NCT01424813|38923509|FG000|Overall Study|Withdrawal by Subject|3|||
16119486|NCT01424813|38923510|FG001|Overall Study|Withdrawal by Subject|0|||
16119487|NCT01424813|38923509|FG000|Overall Study|Protocol Violation|1|||
16119488|NCT01424813|38923510|FG001|Overall Study|Protocol Violation|0|||
16119489|NCT01424813|38923509|FG000|Overall Study|Other|1|||
16119490|NCT01424813|38923510|FG001|Overall Study|Other|2|||
16119491|NCT00233480|38923511|FG000|Overall Study|Underwent status II heart transplant|0|||
16119492|NCT00233480|38923512|FG001|Overall Study|Underwent status II heart transplant|1|||
16119493|NCT01606670|38923519|FG000|Overall Study|Adverse Event|6|||
16119494|NCT01606670|38923519|FG000|Overall Study|Lack of Efficacy|2|||
16119495|NCT01606670|38923519|FG000|Overall Study|Lost to Follow-up|3|||
16119496|NCT01606670|38923519|FG000|Overall Study|Withdrawal by Subject|3|||
16119497|NCT01606670|38923519|FG000|Overall Study|Other Reason|2|||
16173307|NCT01287104|39111176|FG000|Overall Study|Patient developed progressive disease|1|||
16173308|NCT01287104|39111177|FG001|Overall Study|Patient developed progressive disease|1|||
16173309|NCT01287104|39111178|FG002|Overall Study|Patient developed progressive disease|3|||
16173310|NCT01287104|39111179|FG003|Overall Study|Patient developed progressive disease|2|||
16173311|NCT01287104|39111176|FG000|Overall Study|Donor anaphylaxis|0|||
16173312|NCT01287104|39111177|FG001|Overall Study|Donor anaphylaxis|1|||
16173313|NCT01287104|39111178|FG002|Overall Study|Donor anaphylaxis|0|||
16230623|NCT03426995|39324461|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16551544|NCT00572624|40481629|FG001|Overall Study|Admitted to being a smoker|0|||
16551545|NCT00572624|40481628|FG000|Overall Study|Refused to do the stress test|1|||
16551546|NCT00572624|40481629|FG001|Overall Study|Refused to do the stress test|0|||
16551547|NCT00572624|40481628|FG000|Overall Study|Problem with vascular access|1|||
16551548|NCT00572624|40481629|FG001|Overall Study|Problem with vascular access|0|||
16551549|NCT00572624|40481628|FG000|Overall Study|Health issues unrelated to the study|1|||
16551550|NCT00572624|40481629|FG001|Overall Study|Health issues unrelated to the study|0|||
16551551|NCT00383240|40481630|FG000|Overall Study|Adverse Event|4|||
16551552|NCT00383240|40481631|FG001|Overall Study|Adverse Event|6|||
16551553|NCT00383240|40481632|FG002|Overall Study|Adverse Event|9|||
16551554|NCT00383240|40481633|FG003|Overall Study|Adverse Event|7|||
16551555|NCT00383240|40481630|FG000|Overall Study|Treatment Failure|8|||
16551556|NCT00383240|40481631|FG001|Overall Study|Treatment Failure|13|||
16551557|NCT00383240|40481632|FG002|Overall Study|Treatment Failure|47|||
16551558|NCT00383240|40481633|FG003|Overall Study|Treatment Failure|46|||
16551559|NCT00383240|40481630|FG000|Overall Study|Lost to Follow-up|3|||
16551560|NCT00383240|40481631|FG001|Overall Study|Lost to Follow-up|0|||
16551561|NCT00383240|40481632|FG002|Overall Study|Lost to Follow-up|0|||
16551562|NCT00383240|40481633|FG003|Overall Study|Lost to Follow-up|2|||
16551563|NCT00383240|40481630|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
16551564|NCT00383240|40481631|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
16551565|NCT00383240|40481632|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
16551566|NCT00383240|40481633|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
16551567|NCT00383240|40481630|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
16551568|NCT00383240|40481631|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
16551569|NCT00383240|40481632|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
16551570|NCT00383240|40481633|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
16551571|NCT00383240|40481630|FG000|Overall Study|Protocol Violation|4|||
16551572|NCT00383240|40481631|FG001|Overall Study|Protocol Violation|5|||
16551573|NCT00383240|40481632|FG002|Overall Study|Protocol Violation|9|||
16551574|NCT00383240|40481633|FG003|Overall Study|Protocol Violation|6|||
16551575|NCT00383240|40481630|FG000|Overall Study|Did not meet protocol eligibility|9|||
16551576|NCT00383240|40481631|FG001|Overall Study|Did not meet protocol eligibility|4|||
16551577|NCT00383240|40481632|FG002|Overall Study|Did not meet protocol eligibility|9|||
16551578|NCT00383240|40481633|FG003|Overall Study|Did not meet protocol eligibility|3|||
16551579|NCT00383240|40481630|FG000|Overall Study|Administrative|1|||
16551580|NCT00383240|40481631|FG001|Overall Study|Administrative|1|||
16551581|NCT00383240|40481632|FG002|Overall Study|Administrative|0|||
16551582|NCT00383240|40481633|FG003|Overall Study|Administrative|0|||
16173314|NCT01287104|39111179|FG003|Overall Study|Donor anaphylaxis|1|||
16173315|NCT01287104|39111176|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
16173316|NCT01287104|39111177|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
16173317|NCT01287104|39111178|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
16173318|NCT01287104|39111179|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
16551583|NCT03056755|40481634|FG000|Treatment- Core Phase|Progressive disease|89|||
16173319|NCT01287104|39111176|FG000|Overall Study|Low donor chimerism|0|||
16173320|NCT01287104|39111177|FG001|Overall Study|Low donor chimerism|1|||
16173321|NCT01287104|39111178|FG002|Overall Study|Low donor chimerism|0|||
16551584|NCT03056755|40481635|FG001|Treatment- Core Phase|Progressive disease|88|||
16551585|NCT03056755|40481636|FG002|Treatment- Core Phase|Progressive disease|90|||
16230624|NCT03426995|39324462|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230625|NCT03426995|39324463|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230626|NCT03426995|39324464|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230627|NCT03426995|39324465|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230628|NCT03426995|39324466|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230629|NCT03426995|39324467|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230630|NCT03426995|39324468|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230631|NCT03426995|39324469|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230632|NCT03426995|39324470|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
16230633|NCT03426995|39324471|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
16230634|NCT03426995|39324472|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230635|NCT03426995|39324473|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230636|NCT03426995|39324474|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
16230637|NCT03426995|39324456|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230638|NCT03426995|39324457|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16119498|NCT00667394|38926972|FG000|Overall Study|Adverse Event|3|||
16119499|NCT00667394|38926973|FG001|Overall Study|Adverse Event|0|||
16119500|NCT00667394|38926972|FG000|Overall Study|Progressive disease|1|||
16119501|NCT00667394|38926973|FG001|Overall Study|Progressive disease|0|||
16119502|NCT02056626|38926974|FG000|Overall Study|patient did not follow directions|3|||
16119503|NCT02056626|38926975|FG001|Overall Study|patient did not follow directions|1|||
16119504|NCT02056626|38926976|FG002|Overall Study|patient did not follow directions|0|||
16119505|NCT02056626|38926977|FG003|Overall Study|patient did not follow directions|0|||
16119506|NCT01110408|38926978|FG000|Overall Study|Protocol Violation|1|||
16119507|NCT01110408|38926979|FG001|Overall Study|Protocol Violation|0|||
16119508|NCT04860297|38926980|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
16119509|NCT04860297|38926981|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
16119510|NCT04860297|38926982|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
16119511|NCT04860297|38926983|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
16119512|NCT04860297|38926984|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
16119513|NCT04860297|38926985|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
16119514|NCT04860297|38926986|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
16119515|NCT04860297|38926987|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
16119516|NCT04860297|38926980|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
16230639|NCT03426995|39324458|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230640|NCT03426995|39324459|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230641|NCT03426995|39324460|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230642|NCT03426995|39324461|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230643|NCT03426995|39324462|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230644|NCT03426995|39324463|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230645|NCT03426995|39324464|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230646|NCT03426995|39324465|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230647|NCT03426995|39324466|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230648|NCT03426995|39324467|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230649|NCT03426995|39324468|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230650|NCT03426995|39324469|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230651|NCT03426995|39324470|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
16230652|NCT03426995|39324471|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
16230653|NCT03426995|39324472|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230654|NCT03426995|39324473|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230655|NCT03426995|39324474|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
16230656|NCT01803464|39324475|FG000|Overall Study|Incomplete data|0|||
16230657|NCT01803464|39324476|FG001|Overall Study|Incomplete data|0|||
16230658|NCT01803464|39324477|FG002|Overall Study|Incomplete data|4|||
16230659|NCT01803464|39324478|FG003|Overall Study|Incomplete data|0|||
16230660|NCT01803464|39324475|FG000|Overall Study|Withdrawal by Subject|1|||
16230661|NCT01803464|39324476|FG001|Overall Study|Withdrawal by Subject|0|||
16230662|NCT01803464|39324477|FG002|Overall Study|Withdrawal by Subject|0|||
16230663|NCT01803464|39324478|FG003|Overall Study|Withdrawal by Subject|0|||
16230664|NCT02067728|39324485|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
16119517|NCT04860297|38926981|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
16119518|NCT04860297|38926982|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
16119519|NCT04860297|38926983|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
16119520|NCT04860297|38926984|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
16119521|NCT04860297|38926985|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
16119522|NCT04860297|38926986|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
16119523|NCT04860297|38926987|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
16119524|NCT04860297|38926980|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
16119525|NCT04860297|38926981|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
16230665|NCT02067728|39324486|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
16230666|NCT02067728|39324485|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
16230667|NCT02067728|39324486|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
16230668|NCT02067728|39324485|FG000|6 Month Measurements|Unable to attend|114|||
16230669|NCT02067728|39324486|FG001|6 Month Measurements|Unable to attend|97|||
16230670|NCT01519635|39324488|FG000|Overall Study|Withdrawal by Subject|0|||
16230671|NCT01519635|39324489|FG001|Overall Study|Withdrawal by Subject|1|||
16230672|NCT01519635|39324488|FG000|Overall Study|No possibility to put a catheter|1|||
16230673|NCT01519635|39324489|FG001|Overall Study|No possibility to put a catheter|2|||
16230674|NCT02163759|39324490|FG000|Overall Study|Withdrawal by Subject|1|||
16230675|NCT02163759|39324491|FG001|Overall Study|Withdrawal by Subject|5|||
16230676|NCT02163759|39324492|FG002|Overall Study|Withdrawal by Subject|1|||
16230677|NCT02163759|39324490|FG000|Overall Study|Adverse Event|0|||
16230678|NCT02163759|39324491|FG001|Overall Study|Adverse Event|0|||
16230679|NCT02163759|39324492|FG002|Overall Study|Adverse Event|1|||
16230680|NCT02163759|39324490|FG000|Overall Study|Death|0|||
16230681|NCT02163759|39324491|FG001|Overall Study|Death|0|||
16230682|NCT02163759|39324492|FG002|Overall Study|Death|1|||
16230683|NCT02674568|39324493|FG000|Overall Study|Withdrawal by Subject|5|||
16230684|NCT02674568|39324493|FG000|Overall Study|Death|303|||
16230685|NCT02674568|39324493|FG000|Overall Study|Physician Decision|2|||
16230686|NCT02674568|39324493|FG000|Overall Study|Lost to Follow-up|9|||
16230687|NCT02674568|39324493|FG000|Overall Study|Other, Not Specified|20|||
16230688|NCT03326323|39324494|FG000|Overall Study|Unable to receive ANH protocol|3|||
16230689|NCT00674440|39324495|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
16230690|NCT00674440|39324495|FG000|Overall Study|did not have surgery, so unevaluable|7|||
16230691|NCT00674440|39324495|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
16230692|NCT01366846|39324496|FG000|Overall Study|Withdrawal by Subject|2|||
16230693|NCT01366846|39324497|FG001|Overall Study|Withdrawal by Subject|0|||
16230694|NCT01366846|39324498|FG002|Overall Study|Withdrawal by Subject|0|||
16230695|NCT01366846|39324499|FG003|Overall Study|Withdrawal by Subject|0|||
16230696|NCT01366846|39324496|FG000|Overall Study|Communication Difficulties|1|||
16230697|NCT01366846|39324497|FG001|Overall Study|Communication Difficulties|4|||
16230698|NCT01366846|39324498|FG002|Overall Study|Communication Difficulties|0|||
16230699|NCT01366846|39324499|FG003|Overall Study|Communication Difficulties|1|||
16230700|NCT01366846|39324496|FG000|Overall Study|Scheduling Conflicts|0|||
16230701|NCT01366846|39324497|FG001|Overall Study|Scheduling Conflicts|0|||
16230702|NCT01366846|39324498|FG002|Overall Study|Scheduling Conflicts|1|||
16230703|NCT01366846|39324499|FG003|Overall Study|Scheduling Conflicts|0|||
16230704|NCT01428882|39324500|FG000|Overall Study|Lack of Efficacy|2|||
16551586|NCT03056755|40481634|FG000|Treatment- Core Phase|Adverse Event|20|||
16551587|NCT03056755|40481635|FG001|Treatment- Core Phase|Adverse Event|14|||
16551588|NCT03056755|40481636|FG002|Treatment- Core Phase|Adverse Event|13|||
16551589|NCT03056755|40481634|FG000|Treatment- Core Phase|Physician Decision|7|||
16551590|NCT03056755|40481635|FG001|Treatment- Core Phase|Physician Decision|13|||
16551591|NCT03056755|40481636|FG002|Treatment- Core Phase|Physician Decision|5|||
16551592|NCT03056755|40481634|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
16551593|NCT03056755|40481635|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
16551594|NCT03056755|40481636|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
16119526|NCT04860297|38926982|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
16230705|NCT01428882|39324501|FG001|Overall Study|Lack of Efficacy|7|||
16230706|NCT01428882|39324500|FG000|Overall Study|Protocol Violation|4|||
16230707|NCT01428882|39324501|FG001|Overall Study|Protocol Violation|3|||
16230708|NCT03919669|39324502|FG000|Overall Study|Withdrawal by Subject|1|||
16230709|NCT03919669|39324503|FG001|Overall Study|Withdrawal by Subject|0|||
16230710|NCT03919669|39324504|FG002|Overall Study|Withdrawal by Subject|0|||
16230711|NCT03732534|39324515|FG000|Overall Study|Study terminated by Sponsor|6|||
16230712|NCT01733758|39324516|FG000|Overall Study|Adverse Event|5|||
16230713|NCT01733758|39324517|FG001|Overall Study|Adverse Event|7|||
16230714|NCT01733758|39324518|FG002|Overall Study|Adverse Event|8|||
16230715|NCT01733758|39324519|FG003|Overall Study|Adverse Event|1|||
16230716|NCT01733758|39324516|FG000|Overall Study|Withdrawal by Subject|1|||
16230717|NCT01733758|39324517|FG001|Overall Study|Withdrawal by Subject|1|||
16230718|NCT01733758|39324518|FG002|Overall Study|Withdrawal by Subject|5|||
16230719|NCT01733758|39324519|FG003|Overall Study|Withdrawal by Subject|3|||
16230720|NCT01733758|39324516|FG000|Overall Study|Persistent Hyperglycemia|3|||
16230721|NCT01733758|39324517|FG001|Overall Study|Persistent Hyperglycemia|2|||
16230722|NCT01733758|39324518|FG002|Overall Study|Persistent Hyperglycemia|0|||
16230723|NCT01733758|39324519|FG003|Overall Study|Persistent Hyperglycemia|0|||
16230724|NCT01733758|39324516|FG000|Overall Study|Protocol Violation|0|||
16230725|NCT01733758|39324517|FG001|Overall Study|Protocol Violation|1|||
16230726|NCT01733758|39324518|FG002|Overall Study|Protocol Violation|2|||
16551595|NCT03056755|40481634|FG000|Treatment- Core Phase|Death|3|||
16551596|NCT03056755|40481635|FG001|Treatment- Core Phase|Death|2|||
16551597|NCT03056755|40481636|FG002|Treatment- Core Phase|Death|4|||
16230727|NCT01733758|39324519|FG003|Overall Study|Protocol Violation|2|||
16230728|NCT01733758|39324516|FG000|Overall Study|Non-compliance|1|||
16230729|NCT01733758|39324517|FG001|Overall Study|Non-compliance|0|||
16230730|NCT01733758|39324518|FG002|Overall Study|Non-compliance|0|||
16230731|NCT01733758|39324519|FG003|Overall Study|Non-compliance|0|||
16230732|NCT01733758|39324516|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
16230733|NCT01733758|39324517|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
16230734|NCT01733758|39324518|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
16230735|NCT01733758|39324519|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
16230736|NCT01733758|39324516|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
16230737|NCT01733758|39324517|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
16230738|NCT01733758|39324518|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
16230739|NCT01733758|39324519|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
16551598|NCT03056755|40481634|FG000|Treatment- Core Phase|Protocol deviation|1|||
16551599|NCT03056755|40481635|FG001|Treatment- Core Phase|Protocol deviation|1|||
16230740|NCT03014570|39324527|FG000|Overall Study|COVID-19 Restrictions|38|||
16230741|NCT03014570|39324528|FG001|Overall Study|COVID-19 Restrictions|24|||
16230742|NCT03014570|39324527|FG000|Overall Study|Death|70|||
16230743|NCT03014570|39324528|FG001|Overall Study|Death|79|||
16230744|NCT03014570|39324527|FG000|Overall Study|Transfer from facility|11|||
16230745|NCT03014570|39324528|FG001|Overall Study|Transfer from facility|14|||
16230746|NCT03014570|39324527|FG000|Overall Study|Hospitalized|5|||
16230747|NCT03014570|39324528|FG001|Overall Study|Hospitalized|3|||
16230748|NCT03014570|39324527|FG000|Overall Study|Transfer within facility|1|||
16230749|NCT03014570|39324528|FG001|Overall Study|Transfer within facility|0|||
16230750|NCT03014570|39324527|FG000|Overall Study|Site refusal|0|||
16230751|NCT03014570|39324528|FG001|Overall Study|Site refusal|11|||
16230752|NCT02230332|39324533|FG000|Overall Study|Adverse Event|2|||
16230753|NCT02230332|39324534|FG001|Overall Study|Adverse Event|1|||
16230754|NCT02230332|39324533|FG000|Overall Study|Lost to Follow-up|1|||
16230755|NCT02230332|39324534|FG001|Overall Study|Lost to Follow-up|0|||
16230756|NCT02230332|39324533|FG000|Overall Study|Protocol Violation|1|||
16230757|NCT02230332|39324534|FG001|Overall Study|Protocol Violation|0|||
16230758|NCT03435224|39324537|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
16230759|NCT04837807|39327925|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
16230760|NCT04837807|39327926|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
16230761|NCT00965458|39327927|FG000|Overall Study|Adverse Event|1|||
16230762|NCT00965458|39327928|FG001|Overall Study|Adverse Event|0|||
16230763|NCT00965458|39327927|FG000|Overall Study|Lost to Follow-up|1|||
16230764|NCT00965458|39327928|FG001|Overall Study|Lost to Follow-up|3|||
16230765|NCT00965458|39327927|FG000|Overall Study|Withdrawal by Subject|0|||
16230766|NCT00965458|39327928|FG001|Overall Study|Withdrawal by Subject|1|||
16230767|NCT01980056|39327929|FG000|Overall Study|Death|1|||
16230768|NCT01980056|39327930|FG001|Overall Study|Death|1|||
16230769|NCT01980056|39327931|FG002|Overall Study|Death|0|||
16230770|NCT03233009|39327932|FG000|Overall Study|Lost to Follow-up|1|||
16230771|NCT02044094|39327940|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
16230772|NCT02044094|39327940|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
16230773|NCT02044094|39327940|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
16230774|NCT02044094|39327940|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
16230775|NCT02044094|39327940|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
16230776|NCT02044094|39327940|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
16230777|NCT02044094|39327940|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
16230778|NCT02044094|39327940|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
16230779|NCT01707667|39327945|FG000|Period 1|expulsion of colonic sensor catheter|1|||
16230780|NCT01707667|39327946|FG001|Period 1|expulsion of colonic sensor catheter|0|||
16230781|NCT00869362|39327947|FG000|Overall Study|Death|0|||
16230782|NCT00869362|39327948|FG001|Overall Study|Death|2|||
16230783|NCT00869362|39327947|FG000|Overall Study|Lost to Follow-up|1|||
16230784|NCT00869362|39327948|FG001|Overall Study|Lost to Follow-up|3|||
16551600|NCT03056755|40481636|FG002|Treatment- Core Phase|Protocol deviation|0|||
16551601|NCT03056755|40481634|FG000|Treatment- Core Phase|Technical problems|1|||
16551602|NCT03056755|40481635|FG001|Treatment- Core Phase|Technical problems|0|||
16551603|NCT03056755|40481636|FG002|Treatment- Core Phase|Technical problems|0|||
16551604|NCT03056755|40481634|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
16551605|NCT03056755|40481635|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
16551606|NCT03056755|40481636|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
16230785|NCT00167414|39327949|FG000|Overall Study|Death|10|||
16230786|NCT00719706|39327951|FG000|Overall Study|Adverse Event|5|||
16230787|NCT00719706|39327952|FG001|Overall Study|Adverse Event|4|||
16230788|NCT00719706|39327951|FG000|Overall Study|Withdrawal by Subject|1|||
16230789|NCT00719706|39327952|FG001|Overall Study|Withdrawal by Subject|2|||
16551607|NCT03056755|40481634|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
16551608|NCT03056755|40481635|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
16551609|NCT03056755|40481636|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
16551610|NCT03056755|40481634|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
16551611|NCT03056755|40481635|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
16551612|NCT03056755|40481636|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
16551613|NCT03056755|40481634|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
16551614|NCT03056755|40481635|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
16551615|NCT03056755|40481636|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
16551616|NCT03377790|40481638|FG000|Overall Study|Withdrawal by Subject|1|||
16551617|NCT03377790|40481639|FG001|Overall Study|Withdrawal by Subject|0|||
16551618|NCT03377790|40481638|FG000|Overall Study|Adverse Event|1|||
16551619|NCT03377790|40481639|FG001|Overall Study|Adverse Event|0|||
16551620|NCT03377790|40481638|FG000|Overall Study|Lost to Follow-up|0|||
16551621|NCT03377790|40481639|FG001|Overall Study|Lost to Follow-up|2|||
16551622|NCT03377790|40481638|FG000|Overall Study|Randomized but not treated|1|||
16551623|NCT03377790|40481639|FG001|Overall Study|Randomized but not treated|0|||
16551624|NCT03377790|40481638|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
16551625|NCT03377790|40481639|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
16551626|NCT02597933|40484499|FG000|Overall Study|Withdrawal by Subject|7|||
16551627|NCT02597933|40484500|FG001|Overall Study|Withdrawal by Subject|5|||
16551628|NCT02597933|40484499|FG000|Overall Study|Protocol Violation|2|||
16551629|NCT02597933|40484500|FG001|Overall Study|Protocol Violation|2|||
16551630|NCT02597933|40484499|FG000|Overall Study|Adverse Event|20|||
16551631|NCT02597933|40484500|FG001|Overall Study|Adverse Event|28|||
16551632|NCT02597933|40484499|FG000|Overall Study|Not treated|2|||
16551633|NCT02597933|40484500|FG001|Overall Study|Not treated|2|||
16551634|NCT02597933|40484499|FG000|Overall Study|Other than stated above|7|||
16412674|NCT00711802|39992234|FG006|Overall Study|Physician Decision|0|||
16412675|NCT00711802|39992235|FG007|Overall Study|Physician Decision|0|||
16412676|NCT00711802|39992228|FG000|Overall Study|Withdrawal by Subject|0|||
16412677|NCT00711802|39992229|FG001|Overall Study|Withdrawal by Subject|1|||
16412678|NCT00711802|39992230|FG002|Overall Study|Withdrawal by Subject|0|||
16412679|NCT00711802|39992231|FG003|Overall Study|Withdrawal by Subject|1|||
16412680|NCT00711802|39992232|FG004|Overall Study|Withdrawal by Subject|0|||
16412681|NCT00711802|39992233|FG005|Overall Study|Withdrawal by Subject|0|||
16412682|NCT00711802|39992234|FG006|Overall Study|Withdrawal by Subject|0|||
16412683|NCT00711802|39992235|FG007|Overall Study|Withdrawal by Subject|0|||
16412684|NCT00711802|39992228|FG000|Overall Study|Lost to Follow-up|0|||
16412685|NCT00711802|39992229|FG001|Overall Study|Lost to Follow-up|0|||
16412686|NCT00711802|39992230|FG002|Overall Study|Lost to Follow-up|3|||
16412687|NCT00711802|39992231|FG003|Overall Study|Lost to Follow-up|1|||
16412688|NCT00711802|39992232|FG004|Overall Study|Lost to Follow-up|10|||
16412689|NCT00711802|39992233|FG005|Overall Study|Lost to Follow-up|6|||
16551635|NCT02597933|40484500|FG001|Overall Study|Other than stated above|14|||
16551636|NCT01617005|40484505|FG000|Overall Study|Pregnancy|1|||
16551637|NCT01617005|40484505|FG000|Overall Study|Lack of motivation for treatment|1|||
16551638|NCT02912468|40484506|FG000|Overall Study|Adverse Event|3|||
16551639|NCT02912468|40484507|FG001|Overall Study|Adverse Event|2|||
16551640|NCT02912468|40484506|FG000|Overall Study|Withdrawal by Subject|6|||
16551641|NCT02912468|40484507|FG001|Overall Study|Withdrawal by Subject|2|||
16412690|NCT00711802|39992234|FG006|Overall Study|Lost to Follow-up|4|||
16412691|NCT00711802|39992235|FG007|Overall Study|Lost to Follow-up|2|||
16412692|NCT00711802|39992228|FG000|Overall Study|Reason not reported|0|||
16412693|NCT00711802|39992229|FG001|Overall Study|Reason not reported|1|||
16551642|NCT02912468|40484506|FG000|Overall Study|Randomized and not treated|0|||
16551643|NCT02912468|40484507|FG001|Overall Study|Randomized and not treated|1|||
16551644|NCT04789577|40484508|FG000|Overall Study|Withdrawal by Subject|1|||
16551645|NCT04789577|40484509|FG001|Overall Study|Withdrawal by Subject|1|||
16551646|NCT04789577|40484510|FG002|Overall Study|Withdrawal by Subject|1|||
16551647|NCT04789577|40484511|FG003|Overall Study|Withdrawal by Subject|3|||
16551648|NCT04789577|40484512|FG004|Overall Study|Withdrawal by Subject|1|||
16551649|NCT04789577|40484513|FG005|Overall Study|Withdrawal by Subject|7|||
16551650|NCT04789577|40484514|FG006|Overall Study|Withdrawal by Subject|1|||
16551651|NCT04789577|40484508|FG000|Overall Study|Lost to Follow-up|7|||
16551652|NCT04789577|40484509|FG001|Overall Study|Lost to Follow-up|12|||
16551653|NCT04789577|40484510|FG002|Overall Study|Lost to Follow-up|7|||
16551654|NCT04789577|40484511|FG003|Overall Study|Lost to Follow-up|10|||
16551655|NCT04789577|40484512|FG004|Overall Study|Lost to Follow-up|8|||
16551656|NCT04789577|40484513|FG005|Overall Study|Lost to Follow-up|6|||
16551657|NCT04789577|40484514|FG006|Overall Study|Lost to Follow-up|10|||
16551658|NCT04789577|40484508|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
16551659|NCT04789577|40484509|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
16412694|NCT00711802|39992230|FG002|Overall Study|Reason not reported|1|||
16412695|NCT00711802|39992231|FG003|Overall Study|Reason not reported|0|||
16412696|NCT00711802|39992232|FG004|Overall Study|Reason not reported|1|||
16412697|NCT00711802|39992233|FG005|Overall Study|Reason not reported|0|||
16412698|NCT00711802|39992234|FG006|Overall Study|Reason not reported|1|||
16412699|NCT00711802|39992235|FG007|Overall Study|Reason not reported|0|||
16412700|NCT02698371|39992236|FG000|All Participants Flow|Lost to Follow-up|3|||
16412701|NCT02698371|39992236|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
16412702|NCT02698371|39992236|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
16412703|NCT02698371|39992236|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
16412704|NCT02698371|39992236|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
16412705|NCT02698371|39992236|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
16412706|NCT02698371|39992236|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
16412707|NCT00334282|39992237|FG000|Overall Study|Lost to Follow-up|11|||
16412708|NCT00334282|39992238|FG001|Overall Study|Lost to Follow-up|5|||
16412709|NCT00334282|39992237|FG000|Overall Study|Withdrawal by Subject|17|||
16412710|NCT00334282|39992238|FG001|Overall Study|Withdrawal by Subject|3|||
16412711|NCT00334282|39992237|FG000|Overall Study|Death|194|||
16412712|NCT00334282|39992238|FG001|Overall Study|Death|100|||
16412713|NCT02528357|39992239|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412714|NCT02528357|39992240|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
16412715|NCT02528357|39992241|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412716|NCT02528357|39992242|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412717|NCT02528357|39992243|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412718|NCT02528357|39992244|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412719|NCT02528357|39992245|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412720|NCT02528357|39992246|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412721|NCT02528357|39992247|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412722|NCT02528357|39992248|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412723|NCT02528357|39992249|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412724|NCT02528357|39992250|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412725|NCT02528357|39992251|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412726|NCT02528357|39992252|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412727|NCT02528357|39992253|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412728|NCT02528357|39992254|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412729|NCT02528357|39992255|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412730|NCT02528357|39992256|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412731|NCT02528357|39992257|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
16412732|NCT02528357|39992239|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412733|NCT02528357|39992240|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412734|NCT02528357|39992241|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412735|NCT02528357|39992242|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
16412736|NCT02528357|39992243|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412737|NCT02528357|39992244|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
16412738|NCT02528357|39992245|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412739|NCT02528357|39992246|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
16412740|NCT02528357|39992247|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412741|NCT02528357|39992248|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412742|NCT02528357|39992249|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412743|NCT02528357|39992250|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412744|NCT02528357|39992251|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412745|NCT02528357|39992252|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16551660|NCT04789577|40484510|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
16551661|NCT04789577|40484511|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
16551662|NCT04789577|40484512|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
16412746|NCT02528357|39992253|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412747|NCT02528357|39992254|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412748|NCT02528357|39992255|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412749|NCT02528357|39992256|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412750|NCT02528357|39992257|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
16412751|NCT02528357|39992239|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412752|NCT02528357|39992240|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412753|NCT02528357|39992241|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
16412754|NCT02528357|39992242|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412755|NCT02528357|39992243|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
16412756|NCT02528357|39992244|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412757|NCT02528357|39992245|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
16412758|NCT02528357|39992246|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
16412759|NCT02528357|39992247|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412760|NCT02528357|39992248|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412761|NCT02528357|39992249|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412762|NCT02528357|39992250|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412763|NCT02528357|39992251|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412764|NCT02528357|39992252|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412765|NCT02528357|39992253|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412766|NCT02528357|39992254|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16230790|NCT00719706|39327951|FG000|Overall Study|Protocol Violation|3|||
16230791|NCT00719706|39327952|FG001|Overall Study|Protocol Violation|0|||
16230792|NCT02646566|39327958|FG000|Overall Study|Lost to Follow-up|5|||
16230793|NCT02646566|39327959|FG001|Overall Study|Lost to Follow-up|4|||
16230794|NCT02646566|39327960|FG002|Overall Study|Lost to Follow-up|5|||
16230795|NCT02646566|39327958|FG000|Overall Study|Treatment failure|1|||
16412767|NCT02528357|39992255|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412768|NCT02528357|39992256|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412769|NCT02528357|39992257|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
16412770|NCT02528357|39992239|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412771|NCT02528357|39992240|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412772|NCT02528357|39992241|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412773|NCT02528357|39992242|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412774|NCT02528357|39992243|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16551663|NCT04789577|40484513|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
16230796|NCT02646566|39327959|FG001|Overall Study|Treatment failure|0|||
16230797|NCT02646566|39327960|FG002|Overall Study|Treatment failure|0|||
16173322|NCT01287104|39111179|FG003|Overall Study|Low donor chimerism|0|||
16230798|NCT03522506|39327963|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16230799|NCT03522506|39327964|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16348354|NCT00436826|39762243|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
16348355|NCT00436826|39762244|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
16348356|NCT00436826|39762245|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
16348357|NCT00436826|39762246|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
16348358|NCT00436826|39762241|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
16348359|NCT00436826|39762242|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
16348360|NCT00436826|39762243|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
16348361|NCT00436826|39762244|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
16348362|NCT00436826|39762245|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
16348363|NCT00436826|39762246|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
16348364|NCT00436826|39762241|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
16348365|NCT00436826|39762242|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
16348366|NCT00436826|39762243|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
16348367|NCT00436826|39762244|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
16348368|NCT00436826|39762245|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
16348369|NCT00436826|39762246|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
16348370|NCT01711983|39765377|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
16348371|NCT01711983|39765377|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
16348372|NCT01711983|39765377|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
16348373|NCT01711983|39765377|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
16348374|NCT00922116|39765380|FG000|Overall Study|Adverse Event|4|||
16348375|NCT00922116|39765380|FG000|Overall Study|Death|1|||
16412775|NCT02528357|39992244|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412776|NCT02528357|39992245|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412777|NCT02528357|39992246|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412778|NCT02528357|39992247|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412779|NCT02528357|39992248|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412780|NCT02528357|39992249|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412781|NCT02528357|39992250|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412782|NCT02528357|39992251|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412783|NCT02528357|39992252|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412784|NCT02528357|39992253|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412785|NCT02528357|39992254|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412786|NCT02528357|39992255|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412787|NCT02528357|39992256|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412788|NCT02528357|39992257|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412789|NCT02528357|39992239|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412790|NCT02528357|39992240|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412791|NCT02528357|39992241|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412792|NCT02528357|39992242|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412793|NCT02528357|39992243|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412794|NCT02528357|39992244|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412795|NCT02528357|39992245|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412796|NCT02528357|39992246|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412797|NCT02528357|39992247|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412798|NCT02528357|39992248|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412799|NCT02528357|39992249|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412800|NCT02528357|39992250|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412801|NCT02528357|39992251|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412802|NCT02528357|39992252|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
16412803|NCT02528357|39992253|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
16412804|NCT02528357|39992254|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412805|NCT02528357|39992255|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412806|NCT02528357|39992256|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412807|NCT02528357|39992257|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
16412808|NCT02528357|39992239|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412809|NCT02528357|39992240|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412810|NCT02528357|39992241|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412811|NCT02528357|39992242|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412812|NCT02528357|39992243|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412813|NCT02528357|39992244|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412814|NCT02528357|39992245|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412815|NCT02528357|39992246|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412816|NCT02528357|39992247|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412817|NCT02528357|39992248|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412818|NCT02528357|39992249|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412819|NCT02528357|39992250|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412820|NCT02528357|39992251|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412821|NCT02528357|39992252|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
16412822|NCT02528357|39992253|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16119527|NCT04860297|38926983|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
16119528|NCT04860297|38926984|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
16119529|NCT04860297|38926985|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
16119530|NCT04860297|38926986|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
16412823|NCT02528357|39992254|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412824|NCT02528357|39992255|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412825|NCT02528357|39992256|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412826|NCT02528357|39992257|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
16412827|NCT02528357|39992239|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16119531|NCT04860297|38926987|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
16119532|NCT04860297|38926980|FG000|Part B (Booster Dose)|Other Than Specified|0|||
16412828|NCT02528357|39992240|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412829|NCT02528357|39992241|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412830|NCT02528357|39992242|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16119533|NCT04860297|38926981|FG001|Part B (Booster Dose)|Other Than Specified|0|||
16119534|NCT04860297|38926982|FG002|Part B (Booster Dose)|Other Than Specified|0|||
16412831|NCT02528357|39992243|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412832|NCT02528357|39992244|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16119535|NCT04860297|38926983|FG003|Part B (Booster Dose)|Other Than Specified|0|||
16119536|NCT04860297|38926984|FG004|Part B (Booster Dose)|Other Than Specified|0|||
16119537|NCT04860297|38926985|FG005|Part B (Booster Dose)|Other Than Specified|1|||
16119538|NCT04860297|38926986|FG006|Part B (Booster Dose)|Other Than Specified|1|||
16119539|NCT04860297|38926987|FG007|Part B (Booster Dose)|Other Than Specified|0|||
16119540|NCT04860297|38926980|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
16119541|NCT04860297|38926981|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
16119542|NCT04860297|38926982|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
16119543|NCT04860297|38926983|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
16119544|NCT04860297|38926984|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
16119545|NCT04860297|38926985|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
16119546|NCT04860297|38926986|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
16119547|NCT04860297|38926987|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
16412833|NCT02528357|39992245|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412834|NCT02528357|39992246|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412835|NCT02528357|39992247|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412836|NCT02528357|39992248|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412837|NCT02528357|39992249|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
16412838|NCT02528357|39992250|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412839|NCT02528357|39992251|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
16412840|NCT02528357|39992252|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
16412841|NCT02528357|39992253|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
16412842|NCT02528357|39992254|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412843|NCT02528357|39992255|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412844|NCT02528357|39992256|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412845|NCT02528357|39992257|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
16412846|NCT02528357|39992239|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412847|NCT02528357|39992240|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412848|NCT02528357|39992241|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412849|NCT02528357|39992242|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412850|NCT02528357|39992243|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412851|NCT02528357|39992244|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412852|NCT02528357|39992245|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412853|NCT02528357|39992246|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412854|NCT02528357|39992247|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16412855|NCT02528357|39992248|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16412856|NCT02528357|39992249|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412857|NCT02528357|39992250|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
16412858|NCT02528357|39992251|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
16412859|NCT02528357|39992252|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16412860|NCT02528357|39992253|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16412861|NCT02528357|39992254|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412862|NCT02528357|39992255|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412863|NCT02528357|39992256|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412864|NCT02528357|39992257|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412865|NCT02528357|39992239|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16119548|NCT04860297|38926980|FG000|Part B (Booster Dose)|Death|0|||
16119549|NCT04860297|38926981|FG001|Part B (Booster Dose)|Death|0|||
16119550|NCT04860297|38926982|FG002|Part B (Booster Dose)|Death|0|||
16119551|NCT04860297|38926983|FG003|Part B (Booster Dose)|Death|0|||
16119552|NCT04860297|38926984|FG004|Part B (Booster Dose)|Death|1|||
16119553|NCT04860297|38926985|FG005|Part B (Booster Dose)|Death|2|||
16119554|NCT04860297|38926986|FG006|Part B (Booster Dose)|Death|1|||
16412866|NCT02528357|39992240|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412867|NCT02528357|39992241|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412868|NCT02528357|39992242|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412869|NCT02528357|39992243|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412870|NCT02528357|39992244|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412871|NCT02528357|39992245|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412872|NCT02528357|39992246|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412873|NCT02528357|39992247|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412874|NCT02528357|39992248|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412875|NCT02528357|39992249|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412876|NCT02528357|39992250|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412877|NCT02528357|39992251|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412878|NCT02528357|39992252|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412879|NCT02528357|39992253|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412880|NCT02528357|39992254|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412881|NCT02528357|39992255|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
16412882|NCT02528357|39992256|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412883|NCT02528357|39992257|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
16412884|NCT02528357|39992239|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412885|NCT02528357|39992240|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412886|NCT02528357|39992241|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412887|NCT02528357|39992242|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412888|NCT02528357|39992243|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412889|NCT02528357|39992244|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412890|NCT02528357|39992245|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412891|NCT02528357|39992246|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412892|NCT02528357|39992247|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412893|NCT02528357|39992248|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412894|NCT02528357|39992249|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412895|NCT02528357|39992250|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412896|NCT02528357|39992251|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412897|NCT02528357|39992252|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412898|NCT02528357|39992253|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412899|NCT02528357|39992254|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
16412900|NCT02528357|39992255|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
16412901|NCT02528357|39992256|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
16412902|NCT02528357|39992257|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
16412903|NCT03204890|39992258|FG000|Overall Study|Withdrawal by Subject|1|||
16412904|NCT00046930|39992259|FG000|Overall Study|Ineligible|12|||
16412905|NCT00046930|39992260|FG001|Overall Study|Ineligible|4|||
16412906|NCT01751776|39992263|FG000|Overall Study|Adverse Event|0|||
16412907|NCT01751776|39992264|FG001|Overall Study|Adverse Event|0|||
16412908|NCT01751776|39992265|FG002|Overall Study|Adverse Event|0|||
16412909|NCT01751776|39992266|FG003|Overall Study|Adverse Event|0|||
16412910|NCT01751776|39992267|FG004|Overall Study|Adverse Event|0|||
16412911|NCT01751776|39992268|FG005|Overall Study|Adverse Event|0|||
16412912|NCT01751776|39992269|FG006|Overall Study|Adverse Event|4|||
16412913|NCT01751776|39992270|FG007|Overall Study|Adverse Event|2|||
16412914|NCT01751776|39992263|FG000|Overall Study|Consent withdrawn|0|||
16412915|NCT01751776|39992264|FG001|Overall Study|Consent withdrawn|0|||
16412916|NCT01751776|39992265|FG002|Overall Study|Consent withdrawn|0|||
16412917|NCT01751776|39992266|FG003|Overall Study|Consent withdrawn|0|||
16412918|NCT01751776|39992267|FG004|Overall Study|Consent withdrawn|0|||
16551664|NCT04789577|40484514|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
16551665|NCT04789577|40484508|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
16551666|NCT04789577|40484509|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
16551667|NCT04789577|40484510|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
16551668|NCT04789577|40484511|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
16551669|NCT04789577|40484512|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
16551670|NCT04789577|40484513|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
16551671|NCT04789577|40484514|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
16119555|NCT04860297|38926987|FG007|Part B (Booster Dose)|Death|0|||
16119556|NCT04860297|38926980|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
16119557|NCT04860297|38926981|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
16119558|NCT04860297|38926982|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
16119559|NCT04860297|38926983|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
16119560|NCT04860297|38926984|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
16119561|NCT04860297|38926985|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
16119562|NCT04860297|38926986|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
16119563|NCT04860297|38926987|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
16119564|NCT00678301|38926989|FG000|Overall Study|Non-compliance with study procedures|0|||
16119565|NCT00678301|38926990|FG001|Overall Study|Non-compliance with study procedures|1|||
16119566|NCT00678301|38926989|FG000|Overall Study|Adverse Event|1|||
16119567|NCT00678301|38926990|FG001|Overall Study|Adverse Event|0|||
16119568|NCT00678301|38926989|FG000|Overall Study|Withdrawal by Subject|4|||
16119569|NCT00678301|38926990|FG001|Overall Study|Withdrawal by Subject|0|||
16119570|NCT00678301|38926989|FG000|Overall Study|Lost to Follow-up|3|||
16119571|NCT00678301|38926990|FG001|Overall Study|Lost to Follow-up|1|||
16119572|NCT00737477|38926991|FG000|Overall Study|Adverse Event|9|||
16119573|NCT00737477|38926991|FG000|Overall Study|Death|9|||
16119574|NCT00737477|38926991|FG000|Overall Study|Treatment Refusal|1|||
16119575|NCT00737477|38926991|FG000|Overall Study|Withdrawal by Subject|1|||
16551672|NCT02262260|40484515|FG000|Overall Study|Adverse Event|4|||
16119576|NCT00737477|38926991|FG000|Overall Study|Renal Transplantation|10|||
16119577|NCT00737477|38926991|FG000|Overall Study|Other|4|||
16119578|NCT03214640|38926992|FG000|Overall Study|Protocol Violation|1|||
16119579|NCT03214640|38926993|FG001|Overall Study|Protocol Violation|2|||
16119580|NCT03214640|38926994|FG002|Overall Study|Protocol Violation|1|||
16119581|NCT03214640|38926995|FG003|Overall Study|Protocol Violation|4|||
16119582|NCT00756457|38926996|FG000|Overall Study|Lost to Follow-up|1|||
16119583|NCT00756457|38926997|FG001|Overall Study|Lost to Follow-up|2|||
16551673|NCT02262260|40484516|FG001|Overall Study|Adverse Event|1|||
16551674|NCT02262260|40484515|FG000|Overall Study|Withdrawal of consent|4|||
16551675|NCT02262260|40484516|FG001|Overall Study|Withdrawal of consent|2|||
16551676|NCT02262260|40484515|FG000|Overall Study|Lost to Follow-up|1|||
16551677|NCT02262260|40484516|FG001|Overall Study|Lost to Follow-up|2|||
16551678|NCT02262260|40484515|FG000|Overall Study|Protocol deviation|2|||
16551679|NCT02262260|40484516|FG001|Overall Study|Protocol deviation|5|||
16551680|NCT01107743|40484517|FG000|Overall Study|Protocol Violation|46|||
16551681|NCT01671748|40484518|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
16551682|NCT01671748|40484519|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
16551683|NCT01671748|40484518|FG000|4 Week run-in Phase|Adverse Event|1|||
16551684|NCT01671748|40484519|FG001|4 Week run-in Phase|Adverse Event|0|||
16119584|NCT00820170|38927003|FG000|Overall Study|Adverse Event|0|||
16119585|NCT00820170|38927004|FG001|Overall Study|Adverse Event|0|||
16119586|NCT00820170|38927005|FG002|Overall Study|Adverse Event|0|||
16551685|NCT01671748|40484518|FG000|4 Week run-in Phase|Not eligible|9|||
16551686|NCT01671748|40484519|FG001|4 Week run-in Phase|Not eligible|0|||
16551687|NCT01320735|40484520|FG000|Overall Study|Adverse Event|3|||
16551688|NCT01320735|40484520|FG000|Overall Study|Withdrawal by Subject|3|||
16551689|NCT01320735|40484520|FG000|Overall Study|Lost to Follow-up|13|||
16551690|NCT01320735|40484520|FG000|Overall Study|Administrative Reason|6|||
16551691|NCT01320735|40484520|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
16551692|NCT01320735|40484520|FG000|Overall Study|Protocol Violation|1|||
16551693|NCT01320735|40484520|FG000|Overall Study|Other|1|||
16551694|NCT01320735|40484520|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
16551695|NCT01320735|40484520|FG000|Overall Study|Investigator Unable to be Contacted|17|||
16551696|NCT04827134|40484523|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
16119587|NCT00820170|38927006|FG003|Overall Study|Adverse Event|0|||
16119588|NCT00820170|38927007|FG004|Overall Study|Adverse Event|2|||
16119589|NCT00820170|38927003|FG000|Overall Study|Progressive Disease|0|||
16119590|NCT00820170|38927004|FG001|Overall Study|Progressive Disease|0|||
16119591|NCT00820170|38927005|FG002|Overall Study|Progressive Disease|0|||
16119592|NCT00820170|38927006|FG003|Overall Study|Progressive Disease|0|||
16119593|NCT00820170|38927007|FG004|Overall Study|Progressive Disease|2|||
16119594|NCT00763451|38927008|FG000|Overall Study|Adverse Event|4|||
16119595|NCT00763451|38927009|FG001|Overall Study|Adverse Event|6|||
16119596|NCT00763451|38927010|FG002|Overall Study|Adverse Event|19|||
16119597|NCT00763451|38927011|FG003|Overall Study|Adverse Event|14|||
16348376|NCT00922116|39765380|FG000|Overall Study|Lost to Follow-up|1|||
16119598|NCT00763451|38927008|FG000|Overall Study|Lack of Efficacy|1|||
16119599|NCT00763451|38927009|FG001|Overall Study|Lack of Efficacy|4|||
16348377|NCT00922116|39765380|FG000|Overall Study|Withdrawal by Subject|4|||
16348378|NCT00922116|39765380|FG000|Overall Study|Other|5|||
16348379|NCT00237692|39765381|FG000|Overall Study|Lost to Follow-up|9|||
16348380|NCT00237692|39765382|FG001|Overall Study|Lost to Follow-up|3|||
16348381|NCT00237692|39765383|FG002|Overall Study|Lost to Follow-up|5|||
16348382|NCT00237692|39765384|FG003|Overall Study|Lost to Follow-up|3|||
16348383|NCT00237692|39765381|FG000|Overall Study|Death|1|||
16348384|NCT00237692|39765382|FG001|Overall Study|Death|2|||
16551697|NCT04827134|40484524|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
16551698|NCT04827134|40484525|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
16551699|NCT04827134|40484526|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
16551700|NCT04320615|40484531|FG000|Overall Study|Withdrawal by Subject|4|||
16551701|NCT04320615|40484532|FG001|Overall Study|Withdrawal by Subject|10|||
16119600|NCT00763451|38927010|FG002|Overall Study|Lack of Efficacy|3|||
16119601|NCT00763451|38927011|FG003|Overall Study|Lack of Efficacy|2|||
16119602|NCT00763451|38927008|FG000|Overall Study|Withdrawal by Subject|1|||
16551702|NCT04320615|40484531|FG000|Overall Study|Physician Decision|2|||
16551703|NCT04320615|40484532|FG001|Overall Study|Physician Decision|0|||
16551704|NCT04320615|40484531|FG000|Overall Study|Other|2|||
16551705|NCT04320615|40484532|FG001|Overall Study|Other|0|||
16551706|NCT04320615|40484531|FG000|Overall Study|Lost to Follow-up|5|||
16551707|NCT04320615|40484532|FG001|Overall Study|Lost to Follow-up|23|||
16551708|NCT04320615|40484531|FG000|Overall Study|Death|35|||
16551709|NCT04320615|40484532|FG001|Overall Study|Death|71|||
16551710|NCT01348776|40484533|FG000|Overall Study|Lost to Follow-up|3|||
16551711|NCT00871351|40484534|FG000|Overall Study|Withdrawal by Subject|1|||
16551712|NCT00871351|40484535|FG001|Overall Study|Withdrawal by Subject|0|||
16551713|NCT00871351|40484536|FG002|Overall Study|Withdrawal by Subject|0|||
16551714|NCT00871351|40484534|FG000|Overall Study|Adverse Event|3|||
16551715|NCT00871351|40484535|FG001|Overall Study|Adverse Event|1|||
16551716|NCT00871351|40484536|FG002|Overall Study|Adverse Event|0|||
16551717|NCT00854295|40484540|FG000|Overall Study|Death|7|||
16551718|NCT00854295|40484541|FG001|Overall Study|Death|0|||
16551719|NCT00854295|40484542|FG002|Overall Study|Death|1|||
16551720|NCT00854295|40484543|FG003|Overall Study|Death|1|||
16551721|NCT00854295|40484540|FG000|Overall Study|Adverse Event|6|||
16551722|NCT00854295|40484541|FG001|Overall Study|Adverse Event|1|||
16551723|NCT00854295|40484542|FG002|Overall Study|Adverse Event|1|||
16551724|NCT00854295|40484543|FG003|Overall Study|Adverse Event|3|||
16551725|NCT00854295|40484540|FG000|Overall Study|Lost to Follow-up|18|||
16551726|NCT00854295|40484541|FG001|Overall Study|Lost to Follow-up|5|||
16551727|NCT00854295|40484542|FG002|Overall Study|Lost to Follow-up|21|||
16551728|NCT00854295|40484543|FG003|Overall Study|Lost to Follow-up|21|||
16551729|NCT00854295|40484540|FG000|Overall Study|Physician Decision|10|||
16551730|NCT00854295|40484541|FG001|Overall Study|Physician Decision|0|||
16551731|NCT00854295|40484542|FG002|Overall Study|Physician Decision|0|||
16551732|NCT00854295|40484543|FG003|Overall Study|Physician Decision|0|||
16551733|NCT04145037|40484544|FG000|Overall Study|Study terminated|2|||
16551734|NCT04145037|40484545|FG001|Overall Study|Study terminated|0|||
16551735|NCT04145037|40484544|FG000|Overall Study|Withdrawal by Subject|1|||
16551736|NCT04145037|40484545|FG001|Overall Study|Withdrawal by Subject|0|||
16551737|NCT04145037|40484544|FG000|Overall Study|Lost to Follow-up|1|||
16551738|NCT04145037|40484545|FG001|Overall Study|Lost to Follow-up|0|||
16551739|NCT01912781|40484546|FG000|Overall Study|Withdrawal by Subject|2|||
16551740|NCT01912781|40484547|FG001|Overall Study|Withdrawal by Subject|0|||
16551741|NCT01250119|40484548|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
16551742|NCT01250119|40484549|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
16551743|NCT01250119|40484548|FG000|Diagnostic Phase|Participants Not Tested|44|||
16551744|NCT01250119|40484549|FG001|Diagnostic Phase|Participants Not Tested|0|||
16551745|NCT01250119|40484548|FG000|Treatment Phase|Progressive Disease|0|||
16551746|NCT01250119|40484549|FG001|Treatment Phase|Progressive Disease|32|||
16551747|NCT01250119|40484548|FG000|Treatment Phase|Death|0|||
16551748|NCT01250119|40484549|FG001|Treatment Phase|Death|2|||
16551749|NCT01250119|40484548|FG000|Treatment Phase|Withdrawal by Subject|0|||
16551750|NCT01250119|40484549|FG001|Treatment Phase|Withdrawal by Subject|1|||
16551751|NCT01250119|40484548|FG000|Treatment Phase|Adverse Event|0|||
16551752|NCT01250119|40484549|FG001|Treatment Phase|Adverse Event|2|||
16551753|NCT01250119|40484548|FG000|Treatment Phase|Unknown reason|0|||
16551754|NCT01250119|40484549|FG001|Treatment Phase|Unknown reason|4|||
16551755|NCT00453310|40484550|FG000|Overall Study|Progression of Disease|10|||
16119603|NCT00763451|38927009|FG001|Overall Study|Withdrawal by Subject|6|||
16119604|NCT00763451|38927010|FG002|Overall Study|Withdrawal by Subject|9|||
16119605|NCT00763451|38927011|FG003|Overall Study|Withdrawal by Subject|7|||
16119606|NCT00763451|38927008|FG000|Overall Study|Protocol Violation|0|||
16119607|NCT00763451|38927009|FG001|Overall Study|Protocol Violation|0|||
16119608|NCT00763451|38927010|FG002|Overall Study|Protocol Violation|1|||
16119609|NCT00763451|38927011|FG003|Overall Study|Protocol Violation|0|||
16551756|NCT03857841|40484551|FG000|Overall Study|Death|1|||
16551757|NCT03857841|40484552|FG001|Overall Study|Death|0|||
16551758|NCT03857841|40484553|FG002|Overall Study|Death|0|||
16551759|NCT03857841|40484554|FG003|Overall Study|Death|0|||
16551760|NCT03857841|40484551|FG000|Overall Study|Study Terminated by Sponsor|1|||
16551761|NCT03857841|40484552|FG001|Overall Study|Study Terminated by Sponsor|0|||
16551762|NCT03857841|40484553|FG002|Overall Study|Study Terminated by Sponsor|0|||
16551763|NCT03857841|40484554|FG003|Overall Study|Study Terminated by Sponsor|0|||
16551764|NCT00210119|40484556|FG000|Overall Study|Protocol Violation|1|||
16551765|NCT00210119|40484556|FG000|Overall Study|Withdrawal by Subject|1|||
16551766|NCT00127413|40484557|FG000|Overall Study|Lost to Follow-up|6|||
16119610|NCT00763451|38927008|FG000|Overall Study|Poor Compliance to Protocol|1|||
16119611|NCT00763451|38927009|FG001|Overall Study|Poor Compliance to Protocol|1|||
16119612|NCT00763451|38927010|FG002|Overall Study|Poor Compliance to Protocol|2|||
16119613|NCT00763451|38927011|FG003|Overall Study|Poor Compliance to Protocol|2|||
16119614|NCT00763451|38927008|FG000|Overall Study|Familial and Personal Reasons|5|||
16119615|NCT00763451|38927009|FG001|Overall Study|Familial and Personal Reasons|3|||
16119616|NCT00763451|38927010|FG002|Overall Study|Familial and Personal Reasons|5|||
16119617|NCT00763451|38927011|FG003|Overall Study|Familial and Personal Reasons|4|||
16119618|NCT00763451|38927008|FG000|Overall Study|Randomized but not Treated|1|||
16119619|NCT00763451|38927009|FG001|Overall Study|Randomized but not Treated|1|||
16119620|NCT00763451|38927010|FG002|Overall Study|Randomized but not Treated|0|||
16119621|NCT00763451|38927011|FG003|Overall Study|Randomized but not Treated|0|||
16119622|NCT00763451|38927008|FG000|Overall Study|Study Site Reason|0|||
16119623|NCT00763451|38927009|FG001|Overall Study|Study Site Reason|1|||
16119624|NCT00763451|38927010|FG002|Overall Study|Study Site Reason|1|||
16119625|NCT00763451|38927011|FG003|Overall Study|Study Site Reason|1|||
16119626|NCT03552523|38927015|FG000|Overall Study|Withdrawal by Subject|1|||
16119627|NCT03552523|38927016|FG001|Overall Study|Withdrawal by Subject|1|||
16119628|NCT03651622|38927017|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
16119629|NCT03651622|38927018|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
16119630|NCT03651622|38927019|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
16119631|NCT03651622|38927017|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
16119632|NCT03651622|38927018|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
16119633|NCT03651622|38927019|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
16119634|NCT03651622|38927017|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
16119635|NCT03651622|38927018|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
16119636|NCT03651622|38927019|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
16119637|NCT03651622|38927017|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
16119638|NCT03651622|38927018|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
16119639|NCT03651622|38927019|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
16119640|NCT03651622|38927017|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
16119641|NCT03651622|38927018|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
16119642|NCT03651622|38927019|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
16119643|NCT02797522|38927020|FG000|Overall Study|Study Terminated by Sponsor|0|||
16119644|NCT02797522|38927021|FG001|Overall Study|Study Terminated by Sponsor|0|||
16119645|NCT02797522|38927022|FG002|Overall Study|Study Terminated by Sponsor|0|||
16119646|NCT02797522|38927023|FG003|Overall Study|Study Terminated by Sponsor|0|||
16119647|NCT02797522|38927024|FG004|Overall Study|Study Terminated by Sponsor|0|||
16119648|NCT02797522|38927025|FG005|Overall Study|Study Terminated by Sponsor|0|||
16119649|NCT02797522|38927026|FG006|Overall Study|Study Terminated by Sponsor|0|||
16119650|NCT02797522|38927027|FG007|Overall Study|Study Terminated by Sponsor|4|||
16119651|NCT02797522|38927028|FG008|Overall Study|Study Terminated by Sponsor|2|||
16119652|NCT02797522|38927029|FG009|Overall Study|Study Terminated by Sponsor|4|||
16119653|NCT02797522|38927030|FG010|Overall Study|Study Terminated by Sponsor|1|||
16119654|NCT00604708|38927031|FG000|Overall Study|Withdrawal by Subject|9|||
16119655|NCT00604708|38927032|FG001|Overall Study|Withdrawal by Subject|10|||
16119656|NCT00604708|38927031|FG000|Overall Study|Protocol Violation|2|||
16119657|NCT00604708|38927032|FG001|Overall Study|Protocol Violation|8|||
16119658|NCT00604708|38927031|FG000|Overall Study|Lost to Follow-up|5|||
16119659|NCT00604708|38927032|FG001|Overall Study|Lost to Follow-up|5|||
16119660|NCT00604708|38927031|FG000|Overall Study|administrative reasons|9|||
16119661|NCT00604708|38927032|FG001|Overall Study|administrative reasons|11|||
16119662|NCT00604708|38927031|FG000|Overall Study|Adverse Event|6|||
16119663|NCT00604708|38927032|FG001|Overall Study|Adverse Event|6|||
16119664|NCT03686423|38927033|FG000|Overall Study|Withdrawal by Subject|9|||
16119665|NCT03686423|38927033|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
16119666|NCT00415051|38927034|FG000|Overall Study|Protocol Violation|1|||
16119667|NCT01725126|38927037|FG000|Overall Study|Protocol Violation|0|||
16119668|NCT01725126|38927038|FG001|Overall Study|Protocol Violation|1|||
16119669|NCT01725126|38927039|FG002|Overall Study|Protocol Violation|0|||
16119670|NCT01725126|38927040|FG003|Overall Study|Protocol Violation|0|||
16119671|NCT01725126|38927041|FG004|Overall Study|Protocol Violation|0|||
16119672|NCT01725126|38927042|FG005|Overall Study|Protocol Violation|0|||
16119673|NCT01725126|38927037|FG000|Overall Study|Withdrawal by Subject|0|||
16119674|NCT01725126|38927038|FG001|Overall Study|Withdrawal by Subject|0|||
16119675|NCT01725126|38927039|FG002|Overall Study|Withdrawal by Subject|0|||
16119676|NCT01725126|38927040|FG003|Overall Study|Withdrawal by Subject|1|||
16119677|NCT01725126|38927041|FG004|Overall Study|Withdrawal by Subject|0|||
16119678|NCT01725126|38927042|FG005|Overall Study|Withdrawal by Subject|0|||
16119679|NCT01598662|38927043|FG000|Overall Study|Lost to Follow-up|10|||
16119680|NCT01598662|38927044|FG001|Overall Study|Lost to Follow-up|17|||
16119681|NCT01598662|38927043|FG000|Overall Study|Physician Decision|1|||
16119682|NCT01598662|38927044|FG001|Overall Study|Physician Decision|2|||
16119683|NCT01598662|38927043|FG000|Overall Study|IUD expelled before month 6|0|||
16230800|NCT03522506|39327965|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16230801|NCT03522506|39327966|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16230802|NCT03522506|39327963|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
16230803|NCT03522506|39327964|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
16230804|NCT03522506|39327965|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
16230805|NCT03522506|39327966|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
16230806|NCT01729559|39327967|FG000|Overall Study|Protocol Violation|31|||
16230807|NCT01729559|39327968|FG001|Overall Study|Protocol Violation|28|||
16230808|NCT02319642|39327969|FG000|Overall Study|Adverse Event|2|||
16230809|NCT02319642|39327970|FG001|Overall Study|Adverse Event|4|||
16230810|NCT02319642|39327969|FG000|Overall Study|Lack of Efficacy|1|||
16230811|NCT02319642|39327970|FG001|Overall Study|Lack of Efficacy|1|||
16230812|NCT02319642|39327969|FG000|Overall Study|Withdrawal by Subject|1|||
16230813|NCT02319642|39327970|FG001|Overall Study|Withdrawal by Subject|1|||
16230814|NCT01463631|39327976|FG000|Overall Study|Withdrawal by Subject|0|||
16230815|NCT01463631|39327977|FG001|Overall Study|Withdrawal by Subject|0|||
16230816|NCT01463631|39327978|FG002|Overall Study|Withdrawal by Subject|0|||
16230817|NCT01463631|39327979|FG003|Overall Study|Withdrawal by Subject|1|||
16230818|NCT01463631|39327976|FG000|Overall Study|Death|0|||
16230819|NCT01463631|39327977|FG001|Overall Study|Death|0|||
16230820|NCT01463631|39327978|FG002|Overall Study|Death|1|||
16230821|NCT01463631|39327979|FG003|Overall Study|Death|0|||
16230822|NCT01463631|39327976|FG000|Overall Study|Progressive Disease|0|||
16230823|NCT01463631|39327977|FG001|Overall Study|Progressive Disease|0|||
16230824|NCT01463631|39327978|FG002|Overall Study|Progressive Disease|0|||
16230825|NCT01463631|39327979|FG003|Overall Study|Progressive Disease|5|||
16230826|NCT01353209|39327980|FG000|Overall Study|Adverse Event|1|||
16230827|NCT01353209|39327981|FG001|Overall Study|Adverse Event|1|||
16230828|NCT00240331|39327989|FG000|Overall Study|Withdrawal by Subject|125|||
16230829|NCT00240331|39327990|FG001|Overall Study|Withdrawal by Subject|132|||
16230830|NCT00240331|39327989|FG000|Overall Study|Option selected by investigator|1|||
16230831|NCT00240331|39327990|FG001|Overall Study|Option selected by investigator|2|||
16230832|NCT01484691|39327994|FG000|Overall Study|Withdrawal by Subject|1|||
16230833|NCT01484691|39327995|FG001|Overall Study|Withdrawal by Subject|1|||
16230834|NCT01484691|39327996|FG002|Overall Study|Withdrawal by Subject|1|||
16230835|NCT01484691|39327994|FG000|Overall Study|Physician Decision|0|||
16230836|NCT01484691|39327995|FG001|Overall Study|Physician Decision|2|||
16230837|NCT01484691|39327996|FG002|Overall Study|Physician Decision|1|||
16230838|NCT01250418|39327997|FG000|Overall Study|monitor data failure|1|||
16230839|NCT01250418|39327998|FG001|Overall Study|monitor data failure|1|||
16230840|NCT00968539|39327999|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
16230841|NCT00968539|39328000|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
16230842|NCT03704194|39328001|FG000|Overall Study|Withdrawal by Subject|0|||
16230843|NCT03704194|39328002|FG001|Overall Study|Withdrawal by Subject|1|||
16230844|NCT00542321|39328010|FG000|Overall Study|Death|0|||
16230845|NCT00542321|39328011|FG001|Overall Study|Death|1|||
16230846|NCT00499694|39328012|FG000|Overall Study|Patient never received treatment.|1|||
16230847|NCT03075826|39328015|FG000|Overall Study|Withdrawal by Subject|1|||
16230848|NCT03075826|39328015|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
16230849|NCT03602976|39328016|FG000|Overall Study|Withdrawal by Subject|1|||
16230850|NCT01503229|39328019|FG000|Overall Study|Withdrew consent|1|||
16230851|NCT04054011|39328022|FG000|Overall Study|COVID|3|||
16230852|NCT03205605|39328023|FG000|Overall Study|Withdrawal by Subject|1|||
16230853|NCT00779142|39328024|FG000|Overall Study|Screen Failures|3|||
16230854|NCT04886596|39328029|FG000|Overall Study|Adverse Event|73|||
16348385|NCT00237692|39765383|FG002|Overall Study|Death|2|||
16348386|NCT00237692|39765384|FG003|Overall Study|Death|3|||
16230855|NCT04886596|39328030|FG001|Overall Study|Adverse Event|78|||
16348387|NCT00237692|39765381|FG000|Overall Study|Excluded - did not meet criteria|4|||
16230856|NCT04886596|39328029|FG000|Overall Study|Lost to Follow-up|104|||
16230857|NCT04886596|39328030|FG001|Overall Study|Lost to Follow-up|104|||
16230858|NCT04886596|39328029|FG000|Overall Study|Ongoing|12095|||
16230859|NCT04886596|39328030|FG001|Overall Study|Ongoing|12107|||
16348388|NCT00237692|39765382|FG001|Overall Study|Excluded - did not meet criteria|3|||
16230860|NCT04886596|39328029|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
16230861|NCT04886596|39328030|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
16119684|NCT01598662|38927044|FG001|Overall Study|IUD expelled before month 6|2|||
16119685|NCT01436253|38927047|FG000|Overall Study|Lost to Follow-up|182|||
16119686|NCT01436253|38927047|FG000|Overall Study|Not meeting all eligibility criteria|117|||
16230862|NCT04886596|39328029|FG000|Overall Study|Migrated / Moved from the study area|17|||
16230863|NCT04886596|39328030|FG001|Overall Study|Migrated / Moved from the study area|14|||
16230864|NCT04886596|39328029|FG000|Overall Study|Unknown reason|16|||
16230865|NCT04886596|39328030|FG001|Overall Study|Unknown reason|23|||
16230866|NCT01409382|39328031|FG000|Overall Study|Lost to Follow-up|1|||
16230867|NCT01409382|39328032|FG001|Overall Study|Lost to Follow-up|1|||
16230868|NCT01409382|39328031|FG000|Overall Study|Protocol Violation|0|||
16230869|NCT01409382|39328032|FG001|Overall Study|Protocol Violation|3|||
16230870|NCT01409382|39328031|FG000|Overall Study|Multiple pregnancy|2|||
16230871|NCT01409382|39328032|FG001|Overall Study|Multiple pregnancy|4|||
16119687|NCT01969851|38927048|FG000|Overall Study|Adverse Event|0|||
16119688|NCT01969851|38927049|FG001|Overall Study|Adverse Event|0|||
16119689|NCT01969851|38927050|FG002|Overall Study|Adverse Event|3|||
16119690|NCT01969851|38927048|FG000|Overall Study|Lack of Efficacy|0|||
16230872|NCT01409382|39328031|FG000|Overall Study|Still pregnant when study ended|13|||
16230873|NCT01409382|39328032|FG001|Overall Study|Still pregnant when study ended|2|||
16230874|NCT01409382|39328031|FG000|Overall Study|Did not manage to get pregnant|64|||
16230875|NCT01409382|39328032|FG001|Overall Study|Did not manage to get pregnant|70|||
16230876|NCT01409382|39328031|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
16230877|NCT01409382|39328032|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
16412919|NCT01751776|39992268|FG005|Overall Study|Consent withdrawn|0|||
16412920|NCT01751776|39992269|FG006|Overall Study|Consent withdrawn|0|||
16412921|NCT01751776|39992270|FG007|Overall Study|Consent withdrawn|1|||
16412922|NCT01751776|39992263|FG000|Overall Study|Other reason not specified above|0|||
16412923|NCT01751776|39992264|FG001|Overall Study|Other reason not specified above|0|||
16412924|NCT01751776|39992265|FG002|Overall Study|Other reason not specified above|0|||
16412925|NCT01751776|39992266|FG003|Overall Study|Other reason not specified above|0|||
16412926|NCT01751776|39992267|FG004|Overall Study|Other reason not specified above|0|||
16412927|NCT01751776|39992268|FG005|Overall Study|Other reason not specified above|0|||
16412928|NCT01751776|39992269|FG006|Overall Study|Other reason not specified above|0|||
16412929|NCT01751776|39992270|FG007|Overall Study|Other reason not specified above|1|||
16412930|NCT01519674|39992271|FG000|Overall Study|Adverse Event|3|||
16412931|NCT01519674|39992272|FG001|Overall Study|Adverse Event|3|||
16412932|NCT01519674|39992273|FG002|Overall Study|Adverse Event|0|||
16412933|NCT01519674|39992271|FG000|Overall Study|Lack of Efficacy|1|||
16412934|NCT01519674|39992272|FG001|Overall Study|Lack of Efficacy|1|||
16412935|NCT01519674|39992273|FG002|Overall Study|Lack of Efficacy|1|||
16412936|NCT01519674|39992271|FG000|Overall Study|Protocol Violation|0|||
16412937|NCT01519674|39992272|FG001|Overall Study|Protocol Violation|3|||
16412938|NCT01519674|39992273|FG002|Overall Study|Protocol Violation|1|||
16412939|NCT01519674|39992271|FG000|Overall Study|Withdrawal Criteria|7|||
16412940|NCT01519674|39992272|FG001|Overall Study|Withdrawal Criteria|2|||
16412941|NCT01519674|39992273|FG002|Overall Study|Withdrawal Criteria|7|||
16412942|NCT01519674|39992271|FG000|Overall Study|Unsclassified|10|||
16412943|NCT01519674|39992272|FG001|Overall Study|Unsclassified|4|||
16412944|NCT01519674|39992273|FG002|Overall Study|Unsclassified|3|||
16412945|NCT00907296|39992274|FG000|Overall Study|Ineligibility Determined|1|||
16119691|NCT01969851|38927049|FG001|Overall Study|Lack of Efficacy|3|||
16412946|NCT00907296|39992275|FG001|Overall Study|Ineligibility Determined|0|||
16412947|NCT00907296|39992276|FG002|Overall Study|Ineligibility Determined|0|||
16119692|NCT01969851|38927050|FG002|Overall Study|Lack of Efficacy|1|||
16119693|NCT01969851|38927048|FG000|Overall Study|Withdrawal by Subject|1|||
16119694|NCT01969851|38927049|FG001|Overall Study|Withdrawal by Subject|0|||
16119695|NCT01969851|38927050|FG002|Overall Study|Withdrawal by Subject|1|||
16119696|NCT01969851|38927048|FG000|Overall Study|No effective dose in Titration period|0|||
16119697|NCT01969851|38927049|FG001|Overall Study|No effective dose in Titration period|0|||
16119698|NCT01969851|38927050|FG002|Overall Study|No effective dose in Titration period|1|||
16119699|NCT01969851|38927048|FG000|Overall Study|Sponsor decision|0|||
16119700|NCT01969851|38927049|FG001|Overall Study|Sponsor decision|0|||
16119701|NCT01969851|38927050|FG002|Overall Study|Sponsor decision|1|||
16119702|NCT02233803|38927051|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
16119703|NCT02233803|38927052|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
16119704|NCT02233803|38927051|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
16119705|NCT02233803|38927052|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
16119706|NCT02233803|38927051|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
16119707|NCT02233803|38927052|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
16119708|NCT02233803|38927051|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
16119709|NCT02233803|38927052|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
16119710|NCT02233803|38927051|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
16119711|NCT02233803|38927052|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
16119712|NCT02233803|38927051|FG000|Washout Period (4-Wks)|Physician Decision|1|||
16119713|NCT02233803|38927052|FG001|Washout Period (4-Wks)|Physician Decision|0|||
16119714|NCT02233803|38927051|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
16119715|NCT02233803|38927052|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
16119716|NCT02233803|38927051|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
16119717|NCT02233803|38927052|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
16119718|NCT02233803|38927051|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
16119719|NCT02233803|38927052|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
16119720|NCT03752970|38927060|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
16119721|NCT03752970|38927061|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
16119722|NCT03752970|38927062|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
16412948|NCT00907296|39992277|FG003|Overall Study|Ineligibility Determined|1|||
16412949|NCT00907296|39992278|FG004|Overall Study|Ineligibility Determined|0|||
16412950|NCT00907296|39992279|FG005|Overall Study|Ineligibility Determined|0|||
16412951|NCT00907296|39992280|FG006|Overall Study|Ineligibility Determined|0|||
16412952|NCT00907296|39992281|FG007|Overall Study|Ineligibility Determined|1|||
16412953|NCT00907296|39992282|FG008|Overall Study|Ineligibility Determined|0|||
16412954|NCT00907296|39992283|FG009|Overall Study|Ineligibility Determined|0|||
16412955|NCT00907296|39992274|FG000|Overall Study|Protocol Deviation|0|||
16412956|NCT00907296|39992275|FG001|Overall Study|Protocol Deviation|1|||
16412957|NCT00907296|39992276|FG002|Overall Study|Protocol Deviation|0|||
16412958|NCT00907296|39992277|FG003|Overall Study|Protocol Deviation|0|||
16412959|NCT00907296|39992278|FG004|Overall Study|Protocol Deviation|0|||
16412960|NCT00907296|39992279|FG005|Overall Study|Protocol Deviation|0|||
16412961|NCT00907296|39992280|FG006|Overall Study|Protocol Deviation|0|||
16412962|NCT00907296|39992281|FG007|Overall Study|Protocol Deviation|0|||
16412963|NCT00907296|39992282|FG008|Overall Study|Protocol Deviation|0|||
16412964|NCT00907296|39992283|FG009|Overall Study|Protocol Deviation|0|||
16412965|NCT00907296|39992274|FG000|Overall Study|Noncompliance|1|||
16119723|NCT03752970|38927060|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
16119724|NCT03752970|38927061|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
16412966|NCT00907296|39992275|FG001|Overall Study|Noncompliance|1|||
16412967|NCT00907296|39992276|FG002|Overall Study|Noncompliance|1|||
16412968|NCT00907296|39992277|FG003|Overall Study|Noncompliance|0|||
16412969|NCT00907296|39992278|FG004|Overall Study|Noncompliance|0|||
16412970|NCT00907296|39992279|FG005|Overall Study|Noncompliance|1|||
16551767|NCT00127413|40484558|FG001|Overall Study|Lost to Follow-up|4|||
16551768|NCT00127413|40484559|FG002|Overall Study|Lost to Follow-up|8|||
16551769|NCT00127413|40484560|FG003|Overall Study|Lost to Follow-up|2|||
16551770|NCT04567693|40484571|FG000|Overall Study|Death|0|||
16551771|NCT04567693|40484572|FG001|Overall Study|Death|0|||
16551772|NCT04567693|40484573|FG002|Overall Study|Death|2|||
16551773|NCT04567693|40484571|FG000|Overall Study|Lost to Follow-up|1|||
16551774|NCT04567693|40484572|FG001|Overall Study|Lost to Follow-up|0|||
16551775|NCT04567693|40484573|FG002|Overall Study|Lost to Follow-up|2|||
16119725|NCT03752970|38927062|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
16119726|NCT03752970|38927060|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
16119727|NCT03752970|38927061|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
16412971|NCT00907296|39992280|FG006|Overall Study|Noncompliance|0|||
16412972|NCT00907296|39992281|FG007|Overall Study|Noncompliance|2|||
16412973|NCT00907296|39992282|FG008|Overall Study|Noncompliance|0|||
16551776|NCT04567693|40484571|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
16551777|NCT04567693|40484572|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
16412974|NCT00907296|39992283|FG009|Overall Study|Noncompliance|0|||
16412975|NCT00907296|39992274|FG000|Overall Study|Adverse Event|2|||
16230878|NCT02057549|39328045|FG000|Overall Study|Lost to Follow-up|1|||
16230879|NCT02057549|39328046|FG001|Overall Study|Lost to Follow-up|0|||
16230880|NCT02057549|39328045|FG000|Overall Study|Physician Decision|1|||
16230881|NCT02057549|39328046|FG001|Overall Study|Physician Decision|0|||
16230882|NCT02057549|39328045|FG000|Overall Study|Withdrawal by Subject|1|||
16230883|NCT02057549|39328046|FG001|Overall Study|Withdrawal by Subject|0|||
16230884|NCT00828009|39328050|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
16230885|NCT00828009|39328050|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
16230886|NCT00828009|39328050|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
16348389|NCT00237692|39765383|FG002|Overall Study|Excluded - did not meet criteria|5|||
16348390|NCT00237692|39765384|FG003|Overall Study|Excluded - did not meet criteria|9|||
16348391|NCT00237692|39765381|FG000|Overall Study|Withdrawal by Subject|4|||
16348392|NCT00237692|39765382|FG001|Overall Study|Withdrawal by Subject|6|||
16348393|NCT00237692|39765383|FG002|Overall Study|Withdrawal by Subject|10|||
16348394|NCT00237692|39765384|FG003|Overall Study|Withdrawal by Subject|4|||
16348395|NCT00509899|39765393|FG000|Overall Study|Progressive disease|1|||
16348396|NCT00509899|39765394|FG001|Overall Study|Progressive disease|3|||
16348397|NCT00509899|39765395|FG002|Overall Study|Progressive disease|5|||
16348398|NCT00509899|39765396|FG003|Overall Study|Progressive disease|1|||
16348399|NCT00509899|39765397|FG004|Overall Study|Progressive disease|0|||
16348400|NCT00509899|39765398|FG005|Overall Study|Progressive disease|1|||
16348401|NCT00509899|39765399|FG006|Overall Study|Progressive disease|0|||
16348402|NCT00509899|39765400|FG007|Overall Study|Progressive disease|0|||
16348403|NCT00509899|39765393|FG000|Overall Study|Unacceptable Toxicity|1|||
16348404|NCT00509899|39765394|FG001|Overall Study|Unacceptable Toxicity|0|||
16348405|NCT00509899|39765395|FG002|Overall Study|Unacceptable Toxicity|0|||
16348406|NCT00509899|39765396|FG003|Overall Study|Unacceptable Toxicity|2|||
16348407|NCT00509899|39765397|FG004|Overall Study|Unacceptable Toxicity|0|||
16348408|NCT00509899|39765398|FG005|Overall Study|Unacceptable Toxicity|0|||
16348409|NCT00509899|39765399|FG006|Overall Study|Unacceptable Toxicity|0|||
16348410|NCT00509899|39765400|FG007|Overall Study|Unacceptable Toxicity|0|||
16348411|NCT00509899|39765393|FG000|Overall Study|Withdrawal by Subject|6|||
16348412|NCT00509899|39765394|FG001|Overall Study|Withdrawal by Subject|2|||
16348413|NCT00509899|39765395|FG002|Overall Study|Withdrawal by Subject|3|||
16348414|NCT00509899|39765396|FG003|Overall Study|Withdrawal by Subject|0|||
16348415|NCT00509899|39765397|FG004|Overall Study|Withdrawal by Subject|3|||
16348416|NCT00509899|39765398|FG005|Overall Study|Withdrawal by Subject|2|||
16348417|NCT00509899|39765399|FG006|Overall Study|Withdrawal by Subject|0|||
16348418|NCT00509899|39765400|FG007|Overall Study|Withdrawal by Subject|0|||
16348419|NCT00509899|39765393|FG000|Overall Study|Physician Decision|4|||
16348420|NCT00509899|39765394|FG001|Overall Study|Physician Decision|2|||
16348421|NCT00509899|39765395|FG002|Overall Study|Physician Decision|7|||
16348422|NCT00509899|39765396|FG003|Overall Study|Physician Decision|0|||
16348423|NCT00509899|39765397|FG004|Overall Study|Physician Decision|1|||
16348424|NCT00509899|39765398|FG005|Overall Study|Physician Decision|4|||
16348425|NCT00509899|39765399|FG006|Overall Study|Physician Decision|0|||
16348426|NCT00509899|39765400|FG007|Overall Study|Physician Decision|0|||
16348427|NCT00509899|39765393|FG000|Overall Study|Intercurrent Illness|1|||
16348428|NCT00509899|39765394|FG001|Overall Study|Intercurrent Illness|0|||
16348429|NCT00509899|39765395|FG002|Overall Study|Intercurrent Illness|0|||
16348430|NCT00509899|39765396|FG003|Overall Study|Intercurrent Illness|1|||
16348431|NCT00509899|39765397|FG004|Overall Study|Intercurrent Illness|0|||
16348432|NCT00509899|39765398|FG005|Overall Study|Intercurrent Illness|1|||
16348433|NCT00509899|39765399|FG006|Overall Study|Intercurrent Illness|0|||
16348434|NCT00509899|39765400|FG007|Overall Study|Intercurrent Illness|0|||
16348435|NCT00509899|39765393|FG000|Overall Study|Death|2|||
16348436|NCT00509899|39765394|FG001|Overall Study|Death|2|||
16348437|NCT00509899|39765395|FG002|Overall Study|Death|3|||
16412976|NCT00907296|39992275|FG001|Overall Study|Adverse Event|0|||
16348438|NCT00509899|39765396|FG003|Overall Study|Death|0|||
16348439|NCT00509899|39765397|FG004|Overall Study|Death|1|||
16348440|NCT00509899|39765398|FG005|Overall Study|Death|1|||
16348441|NCT00509899|39765399|FG006|Overall Study|Death|1|||
16348442|NCT00509899|39765400|FG007|Overall Study|Death|1|||
16348443|NCT00509899|39765393|FG000|Overall Study|Lack of Efficacy|1|||
16119728|NCT03752970|38927062|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
16119729|NCT03752970|38927060|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
16119730|NCT03752970|38927061|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
16119731|NCT03752970|38927062|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
16119732|NCT03752970|38927060|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
16119733|NCT03752970|38927061|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
16119734|NCT03752970|38927062|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
16119735|NCT04546425|38927063|FG000|Overall Study|Protocol Violation|1|||
16119736|NCT04546425|38927064|FG001|Overall Study|Protocol Violation|1|||
16119737|NCT04546425|38927065|FG002|Overall Study|Protocol Violation|0|||
16119738|NCT04546425|38927066|FG003|Overall Study|Protocol Violation|0|||
16119739|NCT04546425|38927063|FG000|Overall Study|Adverse Event|3|||
16119740|NCT04546425|38927064|FG001|Overall Study|Adverse Event|0|||
16119741|NCT04546425|38927065|FG002|Overall Study|Adverse Event|0|||
16119742|NCT04546425|38927066|FG003|Overall Study|Adverse Event|0|||
16119743|NCT04546425|38927063|FG000|Overall Study|Lost to Follow-up|5|||
16119744|NCT04546425|38927064|FG001|Overall Study|Lost to Follow-up|4|||
16119745|NCT04546425|38927065|FG002|Overall Study|Lost to Follow-up|0|||
16119746|NCT04546425|38927066|FG003|Overall Study|Lost to Follow-up|0|||
16119747|NCT04546425|38927063|FG000|Overall Study|No Longer met eligibility criteria|3|||
16119748|NCT04546425|38927064|FG001|Overall Study|No Longer met eligibility criteria|3|||
16119749|NCT04546425|38927065|FG002|Overall Study|No Longer met eligibility criteria|1|||
16119750|NCT04546425|38927066|FG003|Overall Study|No Longer met eligibility criteria|1|||
16119751|NCT04546425|38927063|FG000|Overall Study|Withdrawal by parent/guardian|6|||
16119752|NCT04546425|38927064|FG001|Overall Study|Withdrawal by parent/guardian|5|||
16119753|NCT04546425|38927065|FG002|Overall Study|Withdrawal by parent/guardian|1|||
16119754|NCT04546425|38927066|FG003|Overall Study|Withdrawal by parent/guardian|1|||
16119755|NCT01099215|38927067|FG000|Overall Study|Withdrawal by Subject|1|||
16119756|NCT01099215|38927068|FG001|Overall Study|Withdrawal by Subject|0|||
16119757|NCT01099215|38927067|FG000|Overall Study|Adverse Event|0|||
16119758|NCT01099215|38927068|FG001|Overall Study|Adverse Event|1|||
16119759|NCT00591851|38927069|FG000|Overall Study|Withdrawal by Subject|3|||
16119760|NCT00591851|38927069|FG000|Overall Study|Adverse Event|2|||
16119761|NCT00591851|38927069|FG000|Overall Study|Progressive Disease|1|||
16119762|NCT00468559|38927070|FG000|Open-label Treatment Phase|Adverse Event|5|||
16119763|NCT00468559|38927071|FG001|Open-label Treatment Phase|Adverse Event|0|||
16551778|NCT04567693|40484573|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
16551779|NCT01613027|40484576|FG000|Overall Study|Lost to Follow-up|5|||
16551780|NCT01613027|40484576|FG000|Overall Study|Switched Physician|1|||
16551781|NCT01613027|40484576|FG000|Overall Study|Lack of Efficacy|1|||
16551782|NCT01613027|40484576|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
16551783|NCT00924560|40484577|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
16551784|NCT00924560|40484578|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
16551785|NCT00924560|40484579|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
16551786|NCT00924560|40484577|FG000|Overall Study|Non Compliance with the Protocol|20|||
16551787|NCT00924560|40484578|FG001|Overall Study|Non Compliance with the Protocol|15|||
16551788|NCT00924560|40484579|FG002|Overall Study|Non Compliance with the Protocol|4|||
16551789|NCT00924560|40484577|FG000|Overall Study|Physician Decision|2|||
16551790|NCT00924560|40484578|FG001|Overall Study|Physician Decision|3|||
16551791|NCT00924560|40484579|FG002|Overall Study|Physician Decision|4|||
16119764|NCT00468559|38927072|FG002|Open-label Treatment Phase|Adverse Event|0|||
16119765|NCT00468559|38927070|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
16119766|NCT00468559|38927071|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
16119767|NCT00468559|38927072|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
16119768|NCT00468559|38927070|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
16119769|NCT00468559|38927071|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
16119770|NCT00468559|38927072|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
16119771|NCT00468559|38927070|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
16119772|NCT00468559|38927071|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
16119773|NCT00468559|38927072|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
16119774|NCT00468559|38927070|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
16119775|NCT00468559|38927071|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
16348444|NCT00509899|39765394|FG001|Overall Study|Lack of Efficacy|0|||
16348445|NCT00509899|39765395|FG002|Overall Study|Lack of Efficacy|2|||
16348446|NCT00509899|39765396|FG003|Overall Study|Lack of Efficacy|0|||
16348447|NCT00509899|39765397|FG004|Overall Study|Lack of Efficacy|0|||
16348448|NCT00509899|39765398|FG005|Overall Study|Lack of Efficacy|1|||
16348449|NCT00509899|39765399|FG006|Overall Study|Lack of Efficacy|0|||
16348450|NCT00509899|39765400|FG007|Overall Study|Lack of Efficacy|0|||
16348451|NCT00791999|39765401|FG000|Overall Study|Protocol planed withdrawal|14|||
16348452|NCT00791999|39765402|FG001|Overall Study|Protocol planed withdrawal|11|||
16348453|NCT00791999|39765403|FG002|Overall Study|Protocol planed withdrawal|11|||
16348454|NCT00791999|39765404|FG003|Overall Study|Protocol planed withdrawal|45|||
16348455|NCT00791999|39765401|FG000|Overall Study|Withdrawal by Subject|0|||
16348456|NCT00791999|39765402|FG001|Overall Study|Withdrawal by Subject|1|||
16348457|NCT00791999|39765403|FG002|Overall Study|Withdrawal by Subject|0|||
16348458|NCT00791999|39765404|FG003|Overall Study|Withdrawal by Subject|2|||
16348459|NCT00791999|39765401|FG000|Overall Study|Protocol Violation|3|||
16348460|NCT00791999|39765402|FG001|Overall Study|Protocol Violation|0|||
16348461|NCT00791999|39765403|FG002|Overall Study|Protocol Violation|1|||
16348462|NCT00791999|39765404|FG003|Overall Study|Protocol Violation|0|||
16348463|NCT00791999|39765401|FG000|Overall Study|Adverse Event|3|||
16348464|NCT00791999|39765402|FG001|Overall Study|Adverse Event|3|||
16348465|NCT00791999|39765403|FG002|Overall Study|Adverse Event|7|||
16348466|NCT00791999|39765404|FG003|Overall Study|Adverse Event|3|||
16348467|NCT00791999|39765401|FG000|Overall Study|Lack of Efficacy|0|||
16348468|NCT00791999|39765402|FG001|Overall Study|Lack of Efficacy|1|||
16348469|NCT00791999|39765403|FG002|Overall Study|Lack of Efficacy|0|||
16348470|NCT00791999|39765404|FG003|Overall Study|Lack of Efficacy|2|||
16348471|NCT00791999|39765401|FG000|Overall Study|Reason other than those above|1|||
16348472|NCT00791999|39765402|FG001|Overall Study|Reason other than those above|0|||
16348473|NCT00791999|39765403|FG002|Overall Study|Reason other than those above|1|||
16412977|NCT00907296|39992276|FG002|Overall Study|Adverse Event|0|||
16412978|NCT00907296|39992277|FG003|Overall Study|Adverse Event|0|||
16412979|NCT00907296|39992278|FG004|Overall Study|Adverse Event|0|||
16412980|NCT00907296|39992279|FG005|Overall Study|Adverse Event|0|||
16412981|NCT00907296|39992280|FG006|Overall Study|Adverse Event|1|||
16412982|NCT00907296|39992281|FG007|Overall Study|Adverse Event|0|||
16412983|NCT00907296|39992282|FG008|Overall Study|Adverse Event|0|||
16412984|NCT00907296|39992283|FG009|Overall Study|Adverse Event|1|||
16412985|NCT00907296|39992274|FG000|Overall Study|Withdrawal by Subject|7|||
16412986|NCT00907296|39992275|FG001|Overall Study|Withdrawal by Subject|2|||
16412987|NCT00907296|39992276|FG002|Overall Study|Withdrawal by Subject|1|||
16412988|NCT00907296|39992277|FG003|Overall Study|Withdrawal by Subject|1|||
16412989|NCT00907296|39992278|FG004|Overall Study|Withdrawal by Subject|1|||
16551792|NCT00924560|40484577|FG000|Overall Study|Withdrawal by Subject|50|||
16551793|NCT00924560|40484578|FG001|Overall Study|Withdrawal by Subject|44|||
16551794|NCT00924560|40484579|FG002|Overall Study|Withdrawal by Subject|18|||
16551795|NCT00924560|40484577|FG000|Overall Study|Adverse Event|39|||
16551796|NCT00924560|40484578|FG001|Overall Study|Adverse Event|33|||
16551797|NCT00924560|40484579|FG002|Overall Study|Adverse Event|0|||
16551798|NCT00924560|40484577|FG000|Overall Study|Pregnancy|5|||
16551799|NCT00924560|40484578|FG001|Overall Study|Pregnancy|7|||
16551800|NCT00924560|40484579|FG002|Overall Study|Pregnancy|1|||
16551801|NCT00924560|40484577|FG000|Overall Study|Lost to Follow-up|78|||
16551802|NCT00924560|40484578|FG001|Overall Study|Lost to Follow-up|94|||
16551803|NCT00924560|40484579|FG002|Overall Study|Lost to Follow-up|45|||
16551804|NCT00924560|40484577|FG000|Overall Study|Miscellaneous Reasons|13|||
16551805|NCT00924560|40484578|FG001|Overall Study|Miscellaneous Reasons|10|||
16348474|NCT00791999|39765404|FG003|Overall Study|Reason other than those above|0|||
16348475|NCT02959918|39765405|FG000|Overall Study|Adverse Event|1|||
16348476|NCT02959918|39765406|FG001|Overall Study|Adverse Event|1|||
16551806|NCT00924560|40484579|FG002|Overall Study|Miscellaneous Reasons|10|||
16551807|NCT03107377|40484587|FG000|Overall Study|Adverse Event|3|||
16551808|NCT03107377|40484588|FG001|Overall Study|Adverse Event|3|||
16551809|NCT03107377|40484587|FG000|Overall Study|Protocol Violation|9|||
16551810|NCT03107377|40484588|FG001|Overall Study|Protocol Violation|12|||
16551811|NCT03107377|40484587|FG000|Overall Study|Physician Decision|3|||
16551812|NCT03107377|40484588|FG001|Overall Study|Physician Decision|6|||
16551813|NCT03107377|40484587|FG000|Overall Study|Pregnancy|7|||
16551814|NCT03107377|40484588|FG001|Overall Study|Pregnancy|7|||
16551815|NCT03107377|40484587|FG000|Overall Study|Withdrawal by Subject|16|||
16551816|NCT03107377|40484588|FG001|Overall Study|Withdrawal by Subject|22|||
16551817|NCT03107377|40484587|FG000|Overall Study|Lost to Follow-up|37|||
16119776|NCT00468559|38927072|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
16119777|NCT04546217|38927077|FG000|Overall Study|Withdrawal by Subject|2|||
16119778|NCT04546217|38927078|FG001|Overall Study|Withdrawal by Subject|0|||
16119779|NCT04546217|38927077|FG000|Overall Study|Uncontrolled hypertension|1|||
16119780|NCT04546217|38927078|FG001|Overall Study|Uncontrolled hypertension|0|||
16551818|NCT03107377|40484588|FG001|Overall Study|Lost to Follow-up|34|||
16551819|NCT03107377|40484587|FG000|Overall Study|Other reason not specified|16|||
16551820|NCT03107377|40484588|FG001|Overall Study|Other reason not specified|15|||
16551821|NCT04248465|40484589|FG000|Randomized-Controlled Period|Death|12|||
16551822|NCT04248465|40484590|FG001|Randomized-Controlled Period|Death|5|||
16551823|NCT04248465|40484589|FG000|Randomized-Controlled Period|Adverse Event|2|||
16551824|NCT04248465|40484590|FG001|Randomized-Controlled Period|Adverse Event|0|||
16551825|NCT04248465|40484589|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
16551826|NCT04248465|40484590|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
16551827|NCT04248465|40484589|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
16551828|NCT04248465|40484590|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
16551829|NCT04248465|40484589|FG000|Randomized-Controlled Period|Physician Decision|1|||
16551830|NCT04248465|40484590|FG001|Randomized-Controlled Period|Physician Decision|1|||
16551831|NCT04248465|40484589|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
16551832|NCT04248465|40484590|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
16551833|NCT04248465|40484589|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
16551834|NCT04248465|40484590|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
16551835|NCT04248465|40484589|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
16551836|NCT04248465|40484590|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
16551837|NCT01248962|40484593|FG000|Overall Study|Withdrawal by Subject|1|||
16551838|NCT01248962|40484594|FG001|Overall Study|Withdrawal by Subject|1|||
16551839|NCT01248962|40484593|FG000|Overall Study|Adverse Event|2|||
16551840|NCT01248962|40484594|FG001|Overall Study|Adverse Event|1|||
16551841|NCT01248962|40484593|FG000|Overall Study|Complete Response after 4 Cycles|1|||
16551842|NCT01248962|40484594|FG001|Overall Study|Complete Response after 4 Cycles|0|||
16551843|NCT01248962|40484593|FG000|Overall Study|Complete Response after 3 Cycles|0|||
16551844|NCT01248962|40484594|FG001|Overall Study|Complete Response after 3 Cycles|1|||
16551845|NCT01248962|40484593|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
16551846|NCT01248962|40484594|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
16551847|NCT01775930|40484595|FG000|Overall Study|Futility stopping boundary met|1|||
16551848|NCT01382602|40484596|FG000|Overall Study|Protocol Violation|0|||
16551849|NCT01382602|40484597|FG001|Overall Study|Protocol Violation|3|||
16551850|NCT01382602|40484596|FG000|Overall Study|Withdrawal by Subject|0|||
16119781|NCT01827046|38927079|FG000|Overall Study|Lost to Follow-up|1|||
16119782|NCT01827046|38927080|FG001|Overall Study|Lost to Follow-up|5|||
16119783|NCT01827046|38927079|FG000|Overall Study|Withdrawal by Subject|0|||
16551851|NCT01382602|40484597|FG001|Overall Study|Withdrawal by Subject|1|||
16551852|NCT02684903|40484598|FG000|Overall Study|COVID-19 shutdown of lab|4|||
16551853|NCT02684903|40484599|FG001|Overall Study|COVID-19 shutdown of lab|6|||
16551854|NCT02684903|40484598|FG000|Overall Study|Lost to Follow-up|31|||
16119784|NCT01827046|38927080|FG001|Overall Study|Withdrawal by Subject|4|||
16119785|NCT02180243|38927085|FG000|Overall Study|Withdrawal by Subject|12|||
16551855|NCT02684903|40484599|FG001|Overall Study|Lost to Follow-up|41|||
16119786|NCT02180243|38927086|FG001|Overall Study|Withdrawal by Subject|12|||
16119787|NCT02180243|38927085|FG000|Overall Study|Lost to Follow-up|12|||
16119788|NCT02180243|38927086|FG001|Overall Study|Lost to Follow-up|2|||
16119789|NCT01077518|38927087|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
16119790|NCT01077518|38927088|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
16119791|NCT01077518|38927089|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
16119792|NCT01077518|38927087|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
16119793|NCT01077518|38927088|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
16119794|NCT01077518|38927089|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
16119795|NCT01077518|38927087|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
16119796|NCT01077518|38927088|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
16119797|NCT01077518|38927089|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
16119798|NCT01077518|38927087|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
16119799|NCT01077518|38927088|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
16119800|NCT01077518|38927089|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
16119801|NCT01077518|38927087|FG000|Optional Ofa Phase|Physician Decision|0|||
16119802|NCT01077518|38927088|FG001|Optional Ofa Phase|Physician Decision|0|||
16119803|NCT01077518|38927089|FG002|Optional Ofa Phase|Physician Decision|1|||
16119804|NCT01077518|38927087|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
16119805|NCT01077518|38927088|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
16119806|NCT01077518|38927089|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
16119807|NCT01077518|38927087|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
16119808|NCT01077518|38927088|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
16119809|NCT01077518|38927089|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
16119810|NCT02141620|38927090|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
16119811|NCT02141620|38927091|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
16119812|NCT00283244|38927092|FG000|Overall Study|Adverse Event|0|||
16119813|NCT00283244|38927093|FG001|Overall Study|Adverse Event|8|||
16119814|NCT00283244|38927094|FG002|Overall Study|Adverse Event|11|||
16119815|NCT00283244|38927092|FG000|Overall Study|Death|4|||
16119816|NCT00283244|38927093|FG001|Overall Study|Death|3|||
16119817|NCT00283244|38927094|FG002|Overall Study|Death|2|||
16119818|NCT00283244|38927092|FG000|Overall Study|Lack of Efficacy|8|||
16119819|NCT00283244|38927093|FG001|Overall Study|Lack of Efficacy|32|||
16119820|NCT00283244|38927094|FG002|Overall Study|Lack of Efficacy|26|||
16551856|NCT00621296|40484604|FG000|Overall Study|Adverse Event|2|||
16551857|NCT00621296|40484604|FG000|Overall Study|Lack of Efficacy|1|||
16551858|NCT00621296|40484604|FG000|Overall Study|Physician Decision|7|||
16551859|NCT00621296|40484604|FG000|Overall Study|Unmatch Criteria|1|||
16551860|NCT00621296|40484604|FG000|Overall Study|Stopping Criteria|3|||
16551861|NCT04091360|40484608|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
16551862|NCT04091360|40484609|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
16551863|NCT04091360|40484610|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
16551864|NCT04091360|40484611|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
16551865|NCT04091360|40484612|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
16551866|NCT04091360|40484613|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
16551867|NCT04091360|40484614|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
16119821|NCT00283244|38927092|FG000|Overall Study|Withdrawal by Subject|1|||
16119822|NCT00283244|38927093|FG001|Overall Study|Withdrawal by Subject|2|||
16119823|NCT00283244|38927094|FG002|Overall Study|Withdrawal by Subject|2|||
16119824|NCT00283244|38927092|FG000|Overall Study|Physician Decision|0|||
16119825|NCT00283244|38927093|FG001|Overall Study|Physician Decision|0|||
16119826|NCT00283244|38927094|FG002|Overall Study|Physician Decision|1|||
16119827|NCT00283244|38927092|FG000|Overall Study|Medical illness (other complicating dz)|4|||
16119828|NCT00283244|38927093|FG001|Overall Study|Medical illness (other complicating dz)|3|||
16119829|NCT00283244|38927094|FG002|Overall Study|Medical illness (other complicating dz)|6|||
16119830|NCT00283244|38927092|FG000|Overall Study|Clinical deterioration|1|||
16119831|NCT00283244|38927093|FG001|Overall Study|Clinical deterioration|3|||
16119832|NCT00283244|38927094|FG002|Overall Study|Clinical deterioration|3|||
16119833|NCT04617275|38927095|FG000|Treatment Period|Adverse Event|1|||
16119834|NCT04617275|38927096|FG001|Treatment Period|Adverse Event|6|||
16119835|NCT04617275|38927097|FG002|Treatment Period|Adverse Event|4|||
16119836|NCT04617275|38927098|FG003|Treatment Period|Adverse Event|6|||
16119837|NCT04617275|38927099|FG004|Treatment Period|Adverse Event|7|||
16119838|NCT04617275|38927100|FG005|Treatment Period|Adverse Event|8|||
16119839|NCT04617275|38927101|FG006|Treatment Period|Adverse Event|0|||
16119840|NCT04617275|38927102|FG007|Treatment Period|Adverse Event|12|||
16119841|NCT04617275|38927095|FG000|Treatment Period|Lost to Follow-up|0|||
16119842|NCT04617275|38927096|FG001|Treatment Period|Lost to Follow-up|0|||
16119843|NCT04617275|38927097|FG002|Treatment Period|Lost to Follow-up|2|||
16551868|NCT04091360|40484615|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
16551869|NCT04091360|40484616|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
16551870|NCT04091360|40484617|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
16551871|NCT04091360|40484608|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
16551872|NCT04091360|40484609|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
16551873|NCT04091360|40484610|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
16551874|NCT04091360|40484611|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
16551875|NCT04091360|40484612|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
16551876|NCT04091360|40484613|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
16551877|NCT04091360|40484614|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
16551878|NCT04091360|40484615|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
16551879|NCT04091360|40484616|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
16551880|NCT04091360|40484617|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
16551881|NCT04091360|40484608|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
16551882|NCT04091360|40484609|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
16551883|NCT04091360|40484610|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
16551884|NCT04091360|40484611|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
16551885|NCT04091360|40484612|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
16551886|NCT04091360|40484613|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
16119844|NCT04617275|38927098|FG003|Treatment Period|Lost to Follow-up|0|||
16119845|NCT04617275|38927099|FG004|Treatment Period|Lost to Follow-up|0|||
16119846|NCT04617275|38927100|FG005|Treatment Period|Lost to Follow-up|3|||
16119847|NCT04617275|38927101|FG006|Treatment Period|Lost to Follow-up|0|||
16119848|NCT04617275|38927102|FG007|Treatment Period|Lost to Follow-up|2|||
16119849|NCT04617275|38927095|FG000|Treatment Period|No longer meets eligibility criteria|0|||
16119850|NCT04617275|38927096|FG001|Treatment Period|No longer meets eligibility criteria|0|||
16119851|NCT04617275|38927097|FG002|Treatment Period|No longer meets eligibility criteria|0|||
16119852|NCT04617275|38927098|FG003|Treatment Period|No longer meets eligibility criteria|1|||
16119853|NCT04617275|38927099|FG004|Treatment Period|No longer meets eligibility criteria|0|||
16119854|NCT04617275|38927100|FG005|Treatment Period|No longer meets eligibility criteria|0|||
16119855|NCT04617275|38927101|FG006|Treatment Period|No longer meets eligibility criteria|0|||
16119856|NCT04617275|38927102|FG007|Treatment Period|No longer meets eligibility criteria|0|||
16119857|NCT04617275|38927095|FG000|Treatment Period|Other|0|||
16119858|NCT04617275|38927096|FG001|Treatment Period|Other|1|||
16119859|NCT04617275|38927097|FG002|Treatment Period|Other|0|||
16230887|NCT00828009|39328050|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
16230888|NCT00828009|39328050|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
16230889|NCT00828009|39328050|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
16230890|NCT00828009|39328050|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
16230891|NCT00828009|39328050|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
16230892|NCT00828009|39328050|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
16230893|NCT00828009|39328050|FG000|Step 2 - Maintenance Therapy|Death|1|||
16230894|NCT00828009|39328050|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
16230895|NCT00828009|39328050|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
16230896|NCT00828009|39328050|FG000|Step 2 - Maintenance Therapy|Other|1|||
16230897|NCT03466060|39328051|FG000|Period 1|Test Lens Damage|0|||
16230898|NCT03466060|39328052|FG001|Period 1|Test Lens Damage|2|||
16230899|NCT03466060|39328053|FG002|Period 1|Test Lens Damage|0|||
16230900|NCT03466060|39328054|FG003|Period 1|Test Lens Damage|0|||
16230901|NCT03466060|39328055|FG004|Period 1|Test Lens Damage|0|||
16230902|NCT03466060|39328056|FG005|Period 1|Test Lens Damage|0|||
16230903|NCT03466060|39328051|FG000|Period 1|Withdrawal by Subject|0|||
16348477|NCT02959918|39765407|FG002|Overall Study|Adverse Event|2|||
16348478|NCT02959918|39765408|FG003|Overall Study|Adverse Event|0|||
16348479|NCT02959918|39765409|FG004|Overall Study|Adverse Event|0|||
16348480|NCT02959918|39765410|FG005|Overall Study|Adverse Event|2|||
16348481|NCT02959918|39765411|FG006|Overall Study|Adverse Event|2|||
16348482|NCT02959918|39765412|FG007|Overall Study|Adverse Event|1|||
16348483|NCT02959918|39765413|FG008|Overall Study|Adverse Event|2|||
16348484|NCT02959918|39765414|FG009|Overall Study|Adverse Event|1|||
16348485|NCT02959918|39765415|FG010|Overall Study|Adverse Event|1|||
16348486|NCT02959918|39765416|FG011|Overall Study|Adverse Event|3|||
16348487|NCT02959918|39765417|FG012|Overall Study|Adverse Event|2|||
16348488|NCT02959918|39765418|FG013|Overall Study|Adverse Event|4|||
16348489|NCT02959918|39765405|FG000|Overall Study|Lost to Follow-up|0|||
16348490|NCT02959918|39765406|FG001|Overall Study|Lost to Follow-up|0|||
16348491|NCT02959918|39765407|FG002|Overall Study|Lost to Follow-up|0|||
16348492|NCT02959918|39765408|FG003|Overall Study|Lost to Follow-up|0|||
16348493|NCT02959918|39765409|FG004|Overall Study|Lost to Follow-up|0|||
16348494|NCT02959918|39765410|FG005|Overall Study|Lost to Follow-up|0|||
16348495|NCT02959918|39765411|FG006|Overall Study|Lost to Follow-up|0|||
16348496|NCT02959918|39765412|FG007|Overall Study|Lost to Follow-up|0|||
16348497|NCT02959918|39765413|FG008|Overall Study|Lost to Follow-up|0|||
16348498|NCT02959918|39765414|FG009|Overall Study|Lost to Follow-up|1|||
16348499|NCT02959918|39765415|FG010|Overall Study|Lost to Follow-up|0|||
16348500|NCT02959918|39765416|FG011|Overall Study|Lost to Follow-up|0|||
16348501|NCT02959918|39765417|FG012|Overall Study|Lost to Follow-up|1|||
16348502|NCT02959918|39765418|FG013|Overall Study|Lost to Follow-up|0|||
16230904|NCT03466060|39328052|FG001|Period 1|Withdrawal by Subject|0|||
16230905|NCT03466060|39328053|FG002|Period 1|Withdrawal by Subject|2|||
16230906|NCT03466060|39328054|FG003|Period 1|Withdrawal by Subject|0|||
16230907|NCT03466060|39328055|FG004|Period 1|Withdrawal by Subject|0|||
16230908|NCT03466060|39328056|FG005|Period 1|Withdrawal by Subject|0|||
16230909|NCT03466060|39328051|FG000|Period 1|Lost to Follow-up|0|||
16230910|NCT03466060|39328052|FG001|Period 1|Lost to Follow-up|0|||
16230911|NCT03466060|39328053|FG002|Period 1|Lost to Follow-up|0|||
16230912|NCT03466060|39328054|FG003|Period 1|Lost to Follow-up|1|||
16230913|NCT03466060|39328055|FG004|Period 1|Lost to Follow-up|0|||
16230914|NCT03466060|39328056|FG005|Period 1|Lost to Follow-up|0|||
16230915|NCT03466060|39328051|FG000|Period 1|Grade 2 Conjunctivitis|0|||
16230916|NCT03466060|39328052|FG001|Period 1|Grade 2 Conjunctivitis|0|||
16230917|NCT03466060|39328053|FG002|Period 1|Grade 2 Conjunctivitis|1|||
16230918|NCT03466060|39328054|FG003|Period 1|Grade 2 Conjunctivitis|0|||
16230919|NCT03466060|39328055|FG004|Period 1|Grade 2 Conjunctivitis|0|||
16230920|NCT03466060|39328056|FG005|Period 1|Grade 2 Conjunctivitis|0|||
16230921|NCT03466060|39328051|FG000|Period 2|Lens Handling Difficulties|0|||
16230922|NCT03466060|39328052|FG001|Period 2|Lens Handling Difficulties|0|||
16230923|NCT03466060|39328053|FG002|Period 2|Lens Handling Difficulties|1|||
16230924|NCT03466060|39328054|FG003|Period 2|Lens Handling Difficulties|0|||
16230925|NCT03466060|39328055|FG004|Period 2|Lens Handling Difficulties|0|||
16230926|NCT03466060|39328056|FG005|Period 2|Lens Handling Difficulties|0|||
16230927|NCT03186794|39328057|FG000|Overall Study|Physician Decision|2|||
16230928|NCT03186794|39328057|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
16230929|NCT00920582|39328059|FG000|Overall Study|Lost to Follow-up|5|||
16230930|NCT00920582|39328060|FG001|Overall Study|Lost to Follow-up|1|||
16230931|NCT00920582|39328061|FG002|Overall Study|Lost to Follow-up|2|||
16230932|NCT00920582|39328062|FG003|Overall Study|Lost to Follow-up|0|||
16230933|NCT00920582|39328059|FG000|Overall Study|Withdrawal by Subject|5|||
16230934|NCT00920582|39328060|FG001|Overall Study|Withdrawal by Subject|4|||
16230935|NCT00920582|39328061|FG002|Overall Study|Withdrawal by Subject|6|||
16230936|NCT00920582|39328062|FG003|Overall Study|Withdrawal by Subject|3|||
16230937|NCT00920582|39328059|FG000|Overall Study|Protocol Violation|1|||
16230938|NCT00920582|39328060|FG001|Overall Study|Protocol Violation|0|||
16230939|NCT00920582|39328061|FG002|Overall Study|Protocol Violation|0|||
16230940|NCT00920582|39328062|FG003|Overall Study|Protocol Violation|0|||
16230941|NCT00920582|39328059|FG000|Overall Study|Other|2|||
16230942|NCT00920582|39328060|FG001|Overall Study|Other|1|||
16230943|NCT00920582|39328061|FG002|Overall Study|Other|3|||
16230944|NCT00920582|39328062|FG003|Overall Study|Other|2|||
16230945|NCT01556490|39328066|FG000|Randomized Patients Summary|Protocol Violation|22|||
16230946|NCT01556490|39328067|FG001|Randomized Patients Summary|Protocol Violation|23|||
16230947|NCT01556490|39328066|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
16230948|NCT01556490|39328067|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
16230949|NCT01945866|39328068|FG000|Overall Study|Eyes did not complete or were dropped|2|||
16230950|NCT01945866|39328069|FG001|Overall Study|Eyes did not complete or were dropped|0|||
16230951|NCT01050998|39328070|FG000|Overall Study|Adverse Event|1|||
16230952|NCT01050998|39328071|FG001|Overall Study|Adverse Event|0|||
16230953|NCT01050998|39328072|FG002|Overall Study|Adverse Event|1|||
16230954|NCT01050998|39328073|FG003|Overall Study|Adverse Event|0|||
16230955|NCT01050998|39328074|FG004|Overall Study|Adverse Event|2|||
16230956|NCT01050998|39328070|FG000|Overall Study|Withdrawal by Subject|0|||
16230957|NCT01050998|39328071|FG001|Overall Study|Withdrawal by Subject|0|||
16230958|NCT01050998|39328072|FG002|Overall Study|Withdrawal by Subject|0|||
16230959|NCT01050998|39328073|FG003|Overall Study|Withdrawal by Subject|1|||
16230960|NCT01050998|39328074|FG004|Overall Study|Withdrawal by Subject|3|||
16230961|NCT01050998|39328070|FG000|Overall Study|Other|3|||
16230962|NCT01050998|39328071|FG001|Overall Study|Other|2|||
16230963|NCT01050998|39328072|FG002|Overall Study|Other|1|||
16230964|NCT01050998|39328073|FG003|Overall Study|Other|1|||
16230965|NCT01050998|39328074|FG004|Overall Study|Other|5|||
16230966|NCT01050998|39328070|FG000|Overall Study|Data integrity issues|0|||
16230967|NCT01050998|39328071|FG001|Overall Study|Data integrity issues|0|||
16230968|NCT01050998|39328072|FG002|Overall Study|Data integrity issues|1|||
16230969|NCT01050998|39328073|FG003|Overall Study|Data integrity issues|1|||
16230970|NCT01050998|39328074|FG004|Overall Study|Data integrity issues|4|||
16230971|NCT03155269|39328077|FG000|Overall Study|Withdrawal by Subject|4|||
16230972|NCT03155269|39328078|FG001|Overall Study|Withdrawal by Subject|5|||
16230973|NCT03155269|39328077|FG000|Overall Study|Lost to Follow-up|1|||
16119860|NCT04617275|38927098|FG003|Treatment Period|Other|0|||
16230974|NCT03155269|39328078|FG001|Overall Study|Lost to Follow-up|2|||
16230975|NCT00483717|39328079|FG000|Overall Study|Protocol Violation|5|||
16230976|NCT00483717|39328080|FG001|Overall Study|Protocol Violation|7|||
16230977|NCT00483717|39328079|FG000|Overall Study|Time of dosing missing|1|||
16230978|NCT00483717|39328080|FG001|Overall Study|Time of dosing missing|1|||
16230979|NCT00483717|39328079|FG000|Overall Study|No treatment for migraine|16|||
16230980|NCT00483717|39328080|FG001|Overall Study|No treatment for migraine|13|||
16230981|NCT00483717|39328079|FG000|Overall Study|Lost to Follow-up|1|||
16230982|NCT00483717|39328080|FG001|Overall Study|Lost to Follow-up|0|||
16230983|NCT00483717|39328079|FG000|Overall Study|Withdrawal by Subject|1|||
16230984|NCT00483717|39328080|FG001|Overall Study|Withdrawal by Subject|0|||
16230985|NCT00978120|39328084|FG000|Overall Study|Death|0|||
16230986|NCT00978120|39328085|FG001|Overall Study|Death|0|||
16230987|NCT00978120|39328086|FG002|Overall Study|Death|0|||
16230988|NCT00978120|39328087|FG003|Overall Study|Death|1|||
16230989|NCT00978120|39328084|FG000|Overall Study|Lost to Follow-up|0|||
16230990|NCT00978120|39328085|FG001|Overall Study|Lost to Follow-up|0|||
16230991|NCT00978120|39328086|FG002|Overall Study|Lost to Follow-up|3|||
16230992|NCT00978120|39328087|FG003|Overall Study|Lost to Follow-up|0|||
16230993|NCT00978120|39328084|FG000|Overall Study|Withdrawal by Subject|2|||
16230994|NCT00978120|39328085|FG001|Overall Study|Withdrawal by Subject|0|||
16230995|NCT00978120|39328086|FG002|Overall Study|Withdrawal by Subject|0|||
16230996|NCT00978120|39328087|FG003|Overall Study|Withdrawal by Subject|0|||
16230997|NCT00978120|39328084|FG000|Overall Study|Moved out of state|0|||
16230998|NCT00978120|39328085|FG001|Overall Study|Moved out of state|0|||
16230999|NCT00978120|39328086|FG002|Overall Study|Moved out of state|0|||
16231000|NCT00978120|39328087|FG003|Overall Study|Moved out of state|1|||
16231001|NCT00337727|39328088|FG000|Overall Study|Adverse Event|5|||
16231002|NCT00337727|39328089|FG001|Overall Study|Adverse Event|3|||
16231003|NCT00337727|39328088|FG000|Overall Study|Lost to Follow-up|5|||
16231004|NCT00337727|39328089|FG001|Overall Study|Lost to Follow-up|4|||
16231005|NCT00337727|39328088|FG000|Overall Study|Physician Decision|1|||
16231006|NCT00337727|39328089|FG001|Overall Study|Physician Decision|0|||
16231007|NCT00337727|39328088|FG000|Overall Study|Protocol Violation|4|||
16231008|NCT00337727|39328089|FG001|Overall Study|Protocol Violation|0|||
16231009|NCT00337727|39328088|FG000|Overall Study|Withdrawal by Subject|3|||
16231010|NCT00337727|39328089|FG001|Overall Study|Withdrawal by Subject|5|||
16231011|NCT02146365|39328091|FG000|Overall Study|Lost to Follow-up|2|||
16231012|NCT02146365|39328092|FG001|Overall Study|Lost to Follow-up|1|||
16231013|NCT02146365|39328093|FG002|Overall Study|Lost to Follow-up|3|||
16231014|NCT02146365|39328094|FG003|Overall Study|Lost to Follow-up|3|||
16231015|NCT02146365|39328095|FG004|Overall Study|Lost to Follow-up|1|||
16231016|NCT02146365|39328096|FG005|Overall Study|Lost to Follow-up|1|||
16231017|NCT02146365|39328097|FG006|Overall Study|Lost to Follow-up|0|||
16231018|NCT02146365|39328098|FG007|Overall Study|Lost to Follow-up|1|||
16231019|NCT02146365|39328091|FG000|Overall Study|Withdrawal by Subject|1|||
16231020|NCT02146365|39328092|FG001|Overall Study|Withdrawal by Subject|2|||
16231021|NCT02146365|39328093|FG002|Overall Study|Withdrawal by Subject|1|||
16231022|NCT02146365|39328094|FG003|Overall Study|Withdrawal by Subject|5|||
16231023|NCT02146365|39328095|FG004|Overall Study|Withdrawal by Subject|1|||
16231024|NCT02146365|39328096|FG005|Overall Study|Withdrawal by Subject|0|||
16231025|NCT02146365|39328097|FG006|Overall Study|Withdrawal by Subject|0|||
16231026|NCT02146365|39328098|FG007|Overall Study|Withdrawal by Subject|0|||
16231027|NCT02146365|39328091|FG000|Overall Study|Unable to Comply with Protocol|0|||
16231028|NCT02146365|39328092|FG001|Overall Study|Unable to Comply with Protocol|1|||
16231029|NCT02146365|39328093|FG002|Overall Study|Unable to Comply with Protocol|1|||
16231030|NCT02146365|39328094|FG003|Overall Study|Unable to Comply with Protocol|0|||
16231031|NCT02146365|39328095|FG004|Overall Study|Unable to Comply with Protocol|0|||
16231032|NCT02146365|39328096|FG005|Overall Study|Unable to Comply with Protocol|0|||
16231033|NCT02146365|39328097|FG006|Overall Study|Unable to Comply with Protocol|0|||
16231034|NCT02146365|39328098|FG007|Overall Study|Unable to Comply with Protocol|0|||
16231035|NCT02146365|39328091|FG000|Overall Study|Other|1|||
16231036|NCT02146365|39328092|FG001|Overall Study|Other|0|||
16231037|NCT02146365|39328093|FG002|Overall Study|Other|2|||
16231038|NCT02146365|39328094|FG003|Overall Study|Other|1|||
16231039|NCT02146365|39328095|FG004|Overall Study|Other|0|||
16231040|NCT02146365|39328096|FG005|Overall Study|Other|0|||
16231041|NCT02146365|39328097|FG006|Overall Study|Other|0|||
16231042|NCT02146365|39328098|FG007|Overall Study|Other|0|||
16231043|NCT04456998|39328099|FG000|Overall Study|Adverse Event|0|||
16231044|NCT04456998|39328100|FG001|Overall Study|Adverse Event|4|||
16231045|NCT04456998|39328099|FG000|Overall Study|Protocol Deviation|0|||
16231046|NCT04456998|39328100|FG001|Overall Study|Protocol Deviation|1|||
16231047|NCT04456998|39328099|FG000|Overall Study|Withdrawal by Subject|0|||
16231048|NCT04456998|39328100|FG001|Overall Study|Withdrawal by Subject|1|||
16231049|NCT03735680|39328101|FG000|Overall Study|Withdrawal by Subject|0|||
16231050|NCT03735680|39328102|FG001|Overall Study|Withdrawal by Subject|1|||
16231051|NCT03735680|39328103|FG002|Overall Study|Withdrawal by Subject|0|||
16231052|NCT03735680|39328104|FG003|Overall Study|Withdrawal by Subject|0|||
16231053|NCT03735680|39328105|FG004|Overall Study|Withdrawal by Subject|0|||
16119861|NCT04617275|38927099|FG004|Treatment Period|Other|0|||
16119862|NCT04617275|38927100|FG005|Treatment Period|Other|0|||
16119863|NCT04617275|38927101|FG006|Treatment Period|Other|0|||
16119864|NCT04617275|38927102|FG007|Treatment Period|Other|0|||
16119865|NCT04617275|38927095|FG000|Treatment Period|Withdrawal by Subject|2|||
16119866|NCT04617275|38927096|FG001|Treatment Period|Withdrawal by Subject|0|||
16119867|NCT04617275|38927097|FG002|Treatment Period|Withdrawal by Subject|0|||
16119868|NCT04617275|38927098|FG003|Treatment Period|Withdrawal by Subject|2|||
16119869|NCT04617275|38927099|FG004|Treatment Period|Withdrawal by Subject|2|||
16119870|NCT04617275|38927100|FG005|Treatment Period|Withdrawal by Subject|0|||
16119871|NCT04617275|38927101|FG006|Treatment Period|Withdrawal by Subject|1|||
16119872|NCT04617275|38927102|FG007|Treatment Period|Withdrawal by Subject|2|||
16119873|NCT04617275|38927095|FG000|Follow-up Period|Adverse Event|1|||
16119874|NCT04617275|38927096|FG001|Follow-up Period|Adverse Event|1|||
16119875|NCT04617275|38927097|FG002|Follow-up Period|Adverse Event|2|||
16119876|NCT04617275|38927098|FG003|Follow-up Period|Adverse Event|3|||
16119877|NCT04617275|38927099|FG004|Follow-up Period|Adverse Event|4|||
16119878|NCT04617275|38927100|FG005|Follow-up Period|Adverse Event|3|||
16119879|NCT04617275|38927101|FG006|Follow-up Period|Adverse Event|0|||
16119880|NCT04617275|38927102|FG007|Follow-up Period|Adverse Event|3|||
16119881|NCT04617275|38927095|FG000|Follow-up Period|Lost to Follow-up|0|||
16119882|NCT04617275|38927096|FG001|Follow-up Period|Lost to Follow-up|1|||
16119883|NCT04617275|38927097|FG002|Follow-up Period|Lost to Follow-up|2|||
16119884|NCT04617275|38927098|FG003|Follow-up Period|Lost to Follow-up|0|||
16119885|NCT04617275|38927099|FG004|Follow-up Period|Lost to Follow-up|0|||
16119886|NCT04617275|38927100|FG005|Follow-up Period|Lost to Follow-up|4|||
16119887|NCT04617275|38927101|FG006|Follow-up Period|Lost to Follow-up|0|||
16231054|NCT03735680|39328106|FG005|Overall Study|Withdrawal by Subject|1|||
16119888|NCT04617275|38927102|FG007|Follow-up Period|Lost to Follow-up|3|||
16119889|NCT04617275|38927095|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
16551887|NCT04091360|40484614|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
16551888|NCT04091360|40484615|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
16551889|NCT04091360|40484616|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
16551890|NCT04091360|40484617|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
16551891|NCT01582789|40484621|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
16551892|NCT01582789|40484622|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
16551893|NCT02533258|40484624|FG000|Overall Study|Adverse Event|1|||
16551894|NCT02533258|40484624|FG000|Overall Study|Death|2|||
16551895|NCT02533258|40484624|FG000|Overall Study|Other|1|||
16551896|NCT02533258|40484624|FG000|Overall Study|Economic factor|1|||
16551897|NCT02533258|40484624|FG000|Overall Study|Progression of pleural effusion|1|||
16551898|NCT02533258|40484624|FG000|Overall Study|Lack of Efficacy|2|||
16551899|NCT03154359|40484625|FG000|Overall Study|Adverse Event|1|||
16551900|NCT03154359|40484625|FG000|Overall Study|Lack of Efficacy|2|||
16551901|NCT03154359|40484625|FG000|Overall Study|Lost to Follow-up|3|||
16551902|NCT03154359|40484625|FG000|Overall Study|Physician Decision|3|||
16551903|NCT03154359|40484625|FG000|Overall Study|Protocol Violation|4|||
16551904|NCT03154359|40484625|FG000|Overall Study|Withdrawal by Subject|5|||
16551905|NCT03154359|40484625|FG000|Overall Study|Disruption of study due to COVID-19|4|||
16551906|NCT00636792|40484626|FG000|Overall Study|Adverse Event|16|||
16551907|NCT00636792|40484626|FG000|Overall Study|Physician Decision|7|||
16551908|NCT00636792|40484626|FG000|Overall Study|Progressive Disease|4|||
16551909|NCT00636792|40484626|FG000|Overall Study|Withdrawal by Subject|3|||
16551910|NCT00636792|40484626|FG000|Overall Study|Other|3|||
16551911|NCT02374593|40484628|FG000|Overall Study|non-compliant|2|||
16551912|NCT02374593|40484629|FG001|Overall Study|non-compliant|0|||
16551913|NCT01346514|40484630|FG000|Overall Study|Lost to Follow-up|19|||
16551914|NCT01346514|40484631|FG001|Overall Study|Lost to Follow-up|30|||
16551915|NCT01346514|40484630|FG000|Overall Study|Withdrawal by Subject|7|||
16551916|NCT01346514|40484631|FG001|Overall Study|Withdrawal by Subject|3|||
16551917|NCT01346514|40484630|FG000|Overall Study|Death|3|||
16551918|NCT01346514|40484631|FG001|Overall Study|Death|4|||
16551919|NCT03485911|40484636|FG000|Part 1|Perceived lack of efficacy|1|||
16551920|NCT03485911|40484637|FG001|Part 1|Perceived lack of efficacy|1|||
16551921|NCT03485911|40484638|FG002|Part 1|Perceived lack of efficacy|2|||
16551922|NCT03485911|40484639|FG003|Part 1|Perceived lack of efficacy|0|||
16551923|NCT03485911|40484636|FG000|Part 1|Subject withdrew consent|0|||
16551924|NCT03485911|40484637|FG001|Part 1|Subject withdrew consent|1|||
16551925|NCT03485911|40484638|FG002|Part 1|Subject withdrew consent|0|||
16551926|NCT03485911|40484639|FG003|Part 1|Subject withdrew consent|1|||
16551927|NCT03485911|40484636|FG000|Part 1|Lab abnormalities/AEs|3|||
16551928|NCT03485911|40484637|FG001|Part 1|Lab abnormalities/AEs|1|||
16551929|NCT03485911|40484638|FG002|Part 1|Lab abnormalities/AEs|1|||
16348503|NCT02959918|39765405|FG000|Overall Study|Withdrawal by Subject|0|||
16348504|NCT02959918|39765406|FG001|Overall Study|Withdrawal by Subject|0|||
16348505|NCT02959918|39765407|FG002|Overall Study|Withdrawal by Subject|1|||
16348506|NCT02959918|39765408|FG003|Overall Study|Withdrawal by Subject|2|||
16348507|NCT02959918|39765409|FG004|Overall Study|Withdrawal by Subject|0|||
16348508|NCT02959918|39765410|FG005|Overall Study|Withdrawal by Subject|0|||
16348509|NCT02959918|39765411|FG006|Overall Study|Withdrawal by Subject|1|||
16348510|NCT02959918|39765412|FG007|Overall Study|Withdrawal by Subject|0|||
16348511|NCT02959918|39765413|FG008|Overall Study|Withdrawal by Subject|1|||
16348512|NCT02959918|39765414|FG009|Overall Study|Withdrawal by Subject|1|||
16348513|NCT02959918|39765415|FG010|Overall Study|Withdrawal by Subject|2|||
16348514|NCT02959918|39765416|FG011|Overall Study|Withdrawal by Subject|3|||
16551930|NCT03485911|40484639|FG003|Part 1|Lab abnormalities/AEs|0|||
16551931|NCT03485911|40484636|FG000|Part 1|Withdrew Consent prior to dosing|0|||
16551932|NCT03485911|40484637|FG001|Part 1|Withdrew Consent prior to dosing|0|||
16551933|NCT03485911|40484638|FG002|Part 1|Withdrew Consent prior to dosing|0|||
16551934|NCT03485911|40484639|FG003|Part 1|Withdrew Consent prior to dosing|1|||
16551935|NCT03485911|40484636|FG000|Part 1|Other NOS|0|||
16551936|NCT03485911|40484637|FG001|Part 1|Other NOS|0|||
16551937|NCT03485911|40484638|FG002|Part 1|Other NOS|0|||
16551938|NCT03485911|40484639|FG003|Part 1|Other NOS|1|||
16551939|NCT03485911|40484636|FG000|Part 2|Perceived lack of efficacy|5|||
16348515|NCT02959918|39765417|FG012|Overall Study|Withdrawal by Subject|1|||
16348516|NCT02959918|39765418|FG013|Overall Study|Withdrawal by Subject|1|||
16348517|NCT02959918|39765405|FG000|Overall Study|Protocol Violation|0|||
16348518|NCT02959918|39765406|FG001|Overall Study|Protocol Violation|0|||
16348519|NCT02959918|39765407|FG002|Overall Study|Protocol Violation|1|||
16348520|NCT02959918|39765408|FG003|Overall Study|Protocol Violation|0|||
16348521|NCT02959918|39765409|FG004|Overall Study|Protocol Violation|0|||
16551940|NCT03485911|40484637|FG001|Part 2|Perceived lack of efficacy|3|||
16551941|NCT03485911|40484638|FG002|Part 2|Perceived lack of efficacy|0|||
16551942|NCT03485911|40484639|FG003|Part 2|Perceived lack of efficacy|2|||
16551943|NCT03485911|40484636|FG000|Part 2|Subject withdrew consent|1|||
16551944|NCT03485911|40484637|FG001|Part 2|Subject withdrew consent|0|||
16551945|NCT03485911|40484638|FG002|Part 2|Subject withdrew consent|2|||
16551946|NCT03485911|40484639|FG003|Part 2|Subject withdrew consent|1|||
16551947|NCT03485911|40484636|FG000|Part 2|Lab abnormalities/AEs|1|||
16551948|NCT03485911|40484637|FG001|Part 2|Lab abnormalities/AEs|2|||
16551949|NCT03485911|40484638|FG002|Part 2|Lab abnormalities/AEs|0|||
16551950|NCT03485911|40484639|FG003|Part 2|Lab abnormalities/AEs|0|||
16551951|NCT03485911|40484636|FG000|Part 2|Other NOS|0|||
16551952|NCT03485911|40484637|FG001|Part 2|Other NOS|1|||
16551953|NCT03485911|40484638|FG002|Part 2|Other NOS|0|||
16551954|NCT03485911|40484639|FG003|Part 2|Other NOS|0|||
16119890|NCT04617275|38927096|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
16119891|NCT04617275|38927097|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
16231055|NCT03735680|39328101|FG000|Overall Study|Patient unable or unwilling to continue|0|||
16231056|NCT03735680|39328102|FG001|Overall Study|Patient unable or unwilling to continue|0|||
16231057|NCT03735680|39328103|FG002|Overall Study|Patient unable or unwilling to continue|1|||
16231058|NCT03735680|39328104|FG003|Overall Study|Patient unable or unwilling to continue|0|||
16231059|NCT03735680|39328105|FG004|Overall Study|Patient unable or unwilling to continue|0|||
16231060|NCT03735680|39328106|FG005|Overall Study|Patient unable or unwilling to continue|0|||
16231061|NCT00604175|39328107|FG000|Entry Through Week 28|Death|2|||
16231062|NCT00604175|39328108|FG001|Entry Through Week 28|Death|0|||
16231063|NCT00604175|39328109|FG002|Entry Through Week 28|Death|0|||
16231064|NCT00604175|39328107|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
16231065|NCT00604175|39328108|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
16231066|NCT00604175|39328109|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
16231067|NCT00604175|39328107|FG000|Entry Through Week 28|Lost to Follow-up|4|||
16231068|NCT00604175|39328108|FG001|Entry Through Week 28|Lost to Follow-up|3|||
16231069|NCT00604175|39328109|FG002|Entry Through Week 28|Lost to Follow-up|0|||
16231070|NCT00604175|39328107|FG000|Entry Through Week 28|Ineligible|1|||
16231071|NCT00604175|39328108|FG001|Entry Through Week 28|Ineligible|0|||
16231072|NCT00604175|39328109|FG002|Entry Through Week 28|Ineligible|0|||
16231073|NCT00604175|39328107|FG000|Entry Through Week 28|Did not start intervention|2|||
16231074|NCT00604175|39328108|FG001|Entry Through Week 28|Did not start intervention|0|||
16231075|NCT00604175|39328109|FG002|Entry Through Week 28|Did not start intervention|1|||
16231076|NCT00604175|39328107|FG000|Week 29 Through Week 72|Death|0|||
16231077|NCT00604175|39328108|FG001|Week 29 Through Week 72|Death|0|||
16231078|NCT00604175|39328109|FG002|Week 29 Through Week 72|Death|1|||
16348522|NCT02959918|39765410|FG005|Overall Study|Protocol Violation|1|||
16348523|NCT02959918|39765411|FG006|Overall Study|Protocol Violation|0|||
16348524|NCT02959918|39765412|FG007|Overall Study|Protocol Violation|0|||
16551955|NCT03485911|40484636|FG000|Part 2|Intercurrent illness/new medical condition|1|||
16551956|NCT03485911|40484637|FG001|Part 2|Intercurrent illness/new medical condition|0|||
16551957|NCT03485911|40484638|FG002|Part 2|Intercurrent illness/new medical condition|0|||
16551958|NCT03485911|40484639|FG003|Part 2|Intercurrent illness/new medical condition|0|||
16551959|NCT03485911|40484636|FG000|Part 2|Investigator judgement|1|||
16551960|NCT03485911|40484637|FG001|Part 2|Investigator judgement|0|||
16551961|NCT03485911|40484638|FG002|Part 2|Investigator judgement|0|||
16551962|NCT03485911|40484639|FG003|Part 2|Investigator judgement|0|||
16551963|NCT03485911|40484636|FG000|Part 3|Perceived lack of efficacy|2|||
16551964|NCT03485911|40484637|FG001|Part 3|Perceived lack of efficacy|2|||
16551965|NCT03485911|40484638|FG002|Part 3|Perceived lack of efficacy|2|||
16551966|NCT03485911|40484639|FG003|Part 3|Perceived lack of efficacy|0|||
16551967|NCT03485911|40484636|FG000|Part 3|Subject withdrew consent|1|||
16551968|NCT03485911|40484637|FG001|Part 3|Subject withdrew consent|4|||
16551969|NCT03485911|40484638|FG002|Part 3|Subject withdrew consent|0|||
16551970|NCT03485911|40484639|FG003|Part 3|Subject withdrew consent|1|||
16551971|NCT03485911|40484636|FG000|Part 3|Lab abnormalities/AEs|1|||
16551972|NCT03485911|40484637|FG001|Part 3|Lab abnormalities/AEs|1|||
16551973|NCT03485911|40484638|FG002|Part 3|Lab abnormalities/AEs|0|||
16551974|NCT03485911|40484639|FG003|Part 3|Lab abnormalities/AEs|2|||
16348525|NCT02959918|39765413|FG008|Overall Study|Protocol Violation|2|||
16551975|NCT03485911|40484636|FG000|Part 3|Other NOS|1|||
16551976|NCT03485911|40484637|FG001|Part 3|Other NOS|1|||
16551977|NCT03485911|40484638|FG002|Part 3|Other NOS|0|||
16551978|NCT03485911|40484639|FG003|Part 3|Other NOS|0|||
16119892|NCT04617275|38927098|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
16119893|NCT04617275|38927099|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
16119894|NCT04617275|38927100|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
16119895|NCT04617275|38927101|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
16119896|NCT04617275|38927102|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
16119897|NCT04617275|38927095|FG000|Follow-up Period|Other|0|||
16119898|NCT04617275|38927096|FG001|Follow-up Period|Other|1|||
16119899|NCT04617275|38927097|FG002|Follow-up Period|Other|0|||
16119900|NCT04617275|38927098|FG003|Follow-up Period|Other|0|||
16119901|NCT04617275|38927099|FG004|Follow-up Period|Other|0|||
16119902|NCT04617275|38927100|FG005|Follow-up Period|Other|0|||
16119903|NCT04617275|38927101|FG006|Follow-up Period|Other|0|||
16119904|NCT04617275|38927102|FG007|Follow-up Period|Other|0|||
16119905|NCT04617275|38927095|FG000|Follow-up Period|Withdrawal by Subject|2|||
16119906|NCT04617275|38927096|FG001|Follow-up Period|Withdrawal by Subject|0|||
16119907|NCT04617275|38927097|FG002|Follow-up Period|Withdrawal by Subject|0|||
16119908|NCT04617275|38927098|FG003|Follow-up Period|Withdrawal by Subject|2|||
16119909|NCT04617275|38927099|FG004|Follow-up Period|Withdrawal by Subject|2|||
16119910|NCT04617275|38927100|FG005|Follow-up Period|Withdrawal by Subject|0|||
16119911|NCT04617275|38927101|FG006|Follow-up Period|Withdrawal by Subject|1|||
16119912|NCT04617275|38927102|FG007|Follow-up Period|Withdrawal by Subject|2|||
16551979|NCT03485911|40484636|FG000|Part 3|Intercurrent illness/new medical condition|0|||
16551980|NCT03485911|40484637|FG001|Part 3|Intercurrent illness/new medical condition|1|||
16551981|NCT03485911|40484638|FG002|Part 3|Intercurrent illness/new medical condition|1|||
16551982|NCT03485911|40484639|FG003|Part 3|Intercurrent illness/new medical condition|0|||
16551983|NCT03485911|40484636|FG000|Part 3|Sponsor discontinuation|1|||
16551984|NCT03485911|40484637|FG001|Part 3|Sponsor discontinuation|0|||
16551985|NCT03485911|40484638|FG002|Part 3|Sponsor discontinuation|0|||
16551986|NCT03485911|40484639|FG003|Part 3|Sponsor discontinuation|0|||
16119913|NCT01585155|38927103|FG000|Overall Study|Adverse Event|1|||
16119914|NCT01585155|38927103|FG000|Overall Study|Lack of Efficacy|2|||
16119915|NCT01585155|38927103|FG000|Overall Study|Worsening ulcerative colitis|2|||
16551987|NCT03485911|40484636|FG000|Part 3|Berotralstat provided by alternative means|13|||
16551988|NCT03485911|40484637|FG001|Part 3|Berotralstat provided by alternative means|13|||
16551989|NCT03485911|40484638|FG002|Part 3|Berotralstat provided by alternative means|7|||
16551990|NCT03485911|40484639|FG003|Part 3|Berotralstat provided by alternative means|7|||
16119916|NCT00534495|38927104|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
16119917|NCT00534495|38927105|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
16231079|NCT00604175|39328107|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
16231080|NCT00604175|39328108|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
16231081|NCT00604175|39328109|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
16231082|NCT00604175|39328107|FG000|Week 29 Through Week 72|Site closure|0|||
16231083|NCT00604175|39328108|FG001|Week 29 Through Week 72|Site closure|1|||
16231084|NCT00604175|39328109|FG002|Week 29 Through Week 72|Site closure|0|||
16231085|NCT00604175|39328107|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
16231086|NCT00604175|39328108|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
16231087|NCT00604175|39328109|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
16231088|NCT00807040|39328110|FG000|Overall Study|Death|24|||
16231089|NCT00807040|39328111|FG001|Overall Study|Death|29|||
16231090|NCT00807040|39328110|FG000|Overall Study|Withdrawal by Subject|8|||
16231091|NCT00807040|39328111|FG001|Overall Study|Withdrawal by Subject|6|||
16231092|NCT00807040|39328110|FG000|Overall Study|Lost to Follow-up|4|||
16231093|NCT00807040|39328111|FG001|Overall Study|Lost to Follow-up|6|||
16231094|NCT00945815|39328112|FG000|Overall Study|Death|3|||
16231095|NCT00945815|39328112|FG000|Overall Study|Not protocol specified|1|||
16231096|NCT00945815|39328112|FG000|Overall Study|Ineligible|3|||
16231097|NCT00945815|39328112|FG000|Overall Study|Did not begin protocol therapy|1|||
16231098|NCT03927846|39328113|FG000|Overall Study|Lost to Follow-up|10|||
16231099|NCT03927846|39328114|FG001|Overall Study|Lost to Follow-up|11|||
16231100|NCT03107715|39328115|FG000|Overall Study|did not deliver at the home hospital|4|||
16231101|NCT03107715|39328116|FG001|Overall Study|did not deliver at the home hospital|6|||
16231102|NCT03107715|39328115|FG000|Overall Study|infant stillborn|0|||
16231103|NCT03107715|39328116|FG001|Overall Study|infant stillborn|1|||
16231104|NCT00909857|39328118|FG000|Overall Study|Withdrawal by Subject|6|||
16231105|NCT00909857|39328119|FG001|Overall Study|Withdrawal by Subject|10|||
16231106|NCT00909857|39328118|FG000|Overall Study|Adverse Event|5|||
16231107|NCT00909857|39328119|FG001|Overall Study|Adverse Event|5|||
16231108|NCT00909857|39328118|FG000|Overall Study|Lost to Follow-up|2|||
16231109|NCT00909857|39328119|FG001|Overall Study|Lost to Follow-up|5|||
16231110|NCT00909857|39328118|FG000|Overall Study|Protocol Violation|2|||
16231111|NCT00909857|39328119|FG001|Overall Study|Protocol Violation|1|||
16231112|NCT00909857|39328118|FG000|Overall Study|Pregnancy|1|||
16231113|NCT00909857|39328119|FG001|Overall Study|Pregnancy|0|||
16231114|NCT00909857|39328118|FG000|Overall Study|Other|1|||
16231115|NCT00909857|39328119|FG001|Overall Study|Other|0|||
16231116|NCT00909857|39328118|FG000|Overall Study|Did not receive study medication|19|||
16231117|NCT00909857|39328119|FG001|Overall Study|Did not receive study medication|24|||
16231118|NCT04150107|39328122|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
16231119|NCT04150107|39328123|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
16231120|NCT04150107|39328122|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
16231121|NCT04150107|39328123|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
16231122|NCT01392469|39328126|FG000|Overall Study|Adverse Event|2|||
16231123|NCT01392469|39328126|FG000|Overall Study|Withdrawal by Subject|1|||
16231124|NCT01392469|39328126|FG000|Overall Study|Protocol Violation|1|||
16231125|NCT01958619|39328127|FG000|Overall Study|Protocol Violation|2|||
16231126|NCT01958619|39328128|FG001|Overall Study|Protocol Violation|0|||
16231127|NCT01958619|39328129|FG002|Overall Study|Protocol Violation|1|||
16231128|NCT01958619|39328130|FG003|Overall Study|Protocol Violation|0|||
16231129|NCT05102162|39328131|FG000|Overall Study|Withdrawal by Subject|3|||
16231130|NCT05102162|39328132|FG001|Overall Study|Withdrawal by Subject|0|||
16231131|NCT05102162|39328131|FG000|Overall Study|Baseline cultures negative|4|||
16231132|NCT05102162|39328132|FG001|Overall Study|Baseline cultures negative|2|||
16231133|NCT05102162|39328131|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
16231134|NCT05102162|39328132|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
16231135|NCT05102162|39328131|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
16231136|NCT05102162|39328132|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
16231137|NCT01891669|39328134|FG000|Overall Study|Death|0|||
16231138|NCT01891669|39328135|FG001|Overall Study|Death|0|||
16231139|NCT01891669|39328136|FG002|Overall Study|Death|0|||
16231140|NCT01891669|39328137|FG003|Overall Study|Death|0|||
16231141|NCT01891669|39328138|FG004|Overall Study|Death|0|||
16231142|NCT01891669|39328139|FG005|Overall Study|Death|0|||
16231143|NCT01891669|39328140|FG006|Overall Study|Death|0|||
16231144|NCT01891669|39328141|FG007|Overall Study|Death|1|||
16231145|NCT01891669|39328142|FG008|Overall Study|Death|0|||
16231146|NCT01891669|39328143|FG009|Overall Study|Death|1|||
16231147|NCT01891669|39328134|FG000|Overall Study|Withdrawal by Subject|1|||
16231148|NCT01891669|39328135|FG001|Overall Study|Withdrawal by Subject|1|||
16231149|NCT01891669|39328136|FG002|Overall Study|Withdrawal by Subject|0|||
16231150|NCT01891669|39328137|FG003|Overall Study|Withdrawal by Subject|0|||
16231151|NCT01891669|39328138|FG004|Overall Study|Withdrawal by Subject|0|||
16231152|NCT01891669|39328139|FG005|Overall Study|Withdrawal by Subject|0|||
16231153|NCT01891669|39328140|FG006|Overall Study|Withdrawal by Subject|1|||
16231154|NCT01891669|39328141|FG007|Overall Study|Withdrawal by Subject|2|||
16231155|NCT01891669|39328142|FG008|Overall Study|Withdrawal by Subject|1|||
16231156|NCT01891669|39328143|FG009|Overall Study|Withdrawal by Subject|1|||
16231157|NCT01891669|39328134|FG000|Overall Study|Other|1|||
16231158|NCT01891669|39328135|FG001|Overall Study|Other|0|||
16231159|NCT01891669|39328136|FG002|Overall Study|Other|0|||
16231160|NCT01891669|39328137|FG003|Overall Study|Other|0|||
16231161|NCT01891669|39328138|FG004|Overall Study|Other|0|||
16231162|NCT01891669|39328139|FG005|Overall Study|Other|0|||
16231163|NCT01891669|39328140|FG006|Overall Study|Other|0|||
16231164|NCT01891669|39328141|FG007|Overall Study|Other|1|||
16231165|NCT01891669|39328142|FG008|Overall Study|Other|0|||
16231166|NCT01891669|39328143|FG009|Overall Study|Other|0|||
16231167|NCT01418365|39328149|FG000|First Intervention|Withdrawal by Subject|0|||
16231168|NCT01418365|39328150|FG001|First Intervention|Withdrawal by Subject|1|||
16231169|NCT01418365|39328149|FG000|First Intervention|Non-compliance|1|||
16231170|NCT01418365|39328150|FG001|First Intervention|Non-compliance|0|||
16231171|NCT01418365|39328149|FG000|Second Intervention|Withdrawal by Subject|0|||
16231172|NCT01418365|39328150|FG001|Second Intervention|Withdrawal by Subject|1|||
16231173|NCT01761565|39328151|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
16231174|NCT01694849|39328154|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
16231175|NCT01694849|39328155|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
16231176|NCT01694849|39328156|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
16231177|NCT01694849|39328154|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
16231178|NCT01694849|39328155|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
16231179|NCT01694849|39328156|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
16231180|NCT01694849|39328154|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
16231181|NCT01694849|39328155|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
16231182|NCT01694849|39328156|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
16231183|NCT01694849|39328154|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
16231184|NCT01694849|39328155|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
16231185|NCT01694849|39328156|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
16231186|NCT01694849|39328154|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
16231187|NCT01694849|39328155|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
16231188|NCT01694849|39328156|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
16231189|NCT01694849|39328154|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
16231190|NCT01694849|39328155|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
16231191|NCT01694849|39328156|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
16231192|NCT01694849|39328154|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
16231193|NCT01694849|39328155|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
16231194|NCT01694849|39328156|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
16231195|NCT01694849|39328154|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
16231196|NCT01694849|39328155|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
16231197|NCT01694849|39328156|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
16231198|NCT03179462|39328159|FG000|Overall Study|screening failure|1|||
16231199|NCT03179462|39328160|FG001|Overall Study|screening failure|2|||
16231200|NCT03179462|39328161|FG002|Overall Study|screening failure|0|||
16231201|NCT01789476|39328162|FG000|Overall Study|Lack of Efficacy|6|||
16231202|NCT01789476|39328163|FG001|Overall Study|Lack of Efficacy|2|||
16231203|NCT01789476|39328162|FG000|Overall Study|Adverse Event|1|||
16231204|NCT01789476|39328163|FG001|Overall Study|Adverse Event|0|||
16231205|NCT01789476|39328162|FG000|Overall Study|Unable to get IV access|1|||
16348526|NCT02959918|39765414|FG009|Overall Study|Protocol Violation|1|||
16231206|NCT01789476|39328163|FG001|Overall Study|Unable to get IV access|0|||
16231207|NCT00346775|39328164|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
16231208|NCT00346775|39328165|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
16231209|NCT00346775|39328164|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
16231210|NCT00346775|39328165|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
16231211|NCT00346775|39328164|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
16231212|NCT00346775|39328165|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
16231213|NCT00761891|39328166|FG000|Overall Study|Withdrawal by Subject|10|||
16231214|NCT02797951|39328167|FG000|Overall Study|Adverse Event|4|||
16231215|NCT02797951|39328167|FG000|Overall Study|Death|1|||
16231216|NCT02797951|39328167|FG000|Overall Study|Lack of Efficacy|19|||
16231217|NCT02797951|39328167|FG000|Overall Study|Lost to Follow-up|4|||
16231218|NCT02797951|39328167|FG000|Overall Study|Physician Decision|6|||
16231219|NCT02797951|39328167|FG000|Overall Study|Withdrawal by Subject|15|||
16231220|NCT00859313|39328168|FG000|Overall Study|Lack of Efficacy|2|||
16231221|NCT00859313|39328168|FG000|Overall Study|Adverse Event|1|||
16231222|NCT00859313|39328168|FG000|Overall Study|staff error|1|||
16231223|NCT00314262|39328169|FG000|Overall Study|Adverse Event|2|||
16231224|NCT00314262|39328169|FG000|Overall Study|Withdrawal by Subject|2|||
16231225|NCT00314262|39328169|FG000|Overall Study|Physician Decision|1|||
16231226|NCT01319994|39328170|FG000|Overall Study|Protocol Violation|7|||
16231227|NCT01319994|39328171|FG001|Overall Study|Protocol Violation|6|||
16231228|NCT01275170|39328172|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
16231229|NCT01275170|39328173|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
16231230|NCT01275170|39328174|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
16231231|NCT01275170|39328175|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
16231232|NCT01275170|39328176|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
16231233|NCT01275170|39328177|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
16231234|NCT01275170|39328178|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
16231235|NCT01275170|39328179|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
16231236|NCT01808508|39328182|FG000|Overall Study|Lost to Follow-up|1|||
16231237|NCT01808508|39328183|FG001|Overall Study|Lost to Follow-up|0|||
16231238|NCT01808508|39328184|FG002|Overall Study|Lost to Follow-up|0|||
16231239|NCT02116309|39328185|FG000|Overall Study|Lost to Follow-up|0|||
16231240|NCT02116309|39328186|FG001|Overall Study|Lost to Follow-up|1|||
16231241|NCT00548340|39328187|FG000|Overall Study|Protocol Violation|2|||
16231242|NCT00548340|39328188|FG001|Overall Study|Protocol Violation|3|||
16231243|NCT00548340|39328189|FG002|Overall Study|Protocol Violation|3|||
16231244|NCT00548340|39328187|FG000|Overall Study|Adverse Event|2|||
16231245|NCT00548340|39328188|FG001|Overall Study|Adverse Event|2|||
16231246|NCT00548340|39328189|FG002|Overall Study|Adverse Event|2|||
16231247|NCT00548340|39328187|FG000|Overall Study|Lost to Follow-up|1|||
16231248|NCT00548340|39328188|FG001|Overall Study|Lost to Follow-up|1|||
16231249|NCT00548340|39328189|FG002|Overall Study|Lost to Follow-up|0|||
16231250|NCT00548340|39328187|FG000|Overall Study|Withdrawal by Subject|2|||
16231251|NCT00548340|39328188|FG001|Overall Study|Withdrawal by Subject|4|||
16231252|NCT00548340|39328189|FG002|Overall Study|Withdrawal by Subject|3|||
16231253|NCT00548340|39328187|FG000|Overall Study|Other|1|||
16231254|NCT00548340|39328188|FG001|Overall Study|Other|1|||
16231255|NCT00548340|39328189|FG002|Overall Study|Other|1|||
16231256|NCT00908375|39328190|FG000|Overall Study|Withdrawal by Subject|2|||
16231257|NCT00908375|39328191|FG001|Overall Study|Withdrawal by Subject|4|||
16231258|NCT00908375|39328190|FG000|Overall Study|Lost to Follow-up|8|||
16231259|NCT00908375|39328191|FG001|Overall Study|Lost to Follow-up|6|||
16231260|NCT01855607|39328192|FG000|Overall Study|Withdrawal by Subject|1|||
16231261|NCT01855607|39328192|FG000|Overall Study|Study was terminated|11|||
16231262|NCT01374516|39328193|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
16231263|NCT01374516|39328194|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
16231264|NCT01374516|39328193|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
16231265|NCT01374516|39328194|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
16231266|NCT01374516|39328193|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
16348527|NCT02959918|39765415|FG010|Overall Study|Protocol Violation|0|||
16231267|NCT01374516|39328194|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
16231268|NCT01374516|39328193|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
16231269|NCT01374516|39328194|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
16231270|NCT01374516|39328193|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
16231271|NCT01374516|39328194|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
16348528|NCT02959918|39765416|FG011|Overall Study|Protocol Violation|1|||
16119918|NCT00534495|38927106|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
16119919|NCT00534495|38927104|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
16119920|NCT00534495|38927105|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
16119921|NCT00534495|38927106|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
16119922|NCT00534495|38927104|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
16119923|NCT00534495|38927105|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
16231272|NCT01374516|39328193|FG000|Surveillance Expansion Period|Protocol Violation|386|||
16231273|NCT01374516|39328194|FG001|Surveillance Expansion Period|Protocol Violation|217|||
16231274|NCT01374516|39328193|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
16231275|NCT01374516|39328194|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
16231276|NCT01374516|39328193|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
16231277|NCT01374516|39328194|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
16231278|NCT01374516|39328193|FG000|Surveillance Expansion Period|Serious adverse event|20|||
16231279|NCT01374516|39328194|FG001|Surveillance Expansion Period|Serious adverse event|5|||
16231280|NCT00539006|39328195|FG000|Pre-treatment|Other|0|||
16231281|NCT00539006|39328196|FG001|Pre-treatment|Other|1|||
16231282|NCT00539006|39328197|FG002|Pre-treatment|Other|0|||
16231283|NCT00539006|39328198|FG003|Pre-treatment|Other|0|||
16231284|NCT00539006|39328195|FG000|Treatment Period 1|Lost to Follow-up|0|||
16231285|NCT00539006|39328196|FG001|Treatment Period 1|Lost to Follow-up|0|||
16231286|NCT00539006|39328197|FG002|Treatment Period 1|Lost to Follow-up|1|||
16231287|NCT00539006|39328198|FG003|Treatment Period 1|Lost to Follow-up|0|||
16231288|NCT00539006|39328195|FG000|Treatment Period 1|Protocol Violation|0|||
16231289|NCT00539006|39328196|FG001|Treatment Period 1|Protocol Violation|0|||
16231290|NCT00539006|39328197|FG002|Treatment Period 1|Protocol Violation|1|||
16231291|NCT00539006|39328198|FG003|Treatment Period 1|Protocol Violation|0|||
16231292|NCT00539006|39328195|FG000|Treatment Period 1|Lack of Efficacy|0|||
16231293|NCT00539006|39328196|FG001|Treatment Period 1|Lack of Efficacy|0|||
16231294|NCT00539006|39328197|FG002|Treatment Period 1|Lack of Efficacy|0|||
16231295|NCT00539006|39328198|FG003|Treatment Period 1|Lack of Efficacy|1|||
16231296|NCT00539006|39328195|FG000|Washout|Adverse Event|2|||
16231297|NCT00539006|39328196|FG001|Washout|Adverse Event|1|||
16231298|NCT00539006|39328197|FG002|Washout|Adverse Event|0|||
16231299|NCT00539006|39328198|FG003|Washout|Adverse Event|0|||
16231300|NCT00539006|39328195|FG000|Washout|Protocol Violation|1|||
16231301|NCT00539006|39328196|FG001|Washout|Protocol Violation|1|||
16231302|NCT00539006|39328197|FG002|Washout|Protocol Violation|0|||
16348529|NCT02959918|39765417|FG012|Overall Study|Protocol Violation|1|||
16348530|NCT02959918|39765418|FG013|Overall Study|Protocol Violation|0|||
16551991|NCT03853317|40484640|FG000|Overall Study|Progressive Disease|5|||
16551992|NCT03853317|40484640|FG000|Overall Study|Adverse Event|1|||
16551993|NCT03853317|40484640|FG000|Overall Study|Death|1|||
16551994|NCT03853317|40484640|FG000|Overall Study|other event|2|||
16551995|NCT02443103|40484641|FG000|Overall Study|Adverse Event|2|||
16551996|NCT02443103|40484641|FG000|Overall Study|Noncompliance|1|||
16551997|NCT04521621|40484642|FG000|Overall Study|Death|17|||
16551998|NCT04521621|40484643|FG001|Overall Study|Death|8|||
16551999|NCT04521621|40484644|FG002|Overall Study|Death|8|||
16552000|NCT04521621|40484645|FG003|Overall Study|Death|5|||
16552001|NCT04521621|40484646|FG004|Overall Study|Death|2|||
16552002|NCT04521621|40484647|FG005|Overall Study|Death|7|||
16552003|NCT04521621|40484648|FG006|Overall Study|Death|0|||
16552004|NCT04521621|40484649|FG007|Overall Study|Death|0|||
16552005|NCT04521621|40484642|FG000|Overall Study|Study Terminated by Sponsor|4|||
16552006|NCT04521621|40484643|FG001|Overall Study|Study Terminated by Sponsor|6|||
16552007|NCT04521621|40484644|FG002|Overall Study|Study Terminated by Sponsor|8|||
16552008|NCT04521621|40484645|FG003|Overall Study|Study Terminated by Sponsor|0|||
16552009|NCT04521621|40484646|FG004|Overall Study|Study Terminated by Sponsor|1|||
16552010|NCT04521621|40484647|FG005|Overall Study|Study Terminated by Sponsor|7|||
16552011|NCT04521621|40484648|FG006|Overall Study|Study Terminated by Sponsor|0|||
16552012|NCT04521621|40484649|FG007|Overall Study|Study Terminated by Sponsor|0|||
16552013|NCT04521621|40484642|FG000|Overall Study|Withdrawal by Subject|0|||
16552014|NCT04521621|40484643|FG001|Overall Study|Withdrawal by Subject|0|||
16552015|NCT04521621|40484644|FG002|Overall Study|Withdrawal by Subject|1|||
16552016|NCT04521621|40484645|FG003|Overall Study|Withdrawal by Subject|1|||
16552017|NCT04521621|40484646|FG004|Overall Study|Withdrawal by Subject|0|||
16231303|NCT00539006|39328198|FG003|Washout|Protocol Violation|0|||
16231304|NCT00539006|39328195|FG000|Washout|Withdrawal by Subject|0|||
16231305|NCT00539006|39328196|FG001|Washout|Withdrawal by Subject|2|||
16348531|NCT02959918|39765405|FG000|Overall Study|Stopping Rule Met|1|||
16348532|NCT02959918|39765406|FG001|Overall Study|Stopping Rule Met|0|||
16552018|NCT04521621|40484647|FG005|Overall Study|Withdrawal by Subject|0|||
16552019|NCT04521621|40484648|FG006|Overall Study|Withdrawal by Subject|0|||
16231306|NCT00539006|39328197|FG002|Washout|Withdrawal by Subject|0|||
16231307|NCT00539006|39328198|FG003|Washout|Withdrawal by Subject|0|||
16348533|NCT02959918|39765407|FG002|Overall Study|Stopping Rule Met|3|||
16552020|NCT04521621|40484649|FG007|Overall Study|Withdrawal by Subject|0|||
16552021|NCT04521621|40484642|FG000|Overall Study|Allocated in error without study intervention|1|||
16552022|NCT04521621|40484643|FG001|Overall Study|Allocated in error without study intervention|0|||
16552023|NCT04521621|40484644|FG002|Overall Study|Allocated in error without study intervention|0|||
16552024|NCT04521621|40484645|FG003|Overall Study|Allocated in error without study intervention|0|||
16552025|NCT04521621|40484646|FG004|Overall Study|Allocated in error without study intervention|0|||
16552026|NCT04521621|40484647|FG005|Overall Study|Allocated in error without study intervention|0|||
16552027|NCT04521621|40484648|FG006|Overall Study|Allocated in error without study intervention|0|||
16552028|NCT04521621|40484649|FG007|Overall Study|Allocated in error without study intervention|0|||
16552029|NCT02959671|40484650|FG000|Overall Study|Adverse Event|2|||
16552030|NCT02959671|40484650|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
16552031|NCT04250337|40484651|FG000|Overall Study|Adverse Event|0|||
16552032|NCT04250337|40484652|FG001|Overall Study|Adverse Event|3|||
16552033|NCT04250337|40484651|FG000|Overall Study|Lack of Efficacy|1|||
16552034|NCT04250337|40484652|FG001|Overall Study|Lack of Efficacy|3|||
16552035|NCT04250337|40484651|FG000|Overall Study|Physician Decision|1|||
16552036|NCT04250337|40484652|FG001|Overall Study|Physician Decision|0|||
16552037|NCT04250337|40484651|FG000|Overall Study|Protocol Deviation|2|||
16552038|NCT04250337|40484652|FG001|Overall Study|Protocol Deviation|2|||
16552039|NCT04250337|40484651|FG000|Overall Study|Withdrawal by Subject|4|||
16552040|NCT04250337|40484652|FG001|Overall Study|Withdrawal by Subject|3|||
16552041|NCT01216176|40484653|FG000|Overall Study|Adverse Event|0|||
16552042|NCT01216176|40484654|FG001|Overall Study|Adverse Event|8|||
16552043|NCT01216176|40484655|FG002|Overall Study|Adverse Event|0|||
16552044|NCT01216176|40484653|FG000|Overall Study|Physician Decision|0|||
16552045|NCT01216176|40484654|FG001|Overall Study|Physician Decision|0|||
16552046|NCT01216176|40484655|FG002|Overall Study|Physician Decision|1|||
16552047|NCT02791490|40484658|FG000|Overall Study|Lost to Follow-up|1|||
16552048|NCT02791490|40484659|FG001|Overall Study|Lost to Follow-up|2|||
16552049|NCT02791490|40484658|FG000|Overall Study|Withdrawal by Subject|2|||
16552050|NCT02791490|40484659|FG001|Overall Study|Withdrawal by Subject|6|||
16552051|NCT01018563|40484660|FG000|Overall Study|Termination of the study by Sponsor|2|||
16552052|NCT01018563|40484661|FG001|Overall Study|Termination of the study by Sponsor|1|||
16552053|NCT01478113|40484662|FG000|Overall Study|Withdrawal by Subject|0|||
16552054|NCT01478113|40484663|FG001|Overall Study|Withdrawal by Subject|1|||
16552055|NCT01478113|40484662|FG000|Overall Study|Physician Decision|1|||
16552056|NCT01478113|40484663|FG001|Overall Study|Physician Decision|0|||
16552057|NCT00088205|40484666|FG000|Overall Study|Adverse Event|4|||
16552058|NCT00088205|40484666|FG000|Overall Study|Progressive Disease|51|||
16552059|NCT00088205|40484666|FG000|Overall Study|Physician Decision|1|||
16552060|NCT00088205|40484666|FG000|Overall Study|Death Due to Study Disease|4|||
16552061|NCT01830881|40484667|FG000|Overall Study|Changed decision to have an abortion|0|||
16552062|NCT01830881|40484668|FG001|Overall Study|Changed decision to have an abortion|1|||
16552063|NCT02757521|40484669|FG000|Overall Study|Adverse Event|1|||
16552064|NCT02757521|40484670|FG001|Overall Study|Adverse Event|0|||
16552065|NCT01370603|40484671|FG000|Period 1|Adverse Event|5|||
16552066|NCT01370603|40484672|FG001|Period 1|Adverse Event|3|||
16119924|NCT00534495|38927106|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
16119925|NCT00534495|38927104|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
16552067|NCT01370603|40484671|FG000|Period 1|Lost to Follow-up|2|||
16552068|NCT01370603|40484672|FG001|Period 1|Lost to Follow-up|0|||
16552069|NCT01370603|40484671|FG000|Period 1|Protocol Violation|2|||
16552070|NCT01370603|40484672|FG001|Period 1|Protocol Violation|2|||
16552071|NCT01370603|40484671|FG000|Period 1|Withdrawal by Subject|5|||
16119926|NCT00534495|38927105|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
16119927|NCT00534495|38927106|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
16119928|NCT00534495|38927104|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
16119929|NCT00534495|38927105|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
16119930|NCT00534495|38927106|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
16119931|NCT00534495|38927104|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
16119932|NCT00534495|38927105|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
16119933|NCT00534495|38927106|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
16119934|NCT00534495|38927104|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
16119935|NCT00534495|38927105|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
16119936|NCT00534495|38927106|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
16552072|NCT01370603|40484672|FG001|Period 1|Withdrawal by Subject|5|||
16552073|NCT01370603|40484671|FG000|Crossover Washout|Adverse Event|2|||
16552074|NCT01370603|40484672|FG001|Crossover Washout|Adverse Event|1|||
16552075|NCT01370603|40484671|FG000|Crossover Washout|Lost to Follow-up|2|||
16552076|NCT01370603|40484672|FG001|Crossover Washout|Lost to Follow-up|0|||
16552077|NCT01370603|40484671|FG000|Crossover Washout|Protocol Violation|1|||
16552078|NCT01370603|40484672|FG001|Crossover Washout|Protocol Violation|0|||
16552079|NCT01370603|40484671|FG000|Crossover Washout|Withdrawal by Subject|4|||
16552080|NCT01370603|40484672|FG001|Crossover Washout|Withdrawal by Subject|1|||
16552081|NCT01370603|40484671|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
16552082|NCT01370603|40484672|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
16552083|NCT01370603|40484671|FG000|Period 2|Adverse Event|1|||
16552084|NCT01370603|40484672|FG001|Period 2|Adverse Event|4|||
16552085|NCT01370603|40484671|FG000|Period 2|Lost to Follow-up|1|||
16552086|NCT01370603|40484672|FG001|Period 2|Lost to Follow-up|0|||
16552087|NCT01370603|40484671|FG000|Period 2|Withdrawal by Subject|1|||
16552088|NCT01370603|40484672|FG001|Period 2|Withdrawal by Subject|0|||
16552089|NCT00390455|40484676|FG000|Overall Study|Adverse Event|17|||
16552090|NCT00390455|40484677|FG001|Overall Study|Adverse Event|3|||
16552091|NCT00390455|40484676|FG000|Overall Study|Withdrawal by Subject|8|||
16119937|NCT00534495|38927104|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
16119938|NCT00534495|38927105|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
16119939|NCT00534495|38927106|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
16119940|NCT00534495|38927104|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
16119941|NCT00534495|38927105|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
16119942|NCT00534495|38927106|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
16119943|NCT00586612|38927107|FG000|Primary Phase|Protocol Violation|1|||
16119944|NCT00586612|38927108|FG001|Primary Phase|Protocol Violation|0|||
16119945|NCT00586612|38927107|FG000|Primary Phase|Lost to Follow-up|0|||
16119946|NCT00586612|38927108|FG001|Primary Phase|Lost to Follow-up|1|||
16119947|NCT00586612|38927107|FG000|Primary Phase|Withdrawal by Subject|0|||
16119948|NCT00586612|38927108|FG001|Primary Phase|Withdrawal by Subject|2|||
16119949|NCT00586612|38927107|FG000|Booster Phase|Lost to Follow-up|3|||
16119950|NCT00586612|38927108|FG001|Booster Phase|Lost to Follow-up|1|||
16119951|NCT01782690|38927109|FG000|Overall Study|Not reported|7|||
16119952|NCT01782690|38927109|FG000|Overall Study|Toxicity of gemcitabine|1|||
16119953|NCT01782690|38927109|FG000|Overall Study|Toxicity of erlotinib|1|||
16119954|NCT01782690|38927109|FG000|Overall Study|Lost to Follow-up|31|||
16119955|NCT01782690|38927109|FG000|Overall Study|Withdrawal of informed consent|2|||
16119956|NCT01782690|38927109|FG000|Overall Study|Absent rash|9|||
16119957|NCT01782690|38927109|FG000|Overall Study|Physician Decision|13|||
16119958|NCT01782690|38927109|FG000|Overall Study|Patient's wish|21|||
16119959|NCT01782690|38927109|FG000|Overall Study|Tumor progression|74|||
16119960|NCT01782690|38927109|FG000|Overall Study|Death|133|||
16119961|NCT01782690|38927109|FG000|Overall Study|Study completion unknown|7|||
16119962|NCT01646177|38927110|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
16119963|NCT01646177|38927111|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
16119964|NCT01646177|38927112|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
16119965|NCT01646177|38927113|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
16119966|NCT01646177|38927114|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16119967|NCT01646177|38927115|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16119968|NCT01646177|38927116|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16119969|NCT01646177|38927117|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16119970|NCT01646177|38927118|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16119971|NCT01646177|38927119|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16119972|NCT01646177|38927120|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16119973|NCT01646177|38927121|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
16119974|NCT01646177|38927110|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
16119975|NCT01646177|38927111|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
16119976|NCT01646177|38927112|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
16552092|NCT00390455|40484677|FG001|Overall Study|Withdrawal by Subject|8|||
16552093|NCT00390455|40484676|FG000|Overall Study|Alternate Treatment|0|||
16119977|NCT01646177|38927113|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
16552094|NCT00390455|40484677|FG001|Overall Study|Alternate Treatment|1|||
16552095|NCT00390455|40484676|FG000|Overall Study|Other Medical Reasons|7|||
16412990|NCT00907296|39992279|FG005|Overall Study|Withdrawal by Subject|5|||
16412991|NCT00907296|39992280|FG006|Overall Study|Withdrawal by Subject|3|||
16412992|NCT00907296|39992281|FG007|Overall Study|Withdrawal by Subject|2|||
16412993|NCT00907296|39992282|FG008|Overall Study|Withdrawal by Subject|4|||
16348534|NCT02959918|39765408|FG003|Overall Study|Stopping Rule Met|4|||
16348535|NCT02959918|39765409|FG004|Overall Study|Stopping Rule Met|5|||
16348536|NCT02959918|39765410|FG005|Overall Study|Stopping Rule Met|3|||
16348537|NCT02959918|39765411|FG006|Overall Study|Stopping Rule Met|2|||
16348538|NCT02959918|39765412|FG007|Overall Study|Stopping Rule Met|4|||
16348539|NCT02959918|39765413|FG008|Overall Study|Stopping Rule Met|1|||
16348540|NCT02959918|39765414|FG009|Overall Study|Stopping Rule Met|1|||
16348541|NCT02959918|39765415|FG010|Overall Study|Stopping Rule Met|3|||
16348542|NCT02959918|39765416|FG011|Overall Study|Stopping Rule Met|5|||
16348543|NCT02959918|39765417|FG012|Overall Study|Stopping Rule Met|2|||
16348544|NCT02959918|39765418|FG013|Overall Study|Stopping Rule Met|1|||
16412994|NCT00907296|39992283|FG009|Overall Study|Withdrawal by Subject|2|||
16552096|NCT00390455|40484677|FG001|Overall Study|Other Medical Reasons|11|||
16552097|NCT04880161|40484679|FG000|Overall Study|Withdrawal by Subject|1|||
16552098|NCT04880161|40484680|FG001|Overall Study|Withdrawal by Subject|0|||
16552099|NCT04880161|40484679|FG000|Overall Study|Lack of Compliance|1|||
16552100|NCT04880161|40484680|FG001|Overall Study|Lack of Compliance|1|||
16552101|NCT04880161|40484679|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
16552102|NCT04880161|40484680|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
16552103|NCT04880161|40484679|FG000|Overall Study|Screen Failure|0|||
16552104|NCT04880161|40484680|FG001|Overall Study|Screen Failure|1|||
16552105|NCT03075904|40484687|FG000|Overall Study|Physician Decision|3|||
16552106|NCT03075904|40484687|FG000|Overall Study|Need for Medication not Permitted|1|||
16552107|NCT01317875|40484688|FG000|Overall Study|Other|0|||
16552108|NCT01317875|40484689|FG001|Overall Study|Other|0|||
16348545|NCT02959918|39765405|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
16412995|NCT00907296|39992274|FG000|Overall Study|Lost to Follow-up|9|||
16412996|NCT00907296|39992275|FG001|Overall Study|Lost to Follow-up|1|||
16119978|NCT01646177|38927114|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16119979|NCT01646177|38927115|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16119980|NCT01646177|38927116|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16119981|NCT01646177|38927117|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16119982|NCT01646177|38927118|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16552109|NCT01317875|40484690|FG002|Overall Study|Other|1|||
16552110|NCT01317875|40484691|FG003|Overall Study|Other|0|||
16552111|NCT01317875|40484692|FG004|Overall Study|Other|0|||
16552112|NCT01317875|40484693|FG005|Overall Study|Other|0|||
16552113|NCT01317875|40484694|FG006|Overall Study|Other|0|||
16552114|NCT01317875|40484695|FG007|Overall Study|Other|0|||
16552115|NCT01317875|40484696|FG008|Overall Study|Other|0|||
16552116|NCT01317875|40484697|FG009|Overall Study|Other|0|||
16552117|NCT01317875|40484688|FG000|Overall Study|Noncompliance with study drug|0|||
16552118|NCT01317875|40484689|FG001|Overall Study|Noncompliance with study drug|0|||
16552119|NCT01317875|40484690|FG002|Overall Study|Noncompliance with study drug|1|||
16552120|NCT01317875|40484691|FG003|Overall Study|Noncompliance with study drug|0|||
16552121|NCT01317875|40484692|FG004|Overall Study|Noncompliance with study drug|0|||
16552122|NCT01317875|40484693|FG005|Overall Study|Noncompliance with study drug|0|||
16552123|NCT01317875|40484694|FG006|Overall Study|Noncompliance with study drug|0|||
16552124|NCT01317875|40484695|FG007|Overall Study|Noncompliance with study drug|0|||
16552125|NCT01317875|40484696|FG008|Overall Study|Noncompliance with study drug|0|||
16552126|NCT01317875|40484697|FG009|Overall Study|Noncompliance with study drug|0|||
16119983|NCT01646177|38927119|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16119984|NCT01646177|38927120|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16119985|NCT01646177|38927121|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
16119986|NCT01646177|38927110|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
16119987|NCT01646177|38927111|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
16119988|NCT01646177|38927112|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
16119989|NCT01646177|38927113|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
16119990|NCT01646177|38927114|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16119991|NCT01646177|38927115|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16119992|NCT01646177|38927116|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16119993|NCT01646177|38927117|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16119994|NCT01646177|38927118|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16119995|NCT01646177|38927119|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16119996|NCT01646177|38927120|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16119997|NCT01646177|38927121|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
16231308|NCT00539006|39328195|FG000|Washout|Failed to meet continuation criteria|16|||
16231309|NCT00539006|39328196|FG001|Washout|Failed to meet continuation criteria|5|||
16231310|NCT00539006|39328197|FG002|Washout|Failed to meet continuation criteria|14|||
16552127|NCT01317875|40484688|FG000|Overall Study|Progressive Disease|1|||
16412997|NCT00907296|39992276|FG002|Overall Study|Lost to Follow-up|0|||
16412998|NCT00907296|39992277|FG003|Overall Study|Lost to Follow-up|2|||
16412999|NCT00907296|39992278|FG004|Overall Study|Lost to Follow-up|0|||
16413000|NCT00907296|39992279|FG005|Overall Study|Lost to Follow-up|3|||
16413001|NCT00907296|39992280|FG006|Overall Study|Lost to Follow-up|2|||
16413002|NCT00907296|39992281|FG007|Overall Study|Lost to Follow-up|2|||
16413003|NCT00907296|39992282|FG008|Overall Study|Lost to Follow-up|0|||
16413004|NCT00907296|39992283|FG009|Overall Study|Lost to Follow-up|4|||
16413005|NCT01719003|39992284|FG000|Overall Study|Non compliant with protocol|1|||
16413006|NCT01719003|39992285|FG001|Overall Study|Non compliant with protocol|1|||
16413007|NCT01719003|39992286|FG002|Overall Study|Non compliant with protocol|0|||
16413008|NCT01719003|39992287|FG003|Overall Study|Non compliant with protocol|1|||
16413009|NCT01719003|39992288|FG004|Overall Study|Non compliant with protocol|2|||
16413010|NCT01719003|39992289|FG005|Overall Study|Non compliant with protocol|1|||
16413011|NCT01719003|39992290|FG006|Overall Study|Non compliant with protocol|2|||
16413012|NCT01719003|39992291|FG007|Overall Study|Non compliant with protocol|3|||
16413013|NCT01719003|39992292|FG008|Overall Study|Non compliant with protocol|0|||
16413014|NCT01719003|39992284|FG000|Overall Study|Adverse Event|6|||
16413015|NCT01719003|39992285|FG001|Overall Study|Adverse Event|5|||
16413016|NCT01719003|39992286|FG002|Overall Study|Adverse Event|4|||
16413017|NCT01719003|39992287|FG003|Overall Study|Adverse Event|3|||
16413018|NCT01719003|39992288|FG004|Overall Study|Adverse Event|4|||
16413019|NCT01719003|39992289|FG005|Overall Study|Adverse Event|3|||
16413020|NCT01719003|39992290|FG006|Overall Study|Adverse Event|6|||
16413021|NCT01719003|39992291|FG007|Overall Study|Adverse Event|5|||
16348546|NCT02959918|39765406|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
16348547|NCT02959918|39765407|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
16348548|NCT02959918|39765408|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
16348549|NCT02959918|39765409|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
16348550|NCT02959918|39765410|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
16348551|NCT02959918|39765411|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
16348552|NCT02959918|39765412|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
16348553|NCT02959918|39765413|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
16348554|NCT02959918|39765414|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
16348555|NCT02959918|39765415|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
16348556|NCT02959918|39765416|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
16348557|NCT02959918|39765417|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
16348558|NCT02959918|39765418|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
16348559|NCT02959918|39765405|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16413022|NCT01719003|39992292|FG008|Overall Study|Adverse Event|0|||
16413023|NCT01719003|39992284|FG000|Overall Study|Lost to Follow-up|0|||
16413024|NCT01719003|39992285|FG001|Overall Study|Lost to Follow-up|6|||
16413025|NCT01719003|39992286|FG002|Overall Study|Lost to Follow-up|7|||
16119998|NCT01646177|38927110|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
16348560|NCT02959918|39765406|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16413026|NCT01719003|39992287|FG003|Overall Study|Lost to Follow-up|2|||
16413027|NCT01719003|39992288|FG004|Overall Study|Lost to Follow-up|3|||
16413028|NCT01719003|39992289|FG005|Overall Study|Lost to Follow-up|4|||
16413029|NCT01719003|39992290|FG006|Overall Study|Lost to Follow-up|3|||
16413030|NCT01719003|39992291|FG007|Overall Study|Lost to Follow-up|2|||
16413031|NCT01719003|39992292|FG008|Overall Study|Lost to Follow-up|2|||
16413032|NCT01719003|39992284|FG000|Overall Study|Refusal to continue, not due to AE|2|||
16413033|NCT01719003|39992285|FG001|Overall Study|Refusal to continue, not due to AE|5|||
16413034|NCT01719003|39992286|FG002|Overall Study|Refusal to continue, not due to AE|4|||
16413035|NCT01719003|39992287|FG003|Overall Study|Refusal to continue, not due to AE|4|||
16413036|NCT01719003|39992288|FG004|Overall Study|Refusal to continue, not due to AE|4|||
16413037|NCT01719003|39992289|FG005|Overall Study|Refusal to continue, not due to AE|3|||
16413038|NCT01719003|39992290|FG006|Overall Study|Refusal to continue, not due to AE|8|||
16413039|NCT01719003|39992291|FG007|Overall Study|Refusal to continue, not due to AE|7|||
16413040|NCT01719003|39992292|FG008|Overall Study|Refusal to continue, not due to AE|1|||
16413041|NCT01719003|39992284|FG000|Overall Study|Reason other than those specified|0|||
16413042|NCT01719003|39992285|FG001|Overall Study|Reason other than those specified|0|||
16413043|NCT01719003|39992286|FG002|Overall Study|Reason other than those specified|2|||
16552128|NCT01317875|40484689|FG001|Overall Study|Progressive Disease|0|||
16552129|NCT01317875|40484690|FG002|Overall Study|Progressive Disease|2|||
16552130|NCT01317875|40484691|FG003|Overall Study|Progressive Disease|0|||
16552131|NCT01317875|40484692|FG004|Overall Study|Progressive Disease|1|||
16552132|NCT01317875|40484693|FG005|Overall Study|Progressive Disease|0|||
16552133|NCT01317875|40484694|FG006|Overall Study|Progressive Disease|0|||
16552134|NCT01317875|40484695|FG007|Overall Study|Progressive Disease|1|||
16552135|NCT01317875|40484696|FG008|Overall Study|Progressive Disease|0|||
16231311|NCT00539006|39328198|FG003|Washout|Failed to meet continuation criteria|6|||
16552136|NCT01317875|40484697|FG009|Overall Study|Progressive Disease|0|||
16552137|NCT01317875|40484688|FG000|Overall Study|Withdrawal by Subject|0|||
16552138|NCT01317875|40484689|FG001|Overall Study|Withdrawal by Subject|0|||
16552139|NCT01317875|40484690|FG002|Overall Study|Withdrawal by Subject|0|||
16552140|NCT01317875|40484691|FG003|Overall Study|Withdrawal by Subject|0|||
16552141|NCT01317875|40484692|FG004|Overall Study|Withdrawal by Subject|1|||
16552142|NCT01317875|40484693|FG005|Overall Study|Withdrawal by Subject|0|||
16552143|NCT01317875|40484694|FG006|Overall Study|Withdrawal by Subject|0|||
16552144|NCT01317875|40484695|FG007|Overall Study|Withdrawal by Subject|3|||
16552145|NCT01317875|40484696|FG008|Overall Study|Withdrawal by Subject|0|||
16552146|NCT01317875|40484697|FG009|Overall Study|Withdrawal by Subject|0|||
16552147|NCT01317875|40484688|FG000|Overall Study|Physician Decision|0|||
16552148|NCT01317875|40484689|FG001|Overall Study|Physician Decision|1|||
16552149|NCT01317875|40484690|FG002|Overall Study|Physician Decision|1|||
16552150|NCT01317875|40484691|FG003|Overall Study|Physician Decision|0|||
16552151|NCT01317875|40484692|FG004|Overall Study|Physician Decision|2|||
16552152|NCT01317875|40484693|FG005|Overall Study|Physician Decision|0|||
16552153|NCT01317875|40484694|FG006|Overall Study|Physician Decision|0|||
16552154|NCT01317875|40484695|FG007|Overall Study|Physician Decision|2|||
16552155|NCT01317875|40484696|FG008|Overall Study|Physician Decision|0|||
16552156|NCT01317875|40484697|FG009|Overall Study|Physician Decision|0|||
16552157|NCT01317875|40484688|FG000|Overall Study|Death|0|||
16119999|NCT01646177|38927111|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
16120000|NCT01646177|38927112|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
16120001|NCT01646177|38927113|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
16120002|NCT01646177|38927114|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16120003|NCT01646177|38927115|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16120004|NCT01646177|38927116|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16120005|NCT01646177|38927117|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16231312|NCT00539006|39328195|FG000|Washout|Other|1|||
16231313|NCT00539006|39328196|FG001|Washout|Other|1|||
16231314|NCT00539006|39328197|FG002|Washout|Other|2|||
16231315|NCT00539006|39328198|FG003|Washout|Other|3|||
16231316|NCT00539006|39328195|FG000|Treatment Period 2|Protocol Violation|1|||
16231317|NCT00539006|39328196|FG001|Treatment Period 2|Protocol Violation|0|||
16231318|NCT00539006|39328197|FG002|Treatment Period 2|Protocol Violation|0|||
16231319|NCT00539006|39328198|FG003|Treatment Period 2|Protocol Violation|0|||
16231320|NCT00539006|39328195|FG000|Treatment Period 2|Other|0|||
16231321|NCT00539006|39328196|FG001|Treatment Period 2|Other|1|||
16231322|NCT00539006|39328197|FG002|Treatment Period 2|Other|0|||
16231323|NCT00539006|39328198|FG003|Treatment Period 2|Other|0|||
16231324|NCT03586427|39328201|FG000|Overall Study|Lost to Follow-up|0|||
16231325|NCT03586427|39328202|FG001|Overall Study|Lost to Follow-up|3|||
16231326|NCT03586427|39328203|FG002|Overall Study|Lost to Follow-up|1|||
16231327|NCT03586427|39328204|FG003|Overall Study|Lost to Follow-up|3|||
16231328|NCT03586427|39328205|FG004|Overall Study|Lost to Follow-up|3|||
16231329|NCT03586427|39328201|FG000|Overall Study|Withdrawal by Subject|0|||
16231330|NCT03586427|39328202|FG001|Overall Study|Withdrawal by Subject|1|||
16231331|NCT03586427|39328203|FG002|Overall Study|Withdrawal by Subject|2|||
16231332|NCT03586427|39328204|FG003|Overall Study|Withdrawal by Subject|1|||
16231333|NCT03586427|39328205|FG004|Overall Study|Withdrawal by Subject|1|||
16231334|NCT03586427|39328201|FG000|Overall Study|Adverse Event|0|||
16231335|NCT03586427|39328202|FG001|Overall Study|Adverse Event|0|||
16231336|NCT03586427|39328203|FG002|Overall Study|Adverse Event|1|||
16231337|NCT03586427|39328204|FG003|Overall Study|Adverse Event|0|||
16231338|NCT03586427|39328205|FG004|Overall Study|Adverse Event|0|||
16231339|NCT03586427|39328201|FG000|Overall Study|Protocol Violation|0|||
16231340|NCT03586427|39328202|FG001|Overall Study|Protocol Violation|0|||
16231341|NCT03586427|39328203|FG002|Overall Study|Protocol Violation|1|||
16231342|NCT03586427|39328204|FG003|Overall Study|Protocol Violation|0|||
16231343|NCT03586427|39328205|FG004|Overall Study|Protocol Violation|1|||
16231344|NCT03586427|39328201|FG000|Overall Study|Noncompliance with study drug|0|||
16231345|NCT03586427|39328202|FG001|Overall Study|Noncompliance with study drug|0|||
16231346|NCT03586427|39328203|FG002|Overall Study|Noncompliance with study drug|1|||
16231347|NCT03586427|39328204|FG003|Overall Study|Noncompliance with study drug|0|||
16231348|NCT03586427|39328205|FG004|Overall Study|Noncompliance with study drug|0|||
16231349|NCT00326625|39328206|FG000|Overall Study|Adverse Event|20|||
16231350|NCT00326625|39328207|FG001|Overall Study|Adverse Event|9|||
16231351|NCT00326625|39328206|FG000|Overall Study|Withdrawal by Subject|15|||
16231352|NCT00326625|39328207|FG001|Overall Study|Withdrawal by Subject|12|||
16231353|NCT00326625|39328206|FG000|Overall Study|Death|18|||
16231354|NCT00326625|39328207|FG001|Overall Study|Death|16|||
16231355|NCT00326625|39328206|FG000|Overall Study|Lost to Follow-up|1|||
16231356|NCT00326625|39328207|FG001|Overall Study|Lost to Follow-up|0|||
16231357|NCT00326625|39328206|FG000|Overall Study|prescheduled medical intervention|0|||
16231358|NCT00326625|39328207|FG001|Overall Study|prescheduled medical intervention|1|||
16231359|NCT00381680|39328208|FG000|Overall Study|Adverse Event|9|||
16231360|NCT00381680|39328209|FG001|Overall Study|Adverse Event|3|||
16231361|NCT00381680|39328208|FG000|Overall Study|Death|10|||
16231362|NCT00381680|39328209|FG001|Overall Study|Death|7|||
16231363|NCT00381680|39328208|FG000|Overall Study|Lost to Follow-up|3|||
16231364|NCT00381680|39328209|FG001|Overall Study|Lost to Follow-up|2|||
16348561|NCT02959918|39765407|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16348562|NCT02959918|39765408|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16231365|NCT00381680|39328208|FG000|Overall Study|Physician Decision|25|||
16231366|NCT00381680|39328209|FG001|Overall Study|Physician Decision|6|||
16231367|NCT00381680|39328208|FG000|Overall Study|Withdrawal by Subject|3|||
16231368|NCT00381680|39328209|FG001|Overall Study|Withdrawal by Subject|1|||
16231369|NCT00381680|39328208|FG000|Overall Study|Entry onto another COG Trial|1|||
16231370|NCT00381680|39328209|FG001|Overall Study|Entry onto another COG Trial|2|||
16231371|NCT00381680|39328208|FG000|Overall Study|Alternative Therapy|11|||
16231372|NCT00381680|39328209|FG001|Overall Study|Alternative Therapy|5|||
16231373|NCT00381680|39328208|FG000|Overall Study|Secondary Malignancy|3|||
16231374|NCT00381680|39328209|FG001|Overall Study|Secondary Malignancy|0|||
16231375|NCT00381680|39328208|FG000|Overall Study|Delay initiation|1|||
16231376|NCT00381680|39328209|FG001|Overall Study|Delay initiation|0|||
16231377|NCT00381680|39328208|FG000|Overall Study|Stem Cell Transplant|26|||
16231378|NCT00381680|39328209|FG001|Overall Study|Stem Cell Transplant|10|||
16231379|NCT00381680|39328208|FG000|Overall Study|Relapse|18|||
16231380|NCT00381680|39328209|FG001|Overall Study|Relapse|9|||
16231381|NCT00381680|39328208|FG000|Overall Study|Induction Failure|4|||
16231382|NCT00381680|39328209|FG001|Overall Study|Induction Failure|1|||
16231383|NCT00381680|39328208|FG000|Overall Study|Progression|1|||
16231384|NCT00381680|39328209|FG001|Overall Study|Progression|1|||
16231385|NCT00381680|39328208|FG000|Overall Study|Other not otherwise specified|7|||
16231386|NCT00381680|39328209|FG001|Overall Study|Other not otherwise specified|2|||
16413044|NCT01719003|39992287|FG003|Overall Study|Reason other than those specified|3|||
16413045|NCT01719003|39992288|FG004|Overall Study|Reason other than those specified|4|||
16413046|NCT01719003|39992289|FG005|Overall Study|Reason other than those specified|1|||
16413047|NCT01719003|39992290|FG006|Overall Study|Reason other than those specified|0|||
16413048|NCT01719003|39992291|FG007|Overall Study|Reason other than those specified|3|||
16413049|NCT01719003|39992292|FG008|Overall Study|Reason other than those specified|1|||
16413050|NCT01719003|39992284|FG000|Overall Study|Lack of Efficacy|0|||
16413051|NCT01719003|39992285|FG001|Overall Study|Lack of Efficacy|0|||
16413052|NCT01719003|39992286|FG002|Overall Study|Lack of Efficacy|0|||
16413053|NCT01719003|39992287|FG003|Overall Study|Lack of Efficacy|0|||
16413054|NCT01719003|39992288|FG004|Overall Study|Lack of Efficacy|0|||
16413055|NCT01719003|39992289|FG005|Overall Study|Lack of Efficacy|0|||
16413056|NCT01719003|39992290|FG006|Overall Study|Lack of Efficacy|1|||
16413057|NCT01719003|39992291|FG007|Overall Study|Lack of Efficacy|0|||
16413058|NCT01719003|39992292|FG008|Overall Study|Lack of Efficacy|0|||
16413059|NCT01100528|39992296|FG000|Overall Study|Death|1|||
16413060|NCT01100528|39992296|FG000|Overall Study|Withdrawal by Subject|2|||
16413061|NCT03474081|39995015|FG000|Overall Study|Adverse Event|6|||
16413062|NCT03474081|39995016|FG001|Overall Study|Adverse Event|3|||
16413063|NCT03474081|39995015|FG000|Overall Study|Lost to Follow-up|2|||
16413064|NCT03474081|39995016|FG001|Overall Study|Lost to Follow-up|1|||
16413065|NCT03474081|39995015|FG000|Overall Study|Physician Decision|3|||
16413066|NCT03474081|39995016|FG001|Overall Study|Physician Decision|2|||
16413067|NCT03474081|39995015|FG000|Overall Study|Withdrawal by Subject|5|||
16413068|NCT03474081|39995016|FG001|Overall Study|Withdrawal by Subject|7|||
16413069|NCT03474081|39995015|FG000|Overall Study|Investigator site closed|1|||
16413070|NCT03474081|39995016|FG001|Overall Study|Investigator site closed|0|||
16413071|NCT02565810|39995017|FG000|Overall Study|Withdrawal by Subject|1|||
16413072|NCT02712424|39995018|FG000|Overall Study|Lost to Follow-up|34|||
16413073|NCT02712424|39995019|FG001|Overall Study|Lost to Follow-up|32|||
16413074|NCT03515941|39995020|FG000|Overall Study|Adverse Event|1|||
16413075|NCT03515941|39995021|FG001|Overall Study|Adverse Event|0|||
16413076|NCT00454649|39995022|FG000|Overall Study|Lack of Efficacy|2|||
16413077|NCT00454649|39995023|FG001|Overall Study|Lack of Efficacy|2|||
16413078|NCT00454649|39995024|FG002|Overall Study|Lack of Efficacy|10|||
16413079|NCT00454649|39995025|FG003|Overall Study|Lack of Efficacy|3|||
16413080|NCT00454649|39995026|FG004|Overall Study|Lack of Efficacy|0|||
16413081|NCT00454649|39995027|FG005|Overall Study|Lack of Efficacy|4|||
16413082|NCT00454649|39995028|FG006|Overall Study|Lack of Efficacy|5|||
16413083|NCT00454649|39995029|FG007|Overall Study|Lack of Efficacy|13|||
16413084|NCT00454649|39995030|FG008|Overall Study|Lack of Efficacy|10|||
16413085|NCT00454649|39995031|FG009|Overall Study|Lack of Efficacy|2|||
16413086|NCT00454649|39995022|FG000|Overall Study|Adverse Event|0|||
16413087|NCT00454649|39995023|FG001|Overall Study|Adverse Event|1|||
16413088|NCT00454649|39995024|FG002|Overall Study|Adverse Event|3|||
16413089|NCT00454649|39995025|FG003|Overall Study|Adverse Event|0|||
16413090|NCT00454649|39995026|FG004|Overall Study|Adverse Event|1|||
16413091|NCT00454649|39995027|FG005|Overall Study|Adverse Event|2|||
16413092|NCT00454649|39995028|FG006|Overall Study|Adverse Event|3|||
16413093|NCT00454649|39995029|FG007|Overall Study|Adverse Event|4|||
16413094|NCT00454649|39995030|FG008|Overall Study|Adverse Event|6|||
16413095|NCT00454649|39995031|FG009|Overall Study|Adverse Event|2|||
16413096|NCT00454649|39995022|FG000|Overall Study|Lost to Follow-up|0|||
16552158|NCT01317875|40484689|FG001|Overall Study|Death|0|||
16552159|NCT01317875|40484690|FG002|Overall Study|Death|2|||
16552160|NCT01317875|40484691|FG003|Overall Study|Death|1|||
16552161|NCT01317875|40484692|FG004|Overall Study|Death|0|||
16552162|NCT01317875|40484693|FG005|Overall Study|Death|1|||
16552163|NCT01317875|40484694|FG006|Overall Study|Death|0|||
16231387|NCT00381680|39328208|FG000|Overall Study|Ineligible|3|||
16231388|NCT00381680|39328209|FG001|Overall Study|Ineligible|1|||
16413097|NCT00454649|39995023|FG001|Overall Study|Lost to Follow-up|0|||
16413098|NCT00454649|39995024|FG002|Overall Study|Lost to Follow-up|1|||
16413099|NCT00454649|39995025|FG003|Overall Study|Lost to Follow-up|0|||
16552164|NCT01317875|40484695|FG007|Overall Study|Death|4|||
16231389|NCT01798056|39328212|FG000|Overall Study|Serious Adverse Event|13|||
16231390|NCT01798056|39328213|FG001|Overall Study|Serious Adverse Event|12|||
16231391|NCT01798056|39328212|FG000|Overall Study|Withdrawal by Subject|12|||
16231392|NCT01798056|39328213|FG001|Overall Study|Withdrawal by Subject|9|||
16231393|NCT01798056|39328212|FG000|Overall Study|Migrated/moved from study area|1|||
16231394|NCT01798056|39328213|FG001|Overall Study|Migrated/moved from study area|1|||
16231395|NCT01798056|39328212|FG000|Overall Study|Lost to Follow-up|1|||
16231396|NCT01798056|39328213|FG001|Overall Study|Lost to Follow-up|1|||
16231397|NCT01798056|39328212|FG000|Overall Study|Other|0|||
16231398|NCT01798056|39328213|FG001|Overall Study|Other|2|||
16231399|NCT03668613|39328216|FG000|Overall Study|Adverse Event|1|||
16231400|NCT03668613|39328217|FG001|Overall Study|Adverse Event|2|||
16231401|NCT03668613|39328216|FG000|Overall Study|Lack of Efficacy|5|||
16231402|NCT03668613|39328217|FG001|Overall Study|Lack of Efficacy|1|||
16231403|NCT03668613|39328216|FG000|Overall Study|Pregnancy|0|||
16231404|NCT03668613|39328217|FG001|Overall Study|Pregnancy|2|||
16231405|NCT03668613|39328216|FG000|Overall Study|Protocol Violation|1|||
16231406|NCT03668613|39328217|FG001|Overall Study|Protocol Violation|0|||
16231407|NCT03668613|39328216|FG000|Overall Study|Physician Decision|1|||
16231408|NCT03668613|39328217|FG001|Overall Study|Physician Decision|0|||
16231409|NCT03668613|39328216|FG000|Overall Study|Withdrawal by Subject|2|||
16231410|NCT03668613|39328217|FG001|Overall Study|Withdrawal by Subject|1|||
16231411|NCT03668613|39328216|FG000|Overall Study|Guardian decision|1|||
16231412|NCT03668613|39328217|FG001|Overall Study|Guardian decision|0|||
16231413|NCT00792467|39328218|FG000|Overall Study|progression of disease|17|||
16231414|NCT00792467|39328218|FG000|Overall Study|Adverse Event|1|||
16231415|NCT00792467|39328218|FG000|Overall Study|patient request|1|||
16231416|NCT00792467|39328218|FG000|Overall Study|Lost to Follow-up|1|||
16231417|NCT00792467|39328218|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
16231418|NCT00792467|39328218|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
16231419|NCT02409680|39328223|FG000|Overall Study|Lost to Follow-up|15|||
16231420|NCT02409680|39328224|FG001|Overall Study|Lost to Follow-up|30|||
16231421|NCT01607398|39328227|FG000|Overall Study|Adverse Event|0|||
16231422|NCT01607398|39328228|FG001|Overall Study|Adverse Event|2|||
16231423|NCT01607398|39328227|FG000|Overall Study|Severe COPD|2|||
16231424|NCT01607398|39328228|FG001|Overall Study|Severe COPD|0|||
16231425|NCT00824993|39328229|FG000|Overall Study|Withdrawal by Subject|1|||
16231426|NCT00824993|39328230|FG001|Overall Study|Withdrawal by Subject|1|||
16231427|NCT00824993|39328229|FG000|Overall Study|Malignancy Relapse|9|||
16231428|NCT00824993|39328230|FG001|Overall Study|Malignancy Relapse|10|||
16231429|NCT00824993|39328229|FG000|Overall Study|Rapid Bone Loss|0|||
16231430|NCT00824993|39328230|FG001|Overall Study|Rapid Bone Loss|1|||
16231431|NCT00824993|39328229|FG000|Overall Study|Non-Compliant|2|||
16231432|NCT00824993|39328230|FG001|Overall Study|Non-Compliant|1|||
16231433|NCT00824993|39328229|FG000|Overall Study|Insurance Issue|2|||
16231434|NCT00824993|39328230|FG001|Overall Study|Insurance Issue|1|||
16231435|NCT00824993|39328229|FG000|Overall Study|Death|0|||
16231436|NCT00824993|39328230|FG001|Overall Study|Death|3|||
16231437|NCT00483574|39331085|FG000|Overall Study|Adverse Event|6|||
16231438|NCT00483574|39331086|FG001|Overall Study|Adverse Event|0|||
16231439|NCT00483574|39331085|FG000|Overall Study|Protocol Violation|28|||
16231440|NCT00483574|39331086|FG001|Overall Study|Protocol Violation|9|||
16231441|NCT00483574|39331085|FG000|Overall Study|Lost to Follow-up|16|||
16231442|NCT00483574|39331086|FG001|Overall Study|Lost to Follow-up|4|||
16231443|NCT00483574|39331085|FG000|Overall Study|Withdrawal by Subject|52|||
16231444|NCT00483574|39331086|FG001|Overall Study|Withdrawal by Subject|0|||
16348563|NCT02959918|39765409|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16120006|NCT01646177|38927118|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16231445|NCT02219477|39331089|FG000|Overall Study|Adverse Event|0|||
16231446|NCT02219477|39331090|FG001|Overall Study|Adverse Event|1|||
16231447|NCT02219477|39331091|FG002|Overall Study|Adverse Event|1|||
16231448|NCT02219477|39331089|FG000|Overall Study|Withdrawal by Subject|0|||
16231449|NCT02219477|39331090|FG001|Overall Study|Withdrawal by Subject|1|||
16231450|NCT02219477|39331091|FG002|Overall Study|Withdrawal by Subject|0|||
16231451|NCT00953017|39331092|FG000|Overall Study|DId not show up for colonoscopy|4|||
16231452|NCT00953017|39331093|FG001|Overall Study|DId not show up for colonoscopy|4|||
16231453|NCT00953017|39331094|FG002|Overall Study|DId not show up for colonoscopy|5|||
16231454|NCT00953017|39331095|FG003|Overall Study|DId not show up for colonoscopy|4|||
16231455|NCT00953017|39331092|FG000|Overall Study|Incomplete data|1|||
16231456|NCT00953017|39331093|FG001|Overall Study|Incomplete data|1|||
16231457|NCT00953017|39331094|FG002|Overall Study|Incomplete data|0|||
16231458|NCT00953017|39331095|FG003|Overall Study|Incomplete data|0|||
16231459|NCT00953017|39331092|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
16231460|NCT00953017|39331093|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
16231461|NCT00953017|39331094|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
16231462|NCT00953017|39331095|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
16231463|NCT00953017|39331092|FG000|Overall Study|Brown stool prior to procedure|0|||
16413100|NCT00454649|39995026|FG004|Overall Study|Lost to Follow-up|0|||
16413101|NCT00454649|39995027|FG005|Overall Study|Lost to Follow-up|0|||
16413102|NCT00454649|39995028|FG006|Overall Study|Lost to Follow-up|1|||
16231464|NCT00953017|39331093|FG001|Overall Study|Brown stool prior to procedure|0|||
16231465|NCT00953017|39331094|FG002|Overall Study|Brown stool prior to procedure|1|||
16231466|NCT00953017|39331095|FG003|Overall Study|Brown stool prior to procedure|0|||
16231467|NCT00183170|39331101|FG000|First Intervention|Did not complete study|1|||
16231468|NCT00183170|39331102|FG001|First Intervention|Did not complete study|0|||
16231469|NCT00183170|39331101|FG000|First Intervention|Did not meet targeted BrAC|1|||
16231470|NCT00183170|39331102|FG001|First Intervention|Did not meet targeted BrAC|0|||
16231471|NCT00183170|39331101|FG000|Washout 1 Week|Did not complete study|6|||
16231472|NCT00183170|39331102|FG001|Washout 1 Week|Did not complete study|8|||
16231473|NCT00183170|39331101|FG000|Second Intervention|Did not complete study|1|||
16231474|NCT00183170|39331102|FG001|Second Intervention|Did not complete study|0|||
16231475|NCT00183170|39331101|FG000|Second Intervention|Did not meet targeted BrAC|0|||
16231476|NCT00183170|39331102|FG001|Second Intervention|Did not meet targeted BrAC|2|||
16231477|NCT00943826|39331103|FG000|Concurrent Phase|Adverse Event|50|||
16231478|NCT00943826|39331104|FG001|Concurrent Phase|Adverse Event|27|||
16231479|NCT00943826|39331103|FG000|Concurrent Phase|Withdrew consent|3|||
16231480|NCT00943826|39331104|FG001|Concurrent Phase|Withdrew consent|7|||
16231481|NCT00943826|39331103|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
16231482|NCT00943826|39331104|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
16231483|NCT00943826|39331103|FG000|Concurrent Phase|Administrative reasons|2|||
16231484|NCT00943826|39331104|FG001|Concurrent Phase|Administrative reasons|1|||
16231485|NCT00943826|39331103|FG000|Concurrent Phase|Protocol Violation|1|||
16231486|NCT00943826|39331104|FG001|Concurrent Phase|Protocol Violation|0|||
16231487|NCT00943826|39331103|FG000|Maintenance Phase|Adverse Event|31|||
16231488|NCT00943826|39331104|FG001|Maintenance Phase|Adverse Event|30|||
16231489|NCT00943826|39331103|FG000|Maintenance Phase|Withdrew consent|2|||
16231490|NCT00943826|39331104|FG001|Maintenance Phase|Withdrew consent|4|||
16231491|NCT00943826|39331103|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
16231492|NCT00943826|39331104|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
16231493|NCT00943826|39331103|FG000|Maintenance Phase|Administrative reasons|4|||
16231494|NCT00943826|39331104|FG001|Maintenance Phase|Administrative reasons|1|||
16231495|NCT00943826|39331103|FG000|Maintenance Phase|Failure to return|0|||
16231496|NCT00943826|39331104|FG001|Maintenance Phase|Failure to return|1|||
16231497|NCT00943826|39331103|FG000|Monotherapy Phase|Adverse Event|42|||
16231498|NCT00943826|39331104|FG001|Monotherapy Phase|Adverse Event|5|||
16231499|NCT00943826|39331103|FG000|Monotherapy Phase|Administrative reasons|11|||
16231500|NCT00943826|39331104|FG001|Monotherapy Phase|Administrative reasons|5|||
16231501|NCT00943826|39331103|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
16231502|NCT00943826|39331104|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
16231503|NCT00943826|39331103|FG000|Monotherapy Phase|Withdrew Consent|2|||
16231504|NCT00943826|39331104|FG001|Monotherapy Phase|Withdrew Consent|3|||
16231505|NCT00943826|39331103|FG000|Monotherapy Phase|Failure to return|2|||
16231506|NCT00943826|39331104|FG001|Monotherapy Phase|Failure to return|1|||
16231507|NCT00943826|39331103|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
16231508|NCT00943826|39331104|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
16231509|NCT00943826|39331103|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
16231510|NCT00943826|39331104|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
16231511|NCT00943826|39331103|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
16231512|NCT00943826|39331104|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
16231513|NCT00943826|39331103|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
16231514|NCT00943826|39331104|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
16231515|NCT03446157|39331108|FG000|Overall Study|Death|11|||
16231516|NCT03446157|39331109|FG001|Overall Study|Death|9|||
16231517|NCT03446157|39331108|FG000|Overall Study|Lost to Follow-up|0|||
16231518|NCT03446157|39331109|FG001|Overall Study|Lost to Follow-up|1|||
16231519|NCT03446157|39331108|FG000|Overall Study|Withdrawal by Subject|2|||
16231520|NCT03446157|39331109|FG001|Overall Study|Withdrawal by Subject|1|||
16231521|NCT01283009|39331110|FG000|Overall Study|Death|83|||
16231522|NCT01283009|39331111|FG001|Overall Study|Death|78|||
16231523|NCT01283009|39331110|FG000|Overall Study|Study ended early|23|||
16231524|NCT01283009|39331111|FG001|Overall Study|Study ended early|26|||
16231525|NCT01283009|39331110|FG000|Overall Study|Withdrawal by Subject|10|||
16231526|NCT01283009|39331111|FG001|Overall Study|Withdrawal by Subject|8|||
16231527|NCT01283009|39331110|FG000|Overall Study|Physician Decision|1|||
16231528|NCT01283009|39331111|FG001|Overall Study|Physician Decision|1|||
16231529|NCT01283009|39331110|FG000|Overall Study|Lost to Follow-up|1|||
16120007|NCT01646177|38927119|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16231530|NCT01283009|39331111|FG001|Overall Study|Lost to Follow-up|0|||
16231531|NCT01283009|39331110|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
16231532|NCT01283009|39331111|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
16413103|NCT00454649|39995029|FG007|Overall Study|Lost to Follow-up|0|||
16231533|NCT04003103|39331112|FG000|Overall Study|Death|1|||
16231534|NCT04003103|39331113|FG001|Overall Study|Death|0|||
16231535|NCT04003103|39331114|FG002|Overall Study|Death|0|||
16231536|NCT04003103|39331112|FG000|Overall Study|Lost to Follow-up|4|||
16231537|NCT04003103|39331113|FG001|Overall Study|Lost to Follow-up|3|||
16231538|NCT04003103|39331114|FG002|Overall Study|Lost to Follow-up|2|||
16231539|NCT04003103|39331112|FG000|Overall Study|Withdrawal by Subject|10|||
16231540|NCT04003103|39331113|FG001|Overall Study|Withdrawal by Subject|1|||
16231541|NCT04003103|39331114|FG002|Overall Study|Withdrawal by Subject|1|||
16231542|NCT04003103|39331112|FG000|Overall Study|Status not recorded|0|||
16231543|NCT04003103|39331113|FG001|Overall Study|Status not recorded|2|||
16231544|NCT04003103|39331114|FG002|Overall Study|Status not recorded|0|||
16231545|NCT05147311|39331119|FG000|Overall Study|Did not complete survey|2|||
16231546|NCT05147311|39331120|FG001|Overall Study|Did not complete survey|1|||
16231547|NCT05147311|39331119|FG000|Overall Study|Patient too sick|1|||
16231548|NCT05147311|39331120|FG001|Overall Study|Patient too sick|2|||
16231549|NCT05147311|39331119|FG000|Overall Study|Death|0|||
16231550|NCT05147311|39331120|FG001|Overall Study|Death|1|||
16231551|NCT05147311|39331119|FG000|Overall Study|Declined survey|1|||
16231552|NCT05147311|39331120|FG001|Overall Study|Declined survey|0|||
16231553|NCT04341727|39331124|FG000|Overall Study|Withdrawal by Subject|0|||
16231554|NCT04341727|39331125|FG001|Overall Study|Withdrawal by Subject|0|||
16231555|NCT04341727|39331126|FG002|Overall Study|Withdrawal by Subject|1|||
16231556|NCT04341727|39331127|FG003|Overall Study|Withdrawal by Subject|0|||
16231557|NCT04341727|39331124|FG000|Overall Study|Lost to Follow-up|0|||
16231558|NCT04341727|39331125|FG001|Overall Study|Lost to Follow-up|0|||
16231559|NCT04341727|39331126|FG002|Overall Study|Lost to Follow-up|0|||
16552165|NCT01317875|40484696|FG008|Overall Study|Death|0|||
16231560|NCT04341727|39331127|FG003|Overall Study|Lost to Follow-up|1|||
16231561|NCT02304302|39331128|FG000|Overall Study|Adverse Event|2|||
16231562|NCT02304302|39331129|FG001|Overall Study|Adverse Event|3|||
16231563|NCT02304302|39331128|FG000|Overall Study|Lost to Follow-up|1|||
16231564|NCT02304302|39331129|FG001|Overall Study|Lost to Follow-up|4|||
16231565|NCT02304302|39331128|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
16231566|NCT02304302|39331129|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
16231567|NCT00276458|39331137|FG000|Overall Study|Adverse Event|0|||
16231568|NCT00276458|39331138|FG001|Overall Study|Adverse Event|2|||
16231569|NCT00276458|39331137|FG000|Overall Study|Lost to Follow-up|2|||
16231570|NCT00276458|39331138|FG001|Overall Study|Lost to Follow-up|2|||
16231571|NCT00276458|39331137|FG000|Overall Study|Protocol Violation|4|||
16231572|NCT00276458|39331138|FG001|Overall Study|Protocol Violation|3|||
16231573|NCT03292731|39331139|FG000|Overall Study|Protocol Violation|4|||
16231574|NCT03292731|39331140|FG001|Overall Study|Protocol Violation|11|||
16231575|NCT03292731|39331141|FG002|Overall Study|Protocol Violation|1|||
16231576|NCT01018680|39331144|FG000|Overall Study|Adverse Event|23|||
16231577|NCT01018680|39331145|FG001|Overall Study|Adverse Event|40|||
16231578|NCT01018680|39331144|FG000|Overall Study|Withdrawal by Subject|10|||
16231579|NCT01018680|39331145|FG001|Overall Study|Withdrawal by Subject|10|||
16231580|NCT01018680|39331144|FG000|Overall Study|Protocol Violation|5|||
16231581|NCT01018680|39331145|FG001|Overall Study|Protocol Violation|8|||
16231582|NCT01018680|39331144|FG000|Overall Study|Sponsor Decision|6|||
16231583|NCT01018680|39331145|FG001|Overall Study|Sponsor Decision|7|||
16231584|NCT01018680|39331144|FG000|Overall Study|Lack of Efficacy|8|||
16231585|NCT01018680|39331145|FG001|Overall Study|Lack of Efficacy|2|||
16231586|NCT01018680|39331144|FG000|Overall Study|Lost to Follow-up|5|||
16231587|NCT01018680|39331145|FG001|Overall Study|Lost to Follow-up|3|||
16231588|NCT01018680|39331144|FG000|Overall Study|Entry Criteria Not Met|1|||
16231589|NCT01018680|39331145|FG001|Overall Study|Entry Criteria Not Met|4|||
16231590|NCT01018680|39331144|FG000|Overall Study|Physician Decision|3|||
16552166|NCT01317875|40484697|FG009|Overall Study|Death|0|||
16552167|NCT01317875|40484688|FG000|Overall Study|Adverse Event|2|||
16231591|NCT01018680|39331145|FG001|Overall Study|Physician Decision|1|||
16231592|NCT01058707|39331146|FG000|Overall Study|Disease Progression|15|||
16231593|NCT01058707|39331147|FG001|Overall Study|Disease Progression|20|||
16231594|NCT01058707|39331148|FG002|Overall Study|Disease Progression|20|||
16231595|NCT01058707|39331149|FG003|Overall Study|Disease Progression|15|||
16231596|NCT01058707|39331150|FG004|Overall Study|Disease Progression|23|||
16231597|NCT01058707|39331151|FG005|Overall Study|Disease Progression|10|||
16231598|NCT01058707|39331152|FG006|Overall Study|Disease Progression|12|||
16231599|NCT01058707|39331146|FG000|Overall Study|Adverse Event|11|||
16231600|NCT01058707|39331147|FG001|Overall Study|Adverse Event|4|||
16231601|NCT01058707|39331148|FG002|Overall Study|Adverse Event|7|||
16231602|NCT01058707|39331149|FG003|Overall Study|Adverse Event|6|||
16231603|NCT01058707|39331150|FG004|Overall Study|Adverse Event|7|||
16231604|NCT01058707|39331151|FG005|Overall Study|Adverse Event|3|||
16231605|NCT01058707|39331152|FG006|Overall Study|Adverse Event|1|||
16231606|NCT01058707|39331146|FG000|Overall Study|Subject Decision|5|||
16231607|NCT01058707|39331147|FG001|Overall Study|Subject Decision|3|||
16231608|NCT01058707|39331148|FG002|Overall Study|Subject Decision|3|||
16231609|NCT01058707|39331149|FG003|Overall Study|Subject Decision|1|||
16231610|NCT01058707|39331150|FG004|Overall Study|Subject Decision|2|||
16231611|NCT01058707|39331151|FG005|Overall Study|Subject Decision|3|||
16231612|NCT01058707|39331152|FG006|Overall Study|Subject Decision|6|||
16231613|NCT01058707|39331146|FG000|Overall Study|Lost to Follow-up|0|||
16231614|NCT01058707|39331147|FG001|Overall Study|Lost to Follow-up|0|||
16231615|NCT01058707|39331148|FG002|Overall Study|Lost to Follow-up|1|||
16231616|NCT01058707|39331149|FG003|Overall Study|Lost to Follow-up|0|||
16231617|NCT01058707|39331150|FG004|Overall Study|Lost to Follow-up|0|||
16231618|NCT01058707|39331151|FG005|Overall Study|Lost to Follow-up|0|||
16231619|NCT01058707|39331152|FG006|Overall Study|Lost to Follow-up|0|||
16231620|NCT01058707|39331146|FG000|Overall Study|Reason Not Specified|0|||
16231621|NCT01058707|39331147|FG001|Overall Study|Reason Not Specified|3|||
16231622|NCT01058707|39331148|FG002|Overall Study|Reason Not Specified|2|||
16231623|NCT01058707|39331149|FG003|Overall Study|Reason Not Specified|0|||
16231624|NCT01058707|39331150|FG004|Overall Study|Reason Not Specified|7|||
16231625|NCT01058707|39331151|FG005|Overall Study|Reason Not Specified|1|||
16231626|NCT01058707|39331152|FG006|Overall Study|Reason Not Specified|7|||
16231627|NCT00071006|39331153|FG000|Overall Study|Lack of Efficacy|7|||
16231628|NCT00071006|39331153|FG000|Overall Study|Adverse Event|1|||
16231629|NCT00071006|39331153|FG000|Overall Study|Withdrawal by Subject|1|||
16231630|NCT00071006|39331153|FG000|Overall Study|Other|3|||
16231631|NCT02222246|39331154|FG000|Overall Study|No Emergency Department Visits|27|||
16231632|NCT02222246|39331155|FG001|Overall Study|No Emergency Department Visits|26|||
16231633|NCT02222246|39331154|FG000|Overall Study|Physician Decision|0|||
16231634|NCT02222246|39331155|FG001|Overall Study|Physician Decision|1|||
16231635|NCT00621309|39331158|FG000|Overall Study|Withdrawal by Subject|2|||
16231636|NCT00621309|39331159|FG001|Overall Study|Withdrawal by Subject|0|||
16231637|NCT00621309|39331160|FG002|Overall Study|Withdrawal by Subject|1|||
16231638|NCT00621309|39331161|FG003|Overall Study|Withdrawal by Subject|1|||
16231639|NCT00621309|39331162|FG004|Overall Study|Withdrawal by Subject|1|||
16231640|NCT00621309|39331163|FG005|Overall Study|Withdrawal by Subject|1|||
16231641|NCT02508649|39331164|FG000|Overall Study|Withdrawal by Subject|4|||
16231642|NCT02508649|39331165|FG001|Overall Study|Withdrawal by Subject|6|||
16231643|NCT02508649|39331166|FG002|Overall Study|Withdrawal by Subject|5|||
16231644|NCT02508649|39331167|FG003|Overall Study|Withdrawal by Subject|6|||
16231645|NCT02508649|39331164|FG000|Overall Study|Investigator withdrew the subject|1|||
16231646|NCT02508649|39331165|FG001|Overall Study|Investigator withdrew the subject|2|||
16231647|NCT02508649|39331166|FG002|Overall Study|Investigator withdrew the subject|1|||
16231648|NCT02508649|39331167|FG003|Overall Study|Investigator withdrew the subject|0|||
16231649|NCT02508649|39331164|FG000|Overall Study|Post randomization screening failure|12|||
16231650|NCT02508649|39331165|FG001|Overall Study|Post randomization screening failure|4|||
16231651|NCT02508649|39331166|FG002|Overall Study|Post randomization screening failure|9|||
16231652|NCT02508649|39331167|FG003|Overall Study|Post randomization screening failure|3|||
16231653|NCT02508649|39331164|FG000|Overall Study|Lost to Follow-up|1|||
16231654|NCT02508649|39331165|FG001|Overall Study|Lost to Follow-up|1|||
16231655|NCT02508649|39331166|FG002|Overall Study|Lost to Follow-up|0|||
16231656|NCT02508649|39331167|FG003|Overall Study|Lost to Follow-up|1|||
16231657|NCT01195662|39331168|FG000|Double Blind Treatment Period|Adverse Event|4|||
16231658|NCT01195662|39331169|FG001|Double Blind Treatment Period|Adverse Event|1|||
16552168|NCT01317875|40484689|FG001|Overall Study|Adverse Event|1|||
16552169|NCT01317875|40484690|FG002|Overall Study|Adverse Event|2|||
16552170|NCT01317875|40484691|FG003|Overall Study|Adverse Event|1|||
16552171|NCT01317875|40484692|FG004|Overall Study|Adverse Event|5|||
16552172|NCT01317875|40484693|FG005|Overall Study|Adverse Event|1|||
16552173|NCT01317875|40484694|FG006|Overall Study|Adverse Event|2|||
16552174|NCT01317875|40484695|FG007|Overall Study|Adverse Event|5|||
16231659|NCT01195662|39331170|FG002|Double Blind Treatment Period|Adverse Event|2|||
16231660|NCT01195662|39331168|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
16231661|NCT01195662|39331169|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
16231662|NCT01195662|39331170|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
16231663|NCT01195662|39331168|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
16231664|NCT01195662|39331169|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
16231665|NCT01195662|39331170|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
16348564|NCT02959918|39765410|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16348565|NCT02959918|39765411|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16231666|NCT01195662|39331168|FG000|Double Blind Treatment Period|Administrative reason|2|||
16231667|NCT01195662|39331169|FG001|Double Blind Treatment Period|Administrative reason|1|||
16231668|NCT01195662|39331170|FG002|Double Blind Treatment Period|Administrative reason|1|||
16231669|NCT01195662|39331168|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
16348566|NCT02959918|39765412|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
16552175|NCT01317875|40484696|FG008|Overall Study|Adverse Event|0|||
16552176|NCT01317875|40484697|FG009|Overall Study|Adverse Event|0|||
16231670|NCT01195662|39331169|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
16231671|NCT01195662|39331170|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
16231672|NCT01195662|39331168|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
16231673|NCT01195662|39331169|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
16231674|NCT01195662|39331170|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
16231675|NCT01195662|39331168|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
16231676|NCT01195662|39331169|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
16231677|NCT01195662|39331170|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
16231678|NCT01195662|39331168|FG000|Double Blind Treatment Period|Non-specified|3|||
16231679|NCT01195662|39331169|FG001|Double Blind Treatment Period|Non-specified|0|||
16231680|NCT01195662|39331170|FG002|Double Blind Treatment Period|Non-specified|0|||
16231681|NCT01195662|39331168|FG000|Double Blind Treatment Period|Missing disposition information|0|||
16231682|NCT01195662|39331169|FG001|Double Blind Treatment Period|Missing disposition information|1|||
16231683|NCT01195662|39331170|FG002|Double Blind Treatment Period|Missing disposition information|1|||
16231684|NCT01195662|39331168|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
16231685|NCT01195662|39331169|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
16231686|NCT01195662|39331170|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
16231687|NCT01195662|39331168|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
16231688|NCT01195662|39331169|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
16231689|NCT01195662|39331170|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
16231690|NCT02325414|39331175|FG000|Overall Study|Withdrawal by Subject|3|||
16231691|NCT02325414|39331176|FG001|Overall Study|Withdrawal by Subject|1|||
16231692|NCT02325414|39331175|FG000|Overall Study|Lost to Follow-up|5|||
16231693|NCT02325414|39331176|FG001|Overall Study|Lost to Follow-up|5|||
16231694|NCT00501969|39331178|FG000|Overall Study|Major Protocol Violation|4|||
16231695|NCT00501969|39331178|FG000|Overall Study|Lack of Efficacy|29|||
16231696|NCT00501969|39331178|FG000|Overall Study|Adverse Event|76|||
16231697|NCT00501969|39331178|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
16231698|NCT00501969|39331178|FG000|Overall Study|Subject withdrew consent|51|||
16231699|NCT00501969|39331178|FG000|Overall Study|Lost to Follow-up|4|||
16231700|NCT00501969|39331178|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
16231701|NCT00501969|39331178|FG000|Overall Study|Other: Sponsors Request|10|||
16231702|NCT00501969|39331178|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
16231703|NCT00501969|39331178|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
16231704|NCT00501969|39331178|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
16231705|NCT00501969|39331178|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
16231706|NCT00501969|39331178|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
16231707|NCT00501969|39331178|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
16231708|NCT00501969|39331178|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
16231709|NCT00501969|39331178|FG000|Overall Study|Other: As Required by Local EC|2|||
16231710|NCT00501969|39331178|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
16231711|NCT00501969|39331178|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
16231712|NCT00594568|39331179|FG000|Initial Treatment|Adverse Event|51|||
16231713|NCT00594568|39331180|FG001|Initial Treatment|Adverse Event|121|||
16552177|NCT00996580|40484698|FG000|Overall Study|Adverse Event|466|||
16552178|NCT00996580|40484698|FG000|Overall Study|Lost to Follow-up|480|||
16552179|NCT00996580|40484698|FG000|Overall Study|Noncompliance with the protocol|137|||
16552180|NCT00996580|40484698|FG000|Overall Study|Physician Decision|5|||
16552181|NCT00996580|40484698|FG000|Overall Study|Pregnancy|68|||
16552182|NCT00996580|40484698|FG000|Overall Study|Protocol Violation|16|||
16552183|NCT00996580|40484698|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
16552184|NCT00996580|40484698|FG000|Overall Study|Withdrawal by Subject|217|||
16552185|NCT00996580|40484698|FG000|Overall Study|Other|29|||
16552186|NCT01242176|40484707|FG000|Washout Period of 7 Days|Adverse Event|0|||
16552187|NCT01242176|40484708|FG001|Washout Period of 7 Days|Adverse Event|2|||
16552188|NCT01242176|40484707|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
16552189|NCT01242176|40484708|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
16552190|NCT01923428|40484709|FG000|Overall Study|Adverse Event|8|||
16552191|NCT01923428|40484710|FG001|Overall Study|Adverse Event|6|||
16552192|NCT01923428|40484711|FG002|Overall Study|Adverse Event|3|||
16552193|NCT01923428|40484712|FG003|Overall Study|Adverse Event|3|||
16552194|NCT01923428|40484709|FG000|Overall Study|Withdrawal by Subject|5|||
16552195|NCT01923428|40484710|FG001|Overall Study|Withdrawal by Subject|3|||
16231714|NCT00594568|39331181|FG002|Initial Treatment|Adverse Event|144|||
16231715|NCT00594568|39331179|FG000|Initial Treatment|Death|6|||
16231716|NCT00594568|39331180|FG001|Initial Treatment|Death|11|||
16231717|NCT00594568|39331181|FG002|Initial Treatment|Death|15|||
16231718|NCT00594568|39331179|FG000|Initial Treatment|Lost to Follow-up|4|||
16231719|NCT00594568|39331180|FG001|Initial Treatment|Lost to Follow-up|1|||
16231720|NCT00594568|39331181|FG002|Initial Treatment|Lost to Follow-up|4|||
16552196|NCT01923428|40484711|FG002|Overall Study|Withdrawal by Subject|0|||
16231721|NCT00594568|39331179|FG000|Initial Treatment|Physician Decision|3|||
16231722|NCT00594568|39331180|FG001|Initial Treatment|Physician Decision|2|||
16231723|NCT00594568|39331181|FG002|Initial Treatment|Physician Decision|4|||
16231724|NCT00594568|39331179|FG000|Initial Treatment|Protocol Violation|2|||
16231725|NCT00594568|39331180|FG001|Initial Treatment|Protocol Violation|2|||
16231726|NCT00594568|39331181|FG002|Initial Treatment|Protocol Violation|5|||
16231727|NCT00594568|39331179|FG000|Initial Treatment|Withdrawal by Subject|25|||
16231728|NCT00594568|39331180|FG001|Initial Treatment|Withdrawal by Subject|31|||
16231729|NCT00594568|39331181|FG002|Initial Treatment|Withdrawal by Subject|46|||
16231730|NCT00594568|39331179|FG000|Initial Treatment|Sponsor decision|193|||
16231731|NCT00594568|39331180|FG001|Initial Treatment|Sponsor decision|142|||
16231732|NCT00594568|39331181|FG002|Initial Treatment|Sponsor decision|147|||
16231733|NCT00594568|39331179|FG000|Initial Treatment|Caregiver decision|21|||
16231734|NCT00594568|39331180|FG001|Initial Treatment|Caregiver decision|36|||
16231735|NCT00594568|39331181|FG002|Initial Treatment|Caregiver decision|36|||
16231736|NCT00594568|39331179|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
16231737|NCT00594568|39331180|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
16231738|NCT00594568|39331181|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
16231739|NCT00594568|39331179|FG000|Initial Treatment|Entry criteria exclusion|0|||
16231740|NCT00594568|39331180|FG001|Initial Treatment|Entry criteria exclusion|1|||
16231741|NCT00594568|39331181|FG002|Initial Treatment|Entry criteria exclusion|1|||
16231742|NCT00594568|39331179|FG000|Delayed Start|Death|0|||
16231743|NCT00594568|39331180|FG001|Delayed Start|Death|0|||
16231744|NCT00594568|39331181|FG002|Delayed Start|Death|1|||
16231745|NCT00594568|39331179|FG000|Delayed Start|Adverse Event|12|||
16231746|NCT00594568|39331180|FG001|Delayed Start|Adverse Event|2|||
16231747|NCT00594568|39331181|FG002|Delayed Start|Adverse Event|2|||
16231748|NCT00594568|39331179|FG000|Delayed Start|Withdrawal by Subject|4|||
16231749|NCT00594568|39331180|FG001|Delayed Start|Withdrawal by Subject|3|||
16231750|NCT00594568|39331181|FG002|Delayed Start|Withdrawal by Subject|0|||
16231751|NCT00594568|39331179|FG000|Delayed Start|Physician Decision|0|||
16552197|NCT01923428|40484712|FG003|Overall Study|Withdrawal by Subject|4|||
16552198|NCT01923428|40484709|FG000|Overall Study|Lost to Follow-up|2|||
16231752|NCT00594568|39331180|FG001|Delayed Start|Physician Decision|0|||
16231753|NCT00594568|39331181|FG002|Delayed Start|Physician Decision|1|||
16231754|NCT00594568|39331179|FG000|Delayed Start|Lost to Follow-up|0|||
16231755|NCT00594568|39331180|FG001|Delayed Start|Lost to Follow-up|0|||
16231756|NCT00594568|39331181|FG002|Delayed Start|Lost to Follow-up|1|||
16231757|NCT00594568|39331179|FG000|Delayed Start|Caregiver Decision|5|||
16231758|NCT00594568|39331180|FG001|Delayed Start|Caregiver Decision|6|||
16231759|NCT00594568|39331181|FG002|Delayed Start|Caregiver Decision|2|||
16231760|NCT00594568|39331179|FG000|Delayed Start|Sponsor Decision|77|||
16231761|NCT00594568|39331180|FG001|Delayed Start|Sponsor Decision|66|||
16231762|NCT00594568|39331181|FG002|Delayed Start|Sponsor Decision|59|||
16231763|NCT00594568|39331179|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
16231764|NCT00594568|39331180|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
16231765|NCT00594568|39331181|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
16231766|NCT00594568|39331179|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
16231767|NCT00594568|39331180|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
16231768|NCT00594568|39331181|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
16231769|NCT00594568|39331179|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
16231770|NCT00594568|39331180|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
16231771|NCT00594568|39331181|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
16231772|NCT00594568|39331179|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
16231773|NCT00594568|39331180|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
16231774|NCT00594568|39331181|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
16231775|NCT00594568|39331179|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
16231776|NCT00594568|39331180|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
16231777|NCT00594568|39331181|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
16231778|NCT00594568|39331179|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
16231779|NCT00594568|39331180|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
16231780|NCT00594568|39331181|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
16231781|NCT02501642|39331182|FG000|Overall Study|Lost to Follow-up|7|||
16231782|NCT02501642|39331183|FG001|Overall Study|Lost to Follow-up|11|||
16231783|NCT01004822|39331184|FG000|Overall Study|Objective progression or relapse|3|||
16231784|NCT01004822|39331185|FG001|Overall Study|Objective progression or relapse|3|||
16231785|NCT01004822|39331186|FG002|Overall Study|Objective progression or relapse|0|||
16231786|NCT01004822|39331187|FG003|Overall Study|Objective progression or relapse|1|||
16231787|NCT01004822|39331188|FG004|Overall Study|Objective progression or relapse|2|||
16231788|NCT01004822|39331189|FG005|Overall Study|Objective progression or relapse|2|||
16231789|NCT01004822|39331190|FG006|Overall Study|Objective progression or relapse|1|||
16231790|NCT01004822|39331191|FG007|Overall Study|Objective progression or relapse|4|||
16120008|NCT01646177|38927120|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16552199|NCT01923428|40484710|FG001|Overall Study|Lost to Follow-up|1|||
16231791|NCT01004822|39331184|FG000|Overall Study|Global deterioration of health status|0|||
16231792|NCT01004822|39331185|FG001|Overall Study|Global deterioration of health status|0|||
16231793|NCT01004822|39331186|FG002|Overall Study|Global deterioration of health status|0|||
16231794|NCT01004822|39331187|FG003|Overall Study|Global deterioration of health status|1|||
16231795|NCT01004822|39331188|FG004|Overall Study|Global deterioration of health status|0|||
16231796|NCT01004822|39331189|FG005|Overall Study|Global deterioration of health status|0|||
16231797|NCT01004822|39331190|FG006|Overall Study|Global deterioration of health status|1|||
16413104|NCT00454649|39995030|FG008|Overall Study|Lost to Follow-up|0|||
16413105|NCT00454649|39995031|FG009|Overall Study|Lost to Follow-up|0|||
16413106|NCT00454649|39995022|FG000|Overall Study|Other|1|||
16413107|NCT00454649|39995023|FG001|Overall Study|Other|1|||
16413108|NCT00454649|39995024|FG002|Overall Study|Other|5|||
16552200|NCT01923428|40484711|FG002|Overall Study|Lost to Follow-up|5|||
16552201|NCT01923428|40484712|FG003|Overall Study|Lost to Follow-up|0|||
16231798|NCT01004822|39331191|FG007|Overall Study|Global deterioration of health status|0|||
16231799|NCT01004822|39331184|FG000|Overall Study|No longer willing to continue|0|||
16231800|NCT01004822|39331185|FG001|Overall Study|No longer willing to continue|0|||
16231801|NCT01004822|39331186|FG002|Overall Study|No longer willing to continue|0|||
16231802|NCT01004822|39331187|FG003|Overall Study|No longer willing to continue|1|||
16231803|NCT01004822|39331188|FG004|Overall Study|No longer willing to continue|2|||
16231804|NCT01004822|39331189|FG005|Overall Study|No longer willing to continue|1|||
16231805|NCT01004822|39331190|FG006|Overall Study|No longer willing to continue|1|||
16231806|NCT01004822|39331191|FG007|Overall Study|No longer willing to continue|0|||
16231807|NCT01004822|39331184|FG000|Overall Study|Adverse Event|0|||
16231808|NCT01004822|39331185|FG001|Overall Study|Adverse Event|0|||
16231809|NCT01004822|39331186|FG002|Overall Study|Adverse Event|0|||
16231810|NCT01004822|39331187|FG003|Overall Study|Adverse Event|0|||
16231811|NCT01004822|39331188|FG004|Overall Study|Adverse Event|0|||
16231812|NCT01004822|39331189|FG005|Overall Study|Adverse Event|0|||
16231813|NCT01004822|39331190|FG006|Overall Study|Adverse Event|1|||
16231814|NCT01004822|39331191|FG007|Overall Study|Adverse Event|1|||
16231815|NCT01004822|39331184|FG000|Overall Study|Other|0|||
16231816|NCT01004822|39331185|FG001|Overall Study|Other|0|||
16231817|NCT01004822|39331186|FG002|Overall Study|Other|4|||
16231818|NCT01004822|39331187|FG003|Overall Study|Other|1|||
16231819|NCT01004822|39331188|FG004|Overall Study|Other|0|||
16231820|NCT01004822|39331189|FG005|Overall Study|Other|1|||
16231821|NCT01004822|39331190|FG006|Overall Study|Other|0|||
16231822|NCT01004822|39331191|FG007|Overall Study|Other|0|||
16231823|NCT00347776|39331194|FG000|1.5 Month Follow-up|Death|2|||
16231824|NCT00347776|39331195|FG001|1.5 Month Follow-up|Death|0|||
16231825|NCT00347776|39331196|FG002|1.5 Month Follow-up|Death|0|||
16231826|NCT00347776|39331194|FG000|1.5 Month Follow-up|reached the endpoint|12|||
16231827|NCT00347776|39331195|FG001|1.5 Month Follow-up|reached the endpoint|8|||
16231828|NCT00347776|39331196|FG002|1.5 Month Follow-up|reached the endpoint|12|||
16231829|NCT00347776|39331194|FG000|6 Month Follow-up|Death|2|||
16231830|NCT00347776|39331195|FG001|6 Month Follow-up|Death|1|||
16231831|NCT00347776|39331196|FG002|6 Month Follow-up|Death|3|||
16231832|NCT00347776|39331194|FG000|6 Month Follow-up|reached endpont|20|||
16231833|NCT00347776|39331195|FG001|6 Month Follow-up|reached endpont|12|||
16231834|NCT00347776|39331196|FG002|6 Month Follow-up|reached endpont|15|||
16231835|NCT00347776|39331194|FG000|12 Month Follow-up|Lost to Follow-up|7|||
16231836|NCT00347776|39331195|FG001|12 Month Follow-up|Lost to Follow-up|6|||
16231837|NCT00347776|39331196|FG002|12 Month Follow-up|Lost to Follow-up|6|||
16231838|NCT00347776|39331194|FG000|12 Month Follow-up|Death|3|||
16231839|NCT00347776|39331195|FG001|12 Month Follow-up|Death|4|||
16231840|NCT00347776|39331196|FG002|12 Month Follow-up|Death|4|||
16231841|NCT00347776|39331194|FG000|12 Month Follow-up|Reached endpoint|13|||
16231842|NCT00347776|39331195|FG001|12 Month Follow-up|Reached endpoint|6|||
16231843|NCT00347776|39331196|FG002|12 Month Follow-up|Reached endpoint|9|||
16231844|NCT00122954|39331200|FG000|Overall Study|Withdrawal by Subject|2|||
16413109|NCT00454649|39995025|FG003|Overall Study|Other|3|||
16552202|NCT01923428|40484709|FG000|Overall Study|Protocol Violation|3|||
16552203|NCT01923428|40484710|FG001|Overall Study|Protocol Violation|0|||
16552204|NCT01923428|40484711|FG002|Overall Study|Protocol Violation|2|||
16552205|NCT01923428|40484712|FG003|Overall Study|Protocol Violation|1|||
16552206|NCT01923428|40484709|FG000|Overall Study|Non Compliance to treatment|1|||
16552207|NCT01923428|40484710|FG001|Overall Study|Non Compliance to treatment|2|||
16552208|NCT01923428|40484711|FG002|Overall Study|Non Compliance to treatment|0|||
16231845|NCT00122954|39331201|FG001|Overall Study|Withdrawal by Subject|2|||
16231846|NCT00122954|39331200|FG000|Overall Study|Protocol Violation|0|||
16231847|NCT00122954|39331201|FG001|Overall Study|Protocol Violation|1|||
16231848|NCT00509223|39331203|FG000|Overall Study|Lost to Follow-up|1|||
16231849|NCT00509223|39331204|FG001|Overall Study|Lost to Follow-up|1|||
16231850|NCT00509223|39331203|FG000|Overall Study|Adverse Event|1|||
16413110|NCT00454649|39995026|FG004|Overall Study|Other|0|||
16231851|NCT00509223|39331204|FG001|Overall Study|Adverse Event|1|||
16231852|NCT00509223|39331203|FG000|Overall Study|Withdrawal by Subject|25|||
16231853|NCT00509223|39331204|FG001|Overall Study|Withdrawal by Subject|6|||
16231854|NCT00509223|39331203|FG000|Overall Study|Including: subject change of address|5|||
16231855|NCT00509223|39331204|FG001|Overall Study|Including: subject change of address|2|||
16231856|NCT00509223|39331203|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
16231857|NCT00509223|39331204|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
16231858|NCT01869959|39331207|FG000|Randomization Period|Physician Decision|0|||
16231859|NCT01869959|39331208|FG001|Randomization Period|Physician Decision|0|||
16231860|NCT01869959|39331209|FG002|Randomization Period|Physician Decision|0|||
16231861|NCT01869959|39331210|FG003|Randomization Period|Physician Decision|0|||
16231862|NCT01869959|39331211|FG004|Randomization Period|Physician Decision|1|||
16231863|NCT01869959|39331207|FG000|Treatment Period|Adverse Event|1|||
16231864|NCT01869959|39331208|FG001|Treatment Period|Adverse Event|0|||
16231865|NCT01869959|39331209|FG002|Treatment Period|Adverse Event|3|||
16231866|NCT01869959|39331210|FG003|Treatment Period|Adverse Event|1|||
16231867|NCT01869959|39331211|FG004|Treatment Period|Adverse Event|0|||
16231868|NCT01869959|39331207|FG000|Treatment Period|Sponsor decision|0|||
16231869|NCT01869959|39331208|FG001|Treatment Period|Sponsor decision|1|||
16231870|NCT01869959|39331209|FG002|Treatment Period|Sponsor decision|0|||
16231871|NCT01869959|39331210|FG003|Treatment Period|Sponsor decision|1|||
16231872|NCT01869959|39331211|FG004|Treatment Period|Sponsor decision|0|||
16231873|NCT01869959|39331207|FG000|Treatment Period|Withdrawal by Subject|0|||
16231874|NCT01869959|39331208|FG001|Treatment Period|Withdrawal by Subject|1|||
16231875|NCT01869959|39331209|FG002|Treatment Period|Withdrawal by Subject|0|||
16231876|NCT01869959|39331210|FG003|Treatment Period|Withdrawal by Subject|0|||
16231877|NCT01869959|39331211|FG004|Treatment Period|Withdrawal by Subject|0|||
16231878|NCT01593761|39331216|FG000|Overall Study|Lost to Follow-up|1|||
16231879|NCT01593761|39331216|FG000|Overall Study|culture negative for MRSA at baseline|5|||
16231880|NCT01593761|39331216|FG000|Overall Study|positive for hepatitis C virus|1|||
16231881|NCT01593761|39331216|FG000|Overall Study|secondary cellulitis|1|||
16231882|NCT00124709|39331228|FG000|Overall Study|Randomized but did not take medication|3|||
16231883|NCT00124709|39331229|FG001|Overall Study|Randomized but did not take medication|1|||
16231884|NCT00124709|39331228|FG000|Overall Study|Adverse Event|3|||
16231885|NCT00124709|39331229|FG001|Overall Study|Adverse Event|0|||
16231886|NCT00124709|39331228|FG000|Overall Study|Lack of Efficacy|5|||
16231887|NCT00124709|39331229|FG001|Overall Study|Lack of Efficacy|10|||
16231888|NCT00124709|39331228|FG000|Overall Study|Protocol Violation|3|||
16231889|NCT00124709|39331229|FG001|Overall Study|Protocol Violation|5|||
16231890|NCT00124709|39331228|FG000|Overall Study|Withdrawal by Subject|127|||
16231891|NCT00124709|39331229|FG001|Overall Study|Withdrawal by Subject|136|||
16231892|NCT00124709|39331228|FG000|Overall Study|Lost to Follow-up|114|||
16231893|NCT00124709|39331229|FG001|Overall Study|Lost to Follow-up|120|||
16231894|NCT01740297|39331234|FG000|Overall Study|Withdrawal by Subject|4|||
16231895|NCT01740297|39331235|FG001|Overall Study|Withdrawal by Subject|16|||
16231896|NCT01740297|39331236|FG002|Overall Study|Withdrawal by Subject|17|||
16231897|NCT01740297|39331234|FG000|Overall Study|Death|8|||
16231898|NCT01740297|39331235|FG001|Overall Study|Death|46|||
16231899|NCT01740297|39331236|FG002|Overall Study|Death|40|||
16231900|NCT01740297|39331234|FG000|Overall Study|Lost to Follow-up|1|||
16231901|NCT01740297|39331235|FG001|Overall Study|Lost to Follow-up|2|||
16231902|NCT01740297|39331236|FG002|Overall Study|Lost to Follow-up|4|||
16231903|NCT00464308|39331237|FG000|Overall Study|Adverse Event|22|||
16231904|NCT00464308|39331238|FG001|Overall Study|Adverse Event|27|||
16231905|NCT00464308|39331239|FG002|Overall Study|Adverse Event|16|||
16231906|NCT00464308|39331237|FG000|Overall Study|Lost to Follow-up|29|||
16231907|NCT00464308|39331238|FG001|Overall Study|Lost to Follow-up|19|||
16231908|NCT00464308|39331239|FG002|Overall Study|Lost to Follow-up|20|||
16231909|NCT00464308|39331237|FG000|Overall Study|Patient discontinued and other reasons|17|||
16231910|NCT00464308|39331238|FG001|Overall Study|Patient discontinued and other reasons|17|||
16231911|NCT00464308|39331239|FG002|Overall Study|Patient discontinued and other reasons|23|||
16231912|NCT00464308|39331237|FG000|Overall Study|Physician Decision|1|||
16231913|NCT00464308|39331238|FG001|Overall Study|Physician Decision|0|||
16231914|NCT00464308|39331239|FG002|Overall Study|Physician Decision|0|||
16552209|NCT01923428|40484712|FG003|Overall Study|Non Compliance to treatment|1|||
16552210|NCT01923428|40484709|FG000|Overall Study|Lack of Efficacy|0|||
16552211|NCT01923428|40484710|FG001|Overall Study|Lack of Efficacy|0|||
16552212|NCT01923428|40484711|FG002|Overall Study|Lack of Efficacy|1|||
16552213|NCT01923428|40484712|FG003|Overall Study|Lack of Efficacy|1|||
16552214|NCT01987596|40484713|FG000|Overall Study|Physician Decision|1|||
16552215|NCT01987596|40484714|FG001|Overall Study|Physician Decision|0|||
16552216|NCT01987596|40484713|FG000|Overall Study|Progressive Disease; missing all period|0|||
16231915|NCT03410693|39331240|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
16231916|NCT03410693|39331241|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
16552217|NCT01987596|40484714|FG001|Overall Study|Progressive Disease; missing all period|1|||
16231917|NCT03410693|39331240|FG000|Overall Study|Disc trt: Lost to follow up|0|||
16413111|NCT00454649|39995027|FG005|Overall Study|Other|0|||
16552218|NCT02318719|40484715|FG000|Double-blind Phase|Adverse Event|7|||
16552219|NCT02318719|40484716|FG001|Double-blind Phase|Adverse Event|6|||
16552220|NCT02318719|40484717|FG002|Double-blind Phase|Adverse Event|12|||
16552221|NCT02318719|40484718|FG003|Double-blind Phase|Adverse Event|4|||
16552222|NCT02318719|40484719|FG004|Double-blind Phase|Adverse Event|0|||
16552223|NCT02318719|40484715|FG000|Double-blind Phase|Lack of Efficacy|5|||
16552224|NCT02318719|40484716|FG001|Double-blind Phase|Lack of Efficacy|0|||
16552225|NCT02318719|40484717|FG002|Double-blind Phase|Lack of Efficacy|1|||
16552226|NCT02318719|40484718|FG003|Double-blind Phase|Lack of Efficacy|1|||
16231918|NCT03410693|39331241|FG001|Overall Study|Disc trt: Lost to follow up|1|||
16231919|NCT03410693|39331240|FG000|Overall Study|Disc trt: radiological progression|58|||
16552227|NCT02318719|40484719|FG004|Double-blind Phase|Lack of Efficacy|0|||
16552228|NCT02318719|40484715|FG000|Double-blind Phase|Protocol Violation|0|||
16552229|NCT02318719|40484716|FG001|Double-blind Phase|Protocol Violation|1|||
16552230|NCT02318719|40484717|FG002|Double-blind Phase|Protocol Violation|3|||
16552231|NCT02318719|40484718|FG003|Double-blind Phase|Protocol Violation|0|||
16552232|NCT02318719|40484719|FG004|Double-blind Phase|Protocol Violation|0|||
16552233|NCT02318719|40484715|FG000|Double-blind Phase|Withdrawal by Subject|25|||
16552234|NCT02318719|40484716|FG001|Double-blind Phase|Withdrawal by Subject|7|||
16552235|NCT02318719|40484717|FG002|Double-blind Phase|Withdrawal by Subject|9|||
16552236|NCT02318719|40484718|FG003|Double-blind Phase|Withdrawal by Subject|10|||
16552237|NCT02318719|40484719|FG004|Double-blind Phase|Withdrawal by Subject|0|||
16552238|NCT02318719|40484715|FG000|Double-blind Phase|Other|1|||
16231920|NCT03410693|39331241|FG001|Overall Study|Disc trt: radiological progression|50|||
16231921|NCT03410693|39331240|FG000|Overall Study|Disc trt: Other|1|||
16413112|NCT00454649|39995028|FG006|Overall Study|Other|0|||
16413113|NCT00454649|39995029|FG007|Overall Study|Other|0|||
16413114|NCT00454649|39995030|FG008|Overall Study|Other|3|||
16413115|NCT00454649|39995031|FG009|Overall Study|Other|1|||
16413116|NCT00454649|39995022|FG000|Overall Study|Withdrawal by Subject|0|||
16413117|NCT00454649|39995023|FG001|Overall Study|Withdrawal by Subject|0|||
16552239|NCT02318719|40484716|FG001|Double-blind Phase|Other|2|||
16231922|NCT03410693|39331241|FG001|Overall Study|Disc trt: Other|0|||
16231923|NCT03410693|39331240|FG000|Overall Study|Study drug never administered|1|||
16231924|NCT03410693|39331241|FG001|Overall Study|Study drug never administered|6|||
16231925|NCT03410693|39331240|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
16231926|NCT03410693|39331241|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
16231927|NCT03410693|39331240|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
16231928|NCT03410693|39331241|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
16231929|NCT03410693|39331240|FG000|Overall Study|Disc trt: Physician decision|0|||
16231930|NCT03410693|39331241|FG001|Overall Study|Disc trt: Physician decision|5|||
16231931|NCT03410693|39331240|FG000|Overall Study|Disc trt: clinical progression|1|||
16231932|NCT03410693|39331241|FG001|Overall Study|Disc trt: clinical progression|5|||
16231933|NCT03410693|39331240|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
16231934|NCT03410693|39331241|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
16231935|NCT02396849|39331248|FG000|Overall Study|Lost to Follow-up|1|||
16231936|NCT02396849|39331249|FG001|Overall Study|Lost to Follow-up|1|||
16231937|NCT02396849|39331248|FG000|Overall Study|Did not tolerate intervention|1|||
16231938|NCT02396849|39331249|FG001|Overall Study|Did not tolerate intervention|1|||
16231939|NCT01301625|39331250|FG000|Overall Study|Death|5|||
16231940|NCT01301625|39331250|FG000|Overall Study|Not Due|21|||
16231941|NCT01301625|39331250|FG000|Overall Study|Expected|8|||
16231942|NCT01301625|39331250|FG000|Overall Study|Lost to Follow-up|1|||
16231943|NCT04434937|39331251|FG000|Overall Study|Death|4|||
16231944|NCT04434937|39331251|FG000|Overall Study|Withdrawal by Subject|1|||
16231945|NCT04434937|39331251|FG000|Overall Study|"Captured as Other in Database"|1|||
16231946|NCT04434937|39331251|FG000|Overall Study|Ongoing|36|||
16231947|NCT03185949|39331252|FG000|ITT Analysis|Withdrawal by Subject|4|||
16231948|NCT03185949|39331253|FG001|ITT Analysis|Withdrawal by Subject|3|||
16231949|NCT03185949|39331252|FG000|PP Analysis|Protocol Violation|2|||
16231950|NCT03185949|39331253|FG001|PP Analysis|Protocol Violation|2|||
16231951|NCT03185949|39331252|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
16231952|NCT03185949|39331253|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
16231953|NCT01864746|39331267|FG000|Overall Study|Disease recurrence|25|||
16231954|NCT01864746|39331268|FG001|Overall Study|Disease recurrence|40|||
16231955|NCT01864746|39331267|FG000|Overall Study|Second primary invasive nonbreast|2|||
16413118|NCT00454649|39995024|FG002|Overall Study|Withdrawal by Subject|0|||
16552240|NCT02318719|40484717|FG002|Double-blind Phase|Other|0|||
16552241|NCT02318719|40484718|FG003|Double-blind Phase|Other|0|||
16552242|NCT02318719|40484719|FG004|Double-blind Phase|Other|0|||
16552243|NCT02318719|40484715|FG000|Open-label Extension Phase|Adverse Event|0|||
16552244|NCT02318719|40484716|FG001|Open-label Extension Phase|Adverse Event|0|||
16552245|NCT02318719|40484717|FG002|Open-label Extension Phase|Adverse Event|0|||
16552246|NCT02318719|40484718|FG003|Open-label Extension Phase|Adverse Event|0|||
16231956|NCT01864746|39331268|FG001|Overall Study|Second primary invasive nonbreast|3|||
16231957|NCT01864746|39331267|FG000|Overall Study|Death|2|||
16231958|NCT01864746|39331268|FG001|Overall Study|Death|1|||
16552247|NCT02318719|40484719|FG004|Open-label Extension Phase|Adverse Event|15|||
16552248|NCT02318719|40484715|FG000|Open-label Extension Phase|Death|0|||
16552249|NCT02318719|40484716|FG001|Open-label Extension Phase|Death|0|||
16552250|NCT02318719|40484717|FG002|Open-label Extension Phase|Death|0|||
16552251|NCT02318719|40484718|FG003|Open-label Extension Phase|Death|0|||
16552252|NCT02318719|40484719|FG004|Open-label Extension Phase|Death|1|||
16552253|NCT02318719|40484715|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
16552254|NCT02318719|40484716|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
16552255|NCT02318719|40484717|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
16552256|NCT02318719|40484718|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
16552257|NCT02318719|40484719|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
16552258|NCT02318719|40484715|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
16552259|NCT02318719|40484716|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
16552260|NCT02318719|40484717|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
16552261|NCT02318719|40484718|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
16552262|NCT02318719|40484719|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
16552263|NCT02318719|40484715|FG000|Open-label Extension Phase|Other|0|||
16552264|NCT02318719|40484716|FG001|Open-label Extension Phase|Other|0|||
16552265|NCT02318719|40484717|FG002|Open-label Extension Phase|Other|0|||
16120009|NCT01646177|38927121|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
16348567|NCT02959918|39765413|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16348568|NCT02959918|39765414|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16348569|NCT02959918|39765415|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16348570|NCT02959918|39765416|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16348571|NCT02959918|39765417|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16348572|NCT02959918|39765418|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
16348573|NCT02959918|39765405|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348574|NCT02959918|39765406|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348575|NCT02959918|39765407|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348576|NCT02959918|39765408|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348577|NCT02959918|39765409|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348578|NCT02959918|39765410|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348579|NCT02959918|39765411|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348580|NCT02959918|39765412|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348581|NCT02959918|39765413|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
16348582|NCT02959918|39765414|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348583|NCT02959918|39765415|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348584|NCT02959918|39765416|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348585|NCT02959918|39765417|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348586|NCT02959918|39765418|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
16348587|NCT02959918|39765405|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16413119|NCT00454649|39995025|FG003|Overall Study|Withdrawal by Subject|0|||
16413120|NCT00454649|39995026|FG004|Overall Study|Withdrawal by Subject|0|||
16413121|NCT00454649|39995027|FG005|Overall Study|Withdrawal by Subject|1|||
16413122|NCT00454649|39995028|FG006|Overall Study|Withdrawal by Subject|0|||
16413123|NCT00454649|39995029|FG007|Overall Study|Withdrawal by Subject|2|||
16413124|NCT00454649|39995030|FG008|Overall Study|Withdrawal by Subject|1|||
16413125|NCT00454649|39995031|FG009|Overall Study|Withdrawal by Subject|0|||
16413126|NCT00066469|39995032|FG000|Overall Study|Death|3|||
16413127|NCT00066469|39995032|FG000|Overall Study|Lack of Efficacy|9|||
16413128|NCT00066469|39995032|FG000|Overall Study|Lost to Follow-up|1|||
16413129|NCT00066469|39995032|FG000|Overall Study|Physician Decision|1|||
16413130|NCT00066469|39995032|FG000|Overall Study|Withdrawal by Subject|1|||
16413131|NCT00066469|39995032|FG000|Overall Study|ineligible|1|||
16413132|NCT00424190|39995039|FG000|Overall Study|Withdrew consent|3|||
16413133|NCT00424190|39995040|FG001|Overall Study|Withdrew consent|4|||
16348588|NCT02959918|39765406|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16413134|NCT00424190|39995039|FG000|Overall Study|Death|3|||
16413135|NCT00424190|39995040|FG001|Overall Study|Death|0|||
16413136|NCT00424190|39995039|FG000|Overall Study|Noncompliance|1|||
16413137|NCT00424190|39995040|FG001|Overall Study|Noncompliance|2|||
16413138|NCT00424190|39995039|FG000|Overall Study|Request of sponsor or investigator|0|||
16413139|NCT00424190|39995040|FG001|Overall Study|Request of sponsor or investigator|2|||
16413140|NCT00424190|39995039|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
16413141|NCT00424190|39995040|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
16413142|NCT00424190|39995039|FG000|Overall Study|Other|15|||
16413143|NCT00424190|39995040|FG001|Overall Study|Other|21|||
16413144|NCT00453973|39995042|FG000|Overall Study|Adverse Event|4|||
16413145|NCT00453973|39995043|FG001|Overall Study|Adverse Event|9|||
16413146|NCT00453973|39995042|FG000|Overall Study|Withdrawal by Subject|7|||
16413147|NCT00453973|39995043|FG001|Overall Study|Withdrawal by Subject|6|||
16413148|NCT00453973|39995042|FG000|Overall Study|PI Decision|0|||
16413149|NCT00453973|39995043|FG001|Overall Study|PI Decision|2|||
16413150|NCT00453973|39995042|FG000|Overall Study|Relocation|1|||
16413151|NCT00453973|39995043|FG001|Overall Study|Relocation|0|||
16413152|NCT00453973|39995042|FG000|Overall Study|Renal transplant|1|||
16413153|NCT00453973|39995043|FG001|Overall Study|Renal transplant|1|||
16413154|NCT00453973|39995042|FG000|Overall Study|Site closed by sponsor|3|||
16413155|NCT00453973|39995043|FG001|Overall Study|Site closed by sponsor|0|||
16413156|NCT00453973|39995042|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
16413157|NCT00453973|39995043|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
16413158|NCT02739321|39995044|FG000|Overall Study|Lack of Efficacy|1|||
16413159|NCT02739321|39995045|FG001|Overall Study|Lack of Efficacy|1|||
16413160|NCT02739321|39995044|FG000|Overall Study|Lost to Follow-up|1|||
16413161|NCT02739321|39995045|FG001|Overall Study|Lost to Follow-up|1|||
16413162|NCT02739321|39995044|FG000|Overall Study|Withdrawal by Subject|1|||
16413163|NCT02739321|39995045|FG001|Overall Study|Withdrawal by Subject|2|||
16413164|NCT02006069|39995053|FG000|Overall Study|MPP other programming|239|||
16413165|NCT02006069|39995054|FG001|Overall Study|MPP other programming|0|||
16413166|NCT02006069|39995053|FG000|Overall Study|RV only pacing|0|||
16413167|NCT02006069|39995054|FG001|Overall Study|RV only pacing|3|||
16413168|NCT02241187|39995057|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
16413169|NCT01806064|39995060|FG000|Overall Study|Randomized Not Enrolled|0|||
16413170|NCT01806064|39995061|FG001|Overall Study|Randomized Not Enrolled|0|||
16413171|NCT01806064|39995062|FG002|Overall Study|Randomized Not Enrolled|0|||
16413172|NCT01806064|39995063|FG003|Overall Study|Randomized Not Enrolled|1|||
16413173|NCT01806064|39995064|FG004|Overall Study|Randomized Not Enrolled|2|||
16413174|NCT04109976|39995065|FG000|Overall Study|Withdrawal by Subject|1|||
16413175|NCT04109976|39995066|FG001|Overall Study|Withdrawal by Subject|0|||
16413176|NCT03691779|39995067|FG000|Part B (24 Weeks)|Adverse Event|0|||
16413177|NCT03691779|39995068|FG001|Part B (24 Weeks)|Adverse Event|1|||
16413178|NCT03691779|39995067|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
16413179|NCT03691779|39995068|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
16413180|NCT02080260|39995069|FG000|Overall Study|Death|18|||
16413181|NCT02080260|39995069|FG000|Overall Study|Withdrawal by Subject|1|||
16413182|NCT00707746|39995075|FG000|Treatment Period|Adverse Event|2|||
16413183|NCT00707746|39995076|FG001|Treatment Period|Adverse Event|4|||
16413184|NCT00707746|39995075|FG000|Treatment Period|Ineligibility|0|||
16413185|NCT00707746|39995076|FG001|Treatment Period|Ineligibility|1|||
16413186|NCT00491608|39995077|FG000|Overall Study|Death|2|||
16413187|NCT00491608|39995077|FG000|Overall Study|Withdrawal by Subject|1|||
16413188|NCT01522404|39995079|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
16413189|NCT01522404|39995080|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
16413190|NCT01522404|39995079|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
16413191|NCT01522404|39995080|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
16413192|NCT01522404|39995079|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
16413193|NCT01522404|39995080|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
16413194|NCT01282294|39995081|FG000|Overall Study|Lost to Follow-up|14|||
16413195|NCT01282294|39995081|FG000|Overall Study|Screening failure|1|||
16413196|NCT01282294|39995081|FG000|Overall Study|Adverse Event|1|||
16413197|NCT01282294|39995081|FG000|Overall Study|Patient non-compliance|2|||
16413198|NCT01282294|39995081|FG000|Overall Study|Physician Decision|1|||
16413199|NCT01561963|39995089|FG000|Overall Study|Adverse Event|1|||
16413200|NCT03759041|39995094|FG000|Overall Study|Withdrawal by Subject|4|||
16231959|NCT01864746|39331267|FG000|Overall Study|Adverse Event|33|||
16348589|NCT02959918|39765407|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16348590|NCT02959918|39765408|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16348591|NCT02959918|39765409|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16348592|NCT02959918|39765410|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16348593|NCT02959918|39765411|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16348594|NCT02959918|39765412|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16348595|NCT02959918|39765413|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16348596|NCT02959918|39765414|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
16348597|NCT02959918|39765415|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16348598|NCT02959918|39765416|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16348599|NCT02959918|39765417|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16348600|NCT02959918|39765418|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
16413201|NCT03759041|39995095|FG001|Overall Study|Withdrawal by Subject|10|||
16413202|NCT03759041|39995096|FG002|Overall Study|Withdrawal by Subject|10|||
16413203|NCT03759041|39995094|FG000|Overall Study|Adverse Event|1|||
16413204|NCT03759041|39995095|FG001|Overall Study|Adverse Event|3|||
16413205|NCT03759041|39995096|FG002|Overall Study|Adverse Event|4|||
16413206|NCT03759041|39995094|FG000|Overall Study|Lack of Efficacy|0|||
16413207|NCT03759041|39995095|FG001|Overall Study|Lack of Efficacy|0|||
16231960|NCT01864746|39331268|FG001|Overall Study|Adverse Event|5|||
16413208|NCT03759041|39995096|FG002|Overall Study|Lack of Efficacy|1|||
16413209|NCT03759041|39995094|FG000|Overall Study|Study Terminated by Sponsor|15|||
16413210|NCT03759041|39995095|FG001|Overall Study|Study Terminated by Sponsor|16|||
16413211|NCT03759041|39995096|FG002|Overall Study|Study Terminated by Sponsor|10|||
16413212|NCT03759041|39995094|FG000|Overall Study|Other reason for discontinuation|0|||
16413213|NCT03759041|39995095|FG001|Overall Study|Other reason for discontinuation|2|||
16413214|NCT03759041|39995096|FG002|Overall Study|Other reason for discontinuation|1|||
16413215|NCT03759041|39995094|FG000|Overall Study|Lost to Follow-up|7|||
16413216|NCT03759041|39995095|FG001|Overall Study|Lost to Follow-up|2|||
16413217|NCT03759041|39995096|FG002|Overall Study|Lost to Follow-up|2|||
16413218|NCT03759041|39995094|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
16413219|NCT03759041|39995095|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
16413220|NCT03759041|39995096|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
16413221|NCT02758301|39995097|FG000|Overall Study|Death|12|||
16413222|NCT02758301|39995098|FG001|Overall Study|Death|0|||
16413223|NCT02758301|39995097|FG000|Overall Study|Physician Decision|10|||
16413224|NCT02758301|39995098|FG001|Overall Study|Physician Decision|1|||
16413225|NCT02758301|39995097|FG000|Overall Study|Withdrawal by Subject|5|||
16413226|NCT02758301|39995098|FG001|Overall Study|Withdrawal by Subject|6|||
16413227|NCT02758301|39995097|FG000|Overall Study|Lost to Follow-up|7|||
16413228|NCT02758301|39995098|FG001|Overall Study|Lost to Follow-up|0|||
16413229|NCT02758301|39995097|FG000|Overall Study|Protocol Violation|0|||
16120010|NCT01646177|38927110|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16120011|NCT01646177|38927111|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16120012|NCT01646177|38927112|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
16120013|NCT01646177|38927113|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
16120014|NCT01646177|38927114|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16120015|NCT01646177|38927115|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16120016|NCT01646177|38927116|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16348601|NCT04817332|39765421|FG000|Overall Study|Lost to Follow-up|3|||
16348602|NCT04817332|39765422|FG001|Overall Study|Lost to Follow-up|3|||
16348603|NCT04817332|39765421|FG000|Overall Study|Protocol Violation|2|||
16348604|NCT04817332|39765422|FG001|Overall Study|Protocol Violation|0|||
16348605|NCT03569098|39765423|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
16348606|NCT03569098|39765424|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
16348607|NCT03569098|39765425|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
16348608|NCT03569098|39765423|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
16348609|NCT03569098|39765424|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
16348610|NCT03569098|39765425|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
16348611|NCT03569098|39765423|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
16348612|NCT03569098|39765424|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
16348613|NCT03569098|39765425|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
16348614|NCT03569098|39765423|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
16348615|NCT03569098|39765424|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
16348616|NCT03569098|39765425|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
16348617|NCT03569098|39765423|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
16348618|NCT03569098|39765424|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
16120017|NCT01646177|38927117|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16120018|NCT01646177|38927118|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16120019|NCT01646177|38927119|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16120020|NCT01646177|38927120|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16120021|NCT01646177|38927121|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
16120022|NCT01646177|38927110|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
16120023|NCT01646177|38927111|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
16120024|NCT01646177|38927112|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
16120025|NCT01646177|38927113|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16120026|NCT01646177|38927114|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16120027|NCT01646177|38927115|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16120028|NCT01646177|38927116|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16120029|NCT01646177|38927117|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16120030|NCT01646177|38927118|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16120031|NCT01646177|38927119|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16120032|NCT01646177|38927120|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16120033|NCT01646177|38927121|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
16120034|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16120035|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16120036|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16120037|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16120038|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
16120039|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
16120040|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
16120041|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
16120042|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16120043|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16120044|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16120045|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
16120046|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16120047|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16120048|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16120049|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16120050|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
16120051|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
16120052|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
16120053|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
16120054|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16120055|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16120056|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16120057|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
16120058|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16120059|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16120060|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16413230|NCT02758301|39995098|FG001|Overall Study|Protocol Violation|1|||
16231961|NCT01864746|39331267|FG000|Overall Study|Withdrawal by Subject|56|||
16231962|NCT01864746|39331268|FG001|Overall Study|Withdrawal by Subject|41|||
16231963|NCT01864746|39331267|FG000|Overall Study|Physician Decision|5|||
16231964|NCT01864746|39331268|FG001|Overall Study|Physician Decision|6|||
16231965|NCT03802331|39331269|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
16231966|NCT03802331|39331270|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
16231967|NCT01165424|39331271|FG000|Overall Study|Clinical adverse experiences|1|||
16231968|NCT01165424|39331271|FG000|Overall Study|Laboratory adverse experiences|1|||
16231969|NCT01165424|39331271|FG000|Overall Study|Did not meet entry criteria|1|||
16231970|NCT01165424|39331271|FG000|Overall Study|Participant moved (relocated)|1|||
16231971|NCT00090259|39331272|FG000|Overall Study|Lost to Follow-up|30|||
16231972|NCT00090259|39331273|FG001|Overall Study|Lost to Follow-up|26|||
16231973|NCT00090259|39331272|FG000|Overall Study|Withdrawal by Subject|21|||
16231974|NCT00090259|39331273|FG001|Overall Study|Withdrawal by Subject|15|||
16231975|NCT00090259|39331272|FG000|Overall Study|Investigator site closed|11|||
16231976|NCT00090259|39331273|FG001|Overall Study|Investigator site closed|7|||
16231977|NCT00308555|39331274|FG000|Overall Study|Withdrawal by Subject|1|||
16231978|NCT00308555|39331275|FG001|Overall Study|Withdrawal by Subject|0|||
16231979|NCT00308555|39331274|FG000|Overall Study|Physician Decision|2|||
16231980|NCT00308555|39331275|FG001|Overall Study|Physician Decision|0|||
16231981|NCT00572910|39331276|FG000|Overall Study|Adverse Event|1|||
16231982|NCT00572910|39331277|FG001|Overall Study|Adverse Event|2|||
16231983|NCT00572910|39331278|FG002|Overall Study|Adverse Event|0|||
16231984|NCT00572910|39331279|FG003|Overall Study|Adverse Event|2|||
16231985|NCT00572910|39331280|FG004|Overall Study|Adverse Event|0|||
16231986|NCT00572910|39331281|FG005|Overall Study|Adverse Event|0|||
16231987|NCT00572910|39331282|FG006|Overall Study|Adverse Event|4|||
16231988|NCT00572910|39331283|FG007|Overall Study|Adverse Event|2|||
16231989|NCT00572910|39331284|FG008|Overall Study|Adverse Event|1|||
16231990|NCT00572910|39331285|FG009|Overall Study|Adverse Event|3|||
16231991|NCT00572910|39331286|FG010|Overall Study|Adverse Event|2|||
16231992|NCT00572910|39331276|FG000|Overall Study|Lost to Follow-up|0|||
16231993|NCT00572910|39331277|FG001|Overall Study|Lost to Follow-up|1|||
16231994|NCT00572910|39331278|FG002|Overall Study|Lost to Follow-up|1|||
16231995|NCT00572910|39331279|FG003|Overall Study|Lost to Follow-up|2|||
16231996|NCT00572910|39331280|FG004|Overall Study|Lost to Follow-up|1|||
16231997|NCT00572910|39331281|FG005|Overall Study|Lost to Follow-up|0|||
16231998|NCT00572910|39331282|FG006|Overall Study|Lost to Follow-up|0|||
16231999|NCT00572910|39331283|FG007|Overall Study|Lost to Follow-up|0|||
16232000|NCT00572910|39331284|FG008|Overall Study|Lost to Follow-up|0|||
16232001|NCT00572910|39331285|FG009|Overall Study|Lost to Follow-up|1|||
16232002|NCT00572910|39331286|FG010|Overall Study|Lost to Follow-up|0|||
16232003|NCT00572910|39331276|FG000|Overall Study|Withdrawal by Subject|3|||
16232004|NCT00572910|39331277|FG001|Overall Study|Withdrawal by Subject|0|||
16348619|NCT03569098|39765425|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
16348620|NCT03569098|39765423|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
16348621|NCT03569098|39765424|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
16348622|NCT03569098|39765425|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
16348623|NCT03569098|39765423|FG000|Double-Blind Treatment Cycle 1|Other|1|||
16348624|NCT03569098|39765424|FG001|Double-Blind Treatment Cycle 1|Other|0|||
16120061|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16232005|NCT00572910|39331278|FG002|Overall Study|Withdrawal by Subject|1|||
16232006|NCT00572910|39331279|FG003|Overall Study|Withdrawal by Subject|0|||
16232007|NCT00572910|39331280|FG004|Overall Study|Withdrawal by Subject|1|||
16232008|NCT00572910|39331281|FG005|Overall Study|Withdrawal by Subject|3|||
16232009|NCT00572910|39331282|FG006|Overall Study|Withdrawal by Subject|0|||
16232010|NCT00572910|39331283|FG007|Overall Study|Withdrawal by Subject|2|||
16232011|NCT00572910|39331284|FG008|Overall Study|Withdrawal by Subject|2|||
16232012|NCT00572910|39331285|FG009|Overall Study|Withdrawal by Subject|2|||
16232013|NCT00572910|39331286|FG010|Overall Study|Withdrawal by Subject|1|||
16232014|NCT02769832|39331287|FG000|Overall Study|Death|30|||
16232015|NCT00270205|39331288|FG000|Overall Study|Lost to Follow-up|1|||
16232016|NCT00270205|39331289|FG001|Overall Study|Lost to Follow-up|0|||
16232017|NCT00270205|39331290|FG002|Overall Study|Lost to Follow-up|0|||
16232018|NCT00270205|39331291|FG003|Overall Study|Lost to Follow-up|1|||
16232019|NCT02660489|39331292|FG000|Overall Study|Lost to Follow-up|1|||
16232020|NCT02660489|39331293|FG001|Overall Study|Lost to Follow-up|1|||
16232021|NCT02660489|39331292|FG000|Overall Study|Adverse Event|1|||
16232022|NCT02660489|39331293|FG001|Overall Study|Adverse Event|3|||
16232023|NCT02660489|39331292|FG000|Overall Study|no rhinovirus infection|4|||
16232024|NCT02660489|39331293|FG001|Overall Study|no rhinovirus infection|4|||
16232025|NCT04984889|39331294|FG000|Extension Part|Ongoing|5|||
16232026|NCT00883129|39331295|FG000|Overall Study|Adverse Event|7|||
16232027|NCT00883129|39331296|FG001|Overall Study|Adverse Event|15|||
16232028|NCT00883129|39331295|FG000|Overall Study|Withdrawal by Subject|8|||
16232029|NCT00883129|39331296|FG001|Overall Study|Withdrawal by Subject|9|||
16232030|NCT00883129|39331295|FG000|Overall Study|Non-compliance|3|||
16232031|NCT00883129|39331296|FG001|Overall Study|Non-compliance|6|||
16232032|NCT00883129|39331295|FG000|Overall Study|Lost to Follow-up|1|||
16232033|NCT00883129|39331296|FG001|Overall Study|Lost to Follow-up|2|||
16232034|NCT00883129|39331295|FG000|Overall Study|Death|1|||
16232035|NCT00883129|39331296|FG001|Overall Study|Death|2|||
16232036|NCT00883129|39331295|FG000|Overall Study|Defined Treatment Failure|0|||
16232037|NCT00883129|39331296|FG001|Overall Study|Defined Treatment Failure|2|||
16232038|NCT03940742|39331300|FG000|Overall Study|Lost to Follow-up|0|||
16232039|NCT03940742|39331301|FG001|Overall Study|Lost to Follow-up|0|||
16232040|NCT03940742|39331302|FG002|Overall Study|Lost to Follow-up|0|||
16232041|NCT03940742|39331303|FG003|Overall Study|Lost to Follow-up|1|||
16232042|NCT00061568|39331306|FG000|Overall Study|Lost to Follow-up|12|||
16232043|NCT00061568|39331307|FG001|Overall Study|Lost to Follow-up|0|||
16232044|NCT00061568|39331306|FG000|Overall Study|Death|6|||
16232045|NCT00061568|39331307|FG001|Overall Study|Death|0|||
16232046|NCT00061568|39331306|FG000|Overall Study|Withdrawal by Subject|1|||
16232047|NCT00061568|39331307|FG001|Overall Study|Withdrawal by Subject|0|||
16232048|NCT02087865|39331308|FG000|Overall Study|Withdrawal by Subject|6|||
16232049|NCT02087865|39331309|FG001|Overall Study|Withdrawal by Subject|0|||
16232050|NCT02087865|39331310|FG002|Overall Study|Withdrawal by Subject|1|||
16232051|NCT02087865|39331308|FG000|Overall Study|Lost to Follow-up|0|||
16232052|NCT02087865|39331309|FG001|Overall Study|Lost to Follow-up|0|||
16232053|NCT02087865|39331310|FG002|Overall Study|Lost to Follow-up|1|||
16232054|NCT02087865|39331308|FG000|Overall Study|Drug Non-compliance|0|||
16232055|NCT02087865|39331309|FG001|Overall Study|Drug Non-compliance|2|||
16232056|NCT02087865|39331310|FG002|Overall Study|Drug Non-compliance|0|||
16232057|NCT02087865|39331308|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
16232058|NCT02087865|39331309|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
16232059|NCT02087865|39331310|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
16348625|NCT03569098|39765425|FG002|Double-Blind Treatment Cycle 1|Other|1|||
16348626|NCT03569098|39765423|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
16348627|NCT03569098|39765424|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
16348628|NCT03569098|39765425|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
16348629|NCT03569098|39765423|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
16348630|NCT03569098|39765424|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
16348631|NCT03569098|39765425|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
16348632|NCT03569098|39765423|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
16413231|NCT00581828|39995099|FG000|Overall Study|Protocol Violation|1|||
16232060|NCT01612780|39331312|FG000|Overall Study|Treatment not completed|1|||
16232061|NCT01612780|39331312|FG000|Overall Study|Withdrawal by Subject|5|||
16232062|NCT01353586|39331313|FG000|Overall Study|Procedure terminated prior to ablation|3|||
16232063|NCT01353586|39331314|FG001|Overall Study|Procedure terminated prior to ablation|0|||
16232064|NCT01353586|39331313|FG000|Overall Study|Never had insertion of study catheter|4|||
16232065|NCT01353586|39331314|FG001|Overall Study|Never had insertion of study catheter|1|||
16232066|NCT01353586|39331313|FG000|Overall Study|Neurological exam not done|0|||
16232067|NCT01353586|39331314|FG001|Overall Study|Neurological exam not done|1|||
16232068|NCT01336647|39331315|FG000|Overall Study|Lost to Follow-up|4|||
16232069|NCT01336647|39331316|FG001|Overall Study|Lost to Follow-up|1|||
16232070|NCT01336647|39331317|FG002|Overall Study|Lost to Follow-up|3|||
16232071|NCT01360021|39331322|FG000|Overall Study|Eligibility criteria + other|2|||
16232072|NCT01360021|39331323|FG001|Overall Study|Eligibility criteria + other|1|||
16232073|NCT01360021|39331324|FG002|Overall Study|Eligibility criteria + other|1|||
16232074|NCT01360021|39331322|FG000|Overall Study|Protocol Violation|0|||
16232075|NCT01360021|39331323|FG001|Overall Study|Protocol Violation|0|||
16232076|NCT01360021|39331324|FG002|Overall Study|Protocol Violation|1|||
16232077|NCT01360021|39331322|FG000|Overall Study|Withdrawal by Subject|4|||
16232078|NCT01360021|39331323|FG001|Overall Study|Withdrawal by Subject|0|||
16232079|NCT01360021|39331324|FG002|Overall Study|Withdrawal by Subject|2|||
16232080|NCT01360021|39331322|FG000|Overall Study|Adverse Event|2|||
16232081|NCT01360021|39331323|FG001|Overall Study|Adverse Event|3|||
16232082|NCT01360021|39331324|FG002|Overall Study|Adverse Event|3|||
16232083|NCT00457249|39331327|FG000|Overall Study|Lost to Follow-up|3|||
16232084|NCT00457249|39331328|FG001|Overall Study|Lost to Follow-up|0|||
16232085|NCT00457249|39331327|FG000|Overall Study|Protocol Violation|4|||
16232086|NCT00457249|39331328|FG001|Overall Study|Protocol Violation|1|||
16232087|NCT00457249|39331327|FG000|Overall Study|Withdrawal by Subject|3|||
16232088|NCT00457249|39331328|FG001|Overall Study|Withdrawal by Subject|1|||
16232089|NCT00457249|39331327|FG000|Overall Study|Serious Adverse Events|2|||
16232090|NCT00457249|39331328|FG001|Overall Study|Serious Adverse Events|0|||
16232091|NCT00538473|39331331|FG000|Overall Study|Adverse Event|1|||
16232092|NCT00538473|39331332|FG001|Overall Study|Adverse Event|0|||
16232093|NCT00247416|39331333|FG000|Overall Study|3 patients were found to be ineligible|1|||
16232094|NCT00247416|39331334|FG001|Overall Study|3 patients were found to be ineligible|2|||
16232095|NCT00975000|39331335|FG000|Overall Study|Other|1|||
16232096|NCT00975000|39331336|FG001|Overall Study|Other|0|||
16232097|NCT00975000|39331335|FG000|Overall Study|Adverse Event|1|||
16232098|NCT00975000|39331336|FG001|Overall Study|Adverse Event|1|||
16232099|NCT00975000|39331335|FG000|Overall Study|Withdrawal by Subject|2|||
16232100|NCT00975000|39331336|FG001|Overall Study|Withdrawal by Subject|2|||
16232101|NCT00975000|39331335|FG000|Overall Study|Lost to Follow-up|0|||
16232102|NCT00975000|39331336|FG001|Overall Study|Lost to Follow-up|1|||
16232103|NCT00975000|39331335|FG000|Overall Study|Protocol-specified Criteria|1|||
16232104|NCT00975000|39331336|FG001|Overall Study|Protocol-specified Criteria|0|||
16232105|NCT00975000|39331335|FG000|Overall Study|Non-compliance|0|||
16232106|NCT00975000|39331336|FG001|Overall Study|Non-compliance|1|||
16232107|NCT01901393|39331337|FG000|Overall Study|Adverse Event|1|||
16232108|NCT01901393|39331338|FG001|Overall Study|Adverse Event|0|||
16232109|NCT01826201|39331351|FG000|Overall Study|Non compliance with protocol|4|||
16232110|NCT00491322|39331352|FG000|Overall Study|Protocol Violation|1|||
16232111|NCT00491322|39331353|FG001|Overall Study|Protocol Violation|0|||
16232112|NCT00491322|39331352|FG000|Overall Study|Pregnancy|0|||
16232113|NCT00491322|39331353|FG001|Overall Study|Pregnancy|1|||
16232114|NCT03839693|39331354|FG000|Overall Study|Lost to Follow-up|0|||
16232115|NCT03839693|39331355|FG001|Overall Study|Lost to Follow-up|2|||
16232116|NCT03839693|39331356|FG002|Overall Study|Lost to Follow-up|2|||
16232117|NCT03839693|39331354|FG000|Overall Study|Withdrawal by Subject|1|||
16232118|NCT03839693|39331355|FG001|Overall Study|Withdrawal by Subject|0|||
16232119|NCT03839693|39331356|FG002|Overall Study|Withdrawal by Subject|2|||
16232120|NCT03839693|39331354|FG000|Overall Study|subject moved out of the area|1|||
16232121|NCT03839693|39331355|FG001|Overall Study|subject moved out of the area|0|||
16232122|NCT03839693|39331356|FG002|Overall Study|subject moved out of the area|0|||
16232123|NCT03605758|39331357|FG000|Overall Study|Lost to Follow-up|2|||
16232124|NCT03605758|39331358|FG001|Overall Study|Lost to Follow-up|1|||
16232125|NCT03605758|39331357|FG000|Overall Study|Illness|0|||
16232126|NCT03605758|39331358|FG001|Overall Study|Illness|1|||
16232127|NCT03605758|39331357|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
16232128|NCT03605758|39331358|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
16552266|NCT02318719|40484718|FG003|Open-label Extension Phase|Other|0|||
16232129|NCT00585468|39331359|FG000|First Intervention|Withdrawal by Subject|1|||
16232130|NCT00585468|39331360|FG001|First Intervention|Withdrawal by Subject|1|||
16232131|NCT00563706|39331361|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
16232132|NCT00563706|39331362|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
16232133|NCT00563706|39331363|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
16232134|NCT00563706|39331364|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
16232135|NCT00563706|39331365|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
16232136|NCT00563706|39331366|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
16232137|NCT00563706|39331367|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
16232138|NCT00563706|39331368|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
16232139|NCT00563706|39331369|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
16232140|NCT00563706|39331361|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
16232141|NCT00563706|39331362|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
16232142|NCT00563706|39331363|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
16552267|NCT02318719|40484719|FG004|Open-label Extension Phase|Other|7|||
16552268|NCT00810082|40484720|FG000|Overall Study|Lost to Follow-up|0|||
16552269|NCT00810082|40484721|FG001|Overall Study|Lost to Follow-up|4|||
16552270|NCT00308737|40484723|FG000|Overall Study|Adverse Event|104|||
16552271|NCT00308737|40484724|FG001|Overall Study|Adverse Event|9|||
16552272|NCT00308737|40484725|FG002|Overall Study|Adverse Event|0|||
16552273|NCT00308737|40484723|FG000|Overall Study|Death|4|||
16552274|NCT00308737|40484724|FG001|Overall Study|Death|3|||
16552275|NCT00308737|40484725|FG002|Overall Study|Death|0|||
16552276|NCT00308737|40484723|FG000|Overall Study|Lost to Follow-up|56|||
16552277|NCT00308737|40484724|FG001|Overall Study|Lost to Follow-up|80|||
16552278|NCT00308737|40484725|FG002|Overall Study|Lost to Follow-up|5|||
16552279|NCT00308737|40484723|FG000|Overall Study|Physician Decision|15|||
16552280|NCT00308737|40484724|FG001|Overall Study|Physician Decision|2|||
16552281|NCT00308737|40484725|FG002|Overall Study|Physician Decision|1|||
16552282|NCT00308737|40484723|FG000|Overall Study|Protocol Violation|34|||
16232143|NCT00563706|39331364|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
16232144|NCT00563706|39331365|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
16232145|NCT00563706|39331366|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
16232146|NCT00563706|39331367|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
16232147|NCT00563706|39331368|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
16232148|NCT00563706|39331369|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
16232149|NCT00563706|39331361|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
16232150|NCT00563706|39331362|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
16232151|NCT00563706|39331363|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
16232152|NCT00563706|39331364|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
16232153|NCT00563706|39331365|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
16232154|NCT00563706|39331366|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
16232155|NCT00563706|39331367|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
16232156|NCT00563706|39331368|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
16232157|NCT00563706|39331369|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
16232158|NCT00563706|39331361|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
16232159|NCT00563706|39331362|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
16232160|NCT00563706|39331363|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
16232161|NCT00563706|39331364|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
16232162|NCT00563706|39331365|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
16232163|NCT00563706|39331366|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
16232164|NCT00563706|39331367|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
16232165|NCT00563706|39331368|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
16232166|NCT00563706|39331369|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
16232167|NCT00563706|39331361|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
16232168|NCT00563706|39331362|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
16232169|NCT00563706|39331363|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
16232170|NCT00563706|39331364|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
16232171|NCT00563706|39331365|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
16232172|NCT00563706|39331366|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
16232173|NCT00563706|39331367|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
16232174|NCT00563706|39331368|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
16232175|NCT00563706|39331369|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
16232176|NCT01600755|39331370|FG000|Overall Study|Withdrawal by Subject|6|||
16232177|NCT01683565|39331373|FG000|Overall Study|Lost to Follow-up|2|||
16232178|NCT01683565|39331374|FG001|Overall Study|Lost to Follow-up|0|||
16232179|NCT01683565|39331373|FG000|Overall Study|Discontinued Intervention|1|||
16232180|NCT01683565|39331374|FG001|Overall Study|Discontinued Intervention|1|||
16232181|NCT00285012|39334505|FG000|Assigned to Study Treatment (Tx)|Other|2|||
16232182|NCT00285012|39334506|FG001|Assigned to Study Treatment (Tx)|Other|3|||
16232183|NCT00285012|39334505|FG000|Received Study Tx|Death|2|||
16232184|NCT00285012|39334506|FG001|Received Study Tx|Death|1|||
16232185|NCT00285012|39334505|FG000|Received Study Tx|Adverse Event|5|||
16232186|NCT00285012|39334506|FG001|Received Study Tx|Adverse Event|11|||
16552283|NCT00308737|40484724|FG001|Overall Study|Protocol Violation|9|||
16552284|NCT00308737|40484725|FG002|Overall Study|Protocol Violation|5|||
16552285|NCT00308737|40484723|FG000|Overall Study|Withdrawal by Subject|218|||
16552286|NCT00308737|40484724|FG001|Overall Study|Withdrawal by Subject|166|||
16552287|NCT00308737|40484725|FG002|Overall Study|Withdrawal by Subject|18|||
16552288|NCT00308737|40484723|FG000|Overall Study|Various|32|||
16552289|NCT00308737|40484724|FG001|Overall Study|Various|20|||
16232187|NCT00285012|39334505|FG000|Received Study Tx|Lack of Efficacy|0|||
16232188|NCT00285012|39334506|FG001|Received Study Tx|Lack of Efficacy|3|||
16232189|NCT00285012|39334505|FG000|Received Study Tx|Lost to Follow-up|29|||
16232190|NCT00285012|39334506|FG001|Received Study Tx|Lost to Follow-up|31|||
16232191|NCT00285012|39334505|FG000|Received Study Tx|Withdrawal by Subject|31|||
16232192|NCT00285012|39334506|FG001|Received Study Tx|Withdrawal by Subject|43|||
16232193|NCT00285012|39334505|FG000|Received Study Tx|Other|5|||
16232194|NCT00285012|39334506|FG001|Received Study Tx|Other|5|||
16232195|NCT02074982|39334508|FG000|Overall Study|Adverse Event|15|||
16232196|NCT02074982|39334509|FG001|Overall Study|Adverse Event|7|||
16232197|NCT02074982|39334508|FG000|Overall Study|Lack of Efficacy|6|||
16232198|NCT02074982|39334509|FG001|Overall Study|Lack of Efficacy|1|||
16232199|NCT02074982|39334508|FG000|Overall Study|Lost to Follow-up|9|||
16232200|NCT02074982|39334509|FG001|Overall Study|Lost to Follow-up|10|||
16232201|NCT02074982|39334508|FG000|Overall Study|Non-compliance with study treatment|0|||
16232202|NCT02074982|39334509|FG001|Overall Study|Non-compliance with study treatment|2|||
16232203|NCT02074982|39334508|FG000|Overall Study|Physician Decision|1|||
16232204|NCT02074982|39334509|FG001|Overall Study|Physician Decision|1|||
16232205|NCT02074982|39334508|FG000|Overall Study|Pregnancy|1|||
16232206|NCT02074982|39334509|FG001|Overall Study|Pregnancy|2|||
16232207|NCT02074982|39334508|FG000|Overall Study|Protocol deviation|4|||
16232208|NCT02074982|39334509|FG001|Overall Study|Protocol deviation|3|||
16232209|NCT02074982|39334508|FG000|Overall Study|Technical problems|0|||
16232210|NCT02074982|39334509|FG001|Overall Study|Technical problems|2|||
16232211|NCT02074982|39334508|FG000|Overall Study|Subject/guardian decision|15|||
16232212|NCT02074982|39334509|FG001|Overall Study|Subject/guardian decision|24|||
16232213|NCT02074982|39334508|FG000|Overall Study|Death|0|||
16232214|NCT02074982|39334509|FG001|Overall Study|Death|2|||
16232215|NCT00556166|39334510|FG000|Overall Study|Withdrawal by Subject|1|||
16232216|NCT02392377|39334511|FG000|Overall Study|Withdrawal by Subject|0|||
16232217|NCT02392377|39334512|FG001|Overall Study|Withdrawal by Subject|1|||
16232218|NCT00054275|39334515|FG000|Overall Study|Withdrawal by Subject|4|||
16232219|NCT00054275|39334515|FG000|Overall Study|Adverse Event|5|||
16232220|NCT00054275|39334515|FG000|Overall Study|Progressive disease in cycle 1|1|||
16232221|NCT00054275|39334515|FG000|Overall Study|Physician Decision|1|||
16232222|NCT00665366|39334516|FG000|Overall Study|Lack of Efficacy|11|||
16232223|NCT00665366|39334517|FG001|Overall Study|Lack of Efficacy|10|||
16232224|NCT00665366|39334516|FG000|Overall Study|Adverse Event|25|||
16232225|NCT00665366|39334517|FG001|Overall Study|Adverse Event|23|||
16232226|NCT00665366|39334516|FG000|Overall Study|Withdrawal by Subject|11|||
16232227|NCT00665366|39334517|FG001|Overall Study|Withdrawal by Subject|14|||
16232228|NCT00665366|39334516|FG000|Overall Study|Lost to Follow-up|3|||
16232229|NCT00665366|39334517|FG001|Overall Study|Lost to Follow-up|5|||
16232230|NCT00665366|39334516|FG000|Overall Study|Poor compliance/noncompliance|3|||
16232231|NCT00665366|39334517|FG001|Overall Study|Poor compliance/noncompliance|5|||
16232232|NCT00665366|39334516|FG000|Overall Study|Pregnancy|1|||
16232233|NCT00665366|39334517|FG001|Overall Study|Pregnancy|0|||
16232234|NCT00665366|39334516|FG000|Overall Study|No longer meets study criteria|0|||
16232235|NCT00665366|39334517|FG001|Overall Study|No longer meets study criteria|1|||
16232236|NCT00665366|39334516|FG000|Overall Study|Other reasons|4|||
16232237|NCT00665366|39334517|FG001|Overall Study|Other reasons|1|||
16232238|NCT02866695|39334518|FG000|Overall Study|Adverse Event|1|||
16232239|NCT02866695|39334518|FG000|Overall Study|Lost to Follow-up|1|||
16232240|NCT03280628|39334519|FG000|Overall Study|Lost to Follow-up|8|||
16232241|NCT03280628|39334520|FG001|Overall Study|Lost to Follow-up|6|||
16232242|NCT03280628|39334521|FG002|Overall Study|Lost to Follow-up|11|||
16232243|NCT03628781|39334522|FG000|Overall Study|Lost to Follow-up|16|||
16232244|NCT03628781|39334523|FG001|Overall Study|Lost to Follow-up|8|||
16232245|NCT03628781|39334522|FG000|Overall Study|Withdrawal by Subject|16|||
16232246|NCT03628781|39334523|FG001|Overall Study|Withdrawal by Subject|1|||
16232247|NCT00998166|39334524|FG000|Overall Study|Early Study Termination|8|||
16232248|NCT02871921|39334540|FG000|Overall Study|Withdrawal by Subject|34|||
16232249|NCT02871921|39334541|FG001|Overall Study|Withdrawal by Subject|27|||
16232250|NCT02871921|39334542|FG002|Overall Study|Withdrawal by Subject|27|||
16232251|NCT02871921|39334543|FG003|Overall Study|Withdrawal by Subject|30|||
16232252|NCT01819467|39334544|FG000|Overall Study|Physician Decision|20|||
16232253|NCT01819467|39334545|FG001|Overall Study|Physician Decision|9|||
16232254|NCT03992456|39334546|FG000|Overall Study|Withdrawal by Subject|1|||
16232255|NCT03992456|39334547|FG001|Overall Study|Withdrawal by Subject|0|||
16232256|NCT03992456|39334546|FG000|Overall Study|Disease progression|4|||
16232257|NCT03992456|39334547|FG001|Overall Study|Disease progression|5|||
16232258|NCT03992456|39334546|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
16232259|NCT03992456|39334547|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
16232260|NCT03972709|39334548|FG000|Overall Study|Withdrawal by Subject|18|||
16232261|NCT03972709|39334549|FG001|Overall Study|Withdrawal by Subject|7|||
16232262|NCT03972709|39334550|FG002|Overall Study|Withdrawal by Subject|14|||
16232263|NCT03972709|39334548|FG000|Overall Study|Study Terminated by Sponsor|48|||
16232264|NCT03972709|39334549|FG001|Overall Study|Study Terminated by Sponsor|25|||
16232265|NCT03972709|39334550|FG002|Overall Study|Study Terminated by Sponsor|50|||
16232266|NCT03972709|39334548|FG000|Overall Study|Physician Decision|1|||
16232267|NCT03972709|39334549|FG001|Overall Study|Physician Decision|0|||
16232268|NCT03972709|39334550|FG002|Overall Study|Physician Decision|0|||
16232269|NCT03972709|39334548|FG000|Overall Study|COVID-19|0|||
16232270|NCT03972709|39334549|FG001|Overall Study|COVID-19|1|||
16232271|NCT03972709|39334550|FG002|Overall Study|COVID-19|1|||
16232272|NCT03972709|39334548|FG000|Overall Study|Lost to Follow-up|6|||
16232273|NCT03972709|39334549|FG001|Overall Study|Lost to Follow-up|1|||
16232274|NCT03972709|39334550|FG002|Overall Study|Lost to Follow-up|2|||
16232275|NCT03972709|39334548|FG000|Overall Study|Death|5|||
16232276|NCT03972709|39334549|FG001|Overall Study|Death|1|||
16232277|NCT03972709|39334550|FG002|Overall Study|Death|4|||
16232278|NCT03972709|39334548|FG000|Overall Study|Adverse Event|3|||
16232279|NCT03972709|39334549|FG001|Overall Study|Adverse Event|1|||
16232280|NCT03972709|39334550|FG002|Overall Study|Adverse Event|4|||
16232281|NCT03972709|39334548|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
16232282|NCT03972709|39334549|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
16232283|NCT03972709|39334550|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
16232284|NCT03972709|39334548|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
16232285|NCT03972709|39334549|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
16232286|NCT03972709|39334550|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
16232287|NCT03972709|39334548|FG000|Overall Study|Subject Unable to be Contacted|0|||
16232288|NCT03972709|39334549|FG001|Overall Study|Subject Unable to be Contacted|1|||
16232289|NCT03972709|39334550|FG002|Overall Study|Subject Unable to be Contacted|0|||
16232290|NCT03972709|39334548|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
16232291|NCT03972709|39334549|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
16232292|NCT03972709|39334550|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
16232293|NCT03972709|39334548|FG000|Overall Study|Subject Moved|0|||
16232294|NCT03972709|39334549|FG001|Overall Study|Subject Moved|1|||
16232295|NCT03972709|39334550|FG002|Overall Study|Subject Moved|0|||
16232296|NCT03972709|39334548|FG000|Overall Study|Missed Study Visits|1|||
16232297|NCT03972709|39334549|FG001|Overall Study|Missed Study Visits|0|||
16232298|NCT03972709|39334550|FG002|Overall Study|Missed Study Visits|0|||
16232299|NCT01211613|39334551|FG000|Overall Study|Lost to Follow-up|2|||
16232300|NCT01211613|39334552|FG001|Overall Study|Lost to Follow-up|2|||
16232301|NCT01211613|39334553|FG002|Overall Study|Lost to Follow-up|2|||
16232302|NCT01211613|39334551|FG000|Overall Study|Withdrawal by Subject|1|||
16232303|NCT01211613|39334552|FG001|Overall Study|Withdrawal by Subject|0|||
16232304|NCT01211613|39334553|FG002|Overall Study|Withdrawal by Subject|0|||
16232305|NCT03205046|39334556|FG000|Overall Study|Death|10|||
16232306|NCT03205046|39334557|FG001|Overall Study|Death|6|||
16232307|NCT03205046|39334556|FG000|Overall Study|Withdrawal by Subject|1|||
16232308|NCT03205046|39334557|FG001|Overall Study|Withdrawal by Subject|2|||
16232309|NCT03205046|39334556|FG000|Overall Study|Lost to Follow-up|0|||
16232310|NCT03205046|39334557|FG001|Overall Study|Lost to Follow-up|1|||
16232311|NCT03205046|39334556|FG000|Overall Study|Study terminated by sponsor|2|||
16232312|NCT03205046|39334557|FG001|Overall Study|Study terminated by sponsor|1|||
16232313|NCT00956813|39334558|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
16232314|NCT00956813|39334559|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
16232315|NCT00956813|39334558|FG000|Flaxseed and Placebo|Ineligible|3|||
16232316|NCT00956813|39334559|FG001|Flaxseed and Placebo|Ineligible|1|||
16232317|NCT01541644|39334560|FG000|Overall Study|Withdrawal by Subject|3|||
16232318|NCT04629534|39334561|FG000|Overall Study|Physician Decision|1|||
16232319|NCT04629534|39334562|FG001|Overall Study|Physician Decision|0|||
16232320|NCT04629534|39334561|FG000|Overall Study|Protocol Violation|0|||
16232321|NCT04629534|39334562|FG001|Overall Study|Protocol Violation|2|||
16232322|NCT01725217|39334563|FG000|Overall Study|Withdrawal by Subject|1|||
16232323|NCT01725217|39334564|FG001|Overall Study|Withdrawal by Subject|0|||
16232324|NCT01725217|39334565|FG002|Overall Study|Withdrawal by Subject|0|||
16232325|NCT02325401|39334566|FG000|Overall Study|Withdrawal by Subject|0|||
16232326|NCT02325401|39334567|FG001|Overall Study|Withdrawal by Subject|1|||
16232327|NCT02325401|39334568|FG002|Overall Study|Withdrawal by Subject|1|||
16232328|NCT04139642|39334569|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
16232329|NCT04139642|39334570|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
16232330|NCT00351611|39334571|FG000|Overall Study|Adverse Event|11|||
16232331|NCT00351611|39334572|FG001|Overall Study|Adverse Event|3|||
16232332|NCT00351611|39334571|FG000|Overall Study|Death|1|||
16232333|NCT00351611|39334572|FG001|Overall Study|Death|0|||
16232334|NCT00351611|39334571|FG000|Overall Study|Lost to Follow-up|1|||
16232335|NCT00351611|39334572|FG001|Overall Study|Lost to Follow-up|0|||
16232336|NCT00351611|39334571|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
16232337|NCT00351611|39334572|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
16232338|NCT00351611|39334571|FG000|Overall Study|Other|1|||
16232339|NCT00351611|39334572|FG001|Overall Study|Other|0|||
16232340|NCT00351611|39334571|FG000|Overall Study|Protocol Violation|0|||
16232341|NCT00351611|39334572|FG001|Overall Study|Protocol Violation|2|||
16232342|NCT02851069|39334573|FG000|Overall Study|Failure to Return|3|||
16232343|NCT02851069|39334573|FG000|Overall Study|Other|3|||
16232344|NCT04066894|39334574|FG000|Overall Study|Lack of Efficacy|1|||
16232345|NCT04066894|39334574|FG000|Overall Study|Screen Failure|1|||
16232346|NCT03353415|39334575|FG000|Masked CGM Wear|Lost to Follow-up|2|||
16232347|NCT03353415|39334575|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
16232348|NCT00762073|39334582|FG000|Overall Study|Lack of Efficacy|1|||
16232349|NCT00762073|39334583|FG001|Overall Study|Lack of Efficacy|1|||
16232350|NCT00762073|39334584|FG002|Overall Study|Lack of Efficacy|0|||
16232351|NCT00762073|39334585|FG003|Overall Study|Lack of Efficacy|0|||
16232352|NCT00762073|39334582|FG000|Overall Study|Adverse Event|1|||
16232353|NCT00762073|39334583|FG001|Overall Study|Adverse Event|0|||
16232354|NCT00762073|39334584|FG002|Overall Study|Adverse Event|1|||
16232355|NCT00762073|39334585|FG003|Overall Study|Adverse Event|1|||
16232356|NCT00762073|39334582|FG000|Overall Study|Significant Subject Noncompliance|0|||
16232357|NCT00762073|39334583|FG001|Overall Study|Significant Subject Noncompliance|1|||
16232358|NCT00762073|39334584|FG002|Overall Study|Significant Subject Noncompliance|0|||
16232359|NCT00762073|39334585|FG003|Overall Study|Significant Subject Noncompliance|1|||
16232360|NCT00762073|39334582|FG000|Overall Study|Withdrawal by Subject|1|||
16232361|NCT00762073|39334583|FG001|Overall Study|Withdrawal by Subject|2|||
16232362|NCT00762073|39334584|FG002|Overall Study|Withdrawal by Subject|1|||
16232363|NCT00762073|39334585|FG003|Overall Study|Withdrawal by Subject|1|||
16232364|NCT00762073|39334582|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
16232365|NCT00762073|39334583|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
16232366|NCT00762073|39334584|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
16232367|NCT00762073|39334585|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
16232368|NCT04113746|39334586|FG000|Overall Study|Lost to Follow-up|4|||
16232369|NCT04113746|39334587|FG001|Overall Study|Lost to Follow-up|4|||
16232370|NCT03575806|39334588|FG000|Overall Study|Withdrawal by Subject|0|||
16232371|NCT03575806|39334589|FG001|Overall Study|Withdrawal by Subject|2|||
16232372|NCT03575806|39334588|FG000|Overall Study|Protocol Violation|0|||
16232373|NCT03575806|39334589|FG001|Overall Study|Protocol Violation|2|||
16232374|NCT04165824|39334592|FG000|Overall Study|Adverse Event|23|||
16232375|NCT04165824|39334592|FG000|Overall Study|Physician Decision|1|||
16232376|NCT04165824|39334592|FG000|Overall Study|Withdrawal by Subject|17|||
16232377|NCT04165824|39334592|FG000|Overall Study|Other|5|||
16232378|NCT00656669|39334596|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
16232379|NCT00656669|39334596|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
16232380|NCT00656669|39334596|FG000|AC (Cycles 6-9)|Adverse Event|1|||
16232381|NCT00656669|39334596|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
16232382|NCT01347931|39334597|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
16232383|NCT01545375|39334598|FG000|Overall Study|Adverse Event|2|||
16232384|NCT01545375|39334599|FG001|Overall Study|Adverse Event|1|||
16232385|NCT01545375|39334598|FG000|Overall Study|Lost to Follow-up|34|||
16232386|NCT01545375|39334599|FG001|Overall Study|Lost to Follow-up|31|||
16232387|NCT01545375|39334598|FG000|Overall Study|Protocol Violation|3|||
16232388|NCT01545375|39334599|FG001|Overall Study|Protocol Violation|3|||
16232389|NCT01545375|39334598|FG000|Overall Study|Withdrawal by Subject|58|||
16232390|NCT01545375|39334599|FG001|Overall Study|Withdrawal by Subject|55|||
16232391|NCT01071083|39334600|FG000|Overall Study|Adverse Event|1|||
16232392|NCT01071083|39334601|FG001|Overall Study|Adverse Event|0|||
16232393|NCT01071083|39334602|FG002|Overall Study|Adverse Event|1|||
16232394|NCT01071083|39334603|FG003|Overall Study|Adverse Event|0|||
16232395|NCT01071083|39334604|FG004|Overall Study|Adverse Event|1|||
16232396|NCT01071083|39334600|FG000|Overall Study|Withdrawal by Subject|3|||
16232397|NCT01071083|39334601|FG001|Overall Study|Withdrawal by Subject|0|||
16232398|NCT01071083|39334602|FG002|Overall Study|Withdrawal by Subject|2|||
16232399|NCT01071083|39334603|FG003|Overall Study|Withdrawal by Subject|0|||
16232400|NCT01071083|39334604|FG004|Overall Study|Withdrawal by Subject|3|||
16232401|NCT01071083|39334600|FG000|Overall Study|Physician Decision|1|||
16232402|NCT01071083|39334601|FG001|Overall Study|Physician Decision|0|||
16232403|NCT01071083|39334602|FG002|Overall Study|Physician Decision|0|||
16232404|NCT01071083|39334603|FG003|Overall Study|Physician Decision|1|||
16232405|NCT01071083|39334604|FG004|Overall Study|Physician Decision|1|||
16232406|NCT01071083|39334600|FG000|Overall Study|Early Rescue|1|||
16232407|NCT01071083|39334601|FG001|Overall Study|Early Rescue|0|||
16232408|NCT01071083|39334602|FG002|Overall Study|Early Rescue|0|||
16120062|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
16232409|NCT01071083|39334603|FG003|Overall Study|Early Rescue|0|||
16232410|NCT01071083|39334604|FG004|Overall Study|Early Rescue|1|||
16232411|NCT01071083|39334600|FG000|Overall Study|Subject Moved|0|||
16232412|NCT01071083|39334601|FG001|Overall Study|Subject Moved|1|||
16232413|NCT01071083|39334602|FG002|Overall Study|Subject Moved|0|||
16232414|NCT01071083|39334603|FG003|Overall Study|Subject Moved|0|||
16232415|NCT01071083|39334604|FG004|Overall Study|Subject Moved|0|||
16232416|NCT01071083|39334600|FG000|Overall Study|Images Not Usable (Motion)|0|||
16232417|NCT01071083|39334601|FG001|Overall Study|Images Not Usable (Motion)|1|||
16232418|NCT01071083|39334602|FG002|Overall Study|Images Not Usable (Motion)|0|||
16232419|NCT01071083|39334603|FG003|Overall Study|Images Not Usable (Motion)|0|||
16232420|NCT01071083|39334604|FG004|Overall Study|Images Not Usable (Motion)|0|||
16232421|NCT01071083|39334600|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
16232422|NCT01071083|39334601|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
16232423|NCT01071083|39334602|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
16232424|NCT01071083|39334603|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
16232425|NCT01071083|39334604|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
16232426|NCT01071083|39334600|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
16232427|NCT01071083|39334601|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
16232428|NCT01071083|39334602|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
16232429|NCT01071083|39334603|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
16232430|NCT01071083|39334604|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
16232431|NCT01071083|39334600|FG000|Overall Study|Subject Refused to Continue|1|||
16232432|NCT01071083|39334601|FG001|Overall Study|Subject Refused to Continue|0|||
16232433|NCT01071083|39334602|FG002|Overall Study|Subject Refused to Continue|0|||
16232434|NCT01071083|39334603|FG003|Overall Study|Subject Refused to Continue|0|||
16232435|NCT01071083|39334604|FG004|Overall Study|Subject Refused to Continue|0|||
16232436|NCT00761969|39334605|FG000|Overall Study|Death|112|||
16232437|NCT00761969|39334606|FG001|Overall Study|Death|47|||
16232438|NCT00761969|39334605|FG000|Overall Study|Lost to Follow-up|88|||
16232439|NCT00761969|39334606|FG001|Overall Study|Lost to Follow-up|93|||
16232440|NCT00814502|39334612|FG000|Overall Study|Adverse Event|1|||
16232441|NCT00814502|39334613|FG001|Overall Study|Adverse Event|0|||
16232442|NCT00814502|39334612|FG000|Overall Study|Withdrawal by Subject|0|||
16232443|NCT00814502|39334613|FG001|Overall Study|Withdrawal by Subject|2|||
16232444|NCT03417245|39334617|FG000|Overall Study|Adverse Event|1|||
16232445|NCT03417245|39334618|FG001|Overall Study|Adverse Event|0|||
16232446|NCT03417245|39334617|FG000|Overall Study|Protocol Violation|1|||
16232447|NCT03417245|39334618|FG001|Overall Study|Protocol Violation|0|||
16232448|NCT03417245|39334617|FG000|Overall Study|Withdrawal by Subject|1|||
16232449|NCT03417245|39334618|FG001|Overall Study|Withdrawal by Subject|1|||
16232450|NCT03471507|39334619|FG000|Overall Study|Lost to Follow-up|1|||
16232451|NCT03471507|39334620|FG001|Overall Study|Lost to Follow-up|3|||
16232452|NCT03471507|39334619|FG000|Overall Study|Physician Decision|0|||
16232453|NCT03471507|39334620|FG001|Overall Study|Physician Decision|1|||
16232454|NCT03471507|39334619|FG000|Overall Study|Withdrawal by Subject|2|||
16232455|NCT03471507|39334620|FG001|Overall Study|Withdrawal by Subject|1|||
16232456|NCT02815540|39334624|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
16232457|NCT03273257|39334625|FG000|Overall Study|Death|0|||
16232458|NCT03273257|39334626|FG001|Overall Study|Death|1|||
16232459|NCT03273257|39334625|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
16232460|NCT03273257|39334626|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
16232461|NCT03273257|39334625|FG000|Overall Study|Study terminated|3|||
16232462|NCT03273257|39334626|FG001|Overall Study|Study terminated|2|||
16232463|NCT04120116|39334628|FG000|Overall Study|Lost to Follow-up|0|||
16232464|NCT04120116|39334629|FG001|Overall Study|Lost to Follow-up|1|||
16232465|NCT04120116|39334630|FG002|Overall Study|Lost to Follow-up|0|||
16232466|NCT04120116|39334631|FG003|Overall Study|Lost to Follow-up|2|||
16232467|NCT04120116|39334628|FG000|Overall Study|Withdrawal by Subject|1|||
16232468|NCT04120116|39334629|FG001|Overall Study|Withdrawal by Subject|0|||
16232469|NCT04120116|39334630|FG002|Overall Study|Withdrawal by Subject|1|||
16232470|NCT04120116|39334631|FG003|Overall Study|Withdrawal by Subject|1|||
16232471|NCT04120116|39334628|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
16232472|NCT04120116|39334629|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
16232473|NCT04120116|39334630|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
16232474|NCT04120116|39334631|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
16232475|NCT00905437|39334632|FG000|Overall Study|Adverse Event|3|||
16232476|NCT00905437|39334633|FG001|Overall Study|Adverse Event|2|||
16232477|NCT00905437|39334632|FG000|Overall Study|Lost to Follow-up|0|||
16232478|NCT00905437|39334633|FG001|Overall Study|Lost to Follow-up|1|||
16232479|NCT00905437|39334632|FG000|Overall Study|Withdrawal by Subject|0|||
16232480|NCT00905437|39334633|FG001|Overall Study|Withdrawal by Subject|1|||
16232481|NCT00905437|39334632|FG000|Overall Study|Other|5|||
16232482|NCT00905437|39334633|FG001|Overall Study|Other|6|||
16232483|NCT03985293|39334634|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
16232484|NCT03985293|39334635|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
16232485|NCT03985293|39334636|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
16232486|NCT03985293|39334637|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
16232487|NCT03985293|39334638|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
16232488|NCT03985293|39334639|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
16232489|NCT03985293|39334634|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
16232490|NCT03985293|39334635|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
16232491|NCT03985293|39334636|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
16232492|NCT03985293|39334637|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
16232493|NCT03985293|39334638|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
16232494|NCT03985293|39334639|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
16232495|NCT03985293|39334634|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
16232496|NCT03985293|39334635|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
16232497|NCT03985293|39334636|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
16232498|NCT03985293|39334637|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
16232499|NCT03985293|39334638|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
16232500|NCT03985293|39334639|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
16232501|NCT03985293|39334634|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
16232502|NCT03985293|39334635|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
16232503|NCT03985293|39334636|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
16232504|NCT03985293|39334637|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
16232505|NCT03985293|39334638|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
16232506|NCT03985293|39334639|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
16232507|NCT03985293|39334634|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
16232508|NCT03985293|39334635|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
16232509|NCT03985293|39334636|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
16232510|NCT03985293|39334637|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
16232511|NCT03985293|39334638|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
16232512|NCT03985293|39334639|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
16232513|NCT03985293|39334634|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
16232514|NCT03985293|39334635|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
16232515|NCT03985293|39334636|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
16232516|NCT03985293|39334637|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
16232517|NCT03985293|39334638|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
16232518|NCT03985293|39334639|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
16232519|NCT03985293|39334634|FG000|FOLLOW-UP|Lost to Follow-up|0|||
16232520|NCT03985293|39334635|FG001|FOLLOW-UP|Lost to Follow-up|0|||
16232521|NCT03985293|39334636|FG002|FOLLOW-UP|Lost to Follow-up|1|||
16232522|NCT03985293|39334637|FG003|FOLLOW-UP|Lost to Follow-up|0|||
16232523|NCT03985293|39334638|FG004|FOLLOW-UP|Lost to Follow-up|0|||
16232524|NCT03985293|39334639|FG005|FOLLOW-UP|Lost to Follow-up|0|||
16232525|NCT04355767|39334640|FG000|Overall Study|Withdrawal by Subject|2|||
16232526|NCT04355767|39334641|FG001|Overall Study|Withdrawal by Subject|2|||
16232527|NCT04355767|39334640|FG000|Overall Study|Death|5|||
16232528|NCT04355767|39334641|FG001|Overall Study|Death|1|||
16232529|NCT01265875|39334646|FG000|Overall Study|Uncooperative/unreliable|1|||
16232530|NCT04189224|39334647|FG000|Period 2|Adverse Event|0|||
16232531|NCT04189224|39334648|FG001|Period 2|Adverse Event|1|||
16232532|NCT01118949|39334649|FG000|Overall Study|Adverse Event|5|||
16232533|NCT01118949|39334649|FG000|Overall Study|Withdrawal by Subject|4|||
16232534|NCT04682639|39334650|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
16232535|NCT04682639|39334651|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
16232536|NCT04682639|39334652|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
16232537|NCT04682639|39334653|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
16232538|NCT04682639|39334654|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
16232539|NCT04682639|39334650|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
16552290|NCT00308737|40484725|FG002|Overall Study|Various|8|||
16552291|NCT01342887|40484726|FG000|Overall Study|Death|2|||
16552292|NCT02032173|40484728|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
16552293|NCT02593305|40484733|FG000|Post 1|Comparison only group. No intervention.|0|||
16552294|NCT02593305|40484734|FG001|Post 1|Comparison only group. No intervention.|0|||
16552295|NCT02593305|40484735|FG002|Post 1|Comparison only group. No intervention.|10|||
16552296|NCT02961374|40484736|FG000|Overall Study|Adverse Event|4|||
16232540|NCT04682639|39334651|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
16232541|NCT04682639|39334652|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
16232542|NCT04682639|39334653|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16552297|NCT01923896|40484737|FG000|Overall Study|Adverse Event|1|||
16552298|NCT01923896|40484738|FG001|Overall Study|Adverse Event|0|||
16552299|NCT01193582|40484739|FG000|Vaccination Series|Withdrawal by Subject|11|||
16552300|NCT01193582|40484740|FG001|Vaccination Series|Withdrawal by Subject|13|||
16552301|NCT01193582|40484741|FG002|Vaccination Series|Withdrawal by Subject|8|||
16232543|NCT04682639|39334654|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16232544|NCT04682639|39334650|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
16232545|NCT04682639|39334651|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
16232546|NCT04682639|39334652|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16232547|NCT04682639|39334653|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16232548|NCT04682639|39334654|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16232549|NCT04682639|39334650|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
16232550|NCT04682639|39334651|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
16232551|NCT04682639|39334652|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
16413232|NCT03283150|39995100|FG000|Overall Study|Withdrawal by Subject|6|||
16413233|NCT03283150|39995101|FG001|Overall Study|Withdrawal by Subject|0|||
16413234|NCT03283150|39995102|FG002|Overall Study|Withdrawal by Subject|0|||
16552302|NCT01193582|40484742|FG003|Vaccination Series|Withdrawal by Subject|3|||
16552303|NCT01193582|40484739|FG000|12 Month Follow-up|Death|0|||
16552304|NCT01193582|40484740|FG001|12 Month Follow-up|Death|0|||
16552305|NCT01193582|40484741|FG002|12 Month Follow-up|Death|1|||
16552306|NCT01193582|40484742|FG003|12 Month Follow-up|Death|0|||
16552307|NCT01193582|40484739|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
16552308|NCT01193582|40484740|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
16552309|NCT01193582|40484741|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
16552310|NCT01193582|40484742|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
16552311|NCT01874145|40484753|FG000|Core Period|Non-compliance|1|||
16552312|NCT01874145|40484754|FG001|Core Period|Non-compliance|0|||
16552313|NCT01874145|40484753|FG000|Core Period|Protocol Violation|1|||
16552314|NCT01874145|40484754|FG001|Core Period|Protocol Violation|1|||
16552315|NCT01874145|40484753|FG000|Core Period|Physician Decision|1|||
16552316|NCT01874145|40484754|FG001|Core Period|Physician Decision|1|||
16413235|NCT02308488|39995103|FG000|Overall Study|Withdrawal by Subject|2|||
16413236|NCT00685373|39995111|FG000|Overall Study|Adverse Event|3|||
16413237|NCT00685373|39995111|FG000|Overall Study|Withdrawal by Subject|5|||
16413238|NCT00685373|39995111|FG000|Overall Study|Lack of Efficacy|3|||
16413239|NCT00685373|39995111|FG000|Overall Study|Condition no longer requires study drug|1|||
16413240|NCT00685373|39995111|FG000|Overall Study|Lost to Follow-up|2|||
16413241|NCT00685373|39995111|FG000|Overall Study|Protocol Violation|1|||
16413242|NCT01459913|39995114|FG000|Overall Study|Adverse Event|0|||
16413243|NCT01459913|39995115|FG001|Overall Study|Adverse Event|0|||
16413244|NCT01459913|39995116|FG002|Overall Study|Adverse Event|0|||
16413245|NCT01459913|39995117|FG003|Overall Study|Adverse Event|3|||
16413246|NCT01459913|39995114|FG000|Overall Study|Withdrawal by Subject|4|||
16413247|NCT01459913|39995115|FG001|Overall Study|Withdrawal by Subject|0|||
16413248|NCT01459913|39995116|FG002|Overall Study|Withdrawal by Subject|0|||
16413249|NCT01459913|39995117|FG003|Overall Study|Withdrawal by Subject|5|||
16413250|NCT01459913|39995114|FG000|Overall Study|Lost to Follow-up|7|||
16413251|NCT01459913|39995115|FG001|Overall Study|Lost to Follow-up|4|||
16413252|NCT01459913|39995116|FG002|Overall Study|Lost to Follow-up|1|||
16413253|NCT01459913|39995117|FG003|Overall Study|Lost to Follow-up|8|||
16413254|NCT01459913|39995114|FG000|Overall Study|Death|0|||
16413255|NCT01459913|39995115|FG001|Overall Study|Death|0|||
16413256|NCT01459913|39995116|FG002|Overall Study|Death|0|||
16413257|NCT01459913|39995117|FG003|Overall Study|Death|1|||
16413258|NCT01459913|39995114|FG000|Overall Study|Non- Compliance|0|||
16552317|NCT01874145|40484753|FG000|Core Period|Adverse Event|0|||
16552318|NCT01874145|40484754|FG001|Core Period|Adverse Event|1|||
16552319|NCT01874145|40484753|FG000|Core Period|Withdrawal by Subject|0|||
16552320|NCT01874145|40484754|FG001|Core Period|Withdrawal by Subject|4|||
16552321|NCT01874145|40484753|FG000|Extension Period|Adverse Event|3|||
16413259|NCT01459913|39995115|FG001|Overall Study|Non- Compliance|0|||
16552322|NCT01874145|40484754|FG001|Extension Period|Adverse Event|2|||
16552323|NCT01874145|40484753|FG000|Extension Period|Withdrawal by Subject|2|||
16552324|NCT01874145|40484754|FG001|Extension Period|Withdrawal by Subject|1|||
16552325|NCT01874145|40484753|FG000|Extension Period|Lost to Follow-up|1|||
16120063|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
16413260|NCT01459913|39995116|FG002|Overall Study|Non- Compliance|0|||
16413261|NCT01459913|39995117|FG003|Overall Study|Non- Compliance|3|||
16413262|NCT01459913|39995114|FG000|Overall Study|Physician Decision|0|||
16413263|NCT01459913|39995115|FG001|Overall Study|Physician Decision|1|||
16413264|NCT01459913|39995116|FG002|Overall Study|Physician Decision|0|||
16552326|NCT01874145|40484754|FG001|Extension Period|Lost to Follow-up|1|||
16552327|NCT00235443|40484755|FG000|Overall Study|Adverse Event|4|||
16552328|NCT00235443|40484756|FG001|Overall Study|Adverse Event|12|||
16413265|NCT01459913|39995117|FG003|Overall Study|Physician Decision|0|||
16413266|NCT01459913|39995114|FG000|Overall Study|Study Terminated by Sponsor|30|||
16413267|NCT01459913|39995115|FG001|Overall Study|Study Terminated by Sponsor|15|||
16552329|NCT00235443|40484757|FG002|Overall Study|Adverse Event|17|||
16120064|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
16120065|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
16120066|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16120067|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16413268|NCT01459913|39995116|FG002|Overall Study|Study Terminated by Sponsor|9|||
16413269|NCT01459913|39995117|FG003|Overall Study|Study Terminated by Sponsor|11|||
16413270|NCT01459913|39995114|FG000|Overall Study|Other|0|||
16413271|NCT01459913|39995115|FG001|Overall Study|Other|0|||
16413272|NCT01459913|39995116|FG002|Overall Study|Other|3|||
16413273|NCT01459913|39995117|FG003|Overall Study|Other|1|||
16413274|NCT01459913|39995114|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
16413275|NCT01459913|39995115|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
16413276|NCT01459913|39995116|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
16413277|NCT01459913|39995117|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
16413278|NCT01116427|39995118|FG000|Core Phase|Adverse Event|0|||
16413279|NCT01116427|39995119|FG001|Core Phase|Adverse Event|1|||
16413280|NCT01116427|39995118|FG000|Core Phase|Lost to Follow-up|1|||
16413281|NCT01116427|39995119|FG001|Core Phase|Lost to Follow-up|0|||
16552330|NCT00235443|40484758|FG003|Overall Study|Adverse Event|44|||
16552331|NCT00235443|40484759|FG004|Overall Study|Adverse Event|10|||
16552332|NCT00235443|40484760|FG005|Overall Study|Adverse Event|15|||
16552333|NCT00235443|40484755|FG000|Overall Study|Lack of Efficacy|0|||
16552334|NCT00235443|40484756|FG001|Overall Study|Lack of Efficacy|1|||
16120068|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16120069|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
16120070|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16120071|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16552335|NCT00235443|40484757|FG002|Overall Study|Lack of Efficacy|5|||
16552336|NCT00235443|40484758|FG003|Overall Study|Lack of Efficacy|12|||
16552337|NCT00235443|40484759|FG004|Overall Study|Lack of Efficacy|2|||
16552338|NCT00235443|40484760|FG005|Overall Study|Lack of Efficacy|9|||
16552339|NCT00235443|40484755|FG000|Overall Study|Withdrawal by Subject|3|||
16552340|NCT00235443|40484756|FG001|Overall Study|Withdrawal by Subject|9|||
16552341|NCT00235443|40484757|FG002|Overall Study|Withdrawal by Subject|25|||
16552342|NCT00235443|40484758|FG003|Overall Study|Withdrawal by Subject|24|||
16552343|NCT00235443|40484759|FG004|Overall Study|Withdrawal by Subject|10|||
16552344|NCT00235443|40484760|FG005|Overall Study|Withdrawal by Subject|12|||
16552345|NCT00235443|40484755|FG000|Overall Study|Lost to Follow-up|0|||
16552346|NCT00235443|40484756|FG001|Overall Study|Lost to Follow-up|8|||
16552347|NCT00235443|40484757|FG002|Overall Study|Lost to Follow-up|6|||
16552348|NCT00235443|40484758|FG003|Overall Study|Lost to Follow-up|6|||
16552349|NCT00235443|40484759|FG004|Overall Study|Lost to Follow-up|4|||
16552350|NCT00235443|40484760|FG005|Overall Study|Lost to Follow-up|3|||
16552351|NCT00235443|40484755|FG000|Overall Study|Unsatisfactory compliance|0|||
16552352|NCT00235443|40484756|FG001|Overall Study|Unsatisfactory compliance|2|||
16552353|NCT00235443|40484757|FG002|Overall Study|Unsatisfactory compliance|3|||
16552354|NCT00235443|40484758|FG003|Overall Study|Unsatisfactory compliance|4|||
16552355|NCT00235443|40484759|FG004|Overall Study|Unsatisfactory compliance|1|||
16552356|NCT00235443|40484760|FG005|Overall Study|Unsatisfactory compliance|0|||
16552357|NCT00235443|40484755|FG000|Overall Study|Other reasons for premature termination|1|||
16552358|NCT00235443|40484756|FG001|Overall Study|Other reasons for premature termination|6|||
16552359|NCT00235443|40484757|FG002|Overall Study|Other reasons for premature termination|6|||
16552360|NCT00235443|40484758|FG003|Overall Study|Other reasons for premature termination|7|||
16552361|NCT00235443|40484759|FG004|Overall Study|Other reasons for premature termination|3|||
16552362|NCT00235443|40484760|FG005|Overall Study|Other reasons for premature termination|6|||
16120072|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16552363|NCT01486758|40484761|FG000|Overall Study|Lost to Follow-up|0|||
16552364|NCT01486758|40484762|FG001|Overall Study|Lost to Follow-up|1|||
16413282|NCT01116427|39995118|FG000|Core Phase|Withdrawal by Subject|3|||
16413283|NCT01116427|39995119|FG001|Core Phase|Withdrawal by Subject|0|||
16552365|NCT01351025|40484766|FG000|Week 0 - 20|Lost to Follow-up|2|||
16413284|NCT01116427|39995118|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
16120073|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16413285|NCT01116427|39995119|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
16413286|NCT01116427|39995118|FG000|Extension Phase|Adverse Event|1|||
16413287|NCT01116427|39995119|FG001|Extension Phase|Adverse Event|1|||
16552366|NCT01351025|40484767|FG001|Week 0 - 20|Lost to Follow-up|1|||
16552367|NCT01351025|40484766|FG000|Week 0 - 20|Withdrawal by Subject|1|||
16552368|NCT01351025|40484767|FG001|Week 0 - 20|Withdrawal by Subject|0|||
16413288|NCT01116427|39995118|FG000|Extension Phase|Lost to Follow-up|2|||
16413289|NCT01116427|39995119|FG001|Extension Phase|Lost to Follow-up|0|||
16413290|NCT01116427|39995118|FG000|Extension Phase|Withdrawal by Subject|5|||
16413291|NCT01116427|39995119|FG001|Extension Phase|Withdrawal by Subject|1|||
16413292|NCT01116427|39995118|FG000|Extension Phase|Not using appropriate birth control|1|||
16413293|NCT01116427|39995119|FG001|Extension Phase|Not using appropriate birth control|0|||
16413294|NCT01416441|39995123|FG000|Overall Study|Lost to Follow-up|5|||
16413295|NCT01416441|39995123|FG000|Overall Study|Adverse Event|6|||
16413296|NCT01416441|39995123|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
16413297|NCT01416441|39995123|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
16413298|NCT01416441|39995123|FG000|Overall Study|Investigator Withdrew Subject|2|||
16413299|NCT01416441|39995123|FG000|Overall Study|Subject Withdrew Consent|12|||
16413300|NCT01416441|39995123|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
16413301|NCT02428413|39995124|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
16413302|NCT02428413|39995125|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
16413303|NCT02428413|39995124|FG000|Overall Study|Protocol Violation|1|||
16413304|NCT02428413|39995125|FG001|Overall Study|Protocol Violation|2|||
16413305|NCT02428413|39995124|FG000|Overall Study|Case Cancelled|2|||
16413306|NCT02428413|39995125|FG001|Overall Study|Case Cancelled|0|||
16413307|NCT02428413|39995124|FG000|Overall Study|Missed Cases|1|||
16413308|NCT02428413|39995125|FG001|Overall Study|Missed Cases|2|||
16413309|NCT02428413|39995124|FG000|Overall Study|Nurse Refusal|1|||
16413310|NCT02428413|39995125|FG001|Overall Study|Nurse Refusal|0|||
16413311|NCT03157583|39995130|FG000|Overall Study|Other (did not meet study criteria)|1|||
16413312|NCT00549770|39995131|FG000|Overall Study|Protocol deviation|1|||
16413313|NCT00549770|39995132|FG001|Overall Study|Protocol deviation|1|||
16413314|NCT00549770|39995133|FG002|Overall Study|Protocol deviation|1|||
16413315|NCT00549770|39995134|FG003|Overall Study|Protocol deviation|2|||
16413316|NCT00549770|39995135|FG004|Overall Study|Protocol deviation|2|||
16413317|NCT00549770|39995136|FG005|Overall Study|Protocol deviation|2|||
16413318|NCT00549770|39995137|FG006|Overall Study|Protocol deviation|1|||
16413319|NCT00549770|39995138|FG007|Overall Study|Protocol deviation|2|||
16413320|NCT00549770|39995131|FG000|Overall Study|Administrative problems|0|||
16413321|NCT00549770|39995132|FG001|Overall Study|Administrative problems|1|||
16413322|NCT00549770|39995133|FG002|Overall Study|Administrative problems|0|||
16413323|NCT00549770|39995134|FG003|Overall Study|Administrative problems|0|||
16413324|NCT00549770|39995135|FG004|Overall Study|Administrative problems|0|||
16413325|NCT00549770|39995136|FG005|Overall Study|Administrative problems|0|||
16552369|NCT01351025|40484766|FG000|Week 24 - 44|Lost to Follow-up|0|||
16552370|NCT01351025|40484767|FG001|Week 24 - 44|Lost to Follow-up|2|||
16552371|NCT01351025|40484766|FG000|Week 24 - 44|Site closed|0|||
16552372|NCT01351025|40484767|FG001|Week 24 - 44|Site closed|1|||
16552373|NCT01351025|40484766|FG000|Week 24 - 44|unable to get to clinic|1|||
16552374|NCT01351025|40484767|FG001|Week 24 - 44|unable to get to clinic|1|||
16552375|NCT01284140|40488189|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
16552376|NCT01284140|40488190|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
16552377|NCT01284140|40488189|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
16552378|NCT01284140|40488190|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
16552379|NCT02609659|40488196|FG000|Overall Study|Adverse Event|1|||
16552380|NCT02609659|40488196|FG000|Overall Study|Lost to Follow-up|6|||
16552381|NCT02609659|40488196|FG000|Overall Study|Other|1|||
16552382|NCT02337478|40488197|FG000|Overall Study|Lack of Efficacy|5|||
16552383|NCT01364727|40488198|FG000|Overall Study|Not Eligible|2|||
16120074|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
16120075|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
16120076|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
16120077|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
16120078|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16120079|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16120080|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16120081|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
16120082|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16413326|NCT00549770|39995137|FG006|Overall Study|Administrative problems|0|||
16413327|NCT00549770|39995138|FG007|Overall Study|Administrative problems|1|||
16413328|NCT00549770|39995131|FG000|Overall Study|Lost to Follow-up|0|||
16413329|NCT00549770|39995132|FG001|Overall Study|Lost to Follow-up|0|||
16413330|NCT00549770|39995133|FG002|Overall Study|Lost to Follow-up|2|||
16413331|NCT00549770|39995134|FG003|Overall Study|Lost to Follow-up|2|||
16413332|NCT00549770|39995135|FG004|Overall Study|Lost to Follow-up|3|||
16413333|NCT00549770|39995136|FG005|Overall Study|Lost to Follow-up|2|||
16413334|NCT00549770|39995137|FG006|Overall Study|Lost to Follow-up|0|||
16413335|NCT00549770|39995138|FG007|Overall Study|Lost to Follow-up|0|||
16413336|NCT00549770|39995131|FG000|Overall Study|Withdrawal by Subject|4|||
16348633|NCT03569098|39765424|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
16348634|NCT03569098|39765425|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
16348635|NCT03569098|39765423|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
16348636|NCT03569098|39765424|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
16348637|NCT03569098|39765425|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
16348638|NCT03569098|39765423|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
16348639|NCT03569098|39765424|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
16348640|NCT03569098|39765425|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
16348641|NCT03569098|39765423|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
16348642|NCT03569098|39765424|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
16413337|NCT00549770|39995132|FG001|Overall Study|Withdrawal by Subject|6|||
16413338|NCT00549770|39995133|FG002|Overall Study|Withdrawal by Subject|4|||
16413339|NCT00549770|39995134|FG003|Overall Study|Withdrawal by Subject|5|||
16413340|NCT00549770|39995135|FG004|Overall Study|Withdrawal by Subject|6|||
16413341|NCT00549770|39995136|FG005|Overall Study|Withdrawal by Subject|6|||
16413342|NCT00549770|39995137|FG006|Overall Study|Withdrawal by Subject|4|||
16413343|NCT00549770|39995138|FG007|Overall Study|Withdrawal by Subject|9|||
16413344|NCT00549770|39995131|FG000|Overall Study|Lack of Efficacy|1|||
16413345|NCT00549770|39995132|FG001|Overall Study|Lack of Efficacy|0|||
16413346|NCT00549770|39995133|FG002|Overall Study|Lack of Efficacy|2|||
16413347|NCT00549770|39995134|FG003|Overall Study|Lack of Efficacy|3|||
16413348|NCT00549770|39995135|FG004|Overall Study|Lack of Efficacy|5|||
16413349|NCT00549770|39995136|FG005|Overall Study|Lack of Efficacy|1|||
16413350|NCT00549770|39995137|FG006|Overall Study|Lack of Efficacy|3|||
16413351|NCT00549770|39995138|FG007|Overall Study|Lack of Efficacy|8|||
16413352|NCT00549770|39995131|FG000|Overall Study|Abnormal test procedure results|0|||
16413353|NCT00549770|39995132|FG001|Overall Study|Abnormal test procedure results|0|||
16413354|NCT00549770|39995133|FG002|Overall Study|Abnormal test procedure results|0|||
16413355|NCT00549770|39995134|FG003|Overall Study|Abnormal test procedure results|2|||
16413356|NCT00549770|39995135|FG004|Overall Study|Abnormal test procedure results|0|||
16413357|NCT00549770|39995136|FG005|Overall Study|Abnormal test procedure results|1|||
16413358|NCT00549770|39995137|FG006|Overall Study|Abnormal test procedure results|1|||
16413359|NCT00549770|39995138|FG007|Overall Study|Abnormal test procedure results|1|||
16413360|NCT00549770|39995131|FG000|Overall Study|Abnormal laboratory values|0|||
16413361|NCT00549770|39995132|FG001|Overall Study|Abnormal laboratory values|0|||
16413362|NCT00549770|39995133|FG002|Overall Study|Abnormal laboratory values|0|||
16413363|NCT00549770|39995134|FG003|Overall Study|Abnormal laboratory values|0|||
16413364|NCT00549770|39995135|FG004|Overall Study|Abnormal laboratory values|0|||
16413365|NCT00549770|39995136|FG005|Overall Study|Abnormal laboratory values|1|||
16413366|NCT00549770|39995137|FG006|Overall Study|Abnormal laboratory values|0|||
16413367|NCT00549770|39995138|FG007|Overall Study|Abnormal laboratory values|0|||
16413368|NCT00549770|39995131|FG000|Overall Study|Adverse Event|1|||
16413369|NCT00549770|39995132|FG001|Overall Study|Adverse Event|3|||
16413370|NCT00549770|39995133|FG002|Overall Study|Adverse Event|1|||
16413371|NCT00549770|39995134|FG003|Overall Study|Adverse Event|2|||
16413372|NCT00549770|39995135|FG004|Overall Study|Adverse Event|1|||
16413373|NCT00549770|39995136|FG005|Overall Study|Adverse Event|0|||
16413374|NCT00549770|39995137|FG006|Overall Study|Adverse Event|5|||
16413375|NCT00549770|39995138|FG007|Overall Study|Adverse Event|4|||
16413376|NCT02760810|39995141|FG000|Overall Study|Protocol Violation|1|||
16348643|NCT03569098|39765425|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
16348644|NCT02143024|39765426|FG000|Overall Study|Lost to Follow-up|1|||
16413377|NCT00084656|39995143|FG000|Overall Study|Other reasons|0|||
16413378|NCT00084656|39995144|FG001|Overall Study|Other reasons|12|||
16413379|NCT00084656|39995145|FG002|Overall Study|Other reasons|11|||
16413380|NCT00084656|39995143|FG000|Overall Study|Withdrawal by Subject|15|||
16413381|NCT00084656|39995144|FG001|Overall Study|Withdrawal by Subject|4|||
16413382|NCT00084656|39995145|FG002|Overall Study|Withdrawal by Subject|4|||
16413383|NCT00084656|39995143|FG000|Overall Study|Disease relapse|0|||
16413384|NCT00084656|39995144|FG001|Overall Study|Disease relapse|9|||
16413385|NCT00084656|39995145|FG002|Overall Study|Disease relapse|10|||
16413386|NCT00084656|39995143|FG000|Overall Study|Disease progression|9|||
16413387|NCT00084656|39995144|FG001|Overall Study|Disease progression|0|||
16413388|NCT00084656|39995145|FG002|Overall Study|Disease progression|0|||
16413389|NCT00084656|39995143|FG000|Overall Study|Lost to Follow-up|1|||
16413390|NCT00084656|39995144|FG001|Overall Study|Lost to Follow-up|0|||
16413391|NCT00084656|39995145|FG002|Overall Study|Lost to Follow-up|1|||
16232552|NCT04682639|39334653|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
16232553|NCT04682639|39334654|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
16232554|NCT04682639|39334650|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
16232555|NCT04682639|39334651|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
16232556|NCT04682639|39334652|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
16232557|NCT04682639|39334653|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
16348645|NCT02143024|39765427|FG001|Overall Study|Lost to Follow-up|1|||
16348646|NCT02143024|39765426|FG000|Overall Study|Withdrawal by Subject|1|||
16348647|NCT02143024|39765427|FG001|Overall Study|Withdrawal by Subject|0|||
16348648|NCT01076543|39765428|FG000|Overall Study|Withdrawal by Subject|2|||
16348649|NCT01076543|39765429|FG001|Overall Study|Withdrawal by Subject|0|||
16348650|NCT01076543|39765430|FG002|Overall Study|Withdrawal by Subject|0|||
16348651|NCT01076543|39765431|FG003|Overall Study|Withdrawal by Subject|0|||
16348652|NCT01076543|39765432|FG004|Overall Study|Withdrawal by Subject|0|||
16348653|NCT01076543|39765433|FG005|Overall Study|Withdrawal by Subject|0|||
16348654|NCT01716663|39765435|FG000|Overall Study|Withdrawn prior to procedure|4|||
16348655|NCT01716663|39765435|FG000|Overall Study|Treated with non-study catheter|2|||
16348656|NCT02782741|39765441|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
16348657|NCT02782741|39765442|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
16348658|NCT02782741|39765443|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
16348659|NCT02782741|39765441|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
16348660|NCT02782741|39765442|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
16348661|NCT02782741|39765443|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
16348662|NCT02782741|39765441|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
16348663|NCT02782741|39765442|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
16348664|NCT02782741|39765443|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
16348665|NCT02782741|39765441|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
16348666|NCT02782741|39765442|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
16232558|NCT04682639|39334654|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
16232559|NCT04682639|39334650|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
16348667|NCT02782741|39765443|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
16413392|NCT00746733|39995147|FG000|Second Intervention|Adverse Event|1|||
16348668|NCT02782741|39765441|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
16413393|NCT00746733|39995148|FG001|Second Intervention|Adverse Event|0|||
16413394|NCT00746733|39995147|FG000|Third Intervention|Withdrawal by Subject|1|||
16413395|NCT00746733|39995148|FG001|Third Intervention|Withdrawal by Subject|1|||
16552384|NCT00423852|40488199|FG000|Overall Study|Removed pior to the high-dose portion|3|||
16552385|NCT03225846|40488200|FG000|Overall Study|Adverse Event|0|||
16552386|NCT03225846|40488201|FG001|Overall Study|Adverse Event|0|||
16552387|NCT03225846|40488202|FG002|Overall Study|Adverse Event|0|||
16552388|NCT03225846|40488203|FG003|Overall Study|Adverse Event|0|||
16552389|NCT03225846|40488204|FG004|Overall Study|Adverse Event|0|||
16552390|NCT03225846|40488205|FG005|Overall Study|Adverse Event|0|||
16552391|NCT03225846|40488206|FG006|Overall Study|Adverse Event|6|||
16552392|NCT03225846|40488200|FG000|Overall Study|Withdrawal by Subject|0|||
16552393|NCT03225846|40488201|FG001|Overall Study|Withdrawal by Subject|1|||
16552394|NCT03225846|40488202|FG002|Overall Study|Withdrawal by Subject|0|||
16552395|NCT03225846|40488203|FG003|Overall Study|Withdrawal by Subject|0|||
16552396|NCT03225846|40488204|FG004|Overall Study|Withdrawal by Subject|0|||
16552397|NCT03225846|40488205|FG005|Overall Study|Withdrawal by Subject|0|||
16552398|NCT03225846|40488206|FG006|Overall Study|Withdrawal by Subject|0|||
16552399|NCT03225846|40488200|FG000|Overall Study|Death|0|||
16552400|NCT03225846|40488201|FG001|Overall Study|Death|1|||
16552401|NCT03225846|40488202|FG002|Overall Study|Death|0|||
16552402|NCT03225846|40488203|FG003|Overall Study|Death|0|||
16552403|NCT03225846|40488204|FG004|Overall Study|Death|0|||
16552404|NCT03225846|40488205|FG005|Overall Study|Death|0|||
16552405|NCT03225846|40488206|FG006|Overall Study|Death|0|||
16552406|NCT03225846|40488200|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
16552407|NCT03225846|40488201|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
16552408|NCT03225846|40488202|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
16552409|NCT03225846|40488203|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
16552410|NCT03225846|40488204|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
16552411|NCT03225846|40488205|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
16552412|NCT03225846|40488206|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
16552413|NCT03225846|40488200|FG000|Overall Study|Patient decision|0|||
16552414|NCT03225846|40488201|FG001|Overall Study|Patient decision|0|||
16552415|NCT03225846|40488202|FG002|Overall Study|Patient decision|0|||
16552416|NCT03225846|40488203|FG003|Overall Study|Patient decision|0|||
16552417|NCT03225846|40488204|FG004|Overall Study|Patient decision|0|||
16552418|NCT03225846|40488205|FG005|Overall Study|Patient decision|0|||
16552419|NCT03225846|40488206|FG006|Overall Study|Patient decision|1|||
16552420|NCT02930122|40488210|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
16552421|NCT02930122|40488211|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
16552422|NCT03428815|40488212|FG000|Overall Study|Lost to Follow-up|2|||
16552423|NCT03428815|40488213|FG001|Overall Study|Lost to Follow-up|2|||
16552424|NCT03428815|40488212|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
16552425|NCT03428815|40488213|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
16552426|NCT03428815|40488212|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
16413396|NCT03320330|39995149|FG000|Overall Study|Lack of Efficacy|5|||
16413397|NCT03320330|39995150|FG001|Overall Study|Lack of Efficacy|5|||
16413398|NCT03320330|39995151|FG002|Overall Study|Lack of Efficacy|14|||
16413399|NCT03320330|39995149|FG000|Overall Study|Physician Decision|1|||
16413400|NCT03320330|39995150|FG001|Overall Study|Physician Decision|0|||
16413401|NCT03320330|39995151|FG002|Overall Study|Physician Decision|0|||
16413402|NCT02469415|39995154|FG000|Overall Study|Withdrawal by Subject|1|||
16413403|NCT02469415|39995154|FG000|Overall Study|Investigational agent placed on hold|2|||
16413404|NCT01350115|39995155|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
16120083|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16120084|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16120085|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16120086|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
16120087|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
16120088|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
16120089|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
16120090|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16120091|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16120092|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16120093|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
16120094|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16120095|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16120096|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16120097|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16120098|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
16120099|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
16120100|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16120101|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
16120102|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16120103|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16120104|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16120105|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
16120106|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16120107|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16120108|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16120109|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16120110|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
16120111|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
16120112|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
16120113|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
16120114|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16120115|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16232560|NCT04682639|39334651|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
16232561|NCT04682639|39334652|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
16232562|NCT04682639|39334653|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
16232563|NCT04682639|39334654|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
16232564|NCT04682639|39334650|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
16232565|NCT04682639|39334651|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
16232566|NCT04682639|39334652|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
16232567|NCT04682639|39334653|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
16232568|NCT04682639|39334654|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
16232569|NCT04682639|39334650|FG000|OLE Period (28 Weeks)|Other|1|||
16232570|NCT04682639|39334651|FG001|OLE Period (28 Weeks)|Other|2|||
16232571|NCT04682639|39334652|FG002|OLE Period (28 Weeks)|Other|0|||
16232572|NCT04682639|39334653|FG003|OLE Period (28 Weeks)|Other|0|||
16232573|NCT04682639|39334654|FG004|OLE Period (28 Weeks)|Other|1|||
16232574|NCT04682639|39334650|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
16232575|NCT04682639|39334651|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
16232576|NCT04682639|39334652|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
16120116|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16120117|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
16120118|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
16232577|NCT04682639|39334653|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
16232578|NCT04682639|39334654|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
16232579|NCT04682639|39334650|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
16232580|NCT04682639|39334651|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
16232581|NCT04682639|39334652|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
16232582|NCT04682639|39334653|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
16232583|NCT04682639|39334654|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
16232584|NCT04682639|39334650|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
16232585|NCT04682639|39334651|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
16232586|NCT04682639|39334652|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
16232587|NCT04682639|39334653|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
16232588|NCT04682639|39334654|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
16232589|NCT04682639|39334650|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
16232590|NCT04682639|39334651|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
16120119|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
16120120|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
16120121|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
16120122|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
16120123|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
16120124|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
16120125|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
16120126|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
16232591|NCT04682639|39334652|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
16232592|NCT04682639|39334653|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
16348669|NCT02782741|39765442|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
16348670|NCT02782741|39765443|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
16348671|NCT02576977|39765444|FG000|Overall Study|Adverse Event|13|||
16348672|NCT02576977|39765445|FG001|Overall Study|Adverse Event|2|||
16348673|NCT02576977|39765444|FG000|Overall Study|Death|73|||
16348674|NCT02576977|39765445|FG001|Overall Study|Death|60|||
16232593|NCT04682639|39334654|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
16232594|NCT03253809|39334655|FG000|Overall Study|Unable to obtain study related data|14|||
16232595|NCT02389621|39334658|FG000|Treatment Period|Withdrawal by Subject|1|||
16348675|NCT02576977|39765444|FG000|Overall Study|Screen failure|1|||
16348676|NCT02576977|39765445|FG001|Overall Study|Screen failure|0|||
16348677|NCT02576977|39765444|FG000|Overall Study|Study Terminated at Selected Sites|27|||
16348678|NCT02576977|39765445|FG001|Overall Study|Study Terminated at Selected Sites|50|||
16232596|NCT02389621|39334659|FG001|Treatment Period|Withdrawal by Subject|1|||
16232597|NCT02389621|39334658|FG000|Posttreatment Period|Adverse Event|3|||
16232598|NCT02389621|39334659|FG001|Posttreatment Period|Adverse Event|1|||
16232599|NCT02389621|39334658|FG000|Posttreatment Period|Withdrawal by Subject|3|||
16232600|NCT02389621|39334659|FG001|Posttreatment Period|Withdrawal by Subject|2|||
16232601|NCT02389621|39334658|FG000|Posttreatment Period|Lost to Follow-up|1|||
16232602|NCT02389621|39334659|FG001|Posttreatment Period|Lost to Follow-up|1|||
16232603|NCT02389621|39334658|FG000|Posttreatment Period|Other - Miscellaneous|2|||
16232604|NCT02389621|39334659|FG001|Posttreatment Period|Other - Miscellaneous|0|||
16232605|NCT00145795|39334663|FG000|Overall Study|Adverse Event|1|||
16232606|NCT00145795|39334664|FG001|Overall Study|Adverse Event|0|||
16232607|NCT00578448|39334667|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
16232608|NCT00578448|39334667|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
16232609|NCT00578448|39334667|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
16232610|NCT00578448|39334667|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
16232611|NCT02190604|39334671|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232612|NCT02190604|39334672|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232613|NCT02190604|39334673|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232614|NCT02190604|39334674|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232615|NCT02190604|39334675|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232616|NCT02190604|39334676|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232617|NCT02190604|39334677|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232618|NCT02190604|39334678|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232619|NCT02190604|39334679|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16348679|NCT02576977|39765444|FG000|Overall Study|Withdrawal by Subject|11|||
16120127|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
16232620|NCT02190604|39334680|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16348680|NCT02576977|39765445|FG001|Overall Study|Withdrawal by Subject|11|||
16348681|NCT02576977|39765444|FG000|Overall Study|Final Disposition Unknown|0|||
16348682|NCT02576977|39765445|FG001|Overall Study|Final Disposition Unknown|1|||
16120128|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
16348683|NCT02576977|39765444|FG000|Overall Study|Lost to Follow-up|1|||
16232621|NCT02190604|39334681|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232622|NCT02190604|39334682|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232623|NCT02190604|39334683|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232624|NCT02190604|39334684|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16120129|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
16120130|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16232625|NCT02190604|39334685|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
16232626|NCT02190604|39334686|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232627|NCT02190604|39334687|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232628|NCT02190604|39334688|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232629|NCT02190604|39334689|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
16232630|NCT02190604|39334671|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232631|NCT02190604|39334672|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232632|NCT02190604|39334673|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232633|NCT02190604|39334674|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232634|NCT02190604|39334675|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232635|NCT02190604|39334676|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232636|NCT02190604|39334677|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232637|NCT02190604|39334678|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232638|NCT02190604|39334679|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232639|NCT02190604|39334680|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232640|NCT02190604|39334681|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232641|NCT02190604|39334682|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232642|NCT02190604|39334683|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232643|NCT02190604|39334684|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
16232644|NCT02190604|39334685|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232645|NCT02190604|39334686|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232646|NCT02190604|39334687|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232647|NCT02190604|39334688|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232648|NCT02190604|39334689|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
16232649|NCT02243709|39334690|FG000|Phase 1|Lost to Follow-up|0|||
16232650|NCT02243709|39334691|FG001|Phase 1|Lost to Follow-up|1|||
16232651|NCT02243709|39334690|FG000|Phase 1|Withdrawal by Subject|1|||
16232652|NCT02243709|39334691|FG001|Phase 1|Withdrawal by Subject|0|||
16232653|NCT02243709|39334690|FG000|Phase 1|Protocol Violation|0|||
16232654|NCT02243709|39334691|FG001|Phase 1|Protocol Violation|1|||
16232655|NCT02243709|39334690|FG000|Phase 1|Adverse Event|0|||
16232656|NCT02243709|39334691|FG001|Phase 1|Adverse Event|1|||
16232657|NCT00577382|39334694|FG000|Overall Study|Adverse Event|0|||
16232658|NCT00577382|39334695|FG001|Overall Study|Adverse Event|6|||
16232659|NCT00577382|39334694|FG000|Overall Study|Withdrawal by Subject|0|||
16232660|NCT00577382|39334695|FG001|Overall Study|Withdrawal by Subject|1|||
16232661|NCT00577382|39334694|FG000|Overall Study|Progressive Disease|17|||
16232662|NCT00577382|39334695|FG001|Overall Study|Progressive Disease|19|||
16232663|NCT00577382|39334694|FG000|Overall Study|Intercurrent Illness|1|||
16232664|NCT00577382|39334695|FG001|Overall Study|Intercurrent Illness|2|||
16232665|NCT00577382|39334694|FG000|Overall Study|Death|1|||
16232666|NCT00577382|39334695|FG001|Overall Study|Death|1|||
16232667|NCT00577382|39334694|FG000|Overall Study|Lost to Follow-up|2|||
16232668|NCT00577382|39334695|FG001|Overall Study|Lost to Follow-up|2|||
16232669|NCT02279888|39334697|FG000|Overall Study|Death|326|||
16232670|NCT02279888|39334697|FG000|Overall Study|Withdrawal by Subject|38|||
16232671|NCT02279888|39334697|FG000|Overall Study|Lost to Follow-up|21|||
16232672|NCT02279888|39334697|FG000|Overall Study|Physician Decision|62|||
16232673|NCT02279888|39334697|FG000|Overall Study|Subject Non-compliance|43|||
16232674|NCT02279888|39334697|FG000|Overall Study|Not implanted|14|||
16232675|NCT02279888|39334697|FG000|Overall Study|Visit not performed|26|||
16232676|NCT00446134|39334700|FG000|Overall Study|Adverse Event|7|||
16232677|NCT00446134|39334701|FG001|Overall Study|Adverse Event|17|||
16232678|NCT00446134|39334702|FG002|Overall Study|Adverse Event|13|||
16232679|NCT00446134|39334703|FG003|Overall Study|Adverse Event|18|||
16232680|NCT00446134|39334700|FG000|Overall Study|Lack of Efficacy|19|||
16232681|NCT00446134|39334701|FG001|Overall Study|Lack of Efficacy|19|||
16232682|NCT00446134|39334702|FG002|Overall Study|Lack of Efficacy|24|||
16232683|NCT00446134|39334703|FG003|Overall Study|Lack of Efficacy|19|||
16232684|NCT00446134|39334700|FG000|Overall Study|Protocol Violation|0|||
16232685|NCT00446134|39334701|FG001|Overall Study|Protocol Violation|2|||
16232686|NCT00446134|39334702|FG002|Overall Study|Protocol Violation|1|||
16232687|NCT00446134|39334703|FG003|Overall Study|Protocol Violation|0|||
16232688|NCT00446134|39334700|FG000|Overall Study|Lost to Follow-up|1|||
16232689|NCT00446134|39334701|FG001|Overall Study|Lost to Follow-up|3|||
16232690|NCT00446134|39334702|FG002|Overall Study|Lost to Follow-up|1|||
16232691|NCT00446134|39334703|FG003|Overall Study|Lost to Follow-up|1|||
16232692|NCT00446134|39334700|FG000|Overall Study|Withdrawal by Subject|3|||
16232693|NCT00446134|39334701|FG001|Overall Study|Withdrawal by Subject|3|||
16232694|NCT00446134|39334702|FG002|Overall Study|Withdrawal by Subject|1|||
16232695|NCT00446134|39334703|FG003|Overall Study|Withdrawal by Subject|3|||
16232696|NCT00446134|39334700|FG000|Overall Study|Physician Decision|0|||
16232697|NCT00446134|39334701|FG001|Overall Study|Physician Decision|0|||
16232698|NCT00446134|39334702|FG002|Overall Study|Physician Decision|0|||
16232699|NCT00446134|39334703|FG003|Overall Study|Physician Decision|2|||
16232700|NCT00446134|39334700|FG000|Overall Study|Adverse Event-Diarrhea|1|||
16232701|NCT00446134|39334701|FG001|Overall Study|Adverse Event-Diarrhea|1|||
16232702|NCT00446134|39334702|FG002|Overall Study|Adverse Event-Diarrhea|2|||
16232703|NCT00446134|39334703|FG003|Overall Study|Adverse Event-Diarrhea|0|||
16232704|NCT00446134|39334700|FG000|Overall Study|Reason Not Completed|3|||
16232705|NCT00446134|39334701|FG001|Overall Study|Reason Not Completed|0|||
16232706|NCT00446134|39334702|FG002|Overall Study|Reason Not Completed|1|||
16232707|NCT00446134|39334703|FG003|Overall Study|Reason Not Completed|2|||
16232708|NCT00437294|39334707|FG000|Overall Study|Adverse Event|5|||
16232709|NCT00437294|39334708|FG001|Overall Study|Adverse Event|4|||
16232710|NCT00437294|39334707|FG000|Overall Study|Death|5|||
16232711|NCT00437294|39334708|FG001|Overall Study|Death|2|||
16232712|NCT00437294|39334707|FG000|Overall Study|Physician Decision|0|||
16232713|NCT00437294|39334708|FG001|Overall Study|Physician Decision|3|||
16232714|NCT00437294|39334707|FG000|Overall Study|Withdrawal by Subject|5|||
16232715|NCT00437294|39334708|FG001|Overall Study|Withdrawal by Subject|0|||
16232716|NCT00437294|39334707|FG000|Overall Study|Progressive Disease|19|||
16232717|NCT00437294|39334708|FG001|Overall Study|Progressive Disease|23|||
16348684|NCT02576977|39765445|FG001|Overall Study|Lost to Follow-up|0|||
16552427|NCT03428815|40488213|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
16552428|NCT00957931|40488214|FG000|Overall Study|Death|4|||
16552429|NCT01382940|40488215|FG000|Overall Study|Adverse Event|19|||
16552430|NCT01382940|40488215|FG000|Overall Study|Lost to Follow-up|4|||
16552431|NCT01382940|40488215|FG000|Overall Study|Physician Decision|7|||
16552432|NCT01382940|40488215|FG000|Overall Study|Withdrawal by Subject|23|||
16552433|NCT01382940|40488215|FG000|Overall Study|Protocol Violation|20|||
16552434|NCT03929913|40488216|FG000|Overall Study|Death|4|||
16552435|NCT03929913|40488216|FG000|Overall Study|Lost to Follow-up|1|||
16552436|NCT03929913|40488216|FG000|Overall Study|Failed Procedure|2|||
16552437|NCT01558674|40488219|FG000|Part 1|Study Terminated by Sponsor|10|||
16552438|NCT01558674|40488220|FG001|Part 1|Study Terminated by Sponsor|0|||
16552439|NCT01558674|40488219|FG000|Part 1|Withdrawal by Subject|1|||
16552440|NCT01558674|40488220|FG001|Part 1|Withdrawal by Subject|0|||
16552441|NCT01406717|40488222|FG000|Overall Study|Subject non-compliance|4|||
16552442|NCT01406717|40488223|FG001|Overall Study|Subject non-compliance|3|||
16348685|NCT02576977|39765444|FG000|Overall Study|Progressive Disease|0|||
16232718|NCT00437294|39334707|FG000|Overall Study|Sponsor Decision|8|||
16232719|NCT00437294|39334708|FG001|Overall Study|Sponsor Decision|9|||
16232720|NCT00437294|39334707|FG000|Overall Study|Protocol Violation|0|||
16232721|NCT00437294|39334708|FG001|Overall Study|Protocol Violation|1|||
16232722|NCT00437294|39334707|FG000|Overall Study|Entry criteria not met|1|||
16552443|NCT01406717|40488222|FG000|Overall Study|Protocol Violation|5|||
16552444|NCT01406717|40488223|FG001|Overall Study|Protocol Violation|1|||
16232723|NCT00437294|39334708|FG001|Overall Study|Entry criteria not met|1|||
16552445|NCT01406717|40488222|FG000|Overall Study|Lost to Follow-up|14|||
16552446|NCT01406717|40488223|FG001|Overall Study|Lost to Follow-up|8|||
16552447|NCT01406717|40488222|FG000|Overall Study|Withdrawal by Subject|19|||
16552448|NCT01406717|40488223|FG001|Overall Study|Withdrawal by Subject|15|||
16552449|NCT01406717|40488222|FG000|Overall Study|Adverse Event|1|||
16552450|NCT01406717|40488223|FG001|Overall Study|Adverse Event|2|||
16552451|NCT01406717|40488222|FG000|Overall Study|Lack of Efficacy|0|||
16552452|NCT01406717|40488223|FG001|Overall Study|Lack of Efficacy|1|||
16552453|NCT01406717|40488222|FG000|Overall Study|Non-completion of visit activity|0|||
16552454|NCT01406717|40488223|FG001|Overall Study|Non-completion of visit activity|1|||
16552455|NCT01679236|40488224|FG000|Overall Study|Lost to Follow-up|15|||
16552456|NCT01679236|40488225|FG001|Overall Study|Lost to Follow-up|15|||
16552457|NCT00924469|40488226|FG000|Overall Study|Adverse Event|2|||
16552458|NCT00924469|40488227|FG001|Overall Study|Adverse Event|0|||
16552459|NCT00924469|40488226|FG000|Overall Study|Withdrawal by Subject|0|||
16552460|NCT00924469|40488227|FG001|Overall Study|Withdrawal by Subject|1|||
16552461|NCT00924469|40488226|FG000|Overall Study|Lost to Follow-up|0|||
16552462|NCT00924469|40488227|FG001|Overall Study|Lost to Follow-up|1|||
16552463|NCT03621982|40488230|FG000|Overall Study|Withdrawal by Subject|1|||
16552464|NCT03621982|40488231|FG001|Overall Study|Withdrawal by Subject|0|||
16552465|NCT03621982|40488232|FG002|Overall Study|Withdrawal by Subject|0|||
16552466|NCT03621982|40488233|FG003|Overall Study|Withdrawal by Subject|1|||
16552467|NCT03621982|40488234|FG004|Overall Study|Withdrawal by Subject|0|||
16552468|NCT03621982|40488235|FG005|Overall Study|Withdrawal by Subject|1|||
16552469|NCT03621982|40488236|FG006|Overall Study|Withdrawal by Subject|1|||
16552470|NCT03621982|40488237|FG007|Overall Study|Withdrawal by Subject|0|||
16120131|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16120132|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16120133|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16552471|NCT03621982|40488238|FG008|Overall Study|Withdrawal by Subject|1|||
16552472|NCT03621982|40488239|FG009|Overall Study|Withdrawal by Subject|0|||
16552473|NCT03621982|40488240|FG010|Overall Study|Withdrawal by Subject|2|||
16552474|NCT03621982|40488241|FG011|Overall Study|Withdrawal by Subject|1|||
16552475|NCT03621982|40488242|FG012|Overall Study|Withdrawal by Subject|2|||
16552476|NCT03621982|40488243|FG013|Overall Study|Withdrawal by Subject|2|||
16552477|NCT03621982|40488230|FG000|Overall Study|Investigator/Sponsor decision|0|||
16120134|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
16120135|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
16120136|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
16120137|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
16120138|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16120139|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16120140|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16120141|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
16120142|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16120143|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16120144|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16232724|NCT00684645|39334709|FG000|Overall Study|Death|2|||
16552478|NCT03621982|40488231|FG001|Overall Study|Investigator/Sponsor decision|0|||
16552479|NCT03621982|40488232|FG002|Overall Study|Investigator/Sponsor decision|0|||
16232725|NCT00684645|39334709|FG000|Overall Study|Progressive disease|67|||
16232726|NCT00684645|39334709|FG000|Overall Study|Adverse Event|27|||
16552480|NCT03621982|40488233|FG003|Overall Study|Investigator/Sponsor decision|0|||
16552481|NCT03621982|40488234|FG004|Overall Study|Investigator/Sponsor decision|0|||
16552482|NCT03621982|40488235|FG005|Overall Study|Investigator/Sponsor decision|0|||
16552483|NCT03621982|40488236|FG006|Overall Study|Investigator/Sponsor decision|0|||
16552484|NCT03621982|40488237|FG007|Overall Study|Investigator/Sponsor decision|0|||
16552485|NCT03621982|40488238|FG008|Overall Study|Investigator/Sponsor decision|0|||
16552486|NCT03621982|40488239|FG009|Overall Study|Investigator/Sponsor decision|0|||
16232727|NCT00684645|39334709|FG000|Overall Study|Lost to Follow-up|3|||
16232728|NCT00684645|39334709|FG000|Overall Study|Other|15|||
16232729|NCT01068418|39334712|FG000|Overall Study|Physician Decision|12|||
16232730|NCT00938015|39334713|FG000|Overall Study|Death|2|||
16232731|NCT00938015|39334713|FG000|Overall Study|Lost to Follow-up|32|||
16232732|NCT00938015|39334713|FG000|Overall Study|Adverse Event|32|||
16232733|NCT00938015|39334713|FG000|Overall Study|Non-responder|52|||
16232734|NCT00938015|39334713|FG000|Overall Study|Reason not related to Etanercept|29|||
16232735|NCT00795886|39334714|FG000|Overall Study|Death|10|||
16232736|NCT01458535|39334716|FG000|Overall Study|Other|0|||
16232737|NCT01458535|39334717|FG001|Overall Study|Other|0|||
16232738|NCT01458535|39334718|FG002|Overall Study|Other|0|||
16232739|NCT01458535|39334719|FG003|Overall Study|Other|0|||
16232740|NCT01458535|39334720|FG004|Overall Study|Other|1|||
16232741|NCT01458535|39334721|FG005|Overall Study|Other|1|||
16232742|NCT01458535|39334716|FG000|Overall Study|Withdrawal by Subject|0|||
16232743|NCT01458535|39334717|FG001|Overall Study|Withdrawal by Subject|0|||
16232744|NCT01458535|39334718|FG002|Overall Study|Withdrawal by Subject|2|||
16232745|NCT01458535|39334719|FG003|Overall Study|Withdrawal by Subject|0|||
16232746|NCT01458535|39334720|FG004|Overall Study|Withdrawal by Subject|1|||
16232747|NCT01458535|39334721|FG005|Overall Study|Withdrawal by Subject|1|||
16348686|NCT02576977|39765445|FG001|Overall Study|Progressive Disease|1|||
16552487|NCT03621982|40488240|FG010|Overall Study|Investigator/Sponsor decision|0|||
16552488|NCT03621982|40488241|FG011|Overall Study|Investigator/Sponsor decision|4|||
16232748|NCT01458535|39334716|FG000|Overall Study|Lost to Follow-up|0|||
16232749|NCT01458535|39334717|FG001|Overall Study|Lost to Follow-up|2|||
16348687|NCT00268983|39765455|FG000|Overall Study|Death|3|||
16348688|NCT00268983|39765456|FG001|Overall Study|Death|0|||
16232750|NCT01458535|39334718|FG002|Overall Study|Lost to Follow-up|0|||
16232751|NCT01458535|39334719|FG003|Overall Study|Lost to Follow-up|3|||
16232752|NCT01458535|39334720|FG004|Overall Study|Lost to Follow-up|2|||
16232753|NCT01458535|39334721|FG005|Overall Study|Lost to Follow-up|2|||
16232754|NCT01458535|39334716|FG000|Overall Study|Adverse Event|0|||
16232755|NCT01458535|39334717|FG001|Overall Study|Adverse Event|0|||
16232756|NCT01458535|39334718|FG002|Overall Study|Adverse Event|0|||
16232757|NCT01458535|39334719|FG003|Overall Study|Adverse Event|1|||
16232758|NCT01458535|39334720|FG004|Overall Study|Adverse Event|0|||
16232759|NCT01458535|39334721|FG005|Overall Study|Adverse Event|0|||
16232760|NCT00290511|39334722|FG000|Overall Study|Adverse Event|1|||
16232761|NCT00290511|39334722|FG000|Overall Study|Death|1|||
16232762|NCT00290511|39334722|FG000|Overall Study|Physician Decision|1|||
16232763|NCT00290511|39334722|FG000|Overall Study|Withdrawal by Subject|1|||
16232764|NCT02641730|39334724|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
16552489|NCT03621982|40488242|FG012|Overall Study|Investigator/Sponsor decision|0|||
16552490|NCT03621982|40488243|FG013|Overall Study|Investigator/Sponsor decision|2|||
16552491|NCT03621982|40488230|FG000|Overall Study|Death|2|||
16552492|NCT03621982|40488231|FG001|Overall Study|Death|4|||
16552493|NCT03621982|40488232|FG002|Overall Study|Death|4|||
16120145|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16120146|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16120147|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16120148|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16120149|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
16232765|NCT02641730|39334725|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
16232766|NCT02641730|39334726|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
16232767|NCT02641730|39334727|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
16232768|NCT02641730|39334728|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
16232769|NCT02641730|39334724|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
16232770|NCT02641730|39334725|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
16232771|NCT02641730|39334726|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
16232772|NCT02641730|39334727|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
16232773|NCT02641730|39334728|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
16232774|NCT02641730|39334724|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
16232775|NCT02641730|39334725|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
16232776|NCT02641730|39334726|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
16232777|NCT02641730|39334727|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
16232778|NCT02641730|39334728|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
16232779|NCT02641730|39334724|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16232780|NCT02641730|39334725|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16232781|NCT02641730|39334726|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16232782|NCT02641730|39334727|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
16232783|NCT02641730|39334728|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
16232784|NCT02641730|39334724|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
16232785|NCT02641730|39334725|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
16232786|NCT02641730|39334726|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
16232787|NCT02641730|39334727|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
16232788|NCT02641730|39334728|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
16232789|NCT02641730|39334724|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
16232790|NCT02641730|39334725|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
16232791|NCT02641730|39334726|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
16232792|NCT02641730|39334727|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
16232793|NCT02641730|39334728|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
16232794|NCT00536991|39334730|FG000|Overall Study|Withdrawal by Subject|10|||
16232795|NCT00536991|39334730|FG000|Overall Study|Physician Decision|1|||
16232796|NCT00536991|39334730|FG000|Overall Study|patient ineligible|2|||
16232797|NCT04158739|39334731|FG000|Overall Study|Adverse Event|1|||
16232798|NCT04158739|39334732|FG001|Overall Study|Adverse Event|0|||
16232799|NCT04158739|39334731|FG000|Overall Study|Death|0|||
16232800|NCT04158739|39334732|FG001|Overall Study|Death|1|||
16348689|NCT02111174|39765457|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
16348690|NCT02111174|39765458|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
16348691|NCT02111174|39765457|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
16120150|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16120151|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16120152|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16120153|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
16232801|NCT04158739|39334731|FG000|Overall Study|Lack of Efficacy|3|||
16232802|NCT04158739|39334732|FG001|Overall Study|Lack of Efficacy|7|||
16232803|NCT04158739|39334731|FG000|Overall Study|Physician Decision|0|||
16232804|NCT04158739|39334732|FG001|Overall Study|Physician Decision|1|||
16348692|NCT02111174|39765458|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
16348693|NCT02111174|39765457|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
16232805|NCT04158739|39334731|FG000|Overall Study|Withdrawal by Subject|3|||
16232806|NCT04158739|39334732|FG001|Overall Study|Withdrawal by Subject|0|||
16232807|NCT03526549|39334733|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
16232808|NCT03526549|39334734|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
16232809|NCT03526549|39334733|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
16232810|NCT03526549|39334734|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
16232811|NCT03526549|39334733|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
16232812|NCT03526549|39334734|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
16232813|NCT03526549|39334733|FG000|Open-label Phase|Adverse Event|4|||
16232814|NCT03526549|39334734|FG001|Open-label Phase|Adverse Event|0|||
16232815|NCT03526549|39334733|FG000|Open-label Phase|Withdrawal by Subject|54|||
16232816|NCT03526549|39334734|FG001|Open-label Phase|Withdrawal by Subject|0|||
16232817|NCT03526549|39334733|FG000|Open-label Phase|Lost to Follow-up|35|||
16232818|NCT03526549|39334734|FG001|Open-label Phase|Lost to Follow-up|0|||
16232819|NCT03526549|39334733|FG000|Open-label Phase|Other than Specified|5|||
16232820|NCT03526549|39334734|FG001|Open-label Phase|Other than Specified|0|||
16232821|NCT00648739|39334737|FG000|Overall Study|Adverse Event|1|||
16232822|NCT00648739|39334738|FG001|Overall Study|Adverse Event|0|||
16232823|NCT00648739|39334739|FG002|Overall Study|Adverse Event|1|||
16232824|NCT00648739|39334740|FG003|Overall Study|Adverse Event|2|||
16232825|NCT00648739|39334741|FG004|Overall Study|Adverse Event|1|||
16232826|NCT00648739|39334742|FG005|Overall Study|Adverse Event|0|||
16232827|NCT00648739|39334743|FG006|Overall Study|Adverse Event|0|||
16232828|NCT00648739|39334737|FG000|Overall Study|Withdrawal by Subject|1|||
16232829|NCT00648739|39334738|FG001|Overall Study|Withdrawal by Subject|0|||
16232830|NCT00648739|39334739|FG002|Overall Study|Withdrawal by Subject|1|||
16232831|NCT00648739|39334740|FG003|Overall Study|Withdrawal by Subject|0|||
16232832|NCT00648739|39334741|FG004|Overall Study|Withdrawal by Subject|0|||
16232833|NCT00648739|39334742|FG005|Overall Study|Withdrawal by Subject|2|||
16232834|NCT00648739|39334743|FG006|Overall Study|Withdrawal by Subject|0|||
16232835|NCT00648739|39334737|FG000|Overall Study|Lack of Efficacy|0|||
16232836|NCT00648739|39334738|FG001|Overall Study|Lack of Efficacy|0|||
16232837|NCT00648739|39334739|FG002|Overall Study|Lack of Efficacy|0|||
16413405|NCT01350115|39995156|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
16413406|NCT01350115|39995155|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
16413407|NCT01350115|39995156|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
16413408|NCT01350115|39995155|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
16413409|NCT01350115|39995156|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
16413410|NCT00762996|39995157|FG000|Period One|Protocol Violation|0|||
16413411|NCT00762996|39995158|FG001|Period One|Protocol Violation|0|||
16552494|NCT03621982|40488233|FG003|Overall Study|Death|3|||
16552495|NCT03621982|40488234|FG004|Overall Study|Death|8|||
16552496|NCT03621982|40488235|FG005|Overall Study|Death|4|||
16120154|NCT01646177|38927110|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16552497|NCT03621982|40488236|FG006|Overall Study|Death|6|||
16552498|NCT03621982|40488237|FG007|Overall Study|Death|3|||
16552499|NCT03621982|40488238|FG008|Overall Study|Death|0|||
16552500|NCT03621982|40488239|FG009|Overall Study|Death|3|||
16552501|NCT03621982|40488240|FG010|Overall Study|Death|8|||
16552502|NCT03621982|40488241|FG011|Overall Study|Death|4|||
16552503|NCT03621982|40488242|FG012|Overall Study|Death|2|||
16552504|NCT03621982|40488243|FG013|Overall Study|Death|2|||
16552505|NCT03621982|40488230|FG000|Overall Study|Lost to Follow-up|0|||
16552506|NCT03621982|40488231|FG001|Overall Study|Lost to Follow-up|0|||
16120155|NCT01646177|38927111|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16120156|NCT01646177|38927112|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16120157|NCT01646177|38927113|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16120158|NCT01646177|38927114|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16120159|NCT01646177|38927115|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
16120160|NCT01646177|38927116|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
16120161|NCT01646177|38927117|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
16120162|NCT01646177|38927118|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16120163|NCT01646177|38927119|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16120164|NCT01646177|38927120|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16120165|NCT01646177|38927121|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
16232838|NCT00648739|39334740|FG003|Overall Study|Lack of Efficacy|0|||
16232839|NCT00648739|39334741|FG004|Overall Study|Lack of Efficacy|1|||
16232840|NCT00648739|39334742|FG005|Overall Study|Lack of Efficacy|2|||
16232841|NCT00648739|39334743|FG006|Overall Study|Lack of Efficacy|0|||
16232842|NCT00648739|39334737|FG000|Overall Study|Investigator Considered it Advisable|0|||
16232843|NCT00648739|39334738|FG001|Overall Study|Investigator Considered it Advisable|0|||
16413412|NCT00762996|39995159|FG002|Period One|Protocol Violation|1|||
16552507|NCT03621982|40488232|FG002|Overall Study|Lost to Follow-up|1|||
16552508|NCT03621982|40488233|FG003|Overall Study|Lost to Follow-up|0|||
16552509|NCT03621982|40488234|FG004|Overall Study|Lost to Follow-up|0|||
16552510|NCT03621982|40488235|FG005|Overall Study|Lost to Follow-up|0|||
16552511|NCT03621982|40488236|FG006|Overall Study|Lost to Follow-up|1|||
16552512|NCT03621982|40488237|FG007|Overall Study|Lost to Follow-up|0|||
16552513|NCT03621982|40488238|FG008|Overall Study|Lost to Follow-up|0|||
16552514|NCT03621982|40488239|FG009|Overall Study|Lost to Follow-up|1|||
16552515|NCT03621982|40488240|FG010|Overall Study|Lost to Follow-up|0|||
16232844|NCT00648739|39334739|FG002|Overall Study|Investigator Considered it Advisable|0|||
16232845|NCT00648739|39334740|FG003|Overall Study|Investigator Considered it Advisable|0|||
16552516|NCT03621982|40488241|FG011|Overall Study|Lost to Follow-up|0|||
16552517|NCT03621982|40488242|FG012|Overall Study|Lost to Follow-up|0|||
16552518|NCT03621982|40488243|FG013|Overall Study|Lost to Follow-up|0|||
16552519|NCT02367716|40488245|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
16552520|NCT03918239|40488246|FG000|Overall Study|Lost to Follow-up|3|||
16552521|NCT03918239|40488247|FG001|Overall Study|Lost to Follow-up|1|||
16552522|NCT03918239|40488246|FG000|Overall Study|Pregnancy|0|||
16552523|NCT03918239|40488247|FG001|Overall Study|Pregnancy|2|||
16552524|NCT03918239|40488246|FG000|Overall Study|Withdrawal by Subject|3|||
16552525|NCT03918239|40488247|FG001|Overall Study|Withdrawal by Subject|3|||
16552526|NCT03918239|40488246|FG000|Overall Study|positive urine drug screening results|4|||
16552527|NCT03918239|40488247|FG001|Overall Study|positive urine drug screening results|1|||
16552528|NCT01493960|40488248|FG000|Overall Study|Adverse Event|0|||
16552529|NCT01493960|40488249|FG001|Overall Study|Adverse Event|1|||
16552530|NCT01493960|40488248|FG000|Overall Study|Lack of Efficacy|15|||
16552531|NCT01493960|40488249|FG001|Overall Study|Lack of Efficacy|9|||
16552532|NCT01493960|40488248|FG000|Overall Study|Protocol Violation|3|||
16552533|NCT01493960|40488249|FG001|Overall Study|Protocol Violation|0|||
16552534|NCT01493960|40488248|FG000|Overall Study|Withdrawal by Subject|10|||
16552535|NCT01493960|40488249|FG001|Overall Study|Withdrawal by Subject|4|||
16552536|NCT01493960|40488248|FG000|Overall Study|Non-specified|4|||
16552537|NCT01493960|40488249|FG001|Overall Study|Non-specified|4|||
16552538|NCT03075501|40488252|FG000|Overall Study|Scheduling difficulties|15|||
16552539|NCT03075501|40488253|FG001|Overall Study|Scheduling difficulties|9|||
16552540|NCT00744237|40488254|FG000|Overall Study|Lack of Efficacy|1|||
16552541|NCT00744237|40488255|FG001|Overall Study|Lack of Efficacy|1|||
16552542|NCT00744237|40488256|FG002|Overall Study|Lack of Efficacy|0|||
16552543|NCT00744237|40488254|FG000|Overall Study|Withdrawal by Subject|9|||
16552544|NCT00744237|40488255|FG001|Overall Study|Withdrawal by Subject|5|||
16552545|NCT00744237|40488256|FG002|Overall Study|Withdrawal by Subject|3|||
16552546|NCT00744237|40488254|FG000|Overall Study|Lost to Follow-up|1|||
16552547|NCT00744237|40488255|FG001|Overall Study|Lost to Follow-up|1|||
16552548|NCT00744237|40488256|FG002|Overall Study|Lost to Follow-up|1|||
16552549|NCT00744237|40488254|FG000|Overall Study|Protocol Violation|3|||
16552550|NCT00744237|40488255|FG001|Overall Study|Protocol Violation|4|||
16552551|NCT00744237|40488256|FG002|Overall Study|Protocol Violation|3|||
16552552|NCT00744237|40488254|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
16552553|NCT00744237|40488255|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
16552554|NCT00744237|40488256|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
16552555|NCT00744237|40488254|FG000|Overall Study|Dosing Error|1|||
16552556|NCT00744237|40488255|FG001|Overall Study|Dosing Error|0|||
16552557|NCT00744237|40488256|FG002|Overall Study|Dosing Error|1|||
16552558|NCT00744237|40488254|FG000|Overall Study|Study Drug Error|1|||
16552559|NCT00744237|40488255|FG001|Overall Study|Study Drug Error|0|||
16552560|NCT00744237|40488256|FG002|Overall Study|Study Drug Error|0|||
16552561|NCT00744237|40488254|FG000|Overall Study|Prohibited Concomitant Medication|0|||
16552562|NCT00744237|40488255|FG001|Overall Study|Prohibited Concomitant Medication|0|||
16552563|NCT00744237|40488256|FG002|Overall Study|Prohibited Concomitant Medication|1|||
16552564|NCT00744237|40488254|FG000|Overall Study|Poor Compliance|0|||
16552565|NCT00744237|40488255|FG001|Overall Study|Poor Compliance|2|||
16552566|NCT00744237|40488256|FG002|Overall Study|Poor Compliance|0|||
16552567|NCT00744237|40488254|FG000|Overall Study|Administrative. Site Closed|1|||
16552568|NCT00744237|40488255|FG001|Overall Study|Administrative. Site Closed|1|||
16552569|NCT00744237|40488256|FG002|Overall Study|Administrative. Site Closed|1|||
16552570|NCT00744237|40488254|FG000|Overall Study|Adverse Event|9|||
16552571|NCT00744237|40488255|FG001|Overall Study|Adverse Event|13|||
16552572|NCT00744237|40488256|FG002|Overall Study|Adverse Event|5|||
16552573|NCT03679767|40488259|FG000|Overall Study|Death|16|||
16552574|NCT03679767|40488260|FG001|Overall Study|Death|11|||
16552575|NCT03679767|40488261|FG002|Overall Study|Death|17|||
16552576|NCT03679767|40488262|FG003|Overall Study|Death|10|||
16552577|NCT03679767|40488259|FG000|Overall Study|Lost to Follow-up|1|||
16552578|NCT03679767|40488260|FG001|Overall Study|Lost to Follow-up|1|||
16552579|NCT03679767|40488261|FG002|Overall Study|Lost to Follow-up|1|||
16552580|NCT03679767|40488262|FG003|Overall Study|Lost to Follow-up|1|||
16552581|NCT03679767|40488259|FG000|Overall Study|Withdrawal by Subject|0|||
16552582|NCT03679767|40488260|FG001|Overall Study|Withdrawal by Subject|0|||
16552583|NCT03679767|40488261|FG002|Overall Study|Withdrawal by Subject|0|||
16552584|NCT03679767|40488262|FG003|Overall Study|Withdrawal by Subject|1|||
16552585|NCT03679767|40488259|FG000|Overall Study|Follow-up Completed|18|||
16552586|NCT03679767|40488260|FG001|Overall Study|Follow-up Completed|11|||
16552587|NCT03679767|40488261|FG002|Overall Study|Follow-up Completed|11|||
16552588|NCT03679767|40488262|FG003|Overall Study|Follow-up Completed|20|||
16120166|NCT01646177|38927110|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16120167|NCT01646177|38927111|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16120168|NCT01646177|38927112|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16120169|NCT01646177|38927113|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16120170|NCT01646177|38927114|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16120171|NCT01646177|38927115|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16552589|NCT03679767|40488259|FG000|Overall Study|Entered Hospice Care|0|||
16552590|NCT03679767|40488260|FG001|Overall Study|Entered Hospice Care|0|||
16552591|NCT03679767|40488261|FG002|Overall Study|Entered Hospice Care|0|||
16552592|NCT03679767|40488262|FG003|Overall Study|Entered Hospice Care|1|||
16120172|NCT01646177|38927116|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16120173|NCT01646177|38927117|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
16120174|NCT01646177|38927118|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
16120175|NCT01646177|38927119|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
16552593|NCT03679767|40488259|FG000|Overall Study|Progressive Disease|0|||
16552594|NCT03679767|40488260|FG001|Overall Study|Progressive Disease|0|||
16552595|NCT03679767|40488261|FG002|Overall Study|Progressive Disease|0|||
16552596|NCT03679767|40488262|FG003|Overall Study|Progressive Disease|1|||
16552597|NCT00525265|40488265|FG000|Overall Study|Protocol Violation|1|||
16552598|NCT00525265|40488266|FG001|Overall Study|Protocol Violation|0|||
16552599|NCT00592319|40488269|FG000|Overall Study|Lost to Follow-up|0|||
16120176|NCT01646177|38927120|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
16120177|NCT01646177|38927121|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
16120178|NCT01646177|38927110|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16552600|NCT00592319|40488270|FG001|Overall Study|Lost to Follow-up|3|||
16552601|NCT03283696|40488274|FG000|Overall Study|Physician Decision|5|||
16552602|NCT03283696|40488275|FG001|Overall Study|Physician Decision|6|||
16552603|NCT03283696|40488274|FG000|Overall Study|Withdrawal by Subject|2|||
16552604|NCT03283696|40488275|FG001|Overall Study|Withdrawal by Subject|0|||
16552605|NCT00684762|40488278|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
16552606|NCT00684762|40488279|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
16552607|NCT01976364|40488280|FG000|Main Study (36 Months)|Adverse Event|63|||
16552608|NCT01976364|40488281|FG001|Main Study (36 Months)|Adverse Event|0|||
16552609|NCT01976364|40488282|FG002|Main Study (36 Months)|Adverse Event|0|||
16552610|NCT01976364|40488280|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
16552611|NCT01976364|40488281|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
16552612|NCT01976364|40488282|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
16552613|NCT01976364|40488280|FG000|Main Study (36 Months)|Other|13|||
16552614|NCT01976364|40488281|FG001|Main Study (36 Months)|Other|0|||
16552615|NCT01976364|40488282|FG002|Main Study (36 Months)|Other|0|||
16552616|NCT01976364|40488280|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
16552617|NCT01976364|40488281|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
16552618|NCT01976364|40488282|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
16552619|NCT01976364|40488280|FG000|Main Study (36 Months)|Medication error|1|||
16552620|NCT01976364|40488281|FG001|Main Study (36 Months)|Medication error|0|||
16552621|NCT01976364|40488282|FG002|Main Study (36 Months)|Medication error|0|||
16552622|NCT01976364|40488280|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
16552623|NCT01976364|40488281|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
16552624|NCT01976364|40488282|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
16552625|NCT01976364|40488280|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
16552626|NCT01976364|40488281|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
16552627|NCT01976364|40488282|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
16120179|NCT01646177|38927111|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16120180|NCT01646177|38927112|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16120181|NCT01646177|38927113|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16120182|NCT01646177|38927114|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16120183|NCT01646177|38927115|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16552628|NCT01976364|40488280|FG000|Main Study (36 Months)|Protocol Violation|13|||
16552629|NCT01976364|40488281|FG001|Main Study (36 Months)|Protocol Violation|0|||
16552630|NCT01976364|40488282|FG002|Main Study (36 Months)|Protocol Violation|0|||
16552631|NCT01976364|40488280|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
16552632|NCT01976364|40488281|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
16552633|NCT01976364|40488282|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
16552634|NCT01976364|40488280|FG000|Main Study (36 Months)|Death|5|||
16552635|NCT01976364|40488281|FG001|Main Study (36 Months)|Death|0|||
16552636|NCT01976364|40488282|FG002|Main Study (36 Months)|Death|0|||
16552637|NCT01976364|40488280|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
16552638|NCT01976364|40488281|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
16552639|NCT01976364|40488282|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
16552640|NCT01976364|40488280|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
16552641|NCT01976364|40488281|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
16552642|NCT01976364|40488282|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
16552643|NCT01976364|40488280|FG000|Sub-study (12 Months)|Protocol Violation|0|||
16552644|NCT01976364|40488281|FG001|Sub-study (12 Months)|Protocol Violation|1|||
16552645|NCT01976364|40488282|FG002|Sub-study (12 Months)|Protocol Violation|1|||
16552646|NCT01976364|40488280|FG000|Sub-study (12 Months)|Adverse Event|0|||
16552647|NCT01976364|40488281|FG001|Sub-study (12 Months)|Adverse Event|4|||
16552648|NCT01976364|40488282|FG002|Sub-study (12 Months)|Adverse Event|3|||
16552649|NCT02406261|40488283|FG000|Period 1|Lost to Follow-up|2|||
16552650|NCT02406261|40488284|FG001|Period 1|Lost to Follow-up|0|||
16552651|NCT02406261|40488283|FG000|Period 1|Adverse Event|1|||
16552652|NCT02406261|40488284|FG001|Period 1|Adverse Event|0|||
16552653|NCT02406261|40488283|FG000|Period 2|Physician Decision|0|||
16552654|NCT02406261|40488284|FG001|Period 2|Physician Decision|1|||
16552655|NCT02406261|40488283|FG000|Period 2|Protocol Violation|0|||
16552656|NCT02406261|40488284|FG001|Period 2|Protocol Violation|1|||
16552657|NCT02406261|40488283|FG000|Period 2|Withdrawal by Subject|0|||
16552658|NCT02406261|40488284|FG001|Period 2|Withdrawal by Subject|1|||
16552659|NCT00597714|40488291|FG000|Overall Study|Death|56|||
16552660|NCT00597714|40488292|FG001|Overall Study|Death|46|||
16552661|NCT00597714|40488293|FG002|Overall Study|Death|0|||
16552662|NCT00597714|40488291|FG000|Overall Study|Recipient death|0|||
16552663|NCT00597714|40488292|FG001|Overall Study|Recipient death|0|||
16552664|NCT00597714|40488293|FG002|Overall Study|Recipient death|10|||
16552665|NCT01987830|40488294|FG000|Overall Study|Never received baseline scan|1|||
16552666|NCT03493451|40488295|FG000|Overall Study|Death|11|||
16552667|NCT03493451|40488296|FG001|Overall Study|Death|26|||
16552668|NCT03493451|40488297|FG002|Overall Study|Death|3|||
16232846|NCT00648739|39334741|FG004|Overall Study|Investigator Considered it Advisable|0|||
16232847|NCT00648739|39334742|FG005|Overall Study|Investigator Considered it Advisable|1|||
16232848|NCT00648739|39334743|FG006|Overall Study|Investigator Considered it Advisable|1|||
16232849|NCT00648739|39334737|FG000|Overall Study|Death|0|||
16232850|NCT00648739|39334738|FG001|Overall Study|Death|1|||
16232851|NCT00648739|39334739|FG002|Overall Study|Death|0|||
16232852|NCT00648739|39334740|FG003|Overall Study|Death|0|||
16232853|NCT00648739|39334741|FG004|Overall Study|Death|0|||
16232854|NCT00648739|39334742|FG005|Overall Study|Death|0|||
16232855|NCT00648739|39334743|FG006|Overall Study|Death|0|||
16232856|NCT00648739|39334737|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
16232857|NCT00648739|39334738|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
16232858|NCT00648739|39334739|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
16232859|NCT00648739|39334740|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
16232860|NCT00648739|39334741|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
16232861|NCT00648739|39334742|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
16232862|NCT00648739|39334743|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
16232863|NCT00648739|39334737|FG000|Overall Study|Follow-up Visits Not Completed|0|||
16232864|NCT00648739|39334738|FG001|Overall Study|Follow-up Visits Not Completed|1|||
16232865|NCT00648739|39334739|FG002|Overall Study|Follow-up Visits Not Completed|0|||
16232866|NCT00648739|39334740|FG003|Overall Study|Follow-up Visits Not Completed|0|||
16232867|NCT00648739|39334741|FG004|Overall Study|Follow-up Visits Not Completed|0|||
16232868|NCT00648739|39334742|FG005|Overall Study|Follow-up Visits Not Completed|0|||
16232869|NCT00648739|39334743|FG006|Overall Study|Follow-up Visits Not Completed|0|||
16232870|NCT03064126|39334745|FG000|Overall Study|Death|6|||
16232871|NCT03064126|39334746|FG001|Overall Study|Death|2|||
16232872|NCT03064126|39334747|FG002|Overall Study|Death|2|||
16232873|NCT03064126|39334748|FG003|Overall Study|Death|1|||
16232874|NCT03064126|39334745|FG000|Overall Study|Investigator Discretion|1|||
16232875|NCT03064126|39334746|FG001|Overall Study|Investigator Discretion|0|||
16232876|NCT03064126|39334747|FG002|Overall Study|Investigator Discretion|0|||
16232877|NCT03064126|39334748|FG003|Overall Study|Investigator Discretion|0|||
16232878|NCT03064126|39334745|FG000|Overall Study|Withdrawal by Subject|7|||
16232879|NCT03064126|39334746|FG001|Overall Study|Withdrawal by Subject|4|||
16552669|NCT03493451|40488295|FG000|Overall Study|Lost to Follow-up|1|||
16232880|NCT03064126|39334747|FG002|Overall Study|Withdrawal by Subject|0|||
16232881|NCT03064126|39334748|FG003|Overall Study|Withdrawal by Subject|0|||
16232882|NCT03064126|39334745|FG000|Overall Study|Subject moved|1|||
16232883|NCT03064126|39334746|FG001|Overall Study|Subject moved|0|||
16232884|NCT03064126|39334747|FG002|Overall Study|Subject moved|0|||
16552670|NCT03493451|40488296|FG001|Overall Study|Lost to Follow-up|4|||
16552671|NCT03493451|40488297|FG002|Overall Study|Lost to Follow-up|1|||
16552672|NCT03493451|40488295|FG000|Overall Study|Withdrawal by Subject|1|||
16552673|NCT03493451|40488296|FG001|Overall Study|Withdrawal by Subject|1|||
16552674|NCT03493451|40488297|FG002|Overall Study|Withdrawal by Subject|2|||
16552675|NCT03493451|40488295|FG000|Overall Study|Progressive Disease|1|||
16552676|NCT03493451|40488296|FG001|Overall Study|Progressive Disease|0|||
16552677|NCT03493451|40488297|FG002|Overall Study|Progressive Disease|0|||
16552678|NCT03493451|40488295|FG000|Overall Study|Transferred to long term extension study|8|||
16552679|NCT03493451|40488296|FG001|Overall Study|Transferred to long term extension study|13|||
16552680|NCT03493451|40488297|FG002|Overall Study|Transferred to long term extension study|5|||
16552681|NCT02258464|40488298|FG000|Overall Study|Progressive disease (PD)|9|||
16552682|NCT02258464|40488299|FG001|Overall Study|Progressive disease (PD)|17|||
16552683|NCT02258464|40488298|FG000|Overall Study|Study drug never administered|1|||
16552684|NCT02258464|40488299|FG001|Overall Study|Study drug never administered|1|||
16552685|NCT02258464|40488298|FG000|Overall Study|AE not related to clinical PD|1|||
16552686|NCT02258464|40488299|FG001|Overall Study|AE not related to clinical PD|3|||
16552687|NCT02258464|40488298|FG000|Overall Study|Withdrawal by Subject|5|||
16552688|NCT02258464|40488299|FG001|Overall Study|Withdrawal by Subject|4|||
16552689|NCT02258464|40488298|FG000|Overall Study|AE related to clinical PD|1|||
16552690|NCT02258464|40488299|FG001|Overall Study|AE related to clinical PD|0|||
16552691|NCT02105636|40488300|FG000|Pre-Treatment|Disease Progression|1|||
16552692|NCT02105636|40488301|FG001|Pre-Treatment|Disease Progression|0|||
16120184|NCT01646177|38927116|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16552693|NCT02105636|40488300|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
16120185|NCT01646177|38927117|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
16120186|NCT01646177|38927118|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
16120187|NCT01646177|38927119|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
16120188|NCT01646177|38927120|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
16120189|NCT01646177|38927121|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
16120190|NCT01646177|38927110|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16120191|NCT01646177|38927111|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16120192|NCT01646177|38927112|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16120193|NCT01646177|38927113|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16120194|NCT01646177|38927114|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16120195|NCT01646177|38927115|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16120196|NCT01646177|38927116|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16120197|NCT01646177|38927117|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
16120198|NCT01646177|38927118|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
16120199|NCT01646177|38927119|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
16120200|NCT01646177|38927120|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
16120201|NCT01646177|38927121|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
16120202|NCT01646177|38927110|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16120203|NCT01646177|38927111|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16120204|NCT01646177|38927112|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16120205|NCT01646177|38927113|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16120206|NCT01646177|38927114|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16120207|NCT01646177|38927115|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16120208|NCT01646177|38927116|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16120209|NCT01646177|38927117|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
16120210|NCT01646177|38927118|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
16120211|NCT01646177|38927119|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
16120212|NCT01646177|38927120|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
16120213|NCT01646177|38927121|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
16120214|NCT01646177|38927110|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16120215|NCT01646177|38927111|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16120216|NCT01646177|38927112|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16120217|NCT01646177|38927113|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16120218|NCT01646177|38927114|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16120219|NCT01646177|38927115|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16120220|NCT01646177|38927116|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16120221|NCT01646177|38927117|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
16120222|NCT01646177|38927118|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
16120223|NCT01646177|38927119|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
16120224|NCT01646177|38927120|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
16120225|NCT01646177|38927121|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
16120226|NCT01646177|38927110|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16120227|NCT01646177|38927111|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16120228|NCT01646177|38927112|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16120229|NCT01646177|38927113|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16120230|NCT01646177|38927114|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16232885|NCT03064126|39334748|FG003|Overall Study|Subject moved|0|||
16232886|NCT03064126|39334745|FG000|Overall Study|Protocol Violation|11|||
16232887|NCT03064126|39334746|FG001|Overall Study|Protocol Violation|1|||
16232888|NCT03064126|39334747|FG002|Overall Study|Protocol Violation|1|||
16232889|NCT03064126|39334748|FG003|Overall Study|Protocol Violation|0|||
16232890|NCT03151707|39334751|FG000|Overall Study|Lost to Follow-up|6|||
16232891|NCT01014442|39334754|FG000|Overall Study|Adverse Event|0|||
16232892|NCT01014442|39334755|FG001|Overall Study|Adverse Event|8|||
16232893|NCT01014442|39334754|FG000|Overall Study|Withdrawal by Subject|4|||
16232894|NCT01014442|39334755|FG001|Overall Study|Withdrawal by Subject|4|||
16232895|NCT01014442|39334754|FG000|Overall Study|Protocol Violation|2|||
16232896|NCT01014442|39334755|FG001|Overall Study|Protocol Violation|5|||
16232897|NCT01014442|39334754|FG000|Overall Study|Lack of Compliance|0|||
16232898|NCT01014442|39334755|FG001|Overall Study|Lack of Compliance|1|||
16232899|NCT01014442|39334754|FG000|Overall Study|Unspecified Reason|1|||
16232900|NCT01014442|39334755|FG001|Overall Study|Unspecified Reason|1|||
16232901|NCT00798161|39334760|FG000|Overall Study|Adverse Event|3|||
16232902|NCT00798161|39334761|FG001|Overall Study|Adverse Event|4|||
16232903|NCT00798161|39334762|FG002|Overall Study|Adverse Event|6|||
16232904|NCT00798161|39334763|FG003|Overall Study|Adverse Event|6|||
16232905|NCT00798161|39334764|FG004|Overall Study|Adverse Event|5|||
16232906|NCT00798161|39334765|FG005|Overall Study|Adverse Event|2|||
16232907|NCT00798161|39334766|FG006|Overall Study|Adverse Event|4|||
16232908|NCT00798161|39334760|FG000|Overall Study|Protocol Violation|2|||
16232909|NCT00798161|39334761|FG001|Overall Study|Protocol Violation|1|||
16232910|NCT00798161|39334762|FG002|Overall Study|Protocol Violation|3|||
16232911|NCT00798161|39334763|FG003|Overall Study|Protocol Violation|3|||
16232912|NCT00798161|39334764|FG004|Overall Study|Protocol Violation|3|||
16232913|NCT00798161|39334765|FG005|Overall Study|Protocol Violation|2|||
16232914|NCT00798161|39334766|FG006|Overall Study|Protocol Violation|0|||
16232915|NCT00798161|39334760|FG000|Overall Study|Lost to Follow-up|1|||
16232916|NCT00798161|39334761|FG001|Overall Study|Lost to Follow-up|3|||
16232917|NCT00798161|39334762|FG002|Overall Study|Lost to Follow-up|4|||
16232918|NCT00798161|39334763|FG003|Overall Study|Lost to Follow-up|3|||
16232919|NCT00798161|39334764|FG004|Overall Study|Lost to Follow-up|4|||
16232920|NCT00798161|39334765|FG005|Overall Study|Lost to Follow-up|0|||
16232921|NCT00798161|39334766|FG006|Overall Study|Lost to Follow-up|0|||
16232922|NCT00798161|39334760|FG000|Overall Study|Withdrawal by Subject|5|||
16232923|NCT00798161|39334761|FG001|Overall Study|Withdrawal by Subject|4|||
16232924|NCT00798161|39334762|FG002|Overall Study|Withdrawal by Subject|5|||
16232925|NCT00798161|39334763|FG003|Overall Study|Withdrawal by Subject|4|||
16232926|NCT00798161|39334764|FG004|Overall Study|Withdrawal by Subject|2|||
16232927|NCT00798161|39334765|FG005|Overall Study|Withdrawal by Subject|3|||
16232928|NCT00798161|39334766|FG006|Overall Study|Withdrawal by Subject|1|||
16232929|NCT00798161|39334760|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
16232930|NCT00798161|39334761|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
16232931|NCT00798161|39334762|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
16232932|NCT00798161|39334763|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
16232933|NCT00798161|39334764|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
16232934|NCT00798161|39334765|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
16232935|NCT00798161|39334766|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
16232936|NCT01207219|39334770|FG000|Overall Study|changed diagnosis during study period|5|||
16232937|NCT01207219|39334771|FG001|Overall Study|changed diagnosis during study period|3|||
16232938|NCT01207219|39334772|FG002|Overall Study|changed diagnosis during study period|1|||
16232939|NCT01207219|39334770|FG000|Overall Study|Lost to Follow-up|6|||
16232940|NCT01207219|39334771|FG001|Overall Study|Lost to Follow-up|8|||
16232941|NCT01207219|39334772|FG002|Overall Study|Lost to Follow-up|6|||
16232942|NCT00924313|39334775|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
16232943|NCT00592007|39334776|FG000|Overall Study|Withdrawal by Subject|1|||
16232944|NCT00592007|39334776|FG000|Overall Study|patient ineligible (out of lab range)|1|||
16232945|NCT00564486|39334777|FG000|Overall Study|Adverse Event|0|||
16232946|NCT00564486|39334778|FG001|Overall Study|Adverse Event|1|||
16232947|NCT00564486|39334779|FG002|Overall Study|Adverse Event|0|||
16232948|NCT00564486|39334780|FG003|Overall Study|Adverse Event|0|||
16232949|NCT00564486|39334777|FG000|Overall Study|Withdrawal by Subject|4|||
16232950|NCT00564486|39334778|FG001|Overall Study|Withdrawal by Subject|0|||
16232951|NCT00564486|39334779|FG002|Overall Study|Withdrawal by Subject|0|||
16232952|NCT00564486|39334780|FG003|Overall Study|Withdrawal by Subject|5|||
16232953|NCT00564486|39334777|FG000|Overall Study|Subject refused to have blood drawn|0|||
16413413|NCT00762996|39995160|FG003|Period One|Protocol Violation|0|||
16120231|NCT01646177|38927115|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16232954|NCT00564486|39334778|FG001|Overall Study|Subject refused to have blood drawn|0|||
16232955|NCT00564486|39334779|FG002|Overall Study|Subject refused to have blood drawn|1|||
16232956|NCT00564486|39334780|FG003|Overall Study|Subject refused to have blood drawn|0|||
16232957|NCT00564486|39334777|FG000|Overall Study|Lost to Follow-up|3|||
16232958|NCT00564486|39334778|FG001|Overall Study|Lost to Follow-up|0|||
16232959|NCT00564486|39334779|FG002|Overall Study|Lost to Follow-up|2|||
16232960|NCT00564486|39334780|FG003|Overall Study|Lost to Follow-up|2|||
16232961|NCT01500434|39334781|FG000|Overall Study|Death|1|||
16232962|NCT01500434|39334781|FG000|Overall Study|Withdrawal by Subject|1|||
16232963|NCT01500434|39334781|FG000|Overall Study|Missed 12-month follow-up|5|||
16232964|NCT03329404|39334782|FG000|Overall Study|The study was suspended.|1|||
16232965|NCT03329404|39334783|FG001|Overall Study|The study was suspended.|4|||
16232966|NCT00054639|39334784|FG000|Overall Study|Lack of Efficacy|1|||
16232967|NCT00054639|39334784|FG000|Overall Study|Physician Decision|1|||
16232968|NCT04281030|39334785|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
16232969|NCT04281030|39334786|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
16232970|NCT04281030|39334785|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
16232971|NCT04281030|39334786|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
16232972|NCT01157065|39334787|FG000|Overall Study|Death|0|||
16232973|NCT01157065|39334788|FG001|Overall Study|Death|1|||
16232974|NCT04881448|39338053|FG000|Overall Study|Study cancelled by sponsor|220|||
16232975|NCT04881448|39338053|FG000|Overall Study|Withdrawal by Subject|2|||
16232976|NCT04881448|39338053|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
16232977|NCT00669110|39338054|FG000|Overall Study|Adverse Event|4|||
16232978|NCT00669110|39338055|FG001|Overall Study|Adverse Event|3|||
16232979|NCT00669110|39338054|FG000|Overall Study|Caregiver request|3|||
16232980|NCT00669110|39338055|FG001|Overall Study|Caregiver request|2|||
16232981|NCT00669110|39338054|FG000|Overall Study|Physician Decision|0|||
16232982|NCT00669110|39338055|FG001|Overall Study|Physician Decision|1|||
16232983|NCT00669110|39338054|FG000|Overall Study|Lost to Follow-up|1|||
16232984|NCT00669110|39338055|FG001|Overall Study|Lost to Follow-up|0|||
16232985|NCT00669110|39338054|FG000|Overall Study|Protocol Violation|0|||
16232986|NCT00669110|39338055|FG001|Overall Study|Protocol Violation|5|||
16232987|NCT00669110|39338054|FG000|Overall Study|Withdrawal by Subject|0|||
16232988|NCT00669110|39338055|FG001|Overall Study|Withdrawal by Subject|2|||
16232989|NCT00713830|39338060|FG000|Overall Study|Adverse Event|23|||
16232990|NCT00713830|39338061|FG001|Overall Study|Adverse Event|71|||
16232991|NCT00713830|39338060|FG000|Overall Study|Lack of Efficacy|24|||
16232992|NCT00713830|39338061|FG001|Overall Study|Lack of Efficacy|16|||
16232993|NCT00713830|39338060|FG000|Overall Study|Lost to Follow-up|2|||
16232994|NCT00713830|39338061|FG001|Overall Study|Lost to Follow-up|9|||
16232995|NCT00713830|39338060|FG000|Overall Study|Withdrawal by Subject|13|||
16232996|NCT00713830|39338061|FG001|Overall Study|Withdrawal by Subject|23|||
16232997|NCT00713830|39338060|FG000|Overall Study|Poor Compliance to Protocol|7|||
16232998|NCT00713830|39338061|FG001|Overall Study|Poor Compliance to Protocol|14|||
16232999|NCT00713830|39338060|FG000|Overall Study|Familial and Personal Reasons|9|||
16233000|NCT00713830|39338061|FG001|Overall Study|Familial and Personal Reasons|34|||
16233001|NCT00713830|39338060|FG000|Overall Study|Sponsor Decision|4|||
16233002|NCT00713830|39338061|FG001|Overall Study|Sponsor Decision|10|||
16233003|NCT00057330|39338062|FG000|Overall Study|Adverse Event|9|||
16233004|NCT00057330|39338063|FG001|Overall Study|Adverse Event|12|||
16233005|NCT00057330|39338062|FG000|Overall Study|Death|1|||
16233006|NCT00057330|39338063|FG001|Overall Study|Death|0|||
16233007|NCT00057330|39338062|FG000|Overall Study|Protocol Violation|1|||
16233008|NCT00057330|39338063|FG001|Overall Study|Protocol Violation|1|||
16233009|NCT00057330|39338062|FG000|Overall Study|Withdrawal by Subject|115|||
16233010|NCT00057330|39338063|FG001|Overall Study|Withdrawal by Subject|84|||
16233011|NCT00057330|39338062|FG000|Overall Study|Lost to Follow-up|745|||
16233012|NCT00057330|39338063|FG001|Overall Study|Lost to Follow-up|617|||
16233013|NCT00057330|39338062|FG000|Overall Study|Physician Decision|1|||
16233014|NCT00057330|39338063|FG001|Overall Study|Physician Decision|0|||
16233015|NCT00057330|39338062|FG000|Overall Study|Other|260|||
16233016|NCT00057330|39338063|FG001|Overall Study|Other|206|||
16233017|NCT00938392|39338066|FG000|Overall Study|Adverse Event|0|||
16233018|NCT00938392|39338067|FG001|Overall Study|Adverse Event|1|||
16233019|NCT00938392|39338066|FG000|Overall Study|Withdrawal by Subject|0|||
16233020|NCT00938392|39338067|FG001|Overall Study|Withdrawal by Subject|1|||
16233021|NCT00938392|39338066|FG000|Overall Study|Lost to Follow-up|2|||
16233022|NCT00938392|39338067|FG001|Overall Study|Lost to Follow-up|2|||
16233023|NCT02803138|39338070|FG000|Overall Study|Failure to return|38|||
16233024|NCT02803138|39338070|FG000|Overall Study|Insufficient virological response|2|||
16233025|NCT02803138|39338070|FG000|Overall Study|Withdrawn consent|1|||
16233026|NCT02803138|39338070|FG000|Overall Study|Death|1|||
16233027|NCT02803138|39338070|FG000|Overall Study|Other, not specified|28|||
16233028|NCT02058368|39338074|FG000|Overall Study|Adverse Event|15|||
16233029|NCT02058368|39338075|FG001|Overall Study|Adverse Event|20|||
16233030|NCT02058368|39338074|FG000|Overall Study|Lack of Efficacy|0|||
16120232|NCT01646177|38927116|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16120233|NCT01646177|38927117|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
16120234|NCT01646177|38927118|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
16120235|NCT01646177|38927119|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
16120236|NCT01646177|38927120|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
16120237|NCT01646177|38927121|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
16120238|NCT01646177|38927110|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16120239|NCT01646177|38927111|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16120240|NCT01646177|38927112|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16120241|NCT01646177|38927113|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16120242|NCT01646177|38927114|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16120243|NCT01646177|38927115|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16120244|NCT01646177|38927116|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16120245|NCT01646177|38927117|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16120246|NCT01646177|38927118|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
16120247|NCT01646177|38927119|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
16120248|NCT01646177|38927120|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
16120249|NCT01646177|38927121|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
16120250|NCT01646177|38927110|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16120251|NCT01646177|38927111|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16120252|NCT01646177|38927112|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16120253|NCT01646177|38927113|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16120254|NCT01646177|38927114|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16120255|NCT01646177|38927115|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16120256|NCT01646177|38927116|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16120257|NCT01646177|38927117|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16120258|NCT01646177|38927118|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
16120259|NCT01646177|38927119|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
16120260|NCT01646177|38927120|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
16120261|NCT01646177|38927121|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
16120262|NCT01646177|38927110|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16120263|NCT01646177|38927111|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16120264|NCT01646177|38927112|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16120265|NCT01646177|38927113|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16120266|NCT01646177|38927114|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16120267|NCT01646177|38927115|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16120268|NCT01646177|38927116|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16120269|NCT01646177|38927117|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16120270|NCT01646177|38927118|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
16120271|NCT01646177|38927119|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
16120272|NCT01646177|38927120|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
16120273|NCT01646177|38927121|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
16120274|NCT01646177|38927110|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16120275|NCT01646177|38927111|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16120276|NCT01646177|38927112|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16120277|NCT01646177|38927113|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16120278|NCT01646177|38927114|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16120279|NCT01646177|38927115|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16120280|NCT01646177|38927116|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16120281|NCT01646177|38927117|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16120282|NCT01646177|38927118|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16120283|NCT01646177|38927119|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
16120284|NCT01646177|38927120|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
16120285|NCT01646177|38927121|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
16120286|NCT01361594|38927122|FG000|Overall Study|Withdrawal by Subject|1|||
16120287|NCT01361594|38927123|FG001|Overall Study|Withdrawal by Subject|2|||
16120288|NCT02224703|38927124|FG000|Overall Study|Adverse Event|0|||
16120289|NCT02224703|38927125|FG001|Overall Study|Adverse Event|5|||
16120290|NCT02224703|38927126|FG002|Overall Study|Adverse Event|0|||
16120291|NCT02224703|38927124|FG000|Overall Study|Withdrawn by investigator|1|||
16120292|NCT02224703|38927125|FG001|Overall Study|Withdrawn by investigator|0|||
16120293|NCT02224703|38927126|FG002|Overall Study|Withdrawn by investigator|0|||
16120294|NCT02224703|38927124|FG000|Overall Study|Advised by medical monitor|1|||
16120295|NCT02224703|38927125|FG001|Overall Study|Advised by medical monitor|0|||
16120296|NCT02224703|38927126|FG002|Overall Study|Advised by medical monitor|0|||
16120297|NCT02224703|38927124|FG000|Overall Study|Withdrawn by parent/guardian|0|||
16120298|NCT02224703|38927125|FG001|Overall Study|Withdrawn by parent/guardian|1|||
16233031|NCT02058368|39338075|FG001|Overall Study|Lack of Efficacy|1|||
16233032|NCT02058368|39338074|FG000|Overall Study|Protocol Violation|0|||
16233033|NCT02058368|39338075|FG001|Overall Study|Protocol Violation|4|||
16233034|NCT02058368|39338074|FG000|Overall Study|Lost to Follow-up|2|||
16233035|NCT02058368|39338075|FG001|Overall Study|Lost to Follow-up|0|||
16233036|NCT02058368|39338074|FG000|Overall Study|Physician Decision|2|||
16233037|NCT02058368|39338075|FG001|Overall Study|Physician Decision|3|||
16233038|NCT02058368|39338074|FG000|Overall Study|Withdrawal by Subject|22|||
16233039|NCT02058368|39338075|FG001|Overall Study|Withdrawal by Subject|26|||
16233040|NCT01215955|39338078|FG000|Overall Study|Adverse Event|1|||
16233041|NCT01215955|39338079|FG001|Overall Study|Adverse Event|4|||
16233042|NCT01215955|39338080|FG002|Overall Study|Adverse Event|2|||
16233043|NCT01215955|39338081|FG003|Overall Study|Adverse Event|3|||
16233044|NCT01215955|39338078|FG000|Overall Study|Death|2|||
16233045|NCT01215955|39338079|FG001|Overall Study|Death|0|||
16233046|NCT01215955|39338080|FG002|Overall Study|Death|1|||
16233047|NCT01215955|39338081|FG003|Overall Study|Death|3|||
16233048|NCT01215955|39338078|FG000|Overall Study|Entry Criteria Not Met|1|||
16233049|NCT01215955|39338079|FG001|Overall Study|Entry Criteria Not Met|3|||
16233050|NCT01215955|39338080|FG002|Overall Study|Entry Criteria Not Met|4|||
16233051|NCT01215955|39338081|FG003|Overall Study|Entry Criteria Not Met|7|||
16233052|NCT01215955|39338078|FG000|Overall Study|Lack of Efficacy|1|||
16233053|NCT01215955|39338079|FG001|Overall Study|Lack of Efficacy|2|||
16233054|NCT01215955|39338080|FG002|Overall Study|Lack of Efficacy|1|||
16233055|NCT01215955|39338081|FG003|Overall Study|Lack of Efficacy|0|||
16233056|NCT01215955|39338078|FG000|Overall Study|Lost to Follow-up|4|||
16233057|NCT01215955|39338079|FG001|Overall Study|Lost to Follow-up|4|||
16233058|NCT01215955|39338080|FG002|Overall Study|Lost to Follow-up|8|||
16233059|NCT01215955|39338081|FG003|Overall Study|Lost to Follow-up|9|||
16233060|NCT01215955|39338078|FG000|Overall Study|Physician Decision|4|||
16233061|NCT01215955|39338079|FG001|Overall Study|Physician Decision|10|||
16233062|NCT01215955|39338080|FG002|Overall Study|Physician Decision|8|||
16233063|NCT01215955|39338081|FG003|Overall Study|Physician Decision|11|||
16233064|NCT01215955|39338078|FG000|Overall Study|Protocol Violation|17|||
16233065|NCT01215955|39338079|FG001|Overall Study|Protocol Violation|13|||
16233066|NCT01215955|39338080|FG002|Overall Study|Protocol Violation|8|||
16233067|NCT01215955|39338081|FG003|Overall Study|Protocol Violation|8|||
16233068|NCT01215955|39338078|FG000|Overall Study|Sponsor Decision|1|||
16233069|NCT01215955|39338079|FG001|Overall Study|Sponsor Decision|2|||
16233070|NCT01215955|39338080|FG002|Overall Study|Sponsor Decision|0|||
16233071|NCT01215955|39338081|FG003|Overall Study|Sponsor Decision|1|||
16233072|NCT01215955|39338078|FG000|Overall Study|Withdrawal by Subject|14|||
16233073|NCT01215955|39338079|FG001|Overall Study|Withdrawal by Subject|15|||
16233074|NCT01215955|39338080|FG002|Overall Study|Withdrawal by Subject|13|||
16233075|NCT01215955|39338081|FG003|Overall Study|Withdrawal by Subject|9|||
16233076|NCT01215955|39338078|FG000|Overall Study|Quality Issues|0|||
16233077|NCT01215955|39338079|FG001|Overall Study|Quality Issues|0|||
16233078|NCT01215955|39338080|FG002|Overall Study|Quality Issues|3|||
16233079|NCT01215955|39338081|FG003|Overall Study|Quality Issues|2|||
16233080|NCT01036594|39338082|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
16233081|NCT01036594|39338083|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
16233082|NCT01036594|39338082|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
16233083|NCT01036594|39338083|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
16233084|NCT01036594|39338082|FG000|Week 12 Evaluation|Adverse Event|5|||
16233085|NCT01036594|39338083|FG001|Week 12 Evaluation|Adverse Event|0|||
16233086|NCT01036594|39338082|FG000|Week 12 Evaluation|Physician Decision|1|||
16233087|NCT01036594|39338083|FG001|Week 12 Evaluation|Physician Decision|0|||
16233088|NCT01036594|39338082|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
16233089|NCT01036594|39338083|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
16233090|NCT01036594|39338082|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
16233091|NCT01036594|39338083|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
16233092|NCT01036594|39338082|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
16233093|NCT01036594|39338083|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
16233094|NCT01036594|39338082|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
16348694|NCT02111174|39765458|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
16348695|NCT02111174|39765457|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
16348696|NCT02111174|39765458|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
16348697|NCT03143101|39765465|FG000|Overall Study|Withdrawal by Subject|0|||
16348698|NCT03143101|39765466|FG001|Overall Study|Withdrawal by Subject|1|||
16348699|NCT03143101|39765467|FG002|Overall Study|Withdrawal by Subject|0|||
16348700|NCT03143101|39765465|FG000|Overall Study|Lost to Follow-up|2|||
16348701|NCT03143101|39765466|FG001|Overall Study|Lost to Follow-up|2|||
16348702|NCT03143101|39765467|FG002|Overall Study|Lost to Follow-up|0|||
16348703|NCT00732069|39765468|FG000|Washout After First Study Drug|Adverse Event|1|||
16348704|NCT00732069|39765469|FG001|Washout After First Study Drug|Adverse Event|0|||
16348705|NCT00732069|39765470|FG002|Washout After First Study Drug|Adverse Event|0|||
16233095|NCT01036594|39338083|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
16233096|NCT01036594|39338082|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
16233097|NCT01036594|39338083|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
16233098|NCT01965600|39338086|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
16233099|NCT01965600|39338087|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
16233100|NCT01965600|39338088|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
16233101|NCT01965600|39338089|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
16233102|NCT01965600|39338086|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
16233103|NCT01965600|39338087|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
16233104|NCT01965600|39338088|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
16233105|NCT01965600|39338089|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
16233106|NCT01965600|39338086|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
16233107|NCT01965600|39338087|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
16233108|NCT01965600|39338088|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
16233109|NCT01965600|39338089|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
16233110|NCT01965600|39338086|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
16233111|NCT01965600|39338087|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
16233112|NCT01965600|39338088|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
16233113|NCT01965600|39338089|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
16233114|NCT01965600|39338086|FG000|Second Intervention|Study terminated by Sponsor|0|||
16233115|NCT01965600|39338087|FG001|Second Intervention|Study terminated by Sponsor|0|||
16233116|NCT01965600|39338088|FG002|Second Intervention|Study terminated by Sponsor|2|||
16233117|NCT01965600|39338089|FG003|Second Intervention|Study terminated by Sponsor|2|||
16233118|NCT03099161|39338091|FG000|Overall Study|Adverse Event|0|||
16552694|NCT02105636|40488301|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
16552695|NCT02105636|40488300|FG000|Pre-Treatment|Participant withdrew consent|0|||
16552696|NCT02105636|40488301|FG001|Pre-Treatment|Participant withdrew consent|6|||
16552697|NCT02105636|40488300|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
16552698|NCT02105636|40488301|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
16552699|NCT02105636|40488300|FG000|Treatment|Study Drug Toxicity|14|||
16552700|NCT02105636|40488301|FG001|Treatment|Study Drug Toxicity|10|||
16552701|NCT02105636|40488300|FG000|Treatment|Adverse event unrelated to study drug|19|||
16552702|NCT02105636|40488301|FG001|Treatment|Adverse event unrelated to study drug|3|||
16552703|NCT02105636|40488300|FG000|Treatment|Participant request to discontinue study treatment|8|||
16552704|NCT02105636|40488301|FG001|Treatment|Participant request to discontinue study treatment|6|||
16552705|NCT02105636|40488300|FG000|Treatment|Participant withdrew consent|5|||
16552706|NCT02105636|40488301|FG001|Treatment|Participant withdrew consent|1|||
16552707|NCT02105636|40488300|FG000|Treatment|Lost to Follow-up|1|||
16552708|NCT02105636|40488301|FG001|Treatment|Lost to Follow-up|0|||
16552709|NCT02105636|40488300|FG000|Treatment|Maximum Clinical Benefit|1|||
16552710|NCT02105636|40488301|FG001|Treatment|Maximum Clinical Benefit|3|||
16552711|NCT02105636|40488300|FG000|Treatment|Poor/Non-compliance|0|||
16552712|NCT02105636|40488301|FG001|Treatment|Poor/Non-compliance|1|||
16552713|NCT02105636|40488300|FG000|Treatment|Participant no longer meets study criteria|1|||
16552714|NCT02105636|40488301|FG001|Treatment|Participant no longer meets study criteria|0|||
16552715|NCT02105636|40488300|FG000|Treatment|Other reasons|1|||
16552716|NCT02105636|40488301|FG001|Treatment|Other reasons|0|||
16552717|NCT02105636|40488300|FG000|Treatment|Disease Progression|185|||
16552718|NCT02105636|40488301|FG001|Treatment|Disease Progression|87|||
16552719|NCT00988351|40488302|FG000|Overall Study|Withdrawal by Subject|8|||
16552720|NCT00988351|40488303|FG001|Overall Study|Withdrawal by Subject|0|||
16552721|NCT00988351|40488302|FG000|Overall Study|Lost to Follow-up|6|||
16552722|NCT00988351|40488303|FG001|Overall Study|Lost to Follow-up|9|||
16552723|NCT00988351|40488302|FG000|Overall Study|not using CPAP|5|||
16552724|NCT00988351|40488303|FG001|Overall Study|not using CPAP|3|||
16552725|NCT01928225|40488307|FG000|Overall Study|Pregnancy|1|||
16552726|NCT01928225|40488308|FG001|Overall Study|Pregnancy|0|||
16552727|NCT01928225|40488307|FG000|Overall Study|basaloid cervical cancer|1|||
16552728|NCT01928225|40488308|FG001|Overall Study|basaloid cervical cancer|0|||
16552729|NCT01928225|40488307|FG000|Overall Study|Lost to Follow-up|1|||
16552730|NCT01928225|40488308|FG001|Overall Study|Lost to Follow-up|3|||
16552731|NCT02550873|40488311|FG000|Randomized Double Blind|Adverse Event|3|||
16552732|NCT02550873|40488312|FG001|Randomized Double Blind|Adverse Event|1|||
16552733|NCT02550873|40488313|FG002|Randomized Double Blind|Adverse Event|0|||
16552734|NCT02550873|40488311|FG000|Randomized Double Blind|Disease progression|1|||
16552735|NCT02550873|40488312|FG001|Randomized Double Blind|Disease progression|1|||
16233119|NCT03099161|39338092|FG001|Overall Study|Adverse Event|0|||
16552736|NCT02550873|40488313|FG002|Randomized Double Blind|Disease progression|0|||
16552737|NCT02550873|40488311|FG000|Open Label Extension|Study ongoing|0|||
16552738|NCT02550873|40488312|FG001|Open Label Extension|Study ongoing|0|||
16552739|NCT02550873|40488313|FG002|Open Label Extension|Study ongoing|111|||
16120299|NCT02224703|38927126|FG002|Overall Study|Withdrawn by parent/guardian|0|||
16552740|NCT02572817|40488314|FG000|Overall Study|Death|6|||
16552741|NCT02572817|40488315|FG001|Overall Study|Death|3|||
16552742|NCT02572817|40488314|FG000|Overall Study|Lost to Follow-up|3|||
16552743|NCT02572817|40488315|FG001|Overall Study|Lost to Follow-up|3|||
16552744|NCT00976482|40488318|FG000|Overall Study|Death|208|||
16552745|NCT00976482|40488318|FG000|Overall Study|Withdrawal by Subject|45|||
16552746|NCT00976482|40488318|FG000|Overall Study|Center terminated|1|||
16552747|NCT00976482|40488318|FG000|Overall Study|Protocol Violation|5|||
16552748|NCT01556763|40488322|FG000|Overall Study|Withdrawal by Subject|0|||
16552749|NCT01556763|40488323|FG001|Overall Study|Withdrawal by Subject|1|||
16552750|NCT01556763|40488324|FG002|Overall Study|Withdrawal by Subject|0|||
16552751|NCT04716881|40488325|FG000|Overall Study|Adverse Event|1|||
16552752|NCT04716881|40488325|FG000|Overall Study|Lost to Follow-up|1|||
16552753|NCT03810313|40488326|FG000|Overall Study|Study terminated by sponsor|164|||
16552754|NCT03810313|40488327|FG001|Overall Study|Study terminated by sponsor|159|||
16552755|NCT03810313|40488326|FG000|Overall Study|Subject decision|10|||
16552756|NCT03810313|40488327|FG001|Overall Study|Subject decision|11|||
16552757|NCT03810313|40488326|FG000|Overall Study|Lost to Follow-up|3|||
16120300|NCT02224703|38927124|FG000|Overall Study|Lack of Efficacy|1|||
16552758|NCT03810313|40488327|FG001|Overall Study|Lost to Follow-up|3|||
16120301|NCT02224703|38927125|FG001|Overall Study|Lack of Efficacy|0|||
16120302|NCT02224703|38927126|FG002|Overall Study|Lack of Efficacy|0|||
16120303|NCT00477490|38927127|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
16120304|NCT00477490|38927128|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
16120305|NCT00477490|38927129|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
16120306|NCT00477490|38927130|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
16120307|NCT00477490|38927131|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
16120308|NCT00477490|38927132|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
16120309|NCT00477490|38927133|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
16120310|NCT00477490|38927134|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
16120311|NCT00477490|38927135|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
16120312|NCT00477490|38927127|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
16120313|NCT00477490|38927128|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16120314|NCT00477490|38927129|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16120315|NCT00477490|38927130|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
16120316|NCT00477490|38927131|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
16120317|NCT00477490|38927132|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16120318|NCT00477490|38927133|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16120319|NCT00477490|38927134|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16120320|NCT00477490|38927135|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
16120321|NCT00477490|38927127|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
16120322|NCT00477490|38927128|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
16120323|NCT00477490|38927129|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
16120324|NCT00477490|38927130|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
16120325|NCT00477490|38927131|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
16120326|NCT00477490|38927132|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
16120327|NCT00477490|38927133|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
16120328|NCT00477490|38927134|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
16120329|NCT00477490|38927135|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
16120330|NCT00477490|38927127|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
16120331|NCT00477490|38927128|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
16120332|NCT00477490|38927129|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
16120333|NCT00477490|38927130|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
16120334|NCT00477490|38927131|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
16120335|NCT00477490|38927132|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
16120336|NCT00477490|38927133|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
16552759|NCT03810313|40488326|FG000|Overall Study|Adverse Event|2|||
16552760|NCT03810313|40488327|FG001|Overall Study|Adverse Event|1|||
16120337|NCT00477490|38927134|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
16120338|NCT00477490|38927135|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
16120339|NCT00477490|38927127|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
16552761|NCT03810313|40488326|FG000|Overall Study|Death|2|||
16552762|NCT03810313|40488327|FG001|Overall Study|Death|1|||
16233120|NCT03099161|39338093|FG002|Overall Study|Adverse Event|2|||
16233121|NCT03099161|39338091|FG000|Overall Study|Physician Decision|2|||
16233122|NCT03099161|39338092|FG001|Overall Study|Physician Decision|0|||
16233123|NCT03099161|39338093|FG002|Overall Study|Physician Decision|0|||
16233124|NCT03099161|39338091|FG000|Overall Study|Progressive Disease|1|||
16233125|NCT03099161|39338092|FG001|Overall Study|Progressive Disease|4|||
16233126|NCT03099161|39338093|FG002|Overall Study|Progressive Disease|1|||
16552763|NCT03810313|40488326|FG000|Overall Study|Physician Decision|0|||
16552764|NCT03810313|40488327|FG001|Overall Study|Physician Decision|1|||
16552765|NCT02118714|40488328|FG000|Overall Study|Lost to Follow-up|2|||
16552766|NCT02118714|40488328|FG000|Overall Study|Protocol Violation|1|||
16552767|NCT00582491|40488329|FG000|Overall Study|Withdrawal by Subject|1|||
16552768|NCT00582491|40488330|FG001|Overall Study|Withdrawal by Subject|0|||
16552769|NCT00003458|40488334|FG000|Overall Study|Not evaluable|4|||
16552770|NCT00452413|40488339|FG000|Overall Study|Progressive Disease|4|||
16552771|NCT00452413|40488340|FG001|Overall Study|Progressive Disease|11|||
16552772|NCT00452413|40488341|FG002|Overall Study|Progressive Disease|30|||
16552773|NCT00452413|40488339|FG000|Overall Study|Withdrawal by Subject|0|||
16552774|NCT00452413|40488340|FG001|Overall Study|Withdrawal by Subject|1|||
16552775|NCT00452413|40488341|FG002|Overall Study|Withdrawal by Subject|4|||
16552776|NCT00452413|40488339|FG000|Overall Study|Adverse Event|0|||
16552777|NCT00452413|40488340|FG001|Overall Study|Adverse Event|0|||
16233127|NCT02596009|39338095|FG000|Overall Study|Administrative problems|0|||
16233128|NCT02596009|39338096|FG001|Overall Study|Administrative problems|1|||
16233129|NCT02596009|39338097|FG002|Overall Study|Administrative problems|0|||
16233130|NCT02596009|39338098|FG003|Overall Study|Administrative problems|0|||
16233131|NCT02596009|39338099|FG004|Overall Study|Administrative problems|0|||
16233132|NCT02596009|39338100|FG005|Overall Study|Administrative problems|0|||
16233133|NCT01682681|39338112|FG000|Overall Study|Lack of Efficacy|62|||
16233134|NCT01682681|39338112|FG000|Overall Study|Withdrawal by Subject|1|||
16233135|NCT01682681|39338112|FG000|Overall Study|Moved to other hospital|10|||
16233136|NCT01682681|39338112|FG000|Overall Study|Lost to Follow-up|174|||
16233137|NCT01682681|39338112|FG000|Overall Study|Adverse Event|46|||
16233138|NCT01682681|39338112|FG000|Overall Study|tapering of topiramate|5|||
16233139|NCT01682681|39338112|FG000|Overall Study|Other|21|||
16233140|NCT01682681|39338112|FG000|Overall Study|Low compliance|13|||
16233141|NCT01125358|39338115|FG000|Overall Study|Adverse Event|3|||
16233142|NCT01125358|39338116|FG001|Overall Study|Adverse Event|0|||
16233143|NCT01125358|39338117|FG002|Overall Study|Adverse Event|0|||
16233144|NCT01125358|39338118|FG003|Overall Study|Adverse Event|2|||
16233145|NCT01125358|39338115|FG000|Overall Study|Perceived Lack of Efficacy|6|||
16233146|NCT01125358|39338116|FG001|Overall Study|Perceived Lack of Efficacy|3|||
16233147|NCT01125358|39338117|FG002|Overall Study|Perceived Lack of Efficacy|7|||
16233148|NCT01125358|39338118|FG003|Overall Study|Perceived Lack of Efficacy|4|||
16233149|NCT01125358|39338115|FG000|Overall Study|Protocol Violation|1|||
16233150|NCT01125358|39338116|FG001|Overall Study|Protocol Violation|0|||
16233151|NCT01125358|39338117|FG002|Overall Study|Protocol Violation|0|||
16233152|NCT01125358|39338118|FG003|Overall Study|Protocol Violation|0|||
16233153|NCT01125358|39338115|FG000|Overall Study|Sponsor Decision|0|||
16233154|NCT01125358|39338116|FG001|Overall Study|Sponsor Decision|0|||
16552778|NCT00452413|40488341|FG002|Overall Study|Adverse Event|5|||
16552779|NCT00452413|40488339|FG000|Overall Study|Physician Decision|0|||
16552780|NCT00452413|40488340|FG001|Overall Study|Physician Decision|0|||
16552781|NCT00452413|40488341|FG002|Overall Study|Physician Decision|4|||
16552782|NCT00452413|40488339|FG000|Overall Study|Death due to study disease|0|||
16552783|NCT00452413|40488340|FG001|Overall Study|Death due to study disease|0|||
16552784|NCT00452413|40488341|FG002|Overall Study|Death due to study disease|2|||
16552785|NCT00452413|40488339|FG000|Overall Study|Death due to adverse event (AE)|0|||
16552786|NCT00452413|40488340|FG001|Overall Study|Death due to adverse event (AE)|0|||
16552787|NCT00452413|40488341|FG002|Overall Study|Death due to adverse event (AE)|1|||
16552788|NCT00452413|40488339|FG000|Overall Study|On treatment|0|||
16552789|NCT00452413|40488340|FG001|Overall Study|On treatment|0|||
16233155|NCT01125358|39338117|FG002|Overall Study|Sponsor Decision|1|||
16233156|NCT01125358|39338118|FG003|Overall Study|Sponsor Decision|1|||
16233157|NCT01125358|39338115|FG000|Overall Study|Withdrawal by Subject|2|||
16233158|NCT01125358|39338116|FG001|Overall Study|Withdrawal by Subject|1|||
16233159|NCT01125358|39338117|FG002|Overall Study|Withdrawal by Subject|1|||
16552790|NCT00452413|40488341|FG002|Overall Study|On treatment|3|||
16552791|NCT02746575|40488342|FG000|Overall Study|Surgery cancelled or time chaned|13|||
16552792|NCT02746575|40488342|FG000|Overall Study|Received epidural|10|||
16552793|NCT02746575|40488342|FG000|Overall Study|Withdrawal by Subject|3|||
16233160|NCT01125358|39338118|FG003|Overall Study|Withdrawal by Subject|1|||
16233161|NCT01846039|39338121|FG000|Overall Study|Protocol Violation|1|||
16233162|NCT01846039|39338121|FG000|Overall Study|Subject Withdrew Consent|1|||
16233163|NCT02181673|39338122|FG000|Up to Week 24|Adverse Event|2|||
16233164|NCT02181673|39338123|FG001|Up to Week 24|Adverse Event|0|||
16233165|NCT02181673|39338124|FG002|Up to Week 24|Adverse Event|3|||
16233166|NCT02181673|39338122|FG000|Up to Week 24|Death|1|||
16233167|NCT02181673|39338123|FG001|Up to Week 24|Death|0|||
16552794|NCT02746575|40488342|FG000|Overall Study|Bradycardia/hypotension|9|||
16552795|NCT02746575|40488342|FG000|Overall Study|Study paused|8|||
16552796|NCT02746575|40488342|FG000|Overall Study|put on beta-blocker|3|||
16552797|NCT02746575|40488342|FG000|Overall Study|type of surgery|1|||
16233168|NCT02181673|39338124|FG002|Up to Week 24|Death|0|||
16233169|NCT02181673|39338122|FG000|Up to Week 24|Lack of Efficacy|1|||
16233170|NCT02181673|39338123|FG001|Up to Week 24|Lack of Efficacy|0|||
16233171|NCT02181673|39338124|FG002|Up to Week 24|Lack of Efficacy|0|||
16233172|NCT02181673|39338122|FG000|Up to Week 24|Lost to Follow-up|1|||
16233173|NCT02181673|39338123|FG001|Up to Week 24|Lost to Follow-up|0|||
16233174|NCT02181673|39338124|FG002|Up to Week 24|Lost to Follow-up|0|||
16233175|NCT02181673|39338122|FG000|Up to Week 24|Physician Decision|0|||
16233176|NCT02181673|39338123|FG001|Up to Week 24|Physician Decision|0|||
16233177|NCT02181673|39338124|FG002|Up to Week 24|Physician Decision|3|||
16233178|NCT02181673|39338122|FG000|Up to Week 24|Withdrawal by Subject|10|||
16233179|NCT02181673|39338123|FG001|Up to Week 24|Withdrawal by Subject|0|||
16233180|NCT02181673|39338124|FG002|Up to Week 24|Withdrawal by Subject|1|||
16233181|NCT02181673|39338122|FG000|Up to Week 24|Other|2|||
16233182|NCT02181673|39338123|FG001|Up to Week 24|Other|0|||
16233183|NCT02181673|39338124|FG002|Up to Week 24|Other|3|||
16552798|NCT02746575|40488342|FG000|Overall Study|typ of surgery|1|||
16552799|NCT02746575|40488342|FG000|Overall Study|PI unavailable|1|||
16552800|NCT02746575|40488342|FG000|Overall Study|Unknown history of CVA|1|||
16552801|NCT04192630|40488348|FG000|Overall Study|Discontinued before surgery|2|||
16552802|NCT04192630|40488349|FG001|Overall Study|Discontinued before surgery|0|||
16552803|NCT04192630|40488348|FG000|Overall Study|Discontinued after surgery|5|||
16552804|NCT04192630|40488349|FG001|Overall Study|Discontinued after surgery|3|||
16552805|NCT01108510|40488353|FG000|Overall Study|Randomized but Not Treated|5|||
16552806|NCT01108510|40488354|FG001|Overall Study|Randomized but Not Treated|1|||
16552807|NCT01108510|40488353|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
16552808|NCT01108510|40488354|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
16552809|NCT01108510|40488353|FG000|Overall Study|Adverse Event|26|||
16552810|NCT01108510|40488354|FG001|Overall Study|Adverse Event|19|||
16552811|NCT01108510|40488353|FG000|Overall Study|Lost to Follow-up|20|||
16552812|NCT01108510|40488354|FG001|Overall Study|Lost to Follow-up|17|||
16233184|NCT02181673|39338122|FG000|Up to Week 24|Randomized not Treated|0|||
16233185|NCT02181673|39338123|FG001|Up to Week 24|Randomized not Treated|0|||
16233186|NCT02181673|39338124|FG002|Up to Week 24|Randomized not Treated|1|||
16233187|NCT02181673|39338122|FG000|Week 24-Week 60|Adverse Event|0|||
16233188|NCT02181673|39338123|FG001|Week 24-Week 60|Adverse Event|4|||
16552813|NCT01108510|40488353|FG000|Overall Study|Withdrew Consent|21|||
16552814|NCT01108510|40488354|FG001|Overall Study|Withdrew Consent|15|||
16552815|NCT01108510|40488353|FG000|Overall Study|Investigator's Discretion|12|||
16552816|NCT01108510|40488354|FG001|Overall Study|Investigator's Discretion|10|||
16552817|NCT01108510|40488353|FG000|Overall Study|Participant Noncompliance|5|||
16552818|NCT01108510|40488354|FG001|Overall Study|Participant Noncompliance|7|||
16552819|NCT01108510|40488353|FG000|Overall Study|Lack of Efficacy|3|||
16552820|NCT01108510|40488354|FG001|Overall Study|Lack of Efficacy|0|||
16552821|NCT01108510|40488353|FG000|Overall Study|Pregnancy|0|||
16552822|NCT01108510|40488354|FG001|Overall Study|Pregnancy|3|||
16552823|NCT01108510|40488353|FG000|Overall Study|Death|1|||
16552824|NCT01108510|40488354|FG001|Overall Study|Death|1|||
16233189|NCT02181673|39338124|FG002|Week 24-Week 60|Adverse Event|10|||
16233190|NCT02181673|39338122|FG000|Week 24-Week 60|Other|0|||
16233191|NCT02181673|39338123|FG001|Week 24-Week 60|Other|2|||
16233192|NCT02181673|39338124|FG002|Week 24-Week 60|Other|1|||
16233193|NCT02181673|39338122|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
16233194|NCT02181673|39338123|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
16233195|NCT02181673|39338124|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
16233196|NCT02181673|39338122|FG000|Week 24-Week 60|Pregnancy|0|||
16233197|NCT02181673|39338123|FG001|Week 24-Week 60|Pregnancy|0|||
16552825|NCT01734434|40488355|FG000|Overall Study|Death Infant|3|||
16233198|NCT02181673|39338124|FG002|Week 24-Week 60|Pregnancy|1|||
16233199|NCT02181673|39338122|FG000|Week 24-Week 60|Lack of Efficacy|0|||
16233200|NCT02181673|39338123|FG001|Week 24-Week 60|Lack of Efficacy|0|||
16233201|NCT02181673|39338124|FG002|Week 24-Week 60|Lack of Efficacy|1|||
16233202|NCT02181673|39338122|FG000|Week 24-Week 60|Lost to Follow-up|0|||
16233203|NCT02181673|39338123|FG001|Week 24-Week 60|Lost to Follow-up|0|||
16233204|NCT02181673|39338124|FG002|Week 24-Week 60|Lost to Follow-up|1|||
16233205|NCT02181673|39338122|FG000|Week 24-Week 60|Physician Decision|0|||
16233206|NCT02181673|39338123|FG001|Week 24-Week 60|Physician Decision|0|||
16552826|NCT01734434|40488356|FG001|Overall Study|Death Infant|1|||
16552827|NCT01734434|40488357|FG002|Overall Study|Death Infant|17|||
16552828|NCT01734434|40488358|FG003|Overall Study|Death Infant|5|||
16552829|NCT01734434|40488355|FG000|Overall Study|Lost to Follow-up|2|||
16233207|NCT02181673|39338124|FG002|Week 24-Week 60|Physician Decision|1|||
16233208|NCT04163991|39338128|FG000|Overall Study|Adverse Event|0|||
16552830|NCT01734434|40488356|FG001|Overall Study|Lost to Follow-up|9|||
16552831|NCT01734434|40488357|FG002|Overall Study|Lost to Follow-up|67|||
16552832|NCT01734434|40488358|FG003|Overall Study|Lost to Follow-up|11|||
16233209|NCT04163991|39338129|FG001|Overall Study|Adverse Event|0|||
16233210|NCT04163991|39338130|FG002|Overall Study|Adverse Event|0|||
16233211|NCT04163991|39338131|FG003|Overall Study|Adverse Event|1|||
16233212|NCT04163991|39338132|FG004|Overall Study|Adverse Event|0|||
16233213|NCT04163991|39338128|FG000|Overall Study|Death|0|||
16233214|NCT04163991|39338129|FG001|Overall Study|Death|0|||
16233215|NCT04163991|39338130|FG002|Overall Study|Death|1|||
16233216|NCT04163991|39338131|FG003|Overall Study|Death|0|||
16233217|NCT04163991|39338132|FG004|Overall Study|Death|0|||
16233218|NCT04163991|39338128|FG000|Overall Study|Lost to Follow-up|0|||
16233219|NCT04163991|39338129|FG001|Overall Study|Lost to Follow-up|1|||
16233220|NCT04163991|39338130|FG002|Overall Study|Lost to Follow-up|0|||
16233221|NCT04163991|39338131|FG003|Overall Study|Lost to Follow-up|0|||
16233222|NCT04163991|39338132|FG004|Overall Study|Lost to Follow-up|0|||
16233223|NCT04163991|39338128|FG000|Overall Study|Withdrawal by Subject|1|||
16233224|NCT04163991|39338129|FG001|Overall Study|Withdrawal by Subject|1|||
16233225|NCT04163991|39338130|FG002|Overall Study|Withdrawal by Subject|3|||
16233226|NCT04163991|39338131|FG003|Overall Study|Withdrawal by Subject|1|||
16233227|NCT04163991|39338132|FG004|Overall Study|Withdrawal by Subject|1|||
16233228|NCT04163991|39338128|FG000|Overall Study|Other, Not Specified|0|||
16233229|NCT04163991|39338129|FG001|Overall Study|Other, Not Specified|1|||
16233230|NCT04163991|39338130|FG002|Overall Study|Other, Not Specified|1|||
16233231|NCT04163991|39338131|FG003|Overall Study|Other, Not Specified|1|||
16233232|NCT04163991|39338132|FG004|Overall Study|Other, Not Specified|0|||
16233233|NCT01876082|39338133|FG000|Overall Study|Withdrawal by Subject|0|||
16233234|NCT01876082|39338134|FG001|Overall Study|Withdrawal by Subject|2|||
16233235|NCT01876082|39338133|FG000|Overall Study|Protocol Violation|1|||
16233236|NCT01876082|39338134|FG001|Overall Study|Protocol Violation|0|||
16233237|NCT01876082|39338133|FG000|Overall Study|Adverse Event|1|||
16233238|NCT01876082|39338134|FG001|Overall Study|Adverse Event|1|||
16233239|NCT01876082|39338133|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
16233240|NCT01876082|39338134|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
16233241|NCT01728376|39338135|FG000|Overall Study|Adverse Event|1|||
16233242|NCT01728376|39338136|FG001|Overall Study|Adverse Event|1|||
16233243|NCT01728376|39338137|FG002|Overall Study|Adverse Event|1|||
16233244|NCT01728376|39338138|FG003|Overall Study|Adverse Event|1|||
16233245|NCT01728376|39338139|FG004|Overall Study|Adverse Event|1|||
16233246|NCT01728376|39338140|FG005|Overall Study|Adverse Event|0|||
16233247|NCT01728376|39338135|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
16233248|NCT01728376|39338136|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
16552833|NCT01734434|40488355|FG000|Overall Study|No Live Birth|1|||
16552834|NCT01734434|40488356|FG001|Overall Study|No Live Birth|2|||
16552835|NCT01734434|40488357|FG002|Overall Study|No Live Birth|32|||
16552836|NCT01734434|40488358|FG003|Overall Study|No Live Birth|6|||
16233249|NCT01728376|39338137|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
16233250|NCT01728376|39338138|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
16233251|NCT01728376|39338139|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
16233252|NCT01728376|39338140|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
16233253|NCT01728376|39338135|FG000|Overall Study|No relevant bacteria|2|||
16233254|NCT01728376|39338136|FG001|Overall Study|No relevant bacteria|0|||
16233255|NCT01728376|39338137|FG002|Overall Study|No relevant bacteria|0|||
16233256|NCT01728376|39338138|FG003|Overall Study|No relevant bacteria|0|||
16233257|NCT01728376|39338139|FG004|Overall Study|No relevant bacteria|1|||
16233258|NCT01728376|39338140|FG005|Overall Study|No relevant bacteria|1|||
16233259|NCT01728376|39338135|FG000|Overall Study|Did not receive treatment|0|||
16233260|NCT01728376|39338136|FG001|Overall Study|Did not receive treatment|1|||
16233261|NCT01728376|39338137|FG002|Overall Study|Did not receive treatment|0|||
16233262|NCT01728376|39338138|FG003|Overall Study|Did not receive treatment|0|||
16233263|NCT01728376|39338139|FG004|Overall Study|Did not receive treatment|0|||
16233264|NCT01728376|39338140|FG005|Overall Study|Did not receive treatment|0|||
16233265|NCT01728376|39338135|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
16233266|NCT01728376|39338136|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
16233267|NCT01728376|39338137|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
16233268|NCT01728376|39338138|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
16233269|NCT01728376|39338139|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
16233270|NCT01728376|39338140|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
16233271|NCT01186744|39338147|FG000|Overall Study|Lack of Efficacy|156|||
16233272|NCT01186744|39338148|FG001|Overall Study|Lack of Efficacy|99|||
16233273|NCT01186744|39338149|FG002|Overall Study|Lack of Efficacy|0|||
16233274|NCT01186744|39338150|FG003|Overall Study|Lack of Efficacy|2|||
16233275|NCT01186744|39338151|FG004|Overall Study|Lack of Efficacy|2|||
16233276|NCT01186744|39338152|FG005|Overall Study|Lack of Efficacy|5|||
16233277|NCT01186744|39338147|FG000|Overall Study|Protocol Violation|1|||
16552837|NCT01734434|40488355|FG000|Overall Study|Withdrawal by Subject|4|||
16552838|NCT01734434|40488356|FG001|Overall Study|Withdrawal by Subject|0|||
16233278|NCT01186744|39338148|FG001|Overall Study|Protocol Violation|2|||
16233279|NCT01186744|39338149|FG002|Overall Study|Protocol Violation|0|||
16233280|NCT01186744|39338150|FG003|Overall Study|Protocol Violation|1|||
16233281|NCT01186744|39338151|FG004|Overall Study|Protocol Violation|1|||
16233282|NCT01186744|39338152|FG005|Overall Study|Protocol Violation|2|||
16233283|NCT01186744|39338147|FG000|Overall Study|Lost to Follow-up|15|||
16233284|NCT01186744|39338148|FG001|Overall Study|Lost to Follow-up|16|||
16233285|NCT01186744|39338149|FG002|Overall Study|Lost to Follow-up|2|||
16552839|NCT01734434|40488357|FG002|Overall Study|Withdrawal by Subject|8|||
16552840|NCT01734434|40488358|FG003|Overall Study|Withdrawal by Subject|1|||
16552841|NCT01734434|40488355|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
16552842|NCT01734434|40488356|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
16552843|NCT01734434|40488357|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
16552844|NCT01734434|40488358|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
16552845|NCT01734434|40488355|FG000|Overall Study|Subject Not Reachable|0|||
16552846|NCT01734434|40488356|FG001|Overall Study|Subject Not Reachable|0|||
16552847|NCT01734434|40488357|FG002|Overall Study|Subject Not Reachable|1|||
16552848|NCT01734434|40488358|FG003|Overall Study|Subject Not Reachable|0|||
16552849|NCT01734434|40488355|FG000|Overall Study|Treatment Defaulter|0|||
16552850|NCT01734434|40488356|FG001|Overall Study|Treatment Defaulter|0|||
16233286|NCT01186744|39338150|FG003|Overall Study|Lost to Follow-up|1|||
16233287|NCT01186744|39338151|FG004|Overall Study|Lost to Follow-up|1|||
16233288|NCT01186744|39338152|FG005|Overall Study|Lost to Follow-up|4|||
16233289|NCT01186744|39338147|FG000|Overall Study|Screen failure|1|||
16233290|NCT01186744|39338148|FG001|Overall Study|Screen failure|1|||
16233291|NCT01186744|39338149|FG002|Overall Study|Screen failure|0|||
16233292|NCT01186744|39338150|FG003|Overall Study|Screen failure|1|||
16233293|NCT01186744|39338151|FG004|Overall Study|Screen failure|0|||
16233294|NCT01186744|39338152|FG005|Overall Study|Screen failure|0|||
16233295|NCT01186744|39338147|FG000|Overall Study|Withdrawal by Subject|14|||
16233296|NCT01186744|39338148|FG001|Overall Study|Withdrawal by Subject|10|||
16233297|NCT01186744|39338149|FG002|Overall Study|Withdrawal by Subject|2|||
16233298|NCT01186744|39338150|FG003|Overall Study|Withdrawal by Subject|5|||
16233299|NCT01186744|39338151|FG004|Overall Study|Withdrawal by Subject|0|||
16233300|NCT01186744|39338152|FG005|Overall Study|Withdrawal by Subject|6|||
16233301|NCT01186744|39338147|FG000|Overall Study|Study terminated by Sponsor|1|||
16233302|NCT01186744|39338148|FG001|Overall Study|Study terminated by Sponsor|0|||
16233303|NCT01186744|39338149|FG002|Overall Study|Study terminated by Sponsor|0|||
16233304|NCT01186744|39338150|FG003|Overall Study|Study terminated by Sponsor|0|||
16233305|NCT01186744|39338151|FG004|Overall Study|Study terminated by Sponsor|0|||
16233306|NCT01186744|39338152|FG005|Overall Study|Study terminated by Sponsor|0|||
16233307|NCT01186744|39338147|FG000|Overall Study|Other|9|||
16233308|NCT01186744|39338148|FG001|Overall Study|Other|10|||
16233309|NCT01186744|39338149|FG002|Overall Study|Other|1|||
16233310|NCT01186744|39338150|FG003|Overall Study|Other|2|||
16233311|NCT01186744|39338151|FG004|Overall Study|Other|1|||
16233312|NCT01186744|39338152|FG005|Overall Study|Other|5|||
16233313|NCT01186744|39338147|FG000|Overall Study|Adverse Event|10|||
16233314|NCT01186744|39338148|FG001|Overall Study|Adverse Event|14|||
16233315|NCT01186744|39338149|FG002|Overall Study|Adverse Event|1|||
16233316|NCT01186744|39338150|FG003|Overall Study|Adverse Event|0|||
16233317|NCT01186744|39338151|FG004|Overall Study|Adverse Event|1|||
16233318|NCT01186744|39338152|FG005|Overall Study|Adverse Event|4|||
16233319|NCT01186744|39338147|FG000|Overall Study|Death|1|||
16233320|NCT01186744|39338148|FG001|Overall Study|Death|0|||
16233321|NCT01186744|39338149|FG002|Overall Study|Death|0|||
16233322|NCT01186744|39338150|FG003|Overall Study|Death|0|||
16233323|NCT01186744|39338151|FG004|Overall Study|Death|0|||
16233324|NCT01186744|39338152|FG005|Overall Study|Death|0|||
16233325|NCT03083639|39338153|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
16552851|NCT01734434|40488357|FG002|Overall Study|Treatment Defaulter|1|||
16233326|NCT03083639|39338154|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
16233327|NCT03083639|39338153|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
16233328|NCT03083639|39338154|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
16552852|NCT01734434|40488358|FG003|Overall Study|Treatment Defaulter|0|||
16233329|NCT00664066|39338156|FG000|Overall Study|Study terminated|3|||
16233330|NCT01777191|39338157|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
16233331|NCT01777191|39338158|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
16233332|NCT01777191|39338157|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
16233333|NCT01777191|39338158|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
16552853|NCT01734434|40488355|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
16552854|NCT01734434|40488356|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
16552855|NCT01734434|40488357|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
16552856|NCT01734434|40488358|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
16552857|NCT01734434|40488355|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
16552858|NCT01734434|40488356|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
16552859|NCT01734434|40488357|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
16552860|NCT01734434|40488358|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
16552861|NCT00284141|40488363|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
16233334|NCT01777191|39338157|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
16233335|NCT01777191|39338158|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
16233336|NCT01777191|39338157|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
16233337|NCT01777191|39338158|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
16233338|NCT01777191|39338157|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
16233339|NCT01777191|39338158|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
16233340|NCT01777191|39338157|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
16233341|NCT01777191|39338158|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
16233342|NCT01777191|39338157|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
16233343|NCT01777191|39338158|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
16233344|NCT01777191|39338157|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
16233345|NCT01777191|39338158|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
16233346|NCT01777191|39338157|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
16233347|NCT01777191|39338158|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
16233348|NCT01777191|39338157|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
16233349|NCT01777191|39338158|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
16233350|NCT01777191|39338157|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
16233351|NCT01777191|39338158|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
16233352|NCT00816166|39338159|FG000|Overall Study|Lost to Follow-up|6|||
16552862|NCT00284141|40488363|FG000|Overall Study|Adverse Event|19|||
16552863|NCT00284141|40488363|FG000|Overall Study|Participant's request|9|||
16120340|NCT00477490|38927128|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
16552864|NCT00284141|40488363|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
16552865|NCT00284141|40488363|FG000|Overall Study|Clinical deterioration / death|2|||
16552866|NCT00284141|40488363|FG000|Overall Study|General decline|1|||
16552867|NCT00284141|40488363|FG000|Overall Study|Pneumonia|1|||
16552868|NCT00284141|40488363|FG000|Overall Study|Did not take study medication|2|||
16552869|NCT00284141|40488363|FG000|Overall Study|Ongoing treatment|2|||
16552870|NCT03898180|40488367|FG000|Overall Study|Ongoing in Study|133|||
16552871|NCT03898180|40488368|FG001|Overall Study|Ongoing in Study|134|||
16552872|NCT03898180|40488367|FG000|Overall Study|Withdrawal by Subject|3|||
16552873|NCT03898180|40488368|FG001|Overall Study|Withdrawal by Subject|2|||
16552874|NCT03898180|40488367|FG000|Overall Study|Death|109|||
16552875|NCT03898180|40488368|FG001|Overall Study|Death|106|||
16552876|NCT00519636|40488369|FG000|Treatment Period 1|Adverse Event|1|||
16552877|NCT00519636|40488370|FG001|Treatment Period 1|Adverse Event|0|||
16552878|NCT00519636|40488371|FG002|Treatment Period 1|Adverse Event|1|||
16552879|NCT00519636|40488372|FG003|Treatment Period 1|Adverse Event|0|||
16552880|NCT00519636|40488369|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
16552881|NCT00519636|40488370|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
16552882|NCT00519636|40488371|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
16552883|NCT00519636|40488372|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
16552884|NCT00519636|40488369|FG000|Washout Period|Adverse Event|2|||
16552885|NCT00519636|40488370|FG001|Washout Period|Adverse Event|1|||
16552886|NCT00519636|40488371|FG002|Washout Period|Adverse Event|1|||
16552887|NCT00519636|40488372|FG003|Washout Period|Adverse Event|0|||
16552888|NCT00519636|40488369|FG000|Washout Period|Lost to Follow-up|1|||
16552889|NCT00519636|40488370|FG001|Washout Period|Lost to Follow-up|0|||
16552890|NCT00519636|40488371|FG002|Washout Period|Lost to Follow-up|0|||
16552891|NCT00519636|40488372|FG003|Washout Period|Lost to Follow-up|0|||
16120341|NCT00477490|38927129|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
16120342|NCT00477490|38927130|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
16120343|NCT00477490|38927131|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
16120344|NCT00477490|38927132|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
16120345|NCT00477490|38927133|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
16120346|NCT00477490|38927134|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
16120347|NCT00477490|38927135|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
16120348|NCT00477490|38927127|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
16120349|NCT00477490|38927128|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
16120350|NCT00477490|38927129|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
16120351|NCT00477490|38927130|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
16120352|NCT00477490|38927131|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
16120353|NCT00477490|38927132|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
16120354|NCT00477490|38927133|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
16120355|NCT00477490|38927134|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
16120356|NCT00477490|38927135|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
16120357|NCT00477490|38927127|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
16120358|NCT00477490|38927128|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
16120359|NCT00477490|38927129|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
16120360|NCT00477490|38927130|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
16552892|NCT00519636|40488369|FG000|Washout Period|Protocol Violation|0|||
16552893|NCT00519636|40488370|FG001|Washout Period|Protocol Violation|0|||
16552894|NCT00519636|40488371|FG002|Washout Period|Protocol Violation|1|||
16552895|NCT00519636|40488372|FG003|Washout Period|Protocol Violation|2|||
16552896|NCT00519636|40488369|FG000|Washout Period|Withdrawal by Subject|1|||
16552897|NCT00519636|40488370|FG001|Washout Period|Withdrawal by Subject|0|||
16120361|NCT00477490|38927131|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
16552898|NCT00519636|40488371|FG002|Washout Period|Withdrawal by Subject|1|||
16552899|NCT00519636|40488372|FG003|Washout Period|Withdrawal by Subject|0|||
16552900|NCT00519636|40488369|FG000|Washout Period|Failed to meet continuation criteria|14|||
16552901|NCT00519636|40488370|FG001|Washout Period|Failed to meet continuation criteria|11|||
16552902|NCT00519636|40488371|FG002|Washout Period|Failed to meet continuation criteria|9|||
16552903|NCT00519636|40488372|FG003|Washout Period|Failed to meet continuation criteria|3|||
16552904|NCT00519636|40488369|FG000|Washout Period|Out of pollen area > 48 hours|1|||
16120362|NCT00477490|38927132|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
16120363|NCT00477490|38927133|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
16120364|NCT00477490|38927134|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
16552905|NCT00519636|40488370|FG001|Washout Period|Out of pollen area > 48 hours|0|||
16552906|NCT00519636|40488371|FG002|Washout Period|Out of pollen area > 48 hours|0|||
16552907|NCT00519636|40488372|FG003|Washout Period|Out of pollen area > 48 hours|0|||
16552908|NCT00519636|40488369|FG000|Washout Period|Participating in study at another site|1|||
16552909|NCT00519636|40488370|FG001|Washout Period|Participating in study at another site|0|||
16552910|NCT00519636|40488371|FG002|Washout Period|Participating in study at another site|0|||
16552911|NCT00519636|40488372|FG003|Washout Period|Participating in study at another site|0|||
16552912|NCT00519636|40488369|FG000|Washout Period|Non-compliant|0|||
16552913|NCT00519636|40488370|FG001|Washout Period|Non-compliant|1|||
16552914|NCT00519636|40488371|FG002|Washout Period|Non-compliant|0|||
16552915|NCT00519636|40488372|FG003|Washout Period|Non-compliant|0|||
16552916|NCT00519636|40488369|FG000|Washout Period|Per doctors request|0|||
16552917|NCT00519636|40488370|FG001|Washout Period|Per doctors request|1|||
16552918|NCT00519636|40488371|FG002|Washout Period|Per doctors request|0|||
16552919|NCT00519636|40488372|FG003|Washout Period|Per doctors request|0|||
16552920|NCT00519636|40488369|FG000|Washout Period|Subject randomized in error|0|||
16552921|NCT00519636|40488370|FG001|Washout Period|Subject randomized in error|0|||
16552922|NCT00519636|40488371|FG002|Washout Period|Subject randomized in error|1|||
16552923|NCT00519636|40488372|FG003|Washout Period|Subject randomized in error|0|||
16552924|NCT00519636|40488369|FG000|Washout Period|Prohibited medications|0|||
16552925|NCT00519636|40488370|FG001|Washout Period|Prohibited medications|0|||
16552926|NCT00519636|40488371|FG002|Washout Period|Prohibited medications|1|||
16552927|NCT00519636|40488372|FG003|Washout Period|Prohibited medications|0|||
16552928|NCT00519636|40488369|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
16552929|NCT00519636|40488370|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
16552930|NCT00519636|40488371|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
16552931|NCT00519636|40488372|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
16552932|NCT00519636|40488369|FG000|Treatment Period 2|Subject randomized in error|0|||
16552933|NCT00519636|40488370|FG001|Treatment Period 2|Subject randomized in error|1|||
16552934|NCT00519636|40488371|FG002|Treatment Period 2|Subject randomized in error|0|||
16552935|NCT00519636|40488372|FG003|Treatment Period 2|Subject randomized in error|0|||
16552936|NCT00519636|40488369|FG000|Treatment Period 2|Per doctors request|0|||
16552937|NCT00519636|40488370|FG001|Treatment Period 2|Per doctors request|0|||
16552938|NCT00519636|40488371|FG002|Treatment Period 2|Per doctors request|1|||
16552939|NCT00519636|40488372|FG003|Treatment Period 2|Per doctors request|0|||
16552940|NCT00519636|40488369|FG000|Treatment Period 2|Subject misrandomized|0|||
16552941|NCT00519636|40488370|FG001|Treatment Period 2|Subject misrandomized|0|||
16552942|NCT00519636|40488371|FG002|Treatment Period 2|Subject misrandomized|0|||
16552943|NCT00519636|40488372|FG003|Treatment Period 2|Subject misrandomized|1|||
16552944|NCT00519636|40488369|FG000|Post Study Period|Subject randomized in error|0|||
16552945|NCT00519636|40488370|FG001|Post Study Period|Subject randomized in error|0|||
16552946|NCT00519636|40488371|FG002|Post Study Period|Subject randomized in error|0|||
16552947|NCT00519636|40488372|FG003|Post Study Period|Subject randomized in error|1|||
16552948|NCT01275196|40488374|FG000|Overall Study|Adverse Event|3|||
16552949|NCT01275196|40488375|FG001|Overall Study|Adverse Event|5|||
16552950|NCT01275196|40488374|FG000|Overall Study|Withdrawal by Subject|4|||
16552951|NCT01275196|40488375|FG001|Overall Study|Withdrawal by Subject|5|||
16552952|NCT01275196|40488374|FG000|Overall Study|Lost to Follow-up|1|||
16552953|NCT01275196|40488375|FG001|Overall Study|Lost to Follow-up|0|||
16552954|NCT01275196|40488374|FG000|Overall Study|Disease Progression|6|||
16552955|NCT01275196|40488375|FG001|Overall Study|Disease Progression|5|||
16552956|NCT01275196|40488374|FG000|Overall Study|Protocol Violation|1|||
16552957|NCT01275196|40488375|FG001|Overall Study|Protocol Violation|0|||
16552958|NCT01275196|40488374|FG000|Overall Study|Suboptimal response/treatment failure|5|||
16552959|NCT01275196|40488375|FG001|Overall Study|Suboptimal response/treatment failure|6|||
16552960|NCT02589392|40488386|FG000|Overall Study|Adverse Event|1|||
16552961|NCT02589392|40488387|FG001|Overall Study|Adverse Event|1|||
16552962|NCT02589392|40488386|FG000|Overall Study|Withdrawal by Subject|1|||
16552963|NCT02589392|40488387|FG001|Overall Study|Withdrawal by Subject|2|||
16552964|NCT02589392|40488386|FG000|Overall Study|Protocol Violation|1|||
16552965|NCT02589392|40488387|FG001|Overall Study|Protocol Violation|1|||
16552966|NCT02589392|40488386|FG000|Overall Study|Lost to Follow-up|2|||
16552967|NCT02589392|40488387|FG001|Overall Study|Lost to Follow-up|2|||
16552968|NCT02589392|40488386|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
16552969|NCT02589392|40488387|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
16552970|NCT02878213|40488388|FG000|Overall Study|Withdrawal by Subject|2|||
16552971|NCT02878213|40488388|FG000|Overall Study|Adverse Event|1|||
16552972|NCT00605189|40488389|FG000|Overall Study|Adverse Event|1|||
16552973|NCT00605189|40488390|FG001|Overall Study|Adverse Event|0|||
16552974|NCT00605189|40488391|FG002|Overall Study|Adverse Event|0|||
16552975|NCT00605189|40488389|FG000|Overall Study|Other|2|||
16552976|NCT00605189|40488390|FG001|Overall Study|Other|2|||
16552977|NCT00605189|40488391|FG002|Overall Study|Other|0|||
16552978|NCT01289041|40488392|FG000|Overall Study|Adverse Event|24|||
16552979|NCT01289041|40488392|FG000|Overall Study|Physician Decision|1|||
16552980|NCT01289041|40488392|FG000|Overall Study|Progressive Disease|41|||
16552981|NCT01289041|40488392|FG000|Overall Study|Withdrawal by Subject|3|||
16552982|NCT01289041|40488392|FG000|Overall Study|Death|1|||
16552983|NCT00794820|40488393|FG000|Overall Study|Adverse Event|11|||
16552984|NCT00794820|40488393|FG000|Overall Study|Secondary Malignancies|2|||
16552985|NCT00794820|40488393|FG000|Overall Study|Resistant Disease|2|||
16552986|NCT00794820|40488393|FG000|Overall Study|Ineligible/Screen Failure|1|||
16552987|NCT01009047|40488394|FG000|Overall Study|Adverse Event|5|||
16552988|NCT01009047|40488395|FG001|Overall Study|Adverse Event|0|||
16552989|NCT01009047|40488394|FG000|Overall Study|Lost to Follow-up|0|||
16552990|NCT01009047|40488395|FG001|Overall Study|Lost to Follow-up|2|||
16552991|NCT01009047|40488394|FG000|Overall Study|Lack of Efficacy|4|||
16552992|NCT01009047|40488395|FG001|Overall Study|Lack of Efficacy|11|||
16552993|NCT01009047|40488394|FG000|Overall Study|Withdrawal by consent|16|||
16552994|NCT01009047|40488395|FG001|Overall Study|Withdrawal by consent|11|||
16552995|NCT01009047|40488394|FG000|Overall Study|Other|3|||
16552996|NCT01009047|40488395|FG001|Overall Study|Other|2|||
16552997|NCT01258660|40488396|FG000|Overall Study|Adverse Event|2|||
16552998|NCT01258660|40488397|FG001|Overall Study|Adverse Event|4|||
16552999|NCT01258660|40488396|FG000|Overall Study|Withdrawal by Subject|3|||
16553000|NCT01258660|40488397|FG001|Overall Study|Withdrawal by Subject|0|||
16553001|NCT01258660|40488396|FG000|Overall Study|due to relocation|2|||
16553002|NCT01258660|40488397|FG001|Overall Study|due to relocation|0|||
16553003|NCT01258660|40488396|FG000|Overall Study|Protocol Violation|0|||
16553004|NCT01258660|40488397|FG001|Overall Study|Protocol Violation|1|||
16553005|NCT01258660|40488396|FG000|Overall Study|Invalid for primary analysis data set|4|||
16553006|NCT01258660|40488397|FG001|Overall Study|Invalid for primary analysis data set|6|||
16553007|NCT00663962|40488400|FG000|Overall Study|somnolence|1|||
16233353|NCT00816166|39338160|FG001|Overall Study|Lost to Follow-up|10|||
16233354|NCT00816166|39338159|FG000|Overall Study|Death|4|||
16233355|NCT00816166|39338160|FG001|Overall Study|Death|2|||
16233356|NCT00244881|39338161|FG000|Overall Study|Withdrawal by Subject|3|||
16233357|NCT04101721|39338168|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
16233358|NCT04101721|39338169|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
16233359|NCT04101721|39338168|FG000|Overall Study|Death|0|||
16233360|NCT04101721|39338169|FG001|Overall Study|Death|1|||
16233361|NCT04101721|39338168|FG000|Overall Study|Lost to Follow-up|0|||
16233362|NCT04101721|39338169|FG001|Overall Study|Lost to Follow-up|3|||
16233363|NCT02086968|39338170|FG000|Overall Study|Adverse Event|1|||
16233364|NCT02086968|39338171|FG001|Overall Study|Adverse Event|5|||
16233365|NCT02086968|39338170|FG000|Overall Study|Lost to Follow-up|2|||
16233366|NCT02086968|39338171|FG001|Overall Study|Lost to Follow-up|3|||
16233367|NCT02086968|39338170|FG000|Overall Study|Study drug received outside protocol|0|||
16233368|NCT02086968|39338171|FG001|Overall Study|Study drug received outside protocol|1|||
16233369|NCT02086968|39338170|FG000|Overall Study|Physician Decision|4|||
16233370|NCT02086968|39338171|FG001|Overall Study|Physician Decision|0|||
16233371|NCT02086968|39338170|FG000|Overall Study|Withdrawal by Subject|1|||
16553008|NCT00663962|40488401|FG001|Overall Study|somnolence|0|||
16553009|NCT03548064|40488402|FG000|Overall Study|Withdrawal by Subject|0|||
16553010|NCT03548064|40488403|FG001|Overall Study|Withdrawal by Subject|0|||
16233372|NCT02086968|39338171|FG001|Overall Study|Withdrawal by Subject|4|||
16553011|NCT03548064|40488404|FG002|Overall Study|Withdrawal by Subject|0|||
16120365|NCT00477490|38927135|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
16120366|NCT00477490|38927127|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
16120367|NCT00477490|38927128|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
16120368|NCT00477490|38927129|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
16120369|NCT00477490|38927130|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
16120370|NCT00477490|38927131|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
16120371|NCT00477490|38927132|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
16120372|NCT00477490|38927133|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
16120373|NCT00477490|38927134|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
16120374|NCT00477490|38927135|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
16120375|NCT00477490|38927127|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
16120376|NCT00477490|38927128|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
16120377|NCT00477490|38927129|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
16120378|NCT00477490|38927130|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
16120379|NCT00477490|38927131|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
16120380|NCT00477490|38927132|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
16120381|NCT00477490|38927133|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
16120382|NCT00477490|38927134|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
16120383|NCT00477490|38927135|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
16120384|NCT00477490|38927127|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
16120385|NCT00477490|38927128|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
16120386|NCT00477490|38927129|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
16120387|NCT00477490|38927130|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
16120388|NCT00477490|38927131|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
16233373|NCT00646282|39338172|FG000|Overall Study|Protocol terminated|4|||
16233374|NCT00646282|39338173|FG001|Overall Study|Protocol terminated|4|||
16233375|NCT00819091|39338175|FG000|Overall Study|Adverse Event|3|||
16233376|NCT00819091|39338176|FG001|Overall Study|Adverse Event|5|||
16233377|NCT00819091|39338175|FG000|Overall Study|Protocol Violation|0|||
16233378|NCT00819091|39338176|FG001|Overall Study|Protocol Violation|1|||
16233379|NCT00819091|39338175|FG000|Overall Study|Lost to Follow-up|2|||
16553012|NCT03548064|40488405|FG003|Overall Study|Withdrawal by Subject|1|||
16553013|NCT03548064|40488406|FG004|Overall Study|Withdrawal by Subject|0|||
16553014|NCT03548064|40488407|FG005|Overall Study|Withdrawal by Subject|0|||
16553015|NCT03548064|40488408|FG006|Overall Study|Withdrawal by Subject|0|||
16233380|NCT00819091|39338176|FG001|Overall Study|Lost to Follow-up|0|||
16233381|NCT00819091|39338175|FG000|Overall Study|Withdrawal by Subject|1|||
16233382|NCT00819091|39338176|FG001|Overall Study|Withdrawal by Subject|2|||
16233383|NCT00819091|39338175|FG000|Overall Study|Other|1|||
16233384|NCT00819091|39338176|FG001|Overall Study|Other|2|||
16553016|NCT03548064|40488409|FG007|Overall Study|Withdrawal by Subject|0|||
16553017|NCT03548064|40488402|FG000|Overall Study|Lost to Follow-up|0|||
16553018|NCT03548064|40488403|FG001|Overall Study|Lost to Follow-up|0|||
16553019|NCT03548064|40488404|FG002|Overall Study|Lost to Follow-up|0|||
16553020|NCT03548064|40488405|FG003|Overall Study|Lost to Follow-up|0|||
16553021|NCT03548064|40488406|FG004|Overall Study|Lost to Follow-up|2|||
16553022|NCT03548064|40488407|FG005|Overall Study|Lost to Follow-up|0|||
16553023|NCT03548064|40488408|FG006|Overall Study|Lost to Follow-up|0|||
16553024|NCT03548064|40488409|FG007|Overall Study|Lost to Follow-up|0|||
16553025|NCT03548064|40488402|FG000|Overall Study|Covid-19 Pandemic|0|||
16553026|NCT03548064|40488403|FG001|Overall Study|Covid-19 Pandemic|0|||
16553027|NCT03548064|40488404|FG002|Overall Study|Covid-19 Pandemic|0|||
16553028|NCT03548064|40488405|FG003|Overall Study|Covid-19 Pandemic|0|||
16553029|NCT03548064|40488406|FG004|Overall Study|Covid-19 Pandemic|10|||
16553030|NCT03548064|40488407|FG005|Overall Study|Covid-19 Pandemic|3|||
16553031|NCT03548064|40488408|FG006|Overall Study|Covid-19 Pandemic|0|||
16553032|NCT03548064|40488409|FG007|Overall Study|Covid-19 Pandemic|0|||
16553033|NCT00287469|40488410|FG000|Overall Study|serious adverse event|1|||
16553034|NCT00287469|40488411|FG001|Overall Study|serious adverse event|6|||
16553035|NCT00287469|40488410|FG000|Overall Study|Adverse Event|1|||
16553036|NCT00287469|40488411|FG001|Overall Study|Adverse Event|1|||
16553037|NCT00287469|40488410|FG000|Overall Study|moved from area|144|||
16553038|NCT00287469|40488411|FG001|Overall Study|moved from area|138|||
16553039|NCT00287469|40488410|FG000|Overall Study|Lost to Follow-up|74|||
16553040|NCT00287469|40488411|FG001|Overall Study|Lost to Follow-up|69|||
16233385|NCT02628418|39338179|FG000|Overall Study|Lost to Follow-up|1|||
16553041|NCT03119610|40488413|FG000|Overall Study|Adverse Event|1|||
16553042|NCT03119610|40488414|FG001|Overall Study|Adverse Event|0|||
16553043|NCT03119610|40488413|FG000|Overall Study|Lost to Follow-up|0|||
16553044|NCT03119610|40488414|FG001|Overall Study|Lost to Follow-up|1|||
16553045|NCT01004250|40488427|FG000|Induction Therapy Period|Adverse Event|10|||
16553046|NCT01004250|40488427|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
16553047|NCT01004250|40488427|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
16553048|NCT01004250|40488427|FG000|Induction Therapy Period|Physician Decision|2|||
16553049|NCT01004250|40488427|FG000|Maintenance Therapy Period|Adverse Event|15|||
16553050|NCT01004250|40488427|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
16553051|NCT01004250|40488427|FG000|Maintenance Therapy Period|Protocol Violation|1|||
16120389|NCT00477490|38927132|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
16120390|NCT00477490|38927133|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
16120391|NCT00477490|38927134|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
16120392|NCT00477490|38927135|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
16120393|NCT00477490|38927127|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16120394|NCT00477490|38927128|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16120395|NCT00477490|38927129|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16120396|NCT00477490|38927130|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16120397|NCT00477490|38927131|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
16553052|NCT01004250|40488427|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
16553053|NCT01004250|40488427|FG000|Maintenance Therapy Period|Physician Decision|4|||
16553054|NCT01004250|40488427|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
16553055|NCT01090310|40488428|FG000|Core Study|Adverse Event|2|||
16553056|NCT01090310|40488429|FG001|Core Study|Adverse Event|2|||
16120398|NCT00477490|38927132|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16120399|NCT00477490|38927133|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
16120400|NCT00477490|38927134|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
16120401|NCT00477490|38927135|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
16120402|NCT00477490|38927127|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16120403|NCT00477490|38927128|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
16120404|NCT00477490|38927129|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16120405|NCT00477490|38927130|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16120406|NCT00477490|38927131|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16120407|NCT00477490|38927132|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16120408|NCT00477490|38927133|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16120409|NCT00477490|38927134|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16120410|NCT00477490|38927135|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
16120411|NCT00477490|38927127|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
16120412|NCT00477490|38927128|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
16120413|NCT00477490|38927129|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
16120414|NCT00477490|38927130|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
16120415|NCT00477490|38927131|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
16120416|NCT00477490|38927132|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
16120417|NCT00477490|38927133|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
16120418|NCT00477490|38927134|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
16120419|NCT00477490|38927135|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
16120420|NCT00477490|38927127|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16120421|NCT00477490|38927128|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
16120422|NCT00477490|38927129|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
16120423|NCT00477490|38927130|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16120424|NCT00477490|38927131|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
16120425|NCT00477490|38927132|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16120426|NCT00477490|38927133|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16120427|NCT00477490|38927134|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16120428|NCT00477490|38927135|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
16120429|NCT01038427|38927136|FG000|Overall Study|Lost to follow up|1|||
16120430|NCT01038427|38927137|FG001|Overall Study|Lost to follow up|1|||
16120431|NCT01038427|38927138|FG002|Overall Study|Lost to follow up|0|||
16120432|NCT01038427|38927136|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
16120433|NCT01038427|38927137|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
16120434|NCT01038427|38927138|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
16120435|NCT01038427|38927136|FG000|Overall Study|Withdrew consent|0|||
16120436|NCT01038427|38927137|FG001|Overall Study|Withdrew consent|0|||
16120437|NCT01038427|38927138|FG002|Overall Study|Withdrew consent|1|||
16120438|NCT01038427|38927136|FG000|Overall Study|Adverse Event|2|||
16120439|NCT01038427|38927137|FG001|Overall Study|Adverse Event|2|||
16120440|NCT01038427|38927138|FG002|Overall Study|Adverse Event|1|||
16120441|NCT01038427|38927136|FG000|Overall Study|Enrolled in error|0|||
16120442|NCT01038427|38927137|FG001|Overall Study|Enrolled in error|1|||
16120443|NCT01038427|38927138|FG002|Overall Study|Enrolled in error|1|||
16120444|NCT01038427|38927136|FG000|Overall Study|Other|0|||
16120445|NCT01038427|38927137|FG001|Overall Study|Other|2|||
16120446|NCT01038427|38927138|FG002|Overall Study|Other|0|||
16553057|NCT01090310|40488430|FG002|Core Study|Adverse Event|1|||
16553058|NCT01090310|40488431|FG003|Core Study|Adverse Event|1|||
16553059|NCT01090310|40488428|FG000|Core Study|Subject withdrew consent|0|||
16233386|NCT02628418|39338180|FG001|Overall Study|Lost to Follow-up|2|||
16233387|NCT02875340|39338181|FG000|Overall Study|Death|2|||
16553060|NCT01090310|40488429|FG001|Core Study|Subject withdrew consent|3|||
16553061|NCT01090310|40488430|FG002|Core Study|Subject withdrew consent|1|||
16553062|NCT01090310|40488431|FG003|Core Study|Subject withdrew consent|1|||
16553063|NCT01090310|40488428|FG000|Core Study|Abnormal test procedure result|0|||
16553064|NCT01090310|40488429|FG001|Core Study|Abnormal test procedure result|0|||
16553065|NCT01090310|40488430|FG002|Core Study|Abnormal test procedure result|1|||
16553066|NCT01090310|40488431|FG003|Core Study|Abnormal test procedure result|0|||
16553067|NCT01090310|40488428|FG000|Core Study|Administrative reasons|5|||
16553068|NCT01090310|40488429|FG001|Core Study|Administrative reasons|6|||
16553069|NCT01090310|40488430|FG002|Core Study|Administrative reasons|4|||
16553070|NCT01090310|40488431|FG003|Core Study|Administrative reasons|4|||
16233388|NCT02875340|39338181|FG000|Overall Study|Withdrawal by Subject|2|||
16233389|NCT02875340|39338181|FG000|Overall Study|Physician Decision|3|||
16233390|NCT02875340|39338181|FG000|Overall Study|Adverse Event|1|||
16233391|NCT02575807|39338183|FG000|Overall Study|Death|8|||
16233392|NCT02575807|39338184|FG001|Overall Study|Death|3|||
16233393|NCT02575807|39338185|FG002|Overall Study|Death|7|||
16233394|NCT02575807|39338186|FG003|Overall Study|Death|0|||
16233395|NCT02575807|39338187|FG004|Overall Study|Death|1|||
16233396|NCT02575807|39338183|FG000|Overall Study|Study terminated by Sponsor|0|||
16233397|NCT02575807|39338184|FG001|Overall Study|Study terminated by Sponsor|1|||
16233398|NCT02575807|39338185|FG002|Overall Study|Study terminated by Sponsor|7|||
16233399|NCT02575807|39338186|FG003|Overall Study|Study terminated by Sponsor|0|||
16233400|NCT02575807|39338187|FG004|Overall Study|Study terminated by Sponsor|1|||
16233401|NCT02575807|39338183|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
16233402|NCT02575807|39338184|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
16233403|NCT02575807|39338185|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
16233404|NCT02575807|39338186|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
16233405|NCT02575807|39338187|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
16233406|NCT02575807|39338183|FG000|Overall Study|Terminated due to physician decision|0|||
16233407|NCT02575807|39338184|FG001|Overall Study|Terminated due to physician decision|0|||
16233408|NCT02575807|39338185|FG002|Overall Study|Terminated due to physician decision|1|||
16553071|NCT01090310|40488428|FG000|Core Study|Protocol deviation|1|||
16233409|NCT02575807|39338186|FG003|Overall Study|Terminated due to physician decision|0|||
16233410|NCT02575807|39338187|FG004|Overall Study|Terminated due to physician decision|0|||
16233411|NCT02575807|39338183|FG000|Overall Study|Subject ineligible - medical implant|0|||
16233412|NCT02575807|39338184|FG001|Overall Study|Subject ineligible - medical implant|0|||
16233413|NCT02575807|39338185|FG002|Overall Study|Subject ineligible - medical implant|0|||
16233414|NCT02575807|39338186|FG003|Overall Study|Subject ineligible - medical implant|1|||
16233415|NCT02575807|39338187|FG004|Overall Study|Subject ineligible - medical implant|0|||
16233416|NCT02575807|39338183|FG000|Overall Study|Withdrawal by Subject|0|||
16233417|NCT02575807|39338184|FG001|Overall Study|Withdrawal by Subject|0|||
16233418|NCT02575807|39338185|FG002|Overall Study|Withdrawal by Subject|1|||
16233419|NCT02575807|39338186|FG003|Overall Study|Withdrawal by Subject|1|||
16233420|NCT02575807|39338187|FG004|Overall Study|Withdrawal by Subject|2|||
16233421|NCT03075215|39338188|FG000|12-Month Primary Endpoint|Death|152|||
16233422|NCT03075215|39338188|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
16233423|NCT03075215|39338188|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
16553072|NCT01090310|40488429|FG001|Core Study|Protocol deviation|0|||
16120447|NCT02979249|38927146|FG000|Overall Study|Lost to Follow-up|2|||
16233424|NCT03075215|39338188|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
16233425|NCT02900976|39338189|FG000|Overall Study|Adverse Event|0|||
16233426|NCT02900976|39338190|FG001|Overall Study|Adverse Event|1|||
16233427|NCT02900976|39338189|FG000|Overall Study|Physician Decision|0|||
16233428|NCT02900976|39338190|FG001|Overall Study|Physician Decision|2|||
16553073|NCT01090310|40488430|FG002|Core Study|Protocol deviation|0|||
16553074|NCT01090310|40488431|FG003|Core Study|Protocol deviation|1|||
16120448|NCT02979249|38927146|FG000|Overall Study|Withdrawal by Subject|4|||
16120449|NCT00669877|38927147|FG000|Overall Study|Disease Progression/Death|4|||
16120450|NCT00403767|38927148|FG000|Overall Study|Adverse Event|993|||
16120451|NCT00403767|38927149|FG001|Overall Study|Adverse Event|919|||
16120452|NCT00403767|38927148|FG000|Overall Study|Non-compliant with study medication|134|||
16120453|NCT00403767|38927149|FG001|Overall Study|Non-compliant with study medication|164|||
16120454|NCT00403767|38927148|FG000|Overall Study|Consent withdrawn|671|||
16120455|NCT00403767|38927149|FG001|Overall Study|Consent withdrawn|673|||
16120456|NCT00403767|38927148|FG000|Overall Study|Investigator dec./not protocol-related|191|||
16120457|NCT00403767|38927149|FG001|Overall Study|Investigator dec./not protocol-related|178|||
16120458|NCT00403767|38927148|FG000|Overall Study|Lost to Follow-up|6|||
16120459|NCT00403767|38927149|FG001|Overall Study|Lost to Follow-up|8|||
16120460|NCT00403767|38927148|FG000|Overall Study|Protocol Violation|142|||
16120461|NCT00403767|38927149|FG001|Overall Study|Protocol Violation|124|||
16120462|NCT00403767|38927148|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
16120463|NCT00403767|38927149|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
16120464|NCT00403767|38927148|FG000|Overall Study|Study terminated by sponsor|82|||
16120465|NCT00403767|38927149|FG001|Overall Study|Study terminated by sponsor|69|||
16120466|NCT00403767|38927148|FG000|Overall Study|Missing/incomplete data|1|||
16120467|NCT00403767|38927149|FG001|Overall Study|Missing/incomplete data|1|||
16120468|NCT01892540|38927150|FG000|Overall Study|Did not complete PET/MRI|0|||
16120469|NCT01892540|38927151|FG001|Overall Study|Did not complete PET/MRI|0|||
16120470|NCT01892540|38927152|FG002|Overall Study|Did not complete PET/MRI|2|||
16120471|NCT01892540|38927150|FG000|Overall Study|Did not fit in scanner|0|||
16120472|NCT01892540|38927151|FG001|Overall Study|Did not fit in scanner|0|||
16120473|NCT01892540|38927152|FG002|Overall Study|Did not fit in scanner|1|||
16120474|NCT01162863|38927153|FG000|Overall Study|Lack of Efficacy|1|||
16120475|NCT01162863|38927154|FG001|Overall Study|Lack of Efficacy|0|||
16120476|NCT01162863|38927155|FG002|Overall Study|Lack of Efficacy|0|||
16120477|NCT01162863|38927153|FG000|Overall Study|Adverse Event|0|||
16120478|NCT01162863|38927154|FG001|Overall Study|Adverse Event|1|||
16120479|NCT01162863|38927155|FG002|Overall Study|Adverse Event|0|||
16120480|NCT01735175|38927158|FG000|Overall Study|Withdrawal by Subject|9|||
16120481|NCT01735175|38927159|FG001|Overall Study|Withdrawal by Subject|2|||
16120482|NCT01735175|38927158|FG000|Overall Study|Lost to Follow-up|4|||
16120483|NCT01735175|38927159|FG001|Overall Study|Lost to Follow-up|2|||
16120484|NCT01735175|38927158|FG000|Overall Study|Death|3|||
16120485|NCT01735175|38927159|FG001|Overall Study|Death|2|||
16120486|NCT01735175|38927158|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
16120487|NCT01735175|38927159|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
16120488|NCT05110690|38927160|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
16120489|NCT05110690|38927160|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
16120490|NCT05110690|38927160|FG000|Completion of Intervention|Lost to Follow-up|1|||
16120491|NCT05110690|38927160|FG000|Completion of Intervention|Death|1|||
16120492|NCT05110690|38927160|FG000|Completion of Intervention|Withdrawal by Subject|2|||
16120493|NCT03738475|38927172|FG000|Overall Study|Participant Non-Compliance|1|||
16120494|NCT03738475|38927173|FG001|Overall Study|Participant Non-Compliance|0|||
16120495|NCT00357110|38927174|FG000|Overall Study|Early study termination|5|||
16120496|NCT00357110|38927175|FG001|Overall Study|Early study termination|5|||
16120497|NCT00603525|38927176|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
16120498|NCT00603525|38927177|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
16120499|NCT00603525|38927178|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
16120500|NCT00603525|38927176|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
16120501|NCT00603525|38927177|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
16120502|NCT00603525|38927178|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
16120503|NCT00603525|38927176|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
16120504|NCT00603525|38927177|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
16120505|NCT00603525|38927178|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
16120506|NCT00603525|38927176|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
16120507|NCT00603525|38927177|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
16120508|NCT00603525|38927178|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16120509|NCT00603525|38927176|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
16233429|NCT02900976|39338189|FG000|Overall Study|Progressive disease|0|||
16233430|NCT02900976|39338190|FG001|Overall Study|Progressive disease|6|||
16233431|NCT00530621|39338191|FG000|Overall Study|Adverse Event|11|||
16233432|NCT00530621|39338192|FG001|Overall Study|Adverse Event|8|||
16233433|NCT00530621|39338191|FG000|Overall Study|Physician Decision|2|||
16233434|NCT00530621|39338192|FG001|Overall Study|Physician Decision|4|||
16233435|NCT00530621|39338191|FG000|Overall Study|Progressive Disease (PD)|47|||
16233436|NCT00530621|39338192|FG001|Overall Study|Progressive Disease (PD)|40|||
16233437|NCT00530621|39338191|FG000|Overall Study|Sponsor Decision|12|||
16233438|NCT00530621|39338192|FG001|Overall Study|Sponsor Decision|15|||
16233439|NCT00530621|39338191|FG000|Overall Study|Subject Decision|4|||
16233440|NCT00530621|39338192|FG001|Overall Study|Subject Decision|7|||
16233441|NCT00530621|39338191|FG000|Overall Study|Death|3|||
16233442|NCT00530621|39338192|FG001|Overall Study|Death|6|||
16233443|NCT00530621|39338191|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
16233444|NCT00530621|39338192|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
16233445|NCT00209560|39338193|FG000|Overall Study|Lack of Efficacy|1|||
16233446|NCT00209560|39338194|FG001|Overall Study|Lack of Efficacy|0|||
16233447|NCT01371006|39338196|FG000|Overall Study|Adverse Event|1|||
16233448|NCT01371006|39338197|FG001|Overall Study|Adverse Event|0|||
16233449|NCT00962013|39338200|FG000|Overall Study|Did not have surgery|1|||
16233450|NCT00962013|39338200|FG000|Overall Study|Death|8|||
16233451|NCT00962013|39338200|FG000|Overall Study|Lost to Follow-up|12|||
16233452|NCT00962013|39338200|FG000|Overall Study|Unable/Unwilling to return|6|||
16233453|NCT00962013|39338200|FG000|Overall Study|Withdrawal by Subject|8|||
16233454|NCT00962013|39338200|FG000|Overall Study|Removal of study device|3|||
16233455|NCT00962013|39338200|FG000|Overall Study|Site Termination|24|||
16233456|NCT00962013|39338200|FG000|Overall Study|No 5 year evaluation|6|||
16233457|NCT01023815|39338202|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
16233458|NCT01023815|39338203|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
16233459|NCT01023815|39338204|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
16233460|NCT01023815|39338205|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
16233461|NCT01023815|39338202|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
16233462|NCT01023815|39338203|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
16233463|NCT01023815|39338204|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
16233464|NCT01023815|39338205|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
16233465|NCT01023815|39338202|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
16233466|NCT01023815|39338203|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
16233467|NCT01023815|39338204|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
16233468|NCT01023815|39338205|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
16233469|NCT01023815|39338202|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
16233470|NCT01023815|39338203|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
16233471|NCT01023815|39338204|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
16233472|NCT01023815|39338205|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
16233473|NCT01023815|39338202|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
16233474|NCT01023815|39338203|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
16233475|NCT01023815|39338204|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
16233476|NCT01023815|39338205|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
16233477|NCT03644927|39338207|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
16233478|NCT03644927|39338208|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
16233479|NCT02526017|39338209|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16233480|NCT02526017|39338210|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16233481|NCT02526017|39338211|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16233482|NCT02526017|39338212|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16233483|NCT02526017|39338213|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
16233484|NCT02526017|39338214|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16233485|NCT02526017|39338215|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16233486|NCT02526017|39338216|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16233487|NCT02526017|39338217|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
16233488|NCT02916056|39338219|FG000|Overall Study|Adverse Event|6|||
16233489|NCT02916056|39338219|FG000|Overall Study|Lost to Follow-up|1|||
16233490|NCT02916056|39338219|FG000|Overall Study|Other|12|||
16233491|NCT02916056|39338219|FG000|Overall Study|Protocol Violation|1|||
16233492|NCT02916056|39338219|FG000|Overall Study|Withdrawal by Subject|8|||
16233493|NCT02916056|39338219|FG000|Overall Study|Study Terminated by Sponsor|269|||
16233494|NCT03170271|39338220|FG000|Overall Study|Adverse Event|7|||
16233495|NCT03170271|39338221|FG001|Overall Study|Adverse Event|2|||
16233496|NCT03170271|39338220|FG000|Overall Study|Lost to Follow-up|0|||
16233497|NCT03170271|39338221|FG001|Overall Study|Lost to Follow-up|1|||
16233498|NCT03170271|39338220|FG000|Overall Study|Physician Decision|1|||
16233499|NCT03170271|39338221|FG001|Overall Study|Physician Decision|0|||
16233500|NCT03170271|39338220|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
16233501|NCT03170271|39338221|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
16233502|NCT03170271|39338220|FG000|Overall Study|Withdrawal by Subject|17|||
16233503|NCT03170271|39338221|FG001|Overall Study|Withdrawal by Subject|5|||
16233504|NCT03170271|39338220|FG000|Overall Study|Other|2|||
16233505|NCT03170271|39338221|FG001|Overall Study|Other|2|||
16233506|NCT03170271|39338220|FG000|Overall Study|Randomized in error|4|||
16233507|NCT03170271|39338221|FG001|Overall Study|Randomized in error|0|||
16233508|NCT00806416|39338229|FG000|Period 1 - Part I|Adverse Event|0|||
16233509|NCT00806416|39338230|FG001|Period 1 - Part I|Adverse Event|1|||
16233510|NCT00806416|39338231|FG002|Period 1 - Part I|Adverse Event|0|||
16233511|NCT00806416|39338232|FG003|Period 1 - Part I|Adverse Event|0|||
16233512|NCT00806416|39338229|FG000|Period 1 - Part I|Lost to Follow-up|0|||
16233513|NCT00806416|39338230|FG001|Period 1 - Part I|Lost to Follow-up|2|||
16233514|NCT00806416|39338231|FG002|Period 1 - Part I|Lost to Follow-up|0|||
16233515|NCT00806416|39338232|FG003|Period 1 - Part I|Lost to Follow-up|0|||
16233516|NCT00806416|39338229|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
16233517|NCT00806416|39338230|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
16233518|NCT00806416|39338231|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
16233519|NCT00806416|39338232|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
16233520|NCT00806416|39338229|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
16233521|NCT00806416|39338230|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
16233522|NCT00806416|39338231|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
16233523|NCT00806416|39338232|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
16233524|NCT00424632|39338233|FG000|Overall Study|Death|0|||
16233525|NCT00424632|39338234|FG001|Overall Study|Death|0|||
16233526|NCT00424632|39338235|FG002|Overall Study|Death|0|||
16233527|NCT00424632|39338236|FG003|Overall Study|Death|0|||
16233528|NCT00424632|39338237|FG004|Overall Study|Death|0|||
16233529|NCT00424632|39338238|FG005|Overall Study|Death|2|||
16233530|NCT00424632|39338239|FG006|Overall Study|Death|0|||
16233531|NCT00424632|39338240|FG007|Overall Study|Death|0|||
16233532|NCT00424632|39338241|FG008|Overall Study|Death|0|||
16233533|NCT00424632|39338242|FG009|Overall Study|Death|0|||
16233534|NCT00424632|39338233|FG000|Overall Study|Adverse Event|0|||
16233535|NCT00424632|39338234|FG001|Overall Study|Adverse Event|0|||
16233536|NCT00424632|39338235|FG002|Overall Study|Adverse Event|0|||
16233537|NCT00424632|39338236|FG003|Overall Study|Adverse Event|0|||
16233538|NCT00424632|39338237|FG004|Overall Study|Adverse Event|0|||
16233539|NCT00424632|39338238|FG005|Overall Study|Adverse Event|0|||
16233540|NCT00424632|39338239|FG006|Overall Study|Adverse Event|0|||
16233541|NCT00424632|39338240|FG007|Overall Study|Adverse Event|0|||
16233542|NCT00424632|39338241|FG008|Overall Study|Adverse Event|3|||
16233543|NCT00424632|39338242|FG009|Overall Study|Adverse Event|2|||
16233544|NCT00424632|39338233|FG000|Overall Study|Global deterioration of health status|0|||
16233545|NCT00424632|39338234|FG001|Overall Study|Global deterioration of health status|0|||
16233546|NCT00424632|39338235|FG002|Overall Study|Global deterioration of health status|0|||
16233547|NCT00424632|39338236|FG003|Overall Study|Global deterioration of health status|1|||
16233548|NCT00424632|39338237|FG004|Overall Study|Global deterioration of health status|1|||
16233549|NCT00424632|39338238|FG005|Overall Study|Global deterioration of health status|0|||
16233550|NCT00424632|39338239|FG006|Overall Study|Global deterioration of health status|0|||
16553075|NCT01090310|40488428|FG000|Extension Study|Aministrative problems|13|||
16553076|NCT01090310|40488429|FG001|Extension Study|Aministrative problems|15|||
16553077|NCT01090310|40488430|FG002|Extension Study|Aministrative problems|14|||
16553078|NCT01090310|40488431|FG003|Extension Study|Aministrative problems|18|||
16553079|NCT01090310|40488428|FG000|Extension Study|Adverse Event|0|||
16553080|NCT01090310|40488429|FG001|Extension Study|Adverse Event|0|||
16233551|NCT00424632|39338240|FG007|Overall Study|Global deterioration of health status|0|||
16553081|NCT01090310|40488430|FG002|Extension Study|Adverse Event|0|||
16553082|NCT01090310|40488431|FG003|Extension Study|Adverse Event|1|||
16553083|NCT01090310|40488428|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
16553084|NCT01090310|40488429|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
16553085|NCT01090310|40488430|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
16233552|NCT00424632|39338241|FG008|Overall Study|Global deterioration of health status|0|||
16233553|NCT00424632|39338242|FG009|Overall Study|Global deterioration of health status|0|||
16233554|NCT00424632|39338233|FG000|Overall Study|Objective progression or relapse|1|||
16233555|NCT00424632|39338234|FG001|Overall Study|Objective progression or relapse|1|||
16233556|NCT00424632|39338235|FG002|Overall Study|Objective progression or relapse|1|||
16233557|NCT00424632|39338236|FG003|Overall Study|Objective progression or relapse|2|||
16233558|NCT00424632|39338237|FG004|Overall Study|Objective progression or relapse|2|||
16233559|NCT00424632|39338238|FG005|Overall Study|Objective progression or relapse|13|||
16233560|NCT00424632|39338239|FG006|Overall Study|Objective progression or relapse|7|||
16233561|NCT00424632|39338240|FG007|Overall Study|Objective progression or relapse|3|||
16233562|NCT00424632|39338241|FG008|Overall Study|Objective progression or relapse|12|||
16553086|NCT01090310|40488431|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
16553087|NCT01090310|40488428|FG000|Extension Study|Subject withdrew consent|0|||
16553088|NCT01090310|40488429|FG001|Extension Study|Subject withdrew consent|1|||
16553089|NCT01090310|40488430|FG002|Extension Study|Subject withdrew consent|0|||
16553090|NCT01090310|40488431|FG003|Extension Study|Subject withdrew consent|0|||
16553091|NCT03545113|40488436|FG000|Overall Study|Surgery Cancelled|1|||
16553092|NCT03545113|40488437|FG001|Overall Study|Surgery Cancelled|0|||
16553093|NCT03545113|40488436|FG000|Overall Study|Death|1|||
16553094|NCT03545113|40488437|FG001|Overall Study|Death|0|||
16553095|NCT03545113|40488436|FG000|Overall Study|Adverse Event|2|||
16553096|NCT03545113|40488437|FG001|Overall Study|Adverse Event|0|||
16553097|NCT03545113|40488436|FG000|Overall Study|Received different surgery|1|||
16553098|NCT03545113|40488437|FG001|Overall Study|Received different surgery|0|||
16553099|NCT02366936|40488438|FG000|Overall Study|Withdrawal by Subject|2|||
16553100|NCT02366936|40488438|FG000|Overall Study|Lost to Follow-up|4|||
16553101|NCT02366936|40488438|FG000|Overall Study|Physician Decision|2|||
16553102|NCT00539643|40488439|FG000|Overall Study|Adverse Event|1|||
16553103|NCT00539643|40488440|FG001|Overall Study|Adverse Event|0|||
16120510|NCT00603525|38927177|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
16120511|NCT00603525|38927178|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
16120512|NCT00603525|38927176|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
16120513|NCT00603525|38927177|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
16120514|NCT00603525|38927178|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
16120515|NCT00603525|38927176|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
16120516|NCT00603525|38927177|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
16120517|NCT00603525|38927178|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
16120518|NCT00603525|38927176|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
16120519|NCT00603525|38927177|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
16120520|NCT00603525|38927178|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
16120521|NCT00603525|38927176|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
16120522|NCT00603525|38927177|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
16120523|NCT00603525|38927178|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
16120524|NCT00603525|38927176|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
16120525|NCT00603525|38927177|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
16120526|NCT00603525|38927178|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
16120527|NCT00603525|38927176|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
16120528|NCT00603525|38927177|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
16120529|NCT00603525|38927178|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
16120530|NCT00603525|38927176|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
16120531|NCT00603525|38927177|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
16120532|NCT00603525|38927178|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
16233563|NCT00424632|39338242|FG009|Overall Study|Objective progression or relapse|4|||
16120533|NCT00603525|38927176|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
16120534|NCT00603525|38927177|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
16120535|NCT00603525|38927178|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
16120536|NCT00603525|38927176|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
16553104|NCT00539643|40488439|FG000|Overall Study|Death|2|||
16553105|NCT00539643|40488440|FG001|Overall Study|Death|1|||
16553106|NCT00539643|40488439|FG000|Overall Study|Physician Decision|3|||
16553107|NCT00539643|40488440|FG001|Overall Study|Physician Decision|1|||
16553108|NCT00539643|40488439|FG000|Overall Study|Withdrawal by Subject|0|||
16233564|NCT00424632|39338233|FG000|Overall Study|Other|0|||
16233565|NCT00424632|39338234|FG001|Overall Study|Other|0|||
16233566|NCT00424632|39338235|FG002|Overall Study|Other|0|||
16233567|NCT00424632|39338236|FG003|Overall Study|Other|1|||
16233568|NCT00424632|39338237|FG004|Overall Study|Other|0|||
16233569|NCT00424632|39338238|FG005|Overall Study|Other|0|||
16233570|NCT00424632|39338239|FG006|Overall Study|Other|0|||
16233571|NCT00424632|39338240|FG007|Overall Study|Other|0|||
16233572|NCT00424632|39338241|FG008|Overall Study|Other|1|||
16233573|NCT00424632|39338242|FG009|Overall Study|Other|0|||
16233574|NCT05000931|39338243|FG000|Overall Study|Lost to Follow-up|1|||
16233575|NCT03256526|39338244|FG000|Overall Study|Adverse Event|1|||
16233576|NCT03256526|39338245|FG001|Overall Study|Adverse Event|0|||
16233577|NCT03256526|39338246|FG002|Overall Study|Adverse Event|1|||
16233578|NCT03256526|39338244|FG000|Overall Study|Lost to Follow-up|1|||
16553109|NCT00539643|40488440|FG001|Overall Study|Withdrawal by Subject|1|||
16233579|NCT03256526|39338245|FG001|Overall Study|Lost to Follow-up|0|||
16233580|NCT03256526|39338246|FG002|Overall Study|Lost to Follow-up|2|||
16233581|NCT01102972|39338252|FG000|Overall Study|Adverse Event|8|||
16233582|NCT01102972|39338253|FG001|Overall Study|Adverse Event|2|||
16553110|NCT04768296|40488443|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
16553111|NCT04768296|40488444|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
16553112|NCT01473381|40488448|FG000|Overall Study|Adverse Event|8|||
16553113|NCT01473381|40488449|FG001|Overall Study|Adverse Event|20|||
16233583|NCT01102972|39338252|FG000|Overall Study|Lack of Efficacy|2|||
16233584|NCT01102972|39338253|FG001|Overall Study|Lack of Efficacy|1|||
16233585|NCT01102972|39338252|FG000|Overall Study|Protocol Violation|1|||
16233586|NCT01102972|39338253|FG001|Overall Study|Protocol Violation|0|||
16233587|NCT01102972|39338252|FG000|Overall Study|Lost to Follow-up|10|||
16233588|NCT01102972|39338253|FG001|Overall Study|Lost to Follow-up|5|||
16233589|NCT01102972|39338252|FG000|Overall Study|Investigator Discretion|2|||
16233590|NCT01102972|39338253|FG001|Overall Study|Investigator Discretion|0|||
16233591|NCT01102972|39338252|FG000|Overall Study|Withdrawal by Subject|6|||
16233592|NCT01102972|39338253|FG001|Overall Study|Withdrawal by Subject|6|||
16233593|NCT02759731|39338256|FG000|Overall Study|Did not complete treatment.|8|||
16233594|NCT03808298|39338257|FG000|Overall Study|Adverse Event|3|||
16233595|NCT03808298|39338257|FG000|Overall Study|Physician Decision|1|||
16233596|NCT03808298|39338257|FG000|Overall Study|Withdrawal by Subject|1|||
16233597|NCT03808298|39338257|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
16233598|NCT01153971|39338261|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
16553114|NCT01473381|40488450|FG002|Overall Study|Adverse Event|25|||
16553115|NCT01473381|40488451|FG003|Overall Study|Adverse Event|17|||
16553116|NCT01473381|40488448|FG000|Overall Study|Insufficient Therapeutic Response|10|||
16233599|NCT01153971|39338261|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
16233600|NCT01153971|39338261|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
16233601|NCT01153971|39338261|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
16553117|NCT01473381|40488449|FG001|Overall Study|Insufficient Therapeutic Response|1|||
16553118|NCT01473381|40488450|FG002|Overall Study|Insufficient Therapeutic Response|2|||
16233602|NCT01153971|39338261|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
16233603|NCT01153971|39338261|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
16233604|NCT01153971|39338261|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
16233605|NCT03409328|39338264|FG000|Overall Study|Lost to Follow-up|6|||
16233606|NCT03409328|39338265|FG001|Overall Study|Lost to Follow-up|3|||
16233607|NCT03231709|39338266|FG000|Treatment Period 1|Reason not Specified|0|||
16233608|NCT03231709|39338267|FG001|Treatment Period 1|Reason not Specified|1|||
16233609|NCT03231709|39338266|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
16233610|NCT03231709|39338267|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
16233611|NCT00299546|39338271|FG000|Overall Study|Death|3|||
16233612|NCT00299546|39338272|FG001|Overall Study|Death|2|||
16233613|NCT00299546|39338273|FG002|Overall Study|Death|0|||
16233614|NCT00299546|39338271|FG000|Overall Study|Lost to Follow-up|2|||
16348706|NCT00732069|39765471|FG003|Washout After First Study Drug|Adverse Event|0|||
16348707|NCT00732069|39765472|FG004|Washout After First Study Drug|Adverse Event|0|||
16348708|NCT00732069|39765473|FG005|Washout After First Study Drug|Adverse Event|0|||
16348709|NCT02619617|39765474|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
16348710|NCT02619617|39765475|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
16348711|NCT02619617|39765474|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
16348712|NCT02619617|39765475|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
16348713|NCT04158219|39765476|FG000|Overall Study|Lost to Follow-up|1|||
16348714|NCT02718911|39765477|FG000|Overall Study|Adverse Event|0|||
16348715|NCT02718911|39765478|FG001|Overall Study|Adverse Event|0|||
16348716|NCT02718911|39765479|FG002|Overall Study|Adverse Event|0|||
16348717|NCT02718911|39765480|FG003|Overall Study|Adverse Event|0|||
16348718|NCT02718911|39765481|FG004|Overall Study|Adverse Event|0|||
16348719|NCT02718911|39765482|FG005|Overall Study|Adverse Event|0|||
16348720|NCT02718911|39765483|FG006|Overall Study|Adverse Event|0|||
16348721|NCT02718911|39765484|FG007|Overall Study|Adverse Event|0|||
16348722|NCT02718911|39765485|FG008|Overall Study|Adverse Event|0|||
16348723|NCT02718911|39765486|FG009|Overall Study|Adverse Event|2|||
16348724|NCT02718911|39765477|FG000|Overall Study|Death|2|||
16348725|NCT02718911|39765478|FG001|Overall Study|Death|3|||
16348726|NCT02718911|39765479|FG002|Overall Study|Death|1|||
16348727|NCT02718911|39765480|FG003|Overall Study|Death|0|||
16348728|NCT02718911|39765481|FG004|Overall Study|Death|1|||
16348729|NCT02718911|39765482|FG005|Overall Study|Death|3|||
16348730|NCT02718911|39765483|FG006|Overall Study|Death|1|||
16348731|NCT02718911|39765484|FG007|Overall Study|Death|1|||
16348732|NCT02718911|39765485|FG008|Overall Study|Death|4|||
16348733|NCT02718911|39765486|FG009|Overall Study|Death|3|||
16553119|NCT01473381|40488451|FG003|Overall Study|Insufficient Therapeutic Response|3|||
16553120|NCT01473381|40488448|FG000|Overall Study|Protocol Violation|17|||
16553121|NCT01473381|40488449|FG001|Overall Study|Protocol Violation|23|||
16553122|NCT01473381|40488450|FG002|Overall Study|Protocol Violation|19|||
16553123|NCT01473381|40488451|FG003|Overall Study|Protocol Violation|17|||
16553124|NCT01473381|40488448|FG000|Overall Study|Withdrawal of Consent|20|||
16553125|NCT01473381|40488449|FG001|Overall Study|Withdrawal of Consent|21|||
16553126|NCT01473381|40488450|FG002|Overall Study|Withdrawal of Consent|20|||
16553127|NCT01473381|40488451|FG003|Overall Study|Withdrawal of Consent|26|||
16553128|NCT01473381|40488448|FG000|Overall Study|Lost to Follow-up|25|||
16553129|NCT01473381|40488449|FG001|Overall Study|Lost to Follow-up|28|||
16553130|NCT01473381|40488450|FG002|Overall Study|Lost to Follow-up|35|||
16553131|NCT01473381|40488451|FG003|Overall Study|Lost to Follow-up|23|||
16553132|NCT01473381|40488448|FG000|Overall Study|Other Reasons|0|||
16553133|NCT01473381|40488449|FG001|Overall Study|Other Reasons|0|||
16553134|NCT01473381|40488450|FG002|Overall Study|Other Reasons|1|||
16553135|NCT01473381|40488451|FG003|Overall Study|Other Reasons|3|||
16553136|NCT00735644|40488452|FG000|Overall Study|Did not receive study vaccine|0|||
16553137|NCT00735644|40488453|FG001|Overall Study|Did not receive study vaccine|1|||
16553138|NCT00735644|40488454|FG002|Overall Study|Did not receive study vaccine|0|||
16233615|NCT00299546|39338272|FG001|Overall Study|Lost to Follow-up|2|||
16233616|NCT00299546|39338273|FG002|Overall Study|Lost to Follow-up|5|||
16348734|NCT02718911|39765477|FG000|Overall Study|Lost to Follow-up|0|||
16348735|NCT02718911|39765478|FG001|Overall Study|Lost to Follow-up|0|||
16348736|NCT02718911|39765479|FG002|Overall Study|Lost to Follow-up|0|||
16348737|NCT02718911|39765480|FG003|Overall Study|Lost to Follow-up|0|||
16348738|NCT02718911|39765481|FG004|Overall Study|Lost to Follow-up|0|||
16348739|NCT02718911|39765482|FG005|Overall Study|Lost to Follow-up|0|||
16348740|NCT02718911|39765483|FG006|Overall Study|Lost to Follow-up|0|||
16348741|NCT02718911|39765484|FG007|Overall Study|Lost to Follow-up|0|||
16553139|NCT00735644|40488455|FG003|Overall Study|Did not receive study vaccine|0|||
16553140|NCT00735644|40488456|FG004|Overall Study|Did not receive study vaccine|0|||
16553141|NCT00735644|40488452|FG000|Overall Study|Withdrawal by Subject|0|||
16553142|NCT00735644|40488453|FG001|Overall Study|Withdrawal by Subject|1|||
16348742|NCT02718911|39765485|FG008|Overall Study|Lost to Follow-up|1|||
16553143|NCT00735644|40488454|FG002|Overall Study|Withdrawal by Subject|1|||
16553144|NCT00735644|40488455|FG003|Overall Study|Withdrawal by Subject|1|||
16553145|NCT00735644|40488456|FG004|Overall Study|Withdrawal by Subject|0|||
16233617|NCT00299546|39338271|FG000|Overall Study|Adverse Event|37|||
16233618|NCT00299546|39338272|FG001|Overall Study|Adverse Event|22|||
16233619|NCT00299546|39338273|FG002|Overall Study|Adverse Event|27|||
16233620|NCT00299546|39338271|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
16233621|NCT00299546|39338272|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
16233622|NCT00299546|39338273|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
16233623|NCT00299546|39338271|FG000|Overall Study|Other|24|||
16233624|NCT00299546|39338272|FG001|Overall Study|Other|26|||
16233625|NCT00299546|39338273|FG002|Overall Study|Other|19|||
16233626|NCT00299546|39338271|FG000|Overall Study|Not treated|0|||
16233627|NCT00299546|39338272|FG001|Overall Study|Not treated|1|||
16233628|NCT00299546|39338273|FG002|Overall Study|Not treated|1|||
16233629|NCT03290131|39338274|FG000|Overall Study|Adverse Event|22|||
16233630|NCT03290131|39338275|FG001|Overall Study|Adverse Event|57|||
16233631|NCT03290131|39338276|FG002|Overall Study|Adverse Event|11|||
16233632|NCT03290131|39338274|FG000|Overall Study|Withdrawal by Subject|18|||
16233633|NCT03290131|39338275|FG001|Overall Study|Withdrawal by Subject|13|||
16233634|NCT03290131|39338276|FG002|Overall Study|Withdrawal by Subject|8|||
16233635|NCT03290131|39338274|FG000|Overall Study|MS Relapse|2|||
16233636|NCT03290131|39338275|FG001|Overall Study|MS Relapse|1|||
16233637|NCT03290131|39338276|FG002|Overall Study|MS Relapse|0|||
16233638|NCT03290131|39338274|FG000|Overall Study|Unknown reason|0|||
16233639|NCT03290131|39338275|FG001|Overall Study|Unknown reason|1|||
16233640|NCT03290131|39338276|FG002|Overall Study|Unknown reason|0|||
16233641|NCT00110084|39338277|FG000|Overall Study|Adverse Event|9|||
16233642|NCT00110084|39338277|FG000|Overall Study|Death|1|||
16233643|NCT00110084|39338277|FG000|Overall Study|Patient Refusal|10|||
16233644|NCT00110084|39338277|FG000|Overall Study|Alternate Therapy|5|||
16233645|NCT00110084|39338277|FG000|Overall Study|Intercurrent Illness|1|||
16233646|NCT00110084|39338277|FG000|Overall Study|Other|2|||
16233647|NCT01257737|39338283|FG000|Overall Study|Lost to Follow-up|1|||
16233648|NCT01257737|39338284|FG001|Overall Study|Lost to Follow-up|2|||
16233649|NCT01257737|39338283|FG000|Overall Study|Liver transplant|1|||
16233650|NCT01257737|39338284|FG001|Overall Study|Liver transplant|0|||
16233651|NCT01257737|39338283|FG000|Overall Study|Relocation out of the country|0|||
16233652|NCT01257737|39338284|FG001|Overall Study|Relocation out of the country|1|||
16233653|NCT01257737|39338283|FG000|Overall Study|Withdrew from study|0|||
16233654|NCT01257737|39338284|FG001|Overall Study|Withdrew from study|1|||
16233655|NCT01300741|39338285|FG000|Overall Study|Lens deposits|1|||
16233656|NCT01300741|39338285|FG000|Overall Study|Lost to Follow-up|1|||
16233657|NCT01300741|39338285|FG000|Overall Study|Discomfort|1|||
16233658|NCT02946515|39338286|FG000|Overall Study|Lost to Follow-up|2|||
16233659|NCT02946515|39338287|FG001|Overall Study|Lost to Follow-up|1|||
16233660|NCT01329562|39338288|FG000|Overall Study|Protocol Violation|5|||
16233661|NCT01329562|39338289|FG001|Overall Study|Protocol Violation|3|||
16233662|NCT01329562|39338288|FG000|Overall Study|Lost to Follow-up|1|||
16233663|NCT01329562|39338289|FG001|Overall Study|Lost to Follow-up|1|||
16233664|NCT01329562|39338288|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
16233665|NCT01329562|39338289|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
16233666|NCT01329562|39338288|FG000|Overall Study|Physician Decision|0|||
16233667|NCT01329562|39338289|FG001|Overall Study|Physician Decision|1|||
16233668|NCT04887922|39338290|FG000|1st Randomization|Decided not to have surgery|0|||
16233669|NCT04887922|39338291|FG001|1st Randomization|Decided not to have surgery|1|||
16233670|NCT04887922|39338292|FG002|1st Randomization|Decided not to have surgery|0|||
16233671|NCT04887922|39338293|FG003|1st Randomization|Decided not to have surgery|0|||
16233672|NCT04887922|39338294|FG004|1st Randomization|Decided not to have surgery|0|||
16233673|NCT03053102|39338295|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
16233674|NCT03053102|39338295|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
16233675|NCT00902265|39338296|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
16233676|NCT00902265|39338296|FG000|Overall Study|Adverse Event|2|||
16233677|NCT00902265|39338296|FG000|Overall Study|Lack of Efficacy|2|||
16233678|NCT00902265|39338296|FG000|Overall Study|Protocol Violation|1|||
16233679|NCT03733301|39338297|FG000|Overall Study|Screen Fail|1|||
16233680|NCT03733301|39338298|FG001|Overall Study|Screen Fail|0|||
16233681|NCT03733301|39338299|FG002|Overall Study|Screen Fail|0|||
16233682|NCT03733301|39338297|FG000|Overall Study|Non-compliance|1|||
16233683|NCT03733301|39338298|FG001|Overall Study|Non-compliance|0|||
16233684|NCT03733301|39338299|FG002|Overall Study|Non-compliance|0|||
16233685|NCT03733301|39338297|FG000|Overall Study|Lack of Efficacy|2|||
16233686|NCT03733301|39338298|FG001|Overall Study|Lack of Efficacy|3|||
16233687|NCT03733301|39338299|FG002|Overall Study|Lack of Efficacy|0|||
16553146|NCT02748694|40488460|FG000|Overall Study|Voluntary Withdrawal|0|||
16553147|NCT02748694|40488461|FG001|Overall Study|Voluntary Withdrawal|0|||
16233688|NCT03733301|39338297|FG000|Overall Study|Adverse Event|0|||
16233689|NCT03733301|39338298|FG001|Overall Study|Adverse Event|1|||
16233690|NCT03733301|39338299|FG002|Overall Study|Adverse Event|3|||
16233691|NCT03733301|39338297|FG000|Overall Study|Withdrawal by Subject|3|||
16233692|NCT03733301|39338298|FG001|Overall Study|Withdrawal by Subject|5|||
16233693|NCT03733301|39338299|FG002|Overall Study|Withdrawal by Subject|1|||
16233694|NCT03930615|39338301|FG000|Overall Study|Death|9|||
16233695|NCT03930615|39338302|FG001|Overall Study|Death|3|||
16233696|NCT03930615|39338301|FG000|Overall Study|Lost to Follow-up|1|||
16233697|NCT03930615|39338302|FG001|Overall Study|Lost to Follow-up|2|||
16553148|NCT02748694|40488462|FG002|Overall Study|Voluntary Withdrawal|0|||
16233698|NCT03930615|39338301|FG000|Overall Study|Physician Decision|3|||
16233699|NCT03930615|39338302|FG001|Overall Study|Physician Decision|4|||
16553149|NCT02748694|40488463|FG003|Overall Study|Voluntary Withdrawal|0|||
16553150|NCT02748694|40488464|FG004|Overall Study|Voluntary Withdrawal|0|||
16553151|NCT02748694|40488465|FG005|Overall Study|Voluntary Withdrawal|0|||
16233700|NCT03930615|39338301|FG000|Overall Study|Withdrawal by Subject|13|||
16233701|NCT03930615|39338302|FG001|Overall Study|Withdrawal by Subject|2|||
16233702|NCT03930615|39338301|FG000|Overall Study|Not treated|1|||
16233703|NCT03930615|39338302|FG001|Overall Study|Not treated|1|||
16233704|NCT00111007|39338304|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
16233705|NCT00111007|39338305|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
16233706|NCT00111007|39338304|FG000|Double-blind (DB) Treatment|Death|5|||
16233707|NCT00111007|39338305|FG001|Double-blind (DB) Treatment|Death|2|||
16233708|NCT00111007|39338304|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
16233709|NCT00111007|39338305|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
16233710|NCT00111007|39338304|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
16233711|NCT00111007|39338305|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
16233712|NCT00111007|39338304|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
16233713|NCT00111007|39338305|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
16233714|NCT00111007|39338304|FG000|Double-blind (DB) Treatment|Relapse|1|||
16233715|NCT00111007|39338305|FG001|Double-blind (DB) Treatment|Relapse|0|||
16233716|NCT00111007|39338304|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
16233717|NCT00111007|39338305|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
16233718|NCT00111007|39338304|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
16233719|NCT00111007|39338305|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
16233720|NCT00111007|39338304|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
16233721|NCT00111007|39338305|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
16233722|NCT00111007|39338304|FG000|Active Follow-up|Adverse Event|1|||
16233723|NCT00111007|39338305|FG001|Active Follow-up|Adverse Event|0|||
16233724|NCT00111007|39338304|FG000|Active Follow-up|Death|2|||
16233725|NCT00111007|39338305|FG001|Active Follow-up|Death|0|||
16233726|NCT00111007|39338304|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
16233727|NCT00111007|39338305|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
16233728|NCT00111007|39338304|FG000|Long Term Follow-up|Death|34|||
16233729|NCT00111007|39338305|FG001|Long Term Follow-up|Death|39|||
16233730|NCT00111007|39338304|FG000|Long Term Follow-up|Lost to Follow-up|1|||
16233731|NCT00111007|39338305|FG001|Long Term Follow-up|Lost to Follow-up|1|||
16233732|NCT00111007|39338304|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
16233733|NCT00111007|39338305|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
16233734|NCT00111007|39338304|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
16233735|NCT00111007|39338305|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
16233736|NCT00111007|39338304|FG000|Long Term Follow-up|Missing|10|||
16233737|NCT00111007|39338305|FG001|Long Term Follow-up|Missing|3|||
16233738|NCT01238861|39338311|FG000|Overall Study|Lost to Follow-up|4|||
16233739|NCT01238861|39338312|FG001|Overall Study|Lost to Follow-up|2|||
16233740|NCT01238861|39338313|FG002|Overall Study|Lost to Follow-up|3|||
16233741|NCT01238861|39338314|FG003|Overall Study|Lost to Follow-up|1|||
16233742|NCT01238861|39338315|FG004|Overall Study|Lost to Follow-up|1|||
16233743|NCT01238861|39338316|FG005|Overall Study|Lost to Follow-up|2|||
16233744|NCT01238861|39338311|FG000|Overall Study|Unplanned surgery|1|||
16233745|NCT01238861|39338312|FG001|Overall Study|Unplanned surgery|0|||
16233746|NCT01238861|39338313|FG002|Overall Study|Unplanned surgery|0|||
16233747|NCT01238861|39338314|FG003|Overall Study|Unplanned surgery|0|||
16233748|NCT01238861|39338315|FG004|Overall Study|Unplanned surgery|0|||
16233749|NCT01238861|39338316|FG005|Overall Study|Unplanned surgery|0|||
16233750|NCT01238861|39338311|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
16233751|NCT01238861|39338312|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
16233752|NCT01238861|39338313|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
16233753|NCT01238861|39338314|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
16233754|NCT01238861|39338315|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
16233755|NCT01238861|39338316|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
16233756|NCT01238861|39338311|FG000|Overall Study|Incorrect enrollment/randomization|0|||
16233757|NCT01238861|39338312|FG001|Overall Study|Incorrect enrollment/randomization|0|||
16233758|NCT01238861|39338313|FG002|Overall Study|Incorrect enrollment/randomization|1|||
16553152|NCT02748694|40488466|FG006|Overall Study|Voluntary Withdrawal|0|||
16233759|NCT01238861|39338314|FG003|Overall Study|Incorrect enrollment/randomization|0|||
16233760|NCT01238861|39338315|FG004|Overall Study|Incorrect enrollment/randomization|1|||
16233761|NCT01238861|39338316|FG005|Overall Study|Incorrect enrollment/randomization|0|||
16553153|NCT02748694|40488467|FG007|Overall Study|Voluntary Withdrawal|0|||
16233762|NCT01238861|39338311|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
16233763|NCT01238861|39338312|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
16233764|NCT01238861|39338313|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
16233765|NCT01238861|39338314|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
16233766|NCT01238861|39338315|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
16233767|NCT01238861|39338316|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
16233768|NCT01238861|39338311|FG000|Overall Study|Subject moved out of state/area|0|||
16233769|NCT01238861|39338312|FG001|Overall Study|Subject moved out of state/area|0|||
16233770|NCT01238861|39338313|FG002|Overall Study|Subject moved out of state/area|1|||
16233771|NCT01238861|39338314|FG003|Overall Study|Subject moved out of state/area|1|||
16233772|NCT01238861|39338315|FG004|Overall Study|Subject moved out of state/area|0|||
16233773|NCT01238861|39338316|FG005|Overall Study|Subject moved out of state/area|0|||
16233774|NCT01238861|39338311|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
16233775|NCT01238861|39338312|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
16233776|NCT01238861|39338313|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
16233777|NCT01238861|39338314|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
16233778|NCT01238861|39338315|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
16233779|NCT01238861|39338316|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
16233780|NCT01238861|39338311|FG000|Overall Study|Personal problems|0|||
16233781|NCT01238861|39338312|FG001|Overall Study|Personal problems|0|||
16233782|NCT01238861|39338313|FG002|Overall Study|Personal problems|0|||
16233783|NCT01238861|39338314|FG003|Overall Study|Personal problems|1|||
16233784|NCT01238861|39338315|FG004|Overall Study|Personal problems|0|||
16233785|NCT01238861|39338316|FG005|Overall Study|Personal problems|0|||
16233786|NCT01238861|39338311|FG000|Overall Study|Unable to continue visits|0|||
16233787|NCT01238861|39338312|FG001|Overall Study|Unable to continue visits|0|||
16233788|NCT01238861|39338313|FG002|Overall Study|Unable to continue visits|0|||
16233789|NCT01238861|39338314|FG003|Overall Study|Unable to continue visits|1|||
16233790|NCT01238861|39338315|FG004|Overall Study|Unable to continue visits|0|||
16233791|NCT01238861|39338316|FG005|Overall Study|Unable to continue visits|1|||
16233792|NCT01238861|39338311|FG000|Overall Study|Serious adverse event|0|||
16233793|NCT01238861|39338312|FG001|Overall Study|Serious adverse event|0|||
16233794|NCT01238861|39338313|FG002|Overall Study|Serious adverse event|0|||
16233795|NCT01238861|39338314|FG003|Overall Study|Serious adverse event|0|||
16233796|NCT01238861|39338315|FG004|Overall Study|Serious adverse event|0|||
16233797|NCT01238861|39338316|FG005|Overall Study|Serious adverse event|1|||
16233798|NCT01238861|39338311|FG000|Overall Study|Lack of compliance|0|||
16233799|NCT01238861|39338312|FG001|Overall Study|Lack of compliance|0|||
16233800|NCT01238861|39338313|FG002|Overall Study|Lack of compliance|0|||
16233801|NCT01238861|39338314|FG003|Overall Study|Lack of compliance|0|||
16233802|NCT01238861|39338315|FG004|Overall Study|Lack of compliance|0|||
16233803|NCT01238861|39338316|FG005|Overall Study|Lack of compliance|1|||
16233804|NCT01238861|39338311|FG000|Overall Study|Adverse Event|0|||
16233805|NCT01238861|39338312|FG001|Overall Study|Adverse Event|1|||
16233806|NCT01238861|39338313|FG002|Overall Study|Adverse Event|0|||
16233807|NCT01238861|39338314|FG003|Overall Study|Adverse Event|0|||
16233808|NCT01238861|39338315|FG004|Overall Study|Adverse Event|0|||
16233809|NCT01238861|39338316|FG005|Overall Study|Adverse Event|0|||
16233810|NCT01238861|39338311|FG000|Overall Study|Withdrawal by Subject|6|||
16233811|NCT01238861|39338312|FG001|Overall Study|Withdrawal by Subject|5|||
16233812|NCT01238861|39338313|FG002|Overall Study|Withdrawal by Subject|4|||
16233813|NCT01238861|39338314|FG003|Overall Study|Withdrawal by Subject|8|||
16233814|NCT01238861|39338315|FG004|Overall Study|Withdrawal by Subject|10|||
16233815|NCT01238861|39338316|FG005|Overall Study|Withdrawal by Subject|9|||
16233816|NCT01856257|39338339|FG000|Overall Study|Death|2|||
16233817|NCT01856257|39338340|FG001|Overall Study|Death|0|||
16233818|NCT01856257|39338341|FG002|Overall Study|Death|0|||
16233819|NCT01856257|39338342|FG003|Overall Study|Death|0|||
16233820|NCT01856257|39338339|FG000|Overall Study|Physician Decision|0|||
16233821|NCT01856257|39338340|FG001|Overall Study|Physician Decision|0|||
16233822|NCT01856257|39338341|FG002|Overall Study|Physician Decision|0|||
16233823|NCT01856257|39338342|FG003|Overall Study|Physician Decision|1|||
16233824|NCT01856257|39338339|FG000|Overall Study|Withdrawal by Subject|1|||
16233825|NCT01856257|39338340|FG001|Overall Study|Withdrawal by Subject|1|||
16233826|NCT01856257|39338341|FG002|Overall Study|Withdrawal by Subject|0|||
16233827|NCT01856257|39338342|FG003|Overall Study|Withdrawal by Subject|0|||
16233828|NCT01856257|39338339|FG000|Overall Study|Donor complication|0|||
16233829|NCT01856257|39338340|FG001|Overall Study|Donor complication|0|||
16233830|NCT01856257|39338341|FG002|Overall Study|Donor complication|0|||
16233831|NCT01856257|39338342|FG003|Overall Study|Donor complication|1|||
16233832|NCT00891527|39338343|FG000|Overall Study|Withdrawal by Subject|2|||
16233833|NCT00151775|39338344|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
16233834|NCT00151775|39338345|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
16233835|NCT00151775|39338346|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16233836|NCT00151775|39338347|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16233837|NCT00151775|39338348|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16233838|NCT00151775|39338349|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16233839|NCT00151775|39338350|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16233840|NCT00151775|39338351|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16233841|NCT00151775|39338352|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16120537|NCT00603525|38927177|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
16120538|NCT00603525|38927178|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
16120539|NCT00603525|38927176|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
16120540|NCT00603525|38927177|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
16120541|NCT00603525|38927178|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
16120542|NCT02947100|38927179|FG000|Overall Study|study terminated early|3|||
16120543|NCT02947100|38927179|FG000|Overall Study|did not meet inclusion criteria|1|||
16120544|NCT02628028|38927180|FG000|Dosing Period|Withdrawal by Subject|0|||
16120545|NCT02628028|38927181|FG001|Dosing Period|Withdrawal by Subject|0|||
16120546|NCT02628028|38927182|FG002|Dosing Period|Withdrawal by Subject|1|||
16120547|NCT02628028|38927183|FG003|Dosing Period|Withdrawal by Subject|0|||
16120548|NCT02628028|38927184|FG004|Dosing Period|Withdrawal by Subject|2|||
16120549|NCT02628028|38927185|FG005|Dosing Period|Withdrawal by Subject|4|||
16120550|NCT02628028|38927186|FG006|Dosing Period|Withdrawal by Subject|1|||
16120551|NCT02628028|38927187|FG007|Dosing Period|Withdrawal by Subject|1|||
16120552|NCT02628028|38927180|FG000|Dosing Period|Adverse Event|0|||
16120553|NCT02628028|38927181|FG001|Dosing Period|Adverse Event|0|||
16120554|NCT02628028|38927182|FG002|Dosing Period|Adverse Event|0|||
16120555|NCT02628028|38927183|FG003|Dosing Period|Adverse Event|0|||
16120556|NCT02628028|38927184|FG004|Dosing Period|Adverse Event|2|||
16120557|NCT02628028|38927185|FG005|Dosing Period|Adverse Event|1|||
16120558|NCT02628028|38927186|FG006|Dosing Period|Adverse Event|3|||
16120559|NCT02628028|38927187|FG007|Dosing Period|Adverse Event|2|||
16120560|NCT02628028|38927180|FG000|Dosing Period|Death|0|||
16120561|NCT02628028|38927181|FG001|Dosing Period|Death|0|||
16120562|NCT02628028|38927182|FG002|Dosing Period|Death|0|||
16233842|NCT00151775|39338353|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16233843|NCT00151775|39338354|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16233844|NCT00151775|39338355|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
16233845|NCT00151775|39338344|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
16233846|NCT00151775|39338345|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16120563|NCT02628028|38927183|FG003|Dosing Period|Death|0|||
16120564|NCT02628028|38927184|FG004|Dosing Period|Death|0|||
16120565|NCT02628028|38927185|FG005|Dosing Period|Death|0|||
16120566|NCT02628028|38927186|FG006|Dosing Period|Death|0|||
16120567|NCT02628028|38927187|FG007|Dosing Period|Death|1|||
16120568|NCT02628028|38927180|FG000|Dosing Period|Lack of Efficacy|0|||
16120569|NCT02628028|38927181|FG001|Dosing Period|Lack of Efficacy|0|||
16120570|NCT02628028|38927182|FG002|Dosing Period|Lack of Efficacy|0|||
16120571|NCT02628028|38927183|FG003|Dosing Period|Lack of Efficacy|0|||
16233847|NCT00151775|39338346|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16233848|NCT00151775|39338347|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16233849|NCT00151775|39338348|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16233850|NCT00151775|39338349|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16233851|NCT00151775|39338350|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
16233852|NCT00151775|39338351|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16233853|NCT00151775|39338352|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16233854|NCT00151775|39338353|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16233855|NCT00151775|39338354|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
16233856|NCT00151775|39338355|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
16233857|NCT00151775|39338344|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16233858|NCT00151775|39338345|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
16233859|NCT00151775|39338346|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16553154|NCT02748694|40488468|FG008|Overall Study|Voluntary Withdrawal|0|||
16553155|NCT02748694|40488469|FG009|Overall Study|Voluntary Withdrawal|0|||
16553156|NCT02748694|40488470|FG010|Overall Study|Voluntary Withdrawal|0|||
16553157|NCT02748694|40488471|FG011|Overall Study|Voluntary Withdrawal|0|||
16553158|NCT02748694|40488472|FG012|Overall Study|Voluntary Withdrawal|0|||
16553159|NCT02748694|40488473|FG013|Overall Study|Voluntary Withdrawal|0|||
16553160|NCT02748694|40488474|FG014|Overall Study|Voluntary Withdrawal|2|||
16553161|NCT00245856|40488475|FG000|Period Two|Withdrawal by Subject|0|||
16553162|NCT00245856|40488476|FG001|Period Two|Withdrawal by Subject|1|||
16553163|NCT00402337|40488479|FG000|Overall Study|Adverse Event|0|||
16553164|NCT00402337|40488480|FG001|Overall Study|Adverse Event|2|||
16553165|NCT00402337|40488481|FG002|Overall Study|Adverse Event|2|||
16553166|NCT00402337|40488482|FG003|Overall Study|Adverse Event|3|||
16553167|NCT00402337|40488483|FG004|Overall Study|Adverse Event|2|||
16553168|NCT00402337|40488479|FG000|Overall Study|Noncompliance|0|||
16553169|NCT00402337|40488480|FG001|Overall Study|Noncompliance|0|||
16553170|NCT00402337|40488481|FG002|Overall Study|Noncompliance|0|||
16553171|NCT00402337|40488482|FG003|Overall Study|Noncompliance|0|||
16553172|NCT00402337|40488483|FG004|Overall Study|Noncompliance|2|||
16233860|NCT00151775|39338347|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16233861|NCT00151775|39338348|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16233862|NCT00151775|39338349|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16233863|NCT00151775|39338350|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16233864|NCT00151775|39338351|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16233865|NCT00151775|39338352|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16233866|NCT00151775|39338353|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16233867|NCT00151775|39338354|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16233868|NCT00151775|39338355|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
16233869|NCT00151775|39338344|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
16233870|NCT00151775|39338345|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
16233871|NCT00151775|39338346|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
16233872|NCT00151775|39338347|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
16233873|NCT00151775|39338348|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
16233874|NCT00151775|39338349|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
16233875|NCT00151775|39338350|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
16233876|NCT00151775|39338351|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
16233877|NCT00151775|39338352|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
16233878|NCT00151775|39338353|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
16233879|NCT00151775|39338354|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
16233880|NCT00151775|39338355|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
16233881|NCT00151775|39338344|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233882|NCT00151775|39338345|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233883|NCT00151775|39338346|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233884|NCT00151775|39338347|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233885|NCT00151775|39338348|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233886|NCT00151775|39338349|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
16233887|NCT00151775|39338350|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233888|NCT00151775|39338351|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233889|NCT00151775|39338352|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233890|NCT00151775|39338353|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233891|NCT00151775|39338354|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233892|NCT00151775|39338355|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
16233893|NCT00151775|39338344|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16553173|NCT00402337|40488479|FG000|Overall Study|Withdrawal by Subject|5|||
16553174|NCT00402337|40488480|FG001|Overall Study|Withdrawal by Subject|3|||
16553175|NCT00402337|40488481|FG002|Overall Study|Withdrawal by Subject|1|||
16553176|NCT00402337|40488482|FG003|Overall Study|Withdrawal by Subject|6|||
16233894|NCT00151775|39338345|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16233895|NCT00151775|39338346|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16233896|NCT00151775|39338347|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16233897|NCT00151775|39338348|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16233898|NCT00151775|39338349|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
16233899|NCT00151775|39338350|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16233900|NCT00151775|39338351|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16233901|NCT00151775|39338352|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16233902|NCT00151775|39338353|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16233903|NCT00151775|39338354|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16233904|NCT00151775|39338355|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
16233905|NCT00151775|39338344|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233906|NCT00151775|39338345|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233907|NCT00151775|39338346|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233908|NCT00151775|39338347|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233909|NCT00151775|39338348|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233910|NCT00151775|39338349|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233911|NCT00151775|39338350|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
16233912|NCT00151775|39338351|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233913|NCT00151775|39338352|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233914|NCT00151775|39338353|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233915|NCT00151775|39338354|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233916|NCT00151775|39338355|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
16233917|NCT00151775|39338344|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233918|NCT00151775|39338345|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233919|NCT00151775|39338346|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233920|NCT00151775|39338347|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233921|NCT00151775|39338348|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233922|NCT00151775|39338349|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
16233923|NCT00151775|39338350|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233924|NCT00151775|39338351|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233925|NCT00151775|39338352|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233926|NCT00151775|39338353|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233927|NCT00151775|39338354|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233928|NCT00151775|39338355|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
16233929|NCT00151775|39338344|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
16233930|NCT00151775|39338345|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
16553177|NCT00402337|40488483|FG004|Overall Study|Withdrawal by Subject|4|||
16553178|NCT00402337|40488479|FG000|Overall Study|Lost to Follow-up|0|||
16553179|NCT00402337|40488480|FG001|Overall Study|Lost to Follow-up|0|||
16553180|NCT00402337|40488481|FG002|Overall Study|Lost to Follow-up|1|||
16553181|NCT00402337|40488482|FG003|Overall Study|Lost to Follow-up|2|||
16553182|NCT00402337|40488483|FG004|Overall Study|Lost to Follow-up|0|||
16233931|NCT00151775|39338346|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
16233932|NCT00151775|39338347|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
16233933|NCT00151775|39338348|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
16233934|NCT00151775|39338349|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
16233935|NCT00151775|39338350|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
16233936|NCT00151775|39338351|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
16233937|NCT00151775|39338352|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
16233938|NCT00151775|39338353|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
16553183|NCT00402337|40488479|FG000|Overall Study|Physician Decision|0|||
16553184|NCT00402337|40488480|FG001|Overall Study|Physician Decision|0|||
16553185|NCT00402337|40488481|FG002|Overall Study|Physician Decision|0|||
16553186|NCT00402337|40488482|FG003|Overall Study|Physician Decision|1|||
16553187|NCT00402337|40488483|FG004|Overall Study|Physician Decision|0|||
16553188|NCT00402337|40488479|FG000|Overall Study|Other Reason|0|||
16553189|NCT00402337|40488480|FG001|Overall Study|Other Reason|1|||
16553190|NCT00402337|40488481|FG002|Overall Study|Other Reason|0|||
16553191|NCT00402337|40488482|FG003|Overall Study|Other Reason|0|||
16233939|NCT00151775|39338354|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
16233940|NCT00151775|39338355|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
16233941|NCT00151775|39338344|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233942|NCT00151775|39338345|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233943|NCT00151775|39338346|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233944|NCT00151775|39338347|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233945|NCT00151775|39338348|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233946|NCT00151775|39338349|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233947|NCT00151775|39338350|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
16233948|NCT00151775|39338351|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233949|NCT00151775|39338352|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233950|NCT00151775|39338353|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233951|NCT00151775|39338354|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233952|NCT00151775|39338355|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
16233953|NCT00151775|39338344|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233954|NCT00151775|39338345|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233955|NCT00151775|39338346|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
16233956|NCT00151775|39338347|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233957|NCT00151775|39338348|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233958|NCT00151775|39338349|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233959|NCT00151775|39338350|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233960|NCT00151775|39338351|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233961|NCT00151775|39338352|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233962|NCT00151775|39338353|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233963|NCT00151775|39338354|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233964|NCT00151775|39338355|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
16233965|NCT00151775|39338344|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16233966|NCT00151775|39338345|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16233967|NCT00151775|39338346|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
16233968|NCT00151775|39338347|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16233969|NCT00151775|39338348|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16233970|NCT00151775|39338349|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16233971|NCT00151775|39338350|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16233972|NCT00151775|39338351|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16553192|NCT00402337|40488483|FG004|Overall Study|Other Reason|0|||
16553193|NCT00098254|40488484|FG000|Overall Study|Adverse Event|2|||
16553194|NCT00098254|40488484|FG000|Overall Study|Death|1|||
16553195|NCT02302066|40488485|FG000|Overall Study|Adverse Event|1|||
16553196|NCT02302066|40488486|FG001|Overall Study|Adverse Event|1|||
16553197|NCT02302066|40488487|FG002|Overall Study|Adverse Event|3|||
16553198|NCT02302066|40488488|FG003|Overall Study|Adverse Event|0|||
16553199|NCT02302066|40488485|FG000|Overall Study|Lost to Follow-up|4|||
16553200|NCT02302066|40488486|FG001|Overall Study|Lost to Follow-up|5|||
16553201|NCT02302066|40488487|FG002|Overall Study|Lost to Follow-up|24|||
16553202|NCT02302066|40488488|FG003|Overall Study|Lost to Follow-up|7|||
16553203|NCT02302066|40488485|FG000|Overall Study|Withdrawal by Subject|25|||
16553204|NCT02302066|40488486|FG001|Overall Study|Withdrawal by Subject|58|||
16553205|NCT02302066|40488487|FG002|Overall Study|Withdrawal by Subject|124|||
16553206|NCT02302066|40488488|FG003|Overall Study|Withdrawal by Subject|33|||
16553207|NCT02302066|40488485|FG000|Overall Study|Pregnancy|2|||
16553208|NCT02302066|40488486|FG001|Overall Study|Pregnancy|10|||
16553209|NCT02302066|40488487|FG002|Overall Study|Pregnancy|12|||
16233973|NCT00151775|39338352|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16233974|NCT00151775|39338353|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16233975|NCT00151775|39338354|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16233976|NCT00151775|39338355|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
16233977|NCT00151775|39338344|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16233978|NCT00151775|39338345|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16233979|NCT00151775|39338346|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16233980|NCT00151775|39338347|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16233981|NCT00151775|39338348|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16233982|NCT00151775|39338349|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16233983|NCT00151775|39338350|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16233984|NCT00151775|39338351|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16233985|NCT00151775|39338352|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16553210|NCT02302066|40488488|FG003|Overall Study|Pregnancy|0|||
16553211|NCT02302066|40488485|FG000|Overall Study|Reason Not Specified|1|||
16553212|NCT02302066|40488486|FG001|Overall Study|Reason Not Specified|1|||
16553213|NCT02302066|40488487|FG002|Overall Study|Reason Not Specified|9|||
16553214|NCT02302066|40488488|FG003|Overall Study|Reason Not Specified|1|||
16553215|NCT01822353|40488491|FG000|Overall Study|Adverse Event|1|||
16553216|NCT01822353|40488492|FG001|Overall Study|Adverse Event|3|||
16553217|NCT01822353|40488493|FG002|Overall Study|Adverse Event|1|||
16233986|NCT00151775|39338353|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16233987|NCT00151775|39338354|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
16233988|NCT00151775|39338355|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
16233989|NCT00151775|39338344|FG000|Period 4: Open Label|Increased blood pressure|0|||
16233990|NCT00151775|39338345|FG001|Period 4: Open Label|Increased blood pressure|0|||
16233991|NCT00151775|39338346|FG002|Period 4: Open Label|Increased blood pressure|0|||
16233992|NCT00151775|39338347|FG003|Period 4: Open Label|Increased blood pressure|0|||
16233993|NCT00151775|39338348|FG004|Period 4: Open Label|Increased blood pressure|1|||
16233994|NCT00151775|39338349|FG005|Period 4: Open Label|Increased blood pressure|0|||
16233995|NCT00151775|39338350|FG006|Period 4: Open Label|Increased blood pressure|0|||
16233996|NCT00151775|39338351|FG007|Period 4: Open Label|Increased blood pressure|0|||
16233997|NCT00151775|39338352|FG008|Period 4: Open Label|Increased blood pressure|0|||
16233998|NCT00151775|39338353|FG009|Period 4: Open Label|Increased blood pressure|1|||
16233999|NCT00151775|39338354|FG010|Period 4: Open Label|Increased blood pressure|0|||
16234000|NCT00151775|39338355|FG011|Period 4: Open Label|Increased blood pressure|0|||
16234001|NCT00151775|39338344|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
16234002|NCT00151775|39338345|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
16234003|NCT00151775|39338346|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
16234004|NCT00151775|39338347|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
16234005|NCT00151775|39338348|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
16234006|NCT00151775|39338349|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
16234007|NCT00151775|39338350|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
16234008|NCT00151775|39338351|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
16234009|NCT00151775|39338352|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
16234010|NCT00151775|39338353|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
16234011|NCT00151775|39338354|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
16234012|NCT00151775|39338355|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
16234013|NCT00151775|39338344|FG000|Period 4: Open Label|Adverse Event|0|||
16234014|NCT00151775|39338345|FG001|Period 4: Open Label|Adverse Event|0|||
16234015|NCT00151775|39338346|FG002|Period 4: Open Label|Adverse Event|0|||
16234016|NCT00151775|39338347|FG003|Period 4: Open Label|Adverse Event|0|||
16234017|NCT00151775|39338348|FG004|Period 4: Open Label|Adverse Event|1|||
16234018|NCT00151775|39338349|FG005|Period 4: Open Label|Adverse Event|0|||
16234019|NCT00151775|39338350|FG006|Period 4: Open Label|Adverse Event|0|||
16234020|NCT00151775|39338351|FG007|Period 4: Open Label|Adverse Event|0|||
16234021|NCT00151775|39338352|FG008|Period 4: Open Label|Adverse Event|0|||
16234022|NCT00151775|39338353|FG009|Period 4: Open Label|Adverse Event|2|||
16234023|NCT00151775|39338354|FG010|Period 4: Open Label|Adverse Event|0|||
16234024|NCT00151775|39338355|FG011|Period 4: Open Label|Adverse Event|0|||
16234025|NCT00151775|39338344|FG000|Period 4: Open Label|Lost to Follow-up|0|||
16234026|NCT00151775|39338345|FG001|Period 4: Open Label|Lost to Follow-up|0|||
16234027|NCT00151775|39338346|FG002|Period 4: Open Label|Lost to Follow-up|0|||
16234028|NCT00151775|39338347|FG003|Period 4: Open Label|Lost to Follow-up|0|||
16234029|NCT00151775|39338348|FG004|Period 4: Open Label|Lost to Follow-up|17|||
16234030|NCT00151775|39338349|FG005|Period 4: Open Label|Lost to Follow-up|0|||
16234031|NCT00151775|39338350|FG006|Period 4: Open Label|Lost to Follow-up|0|||
16234032|NCT00151775|39338351|FG007|Period 4: Open Label|Lost to Follow-up|0|||
16234033|NCT00151775|39338352|FG008|Period 4: Open Label|Lost to Follow-up|0|||
16553218|NCT01822353|40488491|FG000|Overall Study|Pregnancy|0|||
16553219|NCT01822353|40488492|FG001|Overall Study|Pregnancy|1|||
16553220|NCT01822353|40488493|FG002|Overall Study|Pregnancy|0|||
16234034|NCT00151775|39338353|FG009|Period 4: Open Label|Lost to Follow-up|7|||
16234035|NCT00151775|39338354|FG010|Period 4: Open Label|Lost to Follow-up|0|||
16234036|NCT00151775|39338355|FG011|Period 4: Open Label|Lost to Follow-up|0|||
16234037|NCT00151775|39338344|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
16234038|NCT00151775|39338345|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
16234039|NCT00151775|39338346|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
16234040|NCT00151775|39338347|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
16234041|NCT00151775|39338348|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
16234042|NCT00151775|39338349|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
16234043|NCT00151775|39338350|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
16234044|NCT00151775|39338351|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
16234045|NCT00151775|39338352|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
16234046|NCT00151775|39338353|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
16234047|NCT00151775|39338354|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
16234048|NCT00151775|39338355|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
16234049|NCT00151775|39338344|FG000|Period 4: Open Label|Other|0|||
16234050|NCT00151775|39338345|FG001|Period 4: Open Label|Other|0|||
16234051|NCT00151775|39338346|FG002|Period 4: Open Label|Other|0|||
16234052|NCT00151775|39338347|FG003|Period 4: Open Label|Other|0|||
16234053|NCT00151775|39338348|FG004|Period 4: Open Label|Other|1|||
16234054|NCT00151775|39338349|FG005|Period 4: Open Label|Other|0|||
16234055|NCT00151775|39338350|FG006|Period 4: Open Label|Other|0|||
16234056|NCT00151775|39338351|FG007|Period 4: Open Label|Other|0|||
16234057|NCT00151775|39338352|FG008|Period 4: Open Label|Other|0|||
16234058|NCT00151775|39338353|FG009|Period 4: Open Label|Other|3|||
16234059|NCT00151775|39338354|FG010|Period 4: Open Label|Other|0|||
16234060|NCT00151775|39338355|FG011|Period 4: Open Label|Other|0|||
16234061|NCT00151775|39338344|FG000|Period 4: Open Label|Physician Decision|0|||
16234062|NCT00151775|39338345|FG001|Period 4: Open Label|Physician Decision|0|||
16234063|NCT00151775|39338346|FG002|Period 4: Open Label|Physician Decision|0|||
16234064|NCT00151775|39338347|FG003|Period 4: Open Label|Physician Decision|0|||
16234065|NCT00151775|39338348|FG004|Period 4: Open Label|Physician Decision|0|||
16234066|NCT00151775|39338349|FG005|Period 4: Open Label|Physician Decision|0|||
16234067|NCT00151775|39338350|FG006|Period 4: Open Label|Physician Decision|0|||
16234068|NCT00151775|39338351|FG007|Period 4: Open Label|Physician Decision|0|||
16234069|NCT00151775|39338352|FG008|Period 4: Open Label|Physician Decision|0|||
16234070|NCT00151775|39338353|FG009|Period 4: Open Label|Physician Decision|2|||
16234071|NCT00151775|39338354|FG010|Period 4: Open Label|Physician Decision|0|||
16234072|NCT00151775|39338355|FG011|Period 4: Open Label|Physician Decision|0|||
16234073|NCT00151775|39338344|FG000|Period 4: Open Label|Protocol Violation|0|||
16234074|NCT00151775|39338345|FG001|Period 4: Open Label|Protocol Violation|0|||
16234075|NCT00151775|39338346|FG002|Period 4: Open Label|Protocol Violation|0|||
16234076|NCT00151775|39338347|FG003|Period 4: Open Label|Protocol Violation|0|||
16234077|NCT00151775|39338348|FG004|Period 4: Open Label|Protocol Violation|1|||
16234078|NCT00151775|39338349|FG005|Period 4: Open Label|Protocol Violation|0|||
16234079|NCT00151775|39338350|FG006|Period 4: Open Label|Protocol Violation|0|||
16234080|NCT00151775|39338351|FG007|Period 4: Open Label|Protocol Violation|0|||
16234081|NCT00151775|39338352|FG008|Period 4: Open Label|Protocol Violation|0|||
16234082|NCT00151775|39338353|FG009|Period 4: Open Label|Protocol Violation|0|||
16234083|NCT00151775|39338354|FG010|Period 4: Open Label|Protocol Violation|0|||
16234084|NCT00151775|39338355|FG011|Period 4: Open Label|Protocol Violation|0|||
16234085|NCT00761761|39338356|FG000|Overall Study|Lost to Follow-up|3|||
16234086|NCT00761761|39338357|FG001|Overall Study|Lost to Follow-up|1|||
16234087|NCT00761761|39338356|FG000|Overall Study|Withdrawal by Subject|3|||
16234088|NCT00761761|39338357|FG001|Overall Study|Withdrawal by Subject|0|||
16234089|NCT04362761|39341647|FG000|Part A (48 Weeks)|Adverse Event|2|||
16234090|NCT04362761|39341647|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
16234091|NCT04362761|39341647|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
16234092|NCT04362761|39341647|FG000|Part A (48 Weeks)|Other|5|||
16234093|NCT04362761|39341647|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
16234094|NCT04362761|39341647|FG000|Part B (86 Weeks)|Other|4|||
16234095|NCT01956123|39341648|FG000|COS Cycle 2|Protocol Violation|8|||
16234096|NCT01956123|39341649|FG001|COS Cycle 2|Protocol Violation|3|||
16234097|NCT01956123|39341650|FG002|COS Cycle 2|Protocol Violation|0|||
16234098|NCT01956123|39341651|FG003|COS Cycle 2|Protocol Violation|0|||
16234099|NCT01956123|39341648|FG000|COS Cycle 2|Adverse Event|3|||
16234100|NCT01956123|39341649|FG001|COS Cycle 2|Adverse Event|4|||
16234101|NCT01956123|39341650|FG002|COS Cycle 2|Adverse Event|0|||
16234102|NCT01956123|39341651|FG003|COS Cycle 2|Adverse Event|0|||
16234103|NCT01956123|39341648|FG000|COS Cycle 2|Personal Reasons|2|||
16120572|NCT02628028|38927184|FG004|Dosing Period|Lack of Efficacy|3|||
16234104|NCT01956123|39341649|FG001|COS Cycle 2|Personal Reasons|0|||
16234105|NCT01956123|39341650|FG002|COS Cycle 2|Personal Reasons|0|||
16234106|NCT01956123|39341651|FG003|COS Cycle 2|Personal Reasons|0|||
16234107|NCT01956123|39341648|FG000|COS Cycle 2|Withdrawal by Subject|1|||
16234108|NCT01956123|39341649|FG001|COS Cycle 2|Withdrawal by Subject|0|||
16234109|NCT01956123|39341650|FG002|COS Cycle 2|Withdrawal by Subject|0|||
16234110|NCT01956123|39341651|FG003|COS Cycle 2|Withdrawal by Subject|0|||
16234111|NCT01956123|39341648|FG000|COS Cycle 3|Protocol Violation|0|||
16234112|NCT01956123|39341649|FG001|COS Cycle 3|Protocol Violation|0|||
16234113|NCT01956123|39341650|FG002|COS Cycle 3|Protocol Violation|2|||
16234114|NCT01956123|39341651|FG003|COS Cycle 3|Protocol Violation|1|||
16234115|NCT01956123|39341648|FG000|COS Cycle 3|Adverse Event|0|||
16234116|NCT01956123|39341649|FG001|COS Cycle 3|Adverse Event|0|||
16234117|NCT01956123|39341650|FG002|COS Cycle 3|Adverse Event|3|||
16234118|NCT01956123|39341651|FG003|COS Cycle 3|Adverse Event|0|||
16234119|NCT01956123|39341648|FG000|COS Cycle 3|Personal Reasons|0|||
16234120|NCT01956123|39341649|FG001|COS Cycle 3|Personal Reasons|0|||
16234121|NCT01956123|39341650|FG002|COS Cycle 3|Personal Reasons|1|||
16234122|NCT01956123|39341651|FG003|COS Cycle 3|Personal Reasons|0|||
16234123|NCT01956123|39341648|FG000|COS Cycle 3|Withdrawal by Subject|0|||
16234124|NCT01956123|39341649|FG001|COS Cycle 3|Withdrawal by Subject|0|||
16234125|NCT01956123|39341650|FG002|COS Cycle 3|Withdrawal by Subject|0|||
16234126|NCT01956123|39341651|FG003|COS Cycle 3|Withdrawal by Subject|1|||
16234127|NCT01308762|39341652|FG000|Overall Study|Protocol Violation|0|||
16234128|NCT01308762|39341653|FG001|Overall Study|Protocol Violation|1|||
16234129|NCT01308762|39341654|FG002|Overall Study|Protocol Violation|0|||
16234130|NCT03022799|39341655|FG000|Overall Study|Adverse Event|0|||
16234131|NCT03022799|39341656|FG001|Overall Study|Adverse Event|0|||
16234132|NCT03022799|39341657|FG002|Overall Study|Adverse Event|0|||
16234133|NCT03022799|39341658|FG003|Overall Study|Adverse Event|0|||
16234134|NCT03022799|39341659|FG004|Overall Study|Adverse Event|0|||
16234135|NCT03022799|39341660|FG005|Overall Study|Adverse Event|0|||
16234136|NCT03022799|39341661|FG006|Overall Study|Adverse Event|0|||
16234137|NCT03022799|39341662|FG007|Overall Study|Adverse Event|0|||
16234138|NCT03022799|39341663|FG008|Overall Study|Adverse Event|0|||
16234139|NCT03022799|39341664|FG009|Overall Study|Adverse Event|1|||
16234140|NCT03022799|39341665|FG010|Overall Study|Adverse Event|1|||
16234141|NCT03022799|39341666|FG011|Overall Study|Adverse Event|0|||
16234142|NCT03022799|39341667|FG012|Overall Study|Adverse Event|0|||
16234143|NCT00131937|39341668|FG000|Overall Study|Adverse Event|3|||
16234144|NCT00131937|39341668|FG000|Overall Study|Withdrawal by Subject|2|||
16234145|NCT00131937|39341668|FG000|Overall Study|Physician Decision|1|||
16234146|NCT00131937|39341668|FG000|Overall Study|Disease Progression|7|||
16234147|NCT00131937|39341668|FG000|Overall Study|Alternative therapy|1|||
16234148|NCT04057118|39341674|FG000|Overall Study|Adverse Event|1|||
16234149|NCT04057118|39341675|FG001|Overall Study|Adverse Event|0|||
16234150|NCT04057118|39341676|FG002|Overall Study|Adverse Event|1|||
16234151|NCT04057118|39341677|FG003|Overall Study|Adverse Event|1|||
16234152|NCT04057118|39341674|FG000|Overall Study|Physician Decision|0|||
16234153|NCT04057118|39341675|FG001|Overall Study|Physician Decision|0|||
16234154|NCT04057118|39341676|FG002|Overall Study|Physician Decision|1|||
16234155|NCT04057118|39341677|FG003|Overall Study|Physician Decision|1|||
16553221|NCT01822353|40488491|FG000|Overall Study|Withdrawal by Subject|3|||
16553222|NCT01822353|40488492|FG001|Overall Study|Withdrawal by Subject|1|||
16553223|NCT01822353|40488493|FG002|Overall Study|Withdrawal by Subject|0|||
16553224|NCT00932646|40488503|FG000|Overall Study|Adverse Event|2|||
16553225|NCT00932646|40488504|FG001|Overall Study|Adverse Event|1|||
16553226|NCT00932646|40488505|FG002|Overall Study|Adverse Event|1|||
16553227|NCT00932646|40488506|FG003|Overall Study|Adverse Event|1|||
16553228|NCT00932646|40488503|FG000|Overall Study|Lost to Follow-up|2|||
16553229|NCT00932646|40488504|FG001|Overall Study|Lost to Follow-up|1|||
16553230|NCT00932646|40488505|FG002|Overall Study|Lost to Follow-up|0|||
16553231|NCT00932646|40488506|FG003|Overall Study|Lost to Follow-up|0|||
16553232|NCT00932646|40488503|FG000|Overall Study|Withdrawal by Subject|1|||
16553233|NCT00932646|40488504|FG001|Overall Study|Withdrawal by Subject|1|||
16553234|NCT00932646|40488505|FG002|Overall Study|Withdrawal by Subject|3|||
16553235|NCT00932646|40488506|FG003|Overall Study|Withdrawal by Subject|0|||
16553236|NCT02036515|40488511|FG000|Overall Study|Adverse Event|1|||
16553237|NCT02036515|40488512|FG001|Overall Study|Adverse Event|1|||
16553238|NCT02036515|40488513|FG002|Overall Study|Adverse Event|2|||
16553239|NCT02036515|40488511|FG000|Overall Study|Lost to Follow-up|0|||
16120573|NCT02628028|38927185|FG005|Dosing Period|Lack of Efficacy|0|||
16120574|NCT02628028|38927186|FG006|Dosing Period|Lack of Efficacy|1|||
16234156|NCT04057118|39341674|FG000|Overall Study|Withdrawal by Subject|2|||
16234157|NCT04057118|39341675|FG001|Overall Study|Withdrawal by Subject|2|||
16234158|NCT04057118|39341676|FG002|Overall Study|Withdrawal by Subject|0|||
16234159|NCT04057118|39341677|FG003|Overall Study|Withdrawal by Subject|2|||
16234160|NCT04057118|39341674|FG000|Overall Study|Not Specific|0|||
16234161|NCT04057118|39341675|FG001|Overall Study|Not Specific|0|||
16234162|NCT04057118|39341676|FG002|Overall Study|Not Specific|1|||
16234163|NCT04057118|39341677|FG003|Overall Study|Not Specific|1|||
16234164|NCT00358670|39341680|FG000|Overall Study|Adverse Event|26|||
16553240|NCT02036515|40488512|FG001|Overall Study|Lost to Follow-up|2|||
16553241|NCT02036515|40488513|FG002|Overall Study|Lost to Follow-up|0|||
16553242|NCT02036515|40488511|FG000|Overall Study|Non-compliance with study drug|0|||
16553243|NCT02036515|40488512|FG001|Overall Study|Non-compliance with study drug|0|||
16553244|NCT02036515|40488513|FG002|Overall Study|Non-compliance with study drug|2|||
16553245|NCT02036515|40488511|FG000|Overall Study|Screen failure|0|||
16553246|NCT02036515|40488512|FG001|Overall Study|Screen failure|2|||
16553247|NCT02036515|40488513|FG002|Overall Study|Screen failure|0|||
16553248|NCT02036515|40488511|FG000|Overall Study|Withdrawal by Subject|4|||
16553249|NCT02036515|40488512|FG001|Overall Study|Withdrawal by Subject|7|||
16553250|NCT02036515|40488513|FG002|Overall Study|Withdrawal by Subject|9|||
16553251|NCT02036515|40488511|FG000|Overall Study|Hyperglycemia|0|||
16553252|NCT02036515|40488512|FG001|Overall Study|Hyperglycemia|0|||
16553253|NCT02036515|40488513|FG002|Overall Study|Hyperglycemia|1|||
16553254|NCT02049710|40488514|FG000|Overall Study|Lost to Follow-up|319|||
16553255|NCT02049710|40488515|FG001|Overall Study|Lost to Follow-up|324|||
16553256|NCT04076020|40488516|FG000|Overall Study|Death|4|||
16553257|NCT04076020|40488517|FG001|Overall Study|Death|6|||
16553258|NCT04076020|40488516|FG000|Overall Study|Withdrawal by Subject|12|||
16553259|NCT04076020|40488517|FG001|Overall Study|Withdrawal by Subject|8|||
16553260|NCT01992549|40488518|FG000|Overall Study|Lost to Follow-up|2|||
16553261|NCT01992549|40488518|FG000|Overall Study|Serious Adverse Event|1|||
16553262|NCT01992549|40488518|FG000|Overall Study|Product Switch to Extend Half Life|1|||
16553263|NCT00244374|40488519|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
16553264|NCT00244374|40488520|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
16553265|NCT00244374|40488521|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
16553266|NCT00244374|40488522|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
16553267|NCT00244374|40488523|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
16553268|NCT00244374|40488519|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
16553269|NCT00244374|40488520|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
16553270|NCT00244374|40488521|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
16120575|NCT02628028|38927187|FG007|Dosing Period|Lack of Efficacy|0|||
16120576|NCT02628028|38927180|FG000|Dosing Period|Study Terminated by Sponsor|0|||
16120577|NCT02628028|38927181|FG001|Dosing Period|Study Terminated by Sponsor|0|||
16120578|NCT02628028|38927182|FG002|Dosing Period|Study Terminated by Sponsor|0|||
16120579|NCT02628028|38927183|FG003|Dosing Period|Study Terminated by Sponsor|0|||
16120580|NCT02628028|38927184|FG004|Dosing Period|Study Terminated by Sponsor|7|||
16120581|NCT02628028|38927185|FG005|Dosing Period|Study Terminated by Sponsor|6|||
16120582|NCT02628028|38927186|FG006|Dosing Period|Study Terminated by Sponsor|7|||
16120583|NCT02628028|38927187|FG007|Dosing Period|Study Terminated by Sponsor|7|||
16120584|NCT02628028|38927180|FG000|Dosing Period|Physician Decision|0|||
16120585|NCT02628028|38927181|FG001|Dosing Period|Physician Decision|0|||
16120586|NCT02628028|38927182|FG002|Dosing Period|Physician Decision|0|||
16120587|NCT02628028|38927183|FG003|Dosing Period|Physician Decision|0|||
16120588|NCT02628028|38927184|FG004|Dosing Period|Physician Decision|0|||
16120589|NCT02628028|38927185|FG005|Dosing Period|Physician Decision|1|||
16120590|NCT02628028|38927186|FG006|Dosing Period|Physician Decision|0|||
16120591|NCT02628028|38927187|FG007|Dosing Period|Physician Decision|0|||
16120592|NCT02628028|38927180|FG000|Dosing Period|Site Terminated by Sponsor|0|||
16120593|NCT02628028|38927181|FG001|Dosing Period|Site Terminated by Sponsor|0|||
16234165|NCT00358670|39341681|FG001|Overall Study|Adverse Event|29|||
16234166|NCT00358670|39341680|FG000|Overall Study|Lack of Efficacy|20|||
16348743|NCT02718911|39765486|FG009|Overall Study|Lost to Follow-up|0|||
16553271|NCT00244374|40488522|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
16553272|NCT00244374|40488523|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
16553273|NCT00244374|40488519|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
16120594|NCT02628028|38927182|FG002|Dosing Period|Site Terminated by Sponsor|0|||
16120595|NCT02628028|38927183|FG003|Dosing Period|Site Terminated by Sponsor|0|||
16120596|NCT02628028|38927184|FG004|Dosing Period|Site Terminated by Sponsor|0|||
16120597|NCT02628028|38927185|FG005|Dosing Period|Site Terminated by Sponsor|1|||
16120598|NCT02628028|38927186|FG006|Dosing Period|Site Terminated by Sponsor|1|||
16234167|NCT00358670|39341681|FG001|Overall Study|Lack of Efficacy|23|||
16553274|NCT00244374|40488520|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
16553275|NCT00244374|40488521|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
16553276|NCT00244374|40488522|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
16234168|NCT00358670|39341680|FG000|Overall Study|Protocol Violation|6|||
16234169|NCT00358670|39341681|FG001|Overall Study|Protocol Violation|9|||
16234170|NCT00358670|39341680|FG000|Overall Study|Lost to Follow-up|4|||
16234171|NCT00358670|39341681|FG001|Overall Study|Lost to Follow-up|5|||
16234172|NCT00358670|39341680|FG000|Overall Study|Withdrawal by Subject|13|||
16234173|NCT00358670|39341681|FG001|Overall Study|Withdrawal by Subject|24|||
16234174|NCT00358670|39341680|FG000|Overall Study|Protocol Defined Clinical Event|0|||
16234175|NCT00358670|39341681|FG001|Overall Study|Protocol Defined Clinical Event|1|||
16234176|NCT00358670|39341680|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
16234177|NCT00358670|39341681|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
16234178|NCT00358670|39341680|FG000|Overall Study|Administrative|153|||
16234179|NCT00358670|39341681|FG001|Overall Study|Administrative|125|||
16234180|NCT00396318|39341682|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
16234181|NCT00359073|39341683|FG000|Overall Study|Withdrawal by Subject|1|||
16234182|NCT00359073|39341684|FG001|Overall Study|Withdrawal by Subject|1|||
16234183|NCT00359073|39341683|FG000|Overall Study|Eligibility criteria no longer met|3|||
16234184|NCT00359073|39341684|FG001|Overall Study|Eligibility criteria no longer met|0|||
16234185|NCT00359073|39341683|FG000|Overall Study|developed RV16 antibody|0|||
16234186|NCT00359073|39341684|FG001|Overall Study|developed RV16 antibody|1|||
16234187|NCT01569594|39341685|FG000|Overall Study|Physician Decision|4|||
16348744|NCT02718911|39765477|FG000|Overall Study|Physician Decision|2|||
16348745|NCT02718911|39765478|FG001|Overall Study|Physician Decision|0|||
16348746|NCT02718911|39765479|FG002|Overall Study|Physician Decision|1|||
16348747|NCT02718911|39765480|FG003|Overall Study|Physician Decision|1|||
16348748|NCT02718911|39765481|FG004|Overall Study|Physician Decision|0|||
16348749|NCT02718911|39765482|FG005|Overall Study|Physician Decision|0|||
16348750|NCT02718911|39765483|FG006|Overall Study|Physician Decision|0|||
16348751|NCT02718911|39765484|FG007|Overall Study|Physician Decision|1|||
16348752|NCT02718911|39765485|FG008|Overall Study|Physician Decision|2|||
16348753|NCT02718911|39765486|FG009|Overall Study|Physician Decision|1|||
16348754|NCT02718911|39765477|FG000|Overall Study|Withdrawal by Subject|0|||
16348755|NCT02718911|39765478|FG001|Overall Study|Withdrawal by Subject|0|||
16348756|NCT02718911|39765479|FG002|Overall Study|Withdrawal by Subject|0|||
16348757|NCT02718911|39765480|FG003|Overall Study|Withdrawal by Subject|0|||
16348758|NCT02718911|39765481|FG004|Overall Study|Withdrawal by Subject|1|||
16348759|NCT02718911|39765482|FG005|Overall Study|Withdrawal by Subject|0|||
16348760|NCT02718911|39765483|FG006|Overall Study|Withdrawal by Subject|0|||
16348761|NCT02718911|39765484|FG007|Overall Study|Withdrawal by Subject|0|||
16348762|NCT02718911|39765485|FG008|Overall Study|Withdrawal by Subject|1|||
16348763|NCT02718911|39765486|FG009|Overall Study|Withdrawal by Subject|4|||
16348764|NCT02718911|39765477|FG000|Overall Study|Reason Not Collected|0|||
16348765|NCT02718911|39765478|FG001|Overall Study|Reason Not Collected|0|||
16348766|NCT02718911|39765479|FG002|Overall Study|Reason Not Collected|1|||
16348767|NCT02718911|39765480|FG003|Overall Study|Reason Not Collected|0|||
16348768|NCT02718911|39765481|FG004|Overall Study|Reason Not Collected|0|||
16348769|NCT02718911|39765482|FG005|Overall Study|Reason Not Collected|0|||
16348770|NCT02718911|39765483|FG006|Overall Study|Reason Not Collected|2|||
16348771|NCT02718911|39765484|FG007|Overall Study|Reason Not Collected|1|||
16348772|NCT02718911|39765485|FG008|Overall Study|Reason Not Collected|4|||
16348773|NCT02718911|39765486|FG009|Overall Study|Reason Not Collected|9|||
16348774|NCT02688933|39765490|FG000|Overall Study|Adverse Event|3|||
16348775|NCT02688933|39765491|FG001|Overall Study|Adverse Event|1|||
16348776|NCT02688933|39765490|FG000|Overall Study|Lack of Efficacy|2|||
16348777|NCT02688933|39765491|FG001|Overall Study|Lack of Efficacy|2|||
16348778|NCT02688933|39765490|FG000|Overall Study|Poor compliance to protocol|7|||
16348779|NCT02688933|39765491|FG001|Overall Study|Poor compliance to protocol|4|||
16553277|NCT00244374|40488523|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
16553278|NCT00244374|40488519|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
16553279|NCT00244374|40488520|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
16553280|NCT00244374|40488521|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
16553281|NCT00244374|40488522|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
16553282|NCT00244374|40488523|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
16553283|NCT00244374|40488519|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
16553284|NCT00244374|40488520|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
16553285|NCT00244374|40488521|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
16553286|NCT00244374|40488522|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
16234188|NCT01569594|39341685|FG000|Overall Study|Death|13|||
16234189|NCT01569594|39341685|FG000|Overall Study|Lost to Follow-up|22|||
16348780|NCT02688933|39765490|FG000|Overall Study|Hypoglycemia|2|||
16348781|NCT02688933|39765491|FG001|Overall Study|Hypoglycemia|0|||
16348782|NCT02688933|39765490|FG000|Overall Study|Other than Specified|14|||
16348783|NCT02688933|39765491|FG001|Overall Study|Other than Specified|25|||
16553287|NCT00244374|40488523|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
16553288|NCT00244374|40488519|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
16553289|NCT00244374|40488520|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
16553290|NCT00244374|40488521|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
16553291|NCT00244374|40488522|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
16120599|NCT02628028|38927187|FG007|Dosing Period|Site Terminated by Sponsor|0|||
16120600|NCT02628028|38927180|FG000|Dosing Period|Lost to Follow-up|0|||
16120601|NCT02628028|38927181|FG001|Dosing Period|Lost to Follow-up|0|||
16120602|NCT02628028|38927182|FG002|Dosing Period|Lost to Follow-up|0|||
16120603|NCT02628028|38927183|FG003|Dosing Period|Lost to Follow-up|0|||
16120604|NCT02628028|38927184|FG004|Dosing Period|Lost to Follow-up|0|||
16120605|NCT02628028|38927185|FG005|Dosing Period|Lost to Follow-up|0|||
16120606|NCT02628028|38927186|FG006|Dosing Period|Lost to Follow-up|1|||
16120607|NCT02628028|38927187|FG007|Dosing Period|Lost to Follow-up|0|||
16120608|NCT02628028|38927180|FG000|Dosing Period|Other|0|||
16120609|NCT02628028|38927181|FG001|Dosing Period|Other|0|||
16120610|NCT02628028|38927182|FG002|Dosing Period|Other|0|||
16120611|NCT02628028|38927183|FG003|Dosing Period|Other|0|||
16120612|NCT02628028|38927184|FG004|Dosing Period|Other|2|||
16234190|NCT01569594|39341685|FG000|Overall Study|Adverse Event|2|||
16234191|NCT01569594|39341685|FG000|Overall Study|Withdrawal by Subject|13|||
16234192|NCT01569594|39341685|FG000|Overall Study|Other|4|||
16234193|NCT01569594|39341685|FG000|Overall Study|No ECM used|9|||
16234194|NCT02918318|39341689|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
16234195|NCT02918318|39341690|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
16120613|NCT02628028|38927185|FG005|Dosing Period|Other|1|||
16120614|NCT02628028|38927186|FG006|Dosing Period|Other|2|||
16234196|NCT02918318|39341691|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
16120615|NCT02628028|38927187|FG007|Dosing Period|Other|4|||
16120616|NCT02628028|38927180|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
16120617|NCT02628028|38927181|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
16348784|NCT02688933|39765490|FG000|Overall Study|Lost to Follow-up|1|||
16120618|NCT02628028|38927182|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
16120619|NCT02628028|38927183|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
16120620|NCT02628028|38927184|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
16120621|NCT02628028|38927185|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
16120622|NCT02628028|38927186|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
16120623|NCT02628028|38927187|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
16120624|NCT02628028|38927180|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
16120625|NCT02628028|38927181|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
16120626|NCT02628028|38927182|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
16120627|NCT02628028|38927183|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
16120628|NCT02628028|38927184|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
16120629|NCT02628028|38927185|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
16120630|NCT02628028|38927186|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
16120631|NCT02628028|38927187|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
16120632|NCT02628028|38927180|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
16120633|NCT02628028|38927181|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
16120634|NCT02628028|38927182|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
16120635|NCT02628028|38927183|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
16120636|NCT02628028|38927184|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
16120637|NCT02628028|38927185|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
16120638|NCT02628028|38927186|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
16120639|NCT02628028|38927187|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
16120640|NCT02628028|38927180|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
16120641|NCT02628028|38927181|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
16120642|NCT02628028|38927182|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
16120643|NCT02628028|38927183|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
16120644|NCT02628028|38927184|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
16120645|NCT02628028|38927185|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
16120646|NCT02628028|38927186|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
16120647|NCT02628028|38927187|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
16120648|NCT02628028|38927180|FG000|Long-term Extension (LTE) Period|Other|0|||
16120649|NCT02628028|38927181|FG001|Long-term Extension (LTE) Period|Other|0|||
16120650|NCT02628028|38927182|FG002|Long-term Extension (LTE) Period|Other|0|||
16120651|NCT02628028|38927183|FG003|Long-term Extension (LTE) Period|Other|0|||
16120652|NCT02628028|38927184|FG004|Long-term Extension (LTE) Period|Other|0|||
16120653|NCT02628028|38927185|FG005|Long-term Extension (LTE) Period|Other|3|||
16120654|NCT02628028|38927186|FG006|Long-term Extension (LTE) Period|Other|4|||
16120655|NCT02628028|38927187|FG007|Long-term Extension (LTE) Period|Other|3|||
16120656|NCT00324116|38927199|FG000|Overall Study|Adverse Event|5|||
16120657|NCT00324116|38927199|FG000|Overall Study|Lack of Efficacy|17|||
16120658|NCT00324116|38927199|FG000|Overall Study|Withdrawal by Subject|5|||
16120659|NCT00324116|38927199|FG000|Overall Study|Other|5|||
16348785|NCT02688933|39765491|FG001|Overall Study|Lost to Follow-up|5|||
16553292|NCT00244374|40488523|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
16553293|NCT00244374|40488519|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
16553294|NCT00244374|40488520|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
16553295|NCT00244374|40488521|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
16553296|NCT00244374|40488522|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
16553297|NCT00244374|40488523|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
16553298|NCT00244374|40488519|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
16553299|NCT00244374|40488520|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
16553300|NCT00244374|40488521|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
16553301|NCT00244374|40488522|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
16553302|NCT00244374|40488523|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
16553303|NCT00244374|40488519|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
16120660|NCT01495598|38927201|FG000|Overall Study|Death during follow up period|2|||
16120661|NCT01495598|38927201|FG000|Overall Study|Death on study|1|||
16120662|NCT01495598|38927201|FG000|Overall Study|Lost to Follow-up|3|||
16120663|NCT01495598|38927201|FG000|Overall Study|Physician Decision|8|||
16120664|NCT00780559|38927203|FG000|Overall Study|Lost to Follow-up|2|||
16120665|NCT00780559|38927204|FG001|Overall Study|Lost to Follow-up|7|||
16120666|NCT00780559|38927203|FG000|Overall Study|Death|1|||
16120667|NCT00780559|38927204|FG001|Overall Study|Death|0|||
16120668|NCT03653208|38927207|FG000|Overall Study|Withdrawal by Subject|0|||
16120669|NCT03653208|38927208|FG001|Overall Study|Withdrawal by Subject|0|||
16120670|NCT03653208|38927209|FG002|Overall Study|Withdrawal by Subject|0|||
16120671|NCT03653208|38927210|FG003|Overall Study|Withdrawal by Subject|0|||
16120672|NCT03653208|38927211|FG004|Overall Study|Withdrawal by Subject|1|||
16553304|NCT00244374|40488520|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
16553305|NCT00244374|40488521|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
16120673|NCT03653208|38927212|FG005|Overall Study|Withdrawal by Subject|0|||
16120674|NCT03653208|38927213|FG006|Overall Study|Withdrawal by Subject|0|||
16120675|NCT03653208|38927214|FG007|Overall Study|Withdrawal by Subject|1|||
16120676|NCT03653208|38927215|FG008|Overall Study|Withdrawal by Subject|1|||
16120677|NCT02269423|38927216|FG000|Overall Study|Discontinued due to change in residence|0|||
16120678|NCT02269423|38927217|FG001|Overall Study|Discontinued due to change in residence|1|||
16120679|NCT02269423|38927218|FG002|Overall Study|Discontinued due to change in residence|0|||
16120680|NCT02269423|38927219|FG003|Overall Study|Discontinued due to change in residence|1|||
16120681|NCT02546921|38927227|FG000|Overall Study|Adverse Event|0|||
16120682|NCT02546921|38927228|FG001|Overall Study|Adverse Event|5|||
16120683|NCT02546921|38927229|FG002|Overall Study|Adverse Event|2|||
16120684|NCT02546921|38927230|FG003|Overall Study|Adverse Event|0|||
16120685|NCT02546921|38927231|FG004|Overall Study|Adverse Event|0|||
16120686|NCT02546921|38927232|FG005|Overall Study|Adverse Event|0|||
16120687|NCT02546921|38927233|FG006|Overall Study|Adverse Event|0|||
16120688|NCT02546921|38927227|FG000|Overall Study|Evidence of Disease Progression|1|||
16120689|NCT02546921|38927228|FG001|Overall Study|Evidence of Disease Progression|0|||
16120690|NCT02546921|38927229|FG002|Overall Study|Evidence of Disease Progression|0|||
16120691|NCT02546921|38927230|FG003|Overall Study|Evidence of Disease Progression|0|||
16120692|NCT02546921|38927231|FG004|Overall Study|Evidence of Disease Progression|1|||
16120693|NCT02546921|38927232|FG005|Overall Study|Evidence of Disease Progression|0|||
16120694|NCT02546921|38927233|FG006|Overall Study|Evidence of Disease Progression|0|||
16120695|NCT02546921|38927227|FG000|Overall Study|Patient Choice|0|||
16120696|NCT02546921|38927228|FG001|Overall Study|Patient Choice|1|||
16120697|NCT02546921|38927229|FG002|Overall Study|Patient Choice|0|||
16234197|NCT02918318|39341692|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
16234198|NCT02918318|39341693|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
16234199|NCT02918318|39341689|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
16553306|NCT00244374|40488522|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
16553307|NCT00244374|40488523|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
16553308|NCT01827254|40488526|FG000|Overall Study|Death|10|||
16553309|NCT01827254|40488526|FG000|Overall Study|Case report form not completed|4|||
16553310|NCT01827254|40488526|FG000|Overall Study|Invalidated centre|3|||
16553311|NCT01827254|40488526|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
16553312|NCT01827254|40488526|FG000|Overall Study|Did not complete re-challenge|1|||
16553313|NCT01827254|40488526|FG000|Overall Study|Disease progression|36|||
16553314|NCT01827254|40488526|FG000|Overall Study|Intolerance to treatment|4|||
16120698|NCT02546921|38927230|FG003|Overall Study|Patient Choice|0|||
16120699|NCT02546921|38927231|FG004|Overall Study|Patient Choice|0|||
16120700|NCT02546921|38927232|FG005|Overall Study|Patient Choice|1|||
16120701|NCT02546921|38927233|FG006|Overall Study|Patient Choice|0|||
16120702|NCT03551691|38927236|FG000|Overall Study|Withdrawal by Subject|3|||
16120703|NCT03551691|38927237|FG001|Overall Study|Withdrawal by Subject|3|||
16120704|NCT02389452|38927242|FG000|Overall Study|Lost to Follow-up|13|||
16120705|NCT02389452|38927242|FG000|Overall Study|Adverse Event|1|||
16120706|NCT02389452|38927242|FG000|Overall Study|Withdrawal by Subject|5|||
16120707|NCT02389452|38927242|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
16120708|NCT00680992|38927243|FG000|Overall Study|Complete Resection (as per protocol)|25|||
16120709|NCT00680992|38927244|FG001|Overall Study|Complete Resection (as per protocol)|121|||
16120710|NCT00680992|38927245|FG002|Overall Study|Complete Resection (as per protocol)|0|||
16120711|NCT00680992|38927243|FG000|Overall Study|Administrative Decision|83|||
16120712|NCT00680992|38927244|FG001|Overall Study|Administrative Decision|42|||
16120713|NCT00680992|38927245|FG002|Overall Study|Administrative Decision|5|||
16120714|NCT00680992|38927243|FG000|Overall Study|End of Trial|32|||
16120715|NCT00680992|38927244|FG001|Overall Study|End of Trial|12|||
16120716|NCT00680992|38927245|FG002|Overall Study|End of Trial|3|||
16120717|NCT00680992|38927243|FG000|Overall Study|Withdrawal by Subject|33|||
16120718|NCT00680992|38927244|FG001|Overall Study|Withdrawal by Subject|11|||
16120719|NCT00680992|38927245|FG002|Overall Study|Withdrawal by Subject|1|||
16120720|NCT00680992|38927243|FG000|Overall Study|Adverse Event|21|||
16120721|NCT00680992|38927244|FG001|Overall Study|Adverse Event|19|||
16120722|NCT00680992|38927245|FG002|Overall Study|Adverse Event|1|||
16120723|NCT00680992|38927243|FG000|Overall Study|Other|19|||
16120724|NCT00680992|38927244|FG001|Overall Study|Other|14|||
16120725|NCT00680992|38927245|FG002|Overall Study|Other|1|||
16120726|NCT00680992|38927243|FG000|Overall Study|Disease Progression|21|||
16120727|NCT00680992|38927244|FG001|Overall Study|Disease Progression|9|||
16120728|NCT00680992|38927245|FG002|Overall Study|Disease Progression|0|||
16120729|NCT00680992|38927243|FG000|Overall Study|Lost to Follow-up|12|||
16120730|NCT00680992|38927244|FG001|Overall Study|Lost to Follow-up|14|||
16120731|NCT00680992|38927245|FG002|Overall Study|Lost to Follow-up|0|||
16120732|NCT00680992|38927243|FG000|Overall Study|Noncompliance|4|||
16120733|NCT00680992|38927244|FG001|Overall Study|Noncompliance|6|||
16120734|NCT00680992|38927245|FG002|Overall Study|Noncompliance|0|||
16120735|NCT00680992|38927243|FG000|Overall Study|Requirement for Alternative Therapy|8|||
16120736|NCT00680992|38927244|FG001|Overall Study|Requirement for Alternative Therapy|2|||
16120737|NCT00680992|38927245|FG002|Overall Study|Requirement for Alternative Therapy|0|||
16120738|NCT00680992|38927243|FG000|Overall Study|Pregnancy|5|||
16120739|NCT00680992|38927244|FG001|Overall Study|Pregnancy|0|||
16120740|NCT00680992|38927245|FG002|Overall Study|Pregnancy|1|||
16120741|NCT00680992|38927243|FG000|Overall Study|Death|5|||
16120742|NCT00680992|38927244|FG001|Overall Study|Death|1|||
16120743|NCT00680992|38927245|FG002|Overall Study|Death|0|||
16120744|NCT00680992|38927243|FG000|Overall Study|Ineligibility Determined|0|||
16120745|NCT00680992|38927244|FG001|Overall Study|Ineligibility Determined|1|||
16120746|NCT00680992|38927245|FG002|Overall Study|Ineligibility Determined|0|||
16120747|NCT02310100|38927247|FG000|Overall Study|Physician Decision|3|||
16120748|NCT02310100|38927247|FG000|Overall Study|Withdrawal by Subject|10|||
16120749|NCT02310100|38927247|FG000|Overall Study|Enrollment closure|1|||
16120750|NCT02310100|38927247|FG000|Overall Study|Unapproved ablation operator|1|||
16120751|NCT02310100|38927247|FG000|Overall Study|Visit compliance|1|||
16120752|NCT02310100|38927247|FG000|Overall Study|Lost to Follow-up|2|||
16120753|NCT01513330|38927250|FG000|SenSura Mio First,|Adverse Event|2|||
16120754|NCT01513330|38927251|FG001|SenSura Mio First,|Adverse Event|0|||
16120755|NCT01513330|38927250|FG000|SenSura Mio First,|Lack of Efficacy|0|||
16120756|NCT01513330|38927251|FG001|SenSura Mio First,|Lack of Efficacy|1|||
16120757|NCT01513330|38927250|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
16120758|NCT01513330|38927251|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
16120759|NCT01513330|38927250|FG000|SenSura Mio First,|Other|1|||
16120760|NCT01513330|38927251|FG001|SenSura Mio First,|Other|0|||
16120761|NCT01513330|38927250|FG000|Standard Care First,|Lack of Efficacy|2|||
16120762|NCT01513330|38927251|FG001|Standard Care First,|Lack of Efficacy|2|||
16120763|NCT01513330|38927250|FG000|Standard Care First,|Withdrawal by Subject|1|||
16120764|NCT01513330|38927251|FG001|Standard Care First,|Withdrawal by Subject|2|||
16120765|NCT01513330|38927250|FG000|Standard Care First,|Other|1|||
16120766|NCT01513330|38927251|FG001|Standard Care First,|Other|0|||
16120767|NCT00863681|38927255|FG000|Overall Study|Other|2|||
16120768|NCT00863681|38927256|FG001|Overall Study|Other|0|||
16120769|NCT00863681|38927257|FG002|Overall Study|Other|0|||
16120770|NCT00863681|38927255|FG000|Overall Study|Missing|1|||
16120771|NCT00863681|38927256|FG001|Overall Study|Missing|0|||
16120772|NCT00863681|38927257|FG002|Overall Study|Missing|0|||
16120773|NCT00863681|38927255|FG000|Overall Study|Death|40|||
16120774|NCT00863681|38927256|FG001|Overall Study|Death|23|||
16120775|NCT00863681|38927257|FG002|Overall Study|Death|6|||
16120776|NCT00863681|38927255|FG000|Overall Study|Withdrawal by Subject|12|||
16120777|NCT00863681|38927256|FG001|Overall Study|Withdrawal by Subject|5|||
16120778|NCT00863681|38927257|FG002|Overall Study|Withdrawal by Subject|2|||
16120779|NCT00863681|38927255|FG000|Overall Study|Protocol Violation|2|||
16120780|NCT00863681|38927256|FG001|Overall Study|Protocol Violation|0|||
16553315|NCT02045433|40488527|FG000|Overall Study|Withdrawal by Subject|1|||
16553316|NCT00895843|40488528|FG000|Overall Study|Protocol Violation|12|||
16553317|NCT00895843|40488529|FG001|Overall Study|Protocol Violation|12|||
16553318|NCT04249336|40488530|FG000|Overall Study|Lost to Follow-up|3|||
16553319|NCT04249336|40488531|FG001|Overall Study|Lost to Follow-up|3|||
16234200|NCT02918318|39341690|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
16234201|NCT02918318|39341691|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
16234202|NCT02918318|39341692|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
16234203|NCT02918318|39341693|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
16234204|NCT02918318|39341689|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
16234205|NCT02918318|39341690|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
16234206|NCT02918318|39341691|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
16234207|NCT02918318|39341692|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
16234208|NCT02918318|39341693|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
16234209|NCT02918318|39341689|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
16234210|NCT02918318|39341690|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
16234211|NCT02918318|39341691|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
16234212|NCT02918318|39341692|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
16234213|NCT02918318|39341693|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
16234214|NCT02918318|39341689|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
16234215|NCT02918318|39341690|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
16234216|NCT02918318|39341691|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
16234217|NCT02918318|39341692|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
16234218|NCT02918318|39341693|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
16234219|NCT02918318|39341689|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
16234220|NCT02918318|39341690|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
16234221|NCT02918318|39341691|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
16234222|NCT02918318|39341692|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
16234223|NCT02918318|39341693|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
16553320|NCT04249336|40488532|FG002|Overall Study|Lost to Follow-up|3|||
16553321|NCT04249336|40488533|FG003|Overall Study|Lost to Follow-up|3|||
16553322|NCT01533714|40488534|FG000|Overall Study|Adverse Event|0|||
16553323|NCT01533714|40488535|FG001|Overall Study|Adverse Event|1|||
16553324|NCT01533714|40488536|FG002|Overall Study|Adverse Event|2|||
16553325|NCT01533714|40488537|FG003|Overall Study|Adverse Event|2|||
16234224|NCT02918318|39341689|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
16553326|NCT01533714|40488538|FG004|Overall Study|Adverse Event|2|||
16234225|NCT02918318|39341690|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
16234226|NCT02918318|39341691|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
16553327|NCT01533714|40488539|FG005|Overall Study|Adverse Event|1|||
16553328|NCT01533714|40488534|FG000|Overall Study|Lack of Efficacy|0|||
16553329|NCT01533714|40488535|FG001|Overall Study|Lack of Efficacy|0|||
16553330|NCT01533714|40488536|FG002|Overall Study|Lack of Efficacy|0|||
16553331|NCT01533714|40488537|FG003|Overall Study|Lack of Efficacy|0|||
16553332|NCT01533714|40488538|FG004|Overall Study|Lack of Efficacy|0|||
16553333|NCT01533714|40488539|FG005|Overall Study|Lack of Efficacy|1|||
16553334|NCT01533714|40488534|FG000|Overall Study|Withdrawal by Subject|0|||
16553335|NCT01533714|40488535|FG001|Overall Study|Withdrawal by Subject|1|||
16553336|NCT01533714|40488536|FG002|Overall Study|Withdrawal by Subject|0|||
16553337|NCT01533714|40488537|FG003|Overall Study|Withdrawal by Subject|1|||
16553338|NCT01533714|40488538|FG004|Overall Study|Withdrawal by Subject|1|||
16553339|NCT01533714|40488539|FG005|Overall Study|Withdrawal by Subject|0|||
16553340|NCT01533714|40488534|FG000|Overall Study|Exclusion criteria|0|||
16553341|NCT01533714|40488535|FG001|Overall Study|Exclusion criteria|1|||
16553342|NCT01533714|40488536|FG002|Overall Study|Exclusion criteria|0|||
16553343|NCT01533714|40488537|FG003|Overall Study|Exclusion criteria|0|||
16553344|NCT01533714|40488538|FG004|Overall Study|Exclusion criteria|0|||
16553345|NCT01533714|40488539|FG005|Overall Study|Exclusion criteria|0|||
16553346|NCT01533714|40488534|FG000|Overall Study|Positive for purified protein derivative|0|||
16553347|NCT01533714|40488535|FG001|Overall Study|Positive for purified protein derivative|0|||
16553348|NCT01533714|40488536|FG002|Overall Study|Positive for purified protein derivative|1|||
16553349|NCT01533714|40488537|FG003|Overall Study|Positive for purified protein derivative|0|||
16553350|NCT01533714|40488538|FG004|Overall Study|Positive for purified protein derivative|1|||
16553351|NCT01533714|40488539|FG005|Overall Study|Positive for purified protein derivative|0|||
16120781|NCT00863681|38927257|FG002|Overall Study|Protocol Violation|0|||
16120782|NCT00863681|38927255|FG000|Overall Study|Lost to Follow-up|3|||
16120783|NCT00863681|38927256|FG001|Overall Study|Lost to Follow-up|0|||
16120784|NCT00863681|38927257|FG002|Overall Study|Lost to Follow-up|3|||
16120785|NCT00863681|38927255|FG000|Overall Study|Adverse Event|28|||
16120786|NCT00863681|38927256|FG001|Overall Study|Adverse Event|10|||
16120787|NCT00863681|38927257|FG002|Overall Study|Adverse Event|6|||
16120788|NCT00863681|38927255|FG000|Overall Study|Lack of Efficacy|2|||
16120789|NCT00863681|38927256|FG001|Overall Study|Lack of Efficacy|2|||
16120790|NCT00863681|38927257|FG002|Overall Study|Lack of Efficacy|1|||
16120791|NCT00863681|38927255|FG000|Overall Study|Non-compliance with study drug|1|||
16120792|NCT00863681|38927256|FG001|Overall Study|Non-compliance with study drug|3|||
16120793|NCT00863681|38927257|FG002|Overall Study|Non-compliance with study drug|0|||
16120794|NCT02113124|38927258|FG000|Overall Study|Unable to retrieve blood sample|1|||
16120795|NCT02113124|38927259|FG001|Overall Study|Unable to retrieve blood sample|1|||
16120796|NCT00338962|38927262|FG000|Overall Study|Lost to Follow-up|3|||
16120797|NCT00338962|38927263|FG001|Overall Study|Lost to Follow-up|3|||
16120798|NCT00338962|38927264|FG002|Overall Study|Lost to Follow-up|2|||
16120799|NCT00338962|38927265|FG003|Overall Study|Lost to Follow-up|3|||
16120800|NCT00338962|38927262|FG000|Overall Study|Withdrawal by Subject|1|||
16120801|NCT00338962|38927263|FG001|Overall Study|Withdrawal by Subject|0|||
16120802|NCT00338962|38927264|FG002|Overall Study|Withdrawal by Subject|0|||
16120803|NCT00338962|38927265|FG003|Overall Study|Withdrawal by Subject|0|||
16120804|NCT00338962|38927262|FG000|Overall Study|No Transportation|2|||
16120805|NCT00338962|38927263|FG001|Overall Study|No Transportation|0|||
16120806|NCT00338962|38927264|FG002|Overall Study|No Transportation|0|||
16120807|NCT00338962|38927265|FG003|Overall Study|No Transportation|0|||
16120808|NCT00338962|38927262|FG000|Overall Study|Time Constraint|2|||
16120809|NCT00338962|38927263|FG001|Overall Study|Time Constraint|0|||
16120810|NCT00338962|38927264|FG002|Overall Study|Time Constraint|0|||
16120811|NCT00338962|38927265|FG003|Overall Study|Time Constraint|0|||
16120812|NCT00338962|38927262|FG000|Overall Study|Moved|0|||
16120813|NCT00338962|38927263|FG001|Overall Study|Moved|1|||
16120814|NCT00338962|38927264|FG002|Overall Study|Moved|0|||
16120815|NCT00338962|38927265|FG003|Overall Study|Moved|0|||
16120816|NCT00338962|38927262|FG000|Overall Study|Adverse Event|0|||
16120817|NCT00338962|38927263|FG001|Overall Study|Adverse Event|0|||
16120818|NCT00338962|38927264|FG002|Overall Study|Adverse Event|2|||
16120819|NCT00338962|38927265|FG003|Overall Study|Adverse Event|0|||
16120820|NCT00338962|38927262|FG000|Overall Study|Poor Compliance|0|||
16120821|NCT00338962|38927263|FG001|Overall Study|Poor Compliance|0|||
16120822|NCT00338962|38927264|FG002|Overall Study|Poor Compliance|2|||
16120823|NCT00338962|38927265|FG003|Overall Study|Poor Compliance|0|||
16120824|NCT00438672|38927266|FG000|Overall Study|Lost to Follow-up|7|||
16120825|NCT00438672|38927267|FG001|Overall Study|Lost to Follow-up|9|||
16120826|NCT01413503|38927269|FG000|Overall Study|Lost to Follow-up|1|||
16120827|NCT01255631|38927277|FG000|Overall Study|poor enrollment, no data analyzed|9|||
16120828|NCT01255631|38927278|FG001|Overall Study|poor enrollment, no data analyzed|6|||
16120829|NCT02242097|38927281|FG000|Ibrutinib Treatment|Adverse Event|16|||
16120830|NCT02242097|38927281|FG000|Ibrutinib Treatment|Physician Decision|1|||
16120831|NCT02242097|38927281|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
16120832|NCT02242097|38927281|FG000|Ibrutinib Treatment|Death|1|||
16120833|NCT02242097|38927281|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
16120834|NCT02242097|38927281|FG000|Post Therapy Follow Up|Death|3|||
16120835|NCT02242097|38927281|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
16120836|NCT03167151|38927282|FG000|Overall Study|Withdrawal by Subject|1|||
16120837|NCT03167151|38927283|FG001|Overall Study|Withdrawal by Subject|0|||
16120838|NCT03167151|38927284|FG002|Overall Study|Withdrawal by Subject|0|||
16120839|NCT03167151|38927282|FG000|Overall Study|No evidence of tumour at surgery|0|||
16120840|NCT03167151|38927283|FG001|Overall Study|No evidence of tumour at surgery|1|||
16120841|NCT03167151|38927284|FG002|Overall Study|No evidence of tumour at surgery|1|||
16120842|NCT00293059|38927285|FG000|Overall Study|Adverse Event|12|||
16120843|NCT00293059|38927286|FG001|Overall Study|Adverse Event|4|||
16120844|NCT00293059|38927285|FG000|Overall Study|Lack of Efficacy|2|||
16120845|NCT00293059|38927286|FG001|Overall Study|Lack of Efficacy|0|||
16120846|NCT00293059|38927285|FG000|Overall Study|Lost to Follow-up|2|||
16120847|NCT00293059|38927286|FG001|Overall Study|Lost to Follow-up|3|||
16120848|NCT00293059|38927285|FG000|Overall Study|Pregnancy|1|||
16348786|NCT04147247|39765492|FG000|Overall Study|Progressive disease|3|||
16120849|NCT00293059|38927286|FG001|Overall Study|Pregnancy|1|||
16120850|NCT00293059|38927285|FG000|Overall Study|Protocol Violation|2|||
16120851|NCT00293059|38927286|FG001|Overall Study|Protocol Violation|0|||
16120852|NCT00293059|38927285|FG000|Overall Study|Withdrawal by Subject|11|||
16120853|NCT00293059|38927286|FG001|Overall Study|Withdrawal by Subject|5|||
16553352|NCT01533714|40488534|FG000|Overall Study|Withdrawal criteria|0|||
16553353|NCT01533714|40488535|FG001|Overall Study|Withdrawal criteria|0|||
16553354|NCT01533714|40488536|FG002|Overall Study|Withdrawal criteria|1|||
16553355|NCT01533714|40488537|FG003|Overall Study|Withdrawal criteria|0|||
16553356|NCT01533714|40488538|FG004|Overall Study|Withdrawal criteria|3|||
16553357|NCT01533714|40488539|FG005|Overall Study|Withdrawal criteria|1|||
16553358|NCT01533714|40488534|FG000|Overall Study|Ineligibility reason|0|||
16553359|NCT01533714|40488535|FG001|Overall Study|Ineligibility reason|0|||
16553360|NCT01533714|40488536|FG002|Overall Study|Ineligibility reason|0|||
16553361|NCT01533714|40488537|FG003|Overall Study|Ineligibility reason|1|||
16553362|NCT01533714|40488538|FG004|Overall Study|Ineligibility reason|0|||
16553363|NCT01533714|40488539|FG005|Overall Study|Ineligibility reason|0|||
16553364|NCT00839917|40488540|FG000|Overall Study|Lost to Follow-up|1|||
16553365|NCT00839917|40488541|FG001|Overall Study|Lost to Follow-up|0|||
16553366|NCT00839917|40488540|FG000|Overall Study|Did not receive vaccine|0|||
16553367|NCT00839917|40488541|FG001|Overall Study|Did not receive vaccine|1|||
16553368|NCT02440594|40492705|FG000|Overall Study|Lost to Follow-up|34|||
16553369|NCT02440594|40492706|FG001|Overall Study|Lost to Follow-up|33|||
16553370|NCT02440594|40492707|FG002|Overall Study|Lost to Follow-up|54|||
16553371|NCT02440594|40492708|FG003|Overall Study|Lost to Follow-up|47|||
16553372|NCT02440594|40492709|FG004|Overall Study|Lost to Follow-up|5|||
16553373|NCT02440594|40492710|FG005|Overall Study|Lost to Follow-up|4|||
16553374|NCT02440594|40492711|FG006|Overall Study|Lost to Follow-up|28|||
16120854|NCT00293059|38927285|FG000|Overall Study|Participant moved out of state|1|||
16120855|NCT00293059|38927286|FG001|Overall Study|Participant moved out of state|0|||
16553375|NCT02440594|40492712|FG007|Overall Study|Lost to Follow-up|48|||
16120856|NCT00293059|38927285|FG000|Overall Study|Participant stopped study drug|1|||
16120857|NCT00293059|38927286|FG001|Overall Study|Participant stopped study drug|0|||
16120858|NCT00293059|38927285|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
16120859|NCT00293059|38927286|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
16120860|NCT00293059|38927285|FG000|Overall Study|missing|3|||
16120861|NCT00293059|38927286|FG001|Overall Study|missing|5|||
16120862|NCT01427725|38927296|FG000|Overall Study|Lost to Follow-up|17|||
16120863|NCT01427725|38927296|FG000|Overall Study|Protocol Violation|1|||
16120864|NCT01427725|38927296|FG000|Overall Study|Drug not administered|1|||
16120865|NCT01427725|38927296|FG000|Overall Study|Failure to visit|7|||
16120866|NCT01427725|38927296|FG000|Overall Study|Adverse Event|46|||
16120867|NCT01427725|38927296|FG000|Overall Study|Failure to visit after administration|40|||
16120868|NCT01427725|38927296|FG000|Overall Study|Patient's rejection|27|||
16120869|NCT01427725|38927296|FG000|Overall Study|Transfer to a different hospital|17|||
16120870|NCT01427725|38927296|FG000|Overall Study|Lack of Efficacy|8|||
16120871|NCT01427725|38927296|FG000|Overall Study|Death|7|||
16120872|NCT01427725|38927296|FG000|Overall Study|Symptom improvement|6|||
16120873|NCT01427725|38927296|FG000|Overall Study|AE and Patient's rejection|5|||
16120874|NCT01427725|38927296|FG000|Overall Study|Physician Decision|5|||
16120875|NCT01427725|38927296|FG000|Overall Study|Exacerbation of underlying disease|5|||
16120876|NCT01427725|38927296|FG000|Overall Study|Oral feeding difficulty|5|||
16120877|NCT01427725|38927296|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
16120878|NCT01427725|38927296|FG000|Overall Study|Forgetting prescription|1|||
16120879|NCT01427725|38927296|FG000|Overall Study|Other|2|||
16120880|NCT02993406|38927297|FG000|Overall Study|Withdrawal by Subject|170|||
16120881|NCT02993406|38927298|FG001|Overall Study|Withdrawal by Subject|196|||
16120882|NCT02993406|38927297|FG000|Overall Study|Physician Decision|3|||
16120883|NCT02993406|38927298|FG001|Overall Study|Physician Decision|5|||
16120884|NCT02993406|38927297|FG000|Overall Study|Lost to Follow-up|12|||
16120885|NCT02993406|38927298|FG001|Overall Study|Lost to Follow-up|13|||
16120886|NCT02993406|38927297|FG000|Overall Study|Unclassifiable Response|105|||
16120887|NCT02993406|38927298|FG001|Overall Study|Unclassifiable Response|139|||
16120888|NCT02993406|38927297|FG000|Overall Study|Administrative decision|1|||
16120889|NCT02993406|38927298|FG001|Overall Study|Administrative decision|0|||
16120890|NCT02993406|38927297|FG000|Overall Study|Sponsor decision|4|||
16120891|NCT02993406|38927298|FG001|Overall Study|Sponsor decision|5|||
16120892|NCT00332462|38927307|FG000|Overall Study|Adverse Event|5|||
16120893|NCT00332462|38927307|FG000|Overall Study|Abnormal Lab Value|1|||
16120894|NCT00332462|38927307|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16120895|NCT00332462|38927307|FG000|Overall Study|no longer requires study drug|1|||
16120896|NCT00332462|38927307|FG000|Overall Study|Death|3|||
16120897|NCT00332462|38927307|FG000|Overall Study|Graft Loss|2|||
16120898|NCT01016262|38927310|FG000|Double-blind Phase|Adverse Event|0|||
16120899|NCT01016262|38927311|FG001|Double-blind Phase|Adverse Event|0|||
16120900|NCT01016262|38927312|FG002|Double-blind Phase|Adverse Event|1|||
16348787|NCT04147247|39765493|FG001|Overall Study|Progressive disease|3|||
16553376|NCT02440594|40492705|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
16348788|NCT04147247|39765494|FG002|Overall Study|Progressive disease|4|||
16553377|NCT02440594|40492706|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
16553378|NCT02440594|40492707|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
16553379|NCT02440594|40492708|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
16553380|NCT02440594|40492709|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
16553381|NCT02440594|40492710|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
16553382|NCT02440594|40492711|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
16553383|NCT02440594|40492712|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
16553384|NCT02440594|40492705|FG000|Overall Study|Withdrawal by Subject|81|||
16553385|NCT02440594|40492706|FG001|Overall Study|Withdrawal by Subject|67|||
16553386|NCT02440594|40492707|FG002|Overall Study|Withdrawal by Subject|59|||
16553387|NCT02440594|40492708|FG003|Overall Study|Withdrawal by Subject|38|||
16553388|NCT02440594|40492709|FG004|Overall Study|Withdrawal by Subject|2|||
16553389|NCT02440594|40492710|FG005|Overall Study|Withdrawal by Subject|2|||
16553390|NCT02440594|40492711|FG006|Overall Study|Withdrawal by Subject|7|||
16553391|NCT02440594|40492712|FG007|Overall Study|Withdrawal by Subject|7|||
16234227|NCT02918318|39341692|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
16234228|NCT02918318|39341693|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
16234229|NCT02918318|39341689|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
16234230|NCT02918318|39341690|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
16234231|NCT02918318|39341691|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
16234232|NCT02918318|39341692|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
16234233|NCT02918318|39341693|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
16234234|NCT02918318|39341689|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
16234235|NCT02918318|39341690|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
16234236|NCT02918318|39341691|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
16234237|NCT02918318|39341692|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
16234238|NCT02918318|39341693|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
16234239|NCT02918318|39341689|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
16234240|NCT02918318|39341690|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
16234241|NCT02918318|39341691|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
16234242|NCT02918318|39341692|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
16234243|NCT02918318|39341693|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
16234244|NCT02918318|39341689|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
16234245|NCT02918318|39341690|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
16234246|NCT02918318|39341691|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
16234247|NCT02918318|39341692|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
16234248|NCT02918318|39341693|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
16234249|NCT02918318|39341689|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
16234250|NCT02918318|39341690|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
16234251|NCT02918318|39341691|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
16234252|NCT02918318|39341692|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
16234253|NCT02918318|39341693|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
16234254|NCT04527549|39341700|FG000|Overall Study|Withdrawal by Subject|1|||
16234255|NCT04527549|39341701|FG001|Overall Study|Withdrawal by Subject|1|||
16234256|NCT00759174|39341705|FG000|Overall Study|Other|0|||
16234257|NCT00759174|39341706|FG001|Overall Study|Other|2|||
16234258|NCT02940392|39341707|FG000|Overall Study|Lost to Follow-up|3|||
16234259|NCT02940392|39341707|FG000|Overall Study|Retreatment|3|||
16234260|NCT02940392|39341707|FG000|Overall Study|Death|2|||
16234261|NCT01788163|39341708|FG000|Overall Study|Other|53|||
16234262|NCT01788163|39341709|FG001|Overall Study|Other|0|||
16234263|NCT01788163|39341710|FG002|Overall Study|Other|0|||
16234264|NCT01788163|39341711|FG003|Overall Study|Other|0|||
16234265|NCT01788163|39341712|FG004|Overall Study|Other|0|||
16234266|NCT01788163|39341713|FG005|Overall Study|Other|7|||
16234267|NCT01788163|39341714|FG006|Overall Study|Other|1|||
16234268|NCT01788163|39341715|FG007|Overall Study|Other|48|||
16234269|NCT01788163|39341716|FG008|Overall Study|Other|15|||
16234270|NCT01788163|39341708|FG000|Overall Study|Withdrawal by Subject|2|||
16234271|NCT01788163|39341709|FG001|Overall Study|Withdrawal by Subject|0|||
16234272|NCT01788163|39341710|FG002|Overall Study|Withdrawal by Subject|0|||
16234273|NCT01788163|39341711|FG003|Overall Study|Withdrawal by Subject|0|||
16234274|NCT01788163|39341712|FG004|Overall Study|Withdrawal by Subject|0|||
16234275|NCT01788163|39341713|FG005|Overall Study|Withdrawal by Subject|0|||
16234276|NCT01788163|39341714|FG006|Overall Study|Withdrawal by Subject|0|||
16234277|NCT01788163|39341715|FG007|Overall Study|Withdrawal by Subject|0|||
16234278|NCT01788163|39341716|FG008|Overall Study|Withdrawal by Subject|1|||
16234279|NCT02704130|39341721|FG000|Overall Study|Physician Decision|5|||
16234280|NCT02704130|39341722|FG001|Overall Study|Physician Decision|3|||
16234281|NCT03669640|39341723|FG000|Overall Study|Study Terminated by Sponsor|0|||
16234282|NCT03669640|39341724|FG001|Overall Study|Study Terminated by Sponsor|0|||
16234283|NCT03669640|39341725|FG002|Overall Study|Study Terminated by Sponsor|0|||
16348789|NCT04147247|39765495|FG003|Overall Study|Progressive disease|4|||
16553392|NCT02440594|40492705|FG000|Overall Study|Administratively w/drawn|3|||
16234284|NCT03669640|39341726|FG003|Overall Study|Study Terminated by Sponsor|0|||
16234285|NCT03669640|39341727|FG004|Overall Study|Study Terminated by Sponsor|1|||
16553393|NCT02440594|40492706|FG001|Overall Study|Administratively w/drawn|2|||
16234286|NCT03669640|39341728|FG005|Overall Study|Study Terminated by Sponsor|0|||
16234287|NCT03669640|39341723|FG000|Overall Study|Lost to Follow-up|0|||
16234288|NCT03669640|39341724|FG001|Overall Study|Lost to Follow-up|0|||
16234289|NCT03669640|39341725|FG002|Overall Study|Lost to Follow-up|2|||
16234290|NCT03669640|39341726|FG003|Overall Study|Lost to Follow-up|0|||
16234291|NCT03669640|39341727|FG004|Overall Study|Lost to Follow-up|0|||
16234292|NCT03669640|39341728|FG005|Overall Study|Lost to Follow-up|0|||
16234293|NCT03669640|39341723|FG000|Overall Study|Death|0|||
16234294|NCT03669640|39341724|FG001|Overall Study|Death|0|||
16234295|NCT03669640|39341725|FG002|Overall Study|Death|1|||
16234296|NCT03669640|39341726|FG003|Overall Study|Death|0|||
16234297|NCT03669640|39341727|FG004|Overall Study|Death|0|||
16234298|NCT03669640|39341728|FG005|Overall Study|Death|0|||
16234299|NCT03669640|39341723|FG000|Overall Study|Withdrawal by Subject|1|||
16234300|NCT03669640|39341724|FG001|Overall Study|Withdrawal by Subject|2|||
16234301|NCT03669640|39341725|FG002|Overall Study|Withdrawal by Subject|1|||
16234302|NCT03669640|39341726|FG003|Overall Study|Withdrawal by Subject|0|||
16234303|NCT03669640|39341727|FG004|Overall Study|Withdrawal by Subject|1|||
16234304|NCT03669640|39341728|FG005|Overall Study|Withdrawal by Subject|3|||
16234305|NCT03669640|39341723|FG000|Overall Study|Protocol Violation|1|||
16234306|NCT03669640|39341724|FG001|Overall Study|Protocol Violation|0|||
16234307|NCT03669640|39341725|FG002|Overall Study|Protocol Violation|0|||
16234308|NCT03669640|39341726|FG003|Overall Study|Protocol Violation|0|||
16234309|NCT03669640|39341727|FG004|Overall Study|Protocol Violation|0|||
16234310|NCT03669640|39341728|FG005|Overall Study|Protocol Violation|0|||
16234311|NCT03669640|39341723|FG000|Overall Study|Physician Decision|0|||
16234312|NCT03669640|39341724|FG001|Overall Study|Physician Decision|2|||
16234313|NCT03669640|39341725|FG002|Overall Study|Physician Decision|0|||
16234314|NCT03669640|39341726|FG003|Overall Study|Physician Decision|0|||
16234315|NCT03669640|39341727|FG004|Overall Study|Physician Decision|0|||
16234316|NCT03669640|39341728|FG005|Overall Study|Physician Decision|0|||
16234317|NCT03669640|39341723|FG000|Overall Study|Disease Relapse|1|||
16234318|NCT03669640|39341724|FG001|Overall Study|Disease Relapse|0|||
16234319|NCT03669640|39341725|FG002|Overall Study|Disease Relapse|0|||
16234320|NCT03669640|39341726|FG003|Overall Study|Disease Relapse|0|||
16234321|NCT03669640|39341727|FG004|Overall Study|Disease Relapse|0|||
16234322|NCT03669640|39341728|FG005|Overall Study|Disease Relapse|0|||
16234323|NCT03669640|39341723|FG000|Overall Study|Adverse Event|2|||
16234324|NCT03669640|39341724|FG001|Overall Study|Adverse Event|1|||
16234325|NCT03669640|39341725|FG002|Overall Study|Adverse Event|0|||
16234326|NCT03669640|39341726|FG003|Overall Study|Adverse Event|0|||
16234327|NCT03669640|39341727|FG004|Overall Study|Adverse Event|1|||
16234328|NCT03669640|39341728|FG005|Overall Study|Adverse Event|0|||
16234329|NCT04764669|39341729|FG000|Overall Study|Adverse Event|1|||
16234330|NCT04764669|39341730|FG001|Overall Study|Adverse Event|0|||
16234331|NCT04764669|39341731|FG002|Overall Study|Adverse Event|1|||
16234332|NCT04764669|39341732|FG003|Overall Study|Adverse Event|0|||
16234333|NCT04764669|39341729|FG000|Overall Study|Subject Choice|0|||
16234334|NCT04764669|39341730|FG001|Overall Study|Subject Choice|0|||
16234335|NCT04764669|39341731|FG002|Overall Study|Subject Choice|1|||
16234336|NCT04764669|39341732|FG003|Overall Study|Subject Choice|0|||
16234337|NCT04764669|39341729|FG000|Overall Study|Withdrawal by Subject|2|||
16234338|NCT04764669|39341730|FG001|Overall Study|Withdrawal by Subject|0|||
16234339|NCT04764669|39341731|FG002|Overall Study|Withdrawal by Subject|0|||
16234340|NCT04764669|39341732|FG003|Overall Study|Withdrawal by Subject|0|||
16234341|NCT03911960|39341733|FG000|Overall Study|Lost to Follow-up|5|||
16234342|NCT03911960|39341734|FG001|Overall Study|Lost to Follow-up|3|||
16234343|NCT01591499|39341735|FG000|Baseline Visit|Withdrawal by Subject|0|||
16234344|NCT01591499|39341736|FG001|Baseline Visit|Withdrawal by Subject|2|||
16234345|NCT01591499|39341737|FG002|Baseline Visit|Withdrawal by Subject|0|||
16234346|NCT01591499|39341738|FG003|Baseline Visit|Withdrawal by Subject|2|||
16234347|NCT01591499|39341735|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
16234348|NCT01591499|39341736|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
16234349|NCT01591499|39341737|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
16234350|NCT01591499|39341738|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
16234351|NCT01591499|39341735|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
16234352|NCT01591499|39341736|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
16234353|NCT01591499|39341737|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
16234354|NCT01591499|39341738|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
16234355|NCT04854421|39341739|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
16234356|NCT04854421|39341740|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
16234357|NCT01256398|39341744|FG000|Overall Study|Withdrawal by Subject|1|||
16234358|NCT02787785|39341745|FG000|Overall Study|Death|3|||
16234359|NCT02787785|39341746|FG001|Overall Study|Death|4|||
16234360|NCT02787785|39341745|FG000|Overall Study|Lost to Follow-up|1|||
16234361|NCT02787785|39341746|FG001|Overall Study|Lost to Follow-up|1|||
16234362|NCT02787785|39341745|FG000|Overall Study|Withdrawal by Subject|0|||
16234363|NCT02787785|39341746|FG001|Overall Study|Withdrawal by Subject|5|||
16234364|NCT00595127|39341747|FG000|Overall Study|Death|6|||
16234365|NCT00595127|39341747|FG000|Overall Study|Relapsed|3|||
16234366|NCT00595127|39341747|FG000|Overall Study|joined another trial|1|||
16234367|NCT02861534|39341750|FG000|Overall Study|Death|541|||
16234368|NCT02861534|39341751|FG001|Overall Study|Death|552|||
16234369|NCT02861534|39341750|FG000|Overall Study|Lost to Follow-up|14|||
16234370|NCT02861534|39341751|FG001|Overall Study|Lost to Follow-up|14|||
16234371|NCT02861534|39341750|FG000|Overall Study|Site Terminated by Sponsor|4|||
16234372|NCT02861534|39341751|FG001|Overall Study|Site Terminated by Sponsor|3|||
16234373|NCT02861534|39341750|FG000|Overall Study|Withdrawal by Subject|15|||
16234374|NCT02861534|39341751|FG001|Overall Study|Withdrawal by Subject|18|||
16234375|NCT02362646|39341753|FG000|Overall Study|Death|15|||
16234376|NCT02362646|39341754|FG001|Overall Study|Death|8|||
16234377|NCT02362646|39341753|FG000|Overall Study|Withdrawal by Subject|2|||
16234378|NCT02362646|39341754|FG001|Overall Study|Withdrawal by Subject|2|||
16234379|NCT02362646|39341753|FG000|Overall Study|received transplant|21|||
16234380|NCT02362646|39341754|FG001|Overall Study|received transplant|14|||
16234381|NCT00474994|39341757|FG000|Overall Study|Patient Not treated|1|||
16234382|NCT00474994|39341757|FG000|Overall Study|Patient evaluable for toxicity only|3|||
16234383|NCT00474994|39341757|FG000|Overall Study|Patient found to be ineligible|1|||
16234384|NCT01833897|39341760|FG000|Overall Study|Lack of Efficacy|1|||
16234385|NCT01035229|39341763|FG000|Overall Study|Adverse Event|61|||
16234386|NCT01035229|39341764|FG001|Overall Study|Adverse Event|14|||
16234387|NCT01035229|39341763|FG000|Overall Study|Withdrawal by Subject|20|||
16234388|NCT01035229|39341764|FG001|Overall Study|Withdrawal by Subject|7|||
16234389|NCT01035229|39341763|FG000|Overall Study|Lost to Follow-up|1|||
16234390|NCT01035229|39341764|FG001|Overall Study|Lost to Follow-up|0|||
16234391|NCT01035229|39341763|FG000|Overall Study|Administrative problems|1|||
16234392|NCT01035229|39341764|FG001|Overall Study|Administrative problems|1|||
16234393|NCT01035229|39341763|FG000|Overall Study|Death|13|||
16234394|NCT01035229|39341764|FG001|Overall Study|Death|5|||
16234395|NCT01035229|39341763|FG000|Overall Study|New cancer therapy|2|||
16234396|NCT01035229|39341764|FG001|Overall Study|New cancer therapy|0|||
16234397|NCT01035229|39341763|FG000|Overall Study|Protocol Violation|0|||
16234398|NCT01035229|39341764|FG001|Overall Study|Protocol Violation|2|||
16234399|NCT01035229|39341763|FG000|Overall Study|Sponsor's decision to end study|3|||
16234400|NCT01035229|39341764|FG001|Overall Study|Sponsor's decision to end study|3|||
16234401|NCT01035229|39341763|FG000|Overall Study|Disease Progression|261|||
16234402|NCT01035229|39341764|FG001|Overall Study|Disease Progression|152|||
16234403|NCT02703454|39341765|FG000|Overall Study|Not treated|1|||
16234404|NCT02703454|39341766|FG001|Overall Study|Not treated|3|||
16234405|NCT02703454|39341765|FG000|Overall Study|Withdrawal by Subject|4|||
16234406|NCT02703454|39341766|FG001|Overall Study|Withdrawal by Subject|3|||
16234407|NCT02703454|39341765|FG000|Overall Study|Lost to Follow-up|1|||
16234408|NCT02703454|39341766|FG001|Overall Study|Lost to Follow-up|2|||
16234409|NCT02703454|39341765|FG000|Overall Study|Study discontinuation|5|||
16234410|NCT02703454|39341766|FG001|Overall Study|Study discontinuation|8|||
16234411|NCT00518011|39341767|FG000|Overall Study|Death|1|||
16234412|NCT00518011|39341768|FG001|Overall Study|Death|1|||
16234413|NCT00518011|39341767|FG000|Overall Study|Adverse Event|2|||
16234414|NCT00518011|39341768|FG001|Overall Study|Adverse Event|3|||
16234415|NCT00518011|39341767|FG000|Overall Study|Disease Progression|2|||
16234416|NCT00518011|39341768|FG001|Overall Study|Disease Progression|2|||
16234417|NCT00518011|39341767|FG000|Overall Study|Other Reasons|3|||
16234418|NCT00518011|39341768|FG001|Overall Study|Other Reasons|2|||
16234419|NCT00518011|39341767|FG000|Overall Study|Withdrawal by Subject|1|||
16234420|NCT00518011|39341768|FG001|Overall Study|Withdrawal by Subject|0|||
16234421|NCT04478994|39341769|FG000|Overall Study|Withdrawal by Subject|1|||
16234422|NCT04478994|39341770|FG001|Overall Study|Withdrawal by Subject|1|||
16234423|NCT00463385|39341774|FG000|Overall Study|Other|4|||
16234424|NCT00463385|39341775|FG001|Overall Study|Other|3|||
16234425|NCT00463385|39341776|FG002|Overall Study|Other|6|||
16234426|NCT00463385|39341777|FG003|Overall Study|Other|4|||
16234427|NCT00463385|39341774|FG000|Overall Study|Adverse Event|5|||
16234428|NCT00463385|39341775|FG001|Overall Study|Adverse Event|8|||
16234429|NCT00463385|39341776|FG002|Overall Study|Adverse Event|4|||
16234430|NCT00463385|39341777|FG003|Overall Study|Adverse Event|2|||
16234431|NCT00463385|39341774|FG000|Overall Study|Lack of Efficacy|6|||
16234432|NCT00463385|39341775|FG001|Overall Study|Lack of Efficacy|6|||
16234433|NCT00463385|39341776|FG002|Overall Study|Lack of Efficacy|7|||
16234434|NCT00463385|39341777|FG003|Overall Study|Lack of Efficacy|9|||
16234435|NCT00463385|39341774|FG000|Overall Study|Withdrawal by Subject|3|||
16234436|NCT00463385|39341775|FG001|Overall Study|Withdrawal by Subject|3|||
16234437|NCT00463385|39341776|FG002|Overall Study|Withdrawal by Subject|3|||
16234438|NCT00463385|39341777|FG003|Overall Study|Withdrawal by Subject|4|||
16234439|NCT00463385|39341774|FG000|Overall Study|Lost to Follow-up|0|||
16234440|NCT00463385|39341775|FG001|Overall Study|Lost to Follow-up|0|||
16234441|NCT00463385|39341776|FG002|Overall Study|Lost to Follow-up|0|||
16234442|NCT00463385|39341777|FG003|Overall Study|Lost to Follow-up|1|||
16234443|NCT00463385|39341774|FG000|Overall Study|Death|2|||
16553394|NCT02440594|40492707|FG002|Overall Study|Administratively w/drawn|0|||
16553395|NCT02440594|40492708|FG003|Overall Study|Administratively w/drawn|0|||
16553396|NCT02440594|40492709|FG004|Overall Study|Administratively w/drawn|0|||
16553397|NCT02440594|40492710|FG005|Overall Study|Administratively w/drawn|0|||
16553398|NCT02440594|40492711|FG006|Overall Study|Administratively w/drawn|2|||
16120901|NCT01016262|38927313|FG003|Double-blind Phase|Adverse Event|0|||
16120902|NCT01016262|38927314|FG004|Double-blind Phase|Adverse Event|0|||
16120903|NCT01016262|38927315|FG005|Double-blind Phase|Adverse Event|0|||
16120904|NCT01016262|38927310|FG000|Double-blind Phase|Lack of Efficacy|1|||
16120905|NCT01016262|38927311|FG001|Double-blind Phase|Lack of Efficacy|0|||
16120906|NCT01016262|38927312|FG002|Double-blind Phase|Lack of Efficacy|5|||
16120907|NCT01016262|38927313|FG003|Double-blind Phase|Lack of Efficacy|0|||
16120908|NCT01016262|38927314|FG004|Double-blind Phase|Lack of Efficacy|0|||
16120909|NCT01016262|38927315|FG005|Double-blind Phase|Lack of Efficacy|0|||
16120910|NCT01016262|38927310|FG000|Double-blind Phase|Disease Progression|0|||
16120911|NCT01016262|38927311|FG001|Double-blind Phase|Disease Progression|1|||
16120912|NCT01016262|38927312|FG002|Double-blind Phase|Disease Progression|2|||
16120913|NCT01016262|38927313|FG003|Double-blind Phase|Disease Progression|0|||
16120914|NCT01016262|38927314|FG004|Double-blind Phase|Disease Progression|0|||
16120915|NCT01016262|38927315|FG005|Double-blind Phase|Disease Progression|0|||
16120916|NCT01016262|38927310|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
16120917|NCT01016262|38927311|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
16120918|NCT01016262|38927312|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
16120919|NCT01016262|38927313|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
16120920|NCT01016262|38927314|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
16120921|NCT01016262|38927315|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
16120922|NCT01016262|38927310|FG000|Open-Label Phase|Adverse Event|0|||
16120923|NCT01016262|38927311|FG001|Open-Label Phase|Adverse Event|0|||
16120924|NCT01016262|38927312|FG002|Open-Label Phase|Adverse Event|0|||
16120925|NCT01016262|38927313|FG003|Open-Label Phase|Adverse Event|1|||
16120926|NCT01016262|38927314|FG004|Open-Label Phase|Adverse Event|0|||
16120927|NCT01016262|38927315|FG005|Open-Label Phase|Adverse Event|0|||
16120928|NCT01016262|38927310|FG000|Open-Label Phase|Lost to Follow-up|0|||
16120929|NCT01016262|38927311|FG001|Open-Label Phase|Lost to Follow-up|0|||
16120930|NCT01016262|38927312|FG002|Open-Label Phase|Lost to Follow-up|0|||
16120931|NCT01016262|38927313|FG003|Open-Label Phase|Lost to Follow-up|0|||
16120932|NCT01016262|38927314|FG004|Open-Label Phase|Lost to Follow-up|1|||
16120933|NCT01016262|38927315|FG005|Open-Label Phase|Lost to Follow-up|0|||
16120934|NCT01016262|38927310|FG000|Open-Label Phase|Lack of Efficacy|0|||
16120935|NCT01016262|38927311|FG001|Open-Label Phase|Lack of Efficacy|0|||
16120936|NCT01016262|38927312|FG002|Open-Label Phase|Lack of Efficacy|0|||
16120937|NCT01016262|38927313|FG003|Open-Label Phase|Lack of Efficacy|1|||
16120938|NCT01016262|38927314|FG004|Open-Label Phase|Lack of Efficacy|0|||
16120939|NCT01016262|38927315|FG005|Open-Label Phase|Lack of Efficacy|0|||
16120940|NCT01016262|38927310|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
16120941|NCT01016262|38927311|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
16120942|NCT01016262|38927312|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
16120943|NCT01016262|38927313|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
16120944|NCT01016262|38927314|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
16120945|NCT01016262|38927315|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
16120946|NCT00822770|38927321|FG000|Overall Study|Not treated|1|||
16120947|NCT00822770|38927322|FG001|Overall Study|Not treated|0|||
16120948|NCT00822770|38927321|FG000|Overall Study|Complication/Incomplete treatment|1|||
16120949|NCT00822770|38927322|FG001|Overall Study|Complication/Incomplete treatment|0|||
16120950|NCT00822770|38927321|FG000|Overall Study|Death|1|||
16120951|NCT00822770|38927322|FG001|Overall Study|Death|1|||
16120952|NCT00468143|38927324|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
16120953|NCT00468143|38927325|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
16120954|NCT00468143|38927324|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
16120955|NCT00468143|38927325|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
16120956|NCT02842151|38930042|FG000|Overall Study|Adverse Event|1|||
16120957|NCT02842151|38930042|FG000|Overall Study|Subject moved too far away|1|||
16120958|NCT01643044|38930043|FG000|Overall Study|Lost to Follow-up|1|||
16120959|NCT01643044|38930044|FG001|Overall Study|Lost to Follow-up|1|||
16120960|NCT01643044|38930043|FG000|Overall Study|Miscarried baby|2|||
16120961|NCT01643044|38930044|FG001|Overall Study|Miscarried baby|2|||
16120962|NCT01643044|38930043|FG000|Overall Study|Delivered outside of hospital|1|||
16120963|NCT01643044|38930044|FG001|Overall Study|Delivered outside of hospital|2|||
16120964|NCT01370590|38930045|FG000|Period 1|Adverse Event|8|||
16120965|NCT01370590|38930046|FG001|Period 1|Adverse Event|4|||
16120966|NCT01370590|38930045|FG000|Period 1|Lost to Follow-up|2|||
16120967|NCT01370590|38930046|FG001|Period 1|Lost to Follow-up|2|||
16120968|NCT01370590|38930045|FG000|Period 1|Protocol Violation|2|||
16120969|NCT01370590|38930046|FG001|Period 1|Protocol Violation|2|||
16120970|NCT01370590|38930045|FG000|Period 1|Withdrawal by Subject|4|||
16553399|NCT02440594|40492712|FG007|Overall Study|Administratively w/drawn|1|||
16234444|NCT00463385|39341775|FG001|Overall Study|Death|1|||
16234445|NCT00463385|39341776|FG002|Overall Study|Death|2|||
16234446|NCT00463385|39341777|FG003|Overall Study|Death|0|||
16234447|NCT00463385|39341774|FG000|Overall Study|Missing|2|||
16234448|NCT00463385|39341775|FG001|Overall Study|Missing|0|||
16234449|NCT00463385|39341776|FG002|Overall Study|Missing|0|||
16234450|NCT00463385|39341777|FG003|Overall Study|Missing|2|||
16234451|NCT00463385|39341774|FG000|Overall Study|1 participant received commercial drug|0|||
16234452|NCT00463385|39341775|FG001|Overall Study|1 participant received commercial drug|1|||
16234453|NCT00463385|39341776|FG002|Overall Study|1 participant received commercial drug|0|||
16234454|NCT00463385|39341777|FG003|Overall Study|1 participant received commercial drug|0|||
16234455|NCT05022121|39341778|FG000|Overall Study|Lack of Efficacy|1|||
16234456|NCT05022121|39341779|FG001|Overall Study|Lack of Efficacy|0|||
16234457|NCT05022121|39341778|FG000|Overall Study|Lost to Follow-up|0|||
16234458|NCT05022121|39341779|FG001|Overall Study|Lost to Follow-up|2|||
16234459|NCT01907516|39341780|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
16234460|NCT01907516|39341781|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
16234461|NCT01907516|39341780|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
16234462|NCT01907516|39341781|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
16234463|NCT01907516|39341780|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
16234464|NCT01907516|39341781|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
16234465|NCT01907516|39341780|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
16234466|NCT01907516|39341781|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
16234467|NCT03861273|39341782|FG000|Screening Phase (3 Weeks)|Other|1|||
16234468|NCT03861273|39341782|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
16234469|NCT03861273|39341782|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
16234470|NCT03861273|39341782|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
16234471|NCT03861273|39341782|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
16234472|NCT01674010|39341783|FG000|Open Treatment Phase 1|Adverse Event|10|||
16234473|NCT01674010|39341784|FG001|Open Treatment Phase 1|Adverse Event|0|||
16234474|NCT01674010|39341785|FG002|Open Treatment Phase 1|Adverse Event|0|||
16234475|NCT01674010|39341783|FG000|Open Treatment Phase 1|Death|1|||
16234476|NCT01674010|39341784|FG001|Open Treatment Phase 1|Death|0|||
16234477|NCT01674010|39341785|FG002|Open Treatment Phase 1|Death|0|||
16234478|NCT01674010|39341783|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
16234479|NCT01674010|39341784|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
16234480|NCT01674010|39341785|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
16234481|NCT01674010|39341783|FG000|Open Treatment Phase 1|Physician Decision|9|||
16234482|NCT01674010|39341784|FG001|Open Treatment Phase 1|Physician Decision|0|||
16234483|NCT01674010|39341785|FG002|Open Treatment Phase 1|Physician Decision|0|||
16234484|NCT01674010|39341783|FG000|Open Treatment Phase 1|Protocol Violation|7|||
16234485|NCT01674010|39341784|FG001|Open Treatment Phase 1|Protocol Violation|0|||
16234486|NCT01674010|39341785|FG002|Open Treatment Phase 1|Protocol Violation|0|||
16234487|NCT01674010|39341783|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
16234488|NCT01674010|39341784|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
16234489|NCT01674010|39341785|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
16234490|NCT01674010|39341783|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
16234491|NCT01674010|39341784|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
16234492|NCT01674010|39341785|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
16234493|NCT01674010|39341783|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
16234494|NCT01674010|39341784|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
16234495|NCT01674010|39341785|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
16234496|NCT01674010|39341783|FG000|Randomization Phase 2|Adverse Event|0|||
16234497|NCT01674010|39341784|FG001|Randomization Phase 2|Adverse Event|1|||
16234498|NCT01674010|39341785|FG002|Randomization Phase 2|Adverse Event|1|||
16234499|NCT01674010|39341783|FG000|Randomization Phase 2|Lost to Follow-up|0|||
16234500|NCT01674010|39341784|FG001|Randomization Phase 2|Lost to Follow-up|1|||
16234501|NCT01674010|39341785|FG002|Randomization Phase 2|Lost to Follow-up|2|||
16348790|NCT04147247|39765496|FG004|Overall Study|Progressive disease|3|||
16348791|NCT04147247|39765492|FG000|Overall Study|Physician Decision|0|||
16234502|NCT01674010|39341783|FG000|Randomization Phase 2|Mood episode recurrence|0|||
16234503|NCT01674010|39341784|FG001|Randomization Phase 2|Mood episode recurrence|8|||
16234504|NCT01674010|39341785|FG002|Randomization Phase 2|Mood episode recurrence|2|||
16234505|NCT01674010|39341783|FG000|Randomization Phase 2|Physician Decision|0|||
16234506|NCT01674010|39341784|FG001|Randomization Phase 2|Physician Decision|0|||
16234507|NCT01674010|39341785|FG002|Randomization Phase 2|Physician Decision|2|||
16234508|NCT01674010|39341783|FG000|Randomization Phase 2|Pregnancy|0|||
16234509|NCT01674010|39341784|FG001|Randomization Phase 2|Pregnancy|1|||
16234510|NCT01674010|39341785|FG002|Randomization Phase 2|Pregnancy|1|||
16234511|NCT01674010|39341783|FG000|Randomization Phase 2|Protocol Violation|0|||
16234512|NCT01674010|39341784|FG001|Randomization Phase 2|Protocol Violation|1|||
16234513|NCT01674010|39341785|FG002|Randomization Phase 2|Protocol Violation|1|||
16234514|NCT01674010|39341783|FG000|Randomization Phase 2|Sponsor Decision|0|||
16234515|NCT01674010|39341784|FG001|Randomization Phase 2|Sponsor Decision|42|||
16234516|NCT01674010|39341785|FG002|Randomization Phase 2|Sponsor Decision|45|||
16234517|NCT01674010|39341783|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
16234518|NCT01674010|39341784|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
16234519|NCT01674010|39341785|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
16234520|NCT00769132|39341786|FG000|Period 1|Adverse Event|1|||
16234521|NCT00769132|39341787|FG001|Period 1|Adverse Event|0|||
16234522|NCT00769132|39341788|FG002|Period 1|Adverse Event|0|||
16234523|NCT00769132|39341789|FG003|Period 1|Adverse Event|1|||
16234524|NCT00769132|39341786|FG000|Period 2|Withdrawal by Subject|0|||
16234525|NCT00769132|39341787|FG001|Period 2|Withdrawal by Subject|0|||
16234526|NCT00769132|39341788|FG002|Period 2|Withdrawal by Subject|0|||
16234527|NCT00769132|39341789|FG003|Period 2|Withdrawal by Subject|1|||
16234528|NCT00769132|39341786|FG000|Period 3|Withdrawal by Subject|1|||
16234529|NCT00769132|39341787|FG001|Period 3|Withdrawal by Subject|0|||
16234530|NCT00769132|39341788|FG002|Period 3|Withdrawal by Subject|0|||
16234531|NCT00769132|39341789|FG003|Period 3|Withdrawal by Subject|0|||
16234532|NCT00769132|39341786|FG000|Period 4|Withdrawal by Subject|0|||
16234533|NCT00769132|39341787|FG001|Period 4|Withdrawal by Subject|1|||
16234534|NCT00769132|39341788|FG002|Period 4|Withdrawal by Subject|0|||
16234535|NCT00769132|39341789|FG003|Period 4|Withdrawal by Subject|0|||
16234536|NCT01843660|39341790|FG000|Overall Study|Other|30|||
16234537|NCT02392559|39341799|FG000|Overall Study|Withdrawal by Subject|0|||
16234538|NCT02392559|39341800|FG001|Overall Study|Withdrawal by Subject|1|||
16234539|NCT00883740|39341801|FG000|First Intervention|Lost to Follow-up|1|||
16234540|NCT00883740|39341802|FG001|First Intervention|Lost to Follow-up|0|||
16234541|NCT00883740|39341801|FG000|First Intervention|No longer willing to participate|2|||
16234542|NCT00883740|39341802|FG001|First Intervention|No longer willing to participate|0|||
16234543|NCT00883740|39341801|FG000|First Intervention|Protocol Violation|3|||
16234544|NCT00883740|39341802|FG001|First Intervention|Protocol Violation|6|||
16234545|NCT00883740|39341801|FG000|First Intervention|Adverse Event|1|||
16234546|NCT00883740|39341802|FG001|First Intervention|Adverse Event|2|||
16234547|NCT00883740|39341801|FG000|Second Intervention|Protocol Violation|1|||
16234548|NCT00883740|39341802|FG001|Second Intervention|Protocol Violation|0|||
16234549|NCT00883740|39341801|FG000|Second Intervention|No longer willing to participate|0|||
16234550|NCT00883740|39341802|FG001|Second Intervention|No longer willing to participate|1|||
16234551|NCT04768881|39341803|FG000|Overall Study|Completed Study Follow-up|0|||
16234552|NCT04768881|39341804|FG001|Overall Study|Completed Study Follow-up|2|||
16234553|NCT04768881|39341803|FG000|Overall Study|Death|3|||
16234554|NCT04768881|39341804|FG001|Overall Study|Death|2|||
16234555|NCT04768881|39341803|FG000|Overall Study|Study Terminated by Sponsor|2|||
16234556|NCT04768881|39341804|FG001|Overall Study|Study Terminated by Sponsor|2|||
16348792|NCT04147247|39765493|FG001|Overall Study|Physician Decision|1|||
16348793|NCT04147247|39765494|FG002|Overall Study|Physician Decision|0|||
16348794|NCT04147247|39765495|FG003|Overall Study|Physician Decision|0|||
16348795|NCT04147247|39765496|FG004|Overall Study|Physician Decision|0|||
16348796|NCT04147247|39765492|FG000|Overall Study|Clinical Disease Progression|0|||
16348797|NCT04147247|39765493|FG001|Overall Study|Clinical Disease Progression|0|||
16348798|NCT04147247|39765494|FG002|Overall Study|Clinical Disease Progression|0|||
16348799|NCT04147247|39765495|FG003|Overall Study|Clinical Disease Progression|0|||
16348800|NCT04147247|39765496|FG004|Overall Study|Clinical Disease Progression|1|||
16348801|NCT04147247|39765492|FG000|Overall Study|Adverse Event|0|||
16348802|NCT04147247|39765493|FG001|Overall Study|Adverse Event|0|||
16348803|NCT04147247|39765494|FG002|Overall Study|Adverse Event|1|||
16348804|NCT04147247|39765495|FG003|Overall Study|Adverse Event|0|||
16348805|NCT04147247|39765496|FG004|Overall Study|Adverse Event|1|||
16348806|NCT00846053|39765499|FG000|Overall Study|Physician Decision|3|||
16348807|NCT00846053|39765500|FG001|Overall Study|Physician Decision|0|||
16348808|NCT00402727|39765501|FG000|Overall Study|Adverse Event|10|||
16348809|NCT00402727|39765502|FG001|Overall Study|Adverse Event|6|||
16348810|NCT00402727|39765501|FG000|Overall Study|Death|1|||
16348811|NCT00402727|39765502|FG001|Overall Study|Death|0|||
16348812|NCT00402727|39765501|FG000|Overall Study|Lack of Efficacy|1|||
16348813|NCT00402727|39765502|FG001|Overall Study|Lack of Efficacy|3|||
16348814|NCT00402727|39765501|FG000|Overall Study|Lost to Follow-up|24|||
16348815|NCT00402727|39765502|FG001|Overall Study|Lost to Follow-up|11|||
16348816|NCT00402727|39765501|FG000|Overall Study|Physician Decision|1|||
16348817|NCT00402727|39765502|FG001|Overall Study|Physician Decision|1|||
16348818|NCT00402727|39765501|FG000|Overall Study|Protocol Violation|0|||
16234557|NCT04768881|39341803|FG000|Overall Study|Withdrawal by Subject|2|||
16234558|NCT04768881|39341804|FG001|Overall Study|Withdrawal by Subject|0|||
16234559|NCT04768881|39341803|FG000|Overall Study|Other|2|||
16234560|NCT04768881|39341804|FG001|Overall Study|Other|0|||
16234561|NCT00910000|39341805|FG000|Overall Study|Adverse Event|0|||
16234562|NCT00910000|39341806|FG001|Overall Study|Adverse Event|3|||
16234563|NCT00910000|39341807|FG002|Overall Study|Adverse Event|2|||
16234564|NCT00910000|39341808|FG003|Overall Study|Adverse Event|2|||
16234565|NCT00910000|39341809|FG004|Overall Study|Adverse Event|0|||
16234566|NCT00910000|39341810|FG005|Overall Study|Adverse Event|1|||
16348819|NCT00402727|39765502|FG001|Overall Study|Protocol Violation|4|||
16234567|NCT00910000|39341805|FG000|Overall Study|Withdrawal by Subject|0|||
16348820|NCT00402727|39765501|FG000|Overall Study|Withdrawal by Subject|3|||
16348821|NCT00402727|39765502|FG001|Overall Study|Withdrawal by Subject|7|||
16348822|NCT00402727|39765501|FG000|Overall Study|supply problems|2|||
16348823|NCT00402727|39765502|FG001|Overall Study|supply problems|1|||
16348824|NCT00402727|39765501|FG000|Overall Study|non-compliance|0|||
16348825|NCT00402727|39765502|FG001|Overall Study|non-compliance|1|||
16348826|NCT03275064|39765505|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
16348827|NCT03275064|39765506|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
16348828|NCT03275064|39765507|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
16348829|NCT03275064|39765508|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
16348830|NCT03275064|39765509|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
16348831|NCT03275064|39765505|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
16348832|NCT03275064|39765506|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
16348833|NCT03275064|39765507|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
16348834|NCT03275064|39765508|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
16413414|NCT00762996|39995157|FG000|Period One|ineligible|0|||
16234568|NCT00910000|39341806|FG001|Overall Study|Withdrawal by Subject|0|||
16348835|NCT03275064|39765509|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
16348836|NCT03275064|39765505|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
16348837|NCT03275064|39765506|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
16348838|NCT03275064|39765507|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
16348839|NCT03275064|39765508|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
16348840|NCT03275064|39765509|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
16120971|NCT01370590|38930046|FG001|Period 1|Withdrawal by Subject|2|||
16120972|NCT01370590|38930045|FG000|Period 1|Could not access randomization system|0|||
16120973|NCT01370590|38930046|FG001|Period 1|Could not access randomization system|1|||
16234569|NCT00910000|39341807|FG002|Overall Study|Withdrawal by Subject|1|||
16348841|NCT03275064|39765505|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
16348842|NCT03275064|39765506|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
16348843|NCT03275064|39765507|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
16348844|NCT03275064|39765508|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
16348845|NCT03275064|39765509|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
16348846|NCT03275064|39765505|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
16348847|NCT03275064|39765506|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
16348848|NCT03275064|39765507|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
16348849|NCT03275064|39765508|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
16348850|NCT03275064|39765509|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
16348851|NCT02472886|39765514|FG000|Overall Study|Lack of Efficacy|0|||
16348852|NCT02472886|39765515|FG001|Overall Study|Lack of Efficacy|2|||
16348853|NCT02472886|39765516|FG002|Overall Study|Lack of Efficacy|1|||
16348854|NCT01158261|39765517|FG000|Overall Study|Lost to Follow-up|9|||
16348855|NCT01158261|39765517|FG000|Overall Study|Death|7|||
16348856|NCT01158261|39765517|FG000|Overall Study|Withdrawal by Subject|1|||
16348857|NCT02895295|39765519|FG000|Overall Study|Survey Non-response|71|||
16348858|NCT02895295|39765520|FG001|Overall Study|Survey Non-response|94|||
16348859|NCT02895295|39765521|FG002|Overall Study|Survey Non-response|92|||
16348860|NCT04202497|39765522|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
16348861|NCT04202497|39765523|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
16348862|NCT04202497|39765524|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
16348863|NCT04202497|39765525|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
16348864|NCT04771013|39765526|FG000|Overall Study|Withdrawal by Subject|2|||
16348865|NCT04771013|39765527|FG001|Overall Study|Withdrawal by Subject|0|||
16348866|NCT04771013|39765526|FG000|Overall Study|Death|0|||
16348867|NCT04771013|39765527|FG001|Overall Study|Death|5|||
16348868|NCT04771013|39765526|FG000|Overall Study|Referred to another hospital before day 20|0|||
16348869|NCT04771013|39765527|FG001|Overall Study|Referred to another hospital before day 20|1|||
16348870|NCT00810069|39765532|FG000|Lead-in Period I|Adverse Event|43|||
16348871|NCT00810069|39765533|FG001|Lead-in Period I|Adverse Event|0|||
16348872|NCT00810069|39765534|FG002|Lead-in Period I|Adverse Event|0|||
16348873|NCT00810069|39765532|FG000|Lead-in Period I|Lack of Efficacy|1|||
16348874|NCT00810069|39765533|FG001|Lead-in Period I|Lack of Efficacy|0|||
16348875|NCT00810069|39765534|FG002|Lead-in Period I|Lack of Efficacy|0|||
16348876|NCT00810069|39765532|FG000|Lead-in Period I|Lost to Follow-up|19|||
16348877|NCT00810069|39765533|FG001|Lead-in Period I|Lost to Follow-up|0|||
16348878|NCT00810069|39765534|FG002|Lead-in Period I|Lost to Follow-up|0|||
16348879|NCT00810069|39765532|FG000|Lead-in Period I|Physician Decision|1|||
16348880|NCT00810069|39765533|FG001|Lead-in Period I|Physician Decision|0|||
16348881|NCT00810069|39765534|FG002|Lead-in Period I|Physician Decision|0|||
16348882|NCT00810069|39765532|FG000|Lead-in Period I|Protocol Violation|1|||
16348883|NCT00810069|39765533|FG001|Lead-in Period I|Protocol Violation|0|||
16348884|NCT00810069|39765534|FG002|Lead-in Period I|Protocol Violation|0|||
16348885|NCT00810069|39765532|FG000|Lead-in Period I|Withdrawal by Subject|46|||
16234570|NCT00910000|39341808|FG003|Overall Study|Withdrawal by Subject|0|||
16234571|NCT00910000|39341809|FG004|Overall Study|Withdrawal by Subject|1|||
16234572|NCT00910000|39341810|FG005|Overall Study|Withdrawal by Subject|0|||
16234573|NCT01898884|39341811|FG000|Multiple Dose Period|Adverse Event|0|||
16348886|NCT00810069|39765533|FG001|Lead-in Period I|Withdrawal by Subject|0|||
16348887|NCT00810069|39765534|FG002|Lead-in Period I|Withdrawal by Subject|0|||
16348888|NCT00810069|39765532|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
16348889|NCT00810069|39765533|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
16348890|NCT00810069|39765534|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
16348891|NCT00810069|39765532|FG000|Lead-in Period I|Randomization criteria not met|158|||
16348892|NCT00810069|39765533|FG001|Lead-in Period I|Randomization criteria not met|0|||
16348893|NCT00810069|39765534|FG002|Lead-in Period I|Randomization criteria not met|0|||
16348894|NCT00810069|39765532|FG000|Double-Blind Period II|Adverse Event|0|||
16348895|NCT00810069|39765533|FG001|Double-Blind Period II|Adverse Event|9|||
16348896|NCT00810069|39765534|FG002|Double-Blind Period II|Adverse Event|8|||
16348897|NCT00810069|39765532|FG000|Double-Blind Period II|Lack of Efficacy|0|||
16348898|NCT00810069|39765533|FG001|Double-Blind Period II|Lack of Efficacy|7|||
16348899|NCT00810069|39765534|FG002|Double-Blind Period II|Lack of Efficacy|12|||
16348900|NCT00810069|39765532|FG000|Double-Blind Period II|Lost to Follow-up|0|||
16348901|NCT00810069|39765533|FG001|Double-Blind Period II|Lost to Follow-up|9|||
16348902|NCT00810069|39765534|FG002|Double-Blind Period II|Lost to Follow-up|9|||
16348903|NCT00810069|39765532|FG000|Double-Blind Period II|Physician Decision|0|||
16348904|NCT00810069|39765533|FG001|Double-Blind Period II|Physician Decision|0|||
16348905|NCT00810069|39765534|FG002|Double-Blind Period II|Physician Decision|1|||
16348906|NCT00810069|39765532|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
16348907|NCT00810069|39765533|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
16348908|NCT00810069|39765534|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
16348909|NCT00810069|39765532|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
16348910|NCT00810069|39765533|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
16348911|NCT00810069|39765534|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
16348912|NCT00810069|39765532|FG000|Double-Blind Period II|Clinical relapse|0|||
16348913|NCT00810069|39765533|FG001|Double-Blind Period II|Clinical relapse|3|||
16348914|NCT00810069|39765534|FG002|Double-Blind Period II|Clinical relapse|0|||
16348915|NCT00810069|39765532|FG000|Double-Blind Period II|Protocol Violation|0|||
16348916|NCT00810069|39765533|FG001|Double-Blind Period II|Protocol Violation|7|||
16348917|NCT00810069|39765534|FG002|Double-Blind Period II|Protocol Violation|6|||
16348918|NCT02106351|39765537|FG000|Treatment Cycle 1|Adverse Event|2|||
16348919|NCT02106351|39765538|FG001|Treatment Cycle 1|Adverse Event|0|||
16348920|NCT02106351|39765539|FG002|Treatment Cycle 1|Adverse Event|0|||
16348921|NCT02106351|39765537|FG000|Treatment Cycle 1|Consent withdrawn|1|||
16348922|NCT02106351|39765538|FG001|Treatment Cycle 1|Consent withdrawn|0|||
16348923|NCT02106351|39765539|FG002|Treatment Cycle 1|Consent withdrawn|2|||
16348924|NCT02106351|39765537|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
16413415|NCT00762996|39995158|FG001|Period One|ineligible|0|||
16348925|NCT02106351|39765538|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
16234574|NCT01898884|39341812|FG001|Multiple Dose Period|Adverse Event|0|||
16234575|NCT01898884|39341813|FG002|Multiple Dose Period|Adverse Event|0|||
16234576|NCT01898884|39341814|FG003|Multiple Dose Period|Adverse Event|0|||
16234577|NCT01898884|39341815|FG004|Multiple Dose Period|Adverse Event|0|||
16234578|NCT01898884|39341816|FG005|Multiple Dose Period|Adverse Event|0|||
16234579|NCT01898884|39341817|FG006|Multiple Dose Period|Adverse Event|1|||
16234580|NCT01898884|39341818|FG007|Multiple Dose Period|Adverse Event|0|||
16234581|NCT01898884|39341819|FG008|Multiple Dose Period|Adverse Event|0|||
16234582|NCT01898884|39341811|FG000|Multiple Dose Period|Randomized Not Treated|0|||
16234583|NCT01898884|39341812|FG001|Multiple Dose Period|Randomized Not Treated|0|||
16234584|NCT01898884|39341813|FG002|Multiple Dose Period|Randomized Not Treated|0|||
16234585|NCT01898884|39341814|FG003|Multiple Dose Period|Randomized Not Treated|0|||
16234586|NCT01898884|39341815|FG004|Multiple Dose Period|Randomized Not Treated|0|||
16234587|NCT01898884|39341816|FG005|Multiple Dose Period|Randomized Not Treated|0|||
16234588|NCT01898884|39341817|FG006|Multiple Dose Period|Randomized Not Treated|0|||
16234589|NCT01898884|39341818|FG007|Multiple Dose Period|Randomized Not Treated|0|||
16234590|NCT01898884|39341819|FG008|Multiple Dose Period|Randomized Not Treated|1|||
16234591|NCT02780115|39341820|FG000|Overall Study|Withdrawal by Subject|0|||
16553400|NCT00130793|40492713|FG000|Overall Study|Lost to Follow-up|1|||
16553401|NCT00130793|40492714|FG001|Overall Study|Lost to Follow-up|4|||
16234592|NCT02780115|39341821|FG001|Overall Study|Withdrawal by Subject|1|||
16234593|NCT02780115|39341822|FG002|Overall Study|Withdrawal by Subject|1|||
16234594|NCT02780115|39341823|FG003|Overall Study|Withdrawal by Subject|0|||
16234595|NCT02780115|39341824|FG004|Overall Study|Withdrawal by Subject|0|||
16348926|NCT02106351|39765539|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
16553402|NCT00130793|40492713|FG000|Overall Study|Withdrew consent|2|||
16553403|NCT00130793|40492714|FG001|Overall Study|Withdrew consent|0|||
16120974|NCT01370590|38930045|FG000|Crossover Washout Period|Adverse Event|1|||
16120975|NCT01370590|38930046|FG001|Crossover Washout Period|Adverse Event|4|||
16234596|NCT02780115|39341820|FG000|Overall Study|Adverse Event|0|||
16553404|NCT00594906|40492716|FG000|Overall Study|Physician Decision|1|||
16553405|NCT00594906|40492717|FG001|Overall Study|Physician Decision|0|||
16553406|NCT00594906|40492716|FG000|Overall Study|Physician Decision|0|||
16234597|NCT02780115|39341821|FG001|Overall Study|Adverse Event|0|||
16348927|NCT02106351|39765537|FG000|Treatment Cycle 1|Other|0|||
16234598|NCT02780115|39341822|FG002|Overall Study|Adverse Event|0|||
16553407|NCT00594906|40492717|FG001|Overall Study|Physician Decision|1|||
16553408|NCT00594906|40492716|FG000|Overall Study|Death|0|||
16234599|NCT02780115|39341823|FG003|Overall Study|Adverse Event|1|||
16234600|NCT02780115|39341824|FG004|Overall Study|Adverse Event|1|||
16234601|NCT03606109|39341830|FG000|Overall Study|Lost to Follow-up|2|||
16234602|NCT03606109|39341831|FG001|Overall Study|Lost to Follow-up|1|||
16234603|NCT01721200|39341832|FG000|Overall Study|Lost to Follow-up|3|||
16234604|NCT01721200|39341833|FG001|Overall Study|Lost to Follow-up|5|||
16234605|NCT01513759|39341834|FG000|Overall Study|Protocol Violation|4|||
16234606|NCT01513759|39341834|FG000|Overall Study|Death during catheter placement|1|||
16234607|NCT04285983|39341835|FG000|Overall Study|Protocol Violation|6|||
16234608|NCT05037409|39341836|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
16234609|NCT05037409|39341837|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
16234610|NCT05037409|39341838|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
16234611|NCT00391118|39341839|FG000|Overall Study|Adverse Event|3|||
16234612|NCT00391118|39341840|FG001|Overall Study|Adverse Event|10|||
16234613|NCT00391118|39341841|FG002|Overall Study|Adverse Event|7|||
16234614|NCT00391118|39341839|FG000|Overall Study|Lost to Follow-up|0|||
16234615|NCT00391118|39341840|FG001|Overall Study|Lost to Follow-up|2|||
16234616|NCT00391118|39341841|FG002|Overall Study|Lost to Follow-up|3|||
16234617|NCT00391118|39341839|FG000|Overall Study|Withdrawal by Subject|0|||
16234618|NCT00391118|39341840|FG001|Overall Study|Withdrawal by Subject|9|||
16234619|NCT00391118|39341841|FG002|Overall Study|Withdrawal by Subject|1|||
16234620|NCT00391118|39341839|FG000|Overall Study|Death|0|||
16234621|NCT00391118|39341840|FG001|Overall Study|Death|1|||
16234622|NCT00391118|39341841|FG002|Overall Study|Death|0|||
16234623|NCT00391118|39341839|FG000|Overall Study|Physician Decision|0|||
16234624|NCT00391118|39341840|FG001|Overall Study|Physician Decision|3|||
16234625|NCT00391118|39341841|FG002|Overall Study|Physician Decision|0|||
16234626|NCT00391118|39341839|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
16234627|NCT00391118|39341840|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
16234628|NCT00391118|39341841|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
16234629|NCT00391118|39341839|FG000|Overall Study|Progressive Disease|7|||
16234630|NCT00391118|39341840|FG001|Overall Study|Progressive Disease|26|||
16234631|NCT00391118|39341841|FG002|Overall Study|Progressive Disease|43|||
16234632|NCT00391118|39341839|FG000|Overall Study|Sponsor Decision|0|||
16234633|NCT00391118|39341840|FG001|Overall Study|Sponsor Decision|1|||
16234634|NCT00391118|39341841|FG002|Overall Study|Sponsor Decision|3|||
16234635|NCT00391118|39341839|FG000|Overall Study|Protocol Violation|1|||
16234636|NCT00391118|39341840|FG001|Overall Study|Protocol Violation|0|||
16234637|NCT00391118|39341841|FG002|Overall Study|Protocol Violation|0|||
16234638|NCT00557830|39341842|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
16234639|NCT00557830|39341843|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
16234640|NCT00557830|39341844|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
16234641|NCT00557830|39341842|FG000|Screening Treatment Phase|Adverse Event|2|||
16234642|NCT00557830|39341843|FG001|Screening Treatment Phase|Adverse Event|0|||
16234643|NCT00557830|39341844|FG002|Screening Treatment Phase|Adverse Event|0|||
16234644|NCT00557830|39341842|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
16234645|NCT00557830|39341843|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
16234646|NCT00557830|39341844|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
16234647|NCT00530088|39341846|FG000|Overall Study|Disease Progression|4|||
16234648|NCT00530088|39341846|FG000|Overall Study|Physician Decision|4|||
16234649|NCT00530088|39341846|FG000|Overall Study|Other Not Specified|2|||
16234650|NCT01071278|39341847|FG000|Overall Study|Premature Discontinuation|254|||
16234651|NCT01071278|39341847|FG000|Overall Study|Completion Status Unknown|459|||
16234652|NCT03020966|39341848|FG000|Overall Study|Withdrawal by Subject|2|||
16234653|NCT03020966|39341849|FG001|Overall Study|Withdrawal by Subject|0|||
16234654|NCT01447628|39341850|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
16234655|NCT01447628|39341851|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
16234656|NCT01447628|39341852|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
16234657|NCT01447628|39341853|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
16234658|NCT04936334|39341860|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
16234659|NCT00278473|39341865|FG000|Overall Study|drop out|4|||
16348928|NCT02106351|39765538|FG001|Treatment Cycle 1|Other|3|||
16348929|NCT02106351|39765539|FG002|Treatment Cycle 1|Other|1|||
16348930|NCT02106351|39765537|FG000|Treatment Cycle 1|Randomised but not treated|1|||
16348931|NCT02106351|39765538|FG001|Treatment Cycle 1|Randomised but not treated|0|||
16348932|NCT02106351|39765539|FG002|Treatment Cycle 1|Randomised but not treated|1|||
16348933|NCT02106351|39765537|FG000|Treatment Cycle 2|Adverse Event|0|||
16348934|NCT02106351|39765538|FG001|Treatment Cycle 2|Adverse Event|2|||
16348935|NCT02106351|39765539|FG002|Treatment Cycle 2|Adverse Event|0|||
16348936|NCT02106351|39765537|FG000|Treatment Cycle 2|Consent withdrawn|0|||
16348937|NCT02106351|39765538|FG001|Treatment Cycle 2|Consent withdrawn|1|||
16348938|NCT02106351|39765539|FG002|Treatment Cycle 2|Consent withdrawn|1|||
16348939|NCT02106351|39765537|FG000|Treatment Cycle 2|Other|0|||
16348940|NCT02106351|39765538|FG001|Treatment Cycle 2|Other|2|||
16348941|NCT02106351|39765539|FG002|Treatment Cycle 2|Other|2|||
16348942|NCT02106351|39765537|FG000|Treatment Cycle 3|Adverse Event|0|||
16348943|NCT02106351|39765538|FG001|Treatment Cycle 3|Adverse Event|1|||
16348944|NCT02106351|39765539|FG002|Treatment Cycle 3|Adverse Event|0|||
16348945|NCT02106351|39765537|FG000|Treatment Cycle 3|Consent withdrawn|0|||
16348946|NCT02106351|39765538|FG001|Treatment Cycle 3|Consent withdrawn|0|||
16348947|NCT02106351|39765539|FG002|Treatment Cycle 3|Consent withdrawn|2|||
16348948|NCT02106351|39765537|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
16348949|NCT02106351|39765538|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
16348950|NCT02106351|39765539|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
16348951|NCT02106351|39765537|FG000|Treatment Cycle 3|Other|0|||
16348952|NCT02106351|39765538|FG001|Treatment Cycle 3|Other|2|||
16348953|NCT02106351|39765539|FG002|Treatment Cycle 3|Other|3|||
16348954|NCT02106351|39765537|FG000|Treatment Cycle 4|Consent withdrawn|0|||
16348955|NCT02106351|39765538|FG001|Treatment Cycle 4|Consent withdrawn|0|||
16348956|NCT02106351|39765539|FG002|Treatment Cycle 4|Consent withdrawn|2|||
16348957|NCT02106351|39765537|FG000|Treatment Cycle 4|Other|0|||
16348958|NCT02106351|39765538|FG001|Treatment Cycle 4|Other|1|||
16348959|NCT02106351|39765539|FG002|Treatment Cycle 4|Other|0|||
16348960|NCT00643201|39765540|FG000|Randomized, Completed 6 Months of Study|Death|20|||
16348961|NCT00643201|39765541|FG001|Randomized, Completed 6 Months of Study|Death|26|||
16348962|NCT00643201|39765540|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
16348963|NCT00643201|39765541|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
16348964|NCT00643201|39765540|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
16348965|NCT00643201|39765541|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
16348966|NCT00643201|39765540|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
16348967|NCT00643201|39765541|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
16348968|NCT00643201|39765540|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
16348969|NCT00643201|39765541|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
16348970|NCT00643201|39765540|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
16348971|NCT00643201|39765541|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
16348972|NCT00643201|39765540|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
16348973|NCT00643201|39765541|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
16348974|NCT00643201|39765540|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
16348975|NCT00643201|39765541|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
16348976|NCT00643201|39765540|FG000|Randomized, Completed 6 Months of Study|Other|107|||
16553409|NCT00594906|40492717|FG001|Overall Study|Death|1|||
16553410|NCT01734850|40492718|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
16553411|NCT01734850|40492719|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
16553412|NCT01734850|40492720|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
16553413|NCT01734850|40492718|FG000|Overall Study|Not infused due to manufacturing failure|0|||
16553414|NCT01734850|40492719|FG001|Overall Study|Not infused due to manufacturing failure|0|||
16553415|NCT01734850|40492720|FG002|Overall Study|Not infused due to manufacturing failure|1|||
16553416|NCT00709592|40492725|FG000|Overall Study|Unable to proceed to transplant|0|||
16553417|NCT00709592|40492726|FG001|Overall Study|Unable to proceed to transplant|1|||
16553418|NCT02038764|40492732|FG000|Overall Study|Adverse Event|0|||
16553419|NCT02038764|40492733|FG001|Overall Study|Adverse Event|0|||
16553420|NCT02038764|40492734|FG002|Overall Study|Adverse Event|1|||
16553421|NCT02038764|40492735|FG003|Overall Study|Adverse Event|0|||
16553422|NCT02038764|40492736|FG004|Overall Study|Adverse Event|0|||
16553423|NCT02038764|40492732|FG000|Overall Study|Lost to Follow-up|0|||
16553424|NCT02038764|40492733|FG001|Overall Study|Lost to Follow-up|1|||
16553425|NCT02038764|40492734|FG002|Overall Study|Lost to Follow-up|0|||
16553426|NCT02038764|40492735|FG003|Overall Study|Lost to Follow-up|0|||
16553427|NCT02038764|40492736|FG004|Overall Study|Lost to Follow-up|0|||
16553428|NCT02038764|40492732|FG000|Overall Study|Withdrawal by Subject|0|||
16553429|NCT02038764|40492733|FG001|Overall Study|Withdrawal by Subject|0|||
16553430|NCT02038764|40492734|FG002|Overall Study|Withdrawal by Subject|0|||
16553431|NCT02038764|40492735|FG003|Overall Study|Withdrawal by Subject|0|||
16553432|NCT02038764|40492736|FG004|Overall Study|Withdrawal by Subject|1|||
16553433|NCT02038764|40492732|FG000|Overall Study|Other|1|||
16553434|NCT02038764|40492733|FG001|Overall Study|Other|0|||
16553435|NCT02038764|40492734|FG002|Overall Study|Other|1|||
16553436|NCT02038764|40492735|FG003|Overall Study|Other|0|||
16553437|NCT02038764|40492736|FG004|Overall Study|Other|0|||
16553438|NCT02753530|40492741|FG000|Overall Study|Adverse Event|7|||
16553439|NCT02753530|40492742|FG001|Overall Study|Adverse Event|1|||
16553440|NCT02753530|40492741|FG000|Overall Study|Death|0|||
16553441|NCT02753530|40492742|FG001|Overall Study|Death|1|||
16553442|NCT02753530|40492741|FG000|Overall Study|Physician Decision|0|||
16553443|NCT02753530|40492742|FG001|Overall Study|Physician Decision|1|||
16553444|NCT02753530|40492741|FG000|Overall Study|Protocol Violation|1|||
16553445|NCT02753530|40492742|FG001|Overall Study|Protocol Violation|0|||
16553446|NCT02753530|40492741|FG000|Overall Study|Withdrawal by Subject|4|||
16553447|NCT02753530|40492742|FG001|Overall Study|Withdrawal by Subject|3|||
16553448|NCT03722264|40492743|FG000|Overall Study|Physician Decision|3|||
16553449|NCT01591460|40492744|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
16553450|NCT01591460|40492744|FG000|Overall Study|Futility Rule (Week 12)|7|||
16553451|NCT01591460|40492744|FG000|Overall Study|Futility Rule (Week 24)|3|||
16553452|NCT01591460|40492744|FG000|Overall Study|Rebound or Breakthrough|3|||
16553453|NCT01591460|40492744|FG000|Overall Study|Treatment Discontinued by Error|1|||
16553454|NCT01591460|40492744|FG000|Overall Study|Lost to Follow-up|1|||
16553455|NCT01591460|40492744|FG000|Overall Study|Noncompliance|1|||
16553456|NCT01591460|40492744|FG000|Overall Study|Participant Refusal|3|||
16553457|NCT01591460|40492744|FG000|Overall Study|Withdrawal by Subject|1|||
16553458|NCT01591460|40492744|FG000|Overall Study|Protocol Violation|1|||
16553459|NCT01563978|40492747|FG000|Overall Study|Physician Decision|1|||
16234660|NCT00278473|39341866|FG001|Overall Study|drop out|3|||
16553460|NCT01563978|40492748|FG001|Overall Study|Physician Decision|0|||
16553461|NCT01563978|40492747|FG000|Overall Study|Lost to Follow-up|1|||
16553462|NCT01563978|40492748|FG001|Overall Study|Lost to Follow-up|0|||
16553463|NCT01563978|40492747|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
16553464|NCT01563978|40492748|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
16553465|NCT01563978|40492747|FG000|Overall Study|Adverse Event|1|||
16553466|NCT01563978|40492748|FG001|Overall Study|Adverse Event|2|||
16553467|NCT01146574|40492749|FG000|Overall Study|Death|0|||
16120976|NCT01370590|38930045|FG000|Crossover Washout Period|Lost to Follow-up|2|||
16120977|NCT01370590|38930046|FG001|Crossover Washout Period|Lost to Follow-up|0|||
16120978|NCT01370590|38930045|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
16553468|NCT01146574|40492750|FG001|Overall Study|Death|1|||
16120979|NCT01370590|38930046|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
16120980|NCT01370590|38930045|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
16120981|NCT01370590|38930046|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
16120982|NCT01370590|38930045|FG000|Period 2|Adverse Event|0|||
16120983|NCT01370590|38930046|FG001|Period 2|Adverse Event|1|||
16120984|NCT01370590|38930045|FG000|Period 2|Withdrawal by Subject|1|||
16553469|NCT01146574|40492751|FG002|Overall Study|Death|1|||
16553470|NCT01146574|40492752|FG003|Overall Study|Death|0|||
16553471|NCT01146574|40492753|FG004|Overall Study|Death|0|||
16553472|NCT01146574|40492754|FG005|Overall Study|Death|0|||
16553473|NCT01146574|40492755|FG006|Overall Study|Death|0|||
16553474|NCT01146574|40492749|FG000|Overall Study|Other reasons|0|||
16553475|NCT01146574|40492750|FG001|Overall Study|Other reasons|0|||
16553476|NCT01146574|40492751|FG002|Overall Study|Other reasons|3|||
16553477|NCT01146574|40492752|FG003|Overall Study|Other reasons|0|||
16553478|NCT01146574|40492753|FG004|Overall Study|Other reasons|0|||
16553479|NCT01146574|40492754|FG005|Overall Study|Other reasons|0|||
16553480|NCT01146574|40492755|FG006|Overall Study|Other reasons|0|||
16553481|NCT01146574|40492749|FG000|Overall Study|Kidney transplant|0|||
16553482|NCT01146574|40492750|FG001|Overall Study|Kidney transplant|0|||
16553483|NCT01146574|40492751|FG002|Overall Study|Kidney transplant|1|||
16553484|NCT01146574|40492752|FG003|Overall Study|Kidney transplant|1|||
16553485|NCT01146574|40492753|FG004|Overall Study|Kidney transplant|0|||
16553486|NCT01146574|40492754|FG005|Overall Study|Kidney transplant|0|||
16553487|NCT01146574|40492755|FG006|Overall Study|Kidney transplant|0|||
16553488|NCT01146574|40492749|FG000|Overall Study|Withdrew consent|0|||
16553489|NCT01146574|40492750|FG001|Overall Study|Withdrew consent|0|||
16553490|NCT01146574|40492751|FG002|Overall Study|Withdrew consent|1|||
16553491|NCT01146574|40492752|FG003|Overall Study|Withdrew consent|1|||
16553492|NCT01146574|40492753|FG004|Overall Study|Withdrew consent|2|||
16553493|NCT01146574|40492754|FG005|Overall Study|Withdrew consent|1|||
16553494|NCT01146574|40492755|FG006|Overall Study|Withdrew consent|1|||
16553495|NCT00065468|40492756|FG000|Overall Study|Death|172|||
16553496|NCT00065468|40492757|FG001|Overall Study|Death|169|||
16553497|NCT00065468|40492758|FG002|Overall Study|Death|171|||
16120985|NCT01370590|38930046|FG001|Period 2|Withdrawal by Subject|1|||
16120986|NCT02898077|38930047|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
16120987|NCT02898077|38930048|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
16120988|NCT02898077|38930047|FG000|Overall Study|Lost to Follow-up|4|||
16120989|NCT02898077|38930048|FG001|Overall Study|Lost to Follow-up|3|||
16120990|NCT02898077|38930047|FG000|Overall Study|Physician Decision|0|||
16120991|NCT02898077|38930048|FG001|Overall Study|Physician Decision|2|||
16120992|NCT02898077|38930047|FG000|Overall Study|Sponsor Decision|32|||
16120993|NCT02898077|38930048|FG001|Overall Study|Sponsor Decision|13|||
16120994|NCT02898077|38930047|FG000|Overall Study|Withdrawal by Subject|6|||
16120995|NCT02898077|38930048|FG001|Overall Study|Withdrawal by Subject|3|||
16120996|NCT02898077|38930047|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
16120997|NCT02898077|38930048|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
16120998|NCT02898077|38930047|FG000|Overall Study|Ended extension period|3|||
16120999|NCT02898077|38930048|FG001|Overall Study|Ended extension period|0|||
16121000|NCT02643303|38930049|FG000|Overall Study|Progressive Disease|4|||
16121001|NCT02643303|38930050|FG001|Overall Study|Progressive Disease|4|||
16121002|NCT02643303|38930051|FG002|Overall Study|Progressive Disease|1|||
16121003|NCT02643303|38930052|FG003|Overall Study|Progressive Disease|12|||
16121004|NCT02643303|38930053|FG004|Overall Study|Progressive Disease|6|||
16121005|NCT02643303|38930054|FG005|Overall Study|Progressive Disease|4|||
16121006|NCT02643303|38930055|FG006|Overall Study|Progressive Disease|8|||
16121007|NCT02643303|38930056|FG007|Overall Study|Progressive Disease|2|||
16121008|NCT02643303|38930057|FG008|Overall Study|Progressive Disease|6|||
16553498|NCT00065468|40492756|FG000|Overall Study|Withdrawal by Subject|3|||
16553499|NCT00065468|40492757|FG001|Overall Study|Withdrawal by Subject|4|||
16553500|NCT00065468|40492758|FG002|Overall Study|Withdrawal by Subject|5|||
16553501|NCT00065468|40492756|FG000|Overall Study|Lost to Follow-up|5|||
16121009|NCT02643303|38930049|FG000|Overall Study|Adverse Event|0|||
16121010|NCT02643303|38930050|FG001|Overall Study|Adverse Event|1|||
16121011|NCT02643303|38930051|FG002|Overall Study|Adverse Event|0|||
16121012|NCT02643303|38930052|FG003|Overall Study|Adverse Event|0|||
16121013|NCT02643303|38930053|FG004|Overall Study|Adverse Event|1|||
16413416|NCT00762996|39995159|FG002|Period One|ineligible|1|||
16553502|NCT00065468|40492757|FG001|Overall Study|Lost to Follow-up|3|||
16553503|NCT00065468|40492758|FG002|Overall Study|Lost to Follow-up|2|||
16553504|NCT00065468|40492756|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
16553505|NCT00065468|40492757|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
16553506|NCT00065468|40492758|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
16553507|NCT00065468|40492756|FG000|Overall Study|Disease progression|0|||
16348977|NCT00643201|39765541|FG001|Randomized, Completed 6 Months of Study|Other|107|||
16553508|NCT00065468|40492757|FG001|Overall Study|Disease progression|0|||
16553509|NCT00065468|40492758|FG002|Overall Study|Disease progression|1|||
16553510|NCT00065468|40492756|FG000|Overall Study|Other|14|||
16553511|NCT00065468|40492757|FG001|Overall Study|Other|24|||
16553512|NCT00065468|40492758|FG002|Overall Study|Other|18|||
16553513|NCT01003184|40492759|FG000|Overall Study|Adverse Event|12|||
16553514|NCT01003184|40492760|FG001|Overall Study|Adverse Event|5|||
16553515|NCT01003184|40492759|FG000|Overall Study|Lost to Follow-up|1|||
16553516|NCT01003184|40492760|FG001|Overall Study|Lost to Follow-up|0|||
16553517|NCT01003184|40492759|FG000|Overall Study|Loss of glucose control|1|||
16553518|NCT01003184|40492760|FG001|Overall Study|Loss of glucose control|1|||
16553519|NCT01003184|40492759|FG000|Overall Study|Protocol Violation|3|||
16553520|NCT01003184|40492760|FG001|Overall Study|Protocol Violation|0|||
16553521|NCT01003184|40492759|FG000|Overall Study|Withdrawal by Subject|1|||
16553522|NCT01003184|40492760|FG001|Overall Study|Withdrawal by Subject|6|||
16553523|NCT01003184|40492759|FG000|Overall Study|Physician Decision|1|||
16553524|NCT01003184|40492760|FG001|Overall Study|Physician Decision|0|||
16553525|NCT03327402|40492761|FG000|Overall Study|Withdrawal by Subject|1|||
16553526|NCT03327402|40492761|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
16553527|NCT03638635|40492765|FG000|Initial Hospitalization|Study terminated prematurely|0|||
16553528|NCT03638635|40492766|FG001|Initial Hospitalization|Study terminated prematurely|1|||
16553529|NCT03638635|40492765|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
16553530|NCT03638635|40492766|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
16553531|NCT03638635|40492765|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
16553532|NCT03638635|40492766|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
16553533|NCT00309608|40492767|FG000|Overall Study|Adverse Event|1|||
16553534|NCT00309608|40492768|FG001|Overall Study|Adverse Event|5|||
16553535|NCT00309608|40492769|FG002|Overall Study|Adverse Event|3|||
16553536|NCT00309608|40492770|FG003|Overall Study|Adverse Event|2|||
16553537|NCT00309608|40492771|FG004|Overall Study|Adverse Event|3|||
16553538|NCT00309608|40492767|FG000|Overall Study|Protocol Violation|2|||
16553539|NCT00309608|40492768|FG001|Overall Study|Protocol Violation|0|||
16553540|NCT00309608|40492769|FG002|Overall Study|Protocol Violation|0|||
16553541|NCT00309608|40492770|FG003|Overall Study|Protocol Violation|0|||
16553542|NCT00309608|40492771|FG004|Overall Study|Protocol Violation|0|||
16553543|NCT00309608|40492767|FG000|Overall Study|Lost to Follow-up|0|||
16553544|NCT00309608|40492768|FG001|Overall Study|Lost to Follow-up|0|||
16553545|NCT00309608|40492769|FG002|Overall Study|Lost to Follow-up|2|||
16553546|NCT00309608|40492770|FG003|Overall Study|Lost to Follow-up|0|||
16553547|NCT00309608|40492771|FG004|Overall Study|Lost to Follow-up|1|||
16553548|NCT00309608|40492767|FG000|Overall Study|Withdrawal by Subject|1|||
16553549|NCT00309608|40492768|FG001|Overall Study|Withdrawal by Subject|4|||
16553550|NCT00309608|40492769|FG002|Overall Study|Withdrawal by Subject|2|||
16553551|NCT00309608|40492770|FG003|Overall Study|Withdrawal by Subject|0|||
16553552|NCT00309608|40492771|FG004|Overall Study|Withdrawal by Subject|0|||
16348978|NCT00643201|39765540|FG000|Completed Study Follow Up|Death|28|||
16553553|NCT00309608|40492767|FG000|Overall Study|Other incl. Lack of efficacy|10|||
16553554|NCT00309608|40492768|FG001|Overall Study|Other incl. Lack of efficacy|4|||
16121014|NCT02643303|38930054|FG005|Overall Study|Adverse Event|0|||
16234661|NCT03528369|39341867|FG000|Overall Study|Withdrawal by Subject|2|||
16234662|NCT03528369|39341868|FG001|Overall Study|Withdrawal by Subject|0|||
16234663|NCT03528369|39341869|FG002|Overall Study|Withdrawal by Subject|0|||
16234664|NCT03528369|39341867|FG000|Overall Study|Lost to Follow-up|1|||
16234665|NCT03528369|39341868|FG001|Overall Study|Lost to Follow-up|0|||
16234666|NCT03528369|39341869|FG002|Overall Study|Lost to Follow-up|0|||
16234667|NCT03528369|39341867|FG000|Overall Study|Adverse Event|0|||
16234668|NCT03528369|39341868|FG001|Overall Study|Adverse Event|1|||
16234669|NCT03528369|39341869|FG002|Overall Study|Adverse Event|0|||
16234670|NCT02513732|39341870|FG000|Overall Study|Lost to Follow-up|11|||
16234671|NCT02513732|39341870|FG000|Overall Study|Death|9|||
16553555|NCT00309608|40492769|FG002|Overall Study|Other incl. Lack of efficacy|3|||
16553556|NCT00309608|40492770|FG003|Overall Study|Other incl. Lack of efficacy|4|||
16553557|NCT00309608|40492771|FG004|Overall Study|Other incl. Lack of efficacy|0|||
16553558|NCT01751113|40492785|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16553559|NCT01751113|40492786|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16553560|NCT01751113|40492787|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16553561|NCT01751113|40492788|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
16553562|NCT01751113|40492789|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
16553563|NCT01751113|40492790|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16553564|NCT01751113|40492785|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
16553565|NCT01751113|40492786|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
16553566|NCT01751113|40492787|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
16553567|NCT01751113|40492788|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
16553568|NCT01751113|40492789|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
16553569|NCT01751113|40492790|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
16553570|NCT01700348|40492793|FG000|Overall Study|Withdrawal by Subject|22|||
16553571|NCT01700348|40492793|FG000|Overall Study|Lost to Follow-up|1|||
16553572|NCT02769065|40492794|FG000|Overall Study|Voluntary Withdrawal|1|||
16553573|NCT02769065|40492795|FG001|Overall Study|Voluntary Withdrawal|0|||
16553574|NCT02769065|40492796|FG002|Overall Study|Voluntary Withdrawal|0|||
16553575|NCT02769065|40492797|FG003|Overall Study|Voluntary Withdrawal|0|||
16553576|NCT02769065|40492798|FG004|Overall Study|Voluntary Withdrawal|0|||
16553577|NCT02769065|40492799|FG005|Overall Study|Voluntary Withdrawal|0|||
16553578|NCT02769065|40492800|FG006|Overall Study|Voluntary Withdrawal|0|||
16553579|NCT02769065|40492801|FG007|Overall Study|Voluntary Withdrawal|0|||
16553580|NCT02769065|40492802|FG008|Overall Study|Voluntary Withdrawal|0|||
16553581|NCT02769065|40492803|FG009|Overall Study|Voluntary Withdrawal|0|||
16234672|NCT02513732|39341870|FG000|Overall Study|Changing hospital|2|||
16234673|NCT03425331|39341871|FG000|Overall Study|Withdrawal by Subject|1|||
16234674|NCT03425331|39341871|FG000|Overall Study|Death|1|||
16234675|NCT03425331|39341871|FG000|Overall Study|Adverse Event|1|||
16234676|NCT03425331|39341871|FG000|Overall Study|Disease Progression|2|||
16234677|NCT03359473|39341872|FG000|Overall Study|Adverse Event|0|||
16234678|NCT03359473|39341873|FG001|Overall Study|Adverse Event|2|||
16234679|NCT03359473|39341874|FG002|Overall Study|Adverse Event|5|||
16234680|NCT03359473|39341875|FG003|Overall Study|Adverse Event|3|||
16234681|NCT03359473|39341872|FG000|Overall Study|Lost to Follow-up|0|||
16234682|NCT03359473|39341873|FG001|Overall Study|Lost to Follow-up|1|||
16234683|NCT03359473|39341874|FG002|Overall Study|Lost to Follow-up|0|||
16234684|NCT03359473|39341875|FG003|Overall Study|Lost to Follow-up|0|||
16234685|NCT03359473|39341872|FG000|Overall Study|Physician Decision|0|||
16234686|NCT03359473|39341873|FG001|Overall Study|Physician Decision|1|||
16234687|NCT03359473|39341874|FG002|Overall Study|Physician Decision|0|||
16234688|NCT03359473|39341875|FG003|Overall Study|Physician Decision|1|||
16234689|NCT03359473|39341872|FG000|Overall Study|Withdrawal by Subject|1|||
16234690|NCT03359473|39341873|FG001|Overall Study|Withdrawal by Subject|2|||
16234691|NCT03359473|39341874|FG002|Overall Study|Withdrawal by Subject|1|||
16234692|NCT03359473|39341875|FG003|Overall Study|Withdrawal by Subject|0|||
16234693|NCT03359473|39341872|FG000|Overall Study|Protocol-defined stopping criteria|1|||
16234694|NCT03359473|39341873|FG001|Overall Study|Protocol-defined stopping criteria|0|||
16234695|NCT03359473|39341874|FG002|Overall Study|Protocol-defined stopping criteria|0|||
16234696|NCT03359473|39341875|FG003|Overall Study|Protocol-defined stopping criteria|1|||
16234697|NCT03128931|39341876|FG000|Overall Study|Physician Decision|1|||
16234698|NCT03128931|39341876|FG000|Overall Study|Equipment Issues|3|||
16234699|NCT00447265|39341877|FG000|Overall Study|Physician Decision|1|||
16234700|NCT00447265|39341878|FG001|Overall Study|Physician Decision|0|||
16234701|NCT03069365|39341879|FG000|Overall Study|Adverse Event|1|||
16234702|NCT00398632|39341890|FG000|Overall Study|Withdrawal by Subject|1|||
16234703|NCT00398632|39341890|FG000|Overall Study|Lack of Efficacy|1|||
16234704|NCT01473589|39341891|FG000|Overall Study|Adverse Event|1|||
16234705|NCT01473589|39341892|FG001|Overall Study|Adverse Event|1|||
16234706|NCT01473589|39341891|FG000|Overall Study|Death|2|||
16234707|NCT01473589|39341892|FG001|Overall Study|Death|0|||
16234708|NCT01473589|39341891|FG000|Overall Study|Lost to Follow-up|2|||
16234709|NCT01473589|39341892|FG001|Overall Study|Lost to Follow-up|2|||
16234710|NCT01473589|39341891|FG000|Overall Study|Protocol Violation|1|||
16234711|NCT01473589|39341892|FG001|Overall Study|Protocol Violation|0|||
16234712|NCT01473589|39341891|FG000|Overall Study|Withdrawal by Subject|5|||
16234713|NCT01473589|39341892|FG001|Overall Study|Withdrawal by Subject|11|||
16234714|NCT01473589|39341891|FG000|Overall Study|Physician Decision|0|||
16234715|NCT01473589|39341892|FG001|Overall Study|Physician Decision|1|||
16234716|NCT01473589|39341891|FG000|Overall Study|Entry criteria not met|0|||
16234717|NCT01473589|39341892|FG001|Overall Study|Entry criteria not met|1|||
16234718|NCT02181634|39341893|FG000|Overall Study|Lack of Efficacy|33|||
16234719|NCT02181634|39341893|FG000|Overall Study|Adverse Event|17|||
16234720|NCT02181634|39341893|FG000|Overall Study|Physician Decision|8|||
16234721|NCT02181634|39341893|FG000|Overall Study|Withdrawal by Subject|5|||
16234722|NCT02181634|39341893|FG000|Overall Study|Death|2|||
16234723|NCT02181634|39341893|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
16234724|NCT02181634|39341893|FG000|Overall Study|Ineligible|1|||
16234725|NCT02181634|39341893|FG000|Overall Study|Max number of dose reduction|1|||
16234726|NCT02181634|39341893|FG000|Overall Study|Symptomatic progression|1|||
16234727|NCT02181634|39341893|FG000|Overall Study|Patient opted to proceed to surgery|1|||
16234728|NCT03751124|39341894|FG000|Overall Study|Adverse Event|4|||
16234729|NCT03751124|39341895|FG001|Overall Study|Adverse Event|3|||
16234730|NCT03751124|39341894|FG000|Overall Study|Protocol Deviation|0|||
16234731|NCT03751124|39341895|FG001|Overall Study|Protocol Deviation|1|||
16234732|NCT03751124|39341894|FG000|Overall Study|Lost to Follow-up|6|||
16234733|NCT03751124|39341895|FG001|Overall Study|Lost to Follow-up|4|||
16234734|NCT03751124|39341894|FG000|Overall Study|Withdrawal by Subject|6|||
16234735|NCT03751124|39341895|FG001|Overall Study|Withdrawal by Subject|8|||
16234736|NCT03751124|39341894|FG000|Overall Study|Lack of Efficacy|1|||
16234737|NCT03751124|39341895|FG001|Overall Study|Lack of Efficacy|1|||
16234738|NCT03751124|39341894|FG000|Overall Study|Pregnancy|0|||
16234739|NCT03751124|39341895|FG001|Overall Study|Pregnancy|1|||
16234740|NCT03751124|39341894|FG000|Overall Study|Other|9|||
16234741|NCT03751124|39341895|FG001|Overall Study|Other|9|||
16234742|NCT03751124|39341894|FG000|Overall Study|Participants who did not receive any study drug|0|||
16234743|NCT03751124|39341895|FG001|Overall Study|Participants who did not receive any study drug|1|||
16234744|NCT00203892|39341899|FG000|Overall Study|Physician Decision|1|||
16234745|NCT00203892|39341900|FG001|Overall Study|Physician Decision|2|||
16234746|NCT00203892|39341901|FG002|Overall Study|Physician Decision|0|||
16234747|NCT00203892|39341899|FG000|Overall Study|Death|1|||
16234748|NCT00203892|39341900|FG001|Overall Study|Death|0|||
16234749|NCT00203892|39341901|FG002|Overall Study|Death|0|||
16234750|NCT00138658|39341912|FG000|Overall Study|Adverse Event|23|||
16234751|NCT00138658|39341912|FG000|Overall Study|Death|1|||
16234752|NCT00138658|39341912|FG000|Overall Study|Disease Progression|21|||
16234753|NCT00138658|39341912|FG000|Overall Study|Physician Decision|11|||
16234754|NCT00138658|39341912|FG000|Overall Study|Withdrawal by Subject|5|||
16234755|NCT00352664|39341913|FG000|Overall Study|Withdrawal by Subject|7|||
16234756|NCT00352664|39341914|FG001|Overall Study|Withdrawal by Subject|0|||
16234757|NCT00326118|39341916|FG000|Active Phase|Withdrawal by Subject|4|||
16234758|NCT00326118|39341917|FG001|Active Phase|Withdrawal by Subject|1|||
16234759|NCT03976076|39341920|FG000|Overall Study|Withdrawal by Subject|2|||
16234760|NCT02610842|39341921|FG000|Overall Study|Lost to Follow-up|5|||
16234761|NCT03039686|39341925|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
16234762|NCT03039686|39341926|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
16234763|NCT03039686|39341927|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
16234764|NCT03039686|39341925|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
16234765|NCT03039686|39341926|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
16234766|NCT03039686|39341927|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
16234767|NCT03039686|39341925|FG000|Double-blind Period|Withdrawal by Subject|2|||
16234768|NCT03039686|39341926|FG001|Double-blind Period|Withdrawal by Subject|2|||
16234769|NCT03039686|39341927|FG002|Double-blind Period|Withdrawal by Subject|1|||
16234770|NCT03039686|39341925|FG000|Double-blind Period|Death|0|||
16234771|NCT03039686|39341926|FG001|Double-blind Period|Death|0|||
16234772|NCT03039686|39341927|FG002|Double-blind Period|Death|1|||
16234773|NCT03039686|39341925|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
16234774|NCT03039686|39341926|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
16234775|NCT03039686|39341927|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
16234776|NCT03039686|39341925|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
16234777|NCT03039686|39341926|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
16234778|NCT03039686|39341927|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
16234779|NCT03039686|39341925|FG000|Open Label Period|Withdrawal by Subject|0|||
16234780|NCT03039686|39341926|FG001|Open Label Period|Withdrawal by Subject|3|||
16234781|NCT03039686|39341927|FG002|Open Label Period|Withdrawal by Subject|1|||
16234782|NCT00449761|39341931|FG000|Overall Study|Disease progression|12|||
16234783|NCT00449761|39341931|FG000|Overall Study|Death|5|||
16234784|NCT00449761|39341931|FG000|Overall Study|New cancer therapy|1|||
16234785|NCT04635631|39341932|FG000|Overall Study|Adverse Event|1|||
16234786|NCT04635631|39341932|FG000|Overall Study|Progressive disease|13|||
16234787|NCT04635631|39341932|FG000|Overall Study|Withdrawal by Subject|1|||
16234788|NCT01015118|39341933|FG000|Overall Study|Protocol Violation|5|||
16234789|NCT01015118|39341934|FG001|Overall Study|Protocol Violation|6|||
16234790|NCT01015118|39341933|FG000|Overall Study|Withdrawal by Subject|103|||
16234791|NCT01015118|39341934|FG001|Overall Study|Withdrawal by Subject|27|||
16234792|NCT01015118|39341933|FG000|Overall Study|Other Adverse Event (AE)|141|||
16234793|NCT01015118|39341934|FG001|Overall Study|Other Adverse Event (AE)|33|||
16234794|NCT01015118|39341933|FG000|Overall Study|Worsening or AE of underlying disease|5|||
16234795|NCT01015118|39341934|FG001|Overall Study|Worsening or AE of underlying disease|4|||
16234796|NCT01015118|39341933|FG000|Overall Study|Progressive disease|364|||
16234797|NCT01015118|39341934|FG001|Overall Study|Progressive disease|229|||
16234798|NCT01015118|39341933|FG000|Overall Study|Not treated|9|||
16234799|NCT01015118|39341934|FG001|Overall Study|Not treated|5|||
16234800|NCT01015118|39341933|FG000|Overall Study|Other than stated above|42|||
16234801|NCT01015118|39341934|FG001|Overall Study|Other than stated above|23|||
16234802|NCT04935931|39344770|FG000|Overall Study|Withdrawal by Subject|1|||
16234803|NCT01615822|39344776|FG000|Period 1|Withdrawal by Subject|0|||
16234804|NCT01615822|39344777|FG001|Period 1|Withdrawal by Subject|1|||
16234805|NCT01615822|39344778|FG002|Period 1|Withdrawal by Subject|0|||
16234806|NCT01615822|39344776|FG000|Period 1|Adverse Event|1|||
16234807|NCT01615822|39344777|FG001|Period 1|Adverse Event|1|||
16234808|NCT01615822|39344778|FG002|Period 1|Adverse Event|0|||
16234809|NCT01615822|39344776|FG000|Period 2|Lost to Follow-up|0|||
16234810|NCT01615822|39344777|FG001|Period 2|Lost to Follow-up|1|||
16234811|NCT01615822|39344778|FG002|Period 2|Lost to Follow-up|2|||
16234812|NCT02076113|39344793|FG000|Overall Study|Lost to Follow-up|4|||
16234813|NCT02076113|39344794|FG001|Overall Study|Lost to Follow-up|1|||
16234814|NCT02076113|39344793|FG000|Overall Study|Withdrawal by Subject|2|||
16234815|NCT02076113|39344794|FG001|Overall Study|Withdrawal by Subject|3|||
16234816|NCT02076113|39344793|FG000|Overall Study|Death|1|||
16234817|NCT02076113|39344794|FG001|Overall Study|Death|3|||
16234818|NCT05144477|39344795|FG000|Overall Study|Withdrawal by Subject|1|||
16234819|NCT05144477|39344796|FG001|Overall Study|Withdrawal by Subject|1|||
16234820|NCT02531698|39344802|FG000|Overall Study|Adverse Event|2|||
16234821|NCT02531698|39344803|FG001|Overall Study|Adverse Event|1|||
16234822|NCT02531698|39344802|FG000|Overall Study|Withdrawal by Subject|6|||
16234823|NCT02531698|39344803|FG001|Overall Study|Withdrawal by Subject|1|||
16234824|NCT02531698|39344802|FG000|Overall Study|Protocol Violation|2|||
16234825|NCT02531698|39344803|FG001|Overall Study|Protocol Violation|0|||
16234826|NCT02531698|39344802|FG000|Overall Study|Lost to Follow-up|1|||
16234827|NCT02531698|39344803|FG001|Overall Study|Lost to Follow-up|0|||
16234828|NCT03853213|39344806|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
16348979|NCT00643201|39765541|FG001|Completed Study Follow Up|Death|34|||
16234829|NCT03853213|39344807|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
16234830|NCT03853213|39344806|FG000|Overall Study|Other (e.g., too busy)|0|||
16234831|NCT03853213|39344807|FG001|Overall Study|Other (e.g., too busy)|2|||
16234832|NCT00689273|39344808|FG000|Overall Study|Adverse Event|3|||
16234833|NCT00689273|39344809|FG001|Overall Study|Adverse Event|1|||
16234834|NCT00689273|39344808|FG000|Overall Study|Lack of Efficacy|3|||
16234835|NCT00689273|39344809|FG001|Overall Study|Lack of Efficacy|0|||
16234836|NCT00689273|39344808|FG000|Overall Study|Lost to Follow-up|0|||
16234837|NCT00689273|39344809|FG001|Overall Study|Lost to Follow-up|2|||
16234838|NCT00689273|39344808|FG000|Overall Study|Other|6|||
16234839|NCT00689273|39344809|FG001|Overall Study|Other|2|||
16234840|NCT00689273|39344808|FG000|Overall Study|Randomized but not Treated|1|||
16234841|NCT00689273|39344809|FG001|Overall Study|Randomized but not Treated|0|||
16234842|NCT00038467|39344810|FG000|Overall Study|Adverse Event|170|||
16234843|NCT00038467|39344811|FG001|Overall Study|Adverse Event|145|||
16234844|NCT00038467|39344810|FG000|Overall Study|Withdrawal by Subject|150|||
16234845|NCT00038467|39344811|FG001|Overall Study|Withdrawal by Subject|107|||
16234846|NCT00038467|39344810|FG000|Overall Study|Protocol Violation|19|||
16234847|NCT00038467|39344811|FG001|Overall Study|Protocol Violation|22|||
16234848|NCT00038467|39344810|FG000|Overall Study|Death|22|||
16234849|NCT00038467|39344811|FG001|Overall Study|Death|16|||
16234850|NCT00038467|39344810|FG000|Overall Study|Lost to Follow-up|15|||
16234851|NCT00038467|39344811|FG001|Overall Study|Lost to Follow-up|10|||
16234852|NCT00038467|39344810|FG000|Overall Study|Recurrence|109|||
16234853|NCT00038467|39344811|FG001|Overall Study|Recurrence|179|||
16234854|NCT00038467|39344810|FG000|Overall Study|Randomized, but not treated|31|||
16234855|NCT00038467|39344811|FG001|Overall Study|Randomized, but not treated|35|||
16234856|NCT00038467|39344810|FG000|Overall Study|Other|26|||
16234857|NCT00038467|39344811|FG001|Overall Study|Other|28|||
16234858|NCT03224234|39344821|FG000|Main Study|Lost to Follow-up|5|||
16234859|NCT03224234|39344822|FG001|Main Study|Lost to Follow-up|5|||
16234860|NCT00890409|39344823|FG000|Overall Study|Lost to Follow-up|20|||
16234861|NCT00890409|39344824|FG001|Overall Study|Lost to Follow-up|21|||
16234862|NCT04505592|39344825|FG000|Overall Study|Death|2|||
16234863|NCT04505592|39344826|FG001|Overall Study|Death|1|||
16234864|NCT00761735|39344827|FG000|Overall Study|Lost to Follow-up|6|||
16234865|NCT00761735|39344827|FG000|Overall Study|Withdrawal by Subject|6|||
16234866|NCT00761735|39344827|FG000|Overall Study|Non-compliance with protocol|1|||
16234867|NCT00761735|39344827|FG000|Overall Study|Administrative|1|||
16234868|NCT01414062|39344830|FG000|Overall Study|Lost to Follow-up|3|||
16234869|NCT01414062|39344831|FG001|Overall Study|Lost to Follow-up|2|||
16553582|NCT02769065|40492804|FG010|Overall Study|Voluntary Withdrawal|0|||
16553583|NCT02769065|40492805|FG011|Overall Study|Voluntary Withdrawal|0|||
16553584|NCT02769065|40492806|FG012|Overall Study|Voluntary Withdrawal|0|||
16553585|NCT02769065|40492807|FG013|Overall Study|Voluntary Withdrawal|0|||
16553586|NCT02769065|40492808|FG014|Overall Study|Voluntary Withdrawal|0|||
16553587|NCT02769065|40492809|FG015|Overall Study|Voluntary Withdrawal|0|||
16553588|NCT02769065|40492810|FG016|Overall Study|Voluntary Withdrawal|0|||
16234870|NCT01414062|39344830|FG000|Overall Study|Left Country|1|||
16234871|NCT01414062|39344831|FG001|Overall Study|Left Country|1|||
16234872|NCT01414062|39344830|FG000|Overall Study|Family Disapproval|1|||
16234873|NCT01414062|39344831|FG001|Overall Study|Family Disapproval|0|||
16234874|NCT01414062|39344830|FG000|Overall Study|Withdrawal by Subject|0|||
16234875|NCT01414062|39344831|FG001|Overall Study|Withdrawal by Subject|1|||
16234876|NCT04797637|39344840|FG000|Overall Study|Lost to Follow-up|23|||
16234877|NCT04797637|39344841|FG001|Overall Study|Lost to Follow-up|32|||
16553589|NCT02769065|40492811|FG017|Overall Study|Voluntary Withdrawal|0|||
16553590|NCT02769065|40492812|FG018|Overall Study|Voluntary Withdrawal|0|||
16553591|NCT02769065|40492813|FG019|Overall Study|Voluntary Withdrawal|0|||
16553592|NCT02769065|40492814|FG020|Overall Study|Voluntary Withdrawal|0|||
16553593|NCT02769065|40492815|FG021|Overall Study|Voluntary Withdrawal|0|||
16553594|NCT02769065|40492816|FG022|Overall Study|Voluntary Withdrawal|0|||
16553595|NCT02769065|40492817|FG023|Overall Study|Voluntary Withdrawal|0|||
16553596|NCT02769065|40492818|FG024|Overall Study|Voluntary Withdrawal|0|||
16553597|NCT02769065|40492819|FG025|Overall Study|Voluntary Withdrawal|0|||
16234878|NCT04797637|39344840|FG000|Overall Study|Withdrawal by Subject|0|||
16234879|NCT04797637|39344841|FG001|Overall Study|Withdrawal by Subject|1|||
16553598|NCT02769065|40492820|FG026|Overall Study|Voluntary Withdrawal|0|||
16234880|NCT00391092|39344842|FG000|Overall Study|Death|78|||
16234881|NCT00391092|39344843|FG001|Overall Study|Death|81|||
16234882|NCT00391092|39344842|FG000|Overall Study|Lost to Follow-up|13|||
16234883|NCT00391092|39344843|FG001|Overall Study|Lost to Follow-up|18|||
16234884|NCT00391092|39344842|FG000|Overall Study|Alive on treatment|29|||
16234885|NCT00391092|39344843|FG001|Overall Study|Alive on treatment|33|||
16234886|NCT00391092|39344842|FG000|Overall Study|Alive in follow-up|88|||
16234887|NCT00391092|39344843|FG001|Overall Study|Alive in follow-up|84|||
16234888|NCT02998645|39344844|FG000|Treatment Period 1|Adverse Event|6|||
16234889|NCT02998645|39344844|FG000|Treatment Period 1|Death|5|||
16553599|NCT02769065|40492821|FG027|Overall Study|Voluntary Withdrawal|0|||
16553600|NCT02769065|40492822|FG028|Overall Study|Voluntary Withdrawal|0|||
16234890|NCT02998645|39344844|FG000|Treatment Period 1|Technical Problems|4|||
16234891|NCT02998645|39344844|FG000|Treatment Period 1|Lack of Efficacy|2|||
16234892|NCT02998645|39344844|FG000|Treatment Period 1|Progressive disease|1|||
16234893|NCT02998645|39344844|FG000|Treatment Period 1|Subject/guardian decision|1|||
16234894|NCT02998645|39344844|FG000|Treatment Period 2|Lack of Efficacy|5|||
16234895|NCT02998645|39344844|FG000|Treatment Period 2|Adverse Event|2|||
16234896|NCT02998645|39344844|FG000|Treatment Period 2|Progressive disease|2|||
16234897|NCT02998645|39344844|FG000|Treatment Period 2|Physician Decision|1|||
16234898|NCT01494649|39344849|FG000|Overall Study|Lost to Follow-up|0|||
16234899|NCT01494649|39344850|FG001|Overall Study|Lost to Follow-up|1|||
16234900|NCT04342390|39344852|FG000|Overall Study|Lost to Follow-up|3|||
16234901|NCT04342390|39344853|FG001|Overall Study|Lost to Follow-up|0|||
16234902|NCT03867500|39344854|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
16234903|NCT03996694|39344857|FG000|First Washout (7 Days)|positive urine drug screen|0|||
16234904|NCT03996694|39344858|FG001|First Washout (7 Days)|positive urine drug screen|0|||
16234905|NCT03996694|39344859|FG002|First Washout (7 Days)|positive urine drug screen|1|||
16234906|NCT03996694|39344860|FG003|First Washout (7 Days)|positive urine drug screen|0|||
16234907|NCT03996694|39344861|FG004|First Washout (7 Days)|positive urine drug screen|0|||
16234908|NCT03996694|39344862|FG005|First Washout (7 Days)|positive urine drug screen|0|||
16234909|NCT03996694|39344857|FG000|First Washout (7 Days)|Adverse Event|0|||
16234910|NCT03996694|39344858|FG001|First Washout (7 Days)|Adverse Event|1|||
16234911|NCT03996694|39344859|FG002|First Washout (7 Days)|Adverse Event|0|||
16234912|NCT03996694|39344860|FG003|First Washout (7 Days)|Adverse Event|0|||
16234913|NCT03996694|39344861|FG004|First Washout (7 Days)|Adverse Event|0|||
16234914|NCT03996694|39344862|FG005|First Washout (7 Days)|Adverse Event|0|||
16234915|NCT03996694|39344857|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
16234916|NCT03996694|39344858|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
16234917|NCT03996694|39344859|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
16234918|NCT03996694|39344860|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
16234919|NCT03996694|39344861|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
16234920|NCT03996694|39344862|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
16234921|NCT03996694|39344857|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
16234922|NCT03996694|39344858|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
16234923|NCT03996694|39344859|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
16234924|NCT03996694|39344860|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
16234925|NCT03996694|39344861|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
16234926|NCT03996694|39344862|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
16234927|NCT00555399|39344863|FG000|Overall Study|Withdrawal by Subject|0|||
16234928|NCT00555399|39344864|FG001|Overall Study|Withdrawal by Subject|0|||
16234929|NCT00555399|39344865|FG002|Overall Study|Withdrawal by Subject|1|||
16234930|NCT00555399|39344866|FG003|Overall Study|Withdrawal by Subject|0|||
16234931|NCT00555399|39344867|FG004|Overall Study|Withdrawal by Subject|0|||
16234932|NCT00555399|39344868|FG005|Overall Study|Withdrawal by Subject|0|||
16553601|NCT02769065|40492823|FG029|Overall Study|Voluntary Withdrawal|0|||
16553602|NCT02769065|40492794|FG000|Overall Study|Reason Not Specified|0|||
16553603|NCT02769065|40492795|FG001|Overall Study|Reason Not Specified|0|||
16553604|NCT02769065|40492796|FG002|Overall Study|Reason Not Specified|0|||
16553605|NCT02769065|40492797|FG003|Overall Study|Reason Not Specified|0|||
16553606|NCT02769065|40492798|FG004|Overall Study|Reason Not Specified|0|||
16553607|NCT02769065|40492799|FG005|Overall Study|Reason Not Specified|0|||
16553608|NCT02769065|40492800|FG006|Overall Study|Reason Not Specified|1|||
16553609|NCT02769065|40492801|FG007|Overall Study|Reason Not Specified|0|||
16553610|NCT02769065|40492802|FG008|Overall Study|Reason Not Specified|0|||
16553611|NCT02769065|40492803|FG009|Overall Study|Reason Not Specified|0|||
16553612|NCT02769065|40492804|FG010|Overall Study|Reason Not Specified|0|||
16553613|NCT02769065|40492805|FG011|Overall Study|Reason Not Specified|0|||
16553614|NCT02769065|40492806|FG012|Overall Study|Reason Not Specified|0|||
16553615|NCT02769065|40492807|FG013|Overall Study|Reason Not Specified|0|||
16553616|NCT02769065|40492808|FG014|Overall Study|Reason Not Specified|0|||
16553617|NCT02769065|40492809|FG015|Overall Study|Reason Not Specified|0|||
16553618|NCT02769065|40492810|FG016|Overall Study|Reason Not Specified|0|||
16553619|NCT02769065|40492811|FG017|Overall Study|Reason Not Specified|0|||
16553620|NCT02769065|40492812|FG018|Overall Study|Reason Not Specified|0|||
16553621|NCT02769065|40492813|FG019|Overall Study|Reason Not Specified|0|||
16553622|NCT02769065|40492814|FG020|Overall Study|Reason Not Specified|0|||
16553623|NCT02769065|40492815|FG021|Overall Study|Reason Not Specified|0|||
16553624|NCT02769065|40492816|FG022|Overall Study|Reason Not Specified|0|||
16553625|NCT02769065|40492817|FG023|Overall Study|Reason Not Specified|0|||
16553626|NCT02769065|40492818|FG024|Overall Study|Reason Not Specified|0|||
16234933|NCT00555399|39344869|FG006|Overall Study|Withdrawal by Subject|0|||
16234934|NCT00555399|39344870|FG007|Overall Study|Withdrawal by Subject|0|||
16234935|NCT00555399|39344871|FG008|Overall Study|Withdrawal by Subject|0|||
16234936|NCT00555399|39344872|FG009|Overall Study|Withdrawal by Subject|0|||
16234937|NCT00555399|39344873|FG010|Overall Study|Withdrawal by Subject|0|||
16234938|NCT00555399|39344874|FG011|Overall Study|Withdrawal by Subject|1|||
16234939|NCT00555399|39344863|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
16553627|NCT02769065|40492819|FG025|Overall Study|Reason Not Specified|0|||
16553628|NCT02769065|40492820|FG026|Overall Study|Reason Not Specified|0|||
16553629|NCT02769065|40492821|FG027|Overall Study|Reason Not Specified|0|||
16553630|NCT02769065|40492822|FG028|Overall Study|Reason Not Specified|0|||
16553631|NCT02769065|40492823|FG029|Overall Study|Reason Not Specified|0|||
16553632|NCT02769065|40492794|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553633|NCT02769065|40492795|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553634|NCT02769065|40492796|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553635|NCT02769065|40492797|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553636|NCT02769065|40492798|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553637|NCT02769065|40492799|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
16234940|NCT00555399|39344864|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
16234941|NCT00555399|39344865|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
16234942|NCT00555399|39344866|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
16234943|NCT00555399|39344867|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
16234944|NCT00555399|39344868|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
16234945|NCT00555399|39344869|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
16234946|NCT00555399|39344870|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
16234947|NCT00555399|39344871|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
16234948|NCT00555399|39344872|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
16234949|NCT00555399|39344873|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
16234950|NCT00555399|39344874|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
16234951|NCT04199104|39344875|FG000|Overall Study|Death|148|||
16234952|NCT04199104|39344876|FG001|Overall Study|Death|134|||
16234953|NCT04199104|39344875|FG000|Overall Study|Lost to Follow-up|1|||
16234954|NCT04199104|39344876|FG001|Overall Study|Lost to Follow-up|1|||
16234955|NCT04199104|39344875|FG000|Overall Study|Withdrawal by Subject|4|||
16234956|NCT04199104|39344876|FG001|Overall Study|Withdrawal by Subject|4|||
16234957|NCT04199104|39344875|FG000|Overall Study|Participants Ongoing|103|||
16553638|NCT02769065|40492800|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553639|NCT02769065|40492801|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553640|NCT02769065|40492802|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553641|NCT02769065|40492803|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553642|NCT02769065|40492804|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
16553643|NCT02769065|40492805|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553644|NCT02769065|40492806|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553645|NCT02769065|40492807|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553646|NCT02769065|40492808|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553647|NCT02769065|40492809|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553648|NCT02769065|40492810|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553649|NCT02769065|40492811|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553650|NCT02769065|40492812|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553651|NCT02769065|40492813|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553652|NCT02769065|40492814|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553653|NCT02769065|40492815|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553654|NCT02769065|40492816|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553655|NCT02769065|40492817|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553656|NCT02769065|40492818|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553657|NCT02769065|40492819|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553658|NCT02769065|40492820|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553659|NCT02769065|40492821|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553660|NCT02769065|40492822|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553661|NCT02769065|40492823|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
16553662|NCT02638623|40492824|FG000|Overall Study|Surgery timing|5|||
16553663|NCT02638623|40492825|FG001|Overall Study|Surgery timing|6|||
16553664|NCT02638623|40492824|FG000|Overall Study|Not given intervention|2|||
16553665|NCT02638623|40492825|FG001|Overall Study|Not given intervention|0|||
16553666|NCT04867785|40492831|FG000|Overall Study|Adverse Event|1|||
16553667|NCT04867785|40492832|FG001|Overall Study|Adverse Event|0|||
16553668|NCT04867785|40492833|FG002|Overall Study|Adverse Event|1|||
16553669|NCT04867785|40492834|FG003|Overall Study|Adverse Event|0|||
16553670|NCT04867785|40492835|FG004|Overall Study|Adverse Event|0|||
16553671|NCT04867785|40492836|FG005|Overall Study|Adverse Event|0|||
16553672|NCT04867785|40492837|FG006|Overall Study|Adverse Event|0|||
16553673|NCT04867785|40492838|FG007|Overall Study|Adverse Event|2|||
16553674|NCT04867785|40492831|FG000|Overall Study|Lost to Follow-up|4|||
16553675|NCT04867785|40492832|FG001|Overall Study|Lost to Follow-up|4|||
16234958|NCT04199104|39344876|FG001|Overall Study|Participants Ongoing|116|||
16553676|NCT04867785|40492833|FG002|Overall Study|Lost to Follow-up|3|||
16553677|NCT04867785|40492834|FG003|Overall Study|Lost to Follow-up|2|||
16553678|NCT04867785|40492835|FG004|Overall Study|Lost to Follow-up|0|||
16553679|NCT04867785|40492836|FG005|Overall Study|Lost to Follow-up|1|||
16553680|NCT04867785|40492837|FG006|Overall Study|Lost to Follow-up|0|||
16553681|NCT04867785|40492838|FG007|Overall Study|Lost to Follow-up|1|||
16553682|NCT04867785|40492831|FG000|Overall Study|Withdrawal by Subject|6|||
16553683|NCT04867785|40492832|FG001|Overall Study|Withdrawal by Subject|2|||
16553684|NCT04867785|40492833|FG002|Overall Study|Withdrawal by Subject|2|||
16553685|NCT04867785|40492834|FG003|Overall Study|Withdrawal by Subject|1|||
16553686|NCT04867785|40492835|FG004|Overall Study|Withdrawal by Subject|2|||
16553687|NCT04867785|40492836|FG005|Overall Study|Withdrawal by Subject|0|||
16553688|NCT04867785|40492837|FG006|Overall Study|Withdrawal by Subject|2|||
16553689|NCT04867785|40492838|FG007|Overall Study|Withdrawal by Subject|5|||
16553690|NCT04867785|40492831|FG000|Overall Study|Physician Decision|0|||
16553691|NCT04867785|40492832|FG001|Overall Study|Physician Decision|0|||
16553692|NCT04867785|40492833|FG002|Overall Study|Physician Decision|0|||
16553693|NCT04867785|40492834|FG003|Overall Study|Physician Decision|0|||
16553694|NCT04867785|40492835|FG004|Overall Study|Physician Decision|0|||
16553695|NCT04867785|40492836|FG005|Overall Study|Physician Decision|0|||
16553696|NCT04867785|40492837|FG006|Overall Study|Physician Decision|0|||
16553697|NCT04867785|40492838|FG007|Overall Study|Physician Decision|1|||
16553698|NCT04867785|40492831|FG000|Overall Study|Inadvertent Enrollment|0|||
16553699|NCT04867785|40492832|FG001|Overall Study|Inadvertent Enrollment|0|||
16553700|NCT04867785|40492833|FG002|Overall Study|Inadvertent Enrollment|0|||
16553701|NCT04867785|40492834|FG003|Overall Study|Inadvertent Enrollment|1|||
16553702|NCT04867785|40492835|FG004|Overall Study|Inadvertent Enrollment|1|||
16553703|NCT04867785|40492836|FG005|Overall Study|Inadvertent Enrollment|0|||
16553704|NCT04867785|40492837|FG006|Overall Study|Inadvertent Enrollment|0|||
16553705|NCT04867785|40492838|FG007|Overall Study|Inadvertent Enrollment|1|||
16553706|NCT04867785|40492831|FG000|Overall Study|Eligibility Criteria Not Met|0|||
16553707|NCT04867785|40492832|FG001|Overall Study|Eligibility Criteria Not Met|0|||
16553708|NCT04867785|40492833|FG002|Overall Study|Eligibility Criteria Not Met|0|||
16553709|NCT04867785|40492834|FG003|Overall Study|Eligibility Criteria Not Met|0|||
16553710|NCT04867785|40492835|FG004|Overall Study|Eligibility Criteria Not Met|0|||
16553711|NCT04867785|40492836|FG005|Overall Study|Eligibility Criteria Not Met|0|||
16553712|NCT04867785|40492837|FG006|Overall Study|Eligibility Criteria Not Met|0|||
16553713|NCT04867785|40492838|FG007|Overall Study|Eligibility Criteria Not Met|1|||
16553714|NCT03306043|40492839|FG000|Overall Study|Adverse Event|1|||
16553715|NCT03306043|40492839|FG000|Overall Study|Lost to Follow-up|1|||
16234959|NCT03332212|39344878|FG000|Overall Study|Not treated|0|||
16234960|NCT03332212|39344879|FG001|Overall Study|Not treated|1|||
16234961|NCT03332212|39344880|FG002|Overall Study|Not treated|0|||
16234962|NCT03332212|39344881|FG003|Overall Study|Not treated|0|||
16234963|NCT03332212|39344878|FG000|Overall Study|Adverse Event|0|||
16234964|NCT03332212|39344879|FG001|Overall Study|Adverse Event|0|||
16234965|NCT03332212|39344880|FG002|Overall Study|Adverse Event|0|||
16234966|NCT03332212|39344881|FG003|Overall Study|Adverse Event|1|||
16553716|NCT03306043|40492839|FG000|Overall Study|Withdrawal by Subject|2|||
16553717|NCT01630590|40492842|FG000|Overall Study|Adverse Event|9|||
16553718|NCT01630590|40492842|FG000|Overall Study|Lack of Efficacy|37|||
16553719|NCT01630590|40492842|FG000|Overall Study|Withdrawal by Subject|4|||
16553720|NCT01630590|40492842|FG000|Overall Study|2nd primary tumor|2|||
16553721|NCT01630590|40492842|FG000|Overall Study|Automobile accident|1|||
16553722|NCT01630590|40492842|FG000|Overall Study|Maximum benefit|4|||
16553723|NCT01225822|40492843|FG000|Overall Study|Adverse Event|13|||
16234967|NCT03332212|39344878|FG000|Overall Study|worsening of disease under study|1|||
16553724|NCT01225822|40492844|FG001|Overall Study|Adverse Event|31|||
16348980|NCT00643201|39765540|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
16348981|NCT00643201|39765541|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
16348982|NCT00643201|39765540|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
16348983|NCT00643201|39765541|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
16348984|NCT00643201|39765540|FG000|Completed Study Follow Up|non-specified|1|||
16348985|NCT00643201|39765541|FG001|Completed Study Follow Up|non-specified|0|||
16348986|NCT02419807|39765548|FG000|Overall Study|Withdrawal by Subject|4|||
16348987|NCT02419807|39765548|FG000|Overall Study|Physician Decision|1|||
16348988|NCT02419807|39765548|FG000|Overall Study|Protocol Violation|5|||
16348989|NCT01869777|39765549|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
16348990|NCT00289276|39765550|FG000|Second Part of FAST Study (Expansion)|Death|0|||
16348991|NCT00289276|39765551|FG001|Second Part of FAST Study (Expansion)|Death|2|||
16348992|NCT00289276|39765550|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
16553725|NCT01225822|40492845|FG002|Overall Study|Adverse Event|18|||
16553726|NCT01225822|40492846|FG003|Overall Study|Adverse Event|23|||
16553727|NCT01225822|40492847|FG004|Overall Study|Adverse Event|14|||
16553728|NCT01225822|40492843|FG000|Overall Study|Protocol Violation|6|||
16553729|NCT01225822|40492844|FG001|Overall Study|Protocol Violation|8|||
16553730|NCT01225822|40492845|FG002|Overall Study|Protocol Violation|6|||
16553731|NCT01225822|40492846|FG003|Overall Study|Protocol Violation|7|||
16553732|NCT01225822|40492847|FG004|Overall Study|Protocol Violation|4|||
16553733|NCT01225822|40492843|FG000|Overall Study|Lost to Follow-up|0|||
16553734|NCT01225822|40492844|FG001|Overall Study|Lost to Follow-up|0|||
16553735|NCT01225822|40492845|FG002|Overall Study|Lost to Follow-up|0|||
16553736|NCT01225822|40492846|FG003|Overall Study|Lost to Follow-up|1|||
16553737|NCT01225822|40492847|FG004|Overall Study|Lost to Follow-up|0|||
16553738|NCT01225822|40492843|FG000|Overall Study|Withdrawal by Subject|6|||
16553739|NCT01225822|40492844|FG001|Overall Study|Withdrawal by Subject|7|||
16553740|NCT01225822|40492845|FG002|Overall Study|Withdrawal by Subject|7|||
16553741|NCT01225822|40492846|FG003|Overall Study|Withdrawal by Subject|11|||
16553742|NCT01225822|40492847|FG004|Overall Study|Withdrawal by Subject|6|||
16553743|NCT01225822|40492843|FG000|Overall Study|Other|13|||
16553744|NCT01225822|40492844|FG001|Overall Study|Other|10|||
16553745|NCT01225822|40492845|FG002|Overall Study|Other|7|||
16553746|NCT01225822|40492846|FG003|Overall Study|Other|10|||
16553747|NCT01225822|40492847|FG004|Overall Study|Other|7|||
16553748|NCT05033743|40492850|FG000|Overall Study|Lost to Follow-up|1|||
16553749|NCT05033743|40492850|FG000|Overall Study|Protocol Violation|2|||
16553750|NCT05033743|40492850|FG000|Overall Study|Withdrawal by Subject|1|||
16553751|NCT02065570|40492853|FG000|Induction Study|Adverse Event|5|||
16553752|NCT02065570|40492854|FG001|Induction Study|Adverse Event|12|||
16553753|NCT02065570|40492855|FG002|Induction Study|Adverse Event|0|||
16553754|NCT02065570|40492856|FG003|Induction Study|Adverse Event|0|||
16553755|NCT02065570|40492853|FG000|Induction Study|Withdrawal by Subject|2|||
16553756|NCT02065570|40492854|FG001|Induction Study|Withdrawal by Subject|3|||
16553757|NCT02065570|40492855|FG002|Induction Study|Withdrawal by Subject|0|||
16553758|NCT02065570|40492856|FG003|Induction Study|Withdrawal by Subject|0|||
16553759|NCT02065570|40492853|FG000|Induction Study|Lost to Follow-up|1|||
16553760|NCT02065570|40492854|FG001|Induction Study|Lost to Follow-up|1|||
16553761|NCT02065570|40492855|FG002|Induction Study|Lost to Follow-up|0|||
16553762|NCT02065570|40492856|FG003|Induction Study|Lost to Follow-up|0|||
16553763|NCT02065570|40492853|FG000|Induction Study|Other, Not Specified|6|||
16553764|NCT02065570|40492854|FG001|Induction Study|Other, Not Specified|5|||
16553765|NCT02065570|40492855|FG002|Induction Study|Other, Not Specified|0|||
16553766|NCT02065570|40492856|FG003|Induction Study|Other, Not Specified|0|||
16553767|NCT02065570|40492853|FG000|Maintenance Study|Adverse Event|0|||
16553768|NCT02065570|40492854|FG001|Maintenance Study|Adverse Event|0|||
16553769|NCT02065570|40492855|FG002|Maintenance Study|Adverse Event|8|||
16553770|NCT02065570|40492856|FG003|Maintenance Study|Adverse Event|8|||
16553771|NCT02065570|40492853|FG000|Maintenance Study|Withdrawal by Subject|0|||
16553772|NCT02065570|40492854|FG001|Maintenance Study|Withdrawal by Subject|0|||
16553773|NCT02065570|40492855|FG002|Maintenance Study|Withdrawal by Subject|1|||
16553774|NCT02065570|40492856|FG003|Maintenance Study|Withdrawal by Subject|4|||
16553775|NCT02065570|40492853|FG000|Maintenance Study|Lost to Follow-up|0|||
16553776|NCT02065570|40492854|FG001|Maintenance Study|Lost to Follow-up|0|||
16553777|NCT02065570|40492855|FG002|Maintenance Study|Lost to Follow-up|2|||
16553778|NCT02065570|40492856|FG003|Maintenance Study|Lost to Follow-up|2|||
16553779|NCT02065570|40492853|FG000|Maintenance Study|Other, Not Specified|0|||
16553780|NCT02065570|40492854|FG001|Maintenance Study|Other, Not Specified|0|||
16348993|NCT00289276|39765551|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
16553781|NCT02065570|40492855|FG002|Maintenance Study|Other, Not Specified|11|||
16553782|NCT02065570|40492856|FG003|Maintenance Study|Other, Not Specified|5|||
16348994|NCT02239640|39765553|FG000|Overall Study|Withdrawal by Subject|3|||
16553783|NCT03051659|40492857|FG000|Treatment Period|Withdrawal by Subject|0|||
16553784|NCT03051659|40492858|FG001|Treatment Period|Withdrawal by Subject|2|||
16553785|NCT03051659|40492857|FG000|Survival Follow-up|Lost to Follow-up|23|||
16234968|NCT03332212|39344879|FG001|Overall Study|worsening of disease under study|1|||
16234969|NCT03332212|39344880|FG002|Overall Study|worsening of disease under study|0|||
16234970|NCT03332212|39344881|FG003|Overall Study|worsening of disease under study|0|||
16234971|NCT01100073|39344882|FG000|Overall Study|Lack of Efficacy|4|||
16234972|NCT01100073|39344882|FG000|Overall Study|Insufficient Tolerability|21|||
16234973|NCT01100073|39344882|FG000|Overall Study|Withdrawal by Subject|13|||
16234974|NCT01100073|39344882|FG000|Overall Study|Lost to Follow-up|39|||
16234975|NCT01100073|39344882|FG000|Overall Study|Lack of effect + patient's wish|2|||
16234976|NCT01100073|39344882|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
16553786|NCT03051659|40492858|FG001|Survival Follow-up|Lost to Follow-up|22|||
16553787|NCT01993823|40492859|FG000|Overall Study|Requested by the patient|6|||
16553788|NCT01993823|40492860|FG001|Overall Study|Requested by the patient|11|||
16553789|NCT01993823|40492859|FG000|Overall Study|Protocol Violation|0|||
16553790|NCT01993823|40492860|FG001|Overall Study|Protocol Violation|1|||
16553791|NCT01993823|40492859|FG000|Overall Study|Lost to Follow-up|1|||
16553792|NCT01993823|40492860|FG001|Overall Study|Lost to Follow-up|4|||
16553793|NCT01651936|40492861|FG000|Base Study|Adverse Event|3|||
16553794|NCT01651936|40492862|FG001|Base Study|Adverse Event|0|||
16553795|NCT01651936|40492863|FG002|Base Study|Adverse Event|0|||
16553796|NCT01651936|40492861|FG000|Base Study|Withdrawal by Subject|1|||
16553797|NCT01651936|40492862|FG001|Base Study|Withdrawal by Subject|1|||
16553798|NCT01651936|40492863|FG002|Base Study|Withdrawal by Subject|0|||
16553799|NCT01651936|40492861|FG000|Base Study|Early Escape|2|||
16553800|NCT01651936|40492862|FG001|Base Study|Early Escape|8|||
16553801|NCT01651936|40492863|FG002|Base Study|Early Escape|0|||
16553802|NCT01651936|40492861|FG000|Base Study|Study terminated by sponsor|21|||
16553803|NCT01651936|40492862|FG001|Base Study|Study terminated by sponsor|16|||
16553804|NCT01651936|40492863|FG002|Base Study|Study terminated by sponsor|0|||
16553805|NCT01651936|40492861|FG000|Extension Study|Lack of Efficacy|0|||
16553806|NCT01651936|40492862|FG001|Extension Study|Lack of Efficacy|0|||
16553807|NCT01651936|40492863|FG002|Extension Study|Lack of Efficacy|1|||
16553808|NCT01651936|40492861|FG000|Extension Study|Study terminated by sponsor|0|||
16553809|NCT01651936|40492862|FG001|Extension Study|Study terminated by sponsor|0|||
16553810|NCT01651936|40492863|FG002|Extension Study|Study terminated by sponsor|13|||
16553811|NCT05284019|40492868|FG000|Overall Study|Study terminated|2|||
16553812|NCT05284019|40492869|FG001|Overall Study|Study terminated|2|||
16553813|NCT05284019|40492870|FG002|Overall Study|Study terminated|2|||
16553814|NCT05284019|40492871|FG003|Overall Study|Study terminated|5|||
16553815|NCT05284019|40492872|FG004|Overall Study|Study terminated|15|||
16553816|NCT05284019|40492868|FG000|Overall Study|Withdrawal by Subject|0|||
16553817|NCT05284019|40492869|FG001|Overall Study|Withdrawal by Subject|0|||
16553818|NCT05284019|40492870|FG002|Overall Study|Withdrawal by Subject|0|||
16553819|NCT05284019|40492871|FG003|Overall Study|Withdrawal by Subject|1|||
16553820|NCT05284019|40492872|FG004|Overall Study|Withdrawal by Subject|1|||
16553821|NCT05284019|40492868|FG000|Overall Study|Lost to Follow-up|1|||
16553822|NCT05284019|40492869|FG001|Overall Study|Lost to Follow-up|0|||
16553823|NCT05284019|40492870|FG002|Overall Study|Lost to Follow-up|0|||
16553824|NCT05284019|40492871|FG003|Overall Study|Lost to Follow-up|2|||
16234977|NCT01100073|39344882|FG000|Overall Study|Other|8|||
16234978|NCT01100073|39344882|FG000|Overall Study|Missing|5|||
16234979|NCT01260194|39344883|FG000|Overall Study|Withdrawal of Consent|1|||
16234980|NCT02723786|39344884|FG000|Overall Study|Lost to Follow-up|1|||
16234981|NCT00320801|39344885|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
16234982|NCT00320801|39344886|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
16234983|NCT00320801|39344887|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
16234984|NCT00320801|39344888|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
16234985|NCT00320801|39344885|FG000|Open-label Run-in Period|Adverse Event|33|||
16234986|NCT00320801|39344886|FG001|Open-label Run-in Period|Adverse Event|0|||
16234987|NCT00320801|39344887|FG002|Open-label Run-in Period|Adverse Event|0|||
16234988|NCT00320801|39344888|FG003|Open-label Run-in Period|Adverse Event|0|||
16234989|NCT00320801|39344885|FG000|Open-label Run-in Period|Administrative|10|||
16234990|NCT00320801|39344886|FG001|Open-label Run-in Period|Administrative|0|||
16234991|NCT00320801|39344887|FG002|Open-label Run-in Period|Administrative|0|||
16234992|NCT00320801|39344888|FG003|Open-label Run-in Period|Administrative|0|||
16234993|NCT00320801|39344885|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
16234994|NCT00320801|39344886|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
16234995|NCT00320801|39344887|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
16234996|NCT00320801|39344888|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
16234997|NCT00320801|39344885|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
16234998|NCT00320801|39344886|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
16553825|NCT05284019|40492872|FG004|Overall Study|Lost to Follow-up|1|||
16553826|NCT04182880|40492873|FG000|Overall Study|Pregnancy|1|||
16553827|NCT04182880|40492874|FG001|Overall Study|Pregnancy|0|||
16553828|NCT01807221|40492875|FG000|Overall Study|Progressive disease|1|||
16553829|NCT01807221|40492876|FG001|Overall Study|Progressive disease|0|||
16553830|NCT01807221|40492877|FG002|Overall Study|Progressive disease|1|||
16553831|NCT01807221|40492878|FG003|Overall Study|Progressive disease|0|||
16553832|NCT01807221|40492879|FG004|Overall Study|Progressive disease|0|||
16553833|NCT01807221|40492880|FG005|Overall Study|Progressive disease|0|||
16234999|NCT00320801|39344887|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
16235000|NCT00320801|39344888|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
16235001|NCT00320801|39344885|FG000|Open-label Run-in Period|Did not qualify|1|||
16553834|NCT01807221|40492875|FG000|Overall Study|Death|7|||
16553835|NCT01807221|40492876|FG001|Overall Study|Death|9|||
16553836|NCT01807221|40492877|FG002|Overall Study|Death|4|||
16553837|NCT01807221|40492878|FG003|Overall Study|Death|2|||
16553838|NCT01807221|40492879|FG004|Overall Study|Death|1|||
16553839|NCT01807221|40492880|FG005|Overall Study|Death|6|||
16553840|NCT01807221|40492875|FG000|Overall Study|Physician Decision|2|||
16553841|NCT01807221|40492876|FG001|Overall Study|Physician Decision|1|||
16553842|NCT01807221|40492877|FG002|Overall Study|Physician Decision|0|||
16348995|NCT02239640|39765553|FG000|Overall Study|Lost to Follow-up|72|||
16553843|NCT01807221|40492878|FG003|Overall Study|Physician Decision|0|||
16553844|NCT01807221|40492879|FG004|Overall Study|Physician Decision|0|||
16348996|NCT02239640|39765553|FG000|Overall Study|Death|142|||
16348997|NCT01419314|39765554|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
16348998|NCT01419314|39765555|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
16348999|NCT01419314|39765554|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
16349000|NCT01419314|39765555|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
16349001|NCT01419314|39765554|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
16349002|NCT01419314|39765555|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
16349003|NCT00536510|39765556|FG000|Overall Study|Adverse Event|27|||
16349004|NCT00536510|39765557|FG001|Overall Study|Adverse Event|4|||
16349005|NCT00536510|39765556|FG000|Overall Study|Lost to Follow-up|11|||
16349006|NCT00536510|39765557|FG001|Overall Study|Lost to Follow-up|8|||
16349007|NCT00536510|39765556|FG000|Overall Study|Protocol Violation|4|||
16349008|NCT00536510|39765557|FG001|Overall Study|Protocol Violation|5|||
16349009|NCT00536510|39765556|FG000|Overall Study|Withdrawal by Subject|16|||
16349010|NCT00536510|39765557|FG001|Overall Study|Withdrawal by Subject|9|||
16349011|NCT00536510|39765556|FG000|Overall Study|Flushing with Product|20|||
16349012|NCT00536510|39765557|FG001|Overall Study|Flushing with Product|0|||
16349013|NCT00536510|39765556|FG000|Overall Study|Laboratory Adverse Event|2|||
16349014|NCT00536510|39765557|FG001|Overall Study|Laboratory Adverse Event|1|||
16349015|NCT00536510|39765556|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
16349016|NCT00536510|39765557|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
16349017|NCT05417412|39765564|FG000|Overall Study|Lost to Follow-up|2|||
16553845|NCT01807221|40492880|FG005|Overall Study|Physician Decision|0|||
16553846|NCT01807221|40492875|FG000|Overall Study|Adverse Event|33|||
16553847|NCT01807221|40492876|FG001|Overall Study|Adverse Event|22|||
16553848|NCT01807221|40492877|FG002|Overall Study|Adverse Event|26|||
16553849|NCT01807221|40492878|FG003|Overall Study|Adverse Event|25|||
16553850|NCT01807221|40492879|FG004|Overall Study|Adverse Event|18|||
16553851|NCT01807221|40492880|FG005|Overall Study|Adverse Event|21|||
16553852|NCT01807221|40492875|FG000|Overall Study|Protocol Violation|0|||
16553853|NCT01807221|40492876|FG001|Overall Study|Protocol Violation|2|||
16553854|NCT01807221|40492877|FG002|Overall Study|Protocol Violation|1|||
16553855|NCT01807221|40492878|FG003|Overall Study|Protocol Violation|2|||
16553856|NCT01807221|40492879|FG004|Overall Study|Protocol Violation|0|||
16553857|NCT01807221|40492880|FG005|Overall Study|Protocol Violation|1|||
16553858|NCT01807221|40492875|FG000|Overall Study|Non-compliance|1|||
16553859|NCT01807221|40492876|FG001|Overall Study|Non-compliance|2|||
16553860|NCT01807221|40492877|FG002|Overall Study|Non-compliance|0|||
16553861|NCT01807221|40492878|FG003|Overall Study|Non-compliance|1|||
16553862|NCT01807221|40492879|FG004|Overall Study|Non-compliance|0|||
16553863|NCT01807221|40492880|FG005|Overall Study|Non-compliance|0|||
16553864|NCT01807221|40492875|FG000|Overall Study|Logistical difficulties|0|||
16553865|NCT01807221|40492876|FG001|Overall Study|Logistical difficulties|1|||
16553866|NCT01807221|40492877|FG002|Overall Study|Logistical difficulties|0|||
16553867|NCT01807221|40492878|FG003|Overall Study|Logistical difficulties|0|||
16553868|NCT01807221|40492879|FG004|Overall Study|Logistical difficulties|1|||
16553869|NCT01807221|40492880|FG005|Overall Study|Logistical difficulties|0|||
16553870|NCT01807221|40492875|FG000|Overall Study|Withdrawal by Subject|33|||
16349018|NCT02686164|39765567|FG000|Overall Study|Adverse Event|1|||
16349019|NCT02686164|39765567|FG000|Overall Study|Withdrawal of consent|1|||
16235002|NCT00320801|39344886|FG001|Open-label Run-in Period|Did not qualify|0|||
16235003|NCT00320801|39344887|FG002|Open-label Run-in Period|Did not qualify|0|||
16349020|NCT02686164|39765567|FG000|Overall Study|Clinical progression|1|||
16349021|NCT03160716|39765568|FG000|Overall Study|Lost to Follow-up|1|||
16349022|NCT02557399|39765569|FG000|Overall Study|Adverse Event|6|||
16553871|NCT01807221|40492876|FG001|Overall Study|Withdrawal by Subject|15|||
16553872|NCT01807221|40492877|FG002|Overall Study|Withdrawal by Subject|8|||
16553873|NCT01807221|40492878|FG003|Overall Study|Withdrawal by Subject|14|||
16553874|NCT01807221|40492879|FG004|Overall Study|Withdrawal by Subject|16|||
16553875|NCT01807221|40492880|FG005|Overall Study|Withdrawal by Subject|13|||
16553876|NCT01807221|40492875|FG000|Overall Study|Sponsor decision|2|||
16553877|NCT01807221|40492876|FG001|Overall Study|Sponsor decision|0|||
16553878|NCT01807221|40492877|FG002|Overall Study|Sponsor decision|1|||
16553879|NCT01807221|40492878|FG003|Overall Study|Sponsor decision|1|||
16121015|NCT02643303|38930055|FG006|Overall Study|Adverse Event|0|||
16121016|NCT02643303|38930056|FG007|Overall Study|Adverse Event|0|||
16121017|NCT02643303|38930057|FG008|Overall Study|Adverse Event|0|||
16121018|NCT02643303|38930049|FG000|Overall Study|Withdrawal by Subject|0|||
16121019|NCT02643303|38930050|FG001|Overall Study|Withdrawal by Subject|0|||
16553880|NCT01807221|40492879|FG004|Overall Study|Sponsor decision|0|||
16121020|NCT02643303|38930051|FG002|Overall Study|Withdrawal by Subject|0|||
16121021|NCT02643303|38930052|FG003|Overall Study|Withdrawal by Subject|1|||
16235004|NCT00320801|39344888|FG003|Open-label Run-in Period|Did not qualify|0|||
16553881|NCT01807221|40492880|FG005|Overall Study|Sponsor decision|0|||
16553882|NCT01807221|40492875|FG000|Overall Study|Lost to Follow-up|1|||
16553883|NCT01807221|40492876|FG001|Overall Study|Lost to Follow-up|0|||
16553884|NCT01807221|40492877|FG002|Overall Study|Lost to Follow-up|2|||
16553885|NCT01807221|40492878|FG003|Overall Study|Lost to Follow-up|1|||
16553886|NCT01807221|40492879|FG004|Overall Study|Lost to Follow-up|0|||
16553887|NCT01807221|40492880|FG005|Overall Study|Lost to Follow-up|0|||
16553888|NCT01425632|40492883|FG000|Overall Study|Adverse Event|0|||
16553889|NCT01425632|40492884|FG001|Overall Study|Adverse Event|1|||
16553890|NCT01425632|40492885|FG002|Overall Study|Adverse Event|1|||
16553891|NCT01425632|40492883|FG000|Overall Study|Physician Decision|1|||
16553892|NCT01425632|40492884|FG001|Overall Study|Physician Decision|0|||
16553893|NCT01425632|40492885|FG002|Overall Study|Physician Decision|0|||
16553894|NCT01425632|40492883|FG000|Overall Study|Protocol Violation|0|||
16553895|NCT01425632|40492884|FG001|Overall Study|Protocol Violation|0|||
16553896|NCT01425632|40492885|FG002|Overall Study|Protocol Violation|2|||
16553897|NCT01425632|40492883|FG000|Overall Study|Withdrawal by Subject|0|||
16553898|NCT01425632|40492884|FG001|Overall Study|Withdrawal by Subject|0|||
16553899|NCT01425632|40492885|FG002|Overall Study|Withdrawal by Subject|1|||
16553900|NCT02138747|40492886|FG000|Treatment Period 1|Adverse Event|10|||
16553901|NCT02138747|40492887|FG001|Treatment Period 1|Adverse Event|14|||
16553902|NCT02138747|40492888|FG002|Treatment Period 1|Adverse Event|2|||
16553903|NCT02138747|40492889|FG003|Treatment Period 1|Adverse Event|1|||
16553904|NCT02138747|40492886|FG000|Treatment Period 1|Lost to Follow-up|0|||
16553905|NCT02138747|40492887|FG001|Treatment Period 1|Lost to Follow-up|1|||
16553906|NCT02138747|40492888|FG002|Treatment Period 1|Lost to Follow-up|1|||
16553907|NCT02138747|40492889|FG003|Treatment Period 1|Lost to Follow-up|0|||
16235005|NCT00320801|39344885|FG000|Double-blind Phase|Withdrawal by Subject|0|||
16235006|NCT00320801|39344886|FG001|Double-blind Phase|Withdrawal by Subject|0|||
16553908|NCT02138747|40492886|FG000|Treatment Period 1|Protocol Violation|0|||
16553909|NCT02138747|40492887|FG001|Treatment Period 1|Protocol Violation|2|||
16553910|NCT02138747|40492888|FG002|Treatment Period 1|Protocol Violation|0|||
16553911|NCT02138747|40492889|FG003|Treatment Period 1|Protocol Violation|0|||
16553912|NCT02138747|40492886|FG000|Treatment Period 1|Withdrawal by Subject|8|||
16553913|NCT02138747|40492887|FG001|Treatment Period 1|Withdrawal by Subject|4|||
16553914|NCT02138747|40492888|FG002|Treatment Period 1|Withdrawal by Subject|1|||
16553915|NCT02138747|40492889|FG003|Treatment Period 1|Withdrawal by Subject|3|||
16553916|NCT02138747|40492886|FG000|Treatment Period 1|Other - Miscellaneous|2|||
16553917|NCT02138747|40492887|FG001|Treatment Period 1|Other - Miscellaneous|4|||
16553918|NCT02138747|40492888|FG002|Treatment Period 1|Other - Miscellaneous|0|||
16553919|NCT02138747|40492889|FG003|Treatment Period 1|Other - Miscellaneous|0|||
16553920|NCT02138747|40492886|FG000|Treatment Period 2|Adverse Event|6|||
16553921|NCT02138747|40492887|FG001|Treatment Period 2|Adverse Event|3|||
16553922|NCT02138747|40492888|FG002|Treatment Period 2|Adverse Event|1|||
16553923|NCT02138747|40492889|FG003|Treatment Period 2|Adverse Event|1|||
16121022|NCT02643303|38930053|FG004|Overall Study|Withdrawal by Subject|0|||
16553924|NCT02138747|40492886|FG000|Treatment Period 2|Lost to Follow-up|2|||
16553925|NCT02138747|40492887|FG001|Treatment Period 2|Lost to Follow-up|0|||
16553926|NCT02138747|40492888|FG002|Treatment Period 2|Lost to Follow-up|0|||
16121023|NCT02643303|38930054|FG005|Overall Study|Withdrawal by Subject|0|||
16121024|NCT02643303|38930055|FG006|Overall Study|Withdrawal by Subject|1|||
16121025|NCT02643303|38930056|FG007|Overall Study|Withdrawal by Subject|1|||
16121026|NCT02643303|38930057|FG008|Overall Study|Withdrawal by Subject|1|||
16121027|NCT01006980|38930058|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
16121028|NCT01006980|38930059|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
16121029|NCT01006980|38930058|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
16121030|NCT01006980|38930059|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
16121031|NCT01006980|38930058|FG000|Vemurafenib and Dacarbazine|Death|13|||
16121032|NCT01006980|38930059|FG001|Vemurafenib and Dacarbazine|Death|12|||
16121033|NCT01006980|38930058|FG000|Vemurafenib and Dacarbazine|Progression|257|||
16121034|NCT01006980|38930059|FG001|Vemurafenib and Dacarbazine|Progression|218|||
16121035|NCT01006980|38930058|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
16121036|NCT01006980|38930059|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
16121037|NCT01006980|38930058|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
16121038|NCT01006980|38930059|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
16121039|NCT01006980|38930058|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
16121040|NCT01006980|38930059|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
16121041|NCT01006980|38930058|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
16121042|NCT01006980|38930059|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
16121043|NCT01006980|38930058|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
16121044|NCT01006980|38930059|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
16121045|NCT01006980|38930058|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
16121046|NCT01006980|38930059|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
16121047|NCT01006980|38930058|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
16121048|NCT01006980|38930059|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
16121049|NCT01006980|38930058|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
16121050|NCT01006980|38930059|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
16121051|NCT01006980|38930058|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
16121052|NCT01006980|38930059|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
16121053|NCT03117998|38930060|FG000|Overall Study|Adverse Event|1|||
16121054|NCT03117998|38930061|FG001|Overall Study|Adverse Event|0|||
16121055|NCT03117998|38930062|FG002|Overall Study|Adverse Event|0|||
16121056|NCT03117998|38930063|FG003|Overall Study|Adverse Event|0|||
16121057|NCT03117998|38930064|FG004|Overall Study|Adverse Event|0|||
16121058|NCT03117998|38930065|FG005|Overall Study|Adverse Event|0|||
16121059|NCT03117998|38930060|FG000|Overall Study|Withdrawal by Subject|0|||
16121060|NCT03117998|38930061|FG001|Overall Study|Withdrawal by Subject|0|||
16121061|NCT03117998|38930062|FG002|Overall Study|Withdrawal by Subject|2|||
16553927|NCT02138747|40492889|FG003|Treatment Period 2|Lost to Follow-up|0|||
16553928|NCT02138747|40492886|FG000|Treatment Period 2|Protocol Violation|1|||
16553929|NCT02138747|40492887|FG001|Treatment Period 2|Protocol Violation|0|||
16553930|NCT02138747|40492888|FG002|Treatment Period 2|Protocol Violation|0|||
16553931|NCT02138747|40492889|FG003|Treatment Period 2|Protocol Violation|0|||
16553932|NCT02138747|40492886|FG000|Treatment Period 2|Withdrawal by Subject|5|||
16553933|NCT02138747|40492887|FG001|Treatment Period 2|Withdrawal by Subject|4|||
16553934|NCT02138747|40492888|FG002|Treatment Period 2|Withdrawal by Subject|1|||
16553935|NCT02138747|40492889|FG003|Treatment Period 2|Withdrawal by Subject|2|||
16553936|NCT02138747|40492886|FG000|Treatment Period 2|Other - Miscellaneous|3|||
16553937|NCT02138747|40492887|FG001|Treatment Period 2|Other - Miscellaneous|0|||
16553938|NCT02138747|40492888|FG002|Treatment Period 2|Other - Miscellaneous|0|||
16553939|NCT02138747|40492889|FG003|Treatment Period 2|Other - Miscellaneous|0|||
16553940|NCT00238420|40492890|FG000|Overall Study|Protocol Violation|1|||
16553941|NCT00238420|40492891|FG001|Overall Study|Protocol Violation|1|||
16553942|NCT02790073|40492902|FG000|Overall Study|Death|1|||
16553943|NCT02790073|40492902|FG000|Overall Study|Withdrawal from HD|1|||
16553944|NCT02790073|40492902|FG000|Overall Study|Withdrawal by Subject|1|||
16553945|NCT00661258|40492903|FG000|Overall Study|Death|1|||
16553946|NCT00661258|40492904|FG001|Overall Study|Death|0|||
16553947|NCT00661258|40492903|FG000|Overall Study|caught by police and in detox center|2|||
16553948|NCT00661258|40492904|FG001|Overall Study|caught by police and in detox center|1|||
16553949|NCT03358329|40492905|FG000|Overall Study|Lost to Follow-up|2|||
16553950|NCT03358329|40492905|FG000|Overall Study|Withdrawal by Subject|2|||
16553951|NCT02491892|40492906|FG000|Overall Study|Adverse Event|1|||
16553952|NCT02491892|40492907|FG001|Overall Study|Adverse Event|1|||
16553953|NCT02491892|40492906|FG000|Overall Study|Death|1|||
16553954|NCT02491892|40492907|FG001|Overall Study|Death|1|||
16121062|NCT03117998|38930063|FG003|Overall Study|Withdrawal by Subject|3|||
16121063|NCT03117998|38930064|FG004|Overall Study|Withdrawal by Subject|3|||
16553955|NCT02491892|40492906|FG000|Overall Study|Lack of Efficacy|37|||
16553956|NCT02491892|40492907|FG001|Overall Study|Lack of Efficacy|36|||
16553957|NCT02491892|40492906|FG000|Overall Study|Refused Treatment|1|||
16553958|NCT02491892|40492907|FG001|Overall Study|Refused Treatment|0|||
16121064|NCT03117998|38930065|FG005|Overall Study|Withdrawal by Subject|0|||
16121065|NCT03117998|38930060|FG000|Overall Study|Physician Decision|0|||
16121066|NCT03117998|38930061|FG001|Overall Study|Physician Decision|1|||
16121067|NCT03117998|38930062|FG002|Overall Study|Physician Decision|1|||
16121068|NCT03117998|38930063|FG003|Overall Study|Physician Decision|0|||
16121069|NCT03117998|38930064|FG004|Overall Study|Physician Decision|0|||
16121070|NCT03117998|38930065|FG005|Overall Study|Physician Decision|0|||
16121071|NCT03117998|38930060|FG000|Overall Study|Lost to Follow-up|0|||
16121072|NCT03117998|38930061|FG001|Overall Study|Lost to Follow-up|0|||
16121073|NCT03117998|38930062|FG002|Overall Study|Lost to Follow-up|0|||
16121074|NCT03117998|38930063|FG003|Overall Study|Lost to Follow-up|1|||
16121075|NCT03117998|38930064|FG004|Overall Study|Lost to Follow-up|4|||
16121076|NCT03117998|38930065|FG005|Overall Study|Lost to Follow-up|0|||
16121077|NCT03117998|38930060|FG000|Overall Study|Subject noncompliance|0|||
16121078|NCT03117998|38930061|FG001|Overall Study|Subject noncompliance|0|||
16121079|NCT03117998|38930062|FG002|Overall Study|Subject noncompliance|1|||
16121080|NCT03117998|38930063|FG003|Overall Study|Subject noncompliance|0|||
16121081|NCT03117998|38930064|FG004|Overall Study|Subject noncompliance|0|||
16235007|NCT00320801|39344887|FG002|Double-blind Phase|Withdrawal by Subject|1|||
16235008|NCT00320801|39344888|FG003|Double-blind Phase|Withdrawal by Subject|0|||
16553959|NCT02491892|40492906|FG000|Overall Study|Lost to Follow-up|1|||
16553960|NCT02491892|40492907|FG001|Overall Study|Lost to Follow-up|0|||
16553961|NCT02887989|40492910|FG000|Overall Study|Withdrawal by Subject|8|||
16553962|NCT02887989|40492911|FG001|Overall Study|Withdrawal by Subject|11|||
16553963|NCT02887989|40492910|FG000|Overall Study|Death|1|||
16553964|NCT02887989|40492911|FG001|Overall Study|Death|0|||
16553965|NCT01213173|40492912|FG000|Overall Study|Protocol Violation|2|||
16553966|NCT01213173|40492913|FG001|Overall Study|Protocol Violation|0|||
16553967|NCT01213173|40492912|FG000|Overall Study|Adverse Event|4|||
16553968|NCT01213173|40492913|FG001|Overall Study|Adverse Event|8|||
16553969|NCT01213173|40492912|FG000|Overall Study|Withdrawal by Subject|5|||
16553970|NCT01213173|40492913|FG001|Overall Study|Withdrawal by Subject|5|||
16553971|NCT01213173|40492912|FG000|Overall Study|Incorrect Enrollment|1|||
16553972|NCT01213173|40492913|FG001|Overall Study|Incorrect Enrollment|3|||
16553973|NCT01995357|40492918|FG000|Period 5|Lack of Efficacy|1|||
16553974|NCT01995357|40492919|FG001|Period 5|Lack of Efficacy|0|||
16553975|NCT01995357|40492920|FG002|Period 5|Lack of Efficacy|0|||
16553976|NCT01995357|40492921|FG003|Period 5|Lack of Efficacy|0|||
16553977|NCT01995357|40492922|FG004|Period 5|Lack of Efficacy|0|||
16553978|NCT01995357|40492923|FG005|Period 5|Lack of Efficacy|0|||
16553979|NCT01995357|40492918|FG000|Period 5|Adverse Event|1|||
16553980|NCT01995357|40492919|FG001|Period 5|Adverse Event|0|||
16553981|NCT01995357|40492920|FG002|Period 5|Adverse Event|1|||
16553982|NCT01995357|40492921|FG003|Period 5|Adverse Event|0|||
16553983|NCT01995357|40492922|FG004|Period 5|Adverse Event|0|||
16553984|NCT01995357|40492923|FG005|Period 5|Adverse Event|0|||
16553985|NCT01816763|40492929|FG000|Overall Study|The main reason for an incomplete survey|4|||
16553986|NCT01816763|40492930|FG001|Overall Study|The main reason for an incomplete survey|15|||
16553987|NCT01816763|40492931|FG002|Overall Study|The main reason for an incomplete survey|11|||
16553988|NCT01544582|40492933|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
16553989|NCT01544582|40492934|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
16553990|NCT01544582|40492935|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
16235009|NCT00320801|39344885|FG000|Double-blind Phase|Adverse Event|0|||
16553991|NCT01544582|40492936|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
16553992|NCT01544582|40492933|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
16553993|NCT01544582|40492934|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
16553994|NCT01544582|40492935|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
16553995|NCT01544582|40492936|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
16553996|NCT01544582|40492933|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
16553997|NCT01544582|40492934|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
16553998|NCT01544582|40492935|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
16553999|NCT01544582|40492936|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
16554000|NCT01544582|40492933|FG000|Analysis Population|Physician Decision|0|||
16554001|NCT01544582|40492934|FG001|Analysis Population|Physician Decision|13|||
16554002|NCT01544582|40492935|FG002|Analysis Population|Physician Decision|10|||
16554003|NCT01544582|40492936|FG003|Analysis Population|Physician Decision|9|||
16554004|NCT01544582|40492933|FG000|Analysis Population|Safety Reason|0|||
16554005|NCT01544582|40492934|FG001|Analysis Population|Safety Reason|33|||
16554006|NCT01544582|40492935|FG002|Analysis Population|Safety Reason|31|||
16121082|NCT03117998|38930065|FG005|Overall Study|Subject noncompliance|2|||
16235010|NCT00320801|39344886|FG001|Double-blind Phase|Adverse Event|2|||
16554007|NCT01544582|40492936|FG003|Analysis Population|Safety Reason|8|||
16121083|NCT03117998|38930060|FG000|Overall Study|Protocol Violation|0|||
16121084|NCT03117998|38930061|FG001|Overall Study|Protocol Violation|0|||
16121085|NCT03117998|38930062|FG002|Overall Study|Protocol Violation|0|||
16121086|NCT03117998|38930063|FG003|Overall Study|Protocol Violation|0|||
16235011|NCT00320801|39344887|FG002|Double-blind Phase|Adverse Event|8|||
16554008|NCT01544582|40492933|FG000|Analysis Population|Effectiveness Reason|0|||
16554009|NCT01544582|40492934|FG001|Analysis Population|Effectiveness Reason|48|||
16554010|NCT01544582|40492935|FG002|Analysis Population|Effectiveness Reason|29|||
16554011|NCT01544582|40492936|FG003|Analysis Population|Effectiveness Reason|12|||
16554012|NCT01544582|40492933|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
16554013|NCT01544582|40492934|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
16554014|NCT01544582|40492935|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
16554015|NCT01544582|40492936|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
16554016|NCT01544582|40492933|FG000|Analysis Population|Lost to Follow-up|0|||
16554017|NCT01544582|40492934|FG001|Analysis Population|Lost to Follow-up|6|||
16554018|NCT01544582|40492935|FG002|Analysis Population|Lost to Follow-up|6|||
16554019|NCT01544582|40492936|FG003|Analysis Population|Lost to Follow-up|5|||
16554020|NCT01544582|40492933|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
16554021|NCT01544582|40492934|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
16554022|NCT01544582|40492935|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
16554023|NCT01544582|40492936|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
16554024|NCT01544582|40492933|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
16554025|NCT01544582|40492934|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
16554026|NCT01544582|40492935|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
16554027|NCT01544582|40492936|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
16554028|NCT01544582|40492933|FG000|Analysis Population|Intolerance|0|||
16554029|NCT01544582|40492934|FG001|Analysis Population|Intolerance|1|||
16554030|NCT01544582|40492935|FG002|Analysis Population|Intolerance|0|||
16554031|NCT01544582|40492936|FG003|Analysis Population|Intolerance|0|||
16554032|NCT01544582|40492933|FG000|Analysis Population|Liver Transplantation|0|||
16554033|NCT01544582|40492934|FG001|Analysis Population|Liver Transplantation|0|||
16554034|NCT01544582|40492935|FG002|Analysis Population|Liver Transplantation|1|||
16554035|NCT01544582|40492936|FG003|Analysis Population|Liver Transplantation|0|||
16554036|NCT01544582|40492933|FG000|Analysis Population|No Social Insurance|0|||
16554037|NCT01544582|40492934|FG001|Analysis Population|No Social Insurance|0|||
16554038|NCT01544582|40492935|FG002|Analysis Population|No Social Insurance|1|||
16554039|NCT01544582|40492936|FG003|Analysis Population|No Social Insurance|0|||
16554040|NCT01544582|40492933|FG000|Analysis Population|Poor Adherence|0|||
16554041|NCT01544582|40492934|FG001|Analysis Population|Poor Adherence|0|||
16554042|NCT01544582|40492935|FG002|Analysis Population|Poor Adherence|1|||
16554043|NCT01544582|40492936|FG003|Analysis Population|Poor Adherence|0|||
16554044|NCT01544582|40492933|FG000|Analysis Population|Poor Participant Compliance|0|||
16554045|NCT01544582|40492934|FG001|Analysis Population|Poor Participant Compliance|1|||
16554046|NCT01544582|40492935|FG002|Analysis Population|Poor Participant Compliance|0|||
16554047|NCT01544582|40492936|FG003|Analysis Population|Poor Participant Compliance|0|||
16554048|NCT01544582|40492933|FG000|Analysis Population|Programmed Surgery|0|||
16554049|NCT01544582|40492934|FG001|Analysis Population|Programmed Surgery|1|||
16554050|NCT01544582|40492935|FG002|Analysis Population|Programmed Surgery|0|||
16554051|NCT01544582|40492936|FG003|Analysis Population|Programmed Surgery|0|||
16554052|NCT01544582|40492933|FG000|Analysis Population|Participant in Jail|0|||
16554053|NCT01544582|40492934|FG001|Analysis Population|Participant in Jail|0|||
16554054|NCT01544582|40492935|FG002|Analysis Population|Participant in Jail|1|||
16235012|NCT00320801|39344888|FG003|Double-blind Phase|Adverse Event|0|||
16235013|NCT00320801|39344885|FG000|Double-blind Phase|Administrative|0|||
16235014|NCT00320801|39344886|FG001|Double-blind Phase|Administrative|0|||
16235015|NCT00320801|39344887|FG002|Double-blind Phase|Administrative|4|||
16235016|NCT00320801|39344888|FG003|Double-blind Phase|Administrative|0|||
16235017|NCT00320801|39344885|FG000|Double-blind Phase|Lack of Efficacy|0|||
16235018|NCT00320801|39344886|FG001|Double-blind Phase|Lack of Efficacy|9|||
16235019|NCT00320801|39344887|FG002|Double-blind Phase|Lack of Efficacy|1|||
16235020|NCT00320801|39344888|FG003|Double-blind Phase|Lack of Efficacy|0|||
16235021|NCT00320801|39344885|FG000|Extension Phase|Withdrawal by Subject|0|||
16235022|NCT00320801|39344886|FG001|Extension Phase|Withdrawal by Subject|0|||
16235023|NCT00320801|39344887|FG002|Extension Phase|Withdrawal by Subject|0|||
16235024|NCT00320801|39344888|FG003|Extension Phase|Withdrawal by Subject|6|||
16235025|NCT00320801|39344885|FG000|Extension Phase|Adverse Event|0|||
16235026|NCT00320801|39344886|FG001|Extension Phase|Adverse Event|0|||
16235027|NCT00320801|39344887|FG002|Extension Phase|Adverse Event|0|||
16235028|NCT00320801|39344888|FG003|Extension Phase|Adverse Event|8|||
16235029|NCT00320801|39344885|FG000|Extension Phase|Administrative|0|||
16235030|NCT00320801|39344886|FG001|Extension Phase|Administrative|0|||
16235031|NCT00320801|39344887|FG002|Extension Phase|Administrative|0|||
16235032|NCT00320801|39344888|FG003|Extension Phase|Administrative|29|||
16121087|NCT03117998|38930064|FG004|Overall Study|Protocol Violation|0|||
16121088|NCT03117998|38930065|FG005|Overall Study|Protocol Violation|1|||
16235033|NCT00320801|39344885|FG000|Extension Phase|Lack of Efficacy|0|||
16235034|NCT00320801|39344886|FG001|Extension Phase|Lack of Efficacy|0|||
16235035|NCT00320801|39344887|FG002|Extension Phase|Lack of Efficacy|0|||
16235036|NCT00320801|39344888|FG003|Extension Phase|Lack of Efficacy|2|||
16235037|NCT00320801|39344885|FG000|Extension Phase|Lost to Follow-up|0|||
16121089|NCT03538938|38930067|FG000|Overall Study|Death|0|||
16121090|NCT03538938|38930068|FG001|Overall Study|Death|0|||
16121091|NCT03538938|38930069|FG002|Overall Study|Death|2|||
16121092|NCT03538938|38930070|FG003|Overall Study|Death|0|||
16121093|NCT03538938|38930071|FG004|Overall Study|Death|0|||
16121094|NCT03538938|38930072|FG005|Overall Study|Death|1|||
16121095|NCT03538938|38930073|FG006|Overall Study|Death|0|||
16235038|NCT00320801|39344886|FG001|Extension Phase|Lost to Follow-up|0|||
16235039|NCT00320801|39344887|FG002|Extension Phase|Lost to Follow-up|0|||
16235040|NCT00320801|39344888|FG003|Extension Phase|Lost to Follow-up|3|||
16235041|NCT00960687|39344889|FG000|Washout Period of 7 Days|Adverse Event|3|||
16235042|NCT00960687|39344890|FG001|Washout Period of 7 Days|Adverse Event|2|||
16235043|NCT00960687|39344889|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
16235044|NCT00960687|39344890|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16235045|NCT03926728|39344891|FG000|Overall Study|Withdrawal by Subject|0|||
16235046|NCT03926728|39344892|FG001|Overall Study|Withdrawal by Subject|1|||
16235047|NCT03926728|39344893|FG002|Overall Study|Withdrawal by Subject|1|||
16235048|NCT03926728|39344894|FG003|Overall Study|Withdrawal by Subject|0|||
16235049|NCT03926728|39344895|FG004|Overall Study|Withdrawal by Subject|0|||
16235050|NCT03926728|39344896|FG005|Overall Study|Withdrawal by Subject|1|||
16235051|NCT03926728|39344897|FG006|Overall Study|Withdrawal by Subject|1|||
16235052|NCT03926728|39344898|FG007|Overall Study|Withdrawal by Subject|0|||
16235053|NCT03926728|39344899|FG008|Overall Study|Withdrawal by Subject|0|||
16235054|NCT03926728|39344900|FG009|Overall Study|Withdrawal by Subject|1|||
16235055|NCT03926728|39344901|FG010|Overall Study|Withdrawal by Subject|0|||
16235056|NCT03926728|39344902|FG011|Overall Study|Withdrawal by Subject|0|||
16235057|NCT02711553|39344904|FG000|Overall Study|Withdrawal by Subject|2|||
16235058|NCT02711553|39344905|FG001|Overall Study|Withdrawal by Subject|1|||
16235059|NCT02711553|39344906|FG002|Overall Study|Withdrawal by Subject|1|||
16554055|NCT01544582|40492936|FG003|Analysis Population|Participant in Jail|0|||
16554056|NCT00358150|40492937|FG000|Overall Study|Adverse Event|3|||
16554057|NCT00358150|40492937|FG000|Overall Study|Withdrawal by Subject|1|||
16554058|NCT00358150|40492937|FG000|Overall Study|Undefined|3|||
16554059|NCT02243631|40492945|FG000|Overall Study|no synovial fluid on second aspirate|0|||
16554060|NCT02243631|40492946|FG001|Overall Study|no synovial fluid on second aspirate|1|||
16554061|NCT00432835|40492947|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
16554062|NCT00432835|40492948|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
16554063|NCT00641186|40492951|FG000|Overall Study|Adverse Event|3|||
16554064|NCT03462706|40492952|FG000|Overall Study|Polyp was pedunculated|1|||
16554065|NCT03462706|40492953|FG001|Overall Study|Polyp was pedunculated|0|||
16554066|NCT03462706|40492954|FG002|Overall Study|Polyp was pedunculated|1|||
16554067|NCT03462706|40492955|FG003|Overall Study|Polyp was pedunculated|0|||
16554068|NCT03462706|40492952|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
16554069|NCT03462706|40492953|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
16554070|NCT03462706|40492954|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
16554071|NCT03462706|40492955|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
16554072|NCT00154063|40492956|FG000|Overall Study|Adverse Event|4|||
16554073|NCT00154063|40492957|FG001|Overall Study|Adverse Event|8|||
16554074|NCT00154063|40492956|FG000|Overall Study|Protocol Violation|1|||
16554075|NCT00154063|40492957|FG001|Overall Study|Protocol Violation|1|||
16554076|NCT00154063|40492956|FG000|Overall Study|Investigator or Sponsor Request|0|||
16554077|NCT00154063|40492957|FG001|Overall Study|Investigator or Sponsor Request|1|||
16554078|NCT00154063|40492956|FG000|Overall Study|Withdrawal by Subject|4|||
16554079|NCT00154063|40492957|FG001|Overall Study|Withdrawal by Subject|9|||
16554080|NCT00154063|40492956|FG000|Overall Study|Other|3|||
16554081|NCT00154063|40492957|FG001|Overall Study|Other|3|||
16121096|NCT03538938|38930074|FG007|Overall Study|Death|1|||
16554082|NCT03044353|40492966|FG000|Overall Study|Adverse Event|0|||
16554083|NCT03044353|40492967|FG001|Overall Study|Adverse Event|1|||
16121097|NCT03538938|38930075|FG008|Overall Study|Death|1|||
16121098|NCT03538938|38930076|FG009|Overall Study|Death|1|||
16235060|NCT02711553|39344907|FG003|Overall Study|Withdrawal by Subject|0|||
16235061|NCT02711553|39344904|FG000|Overall Study|Lost to Follow-up|3|||
16235062|NCT02711553|39344905|FG001|Overall Study|Lost to Follow-up|3|||
16235063|NCT02711553|39344906|FG002|Overall Study|Lost to Follow-up|6|||
16235064|NCT02711553|39344907|FG003|Overall Study|Lost to Follow-up|3|||
16235065|NCT02711553|39344904|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
16235066|NCT02711553|39344905|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
16235067|NCT02711553|39344906|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
16235068|NCT02711553|39344907|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
16235069|NCT04611152|39344908|FG000|Overall Study|Adverse Event|9|||
16235070|NCT04611152|39344909|FG001|Overall Study|Adverse Event|8|||
16235071|NCT04611152|39344908|FG000|Overall Study|Non-compliance with study schedule|1|||
16235072|NCT04611152|39344909|FG001|Overall Study|Non-compliance with study schedule|3|||
16235073|NCT04611152|39344908|FG000|Overall Study|Withdrawal by Subject|5|||
16235074|NCT04611152|39344909|FG001|Overall Study|Withdrawal by Subject|6|||
16235075|NCT04611152|39344908|FG000|Overall Study|Lost to Follow-up|11|||
16235076|NCT04611152|39344909|FG001|Overall Study|Lost to Follow-up|2|||
16235077|NCT02487979|39344910|FG000|Overall Study|Physician Decision|2|||
16235078|NCT02487979|39344910|FG000|Overall Study|Withdrawal by Subject|2|||
16235079|NCT02487979|39344910|FG000|Overall Study|Progressive Disease|17|||
16235080|NCT01844986|39344913|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
16235081|NCT01844986|39344914|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
16235082|NCT01844986|39344913|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
16235083|NCT01844986|39344914|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
16235084|NCT01844986|39344913|FG000|Overall Study (Global Cohort)|Death|55|||
16235085|NCT01844986|39344914|FG001|Overall Study (Global Cohort)|Death|26|||
16235086|NCT01844986|39344913|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
16235087|NCT01844986|39344914|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
16235088|NCT01844986|39344913|FG000|Overall Study (China Cohort)|Death|10|||
16235089|NCT01844986|39344914|FG001|Overall Study (China Cohort)|Death|6|||
16235090|NCT00577031|39344915|FG000|Overall Study|Adverse Event|52|||
16235091|NCT00577031|39344915|FG000|Overall Study|Progression of disease|93|||
16235092|NCT00577031|39344915|FG000|Overall Study|Protocol Violation|5|||
16235093|NCT00577031|39344915|FG000|Overall Study|Participant withdrew consent|13|||
16235094|NCT00577031|39344915|FG000|Overall Study|Participant non-compliance|5|||
16235095|NCT00577031|39344915|FG000|Overall Study|Need for surgery|17|||
16235096|NCT00577031|39344915|FG000|Overall Study|Medical decision|14|||
16235097|NCT00577031|39344915|FG000|Overall Study|Death|6|||
16235098|NCT00630994|39344916|FG000|Overall Study|Adverse Event|1|||
16235099|NCT00630994|39344916|FG000|Overall Study|Disease Progression|1|||
16235100|NCT00630994|39344916|FG000|Overall Study|Lack of Efficacy|1|||
16235101|NCT00630994|39344916|FG000|Overall Study|Other|1|||
16235102|NCT05111548|39344919|FG000|Overall Study|Withdrawal by Subject|2|||
16235103|NCT05111548|39344920|FG001|Overall Study|Withdrawal by Subject|1|||
16235104|NCT05111548|39344919|FG000|Overall Study|Adverse Event|1|||
16235105|NCT05111548|39344920|FG001|Overall Study|Adverse Event|0|||
16235106|NCT03575325|39344921|FG000|Overall Study|Death|1|||
16235107|NCT02032823|39344922|FG000|Overall Study|Death|75|||
16235108|NCT02032823|39344923|FG001|Overall Study|Death|109|||
16235109|NCT02032823|39344922|FG000|Overall Study|Lost to Follow-up|18|||
16235110|NCT02032823|39344923|FG001|Overall Study|Lost to Follow-up|17|||
16235111|NCT02032823|39344922|FG000|Overall Study|Withdrawal by Subject|70|||
16235112|NCT02032823|39344923|FG001|Overall Study|Withdrawal by Subject|53|||
16235113|NCT02032823|39344922|FG000|Overall Study|Ongoing study at data cut-off|755|||
16235114|NCT02032823|39344923|FG001|Overall Study|Ongoing study at data cut-off|731|||
16235115|NCT02032823|39344922|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
16235116|NCT02032823|39344923|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
16235117|NCT00605839|39344924|FG000|Overall Study|Protocol Violation|1|||
16554084|NCT03044353|40492968|FG002|Overall Study|Adverse Event|0|||
16554085|NCT01189890|40492973|FG000|Overall Study|Adverse Event|3|||
16554086|NCT01189890|40492974|FG001|Overall Study|Adverse Event|4|||
16554087|NCT01189890|40492973|FG000|Overall Study|Lack of Efficacy|7|||
16554088|NCT01189890|40492974|FG001|Overall Study|Lack of Efficacy|2|||
16554089|NCT01189890|40492973|FG000|Overall Study|Lost to Follow-up|1|||
16554090|NCT01189890|40492974|FG001|Overall Study|Lost to Follow-up|7|||
16121099|NCT03538938|38930077|FG010|Overall Study|Death|0|||
16235118|NCT00605839|39344925|FG001|Overall Study|Protocol Violation|0|||
16235119|NCT00605839|39344926|FG002|Overall Study|Protocol Violation|0|||
16235120|NCT01741259|39344927|FG000|Overall Study|Protocol Violation|6|||
16235121|NCT01741259|39344928|FG001|Overall Study|Protocol Violation|4|||
16235122|NCT01741259|39344927|FG000|Overall Study|Withdrawal by Subject|0|||
16554091|NCT01189890|40492973|FG000|Overall Study|Protocol Violation|1|||
16554092|NCT01189890|40492974|FG001|Overall Study|Protocol Violation|5|||
16235123|NCT01741259|39344928|FG001|Overall Study|Withdrawal by Subject|2|||
16235124|NCT02873195|39344929|FG000|Overall Study|Ineligible|5|||
16235125|NCT02873195|39344930|FG001|Overall Study|Ineligible|0|||
16235126|NCT01383954|39344936|FG000|Overall Study|Lack of Efficacy|2|||
16235127|NCT01383954|39344936|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
16235128|NCT01383954|39344936|FG000|Overall Study|Adverse Event|1|||
16235129|NCT01383954|39344936|FG000|Overall Study|Reason Not Specified|9|||
16235130|NCT03869684|39344937|FG000|Overall Study|Adverse Event|0|||
16235131|NCT03869684|39344938|FG001|Overall Study|Adverse Event|3|||
16235132|NCT03869684|39344939|FG002|Overall Study|Adverse Event|1|||
16235133|NCT03869684|39344937|FG000|Overall Study|Withdrawal by Subject|1|||
16554093|NCT01189890|40492973|FG000|Overall Study|Withdrawal by Subject|15|||
16554094|NCT01189890|40492974|FG001|Overall Study|Withdrawal by Subject|11|||
16121100|NCT03538938|38930078|FG011|Overall Study|Death|0|||
16121101|NCT03538938|38930079|FG012|Overall Study|Death|1|||
16121102|NCT03538938|38930080|FG013|Overall Study|Death|1|||
16121103|NCT03538938|38930081|FG014|Overall Study|Death|0|||
16121104|NCT03538938|38930082|FG015|Overall Study|Death|1|||
16121105|NCT03538938|38930067|FG000|Overall Study|Withdrawal by Subject|4|||
16121106|NCT03538938|38930068|FG001|Overall Study|Withdrawal by Subject|6|||
16121107|NCT03538938|38930069|FG002|Overall Study|Withdrawal by Subject|5|||
16121108|NCT03538938|38930070|FG003|Overall Study|Withdrawal by Subject|3|||
16121109|NCT03538938|38930071|FG004|Overall Study|Withdrawal by Subject|0|||
16121110|NCT03538938|38930072|FG005|Overall Study|Withdrawal by Subject|0|||
16121111|NCT03538938|38930073|FG006|Overall Study|Withdrawal by Subject|3|||
16121112|NCT03538938|38930074|FG007|Overall Study|Withdrawal by Subject|1|||
16121113|NCT03538938|38930075|FG008|Overall Study|Withdrawal by Subject|5|||
16121114|NCT03538938|38930076|FG009|Overall Study|Withdrawal by Subject|1|||
16121115|NCT03538938|38930077|FG010|Overall Study|Withdrawal by Subject|2|||
16121116|NCT03538938|38930078|FG011|Overall Study|Withdrawal by Subject|1|||
16121117|NCT03538938|38930079|FG012|Overall Study|Withdrawal by Subject|3|||
16121118|NCT03538938|38930080|FG013|Overall Study|Withdrawal by Subject|0|||
16121119|NCT03538938|38930081|FG014|Overall Study|Withdrawal by Subject|2|||
16121120|NCT03538938|38930082|FG015|Overall Study|Withdrawal by Subject|4|||
16121121|NCT03538938|38930067|FG000|Overall Study|Incarcerated|0|||
16121122|NCT03538938|38930068|FG001|Overall Study|Incarcerated|0|||
16121123|NCT03538938|38930069|FG002|Overall Study|Incarcerated|0|||
16121124|NCT03538938|38930070|FG003|Overall Study|Incarcerated|0|||
16121125|NCT03538938|38930071|FG004|Overall Study|Incarcerated|0|||
16121126|NCT03538938|38930072|FG005|Overall Study|Incarcerated|0|||
16121127|NCT03538938|38930073|FG006|Overall Study|Incarcerated|0|||
16121128|NCT03538938|38930074|FG007|Overall Study|Incarcerated|0|||
16121129|NCT03538938|38930075|FG008|Overall Study|Incarcerated|0|||
16121130|NCT03538938|38930076|FG009|Overall Study|Incarcerated|0|||
16121131|NCT03538938|38930077|FG010|Overall Study|Incarcerated|0|||
16121132|NCT03538938|38930078|FG011|Overall Study|Incarcerated|1|||
16121133|NCT03538938|38930079|FG012|Overall Study|Incarcerated|0|||
16121134|NCT03538938|38930080|FG013|Overall Study|Incarcerated|0|||
16121135|NCT03538938|38930081|FG014|Overall Study|Incarcerated|0|||
16121136|NCT03538938|38930082|FG015|Overall Study|Incarcerated|0|||
16121137|NCT01416389|38930083|FG000|Overall Study|Lost to Follow-up|1|||
16121138|NCT01416389|38930084|FG001|Overall Study|Lost to Follow-up|0|||
16121139|NCT01416389|38930083|FG000|Overall Study|Started New Therapy|2|||
16121140|NCT01416389|38930084|FG001|Overall Study|Started New Therapy|0|||
16121141|NCT00320528|38930088|FG000|Study Period II|Adverse Event|3|||
16121142|NCT00320528|38930089|FG001|Study Period II|Adverse Event|4|||
16121143|NCT00320528|38930090|FG002|Study Period II|Adverse Event|8|||
16121144|NCT00320528|38930088|FG000|Study Period II|Parent/Caregiver Decision|8|||
16121145|NCT00320528|38930089|FG001|Study Period II|Parent/Caregiver Decision|3|||
16235134|NCT03869684|39344938|FG001|Overall Study|Withdrawal by Subject|0|||
16554095|NCT01189890|40492973|FG000|Overall Study|Non Compliance|0|||
16554096|NCT01189890|40492974|FG001|Overall Study|Non Compliance|1|||
16554097|NCT01189890|40492973|FG000|Overall Study|Physician Decision|5|||
16554098|NCT01189890|40492974|FG001|Overall Study|Physician Decision|4|||
16554099|NCT01189890|40492973|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
16554100|NCT01189890|40492974|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
16554101|NCT01000376|40492975|FG000|Cycle 1 Day 1|Adverse Event|1|||
16554102|NCT01000376|40492976|FG001|Cycle 1 Day 1|Adverse Event|0|||
16554103|NCT01000376|40492975|FG000|Cycle 1 Day 1|Progressive Disease|1|||
16554104|NCT01000376|40492976|FG001|Cycle 1 Day 1|Progressive Disease|0|||
16554105|NCT01290822|40492977|FG000|Overall Study|Withdrawal by Subject|1|||
16554106|NCT01290822|40492977|FG000|Overall Study|Physician Decision|10|||
16554107|NCT03230864|40492978|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
16121146|NCT00320528|38930090|FG002|Study Period II|Parent/Caregiver Decision|11|||
16121147|NCT00320528|38930088|FG000|Study Period II|Withdrawal by Subject|0|||
16121148|NCT00320528|38930089|FG001|Study Period II|Withdrawal by Subject|1|||
16121149|NCT00320528|38930090|FG002|Study Period II|Withdrawal by Subject|1|||
16121150|NCT00320528|38930088|FG000|Study Period II|Entry Criteria Exclusion|0|||
16121151|NCT00320528|38930089|FG001|Study Period II|Entry Criteria Exclusion|2|||
16235135|NCT03869684|39344939|FG002|Overall Study|Withdrawal by Subject|0|||
16235136|NCT03869684|39344937|FG000|Overall Study|Lost to Follow-up|1|||
16235137|NCT03869684|39344938|FG001|Overall Study|Lost to Follow-up|0|||
16235138|NCT03869684|39344939|FG002|Overall Study|Lost to Follow-up|0|||
16235139|NCT03869684|39344937|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
16235140|NCT03869684|39344938|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
16235141|NCT03869684|39344939|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
16235142|NCT02662556|39344940|FG000|Overall Study|Adverse Event|4|||
16235143|NCT02662556|39344940|FG000|Overall Study|Lack of Efficacy|4|||
16235144|NCT00440193|39344941|FG000|Treatment Period|Adverse Event|74|||
16235145|NCT00440193|39344942|FG001|Treatment Period|Adverse Event|67|||
16235146|NCT00440193|39344941|FG000|Treatment Period|Death|19|||
16235147|NCT00440193|39344942|FG001|Treatment Period|Death|22|||
16235148|NCT00440193|39344941|FG000|Treatment Period|Lack of Efficacy|0|||
16235149|NCT00440193|39344942|FG001|Treatment Period|Lack of Efficacy|1|||
16235150|NCT00440193|39344941|FG000|Treatment Period|Lost to Follow-up|12|||
16235151|NCT00440193|39344942|FG001|Treatment Period|Lost to Follow-up|18|||
16235152|NCT00440193|39344941|FG000|Treatment Period|Physician Decision|3|||
16235153|NCT00440193|39344942|FG001|Treatment Period|Physician Decision|6|||
16235154|NCT00440193|39344941|FG000|Treatment Period|Protocol Violation|16|||
16235155|NCT00440193|39344942|FG001|Treatment Period|Protocol Violation|19|||
16235156|NCT00440193|39344941|FG000|Treatment Period|Withdrawal by Subject|36|||
16235157|NCT00440193|39344942|FG001|Treatment Period|Withdrawal by Subject|77|||
16235158|NCT00440193|39344941|FG000|Treatment Period|Clinical endpoint reached|28|||
16235159|NCT00440193|39344942|FG001|Treatment Period|Clinical endpoint reached|25|||
16235160|NCT00440193|39344941|FG000|Treatment Period|Study terminated by sponsor|102|||
16235161|NCT00440193|39344942|FG001|Treatment Period|Study terminated by sponsor|94|||
16235162|NCT00440193|39344941|FG000|Treatment Period|Protocol driven decision point|2|||
16235163|NCT00440193|39344942|FG001|Treatment Period|Protocol driven decision point|2|||
16235164|NCT00440193|39344941|FG000|Treatment Period|Switch to commercial drug|0|||
16554108|NCT03230864|40492979|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
16235165|NCT00440193|39344942|FG001|Treatment Period|Switch to commercial drug|2|||
16235166|NCT00440193|39344941|FG000|Treatment Period|Technical problems|1|||
16235167|NCT00440193|39344942|FG001|Treatment Period|Technical problems|1|||
16235168|NCT00440193|39344941|FG000|Treatment Period|Participant convenience|5|||
16235169|NCT00440193|39344942|FG001|Treatment Period|Participant convenience|2|||
16235170|NCT00440193|39344941|FG000|Treatment Period|Participant did not receive treatment|7|||
16235171|NCT00440193|39344942|FG001|Treatment Period|Participant did not receive treatment|13|||
16235172|NCT00440193|39344941|FG000|Treatment Period|Site closed by investigator|0|||
16235173|NCT00440193|39344942|FG001|Treatment Period|Site closed by investigator|2|||
16235174|NCT00440193|39344941|FG000|Observational Period|Adverse Event|2|||
16235175|NCT00440193|39344942|FG001|Observational Period|Adverse Event|2|||
16235176|NCT00440193|39344941|FG000|Observational Period|Death|15|||
16235177|NCT00440193|39344942|FG001|Observational Period|Death|20|||
16413417|NCT00762996|39995160|FG003|Period One|ineligible|1|||
16413418|NCT00762996|39995157|FG000|Period One|Adverse Event|0|||
16413419|NCT00762996|39995158|FG001|Period One|Adverse Event|0|||
16413420|NCT00762996|39995159|FG002|Period One|Adverse Event|1|||
16554109|NCT03230864|40492980|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
16554110|NCT03230864|40492981|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
16554111|NCT03230864|40492978|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
16554112|NCT03230864|40492979|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
16554113|NCT03230864|40492980|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
16554114|NCT03230864|40492981|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
16554115|NCT03230864|40492978|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
16554116|NCT03230864|40492979|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
16554117|NCT03230864|40492980|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
16554118|NCT03230864|40492981|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
16554119|NCT03230864|40492978|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
16554120|NCT03230864|40492979|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
16554121|NCT03230864|40492980|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
16554122|NCT03230864|40492981|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
16554123|NCT03230864|40492978|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
16554124|NCT03230864|40492979|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
16554125|NCT03230864|40492980|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
16554126|NCT03230864|40492981|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
16554127|NCT03230864|40492978|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
16235178|NCT00440193|39344941|FG000|Observational Period|Lost to Follow-up|12|||
16235179|NCT00440193|39344942|FG001|Observational Period|Lost to Follow-up|8|||
16235180|NCT00440193|39344941|FG000|Observational Period|Protocol Violation|1|||
16235181|NCT00440193|39344942|FG001|Observational Period|Protocol Violation|0|||
16235182|NCT00440193|39344941|FG000|Observational Period|Withdrawal by Subject|11|||
16235183|NCT00440193|39344942|FG001|Observational Period|Withdrawal by Subject|8|||
16554128|NCT03230864|40492979|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
16554129|NCT03230864|40492980|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
16554130|NCT03230864|40492981|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
16554131|NCT03230864|40492978|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
16554132|NCT03230864|40492979|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
16554133|NCT03230864|40492980|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
16554134|NCT03230864|40492981|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
16554135|NCT03230864|40492978|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
16554136|NCT03230864|40492979|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
16554137|NCT03230864|40492980|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
16235184|NCT00440193|39344941|FG000|Observational Period|Physician Decision|1|||
16235185|NCT00440193|39344942|FG001|Observational Period|Physician Decision|0|||
16235186|NCT00440193|39344941|FG000|Observational Period|Clinical endpoint reached|1|||
16235187|NCT00440193|39344942|FG001|Observational Period|Clinical endpoint reached|0|||
16235188|NCT00440193|39344941|FG000|Observational Period|Participant convenience|2|||
16235189|NCT00440193|39344942|FG001|Observational Period|Participant convenience|0|||
16235190|NCT03454672|39344943|FG000|Overall Study|Adverse Event|1|||
16235191|NCT03454672|39344944|FG001|Overall Study|Adverse Event|1|||
16235192|NCT03454672|39344943|FG000|Overall Study|Lost to Follow-up|1|||
16235193|NCT03454672|39344944|FG001|Overall Study|Lost to Follow-up|3|||
16235194|NCT03454672|39344943|FG000|Overall Study|painful|1|||
16235195|NCT03454672|39344944|FG001|Overall Study|painful|2|||
16235196|NCT03454672|39344943|FG000|Overall Study|Non-compliance|2|||
16235197|NCT03454672|39344944|FG001|Overall Study|Non-compliance|4|||
16554138|NCT03230864|40492981|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
16121152|NCT00320528|38930090|FG002|Study Period II|Entry Criteria Exclusion|2|||
16235198|NCT03454672|39344943|FG000|Overall Study|personal reasons|3|||
16235199|NCT03454672|39344944|FG001|Overall Study|personal reasons|2|||
16235200|NCT03454672|39344943|FG000|Overall Study|Withdrawal by Subject|1|||
16349023|NCT02557399|39765570|FG001|Overall Study|Adverse Event|5|||
16349024|NCT02557399|39765569|FG000|Overall Study|Protocol Violation|0|||
16349025|NCT02557399|39765570|FG001|Overall Study|Protocol Violation|1|||
16349026|NCT02557399|39765569|FG000|Overall Study|Protocol-defined stopping criteria|0|||
16349027|NCT02557399|39765570|FG001|Overall Study|Protocol-defined stopping criteria|1|||
16349028|NCT02557399|39765569|FG000|Overall Study|Withdrawal by Subject|1|||
16349029|NCT02557399|39765570|FG001|Overall Study|Withdrawal by Subject|1|||
16349030|NCT01585246|39765571|FG000|Overall Study|Lost to Follow-up|0|||
16349031|NCT01585246|39765572|FG001|Overall Study|Lost to Follow-up|0|||
16235201|NCT03454672|39344944|FG001|Overall Study|Withdrawal by Subject|0|||
16235202|NCT03875235|39344945|FG000|Overall Study|Ongoing study treatment|63|||
16235203|NCT03875235|39344946|FG001|Overall Study|Ongoing study treatment|20|||
16235204|NCT03875235|39344945|FG000|Overall Study|Off treatment|77|||
16235205|NCT03875235|39344946|FG001|Overall Study|Off treatment|91|||
16235206|NCT03875235|39344945|FG000|Overall Study|Withdrawal by Subject|3|||
16235207|NCT03875235|39344946|FG001|Overall Study|Withdrawal by Subject|10|||
16235208|NCT03875235|39344945|FG000|Overall Study|Death|198|||
16235209|NCT03875235|39344946|FG001|Overall Study|Death|223|||
16235210|NCT03981614|39344947|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
16235211|NCT03981614|39344948|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
16235212|NCT03981614|39344949|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
16235213|NCT00902486|39344950|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
16235214|NCT00902486|39344951|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
16235215|NCT00902486|39344952|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
16235216|NCT00902486|39344953|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
16235217|NCT00902486|39344954|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
16235218|NCT00902486|39344955|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
16235219|NCT00902486|39344950|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
16235220|NCT00902486|39344951|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
16235221|NCT00902486|39344952|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
16235222|NCT00902486|39344953|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
16235223|NCT00902486|39344954|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
16235224|NCT00902486|39344955|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
16235225|NCT00902486|39344950|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
16235226|NCT00902486|39344951|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
16235227|NCT00902486|39344952|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
16235228|NCT00902486|39344953|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
16235229|NCT00902486|39344954|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
16235230|NCT00902486|39344955|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
16235231|NCT00902486|39344950|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
16235232|NCT00902486|39344951|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
16235233|NCT00902486|39344952|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
16235234|NCT00902486|39344953|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
16235235|NCT00902486|39344954|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
16235236|NCT00902486|39344955|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
16554139|NCT03230864|40492978|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
16554140|NCT03230864|40492979|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
16554141|NCT03230864|40492980|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
16554142|NCT03230864|40492981|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
16554143|NCT03230864|40492978|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
16554144|NCT03230864|40492979|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
16554145|NCT03230864|40492980|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
16121153|NCT00320528|38930088|FG000|Study Period III|Adverse Event|1|||
16121154|NCT00320528|38930089|FG001|Study Period III|Adverse Event|0|||
16121155|NCT00320528|38930090|FG002|Study Period III|Adverse Event|0|||
16121156|NCT00320528|38930088|FG000|Study Period III|Lost to Follow-up|1|||
16121157|NCT00320528|38930089|FG001|Study Period III|Lost to Follow-up|0|||
16121158|NCT00320528|38930090|FG002|Study Period III|Lost to Follow-up|0|||
16121159|NCT00320528|38930088|FG000|Study Period III|Withdrawal by Subject|1|||
16121160|NCT00320528|38930089|FG001|Study Period III|Withdrawal by Subject|1|||
16121161|NCT00320528|38930090|FG002|Study Period III|Withdrawal by Subject|2|||
16121162|NCT00320528|38930088|FG000|Study Period III|Lack of Efficacy|2|||
16121163|NCT00320528|38930089|FG001|Study Period III|Lack of Efficacy|0|||
16121164|NCT00320528|38930090|FG002|Study Period III|Lack of Efficacy|0|||
16121165|NCT00320528|38930088|FG000|Study Period III|Parent/Caregiver Decision|14|||
16121166|NCT00320528|38930089|FG001|Study Period III|Parent/Caregiver Decision|3|||
16121167|NCT00320528|38930090|FG002|Study Period III|Parent/Caregiver Decision|11|||
16121168|NCT00320528|38930088|FG000|Study Period III|Protocol Violation|0|||
16121169|NCT00320528|38930089|FG001|Study Period III|Protocol Violation|1|||
16121170|NCT00320528|38930090|FG002|Study Period III|Protocol Violation|0|||
16121171|NCT00320528|38930088|FG000|Study Period III|Physician Decision|0|||
16121172|NCT00320528|38930089|FG001|Study Period III|Physician Decision|1|||
16121173|NCT00320528|38930090|FG002|Study Period III|Physician Decision|2|||
16235237|NCT00902486|39344950|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
16554146|NCT03230864|40492981|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
16554147|NCT01267825|40492986|FG000|Overall Study|study terminated. no data collected.|1|||
16121174|NCT00320528|38930088|FG000|Study Period III|Sponsor Decision|0|||
16121175|NCT00320528|38930089|FG001|Study Period III|Sponsor Decision|0|||
16121176|NCT00320528|38930090|FG002|Study Period III|Sponsor Decision|1|||
16235238|NCT00902486|39344951|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
16235239|NCT00902486|39344952|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
16235240|NCT00902486|39344953|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
16235241|NCT00902486|39344954|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
16121177|NCT00320528|38930088|FG000|Study Period III|Atomoxetine Commercially Available|68|||
16121178|NCT00320528|38930089|FG001|Study Period III|Atomoxetine Commercially Available|25|||
16121179|NCT00320528|38930090|FG002|Study Period III|Atomoxetine Commercially Available|90|||
16121180|NCT00545753|38930091|FG000|Overall Study|Withdrawal by Subject|0|||
16235242|NCT00902486|39344955|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
16235243|NCT00902486|39344950|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
16235244|NCT00902486|39344951|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
16349032|NCT01585246|39765573|FG002|Overall Study|Lost to Follow-up|2|||
16349033|NCT01585246|39765574|FG003|Overall Study|Lost to Follow-up|1|||
16349034|NCT01585246|39765575|FG004|Overall Study|Lost to Follow-up|0|||
16554148|NCT01267825|40492987|FG001|Overall Study|study terminated. no data collected.|0|||
16554149|NCT00445601|40492988|FG000|Overall Study|Withdrawal by Subject|11|||
16554150|NCT00445601|40492989|FG001|Overall Study|Withdrawal by Subject|11|||
16554151|NCT00445601|40492988|FG000|Overall Study|TURBT Complication|12|||
16554152|NCT00445601|40492989|FG001|Overall Study|TURBT Complication|8|||
16554153|NCT00445601|40492988|FG000|Overall Study|Incorrect Disease Status|6|||
16554154|NCT00445601|40492989|FG001|Overall Study|Incorrect Disease Status|6|||
16554155|NCT00445601|40492988|FG000|Overall Study|Drug Delivery Issue|2|||
16554156|NCT00445601|40492989|FG001|Overall Study|Drug Delivery Issue|2|||
16554157|NCT00445601|40492988|FG000|Overall Study|Adverse Event|2|||
16554158|NCT00445601|40492989|FG001|Overall Study|Adverse Event|0|||
16554159|NCT00445601|40492988|FG000|Overall Study|Death prior to TURBT|0|||
16554160|NCT00445601|40492989|FG001|Overall Study|Death prior to TURBT|1|||
16554161|NCT00195715|40492990|FG000|Overall Study|Adverse Event|122|||
16554162|NCT00195715|40492990|FG000|Overall Study|Withdrawal by Subject|58|||
16554163|NCT00195715|40492990|FG000|Overall Study|Lost to Follow-up|27|||
16554164|NCT00195715|40492990|FG000|Overall Study|Protocol Violation|13|||
16554165|NCT00195715|40492990|FG000|Overall Study|Lack of Efficacy|93|||
16554166|NCT00195715|40492990|FG000|Overall Study|Pregnancy|14|||
16554167|NCT00195715|40492990|FG000|Overall Study|Investigative site closure|8|||
16554168|NCT00195715|40492990|FG000|Overall Study|Subject moved/relocated|7|||
16554169|NCT00195715|40492990|FG000|Overall Study|Subject non-compliance|6|||
16554170|NCT00195715|40492990|FG000|Overall Study|Subject started commercial Humira|5|||
16554171|NCT00195715|40492990|FG000|Overall Study|Subject choice|3|||
16554172|NCT00195715|40492990|FG000|Overall Study|Loss of response/no improvement|3|||
16554173|NCT00195715|40492990|FG000|Overall Study|Sponsor stopped study|1|||
16554174|NCT00195715|40492990|FG000|Overall Study|Administrative reasons|2|||
16554175|NCT00195715|40492990|FG000|Overall Study|Investigator's decision|2|||
16554176|NCT00195715|40492990|FG000|Overall Study|Subject wants to get pregnant|4|||
16554177|NCT00195715|40492990|FG000|Overall Study|Use of prohibited medication|2|||
16121181|NCT00545753|38930092|FG001|Overall Study|Withdrawal by Subject|1|||
16235245|NCT00902486|39344952|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
16235246|NCT00902486|39344953|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
16235247|NCT00902486|39344954|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
16235248|NCT00902486|39344955|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
16121182|NCT00545753|38930093|FG002|Overall Study|Withdrawal by Subject|10|||
16349035|NCT01585246|39765571|FG000|Overall Study|Protocol Violation|0|||
16349036|NCT01585246|39765572|FG001|Overall Study|Protocol Violation|0|||
16121183|NCT00545753|38930091|FG000|Overall Study|Lost to Follow-up|13|||
16121184|NCT00545753|38930092|FG001|Overall Study|Lost to Follow-up|3|||
16121185|NCT00545753|38930093|FG002|Overall Study|Lost to Follow-up|12|||
16121186|NCT00545753|38930091|FG000|Overall Study|Protocol Violation|3|||
16121187|NCT00545753|38930092|FG001|Overall Study|Protocol Violation|1|||
16121188|NCT00545753|38930093|FG002|Overall Study|Protocol Violation|4|||
16121189|NCT01342341|38930100|FG000|Overall Study|Lost to Follow-up|4|||
16121190|NCT01342341|38930101|FG001|Overall Study|Lost to Follow-up|4|||
16121191|NCT03031496|38930103|FG000|Period 1|Adverse Event|2|||
16349037|NCT01585246|39765573|FG002|Overall Study|Protocol Violation|0|||
16349038|NCT01585246|39765574|FG003|Overall Study|Protocol Violation|0|||
16349039|NCT01585246|39765575|FG004|Overall Study|Protocol Violation|1|||
16349040|NCT01585246|39765571|FG000|Overall Study|Withdrawal by Subject|0|||
16349041|NCT01585246|39765572|FG001|Overall Study|Withdrawal by Subject|0|||
16121192|NCT03031496|38930104|FG001|Period 1|Adverse Event|0|||
16349042|NCT01585246|39765573|FG002|Overall Study|Withdrawal by Subject|1|||
16554178|NCT00195715|40492990|FG000|Overall Study|Planned surgery|2|||
16554179|NCT00195715|40492990|FG000|Overall Study|Increased infection rate|1|||
16554180|NCT00195715|40492990|FG000|Overall Study|Ineligible|1|||
16554181|NCT00195715|40492990|FG000|Overall Study|Colonic stricture|1|||
16554182|NCT00195715|40492990|FG000|Overall Study|Sponsor discontinued trial|1|||
16554183|NCT00195715|40492990|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
16554184|NCT02917265|40492991|FG000|Overall Study|Physician Decision|1|||
16554185|NCT02917265|40492992|FG001|Overall Study|Physician Decision|0|||
16554186|NCT02917265|40492991|FG000|Overall Study|Withdrawal by Subject|1|||
16554187|NCT02917265|40492992|FG001|Overall Study|Withdrawal by Subject|0|||
16554188|NCT01340482|40492993|FG000|Overall Study|Adverse Event|2|||
16554189|NCT01340482|40492994|FG001|Overall Study|Adverse Event|0|||
16554190|NCT01340482|40492995|FG002|Overall Study|Adverse Event|0|||
16554191|NCT02771210|40492996|FG000|Period 1|Adverse Event|5|||
16554192|NCT02771210|40492997|FG001|Period 1|Adverse Event|3|||
16554193|NCT02771210|40492996|FG000|Period 1|Lack of Efficacy|3|||
16554194|NCT02771210|40492997|FG001|Period 1|Lack of Efficacy|6|||
16554195|NCT02771210|40492996|FG000|Period 1|Lost to Follow-up|2|||
16554196|NCT02771210|40492997|FG001|Period 1|Lost to Follow-up|0|||
16121193|NCT03031496|38930103|FG000|Period 1|Withdrawal by Subject|0|||
16554197|NCT02771210|40492996|FG000|Period 1|Physician Decision|0|||
16554198|NCT02771210|40492997|FG001|Period 1|Physician Decision|1|||
16554199|NCT02771210|40492996|FG000|Period 1|Withdrawal by Subject|0|||
16554200|NCT02771210|40492997|FG001|Period 1|Withdrawal by Subject|3|||
16121194|NCT03031496|38930104|FG001|Period 1|Withdrawal by Subject|2|||
16121195|NCT01245140|38930105|FG000|Overall Study|Adverse Event|1|||
16121196|NCT01245140|38930106|FG001|Overall Study|Adverse Event|3|||
16349043|NCT01585246|39765574|FG003|Overall Study|Withdrawal by Subject|2|||
16349044|NCT01585246|39765575|FG004|Overall Study|Withdrawal by Subject|1|||
16349045|NCT01585246|39765571|FG000|Overall Study|Other|0|||
16349046|NCT01585246|39765572|FG001|Overall Study|Other|1|||
16349047|NCT01585246|39765573|FG002|Overall Study|Other|1|||
16349048|NCT01585246|39765574|FG003|Overall Study|Other|1|||
16349049|NCT01585246|39765575|FG004|Overall Study|Other|0|||
16349050|NCT00458003|39765576|FG000|Overall Study|Non protocol spinal anesthesia|1|||
16349051|NCT00458003|39765577|FG001|Overall Study|Non protocol spinal anesthesia|1|||
16349052|NCT02485483|39765582|FG000|Overall Study|Depression at baseline|15|||
16349053|NCT02485483|39765583|FG001|Overall Study|Depression at baseline|0|||
16349054|NCT02485483|39765582|FG000|Overall Study|Discontinued after baseline|39|||
16349055|NCT02485483|39765583|FG001|Overall Study|Discontinued after baseline|0|||
16349056|NCT03092752|39765591|FG000|Overall Study|Aged <40 years|14209|||
16349057|NCT03092752|39765591|FG000|Overall Study|At least one claim with T2DM|61299|||
16349058|NCT03092752|39765591|FG000|Overall Study|Having no claim of study drugs|29282|||
16349059|NCT03092752|39765591|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
16235249|NCT00902486|39344950|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
16235250|NCT00902486|39344951|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
16235251|NCT00902486|39344952|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
16235252|NCT00902486|39344953|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
16235253|NCT00902486|39344954|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
16235254|NCT00902486|39344955|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
16235255|NCT00902486|39344950|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
16235256|NCT00902486|39344951|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
16235257|NCT00902486|39344952|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
16235258|NCT00902486|39344953|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
16235259|NCT00902486|39344954|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
16235260|NCT00902486|39344955|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
16235261|NCT00902486|39344950|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
16349060|NCT03092752|39765591|FG000|Overall Study|<6 month history|245900|||
16349061|NCT02384538|39765594|FG000|Overall Study|Adverse Event|1|||
16349062|NCT02384538|39765595|FG001|Overall Study|Adverse Event|4|||
16349063|NCT02384538|39765594|FG000|Overall Study|Lack of Efficacy|4|||
16349064|NCT02384538|39765595|FG001|Overall Study|Lack of Efficacy|4|||
16349065|NCT02384538|39765594|FG000|Overall Study|Withdrew Consent|0|||
16349066|NCT02384538|39765595|FG001|Overall Study|Withdrew Consent|4|||
16349067|NCT02384538|39765594|FG000|Overall Study|Other|1|||
16349068|NCT02384538|39765595|FG001|Overall Study|Other|3|||
16349069|NCT01801111|39765605|FG000|Overall Study|Adverse Event|12|||
16349070|NCT01801111|39765605|FG000|Overall Study|Death|8|||
16349071|NCT01801111|39765605|FG000|Overall Study|Physician Decision|5|||
16349072|NCT01801111|39765605|FG000|Overall Study|Other|1|||
16349073|NCT01801111|39765605|FG000|Overall Study|Withdrawal by Subject|4|||
16349074|NCT01801111|39765605|FG000|Overall Study|Study Terminated by Sponsor|27|||
16349075|NCT01801111|39765605|FG000|Overall Study|Progressive Disease|81|||
16349076|NCT00128661|39765606|FG000|Overall Study|Adverse Event|14|||
16349077|NCT00128661|39765607|FG001|Overall Study|Adverse Event|11|||
16349078|NCT00128661|39765606|FG000|Overall Study|Lost to Follow-up|10|||
16349079|NCT00128661|39765607|FG001|Overall Study|Lost to Follow-up|7|||
16349080|NCT00128661|39765606|FG000|Overall Study|Withdrawal by Subject|243|||
16554201|NCT02771210|40492996|FG000|Period 1|Withdrawal of informed consent|1|||
16554202|NCT02771210|40492997|FG001|Period 1|Withdrawal of informed consent|5|||
16349081|NCT00128661|39765607|FG001|Overall Study|Withdrawal by Subject|232|||
16349082|NCT00128661|39765606|FG000|Overall Study|Other|7|||
16349083|NCT00128661|39765607|FG001|Overall Study|Other|8|||
16349084|NCT02829047|39765608|FG000|Overall Study|Withdrawal by Subject|1|||
16349085|NCT00823134|39765609|FG000|Overall Study|Invalid measurement|1|||
16349086|NCT01945944|39765611|FG000|Overall Study|Adverse Event|0|||
16349087|NCT01945944|39765612|FG001|Overall Study|Adverse Event|2|||
16349088|NCT01945944|39765611|FG000|Overall Study|Physician Decision|1|||
16349089|NCT01945944|39765612|FG001|Overall Study|Physician Decision|0|||
16349090|NCT01945944|39765611|FG000|Overall Study|Withdrawal by Subject|0|||
16349091|NCT01945944|39765612|FG001|Overall Study|Withdrawal by Subject|1|||
16349092|NCT00493012|39765613|FG000|Overall Study|Lost to Follow-up|18|||
16554203|NCT02771210|40492996|FG000|Period 2|Adverse Event|1|||
16554204|NCT02771210|40492997|FG001|Period 2|Adverse Event|0|||
16554205|NCT02771210|40492996|FG000|Period 2|Lack of Efficacy|0|||
16554206|NCT02771210|40492997|FG001|Period 2|Lack of Efficacy|1|||
16554207|NCT02771210|40492996|FG000|Period 2|Withdrawal by Subject|1|||
16554208|NCT02771210|40492997|FG001|Period 2|Withdrawal by Subject|0|||
16121197|NCT01245140|38930105|FG000|Overall Study|Lack of Efficacy|2|||
16121198|NCT01245140|38930106|FG001|Overall Study|Lack of Efficacy|4|||
16121199|NCT01245140|38930105|FG000|Overall Study|Protocol Violation|0|||
16235262|NCT00902486|39344951|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
16235263|NCT00902486|39344952|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
16235264|NCT00902486|39344953|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
16235265|NCT00902486|39344954|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
16235266|NCT00902486|39344955|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
16235267|NCT00902486|39344950|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
16235268|NCT00902486|39344951|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
16235269|NCT00902486|39344952|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
16235270|NCT00902486|39344953|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
16235271|NCT00902486|39344954|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
16235272|NCT00902486|39344955|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
16235273|NCT00902486|39344950|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
16235274|NCT00902486|39344951|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
16235275|NCT00902486|39344952|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
16235276|NCT00902486|39344953|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
16235277|NCT00902486|39344954|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
16121200|NCT01245140|38930106|FG001|Overall Study|Protocol Violation|1|||
16349093|NCT00493012|39765614|FG001|Overall Study|Lost to Follow-up|17|||
16554209|NCT02771210|40492996|FG000|Period 2|Withdrawal of informed consent|0|||
16554210|NCT02771210|40492997|FG001|Period 2|Withdrawal of informed consent|2|||
16554211|NCT00867490|40492998|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
16349094|NCT05137717|39765621|FG000|Overall Study|Death|2|||
16349095|NCT05137717|39765621|FG000|Overall Study|Withdrawal by Subject|6|||
16349096|NCT00828113|39765622|FG000|Overall Study|Withdrawal by Subject|27|||
16349097|NCT00828113|39765623|FG001|Overall Study|Withdrawal by Subject|26|||
16349098|NCT00828113|39765622|FG000|Overall Study|Lost to Follow-up|3|||
16349099|NCT00828113|39765623|FG001|Overall Study|Lost to Follow-up|5|||
16554212|NCT00867490|40492998|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
16235278|NCT00902486|39344955|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
16235279|NCT04993339|39344956|FG000|Overall Study|Lost to Follow-up|0|||
16235280|NCT04993339|39344957|FG001|Overall Study|Lost to Follow-up|1|||
16235281|NCT04993339|39344956|FG000|Overall Study|no MRI scan|3|||
16235282|NCT04993339|39344957|FG001|Overall Study|no MRI scan|1|||
16235283|NCT03428217|39344964|FG000|Overall Study|Death|89|||
16235284|NCT03428217|39344965|FG001|Overall Study|Death|93|||
16235285|NCT03428217|39344964|FG000|Overall Study|Withdrawal by Subject|8|||
16235286|NCT03428217|39344965|FG001|Overall Study|Withdrawal by Subject|7|||
16235287|NCT03428217|39344964|FG000|Overall Study|Lost to Follow-up|1|||
16235288|NCT03428217|39344965|FG001|Overall Study|Lost to Follow-up|3|||
16349100|NCT01781962|39765624|FG000|Overall Study|Other Miscellaneous Reasons|5|||
16349101|NCT04194489|39765625|FG000|Overall Study|Withdrawal by Subject|5|||
16349102|NCT04194489|39765625|FG000|Overall Study|Lost to Follow-up|48|||
16349103|NCT02824224|39765627|FG000|Overall Study|Discontinued, IUS expulsion|0|||
16349104|NCT02824224|39765628|FG001|Overall Study|Discontinued, IUS expulsion|1|||
16349105|NCT02824224|39765627|FG000|Overall Study|Did not show up for allocation visit|2|||
16349106|NCT02824224|39765628|FG001|Overall Study|Did not show up for allocation visit|0|||
16349107|NCT01275144|39765637|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
16349108|NCT01275144|39765638|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
16349109|NCT02061813|39765642|FG000|Overall Study|Withdrawal by Subject|1|||
16349110|NCT02061813|39765642|FG000|Overall Study|Protocol Violation|2|||
16349111|NCT01526785|39765643|FG000|Overall Study|Study Terminated by Sponsor|8|||
16349112|NCT01526785|39765643|FG000|Overall Study|Death|2|||
16349113|NCT01526785|39765643|FG000|Overall Study|Physician Decision|1|||
16235289|NCT03428217|39344964|FG000|Overall Study|Study terminated by sponsor|124|||
16235290|NCT03428217|39344965|FG001|Overall Study|Study terminated by sponsor|118|||
16235291|NCT03428217|39344964|FG000|Overall Study|Other, Not Specified|1|||
16349114|NCT01526785|39765643|FG000|Overall Study|Withdrawal by Subject|2|||
16349115|NCT01935089|39765644|FG000|Overall Study|Adverse Event|2|||
16349116|NCT01935089|39765644|FG000|Overall Study|Withdrawal by Subject|1|||
16235292|NCT03428217|39344965|FG001|Overall Study|Other, Not Specified|0|||
16349117|NCT02326272|39765645|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349118|NCT02326272|39765646|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
16349119|NCT02326272|39765647|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
16349120|NCT02326272|39765648|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349121|NCT02326272|39765649|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349122|NCT02326272|39765650|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349123|NCT02326272|39765651|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349124|NCT02326272|39765652|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349125|NCT02326272|39765653|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349126|NCT02326272|39765654|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349127|NCT02326272|39765655|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349128|NCT02326272|39765656|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349129|NCT02326272|39765657|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16121201|NCT01245140|38930105|FG000|Overall Study|Withdrawal by Subject|0|||
16121202|NCT01245140|38930106|FG001|Overall Study|Withdrawal by Subject|1|||
16121203|NCT01245140|38930105|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
16121204|NCT01245140|38930106|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
16121205|NCT01072630|38930108|FG000|Overall Study|Adverse Event|11|||
16121206|NCT01072630|38930109|FG001|Overall Study|Adverse Event|19|||
16121207|NCT01072630|38930110|FG002|Overall Study|Adverse Event|2|||
16121208|NCT01072630|38930108|FG000|Overall Study|Lack of Efficacy|10|||
16121209|NCT01072630|38930109|FG001|Overall Study|Lack of Efficacy|10|||
16121210|NCT01072630|38930110|FG002|Overall Study|Lack of Efficacy|1|||
16121211|NCT01072630|38930108|FG000|Overall Study|Withdrawal by Subject|8|||
16121212|NCT01072630|38930109|FG001|Overall Study|Withdrawal by Subject|7|||
16121213|NCT01072630|38930110|FG002|Overall Study|Withdrawal by Subject|2|||
16121214|NCT01072630|38930108|FG000|Overall Study|Protocol Violation|10|||
16121215|NCT01072630|38930109|FG001|Overall Study|Protocol Violation|8|||
16121216|NCT01072630|38930110|FG002|Overall Study|Protocol Violation|4|||
16235293|NCT01689649|39344970|FG000|Overall Study|Lack of Efficacy|3|||
16235294|NCT01689649|39344970|FG000|Overall Study|Non-compliance|11|||
16235295|NCT01689649|39344970|FG000|Overall Study|Protocol Violation|3|||
16235296|NCT01689649|39344970|FG000|Overall Study|Lost to Follow-up|5|||
16235297|NCT04798027|39344971|FG000|Overall Study|Protocol Violation|0|||
16235298|NCT04798027|39344972|FG001|Overall Study|Protocol Violation|0|||
16235299|NCT04798027|39344973|FG002|Overall Study|Protocol Violation|0|||
16235300|NCT04798027|39344974|FG003|Overall Study|Protocol Violation|0|||
16235301|NCT04798027|39344975|FG004|Overall Study|Protocol Violation|1|||
16235302|NCT04798027|39344976|FG005|Overall Study|Protocol Violation|0|||
16235303|NCT04798027|39344977|FG006|Overall Study|Protocol Violation|0|||
16235304|NCT04798027|39344978|FG007|Overall Study|Protocol Violation|1|||
16235305|NCT04798027|39344979|FG008|Overall Study|Protocol Violation|0|||
16235306|NCT04798027|39344971|FG000|Overall Study|Withdrawal by Subject|1|||
16235307|NCT04798027|39344972|FG001|Overall Study|Withdrawal by Subject|0|||
16235308|NCT04798027|39344973|FG002|Overall Study|Withdrawal by Subject|1|||
16235309|NCT04798027|39344974|FG003|Overall Study|Withdrawal by Subject|1|||
16235310|NCT04798027|39344975|FG004|Overall Study|Withdrawal by Subject|1|||
16235311|NCT04798027|39344976|FG005|Overall Study|Withdrawal by Subject|1|||
16121217|NCT01072630|38930108|FG000|Overall Study|Lost to Follow-up|11|||
16121218|NCT01072630|38930109|FG001|Overall Study|Lost to Follow-up|11|||
16121219|NCT01072630|38930110|FG002|Overall Study|Lost to Follow-up|1|||
16235312|NCT04798027|39344977|FG006|Overall Study|Withdrawal by Subject|3|||
16235313|NCT04798027|39344978|FG007|Overall Study|Withdrawal by Subject|2|||
16235314|NCT04798027|39344979|FG008|Overall Study|Withdrawal by Subject|2|||
16349130|NCT02326272|39765658|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349131|NCT02326272|39765659|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
16349132|NCT02326272|39765645|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
16235315|NCT04798027|39344971|FG000|Overall Study|Lost to Follow-up|1|||
16235316|NCT04798027|39344972|FG001|Overall Study|Lost to Follow-up|3|||
16349133|NCT02326272|39765646|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
16349134|NCT02326272|39765647|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16349135|NCT02326272|39765648|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16349136|NCT02326272|39765649|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16349137|NCT02326272|39765650|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16349138|NCT02326272|39765651|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16349139|NCT02326272|39765652|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16235317|NCT04798027|39344973|FG002|Overall Study|Lost to Follow-up|0|||
16235318|NCT04798027|39344974|FG003|Overall Study|Lost to Follow-up|0|||
16235319|NCT04798027|39344975|FG004|Overall Study|Lost to Follow-up|0|||
16235320|NCT04798027|39344976|FG005|Overall Study|Lost to Follow-up|1|||
16235321|NCT04798027|39344977|FG006|Overall Study|Lost to Follow-up|0|||
16235322|NCT04798027|39344978|FG007|Overall Study|Lost to Follow-up|0|||
16235323|NCT04798027|39344979|FG008|Overall Study|Lost to Follow-up|1|||
16235324|NCT04798027|39344971|FG000|Overall Study|Withdrawal by Sponsor|8|||
16235325|NCT04798027|39344972|FG001|Overall Study|Withdrawal by Sponsor|22|||
16349140|NCT02326272|39765653|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16349141|NCT02326272|39765654|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16413421|NCT00762996|39995160|FG003|Period One|Adverse Event|0|||
16554213|NCT00867490|40492998|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
16554214|NCT00867490|40492998|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
16554215|NCT00867490|40492998|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
16554216|NCT00451217|40492999|FG000|Overall Study|Lost to Follow-up|0|||
16554217|NCT00451217|40493000|FG001|Overall Study|Lost to Follow-up|1|||
16554218|NCT00451217|40493001|FG002|Overall Study|Lost to Follow-up|1|||
16554219|NCT00451217|40493002|FG003|Overall Study|Lost to Follow-up|1|||
16554220|NCT00451217|40492999|FG000|Overall Study|Withdrawal by Subject|1|||
16554221|NCT00451217|40493000|FG001|Overall Study|Withdrawal by Subject|0|||
16554222|NCT00451217|40493001|FG002|Overall Study|Withdrawal by Subject|0|||
16554223|NCT00451217|40493002|FG003|Overall Study|Withdrawal by Subject|0|||
16554224|NCT00451217|40492999|FG000|Overall Study|Not Treated|1|||
16554225|NCT00451217|40493000|FG001|Overall Study|Not Treated|1|||
16554226|NCT00451217|40493001|FG002|Overall Study|Not Treated|3|||
16554227|NCT00451217|40493002|FG003|Overall Study|Not Treated|4|||
16554228|NCT04666922|40493007|FG000|Overall Study|Withdrawal by Subject|1|||
16554229|NCT04666922|40493008|FG001|Overall Study|Withdrawal by Subject|0|||
16554230|NCT04666922|40493009|FG002|Overall Study|Withdrawal by Subject|0|||
16554231|NCT04666922|40493010|FG003|Overall Study|Withdrawal by Subject|0|||
16554232|NCT04666922|40493011|FG004|Overall Study|Withdrawal by Subject|0|||
16235326|NCT04798027|39344973|FG002|Overall Study|Withdrawal by Sponsor|9|||
16235327|NCT04798027|39344974|FG003|Overall Study|Withdrawal by Sponsor|26|||
16235328|NCT04798027|39344975|FG004|Overall Study|Withdrawal by Sponsor|24|||
16235329|NCT04798027|39344976|FG005|Overall Study|Withdrawal by Sponsor|11|||
16235330|NCT04798027|39344977|FG006|Overall Study|Withdrawal by Sponsor|25|||
16554233|NCT04666922|40493012|FG005|Overall Study|Withdrawal by Subject|0|||
16554234|NCT04666922|40493013|FG006|Overall Study|Withdrawal by Subject|0|||
16554235|NCT00547911|40493014|FG000|Overall Study|Adverse Event|0|||
16554236|NCT00547911|40493015|FG001|Overall Study|Adverse Event|0|||
16554237|NCT00547911|40493016|FG002|Overall Study|Adverse Event|0|||
16554238|NCT00547911|40493017|FG003|Overall Study|Adverse Event|1|||
16554239|NCT00547911|40493018|FG004|Overall Study|Adverse Event|0|||
16554240|NCT00547911|40493019|FG005|Overall Study|Adverse Event|0|||
16554241|NCT00209274|40493024|FG000|Overall Study|Missed visit|3|||
16554242|NCT00209274|40493025|FG001|Overall Study|Missed visit|2|||
16554243|NCT00209274|40493024|FG000|Overall Study|Death|32|||
16554244|NCT00209274|40493025|FG001|Overall Study|Death|15|||
16554245|NCT00209274|40493024|FG000|Overall Study|Withdrawal by Subject|30|||
16554246|NCT00209274|40493025|FG001|Overall Study|Withdrawal by Subject|15|||
16554247|NCT00209274|40493024|FG000|Overall Study|Randomized not treated (RNT)|6|||
16554248|NCT00209274|40493025|FG001|Overall Study|Randomized not treated (RNT)|15|||
16554249|NCT02388074|40493027|FG000|Overall Study|Lost in Transit|2|||
16554250|NCT02388074|40493027|FG000|Overall Study|Sample Not Returned|1|||
16554251|NCT00358215|40493028|FG000|Overall Study|Ineligibility determined|4|||
16554252|NCT00358215|40493029|FG001|Overall Study|Ineligibility determined|3|||
16235331|NCT04798027|39344978|FG007|Overall Study|Withdrawal by Sponsor|26|||
16235332|NCT04798027|39344979|FG008|Overall Study|Withdrawal by Sponsor|11|||
16235333|NCT00602927|39344980|FG000|Period 1: 13 Days|Protocol Violation|2|||
16554253|NCT00358215|40493028|FG000|Overall Study|Adverse Event|83|||
16554254|NCT00358215|40493029|FG001|Overall Study|Adverse Event|65|||
16554255|NCT00358215|40493028|FG000|Overall Study|Withdrawal by Subject|111|||
16235334|NCT00602927|39344981|FG001|Period 1: 13 Days|Protocol Violation|4|||
16349142|NCT02326272|39765655|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16554256|NCT00358215|40493029|FG001|Overall Study|Withdrawal by Subject|102|||
16554257|NCT00358215|40493028|FG000|Overall Study|Participant request|65|||
16554258|NCT00358215|40493029|FG001|Overall Study|Participant request|64|||
16554259|NCT00358215|40493028|FG000|Overall Study|Physician Decision|47|||
16554260|NCT00358215|40493029|FG001|Overall Study|Physician Decision|39|||
16554261|NCT00358215|40493028|FG000|Overall Study|Lost to Follow-up|16|||
16554262|NCT00358215|40493029|FG001|Overall Study|Lost to Follow-up|22|||
16554263|NCT00358215|40493028|FG000|Overall Study|Death|265|||
16554264|NCT00358215|40493029|FG001|Overall Study|Death|281|||
16554265|NCT00358215|40493028|FG000|Overall Study|Protocol Violation|64|||
16554266|NCT00358215|40493029|FG001|Overall Study|Protocol Violation|59|||
16554267|NCT00358215|40493028|FG000|Overall Study|Pregnancy|1|||
16554268|NCT00358215|40493029|FG001|Overall Study|Pregnancy|0|||
16554269|NCT00358215|40493028|FG000|Overall Study|Other|21|||
16554270|NCT00358215|40493029|FG001|Overall Study|Other|14|||
16554271|NCT00358215|40493028|FG000|Overall Study|Did not receive investigational product|2|||
16554272|NCT00358215|40493029|FG001|Overall Study|Did not receive investigational product|3|||
16554273|NCT02726399|40493030|FG000|Overall Study|Participant Non-Compliance|1|||
16554274|NCT02726399|40493030|FG000|Overall Study|Adverse Event|2|||
16554275|NCT02726399|40493030|FG000|Overall Study|Progression of disease|4|||
16554276|NCT01744782|40493031|FG000|Overall Study|Death|1|||
16235335|NCT00602927|39344980|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
16235336|NCT00602927|39344981|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
16235337|NCT00602927|39344980|FG000|Period 1: 13 Days|Time|1|||
16235338|NCT00602927|39344981|FG001|Period 1: 13 Days|Time|0|||
16235339|NCT00602927|39344980|FG000|Period 1: 13 Days|Claustrophobia|0|||
16235340|NCT00602927|39344981|FG001|Period 1: 13 Days|Claustrophobia|1|||
16235341|NCT00602927|39344980|FG000|Period 2: 14 Days|Protocol Violation|0|||
16235342|NCT00602927|39344981|FG001|Period 2: 14 Days|Protocol Violation|2|||
16235343|NCT00602927|39344980|FG000|Period 3: 13 Days|Protocol Violation|0|||
16235344|NCT00602927|39344981|FG001|Period 3: 13 Days|Protocol Violation|1|||
16235345|NCT00602927|39344980|FG000|Period 3: 13 Days|MRI data quality|2|||
16235346|NCT00602927|39344981|FG001|Period 3: 13 Days|MRI data quality|2|||
16235347|NCT00503035|39344982|FG000|Overall Study|Lost to Follow-up|2|||
16235348|NCT00503035|39344982|FG000|Overall Study|Physician Decision|3|||
16235349|NCT00503035|39344982|FG000|Overall Study|Ineligible|15|||
16235350|NCT00698009|39344986|FG000|Overall Study|Withdrawal by Subject|1|||
16235351|NCT03209973|39344987|FG000|Overall Study|Withdrawal by Subject|7|||
16235352|NCT03209973|39344987|FG000|Overall Study|Lost to Follow-up|2|||
16235353|NCT03209973|39344987|FG000|Overall Study|Death|8|||
16235354|NCT03209973|39344987|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
16235355|NCT03209973|39344987|FG000|Overall Study|Sponsor Decision|18|||
16235356|NCT03209973|39344987|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
16235357|NCT03209973|39344987|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
16235358|NCT00390572|39344988|FG000|Overall Study|Lost to Follow-up|8|||
16235359|NCT00390572|39344989|FG001|Overall Study|Lost to Follow-up|4|||
16235360|NCT00390572|39344988|FG000|Overall Study|health condition|0|||
16235361|NCT00390572|39344989|FG001|Overall Study|health condition|1|||
16235362|NCT03725722|39344990|FG000|Overall Study|Lack of Efficacy|2|||
16235363|NCT03725722|39344991|FG001|Overall Study|Lack of Efficacy|1|||
16235364|NCT03725722|39344992|FG002|Overall Study|Lack of Efficacy|2|||
16235365|NCT03725722|39344993|FG003|Overall Study|Lack of Efficacy|0|||
16235366|NCT03725722|39344994|FG004|Overall Study|Lack of Efficacy|2|||
16235367|NCT03725722|39344990|FG000|Overall Study|Adverse Event|2|||
16235368|NCT03725722|39344991|FG001|Overall Study|Adverse Event|2|||
16235369|NCT03725722|39344992|FG002|Overall Study|Adverse Event|1|||
16235370|NCT03725722|39344993|FG003|Overall Study|Adverse Event|0|||
16235371|NCT03725722|39344994|FG004|Overall Study|Adverse Event|6|||
16235372|NCT03725722|39344990|FG000|Overall Study|Withdrawal by Subject|4|||
16235373|NCT03725722|39344991|FG001|Overall Study|Withdrawal by Subject|1|||
16235374|NCT03725722|39344992|FG002|Overall Study|Withdrawal by Subject|0|||
16235375|NCT03725722|39344993|FG003|Overall Study|Withdrawal by Subject|4|||
16235376|NCT03725722|39344994|FG004|Overall Study|Withdrawal by Subject|4|||
16235377|NCT03725722|39344990|FG000|Overall Study|Lost to Follow-up|3|||
16235378|NCT03725722|39344991|FG001|Overall Study|Lost to Follow-up|1|||
16235379|NCT03725722|39344992|FG002|Overall Study|Lost to Follow-up|2|||
16235380|NCT03725722|39344993|FG003|Overall Study|Lost to Follow-up|2|||
16235381|NCT03725722|39344994|FG004|Overall Study|Lost to Follow-up|1|||
16235382|NCT03725722|39344990|FG000|Overall Study|Personal reasons|0|||
16235383|NCT03725722|39344991|FG001|Overall Study|Personal reasons|0|||
16235384|NCT03725722|39344992|FG002|Overall Study|Personal reasons|1|||
16235385|NCT03725722|39344993|FG003|Overall Study|Personal reasons|0|||
16554277|NCT04297241|40493033|FG000|Overall Study|Withdrawal by Subject|1|||
16554278|NCT04297241|40493033|FG000|Overall Study|Adverse Event|1|||
16554279|NCT04297241|40493033|FG000|Overall Study|Physician Decision|3|||
16235386|NCT03725722|39344994|FG004|Overall Study|Personal reasons|1|||
16235387|NCT03725722|39344990|FG000|Overall Study|COVID-19 situation|0|||
16235388|NCT03725722|39344991|FG001|Overall Study|COVID-19 situation|1|||
16554280|NCT01076088|40493034|FG000|Overall Study|Adverse Event|1|||
16554281|NCT01076088|40493035|FG001|Overall Study|Adverse Event|6|||
16554282|NCT01076088|40493036|FG002|Overall Study|Adverse Event|3|||
16554283|NCT01076088|40493037|FG003|Overall Study|Adverse Event|2|||
16554284|NCT01076088|40493038|FG004|Overall Study|Adverse Event|3|||
16554285|NCT01076088|40493039|FG005|Overall Study|Adverse Event|3|||
16554286|NCT01076088|40493034|FG000|Overall Study|Lost to Follow-up|1|||
16554287|NCT01076088|40493035|FG001|Overall Study|Lost to Follow-up|1|||
16554288|NCT01076088|40493036|FG002|Overall Study|Lost to Follow-up|0|||
16554289|NCT01076088|40493037|FG003|Overall Study|Lost to Follow-up|1|||
16554290|NCT01076088|40493038|FG004|Overall Study|Lost to Follow-up|1|||
16554291|NCT01076088|40493039|FG005|Overall Study|Lost to Follow-up|2|||
16554292|NCT01076088|40493034|FG000|Overall Study|Non-compliance with study drug|0|||
16235389|NCT03725722|39344992|FG002|Overall Study|COVID-19 situation|0|||
16554293|NCT01076088|40493035|FG001|Overall Study|Non-compliance with study drug|0|||
16554294|NCT01076088|40493036|FG002|Overall Study|Non-compliance with study drug|0|||
16554295|NCT01076088|40493037|FG003|Overall Study|Non-compliance with study drug|1|||
16235390|NCT03725722|39344993|FG003|Overall Study|COVID-19 situation|0|||
16235391|NCT03725722|39344994|FG004|Overall Study|COVID-19 situation|0|||
16235392|NCT02856282|39345000|FG000|Overall Study|Withdrawal by Subject|1|||
16235393|NCT00455923|39345001|FG000|Overall Study|Pregnancy|0|||
16235394|NCT00455923|39345002|FG001|Overall Study|Pregnancy|2|||
16235395|NCT00455923|39345001|FG000|Overall Study|Other|3|||
16235396|NCT00455923|39345002|FG001|Overall Study|Other|1|||
16235397|NCT01266642|39345008|FG000|Overall Study|Protocol Violation|0|||
16235398|NCT01266642|39345009|FG001|Overall Study|Protocol Violation|1|||
16235399|NCT00916617|39345011|FG000|Overall Study|Adverse Event|3|||
16235400|NCT00916617|39345012|FG001|Overall Study|Adverse Event|2|||
16235401|NCT00916617|39345013|FG002|Overall Study|Adverse Event|6|||
16235402|NCT00916617|39345014|FG003|Overall Study|Adverse Event|3|||
16235403|NCT00916617|39345011|FG000|Overall Study|Withdrawal by Subject|3|||
16235404|NCT00916617|39345012|FG001|Overall Study|Withdrawal by Subject|2|||
16235405|NCT00916617|39345013|FG002|Overall Study|Withdrawal by Subject|0|||
16235406|NCT00916617|39345014|FG003|Overall Study|Withdrawal by Subject|1|||
16235407|NCT00916617|39345011|FG000|Overall Study|Caregiver Request|3|||
16235408|NCT00916617|39345012|FG001|Overall Study|Caregiver Request|2|||
16235409|NCT00916617|39345013|FG002|Overall Study|Caregiver Request|1|||
16235410|NCT00916617|39345014|FG003|Overall Study|Caregiver Request|0|||
16235411|NCT00916617|39345011|FG000|Overall Study|Physician Decision|1|||
16235412|NCT00916617|39345012|FG001|Overall Study|Physician Decision|1|||
16235413|NCT00916617|39345013|FG002|Overall Study|Physician Decision|0|||
16235414|NCT00916617|39345014|FG003|Overall Study|Physician Decision|0|||
16235415|NCT00916617|39345011|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
16235416|NCT00916617|39345012|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
16235417|NCT00916617|39345013|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
16235418|NCT00916617|39345014|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
16235419|NCT00916617|39345011|FG000|Overall Study|Lost to Follow-up|2|||
16235420|NCT00916617|39345012|FG001|Overall Study|Lost to Follow-up|1|||
16235421|NCT00916617|39345013|FG002|Overall Study|Lost to Follow-up|0|||
16235422|NCT00916617|39345014|FG003|Overall Study|Lost to Follow-up|0|||
16235423|NCT00916617|39345011|FG000|Overall Study|Lack of Efficacy|1|||
16235424|NCT00916617|39345012|FG001|Overall Study|Lack of Efficacy|0|||
16235425|NCT00916617|39345013|FG002|Overall Study|Lack of Efficacy|0|||
16235426|NCT00916617|39345014|FG003|Overall Study|Lack of Efficacy|0|||
16235427|NCT00916617|39345011|FG000|Overall Study|Other|2|||
16235428|NCT00916617|39345012|FG001|Overall Study|Other|0|||
16235429|NCT00916617|39345013|FG002|Overall Study|Other|0|||
16235430|NCT00916617|39345014|FG003|Overall Study|Other|2|||
16235431|NCT03683719|39345017|FG000|Overall Study|Lack of Efficacy|1|||
16235432|NCT03683719|39345018|FG001|Overall Study|Lack of Efficacy|3|||
16235433|NCT03683719|39345019|FG002|Overall Study|Lack of Efficacy|4|||
16235434|NCT03683719|39345020|FG003|Overall Study|Lack of Efficacy|0|||
16235435|NCT03683719|39345021|FG004|Overall Study|Lack of Efficacy|4|||
16235436|NCT03683719|39345017|FG000|Overall Study|Adverse Event|6|||
16235437|NCT03683719|39345018|FG001|Overall Study|Adverse Event|6|||
16235438|NCT03683719|39345019|FG002|Overall Study|Adverse Event|0|||
16235439|NCT03683719|39345020|FG003|Overall Study|Adverse Event|1|||
16235440|NCT03683719|39345021|FG004|Overall Study|Adverse Event|3|||
16235441|NCT03683719|39345017|FG000|Overall Study|Withdrawal by Subject|4|||
16235442|NCT03683719|39345018|FG001|Overall Study|Withdrawal by Subject|4|||
16235443|NCT03683719|39345019|FG002|Overall Study|Withdrawal by Subject|3|||
16235444|NCT03683719|39345020|FG003|Overall Study|Withdrawal by Subject|5|||
16235445|NCT03683719|39345021|FG004|Overall Study|Withdrawal by Subject|5|||
16235446|NCT03683719|39345017|FG000|Overall Study|Lost to Follow-up|1|||
16235447|NCT03683719|39345018|FG001|Overall Study|Lost to Follow-up|0|||
16235448|NCT03683719|39345019|FG002|Overall Study|Lost to Follow-up|0|||
16235449|NCT03683719|39345020|FG003|Overall Study|Lost to Follow-up|1|||
16235450|NCT03683719|39345021|FG004|Overall Study|Lost to Follow-up|1|||
16235451|NCT03683719|39345017|FG000|Overall Study|Other personal reasons|0|||
16235452|NCT03683719|39345018|FG001|Overall Study|Other personal reasons|0|||
16235453|NCT03683719|39345019|FG002|Overall Study|Other personal reasons|1|||
16235454|NCT03683719|39345020|FG003|Overall Study|Other personal reasons|0|||
16235455|NCT03683719|39345021|FG004|Overall Study|Other personal reasons|1|||
16235456|NCT02204449|39345022|FG000|Overall Study|Lost to Follow-up|7|||
16413422|NCT00762996|39995157|FG000|Period One|Withdrawal by Subject|0|||
16413423|NCT00762996|39995158|FG001|Period One|Withdrawal by Subject|0|||
16235457|NCT02204449|39345023|FG001|Overall Study|Lost to Follow-up|9|||
16235458|NCT02204449|39345022|FG000|Overall Study|Death|0|||
16235459|NCT02204449|39345023|FG001|Overall Study|Death|1|||
16235460|NCT02204449|39345022|FG000|Overall Study|Withdrawal by Subject|0|||
16235461|NCT02204449|39345023|FG001|Overall Study|Withdrawal by Subject|1|||
16235462|NCT02353572|39345024|FG000|Overall Study|Withdrawal by Subject|1|||
16235463|NCT02353572|39345024|FG000|Overall Study|Study terminated|2|||
16235464|NCT03993288|39345027|FG000|Overall Study|Lost to Follow-up|2|||
16235465|NCT03993288|39345028|FG001|Overall Study|Lost to Follow-up|1|||
16235466|NCT03993288|39345027|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
16235467|NCT03993288|39345028|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
16235468|NCT03993288|39345027|FG000|Overall Study|wrong randomization|0|||
16235469|NCT03993288|39345028|FG001|Overall Study|wrong randomization|1|||
16235470|NCT03993288|39345027|FG000|Overall Study|improper enrollment|0|||
16235471|NCT03993288|39345028|FG001|Overall Study|improper enrollment|1|||
16235472|NCT03993288|39345027|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
16235473|NCT03993288|39345028|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
16235474|NCT03993288|39345027|FG000|Overall Study|developed SAE|2|||
16235475|NCT03993288|39345028|FG001|Overall Study|developed SAE|0|||
16349143|NCT02326272|39765656|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16349144|NCT02326272|39765657|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16349145|NCT02326272|39765658|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16349146|NCT02326272|39765659|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
16349147|NCT02326272|39765645|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
16349148|NCT02326272|39765646|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
16349149|NCT02326272|39765647|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
16349150|NCT02326272|39765648|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349151|NCT02326272|39765649|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349152|NCT02326272|39765650|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349153|NCT02326272|39765651|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349154|NCT02326272|39765652|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349155|NCT02326272|39765653|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349156|NCT02326272|39765654|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349157|NCT02326272|39765655|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16413424|NCT00762996|39995159|FG002|Period One|Withdrawal by Subject|1|||
16413425|NCT00762996|39995160|FG003|Period One|Withdrawal by Subject|0|||
16413426|NCT00378599|39995165|FG000|Overall Study|Adverse Event|38|||
16413427|NCT00378599|39995165|FG000|Overall Study|Protocol Violation|2|||
16413428|NCT00378599|39995165|FG000|Overall Study|Treatment failure|7|||
16413429|NCT00378599|39995165|FG000|Overall Study|Withdrawal by Subject|5|||
16413430|NCT00096018|39995166|FG000|Overall Study|Became Ineligible (not treated)|0|||
16413431|NCT00096018|39995167|FG001|Overall Study|Became Ineligible (not treated)|3|||
16413432|NCT00096018|39995166|FG000|Overall Study|Miscellaneous (not treated)|0|||
16413433|NCT00096018|39995167|FG001|Overall Study|Miscellaneous (not treated)|2|||
16235476|NCT03993288|39345027|FG000|Overall Study|consent withdrawal|1|||
16235477|NCT03993288|39345028|FG001|Overall Study|consent withdrawal|0|||
16413434|NCT00096018|39995166|FG000|Overall Study|Adverse Event|0|||
16413435|NCT00096018|39995167|FG001|Overall Study|Adverse Event|5|||
16413436|NCT00096018|39995166|FG000|Overall Study|Death|0|||
16413437|NCT00096018|39995167|FG001|Overall Study|Death|1|||
16413438|NCT00096018|39995166|FG000|Overall Study|Withdrawal by Subject|0|||
16413439|NCT00096018|39995167|FG001|Overall Study|Withdrawal by Subject|2|||
16235478|NCT03993288|39345027|FG000|Overall Study|did not follow the treatment schedule|1|||
16413440|NCT00096018|39995166|FG000|Overall Study|Miscellaneous|2|||
16413441|NCT00096018|39995167|FG001|Overall Study|Miscellaneous|1|||
16413442|NCT02634606|39995169|FG000|Overall Study|unable to obtain the drug at start|13|||
16413443|NCT00364533|39995170|FG000|Overall Study|Adverse Event|8|||
16413444|NCT00364533|39995171|FG001|Overall Study|Adverse Event|7|||
16349158|NCT02326272|39765656|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349159|NCT02326272|39765657|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349160|NCT02326272|39765658|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349161|NCT02326272|39765659|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
16349162|NCT02326272|39765645|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349163|NCT02326272|39765646|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349164|NCT02326272|39765647|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
16349165|NCT02326272|39765648|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349166|NCT02326272|39765649|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349167|NCT02326272|39765650|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349168|NCT02326272|39765651|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349169|NCT02326272|39765652|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349170|NCT02326272|39765653|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349171|NCT02326272|39765654|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349172|NCT02326272|39765655|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349173|NCT02326272|39765656|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349174|NCT02326272|39765657|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349175|NCT02326272|39765658|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349176|NCT02326272|39765659|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
16349177|NCT02326272|39765645|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349178|NCT02326272|39765646|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349179|NCT02326272|39765647|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
16349180|NCT02326272|39765648|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349181|NCT02326272|39765649|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349182|NCT02326272|39765650|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349183|NCT02326272|39765651|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349184|NCT02326272|39765652|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349185|NCT02326272|39765653|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349186|NCT02326272|39765654|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349187|NCT02326272|39765655|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349188|NCT02326272|39765656|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349189|NCT02326272|39765657|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349190|NCT02326272|39765658|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349191|NCT02326272|39765659|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
16349192|NCT02326272|39765645|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349193|NCT02326272|39765646|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349194|NCT02326272|39765647|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
16349195|NCT02326272|39765648|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349196|NCT02326272|39765649|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349197|NCT02326272|39765650|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349198|NCT02326272|39765651|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349199|NCT02326272|39765652|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349200|NCT02326272|39765653|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349201|NCT02326272|39765654|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16413445|NCT00364533|39995172|FG002|Overall Study|Adverse Event|15|||
16413446|NCT00364533|39995173|FG003|Overall Study|Adverse Event|5|||
16413447|NCT00364533|39995174|FG004|Overall Study|Adverse Event|2|||
16413448|NCT00364533|39995170|FG000|Overall Study|Withdrawal by Subject|4|||
16413449|NCT00364533|39995171|FG001|Overall Study|Withdrawal by Subject|8|||
16413450|NCT00364533|39995172|FG002|Overall Study|Withdrawal by Subject|6|||
16413451|NCT00364533|39995173|FG003|Overall Study|Withdrawal by Subject|6|||
16413452|NCT00364533|39995174|FG004|Overall Study|Withdrawal by Subject|6|||
16413453|NCT00364533|39995170|FG000|Overall Study|Lack of Efficacy|22|||
16235479|NCT03993288|39345028|FG001|Overall Study|did not follow the treatment schedule|0|||
16235480|NCT03993288|39345027|FG000|Overall Study|did not follow the treatment regimen|1|||
16235481|NCT03993288|39345028|FG001|Overall Study|did not follow the treatment regimen|0|||
16235482|NCT03993288|39345027|FG000|Overall Study|Adverse Event|1|||
16235483|NCT03993288|39345028|FG001|Overall Study|Adverse Event|0|||
16235484|NCT03993288|39345027|FG000|Overall Study|Withdrawal by Subject|1|||
16235485|NCT03993288|39345028|FG001|Overall Study|Withdrawal by Subject|1|||
16235486|NCT01017731|39345029|FG000|Overall Study|Lost to Follow-up|2|||
16235487|NCT01017731|39345029|FG000|Overall Study|Withdrawal by Subject|3|||
16235488|NCT01017731|39345029|FG000|Overall Study|Physician Decision|2|||
16235489|NCT01017731|39345029|FG000|Overall Study|Adverse Event|1|||
16235490|NCT03569891|39345032|FG000|Lead-in|Ineligible during lead-in|8|||
16235491|NCT03569891|39345032|FG000|Lead-in|Withdrawal by Subject|3|||
16235492|NCT03569891|39345032|FG000|Lead-in|Risks related to COVID-19|2|||
16235493|NCT03569891|39345032|FG000|AMT-061|Adverse Event|1|||
16235494|NCT02787746|39345036|FG000|Overall Study|Adverse Event|42|||
16235495|NCT02787746|39345036|FG000|Overall Study|Withdrawal by Subject|65|||
16235496|NCT02787746|39345036|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
16235497|NCT02284373|39345037|FG000|Overall Study|Withdrawal by Subject|0|||
16235498|NCT02284373|39345038|FG001|Overall Study|Withdrawal by Subject|1|||
16235499|NCT02284373|39345039|FG002|Overall Study|Withdrawal by Subject|0|||
16349202|NCT02326272|39765655|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349203|NCT02326272|39765656|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349204|NCT02326272|39765657|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349205|NCT02326272|39765658|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349206|NCT02326272|39765659|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
16349207|NCT02326272|39765645|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349208|NCT02326272|39765646|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349209|NCT02326272|39765647|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
16349210|NCT02326272|39765648|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349211|NCT02326272|39765649|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349212|NCT02326272|39765650|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349213|NCT02326272|39765651|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349214|NCT02326272|39765652|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349215|NCT02326272|39765653|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349216|NCT02326272|39765654|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349217|NCT02326272|39765655|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349218|NCT02326272|39765656|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349219|NCT02326272|39765657|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349220|NCT02326272|39765658|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349221|NCT02326272|39765659|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
16349222|NCT02326272|39765645|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16349223|NCT02326272|39765646|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16349224|NCT02326272|39765647|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16349225|NCT02326272|39765648|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16349226|NCT02326272|39765649|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
16349227|NCT02326272|39765650|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
16349228|NCT02326272|39765651|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
16349229|NCT02326272|39765652|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
16349230|NCT02326272|39765653|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
16349231|NCT02326272|39765654|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16349232|NCT02326272|39765655|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16349233|NCT02326272|39765656|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16349234|NCT02326272|39765657|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16349235|NCT02326272|39765658|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16349236|NCT02326272|39765659|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
16349237|NCT02326272|39765645|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16349238|NCT02326272|39765646|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16349239|NCT02326272|39765647|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16554296|NCT01076088|40493038|FG004|Overall Study|Non-compliance with study drug|0|||
16554297|NCT01076088|40493039|FG005|Overall Study|Non-compliance with study drug|0|||
16554298|NCT01076088|40493034|FG000|Overall Study|Physician Decision|1|||
16554299|NCT01076088|40493035|FG001|Overall Study|Physician Decision|3|||
16554300|NCT01076088|40493036|FG002|Overall Study|Physician Decision|0|||
16554301|NCT01076088|40493037|FG003|Overall Study|Physician Decision|1|||
16554302|NCT01076088|40493038|FG004|Overall Study|Physician Decision|1|||
16235500|NCT02284373|39345037|FG000|Overall Study|Other|0|||
16554303|NCT01076088|40493039|FG005|Overall Study|Physician Decision|0|||
16554304|NCT01076088|40493034|FG000|Overall Study|Withdrawal by Subject|8|||
16554305|NCT01076088|40493035|FG001|Overall Study|Withdrawal by Subject|8|||
16554306|NCT01076088|40493036|FG002|Overall Study|Withdrawal by Subject|14|||
16554307|NCT01076088|40493037|FG003|Overall Study|Withdrawal by Subject|10|||
16554308|NCT01076088|40493038|FG004|Overall Study|Withdrawal by Subject|11|||
16554309|NCT01076088|40493039|FG005|Overall Study|Withdrawal by Subject|17|||
16554310|NCT01076088|40493034|FG000|Overall Study|Other protocol specified criteria|0|||
16554311|NCT01076088|40493035|FG001|Overall Study|Other protocol specified criteria|0|||
16554312|NCT01076088|40493036|FG002|Overall Study|Other protocol specified criteria|0|||
16554313|NCT01076088|40493037|FG003|Overall Study|Other protocol specified criteria|0|||
16554314|NCT01076088|40493038|FG004|Overall Study|Other protocol specified criteria|0|||
16554315|NCT01076088|40493039|FG005|Overall Study|Other protocol specified criteria|1|||
16554316|NCT02133924|40493040|FG000|Overall Study|Death|38|||
16554317|NCT02133924|40493040|FG000|Overall Study|Physician Decision|1|||
16554318|NCT02133924|40493040|FG000|Overall Study|Withdrawal by Subject|3|||
16554319|NCT02307513|40493045|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
16349240|NCT02326272|39765648|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16349241|NCT02326272|39765649|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16349242|NCT02326272|39765650|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
16349243|NCT02326272|39765651|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
16349244|NCT02326272|39765652|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16349245|NCT02326272|39765653|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
16349246|NCT02326272|39765654|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
16349247|NCT02326272|39765655|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16349248|NCT02326272|39765656|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16413454|NCT00364533|39995171|FG001|Overall Study|Lack of Efficacy|22|||
16413455|NCT00364533|39995172|FG002|Overall Study|Lack of Efficacy|21|||
16554320|NCT02307513|40493046|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
16554321|NCT02307513|40493045|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
16554322|NCT02307513|40493046|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
16554323|NCT02307513|40493045|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
16554324|NCT02307513|40493046|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
16554325|NCT02307513|40493045|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
16554326|NCT02307513|40493046|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
16554327|NCT02307513|40493045|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
16554328|NCT02307513|40493046|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
16554329|NCT02307513|40493045|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
16554330|NCT02307513|40493046|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
16554331|NCT02307513|40493045|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
16554332|NCT02307513|40493046|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
16554333|NCT02307513|40493045|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
16554334|NCT02307513|40493046|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
16554335|NCT02307513|40493045|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
16554336|NCT02307513|40493046|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
16554337|NCT02307513|40493045|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
16554338|NCT02307513|40493046|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
16554339|NCT02307513|40493045|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
16554340|NCT02307513|40493046|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
16121220|NCT01072630|38930108|FG000|Overall Study|Noncompliance with study medication|1|||
16121221|NCT01072630|38930109|FG001|Overall Study|Noncompliance with study medication|1|||
16121222|NCT01072630|38930110|FG002|Overall Study|Noncompliance with study medication|1|||
16121223|NCT01072630|38930108|FG000|Overall Study|Noncompliance with study procedures|1|||
16121224|NCT01072630|38930109|FG001|Overall Study|Noncompliance with study procedures|2|||
16121225|NCT01072630|38930110|FG002|Overall Study|Noncompliance with study procedures|1|||
16121226|NCT01072630|38930108|FG000|Overall Study|Other|3|||
16121227|NCT01072630|38930109|FG001|Overall Study|Other|2|||
16121228|NCT01072630|38930110|FG002|Overall Study|Other|1|||
16554341|NCT02307513|40493045|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
16554342|NCT02307513|40493046|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
16554343|NCT02307513|40493045|FG000|Long-term Extension|Physician Decision|1|||
16554344|NCT02307513|40493046|FG001|Long-term Extension|Physician Decision|0|||
16121229|NCT00772330|38930111|FG000|Overall Study|Lost to Follow-up|3|||
16121230|NCT01202903|38930118|FG000|Overall Study|Administrative Probelms|1|||
16121231|NCT01202903|38930119|FG001|Overall Study|Administrative Probelms|4|||
16121232|NCT01202903|38930118|FG000|Overall Study|Protocol Violation|0|||
16121233|NCT01202903|38930119|FG001|Overall Study|Protocol Violation|1|||
16121234|NCT01202903|38930118|FG000|Overall Study|Death|1|||
16121235|NCT01202903|38930119|FG001|Overall Study|Death|0|||
16121236|NCT01202903|38930118|FG000|Overall Study|Lost to Follow-up|1|||
16235501|NCT02284373|39345038|FG001|Overall Study|Other|1|||
16413456|NCT00364533|39995173|FG003|Overall Study|Lack of Efficacy|17|||
16413457|NCT00364533|39995174|FG004|Overall Study|Lack of Efficacy|42|||
16413458|NCT00364533|39995170|FG000|Overall Study|Subject discharged from hospital|4|||
16413459|NCT00364533|39995171|FG001|Overall Study|Subject discharged from hospital|1|||
16413460|NCT00364533|39995172|FG002|Overall Study|Subject discharged from hospital|2|||
16413461|NCT00364533|39995173|FG003|Overall Study|Subject discharged from hospital|3|||
16413462|NCT00364533|39995174|FG004|Overall Study|Subject discharged from hospital|1|||
16413463|NCT00364533|39995170|FG000|Overall Study|Variations in drug compliance|2|||
16413464|NCT00364533|39995171|FG001|Overall Study|Variations in drug compliance|1|||
16413465|NCT00364533|39995172|FG002|Overall Study|Variations in drug compliance|1|||
16413466|NCT00364533|39995173|FG003|Overall Study|Variations in drug compliance|0|||
16413467|NCT00364533|39995174|FG004|Overall Study|Variations in drug compliance|0|||
16413468|NCT00364533|39995170|FG000|Overall Study|Non-compliance|1|||
16554345|NCT02855164|40493047|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
16554346|NCT02855164|40493048|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
16554347|NCT02855164|40493049|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
16554348|NCT02855164|40493050|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
16413469|NCT00364533|39995171|FG001|Overall Study|Non-compliance|0|||
16413470|NCT00364533|39995172|FG002|Overall Study|Non-compliance|0|||
16413471|NCT00364533|39995173|FG003|Overall Study|Non-compliance|0|||
16554349|NCT02855164|40493051|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
16554350|NCT02855164|40493052|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
16554351|NCT02855164|40493053|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
16554352|NCT02855164|40493054|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
16554353|NCT02855164|40493047|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
16554354|NCT02855164|40493048|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
16554355|NCT02855164|40493049|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
16554356|NCT02855164|40493050|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
16554357|NCT02855164|40493051|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
16554358|NCT02855164|40493052|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
16554359|NCT02855164|40493053|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
16554360|NCT02855164|40493054|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
16554361|NCT02855164|40493047|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
16554362|NCT02855164|40493048|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
16554363|NCT02855164|40493049|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
16554364|NCT02855164|40493050|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
16554365|NCT02855164|40493051|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
16554366|NCT02855164|40493052|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
16554367|NCT02855164|40493053|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
16554368|NCT02855164|40493054|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
16554369|NCT02855164|40493047|FG000|Part C (Randomized Set)|Adverse Event|0|||
16554370|NCT02855164|40493048|FG001|Part C (Randomized Set)|Adverse Event|0|||
16554371|NCT02855164|40493049|FG002|Part C (Randomized Set)|Adverse Event|0|||
16554372|NCT02855164|40493050|FG003|Part C (Randomized Set)|Adverse Event|0|||
16121237|NCT01202903|38930119|FG001|Overall Study|Lost to Follow-up|1|||
16554373|NCT02855164|40493051|FG004|Part C (Randomized Set)|Adverse Event|0|||
16554374|NCT02855164|40493052|FG005|Part C (Randomized Set)|Adverse Event|5|||
16554375|NCT02855164|40493053|FG006|Part C (Randomized Set)|Adverse Event|9|||
16554376|NCT02855164|40493054|FG007|Part C (Randomized Set)|Adverse Event|2|||
16554377|NCT02855164|40493047|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
16235502|NCT02284373|39345039|FG002|Overall Study|Other|0|||
16235503|NCT02284373|39345037|FG000|Overall Study|Lost to Follow-up|0|||
16235504|NCT02284373|39345038|FG001|Overall Study|Lost to Follow-up|1|||
16235505|NCT02284373|39345039|FG002|Overall Study|Lost to Follow-up|0|||
16235506|NCT03519386|39347946|FG000|Overall Study|Withdrawal by Subject|4|||
16235507|NCT03519386|39347947|FG001|Overall Study|Withdrawal by Subject|1|||
16235508|NCT03519386|39347948|FG002|Overall Study|Withdrawal by Subject|2|||
16235509|NCT03519386|39347946|FG000|Overall Study|Physician Decision|1|||
16235510|NCT03519386|39347947|FG001|Overall Study|Physician Decision|1|||
16235511|NCT03519386|39347948|FG002|Overall Study|Physician Decision|1|||
16554378|NCT02855164|40493048|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
16554379|NCT02855164|40493049|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
16554380|NCT02855164|40493050|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
16554381|NCT02855164|40493051|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
16554382|NCT02855164|40493052|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
16554383|NCT02855164|40493053|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
16554384|NCT02855164|40493054|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
16554385|NCT02855164|40493047|FG000|Part C (Randomized Set)|Physician Decision|0|||
16235512|NCT03519386|39347946|FG000|Overall Study|Lost to Follow-up|0|||
16235513|NCT03519386|39347947|FG001|Overall Study|Lost to Follow-up|1|||
16235514|NCT03519386|39347948|FG002|Overall Study|Lost to Follow-up|1|||
16235515|NCT03519386|39347946|FG000|Overall Study|Death|1|||
16235516|NCT03519386|39347947|FG001|Overall Study|Death|0|||
16235517|NCT03519386|39347948|FG002|Overall Study|Death|4|||
16235518|NCT03519386|39347946|FG000|Overall Study|Adverse Event|2|||
16235519|NCT03519386|39347947|FG001|Overall Study|Adverse Event|1|||
16235520|NCT03519386|39347948|FG002|Overall Study|Adverse Event|2|||
16235521|NCT03519386|39347946|FG000|Overall Study|Explanted|2|||
16235522|NCT03519386|39347947|FG001|Overall Study|Explanted|1|||
16235523|NCT03519386|39347948|FG002|Overall Study|Explanted|0|||
16235524|NCT03519386|39347946|FG000|Overall Study|Ongoing in study|190|||
16235525|NCT03519386|39347947|FG001|Overall Study|Ongoing in study|192|||
16235526|NCT03519386|39347948|FG002|Overall Study|Ongoing in study|183|||
16235527|NCT02996448|39347949|FG000|Overall Study|Study terminated due to adverse effects|3|||
16235528|NCT02237118|39347952|FG000|Overall Study|Protocol Violation|0|||
16235529|NCT02237118|39347953|FG001|Overall Study|Protocol Violation|1|||
16235530|NCT02237118|39347952|FG000|Overall Study|consent withdrawn|1|||
16235531|NCT02237118|39347953|FG001|Overall Study|consent withdrawn|0|||
16235532|NCT04995419|39347956|FG000|Overall Study|Withdrawal by Subject|3|||
16235533|NCT04995419|39347956|FG000|Overall Study|Progressive Disease|19|||
16235534|NCT04995419|39347956|FG000|Overall Study|Adverse Event|2|||
16235535|NCT04995419|39347956|FG000|Overall Study|Ongoing|16|||
16235536|NCT01977625|39347957|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
16235537|NCT01977625|39347958|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
16235538|NCT01977625|39347957|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16235539|NCT01977625|39347958|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
16235540|NCT00297882|39347959|FG000|Day 14|Lack of Efficacy|12|||
16235541|NCT00297882|39347960|FG001|Day 14|Lack of Efficacy|49|||
16235542|NCT00297882|39347959|FG000|Day 28|Lost to Follow-up|13|||
16235543|NCT00297882|39347960|FG001|Day 28|Lost to Follow-up|23|||
16235544|NCT00297882|39347959|FG000|Day 28|Lack of Efficacy|3|||
16235545|NCT00297882|39347960|FG001|Day 28|Lack of Efficacy|0|||
16235546|NCT01432600|39347961|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
16235547|NCT01432600|39347962|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
16235548|NCT01432600|39347963|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
16235549|NCT00378482|39347966|FG000|Overall Study|Lost to Follow-up|1|||
16235550|NCT00378482|39347966|FG000|Overall Study|Lack of Efficacy|8|||
16349249|NCT02326272|39765657|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16349250|NCT02326272|39765658|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16349251|NCT02326272|39765659|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
16349252|NCT02326272|39765645|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349253|NCT02326272|39765646|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349254|NCT02326272|39765647|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349255|NCT02326272|39765648|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349256|NCT02326272|39765649|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349257|NCT02326272|39765650|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
16349258|NCT02326272|39765651|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16554386|NCT02855164|40493048|FG001|Part C (Randomized Set)|Physician Decision|0|||
16121238|NCT01202903|38930118|FG000|Overall Study|Lack of Efficacy|1|||
16235551|NCT00378482|39347966|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
16235552|NCT00378482|39347966|FG000|Overall Study|Withdrawal by Subject|4|||
16235553|NCT00378482|39347966|FG000|Overall Study|Adverse Event|9|||
16235554|NCT03130777|39347967|FG000|Overall Study|Death|0|||
16235555|NCT03130777|39347968|FG001|Overall Study|Death|1|||
16235556|NCT03130777|39347967|FG000|Overall Study|Did not meet eligibility criteria|1|||
16235557|NCT03130777|39347968|FG001|Overall Study|Did not meet eligibility criteria|0|||
16235558|NCT05083559|39347969|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
16413472|NCT00364533|39995174|FG004|Overall Study|Non-compliance|0|||
16413473|NCT00364533|39995170|FG000|Overall Study|Protocol Violation|1|||
16413474|NCT00364533|39995171|FG001|Overall Study|Protocol Violation|1|||
16413475|NCT00364533|39995172|FG002|Overall Study|Protocol Violation|0|||
16413476|NCT00364533|39995173|FG003|Overall Study|Protocol Violation|0|||
16413477|NCT00364533|39995174|FG004|Overall Study|Protocol Violation|0|||
16413478|NCT02258529|39995177|FG000|Overall Study|Study Terminated by Sponsor|9|||
16413479|NCT02258529|39995177|FG000|Overall Study|Adverse Event|1|||
16413480|NCT01741532|39995178|FG000|Overall Study|Adverse Event|4|||
16413481|NCT01741532|39995179|FG001|Overall Study|Adverse Event|0|||
16413482|NCT01741532|39995178|FG000|Overall Study|Withdrawal by Subject|1|||
16413483|NCT01741532|39995179|FG001|Overall Study|Withdrawal by Subject|1|||
16413484|NCT01741532|39995178|FG000|Overall Study|Protocol Violation|0|||
16413485|NCT01741532|39995179|FG001|Overall Study|Protocol Violation|1|||
16413486|NCT01741532|39995178|FG000|Overall Study|Worsening of the disease|3|||
16413487|NCT01741532|39995179|FG001|Overall Study|Worsening of the disease|1|||
16413488|NCT01741532|39995178|FG000|Overall Study|Sponsor decision|1|||
16413489|NCT01741532|39995179|FG001|Overall Study|Sponsor decision|0|||
16413490|NCT01741532|39995178|FG000|Overall Study|Medical event|1|||
16413491|NCT01741532|39995179|FG001|Overall Study|Medical event|0|||
16413492|NCT00031460|39995180|FG000|Overall Study|Lost to Follow-up|0|||
16413493|NCT00031460|39995181|FG001|Overall Study|Lost to Follow-up|1|||
16413494|NCT00031460|39995180|FG000|Overall Study|Withdrawal by Subject|1|||
16413495|NCT00031460|39995181|FG001|Overall Study|Withdrawal by Subject|1|||
16413496|NCT00031460|39995180|FG000|Overall Study|Non-Compliant|1|||
16413497|NCT00031460|39995181|FG001|Overall Study|Non-Compliant|1|||
16413498|NCT00031460|39995180|FG000|Overall Study|Death|0|||
16413499|NCT00031460|39995181|FG001|Overall Study|Death|1|||
16413500|NCT00031460|39995180|FG000|Overall Study|Reactivation of Disease|5|||
16554387|NCT02855164|40493049|FG002|Part C (Randomized Set)|Physician Decision|0|||
16554388|NCT02855164|40493050|FG003|Part C (Randomized Set)|Physician Decision|0|||
16554389|NCT02855164|40493051|FG004|Part C (Randomized Set)|Physician Decision|0|||
16554390|NCT02855164|40493052|FG005|Part C (Randomized Set)|Physician Decision|1|||
16554391|NCT02855164|40493053|FG006|Part C (Randomized Set)|Physician Decision|0|||
16554392|NCT02855164|40493054|FG007|Part C (Randomized Set)|Physician Decision|1|||
16554393|NCT02855164|40493047|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
16554394|NCT02855164|40493048|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
16554395|NCT02855164|40493049|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
16554396|NCT02855164|40493050|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
16554397|NCT02855164|40493051|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
16554398|NCT02855164|40493052|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
16554399|NCT02855164|40493053|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
16413501|NCT00031460|39995181|FG001|Overall Study|Reactivation of Disease|9|||
16413502|NCT00031460|39995180|FG000|Overall Study|Disruption of blinded drug supply|2|||
16413503|NCT00031460|39995181|FG001|Overall Study|Disruption of blinded drug supply|0|||
16413504|NCT00031460|39995180|FG000|Overall Study|Confirmed unevaluable|0|||
16413505|NCT00031460|39995181|FG001|Overall Study|Confirmed unevaluable|1|||
16413506|NCT03412604|39995182|FG000|Overall Study|Withdrawal by Subject|1|||
16413507|NCT01816906|39995183|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
16413508|NCT01816906|39995184|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
16413509|NCT01816906|39995183|FG000|Six Months|Lost to Follow-up|14|||
16413510|NCT01816906|39995184|FG001|Six Months|Lost to Follow-up|16|||
16554400|NCT02855164|40493054|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
16554401|NCT01051063|40493055|FG000|Overall Study|Death|2|||
16554402|NCT01051063|40493056|FG001|Overall Study|Death|2|||
16554403|NCT01051063|40493055|FG000|Overall Study|Withdrawal by Subject|1|||
16554404|NCT01051063|40493056|FG001|Overall Study|Withdrawal by Subject|1|||
16554405|NCT01051063|40493055|FG000|Overall Study|Termination of the study|5|||
16554406|NCT01051063|40493056|FG001|Overall Study|Termination of the study|0|||
16554407|NCT01051063|40493055|FG000|Overall Study|Moved from the study site area|1|||
16554408|NCT01051063|40493056|FG001|Overall Study|Moved from the study site area|0|||
16554409|NCT01051063|40493055|FG000|Overall Study|Other|1|||
16554410|NCT01051063|40493056|FG001|Overall Study|Other|0|||
16413511|NCT01816906|39995183|FG000|12 Months|Adverse Event|2|||
16413512|NCT01816906|39995184|FG001|12 Months|Adverse Event|2|||
16413513|NCT01816906|39995183|FG000|12 Months|Death|0|||
16413514|NCT01816906|39995184|FG001|12 Months|Death|2|||
16413515|NCT01816906|39995183|FG000|12 Months|Lost to Follow-up|2|||
16413516|NCT01816906|39995184|FG001|12 Months|Lost to Follow-up|1|||
16554411|NCT01051063|40493055|FG000|Overall Study|Lost to Follow-up|0|||
16554412|NCT01051063|40493056|FG001|Overall Study|Lost to Follow-up|1|||
16554413|NCT03990363|40493057|FG000|Overall Study|Withdrawal by Subject|10|||
16554414|NCT03990363|40493058|FG001|Overall Study|Withdrawal by Subject|9|||
16554415|NCT03990363|40493059|FG002|Overall Study|Withdrawal by Subject|18|||
16554416|NCT03990363|40493060|FG003|Overall Study|Withdrawal by Subject|11|||
16413517|NCT02855944|39995185|FG000|Period 1: Treatment|Ongoing|14|||
16413518|NCT02855944|39995186|FG001|Period 1: Treatment|Ongoing|0|||
16554417|NCT03990363|40493061|FG004|Overall Study|Withdrawal by Subject|9|||
16554418|NCT03990363|40493057|FG000|Overall Study|Physician Decision|1|||
16121239|NCT01202903|38930119|FG001|Overall Study|Lack of Efficacy|3|||
16413519|NCT02855944|39995185|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
16413520|NCT02855944|39995186|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
16413521|NCT02855944|39995185|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
16413522|NCT02855944|39995186|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
16413523|NCT01389323|39995188|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
16413524|NCT01389323|39995188|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
16413525|NCT01389323|39995188|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
16413526|NCT01389323|39995188|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
16413527|NCT01389323|39995188|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
16413528|NCT01389323|39995188|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
16413529|NCT01389323|39995188|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
16235559|NCT05083559|39347970|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
16235560|NCT05083559|39347969|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
16235561|NCT05083559|39347970|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
16235562|NCT05083559|39347969|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
16235563|NCT05083559|39347970|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
16235564|NCT01342367|39347971|FG000|Overall Study|Death|1|||
16235565|NCT01342367|39347972|FG001|Overall Study|Death|0|||
16235566|NCT01342367|39347971|FG000|Overall Study|Withdrawal by Subject|1|||
16235567|NCT01342367|39347972|FG001|Overall Study|Withdrawal by Subject|2|||
16235568|NCT00929201|39347973|FG000|Period 1|Withdrawal by Subject|0|||
16235569|NCT00929201|39347974|FG001|Period 1|Withdrawal by Subject|1|||
16235570|NCT00874757|39347975|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
16235571|NCT00755937|39347976|FG000|Recruitment|Unknown if infliximab received|164|||
16235572|NCT00755937|39347976|FG000|Observational Follow-up|Lost to Follow-up|148|||
16235573|NCT00411762|39347977|FG000|Overall Study|Withdrawal by Subject|5|||
16235574|NCT04578548|39347978|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
16235575|NCT04578548|39347979|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
16235576|NCT04578548|39347978|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
16235577|NCT04578548|39347979|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
16235578|NCT04578548|39347978|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
16235579|NCT04578548|39347979|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
16235580|NCT04578548|39347978|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
16235581|NCT04578548|39347979|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
16235582|NCT04578548|39347978|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
16235583|NCT04578548|39347979|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
16235584|NCT04578548|39347978|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
16235585|NCT04578548|39347979|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
16235586|NCT03286426|39347980|FG000|Overall Study|Physician Decision|3|||
16235587|NCT01870921|39347981|FG000|Overall Study|Subject decision|80|||
16235588|NCT01870921|39347981|FG000|Overall Study|Severe non-compliance to protocol|7|||
16235589|NCT01870921|39347981|FG000|Overall Study|Subject Lost to Follow up|2|||
16235590|NCT01870921|39347981|FG000|Overall Study|Other|1|||
16235591|NCT01126359|39347982|FG000|First Intervention (20-minutes)|Physician Decision|0|||
16235592|NCT01126359|39347983|FG001|First Intervention (20-minutes)|Physician Decision|1|||
16235593|NCT04856917|39347993|FG000|Overall Study|Withdrawal by Subject|4|||
16235594|NCT04856917|39347994|FG001|Overall Study|Withdrawal by Subject|3|||
16235595|NCT04856917|39347995|FG002|Overall Study|Withdrawal by Subject|1|||
16235596|NCT04856917|39347993|FG000|Overall Study|Lost to Follow-up|3|||
16235597|NCT04856917|39347994|FG001|Overall Study|Lost to Follow-up|1|||
16235598|NCT04856917|39347995|FG002|Overall Study|Lost to Follow-up|1|||
16235599|NCT04856917|39347993|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
16235600|NCT04856917|39347994|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
16349259|NCT02326272|39765652|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
16349260|NCT02326272|39765653|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349261|NCT02326272|39765654|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349262|NCT02326272|39765655|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349263|NCT02326272|39765656|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349264|NCT02326272|39765657|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349265|NCT02326272|39765658|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349266|NCT02326272|39765659|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
16349267|NCT02326272|39765645|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16413530|NCT01389323|39995188|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
16413531|NCT01389323|39995188|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
16121240|NCT01202903|38930118|FG000|Overall Study|Adverse Event|3|||
16413532|NCT01389323|39995188|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
16413533|NCT01389323|39995188|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
16413534|NCT01995552|39995189|FG000|Overall Study|Protocol Violation|1|||
16413535|NCT01995552|39995189|FG000|Overall Study|Lack of Efficacy|15|||
16413536|NCT01995552|39995189|FG000|Overall Study|Death|1|||
16413537|NCT00483041|39995190|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
16413538|NCT00483041|39995191|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
16413539|NCT02804750|39995193|FG000|Period 1|Adverse Event|0|||
16413540|NCT02804750|39995194|FG001|Period 1|Adverse Event|2|||
16413541|NCT02804750|39995193|FG000|Period 1|Withdrawal by Subject|0|||
16235601|NCT04856917|39347995|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
16235602|NCT04856917|39347993|FG000|Overall Study|Other|1|||
16235603|NCT04856917|39347994|FG001|Overall Study|Other|1|||
16235604|NCT04856917|39347995|FG002|Overall Study|Other|0|||
16413542|NCT02804750|39995194|FG001|Period 1|Withdrawal by Subject|1|||
16413543|NCT02804750|39995193|FG000|Period 2|Adverse Event|1|||
16554419|NCT03990363|40493058|FG001|Overall Study|Physician Decision|0|||
16554420|NCT03990363|40493059|FG002|Overall Study|Physician Decision|0|||
16554421|NCT03990363|40493060|FG003|Overall Study|Physician Decision|0|||
16554422|NCT03990363|40493061|FG004|Overall Study|Physician Decision|0|||
16554423|NCT03990363|40493057|FG000|Overall Study|Adverse Event|1|||
16554424|NCT03990363|40493058|FG001|Overall Study|Adverse Event|3|||
16235605|NCT01248130|39347998|FG000|Overall Study|Protocol Violation|1|||
16235606|NCT01248130|39347999|FG001|Overall Study|Protocol Violation|0|||
16235607|NCT01248130|39347998|FG000|Overall Study|Ineligible|1|||
16235608|NCT01248130|39347999|FG001|Overall Study|Ineligible|0|||
16235609|NCT00433771|39348006|FG000|Overall Study|screen fail|14|||
16235610|NCT00433771|39348006|FG000|Overall Study|Treated and later found to be ineligible|2|||
16235611|NCT00433771|39348006|FG000|Overall Study|Death|2|||
16235612|NCT00433771|39348006|FG000|Overall Study|Failure to deploy stent|1|||
16235613|NCT02858076|39348007|FG000|Overall Study|Death|6|||
16235614|NCT02858076|39348008|FG001|Overall Study|Death|3|||
16235615|NCT02858076|39348007|FG000|Overall Study|Withdrawal by Subject|1|||
16235616|NCT02858076|39348008|FG001|Overall Study|Withdrawal by Subject|5|||
16235617|NCT02858076|39348007|FG000|Overall Study|Lost to Follow-up|2|||
16235618|NCT02858076|39348008|FG001|Overall Study|Lost to Follow-up|7|||
16235619|NCT02858076|39348007|FG000|Overall Study|Completed Out of Window|1|||
16235620|NCT02858076|39348008|FG001|Overall Study|Completed Out of Window|3|||
16235621|NCT00061945|39348009|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
16235622|NCT00061945|39348010|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
16235623|NCT00061945|39348009|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
16235624|NCT00061945|39348010|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
16235625|NCT00061945|39348009|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
16235626|NCT00061945|39348010|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
16235627|NCT00061945|39348009|FG000|Course IV: Alemtuzumab|Early exits|6|||
16413544|NCT02804750|39995194|FG001|Period 2|Adverse Event|0|||
16413545|NCT02804750|39995193|FG000|Period 3|Adverse Event|0|||
16413546|NCT02804750|39995194|FG001|Period 3|Adverse Event|2|||
16413547|NCT02804750|39995193|FG000|Period 4|Adverse Event|0|||
16554425|NCT03990363|40493059|FG002|Overall Study|Adverse Event|2|||
16121241|NCT01202903|38930119|FG001|Overall Study|Adverse Event|3|||
16121242|NCT01202903|38930118|FG000|Overall Study|Withdrawal by Subject|4|||
16121243|NCT01202903|38930119|FG001|Overall Study|Withdrawal by Subject|4|||
16121244|NCT00078338|38930120|FG000|Overall Study|Adverse Event|31|||
16121245|NCT00078338|38930121|FG001|Overall Study|Adverse Event|24|||
16121246|NCT00078338|38930120|FG000|Overall Study|Lost to Follow-up|17|||
16121247|NCT00078338|38930121|FG001|Overall Study|Lost to Follow-up|2|||
16554426|NCT03990363|40493060|FG003|Overall Study|Adverse Event|2|||
16554427|NCT03990363|40493061|FG004|Overall Study|Adverse Event|0|||
16554428|NCT03990363|40493057|FG000|Overall Study|Death|14|||
16554429|NCT03990363|40493058|FG001|Overall Study|Death|8|||
16554430|NCT03990363|40493059|FG002|Overall Study|Death|14|||
16554431|NCT03990363|40493060|FG003|Overall Study|Death|10|||
16554432|NCT03990363|40493061|FG004|Overall Study|Death|11|||
16554433|NCT03990363|40493057|FG000|Overall Study|Failure to meet randomization criteria|0|||
16554434|NCT03990363|40493058|FG001|Overall Study|Failure to meet randomization criteria|1|||
16554435|NCT03990363|40493059|FG002|Overall Study|Failure to meet randomization criteria|1|||
16121248|NCT00078338|38930120|FG000|Overall Study|Protocol Violation|2|||
16121249|NCT00078338|38930121|FG001|Overall Study|Protocol Violation|2|||
16235628|NCT00061945|39348010|FG001|Course IV: Alemtuzumab|Early exits|15|||
16235629|NCT01976663|39348014|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
16235630|NCT01976663|39348014|FG000|Overall Study|Personal Reasons|6|||
16554436|NCT03990363|40493060|FG003|Overall Study|Failure to meet randomization criteria|0|||
16554437|NCT03990363|40493061|FG004|Overall Study|Failure to meet randomization criteria|0|||
16554438|NCT03990363|40493057|FG000|Overall Study|Lost to Follow-up|0|||
16554439|NCT03990363|40493058|FG001|Overall Study|Lost to Follow-up|0|||
16121250|NCT00078338|38930120|FG000|Overall Study|Disease Progression|4|||
16121251|NCT00078338|38930121|FG001|Overall Study|Disease Progression|7|||
16235631|NCT01976663|39348014|FG000|Overall Study|Withdrawal by Subject|4|||
16235632|NCT01976663|39348014|FG000|Overall Study|Screen Failure|3|||
16235633|NCT01976663|39348014|FG000|Overall Study|Adverse Event|2|||
16235634|NCT01976663|39348014|FG000|Overall Study|Lost to Follow-up|3|||
16235635|NCT01508325|39348015|FG000|Overall Study|Withdrawal by Subject|8|||
16235636|NCT01508325|39348016|FG001|Overall Study|Withdrawal by Subject|9|||
16235637|NCT01508325|39348015|FG000|Overall Study|Protocol Violation|0|||
16235638|NCT01508325|39348016|FG001|Overall Study|Protocol Violation|3|||
16235639|NCT01508325|39348015|FG000|Overall Study|Physician Decision|2|||
16235640|NCT01508325|39348016|FG001|Overall Study|Physician Decision|1|||
16235641|NCT01508325|39348015|FG000|Overall Study|Adverse Event|1|||
16235642|NCT01508325|39348016|FG001|Overall Study|Adverse Event|0|||
16235643|NCT01508325|39348015|FG000|Overall Study|Lost to Follow-up|5|||
16235644|NCT01508325|39348016|FG001|Overall Study|Lost to Follow-up|6|||
16235645|NCT01508325|39348015|FG000|Overall Study|Other|2|||
16235646|NCT01508325|39348016|FG001|Overall Study|Other|2|||
16235647|NCT00833976|39348017|FG000|Overall Study|Withdrawal by Subject|5|||
16235648|NCT00833976|39348017|FG000|Overall Study|Lost to Follow-up|4|||
16235649|NCT00833976|39348017|FG000|Overall Study|Did not meet eligibility criteria|41|||
16235650|NCT00833976|39348017|FG000|Overall Study|Physician Decision|1|||
16235651|NCT03533608|39348018|FG000|Overall Study|Withdrawal by Subject|3|||
16235652|NCT03533608|39348018|FG000|Overall Study|Physician Decision|2|||
16235653|NCT03087773|39348023|FG000|Overall Study|Withdrawal by Subject|8|||
16235654|NCT03087773|39348024|FG001|Overall Study|Withdrawal by Subject|4|||
16235655|NCT03087773|39348023|FG000|Overall Study|Lost to Follow-up|12|||
16235656|NCT03087773|39348024|FG001|Overall Study|Lost to Follow-up|8|||
16235689|NCT02594384|39348031|FG000|Overall Study|Disease Progression|3|||
16235690|NCT02594384|39348032|FG001|Overall Study|Disease Progression|7|||
16235691|NCT02594384|39348033|FG002|Overall Study|Disease Progression|0|||
16235692|NCT02594384|39348034|FG003|Overall Study|Disease Progression|2|||
16235693|NCT02594384|39348035|FG004|Overall Study|Disease Progression|2|||
16554440|NCT03990363|40493059|FG002|Overall Study|Lost to Follow-up|0|||
16554441|NCT03990363|40493060|FG003|Overall Study|Lost to Follow-up|1|||
16235694|NCT02594384|39348036|FG005|Overall Study|Disease Progression|12|||
16235695|NCT02594384|39348037|FG006|Overall Study|Disease Progression|5|||
16235696|NCT02594384|39348038|FG007|Overall Study|Disease Progression|5|||
16235697|NCT02594384|39348031|FG000|Overall Study|Adverse Event|0|||
16235698|NCT02594384|39348032|FG001|Overall Study|Adverse Event|1|||
16235699|NCT02594384|39348033|FG002|Overall Study|Adverse Event|4|||
16235700|NCT02594384|39348034|FG003|Overall Study|Adverse Event|1|||
16235701|NCT02594384|39348035|FG004|Overall Study|Adverse Event|0|||
16235702|NCT02594384|39348036|FG005|Overall Study|Adverse Event|6|||
16235703|NCT02594384|39348037|FG006|Overall Study|Adverse Event|1|||
16235704|NCT02594384|39348038|FG007|Overall Study|Adverse Event|1|||
16235705|NCT02594384|39348031|FG000|Overall Study|Withdrawal by Subject|0|||
16235706|NCT02594384|39348032|FG001|Overall Study|Withdrawal by Subject|0|||
16554442|NCT03990363|40493061|FG004|Overall Study|Lost to Follow-up|2|||
16235707|NCT02594384|39348033|FG002|Overall Study|Withdrawal by Subject|0|||
16235708|NCT02594384|39348034|FG003|Overall Study|Withdrawal by Subject|1|||
16235709|NCT02594384|39348035|FG004|Overall Study|Withdrawal by Subject|0|||
16235710|NCT02594384|39348036|FG005|Overall Study|Withdrawal by Subject|0|||
16235711|NCT02594384|39348037|FG006|Overall Study|Withdrawal by Subject|0|||
16235712|NCT02594384|39348038|FG007|Overall Study|Withdrawal by Subject|1|||
16235713|NCT02594384|39348031|FG000|Overall Study|Physician Decision|0|||
16235714|NCT02594384|39348032|FG001|Overall Study|Physician Decision|0|||
16235715|NCT02594384|39348033|FG002|Overall Study|Physician Decision|0|||
16235716|NCT02594384|39348034|FG003|Overall Study|Physician Decision|0|||
16235717|NCT02594384|39348035|FG004|Overall Study|Physician Decision|0|||
16235718|NCT02594384|39348036|FG005|Overall Study|Physician Decision|1|||
16235719|NCT02594384|39348037|FG006|Overall Study|Physician Decision|2|||
16554443|NCT03990363|40493057|FG000|Overall Study|Non-compliance with study drug|2|||
16554444|NCT03990363|40493058|FG001|Overall Study|Non-compliance with study drug|1|||
16554445|NCT03990363|40493059|FG002|Overall Study|Non-compliance with study drug|2|||
16554446|NCT03990363|40493060|FG003|Overall Study|Non-compliance with study drug|0|||
16554447|NCT03990363|40493061|FG004|Overall Study|Non-compliance with study drug|0|||
16235720|NCT02594384|39348038|FG007|Overall Study|Physician Decision|0|||
16235721|NCT02594384|39348031|FG000|Overall Study|Progressive Leukocytosis|0|||
16235722|NCT02594384|39348032|FG001|Overall Study|Progressive Leukocytosis|0|||
16235723|NCT02594384|39348033|FG002|Overall Study|Progressive Leukocytosis|1|||
16235724|NCT02594384|39348034|FG003|Overall Study|Progressive Leukocytosis|0|||
16235725|NCT02594384|39348035|FG004|Overall Study|Progressive Leukocytosis|0|||
16235726|NCT02594384|39348036|FG005|Overall Study|Progressive Leukocytosis|0|||
16235727|NCT02594384|39348037|FG006|Overall Study|Progressive Leukocytosis|0|||
16235728|NCT02594384|39348038|FG007|Overall Study|Progressive Leukocytosis|0|||
16235729|NCT02594384|39348031|FG000|Overall Study|Lack of Efficacy|0|||
16235730|NCT02594384|39348032|FG001|Overall Study|Lack of Efficacy|0|||
16235731|NCT02594384|39348033|FG002|Overall Study|Lack of Efficacy|0|||
16235732|NCT02594384|39348034|FG003|Overall Study|Lack of Efficacy|0|||
16235733|NCT02594384|39348035|FG004|Overall Study|Lack of Efficacy|1|||
16235734|NCT02594384|39348036|FG005|Overall Study|Lack of Efficacy|0|||
16235735|NCT02594384|39348037|FG006|Overall Study|Lack of Efficacy|0|||
16235736|NCT02594384|39348038|FG007|Overall Study|Lack of Efficacy|0|||
16235737|NCT02594384|39348031|FG000|Overall Study|Substantial noncompliance|0|||
16235738|NCT02594384|39348032|FG001|Overall Study|Substantial noncompliance|0|||
16235739|NCT02594384|39348033|FG002|Overall Study|Substantial noncompliance|0|||
16235740|NCT02594384|39348034|FG003|Overall Study|Substantial noncompliance|0|||
16235741|NCT02594384|39348035|FG004|Overall Study|Substantial noncompliance|0|||
16235742|NCT02594384|39348036|FG005|Overall Study|Substantial noncompliance|0|||
16235743|NCT02594384|39348037|FG006|Overall Study|Substantial noncompliance|1|||
16235744|NCT02594384|39348038|FG007|Overall Study|Substantial noncompliance|0|||
16235745|NCT05349188|39348039|FG000|Overall Study|Withdrawal by Subject|1|||
16235746|NCT05349188|39348040|FG001|Overall Study|Withdrawal by Subject|0|||
16235747|NCT05478603|39348041|FG000|Overall Study|Withdrawal by Subject|0|||
16235748|NCT05478603|39348042|FG001|Overall Study|Withdrawal by Subject|1|||
16235749|NCT05478603|39348043|FG002|Overall Study|Withdrawal by Subject|0|||
16235750|NCT05478603|39348044|FG003|Overall Study|Withdrawal by Subject|0|||
16235751|NCT02949219|39348045|FG000|Overall Study|Withdrawal by Subject|1|||
16235752|NCT04939701|39348046|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
16235753|NCT04939701|39348047|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
16235754|NCT04939701|39348048|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
16235755|NCT04939701|39348046|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
16235756|NCT04939701|39348047|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
16554448|NCT03990363|40493057|FG000|Overall Study|Study terminated by sponsor|0|||
16554449|NCT03990363|40493058|FG001|Overall Study|Study terminated by sponsor|1|||
16554450|NCT03990363|40493059|FG002|Overall Study|Study terminated by sponsor|0|||
16554451|NCT03990363|40493060|FG003|Overall Study|Study terminated by sponsor|0|||
16554452|NCT03990363|40493061|FG004|Overall Study|Study terminated by sponsor|0|||
16554453|NCT03990363|40493057|FG000|Overall Study|Site terminated by sponsor|2|||
16554454|NCT03990363|40493058|FG001|Overall Study|Site terminated by sponsor|1|||
16554455|NCT03990363|40493059|FG002|Overall Study|Site terminated by sponsor|2|||
16554456|NCT03990363|40493060|FG003|Overall Study|Site terminated by sponsor|0|||
16235757|NCT04939701|39348048|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
16235758|NCT04939701|39348046|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
16235759|NCT04939701|39348047|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
16235760|NCT04939701|39348048|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
16235761|NCT04939701|39348046|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
16235762|NCT04939701|39348047|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
16235763|NCT04939701|39348048|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
16235764|NCT04939701|39348046|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
16235765|NCT04939701|39348047|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
16235766|NCT04939701|39348048|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
16554457|NCT03990363|40493061|FG004|Overall Study|Site terminated by sponsor|2|||
16554458|NCT03990363|40493057|FG000|Overall Study|Not categorized|5|||
16554459|NCT03990363|40493058|FG001|Overall Study|Not categorized|5|||
16554460|NCT03990363|40493059|FG002|Overall Study|Not categorized|3|||
16554461|NCT03990363|40493060|FG003|Overall Study|Not categorized|2|||
16554462|NCT03990363|40493061|FG004|Overall Study|Not categorized|2|||
16554463|NCT03017235|40493063|FG000|Overall Study|Withdrawal by Subject|4|||
16554464|NCT03017235|40493064|FG001|Overall Study|Withdrawal by Subject|3|||
16554465|NCT03017235|40493063|FG000|Overall Study|Lost to Follow-up|2|||
16554466|NCT03017235|40493064|FG001|Overall Study|Lost to Follow-up|7|||
16554467|NCT03017235|40493063|FG000|Overall Study|Adverse Event|0|||
16554468|NCT03017235|40493064|FG001|Overall Study|Adverse Event|1|||
16235767|NCT04939701|39348046|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
16235768|NCT04939701|39348047|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
16235769|NCT04939701|39348048|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
16235770|NCT04939701|39348046|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
16235771|NCT04939701|39348047|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
16235772|NCT04939701|39348048|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
16235773|NCT03940586|39348050|FG000|Overall Study|Death|3|||
16235774|NCT03940586|39348051|FG001|Overall Study|Death|2|||
16235775|NCT03940586|39348052|FG002|Overall Study|Death|0|||
16235776|NCT03940586|39348050|FG000|Overall Study|Physician Decision|1|||
16235777|NCT03940586|39348051|FG001|Overall Study|Physician Decision|0|||
16235778|NCT03940586|39348052|FG002|Overall Study|Physician Decision|1|||
16235779|NCT03940586|39348050|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
16235780|NCT03940586|39348051|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
16235781|NCT03940586|39348052|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
16235782|NCT03940586|39348050|FG000|Overall Study|Not Treated|0|||
16554469|NCT03017235|40493063|FG000|Overall Study|Protocol Violation|2|||
16554470|NCT03017235|40493064|FG001|Overall Study|Protocol Violation|1|||
16235783|NCT03940586|39348051|FG001|Overall Study|Not Treated|2|||
16235784|NCT03940586|39348052|FG002|Overall Study|Not Treated|0|||
16235785|NCT01640964|39348053|FG000|Overall Study|Lost to Follow-up|0|||
16235786|NCT01640964|39348054|FG001|Overall Study|Lost to Follow-up|0|||
16235787|NCT01640964|39348055|FG002|Overall Study|Lost to Follow-up|1|||
16235788|NCT01640964|39348053|FG000|Overall Study|Protocol Deviation|1|||
16235789|NCT01640964|39348054|FG001|Overall Study|Protocol Deviation|1|||
16235790|NCT01640964|39348055|FG002|Overall Study|Protocol Deviation|2|||
16235791|NCT01396161|39348056|FG000|Overall Study|Withdrawal by Subject|0|||
16235792|NCT01396161|39348057|FG001|Overall Study|Withdrawal by Subject|0|||
16235793|NCT01396161|39348058|FG002|Overall Study|Withdrawal by Subject|0|||
16235794|NCT01396161|39348059|FG003|Overall Study|Withdrawal by Subject|0|||
16235795|NCT01396161|39348060|FG004|Overall Study|Withdrawal by Subject|1|||
16235796|NCT01396161|39348061|FG005|Overall Study|Withdrawal by Subject|0|||
16235797|NCT01396161|39348062|FG006|Overall Study|Withdrawal by Subject|0|||
16235798|NCT01396161|39348056|FG000|Overall Study|Other|0|||
16235799|NCT01396161|39348057|FG001|Overall Study|Other|0|||
16235800|NCT01396161|39348058|FG002|Overall Study|Other|0|||
16235801|NCT01396161|39348059|FG003|Overall Study|Other|0|||
16235802|NCT01396161|39348060|FG004|Overall Study|Other|0|||
16235803|NCT01396161|39348061|FG005|Overall Study|Other|0|||
16235804|NCT01396161|39348062|FG006|Overall Study|Other|1|||
16235805|NCT03159611|39348071|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
16235806|NCT03159611|39348072|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
16235807|NCT03159611|39348071|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
16235808|NCT03159611|39348072|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
16235809|NCT03159611|39348071|FG000|Overall Study|Protocol Violation|7|||
16235810|NCT03159611|39348072|FG001|Overall Study|Protocol Violation|4|||
16235811|NCT03159611|39348071|FG000|Overall Study|Adverse Event|1|||
16235812|NCT03159611|39348072|FG001|Overall Study|Adverse Event|0|||
16235813|NCT03159611|39348071|FG000|Overall Study|Withdrawal by Subject|1|||
16235814|NCT03159611|39348072|FG001|Overall Study|Withdrawal by Subject|1|||
16235815|NCT03159611|39348071|FG000|Overall Study|Non-compliance with protocol requirement|3|||
16235816|NCT03159611|39348072|FG001|Overall Study|Non-compliance with protocol requirement|2|||
16235817|NCT03159611|39348071|FG000|Overall Study|Inability to perform procedures|1|||
16235818|NCT03159611|39348072|FG001|Overall Study|Inability to perform procedures|0|||
16554471|NCT03017235|40493063|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
16235819|NCT04639310|39348073|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
16235820|NCT04639310|39348074|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
16235821|NCT03255226|39348075|FG000|Overall Study|Adverse Event|2|||
16235822|NCT03255226|39348075|FG000|Overall Study|Physician Decision|3|||
16235823|NCT03255226|39348075|FG000|Overall Study|Withdrawal by Subject|1|||
16235824|NCT03255226|39348075|FG000|Overall Study|Serum or blood sodium increased|4|||
16413548|NCT02804750|39995194|FG001|Period 4|Adverse Event|5|||
16554472|NCT03017235|40493064|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
16554473|NCT02632786|40496163|FG000|Overall Study|Adverse Event|2|||
16235825|NCT03255226|39348075|FG000|Overall Study|Serum or blood potassium increased|4|||
16235826|NCT01643928|39348076|FG000|Overall Study|Lost to Follow-up|1|||
16235827|NCT01643928|39348077|FG001|Overall Study|Lost to Follow-up|0|||
16235828|NCT01643928|39348078|FG002|Overall Study|Lost to Follow-up|2|||
16235829|NCT01643928|39348079|FG003|Overall Study|Lost to Follow-up|0|||
16235830|NCT01643928|39348080|FG004|Overall Study|Lost to Follow-up|0|||
16235831|NCT01643928|39348076|FG000|Overall Study|Withdrawal by Subject|2|||
16235832|NCT01643928|39348077|FG001|Overall Study|Withdrawal by Subject|0|||
16235833|NCT01643928|39348078|FG002|Overall Study|Withdrawal by Subject|0|||
16235834|NCT01643928|39348079|FG003|Overall Study|Withdrawal by Subject|1|||
16235835|NCT01643928|39348080|FG004|Overall Study|Withdrawal by Subject|0|||
16235836|NCT01643928|39348076|FG000|Overall Study|Pregnancy|0|||
16235837|NCT01643928|39348077|FG001|Overall Study|Pregnancy|0|||
16235838|NCT01643928|39348078|FG002|Overall Study|Pregnancy|0|||
16235839|NCT01643928|39348079|FG003|Overall Study|Pregnancy|1|||
16235840|NCT01643928|39348080|FG004|Overall Study|Pregnancy|0|||
16235841|NCT01643928|39348076|FG000|Overall Study|Other|5|||
16235842|NCT01643928|39348077|FG001|Overall Study|Other|1|||
16235843|NCT01643928|39348078|FG002|Overall Study|Other|1|||
16235844|NCT01643928|39348079|FG003|Overall Study|Other|0|||
16235845|NCT01643928|39348080|FG004|Overall Study|Other|0|||
16235846|NCT01643928|39348076|FG000|Overall Study|Adverse Event|2|||
16235847|NCT01643928|39348077|FG001|Overall Study|Adverse Event|1|||
16235848|NCT01643928|39348078|FG002|Overall Study|Adverse Event|0|||
16235849|NCT01643928|39348079|FG003|Overall Study|Adverse Event|1|||
16235850|NCT01643928|39348080|FG004|Overall Study|Adverse Event|2|||
16235851|NCT03674827|39348082|FG000|Treatment Phase|Adverse Event|0|||
16235852|NCT03674827|39348083|FG001|Treatment Phase|Adverse Event|0|||
16235853|NCT03674827|39348084|FG002|Treatment Phase|Adverse Event|0|||
16235854|NCT03674827|39348085|FG003|Treatment Phase|Adverse Event|0|||
16235855|NCT03674827|39348086|FG004|Treatment Phase|Adverse Event|0|||
16235856|NCT03674827|39348087|FG005|Treatment Phase|Adverse Event|2|||
16235857|NCT03674827|39348082|FG000|Treatment Phase|Death|2|||
16235858|NCT03674827|39348083|FG001|Treatment Phase|Death|0|||
16235859|NCT03674827|39348084|FG002|Treatment Phase|Death|0|||
16235860|NCT03674827|39348085|FG003|Treatment Phase|Death|0|||
16554474|NCT02632786|40496164|FG001|Overall Study|Adverse Event|1|||
16554475|NCT02632786|40496163|FG000|Overall Study|Death|3|||
16554476|NCT02632786|40496164|FG001|Overall Study|Death|2|||
16554477|NCT02632786|40496163|FG000|Overall Study|Physician Decision|5|||
16554478|NCT02632786|40496164|FG001|Overall Study|Physician Decision|4|||
16554479|NCT02632786|40496163|FG000|Overall Study|Withdrawal by Subject|1|||
16554480|NCT02632786|40496164|FG001|Overall Study|Withdrawal by Subject|0|||
16554481|NCT01734382|40496165|FG000|Part 1|Adverse Event|2|||
16554482|NCT01734382|40496166|FG001|Part 1|Adverse Event|0|||
16235861|NCT03674827|39348086|FG004|Treatment Phase|Death|1|||
16235862|NCT03674827|39348087|FG005|Treatment Phase|Death|0|||
16235863|NCT03674827|39348082|FG000|Treatment Phase|Progressive Disease|0|||
16235864|NCT03674827|39348083|FG001|Treatment Phase|Progressive Disease|4|||
16235865|NCT03674827|39348084|FG002|Treatment Phase|Progressive Disease|3|||
16554483|NCT01734382|40496167|FG002|Part 1|Adverse Event|0|||
16554484|NCT01734382|40496165|FG000|Part 2|Adverse Event|0|||
16554485|NCT01734382|40496166|FG001|Part 2|Adverse Event|0|||
16235866|NCT03674827|39348085|FG003|Treatment Phase|Progressive Disease|4|||
16235867|NCT03674827|39348086|FG004|Treatment Phase|Progressive Disease|4|||
16235868|NCT03674827|39348087|FG005|Treatment Phase|Progressive Disease|9|||
16235869|NCT03674827|39348082|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
16554486|NCT01734382|40496167|FG002|Part 2|Adverse Event|1|||
16554487|NCT01734382|40496165|FG000|Part 2|Lack of Efficacy|0|||
16554488|NCT01734382|40496166|FG001|Part 2|Lack of Efficacy|1|||
16554489|NCT01734382|40496167|FG002|Part 2|Lack of Efficacy|1|||
16413549|NCT01288612|39995197|FG000|Overall Study|Unable to contact|11|||
16413550|NCT01288612|39995198|FG001|Overall Study|Unable to contact|16|||
16413551|NCT01288612|39995199|FG002|Overall Study|Unable to contact|20|||
16413552|NCT01288612|39995197|FG000|Overall Study|Declined|78|||
16413553|NCT01288612|39995198|FG001|Overall Study|Declined|63|||
16413554|NCT01288612|39995199|FG002|Overall Study|Declined|62|||
16413555|NCT01288612|39995197|FG000|Overall Study|Unable to intubate|0|||
16413556|NCT01288612|39995198|FG001|Overall Study|Unable to intubate|3|||
16413557|NCT01288612|39995199|FG002|Overall Study|Unable to intubate|0|||
16413558|NCT00416715|39995201|FG000|Overall Study|Not evaluable for joint aches|7|||
16554490|NCT01734382|40496165|FG000|Part 2|Other|0|||
16554491|NCT01734382|40496166|FG001|Part 2|Other|0|||
16554492|NCT01734382|40496167|FG002|Part 2|Other|1|||
16554493|NCT01734382|40496165|FG000|Part 2|Physician Decision|0|||
16554494|NCT01734382|40496166|FG001|Part 2|Physician Decision|0|||
16554495|NCT01734382|40496167|FG002|Part 2|Physician Decision|3|||
16554496|NCT01734382|40496165|FG000|Part 2|Protocol Violation|0|||
16554497|NCT01734382|40496166|FG001|Part 2|Protocol Violation|1|||
16554498|NCT01734382|40496167|FG002|Part 2|Protocol Violation|0|||
16554499|NCT01734382|40496165|FG000|Part 2|Withdrawal by Subject|0|||
16554500|NCT01734382|40496166|FG001|Part 2|Withdrawal by Subject|0|||
16554501|NCT01734382|40496167|FG002|Part 2|Withdrawal by Subject|1|||
16554502|NCT01313182|40496168|FG000|Overall Study|Protocol Violation|66|||
16554503|NCT01313182|40496169|FG001|Overall Study|Protocol Violation|92|||
16554504|NCT01254565|40496170|FG000|Overall Study|Non-compliance to Study Procedures|0|||
16554505|NCT01254565|40496171|FG001|Overall Study|Non-compliance to Study Procedures|0|||
16554506|NCT01254565|40496172|FG002|Overall Study|Non-compliance to Study Procedures|0|||
16554507|NCT01254565|40496173|FG003|Overall Study|Non-compliance to Study Procedures|0|||
16554508|NCT01254565|40496174|FG004|Overall Study|Non-compliance to Study Procedures|1|||
16554509|NCT01254565|40496175|FG005|Overall Study|Non-compliance to Study Procedures|0|||
16554510|NCT01254565|40496170|FG000|Overall Study|Did not Receive Treatment|1|||
16413559|NCT00416715|39995201|FG000|Overall Study|Vitamin D levels not evaluable|8|||
16554511|NCT01254565|40496171|FG001|Overall Study|Did not Receive Treatment|1|||
16554512|NCT01254565|40496172|FG002|Overall Study|Did not Receive Treatment|0|||
16554513|NCT01254565|40496173|FG003|Overall Study|Did not Receive Treatment|0|||
16554514|NCT01254565|40496174|FG004|Overall Study|Did not Receive Treatment|3|||
16413560|NCT02210832|39995208|FG000|Overall Study|Pregnancy termination .|3|||
16413561|NCT02210832|39995209|FG001|Overall Study|Pregnancy termination .|4|||
16413562|NCT02210832|39995210|FG002|Overall Study|Pregnancy termination .|1|||
16413563|NCT02210832|39995208|FG000|Overall Study|Lost to Follow-up|26|||
16413564|NCT02210832|39995209|FG001|Overall Study|Lost to Follow-up|32|||
16413565|NCT02210832|39995210|FG002|Overall Study|Lost to Follow-up|17|||
16413566|NCT01930890|39995214|FG000|Overall Study|Study Termination|14|||
16413567|NCT01930890|39995215|FG001|Overall Study|Study Termination|28|||
16413568|NCT01930890|39995216|FG002|Overall Study|Study Termination|13|||
16413569|NCT01930890|39995217|FG003|Overall Study|Study Termination|25|||
16413570|NCT01930890|39995214|FG000|Overall Study|Death|0|||
16413571|NCT01930890|39995215|FG001|Overall Study|Death|0|||
16413572|NCT01930890|39995216|FG002|Overall Study|Death|0|||
16413573|NCT01930890|39995217|FG003|Overall Study|Death|1|||
16413574|NCT01930890|39995214|FG000|Overall Study|Investigator Decision|0|||
16413575|NCT01930890|39995215|FG001|Overall Study|Investigator Decision|1|||
16413576|NCT01930890|39995216|FG002|Overall Study|Investigator Decision|0|||
16413577|NCT01930890|39995217|FG003|Overall Study|Investigator Decision|0|||
16413578|NCT01930890|39995214|FG000|Overall Study|Consent Withdrawn|0|||
16121252|NCT00078338|38930120|FG000|Overall Study|Other|28|||
16413579|NCT01930890|39995215|FG001|Overall Study|Consent Withdrawn|3|||
16413580|NCT01930890|39995216|FG002|Overall Study|Consent Withdrawn|0|||
16413581|NCT01930890|39995217|FG003|Overall Study|Consent Withdrawn|1|||
16413582|NCT01930890|39995214|FG000|Overall Study|Adverse Event|0|||
16413583|NCT01930890|39995215|FG001|Overall Study|Adverse Event|1|||
16413584|NCT01930890|39995216|FG002|Overall Study|Adverse Event|0|||
16413585|NCT01930890|39995217|FG003|Overall Study|Adverse Event|0|||
16413586|NCT00117793|39995218|FG000|Overall Study|Withdrawal by Subject|12|||
16121253|NCT00078338|38930121|FG001|Overall Study|Other|16|||
16121254|NCT00078338|38930120|FG000|Overall Study|Subjects randomized, but not treated|3|||
16121255|NCT00078338|38930121|FG001|Overall Study|Subjects randomized, but not treated|3|||
16121256|NCT00573859|38930127|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
16121257|NCT00573859|38930127|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
16121258|NCT04514510|38930128|FG000|Overall Study|Lost to Follow-up|0|||
16121259|NCT04514510|38930129|FG001|Overall Study|Lost to Follow-up|1|||
16413587|NCT00461305|39995219|FG000|Treatment|Adverse Event|26|||
16413588|NCT00461305|39995220|FG001|Treatment|Adverse Event|3|||
16413589|NCT00461305|39995219|FG000|Treatment|Lost to Follow-up|4|||
16413590|NCT00461305|39995220|FG001|Treatment|Lost to Follow-up|2|||
16413591|NCT00461305|39995219|FG000|Treatment|Protocol Violation|13|||
16413592|NCT00461305|39995220|FG001|Treatment|Protocol Violation|2|||
16235870|NCT03674827|39348083|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
16235871|NCT03674827|39348084|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
16235872|NCT03674827|39348085|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
16235873|NCT03674827|39348086|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
16235874|NCT03674827|39348087|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
16235875|NCT03674827|39348082|FG000|Treatment Phase|Withdrawal by Subject|0|||
16235876|NCT03674827|39348083|FG001|Treatment Phase|Withdrawal by Subject|0|||
16235877|NCT03674827|39348084|FG002|Treatment Phase|Withdrawal by Subject|0|||
16235878|NCT03674827|39348085|FG003|Treatment Phase|Withdrawal by Subject|0|||
16235879|NCT03674827|39348086|FG004|Treatment Phase|Withdrawal by Subject|0|||
16235880|NCT03674827|39348087|FG005|Treatment Phase|Withdrawal by Subject|1|||
16235881|NCT03674827|39348082|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
16235882|NCT03674827|39348083|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
16235883|NCT03674827|39348084|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
16235884|NCT03674827|39348085|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
16235885|NCT03674827|39348086|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
16413593|NCT00461305|39995219|FG000|Treatment|Withdrawal by Subject|48|||
16413594|NCT00461305|39995220|FG001|Treatment|Withdrawal by Subject|2|||
16413595|NCT00461305|39995219|FG000|Treatment|Never dispensed|5|||
16413596|NCT00461305|39995220|FG001|Treatment|Never dispensed|0|||
16413597|NCT00461305|39995219|FG000|Treatment|Study drug not taken|1|||
16413598|NCT00461305|39995220|FG001|Treatment|Study drug not taken|0|||
16413599|NCT00461305|39995219|FG000|Treatment|Partially missing diary|2|||
16413600|NCT00461305|39995220|FG001|Treatment|Partially missing diary|0|||
16413601|NCT00461305|39995219|FG000|Treatment|Other (missing drug etc)|2|||
16413602|NCT00461305|39995220|FG001|Treatment|Other (missing drug etc)|0|||
16413603|NCT00461305|39995219|FG000|Continued Treatment|Adverse Event|26|||
16413604|NCT00461305|39995220|FG001|Continued Treatment|Adverse Event|0|||
16413605|NCT00461305|39995219|FG000|Continued Treatment|Lost to Follow-up|4|||
16413606|NCT00461305|39995220|FG001|Continued Treatment|Lost to Follow-up|0|||
16413607|NCT00461305|39995219|FG000|Continued Treatment|Protocol Violation|13|||
16413608|NCT00461305|39995220|FG001|Continued Treatment|Protocol Violation|0|||
16413609|NCT00461305|39995219|FG000|Continued Treatment|Withdrawal by Subject|48|||
16413610|NCT00461305|39995220|FG001|Continued Treatment|Withdrawal by Subject|0|||
16413611|NCT00461305|39995219|FG000|Continued Treatment|Partially missing diary|2|||
16413612|NCT00461305|39995220|FG001|Continued Treatment|Partially missing diary|0|||
16413613|NCT00461305|39995219|FG000|Continued Treatment|Other (missing drug etc)|2|||
16413614|NCT00461305|39995220|FG001|Continued Treatment|Other (missing drug etc)|0|||
16413615|NCT01378429|39995221|FG000|Overall Study|Noncompliance with study drug|1|||
16413616|NCT01378429|39995222|FG001|Overall Study|Noncompliance with study drug|0|||
16554515|NCT01254565|40496175|FG005|Overall Study|Did not Receive Treatment|4|||
16121260|NCT04514510|38930128|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
16235886|NCT03674827|39348087|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
16413617|NCT02434328|39995223|FG000|Overall Study|Adverse Event|9|||
16413618|NCT02434328|39995224|FG001|Overall Study|Adverse Event|4|||
16413619|NCT02434328|39995223|FG000|Overall Study|Lack of Efficacy|0|||
16413620|NCT02434328|39995224|FG001|Overall Study|Lack of Efficacy|2|||
16413621|NCT02434328|39995223|FG000|Overall Study|Physician Decision|0|||
16413622|NCT02434328|39995224|FG001|Overall Study|Physician Decision|1|||
16413623|NCT02434328|39995223|FG000|Overall Study|Withdrawal by Subject|12|||
16413624|NCT02434328|39995224|FG001|Overall Study|Withdrawal by Subject|21|||
16413625|NCT02434328|39995223|FG000|Overall Study|Death|4|||
16413626|NCT02434328|39995224|FG001|Overall Study|Death|7|||
16413627|NCT02434328|39995223|FG000|Overall Study|Lost to Follow-up|1|||
16413628|NCT02434328|39995224|FG001|Overall Study|Lost to Follow-up|6|||
16413629|NCT02434328|39995223|FG000|Overall Study|Other|4|||
16413630|NCT02434328|39995224|FG001|Overall Study|Other|1|||
16413631|NCT01685983|39995225|FG000|Overall Study|Adverse Event|7|||
16413632|NCT01685983|39995225|FG000|Overall Study|Death|1|||
16413633|NCT01685983|39995225|FG000|Overall Study|Withdrawal by Subject|19|||
16413634|NCT01685983|39995225|FG000|Overall Study|Protocol Violation|2|||
16413635|NCT01685983|39995225|FG000|Overall Study|Physician Decision|13|||
16413636|NCT01685983|39995225|FG000|Overall Study|Other|7|||
16554516|NCT01254565|40496170|FG000|Overall Study|Other|0|||
16554517|NCT01254565|40496171|FG001|Overall Study|Other|0|||
16554518|NCT01254565|40496172|FG002|Overall Study|Other|0|||
16554519|NCT01254565|40496173|FG003|Overall Study|Other|1|||
16554520|NCT01254565|40496174|FG004|Overall Study|Other|0|||
16554521|NCT01254565|40496175|FG005|Overall Study|Other|0|||
16554522|NCT03390036|40496177|FG000|Overall Study|Lost to Follow-up|1|||
16554523|NCT03390036|40496178|FG001|Overall Study|Lost to Follow-up|0|||
16554524|NCT03390036|40496179|FG002|Overall Study|Lost to Follow-up|0|||
16554525|NCT03390036|40496177|FG000|Overall Study|Lack of Efficacy|1|||
16554526|NCT03390036|40496178|FG001|Overall Study|Lack of Efficacy|0|||
16554527|NCT03390036|40496179|FG002|Overall Study|Lack of Efficacy|0|||
16554528|NCT04267614|40496180|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
16554529|NCT04267614|40496180|FG000|Overall Study|Lost to Follow-up|115|||
16554530|NCT00363896|40496181|FG000|Overall Study|Withdrawal by Subject|29|||
16554531|NCT00363896|40496182|FG001|Overall Study|Withdrawal by Subject|16|||
16554532|NCT00363896|40496181|FG000|Overall Study|Adverse Event|24|||
16554533|NCT00363896|40496182|FG001|Overall Study|Adverse Event|13|||
16554534|NCT00363896|40496181|FG000|Overall Study|COPD exacerbation|13|||
16554535|NCT00363896|40496182|FG001|Overall Study|COPD exacerbation|7|||
16554536|NCT00363896|40496181|FG000|Overall Study|Lack of Efficacy|12|||
16554537|NCT00363896|40496182|FG001|Overall Study|Lack of Efficacy|8|||
16349268|NCT02326272|39765646|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16349269|NCT02326272|39765647|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16349270|NCT02326272|39765648|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16349271|NCT02326272|39765649|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16349272|NCT02326272|39765650|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
16349273|NCT02326272|39765651|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16349274|NCT02326272|39765652|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16349275|NCT02326272|39765653|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16349276|NCT02326272|39765654|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
16349277|NCT02326272|39765655|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16413637|NCT01685983|39995225|FG000|Overall Study|Progressive Disease|32|||
16413638|NCT01685983|39995225|FG000|Overall Study|Noncompliance with Study Drug|1|||
16413639|NCT03332160|39995228|FG000|Overall Study|Withdrawal by Subject|1|||
16554538|NCT00363896|40496181|FG000|Overall Study|Protocol Violation|6|||
16554539|NCT00363896|40496182|FG001|Overall Study|Protocol Violation|1|||
16413640|NCT03332160|39995229|FG001|Overall Study|Withdrawal by Subject|1|||
16413641|NCT03332160|39995228|FG000|Overall Study|Adverse Event|0|||
16413642|NCT03332160|39995229|FG001|Overall Study|Adverse Event|1|||
16121261|NCT04514510|38930129|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
16121262|NCT01399697|38930130|FG000|Overall Study|Adverse Event|13|||
16121263|NCT01399697|38930131|FG001|Overall Study|Adverse Event|3|||
16121264|NCT01399697|38930132|FG002|Overall Study|Adverse Event|1|||
16121265|NCT01399697|38930130|FG000|Overall Study|Lost to Follow-up|2|||
16121266|NCT01399697|38930131|FG001|Overall Study|Lost to Follow-up|0|||
16121267|NCT01399697|38930132|FG002|Overall Study|Lost to Follow-up|0|||
16121268|NCT01399697|38930130|FG000|Overall Study|Withdrawal by Subject|8|||
16121269|NCT01399697|38930131|FG001|Overall Study|Withdrawal by Subject|0|||
16121270|NCT01399697|38930132|FG002|Overall Study|Withdrawal by Subject|0|||
16413643|NCT03332160|39995228|FG000|Overall Study|Developed Exclusion Criteria|0|||
16413644|NCT03332160|39995229|FG001|Overall Study|Developed Exclusion Criteria|1|||
16413645|NCT03332160|39995228|FG000|Overall Study|Non-adherence to treatment|0|||
16413646|NCT03332160|39995229|FG001|Overall Study|Non-adherence to treatment|2|||
16413647|NCT02559414|39995232|FG000|Overall Study|Lost to Follow-up|0|||
16413648|NCT02559414|39995233|FG001|Overall Study|Lost to Follow-up|1|||
16413649|NCT02559414|39995234|FG002|Overall Study|Lost to Follow-up|0|||
16413650|NCT02559414|39995232|FG000|Overall Study|Withdrawal by Subject|1|||
16413651|NCT02559414|39995233|FG001|Overall Study|Withdrawal by Subject|0|||
16413652|NCT02559414|39995234|FG002|Overall Study|Withdrawal by Subject|1|||
16413653|NCT02559414|39995232|FG000|Overall Study|Other|0|||
16413654|NCT02559414|39995233|FG001|Overall Study|Other|1|||
16413655|NCT02559414|39995234|FG002|Overall Study|Other|1|||
16413656|NCT02242981|39995235|FG000|Overall Study|Withdrawal by Subject|1|||
16413657|NCT02525094|39995236|FG000|Overall Study|Lost to Follow-up|2|||
16413658|NCT02525094|39995237|FG001|Overall Study|Lost to Follow-up|1|||
16413659|NCT02525094|39995236|FG000|Overall Study|Withdrawal by Subject|5|||
16413660|NCT02525094|39995237|FG001|Overall Study|Withdrawal by Subject|6|||
16413661|NCT02525094|39995236|FG000|Overall Study|Not Treated|1|||
16413662|NCT02525094|39995237|FG001|Overall Study|Not Treated|1|||
16413663|NCT01672866|39995238|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
16413664|NCT01672866|39995239|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
16413665|NCT01672866|39995240|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
16413666|NCT01672866|39995238|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
16413667|NCT01672866|39995239|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
16413668|NCT01672866|39995240|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
16413669|NCT01672866|39995238|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
16413670|NCT01672866|39995239|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
16413671|NCT01672866|39995240|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
16413672|NCT01672866|39995238|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
16413673|NCT01672866|39995239|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
16413674|NCT01672866|39995240|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
16413675|NCT01672866|39995238|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
16413676|NCT01672866|39995239|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
16413677|NCT01672866|39995240|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
16554540|NCT00363896|40496181|FG000|Overall Study|Lost to Follow-up|3|||
16554541|NCT00363896|40496182|FG001|Overall Study|Lost to Follow-up|0|||
16554542|NCT00363896|40496181|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
16554543|NCT00363896|40496182|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
16235887|NCT03674827|39348082|FG000|Treatment Phase|Other|0|||
16554544|NCT00363896|40496181|FG000|Overall Study|Other|1|||
16554545|NCT00363896|40496182|FG001|Overall Study|Other|2|||
16554546|NCT02411591|40496183|FG000|Overall Study|Adverse Event|0|||
16554547|NCT02411591|40496184|FG001|Overall Study|Adverse Event|4|||
16554548|NCT02411591|40496185|FG002|Overall Study|Adverse Event|2|||
16554549|NCT02411591|40496183|FG000|Overall Study|Withdrawal by Subject|0|||
16554550|NCT02411591|40496184|FG001|Overall Study|Withdrawal by Subject|3|||
16554551|NCT02411591|40496185|FG002|Overall Study|Withdrawal by Subject|0|||
16554552|NCT02411591|40496183|FG000|Overall Study|Physician Decision|0|||
16554553|NCT02411591|40496184|FG001|Overall Study|Physician Decision|3|||
16554554|NCT02411591|40496185|FG002|Overall Study|Physician Decision|1|||
16554555|NCT00180674|40496198|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
16554556|NCT00180674|40496198|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
16554557|NCT00630058|40496199|FG000|Overall Study|Adverse Event|1|||
16554558|NCT00630058|40496200|FG001|Overall Study|Adverse Event|1|||
16554559|NCT00630058|40496199|FG000|Overall Study|Withdrawal by Subject|0|||
16554560|NCT00630058|40496200|FG001|Overall Study|Withdrawal by Subject|1|||
16554561|NCT00630058|40496199|FG000|Overall Study|stopping criteria|3|||
16554562|NCT00630058|40496200|FG001|Overall Study|stopping criteria|2|||
16554563|NCT01590771|40496201|FG000|Overall Study|Other Protocol Specified Criteria|5|||
16554564|NCT01590771|40496202|FG001|Overall Study|Other Protocol Specified Criteria|14|||
16554565|NCT01590771|40496201|FG000|Overall Study|Withdrawal by Subject|8|||
16554566|NCT01590771|40496202|FG001|Overall Study|Withdrawal by Subject|15|||
16554567|NCT01590771|40496201|FG000|Overall Study|Protocol Violation|1|||
16554568|NCT01590771|40496202|FG001|Overall Study|Protocol Violation|2|||
16554569|NCT01590771|40496201|FG000|Overall Study|Lost to Follow-up|1|||
16554570|NCT01590771|40496202|FG001|Overall Study|Lost to Follow-up|1|||
16554571|NCT01590771|40496201|FG000|Overall Study|Lack of Efficacy|1|||
16554572|NCT01590771|40496202|FG001|Overall Study|Lack of Efficacy|0|||
16554573|NCT01590771|40496201|FG000|Overall Study|Adverse Event|3|||
16554574|NCT01590771|40496202|FG001|Overall Study|Adverse Event|7|||
16554575|NCT04078035|40496205|FG000|Session 2|Lost to Follow-up|3|||
16554576|NCT04078035|40496206|FG001|Session 2|Lost to Follow-up|1|||
16554577|NCT04078035|40496205|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
16554578|NCT04078035|40496206|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
16554579|NCT02982720|40496208|FG000|Overall Study|Adverse Event|3|||
16554580|NCT02982720|40496208|FG000|Overall Study|Death|1|||
16554581|NCT01129336|40496209|FG000|Overall Study|Protocol Violation|1|||
16554582|NCT01129336|40496210|FG001|Overall Study|Protocol Violation|0|||
16554583|NCT01129336|40496209|FG000|Overall Study|Disease Progression|1|||
16554584|NCT01129336|40496210|FG001|Overall Study|Disease Progression|4|||
16554585|NCT01129336|40496209|FG000|Overall Study|Lost to Follow-up|1|||
16554586|NCT01129336|40496210|FG001|Overall Study|Lost to Follow-up|0|||
16554587|NCT01129336|40496209|FG000|Overall Study|Withdrawal by Subject|7|||
16554588|NCT01129336|40496210|FG001|Overall Study|Withdrawal by Subject|4|||
16554589|NCT01129336|40496209|FG000|Overall Study|Adverse Event|0|||
16554590|NCT01129336|40496210|FG001|Overall Study|Adverse Event|1|||
16554591|NCT01129336|40496209|FG000|Overall Study|Missing Study Completion Status|2|||
16554592|NCT01129336|40496210|FG001|Overall Study|Missing Study Completion Status|3|||
16554593|NCT01129336|40496209|FG000|Overall Study|Death|0|||
16554594|NCT01129336|40496210|FG001|Overall Study|Death|4|||
16554595|NCT00429494|40496211|FG000|Overall Study|Withdrawal by Subject|9|||
16554596|NCT00429494|40496211|FG000|Overall Study|Death|6|||
16554597|NCT01880554|40496212|FG000|Overall Study|Protocol Violation|14|||
16554598|NCT01880554|40496212|FG000|Overall Study|Simon's design requirements|2|||
16554599|NCT00318149|40496213|FG000|Overall Study|Adverse Event|0|||
16554600|NCT00318149|40496214|FG001|Overall Study|Adverse Event|0|||
16554601|NCT00318149|40496215|FG002|Overall Study|Adverse Event|0|||
16554602|NCT00318149|40496216|FG003|Overall Study|Adverse Event|0|||
16554603|NCT00318149|40496217|FG004|Overall Study|Adverse Event|0|||
16554604|NCT00318149|40496218|FG005|Overall Study|Adverse Event|2|||
16554605|NCT00453102|40496221|FG000|Overall Study|Withdrawal by Subject|2|||
16554606|NCT03387514|40496222|FG000|Overall Study|Withdrawal by Subject|2|||
16554607|NCT03387514|40496222|FG000|Overall Study|Physician Decision|1|||
16554608|NCT03387514|40496222|FG000|Overall Study|Lost to Follow-up|2|||
16554609|NCT01087723|40496223|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
16554610|NCT01087723|40496224|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
16554611|NCT01087723|40496223|FG000|Overall Study|Withdrawal by Subject|10|||
16554612|NCT01087723|40496224|FG001|Overall Study|Withdrawal by Subject|13|||
16554613|NCT01087723|40496223|FG000|Overall Study|Physician Decision|2|||
16554614|NCT01087723|40496224|FG001|Overall Study|Physician Decision|0|||
16554615|NCT01087723|40496223|FG000|Overall Study|Lost to Follow-up|1|||
16554616|NCT01087723|40496224|FG001|Overall Study|Lost to Follow-up|4|||
16121271|NCT01399697|38930130|FG000|Overall Study|Investigator Decisión|1|||
16413678|NCT01672866|39995238|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
16413679|NCT01672866|39995239|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
16413680|NCT01672866|39995240|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
16413681|NCT01672866|39995238|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
16413682|NCT01672866|39995239|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
16413683|NCT01672866|39995240|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
16413684|NCT01672866|39995238|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
16413685|NCT01672866|39995239|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
16413686|NCT01672866|39995240|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
16413687|NCT01672866|39995238|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
16413688|NCT01672866|39995239|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
16413689|NCT01672866|39995240|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
16121272|NCT01399697|38930131|FG001|Overall Study|Investigator Decisión|0|||
16121273|NCT01399697|38930132|FG002|Overall Study|Investigator Decisión|2|||
16121274|NCT01399697|38930130|FG000|Overall Study|Lack of Efficacy|9|||
16121275|NCT01399697|38930131|FG001|Overall Study|Lack of Efficacy|0|||
16121276|NCT01399697|38930132|FG002|Overall Study|Lack of Efficacy|1|||
16121277|NCT01399697|38930130|FG000|Overall Study|Protocol Violation|2|||
16121278|NCT01399697|38930131|FG001|Overall Study|Protocol Violation|0|||
16121279|NCT01399697|38930132|FG002|Overall Study|Protocol Violation|0|||
16121280|NCT01399697|38930130|FG000|Overall Study|Non-Compliant|1|||
16121281|NCT01399697|38930131|FG001|Overall Study|Non-Compliant|0|||
16121282|NCT01399697|38930132|FG002|Overall Study|Non-Compliant|0|||
16121283|NCT01399697|38930130|FG000|Overall Study|Inclusion Error|2|||
16121284|NCT01399697|38930131|FG001|Overall Study|Inclusion Error|0|||
16121285|NCT01399697|38930132|FG002|Overall Study|Inclusion Error|0|||
16121286|NCT01399697|38930130|FG000|Overall Study|Positive result for hepatitis B|1|||
16121287|NCT01399697|38930131|FG001|Overall Study|Positive result for hepatitis B|0|||
16121288|NCT01399697|38930132|FG002|Overall Study|Positive result for hepatitis B|0|||
16121289|NCT01399697|38930130|FG000|Overall Study|Clinical RA remission|1|||
16121290|NCT01399697|38930131|FG001|Overall Study|Clinical RA remission|0|||
16121291|NCT01399697|38930132|FG002|Overall Study|Clinical RA remission|0|||
16121292|NCT01399697|38930130|FG000|Overall Study|Sponsor Decision|1|||
16121293|NCT01399697|38930131|FG001|Overall Study|Sponsor Decision|0|||
16121294|NCT01399697|38930132|FG002|Overall Study|Sponsor Decision|0|||
16121295|NCT02389764|38930139|FG000|Overall Study|Lack of Efficacy|9|||
16121296|NCT03980808|38930140|FG000|Overall Study|Lost to Follow-up|2|||
16121297|NCT03980808|38930141|FG001|Overall Study|Lost to Follow-up|2|||
16121298|NCT04230122|38930145|FG000|Overall Study|Lost to Follow-up|1|||
16121299|NCT04230122|38930146|FG001|Overall Study|Lost to Follow-up|0|||
16121300|NCT02530970|38930150|FG000|Overall Study|Adverse Event|8|||
16121301|NCT02530970|38930150|FG000|Overall Study|Lost to Follow-up|88|||
16121302|NCT02530970|38930150|FG000|Overall Study|Physician Decision|5|||
16121303|NCT02530970|38930150|FG000|Overall Study|Withdrawal by Subject|14|||
16121304|NCT02530970|38930150|FG000|Overall Study|Death|6|||
16121305|NCT02530970|38930150|FG000|Overall Study|Hospitalization|1|||
16121306|NCT02530970|38930150|FG000|Overall Study|Insurance|2|||
16121307|NCT02530970|38930150|FG000|Overall Study|Explant|2|||
16121308|NCT02530970|38930150|FG000|Overall Study|Change in Provider|5|||
16121309|NCT02530970|38930150|FG000|Overall Study|Relocation|3|||
16121310|NCT01200342|38930151|FG000|Overall Study|Disease Progression|1|||
16121311|NCT05172050|38930152|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
16121312|NCT05172050|38930153|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
16121313|NCT05172050|38930154|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
16121314|NCT05172050|38930152|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
16121315|NCT05172050|38930153|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
16121316|NCT05172050|38930154|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
16121317|NCT05172050|38930152|FG000|Overall Study|Other|2|||
16349278|NCT02326272|39765656|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16349279|NCT02326272|39765657|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16413690|NCT01672866|39995238|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
16349280|NCT02326272|39765658|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16349281|NCT02326272|39765659|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
16349282|NCT02326272|39765645|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349283|NCT02326272|39765646|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349284|NCT02326272|39765647|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349285|NCT02326272|39765648|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349286|NCT02326272|39765649|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349287|NCT02326272|39765650|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349288|NCT02326272|39765651|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349289|NCT02326272|39765652|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
16349290|NCT02326272|39765653|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349291|NCT02326272|39765654|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349292|NCT02326272|39765655|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349293|NCT02326272|39765656|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349294|NCT02326272|39765657|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349295|NCT02326272|39765658|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349296|NCT02326272|39765659|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
16349297|NCT02326272|39765645|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349298|NCT02326272|39765646|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349299|NCT02326272|39765647|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349300|NCT02326272|39765648|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349301|NCT02326272|39765649|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16121318|NCT05172050|38930153|FG001|Overall Study|Other|2|||
16121319|NCT05172050|38930154|FG002|Overall Study|Other|1|||
16121320|NCT01465763|38930155|FG000|Overall Study|Withdrawal by Subject|4|||
16121321|NCT01465763|38930156|FG001|Overall Study|Withdrawal by Subject|0|||
16121322|NCT01465763|38930157|FG002|Overall Study|Withdrawal by Subject|1|||
16121323|NCT01465763|38930155|FG000|Overall Study|Insufficient Clinical Response|11|||
16121324|NCT01465763|38930156|FG001|Overall Study|Insufficient Clinical Response|0|||
16121325|NCT01465763|38930157|FG002|Overall Study|Insufficient Clinical Response|1|||
16349302|NCT02326272|39765650|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349303|NCT02326272|39765651|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
16349304|NCT02326272|39765652|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349305|NCT02326272|39765653|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349306|NCT02326272|39765654|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16413691|NCT01672866|39995239|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
16121326|NCT01465763|38930155|FG000|Overall Study|Adverse Event|9|||
16413692|NCT01672866|39995240|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
16413693|NCT01672866|39995238|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
16413694|NCT01672866|39995239|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
16413695|NCT01672866|39995240|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
16413696|NCT01672866|39995238|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
16413697|NCT01672866|39995239|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
16413698|NCT01672866|39995240|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
16413699|NCT01672866|39995238|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
16413700|NCT01672866|39995239|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
16413701|NCT01672866|39995240|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
16413702|NCT03831945|39995245|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
16413703|NCT03831945|39995246|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
16413704|NCT03831945|39995245|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
16413705|NCT03831945|39995246|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
16473090|NCT00098475|40210743|FG003|Step 1|Still on treatment as of this analysis|0|||
16473091|NCT00098475|40210740|FG000|Step 1|Knee surgery|1|||
16473092|NCT00098475|40210741|FG001|Step 1|Knee surgery|0|||
16554617|NCT01087723|40496223|FG000|Overall Study|Reason Not Specified|1|||
16554618|NCT01087723|40496224|FG001|Overall Study|Reason Not Specified|2|||
16554619|NCT02954575|40496226|FG000|Overall Study|Withdrawal by Subject|2|||
16554620|NCT02954575|40496226|FG000|Overall Study|Adverse Event|1|||
16121327|NCT01465763|38930156|FG001|Overall Study|Adverse Event|0|||
16121328|NCT01465763|38930157|FG002|Overall Study|Adverse Event|1|||
16121329|NCT01465763|38930155|FG000|Overall Study|Other|2|||
16121330|NCT01465763|38930156|FG001|Overall Study|Other|0|||
16121331|NCT01465763|38930157|FG002|Overall Study|Other|0|||
16121332|NCT01465763|38930155|FG000|Overall Study|Protocol Violation|4|||
16554621|NCT01282476|40496227|FG000|Overall Study|Death|11|||
16121333|NCT01465763|38930156|FG001|Overall Study|Protocol Violation|1|||
16235888|NCT03674827|39348083|FG001|Treatment Phase|Other|1|||
16473093|NCT00098475|40210742|FG002|Step 1|Knee surgery|0|||
16121334|NCT01465763|38930157|FG002|Overall Study|Protocol Violation|1|||
16473094|NCT00098475|40210743|FG003|Step 1|Knee surgery|0|||
16473095|NCT00098475|40210740|FG000|Step 1|Complications|1|||
16473096|NCT00098475|40210741|FG001|Step 1|Complications|0|||
16473097|NCT00098475|40210742|FG002|Step 1|Complications|0|||
16473098|NCT00098475|40210743|FG003|Step 1|Complications|0|||
16473099|NCT00098475|40210740|FG000|Step 1|Cannot comply due to other tx|0|||
16473100|NCT00098475|40210741|FG001|Step 1|Cannot comply due to other tx|1|||
16473101|NCT00098475|40210742|FG002|Step 1|Cannot comply due to other tx|0|||
16473102|NCT00098475|40210743|FG003|Step 1|Cannot comply due to other tx|0|||
16473103|NCT00098475|40210740|FG000|Step 1|Both patient and physician's decision|2|||
16473104|NCT00098475|40210741|FG001|Step 1|Both patient and physician's decision|1|||
16473105|NCT00098475|40210742|FG002|Step 1|Both patient and physician's decision|0|||
16473106|NCT00098475|40210743|FG003|Step 1|Both patient and physician's decision|0|||
16473107|NCT00098475|40210740|FG000|Step 1|Incorrect disease assessment|2|||
16473108|NCT00098475|40210741|FG001|Step 1|Incorrect disease assessment|0|||
16473109|NCT00098475|40210742|FG002|Step 1|Incorrect disease assessment|0|||
16473110|NCT00098475|40210743|FG003|Step 1|Incorrect disease assessment|0|||
16473111|NCT00098475|40210740|FG000|Step 1|Off treatment for > specified timeframe|1|||
16473112|NCT00098475|40210741|FG001|Step 1|Off treatment for > specified timeframe|1|||
16473113|NCT00098475|40210742|FG002|Step 1|Off treatment for > specified timeframe|0|||
16473114|NCT00098475|40210743|FG003|Step 1|Off treatment for > specified timeframe|0|||
16473115|NCT00098475|40210740|FG000|Step 1|Declining performance status|0|||
16473116|NCT00098475|40210741|FG001|Step 1|Declining performance status|1|||
16473117|NCT00098475|40210742|FG002|Step 1|Declining performance status|0|||
16473118|NCT00098475|40210743|FG003|Step 1|Declining performance status|0|||
16473119|NCT00098475|40210740|FG000|Step 1|Insurance issue|0|||
16473120|NCT00098475|40210741|FG001|Step 1|Insurance issue|1|||
16473121|NCT00098475|40210742|FG002|Step 1|Insurance issue|0|||
16473122|NCT00098475|40210743|FG003|Step 1|Insurance issue|0|||
16473123|NCT00098475|40210740|FG000|Step 1|Rising paraprotein|0|||
16473124|NCT00098475|40210741|FG001|Step 1|Rising paraprotein|1|||
16473125|NCT00098475|40210742|FG002|Step 1|Rising paraprotein|0|||
16473126|NCT00098475|40210743|FG003|Step 1|Rising paraprotein|0|||
16473127|NCT00098475|40210740|FG000|Step 1|Referred to other physicians|0|||
16473128|NCT00098475|40210741|FG001|Step 1|Referred to other physicians|1|||
16473129|NCT00098475|40210742|FG002|Step 1|Referred to other physicians|0|||
16473130|NCT00098475|40210743|FG003|Step 1|Referred to other physicians|0|||
16473131|NCT00098475|40210740|FG000|Step 1|Criteria to continue treatment not met|0|||
16473132|NCT00098475|40210741|FG001|Step 1|Criteria to continue treatment not met|1|||
16473133|NCT00098475|40210742|FG002|Step 1|Criteria to continue treatment not met|0|||
16413706|NCT03831945|39995245|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
16413707|NCT03831945|39995246|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
16413708|NCT04969198|39995247|FG000|Overall Study|Withdrawal by Subject|20|||
16413709|NCT04969198|39995247|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
16121335|NCT01465763|38930155|FG000|Overall Study|Death|1|||
16235889|NCT03674827|39348084|FG002|Treatment Phase|Other|0|||
16235890|NCT03674827|39348085|FG003|Treatment Phase|Other|0|||
16235891|NCT03674827|39348086|FG004|Treatment Phase|Other|0|||
16235892|NCT03674827|39348087|FG005|Treatment Phase|Other|1|||
16349307|NCT02326272|39765655|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16235893|NCT03674827|39348082|FG000|Long-Term Follow-up Phase|Death|2|||
16235894|NCT03674827|39348083|FG001|Long-Term Follow-up Phase|Death|4|||
16235895|NCT03674827|39348084|FG002|Long-Term Follow-up Phase|Death|2|||
16349308|NCT02326272|39765656|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349309|NCT02326272|39765657|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349310|NCT02326272|39765658|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349311|NCT02326272|39765659|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
16349312|NCT02326272|39765645|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16349313|NCT02326272|39765646|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16349314|NCT02326272|39765647|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16349315|NCT02326272|39765648|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16413710|NCT04969198|39995247|FG000|Overall Study|Lost to Follow-up|20|||
16121336|NCT01465763|38930156|FG001|Overall Study|Death|0|||
16235896|NCT03674827|39348085|FG003|Long-Term Follow-up Phase|Death|3|||
16235897|NCT03674827|39348086|FG004|Long-Term Follow-up Phase|Death|2|||
16235898|NCT03674827|39348087|FG005|Long-Term Follow-up Phase|Death|6|||
16235899|NCT03674827|39348082|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
16235900|NCT03674827|39348083|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
16235901|NCT03674827|39348084|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
16235902|NCT03674827|39348085|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
16235903|NCT03674827|39348086|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
16235904|NCT03674827|39348087|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
16235905|NCT03674827|39348082|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
16235906|NCT03674827|39348083|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
16235907|NCT03674827|39348084|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
16235908|NCT03674827|39348085|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
16349316|NCT02326272|39765649|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16413711|NCT00343382|39995250|FG000|Overall Study|Adverse Event|2|||
16413712|NCT00343382|39995251|FG001|Overall Study|Adverse Event|10|||
16413713|NCT00343382|39995252|FG002|Overall Study|Adverse Event|7|||
16413714|NCT00343382|39995250|FG000|Overall Study|Withdrawal by Subject|1|||
16413715|NCT00343382|39995251|FG001|Overall Study|Withdrawal by Subject|2|||
16413716|NCT00343382|39995252|FG002|Overall Study|Withdrawal by Subject|6|||
16235909|NCT03674827|39348086|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
16235910|NCT03674827|39348087|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
16235911|NCT04980391|39348088|FG000|Overall Study|Death|0|||
16235912|NCT04980391|39348089|FG001|Overall Study|Death|0|||
16235913|NCT04980391|39348090|FG002|Overall Study|Death|1|||
16235914|NCT04980391|39348091|FG003|Overall Study|Death|1|||
16235915|NCT04980391|39348088|FG000|Overall Study|Lost to Follow-up|3|||
16235916|NCT04980391|39348089|FG001|Overall Study|Lost to Follow-up|3|||
16235917|NCT04980391|39348090|FG002|Overall Study|Lost to Follow-up|2|||
16235918|NCT04980391|39348091|FG003|Overall Study|Lost to Follow-up|3|||
16235919|NCT04980391|39348088|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
16235920|NCT04980391|39348089|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
16235921|NCT04980391|39348090|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
16235922|NCT04980391|39348091|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
16235923|NCT04980391|39348088|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16235924|NCT04980391|39348089|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16235925|NCT04980391|39348090|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
16235926|NCT04980391|39348091|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
16235927|NCT04980391|39348088|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
16235928|NCT04980391|39348089|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
16235929|NCT04980391|39348090|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
16235930|NCT04980391|39348091|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
16235931|NCT02094573|39348092|FG000|Overall Study|Adverse Event|4|||
16235932|NCT02094573|39348093|FG001|Overall Study|Adverse Event|14|||
16554622|NCT01394250|40496235|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
16554623|NCT01394250|40496236|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
16554624|NCT01394250|40496235|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
16554625|NCT01394250|40496236|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
16235933|NCT02094573|39348092|FG000|Overall Study|Clinical Progressive Disease|9|||
16235934|NCT02094573|39348093|FG001|Overall Study|Clinical Progressive Disease|13|||
16235935|NCT02094573|39348092|FG000|Overall Study|Death|11|||
16235936|NCT02094573|39348093|FG001|Overall Study|Death|3|||
16235937|NCT02094573|39348092|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
16235938|NCT02094573|39348093|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
16235939|NCT02094573|39348092|FG000|Overall Study|Non-compliance with Study Drug|1|||
16235940|NCT02094573|39348093|FG001|Overall Study|Non-compliance with Study Drug|1|||
16235941|NCT02094573|39348092|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
16235942|NCT02094573|39348093|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
16235943|NCT02094573|39348092|FG000|Overall Study|Physician Decision|4|||
16235944|NCT02094573|39348093|FG001|Overall Study|Physician Decision|4|||
16235945|NCT02094573|39348092|FG000|Overall Study|Site Terminated by Sponsor|10|||
16235946|NCT02094573|39348093|FG001|Overall Study|Site Terminated by Sponsor|17|||
16235947|NCT02094573|39348092|FG000|Overall Study|Withdrawal by Subject|6|||
16235948|NCT02094573|39348093|FG001|Overall Study|Withdrawal by Subject|8|||
16235949|NCT02094573|39348092|FG000|Overall Study|Randomized but not Treated|3|||
16235950|NCT02094573|39348093|FG001|Overall Study|Randomized but not Treated|0|||
16235951|NCT03047031|39348094|FG000|Overall Study|Other than listed|1|||
16235952|NCT03047031|39348095|FG001|Overall Study|Other than listed|0|||
16235953|NCT03047031|39348096|FG002|Overall Study|Other than listed|0|||
16235954|NCT03047031|39348094|FG000|Overall Study|Lost to Follow-up|4|||
16235955|NCT03047031|39348095|FG001|Overall Study|Lost to Follow-up|0|||
16235956|NCT03047031|39348096|FG002|Overall Study|Lost to Follow-up|0|||
16235957|NCT03047031|39348094|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
16235958|NCT03047031|39348095|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
16235959|NCT03047031|39348096|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
16235960|NCT03047031|39348094|FG000|Overall Study|Adverse Event|1|||
16235961|NCT03047031|39348095|FG001|Overall Study|Adverse Event|0|||
16235962|NCT03047031|39348096|FG002|Overall Study|Adverse Event|0|||
16235963|NCT03047031|39348094|FG000|Overall Study|Withdrawal by Subject|2|||
16235964|NCT03047031|39348095|FG001|Overall Study|Withdrawal by Subject|0|||
16554626|NCT00975221|40496239|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
16235965|NCT03047031|39348096|FG002|Overall Study|Withdrawal by Subject|0|||
16235966|NCT03047031|39348094|FG000|Overall Study|Change to other medication|2|||
16235967|NCT03047031|39348095|FG001|Overall Study|Change to other medication|0|||
16235968|NCT03047031|39348096|FG002|Overall Study|Change to other medication|0|||
16235969|NCT03047031|39348094|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
16413717|NCT00343382|39995250|FG000|Overall Study|Other Reason Not Specified|1|||
16554627|NCT00975221|40496240|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
16235970|NCT03047031|39348095|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
16235971|NCT03047031|39348096|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
16235972|NCT00185731|39348098|FG000|Overall Study|Withdrawal by Subject|1|||
16235973|NCT00185731|39348098|FG000|Overall Study|Not Eligible|1|||
16235974|NCT01491737|39348099|FG000|Overall Study|Withdrawal by Subject|20|||
16235975|NCT01491737|39348100|FG001|Overall Study|Withdrawal by Subject|17|||
16235976|NCT01491737|39348099|FG000|Overall Study|Lost to Follow-up|2|||
16235977|NCT01491737|39348100|FG001|Overall Study|Lost to Follow-up|10|||
16235978|NCT01491737|39348099|FG000|Overall Study|Death|63|||
16349317|NCT02326272|39765650|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16349318|NCT02326272|39765651|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16349319|NCT02326272|39765652|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16235979|NCT01491737|39348100|FG001|Overall Study|Death|57|||
16235980|NCT01491737|39348099|FG000|Overall Study|Study Termination by Sponsor|36|||
16235981|NCT01491737|39348100|FG001|Overall Study|Study Termination by Sponsor|36|||
16235982|NCT01491737|39348099|FG000|Overall Study|Reason Not Specified|8|||
16235983|NCT01491737|39348100|FG001|Overall Study|Reason Not Specified|9|||
16235984|NCT00424515|39348104|FG000|Overall Study|Progressive Disease|10|||
16554628|NCT00975221|40496239|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
16554629|NCT00975221|40496240|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
16554630|NCT00975221|40496239|FG000|Titration Phase (Weeks 1-12)|Other|0|||
16554631|NCT00975221|40496240|FG001|Titration Phase (Weeks 1-12)|Other|1|||
16554632|NCT00975221|40496239|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
16554633|NCT00975221|40496240|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
16554634|NCT00975221|40496239|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
16554635|NCT00975221|40496240|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
16554636|NCT00975221|40496239|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
16554637|NCT00975221|40496240|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
16554638|NCT04022889|40496245|FG000|Stage 1: Period 1|Adverse Event|1|||
16554639|NCT04022889|40496246|FG001|Stage 1: Period 1|Adverse Event|0|||
16235985|NCT00424515|39348105|FG001|Overall Study|Progressive Disease|11|||
16235986|NCT00424515|39348104|FG000|Overall Study|Adverse Event|0|||
16235987|NCT00424515|39348105|FG001|Overall Study|Adverse Event|1|||
16235988|NCT00424515|39348104|FG000|Overall Study|Intercurrent Illness|0|||
16235989|NCT00424515|39348105|FG001|Overall Study|Intercurrent Illness|1|||
16235990|NCT00424515|39348104|FG000|Overall Study|Withdrawal by Subject|1|||
16235991|NCT00424515|39348105|FG001|Overall Study|Withdrawal by Subject|0|||
16235992|NCT00810615|39348106|FG000|Overall Study|Withdrawal by Subject|1|||
16235993|NCT00810615|39348107|FG001|Overall Study|Withdrawal by Subject|1|||
16235994|NCT01466673|39348108|FG000|Overall Study|Non-compliance with study treatment|2|||
16235995|NCT01466673|39348109|FG001|Overall Study|Non-compliance with study treatment|0|||
16235996|NCT01466673|39348108|FG000|Overall Study|Lost to Follow-up|3|||
16235997|NCT01466673|39348109|FG001|Overall Study|Lost to Follow-up|5|||
16235998|NCT01466673|39348108|FG000|Overall Study|Adverse Event|2|||
16235999|NCT01466673|39348109|FG001|Overall Study|Adverse Event|1|||
16236000|NCT00742859|39348110|FG000|Overall Study|Adverse Event|5|||
16236001|NCT00742859|39348111|FG001|Overall Study|Adverse Event|6|||
16236002|NCT00742859|39348112|FG002|Overall Study|Adverse Event|3|||
16236003|NCT00742859|39348113|FG003|Overall Study|Adverse Event|1|||
16236004|NCT00742859|39348110|FG000|Overall Study|Death|1|||
16236005|NCT00742859|39348111|FG001|Overall Study|Death|0|||
16349320|NCT02326272|39765653|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
16349321|NCT02326272|39765654|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16349322|NCT02326272|39765655|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16349323|NCT02326272|39765656|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16554640|NCT04022889|40496247|FG002|Stage 1: Period 1|Adverse Event|0|||
16554641|NCT04022889|40496245|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
16554642|NCT04022889|40496246|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
16554643|NCT04022889|40496247|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
16554644|NCT04022889|40496245|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
16554645|NCT04022889|40496246|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
16554646|NCT04022889|40496247|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
16554647|NCT04022889|40496245|FG000|Stage 2|Screen Failure|0|||
16554648|NCT04022889|40496246|FG001|Stage 2|Screen Failure|0|||
16554649|NCT04022889|40496247|FG002|Stage 2|Screen Failure|3|||
16554650|NCT04022889|40496245|FG000|Stage 2|Ineligible for apheresis donation|0|||
16554651|NCT04022889|40496246|FG001|Stage 2|Ineligible for apheresis donation|0|||
16554652|NCT04022889|40496247|FG002|Stage 2|Ineligible for apheresis donation|2|||
16554653|NCT04022889|40496245|FG000|Stage 2|Adverse Event|0|||
16554654|NCT04022889|40496246|FG001|Stage 2|Adverse Event|0|||
16236006|NCT00742859|39348112|FG002|Overall Study|Death|0|||
16236007|NCT00742859|39348113|FG003|Overall Study|Death|1|||
16236008|NCT00742859|39348110|FG000|Overall Study|Physician Decision|1|||
16236009|NCT00742859|39348111|FG001|Overall Study|Physician Decision|2|||
16236010|NCT00742859|39348112|FG002|Overall Study|Physician Decision|0|||
16236011|NCT00742859|39348113|FG003|Overall Study|Physician Decision|0|||
16236012|NCT00742859|39348110|FG000|Overall Study|Withdrawal by Subject|4|||
16236013|NCT00742859|39348111|FG001|Overall Study|Withdrawal by Subject|2|||
16236014|NCT00742859|39348112|FG002|Overall Study|Withdrawal by Subject|4|||
16236015|NCT00742859|39348113|FG003|Overall Study|Withdrawal by Subject|1|||
16236016|NCT00742859|39348110|FG000|Overall Study|Endpoint|0|||
16236017|NCT00742859|39348111|FG001|Overall Study|Endpoint|1|||
16236018|NCT00742859|39348112|FG002|Overall Study|Endpoint|1|||
16236019|NCT00742859|39348113|FG003|Overall Study|Endpoint|2|||
16236020|NCT00742859|39348110|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
16236021|NCT00742859|39348111|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
16236022|NCT00742859|39348112|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
16236023|NCT00742859|39348113|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
16236024|NCT00742859|39348110|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
16236025|NCT00742859|39348111|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
16236026|NCT00742859|39348112|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
16236027|NCT00742859|39348113|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
16236028|NCT00742859|39348110|FG000|Overall Study|Sponsor request patient out of town|0|||
16236029|NCT00742859|39348111|FG001|Overall Study|Sponsor request patient out of town|0|||
16236030|NCT00742859|39348112|FG002|Overall Study|Sponsor request patient out of town|1|||
16236031|NCT00742859|39348113|FG003|Overall Study|Sponsor request patient out of town|1|||
16236032|NCT00742859|39348110|FG000|Overall Study|Site error|0|||
16236033|NCT00742859|39348111|FG001|Overall Study|Site error|0|||
16236034|NCT00742859|39348112|FG002|Overall Study|Site error|1|||
16236035|NCT00742859|39348113|FG003|Overall Study|Site error|1|||
16236036|NCT03862807|39348115|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
16236037|NCT01977482|39348116|FG000|Overall Study|Adverse Event|0|||
16236038|NCT01977482|39348117|FG001|Overall Study|Adverse Event|1|||
16236039|NCT01977482|39348118|FG002|Overall Study|Adverse Event|1|||
16236040|NCT01977482|39348119|FG003|Overall Study|Adverse Event|0|||
16236041|NCT01977482|39348120|FG004|Overall Study|Adverse Event|2|||
16236042|NCT01977482|39348121|FG005|Overall Study|Adverse Event|0|||
16236043|NCT01977482|39348116|FG000|Overall Study|Lost to Follow-up|1|||
16236044|NCT01977482|39348117|FG001|Overall Study|Lost to Follow-up|0|||
16236045|NCT01977482|39348118|FG002|Overall Study|Lost to Follow-up|0|||
16236046|NCT01977482|39348119|FG003|Overall Study|Lost to Follow-up|0|||
16236047|NCT01977482|39348120|FG004|Overall Study|Lost to Follow-up|0|||
16236048|NCT01977482|39348121|FG005|Overall Study|Lost to Follow-up|0|||
16236049|NCT01977482|39348116|FG000|Overall Study|Physician Decision|0|||
16236050|NCT01977482|39348117|FG001|Overall Study|Physician Decision|1|||
16236051|NCT01977482|39348118|FG002|Overall Study|Physician Decision|0|||
16236052|NCT01977482|39348119|FG003|Overall Study|Physician Decision|0|||
16236053|NCT01977482|39348120|FG004|Overall Study|Physician Decision|0|||
16236054|NCT01977482|39348121|FG005|Overall Study|Physician Decision|0|||
16236055|NCT01977482|39348116|FG000|Overall Study|Protocol Violation|0|||
16236056|NCT01977482|39348117|FG001|Overall Study|Protocol Violation|0|||
16236057|NCT01977482|39348118|FG002|Overall Study|Protocol Violation|1|||
16236058|NCT01977482|39348119|FG003|Overall Study|Protocol Violation|0|||
16236059|NCT01977482|39348120|FG004|Overall Study|Protocol Violation|0|||
16236060|NCT01977482|39348121|FG005|Overall Study|Protocol Violation|0|||
16236061|NCT01977482|39348116|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
16236062|NCT01977482|39348117|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
16236063|NCT01977482|39348118|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
16236064|NCT01977482|39348119|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
16236065|NCT01977482|39348120|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
16236066|NCT01977482|39348121|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
16236067|NCT01977482|39348116|FG000|Overall Study|Withdrawal by Subject|2|||
16236068|NCT01977482|39348117|FG001|Overall Study|Withdrawal by Subject|4|||
16236069|NCT01977482|39348118|FG002|Overall Study|Withdrawal by Subject|1|||
16236070|NCT01977482|39348119|FG003|Overall Study|Withdrawal by Subject|3|||
16236071|NCT01977482|39348120|FG004|Overall Study|Withdrawal by Subject|1|||
16236072|NCT01977482|39348121|FG005|Overall Study|Withdrawal by Subject|5|||
16236073|NCT00981409|39348122|FG000|Overall Study|Adverse Event|4|||
16236074|NCT00981409|39348123|FG001|Overall Study|Adverse Event|0|||
16236075|NCT00981409|39348122|FG000|Overall Study|Protocol Violation|0|||
16236076|NCT00981409|39348123|FG001|Overall Study|Protocol Violation|1|||
16236077|NCT00981409|39348122|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
16236078|NCT00981409|39348123|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
16236079|NCT00792948|39348126|FG000|Overall Study|Adverse Event|6|||
16236080|NCT00792948|39348126|FG000|Overall Study|Death|4|||
16236081|NCT00792948|39348126|FG000|Overall Study|Withdrawal by Subject|3|||
16236082|NCT00792948|39348126|FG000|Overall Study|Ineligible|2|||
16236083|NCT00792948|39348126|FG000|Overall Study|Insurance denial - not treated|1|||
16236084|NCT00792948|39348126|FG000|Overall Study|Physician Decision|11|||
16236085|NCT00792948|39348126|FG000|Overall Study|Protocol Violation|1|||
16236086|NCT00798707|39348129|FG000|Overall Study|Adverse Event|6|||
16236087|NCT00798707|39348130|FG001|Overall Study|Adverse Event|8|||
16236088|NCT00798707|39348131|FG002|Overall Study|Adverse Event|8|||
16236089|NCT00798707|39348129|FG000|Overall Study|Failed to return|2|||
16236090|NCT00798707|39348130|FG001|Overall Study|Failed to return|2|||
16236091|NCT00798707|39348131|FG002|Overall Study|Failed to return|0|||
16236092|NCT00798707|39348129|FG000|Overall Study|Investigator|0|||
16236093|NCT00798707|39348130|FG001|Overall Study|Investigator|1|||
16236094|NCT00798707|39348131|FG002|Overall Study|Investigator|2|||
16236095|NCT00798707|39348129|FG000|Overall Study|Lack of Efficacy|2|||
16236096|NCT00798707|39348130|FG001|Overall Study|Lack of Efficacy|2|||
16236097|NCT00798707|39348131|FG002|Overall Study|Lack of Efficacy|1|||
16236098|NCT00798707|39348129|FG000|Overall Study|Lost to Follow-up|5|||
16236099|NCT00798707|39348130|FG001|Overall Study|Lost to Follow-up|6|||
16236100|NCT00798707|39348131|FG002|Overall Study|Lost to Follow-up|6|||
16236101|NCT00798707|39348129|FG000|Overall Study|Other|0|||
16236102|NCT00798707|39348130|FG001|Overall Study|Other|1|||
16236103|NCT00798707|39348131|FG002|Overall Study|Other|0|||
16236104|NCT00798707|39348129|FG000|Overall Study|Protocol Violation|4|||
16236105|NCT00798707|39348130|FG001|Overall Study|Protocol Violation|0|||
16236106|NCT00798707|39348131|FG002|Overall Study|Protocol Violation|2|||
16236107|NCT00798707|39348129|FG000|Overall Study|Withdrawal by Subject|3|||
16236108|NCT00798707|39348130|FG001|Overall Study|Withdrawal by Subject|8|||
16236109|NCT00798707|39348131|FG002|Overall Study|Withdrawal by Subject|2|||
16236110|NCT00798707|39348129|FG000|Overall Study|Randomized not treated|4|||
16236111|NCT00798707|39348130|FG001|Overall Study|Randomized not treated|5|||
16236112|NCT00798707|39348131|FG002|Overall Study|Randomized not treated|1|||
16236113|NCT01523301|39348137|FG000|Overall Study|Adverse Event|25|||
16236114|NCT01523301|39348138|FG001|Overall Study|Adverse Event|16|||
16236115|NCT01523301|39348137|FG000|Overall Study|Lack of Efficacy|0|||
16236116|NCT01523301|39348138|FG001|Overall Study|Lack of Efficacy|2|||
16236117|NCT01523301|39348137|FG000|Overall Study|Protocol Violation|3|||
16236118|NCT01523301|39348138|FG001|Overall Study|Protocol Violation|4|||
16236119|NCT01523301|39348137|FG000|Overall Study|Lost to Follow-up|1|||
16236120|NCT01523301|39348138|FG001|Overall Study|Lost to Follow-up|0|||
16236121|NCT01523301|39348137|FG000|Overall Study|Withdrawal by Subject|6|||
16236122|NCT01523301|39348138|FG001|Overall Study|Withdrawal by Subject|8|||
16236123|NCT01523301|39348137|FG000|Overall Study|Other Reason|0|||
16236124|NCT01523301|39348138|FG001|Overall Study|Other Reason|2|||
16236125|NCT00518531|39348145|FG000|Treatment Period 1|Adverse Event|5|||
16236126|NCT00518531|39348146|FG001|Treatment Period 1|Adverse Event|0|||
16236127|NCT00518531|39348145|FG000|Treatment Period 1|Lost to Follow-up|5|||
16236128|NCT00518531|39348146|FG001|Treatment Period 1|Lost to Follow-up|3|||
16236129|NCT00518531|39348145|FG000|Treatment Period 1|Physician Decision|1|||
16236130|NCT00518531|39348146|FG001|Treatment Period 1|Physician Decision|0|||
16236131|NCT00518531|39348145|FG000|Treatment Period 1|Protocol Violation|2|||
16236132|NCT00518531|39348146|FG001|Treatment Period 1|Protocol Violation|0|||
16236133|NCT00518531|39348145|FG000|Treatment Period 1|Withdrawal by Subject|4|||
16236134|NCT00518531|39348146|FG001|Treatment Period 1|Withdrawal by Subject|6|||
16236135|NCT00518531|39348145|FG000|Treatment Period 1|Early crossover|1|||
16236136|NCT00518531|39348146|FG001|Treatment Period 1|Early crossover|3|||
16349324|NCT02326272|39765657|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16349325|NCT02326272|39765658|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16349326|NCT02326272|39765659|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
16349327|NCT02326272|39765645|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16349328|NCT02326272|39765646|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16349329|NCT02326272|39765647|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16349330|NCT02326272|39765648|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16413718|NCT00343382|39995251|FG001|Overall Study|Other Reason Not Specified|2|||
16413719|NCT00343382|39995252|FG002|Overall Study|Other Reason Not Specified|4|||
16413720|NCT00689793|39995254|FG000|Overall Study|Lost to Follow-up|4|||
16554655|NCT04022889|40496247|FG002|Stage 2|Adverse Event|2|||
16554656|NCT04022889|40496245|FG000|Stage 2|Protocol Violation|0|||
16554657|NCT04022889|40496246|FG001|Stage 2|Protocol Violation|0|||
16554658|NCT04022889|40496247|FG002|Stage 2|Protocol Violation|1|||
16554659|NCT04022889|40496245|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
16554660|NCT04022889|40496246|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
16554661|NCT04022889|40496247|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
16554662|NCT01868074|40496250|FG000|Overall Study|Lost to Follow-up|3|||
16554663|NCT01868074|40496251|FG001|Overall Study|Lost to Follow-up|2|||
16554664|NCT01868074|40496250|FG000|Overall Study|Withdrawal by Subject|4|||
16236137|NCT00518531|39348145|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16236138|NCT00518531|39348146|FG001|Treatment Period 2|Withdrawal by Subject|8|||
16236139|NCT00518531|39348145|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
16236140|NCT00518531|39348146|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
16236141|NCT00518531|39348145|FG000|Treatment Period 2|Adverse Event|1|||
16236142|NCT00518531|39348146|FG001|Treatment Period 2|Adverse Event|7|||
16236143|NCT00518531|39348145|FG000|Treatment Period 2|Protocol-specified criteria|0|||
16236144|NCT00518531|39348146|FG001|Treatment Period 2|Protocol-specified criteria|1|||
16554665|NCT01868074|40496251|FG001|Overall Study|Withdrawal by Subject|2|||
16554666|NCT04668989|40496255|FG000|First Intervention|Covid-19 related self-isolation|0|||
16554667|NCT04668989|40496256|FG001|First Intervention|Covid-19 related self-isolation|1|||
16554668|NCT04668989|40496255|FG000|Second Intervention|Adverse Event|0|||
16554669|NCT04668989|40496256|FG001|Second Intervention|Adverse Event|1|||
16554670|NCT01231503|40496257|FG000|Overall Study|Adverse Event|0|||
16554671|NCT01231503|40496258|FG001|Overall Study|Adverse Event|0|||
16554672|NCT01231503|40496259|FG002|Overall Study|Adverse Event|0|||
16554673|NCT01231503|40496260|FG003|Overall Study|Adverse Event|0|||
16554674|NCT01231503|40496261|FG004|Overall Study|Adverse Event|0|||
16554675|NCT01231503|40496262|FG005|Overall Study|Adverse Event|1|||
16554676|NCT01231503|40496263|FG006|Overall Study|Adverse Event|0|||
16554677|NCT01231503|40496264|FG007|Overall Study|Adverse Event|0|||
16554678|NCT01231503|40496257|FG000|Overall Study|Adverse event, serious fatal|0|||
16554679|NCT01231503|40496258|FG001|Overall Study|Adverse event, serious fatal|0|||
16554680|NCT01231503|40496259|FG002|Overall Study|Adverse event, serious fatal|1|||
16554681|NCT01231503|40496260|FG003|Overall Study|Adverse event, serious fatal|1|||
16236145|NCT00518531|39348145|FG000|Treatment Period 2|Non-compliance|1|||
16236146|NCT00518531|39348146|FG001|Treatment Period 2|Non-compliance|2|||
16236147|NCT00826176|39348147|FG000|Overall Study|Lost to Follow-up|1|||
16236148|NCT00826176|39348148|FG001|Overall Study|Lost to Follow-up|0|||
16236149|NCT00826176|39348147|FG000|Overall Study|Subject Withdrew Consent|3|||
16236150|NCT00826176|39348148|FG001|Overall Study|Subject Withdrew Consent|0|||
16236151|NCT00826176|39348147|FG000|Overall Study|Administrative|9|||
16236152|NCT00826176|39348148|FG001|Overall Study|Administrative|0|||
16236153|NCT02426125|39348149|FG000|Overall Study|Lost to Follow-up|14|||
16236154|NCT02426125|39348150|FG001|Overall Study|Lost to Follow-up|12|||
16236155|NCT02426125|39348149|FG000|Overall Study|Withdrawal by Subject|13|||
16236156|NCT02426125|39348150|FG001|Overall Study|Withdrawal by Subject|14|||
16236157|NCT02426125|39348149|FG000|Overall Study|Death|185|||
16236158|NCT02426125|39348150|FG001|Overall Study|Death|200|||
16236159|NCT02426125|39348149|FG000|Overall Study|Randomized, But Never Treated|5|||
16236160|NCT02426125|39348150|FG001|Overall Study|Randomized, But Never Treated|2|||
16236161|NCT02989610|39348151|FG000|Overall Study|Withdrawal by Subject|20|||
16236162|NCT02989610|39348151|FG000|Overall Study|Departure of PI from Site|8|||
16236163|NCT02989610|39348151|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
16236164|NCT02989610|39348151|FG000|Overall Study|Lost to Follow-up|3|||
16236165|NCT02989610|39348151|FG000|Overall Study|Death|3|||
16236166|NCT02989610|39348151|FG000|Overall Study|System Explant|3|||
16236167|NCT02989610|39348151|FG000|Overall Study|Subject Non-Compliance|2|||
16236168|NCT02989610|39348151|FG000|Overall Study|System Revision|2|||
16236169|NCT02989610|39348151|FG000|Overall Study|PI Left, Study Closing|1|||
16236170|NCT02989610|39348151|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
16236171|NCT02989610|39348151|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
16236172|NCT04359758|39348154|FG000|Overall Study|Protocol Violation|3|||
16236173|NCT04359758|39348155|FG001|Overall Study|Protocol Violation|2|||
16236174|NCT00903409|39348156|FG000|Overall Study|Adverse Event|11|||
16236175|NCT00903409|39348157|FG001|Overall Study|Adverse Event|9|||
16121337|NCT01465763|38930157|FG002|Overall Study|Death|0|||
16121338|NCT00734591|38930166|FG000|Screening for Prospective Period|Site did not participate|1604|||
16121339|NCT00734591|38930167|FG001|Screening for Prospective Period|Site did not participate|1488|||
16121340|NCT00734591|38930166|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
16121341|NCT00734591|38930167|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
16121342|NCT00734591|38930166|FG000|Prospective Period|Withdrawal by Subject|11|||
16121343|NCT00734591|38930167|FG001|Prospective Period|Withdrawal by Subject|9|||
16121344|NCT00734591|38930166|FG000|Prospective Period|Lost to Follow-up|37|||
16121345|NCT00734591|38930167|FG001|Prospective Period|Lost to Follow-up|33|||
16236176|NCT00903409|39348156|FG000|Overall Study|Non-compliance with Protocol|1|||
16236177|NCT00903409|39348157|FG001|Overall Study|Non-compliance with Protocol|1|||
16236178|NCT00903409|39348156|FG000|Overall Study|Laboratory Abnormality|2|||
16236179|NCT00903409|39348157|FG001|Overall Study|Laboratory Abnormality|0|||
16554682|NCT01231503|40496261|FG004|Overall Study|Adverse event, serious fatal|0|||
16121346|NCT00734591|38930166|FG000|Prospective Period|Study Terminated|1|||
16236180|NCT00903409|39348156|FG000|Overall Study|Withdrawal by Subject|8|||
16236181|NCT00903409|39348157|FG001|Overall Study|Withdrawal by Subject|8|||
16236182|NCT00903409|39348156|FG000|Overall Study|Other|2|||
16236183|NCT00903409|39348157|FG001|Overall Study|Other|3|||
16236184|NCT00903409|39348156|FG000|Overall Study|Lost to Follow-up|2|||
16236185|NCT00903409|39348157|FG001|Overall Study|Lost to Follow-up|6|||
16236186|NCT01306968|39348160|FG000|Overall Study|Lost to Follow-up|1|||
16236187|NCT01306968|39348161|FG001|Overall Study|Lost to Follow-up|1|||
16236188|NCT01306968|39348162|FG002|Overall Study|Lost to Follow-up|0|||
16236189|NCT01306968|39348163|FG003|Overall Study|Lost to Follow-up|0|||
16236190|NCT01306968|39348160|FG000|Overall Study|Physician Decision|0|||
16236191|NCT01306968|39348161|FG001|Overall Study|Physician Decision|1|||
16236192|NCT01306968|39348162|FG002|Overall Study|Physician Decision|0|||
16236193|NCT01306968|39348163|FG003|Overall Study|Physician Decision|0|||
16236194|NCT01306968|39348160|FG000|Overall Study|Relocated and left active duty|0|||
16236195|NCT01306968|39348161|FG001|Overall Study|Relocated and left active duty|1|||
16236196|NCT01306968|39348162|FG002|Overall Study|Relocated and left active duty|1|||
16236197|NCT01306968|39348163|FG003|Overall Study|Relocated and left active duty|1|||
16236198|NCT01306968|39348160|FG000|Overall Study|Withdrew - time commitment|0|||
16236199|NCT01306968|39348161|FG001|Overall Study|Withdrew - time commitment|0|||
16236200|NCT01306968|39348162|FG002|Overall Study|Withdrew - time commitment|0|||
16236201|NCT01306968|39348163|FG003|Overall Study|Withdrew - time commitment|2|||
16236202|NCT01306968|39348160|FG000|Overall Study|Withdrew over privacy concerns|0|||
16413721|NCT00689793|39995255|FG001|Overall Study|Lost to Follow-up|5|||
16413722|NCT00129467|39995256|FG000|Received Intervention|Death|1|||
16413723|NCT00129467|39995257|FG001|Received Intervention|Death|1|||
16413724|NCT00129467|39995256|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
16413725|NCT00129467|39995257|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
16413726|NCT00129467|39995256|FG000|Received Intervention|Delirium|2|||
16413727|NCT00129467|39995257|FG001|Received Intervention|Delirium|0|||
16413728|NCT00129467|39995256|FG000|Received Intervention|Withdrawal by Subject|1|||
16413729|NCT00129467|39995257|FG001|Received Intervention|Withdrawal by Subject|0|||
16413730|NCT00129467|39995256|FG000|Received Intervention|Nausea|1|||
16236203|NCT01306968|39348161|FG001|Overall Study|Withdrew over privacy concerns|0|||
16236204|NCT01306968|39348162|FG002|Overall Study|Withdrew over privacy concerns|0|||
16236205|NCT01306968|39348163|FG003|Overall Study|Withdrew over privacy concerns|1|||
16236206|NCT03252015|39348164|FG000|Overall Study|Withdrawal by Subject|0|||
16236207|NCT03252015|39348165|FG001|Overall Study|Withdrawal by Subject|1|||
16236208|NCT03252015|39348166|FG002|Overall Study|Withdrawal by Subject|1|||
16236209|NCT03252015|39348167|FG003|Overall Study|Withdrawal by Subject|0|||
16236210|NCT03252015|39348164|FG000|Overall Study|Adverse Event|1|||
16236211|NCT03252015|39348165|FG001|Overall Study|Adverse Event|0|||
16236212|NCT03252015|39348166|FG002|Overall Study|Adverse Event|0|||
16236213|NCT03252015|39348167|FG003|Overall Study|Adverse Event|1|||
16236214|NCT02545868|39348169|FG000|Overall Study|Lack of Efficacy|1|||
16236215|NCT02545868|39348170|FG001|Overall Study|Lack of Efficacy|1|||
16236216|NCT02545868|39348171|FG002|Overall Study|Lack of Efficacy|0|||
16236217|NCT02545868|39348169|FG000|Overall Study|Lost to Follow-up|1|||
16413731|NCT00129467|39995257|FG001|Received Intervention|Nausea|0|||
16236218|NCT02545868|39348170|FG001|Overall Study|Lost to Follow-up|5|||
16236219|NCT02545868|39348171|FG002|Overall Study|Lost to Follow-up|1|||
16236220|NCT02545868|39348169|FG000|Overall Study|Non-compliance|1|||
16236221|NCT02545868|39348170|FG001|Overall Study|Non-compliance|1|||
16236222|NCT02545868|39348171|FG002|Overall Study|Non-compliance|1|||
16236223|NCT02545868|39348169|FG000|Overall Study|Treatment change|21|||
16236224|NCT02545868|39348170|FG001|Overall Study|Treatment change|19|||
16236225|NCT02545868|39348171|FG002|Overall Study|Treatment change|22|||
16236226|NCT02545868|39348169|FG000|Overall Study|Physician Decision|1|||
16236227|NCT02545868|39348170|FG001|Overall Study|Physician Decision|1|||
16236228|NCT02545868|39348171|FG002|Overall Study|Physician Decision|1|||
16236229|NCT02545868|39348169|FG000|Overall Study|Withdrawal by Subject|6|||
16236230|NCT02545868|39348170|FG001|Overall Study|Withdrawal by Subject|7|||
16236231|NCT02545868|39348171|FG002|Overall Study|Withdrawal by Subject|9|||
16236232|NCT00996918|39348176|FG000|Overall Study|Lack of Efficacy|1|||
16236233|NCT00996918|39348177|FG001|Overall Study|Lack of Efficacy|1|||
16236234|NCT00996918|39348178|FG002|Overall Study|Lack of Efficacy|2|||
16236235|NCT00996918|39348179|FG003|Overall Study|Lack of Efficacy|2|||
16236236|NCT00996918|39348180|FG004|Overall Study|Lack of Efficacy|0|||
16236237|NCT00996918|39348176|FG000|Overall Study|Adverse Event|2|||
16236238|NCT00996918|39348177|FG001|Overall Study|Adverse Event|5|||
16236239|NCT00996918|39348178|FG002|Overall Study|Adverse Event|2|||
16236240|NCT00996918|39348179|FG003|Overall Study|Adverse Event|6|||
16236241|NCT00996918|39348180|FG004|Overall Study|Adverse Event|0|||
16236242|NCT00996918|39348176|FG000|Overall Study|Withdrawal by Subject|1|||
16236243|NCT00996918|39348177|FG001|Overall Study|Withdrawal by Subject|4|||
16236244|NCT00996918|39348178|FG002|Overall Study|Withdrawal by Subject|3|||
16236245|NCT00996918|39348179|FG003|Overall Study|Withdrawal by Subject|3|||
16236246|NCT00996918|39348180|FG004|Overall Study|Withdrawal by Subject|2|||
16236247|NCT00996918|39348176|FG000|Overall Study|Physician Decision|1|||
16236248|NCT00996918|39348177|FG001|Overall Study|Physician Decision|0|||
16236249|NCT00996918|39348178|FG002|Overall Study|Physician Decision|0|||
16236250|NCT00996918|39348179|FG003|Overall Study|Physician Decision|0|||
16236251|NCT00996918|39348180|FG004|Overall Study|Physician Decision|0|||
16236252|NCT00996918|39348176|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
16236253|NCT00996918|39348177|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
16236254|NCT00996918|39348178|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
16236255|NCT00996918|39348179|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
16236256|NCT00996918|39348180|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
16236257|NCT00996918|39348176|FG000|Overall Study|Loss of Caregiver|0|||
16236258|NCT00996918|39348177|FG001|Overall Study|Loss of Caregiver|1|||
16236259|NCT00996918|39348178|FG002|Overall Study|Loss of Caregiver|0|||
16554683|NCT01231503|40496262|FG005|Overall Study|Adverse event, serious fatal|1|||
16554684|NCT01231503|40496263|FG006|Overall Study|Adverse event, serious fatal|0|||
16554685|NCT01231503|40496264|FG007|Overall Study|Adverse event, serious fatal|0|||
16554686|NCT01231503|40496257|FG000|Overall Study|Withdrawal by Subject|6|||
16554687|NCT01231503|40496258|FG001|Overall Study|Withdrawal by Subject|3|||
16236260|NCT00996918|39348179|FG003|Overall Study|Loss of Caregiver|0|||
16236261|NCT00996918|39348180|FG004|Overall Study|Loss of Caregiver|0|||
16236262|NCT00996918|39348176|FG000|Overall Study|Other|3|||
16236263|NCT00996918|39348177|FG001|Overall Study|Other|1|||
16236264|NCT00996918|39348178|FG002|Overall Study|Other|0|||
16236265|NCT00996918|39348179|FG003|Overall Study|Other|0|||
16236266|NCT00996918|39348180|FG004|Overall Study|Other|0|||
16236267|NCT00558831|39348181|FG000|Overall Study|Lost to Follow-up|1|||
16236268|NCT00975884|39348182|FG000|Overall Study|Adverse Event|1|||
16236269|NCT00975884|39348183|FG001|Overall Study|Adverse Event|0|||
16236270|NCT00975884|39348182|FG000|Overall Study|Lost to Follow-up|5|||
16236271|NCT00975884|39348183|FG001|Overall Study|Lost to Follow-up|3|||
16236272|NCT00975884|39348182|FG000|Overall Study|Withdrawal by Subject|9|||
16236273|NCT00975884|39348183|FG001|Overall Study|Withdrawal by Subject|9|||
16236274|NCT00975884|39348182|FG000|Overall Study|Other|1|||
16236275|NCT00975884|39348183|FG001|Overall Study|Other|3|||
16236276|NCT02453282|39348184|FG000|Overall Study|Death|275|||
16236277|NCT02453282|39348185|FG001|Overall Study|Death|277|||
16236278|NCT02453282|39348186|FG002|Overall Study|Death|296|||
16236279|NCT02453282|39348184|FG000|Overall Study|Lost to Follow-up|1|||
16236280|NCT02453282|39348185|FG001|Overall Study|Lost to Follow-up|0|||
16236281|NCT02453282|39348186|FG002|Overall Study|Lost to Follow-up|2|||
16236282|NCT02453282|39348184|FG000|Overall Study|Withdrawal by Subject|12|||
16554688|NCT01231503|40496259|FG002|Overall Study|Withdrawal by Subject|3|||
16554689|NCT01231503|40496260|FG003|Overall Study|Withdrawal by Subject|1|||
16236283|NCT02453282|39348185|FG001|Overall Study|Withdrawal by Subject|10|||
16236284|NCT02453282|39348186|FG002|Overall Study|Withdrawal by Subject|11|||
16236285|NCT02453282|39348184|FG000|Overall Study|Participants ongoing at data cut-off|85|||
16236286|NCT02453282|39348185|FG001|Overall Study|Participants ongoing at data cut-off|84|||
16236287|NCT02453282|39348186|FG002|Overall Study|Participants ongoing at data cut-off|62|||
16236288|NCT02453282|39348184|FG000|Overall Study|Other|1|||
16236289|NCT02453282|39348185|FG001|Overall Study|Other|1|||
16236290|NCT02453282|39348186|FG002|Overall Study|Other|1|||
16236291|NCT01525407|39348187|FG000|Overall Study|Change in recipient treatment plan|2|||
16236292|NCT01525407|39348188|FG001|Overall Study|Change in recipient treatment plan|2|||
16236293|NCT01525407|39348187|FG000|Overall Study|Withdrawal by Subject|0|||
16236294|NCT01525407|39348188|FG001|Overall Study|Withdrawal by Subject|1|||
16236295|NCT01525407|39348187|FG000|Overall Study|Transplant was delayed|0|||
16236296|NCT01525407|39348188|FG001|Overall Study|Transplant was delayed|1|||
16236297|NCT01525407|39348187|FG000|Overall Study|Delay in Transplant|1|||
16236298|NCT01525407|39348188|FG001|Overall Study|Delay in Transplant|0|||
16554690|NCT01231503|40496261|FG004|Overall Study|Withdrawal by Subject|3|||
16554691|NCT01231503|40496262|FG005|Overall Study|Withdrawal by Subject|5|||
16236299|NCT01682512|39348189|FG000|Overall Study|Adverse Event|6|||
16236300|NCT01682512|39348190|FG001|Overall Study|Adverse Event|5|||
16236301|NCT01682512|39348191|FG002|Overall Study|Adverse Event|2|||
16236302|NCT01682512|39348189|FG000|Overall Study|Withdrawal by Subject|2|||
16236303|NCT01682512|39348190|FG001|Overall Study|Withdrawal by Subject|6|||
16236304|NCT01682512|39348191|FG002|Overall Study|Withdrawal by Subject|3|||
16236305|NCT01682512|39348189|FG000|Overall Study|Physician Decision|0|||
16349331|NCT02326272|39765649|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16349332|NCT02326272|39765650|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
16349333|NCT02326272|39765651|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
16349334|NCT02326272|39765652|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
16413732|NCT00129467|39995256|FG000|Received Intervention|Intolerance to citalopram|0|||
16413733|NCT00129467|39995257|FG001|Received Intervention|Intolerance to citalopram|1|||
16413734|NCT00129467|39995256|FG000|Received Intervention|Dizzyness, fatigue|0|||
16413735|NCT00129467|39995257|FG001|Received Intervention|Dizzyness, fatigue|1|||
16349335|NCT02326272|39765653|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
16349336|NCT02326272|39765654|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16349337|NCT02326272|39765655|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16349338|NCT02326272|39765656|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16349339|NCT02326272|39765657|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16413736|NCT00129467|39995256|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
16413737|NCT00129467|39995257|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
16413738|NCT00129467|39995256|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
16413739|NCT00129467|39995257|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
16413740|NCT00576576|39995258|FG000|Overall Study|Lost to Follow-up|6|||
16413741|NCT00576576|39995258|FG000|Overall Study|Protocol Violation|1|||
16413742|NCT00499746|39995263|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
16413743|NCT00499746|39995263|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
16413744|NCT00499746|39995263|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
16413745|NCT00499746|39995263|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
16413746|NCT03135210|39995271|FG000|Overall Study|Death|0|||
16413747|NCT03135210|39995272|FG001|Overall Study|Death|1|||
16413748|NCT00869401|39995276|FG000|Overall Study|Withdrawal by Subject|0|||
16413749|NCT00869401|39995277|FG001|Overall Study|Withdrawal by Subject|0|||
16413750|NCT00869401|39995278|FG002|Overall Study|Withdrawal by Subject|0|||
16413751|NCT00869401|39995279|FG003|Overall Study|Withdrawal by Subject|5|||
16413752|NCT00869401|39995280|FG004|Overall Study|Withdrawal by Subject|3|||
16236306|NCT01682512|39348190|FG001|Overall Study|Physician Decision|2|||
16236307|NCT01682512|39348191|FG002|Overall Study|Physician Decision|0|||
16236308|NCT01682512|39348189|FG000|Overall Study|Study terminated by sponsor|46|||
16236309|NCT01682512|39348190|FG001|Overall Study|Study terminated by sponsor|43|||
16236310|NCT01682512|39348191|FG002|Overall Study|Study terminated by sponsor|0|||
16236311|NCT01682512|39348189|FG000|Overall Study|Lost to Follow-up|3|||
16236312|NCT01682512|39348190|FG001|Overall Study|Lost to Follow-up|0|||
16413753|NCT00440310|39995281|FG000|Overall Study|Lost to Follow-up|4|||
16554692|NCT01231503|40496263|FG006|Overall Study|Withdrawal by Subject|1|||
16554693|NCT01231503|40496264|FG007|Overall Study|Withdrawal by Subject|2|||
16554694|NCT01231503|40496257|FG000|Overall Study|Lost to Follow-up|8|||
16554695|NCT01231503|40496258|FG001|Overall Study|Lost to Follow-up|10|||
16554696|NCT01231503|40496259|FG002|Overall Study|Lost to Follow-up|8|||
16554697|NCT01231503|40496260|FG003|Overall Study|Lost to Follow-up|5|||
16554698|NCT01231503|40496261|FG004|Overall Study|Lost to Follow-up|7|||
16554699|NCT01231503|40496262|FG005|Overall Study|Lost to Follow-up|9|||
16554700|NCT01231503|40496263|FG006|Overall Study|Lost to Follow-up|6|||
16554701|NCT01231503|40496264|FG007|Overall Study|Lost to Follow-up|6|||
16554702|NCT01231503|40496257|FG000|Overall Study|Protocol Violation|0|||
16554703|NCT01231503|40496258|FG001|Overall Study|Protocol Violation|0|||
16554704|NCT01231503|40496259|FG002|Overall Study|Protocol Violation|0|||
16554705|NCT01231503|40496260|FG003|Overall Study|Protocol Violation|1|||
16554706|NCT01231503|40496261|FG004|Overall Study|Protocol Violation|0|||
16554707|NCT01231503|40496262|FG005|Overall Study|Protocol Violation|0|||
16554708|NCT01231503|40496263|FG006|Overall Study|Protocol Violation|0|||
16554709|NCT01231503|40496264|FG007|Overall Study|Protocol Violation|0|||
16554710|NCT03864926|40496265|FG000|Overall Study|Death|0|||
16554711|NCT03864926|40496266|FG001|Overall Study|Death|2|||
16554712|NCT00806624|40496270|FG000|Overall Study|Adverse Event|2|||
16554713|NCT00806624|40496271|FG001|Overall Study|Adverse Event|8|||
16413754|NCT00440310|39995282|FG001|Overall Study|Lost to Follow-up|5|||
16413755|NCT00440310|39995281|FG000|Overall Study|Protocol Violation|0|||
16413756|NCT00440310|39995282|FG001|Overall Study|Protocol Violation|1|||
16236313|NCT01682512|39348191|FG002|Overall Study|Lost to Follow-up|2|||
16236314|NCT01682512|39348189|FG000|Overall Study|Protocol Violation|2|||
16236315|NCT01682512|39348190|FG001|Overall Study|Protocol Violation|3|||
16236316|NCT01682512|39348191|FG002|Overall Study|Protocol Violation|2|||
16236317|NCT01682512|39348189|FG000|Overall Study|Primary lack of efficacy|10|||
16236318|NCT01682512|39348190|FG001|Overall Study|Primary lack of efficacy|7|||
16236319|NCT01682512|39348191|FG002|Overall Study|Primary lack of efficacy|7|||
16236320|NCT01682512|39348189|FG000|Overall Study|Secondary lack of efficacy|1|||
16236321|NCT01682512|39348190|FG001|Overall Study|Secondary lack of efficacy|1|||
16236322|NCT01682512|39348191|FG002|Overall Study|Secondary lack of efficacy|0|||
16236323|NCT01682512|39348189|FG000|Overall Study|Other than stated above|2|||
16236324|NCT01682512|39348190|FG001|Overall Study|Other than stated above|4|||
16236325|NCT01682512|39348191|FG002|Overall Study|Other than stated above|2|||
16236326|NCT00499252|39348196|FG000|Overall Study|Adverse Event|3|||
16236327|NCT00499252|39348196|FG000|Overall Study|Refused further treatment|2|||
16236328|NCT00499252|39348196|FG000|Overall Study|Ineligible|4|||
16236329|NCT00499252|39348196|FG000|Overall Study|<no further label>|3|||
16121347|NCT00734591|38930167|FG001|Prospective Period|Study Terminated|0|||
16121348|NCT00734591|38930166|FG000|Prospective Period|Other|2|||
16121349|NCT00734591|38930167|FG001|Prospective Period|Other|2|||
16121350|NCT02334423|38930172|FG000|Overall Study|Protocol Violation|10|||
16121351|NCT02334423|38930173|FG001|Overall Study|Protocol Violation|3|||
16121352|NCT02574845|38930174|FG000|Overall Study|Consent withdrawn further participation|0|||
16121353|NCT02574845|38930175|FG001|Overall Study|Consent withdrawn further participation|0|||
16121354|NCT02574845|38930176|FG002|Overall Study|Consent withdrawn further participation|0|||
16121355|NCT02574845|38930177|FG003|Overall Study|Consent withdrawn further participation|0|||
16413757|NCT00440310|39995281|FG000|Overall Study|Withdrawal by Subject|15|||
16413758|NCT00440310|39995282|FG001|Overall Study|Withdrawal by Subject|14|||
16413759|NCT00440310|39995281|FG000|Overall Study|No Reply at EOS|7|||
16413760|NCT00440310|39995282|FG001|Overall Study|No Reply at EOS|7|||
16413761|NCT00440310|39995281|FG000|Overall Study|Other|1|||
16413762|NCT00440310|39995282|FG001|Overall Study|Other|0|||
16413763|NCT00440310|39995281|FG000|Overall Study|Status Unknown|1|||
16413764|NCT00440310|39995282|FG001|Overall Study|Status Unknown|3|||
16413765|NCT01565941|39995283|FG000|Overall Study|Withdrawn by parent/guardian|3|||
16413766|NCT01565941|39995284|FG001|Overall Study|Withdrawn by parent/guardian|2|||
16413767|NCT01565941|39995283|FG000|Overall Study|Randomized; did not receive intevention|8|||
16413768|NCT01565941|39995284|FG001|Overall Study|Randomized; did not receive intevention|2|||
16413769|NCT02715726|39995292|FG000|Overall Study|Adverse Event|2|||
16413770|NCT02715726|39995293|FG001|Overall Study|Adverse Event|6|||
16413771|NCT02715726|39995292|FG000|Overall Study|Protocol Violation|1|||
16413772|NCT02715726|39995293|FG001|Overall Study|Protocol Violation|0|||
16413773|NCT02715726|39995292|FG000|Overall Study|Death|2|||
16413774|NCT02715726|39995293|FG001|Overall Study|Death|1|||
16413775|NCT02715726|39995292|FG000|Overall Study|Participant moved|1|||
16413776|NCT02715726|39995293|FG001|Overall Study|Participant moved|3|||
16413777|NCT02715726|39995292|FG000|Overall Study|Other than specified above|11|||
16413778|NCT02715726|39995293|FG001|Overall Study|Other than specified above|15|||
16413779|NCT02715726|39995292|FG000|Overall Study|Randomized but not treated|1|||
16413780|NCT02715726|39995293|FG001|Overall Study|Randomized but not treated|2|||
16413781|NCT03002311|39995294|FG000|Overall Study|Lost to Follow-up|13|||
16413782|NCT03002311|39995295|FG001|Overall Study|Lost to Follow-up|26|||
16413783|NCT03002311|39995294|FG000|Overall Study|Referral provider called to schedule app|3|||
16413784|NCT03002311|39995295|FG001|Overall Study|Referral provider called to schedule app|3|||
16413785|NCT03002311|39995294|FG000|Overall Study|Physician Decision|3|||
16554714|NCT00806624|40496272|FG002|Overall Study|Adverse Event|0|||
16554715|NCT00806624|40496270|FG000|Overall Study|Death|0|||
16554716|NCT00806624|40496271|FG001|Overall Study|Death|1|||
16554717|NCT00806624|40496272|FG002|Overall Study|Death|1|||
16554718|NCT00806624|40496270|FG000|Overall Study|Lost to Follow-up|1|||
16554719|NCT00806624|40496271|FG001|Overall Study|Lost to Follow-up|0|||
16554720|NCT00806624|40496272|FG002|Overall Study|Lost to Follow-up|1|||
16554721|NCT00806624|40496270|FG000|Overall Study|Withdrawal by Subject|6|||
16554722|NCT00806624|40496271|FG001|Overall Study|Withdrawal by Subject|3|||
16554723|NCT00806624|40496272|FG002|Overall Study|Withdrawal by Subject|3|||
16554724|NCT00806624|40496270|FG000|Overall Study|discontinued before start of treatment|0|||
16121356|NCT02574845|38930178|FG004|Overall Study|Consent withdrawn further participation|1|||
16121357|NCT02574845|38930179|FG005|Overall Study|Consent withdrawn further participation|0|||
16121358|NCT02574845|38930174|FG000|Overall Study|Adverse Event|0|||
16121359|NCT02574845|38930175|FG001|Overall Study|Adverse Event|1|||
16121360|NCT02574845|38930176|FG002|Overall Study|Adverse Event|0|||
16121361|NCT02574845|38930177|FG003|Overall Study|Adverse Event|0|||
16121362|NCT02574845|38930178|FG004|Overall Study|Adverse Event|0|||
16121363|NCT02574845|38930179|FG005|Overall Study|Adverse Event|1|||
16121364|NCT03775434|38930180|FG000|Overall Study|Adverse Event|2|||
16121365|NCT03775434|38930180|FG000|Overall Study|Withdrawal by Subject|1|||
16121366|NCT02001064|38930182|FG000|Overall Study|Withdrawal by Subject|2|||
16121367|NCT02001064|38930183|FG001|Overall Study|Withdrawal by Subject|1|||
16121368|NCT03014011|38930186|FG000|First Intervention|Withdrawal by Subject|1|||
16554725|NCT00806624|40496271|FG001|Overall Study|discontinued before start of treatment|0|||
16554726|NCT00806624|40496272|FG002|Overall Study|discontinued before start of treatment|1|||
16554727|NCT02836613|40496273|FG000|Overall Study|Accidental drowning|1|||
16554728|NCT02836613|40496274|FG001|Overall Study|Accidental drowning|0|||
16554729|NCT02836613|40496273|FG000|Overall Study|Lost to Follow-up|0|||
16554730|NCT02836613|40496274|FG001|Overall Study|Lost to Follow-up|1|||
16554731|NCT02836613|40496273|FG000|Overall Study|Withdrawal by Subject|0|||
16554732|NCT02836613|40496274|FG001|Overall Study|Withdrawal by Subject|2|||
16554733|NCT00976703|40496275|FG000|Overall Study|Physician Decision|1|||
16554734|NCT00976703|40496276|FG001|Overall Study|Physician Decision|1|||
16413786|NCT03002311|39995295|FG001|Overall Study|Physician Decision|1|||
16413787|NCT01038713|39995296|FG000|Overall Study|Patient to hospice|1|||
16413788|NCT01038713|39995297|FG001|Overall Study|Patient to hospice|1|||
16413789|NCT01038713|39995298|FG002|Overall Study|Patient to hospice|1|||
16413790|NCT01038713|39995296|FG000|Overall Study|Lost to Follow-up|3|||
16413791|NCT01038713|39995297|FG001|Overall Study|Lost to Follow-up|0|||
16413792|NCT01038713|39995298|FG002|Overall Study|Lost to Follow-up|0|||
16413793|NCT01038713|39995296|FG000|Overall Study|Neuroendocrine Tumor|0|||
16413794|NCT01038713|39995297|FG001|Overall Study|Neuroendocrine Tumor|1|||
16413795|NCT01038713|39995298|FG002|Overall Study|Neuroendocrine Tumor|0|||
16121369|NCT03014011|38930187|FG001|First Intervention|Withdrawal by Subject|0|||
16121370|NCT03014011|38930186|FG000|Washout|Withdrawal by Subject|1|||
16121371|NCT03014011|38930187|FG001|Washout|Withdrawal by Subject|0|||
16121372|NCT00436605|38930188|FG000|Overall Study|Protocol Violation|3|||
16121373|NCT01397422|38930189|FG000|Overall Study|Adverse Event|0|||
16121374|NCT01397422|38930190|FG001|Overall Study|Adverse Event|3|||
16121375|NCT01397422|38930191|FG002|Overall Study|Adverse Event|3|||
16121376|NCT01397422|38930192|FG003|Overall Study|Adverse Event|8|||
16121377|NCT01397422|38930189|FG000|Overall Study|Withdrawal by Subject|1|||
16121378|NCT01397422|38930190|FG001|Overall Study|Withdrawal by Subject|0|||
16121379|NCT01397422|38930191|FG002|Overall Study|Withdrawal by Subject|0|||
16121380|NCT01397422|38930192|FG003|Overall Study|Withdrawal by Subject|0|||
16121381|NCT01397422|38930189|FG000|Overall Study|Increased bradykinesia related to PD|1|||
16121382|NCT01397422|38930190|FG001|Overall Study|Increased bradykinesia related to PD|0|||
16121383|NCT01397422|38930191|FG002|Overall Study|Increased bradykinesia related to PD|0|||
16121384|NCT01397422|38930192|FG003|Overall Study|Increased bradykinesia related to PD|0|||
16121385|NCT02706405|38930193|FG000|Overall Study|Death|3|||
16121386|NCT02706405|38930194|FG001|Overall Study|Death|2|||
16121387|NCT02706405|38930195|FG002|Overall Study|Death|0|||
16121388|NCT02706405|38930196|FG003|Overall Study|Death|1|||
16121389|NCT02706405|38930197|FG004|Overall Study|Death|0|||
16121390|NCT02706405|38930198|FG005|Overall Study|Death|0|||
16121391|NCT02706405|38930199|FG006|Overall Study|Death|3|||
16121392|NCT02706405|38930200|FG007|Overall Study|Death|4|||
16121393|NCT02706405|38930193|FG000|Overall Study|Disease progression|0|||
16349340|NCT02326272|39765658|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16121394|NCT02706405|38930194|FG001|Overall Study|Disease progression|0|||
16121395|NCT02706405|38930195|FG002|Overall Study|Disease progression|0|||
16121396|NCT02706405|38930196|FG003|Overall Study|Disease progression|0|||
16349341|NCT02326272|39765659|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
16349342|NCT02326272|39765645|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349343|NCT02326272|39765646|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349344|NCT02326272|39765647|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349345|NCT02326272|39765648|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349346|NCT02326272|39765649|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349347|NCT02326272|39765650|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
16349348|NCT02326272|39765651|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349349|NCT02326272|39765652|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349350|NCT02326272|39765653|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349351|NCT02326272|39765654|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349352|NCT02326272|39765655|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349353|NCT02326272|39765656|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349354|NCT02326272|39765657|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349355|NCT02326272|39765658|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349356|NCT02326272|39765659|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
16349357|NCT02326272|39765645|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16121397|NCT02706405|38930197|FG004|Overall Study|Disease progression|0|||
16121398|NCT02706405|38930198|FG005|Overall Study|Disease progression|0|||
16121399|NCT02706405|38930199|FG006|Overall Study|Disease progression|0|||
16121400|NCT02706405|38930200|FG007|Overall Study|Disease progression|1|||
16121401|NCT02706405|38930193|FG000|Overall Study|Pt moved to new therapy|0|||
16349358|NCT02326272|39765646|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349359|NCT02326272|39765647|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349360|NCT02326272|39765648|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349361|NCT02326272|39765649|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349362|NCT02326272|39765650|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349363|NCT02326272|39765651|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
16349364|NCT02326272|39765652|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349365|NCT02326272|39765653|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349366|NCT02326272|39765654|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349367|NCT02326272|39765655|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349368|NCT02326272|39765656|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16413796|NCT01038713|39995296|FG000|Overall Study|died from PEP|0|||
16554735|NCT00976703|40496275|FG000|Overall Study|ineligible for study|2|||
16554736|NCT00976703|40496276|FG001|Overall Study|ineligible for study|2|||
16554737|NCT01468922|40496284|FG000|Overall Study|Screening failure|0|||
16554738|NCT01468922|40496285|FG001|Overall Study|Screening failure|0|||
16554739|NCT01468922|40496286|FG002|Overall Study|Screening failure|0|||
16554740|NCT01468922|40496287|FG003|Overall Study|Screening failure|0|||
16121402|NCT02706405|38930194|FG001|Overall Study|Pt moved to new therapy|0|||
16121403|NCT02706405|38930195|FG002|Overall Study|Pt moved to new therapy|0|||
16121404|NCT02706405|38930196|FG003|Overall Study|Pt moved to new therapy|0|||
16121405|NCT02706405|38930197|FG004|Overall Study|Pt moved to new therapy|0|||
16121406|NCT02706405|38930198|FG005|Overall Study|Pt moved to new therapy|1|||
16554741|NCT01468922|40496288|FG004|Overall Study|Screening failure|0|||
16554742|NCT01468922|40496289|FG005|Overall Study|Screening failure|0|||
16121407|NCT02706405|38930199|FG006|Overall Study|Pt moved to new therapy|0|||
16121408|NCT02706405|38930200|FG007|Overall Study|Pt moved to new therapy|1|||
16554743|NCT01468922|40496290|FG006|Overall Study|Screening failure|0|||
16554744|NCT01468922|40496291|FG007|Overall Study|Screening failure|0|||
16121409|NCT02706405|38930193|FG000|Overall Study|Physician Decision|1|||
16121410|NCT02706405|38930194|FG001|Overall Study|Physician Decision|0|||
16121411|NCT02706405|38930195|FG002|Overall Study|Physician Decision|0|||
16349369|NCT02326272|39765657|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349370|NCT02326272|39765658|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349371|NCT02326272|39765659|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
16349372|NCT02326272|39765645|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
16349373|NCT02326272|39765646|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
16349374|NCT02326272|39765647|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
16349375|NCT02326272|39765648|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
16349376|NCT02326272|39765649|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
16349377|NCT02326272|39765650|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
16349378|NCT02326272|39765651|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
16349379|NCT02326272|39765652|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
16349380|NCT02326272|39765653|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
16349381|NCT02326272|39765654|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
16349382|NCT02326272|39765655|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
16349383|NCT02326272|39765656|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
16349384|NCT02326272|39765657|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
16349385|NCT02326272|39765658|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
16349386|NCT02326272|39765659|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
16349387|NCT02326272|39765645|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349388|NCT02326272|39765646|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349389|NCT02326272|39765647|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349390|NCT02326272|39765648|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349391|NCT02326272|39765649|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349392|NCT02326272|39765650|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349393|NCT02326272|39765651|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349394|NCT02326272|39765652|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349395|NCT02326272|39765653|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349396|NCT02326272|39765654|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349397|NCT02326272|39765655|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
16349398|NCT02326272|39765656|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
16349399|NCT02326272|39765657|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
16349400|NCT02326272|39765658|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
16349401|NCT02326272|39765659|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
16349402|NCT02326272|39765645|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16349403|NCT02326272|39765646|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16349404|NCT02326272|39765647|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16349405|NCT02326272|39765648|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16121412|NCT02706405|38930196|FG003|Overall Study|Physician Decision|0|||
16121413|NCT02706405|38930197|FG004|Overall Study|Physician Decision|0|||
16121414|NCT02706405|38930198|FG005|Overall Study|Physician Decision|0|||
16121415|NCT02706405|38930199|FG006|Overall Study|Physician Decision|0|||
16121416|NCT02706405|38930200|FG007|Overall Study|Physician Decision|0|||
16121417|NCT03026075|38930201|FG000|Overall Study|Physician Decision|1|||
16413797|NCT01038713|39995297|FG001|Overall Study|died from PEP|1|||
16121419|NCT01277887|38930203|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
16121420|NCT01277887|38930204|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
16121421|NCT01277887|38930203|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
16121422|NCT01277887|38930204|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
16121423|NCT01277887|38930203|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
16121424|NCT01277887|38930204|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
16121425|NCT01076647|38930212|FG000|Overall Study|Adverse Event|4|||
16121426|NCT01076647|38930213|FG001|Overall Study|Adverse Event|1|||
16121427|NCT01076647|38930212|FG000|Overall Study|Lack of Efficacy|0|||
16121428|NCT01076647|38930213|FG001|Overall Study|Lack of Efficacy|1|||
16121429|NCT01076647|38930212|FG000|Overall Study|Protocol Violation|7|||
16121430|NCT01076647|38930213|FG001|Overall Study|Protocol Violation|9|||
16121431|NCT01076647|38930212|FG000|Overall Study|Withdrawal criteria|2|||
16349406|NCT02326272|39765649|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16349407|NCT02326272|39765650|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16121432|NCT01076647|38930213|FG001|Overall Study|Withdrawal criteria|2|||
16349408|NCT02326272|39765651|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16121433|NCT01076647|38930212|FG000|Overall Study|Unclassified|12|||
16121434|NCT01076647|38930213|FG001|Overall Study|Unclassified|12|||
16554745|NCT01468922|40496292|FG008|Overall Study|Screening failure|1|||
16554746|NCT01468922|40496284|FG000|Overall Study|Per patient choice|1|||
16554747|NCT01468922|40496285|FG001|Overall Study|Per patient choice|0|||
16554748|NCT01468922|40496286|FG002|Overall Study|Per patient choice|0|||
16554749|NCT01468922|40496287|FG003|Overall Study|Per patient choice|0|||
16554750|NCT01468922|40496288|FG004|Overall Study|Per patient choice|0|||
16554751|NCT01468922|40496289|FG005|Overall Study|Per patient choice|0|||
16554752|NCT01468922|40496290|FG006|Overall Study|Per patient choice|0|||
16554753|NCT01468922|40496291|FG007|Overall Study|Per patient choice|0|||
16554754|NCT01468922|40496292|FG008|Overall Study|Per patient choice|0|||
16554755|NCT01468922|40496284|FG000|Overall Study|Switched to alternative treatment|1|||
16554756|NCT01468922|40496285|FG001|Overall Study|Switched to alternative treatment|0|||
16554757|NCT01468922|40496286|FG002|Overall Study|Switched to alternative treatment|0|||
16554758|NCT01468922|40496287|FG003|Overall Study|Switched to alternative treatment|0|||
16554759|NCT01468922|40496288|FG004|Overall Study|Switched to alternative treatment|1|||
16554760|NCT01468922|40496289|FG005|Overall Study|Switched to alternative treatment|0|||
16554761|NCT01468922|40496290|FG006|Overall Study|Switched to alternative treatment|0|||
16236342|NCT02875067|39350877|FG000|Overall Study|Withdrawal by Subject|1|||
16236343|NCT02875067|39350877|FG000|Overall Study|Withdrawal by Termination of Study|5|||
16236344|NCT00720304|39350878|FG000|Overall Study|Withdrawal by Subject|14|||
16236345|NCT00720304|39350879|FG001|Overall Study|Withdrawal by Subject|1|||
16236346|NCT00720304|39350878|FG000|Overall Study|Death|1|||
16236347|NCT00720304|39350879|FG001|Overall Study|Death|0|||
16236348|NCT00720304|39350878|FG000|Overall Study|Physician Decision|5|||
16236349|NCT00720304|39350879|FG001|Overall Study|Physician Decision|2|||
16236350|NCT00720304|39350878|FG000|Overall Study|Adverse Event|3|||
16554762|NCT01468922|40496291|FG007|Overall Study|Switched to alternative treatment|0|||
16554763|NCT01468922|40496292|FG008|Overall Study|Switched to alternative treatment|0|||
16554764|NCT01468922|40496284|FG000|Overall Study|Enrolled on new protocol|0|||
16554765|NCT01468922|40496285|FG001|Overall Study|Enrolled on new protocol|0|||
16554766|NCT01468922|40496286|FG002|Overall Study|Enrolled on new protocol|0|||
16554767|NCT01468922|40496287|FG003|Overall Study|Enrolled on new protocol|0|||
16554768|NCT01468922|40496288|FG004|Overall Study|Enrolled on new protocol|1|||
16554769|NCT01468922|40496289|FG005|Overall Study|Enrolled on new protocol|0|||
16554770|NCT01468922|40496290|FG006|Overall Study|Enrolled on new protocol|0|||
16554771|NCT01468922|40496291|FG007|Overall Study|Enrolled on new protocol|0|||
16554772|NCT01468922|40496292|FG008|Overall Study|Enrolled on new protocol|0|||
16554773|NCT01468922|40496284|FG000|Overall Study|Adverse Event|0|||
16236351|NCT00720304|39350879|FG001|Overall Study|Adverse Event|1|||
16236352|NCT00720304|39350878|FG000|Overall Study|Disease progression|6|||
16236353|NCT00720304|39350879|FG001|Overall Study|Disease progression|1|||
16236354|NCT00865306|39350882|FG000|Controlled Trial|Lost to Follow-up|1|||
16236355|NCT00865306|39350883|FG001|Controlled Trial|Lost to Follow-up|1|||
16236356|NCT00865306|39350882|FG000|Controlled Trial|Difficulty commuting|2|||
16236357|NCT00865306|39350883|FG001|Controlled Trial|Difficulty commuting|0|||
16236358|NCT00865306|39350882|FG000|Controlled Trial|Improved btw baseline and first session|1|||
16236359|NCT00865306|39350883|FG001|Controlled Trial|Improved btw baseline and first session|0|||
16236360|NCT00865306|39350882|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
16236361|NCT00865306|39350883|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
16236362|NCT00865306|39350882|FG000|Controlled Trial|Withdrawal by Subject|0|||
16236363|NCT00865306|39350883|FG001|Controlled Trial|Withdrawal by Subject|1|||
16236364|NCT04651218|39350888|FG000|Overall Study|Withdrawal by Subject|0|||
16236365|NCT04651218|39350889|FG001|Overall Study|Withdrawal by Subject|2|||
16236366|NCT00996632|39350890|FG000|Overall Study|Physician Decision|0|||
16236367|NCT00996632|39350891|FG001|Overall Study|Physician Decision|0|||
16236368|NCT03443973|39350892|FG000|Double-blind Treatment Period|Adverse Event|5|||
16236369|NCT03443973|39350893|FG001|Double-blind Treatment Period|Adverse Event|19|||
16236370|NCT03443973|39350894|FG002|Double-blind Treatment Period|Adverse Event|0|||
16236371|NCT03443973|39350895|FG003|Double-blind Treatment Period|Adverse Event|0|||
16236372|NCT03443973|39350892|FG000|Double-blind Treatment Period|Death|5|||
16236373|NCT03443973|39350893|FG001|Double-blind Treatment Period|Death|7|||
16236374|NCT03443973|39350894|FG002|Double-blind Treatment Period|Death|0|||
16236375|NCT03443973|39350895|FG003|Double-blind Treatment Period|Death|0|||
16236376|NCT03443973|39350892|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
16236377|NCT03443973|39350893|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
16554774|NCT01468922|40496285|FG001|Overall Study|Adverse Event|0|||
16554775|NCT01468922|40496286|FG002|Overall Study|Adverse Event|0|||
16554776|NCT01468922|40496287|FG003|Overall Study|Adverse Event|0|||
16554777|NCT01468922|40496288|FG004|Overall Study|Adverse Event|0|||
16554778|NCT01468922|40496289|FG005|Overall Study|Adverse Event|0|||
16554779|NCT01468922|40496290|FG006|Overall Study|Adverse Event|0|||
16554780|NCT01468922|40496291|FG007|Overall Study|Adverse Event|1|||
16554781|NCT01468922|40496292|FG008|Overall Study|Adverse Event|0|||
16554782|NCT01468922|40496284|FG000|Overall Study|Infection of blood|0|||
16554783|NCT01468922|40496285|FG001|Overall Study|Infection of blood|0|||
16554784|NCT01468922|40496286|FG002|Overall Study|Infection of blood|0|||
16554785|NCT01468922|40496287|FG003|Overall Study|Infection of blood|0|||
16554786|NCT01468922|40496288|FG004|Overall Study|Infection of blood|0|||
16554787|NCT01468922|40496289|FG005|Overall Study|Infection of blood|0|||
16554788|NCT01468922|40496290|FG006|Overall Study|Infection of blood|0|||
16554789|NCT01468922|40496291|FG007|Overall Study|Infection of blood|1|||
16121435|NCT01125046|38930217|FG000|First 6 Months of Treatment|Death|1|||
16121436|NCT01125046|38930217|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
16121437|NCT01125046|38930217|FG000|First 6 Months of Treatment|Non-compliance|1|||
16121438|NCT01125046|38930217|FG000|First 6 Months of Treatment|Surgery|1|||
16121439|NCT01125046|38930217|FG000|First 6 Months of Treatment|Progressive Disease|7|||
16236378|NCT03443973|39350894|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
16236379|NCT03443973|39350895|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
16236380|NCT03443973|39350892|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16236381|NCT03443973|39350893|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
16236382|NCT03443973|39350894|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
16236383|NCT03443973|39350895|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
16236384|NCT03443973|39350892|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
16236385|NCT03443973|39350893|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
16236386|NCT03443973|39350894|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
16236387|NCT03443973|39350895|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
16236388|NCT03443973|39350892|FG000|Double-blind Treatment Period|Physician Decision|5|||
16236389|NCT03443973|39350893|FG001|Double-blind Treatment Period|Physician Decision|6|||
16236390|NCT03443973|39350894|FG002|Double-blind Treatment Period|Physician Decision|0|||
16121440|NCT01125046|38930217|FG000|First 6 Months of Treatment|Adverse Event|2|||
16121441|NCT01125046|38930217|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
16121442|NCT01125046|38930217|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
16236391|NCT03443973|39350895|FG003|Double-blind Treatment Period|Physician Decision|0|||
16236392|NCT03443973|39350892|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
16236393|NCT03443973|39350893|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
16236394|NCT03443973|39350894|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
16236395|NCT03443973|39350895|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
16236396|NCT03443973|39350892|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
16236397|NCT03443973|39350893|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
16236398|NCT03443973|39350894|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16236399|NCT03443973|39350895|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
16236400|NCT03443973|39350892|FG000|Open-label Extension Period|Reason Not Specified|0|||
16236401|NCT03443973|39350893|FG001|Open-label Extension Period|Reason Not Specified|0|||
16236402|NCT03443973|39350894|FG002|Open-label Extension Period|Reason Not Specified|3|||
16236403|NCT03443973|39350895|FG003|Open-label Extension Period|Reason Not Specified|0|||
16236404|NCT03443973|39350892|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
16236405|NCT03443973|39350893|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
16236406|NCT03443973|39350894|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
16236407|NCT03443973|39350895|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
16236408|NCT04057573|39350896|FG000|24-Week Double-Blind Period|Adverse Event|2|||
16236409|NCT04057573|39350897|FG001|24-Week Double-Blind Period|Adverse Event|0|||
16236410|NCT04057573|39350898|FG002|24-Week Double-Blind Period|Adverse Event|0|||
16236411|NCT04057573|39350899|FG003|24-Week Double-Blind Period|Adverse Event|0|||
16413798|NCT01038713|39995298|FG002|Overall Study|died from PEP|0|||
16413799|NCT01038713|39995296|FG000|Overall Study|Autoimmune Pancreatitis|1|||
16554790|NCT01468922|40496292|FG008|Overall Study|Infection of blood|0|||
16236412|NCT04057573|39350896|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
16236413|NCT04057573|39350897|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
16236414|NCT04057573|39350898|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
16236415|NCT04057573|39350899|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
16236416|NCT04057573|39350896|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
16236417|NCT04057573|39350897|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
16236418|NCT04057573|39350898|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
16236419|NCT04057573|39350899|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
16236420|NCT04057573|39350896|FG000|24-Week Double-Blind Period|Physician Decision|1|||
16236421|NCT04057573|39350897|FG001|24-Week Double-Blind Period|Physician Decision|0|||
16236422|NCT04057573|39350898|FG002|24-Week Double-Blind Period|Physician Decision|0|||
16236423|NCT04057573|39350899|FG003|24-Week Double-Blind Period|Physician Decision|0|||
16236424|NCT04057573|39350896|FG000|24-Week Double-Blind Period|Pregnancy|1|||
16236425|NCT04057573|39350897|FG001|24-Week Double-Blind Period|Pregnancy|0|||
16236426|NCT04057573|39350898|FG002|24-Week Double-Blind Period|Pregnancy|0|||
16236427|NCT04057573|39350899|FG003|24-Week Double-Blind Period|Pregnancy|0|||
16236428|NCT04057573|39350896|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
16236429|NCT04057573|39350897|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
16236430|NCT04057573|39350898|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
16236431|NCT04057573|39350899|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
16236432|NCT04057573|39350896|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
16236433|NCT04057573|39350897|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
16236434|NCT04057573|39350898|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
16236435|NCT04057573|39350899|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
16236436|NCT04057573|39350896|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
16236437|NCT04057573|39350897|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
16236438|NCT04057573|39350898|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
16236439|NCT04057573|39350899|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
16236440|NCT04057573|39350896|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
16236441|NCT04057573|39350897|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
16236442|NCT04057573|39350898|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
16236443|NCT04057573|39350899|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
16236444|NCT04057573|39350896|FG000|24-Week Double-Blind Period|Not Treated|1|||
16236445|NCT04057573|39350897|FG001|24-Week Double-Blind Period|Not Treated|0|||
16236446|NCT04057573|39350898|FG002|24-Week Double-Blind Period|Not Treated|0|||
16236447|NCT04057573|39350899|FG003|24-Week Double-Blind Period|Not Treated|0|||
16236448|NCT04057573|39350896|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
16236449|NCT04057573|39350897|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
16236450|NCT04057573|39350898|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
16236451|NCT04057573|39350899|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
16236452|NCT04057573|39350896|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
16236453|NCT04057573|39350897|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
16236454|NCT04057573|39350898|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
16236455|NCT04057573|39350899|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
16236456|NCT04057573|39350896|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
16236457|NCT04057573|39350897|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
16236458|NCT04057573|39350898|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
16236459|NCT04057573|39350899|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
16236460|NCT04057573|39350896|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
16236461|NCT04057573|39350897|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
16349409|NCT02326272|39765652|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16554791|NCT01468922|40496284|FG000|Overall Study|Patient choice - surgery|0|||
16554792|NCT01468922|40496285|FG001|Overall Study|Patient choice - surgery|0|||
16554793|NCT01468922|40496286|FG002|Overall Study|Patient choice - surgery|0|||
16554794|NCT01468922|40496287|FG003|Overall Study|Patient choice - surgery|0|||
16554795|NCT01468922|40496288|FG004|Overall Study|Patient choice - surgery|0|||
16554796|NCT01468922|40496289|FG005|Overall Study|Patient choice - surgery|0|||
16554797|NCT01468922|40496290|FG006|Overall Study|Patient choice - surgery|0|||
16554798|NCT01468922|40496291|FG007|Overall Study|Patient choice - surgery|1|||
16554799|NCT01468922|40496292|FG008|Overall Study|Patient choice - surgery|0|||
16554800|NCT01468922|40496284|FG000|Overall Study|Refused further treatment|0|||
16236462|NCT04057573|39350898|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
16236463|NCT04057573|39350899|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
16236464|NCT04057573|39350896|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
16554801|NCT01468922|40496285|FG001|Overall Study|Refused further treatment|0|||
16236465|NCT04057573|39350897|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
16554802|NCT01468922|40496286|FG002|Overall Study|Refused further treatment|0|||
16236466|NCT04057573|39350898|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
16236467|NCT04057573|39350899|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
16236468|NCT03664024|39350900|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
16236469|NCT03664024|39350900|FG000|Overall Study|Lost to Follow-up|2|||
16236470|NCT03664024|39350900|FG000|Overall Study|Withdrawal by Subject|2|||
16236471|NCT03664024|39350900|FG000|Overall Study|Death|80|||
16236472|NCT04854707|39350901|FG000|Overall Study|Lack of Efficacy|78|||
16236473|NCT04854707|39350902|FG001|Overall Study|Lack of Efficacy|59|||
16236474|NCT04854707|39350903|FG002|Overall Study|Lack of Efficacy|30|||
16236475|NCT02332655|39350906|FG000|Overall Study|Lack of Efficacy|1|||
16236476|NCT03722849|39350907|FG000|Overall Study|Withdrawal by Subject|1|||
16236477|NCT03722849|39350908|FG001|Overall Study|Withdrawal by Subject|1|||
16236478|NCT00447694|39350911|FG000|Overall Study|Adverse Event|2|||
16236479|NCT00447694|39350911|FG000|Overall Study|Abnormal laboratory value|1|||
16236480|NCT00447694|39350911|FG000|Overall Study|Abnormal test procedure result|1|||
16236481|NCT00447694|39350911|FG000|Overall Study|Withdrawal by Subject|2|||
16236482|NCT00963599|39350912|FG000|Overall Study|Adverse Event|2|||
16236483|NCT00963599|39350913|FG001|Overall Study|Adverse Event|0|||
16236484|NCT00963599|39350914|FG002|Overall Study|Adverse Event|1|||
16236485|NCT00963599|39350915|FG003|Overall Study|Adverse Event|2|||
16236486|NCT00963599|39350912|FG000|Overall Study|Lack of Efficacy|0|||
16554803|NCT01468922|40496287|FG003|Overall Study|Refused further treatment|0|||
16554804|NCT01468922|40496288|FG004|Overall Study|Refused further treatment|0|||
16554805|NCT01468922|40496289|FG005|Overall Study|Refused further treatment|0|||
16554806|NCT01468922|40496290|FG006|Overall Study|Refused further treatment|0|||
16554807|NCT01468922|40496291|FG007|Overall Study|Refused further treatment|1|||
16236487|NCT00963599|39350913|FG001|Overall Study|Lack of Efficacy|2|||
16236488|NCT00963599|39350914|FG002|Overall Study|Lack of Efficacy|1|||
16236489|NCT00963599|39350915|FG003|Overall Study|Lack of Efficacy|4|||
16236490|NCT00963599|39350912|FG000|Overall Study|Lost to Follow-up|0|||
16236491|NCT00963599|39350913|FG001|Overall Study|Lost to Follow-up|1|||
16236492|NCT00963599|39350914|FG002|Overall Study|Lost to Follow-up|1|||
16236493|NCT00963599|39350915|FG003|Overall Study|Lost to Follow-up|1|||
16236494|NCT00963599|39350912|FG000|Overall Study|Protocol Violation|2|||
16236495|NCT00963599|39350913|FG001|Overall Study|Protocol Violation|2|||
16236496|NCT00963599|39350914|FG002|Overall Study|Protocol Violation|3|||
16236497|NCT00963599|39350915|FG003|Overall Study|Protocol Violation|4|||
16236498|NCT00963599|39350912|FG000|Overall Study|Withdrawal by Subject|2|||
16236499|NCT00963599|39350913|FG001|Overall Study|Withdrawal by Subject|1|||
16236500|NCT00963599|39350914|FG002|Overall Study|Withdrawal by Subject|3|||
16236501|NCT00963599|39350915|FG003|Overall Study|Withdrawal by Subject|3|||
16236502|NCT01346501|39350918|FG000|Overall Study|Initiated Other Biological Agents|3|||
16236503|NCT01346501|39350919|FG001|Overall Study|Initiated Other Biological Agents|1|||
16236504|NCT01346501|39350918|FG000|Overall Study|Other|8|||
16236505|NCT01346501|39350919|FG001|Overall Study|Other|12|||
16236506|NCT00529802|39350920|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
16236507|NCT00529802|39350920|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
16236508|NCT00529802|39350920|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
16236509|NCT00529802|39350920|FG000|Evaluable for Primary Endpoint|Death|1|||
16236510|NCT00529802|39350920|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
16236511|NCT00529802|39350920|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
16236512|NCT00529802|39350920|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
16236513|NCT00563524|39350921|FG000|Overall Study|Adverse Event|0|||
16236514|NCT00563524|39350922|FG001|Overall Study|Adverse Event|1|||
16236515|NCT00563524|39350923|FG002|Overall Study|Adverse Event|0|||
16236516|NCT00563524|39350924|FG003|Overall Study|Adverse Event|0|||
16236517|NCT00563524|39350925|FG004|Overall Study|Adverse Event|2|||
16236518|NCT00563524|39350926|FG005|Overall Study|Adverse Event|0|||
16236519|NCT00563524|39350921|FG000|Overall Study|Lost to Follow-up|1|||
16236520|NCT00563524|39350922|FG001|Overall Study|Lost to Follow-up|0|||
16236521|NCT00563524|39350923|FG002|Overall Study|Lost to Follow-up|0|||
16236522|NCT00563524|39350924|FG003|Overall Study|Lost to Follow-up|0|||
16554808|NCT01468922|40496292|FG008|Overall Study|Refused further treatment|0|||
16236523|NCT00563524|39350925|FG004|Overall Study|Lost to Follow-up|0|||
16236524|NCT00563524|39350926|FG005|Overall Study|Lost to Follow-up|0|||
16236525|NCT00563524|39350921|FG000|Overall Study|Protocol Violation|0|||
16236526|NCT00563524|39350922|FG001|Overall Study|Protocol Violation|1|||
16236527|NCT00563524|39350923|FG002|Overall Study|Protocol Violation|0|||
16236528|NCT00563524|39350924|FG003|Overall Study|Protocol Violation|0|||
16236529|NCT00563524|39350925|FG004|Overall Study|Protocol Violation|0|||
16236530|NCT00563524|39350926|FG005|Overall Study|Protocol Violation|0|||
16236531|NCT00563524|39350921|FG000|Overall Study|Withdrawal by Subject|1|||
16236532|NCT00563524|39350922|FG001|Overall Study|Withdrawal by Subject|1|||
16236533|NCT00563524|39350923|FG002|Overall Study|Withdrawal by Subject|3|||
16236534|NCT00563524|39350924|FG003|Overall Study|Withdrawal by Subject|0|||
16236535|NCT00563524|39350925|FG004|Overall Study|Withdrawal by Subject|0|||
16554809|NCT00570661|40496293|FG000|Overall Study|Disease worsening|5|||
16349410|NCT02326272|39765653|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16349411|NCT02326272|39765654|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16349412|NCT02326272|39765655|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16349413|NCT02326272|39765656|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16349414|NCT02326272|39765657|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
16236536|NCT00563524|39350926|FG005|Overall Study|Withdrawal by Subject|1|||
16236537|NCT00965263|39350932|FG000|Overall Study|Physician Decision|2|||
16236538|NCT00965263|39350933|FG001|Overall Study|Physician Decision|0|||
16236539|NCT00965263|39350932|FG000|Overall Study|Family emergency|0|||
16236540|NCT00965263|39350933|FG001|Overall Study|Family emergency|1|||
16236541|NCT00965263|39350932|FG000|Overall Study|Protocol Violation|0|||
16236542|NCT00965263|39350933|FG001|Overall Study|Protocol Violation|2|||
16236543|NCT03387735|39350939|FG000|Overall Study|Lost to Follow-up|4|||
16236544|NCT03387735|39350940|FG001|Overall Study|Lost to Follow-up|8|||
16236545|NCT03387735|39350939|FG000|Overall Study|Death|4|||
16236546|NCT03387735|39350940|FG001|Overall Study|Death|8|||
16236547|NCT01988337|39350943|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
16236548|NCT01856686|39350947|FG000|Overall Study|Lost to Follow-up|5|||
16236549|NCT01856686|39350948|FG001|Overall Study|Lost to Follow-up|11|||
16236550|NCT00791154|39350949|FG000|Overall Study|Noncompliance|0|||
16236551|NCT00791154|39350950|FG001|Overall Study|Noncompliance|1|||
16236552|NCT00791154|39350951|FG002|Overall Study|Noncompliance|0|||
16236553|NCT00791154|39350952|FG003|Overall Study|Noncompliance|0|||
16236554|NCT00791154|39350953|FG004|Overall Study|Noncompliance|1|||
16236555|NCT00791154|39350954|FG005|Overall Study|Noncompliance|1|||
16236556|NCT00791154|39350955|FG006|Overall Study|Noncompliance|1|||
16236557|NCT00791154|39350949|FG000|Overall Study|Adverse Event|0|||
16236558|NCT00791154|39350950|FG001|Overall Study|Adverse Event|0|||
16554810|NCT00570661|40496293|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
16236559|NCT00791154|39350951|FG002|Overall Study|Adverse Event|0|||
16236560|NCT00791154|39350952|FG003|Overall Study|Adverse Event|0|||
16236561|NCT00791154|39350953|FG004|Overall Study|Adverse Event|2|||
16236562|NCT00791154|39350954|FG005|Overall Study|Adverse Event|0|||
16236563|NCT00791154|39350955|FG006|Overall Study|Adverse Event|1|||
16236564|NCT00791154|39350949|FG000|Overall Study|Full Consent withdrawn|1|||
16236565|NCT00791154|39350950|FG001|Overall Study|Full Consent withdrawn|3|||
16236566|NCT00791154|39350951|FG002|Overall Study|Full Consent withdrawn|0|||
16236567|NCT00791154|39350952|FG003|Overall Study|Full Consent withdrawn|0|||
16236568|NCT00791154|39350953|FG004|Overall Study|Full Consent withdrawn|1|||
16236569|NCT00791154|39350954|FG005|Overall Study|Full Consent withdrawn|3|||
16236570|NCT00791154|39350955|FG006|Overall Study|Full Consent withdrawn|1|||
16236571|NCT00791154|39350949|FG000|Overall Study|Lost to Follow-up|0|||
16236572|NCT00791154|39350950|FG001|Overall Study|Lost to Follow-up|0|||
16236573|NCT00791154|39350951|FG002|Overall Study|Lost to Follow-up|0|||
16236574|NCT00791154|39350952|FG003|Overall Study|Lost to Follow-up|1|||
16236575|NCT00791154|39350953|FG004|Overall Study|Lost to Follow-up|2|||
16236576|NCT00791154|39350954|FG005|Overall Study|Lost to Follow-up|0|||
16236577|NCT00791154|39350955|FG006|Overall Study|Lost to Follow-up|4|||
16236578|NCT00791154|39350949|FG000|Overall Study|Death|5|||
16236579|NCT00791154|39350950|FG001|Overall Study|Death|4|||
16236580|NCT00791154|39350951|FG002|Overall Study|Death|4|||
16236581|NCT00791154|39350952|FG003|Overall Study|Death|7|||
16236582|NCT00791154|39350953|FG004|Overall Study|Death|54|||
16236583|NCT00791154|39350954|FG005|Overall Study|Death|54|||
16236584|NCT00791154|39350955|FG006|Overall Study|Death|52|||
16236585|NCT00791154|39350949|FG000|Overall Study|Other event|0|||
16236586|NCT00791154|39350950|FG001|Overall Study|Other event|0|||
16236587|NCT00791154|39350951|FG002|Overall Study|Other event|2|||
16236588|NCT00791154|39350952|FG003|Overall Study|Other event|0|||
16236589|NCT00791154|39350953|FG004|Overall Study|Other event|2|||
16236590|NCT00791154|39350954|FG005|Overall Study|Other event|4|||
16236591|NCT00791154|39350955|FG006|Overall Study|Other event|2|||
16236592|NCT01467570|39350957|FG000|Overall Study|Lost to Follow-up|8|||
16349415|NCT02326272|39765658|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16236593|NCT01467570|39350958|FG001|Overall Study|Lost to Follow-up|9|||
16236594|NCT01311505|39350959|FG000|First Intervention Period|Protocol Violation|0|||
16236595|NCT01311505|39350960|FG001|First Intervention Period|Protocol Violation|1|||
16236596|NCT01652872|39350963|FG000|Overall Study|Death|36|||
16236597|NCT01652872|39350964|FG001|Overall Study|Death|39|||
16236598|NCT01652872|39350963|FG000|Overall Study|Lost to Follow-up|28|||
16236599|NCT01652872|39350964|FG001|Overall Study|Lost to Follow-up|23|||
16236600|NCT01652872|39350963|FG000|Overall Study|Decision by sponsor|5|||
16236601|NCT01652872|39350964|FG001|Overall Study|Decision by sponsor|7|||
16236602|NCT01652872|39350963|FG000|Overall Study|Withdrawal by Subject|76|||
16236603|NCT01652872|39350964|FG001|Overall Study|Withdrawal by Subject|84|||
16236604|NCT03264989|39350965|FG000|Overall Study|Lost to Follow-up|1|||
16236605|NCT03264989|39350966|FG001|Overall Study|Lost to Follow-up|0|||
16236606|NCT03264989|39350965|FG000|Overall Study|New Therapy for study Indication|1|||
16349416|NCT02326272|39765659|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
16236607|NCT03264989|39350966|FG001|Overall Study|New Therapy for study Indication|0|||
16236608|NCT03264989|39350965|FG000|Overall Study|Protocol Violation|0|||
16236609|NCT03264989|39350966|FG001|Overall Study|Protocol Violation|1|||
16236610|NCT03264989|39350965|FG000|Overall Study|Patient decision|13|||
16236611|NCT03264989|39350966|FG001|Overall Study|Patient decision|0|||
16236612|NCT03264989|39350965|FG000|Overall Study|Physician Decision|6|||
16236613|NCT03264989|39350966|FG001|Overall Study|Physician Decision|4|||
16236614|NCT03264989|39350965|FG000|Overall Study|Adverse Event|2|||
16236615|NCT03264989|39350966|FG001|Overall Study|Adverse Event|1|||
16236616|NCT03264989|39350965|FG000|Overall Study|Death|1|||
16236617|NCT03264989|39350966|FG001|Overall Study|Death|1|||
16236618|NCT03264989|39350965|FG000|Overall Study|Pregnancy|2|||
16236619|NCT03264989|39350966|FG001|Overall Study|Pregnancy|0|||
16236620|NCT03264989|39350965|FG000|Overall Study|End of Study|19|||
16236621|NCT03264989|39350966|FG001|Overall Study|End of Study|5|||
16236622|NCT01010230|39350967|FG000|Overall Study|Withdrawal by Subject|6|||
16236623|NCT01010230|39350968|FG001|Overall Study|Withdrawal by Subject|5|||
16349417|NCT02326272|39765645|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349418|NCT02326272|39765646|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349419|NCT02326272|39765647|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349420|NCT02326272|39765648|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16121443|NCT01125046|38930217|FG000|Follow-up/Data Cut Off Point|Death|29|||
16236624|NCT01010230|39350967|FG000|Overall Study|Lost to Follow-up|4|||
16236625|NCT01010230|39350968|FG001|Overall Study|Lost to Follow-up|2|||
16349421|NCT02326272|39765649|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349422|NCT02326272|39765650|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349423|NCT02326272|39765651|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349424|NCT02326272|39765652|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16236626|NCT01875991|39350971|FG000|Overall Study|Withdrawal by Subject|6|||
16236627|NCT01875991|39350972|FG001|Overall Study|Withdrawal by Subject|6|||
16236628|NCT01875991|39350971|FG000|Overall Study|Sponsor Decision|1|||
16236629|NCT01875991|39350972|FG001|Overall Study|Sponsor Decision|0|||
16349425|NCT02326272|39765653|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349426|NCT02326272|39765654|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349427|NCT02326272|39765655|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349428|NCT02326272|39765656|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
16349429|NCT02326272|39765657|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349430|NCT02326272|39765658|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349431|NCT02326272|39765659|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
16349432|NCT02326272|39765645|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349433|NCT02326272|39765646|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349434|NCT02326272|39765647|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349435|NCT02326272|39765648|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349436|NCT02326272|39765649|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349437|NCT02326272|39765650|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349438|NCT02326272|39765651|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349439|NCT02326272|39765652|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349440|NCT02326272|39765653|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349441|NCT02326272|39765654|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349442|NCT02326272|39765655|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
16349443|NCT02326272|39765656|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349444|NCT02326272|39765657|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
16349445|NCT02326272|39765658|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
16349446|NCT02326272|39765659|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
16349447|NCT02326272|39765645|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349448|NCT02326272|39765646|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349449|NCT02326272|39765647|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349450|NCT02326272|39765648|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349451|NCT02326272|39765649|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349452|NCT02326272|39765650|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349453|NCT02326272|39765651|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349454|NCT02326272|39765652|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349455|NCT02326272|39765653|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349456|NCT02326272|39765654|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349457|NCT02326272|39765655|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349458|NCT02326272|39765656|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
16349459|NCT02326272|39765657|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349460|NCT02326272|39765658|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
16349461|NCT02326272|39765659|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
16349462|NCT02326272|39765645|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349463|NCT02326272|39765646|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349464|NCT02326272|39765647|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349465|NCT02326272|39765648|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349466|NCT02326272|39765649|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349467|NCT02326272|39765650|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349468|NCT02326272|39765651|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349469|NCT02326272|39765652|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349470|NCT02326272|39765653|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16236630|NCT01817764|39350978|FG000|Overall Study|Adverse Event|7|||
16413800|NCT01038713|39995297|FG001|Overall Study|Autoimmune Pancreatitis|0|||
16413801|NCT01038713|39995298|FG002|Overall Study|Autoimmune Pancreatitis|0|||
16554811|NCT00570661|40496293|FG000|Overall Study|Adverse Event|1|||
16554812|NCT03525574|40496297|FG000|Overall Study|Adverse Event|15|||
16554813|NCT03525574|40496298|FG001|Overall Study|Adverse Event|0|||
16554814|NCT03525574|40496297|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
16554815|NCT03525574|40496298|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
16554816|NCT03525574|40496297|FG000|Overall Study|Lost to Follow-up|4|||
16554817|NCT03525574|40496298|FG001|Overall Study|Lost to Follow-up|0|||
16554818|NCT03525574|40496297|FG000|Overall Study|Commercial drug is Available for participant|48|||
16554819|NCT03525574|40496298|FG001|Overall Study|Commercial drug is Available for participant|0|||
16121444|NCT01125046|38930217|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
16121445|NCT00288639|38930218|FG000|Overall Study|Adverse Event|5|||
16121446|NCT00288639|38930218|FG000|Overall Study|Lack of Efficacy|4|||
16121447|NCT00288639|38930218|FG000|Overall Study|Withdrawal by Subject|2|||
16121448|NCT00288639|38930218|FG000|Overall Study|Other|1|||
16121449|NCT04055090|38930220|FG000|Overall Study|screen failure|1|||
16121450|NCT04055090|38930221|FG001|Overall Study|screen failure|0|||
16121451|NCT04055090|38930220|FG000|Overall Study|Withdrawal by Subject|1|||
16121452|NCT04055090|38930221|FG001|Overall Study|Withdrawal by Subject|0|||
16121453|NCT01638429|38930222|FG000|Overall Study|Withdrawal by Subject|1|||
16121454|NCT00798590|38930225|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
16121455|NCT00798590|38930226|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
16121456|NCT04608773|38930227|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
16121457|NCT04608773|38930228|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
16121458|NCT04608773|38930227|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
16121459|NCT04608773|38930228|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
16121460|NCT04608773|38930227|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
16121461|NCT04608773|38930228|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
16121462|NCT04608773|38930227|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
16121463|NCT04608773|38930228|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
16121464|NCT04608773|38930227|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
16121465|NCT04608773|38930228|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
16121466|NCT03995316|38930229|FG000|Overall Study|Lost to Follow-up|10|||
16121467|NCT03995316|38930230|FG001|Overall Study|Lost to Follow-up|3|||
16121468|NCT02870972|38930231|FG000|Overall Study|Adverse Event|1|||
16121469|NCT02870972|38930232|FG001|Overall Study|Adverse Event|0|||
16121470|NCT02870972|38930233|FG002|Overall Study|Adverse Event|0|||
16121471|NCT02870972|38930234|FG003|Overall Study|Adverse Event|0|||
16121472|NCT02870972|38930235|FG004|Overall Study|Adverse Event|0|||
16121473|NCT01609062|38930236|FG000|Extension Phase|Terminated by Sponsor|14|||
16121474|NCT01609062|38930237|FG001|Extension Phase|Terminated by Sponsor|9|||
16121475|NCT01609062|38930236|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
16121476|NCT01609062|38930237|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
16121477|NCT01609062|38930236|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
16121478|NCT01609062|38930237|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
16121479|NCT01163292|38930238|FG000|Overall Study|Lack of Efficacy|9|||
16121480|NCT01163292|38930239|FG001|Overall Study|Lack of Efficacy|0|||
16121481|NCT01163292|38930238|FG000|Overall Study|Adverse Event|6|||
16121482|NCT01163292|38930239|FG001|Overall Study|Adverse Event|0|||
16121483|NCT01163292|38930238|FG000|Overall Study|Initiation of biological therapy|0|||
16121484|NCT01163292|38930239|FG001|Overall Study|Initiation of biological therapy|15|||
16349471|NCT02326272|39765654|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349472|NCT02326272|39765655|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349473|NCT02326272|39765656|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
16349474|NCT02326272|39765657|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
16349475|NCT02326272|39765658|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
16349476|NCT02326272|39765659|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
16349477|NCT02326272|39765645|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349478|NCT02326272|39765646|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349479|NCT02326272|39765647|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349480|NCT02326272|39765648|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16121485|NCT01163292|38930238|FG000|Overall Study|Sufficient response to adalimumab|8|||
16121486|NCT01163292|38930239|FG001|Overall Study|Sufficient response to adalimumab|0|||
16121487|NCT01163292|38930238|FG000|Overall Study|Refusal to receive adalimumab|7|||
16121488|NCT01163292|38930239|FG001|Overall Study|Refusal to receive adalimumab|0|||
16121489|NCT01163292|38930238|FG000|Overall Study|Economic reasons|6|||
16121490|NCT01163292|38930239|FG001|Overall Study|Economic reasons|0|||
16349481|NCT02326272|39765649|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349482|NCT02326272|39765650|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349483|NCT02326272|39765651|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349484|NCT02326272|39765652|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349485|NCT02326272|39765653|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349486|NCT02326272|39765654|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349487|NCT02326272|39765655|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349488|NCT02326272|39765656|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
16349489|NCT02326272|39765657|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349490|NCT02326272|39765658|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349491|NCT02326272|39765659|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
16349492|NCT02326272|39765645|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349493|NCT02326272|39765646|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349494|NCT02326272|39765647|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349495|NCT02326272|39765648|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349496|NCT02326272|39765649|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349497|NCT02326272|39765650|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349498|NCT02326272|39765651|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349499|NCT02326272|39765652|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349500|NCT02326272|39765653|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349501|NCT02326272|39765654|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16554820|NCT03525574|40496297|FG000|Overall Study|Death|1|||
16554821|NCT03525574|40496298|FG001|Overall Study|Death|0|||
16554822|NCT03525574|40496297|FG000|Overall Study|Other non-compliance|2|||
16554823|NCT03525574|40496298|FG001|Overall Study|Other non-compliance|0|||
16554824|NCT03525574|40496297|FG000|Overall Study|Physician Decision|6|||
16554825|NCT03525574|40496298|FG001|Overall Study|Physician Decision|0|||
16554826|NCT03525574|40496297|FG000|Overall Study|Other|58|||
16554827|NCT03525574|40496298|FG001|Overall Study|Other|0|||
16554828|NCT03525574|40496297|FG000|Overall Study|Enrolled but never dosed|1|||
16554829|NCT03525574|40496298|FG001|Overall Study|Enrolled but never dosed|0|||
16554830|NCT03525574|40496297|FG000|Overall Study|Not enrolled in 105 study|0|||
16554831|NCT03525574|40496298|FG001|Overall Study|Not enrolled in 105 study|3|||
16554832|NCT00584805|40496299|FG000|Overall Study|No longer at risk of exposure|39|||
16554833|NCT00584805|40496299|FG000|Overall Study|Relocation|36|||
16554834|NCT00584805|40496299|FG000|Overall Study|Withdrawal by Subject|18|||
16554835|NCT00584805|40496299|FG000|Overall Study|Non-compliance|1|||
16554836|NCT00584805|40496299|FG000|Overall Study|Lost to follow up|3|||
16554837|NCT00584805|40496299|FG000|Overall Study|Screen failures|2|||
16554838|NCT00785538|40496300|FG000|Treatment Period|Adverse Event|1|||
16121491|NCT01163292|38930238|FG000|Overall Study|No further visits|5|||
16121492|NCT01163292|38930239|FG001|Overall Study|No further visits|7|||
16121493|NCT00859222|38930248|FG000|Overall Study|Adverse Event|2|||
16121494|NCT00859222|38930249|FG001|Overall Study|Adverse Event|3|||
16121495|NCT00859222|38930250|FG002|Overall Study|Adverse Event|6|||
16121496|NCT00859222|38930251|FG003|Overall Study|Adverse Event|24|||
16121497|NCT00859222|38930252|FG004|Overall Study|Adverse Event|15|||
16121498|NCT00859222|38930248|FG000|Overall Study|DLT|1|||
16121499|NCT00859222|38930249|FG001|Overall Study|DLT|0|||
16121500|NCT00859222|38930250|FG002|Overall Study|DLT|0|||
16121501|NCT00859222|38930251|FG003|Overall Study|DLT|0|||
16554839|NCT00785538|40496301|FG001|Treatment Period|Adverse Event|2|||
16554840|NCT00785538|40496302|FG002|Treatment Period|Adverse Event|2|||
16554841|NCT00785538|40496303|FG003|Treatment Period|Adverse Event|0|||
16554842|NCT00785538|40496300|FG000|Treatment Period|Withdrawal by Subject|0|||
16121502|NCT00859222|38930252|FG004|Overall Study|DLT|0|||
16121503|NCT02202785|38930253|FG000|Overall Study|Study Terminated by Sponsor|1|||
16121504|NCT02202785|38930254|FG001|Overall Study|Study Terminated by Sponsor|6|||
16121505|NCT02202785|38930255|FG002|Overall Study|Study Terminated by Sponsor|4|||
16121506|NCT02202785|38930253|FG000|Overall Study|Withdrawal by Subject|0|||
16121507|NCT02202785|38930254|FG001|Overall Study|Withdrawal by Subject|1|||
16121508|NCT02202785|38930255|FG002|Overall Study|Withdrawal by Subject|0|||
16121509|NCT02202785|38930253|FG000|Overall Study|Lost to Follow-up|0|||
16121510|NCT02202785|38930254|FG001|Overall Study|Lost to Follow-up|1|||
16121511|NCT02202785|38930255|FG002|Overall Study|Lost to Follow-up|0|||
16121512|NCT02202785|38930253|FG000|Overall Study|Reason not Specified|10|||
16121513|NCT02202785|38930254|FG001|Overall Study|Reason not Specified|7|||
16121514|NCT02202785|38930255|FG002|Overall Study|Reason not Specified|13|||
16121515|NCT01023958|38930258|FG000|Overall Study|Progressive disease|48|||
16121516|NCT01023958|38930258|FG000|Overall Study|Other adverse event|1|||
16121517|NCT01023958|38930258|FG000|Overall Study|Refused to continue medication|1|||
16121518|NCT00685698|38930259|FG000|Overall Study|Withdrawal by Subject|1|||
16121519|NCT00685698|38930259|FG000|Overall Study|Protocol Violation|6|||
16121520|NCT00685698|38930259|FG000|Overall Study|Adverse Event|3|||
16121521|NCT00685698|38930259|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
16121522|NCT00685698|38930259|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
16121523|NCT00685698|38930259|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
16121524|NCT02712905|38930260|FG000|Monotherapy|Death|2|||
16121525|NCT02712905|38930261|FG001|Monotherapy|Death|5|||
16121526|NCT02712905|38930262|FG002|Monotherapy|Death|0|||
16121527|NCT02712905|38930263|FG003|Monotherapy|Death|3|||
16121528|NCT02712905|38930264|FG004|Monotherapy|Death|15|||
16121529|NCT02712905|38930265|FG005|Monotherapy|Death|1|||
16121530|NCT02712905|38930266|FG006|Monotherapy|Death|3|||
16121531|NCT02712905|38930267|FG007|Monotherapy|Death|3|||
16121532|NCT02712905|38930268|FG008|Monotherapy|Death|0|||
16121533|NCT02712905|38930269|FG009|Monotherapy|Death|27|||
16121534|NCT02712905|38930270|FG010|Monotherapy|Death|2|||
16121535|NCT02712905|38930271|FG011|Monotherapy|Death|5|||
16121536|NCT02712905|38930272|FG012|Monotherapy|Death|0|||
16121537|NCT02712905|38930273|FG013|Monotherapy|Death|0|||
16121538|NCT02712905|38930274|FG014|Monotherapy|Death|0|||
16121539|NCT02712905|38930275|FG015|Monotherapy|Death|0|||
16121540|NCT02712905|38930276|FG016|Monotherapy|Death|0|||
16121541|NCT02712905|38930277|FG017|Monotherapy|Death|0|||
16121542|NCT02712905|38930260|FG000|Monotherapy|Lost to Follow-up|0|||
16121543|NCT02712905|38930261|FG001|Monotherapy|Lost to Follow-up|1|||
16121544|NCT02712905|38930262|FG002|Monotherapy|Lost to Follow-up|0|||
16121545|NCT02712905|38930263|FG003|Monotherapy|Lost to Follow-up|1|||
16554843|NCT00785538|40496301|FG001|Treatment Period|Withdrawal by Subject|0|||
16554844|NCT00785538|40496302|FG002|Treatment Period|Withdrawal by Subject|0|||
16554845|NCT00785538|40496303|FG003|Treatment Period|Withdrawal by Subject|1|||
16554846|NCT03443713|40496305|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
16554847|NCT03443713|40496306|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
16554848|NCT03443713|40496307|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
16554849|NCT00654238|40496308|FG000|Overall Study|Screen Failures|4|||
16554850|NCT05221749|40496309|FG000|Overall Study|Lost to Follow-up|2|||
16554851|NCT05221749|40496310|FG001|Overall Study|Lost to Follow-up|3|||
16554852|NCT01310868|40496311|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
16554853|NCT01515189|40496314|FG000|Induction|Disease Progression|109|||
16554854|NCT01515189|40496315|FG001|Induction|Disease Progression|155|||
16554855|NCT01515189|40496314|FG000|Induction|Study drug toxicity|86|||
16554856|NCT01515189|40496315|FG001|Induction|Study drug toxicity|36|||
16121546|NCT02712905|38930264|FG004|Monotherapy|Lost to Follow-up|0|||
16121547|NCT02712905|38930265|FG005|Monotherapy|Lost to Follow-up|0|||
16121548|NCT02712905|38930266|FG006|Monotherapy|Lost to Follow-up|0|||
16121549|NCT02712905|38930267|FG007|Monotherapy|Lost to Follow-up|0|||
16121550|NCT02712905|38930268|FG008|Monotherapy|Lost to Follow-up|0|||
16121551|NCT02712905|38930269|FG009|Monotherapy|Lost to Follow-up|2|||
16121552|NCT02712905|38930270|FG010|Monotherapy|Lost to Follow-up|0|||
16121553|NCT02712905|38930271|FG011|Monotherapy|Lost to Follow-up|0|||
16554857|NCT01515189|40496314|FG000|Induction|Death|24|||
16554858|NCT01515189|40496315|FG001|Induction|Death|17|||
16554859|NCT01515189|40496314|FG000|Induction|Adverse Event|14|||
16554860|NCT01515189|40496315|FG001|Induction|Adverse Event|9|||
16554861|NCT01515189|40496314|FG000|Induction|Withdrawal by Subject|3|||
16554862|NCT01515189|40496315|FG001|Induction|Withdrawal by Subject|9|||
16554863|NCT01515189|40496314|FG000|Induction|No longer meets study criteria|0|||
16554864|NCT01515189|40496315|FG001|Induction|No longer meets study criteria|2|||
16554865|NCT01515189|40496314|FG000|Induction|Lost to Follow-up|1|||
16554866|NCT01515189|40496315|FG001|Induction|Lost to Follow-up|0|||
16554867|NCT01515189|40496314|FG000|Induction|Other|0|||
16554868|NCT01515189|40496315|FG001|Induction|Other|4|||
16554869|NCT01515189|40496314|FG000|First Re-Induction Phase|Disease progression|6|||
16554870|NCT01515189|40496315|FG001|First Re-Induction Phase|Disease progression|14|||
16554871|NCT01515189|40496314|FG000|First Re-Induction Phase|Study drug toxicity|5|||
16554872|NCT01515189|40496315|FG001|First Re-Induction Phase|Study drug toxicity|0|||
16554873|NCT01515189|40496314|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
16554874|NCT01515189|40496315|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
16554875|NCT01515189|40496314|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
16554876|NCT01515189|40496315|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
16121554|NCT02712905|38930272|FG012|Monotherapy|Lost to Follow-up|0|||
16121555|NCT02712905|38930273|FG013|Monotherapy|Lost to Follow-up|0|||
16121556|NCT02712905|38930274|FG014|Monotherapy|Lost to Follow-up|0|||
16121557|NCT02712905|38930275|FG015|Monotherapy|Lost to Follow-up|0|||
16121558|NCT02712905|38930276|FG016|Monotherapy|Lost to Follow-up|0|||
16121559|NCT02712905|38930277|FG017|Monotherapy|Lost to Follow-up|0|||
16121560|NCT02712905|38930260|FG000|Monotherapy|Physician Decision|1|||
16121561|NCT02712905|38930261|FG001|Monotherapy|Physician Decision|0|||
16121562|NCT02712905|38930262|FG002|Monotherapy|Physician Decision|0|||
16121563|NCT02712905|38930263|FG003|Monotherapy|Physician Decision|1|||
16121564|NCT02712905|38930264|FG004|Monotherapy|Physician Decision|0|||
16121565|NCT02712905|38930265|FG005|Monotherapy|Physician Decision|0|||
16121566|NCT02712905|38930266|FG006|Monotherapy|Physician Decision|0|||
16121567|NCT02712905|38930267|FG007|Monotherapy|Physician Decision|0|||
16121568|NCT02712905|38930268|FG008|Monotherapy|Physician Decision|0|||
16121569|NCT02712905|38930269|FG009|Monotherapy|Physician Decision|1|||
16121570|NCT02712905|38930270|FG010|Monotherapy|Physician Decision|0|||
16121571|NCT02712905|38930271|FG011|Monotherapy|Physician Decision|0|||
16121572|NCT02712905|38930272|FG012|Monotherapy|Physician Decision|0|||
16121573|NCT02712905|38930273|FG013|Monotherapy|Physician Decision|0|||
16121574|NCT02712905|38930274|FG014|Monotherapy|Physician Decision|0|||
16121575|NCT02712905|38930275|FG015|Monotherapy|Physician Decision|0|||
16121576|NCT02712905|38930276|FG016|Monotherapy|Physician Decision|0|||
16121577|NCT02712905|38930277|FG017|Monotherapy|Physician Decision|0|||
16121578|NCT02712905|38930260|FG000|Monotherapy|Study Terminated by Sponsor|0|||
16121579|NCT02712905|38930261|FG001|Monotherapy|Study Terminated by Sponsor|0|||
16121580|NCT02712905|38930262|FG002|Monotherapy|Study Terminated by Sponsor|0|||
16121581|NCT02712905|38930263|FG003|Monotherapy|Study Terminated by Sponsor|0|||
16121582|NCT02712905|38930264|FG004|Monotherapy|Study Terminated by Sponsor|1|||
16121583|NCT02712905|38930265|FG005|Monotherapy|Study Terminated by Sponsor|0|||
16121584|NCT02712905|38930266|FG006|Monotherapy|Study Terminated by Sponsor|0|||
16121585|NCT02712905|38930267|FG007|Monotherapy|Study Terminated by Sponsor|0|||
16121586|NCT02712905|38930268|FG008|Monotherapy|Study Terminated by Sponsor|0|||
16121587|NCT02712905|38930269|FG009|Monotherapy|Study Terminated by Sponsor|2|||
16121588|NCT02712905|38930270|FG010|Monotherapy|Study Terminated by Sponsor|0|||
16121589|NCT02712905|38930271|FG011|Monotherapy|Study Terminated by Sponsor|0|||
16121590|NCT02712905|38930272|FG012|Monotherapy|Study Terminated by Sponsor|0|||
16121591|NCT02712905|38930273|FG013|Monotherapy|Study Terminated by Sponsor|0|||
16121592|NCT02712905|38930274|FG014|Monotherapy|Study Terminated by Sponsor|0|||
16121593|NCT02712905|38930275|FG015|Monotherapy|Study Terminated by Sponsor|0|||
16121594|NCT02712905|38930276|FG016|Monotherapy|Study Terminated by Sponsor|0|||
16121595|NCT02712905|38930277|FG017|Monotherapy|Study Terminated by Sponsor|0|||
16121596|NCT02712905|38930260|FG000|Monotherapy|Withdrawal by Subject|0|||
16121597|NCT02712905|38930261|FG001|Monotherapy|Withdrawal by Subject|0|||
16121598|NCT02712905|38930262|FG002|Monotherapy|Withdrawal by Subject|1|||
16121599|NCT02712905|38930263|FG003|Monotherapy|Withdrawal by Subject|0|||
16121600|NCT02712905|38930264|FG004|Monotherapy|Withdrawal by Subject|2|||
16121601|NCT02712905|38930265|FG005|Monotherapy|Withdrawal by Subject|0|||
16121602|NCT02712905|38930266|FG006|Monotherapy|Withdrawal by Subject|0|||
16121603|NCT02712905|38930267|FG007|Monotherapy|Withdrawal by Subject|0|||
16121604|NCT02712905|38930268|FG008|Monotherapy|Withdrawal by Subject|0|||
16121605|NCT02712905|38930269|FG009|Monotherapy|Withdrawal by Subject|4|||
16121606|NCT02712905|38930270|FG010|Monotherapy|Withdrawal by Subject|1|||
16121607|NCT02712905|38930271|FG011|Monotherapy|Withdrawal by Subject|2|||
16121608|NCT02712905|38930272|FG012|Monotherapy|Withdrawal by Subject|0|||
16121609|NCT02712905|38930273|FG013|Monotherapy|Withdrawal by Subject|0|||
16121610|NCT02712905|38930274|FG014|Monotherapy|Withdrawal by Subject|0|||
16121611|NCT02712905|38930275|FG015|Monotherapy|Withdrawal by Subject|0|||
16121612|NCT02712905|38930276|FG016|Monotherapy|Withdrawal by Subject|0|||
16121613|NCT02712905|38930277|FG017|Monotherapy|Withdrawal by Subject|0|||
16121614|NCT02712905|38930260|FG000|Monotherapy|Started New Cancer Drug|0|||
16121615|NCT02712905|38930261|FG001|Monotherapy|Started New Cancer Drug|0|||
16121616|NCT02712905|38930262|FG002|Monotherapy|Started New Cancer Drug|0|||
16121617|NCT02712905|38930263|FG003|Monotherapy|Started New Cancer Drug|0|||
16121618|NCT02712905|38930264|FG004|Monotherapy|Started New Cancer Drug|0|||
16121619|NCT02712905|38930265|FG005|Monotherapy|Started New Cancer Drug|1|||
16121620|NCT02712905|38930266|FG006|Monotherapy|Started New Cancer Drug|0|||
16121621|NCT02712905|38930267|FG007|Monotherapy|Started New Cancer Drug|0|||
16121622|NCT02712905|38930268|FG008|Monotherapy|Started New Cancer Drug|0|||
16121623|NCT02712905|38930269|FG009|Monotherapy|Started New Cancer Drug|0|||
16121624|NCT02712905|38930270|FG010|Monotherapy|Started New Cancer Drug|0|||
16121625|NCT02712905|38930271|FG011|Monotherapy|Started New Cancer Drug|0|||
16121626|NCT02712905|38930272|FG012|Monotherapy|Started New Cancer Drug|0|||
16121627|NCT02712905|38930273|FG013|Monotherapy|Started New Cancer Drug|0|||
16121628|NCT02712905|38930274|FG014|Monotherapy|Started New Cancer Drug|0|||
16121629|NCT02712905|38930275|FG015|Monotherapy|Started New Cancer Drug|0|||
16121630|NCT02712905|38930276|FG016|Monotherapy|Started New Cancer Drug|0|||
16121631|NCT02712905|38930277|FG017|Monotherapy|Started New Cancer Drug|0|||
16121632|NCT02712905|38930260|FG000|Monotherapy|Adverse Event|0|||
16121633|NCT02712905|38930261|FG001|Monotherapy|Adverse Event|0|||
16121634|NCT02712905|38930262|FG002|Monotherapy|Adverse Event|0|||
16121635|NCT02712905|38930263|FG003|Monotherapy|Adverse Event|0|||
16121636|NCT02712905|38930264|FG004|Monotherapy|Adverse Event|0|||
16121637|NCT02712905|38930265|FG005|Monotherapy|Adverse Event|0|||
16121638|NCT02712905|38930266|FG006|Monotherapy|Adverse Event|0|||
16121639|NCT02712905|38930267|FG007|Monotherapy|Adverse Event|0|||
16121640|NCT02712905|38930268|FG008|Monotherapy|Adverse Event|1|||
16121641|NCT02712905|38930269|FG009|Monotherapy|Adverse Event|0|||
16121642|NCT02712905|38930270|FG010|Monotherapy|Adverse Event|0|||
16121643|NCT02712905|38930271|FG011|Monotherapy|Adverse Event|0|||
16121644|NCT02712905|38930272|FG012|Monotherapy|Adverse Event|0|||
16554877|NCT01515189|40496314|FG000|First Re-Induction Phase|Other|1|||
16554878|NCT01515189|40496315|FG001|First Re-Induction Phase|Other|0|||
16554879|NCT02340520|40496318|FG000|Overall Study|Lost to Follow-up|1|||
16554880|NCT02340520|40496318|FG000|Overall Study|Patient did not take drug as specified|1|||
16121645|NCT02712905|38930273|FG013|Monotherapy|Adverse Event|0|||
16121646|NCT02712905|38930274|FG014|Monotherapy|Adverse Event|0|||
16121647|NCT02712905|38930275|FG015|Monotherapy|Adverse Event|0|||
16121648|NCT02712905|38930276|FG016|Monotherapy|Adverse Event|0|||
16121649|NCT02712905|38930277|FG017|Monotherapy|Adverse Event|0|||
16121650|NCT02712905|38930260|FG000|Combination Therapy|Death|0|||
16121651|NCT02712905|38930261|FG001|Combination Therapy|Death|0|||
16121652|NCT02712905|38930262|FG002|Combination Therapy|Death|0|||
16121653|NCT02712905|38930263|FG003|Combination Therapy|Death|0|||
16121654|NCT02712905|38930264|FG004|Combination Therapy|Death|0|||
16121655|NCT02712905|38930265|FG005|Combination Therapy|Death|0|||
16121656|NCT02712905|38930266|FG006|Combination Therapy|Death|0|||
16121657|NCT02712905|38930267|FG007|Combination Therapy|Death|0|||
16121658|NCT02712905|38930268|FG008|Combination Therapy|Death|0|||
16121659|NCT02712905|38930269|FG009|Combination Therapy|Death|0|||
16121660|NCT02712905|38930270|FG010|Combination Therapy|Death|0|||
16121661|NCT02712905|38930271|FG011|Combination Therapy|Death|0|||
16121662|NCT02712905|38930272|FG012|Combination Therapy|Death|5|||
16121663|NCT02712905|38930273|FG013|Combination Therapy|Death|6|||
16121664|NCT02712905|38930274|FG014|Combination Therapy|Death|1|||
16121665|NCT02712905|38930275|FG015|Combination Therapy|Death|3|||
16121666|NCT02712905|38930276|FG016|Combination Therapy|Death|1|||
16554881|NCT02340520|40496318|FG000|Overall Study|Withdrawal by Subject|1|||
16554882|NCT00786474|40496328|FG000|Overall Study|Death|5|||
16554883|NCT00786474|40496329|FG001|Overall Study|Death|4|||
16554884|NCT00786474|40496328|FG000|Overall Study|Withdrawal by Subject|23|||
16554885|NCT00786474|40496329|FG001|Overall Study|Withdrawal by Subject|31|||
16554886|NCT00786474|40496328|FG000|Overall Study|Lost to Follow-up|3|||
16554887|NCT00786474|40496329|FG001|Overall Study|Lost to Follow-up|3|||
16554888|NCT00786474|40496328|FG000|Overall Study|Physician Decision|2|||
16554889|NCT00786474|40496329|FG001|Overall Study|Physician Decision|1|||
16554890|NCT00786474|40496328|FG000|Overall Study|Other|4|||
16554891|NCT00786474|40496329|FG001|Overall Study|Other|4|||
16554892|NCT01254890|40496330|FG000|Overall Study|Ineligible|0|||
16554893|NCT01254890|40496331|FG001|Overall Study|Ineligible|3|||
16554894|NCT01254890|40496330|FG000|Overall Study|Withdrawal by Subject|1|||
16121667|NCT02712905|38930277|FG017|Combination Therapy|Death|3|||
16121668|NCT02712905|38930260|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
16554895|NCT01254890|40496331|FG001|Overall Study|Withdrawal by Subject|2|||
16554896|NCT01254890|40496330|FG000|Overall Study|Disease Progression|0|||
16554897|NCT01254890|40496331|FG001|Overall Study|Disease Progression|5|||
16121669|NCT02712905|38930261|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
16121670|NCT02712905|38930262|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
16554898|NCT00245011|40496337|FG000|Overall Study|Lack of Efficacy|1|||
16121671|NCT02712905|38930263|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
16121672|NCT02712905|38930264|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
16121673|NCT02712905|38930265|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
16121674|NCT02712905|38930266|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
16554899|NCT00569803|40496340|FG000|Overall Study|Lost to Follow-up|1|||
16554900|NCT00569803|40496341|FG001|Overall Study|Lost to Follow-up|0|||
16554901|NCT00569803|40496342|FG002|Overall Study|Lost to Follow-up|0|||
16554902|NCT00569803|40496343|FG003|Overall Study|Lost to Follow-up|0|||
16554903|NCT00569803|40496344|FG004|Overall Study|Lost to Follow-up|0|||
16554904|NCT00569803|40496345|FG005|Overall Study|Lost to Follow-up|0|||
16554905|NCT00569803|40496346|FG006|Overall Study|Lost to Follow-up|0|||
16554906|NCT00569803|40496347|FG007|Overall Study|Lost to Follow-up|0|||
16554907|NCT00569803|40496340|FG000|Overall Study|injection syringe leaked during dosing|0|||
16554908|NCT00569803|40496341|FG001|Overall Study|injection syringe leaked during dosing|0|||
16554909|NCT00569803|40496342|FG002|Overall Study|injection syringe leaked during dosing|0|||
16554910|NCT00569803|40496343|FG003|Overall Study|injection syringe leaked during dosing|1|||
16554911|NCT00569803|40496344|FG004|Overall Study|injection syringe leaked during dosing|0|||
16554912|NCT00569803|40496345|FG005|Overall Study|injection syringe leaked during dosing|0|||
16554913|NCT00569803|40496346|FG006|Overall Study|injection syringe leaked during dosing|0|||
16554914|NCT00569803|40496347|FG007|Overall Study|injection syringe leaked during dosing|0|||
16554915|NCT00569803|40496340|FG000|Overall Study|Withdrawal by Subject|0|||
16554916|NCT00569803|40496341|FG001|Overall Study|Withdrawal by Subject|0|||
16554917|NCT00569803|40496342|FG002|Overall Study|Withdrawal by Subject|0|||
16121675|NCT02712905|38930267|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
16121676|NCT02712905|38930268|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
16121677|NCT02712905|38930269|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
16121678|NCT02712905|38930270|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
16121679|NCT02712905|38930271|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
16121680|NCT02712905|38930272|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
16121681|NCT02712905|38930273|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
16121682|NCT02712905|38930274|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
16121683|NCT02712905|38930275|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
16121684|NCT02712905|38930276|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
16121685|NCT02712905|38930277|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
16121686|NCT02712905|38930260|FG000|Combination Therapy|Withdrawal by Subject|0|||
16121687|NCT02712905|38930261|FG001|Combination Therapy|Withdrawal by Subject|0|||
16121688|NCT02712905|38930262|FG002|Combination Therapy|Withdrawal by Subject|0|||
16121689|NCT02712905|38930263|FG003|Combination Therapy|Withdrawal by Subject|0|||
16121690|NCT02712905|38930264|FG004|Combination Therapy|Withdrawal by Subject|0|||
16121691|NCT02712905|38930265|FG005|Combination Therapy|Withdrawal by Subject|0|||
16121692|NCT02712905|38930266|FG006|Combination Therapy|Withdrawal by Subject|0|||
16121693|NCT02712905|38930267|FG007|Combination Therapy|Withdrawal by Subject|0|||
16121694|NCT02712905|38930268|FG008|Combination Therapy|Withdrawal by Subject|0|||
16121695|NCT02712905|38930269|FG009|Combination Therapy|Withdrawal by Subject|0|||
16121696|NCT02712905|38930270|FG010|Combination Therapy|Withdrawal by Subject|0|||
16121697|NCT02712905|38930271|FG011|Combination Therapy|Withdrawal by Subject|0|||
16121698|NCT02712905|38930272|FG012|Combination Therapy|Withdrawal by Subject|0|||
16554918|NCT00569803|40496343|FG003|Overall Study|Withdrawal by Subject|0|||
16554919|NCT00569803|40496344|FG004|Overall Study|Withdrawal by Subject|0|||
16554920|NCT00569803|40496345|FG005|Overall Study|Withdrawal by Subject|0|||
16554921|NCT00569803|40496346|FG006|Overall Study|Withdrawal by Subject|0|||
16554922|NCT00569803|40496347|FG007|Overall Study|Withdrawal by Subject|1|||
16554923|NCT00437125|40496348|FG000|Overall Study|Adverse Event|12|||
16121699|NCT02712905|38930273|FG013|Combination Therapy|Withdrawal by Subject|0|||
16236631|NCT01817764|39350979|FG001|Overall Study|Adverse Event|10|||
16554924|NCT00437125|40496348|FG000|Overall Study|Death|1|||
16554925|NCT00437125|40496348|FG000|Overall Study|Clinical Relapse|1|||
16554926|NCT00437125|40496348|FG000|Overall Study|Lack of Efficacy|1|||
16554927|NCT00437125|40496348|FG000|Overall Study|Lost to Follow-up|1|||
16554928|NCT00437125|40496348|FG000|Overall Study|Withdrawal by Subject|13|||
16554929|NCT00437125|40496348|FG000|Overall Study|Withdrawal by Caregiver|2|||
16554930|NCT00437125|40496348|FG000|Overall Study|Physician Decision|1|||
16554931|NCT00840996|40496350|FG000|Overall Study|Withdrawal by Subject|1|||
16554932|NCT00840996|40496351|FG001|Overall Study|Withdrawal by Subject|0|||
16554933|NCT03537261|40496352|FG000|Overall Study|Lost to Follow-up|4|||
16554934|NCT03537261|40496353|FG001|Overall Study|Lost to Follow-up|5|||
16554935|NCT03537261|40496352|FG000|Overall Study|Withdrawal by Subject|4|||
16554936|NCT03537261|40496353|FG001|Overall Study|Withdrawal by Subject|6|||
16554937|NCT03537261|40496352|FG000|Overall Study|Did not return study questionnaires|0|||
16554938|NCT03537261|40496353|FG001|Overall Study|Did not return study questionnaires|1|||
16554939|NCT03824938|40496354|FG000|Overall Study|Withdrawal by Subject|2|||
16554940|NCT03824938|40496355|FG001|Overall Study|Withdrawal by Subject|1|||
16554941|NCT03824938|40496356|FG002|Overall Study|Withdrawal by Subject|0|||
16554942|NCT03824938|40496357|FG003|Overall Study|Withdrawal by Subject|2|||
16554943|NCT03824938|40496358|FG004|Overall Study|Withdrawal by Subject|0|||
16554944|NCT03824938|40496359|FG005|Overall Study|Withdrawal by Subject|1|||
16554945|NCT03824938|40496354|FG000|Overall Study|Lost to Follow-up|0|||
16554946|NCT03824938|40496355|FG001|Overall Study|Lost to Follow-up|1|||
16413802|NCT04284813|39995299|FG000|Overall Study|Withdrawal by Subject|1|||
16413803|NCT01475162|39998258|FG000|Overall Study|Physician Decision|1|||
16236632|NCT01817764|39350978|FG000|Overall Study|Lack of Efficacy|9|||
16413804|NCT01475162|39998258|FG000|Overall Study|Death|10|||
16413805|NCT01475162|39998258|FG000|Overall Study|Study closed for safety|3|||
16413806|NCT03426631|39998259|FG000|Overall Study|Lost to Follow-up|0|||
16413807|NCT03426631|39998260|FG001|Overall Study|Lost to Follow-up|1|||
16413808|NCT02337725|39998263|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
16413809|NCT02337725|39998264|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
16413810|NCT02337725|39998263|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
16413811|NCT02337725|39998264|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
16413812|NCT02337725|39998263|FG000|Overall Study|Major Protocol Deviation|0|||
16413813|NCT02337725|39998264|FG001|Overall Study|Major Protocol Deviation|1|||
16413814|NCT02337725|39998263|FG000|Overall Study|Voluntary Withdrawal|14|||
16413815|NCT02337725|39998264|FG001|Overall Study|Voluntary Withdrawal|3|||
16413816|NCT02337725|39998263|FG000|Overall Study|Lack of Efficacy|4|||
16413817|NCT02337725|39998264|FG001|Overall Study|Lack of Efficacy|0|||
16413818|NCT03464422|39998265|FG000|Overall Study|Lost to Follow-up|2|||
16554947|NCT03824938|40496356|FG002|Overall Study|Lost to Follow-up|0|||
16554948|NCT03824938|40496357|FG003|Overall Study|Lost to Follow-up|0|||
16236633|NCT01817764|39350979|FG001|Overall Study|Lack of Efficacy|7|||
16236634|NCT01817764|39350978|FG000|Overall Study|Protocol Violation|7|||
16236635|NCT01817764|39350979|FG001|Overall Study|Protocol Violation|5|||
16236636|NCT01817764|39350978|FG000|Overall Study|Lost to Follow-up|1|||
16236637|NCT01817764|39350979|FG001|Overall Study|Lost to Follow-up|4|||
16236638|NCT01817764|39350978|FG000|Overall Study|Withdrawal by Subject|10|||
16236639|NCT01817764|39350979|FG001|Overall Study|Withdrawal by Subject|12|||
16413819|NCT03464422|39998265|FG000|Overall Study|Withdrawal by Subject|2|||
16413820|NCT02549352|39998266|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
16413821|NCT02549352|39998267|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
16413822|NCT02549352|39998266|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
16413823|NCT02549352|39998267|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
16554949|NCT03824938|40496358|FG004|Overall Study|Lost to Follow-up|1|||
16349502|NCT02326272|39765655|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349503|NCT02326272|39765656|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349504|NCT02326272|39765657|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
16349505|NCT02326272|39765658|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349506|NCT02326272|39765659|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
16349507|NCT03669549|39765660|FG000|Overall Study|Adverse Event|4|||
16349508|NCT03669549|39765660|FG000|Overall Study|Withdrawal by Subject|1|||
16349509|NCT03669549|39765660|FG000|Overall Study|Study terminated by the Sponsor|1|||
16349510|NCT01247350|39765675|FG000|Overall Study|Adverse Event|0|||
16349511|NCT01247350|39765676|FG001|Overall Study|Adverse Event|0|||
16349512|NCT01247350|39765677|FG002|Overall Study|Adverse Event|1|||
16349513|NCT01247350|39765678|FG003|Overall Study|Adverse Event|0|||
16349514|NCT01247350|39765679|FG004|Overall Study|Adverse Event|0|||
16349515|NCT01247350|39765675|FG000|Overall Study|Withdrawal by Subject|0|||
16349516|NCT01247350|39765676|FG001|Overall Study|Withdrawal by Subject|0|||
16349517|NCT01247350|39765677|FG002|Overall Study|Withdrawal by Subject|0|||
16349518|NCT01247350|39765678|FG003|Overall Study|Withdrawal by Subject|1|||
16349519|NCT01247350|39765679|FG004|Overall Study|Withdrawal by Subject|0|||
16349520|NCT01247350|39765675|FG000|Overall Study|Entry criteria not met|0|||
16349521|NCT01247350|39765676|FG001|Overall Study|Entry criteria not met|0|||
16349522|NCT01247350|39765677|FG002|Overall Study|Entry criteria not met|0|||
16349523|NCT01247350|39765678|FG003|Overall Study|Entry criteria not met|0|||
16349524|NCT01247350|39765679|FG004|Overall Study|Entry criteria not met|1|||
16349525|NCT02492165|39765682|FG000|Overall Study|Withdrawal by Subject|0|||
16349526|NCT02492165|39765683|FG001|Overall Study|Withdrawal by Subject|1|||
16349527|NCT02492165|39765684|FG002|Overall Study|Withdrawal by Subject|0|||
16349528|NCT02492165|39765685|FG003|Overall Study|Withdrawal by Subject|0|||
16349529|NCT00103285|39765686|FG000|Induction|Adverse Event|14|||
16349530|NCT00103285|39765687|FG001|Induction|Adverse Event|0|||
16349531|NCT00103285|39765688|FG002|Induction|Adverse Event|0|||
16349532|NCT00103285|39765689|FG003|Induction|Adverse Event|0|||
16349533|NCT00103285|39765690|FG004|Induction|Adverse Event|0|||
16349534|NCT00103285|39765691|FG005|Induction|Adverse Event|0|||
16349535|NCT00103285|39765692|FG006|Induction|Adverse Event|0|||
16349536|NCT00103285|39765693|FG007|Induction|Adverse Event|0|||
16349537|NCT00103285|39765686|FG000|Induction|Death|24|||
16349538|NCT00103285|39765687|FG001|Induction|Death|0|||
16349539|NCT00103285|39765688|FG002|Induction|Death|0|||
16349540|NCT00103285|39765689|FG003|Induction|Death|0|||
16349541|NCT00103285|39765690|FG004|Induction|Death|0|||
16349542|NCT00103285|39765691|FG005|Induction|Death|0|||
16349543|NCT00103285|39765692|FG006|Induction|Death|0|||
16349544|NCT00103285|39765693|FG007|Induction|Death|0|||
16349545|NCT00103285|39765686|FG000|Induction|Physician Decision|103|||
16349546|NCT00103285|39765687|FG001|Induction|Physician Decision|0|||
16349547|NCT00103285|39765688|FG002|Induction|Physician Decision|0|||
16349548|NCT00103285|39765689|FG003|Induction|Physician Decision|0|||
16349549|NCT00103285|39765690|FG004|Induction|Physician Decision|0|||
16349550|NCT00103285|39765691|FG005|Induction|Physician Decision|0|||
16349551|NCT00103285|39765692|FG006|Induction|Physician Decision|0|||
16349552|NCT00103285|39765693|FG007|Induction|Physician Decision|0|||
16349553|NCT00103285|39765686|FG000|Induction|Withdrawal by Subject|1|||
16349554|NCT00103285|39765687|FG001|Induction|Withdrawal by Subject|0|||
16349555|NCT00103285|39765688|FG002|Induction|Withdrawal by Subject|0|||
16349556|NCT00103285|39765689|FG003|Induction|Withdrawal by Subject|0|||
16349557|NCT00103285|39765690|FG004|Induction|Withdrawal by Subject|0|||
16349558|NCT00103285|39765691|FG005|Induction|Withdrawal by Subject|0|||
16349559|NCT00103285|39765692|FG006|Induction|Withdrawal by Subject|0|||
16349560|NCT00103285|39765693|FG007|Induction|Withdrawal by Subject|0|||
16349561|NCT00103285|39765686|FG000|Induction|Ineligible|43|||
16349562|NCT00103285|39765687|FG001|Induction|Ineligible|0|||
16349563|NCT00103285|39765688|FG002|Induction|Ineligible|0|||
16349564|NCT00103285|39765689|FG003|Induction|Ineligible|0|||
16349565|NCT00103285|39765690|FG004|Induction|Ineligible|0|||
16349566|NCT00103285|39765691|FG005|Induction|Ineligible|0|||
16349567|NCT00103285|39765692|FG006|Induction|Ineligible|0|||
16349568|NCT00103285|39765693|FG007|Induction|Ineligible|0|||
16349569|NCT00103285|39765686|FG000|Induction|Refusal|906|||
16349570|NCT00103285|39765687|FG001|Induction|Refusal|0|||
16349571|NCT00103285|39765688|FG002|Induction|Refusal|0|||
16349572|NCT00103285|39765689|FG003|Induction|Refusal|0|||
16349573|NCT00103285|39765690|FG004|Induction|Refusal|0|||
16349574|NCT00103285|39765691|FG005|Induction|Refusal|0|||
16349575|NCT00103285|39765692|FG006|Induction|Refusal|0|||
16349576|NCT00103285|39765693|FG007|Induction|Refusal|0|||
16349577|NCT00103285|39765686|FG000|Induction|Other|258|||
16349578|NCT00103285|39765687|FG001|Induction|Other|0|||
16349579|NCT00103285|39765688|FG002|Induction|Other|0|||
16349580|NCT00103285|39765689|FG003|Induction|Other|0|||
16349581|NCT00103285|39765690|FG004|Induction|Other|0|||
16349582|NCT00103285|39765691|FG005|Induction|Other|0|||
16349583|NCT00103285|39765692|FG006|Induction|Other|0|||
16349584|NCT00103285|39765693|FG007|Induction|Other|0|||
16349585|NCT00103285|39765686|FG000|Response Assignment|Adverse Event|0|||
16413824|NCT02549352|39998266|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
16413825|NCT02549352|39998267|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
16413826|NCT02549352|39998266|FG000|12-month Follow-up|Withdrawal by Subject|4|||
16413827|NCT02549352|39998267|FG001|12-month Follow-up|Withdrawal by Subject|5|||
16413828|NCT02549352|39998266|FG000|12-month Follow-up|Lost to Follow-up|3|||
16413829|NCT02549352|39998267|FG001|12-month Follow-up|Lost to Follow-up|2|||
16413830|NCT02549352|39998266|FG000|12-month Follow-up|Death|0|||
16554950|NCT03824938|40496359|FG005|Overall Study|Lost to Follow-up|0|||
16554951|NCT01208415|40496361|FG000|Overall Study|Death|1|||
16554952|NCT01208415|40496361|FG000|Overall Study|Lost to Follow-up|2|||
16554953|NCT01208415|40496361|FG000|Overall Study|Withdrawal by Subject|3|||
16554954|NCT01208415|40496361|FG000|Overall Study|Device not placed|1|||
16554955|NCT01208415|40496361|FG000|Overall Study|Still be eligible for follow-up|33|||
16554956|NCT00152763|40496362|FG000|Overall Study|Death|4|||
16554957|NCT00152763|40496363|FG001|Overall Study|Death|1|||
16554958|NCT00152763|40496364|FG002|Overall Study|Death|2|||
16554959|NCT00152763|40496365|FG003|Overall Study|Death|1|||
16554960|NCT00152763|40496362|FG000|Overall Study|Lost to Follow-up|6|||
16554961|NCT00152763|40496363|FG001|Overall Study|Lost to Follow-up|4|||
16554962|NCT00152763|40496364|FG002|Overall Study|Lost to Follow-up|2|||
16554963|NCT00152763|40496365|FG003|Overall Study|Lost to Follow-up|13|||
16554964|NCT01449721|40496366|FG000|Overall Study|Physician Decision|0|||
16554965|NCT01449721|40496367|FG001|Overall Study|Physician Decision|1|||
16554966|NCT01449721|40496366|FG000|Overall Study|Physician Decision|0|||
16554967|NCT01449721|40496367|FG001|Overall Study|Physician Decision|1|||
16554968|NCT04848662|40496368|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
16554969|NCT04848662|40496369|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
16554970|NCT01454830|40496370|FG000|Overall Study|Withdrawal by Subject|4|||
16554971|NCT01454830|40496371|FG001|Overall Study|Withdrawal by Subject|4|||
16554972|NCT01454830|40496370|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
16554973|NCT01454830|40496371|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
16554974|NCT01454830|40496370|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
16554975|NCT01454830|40496371|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
16554976|NCT01454830|40496370|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
16554977|NCT01454830|40496371|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
16554978|NCT01454830|40496370|FG000|Overall Study|Withdrawal - no polysomnography|3|||
16554979|NCT01454830|40496371|FG001|Overall Study|Withdrawal - no polysomnography|2|||
16554980|NCT00557622|40496372|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
16554981|NCT00557622|40496373|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
16554982|NCT00557622|40496372|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
16554983|NCT00557622|40496373|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
16554984|NCT00557622|40496372|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
16554985|NCT00557622|40496373|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
16554986|NCT00211237|40496374|FG000|Baseline|Withdrew|1|||
16554987|NCT00211237|40496375|FG001|Baseline|Withdrew|3|||
16554988|NCT00211237|40496376|FG002|Baseline|Withdrew|0|||
16413831|NCT02549352|39998267|FG001|12-month Follow-up|Death|1|||
16413832|NCT02549352|39998266|FG000|12-month Follow-up|Protocol Violation|0|||
16554989|NCT00211237|40496374|FG000|Baseline|Refused random assignment|1|||
16554990|NCT00211237|40496375|FG001|Baseline|Refused random assignment|0|||
16554991|NCT00211237|40496376|FG002|Baseline|Refused random assignment|0|||
16554992|NCT00211237|40496374|FG000|1 Month|Death|2|||
16554993|NCT00211237|40496375|FG001|1 Month|Death|1|||
16554994|NCT00211237|40496376|FG002|1 Month|Death|0|||
16554995|NCT00211237|40496374|FG000|1 Month|Lost to Follow-up|0|||
16554996|NCT00211237|40496375|FG001|1 Month|Lost to Follow-up|2|||
16554997|NCT00211237|40496376|FG002|1 Month|Lost to Follow-up|0|||
16554998|NCT00211237|40496374|FG000|1 Month|Withdrew|0|||
16554999|NCT00211237|40496375|FG001|1 Month|Withdrew|4|||
16555000|NCT00211237|40496376|FG002|1 Month|Withdrew|0|||
16555001|NCT00211237|40496374|FG000|1 Month|Additional surgery needed|1|||
16555002|NCT00211237|40496375|FG001|1 Month|Additional surgery needed|0|||
16555003|NCT00211237|40496376|FG002|1 Month|Additional surgery needed|0|||
16555004|NCT00211237|40496374|FG000|1 Month|Non-medical problem|0|||
16555005|NCT00211237|40496375|FG001|1 Month|Non-medical problem|2|||
16555006|NCT00211237|40496376|FG002|1 Month|Non-medical problem|0|||
16555007|NCT00211237|40496374|FG000|3 Months|Death|7|||
16555008|NCT00211237|40496375|FG001|3 Months|Death|3|||
16555009|NCT00211237|40496376|FG002|3 Months|Death|0|||
16555010|NCT00211237|40496374|FG000|3 Months|Could not comply with protocol|1|||
16555011|NCT00211237|40496375|FG001|3 Months|Could not comply with protocol|0|||
16555012|NCT00211237|40496376|FG002|3 Months|Could not comply with protocol|0|||
16555013|NCT00211237|40496374|FG000|3 Months|Withdrew|0|||
16555014|NCT00211237|40496375|FG001|3 Months|Withdrew|1|||
16121700|NCT02712905|38930274|FG014|Combination Therapy|Withdrawal by Subject|0|||
16121701|NCT02712905|38930275|FG015|Combination Therapy|Withdrawal by Subject|1|||
16121702|NCT02712905|38930276|FG016|Combination Therapy|Withdrawal by Subject|0|||
16121703|NCT02712905|38930277|FG017|Combination Therapy|Withdrawal by Subject|2|||
16121704|NCT02712905|38930260|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121705|NCT02712905|38930261|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121706|NCT02712905|38930262|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121707|NCT02712905|38930263|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121708|NCT02712905|38930264|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16236640|NCT00759759|39350982|FG000|Overall Study|didn't return for period 2|1|||
16236641|NCT00759759|39350983|FG001|Overall Study|didn't return for period 2|0|||
16236642|NCT00759759|39350982|FG000|Overall Study|Didn't receive drug in period 2|1|||
16236643|NCT00759759|39350983|FG001|Overall Study|Didn't receive drug in period 2|0|||
16236644|NCT00759759|39350982|FG000|Overall Study|Withdrawal by Subject|2|||
16236645|NCT00759759|39350983|FG001|Overall Study|Withdrawal by Subject|1|||
16236646|NCT04440007|39350984|FG000|Overall Study|Adverse Event|0|||
16236647|NCT04440007|39350985|FG001|Overall Study|Adverse Event|1|||
16236648|NCT04440007|39350984|FG000|Overall Study|Lost to Follow-up|1|||
16236649|NCT04440007|39350985|FG001|Overall Study|Lost to Follow-up|3|||
16236650|NCT04440007|39350984|FG000|Overall Study|Death|7|||
16236651|NCT04440007|39350985|FG001|Overall Study|Death|2|||
16236652|NCT04440007|39350984|FG000|Overall Study|Physician Decision|1|||
16236653|NCT04440007|39350985|FG001|Overall Study|Physician Decision|1|||
16236654|NCT04440007|39350984|FG000|Overall Study|Withdrawal by Subject|2|||
16236655|NCT04440007|39350985|FG001|Overall Study|Withdrawal by Subject|1|||
16236656|NCT04440007|39350984|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
16236657|NCT04440007|39350985|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
16236658|NCT04440007|39350984|FG000|Overall Study|Discontinued prior to dosing|0|||
16236659|NCT04440007|39350985|FG001|Overall Study|Discontinued prior to dosing|2|||
16236660|NCT00685763|39350987|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
16236661|NCT00685763|39350987|FG000|Overall Study|Protocol Violation|1|||
16236662|NCT02395536|39350990|FG000|Overall Study|Lost to Follow-up|4|||
16236663|NCT02395536|39350991|FG001|Overall Study|Lost to Follow-up|4|||
16236664|NCT02395536|39350990|FG000|Overall Study|Death|2|||
16236665|NCT02395536|39350991|FG001|Overall Study|Death|0|||
16236666|NCT02395536|39350990|FG000|Overall Study|Physician Decision|4|||
16236667|NCT02395536|39350991|FG001|Overall Study|Physician Decision|6|||
16236668|NCT02395536|39350990|FG000|Overall Study|Withdrawal by Subject|9|||
16236669|NCT02395536|39350991|FG001|Overall Study|Withdrawal by Subject|17|||
16236670|NCT02395536|39350990|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
16236671|NCT02395536|39350991|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
16555015|NCT00211237|40496376|FG002|3 Months|Withdrew|0|||
16555016|NCT00211237|40496374|FG000|3 Months|Non-medical problem|0|||
16555017|NCT00211237|40496375|FG001|3 Months|Non-medical problem|0|||
16236672|NCT02395536|39350990|FG000|Overall Study|Insurance issue|0|||
16236673|NCT02395536|39350991|FG001|Overall Study|Insurance issue|1|||
16236674|NCT05674721|39350994|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
16555018|NCT00211237|40496376|FG002|3 Months|Non-medical problem|1|||
16555019|NCT00211237|40496374|FG000|6 Months|Death|6|||
16555020|NCT00211237|40496375|FG001|6 Months|Death|0|||
16555021|NCT00211237|40496376|FG002|6 Months|Death|3|||
16555022|NCT00211237|40496374|FG000|6 Months|Lost to Follow-up|2|||
16555023|NCT00211237|40496375|FG001|6 Months|Lost to Follow-up|0|||
16555024|NCT00211237|40496376|FG002|6 Months|Lost to Follow-up|0|||
16236675|NCT05674721|39350995|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
16236676|NCT05674721|39350994|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
16236677|NCT05674721|39350995|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
16236678|NCT03576131|39351001|FG000|Overall Study|Investigator decision|0|||
16236679|NCT03576131|39351002|FG001|Overall Study|Investigator decision|0|||
16236680|NCT03576131|39351003|FG002|Overall Study|Investigator decision|0|||
16236681|NCT03576131|39351004|FG003|Overall Study|Investigator decision|1|||
16236682|NCT03576131|39351005|FG004|Overall Study|Investigator decision|0|||
16236683|NCT03576131|39351006|FG005|Overall Study|Investigator decision|1|||
16236684|NCT03576131|39351007|FG006|Overall Study|Investigator decision|0|||
16236685|NCT03576131|39351008|FG007|Overall Study|Investigator decision|0|||
16236686|NCT03576131|39351001|FG000|Overall Study|Withdrawal by Subject|1|||
16236687|NCT03576131|39351002|FG001|Overall Study|Withdrawal by Subject|1|||
16236688|NCT03576131|39351003|FG002|Overall Study|Withdrawal by Subject|0|||
16236689|NCT03576131|39351004|FG003|Overall Study|Withdrawal by Subject|1|||
16236690|NCT03576131|39351005|FG004|Overall Study|Withdrawal by Subject|2|||
16236691|NCT03576131|39351006|FG005|Overall Study|Withdrawal by Subject|3|||
16236692|NCT03576131|39351007|FG006|Overall Study|Withdrawal by Subject|1|||
16236693|NCT03576131|39351008|FG007|Overall Study|Withdrawal by Subject|0|||
16236694|NCT03576131|39351001|FG000|Overall Study|Death|3|||
16236695|NCT03576131|39351002|FG001|Overall Study|Death|3|||
16349586|NCT00103285|39765687|FG001|Response Assignment|Adverse Event|8|||
16349587|NCT00103285|39765688|FG002|Response Assignment|Adverse Event|3|||
16349588|NCT00103285|39765689|FG003|Response Assignment|Adverse Event|2|||
16349589|NCT00103285|39765690|FG004|Response Assignment|Adverse Event|3|||
16555025|NCT00211237|40496374|FG000|6 Months|Could not comply with protocol|0|||
16555026|NCT00211237|40496375|FG001|6 Months|Could not comply with protocol|2|||
16555027|NCT00211237|40496376|FG002|6 Months|Could not comply with protocol|0|||
16555028|NCT00211237|40496374|FG000|12 Months|Death|8|||
16555029|NCT00211237|40496375|FG001|12 Months|Death|2|||
16555030|NCT00211237|40496376|FG002|12 Months|Death|3|||
16555031|NCT00211237|40496374|FG000|12 Months|Lost to Follow-up|1|||
16555032|NCT00211237|40496375|FG001|12 Months|Lost to Follow-up|0|||
16555033|NCT00211237|40496376|FG002|12 Months|Lost to Follow-up|1|||
16555034|NCT00211237|40496374|FG000|12 Months|Withdrew|0|||
16555035|NCT00211237|40496375|FG001|12 Months|Withdrew|0|||
16555036|NCT00211237|40496376|FG002|12 Months|Withdrew|1|||
16555037|NCT00211237|40496374|FG000|12 Months|unrelated medical problem|0|||
16555038|NCT00211237|40496375|FG001|12 Months|unrelated medical problem|0|||
16555039|NCT00211237|40496376|FG002|12 Months|unrelated medical problem|1|||
16555040|NCT03567993|40496377|FG000|Overall Study|Lost to Follow-up|4|||
16555041|NCT03567993|40496378|FG001|Overall Study|Lost to Follow-up|2|||
16555042|NCT03567993|40496377|FG000|Overall Study|Death|1|||
16555043|NCT03567993|40496378|FG001|Overall Study|Death|1|||
16555044|NCT03567993|40496377|FG000|Overall Study|Withdrawal by Subject|1|||
16555045|NCT03567993|40496378|FG001|Overall Study|Withdrawal by Subject|0|||
16236696|NCT03576131|39351003|FG002|Overall Study|Death|1|||
16236697|NCT03576131|39351004|FG003|Overall Study|Death|5|||
16236698|NCT03576131|39351005|FG004|Overall Study|Death|4|||
16349590|NCT00103285|39765691|FG005|Response Assignment|Adverse Event|1|||
16349591|NCT00103285|39765692|FG006|Response Assignment|Adverse Event|1|||
16349592|NCT00103285|39765693|FG007|Response Assignment|Adverse Event|2|||
16349593|NCT00103285|39765686|FG000|Response Assignment|Death|0|||
16236699|NCT03576131|39351006|FG005|Overall Study|Death|1|||
16236700|NCT03576131|39351007|FG006|Overall Study|Death|0|||
16236701|NCT03576131|39351008|FG007|Overall Study|Death|1|||
16236702|NCT03576131|39351001|FG000|Overall Study|New anti-cancer treatment|5|||
16236703|NCT03576131|39351002|FG001|Overall Study|New anti-cancer treatment|1|||
16236704|NCT03576131|39351003|FG002|Overall Study|New anti-cancer treatment|2|||
16236705|NCT03576131|39351004|FG003|Overall Study|New anti-cancer treatment|3|||
16236706|NCT03576131|39351005|FG004|Overall Study|New anti-cancer treatment|0|||
16555046|NCT01990300|40496387|FG000|Overall Study|Case Report Forms Uncollected|89|||
16555047|NCT01990300|40496387|FG000|Overall Study|Protocol Deviation|53|||
16555048|NCT04426006|40496389|FG000|Inclusion|Protocol Violation|1|||
16236707|NCT03576131|39351006|FG005|Overall Study|New anti-cancer treatment|0|||
16236708|NCT03576131|39351007|FG006|Overall Study|New anti-cancer treatment|0|||
16236709|NCT03576131|39351008|FG007|Overall Study|New anti-cancer treatment|0|||
16236710|NCT03576131|39351001|FG000|Overall Study|Unspecified reason|0|||
16555049|NCT04426006|40496389|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
16555050|NCT04426006|40496389|FG000|Inclusion|Blood sample at inclusion not done|1|||
16555051|NCT04426006|40496389|FG000|3 Months|Lost to Follow-up|17|||
16555052|NCT04426006|40496389|FG000|12 Months|Lost to Follow-up|38|||
16555053|NCT01950273|40496390|FG000|Overall Study|Protocol Violation|1|||
16555054|NCT01950273|40496391|FG001|Overall Study|Protocol Violation|0|||
16555055|NCT01950273|40496390|FG000|Overall Study|Withdrawal by Subject|2|||
16555056|NCT01950273|40496391|FG001|Overall Study|Withdrawal by Subject|0|||
16555057|NCT01950273|40496390|FG000|Overall Study|Other not defined above|1|||
16236711|NCT03576131|39351002|FG001|Overall Study|Unspecified reason|0|||
16236712|NCT03576131|39351003|FG002|Overall Study|Unspecified reason|1|||
16236713|NCT03576131|39351004|FG003|Overall Study|Unspecified reason|1|||
16236714|NCT03576131|39351005|FG004|Overall Study|Unspecified reason|1|||
16236715|NCT03576131|39351006|FG005|Overall Study|Unspecified reason|1|||
16236716|NCT03576131|39351007|FG006|Overall Study|Unspecified reason|0|||
16236717|NCT03576131|39351008|FG007|Overall Study|Unspecified reason|0|||
16236718|NCT03576131|39351001|FG000|Overall Study|Subject non-compliance|0|||
16236719|NCT03576131|39351002|FG001|Overall Study|Subject non-compliance|0|||
16236720|NCT03576131|39351003|FG002|Overall Study|Subject non-compliance|0|||
16236721|NCT03576131|39351004|FG003|Overall Study|Subject non-compliance|0|||
16236722|NCT03576131|39351005|FG004|Overall Study|Subject non-compliance|0|||
16236723|NCT03576131|39351006|FG005|Overall Study|Subject non-compliance|1|||
16236724|NCT03576131|39351007|FG006|Overall Study|Subject non-compliance|0|||
16236725|NCT03576131|39351008|FG007|Overall Study|Subject non-compliance|0|||
16236726|NCT03914469|39351011|FG000|Overall Study|Lost to Follow-up|1|||
16236727|NCT03914469|39351012|FG001|Overall Study|Lost to Follow-up|4|||
16236728|NCT03276962|39351013|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
16236729|NCT03276962|39351014|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
16236730|NCT03276962|39351015|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
16236731|NCT03276962|39351016|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
16236732|NCT03276962|39351017|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
16236733|NCT03276962|39351013|FG000|Overall Study|Protocol Deviation|2|||
16236734|NCT03276962|39351014|FG001|Overall Study|Protocol Deviation|0|||
16236735|NCT03276962|39351015|FG002|Overall Study|Protocol Deviation|1|||
16236736|NCT03276962|39351016|FG003|Overall Study|Protocol Deviation|2|||
16236737|NCT03276962|39351017|FG004|Overall Study|Protocol Deviation|1|||
16236738|NCT03276962|39351013|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
16555058|NCT01950273|40496391|FG001|Overall Study|Other not defined above|0|||
16236739|NCT03276962|39351014|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
16236740|NCT03276962|39351015|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
16236741|NCT03276962|39351016|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
16236742|NCT03276962|39351017|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
16236743|NCT03276962|39351013|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
16236744|NCT03276962|39351014|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
16236745|NCT03276962|39351015|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
16236746|NCT03276962|39351016|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
16236747|NCT03276962|39351017|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
16555059|NCT03875911|40496397|FG000|Overall Study|Lost to Follow-up|3|||
16555060|NCT03875911|40496398|FG001|Overall Study|Lost to Follow-up|6|||
16555061|NCT03875911|40496399|FG002|Overall Study|Lost to Follow-up|2|||
16555062|NCT03875911|40496397|FG000|Overall Study|Surgery cancelled|1|||
16555063|NCT03875911|40496398|FG001|Overall Study|Surgery cancelled|0|||
16121709|NCT02712905|38930265|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16236748|NCT03276962|39351013|FG000|Overall Study|Lost to Follow-up|10|||
16236749|NCT03276962|39351014|FG001|Overall Study|Lost to Follow-up|10|||
16236750|NCT03276962|39351015|FG002|Overall Study|Lost to Follow-up|4|||
16236751|NCT03276962|39351016|FG003|Overall Study|Lost to Follow-up|6|||
16236752|NCT03276962|39351017|FG004|Overall Study|Lost to Follow-up|10|||
16236753|NCT03276962|39351013|FG000|Overall Study|Other|0|||
16236754|NCT03276962|39351014|FG001|Overall Study|Other|2|||
16236755|NCT03276962|39351015|FG002|Overall Study|Other|0|||
16236756|NCT03276962|39351016|FG003|Overall Study|Other|2|||
16236757|NCT03276962|39351017|FG004|Overall Study|Other|1|||
16236758|NCT00567996|39351018|FG000|Overall Study|Adverse Event|18|||
16236759|NCT00567996|39351019|FG001|Overall Study|Adverse Event|16|||
16236760|NCT00567996|39351020|FG002|Overall Study|Adverse Event|13|||
16236761|NCT00567996|39351018|FG000|Overall Study|Protocol Deviation|9|||
16236762|NCT00567996|39351019|FG001|Overall Study|Protocol Deviation|11|||
16236763|NCT00567996|39351020|FG002|Overall Study|Protocol Deviation|13|||
16236764|NCT00567996|39351018|FG000|Overall Study|Withdrawal by Subject|8|||
16236765|NCT00567996|39351019|FG001|Overall Study|Withdrawal by Subject|12|||
16236766|NCT00567996|39351020|FG002|Overall Study|Withdrawal by Subject|22|||
16236767|NCT00567996|39351018|FG000|Overall Study|Abnormal Lab value(s)|2|||
16236768|NCT00567996|39351019|FG001|Overall Study|Abnormal Lab value(s)|1|||
16236769|NCT00567996|39351020|FG002|Overall Study|Abnormal Lab value(s)|2|||
16349594|NCT00103285|39765687|FG001|Response Assignment|Death|5|||
16121710|NCT02712905|38930266|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121711|NCT02712905|38930267|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121712|NCT02712905|38930268|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121713|NCT02712905|38930269|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121714|NCT02712905|38930270|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121715|NCT02712905|38930271|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121716|NCT02712905|38930272|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121717|NCT02712905|38930273|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121718|NCT02712905|38930274|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121719|NCT02712905|38930275|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
16121720|NCT02712905|38930276|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121721|NCT02712905|38930277|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
16121722|NCT01430468|38930278|FG000|Overall Study|Physician Decision|2|||
16121723|NCT01430468|38930279|FG001|Overall Study|Physician Decision|1|||
16121724|NCT01430468|38930278|FG000|Overall Study|Withdrawal by Subject|5|||
16121725|NCT01430468|38930279|FG001|Overall Study|Withdrawal by Subject|5|||
16121726|NCT03192475|38930280|FG000|Overall Study|Death|0|||
16121727|NCT03192475|38930281|FG001|Overall Study|Death|1|||
16121728|NCT03192475|38930280|FG000|Overall Study|Lost to Follow-up|13|||
16121729|NCT03192475|38930281|FG001|Overall Study|Lost to Follow-up|8|||
16121730|NCT00755105|38930282|FG000|Overall Study|Withdrawal by Subject|9|||
16121731|NCT00755105|38930283|FG001|Overall Study|Withdrawal by Subject|11|||
16121732|NCT00755105|38930284|FG002|Overall Study|Withdrawal by Subject|4|||
16121733|NCT01294436|38930285|FG000|Overall Study|Adverse Event|10|||
16121734|NCT01294436|38930286|FG001|Overall Study|Adverse Event|17|||
16236770|NCT00567996|39351018|FG000|Overall Study|Abnormal test procedure result(s)|2|||
16236771|NCT00567996|39351019|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16236772|NCT00567996|39351020|FG002|Overall Study|Abnormal test procedure result(s)|1|||
16236773|NCT00567996|39351018|FG000|Overall Study|Lost to Follow-up|2|||
16555064|NCT03875911|40496399|FG002|Overall Study|Surgery cancelled|1|||
16236774|NCT00567996|39351019|FG001|Overall Study|Lost to Follow-up|5|||
16236775|NCT00567996|39351020|FG002|Overall Study|Lost to Follow-up|2|||
16236776|NCT00567996|39351018|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16236777|NCT00567996|39351019|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16236778|NCT00567996|39351020|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
16236779|NCT00567996|39351018|FG000|Overall Study|Administrative problems|1|||
16236780|NCT00567996|39351019|FG001|Overall Study|Administrative problems|1|||
16236781|NCT00567996|39351020|FG002|Overall Study|Administrative problems|0|||
16236782|NCT00567996|39351018|FG000|Overall Study|Death|1|||
16236783|NCT00567996|39351019|FG001|Overall Study|Death|0|||
16236784|NCT00567996|39351020|FG002|Overall Study|Death|2|||
16236785|NCT00567996|39351018|FG000|Overall Study|Patient's inability to use the device|0|||
16236786|NCT00567996|39351019|FG001|Overall Study|Patient's inability to use the device|1|||
16236787|NCT00567996|39351020|FG002|Overall Study|Patient's inability to use the device|0|||
16236788|NCT00414011|39351031|FG000|Overall Study|Physician Decision|3|||
16236789|NCT00414011|39351031|FG000|Overall Study|Withdrawal by Subject|2|||
16236790|NCT00532779|39351032|FG000|Overall Study|Adverse Event|122|||
16236791|NCT00532779|39351033|FG001|Overall Study|Adverse Event|112|||
16236792|NCT00532779|39351034|FG002|Overall Study|Adverse Event|56|||
16236793|NCT00532779|39351032|FG000|Overall Study|Lost to Follow-up|76|||
16236794|NCT00532779|39351033|FG001|Overall Study|Lost to Follow-up|65|||
16236795|NCT00532779|39351034|FG002|Overall Study|Lost to Follow-up|66|||
16236796|NCT00532779|39351032|FG000|Overall Study|Withdrawal by Subject|63|||
16236797|NCT00532779|39351033|FG001|Overall Study|Withdrawal by Subject|60|||
16236798|NCT00532779|39351034|FG002|Overall Study|Withdrawal by Subject|90|||
16236799|NCT00532779|39351032|FG000|Overall Study|Lack of Efficacy|12|||
16236800|NCT00532779|39351033|FG001|Overall Study|Lack of Efficacy|12|||
16555065|NCT03875911|40496397|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
16555066|NCT03875911|40496398|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
16555067|NCT03875911|40496399|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
16555068|NCT04006366|40496400|FG000|Overall Study|Withdrawal by Subject|1|||
16555069|NCT00917267|40496401|FG000|Overall Study|Adverse Event|15|||
16555070|NCT00917267|40496402|FG001|Overall Study|Adverse Event|36|||
16555071|NCT00917267|40496401|FG000|Overall Study|Physician Decision|2|||
16555072|NCT00917267|40496402|FG001|Overall Study|Physician Decision|4|||
16555073|NCT00917267|40496401|FG000|Overall Study|Protocol Violation|9|||
16555074|NCT00917267|40496402|FG001|Overall Study|Protocol Violation|18|||
16555075|NCT00917267|40496401|FG000|Overall Study|Withdrawal by Subject|5|||
16555076|NCT00917267|40496402|FG001|Overall Study|Withdrawal by Subject|12|||
16555077|NCT00917267|40496401|FG000|Overall Study|Lost to follow up|0|||
16121735|NCT01294436|38930285|FG000|Overall Study|Withdrawal by Subject|11|||
16236801|NCT00532779|39351034|FG002|Overall Study|Lack of Efficacy|40|||
16236802|NCT00532779|39351032|FG000|Overall Study|Protocol Violation|5|||
16236803|NCT00532779|39351033|FG001|Overall Study|Protocol Violation|9|||
16236804|NCT00532779|39351034|FG002|Overall Study|Protocol Violation|7|||
16121736|NCT01294436|38930286|FG001|Overall Study|Withdrawal by Subject|28|||
16121737|NCT01294436|38930285|FG000|Overall Study|subject no longer meets study criteria|5|||
16121738|NCT01294436|38930286|FG001|Overall Study|subject no longer meets study criteria|20|||
16121739|NCT01294436|38930285|FG000|Overall Study|poor/non-compliance|2|||
16121740|NCT01294436|38930286|FG001|Overall Study|poor/non-compliance|5|||
16121741|NCT00588692|38930287|FG000|Overall Study|Withdrawal by Subject|4|||
16121742|NCT00588692|38930288|FG001|Overall Study|Withdrawal by Subject|2|||
16121743|NCT00588692|38930287|FG000|Overall Study|Hip Surgery|0|||
16121744|NCT00588692|38930288|FG001|Overall Study|Hip Surgery|1|||
16121745|NCT00588692|38930287|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
16121746|NCT00588692|38930288|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
16121747|NCT00588692|38930287|FG000|Overall Study|Cancer|1|||
16121748|NCT00588692|38930288|FG001|Overall Study|Cancer|0|||
16236805|NCT00532779|39351032|FG000|Overall Study|Pregnancy|2|||
16236806|NCT00532779|39351033|FG001|Overall Study|Pregnancy|5|||
16236807|NCT00532779|39351034|FG002|Overall Study|Pregnancy|3|||
16236808|NCT00532779|39351032|FG000|Overall Study|Death|0|||
16236809|NCT00532779|39351033|FG001|Overall Study|Death|1|||
16349595|NCT00103285|39765688|FG002|Response Assignment|Death|2|||
16349596|NCT00103285|39765689|FG003|Response Assignment|Death|2|||
16349597|NCT00103285|39765690|FG004|Response Assignment|Death|3|||
16349598|NCT00103285|39765691|FG005|Response Assignment|Death|1|||
16349599|NCT00103285|39765692|FG006|Response Assignment|Death|0|||
16349600|NCT00103285|39765693|FG007|Response Assignment|Death|8|||
16349601|NCT00103285|39765686|FG000|Response Assignment|Lost to Follow-up|0|||
16349602|NCT00103285|39765687|FG001|Response Assignment|Lost to Follow-up|9|||
16349603|NCT00103285|39765688|FG002|Response Assignment|Lost to Follow-up|5|||
16349604|NCT00103285|39765689|FG003|Response Assignment|Lost to Follow-up|5|||
16555078|NCT00917267|40496402|FG001|Overall Study|Lost to follow up|2|||
16121749|NCT00588692|38930287|FG000|Overall Study|Death|1|||
16349605|NCT00103285|39765690|FG004|Response Assignment|Lost to Follow-up|1|||
16349606|NCT00103285|39765691|FG005|Response Assignment|Lost to Follow-up|2|||
16349607|NCT00103285|39765692|FG006|Response Assignment|Lost to Follow-up|2|||
16236810|NCT00532779|39351034|FG002|Overall Study|Death|0|||
16236811|NCT00532779|39351032|FG000|Overall Study|Drug noncompliance, moved, other|14|||
16236812|NCT00532779|39351033|FG001|Overall Study|Drug noncompliance, moved, other|23|||
16236813|NCT00532779|39351034|FG002|Overall Study|Drug noncompliance, moved, other|29|||
16236814|NCT01393626|39351038|FG000|Overall Study|Adverse Event|2|||
16236815|NCT01393626|39351039|FG001|Overall Study|Adverse Event|1|||
16236816|NCT01393626|39351040|FG002|Overall Study|Adverse Event|5|||
16236817|NCT01393626|39351041|FG003|Overall Study|Adverse Event|0|||
16236818|NCT01393626|39351038|FG000|Overall Study|Did not meet entrance criteria|1|||
16236819|NCT01393626|39351039|FG001|Overall Study|Did not meet entrance criteria|0|||
16236820|NCT01393626|39351040|FG002|Overall Study|Did not meet entrance criteria|0|||
16236821|NCT01393626|39351041|FG003|Overall Study|Did not meet entrance criteria|0|||
16236822|NCT01393626|39351038|FG000|Overall Study|Lack of Efficacy|6|||
16236823|NCT01393626|39351039|FG001|Overall Study|Lack of Efficacy|6|||
16236824|NCT01393626|39351040|FG002|Overall Study|Lack of Efficacy|4|||
16236825|NCT01393626|39351041|FG003|Overall Study|Lack of Efficacy|1|||
16555079|NCT00917267|40496401|FG000|Overall Study|Entry Criteria Not Met|1|||
16555080|NCT00917267|40496402|FG001|Overall Study|Entry Criteria Not Met|0|||
16555081|NCT00917267|40496401|FG000|Overall Study|Sponsor Decision|5|||
16555082|NCT00917267|40496402|FG001|Overall Study|Sponsor Decision|5|||
16555083|NCT00917267|40496401|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
16555084|NCT00917267|40496402|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
16236826|NCT01393626|39351038|FG000|Overall Study|Lost to Follow-up|1|||
16236827|NCT01393626|39351039|FG001|Overall Study|Lost to Follow-up|1|||
16236828|NCT01393626|39351040|FG002|Overall Study|Lost to Follow-up|1|||
16236829|NCT01393626|39351041|FG003|Overall Study|Lost to Follow-up|0|||
16236830|NCT01393626|39351038|FG000|Overall Study|Withdrawal by Subject|6|||
16236831|NCT01393626|39351039|FG001|Overall Study|Withdrawal by Subject|4|||
16236832|NCT01393626|39351040|FG002|Overall Study|Withdrawal by Subject|0|||
16236833|NCT01393626|39351041|FG003|Overall Study|Withdrawal by Subject|0|||
16236834|NCT01393626|39351038|FG000|Overall Study|Other|1|||
16236835|NCT01393626|39351039|FG001|Overall Study|Other|0|||
16236836|NCT01393626|39351040|FG002|Overall Study|Other|0|||
16236837|NCT01393626|39351041|FG003|Overall Study|Other|0|||
16236838|NCT01393626|39351038|FG000|Overall Study|Protocol Violation|1|||
16236839|NCT01393626|39351039|FG001|Overall Study|Protocol Violation|0|||
16236840|NCT01393626|39351040|FG002|Overall Study|Protocol Violation|2|||
16236841|NCT01393626|39351041|FG003|Overall Study|Protocol Violation|0|||
16236842|NCT00265239|39351042|FG000|Overall Study|Adverse Event|2|||
16236843|NCT00265239|39351043|FG001|Overall Study|Adverse Event|1|||
16236844|NCT01289990|39351044|FG000|Overall Study|Death|0|||
16236845|NCT01289990|39351045|FG001|Overall Study|Death|0|||
16236846|NCT01289990|39351046|FG002|Overall Study|Death|0|||
16236847|NCT01289990|39351047|FG003|Overall Study|Death|1|||
16236848|NCT01289990|39351048|FG004|Overall Study|Death|2|||
16236849|NCT01289990|39351049|FG005|Overall Study|Death|1|||
16236850|NCT01289990|39351050|FG006|Overall Study|Death|0|||
16236851|NCT01289990|39351051|FG007|Overall Study|Death|0|||
16236852|NCT01289990|39351052|FG008|Overall Study|Death|0|||
16236853|NCT01289990|39351053|FG009|Overall Study|Death|0|||
16236854|NCT01289990|39351054|FG010|Overall Study|Death|0|||
16236855|NCT01289990|39351055|FG011|Overall Study|Death|1|||
16236856|NCT01289990|39351056|FG012|Overall Study|Death|0|||
16236857|NCT01289990|39351044|FG000|Overall Study|Lost to Follow-up|3|||
16349608|NCT00103285|39765693|FG007|Response Assignment|Lost to Follow-up|5|||
16349609|NCT00103285|39765686|FG000|Response Assignment|Physician Decision|0|||
16349610|NCT00103285|39765687|FG001|Response Assignment|Physician Decision|13|||
16349611|NCT00103285|39765688|FG002|Response Assignment|Physician Decision|14|||
16349612|NCT00103285|39765689|FG003|Response Assignment|Physician Decision|9|||
16555085|NCT05764239|40496403|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
16236858|NCT01289990|39351045|FG001|Overall Study|Lost to Follow-up|2|||
16349613|NCT00103285|39765690|FG004|Response Assignment|Physician Decision|13|||
16349614|NCT00103285|39765691|FG005|Response Assignment|Physician Decision|7|||
16349615|NCT00103285|39765692|FG006|Response Assignment|Physician Decision|4|||
16349616|NCT00103285|39765693|FG007|Response Assignment|Physician Decision|35|||
16349617|NCT00103285|39765686|FG000|Response Assignment|Protocol Violation|0|||
16349618|NCT00103285|39765687|FG001|Response Assignment|Protocol Violation|2|||
16349619|NCT00103285|39765688|FG002|Response Assignment|Protocol Violation|0|||
16349620|NCT00103285|39765689|FG003|Response Assignment|Protocol Violation|0|||
16349621|NCT00103285|39765690|FG004|Response Assignment|Protocol Violation|0|||
16555086|NCT05764239|40496403|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
16555087|NCT05764239|40496403|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
16236859|NCT01289990|39351046|FG002|Overall Study|Lost to Follow-up|5|||
16236860|NCT01289990|39351047|FG003|Overall Study|Lost to Follow-up|5|||
16236861|NCT01289990|39351048|FG004|Overall Study|Lost to Follow-up|3|||
16236862|NCT01289990|39351049|FG005|Overall Study|Lost to Follow-up|4|||
16236863|NCT01289990|39351050|FG006|Overall Study|Lost to Follow-up|2|||
16349622|NCT00103285|39765691|FG005|Response Assignment|Protocol Violation|0|||
16555088|NCT05764239|40496403|FG000|DEP (Part 1)|Adverse Event|1|||
16555089|NCT05764239|40496403|FG000|DEP (Part 1)|Lost to Follow-up|1|||
16555090|NCT05764239|40496403|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
16555091|NCT05764239|40496403|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
16555092|NCT05764239|40496403|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
16555093|NCT05764239|40496403|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
16555094|NCT03881059|40496404|FG000|Treatment Period - Part A|Adverse Event|1|||
16555095|NCT03881059|40496405|FG001|Treatment Period - Part A|Adverse Event|3|||
16555096|NCT03881059|40496406|FG002|Treatment Period - Part A|Adverse Event|4|||
16555097|NCT03881059|40496404|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
16555098|NCT03881059|40496405|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
16555099|NCT03881059|40496406|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
16555100|NCT03881059|40496404|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
16236864|NCT01289990|39351051|FG007|Overall Study|Lost to Follow-up|2|||
16236865|NCT01289990|39351052|FG008|Overall Study|Lost to Follow-up|1|||
16555101|NCT03881059|40496405|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
16555102|NCT03881059|40496406|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
16555103|NCT03881059|40496404|FG000|Treatment Period - Part A|Other reasons|2|||
16236866|NCT01289990|39351053|FG009|Overall Study|Lost to Follow-up|4|||
16236867|NCT01289990|39351054|FG010|Overall Study|Lost to Follow-up|2|||
16236868|NCT01289990|39351055|FG011|Overall Study|Lost to Follow-up|1|||
16236869|NCT01289990|39351056|FG012|Overall Study|Lost to Follow-up|2|||
16236870|NCT01289990|39351044|FG000|Overall Study|Withdrawal by Subject|15|||
16236871|NCT01289990|39351045|FG001|Overall Study|Withdrawal by Subject|14|||
16236872|NCT01289990|39351046|FG002|Overall Study|Withdrawal by Subject|12|||
16236873|NCT01289990|39351047|FG003|Overall Study|Withdrawal by Subject|13|||
16236874|NCT01289990|39351048|FG004|Overall Study|Withdrawal by Subject|8|||
16236875|NCT01289990|39351049|FG005|Overall Study|Withdrawal by Subject|7|||
16236876|NCT01289990|39351050|FG006|Overall Study|Withdrawal by Subject|13|||
16236877|NCT01289990|39351051|FG007|Overall Study|Withdrawal by Subject|9|||
16236878|NCT01289990|39351052|FG008|Overall Study|Withdrawal by Subject|12|||
16236879|NCT01289990|39351053|FG009|Overall Study|Withdrawal by Subject|13|||
16236880|NCT01289990|39351054|FG010|Overall Study|Withdrawal by Subject|11|||
16236881|NCT01289990|39351055|FG011|Overall Study|Withdrawal by Subject|13|||
16236882|NCT01289990|39351056|FG012|Overall Study|Withdrawal by Subject|16|||
16236883|NCT01289990|39351044|FG000|Overall Study|discontinued in preceding trial|18|||
16236884|NCT01289990|39351045|FG001|Overall Study|discontinued in preceding trial|20|||
16236885|NCT01289990|39351046|FG002|Overall Study|discontinued in preceding trial|41|||
16236886|NCT01289990|39351047|FG003|Overall Study|discontinued in preceding trial|17|||
16236887|NCT01289990|39351048|FG004|Overall Study|discontinued in preceding trial|11|||
16236888|NCT01289990|39351049|FG005|Overall Study|discontinued in preceding trial|12|||
16236889|NCT01289990|39351050|FG006|Overall Study|discontinued in preceding trial|18|||
16236890|NCT01289990|39351051|FG007|Overall Study|discontinued in preceding trial|8|||
16236891|NCT01289990|39351052|FG008|Overall Study|discontinued in preceding trial|17|||
16236892|NCT01289990|39351053|FG009|Overall Study|discontinued in preceding trial|21|||
16236893|NCT01289990|39351054|FG010|Overall Study|discontinued in preceding trial|17|||
16236894|NCT01289990|39351055|FG011|Overall Study|discontinued in preceding trial|17|||
16236895|NCT01289990|39351056|FG012|Overall Study|discontinued in preceding trial|24|||
16236896|NCT01289990|39351044|FG000|Overall Study|did not continue in extension|41|||
16236897|NCT01289990|39351045|FG001|Overall Study|did not continue in extension|45|||
16236898|NCT01289990|39351046|FG002|Overall Study|did not continue in extension|51|||
16236899|NCT01289990|39351047|FG003|Overall Study|did not continue in extension|51|||
16236900|NCT01289990|39351048|FG004|Overall Study|did not continue in extension|48|||
16236901|NCT01289990|39351049|FG005|Overall Study|did not continue in extension|50|||
16236902|NCT01289990|39351050|FG006|Overall Study|did not continue in extension|54|||
16236903|NCT01289990|39351051|FG007|Overall Study|did not continue in extension|36|||
16236904|NCT01289990|39351052|FG008|Overall Study|did not continue in extension|44|||
16236905|NCT01289990|39351053|FG009|Overall Study|did not continue in extension|48|||
16236906|NCT01289990|39351054|FG010|Overall Study|did not continue in extension|45|||
16236907|NCT01289990|39351055|FG011|Overall Study|did not continue in extension|34|||
16236908|NCT01289990|39351056|FG012|Overall Study|did not continue in extension|56|||
16236909|NCT01289990|39351044|FG000|Overall Study|Not treated|0|||
16236910|NCT01289990|39351045|FG001|Overall Study|Not treated|0|||
16236911|NCT01289990|39351046|FG002|Overall Study|Not treated|0|||
16236912|NCT01289990|39351047|FG003|Overall Study|Not treated|0|||
16236913|NCT01289990|39351048|FG004|Overall Study|Not treated|0|||
16236914|NCT01289990|39351049|FG005|Overall Study|Not treated|0|||
16236915|NCT01289990|39351050|FG006|Overall Study|Not treated|1|||
16236916|NCT01289990|39351051|FG007|Overall Study|Not treated|0|||
16236917|NCT01289990|39351052|FG008|Overall Study|Not treated|1|||
16236918|NCT01289990|39351053|FG009|Overall Study|Not treated|0|||
16555104|NCT03881059|40496405|FG001|Treatment Period - Part A|Other reasons|1|||
16236919|NCT01289990|39351054|FG010|Overall Study|Not treated|1|||
16236920|NCT01289990|39351055|FG011|Overall Study|Not treated|2|||
16236921|NCT01289990|39351056|FG012|Overall Study|Not treated|0|||
16236922|NCT04278872|39351057|FG000|Overall Study|Adverse Event|1|||
16236923|NCT04278872|39351058|FG001|Overall Study|Adverse Event|0|||
16236924|NCT04278872|39351057|FG000|Overall Study|Protocol Violation|0|||
16236925|NCT04278872|39351058|FG001|Overall Study|Protocol Violation|1|||
16236926|NCT04278872|39351057|FG000|Overall Study|Study Termination|2|||
16236927|NCT04278872|39351058|FG001|Overall Study|Study Termination|0|||
16236928|NCT02525627|39351059|FG000|Overall Study|Revision|1|||
16236929|NCT02525627|39351060|FG001|Overall Study|Revision|1|||
16236930|NCT02525627|39351059|FG000|Overall Study|Withdrawal by Subject|1|||
16236931|NCT02525627|39351060|FG001|Overall Study|Withdrawal by Subject|2|||
16236932|NCT02525627|39351059|FG000|Overall Study|Death|1|||
16236933|NCT02525627|39351060|FG001|Overall Study|Death|0|||
16236934|NCT02525627|39351059|FG000|Overall Study|Site terminated|11|||
16236935|NCT02525627|39351060|FG001|Overall Study|Site terminated|10|||
16236936|NCT00902278|39351061|FG000|Overall Study|Physician Decision|1|||
16236937|NCT00902278|39351062|FG001|Overall Study|Physician Decision|0|||
16236938|NCT00902278|39351063|FG002|Overall Study|Physician Decision|2|||
16236939|NCT00902278|39351064|FG003|Overall Study|Physician Decision|0|||
16236940|NCT00902278|39351065|FG004|Overall Study|Physician Decision|1|||
16236941|NCT00902278|39351061|FG000|Overall Study|Lost to Follow-up|3|||
16236942|NCT00902278|39351062|FG001|Overall Study|Lost to Follow-up|2|||
16236943|NCT00902278|39351063|FG002|Overall Study|Lost to Follow-up|3|||
16236944|NCT00902278|39351064|FG003|Overall Study|Lost to Follow-up|0|||
16236945|NCT00902278|39351065|FG004|Overall Study|Lost to Follow-up|1|||
16236946|NCT01625286|39351066|FG000|Overall Study|Adverse Event|0|||
16236947|NCT01625286|39351067|FG001|Overall Study|Adverse Event|0|||
16236948|NCT01625286|39351068|FG002|Overall Study|Adverse Event|0|||
16236949|NCT01625286|39351069|FG003|Overall Study|Adverse Event|0|||
16236950|NCT01625286|39351070|FG004|Overall Study|Adverse Event|1|||
16236951|NCT01625286|39351071|FG005|Overall Study|Adverse Event|2|||
16236952|NCT01625286|39351072|FG006|Overall Study|Adverse Event|1|||
16236953|NCT01625286|39351066|FG000|Overall Study|Death|0|||
16236954|NCT01625286|39351067|FG001|Overall Study|Death|0|||
16236955|NCT01625286|39351068|FG002|Overall Study|Death|1|||
16236956|NCT01625286|39351069|FG003|Overall Study|Death|1|||
16236957|NCT01625286|39351070|FG004|Overall Study|Death|0|||
16236958|NCT01625286|39351071|FG005|Overall Study|Death|11|||
16236959|NCT01625286|39351072|FG006|Overall Study|Death|16|||
16349623|NCT00103285|39765692|FG006|Response Assignment|Protocol Violation|0|||
16349624|NCT00103285|39765693|FG007|Response Assignment|Protocol Violation|0|||
16349625|NCT00103285|39765686|FG000|Response Assignment|Withdrawal by Subject|0|||
16349626|NCT00103285|39765687|FG001|Response Assignment|Withdrawal by Subject|4|||
16349627|NCT00103285|39765688|FG002|Response Assignment|Withdrawal by Subject|1|||
16349628|NCT00103285|39765689|FG003|Response Assignment|Withdrawal by Subject|1|||
16349629|NCT00103285|39765690|FG004|Response Assignment|Withdrawal by Subject|2|||
16413833|NCT02549352|39998267|FG001|12-month Follow-up|Protocol Violation|1|||
16413834|NCT02549352|39998266|FG000|12-month Follow-up|Other|1|||
16413835|NCT02549352|39998267|FG001|12-month Follow-up|Other|3|||
16413836|NCT03626545|39998270|FG000|Overall Study|Progressive disease|3|||
16413837|NCT03626545|39998271|FG001|Overall Study|Progressive disease|82|||
16236960|NCT01625286|39351066|FG000|Overall Study|Withdrawal by Subject|0|||
16236961|NCT01625286|39351067|FG001|Overall Study|Withdrawal by Subject|1|||
16236962|NCT01625286|39351068|FG002|Overall Study|Withdrawal by Subject|0|||
16236963|NCT01625286|39351069|FG003|Overall Study|Withdrawal by Subject|1|||
16236964|NCT01625286|39351070|FG004|Overall Study|Withdrawal by Subject|0|||
16349630|NCT00103285|39765691|FG005|Response Assignment|Withdrawal by Subject|2|||
16349631|NCT00103285|39765692|FG006|Response Assignment|Withdrawal by Subject|0|||
16349632|NCT00103285|39765693|FG007|Response Assignment|Withdrawal by Subject|2|||
16349633|NCT00103285|39765686|FG000|Response Assignment|Ineligible|0|||
16349634|NCT00103285|39765687|FG001|Response Assignment|Ineligible|8|||
16349635|NCT00103285|39765688|FG002|Response Assignment|Ineligible|6|||
16349636|NCT00103285|39765689|FG003|Response Assignment|Ineligible|2|||
16349637|NCT00103285|39765690|FG004|Response Assignment|Ineligible|0|||
16413838|NCT03626545|39998272|FG002|Overall Study|Progressive disease|85|||
16349638|NCT00103285|39765691|FG005|Response Assignment|Ineligible|3|||
16349639|NCT00103285|39765692|FG006|Response Assignment|Ineligible|1|||
16349640|NCT00103285|39765693|FG007|Response Assignment|Ineligible|5|||
16349641|NCT00103285|39765686|FG000|Response Assignment|Refusal|0|||
16349642|NCT00103285|39765687|FG001|Response Assignment|Refusal|53|||
16349643|NCT00103285|39765688|FG002|Response Assignment|Refusal|5|||
16349644|NCT00103285|39765689|FG003|Response Assignment|Refusal|3|||
16349645|NCT00103285|39765690|FG004|Response Assignment|Refusal|25|||
16349646|NCT00103285|39765691|FG005|Response Assignment|Refusal|15|||
16349647|NCT00103285|39765692|FG006|Response Assignment|Refusal|30|||
16349648|NCT00103285|39765693|FG007|Response Assignment|Refusal|10|||
16349649|NCT00103285|39765686|FG000|Response Assignment|Other|0|||
16349650|NCT00103285|39765687|FG001|Response Assignment|Other|30|||
16349651|NCT00103285|39765688|FG002|Response Assignment|Other|48|||
16349652|NCT00103285|39765689|FG003|Response Assignment|Other|38|||
16349653|NCT00103285|39765690|FG004|Response Assignment|Other|37|||
16349654|NCT00103285|39765691|FG005|Response Assignment|Other|17|||
16349655|NCT00103285|39765692|FG006|Response Assignment|Other|11|||
16349656|NCT00103285|39765693|FG007|Response Assignment|Other|53|||
16349657|NCT03506438|39765694|FG000|Overall Study|Lost to Follow-up|8|||
16413839|NCT03626545|39998270|FG000|Overall Study|Adverse Event|3|||
16413840|NCT03626545|39998271|FG001|Overall Study|Adverse Event|13|||
16413841|NCT03626545|39998272|FG002|Overall Study|Adverse Event|10|||
16413842|NCT03626545|39998270|FG000|Overall Study|Physician Decision|1|||
16413843|NCT03626545|39998271|FG001|Overall Study|Physician Decision|18|||
16413844|NCT03626545|39998272|FG002|Overall Study|Physician Decision|14|||
16413845|NCT03626545|39998270|FG000|Overall Study|Subject Decision|0|||
16413846|NCT03626545|39998271|FG001|Overall Study|Subject Decision|5|||
16413847|NCT03626545|39998272|FG002|Overall Study|Subject Decision|5|||
16413848|NCT03626545|39998270|FG000|Overall Study|Death|1|||
16413849|NCT03626545|39998271|FG001|Overall Study|Death|1|||
16413850|NCT03626545|39998272|FG002|Overall Study|Death|1|||
16236965|NCT01625286|39351071|FG005|Overall Study|Withdrawal by Subject|0|||
16413851|NCT03626545|39998270|FG000|Overall Study|Protocol Deviation|0|||
16413852|NCT03626545|39998271|FG001|Overall Study|Protocol Deviation|1|||
16236966|NCT01625286|39351072|FG006|Overall Study|Withdrawal by Subject|1|||
16349658|NCT03506438|39765695|FG001|Overall Study|Lost to Follow-up|7|||
16349659|NCT03506438|39765696|FG002|Overall Study|Lost to Follow-up|8|||
16349660|NCT03506438|39765697|FG003|Overall Study|Lost to Follow-up|7|||
16413853|NCT03626545|39998272|FG002|Overall Study|Protocol Deviation|1|||
16413854|NCT03626545|39998270|FG000|Overall Study|Guardian Decision|0|||
16413855|NCT03626545|39998271|FG001|Overall Study|Guardian Decision|0|||
16413856|NCT03626545|39998272|FG002|Overall Study|Guardian Decision|1|||
16413857|NCT03689244|39998274|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
16413858|NCT03689244|39998275|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
16413859|NCT03689244|39998276|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
16413860|NCT03689244|39998277|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
16413861|NCT03689244|39998274|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
16413862|NCT03689244|39998275|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
16413863|NCT03689244|39998276|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
16413864|NCT03689244|39998277|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
16413865|NCT03689244|39998274|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
16413866|NCT03689244|39998275|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
16413867|NCT03689244|39998276|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
16349661|NCT03506438|39765698|FG004|Overall Study|Lost to Follow-up|0|||
16413868|NCT03689244|39998277|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
16413869|NCT03689244|39998274|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
16413870|NCT03689244|39998275|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
16413871|NCT03689244|39998276|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
16236967|NCT01625286|39351066|FG000|Overall Study|Any reason not specifically recorded|0|||
16349662|NCT03506438|39765699|FG005|Overall Study|Lost to Follow-up|0|||
16349663|NCT00485069|39765700|FG000|Overall Study|Adverse Event|10|||
16349664|NCT00485069|39765701|FG001|Overall Study|Adverse Event|4|||
16236968|NCT01625286|39351067|FG001|Overall Study|Any reason not specifically recorded|0|||
16236969|NCT01625286|39351068|FG002|Overall Study|Any reason not specifically recorded|0|||
16236970|NCT01625286|39351069|FG003|Overall Study|Any reason not specifically recorded|0|||
16236971|NCT01625286|39351070|FG004|Overall Study|Any reason not specifically recorded|0|||
16349665|NCT00485069|39765700|FG000|Overall Study|Lack of Efficacy|2|||
16349666|NCT00485069|39765701|FG001|Overall Study|Lack of Efficacy|1|||
16236972|NCT01625286|39351071|FG005|Overall Study|Any reason not specifically recorded|1|||
16349667|NCT00485069|39765700|FG000|Overall Study|Protocol Violation|0|||
16349668|NCT00485069|39765701|FG001|Overall Study|Protocol Violation|1|||
16349669|NCT00485069|39765700|FG000|Overall Study|Withdrawal by Subject|6|||
16349670|NCT00485069|39765701|FG001|Overall Study|Withdrawal by Subject|6|||
16349671|NCT00837967|39765702|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
16349672|NCT00837967|39765703|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
16349673|NCT02039778|39765705|FG000|Overall Study|Death|2|||
16349674|NCT02039778|39765705|FG000|Overall Study|Withdrawal by Subject|1|||
16349675|NCT02039778|39765705|FG000|Overall Study|Never started the protocol treatment|1|||
16349676|NCT02526160|39765708|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
16349677|NCT02526160|39765709|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
16121750|NCT00588692|38930288|FG001|Overall Study|Death|0|||
16121751|NCT02493062|38930289|FG000|Overall Study|Physician Decision|12|||
16121752|NCT00858364|38930294|FG000|Overall Study|Administrative Decision|3|||
16121753|NCT00858364|38930295|FG001|Overall Study|Administrative Decision|2|||
16121754|NCT00858364|38930294|FG000|Overall Study|Adverse Event|5|||
16236973|NCT01625286|39351072|FG006|Overall Study|Any reason not specifically recorded|0|||
16236974|NCT01625286|39351066|FG000|Overall Study|Progressive disease|6|||
16236975|NCT01625286|39351067|FG001|Overall Study|Progressive disease|3|||
16121755|NCT00858364|38930295|FG001|Overall Study|Adverse Event|2|||
16349678|NCT02526160|39765708|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
16349679|NCT02526160|39765709|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
16349680|NCT02526160|39765708|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
16349681|NCT02526160|39765709|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
16349682|NCT02526160|39765708|FG000|Open-Label Treatment Extension Period I|Death|0|||
16349683|NCT02526160|39765709|FG001|Open-Label Treatment Extension Period I|Death|1|||
16349684|NCT02526160|39765708|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
16349685|NCT02526160|39765709|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
16349686|NCT02526160|39765708|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
16349687|NCT02526160|39765709|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
16349688|NCT02526160|39765708|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
16349689|NCT02526160|39765709|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
16349690|NCT02526160|39765708|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
16349691|NCT02526160|39765709|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
16349692|NCT00467519|39765715|FG000|Overall Study|Protocol Violation|8|||
16349693|NCT00467519|39765716|FG001|Overall Study|Protocol Violation|4|||
16121756|NCT00858364|38930294|FG000|Overall Study|Withdrawal by Subject|44|||
16236976|NCT01625286|39351068|FG002|Overall Study|Progressive disease|4|||
16236977|NCT01625286|39351069|FG003|Overall Study|Progressive disease|5|||
16236978|NCT01625286|39351070|FG004|Overall Study|Progressive disease|5|||
16236979|NCT01625286|39351071|FG005|Overall Study|Progressive disease|0|||
16236980|NCT01625286|39351072|FG006|Overall Study|Progressive disease|0|||
16236981|NCT01625286|39351066|FG000|Overall Study|Lost to Follow-up|0|||
16236982|NCT01625286|39351067|FG001|Overall Study|Lost to Follow-up|0|||
16236983|NCT01625286|39351068|FG002|Overall Study|Lost to Follow-up|0|||
16236984|NCT01625286|39351069|FG003|Overall Study|Lost to Follow-up|0|||
16236985|NCT01625286|39351070|FG004|Overall Study|Lost to Follow-up|0|||
16236986|NCT01625286|39351071|FG005|Overall Study|Lost to Follow-up|0|||
16236987|NCT01625286|39351072|FG006|Overall Study|Lost to Follow-up|1|||
16236988|NCT00953927|39351077|FG000|Overall Study|Lost to Follow-up|61|||
16236989|NCT00953927|39351078|FG001|Overall Study|Lost to Follow-up|65|||
16236990|NCT00953927|39351077|FG000|Overall Study|Withdrawal by Subject|36|||
16349694|NCT00467519|39765715|FG000|Overall Study|Lost to Follow-up|2|||
16349695|NCT00467519|39765716|FG001|Overall Study|Lost to Follow-up|9|||
16349696|NCT00467519|39765715|FG000|Overall Study|Withdrawal by Subject|4|||
16349697|NCT00467519|39765716|FG001|Overall Study|Withdrawal by Subject|10|||
16349698|NCT03177148|39765718|FG000|Overall Study|Lost to Follow-up|50|||
16349699|NCT03177148|39765719|FG001|Overall Study|Lost to Follow-up|1|||
16349700|NCT03177148|39765718|FG000|Overall Study|Death|1|||
16555105|NCT03881059|40496406|FG002|Treatment Period - Part A|Other reasons|0|||
16555106|NCT03881059|40496404|FG000|Treatment Period - Part B|Adverse Event|0|||
16555107|NCT03881059|40496405|FG001|Treatment Period - Part B|Adverse Event|0|||
16555108|NCT03881059|40496406|FG002|Treatment Period - Part B|Adverse Event|3|||
16555109|NCT03881059|40496404|FG000|Treatment Period - Part B|Death|0|||
16555110|NCT03881059|40496405|FG001|Treatment Period - Part B|Death|1|||
16555111|NCT03881059|40496406|FG002|Treatment Period - Part B|Death|1|||
16555112|NCT03881059|40496404|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
16555113|NCT03881059|40496405|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
16555114|NCT03881059|40496406|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
16555115|NCT03881059|40496404|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
16555116|NCT03881059|40496405|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
16555117|NCT03881059|40496406|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
16555118|NCT03881059|40496404|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
16555119|NCT03881059|40496405|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
16555120|NCT03881059|40496406|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
16555121|NCT03881059|40496404|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
16555122|NCT03881059|40496405|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
16555123|NCT03881059|40496406|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
16555124|NCT03881059|40496404|FG000|Treatment Period - Part B|Other reasons|4|||
16555125|NCT03881059|40496405|FG001|Treatment Period - Part B|Other reasons|3|||
16555126|NCT03881059|40496406|FG002|Treatment Period - Part B|Other reasons|3|||
16555127|NCT00472186|40496407|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
16555128|NCT00472186|40496408|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
16555129|NCT04466618|40496412|FG000|Overall Study|Withdrawal by Subject|0|||
16555130|NCT04466618|40496413|FG001|Overall Study|Withdrawal by Subject|1|||
16555131|NCT03354637|40496414|FG000|Double-blind Period|Protocol Violation|2|||
16555132|NCT03354637|40496415|FG001|Double-blind Period|Protocol Violation|0|||
16555133|NCT03354637|40496416|FG002|Double-blind Period|Protocol Violation|0|||
16555134|NCT03354637|40496414|FG000|Double-blind Period|Adverse Event|1|||
16555135|NCT03354637|40496415|FG001|Double-blind Period|Adverse Event|2|||
16236991|NCT00953927|39351078|FG001|Overall Study|Withdrawal by Subject|25|||
16236992|NCT00953927|39351077|FG000|Overall Study|Death|7|||
16236993|NCT00953927|39351078|FG001|Overall Study|Death|4|||
16236994|NCT00953927|39351077|FG000|Overall Study|Other study discontinuation|1|||
16555136|NCT03354637|40496416|FG002|Double-blind Period|Adverse Event|0|||
16555137|NCT03354637|40496414|FG000|Double-blind Period|Lost to Follow-up|3|||
16555138|NCT03354637|40496415|FG001|Double-blind Period|Lost to Follow-up|4|||
16555139|NCT03354637|40496416|FG002|Double-blind Period|Lost to Follow-up|3|||
16555140|NCT03354637|40496414|FG000|Double-blind Period|Withdrawal by Subject|10|||
16236995|NCT00953927|39351078|FG001|Overall Study|Other study discontinuation|1|||
16413872|NCT03689244|39998277|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
16413873|NCT03689244|39998274|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
16413874|NCT03689244|39998275|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
16413875|NCT03689244|39998276|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
16413876|NCT03689244|39998277|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
16413877|NCT03689244|39998274|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
16413878|NCT03689244|39998275|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
16413879|NCT03689244|39998276|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
16413880|NCT03689244|39998277|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
16413881|NCT03689244|39998274|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
16413882|NCT03689244|39998275|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
16555141|NCT03354637|40496415|FG001|Double-blind Period|Withdrawal by Subject|6|||
16555142|NCT03354637|40496416|FG002|Double-blind Period|Withdrawal by Subject|4|||
16555143|NCT03354637|40496414|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
16555144|NCT03354637|40496415|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
16555145|NCT03354637|40496416|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
16555146|NCT03354637|40496414|FG000|Open Label Extension|Adverse Event|0|||
16555147|NCT03354637|40496415|FG001|Open Label Extension|Adverse Event|0|||
16555148|NCT03354637|40496416|FG002|Open Label Extension|Adverse Event|1|||
16555149|NCT03354637|40496414|FG000|Open Label Extension|Lost to Follow-up|0|||
16555150|NCT03354637|40496415|FG001|Open Label Extension|Lost to Follow-up|0|||
16555151|NCT03354637|40496416|FG002|Open Label Extension|Lost to Follow-up|2|||
16555152|NCT03354637|40496414|FG000|Open Label Extension|Withdrawal by Subject|0|||
16555153|NCT03354637|40496415|FG001|Open Label Extension|Withdrawal by Subject|0|||
16555154|NCT03354637|40496416|FG002|Open Label Extension|Withdrawal by Subject|5|||
16121757|NCT00858364|38930295|FG001|Overall Study|Withdrawal by Subject|118|||
16121758|NCT00858364|38930294|FG000|Overall Study|Ineligibility Determined|1|||
16121759|NCT00858364|38930295|FG001|Overall Study|Ineligibility Determined|10|||
16121760|NCT00858364|38930294|FG000|Overall Study|Lost to Follow-up|24|||
16121761|NCT00858364|38930295|FG001|Overall Study|Lost to Follow-up|54|||
16555155|NCT03354637|40496414|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
16555156|NCT03354637|40496415|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
16555157|NCT03354637|40496416|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
16555158|NCT03354637|40496414|FG000|Open Label Extension|Subject Noncompliance|0|||
16555159|NCT03354637|40496415|FG001|Open Label Extension|Subject Noncompliance|0|||
16555160|NCT03354637|40496416|FG002|Open Label Extension|Subject Noncompliance|1|||
16555161|NCT03354637|40496414|FG000|Open Label Extension|Lack of Efficacy|0|||
16555162|NCT03354637|40496415|FG001|Open Label Extension|Lack of Efficacy|0|||
16555163|NCT03354637|40496416|FG002|Open Label Extension|Lack of Efficacy|1|||
16555164|NCT03354637|40496414|FG000|Open Label Extension|Physician Decision|0|||
16555165|NCT03354637|40496415|FG001|Open Label Extension|Physician Decision|0|||
16555166|NCT03354637|40496416|FG002|Open Label Extension|Physician Decision|1|||
16555167|NCT01266993|40496420|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
16555168|NCT01266993|40496421|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
16555169|NCT01266993|40496420|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
16555170|NCT01266993|40496421|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
16555171|NCT03580356|40496426|FG000|Treatment Period|Withdrawal by Subject|13|||
16555172|NCT03580356|40496427|FG001|Treatment Period|Withdrawal by Subject|0|||
16121762|NCT00858364|38930294|FG000|Overall Study|Noncompliance|3|||
16121763|NCT00858364|38930295|FG001|Overall Study|Noncompliance|4|||
16555173|NCT03580356|40496428|FG002|Treatment Period|Withdrawal by Subject|13|||
16555174|NCT03580356|40496429|FG003|Treatment Period|Withdrawal by Subject|1|||
16555175|NCT03580356|40496430|FG004|Treatment Period|Withdrawal by Subject|17|||
16555176|NCT03580356|40496431|FG005|Treatment Period|Withdrawal by Subject|0|||
16555177|NCT03580356|40496432|FG006|Treatment Period|Withdrawal by Subject|5|||
16555178|NCT03580356|40496433|FG007|Treatment Period|Withdrawal by Subject|0|||
16555179|NCT03580356|40496426|FG000|Treatment Period|Adverse Event|10|||
16555180|NCT03580356|40496427|FG001|Treatment Period|Adverse Event|0|||
16555181|NCT03580356|40496428|FG002|Treatment Period|Adverse Event|13|||
16555182|NCT03580356|40496429|FG003|Treatment Period|Adverse Event|0|||
16555183|NCT03580356|40496430|FG004|Treatment Period|Adverse Event|5|||
16555184|NCT03580356|40496431|FG005|Treatment Period|Adverse Event|0|||
16555185|NCT03580356|40496432|FG006|Treatment Period|Adverse Event|8|||
16555186|NCT03580356|40496433|FG007|Treatment Period|Adverse Event|0|||
16555187|NCT03580356|40496426|FG000|Treatment Period|Protocol Violation|5|||
16555188|NCT03580356|40496427|FG001|Treatment Period|Protocol Violation|0|||
16555189|NCT03580356|40496428|FG002|Treatment Period|Protocol Violation|6|||
16555190|NCT03580356|40496429|FG003|Treatment Period|Protocol Violation|1|||
16555191|NCT03580356|40496430|FG004|Treatment Period|Protocol Violation|9|||
16555192|NCT03580356|40496431|FG005|Treatment Period|Protocol Violation|1|||
16555193|NCT03580356|40496432|FG006|Treatment Period|Protocol Violation|1|||
16555194|NCT03580356|40496433|FG007|Treatment Period|Protocol Violation|0|||
16555195|NCT03580356|40496426|FG000|Treatment Period|Lack of Efficacy|6|||
16555196|NCT03580356|40496427|FG001|Treatment Period|Lack of Efficacy|0|||
16555197|NCT03580356|40496428|FG002|Treatment Period|Lack of Efficacy|2|||
16555198|NCT03580356|40496429|FG003|Treatment Period|Lack of Efficacy|0|||
16555199|NCT03580356|40496430|FG004|Treatment Period|Lack of Efficacy|3|||
16555200|NCT03580356|40496431|FG005|Treatment Period|Lack of Efficacy|0|||
16555201|NCT03580356|40496432|FG006|Treatment Period|Lack of Efficacy|3|||
16555202|NCT03580356|40496433|FG007|Treatment Period|Lack of Efficacy|0|||
16555203|NCT03580356|40496426|FG000|Treatment Period|Pregnancy|1|||
16555204|NCT03580356|40496427|FG001|Treatment Period|Pregnancy|0|||
16555205|NCT03580356|40496428|FG002|Treatment Period|Pregnancy|7|||
16555206|NCT03580356|40496429|FG003|Treatment Period|Pregnancy|0|||
16555207|NCT03580356|40496430|FG004|Treatment Period|Pregnancy|2|||
16555208|NCT03580356|40496431|FG005|Treatment Period|Pregnancy|0|||
16555209|NCT03580356|40496432|FG006|Treatment Period|Pregnancy|1|||
16555210|NCT03580356|40496433|FG007|Treatment Period|Pregnancy|0|||
16555211|NCT03580356|40496426|FG000|Treatment Period|Physician Decision|2|||
16555212|NCT03580356|40496427|FG001|Treatment Period|Physician Decision|0|||
16555213|NCT03580356|40496428|FG002|Treatment Period|Physician Decision|1|||
16555214|NCT03580356|40496429|FG003|Treatment Period|Physician Decision|0|||
16555215|NCT03580356|40496430|FG004|Treatment Period|Physician Decision|4|||
16555216|NCT03580356|40496431|FG005|Treatment Period|Physician Decision|0|||
16555217|NCT03580356|40496432|FG006|Treatment Period|Physician Decision|2|||
16555218|NCT03580356|40496433|FG007|Treatment Period|Physician Decision|0|||
16555219|NCT03580356|40496426|FG000|Treatment Period|Lost to Follow-up|1|||
16555220|NCT03580356|40496427|FG001|Treatment Period|Lost to Follow-up|1|||
16555221|NCT03580356|40496428|FG002|Treatment Period|Lost to Follow-up|1|||
16555222|NCT03580356|40496429|FG003|Treatment Period|Lost to Follow-up|0|||
16555223|NCT03580356|40496430|FG004|Treatment Period|Lost to Follow-up|3|||
16555224|NCT03580356|40496431|FG005|Treatment Period|Lost to Follow-up|0|||
16555225|NCT03580356|40496432|FG006|Treatment Period|Lost to Follow-up|1|||
16555226|NCT03580356|40496433|FG007|Treatment Period|Lost to Follow-up|0|||
16555227|NCT03580356|40496426|FG000|Treatment Period|Death|0|||
16555228|NCT03580356|40496427|FG001|Treatment Period|Death|0|||
16555229|NCT03580356|40496428|FG002|Treatment Period|Death|1|||
16236996|NCT01052038|39351089|FG000|Overall Study|Lost to Follow-up|2|||
16236997|NCT01052038|39351090|FG001|Overall Study|Lost to Follow-up|3|||
16236998|NCT01052038|39351091|FG002|Overall Study|Lost to Follow-up|1|||
16236999|NCT01052038|39351089|FG000|Overall Study|Protocol Violation|2|||
16237000|NCT01052038|39351090|FG001|Overall Study|Protocol Violation|3|||
16237001|NCT01052038|39351091|FG002|Overall Study|Protocol Violation|3|||
16237002|NCT00782275|39351094|FG000|Overall Study|Adverse Event|11|||
16237003|NCT00782275|39351094|FG000|Overall Study|Withdrawal by Subject|1|||
16237004|NCT00782275|39351094|FG000|Overall Study|Progressive Disease|21|||
16237005|NCT00782275|39351094|FG000|Overall Study|Physician Decision|4|||
16237006|NCT00782275|39351094|FG000|Overall Study|Not started treatment|1|||
16555230|NCT03580356|40496429|FG003|Treatment Period|Death|0|||
16555231|NCT03580356|40496430|FG004|Treatment Period|Death|0|||
16237007|NCT00782275|39351094|FG000|Overall Study|Other|3|||
16237008|NCT04529096|39351097|FG000|Overall Study|Adverse Event|6|||
16555232|NCT03580356|40496431|FG005|Treatment Period|Death|0|||
16555233|NCT03580356|40496432|FG006|Treatment Period|Death|0|||
16555234|NCT03580356|40496433|FG007|Treatment Period|Death|0|||
16555235|NCT03580356|40496426|FG000|Treatment Period|Technical problems|0|||
16555236|NCT03580356|40496427|FG001|Treatment Period|Technical problems|0|||
16555237|NCT03580356|40496428|FG002|Treatment Period|Technical problems|0|||
16555238|NCT03580356|40496429|FG003|Treatment Period|Technical problems|0|||
16555239|NCT03580356|40496430|FG004|Treatment Period|Technical problems|1|||
16555240|NCT03580356|40496431|FG005|Treatment Period|Technical problems|0|||
16555241|NCT03580356|40496432|FG006|Treatment Period|Technical problems|0|||
16555242|NCT03580356|40496433|FG007|Treatment Period|Technical problems|0|||
16555243|NCT03580356|40496426|FG000|Treatment Period|Misrandomized, no treatment|0|||
16555244|NCT03580356|40496427|FG001|Treatment Period|Misrandomized, no treatment|0|||
16555245|NCT03580356|40496428|FG002|Treatment Period|Misrandomized, no treatment|1|||
16555246|NCT03580356|40496429|FG003|Treatment Period|Misrandomized, no treatment|0|||
16555247|NCT03580356|40496430|FG004|Treatment Period|Misrandomized, no treatment|2|||
16555248|NCT03580356|40496431|FG005|Treatment Period|Misrandomized, no treatment|0|||
16555249|NCT03580356|40496432|FG006|Treatment Period|Misrandomized, no treatment|0|||
16555250|NCT03580356|40496433|FG007|Treatment Period|Misrandomized, no treatment|0|||
16237009|NCT04529096|39351098|FG001|Overall Study|Adverse Event|1|||
16237010|NCT04529096|39351097|FG000|Overall Study|Lack of Efficacy|1|||
16237011|NCT04529096|39351098|FG001|Overall Study|Lack of Efficacy|0|||
16237012|NCT04529096|39351097|FG000|Overall Study|Lost to Follow-up|1|||
16237013|NCT04529096|39351098|FG001|Overall Study|Lost to Follow-up|1|||
16237014|NCT04529096|39351097|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16237015|NCT04529096|39351098|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16237016|NCT04529096|39351097|FG000|Overall Study|Physician Decision|1|||
16237017|NCT04529096|39351098|FG001|Overall Study|Physician Decision|3|||
16237018|NCT04529096|39351097|FG000|Overall Study|Withdrawal by Subject|5|||
16237019|NCT04529096|39351098|FG001|Overall Study|Withdrawal by Subject|0|||
16237020|NCT01067339|39351099|FG000|Overall Study|Withdrawal by Subject|6|||
16237021|NCT01067339|39351100|FG001|Overall Study|Withdrawal by Subject|5|||
16237022|NCT01020773|39351107|FG000|Overall Study|Withdrawal by Subject|4|||
16237023|NCT01020773|39351108|FG001|Overall Study|Withdrawal by Subject|3|||
16237024|NCT01861717|39351111|FG000|Overall Study|Lost to Follow-up|1|||
16555251|NCT03580356|40496426|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
16413883|NCT03689244|39998276|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
16413884|NCT03689244|39998277|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
16413885|NCT03689244|39998274|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
16413886|NCT03689244|39998275|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
16413887|NCT03689244|39998276|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
16413888|NCT03689244|39998277|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
16413889|NCT02290938|39998278|FG000|Overall Study|Lost to Follow-up|14|||
16413890|NCT02290938|39998279|FG001|Overall Study|Lost to Follow-up|43|||
16413891|NCT05545644|39998280|FG000|Overall Study|Lost to Follow-up|4|||
16413892|NCT05545644|39998281|FG001|Overall Study|Lost to Follow-up|3|||
16413893|NCT00844805|39998282|FG000|Treatment Phase|Adverse Event|5|||
16413894|NCT00844805|39998283|FG001|Treatment Phase|Adverse Event|1|||
16413895|NCT00844805|39998284|FG002|Treatment Phase|Adverse Event|0|||
16413896|NCT00844805|39998285|FG003|Treatment Phase|Adverse Event|0|||
16413897|NCT00844805|39998282|FG000|Treatment Phase|Withdrawal by Subject|3|||
16413898|NCT00844805|39998283|FG001|Treatment Phase|Withdrawal by Subject|4|||
16413899|NCT00844805|39998284|FG002|Treatment Phase|Withdrawal by Subject|0|||
16413900|NCT00844805|39998285|FG003|Treatment Phase|Withdrawal by Subject|0|||
16413901|NCT00844805|39998282|FG000|Treatment Phase|Noncompliance With Protocol|1|||
16413902|NCT00844805|39998283|FG001|Treatment Phase|Noncompliance With Protocol|0|||
16413903|NCT00844805|39998284|FG002|Treatment Phase|Noncompliance With Protocol|0|||
16413904|NCT00844805|39998285|FG003|Treatment Phase|Noncompliance With Protocol|0|||
16413905|NCT00844805|39998282|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
16413906|NCT00844805|39998283|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
16413907|NCT00844805|39998284|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
16413908|NCT00844805|39998285|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
16413909|NCT00844805|39998282|FG000|Follow-Up Phase|Adverse Event|0|||
16413910|NCT00844805|39998283|FG001|Follow-Up Phase|Adverse Event|0|||
16413911|NCT00844805|39998284|FG002|Follow-Up Phase|Adverse Event|1|||
16413912|NCT00844805|39998285|FG003|Follow-Up Phase|Adverse Event|0|||
16555252|NCT03580356|40496427|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
16555253|NCT03580356|40496428|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
16555254|NCT03580356|40496429|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
16555255|NCT03580356|40496430|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
16555256|NCT03580356|40496431|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
16555257|NCT03580356|40496432|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
16555258|NCT03580356|40496433|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
16121764|NCT00858364|38930294|FG000|Overall Study|Protocol Deviation|0|||
16237025|NCT01861717|39351111|FG000|Overall Study|Withdrawal by Subject|1|||
16237026|NCT03494816|39351116|FG000|Overall Study|Protocol Violation|2|||
16413913|NCT00844805|39998282|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
16413914|NCT00844805|39998283|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
16413915|NCT00844805|39998284|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
16413916|NCT00844805|39998285|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
16413917|NCT00844805|39998282|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
16555259|NCT03580356|40496426|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
16555260|NCT03580356|40496427|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
16555261|NCT03580356|40496428|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
16555262|NCT03580356|40496429|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
16555263|NCT03580356|40496430|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
16555264|NCT03580356|40496431|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
16237027|NCT03494816|39351116|FG000|Overall Study|Physician Decision|2|||
16237028|NCT03494816|39351116|FG000|Overall Study|Did not start trial treatment|1|||
16237029|NCT03494816|39351116|FG000|Overall Study|Adverse Event|1|||
16237030|NCT03079869|39351117|FG000|Overall Study|Adverse Event|6|||
16237031|NCT03079869|39351118|FG001|Overall Study|Adverse Event|8|||
16237032|NCT03079869|39351117|FG000|Overall Study|Withdrawal by Subject|4|||
16237033|NCT03079869|39351118|FG001|Overall Study|Withdrawal by Subject|1|||
16237034|NCT03079869|39351117|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
16237035|NCT03079869|39351118|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
16237036|NCT03594175|39351119|FG000|Overall Study|Not treated|8|||
16237037|NCT03594175|39351120|FG001|Overall Study|Not treated|1|||
16237038|NCT03594175|39351121|FG002|Overall Study|Not treated|5|||
16237039|NCT03594175|39351119|FG000|Overall Study|Adverse Event|3|||
16237040|NCT03594175|39351120|FG001|Overall Study|Adverse Event|0|||
16237041|NCT03594175|39351121|FG002|Overall Study|Adverse Event|0|||
16237042|NCT03594175|39351119|FG000|Overall Study|Withdrawal by Subject|3|||
16237043|NCT03594175|39351120|FG001|Overall Study|Withdrawal by Subject|0|||
16237044|NCT03594175|39351121|FG002|Overall Study|Withdrawal by Subject|0|||
16237045|NCT03594175|39351119|FG000|Overall Study|Protocol Violation|2|||
16237046|NCT03594175|39351120|FG001|Overall Study|Protocol Violation|2|||
16237047|NCT03594175|39351121|FG002|Overall Study|Protocol Violation|2|||
16237048|NCT03252756|39351122|FG000|Overall Study|Protocol Violation|2|||
16237049|NCT03252756|39351123|FG001|Overall Study|Protocol Violation|4|||
16237050|NCT03252756|39351122|FG000|Overall Study|COVID-19 Pandemic|1|||
16237051|NCT03252756|39351123|FG001|Overall Study|COVID-19 Pandemic|1|||
16237052|NCT03252756|39351122|FG000|Overall Study|Study Drug Expiration|0|||
16237053|NCT03252756|39351123|FG001|Overall Study|Study Drug Expiration|1|||
16237054|NCT00817778|39351124|FG000|Overall Study|Adverse Event|1|||
16237055|NCT00817778|39351125|FG001|Overall Study|Adverse Event|0|||
16237056|NCT00817778|39351124|FG000|Overall Study|Withdrawal by Subject|1|||
16237057|NCT00817778|39351125|FG001|Overall Study|Withdrawal by Subject|1|||
16237058|NCT00817778|39351124|FG000|Overall Study|Protocol Violation|0|||
16237059|NCT00817778|39351125|FG001|Overall Study|Protocol Violation|1|||
16237060|NCT00817778|39351124|FG000|Overall Study|Study-specific discontinuation criteria|0|||
16237061|NCT00817778|39351125|FG001|Overall Study|Study-specific discontinuation criteria|1|||
16237062|NCT00817778|39351124|FG000|Overall Study|Poor venous access|1|||
16237063|NCT00817778|39351125|FG001|Overall Study|Poor venous access|0|||
16237064|NCT01612702|39354397|FG000|Overall Study|Protocol Violation|11|||
16237065|NCT01612702|39354398|FG001|Overall Study|Protocol Violation|11|||
16237066|NCT02059187|39354401|FG000|Overall Study|Adverse Event|0|||
16237067|NCT02059187|39354402|FG001|Overall Study|Adverse Event|3|||
16237068|NCT02059187|39354401|FG000|Overall Study|Death|1|||
16237069|NCT02059187|39354402|FG001|Overall Study|Death|1|||
16237070|NCT02059187|39354401|FG000|Overall Study|Lost to Follow-up|9|||
16237071|NCT02059187|39354402|FG001|Overall Study|Lost to Follow-up|8|||
16237072|NCT02059187|39354401|FG000|Overall Study|Non-compliance with study drug|1|||
16237073|NCT02059187|39354402|FG001|Overall Study|Non-compliance with study drug|0|||
16237074|NCT02059187|39354401|FG000|Overall Study|Physician Decision|1|||
16237075|NCT02059187|39354402|FG001|Overall Study|Physician Decision|2|||
16237076|NCT02059187|39354401|FG000|Overall Study|Protocol Violation|1|||
16237077|NCT02059187|39354402|FG001|Overall Study|Protocol Violation|0|||
16237078|NCT02059187|39354401|FG000|Overall Study|Withdrawal by Subject|12|||
16237079|NCT02059187|39354402|FG001|Overall Study|Withdrawal by Subject|8|||
16237080|NCT00827359|39354403|FG000|Overall Study|Progressive Diseas|19|||
16237081|NCT00827359|39354403|FG000|Overall Study|Unacceptable Toxicity|5|||
16237082|NCT00827359|39354403|FG000|Overall Study|Ineligible|1|||
16237083|NCT01784419|39354404|FG000|Overall Study|Adverse Event|3|||
16237084|NCT02406742|39354411|FG000|Overall Study|Progression of Disease|5|||
16237085|NCT02406742|39354412|FG001|Overall Study|Progression of Disease|1|||
16237086|NCT02406742|39354413|FG002|Overall Study|Progression of Disease|6|||
16237087|NCT02406742|39354411|FG000|Overall Study|Adverse Event|3|||
16237088|NCT02406742|39354412|FG001|Overall Study|Adverse Event|0|||
16237089|NCT02406742|39354413|FG002|Overall Study|Adverse Event|2|||
16237090|NCT02406742|39354411|FG000|Overall Study|Death|1|||
16237091|NCT02406742|39354412|FG001|Overall Study|Death|0|||
16237092|NCT02406742|39354413|FG002|Overall Study|Death|0|||
16237093|NCT02406742|39354411|FG000|Overall Study|Lack of Efficacy|0|||
16237094|NCT02406742|39354412|FG001|Overall Study|Lack of Efficacy|0|||
16237095|NCT02406742|39354413|FG002|Overall Study|Lack of Efficacy|1|||
16555265|NCT03580356|40496432|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
16555266|NCT03580356|40496433|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
16555267|NCT03580356|40496426|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
16237096|NCT02406742|39354411|FG000|Overall Study|Withdrawal by Participant|1|||
16237097|NCT02406742|39354412|FG001|Overall Study|Withdrawal by Participant|2|||
16237098|NCT02406742|39354413|FG002|Overall Study|Withdrawal by Participant|0|||
16237099|NCT02406742|39354411|FG000|Overall Study|Physician Decision|1|||
16237100|NCT02406742|39354412|FG001|Overall Study|Physician Decision|2|||
16237101|NCT02406742|39354413|FG002|Overall Study|Physician Decision|1|||
16237102|NCT02406742|39354411|FG000|Overall Study|Transition to other treatment|2|||
16237103|NCT02406742|39354412|FG001|Overall Study|Transition to other treatment|0|||
16237104|NCT02406742|39354413|FG002|Overall Study|Transition to other treatment|1|||
16237105|NCT02406742|39354411|FG000|Overall Study|Other Reasons|1|||
16237106|NCT02406742|39354412|FG001|Overall Study|Other Reasons|11|||
16237107|NCT02406742|39354413|FG002|Overall Study|Other Reasons|5|||
16237108|NCT03672396|39354415|FG000|Overall Study|Withdrawal by Subject|4|||
16237109|NCT03672396|39354415|FG000|Overall Study|Physician Decision|1|||
16237110|NCT03672396|39354415|FG000|Overall Study|Adverse Event|1|||
16237111|NCT02766088|39354416|FG000|Overall Study|Sponsor study termination|498|||
16237112|NCT02766088|39354416|FG000|Overall Study|Migrated/moved from the study area|1|||
16237113|NCT02766088|39354416|FG000|Overall Study|Lost to Follow-up|5|||
16237114|NCT02766088|39354416|FG000|Overall Study|Other|1|||
16237115|NCT02766088|39354416|FG000|Overall Study|Death|1|||
16237116|NCT01825876|39354419|FG000|Period 2|Withdrawal by Subject|0|||
16237117|NCT01825876|39354420|FG001|Period 2|Withdrawal by Subject|1|||
16237118|NCT02595528|39354421|FG000|Overall Study|Withdrawal by Subject|1|||
16237119|NCT02595528|39354422|FG001|Overall Study|Withdrawal by Subject|2|||
16237120|NCT02595528|39354423|FG002|Overall Study|Withdrawal by Subject|1|||
16237121|NCT02595528|39354424|FG003|Overall Study|Withdrawal by Subject|3|||
16237122|NCT02595528|39354421|FG000|Overall Study|Lost to Follow-up|1|||
16237123|NCT02595528|39354422|FG001|Overall Study|Lost to Follow-up|1|||
16237124|NCT02595528|39354423|FG002|Overall Study|Lost to Follow-up|0|||
16237125|NCT02595528|39354424|FG003|Overall Study|Lost to Follow-up|1|||
16237126|NCT02162511|39354425|FG000|Overall Study|Lack of Efficacy|0|||
16237127|NCT02162511|39354426|FG001|Overall Study|Lack of Efficacy|0|||
16237128|NCT02162511|39354427|FG002|Overall Study|Lack of Efficacy|2|||
16237129|NCT01548573|39354428|FG000|Overall Study|Death|3|||
16237130|NCT01548573|39354428|FG000|Overall Study|Withdrawal by Subject|2|||
16237131|NCT02702271|39354429|FG000|Overall Study|Death|36|||
16237132|NCT02702271|39354430|FG001|Overall Study|Death|7|||
16237133|NCT02702271|39354429|FG000|Overall Study|Lost to Follow-up|12|||
16237134|NCT02702271|39354430|FG001|Overall Study|Lost to Follow-up|0|||
16237135|NCT02702271|39354429|FG000|Overall Study|Withdrawal by Subject|8|||
16237136|NCT02702271|39354430|FG001|Overall Study|Withdrawal by Subject|1|||
16237137|NCT02702271|39354429|FG000|Overall Study|Physician Decision|2|||
16237138|NCT02702271|39354430|FG001|Overall Study|Physician Decision|0|||
16237139|NCT02702271|39354429|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
16237140|NCT02702271|39354430|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
16237141|NCT02962739|39354431|FG000|Overall Study|Withdrawal by Subject|0|||
16237142|NCT02962739|39354432|FG001|Overall Study|Withdrawal by Subject|1|||
16237143|NCT02962739|39354433|FG002|Overall Study|Withdrawal by Subject|0|||
16237144|NCT02962739|39354434|FG003|Overall Study|Withdrawal by Subject|0|||
16237145|NCT02962739|39354435|FG004|Overall Study|Withdrawal by Subject|0|||
16237146|NCT02962739|39354436|FG005|Overall Study|Withdrawal by Subject|0|||
16237147|NCT02962739|39354431|FG000|Overall Study|Protocol Violation|0|||
16237148|NCT02962739|39354432|FG001|Overall Study|Protocol Violation|0|||
16237149|NCT02962739|39354433|FG002|Overall Study|Protocol Violation|1|||
16237150|NCT02962739|39354434|FG003|Overall Study|Protocol Violation|0|||
16237151|NCT02962739|39354435|FG004|Overall Study|Protocol Violation|1|||
16237152|NCT02962739|39354436|FG005|Overall Study|Protocol Violation|0|||
16237153|NCT01610284|39354437|FG000|Randomization Phase|Adverse Event|1|||
16237154|NCT01610284|39354438|FG001|Randomization Phase|Adverse Event|0|||
16237155|NCT01610284|39354437|FG000|Randomization Phase|Physician Decision|1|||
16237156|NCT01610284|39354438|FG001|Randomization Phase|Physician Decision|1|||
16237157|NCT01610284|39354437|FG000|Randomization Phase|Death|0|||
16237158|NCT01610284|39354438|FG001|Randomization Phase|Death|1|||
16237159|NCT01610284|39354437|FG000|Treatment Phase|Adverse Event|80|||
16237160|NCT01610284|39354438|FG001|Treatment Phase|Adverse Event|12|||
16237161|NCT01610284|39354437|FG000|Treatment Phase|Lost to Follow-up|1|||
16237162|NCT01610284|39354438|FG001|Treatment Phase|Lost to Follow-up|0|||
16237163|NCT01610284|39354437|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
16237164|NCT01610284|39354438|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
16237165|NCT01610284|39354437|FG000|Treatment Phase|Physician Decision|27|||
16237166|NCT01610284|39354438|FG001|Treatment Phase|Physician Decision|24|||
16237167|NCT01610284|39354437|FG000|Treatment Phase|Progressive Disease|377|||
16237168|NCT01610284|39354438|FG001|Treatment Phase|Progressive Disease|486|||
16555268|NCT03580356|40496427|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
16237169|NCT01610284|39354437|FG000|Treatment Phase|Protocol Deviation|2|||
16237170|NCT01610284|39354438|FG001|Treatment Phase|Protocol Deviation|3|||
16237171|NCT01610284|39354437|FG000|Treatment Phase|Study terminated by Sponsor|18|||
16237172|NCT01610284|39354438|FG001|Treatment Phase|Study terminated by Sponsor|15|||
16237173|NCT01610284|39354437|FG000|Treatment Phase|Subject/Guardian Decision|55|||
16237174|NCT01610284|39354438|FG001|Treatment Phase|Subject/Guardian Decision|23|||
16237175|NCT01610284|39354437|FG000|Treatment Phase|Death|6|||
16237176|NCT01610284|39354438|FG001|Treatment Phase|Death|5|||
16237177|NCT01610284|39354437|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
16237178|NCT01610284|39354438|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
16237179|NCT01610284|39354437|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
16237180|NCT01610284|39354438|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
16237181|NCT01610284|39354437|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
16237182|NCT01610284|39354438|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
16237183|NCT01610284|39354437|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
16237184|NCT01610284|39354438|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
16237185|NCT01610284|39354437|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
16237186|NCT01610284|39354438|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
16237187|NCT01610284|39354437|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
16237188|NCT01610284|39354438|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
16237189|NCT03343054|39354439|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
16237190|NCT03343054|39354440|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
16237191|NCT03343054|39354441|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
16237192|NCT03343054|39354439|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
16237193|NCT03343054|39354440|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
16237194|NCT03343054|39354441|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
16555269|NCT03580356|40496428|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
16555270|NCT03580356|40496429|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
16555271|NCT03580356|40496430|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
16555272|NCT03580356|40496431|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
16555273|NCT03580356|40496432|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
16555274|NCT03580356|40496433|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
16555275|NCT03580356|40496426|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
16555276|NCT03580356|40496427|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
16237195|NCT03343054|39354439|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
16237196|NCT03343054|39354440|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
16237197|NCT03343054|39354441|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
16237198|NCT03343054|39354439|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
16237199|NCT03343054|39354440|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
16237200|NCT03343054|39354441|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
16237201|NCT04347161|39354442|FG000|Overall Study|Death|0|||
16237202|NCT04347161|39354443|FG001|Overall Study|Death|2|||
16237203|NCT04347161|39354442|FG000|Overall Study|Withdrawal by Subject|1|||
16237204|NCT04347161|39354443|FG001|Overall Study|Withdrawal by Subject|0|||
16237205|NCT04347161|39354442|FG000|Overall Study|Lost to Follow-up|0|||
16237206|NCT04347161|39354443|FG001|Overall Study|Lost to Follow-up|1|||
16237207|NCT04347161|39354442|FG000|Overall Study|No longer on study medication|1|||
16237208|NCT04347161|39354443|FG001|Overall Study|No longer on study medication|1|||
16237209|NCT03333382|39354444|FG000|Overall Study|Lost to Follow-up|1|||
16237210|NCT03333382|39354445|FG001|Overall Study|Lost to Follow-up|0|||
16237211|NCT02886494|39354446|FG000|Overall Study|Adverse Event|1|||
16237212|NCT02886494|39354447|FG001|Overall Study|Adverse Event|0|||
16237213|NCT02886494|39354446|FG000|Overall Study|Withdrawal by Subject|12|||
16237214|NCT02886494|39354447|FG001|Overall Study|Withdrawal by Subject|3|||
16237215|NCT02886494|39354446|FG000|Overall Study|Protocol Violation|4|||
16237216|NCT02886494|39354447|FG001|Overall Study|Protocol Violation|1|||
16237217|NCT00343642|39354449|FG000|Overall Study|Lost to Follow-up|0|||
16237218|NCT00343642|39354450|FG001|Overall Study|Lost to Follow-up|1|||
16237219|NCT00343642|39354451|FG002|Overall Study|Lost to Follow-up|0|||
16237220|NCT00343642|39354449|FG000|Overall Study|Pregnancy|1|||
16237221|NCT00343642|39354450|FG001|Overall Study|Pregnancy|0|||
16237222|NCT00343642|39354451|FG002|Overall Study|Pregnancy|2|||
16237223|NCT00343642|39354449|FG000|Overall Study|Withdrawal by Subject|2|||
16237224|NCT00343642|39354450|FG001|Overall Study|Withdrawal by Subject|3|||
16237225|NCT00343642|39354451|FG002|Overall Study|Withdrawal by Subject|4|||
16237226|NCT00343642|39354449|FG000|Overall Study|Adverse Event|0|||
16237227|NCT00343642|39354450|FG001|Overall Study|Adverse Event|0|||
16237228|NCT00343642|39354451|FG002|Overall Study|Adverse Event|1|||
16237229|NCT00343642|39354449|FG000|Overall Study|Flare up|6|||
16237230|NCT00343642|39354450|FG001|Overall Study|Flare up|4|||
16237231|NCT00343642|39354451|FG002|Overall Study|Flare up|0|||
16237232|NCT01461369|39354452|FG000|Overall Study|Lack of Efficacy|2|||
16237233|NCT01461369|39354453|FG001|Overall Study|Lack of Efficacy|0|||
16237234|NCT01461369|39354454|FG002|Overall Study|Lack of Efficacy|6|||
16555277|NCT03580356|40496428|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
16237235|NCT01461369|39354452|FG000|Overall Study|Lost to Follow-up|0|||
16237236|NCT01461369|39354453|FG001|Overall Study|Lost to Follow-up|0|||
16237237|NCT01461369|39354454|FG002|Overall Study|Lost to Follow-up|3|||
16237238|NCT01461369|39354452|FG000|Overall Study|Adverse Event|9|||
16237239|NCT01461369|39354453|FG001|Overall Study|Adverse Event|12|||
16237240|NCT01461369|39354454|FG002|Overall Study|Adverse Event|4|||
16237241|NCT01461369|39354452|FG000|Overall Study|Protocol Violation|1|||
16237242|NCT01461369|39354453|FG001|Overall Study|Protocol Violation|2|||
16237243|NCT01461369|39354454|FG002|Overall Study|Protocol Violation|2|||
16237244|NCT01461369|39354452|FG000|Overall Study|Withdrawal by Subject|1|||
16237245|NCT01461369|39354453|FG001|Overall Study|Withdrawal by Subject|3|||
16237246|NCT01461369|39354454|FG002|Overall Study|Withdrawal by Subject|2|||
16237247|NCT03125915|39354455|FG000|1 Month Follow up|Lost to Follow-up|3|||
16237248|NCT03125915|39354456|FG001|1 Month Follow up|Lost to Follow-up|3|||
16237249|NCT03125915|39354457|FG002|1 Month Follow up|Lost to Follow-up|2|||
16237250|NCT03125915|39354458|FG003|1 Month Follow up|Lost to Follow-up|3|||
16237251|NCT03125915|39354455|FG000|3 Month Follow-up|Lost to Follow-up|6|||
16237252|NCT03125915|39354456|FG001|3 Month Follow-up|Lost to Follow-up|4|||
16237253|NCT03125915|39354457|FG002|3 Month Follow-up|Lost to Follow-up|4|||
16237254|NCT03125915|39354458|FG003|3 Month Follow-up|Lost to Follow-up|2|||
16237255|NCT03125915|39354455|FG000|6 Month Follow-up|Lost to Follow-up|7|||
16237256|NCT03125915|39354456|FG001|6 Month Follow-up|Lost to Follow-up|3|||
16237257|NCT03125915|39354457|FG002|6 Month Follow-up|Lost to Follow-up|6|||
16237258|NCT03125915|39354458|FG003|6 Month Follow-up|Lost to Follow-up|3|||
16237259|NCT00928135|39354459|FG000|Overall Study|Withdrawal by Subject|1|||
16237260|NCT00928135|39354460|FG001|Overall Study|Withdrawal by Subject|0|||
16237261|NCT03099265|39354477|FG000|Overall Study|Adverse Event|1|||
16237262|NCT01286207|39354478|FG000|Overall Study|Adverse Event|27|||
16237263|NCT01286207|39354479|FG001|Overall Study|Adverse Event|41|||
16237264|NCT01286207|39354480|FG002|Overall Study|Adverse Event|8|||
16237265|NCT01286207|39354478|FG000|Overall Study|Lost to Follow-up|49|||
16237266|NCT01286207|39354479|FG001|Overall Study|Lost to Follow-up|43|||
16237267|NCT01286207|39354480|FG002|Overall Study|Lost to Follow-up|20|||
16237268|NCT01286207|39354478|FG000|Overall Study|Withdrawal by Subject|93|||
16237269|NCT01286207|39354479|FG001|Overall Study|Withdrawal by Subject|79|||
16237270|NCT01286207|39354480|FG002|Overall Study|Withdrawal by Subject|41|||
16237271|NCT01286207|39354478|FG000|Overall Study|Lack of Response|92|||
16555278|NCT03580356|40496429|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
16555279|NCT03580356|40496430|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
16555280|NCT03580356|40496431|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
16555281|NCT03580356|40496432|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
16237272|NCT01286207|39354479|FG001|Overall Study|Lack of Response|38|||
16237273|NCT01286207|39354480|FG002|Overall Study|Lack of Response|8|||
16237274|NCT01286207|39354478|FG000|Overall Study|Other|37|||
16237275|NCT01286207|39354479|FG001|Overall Study|Other|47|||
16237276|NCT01286207|39354480|FG002|Overall Study|Other|13|||
16237277|NCT03056001|39354485|FG000|Overall Study|Death|24|||
16237278|NCT00725725|39354486|FG000|Overall Study|Adverse Event|1|||
16237279|NCT00725725|39354487|FG001|Overall Study|Adverse Event|3|||
16237280|NCT00725725|39354488|FG002|Overall Study|Adverse Event|2|||
16237281|NCT00725725|39354486|FG000|Overall Study|Lost to Follow-up|2|||
16237282|NCT00725725|39354487|FG001|Overall Study|Lost to Follow-up|0|||
16237283|NCT00725725|39354488|FG002|Overall Study|Lost to Follow-up|2|||
16237284|NCT00725725|39354486|FG000|Overall Study|Withdrawal by Subject|1|||
16237285|NCT00725725|39354487|FG001|Overall Study|Withdrawal by Subject|0|||
16237286|NCT00725725|39354488|FG002|Overall Study|Withdrawal by Subject|1|||
16237287|NCT00725725|39354486|FG000|Overall Study|Protocol Violation|0|||
16237288|NCT00725725|39354487|FG001|Overall Study|Protocol Violation|1|||
16237289|NCT00725725|39354488|FG002|Overall Study|Protocol Violation|0|||
16237290|NCT00589693|39354491|FG000|Overall Study|randomized in error|12|||
16237291|NCT00589693|39354492|FG001|Overall Study|randomized in error|6|||
16237292|NCT00589693|39354491|FG000|Overall Study|Adverse Event|4|||
16237293|NCT00589693|39354492|FG001|Overall Study|Adverse Event|4|||
16237294|NCT00589693|39354491|FG000|Overall Study|Death|26|||
16237295|NCT00589693|39354492|FG001|Overall Study|Death|16|||
16237296|NCT00589693|39354491|FG000|Overall Study|Lack of Efficacy|0|||
16237297|NCT00589693|39354492|FG001|Overall Study|Lack of Efficacy|1|||
16237298|NCT00589693|39354491|FG000|Overall Study|Lost to Follow-up|1|||
16237299|NCT00589693|39354492|FG001|Overall Study|Lost to Follow-up|0|||
16237300|NCT00589693|39354491|FG000|Overall Study|Physician Decision|0|||
16237301|NCT00589693|39354492|FG001|Overall Study|Physician Decision|1|||
16237302|NCT00589693|39354491|FG000|Overall Study|Protocol Violation|1|||
16237303|NCT00589693|39354492|FG001|Overall Study|Protocol Violation|1|||
16237304|NCT00929864|39354494|FG000|Overall Study|Death|1|||
16237305|NCT00929864|39354495|FG001|Overall Study|Death|1|||
16237306|NCT00929864|39354494|FG000|Overall Study|Adverse Event|11|||
16237307|NCT00929864|39354495|FG001|Overall Study|Adverse Event|30|||
16237308|NCT00929864|39354494|FG000|Overall Study|Lack of Efficacy|19|||
16237309|NCT00929864|39354495|FG001|Overall Study|Lack of Efficacy|16|||
16237310|NCT00929864|39354494|FG000|Overall Study|Lost to Follow-up|7|||
16555282|NCT03580356|40496433|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
16555283|NCT03580356|40496426|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
16555284|NCT03580356|40496427|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
16555285|NCT03580356|40496428|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
16121765|NCT00858364|38930295|FG001|Overall Study|Protocol Deviation|2|||
16121766|NCT00858364|38930294|FG000|Overall Study|Other|9|||
16121767|NCT00858364|38930295|FG001|Overall Study|Other|17|||
16121768|NCT00858364|38930294|FG000|Overall Study|Missing|1|||
16121769|NCT00858364|38930295|FG001|Overall Study|Missing|1|||
16121770|NCT00858364|38930294|FG000|Overall Study|Still on-study|114|||
16121771|NCT00858364|38930295|FG001|Overall Study|Still on-study|247|||
16121772|NCT02510040|38930296|FG000|Overall Study|Deemed no longer eligible|18|||
16121773|NCT02510040|38930297|FG001|Overall Study|Deemed no longer eligible|3|||
16121774|NCT02510040|38930298|FG002|Overall Study|Deemed no longer eligible|1|||
16555286|NCT03580356|40496429|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
16555287|NCT03580356|40496430|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
16555288|NCT03580356|40496431|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
16555289|NCT03580356|40496432|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
16555290|NCT03580356|40496433|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
16555291|NCT03580356|40496426|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
16555292|NCT03580356|40496427|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
16555293|NCT03580356|40496428|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
16555294|NCT03580356|40496429|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
16555295|NCT03580356|40496430|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
16555296|NCT03580356|40496431|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
16555297|NCT03580356|40496432|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
16555298|NCT03580356|40496433|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
16555299|NCT03580356|40496426|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
16555300|NCT03580356|40496427|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
16555301|NCT03580356|40496428|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
16555302|NCT03580356|40496429|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
16555303|NCT03580356|40496430|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
16555304|NCT03580356|40496431|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
16555305|NCT03580356|40496432|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
16555306|NCT03580356|40496433|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
16555307|NCT04489888|40496434|FG000|Overall Study|Death|61|||
16555308|NCT04489888|40496434|FG000|Overall Study|Participant On-going|40|||
16555309|NCT02611830|40496435|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
16555310|NCT02611830|40496436|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
16555311|NCT02611830|40496437|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
16555312|NCT02611830|40496438|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
16555313|NCT02611830|40496435|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
16555314|NCT02611830|40496436|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
16555315|NCT02611830|40496437|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
16555316|NCT02611830|40496438|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
16555317|NCT02611830|40496435|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
16555318|NCT02611830|40496436|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
16555319|NCT02611830|40496437|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
16555320|NCT02611830|40496438|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
16555321|NCT02611830|40496435|FG000|OL Induction Phase|Lack of Efficacy|9|||
16555322|NCT02611830|40496436|FG001|OL Induction Phase|Lack of Efficacy|0|||
16555323|NCT02611830|40496437|FG002|OL Induction Phase|Lack of Efficacy|0|||
16555324|NCT02611830|40496438|FG003|OL Induction Phase|Lack of Efficacy|0|||
16555325|NCT02611830|40496435|FG000|OL Induction Phase|Reason not specified|3|||
16555326|NCT02611830|40496436|FG001|OL Induction Phase|Reason not specified|0|||
16555327|NCT02611830|40496437|FG002|OL Induction Phase|Reason not specified|0|||
16555328|NCT02611830|40496438|FG003|OL Induction Phase|Reason not specified|0|||
16555329|NCT02611830|40496435|FG000|Maintenance Phase|Lack of Efficacy|0|||
16555330|NCT02611830|40496436|FG001|Maintenance Phase|Lack of Efficacy|29|||
16555331|NCT02611830|40496437|FG002|Maintenance Phase|Lack of Efficacy|18|||
16555332|NCT02611830|40496438|FG003|Maintenance Phase|Lack of Efficacy|6|||
16555333|NCT02611830|40496435|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
16555334|NCT02611830|40496436|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
16121775|NCT00515671|38930299|FG000|Overall Study|Lost to Follow-up|13|||
16121776|NCT00515671|38930300|FG001|Overall Study|Lost to Follow-up|10|||
16121777|NCT00515671|38930299|FG000|Overall Study|Withdrawal by Subject|3|||
16121778|NCT00515671|38930300|FG001|Overall Study|Withdrawal by Subject|5|||
16121779|NCT00515671|38930299|FG000|Overall Study|incarcerated|1|||
16121780|NCT00515671|38930300|FG001|Overall Study|incarcerated|2|||
16121781|NCT00368927|38930304|FG000|Overall Study|Lost to Follow-up|2|||
16121782|NCT00368927|38930305|FG001|Overall Study|Lost to Follow-up|0|||
16121783|NCT00368927|38930304|FG000|Overall Study|Adverse Event|1|||
16121784|NCT00368927|38930305|FG001|Overall Study|Adverse Event|1|||
16121785|NCT00368927|38930304|FG000|Overall Study|Withdrawal by Subject|1|||
16237311|NCT00929864|39354495|FG001|Overall Study|Lost to Follow-up|12|||
16237312|NCT00929864|39354494|FG000|Overall Study|Withdrawal by Subject|20|||
16237313|NCT00929864|39354495|FG001|Overall Study|Withdrawal by Subject|9|||
16237314|NCT00929864|39354494|FG000|Overall Study|No longer met criteria|2|||
16121786|NCT00368927|38930305|FG001|Overall Study|Withdrawal by Subject|2|||
16121787|NCT00368927|38930304|FG000|Overall Study|Physician Decision|1|||
16237315|NCT00929864|39354495|FG001|Overall Study|No longer met criteria|1|||
16237316|NCT00929864|39354494|FG000|Overall Study|Poor or non-compliance|3|||
16237317|NCT00929864|39354495|FG001|Overall Study|Poor or non-compliance|3|||
16237318|NCT00929864|39354494|FG000|Overall Study|Pregnancy|0|||
16237319|NCT00929864|39354495|FG001|Overall Study|Pregnancy|3|||
16237320|NCT00929864|39354494|FG000|Overall Study|Administrative reason by Sponsor|1|||
16237321|NCT00929864|39354495|FG001|Overall Study|Administrative reason by Sponsor|1|||
16237322|NCT00929864|39354494|FG000|Overall Study|Non-specified|2|||
16237323|NCT00929864|39354495|FG001|Overall Study|Non-specified|7|||
16237324|NCT02494583|39354500|FG000|Overall Study|Death|224|||
16237325|NCT02494583|39354501|FG001|Overall Study|Death|214|||
16237326|NCT02494583|39354502|FG002|Overall Study|Death|225|||
16237327|NCT02494583|39354500|FG000|Overall Study|Lost to Follow-up|1|||
16237328|NCT02494583|39354501|FG001|Overall Study|Lost to Follow-up|0|||
16237329|NCT02494583|39354502|FG002|Overall Study|Lost to Follow-up|0|||
16237330|NCT02494583|39354500|FG000|Overall Study|Protocol Violation|1|||
16237331|NCT02494583|39354501|FG001|Overall Study|Protocol Violation|2|||
16237332|NCT02494583|39354502|FG002|Overall Study|Protocol Violation|0|||
16237333|NCT02494583|39354500|FG000|Overall Study|Screen Failure|0|||
16237334|NCT02494583|39354501|FG001|Overall Study|Screen Failure|1|||
16413918|NCT00844805|39998283|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
16413919|NCT00844805|39998284|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
16413920|NCT00844805|39998285|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
16413921|NCT00844805|39998282|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
16413922|NCT00844805|39998283|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
16413923|NCT00844805|39998284|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
16413924|NCT00844805|39998285|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
16413925|NCT00844805|39998282|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
16413926|NCT00844805|39998283|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
16413927|NCT00844805|39998284|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
16413928|NCT00844805|39998285|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
16413929|NCT01319721|39998286|FG000|Overall Study|Lost to Follow-up|1|||
16413930|NCT01319721|39998287|FG001|Overall Study|Lost to Follow-up|6|||
16413931|NCT01287195|39998288|FG000|Overall Study|Withdrawal by Subject|2|||
16413932|NCT03869333|39998292|FG000|Overall Study|Lost to Follow-up|1|||
16413933|NCT03869333|39998293|FG001|Overall Study|Lost to Follow-up|0|||
16413934|NCT03869333|39998294|FG002|Overall Study|Lost to Follow-up|0|||
16413935|NCT03869333|39998295|FG003|Overall Study|Lost to Follow-up|0|||
16413936|NCT03869333|39998292|FG000|Overall Study|Pregnancy|1|||
16413937|NCT03869333|39998293|FG001|Overall Study|Pregnancy|0|||
16413938|NCT03869333|39998294|FG002|Overall Study|Pregnancy|0|||
16413939|NCT03869333|39998295|FG003|Overall Study|Pregnancy|0|||
16413940|NCT03869333|39998292|FG000|Overall Study|Physician Decision|0|||
16413941|NCT03869333|39998293|FG001|Overall Study|Physician Decision|1|||
16413942|NCT03869333|39998294|FG002|Overall Study|Physician Decision|0|||
16413943|NCT03869333|39998295|FG003|Overall Study|Physician Decision|0|||
16413944|NCT00664326|39998296|FG000|Overall Study|Adverse Event|14|||
16413945|NCT00664326|39998296|FG000|Overall Study|Noncompliance with study medication|3|||
16413946|NCT00664326|39998296|FG000|Overall Study|Withdrawal by Subject|1|||
16413947|NCT00664326|39998296|FG000|Overall Study|Physician Decision|1|||
16413948|NCT00664326|39998296|FG000|Overall Study|Other Reasons|3|||
16555335|NCT02611830|40496437|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
16121788|NCT00368927|38930305|FG001|Overall Study|Physician Decision|0|||
16121789|NCT04157400|38930307|FG000|Overall Study|Withdrawal by Subject|1|||
16237335|NCT02494583|39354502|FG002|Overall Study|Screen Failure|0|||
16237336|NCT02494583|39354500|FG000|Overall Study|Transferred to Extension Study|15|||
16237337|NCT02494583|39354501|FG001|Overall Study|Transferred to Extension Study|15|||
16237338|NCT02494583|39354502|FG002|Overall Study|Transferred to Extension Study|6|||
16237339|NCT02494583|39354500|FG000|Overall Study|Did Not Continue on Extension Study|8|||
16237340|NCT02494583|39354501|FG001|Overall Study|Did Not Continue on Extension Study|10|||
16237341|NCT02494583|39354502|FG002|Overall Study|Did Not Continue on Extension Study|4|||
16413949|NCT00664326|39998296|FG000|Overall Study|Death|2|||
16413950|NCT00664326|39998296|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
16413951|NCT03361189|39998299|FG000|Overall Study|Received heart transplant|1|||
16413952|NCT03361189|39998300|FG001|Overall Study|Received heart transplant|0|||
16349701|NCT03177148|39765719|FG001|Overall Study|Death|0|||
16121790|NCT04157400|38930307|FG000|Overall Study|Lost to Follow-up|3|||
16349702|NCT00522548|39765720|FG000|Overall Study|Adverse Event|2|||
16349703|NCT00522548|39765721|FG001|Overall Study|Adverse Event|2|||
16349704|NCT00522548|39765720|FG000|Overall Study|Withdrawal by Subject|0|||
16349705|NCT00522548|39765721|FG001|Overall Study|Withdrawal by Subject|2|||
16349706|NCT01411319|39765722|FG000|Overall Study|Lost to Follow-up|1|||
16349707|NCT00760487|39765725|FG000|Overall Study|Unilateral implantation|3|||
16349708|NCT04980014|39765726|FG000|Overall Study|Participants who are Duplicated|1|||
16349709|NCT04980014|39765726|FG000|Overall Study|Follow-up Failure|13|||
16349710|NCT04980014|39765726|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
16349711|NCT04980014|39765726|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
16349712|NCT04980014|39765726|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
16349713|NCT02521792|39765727|FG000|Overall Study|Study Terminated|6|||
16349714|NCT00377637|39768801|FG000|Induction Phase|Adverse Event|12|||
16349715|NCT00377637|39768802|FG001|Induction Phase|Adverse Event|21|||
16349716|NCT00377637|39768803|FG002|Induction Phase|Adverse Event|0|||
16349717|NCT00377637|39768804|FG003|Induction Phase|Adverse Event|0|||
16349718|NCT00377637|39768801|FG000|Induction Phase|Deterioration/serum creatinine|2|||
16349719|NCT00377637|39768802|FG001|Induction Phase|Deterioration/serum creatinine|0|||
16349720|NCT00377637|39768803|FG002|Induction Phase|Deterioration/serum creatinine|0|||
16349721|NCT00377637|39768804|FG003|Induction Phase|Deterioration/serum creatinine|0|||
16349722|NCT00377637|39768801|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
16349723|NCT00377637|39768802|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
16349724|NCT00377637|39768803|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
16349725|NCT00377637|39768804|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
16349726|NCT00377637|39768801|FG000|Induction Phase|Lost to Follow-up|2|||
16349727|NCT00377637|39768802|FG001|Induction Phase|Lost to Follow-up|1|||
16349728|NCT00377637|39768803|FG002|Induction Phase|Lost to Follow-up|0|||
16349729|NCT00377637|39768804|FG003|Induction Phase|Lost to Follow-up|0|||
16349730|NCT00377637|39768801|FG000|Induction Phase|Death|1|||
16349731|NCT00377637|39768802|FG001|Induction Phase|Death|3|||
16349732|NCT00377637|39768803|FG002|Induction Phase|Death|0|||
16349733|NCT00377637|39768804|FG003|Induction Phase|Death|0|||
16349734|NCT00377637|39768801|FG000|Induction Phase|Withdrawal by Subject|5|||
16349735|NCT00377637|39768802|FG001|Induction Phase|Withdrawal by Subject|6|||
16349736|NCT00377637|39768803|FG002|Induction Phase|Withdrawal by Subject|0|||
16413953|NCT03361189|39998299|FG000|Overall Study|Pacemake replacement|0|||
16349737|NCT00377637|39768804|FG003|Induction Phase|Withdrawal by Subject|0|||
16349738|NCT00377637|39768801|FG000|Induction Phase|Physician Decision|3|||
16413954|NCT03361189|39998300|FG001|Overall Study|Pacemake replacement|1|||
16121791|NCT01641159|38930308|FG000|Overall Study|Lost to Follow-up|2|||
16121792|NCT01641159|38930309|FG001|Overall Study|Lost to Follow-up|1|||
16121793|NCT01641159|38930308|FG000|Overall Study|Withdrawal by Subject|0|||
16121794|NCT01641159|38930309|FG001|Overall Study|Withdrawal by Subject|1|||
16121795|NCT05262517|38930310|FG000|Overall Study|Randomized but not treated|5|||
16121796|NCT05262517|38930311|FG001|Overall Study|Randomized but not treated|11|||
16121797|NCT00725543|38930312|FG000|Overall Study|Adverse Event|10|||
16121798|NCT00725543|38930312|FG000|Overall Study|Lack of Efficacy|3|||
16121799|NCT00725543|38930312|FG000|Overall Study|Withdrawal by Subject|10|||
16121800|NCT00725543|38930312|FG000|Overall Study|Physician Decision|5|||
16121801|NCT00725543|38930312|FG000|Overall Study|Lost to Follow-up|4|||
16121802|NCT00725543|38930312|FG000|Overall Study|Non-compliance|2|||
16121803|NCT00725543|38930312|FG000|Overall Study|Other|119|||
16121804|NCT00128102|38930313|FG000|Overall Study|Site Discontinued|3|||
16121805|NCT00128102|38930314|FG001|Overall Study|Site Discontinued|6|||
16121806|NCT00128102|38930313|FG000|Overall Study|Other|0|||
16121807|NCT00128102|38930314|FG001|Overall Study|Other|1|||
16121808|NCT00128102|38930313|FG000|Overall Study|Progressive Disease|255|||
16121809|NCT00128102|38930314|FG001|Overall Study|Progressive Disease|285|||
16121810|NCT00128102|38930313|FG000|Overall Study|Adverse Event|34|||
16121811|NCT00128102|38930314|FG001|Overall Study|Adverse Event|11|||
16121812|NCT00128102|38930313|FG000|Overall Study|Death|12|||
16121813|NCT00128102|38930314|FG001|Overall Study|Death|13|||
16121814|NCT00128102|38930313|FG000|Overall Study|Physician Decision|3|||
16121815|NCT00128102|38930314|FG001|Overall Study|Physician Decision|3|||
16121816|NCT00128102|38930313|FG000|Overall Study|Withdrawal by Subject|19|||
16121817|NCT00128102|38930314|FG001|Overall Study|Withdrawal by Subject|11|||
16121818|NCT00128102|38930313|FG000|Overall Study|Protocol Violation|2|||
16121819|NCT00128102|38930314|FG001|Overall Study|Protocol Violation|2|||
16121820|NCT01232738|38930324|FG000|Overall Study|Death|3|||
16121821|NCT01232738|38930324|FG000|Overall Study|Physician Decision|2|||
16121822|NCT01232738|38930324|FG000|Overall Study|Lost to Follow-up|1|||
16121823|NCT01232738|38930324|FG000|Overall Study|Withdrawal by Subject|2|||
16349739|NCT00377637|39768802|FG001|Induction Phase|Physician Decision|1|||
16349740|NCT00377637|39768803|FG002|Induction Phase|Physician Decision|0|||
16349741|NCT00377637|39768804|FG003|Induction Phase|Physician Decision|0|||
16349742|NCT00377637|39768801|FG000|Induction Phase|Sponsor decision|1|||
16349743|NCT00377637|39768802|FG001|Induction Phase|Sponsor decision|2|||
16349744|NCT00377637|39768803|FG002|Induction Phase|Sponsor decision|0|||
16349745|NCT00377637|39768804|FG003|Induction Phase|Sponsor decision|0|||
16349746|NCT00377637|39768801|FG000|Induction Phase|Non-Compliance|1|||
16349747|NCT00377637|39768802|FG001|Induction Phase|Non-Compliance|0|||
16349748|NCT00377637|39768803|FG002|Induction Phase|Non-Compliance|0|||
16349749|NCT00377637|39768804|FG003|Induction Phase|Non-Compliance|0|||
16349750|NCT00377637|39768801|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
16349751|NCT00377637|39768802|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
16349752|NCT00377637|39768803|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
16349753|NCT00377637|39768804|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
16349754|NCT00377637|39768801|FG000|Maintenance Phase|Adverse Event|0|||
16349755|NCT00377637|39768802|FG001|Maintenance Phase|Adverse Event|0|||
16349756|NCT00377637|39768803|FG002|Maintenance Phase|Adverse Event|29|||
16349757|NCT00377637|39768804|FG003|Maintenance Phase|Adverse Event|43|||
16349758|NCT00377637|39768801|FG000|Maintenance Phase|Physician Decision|0|||
16349759|NCT00377637|39768802|FG001|Maintenance Phase|Physician Decision|0|||
16349760|NCT00377637|39768803|FG002|Maintenance Phase|Physician Decision|5|||
16349761|NCT00377637|39768804|FG003|Maintenance Phase|Physician Decision|4|||
16349762|NCT00377637|39768801|FG000|Maintenance Phase|Lost to Follow-up|0|||
16349763|NCT00377637|39768802|FG001|Maintenance Phase|Lost to Follow-up|0|||
16349764|NCT00377637|39768803|FG002|Maintenance Phase|Lost to Follow-up|3|||
16349765|NCT00377637|39768804|FG003|Maintenance Phase|Lost to Follow-up|1|||
16349766|NCT00377637|39768801|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16349767|NCT00377637|39768802|FG001|Maintenance Phase|Withdrawal by Subject|0|||
16349768|NCT00377637|39768803|FG002|Maintenance Phase|Withdrawal by Subject|3|||
16349769|NCT00377637|39768804|FG003|Maintenance Phase|Withdrawal by Subject|3|||
16349770|NCT00377637|39768801|FG000|Maintenance Phase|Sponsor decision|0|||
16349771|NCT00377637|39768802|FG001|Maintenance Phase|Sponsor decision|0|||
16349772|NCT00377637|39768803|FG002|Maintenance Phase|Sponsor decision|2|||
16349773|NCT00377637|39768804|FG003|Maintenance Phase|Sponsor decision|3|||
16349774|NCT00377637|39768801|FG000|Maintenance Phase|Non-compliance|0|||
16349775|NCT00377637|39768802|FG001|Maintenance Phase|Non-compliance|0|||
16349776|NCT00377637|39768803|FG002|Maintenance Phase|Non-compliance|1|||
16349777|NCT00377637|39768804|FG003|Maintenance Phase|Non-compliance|1|||
16349778|NCT00377637|39768801|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
16349779|NCT00377637|39768802|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
16349780|NCT00377637|39768803|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
16349781|NCT00377637|39768804|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
16349782|NCT00377637|39768801|FG000|Maintenance Phase|Death|0|||
16349783|NCT00377637|39768802|FG001|Maintenance Phase|Death|0|||
16349784|NCT00377637|39768803|FG002|Maintenance Phase|Death|0|||
16555336|NCT02611830|40496438|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
16555337|NCT02611830|40496435|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
16555338|NCT02611830|40496436|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
16555339|NCT02611830|40496437|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
16555340|NCT02611830|40496438|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
16555341|NCT02611830|40496435|FG000|Maintenance Phase|Lost to Follow-up|0|||
16555342|NCT02611830|40496436|FG001|Maintenance Phase|Lost to Follow-up|0|||
16555343|NCT02611830|40496437|FG002|Maintenance Phase|Lost to Follow-up|0|||
16555344|NCT02611830|40496438|FG003|Maintenance Phase|Lost to Follow-up|1|||
16555345|NCT02611830|40496435|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
16555346|NCT02611830|40496436|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
16555347|NCT02611830|40496437|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
16121824|NCT01232738|38930324|FG000|Overall Study|Adverse Event|5|||
16349785|NCT00377637|39768804|FG003|Maintenance Phase|Death|1|||
16349786|NCT01587885|39768810|FG000|Treatment Period 1|Failure to Return|0|||
16555348|NCT02611830|40496438|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
16555349|NCT02611830|40496435|FG000|Maintenance Phase|Pregnancy|0|||
16555350|NCT02611830|40496436|FG001|Maintenance Phase|Pregnancy|0|||
16555351|NCT02611830|40496437|FG002|Maintenance Phase|Pregnancy|1|||
16555352|NCT02611830|40496438|FG003|Maintenance Phase|Pregnancy|0|||
16555353|NCT02611830|40496435|FG000|Maintenance Phase|Reason not specified|0|||
16555354|NCT02611830|40496436|FG001|Maintenance Phase|Reason not specified|1|||
16555355|NCT02611830|40496437|FG002|Maintenance Phase|Reason not specified|4|||
16555356|NCT02611830|40496438|FG003|Maintenance Phase|Reason not specified|0|||
16349787|NCT01587885|39768811|FG001|Treatment Period 1|Failure to Return|1|||
16349788|NCT01587885|39768810|FG000|Treatment Period 1|Protocol Violation|0|||
16349789|NCT01587885|39768811|FG001|Treatment Period 1|Protocol Violation|2|||
16349790|NCT02750332|39768814|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16349791|NCT02750332|39768815|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16349792|NCT02616783|39768823|FG000|Overall Study|Randomized but Not Treated|1|||
16121825|NCT01299480|38930325|FG000|Overall Study|No longer willing to participate|19|||
16121826|NCT01299480|38930326|FG001|Overall Study|No longer willing to participate|17|||
16121827|NCT01299480|38930327|FG002|Overall Study|No longer willing to participate|14|||
16121828|NCT01299480|38930328|FG003|Overall Study|No longer willing to participate|13|||
16121829|NCT01299480|38930329|FG004|Overall Study|No longer willing to participate|10|||
16121830|NCT01299480|38930325|FG000|Overall Study|Protocol Violation|7|||
16413955|NCT00308074|39998301|FG000|Overall Study|Withdrawal by Subject|1|||
16413956|NCT00409344|39998302|FG000|Overall Study|no enrollment|0|||
16413957|NCT00409344|39998303|FG001|Overall Study|no enrollment|0|||
16413958|NCT03836677|39998304|FG000|Period 1|Adverse Event|0|||
16413959|NCT03836677|39998305|FG001|Period 1|Adverse Event|1|||
16413960|NCT03836677|39998304|FG000|Period 2|Severe non-compliance to protocol|1|||
16413961|NCT03836677|39998305|FG001|Period 2|Severe non-compliance to protocol|0|||
16413962|NCT02096263|39998306|FG000|Overall Study|Adverse Event|1|||
16413963|NCT02096263|39998307|FG001|Overall Study|Adverse Event|0|||
16413964|NCT02096263|39998308|FG002|Overall Study|Adverse Event|1|||
16413965|NCT02096263|39998306|FG000|Overall Study|Lost to Follow-up|14|||
16413966|NCT02096263|39998307|FG001|Overall Study|Lost to Follow-up|18|||
16413967|NCT02096263|39998308|FG002|Overall Study|Lost to Follow-up|15|||
16413968|NCT02096263|39998306|FG000|Overall Study|Other|7|||
16413969|NCT02096263|39998307|FG001|Overall Study|Other|9|||
16413970|NCT02096263|39998308|FG002|Overall Study|Other|6|||
16413971|NCT02096263|39998306|FG000|Overall Study|Sponsor study termination|0|||
16413972|NCT02096263|39998307|FG001|Overall Study|Sponsor study termination|0|||
16413973|NCT02096263|39998308|FG002|Overall Study|Sponsor study termination|1|||
16413974|NCT02096263|39998306|FG000|Overall Study|Protocol Violation|7|||
16413975|NCT02096263|39998307|FG001|Overall Study|Protocol Violation|2|||
16555357|NCT02293837|40496443|FG000|Overall Study|Lost to Follow-up|0|||
16555358|NCT02293837|40496444|FG001|Overall Study|Lost to Follow-up|2|||
16555359|NCT02293837|40496445|FG002|Overall Study|Lost to Follow-up|1|||
16121831|NCT01299480|38930326|FG001|Overall Study|Protocol Violation|5|||
16121832|NCT01299480|38930327|FG002|Overall Study|Protocol Violation|8|||
16555360|NCT02293837|40496446|FG003|Overall Study|Lost to Follow-up|0|||
16555361|NCT02293837|40496443|FG000|Overall Study|Withdrawal by Subject|2|||
16555362|NCT02293837|40496444|FG001|Overall Study|Withdrawal by Subject|1|||
16555363|NCT02293837|40496445|FG002|Overall Study|Withdrawal by Subject|2|||
16555364|NCT02293837|40496446|FG003|Overall Study|Withdrawal by Subject|1|||
16121833|NCT01299480|38930328|FG003|Overall Study|Protocol Violation|1|||
16121834|NCT01299480|38930329|FG004|Overall Study|Protocol Violation|1|||
16121835|NCT01299480|38930325|FG000|Overall Study|Withdrawal by Subject|3|||
16121836|NCT01299480|38930326|FG001|Overall Study|Withdrawal by Subject|4|||
16121837|NCT01299480|38930327|FG002|Overall Study|Withdrawal by Subject|7|||
16121838|NCT01299480|38930328|FG003|Overall Study|Withdrawal by Subject|3|||
16121839|NCT01299480|38930329|FG004|Overall Study|Withdrawal by Subject|4|||
16121840|NCT01299480|38930325|FG000|Overall Study|Adverse Event|6|||
16121841|NCT01299480|38930326|FG001|Overall Study|Adverse Event|4|||
16121842|NCT01299480|38930327|FG002|Overall Study|Adverse Event|5|||
16237342|NCT02494583|39354500|FG000|Overall Study|Withdrawal by Subject|7|||
16237343|NCT02494583|39354501|FG001|Overall Study|Withdrawal by Subject|15|||
16237344|NCT02494583|39354502|FG002|Overall Study|Withdrawal by Subject|15|||
16555365|NCT02293837|40496443|FG000|Overall Study|COVID-19 Related|1|||
16555366|NCT02293837|40496444|FG001|Overall Study|COVID-19 Related|1|||
16555367|NCT02293837|40496445|FG002|Overall Study|COVID-19 Related|0|||
16555368|NCT02293837|40496446|FG003|Overall Study|COVID-19 Related|0|||
16555369|NCT02293837|40496443|FG000|Overall Study|Participant ill and could not be infused|0|||
16555370|NCT02293837|40496444|FG001|Overall Study|Participant ill and could not be infused|0|||
16555371|NCT02293837|40496445|FG002|Overall Study|Participant ill and could not be infused|1|||
16121843|NCT01299480|38930328|FG003|Overall Study|Adverse Event|4|||
16237345|NCT04476017|39354503|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
16237346|NCT04476017|39354504|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
16237347|NCT01216319|39354506|FG000|Overall Study|Lost to Follow-up|2|||
16413976|NCT02096263|39998308|FG002|Overall Study|Protocol Violation|8|||
16413977|NCT02096263|39998306|FG000|Overall Study|Withdrawal by Subject|5|||
16555372|NCT02293837|40496446|FG003|Overall Study|Participant ill and could not be infused|0|||
16555373|NCT01586338|40496448|FG000|Overall Study|Adverse Event|3|||
16413978|NCT02096263|39998307|FG001|Overall Study|Withdrawal by Subject|7|||
16413979|NCT02096263|39998308|FG002|Overall Study|Withdrawal by Subject|8|||
16555374|NCT01586338|40496448|FG000|Overall Study|Lost to Follow-up|1|||
16555375|NCT01586338|40496448|FG000|Overall Study|Withdrawal by participant|3|||
16237348|NCT01216319|39354506|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
16237349|NCT01614925|39354507|FG000|Overall Study|Withdrawal by Subject|1|||
16237350|NCT01614925|39354508|FG001|Overall Study|Withdrawal by Subject|0|||
16237351|NCT01614925|39354507|FG000|Overall Study|Protocol Violation|3|||
16237352|NCT01614925|39354508|FG001|Overall Study|Protocol Violation|2|||
16237353|NCT04311411|39354510|FG000|Overall Study|Adverse Event|2|||
16237354|NCT04311411|39354511|FG001|Overall Study|Adverse Event|3|||
16237355|NCT04311411|39354512|FG002|Overall Study|Adverse Event|2|||
16237356|NCT04311411|39354510|FG000|Overall Study|Withdrawal by Subject|3|||
16237357|NCT04311411|39354511|FG001|Overall Study|Withdrawal by Subject|3|||
16237358|NCT04311411|39354512|FG002|Overall Study|Withdrawal by Subject|0|||
16237359|NCT05180630|39354517|FG000|First Intervention|Physician Decision|0|||
16237360|NCT05180630|39354518|FG001|First Intervention|Physician Decision|0|||
16237361|NCT05180630|39354519|FG002|First Intervention|Physician Decision|3|||
16237362|NCT01988493|39354520|FG000|Overall Study|Randomized but not treated|0|||
16237363|NCT01988493|39354521|FG001|Overall Study|Randomized but not treated|0|||
16237364|NCT01988493|39354522|FG002|Overall Study|Randomized but not treated|0|||
16237365|NCT01988493|39354523|FG003|Overall Study|Randomized but not treated|0|||
16237366|NCT01988493|39354524|FG004|Overall Study|Randomized but not treated|1|||
16237367|NCT01559818|39354525|FG000|Overall Study|Physician Decision|1|||
16237368|NCT01559818|39354525|FG000|Overall Study|Pregnancy|1|||
16237369|NCT01559818|39354525|FG000|Overall Study|Study terminated by Sponsor|4|||
16237370|NCT01559818|39354525|FG000|Overall Study|Withdrawal by Subject|1|||
16237371|NCT03543046|39354526|FG000|Overall Study|Adverse Event|1|||
16237372|NCT03543046|39354527|FG001|Overall Study|Adverse Event|1|||
16237373|NCT03543046|39354526|FG000|Overall Study|Physician Decision|1|||
16237374|NCT03543046|39354527|FG001|Overall Study|Physician Decision|1|||
16237375|NCT03543046|39354526|FG000|Overall Study|Protocol Violation|1|||
16237376|NCT03543046|39354527|FG001|Overall Study|Protocol Violation|0|||
16237377|NCT03205163|39354528|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
16237378|NCT03205163|39354529|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
16237379|NCT03338673|39354537|FG000|Overall Study|Lost to Follow-up|1|||
16237380|NCT03338673|39354538|FG001|Overall Study|Lost to Follow-up|1|||
16237381|NCT02149199|39354539|FG000|Overall Study|Study specific withdrawal criteria|4|||
16237382|NCT02149199|39354540|FG001|Overall Study|Study specific withdrawal criteria|21|||
16237383|NCT02149199|39354541|FG002|Overall Study|Study specific withdrawal criteria|6|||
16237384|NCT02149199|39354539|FG000|Overall Study|Other|20|||
16237385|NCT02149199|39354540|FG001|Overall Study|Other|25|||
16237386|NCT02149199|39354541|FG002|Overall Study|Other|20|||
16237387|NCT02149199|39354539|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
16237388|NCT02149199|39354540|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
16237389|NCT02149199|39354541|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
16237390|NCT02149199|39354539|FG000|Overall Study|Withdrawal by Subject|75|||
16237391|NCT02149199|39354540|FG001|Overall Study|Withdrawal by Subject|93|||
16237392|NCT02149199|39354541|FG002|Overall Study|Withdrawal by Subject|77|||
16237393|NCT02149199|39354539|FG000|Overall Study|Protocol Violation|16|||
16237394|NCT02149199|39354540|FG001|Overall Study|Protocol Violation|13|||
16237395|NCT02149199|39354541|FG002|Overall Study|Protocol Violation|15|||
16237396|NCT02149199|39354539|FG000|Overall Study|Lost to Follow-up|3|||
16237397|NCT02149199|39354540|FG001|Overall Study|Lost to Follow-up|12|||
16237398|NCT02149199|39354541|FG002|Overall Study|Lost to Follow-up|11|||
16237399|NCT02149199|39354539|FG000|Overall Study|Death|0|||
16237400|NCT02149199|39354540|FG001|Overall Study|Death|0|||
16237401|NCT02149199|39354541|FG002|Overall Study|Death|1|||
16237402|NCT02149199|39354539|FG000|Overall Study|Adverse Event|6|||
16237403|NCT02149199|39354540|FG001|Overall Study|Adverse Event|15|||
16237404|NCT02149199|39354541|FG002|Overall Study|Adverse Event|9|||
16237405|NCT02163694|39354542|FG000|Overall Study|Adverse event- related to progression|3|||
16237406|NCT02163694|39354543|FG001|Overall Study|Adverse event- related to progression|8|||
16237407|NCT02163694|39354542|FG000|Overall Study|Adverse event- not related to progression|7|||
16237408|NCT02163694|39354543|FG001|Overall Study|Adverse event- not related to progression|17|||
16555376|NCT01586338|40496448|FG000|Overall Study|Other|1|||
16555377|NCT01368211|40496453|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
16555378|NCT01368211|40496454|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
16237409|NCT02163694|39354542|FG000|Overall Study|Withdrew consent|8|||
16237410|NCT02163694|39354543|FG001|Overall Study|Withdrew consent|21|||
16237411|NCT02163694|39354542|FG000|Overall Study|Lost to Follow-up|1|||
16237412|NCT02163694|39354543|FG001|Overall Study|Lost to Follow-up|2|||
16237413|NCT02163694|39354542|FG000|Overall Study|Progressive disease per protocol|122|||
16237414|NCT02163694|39354543|FG001|Overall Study|Progressive disease per protocol|197|||
16237415|NCT02163694|39354542|FG000|Overall Study|Other, not specified|13|||
16237416|NCT02163694|39354543|FG001|Overall Study|Other, not specified|22|||
16237417|NCT01999322|39354544|FG000|Overall Study|Adverse Event|1|||
16237418|NCT01999322|39354545|FG001|Overall Study|Adverse Event|0|||
16237419|NCT02773446|39354546|FG000|First Admission|Withdrawal by Subject|0|||
16555379|NCT02670538|40496464|FG000|Overall Study|Withdrawal of Consent|8|||
16555380|NCT02670538|40496465|FG001|Overall Study|Withdrawal of Consent|6|||
16555381|NCT02670538|40496466|FG002|Overall Study|Withdrawal of Consent|5|||
16555382|NCT02670538|40496464|FG000|Overall Study|Lost to Follow-up|8|||
16555383|NCT02670538|40496465|FG001|Overall Study|Lost to Follow-up|12|||
16555384|NCT02670538|40496466|FG002|Overall Study|Lost to Follow-up|7|||
16555385|NCT02670538|40496464|FG000|Overall Study|Adverse Event|5|||
16555386|NCT02670538|40496465|FG001|Overall Study|Adverse Event|5|||
16555387|NCT02670538|40496466|FG002|Overall Study|Adverse Event|11|||
16555388|NCT02670538|40496464|FG000|Overall Study|Lack of Efficacy|7|||
16555389|NCT02670538|40496465|FG001|Overall Study|Lack of Efficacy|1|||
16237420|NCT02773446|39354547|FG001|First Admission|Withdrawal by Subject|0|||
16237421|NCT02773446|39354548|FG002|First Admission|Withdrawal by Subject|0|||
16237422|NCT02773446|39354549|FG003|First Admission|Withdrawal by Subject|1|||
16237423|NCT02773446|39354550|FG004|First Admission|Withdrawal by Subject|0|||
16237424|NCT02773446|39354551|FG005|First Admission|Withdrawal by Subject|0|||
16237425|NCT02773446|39354546|FG000|First Admission|Lost to Follow-up|1|||
16237426|NCT02773446|39354547|FG001|First Admission|Lost to Follow-up|0|||
16237427|NCT02773446|39354548|FG002|First Admission|Lost to Follow-up|0|||
16237428|NCT02773446|39354549|FG003|First Admission|Lost to Follow-up|0|||
16237429|NCT02773446|39354550|FG004|First Admission|Lost to Follow-up|0|||
16237430|NCT02773446|39354551|FG005|First Admission|Lost to Follow-up|0|||
16237431|NCT01422720|39354552|FG000|Overall Study|Adverse Event|16|||
16237432|NCT01422720|39354552|FG000|Overall Study|Lack of Efficacy|1|||
16237433|NCT01422720|39354552|FG000|Overall Study|Withdrawal by Subject|4|||
16237434|NCT01422720|39354552|FG000|Overall Study|Ineligibility|1|||
16237435|NCT04333199|39354563|FG000|Evaluated Patients|Lost to Follow-up|0|||
16237436|NCT04333199|39354564|FG001|Evaluated Patients|Lost to Follow-up|1|||
16237437|NCT04333199|39354565|FG002|Evaluated Patients|Lost to Follow-up|2|||
16237438|NCT00445458|39354566|FG000|Overall Study|Disease Progression|3|||
16237439|NCT00445458|39354567|FG001|Overall Study|Disease Progression|4|||
16237440|NCT00445458|39354568|FG002|Overall Study|Disease Progression|54|||
16237441|NCT00445458|39354569|FG003|Overall Study|Disease Progression|27|||
16237442|NCT00445458|39354566|FG000|Overall Study|Withdrawal by Subject|0|||
16237443|NCT00445458|39354567|FG001|Overall Study|Withdrawal by Subject|0|||
16237444|NCT00445458|39354568|FG002|Overall Study|Withdrawal by Subject|7|||
16237445|NCT00445458|39354569|FG003|Overall Study|Withdrawal by Subject|0|||
16237446|NCT00445458|39354566|FG000|Overall Study|Adverse Event|0|||
16237447|NCT00445458|39354567|FG001|Overall Study|Adverse Event|0|||
16237448|NCT00445458|39354568|FG002|Overall Study|Adverse Event|3|||
16237449|NCT00445458|39354569|FG003|Overall Study|Adverse Event|0|||
16237450|NCT00445458|39354566|FG000|Overall Study|Death|0|||
16237451|NCT00445458|39354567|FG001|Overall Study|Death|1|||
16237452|NCT00445458|39354568|FG002|Overall Study|Death|2|||
16237453|NCT00445458|39354569|FG003|Overall Study|Death|0|||
16237454|NCT00445458|39354566|FG000|Overall Study|Physician Decision|0|||
16237455|NCT00445458|39354567|FG001|Overall Study|Physician Decision|0|||
16237456|NCT00445458|39354568|FG002|Overall Study|Physician Decision|1|||
16237457|NCT00445458|39354569|FG003|Overall Study|Physician Decision|1|||
16237458|NCT00445458|39354566|FG000|Overall Study|Surgery|0|||
16237459|NCT00445458|39354567|FG001|Overall Study|Surgery|0|||
16237460|NCT00445458|39354568|FG002|Overall Study|Surgery|1|||
16237461|NCT00445458|39354569|FG003|Overall Study|Surgery|0|||
16237462|NCT01246986|39354570|FG000|Overall Study|Lost to Follow-up|0|||
16237463|NCT01246986|39354571|FG001|Overall Study|Lost to Follow-up|1|||
16237464|NCT01246986|39354572|FG002|Overall Study|Lost to Follow-up|3|||
16237465|NCT01246986|39354573|FG003|Overall Study|Lost to Follow-up|0|||
16237466|NCT01246986|39354574|FG004|Overall Study|Lost to Follow-up|0|||
16237467|NCT01246986|39354575|FG005|Overall Study|Lost to Follow-up|1|||
16237468|NCT01246986|39354576|FG006|Overall Study|Lost to Follow-up|0|||
16237469|NCT01246986|39354570|FG000|Overall Study|Withdrawal by Subject|3|||
16237470|NCT01246986|39354571|FG001|Overall Study|Withdrawal by Subject|4|||
16237471|NCT01246986|39354572|FG002|Overall Study|Withdrawal by Subject|3|||
16237472|NCT01246986|39354573|FG003|Overall Study|Withdrawal by Subject|0|||
16237473|NCT01246986|39354574|FG004|Overall Study|Withdrawal by Subject|4|||
16555390|NCT02670538|40496466|FG002|Overall Study|Lack of Efficacy|2|||
16555391|NCT02670538|40496464|FG000|Overall Study|Protocol Violation|3|||
16555392|NCT02670538|40496465|FG001|Overall Study|Protocol Violation|4|||
16555393|NCT02670538|40496466|FG002|Overall Study|Protocol Violation|1|||
16555394|NCT02670538|40496464|FG000|Overall Study|Noncompliance with Study Drug|1|||
16555395|NCT02670538|40496465|FG001|Overall Study|Noncompliance with Study Drug|3|||
16237474|NCT01246986|39354575|FG005|Overall Study|Withdrawal by Subject|0|||
16237475|NCT01246986|39354576|FG006|Overall Study|Withdrawal by Subject|0|||
16237476|NCT03457727|39354580|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
16555396|NCT02670538|40496466|FG002|Overall Study|Noncompliance with Study Drug|2|||
16555397|NCT02670538|40496464|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16237477|NCT03457727|39354581|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
16237478|NCT03457727|39354582|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
16237479|NCT03457727|39354583|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
16237480|NCT04440163|39354590|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
16237481|NCT04440163|39354591|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
16237482|NCT04440163|39354592|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
16237483|NCT04440163|39354593|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
16237484|NCT04440163|39354594|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
16237485|NCT04440163|39354595|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
16237486|NCT04440163|39354596|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
16237487|NCT04440163|39354597|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
16237488|NCT04440163|39354590|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
16237489|NCT04440163|39354591|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
16237490|NCT04440163|39354592|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
16237491|NCT04440163|39354593|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
16237492|NCT04440163|39354594|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
16237493|NCT04440163|39354595|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
16237494|NCT04440163|39354596|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
16237495|NCT04440163|39354597|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
16237496|NCT04440163|39354590|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
16237497|NCT04440163|39354591|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
16237498|NCT04440163|39354592|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
16237499|NCT04440163|39354593|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
16237500|NCT04440163|39354594|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
16237501|NCT04440163|39354595|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
16237502|NCT04440163|39354596|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
16237503|NCT04440163|39354597|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
16237504|NCT04440163|39354590|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
16237505|NCT04440163|39354591|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
16237506|NCT04440163|39354592|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
16237507|NCT04440163|39354593|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
16237508|NCT04440163|39354594|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
16237509|NCT04440163|39354595|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
16237510|NCT04440163|39354596|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
16555398|NCT02670538|40496465|FG001|Overall Study|Other Miscellaneous Reasons|1|||
16237511|NCT04440163|39354597|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
16237512|NCT04440163|39354590|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
16237513|NCT04440163|39354591|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
16237514|NCT04440163|39354592|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
16237515|NCT04440163|39354593|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
16237516|NCT04440163|39354594|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
16237517|NCT04440163|39354595|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
16237518|NCT04440163|39354596|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
16237519|NCT04440163|39354597|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
16237520|NCT04440163|39354590|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
16237521|NCT04440163|39354591|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
16237522|NCT04440163|39354592|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
16237523|NCT04440163|39354593|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
16237524|NCT04440163|39354594|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
16237525|NCT04440163|39354595|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
16237526|NCT04440163|39354596|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
16237527|NCT04440163|39354597|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
16237528|NCT04440163|39354590|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
16237529|NCT04440163|39354591|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
16237530|NCT04440163|39354592|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
16237531|NCT04440163|39354593|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
16237532|NCT04440163|39354594|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
16237533|NCT04440163|39354595|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
16237534|NCT04440163|39354596|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
16237535|NCT04440163|39354597|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
16237536|NCT04440163|39354590|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
16413980|NCT00007020|39998310|FG000|Overall Study|Death|16|||
16413981|NCT00007020|39998310|FG000|Overall Study|Lost to Follow-up|13|||
16121844|NCT01299480|38930329|FG004|Overall Study|Adverse Event|0|||
16121845|NCT01299480|38930325|FG000|Overall Study|Withdrawal due to pregnancy|0|||
16121846|NCT01299480|38930326|FG001|Overall Study|Withdrawal due to pregnancy|1|||
16121847|NCT01299480|38930327|FG002|Overall Study|Withdrawal due to pregnancy|1|||
16121848|NCT01299480|38930328|FG003|Overall Study|Withdrawal due to pregnancy|0|||
16121849|NCT01299480|38930329|FG004|Overall Study|Withdrawal due to pregnancy|0|||
16121850|NCT01299480|38930325|FG000|Overall Study|Physician Decision|1|||
16121851|NCT01299480|38930326|FG001|Overall Study|Physician Decision|1|||
16555399|NCT02670538|40496466|FG002|Overall Study|Other Miscellaneous Reasons|2|||
16555400|NCT02310126|40496467|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
16555401|NCT02310126|40496468|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
16555402|NCT02310126|40496467|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
16555403|NCT02310126|40496468|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
16555404|NCT02066532|40499676|FG000|Phase II|Withdrawal by Subject|1|||
16555405|NCT02066532|40499677|FG001|Phase II|Withdrawal by Subject|0|||
16555406|NCT02066532|40499678|FG002|Phase II|Withdrawal by Subject|0|||
16555407|NCT02066532|40499679|FG003|Phase II|Withdrawal by Subject|0|||
16555408|NCT01551303|40499683|FG000|Overall Study|failed awareness check on vision test|4|||
16121852|NCT01299480|38930327|FG002|Overall Study|Physician Decision|0|||
16121853|NCT01299480|38930328|FG003|Overall Study|Physician Decision|2|||
16121854|NCT01299480|38930329|FG004|Overall Study|Physician Decision|0|||
16121855|NCT01299480|38930325|FG000|Overall Study|Lost to Follow-up|3|||
16121856|NCT01299480|38930326|FG001|Overall Study|Lost to Follow-up|1|||
16555409|NCT01551303|40499684|FG001|Overall Study|failed awareness check on vision test|7|||
16555410|NCT02353832|40499685|FG000|Overall Study|Ineligible after enrollment|1|||
16555411|NCT02353832|40499685|FG000|Overall Study|Lost to Follow-up|1|||
16237537|NCT04440163|39354591|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
16237538|NCT04440163|39354592|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
16237539|NCT04440163|39354593|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
16121857|NCT01299480|38930327|FG002|Overall Study|Lost to Follow-up|2|||
16237540|NCT04440163|39354594|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
16237541|NCT04440163|39354595|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
16237542|NCT04440163|39354596|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
16237543|NCT04440163|39354597|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
16237544|NCT04440163|39354590|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
16237545|NCT04440163|39354591|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
16237546|NCT04440163|39354592|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
16237547|NCT04440163|39354593|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
16237548|NCT04440163|39354594|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
16237549|NCT04440163|39354595|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
16237550|NCT04440163|39354596|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
16237551|NCT04440163|39354597|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
16237552|NCT04440163|39354590|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
16237553|NCT04440163|39354591|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
16237554|NCT04440163|39354592|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
16237555|NCT04440163|39354593|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
16237556|NCT04440163|39354594|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
16237557|NCT04440163|39354595|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
16237558|NCT04440163|39354596|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
16237559|NCT04440163|39354597|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
16237560|NCT04440163|39354590|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
16237561|NCT04440163|39354591|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
16237562|NCT04440163|39354592|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
16237563|NCT04440163|39354593|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
16237564|NCT04440163|39354594|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
16237565|NCT04440163|39354595|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
16237566|NCT04440163|39354596|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
16237567|NCT04440163|39354597|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
16237568|NCT04440163|39354590|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
16237569|NCT04440163|39354591|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
16237570|NCT04440163|39354592|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
16237571|NCT04440163|39354593|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
16237572|NCT04440163|39354594|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
16237573|NCT04440163|39354595|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
16237574|NCT04440163|39354596|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
16237575|NCT04440163|39354597|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
16237576|NCT00981019|39354598|FG000|Overall Study|Did not respond|65|||
16237577|NCT00981019|39354598|FG000|Overall Study|Did not match target population|94|||
16237578|NCT00981019|39354598|FG000|Overall Study|Inadvertent exclusion|239|||
16237579|NCT00981019|39354598|FG000|Overall Study|Hit the survey after closure|79|||
16237580|NCT02617446|39354599|FG000|Overall Study|Withdrawal by Subject|0|||
16237581|NCT02617446|39354600|FG001|Overall Study|Withdrawal by Subject|2|||
16237582|NCT02617446|39354601|FG002|Overall Study|Withdrawal by Subject|0|||
16237583|NCT02617446|39354599|FG000|Overall Study|Adverse Event|1|||
16237584|NCT02617446|39354600|FG001|Overall Study|Adverse Event|0|||
16237585|NCT02617446|39354601|FG002|Overall Study|Adverse Event|5|||
16237586|NCT02617446|39354599|FG000|Overall Study|Lost to Follow-up|3|||
16237587|NCT02617446|39354600|FG001|Overall Study|Lost to Follow-up|0|||
16237588|NCT02617446|39354601|FG002|Overall Study|Lost to Follow-up|0|||
16237589|NCT02617446|39354599|FG000|Overall Study|Death|0|||
16237590|NCT02617446|39354600|FG001|Overall Study|Death|0|||
16237591|NCT02617446|39354601|FG002|Overall Study|Death|2|||
16237592|NCT00854607|39354602|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
16237593|NCT03033069|39354603|FG000|Overall Study|Adverse Event|6|||
16237594|NCT03033069|39354604|FG001|Overall Study|Adverse Event|7|||
16413982|NCT00007020|39998310|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
16413983|NCT00007020|39998310|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
16413984|NCT00007020|39998310|FG000|Overall Study|Pt cared for by outside physician|4|||
16413985|NCT00007020|39998310|FG000|Overall Study|No evidence of treatment|6|||
16413986|NCT01927055|39998314|FG000|Open-label|Adverse Event|6|||
16413987|NCT01927055|39998315|FG001|Open-label|Adverse Event|0|||
16121858|NCT01299480|38930328|FG003|Overall Study|Lost to Follow-up|1|||
16121859|NCT01299480|38930329|FG004|Overall Study|Lost to Follow-up|2|||
16413988|NCT01927055|39998316|FG002|Open-label|Adverse Event|0|||
16413989|NCT01927055|39998314|FG000|Open-label|Withdrawal by Subject|1|||
16413990|NCT01927055|39998315|FG001|Open-label|Withdrawal by Subject|0|||
16413991|NCT01927055|39998316|FG002|Open-label|Withdrawal by Subject|0|||
16413992|NCT01927055|39998314|FG000|Open-label|Study Stopped|4|||
16237595|NCT03033069|39354605|FG002|Overall Study|Adverse Event|4|||
16237596|NCT03033069|39354606|FG003|Overall Study|Adverse Event|6|||
16237597|NCT03033069|39354603|FG000|Overall Study|Lack of Efficacy|0|||
16237598|NCT03033069|39354604|FG001|Overall Study|Lack of Efficacy|0|||
16237599|NCT03033069|39354605|FG002|Overall Study|Lack of Efficacy|1|||
16237600|NCT03033069|39354606|FG003|Overall Study|Lack of Efficacy|0|||
16237601|NCT03033069|39354603|FG000|Overall Study|Lost to Follow-up|6|||
16237602|NCT03033069|39354604|FG001|Overall Study|Lost to Follow-up|5|||
16237603|NCT03033069|39354605|FG002|Overall Study|Lost to Follow-up|5|||
16237604|NCT03033069|39354606|FG003|Overall Study|Lost to Follow-up|6|||
16237605|NCT03033069|39354603|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16237606|NCT03033069|39354604|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16237607|NCT03033069|39354605|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16237608|NCT03033069|39354606|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16237609|NCT03033069|39354603|FG000|Overall Study|Protocol Deviation|0|||
16237610|NCT03033069|39354604|FG001|Overall Study|Protocol Deviation|1|||
16237611|NCT03033069|39354605|FG002|Overall Study|Protocol Deviation|0|||
16237612|NCT03033069|39354606|FG003|Overall Study|Protocol Deviation|0|||
16237613|NCT03033069|39354603|FG000|Overall Study|Withdrawal by Subject|10|||
16237614|NCT03033069|39354604|FG001|Overall Study|Withdrawal by Subject|10|||
16237615|NCT03033069|39354605|FG002|Overall Study|Withdrawal by Subject|11|||
16237616|NCT03033069|39354606|FG003|Overall Study|Withdrawal by Subject|6|||
16237617|NCT03033069|39354603|FG000|Overall Study|Withdrawal By Caregiver|1|||
16237618|NCT03033069|39354604|FG001|Overall Study|Withdrawal By Caregiver|0|||
16237619|NCT03033069|39354605|FG002|Overall Study|Withdrawal By Caregiver|0|||
16237620|NCT03033069|39354606|FG003|Overall Study|Withdrawal By Caregiver|0|||
16237621|NCT03033069|39354603|FG000|Overall Study|Reason not Specified|0|||
16237622|NCT03033069|39354604|FG001|Overall Study|Reason not Specified|1|||
16237623|NCT03033069|39354605|FG002|Overall Study|Reason not Specified|0|||
16237624|NCT03033069|39354606|FG003|Overall Study|Reason not Specified|1|||
16237625|NCT03402126|39354615|FG000|Overall Study|Lost to Follow-up|6|||
16237626|NCT03402126|39354615|FG000|Overall Study|Protocol Violation|10|||
16237627|NCT03402126|39354615|FG000|Overall Study|Sponsor request/Study termination|29|||
16237628|NCT03402126|39354615|FG000|Overall Study|Study product no longer in use|1|||
16237629|NCT03402126|39354615|FG000|Overall Study|Technical problems|1|||
16237630|NCT03402126|39354615|FG000|Overall Study|Withdrawal by Subject|6|||
16237631|NCT03402126|39354615|FG000|Overall Study|Physician Decision|2|||
16237632|NCT03402126|39354615|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
16237633|NCT03402126|39354615|FG000|Overall Study|Death|4|||
16237634|NCT02862535|39354616|FG000|Overall Study|Death|7|||
16237635|NCT02862535|39354617|FG001|Overall Study|Death|3|||
16237636|NCT02862535|39354618|FG002|Overall Study|Death|2|||
16237637|NCT02862535|39354619|FG003|Overall Study|Death|5|||
16237638|NCT02862535|39354616|FG000|Overall Study|Study Terminated by Sponsor|1|||
16237639|NCT02862535|39354617|FG001|Overall Study|Study Terminated by Sponsor|3|||
16237640|NCT02862535|39354618|FG002|Overall Study|Study Terminated by Sponsor|8|||
16237641|NCT02862535|39354619|FG003|Overall Study|Study Terminated by Sponsor|5|||
16237642|NCT02862535|39354616|FG000|Overall Study|Enrolled, not Treated|1|||
16237643|NCT02862535|39354617|FG001|Overall Study|Enrolled, not Treated|0|||
16237644|NCT02862535|39354618|FG002|Overall Study|Enrolled, not Treated|0|||
16237645|NCT02862535|39354619|FG003|Overall Study|Enrolled, not Treated|1|||
16237646|NCT00572156|39354620|FG000|Overall Study|Adverse Event|3|||
16237647|NCT00572156|39354621|FG001|Overall Study|Adverse Event|1|||
16237648|NCT00572156|39354622|FG002|Overall Study|Adverse Event|5|||
16237649|NCT00572156|39354623|FG003|Overall Study|Adverse Event|1|||
16237650|NCT00572156|39354620|FG000|Overall Study|Lost to Follow-up|1|||
16237651|NCT00572156|39354621|FG001|Overall Study|Lost to Follow-up|1|||
16237652|NCT00572156|39354622|FG002|Overall Study|Lost to Follow-up|1|||
16237653|NCT00572156|39354623|FG003|Overall Study|Lost to Follow-up|0|||
16237654|NCT00572156|39354620|FG000|Overall Study|Protocol Violation|1|||
16237655|NCT00572156|39354621|FG001|Overall Study|Protocol Violation|2|||
16237656|NCT00572156|39354622|FG002|Overall Study|Protocol Violation|0|||
16237657|NCT00572156|39354623|FG003|Overall Study|Protocol Violation|2|||
16237658|NCT00572156|39354620|FG000|Overall Study|Patient/Parent Decision|1|||
16237659|NCT00572156|39354621|FG001|Overall Study|Patient/Parent Decision|6|||
16237660|NCT00572156|39354622|FG002|Overall Study|Patient/Parent Decision|4|||
16413993|NCT01927055|39998315|FG001|Open-label|Study Stopped|0|||
16237661|NCT00572156|39354623|FG003|Overall Study|Patient/Parent Decision|3|||
16237662|NCT00572156|39354620|FG000|Overall Study|Sponsor Decision|20|||
16237663|NCT00572156|39354621|FG001|Overall Study|Sponsor Decision|16|||
16237664|NCT00572156|39354622|FG002|Overall Study|Sponsor Decision|17|||
16237665|NCT00572156|39354623|FG003|Overall Study|Sponsor Decision|19|||
16237666|NCT00021229|39354632|FG000|Overall Study|Adverse Event|10|||
16237667|NCT00021229|39354633|FG001|Overall Study|Adverse Event|5|||
16237668|NCT00021229|39354634|FG002|Overall Study|Adverse Event|2|||
16237669|NCT00021229|39354632|FG000|Overall Study|Death|0|||
16237670|NCT00021229|39354633|FG001|Overall Study|Death|1|||
16237671|NCT00021229|39354634|FG002|Overall Study|Death|0|||
16237672|NCT00021229|39354632|FG000|Overall Study|Withdrawal by Subject|7|||
16237673|NCT00021229|39354633|FG001|Overall Study|Withdrawal by Subject|7|||
16237674|NCT00021229|39354634|FG002|Overall Study|Withdrawal by Subject|1|||
16237675|NCT00021229|39354632|FG000|Overall Study|Progressive Disease|15|||
16237676|NCT00021229|39354633|FG001|Overall Study|Progressive Disease|19|||
16237677|NCT00021229|39354634|FG002|Overall Study|Progressive Disease|12|||
16237678|NCT00021229|39354632|FG000|Overall Study|Protocol Violation|1|||
16237679|NCT00021229|39354633|FG001|Overall Study|Protocol Violation|1|||
16237680|NCT00021229|39354634|FG002|Overall Study|Protocol Violation|0|||
16237681|NCT00021229|39354632|FG000|Overall Study|Physician Decision|0|||
16237682|NCT00021229|39354633|FG001|Overall Study|Physician Decision|0|||
16237683|NCT00021229|39354634|FG002|Overall Study|Physician Decision|1|||
16237684|NCT00021229|39354632|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
16237685|NCT00021229|39354633|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
16237686|NCT00021229|39354634|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
16237687|NCT01174368|39354635|FG000|Overall Study|Withdrawal by Subject|1|||
16237688|NCT00267007|39354636|FG000|Overall Study|Withdrawal by Subject|6|||
16237689|NCT00267007|39354637|FG001|Overall Study|Withdrawal by Subject|0|||
16237690|NCT00267007|39354636|FG000|Overall Study|Lost to Follow-up|1|||
16237691|NCT00267007|39354637|FG001|Overall Study|Lost to Follow-up|0|||
16237692|NCT00267007|39354636|FG000|Overall Study|Non-compliance|0|||
16237693|NCT00267007|39354637|FG001|Overall Study|Non-compliance|1|||
16237694|NCT00267007|39354636|FG000|Overall Study|Adverse Event|1|||
16237695|NCT00267007|39354637|FG001|Overall Study|Adverse Event|0|||
16237696|NCT03876873|39354640|FG000|Overall Study|Physician Decision|0|||
16237697|NCT03876873|39354641|FG001|Overall Study|Physician Decision|1|||
16237698|NCT02729545|39354642|FG000|Overall Study|Pregnancy|1|||
16237699|NCT02729545|39354643|FG001|Overall Study|Pregnancy|1|||
16237700|NCT02729545|39354642|FG000|Overall Study|Lost to Follow-up|0|||
16237701|NCT02729545|39354643|FG001|Overall Study|Lost to Follow-up|1|||
16237702|NCT02729545|39354642|FG000|Overall Study|Withdrawal by Subject|2|||
16237703|NCT02729545|39354643|FG001|Overall Study|Withdrawal by Subject|3|||
16237704|NCT01345058|39354646|FG000|Overall Study|Withdrawal by Subject|1|||
16237705|NCT01345058|39354647|FG001|Overall Study|Withdrawal by Subject|0|||
16237706|NCT01345058|39354646|FG000|Overall Study|Participant Reported Increase in Events|1|||
16237707|NCT01345058|39354647|FG001|Overall Study|Participant Reported Increase in Events|0|||
16237708|NCT01345058|39354646|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
16237709|NCT01345058|39354647|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
16237710|NCT01345058|39354646|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
16121860|NCT01299480|38930325|FG000|Overall Study|Other|3|||
16121861|NCT01299480|38930326|FG001|Overall Study|Other|2|||
16121862|NCT01299480|38930327|FG002|Overall Study|Other|3|||
16237711|NCT01345058|39354647|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
16237712|NCT01345058|39354646|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
16237713|NCT01345058|39354647|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
16237714|NCT00585039|39354648|FG000|Overall Study|medication spilled|2|||
16237715|NCT00585039|39354649|FG001|Overall Study|medication spilled|0|||
16237716|NCT01785472|39354654|FG000|Overall Study|Adverse Event|5|||
16237717|NCT01785472|39354655|FG001|Overall Study|Adverse Event|4|||
16237718|NCT01785472|39354656|FG002|Overall Study|Adverse Event|6|||
16237719|NCT01785472|39354654|FG000|Overall Study|Lack of Efficacy|2|||
16237720|NCT01785472|39354655|FG001|Overall Study|Lack of Efficacy|0|||
16237721|NCT01785472|39354656|FG002|Overall Study|Lack of Efficacy|1|||
16237722|NCT01785472|39354654|FG000|Overall Study|Lost to Follow-up|1|||
16237723|NCT01785472|39354655|FG001|Overall Study|Lost to Follow-up|2|||
16237724|NCT01785472|39354656|FG002|Overall Study|Lost to Follow-up|0|||
16237725|NCT01785472|39354654|FG000|Overall Study|Physician Decision|1|||
16237726|NCT01785472|39354655|FG001|Overall Study|Physician Decision|1|||
16237727|NCT01785472|39354656|FG002|Overall Study|Physician Decision|1|||
16237728|NCT01785472|39354654|FG000|Overall Study|Protocol deviation|0|||
16237729|NCT01785472|39354655|FG001|Overall Study|Protocol deviation|2|||
16237730|NCT01785472|39354656|FG002|Overall Study|Protocol deviation|2|||
16237731|NCT01785472|39354654|FG000|Overall Study|Subject/guardian decision|15|||
16237732|NCT01785472|39354655|FG001|Overall Study|Subject/guardian decision|10|||
16237733|NCT01785472|39354656|FG002|Overall Study|Subject/guardian decision|11|||
16237734|NCT01785472|39354654|FG000|Overall Study|Technical problems|0|||
16237735|NCT01785472|39354655|FG001|Overall Study|Technical problems|0|||
16237736|NCT01785472|39354656|FG002|Overall Study|Technical problems|1|||
16237737|NCT00934622|39354657|FG000|Overall Study|Lost to Follow-up|7|||
16237738|NCT00934622|39354657|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
16237739|NCT00765999|39354660|FG000|Overall Study|Adverse Event|203|||
16237740|NCT00765999|39354660|FG000|Overall Study|Insufficient Therapeutic Response|100|||
16413994|NCT01927055|39998316|FG002|Open-label|Study Stopped|0|||
16555412|NCT00089895|40499686|FG000|Overall Study|Consent Withdrawn|11|||
16555413|NCT00089895|40499687|FG001|Overall Study|Consent Withdrawn|14|||
16555414|NCT00089895|40499686|FG000|Overall Study|Technical reason|7|||
16555415|NCT00089895|40499687|FG001|Overall Study|Technical reason|2|||
16555416|NCT00089895|40499686|FG000|Overall Study|Surgery|0|||
16555417|NCT00089895|40499687|FG001|Overall Study|Surgery|1|||
16555418|NCT00089895|40499686|FG000|Overall Study|Bleeding|0|||
16555419|NCT00089895|40499687|FG001|Overall Study|Bleeding|2|||
16555420|NCT00089895|40499686|FG000|Overall Study|Physician Decision|3|||
16555421|NCT00089895|40499687|FG001|Overall Study|Physician Decision|7|||
16555422|NCT00089895|40499686|FG000|Overall Study|Exclusion criteria met|6|||
16555423|NCT00089895|40499687|FG001|Overall Study|Exclusion criteria met|6|||
16555424|NCT00089895|40499686|FG000|Overall Study|Not otherwise specified|4|||
16555425|NCT00089895|40499687|FG001|Overall Study|Not otherwise specified|8|||
16555426|NCT00089895|40499686|FG000|Overall Study|Missing|4|||
16555427|NCT00089895|40499687|FG001|Overall Study|Missing|2|||
16555428|NCT01681368|40499688|FG000|Overall Study|Refused further treatment|1|||
16555429|NCT01681368|40499688|FG000|Overall Study|Refused further follow up|1|||
16555430|NCT02471404|40499689|FG000|Overall Study|Adverse Event|7|||
16555431|NCT02471404|40499690|FG001|Overall Study|Adverse Event|1|||
16555432|NCT02471404|40499691|FG002|Overall Study|Adverse Event|2|||
16555433|NCT02471404|40499689|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
16555434|NCT02471404|40499690|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
16555435|NCT02471404|40499691|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
16555436|NCT02471404|40499689|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
16555437|NCT02471404|40499690|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
16555438|NCT02471404|40499691|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
16555439|NCT02471404|40499689|FG000|Overall Study|Lost to Follow-up|1|||
16555440|NCT02471404|40499690|FG001|Overall Study|Lost to Follow-up|1|||
16555441|NCT02471404|40499691|FG002|Overall Study|Lost to Follow-up|3|||
16555442|NCT02471404|40499689|FG000|Overall Study|Protocol Violation|1|||
16555443|NCT02471404|40499690|FG001|Overall Study|Protocol Violation|0|||
16555444|NCT02471404|40499691|FG002|Overall Study|Protocol Violation|0|||
16555445|NCT02471404|40499689|FG000|Overall Study|Withdrawal by Subject|8|||
16555446|NCT02471404|40499690|FG001|Overall Study|Withdrawal by Subject|4|||
16555447|NCT02471404|40499691|FG002|Overall Study|Withdrawal by Subject|5|||
16555448|NCT02471404|40499689|FG000|Overall Study|Other reasons not specified|10|||
16555449|NCT02471404|40499690|FG001|Overall Study|Other reasons not specified|7|||
16555450|NCT02471404|40499691|FG002|Overall Study|Other reasons not specified|12|||
16555451|NCT00442286|40499692|FG000|Overall Study|Death|2|||
16555452|NCT00442286|40499693|FG001|Overall Study|Death|2|||
16555453|NCT00442286|40499692|FG000|Overall Study|Lost to Follow-up|1|||
16555454|NCT00442286|40499693|FG001|Overall Study|Lost to Follow-up|0|||
16555455|NCT00442286|40499692|FG000|Overall Study|Withdrawal by Subject|2|||
16555456|NCT00442286|40499693|FG001|Overall Study|Withdrawal by Subject|0|||
16555457|NCT00442286|40499692|FG000|Overall Study|System explanted|1|||
16237741|NCT00765999|39354660|FG000|Overall Study|Protocol Violation|95|||
16237742|NCT00765999|39354660|FG000|Overall Study|Consent Withdrawn|202|||
16237743|NCT00765999|39354660|FG000|Overall Study|Lost to Follow-up|131|||
16237744|NCT00765999|39354660|FG000|Overall Study|Study Terminated by Sponsor|2|||
16555458|NCT00442286|40499693|FG001|Overall Study|System explanted|0|||
16555459|NCT00442286|40499692|FG000|Overall Study|Patient Injury|1|||
16555460|NCT00442286|40499693|FG001|Overall Study|Patient Injury|0|||
16555461|NCT00653263|40499694|FG000|Overall Study|Withdrawal by Subject|1|||
16555462|NCT00653263|40499694|FG000|Overall Study|Physician Decision|1|||
16555463|NCT02942004|40499695|FG000|Overall Study|Withdrawal by Subject|0|||
16555464|NCT02942004|40499696|FG001|Overall Study|Withdrawal by Subject|2|||
16237745|NCT00765999|39354660|FG000|Overall Study|Other Miscellaneous Reasons|51|||
16413995|NCT01927055|39998314|FG000|Open-label|Supine Hypertension|4|||
16237746|NCT02756078|39354680|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
16237747|NCT02756078|39354681|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
16237748|NCT02756078|39354680|FG000|Period 1|Lost to Follow-up|0|||
16237749|NCT02756078|39354681|FG001|Period 1|Lost to Follow-up|2|||
16237750|NCT02756078|39354680|FG000|Period 1|Protocol Violation|0|||
16237751|NCT02756078|39354681|FG001|Period 1|Protocol Violation|1|||
16237752|NCT02756078|39354680|FG000|Period 1|Adverse Event|1|||
16237753|NCT02756078|39354681|FG001|Period 1|Adverse Event|10|||
16237754|NCT02756078|39354680|FG000|Period 1|Withdrawal by Subject|6|||
16237755|NCT02756078|39354681|FG001|Period 1|Withdrawal by Subject|6|||
16237756|NCT02756078|39354680|FG000|Period 1|Lens Discomfort|2|||
16237757|NCT02756078|39354681|FG001|Period 1|Lens Discomfort|2|||
16237758|NCT02756078|39354680|FG000|Period 2|Adverse Event|3|||
16237759|NCT02756078|39354681|FG001|Period 2|Adverse Event|5|||
16237760|NCT02756078|39354680|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
16237761|NCT02756078|39354681|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
16237762|NCT02756078|39354680|FG000|Period 2|Withdrawal by Subject|3|||
16237763|NCT02756078|39354681|FG001|Period 2|Withdrawal by Subject|1|||
16237764|NCT02050373|39354683|FG000|Overall Study|Adverse Event|4|||
16237765|NCT02050373|39354684|FG001|Overall Study|Adverse Event|7|||
16237766|NCT02050373|39354683|FG000|Overall Study|Death|3|||
16237767|NCT02050373|39354684|FG001|Overall Study|Death|3|||
16237768|NCT00665626|39354685|FG000|Overall Study|Lack of Efficacy|8|||
16237769|NCT00665626|39354686|FG001|Overall Study|Lack of Efficacy|5|||
16237770|NCT00665626|39354685|FG000|Overall Study|Lost to Follow-up|0|||
16237771|NCT00665626|39354686|FG001|Overall Study|Lost to Follow-up|2|||
16237772|NCT00665626|39354685|FG000|Overall Study|Withdrawal by Subject|0|||
16237773|NCT00665626|39354686|FG001|Overall Study|Withdrawal by Subject|1|||
16237774|NCT00665626|39354685|FG000|Overall Study|Protocol Violation|0|||
16237775|NCT00665626|39354686|FG001|Overall Study|Protocol Violation|2|||
16237776|NCT00665626|39354685|FG000|Overall Study|Adverse Event|1|||
16237777|NCT00665626|39354686|FG001|Overall Study|Adverse Event|9|||
16237778|NCT00665626|39354685|FG000|Overall Study|Due to exclusion criteria|0|||
16237779|NCT00665626|39354686|FG001|Overall Study|Due to exclusion criteria|1|||
16237780|NCT00665626|39354685|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
16237781|NCT00665626|39354686|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
16237782|NCT00665626|39354685|FG000|Overall Study|Unably to comply with dosing regimen|0|||
16237783|NCT00665626|39354686|FG001|Overall Study|Unably to comply with dosing regimen|1|||
16237784|NCT00665626|39354685|FG000|Overall Study|Death|1|||
16237785|NCT00665626|39354686|FG001|Overall Study|Death|0|||
16237786|NCT00990093|39354688|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
16237787|NCT00990093|39354689|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
16237788|NCT00990093|39354688|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
16237789|NCT00990093|39354689|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
16237790|NCT00990093|39354688|FG000|Test Period 1 (1-14 Days)|Other|1|||
16237791|NCT00990093|39354689|FG001|Test Period 1 (1-14 Days)|Other|0|||
16237792|NCT00990093|39354688|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
16237793|NCT00990093|39354689|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
16237794|NCT00990093|39354688|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
16237795|NCT00990093|39354689|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
16237796|NCT00990093|39354688|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
16237797|NCT00990093|39354689|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
16237798|NCT00990093|39354688|FG000|Test Period 2 (15-28 Days)|Other|0|||
16237799|NCT00990093|39354689|FG001|Test Period 2 (15-28 Days)|Other|1|||
16237800|NCT02367781|39354693|FG000|Overall Study|Withdrawal by Subject|20|||
16237801|NCT02367781|39354694|FG001|Overall Study|Withdrawal by Subject|13|||
16237802|NCT02367781|39354693|FG000|Overall Study|Protocol Violation|0|||
16237803|NCT02367781|39354694|FG001|Overall Study|Protocol Violation|1|||
16237804|NCT02367781|39354693|FG000|Overall Study|Physician Decision|7|||
16237805|NCT02367781|39354694|FG001|Overall Study|Physician Decision|0|||
16237806|NCT02367781|39354693|FG000|Overall Study|Randomized in Error|5|||
16237807|NCT02367781|39354694|FG001|Overall Study|Randomized in Error|4|||
16237808|NCT02367781|39354693|FG000|Overall Study|Non-Compliance|1|||
16237809|NCT02367781|39354694|FG001|Overall Study|Non-Compliance|0|||
16237810|NCT02367781|39354693|FG000|Overall Study|Lost to Follow-up|1|||
16237811|NCT02367781|39354694|FG001|Overall Study|Lost to Follow-up|2|||
16237812|NCT02367781|39354693|FG000|Overall Study|Death|330|||
16237813|NCT02367781|39354694|FG001|Overall Study|Death|176|||
16237814|NCT02367781|39354693|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
16237815|NCT02367781|39354694|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
16237816|NCT02367781|39354693|FG000|Overall Study|Prolonged Hospitalization|1|||
16237817|NCT02367781|39354694|FG001|Overall Study|Prolonged Hospitalization|0|||
16237818|NCT02367781|39354693|FG000|Overall Study|Death Prior First Dose|1|||
16237819|NCT02367781|39354694|FG001|Overall Study|Death Prior First Dose|0|||
16237820|NCT02367781|39354693|FG000|Overall Study|Administrative-Change Facility|1|||
16237821|NCT02367781|39354694|FG001|Overall Study|Administrative-Change Facility|0|||
16237822|NCT02367781|39354693|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
16273125|NCT03961204|39484414|FG000|Overall Study|Withdrawal by Subject|2|||
16237823|NCT02367781|39354694|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
16237824|NCT02367781|39354693|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
16237825|NCT02367781|39354694|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
16237826|NCT02367781|39354693|FG000|Overall Study|Study Terminated by Sponsor|3|||
16237827|NCT02367781|39354694|FG001|Overall Study|Study Terminated by Sponsor|1|||
16237828|NCT02367781|39354693|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
16237829|NCT02367781|39354694|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
16237830|NCT02367781|39354693|FG000|Overall Study|Sponsor Decision|2|||
16237831|NCT02367781|39354694|FG001|Overall Study|Sponsor Decision|0|||
16237832|NCT02367781|39354693|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
16237833|NCT02367781|39354694|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
16237834|NCT01966107|39354695|FG000|Overall Study|excluded from FAS|21|||
16237835|NCT01966107|39354696|FG001|Overall Study|excluded from FAS|20|||
16237836|NCT01966107|39354695|FG000|Overall Study|discontinued treatment|345|||
16237837|NCT01966107|39354696|FG001|Overall Study|discontinued treatment|372|||
16237838|NCT01966107|39354695|FG000|Overall Study|due to study closure|164|||
16237839|NCT01966107|39354696|FG001|Overall Study|due to study closure|186|||
16237840|NCT01966107|39354695|FG000|Overall Study|withdrew from the study|272|||
16237841|NCT01966107|39354696|FG001|Overall Study|withdrew from the study|303|||
16237842|NCT03151226|39354697|FG000|Overall Study|Withdrawal by Subject|2|||
16237843|NCT03151226|39354697|FG000|Overall Study|not wear device correctly|1|||
16237844|NCT01227954|39354698|FG000|Overall Study|Protocol Violation|6|||
16237845|NCT01227954|39354698|FG000|Overall Study|No protocol treatment|7|||
16273126|NCT03961204|39484414|FG000|Overall Study|Lost to Follow-up|3|||
16121863|NCT01299480|38930328|FG003|Overall Study|Other|0|||
16121864|NCT01299480|38930329|FG004|Overall Study|Other|3|||
16121865|NCT01299480|38930325|FG000|Overall Study|Started, but not vaccinated|0|||
16121866|NCT01299480|38930326|FG001|Overall Study|Started, but not vaccinated|0|||
16121867|NCT01299480|38930327|FG002|Overall Study|Started, but not vaccinated|1|||
16121868|NCT01299480|38930328|FG003|Overall Study|Started, but not vaccinated|1|||
16121869|NCT01299480|38930329|FG004|Overall Study|Started, but not vaccinated|0|||
16413996|NCT01927055|39998315|FG001|Open-label|Supine Hypertension|0|||
16413997|NCT01927055|39998316|FG002|Open-label|Supine Hypertension|0|||
16413998|NCT01927055|39998314|FG000|Open-label|Difficulty attending study visits|1|||
16413999|NCT01927055|39998315|FG001|Open-label|Difficulty attending study visits|0|||
16121870|NCT00264303|38930330|FG000|Overall Study|Adverse Event|4|||
16237846|NCT01333475|39354699|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
16273127|NCT03961204|39484414|FG000|Overall Study|Other|1|||
16414000|NCT01927055|39998316|FG002|Open-label|Difficulty attending study visits|0|||
16414001|NCT01927055|39998314|FG000|Double-Blind|Adverse Event|0|||
16414002|NCT01927055|39998315|FG001|Double-Blind|Adverse Event|1|||
16414003|NCT01927055|39998316|FG002|Double-Blind|Adverse Event|1|||
16414004|NCT01927055|39998314|FG000|Double-Blind|Protocol Violation|0|||
16414005|NCT01927055|39998315|FG001|Double-Blind|Protocol Violation|0|||
16414006|NCT01927055|39998316|FG002|Double-Blind|Protocol Violation|1|||
16414007|NCT01927055|39998314|FG000|Double-Blind|Withdrawal by Subject|0|||
16414008|NCT01927055|39998315|FG001|Double-Blind|Withdrawal by Subject|2|||
16414009|NCT01927055|39998316|FG002|Double-Blind|Withdrawal by Subject|3|||
16414010|NCT01927055|39998314|FG000|Double-Blind|Study Stopped|0|||
16414011|NCT01927055|39998315|FG001|Double-Blind|Study Stopped|7|||
16414012|NCT01927055|39998316|FG002|Double-Blind|Study Stopped|7|||
16414013|NCT01927055|39998314|FG000|Double-Blind|Supine Hypertension|0|||
16414014|NCT01927055|39998315|FG001|Double-Blind|Supine Hypertension|0|||
16414015|NCT01927055|39998316|FG002|Double-Blind|Supine Hypertension|1|||
16414016|NCT01927055|39998314|FG000|Double-Blind|Extended Vacation|0|||
16414017|NCT01927055|39998315|FG001|Double-Blind|Extended Vacation|1|||
16414018|NCT01927055|39998316|FG002|Double-Blind|Extended Vacation|0|||
16414019|NCT04598269|39998317|FG000|Overall Study|Adverse Event|0|||
16414020|NCT04598269|39998318|FG001|Overall Study|Adverse Event|3|||
16414021|NCT04598269|39998317|FG000|Overall Study|Withdrawal by Subject|1|||
16414022|NCT04598269|39998318|FG001|Overall Study|Withdrawal by Subject|4|||
16414023|NCT04598269|39998317|FG000|Overall Study|Lost to Follow-up|1|||
16414024|NCT04598269|39998318|FG001|Overall Study|Lost to Follow-up|0|||
16414025|NCT04598269|39998317|FG000|Overall Study|Not Treated|2|||
16414026|NCT04598269|39998318|FG001|Overall Study|Not Treated|0|||
16414027|NCT00708734|39998319|FG000|Overall Study|scheduling conflict|2|||
16414028|NCT00708734|39998319|FG000|Overall Study|moved|1|||
16414029|NCT00708734|39998319|FG000|Overall Study|leg injury|1|||
16414030|NCT00708734|39998319|FG000|Overall Study|knee replacement|1|||
16414031|NCT00708734|39998319|FG000|Overall Study|vertigo|1|||
16414032|NCT00708734|39998319|FG000|Overall Study|leg fracture|1|||
16414033|NCT00320372|39998320|FG000|Overall Study|Physician Decision|4|||
16414034|NCT00320372|39998321|FG001|Overall Study|Physician Decision|7|||
16414035|NCT00320372|39998320|FG000|Overall Study|Death|7|||
16414036|NCT00320372|39998321|FG001|Overall Study|Death|8|||
16414037|NCT00320372|39998320|FG000|Overall Study|Withdrawal by Subject|55|||
16414038|NCT00320372|39998321|FG001|Overall Study|Withdrawal by Subject|37|||
16414039|NCT00320372|39998320|FG000|Overall Study|Non-Compliance|40|||
16414040|NCT00320372|39998321|FG001|Overall Study|Non-Compliance|39|||
16414041|NCT00320372|39998320|FG000|Overall Study|Did not Meet (I/E)|3|||
16414042|NCT00320372|39998321|FG001|Overall Study|Did not Meet (I/E)|1|||
16414043|NCT00320372|39998320|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
16414044|NCT00320372|39998321|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
16414045|NCT01659255|39998322|FG000|Overall Study|Adverse Event|0|||
16414046|NCT01659255|39998323|FG001|Overall Study|Adverse Event|0|||
16414047|NCT01659255|39998324|FG002|Overall Study|Adverse Event|0|||
16414048|NCT01659255|39998325|FG003|Overall Study|Adverse Event|0|||
16414049|NCT01659255|39998326|FG004|Overall Study|Adverse Event|0|||
16414050|NCT01659255|39998327|FG005|Overall Study|Adverse Event|1|||
16414051|NCT01659255|39998328|FG006|Overall Study|Adverse Event|1|||
16414052|NCT01659255|39998329|FG007|Overall Study|Adverse Event|0|||
16414053|NCT01659255|39998330|FG008|Overall Study|Adverse Event|0|||
16414054|NCT01659255|39998331|FG009|Overall Study|Adverse Event|1|||
16121871|NCT00264303|38930331|FG001|Overall Study|Adverse Event|3|||
16121872|NCT00264303|38930330|FG000|Overall Study|Lack of Efficacy|10|||
16121873|NCT00264303|38930331|FG001|Overall Study|Lack of Efficacy|13|||
16121874|NCT00264303|38930330|FG000|Overall Study|Lost to Follow-up|3|||
16121875|NCT00264303|38930331|FG001|Overall Study|Lost to Follow-up|3|||
16121876|NCT00264303|38930330|FG000|Overall Study|Withdrawal by Subject|2|||
16121877|NCT00264303|38930331|FG001|Overall Study|Withdrawal by Subject|3|||
16121878|NCT00264303|38930330|FG000|Overall Study|Various reasons listed in study report|6|||
16121879|NCT00264303|38930331|FG001|Overall Study|Various reasons listed in study report|7|||
16121880|NCT02922023|38930332|FG000|Overall Study|Lost to Follow-up|2|||
16237847|NCT01333475|39354700|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
16349793|NCT02616783|39768824|FG001|Overall Study|Randomized but Not Treated|0|||
16349794|NCT02616783|39768823|FG000|Overall Study|Adverse Event|1|||
16349795|NCT02616783|39768824|FG001|Overall Study|Adverse Event|0|||
16349796|NCT02616783|39768823|FG000|Overall Study|Death|1|||
16349797|NCT02616783|39768824|FG001|Overall Study|Death|0|||
16349798|NCT02616783|39768823|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16349799|NCT02616783|39768824|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16349800|NCT02616783|39768823|FG000|Overall Study|Protocol Violation|1|||
16349801|NCT02616783|39768824|FG001|Overall Study|Protocol Violation|1|||
16349802|NCT02616783|39768823|FG000|Overall Study|Withdrew Consent|1|||
16349803|NCT02616783|39768824|FG001|Overall Study|Withdrew Consent|1|||
16349804|NCT02620787|39768827|FG000|Overall Study|Adverse Event|1|||
16349805|NCT02620787|39768828|FG001|Overall Study|Adverse Event|0|||
16349806|NCT02620787|39768827|FG000|Overall Study|Eligibility Criteria Not Met|1|||
16349807|NCT02620787|39768828|FG001|Overall Study|Eligibility Criteria Not Met|0|||
16349808|NCT02493517|39768829|FG000|Overall Study|Protocol Violation|1|||
16349809|NCT02493517|39768830|FG001|Overall Study|Protocol Violation|2|||
16555465|NCT02942004|40499697|FG002|Overall Study|Withdrawal by Subject|3|||
16555466|NCT02942004|40499695|FG000|Overall Study|Lost to Follow-up|1|||
16349810|NCT02493517|39768829|FG000|Overall Study|Withdrawal by Subject|1|||
16349811|NCT02493517|39768830|FG001|Overall Study|Withdrawal by Subject|2|||
16349812|NCT02493517|39768829|FG000|Overall Study|Adverse Event|0|||
16349813|NCT02493517|39768830|FG001|Overall Study|Adverse Event|2|||
16555467|NCT02942004|40499696|FG001|Overall Study|Lost to Follow-up|1|||
16555468|NCT02942004|40499697|FG002|Overall Study|Lost to Follow-up|2|||
16555469|NCT02942004|40499695|FG000|Overall Study|Randomized but not dosed|3|||
16555470|NCT02942004|40499696|FG001|Overall Study|Randomized but not dosed|9|||
16555471|NCT02942004|40499697|FG002|Overall Study|Randomized but not dosed|4|||
16555472|NCT01923389|40499698|FG000|Overall Study|Protocol Violation|1|||
16555473|NCT01923389|40499699|FG001|Overall Study|Protocol Violation|0|||
16555474|NCT01785628|40499700|FG000|Overall Study|Lost to Follow-up|2|||
16555475|NCT01785628|40499701|FG001|Overall Study|Lost to Follow-up|3|||
16555476|NCT02593539|40499702|FG000|Overall Study|Adverse Event|1|||
16555477|NCT03685708|40499708|FG000|Overall Study|Withdrawal by Subject|0|||
16555478|NCT03685708|40499709|FG001|Overall Study|Withdrawal by Subject|0|||
16555479|NCT03685708|40499710|FG002|Overall Study|Withdrawal by Subject|1|||
16555480|NCT03685708|40499708|FG000|Overall Study|Screen Fail|0|||
16555481|NCT03685708|40499709|FG001|Overall Study|Screen Fail|1|||
16555482|NCT03685708|40499710|FG002|Overall Study|Screen Fail|1|||
16555483|NCT03685708|40499708|FG000|Overall Study|COVID 19 Pandemic|1|||
16555484|NCT03685708|40499709|FG001|Overall Study|COVID 19 Pandemic|1|||
16555485|NCT03685708|40499710|FG002|Overall Study|COVID 19 Pandemic|6|||
16555486|NCT03685708|40499708|FG000|Overall Study|Disease Progression|0|||
16555487|NCT03685708|40499709|FG001|Overall Study|Disease Progression|0|||
16555488|NCT03685708|40499710|FG002|Overall Study|Disease Progression|1|||
16555489|NCT03935217|40499711|FG000|Overall Study|Adverse Event|1|||
16555490|NCT03935217|40499712|FG001|Overall Study|Adverse Event|0|||
16555491|NCT03935217|40499711|FG000|Overall Study|Lost to Follow-up|0|||
16555492|NCT03935217|40499712|FG001|Overall Study|Lost to Follow-up|1|||
16555493|NCT03935217|40499711|FG000|Overall Study|Withdrawal by Subject|0|||
16555494|NCT03935217|40499712|FG001|Overall Study|Withdrawal by Subject|2|||
16555495|NCT02372058|40499713|FG000|Overall Study|Withdrawal by Subject|3|||
16555496|NCT00293462|40499714|FG000|Overall Study|Withdrawal by Subject|4|||
16555497|NCT00293462|40499715|FG001|Overall Study|Withdrawal by Subject|3|||
16555498|NCT00293462|40499716|FG002|Overall Study|Withdrawal by Subject|8|||
16555499|NCT00293462|40499714|FG000|Overall Study|Death|1|||
16555500|NCT00293462|40499715|FG001|Overall Study|Death|0|||
16555501|NCT00293462|40499716|FG002|Overall Study|Death|0|||
16555502|NCT00293462|40499714|FG000|Overall Study|Lost to Follow-up|0|||
16555503|NCT00293462|40499715|FG001|Overall Study|Lost to Follow-up|1|||
16121881|NCT02922023|38930333|FG001|Overall Study|Lost to Follow-up|0|||
16349814|NCT02493517|39768829|FG000|Overall Study|Missed study visit|0|||
16349815|NCT02493517|39768830|FG001|Overall Study|Missed study visit|1|||
16349816|NCT03225287|39768831|FG000|Overall Study|Adverse Event|0|||
16349817|NCT03225287|39768832|FG001|Overall Study|Adverse Event|0|||
16349818|NCT03225287|39768833|FG002|Overall Study|Adverse Event|1|||
16555504|NCT00293462|40499716|FG002|Overall Study|Lost to Follow-up|0|||
16555505|NCT00293462|40499714|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
16121882|NCT00902746|38934318|FG000|Overall Study|Protocol Violation|7|||
16121883|NCT00902746|38934318|FG000|Overall Study|Withdrawal by Subject|16|||
16121884|NCT00902746|38934318|FG000|Overall Study|Adverse Event|8|||
16121885|NCT00902746|38934318|FG000|Overall Study|Lost to Follow-up|3|||
16121886|NCT00902746|38934318|FG000|Overall Study|Physician Decision|2|||
16121887|NCT01228318|38934319|FG000|Overall Study|Clinic no show to receive intervention|1|||
16121888|NCT01228318|38934320|FG001|Overall Study|Clinic no show to receive intervention|0|||
16121889|NCT01228318|38934319|FG000|Overall Study|Unable to contact|2|||
16121890|NCT01228318|38934320|FG001|Overall Study|Unable to contact|5|||
16121891|NCT01228318|38934319|FG000|Overall Study|Moved|0|||
16121892|NCT01228318|38934320|FG001|Overall Study|Moved|2|||
16121893|NCT01228318|38934319|FG000|Overall Study|Incarcerated|1|||
16121894|NCT01228318|38934320|FG001|Overall Study|Incarcerated|0|||
16349819|NCT03225287|39768831|FG000|Overall Study|Protocol non-compliance|0|||
16349820|NCT03225287|39768832|FG001|Overall Study|Protocol non-compliance|0|||
16349821|NCT03225287|39768833|FG002|Overall Study|Protocol non-compliance|1|||
16349822|NCT03225287|39768831|FG000|Overall Study|Subject withdraws consent|3|||
16349823|NCT03225287|39768832|FG001|Overall Study|Subject withdraws consent|0|||
16349824|NCT03225287|39768833|FG002|Overall Study|Subject withdraws consent|0|||
16349825|NCT03225287|39768831|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
16349826|NCT03225287|39768832|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
16414055|NCT01659255|39998332|FG010|Overall Study|Adverse Event|0|||
16414056|NCT01659255|39998333|FG011|Overall Study|Adverse Event|1|||
16414057|NCT01659255|39998334|FG012|Overall Study|Adverse Event|0|||
16121895|NCT01696045|38934331|FG000|Overall Study|Study drug toxicity|1|||
16121896|NCT01696045|38934332|FG001|Overall Study|Study drug toxicity|5|||
16121897|NCT01696045|38934331|FG000|Overall Study|Disease progression|2|||
16121898|NCT01696045|38934332|FG001|Overall Study|Disease progression|2|||
16121899|NCT00406692|38934339|FG000|Overall Study|Withdrawal by Subject|4|||
16121900|NCT00406692|38934339|FG000|Overall Study|Physician Decision|1|||
16121901|NCT00406692|38934339|FG000|Overall Study|Adverse Event|1|||
16121902|NCT00406692|38934339|FG000|Overall Study|Lack of Efficacy|1|||
16121903|NCT00127205|38934340|FG000|Overall Study|Adverse Event|228|||
16121904|NCT00127205|38934341|FG001|Overall Study|Adverse Event|387|||
16121905|NCT00127205|38934342|FG002|Overall Study|Adverse Event|273|||
16121906|NCT00127205|38934340|FG000|Overall Study|Death|8|||
16121907|NCT00127205|38934341|FG001|Overall Study|Death|6|||
16121908|NCT00127205|38934342|FG002|Overall Study|Death|5|||
16121909|NCT00127205|38934340|FG000|Overall Study|Withdrawal by Subject|318|||
16121910|NCT00127205|38934341|FG001|Overall Study|Withdrawal by Subject|310|||
16121911|NCT00127205|38934342|FG002|Overall Study|Withdrawal by Subject|172|||
16555506|NCT00293462|40499715|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
16555507|NCT00293462|40499716|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
16555508|NCT00293462|40499714|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
16555509|NCT00293462|40499715|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
16555510|NCT00293462|40499716|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
16555511|NCT00293462|40499714|FG000|Overall Study|Refuse Radiation Treatment|1|||
16555512|NCT00293462|40499715|FG001|Overall Study|Refuse Radiation Treatment|0|||
16555513|NCT00293462|40499716|FG002|Overall Study|Refuse Radiation Treatment|0|||
16555514|NCT00293462|40499714|FG000|Overall Study|No Show|0|||
16555515|NCT00293462|40499715|FG001|Overall Study|No Show|0|||
16555516|NCT00293462|40499716|FG002|Overall Study|No Show|1|||
16555517|NCT00293462|40499714|FG000|Overall Study|Went back to his home country|0|||
16555518|NCT00293462|40499715|FG001|Overall Study|Went back to his home country|0|||
16555519|NCT00293462|40499716|FG002|Overall Study|Went back to his home country|1|||
16555520|NCT00293462|40499714|FG000|Overall Study|Blood clot after chemotherapy|0|||
16555521|NCT00293462|40499715|FG001|Overall Study|Blood clot after chemotherapy|0|||
16555522|NCT00293462|40499716|FG002|Overall Study|Blood clot after chemotherapy|1|||
16555523|NCT00293462|40499714|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
16555524|NCT00293462|40499715|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
16555525|NCT00293462|40499716|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
16121912|NCT00127205|38934340|FG000|Overall Study|Other-non protocol specified|142|||
16121913|NCT00127205|38934341|FG001|Overall Study|Other-non protocol specified|129|||
16121914|NCT00127205|38934342|FG002|Overall Study|Other-non protocol specified|77|||
16121915|NCT00127205|38934340|FG000|Overall Study|Data not reported|6|||
16555526|NCT00293462|40499714|FG000|Overall Study|Possible Tracheostomy leakage|0|||
16555527|NCT00293462|40499715|FG001|Overall Study|Possible Tracheostomy leakage|1|||
16121916|NCT00127205|38934341|FG001|Overall Study|Data not reported|10|||
16121917|NCT00127205|38934342|FG002|Overall Study|Data not reported|1|||
16121918|NCT00127205|38934340|FG000|Overall Study|Progression|127|||
16121919|NCT00127205|38934341|FG001|Overall Study|Progression|131|||
16121920|NCT00127205|38934342|FG002|Overall Study|Progression|84|||
16121921|NCT02416453|38934350|FG000|Overall Study|Adverse Event|0|||
16121922|NCT02416453|38934351|FG001|Overall Study|Adverse Event|0|||
16121923|NCT02416453|38934352|FG002|Overall Study|Adverse Event|0|||
16121924|NCT02416453|38934353|FG003|Overall Study|Adverse Event|2|||
16121925|NCT02416453|38934354|FG004|Overall Study|Adverse Event|0|||
16121926|NCT02416453|38934355|FG005|Overall Study|Adverse Event|1|||
16121927|NCT02416453|38934356|FG006|Overall Study|Adverse Event|0|||
16121928|NCT02416453|38934357|FG007|Overall Study|Adverse Event|0|||
16121929|NCT02416453|38934358|FG008|Overall Study|Adverse Event|0|||
16121930|NCT02416453|38934359|FG009|Overall Study|Adverse Event|0|||
16121931|NCT02416453|38934360|FG010|Overall Study|Adverse Event|0|||
16555528|NCT00293462|40499716|FG002|Overall Study|Possible Tracheostomy leakage|0|||
16555529|NCT00293462|40499714|FG000|Overall Study|Low radiation dose in oral cavity|0|||
16555530|NCT00293462|40499715|FG001|Overall Study|Low radiation dose in oral cavity|1|||
16555531|NCT00293462|40499716|FG002|Overall Study|Low radiation dose in oral cavity|0|||
16555532|NCT00293462|40499714|FG000|Overall Study|Physician Decision|0|||
16555533|NCT00293462|40499715|FG001|Overall Study|Physician Decision|1|||
16555534|NCT00293462|40499716|FG002|Overall Study|Physician Decision|0|||
16555535|NCT04140890|40499717|FG000|Overall Study|Withdrawal by Subject|0|||
16555536|NCT04140890|40499718|FG001|Overall Study|Withdrawal by Subject|1|||
16555537|NCT01464255|40499719|FG000|Overall Study|unresolve corneal staining|0|||
16555538|NCT01464255|40499720|FG001|Overall Study|unresolve corneal staining|1|||
16555539|NCT01555021|40499723|FG000|Overall Study|Lost to Follow-up|1|||
16555540|NCT01555021|40499724|FG001|Overall Study|Lost to Follow-up|2|||
16555541|NCT04003974|40499725|FG000|Overall Study|Missing|1|||
16555542|NCT04003974|40499726|FG001|Overall Study|Missing|0|||
16555543|NCT04003974|40499725|FG000|Overall Study|Withdrawal by Subject|0|||
16555544|NCT04003974|40499726|FG001|Overall Study|Withdrawal by Subject|2|||
16555545|NCT03890120|40499735|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
16555546|NCT03890120|40499736|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
16555547|NCT03890120|40499737|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
16555548|NCT03890120|40499738|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
16555549|NCT03890120|40499735|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
16555550|NCT03890120|40499736|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
16555551|NCT03890120|40499737|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
16555552|NCT03890120|40499738|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
16555553|NCT03890120|40499735|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
16555554|NCT03890120|40499736|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
16555555|NCT03890120|40499737|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
16555556|NCT03890120|40499738|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
16555557|NCT03890120|40499735|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
16555558|NCT03890120|40499736|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
16555559|NCT03890120|40499737|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
16555560|NCT03890120|40499738|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
16555561|NCT03890120|40499735|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
16555562|NCT03890120|40499736|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
16555563|NCT03890120|40499737|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
16555564|NCT03890120|40499738|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
16555565|NCT03890120|40499735|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
16555566|NCT03890120|40499736|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
16555567|NCT03890120|40499737|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
16555568|NCT03890120|40499738|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
16555569|NCT03890120|40499735|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
16555570|NCT03890120|40499736|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
16555571|NCT03890120|40499737|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
16555572|NCT03890120|40499738|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
16555573|NCT03890120|40499735|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
16555574|NCT03890120|40499736|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
16555575|NCT03890120|40499737|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
16555576|NCT03890120|40499738|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
16555577|NCT03890120|40499735|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
16555578|NCT03890120|40499736|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
16555579|NCT03890120|40499737|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
16555580|NCT03890120|40499738|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
16555581|NCT03890120|40499735|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
16555582|NCT03890120|40499736|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
16121932|NCT02416453|38934350|FG000|Overall Study|Lost to Follow-up|1|||
16121933|NCT02416453|38934351|FG001|Overall Study|Lost to Follow-up|3|||
16414058|NCT01659255|39998335|FG013|Overall Study|Adverse Event|2|||
16414059|NCT01659255|39998336|FG014|Overall Study|Adverse Event|0|||
16414060|NCT01659255|39998337|FG015|Overall Study|Adverse Event|1|||
16414061|NCT01659255|39998338|FG016|Overall Study|Adverse Event|0|||
16414062|NCT01659255|39998322|FG000|Overall Study|Death|0|||
16414063|NCT01659255|39998323|FG001|Overall Study|Death|1|||
16414064|NCT01659255|39998324|FG002|Overall Study|Death|0|||
16414065|NCT01659255|39998325|FG003|Overall Study|Death|0|||
16414066|NCT01659255|39998326|FG004|Overall Study|Death|0|||
16414067|NCT01659255|39998327|FG005|Overall Study|Death|0|||
16414068|NCT01659255|39998328|FG006|Overall Study|Death|0|||
16414069|NCT01659255|39998329|FG007|Overall Study|Death|1|||
16414070|NCT01659255|39998330|FG008|Overall Study|Death|1|||
16414071|NCT01659255|39998331|FG009|Overall Study|Death|0|||
16414072|NCT01659255|39998332|FG010|Overall Study|Death|0|||
16414073|NCT01659255|39998333|FG011|Overall Study|Death|0|||
16414074|NCT01659255|39998334|FG012|Overall Study|Death|1|||
16414075|NCT01659255|39998335|FG013|Overall Study|Death|1|||
16414076|NCT01659255|39998336|FG014|Overall Study|Death|2|||
16414077|NCT01659255|39998337|FG015|Overall Study|Death|1|||
16414078|NCT01659255|39998338|FG016|Overall Study|Death|0|||
16414079|NCT01659255|39998322|FG000|Overall Study|Progressive Disease|2|||
16414080|NCT01659255|39998323|FG001|Overall Study|Progressive Disease|0|||
16414081|NCT01659255|39998324|FG002|Overall Study|Progressive Disease|0|||
16414082|NCT01659255|39998325|FG003|Overall Study|Progressive Disease|0|||
16414083|NCT01659255|39998326|FG004|Overall Study|Progressive Disease|0|||
16414084|NCT01659255|39998327|FG005|Overall Study|Progressive Disease|0|||
16414085|NCT01659255|39998328|FG006|Overall Study|Progressive Disease|0|||
16414086|NCT01659255|39998329|FG007|Overall Study|Progressive Disease|1|||
16414087|NCT01659255|39998330|FG008|Overall Study|Progressive Disease|0|||
16414088|NCT01659255|39998331|FG009|Overall Study|Progressive Disease|2|||
16414089|NCT01659255|39998332|FG010|Overall Study|Progressive Disease|2|||
16414090|NCT01659255|39998333|FG011|Overall Study|Progressive Disease|3|||
16414091|NCT01659255|39998334|FG012|Overall Study|Progressive Disease|5|||
16414092|NCT01659255|39998335|FG013|Overall Study|Progressive Disease|13|||
16414093|NCT01659255|39998336|FG014|Overall Study|Progressive Disease|6|||
16414094|NCT01659255|39998337|FG015|Overall Study|Progressive Disease|2|||
16414095|NCT01659255|39998338|FG016|Overall Study|Progressive Disease|3|||
16414096|NCT01659255|39998322|FG000|Overall Study|Withdrew Consent|0|||
16414097|NCT01659255|39998323|FG001|Overall Study|Withdrew Consent|0|||
16414098|NCT01659255|39998324|FG002|Overall Study|Withdrew Consent|0|||
16414099|NCT01659255|39998325|FG003|Overall Study|Withdrew Consent|0|||
16414100|NCT01659255|39998326|FG004|Overall Study|Withdrew Consent|0|||
16555583|NCT03890120|40499737|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
16555584|NCT03890120|40499738|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
16555585|NCT03890120|40499735|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
16555586|NCT03890120|40499736|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
16555587|NCT03890120|40499737|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
16555588|NCT03890120|40499738|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
16121934|NCT02416453|38934352|FG002|Overall Study|Lost to Follow-up|0|||
16121935|NCT02416453|38934353|FG003|Overall Study|Lost to Follow-up|8|||
16555589|NCT03890120|40499735|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
16555590|NCT03890120|40499736|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
16555591|NCT03890120|40499737|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
16555592|NCT03890120|40499738|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
16555593|NCT03890120|40499735|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
16555594|NCT03890120|40499736|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
16555595|NCT03890120|40499737|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
16555596|NCT03890120|40499738|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
16555597|NCT02141659|40499739|FG000|Overall Study|Major Protocol Deviation|0|||
16555598|NCT02141659|40499740|FG001|Overall Study|Major Protocol Deviation|1|||
16555599|NCT02141659|40499741|FG002|Overall Study|Major Protocol Deviation|0|||
16555600|NCT02141659|40499742|FG003|Overall Study|Major Protocol Deviation|0|||
16555601|NCT02141659|40499743|FG004|Overall Study|Major Protocol Deviation|0|||
16555602|NCT02141659|40499744|FG005|Overall Study|Major Protocol Deviation|0|||
16555603|NCT02141659|40499739|FG000|Overall Study|Lack of Efficacy|0|||
16555604|NCT02141659|40499740|FG001|Overall Study|Lack of Efficacy|0|||
16555605|NCT02141659|40499741|FG002|Overall Study|Lack of Efficacy|0|||
16555606|NCT02141659|40499742|FG003|Overall Study|Lack of Efficacy|0|||
16555607|NCT02141659|40499743|FG004|Overall Study|Lack of Efficacy|0|||
16555608|NCT02141659|40499744|FG005|Overall Study|Lack of Efficacy|1|||
16555609|NCT02141659|40499739|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
16555610|NCT02141659|40499740|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
16555611|NCT02141659|40499741|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
16555612|NCT02141659|40499742|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
16555613|NCT02141659|40499743|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
16555614|NCT02141659|40499744|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
16555615|NCT02204293|40499745|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
16555616|NCT02204293|40499746|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
16555617|NCT02204293|40499747|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
16555618|NCT02204293|40499748|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
16555619|NCT02204293|40499749|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
16555620|NCT02204293|40499750|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
16555621|NCT02204293|40499745|FG000|Core Study Part I|Adverse Event|1|||
16555622|NCT02204293|40499746|FG001|Core Study Part I|Adverse Event|0|||
16121936|NCT02416453|38934354|FG004|Overall Study|Lost to Follow-up|0|||
16555623|NCT02204293|40499747|FG002|Core Study Part I|Adverse Event|0|||
16555624|NCT02204293|40499748|FG003|Core Study Part I|Adverse Event|0|||
16555625|NCT02204293|40499749|FG004|Core Study Part I|Adverse Event|0|||
16555626|NCT02204293|40499750|FG005|Core Study Part I|Adverse Event|0|||
16555627|NCT02204293|40499745|FG000|Core Study Part I|Physician Decision|0|||
16121937|NCT02416453|38934355|FG005|Overall Study|Lost to Follow-up|5|||
16121938|NCT02416453|38934356|FG006|Overall Study|Lost to Follow-up|1|||
16121939|NCT02416453|38934357|FG007|Overall Study|Lost to Follow-up|3|||
16121940|NCT02416453|38934358|FG008|Overall Study|Lost to Follow-up|1|||
16121941|NCT02416453|38934359|FG009|Overall Study|Lost to Follow-up|0|||
16237848|NCT01333475|39354699|FG000|Overall Study|Toxicity|1|||
16237849|NCT01333475|39354700|FG001|Overall Study|Toxicity|3|||
16237850|NCT04388527|39354702|FG000|Overall Study|Death|14|||
16555628|NCT02204293|40499746|FG001|Core Study Part I|Physician Decision|3|||
16555629|NCT02204293|40499747|FG002|Core Study Part I|Physician Decision|0|||
16555630|NCT02204293|40499748|FG003|Core Study Part I|Physician Decision|0|||
16555631|NCT02204293|40499749|FG004|Core Study Part I|Physician Decision|0|||
16555632|NCT02204293|40499750|FG005|Core Study Part I|Physician Decision|0|||
16555633|NCT02204293|40499745|FG000|LTE Phase|Study Suspended|0|||
16555634|NCT02204293|40499746|FG001|LTE Phase|Study Suspended|0|||
16555635|NCT02204293|40499747|FG002|LTE Phase|Study Suspended|0|||
16555636|NCT02204293|40499748|FG003|LTE Phase|Study Suspended|0|||
16555637|NCT02204293|40499749|FG004|LTE Phase|Study Suspended|0|||
16555638|NCT02204293|40499750|FG005|LTE Phase|Study Suspended|7|||
16555639|NCT03204695|40499753|FG000|Overall Study|Death|1|||
16555640|NCT03204695|40499753|FG000|Overall Study|Participant was treated with another device|1|||
16555641|NCT03204695|40499753|FG000|Overall Study|Physician Decision|2|||
16555642|NCT02111213|40499754|FG000|Overall Study|Withdrawal by Subject|3|||
16555643|NCT02111213|40499755|FG001|Overall Study|Withdrawal by Subject|2|||
16555644|NCT02111213|40499754|FG000|Overall Study|Lost to Follow-up|3|||
16555645|NCT02111213|40499755|FG001|Overall Study|Lost to Follow-up|4|||
16555646|NCT01448044|40499756|FG000|Treatment Period|Adverse Event|4|||
16555647|NCT01448044|40499757|FG001|Treatment Period|Adverse Event|3|||
16555648|NCT01448044|40499756|FG000|Treatment Period|Lack of Efficacy|5|||
16555649|NCT01448044|40499757|FG001|Treatment Period|Lack of Efficacy|12|||
16555650|NCT01448044|40499756|FG000|Treatment Period|Subject requested discontinue study drug|1|||
16555651|NCT01448044|40499757|FG001|Treatment Period|Subject requested discontinue study drug|0|||
16555652|NCT01448044|40499756|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
16555653|NCT01448044|40499757|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
16555654|NCT01448044|40499756|FG000|Treatment Period|Participant does not meet study criteria|1|||
16555655|NCT01448044|40499757|FG001|Treatment Period|Participant does not meet study criteria|0|||
16555656|NCT01448044|40499756|FG000|Treatment Period|Lost to Follow-up|2|||
16555657|NCT01448044|40499757|FG001|Treatment Period|Lost to Follow-up|1|||
16555658|NCT01448044|40499756|FG000|Treatment Period|Other reason|2|||
16555659|NCT01448044|40499757|FG001|Treatment Period|Other reason|0|||
16555660|NCT01448044|40499756|FG000|Follow Up Period|Withdrawal by Subject|1|||
16555661|NCT01448044|40499757|FG001|Follow Up Period|Withdrawal by Subject|1|||
16555662|NCT01448044|40499756|FG000|Follow Up Period|Lost to Follow-up|6|||
16555663|NCT01448044|40499757|FG001|Follow Up Period|Lost to Follow-up|2|||
16555664|NCT01448044|40499756|FG000|Follow Up Period|Other|5|||
16555665|NCT01448044|40499757|FG001|Follow Up Period|Other|11|||
16555666|NCT00972543|40499760|FG000|Overall Study|Adverse Event|1|||
16555667|NCT00972543|40499761|FG001|Overall Study|Adverse Event|0|||
16555668|NCT00972543|40499760|FG000|Overall Study|Early study termination by sponsor|4|||
16555669|NCT00972543|40499761|FG001|Overall Study|Early study termination by sponsor|1|||
16555670|NCT01912222|40499762|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
16121942|NCT02416453|38934360|FG010|Overall Study|Lost to Follow-up|0|||
16237851|NCT04388527|39354702|FG000|Overall Study|Withdrawal by Subject|2|||
16237852|NCT04388527|39354702|FG000|Overall Study|Lost to Follow-up|1|||
16121943|NCT02416453|38934350|FG000|Overall Study|Physician Decision|0|||
16121944|NCT02416453|38934351|FG001|Overall Study|Physician Decision|0|||
16237853|NCT03506425|39354712|FG000|Overall Study|Adverse Event|1|||
16237854|NCT03506425|39354713|FG001|Overall Study|Adverse Event|3|||
16555671|NCT01912222|40499763|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
16555672|NCT01912222|40499764|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
16555673|NCT01912222|40499762|FG000|Part B: Treatment Period|Progressive disease|10|||
16555674|NCT01912222|40499763|FG001|Part B: Treatment Period|Progressive disease|12|||
16555675|NCT01912222|40499764|FG002|Part B: Treatment Period|Progressive disease|15|||
16555676|NCT01912222|40499762|FG000|Part B: Treatment Period|Adverse Event|1|||
16237855|NCT03506425|39354714|FG002|Overall Study|Adverse Event|0|||
16237856|NCT03506425|39354712|FG000|Overall Study|Death|1|||
16237857|NCT03506425|39354713|FG001|Overall Study|Death|0|||
16237858|NCT03506425|39354714|FG002|Overall Study|Death|0|||
16237859|NCT03506425|39354712|FG000|Overall Study|Withdrawal by Subject|0|||
16237860|NCT03506425|39354713|FG001|Overall Study|Withdrawal by Subject|0|||
16237861|NCT03506425|39354714|FG002|Overall Study|Withdrawal by Subject|1|||
16237862|NCT03123120|39354715|FG000|Overall Study|Lost to Follow-up|0|||
16237863|NCT03123120|39354716|FG001|Overall Study|Lost to Follow-up|1|||
16237864|NCT03123120|39354715|FG000|Overall Study|Withdrawal by Subject|0|||
16237865|NCT03123120|39354716|FG001|Overall Study|Withdrawal by Subject|1|||
16237866|NCT01890109|39354717|FG000|Overall Study|Withdrawal by Subject|0|||
16237867|NCT01890109|39354718|FG001|Overall Study|Withdrawal by Subject|3|||
16237868|NCT01890109|39354717|FG000|Overall Study|Lost to Follow-up|1|||
16237869|NCT01890109|39354718|FG001|Overall Study|Lost to Follow-up|2|||
16237870|NCT02181842|39354724|FG000|Overall Study|Case Report Forms Uncollected|2|||
16237871|NCT01892020|39354730|FG000|Period 1|Adverse Event|1|||
16237872|NCT01892020|39354731|FG001|Period 1|Adverse Event|1|||
16237873|NCT01892020|39354730|FG000|Period 1|Protocol Violation|2|||
16237874|NCT01892020|39354731|FG001|Period 1|Protocol Violation|4|||
16237875|NCT01892020|39354730|FG000|Period 1|Unclassified|0|||
16237876|NCT01892020|39354731|FG001|Period 1|Unclassified|1|||
16237877|NCT01892020|39354730|FG000|Period 2|Protocol Violation|1|||
16237878|NCT01892020|39354731|FG001|Period 2|Protocol Violation|0|||
16237879|NCT00434148|39354737|FG000|Overall Study|Adverse Event|18|||
16237880|NCT00434148|39354738|FG001|Overall Study|Adverse Event|18|||
16237881|NCT00434148|39354737|FG000|Overall Study|Lack of Efficacy|25|||
16237882|NCT00434148|39354738|FG001|Overall Study|Lack of Efficacy|28|||
16237883|NCT00434148|39354737|FG000|Overall Study|Withdrawal by Subject|15|||
16237884|NCT00434148|39354738|FG001|Overall Study|Withdrawal by Subject|15|||
16237885|NCT00434148|39354737|FG000|Overall Study|Protocol Violation|4|||
16237886|NCT00434148|39354738|FG001|Overall Study|Protocol Violation|0|||
16237887|NCT00434148|39354737|FG000|Overall Study|Administrative problems|6|||
16237888|NCT00434148|39354738|FG001|Overall Study|Administrative problems|10|||
16237889|NCT00434148|39354737|FG000|Overall Study|Lost to Follow-up|0|||
16237890|NCT00434148|39354738|FG001|Overall Study|Lost to Follow-up|1|||
16237891|NCT00434148|39354737|FG000|Overall Study|Condition no longer requires study drug|1|||
16237892|NCT00434148|39354738|FG001|Overall Study|Condition no longer requires study drug|0|||
16237893|NCT00434148|39354737|FG000|Overall Study|Abnormal test procedure result|0|||
16237894|NCT00434148|39354738|FG001|Overall Study|Abnormal test procedure result|1|||
16237895|NCT00242567|39354743|FG000|Overall Study|Adverse Event|70|||
16237896|NCT00242567|39354744|FG001|Overall Study|Adverse Event|43|||
16237897|NCT00242567|39354743|FG000|Overall Study|Disease Progression|17|||
16555677|NCT01912222|40499763|FG001|Part B: Treatment Period|Adverse Event|2|||
16555678|NCT01912222|40499764|FG002|Part B: Treatment Period|Adverse Event|3|||
16555679|NCT01912222|40499762|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
16555680|NCT01912222|40499763|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
16555681|NCT01912222|40499764|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
16555682|NCT01539863|40499774|FG000|Overall Study|Lost to Follow-up|5|||
16555683|NCT01539863|40499775|FG001|Overall Study|Lost to Follow-up|4|||
16555684|NCT02087150|40499782|FG000|Overall Study|Death|0|||
16555685|NCT02087150|40499783|FG001|Overall Study|Death|1|||
16555686|NCT02087150|40499784|FG002|Overall Study|Death|0|||
16555687|NCT02087150|40499782|FG000|Overall Study|Lost to Follow-up|6|||
16555688|NCT02087150|40499783|FG001|Overall Study|Lost to Follow-up|13|||
16555689|NCT02087150|40499784|FG002|Overall Study|Lost to Follow-up|7|||
16555690|NCT02087150|40499782|FG000|Overall Study|Withdrawal by Subject|2|||
16555691|NCT02087150|40499783|FG001|Overall Study|Withdrawal by Subject|5|||
16555692|NCT02087150|40499784|FG002|Overall Study|Withdrawal by Subject|3|||
16555693|NCT02087150|40499782|FG000|Overall Study|Physician Decision|0|||
16555694|NCT02087150|40499783|FG001|Overall Study|Physician Decision|1|||
16555695|NCT02087150|40499784|FG002|Overall Study|Physician Decision|0|||
16555696|NCT02087150|40499782|FG000|Overall Study|Procedure not done|1|||
16555697|NCT02087150|40499783|FG001|Overall Study|Procedure not done|13|||
16237898|NCT00242567|39354744|FG001|Overall Study|Disease Progression|22|||
16237899|NCT00242567|39354743|FG000|Overall Study|Symptomatic deterioration|9|||
16237900|NCT00242567|39354744|FG001|Overall Study|Symptomatic deterioration|3|||
16237901|NCT00242567|39354743|FG000|Overall Study|Lack of Efficacy|2|||
16237902|NCT00242567|39354744|FG001|Overall Study|Lack of Efficacy|2|||
16237903|NCT00242567|39354743|FG000|Overall Study|Lost to Follow-up|9|||
16237904|NCT00242567|39354744|FG001|Overall Study|Lost to Follow-up|19|||
16555698|NCT02087150|40499784|FG002|Overall Study|Procedure not done|0|||
16237905|NCT00242567|39354743|FG000|Overall Study|Withdrawal by Subject|33|||
16555699|NCT02087150|40499782|FG000|Overall Study|F/U not completed w/in study window|0|||
16555700|NCT02087150|40499783|FG001|Overall Study|F/U not completed w/in study window|0|||
16555701|NCT02087150|40499784|FG002|Overall Study|F/U not completed w/in study window|1|||
16555702|NCT02087150|40499782|FG000|Overall Study|Other|1|||
16555703|NCT02087150|40499783|FG001|Overall Study|Other|0|||
16555704|NCT02087150|40499784|FG002|Overall Study|Other|0|||
16237906|NCT00242567|39354744|FG001|Overall Study|Withdrawal by Subject|28|||
16237907|NCT00242567|39354743|FG000|Overall Study|Protocol Violation|12|||
16237908|NCT00242567|39354744|FG001|Overall Study|Protocol Violation|12|||
16237909|NCT00242567|39354743|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
16237910|NCT00242567|39354744|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
16237911|NCT00242567|39354743|FG000|Overall Study|Other|14|||
16237912|NCT00242567|39354744|FG001|Overall Study|Other|9|||
16237913|NCT00457418|39354749|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
16237914|NCT00457418|39354749|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
16237915|NCT00457418|39354749|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
16237916|NCT00457418|39354749|FG000|Post PK Maintenance|Adverse Event|10|||
16237917|NCT00457418|39354749|FG000|Post PK Maintenance|Progression of Disease|6|||
16237918|NCT00457418|39354749|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
16237919|NCT00457418|39354749|FG000|Post PK Maintenance|Lost to Follow-up|1|||
16237920|NCT00829439|39354751|FG000|Overall Study|Adverse Event|0|||
16237921|NCT00829439|39354752|FG001|Overall Study|Adverse Event|0|||
16237922|NCT00829439|39354753|FG002|Overall Study|Adverse Event|1|||
16237923|NCT00829439|39354754|FG003|Overall Study|Adverse Event|0|||
16237924|NCT00537056|39354755|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
16237925|NCT02525562|39357447|FG000|Overall Study|Death|9|||
16237926|NCT02525562|39357448|FG001|Overall Study|Death|0|||
16237927|NCT02525562|39357449|FG002|Overall Study|Death|0|||
16237928|NCT02525562|39357447|FG000|Overall Study|Lost to Follow-up|19|||
16237929|NCT02525562|39357448|FG001|Overall Study|Lost to Follow-up|0|||
16237930|NCT02525562|39357449|FG002|Overall Study|Lost to Follow-up|0|||
16237931|NCT02525562|39357447|FG000|Overall Study|Withdrawal by Subject|37|||
16237932|NCT02525562|39357448|FG001|Overall Study|Withdrawal by Subject|0|||
16237933|NCT02525562|39357449|FG002|Overall Study|Withdrawal by Subject|0|||
16237934|NCT02525562|39357447|FG000|Overall Study|Revision/Removal of Study Device|4|||
16237935|NCT02525562|39357448|FG001|Overall Study|Revision/Removal of Study Device|0|||
16237936|NCT02525562|39357449|FG002|Overall Study|Revision/Removal of Study Device|0|||
16237937|NCT02525562|39357447|FG000|Overall Study|Study Closed by Sponsor|154|||
16237938|NCT02525562|39357448|FG001|Overall Study|Study Closed by Sponsor|0|||
16237939|NCT02525562|39357449|FG002|Overall Study|Study Closed by Sponsor|0|||
16237940|NCT02602080|39357451|FG000|Overall Study|Protocol Violation|6|||
16237941|NCT02602080|39357452|FG001|Overall Study|Protocol Violation|1|||
16237942|NCT02602080|39357453|FG002|Overall Study|Protocol Violation|3|||
16237943|NCT01850108|39357454|FG000|Overall Study|Lost to Follow-up|4|||
16237944|NCT01850108|39357454|FG000|Overall Study|Not eligible|1|||
16237945|NCT01850108|39357454|FG000|Overall Study|Failed engraftment|2|||
16237946|NCT01850108|39357454|FG000|Overall Study|Physician Decision|1|||
16237947|NCT00545441|39357455|FG000|Overall Study|Fistula draining at 6 months|2|||
16237948|NCT00545441|39357456|FG001|Overall Study|Fistula draining at 6 months|4|||
16237949|NCT00545441|39357455|FG000|Overall Study|Lost to Follow-up|9|||
16237950|NCT00545441|39357456|FG001|Overall Study|Lost to Follow-up|5|||
16237951|NCT00545441|39357455|FG000|Overall Study|Technical failure|0|||
16237952|NCT00545441|39357456|FG001|Overall Study|Technical failure|1|||
16237953|NCT00545441|39357455|FG000|Overall Study|Withdrawal by Subject|1|||
16237954|NCT00545441|39357456|FG001|Overall Study|Withdrawal by Subject|1|||
16237955|NCT00545441|39357455|FG000|Overall Study|Persistence or recurrence of fistula|5|||
16237956|NCT00545441|39357456|FG001|Overall Study|Persistence or recurrence of fistula|2|||
16237957|NCT00545441|39357455|FG000|Overall Study|Patients were not treated|1|||
16237958|NCT00545441|39357456|FG001|Overall Study|Patients were not treated|3|||
16237959|NCT02441179|39357457|FG000|Overall Study|Withdrawal by Subject|1|||
16237960|NCT02441179|39357458|FG001|Overall Study|Withdrawal by Subject|1|||
16237961|NCT00915473|39357459|FG000|Screening|Withdrawal by Subject|1|||
16237962|NCT00915473|39357460|FG001|Screening|Withdrawal by Subject|0|||
16237963|NCT00915473|39357459|FG000|4-week Follow Up|Lost to Follow-up|1|||
16237964|NCT00915473|39357460|FG001|4-week Follow Up|Lost to Follow-up|5|||
16237965|NCT05553600|39357461|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
16237966|NCT05553600|39357462|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
16555705|NCT02087150|40499782|FG000|Overall Study|Pt moved out of town|0|||
16555706|NCT02087150|40499783|FG001|Overall Study|Pt moved out of town|1|||
16555707|NCT02087150|40499784|FG002|Overall Study|Pt moved out of town|0|||
16555708|NCT00849680|40499785|FG000|Overall Study|Adverse Event|0|||
16555709|NCT00849680|40499786|FG001|Overall Study|Adverse Event|0|||
16555710|NCT00849680|40499787|FG002|Overall Study|Adverse Event|0|||
16555711|NCT00849680|40499788|FG003|Overall Study|Adverse Event|0|||
16237967|NCT05553600|39357463|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
16237968|NCT05553600|39357464|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
16273128|NCT03961204|39484414|FG000|Overall Study|Missing|1|||
16555712|NCT00849680|40499789|FG004|Overall Study|Adverse Event|0|||
16555713|NCT00849680|40499790|FG005|Overall Study|Adverse Event|0|||
16237969|NCT05553600|39357461|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
16237970|NCT05553600|39357462|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
16237971|NCT05553600|39357463|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
16237972|NCT05553600|39357464|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
16237973|NCT05553600|39357461|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
16237974|NCT05553600|39357462|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
16237975|NCT05553600|39357463|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
16237976|NCT05553600|39357464|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
16237977|NCT05553600|39357461|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
16237978|NCT05553600|39357462|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
16237979|NCT05553600|39357463|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
16237980|NCT05553600|39357464|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
16237981|NCT05553600|39357461|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
16237982|NCT05553600|39357462|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
16237983|NCT05553600|39357463|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
16237984|NCT05553600|39357464|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
16237985|NCT05553600|39357461|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
16237986|NCT05553600|39357462|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
16237987|NCT05553600|39357463|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
16237988|NCT05553600|39357464|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
16237989|NCT05553600|39357461|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
16237990|NCT05553600|39357462|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
16237991|NCT05553600|39357463|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
16237992|NCT05553600|39357464|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
16237993|NCT05553600|39357461|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
16237994|NCT05553600|39357462|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
16237995|NCT05553600|39357463|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
16237996|NCT05553600|39357464|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
16237997|NCT05553600|39357461|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
16237998|NCT05553600|39357462|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
16237999|NCT05553600|39357463|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
16238000|NCT05553600|39357464|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
16238001|NCT05553600|39357461|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
16238002|NCT05553600|39357462|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
16238003|NCT05553600|39357463|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
16238004|NCT05553600|39357464|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
16238005|NCT05553600|39357461|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
16238006|NCT05553600|39357462|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
16238007|NCT05553600|39357463|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
16238008|NCT05553600|39357464|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
16238009|NCT05553600|39357461|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
16238010|NCT05553600|39357462|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
16238011|NCT05553600|39357463|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
16414101|NCT01659255|39998327|FG005|Overall Study|Withdrew Consent|0|||
16555714|NCT00849680|40499791|FG006|Overall Study|Adverse Event|2|||
16555715|NCT00849680|40499792|FG007|Overall Study|Adverse Event|0|||
16555716|NCT00849680|40499785|FG000|Overall Study|Lost to Follow-up|7|||
16555717|NCT00849680|40499786|FG001|Overall Study|Lost to Follow-up|3|||
16555718|NCT00849680|40499787|FG002|Overall Study|Lost to Follow-up|12|||
16555719|NCT00849680|40499788|FG003|Overall Study|Lost to Follow-up|11|||
16555720|NCT00849680|40499789|FG004|Overall Study|Lost to Follow-up|8|||
16555721|NCT00849680|40499790|FG005|Overall Study|Lost to Follow-up|11|||
16238012|NCT05553600|39357464|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
16238013|NCT00306852|39357465|FG000|Overall Study|Death|14|||
16555722|NCT00849680|40499791|FG006|Overall Study|Lost to Follow-up|12|||
16555723|NCT00849680|40499792|FG007|Overall Study|Lost to Follow-up|5|||
16555724|NCT00849680|40499785|FG000|Overall Study|Subject moved|1|||
16555725|NCT00849680|40499786|FG001|Overall Study|Subject moved|0|||
16555726|NCT00849680|40499787|FG002|Overall Study|Subject moved|3|||
16555727|NCT00849680|40499788|FG003|Overall Study|Subject moved|1|||
16555728|NCT00849680|40499789|FG004|Overall Study|Subject moved|0|||
16555729|NCT00849680|40499790|FG005|Overall Study|Subject moved|2|||
16555730|NCT00849680|40499791|FG006|Overall Study|Subject moved|2|||
16555731|NCT00849680|40499792|FG007|Overall Study|Subject moved|2|||
16238014|NCT00306852|39357466|FG001|Overall Study|Death|14|||
16238015|NCT00306852|39357465|FG000|Overall Study|Lost to Follow-up|15|||
16238016|NCT00306852|39357466|FG001|Overall Study|Lost to Follow-up|24|||
16238017|NCT01074307|39357471|FG000|Overall Study|No primary endpoint evaluation|14|||
16238018|NCT01074307|39357472|FG001|Overall Study|No primary endpoint evaluation|6|||
16238019|NCT01074307|39357471|FG000|Overall Study|Exclusion criterion|0|||
16238020|NCT01074307|39357472|FG001|Overall Study|Exclusion criterion|1|||
16238021|NCT01074307|39357471|FG000|Overall Study|Protocol Violation|8|||
16238022|NCT01074307|39357472|FG001|Overall Study|Protocol Violation|5|||
16238023|NCT02748616|39357476|FG000|Overall Study|Lost to Follow-up|1|||
16238024|NCT02748616|39357476|FG000|Overall Study|Withdrawal by Subject|2|||
16555732|NCT00849680|40499785|FG000|Overall Study|Withdrawal by Subject|2|||
16555733|NCT00849680|40499786|FG001|Overall Study|Withdrawal by Subject|0|||
16555734|NCT00849680|40499787|FG002|Overall Study|Withdrawal by Subject|0|||
16555735|NCT00849680|40499788|FG003|Overall Study|Withdrawal by Subject|2|||
16555736|NCT00849680|40499789|FG004|Overall Study|Withdrawal by Subject|2|||
16555737|NCT00849680|40499790|FG005|Overall Study|Withdrawal by Subject|2|||
16555738|NCT00849680|40499791|FG006|Overall Study|Withdrawal by Subject|1|||
16555739|NCT00849680|40499792|FG007|Overall Study|Withdrawal by Subject|1|||
16555740|NCT00849680|40499785|FG000|Overall Study|Subject unable to comply with protocol|1|||
16555741|NCT00849680|40499786|FG001|Overall Study|Subject unable to comply with protocol|0|||
16555742|NCT00849680|40499787|FG002|Overall Study|Subject unable to comply with protocol|0|||
16555743|NCT00849680|40499788|FG003|Overall Study|Subject unable to comply with protocol|0|||
16555744|NCT00849680|40499789|FG004|Overall Study|Subject unable to comply with protocol|0|||
16555745|NCT00849680|40499790|FG005|Overall Study|Subject unable to comply with protocol|0|||
16238025|NCT02748616|39357476|FG000|Overall Study|Physician Decision|2|||
16238026|NCT02748616|39357476|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
16238027|NCT00450177|39357478|FG000|Overall Study|Adverse Event|7|||
16238028|NCT00450177|39357479|FG001|Overall Study|Adverse Event|4|||
16238029|NCT00450177|39357478|FG000|Overall Study|Withdrawal by Subject|1|||
16555746|NCT00849680|40499791|FG006|Overall Study|Subject unable to comply with protocol|0|||
16555747|NCT00849680|40499792|FG007|Overall Study|Subject unable to comply with protocol|0|||
16555748|NCT04430335|40499794|FG000|Overall Study|Withdrawal by Subject|1|||
16238030|NCT00450177|39357479|FG001|Overall Study|Withdrawal by Subject|6|||
16238031|NCT00450177|39357478|FG000|Overall Study|Withdrawal by Primary Team|1|||
16238032|NCT00450177|39357479|FG001|Overall Study|Withdrawal by Primary Team|1|||
16555749|NCT02019602|40499797|FG000|Screening Period|Ineligibility|4|||
16555750|NCT02019602|40499798|FG001|Screening Period|Ineligibility|0|||
16555751|NCT02019602|40499797|FG000|Screening Period|Adverse Event|1|||
16555752|NCT02019602|40499798|FG001|Screening Period|Adverse Event|0|||
16555753|NCT01115491|40499805|FG000|Overall Study|Death|22|||
16238033|NCT01179191|39357483|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
16238034|NCT01179191|39357483|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
16555754|NCT01115491|40499805|FG000|Overall Study|Adverse Event|3|||
16555755|NCT01115491|40499805|FG000|Overall Study|Lost to Follow-up|3|||
16555756|NCT01115491|40499805|FG000|Overall Study|Withdrawal by Subject|1|||
16238035|NCT01179191|39357483|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
16238036|NCT01179191|39357483|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
16238037|NCT01179191|39357483|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
16238038|NCT01179191|39357483|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
16238039|NCT01179191|39357483|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
16238040|NCT01179191|39357483|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
16555757|NCT01115491|40499805|FG000|Overall Study|Physician Decision|1|||
16555758|NCT04276090|40499806|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
16555759|NCT04276090|40499807|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
16555760|NCT04230980|40499812|FG000|Overall Study|Lost to Follow-up|1|||
16555761|NCT04230980|40499813|FG001|Overall Study|Lost to Follow-up|2|||
16555762|NCT04230980|40499812|FG000|Overall Study|Adverse Event|0|||
16555763|NCT04230980|40499813|FG001|Overall Study|Adverse Event|1|||
16555764|NCT01778062|40499819|FG000|Overall Study|Adverse Event|1|||
16555765|NCT01778062|40499820|FG001|Overall Study|Adverse Event|3|||
16555766|NCT01778062|40499819|FG000|Overall Study|Consent Withdrawal|1|||
16555767|NCT01778062|40499820|FG001|Overall Study|Consent Withdrawal|5|||
16555768|NCT01778062|40499819|FG000|Overall Study|major protocol deviation|4|||
16555769|NCT01778062|40499820|FG001|Overall Study|major protocol deviation|3|||
16555770|NCT00598481|40499823|FG000|Treatment|Physician Decision|1|||
16555771|NCT02788006|40499824|FG000|Overall Study|Patient not treated|1|||
16238041|NCT01179191|39357483|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
16238042|NCT01179191|39357483|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
16238043|NCT01179191|39357483|FG000|Maintenance Phase (8 Weeks)|Other|66|||
16555772|NCT02341456|40499826|FG000|Overall Study|Disease progression|2|||
16238044|NCT00683904|39357484|FG000|Dose Level 1|Disease progression|2|||
16238045|NCT00683904|39357485|FG001|Dose Level 1|Disease progression|0|||
16238046|NCT00683904|39357484|FG000|Dose Level 1|Adverse Event|1|||
16238047|NCT00683904|39357485|FG001|Dose Level 1|Adverse Event|0|||
16238048|NCT00683904|39357484|FG000|Dose Level 2|Adverse Event|0|||
16238049|NCT00683904|39357485|FG001|Dose Level 2|Adverse Event|2|||
16555773|NCT02341456|40499827|FG001|Overall Study|Disease progression|3|||
16555774|NCT02341456|40499828|FG002|Overall Study|Disease progression|1|||
16555775|NCT02341456|40499826|FG000|Overall Study|Death|1|||
16555776|NCT02341456|40499827|FG001|Overall Study|Death|1|||
16555777|NCT02341456|40499828|FG002|Overall Study|Death|1|||
16555778|NCT02341456|40499826|FG000|Overall Study|Withdrawal by Subject|0|||
16238050|NCT00797316|39357486|FG000|Overall Study|Administrative problems|1|||
16238051|NCT00797316|39357487|FG001|Overall Study|Administrative problems|0|||
16238052|NCT00797316|39357486|FG000|Overall Study|Adverse Event|5|||
16238053|NCT00797316|39357487|FG001|Overall Study|Adverse Event|3|||
16555779|NCT02341456|40499827|FG001|Overall Study|Withdrawal by Subject|1|||
16555780|NCT02341456|40499828|FG002|Overall Study|Withdrawal by Subject|1|||
16555781|NCT02341456|40499826|FG000|Overall Study|Moved to local access programme.|0|||
16555782|NCT02341456|40499827|FG001|Overall Study|Moved to local access programme.|1|||
16555783|NCT02341456|40499828|FG002|Overall Study|Moved to local access programme.|1|||
16555784|NCT02341456|40499826|FG000|Overall Study|Physician Decision|1|||
16555785|NCT02341456|40499827|FG001|Overall Study|Physician Decision|0|||
16555786|NCT02341456|40499828|FG002|Overall Study|Physician Decision|0|||
16238054|NCT00797316|39357486|FG000|Overall Study|Lost to Follow-up|4|||
16238055|NCT00797316|39357487|FG001|Overall Study|Lost to Follow-up|8|||
16238056|NCT00797316|39357486|FG000|Overall Study|Protocol Deviation|1|||
16349827|NCT03225287|39768833|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
16349828|NCT03225287|39768831|FG000|Overall Study|Trial drug not effective|0|||
16349829|NCT03225287|39768832|FG001|Overall Study|Trial drug not effective|1|||
16349830|NCT03225287|39768833|FG002|Overall Study|Trial drug not effective|0|||
16349831|NCT03225287|39768831|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
16349832|NCT03225287|39768832|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
16349833|NCT03225287|39768833|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
16349834|NCT03225287|39768831|FG000|Overall Study|Stem cell transplantation|0|||
16349835|NCT03225287|39768832|FG001|Overall Study|Stem cell transplantation|1|||
16349836|NCT03225287|39768833|FG002|Overall Study|Stem cell transplantation|0|||
16349837|NCT01939314|39768834|FG000|Overall Study|Withdrawal by Subject|3|||
16349838|NCT01939314|39768835|FG001|Overall Study|Withdrawal by Subject|1|||
16349839|NCT01939314|39768834|FG000|Overall Study|Protocol Violation|1|||
16349840|NCT01939314|39768835|FG001|Overall Study|Protocol Violation|0|||
16349841|NCT01939314|39768834|FG000|Overall Study|Pregnancy|0|||
16349842|NCT01939314|39768835|FG001|Overall Study|Pregnancy|1|||
16349843|NCT01939314|39768834|FG000|Overall Study|Lost to Follow-up|5|||
16349844|NCT01939314|39768835|FG001|Overall Study|Lost to Follow-up|6|||
16349845|NCT01261390|39768839|FG000|Overall Study|Significant Concurrent Illness|1|||
16349846|NCT01261390|39768840|FG001|Overall Study|Significant Concurrent Illness|0|||
16349847|NCT01261390|39768841|FG002|Overall Study|Significant Concurrent Illness|1|||
16349848|NCT01261390|39768842|FG003|Overall Study|Significant Concurrent Illness|0|||
16349849|NCT01261390|39768839|FG000|Overall Study|Dissatisfaction with Treatment|2|||
16349850|NCT01261390|39768840|FG001|Overall Study|Dissatisfaction with Treatment|1|||
16349851|NCT01261390|39768841|FG002|Overall Study|Dissatisfaction with Treatment|1|||
16121945|NCT02416453|38934352|FG002|Overall Study|Physician Decision|0|||
16121946|NCT02416453|38934353|FG003|Overall Study|Physician Decision|0|||
16121947|NCT02416453|38934354|FG004|Overall Study|Physician Decision|0|||
16121948|NCT02416453|38934355|FG005|Overall Study|Physician Decision|1|||
16121949|NCT02416453|38934356|FG006|Overall Study|Physician Decision|1|||
16121950|NCT02416453|38934357|FG007|Overall Study|Physician Decision|1|||
16121951|NCT02416453|38934358|FG008|Overall Study|Physician Decision|0|||
16121952|NCT02416453|38934359|FG009|Overall Study|Physician Decision|0|||
16121953|NCT02416453|38934360|FG010|Overall Study|Physician Decision|0|||
16121954|NCT02416453|38934350|FG000|Overall Study|Withdrawal by Subject|2|||
16121955|NCT02416453|38934351|FG001|Overall Study|Withdrawal by Subject|0|||
16121956|NCT02416453|38934352|FG002|Overall Study|Withdrawal by Subject|0|||
16121957|NCT02416453|38934353|FG003|Overall Study|Withdrawal by Subject|5|||
16121958|NCT02416453|38934354|FG004|Overall Study|Withdrawal by Subject|1|||
16121959|NCT02416453|38934355|FG005|Overall Study|Withdrawal by Subject|8|||
16121960|NCT02416453|38934356|FG006|Overall Study|Withdrawal by Subject|0|||
16121961|NCT02416453|38934357|FG007|Overall Study|Withdrawal by Subject|8|||
16121962|NCT02416453|38934358|FG008|Overall Study|Withdrawal by Subject|4|||
16121963|NCT02416453|38934359|FG009|Overall Study|Withdrawal by Subject|0|||
16121964|NCT02416453|38934360|FG010|Overall Study|Withdrawal by Subject|0|||
16121965|NCT02416453|38934350|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16121966|NCT02416453|38934351|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16238057|NCT00797316|39357487|FG001|Overall Study|Protocol Deviation|2|||
16238058|NCT00797316|39357486|FG000|Overall Study|Patient withdrew consent|12|||
16238059|NCT00797316|39357487|FG001|Overall Study|Patient withdrew consent|6|||
16238060|NCT00797316|39357486|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16238061|NCT00797316|39357487|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
16238062|NCT01954082|39357491|FG000|Overall Study|Study Suspension|42|||
16349852|NCT01261390|39768842|FG003|Overall Study|Dissatisfaction with Treatment|2|||
16121967|NCT02416453|38934352|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
16121968|NCT02416453|38934353|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16121969|NCT02416453|38934354|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16121970|NCT02416453|38934355|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16238063|NCT01954082|39357492|FG001|Overall Study|Study Suspension|36|||
16238064|NCT01954082|39357491|FG000|Overall Study|Adverse Event|10|||
16349853|NCT01261390|39768839|FG000|Overall Study|Relocation|0|||
16349854|NCT01261390|39768840|FG001|Overall Study|Relocation|1|||
16349855|NCT01261390|39768841|FG002|Overall Study|Relocation|0|||
16349856|NCT01261390|39768842|FG003|Overall Study|Relocation|0|||
16238065|NCT01954082|39357492|FG001|Overall Study|Adverse Event|4|||
16121971|NCT02416453|38934356|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16121972|NCT02416453|38934357|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16121973|NCT02416453|38934358|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16121974|NCT02416453|38934359|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16238066|NCT01954082|39357491|FG000|Overall Study|Intolerance|0|||
16238067|NCT01954082|39357492|FG001|Overall Study|Intolerance|1|||
16238068|NCT01954082|39357491|FG000|Overall Study|Non-compliance|6|||
16238069|NCT01954082|39357492|FG001|Overall Study|Non-compliance|4|||
16238070|NCT01954082|39357491|FG000|Overall Study|Physician Decision|2|||
16238071|NCT01954082|39357492|FG001|Overall Study|Physician Decision|0|||
16238072|NCT01954082|39357491|FG000|Overall Study|Parent Decision|1|||
16238073|NCT01954082|39357492|FG001|Overall Study|Parent Decision|0|||
16238074|NCT01954082|39357491|FG000|Overall Study|Withdrawal by Subject|0|||
16238075|NCT01954082|39357492|FG001|Overall Study|Withdrawal by Subject|1|||
16238076|NCT01954082|39357491|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
16238077|NCT01954082|39357492|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
16238078|NCT01954082|39357491|FG000|Overall Study|Redirection of Care|0|||
16238079|NCT01954082|39357492|FG001|Overall Study|Redirection of Care|2|||
16238080|NCT01954082|39357491|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
16238081|NCT01954082|39357492|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
16238082|NCT01954082|39357491|FG000|Overall Study|Comfort Care|0|||
16238083|NCT01954082|39357492|FG001|Overall Study|Comfort Care|1|||
16238084|NCT01954082|39357491|FG000|Overall Study|Infant Moved|0|||
16238085|NCT01954082|39357492|FG001|Overall Study|Infant Moved|1|||
16238086|NCT01954082|39357491|FG000|Overall Study|Randomized not Treated|4|||
16238087|NCT01954082|39357492|FG001|Overall Study|Randomized not Treated|2|||
16238088|NCT00430638|39357493|FG000|Overall Study|Adverse Event|15|||
16238089|NCT00430638|39357494|FG001|Overall Study|Adverse Event|15|||
16238090|NCT00430638|39357493|FG000|Overall Study|Uncontrolled blood pressure|48|||
16238091|NCT00430638|39357494|FG001|Overall Study|Uncontrolled blood pressure|13|||
16238092|NCT00430638|39357493|FG000|Overall Study|Lost to Follow-up|1|||
16238093|NCT00430638|39357494|FG001|Overall Study|Lost to Follow-up|7|||
16238094|NCT00430638|39357493|FG000|Overall Study|Protocol Violation|6|||
16238095|NCT00430638|39357494|FG001|Overall Study|Protocol Violation|4|||
16238096|NCT00430638|39357493|FG000|Overall Study|Withdrawal by Subject|4|||
16238097|NCT00430638|39357494|FG001|Overall Study|Withdrawal by Subject|6|||
16238098|NCT00430638|39357493|FG000|Overall Study|Non-compliant|2|||
16238099|NCT00430638|39357494|FG001|Overall Study|Non-compliant|1|||
16238100|NCT00430638|39357493|FG000|Overall Study|Other|2|||
16238101|NCT00430638|39357494|FG001|Overall Study|Other|2|||
16238102|NCT04523831|39357503|FG000|Overall Study|Lost to Follow-up|15|||
16238103|NCT04523831|39357504|FG001|Overall Study|Lost to Follow-up|17|||
16238104|NCT04523831|39357503|FG000|Overall Study|Death|0|||
16238105|NCT04523831|39357504|FG001|Overall Study|Death|3|||
16238106|NCT04523831|39357503|FG000|Overall Study|Adverse Event|2|||
16238107|NCT04523831|39357504|FG001|Overall Study|Adverse Event|0|||
16238108|NCT00386100|39357505|FG000|Overall Study|Did not receive study medication|6|||
16238109|NCT00386100|39357506|FG001|Overall Study|Did not receive study medication|4|||
16238110|NCT00386100|39357505|FG000|Overall Study|Adverse Event|15|||
16238111|NCT00386100|39357506|FG001|Overall Study|Adverse Event|25|||
16238112|NCT00386100|39357505|FG000|Overall Study|Death|0|||
16238113|NCT00386100|39357506|FG001|Overall Study|Death|1|||
16238114|NCT00386100|39357505|FG000|Overall Study|Insufficient therapeutic effect|30|||
16238115|NCT00386100|39357506|FG001|Overall Study|Insufficient therapeutic effect|6|||
16238116|NCT00386100|39357505|FG000|Overall Study|Lost to Follow-up|29|||
16238117|NCT00386100|39357506|FG001|Overall Study|Lost to Follow-up|29|||
16238118|NCT00386100|39357505|FG000|Overall Study|Non-compliance|18|||
16238119|NCT00386100|39357506|FG001|Overall Study|Non-compliance|19|||
16238120|NCT00386100|39357505|FG000|Overall Study|Protocol Violation|5|||
16238121|NCT00386100|39357506|FG001|Overall Study|Protocol Violation|3|||
16238122|NCT00386100|39357505|FG000|Overall Study|Withdrawal by Subject|32|||
16238123|NCT00386100|39357506|FG001|Overall Study|Withdrawal by Subject|31|||
16238124|NCT00386100|39357505|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
16238125|NCT00386100|39357506|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
16238126|NCT00386100|39357505|FG000|Overall Study|BMD <2.5|1|||
16238127|NCT00386100|39357506|FG001|Overall Study|BMD <2.5|0|||
16238128|NCT00386100|39357505|FG000|Overall Study|Consecutive elevated Hba1C|1|||
16238129|NCT00386100|39357506|FG001|Overall Study|Consecutive elevated Hba1C|0|||
16238130|NCT00386100|39357505|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
16238131|NCT00386100|39357506|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
16238132|NCT00386100|39357505|FG000|Overall Study|Laboratory findings|1|||
16238133|NCT00386100|39357506|FG001|Overall Study|Laboratory findings|0|||
16238134|NCT00386100|39357505|FG000|Overall Study|Participant's concern due to CPK levels|1|||
16238135|NCT00386100|39357506|FG001|Overall Study|Participant's concern due to CPK levels|0|||
16238136|NCT00386100|39357505|FG000|Overall Study|Participant moving out of state|2|||
16238137|NCT00386100|39357506|FG001|Overall Study|Participant moving out of state|0|||
16238138|NCT00386100|39357505|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
16238139|NCT00386100|39357506|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
16238140|NCT00386100|39357505|FG000|Overall Study|Didn't meet entry criteria|1|||
16238141|NCT00386100|39357506|FG001|Overall Study|Didn't meet entry criteria|1|||
16238142|NCT00386100|39357505|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
16238143|NCT00386100|39357506|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
16238144|NCT00386100|39357505|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
16238145|NCT00386100|39357506|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
16238146|NCT00386100|39357505|FG000|Overall Study|Bad metabolic control & patient security|1|||
16238147|NCT00386100|39357506|FG001|Overall Study|Bad metabolic control & patient security|0|||
16238148|NCT00386100|39357505|FG000|Overall Study|Bone loss by DXA bone scan|1|||
16238149|NCT00386100|39357506|FG001|Overall Study|Bone loss by DXA bone scan|0|||
16238150|NCT00386100|39357505|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
16238151|NCT00386100|39357506|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
16238152|NCT00386100|39357505|FG000|Overall Study|7.6% bone loss|1|||
16238153|NCT00386100|39357506|FG001|Overall Study|7.6% bone loss|0|||
16238154|NCT00386100|39357505|FG000|Overall Study|Osteoporosis|0|||
16238155|NCT00386100|39357506|FG001|Overall Study|Osteoporosis|1|||
16238156|NCT00386100|39357505|FG000|Overall Study|Positive pregnancy test|1|||
16238157|NCT00386100|39357506|FG001|Overall Study|Positive pregnancy test|3|||
16238158|NCT00386100|39357505|FG000|Overall Study|Out of country for 5 months|1|||
16238159|NCT00386100|39357506|FG001|Overall Study|Out of country for 5 months|0|||
16238160|NCT00386100|39357505|FG000|Overall Study|Hb1Ac >8%|0|||
16238161|NCT00386100|39357506|FG001|Overall Study|Hb1Ac >8%|1|||
16238162|NCT00386100|39357505|FG000|Overall Study|Participant randomized in error|1|||
16238163|NCT00386100|39357506|FG001|Overall Study|Participant randomized in error|0|||
16238164|NCT01299272|39357507|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
16238165|NCT01299272|39357508|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
16121975|NCT02416453|38934360|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
16121976|NCT02416453|38934350|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16121977|NCT02416453|38934351|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16121978|NCT02416453|38934352|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16121979|NCT02416453|38934353|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16121980|NCT02416453|38934354|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16121981|NCT02416453|38934355|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
16121982|NCT02416453|38934356|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16121983|NCT02416453|38934357|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16121984|NCT02416453|38934358|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16121985|NCT02416453|38934359|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16121986|NCT02416453|38934360|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
16121987|NCT04155047|38934363|FG000|Overall Study|Adverse Event|1|||
16121988|NCT04155047|38934364|FG001|Overall Study|Adverse Event|0|||
16121989|NCT04155047|38934363|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
16121990|NCT04155047|38934364|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
16121991|NCT04313608|38934367|FG000|Overall Study|Death|12|||
16121992|NCT04313608|38934368|FG001|Overall Study|Death|3|||
16121993|NCT02472145|38934369|FG000|Overall Study|Death|10|||
16121994|NCT02472145|38934370|FG001|Overall Study|Death|101|||
16121995|NCT02472145|38934371|FG002|Overall Study|Death|99|||
16121996|NCT02472145|38934369|FG000|Overall Study|Lost to Follow-up|0|||
16121997|NCT02472145|38934370|FG001|Overall Study|Lost to Follow-up|1|||
16121998|NCT02472145|38934371|FG002|Overall Study|Lost to Follow-up|0|||
16121999|NCT02472145|38934369|FG000|Overall Study|Withdrawal by Subject|0|||
16122000|NCT02472145|38934370|FG001|Overall Study|Withdrawal by Subject|9|||
16122001|NCT02472145|38934371|FG002|Overall Study|Withdrawal by Subject|13|||
16122002|NCT02472145|38934369|FG000|Overall Study|Sponsor decision|0|||
16122003|NCT02472145|38934370|FG001|Overall Study|Sponsor decision|3|||
16122004|NCT02472145|38934371|FG002|Overall Study|Sponsor decision|2|||
16122005|NCT02472145|38934369|FG000|Overall Study|Other|0|||
16122006|NCT02472145|38934370|FG001|Overall Study|Other|45|||
16122007|NCT02472145|38934371|FG002|Overall Study|Other|43|||
16122008|NCT02550938|38934373|FG000|Overall Study|Lost to Follow-up|8|||
16122009|NCT02550938|38934374|FG001|Overall Study|Lost to Follow-up|7|||
16122010|NCT02550938|38934375|FG002|Overall Study|Lost to Follow-up|12|||
16122011|NCT02550938|38934376|FG003|Overall Study|Lost to Follow-up|11|||
16122012|NCT02992691|38934377|FG000|Overall Study|Adverse Event|2|||
16122013|NCT02992691|38934377|FG000|Overall Study|Withdrawal by Subject|1|||
16122014|NCT00939822|38934380|FG000|Overall Study|Lost to Follow-up|1|||
16122015|NCT00939822|38934381|FG001|Overall Study|Lost to Follow-up|0|||
16122016|NCT00939822|38934380|FG000|Overall Study|withdrew from study due to busy schedule|1|||
16122017|NCT00939822|38934381|FG001|Overall Study|withdrew from study due to busy schedule|1|||
16238166|NCT01299272|39357509|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
16238167|NCT01299272|39357510|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
16238168|NCT01299272|39357507|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
16122018|NCT00939822|38934380|FG000|Overall Study|Mental health issues|0|||
16122019|NCT00939822|38934381|FG001|Overall Study|Mental health issues|2|||
16122020|NCT01253135|38934384|FG000|Original Protocol|Protocol Amendment|15|||
16122021|NCT01253135|38934384|FG000|Amended Protocol|Non-compliance|1|||
16122022|NCT00652327|38934385|FG000|Overall Study|Adverse Event|0|||
16122023|NCT00652327|38934386|FG001|Overall Study|Adverse Event|2|||
16122024|NCT00652327|38934385|FG000|Overall Study|Lost to Follow-up|0|||
16122025|NCT00652327|38934386|FG001|Overall Study|Lost to Follow-up|3|||
16122026|NCT02159040|38934387|FG000|Overall Study|Death|1|||
16122027|NCT00350103|38934398|FG000|Overall Study|Adverse Event|12|||
16122028|NCT00350103|38934399|FG001|Overall Study|Adverse Event|29|||
16122029|NCT00350103|38934400|FG002|Overall Study|Adverse Event|17|||
16122030|NCT00350103|38934398|FG000|Overall Study|Lack of Efficacy|5|||
16122031|NCT00350103|38934399|FG001|Overall Study|Lack of Efficacy|1|||
16122032|NCT00350103|38934400|FG002|Overall Study|Lack of Efficacy|3|||
16122033|NCT00350103|38934398|FG000|Overall Study|Withdrawal by Subject|6|||
16122034|NCT00350103|38934399|FG001|Overall Study|Withdrawal by Subject|6|||
16122035|NCT00350103|38934400|FG002|Overall Study|Withdrawal by Subject|8|||
16122036|NCT00350103|38934398|FG000|Overall Study|Protocol Violation|0|||
16122037|NCT00350103|38934399|FG001|Overall Study|Protocol Violation|0|||
16122038|NCT00350103|38934400|FG002|Overall Study|Protocol Violation|1|||
16122039|NCT00350103|38934398|FG000|Overall Study|Unsatisfactory Compliance|2|||
16122040|NCT00350103|38934399|FG001|Overall Study|Unsatisfactory Compliance|2|||
16122041|NCT00350103|38934400|FG002|Overall Study|Unsatisfactory Compliance|1|||
16122042|NCT00350103|38934398|FG000|Overall Study|Investigator´s decision|1|||
16122043|NCT00350103|38934399|FG001|Overall Study|Investigator´s decision|1|||
16122044|NCT00350103|38934400|FG002|Overall Study|Investigator´s decision|0|||
16122045|NCT00350103|38934398|FG000|Overall Study|Exclusion criteria met|0|||
16122046|NCT00350103|38934399|FG001|Overall Study|Exclusion criteria met|0|||
16122047|NCT00350103|38934400|FG002|Overall Study|Exclusion criteria met|1|||
16122048|NCT00350103|38934398|FG000|Overall Study|Patient relocated|0|||
16122049|NCT00350103|38934399|FG001|Overall Study|Patient relocated|0|||
16122050|NCT00350103|38934400|FG002|Overall Study|Patient relocated|1|||
16122051|NCT00350103|38934398|FG000|Overall Study|Need for prohibited medication|1|||
16122052|NCT00350103|38934399|FG001|Overall Study|Need for prohibited medication|0|||
16122053|NCT00350103|38934400|FG002|Overall Study|Need for prohibited medication|0|||
16122054|NCT00350103|38934398|FG000|Overall Study|Personal reasons|0|||
16122055|NCT00350103|38934399|FG001|Overall Study|Personal reasons|0|||
16122056|NCT00350103|38934400|FG002|Overall Study|Personal reasons|1|||
16122057|NCT00350103|38934398|FG000|Overall Study|Patient stopped feeling pain|1|||
16122058|NCT00350103|38934399|FG001|Overall Study|Patient stopped feeling pain|0|||
16122059|NCT00350103|38934400|FG002|Overall Study|Patient stopped feeling pain|0|||
16122060|NCT00350103|38934398|FG000|Overall Study|PR greater than 250ms|0|||
16122061|NCT00350103|38934399|FG001|Overall Study|PR greater than 250ms|0|||
16122062|NCT00350103|38934400|FG002|Overall Study|PR greater than 250ms|1|||
16122063|NCT00350103|38934398|FG000|Overall Study|Wrong calculation of QT interval|0|||
16122064|NCT00350103|38934399|FG001|Overall Study|Wrong calculation of QT interval|0|||
16122065|NCT00350103|38934400|FG002|Overall Study|Wrong calculation of QT interval|1|||
16122066|NCT00350103|38934398|FG000|Overall Study|Sponsor mistake|1|||
16122067|NCT00350103|38934399|FG001|Overall Study|Sponsor mistake|0|||
16122068|NCT00350103|38934400|FG002|Overall Study|Sponsor mistake|0|||
16122069|NCT00350103|38934398|FG000|Overall Study|Randomization mistake|0|||
16122070|NCT00350103|38934399|FG001|Overall Study|Randomization mistake|1|||
16122071|NCT00350103|38934400|FG002|Overall Study|Randomization mistake|1|||
16122072|NCT00350103|38934398|FG000|Overall Study|Sponsor´s decision|0|||
16122073|NCT00350103|38934399|FG001|Overall Study|Sponsor´s decision|1|||
16122074|NCT00350103|38934400|FG002|Overall Study|Sponsor´s decision|0|||
16122075|NCT00350103|38934398|FG000|Overall Study|Lost, Reason unknown|1|||
16122076|NCT00350103|38934399|FG001|Overall Study|Lost, Reason unknown|1|||
16122077|NCT00350103|38934400|FG002|Overall Study|Lost, Reason unknown|0|||
16349857|NCT01261390|39768839|FG000|Overall Study|Loss of Interest in the Study|3|||
16349858|NCT01261390|39768840|FG001|Overall Study|Loss of Interest in the Study|1|||
16349859|NCT01261390|39768841|FG002|Overall Study|Loss of Interest in the Study|0|||
16349860|NCT01261390|39768842|FG003|Overall Study|Loss of Interest in the Study|0|||
16349861|NCT01261390|39768839|FG000|Overall Study|Lost to Follow-up|1|||
16349862|NCT01261390|39768840|FG001|Overall Study|Lost to Follow-up|6|||
16349863|NCT01261390|39768841|FG002|Overall Study|Lost to Follow-up|5|||
16349864|NCT01261390|39768842|FG003|Overall Study|Lost to Follow-up|6|||
16349865|NCT01096160|39768848|FG000|Overall Study|Adverse Event|0|||
16349866|NCT01096160|39768849|FG001|Overall Study|Adverse Event|0|||
16349867|NCT01096160|39768850|FG002|Overall Study|Adverse Event|1|||
16349868|NCT01096160|39768851|FG003|Overall Study|Adverse Event|0|||
16349869|NCT01096160|39768852|FG004|Overall Study|Adverse Event|0|||
16349870|NCT01096160|39768853|FG005|Overall Study|Adverse Event|0|||
16349871|NCT01096160|39768854|FG006|Overall Study|Adverse Event|0|||
16349872|NCT01096160|39768855|FG007|Overall Study|Adverse Event|0|||
16555787|NCT02441946|40499829|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
16555788|NCT02441946|40499830|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
16555789|NCT02441946|40499831|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
16555790|NCT02441946|40499829|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
16555791|NCT02441946|40499830|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
16555792|NCT02441946|40499831|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
16555793|NCT02441946|40499829|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16122078|NCT03208036|38934402|FG000|Baseline Assessment|Withdrawal by Subject|1|||
16122079|NCT03208036|38934403|FG001|Baseline Assessment|Withdrawal by Subject|1|||
16122080|NCT03208036|38934402|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
16122081|NCT03208036|38934403|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
16122082|NCT03208036|38934402|FG000|Intervention|Withdrawal by Subject|3|||
16122083|NCT03208036|38934403|FG001|Intervention|Withdrawal by Subject|2|||
16122084|NCT03208036|38934402|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
16122085|NCT03208036|38934403|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
16122086|NCT03284203|38934404|FG000|Overall Study|Lost to Follow-up|3|||
16122087|NCT00821587|38934409|FG000|Overall Study|Physician Decision|0|||
16122088|NCT00821587|38934410|FG001|Overall Study|Physician Decision|1|||
16122089|NCT00400725|38934411|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
16349873|NCT01096160|39768856|FG008|Overall Study|Adverse Event|0|||
16555794|NCT02441946|40499830|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
16414102|NCT01659255|39998328|FG006|Overall Study|Withdrew Consent|0|||
16414103|NCT01659255|39998329|FG007|Overall Study|Withdrew Consent|0|||
16414104|NCT01659255|39998330|FG008|Overall Study|Withdrew Consent|0|||
16414105|NCT01659255|39998331|FG009|Overall Study|Withdrew Consent|0|||
16414106|NCT01659255|39998332|FG010|Overall Study|Withdrew Consent|1|||
16414107|NCT01659255|39998333|FG011|Overall Study|Withdrew Consent|0|||
16414108|NCT01659255|39998334|FG012|Overall Study|Withdrew Consent|0|||
16414109|NCT01659255|39998335|FG013|Overall Study|Withdrew Consent|1|||
16414110|NCT01659255|39998336|FG014|Overall Study|Withdrew Consent|0|||
16414111|NCT01659255|39998337|FG015|Overall Study|Withdrew Consent|0|||
16414112|NCT01659255|39998338|FG016|Overall Study|Withdrew Consent|0|||
16414113|NCT01659255|39998322|FG000|Overall Study|Investigator Decision|0|||
16414114|NCT01659255|39998323|FG001|Overall Study|Investigator Decision|0|||
16414115|NCT01659255|39998324|FG002|Overall Study|Investigator Decision|0|||
16414116|NCT01659255|39998325|FG003|Overall Study|Investigator Decision|0|||
16414117|NCT01659255|39998326|FG004|Overall Study|Investigator Decision|0|||
16414118|NCT01659255|39998327|FG005|Overall Study|Investigator Decision|0|||
16414119|NCT01659255|39998328|FG006|Overall Study|Investigator Decision|0|||
16414120|NCT01659255|39998329|FG007|Overall Study|Investigator Decision|0|||
16414121|NCT01659255|39998330|FG008|Overall Study|Investigator Decision|0|||
16414122|NCT01659255|39998331|FG009|Overall Study|Investigator Decision|0|||
16414123|NCT01659255|39998332|FG010|Overall Study|Investigator Decision|0|||
16414124|NCT01659255|39998333|FG011|Overall Study|Investigator Decision|0|||
16414125|NCT01659255|39998334|FG012|Overall Study|Investigator Decision|1|||
16414126|NCT01659255|39998335|FG013|Overall Study|Investigator Decision|1|||
16414127|NCT01659255|39998336|FG014|Overall Study|Investigator Decision|0|||
16414128|NCT01659255|39998337|FG015|Overall Study|Investigator Decision|0|||
16414129|NCT01659255|39998338|FG016|Overall Study|Investigator Decision|0|||
16414130|NCT01659255|39998322|FG000|Overall Study|Sponsor's Decision|0|||
16414131|NCT01659255|39998323|FG001|Overall Study|Sponsor's Decision|0|||
16414132|NCT01659255|39998324|FG002|Overall Study|Sponsor's Decision|0|||
16414133|NCT01659255|39998325|FG003|Overall Study|Sponsor's Decision|0|||
16414134|NCT01659255|39998326|FG004|Overall Study|Sponsor's Decision|0|||
16414135|NCT01659255|39998327|FG005|Overall Study|Sponsor's Decision|0|||
16414136|NCT01659255|39998328|FG006|Overall Study|Sponsor's Decision|1|||
16414137|NCT01659255|39998329|FG007|Overall Study|Sponsor's Decision|0|||
16414138|NCT01659255|39998330|FG008|Overall Study|Sponsor's Decision|0|||
16555795|NCT02441946|40499831|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16555796|NCT02441946|40499829|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
16555797|NCT02441946|40499830|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
16555798|NCT02441946|40499831|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
16555799|NCT02441946|40499829|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
16555800|NCT02441946|40499830|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
16555801|NCT02441946|40499831|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
16555802|NCT02441946|40499829|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
16555803|NCT02441946|40499830|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
16414139|NCT01659255|39998331|FG009|Overall Study|Sponsor's Decision|0|||
16414140|NCT01659255|39998332|FG010|Overall Study|Sponsor's Decision|0|||
16414141|NCT01659255|39998333|FG011|Overall Study|Sponsor's Decision|0|||
16414142|NCT01659255|39998334|FG012|Overall Study|Sponsor's Decision|0|||
16414143|NCT01659255|39998335|FG013|Overall Study|Sponsor's Decision|0|||
16414144|NCT01659255|39998336|FG014|Overall Study|Sponsor's Decision|0|||
16414145|NCT01659255|39998337|FG015|Overall Study|Sponsor's Decision|0|||
16555804|NCT02441946|40499831|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
16555805|NCT02441946|40499829|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
16555806|NCT02441946|40499830|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
16555807|NCT02441946|40499831|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
16555808|NCT02441946|40499829|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
16555809|NCT02441946|40499830|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
16555810|NCT02441946|40499831|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
16555811|NCT02441946|40499829|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
16555812|NCT02441946|40499830|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
16555813|NCT02441946|40499831|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
16555814|NCT02441946|40499829|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
16555815|NCT02441946|40499830|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
16555816|NCT02441946|40499831|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
16555817|NCT02441946|40499829|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
16555818|NCT02441946|40499830|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
16555819|NCT02441946|40499831|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
16555820|NCT01477749|40499834|FG000|Overall Study|Physician Decision|4|||
16555821|NCT03541642|40499835|FG000|Overall Study|Withdrawal by Subject|1|||
16555822|NCT03541642|40499836|FG001|Overall Study|Withdrawal by Subject|2|||
16555823|NCT03541642|40499835|FG000|Overall Study|Lost to Follow-up|16|||
16555824|NCT03541642|40499836|FG001|Overall Study|Lost to Follow-up|12|||
16555825|NCT03541642|40499835|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
16555826|NCT03541642|40499836|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
16555827|NCT04003142|40499837|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
16555828|NCT04003142|40499838|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
16238169|NCT01299272|39357508|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
16555829|NCT04003142|40499839|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
16555830|NCT04003142|40499840|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
16555831|NCT04003142|40499841|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
16122090|NCT00400725|38934412|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
16555832|NCT04003142|40499837|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
16555833|NCT04003142|40499838|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
16555834|NCT04003142|40499839|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
16555835|NCT04003142|40499840|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
16555836|NCT04003142|40499841|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
16555837|NCT04003142|40499837|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
16555838|NCT04003142|40499838|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
16555839|NCT04003142|40499839|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
16555840|NCT04003142|40499840|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
16555841|NCT04003142|40499841|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
16555842|NCT04003142|40499837|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
16555843|NCT04003142|40499838|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
16555844|NCT04003142|40499839|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
16555845|NCT04003142|40499840|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
16555846|NCT04003142|40499841|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
16122091|NCT00400725|38934413|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
16414146|NCT01659255|39998338|FG016|Overall Study|Sponsor's Decision|0|||
16122092|NCT00400725|38934411|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
16238170|NCT01299272|39357509|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
16238171|NCT01299272|39357510|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
16238172|NCT01299272|39357507|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
16238173|NCT01299272|39357508|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
16238174|NCT01299272|39357509|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
16238175|NCT01299272|39357510|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
16238176|NCT01299272|39357507|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
16238177|NCT01299272|39357508|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
16238178|NCT01299272|39357509|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
16238179|NCT01299272|39357510|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
16238180|NCT01299272|39357507|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
16238181|NCT01299272|39357508|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
16238182|NCT01299272|39357509|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
16238183|NCT01299272|39357510|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
16238184|NCT01299272|39357507|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
16238185|NCT01299272|39357508|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
16238186|NCT01299272|39357509|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
16238187|NCT01299272|39357510|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
16238188|NCT01299272|39357507|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
16238189|NCT01299272|39357508|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
16238190|NCT01299272|39357509|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
16238191|NCT01299272|39357510|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
16238192|NCT01299272|39357507|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
16238193|NCT01299272|39357508|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
16238194|NCT01299272|39357509|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
16238195|NCT01299272|39357510|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
16238196|NCT01299272|39357507|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
16238197|NCT01299272|39357508|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
16238198|NCT01299272|39357509|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
16238199|NCT01299272|39357510|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
16238200|NCT01299272|39357507|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
16238201|NCT01299272|39357508|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
16122093|NCT00400725|38934412|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
16122094|NCT00400725|38934413|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
16122095|NCT00400725|38934411|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
16122096|NCT00400725|38934412|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
16122097|NCT00400725|38934413|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
16122098|NCT00400725|38934411|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
16122099|NCT00400725|38934412|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
16122100|NCT00400725|38934413|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
16122101|NCT00400725|38934411|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
16122102|NCT00400725|38934412|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
16122103|NCT00400725|38934413|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
16555847|NCT04003142|40499837|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
16555848|NCT04003142|40499838|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
16555849|NCT04003142|40499839|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
16555850|NCT04003142|40499840|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
16122104|NCT00400725|38934411|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
16122105|NCT00400725|38934412|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
16122106|NCT00400725|38934413|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
16122107|NCT00400725|38934411|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
16122108|NCT00400725|38934412|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
16122109|NCT00400725|38934413|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
16122110|NCT00400725|38934411|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
16122111|NCT00400725|38934412|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
16122112|NCT00400725|38934413|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
16122113|NCT00400725|38934411|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
16122114|NCT00400725|38934412|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
16122115|NCT00400725|38934413|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
16122116|NCT01655693|38934414|FG000|Overall Study|Progression of Disease|92|||
16122117|NCT01655693|38934415|FG001|Overall Study|Progression of Disease|76|||
16122118|NCT01655693|38934416|FG002|Overall Study|Progression of Disease|58|||
16122119|NCT01655693|38934414|FG000|Overall Study|Death|8|||
16122120|NCT01655693|38934415|FG001|Overall Study|Death|9|||
16122121|NCT01655693|38934416|FG002|Overall Study|Death|12|||
16122122|NCT01655693|38934414|FG000|Overall Study|Serious Adverse Event|3|||
16122123|NCT01655693|38934415|FG001|Overall Study|Serious Adverse Event|15|||
16122124|NCT01655693|38934416|FG002|Overall Study|Serious Adverse Event|11|||
16555851|NCT04003142|40499841|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
16555852|NCT04003142|40499837|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
16555853|NCT04003142|40499838|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
16555854|NCT04003142|40499839|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
16555855|NCT04003142|40499840|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
16555856|NCT04003142|40499841|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
16555857|NCT04003142|40499837|FG000|Extension Period (40 Weeks)|Death|0|||
16555858|NCT04003142|40499838|FG001|Extension Period (40 Weeks)|Death|0|||
16555859|NCT04003142|40499839|FG002|Extension Period (40 Weeks)|Death|0|||
16555860|NCT04003142|40499840|FG003|Extension Period (40 Weeks)|Death|0|||
16555861|NCT04003142|40499841|FG004|Extension Period (40 Weeks)|Death|1|||
16555862|NCT04003142|40499837|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
16555863|NCT04003142|40499838|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
16555864|NCT04003142|40499839|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
16555865|NCT04003142|40499840|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
16555866|NCT04003142|40499841|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
16555867|NCT04003142|40499837|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
16555868|NCT04003142|40499838|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
16555869|NCT04003142|40499839|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
16555870|NCT04003142|40499840|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
16555871|NCT04003142|40499841|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
16555872|NCT04003142|40499837|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
16555873|NCT04003142|40499838|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
16555874|NCT04003142|40499839|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
16555875|NCT04003142|40499840|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
16555876|NCT04003142|40499841|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
16555877|NCT04003142|40499837|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
16555878|NCT04003142|40499838|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
16555879|NCT04003142|40499839|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
16555880|NCT04003142|40499840|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
16555881|NCT04003142|40499841|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
16555882|NCT00649389|40499844|FG000|Overall Study|Adverse Event|22|||
16555883|NCT00649389|40499845|FG001|Overall Study|Adverse Event|46|||
16122125|NCT01655693|38934414|FG000|Overall Study|Withdrawal by Subject|3|||
16122126|NCT01655693|38934415|FG001|Overall Study|Withdrawal by Subject|2|||
16122127|NCT01655693|38934416|FG002|Overall Study|Withdrawal by Subject|20|||
16122128|NCT01655693|38934414|FG000|Overall Study|Adverse Event|3|||
16349874|NCT01096160|39768857|FG009|Overall Study|Adverse Event|1|||
16122129|NCT01655693|38934415|FG001|Overall Study|Adverse Event|11|||
16122130|NCT01655693|38934416|FG002|Overall Study|Adverse Event|3|||
16122131|NCT01655693|38934414|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
16122132|NCT01655693|38934415|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
16122133|NCT01655693|38934416|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
16122134|NCT01655693|38934414|FG000|Overall Study|Non-Compliance|0|||
16122135|NCT01655693|38934415|FG001|Overall Study|Non-Compliance|0|||
16122136|NCT01655693|38934416|FG002|Overall Study|Non-Compliance|7|||
16122137|NCT01655693|38934414|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
16122138|NCT01655693|38934415|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
16122139|NCT01655693|38934416|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
16122140|NCT01655693|38934414|FG000|Overall Study|Protocol Violation|1|||
16122141|NCT01655693|38934415|FG001|Overall Study|Protocol Violation|0|||
16122142|NCT01655693|38934416|FG002|Overall Study|Protocol Violation|3|||
16122143|NCT01655693|38934414|FG000|Overall Study|Lost to Follow-up|1|||
16122144|NCT01655693|38934415|FG001|Overall Study|Lost to Follow-up|0|||
16122145|NCT01655693|38934416|FG002|Overall Study|Lost to Follow-up|1|||
16122146|NCT01655693|38934414|FG000|Overall Study|Screening Failure|1|||
16122147|NCT01655693|38934415|FG001|Overall Study|Screening Failure|0|||
16122148|NCT01655693|38934416|FG002|Overall Study|Screening Failure|0|||
16122149|NCT01655693|38934414|FG000|Overall Study|Other|8|||
16122150|NCT01655693|38934415|FG001|Overall Study|Other|6|||
16122151|NCT01655693|38934416|FG002|Overall Study|Other|15|||
16122152|NCT02815579|38934417|FG000|Overall Study|Non-payment of loan down-payment|16|||
16122153|NCT02815579|38934418|FG001|Overall Study|Non-payment of loan down-payment|0|||
16122154|NCT02815579|38934417|FG000|Overall Study|Withdrawal by Subject|7|||
16122155|NCT02815579|38934418|FG001|Overall Study|Withdrawal by Subject|1|||
16122156|NCT02815579|38934417|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
16122157|NCT02815579|38934418|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
16122158|NCT02815579|38934417|FG000|Overall Study|Lost to Follow-up|7|||
16122159|NCT02815579|38934418|FG001|Overall Study|Lost to Follow-up|4|||
16555884|NCT00649389|40499846|FG002|Overall Study|Adverse Event|38|||
16555885|NCT00649389|40499847|FG003|Overall Study|Adverse Event|48|||
16555886|NCT00649389|40499844|FG000|Overall Study|Lost to Follow-up|15|||
16555887|NCT00649389|40499845|FG001|Overall Study|Lost to Follow-up|17|||
16555888|NCT00649389|40499846|FG002|Overall Study|Lost to Follow-up|21|||
16555889|NCT00649389|40499847|FG003|Overall Study|Lost to Follow-up|26|||
16555890|NCT00649389|40499844|FG000|Overall Study|Protocol Violation|11|||
16238202|NCT01299272|39357509|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
16238203|NCT01299272|39357510|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
16122160|NCT02815579|38934417|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
16122161|NCT02815579|38934418|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
16122162|NCT02815579|38934417|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
16122163|NCT02815579|38934418|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
16122164|NCT02815579|38934417|FG000|Overall Study|Death|5|||
16122165|NCT02815579|38934418|FG001|Overall Study|Death|4|||
16122166|NCT02815579|38934417|FG000|Overall Study|Imprisoned|0|||
16122167|NCT02815579|38934418|FG001|Overall Study|Imprisoned|2|||
16238204|NCT01299272|39357507|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
16238205|NCT01299272|39357508|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
16238206|NCT01299272|39357509|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
16238207|NCT01299272|39357510|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
16238208|NCT01299272|39357507|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
16238209|NCT01299272|39357508|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
16122168|NCT02815579|38934417|FG000|Overall Study|Did not meet enrollment criteria|0|||
16122169|NCT02815579|38934418|FG001|Overall Study|Did not meet enrollment criteria|1|||
16122170|NCT00790205|38934423|FG000|Overall Study|Lost to Follow-up|61|||
16122171|NCT00790205|38934424|FG001|Overall Study|Lost to Follow-up|71|||
16238210|NCT01299272|39357509|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
16238211|NCT01299272|39357510|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
16238212|NCT01299272|39357507|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
16555891|NCT00649389|40499845|FG001|Overall Study|Protocol Violation|13|||
16555892|NCT00649389|40499846|FG002|Overall Study|Protocol Violation|9|||
16122172|NCT00790205|38934423|FG000|Overall Study|Withdrawal by Subject|299|||
16122173|NCT00790205|38934424|FG001|Overall Study|Withdrawal by Subject|363|||
16122174|NCT00953771|38934425|FG000|Overall Study|Death|1|||
16555893|NCT00649389|40499847|FG003|Overall Study|Protocol Violation|8|||
16555894|NCT00649389|40499844|FG000|Overall Study|Withdrawal by Subject|20|||
16122175|NCT00953771|38934426|FG001|Overall Study|Death|0|||
16122176|NCT03339245|38934431|FG000|Overall Study|Adverse Event|1|||
16122177|NCT03339245|38934432|FG001|Overall Study|Adverse Event|1|||
16122178|NCT03339245|38934431|FG000|Overall Study|Withdrawal by Subject|1|||
16122179|NCT03339245|38934432|FG001|Overall Study|Withdrawal by Subject|0|||
16122180|NCT00474526|38934433|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
16122181|NCT00474526|38934434|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
16122182|NCT00474526|38934435|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
16122183|NCT00474526|38934436|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
16122184|NCT00474526|38934437|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
16122185|NCT00474526|38934438|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
16122186|NCT00474526|38934439|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
16122187|NCT00474526|38934440|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
16122188|NCT00474526|38934441|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
16122189|NCT00474526|38934442|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
16122190|NCT00474526|38934443|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
16122191|NCT00474526|38934444|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
16122192|NCT00474526|38934445|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
16122193|NCT00474526|38934446|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
16122194|NCT00474526|38934447|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
16122195|NCT00474526|38934448|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
16122196|NCT00474526|38934449|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
16122197|NCT00474526|38934433|FG000|Overall Study|Adverse Event|2|||
16555895|NCT00649389|40499845|FG001|Overall Study|Withdrawal by Subject|21|||
16555896|NCT00649389|40499846|FG002|Overall Study|Withdrawal by Subject|19|||
16555897|NCT00649389|40499847|FG003|Overall Study|Withdrawal by Subject|23|||
16555898|NCT00649389|40499844|FG000|Overall Study|Other|3|||
16555899|NCT00649389|40499845|FG001|Overall Study|Other|9|||
16555900|NCT00649389|40499846|FG002|Overall Study|Other|1|||
16555901|NCT00649389|40499847|FG003|Overall Study|Other|6|||
16555902|NCT02269943|40499850|FG000|Treatment Period|Death|0|||
16555903|NCT02269943|40499851|FG001|Treatment Period|Death|1|||
16555904|NCT02269943|40499850|FG000|Treatment Period|Adverse Event|1|||
16555905|NCT02269943|40499851|FG001|Treatment Period|Adverse Event|10|||
16555906|NCT02269943|40499850|FG000|Treatment Period|Progressive Disease|5|||
16555907|NCT02269943|40499851|FG001|Treatment Period|Progressive Disease|17|||
16122198|NCT00474526|38934434|FG001|Overall Study|Adverse Event|0|||
16122199|NCT00474526|38934435|FG002|Overall Study|Adverse Event|2|||
16122200|NCT00474526|38934436|FG003|Overall Study|Adverse Event|4|||
16122201|NCT00474526|38934437|FG004|Overall Study|Adverse Event|2|||
16122202|NCT00474526|38934438|FG005|Overall Study|Adverse Event|1|||
16555908|NCT02269943|40499850|FG000|Treatment Period|Symptomatic Deterioration|0|||
16555909|NCT02269943|40499851|FG001|Treatment Period|Symptomatic Deterioration|2|||
16555910|NCT02269943|40499850|FG000|Follow-Up Survival Period|Death|3|||
16555911|NCT02269943|40499851|FG001|Follow-Up Survival Period|Death|16|||
16555912|NCT02269943|40499850|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
16555913|NCT02269943|40499851|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
16555914|NCT02269943|40499850|FG000|Follow-Up Survival Period|Alive|2|||
16555915|NCT02269943|40499851|FG001|Follow-Up Survival Period|Alive|8|||
16555916|NCT00432679|40499852|FG000|Overall Study|Adverse Event|2|||
16555917|NCT00432679|40499853|FG001|Overall Study|Adverse Event|1|||
16555918|NCT00432679|40499852|FG000|Overall Study|Withdrawal by Subject|3|||
16555919|NCT00432679|40499853|FG001|Overall Study|Withdrawal by Subject|2|||
16555920|NCT01781611|40499854|FG000|Overall Study|Adverse Event|4|||
16555921|NCT01781611|40499855|FG001|Overall Study|Adverse Event|0|||
16555922|NCT03255941|40499858|FG000|Overall Study|Not eligible or refused injection|37|||
16555923|NCT03255941|40499859|FG001|Overall Study|Not eligible or refused injection|44|||
16555924|NCT03255941|40499860|FG002|Overall Study|Not eligible or refused injection|5|||
16555925|NCT03255941|40499861|FG003|Overall Study|Not eligible or refused injection|6|||
16555926|NCT03255941|40499858|FG000|Overall Study|Did not complete exit interview|1|||
16555927|NCT03255941|40499859|FG001|Overall Study|Did not complete exit interview|2|||
16555928|NCT03255941|40499860|FG002|Overall Study|Did not complete exit interview|0|||
16555929|NCT03255941|40499861|FG003|Overall Study|Did not complete exit interview|0|||
16555930|NCT03632434|40499867|FG000|Overall Study|Withdrawal by Subject|2|||
16555931|NCT01235975|40499868|FG000|Overall Study|Serious Adverse Event|0|||
16555932|NCT01235975|40499869|FG001|Overall Study|Serious Adverse Event|1|||
16555933|NCT01235975|40499868|FG000|Overall Study|Withdrawal by Subject|8|||
16555934|NCT01235975|40499869|FG001|Overall Study|Withdrawal by Subject|2|||
16555935|NCT01235975|40499868|FG000|Overall Study|Migrated/moved from study area|2|||
16555936|NCT01235975|40499869|FG001|Overall Study|Migrated/moved from study area|1|||
16555937|NCT01235975|40499868|FG000|Overall Study|Lost to Follow-up|7|||
16555938|NCT01235975|40499869|FG001|Overall Study|Lost to Follow-up|3|||
16555939|NCT00305864|40499870|FG000|Overall Study|Ineligible / No protocol treatment|0|||
16555940|NCT00305864|40499871|FG001|Overall Study|Ineligible / No protocol treatment|1|||
16555941|NCT00305864|40499872|FG002|Overall Study|Ineligible / No protocol treatment|1|||
16555942|NCT00305864|40499873|FG003|Overall Study|Ineligible / No protocol treatment|13|||
16555943|NCT01644474|40499876|FG000|Overall Study|Poor compliance to protocol|1|||
16555944|NCT01644474|40499877|FG001|Overall Study|Poor compliance to protocol|0|||
16555945|NCT01644474|40499876|FG000|Overall Study|Consent withdrawn by participant|0|||
16555946|NCT01644474|40499877|FG001|Overall Study|Consent withdrawn by participant|1|||
16555947|NCT01644474|40499876|FG000|Overall Study|Participant moved|0|||
16555948|NCT01644474|40499877|FG001|Overall Study|Participant moved|1|||
16555949|NCT01644474|40499876|FG000|Overall Study|Adverse Event|4|||
16555950|NCT01644474|40499877|FG001|Overall Study|Adverse Event|5|||
16555951|NCT01644474|40499876|FG000|Overall Study|Site scheduling error|1|||
16555952|NCT01644474|40499877|FG001|Overall Study|Site scheduling error|1|||
16555953|NCT01644474|40499876|FG000|Overall Study|Protocol Violation|1|||
16555954|NCT01644474|40499877|FG001|Overall Study|Protocol Violation|0|||
16555955|NCT01622348|40499878|FG000|Overall Study|Withdrawal by Subject|1|||
16555956|NCT01622348|40499879|FG001|Overall Study|Withdrawal by Subject|0|||
16555957|NCT01622348|40499880|FG002|Overall Study|Withdrawal by Subject|1|||
16555958|NCT01383993|40499888|FG000|Overall Study|Adverse Event|1|||
16555959|NCT01383993|40499889|FG001|Overall Study|Adverse Event|1|||
16555960|NCT01383993|40499890|FG002|Overall Study|Adverse Event|0|||
16555961|NCT01383993|40499888|FG000|Overall Study|Withdrawal by Subject|0|||
16555962|NCT01383993|40499889|FG001|Overall Study|Withdrawal by Subject|0|||
16555963|NCT01383993|40499890|FG002|Overall Study|Withdrawal by Subject|1|||
16555964|NCT01383993|40499888|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
16555965|NCT01383993|40499889|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
16555966|NCT01383993|40499890|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
16555967|NCT01592695|40499893|FG000|Overall Study|Lost to Follow-up|8|||
16555968|NCT01592695|40499894|FG001|Overall Study|Lost to Follow-up|4|||
16555969|NCT03856996|40499899|FG000|Overall Study|Withdrawal by Subject|1|||
16555970|NCT03856996|40499900|FG001|Overall Study|Withdrawal by Subject|0|||
16555971|NCT03856996|40499899|FG000|Overall Study|Lost to Follow-up|0|||
16555972|NCT03856996|40499900|FG001|Overall Study|Lost to Follow-up|1|||
16555973|NCT03856996|40499899|FG000|Overall Study|Adverse Event|1|||
16555974|NCT03856996|40499900|FG001|Overall Study|Adverse Event|1|||
16555975|NCT03856996|40499899|FG000|Overall Study|Other|1|||
16555976|NCT03856996|40499900|FG001|Overall Study|Other|0|||
16555977|NCT01313923|40499901|FG000|Overall Study|Physician Decision|3|||
16555978|NCT02222896|40499902|FG000|Abdomen|Did not qualify|34|||
16555979|NCT02222896|40499903|FG001|Abdomen|Did not qualify|10|||
16555980|NCT02222896|40499904|FG002|Abdomen|Did not qualify|32|||
16555981|NCT02222896|40499902|FG000|Groin|Did not qualify|43|||
16555982|NCT02222896|40499903|FG001|Groin|Did not qualify|9|||
16555983|NCT02222896|40499904|FG002|Groin|Did not qualify|40|||
16555984|NCT00322374|40499905|FG000|Starting Dose|Physician Decision|2|||
16555985|NCT00322374|40499906|FG001|Starting Dose|Physician Decision|0|||
16555986|NCT00322374|40499907|FG002|Starting Dose|Physician Decision|0|||
16555987|NCT00322374|40499908|FG003|Starting Dose|Physician Decision|0|||
16555988|NCT00322374|40499905|FG000|Starting Dose|Study Drug Toxicity|4|||
16122203|NCT00474526|38934439|FG006|Overall Study|Adverse Event|1|||
16122204|NCT00474526|38934440|FG007|Overall Study|Adverse Event|0|||
16555989|NCT00322374|40499906|FG001|Starting Dose|Study Drug Toxicity|0|||
16555990|NCT00322374|40499907|FG002|Starting Dose|Study Drug Toxicity|0|||
16555991|NCT00322374|40499908|FG003|Starting Dose|Study Drug Toxicity|0|||
16555992|NCT00322374|40499905|FG000|First Escalation|Documented Disease Progression|0|||
16555993|NCT00322374|40499906|FG001|First Escalation|Documented Disease Progression|6|||
16555994|NCT00322374|40499907|FG002|First Escalation|Documented Disease Progression|0|||
16555995|NCT00322374|40499908|FG003|First Escalation|Documented Disease Progression|0|||
16555996|NCT00322374|40499905|FG000|First Escalation|Physician Decision|0|||
16555997|NCT00322374|40499906|FG001|First Escalation|Physician Decision|12|||
16555998|NCT00322374|40499907|FG002|First Escalation|Physician Decision|0|||
16555999|NCT00322374|40499908|FG003|First Escalation|Physician Decision|0|||
16556000|NCT00322374|40499905|FG000|First Escalation|Study Drug Toxicity|0|||
16556001|NCT00322374|40499906|FG001|First Escalation|Study Drug Toxicity|11|||
16556002|NCT00322374|40499907|FG002|First Escalation|Study Drug Toxicity|0|||
16556003|NCT00322374|40499908|FG003|First Escalation|Study Drug Toxicity|0|||
16556004|NCT00322374|40499905|FG000|First Escalation|Participant Request|0|||
16556005|NCT00322374|40499906|FG001|First Escalation|Participant Request|1|||
16556006|NCT00322374|40499907|FG002|First Escalation|Participant Request|0|||
16556007|NCT00322374|40499908|FG003|First Escalation|Participant Request|0|||
16556008|NCT00322374|40499905|FG000|Second Escalation|Physician Decision|0|||
16556009|NCT00322374|40499906|FG001|Second Escalation|Physician Decision|0|||
16556010|NCT00322374|40499907|FG002|Second Escalation|Physician Decision|5|||
16556011|NCT00322374|40499908|FG003|Second Escalation|Physician Decision|0|||
16556012|NCT00322374|40499905|FG000|Second Escalation|Study Drug Toxicity|0|||
16122205|NCT00474526|38934441|FG008|Overall Study|Adverse Event|0|||
16122206|NCT00474526|38934442|FG009|Overall Study|Adverse Event|0|||
16122207|NCT00474526|38934443|FG010|Overall Study|Adverse Event|0|||
16122208|NCT00474526|38934444|FG011|Overall Study|Adverse Event|0|||
16122209|NCT00474526|38934445|FG012|Overall Study|Adverse Event|0|||
16122210|NCT00474526|38934446|FG013|Overall Study|Adverse Event|0|||
16122211|NCT00474526|38934447|FG014|Overall Study|Adverse Event|1|||
16122212|NCT00474526|38934448|FG015|Overall Study|Adverse Event|1|||
16414147|NCT01659255|39998322|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414148|NCT01659255|39998323|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414149|NCT01659255|39998324|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414150|NCT01659255|39998325|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414151|NCT01659255|39998326|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414152|NCT01659255|39998327|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414153|NCT01659255|39998328|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414154|NCT01659255|39998329|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414155|NCT01659255|39998330|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414156|NCT01659255|39998331|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16556013|NCT00322374|40499906|FG001|Second Escalation|Study Drug Toxicity|0|||
16122213|NCT00474526|38934449|FG016|Overall Study|Adverse Event|0|||
16122214|NCT00474526|38934433|FG000|Overall Study|Death|0|||
16556014|NCT00322374|40499907|FG002|Second Escalation|Study Drug Toxicity|1|||
16122215|NCT00474526|38934434|FG001|Overall Study|Death|0|||
16122216|NCT00474526|38934435|FG002|Overall Study|Death|0|||
16122217|NCT00474526|38934436|FG003|Overall Study|Death|0|||
16122218|NCT00474526|38934437|FG004|Overall Study|Death|0|||
16556015|NCT00322374|40499908|FG003|Second Escalation|Study Drug Toxicity|0|||
16122219|NCT00474526|38934438|FG005|Overall Study|Death|0|||
16556016|NCT01155726|40499909|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
16556017|NCT01155726|40499910|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
16556018|NCT01155726|40499911|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
16556019|NCT01155726|40499912|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
16556020|NCT00284089|40499913|FG000|Multiple Dose Phase|Adverse Event|1|||
16556021|NCT00284089|40499914|FG001|Multiple Dose Phase|Adverse Event|0|||
16556022|NCT00284089|40499915|FG002|Multiple Dose Phase|Adverse Event|1|||
16556023|NCT00284089|40499916|FG003|Multiple Dose Phase|Adverse Event|1|||
16556024|NCT00284089|40499913|FG000|Multiple Dose Phase|Protocol Violation|0|||
16556025|NCT00284089|40499914|FG001|Multiple Dose Phase|Protocol Violation|0|||
16556026|NCT00284089|40499915|FG002|Multiple Dose Phase|Protocol Violation|1|||
16556027|NCT00284089|40499916|FG003|Multiple Dose Phase|Protocol Violation|0|||
16556028|NCT00284089|40499913|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
16556029|NCT00284089|40499914|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
16556030|NCT00284089|40499915|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
16556031|NCT00284089|40499916|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
16556032|NCT00284089|40499913|FG000|Multiple Dose Phase|Death|0|||
16556033|NCT00284089|40499914|FG001|Multiple Dose Phase|Death|0|||
16556034|NCT00284089|40499915|FG002|Multiple Dose Phase|Death|1|||
16556035|NCT00284089|40499916|FG003|Multiple Dose Phase|Death|1|||
16556036|NCT00284089|40499913|FG000|Extension Phase|Adverse Event|0|||
16556037|NCT00284089|40499914|FG001|Extension Phase|Adverse Event|0|||
16556038|NCT00284089|40499915|FG002|Extension Phase|Adverse Event|2|||
16556039|NCT00284089|40499916|FG003|Extension Phase|Adverse Event|2|||
16556040|NCT00284089|40499913|FG000|Extension Phase|condition no longer requires study drug|2|||
16556041|NCT00284089|40499914|FG001|Extension Phase|condition no longer requires study drug|0|||
16556042|NCT00284089|40499915|FG002|Extension Phase|condition no longer requires study drug|2|||
16556043|NCT00284089|40499916|FG003|Extension Phase|condition no longer requires study drug|7|||
16556044|NCT00284089|40499913|FG000|Extension Phase|Protocol Violation|0|||
16556045|NCT00284089|40499914|FG001|Extension Phase|Protocol Violation|0|||
16556046|NCT00284089|40499915|FG002|Extension Phase|Protocol Violation|1|||
16414157|NCT01659255|39998332|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414158|NCT01659255|39998333|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414159|NCT01659255|39998334|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414160|NCT01659255|39998335|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414161|NCT01659255|39998336|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414162|NCT01659255|39998337|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
16414163|NCT01659255|39998338|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
16414164|NCT01659255|39998322|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
16414165|NCT01659255|39998323|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
16414166|NCT01659255|39998324|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
16414167|NCT01659255|39998325|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
16414168|NCT01659255|39998326|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
16414169|NCT01659255|39998327|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
16414170|NCT01659255|39998328|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
16414171|NCT01659255|39998329|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
16414172|NCT01659255|39998330|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
16414173|NCT01659255|39998331|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
16556047|NCT00284089|40499916|FG003|Extension Phase|Protocol Violation|0|||
16556048|NCT00284089|40499913|FG000|Extension Phase|Withdrawal by Subject|0|||
16556049|NCT00284089|40499914|FG001|Extension Phase|Withdrawal by Subject|0|||
16556050|NCT00284089|40499915|FG002|Extension Phase|Withdrawal by Subject|1|||
16556051|NCT00284089|40499916|FG003|Extension Phase|Withdrawal by Subject|3|||
16556052|NCT00776100|40499919|FG000|Overall Study|Disease Progression|1|||
16556053|NCT00776100|40499920|FG001|Overall Study|Disease Progression|0|||
16556054|NCT01091428|40499924|FG000|Phase 1|Progressive Disease|24|||
16122220|NCT00474526|38934439|FG006|Overall Study|Death|0|||
16122221|NCT00474526|38934440|FG007|Overall Study|Death|0|||
16238213|NCT01299272|39357508|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
16238214|NCT01299272|39357509|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
16238215|NCT01299272|39357510|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
16238216|NCT01299272|39357507|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
16414174|NCT01659255|39998332|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
16556055|NCT01091428|40499925|FG001|Phase 1|Progressive Disease|8|||
16556056|NCT01091428|40499926|FG002|Phase 1|Progressive Disease|0|||
16556057|NCT01091428|40499927|FG003|Phase 1|Progressive Disease|0|||
16556058|NCT01091428|40499924|FG000|Phase 1|Symptomatic Deterioration|3|||
16556059|NCT01091428|40499925|FG001|Phase 1|Symptomatic Deterioration|2|||
16556060|NCT01091428|40499926|FG002|Phase 1|Symptomatic Deterioration|0|||
16556061|NCT01091428|40499927|FG003|Phase 1|Symptomatic Deterioration|0|||
16556062|NCT01091428|40499924|FG000|Phase 1|Adverse Event|2|||
16556063|NCT01091428|40499925|FG001|Phase 1|Adverse Event|0|||
16556064|NCT01091428|40499926|FG002|Phase 1|Adverse Event|0|||
16556065|NCT01091428|40499927|FG003|Phase 1|Adverse Event|0|||
16556066|NCT01091428|40499924|FG000|Phase 1|Withdrawal by Subject|7|||
16556067|NCT01091428|40499925|FG001|Phase 1|Withdrawal by Subject|0|||
16556068|NCT01091428|40499926|FG002|Phase 1|Withdrawal by Subject|0|||
16556069|NCT01091428|40499927|FG003|Phase 1|Withdrawal by Subject|0|||
16556070|NCT01091428|40499924|FG000|Phase 1|Reason not specified|0|||
16556071|NCT01091428|40499925|FG001|Phase 1|Reason not specified|1|||
16556072|NCT01091428|40499926|FG002|Phase 1|Reason not specified|0|||
16556073|NCT01091428|40499927|FG003|Phase 1|Reason not specified|0|||
16556074|NCT01091428|40499924|FG000|Phase 1|Single-Patient IND|2|||
16556075|NCT01091428|40499925|FG001|Phase 1|Single-Patient IND|0|||
16556076|NCT01091428|40499926|FG002|Phase 1|Single-Patient IND|0|||
16556077|NCT01091428|40499927|FG003|Phase 1|Single-Patient IND|0|||
16556078|NCT01091428|40499924|FG000|Phase 2|Progressive Disease|0|||
16556079|NCT01091428|40499925|FG001|Phase 2|Progressive Disease|0|||
16556080|NCT01091428|40499926|FG002|Phase 2|Progressive Disease|44|||
16556081|NCT01091428|40499927|FG003|Phase 2|Progressive Disease|46|||
16556082|NCT01091428|40499924|FG000|Phase 2|Symptomatic Deterioration|0|||
16556083|NCT01091428|40499925|FG001|Phase 2|Symptomatic Deterioration|0|||
16556084|NCT01091428|40499926|FG002|Phase 2|Symptomatic Deterioration|1|||
16238217|NCT01299272|39357508|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
16238218|NCT01299272|39357509|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
16556085|NCT01091428|40499927|FG003|Phase 2|Symptomatic Deterioration|6|||
16556086|NCT01091428|40499924|FG000|Phase 2|Adverse Event|0|||
16556087|NCT01091428|40499925|FG001|Phase 2|Adverse Event|0|||
16556088|NCT01091428|40499926|FG002|Phase 2|Adverse Event|12|||
16556089|NCT01091428|40499927|FG003|Phase 2|Adverse Event|5|||
16556090|NCT01091428|40499924|FG000|Phase 2|Withdrawal by Subject|0|||
16556091|NCT01091428|40499925|FG001|Phase 2|Withdrawal by Subject|0|||
16556092|NCT01091428|40499926|FG002|Phase 2|Withdrawal by Subject|9|||
16556093|NCT01091428|40499927|FG003|Phase 2|Withdrawal by Subject|8|||
16556094|NCT01091428|40499924|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
16556095|NCT01091428|40499925|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
16556096|NCT01091428|40499926|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
16556097|NCT01091428|40499927|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
16556098|NCT01091428|40499924|FG000|Phase 2|Reason not specified|0|||
16556099|NCT01091428|40499925|FG001|Phase 2|Reason not specified|0|||
16556100|NCT01091428|40499926|FG002|Phase 2|Reason not specified|4|||
16556101|NCT01091428|40499927|FG003|Phase 2|Reason not specified|3|||
16556102|NCT01091428|40499924|FG000|Phase 2|Physician Decision|0|||
16556103|NCT01091428|40499925|FG001|Phase 2|Physician Decision|0|||
16556104|NCT01091428|40499926|FG002|Phase 2|Physician Decision|2|||
16556105|NCT01091428|40499927|FG003|Phase 2|Physician Decision|0|||
16556106|NCT02102464|40499928|FG000|Randomized Study|Withdrawal by Subject|0|||
16556107|NCT02102464|40499929|FG001|Randomized Study|Withdrawal by Subject|1|||
16556108|NCT02102464|40499930|FG002|Randomized Study|Withdrawal by Subject|0|||
16556109|NCT04102540|40499931|FG000|Overall Study|Withdrawn by PI|2|||
16556110|NCT04102540|40499931|FG000|Overall Study|Lost to Follow-up|6|||
16556111|NCT02764775|40499932|FG000|Overall Study|Death|1|||
16556112|NCT02764775|40499932|FG000|Overall Study|Lost to Follow-up|2|||
16556113|NCT02764775|40499932|FG000|Overall Study|Withdrawal by Subject|3|||
16556114|NCT00962585|40499945|FG000|Overall Study|Adverse Event|0|||
16556115|NCT00962585|40499946|FG001|Overall Study|Adverse Event|2|||
16556116|NCT00962585|40499947|FG002|Overall Study|Adverse Event|1|||
16556117|NCT00962585|40499948|FG003|Overall Study|Adverse Event|0|||
16556118|NCT00962585|40499945|FG000|Overall Study|Lost to Follow-up|3|||
16556119|NCT00962585|40499946|FG001|Overall Study|Lost to Follow-up|0|||
16556120|NCT00962585|40499947|FG002|Overall Study|Lost to Follow-up|1|||
16238219|NCT01299272|39357510|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
16238220|NCT01299272|39357507|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
16238221|NCT01299272|39357508|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
16238222|NCT01299272|39357509|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
16238223|NCT01299272|39357510|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
16238224|NCT01299272|39357507|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
16238225|NCT01299272|39357508|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
16238226|NCT01299272|39357509|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
16238227|NCT01299272|39357510|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
16238228|NCT01299272|39357507|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
16238229|NCT01299272|39357508|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
16238230|NCT01299272|39357509|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
16238231|NCT01299272|39357510|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
16238232|NCT01299272|39357507|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
16238233|NCT01299272|39357508|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
16238234|NCT01299272|39357509|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
16238235|NCT01299272|39357510|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
16238236|NCT01299272|39357507|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
16238237|NCT01299272|39357508|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
16238238|NCT01299272|39357509|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
16238239|NCT01299272|39357510|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
16238240|NCT01299272|39357507|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
16238241|NCT01299272|39357508|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
16238242|NCT01299272|39357509|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
16238243|NCT01299272|39357510|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
16556121|NCT00962585|40499948|FG003|Overall Study|Lost to Follow-up|0|||
16556122|NCT00962585|40499945|FG000|Overall Study|Protocol Violation|0|||
16556123|NCT00962585|40499946|FG001|Overall Study|Protocol Violation|0|||
16122222|NCT00474526|38934441|FG008|Overall Study|Death|0|||
16556124|NCT00962585|40499947|FG002|Overall Study|Protocol Violation|1|||
16556125|NCT00962585|40499948|FG003|Overall Study|Protocol Violation|0|||
16556126|NCT00962585|40499945|FG000|Overall Study|Withdrawal by Subject|1|||
16556127|NCT00962585|40499946|FG001|Overall Study|Withdrawal by Subject|0|||
16122223|NCT00474526|38934442|FG009|Overall Study|Death|0|||
16238244|NCT01299272|39357507|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
16238245|NCT01299272|39357508|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
16238246|NCT01299272|39357509|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
16238247|NCT01299272|39357510|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
16238248|NCT01299272|39357507|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
16238249|NCT01299272|39357508|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
16238250|NCT01299272|39357509|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
16238251|NCT01299272|39357510|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
16238252|NCT01299272|39357507|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
16238253|NCT01299272|39357508|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
16238254|NCT01299272|39357509|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
16238255|NCT01299272|39357510|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
16238256|NCT01299272|39357507|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
16238257|NCT01299272|39357508|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
16238258|NCT01299272|39357509|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
16238259|NCT01299272|39357510|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
16238260|NCT01299272|39357507|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
16238261|NCT01299272|39357508|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
16238262|NCT01299272|39357509|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
16238263|NCT01299272|39357510|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
16238264|NCT03284424|39357517|FG000|Overall Study|Death|70|||
16238265|NCT03284424|39357518|FG001|Overall Study|Death|24|||
16238266|NCT03284424|39357517|FG000|Overall Study|Lost to Follow-up|3|||
16238267|NCT03284424|39357518|FG001|Overall Study|Lost to Follow-up|1|||
16238268|NCT03284424|39357517|FG000|Overall Study|Physician Decision|1|||
16238269|NCT03284424|39357518|FG001|Overall Study|Physician Decision|2|||
16238270|NCT03284424|39357517|FG000|Overall Study|Withdrawal by Subject|4|||
16238271|NCT03284424|39357518|FG001|Overall Study|Withdrawal by Subject|5|||
16238272|NCT03284424|39357517|FG000|Overall Study|Sponsor's decision|27|||
16238273|NCT03284424|39357518|FG001|Overall Study|Sponsor's decision|22|||
16238274|NCT03273712|39357519|FG000|Overall Study|Death|5|||
16238275|NCT03273712|39357519|FG000|Overall Study|Adverse Event|1|||
16238276|NCT03273712|39357519|FG000|Overall Study|Disease Progression|1|||
16238277|NCT00560573|39357527|FG000|Overall Study|Death|4|||
16238278|NCT00560573|39357528|FG001|Overall Study|Death|1|||
16238279|NCT00560573|39357529|FG002|Overall Study|Death|4|||
16238280|NCT00560573|39357530|FG003|Overall Study|Death|5|||
16238281|NCT00560573|39357531|FG004|Overall Study|Death|1|||
16238282|NCT00560573|39357532|FG005|Overall Study|Death|10|||
16238283|NCT00560573|39357527|FG000|Overall Study|Lost to Follow-up|0|||
16238284|NCT00560573|39357528|FG001|Overall Study|Lost to Follow-up|0|||
16238285|NCT00560573|39357529|FG002|Overall Study|Lost to Follow-up|0|||
16238286|NCT00560573|39357530|FG003|Overall Study|Lost to Follow-up|1|||
16238287|NCT00560573|39357531|FG004|Overall Study|Lost to Follow-up|1|||
16238288|NCT00560573|39357532|FG005|Overall Study|Lost to Follow-up|0|||
16238289|NCT00560573|39357527|FG000|Overall Study|Withdrawal by Subject|0|||
16556128|NCT00962585|40499947|FG002|Overall Study|Withdrawal by Subject|0|||
16556129|NCT00962585|40499948|FG003|Overall Study|Withdrawal by Subject|0|||
16556130|NCT00962585|40499945|FG000|Overall Study|Withdrew Consent|2|||
16556131|NCT00962585|40499946|FG001|Overall Study|Withdrew Consent|0|||
16556132|NCT00962585|40499947|FG002|Overall Study|Withdrew Consent|0|||
16556133|NCT00962585|40499948|FG003|Overall Study|Withdrew Consent|0|||
16556134|NCT03590743|40499949|FG000|Overall Study|Withdrawal by Subject|0|||
16556135|NCT03590743|40499950|FG001|Overall Study|Withdrawal by Subject|1|||
16556136|NCT00393094|40499952|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
16556137|NCT00393094|40499952|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
16556138|NCT01388530|40499956|FG000|Overall Study|Lost to Follow-up|5|||
16556139|NCT04147260|40499957|FG000|Overall Study|Adverse Event|1|||
16556140|NCT04147260|40499958|FG001|Overall Study|Adverse Event|0|||
16556141|NCT04147260|40499959|FG002|Overall Study|Adverse Event|1|||
16556142|NCT04147260|40499960|FG003|Overall Study|Adverse Event|2|||
16556143|NCT04147260|40499961|FG004|Overall Study|Adverse Event|0|||
16238290|NCT00560573|39357528|FG001|Overall Study|Withdrawal by Subject|0|||
16238291|NCT00560573|39357529|FG002|Overall Study|Withdrawal by Subject|0|||
16238292|NCT00560573|39357530|FG003|Overall Study|Withdrawal by Subject|1|||
16556144|NCT04147260|40499957|FG000|Overall Study|Withdrawal by Subject|0|||
16238293|NCT00560573|39357531|FG004|Overall Study|Withdrawal by Subject|1|||
16238294|NCT00560573|39357532|FG005|Overall Study|Withdrawal by Subject|0|||
16238295|NCT00560573|39357527|FG000|Overall Study|Other|2|||
16238296|NCT00560573|39357528|FG001|Overall Study|Other|2|||
16556145|NCT04147260|40499958|FG001|Overall Study|Withdrawal by Subject|0|||
16556146|NCT04147260|40499959|FG002|Overall Study|Withdrawal by Subject|1|||
16238297|NCT00560573|39357529|FG002|Overall Study|Other|2|||
16238298|NCT00560573|39357530|FG003|Overall Study|Other|3|||
16238299|NCT00560573|39357531|FG004|Overall Study|Other|3|||
16414175|NCT01659255|39998333|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
16414176|NCT01659255|39998334|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
16414177|NCT01659255|39998335|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
16238300|NCT00560573|39357532|FG005|Overall Study|Other|3|||
16238301|NCT00560573|39357527|FG000|Overall Study|Enrolled, not treated|0|||
16238302|NCT00560573|39357528|FG001|Overall Study|Enrolled, not treated|0|||
16238303|NCT00560573|39357529|FG002|Overall Study|Enrolled, not treated|0|||
16238304|NCT00560573|39357530|FG003|Overall Study|Enrolled, not treated|0|||
16238305|NCT00560573|39357531|FG004|Overall Study|Enrolled, not treated|1|||
16238306|NCT00560573|39357532|FG005|Overall Study|Enrolled, not treated|0|||
16238307|NCT00550420|39357533|FG000|Overall Study|Adverse Event|28|||
16238308|NCT00550420|39357533|FG000|Overall Study|Lost to Follow-up|8|||
16238309|NCT00550420|39357533|FG000|Overall Study|Protocol Violation|11|||
16238310|NCT00550420|39357533|FG000|Overall Study|Withdrawal by Subject|30|||
16238311|NCT00550420|39357533|FG000|Overall Study|Still in study at termination|206|||
16238312|NCT00550420|39357533|FG000|Overall Study|Missing|2|||
16238313|NCT00550420|39357533|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
16238314|NCT00550420|39357533|FG000|Overall Study|Investigators opinion|1|||
16238315|NCT00550420|39357533|FG000|Overall Study|Lack of curative effect|1|||
16238316|NCT00550420|39357533|FG000|Overall Study|Unethical stop of enrollment|2|||
16238317|NCT00550420|39357533|FG000|Overall Study|Caregiver's decision to withdraw|1|||
16238318|NCT00550420|39357533|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
16238319|NCT00550420|39357533|FG000|Overall Study|Exclusion criteria|1|||
16238320|NCT00550420|39357533|FG000|Overall Study|Prohibited medicine|1|||
16238321|NCT00728988|39357539|FG000|Overall Study|Not Treated|2|||
16238322|NCT00728988|39357540|FG001|Overall Study|Not Treated|2|||
16238323|NCT00728988|39357539|FG000|Overall Study|Death|1|||
16238324|NCT00728988|39357540|FG001|Overall Study|Death|1|||
16238325|NCT00728988|39357539|FG000|Overall Study|Adverse Event|3|||
16238326|NCT00728988|39357540|FG001|Overall Study|Adverse Event|2|||
16238327|NCT00728988|39357539|FG000|Overall Study|Other|85|||
16238328|NCT00728988|39357540|FG001|Overall Study|Other|77|||
16238329|NCT00728988|39357539|FG000|Overall Study|Withdrawal by Subject|2|||
16238330|NCT00728988|39357540|FG001|Overall Study|Withdrawal by Subject|6|||
16238331|NCT02713243|39357541|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
16238332|NCT02713243|39357542|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
16238333|NCT02713243|39357541|FG000|Overall Study|Administrative problems|0|||
16238334|NCT02713243|39357542|FG001|Overall Study|Administrative problems|1|||
16238335|NCT02713243|39357541|FG000|Overall Study|Protocol deviation|0|||
16238336|NCT02713243|39357542|FG001|Overall Study|Protocol deviation|1|||
16238337|NCT03746080|39357543|FG000|Overall Study|In follow up|2|||
16238338|NCT03746080|39357543|FG000|Overall Study|Death|15|||
16238339|NCT01406873|39357544|FG000|Overall Study|Withdrawal by Subject|1|||
16238340|NCT01406873|39357545|FG001|Overall Study|Withdrawal by Subject|1|||
16238341|NCT02475980|39357546|FG000|Overall Study|Lost to Follow-up|4|||
16414178|NCT01659255|39998336|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
16556147|NCT04147260|40499960|FG003|Overall Study|Withdrawal by Subject|1|||
16556148|NCT04147260|40499961|FG004|Overall Study|Withdrawal by Subject|0|||
16556149|NCT04362137|40499962|FG000|Overall Study|Death|9|||
16556150|NCT04362137|40499963|FG001|Overall Study|Death|3|||
16556151|NCT04362137|40499962|FG000|Overall Study|Patient decision|6|||
16556152|NCT04362137|40499963|FG001|Overall Study|Patient decision|3|||
16556153|NCT04362137|40499962|FG000|Overall Study|Adverse Event|1|||
16556154|NCT04362137|40499963|FG001|Overall Study|Adverse Event|0|||
16556155|NCT04362137|40499962|FG000|Overall Study|Lost to Follow-up|1|||
16556156|NCT04362137|40499963|FG001|Overall Study|Lost to Follow-up|0|||
16556157|NCT04362137|40499962|FG000|Overall Study|Protocol deviation|1|||
16556158|NCT04362137|40499963|FG001|Overall Study|Protocol deviation|0|||
16556159|NCT01927731|40499966|FG000|Overall Study|Graft Failure|1|||
16556160|NCT01927731|40499967|FG001|Overall Study|Graft Failure|2|||
16556161|NCT01927731|40499966|FG000|Overall Study|Physician Decision|2|||
16556162|NCT01927731|40499967|FG001|Overall Study|Physician Decision|3|||
16556163|NCT01927731|40499966|FG000|Overall Study|Withdrawal by Subject|0|||
16556164|NCT01927731|40499967|FG001|Overall Study|Withdrawal by Subject|2|||
16556165|NCT01927731|40499966|FG000|Overall Study|Death|0|||
16556166|NCT01927731|40499967|FG001|Overall Study|Death|3|||
16556167|NCT02206152|40499974|FG000|Pre-Randomization|Withdrawal by Subject|2|||
16238342|NCT02475980|39357546|FG000|Overall Study|Withdrawal by Subject|1|||
16556168|NCT01951092|40499975|FG000|Overall Study|Lost to Follow-up|10|||
16556169|NCT01951092|40499975|FG000|Overall Study|Incarceration|1|||
16238343|NCT00402779|39357547|FG000|Overall Study|Screen Failure|77|||
16238344|NCT00402779|39357548|FG001|Overall Study|Screen Failure|76|||
16238345|NCT00297492|39357551|FG000|Set Quit Date|Lost to Follow-up|7|||
16556170|NCT01951092|40499975|FG000|Overall Study|Transfer of Care|1|||
16556171|NCT02765490|40499977|FG000|Overall Study|Lost to Follow-up|1|||
16556172|NCT02765490|40499978|FG001|Overall Study|Lost to Follow-up|1|||
16122224|NCT00474526|38934443|FG010|Overall Study|Death|0|||
16122225|NCT00474526|38934444|FG011|Overall Study|Death|0|||
16122226|NCT00474526|38934445|FG012|Overall Study|Death|0|||
16122227|NCT00474526|38934446|FG013|Overall Study|Death|3|||
16122228|NCT00474526|38934447|FG014|Overall Study|Death|0|||
16122229|NCT00474526|38934448|FG015|Overall Study|Death|0|||
16122230|NCT00474526|38934449|FG016|Overall Study|Death|0|||
16122231|NCT00474526|38934433|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16122232|NCT00474526|38934434|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
16122233|NCT00474526|38934435|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16122234|NCT00474526|38934436|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
16122235|NCT00474526|38934437|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
16122236|NCT00474526|38934438|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16122237|NCT00474526|38934439|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16122238|NCT00474526|38934440|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16122239|NCT00474526|38934441|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16238346|NCT00297492|39357552|FG001|Set Quit Date|Lost to Follow-up|13|||
16238347|NCT00297492|39357553|FG002|Set Quit Date|Lost to Follow-up|5|||
16238348|NCT00297492|39357551|FG000|6 Month Follow-up|Lost to Follow-up|63|||
16238349|NCT00297492|39357552|FG001|6 Month Follow-up|Lost to Follow-up|49|||
16238350|NCT00297492|39357553|FG002|6 Month Follow-up|Lost to Follow-up|27|||
16238351|NCT02125734|39357554|FG000|Period 2|Adverse Event|0|||
16238352|NCT02125734|39357555|FG001|Period 2|Adverse Event|1|||
16238353|NCT00527397|39357557|FG000|Overall Study|Adverse Event|3|||
16238354|NCT00527397|39357557|FG000|Overall Study|Lack of Efficacy|1|||
16238355|NCT00527397|39357557|FG000|Overall Study|Protocol Violation|1|||
16238356|NCT00527397|39357557|FG000|Overall Study|Withdrawal by Subject|6|||
16238357|NCT00527397|39357557|FG000|Overall Study|Study terminated by sponsor|13|||
16349875|NCT01096160|39768848|FG000|Overall Study|Met stopping criteria per protocol|0|||
16349876|NCT01096160|39768849|FG001|Overall Study|Met stopping criteria per protocol|0|||
16349877|NCT01096160|39768850|FG002|Overall Study|Met stopping criteria per protocol|0|||
16349878|NCT01096160|39768851|FG003|Overall Study|Met stopping criteria per protocol|0|||
16238358|NCT04288115|39357559|FG000|Overall Study|Withdrawal by Subject|0|||
16238359|NCT04288115|39357560|FG001|Overall Study|Withdrawal by Subject|1|||
16238360|NCT04288115|39357559|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
16238361|NCT04288115|39357560|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
16238362|NCT03724916|39357561|FG000|Overall Study|Withdrawal by Subject|0|||
16238363|NCT03724916|39357562|FG001|Overall Study|Withdrawal by Subject|1|||
16238364|NCT03724916|39357563|FG002|Overall Study|Withdrawal by Subject|1|||
16238365|NCT03724916|39357564|FG003|Overall Study|Withdrawal by Subject|2|||
16238366|NCT03724916|39357561|FG000|Overall Study|Randomized but not Treated|1|||
16349879|NCT01096160|39768852|FG004|Overall Study|Met stopping criteria per protocol|1|||
16349880|NCT01096160|39768853|FG005|Overall Study|Met stopping criteria per protocol|0|||
16349881|NCT01096160|39768854|FG006|Overall Study|Met stopping criteria per protocol|2|||
16349882|NCT01096160|39768855|FG007|Overall Study|Met stopping criteria per protocol|0|||
16349883|NCT01096160|39768856|FG008|Overall Study|Met stopping criteria per protocol|2|||
16349884|NCT01096160|39768857|FG009|Overall Study|Met stopping criteria per protocol|0|||
16349885|NCT03188055|39768858|FG000|Overall Study|Unavailable for training|0|||
16349886|NCT03188055|39768859|FG001|Overall Study|Unavailable for training|0|||
16349887|NCT03188055|39768860|FG002|Overall Study|Unavailable for training|19|||
16349888|NCT03188055|39768861|FG003|Overall Study|Unavailable for training|0|||
16349889|NCT03188055|39768862|FG004|Overall Study|Unavailable for training|0|||
16349890|NCT03188055|39768863|FG005|Overall Study|Unavailable for training|0|||
16349891|NCT03188055|39768858|FG000|Overall Study|Lost to Follow-up|0|||
16349892|NCT03188055|39768859|FG001|Overall Study|Lost to Follow-up|18|||
16349893|NCT03188055|39768860|FG002|Overall Study|Lost to Follow-up|0|||
16349894|NCT03188055|39768861|FG003|Overall Study|Lost to Follow-up|11|||
16349895|NCT03188055|39768862|FG004|Overall Study|Lost to Follow-up|0|||
16349896|NCT03188055|39768863|FG005|Overall Study|Lost to Follow-up|0|||
16349897|NCT03188055|39768858|FG000|Overall Study|Withdrawal by Subject|0|||
16349898|NCT03188055|39768859|FG001|Overall Study|Withdrawal by Subject|1|||
16349899|NCT03188055|39768860|FG002|Overall Study|Withdrawal by Subject|0|||
16349900|NCT03188055|39768861|FG003|Overall Study|Withdrawal by Subject|1|||
16349901|NCT03188055|39768862|FG004|Overall Study|Withdrawal by Subject|0|||
16349902|NCT03188055|39768863|FG005|Overall Study|Withdrawal by Subject|0|||
16349903|NCT01324947|39768864|FG000|Overall Study|Adverse Event|7|||
16349904|NCT01324947|39768864|FG000|Overall Study|Death|10|||
16349905|NCT01324947|39768864|FG000|Overall Study|Other|3|||
16349906|NCT01324947|39768864|FG000|Overall Study|Progressive Disease|50|||
16414179|NCT01659255|39998337|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
16122240|NCT00474526|38934442|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16122241|NCT00474526|38934443|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16122242|NCT00474526|38934444|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16238367|NCT03724916|39357562|FG001|Overall Study|Randomized but not Treated|0|||
16238368|NCT03724916|39357563|FG002|Overall Study|Randomized but not Treated|0|||
16122243|NCT00474526|38934445|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16122244|NCT00474526|38934446|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
16122245|NCT00474526|38934447|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
16122246|NCT00474526|38934448|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16238369|NCT03724916|39357564|FG003|Overall Study|Randomized but not Treated|0|||
16238370|NCT00005879|39357565|FG000|Overall Study|Withdrawal by Subject|8|||
16238371|NCT00005879|39357566|FG001|Overall Study|Withdrawal by Subject|10|||
16238372|NCT00640614|39357567|FG000|Overall Study|Lost to Follow-up|1|||
16238373|NCT00640614|39357568|FG001|Overall Study|Lost to Follow-up|0|||
16238374|NCT02561000|39357571|FG000|Overall Study|Withdrawal by Subject|2|||
16238375|NCT02561000|39357572|FG001|Overall Study|Withdrawal by Subject|3|||
16238376|NCT02561000|39357573|FG002|Overall Study|Withdrawal by Subject|0|||
16238377|NCT02561000|39357571|FG000|Overall Study|Adverse Event|0|||
16238378|NCT02561000|39357572|FG001|Overall Study|Adverse Event|1|||
16238379|NCT02561000|39357573|FG002|Overall Study|Adverse Event|0|||
16238380|NCT01220128|39357574|FG000|Overall Study|Progressive disease|0|||
16238381|NCT01220128|39357575|FG001|Overall Study|Progressive disease|0|||
16238382|NCT01220128|39357576|FG002|Overall Study|Progressive disease|2|||
16238383|NCT01220128|39357577|FG003|Overall Study|Progressive disease|0|||
16238384|NCT01220128|39357578|FG004|Overall Study|Progressive disease|0|||
16238385|NCT01220128|39357579|FG005|Overall Study|Progressive disease|0|||
16238386|NCT01220128|39357580|FG006|Overall Study|Progressive disease|0|||
16238387|NCT01220128|39357574|FG000|Overall Study|Sponsor study termination|0|||
16238388|NCT01220128|39357575|FG001|Overall Study|Sponsor study termination|1|||
16238389|NCT01220128|39357576|FG002|Overall Study|Sponsor study termination|0|||
16238390|NCT01220128|39357577|FG003|Overall Study|Sponsor study termination|0|||
16238391|NCT01220128|39357578|FG004|Overall Study|Sponsor study termination|0|||
16238392|NCT01220128|39357579|FG005|Overall Study|Sponsor study termination|0|||
16238393|NCT01220128|39357580|FG006|Overall Study|Sponsor study termination|1|||
16238394|NCT01220128|39357574|FG000|Overall Study|Adverse event, serious fatal|2|||
16238395|NCT01220128|39357575|FG001|Overall Study|Adverse event, serious fatal|0|||
16238396|NCT01220128|39357576|FG002|Overall Study|Adverse event, serious fatal|0|||
16238397|NCT01220128|39357577|FG003|Overall Study|Adverse event, serious fatal|0|||
16238398|NCT01220128|39357578|FG004|Overall Study|Adverse event, serious fatal|0|||
16238399|NCT01220128|39357579|FG005|Overall Study|Adverse event, serious fatal|0|||
16238400|NCT01220128|39357580|FG006|Overall Study|Adverse event, serious fatal|1|||
16238401|NCT01220128|39357574|FG000|Overall Study|Adverse event, non-fatal|1|||
16238402|NCT01220128|39357575|FG001|Overall Study|Adverse event, non-fatal|0|||
16238403|NCT01220128|39357576|FG002|Overall Study|Adverse event, non-fatal|0|||
16238404|NCT01220128|39357577|FG003|Overall Study|Adverse event, non-fatal|0|||
16238405|NCT01220128|39357578|FG004|Overall Study|Adverse event, non-fatal|0|||
16238406|NCT01220128|39357579|FG005|Overall Study|Adverse event, non-fatal|0|||
16238407|NCT01220128|39357580|FG006|Overall Study|Adverse event, non-fatal|3|||
16238408|NCT01220128|39357574|FG000|Overall Study|Other|0|||
16238409|NCT01220128|39357575|FG001|Overall Study|Other|0|||
16238410|NCT01220128|39357576|FG002|Overall Study|Other|1|||
16349907|NCT01324947|39768864|FG000|Overall Study|Withdrawal by Subject|3|||
16349908|NCT01324947|39768864|FG000|Overall Study|1 discontinued before starting drug|1|||
16349909|NCT00115778|39768865|FG000|Overall Study|Withdrawal by Subject|0|||
16349910|NCT00115778|39768866|FG001|Overall Study|Withdrawal by Subject|1|||
16349911|NCT02848664|39768867|FG000|Overall Study|Withdrawal by Subject|2|||
16238411|NCT01220128|39357577|FG003|Overall Study|Other|0|||
16238412|NCT01220128|39357578|FG004|Overall Study|Other|0|||
16238413|NCT01220128|39357579|FG005|Overall Study|Other|0|||
16238414|NCT01220128|39357580|FG006|Overall Study|Other|0|||
16238415|NCT01220128|39357574|FG000|Overall Study|Consent withdrawn by subject|1|||
16238416|NCT01220128|39357575|FG001|Overall Study|Consent withdrawn by subject|0|||
16238417|NCT01220128|39357576|FG002|Overall Study|Consent withdrawn by subject|0|||
16238418|NCT01220128|39357577|FG003|Overall Study|Consent withdrawn by subject|0|||
16349912|NCT02848664|39768867|FG000|Overall Study|Adverse Event|1|||
16238419|NCT01220128|39357578|FG004|Overall Study|Consent withdrawn by subject|0|||
16238420|NCT01220128|39357579|FG005|Overall Study|Consent withdrawn by subject|0|||
16238421|NCT01220128|39357580|FG006|Overall Study|Consent withdrawn by subject|0|||
16238422|NCT02200614|39357581|FG000|Double Blind Treatment|Adverse Event|86|||
16238423|NCT02200614|39357582|FG001|Double Blind Treatment|Adverse Event|48|||
16238424|NCT02200614|39357581|FG000|Double Blind Treatment|Confirmed metastasis|120|||
16349913|NCT02848664|39768867|FG000|Overall Study|no assistance for device training|1|||
16238425|NCT02200614|39357582|FG001|Double Blind Treatment|Confirmed metastasis|140|||
16349914|NCT01223404|39768872|FG000|First Intervention (1 Day)|Adverse Event|0|||
16349915|NCT01223404|39768873|FG001|First Intervention (1 Day)|Adverse Event|0|||
16349916|NCT01223404|39768874|FG002|First Intervention (1 Day)|Adverse Event|0|||
16349917|NCT01223404|39768875|FG003|First Intervention (1 Day)|Adverse Event|1|||
16349918|NCT01223404|39768876|FG004|First Intervention (1 Day)|Adverse Event|0|||
16349919|NCT01223404|39768877|FG005|First Intervention (1 Day)|Adverse Event|0|||
16349920|NCT01223404|39768872|FG000|Second Intervention (1 Day)|Adverse Event|1|||
16349921|NCT01223404|39768873|FG001|Second Intervention (1 Day)|Adverse Event|0|||
16349922|NCT01223404|39768874|FG002|Second Intervention (1 Day)|Adverse Event|0|||
16349923|NCT01223404|39768875|FG003|Second Intervention (1 Day)|Adverse Event|0|||
16349924|NCT01223404|39768876|FG004|Second Intervention (1 Day)|Adverse Event|0|||
16349925|NCT01223404|39768877|FG005|Second Intervention (1 Day)|Adverse Event|0|||
16349926|NCT01223404|39768872|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
16349927|NCT01223404|39768873|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
16349928|NCT01223404|39768874|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
16349929|NCT01223404|39768875|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
16349930|NCT01223404|39768876|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
16349931|NCT01223404|39768877|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
16349932|NCT01628848|39768878|FG000|Overall Study|Adverse Event|9|||
16349933|NCT01628848|39768879|FG001|Overall Study|Adverse Event|7|||
16349934|NCT01628848|39768878|FG000|Overall Study|Lack of Efficacy|0|||
16349935|NCT01628848|39768879|FG001|Overall Study|Lack of Efficacy|4|||
16349936|NCT01628848|39768878|FG000|Overall Study|Withdrawal by Subject|0|||
16349937|NCT01628848|39768879|FG001|Overall Study|Withdrawal by Subject|2|||
16349938|NCT01628848|39768878|FG000|Overall Study|Physician Decision|3|||
16349939|NCT01628848|39768879|FG001|Overall Study|Physician Decision|1|||
16349940|NCT00165503|39768880|FG000|Overall Study|Death|1|||
16349941|NCT00165503|39768880|FG000|Overall Study|Lost to Follow-up|12|||
16349942|NCT00165503|39768880|FG000|Overall Study|Unresectable|3|||
16349943|NCT02976519|39768881|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
16122247|NCT00474526|38934449|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
16122248|NCT00474526|38934433|FG000|Overall Study|Lost to Follow-up|8|||
16122249|NCT00474526|38934434|FG001|Overall Study|Lost to Follow-up|6|||
16122250|NCT00474526|38934435|FG002|Overall Study|Lost to Follow-up|13|||
16122251|NCT00474526|38934436|FG003|Overall Study|Lost to Follow-up|29|||
16122252|NCT00474526|38934437|FG004|Overall Study|Lost to Follow-up|11|||
16122253|NCT00474526|38934438|FG005|Overall Study|Lost to Follow-up|5|||
16122254|NCT00474526|38934439|FG006|Overall Study|Lost to Follow-up|8|||
16122255|NCT00474526|38934440|FG007|Overall Study|Lost to Follow-up|1|||
16122256|NCT00474526|38934441|FG008|Overall Study|Lost to Follow-up|0|||
16122257|NCT00474526|38934442|FG009|Overall Study|Lost to Follow-up|6|||
16122258|NCT00474526|38934443|FG010|Overall Study|Lost to Follow-up|2|||
16122259|NCT00474526|38934444|FG011|Overall Study|Lost to Follow-up|4|||
16122260|NCT00474526|38934445|FG012|Overall Study|Lost to Follow-up|6|||
16122261|NCT00474526|38934446|FG013|Overall Study|Lost to Follow-up|74|||
16122262|NCT00474526|38934447|FG014|Overall Study|Lost to Follow-up|29|||
16122263|NCT00474526|38934448|FG015|Overall Study|Lost to Follow-up|4|||
16122264|NCT00474526|38934449|FG016|Overall Study|Lost to Follow-up|5|||
16122265|NCT00474526|38934433|FG000|Overall Study|Protocol Violation|2|||
16122266|NCT00474526|38934434|FG001|Overall Study|Protocol Violation|6|||
16349944|NCT02976519|39768882|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
16349945|NCT02976519|39768883|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
16122267|NCT00474526|38934435|FG002|Overall Study|Protocol Violation|4|||
16122268|NCT00474526|38934436|FG003|Overall Study|Protocol Violation|12|||
16122269|NCT00474526|38934437|FG004|Overall Study|Protocol Violation|3|||
16122270|NCT00474526|38934438|FG005|Overall Study|Protocol Violation|1|||
16122271|NCT00474526|38934439|FG006|Overall Study|Protocol Violation|3|||
16349946|NCT02976519|39768884|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
16349947|NCT02976519|39768885|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
16349948|NCT02976519|39768886|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
16349949|NCT02976519|39768887|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
16349950|NCT02976519|39768881|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
16349951|NCT02976519|39768882|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
16349952|NCT02976519|39768883|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
16349953|NCT02976519|39768884|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
16349954|NCT02976519|39768885|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
16349955|NCT02976519|39768886|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
16349956|NCT02976519|39768887|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
16349957|NCT02976519|39768881|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
16349958|NCT02976519|39768882|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
16349959|NCT02976519|39768883|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
16349960|NCT02976519|39768884|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
16349961|NCT02976519|39768885|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
16349962|NCT02976519|39768886|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
16349963|NCT02976519|39768887|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
16349964|NCT02976519|39768881|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
16349965|NCT02976519|39768882|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
16349966|NCT02976519|39768883|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
16349967|NCT02976519|39768884|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
16349968|NCT02976519|39768885|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
16349969|NCT02976519|39768886|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
16349970|NCT02976519|39768887|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
16349971|NCT02976519|39768881|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
16414180|NCT01659255|39998338|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
16414181|NCT00884832|39998340|FG000|Overall Study|Withdrawal by Subject|0|||
16414182|NCT00884832|39998341|FG001|Overall Study|Withdrawal by Subject|1|||
16556173|NCT02765490|40499977|FG000|Overall Study|Other|0|||
16556174|NCT02765490|40499978|FG001|Overall Study|Other|1|||
16556175|NCT02765490|40499977|FG000|Overall Study|Death|0|||
16556176|NCT02765490|40499978|FG001|Overall Study|Death|1|||
16556177|NCT00750893|40499981|FG000|Overall Study|Adverse Event|5|||
16556178|NCT00750893|40499981|FG000|Overall Study|Withdrawal by Subject|10|||
16556179|NCT00750893|40499981|FG000|Overall Study|Lost to Follow-up|510|||
16556180|NCT00750893|40499981|FG000|Overall Study|Other|17|||
16556181|NCT02207374|40499982|FG000|Overall Study|Withdrawal by Subject|5|||
16556182|NCT02207374|40499983|FG001|Overall Study|Withdrawal by Subject|9|||
16556183|NCT02207374|40499984|FG002|Overall Study|Withdrawal by Subject|4|||
16556184|NCT02207374|40499982|FG000|Overall Study|Death|1|||
16556185|NCT02207374|40499983|FG001|Overall Study|Death|0|||
16556186|NCT02207374|40499984|FG002|Overall Study|Death|1|||
16556187|NCT02207374|40499982|FG000|Overall Study|Missing follow-up information|0|||
16556188|NCT02207374|40499983|FG001|Overall Study|Missing follow-up information|1|||
16556189|NCT02207374|40499984|FG002|Overall Study|Missing follow-up information|1|||
16556190|NCT03662997|40499985|FG000|Overall Study|Adverse Event|0|||
16556191|NCT03662997|40499986|FG001|Overall Study|Adverse Event|2|||
16556192|NCT03662997|40499987|FG002|Overall Study|Adverse Event|0|||
16556193|NCT03662997|40499988|FG003|Overall Study|Adverse Event|0|||
16556194|NCT01254305|40499993|FG000|Overall Study|Adverse Event|6|||
16556195|NCT01254305|40499994|FG001|Overall Study|Adverse Event|3|||
16556196|NCT01254305|40499995|FG002|Overall Study|Adverse Event|2|||
16556197|NCT01254305|40499993|FG000|Overall Study|Lack of Efficacy|1|||
16556198|NCT01254305|40499994|FG001|Overall Study|Lack of Efficacy|0|||
16556199|NCT01254305|40499995|FG002|Overall Study|Lack of Efficacy|1|||
16556200|NCT01254305|40499993|FG000|Overall Study|Protocol Violation|1|||
16556201|NCT01254305|40499994|FG001|Overall Study|Protocol Violation|7|||
16556202|NCT01254305|40499995|FG002|Overall Study|Protocol Violation|3|||
16556203|NCT01254305|40499993|FG000|Overall Study|Withdrawal by Subject|4|||
16556204|NCT01254305|40499994|FG001|Overall Study|Withdrawal by Subject|2|||
16349972|NCT02976519|39768882|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
16349973|NCT02976519|39768883|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
16349974|NCT02976519|39768884|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
16349975|NCT02976519|39768885|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
16122272|NCT00474526|38934440|FG007|Overall Study|Protocol Violation|0|||
16122273|NCT00474526|38934441|FG008|Overall Study|Protocol Violation|0|||
16122274|NCT00474526|38934442|FG009|Overall Study|Protocol Violation|4|||
16349976|NCT02976519|39768886|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
16349977|NCT02976519|39768887|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
16349978|NCT02949947|39768890|FG000|Overall Study|Non Compliance|0|||
16349979|NCT02949947|39768891|FG001|Overall Study|Non Compliance|1|||
16349980|NCT02949947|39768890|FG000|Overall Study|Insurance change|1|||
16349981|NCT02949947|39768891|FG001|Overall Study|Insurance change|0|||
16349982|NCT00752089|39768894|FG000|Overall Study|Adverse Event|1|||
16349983|NCT00752089|39768894|FG000|Overall Study|Protocol Deviation|2|||
16349984|NCT00752089|39768894|FG000|Overall Study|Could not attend visit 9|1|||
16349985|NCT00752089|39768894|FG000|Overall Study|Not capable of wearing partial denture|1|||
16349986|NCT00752089|39768894|FG000|Overall Study|Cannot continue the study|1|||
16349987|NCT03872843|39768895|FG000|Overall Study|Lost to Follow-up|5|||
16349988|NCT03872843|39768896|FG001|Overall Study|Lost to Follow-up|7|||
16349989|NCT02246621|39768897|FG000|Overall Study|Withdrawal by Subject|28|||
16349990|NCT02246621|39768898|FG001|Overall Study|Withdrawal by Subject|16|||
16349991|NCT02246621|39768897|FG000|Overall Study|Lost to Follow-up|1|||
16349992|NCT02246621|39768898|FG001|Overall Study|Lost to Follow-up|0|||
16349993|NCT02246621|39768897|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
16349994|NCT02246621|39768898|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
16349995|NCT00338741|39768899|FG000|Overall Study|Lost to Follow-up|2|||
16349996|NCT00338741|39768900|FG001|Overall Study|Lost to Follow-up|0|||
16349997|NCT04534517|39768903|FG000|Overall Study|Adverse Event|1|||
16349998|NCT04534517|39768903|FG000|Overall Study|Withdrawal by Subject|1|||
16349999|NCT04534517|39768903|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
16350000|NCT04534517|39768903|FG000|Overall Study|COVID-19 Related|1|||
16350001|NCT01619878|39768904|FG000|6 Week Follow-up Phase|Adverse Event|1|||
16350002|NCT01619878|39768904|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
16350003|NCT01619878|39768904|FG000|Follow-up at 12 Months of Age|Death|2|||
16350004|NCT00698815|39768925|FG000|Overall Study|Death|1|||
16350005|NCT00698815|39768926|FG001|Overall Study|Death|2|||
16350006|NCT00698815|39768927|FG002|Overall Study|Death|4|||
16350007|NCT00698815|39768925|FG000|Overall Study|Withdrawal by Subject|6|||
16350008|NCT00698815|39768926|FG001|Overall Study|Withdrawal by Subject|3|||
16350009|NCT00698815|39768927|FG002|Overall Study|Withdrawal by Subject|2|||
16350010|NCT00698815|39768925|FG000|Overall Study|MD discretion|2|||
16350011|NCT00698815|39768926|FG001|Overall Study|MD discretion|7|||
16350012|NCT00698815|39768927|FG002|Overall Study|MD discretion|2|||
16350013|NCT00698815|39768925|FG000|Overall Study|Did not receive protocol treatment|1|||
16350014|NCT00698815|39768926|FG001|Overall Study|Did not receive protocol treatment|2|||
16350015|NCT00698815|39768927|FG002|Overall Study|Did not receive protocol treatment|2|||
16350016|NCT02185417|39768928|FG000|Overall Study|Death|448|||
16350017|NCT02185417|39768929|FG001|Overall Study|Death|446|||
16350018|NCT02185417|39768930|FG002|Overall Study|Death|0|||
16350019|NCT02185417|39768928|FG000|Overall Study|Withdrawal by Subject|7|||
16350020|NCT02185417|39768929|FG001|Overall Study|Withdrawal by Subject|12|||
16350021|NCT02185417|39768930|FG002|Overall Study|Withdrawal by Subject|0|||
16350022|NCT02337491|39768932|FG000|Overall Study|Death|1|||
16350023|NCT02337491|39768933|FG001|Overall Study|Death|1|||
16350024|NCT02337491|39768932|FG000|Overall Study|Adverse Event|0|||
16122275|NCT00474526|38934443|FG010|Overall Study|Protocol Violation|2|||
16350025|NCT02337491|39768933|FG001|Overall Study|Adverse Event|1|||
16350026|NCT02337491|39768932|FG000|Overall Study|Withdrawal by Subject|3|||
16350027|NCT02337491|39768933|FG001|Overall Study|Withdrawal by Subject|0|||
16350028|NCT02337491|39768932|FG000|Overall Study|Progressive Disease|44|||
16350029|NCT02337491|39768933|FG001|Overall Study|Progressive Disease|28|||
16350030|NCT02337491|39768932|FG000|Overall Study|On Treatment|2|||
16350031|NCT02337491|39768933|FG001|Overall Study|On Treatment|0|||
16350032|NCT02144701|39768934|FG000|Overall Study|development of relapse, GVHD or death|9|||
16350033|NCT02144701|39768935|FG001|Overall Study|development of relapse, GVHD or death|3|||
16350034|NCT04552132|39768936|FG000|Overall Study|Lost to Follow-up|4|||
16350035|NCT04552132|39768937|FG001|Overall Study|Lost to Follow-up|3|||
16350036|NCT04552132|39768936|FG000|Overall Study|Protocol Violation|1|||
16350037|NCT04552132|39768937|FG001|Overall Study|Protocol Violation|0|||
16350038|NCT00610168|39768938|FG000|Overall Study|Withdrawal by Subject|2|||
16350039|NCT00610168|39768939|FG001|Overall Study|Withdrawal by Subject|0|||
16350040|NCT04010461|39768944|FG000|Overall Study|COVID based withdrawal|5|||
16350041|NCT04010461|39768944|FG000|Overall Study|Withdrawal by Subject|5|||
16350042|NCT04010461|39768944|FG000|Overall Study|Adverse Event|1|||
16350043|NCT04010461|39768944|FG000|Overall Study|No Motor Threshold obtainable|1|||
16350044|NCT04010461|39768944|FG000|Overall Study|Physician Decision|1|||
16350045|NCT03286218|39768951|FG000|Qualification Phase Period 1|Adverse Event|1|||
16350046|NCT03286218|39768952|FG001|Qualification Phase Period 1|Adverse Event|0|||
16122276|NCT00474526|38934444|FG011|Overall Study|Protocol Violation|2|||
16122277|NCT00474526|38934445|FG012|Overall Study|Protocol Violation|4|||
16122278|NCT00474526|38934446|FG013|Overall Study|Protocol Violation|19|||
16350047|NCT03286218|39768953|FG002|Qualification Phase Period 1|Adverse Event|0|||
16350048|NCT03286218|39768954|FG003|Qualification Phase Period 1|Adverse Event|0|||
16350049|NCT03286218|39768955|FG004|Qualification Phase Period 1|Adverse Event|0|||
16414183|NCT01617447|39998342|FG000|Overall Study|Adverse Event|0|||
16122279|NCT00474526|38934447|FG014|Overall Study|Protocol Violation|9|||
16122280|NCT00474526|38934448|FG015|Overall Study|Protocol Violation|6|||
16238426|NCT02200614|39357581|FG000|Double Blind Treatment|Judgment of the investigator|59|||
16556205|NCT01254305|40499995|FG002|Overall Study|Withdrawal by Subject|4|||
16556206|NCT01254305|40499993|FG000|Overall Study|Lost to Follow-up|10|||
16556207|NCT01254305|40499994|FG001|Overall Study|Lost to Follow-up|6|||
16556208|NCT01254305|40499995|FG002|Overall Study|Lost to Follow-up|5|||
16556209|NCT01254305|40499993|FG000|Overall Study|Other Reasons|0|||
16556210|NCT01254305|40499994|FG001|Overall Study|Other Reasons|0|||
16556211|NCT01254305|40499995|FG002|Overall Study|Other Reasons|2|||
16556212|NCT01676220|40499996|FG000|Overall Study|Randomized But Not Treated|4|||
16556213|NCT01676220|40499997|FG001|Overall Study|Randomized But Not Treated|1|||
16556214|NCT01676220|40499996|FG000|Overall Study|Adverse Event|10|||
16556215|NCT01676220|40499997|FG001|Overall Study|Adverse Event|8|||
16556216|NCT01676220|40499996|FG000|Overall Study|Lack of Efficacy|2|||
16556217|NCT01676220|40499997|FG001|Overall Study|Lack of Efficacy|5|||
16556218|NCT01676220|40499996|FG000|Overall Study|Protocol Violation|11|||
16556219|NCT01676220|40499997|FG001|Overall Study|Protocol Violation|12|||
16556220|NCT01676220|40499996|FG000|Overall Study|Received Rescue Therapy|14|||
16556221|NCT01676220|40499997|FG001|Overall Study|Received Rescue Therapy|22|||
16556222|NCT01676220|40499996|FG000|Overall Study|Personal Reason|34|||
16556223|NCT01676220|40499997|FG001|Overall Study|Personal Reason|45|||
16556224|NCT01676220|40499996|FG000|Overall Study|Lost to Follow-up|11|||
16556225|NCT01676220|40499997|FG001|Overall Study|Lost to Follow-up|18|||
16556226|NCT01676220|40499996|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
16556227|NCT01676220|40499997|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
16556228|NCT01676220|40499996|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
16556229|NCT01676220|40499997|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
16556230|NCT01676220|40499996|FG000|Overall Study|Perceived Lack of Efficacy|3|||
16556231|NCT01676220|40499997|FG001|Overall Study|Perceived Lack of Efficacy|1|||
16556232|NCT01676220|40499996|FG000|Overall Study|Non Serious Hypoglycemia|2|||
16556233|NCT01676220|40499997|FG001|Overall Study|Non Serious Hypoglycemia|0|||
16556234|NCT01676220|40499996|FG000|Overall Study|No More Need of Insulin|1|||
16556235|NCT01676220|40499997|FG001|Overall Study|No More Need of Insulin|0|||
16556236|NCT01349660|40499998|FG000|Overall Study|Still Receiving Study Treatment|0|||
16556237|NCT01349660|40499999|FG001|Overall Study|Still Receiving Study Treatment|0|||
16556238|NCT01349660|40500000|FG002|Overall Study|Still Receiving Study Treatment|1|||
16556239|NCT01349660|40499998|FG000|Overall Study|Disease Progression|2|||
16556240|NCT01349660|40499999|FG001|Overall Study|Disease Progression|4|||
16556241|NCT01349660|40500000|FG002|Overall Study|Disease Progression|50|||
16556242|NCT01349660|40499998|FG000|Overall Study|Adverse Event|1|||
16556243|NCT01349660|40499999|FG001|Overall Study|Adverse Event|1|||
16556244|NCT01349660|40500000|FG002|Overall Study|Adverse Event|12|||
16556245|NCT01349660|40499998|FG000|Overall Study|Withdrawal by Subject|2|||
16556246|NCT01349660|40499999|FG001|Overall Study|Withdrawal by Subject|0|||
16556247|NCT01349660|40500000|FG002|Overall Study|Withdrawal by Subject|9|||
16556248|NCT01349660|40499998|FG000|Overall Study|Death|1|||
16556249|NCT01349660|40499999|FG001|Overall Study|Death|1|||
16556250|NCT01349660|40500000|FG002|Overall Study|Death|0|||
16556251|NCT01349660|40499998|FG000|Overall Study|Non-Permitted Interventions|0|||
16556252|NCT01349660|40499999|FG001|Overall Study|Non-Permitted Interventions|0|||
16556253|NCT01349660|40500000|FG002|Overall Study|Non-Permitted Interventions|2|||
16556254|NCT01349660|40499998|FG000|Overall Study|Study Compliance|0|||
16556255|NCT01349660|40499999|FG001|Overall Study|Study Compliance|0|||
16556256|NCT01349660|40500000|FG002|Overall Study|Study Compliance|1|||
16556257|NCT01349660|40499998|FG000|Overall Study|Declining Performance Status|0|||
16556258|NCT01349660|40499999|FG001|Overall Study|Declining Performance Status|0|||
16556259|NCT01349660|40500000|FG002|Overall Study|Declining Performance Status|1|||
16556260|NCT01163747|40500006|FG000|Overall Study|Adverse Event|0|||
16556261|NCT01163747|40500007|FG001|Overall Study|Adverse Event|5|||
16556262|NCT01163747|40500006|FG000|Overall Study|Insufficient Therapeutic Response|0|||
16556263|NCT01163747|40500007|FG001|Overall Study|Insufficient Therapeutic Response|1|||
16556264|NCT01163747|40500006|FG000|Overall Study|Protocol Violation|0|||
16556265|NCT01163747|40500007|FG001|Overall Study|Protocol Violation|1|||
16556266|NCT01163747|40500006|FG000|Overall Study|Refused Treatment|6|||
16556267|NCT01163747|40500007|FG001|Overall Study|Refused Treatment|4|||
16556268|NCT00581113|40500008|FG000|Overall Study|Withdrawal by Subject|0|||
16556269|NCT00581113|40500009|FG001|Overall Study|Withdrawal by Subject|1|||
16556270|NCT04213989|40500013|FG000|Overall Study|Withdrawal by Subject|3|||
16556271|NCT04213989|40500014|FG001|Overall Study|Withdrawal by Subject|2|||
16556272|NCT04213989|40500013|FG000|Overall Study|Physician Decision|1|||
16556273|NCT04213989|40500014|FG001|Overall Study|Physician Decision|0|||
16556274|NCT04213989|40500013|FG000|Overall Study|Lost to Follow-up|0|||
16556275|NCT04213989|40500014|FG001|Overall Study|Lost to Follow-up|4|||
16556276|NCT01003639|40500017|FG000|Overall Study|Lost to Follow-up|6|||
16122281|NCT00474526|38934449|FG016|Overall Study|Protocol Violation|2|||
16556277|NCT01003639|40500018|FG001|Overall Study|Lost to Follow-up|9|||
16122282|NCT00474526|38934433|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
16122283|NCT00474526|38934434|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
16122284|NCT00474526|38934435|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
16122285|NCT00474526|38934436|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
16122286|NCT00474526|38934437|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
16122287|NCT00474526|38934438|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
16122288|NCT00474526|38934439|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
16122289|NCT00474526|38934440|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
16122290|NCT00474526|38934441|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
16122291|NCT00474526|38934442|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
16122292|NCT00474526|38934443|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
16122293|NCT00474526|38934444|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
16122294|NCT00474526|38934445|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
16122295|NCT00474526|38934446|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
16122296|NCT00474526|38934447|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
16122297|NCT00474526|38934448|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
16122298|NCT00474526|38934449|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
16122299|NCT00474526|38934433|FG000|Overall Study|Withdrawal by Subject|9|||
16122300|NCT00474526|38934434|FG001|Overall Study|Withdrawal by Subject|24|||
16122301|NCT00474526|38934435|FG002|Overall Study|Withdrawal by Subject|21|||
16122302|NCT00474526|38934436|FG003|Overall Study|Withdrawal by Subject|52|||
16122303|NCT00474526|38934437|FG004|Overall Study|Withdrawal by Subject|38|||
16122304|NCT00474526|38934438|FG005|Overall Study|Withdrawal by Subject|6|||
16122305|NCT00474526|38934439|FG006|Overall Study|Withdrawal by Subject|12|||
16122306|NCT00474526|38934440|FG007|Overall Study|Withdrawal by Subject|4|||
16122307|NCT00474526|38934441|FG008|Overall Study|Withdrawal by Subject|4|||
16122308|NCT00474526|38934442|FG009|Overall Study|Withdrawal by Subject|13|||
16122309|NCT00474526|38934443|FG010|Overall Study|Withdrawal by Subject|5|||
16122310|NCT00474526|38934444|FG011|Overall Study|Withdrawal by Subject|4|||
16122311|NCT00474526|38934445|FG012|Overall Study|Withdrawal by Subject|4|||
16122312|NCT00474526|38934446|FG013|Overall Study|Withdrawal by Subject|37|||
16122313|NCT00474526|38934447|FG014|Overall Study|Withdrawal by Subject|22|||
16122314|NCT00474526|38934448|FG015|Overall Study|Withdrawal by Subject|1|||
16122315|NCT00474526|38934449|FG016|Overall Study|Withdrawal by Subject|1|||
16122316|NCT00862719|38934450|FG000|Overall Study|Disease Progression|5|||
16122317|NCT00862719|38934451|FG001|Overall Study|Disease Progression|0|||
16122318|NCT00862719|38934452|FG002|Overall Study|Disease Progression|1|||
16122319|NCT00862719|38934453|FG003|Overall Study|Disease Progression|0|||
16122320|NCT00862719|38934450|FG000|Overall Study|Death|5|||
16122321|NCT00862719|38934451|FG001|Overall Study|Death|6|||
16122322|NCT00862719|38934452|FG002|Overall Study|Death|1|||
16122323|NCT00862719|38934453|FG003|Overall Study|Death|1|||
16122324|NCT00862719|38934450|FG000|Overall Study|Engraftment failure|0|||
16122325|NCT00862719|38934451|FG001|Overall Study|Engraftment failure|0|||
16122326|NCT00862719|38934452|FG002|Overall Study|Engraftment failure|1|||
16122327|NCT00862719|38934453|FG003|Overall Study|Engraftment failure|0|||
16122328|NCT00862719|38934450|FG000|Overall Study|Veno-Occlusive Disease|0|||
16122329|NCT00862719|38934451|FG001|Overall Study|Veno-Occlusive Disease|0|||
16122330|NCT00862719|38934452|FG002|Overall Study|Veno-Occlusive Disease|1|||
16122331|NCT00862719|38934453|FG003|Overall Study|Veno-Occlusive Disease|0|||
16122332|NCT00867308|38934454|FG000|Overall Study|Death|1|||
16122333|NCT00867308|38934455|FG001|Overall Study|Death|0|||
16122334|NCT00867308|38934454|FG000|Overall Study|Adverse Event|1|||
16122335|NCT00867308|38934455|FG001|Overall Study|Adverse Event|4|||
16122336|NCT00867308|38934454|FG000|Overall Study|Lack of Efficacy|6|||
16122337|NCT00867308|38934455|FG001|Overall Study|Lack of Efficacy|12|||
16122338|NCT00867308|38934454|FG000|Overall Study|Withdrawal by Subject|1|||
16122339|NCT00867308|38934455|FG001|Overall Study|Withdrawal by Subject|2|||
16122340|NCT00742326|38934459|FG000|Overall Study|Physician Decision|0|||
16122341|NCT00742326|38934460|FG001|Overall Study|Physician Decision|1|||
16122342|NCT04531904|38934462|FG000|Overall Study|Lost to Follow-up|1|||
16122343|NCT04531904|38934462|FG000|Overall Study|Death|14|||
16122344|NCT01374568|38934466|FG000|Overall Study|Lab unable to analyze BTM|0|||
16122345|NCT01374568|38934467|FG001|Overall Study|Lab unable to analyze BTM|2|||
16122346|NCT04655027|38934470|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
16122347|NCT04655027|38934471|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
16122348|NCT01806623|38934472|FG000|Overall Study|Withdrawal by Subject|1|||
16122349|NCT01806623|38934472|FG000|Overall Study|Adverse Event|1|||
16122350|NCT01806623|38934472|FG000|Overall Study|Did not meet the inclusion criteria|56|||
16122351|NCT02145468|38934473|FG000|Overall Study|Withdrawal by Subject|5|||
16122352|NCT02145468|38934474|FG001|Overall Study|Withdrawal by Subject|8|||
16122353|NCT03046121|38934475|FG000|Overall Study|Death|32|||
16122354|NCT03046121|38934476|FG001|Overall Study|Death|60|||
16122355|NCT03046121|38934475|FG000|Overall Study|Withdrawal by Subject|14|||
16122356|NCT03046121|38934476|FG001|Overall Study|Withdrawal by Subject|12|||
16122357|NCT04811131|38934498|FG000|Overall Study|Adverse Event|0|||
16122358|NCT04811131|38934499|FG001|Overall Study|Adverse Event|0|||
16122359|NCT04811131|38934500|FG002|Overall Study|Adverse Event|1|||
16122360|NCT04811131|38934501|FG003|Overall Study|Adverse Event|0|||
16122361|NCT04811131|38934498|FG000|Overall Study|Lack of Efficacy|0|||
16122362|NCT04811131|38934499|FG001|Overall Study|Lack of Efficacy|0|||
16122363|NCT04811131|38934500|FG002|Overall Study|Lack of Efficacy|0|||
16122364|NCT04811131|38934501|FG003|Overall Study|Lack of Efficacy|1|||
16122365|NCT04811131|38934498|FG000|Overall Study|Lost to Follow-up|0|||
16122366|NCT04811131|38934499|FG001|Overall Study|Lost to Follow-up|1|||
16122367|NCT04811131|38934500|FG002|Overall Study|Lost to Follow-up|0|||
16122368|NCT04811131|38934501|FG003|Overall Study|Lost to Follow-up|0|||
16122369|NCT04811131|38934498|FG000|Overall Study|Sponsor request|31|||
16122370|NCT04811131|38934499|FG001|Overall Study|Sponsor request|35|||
16122371|NCT04811131|38934500|FG002|Overall Study|Sponsor request|27|||
16122372|NCT04811131|38934501|FG003|Overall Study|Sponsor request|10|||
16122373|NCT04811131|38934498|FG000|Overall Study|Withdrawal by Subject|3|||
16122374|NCT04811131|38934499|FG001|Overall Study|Withdrawal by Subject|1|||
16122375|NCT04811131|38934500|FG002|Overall Study|Withdrawal by Subject|3|||
16122376|NCT04811131|38934501|FG003|Overall Study|Withdrawal by Subject|1|||
16122377|NCT00659880|38934502|FG000|Overall Study|Lost to Follow-up|5|||
16122378|NCT01559129|38934503|FG000|Treatment Phase|Adverse Event|0|||
16122379|NCT01559129|38934504|FG001|Treatment Phase|Adverse Event|2|||
16122380|NCT01559129|38934503|FG000|Treatment Phase|Progressive Disease|1|||
16122381|NCT01559129|38934504|FG001|Treatment Phase|Progressive Disease|1|||
16122382|NCT01559129|38934503|FG000|Treatment Phase|Lack of Efficacy|0|||
16122383|NCT01559129|38934504|FG001|Treatment Phase|Lack of Efficacy|1|||
16122384|NCT01559129|38934503|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
16122385|NCT01559129|38934504|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
16122386|NCT01559129|38934503|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
16122387|NCT01559129|38934504|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
16122388|NCT01559129|38934503|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
16122389|NCT01559129|38934504|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
16122390|NCT01559129|38934503|FG000|Open-label Extension Period|Adverse Event|1|||
16122391|NCT01559129|38934504|FG001|Open-label Extension Period|Adverse Event|0|||
16122392|NCT01559129|38934503|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
16122393|NCT01559129|38934504|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
16122394|NCT01531673|38934506|FG000|Overall Study|Non-Compliance|0|||
16122395|NCT01531673|38934507|FG001|Overall Study|Non-Compliance|0|||
16122396|NCT01531673|38934508|FG002|Overall Study|Non-Compliance|0|||
16122397|NCT01531673|38934509|FG003|Overall Study|Non-Compliance|0|||
16122398|NCT01531673|38934510|FG004|Overall Study|Non-Compliance|0|||
16122399|NCT01531673|38934511|FG005|Overall Study|Non-Compliance|1|||
16122400|NCT01531673|38934512|FG006|Overall Study|Non-Compliance|0|||
16122401|NCT01531673|38934513|FG007|Overall Study|Non-Compliance|0|||
16122402|NCT01531673|38934514|FG008|Overall Study|Non-Compliance|0|||
16122403|NCT01531673|38934515|FG009|Overall Study|Non-Compliance|0|||
16122404|NCT01531673|38934516|FG010|Overall Study|Non-Compliance|0|||
16122405|NCT01531673|38934517|FG011|Overall Study|Non-Compliance|0|||
16122406|NCT01531673|38934518|FG012|Overall Study|Non-Compliance|0|||
16122407|NCT01531673|38934506|FG000|Overall Study|Adverse Event|0|||
16122408|NCT01531673|38934507|FG001|Overall Study|Adverse Event|1|||
16122409|NCT01531673|38934508|FG002|Overall Study|Adverse Event|0|||
16122410|NCT01531673|38934509|FG003|Overall Study|Adverse Event|0|||
16122411|NCT01531673|38934510|FG004|Overall Study|Adverse Event|0|||
16122412|NCT01531673|38934511|FG005|Overall Study|Adverse Event|0|||
16122413|NCT01531673|38934512|FG006|Overall Study|Adverse Event|0|||
16122414|NCT01531673|38934513|FG007|Overall Study|Adverse Event|0|||
16122415|NCT01531673|38934514|FG008|Overall Study|Adverse Event|0|||
16122416|NCT01531673|38934515|FG009|Overall Study|Adverse Event|0|||
16122417|NCT01531673|38934516|FG010|Overall Study|Adverse Event|0|||
16122418|NCT01531673|38934517|FG011|Overall Study|Adverse Event|0|||
16122419|NCT01531673|38934518|FG012|Overall Study|Adverse Event|0|||
16122420|NCT01531673|38934506|FG000|Overall Study|Lost to Follow-up|0|||
16122421|NCT01531673|38934507|FG001|Overall Study|Lost to Follow-up|0|||
16122422|NCT01531673|38934508|FG002|Overall Study|Lost to Follow-up|0|||
16122423|NCT01531673|38934509|FG003|Overall Study|Lost to Follow-up|0|||
16122424|NCT01531673|38934510|FG004|Overall Study|Lost to Follow-up|1|||
16122425|NCT01531673|38934511|FG005|Overall Study|Lost to Follow-up|0|||
16122426|NCT01531673|38934512|FG006|Overall Study|Lost to Follow-up|0|||
16122427|NCT01531673|38934513|FG007|Overall Study|Lost to Follow-up|0|||
16122428|NCT01531673|38934514|FG008|Overall Study|Lost to Follow-up|0|||
16122429|NCT01531673|38934515|FG009|Overall Study|Lost to Follow-up|0|||
16122430|NCT01531673|38934516|FG010|Overall Study|Lost to Follow-up|0|||
16122431|NCT01531673|38934517|FG011|Overall Study|Lost to Follow-up|0|||
16122432|NCT01531673|38934518|FG012|Overall Study|Lost to Follow-up|0|||
16122433|NCT01531673|38934506|FG000|Overall Study|Other|0|||
16122434|NCT01531673|38934507|FG001|Overall Study|Other|0|||
16122435|NCT01531673|38934508|FG002|Overall Study|Other|0|||
16122436|NCT01531673|38934509|FG003|Overall Study|Other|1|||
16122437|NCT01531673|38934510|FG004|Overall Study|Other|0|||
16122438|NCT01531673|38934511|FG005|Overall Study|Other|0|||
16122439|NCT01531673|38934512|FG006|Overall Study|Other|0|||
16122440|NCT01531673|38934513|FG007|Overall Study|Other|0|||
16122441|NCT01531673|38934514|FG008|Overall Study|Other|0|||
16122442|NCT01531673|38934515|FG009|Overall Study|Other|1|||
16122443|NCT01531673|38934516|FG010|Overall Study|Other|0|||
16122444|NCT01531673|38934517|FG011|Overall Study|Other|0|||
16122445|NCT01531673|38934518|FG012|Overall Study|Other|0|||
16122446|NCT00910039|38934520|FG000|Overall Study|Physician Decision|1|||
16122447|NCT02930226|38934522|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
16122448|NCT02930226|38934523|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
16122449|NCT02930226|38934524|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
16122450|NCT02930226|38934525|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
16122451|NCT02930226|38934526|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
16122452|NCT02930226|38934527|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
16122453|NCT01803282|38934531|FG000|Overall Study|Progressive Disease|4|||
16122454|NCT01803282|38934532|FG001|Overall Study|Progressive Disease|3|||
16122455|NCT01803282|38934533|FG002|Overall Study|Progressive Disease|6|||
16122456|NCT01803282|38934534|FG003|Overall Study|Progressive Disease|22|||
16122457|NCT01803282|38934535|FG004|Overall Study|Progressive Disease|5|||
16122458|NCT01803282|38934536|FG005|Overall Study|Progressive Disease|8|||
16122459|NCT01803282|38934537|FG006|Overall Study|Progressive Disease|23|||
16122460|NCT01803282|38934538|FG007|Overall Study|Progressive Disease|24|||
16122461|NCT01803282|38934539|FG008|Overall Study|Progressive Disease|3|||
16122462|NCT01803282|38934540|FG009|Overall Study|Progressive Disease|29|||
16414184|NCT01617447|39998343|FG001|Overall Study|Adverse Event|1|||
16414185|NCT01617447|39998342|FG000|Overall Study|Physician Decision|0|||
16122463|NCT01803282|38934541|FG010|Overall Study|Progressive Disease|6|||
16122464|NCT01803282|38934542|FG011|Overall Study|Progressive Disease|11|||
16122465|NCT01803282|38934531|FG000|Overall Study|Death|0|||
16122466|NCT01803282|38934532|FG001|Overall Study|Death|0|||
16122467|NCT01803282|38934533|FG002|Overall Study|Death|0|||
16122468|NCT01803282|38934534|FG003|Overall Study|Death|0|||
16122469|NCT01803282|38934535|FG004|Overall Study|Death|2|||
16122470|NCT01803282|38934536|FG005|Overall Study|Death|1|||
16122471|NCT01803282|38934537|FG006|Overall Study|Death|1|||
16122472|NCT01803282|38934538|FG007|Overall Study|Death|5|||
16122473|NCT01803282|38934539|FG008|Overall Study|Death|1|||
16122474|NCT01803282|38934540|FG009|Overall Study|Death|1|||
16122475|NCT01803282|38934541|FG010|Overall Study|Death|0|||
16122476|NCT01803282|38934542|FG011|Overall Study|Death|0|||
16122477|NCT01803282|38934531|FG000|Overall Study|Withdrew Consent|0|||
16122478|NCT01803282|38934532|FG001|Overall Study|Withdrew Consent|0|||
16122479|NCT01803282|38934533|FG002|Overall Study|Withdrew Consent|0|||
16122480|NCT01803282|38934534|FG003|Overall Study|Withdrew Consent|6|||
16122481|NCT01803282|38934535|FG004|Overall Study|Withdrew Consent|1|||
16122482|NCT01803282|38934536|FG005|Overall Study|Withdrew Consent|0|||
16122483|NCT01803282|38934537|FG006|Overall Study|Withdrew Consent|8|||
16122484|NCT01803282|38934538|FG007|Overall Study|Withdrew Consent|3|||
16122485|NCT01803282|38934539|FG008|Overall Study|Withdrew Consent|1|||
16122486|NCT01803282|38934540|FG009|Overall Study|Withdrew Consent|5|||
16122487|NCT01803282|38934541|FG010|Overall Study|Withdrew Consent|0|||
16122488|NCT01803282|38934542|FG011|Overall Study|Withdrew Consent|1|||
16122489|NCT01803282|38934531|FG000|Overall Study|Investigator's Discretion|0|||
16122490|NCT01803282|38934532|FG001|Overall Study|Investigator's Discretion|0|||
16122491|NCT01803282|38934533|FG002|Overall Study|Investigator's Discretion|0|||
16122492|NCT01803282|38934534|FG003|Overall Study|Investigator's Discretion|7|||
16122493|NCT01803282|38934535|FG004|Overall Study|Investigator's Discretion|2|||
16122494|NCT01803282|38934536|FG005|Overall Study|Investigator's Discretion|1|||
16122495|NCT01803282|38934537|FG006|Overall Study|Investigator's Discretion|7|||
16122496|NCT01803282|38934538|FG007|Overall Study|Investigator's Discretion|10|||
16122497|NCT01803282|38934539|FG008|Overall Study|Investigator's Discretion|6|||
16122498|NCT01803282|38934540|FG009|Overall Study|Investigator's Discretion|7|||
16122499|NCT01803282|38934541|FG010|Overall Study|Investigator's Discretion|1|||
16122500|NCT01803282|38934542|FG011|Overall Study|Investigator's Discretion|0|||
16122501|NCT01803282|38934531|FG000|Overall Study|Adverse Event|0|||
16122502|NCT01803282|38934532|FG001|Overall Study|Adverse Event|0|||
16122503|NCT01803282|38934533|FG002|Overall Study|Adverse Event|0|||
16122504|NCT01803282|38934534|FG003|Overall Study|Adverse Event|0|||
16122505|NCT01803282|38934535|FG004|Overall Study|Adverse Event|0|||
16122506|NCT01803282|38934536|FG005|Overall Study|Adverse Event|0|||
16122507|NCT01803282|38934537|FG006|Overall Study|Adverse Event|1|||
16122508|NCT01803282|38934538|FG007|Overall Study|Adverse Event|2|||
16122509|NCT01803282|38934539|FG008|Overall Study|Adverse Event|0|||
16122510|NCT01803282|38934540|FG009|Overall Study|Adverse Event|1|||
16122511|NCT01803282|38934541|FG010|Overall Study|Adverse Event|0|||
16122512|NCT01803282|38934542|FG011|Overall Study|Adverse Event|3|||
16122513|NCT01803282|38934531|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16122514|NCT01803282|38934532|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16122515|NCT01803282|38934533|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16122516|NCT01803282|38934534|FG003|Overall Study|Non-Compliance with Study Drug|1|||
16122517|NCT01803282|38934535|FG004|Overall Study|Non-Compliance with Study Drug|0|||
16122518|NCT01803282|38934536|FG005|Overall Study|Non-Compliance with Study Drug|0|||
16122519|NCT01803282|38934537|FG006|Overall Study|Non-Compliance with Study Drug|0|||
16122520|NCT01803282|38934538|FG007|Overall Study|Non-Compliance with Study Drug|0|||
16122521|NCT01803282|38934539|FG008|Overall Study|Non-Compliance with Study Drug|0|||
16122522|NCT01803282|38934540|FG009|Overall Study|Non-Compliance with Study Drug|0|||
16350050|NCT03286218|39768956|FG005|Qualification Phase Period 1|Adverse Event|0|||
16350051|NCT03286218|39768957|FG006|Qualification Phase Period 1|Adverse Event|0|||
16350052|NCT03286218|39768958|FG007|Qualification Phase Period 1|Adverse Event|0|||
16350053|NCT03286218|39768959|FG008|Qualification Phase Period 1|Adverse Event|0|||
16350054|NCT03286218|39768960|FG009|Qualification Phase Period 1|Adverse Event|0|||
16350055|NCT03286218|39768961|FG010|Qualification Phase Period 1|Adverse Event|0|||
16350056|NCT03286218|39768962|FG011|Qualification Phase Period 1|Adverse Event|0|||
16350057|NCT03286218|39768951|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
16350058|NCT03286218|39768952|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
16350059|NCT03286218|39768953|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
16350060|NCT03286218|39768954|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
16350061|NCT03286218|39768955|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
16350062|NCT03286218|39768956|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
16414186|NCT01617447|39998343|FG001|Overall Study|Physician Decision|2|||
16414187|NCT05943990|39998345|FG000|Overall Study|Study Terminated by Sponsor|0|||
16122523|NCT01803282|38934541|FG010|Overall Study|Non-Compliance with Study Drug|0|||
16122524|NCT01803282|38934542|FG011|Overall Study|Non-Compliance with Study Drug|0|||
16122525|NCT01803282|38934531|FG000|Overall Study|Unknown Reason|0|||
16122526|NCT01803282|38934532|FG001|Overall Study|Unknown Reason|0|||
16122527|NCT01803282|38934533|FG002|Overall Study|Unknown Reason|0|||
16122528|NCT01803282|38934534|FG003|Overall Study|Unknown Reason|0|||
16122529|NCT01803282|38934535|FG004|Overall Study|Unknown Reason|0|||
16122530|NCT01803282|38934536|FG005|Overall Study|Unknown Reason|0|||
16122531|NCT01803282|38934537|FG006|Overall Study|Unknown Reason|0|||
16122532|NCT01803282|38934538|FG007|Overall Study|Unknown Reason|1|||
16122533|NCT01803282|38934539|FG008|Overall Study|Unknown Reason|0|||
16122534|NCT01803282|38934540|FG009|Overall Study|Unknown Reason|0|||
16122535|NCT01803282|38934541|FG010|Overall Study|Unknown Reason|0|||
16122536|NCT01803282|38934542|FG011|Overall Study|Unknown Reason|0|||
16122537|NCT01803282|38934531|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
16122538|NCT01803282|38934532|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
16122539|NCT01803282|38934533|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
16122540|NCT01803282|38934534|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
16122541|NCT01803282|38934535|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
16122542|NCT01803282|38934536|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
16122543|NCT01803282|38934537|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
16122544|NCT01803282|38934538|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
16122545|NCT01803282|38934539|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
16122546|NCT01803282|38934540|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
16122547|NCT01803282|38934541|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
16122548|NCT01803282|38934542|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
16122549|NCT01803282|38934531|FG000|Overall Study|Enrolled but Never Treated|0|||
16122550|NCT01803282|38934532|FG001|Overall Study|Enrolled but Never Treated|0|||
16122551|NCT01803282|38934533|FG002|Overall Study|Enrolled but Never Treated|0|||
16122552|NCT01803282|38934534|FG003|Overall Study|Enrolled but Never Treated|0|||
16122553|NCT01803282|38934535|FG004|Overall Study|Enrolled but Never Treated|1|||
16122554|NCT01803282|38934536|FG005|Overall Study|Enrolled but Never Treated|0|||
16122555|NCT01803282|38934537|FG006|Overall Study|Enrolled but Never Treated|1|||
16122556|NCT01803282|38934538|FG007|Overall Study|Enrolled but Never Treated|1|||
16122557|NCT01803282|38934539|FG008|Overall Study|Enrolled but Never Treated|0|||
16122558|NCT01803282|38934540|FG009|Overall Study|Enrolled but Never Treated|1|||
16122559|NCT01803282|38934541|FG010|Overall Study|Enrolled but Never Treated|0|||
16122560|NCT01803282|38934542|FG011|Overall Study|Enrolled but Never Treated|0|||
16122561|NCT04145700|38934543|FG000|Overall Study|Withdrawal by Subject|8|||
16122562|NCT04145700|38934544|FG001|Overall Study|Withdrawal by Subject|3|||
16122563|NCT01022112|38934545|FG000|Overall Study|Adverse Event|1|||
16122564|NCT01022112|38934546|FG001|Overall Study|Adverse Event|2|||
16556278|NCT01003639|40500017|FG000|Overall Study|Withdrawal by Subject|9|||
16556279|NCT01003639|40500018|FG001|Overall Study|Withdrawal by Subject|5|||
16556280|NCT01003639|40500017|FG000|Overall Study|Lack of Efficacy|1|||
16556281|NCT01003639|40500018|FG001|Overall Study|Lack of Efficacy|6|||
16556282|NCT01003639|40500017|FG000|Overall Study|Adverse Event|0|||
16556283|NCT01003639|40500018|FG001|Overall Study|Adverse Event|1|||
16556284|NCT01003639|40500017|FG000|Overall Study|Protocol Violation|0|||
16122565|NCT01022112|38934547|FG002|Overall Study|Adverse Event|0|||
16122566|NCT01022112|38934548|FG003|Overall Study|Adverse Event|1|||
16122567|NCT01022112|38934549|FG004|Overall Study|Adverse Event|0|||
16122568|NCT01022112|38934545|FG000|Overall Study|Lack of Efficacy|1|||
16122569|NCT01022112|38934546|FG001|Overall Study|Lack of Efficacy|0|||
16122570|NCT01022112|38934547|FG002|Overall Study|Lack of Efficacy|0|||
16122571|NCT01022112|38934548|FG003|Overall Study|Lack of Efficacy|0|||
16122572|NCT01022112|38934549|FG004|Overall Study|Lack of Efficacy|1|||
16122573|NCT01022112|38934545|FG000|Overall Study|Physician Decision|0|||
16122574|NCT01022112|38934546|FG001|Overall Study|Physician Decision|0|||
16122575|NCT01022112|38934547|FG002|Overall Study|Physician Decision|1|||
16122576|NCT01022112|38934548|FG003|Overall Study|Physician Decision|0|||
16122577|NCT01022112|38934549|FG004|Overall Study|Physician Decision|1|||
16122578|NCT01022112|38934545|FG000|Overall Study|Withdrawal by Subject|0|||
16122579|NCT01022112|38934546|FG001|Overall Study|Withdrawal by Subject|1|||
16122580|NCT01022112|38934547|FG002|Overall Study|Withdrawal by Subject|2|||
16122581|NCT01022112|38934548|FG003|Overall Study|Withdrawal by Subject|2|||
16122582|NCT01022112|38934549|FG004|Overall Study|Withdrawal by Subject|1|||
16122583|NCT01022112|38934545|FG000|Overall Study|Fasting plasma glucose level increased|1|||
16122584|NCT01022112|38934546|FG001|Overall Study|Fasting plasma glucose level increased|0|||
16122585|NCT01022112|38934547|FG002|Overall Study|Fasting plasma glucose level increased|0|||
16122586|NCT01022112|38934548|FG003|Overall Study|Fasting plasma glucose level increased|0|||
16122587|NCT01022112|38934549|FG004|Overall Study|Fasting plasma glucose level increased|7|||
16122588|NCT01519089|38934550|FG000|Overall Study|Adverse Event|4|||
16122589|NCT01519089|38934551|FG001|Overall Study|Adverse Event|4|||
16122590|NCT01519089|38934550|FG000|Overall Study|Lack of Efficacy|0|||
16122591|NCT01519089|38934551|FG001|Overall Study|Lack of Efficacy|2|||
16122592|NCT01519089|38934550|FG000|Overall Study|Lost to Follow-up|1|||
16122593|NCT01519089|38934551|FG001|Overall Study|Lost to Follow-up|0|||
16122594|NCT01519089|38934550|FG000|Overall Study|Withdrawal by Subject|0|||
16122595|NCT01519089|38934551|FG001|Overall Study|Withdrawal by Subject|2|||
16122596|NCT01519089|38934550|FG000|Overall Study|Other|2|||
16122597|NCT01519089|38934551|FG001|Overall Study|Other|6|||
16122598|NCT01519089|38934550|FG000|Overall Study|Not received study drug|0|||
16122599|NCT01519089|38934551|FG001|Overall Study|Not received study drug|1|||
16414188|NCT05943990|39998346|FG001|Overall Study|Study Terminated by Sponsor|0|||
16122600|NCT03921723|38934552|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
16556285|NCT01003639|40500018|FG001|Overall Study|Protocol Violation|1|||
16122601|NCT03921723|38934552|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
16556286|NCT01003639|40500017|FG000|Overall Study|Physician Decision|1|||
16556287|NCT01003639|40500018|FG001|Overall Study|Physician Decision|0|||
16556288|NCT02950545|40500024|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
16556289|NCT02950545|40500025|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
16556290|NCT02950545|40500026|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
16556291|NCT02950545|40500027|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
16556292|NCT02950545|40500028|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
16556293|NCT02950545|40500029|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
16556294|NCT02950545|40500024|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
16556295|NCT02950545|40500025|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
16556296|NCT02950545|40500026|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
16556297|NCT02950545|40500027|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
16556298|NCT02950545|40500028|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
16556299|NCT02950545|40500029|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
16556300|NCT02950545|40500024|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
16556301|NCT02950545|40500025|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
16556302|NCT02950545|40500026|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
16556303|NCT02950545|40500027|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
16556304|NCT02950545|40500028|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
16556305|NCT02950545|40500029|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
16556306|NCT02950545|40500024|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
16556307|NCT02950545|40500025|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
16556308|NCT02950545|40500026|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
16556309|NCT02950545|40500027|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
16556310|NCT02950545|40500028|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
16556311|NCT02950545|40500029|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
16556312|NCT02950545|40500024|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
16556313|NCT02950545|40500025|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
16556314|NCT02950545|40500026|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
16556315|NCT02950545|40500027|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
16556316|NCT02950545|40500028|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
16556317|NCT02950545|40500029|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
16556318|NCT04537949|40500034|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
16556319|NCT04537949|40500035|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
16556320|NCT04537949|40500036|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
16556321|NCT04537949|40500037|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
16556322|NCT04537949|40500038|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
16556323|NCT04537949|40500039|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
16556324|NCT04537949|40500040|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
16556325|NCT04537949|40500041|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
16556326|NCT04537949|40500034|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
16556327|NCT04537949|40500035|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
16556328|NCT04537949|40500036|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
16556329|NCT04537949|40500037|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
16556330|NCT04537949|40500038|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
16556331|NCT04537949|40500039|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
16556332|NCT04537949|40500040|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
16556333|NCT04537949|40500041|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
16556334|NCT04537949|40500034|FG000|Follow-up Phase|Lost to Follow-up|0|||
16238427|NCT02200614|39357582|FG001|Double Blind Treatment|Judgment of the investigator|99|||
16238428|NCT02200614|39357581|FG000|Double Blind Treatment|Metastasis by local reading|1|||
16238429|NCT02200614|39357582|FG001|Double Blind Treatment|Metastasis by local reading|3|||
16238430|NCT02200614|39357581|FG000|Double Blind Treatment|Other reason|6|||
16238431|NCT02200614|39357582|FG001|Double Blind Treatment|Other reason|2|||
16238432|NCT02200614|39357581|FG000|Double Blind Treatment|Personal reason|77|||
16238433|NCT02200614|39357582|FG001|Double Blind Treatment|Personal reason|85|||
16238434|NCT02200614|39357581|FG000|Double Blind Treatment|Protocol deviation|14|||
16238435|NCT02200614|39357582|FG001|Double Blind Treatment|Protocol deviation|7|||
16238436|NCT02200614|39357581|FG000|Double Blind Treatment|Not treated|1|||
16238437|NCT02200614|39357582|FG001|Double Blind Treatment|Not treated|0|||
16238438|NCT02200614|39357581|FG000|Open Label|Adverse Event|41|||
16238439|NCT02200614|39357582|FG001|Open Label|Adverse Event|11|||
16238440|NCT02200614|39357581|FG000|Open Label|Confirmed metastasis|1|||
16350063|NCT03286218|39768957|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
16350064|NCT03286218|39768958|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
16350065|NCT03286218|39768959|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
16350066|NCT03286218|39768960|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
16350067|NCT03286218|39768961|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
16350068|NCT03286218|39768962|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
16350069|NCT03286218|39768951|FG000|Qualification Phase Period 2|Adverse Event|0|||
16350070|NCT03286218|39768952|FG001|Qualification Phase Period 2|Adverse Event|1|||
16350071|NCT03286218|39768953|FG002|Qualification Phase Period 2|Adverse Event|0|||
16350072|NCT03286218|39768954|FG003|Qualification Phase Period 2|Adverse Event|0|||
16350073|NCT03286218|39768955|FG004|Qualification Phase Period 2|Adverse Event|0|||
16350074|NCT03286218|39768956|FG005|Qualification Phase Period 2|Adverse Event|0|||
16350075|NCT03286218|39768957|FG006|Qualification Phase Period 2|Adverse Event|0|||
16350076|NCT03286218|39768958|FG007|Qualification Phase Period 2|Adverse Event|0|||
16350077|NCT03286218|39768959|FG008|Qualification Phase Period 2|Adverse Event|0|||
16350078|NCT03286218|39768960|FG009|Qualification Phase Period 2|Adverse Event|0|||
16350079|NCT03286218|39768961|FG010|Qualification Phase Period 2|Adverse Event|0|||
16350080|NCT03286218|39768962|FG011|Qualification Phase Period 2|Adverse Event|0|||
16350081|NCT03286218|39768951|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
16350082|NCT03286218|39768952|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
16350083|NCT03286218|39768953|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16350084|NCT03286218|39768954|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16350085|NCT03286218|39768955|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16350086|NCT03286218|39768956|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16350087|NCT03286218|39768957|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16238441|NCT02200614|39357582|FG001|Open Label|Confirmed metastasis|0|||
16238442|NCT02200614|39357581|FG000|Open Label|Judgment of the investigator|29|||
16238443|NCT02200614|39357582|FG001|Open Label|Judgment of the investigator|2|||
16350088|NCT03286218|39768958|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16122602|NCT01685229|38934555|FG000|Overall Study|Subjects missing Study Exit form|3|||
16122603|NCT01685229|38934556|FG001|Overall Study|Subjects missing Study Exit form|1|||
16122604|NCT01685229|38934555|FG000|Overall Study|Lost to Follow-up|16|||
16122605|NCT01685229|38934556|FG001|Overall Study|Lost to Follow-up|10|||
16122606|NCT01685229|38934555|FG000|Overall Study|Withdrawal by Subject|6|||
16122607|NCT01685229|38934556|FG001|Overall Study|Withdrawal by Subject|5|||
16122608|NCT01685229|38934555|FG000|Overall Study|Death|1|||
16122609|NCT01685229|38934556|FG001|Overall Study|Death|0|||
16122610|NCT01080326|38934557|FG000|Overall Study|Patient deterioration prior to procedure|3|||
16122611|NCT01080326|38934557|FG000|Overall Study|Surgeon decision|1|||
16122612|NCT00958841|38934558|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16122613|NCT00958841|38934558|FG000|Overall Study|Abnormal test procedure result(s)|3|||
16122614|NCT00958841|38934558|FG000|Overall Study|Administrative problems|1|||
16122615|NCT00958841|38934558|FG000|Overall Study|Adverse Event|8|||
16122616|NCT00958841|38934558|FG000|Overall Study|New cancer therapy|5|||
16122617|NCT00958841|38934558|FG000|Overall Study|Withdrawal by Subject|1|||
16122618|NCT00958841|38934558|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
16122619|NCT00958841|38934558|FG000|Overall Study|Completed M6/did not enter extension|27|||
16122620|NCT00958841|38934558|FG000|Overall Study|Discontinued prior to M*|28|||
16122621|NCT05032872|38934563|FG000|Overall Study|Adverse Event|1|||
16122622|NCT05032872|38934564|FG001|Overall Study|Adverse Event|0|||
16122623|NCT05032872|38934563|FG000|Overall Study|Lost to Follow-up|2|||
16122624|NCT05032872|38934564|FG001|Overall Study|Lost to Follow-up|4|||
16122625|NCT05032872|38934563|FG000|Overall Study|Withdrawal by Subject|4|||
16122626|NCT05032872|38934564|FG001|Overall Study|Withdrawal by Subject|3|||
16122627|NCT02949362|38934569|FG000|Retrospective Period|Inform consent not signed by participant|4|||
16122628|NCT02949362|38934570|FG001|Retrospective Period|Inform consent not signed by participant|1|||
16122629|NCT02949362|38934571|FG002|Retrospective Period|Inform consent not signed by participant|0|||
16122630|NCT02949362|38934572|FG003|Retrospective Period|Inform consent not signed by participant|0|||
16122631|NCT02949362|38934569|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
16122632|NCT02949362|38934570|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
16122633|NCT02949362|38934571|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
16122634|NCT02949362|38934572|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
16122635|NCT02949362|38934569|FG000|Prospective Period|Other|0|||
16122636|NCT02949362|38934570|FG001|Prospective Period|Other|0|||
16122637|NCT02949362|38934571|FG002|Prospective Period|Other|0|||
16122638|NCT02949362|38934572|FG003|Prospective Period|Other|4|||
16122639|NCT04076943|38934573|FG000|Overall Study|Withdrawal by Subject|12|||
16122640|NCT04076943|38934573|FG000|Overall Study|Adverse Event|1|||
16122641|NCT04076943|38934573|FG000|Overall Study|Progressive Disease|2|||
16122642|NCT04076943|38934573|FG000|Overall Study|Death|13|||
16122643|NCT04076943|38934573|FG000|Overall Study|Other than specified|6|||
16122644|NCT00929110|38934578|FG000|Overall Study|Adverse Event|40|||
16122645|NCT00929110|38934579|FG001|Overall Study|Adverse Event|29|||
16122646|NCT00929110|38934580|FG002|Overall Study|Adverse Event|18|||
16122647|NCT00929110|38934578|FG000|Overall Study|Subject withdrew consent|40|||
16122648|NCT00929110|38934579|FG001|Overall Study|Subject withdrew consent|23|||
16122649|NCT00929110|38934580|FG002|Overall Study|Subject withdrew consent|26|||
16122650|NCT00929110|38934578|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
16122651|NCT00929110|38934579|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
16122652|NCT00929110|38934580|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
16122653|NCT00929110|38934578|FG000|Overall Study|Lost to Follow-up|7|||
16122654|NCT00929110|38934579|FG001|Overall Study|Lost to Follow-up|7|||
16122655|NCT00929110|38934580|FG002|Overall Study|Lost to Follow-up|3|||
16122656|NCT00929110|38934578|FG000|Overall Study|Protocol deviation|5|||
16122657|NCT00929110|38934579|FG001|Overall Study|Protocol deviation|2|||
16122658|NCT00929110|38934580|FG002|Overall Study|Protocol deviation|4|||
16122659|NCT00929110|38934578|FG000|Overall Study|Administrative problems|4|||
16122660|NCT00929110|38934579|FG001|Overall Study|Administrative problems|1|||
16122661|NCT00929110|38934580|FG002|Overall Study|Administrative problems|2|||
16122662|NCT00929110|38934578|FG000|Overall Study|Death|2|||
16122663|NCT00929110|38934579|FG001|Overall Study|Death|2|||
16122664|NCT00929110|38934580|FG002|Overall Study|Death|2|||
16350089|NCT03286218|39768959|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16350090|NCT03286218|39768960|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16556335|NCT04537949|40500035|FG001|Follow-up Phase|Lost to Follow-up|3|||
16556336|NCT04537949|40500036|FG002|Follow-up Phase|Lost to Follow-up|0|||
16556337|NCT04537949|40500037|FG003|Follow-up Phase|Lost to Follow-up|0|||
16556338|NCT04537949|40500038|FG004|Follow-up Phase|Lost to Follow-up|0|||
16556339|NCT04537949|40500039|FG005|Follow-up Phase|Lost to Follow-up|0|||
16556340|NCT04537949|40500040|FG006|Follow-up Phase|Lost to Follow-up|0|||
16556341|NCT04537949|40500041|FG007|Follow-up Phase|Lost to Follow-up|0|||
16556342|NCT04537949|40500034|FG000|Follow-up Phase|personal reasons|0|||
16556343|NCT04537949|40500035|FG001|Follow-up Phase|personal reasons|0|||
16238444|NCT02200614|39357581|FG000|Open Label|Metastasis by local reading|138|||
16238445|NCT02200614|39357582|FG001|Open Label|Metastasis by local reading|27|||
16238446|NCT02200614|39357581|FG000|Open Label|Other reason|22|||
16238447|NCT02200614|39357582|FG001|Open Label|Other reason|4|||
16238448|NCT02200614|39357581|FG000|Open Label|Personal reason|60|||
16238449|NCT02200614|39357582|FG001|Open Label|Personal reason|8|||
16238450|NCT02200614|39357581|FG000|Open Label|Protocol deviation|3|||
16238451|NCT02200614|39357582|FG001|Open Label|Protocol deviation|2|||
16238452|NCT02200614|39357581|FG000|Open Label|Missing|2|||
16238453|NCT02200614|39357582|FG001|Open Label|Missing|2|||
16238454|NCT04465916|39357583|FG000|Overall Study|Withdrawal by Subject|0|||
16238455|NCT04465916|39357584|FG001|Overall Study|Withdrawal by Subject|1|||
16238456|NCT01185639|39357587|FG000|Overall Study|Progressed and didn't receive therapy|2|||
16238457|NCT00552617|39357590|FG000|Overall Study|Not Treated|0|||
16238458|NCT00552617|39357591|FG001|Overall Study|Not Treated|0|||
16238459|NCT00552617|39357592|FG002|Overall Study|Not Treated|1|||
16238460|NCT00552617|39357593|FG003|Overall Study|Not Treated|0|||
16238461|NCT00552617|39357594|FG004|Overall Study|Not Treated|0|||
16238462|NCT00552617|39357595|FG005|Overall Study|Not Treated|0|||
16238463|NCT00552617|39357596|FG006|Overall Study|Not Treated|0|||
16238464|NCT00552617|39357597|FG007|Overall Study|Not Treated|0|||
16238465|NCT00552617|39357598|FG008|Overall Study|Not Treated|0|||
16238466|NCT00552617|39357599|FG009|Overall Study|Not Treated|1|||
16238467|NCT00552617|39357590|FG000|Overall Study|Lost to Follow-up|0|||
16238468|NCT00552617|39357591|FG001|Overall Study|Lost to Follow-up|0|||
16238469|NCT00552617|39357592|FG002|Overall Study|Lost to Follow-up|0|||
16238470|NCT00552617|39357593|FG003|Overall Study|Lost to Follow-up|1|||
16238471|NCT00552617|39357594|FG004|Overall Study|Lost to Follow-up|0|||
16238472|NCT00552617|39357595|FG005|Overall Study|Lost to Follow-up|2|||
16238473|NCT00552617|39357596|FG006|Overall Study|Lost to Follow-up|0|||
16238474|NCT00552617|39357597|FG007|Overall Study|Lost to Follow-up|0|||
16238475|NCT00552617|39357598|FG008|Overall Study|Lost to Follow-up|2|||
16238476|NCT00552617|39357599|FG009|Overall Study|Lost to Follow-up|0|||
16238477|NCT00420290|39357600|FG000|Overall Study|Adverse Event|3|||
16238478|NCT00420290|39357601|FG001|Overall Study|Adverse Event|1|||
16238479|NCT00420290|39357600|FG000|Overall Study|Withdrawal by Subject|0|||
16238480|NCT00420290|39357601|FG001|Overall Study|Withdrawal by Subject|2|||
16238481|NCT00420290|39357600|FG000|Overall Study|did not meet inclusion/exclusion|1|||
16238482|NCT00420290|39357601|FG001|Overall Study|did not meet inclusion/exclusion|1|||
16350091|NCT03286218|39768961|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16350092|NCT03286218|39768962|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
16350093|NCT03286218|39768951|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
16350094|NCT03286218|39768952|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
16350095|NCT03286218|39768953|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
16556344|NCT04537949|40500036|FG002|Follow-up Phase|personal reasons|0|||
16238483|NCT00530439|39357605|FG000|Overall Study|GDM|9|||
16238484|NCT00530439|39357606|FG001|Overall Study|GDM|3|||
16238485|NCT00530439|39357605|FG000|Overall Study|Withdraw|18|||
16238486|NCT00530439|39357606|FG001|Overall Study|Withdraw|14|||
16556345|NCT04537949|40500037|FG003|Follow-up Phase|personal reasons|1|||
16238487|NCT00530439|39357605|FG000|Overall Study|Missed abortion|1|||
16238488|NCT00530439|39357606|FG001|Overall Study|Missed abortion|4|||
16238489|NCT00530439|39357605|FG000|Overall Study|Misclassification|2|||
16238490|NCT00530439|39357606|FG001|Overall Study|Misclassification|0|||
16238491|NCT00530439|39357605|FG000|Overall Study|Twin pregnancy|0|||
16238492|NCT00530439|39357606|FG001|Overall Study|Twin pregnancy|2|||
16238493|NCT00530439|39357605|FG000|Overall Study|Severe malformation/abortion|0|||
16238494|NCT00530439|39357606|FG001|Overall Study|Severe malformation/abortion|3|||
16238495|NCT03959137|39357607|FG000|Overall Study|Protocol Violation|6|||
16238496|NCT01205529|39357611|FG000|Overall Study|Procedure Cancelled|4|||
16238497|NCT01205529|39357611|FG000|Overall Study|Withdrawal by Subject|2|||
16238498|NCT01205529|39357611|FG000|Overall Study|Physician Decision|4|||
16238499|NCT01205529|39357611|FG000|Overall Study|Unstable post op|15|||
16238500|NCT01205529|39357611|FG000|Overall Study|No longer met criteria|30|||
16238501|NCT04723173|39357613|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
16238502|NCT02499406|39357614|FG000|Overall Study|missed 3 treatment sessions|4|||
16238503|NCT00849524|39357615|FG000|Overall Study|Lack of Efficacy|3|||
16238504|NCT01858558|39357618|FG000|Overall Study|Death|1|||
16238505|NCT01858558|39357619|FG001|Overall Study|Death|1|||
16238506|NCT01858558|39357618|FG000|Overall Study|Lost to Follow-up|1|||
16238507|NCT01858558|39357619|FG001|Overall Study|Lost to Follow-up|0|||
16238508|NCT01858558|39357618|FG000|Overall Study|Disease progression|3|||
16238509|NCT01858558|39357619|FG001|Overall Study|Disease progression|1|||
16238510|NCT01858558|39357618|FG000|Overall Study|Product contamination|2|||
16238511|NCT01858558|39357619|FG001|Overall Study|Product contamination|0|||
16238512|NCT01858558|39357618|FG000|Overall Study|Failed expansion of cell product|2|||
16238513|NCT01858558|39357619|FG001|Overall Study|Failed expansion of cell product|0|||
16238514|NCT00666718|39357622|FG000|Overall Study|Adverse Event|0|||
16238515|NCT00666718|39357623|FG001|Overall Study|Adverse Event|1|||
16238516|NCT00666718|39357622|FG000|Overall Study|Death|1|||
16238517|NCT00666718|39357623|FG001|Overall Study|Death|0|||
16238518|NCT00666718|39357622|FG000|Overall Study|Lost to Follow-up|1|||
16238519|NCT00666718|39357623|FG001|Overall Study|Lost to Follow-up|0|||
16238520|NCT00666718|39357622|FG000|Overall Study|Entry Criteria Not Met|2|||
16238521|NCT00666718|39357623|FG001|Overall Study|Entry Criteria Not Met|0|||
16238522|NCT00666718|39357622|FG000|Overall Study|Protocol Violation|1|||
16238523|NCT00666718|39357623|FG001|Overall Study|Protocol Violation|3|||
16238524|NCT00666718|39357622|FG000|Overall Study|Withdrawal by Subject|7|||
16238525|NCT00666718|39357623|FG001|Overall Study|Withdrawal by Subject|12|||
16238526|NCT00666718|39357622|FG000|Overall Study|Physician Decision|0|||
16238527|NCT00666718|39357623|FG001|Overall Study|Physician Decision|2|||
16238528|NCT00515073|39357631|FG000|Overall Study|Withdrawal by Subject|1|||
16238529|NCT00515073|39357631|FG000|Overall Study|Physician Decision|1|||
16238530|NCT04247594|39357632|FG000|Overall Study|Withdrawal by Subject|4|||
16238531|NCT03547531|39357633|FG000|Overall Study|not coming in data collection : sick|2|||
16238532|NCT03547531|39357634|FG001|Overall Study|not coming in data collection : sick|2|||
16238533|NCT03547531|39357633|FG000|Overall Study|having family occasion|0|||
16238534|NCT03547531|39357634|FG001|Overall Study|having family occasion|2|||
16238535|NCT00291330|39357639|FG000|Overall Study|Adverse Event|47|||
16238536|NCT00291330|39357640|FG001|Overall Study|Adverse Event|40|||
16238537|NCT00291330|39357639|FG000|Overall Study|Protocol Violation|13|||
16238538|NCT00291330|39357640|FG001|Overall Study|Protocol Violation|20|||
16238539|NCT00291330|39357639|FG000|Overall Study|Lost to Follow-up|16|||
16238540|NCT00291330|39357640|FG001|Overall Study|Lost to Follow-up|11|||
16238541|NCT00291330|39357639|FG000|Overall Study|Withdrawal by Subject|22|||
16238542|NCT00291330|39357640|FG001|Overall Study|Withdrawal by Subject|25|||
16238543|NCT00291330|39357639|FG000|Overall Study|Other|3|||
16238544|NCT00291330|39357640|FG001|Overall Study|Other|1|||
16238545|NCT00190684|39357643|FG000|Overall Study|Adverse Event|86|||
16238546|NCT00190684|39357643|FG000|Overall Study|Satisfactory response|80|||
16238547|NCT00190684|39357643|FG000|Overall Study|Lack of efficacy|204|||
16238548|NCT00190684|39357643|FG000|Overall Study|Lost to Follow-up|232|||
16238549|NCT00190684|39357643|FG000|Overall Study|Patient moved|60|||
16238550|NCT00190684|39357643|FG000|Overall Study|Patient Decision|432|||
16238551|NCT00190684|39357643|FG000|Overall Study|Clinical relapse|67|||
16238552|NCT00190684|39357643|FG000|Overall Study|Sponsor's decision|17|||
16238553|NCT00190684|39357643|FG000|Overall Study|Physician Decision|84|||
16238554|NCT00190684|39357643|FG000|Overall Study|Protocol Violation|123|||
16238555|NCT00190684|39357643|FG000|Overall Study|Study Period III Completed|103|||
16238556|NCT00190684|39357643|FG000|Overall Study|Study Period V Completed|1|||
16238557|NCT03174925|39357644|FG000|Overall Study|Elastographic images not retrievable|2|||
16238558|NCT03174925|39357644|FG000|Overall Study|Elastography image not interpretable|1|||
16238559|NCT03959423|39357645|FG000|Overall Study|Withdrawal by Subject|2|||
16238560|NCT03959423|39357646|FG001|Overall Study|Withdrawal by Subject|3|||
16238561|NCT03959423|39357645|FG000|Overall Study|Physician Decision|0|||
16238562|NCT03959423|39357646|FG001|Overall Study|Physician Decision|1|||
16238563|NCT03959423|39357645|FG000|Overall Study|Lost to Follow-up|1|||
16238564|NCT03959423|39357646|FG001|Overall Study|Lost to Follow-up|0|||
16238565|NCT03959423|39357645|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
16238566|NCT03959423|39357646|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16238567|NCT04701658|39357647|FG000|Overall Study|Lost to Follow-up|6|||
16238568|NCT01325701|39357648|FG000|Overall Study|Adverse Event|12|||
16238569|NCT01325701|39357649|FG001|Overall Study|Adverse Event|0|||
16238570|NCT01325701|39357648|FG000|Overall Study|Protocol Violation|1|||
16238571|NCT01325701|39357649|FG001|Overall Study|Protocol Violation|0|||
16238572|NCT01325701|39357648|FG000|Overall Study|Physician Decision|2|||
16238573|NCT01325701|39357649|FG001|Overall Study|Physician Decision|2|||
16238574|NCT01325701|39357648|FG000|Overall Study|Withdrawal by Subject|2|||
16238575|NCT01325701|39357649|FG001|Overall Study|Withdrawal by Subject|1|||
16238576|NCT01325701|39357648|FG000|Overall Study|Rollerover Extension Study|4|||
16238577|NCT01325701|39357649|FG001|Overall Study|Rollerover Extension Study|0|||
16238578|NCT01791127|39357655|FG000|Overall Study|Death|356|||
16238579|NCT01791127|39357655|FG000|Overall Study|Patient has withdrawn from study|293|||
16238580|NCT01791127|39357655|FG000|Overall Study|Lost to Follow-up|42|||
16238581|NCT01791127|39357655|FG000|Overall Study|All Siello leads are explanted|31|||
16238582|NCT01791127|39357655|FG000|Overall Study|Completion of 30 day safety registry|1|||
16238583|NCT01791127|39357655|FG000|Overall Study|Study terminated for EP Passion|749|||
16238584|NCT00096200|39357656|FG000|Overall Study|Adverse Event|0|||
16238585|NCT00096200|39357657|FG001|Overall Study|Adverse Event|4|||
16238586|NCT00096200|39357658|FG002|Overall Study|Adverse Event|0|||
16238587|NCT00096200|39357656|FG000|Overall Study|Withdrawal by Subject|1|||
16238588|NCT00096200|39357657|FG001|Overall Study|Withdrawal by Subject|2|||
16238589|NCT00096200|39357658|FG002|Overall Study|Withdrawal by Subject|0|||
16238590|NCT00096200|39357656|FG000|Overall Study|Ineligible pathology|0|||
16238591|NCT00096200|39357657|FG001|Overall Study|Ineligible pathology|1|||
16238592|NCT00096200|39357658|FG002|Overall Study|Ineligible pathology|0|||
16238593|NCT01066039|39357659|FG000|Overall Study|Adverse Event|6|||
16238594|NCT01066039|39357659|FG000|Overall Study|Withdrawal by Subject|17|||
16238595|NCT01066039|39357659|FG000|Overall Study|Protocol Violation|2|||
16238596|NCT01066039|39357659|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
16238597|NCT01066039|39357659|FG000|Overall Study|Investigator's Request|1|||
16238598|NCT01066039|39357659|FG000|Overall Study|Dropout due to Insulin Administration|1|||
16238599|NCT01066039|39357659|FG000|Overall Study|Additional Antihypertensive Required|4|||
16238600|NCT01066039|39357659|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
16238601|NCT01066039|39357659|FG000|Overall Study|Failure to Control Blood Pressure|1|||
16238602|NCT01066039|39357659|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
16238603|NCT01050673|39357660|FG000|Overall Study|Physician Decision|4|||
16556346|NCT04537949|40500038|FG004|Follow-up Phase|personal reasons|1|||
16556347|NCT04537949|40500039|FG005|Follow-up Phase|personal reasons|0|||
16556348|NCT04537949|40500040|FG006|Follow-up Phase|personal reasons|0|||
16556349|NCT04537949|40500041|FG007|Follow-up Phase|personal reasons|0|||
16556350|NCT04537949|40500034|FG000|Follow-up Phase|Withdrawal by Subject|0|||
16556351|NCT04537949|40500035|FG001|Follow-up Phase|Withdrawal by Subject|0|||
16556352|NCT04537949|40500036|FG002|Follow-up Phase|Withdrawal by Subject|0|||
16556353|NCT04537949|40500037|FG003|Follow-up Phase|Withdrawal by Subject|0|||
16556354|NCT04537949|40500038|FG004|Follow-up Phase|Withdrawal by Subject|1|||
16556355|NCT04537949|40500039|FG005|Follow-up Phase|Withdrawal by Subject|0|||
16556356|NCT04537949|40500040|FG006|Follow-up Phase|Withdrawal by Subject|0|||
16556357|NCT04537949|40500041|FG007|Follow-up Phase|Withdrawal by Subject|0|||
16556358|NCT01234649|40503330|FG000|Overall Study|Withdrawal by Subject|32|||
16556359|NCT01234649|40503331|FG001|Overall Study|Withdrawal by Subject|26|||
16556360|NCT01234649|40503330|FG000|Overall Study|Pregnancy|6|||
16556361|NCT01234649|40503331|FG001|Overall Study|Pregnancy|6|||
16556362|NCT01234649|40503330|FG000|Overall Study|intolerant to side effects|4|||
16556363|NCT01234649|40503331|FG001|Overall Study|intolerant to side effects|3|||
16556364|NCT01234649|40503330|FG000|Overall Study|Allergic reaction|1|||
16556365|NCT01234649|40503331|FG001|Overall Study|Allergic reaction|0|||
16556366|NCT01234649|40503330|FG000|Overall Study|Lack of Efficacy|0|||
16556367|NCT01234649|40503331|FG001|Overall Study|Lack of Efficacy|3|||
16556368|NCT02696226|40503345|FG000|Overall Study|Study terminated - lack of enrollment|1|||
16556369|NCT02696226|40503346|FG001|Overall Study|Study terminated - lack of enrollment|0|||
16556370|NCT02696226|40503347|FG002|Overall Study|Study terminated - lack of enrollment|2|||
16556371|NCT02696226|40503348|FG003|Overall Study|Study terminated - lack of enrollment|0|||
16556372|NCT00681187|40503349|FG000|Overall Study|Withdrawal by Subject|1|||
16556373|NCT00681187|40503350|FG001|Overall Study|Withdrawal by Subject|0|||
16556374|NCT00681187|40503349|FG000|Overall Study|Death|0|||
16556375|NCT00681187|40503350|FG001|Overall Study|Death|1|||
16556376|NCT00681187|40503349|FG000|Overall Study|Adverse Event|0|||
16556377|NCT00681187|40503350|FG001|Overall Study|Adverse Event|1|||
16238604|NCT01050673|39357661|FG001|Overall Study|Physician Decision|5|||
16238605|NCT02038959|39357665|FG000|Overall Study|Withdrawal by Subject|6|||
16238606|NCT02038959|39357666|FG001|Overall Study|Withdrawal by Subject|8|||
16238607|NCT01154673|39357670|FG000|Overall Study|Lost to Follow-up|1|||
16238608|NCT01154673|39357671|FG001|Overall Study|Lost to Follow-up|0|||
16238609|NCT01154673|39357670|FG000|Overall Study|moved out of province|1|||
16238610|NCT01154673|39357671|FG001|Overall Study|moved out of province|0|||
16238611|NCT02574260|39357672|FG000|Overall Study|Disease Progression|1|||
16238612|NCT02983227|39357673|FG000|Overall Study|Adverse Event|21|||
16238613|NCT02983227|39357674|FG001|Overall Study|Adverse Event|3|||
16238614|NCT02983227|39357673|FG000|Overall Study|Death|3|||
16238615|NCT02983227|39357674|FG001|Overall Study|Death|0|||
16238616|NCT02983227|39357673|FG000|Overall Study|Lack of Efficacy|8|||
16238617|NCT02983227|39357674|FG001|Overall Study|Lack of Efficacy|1|||
16238618|NCT02983227|39357673|FG000|Overall Study|Lost to Follow-up|3|||
16238619|NCT02983227|39357674|FG001|Overall Study|Lost to Follow-up|0|||
16238620|NCT02983227|39357673|FG000|Overall Study|Multiple Reasons|2|||
16238621|NCT02983227|39357674|FG001|Overall Study|Multiple Reasons|1|||
16238622|NCT02983227|39357673|FG000|Overall Study|Physician Decision|3|||
16238623|NCT02983227|39357674|FG001|Overall Study|Physician Decision|1|||
16238624|NCT02983227|39357673|FG000|Overall Study|Withdrawal by Subject|19|||
16556378|NCT04834362|40503351|FG000|Overall Study|Death|1|||
16556379|NCT04834362|40503352|FG001|Overall Study|Death|2|||
16556380|NCT02404493|40503353|FG000|Overall Study|Adverse Event|1|||
16556381|NCT02404493|40503354|FG001|Overall Study|Adverse Event|1|||
16556382|NCT02800928|40503355|FG000|Overall Study|Withdrawal by Subject|1|||
16556383|NCT02800928|40503356|FG001|Overall Study|Withdrawal by Subject|1|||
16556384|NCT02800928|40503355|FG000|Overall Study|Protocol Violation|1|||
16556385|NCT02800928|40503356|FG001|Overall Study|Protocol Violation|1|||
16556386|NCT01744496|40503357|FG000|Titration Period|Adverse Event|2|||
16556387|NCT01744496|40503358|FG001|Titration Period|Adverse Event|1|||
16556388|NCT01744496|40503357|FG000|Titration Period|Personal reasons|0|||
16556389|NCT01744496|40503358|FG001|Titration Period|Personal reasons|1|||
16556390|NCT01744496|40503357|FG000|Maintenance Period|Adverse Event|1|||
16556391|NCT01744496|40503358|FG001|Maintenance Period|Adverse Event|3|||
16556392|NCT01744496|40503357|FG000|Maintenance Period|Protocol Violation|1|||
16556393|NCT01744496|40503358|FG001|Maintenance Period|Protocol Violation|0|||
16556394|NCT01744496|40503357|FG000|Maintenance Period|Withdrawal by Subject|1|||
16556395|NCT01744496|40503358|FG001|Maintenance Period|Withdrawal by Subject|1|||
16556396|NCT01744496|40503357|FG000|Maintenance Period|Subject left town|1|||
16556397|NCT01744496|40503358|FG001|Maintenance Period|Subject left town|0|||
16556398|NCT02959138|40503361|FG000|Overall Study|Enrolled but Never Treated|0|||
16238625|NCT02983227|39357674|FG001|Overall Study|Withdrawal by Subject|8|||
16556399|NCT02959138|40503362|FG001|Overall Study|Enrolled but Never Treated|1|||
16556400|NCT02959138|40503363|FG002|Overall Study|Enrolled but Never Treated|0|||
16556401|NCT00179010|40503364|FG000|Overall Study|Muscle probe defective|1|||
16556402|NCT00179010|40503365|FG001|Overall Study|Muscle probe defective|1|||
16556403|NCT00179010|40503364|FG000|Overall Study|Failure to place arterial line|0|||
16556404|NCT00179010|40503365|FG001|Overall Study|Failure to place arterial line|1|||
16556405|NCT03040687|40503376|FG000|Overall Study|Withdrawal by Subject|1|||
16238626|NCT00808015|39357678|FG000|Overall Study|Death|1|||
16238627|NCT00808015|39357678|FG000|Overall Study|Lack of Efficacy|58|||
16238628|NCT00808015|39357678|FG000|Overall Study|Lost to Follow-up|76|||
16238629|NCT00808015|39357678|FG000|Overall Study|Participants not willing to participate|158|||
16556406|NCT03040687|40503377|FG001|Overall Study|Withdrawal by Subject|0|||
16556407|NCT03040687|40503378|FG002|Overall Study|Withdrawal by Subject|0|||
16556408|NCT01865617|40503380|FG000|Overall Study|Death|27|||
16556409|NCT01865617|40503381|FG001|Overall Study|Death|3|||
16556410|NCT01865617|40503382|FG002|Overall Study|Death|1|||
16556411|NCT01865617|40503383|FG003|Overall Study|Death|1|||
16556412|NCT01865617|40503384|FG004|Overall Study|Death|5|||
16556413|NCT01865617|40503385|FG005|Overall Study|Death|1|||
16122665|NCT00929110|38934578|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16238630|NCT00808015|39357678|FG000|Overall Study|Adverse Event|22|||
16238631|NCT00808015|39357678|FG000|Overall Study|Other|25|||
16238632|NCT00808015|39357678|FG000|Overall Study|Enrolled but not treated|4|||
16238633|NCT04603937|39357679|FG000|Overall Study|Adverse Event|9|||
16238634|NCT04603937|39357680|FG001|Overall Study|Adverse Event|10|||
16238635|NCT04603937|39357679|FG000|Overall Study|Withdrawal by Subject|7|||
16238636|NCT04603937|39357680|FG001|Overall Study|Withdrawal by Subject|6|||
16238637|NCT04603937|39357679|FG000|Overall Study|Lost to Follow-up|5|||
16238638|NCT04603937|39357680|FG001|Overall Study|Lost to Follow-up|6|||
16238639|NCT04603937|39357679|FG000|Overall Study|Physician Decision|0|||
16238640|NCT04603937|39357680|FG001|Overall Study|Physician Decision|1|||
16238641|NCT04603937|39357679|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
16238642|NCT04603937|39357680|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
16238643|NCT03349437|39357681|FG000|Screening|Screen Fail|4|||
16238644|NCT03349437|39357682|FG001|Screening|Screen Fail|0|||
16238645|NCT03349437|39357683|FG002|Screening|Screen Fail|0|||
16238646|NCT03349437|39357681|FG000|Screening|Withdrawn|1|||
16238647|NCT03349437|39357682|FG001|Screening|Withdrawn|0|||
16238648|NCT03349437|39357683|FG002|Screening|Withdrawn|0|||
16238649|NCT01244516|39357684|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
16238650|NCT01244516|39357685|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
16238651|NCT01244516|39357686|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
16238652|NCT01244516|39357684|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
16238653|NCT01244516|39357685|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
16238654|NCT01244516|39357686|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
16238655|NCT01244516|39357684|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
16238656|NCT01244516|39357685|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
16238657|NCT01244516|39357686|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
16238658|NCT01244516|39357684|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
16238659|NCT01244516|39357685|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
16238660|NCT01244516|39357686|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
16238661|NCT01244516|39357684|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
16238662|NCT01244516|39357685|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
16238663|NCT01244516|39357686|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
16238664|NCT01244516|39357684|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
16238665|NCT01244516|39357685|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
16238666|NCT01244516|39357686|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
16238667|NCT01244516|39357684|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
16238668|NCT01244516|39357685|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
16238669|NCT01244516|39357686|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
16238670|NCT01339000|39357687|FG000|Overall Study|study closed due to lack of drug supply|1|||
16238671|NCT01339000|39357688|FG001|Overall Study|study closed due to lack of drug supply|0|||
16238672|NCT04508621|39357689|FG000|Overall Study|Adverse Event|39|||
16238673|NCT04508621|39357690|FG001|Overall Study|Adverse Event|16|||
16238674|NCT04508621|39357689|FG000|Overall Study|Lack of Efficacy|2|||
16238675|NCT04508621|39357690|FG001|Overall Study|Lack of Efficacy|8|||
16238676|NCT04508621|39357689|FG000|Overall Study|Physician Decision|0|||
16238677|NCT04508621|39357690|FG001|Overall Study|Physician Decision|1|||
16556414|NCT01865617|40503386|FG006|Overall Study|Death|11|||
16556415|NCT01865617|40503387|FG007|Overall Study|Death|1|||
16556416|NCT01865617|40503388|FG008|Overall Study|Death|11|||
16556417|NCT01865617|40503389|FG009|Overall Study|Death|3|||
16556418|NCT01865617|40503390|FG010|Overall Study|Death|32|||
16556419|NCT01865617|40503391|FG011|Overall Study|Death|6|||
16556420|NCT01865617|40503392|FG012|Overall Study|Death|13|||
16556421|NCT01865617|40503380|FG000|Overall Study|Lost to Follow-up|2|||
16556422|NCT01865617|40503381|FG001|Overall Study|Lost to Follow-up|0|||
16122666|NCT00929110|38934579|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16238678|NCT04508621|39357689|FG000|Overall Study|Withdrawal by Subject|10|||
16238679|NCT04508621|39357690|FG001|Overall Study|Withdrawal by Subject|14|||
16238680|NCT04508621|39357689|FG000|Overall Study|Lost to Follow-up|12|||
16238681|NCT04508621|39357690|FG001|Overall Study|Lost to Follow-up|9|||
16238682|NCT04508621|39357689|FG000|Overall Study|COVID-19 related crisis|3|||
16238683|NCT04508621|39357690|FG001|Overall Study|COVID-19 related crisis|0|||
16556423|NCT01865617|40503382|FG002|Overall Study|Lost to Follow-up|0|||
16556424|NCT01865617|40503383|FG003|Overall Study|Lost to Follow-up|0|||
16556425|NCT01865617|40503384|FG004|Overall Study|Lost to Follow-up|0|||
16238684|NCT04508621|39357689|FG000|Overall Study|Subject non-compliance|1|||
16238685|NCT04508621|39357690|FG001|Overall Study|Subject non-compliance|0|||
16238686|NCT02609178|39357691|FG000|First Crown|Withdrawal by Subject|0|||
16556426|NCT01865617|40503385|FG005|Overall Study|Lost to Follow-up|0|||
16238687|NCT02609178|39357692|FG001|First Crown|Withdrawal by Subject|0|||
16238688|NCT02609178|39357693|FG002|First Crown|Withdrawal by Subject|1|||
16238689|NCT02609178|39357694|FG003|First Crown|Withdrawal by Subject|1|||
16238690|NCT02609178|39357695|FG004|First Crown|Withdrawal by Subject|0|||
16238691|NCT02609178|39357696|FG005|First Crown|Withdrawal by Subject|0|||
16238692|NCT01835470|39357703|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
16238693|NCT01835470|39357703|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
16238694|NCT03496207|39357708|FG000|Base Study|Adverse Event|0|||
16238695|NCT03496207|39357709|FG001|Base Study|Adverse Event|0|||
16238696|NCT03496207|39357710|FG002|Base Study|Adverse Event|1|||
16238697|NCT03496207|39357711|FG003|Base Study|Adverse Event|1|||
16556427|NCT01865617|40503386|FG006|Overall Study|Lost to Follow-up|0|||
16556428|NCT01865617|40503387|FG007|Overall Study|Lost to Follow-up|0|||
16556429|NCT01865617|40503388|FG008|Overall Study|Lost to Follow-up|0|||
16556430|NCT01865617|40503389|FG009|Overall Study|Lost to Follow-up|0|||
16556431|NCT01865617|40503390|FG010|Overall Study|Lost to Follow-up|0|||
16556432|NCT01865617|40503391|FG011|Overall Study|Lost to Follow-up|0|||
16556433|NCT01865617|40503392|FG012|Overall Study|Lost to Follow-up|0|||
16556434|NCT01865617|40503380|FG000|Overall Study|Withdrawal by Subject|1|||
16556435|NCT01865617|40503381|FG001|Overall Study|Withdrawal by Subject|0|||
16556436|NCT01865617|40503382|FG002|Overall Study|Withdrawal by Subject|0|||
16556437|NCT01865617|40503383|FG003|Overall Study|Withdrawal by Subject|0|||
16556438|NCT01865617|40503384|FG004|Overall Study|Withdrawal by Subject|0|||
16556439|NCT01865617|40503385|FG005|Overall Study|Withdrawal by Subject|0|||
16556440|NCT01865617|40503386|FG006|Overall Study|Withdrawal by Subject|0|||
16556441|NCT01865617|40503387|FG007|Overall Study|Withdrawal by Subject|0|||
16556442|NCT01865617|40503388|FG008|Overall Study|Withdrawal by Subject|0|||
16556443|NCT01865617|40503389|FG009|Overall Study|Withdrawal by Subject|0|||
16556444|NCT01865617|40503390|FG010|Overall Study|Withdrawal by Subject|0|||
16556445|NCT01865617|40503391|FG011|Overall Study|Withdrawal by Subject|0|||
16556446|NCT01865617|40503392|FG012|Overall Study|Withdrawal by Subject|0|||
16556447|NCT01865617|40503380|FG000|Overall Study|Patient proceeded to new therapy|0|||
16556448|NCT01865617|40503381|FG001|Overall Study|Patient proceeded to new therapy|0|||
16556449|NCT01865617|40503382|FG002|Overall Study|Patient proceeded to new therapy|0|||
16556450|NCT01865617|40503383|FG003|Overall Study|Patient proceeded to new therapy|0|||
16556451|NCT01865617|40503384|FG004|Overall Study|Patient proceeded to new therapy|2|||
16556452|NCT01865617|40503385|FG005|Overall Study|Patient proceeded to new therapy|0|||
16556453|NCT01865617|40503386|FG006|Overall Study|Patient proceeded to new therapy|0|||
16556454|NCT01865617|40503387|FG007|Overall Study|Patient proceeded to new therapy|0|||
16556455|NCT01865617|40503388|FG008|Overall Study|Patient proceeded to new therapy|0|||
16556456|NCT01865617|40503389|FG009|Overall Study|Patient proceeded to new therapy|0|||
16556457|NCT01865617|40503390|FG010|Overall Study|Patient proceeded to new therapy|0|||
16556458|NCT01865617|40503391|FG011|Overall Study|Patient proceeded to new therapy|0|||
16556459|NCT01865617|40503392|FG012|Overall Study|Patient proceeded to new therapy|0|||
16556460|NCT01865617|40503380|FG000|Overall Study|Other|0|||
16556461|NCT01865617|40503381|FG001|Overall Study|Other|0|||
16556462|NCT01865617|40503382|FG002|Overall Study|Other|0|||
16122667|NCT00929110|38934580|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16122668|NCT00929110|38934578|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16122669|NCT00929110|38934579|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16122670|NCT00929110|38934580|FG002|Overall Study|Abnormal test procedure result(s)|1|||
16122671|NCT00929110|38934578|FG000|Overall Study|Patient inability to use the device|0|||
16122672|NCT00929110|38934579|FG001|Overall Study|Patient inability to use the device|1|||
16122673|NCT00929110|38934580|FG002|Overall Study|Patient inability to use the device|0|||
16122674|NCT02993523|38934581|FG000|Overall Study|Withdrew Consent|0|||
16122675|NCT02993523|38934582|FG001|Overall Study|Withdrew Consent|0|||
16122676|NCT02993523|38934583|FG002|Overall Study|Withdrew Consent|2|||
16122677|NCT02993523|38934584|FG003|Overall Study|Withdrew Consent|9|||
16122678|NCT02993523|38934585|FG004|Overall Study|Withdrew Consent|0|||
16122679|NCT02993523|38934581|FG000|Overall Study|Lost to Follow-up|0|||
16122680|NCT02993523|38934582|FG001|Overall Study|Lost to Follow-up|0|||
16122681|NCT02993523|38934583|FG002|Overall Study|Lost to Follow-up|3|||
16122682|NCT02993523|38934584|FG003|Overall Study|Lost to Follow-up|6|||
16122683|NCT02993523|38934585|FG004|Overall Study|Lost to Follow-up|0|||
16122684|NCT02993523|38934581|FG000|Overall Study|Death|1|||
16122685|NCT02993523|38934582|FG001|Overall Study|Death|1|||
16122686|NCT02993523|38934583|FG002|Overall Study|Death|138|||
16122687|NCT02993523|38934584|FG003|Overall Study|Death|222|||
16122688|NCT02993523|38934585|FG004|Overall Study|Death|6|||
16122689|NCT02993523|38934581|FG000|Overall Study|Reason not Specified|0|||
16122690|NCT02993523|38934582|FG001|Overall Study|Reason not Specified|0|||
16122691|NCT02993523|38934583|FG002|Overall Study|Reason not Specified|1|||
16122692|NCT02993523|38934584|FG003|Overall Study|Reason not Specified|1|||
16122693|NCT02993523|38934585|FG004|Overall Study|Reason not Specified|0|||
16122694|NCT03231800|38934586|FG000|Overall Study|Lost to Follow-up|0|||
16122695|NCT03231800|38934587|FG001|Overall Study|Lost to Follow-up|2|||
16122696|NCT03231800|38934586|FG000|Overall Study|Protocol Violation|1|||
16122697|NCT03231800|38934587|FG001|Overall Study|Protocol Violation|1|||
16122698|NCT03231800|38934586|FG000|Overall Study|reason not provided|2|||
16122699|NCT03231800|38934587|FG001|Overall Study|reason not provided|0|||
16122700|NCT01302080|38934588|FG000|Overall Study|Withdrew Consent|92|||
16122701|NCT01302080|38934589|FG001|Overall Study|Withdrew Consent|39|||
16122702|NCT01302080|38934588|FG000|Overall Study|Patient/Family Moved|28|||
16122703|NCT01302080|38934589|FG001|Overall Study|Patient/Family Moved|3|||
16122704|NCT01302080|38934588|FG000|Overall Study|Lost to Follow-up|192|||
16122705|NCT01302080|38934589|FG001|Overall Study|Lost to Follow-up|93|||
16122706|NCT01302080|38934588|FG000|Overall Study|Death|1|||
16122707|NCT01302080|38934589|FG001|Overall Study|Death|0|||
16238698|NCT03496207|39357712|FG004|Base Study|Adverse Event|4|||
16350096|NCT03286218|39768954|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
16350097|NCT03286218|39768955|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
16350098|NCT03286218|39768956|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
16350099|NCT03286218|39768957|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
16350100|NCT03286218|39768958|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
16350101|NCT03286218|39768959|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
16350102|NCT03286218|39768960|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
16350103|NCT03286218|39768961|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
16122708|NCT01302080|38934588|FG000|Overall Study|Other|52|||
16122709|NCT01302080|38934589|FG001|Overall Study|Other|8|||
16122710|NCT01302080|38934588|FG000|Overall Study|Reason Missing For Discontinuation|1|||
16238699|NCT03496207|39357708|FG000|Base Study|Death|0|||
16238700|NCT03496207|39357709|FG001|Base Study|Death|0|||
16350104|NCT03286218|39768962|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
16122711|NCT01302080|38934589|FG001|Overall Study|Reason Missing For Discontinuation|0|||
16350105|NCT03286218|39768951|FG000|Qualification Phase Period 2|Protocol Violation|2|||
16350106|NCT03286218|39768952|FG001|Qualification Phase Period 2|Protocol Violation|0|||
16350107|NCT03286218|39768953|FG002|Qualification Phase Period 2|Protocol Violation|0|||
16350108|NCT03286218|39768954|FG003|Qualification Phase Period 2|Protocol Violation|0|||
16350109|NCT03286218|39768955|FG004|Qualification Phase Period 2|Protocol Violation|0|||
16350110|NCT03286218|39768956|FG005|Qualification Phase Period 2|Protocol Violation|0|||
16350111|NCT03286218|39768957|FG006|Qualification Phase Period 2|Protocol Violation|0|||
16350112|NCT03286218|39768958|FG007|Qualification Phase Period 2|Protocol Violation|0|||
16350113|NCT03286218|39768959|FG008|Qualification Phase Period 2|Protocol Violation|0|||
16350114|NCT03286218|39768960|FG009|Qualification Phase Period 2|Protocol Violation|0|||
16350115|NCT03286218|39768961|FG010|Qualification Phase Period 2|Protocol Violation|0|||
16350116|NCT03286218|39768962|FG011|Qualification Phase Period 2|Protocol Violation|0|||
16350117|NCT03286218|39768951|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
16350118|NCT03286218|39768952|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
16350119|NCT03286218|39768953|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
16350120|NCT03286218|39768954|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
16350121|NCT03286218|39768955|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
16350122|NCT03286218|39768956|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
16556463|NCT01865617|40503383|FG003|Overall Study|Other|0|||
16556464|NCT01865617|40503384|FG004|Overall Study|Other|0|||
16122712|NCT01607879|38934590|FG000|Overall Study|Death|1|||
16122713|NCT01607879|38934591|FG001|Overall Study|Death|0|||
16122714|NCT03174431|38934592|FG000|Overall Study|Withdrawal by Subject|14|||
16122715|NCT03174431|38934593|FG001|Overall Study|Withdrawal by Subject|11|||
16122716|NCT03174431|38934592|FG000|Overall Study|alternative treatment|2|||
16122717|NCT03174431|38934593|FG001|Overall Study|alternative treatment|0|||
16122718|NCT03174431|38934592|FG000|Overall Study|Lost to Follow-up|1|||
16556465|NCT01865617|40503385|FG005|Overall Study|Other|0|||
16556466|NCT01865617|40503386|FG006|Overall Study|Other|1|||
16122719|NCT03174431|38934593|FG001|Overall Study|Lost to Follow-up|5|||
16556467|NCT01865617|40503387|FG007|Overall Study|Other|0|||
16556468|NCT01865617|40503388|FG008|Overall Study|Other|0|||
16556469|NCT01865617|40503389|FG009|Overall Study|Other|0|||
16556470|NCT01865617|40503390|FG010|Overall Study|Other|0|||
16556471|NCT01865617|40503391|FG011|Overall Study|Other|0|||
16556472|NCT01865617|40503392|FG012|Overall Study|Other|0|||
16556473|NCT03688711|40503393|FG000|Overall Study|Withdrawal by Subject|0|||
16556474|NCT03688711|40503394|FG001|Overall Study|Withdrawal by Subject|1|||
16556475|NCT01077362|40503409|FG000|Overall Study|Lack of Efficacy|13|||
16556476|NCT01077362|40503410|FG001|Overall Study|Lack of Efficacy|8|||
16556477|NCT01077362|40503411|FG002|Overall Study|Lack of Efficacy|10|||
16556478|NCT01077362|40503409|FG000|Overall Study|Lost to Follow-up|1|||
16556479|NCT01077362|40503410|FG001|Overall Study|Lost to Follow-up|0|||
16556480|NCT01077362|40503411|FG002|Overall Study|Lost to Follow-up|3|||
16556481|NCT01077362|40503409|FG000|Overall Study|Adverse Event|12|||
16556482|NCT01077362|40503410|FG001|Overall Study|Adverse Event|7|||
16556483|NCT01077362|40503411|FG002|Overall Study|Adverse Event|4|||
16556484|NCT01077362|40503409|FG000|Overall Study|Withdrawal by Subject|5|||
16556485|NCT01077362|40503410|FG001|Overall Study|Withdrawal by Subject|3|||
16556486|NCT01077362|40503411|FG002|Overall Study|Withdrawal by Subject|5|||
16556487|NCT01077362|40503409|FG000|Overall Study|Other|0|||
16556488|NCT01077362|40503410|FG001|Overall Study|Other|1|||
16556489|NCT01077362|40503411|FG002|Overall Study|Other|2|||
16556490|NCT02023879|40503414|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
16556491|NCT02023879|40503415|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
16556492|NCT02023879|40503416|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
16556493|NCT02023879|40503414|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
16556494|NCT02023879|40503415|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
16556495|NCT02023879|40503416|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
16556496|NCT02023879|40503414|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
16238701|NCT03496207|39357710|FG002|Base Study|Death|0|||
16238702|NCT03496207|39357711|FG003|Base Study|Death|0|||
16238703|NCT03496207|39357712|FG004|Base Study|Death|1|||
16238704|NCT03496207|39357708|FG000|Base Study|Withdrawal by Subject|0|||
16238705|NCT03496207|39357709|FG001|Base Study|Withdrawal by Subject|0|||
16238706|NCT03496207|39357710|FG002|Base Study|Withdrawal by Subject|1|||
16238707|NCT03496207|39357711|FG003|Base Study|Withdrawal by Subject|0|||
16238708|NCT03496207|39357712|FG004|Base Study|Withdrawal by Subject|1|||
16238709|NCT03496207|39357708|FG000|Extension Period|Adverse Event|0|||
16238710|NCT03496207|39357709|FG001|Extension Period|Adverse Event|0|||
16238711|NCT03496207|39357710|FG002|Extension Period|Adverse Event|0|||
16238712|NCT03496207|39357711|FG003|Extension Period|Adverse Event|1|||
16238713|NCT03496207|39357712|FG004|Extension Period|Adverse Event|1|||
16238714|NCT03496207|39357708|FG000|Extension Period|Death|1|||
16238715|NCT03496207|39357709|FG001|Extension Period|Death|0|||
16238716|NCT03496207|39357710|FG002|Extension Period|Death|0|||
16238717|NCT03496207|39357711|FG003|Extension Period|Death|1|||
16238718|NCT03496207|39357712|FG004|Extension Period|Death|2|||
16238719|NCT03496207|39357708|FG000|Extension Period|Withdrawal by Subject|1|||
16238720|NCT03496207|39357709|FG001|Extension Period|Withdrawal by Subject|0|||
16238721|NCT03496207|39357710|FG002|Extension Period|Withdrawal by Subject|0|||
16238722|NCT03496207|39357711|FG003|Extension Period|Withdrawal by Subject|1|||
16238723|NCT03496207|39357712|FG004|Extension Period|Withdrawal by Subject|1|||
16238724|NCT03496207|39357708|FG000|Extension Period|Elevated hemoglobin levels|0|||
16238725|NCT03496207|39357709|FG001|Extension Period|Elevated hemoglobin levels|0|||
16238726|NCT03496207|39357710|FG002|Extension Period|Elevated hemoglobin levels|0|||
16238727|NCT03496207|39357711|FG003|Extension Period|Elevated hemoglobin levels|0|||
16238728|NCT03496207|39357712|FG004|Extension Period|Elevated hemoglobin levels|1|||
16238729|NCT01610167|39357713|FG000|Overall Study|Scheduling conflict.|0|||
16238730|NCT01610167|39357714|FG001|Overall Study|Scheduling conflict.|0|||
16238731|NCT01610167|39357715|FG002|Overall Study|Scheduling conflict.|2|||
16238732|NCT01586624|39357716|FG000|Overall Study|Adverse Event|3|||
16238733|NCT01586624|39357717|FG001|Overall Study|Adverse Event|0|||
16238734|NCT01586624|39357718|FG002|Overall Study|Adverse Event|2|||
16238735|NCT01586624|39357719|FG003|Overall Study|Adverse Event|1|||
16238736|NCT01586624|39357720|FG004|Overall Study|Adverse Event|3|||
16238737|NCT01586624|39357721|FG005|Overall Study|Adverse Event|3|||
16238738|NCT01586624|39357722|FG006|Overall Study|Adverse Event|2|||
16238739|NCT01586624|39357723|FG007|Overall Study|Adverse Event|3|||
16238740|NCT01586624|39357716|FG000|Overall Study|Physician Decision|0|||
16238741|NCT01586624|39357717|FG001|Overall Study|Physician Decision|1|||
16238742|NCT01586624|39357718|FG002|Overall Study|Physician Decision|1|||
16122720|NCT00886795|38934594|FG000|Overall Study|Lack of Efficacy|1|||
16122721|NCT03480932|38934595|FG000|Overall Study|Death|1|||
16238743|NCT01586624|39357719|FG003|Overall Study|Physician Decision|0|||
16238744|NCT01586624|39357720|FG004|Overall Study|Physician Decision|2|||
16238745|NCT01586624|39357721|FG005|Overall Study|Physician Decision|0|||
16238746|NCT01586624|39357722|FG006|Overall Study|Physician Decision|1|||
16238747|NCT01586624|39357723|FG007|Overall Study|Physician Decision|1|||
16238748|NCT01586624|39357716|FG000|Overall Study|Withdrawal by Subject|0|||
16238749|NCT01586624|39357717|FG001|Overall Study|Withdrawal by Subject|0|||
16238750|NCT01586624|39357718|FG002|Overall Study|Withdrawal by Subject|0|||
16238751|NCT01586624|39357719|FG003|Overall Study|Withdrawal by Subject|1|||
16238752|NCT01586624|39357720|FG004|Overall Study|Withdrawal by Subject|0|||
16238753|NCT01586624|39357721|FG005|Overall Study|Withdrawal by Subject|0|||
16238754|NCT01586624|39357722|FG006|Overall Study|Withdrawal by Subject|0|||
16238755|NCT01586624|39357723|FG007|Overall Study|Withdrawal by Subject|0|||
16238756|NCT01586624|39357716|FG000|Overall Study|Evidence of disease progression|1|||
16238757|NCT01586624|39357717|FG001|Overall Study|Evidence of disease progression|3|||
16238758|NCT01586624|39357718|FG002|Overall Study|Evidence of disease progression|2|||
16238759|NCT01586624|39357719|FG003|Overall Study|Evidence of disease progression|5|||
16238760|NCT01586624|39357720|FG004|Overall Study|Evidence of disease progression|3|||
16238761|NCT01586624|39357721|FG005|Overall Study|Evidence of disease progression|5|||
16238762|NCT01586624|39357722|FG006|Overall Study|Evidence of disease progression|4|||
16238763|NCT01586624|39357723|FG007|Overall Study|Evidence of disease progression|6|||
16238764|NCT01586624|39357716|FG000|Overall Study|Screen failure (no treatment received)|0|||
16238765|NCT01586624|39357717|FG001|Overall Study|Screen failure (no treatment received)|0|||
16238766|NCT01586624|39357718|FG002|Overall Study|Screen failure (no treatment received)|0|||
16238767|NCT01586624|39357719|FG003|Overall Study|Screen failure (no treatment received)|0|||
16238768|NCT01586624|39357720|FG004|Overall Study|Screen failure (no treatment received)|0|||
16238769|NCT01586624|39357721|FG005|Overall Study|Screen failure (no treatment received)|0|||
16238770|NCT01586624|39357722|FG006|Overall Study|Screen failure (no treatment received)|1|||
16238771|NCT01586624|39357723|FG007|Overall Study|Screen failure (no treatment received)|0|||
16238772|NCT01238172|39357728|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
16238773|NCT01238172|39357729|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
16238774|NCT01238172|39357728|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
16238775|NCT01238172|39357729|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
16238776|NCT02411110|39360647|FG000|Treatment Period 1|Adverse Event|4|||
16238777|NCT02411110|39360648|FG001|Treatment Period 1|Adverse Event|2|||
16238778|NCT02411110|39360647|FG000|Treatment Period 1|Lost to Follow-up|1|||
16238779|NCT02411110|39360648|FG001|Treatment Period 1|Lost to Follow-up|0|||
16350123|NCT03286218|39768957|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
16122722|NCT03480932|38934596|FG001|Overall Study|Death|1|||
16122723|NCT03480932|38934597|FG002|Overall Study|Death|0|||
16122724|NCT03480932|38934595|FG000|Overall Study|Lost to Follow-up|0|||
16122725|NCT03480932|38934596|FG001|Overall Study|Lost to Follow-up|2|||
16122726|NCT03480932|38934597|FG002|Overall Study|Lost to Follow-up|3|||
16122727|NCT03480932|38934595|FG000|Overall Study|Incarcerated|2|||
16122728|NCT03480932|38934596|FG001|Overall Study|Incarcerated|2|||
16122729|NCT03480932|38934597|FG002|Overall Study|Incarcerated|2|||
16122730|NCT02535091|38934598|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
16122731|NCT02535091|38934599|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
16122732|NCT02535091|38934600|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
16122733|NCT02535091|38934598|FG000|Overall Study|Withdrawal by Subject|14|||
16122734|NCT02535091|38934599|FG001|Overall Study|Withdrawal by Subject|5|||
16122735|NCT02535091|38934600|FG002|Overall Study|Withdrawal by Subject|121|||
16122736|NCT02535091|38934598|FG000|Overall Study|Adverse Event|9|||
16122737|NCT02535091|38934599|FG001|Overall Study|Adverse Event|4|||
16122738|NCT02535091|38934600|FG002|Overall Study|Adverse Event|170|||
16122739|NCT02535091|38934598|FG000|Overall Study|Other|4|||
16122740|NCT02535091|38934599|FG001|Overall Study|Other|3|||
16122741|NCT02535091|38934600|FG002|Overall Study|Other|81|||
16122742|NCT02535091|38934598|FG000|Overall Study|Lost to Follow-up|0|||
16238780|NCT02411110|39360647|FG000|Treatment Period 1|Personal Reasons|2|||
16122743|NCT02535091|38934599|FG001|Overall Study|Lost to Follow-up|1|||
16122744|NCT02535091|38934600|FG002|Overall Study|Lost to Follow-up|19|||
16122745|NCT02535091|38934598|FG000|Overall Study|Protocol Violation|0|||
16122746|NCT02535091|38934599|FG001|Overall Study|Protocol Violation|1|||
16122747|NCT02535091|38934600|FG002|Overall Study|Protocol Violation|11|||
16122748|NCT02535091|38934598|FG000|Overall Study|Pregnancy|0|||
16122749|NCT02535091|38934599|FG001|Overall Study|Pregnancy|0|||
16122750|NCT02535091|38934600|FG002|Overall Study|Pregnancy|7|||
16122751|NCT01259089|38934601|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
16122752|NCT01259089|38934602|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
16122753|NCT01259089|38934603|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
16122754|NCT01259089|38934604|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
16122755|NCT01259089|38934605|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
16122756|NCT01259089|38934606|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
16238781|NCT02411110|39360648|FG001|Treatment Period 1|Personal Reasons|5|||
16238782|NCT02411110|39360647|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
16122757|NCT01259089|38934601|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
16122758|NCT01259089|38934602|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
16122759|NCT01259089|38934603|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
16122760|NCT01259089|38934604|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
16122761|NCT01259089|38934605|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
16122762|NCT01259089|38934606|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
16122763|NCT01259089|38934601|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
16122764|NCT01259089|38934602|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
16238783|NCT02411110|39360648|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
16122765|NCT01259089|38934603|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
16122766|NCT01259089|38934604|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
16122767|NCT01259089|38934605|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
16350124|NCT03286218|39768958|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
16350125|NCT03286218|39768959|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
16350126|NCT03286218|39768960|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
16122768|NCT01259089|38934606|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
16122769|NCT01259089|38934601|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
16122770|NCT01259089|38934602|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
16122771|NCT01259089|38934603|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
16122772|NCT01259089|38934604|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
16122773|NCT01259089|38934605|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
16122774|NCT01259089|38934606|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
16122775|NCT01259089|38934601|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
16122776|NCT01259089|38934602|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
16122777|NCT01259089|38934603|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
16122778|NCT01259089|38934604|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
16122779|NCT01259089|38934605|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
16122780|NCT01259089|38934606|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
16122781|NCT01259089|38934601|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
16122782|NCT01259089|38934602|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
16122783|NCT01259089|38934603|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
16122784|NCT01259089|38934604|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
16122785|NCT01259089|38934605|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
16122786|NCT01259089|38934606|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
16122787|NCT01259089|38934601|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
16122788|NCT01259089|38934602|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
16122789|NCT01259089|38934603|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
16122790|NCT01259089|38934604|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
16122791|NCT01259089|38934605|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
16122792|NCT01259089|38934606|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
16122793|NCT01259089|38934601|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
16122794|NCT01259089|38934602|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
16122795|NCT01259089|38934603|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
16122796|NCT01259089|38934604|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
16122797|NCT01259089|38934605|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
16122798|NCT01259089|38934606|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
16122799|NCT01259089|38934601|FG000|Survival Follow up for Two Years|Death|3|||
16122800|NCT01259089|38934602|FG001|Survival Follow up for Two Years|Death|2|||
16122801|NCT01259089|38934603|FG002|Survival Follow up for Two Years|Death|2|||
16122802|NCT01259089|38934604|FG003|Survival Follow up for Two Years|Death|3|||
16122803|NCT01259089|38934605|FG004|Survival Follow up for Two Years|Death|6|||
16122804|NCT01259089|38934606|FG005|Survival Follow up for Two Years|Death|13|||
16122805|NCT01259089|38934601|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
16238784|NCT02411110|39360647|FG000|Treatment Period 2|Adverse Event|1|||
16238785|NCT02411110|39360648|FG001|Treatment Period 2|Adverse Event|0|||
16556497|NCT02023879|40503415|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
16556498|NCT02023879|40503416|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
16556499|NCT02023879|40503414|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
16556500|NCT02023879|40503415|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
16556501|NCT02023879|40503416|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
16556502|NCT02023879|40503414|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
16556503|NCT02023879|40503415|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
16556504|NCT02023879|40503416|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
16556505|NCT02023879|40503414|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
16556506|NCT02023879|40503415|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
16122806|NCT01259089|38934602|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
16122807|NCT01259089|38934603|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
16238786|NCT02411110|39360647|FG000|Treatment Period 2|Lost to Follow-up|0|||
16238787|NCT02411110|39360648|FG001|Treatment Period 2|Lost to Follow-up|2|||
16414189|NCT05943990|39998347|FG002|Overall Study|Study Terminated by Sponsor|1|||
16414190|NCT04376827|39998348|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
16414191|NCT04376827|39998349|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
16414192|NCT04376827|39998348|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
16414193|NCT04376827|39998349|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
16414194|NCT04376827|39998348|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
16414195|NCT04376827|39998349|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
16414196|NCT04376827|39998348|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
16122808|NCT01259089|38934604|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
16122809|NCT01259089|38934605|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
16122810|NCT01259089|38934606|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
16122811|NCT01259089|38934601|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
16122812|NCT01259089|38934602|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
16122813|NCT01259089|38934603|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
16122814|NCT01259089|38934604|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
16122815|NCT01259089|38934605|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
16122816|NCT01259089|38934606|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
16122817|NCT01182441|38934607|FG000|Overall Study|Patient Still in Follow-up|152|||
16122818|NCT01182441|38934608|FG001|Overall Study|Patient Still in Follow-up|72|||
16122819|NCT01182441|38934607|FG000|Overall Study|Death|37|||
16122820|NCT01182441|38934608|FG001|Overall Study|Death|25|||
16122821|NCT01182441|38934607|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
16122822|NCT01182441|38934608|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
16122823|NCT01182441|38934607|FG000|Overall Study|Lost to Follow-up|5|||
16122824|NCT01182441|38934608|FG001|Overall Study|Lost to Follow-up|8|||
16122825|NCT01182441|38934607|FG000|Overall Study|Withdrawal by Subject|6|||
16122826|NCT01182441|38934608|FG001|Overall Study|Withdrawal by Subject|13|||
16122827|NCT01182441|38934607|FG000|Overall Study|Implant Not Attempted|4|||
16122828|NCT01182441|38934608|FG001|Overall Study|Implant Not Attempted|0|||
16122829|NCT01182441|38934607|FG000|Overall Study|Adverse Event|2|||
16122830|NCT01182441|38934608|FG001|Overall Study|Adverse Event|0|||
16122831|NCT01182441|38934607|FG000|Overall Study|Physician Decision|1|||
16122832|NCT01182441|38934608|FG001|Overall Study|Physician Decision|1|||
16122833|NCT03868787|38934609|FG000|Overall Study|Withdrawal by Subject|2|||
16122834|NCT03868787|38934610|FG001|Overall Study|Withdrawal by Subject|1|||
16122835|NCT03683823|38934611|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
16122836|NCT03683823|38934612|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
16122837|NCT03683823|38934611|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
16122838|NCT03683823|38934612|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
16122839|NCT03683823|38934611|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
16350127|NCT03286218|39768961|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
16122840|NCT03683823|38934612|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
16122841|NCT01305239|38934618|FG000|Overall Study|Adverse Event|22|||
16122842|NCT01305239|38934618|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
16122843|NCT01152814|38934619|FG000|Overall Study|Lost to Follow-up|2|||
16122844|NCT01075958|38934620|FG000|Overall Study|Blood sample could not be obtained|44|||
16122845|NCT00890695|38934621|FG000|Overall Study|Protocol Violation|1|||
16122846|NCT00890695|38934622|FG001|Overall Study|Protocol Violation|0|||
16122847|NCT02232243|38934626|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
16122848|NCT02232243|38934627|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
16122849|NCT02232243|38934628|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
16122850|NCT04307940|38934629|FG000|Overall Study|Adverse Event|1|||
16122851|NCT04307940|38934630|FG001|Overall Study|Adverse Event|0|||
16238788|NCT02411110|39360647|FG000|Treatment Period 2|Personal Reasons|0|||
16238789|NCT02411110|39360648|FG001|Treatment Period 2|Personal Reasons|2|||
16414197|NCT04376827|39998349|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
16122852|NCT04307940|38934631|FG002|Overall Study|Adverse Event|0|||
16122853|NCT04307940|38934629|FG000|Overall Study|Withdrawal by Subject|2|||
16122854|NCT04307940|38934630|FG001|Overall Study|Withdrawal by Subject|3|||
16122855|NCT04307940|38934631|FG002|Overall Study|Withdrawal by Subject|1|||
16122856|NCT04307940|38934629|FG000|Overall Study|Lost to Follow-up|2|||
16122857|NCT04307940|38934630|FG001|Overall Study|Lost to Follow-up|0|||
16122858|NCT04307940|38934631|FG002|Overall Study|Lost to Follow-up|1|||
16122859|NCT01258595|38934632|FG000|Overall Study|Lost to Follow-up|1|||
16122860|NCT01258595|38934633|FG001|Overall Study|Lost to Follow-up|0|||
16122861|NCT01258595|38934632|FG000|Overall Study|Withdrawal by Subject|0|||
16122862|NCT01258595|38934633|FG001|Overall Study|Withdrawal by Subject|1|||
16122863|NCT02671500|38934634|FG000|Overall Study|Lack of Efficacy|12|||
16122864|NCT02671500|38934634|FG000|Overall Study|Lost to Follow-up|2|||
16122865|NCT02460575|38934635|FG000|Overall Study|Lost to Follow-up|1|||
16122866|NCT02460575|38934636|FG001|Overall Study|Lost to Follow-up|0|||
16122867|NCT01114880|38934643|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
16122868|NCT01114880|38934644|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
16122869|NCT01114880|38934643|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
16122870|NCT01114880|38934644|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
16122871|NCT01114880|38934643|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
16122872|NCT01114880|38934644|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
16122873|NCT01114880|38934643|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
16122874|NCT01114880|38934644|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
16122875|NCT01114880|38934643|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
16122876|NCT01114880|38934644|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
16122877|NCT01114880|38934643|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
16122878|NCT01114880|38934644|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
16122879|NCT02311673|38934645|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
16122880|NCT02311673|38934646|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
16122881|NCT02311673|38934647|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
16122882|NCT02311673|38934648|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
16122883|NCT01373151|38934651|FG000|Period 1|Lack of Efficacy|3|||
16122884|NCT01373151|38934652|FG001|Period 1|Lack of Efficacy|0|||
16122885|NCT01373151|38934653|FG002|Period 1|Lack of Efficacy|0|||
16122886|NCT01373151|38934654|FG003|Period 1|Lack of Efficacy|0|||
16122887|NCT01373151|38934655|FG004|Period 1|Lack of Efficacy|1|||
16122888|NCT01373151|38934656|FG005|Period 1|Lack of Efficacy|0|||
16122889|NCT01373151|38934657|FG006|Period 1|Lack of Efficacy|0|||
16122890|NCT01373151|38934651|FG000|Period 1|Adverse Event|0|||
16122891|NCT01373151|38934652|FG001|Period 1|Adverse Event|0|||
16122892|NCT01373151|38934653|FG002|Period 1|Adverse Event|1|||
16122893|NCT01373151|38934654|FG003|Period 1|Adverse Event|0|||
16122894|NCT01373151|38934655|FG004|Period 1|Adverse Event|4|||
16122895|NCT01373151|38934656|FG005|Period 1|Adverse Event|3|||
16122896|NCT01373151|38934657|FG006|Period 1|Adverse Event|0|||
16122897|NCT01373151|38934651|FG000|Period 1|Withdrawal by Subject|2|||
16122898|NCT01373151|38934652|FG001|Period 1|Withdrawal by Subject|0|||
16122899|NCT01373151|38934653|FG002|Period 1|Withdrawal by Subject|3|||
16122900|NCT01373151|38934654|FG003|Period 1|Withdrawal by Subject|1|||
16122901|NCT01373151|38934655|FG004|Period 1|Withdrawal by Subject|0|||
16122902|NCT01373151|38934656|FG005|Period 1|Withdrawal by Subject|1|||
16122903|NCT01373151|38934657|FG006|Period 1|Withdrawal by Subject|0|||
16122904|NCT01373151|38934651|FG000|Period 2|Lack of Efficacy|9|||
16122905|NCT01373151|38934652|FG001|Period 2|Lack of Efficacy|0|||
16122906|NCT01373151|38934653|FG002|Period 2|Lack of Efficacy|0|||
16122907|NCT01373151|38934654|FG003|Period 2|Lack of Efficacy|1|||
16122908|NCT01373151|38934655|FG004|Period 2|Lack of Efficacy|2|||
16122909|NCT01373151|38934656|FG005|Period 2|Lack of Efficacy|0|||
16122910|NCT01373151|38934657|FG006|Period 2|Lack of Efficacy|3|||
16122911|NCT01373151|38934651|FG000|Period 2|Adverse Event|0|||
16122912|NCT01373151|38934652|FG001|Period 2|Adverse Event|0|||
16122913|NCT01373151|38934653|FG002|Period 2|Adverse Event|3|||
16122914|NCT01373151|38934654|FG003|Period 2|Adverse Event|3|||
16122915|NCT01373151|38934655|FG004|Period 2|Adverse Event|0|||
16122916|NCT01373151|38934656|FG005|Period 2|Adverse Event|0|||
16122917|NCT01373151|38934657|FG006|Period 2|Adverse Event|1|||
16122918|NCT01373151|38934651|FG000|Period 2|subject request to discontinue|0|||
16122919|NCT01373151|38934652|FG001|Period 2|subject request to discontinue|1|||
16122920|NCT01373151|38934653|FG002|Period 2|subject request to discontinue|0|||
16122921|NCT01373151|38934654|FG003|Period 2|subject request to discontinue|0|||
16122922|NCT01373151|38934655|FG004|Period 2|subject request to discontinue|0|||
16122923|NCT01373151|38934656|FG005|Period 2|subject request to discontinue|0|||
16122924|NCT01373151|38934657|FG006|Period 2|subject request to discontinue|0|||
16122925|NCT01373151|38934651|FG000|Period 2|Withdrawal by Subject|0|||
16122926|NCT01373151|38934652|FG001|Period 2|Withdrawal by Subject|0|||
16122927|NCT01373151|38934653|FG002|Period 2|Withdrawal by Subject|0|||
16122928|NCT01373151|38934654|FG003|Period 2|Withdrawal by Subject|1|||
16122929|NCT01373151|38934655|FG004|Period 2|Withdrawal by Subject|0|||
16122930|NCT01373151|38934656|FG005|Period 2|Withdrawal by Subject|0|||
16122931|NCT01373151|38934657|FG006|Period 2|Withdrawal by Subject|0|||
16122932|NCT01373151|38934651|FG000|Period 2|Other|0|||
16122933|NCT01373151|38934652|FG001|Period 2|Other|0|||
16122934|NCT01373151|38934653|FG002|Period 2|Other|1|||
16122935|NCT01373151|38934654|FG003|Period 2|Other|0|||
16122936|NCT01373151|38934655|FG004|Period 2|Other|0|||
16122937|NCT01373151|38934656|FG005|Period 2|Other|0|||
16122938|NCT01373151|38934657|FG006|Period 2|Other|1|||
16122939|NCT01251770|38934658|FG000|Overall Study|Protocol Violation|13|||
16122940|NCT01251770|38934659|FG001|Overall Study|Protocol Violation|7|||
16122941|NCT03433677|38934666|FG000|Period 1|Protocol Violation|1|||
16122942|NCT03433677|38934667|FG001|Period 1|Protocol Violation|0|||
16122943|NCT03433677|38934666|FG000|Period 2|Withdrawal by Subject|1|||
16122944|NCT03433677|38934667|FG001|Period 2|Withdrawal by Subject|1|||
16122945|NCT01014208|38934668|FG000|Overall Study|Lost to Follow-up|2|||
16122946|NCT01014208|38934669|FG001|Overall Study|Lost to Follow-up|5|||
16122947|NCT01014208|38934668|FG000|Overall Study|Participant Withdrew Consent|12|||
16122948|NCT01014208|38934669|FG001|Overall Study|Participant Withdrew Consent|12|||
16122949|NCT01014208|38934668|FG000|Overall Study|Did Not Receive Study Drug|2|||
16122950|NCT01014208|38934669|FG001|Overall Study|Did Not Receive Study Drug|0|||
16122951|NCT01014208|38934668|FG000|Overall Study|Study Closed/terminated|78|||
16122952|NCT01014208|38934669|FG001|Overall Study|Study Closed/terminated|83|||
16122953|NCT01451827|38934673|FG000|Overall Study|Adverse Event|2|||
16122954|NCT01451827|38934674|FG001|Overall Study|Adverse Event|0|||
16122955|NCT01451827|38934675|FG002|Overall Study|Adverse Event|1|||
16122956|NCT01451827|38934676|FG003|Overall Study|Adverse Event|1|||
16556507|NCT02023879|40503416|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
16556508|NCT02023879|40503414|FG000|Extension Open Label Treatment|Adverse Event|1|||
16556509|NCT02023879|40503415|FG001|Extension Open Label Treatment|Adverse Event|7|||
16556510|NCT02023879|40503416|FG002|Extension Open Label Treatment|Adverse Event|3|||
16556511|NCT02023879|40503414|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
16556512|NCT02023879|40503415|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
16556513|NCT02023879|40503416|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
16556514|NCT02023879|40503414|FG000|Extension Open Label Treatment|Participant moved|1|||
16122957|NCT01451827|38934673|FG000|Overall Study|Protocol deviation|1|||
16122958|NCT01451827|38934674|FG001|Overall Study|Protocol deviation|0|||
16122959|NCT01451827|38934675|FG002|Overall Study|Protocol deviation|0|||
16122960|NCT01451827|38934676|FG003|Overall Study|Protocol deviation|0|||
16122961|NCT01451827|38934673|FG000|Overall Study|Lost to Follow-up|0|||
16122962|NCT01451827|38934674|FG001|Overall Study|Lost to Follow-up|3|||
16122963|NCT01451827|38934675|FG002|Overall Study|Lost to Follow-up|0|||
16122964|NCT01451827|38934676|FG003|Overall Study|Lost to Follow-up|2|||
16122965|NCT01451827|38934673|FG000|Overall Study|Participant met withdrawal criteria|0|||
16122966|NCT01451827|38934674|FG001|Overall Study|Participant met withdrawal criteria|2|||
16122967|NCT01451827|38934675|FG002|Overall Study|Participant met withdrawal criteria|0|||
16122968|NCT01451827|38934676|FG003|Overall Study|Participant met withdrawal criteria|0|||
16122969|NCT01451827|38934673|FG000|Overall Study|Withdrawal by Subject|0|||
16122970|NCT01451827|38934674|FG001|Overall Study|Withdrawal by Subject|0|||
16122971|NCT01451827|38934675|FG002|Overall Study|Withdrawal by Subject|1|||
16122972|NCT01451827|38934676|FG003|Overall Study|Withdrawal by Subject|1|||
16122973|NCT00727311|38934677|FG000|Overall Study|Did not receive drug|316|||
16122974|NCT00727311|38934677|FG000|Overall Study|Missing end of therapy data|205|||
16122975|NCT00727311|38934677|FG000|Overall Study|Adverse Event|58|||
16122976|NCT00727311|38934677|FG000|Overall Study|Lack of Efficacy|242|||
16122977|NCT00727311|38934677|FG000|Overall Study|Lost to Follow-up|73|||
16122978|NCT00727311|38934677|FG000|Overall Study|Withdrawal by Subject|77|||
16122979|NCT00727311|38934677|FG000|Overall Study|Other|97|||
16122980|NCT00727311|38934677|FG000|Overall Study|Multiple reasons|39|||
16122981|NCT02514239|38934678|FG000|Overall Study|Refused to continue trial medication|0|||
16122982|NCT02514239|38934679|FG001|Overall Study|Refused to continue trial medication|0|||
16556515|NCT02023879|40503415|FG001|Extension Open Label Treatment|Participant moved|2|||
16556516|NCT02023879|40503416|FG002|Extension Open Label Treatment|Participant moved|0|||
16556517|NCT02023879|40503414|FG000|Extension Open Label Treatment|Other than specified above|2|||
16556518|NCT02023879|40503415|FG001|Extension Open Label Treatment|Other than specified above|7|||
16556519|NCT02023879|40503416|FG002|Extension Open Label Treatment|Other than specified above|2|||
16122983|NCT02514239|38934680|FG002|Overall Study|Refused to continue trial medication|0|||
16556520|NCT03518658|40503417|FG000|Overall Study|Other|51|||
16556521|NCT03518658|40503418|FG001|Overall Study|Other|0|||
16122984|NCT02514239|38934681|FG003|Overall Study|Refused to continue trial medication|0|||
16122985|NCT02514239|38934682|FG004|Overall Study|Refused to continue trial medication|0|||
16556522|NCT04642469|40503419|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
16122986|NCT02514239|38934683|FG005|Overall Study|Refused to continue trial medication|0|||
16122987|NCT02514239|38934684|FG006|Overall Study|Refused to continue trial medication|0|||
16122988|NCT02514239|38934685|FG007|Overall Study|Refused to continue trial medication|0|||
16122989|NCT02514239|38934686|FG008|Overall Study|Refused to continue trial medication|0|||
16556523|NCT04642469|40503420|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
16556524|NCT04642469|40503419|FG000|Overall Study|Death|1|||
16556525|NCT04642469|40503420|FG001|Overall Study|Death|2|||
16556526|NCT04642469|40503419|FG000|Overall Study|Study/site closed following amendment 1|11|||
16556527|NCT04642469|40503420|FG001|Overall Study|Study/site closed following amendment 1|11|||
16556528|NCT04642469|40503419|FG000|Overall Study|Other|1|||
16556529|NCT04642469|40503420|FG001|Overall Study|Other|1|||
16556530|NCT04642469|40503419|FG000|Overall Study|Withdrawal by Subject|1|||
16556531|NCT04642469|40503420|FG001|Overall Study|Withdrawal by Subject|0|||
16556532|NCT04159896|40503424|FG000|Overall Study|Lack of Efficacy|7|||
16238790|NCT03591107|39360649|FG000|Overall Study|Same patient in both arms|1|||
16238791|NCT03591107|39360650|FG001|Overall Study|Same patient in both arms|1|||
16238792|NCT03591107|39360649|FG000|Overall Study|Sought care at other clinics|0|||
16238793|NCT03591107|39360650|FG001|Overall Study|Sought care at other clinics|2|||
16238794|NCT03591107|39360649|FG000|Overall Study|Discharged from clinic|0|||
16238795|NCT03591107|39360650|FG001|Overall Study|Discharged from clinic|1|||
16238796|NCT03591107|39360649|FG000|Overall Study|Withdrawal by Subject|0|||
16238797|NCT03591107|39360650|FG001|Overall Study|Withdrawal by Subject|1|||
16238798|NCT03634488|39360651|FG000|Overall Study|Death|1|||
16238799|NCT03634488|39360652|FG001|Overall Study|Death|0|||
16238800|NCT03634488|39360653|FG002|Overall Study|Death|0|||
16238801|NCT03634488|39360651|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
16238802|NCT03634488|39360652|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
16238803|NCT03634488|39360653|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
16238804|NCT01556165|39360654|FG000|Overall Study|Adverse Event|5|||
16238805|NCT01556165|39360655|FG001|Overall Study|Adverse Event|3|||
16238806|NCT01556165|39360654|FG000|Overall Study|Protocol Violation|0|||
16238807|NCT01556165|39360655|FG001|Overall Study|Protocol Violation|3|||
16238808|NCT01556165|39360654|FG000|Overall Study|Withdrawal of Consent|7|||
16238809|NCT01556165|39360655|FG001|Overall Study|Withdrawal of Consent|1|||
16238810|NCT02367729|39360658|FG000|Overall Study|Organic disorder diagnosed|2|||
16238811|NCT02367729|39360659|FG001|Overall Study|Organic disorder diagnosed|1|||
16238812|NCT02367729|39360658|FG000|Overall Study|Adverse Event|1|||
16238813|NCT02367729|39360659|FG001|Overall Study|Adverse Event|2|||
16238814|NCT02367729|39360658|FG000|Overall Study|Withdrawal by Subject|0|||
16238815|NCT02367729|39360659|FG001|Overall Study|Withdrawal by Subject|5|||
16238816|NCT03237481|39360660|FG000|Overall Study|Lost to Follow-up|1|||
16238817|NCT03237481|39360661|FG001|Overall Study|Lost to Follow-up|0|||
16238818|NCT03237481|39360662|FG002|Overall Study|Lost to Follow-up|0|||
16238819|NCT03237481|39360660|FG000|Overall Study|Protocol Violation|1|||
16238820|NCT03237481|39360661|FG001|Overall Study|Protocol Violation|0|||
16238821|NCT03237481|39360662|FG002|Overall Study|Protocol Violation|0|||
16238822|NCT03237481|39360660|FG000|Overall Study|Withdrawal by Subject|3|||
16238823|NCT03237481|39360661|FG001|Overall Study|Withdrawal by Subject|2|||
16238824|NCT03237481|39360662|FG002|Overall Study|Withdrawal by Subject|1|||
16238825|NCT04529499|39360663|FG000|Overall Study|Withdrawal by Subject|9|||
16238826|NCT04529499|39360664|FG001|Overall Study|Withdrawal by Subject|11|||
16238827|NCT04529499|39360663|FG000|Overall Study|Physician Decision|1|||
16238828|NCT04529499|39360664|FG001|Overall Study|Physician Decision|2|||
16238829|NCT04529499|39360663|FG000|Overall Study|Adverse Event|4|||
16556533|NCT04159896|40503424|FG000|Overall Study|Withdrawal by Subject|1|||
16556534|NCT04159896|40503424|FG000|Overall Study|Adverse Event|1|||
16556535|NCT04159896|40503424|FG000|Overall Study|A transient ischaemic attack|1|||
16238830|NCT04529499|39360664|FG001|Overall Study|Adverse Event|4|||
16238831|NCT04529499|39360663|FG000|Overall Study|Death|14|||
16238832|NCT04529499|39360664|FG001|Overall Study|Death|11|||
16238833|NCT04529499|39360663|FG000|Overall Study|Lost to Follow-up|1|||
16238834|NCT04529499|39360664|FG001|Overall Study|Lost to Follow-up|1|||
16238835|NCT04529499|39360663|FG000|Overall Study|Others|7|||
16238836|NCT04529499|39360664|FG001|Overall Study|Others|11|||
16238837|NCT00701558|39360667|FG000|Overall Study|Death|7|||
16238838|NCT00701558|39360667|FG000|Overall Study|Lost to Follow-up|8|||
16238839|NCT00449930|39360670|FG000|Overall Study|Adverse Event|9|||
16238840|NCT00449930|39360671|FG001|Overall Study|Adverse Event|19|||
16238841|NCT00449930|39360670|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
16238842|NCT00449930|39360671|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
16238843|NCT00449930|39360670|FG000|Overall Study|Lack of Efficacy|10|||
16238844|NCT00449930|39360671|FG001|Overall Study|Lack of Efficacy|1|||
16238845|NCT00449930|39360670|FG000|Overall Study|Lost to Follow-up|9|||
16238846|NCT00449930|39360671|FG001|Overall Study|Lost to Follow-up|14|||
16238847|NCT00449930|39360670|FG000|Overall Study|Physician Decision|1|||
16238848|NCT00449930|39360671|FG001|Overall Study|Physician Decision|2|||
16238849|NCT00449930|39360670|FG000|Overall Study|Protocol Violation|14|||
16238850|NCT00449930|39360671|FG001|Overall Study|Protocol Violation|15|||
16238851|NCT00449930|39360670|FG000|Overall Study|Withdrawal by Subject|16|||
16238852|NCT00449930|39360671|FG001|Overall Study|Withdrawal by Subject|23|||
16238853|NCT00449930|39360670|FG000|Overall Study|Glycemic discontinuation criteria|1|||
16238854|NCT00449930|39360671|FG001|Overall Study|Glycemic discontinuation criteria|1|||
16122990|NCT02514239|38934687|FG009|Overall Study|Refused to continue trial medication|1|||
16122991|NCT02514239|38934678|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
16122992|NCT02514239|38934679|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
16238855|NCT00289731|39360672|FG000|Overall Study|Adverse Event|1|||
16238856|NCT00289731|39360673|FG001|Overall Study|Adverse Event|2|||
16238857|NCT00289731|39360674|FG002|Overall Study|Adverse Event|2|||
16238858|NCT00289731|39360672|FG000|Overall Study|Other|1|||
16238859|NCT00289731|39360673|FG001|Overall Study|Other|0|||
16238860|NCT00289731|39360674|FG002|Overall Study|Other|0|||
16238861|NCT02564952|39360677|FG000|Overall Study|Adverse Event|6|||
16556536|NCT03382600|40503425|FG000|Overall Study|Adverse Event|3|||
16556537|NCT03382600|40503426|FG001|Overall Study|Adverse Event|3|||
16238862|NCT02564952|39360677|FG000|Overall Study|Lost to Follow-up|1|||
16238863|NCT02564952|39360677|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
16238864|NCT02564952|39360677|FG000|Overall Study|Withdrawal by Subject|1|||
16238865|NCT02564952|39360677|FG000|Overall Study|Low Efficacy|1|||
16238866|NCT02564952|39360677|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
16238867|NCT00627458|39360678|FG000|Overall Study|Migrated from study area|1|||
16238868|NCT00627458|39360679|FG001|Overall Study|Migrated from study area|0|||
16238869|NCT00627458|39360680|FG002|Overall Study|Migrated from study area|1|||
16238870|NCT00627458|39360678|FG000|Overall Study|Withdrawal by Subject|2|||
16238871|NCT00627458|39360679|FG001|Overall Study|Withdrawal by Subject|6|||
16238872|NCT00627458|39360680|FG002|Overall Study|Withdrawal by Subject|5|||
16238873|NCT00627458|39360678|FG000|Overall Study|Lost to Follow-up|1|||
16238874|NCT00627458|39360679|FG001|Overall Study|Lost to Follow-up|1|||
16238875|NCT00627458|39360680|FG002|Overall Study|Lost to Follow-up|0|||
16238876|NCT00468312|39360681|FG000|Overall Study|Adverse Event|2|||
16238877|NCT00468312|39360682|FG001|Overall Study|Adverse Event|1|||
16238878|NCT00468312|39360681|FG000|Overall Study|Lack of Efficacy|0|||
16238879|NCT00468312|39360682|FG001|Overall Study|Lack of Efficacy|1|||
16238880|NCT00468312|39360681|FG000|Overall Study|Withdrawal by Subject|0|||
16238881|NCT00468312|39360682|FG001|Overall Study|Withdrawal by Subject|1|||
16238882|NCT00468312|39360681|FG000|Overall Study|Protocol Violation|2|||
16238883|NCT00468312|39360682|FG001|Overall Study|Protocol Violation|1|||
16238884|NCT00468312|39360681|FG000|Overall Study|Did not meet protocol eligibility|0|||
16238885|NCT00468312|39360682|FG001|Overall Study|Did not meet protocol eligibility|1|||
16238886|NCT02956005|39360683|FG000|Overall Study|Not eligible|1|||
16238887|NCT02956005|39360683|FG000|Overall Study|Withdrawal by Subject|3|||
16238888|NCT02956005|39360683|FG000|Overall Study|Physician Decision|12|||
16238889|NCT02239692|39360684|FG000|Overall Study|Incomplete colonoscopy|1|||
16238890|NCT02239692|39360685|FG001|Overall Study|Incomplete colonoscopy|2|||
16238891|NCT02239692|39360684|FG000|Overall Study|Adverse Event|0|||
16238892|NCT02239692|39360685|FG001|Overall Study|Adverse Event|1|||
16556538|NCT03382600|40503425|FG000|Overall Study|Clinical Disease Progression|2|||
16556539|NCT03382600|40503426|FG001|Overall Study|Clinical Disease Progression|4|||
16556540|NCT03382600|40503425|FG000|Overall Study|Radiological Progression|40|||
16556541|NCT03382600|40503426|FG001|Overall Study|Radiological Progression|31|||
16556542|NCT03382600|40503425|FG000|Overall Study|Withdrawal by Subject|0|||
16556543|NCT03382600|40503426|FG001|Overall Study|Withdrawal by Subject|1|||
16556544|NCT03382600|40503425|FG000|Overall Study|Other|9|||
16556545|NCT03382600|40503426|FG001|Overall Study|Other|7|||
16238893|NCT02239692|39360684|FG000|Overall Study|Physician Decision|0|||
16556546|NCT00278564|40503431|FG000|Overall Study|Lack of Efficacy|4|||
16238894|NCT02239692|39360685|FG001|Overall Study|Physician Decision|1|||
16238895|NCT02239692|39360684|FG000|Overall Study|Lost to Follow-up|1|||
16238896|NCT02239692|39360685|FG001|Overall Study|Lost to Follow-up|4|||
16238897|NCT02239692|39360684|FG000|Overall Study|Withdrawal by Subject|3|||
16238898|NCT02239692|39360685|FG001|Overall Study|Withdrawal by Subject|5|||
16238899|NCT02239692|39360684|FG000|Overall Study|Other reason|1|||
16238900|NCT02239692|39360685|FG001|Overall Study|Other reason|0|||
16238901|NCT01120600|39360686|FG000|Overall Study|Adverse Event|7|||
16238902|NCT01120600|39360687|FG001|Overall Study|Adverse Event|7|||
16238903|NCT01120600|39360686|FG000|Overall Study|Excessive Bone Loss|0|||
16238904|NCT01120600|39360687|FG001|Overall Study|Excessive Bone Loss|4|||
16238905|NCT01120600|39360686|FG000|Overall Study|Lost to Follow-up|1|||
16238906|NCT01120600|39360687|FG001|Overall Study|Lost to Follow-up|3|||
16238907|NCT01120600|39360686|FG000|Overall Study|Physician Decision|1|||
16238908|NCT01120600|39360687|FG001|Overall Study|Physician Decision|3|||
16238909|NCT01120600|39360686|FG000|Overall Study|Protocol Violation|0|||
16238910|NCT01120600|39360687|FG001|Overall Study|Protocol Violation|4|||
16238911|NCT01120600|39360686|FG000|Overall Study|Withdrawal by Subject|10|||
16238912|NCT01120600|39360687|FG001|Overall Study|Withdrawal by Subject|11|||
16238913|NCT04128696|39360689|FG000|Overall Study|Lost to Follow-up|3|||
16238914|NCT04128696|39360690|FG001|Overall Study|Lost to Follow-up|7|||
16238915|NCT04128696|39360689|FG000|Overall Study|Withdrawal by Subject|12|||
16238916|NCT04128696|39360690|FG001|Overall Study|Withdrawal by Subject|11|||
16238917|NCT04128696|39360689|FG000|Overall Study|Study Closed/Terminated|26|||
16238918|NCT04128696|39360690|FG001|Overall Study|Study Closed/Terminated|38|||
16238919|NCT04128696|39360689|FG000|Overall Study|Physician Decision|2|||
16238920|NCT04128696|39360690|FG001|Overall Study|Physician Decision|3|||
16238921|NCT02470585|39360693|FG000|Overall Study|Death|82|||
16238922|NCT02470585|39360694|FG001|Overall Study|Death|87|||
16238923|NCT02470585|39360695|FG002|Overall Study|Death|86|||
16238924|NCT02470585|39360693|FG000|Overall Study|Withdrawal by Subject|19|||
16238925|NCT02470585|39360694|FG001|Overall Study|Withdrawal by Subject|21|||
16238926|NCT02470585|39360695|FG002|Overall Study|Withdrawal by Subject|29|||
16238927|NCT02470585|39360693|FG000|Overall Study|Lost to Follow-up|2|||
16238928|NCT02470585|39360694|FG001|Overall Study|Lost to Follow-up|5|||
16238929|NCT02470585|39360695|FG002|Overall Study|Lost to Follow-up|4|||
16238930|NCT02470585|39360693|FG000|Overall Study|Other|4|||
16238931|NCT02470585|39360694|FG001|Overall Study|Other|4|||
16238932|NCT02470585|39360695|FG002|Overall Study|Other|6|||
16238933|NCT01963676|39360696|FG000|Overall Study|Withdrawal by Subject|1|||
16238934|NCT01963676|39360697|FG001|Overall Study|Withdrawal by Subject|0|||
16238935|NCT01678924|39360698|FG000|Overall Study|Adverse Event|1|||
16238936|NCT01678924|39360699|FG001|Overall Study|Adverse Event|1|||
16238937|NCT01678924|39360700|FG002|Overall Study|Adverse Event|0|||
16238938|NCT01678924|39360701|FG003|Overall Study|Adverse Event|1|||
16238939|NCT01678924|39360698|FG000|Overall Study|Lack of Efficacy|7|||
16238940|NCT01678924|39360699|FG001|Overall Study|Lack of Efficacy|2|||
16238941|NCT01678924|39360700|FG002|Overall Study|Lack of Efficacy|0|||
16238942|NCT01678924|39360701|FG003|Overall Study|Lack of Efficacy|5|||
16350128|NCT03286218|39768962|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
16350129|NCT03286218|39768951|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
16238943|NCT01678924|39360698|FG000|Overall Study|Lost to Follow-up|0|||
16238944|NCT01678924|39360699|FG001|Overall Study|Lost to Follow-up|4|||
16238945|NCT01678924|39360700|FG002|Overall Study|Lost to Follow-up|0|||
16238946|NCT01678924|39360701|FG003|Overall Study|Lost to Follow-up|2|||
16238947|NCT01678924|39360698|FG000|Overall Study|Personal Reasons|2|||
16238948|NCT01678924|39360699|FG001|Overall Study|Personal Reasons|2|||
16238949|NCT01678924|39360700|FG002|Overall Study|Personal Reasons|2|||
16238950|NCT01678924|39360701|FG003|Overall Study|Personal Reasons|7|||
16238951|NCT01678924|39360698|FG000|Overall Study|Withdrawal by Subject|0|||
16238952|NCT01678924|39360699|FG001|Overall Study|Withdrawal by Subject|3|||
16238953|NCT01678924|39360700|FG002|Overall Study|Withdrawal by Subject|0|||
16238954|NCT01678924|39360701|FG003|Overall Study|Withdrawal by Subject|2|||
16238955|NCT01678924|39360698|FG000|Overall Study|Unable to attend scheduled visits|0|||
16238956|NCT01678924|39360699|FG001|Overall Study|Unable to attend scheduled visits|0|||
16238957|NCT01678924|39360700|FG002|Overall Study|Unable to attend scheduled visits|0|||
16238958|NCT01678924|39360701|FG003|Overall Study|Unable to attend scheduled visits|1|||
16122993|NCT02514239|38934680|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
16122994|NCT02514239|38934681|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
16122995|NCT02514239|38934682|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
16238959|NCT00802529|39360705|FG000|Overall Study|Lost to Follow-up|0|||
16238960|NCT00802529|39360706|FG001|Overall Study|Lost to Follow-up|1|||
16238961|NCT00068406|39360711|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
16238962|NCT00068406|39360711|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
16238963|NCT00337129|39360712|FG000|Overall Study|Adverse Event|4|||
16238964|NCT00337129|39360712|FG000|Overall Study|Withdrawal by Subject|1|||
16238965|NCT00337129|39360712|FG000|Overall Study|Lack of Efficacy|32|||
16238966|NCT00337129|39360712|FG000|Overall Study|Death|2|||
16238967|NCT00337129|39360712|FG000|Overall Study|not protocol specified|1|||
16238968|NCT00478673|39360713|FG000|30-Days Post-Procedure|Death|2|||
16238969|NCT00478673|39360713|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
16238970|NCT00478673|39360713|FG000|30-Days Post-Procedure|Missed Visit|7|||
16238971|NCT00478673|39360713|FG000|12-Months Post-Procedure|Death|23|||
16238972|NCT00478673|39360713|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
16238973|NCT00478673|39360713|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
16238974|NCT00478673|39360713|FG000|12-Months Post-Procedure|Missed Visit|25|||
16238975|NCT00478673|39360713|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
16238976|NCT02556632|39360716|FG000|Overall Study|Lost to Follow-up|1|||
16238977|NCT02556632|39360717|FG001|Overall Study|Lost to Follow-up|0|||
16238978|NCT02556632|39360718|FG002|Overall Study|Lost to Follow-up|0|||
16238979|NCT02556632|39360716|FG000|Overall Study|Disliked Intervention|1|||
16238980|NCT02556632|39360717|FG001|Overall Study|Disliked Intervention|1|||
16238981|NCT02556632|39360718|FG002|Overall Study|Disliked Intervention|1|||
16238982|NCT02556632|39360716|FG000|Overall Study|No Reason|1|||
16238983|NCT02556632|39360717|FG001|Overall Study|No Reason|0|||
16238984|NCT02556632|39360718|FG002|Overall Study|No Reason|1|||
16238985|NCT02556632|39360716|FG000|Overall Study|Personal Issues|0|||
16238986|NCT02556632|39360717|FG001|Overall Study|Personal Issues|1|||
16238987|NCT02556632|39360718|FG002|Overall Study|Personal Issues|1|||
16122996|NCT02514239|38934683|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
16122997|NCT02514239|38934684|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
16238988|NCT02556632|39360716|FG000|Overall Study|Changed Mind|0|||
16238989|NCT02556632|39360717|FG001|Overall Study|Changed Mind|1|||
16238990|NCT02556632|39360718|FG002|Overall Study|Changed Mind|0|||
16238991|NCT02556632|39360716|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
16238992|NCT02556632|39360717|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
16238993|NCT02556632|39360718|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
16238994|NCT02556632|39360716|FG000|Overall Study|Unrelated Adverse Event|1|||
16238995|NCT02556632|39360717|FG001|Overall Study|Unrelated Adverse Event|0|||
16238996|NCT02556632|39360718|FG002|Overall Study|Unrelated Adverse Event|3|||
16238997|NCT02556632|39360716|FG000|Overall Study|Related Adverse Event|0|||
16238998|NCT02556632|39360717|FG001|Overall Study|Related Adverse Event|1|||
16238999|NCT02556632|39360718|FG002|Overall Study|Related Adverse Event|0|||
16239000|NCT02556632|39360716|FG000|Overall Study|Possibly Related Adverse Event|0|||
16239001|NCT02556632|39360717|FG001|Overall Study|Possibly Related Adverse Event|0|||
16239002|NCT02556632|39360718|FG002|Overall Study|Possibly Related Adverse Event|1|||
16239003|NCT02556632|39360716|FG000|Overall Study|Did Not Start RT|0|||
16239004|NCT02556632|39360717|FG001|Overall Study|Did Not Start RT|1|||
16239005|NCT02556632|39360718|FG002|Overall Study|Did Not Start RT|0|||
16239006|NCT02556632|39360716|FG000|Overall Study|Ineligible|0|||
16239007|NCT02556632|39360717|FG001|Overall Study|Ineligible|1|||
16239008|NCT02556632|39360718|FG002|Overall Study|Ineligible|0|||
16239009|NCT02556632|39360716|FG000|Overall Study|Disliked Study Procedures|0|||
16239010|NCT02556632|39360717|FG001|Overall Study|Disliked Study Procedures|0|||
16239011|NCT02556632|39360718|FG002|Overall Study|Disliked Study Procedures|1|||
16239012|NCT02556632|39360716|FG000|Overall Study|Treatment or Change Delay|0|||
16239013|NCT02556632|39360717|FG001|Overall Study|Treatment or Change Delay|0|||
16239014|NCT02556632|39360718|FG002|Overall Study|Treatment or Change Delay|1|||
16239015|NCT00068445|39360719|FG000|Randomization|Cancel|1|||
16239016|NCT00068445|39360720|FG001|Randomization|Cancel|3|||
16239017|NCT00068445|39360719|FG000|Randomization|Ineligible|1|||
16239018|NCT00068445|39360720|FG001|Randomization|Ineligible|1|||
16239019|NCT00068445|39360719|FG000|Treatment|Refused Further Treatment|13|||
16239020|NCT00068445|39360720|FG001|Treatment|Refused Further Treatment|10|||
16239021|NCT00068445|39360719|FG000|Treatment|Adverse Event|7|||
16239022|NCT00068445|39360720|FG001|Treatment|Adverse Event|1|||
16239023|NCT00068445|39360719|FG000|Treatment|Other (Specifics not available)|9|||
16239024|NCT00068445|39360720|FG001|Treatment|Other (Specifics not available)|5|||
16239025|NCT01418352|39360721|FG000|Overall Study|Lost to Follow-up|2|||
16239026|NCT01418352|39360722|FG001|Overall Study|Lost to Follow-up|0|||
16556547|NCT04445155|40503434|FG000|Overall Study|Lost to Follow-up|11|||
16556548|NCT04445155|40503435|FG001|Overall Study|Lost to Follow-up|2|||
16556549|NCT04445155|40503436|FG002|Overall Study|Lost to Follow-up|3|||
16556550|NCT04445155|40503437|FG003|Overall Study|Lost to Follow-up|0|||
16556551|NCT04445155|40503434|FG000|Overall Study|Withdrawal by Subject|8|||
16556552|NCT04445155|40503435|FG001|Overall Study|Withdrawal by Subject|0|||
16556553|NCT04445155|40503436|FG002|Overall Study|Withdrawal by Subject|0|||
16556554|NCT04445155|40503437|FG003|Overall Study|Withdrawal by Subject|0|||
16556555|NCT04445155|40503434|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
16556556|NCT04445155|40503435|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
16556557|NCT04445155|40503436|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
16556558|NCT04445155|40503437|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
16556559|NCT04445155|40503434|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
16556560|NCT04445155|40503435|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
16239027|NCT01418352|39360723|FG002|Overall Study|Lost to Follow-up|0|||
16239028|NCT01418352|39360724|FG003|Overall Study|Lost to Follow-up|0|||
16239029|NCT01418352|39360721|FG000|Overall Study|Adverse Event|0|||
16239030|NCT01418352|39360722|FG001|Overall Study|Adverse Event|1|||
16239031|NCT01418352|39360723|FG002|Overall Study|Adverse Event|0|||
16239032|NCT01418352|39360724|FG003|Overall Study|Adverse Event|0|||
16239033|NCT01418352|39360721|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
16239034|NCT01418352|39360722|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
16239035|NCT01418352|39360723|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
16239036|NCT01418352|39360724|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
16239037|NCT01418352|39360721|FG000|Overall Study|Subject Withdrew Consent|0|||
16239038|NCT01418352|39360722|FG001|Overall Study|Subject Withdrew Consent|1|||
16239039|NCT01418352|39360723|FG002|Overall Study|Subject Withdrew Consent|2|||
16239040|NCT01418352|39360724|FG003|Overall Study|Subject Withdrew Consent|1|||
16239041|NCT01418352|39360721|FG000|Overall Study|Protocol Deviation|0|||
16239042|NCT01418352|39360722|FG001|Overall Study|Protocol Deviation|0|||
16239043|NCT01418352|39360723|FG002|Overall Study|Protocol Deviation|1|||
16239044|NCT01418352|39360724|FG003|Overall Study|Protocol Deviation|0|||
16239045|NCT01418352|39360721|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
16239046|NCT01418352|39360722|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
16239047|NCT01418352|39360723|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
16239048|NCT01418352|39360724|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
16239049|NCT00895583|39360725|FG000|Overall Study|Adverse Event|28|||
16239050|NCT00895583|39360726|FG001|Overall Study|Adverse Event|4|||
16414198|NCT04376827|39998348|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
16414199|NCT04376827|39998349|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
16414200|NCT02581930|39998355|FG000|Overall Study|Withdrawal by Subject|1|||
16414201|NCT02581930|39998355|FG000|Overall Study|patient declined further treatment|1|||
16414202|NCT00975143|39998356|FG000|Overall Study|Adverse Event|19|||
16414203|NCT00975143|39998357|FG001|Overall Study|Adverse Event|15|||
16414204|NCT00975143|39998356|FG000|Overall Study|Withdrawal by Subject|15|||
16414205|NCT00975143|39998357|FG001|Overall Study|Withdrawal by Subject|15|||
16414206|NCT00975143|39998356|FG000|Overall Study|Lost to Follow-up|20|||
16414207|NCT00975143|39998357|FG001|Overall Study|Lost to Follow-up|16|||
16239051|NCT00895583|39360725|FG000|Overall Study|Death|2|||
16239052|NCT00895583|39360726|FG001|Overall Study|Death|1|||
16239053|NCT00895583|39360725|FG000|Overall Study|Physician Decision|3|||
16239054|NCT00895583|39360726|FG001|Overall Study|Physician Decision|1|||
16239055|NCT00895583|39360725|FG000|Overall Study|Lost to Follow-up|1|||
16239056|NCT00895583|39360726|FG001|Overall Study|Lost to Follow-up|3|||
16239057|NCT00895583|39360725|FG000|Overall Study|Protocol Violation|1|||
16239058|NCT00895583|39360726|FG001|Overall Study|Protocol Violation|0|||
16239059|NCT00895583|39360725|FG000|Overall Study|Withdrawal by Subject|4|||
16239060|NCT00895583|39360726|FG001|Overall Study|Withdrawal by Subject|2|||
16239061|NCT00895583|39360725|FG000|Overall Study|Lack of Efficacy|5|||
16239062|NCT00895583|39360726|FG001|Overall Study|Lack of Efficacy|0|||
16239063|NCT00895583|39360725|FG000|Overall Study|Other|0|||
16239064|NCT00895583|39360726|FG001|Overall Study|Other|1|||
16239065|NCT00000135|39360732|FG000|Overall Study|Death|27|||
16239066|NCT00000135|39360733|FG001|Overall Study|Death|14|||
16239067|NCT00267020|39360734|FG000|Overall Study|Adverse Event|22|||
16239068|NCT00267020|39360735|FG001|Overall Study|Adverse Event|5|||
16239069|NCT00267020|39360734|FG000|Overall Study|Death|2|||
16239070|NCT00267020|39360735|FG001|Overall Study|Death|1|||
16239071|NCT00267020|39360734|FG000|Overall Study|Withdrawal by Subject|17|||
16239072|NCT00267020|39360735|FG001|Overall Study|Withdrawal by Subject|7|||
16239073|NCT00267020|39360734|FG000|Overall Study|Physician Decision|3|||
16239074|NCT00267020|39360735|FG001|Overall Study|Physician Decision|2|||
16239075|NCT00267020|39360734|FG000|Overall Study|Disease Progression|39|||
16239076|NCT00267020|39360735|FG001|Overall Study|Disease Progression|25|||
16239077|NCT00267020|39360734|FG000|Overall Study|Unrelated Complication|1|||
16239078|NCT00267020|39360735|FG001|Overall Study|Unrelated Complication|1|||
16239079|NCT00267020|39360734|FG000|Overall Study|Sponsor Request|1|||
16239080|NCT00267020|39360735|FG001|Overall Study|Sponsor Request|0|||
16239081|NCT00267020|39360734|FG000|Overall Study|Other|1|||
16239082|NCT00267020|39360735|FG001|Overall Study|Other|2|||
16239083|NCT02913261|39360744|FG000|Overall Study|Technical problems|0|||
16239084|NCT02913261|39360745|FG001|Overall Study|Technical problems|1|||
16239085|NCT02913261|39360744|FG000|Overall Study|Lack of Efficacy|32|||
16239086|NCT02913261|39360745|FG001|Overall Study|Lack of Efficacy|69|||
16239087|NCT02913261|39360744|FG000|Overall Study|Adverse Event|27|||
16239088|NCT02913261|39360745|FG001|Overall Study|Adverse Event|5|||
16239089|NCT02913261|39360744|FG000|Overall Study|Death|25|||
16239090|NCT02913261|39360745|FG001|Overall Study|Death|22|||
16239091|NCT02913261|39360744|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
16239092|NCT02913261|39360745|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
16239093|NCT02913261|39360744|FG000|Overall Study|Disease relapse|8|||
16239094|NCT02913261|39360745|FG001|Overall Study|Disease relapse|13|||
16239095|NCT02913261|39360744|FG000|Overall Study|Physician Decision|8|||
16239096|NCT02913261|39360745|FG001|Overall Study|Physician Decision|9|||
16239097|NCT02913261|39360744|FG000|Overall Study|Subject/guardian decision|4|||
16239098|NCT02913261|39360745|FG001|Overall Study|Subject/guardian decision|6|||
16239099|NCT02913261|39360744|FG000|Overall Study|Graft loss|2|||
16239100|NCT02913261|39360745|FG001|Overall Study|Graft loss|0|||
16239101|NCT03044431|39360746|FG000|Overall Study|Lost to Follow-up|59|||
16239102|NCT03701516|39360747|FG000|Period 1|Lost to Follow-up|0|||
16239103|NCT03701516|39360748|FG001|Period 1|Lost to Follow-up|1|||
16239104|NCT03701516|39360747|FG000|Period 1|Adverse Event|0|||
16239105|NCT03701516|39360748|FG001|Period 1|Adverse Event|2|||
16239106|NCT03701516|39360747|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
16239107|NCT03701516|39360748|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
16239108|NCT03701516|39360747|FG000|Period 1|Non Compliance to Protocol|2|||
16239109|NCT03701516|39360748|FG001|Period 1|Non Compliance to Protocol|1|||
16239110|NCT03701516|39360747|FG000|Period 1|Withdrawal by Subject|0|||
16239111|NCT03701516|39360748|FG001|Period 1|Withdrawal by Subject|1|||
16239112|NCT03701516|39360747|FG000|Period 2|failed to meet all eligibility creiteria|1|||
16239113|NCT03701516|39360748|FG001|Period 2|failed to meet all eligibility creiteria|0|||
16239114|NCT03701516|39360747|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
16239115|NCT03701516|39360748|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
16239116|NCT01652573|39360749|FG000|Overall Study|Adverse Event|0|||
16239117|NCT01652573|39360750|FG001|Overall Study|Adverse Event|1|||
16239118|NCT00756652|39360751|FG000|Original Phase|Withdrawal by Subject|864|||
16239119|NCT00756652|39360752|FG001|Original Phase|Withdrawal by Subject|23|||
16239120|NCT00756652|39360751|FG000|Original Phase|Lost to Follow-up|601|||
16239121|NCT00756652|39360752|FG001|Original Phase|Lost to Follow-up|0|||
16239122|NCT00756652|39360751|FG000|Original Phase|Other Discontinuation|797|||
16239123|NCT00756652|39360752|FG001|Original Phase|Other Discontinuation|5|||
16556561|NCT04445155|40503436|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
16556562|NCT04445155|40503437|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
16556563|NCT00619476|40503443|FG000|Overall Study|Adverse Event|12|||
16239124|NCT00756652|39360751|FG000|Original Phase|Participant Noncompliance|18622|||
16239125|NCT00756652|39360752|FG001|Original Phase|Participant Noncompliance|424|||
16239126|NCT00756652|39360751|FG000|Original Phase|Unknown Discontinuation Reason|2|||
16239127|NCT00756652|39360752|FG001|Original Phase|Unknown Discontinuation Reason|0|||
16239128|NCT00756652|39360751|FG000|Original Phase|Participants without data|3259|||
16556564|NCT00619476|40503444|FG001|Overall Study|Adverse Event|6|||
16239129|NCT00756652|39360752|FG001|Original Phase|Participants without data|466|||
16239130|NCT00756652|39360751|FG000|Original Phase|Death|168|||
16239131|NCT00756652|39360752|FG001|Original Phase|Death|1|||
16414208|NCT00975143|39998356|FG000|Overall Study|Non-compliance|5|||
16122998|NCT02514239|38934685|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
16122999|NCT02514239|38934686|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
16123000|NCT02514239|38934687|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
16123001|NCT02514239|38934678|FG000|Overall Study|Not treated|0|||
16239132|NCT00756652|39360751|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
16556565|NCT00619476|40503445|FG002|Overall Study|Adverse Event|12|||
16556566|NCT00619476|40503446|FG003|Overall Study|Adverse Event|16|||
16350130|NCT03286218|39768952|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
16350131|NCT03286218|39768953|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
16556567|NCT00619476|40503443|FG000|Overall Study|Lack of Efficacy|6|||
16556568|NCT00619476|40503444|FG001|Overall Study|Lack of Efficacy|1|||
16350132|NCT03286218|39768954|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
16350133|NCT03286218|39768955|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
16350134|NCT03286218|39768956|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
16556569|NCT00619476|40503445|FG002|Overall Study|Lack of Efficacy|1|||
16556570|NCT00619476|40503446|FG003|Overall Study|Lack of Efficacy|4|||
16556571|NCT00619476|40503443|FG000|Overall Study|Protocol Violation|5|||
16556572|NCT00619476|40503444|FG001|Overall Study|Protocol Violation|4|||
16556573|NCT00619476|40503445|FG002|Overall Study|Protocol Violation|4|||
16556574|NCT00619476|40503446|FG003|Overall Study|Protocol Violation|9|||
16556575|NCT00619476|40503443|FG000|Overall Study|Lost to Follow-up|1|||
16556576|NCT00619476|40503444|FG001|Overall Study|Lost to Follow-up|2|||
16556577|NCT00619476|40503445|FG002|Overall Study|Lost to Follow-up|0|||
16556578|NCT00619476|40503446|FG003|Overall Study|Lost to Follow-up|1|||
16556579|NCT00619476|40503443|FG000|Overall Study|Investigator Discretion|2|||
16556580|NCT00619476|40503444|FG001|Overall Study|Investigator Discretion|2|||
16556581|NCT00619476|40503445|FG002|Overall Study|Investigator Discretion|2|||
16556582|NCT00619476|40503446|FG003|Overall Study|Investigator Discretion|0|||
16556583|NCT00619476|40503443|FG000|Overall Study|Withdrawal by Subject|5|||
16556584|NCT00619476|40503444|FG001|Overall Study|Withdrawal by Subject|7|||
16556585|NCT00619476|40503445|FG002|Overall Study|Withdrawal by Subject|5|||
16556586|NCT00619476|40503446|FG003|Overall Study|Withdrawal by Subject|4|||
16123002|NCT02514239|38934679|FG001|Overall Study|Not treated|1|||
16556587|NCT00550173|40503450|FG000|Overall Study|Death|45|||
16123003|NCT02514239|38934680|FG002|Overall Study|Not treated|0|||
16123004|NCT02514239|38934681|FG003|Overall Study|Not treated|0|||
16123005|NCT02514239|38934682|FG004|Overall Study|Not treated|0|||
16123006|NCT02514239|38934683|FG005|Overall Study|Not treated|0|||
16123007|NCT02514239|38934684|FG006|Overall Study|Not treated|0|||
16123008|NCT02514239|38934685|FG007|Overall Study|Not treated|0|||
16123009|NCT02514239|38934686|FG008|Overall Study|Not treated|0|||
16123010|NCT02514239|38934687|FG009|Overall Study|Not treated|0|||
16123011|NCT02514239|38934678|FG000|Overall Study|Other Adverse Events|2|||
16123012|NCT02514239|38934679|FG001|Overall Study|Other Adverse Events|0|||
16556588|NCT00550173|40503451|FG001|Overall Study|Death|38|||
16556589|NCT00550173|40503452|FG002|Overall Study|Death|50|||
16556590|NCT00550173|40503450|FG000|Overall Study|Physician Decision|1|||
16556591|NCT00550173|40503451|FG001|Overall Study|Physician Decision|2|||
16556592|NCT00550173|40503452|FG002|Overall Study|Physician Decision|2|||
16556593|NCT00550173|40503450|FG000|Overall Study|Withdrawal by Subject|9|||
16556594|NCT00550173|40503451|FG001|Overall Study|Withdrawal by Subject|12|||
16556595|NCT00550173|40503452|FG002|Overall Study|Withdrawal by Subject|17|||
16556596|NCT00550173|40503450|FG000|Overall Study|Sponsor Decision|13|||
16556597|NCT00550173|40503451|FG001|Overall Study|Sponsor Decision|7|||
16556598|NCT00550173|40503452|FG002|Overall Study|Sponsor Decision|1|||
16556599|NCT00550173|40503450|FG000|Overall Study|Lost to Follow-up|4|||
16556600|NCT00550173|40503451|FG001|Overall Study|Lost to Follow-up|4|||
16556601|NCT00550173|40503452|FG002|Overall Study|Lost to Follow-up|3|||
16556602|NCT01804673|40503453|FG000|Overall Study|Adverse Event|4|||
16556603|NCT01804673|40503453|FG000|Overall Study|Withdrawal by Subject|1|||
16556604|NCT01804673|40503453|FG000|Overall Study|Lack of Efficacy|9|||
16556605|NCT01804673|40503453|FG000|Overall Study|Change to Oral Therapy|37|||
16556606|NCT01804673|40503453|FG000|Overall Study|No Further Therapy Required|84|||
16556607|NCT01804673|40503453|FG000|Overall Study|Use of Prohibited Medication|1|||
16556608|NCT01804673|40503453|FG000|Overall Study|Other|4|||
16556609|NCT00791921|40503454|FG000|Overall Study|Protocol planed|24|||
16556610|NCT00791921|40503455|FG001|Overall Study|Protocol planed|88|||
16556611|NCT00791921|40503454|FG000|Overall Study|Withdrawal by Subject|1|||
16556612|NCT00791921|40503455|FG001|Overall Study|Withdrawal by Subject|2|||
16556613|NCT00791921|40503454|FG000|Overall Study|Adverse Event|8|||
16556614|NCT00791921|40503455|FG001|Overall Study|Adverse Event|2|||
16556615|NCT00791921|40503454|FG000|Overall Study|Lack of Efficacy|0|||
16556616|NCT00791921|40503455|FG001|Overall Study|Lack of Efficacy|2|||
16556617|NCT00791921|40503454|FG000|Overall Study|Lack of study drug administration|1|||
16556618|NCT00791921|40503455|FG001|Overall Study|Lack of study drug administration|1|||
16556619|NCT00791921|40503454|FG000|Overall Study|Reason other than those above|0|||
16556620|NCT00791921|40503455|FG001|Overall Study|Reason other than those above|1|||
16556621|NCT00729690|40503456|FG000|Overall Study|IT Catheter Malfunction|0|||
16556622|NCT00729690|40503457|FG001|Overall Study|IT Catheter Malfunction|2|||
16556623|NCT00729690|40503458|FG002|Overall Study|IT Catheter Malfunction|2|||
16556624|NCT02117544|40503459|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
16556625|NCT02117544|40503460|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
16556626|NCT01625338|40503462|FG000|Overall Study|Enrolled but not Treated|0|||
16556627|NCT01625338|40503463|FG001|Overall Study|Enrolled but not Treated|0|||
16556628|NCT01625338|40503464|FG002|Overall Study|Enrolled but not Treated|1|||
16556629|NCT01625338|40503462|FG000|Overall Study|Efficacy Failure|27|||
16556630|NCT01625338|40503463|FG001|Overall Study|Efficacy Failure|39|||
16556631|NCT01625338|40503464|FG002|Overall Study|Efficacy Failure|31|||
16556632|NCT01625338|40503462|FG000|Overall Study|Lost to Follow-up|3|||
16556633|NCT01625338|40503463|FG001|Overall Study|Lost to Follow-up|3|||
16556634|NCT01625338|40503464|FG002|Overall Study|Lost to Follow-up|2|||
16556635|NCT01625338|40503462|FG000|Overall Study|Investigator Decision|0|||
16556636|NCT01625338|40503463|FG001|Overall Study|Investigator Decision|2|||
16556637|NCT01625338|40503464|FG002|Overall Study|Investigator Decision|1|||
16556638|NCT01625338|40503462|FG000|Overall Study|Subject Withdrew Consent|1|||
16556639|NCT01625338|40503463|FG001|Overall Study|Subject Withdrew Consent|0|||
16556640|NCT01625338|40503464|FG002|Overall Study|Subject Withdrew Consent|2|||
16556641|NCT01625338|40503462|FG000|Overall Study|Adverse Event|1|||
16556642|NCT01625338|40503463|FG001|Overall Study|Adverse Event|0|||
16556643|NCT01625338|40503464|FG002|Overall Study|Adverse Event|1|||
16556644|NCT01625338|40503462|FG000|Overall Study|Study Discontinued by Sponsor|0|||
16556645|NCT01625338|40503463|FG001|Overall Study|Study Discontinued by Sponsor|0|||
16556646|NCT01625338|40503464|FG002|Overall Study|Study Discontinued by Sponsor|1|||
16556647|NCT03095599|40503466|FG000|Overall Study|Withdrawal by Subject|1|||
16556648|NCT03095599|40503467|FG001|Overall Study|Withdrawal by Subject|0|||
16556649|NCT03095599|40503466|FG000|Overall Study|Lost to Follow-up|1|||
16556650|NCT03095599|40503467|FG001|Overall Study|Lost to Follow-up|0|||
16123013|NCT02514239|38934680|FG002|Overall Study|Other Adverse Events|0|||
16123014|NCT02514239|38934681|FG003|Overall Study|Other Adverse Events|1|||
16239133|NCT00756652|39360752|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
16239134|NCT00756652|39360751|FG000|Re-Op Phase|Withdrawal by Subject|62|||
16239135|NCT00756652|39360752|FG001|Re-Op Phase|Withdrawal by Subject|0|||
16239136|NCT00756652|39360751|FG000|Re-Op Phase|Death|6|||
16239137|NCT00756652|39360752|FG001|Re-Op Phase|Death|0|||
16239138|NCT00756652|39360751|FG000|Re-Op Phase|Lost to Follow-up|340|||
16239139|NCT00756652|39360752|FG001|Re-Op Phase|Lost to Follow-up|0|||
16239140|NCT00756652|39360751|FG000|Re-Op Phase|Site Closed|2454|||
16556651|NCT03095599|40503466|FG000|Overall Study|Withdrawal prior to vaccination|1|||
16556652|NCT03095599|40503467|FG001|Overall Study|Withdrawal prior to vaccination|0|||
16556653|NCT03257995|40503468|FG000|Overall Study|Adverse Event|0|||
16556654|NCT03257995|40503469|FG001|Overall Study|Adverse Event|1|||
16556655|NCT03257995|40503470|FG002|Overall Study|Adverse Event|0|||
16556656|NCT03257995|40503471|FG003|Overall Study|Adverse Event|0|||
16556657|NCT03257995|40503472|FG004|Overall Study|Adverse Event|0|||
16556658|NCT03257995|40503473|FG005|Overall Study|Adverse Event|0|||
16556659|NCT03257995|40503468|FG000|Overall Study|Protocol deviation|0|||
16556660|NCT03257995|40503469|FG001|Overall Study|Protocol deviation|0|||
16556661|NCT03257995|40503470|FG002|Overall Study|Protocol deviation|0|||
16556662|NCT03257995|40503471|FG003|Overall Study|Protocol deviation|0|||
16556663|NCT03257995|40503472|FG004|Overall Study|Protocol deviation|0|||
16556664|NCT03257995|40503473|FG005|Overall Study|Protocol deviation|2|||
16556665|NCT01804816|40503474|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
16556666|NCT01804816|40503474|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
16556667|NCT01440049|40503480|FG000|Overall Study|Adverse Event|5|||
16556668|NCT02846558|40503484|FG000|Overall Study|Adverse Event|1|||
16556669|NCT02846558|40503485|FG001|Overall Study|Adverse Event|0|||
16556670|NCT02846558|40503486|FG002|Overall Study|Adverse Event|0|||
16556671|NCT02846558|40503487|FG003|Overall Study|Adverse Event|0|||
16556672|NCT02846558|40503484|FG000|Overall Study|Withdrawal by Subject|5|||
16556673|NCT02846558|40503485|FG001|Overall Study|Withdrawal by Subject|4|||
16556674|NCT02846558|40503486|FG002|Overall Study|Withdrawal by Subject|2|||
16556675|NCT02846558|40503487|FG003|Overall Study|Withdrawal by Subject|2|||
16556676|NCT02846558|40503484|FG000|Overall Study|Lost to Follow-up|2|||
16556677|NCT02846558|40503485|FG001|Overall Study|Lost to Follow-up|0|||
16556678|NCT02846558|40503486|FG002|Overall Study|Lost to Follow-up|0|||
16556679|NCT02846558|40503487|FG003|Overall Study|Lost to Follow-up|0|||
16556680|NCT00627042|40503499|FG000|Overall Study|Withdrawal by Subject|2|||
16556681|NCT02226172|40503502|FG000|Overall Study|Participant refused further follow-up|4|||
16556682|NCT02226172|40503502|FG000|Overall Study|Other|5|||
16556683|NCT02226172|40503502|FG000|Overall Study|Death|1|||
16556684|NCT02226172|40503502|FG000|Overall Study|Study terminated by sponsor|1|||
16556685|NCT02226172|40503502|FG000|Overall Study|Adverse Event|6|||
16556686|NCT01040780|40503503|FG000|Overall Study|Protocol Violation|1|||
16239141|NCT00756652|39360752|FG001|Re-Op Phase|Site Closed|0|||
16239142|NCT00756652|39360751|FG000|Re-Op Phase|Withdrawn after explant|14|||
16556687|NCT01040780|40503504|FG001|Overall Study|Protocol Violation|3|||
16556688|NCT00478608|40503506|FG000|Overall Study|Adverse Event|1|||
16556689|NCT00478608|40503506|FG000|Overall Study|Serious Adverse Event|14|||
16556690|NCT00478608|40503506|FG000|Overall Study|Withdrawal by Subject|2|||
16556691|NCT00478608|40503506|FG000|Overall Study|Protocol Violation|3|||
16556692|NCT00180713|40503508|FG000|Overall Study|Withdrawal by Subject|2|||
16239143|NCT00756652|39360752|FG001|Re-Op Phase|Withdrawn after explant|0|||
16556693|NCT00180713|40503509|FG001|Overall Study|Withdrawal by Subject|0|||
16123015|NCT02514239|38934682|FG004|Overall Study|Other Adverse Events|0|||
16123016|NCT02514239|38934683|FG005|Overall Study|Other Adverse Events|1|||
16556694|NCT00180713|40503508|FG000|Overall Study|Adverse Event|3|||
16556695|NCT00180713|40503509|FG001|Overall Study|Adverse Event|3|||
16556696|NCT00507026|40503510|FG000|Overall Study|Lack of Efficacy|6|||
16556697|NCT00507026|40503511|FG001|Overall Study|Lack of Efficacy|4|||
16556698|NCT00507026|40503512|FG002|Overall Study|Lack of Efficacy|21|||
16556699|NCT00507026|40503510|FG000|Overall Study|Withdrawal by Subject|2|||
16556700|NCT00507026|40503511|FG001|Overall Study|Withdrawal by Subject|0|||
16556701|NCT00507026|40503512|FG002|Overall Study|Withdrawal by Subject|0|||
16556702|NCT00507026|40503510|FG000|Overall Study|Investigator Decision|1|||
16556703|NCT00507026|40503511|FG001|Overall Study|Investigator Decision|0|||
16556704|NCT00507026|40503512|FG002|Overall Study|Investigator Decision|0|||
16556705|NCT00507026|40503510|FG000|Overall Study|Adverse Event|2|||
16556706|NCT00507026|40503511|FG001|Overall Study|Adverse Event|0|||
16239144|NCT03944707|39360757|FG000|Overall Study|Adverse Event|0|||
16123017|NCT02514239|38934684|FG006|Overall Study|Other Adverse Events|0|||
16556707|NCT00507026|40503512|FG002|Overall Study|Adverse Event|0|||
16556708|NCT00507026|40503510|FG000|Overall Study|Protocol Violation|1|||
16123018|NCT02514239|38934685|FG007|Overall Study|Other Adverse Events|1|||
16123019|NCT02514239|38934686|FG008|Overall Study|Other Adverse Events|2|||
16123020|NCT02514239|38934687|FG009|Overall Study|Other Adverse Events|0|||
16123021|NCT02514239|38934678|FG000|Overall Study|Progressive disease|3|||
16123022|NCT02514239|38934679|FG001|Overall Study|Progressive disease|3|||
16123023|NCT02514239|38934680|FG002|Overall Study|Progressive disease|2|||
16123024|NCT02514239|38934681|FG003|Overall Study|Progressive disease|2|||
16123025|NCT02514239|38934682|FG004|Overall Study|Progressive disease|3|||
16123026|NCT02514239|38934683|FG005|Overall Study|Progressive disease|3|||
16123027|NCT02514239|38934684|FG006|Overall Study|Progressive disease|4|||
16123028|NCT02514239|38934685|FG007|Overall Study|Progressive disease|2|||
16123029|NCT02514239|38934686|FG008|Overall Study|Progressive disease|5|||
16123030|NCT02514239|38934687|FG009|Overall Study|Progressive disease|0|||
16123031|NCT01008553|38934688|FG000|Period 1 (Titration Period)|Physician Decision|2|||
16123032|NCT01008553|38934689|FG001|Period 1 (Titration Period)|Physician Decision|0|||
16123033|NCT01008553|38934690|FG002|Period 1 (Titration Period)|Physician Decision|0|||
16123034|NCT01008553|38934688|FG000|Period 1 (Titration Period)|Adverse Event|33|||
16123035|NCT01008553|38934689|FG001|Period 1 (Titration Period)|Adverse Event|0|||
16123036|NCT01008553|38934690|FG002|Period 1 (Titration Period)|Adverse Event|0|||
16123037|NCT01008553|38934688|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
16123038|NCT01008553|38934689|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
16123039|NCT01008553|38934690|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
16123040|NCT01008553|38934688|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
16123041|NCT01008553|38934689|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
16123042|NCT01008553|38934690|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
16123043|NCT01008553|38934688|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
16123044|NCT01008553|38934689|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
16123045|NCT01008553|38934690|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
16123046|NCT01008553|38934688|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
16123047|NCT01008553|38934689|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
16123048|NCT01008553|38934690|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
16123049|NCT01008553|38934688|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
16123050|NCT01008553|38934689|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
16123051|NCT01008553|38934690|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
16123052|NCT01008553|38934688|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
16123053|NCT01008553|38934689|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
16123054|NCT01008553|38934690|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
16123055|NCT01008553|38934688|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
16123056|NCT01008553|38934689|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
16123057|NCT01008553|38934690|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
16123058|NCT01008553|38934688|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
16123059|NCT01008553|38934689|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
16123060|NCT01008553|38934690|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
16123061|NCT01008553|38934688|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
16123062|NCT01008553|38934689|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
16123063|NCT01008553|38934690|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
16123064|NCT01008553|38934688|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
16123065|NCT01008553|38934689|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
16123066|NCT01008553|38934690|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
16123067|NCT01008553|38934688|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
16123068|NCT01008553|38934689|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
16123069|NCT01008553|38934690|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
16123070|NCT01008553|38934688|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
16123071|NCT01008553|38934689|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
16123072|NCT01008553|38934690|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
16123073|NCT00626197|38934691|FG000|Overall Study|Did not cooperate|2|||
16239145|NCT03944707|39360758|FG001|Overall Study|Adverse Event|2|||
16239146|NCT03944707|39360757|FG000|Overall Study|Study terminated by sponsor|12|||
16239147|NCT03944707|39360758|FG001|Overall Study|Study terminated by sponsor|7|||
16239148|NCT03944707|39360757|FG000|Overall Study|Subject decision|0|||
16123074|NCT00626197|38934692|FG001|Overall Study|Did not cooperate|6|||
16123075|NCT00626197|38934693|FG002|Overall Study|Did not cooperate|1|||
16123076|NCT00626197|38934691|FG000|Overall Study|Failure to return|6|||
16123077|NCT00626197|38934692|FG001|Overall Study|Failure to return|5|||
16123078|NCT00626197|38934693|FG002|Overall Study|Failure to return|6|||
16123079|NCT00626197|38934691|FG000|Overall Study|Adverse event, serious fatal|3|||
16123080|NCT00626197|38934692|FG001|Overall Study|Adverse event, serious fatal|6|||
16123081|NCT00626197|38934693|FG002|Overall Study|Adverse event, serious fatal|6|||
16123082|NCT00626197|38934691|FG000|Overall Study|Adverse Event|1|||
16123083|NCT00626197|38934692|FG001|Overall Study|Adverse Event|1|||
16123084|NCT00626197|38934693|FG002|Overall Study|Adverse Event|2|||
16123085|NCT00626197|38934691|FG000|Overall Study|Withdrawal by Subject|17|||
16123086|NCT00626197|38934692|FG001|Overall Study|Withdrawal by Subject|17|||
16123087|NCT00626197|38934693|FG002|Overall Study|Withdrawal by Subject|7|||
16123088|NCT00626197|38934691|FG000|Overall Study|Administrative reasons|15|||
16123089|NCT00626197|38934692|FG001|Overall Study|Administrative reasons|19|||
16123090|NCT00626197|38934693|FG002|Overall Study|Administrative reasons|55|||
16123091|NCT00635427|38934694|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
16123092|NCT00635427|38934695|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
16123093|NCT00635427|38934696|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
16123094|NCT00635427|38934697|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
16123095|NCT00635427|38934698|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
16123096|NCT00635427|38934694|FG000|Overall Study|Death|0|||
16123097|NCT00635427|38934695|FG001|Overall Study|Death|0|||
16123098|NCT00635427|38934696|FG002|Overall Study|Death|0|||
16123099|NCT00635427|38934697|FG003|Overall Study|Death|1|||
16123100|NCT00635427|38934698|FG004|Overall Study|Death|0|||
16123101|NCT00635427|38934694|FG000|Overall Study|Termination Of Study By Sponsor|12|||
16123102|NCT00635427|38934695|FG001|Overall Study|Termination Of Study By Sponsor|6|||
16123103|NCT00635427|38934696|FG002|Overall Study|Termination Of Study By Sponsor|10|||
16123104|NCT00635427|38934697|FG003|Overall Study|Termination Of Study By Sponsor|6|||
16123105|NCT00635427|38934698|FG004|Overall Study|Termination Of Study By Sponsor|6|||
16123106|NCT00635427|38934694|FG000|Overall Study|Withdrawal Of Consent|0|||
16123107|NCT00635427|38934695|FG001|Overall Study|Withdrawal Of Consent|0|||
16123108|NCT00635427|38934696|FG002|Overall Study|Withdrawal Of Consent|0|||
16123109|NCT00635427|38934697|FG003|Overall Study|Withdrawal Of Consent|2|||
16123110|NCT00635427|38934698|FG004|Overall Study|Withdrawal Of Consent|2|||
16123111|NCT00461981|38934699|FG000|Overall Study|Lost to Follow-up|9|||
16123112|NCT00461981|38934700|FG001|Overall Study|Lost to Follow-up|6|||
16123113|NCT00461981|38934699|FG000|Overall Study|Withdrawal by Subject|2|||
16123114|NCT00461981|38934700|FG001|Overall Study|Withdrawal by Subject|3|||
16123115|NCT00513305|38934702|FG000|Overall Study|Adverse Event|6|||
16123116|NCT00513305|38934703|FG001|Overall Study|Adverse Event|2|||
16123117|NCT00513305|38934702|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
16123118|NCT00513305|38934703|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
16123119|NCT00513305|38934702|FG000|Overall Study|Lack of Efficacy|8|||
16123120|NCT00513305|38934703|FG001|Overall Study|Lack of Efficacy|13|||
16123121|NCT00513305|38934702|FG000|Overall Study|Withdrawal by Subject|1|||
16123122|NCT00513305|38934703|FG001|Overall Study|Withdrawal by Subject|2|||
16123123|NCT00513305|38934702|FG000|Overall Study|Disease progression|8|||
16123124|NCT00513305|38934703|FG001|Overall Study|Disease progression|5|||
16123125|NCT00513305|38934702|FG000|Overall Study|Eligible for stem cell transplant|1|||
16123126|NCT00513305|38934703|FG001|Overall Study|Eligible for stem cell transplant|0|||
16123127|NCT00513305|38934702|FG000|Overall Study|Hematologic counts did not recover|1|||
16123128|NCT00513305|38934703|FG001|Overall Study|Hematologic counts did not recover|0|||
16123129|NCT00513305|38934702|FG000|Overall Study|Physician Decision|1|||
16123130|NCT00513305|38934703|FG001|Overall Study|Physician Decision|0|||
16123131|NCT00513305|38934702|FG000|Overall Study|Persistent hypocellularity|0|||
16123132|NCT00513305|38934703|FG001|Overall Study|Persistent hypocellularity|1|||
16123133|NCT00513305|38934702|FG000|Overall Study|Sponsor Decision|0|||
16123134|NCT00513305|38934703|FG001|Overall Study|Sponsor Decision|2|||
16123135|NCT01886287|38934704|FG000|Overall Study|Radiographic disease progression|1|||
16123136|NCT01886287|38934704|FG000|Overall Study|Clinical progression due to disease|1|||
16123137|NCT01468181|38934705|FG000|Overall Study|Adverse Event|8|||
16123138|NCT01468181|38934706|FG001|Overall Study|Adverse Event|1|||
16123139|NCT01468181|38934707|FG002|Overall Study|Adverse Event|6|||
16123140|NCT01468181|38934708|FG003|Overall Study|Adverse Event|2|||
16123141|NCT01468181|38934709|FG004|Overall Study|Adverse Event|2|||
16350135|NCT03286218|39768957|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
16350136|NCT03286218|39768958|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
16123142|NCT01468181|38934705|FG000|Overall Study|Protocol Violation|2|||
16123143|NCT01468181|38934706|FG001|Overall Study|Protocol Violation|0|||
16123144|NCT01468181|38934707|FG002|Overall Study|Protocol Violation|1|||
16123145|NCT01468181|38934708|FG003|Overall Study|Protocol Violation|0|||
16123146|NCT01468181|38934709|FG004|Overall Study|Protocol Violation|1|||
16123147|NCT01468181|38934705|FG000|Overall Study|Physician Decision|0|||
16123148|NCT01468181|38934706|FG001|Overall Study|Physician Decision|0|||
16123149|NCT01468181|38934707|FG002|Overall Study|Physician Decision|0|||
16123150|NCT01468181|38934708|FG003|Overall Study|Physician Decision|1|||
16123151|NCT01468181|38934709|FG004|Overall Study|Physician Decision|1|||
16123152|NCT01468181|38934705|FG000|Overall Study|Lost to Follow-up|0|||
16123153|NCT01468181|38934706|FG001|Overall Study|Lost to Follow-up|0|||
16123154|NCT01468181|38934707|FG002|Overall Study|Lost to Follow-up|1|||
16123155|NCT01468181|38934708|FG003|Overall Study|Lost to Follow-up|0|||
16123156|NCT01468181|38934709|FG004|Overall Study|Lost to Follow-up|1|||
16123157|NCT01468181|38934705|FG000|Overall Study|Withdrawal by Subject|0|||
16123158|NCT01468181|38934706|FG001|Overall Study|Withdrawal by Subject|1|||
16123159|NCT01468181|38934707|FG002|Overall Study|Withdrawal by Subject|0|||
16123160|NCT01468181|38934708|FG003|Overall Study|Withdrawal by Subject|0|||
16123161|NCT01468181|38934709|FG004|Overall Study|Withdrawal by Subject|0|||
16123162|NCT02060370|38938416|FG000|Overall Study|Physician Decision|1|||
16123163|NCT01012414|38938417|FG000|Overall Study|Withdrawal by Subject|2|||
16123164|NCT01012414|38938417|FG000|Overall Study|Lost to Follow-up|1|||
16123165|NCT01012414|38938417|FG000|Overall Study|Trial was stopped before completed|7|||
16123166|NCT00837694|38938423|FG000|Overall Study|Lost to Follow-up|2|||
16123167|NCT00837694|38938424|FG001|Overall Study|Lost to Follow-up|0|||
16123168|NCT00837694|38938425|FG002|Overall Study|Lost to Follow-up|2|||
16123169|NCT00837694|38938426|FG003|Overall Study|Lost to Follow-up|1|||
16123170|NCT00837694|38938427|FG004|Overall Study|Lost to Follow-up|1|||
16123171|NCT00837694|38938428|FG005|Overall Study|Lost to Follow-up|1|||
16123172|NCT04445987|38938440|FG000|Overall Study|Adverse Event|0|||
16123173|NCT04445987|38938441|FG001|Overall Study|Adverse Event|0|||
16123174|NCT04445987|38938442|FG002|Overall Study|Adverse Event|1|||
16123175|NCT04445987|38938443|FG003|Overall Study|Adverse Event|0|||
16123176|NCT04445987|38938444|FG004|Overall Study|Adverse Event|4|||
16123177|NCT04445987|38938445|FG005|Overall Study|Adverse Event|0|||
16123178|NCT04445987|38938440|FG000|Overall Study|Lost to Follow-up|4|||
16123179|NCT04445987|38938441|FG001|Overall Study|Lost to Follow-up|3|||
16239149|NCT03944707|39360758|FG001|Overall Study|Subject decision|1|||
16239150|NCT03611751|39360759|FG000|Pre-treatment|Randomized but not treated|1|||
16239151|NCT03611751|39360760|FG001|Pre-treatment|Randomized but not treated|1|||
16239152|NCT03611751|39360761|FG002|Pre-treatment|Randomized but not treated|0|||
16239153|NCT03611751|39360759|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
16239154|NCT03611751|39360760|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
16239155|NCT03611751|39360761|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
16239156|NCT03611751|39360759|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
16239157|NCT03611751|39360760|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
16239158|NCT03611751|39360761|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
16239159|NCT03611751|39360759|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
16556709|NCT00507026|40503511|FG001|Overall Study|Protocol Violation|0|||
16556710|NCT00507026|40503512|FG002|Overall Study|Protocol Violation|0|||
16556711|NCT00507026|40503510|FG000|Overall Study|Other|1|||
16556712|NCT00507026|40503511|FG001|Overall Study|Other|0|||
16556713|NCT00507026|40503512|FG002|Overall Study|Other|0|||
16556714|NCT00767104|40503517|FG000|Overall Study|Lost to Follow-up|1|||
16556715|NCT00767104|40503518|FG001|Overall Study|Lost to Follow-up|2|||
16556716|NCT03053492|40503521|FG000|Overall Study|Adverse Event|1|||
16556717|NCT03053492|40503522|FG001|Overall Study|Adverse Event|1|||
16556718|NCT03053492|40503521|FG000|Overall Study|Withdrawal by Subject|7|||
16556719|NCT03053492|40503522|FG001|Overall Study|Withdrawal by Subject|5|||
16556720|NCT01628874|40503525|FG000|Overall Study|Physician Decision|1|||
16556721|NCT01628874|40503526|FG001|Overall Study|Physician Decision|1|||
16556722|NCT01628874|40503525|FG000|Overall Study|Age >4 months|4|||
16556723|NCT01628874|40503526|FG001|Overall Study|Age >4 months|2|||
16556724|NCT00802737|40503528|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
16123180|NCT04445987|38938442|FG002|Overall Study|Lost to Follow-up|1|||
16123181|NCT04445987|38938443|FG003|Overall Study|Lost to Follow-up|1|||
16123182|NCT04445987|38938444|FG004|Overall Study|Lost to Follow-up|29|||
16123183|NCT04445987|38938445|FG005|Overall Study|Lost to Follow-up|0|||
16123184|NCT04445987|38938440|FG000|Overall Study|Physician Decision|0|||
16123185|NCT04445987|38938441|FG001|Overall Study|Physician Decision|0|||
16123186|NCT04445987|38938442|FG002|Overall Study|Physician Decision|0|||
16239160|NCT03611751|39360760|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
16414209|NCT00975143|39998357|FG001|Overall Study|Non-compliance|8|||
16414210|NCT00975143|39998356|FG000|Overall Study|Physician Decision|1|||
16414211|NCT00975143|39998357|FG001|Overall Study|Physician Decision|2|||
16414212|NCT00975143|39998356|FG000|Overall Study|Details not available|10|||
16414213|NCT00975143|39998357|FG001|Overall Study|Details not available|4|||
16414214|NCT02211313|39998358|FG000|Overall Study|Treatment Failure|5|||
16414215|NCT02211313|39998359|FG001|Overall Study|Treatment Failure|2|||
16414216|NCT02211313|39998358|FG000|Overall Study|No Follow up Questionnaires|1|||
16414217|NCT02211313|39998359|FG001|Overall Study|No Follow up Questionnaires|1|||
16556725|NCT00802737|40503529|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
16556726|NCT00802737|40503530|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
16123187|NCT04445987|38938443|FG003|Overall Study|Physician Decision|0|||
16556727|NCT00802737|40503528|FG000|Overall Study|Death|6|||
16556728|NCT00802737|40503529|FG001|Overall Study|Death|5|||
16556729|NCT00802737|40503530|FG002|Overall Study|Death|1|||
16556730|NCT00802737|40503528|FG000|Overall Study|Adverse Event|1|||
16556731|NCT00802737|40503529|FG001|Overall Study|Adverse Event|0|||
16556732|NCT00802737|40503530|FG002|Overall Study|Adverse Event|0|||
16123188|NCT04445987|38938444|FG004|Overall Study|Physician Decision|1|||
16123189|NCT04445987|38938445|FG005|Overall Study|Physician Decision|0|||
16556733|NCT00802737|40503528|FG000|Overall Study|Received Prohibited Therapy|1|||
16556734|NCT00802737|40503529|FG001|Overall Study|Received Prohibited Therapy|0|||
16123190|NCT04445987|38938440|FG000|Overall Study|Protocol Violation|1|||
16123191|NCT04445987|38938441|FG001|Overall Study|Protocol Violation|0|||
16123192|NCT04445987|38938442|FG002|Overall Study|Protocol Violation|0|||
16123193|NCT04445987|38938443|FG003|Overall Study|Protocol Violation|0|||
16123194|NCT04445987|38938444|FG004|Overall Study|Protocol Violation|2|||
16123195|NCT04445987|38938445|FG005|Overall Study|Protocol Violation|0|||
16123196|NCT04445987|38938440|FG000|Overall Study|Withdrawal by Subject|4|||
16123197|NCT04445987|38938441|FG001|Overall Study|Withdrawal by Subject|0|||
16123198|NCT04445987|38938442|FG002|Overall Study|Withdrawal by Subject|1|||
16123199|NCT04445987|38938443|FG003|Overall Study|Withdrawal by Subject|0|||
16123200|NCT04445987|38938444|FG004|Overall Study|Withdrawal by Subject|18|||
16123201|NCT04445987|38938445|FG005|Overall Study|Withdrawal by Subject|1|||
16123202|NCT04445987|38938440|FG000|Overall Study|Other reason|0|||
16414218|NCT01977690|39998362|FG000|Overall Study|Withdrawal by Subject|0|||
16414219|NCT01977690|39998363|FG001|Overall Study|Withdrawal by Subject|4|||
16414220|NCT03743064|39998364|FG000|Overall Study|Adverse Event|7|||
16556735|NCT00802737|40503530|FG002|Overall Study|Received Prohibited Therapy|0|||
16123203|NCT04445987|38938441|FG001|Overall Study|Other reason|0|||
16123204|NCT04445987|38938442|FG002|Overall Study|Other reason|1|||
16123205|NCT04445987|38938443|FG003|Overall Study|Other reason|0|||
16123206|NCT04445987|38938444|FG004|Overall Study|Other reason|2|||
16414221|NCT03743064|39998365|FG001|Overall Study|Adverse Event|9|||
16556736|NCT00802737|40503528|FG000|Overall Study|Ongoing CLL-Treatment|0|||
16556737|NCT00802737|40503529|FG001|Overall Study|Ongoing CLL-Treatment|1|||
16239161|NCT03611751|39360761|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
16239162|NCT03611751|39360759|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
16239163|NCT03611751|39360760|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
16239164|NCT03611751|39360761|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
16239165|NCT03611751|39360759|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
16239166|NCT03611751|39360760|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
16239167|NCT03611751|39360761|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
16239168|NCT03611751|39360759|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
16239169|NCT03611751|39360760|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
16239170|NCT03611751|39360761|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
16239171|NCT03611751|39360759|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
16239172|NCT03611751|39360760|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
16239173|NCT03611751|39360761|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
16239174|NCT03611751|39360759|FG000|Treatment Week 0 - Week 16|Death|0|||
16239175|NCT03611751|39360760|FG001|Treatment Week 0 - Week 16|Death|0|||
16239176|NCT03611751|39360761|FG002|Treatment Week 0 - Week 16|Death|1|||
16239177|NCT03611751|39360759|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
16239178|NCT03611751|39360760|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
16239179|NCT03611751|39360761|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
16414222|NCT03743064|39998364|FG000|Overall Study|Death|25|||
16414223|NCT03743064|39998365|FG001|Overall Study|Death|28|||
16239180|NCT03611751|39360759|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
16239181|NCT03611751|39360760|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
16239182|NCT03611751|39360761|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
16239183|NCT03611751|39360759|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
16239184|NCT03611751|39360760|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
16239185|NCT03611751|39360761|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
16239186|NCT03611751|39360759|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
16239187|NCT03611751|39360760|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
16239188|NCT03611751|39360761|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
16239189|NCT03611751|39360759|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
16239190|NCT03611751|39360760|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
16239191|NCT03611751|39360761|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
16239192|NCT03611751|39360759|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
16239193|NCT03611751|39360760|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
16239194|NCT03611751|39360761|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
16239195|NCT03611751|39360759|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
16239196|NCT03611751|39360760|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
16239197|NCT03611751|39360761|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
16239198|NCT03611751|39360759|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
16239199|NCT03611751|39360760|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
16239200|NCT03611751|39360761|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
16239201|NCT03611751|39360759|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
16239202|NCT03611751|39360760|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
16239203|NCT03611751|39360761|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
16239204|NCT03611751|39360759|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
16239205|NCT03611751|39360760|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
16239206|NCT03611751|39360761|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
16239207|NCT03611751|39360759|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
16239208|NCT03611751|39360760|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
16239209|NCT03611751|39360761|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
16239210|NCT03611751|39360759|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
16239211|NCT03611751|39360760|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
16239212|NCT03611751|39360761|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
16239213|NCT03611751|39360759|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
16239214|NCT03611751|39360760|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
16239215|NCT03611751|39360761|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
16239216|NCT03611751|39360759|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
16239217|NCT03611751|39360760|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
16239218|NCT03611751|39360761|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
16239219|NCT00858234|39360762|FG000|Overall Study|Adverse Event|6|||
16239220|NCT00858234|39360762|FG000|Overall Study|Progressive disease|2|||
16239221|NCT00858234|39360762|FG000|Overall Study|Status unknown|1|||
16239222|NCT01600014|39360763|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
16556738|NCT00802737|40503530|FG002|Overall Study|Ongoing CLL-Treatment|0|||
16556739|NCT00802737|40503528|FG000|Overall Study|Participant too Unwell|0|||
16556740|NCT00802737|40503529|FG001|Overall Study|Participant too Unwell|2|||
16556741|NCT00802737|40503530|FG002|Overall Study|Participant too Unwell|0|||
16239223|NCT01600014|39360764|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
16239224|NCT01600014|39360763|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
16239225|NCT01600014|39360764|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
16239226|NCT01600014|39360763|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
16239227|NCT01600014|39360764|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
16239228|NCT01600014|39360763|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
16239229|NCT01600014|39360764|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
16239230|NCT01600014|39360763|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
16239231|NCT01600014|39360764|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
16239232|NCT01600014|39360763|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
16239233|NCT01600014|39360764|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
16239234|NCT01600014|39360763|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
16239235|NCT01600014|39360764|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
16239236|NCT01600014|39360763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
16239237|NCT01600014|39360764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
16239238|NCT01600014|39360763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
16239239|NCT01600014|39360764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
16239240|NCT01600014|39360763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
16239241|NCT01600014|39360764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
16239242|NCT01600014|39360763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
16239243|NCT01600014|39360764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
16239244|NCT01600014|39360763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
16239245|NCT01600014|39360764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
16239246|NCT01600014|39360763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
16556742|NCT00604786|40503534|FG000|Overall Study|Lost to Follow-up|2|||
16556743|NCT00604786|40503535|FG001|Overall Study|Lost to Follow-up|0|||
16556744|NCT02213055|40503536|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
16556745|NCT02213055|40503537|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
16239247|NCT01600014|39360764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
16239248|NCT01600014|39360763|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
16239249|NCT01600014|39360764|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
16239250|NCT01600014|39360763|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
16239251|NCT01600014|39360764|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
16239252|NCT01600014|39360763|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
16239253|NCT01600014|39360764|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
16239254|NCT01600014|39360763|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
16239255|NCT01600014|39360764|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
16239256|NCT00835068|39360766|FG000|Overall Study|Death|1|||
16239257|NCT00835068|39360767|FG001|Overall Study|Death|0|||
16239258|NCT00835068|39360766|FG000|Overall Study|Adverse Event|0|||
16239259|NCT00835068|39360767|FG001|Overall Study|Adverse Event|1|||
16239260|NCT00835068|39360766|FG000|Overall Study|Other|8|||
16239261|NCT00835068|39360767|FG001|Overall Study|Other|0|||
16239262|NCT00835068|39360766|FG000|Overall Study|Withdrawal by Subject|1|||
16239263|NCT00835068|39360767|FG001|Overall Study|Withdrawal by Subject|0|||
16239264|NCT01965431|39360770|FG000|Overall Study|Adverse Event|0|||
16239265|NCT01965431|39360771|FG001|Overall Study|Adverse Event|1|||
16239266|NCT01965431|39360772|FG002|Overall Study|Adverse Event|0|||
16239267|NCT01965431|39360773|FG003|Overall Study|Adverse Event|0|||
16239268|NCT01965431|39360774|FG004|Overall Study|Adverse Event|0|||
16239269|NCT01965431|39360775|FG005|Overall Study|Adverse Event|0|||
16239270|NCT01965431|39360770|FG000|Overall Study|Other than stated above|6|||
16239271|NCT01965431|39360771|FG001|Overall Study|Other than stated above|5|||
16239272|NCT01965431|39360772|FG002|Overall Study|Other than stated above|6|||
16239273|NCT01965431|39360773|FG003|Overall Study|Other than stated above|6|||
16239274|NCT01965431|39360774|FG004|Overall Study|Other than stated above|6|||
16239275|NCT01965431|39360775|FG005|Overall Study|Other than stated above|6|||
16239276|NCT00319020|39360776|FG000|Overall Study|Death|2|||
16239277|NCT00319020|39360777|FG001|Overall Study|Death|2|||
16239278|NCT00319020|39360776|FG000|Overall Study|Withdrawal by Subject|4|||
16239279|NCT00319020|39360777|FG001|Overall Study|Withdrawal by Subject|1|||
16239280|NCT00319020|39360776|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
16239281|NCT00319020|39360777|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
16239282|NCT00319020|39360776|FG000|Overall Study|Administrative reason|0|||
16239283|NCT00319020|39360777|FG001|Overall Study|Administrative reason|5|||
16239284|NCT00319020|39360776|FG000|Overall Study|Disease progression|0|||
16239285|NCT00319020|39360777|FG001|Overall Study|Disease progression|2|||
16239286|NCT00319020|39360776|FG000|Overall Study|Transplant|0|||
16239287|NCT00319020|39360777|FG001|Overall Study|Transplant|1|||
16239288|NCT00319020|39360776|FG000|Overall Study|Treatment failure|0|||
16239289|NCT00319020|39360777|FG001|Overall Study|Treatment failure|1|||
16556746|NCT02213055|40503536|FG000|Overall Study|Protocol was not Followed during Study|1|||
16556747|NCT02213055|40503537|FG001|Overall Study|Protocol was not Followed during Study|0|||
16239290|NCT00319020|39360776|FG000|Overall Study|Adverse Event|0|||
16239291|NCT00319020|39360777|FG001|Overall Study|Adverse Event|1|||
16239292|NCT00647426|39360778|FG000|Overall Study|Withdrawal by Subject|2|||
16239293|NCT02524665|39360781|FG000|Overall Study|Lost to Follow-up|1|||
16239294|NCT01399125|39360784|FG000|Overall Study|Adverse Event|32|||
16239295|NCT01399125|39360785|FG001|Overall Study|Adverse Event|30|||
16239296|NCT01399125|39360784|FG000|Overall Study|Abnormal Lab values|0|||
16239297|NCT01399125|39360785|FG001|Overall Study|Abnormal Lab values|1|||
16239298|NCT01399125|39360784|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16239299|NCT01399125|39360785|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
16239300|NCT01399125|39360784|FG000|Overall Study|Withdrawal by Subject|5|||
16239301|NCT01399125|39360785|FG001|Overall Study|Withdrawal by Subject|8|||
16239302|NCT01399125|39360784|FG000|Overall Study|Lost to Follow-up|2|||
16239303|NCT01399125|39360785|FG001|Overall Study|Lost to Follow-up|3|||
16239304|NCT01399125|39360784|FG000|Overall Study|Administrative Problems|7|||
16239305|NCT01399125|39360785|FG001|Overall Study|Administrative Problems|11|||
16239306|NCT01399125|39360784|FG000|Overall Study|Death|0|||
16239307|NCT01399125|39360785|FG001|Overall Study|Death|1|||
16239308|NCT01399125|39360784|FG000|Overall Study|Protocol Deviation|5|||
16239309|NCT01399125|39360785|FG001|Overall Study|Protocol Deviation|2|||
16239310|NCT00529568|39360786|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
16239311|NCT00529568|39360787|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
16239312|NCT00529568|39360788|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
16239313|NCT00529568|39360786|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
16239314|NCT00529568|39360787|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
16239315|NCT00529568|39360788|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
16239316|NCT00529568|39360786|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
16239317|NCT00529568|39360787|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
16239318|NCT00529568|39360788|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
16239319|NCT00529568|39360786|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
16239320|NCT00529568|39360787|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
16239321|NCT00529568|39360788|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
16239322|NCT00529568|39360786|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
16239323|NCT00529568|39360787|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
16239324|NCT00529568|39360788|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
16239325|NCT00529568|39360786|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
16239326|NCT00529568|39360787|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
16239327|NCT00529568|39360788|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
16239328|NCT00529568|39360786|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
16239329|NCT00529568|39360787|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
16239330|NCT00529568|39360788|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
16239331|NCT00529568|39360786|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
16239332|NCT00529568|39360787|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
16239333|NCT00529568|39360788|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
16239334|NCT00529568|39360786|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
16239335|NCT00529568|39360787|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
16239336|NCT00529568|39360788|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
16239337|NCT00529568|39360786|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
16239338|NCT00529568|39360787|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
16239339|NCT00529568|39360788|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
16350137|NCT03286218|39768959|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
16350138|NCT03286218|39768960|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
16350139|NCT03286218|39768961|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
16350140|NCT03286218|39768962|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
16350141|NCT03286218|39768951|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
16350142|NCT03286218|39768952|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
16239340|NCT00529568|39360786|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
16350143|NCT03286218|39768953|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
16123207|NCT04445987|38938445|FG005|Overall Study|Other reason|0|||
16123208|NCT03258723|38938446|FG000|Overall Study|COVID Interruption of study|54|||
16123209|NCT03258723|38938446|FG000|Overall Study|Lost to Follow-up|8|||
16350144|NCT03286218|39768954|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
16350145|NCT03286218|39768955|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
16350146|NCT03286218|39768956|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
16350147|NCT03286218|39768957|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
16350148|NCT03286218|39768958|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
16350149|NCT03286218|39768959|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
16350150|NCT03286218|39768960|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
16350151|NCT03286218|39768961|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
16123210|NCT01213524|38938456|FG000|Baseline|Withdrawal by Subject|5|||
16123211|NCT01213524|38938456|FG000|Baseline|high breath alcohol levels|1|||
16123212|NCT01213524|38938456|FG000|Baseline|Physician Decision|1|||
16123213|NCT01213524|38938456|FG000|Session 2|Withdrawal by Subject|5|||
16123214|NCT01213524|38938456|FG000|Session 3|Withdrawal by Subject|4|||
16123215|NCT01213524|38938456|FG000|Session 4|Physician Decision|1|||
16123216|NCT01213524|38938456|FG000|Session 4|Withdrawal by Subject|2|||
16123217|NCT02624791|38938457|FG000|Overall Study|Withdrawal by Subject|2|||
16123218|NCT02624791|38938458|FG001|Overall Study|Withdrawal by Subject|0|||
16123219|NCT02624791|38938459|FG002|Overall Study|Withdrawal by Subject|0|||
16123220|NCT02624791|38938460|FG003|Overall Study|Withdrawal by Subject|0|||
16123221|NCT02624791|38938461|FG004|Overall Study|Withdrawal by Subject|0|||
16123222|NCT02624791|38938462|FG005|Overall Study|Withdrawal by Subject|0|||
16123223|NCT03965351|38938467|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
16123224|NCT03965351|38938468|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
16123225|NCT03965351|38938467|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
16123226|NCT03965351|38938468|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
16123227|NCT00667225|38938471|FG000|Overall Study|Subject had no more lesions to treat.|1|||
16123228|NCT00667225|38938472|FG001|Overall Study|Subject had no more lesions to treat.|0|||
16123229|NCT00667225|38938471|FG000|Overall Study|Lost to Follow-up|0|||
16123230|NCT00667225|38938472|FG001|Overall Study|Lost to Follow-up|1|||
16123231|NCT02703259|38938473|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
16123232|NCT02703259|38938474|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
16123233|NCT02703259|38938473|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
16123234|NCT02703259|38938474|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
16123235|NCT02703259|38938473|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
16123236|NCT02703259|38938474|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
16123237|NCT00488475|38938477|FG000|Overall Study|Other|1754|||
16123238|NCT02559895|38938478|FG000|Overall Study|Adverse Event|3|||
16123239|NCT02559895|38938479|FG001|Overall Study|Adverse Event|3|||
16123240|NCT02559895|38938480|FG002|Overall Study|Adverse Event|2|||
16123241|NCT02559895|38938481|FG003|Overall Study|Adverse Event|1|||
16123242|NCT02559895|38938478|FG000|Overall Study|Lack of Efficacy|2|||
16123243|NCT02559895|38938479|FG001|Overall Study|Lack of Efficacy|3|||
16123244|NCT02559895|38938480|FG002|Overall Study|Lack of Efficacy|2|||
16123245|NCT02559895|38938481|FG003|Overall Study|Lack of Efficacy|8|||
16123246|NCT02559895|38938478|FG000|Overall Study|Lost to Follow-up|22|||
16123247|NCT02559895|38938479|FG001|Overall Study|Lost to Follow-up|16|||
16123248|NCT02559895|38938480|FG002|Overall Study|Lost to Follow-up|12|||
16123249|NCT02559895|38938481|FG003|Overall Study|Lost to Follow-up|17|||
16123250|NCT02559895|38938478|FG000|Overall Study|Physician Decision|1|||
16123251|NCT02559895|38938479|FG001|Overall Study|Physician Decision|1|||
16123252|NCT02559895|38938480|FG002|Overall Study|Physician Decision|3|||
16123253|NCT02559895|38938481|FG003|Overall Study|Physician Decision|0|||
16123254|NCT02559895|38938478|FG000|Overall Study|Withdrawal by Subject|16|||
16123255|NCT02559895|38938479|FG001|Overall Study|Withdrawal by Subject|9|||
16123256|NCT02559895|38938480|FG002|Overall Study|Withdrawal by Subject|20|||
16123257|NCT02559895|38938481|FG003|Overall Study|Withdrawal by Subject|9|||
16123258|NCT02559895|38938478|FG000|Overall Study|Study Burden|10|||
16123259|NCT02559895|38938479|FG001|Overall Study|Study Burden|16|||
16123260|NCT02559895|38938480|FG002|Overall Study|Study Burden|12|||
16123261|NCT02559895|38938481|FG003|Overall Study|Study Burden|22|||
16123262|NCT02559895|38938478|FG000|Overall Study|Other|1|||
16123263|NCT02559895|38938479|FG001|Overall Study|Other|5|||
16123264|NCT02559895|38938480|FG002|Overall Study|Other|3|||
16123265|NCT02559895|38938481|FG003|Overall Study|Other|3|||
16123266|NCT02179177|38938482|FG000|Overall Study|Lost to Follow-up|1|||
16123267|NCT02179177|38938483|FG001|Overall Study|Lost to Follow-up|1|||
16123268|NCT02179177|38938482|FG000|Overall Study|Withdrawal by Subject|1|||
16556748|NCT02213055|40503536|FG000|Overall Study|Documentation Issue at Enrollment|1|||
16123269|NCT02179177|38938483|FG001|Overall Study|Withdrawal by Subject|1|||
16123270|NCT02738853|38938484|FG000|Enrollment|Inclusion/Exclusion not met|21|||
16123271|NCT02738853|38938484|FG000|Enrollment|Withdrawal by Subject|3|||
16123272|NCT02738853|38938484|FG000|Enrollment|Subject treated with commercially available device|6|||
16556749|NCT02213055|40503537|FG001|Overall Study|Documentation Issue at Enrollment|0|||
16556750|NCT02213055|40503536|FG000|Overall Study|Documentation Issue during Study|10|||
16556751|NCT02213055|40503537|FG001|Overall Study|Documentation Issue during Study|0|||
16556752|NCT02213055|40503536|FG000|Overall Study|Did not have Live Lice|8|||
16556753|NCT02213055|40503537|FG001|Overall Study|Did not have Live Lice|0|||
16556754|NCT02213055|40503536|FG000|Overall Study|Had another Treatment during the Study|3|||
16556755|NCT02213055|40503537|FG001|Overall Study|Had another Treatment during the Study|0|||
16556756|NCT02213055|40503536|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
16556757|NCT02213055|40503537|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
16239341|NCT00529568|39360787|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
16556758|NCT02213055|40503536|FG000|Overall Study|Did not Return to School|5|||
16556759|NCT02213055|40503537|FG001|Overall Study|Did not Return to School|0|||
16556760|NCT01066156|40503539|FG000|Overall Study|ineligible|2|||
16556761|NCT01066156|40503539|FG000|Overall Study|Lost to Follow-up|7|||
16556762|NCT01066156|40503539|FG000|Overall Study|Withdrawal by Subject|1|||
16556763|NCT02555371|40503540|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
16556764|NCT02555371|40503541|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
16556765|NCT02555371|40503542|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
16556766|NCT02555371|40503543|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
16556767|NCT02555371|40503544|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
16556768|NCT02555371|40503540|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
16556769|NCT02555371|40503541|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
16556770|NCT02555371|40503542|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
16556771|NCT02555371|40503543|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
16239342|NCT00529568|39360788|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
16239343|NCT01360632|39360789|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
16239344|NCT01360632|39360790|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
16414224|NCT03743064|39998364|FG000|Overall Study|Lost to Follow-up|3|||
16239345|NCT01360632|39360791|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
16239346|NCT01360632|39360792|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
16239347|NCT01360632|39360793|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
16239348|NCT01360632|39360789|FG000|Phase A (8 Weeks)|Adverse Event|60|||
16239349|NCT01360632|39360790|FG001|Phase A (8 Weeks)|Adverse Event|0|||
16239350|NCT01360632|39360791|FG002|Phase A (8 Weeks)|Adverse Event|0|||
16239351|NCT01360632|39360792|FG003|Phase A (8 Weeks)|Adverse Event|0|||
16239352|NCT01360632|39360793|FG004|Phase A (8 Weeks)|Adverse Event|0|||
16239353|NCT01360632|39360789|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
16239354|NCT01360632|39360790|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
16239355|NCT01360632|39360791|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
16239356|NCT01360632|39360792|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
16239357|NCT01360632|39360793|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
16239358|NCT01360632|39360789|FG000|Phase A (8 Weeks)|Physician Decision|10|||
16239359|NCT01360632|39360790|FG001|Phase A (8 Weeks)|Physician Decision|0|||
16239360|NCT01360632|39360791|FG002|Phase A (8 Weeks)|Physician Decision|0|||
16239361|NCT01360632|39360792|FG003|Phase A (8 Weeks)|Physician Decision|0|||
16239362|NCT01360632|39360793|FG004|Phase A (8 Weeks)|Physician Decision|0|||
16239363|NCT01360632|39360789|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
16239364|NCT01360632|39360790|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
16556772|NCT02555371|40503544|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
16556773|NCT02555371|40503540|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
16239365|NCT01360632|39360791|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
16239366|NCT01360632|39360792|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
16239367|NCT01360632|39360793|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
16123273|NCT02738853|38938484|FG000|Enrollment|Study Enrollment Closed|3|||
16123274|NCT02738853|38938484|FG000|Procedure|Death|1|||
16123275|NCT02738853|38938484|FG000|1 Month|Death|2|||
16123276|NCT02738853|38938484|FG000|6 Month|Death|4|||
16123277|NCT02738853|38938484|FG000|6 Month|Withdrawal by Subject|2|||
16123278|NCT02738853|38938484|FG000|1 Year|Death|6|||
16123279|NCT02738853|38938484|FG000|1 Year|Withdrawal by Subject|1|||
16123280|NCT02738853|38938484|FG000|2 Year|Death|2|||
16123281|NCT02738853|38938484|FG000|2 Year|Lost to Follow-up|1|||
16123282|NCT02738853|38938484|FG000|3 Year|Death|2|||
16123283|NCT02738853|38938484|FG000|3 Year|Withdrawal by Subject|1|||
16123284|NCT02738853|38938484|FG000|4 Year|Death|9|||
16123285|NCT02738853|38938484|FG000|5 Year|Lost to Follow-up|4|||
16123286|NCT02136134|38938485|FG000|Overall Study|Death|170|||
16123287|NCT02136134|38938486|FG001|Overall Study|Death|148|||
16239368|NCT01360632|39360789|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
16239369|NCT01360632|39360790|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
16239370|NCT01360632|39360791|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
16239371|NCT01360632|39360792|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
16239372|NCT01360632|39360793|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
16556774|NCT02555371|40503541|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
16556775|NCT02555371|40503542|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
16556776|NCT02555371|40503543|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
16556777|NCT02555371|40503544|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
16556778|NCT02555371|40503540|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
16556779|NCT02555371|40503541|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
16556780|NCT02555371|40503542|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
16556781|NCT02555371|40503543|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
16556782|NCT02555371|40503544|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
16556783|NCT02555371|40503540|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
16123288|NCT02136134|38938485|FG000|Overall Study|Withdrawal by Subject|19|||
16123289|NCT02136134|38938486|FG001|Overall Study|Withdrawal by Subject|10|||
16123290|NCT02136134|38938485|FG000|Overall Study|Lost to Follow-up|3|||
16239373|NCT01360632|39360789|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
16123291|NCT02136134|38938486|FG001|Overall Study|Lost to Follow-up|3|||
16414225|NCT03743064|39998365|FG001|Overall Study|Lost to Follow-up|6|||
16123292|NCT02136134|38938485|FG000|Overall Study|Uspecified|55|||
16123293|NCT02136134|38938486|FG001|Overall Study|Uspecified|90|||
16123294|NCT01879553|38938488|FG000|Overall Study|Withdrawal by Subject|1|||
16123295|NCT01879553|38938489|FG001|Overall Study|Withdrawal by Subject|0|||
16123296|NCT00568178|38938490|FG000|Double Blind Base Study|Adverse Event|0|||
16123297|NCT00568178|38938491|FG001|Double Blind Base Study|Adverse Event|2|||
16123298|NCT00568178|38938492|FG002|Double Blind Base Study|Adverse Event|1|||
16123299|NCT00568178|38938493|FG003|Double Blind Base Study|Adverse Event|2|||
16123300|NCT00568178|38938494|FG004|Double Blind Base Study|Adverse Event|0|||
16123301|NCT00568178|38938495|FG005|Double Blind Base Study|Adverse Event|0|||
16123302|NCT00568178|38938490|FG000|Double Blind Base Study|Lost to Follow-up|1|||
16123303|NCT00568178|38938491|FG001|Double Blind Base Study|Lost to Follow-up|0|||
16123304|NCT00568178|38938492|FG002|Double Blind Base Study|Lost to Follow-up|0|||
16123305|NCT00568178|38938493|FG003|Double Blind Base Study|Lost to Follow-up|1|||
16123306|NCT00568178|38938494|FG004|Double Blind Base Study|Lost to Follow-up|0|||
16123307|NCT00568178|38938495|FG005|Double Blind Base Study|Lost to Follow-up|0|||
16123308|NCT00568178|38938490|FG000|Double Blind Base Study|Physician Decision|1|||
16123309|NCT00568178|38938491|FG001|Double Blind Base Study|Physician Decision|1|||
16123310|NCT00568178|38938492|FG002|Double Blind Base Study|Physician Decision|0|||
16123311|NCT00568178|38938493|FG003|Double Blind Base Study|Physician Decision|1|||
16123312|NCT00568178|38938494|FG004|Double Blind Base Study|Physician Decision|0|||
16123313|NCT00568178|38938495|FG005|Double Blind Base Study|Physician Decision|0|||
16123314|NCT00568178|38938490|FG000|Double Blind Base Study|Protocol Violation|3|||
16123315|NCT00568178|38938491|FG001|Double Blind Base Study|Protocol Violation|2|||
16123316|NCT00568178|38938492|FG002|Double Blind Base Study|Protocol Violation|0|||
16123317|NCT00568178|38938493|FG003|Double Blind Base Study|Protocol Violation|0|||
16556784|NCT02555371|40503541|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
16556785|NCT02555371|40503542|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
16556786|NCT02555371|40503543|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
16123318|NCT00568178|38938494|FG004|Double Blind Base Study|Protocol Violation|0|||
16123319|NCT00568178|38938495|FG005|Double Blind Base Study|Protocol Violation|0|||
16239374|NCT01360632|39360790|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
16239375|NCT01360632|39360791|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
16239376|NCT01360632|39360792|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
16239377|NCT01360632|39360793|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
16239378|NCT01360632|39360789|FG000|Phase B (6 Weeks)|Adverse Event|0|||
16239379|NCT01360632|39360790|FG001|Phase B (6 Weeks)|Adverse Event|3|||
16239380|NCT01360632|39360791|FG002|Phase B (6 Weeks)|Adverse Event|9|||
16239381|NCT01360632|39360792|FG003|Phase B (6 Weeks)|Adverse Event|3|||
16239382|NCT01360632|39360793|FG004|Phase B (6 Weeks)|Adverse Event|0|||
16239383|NCT01360632|39360789|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
16239384|NCT01360632|39360790|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
16239385|NCT01360632|39360791|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
16239386|NCT01360632|39360792|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
16239387|NCT01360632|39360793|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
16123320|NCT00568178|38938490|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
16123321|NCT00568178|38938491|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
16123322|NCT00568178|38938492|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
16123323|NCT00568178|38938493|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
16123324|NCT00568178|38938494|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
16123325|NCT00568178|38938495|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
16123326|NCT00568178|38938490|FG000|Double Blind Base Study|Progressive Disease|0|||
16123327|NCT00568178|38938491|FG001|Double Blind Base Study|Progressive Disease|0|||
16123328|NCT00568178|38938492|FG002|Double Blind Base Study|Progressive Disease|0|||
16239388|NCT01360632|39360789|FG000|Phase B (6 Weeks)|Physician Decision|0|||
16239389|NCT01360632|39360790|FG001|Phase B (6 Weeks)|Physician Decision|0|||
16556787|NCT02555371|40503544|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
16556788|NCT02555371|40503540|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
16556789|NCT02555371|40503541|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
16556790|NCT02555371|40503542|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
16556791|NCT02555371|40503543|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
16556792|NCT02555371|40503544|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
16556793|NCT02555371|40503540|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
16556794|NCT02555371|40503541|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
16556795|NCT02555371|40503542|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
16556796|NCT02555371|40503543|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
16556797|NCT02555371|40503544|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
16556798|NCT02555371|40503540|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
16556799|NCT02555371|40503541|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
16556800|NCT02555371|40503542|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
16123329|NCT00568178|38938493|FG003|Double Blind Base Study|Progressive Disease|1|||
16123330|NCT00568178|38938494|FG004|Double Blind Base Study|Progressive Disease|0|||
16239390|NCT01360632|39360791|FG002|Phase B (6 Weeks)|Physician Decision|0|||
16239391|NCT01360632|39360792|FG003|Phase B (6 Weeks)|Physician Decision|1|||
16239392|NCT01360632|39360793|FG004|Phase B (6 Weeks)|Physician Decision|0|||
16239393|NCT01360632|39360789|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
16239394|NCT01360632|39360790|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
16239395|NCT01360632|39360791|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
16239396|NCT01360632|39360792|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
16239397|NCT01360632|39360793|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
16239398|NCT01360632|39360789|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
16239399|NCT01360632|39360790|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
16239400|NCT01360632|39360791|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
16239401|NCT01360632|39360792|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
16239402|NCT01360632|39360793|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
16239403|NCT01360632|39360789|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
16239404|NCT01360632|39360790|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
16239405|NCT01360632|39360791|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
16239406|NCT01360632|39360792|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
16239407|NCT01360632|39360793|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
16239408|NCT01360632|39360789|FG000|Phase A+|Lost to Follow-up|0|||
16239409|NCT01360632|39360790|FG001|Phase A+|Lost to Follow-up|0|||
16239410|NCT01360632|39360791|FG002|Phase A+|Lost to Follow-up|0|||
16239411|NCT01360632|39360792|FG003|Phase A+|Lost to Follow-up|0|||
16239412|NCT01360632|39360793|FG004|Phase A+|Lost to Follow-up|2|||
16239413|NCT01360632|39360789|FG000|Phase A+|Adverse Event|0|||
16239414|NCT01360632|39360790|FG001|Phase A+|Adverse Event|0|||
16239415|NCT01360632|39360791|FG002|Phase A+|Adverse Event|0|||
16239416|NCT01360632|39360792|FG003|Phase A+|Adverse Event|0|||
16239417|NCT01360632|39360793|FG004|Phase A+|Adverse Event|2|||
16239418|NCT01360632|39360789|FG000|Phase A+|Met Withdrawal Criteria|0|||
16239419|NCT01360632|39360790|FG001|Phase A+|Met Withdrawal Criteria|0|||
16239420|NCT01360632|39360791|FG002|Phase A+|Met Withdrawal Criteria|0|||
16239421|NCT01360632|39360792|FG003|Phase A+|Met Withdrawal Criteria|0|||
16239422|NCT01360632|39360793|FG004|Phase A+|Met Withdrawal Criteria|7|||
16239423|NCT01360632|39360789|FG000|Phase A+|Physician Decision|0|||
16239424|NCT01360632|39360790|FG001|Phase A+|Physician Decision|0|||
16239425|NCT01360632|39360791|FG002|Phase A+|Physician Decision|0|||
16239426|NCT01360632|39360792|FG003|Phase A+|Physician Decision|0|||
16239427|NCT01360632|39360793|FG004|Phase A+|Physician Decision|3|||
16239428|NCT01360632|39360789|FG000|Phase A+|Withdrawal by Subject|0|||
16239429|NCT01360632|39360790|FG001|Phase A+|Withdrawal by Subject|0|||
16239430|NCT01360632|39360791|FG002|Phase A+|Withdrawal by Subject|0|||
16239431|NCT01360632|39360792|FG003|Phase A+|Withdrawal by Subject|0|||
16239432|NCT01360632|39360793|FG004|Phase A+|Withdrawal by Subject|8|||
16239433|NCT01360632|39360789|FG000|Phase A+|Protocol Deviation|0|||
16239434|NCT01360632|39360790|FG001|Phase A+|Protocol Deviation|0|||
16239435|NCT01360632|39360791|FG002|Phase A+|Protocol Deviation|0|||
16239436|NCT01360632|39360792|FG003|Phase A+|Protocol Deviation|0|||
16239437|NCT01360632|39360793|FG004|Phase A+|Protocol Deviation|3|||
16239438|NCT01571635|39360797|FG000|Overall Study|Adverse Event|3|||
16239439|NCT01571635|39360798|FG001|Overall Study|Adverse Event|0|||
16239440|NCT01571635|39360799|FG002|Overall Study|Adverse Event|2|||
16239441|NCT01571635|39360800|FG003|Overall Study|Adverse Event|3|||
16239442|NCT01571635|39360801|FG004|Overall Study|Adverse Event|5|||
16239443|NCT01571635|39360797|FG000|Overall Study|Other reasons|2|||
16239444|NCT01571635|39360798|FG001|Overall Study|Other reasons|1|||
16239445|NCT01571635|39360799|FG002|Overall Study|Other reasons|2|||
16239446|NCT01571635|39360800|FG003|Overall Study|Other reasons|2|||
16239447|NCT01571635|39360801|FG004|Overall Study|Other reasons|1|||
16239448|NCT01571635|39360797|FG000|Overall Study|Study terminated by sponsor|0|||
16239449|NCT01571635|39360798|FG001|Overall Study|Study terminated by sponsor|4|||
16239450|NCT01571635|39360799|FG002|Overall Study|Study terminated by sponsor|1|||
16239451|NCT01571635|39360800|FG003|Overall Study|Study terminated by sponsor|3|||
16239452|NCT01571635|39360801|FG004|Overall Study|Study terminated by sponsor|1|||
16239453|NCT01571635|39360797|FG000|Overall Study|Withdrew consent|1|||
16239454|NCT01571635|39360798|FG001|Overall Study|Withdrew consent|1|||
16239455|NCT01571635|39360799|FG002|Overall Study|Withdrew consent|2|||
16239456|NCT01571635|39360800|FG003|Overall Study|Withdrew consent|3|||
16239457|NCT01571635|39360801|FG004|Overall Study|Withdrew consent|0|||
16239458|NCT01571635|39360797|FG000|Overall Study|Lack of Efficacy|0|||
16239459|NCT01571635|39360798|FG001|Overall Study|Lack of Efficacy|2|||
16239460|NCT01571635|39360799|FG002|Overall Study|Lack of Efficacy|0|||
16239461|NCT01571635|39360800|FG003|Overall Study|Lack of Efficacy|1|||
16239462|NCT01571635|39360801|FG004|Overall Study|Lack of Efficacy|2|||
16239463|NCT01374906|39360808|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16239464|NCT01374906|39360809|FG001|Overall Study|Abnormal laboratory value(s)|3|||
16239465|NCT01374906|39360808|FG000|Overall Study|Administrative problems|2|||
16239466|NCT01374906|39360809|FG001|Overall Study|Administrative problems|2|||
16239467|NCT01374906|39360808|FG000|Overall Study|Adverse Event|10|||
16239468|NCT01374906|39360809|FG001|Overall Study|Adverse Event|11|||
16239469|NCT01374906|39360808|FG000|Overall Study|Death|0|||
16239470|NCT01374906|39360809|FG001|Overall Study|Death|2|||
16239471|NCT01374906|39360808|FG000|Overall Study|Protocol Violation|2|||
16239472|NCT01374906|39360809|FG001|Overall Study|Protocol Violation|2|||
16239473|NCT01374906|39360808|FG000|Overall Study|Withdrawal by Subject|15|||
16239474|NCT01374906|39360809|FG001|Overall Study|Withdrawal by Subject|9|||
16239475|NCT01374906|39360808|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
16239476|NCT01374906|39360809|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
16239477|NCT03471182|39360810|FG000|Overall Study|Withdrawal by Subject|1|||
16239478|NCT03471182|39360811|FG001|Overall Study|Withdrawal by Subject|1|||
16239479|NCT03471182|39360812|FG002|Overall Study|Withdrawal by Subject|0|||
16239480|NCT03471182|39360810|FG000|Overall Study|Technical failure|2|||
16239481|NCT03471182|39360811|FG001|Overall Study|Technical failure|0|||
16239482|NCT03471182|39360812|FG002|Overall Study|Technical failure|0|||
16239483|NCT00738920|39360816|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
16239484|NCT00738920|39360817|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
16239485|NCT00738920|39360818|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
16239486|NCT00738920|39360816|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
16239487|NCT00738920|39360817|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
16239488|NCT00738920|39360818|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
16239489|NCT00738920|39360816|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
16239490|NCT00738920|39360817|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
16239491|NCT00738920|39360818|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
16239492|NCT00738920|39360816|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
16239493|NCT00738920|39360817|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
16239494|NCT00738920|39360818|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
16239495|NCT00738920|39360816|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
16239496|NCT00738920|39360817|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
16239497|NCT00738920|39360818|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
16239498|NCT00738920|39360816|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
16239499|NCT00738920|39360817|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
16239500|NCT00738920|39360818|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
16239501|NCT00738920|39360816|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
16239502|NCT00738920|39360817|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
16239503|NCT00738920|39360818|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
16239504|NCT00738920|39360816|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
16239505|NCT00738920|39360817|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
16239506|NCT00738920|39360818|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
16239507|NCT00738920|39360816|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
16239508|NCT00738920|39360817|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
16239509|NCT00738920|39360818|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
16239510|NCT00738920|39360816|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
16239511|NCT00738920|39360817|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
16239512|NCT00738920|39360818|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
16239513|NCT00734617|39360819|FG000|Overall Study|Adverse Event|4|||
16239514|NCT00734617|39360820|FG001|Overall Study|Adverse Event|7|||
16239515|NCT00734617|39360819|FG000|Overall Study|Withdrawal by Subject|103|||
16239516|NCT00734617|39360820|FG001|Overall Study|Withdrawal by Subject|95|||
16239517|NCT00656019|39360825|FG000|Overall Study|Not Eligible|10|||
16239518|NCT00656019|39360826|FG001|Overall Study|Not Eligible|0|||
16239519|NCT00656019|39360827|FG002|Overall Study|Not Eligible|0|||
16239520|NCT00656019|39360828|FG003|Overall Study|Not Eligible|0|||
16239521|NCT00656019|39360825|FG000|Overall Study|Withdrawal by Subject|2|||
16239522|NCT00656019|39360826|FG001|Overall Study|Withdrawal by Subject|0|||
16239523|NCT00656019|39360827|FG002|Overall Study|Withdrawal by Subject|0|||
16556801|NCT02555371|40503543|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
16239524|NCT00656019|39360828|FG003|Overall Study|Withdrawal by Subject|0|||
16239525|NCT00656019|39360825|FG000|Overall Study|Lost to Follow-up|2|||
16239526|NCT00656019|39360826|FG001|Overall Study|Lost to Follow-up|1|||
16239527|NCT00656019|39360827|FG002|Overall Study|Lost to Follow-up|0|||
16239528|NCT00656019|39360828|FG003|Overall Study|Lost to Follow-up|0|||
16556802|NCT02555371|40503544|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
16556803|NCT02555371|40503540|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
16556804|NCT02555371|40503541|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
16556805|NCT02555371|40503542|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
16556806|NCT02555371|40503543|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
16556807|NCT02555371|40503544|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
16556808|NCT02555371|40503540|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
16556809|NCT02555371|40503541|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
16556810|NCT02555371|40503542|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
16556811|NCT02555371|40503543|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
16556812|NCT02555371|40503544|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
16556813|NCT02555371|40503540|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
16556814|NCT02555371|40503541|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
16556815|NCT02555371|40503542|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
16556816|NCT02555371|40503543|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
16556817|NCT02555371|40503544|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
16556818|NCT02555371|40503540|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
16239529|NCT04380701|39360829|FG000|Overall Study|Pregnancy|0|||
16239530|NCT04380701|39360830|FG001|Overall Study|Pregnancy|0|||
16239531|NCT04380701|39360831|FG002|Overall Study|Pregnancy|0|||
16239532|NCT04380701|39360832|FG003|Overall Study|Pregnancy|0|||
16239533|NCT04380701|39360833|FG004|Overall Study|Pregnancy|0|||
16239534|NCT04380701|39360834|FG005|Overall Study|Pregnancy|0|||
16239535|NCT04380701|39360835|FG006|Overall Study|Pregnancy|0|||
16239536|NCT04380701|39360836|FG007|Overall Study|Pregnancy|0|||
16239537|NCT04380701|39360837|FG008|Overall Study|Pregnancy|0|||
16239538|NCT04380701|39360838|FG009|Overall Study|Pregnancy|0|||
16239539|NCT04380701|39360839|FG010|Overall Study|Pregnancy|0|||
16239540|NCT04380701|39360840|FG011|Overall Study|Pregnancy|0|||
16239541|NCT04380701|39360841|FG012|Overall Study|Pregnancy|0|||
16239542|NCT04380701|39360842|FG013|Overall Study|Pregnancy|0|||
16239543|NCT04380701|39360843|FG014|Overall Study|Pregnancy|0|||
16239544|NCT04380701|39360844|FG015|Overall Study|Pregnancy|0|||
16239545|NCT04380701|39360845|FG016|Overall Study|Pregnancy|0|||
16239546|NCT04380701|39360846|FG017|Overall Study|Pregnancy|0|||
16239547|NCT04380701|39360847|FG018|Overall Study|Pregnancy|0|||
16239548|NCT04380701|39360848|FG019|Overall Study|Pregnancy|0|||
16239549|NCT04380701|39360849|FG020|Overall Study|Pregnancy|0|||
16239550|NCT04380701|39360850|FG021|Overall Study|Pregnancy|0|||
16239551|NCT04380701|39360851|FG022|Overall Study|Pregnancy|0|||
16239552|NCT04380701|39360852|FG023|Overall Study|Pregnancy|0|||
16239553|NCT04380701|39360853|FG024|Overall Study|Pregnancy|0|||
16239554|NCT04380701|39360854|FG025|Overall Study|Pregnancy|0|||
16239555|NCT04380701|39360855|FG026|Overall Study|Pregnancy|0|||
16239556|NCT04380701|39360856|FG027|Overall Study|Pregnancy|0|||
16239557|NCT04380701|39360857|FG028|Overall Study|Pregnancy|0|||
16239558|NCT04380701|39360858|FG029|Overall Study|Pregnancy|0|||
16239559|NCT04380701|39360859|FG030|Overall Study|Pregnancy|0|||
16239560|NCT04380701|39360860|FG031|Overall Study|Pregnancy|0|||
16239561|NCT04380701|39360861|FG032|Overall Study|Pregnancy|1|||
16239562|NCT04380701|39360862|FG033|Overall Study|Pregnancy|0|||
16239563|NCT04380701|39360829|FG000|Overall Study|Lost to Follow-up|0|||
16239564|NCT04380701|39360830|FG001|Overall Study|Lost to Follow-up|0|||
16556819|NCT02555371|40503541|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
16556820|NCT02555371|40503542|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
16556821|NCT02555371|40503543|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
16556822|NCT02555371|40503544|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
16556823|NCT02555371|40503540|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
16556824|NCT02555371|40503541|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
16556825|NCT02555371|40503542|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
16556826|NCT02555371|40503543|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
16556827|NCT02555371|40503544|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
16239565|NCT04380701|39360831|FG002|Overall Study|Lost to Follow-up|0|||
16239566|NCT04380701|39360832|FG003|Overall Study|Lost to Follow-up|0|||
16239567|NCT04380701|39360833|FG004|Overall Study|Lost to Follow-up|0|||
16239568|NCT04380701|39360834|FG005|Overall Study|Lost to Follow-up|0|||
16239569|NCT04380701|39360835|FG006|Overall Study|Lost to Follow-up|0|||
16239570|NCT04380701|39360836|FG007|Overall Study|Lost to Follow-up|0|||
16239571|NCT04380701|39360837|FG008|Overall Study|Lost to Follow-up|0|||
16239572|NCT04380701|39360838|FG009|Overall Study|Lost to Follow-up|0|||
16239573|NCT04380701|39360839|FG010|Overall Study|Lost to Follow-up|0|||
16239574|NCT04380701|39360840|FG011|Overall Study|Lost to Follow-up|0|||
16239575|NCT04380701|39360841|FG012|Overall Study|Lost to Follow-up|0|||
16239576|NCT04380701|39360842|FG013|Overall Study|Lost to Follow-up|0|||
16239577|NCT04380701|39360843|FG014|Overall Study|Lost to Follow-up|0|||
16239578|NCT04380701|39360844|FG015|Overall Study|Lost to Follow-up|0|||
16239579|NCT04380701|39360845|FG016|Overall Study|Lost to Follow-up|0|||
16239580|NCT04380701|39360846|FG017|Overall Study|Lost to Follow-up|0|||
16239581|NCT04380701|39360847|FG018|Overall Study|Lost to Follow-up|0|||
16239582|NCT04380701|39360848|FG019|Overall Study|Lost to Follow-up|0|||
16239583|NCT04380701|39360849|FG020|Overall Study|Lost to Follow-up|1|||
16239584|NCT04380701|39360850|FG021|Overall Study|Lost to Follow-up|0|||
16239585|NCT04380701|39360851|FG022|Overall Study|Lost to Follow-up|0|||
16239586|NCT04380701|39360852|FG023|Overall Study|Lost to Follow-up|1|||
16239587|NCT04380701|39360853|FG024|Overall Study|Lost to Follow-up|0|||
16239588|NCT04380701|39360854|FG025|Overall Study|Lost to Follow-up|0|||
16239589|NCT04380701|39360855|FG026|Overall Study|Lost to Follow-up|0|||
16239590|NCT04380701|39360856|FG027|Overall Study|Lost to Follow-up|0|||
16239591|NCT04380701|39360857|FG028|Overall Study|Lost to Follow-up|0|||
16239592|NCT04380701|39360858|FG029|Overall Study|Lost to Follow-up|1|||
16239593|NCT04380701|39360859|FG030|Overall Study|Lost to Follow-up|0|||
16239594|NCT04380701|39360860|FG031|Overall Study|Lost to Follow-up|0|||
16239595|NCT04380701|39360861|FG032|Overall Study|Lost to Follow-up|0|||
16239596|NCT04380701|39360862|FG033|Overall Study|Lost to Follow-up|1|||
16239597|NCT04380701|39360829|FG000|Overall Study|Private reason(s)|0|||
16239598|NCT04380701|39360830|FG001|Overall Study|Private reason(s)|0|||
16239599|NCT04380701|39360831|FG002|Overall Study|Private reason(s)|0|||
16239600|NCT04380701|39360832|FG003|Overall Study|Private reason(s)|0|||
16239601|NCT04380701|39360833|FG004|Overall Study|Private reason(s)|0|||
16239602|NCT04380701|39360834|FG005|Overall Study|Private reason(s)|0|||
16239603|NCT04380701|39360835|FG006|Overall Study|Private reason(s)|1|||
16239604|NCT04380701|39360836|FG007|Overall Study|Private reason(s)|0|||
16239605|NCT04380701|39360837|FG008|Overall Study|Private reason(s)|1|||
16239606|NCT04380701|39360838|FG009|Overall Study|Private reason(s)|1|||
16239607|NCT04380701|39360839|FG010|Overall Study|Private reason(s)|0|||
16239608|NCT04380701|39360840|FG011|Overall Study|Private reason(s)|0|||
16239609|NCT04380701|39360841|FG012|Overall Study|Private reason(s)|0|||
16239610|NCT04380701|39360842|FG013|Overall Study|Private reason(s)|0|||
16239611|NCT04380701|39360843|FG014|Overall Study|Private reason(s)|0|||
16239612|NCT04380701|39360844|FG015|Overall Study|Private reason(s)|0|||
16239613|NCT04380701|39360845|FG016|Overall Study|Private reason(s)|0|||
16239614|NCT04380701|39360846|FG017|Overall Study|Private reason(s)|0|||
16239615|NCT04380701|39360847|FG018|Overall Study|Private reason(s)|0|||
16239616|NCT04380701|39360848|FG019|Overall Study|Private reason(s)|0|||
16239617|NCT04380701|39360849|FG020|Overall Study|Private reason(s)|0|||
16239618|NCT04380701|39360850|FG021|Overall Study|Private reason(s)|0|||
16239619|NCT04380701|39360851|FG022|Overall Study|Private reason(s)|0|||
16239620|NCT04380701|39360852|FG023|Overall Study|Private reason(s)|1|||
16350152|NCT03286218|39768962|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
16239621|NCT04380701|39360853|FG024|Overall Study|Private reason(s)|0|||
16239622|NCT04380701|39360854|FG025|Overall Study|Private reason(s)|0|||
16239623|NCT04380701|39360855|FG026|Overall Study|Private reason(s)|0|||
16239624|NCT04380701|39360856|FG027|Overall Study|Private reason(s)|0|||
16239625|NCT04380701|39360857|FG028|Overall Study|Private reason(s)|0|||
16239626|NCT04380701|39360858|FG029|Overall Study|Private reason(s)|1|||
16239627|NCT04380701|39360859|FG030|Overall Study|Private reason(s)|0|||
16239628|NCT04380701|39360860|FG031|Overall Study|Private reason(s)|0|||
16239629|NCT04380701|39360861|FG032|Overall Study|Private reason(s)|0|||
16239630|NCT04380701|39360862|FG033|Overall Study|Private reason(s)|0|||
16239631|NCT04380701|39360829|FG000|Overall Study|Withdrawal by Subject|0|||
16239632|NCT04380701|39360830|FG001|Overall Study|Withdrawal by Subject|0|||
16239633|NCT04380701|39360831|FG002|Overall Study|Withdrawal by Subject|0|||
16239634|NCT04380701|39360832|FG003|Overall Study|Withdrawal by Subject|0|||
16239635|NCT04380701|39360833|FG004|Overall Study|Withdrawal by Subject|0|||
16239636|NCT04380701|39360834|FG005|Overall Study|Withdrawal by Subject|0|||
16239637|NCT04380701|39360835|FG006|Overall Study|Withdrawal by Subject|1|||
16239638|NCT04380701|39360836|FG007|Overall Study|Withdrawal by Subject|1|||
16239639|NCT04380701|39360837|FG008|Overall Study|Withdrawal by Subject|0|||
16239640|NCT04380701|39360838|FG009|Overall Study|Withdrawal by Subject|0|||
16239641|NCT04380701|39360839|FG010|Overall Study|Withdrawal by Subject|0|||
16239642|NCT04380701|39360840|FG011|Overall Study|Withdrawal by Subject|1|||
16239643|NCT04380701|39360841|FG012|Overall Study|Withdrawal by Subject|0|||
16239644|NCT04380701|39360842|FG013|Overall Study|Withdrawal by Subject|1|||
16239645|NCT04380701|39360843|FG014|Overall Study|Withdrawal by Subject|0|||
16239646|NCT04380701|39360844|FG015|Overall Study|Withdrawal by Subject|0|||
16239647|NCT04380701|39360845|FG016|Overall Study|Withdrawal by Subject|1|||
16239648|NCT04380701|39360846|FG017|Overall Study|Withdrawal by Subject|0|||
16239649|NCT04380701|39360847|FG018|Overall Study|Withdrawal by Subject|0|||
16239650|NCT04380701|39360848|FG019|Overall Study|Withdrawal by Subject|0|||
16239651|NCT04380701|39360849|FG020|Overall Study|Withdrawal by Subject|0|||
16239652|NCT04380701|39360850|FG021|Overall Study|Withdrawal by Subject|0|||
16239653|NCT04380701|39360851|FG022|Overall Study|Withdrawal by Subject|2|||
16239654|NCT04380701|39360852|FG023|Overall Study|Withdrawal by Subject|2|||
16239655|NCT04380701|39360853|FG024|Overall Study|Withdrawal by Subject|1|||
16239656|NCT04380701|39360854|FG025|Overall Study|Withdrawal by Subject|1|||
16239657|NCT04380701|39360855|FG026|Overall Study|Withdrawal by Subject|0|||
16239658|NCT04380701|39360856|FG027|Overall Study|Withdrawal by Subject|0|||
16239659|NCT04380701|39360857|FG028|Overall Study|Withdrawal by Subject|0|||
16239660|NCT04380701|39360858|FG029|Overall Study|Withdrawal by Subject|0|||
16239661|NCT04380701|39360859|FG030|Overall Study|Withdrawal by Subject|0|||
16239662|NCT04380701|39360860|FG031|Overall Study|Withdrawal by Subject|0|||
16239663|NCT04380701|39360861|FG032|Overall Study|Withdrawal by Subject|0|||
16239664|NCT04380701|39360862|FG033|Overall Study|Withdrawal by Subject|0|||
16239665|NCT04380701|39360829|FG000|Overall Study|Adverse Event|0|||
16239666|NCT04380701|39360830|FG001|Overall Study|Adverse Event|0|||
16239667|NCT04380701|39360831|FG002|Overall Study|Adverse Event|0|||
16239668|NCT04380701|39360832|FG003|Overall Study|Adverse Event|0|||
16239669|NCT04380701|39360833|FG004|Overall Study|Adverse Event|0|||
16239670|NCT04380701|39360834|FG005|Overall Study|Adverse Event|1|||
16239671|NCT04380701|39360835|FG006|Overall Study|Adverse Event|0|||
16239672|NCT04380701|39360836|FG007|Overall Study|Adverse Event|0|||
16239673|NCT04380701|39360837|FG008|Overall Study|Adverse Event|0|||
16239674|NCT04380701|39360838|FG009|Overall Study|Adverse Event|0|||
16239675|NCT04380701|39360839|FG010|Overall Study|Adverse Event|0|||
16239676|NCT04380701|39360840|FG011|Overall Study|Adverse Event|0|||
16239677|NCT04380701|39360841|FG012|Overall Study|Adverse Event|0|||
16239678|NCT04380701|39360842|FG013|Overall Study|Adverse Event|0|||
16239679|NCT04380701|39360843|FG014|Overall Study|Adverse Event|0|||
16239680|NCT04380701|39360844|FG015|Overall Study|Adverse Event|1|||
16239681|NCT04380701|39360845|FG016|Overall Study|Adverse Event|0|||
16239682|NCT04380701|39360846|FG017|Overall Study|Adverse Event|0|||
16239683|NCT04380701|39360847|FG018|Overall Study|Adverse Event|0|||
16239684|NCT04380701|39360848|FG019|Overall Study|Adverse Event|1|||
16239685|NCT04380701|39360849|FG020|Overall Study|Adverse Event|0|||
16239686|NCT04380701|39360850|FG021|Overall Study|Adverse Event|0|||
16239687|NCT04380701|39360851|FG022|Overall Study|Adverse Event|0|||
16239688|NCT04380701|39360852|FG023|Overall Study|Adverse Event|0|||
16239689|NCT04380701|39360853|FG024|Overall Study|Adverse Event|0|||
16239690|NCT04380701|39360854|FG025|Overall Study|Adverse Event|0|||
16239691|NCT04380701|39360855|FG026|Overall Study|Adverse Event|0|||
16239692|NCT04380701|39360856|FG027|Overall Study|Adverse Event|0|||
16239693|NCT04380701|39360857|FG028|Overall Study|Adverse Event|0|||
16239694|NCT04380701|39360858|FG029|Overall Study|Adverse Event|0|||
16239695|NCT04380701|39360859|FG030|Overall Study|Adverse Event|0|||
16239696|NCT04380701|39360860|FG031|Overall Study|Adverse Event|0|||
16239697|NCT04380701|39360861|FG032|Overall Study|Adverse Event|0|||
16239698|NCT04380701|39360862|FG033|Overall Study|Adverse Event|0|||
16239699|NCT04380701|39360829|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
16239700|NCT04380701|39360830|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
16239701|NCT04380701|39360831|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
16239702|NCT04380701|39360832|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
16239703|NCT04380701|39360833|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
16239704|NCT04380701|39360834|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
16239705|NCT04380701|39360835|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
16239706|NCT04380701|39360836|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
16239707|NCT04380701|39360837|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
16239708|NCT04380701|39360838|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
16239709|NCT04380701|39360839|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
16239710|NCT04380701|39360840|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
16239711|NCT04380701|39360841|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
16239712|NCT04380701|39360842|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
16123331|NCT00568178|38938495|FG005|Double Blind Base Study|Progressive Disease|0|||
16239713|NCT04380701|39360843|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
16239714|NCT04380701|39360844|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
16239715|NCT04380701|39360845|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
16239716|NCT04380701|39360846|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
16239717|NCT04380701|39360847|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
16239718|NCT04380701|39360848|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
16239719|NCT04380701|39360849|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
16239720|NCT04380701|39360850|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
16239721|NCT04380701|39360851|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
16239722|NCT04380701|39360852|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
16239723|NCT04380701|39360853|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
16239724|NCT04380701|39360854|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
16239725|NCT04380701|39360855|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
16239726|NCT04380701|39360856|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
16239727|NCT04380701|39360857|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
16239728|NCT04380701|39360858|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
16239729|NCT04380701|39360859|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
16239730|NCT04380701|39360860|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
16239731|NCT04380701|39360861|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
16239732|NCT04380701|39360862|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
16239733|NCT04380701|39360829|FG000|Overall Study|Physician Decision|0|||
16239734|NCT04380701|39360830|FG001|Overall Study|Physician Decision|0|||
16239735|NCT04380701|39360831|FG002|Overall Study|Physician Decision|0|||
16123332|NCT00568178|38938490|FG000|Open Label Extension|Adverse Event|0|||
16123333|NCT00568178|38938491|FG001|Open Label Extension|Adverse Event|0|||
16123334|NCT00568178|38938492|FG002|Open Label Extension|Adverse Event|0|||
16123335|NCT00568178|38938493|FG003|Open Label Extension|Adverse Event|0|||
16123336|NCT00568178|38938494|FG004|Open Label Extension|Adverse Event|11|||
16123337|NCT00568178|38938495|FG005|Open Label Extension|Adverse Event|8|||
16123338|NCT00568178|38938490|FG000|Open Label Extension|Protocol Violation|0|||
16123339|NCT00568178|38938491|FG001|Open Label Extension|Protocol Violation|0|||
16123340|NCT00568178|38938492|FG002|Open Label Extension|Protocol Violation|0|||
16123341|NCT00568178|38938493|FG003|Open Label Extension|Protocol Violation|0|||
16123342|NCT00568178|38938494|FG004|Open Label Extension|Protocol Violation|1|||
16123343|NCT00568178|38938495|FG005|Open Label Extension|Protocol Violation|0|||
16123344|NCT00568178|38938490|FG000|Open Label Extension|Lost to Follow-up|0|||
16123345|NCT00568178|38938491|FG001|Open Label Extension|Lost to Follow-up|0|||
16123346|NCT00568178|38938492|FG002|Open Label Extension|Lost to Follow-up|0|||
16123347|NCT00568178|38938493|FG003|Open Label Extension|Lost to Follow-up|0|||
16123348|NCT00568178|38938494|FG004|Open Label Extension|Lost to Follow-up|6|||
16123349|NCT00568178|38938495|FG005|Open Label Extension|Lost to Follow-up|11|||
16123350|NCT00568178|38938490|FG000|Open Label Extension|Physician Decision|0|||
16123351|NCT00568178|38938491|FG001|Open Label Extension|Physician Decision|0|||
16123352|NCT00568178|38938492|FG002|Open Label Extension|Physician Decision|0|||
16123353|NCT00568178|38938493|FG003|Open Label Extension|Physician Decision|0|||
16123354|NCT00568178|38938494|FG004|Open Label Extension|Physician Decision|9|||
16123355|NCT00568178|38938495|FG005|Open Label Extension|Physician Decision|8|||
16123356|NCT00568178|38938490|FG000|Open Label Extension|Pregnancy|0|||
16123357|NCT00568178|38938491|FG001|Open Label Extension|Pregnancy|0|||
16123358|NCT00568178|38938492|FG002|Open Label Extension|Pregnancy|0|||
16123359|NCT00568178|38938493|FG003|Open Label Extension|Pregnancy|0|||
16123360|NCT00568178|38938494|FG004|Open Label Extension|Pregnancy|0|||
16123361|NCT00568178|38938495|FG005|Open Label Extension|Pregnancy|1|||
16123362|NCT00568178|38938490|FG000|Open Label Extension|Progressive Disease|0|||
16123363|NCT00568178|38938491|FG001|Open Label Extension|Progressive Disease|0|||
16123364|NCT00568178|38938492|FG002|Open Label Extension|Progressive Disease|0|||
16123365|NCT00568178|38938493|FG003|Open Label Extension|Progressive Disease|0|||
16123366|NCT00568178|38938494|FG004|Open Label Extension|Progressive Disease|3|||
16123367|NCT00568178|38938495|FG005|Open Label Extension|Progressive Disease|1|||
16123368|NCT00568178|38938490|FG000|Open Label Extension|Termination of Trial|0|||
16123369|NCT00568178|38938491|FG001|Open Label Extension|Termination of Trial|0|||
16123370|NCT00568178|38938492|FG002|Open Label Extension|Termination of Trial|0|||
16123371|NCT00568178|38938493|FG003|Open Label Extension|Termination of Trial|0|||
16123372|NCT00568178|38938494|FG004|Open Label Extension|Termination of Trial|45|||
16123373|NCT00568178|38938495|FG005|Open Label Extension|Termination of Trial|47|||
16123374|NCT00568178|38938490|FG000|Open Label Extension|Withdrawal by Subject|0|||
16123375|NCT00568178|38938491|FG001|Open Label Extension|Withdrawal by Subject|0|||
16123376|NCT00568178|38938492|FG002|Open Label Extension|Withdrawal by Subject|0|||
16123377|NCT00568178|38938493|FG003|Open Label Extension|Withdrawal by Subject|0|||
16123378|NCT00568178|38938494|FG004|Open Label Extension|Withdrawal by Subject|4|||
16123379|NCT00568178|38938495|FG005|Open Label Extension|Withdrawal by Subject|4|||
16123380|NCT00818168|38938496|FG000|Overall Study|Lack of Efficacy|18|||
16123381|NCT00818168|38938496|FG000|Overall Study|Pregnancy|2|||
16123382|NCT00818168|38938496|FG000|Overall Study|Withdrawal by Subject|16|||
16123383|NCT00818168|38938496|FG000|Overall Study|Lost to Follow-up|7|||
16123384|NCT00818168|38938496|FG000|Overall Study|Adverse Event|19|||
16123385|NCT00818168|38938496|FG000|Overall Study|Reason for Non-completion Not reported|6|||
16123386|NCT00818168|38938496|FG000|Overall Study|Participant Moved|2|||
16123387|NCT02964325|38938497|FG000|Overall Study|Lost to Follow-up|3|||
16123388|NCT02964325|38938498|FG001|Overall Study|Lost to Follow-up|3|||
16123389|NCT02964325|38938497|FG000|Overall Study|Physician Decision|5|||
16123390|NCT02964325|38938498|FG001|Overall Study|Physician Decision|4|||
16123391|NCT02964325|38938497|FG000|Overall Study|Death|1|||
16123392|NCT02964325|38938498|FG001|Overall Study|Death|3|||
16123393|NCT02964325|38938497|FG000|Overall Study|Withdrawal by Subject|2|||
16123394|NCT02964325|38938498|FG001|Overall Study|Withdrawal by Subject|1|||
16239736|NCT04380701|39360832|FG003|Overall Study|Physician Decision|0|||
16239737|NCT04380701|39360833|FG004|Overall Study|Physician Decision|0|||
16239738|NCT04380701|39360834|FG005|Overall Study|Physician Decision|0|||
16239739|NCT04380701|39360835|FG006|Overall Study|Physician Decision|0|||
16239740|NCT04380701|39360836|FG007|Overall Study|Physician Decision|0|||
16239741|NCT04380701|39360837|FG008|Overall Study|Physician Decision|0|||
16239742|NCT04380701|39360838|FG009|Overall Study|Physician Decision|0|||
16239743|NCT04380701|39360839|FG010|Overall Study|Physician Decision|0|||
16239744|NCT04380701|39360840|FG011|Overall Study|Physician Decision|0|||
16239745|NCT04380701|39360841|FG012|Overall Study|Physician Decision|0|||
16239746|NCT04380701|39360842|FG013|Overall Study|Physician Decision|0|||
16239747|NCT04380701|39360843|FG014|Overall Study|Physician Decision|0|||
16239748|NCT04380701|39360844|FG015|Overall Study|Physician Decision|0|||
16239749|NCT04380701|39360845|FG016|Overall Study|Physician Decision|0|||
16239750|NCT04380701|39360846|FG017|Overall Study|Physician Decision|0|||
16239751|NCT04380701|39360847|FG018|Overall Study|Physician Decision|0|||
16239752|NCT04380701|39360848|FG019|Overall Study|Physician Decision|0|||
16239753|NCT04380701|39360849|FG020|Overall Study|Physician Decision|0|||
16239754|NCT04380701|39360850|FG021|Overall Study|Physician Decision|0|||
16239755|NCT04380701|39360851|FG022|Overall Study|Physician Decision|0|||
16239756|NCT04380701|39360852|FG023|Overall Study|Physician Decision|0|||
16239757|NCT04380701|39360853|FG024|Overall Study|Physician Decision|2|||
16239758|NCT04380701|39360854|FG025|Overall Study|Physician Decision|0|||
16239759|NCT04380701|39360855|FG026|Overall Study|Physician Decision|0|||
16239760|NCT04380701|39360856|FG027|Overall Study|Physician Decision|0|||
16239761|NCT04380701|39360857|FG028|Overall Study|Physician Decision|0|||
16239762|NCT04380701|39360858|FG029|Overall Study|Physician Decision|0|||
16239763|NCT04380701|39360859|FG030|Overall Study|Physician Decision|0|||
16239764|NCT04380701|39360860|FG031|Overall Study|Physician Decision|0|||
16239765|NCT04380701|39360861|FG032|Overall Study|Physician Decision|0|||
16239766|NCT04380701|39360862|FG033|Overall Study|Physician Decision|0|||
16239767|NCT04380701|39360829|FG000|Overall Study|Death|0|||
16239768|NCT04380701|39360830|FG001|Overall Study|Death|0|||
16239769|NCT04380701|39360831|FG002|Overall Study|Death|0|||
16239770|NCT04380701|39360832|FG003|Overall Study|Death|0|||
16239771|NCT04380701|39360833|FG004|Overall Study|Death|0|||
16239772|NCT04380701|39360834|FG005|Overall Study|Death|0|||
16239773|NCT04380701|39360835|FG006|Overall Study|Death|0|||
16239774|NCT04380701|39360836|FG007|Overall Study|Death|0|||
16239775|NCT04380701|39360837|FG008|Overall Study|Death|0|||
16239776|NCT04380701|39360838|FG009|Overall Study|Death|0|||
16239777|NCT04380701|39360839|FG010|Overall Study|Death|0|||
16239778|NCT04380701|39360840|FG011|Overall Study|Death|0|||
16239779|NCT04380701|39360841|FG012|Overall Study|Death|0|||
16239780|NCT04380701|39360842|FG013|Overall Study|Death|0|||
16239781|NCT04380701|39360843|FG014|Overall Study|Death|0|||
16239782|NCT04380701|39360844|FG015|Overall Study|Death|0|||
16239783|NCT04380701|39360845|FG016|Overall Study|Death|0|||
16239784|NCT04380701|39360846|FG017|Overall Study|Death|0|||
16239785|NCT04380701|39360847|FG018|Overall Study|Death|0|||
16239786|NCT04380701|39360848|FG019|Overall Study|Death|0|||
16239787|NCT04380701|39360849|FG020|Overall Study|Death|0|||
16239788|NCT04380701|39360850|FG021|Overall Study|Death|0|||
16239789|NCT04380701|39360851|FG022|Overall Study|Death|0|||
16239790|NCT04380701|39360852|FG023|Overall Study|Death|0|||
16239791|NCT04380701|39360853|FG024|Overall Study|Death|1|||
16239792|NCT04380701|39360854|FG025|Overall Study|Death|0|||
16239793|NCT04380701|39360855|FG026|Overall Study|Death|0|||
16239794|NCT04380701|39360856|FG027|Overall Study|Death|0|||
16239795|NCT04380701|39360857|FG028|Overall Study|Death|0|||
16239796|NCT04380701|39360858|FG029|Overall Study|Death|0|||
16239797|NCT04380701|39360859|FG030|Overall Study|Death|0|||
16239798|NCT04380701|39360860|FG031|Overall Study|Death|0|||
16239799|NCT04380701|39360861|FG032|Overall Study|Death|0|||
16239800|NCT04380701|39360862|FG033|Overall Study|Death|0|||
16239801|NCT04380701|39360829|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239802|NCT04380701|39360830|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239803|NCT04380701|39360831|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239804|NCT04380701|39360832|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239805|NCT04380701|39360833|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16123395|NCT02964325|38938497|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
16123396|NCT02964325|38938498|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
16123397|NCT00941070|38938499|FG000|Overall Study|Patient non-compliant|1|||
16123398|NCT00789360|38938500|FG000|Overall Study|Protocol Violation|3|||
16123399|NCT00789360|38938501|FG001|Overall Study|Protocol Violation|1|||
16123400|NCT00974259|38938511|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
16123401|NCT00974259|38938512|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
16123402|NCT01280357|38938515|FG000|Overall Study|Excluded no internal monitoring|14|||
16123403|NCT01280357|38938515|FG000|Overall Study|IInsufficient data/No data supplied|12|||
16123404|NCT04738292|38938516|FG000|Overall Study|Death|1|||
16123405|NCT02383940|38938517|FG000|Overall Study|Adverse Event|1|||
16123406|NCT02383940|38938518|FG001|Overall Study|Adverse Event|0|||
16123407|NCT02383940|38938517|FG000|Overall Study|Lost to Follow-up|2|||
16123408|NCT02383940|38938518|FG001|Overall Study|Lost to Follow-up|2|||
16123409|NCT02383940|38938517|FG000|Overall Study|Physician Decision|2|||
16123410|NCT02383940|38938518|FG001|Overall Study|Physician Decision|0|||
16123411|NCT02383940|38938517|FG000|Overall Study|Withdrawal by Subject|1|||
16123412|NCT02383940|38938518|FG001|Overall Study|Withdrawal by Subject|1|||
16123413|NCT02383940|38938517|FG000|Overall Study|Randomized but not treated|2|||
16123414|NCT02383940|38938518|FG001|Overall Study|Randomized but not treated|0|||
16123415|NCT02383940|38938517|FG000|Overall Study|Other than specified above|1|||
16123416|NCT02383940|38938518|FG001|Overall Study|Other than specified above|0|||
16123417|NCT00663702|38938519|FG000|Overall Study|Adverse Event|8|||
16123418|NCT00663702|38938520|FG001|Overall Study|Adverse Event|4|||
16123419|NCT00663702|38938519|FG000|Overall Study|Withdrawal by Subject|3|||
16123420|NCT00663702|38938520|FG001|Overall Study|Withdrawal by Subject|1|||
16123421|NCT00663702|38938519|FG000|Overall Study|Pregnancy|0|||
16123422|NCT00663702|38938520|FG001|Overall Study|Pregnancy|1|||
16123423|NCT00663702|38938519|FG000|Overall Study|Lost to Follow-up|3|||
16123424|NCT00663702|38938520|FG001|Overall Study|Lost to Follow-up|0|||
16123425|NCT00663702|38938519|FG000|Overall Study|Death|1|||
16123426|NCT00663702|38938520|FG001|Overall Study|Death|1|||
16123427|NCT00663702|38938519|FG000|Overall Study|Lack of Efficacy|3|||
16123428|NCT00663702|38938520|FG001|Overall Study|Lack of Efficacy|3|||
16123429|NCT03554629|38938523|FG000|Overall Study|Inadequate data|6|||
16123430|NCT01205152|38938524|FG000|Overall Study|Death|1|||
16123431|NCT00266227|38938525|FG000|Initial Treatment|Adverse Event|0|||
16123432|NCT00266227|38938526|FG001|Initial Treatment|Adverse Event|0|||
16123433|NCT00266227|38938527|FG002|Initial Treatment|Adverse Event|13|||
16123434|NCT00266227|38938525|FG000|Initial Treatment|Lost to Follow-up|0|||
16123435|NCT00266227|38938526|FG001|Initial Treatment|Lost to Follow-up|0|||
16123436|NCT00266227|38938527|FG002|Initial Treatment|Lost to Follow-up|6|||
16123437|NCT00266227|38938525|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
16123438|NCT00266227|38938526|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
16123439|NCT00266227|38938527|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
16123440|NCT00266227|38938525|FG000|Initial Treatment|Physician decision to withdraw|0|||
16123441|NCT00266227|38938526|FG001|Initial Treatment|Physician decision to withdraw|0|||
16123442|NCT00266227|38938527|FG002|Initial Treatment|Physician decision to withdraw|12|||
16123443|NCT00266227|38938525|FG000|Initial Treatment|Pregnancy|0|||
16123444|NCT00266227|38938526|FG001|Initial Treatment|Pregnancy|0|||
16123445|NCT00266227|38938527|FG002|Initial Treatment|Pregnancy|1|||
16123446|NCT00266227|38938525|FG000|Retreatment: Up to Week 48|Death|1|||
16123447|NCT00266227|38938526|FG001|Retreatment: Up to Week 48|Death|0|||
16123448|NCT00266227|38938527|FG002|Retreatment: Up to Week 48|Death|0|||
16123449|NCT00266227|38938525|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
16123450|NCT00266227|38938526|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
16123451|NCT00266227|38938527|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
16123452|NCT00266227|38938525|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
16123453|NCT00266227|38938526|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
16123454|NCT00266227|38938527|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
16350153|NCT01747499|39768963|FG000|Overall Study|Steroid refractory aGvHD|1|||
16350154|NCT01747499|39768964|FG001|Overall Study|Steroid refractory aGvHD|0|||
16350155|NCT01747499|39768965|FG002|Overall Study|Steroid refractory aGvHD|0|||
16350156|NCT01747499|39768966|FG003|Overall Study|Steroid refractory aGvHD|1|||
16123455|NCT00266227|38938525|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
16123456|NCT00266227|38938526|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
16123457|NCT00266227|38938527|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
16123458|NCT00266227|38938525|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
16123459|NCT00266227|38938526|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
16123460|NCT00266227|38938527|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
16123461|NCT00266227|38938525|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
16123462|NCT00266227|38938526|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
16123463|NCT00266227|38938527|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
16123464|NCT00266227|38938525|FG000|Retreatment: Week 48 to Week 72|Death|1|||
16123465|NCT00266227|38938526|FG001|Retreatment: Week 48 to Week 72|Death|1|||
16123466|NCT00266227|38938527|FG002|Retreatment: Week 48 to Week 72|Death|0|||
16123467|NCT00266227|38938525|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
16123468|NCT00266227|38938526|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
16239806|NCT04380701|39360834|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239807|NCT04380701|39360835|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16123469|NCT00266227|38938527|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
16123470|NCT00266227|38938525|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
16123471|NCT00266227|38938526|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
16123472|NCT00266227|38938527|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
16123473|NCT00266227|38938525|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
16123474|NCT00266227|38938526|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
16123475|NCT00266227|38938527|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
16123476|NCT00266227|38938525|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
16123477|NCT00266227|38938526|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
16123478|NCT00266227|38938527|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
16123479|NCT02971761|38938537|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
16123480|NCT00943111|38938538|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
16123481|NCT00943111|38938539|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
16350157|NCT01747499|39768967|FG004|Overall Study|Steroid refractory aGvHD|4|||
16123482|NCT00943111|38938540|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
16414226|NCT03743064|39998364|FG000|Overall Study|Withdrawal by Subject|28|||
16414227|NCT03743064|39998365|FG001|Overall Study|Withdrawal by Subject|25|||
16123483|NCT00943111|38938538|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
16123484|NCT00943111|38938539|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
16123485|NCT00943111|38938540|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
16123486|NCT00943111|38938538|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
16123487|NCT00943111|38938539|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
16123488|NCT00943111|38938540|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
16123489|NCT00943111|38938538|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
16123490|NCT00943111|38938539|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
16123491|NCT00943111|38938540|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
16123492|NCT00943111|38938538|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
16123493|NCT00943111|38938539|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
16123494|NCT00943111|38938540|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
16556828|NCT02555371|40503540|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
16556829|NCT02555371|40503541|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
16556830|NCT02555371|40503542|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
16556831|NCT02555371|40503543|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
16556832|NCT02555371|40503544|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
16556833|NCT01799720|40503545|FG000|Overall Study|Withdrawal by Subject|3|||
16556834|NCT01799720|40503546|FG001|Overall Study|Withdrawal by Subject|0|||
16556835|NCT01799720|40503547|FG002|Overall Study|Withdrawal by Subject|0|||
16556836|NCT01799720|40503545|FG000|Overall Study|Protocol Violation|0|||
16556837|NCT01799720|40503546|FG001|Overall Study|Protocol Violation|1|||
16556838|NCT01799720|40503547|FG002|Overall Study|Protocol Violation|0|||
16556839|NCT01799720|40503545|FG000|Overall Study|Pregnancy|0|||
16556840|NCT01799720|40503546|FG001|Overall Study|Pregnancy|0|||
16556841|NCT01799720|40503547|FG002|Overall Study|Pregnancy|1|||
16556842|NCT02531295|40503555|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
16556843|NCT02531295|40503556|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
16556844|NCT02531295|40503557|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
16556845|NCT02531295|40503558|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
16556846|NCT02531295|40503559|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
16556847|NCT02531295|40503560|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
16556848|NCT01186328|40503561|FG000|Overall Study|Death|1|||
16556849|NCT01186328|40503562|FG001|Overall Study|Death|0|||
16556850|NCT01186328|40503563|FG002|Overall Study|Death|0|||
16556851|NCT03249376|40503564|FG000|Overall Study|Adverse Event|11|||
16556852|NCT03249376|40503565|FG001|Overall Study|Adverse Event|5|||
16556853|NCT03249376|40503564|FG000|Overall Study|Lack of Efficacy|2|||
16556854|NCT03249376|40503565|FG001|Overall Study|Lack of Efficacy|4|||
16556855|NCT03249376|40503564|FG000|Overall Study|Protocol Violation|3|||
16556856|NCT03249376|40503565|FG001|Overall Study|Protocol Violation|2|||
16556857|NCT03249376|40503564|FG000|Overall Study|Physician Decision|0|||
16556858|NCT03249376|40503565|FG001|Overall Study|Physician Decision|2|||
16556859|NCT03249376|40503564|FG000|Overall Study|Withdrawal by Subject|3|||
16556860|NCT03249376|40503565|FG001|Overall Study|Withdrawal by Subject|9|||
16556861|NCT03249376|40503564|FG000|Overall Study|LTFU|2|||
16556862|NCT03249376|40503565|FG001|Overall Study|LTFU|1|||
16556863|NCT01900054|40503566|FG000|Overall Study|Physician Decision|1|||
16556864|NCT01900054|40503566|FG000|Overall Study|Withdrawal by Subject|1|||
16556865|NCT00614744|40503569|FG000|Overall Study|Lost to Follow-up|5|||
16556866|NCT00614744|40503570|FG001|Overall Study|Lost to Follow-up|4|||
16556867|NCT00614744|40503569|FG000|Overall Study|Incomplete for Behavior Issues|0|||
16556868|NCT00614744|40503570|FG001|Overall Study|Incomplete for Behavior Issues|2|||
16556869|NCT03405792|40503574|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
16556870|NCT03405792|40503575|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
16414228|NCT03743064|39998364|FG000|Overall Study|Physician Decision|2|||
16123495|NCT00943111|38938538|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
16123496|NCT00943111|38938539|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
16123497|NCT00943111|38938540|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
16123498|NCT00943111|38938538|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
16123499|NCT00943111|38938539|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
16123500|NCT00943111|38938540|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
16123501|NCT00943111|38938538|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
16123502|NCT00943111|38938539|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
16123503|NCT00943111|38938540|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
16556871|NCT03405792|40503574|FG000|Overall Study|o Did not receive pembrolizumab|1|||
16556872|NCT03405792|40503575|FG001|Overall Study|o Did not receive pembrolizumab|0|||
16556873|NCT02218489|40503576|FG000|Overall Study|Withdrawal by Subject|4|||
16556874|NCT02218489|40503577|FG001|Overall Study|Withdrawal by Subject|3|||
16556875|NCT02218489|40503576|FG000|Overall Study|Lost to Follow-up|1|||
16556876|NCT02218489|40503577|FG001|Overall Study|Lost to Follow-up|0|||
16556877|NCT02743793|40503578|FG000|Overall Study|Death|1|||
16556878|NCT02743793|40503579|FG001|Overall Study|Death|1|||
16556879|NCT02743793|40503578|FG000|Overall Study|Withdrawal by Subject|0|||
16556880|NCT02743793|40503579|FG001|Overall Study|Withdrawal by Subject|1|||
16556881|NCT02743793|40503578|FG000|Overall Study|Screen Failure|4|||
16556882|NCT02743793|40503579|FG001|Overall Study|Screen Failure|0|||
16556883|NCT02743793|40503578|FG000|Overall Study|No Primary Care Physician|0|||
16556884|NCT02743793|40503579|FG001|Overall Study|No Primary Care Physician|1|||
16123504|NCT02781090|38938541|FG000|3-Month Follow-Up|Missed Visit|20|||
16123505|NCT02781090|38938542|FG001|3-Month Follow-Up|Missed Visit|20|||
16123506|NCT02781090|38938541|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
16123507|NCT02781090|38938542|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
16123508|NCT02781090|38938541|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
16123509|NCT02781090|38938542|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
16123510|NCT02781090|38938541|FG000|3-Month Follow-Up|Death|1|||
16123511|NCT02781090|38938542|FG001|3-Month Follow-Up|Death|0|||
16123512|NCT02781090|38938541|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
16123513|NCT02781090|38938542|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
16123514|NCT02781090|38938541|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
16123515|NCT02781090|38938542|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
16123516|NCT02781090|38938541|FG000|6-Month Follow-Up|Death|0|||
16123517|NCT02781090|38938542|FG001|6-Month Follow-Up|Death|1|||
16123518|NCT01498887|38938543|FG000|Overall Study|Administrative problems|1|||
16123519|NCT01498887|38938544|FG001|Overall Study|Administrative problems|0|||
16123520|NCT01498887|38938543|FG000|Overall Study|Lost to Follow-up|1|||
16123521|NCT01498887|38938544|FG001|Overall Study|Lost to Follow-up|1|||
16123522|NCT01498887|38938543|FG000|Overall Study|Withdrawal by Subject|1|||
16123523|NCT01498887|38938544|FG001|Overall Study|Withdrawal by Subject|0|||
16123524|NCT01498887|38938543|FG000|Overall Study|Protocol Violation|1|||
16556885|NCT02743793|40503578|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
16556886|NCT02743793|40503579|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
16556887|NCT02743793|40503578|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
16556888|NCT02743793|40503579|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
16556889|NCT04296890|40503580|FG000|Overall Study|Withdrawal by Subject|1|||
16556890|NCT04296890|40503580|FG000|Overall Study|Death|62|||
16123525|NCT01498887|38938544|FG001|Overall Study|Protocol Violation|3|||
16123526|NCT01498887|38938543|FG000|Overall Study|Lack of Efficacy|5|||
16123527|NCT01498887|38938544|FG001|Overall Study|Lack of Efficacy|3|||
16123528|NCT01498887|38938543|FG000|Overall Study|Abnormal result from test procedure|1|||
16123529|NCT01498887|38938544|FG001|Overall Study|Abnormal result from test procedure|1|||
16123530|NCT01498887|38938543|FG000|Overall Study|Abnormal laboratory value|2|||
16123531|NCT01498887|38938544|FG001|Overall Study|Abnormal laboratory value|2|||
16123532|NCT01498887|38938543|FG000|Overall Study|Adverse Event|4|||
16123533|NCT01498887|38938544|FG001|Overall Study|Adverse Event|1|||
16123534|NCT03596762|38938545|FG000|Overall Study|Protocol Violation|0|||
16123535|NCT03596762|38938546|FG001|Overall Study|Protocol Violation|0|||
16123536|NCT03596762|38938547|FG002|Overall Study|Protocol Violation|0|||
16123537|NCT03596762|38938548|FG003|Overall Study|Protocol Violation|0|||
16123538|NCT03596762|38938549|FG004|Overall Study|Protocol Violation|1|||
16123539|NCT03596762|38938545|FG000|Overall Study|Adverse Event|2|||
16123540|NCT03596762|38938546|FG001|Overall Study|Adverse Event|0|||
16123541|NCT03596762|38938547|FG002|Overall Study|Adverse Event|1|||
16123542|NCT03596762|38938548|FG003|Overall Study|Adverse Event|0|||
16123543|NCT03596762|38938549|FG004|Overall Study|Adverse Event|5|||
16123544|NCT03596762|38938545|FG000|Overall Study|Withdrawal by Subject|2|||
16123545|NCT03596762|38938546|FG001|Overall Study|Withdrawal by Subject|1|||
16123546|NCT03596762|38938547|FG002|Overall Study|Withdrawal by Subject|0|||
16556891|NCT04296890|40503580|FG000|Overall Study|Lost to Follow-up|3|||
16556892|NCT04296890|40503580|FG000|Overall Study|Other than specified|2|||
16556893|NCT00289770|40503583|FG000|Year 15|Withdrawal by Subject|1|||
16556894|NCT02148718|40503588|FG000|Overall Study|Protocol Violation|26|||
16239808|NCT04380701|39360836|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239809|NCT04380701|39360837|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239810|NCT04380701|39360838|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239811|NCT04380701|39360839|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239812|NCT04380701|39360840|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239813|NCT04380701|39360841|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239814|NCT04380701|39360842|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239815|NCT04380701|39360843|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239816|NCT04380701|39360844|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239817|NCT04380701|39360845|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239818|NCT04380701|39360846|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239819|NCT04380701|39360847|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239820|NCT04380701|39360848|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239821|NCT04380701|39360849|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239822|NCT04380701|39360850|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
16239823|NCT04380701|39360851|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
16239824|NCT04380701|39360852|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
16239825|NCT04380701|39360853|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
16239826|NCT04380701|39360854|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239827|NCT04380701|39360855|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239828|NCT04380701|39360856|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16556895|NCT02148718|40503588|FG000|Overall Study|Discontinued Study Prematurely|5|||
16556896|NCT01818141|40503591|FG000|Overall Study|Withdrawal by Subject|2|||
16556897|NCT01818141|40503592|FG001|Overall Study|Withdrawal by Subject|0|||
16556898|NCT01818141|40503591|FG000|Overall Study|No baseline C.diff colonies|1|||
16556899|NCT01818141|40503592|FG001|Overall Study|No baseline C.diff colonies|1|||
16556900|NCT01818141|40503591|FG000|Overall Study|Lost to Follow-up|0|||
16556901|NCT01818141|40503592|FG001|Overall Study|Lost to Follow-up|2|||
16556902|NCT03713593|40503593|FG000|Overall Study|Participants Ongoing|140|||
16556903|NCT03713593|40503594|FG001|Overall Study|Participants Ongoing|114|||
16556904|NCT03713593|40503593|FG000|Overall Study|Withdrawal by Subject|3|||
16556905|NCT03713593|40503594|FG001|Overall Study|Withdrawal by Subject|6|||
16556906|NCT03713593|40503593|FG000|Overall Study|Death|252|||
16556907|NCT03713593|40503594|FG001|Overall Study|Death|279|||
16556908|NCT03873246|40503599|FG000|Overall Study|Adverse Event|1|||
16556909|NCT03873246|40503600|FG001|Overall Study|Adverse Event|3|||
16556910|NCT03873246|40503601|FG002|Overall Study|Adverse Event|3|||
16556911|NCT03873246|40503599|FG000|Overall Study|Lost to Follow-up|4|||
16239829|NCT04380701|39360857|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239830|NCT04380701|39360858|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239831|NCT04380701|39360859|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239832|NCT04380701|39360860|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239833|NCT04380701|39360861|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239834|NCT04380701|39360862|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
16239835|NCT02598622|39360867|FG000|Overall Study|Withdrawal by Subject|3|||
16239836|NCT02598622|39360868|FG001|Overall Study|Withdrawal by Subject|0|||
16239837|NCT02598622|39360867|FG000|Overall Study|Physician Decision|3|||
16239838|NCT02598622|39360868|FG001|Overall Study|Physician Decision|0|||
16239839|NCT02164539|39360869|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
16239840|NCT02164539|39360870|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
16239841|NCT02164539|39360871|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
16239842|NCT02164539|39360872|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
16239843|NCT02164539|39360873|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
16239844|NCT02164539|39360874|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
16239845|NCT02164539|39360875|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
16239846|NCT02164539|39360869|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
16239847|NCT02164539|39360870|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
16239848|NCT02164539|39360871|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
16239849|NCT02164539|39360872|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
16239850|NCT02164539|39360873|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
16239851|NCT02164539|39360874|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
16239852|NCT02164539|39360875|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
16556912|NCT03873246|40503600|FG001|Overall Study|Lost to Follow-up|4|||
16556913|NCT03873246|40503601|FG002|Overall Study|Lost to Follow-up|5|||
16556914|NCT03873246|40503599|FG000|Overall Study|Protocol Violation|0|||
16239853|NCT02164539|39360869|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
16350158|NCT01747499|39768963|FG000|Overall Study|Physician Decision|0|||
16350159|NCT01747499|39768964|FG001|Overall Study|Physician Decision|1|||
16556915|NCT03873246|40503600|FG001|Overall Study|Protocol Violation|1|||
16123547|NCT03596762|38938548|FG003|Overall Study|Withdrawal by Subject|1|||
16123548|NCT03596762|38938549|FG004|Overall Study|Withdrawal by Subject|1|||
16414229|NCT03743064|39998365|FG001|Overall Study|Physician Decision|4|||
16414230|NCT03743064|39998364|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
16414231|NCT03743064|39998365|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
16556916|NCT03873246|40503601|FG002|Overall Study|Protocol Violation|0|||
16556917|NCT03873246|40503599|FG000|Overall Study|Withdrawal by Subject|0|||
16556918|NCT03873246|40503600|FG001|Overall Study|Withdrawal by Subject|4|||
16556919|NCT03873246|40503601|FG002|Overall Study|Withdrawal by Subject|1|||
16556920|NCT04039503|40503602|FG000|Overall Study|Adverse Event|3|||
16556921|NCT04039503|40503603|FG001|Overall Study|Adverse Event|0|||
16123549|NCT02229851|38938550|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
16123550|NCT02229851|38938551|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
16123551|NCT02229851|38938552|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
16123552|NCT02229851|38938553|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
16556922|NCT04039503|40503604|FG002|Overall Study|Adverse Event|2|||
16556923|NCT04039503|40503605|FG003|Overall Study|Adverse Event|0|||
16556924|NCT04039503|40503602|FG000|Overall Study|Lost to Follow-up|0|||
16556925|NCT04039503|40503603|FG001|Overall Study|Lost to Follow-up|0|||
16556926|NCT04039503|40503604|FG002|Overall Study|Lost to Follow-up|1|||
16556927|NCT04039503|40503605|FG003|Overall Study|Lost to Follow-up|0|||
16556928|NCT04039503|40503602|FG000|Overall Study|Protocol Violation|0|||
16556929|NCT04039503|40503603|FG001|Overall Study|Protocol Violation|1|||
16556930|NCT04039503|40503604|FG002|Overall Study|Protocol Violation|2|||
16556931|NCT04039503|40503605|FG003|Overall Study|Protocol Violation|1|||
16556932|NCT04039503|40503602|FG000|Overall Study|Withdrawal by Subject|4|||
16556933|NCT04039503|40503603|FG001|Overall Study|Withdrawal by Subject|3|||
16556934|NCT04039503|40503604|FG002|Overall Study|Withdrawal by Subject|5|||
16556935|NCT04039503|40503605|FG003|Overall Study|Withdrawal by Subject|2|||
16556936|NCT03285113|40503609|FG000|Overall Study|Unable to implant leads|2|||
16556937|NCT02698436|40503616|FG000|Overall Study|Adverse Event|1|||
16556938|NCT02698436|40503617|FG001|Overall Study|Adverse Event|0|||
16556939|NCT02698436|40503616|FG000|Overall Study|Withdrawal by Subject|3|||
16556940|NCT02698436|40503617|FG001|Overall Study|Withdrawal by Subject|3|||
16556941|NCT02698436|40503616|FG000|Overall Study|Lost to Follow-up|2|||
16556942|NCT02698436|40503617|FG001|Overall Study|Lost to Follow-up|4|||
16556943|NCT02698436|40503616|FG000|Overall Study|Non-compliance with study regimen|1|||
16556944|NCT02698436|40503617|FG001|Overall Study|Non-compliance with study regimen|0|||
16556945|NCT04781647|40503620|FG000|Overall Study|Study terminated by Sponsor|11|||
16556946|NCT04781647|40503621|FG001|Overall Study|Study terminated by Sponsor|9|||
16556947|NCT04781647|40503622|FG002|Overall Study|Study terminated by Sponsor|9|||
16556948|NCT04781647|40503620|FG000|Overall Study|Withdrawal by Subject|1|||
16556949|NCT04781647|40503621|FG001|Overall Study|Withdrawal by Subject|2|||
16556950|NCT04781647|40503622|FG002|Overall Study|Withdrawal by Subject|0|||
16556951|NCT04781647|40503620|FG000|Overall Study|Adverse Event|0|||
16556952|NCT04781647|40503621|FG001|Overall Study|Adverse Event|1|||
16123553|NCT02229851|38938554|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
16123554|NCT02229851|38938555|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
16239854|NCT02164539|39360870|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
16239855|NCT02164539|39360871|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
16239856|NCT02164539|39360872|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
16239857|NCT02164539|39360873|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
16239858|NCT02164539|39360874|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
16239859|NCT02164539|39360875|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
16239860|NCT02164539|39360869|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
16239861|NCT02164539|39360870|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16239862|NCT02164539|39360871|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16239863|NCT02164539|39360872|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16239864|NCT02164539|39360873|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16239865|NCT02164539|39360874|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16239866|NCT02164539|39360875|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
16239867|NCT02164539|39360869|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
16239868|NCT02164539|39360870|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
16123555|NCT02229851|38938556|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
16123556|NCT02229851|38938550|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16239869|NCT02164539|39360871|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
16239870|NCT02164539|39360872|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
16239871|NCT02164539|39360873|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
16556953|NCT04781647|40503622|FG002|Overall Study|Adverse Event|1|||
16556954|NCT04781647|40503620|FG000|Overall Study|Protocol Violation|1|||
16239872|NCT02164539|39360874|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
16556955|NCT04781647|40503621|FG001|Overall Study|Protocol Violation|0|||
16556956|NCT04781647|40503622|FG002|Overall Study|Protocol Violation|0|||
16556957|NCT04781647|40503620|FG000|Overall Study|Pregnancy|0|||
16239873|NCT02164539|39360875|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
16123557|NCT02229851|38938551|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
16123558|NCT02229851|38938552|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16123559|NCT02229851|38938553|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16123560|NCT02229851|38938554|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16123561|NCT02229851|38938555|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16123562|NCT02229851|38938556|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
16123563|NCT02229851|38938550|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
16123564|NCT02229851|38938551|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
16123565|NCT02229851|38938552|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
16123566|NCT02229851|38938553|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
16123567|NCT02229851|38938554|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
16123568|NCT02229851|38938555|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
16123569|NCT02229851|38938556|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
16123570|NCT02229851|38938550|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16123571|NCT02229851|38938551|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16123572|NCT02229851|38938552|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
16123573|NCT02229851|38938553|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16123574|NCT02229851|38938554|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16123575|NCT02229851|38938555|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16123576|NCT02229851|38938556|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
16123577|NCT02229851|38938550|FG000|Main Phase (Double-blind Phase)|Death|1|||
16556958|NCT04781647|40503621|FG001|Overall Study|Pregnancy|0|||
16556959|NCT04781647|40503622|FG002|Overall Study|Pregnancy|1|||
16556960|NCT04781647|40503620|FG000|Overall Study|Virology rebounded|1|||
16556961|NCT04781647|40503621|FG001|Overall Study|Virology rebounded|0|||
16123578|NCT02229851|38938551|FG001|Main Phase (Double-blind Phase)|Death|1|||
16123579|NCT02229851|38938552|FG002|Main Phase (Double-blind Phase)|Death|0|||
16123580|NCT02229851|38938553|FG003|Main Phase (Double-blind Phase)|Death|0|||
16123581|NCT02229851|38938554|FG004|Main Phase (Double-blind Phase)|Death|0|||
16123582|NCT02229851|38938555|FG005|Main Phase (Double-blind Phase)|Death|0|||
16123583|NCT02229851|38938556|FG006|Main Phase (Double-blind Phase)|Death|0|||
16123584|NCT02229851|38938550|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
16123585|NCT02229851|38938551|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
16123586|NCT02229851|38938552|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
16123587|NCT02229851|38938553|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
16123588|NCT02229851|38938554|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
16123589|NCT02229851|38938555|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
16239874|NCT02164539|39360869|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
16239875|NCT02164539|39360870|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
16239876|NCT02164539|39360871|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
16239877|NCT02164539|39360872|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
16239878|NCT02164539|39360873|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
16239879|NCT02164539|39360874|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
16239880|NCT02164539|39360875|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
16239881|NCT02173301|39360876|FG000|Overall Study|Adverse Event|7|||
16239882|NCT02173301|39360877|FG001|Overall Study|Adverse Event|8|||
16239883|NCT02173301|39360878|FG002|Overall Study|Adverse Event|13|||
16239884|NCT02173301|39360879|FG003|Overall Study|Adverse Event|5|||
16239885|NCT02173301|39360876|FG000|Overall Study|Withdrawal by Subject|8|||
16239886|NCT02173301|39360877|FG001|Overall Study|Withdrawal by Subject|10|||
16239887|NCT02173301|39360878|FG002|Overall Study|Withdrawal by Subject|4|||
16239888|NCT02173301|39360879|FG003|Overall Study|Withdrawal by Subject|8|||
16239889|NCT02173301|39360876|FG000|Overall Study|Lost to Follow-up|4|||
16239890|NCT02173301|39360877|FG001|Overall Study|Lost to Follow-up|4|||
16556962|NCT04781647|40503622|FG002|Overall Study|Virology rebounded|0|||
16556963|NCT01708187|40503624|FG000|Overall Study|Lost to Follow-up|0|||
16556964|NCT01708187|40503625|FG001|Overall Study|Lost to Follow-up|1|||
16556965|NCT04227340|40503626|FG000|Overall Study|Withdrawal by Subject|3|||
16556966|NCT01461993|40506371|FG000|Overall Study|Withdrawal by Subject|60|||
16556967|NCT01461993|40506372|FG001|Overall Study|Withdrawal by Subject|53|||
16556968|NCT01461993|40506373|FG002|Overall Study|Withdrawal by Subject|16|||
16556969|NCT01461993|40506371|FG000|Overall Study|Lost to Follow-up|44|||
16556970|NCT01461993|40506372|FG001|Overall Study|Lost to Follow-up|48|||
16239891|NCT02173301|39360878|FG002|Overall Study|Lost to Follow-up|2|||
16239892|NCT02173301|39360879|FG003|Overall Study|Lost to Follow-up|2|||
16239893|NCT02173301|39360876|FG000|Overall Study|Protocol Violation|0|||
16239894|NCT02173301|39360877|FG001|Overall Study|Protocol Violation|1|||
16239895|NCT02173301|39360878|FG002|Overall Study|Protocol Violation|0|||
16239896|NCT02173301|39360879|FG003|Overall Study|Protocol Violation|0|||
16239897|NCT02173301|39360876|FG000|Overall Study|Physician Decision|0|||
16239898|NCT02173301|39360877|FG001|Overall Study|Physician Decision|0|||
16239899|NCT02173301|39360878|FG002|Overall Study|Physician Decision|1|||
16239900|NCT02173301|39360879|FG003|Overall Study|Physician Decision|0|||
16239901|NCT02173301|39360876|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
16239902|NCT02173301|39360877|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
16239903|NCT02173301|39360878|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
16239904|NCT02173301|39360879|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
16239905|NCT05288673|39360882|FG000|Overall Study|Consent withdrawn by subject|0|||
16239906|NCT05288673|39360883|FG001|Overall Study|Consent withdrawn by subject|0|||
16239907|NCT05288673|39360884|FG002|Overall Study|Consent withdrawn by subject|1|||
16239908|NCT01238211|39360885|FG000|Overall Study|Continues active treatment|31|||
16239909|NCT01238211|39360885|FG000|Overall Study|Adverse Event|7|||
16239910|NCT01238211|39360885|FG000|Overall Study|Death|4|||
16239911|NCT01238211|39360885|FG000|Overall Study|Relapse/Progression|2|||
16239912|NCT01238211|39360885|FG000|Overall Study|Withdrawal by Subject|7|||
16239913|NCT01238211|39360885|FG000|Overall Study|Non-protocol treatment|4|||
16239914|NCT01238211|39360885|FG000|Overall Study|Investigator/Patient Decision|3|||
16239915|NCT02742818|39360886|FG000|Overall Study|Adverse Event|0|||
16239916|NCT02742818|39360887|FG001|Overall Study|Adverse Event|1|||
16239917|NCT02742818|39360886|FG000|Overall Study|Protocol Violation|0|||
16239918|NCT02742818|39360887|FG001|Overall Study|Protocol Violation|1|||
16239919|NCT02176642|39360888|FG000|Overall Study|Withdrawal by Subject|0|||
16239920|NCT02176642|39360889|FG001|Overall Study|Withdrawal by Subject|1|||
16239921|NCT01389024|39360890|FG000|Overall Study|Withdrawal by Subject|0|||
16239922|NCT01389024|39360891|FG001|Overall Study|Withdrawal by Subject|1|||
16239923|NCT01389024|39360890|FG000|Overall Study|Lost to Follow-up|1|||
16239924|NCT01389024|39360891|FG001|Overall Study|Lost to Follow-up|0|||
16239925|NCT00828516|39360892|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
16239926|NCT01959230|39360893|FG000|Overall Study|Failure to follow study procedures|0|||
16239927|NCT01959230|39360894|FG001|Overall Study|Failure to follow study procedures|1|||
16239928|NCT01959230|39360893|FG000|Overall Study|Administrative reasons|2|||
16239929|NCT01959230|39360894|FG001|Overall Study|Administrative reasons|0|||
16239930|NCT01959230|39360893|FG000|Overall Study|Withdrawal by Subject|2|||
16239931|NCT01959230|39360894|FG001|Overall Study|Withdrawal by Subject|0|||
16239932|NCT00995930|39360897|FG000|Overall Study|Protocol deviation|2|||
16239933|NCT00995930|39360898|FG001|Overall Study|Protocol deviation|5|||
16239934|NCT00995930|39360897|FG000|Overall Study|Death|0|||
16239935|NCT00995930|39360898|FG001|Overall Study|Death|1|||
16239936|NCT00995930|39360897|FG000|Overall Study|Administrative problems|4|||
16239937|NCT00995930|39360898|FG001|Overall Study|Administrative problems|2|||
16239938|NCT00995930|39360897|FG000|Overall Study|Lost to Follow-up|1|||
16239939|NCT00995930|39360898|FG001|Overall Study|Lost to Follow-up|2|||
16239940|NCT00995930|39360897|FG000|Overall Study|Withdrawal by Subject|3|||
16350160|NCT01747499|39768965|FG002|Overall Study|Physician Decision|0|||
16239941|NCT00995930|39360898|FG001|Overall Study|Withdrawal by Subject|4|||
16239942|NCT00995930|39360897|FG000|Overall Study|Adverse Event|11|||
16239943|NCT00995930|39360898|FG001|Overall Study|Adverse Event|14|||
16239944|NCT01902134|39360900|FG000|Overall Study|Adverse Event|3|||
16239945|NCT01902134|39360901|FG001|Overall Study|Adverse Event|1|||
16239946|NCT01902134|39360902|FG002|Overall Study|Adverse Event|2|||
16239947|NCT01902134|39360903|FG003|Overall Study|Adverse Event|1|||
16239948|NCT01902134|39360904|FG004|Overall Study|Adverse Event|1|||
16239949|NCT01902134|39360905|FG005|Overall Study|Adverse Event|3|||
16239950|NCT01902134|39360900|FG000|Overall Study|Lack of Efficacy|0|||
16239951|NCT01902134|39360901|FG001|Overall Study|Lack of Efficacy|0|||
16239952|NCT01902134|39360902|FG002|Overall Study|Lack of Efficacy|2|||
16239953|NCT01902134|39360903|FG003|Overall Study|Lack of Efficacy|0|||
16239954|NCT01902134|39360904|FG004|Overall Study|Lack of Efficacy|0|||
16239955|NCT01902134|39360905|FG005|Overall Study|Lack of Efficacy|1|||
16556971|NCT01461993|40506373|FG002|Overall Study|Lost to Follow-up|22|||
16239956|NCT01902134|39360900|FG000|Overall Study|Physician Decision|0|||
16239957|NCT01902134|39360901|FG001|Overall Study|Physician Decision|1|||
16123590|NCT02229851|38938556|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
16239958|NCT01902134|39360902|FG002|Overall Study|Physician Decision|0|||
16239959|NCT01902134|39360903|FG003|Overall Study|Physician Decision|0|||
16239960|NCT01902134|39360904|FG004|Overall Study|Physician Decision|0|||
16239961|NCT01902134|39360905|FG005|Overall Study|Physician Decision|0|||
16239962|NCT01902134|39360900|FG000|Overall Study|Protocol Violation|0|||
16239963|NCT01902134|39360901|FG001|Overall Study|Protocol Violation|0|||
16239964|NCT01902134|39360902|FG002|Overall Study|Protocol Violation|0|||
16239965|NCT01902134|39360903|FG003|Overall Study|Protocol Violation|0|||
16239966|NCT01902134|39360904|FG004|Overall Study|Protocol Violation|0|||
16239967|NCT01902134|39360905|FG005|Overall Study|Protocol Violation|1|||
16239968|NCT01902134|39360900|FG000|Overall Study|Withdrawal by Subject|4|||
16239969|NCT01902134|39360901|FG001|Overall Study|Withdrawal by Subject|8|||
16239970|NCT01902134|39360902|FG002|Overall Study|Withdrawal by Subject|9|||
16239971|NCT01902134|39360903|FG003|Overall Study|Withdrawal by Subject|1|||
16239972|NCT01902134|39360904|FG004|Overall Study|Withdrawal by Subject|5|||
16239973|NCT01902134|39360905|FG005|Overall Study|Withdrawal by Subject|4|||
16239974|NCT01902134|39360900|FG000|Overall Study|no compliance|1|||
16239975|NCT01902134|39360901|FG001|Overall Study|no compliance|0|||
16239976|NCT01902134|39360902|FG002|Overall Study|no compliance|0|||
16239977|NCT01902134|39360903|FG003|Overall Study|no compliance|0|||
16239978|NCT01902134|39360904|FG004|Overall Study|no compliance|0|||
16239979|NCT01902134|39360905|FG005|Overall Study|no compliance|0|||
16556972|NCT01461993|40506371|FG000|Overall Study|Protocol Violation|10|||
16556973|NCT01461993|40506372|FG001|Overall Study|Protocol Violation|9|||
16556974|NCT01461993|40506373|FG002|Overall Study|Protocol Violation|7|||
16556975|NCT01461993|40506371|FG000|Overall Study|Adverse Event|9|||
16556976|NCT01461993|40506372|FG001|Overall Study|Adverse Event|11|||
16556977|NCT01461993|40506373|FG002|Overall Study|Adverse Event|3|||
16556978|NCT01461993|40506371|FG000|Overall Study|No longer met eligibility criteria|13|||
16556979|NCT01461993|40506372|FG001|Overall Study|No longer met eligibility criteria|18|||
16556980|NCT01461993|40506373|FG002|Overall Study|No longer met eligibility criteria|10|||
16556981|NCT01461993|40506371|FG000|Overall Study|Did not meet entrance criteria|2|||
16556982|NCT01461993|40506372|FG001|Overall Study|Did not meet entrance criteria|3|||
16556983|NCT01461993|40506373|FG002|Overall Study|Did not meet entrance criteria|0|||
16556984|NCT01461993|40506371|FG000|Overall Study|Other|13|||
16556985|NCT01461993|40506372|FG001|Overall Study|Other|15|||
16556986|NCT01461993|40506373|FG002|Overall Study|Other|6|||
16556987|NCT01083160|40506374|FG000|Overall Study|Adverse Event|1|||
16556988|NCT01544491|40506379|FG000|Overall Study|Withdrawal by Subject|3|||
16239980|NCT01902134|39360900|FG000|Overall Study|Other|0|||
16239981|NCT01902134|39360901|FG001|Overall Study|Other|1|||
16239982|NCT01902134|39360902|FG002|Overall Study|Other|2|||
16239983|NCT01902134|39360903|FG003|Overall Study|Other|0|||
16239984|NCT01902134|39360904|FG004|Overall Study|Other|1|||
16239985|NCT01902134|39360905|FG005|Overall Study|Other|0|||
16239986|NCT00766506|39360906|FG000|Overall Study|Use rescue medication after 3 hours|3|||
16239987|NCT00766506|39360907|FG001|Overall Study|Use rescue medication after 3 hours|0|||
16239988|NCT00766506|39360906|FG000|Overall Study|Other|2|||
16239989|NCT00766506|39360907|FG001|Overall Study|Other|2|||
16239990|NCT01787188|39360911|FG000|Overall Study|Adverse Event|2|||
16239991|NCT01787188|39360912|FG001|Overall Study|Adverse Event|4|||
16239992|NCT01787188|39360913|FG002|Overall Study|Adverse Event|6|||
16556989|NCT01544491|40506380|FG001|Overall Study|Withdrawal by Subject|2|||
16556990|NCT01544491|40506379|FG000|Overall Study|Lost to Follow-up|0|||
16239993|NCT01787188|39360911|FG000|Overall Study|Lack of Efficacy|7|||
16556991|NCT01544491|40506380|FG001|Overall Study|Lost to Follow-up|1|||
16239994|NCT01787188|39360912|FG001|Overall Study|Lack of Efficacy|3|||
16239995|NCT01787188|39360913|FG002|Overall Study|Lack of Efficacy|5|||
16239996|NCT01787188|39360911|FG000|Overall Study|Non-compliance with Study Drug|0|||
16350161|NCT01747499|39768966|FG003|Overall Study|Physician Decision|0|||
16350162|NCT01747499|39768967|FG004|Overall Study|Physician Decision|2|||
16239997|NCT01787188|39360912|FG001|Overall Study|Non-compliance with Study Drug|1|||
16239998|NCT01787188|39360913|FG002|Overall Study|Non-compliance with Study Drug|0|||
16239999|NCT01787188|39360911|FG000|Overall Study|Withdrawal by Subject|4|||
16240000|NCT01787188|39360912|FG001|Overall Study|Withdrawal by Subject|3|||
16240001|NCT01787188|39360913|FG002|Overall Study|Withdrawal by Subject|2|||
16240002|NCT01787188|39360911|FG000|Overall Study|Protocol Violation|3|||
16240003|NCT01787188|39360912|FG001|Overall Study|Protocol Violation|2|||
16240004|NCT01787188|39360913|FG002|Overall Study|Protocol Violation|3|||
16240005|NCT01787188|39360911|FG000|Overall Study|Lost to Follow-up|1|||
16240006|NCT01787188|39360912|FG001|Overall Study|Lost to Follow-up|2|||
16240007|NCT01787188|39360913|FG002|Overall Study|Lost to Follow-up|2|||
16240008|NCT01787188|39360911|FG000|Overall Study|Other, including patient moved|0|||
16240009|NCT01787188|39360912|FG001|Overall Study|Other, including patient moved|3|||
16240010|NCT01787188|39360913|FG002|Overall Study|Other, including patient moved|0|||
16240011|NCT00619619|39360915|FG000|Overall Study|Physician Decision|0|||
16240012|NCT00619619|39360916|FG001|Overall Study|Physician Decision|0|||
16240013|NCT00619619|39360917|FG002|Overall Study|Physician Decision|1|||
16240014|NCT00619619|39360918|FG003|Overall Study|Physician Decision|0|||
16240015|NCT00619619|39360919|FG004|Overall Study|Physician Decision|0|||
16240016|NCT00619619|39360920|FG005|Overall Study|Physician Decision|0|||
16240017|NCT00619619|39360921|FG006|Overall Study|Physician Decision|0|||
16240018|NCT00619619|39360922|FG007|Overall Study|Physician Decision|0|||
16240019|NCT00619619|39360915|FG000|Overall Study|Protocol Violation|0|||
16240020|NCT00619619|39360916|FG001|Overall Study|Protocol Violation|0|||
16240021|NCT00619619|39360917|FG002|Overall Study|Protocol Violation|0|||
16240022|NCT00619619|39360918|FG003|Overall Study|Protocol Violation|1|||
16240023|NCT00619619|39360919|FG004|Overall Study|Protocol Violation|0|||
16240024|NCT00619619|39360920|FG005|Overall Study|Protocol Violation|0|||
16240025|NCT00619619|39360921|FG006|Overall Study|Protocol Violation|1|||
16240026|NCT00619619|39360922|FG007|Overall Study|Protocol Violation|1|||
16240027|NCT00619619|39360915|FG000|Overall Study|Adverse Event|0|||
16240028|NCT00619619|39360916|FG001|Overall Study|Adverse Event|0|||
16240029|NCT00619619|39360917|FG002|Overall Study|Adverse Event|0|||
16240030|NCT00619619|39360918|FG003|Overall Study|Adverse Event|0|||
16240031|NCT00619619|39360919|FG004|Overall Study|Adverse Event|2|||
16240032|NCT00619619|39360920|FG005|Overall Study|Adverse Event|0|||
16240033|NCT00619619|39360921|FG006|Overall Study|Adverse Event|0|||
16240034|NCT00619619|39360922|FG007|Overall Study|Adverse Event|2|||
16240035|NCT01271933|39360923|FG000|Single-Blind Phase|Lack of Efficacy|37|||
16240036|NCT01271933|39360924|FG001|Single-Blind Phase|Lack of Efficacy|0|||
16240037|NCT01271933|39360925|FG002|Single-Blind Phase|Lack of Efficacy|0|||
16240038|NCT01271933|39360923|FG000|Single-Blind Phase|Lost to Follow-up|10|||
16240039|NCT01271933|39360924|FG001|Single-Blind Phase|Lost to Follow-up|0|||
16240040|NCT01271933|39360925|FG002|Single-Blind Phase|Lost to Follow-up|0|||
16240041|NCT01271933|39360923|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
16240042|NCT01271933|39360924|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
16414232|NCT04143594|39998366|FG000|Overall Study|Still on study|48|||
16414233|NCT04143594|39998367|FG001|Overall Study|Still on study|42|||
16414234|NCT04143594|39998368|FG002|Overall Study|Still on study|48|||
16414235|NCT04143594|39998369|FG003|Overall Study|Still on study|18|||
16414236|NCT04143594|39998366|FG000|Overall Study|Withdrew consent|0|||
16414237|NCT04143594|39998367|FG001|Overall Study|Withdrew consent|6|||
16414238|NCT04143594|39998368|FG002|Overall Study|Withdrew consent|1|||
16414239|NCT04143594|39998369|FG003|Overall Study|Withdrew consent|1|||
16414240|NCT04143594|39998366|FG000|Overall Study|Lost to Follow-up|2|||
16414241|NCT04143594|39998367|FG001|Overall Study|Lost to Follow-up|2|||
16414242|NCT04143594|39998368|FG002|Overall Study|Lost to Follow-up|3|||
16414243|NCT04143594|39998369|FG003|Overall Study|Lost to Follow-up|0|||
16414244|NCT04143594|39998366|FG000|Overall Study|Investigator's discretion|1|||
16414245|NCT04143594|39998367|FG001|Overall Study|Investigator's discretion|2|||
16414246|NCT04143594|39998368|FG002|Overall Study|Investigator's discretion|0|||
16414247|NCT04143594|39998369|FG003|Overall Study|Investigator's discretion|0|||
16240043|NCT01271933|39360925|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
16240044|NCT01271933|39360923|FG000|Single-Blind Phase|Protocol Violation|3|||
16240045|NCT01271933|39360924|FG001|Single-Blind Phase|Protocol Violation|0|||
16240046|NCT01271933|39360925|FG002|Single-Blind Phase|Protocol Violation|0|||
16414248|NCT04143594|39998366|FG000|Overall Study|Lack of Efficacy|0|||
16414249|NCT04143594|39998367|FG001|Overall Study|Lack of Efficacy|1|||
16414250|NCT04143594|39998368|FG002|Overall Study|Lack of Efficacy|0|||
16414251|NCT04143594|39998369|FG003|Overall Study|Lack of Efficacy|0|||
16240047|NCT01271933|39360923|FG000|Single-Blind Phase|Adverse Event|52|||
16240048|NCT01271933|39360924|FG001|Single-Blind Phase|Adverse Event|0|||
16240049|NCT01271933|39360925|FG002|Single-Blind Phase|Adverse Event|0|||
16240050|NCT01271933|39360923|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
16240051|NCT01271933|39360924|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
16240052|NCT01271933|39360925|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
16240053|NCT01271933|39360923|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
16414252|NCT04143594|39998366|FG000|Overall Study|Protocol Violation|0|||
16240054|NCT01271933|39360924|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
16240055|NCT01271933|39360925|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
16240056|NCT01271933|39360923|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
16240057|NCT01271933|39360924|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
16240058|NCT01271933|39360925|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
16240059|NCT01271933|39360923|FG000|Double-Blind Phase|Randomized but not treated|0|||
16240060|NCT01271933|39360924|FG001|Double-Blind Phase|Randomized but not treated|0|||
16240061|NCT01271933|39360925|FG002|Double-Blind Phase|Randomized but not treated|1|||
16240062|NCT01271933|39360923|FG000|Double-Blind Phase|Lack of Efficacy|0|||
16240063|NCT01271933|39360924|FG001|Double-Blind Phase|Lack of Efficacy|6|||
16240064|NCT01271933|39360925|FG002|Double-Blind Phase|Lack of Efficacy|9|||
16240065|NCT01271933|39360923|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16240066|NCT01271933|39360924|FG001|Double-Blind Phase|Lost to Follow-up|1|||
16240067|NCT01271933|39360925|FG002|Double-Blind Phase|Lost to Follow-up|1|||
16240068|NCT01271933|39360923|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
16240069|NCT01271933|39360924|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
16240070|NCT01271933|39360925|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
16240071|NCT01271933|39360923|FG000|Double-Blind Phase|Adverse Event|0|||
16240072|NCT01271933|39360924|FG001|Double-Blind Phase|Adverse Event|3|||
16240073|NCT01271933|39360925|FG002|Double-Blind Phase|Adverse Event|0|||
16240074|NCT01271933|39360923|FG000|Double-Blind Phase|Participant request-personal reason|0|||
16240075|NCT01271933|39360924|FG001|Double-Blind Phase|Participant request-personal reason|1|||
16240076|NCT01271933|39360925|FG002|Double-Blind Phase|Participant request-personal reason|0|||
16240077|NCT01896700|39360926|FG000|Overall Study|Adverse Event|4|||
16240078|NCT01896700|39360927|FG001|Overall Study|Adverse Event|5|||
16240079|NCT01896700|39360926|FG000|Overall Study|Withdrawal by Subject|0|||
16240080|NCT01896700|39360927|FG001|Overall Study|Withdrawal by Subject|1|||
16240081|NCT01766310|39360930|FG000|Overall Study|Lost to Follow-up|1|||
16240082|NCT01766310|39360931|FG001|Overall Study|Lost to Follow-up|3|||
16240083|NCT02567266|39360932|FG000|Overall Study|Withdrawal by Subject|10|||
16240084|NCT02567266|39360933|FG001|Overall Study|Withdrawal by Subject|7|||
16240085|NCT02567266|39360934|FG002|Overall Study|Withdrawal by Subject|6|||
16240086|NCT02567266|39360932|FG000|Overall Study|Lost to Follow-up|13|||
16240087|NCT02567266|39360933|FG001|Overall Study|Lost to Follow-up|8|||
16240088|NCT02567266|39360934|FG002|Overall Study|Lost to Follow-up|10|||
16240089|NCT01155284|39360935|FG000|Overall Study|Withdrawal by Subject|4|||
16240090|NCT01155284|39360936|FG001|Overall Study|Withdrawal by Subject|3|||
16240091|NCT01155284|39360935|FG000|Overall Study|Lost to Follow-up|1|||
16240092|NCT01155284|39360936|FG001|Overall Study|Lost to Follow-up|2|||
16240093|NCT01155284|39360935|FG000|Overall Study|Physician Decision|1|||
16240094|NCT01155284|39360936|FG001|Overall Study|Physician Decision|0|||
16240095|NCT01155284|39360935|FG000|Overall Study|Adverse Event|1|||
16240096|NCT01155284|39360936|FG001|Overall Study|Adverse Event|0|||
16240097|NCT03550794|39360937|FG000|Overall Study|No longer met inclusion criteria|1|||
16240098|NCT03550794|39360938|FG001|Overall Study|No longer met inclusion criteria|2|||
16240099|NCT03550794|39360937|FG000|Overall Study|Goals of care changed|1|||
16240100|NCT03550794|39360938|FG001|Overall Study|Goals of care changed|0|||
16240101|NCT03550794|39360937|FG000|Overall Study|Withdrawal by Subject|2|||
16240102|NCT03550794|39360938|FG001|Overall Study|Withdrawal by Subject|0|||
16240103|NCT03550794|39360937|FG000|Overall Study|Death|0|||
16240104|NCT03550794|39360938|FG001|Overall Study|Death|1|||
16240105|NCT01123980|39360939|FG000|Overall Study|Adverse Event|1|||
16240106|NCT01123980|39360940|FG001|Overall Study|Adverse Event|1|||
16240107|NCT01123980|39360939|FG000|Overall Study|Lack of Efficacy|1|||
16240108|NCT01123980|39360940|FG001|Overall Study|Lack of Efficacy|0|||
16240109|NCT01123980|39360939|FG000|Overall Study|Physician Decision|0|||
16240110|NCT01123980|39360940|FG001|Overall Study|Physician Decision|1|||
16240111|NCT01123980|39360939|FG000|Overall Study|Lost to Follow-up|0|||
16240112|NCT01123980|39360940|FG001|Overall Study|Lost to Follow-up|6|||
16240113|NCT01123980|39360939|FG000|Overall Study|Protocol Violation|6|||
16240114|NCT01123980|39360940|FG001|Overall Study|Protocol Violation|6|||
16240115|NCT01123980|39360939|FG000|Overall Study|Withdrawal by Subject|5|||
16240116|NCT01123980|39360940|FG001|Overall Study|Withdrawal by Subject|3|||
16240117|NCT01123980|39360939|FG000|Overall Study|Unclassified|6|||
16240118|NCT01123980|39360940|FG001|Overall Study|Unclassified|7|||
16240119|NCT00383019|39360941|FG000|Overall Study|Adverse Event|5|||
16240120|NCT00383019|39360942|FG001|Overall Study|Adverse Event|1|||
16240121|NCT00383019|39360941|FG000|Overall Study|Withdrawal by Subject|0|||
16240122|NCT00383019|39360942|FG001|Overall Study|Withdrawal by Subject|1|||
16240123|NCT03302299|39360943|FG000|Overall Study|Protocol Violation|1|||
16240124|NCT01629693|39363487|FG000|Overall Study|Lost to Follow-up|2|||
16240125|NCT01629693|39363488|FG001|Overall Study|Lost to Follow-up|4|||
16240126|NCT01629693|39363487|FG000|Overall Study|Withdrawal by Subject|2|||
16240127|NCT01629693|39363488|FG001|Overall Study|Withdrawal by Subject|2|||
16240128|NCT01629693|39363487|FG000|Overall Study|Adverse Event|1|||
16240129|NCT01629693|39363488|FG001|Overall Study|Adverse Event|0|||
16240130|NCT01629693|39363487|FG000|Overall Study|Investigator decision|0|||
16240131|NCT01629693|39363488|FG001|Overall Study|Investigator decision|1|||
16240132|NCT01629693|39363487|FG000|Overall Study|Poor comfort of study lenses|0|||
16414253|NCT04143594|39998367|FG001|Overall Study|Protocol Violation|0|||
16414254|NCT04143594|39998368|FG002|Overall Study|Protocol Violation|0|||
16414255|NCT04143594|39998369|FG003|Overall Study|Protocol Violation|1|||
16414256|NCT02299076|39998380|FG000|Overall Study|Fraudulent Entries|20|||
16414257|NCT02299076|39998381|FG001|Overall Study|Fraudulent Entries|14|||
16414258|NCT02438813|39998384|FG000|Overall Study|Patient Decision|59|||
16414259|NCT02438813|39998384|FG000|Overall Study|Patient Lost to Follow-Up|137|||
16414260|NCT02438813|39998384|FG000|Overall Study|Study Ended by Sponsor|80|||
16414261|NCT02438813|39998384|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
16414262|NCT00262847|39998385|FG000|Overall Study|Disease Progression|309|||
16414263|NCT00262847|39998386|FG001|Overall Study|Disease Progression|274|||
16414264|NCT00262847|39998387|FG002|Overall Study|Disease Progression|195|||
16414265|NCT00262847|39998385|FG000|Overall Study|Patient Refusal|41|||
16414266|NCT00262847|39998386|FG001|Overall Study|Patient Refusal|52|||
16414267|NCT00262847|39998387|FG002|Overall Study|Patient Refusal|47|||
16414268|NCT00262847|39998385|FG000|Overall Study|Adverse Event|74|||
16414269|NCT00262847|39998386|FG001|Overall Study|Adverse Event|88|||
16414270|NCT00262847|39998387|FG002|Overall Study|Adverse Event|108|||
16414271|NCT00262847|39998385|FG000|Overall Study|Death|8|||
16240133|NCT01629693|39363488|FG001|Overall Study|Poor comfort of study lenses|2|||
16240134|NCT01629693|39363487|FG000|Overall Study|Subject decision unrelated to AE|0|||
16240135|NCT01629693|39363488|FG001|Overall Study|Subject decision unrelated to AE|1|||
16240136|NCT03578276|39363489|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
16240137|NCT03578276|39363490|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
16240138|NCT00366678|39363491|FG000|Infant Series|Withdrawal by Subject|8|||
16240139|NCT00366678|39363492|FG001|Infant Series|Withdrawal by Subject|6|||
16240140|NCT00366678|39363493|FG002|Infant Series|Withdrawal by Subject|0|||
16240141|NCT00366678|39363491|FG000|Infant Series|Protocol Violation|4|||
16240142|NCT00366678|39363492|FG001|Infant Series|Protocol Violation|3|||
16240143|NCT00366678|39363493|FG002|Infant Series|Protocol Violation|0|||
16240144|NCT00366678|39363491|FG000|Infant Series|Failed to return|1|||
16240145|NCT00366678|39363492|FG001|Infant Series|Failed to return|1|||
16240146|NCT00366678|39363493|FG002|Infant Series|Failed to return|0|||
16240147|NCT00366678|39363491|FG000|Infant Series|Adverse Event|1|||
16240148|NCT00366678|39363492|FG001|Infant Series|Adverse Event|0|||
16240149|NCT00366678|39363493|FG002|Infant Series|Adverse Event|0|||
16240150|NCT00366678|39363491|FG000|After Infant|Withdrawal by Subject|8|||
16240151|NCT00366678|39363492|FG001|After Infant|Withdrawal by Subject|4|||
16240152|NCT00366678|39363493|FG002|After Infant|Withdrawal by Subject|0|||
16240153|NCT00366678|39363491|FG000|After Infant|Lost to Follow-up|2|||
16240154|NCT00366678|39363492|FG001|After Infant|Lost to Follow-up|1|||
16240155|NCT00366678|39363493|FG002|After Infant|Lost to Follow-up|0|||
16240156|NCT00366678|39363491|FG000|After Infant|Failed to return|5|||
16240157|NCT00366678|39363492|FG001|After Infant|Failed to return|5|||
16240158|NCT00366678|39363493|FG002|After Infant|Failed to return|0|||
16240159|NCT00366678|39363491|FG000|After Infant|Adverse Event|1|||
16240160|NCT00366678|39363492|FG001|After Infant|Adverse Event|0|||
16240161|NCT00366678|39363493|FG002|After Infant|Adverse Event|0|||
16240162|NCT00366678|39363491|FG000|After Infant|Protocol Violation|1|||
16240163|NCT00366678|39363492|FG001|After Infant|Protocol Violation|0|||
16240164|NCT00366678|39363493|FG002|After Infant|Protocol Violation|0|||
16240165|NCT00366678|39363491|FG000|Toddler Dose|Protocol Violation|2|||
16240166|NCT00366678|39363492|FG001|Toddler Dose|Protocol Violation|1|||
16240167|NCT00366678|39363493|FG002|Toddler Dose|Protocol Violation|0|||
16240168|NCT00366678|39363491|FG000|Toddler Dose|Failed to return|1|||
16240169|NCT00366678|39363492|FG001|Toddler Dose|Failed to return|0|||
16240170|NCT00366678|39363493|FG002|Toddler Dose|Failed to return|0|||
16556992|NCT01544491|40506379|FG000|Overall Study|administrative problems|2|||
16556993|NCT01544491|40506380|FG001|Overall Study|administrative problems|0|||
16556994|NCT00378105|40506383|FG000|Overall Study|Adverse Event|3|||
16556995|NCT00378105|40506384|FG001|Overall Study|Adverse Event|1|||
16556996|NCT00378105|40506383|FG000|Overall Study|Withdrawal by Subject|3|||
16240171|NCT00366678|39363491|FG000|Toddler Dose|Withdrawal by Subject|1|||
16240172|NCT00366678|39363492|FG001|Toddler Dose|Withdrawal by Subject|0|||
16240173|NCT00366678|39363493|FG002|Toddler Dose|Withdrawal by Subject|0|||
16240174|NCT00366678|39363491|FG000|Toddler Dose|protocol deviation|1|||
16240175|NCT00366678|39363492|FG001|Toddler Dose|protocol deviation|0|||
16240176|NCT00366678|39363493|FG002|Toddler Dose|protocol deviation|0|||
16240177|NCT04060654|39363498|FG000|Overall Study|Withdrawal by Subject|1|||
16240178|NCT04060654|39363498|FG000|Overall Study|Lost to Follow-up|5|||
16240179|NCT01027884|39363499|FG000|Overall Study|Adverse Event|2|||
16414272|NCT00262847|39998386|FG001|Overall Study|Death|8|||
16414273|NCT00262847|39998387|FG002|Overall Study|Death|11|||
16414274|NCT00262847|39998385|FG000|Overall Study|Concomitant disease|3|||
16556997|NCT00378105|40506384|FG001|Overall Study|Withdrawal by Subject|3|||
16556998|NCT00378105|40506383|FG000|Overall Study|Death|1|||
16240180|NCT01027884|39363500|FG001|Overall Study|Adverse Event|1|||
16240181|NCT01027884|39363499|FG000|Overall Study|Protocol Violation|1|||
16240182|NCT01027884|39363500|FG001|Overall Study|Protocol Violation|0|||
16240183|NCT01027884|39363499|FG000|Overall Study|Non-compliance|1|||
16240184|NCT01027884|39363500|FG001|Overall Study|Non-compliance|1|||
16240185|NCT01027884|39363499|FG000|Overall Study|Withdrawal by Subject|0|||
16240186|NCT01027884|39363500|FG001|Overall Study|Withdrawal by Subject|1|||
16240187|NCT01027884|39363499|FG000|Overall Study|Lost to Follow-up|0|||
16240188|NCT01027884|39363500|FG001|Overall Study|Lost to Follow-up|1|||
16240189|NCT01027884|39363499|FG000|Overall Study|Spinal fixation surgery|0|||
16240190|NCT01027884|39363500|FG001|Overall Study|Spinal fixation surgery|3|||
16240191|NCT01106352|39363501|FG000|Overall Study|Subjects untreated|0|||
16240192|NCT01106352|39363502|FG001|Overall Study|Subjects untreated|0|||
16240193|NCT01106352|39363503|FG002|Overall Study|Subjects untreated|0|||
16240194|NCT01106352|39363504|FG003|Overall Study|Subjects untreated|3|||
16240195|NCT01106352|39363505|FG004|Overall Study|Subjects untreated|4|||
16240196|NCT01106352|39363501|FG000|Overall Study|Sponsor Decision|1|||
16240197|NCT01106352|39363502|FG001|Overall Study|Sponsor Decision|0|||
16240198|NCT01106352|39363503|FG002|Overall Study|Sponsor Decision|0|||
16240199|NCT01106352|39363504|FG003|Overall Study|Sponsor Decision|0|||
16240200|NCT01106352|39363505|FG004|Overall Study|Sponsor Decision|0|||
16240201|NCT01106352|39363501|FG000|Overall Study|Too ill to come in for the visit|0|||
16240202|NCT01106352|39363502|FG001|Overall Study|Too ill to come in for the visit|0|||
16240203|NCT01106352|39363503|FG002|Overall Study|Too ill to come in for the visit|1|||
16240204|NCT01106352|39363504|FG003|Overall Study|Too ill to come in for the visit|0|||
16240205|NCT01106352|39363505|FG004|Overall Study|Too ill to come in for the visit|0|||
16240206|NCT01106352|39363501|FG000|Overall Study|Lost to Follow-up|0|||
16240207|NCT01106352|39363502|FG001|Overall Study|Lost to Follow-up|0|||
16240208|NCT01106352|39363503|FG002|Overall Study|Lost to Follow-up|0|||
16240209|NCT01106352|39363504|FG003|Overall Study|Lost to Follow-up|0|||
16240210|NCT01106352|39363505|FG004|Overall Study|Lost to Follow-up|1|||
16240211|NCT01106352|39363501|FG000|Overall Study|Death|0|||
16240212|NCT01106352|39363502|FG001|Overall Study|Death|0|||
16240213|NCT01106352|39363503|FG002|Overall Study|Death|1|||
16240214|NCT01106352|39363504|FG003|Overall Study|Death|3|||
16240215|NCT01106352|39363505|FG004|Overall Study|Death|1|||
16240216|NCT01106352|39363501|FG000|Overall Study|Disease progression|0|||
16240217|NCT01106352|39363502|FG001|Overall Study|Disease progression|0|||
16240218|NCT01106352|39363503|FG002|Overall Study|Disease progression|0|||
16240219|NCT01106352|39363504|FG003|Overall Study|Disease progression|1|||
16240220|NCT01106352|39363505|FG004|Overall Study|Disease progression|0|||
16240221|NCT01106352|39363501|FG000|Overall Study|Withdrawal by Subject|0|||
16240222|NCT01106352|39363502|FG001|Overall Study|Withdrawal by Subject|0|||
16240223|NCT01106352|39363503|FG002|Overall Study|Withdrawal by Subject|0|||
16240224|NCT01106352|39363504|FG003|Overall Study|Withdrawal by Subject|3|||
16240225|NCT01106352|39363505|FG004|Overall Study|Withdrawal by Subject|2|||
16240226|NCT01106352|39363501|FG000|Overall Study|Went on hospice|0|||
16240227|NCT01106352|39363502|FG001|Overall Study|Went on hospice|0|||
16240228|NCT01106352|39363503|FG002|Overall Study|Went on hospice|0|||
16240229|NCT01106352|39363504|FG003|Overall Study|Went on hospice|1|||
16240230|NCT01106352|39363505|FG004|Overall Study|Went on hospice|0|||
16240231|NCT01106352|39363501|FG000|Overall Study|Subject entered hospice|0|||
16240232|NCT01106352|39363502|FG001|Overall Study|Subject entered hospice|0|||
16240233|NCT01106352|39363503|FG002|Overall Study|Subject entered hospice|0|||
16240234|NCT01106352|39363504|FG003|Overall Study|Subject entered hospice|1|||
16240235|NCT01106352|39363505|FG004|Overall Study|Subject entered hospice|0|||
16240236|NCT01106352|39363501|FG000|Overall Study|Home hospice since July 2013|0|||
16240237|NCT01106352|39363502|FG001|Overall Study|Home hospice since July 2013|0|||
16240238|NCT01106352|39363503|FG002|Overall Study|Home hospice since July 2013|0|||
16240239|NCT01106352|39363504|FG003|Overall Study|Home hospice since July 2013|1|||
16240240|NCT01106352|39363505|FG004|Overall Study|Home hospice since July 2013|0|||
16240241|NCT02117479|39363506|FG000|Overall Study|Death|13|||
16240242|NCT02117479|39363507|FG001|Overall Study|Death|8|||
16240243|NCT02117479|39363506|FG000|Overall Study|Adverse Event|8|||
16240244|NCT02117479|39363507|FG001|Overall Study|Adverse Event|16|||
16240245|NCT02117479|39363506|FG000|Overall Study|Subject decision|8|||
16240246|NCT02117479|39363507|FG001|Overall Study|Subject decision|9|||
16240247|NCT02117479|39363506|FG000|Overall Study|Disease progression|104|||
16240248|NCT02117479|39363507|FG001|Overall Study|Disease progression|108|||
16240249|NCT02117479|39363506|FG000|Overall Study|Noncompliance with study treatment|1|||
16240250|NCT02117479|39363507|FG001|Overall Study|Noncompliance with study treatment|0|||
16240251|NCT02117479|39363506|FG000|Overall Study|Study terminated by the sponsor|4|||
16240252|NCT02117479|39363507|FG001|Overall Study|Study terminated by the sponsor|6|||
16240253|NCT02117479|39363506|FG000|Overall Study|Physician Decision|7|||
16240254|NCT02117479|39363507|FG001|Overall Study|Physician Decision|2|||
16240255|NCT02117479|39363506|FG000|Overall Study|Other unspecified|11|||
16240256|NCT02117479|39363507|FG001|Overall Study|Other unspecified|7|||
16240257|NCT00886782|39363508|FG000|Overall Study|Disease progression|3|||
16240258|NCT00886782|39363509|FG001|Overall Study|Disease progression|3|||
16240259|NCT00886782|39363510|FG002|Overall Study|Disease progression|3|||
16240260|NCT00886782|39363508|FG000|Overall Study|Study drug toxicity|0|||
16240261|NCT00886782|39363509|FG001|Overall Study|Study drug toxicity|0|||
16240262|NCT00886782|39363510|FG002|Overall Study|Study drug toxicity|1|||
16240263|NCT00886782|39363508|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
16240264|NCT00886782|39363509|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
16240265|NCT00886782|39363510|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
16240266|NCT01563029|39363514|FG000|Overall Study|Adverse Event|1|||
16240267|NCT01563029|39363515|FG001|Overall Study|Adverse Event|0|||
16240268|NCT01563029|39363516|FG002|Overall Study|Adverse Event|1|||
16240269|NCT01563029|39363517|FG003|Overall Study|Adverse Event|2|||
16240270|NCT01563029|39363518|FG004|Overall Study|Adverse Event|1|||
16240271|NCT01563029|39363514|FG000|Overall Study|Lack of Efficacy|42|||
16240272|NCT01563029|39363515|FG001|Overall Study|Lack of Efficacy|16|||
16240273|NCT01563029|39363516|FG002|Overall Study|Lack of Efficacy|23|||
16240274|NCT01563029|39363517|FG003|Overall Study|Lack of Efficacy|21|||
16240275|NCT01563029|39363518|FG004|Overall Study|Lack of Efficacy|19|||
16240276|NCT01563029|39363514|FG000|Overall Study|Protocol Violation|1|||
16240277|NCT01563029|39363515|FG001|Overall Study|Protocol Violation|2|||
16240278|NCT01563029|39363516|FG002|Overall Study|Protocol Violation|3|||
16240279|NCT01563029|39363517|FG003|Overall Study|Protocol Violation|1|||
16240280|NCT01563029|39363518|FG004|Overall Study|Protocol Violation|3|||
16240281|NCT01563029|39363514|FG000|Overall Study|Protocol defined stopping criteria|1|||
16240282|NCT01563029|39363515|FG001|Overall Study|Protocol defined stopping criteria|0|||
16240283|NCT01563029|39363516|FG002|Overall Study|Protocol defined stopping criteria|0|||
16240284|NCT01563029|39363517|FG003|Overall Study|Protocol defined stopping criteria|0|||
16240285|NCT01563029|39363518|FG004|Overall Study|Protocol defined stopping criteria|0|||
16240286|NCT01563029|39363514|FG000|Overall Study|Lost to Follow-up|1|||
16240287|NCT01563029|39363515|FG001|Overall Study|Lost to Follow-up|0|||
16240288|NCT01563029|39363516|FG002|Overall Study|Lost to Follow-up|1|||
16240289|NCT01563029|39363517|FG003|Overall Study|Lost to Follow-up|1|||
16240290|NCT01563029|39363518|FG004|Overall Study|Lost to Follow-up|1|||
16240291|NCT01563029|39363514|FG000|Overall Study|Physician Decision|3|||
16240292|NCT01563029|39363515|FG001|Overall Study|Physician Decision|5|||
16240293|NCT01563029|39363516|FG002|Overall Study|Physician Decision|2|||
16240294|NCT01563029|39363517|FG003|Overall Study|Physician Decision|4|||
16240295|NCT01563029|39363518|FG004|Overall Study|Physician Decision|2|||
16240296|NCT01563029|39363514|FG000|Overall Study|Withdrawal by Subject|4|||
16240297|NCT01563029|39363515|FG001|Overall Study|Withdrawal by Subject|1|||
16240298|NCT01563029|39363516|FG002|Overall Study|Withdrawal by Subject|3|||
16240299|NCT01563029|39363517|FG003|Overall Study|Withdrawal by Subject|4|||
16240300|NCT01563029|39363518|FG004|Overall Study|Withdrawal by Subject|3|||
16240301|NCT00078312|39363520|FG000|Overall Study|Adverse Event|43|||
16240302|NCT00078312|39363520|FG000|Overall Study|Lack of Efficacy|15|||
16240303|NCT00078312|39363520|FG000|Overall Study|Lost to Follow-up|41|||
16240304|NCT00078312|39363520|FG000|Overall Study|Physician Decision|9|||
16240305|NCT00078312|39363520|FG000|Overall Study|Protocol Violation|3|||
16240306|NCT00078312|39363520|FG000|Overall Study|Withdrawal by Subject|33|||
16240307|NCT00078312|39363520|FG000|Overall Study|Miscellaneous|33|||
16556999|NCT00378105|40506384|FG001|Overall Study|Death|0|||
16557000|NCT00378105|40506383|FG000|Overall Study|Going to transplant|7|||
16557001|NCT00378105|40506384|FG001|Overall Study|Going to transplant|8|||
16557002|NCT00378105|40506383|FG000|Overall Study|Progressive disease|3|||
16557003|NCT00378105|40506384|FG001|Overall Study|Progressive disease|3|||
16557004|NCT00378105|40506383|FG000|Overall Study|remain on study|3|||
16557005|NCT00378105|40506384|FG001|Overall Study|remain on study|11|||
16557006|NCT00378105|40506383|FG000|Overall Study|Physician Decision|0|||
16557007|NCT00378105|40506384|FG001|Overall Study|Physician Decision|2|||
16557008|NCT00378105|40506383|FG000|Overall Study|Going non-protocol therapy|0|||
16557009|NCT00378105|40506384|FG001|Overall Study|Going non-protocol therapy|1|||
16557010|NCT00378105|40506383|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
16557011|NCT00378105|40506384|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
16557012|NCT02169219|40506392|FG000|Overall Study|Lack of Efficacy|6|||
16557013|NCT03958630|40506393|FG000|Overall Study|Withdrawal by Subject|0|||
16240308|NCT03797222|39363521|FG000|Overall Study|Withdrawal by Subject|1|||
16240309|NCT00370396|39363524|FG000|Overall Study|Withdrawal by Subject|0|||
16240310|NCT00370396|39363525|FG001|Overall Study|Withdrawal by Subject|0|||
16240311|NCT00370396|39363526|FG002|Overall Study|Withdrawal by Subject|1|||
16240312|NCT00370396|39363524|FG000|Overall Study|Lost to Follow-up|11|||
16240313|NCT00370396|39363525|FG001|Overall Study|Lost to Follow-up|1|||
16240314|NCT00370396|39363526|FG002|Overall Study|Lost to Follow-up|0|||
16240315|NCT02156466|39363527|FG000|Overall Study|Adverse Event|0|||
16240316|NCT02156466|39363528|FG001|Overall Study|Adverse Event|0|||
16240317|NCT02156466|39363529|FG002|Overall Study|Adverse Event|1|||
16240318|NCT02156466|39363530|FG003|Overall Study|Adverse Event|1|||
16557014|NCT03958630|40506394|FG001|Overall Study|Withdrawal by Subject|0|||
16557015|NCT03958630|40506395|FG002|Overall Study|Withdrawal by Subject|1|||
16557016|NCT03958630|40506393|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
16240319|NCT02156466|39363531|FG004|Overall Study|Adverse Event|0|||
16240320|NCT02156466|39363527|FG000|Overall Study|Quantiferon Positivity|0|||
16240321|NCT02156466|39363528|FG001|Overall Study|Quantiferon Positivity|0|||
16240322|NCT02156466|39363529|FG002|Overall Study|Quantiferon Positivity|0|||
16240323|NCT02156466|39363530|FG003|Overall Study|Quantiferon Positivity|1|||
16240324|NCT02156466|39363531|FG004|Overall Study|Quantiferon Positivity|0|||
16240325|NCT01358708|39363536|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
16240326|NCT01358708|39363537|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16240327|NCT01358708|39363536|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
16240328|NCT01358708|39363537|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
16240329|NCT00602979|39363546|FG000|Overall Study|Lost to Follow-up|3|||
16240330|NCT00602979|39363547|FG001|Overall Study|Lost to Follow-up|2|||
16240331|NCT00602979|39363548|FG002|Overall Study|Lost to Follow-up|3|||
16240332|NCT00602979|39363549|FG003|Overall Study|Lost to Follow-up|2|||
16240333|NCT00602979|39363550|FG004|Overall Study|Lost to Follow-up|3|||
16240334|NCT00602979|39363546|FG000|Overall Study|Failed Intubation|0|||
16240335|NCT00602979|39363547|FG001|Overall Study|Failed Intubation|1|||
16240336|NCT00602979|39363548|FG002|Overall Study|Failed Intubation|0|||
16240337|NCT00602979|39363549|FG003|Overall Study|Failed Intubation|1|||
16240338|NCT00602979|39363550|FG004|Overall Study|Failed Intubation|0|||
16240339|NCT00435825|39363554|FG000|Overall Study|Abnormality of Laboratory Test|0|||
16240340|NCT00435825|39363555|FG001|Overall Study|Abnormality of Laboratory Test|1|||
16240341|NCT00435825|39363556|FG002|Overall Study|Abnormality of Laboratory Test|0|||
16240342|NCT00435825|39363557|FG003|Overall Study|Abnormality of Laboratory Test|0|||
16240343|NCT00435825|39363554|FG000|Overall Study|Insufficient Therapeutic Response|3|||
16240344|NCT00435825|39363555|FG001|Overall Study|Insufficient Therapeutic Response|1|||
16240345|NCT00435825|39363556|FG002|Overall Study|Insufficient Therapeutic Response|0|||
16240346|NCT00435825|39363557|FG003|Overall Study|Insufficient Therapeutic Response|3|||
16240347|NCT00435825|39363554|FG000|Overall Study|Other Protocol Violation|1|||
16557017|NCT03958630|40506394|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
16557018|NCT03958630|40506395|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
16240348|NCT00435825|39363555|FG001|Overall Study|Other Protocol Violation|0|||
16240349|NCT00435825|39363556|FG002|Overall Study|Other Protocol Violation|0|||
16240350|NCT00435825|39363557|FG003|Overall Study|Other Protocol Violation|0|||
16240351|NCT00435825|39363554|FG000|Overall Study|Refused treatment|2|||
16240352|NCT00435825|39363555|FG001|Overall Study|Refused treatment|0|||
16240353|NCT00435825|39363556|FG002|Overall Study|Refused treatment|0|||
16240354|NCT00435825|39363557|FG003|Overall Study|Refused treatment|5|||
16240355|NCT00435825|39363554|FG000|Overall Study|Failure to return|5|||
16240356|NCT00435825|39363555|FG001|Overall Study|Failure to return|0|||
16240357|NCT00435825|39363556|FG002|Overall Study|Failure to return|4|||
16240358|NCT00435825|39363557|FG003|Overall Study|Failure to return|0|||
16240359|NCT00435825|39363554|FG000|Overall Study|Did not receive study drug|1|||
16240360|NCT00435825|39363555|FG001|Overall Study|Did not receive study drug|0|||
16240361|NCT00435825|39363556|FG002|Overall Study|Did not receive study drug|2|||
16240362|NCT00435825|39363557|FG003|Overall Study|Did not receive study drug|0|||
16240363|NCT00435825|39363554|FG000|Overall Study|Did not enter follow-up|0|||
16240364|NCT00435825|39363555|FG001|Overall Study|Did not enter follow-up|4|||
16240365|NCT00435825|39363556|FG002|Overall Study|Did not enter follow-up|1|||
16240366|NCT00435825|39363557|FG003|Overall Study|Did not enter follow-up|3|||
16240367|NCT00435825|39363554|FG000|Overall Study|Did not complete full follow-up period|6|||
16240368|NCT00435825|39363555|FG001|Overall Study|Did not complete full follow-up period|6|||
16240369|NCT00435825|39363556|FG002|Overall Study|Did not complete full follow-up period|4|||
16240370|NCT00435825|39363557|FG003|Overall Study|Did not complete full follow-up period|5|||
16240371|NCT00830063|39363558|FG000|Overall Study|Adverse Event|7|||
16240372|NCT00830063|39363559|FG001|Overall Study|Adverse Event|13|||
16240373|NCT00830063|39363560|FG002|Overall Study|Adverse Event|16|||
16240374|NCT00830063|39363561|FG003|Overall Study|Adverse Event|13|||
16240375|NCT00830063|39363558|FG000|Overall Study|Death|1|||
16240376|NCT00830063|39363559|FG001|Overall Study|Death|0|||
16240377|NCT00830063|39363560|FG002|Overall Study|Death|0|||
16240378|NCT00830063|39363561|FG003|Overall Study|Death|0|||
16240379|NCT00830063|39363558|FG000|Overall Study|Lost to Follow-up|0|||
16240380|NCT00830063|39363559|FG001|Overall Study|Lost to Follow-up|0|||
16240381|NCT00830063|39363560|FG002|Overall Study|Lost to Follow-up|3|||
16240382|NCT00830063|39363561|FG003|Overall Study|Lost to Follow-up|1|||
16240383|NCT00830063|39363558|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
16240384|NCT00830063|39363559|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
16240385|NCT00830063|39363560|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
16240386|NCT00830063|39363561|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
16240387|NCT00830063|39363558|FG000|Overall Study|Lack of Efficacy|51|||
16240388|NCT00830063|39363559|FG001|Overall Study|Lack of Efficacy|23|||
16240389|NCT00830063|39363560|FG002|Overall Study|Lack of Efficacy|25|||
16240390|NCT00830063|39363561|FG003|Overall Study|Lack of Efficacy|32|||
16240391|NCT00830063|39363558|FG000|Overall Study|Other|5|||
16240392|NCT00830063|39363559|FG001|Overall Study|Other|5|||
16240393|NCT00830063|39363560|FG002|Overall Study|Other|8|||
16240394|NCT00830063|39363561|FG003|Overall Study|Other|6|||
16240395|NCT00830063|39363558|FG000|Overall Study|Withdrawal by Subject|16|||
16240396|NCT00830063|39363559|FG001|Overall Study|Withdrawal by Subject|10|||
16240397|NCT00830063|39363560|FG002|Overall Study|Withdrawal by Subject|16|||
16240398|NCT00830063|39363561|FG003|Overall Study|Withdrawal by Subject|13|||
16240399|NCT00830063|39363558|FG000|Overall Study|Protocol Violation|1|||
16240400|NCT00830063|39363559|FG001|Overall Study|Protocol Violation|0|||
16240401|NCT00830063|39363560|FG002|Overall Study|Protocol Violation|3|||
16240402|NCT00830063|39363561|FG003|Overall Study|Protocol Violation|2|||
16240403|NCT00830063|39363558|FG000|Overall Study|Randomized But Not Treated|0|||
16240404|NCT00830063|39363559|FG001|Overall Study|Randomized But Not Treated|2|||
16240405|NCT00830063|39363560|FG002|Overall Study|Randomized But Not Treated|0|||
16240406|NCT00830063|39363561|FG003|Overall Study|Randomized But Not Treated|2|||
16240407|NCT00331773|39363562|FG000|Overall Study|Withdrawal by Subject|6|||
16240408|NCT00331773|39363563|FG001|Overall Study|Withdrawal by Subject|4|||
16240409|NCT00331773|39363562|FG000|Overall Study|Protocol Violation|10|||
16240410|NCT00331773|39363563|FG001|Overall Study|Protocol Violation|3|||
16240411|NCT02380248|39363564|FG000|Overall Study|Lost to Follow-up|11|||
16240412|NCT02380248|39363564|FG000|Overall Study|Withdrawal by Subject|3|||
16240413|NCT00033631|39363565|FG000|Overall Study|Protocol Violation|14|||
16240414|NCT00033631|39363566|FG001|Overall Study|Protocol Violation|11|||
16240415|NCT00033631|39363565|FG000|Overall Study|Withdrawal by Subject|4|||
16240416|NCT00033631|39363566|FG001|Overall Study|Withdrawal by Subject|4|||
16240417|NCT02868281|39363569|FG000|Overall Study|Adverse Event|2|||
16240418|NCT02868281|39363570|FG001|Overall Study|Adverse Event|2|||
16240419|NCT02868281|39363569|FG000|Overall Study|Protocol Violation|13|||
16240420|NCT02868281|39363570|FG001|Overall Study|Protocol Violation|10|||
16240421|NCT02868281|39363569|FG000|Overall Study|Lost to Follow-up|3|||
16240422|NCT02868281|39363570|FG001|Overall Study|Lost to Follow-up|6|||
16240423|NCT02868281|39363569|FG000|Overall Study|Withdrawal by Subject|11|||
16240424|NCT02868281|39363570|FG001|Overall Study|Withdrawal by Subject|15|||
16240425|NCT02868281|39363569|FG000|Overall Study|Physician Decision|2|||
16240426|NCT02868281|39363570|FG001|Overall Study|Physician Decision|0|||
16240427|NCT02868281|39363569|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
16240428|NCT02868281|39363570|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
16240429|NCT02868281|39363569|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
16240430|NCT02868281|39363570|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
16240431|NCT02868281|39363569|FG000|Overall Study|Long journey/moving away|1|||
16240432|NCT02868281|39363570|FG001|Overall Study|Long journey/moving away|1|||
16240433|NCT02295280|39363571|FG000|Overall Study|Adverse Event|0|||
16240434|NCT02295280|39363572|FG001|Overall Study|Adverse Event|1|||
16240455|NCT01336608|39363587|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
16240456|NCT01336608|39363588|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16240457|NCT01336608|39363589|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16240458|NCT01336608|39363590|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16240459|NCT01336608|39363587|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
16240460|NCT01336608|39363588|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16240461|NCT01336608|39363589|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16240462|NCT01336608|39363590|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16240463|NCT01336608|39363587|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
16240464|NCT01336608|39363588|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
16240465|NCT01336608|39363589|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
16240466|NCT01336608|39363590|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
16240467|NCT01336608|39363587|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
16240468|NCT01336608|39363588|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
16240469|NCT01336608|39363589|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
16240470|NCT01336608|39363590|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
16240471|NCT01336608|39363587|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
16240472|NCT01336608|39363588|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16240473|NCT01336608|39363589|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16240474|NCT01336608|39363590|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16240475|NCT01336608|39363587|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
16240476|NCT01336608|39363588|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
16240477|NCT01336608|39363589|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
16240478|NCT01336608|39363590|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
16240479|NCT01336608|39363587|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16240480|NCT01336608|39363588|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
16240481|NCT01336608|39363589|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16240482|NCT01336608|39363590|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16240483|NCT01336608|39363587|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
16240484|NCT01336608|39363588|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
16240485|NCT01336608|39363589|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
16240486|NCT01336608|39363590|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
16240487|NCT01336608|39363587|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
16240488|NCT01336608|39363588|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
16557019|NCT04908683|40506396|FG000|Overall Study|Failure to meet continuation criteria|34|||
16557020|NCT04908683|40506397|FG001|Overall Study|Failure to meet continuation criteria|22|||
16557021|NCT04908683|40506396|FG000|Overall Study|Initiated prohibited medication|3|||
16557022|NCT04908683|40506397|FG001|Overall Study|Initiated prohibited medication|0|||
16557023|NCT04908683|40506396|FG000|Overall Study|Randomized by mistake|1|||
16557024|NCT04908683|40506397|FG001|Overall Study|Randomized by mistake|0|||
16557025|NCT04908683|40506396|FG000|Overall Study|Lost to Follow-up|679|||
16557026|NCT04908683|40506397|FG001|Overall Study|Lost to Follow-up|341|||
16557027|NCT04908683|40506396|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
16557028|NCT04908683|40506397|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
16557029|NCT04908683|40506396|FG000|Overall Study|Physician Decision|44|||
16557030|NCT04908683|40506397|FG001|Overall Study|Physician Decision|35|||
16557031|NCT04908683|40506396|FG000|Overall Study|Technical problems|12|||
16557032|NCT04908683|40506397|FG001|Overall Study|Technical problems|9|||
16240489|NCT01336608|39363589|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
16240490|NCT01336608|39363590|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
16557033|NCT04908683|40506396|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
16557034|NCT04908683|40506397|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
16557035|NCT04908683|40506396|FG000|Overall Study|Protocol Violation|2|||
16557036|NCT04908683|40506397|FG001|Overall Study|Protocol Violation|0|||
16557037|NCT04908683|40506396|FG000|Overall Study|Withdrawal by Subject|1188|||
16557038|NCT04908683|40506397|FG001|Overall Study|Withdrawal by Subject|570|||
16557039|NCT04908683|40506396|FG000|Overall Study|Site Closure by Sponsor|6|||
16557040|NCT04908683|40506397|FG001|Overall Study|Site Closure by Sponsor|3|||
16557041|NCT04908683|40506396|FG000|Overall Study|Adverse Event|21|||
16557042|NCT04908683|40506397|FG001|Overall Study|Adverse Event|11|||
16557043|NCT04908683|40506396|FG000|Overall Study|Death|101|||
16557044|NCT04908683|40506397|FG001|Overall Study|Death|61|||
16557045|NCT04908683|40506396|FG000|Overall Study|Sponsor's decision|14398|||
16557046|NCT04908683|40506397|FG001|Overall Study|Sponsor's decision|7205|||
16557047|NCT04908683|40506396|FG000|Overall Study|Other|92|||
16557048|NCT04908683|40506397|FG001|Overall Study|Other|50|||
16557049|NCT04908683|40506396|FG000|Overall Study|Randomized not vaccinated|108|||
16557050|NCT04908683|40506397|FG001|Overall Study|Randomized not vaccinated|52|||
16557051|NCT04424290|40506398|FG000|Overall Study|Not treated|0|||
16557052|NCT04424290|40506399|FG001|Overall Study|Not treated|0|||
16557053|NCT04424290|40506400|FG002|Overall Study|Not treated|1|||
16557054|NCT04424290|40506401|FG003|Overall Study|Not treated|0|||
16557055|NCT04424290|40506402|FG004|Overall Study|Not treated|1|||
16557056|NCT04424290|40506398|FG000|Overall Study|Adverse Event|0|||
16557057|NCT04424290|40506399|FG001|Overall Study|Adverse Event|0|||
16557058|NCT04424290|40506400|FG002|Overall Study|Adverse Event|0|||
16557059|NCT04424290|40506401|FG003|Overall Study|Adverse Event|2|||
16557060|NCT04424290|40506402|FG004|Overall Study|Adverse Event|0|||
16557061|NCT04424290|40506398|FG000|Overall Study|Withdrawal by Subject|0|||
16557062|NCT04424290|40506399|FG001|Overall Study|Withdrawal by Subject|0|||
16557063|NCT04424290|40506400|FG002|Overall Study|Withdrawal by Subject|0|||
16557064|NCT04424290|40506401|FG003|Overall Study|Withdrawal by Subject|0|||
16557065|NCT04424290|40506402|FG004|Overall Study|Withdrawal by Subject|1|||
16557066|NCT04424290|40506398|FG000|Overall Study|Other than listed|0|||
16557067|NCT04424290|40506399|FG001|Overall Study|Other than listed|0|||
16557068|NCT04424290|40506400|FG002|Overall Study|Other than listed|0|||
16557069|NCT04424290|40506401|FG003|Overall Study|Other than listed|1|||
16240491|NCT01336608|39363587|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
16557070|NCT04424290|40506402|FG004|Overall Study|Other than listed|0|||
16557071|NCT04467840|40506406|FG000|Overall Study|Death|35|||
16557072|NCT04467840|40506407|FG001|Overall Study|Death|39|||
16557073|NCT04467840|40506406|FG000|Overall Study|Withdrawal by Subject|8|||
16557074|NCT04467840|40506407|FG001|Overall Study|Withdrawal by Subject|4|||
16557075|NCT04467840|40506406|FG000|Overall Study|Adverse Event|2|||
16557076|NCT04467840|40506407|FG001|Overall Study|Adverse Event|0|||
16557077|NCT04467840|40506406|FG000|Overall Study|Lost to Follow-up|1|||
16557078|NCT04467840|40506407|FG001|Overall Study|Lost to Follow-up|3|||
16557079|NCT04467840|40506406|FG000|Overall Study|Physician Decision|1|||
16557080|NCT04467840|40506407|FG001|Overall Study|Physician Decision|0|||
16557081|NCT04467840|40506406|FG000|Overall Study|Other|1|||
16240492|NCT01336608|39363588|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
16240493|NCT01336608|39363589|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
16240494|NCT01336608|39363590|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
16240495|NCT01336608|39363587|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16240496|NCT01336608|39363588|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
16240497|NCT01336608|39363589|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16240498|NCT01336608|39363590|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16240499|NCT01336608|39363587|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
16240500|NCT01336608|39363588|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
16240501|NCT01336608|39363589|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
16240502|NCT01336608|39363590|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
16240503|NCT01336608|39363587|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16240504|NCT01336608|39363588|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
16240505|NCT01336608|39363589|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
16240506|NCT01336608|39363590|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
16240507|NCT00096486|39363591|FG000|Overall Study|Withdrawal by Subject|0|||
16240508|NCT00096486|39363592|FG001|Overall Study|Withdrawal by Subject|0|||
16240509|NCT00096486|39363593|FG002|Overall Study|Withdrawal by Subject|1|||
16240510|NCT00096486|39363594|FG003|Overall Study|Withdrawal by Subject|1|||
16240511|NCT00096486|39363591|FG000|Overall Study|Not Treated|0|||
16240512|NCT00096486|39363592|FG001|Overall Study|Not Treated|0|||
16240513|NCT00096486|39363593|FG002|Overall Study|Not Treated|1|||
16240514|NCT00096486|39363594|FG003|Overall Study|Not Treated|1|||
16240515|NCT01488071|39363595|FG000|Overall Study|Adverse Event|15|||
16240516|NCT01488071|39363596|FG001|Overall Study|Adverse Event|23|||
16240517|NCT01488071|39363595|FG000|Overall Study|Lack of Efficacy|11|||
16240518|NCT01488071|39363596|FG001|Overall Study|Lack of Efficacy|17|||
16240519|NCT01488071|39363595|FG000|Overall Study|Non-compliance with study drug|2|||
16240520|NCT01488071|39363596|FG001|Overall Study|Non-compliance with study drug|0|||
16240521|NCT01488071|39363595|FG000|Overall Study|Protocol Violation|5|||
16240522|NCT01488071|39363596|FG001|Overall Study|Protocol Violation|7|||
16240523|NCT01488071|39363595|FG000|Overall Study|Withdrawal of Consent|14|||
16240524|NCT01488071|39363596|FG001|Overall Study|Withdrawal of Consent|12|||
16240525|NCT01488071|39363595|FG000|Overall Study|Lost to Follow-up|1|||
16240526|NCT01488071|39363596|FG001|Overall Study|Lost to Follow-up|0|||
16123591|NCT02229851|38938550|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
16123592|NCT02229851|38938551|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
16123593|NCT02229851|38938552|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
16123594|NCT02229851|38938553|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
16123595|NCT02229851|38938554|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
16123596|NCT02229851|38938555|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
16123597|NCT02229851|38938556|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
16123598|NCT02229851|38938550|FG000|Extension Phase (Open-label Phase)|Death|0|||
16123599|NCT02229851|38938551|FG001|Extension Phase (Open-label Phase)|Death|0|||
16123600|NCT02229851|38938552|FG002|Extension Phase (Open-label Phase)|Death|0|||
16123601|NCT02229851|38938553|FG003|Extension Phase (Open-label Phase)|Death|1|||
16123602|NCT02229851|38938554|FG004|Extension Phase (Open-label Phase)|Death|0|||
16123603|NCT02229851|38938555|FG005|Extension Phase (Open-label Phase)|Death|1|||
16123604|NCT02229851|38938556|FG006|Extension Phase (Open-label Phase)|Death|1|||
16123605|NCT03139604|38938559|FG000|Overall Study|Other|7|||
16123606|NCT03139604|38938560|FG001|Overall Study|Other|3|||
16123607|NCT03139604|38938559|FG000|Overall Study|Withdrawal by Subject|16|||
16123608|NCT03139604|38938560|FG001|Overall Study|Withdrawal by Subject|17|||
16123609|NCT03139604|38938559|FG000|Overall Study|Physician Decision|1|||
16123610|NCT03139604|38938560|FG001|Overall Study|Physician Decision|2|||
16123611|NCT03139604|38938559|FG000|Overall Study|Lost to Follow-up|3|||
16123612|NCT03139604|38938560|FG001|Overall Study|Lost to Follow-up|1|||
16123613|NCT03139604|38938559|FG000|Overall Study|Death|65|||
16123614|NCT03139604|38938560|FG001|Overall Study|Death|67|||
16123615|NCT03139604|38938559|FG000|Overall Study|Study Terminated by Sponsor|122|||
16123616|NCT03139604|38938560|FG001|Overall Study|Study Terminated by Sponsor|127|||
16123617|NCT03139604|38938559|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
16123618|NCT03139604|38938560|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
16123619|NCT01215188|38938561|FG000|Overall Study|Lost to Follow-up|22|||
16123620|NCT01215188|38938562|FG001|Overall Study|Lost to Follow-up|22|||
16240527|NCT01488071|39363595|FG000|Overall Study|Administrative or Other Reason(s)|5|||
16240528|NCT01488071|39363596|FG001|Overall Study|Administrative or Other Reason(s)|4|||
16240529|NCT00923195|39363597|FG000|Overall Study|Death|0|||
16123621|NCT01215188|38938563|FG002|Overall Study|Lost to Follow-up|16|||
16123622|NCT01215188|38938561|FG000|Overall Study|Adverse Event|1|||
16123623|NCT01215188|38938562|FG001|Overall Study|Adverse Event|1|||
16123624|NCT01215188|38938563|FG002|Overall Study|Adverse Event|3|||
16240530|NCT00923195|39363598|FG001|Overall Study|Death|1|||
16240531|NCT02555618|39363599|FG000|Overall Study|Sponsor's Circumstances|1|||
16123625|NCT01215188|38938561|FG000|Overall Study|Physician Decision|2|||
16123626|NCT01215188|38938562|FG001|Overall Study|Physician Decision|1|||
16123627|NCT01215188|38938563|FG002|Overall Study|Physician Decision|0|||
16123628|NCT01215188|38938561|FG000|Overall Study|Lack of Efficacy|0|||
16123629|NCT01215188|38938562|FG001|Overall Study|Lack of Efficacy|0|||
16123630|NCT01215188|38938563|FG002|Overall Study|Lack of Efficacy|1|||
16123631|NCT01215188|38938561|FG000|Overall Study|Protocol Violation|1|||
16123632|NCT01215188|38938562|FG001|Overall Study|Protocol Violation|1|||
16123633|NCT01215188|38938563|FG002|Overall Study|Protocol Violation|1|||
16123634|NCT01215188|38938561|FG000|Overall Study|Withdrawal by Subject|32|||
16123635|NCT01215188|38938562|FG001|Overall Study|Withdrawal by Subject|34|||
16123636|NCT01215188|38938563|FG002|Overall Study|Withdrawal by Subject|31|||
16123637|NCT02636725|38938564|FG000|Overall Study|Adverse Event|1|||
16240532|NCT02555618|39363600|FG001|Overall Study|Sponsor's Circumstances|0|||
16240533|NCT01458132|39363603|FG000|Overall Study|Other|15|||
16240534|NCT01458132|39363604|FG001|Overall Study|Other|3|||
16240535|NCT00051636|39363605|FG000|Period 1 - Core|Adverse Event|2|||
16240536|NCT00051636|39363606|FG001|Period 1 - Core|Adverse Event|2|||
16350163|NCT01747499|39768963|FG000|Overall Study|Death|0|||
16123638|NCT02235311|38938575|FG000|Overall Study|Lost to Follow-up|0|||
16123639|NCT02235311|38938576|FG001|Overall Study|Lost to Follow-up|1|||
16240537|NCT00051636|39363605|FG000|Period 1 - Core|Protocol Violation|1|||
16240538|NCT00051636|39363606|FG001|Period 1 - Core|Protocol Violation|0|||
16240539|NCT00051636|39363605|FG000|Period 1 - Core|Withdrawal by Subject|1|||
16123640|NCT02235311|38938575|FG000|Overall Study|Protocol Violation|0|||
16350164|NCT01747499|39768964|FG001|Overall Study|Death|0|||
16123641|NCT02235311|38938576|FG001|Overall Study|Protocol Violation|1|||
16123642|NCT05327816|38938577|FG000|Overall Study|Lost to Follow-up|1|||
16123643|NCT05327816|38938578|FG001|Overall Study|Lost to Follow-up|0|||
16123644|NCT05327816|38938579|FG002|Overall Study|Lost to Follow-up|0|||
16123645|NCT05327816|38938580|FG003|Overall Study|Lost to Follow-up|0|||
16123646|NCT05327816|38938581|FG004|Overall Study|Lost to Follow-up|0|||
16123647|NCT05327816|38938582|FG005|Overall Study|Lost to Follow-up|0|||
16123648|NCT05327816|38938583|FG006|Overall Study|Lost to Follow-up|0|||
16123649|NCT05327816|38938584|FG007|Overall Study|Lost to Follow-up|0|||
16123650|NCT05327816|38938585|FG008|Overall Study|Lost to Follow-up|0|||
16123651|NCT05327816|38938586|FG009|Overall Study|Lost to Follow-up|1|||
16123652|NCT05327816|38938587|FG010|Overall Study|Lost to Follow-up|0|||
16123653|NCT05327816|38938577|FG000|Overall Study|Withdrawal by Subject|0|||
16123654|NCT05327816|38938578|FG001|Overall Study|Withdrawal by Subject|0|||
16123655|NCT05327816|38938579|FG002|Overall Study|Withdrawal by Subject|0|||
16123656|NCT05327816|38938580|FG003|Overall Study|Withdrawal by Subject|0|||
16123657|NCT05327816|38938581|FG004|Overall Study|Withdrawal by Subject|1|||
16123658|NCT05327816|38938582|FG005|Overall Study|Withdrawal by Subject|1|||
16123659|NCT05327816|38938583|FG006|Overall Study|Withdrawal by Subject|0|||
16123660|NCT05327816|38938584|FG007|Overall Study|Withdrawal by Subject|0|||
16123661|NCT05327816|38938585|FG008|Overall Study|Withdrawal by Subject|0|||
16123662|NCT05327816|38938586|FG009|Overall Study|Withdrawal by Subject|0|||
16123663|NCT05327816|38938587|FG010|Overall Study|Withdrawal by Subject|0|||
16123664|NCT05327816|38938577|FG000|Overall Study|Study Terminated by Sponsor|11|||
16123665|NCT05327816|38938578|FG001|Overall Study|Study Terminated by Sponsor|12|||
16123666|NCT05327816|38938579|FG002|Overall Study|Study Terminated by Sponsor|12|||
16123667|NCT05327816|38938580|FG003|Overall Study|Study Terminated by Sponsor|12|||
16123668|NCT05327816|38938581|FG004|Overall Study|Study Terminated by Sponsor|11|||
16123669|NCT05327816|38938582|FG005|Overall Study|Study Terminated by Sponsor|11|||
16123670|NCT05327816|38938583|FG006|Overall Study|Study Terminated by Sponsor|11|||
16123671|NCT05327816|38938584|FG007|Overall Study|Study Terminated by Sponsor|11|||
16123672|NCT05327816|38938585|FG008|Overall Study|Study Terminated by Sponsor|11|||
16123673|NCT05327816|38938586|FG009|Overall Study|Study Terminated by Sponsor|11|||
16123674|NCT05327816|38938587|FG010|Overall Study|Study Terminated by Sponsor|12|||
16123675|NCT05327816|38938577|FG000|Overall Study|Randomized but not treated|0|||
16123676|NCT05327816|38938578|FG001|Overall Study|Randomized but not treated|0|||
16123677|NCT05327816|38938579|FG002|Overall Study|Randomized but not treated|0|||
16123678|NCT05327816|38938580|FG003|Overall Study|Randomized but not treated|0|||
16123679|NCT05327816|38938581|FG004|Overall Study|Randomized but not treated|0|||
16123680|NCT05327816|38938582|FG005|Overall Study|Randomized but not treated|0|||
16123681|NCT05327816|38938583|FG006|Overall Study|Randomized but not treated|1|||
16123682|NCT05327816|38938584|FG007|Overall Study|Randomized but not treated|1|||
16123683|NCT05327816|38938585|FG008|Overall Study|Randomized but not treated|1|||
16123684|NCT05327816|38938586|FG009|Overall Study|Randomized but not treated|0|||
16123685|NCT05327816|38938587|FG010|Overall Study|Randomized but not treated|0|||
16123686|NCT01758900|38938588|FG000|Overall Study|difficulty for further intubation|7|||
16123687|NCT01758900|38938589|FG001|Overall Study|difficulty for further intubation|8|||
16123688|NCT02075476|38938590|FG000|Overall Study|Death|2|||
16123689|NCT02075476|38938591|FG001|Overall Study|Death|2|||
16123690|NCT02075476|38938590|FG000|Overall Study|Lost to Follow-up|1|||
16123691|NCT02075476|38938591|FG001|Overall Study|Lost to Follow-up|3|||
16123692|NCT02248818|38938592|FG000|Screening|Protocol Violation|0|||
16123693|NCT02248818|38938593|FG001|Screening|Protocol Violation|0|||
16123694|NCT02248818|38938594|FG002|Screening|Protocol Violation|0|||
16123695|NCT02248818|38938595|FG003|Screening|Protocol Violation|0|||
16123696|NCT02248818|38938596|FG004|Screening|Protocol Violation|0|||
16123697|NCT02248818|38938597|FG005|Screening|Protocol Violation|0|||
16123698|NCT02248818|38938598|FG006|Screening|Protocol Violation|0|||
16123699|NCT02248818|38938599|FG007|Screening|Protocol Violation|0|||
16123700|NCT02248818|38938600|FG008|Screening|Protocol Violation|7|||
16123701|NCT02248818|38938592|FG000|Screening|Study fully enrolled|0|||
16123702|NCT02248818|38938593|FG001|Screening|Study fully enrolled|0|||
16123703|NCT02248818|38938594|FG002|Screening|Study fully enrolled|0|||
16123704|NCT02248818|38938595|FG003|Screening|Study fully enrolled|0|||
16123705|NCT02248818|38938596|FG004|Screening|Study fully enrolled|0|||
16123706|NCT02248818|38938597|FG005|Screening|Study fully enrolled|0|||
16123707|NCT02248818|38938598|FG006|Screening|Study fully enrolled|0|||
16123708|NCT02248818|38938599|FG007|Screening|Study fully enrolled|0|||
16123709|NCT02248818|38938600|FG008|Screening|Study fully enrolled|14|||
16123710|NCT02248818|38938592|FG000|Screening|Physician Decision|0|||
16123711|NCT02248818|38938593|FG001|Screening|Physician Decision|0|||
16123712|NCT02248818|38938594|FG002|Screening|Physician Decision|0|||
16123713|NCT02248818|38938595|FG003|Screening|Physician Decision|0|||
16123714|NCT02248818|38938596|FG004|Screening|Physician Decision|0|||
16123715|NCT02248818|38938597|FG005|Screening|Physician Decision|0|||
16123716|NCT02248818|38938598|FG006|Screening|Physician Decision|0|||
16123717|NCT02248818|38938599|FG007|Screening|Physician Decision|0|||
16123718|NCT02248818|38938600|FG008|Screening|Physician Decision|73|||
16123719|NCT02248818|38938592|FG000|Screening|Withdrawal by Subject|0|||
16123720|NCT02248818|38938593|FG001|Screening|Withdrawal by Subject|0|||
16123721|NCT02248818|38938594|FG002|Screening|Withdrawal by Subject|0|||
16123722|NCT02248818|38938595|FG003|Screening|Withdrawal by Subject|0|||
16123723|NCT02248818|38938596|FG004|Screening|Withdrawal by Subject|0|||
16123724|NCT02248818|38938597|FG005|Screening|Withdrawal by Subject|0|||
16123725|NCT02248818|38938598|FG006|Screening|Withdrawal by Subject|0|||
16123726|NCT02248818|38938599|FG007|Screening|Withdrawal by Subject|0|||
16123727|NCT02248818|38938600|FG008|Screening|Withdrawal by Subject|6|||
16123728|NCT02248818|38938592|FG000|Screening|Lost to Follow-up|0|||
16123729|NCT02248818|38938593|FG001|Screening|Lost to Follow-up|0|||
16123730|NCT02248818|38938594|FG002|Screening|Lost to Follow-up|0|||
16123731|NCT02248818|38938595|FG003|Screening|Lost to Follow-up|0|||
16123732|NCT02248818|38938596|FG004|Screening|Lost to Follow-up|0|||
16123733|NCT02248818|38938597|FG005|Screening|Lost to Follow-up|0|||
16123734|NCT02248818|38938598|FG006|Screening|Lost to Follow-up|0|||
16123735|NCT02248818|38938599|FG007|Screening|Lost to Follow-up|0|||
16123736|NCT02248818|38938600|FG008|Screening|Lost to Follow-up|7|||
16123737|NCT02248818|38938592|FG000|Randomised Study|Administrative - randomization error|0|||
16123738|NCT02248818|38938593|FG001|Randomised Study|Administrative - randomization error|0|||
16123739|NCT02248818|38938594|FG002|Randomised Study|Administrative - randomization error|0|||
16123740|NCT02248818|38938595|FG003|Randomised Study|Administrative - randomization error|0|||
16123741|NCT02248818|38938596|FG004|Randomised Study|Administrative - randomization error|0|||
16123742|NCT02248818|38938597|FG005|Randomised Study|Administrative - randomization error|8|||
16123743|NCT02248818|38938598|FG006|Randomised Study|Administrative - randomization error|0|||
16123744|NCT02248818|38938599|FG007|Randomised Study|Administrative - randomization error|0|||
16123745|NCT02248818|38938600|FG008|Randomised Study|Administrative - randomization error|0|||
16123746|NCT01853475|38938601|FG000|Overall Study|Withdrawal by Subject|0|||
16123747|NCT01853475|38938602|FG001|Overall Study|Withdrawal by Subject|1|||
16123748|NCT01853475|38938603|FG002|Overall Study|Withdrawal by Subject|0|||
16350165|NCT01747499|39768965|FG002|Overall Study|Death|0|||
16123749|NCT00316602|38938606|FG000|Overall Study|Withdrawal by Subject|3|||
16123750|NCT00316602|38938607|FG001|Overall Study|Withdrawal by Subject|2|||
16123751|NCT00316602|38938606|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
16123752|NCT00316602|38938607|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
16123753|NCT00316602|38938606|FG000|Overall Study|Adverse Event|1|||
16123754|NCT00316602|38938607|FG001|Overall Study|Adverse Event|0|||
16123755|NCT00316602|38938606|FG000|Overall Study|Other|3|||
16123756|NCT00316602|38938607|FG001|Overall Study|Other|6|||
16123757|NCT02672852|38938609|FG000|Part A1|Disease Worsening|1|||
16123758|NCT02672852|38938610|FG001|Part A1|Disease Worsening|0|||
16123759|NCT02672852|38938611|FG002|Part A1|Disease Worsening|0|||
16123760|NCT02672852|38938612|FG003|Part A1|Disease Worsening|0|||
16123761|NCT02672852|38938613|FG004|Part A1|Disease Worsening|0|||
16123762|NCT02672852|38938614|FG005|Part A1|Disease Worsening|0|||
16123763|NCT02672852|38938615|FG006|Part A1|Disease Worsening|0|||
16123764|NCT02672852|38938609|FG000|Part A1|Adverse Event|0|||
16123765|NCT02672852|38938610|FG001|Part A1|Adverse Event|1|||
16123766|NCT02672852|38938611|FG002|Part A1|Adverse Event|0|||
16123767|NCT02672852|38938612|FG003|Part A1|Adverse Event|0|||
16123768|NCT02672852|38938613|FG004|Part A1|Adverse Event|0|||
16123769|NCT02672852|38938614|FG005|Part A1|Adverse Event|0|||
16123770|NCT02672852|38938615|FG006|Part A1|Adverse Event|0|||
16123771|NCT02672852|38938609|FG000|Part A1|Lost to Follow-up|1|||
16123772|NCT02672852|38938610|FG001|Part A1|Lost to Follow-up|2|||
16123773|NCT02672852|38938611|FG002|Part A1|Lost to Follow-up|0|||
16123774|NCT02672852|38938612|FG003|Part A1|Lost to Follow-up|0|||
16123775|NCT02672852|38938613|FG004|Part A1|Lost to Follow-up|0|||
16123776|NCT02672852|38938614|FG005|Part A1|Lost to Follow-up|0|||
16123777|NCT02672852|38938615|FG006|Part A1|Lost to Follow-up|0|||
16123778|NCT02672852|38938609|FG000|Part A1|Withdrawal by Subject|1|||
16123779|NCT02672852|38938610|FG001|Part A1|Withdrawal by Subject|1|||
16123780|NCT02672852|38938611|FG002|Part A1|Withdrawal by Subject|0|||
16123781|NCT02672852|38938612|FG003|Part A1|Withdrawal by Subject|0|||
16123782|NCT02672852|38938613|FG004|Part A1|Withdrawal by Subject|0|||
16123783|NCT02672852|38938614|FG005|Part A1|Withdrawal by Subject|0|||
16123784|NCT02672852|38938615|FG006|Part A1|Withdrawal by Subject|0|||
16123785|NCT02672852|38938609|FG000|Part A2|Disease worsening|0|||
16123786|NCT02672852|38938610|FG001|Part A2|Disease worsening|0|||
16123787|NCT02672852|38938611|FG002|Part A2|Disease worsening|1|||
16123788|NCT02672852|38938612|FG003|Part A2|Disease worsening|0|||
16123789|NCT02672852|38938613|FG004|Part A2|Disease worsening|0|||
16123790|NCT02672852|38938614|FG005|Part A2|Disease worsening|0|||
16123791|NCT02672852|38938615|FG006|Part A2|Disease worsening|0|||
16123792|NCT02672852|38938609|FG000|Part A2|Adverse Event|0|||
16123793|NCT02672852|38938610|FG001|Part A2|Adverse Event|0|||
16123794|NCT02672852|38938611|FG002|Part A2|Adverse Event|3|||
16123795|NCT02672852|38938612|FG003|Part A2|Adverse Event|0|||
16123796|NCT02672852|38938613|FG004|Part A2|Adverse Event|0|||
16123797|NCT02672852|38938614|FG005|Part A2|Adverse Event|0|||
16123798|NCT02672852|38938615|FG006|Part A2|Adverse Event|0|||
16123799|NCT02672852|38938609|FG000|Part A2|Lost to Follow-up|0|||
16123800|NCT02672852|38938610|FG001|Part A2|Lost to Follow-up|0|||
16123801|NCT02672852|38938611|FG002|Part A2|Lost to Follow-up|2|||
16123802|NCT02672852|38938612|FG003|Part A2|Lost to Follow-up|0|||
16123803|NCT02672852|38938613|FG004|Part A2|Lost to Follow-up|0|||
16123804|NCT02672852|38938614|FG005|Part A2|Lost to Follow-up|0|||
16123805|NCT02672852|38938615|FG006|Part A2|Lost to Follow-up|0|||
16123806|NCT02672852|38938609|FG000|Part A2|Withdrawal by Subject|0|||
16123807|NCT02672852|38938610|FG001|Part A2|Withdrawal by Subject|0|||
16123808|NCT02672852|38938611|FG002|Part A2|Withdrawal by Subject|1|||
16123809|NCT02672852|38938612|FG003|Part A2|Withdrawal by Subject|0|||
16123810|NCT02672852|38938613|FG004|Part A2|Withdrawal by Subject|0|||
16123811|NCT02672852|38938614|FG005|Part A2|Withdrawal by Subject|0|||
16123812|NCT02672852|38938615|FG006|Part A2|Withdrawal by Subject|0|||
16123813|NCT02672852|38938609|FG000|Part A2|Other|0|||
16123814|NCT02672852|38938610|FG001|Part A2|Other|0|||
16123815|NCT02672852|38938611|FG002|Part A2|Other|3|||
16123816|NCT02672852|38938612|FG003|Part A2|Other|0|||
16123817|NCT02672852|38938613|FG004|Part A2|Other|0|||
16123818|NCT02672852|38938614|FG005|Part A2|Other|0|||
16123819|NCT02672852|38938615|FG006|Part A2|Other|0|||
16123820|NCT02672852|38938609|FG000|Part A2|Not entered in Part B|0|||
16123821|NCT02672852|38938610|FG001|Part A2|Not entered in Part B|0|||
16123822|NCT02672852|38938611|FG002|Part A2|Not entered in Part B|0|||
16123823|NCT02672852|38938612|FG003|Part A2|Not entered in Part B|4|||
16123824|NCT02672852|38938613|FG004|Part A2|Not entered in Part B|0|||
16123825|NCT02672852|38938614|FG005|Part A2|Not entered in Part B|0|||
16123826|NCT02672852|38938615|FG006|Part A2|Not entered in Part B|0|||
16123827|NCT02672852|38938609|FG000|Part B|Disease worsening|0|||
16123828|NCT02672852|38938610|FG001|Part B|Disease worsening|0|||
16123829|NCT02672852|38938611|FG002|Part B|Disease worsening|0|||
16123830|NCT02672852|38938612|FG003|Part B|Disease worsening|0|||
16123831|NCT02672852|38938613|FG004|Part B|Disease worsening|1|||
16123832|NCT02672852|38938614|FG005|Part B|Disease worsening|0|||
16123833|NCT02672852|38938615|FG006|Part B|Disease worsening|1|||
16123834|NCT02672852|38938609|FG000|Part B|Worsening pre-existing condition|0|||
16123835|NCT02672852|38938610|FG001|Part B|Worsening pre-existing condition|0|||
16123836|NCT02672852|38938611|FG002|Part B|Worsening pre-existing condition|0|||
16123837|NCT02672852|38938612|FG003|Part B|Worsening pre-existing condition|0|||
16123838|NCT02672852|38938613|FG004|Part B|Worsening pre-existing condition|0|||
16123839|NCT02672852|38938614|FG005|Part B|Worsening pre-existing condition|1|||
16123840|NCT02672852|38938615|FG006|Part B|Worsening pre-existing condition|0|||
16123841|NCT02672852|38938609|FG000|Part B|Other adverse event|0|||
16123842|NCT02672852|38938610|FG001|Part B|Other adverse event|0|||
16123843|NCT02672852|38938611|FG002|Part B|Other adverse event|0|||
16123844|NCT02672852|38938612|FG003|Part B|Other adverse event|0|||
16123845|NCT02672852|38938613|FG004|Part B|Other adverse event|3|||
16123846|NCT02672852|38938614|FG005|Part B|Other adverse event|5|||
16123847|NCT02672852|38938615|FG006|Part B|Other adverse event|1|||
16123848|NCT02672852|38938609|FG000|Part B|Lost to Follow-up|0|||
16123849|NCT02672852|38938610|FG001|Part B|Lost to Follow-up|0|||
16123850|NCT02672852|38938611|FG002|Part B|Lost to Follow-up|0|||
16123851|NCT02672852|38938612|FG003|Part B|Lost to Follow-up|0|||
16557082|NCT04467840|40506407|FG001|Overall Study|Other|5|||
16123852|NCT02672852|38938613|FG004|Part B|Lost to Follow-up|3|||
16123853|NCT02672852|38938614|FG005|Part B|Lost to Follow-up|4|||
16123854|NCT02672852|38938615|FG006|Part B|Lost to Follow-up|1|||
16123855|NCT02672852|38938609|FG000|Part B|Withdrawal by Subject|0|||
16123856|NCT02672852|38938610|FG001|Part B|Withdrawal by Subject|0|||
16123857|NCT02672852|38938611|FG002|Part B|Withdrawal by Subject|0|||
16123858|NCT02672852|38938612|FG003|Part B|Withdrawal by Subject|0|||
16123859|NCT02672852|38938613|FG004|Part B|Withdrawal by Subject|5|||
16123860|NCT02672852|38938614|FG005|Part B|Withdrawal by Subject|0|||
16123861|NCT02672852|38938615|FG006|Part B|Withdrawal by Subject|7|||
16123862|NCT02672852|38938609|FG000|Part B|Other|0|||
16123863|NCT02672852|38938610|FG001|Part B|Other|0|||
16557083|NCT04467840|40506406|FG000|Overall Study|Missing study completion status|3|||
16557084|NCT04467840|40506407|FG001|Overall Study|Missing study completion status|1|||
16557085|NCT05114590|40506410|FG000|Overall Study|Adverse Event|1|||
16557086|NCT05114590|40506410|FG000|Overall Study|Investigator decision|1|||
16123864|NCT02672852|38938611|FG002|Part B|Other|0|||
16123865|NCT02672852|38938612|FG003|Part B|Other|0|||
16123866|NCT02672852|38938613|FG004|Part B|Other|4|||
16123867|NCT02672852|38938614|FG005|Part B|Other|1|||
16123868|NCT02672852|38938615|FG006|Part B|Other|2|||
16123869|NCT00022659|38938618|FG000|Overall Study|Ineligible: wrong primary|1|||
16123870|NCT00022659|38938618|FG000|Overall Study|Never treated|1|||
16123871|NCT03141905|38938619|FG000|Overall Study|Death|3|||
16123872|NCT03141905|38938620|FG001|Overall Study|Death|2|||
16123873|NCT03141905|38938619|FG000|Overall Study|Withdrawal by Subject|1|||
16123874|NCT03141905|38938620|FG001|Overall Study|Withdrawal by Subject|0|||
16123875|NCT03141905|38938619|FG000|Overall Study|Lost to Follow-up|3|||
16123876|NCT03141905|38938620|FG001|Overall Study|Lost to Follow-up|7|||
16123877|NCT03141905|38938619|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
16123878|NCT03141905|38938620|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
16123879|NCT02601300|38938621|FG000|Induction Phase|Lack of Efficacy|2|||
16123880|NCT02601300|38938621|FG000|Induction Phase|Protocol Violation|1|||
16123881|NCT02601300|38938621|FG000|Extension Phase|Withdrawal by Subject|3|||
16123882|NCT02601300|38938621|FG000|Extension Phase|Adverse Event|4|||
16123883|NCT02601300|38938621|FG000|Extension Phase|Lack of Efficacy|10|||
16123884|NCT02735577|38938626|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
16123885|NCT02735577|38938626|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
16123886|NCT04101318|38938627|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
16123887|NCT04101318|38938628|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
16123888|NCT04101318|38938627|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
16123889|NCT04101318|38938628|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
16123890|NCT04101318|38938627|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
16123891|NCT04101318|38938628|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
16123892|NCT02580305|38938629|FG000|Overall Study|Adverse Event|15|||
16123893|NCT02580305|38938630|FG001|Overall Study|Adverse Event|19|||
16123894|NCT02580305|38938631|FG002|Overall Study|Adverse Event|10|||
16123895|NCT02580305|38938629|FG000|Overall Study|Lack of Efficacy|5|||
16123896|NCT02580305|38938630|FG001|Overall Study|Lack of Efficacy|0|||
16123897|NCT02580305|38938631|FG002|Overall Study|Lack of Efficacy|2|||
16414275|NCT00262847|39998386|FG001|Overall Study|Concomitant disease|2|||
16414276|NCT00262847|39998387|FG002|Overall Study|Concomitant disease|4|||
16414277|NCT00262847|39998385|FG000|Overall Study|Other Reasons|79|||
16414278|NCT00262847|39998386|FG001|Overall Study|Other Reasons|88|||
16414279|NCT00262847|39998387|FG002|Overall Study|Other Reasons|27|||
16414280|NCT00262847|39998385|FG000|Overall Study|Did not receive study treatment|4|||
16414281|NCT00262847|39998386|FG001|Overall Study|Did not receive study treatment|1|||
16414282|NCT00262847|39998387|FG002|Overall Study|Did not receive study treatment|4|||
16557087|NCT05114590|40506410|FG000|Overall Study|Lost to Follow-up|5|||
16123898|NCT02580305|38938629|FG000|Overall Study|Protocol Violation|4|||
16123899|NCT02580305|38938630|FG001|Overall Study|Protocol Violation|9|||
16123900|NCT02580305|38938631|FG002|Overall Study|Protocol Violation|6|||
16123901|NCT02580305|38938629|FG000|Overall Study|Lost to Follow-up|4|||
16123902|NCT02580305|38938630|FG001|Overall Study|Lost to Follow-up|4|||
16123903|NCT02580305|38938631|FG002|Overall Study|Lost to Follow-up|2|||
16123904|NCT02580305|38938629|FG000|Overall Study|Withdrawal by Subject|11|||
16123905|NCT02580305|38938630|FG001|Overall Study|Withdrawal by Subject|9|||
16123906|NCT02580305|38938631|FG002|Overall Study|Withdrawal by Subject|7|||
16123907|NCT02580305|38938629|FG000|Overall Study|Randomized in error and never treated|4|||
16123908|NCT02580305|38938630|FG001|Overall Study|Randomized in error and never treated|8|||
16123909|NCT02580305|38938631|FG002|Overall Study|Randomized in error and never treated|5|||
16414283|NCT01853072|39998395|FG000|Overall Study|Adverse event prior to treatment|0|||
16123910|NCT02182947|38938632|FG000|Overall Study|Withdrawal by Subject|7|||
16123911|NCT02182947|38938632|FG000|Overall Study|Lost to Follow-up|3|||
16123912|NCT02182947|38938632|FG000|Overall Study|Failed screening activities|8|||
16123913|NCT01253018|38938633|FG000|Overall Study|Lost to Follow-up|1|||
16123914|NCT01253018|38938634|FG001|Overall Study|Lost to Follow-up|1|||
16123915|NCT01253018|38938633|FG000|Overall Study|Robot Repair Issues|2|||
16123916|NCT01253018|38938634|FG001|Overall Study|Robot Repair Issues|0|||
16123917|NCT01253018|38938633|FG000|Overall Study|Withdrawal by Subject|1|||
16123918|NCT01253018|38938634|FG001|Overall Study|Withdrawal by Subject|1|||
16123919|NCT04664400|38938639|FG000|Overall Study|Withdrawal by Subject|2|||
16123920|NCT01137578|38938640|FG000|Overall Study|Participant requested to Discontinue|3|||
16123921|NCT01137578|38938641|FG001|Overall Study|Participant requested to Discontinue|0|||
16123922|NCT01137578|38938642|FG002|Overall Study|Participant requested to Discontinue|0|||
16123923|NCT01137578|38938640|FG000|Overall Study|Withdrawal by Subject|1|||
16123924|NCT01137578|38938641|FG001|Overall Study|Withdrawal by Subject|0|||
16123925|NCT01137578|38938642|FG002|Overall Study|Withdrawal by Subject|0|||
16123926|NCT01137578|38938640|FG000|Overall Study|Other|12|||
16123927|NCT01137578|38938641|FG001|Overall Study|Other|2|||
16123928|NCT01137578|38938642|FG002|Overall Study|Other|6|||
16123929|NCT00506441|38938643|FG000|Period 1; Open-label Period|Adverse Event|21|||
16123930|NCT00506441|38938644|FG001|Period 1; Open-label Period|Adverse Event|0|||
16123931|NCT00506441|38938643|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
16123932|NCT00506441|38938644|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
16123933|NCT00506441|38938643|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
16123934|NCT00506441|38938644|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
16123935|NCT00506441|38938643|FG000|Period 1; Open-label Period|Physician Decision|5|||
16123936|NCT00506441|38938644|FG001|Period 1; Open-label Period|Physician Decision|0|||
16123937|NCT00506441|38938643|FG000|Period 1; Open-label Period|Protocol Violation|9|||
16123938|NCT00506441|38938644|FG001|Period 1; Open-label Period|Protocol Violation|0|||
16123939|NCT00506441|38938643|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
16123940|NCT00506441|38938644|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
16123941|NCT00506441|38938643|FG000|Period 1; Open-label Period|Other Reasons|13|||
16123942|NCT00506441|38938644|FG001|Period 1; Open-label Period|Other Reasons|0|||
16123943|NCT00506441|38938643|FG000|Period 2; Double-blind Period|Adverse Event|0|||
16123944|NCT00506441|38938644|FG001|Period 2; Double-blind Period|Adverse Event|1|||
16123945|NCT00506441|38938643|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
16123946|NCT00506441|38938644|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
16123947|NCT00506441|38938643|FG000|Period 2; Double-blind Period|Physician Decision|1|||
16123948|NCT00506441|38938644|FG001|Period 2; Double-blind Period|Physician Decision|1|||
16123949|NCT00506441|38938643|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
16123950|NCT00506441|38938644|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
16123951|NCT00506441|38938643|FG000|Period 2; Double-blind Period|Other Reason|1|||
16123952|NCT00506441|38938644|FG001|Period 2; Double-blind Period|Other Reason|1|||
16123953|NCT00515853|38938657|FG000|Overall Study|Lost to Follow-up|9|||
16350166|NCT01747499|39768966|FG003|Overall Study|Death|1|||
16350167|NCT01747499|39768967|FG004|Overall Study|Death|1|||
16350168|NCT01747499|39768963|FG000|Overall Study|Withdrawal by Subject|0|||
16350169|NCT01747499|39768964|FG001|Overall Study|Withdrawal by Subject|0|||
16123954|NCT00515853|38938658|FG001|Overall Study|Lost to Follow-up|13|||
16123955|NCT00515853|38938657|FG000|Overall Study|Withdrawal by Subject|6|||
16123956|NCT00515853|38938658|FG001|Overall Study|Withdrawal by Subject|4|||
16123957|NCT03466073|38938660|FG000|Overall Study|Death|1|||
16123958|NCT03466073|38938661|FG001|Overall Study|Death|0|||
16123959|NCT03466073|38938662|FG002|Overall Study|Death|0|||
16123960|NCT03466073|38938663|FG003|Overall Study|Death|0|||
16123961|NCT03466073|38938664|FG004|Overall Study|Death|0|||
16123962|NCT03466073|38938665|FG005|Overall Study|Death|1|||
16123963|NCT00414908|38938670|FG000|Overall Study|Protocol Violation|1|||
16123964|NCT00414908|38938671|FG001|Overall Study|Protocol Violation|1|||
16123965|NCT01528345|38938672|FG000|Overall Study|Adverse Event|10|||
16123966|NCT01528345|38938673|FG001|Overall Study|Adverse Event|1|||
16123967|NCT01528345|38938672|FG000|Overall Study|Death|1|||
16123968|NCT01528345|38938673|FG001|Overall Study|Death|1|||
16123969|NCT01528345|38938672|FG000|Overall Study|Non-compliance with study treatment|1|||
16123970|NCT01528345|38938673|FG001|Overall Study|Non-compliance with study treatment|0|||
16123971|NCT01528345|38938672|FG000|Overall Study|Progressive Disease|26|||
16123972|NCT01528345|38938673|FG001|Overall Study|Progressive Disease|40|||
16123973|NCT01528345|38938672|FG000|Overall Study|Study Terminated by Sponsor|4|||
16123974|NCT01528345|38938673|FG001|Overall Study|Study Terminated by Sponsor|8|||
16123975|NCT01528345|38938672|FG000|Overall Study|Subject/Guardian Decision|5|||
16123976|NCT01528345|38938673|FG001|Overall Study|Subject/Guardian Decision|0|||
16123977|NCT00992225|38938676|FG000|Overall Study|Entry Criteria Not Met|8|||
16123978|NCT00992225|38938676|FG000|Overall Study|Adverse Event|2|||
16123979|NCT00564889|38938677|FG000|Overall Study|Death|7|||
16123980|NCT00564889|38938677|FG000|Overall Study|Adverse Event|12|||
16123981|NCT00564889|38938677|FG000|Overall Study|Alternative treatment|3|||
16123982|NCT00564889|38938677|FG000|Overall Study|Disease progression|3|||
16123983|NCT00564889|38938677|FG000|Overall Study|Other, not specified|4|||
16123984|NCT03449901|38938678|FG000|Overall Study|Progression|57|||
16123985|NCT03449901|38938679|FG001|Overall Study|Progression|12|||
16123986|NCT03449901|38938678|FG000|Overall Study|Adverse Event|3|||
16123987|NCT03449901|38938679|FG001|Overall Study|Adverse Event|0|||
16123988|NCT03449901|38938678|FG000|Overall Study|Death|6|||
16123989|NCT03449901|38938679|FG001|Overall Study|Death|2|||
16123990|NCT03449901|38938678|FG000|Overall Study|Withdrawal by Subject|12|||
16123991|NCT03449901|38938679|FG001|Overall Study|Withdrawal by Subject|1|||
16123992|NCT03449901|38938678|FG000|Overall Study|Physician Decision|1|||
16123993|NCT03449901|38938679|FG001|Overall Study|Physician Decision|0|||
16123994|NCT03449901|38938678|FG000|Overall Study|Patient elected for surgical intervention|1|||
16123995|NCT03449901|38938679|FG001|Overall Study|Patient elected for surgical intervention|0|||
16123996|NCT03449901|38938678|FG000|Overall Study|Patient off for other complicating disease|1|||
16123997|NCT03449901|38938679|FG001|Overall Study|Patient off for other complicating disease|0|||
16123998|NCT01994837|38938680|FG000|Overall Study|Progressive disease per protocol|23|||
16123999|NCT01994837|38938680|FG000|Overall Study|Adv event related to progressive disease|3|||
16124000|NCT01994837|38938680|FG000|Overall Study|Fatal progressive disease|2|||
16124001|NCT01994837|38938680|FG000|Overall Study|Adverse event not related to progression|1|||
16124002|NCT01994837|38938680|FG000|Overall Study|Chose palliative care|1|||
16124003|NCT01994837|38938680|FG000|Overall Study|Proceeded to transplant|1|||
16124004|NCT01994837|38938680|FG000|Overall Study|Removed from study due to no response|1|||
16124005|NCT00503139|38938681|FG000|Overall Study|Case Report Forms were not collected|4|||
16240540|NCT00051636|39363606|FG001|Period 1 - Core|Withdrawal by Subject|2|||
16124006|NCT00503139|38938681|FG000|Overall Study|Protocol Violation|4|||
16350170|NCT01747499|39768965|FG002|Overall Study|Withdrawal by Subject|0|||
16240541|NCT00051636|39363605|FG000|Period 1 - Core|Lost to Follow-up|0|||
16240542|NCT00051636|39363606|FG001|Period 1 - Core|Lost to Follow-up|2|||
16240543|NCT00051636|39363605|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
16240544|NCT00051636|39363606|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
16240545|NCT00051636|39363605|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
16240546|NCT00051636|39363606|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
16240547|NCT00051636|39363605|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
16240548|NCT00051636|39363606|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
16240549|NCT00051636|39363605|FG000|Period 2- Extended Observation Period|Death|4|||
16240550|NCT00051636|39363606|FG001|Period 2- Extended Observation Period|Death|5|||
16240551|NCT00051636|39363605|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
16240552|NCT00051636|39363606|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
16240553|NCT01005680|39363608|FG000|Overall Study|Lost to Follow-up|4|||
16240554|NCT01005680|39363609|FG001|Overall Study|Lost to Follow-up|6|||
16240555|NCT01005680|39363608|FG000|Overall Study|Withdrawal by Subject|1|||
16240556|NCT01005680|39363609|FG001|Overall Study|Withdrawal by Subject|4|||
16240557|NCT01005680|39363608|FG000|Overall Study|Physician Decision|1|||
16557088|NCT05114590|40506410|FG000|Overall Study|Withdrawal by Subject|5|||
16557089|NCT05114590|40506410|FG000|Overall Study|Other|2|||
16557090|NCT01824472|40506416|FG000|Overall Study|Lost to Follow-up|0|||
16557091|NCT01824472|40506417|FG001|Overall Study|Lost to Follow-up|0|||
16557092|NCT01824472|40506418|FG002|Overall Study|Lost to Follow-up|1|||
16557093|NCT01824472|40506416|FG000|Overall Study|Withdrawal by Subject|1|||
16557094|NCT01824472|40506417|FG001|Overall Study|Withdrawal by Subject|5|||
16557095|NCT01824472|40506418|FG002|Overall Study|Withdrawal by Subject|3|||
16557096|NCT01824472|40506416|FG000|Overall Study|Ineligible post randomization&screening|0|||
16557097|NCT01824472|40506417|FG001|Overall Study|Ineligible post randomization&screening|2|||
16557098|NCT01824472|40506418|FG002|Overall Study|Ineligible post randomization&screening|0|||
16557099|NCT01646320|40506419|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
16557100|NCT01646320|40506420|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
16557101|NCT01646320|40506419|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
16557102|NCT01646320|40506420|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
16557103|NCT01646320|40506419|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
16557104|NCT01646320|40506420|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
16557105|NCT01646320|40506419|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
16557106|NCT01646320|40506420|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
16557107|NCT01646320|40506419|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
16557108|NCT01646320|40506420|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
16557109|NCT01646320|40506419|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
16557110|NCT01646320|40506420|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
16557111|NCT01646320|40506419|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
16557112|NCT01646320|40506420|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
16557113|NCT01646320|40506419|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
16557114|NCT01646320|40506420|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
16557115|NCT01646320|40506419|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
16557116|NCT01646320|40506420|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
16557117|NCT01646320|40506419|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
16557118|NCT01646320|40506420|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
16557119|NCT01646320|40506419|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
16557120|NCT01646320|40506420|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
16557121|NCT00918749|40506422|FG000|Overall Study|Adverse Event|1|||
16557122|NCT00918749|40506423|FG001|Overall Study|Adverse Event|0|||
16557123|NCT00918749|40506424|FG002|Overall Study|Adverse Event|1|||
16557124|NCT00918749|40506422|FG000|Overall Study|Lost to Follow-up|0|||
16557125|NCT00918749|40506423|FG001|Overall Study|Lost to Follow-up|0|||
16557126|NCT00918749|40506424|FG002|Overall Study|Lost to Follow-up|1|||
16557127|NCT00918749|40506422|FG000|Overall Study|Withdrawal by Subject|5|||
16557128|NCT00918749|40506423|FG001|Overall Study|Withdrawal by Subject|3|||
16557129|NCT00918749|40506424|FG002|Overall Study|Withdrawal by Subject|5|||
16557130|NCT00918749|40506422|FG000|Overall Study|No Study Medication Taken|1|||
16557131|NCT00918749|40506423|FG001|Overall Study|No Study Medication Taken|0|||
16557132|NCT00918749|40506424|FG002|Overall Study|No Study Medication Taken|0|||
16557133|NCT01052662|40506429|FG000|Overall Study|Lost to Follow-up|15|||
16557134|NCT01052662|40506430|FG001|Overall Study|Lost to Follow-up|13|||
16557135|NCT01052662|40506431|FG002|Overall Study|Lost to Follow-up|18|||
16557136|NCT01052662|40506429|FG000|Overall Study|Withdrawal by Subject|3|||
16557137|NCT01052662|40506430|FG001|Overall Study|Withdrawal by Subject|2|||
16557138|NCT01052662|40506431|FG002|Overall Study|Withdrawal by Subject|1|||
16240558|NCT01005680|39363609|FG001|Overall Study|Physician Decision|1|||
16240559|NCT00837577|39363619|FG000|Double-blind Period|Clinical Adverse Event|1|||
16124007|NCT03772587|38938682|FG000|Overall Study|COVID-19|0|||
16124008|NCT03772587|38938683|FG001|Overall Study|COVID-19|0|||
16124009|NCT03772587|38938684|FG002|Overall Study|COVID-19|1|||
16124010|NCT03772587|38938685|FG003|Overall Study|COVID-19|1|||
16124011|NCT03772587|38938686|FG004|Overall Study|COVID-19|0|||
16124012|NCT03772587|38938682|FG000|Overall Study|Withdrawal by Subject|1|||
16414284|NCT01853072|39998396|FG001|Overall Study|Adverse event prior to treatment|1|||
16414285|NCT01853072|39998395|FG000|Overall Study|Adverse Event|0|||
16414286|NCT01853072|39998396|FG001|Overall Study|Adverse Event|3|||
16414287|NCT01853072|39998395|FG000|Overall Study|Death|1|||
16414288|NCT01853072|39998396|FG001|Overall Study|Death|4|||
16414289|NCT01853072|39998395|FG000|Overall Study|Lost to Follow-up|0|||
16414290|NCT01853072|39998396|FG001|Overall Study|Lost to Follow-up|3|||
16414291|NCT01853072|39998395|FG000|Overall Study|Non-compliance with study drug|0|||
16414292|NCT01853072|39998396|FG001|Overall Study|Non-compliance with study drug|1|||
16414293|NCT01853072|39998395|FG000|Overall Study|Physician Decision|1|||
16414294|NCT01853072|39998396|FG001|Overall Study|Physician Decision|1|||
16414295|NCT01853072|39998395|FG000|Overall Study|Withdrawal by Subject|1|||
16414296|NCT01853072|39998396|FG001|Overall Study|Withdrawal by Subject|2|||
16414297|NCT01853072|39998395|FG000|Overall Study|Reason not specified|9|||
16414298|NCT01853072|39998396|FG001|Overall Study|Reason not specified|6|||
16414299|NCT02745535|39998398|FG000|Overall Study|Death|1|||
16414300|NCT02745535|39998398|FG000|Overall Study|Adverse Event|3|||
16414301|NCT02745535|39998398|FG000|Overall Study|Lost to Follow-up|2|||
16414302|NCT04524455|39998399|FG000|Overall Study|Death|3|||
16414303|NCT04524455|39998400|FG001|Overall Study|Death|3|||
16414304|NCT04524455|39998399|FG000|Overall Study|Decision by Sponsor|0|||
16414305|NCT04524455|39998400|FG001|Overall Study|Decision by Sponsor|2|||
16414306|NCT04524455|39998399|FG000|Overall Study|Withdrawal of Consent From Study|1|||
16414307|NCT04524455|39998400|FG001|Overall Study|Withdrawal of Consent From Study|0|||
16414308|NCT04524455|39998399|FG000|Overall Study|Lost to Follow-up|0|||
16414309|NCT04524455|39998400|FG001|Overall Study|Lost to Follow-up|1|||
16414310|NCT02477553|39998402|FG000|Overall Study|Screening up-to-date|12|||
16414311|NCT02477553|39998403|FG001|Overall Study|Screening up-to-date|13|||
16414312|NCT02477553|39998402|FG000|Overall Study|No MD visit|1|||
16414313|NCT02477553|39998403|FG001|Overall Study|No MD visit|1|||
16414314|NCT02477553|39998402|FG000|Overall Study|Workup consistent w/CRC|1|||
16414315|NCT02477553|39998403|FG001|Overall Study|Workup consistent w/CRC|1|||
16124013|NCT03772587|38938683|FG001|Overall Study|Withdrawal by Subject|0|||
16124014|NCT03772587|38938684|FG002|Overall Study|Withdrawal by Subject|0|||
16124015|NCT03772587|38938685|FG003|Overall Study|Withdrawal by Subject|0|||
16124016|NCT03772587|38938686|FG004|Overall Study|Withdrawal by Subject|0|||
16414316|NCT02477553|39998402|FG000|Overall Study|Technical issues with intervention|2|||
16414317|NCT02477553|39998403|FG001|Overall Study|Technical issues with intervention|0|||
16414318|NCT02477553|39998402|FG000|Overall Study|Elevated risk for CRC|2|||
16414319|NCT02477553|39998403|FG001|Overall Study|Elevated risk for CRC|2|||
16414320|NCT02477553|39998402|FG000|Overall Study|MD advised against screening|1|||
16124017|NCT00490490|38938695|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
16124018|NCT00490490|38938695|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
16124019|NCT01253304|38938696|FG000|Overall Study|Adverse Event|0|||
16124020|NCT01253304|38938697|FG001|Overall Study|Adverse Event|0|||
16124021|NCT01253304|38938698|FG002|Overall Study|Adverse Event|0|||
16124022|NCT01253304|38938699|FG003|Overall Study|Adverse Event|1|||
16124023|NCT01034163|38938707|FG000|Overall Study|Treatment completed as per protocol|8|||
16124024|NCT01034163|38938708|FG001|Overall Study|Treatment completed as per protocol|7|||
16124025|NCT01034163|38938707|FG000|Overall Study|Withdrawal by Subject|8|||
16124026|NCT01034163|38938708|FG001|Overall Study|Withdrawal by Subject|2|||
16124027|NCT01034163|38938707|FG000|Overall Study|Protocol deviation|1|||
16124028|NCT01034163|38938708|FG001|Overall Study|Protocol deviation|0|||
16124029|NCT01034163|38938707|FG000|Overall Study|Disease progression|3|||
16124030|NCT01034163|38938708|FG001|Overall Study|Disease progression|4|||
16124031|NCT01034163|38938707|FG000|Overall Study|Adverse Event|6|||
16124032|NCT01034163|38938708|FG001|Overall Study|Adverse Event|0|||
16124033|NCT01034163|38938707|FG000|Overall Study|Administrative problems|0|||
16124034|NCT01034163|38938708|FG001|Overall Study|Administrative problems|1|||
16124035|NCT01034163|38938707|FG000|Overall Study|Abnormal laboratory value|1|||
16124036|NCT01034163|38938708|FG001|Overall Study|Abnormal laboratory value|0|||
16124037|NCT00316017|38938709|FG000|Overall Study|Protocol Violation|11|||
16124038|NCT00316017|38938710|FG001|Overall Study|Protocol Violation|13|||
16124039|NCT00316017|38938711|FG002|Overall Study|Protocol Violation|19|||
16124040|NCT03845140|38938712|FG000|Overall Study|Participant travelled outside study area|0|||
16124041|NCT03845140|38938713|FG001|Overall Study|Participant travelled outside study area|1|||
16124042|NCT03845140|38938714|FG002|Overall Study|Participant travelled outside study area|0|||
16124043|NCT03845140|38938715|FG003|Overall Study|Participant travelled outside study area|0|||
16124044|NCT03845140|38938716|FG004|Overall Study|Participant travelled outside study area|0|||
16124045|NCT03845140|38938717|FG005|Overall Study|Participant travelled outside study area|0|||
16124046|NCT03122223|38938720|FG000|Overall Study|Withdrawal by Subject|2|||
16124047|NCT03122223|38938721|FG001|Overall Study|Withdrawal by Subject|2|||
16124048|NCT03122223|38938722|FG002|Overall Study|Withdrawal by Subject|1|||
16124049|NCT03122223|38938723|FG003|Overall Study|Withdrawal by Subject|0|||
16124050|NCT03122223|38938720|FG000|Overall Study|Lost to Follow-up|0|||
16124051|NCT03122223|38938721|FG001|Overall Study|Lost to Follow-up|2|||
16124052|NCT03122223|38938722|FG002|Overall Study|Lost to Follow-up|2|||
16124053|NCT03122223|38938723|FG003|Overall Study|Lost to Follow-up|0|||
16124054|NCT03122223|38938720|FG000|Overall Study|Participant unable to adhere|1|||
16124055|NCT03122223|38938721|FG001|Overall Study|Participant unable to adhere|1|||
16124056|NCT03122223|38938722|FG002|Overall Study|Participant unable to adhere|1|||
16124057|NCT03122223|38938723|FG003|Overall Study|Participant unable to adhere|0|||
16124058|NCT01153958|38942076|FG000|Overall Study|Study Terminated|36|||
16124059|NCT01153958|38942077|FG001|Overall Study|Study Terminated|32|||
16124060|NCT03274687|38942092|FG000|Overall Study|Protocol Violation|1|||
16124061|NCT03274687|38942093|FG001|Overall Study|Protocol Violation|1|||
16124062|NCT04540887|38942094|FG000|Overall Study|Withdrawal by Subject|2|||
16124063|NCT01743989|38942095|FG000|Treatment Phase|Unstable MR4.0|0|||
16124064|NCT01743989|38942096|FG001|Treatment Phase|Unstable MR4.0|6|||
16124065|NCT01743989|38942097|FG002|Treatment Phase|Unstable MR4.0|263|||
16124066|NCT01743989|38942095|FG000|Treatment Phase|Adverse Event|0|||
16124067|NCT01743989|38942096|FG001|Treatment Phase|Adverse Event|4|||
16124068|NCT01743989|38942097|FG002|Treatment Phase|Adverse Event|67|||
16124069|NCT01743989|38942095|FG000|Treatment Phase|Withdrawal by Subject|1|||
16124070|NCT01743989|38942096|FG001|Treatment Phase|Withdrawal by Subject|3|||
16124071|NCT01743989|38942097|FG002|Treatment Phase|Withdrawal by Subject|28|||
16124072|NCT01743989|38942095|FG000|Treatment Phase|Death|0|||
16124073|NCT01743989|38942096|FG001|Treatment Phase|Death|1|||
16124074|NCT01743989|38942097|FG002|Treatment Phase|Death|3|||
16124075|NCT01743989|38942095|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
16124076|NCT01743989|38942096|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
16124077|NCT01743989|38942097|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
16124078|NCT01743989|38942095|FG000|Treatment Phase|Protocol deviation|0|||
16124079|NCT01743989|38942096|FG001|Treatment Phase|Protocol deviation|0|||
16124080|NCT01743989|38942097|FG002|Treatment Phase|Protocol deviation|3|||
16124081|NCT01743989|38942095|FG000|Treatment Phase|Pregnancy|0|||
16124082|NCT01743989|38942096|FG001|Treatment Phase|Pregnancy|0|||
16124083|NCT01743989|38942097|FG002|Treatment Phase|Pregnancy|2|||
16124084|NCT01743989|38942095|FG000|Treatment Phase|Lost to Follow-up|0|||
16124085|NCT01743989|38942096|FG001|Treatment Phase|Lost to Follow-up|0|||
16124086|NCT01743989|38942097|FG002|Treatment Phase|Lost to Follow-up|2|||
16124087|NCT01743989|38942095|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
16124088|NCT01743989|38942096|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
16124089|NCT01743989|38942097|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
16124090|NCT01743989|38942095|FG000|Treatment Phase|Administrative problems|0|||
16124091|NCT01743989|38942096|FG001|Treatment Phase|Administrative problems|0|||
16124092|NCT01743989|38942097|FG002|Treatment Phase|Administrative problems|1|||
16240560|NCT00837577|39363620|FG001|Double-blind Period|Clinical Adverse Event|0|||
16414321|NCT02477553|39998403|FG001|Overall Study|MD advised against screening|3|||
16124093|NCT01743989|38942095|FG000|Treatment Phase|New cancer (CML) therapy|0|||
16124094|NCT01743989|38942096|FG001|Treatment Phase|New cancer (CML) therapy|1|||
16124095|NCT01743989|38942097|FG002|Treatment Phase|New cancer (CML) therapy|0|||
16124096|NCT01743989|38942095|FG000|Treatment Phase|Physician Decision|0|||
16124097|NCT01743989|38942096|FG001|Treatment Phase|Physician Decision|0|||
16124098|NCT01743989|38942097|FG002|Treatment Phase|Physician Decision|3|||
16124099|NCT01743989|38942095|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
16124100|NCT01743989|38942096|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
16124101|NCT01743989|38942097|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
16557139|NCT01052662|40506429|FG000|Overall Study|Pharmacy issue|1|||
16557140|NCT01052662|40506430|FG001|Overall Study|Pharmacy issue|3|||
16557141|NCT01052662|40506431|FG002|Overall Study|Pharmacy issue|3|||
16557142|NCT01052662|40506429|FG000|Overall Study|Adverse Event|1|||
16557143|NCT01052662|40506430|FG001|Overall Study|Adverse Event|1|||
16557144|NCT01052662|40506431|FG002|Overall Study|Adverse Event|0|||
16557145|NCT01052662|40506429|FG000|Overall Study|Legal Problem|2|||
16557146|NCT01052662|40506430|FG001|Overall Study|Legal Problem|0|||
16124102|NCT01743989|38942095|FG000|Treatment Phase|Not randomized by mistake|0|||
16124103|NCT01743989|38942096|FG001|Treatment Phase|Not randomized by mistake|0|||
16124104|NCT01743989|38942097|FG002|Treatment Phase|Not randomized by mistake|1|||
16124105|NCT01743989|38942095|FG000|Treatment Phase|Included by mistake|0|||
16124106|NCT01743989|38942096|FG001|Treatment Phase|Included by mistake|0|||
16124107|NCT01743989|38942097|FG002|Treatment Phase|Included by mistake|1|||
16124108|NCT01743989|38942095|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
16124109|NCT01743989|38942096|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
16124110|NCT01743989|38942097|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
16240561|NCT00837577|39363619|FG000|Double-blind Period|Withdrawal by Subject|1|||
16414322|NCT02477553|39998402|FG000|Overall Study|patient deceased|1|||
16414323|NCT02477553|39998403|FG001|Overall Study|patient deceased|0|||
16414324|NCT01498185|39998404|FG000|Overall Study|Adverse Event|0|||
16414325|NCT01498185|39998405|FG001|Overall Study|Adverse Event|0|||
16414326|NCT01498185|39998406|FG002|Overall Study|Adverse Event|0|||
16557147|NCT01052662|40506431|FG002|Overall Study|Legal Problem|0|||
16124111|NCT01743989|38942095|FG000|TFR Phase|Adverse Event|0|||
16124112|NCT01743989|38942096|FG001|TFR Phase|Adverse Event|1|||
16124113|NCT01743989|38942097|FG002|TFR Phase|Adverse Event|0|||
16124114|NCT01743989|38942095|FG000|TFR Phase|Lost to Follow-up|0|||
16414327|NCT01498185|39998407|FG003|Overall Study|Adverse Event|1|||
16414328|NCT01498185|39998408|FG004|Overall Study|Adverse Event|0|||
16557148|NCT01052662|40506429|FG000|Overall Study|Administrative|0|||
16557149|NCT01052662|40506430|FG001|Overall Study|Administrative|3|||
16557150|NCT01052662|40506431|FG002|Overall Study|Administrative|0|||
16124115|NCT01743989|38942096|FG001|TFR Phase|Lost to Follow-up|2|||
16124116|NCT01743989|38942097|FG002|TFR Phase|Lost to Follow-up|0|||
16124117|NCT01743989|38942095|FG000|TFR Phase|Physician Decision|0|||
16124118|NCT01743989|38942096|FG001|TFR Phase|Physician Decision|1|||
16124119|NCT01743989|38942097|FG002|TFR Phase|Physician Decision|0|||
16124120|NCT01743989|38942095|FG000|TFR Phase|Logistical problems|0|||
16124121|NCT01743989|38942096|FG001|TFR Phase|Logistical problems|2|||
16124122|NCT01743989|38942097|FG002|TFR Phase|Logistical problems|0|||
16124123|NCT01743989|38942095|FG000|TFR Phase|Protocol deviation|0|||
16124124|NCT01743989|38942096|FG001|TFR Phase|Protocol deviation|1|||
16124125|NCT01743989|38942097|FG002|TFR Phase|Protocol deviation|0|||
16124126|NCT01743989|38942095|FG000|TFR Phase|Withdrawal by Subject|0|||
16124127|NCT01743989|38942096|FG001|TFR Phase|Withdrawal by Subject|2|||
16124128|NCT01743989|38942097|FG002|TFR Phase|Withdrawal by Subject|0|||
16124129|NCT01743989|38942095|FG000|Re-treatment Phase|Adverse Event|8|||
16124130|NCT01743989|38942096|FG001|Re-treatment Phase|Adverse Event|4|||
16124131|NCT01743989|38942097|FG002|Re-treatment Phase|Adverse Event|0|||
16124132|NCT01743989|38942095|FG000|Re-treatment Phase|Death|1|||
16124133|NCT01743989|38942096|FG001|Re-treatment Phase|Death|1|||
16124134|NCT01743989|38942097|FG002|Re-treatment Phase|Death|0|||
16124135|NCT01743989|38942095|FG000|Re-treatment Phase|Administrative problems|1|||
16124136|NCT01743989|38942096|FG001|Re-treatment Phase|Administrative problems|1|||
16124137|NCT01743989|38942097|FG002|Re-treatment Phase|Administrative problems|0|||
16124138|NCT01743989|38942095|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
16124139|NCT01743989|38942096|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
16124140|NCT01743989|38942097|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
16124141|NCT01743989|38942095|FG000|Re-treatment Phase|Unstable MR|1|||
16124142|NCT01743989|38942096|FG001|Re-treatment Phase|Unstable MR|0|||
16124143|NCT01743989|38942097|FG002|Re-treatment Phase|Unstable MR|0|||
16557151|NCT03317379|40506435|FG000|Overall Study|Lost to Follow-up|0|||
16557152|NCT03317379|40506436|FG001|Overall Study|Lost to Follow-up|3|||
16557153|NCT03317379|40506437|FG002|Overall Study|Lost to Follow-up|2|||
16557154|NCT00109928|40506438|FG000|Overall Study|Adverse Event|2|||
16557155|NCT00109928|40506438|FG000|Overall Study|Progression|6|||
16557156|NCT00109928|40506438|FG000|Overall Study|Death|2|||
16557157|NCT00109928|40506438|FG000|Overall Study|not protocol specified|2|||
16557158|NCT00109928|40506438|FG000|Overall Study|not eligible|1|||
16557159|NCT02169830|40506441|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
16557160|NCT02169830|40506442|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
16557161|NCT02169830|40506443|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
16557162|NCT02169830|40506441|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
16557163|NCT02169830|40506442|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
16557164|NCT02169830|40506443|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
16557165|NCT02169830|40506441|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
16557166|NCT02169830|40506442|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
16557167|NCT02169830|40506443|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
16557168|NCT02169830|40506441|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
16557169|NCT02169830|40506442|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
16557170|NCT02169830|40506443|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
16557171|NCT02169830|40506441|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
16557172|NCT02169830|40506442|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
16557173|NCT02169830|40506443|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
16557174|NCT03050398|40506447|FG000|Overall Study|Study terminated by sponsor|8|||
16557175|NCT02248961|40506448|FG000|Overall Study|Adverse Event|1|||
16557176|NCT02248961|40506449|FG001|Overall Study|Adverse Event|0|||
16557177|NCT02248961|40506448|FG000|Overall Study|Withdrawal by Subject|1|||
16557178|NCT02248961|40506449|FG001|Overall Study|Withdrawal by Subject|2|||
16557179|NCT02248961|40506448|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
16557180|NCT02248961|40506449|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
16557181|NCT00896454|40506450|FG000|Overall Study|Death|10|||
16557182|NCT00896454|40506450|FG000|Overall Study|Adverse Event|8|||
16557183|NCT00896454|40506450|FG000|Overall Study|Disease Progression|5|||
16557184|NCT00896454|40506450|FG000|Overall Study|Other|4|||
16557185|NCT00896454|40506450|FG000|Overall Study|Requirement for alternative therapy|3|||
16124144|NCT01743989|38942095|FG000|Re-treatment Phase|Physician Decision|0|||
16124145|NCT01743989|38942096|FG001|Re-treatment Phase|Physician Decision|1|||
16124146|NCT01743989|38942097|FG002|Re-treatment Phase|Physician Decision|0|||
16557186|NCT00896454|40506450|FG000|Overall Study|Ongoing in study|2|||
16124147|NCT01743989|38942095|FG000|Re-treatment Phase|Lost to Follow-up|0|||
16124148|NCT01743989|38942096|FG001|Re-treatment Phase|Lost to Follow-up|1|||
16124149|NCT01743989|38942097|FG002|Re-treatment Phase|Lost to Follow-up|0|||
16124150|NCT00953745|38942098|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
16124151|NCT00953745|38942099|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
16557187|NCT00896454|40506450|FG000|Overall Study|Withdrawal by Subject|1|||
16557188|NCT00873093|40506455|FG000|Overall Study|Adverse Event|0|||
16557189|NCT00873093|40506456|FG001|Overall Study|Adverse Event|2|||
16557190|NCT00873093|40506457|FG002|Overall Study|Adverse Event|0|||
16557191|NCT00873093|40506458|FG003|Overall Study|Adverse Event|0|||
16557192|NCT00873093|40506459|FG004|Overall Study|Adverse Event|0|||
16557193|NCT00873093|40506455|FG000|Overall Study|Death|0|||
16557194|NCT00873093|40506456|FG001|Overall Study|Death|3|||
16557195|NCT00873093|40506457|FG002|Overall Study|Death|2|||
16557196|NCT00873093|40506458|FG003|Overall Study|Death|0|||
16557197|NCT00873093|40506459|FG004|Overall Study|Death|0|||
16557198|NCT00873093|40506455|FG000|Overall Study|Physician Decision|0|||
16557199|NCT00873093|40506456|FG001|Overall Study|Physician Decision|17|||
16557200|NCT00873093|40506457|FG002|Overall Study|Physician Decision|10|||
16557201|NCT00873093|40506458|FG003|Overall Study|Physician Decision|10|||
16557202|NCT00873093|40506459|FG004|Overall Study|Physician Decision|2|||
16557203|NCT00873093|40506455|FG000|Overall Study|Withdrawal by Subject|1|||
16557204|NCT00873093|40506456|FG001|Overall Study|Withdrawal by Subject|4|||
16557205|NCT00873093|40506457|FG002|Overall Study|Withdrawal by Subject|4|||
16557206|NCT00873093|40506458|FG003|Overall Study|Withdrawal by Subject|0|||
16557207|NCT00873093|40506459|FG004|Overall Study|Withdrawal by Subject|0|||
16557208|NCT00873093|40506455|FG000|Overall Study|Ineligible|0|||
16557209|NCT00873093|40506456|FG001|Overall Study|Ineligible|1|||
16240562|NCT00837577|39363620|FG001|Double-blind Period|Withdrawal by Subject|0|||
16240563|NCT00837577|39363619|FG000|Open-label Period|Clinical Adverse Event|2|||
16240564|NCT00837577|39363620|FG001|Open-label Period|Clinical Adverse Event|2|||
16240565|NCT00837577|39363619|FG000|Open-label Period|Laboratory Adverse Event|0|||
16240566|NCT00837577|39363620|FG001|Open-label Period|Laboratory Adverse Event|1|||
16240567|NCT00837577|39363619|FG000|Open-label Period|Lack of Efficacy|4|||
16240568|NCT00837577|39363620|FG001|Open-label Period|Lack of Efficacy|3|||
16240569|NCT00837577|39363619|FG000|Open-label Period|Withdrawal by Subject|1|||
16240570|NCT00837577|39363620|FG001|Open-label Period|Withdrawal by Subject|2|||
16240571|NCT00837577|39363619|FG000|Open-label Period|Other Reason|1|||
16240572|NCT00837577|39363620|FG001|Open-label Period|Other Reason|1|||
16240573|NCT02643394|39363621|FG000|Overall Study|Protocol Violation|4|||
16240574|NCT02643394|39363622|FG001|Overall Study|Protocol Violation|5|||
16240575|NCT02482571|39363623|FG000|Overall Study|Adverse Event|1|||
16240576|NCT02482571|39363623|FG000|Overall Study|Scanner or Respiract failure|3|||
16240577|NCT02482571|39363623|FG000|Overall Study|Withdrawal by Subject|4|||
16240578|NCT01328054|39363624|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
16240579|NCT01328054|39363625|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
16240580|NCT01328054|39363624|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
16240581|NCT01328054|39363625|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
16240582|NCT01328054|39363624|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
16240583|NCT01328054|39363625|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
16240584|NCT01493531|39363626|FG000|Overall Study|Adverse Event|4|||
16240585|NCT01493531|39363627|FG001|Overall Study|Adverse Event|12|||
16240586|NCT01493531|39363628|FG002|Overall Study|Adverse Event|9|||
16240587|NCT01493531|39363626|FG000|Overall Study|Gout flare|3|||
16240588|NCT01493531|39363627|FG001|Overall Study|Gout flare|0|||
16240589|NCT01493531|39363628|FG002|Overall Study|Gout flare|2|||
16240590|NCT01493531|39363626|FG000|Overall Study|Protocol Violation|8|||
16240591|NCT01493531|39363627|FG001|Overall Study|Protocol Violation|15|||
16240592|NCT01493531|39363628|FG002|Overall Study|Protocol Violation|12|||
16240593|NCT01493531|39363626|FG000|Overall Study|Sponsor terminated study|5|||
16240594|NCT01493531|39363627|FG001|Overall Study|Sponsor terminated study|2|||
16240595|NCT01493531|39363628|FG002|Overall Study|Sponsor terminated study|3|||
16240596|NCT01493531|39363626|FG000|Overall Study|Lost to Follow-up|5|||
16240597|NCT01493531|39363627|FG001|Overall Study|Lost to Follow-up|7|||
16240598|NCT01493531|39363628|FG002|Overall Study|Lost to Follow-up|11|||
16240599|NCT01493531|39363626|FG000|Overall Study|Withdrawal by Subject|16|||
16240600|NCT01493531|39363627|FG001|Overall Study|Withdrawal by Subject|13|||
16240601|NCT01493531|39363628|FG002|Overall Study|Withdrawal by Subject|11|||
16240602|NCT01493531|39363626|FG000|Overall Study|Death|0|||
16240603|NCT01493531|39363627|FG001|Overall Study|Death|1|||
16240604|NCT01493531|39363628|FG002|Overall Study|Death|0|||
16240605|NCT03091400|39363629|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
16240606|NCT03091400|39363630|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
16557210|NCT00873093|40506457|FG002|Overall Study|Ineligible|0|||
16557211|NCT00873093|40506458|FG003|Overall Study|Ineligible|1|||
16557212|NCT00873093|40506459|FG004|Overall Study|Ineligible|0|||
16240607|NCT02746705|39363631|FG000|Overall Study|Physician Decision|1|||
16557213|NCT03486899|40506475|FG000|Overall Study|Lost to Follow-up|4|||
16557214|NCT03486899|40506476|FG001|Overall Study|Lost to Follow-up|1|||
16557215|NCT03486899|40506477|FG002|Overall Study|Lost to Follow-up|4|||
16557216|NCT03486899|40506478|FG003|Overall Study|Lost to Follow-up|3|||
16557217|NCT03486899|40506475|FG000|Overall Study|Death|1|||
16240608|NCT02746705|39363632|FG001|Overall Study|Physician Decision|1|||
16240609|NCT02746705|39363631|FG000|Overall Study|Lost to Follow-up|1|||
16240610|NCT02746705|39363632|FG001|Overall Study|Lost to Follow-up|0|||
16240611|NCT02746705|39363631|FG000|Overall Study|outlier scores deemed not valid|0|||
16240612|NCT02746705|39363632|FG001|Overall Study|outlier scores deemed not valid|1|||
16240613|NCT00678379|39363635|FG000|Overall Study|Injection performed after tonsillectomy|2|||
16240614|NCT00678379|39363636|FG001|Overall Study|Injection performed after tonsillectomy|0|||
16240615|NCT00678379|39363637|FG002|Overall Study|Injection performed after tonsillectomy|1|||
16240616|NCT00678379|39363635|FG000|Overall Study|Incomplete Data|4|||
16240617|NCT00678379|39363636|FG001|Overall Study|Incomplete Data|3|||
16240618|NCT00678379|39363637|FG002|Overall Study|Incomplete Data|3|||
16240619|NCT00995488|39363651|FG000|Overall Study|Withdrawal by Subject|1|||
16240620|NCT00363129|39363652|FG000|Overall Study|Withdrawal by Subject|11|||
16240621|NCT00363129|39363653|FG001|Overall Study|Withdrawal by Subject|18|||
16240622|NCT00363129|39363652|FG000|Overall Study|Adverse Event|8|||
16240623|NCT00363129|39363653|FG001|Overall Study|Adverse Event|3|||
16240624|NCT00363129|39363652|FG000|Overall Study|Alternate Treatment|2|||
16240625|NCT00363129|39363653|FG001|Overall Study|Alternate Treatment|4|||
16240626|NCT00363129|39363652|FG000|Overall Study|Other Medical Problems|2|||
16240627|NCT00363129|39363653|FG001|Overall Study|Other Medical Problems|4|||
16240628|NCT00363129|39363652|FG000|Overall Study|Death|0|||
16240629|NCT00363129|39363653|FG001|Overall Study|Death|1|||
16240630|NCT00363129|39363652|FG000|Overall Study|Other Reasons|6|||
16240631|NCT00363129|39363653|FG001|Overall Study|Other Reasons|3|||
16240632|NCT02428231|39363654|FG000|Overall Study|Other|10|||
16240633|NCT02428231|39363655|FG001|Overall Study|Other|16|||
16240634|NCT02428231|39363654|FG000|Overall Study|Required Symptomatic Therapy|0|||
16240635|NCT02428231|39363655|FG001|Overall Study|Required Symptomatic Therapy|1|||
16240636|NCT02428231|39363654|FG000|Overall Study|Adverse Event|3|||
16240637|NCT02428231|39363655|FG001|Overall Study|Adverse Event|0|||
16240638|NCT00457665|39363656|FG000|12 Months|Drug allergy|1|||
16240639|NCT00457665|39363657|FG001|12 Months|Drug allergy|1|||
16240640|NCT00457665|39363656|FG000|12 Months|High HIV viral load|5|||
16240641|NCT00457665|39363657|FG001|12 Months|High HIV viral load|1|||
16240642|NCT00457665|39363656|FG000|12 Months|Lipodystrophy|2|||
16240643|NCT00457665|39363657|FG001|12 Months|Lipodystrophy|0|||
16240644|NCT00457665|39363656|FG000|12 Months|Withdrawal by Subject|0|||
16240645|NCT00457665|39363657|FG001|12 Months|Withdrawal by Subject|2|||
16240646|NCT00457665|39363656|FG000|12 Months|Abnormal Liver function tests|0|||
16240647|NCT00457665|39363657|FG001|12 Months|Abnormal Liver function tests|5|||
16240648|NCT00457665|39363656|FG000|24 Months|Withdrawal by Subject|3|||
16240649|NCT00457665|39363657|FG001|24 Months|Withdrawal by Subject|2|||
16240650|NCT00457665|39363656|FG000|24 Months|Lipodystrophy|1|||
16240651|NCT00457665|39363657|FG001|24 Months|Lipodystrophy|1|||
16240652|NCT00457665|39363656|FG000|24 Months|Abnormal liver function tests|1|||
16240653|NCT00457665|39363657|FG001|24 Months|Abnormal liver function tests|5|||
16240654|NCT05003167|39363658|FG000|Overall Study|Withdrawal by Subject|1|||
16240655|NCT00479401|39363661|FG000|Overall Study|Adverse Event|24|||
16240656|NCT00479401|39363662|FG001|Overall Study|Adverse Event|20|||
16240657|NCT00479401|39363663|FG002|Overall Study|Adverse Event|4|||
16240658|NCT00479401|39363661|FG000|Overall Study|Lack of Efficacy|2|||
16240659|NCT00479401|39363662|FG001|Overall Study|Lack of Efficacy|2|||
16240660|NCT00479401|39363663|FG002|Overall Study|Lack of Efficacy|4|||
16240661|NCT00479401|39363661|FG000|Overall Study|Protocol Violation|2|||
16240662|NCT00479401|39363662|FG001|Overall Study|Protocol Violation|1|||
16350171|NCT01747499|39768966|FG003|Overall Study|Withdrawal by Subject|0|||
16350172|NCT01747499|39768967|FG004|Overall Study|Withdrawal by Subject|6|||
16350173|NCT01747499|39768963|FG000|Overall Study|Developed AML and death|0|||
16350174|NCT01747499|39768964|FG001|Overall Study|Developed AML and death|0|||
16350175|NCT01747499|39768965|FG002|Overall Study|Developed AML and death|0|||
16350176|NCT01747499|39768966|FG003|Overall Study|Developed AML and death|0|||
16350177|NCT01747499|39768967|FG004|Overall Study|Developed AML and death|1|||
16350178|NCT01747499|39768963|FG000|Overall Study|Determined not to be eligible|0|||
16350179|NCT01747499|39768964|FG001|Overall Study|Determined not to be eligible|0|||
16350180|NCT01747499|39768965|FG002|Overall Study|Determined not to be eligible|0|||
16557218|NCT03486899|40506476|FG001|Overall Study|Death|0|||
16240663|NCT00479401|39363663|FG002|Overall Study|Protocol Violation|1|||
16557219|NCT03486899|40506477|FG002|Overall Study|Death|0|||
16240664|NCT00479401|39363661|FG000|Overall Study|Lost to Follow-up|1|||
16240665|NCT00479401|39363662|FG001|Overall Study|Lost to Follow-up|1|||
16240666|NCT00479401|39363663|FG002|Overall Study|Lost to Follow-up|1|||
16240667|NCT00479401|39363661|FG000|Overall Study|Withdrawal by Subject|16|||
16240668|NCT00479401|39363662|FG001|Overall Study|Withdrawal by Subject|10|||
16240669|NCT00479401|39363663|FG002|Overall Study|Withdrawal by Subject|2|||
16350181|NCT01747499|39768966|FG003|Overall Study|Determined not to be eligible|0|||
16350182|NCT01747499|39768967|FG004|Overall Study|Determined not to be eligible|1|||
16240670|NCT00479401|39363661|FG000|Overall Study|Exclusion criteria, relocation|4|||
16240671|NCT00479401|39363662|FG001|Overall Study|Exclusion criteria, relocation|3|||
16240672|NCT00479401|39363663|FG002|Overall Study|Exclusion criteria, relocation|0|||
16240673|NCT00566631|39363666|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
16240674|NCT00566631|39363666|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
16240675|NCT00566631|39363666|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
16240676|NCT00566631|39363666|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
16240677|NCT00566631|39363666|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
16240678|NCT00566631|39363666|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
16240679|NCT00566631|39363666|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
16240680|NCT00566631|39363666|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
16240681|NCT00566631|39363666|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
16240682|NCT00566631|39363666|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
16240683|NCT00566631|39363666|FG000|Part 2: Extension Phase|Adverse Event|11|||
16240684|NCT00566631|39363666|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
16240685|NCT00566631|39363666|FG000|Part 2: Extension Phase|Death|1|||
16240686|NCT00566631|39363666|FG000|Part 2: Extension Phase|Other|5|||
16240687|NCT01355523|39363667|FG000|Overall Study|Withdrawal by Subject|1|||
16240688|NCT01355523|39363668|FG001|Overall Study|Withdrawal by Subject|4|||
16240689|NCT01355523|39363667|FG000|Overall Study|Lost to Follow-up|0|||
16240690|NCT01355523|39363668|FG001|Overall Study|Lost to Follow-up|2|||
16240691|NCT01355523|39363667|FG000|Overall Study|Protocol Violation|0|||
16240692|NCT01355523|39363668|FG001|Overall Study|Protocol Violation|2|||
16240693|NCT01355523|39363667|FG000|Overall Study|Adverse Event|0|||
16240694|NCT01355523|39363668|FG001|Overall Study|Adverse Event|2|||
16240695|NCT01864525|39363671|FG000|Overall Study|Adverse Event|1|||
16240696|NCT01864525|39363672|FG001|Overall Study|Adverse Event|0|||
16240697|NCT01529749|39363675|FG000|Overall Study|Lost to Follow-up|0|||
16240698|NCT01529749|39363676|FG001|Overall Study|Lost to Follow-up|1|||
16240699|NCT01529749|39363677|FG002|Overall Study|Lost to Follow-up|1|||
16240700|NCT01529749|39363678|FG003|Overall Study|Lost to Follow-up|0|||
16240701|NCT01529749|39363675|FG000|Overall Study|Physician Decision|0|||
16240702|NCT01529749|39363676|FG001|Overall Study|Physician Decision|0|||
16240703|NCT01529749|39363677|FG002|Overall Study|Physician Decision|0|||
16240704|NCT01529749|39363678|FG003|Overall Study|Physician Decision|1|||
16240705|NCT01529749|39363675|FG000|Overall Study|Withdrawal by Subject|0|||
16240706|NCT01529749|39363676|FG001|Overall Study|Withdrawal by Subject|1|||
16240707|NCT01529749|39363677|FG002|Overall Study|Withdrawal by Subject|1|||
16240708|NCT01529749|39363678|FG003|Overall Study|Withdrawal by Subject|0|||
16240709|NCT01529749|39363675|FG000|Overall Study|Protocol Violation|0|||
16240710|NCT01529749|39363676|FG001|Overall Study|Protocol Violation|0|||
16240711|NCT01529749|39363677|FG002|Overall Study|Protocol Violation|0|||
16240712|NCT01529749|39363678|FG003|Overall Study|Protocol Violation|1|||
16240713|NCT00743119|39363679|FG000|Overall Study|unreliable|3|||
16240714|NCT00743119|39363679|FG000|Overall Study|Withdrawal by Subject|1|||
16240715|NCT01222715|39363680|FG000|Overall Study|Adverse Event|0|||
16240716|NCT01222715|39363681|FG001|Overall Study|Adverse Event|4|||
16240717|NCT01222715|39363680|FG000|Overall Study|Death|0|||
16240718|NCT01222715|39363681|FG001|Overall Study|Death|1|||
16240719|NCT01222715|39363680|FG000|Overall Study|Lack of Efficacy|22|||
16240720|NCT01222715|39363681|FG001|Overall Study|Lack of Efficacy|14|||
16240721|NCT01222715|39363680|FG000|Overall Study|Physician Decision|12|||
16240722|NCT01222715|39363681|FG001|Overall Study|Physician Decision|2|||
16240723|NCT01222715|39363680|FG000|Overall Study|Refusal of further protocol therapy|0|||
16240724|NCT01222715|39363681|FG001|Overall Study|Refusal of further protocol therapy|4|||
16240725|NCT01222715|39363680|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
16240726|NCT01222715|39363681|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
16240727|NCT01222715|39363680|FG000|Overall Study|Ineligible|0|||
16240728|NCT01222715|39363681|FG001|Overall Study|Ineligible|1|||
16240729|NCT01222715|39363680|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
16240730|NCT01222715|39363681|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
16240731|NCT00667719|39363682|FG000|Overall Study|Adverse Event|39|||
16557220|NCT03486899|40506478|FG003|Overall Study|Death|1|||
16240732|NCT00667719|39363682|FG000|Overall Study|Abnormal Test Procedure|1|||
16240733|NCT00667719|39363682|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16240734|NCT00667719|39363682|FG000|Overall Study|Protocol Violation|3|||
16240735|NCT00667719|39363682|FG000|Overall Study|Withdrawal by Subject|17|||
16240736|NCT00667719|39363682|FG000|Overall Study|Lost to Follow-up|8|||
16240737|NCT00591253|39363683|FG000|Overall Study|Adverse Event|3|||
16240738|NCT00591253|39363684|FG001|Overall Study|Adverse Event|3|||
16240739|NCT00591253|39363685|FG002|Overall Study|Adverse Event|1|||
16240740|NCT00591253|39363683|FG000|Overall Study|Protocol Violation|2|||
16240741|NCT00591253|39363684|FG001|Overall Study|Protocol Violation|2|||
16240742|NCT00591253|39363685|FG002|Overall Study|Protocol Violation|2|||
16240743|NCT00591253|39363683|FG000|Overall Study|Lost to Follow-up|2|||
16240744|NCT00591253|39363684|FG001|Overall Study|Lost to Follow-up|4|||
16240745|NCT00591253|39363685|FG002|Overall Study|Lost to Follow-up|0|||
16240746|NCT00591253|39363683|FG000|Overall Study|Withdrawal by Subject|1|||
16240747|NCT00591253|39363684|FG001|Overall Study|Withdrawal by Subject|7|||
16240748|NCT00591253|39363685|FG002|Overall Study|Withdrawal by Subject|6|||
16240749|NCT00591253|39363683|FG000|Overall Study|Lack of Efficacy|1|||
16240750|NCT00591253|39363684|FG001|Overall Study|Lack of Efficacy|0|||
16240751|NCT00591253|39363685|FG002|Overall Study|Lack of Efficacy|3|||
16240752|NCT00591253|39363683|FG000|Overall Study|Other|5|||
16240753|NCT00591253|39363684|FG001|Overall Study|Other|5|||
16240754|NCT00591253|39363685|FG002|Overall Study|Other|3|||
16240755|NCT03891875|39363686|FG000|Overall Study|Withdrawal by Subject|20|||
16414329|NCT01498185|39998404|FG000|Overall Study|Withdrawal by Subject|1|||
16414330|NCT01498185|39998405|FG001|Overall Study|Withdrawal by Subject|1|||
16414331|NCT01498185|39998406|FG002|Overall Study|Withdrawal by Subject|0|||
16414332|NCT01498185|39998407|FG003|Overall Study|Withdrawal by Subject|2|||
16414333|NCT01498185|39998408|FG004|Overall Study|Withdrawal by Subject|1|||
16414334|NCT01498185|39998404|FG000|Overall Study|No longer met criteria, etc|0|||
16414335|NCT01498185|39998405|FG001|Overall Study|No longer met criteria, etc|0|||
16414336|NCT01498185|39998406|FG002|Overall Study|No longer met criteria, etc|0|||
16414337|NCT01498185|39998407|FG003|Overall Study|No longer met criteria, etc|0|||
16414338|NCT01498185|39998408|FG004|Overall Study|No longer met criteria, etc|2|||
16414339|NCT00495755|39998409|FG000|Overall Study|Adverse Event|3|||
16414340|NCT00121641|39998410|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
16414341|NCT00121641|39998411|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
16414342|NCT00121641|39998412|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
16414343|NCT00121641|39998413|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
16414344|NCT00121641|39998414|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
16414345|NCT00121641|39998410|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
16414346|NCT00121641|39998411|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
16414347|NCT00121641|39998412|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
16414348|NCT00121641|39998413|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
16414349|NCT00121641|39998414|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
16414350|NCT00121641|39998410|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
16414351|NCT00121641|39998411|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
16414352|NCT00121641|39998412|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
16414353|NCT00121641|39998413|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
16414354|NCT00121641|39998414|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
16414355|NCT00121641|39998410|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
16414356|NCT00121641|39998411|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
16414357|NCT00121641|39998412|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
16414358|NCT00121641|39998413|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
16414359|NCT00121641|39998414|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
16414360|NCT00121641|39998410|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
16414361|NCT00121641|39998411|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
16240756|NCT03891875|39363687|FG001|Overall Study|Withdrawal by Subject|3|||
16240757|NCT03891875|39363686|FG000|Overall Study|Adverse Event|10|||
16240758|NCT03891875|39363687|FG001|Overall Study|Adverse Event|4|||
16240759|NCT03891875|39363686|FG000|Overall Study|Physician Decision|1|||
16240760|NCT03891875|39363687|FG001|Overall Study|Physician Decision|1|||
16240761|NCT03891875|39363686|FG000|Overall Study|Protocol Violation|1|||
16240762|NCT03891875|39363687|FG001|Overall Study|Protocol Violation|0|||
16240763|NCT03891875|39363686|FG000|Overall Study|Lost to Follow-up|1|||
16240764|NCT03891875|39363687|FG001|Overall Study|Lost to Follow-up|0|||
16414362|NCT00121641|39998412|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
16557221|NCT03486899|40506475|FG000|Overall Study|Adverse Event|0|||
16414363|NCT00121641|39998413|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
16414364|NCT00121641|39998414|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
16414365|NCT00121641|39998410|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
16414366|NCT00121641|39998411|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
16414367|NCT00121641|39998412|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
16414368|NCT00121641|39998413|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
16414369|NCT00121641|39998414|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
16414370|NCT00121641|39998410|FG000|24-week Short-term Treatment Period|Other Reason|1|||
16124152|NCT00953745|38942098|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
16124153|NCT00953745|38942099|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
16124154|NCT00953745|38942098|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
16557222|NCT03486899|40506476|FG001|Overall Study|Adverse Event|2|||
16557223|NCT03486899|40506477|FG002|Overall Study|Adverse Event|0|||
16557224|NCT03486899|40506478|FG003|Overall Study|Adverse Event|2|||
16240765|NCT03891875|39363686|FG000|Overall Study|COVID-19 infection|1|||
16240766|NCT03891875|39363687|FG001|Overall Study|COVID-19 infection|0|||
16240767|NCT01092702|39363690|FG000|Overall Study|Withdrawal by Subject|7|||
16240768|NCT01092702|39363690|FG000|Overall Study|Lost to Follow-up|2|||
16240769|NCT01011907|39363691|FG000|Overall Study|Withdrawal by Subject|13|||
16240770|NCT01011907|39363692|FG001|Overall Study|Withdrawal by Subject|11|||
16240771|NCT01011907|39363691|FG000|Overall Study|Adverse Event|1|||
16240772|NCT01011907|39363692|FG001|Overall Study|Adverse Event|4|||
16240773|NCT03548207|39363698|FG000|Overall Study|Death|10|||
16240774|NCT03548207|39363699|FG001|Overall Study|Death|23|||
16240775|NCT03548207|39363700|FG002|Overall Study|Death|3|||
16240776|NCT03548207|39363698|FG000|Overall Study|Lost to Follow-up|0|||
16240777|NCT03548207|39363699|FG001|Overall Study|Lost to Follow-up|2|||
16240778|NCT03548207|39363700|FG002|Overall Study|Lost to Follow-up|0|||
16240779|NCT03548207|39363698|FG000|Overall Study|Withdrawal by Subject|0|||
16240780|NCT03548207|39363699|FG001|Overall Study|Withdrawal by Subject|3|||
16240781|NCT03548207|39363700|FG002|Overall Study|Withdrawal by Subject|0|||
16240782|NCT03548207|39363698|FG000|Overall Study|Sponsor decision|19|||
16240783|NCT03548207|39363699|FG001|Overall Study|Sponsor decision|40|||
16240784|NCT03548207|39363700|FG002|Overall Study|Sponsor decision|6|||
16240785|NCT03548207|39363698|FG000|Overall Study|Randomized but not treated|6|||
16240786|NCT03548207|39363699|FG001|Overall Study|Randomized but not treated|10|||
16240787|NCT03548207|39363700|FG002|Overall Study|Randomized but not treated|4|||
16240788|NCT00681824|39363702|FG000|Overall Study|withdrawn by investigator|0|||
16240789|NCT00681824|39363703|FG001|Overall Study|withdrawn by investigator|0|||
16240790|NCT00681824|39363704|FG002|Overall Study|withdrawn by investigator|1|||
16240791|NCT00681824|39363702|FG000|Overall Study|scheduling conflict|1|||
16240792|NCT00681824|39363703|FG001|Overall Study|scheduling conflict|0|||
16240793|NCT00681824|39363704|FG002|Overall Study|scheduling conflict|0|||
16557225|NCT03486899|40506475|FG000|Overall Study|Withdrawal by Subject|3|||
16124155|NCT00953745|38942099|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
16240794|NCT00681824|39363702|FG000|Overall Study|Death|0|||
16240795|NCT00681824|39363703|FG001|Overall Study|Death|1|||
16240796|NCT00681824|39363704|FG002|Overall Study|Death|0|||
16240797|NCT03724968|39363705|FG000|Overall Study|Insurance issues|0|||
16240798|NCT03724968|39363706|FG001|Overall Study|Insurance issues|1|||
16240799|NCT03724968|39363705|FG000|Overall Study|Study closed|0|||
16240800|NCT03724968|39363706|FG001|Overall Study|Study closed|1|||
16557226|NCT03486899|40506476|FG001|Overall Study|Withdrawal by Subject|7|||
16557227|NCT03486899|40506477|FG002|Overall Study|Withdrawal by Subject|4|||
16557228|NCT03486899|40506478|FG003|Overall Study|Withdrawal by Subject|3|||
16557229|NCT03486899|40506475|FG000|Overall Study|Other Reasons|0|||
16557230|NCT03486899|40506476|FG001|Overall Study|Other Reasons|1|||
16557231|NCT03486899|40506477|FG002|Overall Study|Other Reasons|0|||
16557232|NCT03486899|40506478|FG003|Overall Study|Other Reasons|1|||
16557233|NCT01567163|40506481|FG000|Overall Study|Progressive Disease|2|||
16557234|NCT01567163|40506481|FG000|Overall Study|Lost to Follow-up|2|||
16557235|NCT01755689|40506482|FG000|Overall Study|Withdrawal by Subject|1|||
16557236|NCT01755689|40506483|FG001|Overall Study|Withdrawal by Subject|3|||
16557237|NCT01755689|40506484|FG002|Overall Study|Withdrawal by Subject|2|||
16557238|NCT01755689|40506485|FG003|Overall Study|Withdrawal by Subject|1|||
16557239|NCT01755689|40506486|FG004|Overall Study|Withdrawal by Subject|1|||
16557240|NCT01755689|40506482|FG000|Overall Study|Migrated/moved from study area|0|||
16557241|NCT01755689|40506483|FG001|Overall Study|Migrated/moved from study area|1|||
16557242|NCT01755689|40506484|FG002|Overall Study|Migrated/moved from study area|1|||
16557243|NCT01755689|40506485|FG003|Overall Study|Migrated/moved from study area|1|||
16557244|NCT01755689|40506486|FG004|Overall Study|Migrated/moved from study area|1|||
16557245|NCT01755689|40506482|FG000|Overall Study|Lost to Follow-up|1|||
16240801|NCT01401478|39363707|FG000|Overall Study|Study drug not available|6|||
16240802|NCT01401478|39363707|FG000|Overall Study|Adverse Event|5|||
16240803|NCT01401478|39363707|FG000|Overall Study|Hyperphosphatemia|5|||
16414371|NCT00121641|39998411|FG001|24-week Short-term Treatment Period|Other Reason|0|||
16414372|NCT00121641|39998412|FG002|24-week Short-term Treatment Period|Other Reason|0|||
16414373|NCT00121641|39998413|FG003|24-week Short-term Treatment Period|Other Reason|0|||
16414374|NCT00121641|39998414|FG004|24-week Short-term Treatment Period|Other Reason|0|||
16414375|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
16414376|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
16414377|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
16414378|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
16124156|NCT00953745|38942098|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
16124157|NCT00953745|38942099|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
16124158|NCT00953745|38942098|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
16124159|NCT00953745|38942099|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
16557246|NCT01755689|40506483|FG001|Overall Study|Lost to Follow-up|0|||
16124160|NCT00953745|38942098|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
16124161|NCT00953745|38942099|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
16124162|NCT01669577|38942101|FG000|Overall Study|Death|22|||
16124163|NCT01669577|38942101|FG000|Overall Study|Lost to Follow-up|78|||
16124164|NCT01669577|38942101|FG000|Overall Study|Physician Decision|34|||
16124165|NCT03218397|38942102|FG000|Overall Study|Prior positive blood culture|8|||
16124166|NCT03218397|38942103|FG001|Overall Study|Prior positive blood culture|13|||
16124167|NCT03218397|38942102|FG000|Overall Study|Comfort care|8|||
16124168|NCT03218397|38942103|FG001|Overall Study|Comfort care|5|||
16124169|NCT03218397|38942102|FG000|Overall Study|Comfort care and positive blood culture|1|||
16124170|NCT03218397|38942103|FG001|Overall Study|Comfort care and positive blood culture|0|||
16124171|NCT03218397|38942102|FG000|Overall Study|Comfort care and mixed culture|0|||
16124172|NCT03218397|38942103|FG001|Overall Study|Comfort care and mixed culture|1|||
16240804|NCT01401478|39363707|FG000|Overall Study|Lost to Follow-up|5|||
16240805|NCT01401478|39363707|FG000|Overall Study|Kidney transplantation|3|||
16240806|NCT01401478|39363707|FG000|Overall Study|Withdrawal by Subject|3|||
16240807|NCT01401478|39363707|FG000|Overall Study|Blood samples not available|1|||
16240808|NCT01401478|39363707|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
16240809|NCT01401478|39363707|FG000|Overall Study|Low intact parathyroid hormone|1|||
16240810|NCT01401478|39363707|FG000|Overall Study|Serious adverse event|1|||
16240811|NCT04330482|39363708|FG000|Overall Study|Lost to Follow-up|2|||
16240812|NCT04330482|39363709|FG001|Overall Study|Lost to Follow-up|1|||
16240813|NCT04330482|39363708|FG000|Overall Study|Withdrawal by Subject|0|||
16240814|NCT04330482|39363709|FG001|Overall Study|Withdrawal by Subject|3|||
16240815|NCT01190098|39363710|FG000|Overall Study|Adverse Event|2|||
16240816|NCT01190098|39363711|FG001|Overall Study|Adverse Event|0|||
16240817|NCT01190098|39363710|FG000|Overall Study|Patient coomorbidity|0|||
16240818|NCT01190098|39363711|FG001|Overall Study|Patient coomorbidity|1|||
16124173|NCT03218397|38942102|FG000|Overall Study|Mixed culture|2|||
16240819|NCT01190098|39363710|FG000|Overall Study|Lack of transportation|1|||
16240820|NCT01190098|39363711|FG001|Overall Study|Lack of transportation|0|||
16240821|NCT01190098|39363710|FG000|Overall Study|Other|0|||
16414379|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
16557247|NCT01755689|40506484|FG002|Overall Study|Lost to Follow-up|1|||
16557248|NCT01755689|40506485|FG003|Overall Study|Lost to Follow-up|0|||
16557249|NCT01755689|40506486|FG004|Overall Study|Lost to Follow-up|2|||
16557250|NCT01755689|40506482|FG000|Overall Study|Pregnancy|1|||
16557251|NCT01755689|40506483|FG001|Overall Study|Pregnancy|1|||
16557252|NCT01755689|40506484|FG002|Overall Study|Pregnancy|2|||
16557253|NCT01755689|40506485|FG003|Overall Study|Pregnancy|4|||
16557254|NCT01755689|40506486|FG004|Overall Study|Pregnancy|2|||
16557255|NCT02838628|40506487|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
16557256|NCT02838628|40506488|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
16557257|NCT02838628|40506487|FG000|Recurrence Follow-up Period|Adverse Event|1|||
16557258|NCT02838628|40506488|FG001|Recurrence Follow-up Period|Adverse Event|0|||
16557259|NCT02838628|40506487|FG000|Recurrence Follow-up Period|Non-compliance|0|||
16557260|NCT02838628|40506488|FG001|Recurrence Follow-up Period|Non-compliance|1|||
16557261|NCT02838628|40506487|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
16557262|NCT02838628|40506488|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
16557263|NCT02838628|40506487|FG000|Recurrence Follow-up Period|Other un-specified|1|||
16557264|NCT02838628|40506488|FG001|Recurrence Follow-up Period|Other un-specified|1|||
16557265|NCT01221181|40506489|FG000|Overall Study|Lost to Follow-up|1|||
16557266|NCT00802841|40506493|FG000|Overall Study|Administrative problems|1|||
16557267|NCT00802841|40506494|FG001|Overall Study|Administrative problems|0|||
16557268|NCT00802841|40506493|FG000|Overall Study|Lost to Follow-up|2|||
16557269|NCT00802841|40506494|FG001|Overall Study|Lost to Follow-up|1|||
16557270|NCT00802841|40506493|FG000|Overall Study|Death|1|||
16557271|NCT00802841|40506494|FG001|Overall Study|Death|2|||
16557272|NCT00802841|40506493|FG000|Overall Study|Adverse Event|8|||
16124174|NCT03218397|38942103|FG001|Overall Study|Mixed culture|2|||
16124175|NCT03218397|38942102|FG000|Overall Study|Inaccessible hospital records|2|||
16124176|NCT03218397|38942103|FG001|Overall Study|Inaccessible hospital records|5|||
16124177|NCT03218397|38942102|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
16124178|NCT03218397|38942103|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
16124179|NCT03218397|38942102|FG000|Overall Study|Randomized during laboratory off hours|2|||
16240822|NCT01190098|39363711|FG001|Overall Study|Other|1|||
16240823|NCT01458119|39363714|FG000|Overall Study|Physician Decision|4|||
16414380|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
16414381|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
16414382|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
16414383|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
16414384|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
16557273|NCT00802841|40506494|FG001|Overall Study|Adverse Event|2|||
16124180|NCT03218397|38942103|FG001|Overall Study|Randomized during laboratory off hours|1|||
16124181|NCT00528931|38942106|FG000|Overall Study|Lost to Follow-up|1|||
16124182|NCT01327495|38942110|FG000|Overall Study|Adverse Event|2|||
16124183|NCT01327495|38942111|FG001|Overall Study|Adverse Event|1|||
16124184|NCT01327495|38942112|FG002|Overall Study|Adverse Event|1|||
16124185|NCT01327495|38942113|FG003|Overall Study|Adverse Event|0|||
16124186|NCT01327495|38942114|FG004|Overall Study|Adverse Event|0|||
16124187|NCT01327495|38942115|FG005|Overall Study|Adverse Event|2|||
16124188|NCT01327495|38942110|FG000|Overall Study|Withdrawal by Subject|0|||
16124189|NCT01327495|38942111|FG001|Overall Study|Withdrawal by Subject|1|||
16124190|NCT01327495|38942112|FG002|Overall Study|Withdrawal by Subject|1|||
16124191|NCT01327495|38942113|FG003|Overall Study|Withdrawal by Subject|0|||
16124192|NCT01327495|38942114|FG004|Overall Study|Withdrawal by Subject|1|||
16124193|NCT01327495|38942115|FG005|Overall Study|Withdrawal by Subject|0|||
16124194|NCT01327495|38942110|FG000|Overall Study|Physician Decision|0|||
16124195|NCT01327495|38942111|FG001|Overall Study|Physician Decision|0|||
16124196|NCT01327495|38942112|FG002|Overall Study|Physician Decision|0|||
16124197|NCT01327495|38942113|FG003|Overall Study|Physician Decision|0|||
16124198|NCT01327495|38942114|FG004|Overall Study|Physician Decision|2|||
16414385|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
16124199|NCT01327495|38942115|FG005|Overall Study|Physician Decision|0|||
16124200|NCT01394978|38942116|FG000|Overall Study|Withdrawal by Subject|2|||
16124201|NCT01394978|38942117|FG001|Overall Study|Withdrawal by Subject|4|||
16124202|NCT01394978|38942116|FG000|Overall Study|Lost to Follow-up|13|||
16124203|NCT01394978|38942117|FG001|Overall Study|Lost to Follow-up|20|||
16124204|NCT01394978|38942116|FG000|Overall Study|Death|6|||
16124205|NCT01394978|38942117|FG001|Overall Study|Death|7|||
16124206|NCT02285153|38942118|FG000|Overall Study|Adverse Event|1|||
16124207|NCT02285153|38942119|FG001|Overall Study|Adverse Event|0|||
16124208|NCT04400487|38942122|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
16124209|NCT04400487|38942122|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
16124210|NCT04400487|38942122|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
16124211|NCT03014479|38942125|FG000|Overall Study|Adverse Event|0|||
16124212|NCT03014479|38942126|FG001|Overall Study|Adverse Event|1|||
16124213|NCT03014479|38942125|FG000|Overall Study|Voluntary Withdrawal|0|||
16124214|NCT03014479|38942126|FG001|Overall Study|Voluntary Withdrawal|2|||
16124215|NCT03014479|38942125|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
16124216|NCT03014479|38942126|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
16124217|NCT02643472|38942127|FG000|Overall Study|Death|2|||
16124218|NCT02643472|38942128|FG001|Overall Study|Death|5|||
16124219|NCT02643472|38942127|FG000|Overall Study|Withdrawal by Subject|3|||
16124220|NCT02643472|38942128|FG001|Overall Study|Withdrawal by Subject|2|||
16240824|NCT01458119|39363714|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
16240825|NCT01458119|39363714|FG000|Overall Study|Pregnancy|1|||
16240826|NCT01458119|39363714|FG000|Overall Study|Death|2|||
16124221|NCT02643472|38942127|FG000|Overall Study|Protocol Violation|0|||
16124222|NCT02643472|38942128|FG001|Overall Study|Protocol Violation|1|||
16124223|NCT02643472|38942127|FG000|Overall Study|Lost to Follow-up|22|||
16124224|NCT02643472|38942128|FG001|Overall Study|Lost to Follow-up|26|||
16240827|NCT01458119|39363714|FG000|Overall Study|Adverse Event|1|||
16124225|NCT01964924|38942129|FG000|Trametinib Monotherapy|Progression|19|||
16124226|NCT01964924|38942130|FG001|Trametinib Monotherapy|Progression|0|||
16124227|NCT00577577|38942131|FG000|Overall Study|Adverse Event|3|||
16124228|NCT00577577|38942132|FG001|Overall Study|Adverse Event|2|||
16124229|NCT00577577|38942131|FG000|Overall Study|Lost to Follow-up|1|||
16124230|NCT00577577|38942132|FG001|Overall Study|Lost to Follow-up|0|||
16124231|NCT00577577|38942131|FG000|Overall Study|Protocol Violation|0|||
16124232|NCT00577577|38942132|FG001|Overall Study|Protocol Violation|3|||
16124233|NCT00577577|38942131|FG000|Overall Study|Transportation|1|||
16124234|NCT00577577|38942132|FG001|Overall Study|Transportation|0|||
16124235|NCT02665338|38942133|FG000|Overall Study|Withdrawal by Subject|0|||
16124236|NCT02665338|38942134|FG001|Overall Study|Withdrawal by Subject|1|||
16124237|NCT01332630|38942141|FG000|Overall Study|Withdrawal by Subject|3|||
16124238|NCT01131182|38942142|FG000|Overall Study|Withdrawal by Subject|1|||
16124239|NCT01131182|38942143|FG001|Overall Study|Withdrawal by Subject|1|||
16124240|NCT01131182|38942142|FG000|Overall Study|Lost to Follow-up|14|||
16124241|NCT01131182|38942143|FG001|Overall Study|Lost to Follow-up|15|||
16124242|NCT01131182|38942142|FG000|Overall Study|Other Reason|1|||
16124243|NCT01131182|38942143|FG001|Overall Study|Other Reason|0|||
16124244|NCT00490724|38942144|FG000|Period I|Physician Decision|0|||
16124245|NCT00490724|38942145|FG001|Period I|Physician Decision|0|||
16124246|NCT00490724|38942146|FG002|Period I|Physician Decision|1|||
16124247|NCT00490724|38942144|FG000|Period II|Treatment Discontinuation|3|||
16124248|NCT00490724|38942145|FG001|Period II|Treatment Discontinuation|1|||
16124249|NCT00490724|38942146|FG002|Period II|Treatment Discontinuation|3|||
16124250|NCT03377699|38942149|FG000|Overall Study|Withdrawal by Subject|2|||
16124251|NCT03377699|38942150|FG001|Overall Study|Withdrawal by Subject|9|||
16124252|NCT03377699|38942149|FG000|Overall Study|Lost to Follow-up|1|||
16124253|NCT03377699|38942150|FG001|Overall Study|Lost to Follow-up|1|||
16124254|NCT03377699|38942149|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
16124255|NCT03377699|38942150|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
16124256|NCT03377699|38942149|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
16124257|NCT03377699|38942150|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
16124258|NCT03377699|38942149|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
16124259|NCT03377699|38942150|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
16124260|NCT03377699|38942149|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
16124261|NCT03377699|38942150|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
16124262|NCT01195948|38942151|FG000|Overall Study|Lost to Follow-up|0|||
16124263|NCT01195948|38942152|FG001|Overall Study|Lost to Follow-up|1|||
16124264|NCT01195948|38942153|FG002|Overall Study|Lost to Follow-up|2|||
16557274|NCT00802841|40506493|FG000|Overall Study|Disease progression|7|||
16557275|NCT00802841|40506494|FG001|Overall Study|Disease progression|3|||
16124265|NCT02217475|38942154|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
16124266|NCT02217475|38942155|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
16124267|NCT02217475|38942156|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
16124268|NCT02217475|38942154|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
16124269|NCT02217475|38942155|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
16124270|NCT02217475|38942156|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
16124271|NCT02217475|38942154|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
16124272|NCT02217475|38942155|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
16124273|NCT02217475|38942156|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
16124274|NCT02217475|38942154|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
16124275|NCT02217475|38942155|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
16124276|NCT02217475|38942156|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
16124277|NCT02217475|38942154|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
16124278|NCT02217475|38942155|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
16124279|NCT02217475|38942156|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
16124280|NCT02217475|38942154|FG000|Discontinued After Period 1|Adverse Event|1|||
16124281|NCT02217475|38942155|FG001|Discontinued After Period 1|Adverse Event|2|||
16240828|NCT01458119|39363714|FG000|Overall Study|Consent Withdrawn by Participant|8|||
16557276|NCT00802841|40506493|FG000|Overall Study|Withdrawal by Subject|9|||
16557277|NCT00802841|40506494|FG001|Overall Study|Withdrawal by Subject|5|||
16124282|NCT02217475|38942156|FG002|Discontinued After Period 1|Adverse Event|0|||
16124283|NCT02217475|38942154|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
16124284|NCT02217475|38942155|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
16124285|NCT02217475|38942156|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
16124286|NCT02217475|38942154|FG000|Discontinued After Period 1|Physician Decision|0|||
16124287|NCT02217475|38942155|FG001|Discontinued After Period 1|Physician Decision|0|||
16240829|NCT01458119|39363714|FG000|Overall Study|Non-compliance With Study Drug|3|||
16557278|NCT00802841|40506493|FG000|Overall Study|Protocol deviation|2|||
16124288|NCT02217475|38942156|FG002|Discontinued After Period 1|Physician Decision|1|||
16124289|NCT02217475|38942154|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
16124290|NCT02217475|38942155|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
16124291|NCT02217475|38942156|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
16124292|NCT02217475|38942154|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
16124293|NCT02217475|38942155|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
16124294|NCT02217475|38942156|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
16124295|NCT02217475|38942154|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
16124296|NCT02217475|38942155|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
16557279|NCT00802841|40506494|FG001|Overall Study|Protocol deviation|6|||
16557280|NCT00802841|40506493|FG000|Overall Study|Treatment duration completed|66|||
16557281|NCT00802841|40506494|FG001|Overall Study|Treatment duration completed|76|||
16557282|NCT04793464|40506495|FG000|Overall Study|Lost to Follow-up|458|||
16557283|NCT04793464|40506496|FG001|Overall Study|Lost to Follow-up|168|||
16557284|NCT04793464|40506497|FG002|Overall Study|Lost to Follow-up|5|||
16557285|NCT04793464|40506495|FG000|Overall Study|Withdrawal by Subject|43|||
16557286|NCT04793464|40506496|FG001|Overall Study|Withdrawal by Subject|15|||
16557287|NCT04793464|40506497|FG002|Overall Study|Withdrawal by Subject|0|||
16557288|NCT01811563|40506504|FG000|Overall Study|Lost to Follow-up|5|||
16557289|NCT01811563|40506505|FG001|Overall Study|Lost to Follow-up|2|||
16557290|NCT01811563|40506504|FG000|Overall Study|Incorrect Randomization procedure|0|||
16557291|NCT01811563|40506505|FG001|Overall Study|Incorrect Randomization procedure|1|||
16557292|NCT01579578|40506506|FG000|Overall Study|Death|4|||
16557293|NCT01579578|40506507|FG001|Overall Study|Death|1|||
16557294|NCT01579578|40506506|FG000|Overall Study|Lost to Follow-up|1|||
16557295|NCT01579578|40506507|FG001|Overall Study|Lost to Follow-up|1|||
16557296|NCT01579578|40506506|FG000|Overall Study|Withdrawal by Subject|2|||
16557297|NCT01579578|40506507|FG001|Overall Study|Withdrawal by Subject|1|||
16557298|NCT01579578|40506506|FG000|Overall Study|Eligibility criteria|3|||
16557299|NCT01579578|40506507|FG001|Overall Study|Eligibility criteria|9|||
16557300|NCT01579578|40506506|FG000|Overall Study|Ongoing|3|||
16557301|NCT01579578|40506507|FG001|Overall Study|Ongoing|0|||
16557302|NCT00463151|40506508|FG000|Overall Study|Adverse Event|0|||
16557303|NCT00463151|40506509|FG001|Overall Study|Adverse Event|0|||
16557304|NCT00463151|40506510|FG002|Overall Study|Adverse Event|1|||
16557305|NCT00463151|40506511|FG003|Overall Study|Adverse Event|0|||
16557306|NCT00463151|40506508|FG000|Overall Study|Lack of Efficacy|2|||
16557307|NCT00463151|40506509|FG001|Overall Study|Lack of Efficacy|5|||
16557308|NCT00463151|40506510|FG002|Overall Study|Lack of Efficacy|2|||
16557309|NCT00463151|40506511|FG003|Overall Study|Lack of Efficacy|5|||
16557310|NCT00463151|40506508|FG000|Overall Study|Protocol Violation|0|||
16557311|NCT00463151|40506509|FG001|Overall Study|Protocol Violation|0|||
16557312|NCT00463151|40506510|FG002|Overall Study|Protocol Violation|0|||
16557313|NCT00463151|40506511|FG003|Overall Study|Protocol Violation|1|||
16557314|NCT00463151|40506508|FG000|Overall Study|Withdrawal by Subject|0|||
16557315|NCT00463151|40506509|FG001|Overall Study|Withdrawal by Subject|0|||
16557316|NCT00463151|40506510|FG002|Overall Study|Withdrawal by Subject|0|||
16557317|NCT00463151|40506511|FG003|Overall Study|Withdrawal by Subject|1|||
16557318|NCT01857323|40506512|FG000|Overall Study|Adverse Event|1|||
16557319|NCT01857323|40506512|FG000|Overall Study|Withdrawal by Subject|3|||
16557320|NCT01857323|40506512|FG000|Overall Study|Non-compliance|1|||
16557321|NCT01857323|40506512|FG000|Overall Study|Protocol Violation|6|||
16557322|NCT01857323|40506512|FG000|Overall Study|Lost to Follow-up|1|||
16557323|NCT01857323|40506512|FG000|Overall Study|Other|4|||
16557324|NCT01857323|40506512|FG000|Overall Study|Did not complete 180 doses|48|||
16557325|NCT04157686|40506513|FG000|Overall Study|Adverse Event|1|||
16557326|NCT04157686|40506514|FG001|Overall Study|Adverse Event|0|||
16557327|NCT04157686|40506515|FG002|Overall Study|Adverse Event|1|||
16557328|NCT04157686|40506516|FG003|Overall Study|Adverse Event|0|||
16557329|NCT04157686|40506517|FG004|Overall Study|Adverse Event|1|||
16557330|NCT04157686|40506518|FG005|Overall Study|Adverse Event|0|||
16557331|NCT04157686|40506519|FG006|Overall Study|Adverse Event|0|||
16124297|NCT02217475|38942156|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
16350183|NCT00095979|39768968|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
16350184|NCT03028142|39768969|FG000|Overall Study|Adverse Event|1|||
16557332|NCT04157686|40506520|FG007|Overall Study|Adverse Event|0|||
16557333|NCT04157686|40506513|FG000|Overall Study|Pregnancy|0|||
16557334|NCT04157686|40506514|FG001|Overall Study|Pregnancy|1|||
16557335|NCT04157686|40506515|FG002|Overall Study|Pregnancy|3|||
16557336|NCT04157686|40506516|FG003|Overall Study|Pregnancy|0|||
16557337|NCT04157686|40506517|FG004|Overall Study|Pregnancy|0|||
16557338|NCT04157686|40506518|FG005|Overall Study|Pregnancy|0|||
16557339|NCT04157686|40506519|FG006|Overall Study|Pregnancy|3|||
16557340|NCT04157686|40506520|FG007|Overall Study|Pregnancy|0|||
16557341|NCT04157686|40506513|FG000|Overall Study|Lost to Follow-up|1|||
16557342|NCT04157686|40506514|FG001|Overall Study|Lost to Follow-up|2|||
16557343|NCT04157686|40506515|FG002|Overall Study|Lost to Follow-up|8|||
16557344|NCT04157686|40506516|FG003|Overall Study|Lost to Follow-up|6|||
16557345|NCT04157686|40506517|FG004|Overall Study|Lost to Follow-up|6|||
16350185|NCT03028142|39768970|FG001|Overall Study|Adverse Event|1|||
16350186|NCT03028142|39768971|FG002|Overall Study|Adverse Event|0|||
16124298|NCT02217475|38942154|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
16124299|NCT02217475|38942155|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
16124300|NCT02217475|38942156|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
16124301|NCT02217475|38942154|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
16124302|NCT02217475|38942155|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
16124303|NCT02217475|38942156|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
16124304|NCT01901419|38942157|FG000|Overall Study|Protocol Violation|2|||
16124305|NCT01901419|38942158|FG001|Overall Study|Protocol Violation|6|||
16124306|NCT01901419|38942157|FG000|Overall Study|unavailable researchers|6|||
16124307|NCT01901419|38942158|FG001|Overall Study|unavailable researchers|3|||
16124308|NCT00307684|38942159|FG000|Open Label Phase|Lack of Efficacy|0|||
16124309|NCT00307684|38942160|FG001|Open Label Phase|Lack of Efficacy|0|||
16124310|NCT00307684|38942161|FG002|Open Label Phase|Lack of Efficacy|3|||
16124311|NCT00307684|38942159|FG000|Open Label Phase|Adverse Event|0|||
16124312|NCT00307684|38942160|FG001|Open Label Phase|Adverse Event|0|||
16124313|NCT00307684|38942161|FG002|Open Label Phase|Adverse Event|16|||
16124314|NCT00307684|38942159|FG000|Open Label Phase|Withdrawal by Subject|0|||
16124315|NCT00307684|38942160|FG001|Open Label Phase|Withdrawal by Subject|0|||
16124316|NCT00307684|38942161|FG002|Open Label Phase|Withdrawal by Subject|15|||
16124317|NCT00307684|38942159|FG000|Open Label Phase|Lost to Follow-up|0|||
16124318|NCT00307684|38942160|FG001|Open Label Phase|Lost to Follow-up|0|||
16124319|NCT00307684|38942161|FG002|Open Label Phase|Lost to Follow-up|11|||
16124320|NCT00307684|38942159|FG000|Open Label Phase|non compliance|0|||
16124321|NCT00307684|38942160|FG001|Open Label Phase|non compliance|0|||
16124322|NCT00307684|38942161|FG002|Open Label Phase|non compliance|5|||
16124323|NCT00307684|38942159|FG000|Open Label Phase|other|0|||
16124324|NCT00307684|38942160|FG001|Open Label Phase|other|0|||
16124325|NCT00307684|38942161|FG002|Open Label Phase|other|6|||
16124326|NCT00307684|38942159|FG000|Double Blind Phase|Lack of Efficacy|2|||
16350187|NCT03028142|39768972|FG003|Overall Study|Adverse Event|0|||
16350188|NCT03028142|39768973|FG004|Overall Study|Adverse Event|0|||
16350189|NCT03028142|39768974|FG005|Overall Study|Adverse Event|1|||
16350190|NCT03028142|39768969|FG000|Overall Study|Withdrawal by Subject|0|||
16350191|NCT03028142|39768970|FG001|Overall Study|Withdrawal by Subject|0|||
16350192|NCT03028142|39768971|FG002|Overall Study|Withdrawal by Subject|0|||
16350193|NCT03028142|39768972|FG003|Overall Study|Withdrawal by Subject|0|||
16350194|NCT03028142|39768973|FG004|Overall Study|Withdrawal by Subject|1|||
16350195|NCT03028142|39768974|FG005|Overall Study|Withdrawal by Subject|0|||
16350196|NCT02168491|39768975|FG000|Overall Study|Withdrawal by Subject|1|||
16350197|NCT00837096|39768976|FG000|Overall Study|Physician Decision|1|||
16350198|NCT00837096|39768977|FG001|Overall Study|Physician Decision|1|||
16350199|NCT00837096|39768976|FG000|Overall Study|Not reported|9|||
16350200|NCT00837096|39768977|FG001|Overall Study|Not reported|8|||
16350201|NCT02287038|39768978|FG000|Overall Study|Stopped attending appointments|3|||
16350202|NCT02287038|39768979|FG001|Overall Study|Stopped attending appointments|2|||
16350203|NCT02287038|39768978|FG000|Overall Study|Anxiety after starting medication|0|||
16350204|NCT02287038|39768979|FG001|Overall Study|Anxiety after starting medication|1|||
16350205|NCT02287038|39768978|FG000|Overall Study|Nausea after starting medication|1|||
16350206|NCT02287038|39768979|FG001|Overall Study|Nausea after starting medication|0|||
16350207|NCT02287038|39768978|FG000|Overall Study|Abnormal ECG after starting medication|1|||
16350208|NCT02287038|39768979|FG001|Overall Study|Abnormal ECG after starting medication|0|||
16350209|NCT03797898|39768999|FG000|Overall Study|Lost to Follow-up|60|||
16350210|NCT03797898|39769000|FG001|Overall Study|Lost to Follow-up|69|||
16124327|NCT00307684|38942160|FG001|Double Blind Phase|Lack of Efficacy|5|||
16124328|NCT00307684|38942161|FG002|Double Blind Phase|Lack of Efficacy|0|||
16124329|NCT03284229|38942162|FG000|Overall Study|Lost to Follow-up|3|||
16124330|NCT00770029|38942163|FG000|Overall Study|Lost to Follow-up|2|||
16124331|NCT00770029|38942164|FG001|Overall Study|Lost to Follow-up|0|||
16124332|NCT00770029|38942163|FG000|Overall Study|Withdrawal by Subject|3|||
16124333|NCT00770029|38942164|FG001|Overall Study|Withdrawal by Subject|3|||
16124334|NCT00770029|38942163|FG000|Overall Study|Adverse Event|1|||
16350211|NCT03797898|39768999|FG000|Overall Study|Withdrawal by Subject|9|||
16350212|NCT03797898|39769000|FG001|Overall Study|Withdrawal by Subject|7|||
16350213|NCT03797898|39768999|FG000|Overall Study|Became ineligible|5|||
16350214|NCT03797898|39769000|FG001|Overall Study|Became ineligible|2|||
16350215|NCT00929994|39769001|FG000|Overall Study|Withdrawal by Subject|1|||
16124335|NCT00770029|38942164|FG001|Overall Study|Adverse Event|0|||
16124336|NCT00818779|38942165|FG000|Overall Study|Protocol Violation|1|||
16124337|NCT00818779|38942166|FG001|Overall Study|Protocol Violation|0|||
16124338|NCT00818779|38942165|FG000|Overall Study|Lost to Follow-up|1|||
16124339|NCT00818779|38942166|FG001|Overall Study|Lost to Follow-up|0|||
16124340|NCT00818779|38942165|FG000|Overall Study|Adverse Event|4|||
16124341|NCT00818779|38942166|FG001|Overall Study|Adverse Event|1|||
16124342|NCT03525392|38942173|FG000|Overall Study|Adverse Event|1|||
16124343|NCT03525392|38942174|FG001|Overall Study|Adverse Event|0|||
16414386|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
16124344|NCT03525392|38942175|FG002|Overall Study|Adverse Event|2|||
16124345|NCT03525392|38942176|FG003|Overall Study|Adverse Event|0|||
16124346|NCT03525392|38942177|FG004|Overall Study|Adverse Event|0|||
16124347|NCT03525392|38942173|FG000|Overall Study|Progressive disease|0|||
16414387|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
16124348|NCT03525392|38942174|FG001|Overall Study|Progressive disease|1|||
16124349|NCT03525392|38942175|FG002|Overall Study|Progressive disease|1|||
16124350|NCT03525392|38942176|FG003|Overall Study|Progressive disease|3|||
16124351|NCT03525392|38942177|FG004|Overall Study|Progressive disease|1|||
16124352|NCT04216589|38942182|FG000|Overall Study|Withdrawal by Subject|2|||
16124353|NCT04216589|38942182|FG000|Overall Study|Protocol Violation|1|||
16124354|NCT04216589|38942182|FG000|Overall Study|Incarceration|1|||
16124355|NCT03167359|38942185|FG000|Overall Study|Physician Decision|1|||
16124356|NCT03167359|38942185|FG000|Overall Study|Lost to Follow-up|1|||
16124357|NCT04725240|38942186|FG000|Overall Study|Adverse Event|2|||
16124358|NCT03500159|38942187|FG000|Overall Study|Study Terminated|2|||
16124359|NCT03500159|38942188|FG001|Overall Study|Study Terminated|1|||
16124360|NCT03181789|38942190|FG000|Overall Study|Withdrawal by Subject|0|||
16124361|NCT03181789|38942191|FG001|Overall Study|Withdrawal by Subject|1|||
16124362|NCT03181789|38942192|FG002|Overall Study|Withdrawal by Subject|1|||
16124363|NCT03181789|38942193|FG003|Overall Study|Withdrawal by Subject|0|||
16124364|NCT03181789|38942190|FG000|Overall Study|Lost to Follow-up|7|||
16124365|NCT03181789|38942191|FG001|Overall Study|Lost to Follow-up|1|||
16124366|NCT03181789|38942192|FG002|Overall Study|Lost to Follow-up|0|||
16124367|NCT03181789|38942193|FG003|Overall Study|Lost to Follow-up|0|||
16124368|NCT03181789|38942190|FG000|Overall Study|Participant unable to adhere to visit|0|||
16124369|NCT03181789|38942191|FG001|Overall Study|Participant unable to adhere to visit|1|||
16124370|NCT03181789|38942192|FG002|Overall Study|Participant unable to adhere to visit|0|||
16124371|NCT03181789|38942193|FG003|Overall Study|Participant unable to adhere to visit|0|||
16124372|NCT00620282|38942196|FG000|Overall Study|Adverse Event|0|||
16124373|NCT00620282|38942197|FG001|Overall Study|Adverse Event|1|||
16124374|NCT00620282|38942198|FG002|Overall Study|Adverse Event|0|||
16124375|NCT00620282|38942196|FG000|Overall Study|Arterial line unable to be placed|0|||
16124376|NCT00620282|38942197|FG001|Overall Study|Arterial line unable to be placed|0|||
16124377|NCT00620282|38942198|FG002|Overall Study|Arterial line unable to be placed|1|||
16124378|NCT00620282|38942196|FG000|Overall Study|Withdrawal by Subject|0|||
16124379|NCT00620282|38942197|FG001|Overall Study|Withdrawal by Subject|1|||
16124380|NCT00620282|38942198|FG002|Overall Study|Withdrawal by Subject|0|||
16124381|NCT02314780|38942201|FG000|Overall Study|organizational reasons|0|||
16124382|NCT02314780|38942202|FG001|Overall Study|organizational reasons|2|||
16124383|NCT02314780|38942203|FG002|Overall Study|organizational reasons|0|||
16124384|NCT02314780|38942201|FG000|Overall Study|Adverse Event|0|||
16124385|NCT02314780|38942202|FG001|Overall Study|Adverse Event|1|||
16124386|NCT02314780|38942203|FG002|Overall Study|Adverse Event|0|||
16124387|NCT01353859|38942204|FG000|Overall Study|Adverse Event|3|||
16124388|NCT01353859|38942204|FG000|Overall Study|Lack of Efficacy|1|||
16124389|NCT01871805|38942205|FG000|Phase I|Death|7|||
16124390|NCT01871805|38942206|FG001|Phase I|Death|4|||
16124391|NCT01871805|38942207|FG002|Phase I|Death|6|||
16124392|NCT01871805|38942208|FG003|Phase I|Death|2|||
16124393|NCT01871805|38942209|FG004|Phase I|Death|9|||
16124394|NCT01871805|38942210|FG005|Phase I|Death|0|||
16124395|NCT01871805|38942205|FG000|Phase I|Alive in Survival Follow-up|0|||
16124396|NCT01871805|38942206|FG001|Phase I|Alive in Survival Follow-up|2|||
16124397|NCT01871805|38942207|FG002|Phase I|Alive in Survival Follow-up|4|||
16124398|NCT01871805|38942208|FG003|Phase I|Alive in Survival Follow-up|5|||
16124399|NCT01871805|38942209|FG004|Phase I|Alive in Survival Follow-up|4|||
16124400|NCT01871805|38942210|FG005|Phase I|Alive in Survival Follow-up|0|||
16124401|NCT01871805|38942205|FG000|Phase I|Lost to Follow-up|0|||
16124402|NCT01871805|38942206|FG001|Phase I|Lost to Follow-up|1|||
16124403|NCT01871805|38942207|FG002|Phase I|Lost to Follow-up|3|||
16240830|NCT04056299|39363717|FG000|Overall Study|Sponsor discontinued study|3|||
16240831|NCT04056299|39363718|FG001|Overall Study|Sponsor discontinued study|3|||
16240832|NCT03740100|39363719|FG000|Overall Study|Adverse Event|1|||
16240833|NCT03740100|39363719|FG000|Overall Study|Death|1|||
16240834|NCT00350519|39363722|FG000|Overall Study|Death|0|||
16240835|NCT00350519|39363723|FG001|Overall Study|Death|1|||
16240836|NCT00350519|39363722|FG000|Overall Study|Physician Decision|0|||
16240837|NCT00350519|39363723|FG001|Overall Study|Physician Decision|1|||
16240838|NCT00350519|39363722|FG000|Overall Study|Protocol Violation|1|||
16240839|NCT00350519|39363723|FG001|Overall Study|Protocol Violation|2|||
16240840|NCT00350519|39363722|FG000|Overall Study|Withdrawal by Subject|3|||
16240841|NCT00350519|39363723|FG001|Overall Study|Withdrawal by Subject|2|||
16240842|NCT03255031|39363724|FG000|Overall Study|Adverse Event|5|||
16240843|NCT03255031|39363725|FG001|Overall Study|Adverse Event|3|||
16240844|NCT03255031|39363724|FG000|Overall Study|Physician Decision|2|||
16240845|NCT03255031|39363725|FG001|Overall Study|Physician Decision|1|||
16240846|NCT03255031|39363724|FG000|Overall Study|Withdrawal by Subject|9|||
16124404|NCT01871805|38942208|FG003|Phase I|Lost to Follow-up|0|||
16124405|NCT01871805|38942209|FG004|Phase I|Lost to Follow-up|0|||
16124406|NCT01871805|38942210|FG005|Phase I|Lost to Follow-up|0|||
16124407|NCT01871805|38942205|FG000|Phase II|Death|0|||
16124408|NCT01871805|38942206|FG001|Phase II|Death|0|||
16124409|NCT01871805|38942207|FG002|Phase II|Death|0|||
16240847|NCT03255031|39363725|FG001|Overall Study|Withdrawal by Subject|3|||
16240848|NCT02626182|39366152|FG000|Overall Study|Adverse Event|2|||
16240849|NCT02626182|39366153|FG001|Overall Study|Adverse Event|0|||
16240850|NCT03120520|39366154|FG000|Overall Study|Lost to Follow-up|1|||
16240851|NCT03120520|39366155|FG001|Overall Study|Lost to Follow-up|1|||
16240852|NCT03120520|39366156|FG002|Overall Study|Lost to Follow-up|1|||
16240853|NCT03120520|39366157|FG003|Overall Study|Lost to Follow-up|1|||
16240854|NCT03120520|39366154|FG000|Overall Study|Withdrawal by Subject|3|||
16240855|NCT03120520|39366155|FG001|Overall Study|Withdrawal by Subject|2|||
16240856|NCT03120520|39366156|FG002|Overall Study|Withdrawal by Subject|3|||
16240857|NCT03120520|39366157|FG003|Overall Study|Withdrawal by Subject|2|||
16240858|NCT03120520|39366154|FG000|Overall Study|Other|0|||
16240859|NCT03120520|39366155|FG001|Overall Study|Other|1|||
16240860|NCT03120520|39366156|FG002|Overall Study|Other|0|||
16240861|NCT03120520|39366157|FG003|Overall Study|Other|0|||
16240862|NCT00869089|39366160|FG000|Overall Study|Lost to Follow-up|1|||
16240863|NCT00869089|39366160|FG000|Overall Study|Withdrawal by Subject|1|||
16240864|NCT00869089|39366160|FG000|Overall Study|Screen Fail|1|||
16240865|NCT02860039|39366161|FG000|Overall Study|Death|4|||
16240866|NCT02860039|39366162|FG001|Overall Study|Death|0|||
16240867|NCT02860039|39366161|FG000|Overall Study|Lost to Follow-up|2|||
16240868|NCT02860039|39366162|FG001|Overall Study|Lost to Follow-up|2|||
16240869|NCT02860039|39366161|FG000|Overall Study|Protocol Violation|3|||
16240870|NCT02860039|39366162|FG001|Overall Study|Protocol Violation|1|||
16240871|NCT02860039|39366161|FG000|Overall Study|Withdrawal by Subject|1|||
16240872|NCT02860039|39366162|FG001|Overall Study|Withdrawal by Subject|0|||
16240873|NCT02860039|39366161|FG000|Overall Study|Not otherwise eligible|1|||
16240874|NCT02860039|39366162|FG001|Overall Study|Not otherwise eligible|1|||
16240875|NCT03412019|39366167|FG000|Overall Study|Withdrawal by Subject|1|||
16240876|NCT03412019|39366168|FG001|Overall Study|Withdrawal by Subject|1|||
16240877|NCT01946282|39366172|FG000|Year 1|Did not return FIT kit|4186|||
16240878|NCT01946282|39366173|FG001|Year 1|Did not return FIT kit|608|||
16240879|NCT01946282|39366174|FG002|Year 1|Did not return FIT kit|654|||
16240880|NCT01946282|39366172|FG000|Year 2|Did not return FIT kit|803|||
16240881|NCT01946282|39366173|FG001|Year 2|Did not return FIT kit|131|||
16240882|NCT01946282|39366174|FG002|Year 2|Did not return FIT kit|115|||
16240883|NCT01946282|39366172|FG000|Year 3|Did not return FIT kit|288|||
16240884|NCT01946282|39366173|FG001|Year 3|Did not return FIT kit|43|||
16240885|NCT01946282|39366174|FG002|Year 3|Did not return FIT kit|30|||
16240886|NCT00388674|39366178|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
16240887|NCT00388674|39366179|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
16350216|NCT00929994|39769001|FG000|Overall Study|medical issue unrelated to intervention|4|||
16350217|NCT00929994|39769001|FG000|Overall Study|employment|1|||
16350218|NCT01152996|39769002|FG000|Overall Study|Withdrawal by Subject|142|||
16350219|NCT01152996|39769002|FG000|Overall Study|Adverse Event|115|||
16350220|NCT01152996|39769002|FG000|Overall Study|Lost to Follow-up|112|||
16350221|NCT01152996|39769002|FG000|Overall Study|Lack of Efficacy|68|||
16350222|NCT01152996|39769002|FG000|Overall Study|Noncompliance|41|||
16350223|NCT01152996|39769002|FG000|Overall Study|Other|36|||
16350224|NCT01152996|39769002|FG000|Overall Study|Protocol Violation|22|||
16350225|NCT01152996|39769002|FG000|Overall Study|Elevated liver enzymes|1|||
16350226|NCT00735943|39769003|FG000|Overall Study|Lost to Follow-up|1|||
16350227|NCT00735943|39769003|FG000|Overall Study|Adverse Event|1|||
16350228|NCT02573259|39769004|FG000|Overall Study|Death|1|||
16240888|NCT00388674|39366178|FG000|Initial Treatment|Adverse Event|22|||
16240889|NCT00388674|39366179|FG001|Initial Treatment|Adverse Event|87|||
16240890|NCT00388674|39366178|FG000|Initial Treatment|Death|215|||
16240891|NCT00388674|39366179|FG001|Initial Treatment|Death|216|||
16240892|NCT00388674|39366178|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
16240893|NCT00388674|39366179|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
16240894|NCT00388674|39366178|FG000|Initial Treatment|HCC|12|||
16240895|NCT00388674|39366179|FG001|Initial Treatment|HCC|20|||
16350229|NCT02573259|39769005|FG001|Overall Study|Death|6|||
16350230|NCT02573259|39769006|FG002|Overall Study|Death|5|||
16350231|NCT02573259|39769007|FG003|Overall Study|Death|6|||
16124410|NCT01871805|38942208|FG003|Phase II|Death|0|||
16124411|NCT01871805|38942209|FG004|Phase II|Death|0|||
16124412|NCT01871805|38942210|FG005|Phase II|Death|45|||
16124413|NCT01871805|38942205|FG000|Phase II|Alive in Survival Follow-up|0|||
16124414|NCT01871805|38942206|FG001|Phase II|Alive in Survival Follow-up|0|||
16124415|NCT01871805|38942207|FG002|Phase II|Alive in Survival Follow-up|0|||
16124416|NCT01871805|38942208|FG003|Phase II|Alive in Survival Follow-up|0|||
16124417|NCT01871805|38942209|FG004|Phase II|Alive in Survival Follow-up|0|||
16124418|NCT01871805|38942210|FG005|Phase II|Alive in Survival Follow-up|29|||
16124419|NCT01871805|38942205|FG000|Phase II|Lost to Follow-up|0|||
16124420|NCT01871805|38942206|FG001|Phase II|Lost to Follow-up|0|||
16124421|NCT01871805|38942207|FG002|Phase II|Lost to Follow-up|0|||
16124422|NCT01871805|38942208|FG003|Phase II|Lost to Follow-up|0|||
16124423|NCT01871805|38942209|FG004|Phase II|Lost to Follow-up|0|||
16124424|NCT01871805|38942210|FG005|Phase II|Lost to Follow-up|13|||
16124425|NCT00688103|38942215|FG000|Overall Study|Adverse Event|4|||
16124426|NCT00688103|38942216|FG001|Overall Study|Adverse Event|1|||
16124427|NCT00688103|38942215|FG000|Overall Study|Lack of Efficacy|11|||
16124428|NCT00688103|38942216|FG001|Overall Study|Lack of Efficacy|1|||
16124429|NCT00688103|38942215|FG000|Overall Study|Withdrawal by Subject|4|||
16124430|NCT00688103|38942216|FG001|Overall Study|Withdrawal by Subject|2|||
16124431|NCT00688103|38942215|FG000|Overall Study|complex reasons|11|||
16124432|NCT00688103|38942216|FG001|Overall Study|complex reasons|9|||
16124433|NCT05330676|38942217|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
16124434|NCT05330676|38942218|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
16124435|NCT01011153|38942219|FG000|Overall Study|Less than 78 cases completed|8|||
16124436|NCT01011153|38942220|FG001|Overall Study|Less than 78 cases completed|11|||
16124437|NCT01011153|38942221|FG002|Overall Study|Less than 78 cases completed|9|||
16124438|NCT03330405|38942223|FG000|Overall Study|Other|1|||
16124439|NCT03330405|38942224|FG001|Overall Study|Other|3|||
16124440|NCT03330405|38942225|FG002|Overall Study|Other|1|||
16124441|NCT03330405|38942226|FG003|Overall Study|Other|0|||
16124442|NCT03330405|38942227|FG004|Overall Study|Other|2|||
16124443|NCT03330405|38942228|FG005|Overall Study|Other|0|||
16124444|NCT03330405|38942229|FG006|Overall Study|Other|1|||
16124445|NCT03330405|38942230|FG007|Overall Study|Other|0|||
16124446|NCT03330405|38942231|FG008|Overall Study|Other|0|||
16124447|NCT03330405|38942232|FG009|Overall Study|Other|0|||
16124448|NCT03330405|38942233|FG010|Overall Study|Other|0|||
16124449|NCT03330405|38942223|FG000|Overall Study|Progressive disease|8|||
16124450|NCT03330405|38942224|FG001|Overall Study|Progressive disease|27|||
16557346|NCT04157686|40506518|FG005|Overall Study|Lost to Follow-up|3|||
16557347|NCT04157686|40506519|FG006|Overall Study|Lost to Follow-up|7|||
16557348|NCT04157686|40506520|FG007|Overall Study|Lost to Follow-up|9|||
16557349|NCT04157686|40506513|FG000|Overall Study|Lack of Efficacy|0|||
16557350|NCT04157686|40506514|FG001|Overall Study|Lack of Efficacy|0|||
16557351|NCT04157686|40506515|FG002|Overall Study|Lack of Efficacy|0|||
16124451|NCT03330405|38942225|FG002|Overall Study|Progressive disease|4|||
16124452|NCT03330405|38942226|FG003|Overall Study|Progressive disease|18|||
16557352|NCT04157686|40506516|FG003|Overall Study|Lack of Efficacy|0|||
16557353|NCT04157686|40506517|FG004|Overall Study|Lack of Efficacy|0|||
16557354|NCT04157686|40506518|FG005|Overall Study|Lack of Efficacy|2|||
16557355|NCT04157686|40506519|FG006|Overall Study|Lack of Efficacy|0|||
16124453|NCT03330405|38942227|FG004|Overall Study|Progressive disease|16|||
16124454|NCT03330405|38942228|FG005|Overall Study|Progressive disease|14|||
16124455|NCT03330405|38942229|FG006|Overall Study|Progressive disease|7|||
16124456|NCT03330405|38942230|FG007|Overall Study|Progressive disease|29|||
16124457|NCT03330405|38942231|FG008|Overall Study|Progressive disease|9|||
16124458|NCT03330405|38942232|FG009|Overall Study|Progressive disease|11|||
16124459|NCT03330405|38942233|FG010|Overall Study|Progressive disease|5|||
16124460|NCT03330405|38942223|FG000|Overall Study|Withdrawal by Subject|1|||
16124461|NCT03330405|38942224|FG001|Overall Study|Withdrawal by Subject|4|||
16124462|NCT03330405|38942225|FG002|Overall Study|Withdrawal by Subject|0|||
16124463|NCT03330405|38942226|FG003|Overall Study|Withdrawal by Subject|1|||
16124464|NCT03330405|38942227|FG004|Overall Study|Withdrawal by Subject|1|||
16124465|NCT03330405|38942228|FG005|Overall Study|Withdrawal by Subject|1|||
16124466|NCT03330405|38942229|FG006|Overall Study|Withdrawal by Subject|0|||
16124467|NCT03330405|38942230|FG007|Overall Study|Withdrawal by Subject|2|||
16557356|NCT04157686|40506520|FG007|Overall Study|Lack of Efficacy|1|||
16557357|NCT04157686|40506513|FG000|Overall Study|Withdrawal by Subject|10|||
16557358|NCT04157686|40506514|FG001|Overall Study|Withdrawal by Subject|10|||
16124468|NCT03330405|38942231|FG008|Overall Study|Withdrawal by Subject|2|||
16124469|NCT03330405|38942232|FG009|Overall Study|Withdrawal by Subject|1|||
16557359|NCT04157686|40506515|FG002|Overall Study|Withdrawal by Subject|12|||
16557360|NCT04157686|40506516|FG003|Overall Study|Withdrawal by Subject|20|||
16557361|NCT04157686|40506517|FG004|Overall Study|Withdrawal by Subject|12|||
16557362|NCT04157686|40506518|FG005|Overall Study|Withdrawal by Subject|11|||
16557363|NCT04157686|40506519|FG006|Overall Study|Withdrawal by Subject|18|||
16557364|NCT04157686|40506520|FG007|Overall Study|Withdrawal by Subject|24|||
16557365|NCT04157686|40506513|FG000|Overall Study|Physician Decision|0|||
16557366|NCT04157686|40506514|FG001|Overall Study|Physician Decision|0|||
16557367|NCT04157686|40506515|FG002|Overall Study|Physician Decision|1|||
16557368|NCT04157686|40506516|FG003|Overall Study|Physician Decision|0|||
16557369|NCT04157686|40506517|FG004|Overall Study|Physician Decision|1|||
16557370|NCT04157686|40506518|FG005|Overall Study|Physician Decision|0|||
16124470|NCT03330405|38942233|FG010|Overall Study|Withdrawal by Subject|1|||
16124471|NCT03330405|38942223|FG000|Overall Study|Global deterioration of health status|2|||
16124472|NCT03330405|38942224|FG001|Overall Study|Global deterioration of health status|3|||
16124473|NCT03330405|38942225|FG002|Overall Study|Global deterioration of health status|0|||
16124474|NCT03330405|38942226|FG003|Overall Study|Global deterioration of health status|2|||
16124475|NCT03330405|38942227|FG004|Overall Study|Global deterioration of health status|3|||
16124476|NCT03330405|38942228|FG005|Overall Study|Global deterioration of health status|3|||
16124477|NCT03330405|38942229|FG006|Overall Study|Global deterioration of health status|0|||
16124478|NCT03330405|38942230|FG007|Overall Study|Global deterioration of health status|2|||
16124479|NCT03330405|38942231|FG008|Overall Study|Global deterioration of health status|8|||
16124480|NCT03330405|38942232|FG009|Overall Study|Global deterioration of health status|4|||
16124481|NCT03330405|38942233|FG010|Overall Study|Global deterioration of health status|1|||
16124482|NCT03330405|38942223|FG000|Overall Study|Adverse Event|0|||
16124483|NCT03330405|38942224|FG001|Overall Study|Adverse Event|1|||
16124484|NCT03330405|38942225|FG002|Overall Study|Adverse Event|0|||
16124485|NCT03330405|38942226|FG003|Overall Study|Adverse Event|1|||
16124486|NCT03330405|38942227|FG004|Overall Study|Adverse Event|1|||
16124487|NCT03330405|38942228|FG005|Overall Study|Adverse Event|1|||
16124488|NCT03330405|38942229|FG006|Overall Study|Adverse Event|3|||
16414388|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
16414389|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
16414390|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
16414391|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
16557371|NCT04157686|40506519|FG006|Overall Study|Physician Decision|3|||
16557372|NCT04157686|40506520|FG007|Overall Study|Physician Decision|0|||
16557373|NCT04157686|40506513|FG000|Overall Study|Death|0|||
16557374|NCT04157686|40506514|FG001|Overall Study|Death|0|||
16557375|NCT04157686|40506515|FG002|Overall Study|Death|0|||
16557376|NCT04157686|40506516|FG003|Overall Study|Death|2|||
16557377|NCT04157686|40506517|FG004|Overall Study|Death|0|||
16557378|NCT04157686|40506518|FG005|Overall Study|Death|0|||
16557379|NCT04157686|40506519|FG006|Overall Study|Death|0|||
16557380|NCT04157686|40506520|FG007|Overall Study|Death|0|||
16557381|NCT04157686|40506513|FG000|Overall Study|Protocol Violation|0|||
16124489|NCT03330405|38942230|FG007|Overall Study|Adverse Event|4|||
16124490|NCT03330405|38942231|FG008|Overall Study|Adverse Event|2|||
16124491|NCT03330405|38942232|FG009|Overall Study|Adverse Event|2|||
16124492|NCT03330405|38942233|FG010|Overall Study|Adverse Event|2|||
16124493|NCT03330405|38942223|FG000|Overall Study|Death|0|||
16557382|NCT04157686|40506514|FG001|Overall Study|Protocol Violation|0|||
16557383|NCT04157686|40506515|FG002|Overall Study|Protocol Violation|0|||
16557384|NCT04157686|40506516|FG003|Overall Study|Protocol Violation|0|||
16557385|NCT04157686|40506517|FG004|Overall Study|Protocol Violation|1|||
16557386|NCT04157686|40506518|FG005|Overall Study|Protocol Violation|0|||
16557387|NCT04157686|40506519|FG006|Overall Study|Protocol Violation|0|||
16557388|NCT04157686|40506520|FG007|Overall Study|Protocol Violation|0|||
16557389|NCT04157686|40506513|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
16557390|NCT04157686|40506514|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
16557391|NCT04157686|40506515|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
16557392|NCT04157686|40506516|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
16557393|NCT04157686|40506517|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
16557394|NCT04157686|40506518|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
16240896|NCT00388674|39366178|FG000|Initial Treatment|Lost to Follow-up|526|||
16240897|NCT00388674|39366179|FG001|Initial Treatment|Lost to Follow-up|624|||
16240898|NCT00388674|39366178|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
16240899|NCT00388674|39366179|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
16240900|NCT00388674|39366178|FG000|Initial Treatment|Never Treated with Study Medication|1|||
16240901|NCT00388674|39366179|FG001|Initial Treatment|Never Treated with Study Medication|7|||
16240902|NCT00388674|39366178|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
16240903|NCT00388674|39366179|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
16240904|NCT00388674|39366178|FG000|Initial Treatment|Not Defined|125|||
16240905|NCT00388674|39366179|FG001|Initial Treatment|Not Defined|172|||
16240906|NCT00388674|39366178|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
16240907|NCT00388674|39366179|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
16240908|NCT00388674|39366178|FG000|Initial Treatment|Pregnancy|26|||
16240909|NCT00388674|39366179|FG001|Initial Treatment|Pregnancy|16|||
16240910|NCT00388674|39366178|FG000|Initial Treatment|Study Drug Toxicity|5|||
16240911|NCT00388674|39366179|FG001|Initial Treatment|Study Drug Toxicity|92|||
16240912|NCT00388674|39366178|FG000|Initial Treatment|Participant Request|501|||
16240913|NCT00388674|39366179|FG001|Initial Treatment|Participant Request|673|||
16240914|NCT00388674|39366178|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
16240915|NCT00388674|39366179|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
16240916|NCT00388674|39366178|FG000|Initial Treatment|Not Reported|10|||
16240917|NCT00388674|39366179|FG001|Initial Treatment|Not Reported|12|||
16124494|NCT03330405|38942224|FG001|Overall Study|Death|4|||
16240918|NCT00388674|39366178|FG000|End of Study|Administrative Reason By Sponsor|299|||
16240919|NCT00388674|39366179|FG001|End of Study|Administrative Reason By Sponsor|253|||
16240920|NCT00388674|39366178|FG000|End of Study|Death|239|||
16240921|NCT00388674|39366179|FG001|End of Study|Death|262|||
16240922|NCT00388674|39366178|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
16240923|NCT00388674|39366179|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
16240924|NCT00388674|39366178|FG000|End of Study|HCC|8|||
16240925|NCT00388674|39366179|FG001|End of Study|HCC|7|||
16414392|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
16557395|NCT04157686|40506519|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
16557396|NCT04157686|40506520|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
16557397|NCT00474175|40506521|FG000|Overall Study|Lack of Efficacy|0|||
16557398|NCT00474175|40506522|FG001|Overall Study|Lack of Efficacy|0|||
16557399|NCT00474175|40506523|FG002|Overall Study|Lack of Efficacy|1|||
16557400|NCT00474175|40506521|FG000|Overall Study|Withdrawal by Subject|0|||
16557401|NCT00474175|40506522|FG001|Overall Study|Withdrawal by Subject|1|||
16557402|NCT00474175|40506523|FG002|Overall Study|Withdrawal by Subject|1|||
16557403|NCT00474175|40506521|FG000|Overall Study|Ineligible|1|||
16557404|NCT00474175|40506522|FG001|Overall Study|Ineligible|3|||
16557405|NCT00474175|40506523|FG002|Overall Study|Ineligible|1|||
16557406|NCT00474175|40506521|FG000|Overall Study|Protocol Violation|0|||
16557407|NCT00474175|40506522|FG001|Overall Study|Protocol Violation|2|||
16557408|NCT00474175|40506523|FG002|Overall Study|Protocol Violation|1|||
16557409|NCT00474175|40506521|FG000|Overall Study|Administrative|0|||
16557410|NCT00474175|40506522|FG001|Overall Study|Administrative|1|||
16557411|NCT00474175|40506523|FG002|Overall Study|Administrative|0|||
16557412|NCT00884286|40506525|FG000|Overall Study|Progressive disease|21|||
16557413|NCT00884286|40506526|FG001|Overall Study|Progressive disease|28|||
16557414|NCT00884286|40506525|FG000|Overall Study|Toxicity|4|||
16557415|NCT00884286|40506526|FG001|Overall Study|Toxicity|1|||
16557416|NCT00884286|40506525|FG000|Overall Study|Death|2|||
16557417|NCT00884286|40506526|FG001|Overall Study|Death|2|||
16557418|NCT00884286|40506525|FG000|Overall Study|Physician Decision|1|||
16557419|NCT00884286|40506526|FG001|Overall Study|Physician Decision|0|||
16557420|NCT00884286|40506525|FG000|Overall Study|Septic shock|1|||
16557421|NCT00884286|40506526|FG001|Overall Study|Septic shock|0|||
16557422|NCT00884286|40506525|FG000|Overall Study|Thrombus in right auricle|1|||
16557423|NCT00884286|40506526|FG001|Overall Study|Thrombus in right auricle|0|||
16557424|NCT00884286|40506525|FG000|Overall Study|Not treated|2|||
16240926|NCT00388674|39366178|FG000|End of Study|Lost to Follow-up|587|||
16240927|NCT00388674|39366179|FG001|End of Study|Lost to Follow-up|715|||
16240928|NCT00388674|39366178|FG000|End of Study|Malignancy (Non-HCC)|1|||
16240929|NCT00388674|39366179|FG001|End of Study|Malignancy (Non-HCC)|1|||
16240930|NCT00388674|39366178|FG000|End of Study|Non-Study Related Comorbidities|3|||
16240931|NCT00388674|39366179|FG001|End of Study|Non-Study Related Comorbidities|4|||
16240932|NCT00388674|39366178|FG000|End of Study|Not Defined|135|||
16240933|NCT00388674|39366179|FG001|End of Study|Not Defined|214|||
16240934|NCT00388674|39366178|FG000|End of Study|Participant Withdrew Consent|437|||
16240935|NCT00388674|39366179|FG001|End of Study|Participant Withdrew Consent|673|||
16240936|NCT00388674|39366178|FG000|End of Study|No Off-Treatment Status Data|22|||
16240937|NCT00388674|39366179|FG001|End of Study|No Off-Treatment Status Data|30|||
16240938|NCT00388674|39366178|FG000|End of Study|Not Reported|0|||
16240939|NCT00388674|39366179|FG001|End of Study|Not Reported|1|||
16240940|NCT04147611|39366184|FG000|Overall Study|Physician Decision|0|||
16240941|NCT04147611|39366185|FG001|Overall Study|Physician Decision|1|||
16240942|NCT01715415|39366186|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
16240943|NCT01715415|39366187|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
16240944|NCT01715415|39366186|FG000|Double-blind Treatment|Adverse Event|3|||
16240945|NCT01715415|39366187|FG001|Double-blind Treatment|Adverse Event|0|||
16240946|NCT01715415|39366186|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
16240947|NCT01715415|39366187|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
16240948|NCT01715415|39366186|FG000|Double-blind Treatment|Other|1|||
16240949|NCT01715415|39366187|FG001|Double-blind Treatment|Other|0|||
16240950|NCT01715415|39366186|FG000|Open-label Treatment|Adverse Event|0|||
16240951|NCT01715415|39366187|FG001|Open-label Treatment|Adverse Event|1|||
16240952|NCT01715415|39366186|FG000|Open-label Treatment|Subject Noncompliant|0|||
16240953|NCT01715415|39366187|FG001|Open-label Treatment|Subject Noncompliant|1|||
16240954|NCT01726335|39366188|FG000|Overall Study|Lost to Follow-up|2|||
16240955|NCT01726335|39366188|FG000|Overall Study|Withdrawal by Subject|15|||
16240956|NCT01726335|39366188|FG000|Overall Study|Adverse Event|4|||
16240957|NCT01726335|39366188|FG000|Overall Study|Lost to Follow-up|2|||
16240958|NCT01726335|39366188|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
16240959|NCT03286400|39366190|FG000|Overall Study|Death|10|||
16240960|NCT03286400|39366190|FG000|Overall Study|Lost to Follow-up|10|||
16240961|NCT03286400|39366190|FG000|Overall Study|Physician Decision|1|||
16240962|NCT03286400|39366190|FG000|Overall Study|Scheduling difficulty|4|||
16240963|NCT03499249|39366192|FG000|Overall Study|Physician Decision|1|||
16240964|NCT00606801|39366193|FG000|Intervention|Protocol Violation|3|||
16240965|NCT00606801|39366194|FG001|Intervention|Protocol Violation|3|||
16240966|NCT04098068|39366195|FG000|Overall Study|Disease Progression|7|||
16240967|NCT04098068|39366195|FG000|Overall Study|Withdrawal by Subject|2|||
16240968|NCT04098068|39366195|FG000|Overall Study|New Cancer Diagnosis|1|||
16240969|NCT02124746|39366197|FG000|Overall Study|Adverse Event|2|||
16240970|NCT02124746|39366198|FG001|Overall Study|Adverse Event|1|||
16240971|NCT02124746|39366199|FG002|Overall Study|Adverse Event|2|||
16240972|NCT02124746|39366197|FG000|Overall Study|Death|2|||
16350232|NCT02573259|39769008|FG004|Overall Study|Death|9|||
16350233|NCT02573259|39769009|FG005|Overall Study|Death|32|||
16350234|NCT02573259|39769010|FG006|Overall Study|Death|21|||
16350235|NCT02573259|39769004|FG000|Overall Study|Lost to Follow-up|0|||
16350236|NCT02573259|39769005|FG001|Overall Study|Lost to Follow-up|0|||
16350237|NCT02573259|39769006|FG002|Overall Study|Lost to Follow-up|0|||
16350238|NCT02573259|39769007|FG003|Overall Study|Lost to Follow-up|0|||
16350239|NCT02573259|39769008|FG004|Overall Study|Lost to Follow-up|0|||
16350240|NCT02573259|39769009|FG005|Overall Study|Lost to Follow-up|2|||
16350241|NCT02573259|39769010|FG006|Overall Study|Lost to Follow-up|1|||
16350242|NCT02573259|39769004|FG000|Overall Study|Participant refused further follow-up|0|||
16350243|NCT02573259|39769005|FG001|Overall Study|Participant refused further follow-up|2|||
16350244|NCT02573259|39769006|FG002|Overall Study|Participant refused further follow-up|1|||
16350245|NCT02573259|39769007|FG003|Overall Study|Participant refused further follow-up|0|||
16350246|NCT02573259|39769008|FG004|Overall Study|Participant refused further follow-up|3|||
16350247|NCT02573259|39769009|FG005|Overall Study|Participant refused further follow-up|20|||
16350248|NCT02573259|39769010|FG006|Overall Study|Participant refused further follow-up|7|||
16350249|NCT02573259|39769004|FG000|Overall Study|Other|0|||
16350250|NCT02573259|39769005|FG001|Overall Study|Other|0|||
16350251|NCT02573259|39769006|FG002|Overall Study|Other|0|||
16350252|NCT02573259|39769007|FG003|Overall Study|Other|0|||
16350253|NCT02573259|39769008|FG004|Overall Study|Other|1|||
16350254|NCT02573259|39769009|FG005|Overall Study|Other|4|||
16350255|NCT02573259|39769010|FG006|Overall Study|Other|5|||
16350256|NCT00723229|39769011|FG000|First Intervention|Lost to Follow-up|7|||
16240973|NCT02124746|39366198|FG001|Overall Study|Death|1|||
16350257|NCT00723229|39769012|FG001|First Intervention|Lost to Follow-up|3|||
16350258|NCT00424593|39769017|FG000|Acute Double-Blind Period|Adverse Event|16|||
16240974|NCT02124746|39366199|FG002|Overall Study|Death|3|||
16240975|NCT02124746|39366197|FG000|Overall Study|Lack of Efficacy|3|||
16240976|NCT02124746|39366198|FG001|Overall Study|Lack of Efficacy|2|||
16240977|NCT02124746|39366199|FG002|Overall Study|Lack of Efficacy|2|||
16240978|NCT02124746|39366197|FG000|Overall Study|Physician Decision|6|||
16240979|NCT02124746|39366198|FG001|Overall Study|Physician Decision|4|||
16240980|NCT02124746|39366199|FG002|Overall Study|Physician Decision|5|||
16240981|NCT02124746|39366197|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16240982|NCT02124746|39366198|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16240983|NCT02124746|39366199|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16240984|NCT02124746|39366197|FG000|Overall Study|Withdrawal by Subject|3|||
16240985|NCT02124746|39366198|FG001|Overall Study|Withdrawal by Subject|3|||
16240986|NCT02124746|39366199|FG002|Overall Study|Withdrawal by Subject|0|||
16240987|NCT02124746|39366197|FG000|Overall Study|Study Terminated by Sponsor|0|||
16240988|NCT02124746|39366198|FG001|Overall Study|Study Terminated by Sponsor|0|||
16240989|NCT02124746|39366199|FG002|Overall Study|Study Terminated by Sponsor|6|||
16240990|NCT02124746|39366197|FG000|Overall Study|Disease Progression|3|||
16240991|NCT02124746|39366198|FG001|Overall Study|Disease Progression|6|||
16240992|NCT02124746|39366199|FG002|Overall Study|Disease Progression|4|||
16240993|NCT01162135|39366200|FG000|Overall Study|Withdrawal by Subject|1|||
16240994|NCT01162135|39366200|FG000|Overall Study|Severe back pain|1|||
16240995|NCT01162135|39366200|FG000|Overall Study|Ineligible|1|||
16240996|NCT01270841|39366203|FG000|Overall Study|Adverse Event|0|||
16240997|NCT01270841|39366204|FG001|Overall Study|Adverse Event|1|||
16240998|NCT01270841|39366205|FG002|Overall Study|Adverse Event|0|||
16240999|NCT01270841|39366206|FG003|Overall Study|Adverse Event|3|||
16241000|NCT01270841|39366203|FG000|Overall Study|Withdrawal by Subject|3|||
16241001|NCT01270841|39366204|FG001|Overall Study|Withdrawal by Subject|2|||
16241002|NCT01270841|39366205|FG002|Overall Study|Withdrawal by Subject|3|||
16241003|NCT01270841|39366206|FG003|Overall Study|Withdrawal by Subject|3|||
16241004|NCT01270841|39366203|FG000|Overall Study|Lost to Follow-up|3|||
16241005|NCT01270841|39366204|FG001|Overall Study|Lost to Follow-up|1|||
16241006|NCT01270841|39366205|FG002|Overall Study|Lost to Follow-up|4|||
16241007|NCT01270841|39366206|FG003|Overall Study|Lost to Follow-up|2|||
16241008|NCT01270841|39366203|FG000|Overall Study|Physician Decision|0|||
16241009|NCT01270841|39366204|FG001|Overall Study|Physician Decision|1|||
16241010|NCT01270841|39366205|FG002|Overall Study|Physician Decision|0|||
16241011|NCT01270841|39366206|FG003|Overall Study|Physician Decision|0|||
16241012|NCT01270841|39366203|FG000|Overall Study|Did not qualify|6|||
16241013|NCT01270841|39366204|FG001|Overall Study|Did not qualify|3|||
16241014|NCT01270841|39366205|FG002|Overall Study|Did not qualify|4|||
16241015|NCT01270841|39366206|FG003|Overall Study|Did not qualify|5|||
16241016|NCT01270841|39366203|FG000|Overall Study|Protocol Violation|1|||
16241017|NCT01270841|39366204|FG001|Overall Study|Protocol Violation|5|||
16241018|NCT01270841|39366205|FG002|Overall Study|Protocol Violation|0|||
16241019|NCT01270841|39366206|FG003|Overall Study|Protocol Violation|0|||
16241020|NCT01270841|39366203|FG000|Overall Study|Enrolled in error|0|||
16241021|NCT01270841|39366204|FG001|Overall Study|Enrolled in error|1|||
16241022|NCT01270841|39366205|FG002|Overall Study|Enrolled in error|0|||
16241023|NCT01270841|39366206|FG003|Overall Study|Enrolled in error|0|||
16241024|NCT03263819|39366207|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
16241025|NCT03263819|39366208|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
16241026|NCT02623426|39366209|FG000|Overall Study|Lost to Follow-up|0|||
16241027|NCT02623426|39366210|FG001|Overall Study|Lost to Follow-up|0|||
16241028|NCT02623426|39366211|FG002|Overall Study|Lost to Follow-up|1|||
16241029|NCT02623426|39366209|FG000|Overall Study|Withdrawal by Subject|1|||
16241030|NCT02623426|39366210|FG001|Overall Study|Withdrawal by Subject|2|||
16241031|NCT02623426|39366211|FG002|Overall Study|Withdrawal by Subject|2|||
16241032|NCT03031431|39366212|FG000|Overall Study|Infant removed by maternal request|1|||
16241033|NCT03182686|39366215|FG000|Overall Study|Lost to Follow-up|2|||
16241034|NCT03182686|39366216|FG001|Overall Study|Lost to Follow-up|0|||
16241035|NCT03182686|39366215|FG000|Overall Study|Adverse Event|2|||
16241036|NCT03182686|39366216|FG001|Overall Study|Adverse Event|0|||
16241037|NCT03182686|39366215|FG000|Overall Study|Withdrawal by Subject|3|||
16241038|NCT03182686|39366216|FG001|Overall Study|Withdrawal by Subject|0|||
16241039|NCT01585831|39366227|FG000|Overall Study|Physician Decision|0|||
16241040|NCT01585831|39366228|FG001|Overall Study|Physician Decision|1|||
16241041|NCT01585831|39366227|FG000|Overall Study|Withdrawal by Subject|2|||
16241042|NCT01585831|39366228|FG001|Overall Study|Withdrawal by Subject|1|||
16241043|NCT03216954|39366229|FG000|Overall Study|Adverse Event|0|||
16241044|NCT03216954|39366230|FG001|Overall Study|Adverse Event|0|||
16241045|NCT03216954|39366231|FG002|Overall Study|Adverse Event|1|||
16241046|NCT03216954|39366232|FG003|Overall Study|Adverse Event|0|||
16241047|NCT03216954|39366233|FG004|Overall Study|Adverse Event|1|||
16241048|NCT03216954|39366229|FG000|Overall Study|Withdrawal by Subject|2|||
16241049|NCT03216954|39366230|FG001|Overall Study|Withdrawal by Subject|0|||
16241050|NCT03216954|39366231|FG002|Overall Study|Withdrawal by Subject|0|||
16241051|NCT03216954|39366232|FG003|Overall Study|Withdrawal by Subject|0|||
16241052|NCT03216954|39366233|FG004|Overall Study|Withdrawal by Subject|0|||
16241053|NCT03216954|39366229|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
16241054|NCT03216954|39366230|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
16241055|NCT03216954|39366231|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
16241056|NCT03216954|39366232|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
16241057|NCT03216954|39366233|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
16241058|NCT00740480|39366235|FG000|Overall Study|Adverse Event|1|||
16241059|NCT00740480|39366235|FG000|Overall Study|Physician Decision|1|||
16241060|NCT00283686|39366236|FG000|Overall Study|Death|1|||
16241061|NCT00283686|39366237|FG001|Overall Study|Death|1|||
16241062|NCT00283686|39366238|FG002|Overall Study|Death|1|||
16241063|NCT00283686|39366239|FG003|Overall Study|Death|0|||
16241064|NCT00283686|39366236|FG000|Overall Study|Lost to Follow-up|21|||
16241065|NCT00283686|39366237|FG001|Overall Study|Lost to Follow-up|31|||
16241066|NCT00283686|39366238|FG002|Overall Study|Lost to Follow-up|26|||
16241067|NCT00283686|39366239|FG003|Overall Study|Lost to Follow-up|20|||
16241068|NCT00283686|39366236|FG000|Overall Study|Less than full participation|7|||
16241069|NCT00283686|39366237|FG001|Overall Study|Less than full participation|9|||
16241070|NCT00283686|39366238|FG002|Overall Study|Less than full participation|6|||
16241071|NCT00283686|39366239|FG003|Overall Study|Less than full participation|12|||
16241072|NCT01977352|39366248|FG000|Overall Study|Lost to Follow-up|1|||
16241073|NCT01977352|39366249|FG001|Overall Study|Lost to Follow-up|2|||
16241074|NCT02261974|39366252|FG000|Overall Study|Withdrawal by Subject|3|||
16241075|NCT02261974|39366253|FG001|Overall Study|Withdrawal by Subject|2|||
16241076|NCT02261974|39366252|FG000|Overall Study|Pregnancy|0|||
16241077|NCT02261974|39366253|FG001|Overall Study|Pregnancy|1|||
16241078|NCT02261974|39366252|FG000|Overall Study|Missed treatment cut-off date|6|||
16241079|NCT02261974|39366253|FG001|Overall Study|Missed treatment cut-off date|3|||
16241080|NCT02261974|39366252|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
16241081|NCT02261974|39366253|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
16241082|NCT02261974|39366252|FG000|Overall Study|Lost to Follow-up|2|||
16241083|NCT02261974|39366253|FG001|Overall Study|Lost to Follow-up|0|||
16241084|NCT02261974|39366252|FG000|Overall Study|Adverse Event|1|||
16241085|NCT02261974|39366253|FG001|Overall Study|Adverse Event|0|||
16241086|NCT01507831|39366256|FG000|Overall Study|Randomized but not treated|0|||
16241087|NCT01507831|39366257|FG001|Overall Study|Randomized but not treated|3|||
16241088|NCT01507831|39366256|FG000|Overall Study|Adverse Event|48|||
16241089|NCT01507831|39366257|FG001|Overall Study|Adverse Event|113|||
16241090|NCT01507831|39366256|FG000|Overall Study|Death|6|||
16241091|NCT01507831|39366257|FG001|Overall Study|Death|2|||
16241092|NCT01507831|39366256|FG000|Overall Study|Poor compliance to protocol|38|||
16241093|NCT01507831|39366257|FG001|Overall Study|Poor compliance to protocol|60|||
16241094|NCT01507831|39366256|FG000|Overall Study|Physician Decision|0|||
16241095|NCT01507831|39366257|FG001|Overall Study|Physician Decision|4|||
16241096|NCT01507831|39366256|FG000|Overall Study|Participant moved|5|||
16241097|NCT01507831|39366257|FG001|Overall Study|Participant moved|19|||
16241098|NCT01507831|39366256|FG000|Overall Study|Consent withdrawn by participant|34|||
16241099|NCT01507831|39366257|FG001|Overall Study|Consent withdrawn by participant|72|||
16241100|NCT01507831|39366256|FG000|Overall Study|Related to study drug administration|5|||
16241101|NCT01507831|39366257|FG001|Overall Study|Related to study drug administration|14|||
16557425|NCT00884286|40506526|FG001|Overall Study|Not treated|1|||
16557426|NCT00884286|40506525|FG000|Overall Study|Comprised lung carcinoma|0|||
16557427|NCT00884286|40506526|FG001|Overall Study|Comprised lung carcinoma|1|||
16557428|NCT01058863|40506527|FG000|Overall Study|Lost to Follow-up|1|||
16557429|NCT01058863|40506527|FG000|Overall Study|Withdrawal by Subject|1|||
16557430|NCT01058863|40506527|FG000|Overall Study|Sponsor requested withdrawal|1|||
16557431|NCT01058863|40506527|FG000|Overall Study|Randomized in error|1|||
16557432|NCT04747275|40506528|FG000|Overall Study|Study terminated|0|||
16557433|NCT04747275|40506529|FG001|Overall Study|Study terminated|1|||
16557434|NCT03628924|40506533|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
16557435|NCT03628924|40506534|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
16557436|NCT03628924|40506535|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
16557437|NCT03628924|40506536|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
16557438|NCT03628924|40506537|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
16557439|NCT03628924|40506538|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
16124495|NCT03330405|38942225|FG002|Overall Study|Death|0|||
16241102|NCT01507831|39366256|FG000|Overall Study|Last visit outside protocol visit window|51|||
16557440|NCT03628924|40506539|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
16241103|NCT01507831|39366257|FG001|Overall Study|Last visit outside protocol visit window|143|||
16241104|NCT01507831|39366256|FG000|Overall Study|Selection criteria finally not met|0|||
16241105|NCT01507831|39366257|FG001|Overall Study|Selection criteria finally not met|1|||
16241106|NCT01507831|39366256|FG000|Overall Study|Site closure|0|||
16241107|NCT01507831|39366257|FG001|Overall Study|Site closure|3|||
16241108|NCT01507831|39366256|FG000|Overall Study|Potential lost to follow-up|3|||
16557441|NCT03628924|40506533|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16557442|NCT03628924|40506534|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16557443|NCT03628924|40506535|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
16557444|NCT03628924|40506536|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16557445|NCT03628924|40506537|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16557446|NCT03628924|40506538|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16557447|NCT03628924|40506539|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16557448|NCT03628924|40506533|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
16557449|NCT03628924|40506534|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
16557450|NCT03628924|40506535|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
16557451|NCT03628924|40506536|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
16557452|NCT03628924|40506537|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
16557453|NCT03628924|40506538|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
16557454|NCT03628924|40506539|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
16557455|NCT03628924|40506533|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
16557456|NCT03628924|40506534|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
16557457|NCT03628924|40506535|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
16557458|NCT03628924|40506536|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
16557459|NCT03628924|40506537|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
16557460|NCT03628924|40506538|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
16557461|NCT03628924|40506539|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
16557462|NCT03628924|40506533|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
16557463|NCT03628924|40506534|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
16557464|NCT03628924|40506535|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
16557465|NCT03628924|40506536|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
16557466|NCT03628924|40506537|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
16557467|NCT03628924|40506538|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
16557468|NCT03628924|40506539|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
16557469|NCT03628924|40506533|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
16557470|NCT03628924|40506534|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
16557471|NCT03628924|40506535|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
16557472|NCT03628924|40506536|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
16557473|NCT03628924|40506537|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
16557474|NCT03628924|40506538|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
16557475|NCT03628924|40506539|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
16557476|NCT03628924|40506533|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
16557477|NCT03628924|40506534|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
16557478|NCT03628924|40506535|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
16557479|NCT03628924|40506536|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
16557480|NCT03628924|40506537|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
16557481|NCT03628924|40506538|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
16557482|NCT03628924|40506539|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
16557483|NCT03628924|40506533|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
16557484|NCT03628924|40506534|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
16557485|NCT03628924|40506535|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
16557486|NCT03628924|40506536|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
16557487|NCT03628924|40506537|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
16557488|NCT03628924|40506538|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
16557489|NCT03628924|40506539|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
16557490|NCT03628924|40506533|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
16557491|NCT03628924|40506534|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
16557492|NCT03628924|40506535|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
16124496|NCT03330405|38942226|FG003|Overall Study|Death|0|||
16241109|NCT01507831|39366257|FG001|Overall Study|Potential lost to follow-up|0|||
16350259|NCT00424593|39769018|FG001|Acute Double-Blind Period|Adverse Event|7|||
16350260|NCT00424593|39769017|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
16124497|NCT03330405|38942227|FG004|Overall Study|Death|0|||
16241110|NCT01507831|39366256|FG000|Overall Study|Other|3|||
16241111|NCT01507831|39366257|FG001|Overall Study|Other|6|||
16241112|NCT00972153|39366258|FG000|Overall Study|Equipment malfunction during case|0|||
16124498|NCT03330405|38942228|FG005|Overall Study|Death|1|||
16241113|NCT00972153|39366259|FG001|Overall Study|Equipment malfunction during case|1|||
16350261|NCT00424593|39769018|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
16350262|NCT00424593|39769017|FG000|Acute Double-Blind Period|Protocol Violation|2|||
16350263|NCT00424593|39769018|FG001|Acute Double-Blind Period|Protocol Violation|2|||
16350264|NCT00424593|39769017|FG000|Acute Double-Blind Period|Physician Decision|1|||
16350265|NCT00424593|39769018|FG001|Acute Double-Blind Period|Physician Decision|2|||
16350266|NCT00424593|39769017|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
16350267|NCT00424593|39769018|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
16350268|NCT00424593|39769017|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
16350269|NCT00424593|39769018|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
16241114|NCT00972153|39366260|FG002|Overall Study|Equipment malfunction during case|0|||
16241115|NCT02643966|39366264|FG000|First Screening Round|ineligible|1|||
16241116|NCT02643966|39366264|FG000|First Screening Round|excluded from analysis|2|||
16241117|NCT02643966|39366264|FG000|First Screening Round|Lost to Follow-up|56|||
16241118|NCT02643966|39366264|FG000|First Screening Round|Withdrawal by Subject|28|||
16241119|NCT02643966|39366264|FG000|First Screening Round|Death|1|||
16414393|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
16414394|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
16414395|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
16414396|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
16414397|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
16414398|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
16414399|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
16414400|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
16414401|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
16414402|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
16414403|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
16414404|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
16414405|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
16414406|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
16414407|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
16414408|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
16414409|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
16414410|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
16414411|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
16414412|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
16414413|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
16414414|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
16414415|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Death|0|||
16414416|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Death|0|||
16414417|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Death|0|||
16414418|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Death|1|||
16414419|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Death|0|||
16414420|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Missing|0|||
16414421|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Missing|0|||
16414422|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Missing|1|||
16414423|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Missing|0|||
16414424|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Missing|0|||
16241120|NCT02643966|39366264|FG000|Between First and Second Screening|Lost to Follow-up|65|||
16241121|NCT02643966|39366264|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
16241122|NCT02643966|39366264|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
16350270|NCT00424593|39769017|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
16124499|NCT03330405|38942229|FG006|Overall Study|Death|0|||
16124500|NCT03330405|38942230|FG007|Overall Study|Death|2|||
16350271|NCT00424593|39769018|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
16350272|NCT00424593|39769017|FG000|Dose-Blind Extension Period|Adverse Event|18|||
16350273|NCT00424593|39769018|FG001|Dose-Blind Extension Period|Adverse Event|0|||
16350274|NCT00424593|39769017|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
16350275|NCT00424593|39769018|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
16350276|NCT00424593|39769017|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
16350277|NCT00424593|39769018|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
16241123|NCT02643966|39366264|FG000|Second Screening Round|Withdrawal by Subject|20|||
16350278|NCT00424593|39769017|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
16350279|NCT00424593|39769018|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
16124501|NCT03330405|38942231|FG008|Overall Study|Death|0|||
16124502|NCT03330405|38942232|FG009|Overall Study|Death|0|||
16124503|NCT03330405|38942233|FG010|Overall Study|Death|0|||
16124504|NCT03330405|38942223|FG000|Overall Study|Physician Decision|0|||
16124505|NCT03330405|38942224|FG001|Overall Study|Physician Decision|0|||
16124506|NCT03330405|38942225|FG002|Overall Study|Physician Decision|0|||
16557493|NCT03628924|40506536|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
16557494|NCT03628924|40506537|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
16557495|NCT03628924|40506538|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
16557496|NCT03628924|40506539|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
16557497|NCT03628924|40506533|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
16557498|NCT03628924|40506534|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
16557499|NCT03628924|40506535|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
16557500|NCT03628924|40506536|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
16557501|NCT03628924|40506537|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
16557502|NCT03628924|40506538|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
16557503|NCT03628924|40506539|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
16557504|NCT03653416|40506542|FG000|Overall Study|Protocol Violation|6|||
16557505|NCT03653416|40506543|FG001|Overall Study|Protocol Violation|1|||
16557506|NCT03237013|40506544|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
16557507|NCT03237013|40506545|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
16557508|NCT03237013|40506546|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
16557509|NCT02703532|40506550|FG000|Overall Study|Withdrawal by Subject|0|||
16557510|NCT02703532|40506551|FG001|Overall Study|Withdrawal by Subject|1|||
16557511|NCT02703532|40506552|FG002|Overall Study|Withdrawal by Subject|0|||
16557512|NCT02703532|40506553|FG003|Overall Study|Withdrawal by Subject|1|||
16557513|NCT02703532|40506550|FG000|Overall Study|Lost to Follow-up|2|||
16557514|NCT02703532|40506551|FG001|Overall Study|Lost to Follow-up|0|||
16557515|NCT02703532|40506552|FG002|Overall Study|Lost to Follow-up|2|||
16350280|NCT00424593|39769017|FG000|Dose-Blind Extension Period|Physician Decision|3|||
16350281|NCT00424593|39769018|FG001|Dose-Blind Extension Period|Physician Decision|0|||
16350282|NCT03113968|39769020|FG000|Overall Study|Withdrawal by Subject|31|||
16557516|NCT02703532|40506553|FG003|Overall Study|Lost to Follow-up|0|||
16557517|NCT00531011|40506555|FG000|Overall Study|Withdrawal by Subject|2|||
16557518|NCT00531011|40506556|FG001|Overall Study|Withdrawal by Subject|4|||
16557519|NCT00531011|40506555|FG000|Overall Study|Death|1|||
16557520|NCT00531011|40506556|FG001|Overall Study|Death|0|||
16557521|NCT00531011|40506555|FG000|Overall Study|Lost to Follow-up|1|||
16557522|NCT00531011|40506556|FG001|Overall Study|Lost to Follow-up|0|||
16557523|NCT00531011|40506555|FG000|Overall Study|Physician Decision|0|||
16557524|NCT00531011|40506556|FG001|Overall Study|Physician Decision|3|||
16557525|NCT02400307|40506557|FG000|Overall Study|Enrolled and Never Dosed|1|||
16557526|NCT02400307|40506558|FG001|Overall Study|Enrolled and Never Dosed|0|||
16557527|NCT01458275|40506562|FG000|Overall Study|Adverse Event|3|||
16557528|NCT01458275|40506563|FG001|Overall Study|Adverse Event|4|||
16557529|NCT01458275|40506564|FG002|Overall Study|Adverse Event|1|||
16557530|NCT01458275|40506562|FG000|Overall Study|Lost to Follow-up|3|||
16557531|NCT01458275|40506563|FG001|Overall Study|Lost to Follow-up|2|||
16557532|NCT01458275|40506564|FG002|Overall Study|Lost to Follow-up|5|||
16350283|NCT03113968|39769021|FG001|Overall Study|Withdrawal by Subject|4|||
16350284|NCT02592447|39769031|FG000|Overall Study|Lost to Follow-up|1|||
16350285|NCT02592447|39769032|FG001|Overall Study|Lost to Follow-up|0|||
16350286|NCT02592447|39769031|FG000|Overall Study|Ineligible after randomization|1|||
16350287|NCT02592447|39769032|FG001|Overall Study|Ineligible after randomization|0|||
16350288|NCT02592447|39769031|FG000|Overall Study|Withdrawal by Subject|0|||
16350289|NCT02592447|39769032|FG001|Overall Study|Withdrawal by Subject|1|||
16350290|NCT01078662|39769033|FG000|Overall Study|Death|41|||
16350291|NCT01078662|39769034|FG001|Overall Study|Death|103|||
16350292|NCT01078662|39769035|FG002|Overall Study|Death|18|||
16350293|NCT01078662|39769036|FG003|Overall Study|Death|5|||
16350294|NCT01078662|39769037|FG004|Overall Study|Death|8|||
16350295|NCT01078662|39769033|FG000|Overall Study|Patients reached data cut-off|12|||
16350296|NCT01078662|39769034|FG001|Overall Study|Patients reached data cut-off|53|||
16350297|NCT01078662|39769035|FG002|Overall Study|Patients reached data cut-off|2|||
16414425|NCT00121641|39998410|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
16414426|NCT00121641|39998411|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
16557533|NCT01458275|40506562|FG000|Overall Study|Protocol Violation|5|||
16557534|NCT01458275|40506563|FG001|Overall Study|Protocol Violation|5|||
16557535|NCT01458275|40506564|FG002|Overall Study|Protocol Violation|2|||
16557536|NCT01458275|40506562|FG000|Overall Study|Withdrawal by Subject|3|||
16557537|NCT01458275|40506563|FG001|Overall Study|Withdrawal by Subject|2|||
16557538|NCT01458275|40506564|FG002|Overall Study|Withdrawal by Subject|1|||
16124507|NCT03330405|38942226|FG003|Overall Study|Physician Decision|0|||
16124508|NCT03330405|38942227|FG004|Overall Study|Physician Decision|0|||
16124509|NCT03330405|38942228|FG005|Overall Study|Physician Decision|0|||
16350298|NCT01078662|39769036|FG003|Overall Study|Patients reached data cut-off|2|||
16350299|NCT01078662|39769037|FG004|Overall Study|Patients reached data cut-off|3|||
16350300|NCT01078662|39769033|FG000|Overall Study|Withdrawal by Subject|4|||
16350301|NCT01078662|39769034|FG001|Overall Study|Withdrawal by Subject|11|||
16350302|NCT01078662|39769035|FG002|Overall Study|Withdrawal by Subject|1|||
16350303|NCT01078662|39769036|FG003|Overall Study|Withdrawal by Subject|0|||
16350304|NCT01078662|39769037|FG004|Overall Study|Withdrawal by Subject|0|||
16350305|NCT01078662|39769033|FG000|Overall Study|Protocol Violation|0|||
16350306|NCT01078662|39769034|FG001|Overall Study|Protocol Violation|1|||
16350307|NCT01078662|39769035|FG002|Overall Study|Protocol Violation|0|||
16350308|NCT01078662|39769036|FG003|Overall Study|Protocol Violation|0|||
16350309|NCT01078662|39769037|FG004|Overall Study|Protocol Violation|0|||
16350310|NCT01078662|39769033|FG000|Overall Study|Lost to Follow-up|1|||
16350311|NCT01078662|39769034|FG001|Overall Study|Lost to Follow-up|0|||
16350312|NCT01078662|39769035|FG002|Overall Study|Lost to Follow-up|0|||
16350313|NCT01078662|39769036|FG003|Overall Study|Lost to Follow-up|0|||
16350314|NCT01078662|39769037|FG004|Overall Study|Lost to Follow-up|0|||
16350315|NCT02922153|39769038|FG000|Overall Study|Death|8|||
16350316|NCT02922153|39769039|FG001|Overall Study|Death|1|||
16350317|NCT02922153|39769038|FG000|Overall Study|Lost to Follow-up|1|||
16350318|NCT02922153|39769039|FG001|Overall Study|Lost to Follow-up|0|||
16350319|NCT02922153|39769038|FG000|Overall Study|Physician Decision|1|||
16350320|NCT02922153|39769039|FG001|Overall Study|Physician Decision|1|||
16350321|NCT01964989|39769040|FG000|Overall Study|Protocol Violation|3|||
16350322|NCT01964989|39769041|FG001|Overall Study|Protocol Violation|4|||
16414427|NCT00121641|39998412|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
16414428|NCT00121641|39998413|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
16414429|NCT00121641|39998414|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
16414430|NCT00160654|39998416|FG000|Overall Study|Adverse Event|14|||
16414431|NCT00160654|39998416|FG000|Overall Study|Lack of Efficacy|4|||
16414432|NCT00160654|39998416|FG000|Overall Study|Lost to Follow-up|2|||
16414433|NCT00160654|39998416|FG000|Overall Study|Intake of expired drug|7|||
16414434|NCT00160654|39998416|FG000|Overall Study|Psychological trauma|1|||
16414435|NCT00160654|39998416|FG000|Overall Study|Sponsor decision|1|||
16414436|NCT00160654|39998416|FG000|Overall Study|Patient met exclusion criteria|1|||
16414437|NCT00160654|39998416|FG000|Overall Study|Patient decision|1|||
16414438|NCT00160654|39998416|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
16414439|NCT00160654|39998416|FG000|Overall Study|Met exclusion criteria|1|||
16414440|NCT03812185|39998423|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
16414441|NCT02621073|39998424|FG000|Overall Study|Lost to Follow-up|0|||
16414442|NCT02621073|39998425|FG001|Overall Study|Lost to Follow-up|1|||
16414443|NCT02621073|39998424|FG000|Overall Study|Physician Decision|3|||
16124510|NCT03330405|38942229|FG006|Overall Study|Physician Decision|0|||
16124511|NCT03330405|38942230|FG007|Overall Study|Physician Decision|1|||
16124512|NCT03330405|38942231|FG008|Overall Study|Physician Decision|0|||
16124513|NCT03330405|38942232|FG009|Overall Study|Physician Decision|0|||
16124514|NCT03330405|38942233|FG010|Overall Study|Physician Decision|0|||
16124515|NCT03001076|38942235|FG000|Overall Study|Withdrawal by patient|2|||
16124516|NCT03001076|38942236|FG001|Overall Study|Withdrawal by patient|0|||
16124517|NCT03001076|38942235|FG000|Overall Study|Other|1|||
16124518|NCT03001076|38942236|FG001|Overall Study|Other|0|||
16124519|NCT03001076|38942235|FG000|Overall Study|Adverse Event|3|||
16124520|NCT03001076|38942236|FG001|Overall Study|Adverse Event|3|||
16124521|NCT03001076|38942235|FG000|Overall Study|Sponsor decision|1|||
16124522|NCT03001076|38942236|FG001|Overall Study|Sponsor decision|0|||
16124523|NCT03001076|38942235|FG000|Overall Study|Lost to Follow-up|0|||
16124524|NCT03001076|38942236|FG001|Overall Study|Lost to Follow-up|2|||
16124525|NCT04189952|38942239|FG000|Follow-up Period|Death|1|||
16124526|NCT04189952|38942239|FG000|Follow-up Period|Withdrawal by Subject|1|||
16124527|NCT03507777|38942240|FG000|Overall Study|Lost to Follow-up|5|||
16124528|NCT03507777|38942241|FG001|Overall Study|Lost to Follow-up|7|||
16124529|NCT03507777|38942240|FG000|Overall Study|Withdrawal by Subject|6|||
16124530|NCT03507777|38942241|FG001|Overall Study|Withdrawal by Subject|11|||
16241124|NCT02643966|39366264|FG000|Second Screening Round|Lost to Follow-up|57|||
16350323|NCT01964989|39769040|FG000|Overall Study|Administrative Reason|103|||
16350324|NCT01964989|39769041|FG001|Overall Study|Administrative Reason|95|||
16350325|NCT01964989|39769040|FG000|Overall Study|Adverse Event|0|||
16350326|NCT01964989|39769041|FG001|Overall Study|Adverse Event|1|||
16414444|NCT02621073|39998425|FG001|Overall Study|Physician Decision|2|||
16414445|NCT05219669|39998430|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
16414446|NCT05219669|39998431|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
16414447|NCT05219669|39998432|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
16124531|NCT03507777|38942240|FG000|Overall Study|Death|30|||
16124532|NCT03507777|38942241|FG001|Overall Study|Death|44|||
16124533|NCT03507777|38942240|FG000|Overall Study|Other Reasons|3|||
16124534|NCT03507777|38942241|FG001|Overall Study|Other Reasons|8|||
16124535|NCT03248882|38942245|FG000|Overall Study|Adverse Event|3|||
16124536|NCT03248882|38942246|FG001|Overall Study|Adverse Event|3|||
16124537|NCT03248882|38942247|FG002|Overall Study|Adverse Event|2|||
16557539|NCT00479674|40506569|FG000|Overall Study|Adverse Event|18|||
16557540|NCT00479674|40506569|FG000|Overall Study|Withdrawal by Subject|6|||
16557541|NCT00479674|40506569|FG000|Overall Study|Physician Decision|14|||
16557542|NCT00479674|40506569|FG000|Overall Study|none provided|3|||
16557543|NCT02494206|40506572|FG000|Overall Study|Adverse Event|1|||
16557544|NCT02494206|40506572|FG000|Overall Study|Disease Progression|1|||
16557545|NCT03283553|40506573|FG000|Patient Participant Flow|Death|5|||
16557546|NCT03283553|40506574|FG001|Patient Participant Flow|Death|10|||
16557547|NCT03283553|40506573|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
16557548|NCT03283553|40506574|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
16557549|NCT03283553|40506573|FG000|Patient Participant Flow|Lost to Follow-up|1|||
16557550|NCT03283553|40506574|FG001|Patient Participant Flow|Lost to Follow-up|1|||
16557551|NCT03283553|40506573|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
16557552|NCT03283553|40506574|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
16124538|NCT03248882|38942248|FG003|Overall Study|Adverse Event|6|||
16124539|NCT03248882|38942249|FG004|Overall Study|Adverse Event|9|||
16124540|NCT03248882|38942245|FG000|Overall Study|Lost to Follow-up|0|||
16124541|NCT03248882|38942246|FG001|Overall Study|Lost to Follow-up|0|||
16124542|NCT03248882|38942247|FG002|Overall Study|Lost to Follow-up|0|||
16124543|NCT03248882|38942248|FG003|Overall Study|Lost to Follow-up|0|||
16124544|NCT03248882|38942249|FG004|Overall Study|Lost to Follow-up|1|||
16124545|NCT03248882|38942245|FG000|Overall Study|Protocol Violation|2|||
16124546|NCT03248882|38942246|FG001|Overall Study|Protocol Violation|0|||
16350327|NCT01964989|39769040|FG000|Overall Study|Death|1|||
16557553|NCT03283553|40506573|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
16557554|NCT03283553|40506574|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
16557555|NCT03283553|40506573|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
16557556|NCT03283553|40506574|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
16557557|NCT01513967|40506575|FG000|Overall Study|Pregnancy|0|||
16557558|NCT01513967|40506576|FG001|Overall Study|Pregnancy|0|||
16557559|NCT01513967|40506577|FG002|Overall Study|Pregnancy|0|||
16557560|NCT01513967|40506578|FG003|Overall Study|Pregnancy|0|||
16557561|NCT01513967|40506579|FG004|Overall Study|Pregnancy|0|||
16557562|NCT01513967|40506580|FG005|Overall Study|Pregnancy|0|||
16557563|NCT01513967|40506581|FG006|Overall Study|Pregnancy|1|||
16557564|NCT01513967|40506582|FG007|Overall Study|Pregnancy|0|||
16557565|NCT01513967|40506575|FG000|Overall Study|missed a study visit|0|||
16557566|NCT01513967|40506576|FG001|Overall Study|missed a study visit|0|||
16557567|NCT01513967|40506577|FG002|Overall Study|missed a study visit|0|||
16557568|NCT01513967|40506578|FG003|Overall Study|missed a study visit|0|||
16557569|NCT01513967|40506579|FG004|Overall Study|missed a study visit|0|||
16557570|NCT01513967|40506580|FG005|Overall Study|missed a study visit|0|||
16557571|NCT01513967|40506581|FG006|Overall Study|missed a study visit|1|||
16557572|NCT01513967|40506582|FG007|Overall Study|missed a study visit|0|||
16557573|NCT01513967|40506575|FG000|Overall Study|excluded due to positive drug screen|0|||
16557574|NCT01513967|40506576|FG001|Overall Study|excluded due to positive drug screen|0|||
16557575|NCT01513967|40506577|FG002|Overall Study|excluded due to positive drug screen|0|||
16557576|NCT01513967|40506578|FG003|Overall Study|excluded due to positive drug screen|0|||
16557577|NCT01513967|40506579|FG004|Overall Study|excluded due to positive drug screen|0|||
16557578|NCT01513967|40506580|FG005|Overall Study|excluded due to positive drug screen|0|||
16557579|NCT01513967|40506581|FG006|Overall Study|excluded due to positive drug screen|0|||
16557580|NCT01513967|40506582|FG007|Overall Study|excluded due to positive drug screen|2|||
16124547|NCT03248882|38942247|FG002|Overall Study|Protocol Violation|2|||
16124548|NCT03248882|38942248|FG003|Overall Study|Protocol Violation|0|||
16124549|NCT03248882|38942249|FG004|Overall Study|Protocol Violation|1|||
16124550|NCT03248882|38942245|FG000|Overall Study|Withdrawal by Subject|2|||
16124551|NCT03248882|38942246|FG001|Overall Study|Withdrawal by Subject|2|||
16350328|NCT01964989|39769041|FG001|Overall Study|Death|3|||
16350329|NCT01964989|39769040|FG000|Overall Study|Withdrawal by Subject|156|||
16350330|NCT01964989|39769041|FG001|Overall Study|Withdrawal by Subject|160|||
16350331|NCT01964989|39769040|FG000|Overall Study|Lost to Follow-up|254|||
16350332|NCT01964989|39769041|FG001|Overall Study|Lost to Follow-up|232|||
16350333|NCT01964989|39769040|FG000|Overall Study|Other|267|||
16124552|NCT03248882|38942247|FG002|Overall Study|Withdrawal by Subject|3|||
16414448|NCT05219669|39998433|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
16414449|NCT05219669|39998434|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
16414450|NCT05219669|39998435|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
16414451|NCT03599713|39998436|FG000|Overall Study|Death|26|||
16414452|NCT03599713|39998437|FG001|Overall Study|Death|3|||
16414453|NCT03599713|39998436|FG000|Overall Study|Withdrawal by Subject|6|||
16414454|NCT03599713|39998437|FG001|Overall Study|Withdrawal by Subject|0|||
16414455|NCT03599713|39998436|FG000|Overall Study|Ongoing|69|||
16414456|NCT03599713|39998437|FG001|Overall Study|Ongoing|3|||
16124553|NCT03248882|38942248|FG003|Overall Study|Withdrawal by Subject|4|||
16124554|NCT03248882|38942249|FG004|Overall Study|Withdrawal by Subject|2|||
16557581|NCT01513967|40506575|FG000|Overall Study|Physician Decision|0|||
16557582|NCT01513967|40506576|FG001|Overall Study|Physician Decision|0|||
16557583|NCT01513967|40506577|FG002|Overall Study|Physician Decision|0|||
16124555|NCT00979576|38942250|FG000|Combination Treatment Phase|Progressive disease|3|||
16124556|NCT00979576|38942251|FG001|Combination Treatment Phase|Progressive disease|1|||
16124557|NCT00979576|38942252|FG002|Combination Treatment Phase|Progressive disease|5|||
16124558|NCT00979576|38942250|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
16557584|NCT01513967|40506578|FG003|Overall Study|Physician Decision|0|||
16557585|NCT01513967|40506579|FG004|Overall Study|Physician Decision|0|||
16124559|NCT00979576|38942251|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
16414457|NCT04375397|39998438|FG000|Overall Study|Death|1|||
16414458|NCT04375397|39998439|FG001|Overall Study|Death|1|||
16414459|NCT04375397|39998438|FG000|Overall Study|Withdrew consent|2|||
16414460|NCT04375397|39998439|FG001|Overall Study|Withdrew consent|0|||
16414461|NCT04375397|39998438|FG000|Overall Study|Lost to Follow-up|6|||
16414462|NCT04375397|39998439|FG001|Overall Study|Lost to Follow-up|4|||
16414463|NCT04375397|39998438|FG000|Overall Study|Other, not specified|0|||
16414464|NCT04375397|39998439|FG001|Overall Study|Other, not specified|1|||
16414465|NCT01110382|39998440|FG000|Overall Study|Withdrawal by Subject|0|||
16414466|NCT01110382|39998441|FG001|Overall Study|Withdrawal by Subject|1|||
16414467|NCT01110382|39998440|FG000|Overall Study|Protocol Violation|0|||
16414468|NCT01110382|39998441|FG001|Overall Study|Protocol Violation|1|||
16414469|NCT03242018|39998442|FG000|Overall Study|Adverse Event|7|||
16124560|NCT00979576|38942252|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
16124561|NCT00979576|38942250|FG000|Combination Treatment Phase|Adverse Event|0|||
16124562|NCT00979576|38942251|FG001|Combination Treatment Phase|Adverse Event|2|||
16124563|NCT00979576|38942252|FG002|Combination Treatment Phase|Adverse Event|2|||
16124564|NCT00979576|38942250|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
16124565|NCT00979576|38942251|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
16124566|NCT00979576|38942252|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
16124567|NCT01732822|38942253|FG000|Overall Study|Withdrawal by Subject|123|||
16124568|NCT01732822|38942254|FG001|Overall Study|Withdrawal by Subject|113|||
16124569|NCT01499303|38942255|FG000|Overall Study|Ongoing|2|||
16241125|NCT02643966|39366264|FG000|Second Screening Round|Physician Decision|2|||
16241126|NCT02643966|39366264|FG000|Second Screening Round|Death|4|||
16241127|NCT02643966|39366264|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
16241128|NCT02643966|39366264|FG000|Between Second and Third Screening|Death|1|||
16241129|NCT02643966|39366264|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
16241130|NCT02643966|39366264|FG000|Third Screening Round|PI excluded|2|||
16241131|NCT02643966|39366264|FG000|Third Screening Round|Lost to Follow-up|241|||
16241132|NCT02729194|39366267|FG000|Overall Study|Withdrawal by Subject|3|||
16241133|NCT01984229|39366272|FG000|Safety Follow-up Period|Adverse Event|1|||
16241134|NCT01984229|39366273|FG001|Safety Follow-up Period|Adverse Event|1|||
16241135|NCT01984229|39366272|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
16241136|NCT01984229|39366273|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
16414470|NCT03242018|39998443|FG001|Overall Study|Adverse Event|7|||
16414471|NCT03242018|39998444|FG002|Overall Study|Adverse Event|6|||
16414472|NCT03242018|39998442|FG000|Overall Study|Lost to Follow-up|2|||
16557586|NCT01513967|40506580|FG005|Overall Study|Physician Decision|1|||
16557587|NCT01513967|40506581|FG006|Overall Study|Physician Decision|0|||
16414473|NCT03242018|39998443|FG001|Overall Study|Lost to Follow-up|2|||
16414474|NCT03242018|39998444|FG002|Overall Study|Lost to Follow-up|2|||
16557588|NCT01513967|40506582|FG007|Overall Study|Physician Decision|0|||
16241137|NCT01783730|39366274|FG000|Overall Study|Failed to meet inclusion criteria|6|||
16241138|NCT01169987|39366275|FG000|Overall Study|Withdrawal by Subject|3|||
16241139|NCT01169987|39366275|FG000|Overall Study|Lost to Follow-up|24|||
16241140|NCT01169987|39366275|FG000|Overall Study|Other|4|||
16241141|NCT01430104|39366278|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
16241142|NCT00597207|39366279|FG000|Overall Study|Lost to Follow-up|5|||
16241143|NCT00597207|39366280|FG001|Overall Study|Lost to Follow-up|7|||
16241144|NCT04356573|39366284|FG000|Overall Study|Didn't Qualify|1|||
16241145|NCT04356573|39366285|FG001|Overall Study|Didn't Qualify|0|||
16241146|NCT00558519|39366286|FG000|Overall Study|Ph+|20|||
16241147|NCT00558519|39366286|FG000|Overall Study|Ineligible|1|||
16241148|NCT00558519|39366286|FG000|Overall Study|Insufficient data|1|||
16241149|NCT00558519|39366286|FG000|Overall Study|Never received treatment|1|||
16241150|NCT01964105|39366295|FG000|Overall Study|Lost to Follow-up|2|||
16241151|NCT01964105|39366296|FG001|Overall Study|Lost to Follow-up|13|||
16241152|NCT01964105|39366297|FG002|Overall Study|Lost to Follow-up|0|||
16241153|NCT01169844|39366298|FG000|Overall Study|Adverse Event|0|||
16241154|NCT01169844|39366299|FG001|Overall Study|Adverse Event|1|||
16241155|NCT01169844|39366298|FG000|Overall Study|Patient withdrew consent|4|||
16241156|NCT01169844|39366299|FG001|Overall Study|Patient withdrew consent|0|||
16241157|NCT01169844|39366298|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16241158|NCT01169844|39366299|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16241159|NCT03734679|39366300|FG000|Overall Study|Missed Visit|1|||
16241160|NCT02953262|39366301|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
16241161|NCT02953262|39366302|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
16241162|NCT02953262|39366303|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
16241163|NCT02953262|39366304|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
16241164|NCT02209454|39366305|FG000|Second Period|Adverse Event|1|||
16241165|NCT02209454|39366306|FG001|Second Period|Adverse Event|0|||
16241166|NCT03456726|39366308|FG000|Overall Study|Disease Progression|6|||
16241167|NCT03456726|39366309|FG001|Overall Study|Disease Progression|1|||
16241168|NCT03456726|39366308|FG000|Overall Study|Adverse Event|4|||
16241169|NCT03456726|39366309|FG001|Overall Study|Adverse Event|2|||
16241170|NCT03456726|39366308|FG000|Overall Study|Withdrawal by Subject|1|||
16241171|NCT03456726|39366309|FG001|Overall Study|Withdrawal by Subject|0|||
16241172|NCT03456726|39366308|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
16241173|NCT03456726|39366309|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
16241174|NCT00568776|39366310|FG000|Overall Study|Adverse Event|8|||
16241175|NCT00568776|39366311|FG001|Overall Study|Adverse Event|8|||
16241176|NCT00568776|39366312|FG002|Overall Study|Adverse Event|10|||
16241177|NCT00568776|39366313|FG003|Overall Study|Adverse Event|8|||
16241178|NCT00568776|39366310|FG000|Overall Study|Death|0|||
16241179|NCT00568776|39366311|FG001|Overall Study|Death|1|||
16241180|NCT00568776|39366312|FG002|Overall Study|Death|4|||
16241181|NCT00568776|39366313|FG003|Overall Study|Death|3|||
16241182|NCT00568776|39366310|FG000|Overall Study|Physician Decision|0|||
16241183|NCT00568776|39366311|FG001|Overall Study|Physician Decision|2|||
16241184|NCT00568776|39366312|FG002|Overall Study|Physician Decision|0|||
16241185|NCT00568776|39366313|FG003|Overall Study|Physician Decision|0|||
16241186|NCT00568776|39366310|FG000|Overall Study|Lack of Efficacy|2|||
16241187|NCT00568776|39366311|FG001|Overall Study|Lack of Efficacy|2|||
16241188|NCT00568776|39366312|FG002|Overall Study|Lack of Efficacy|2|||
16241189|NCT00568776|39366313|FG003|Overall Study|Lack of Efficacy|4|||
16241190|NCT00568776|39366310|FG000|Overall Study|Lost to Follow-up|1|||
16241191|NCT00568776|39366311|FG001|Overall Study|Lost to Follow-up|1|||
16241192|NCT00568776|39366312|FG002|Overall Study|Lost to Follow-up|1|||
16241193|NCT00568776|39366313|FG003|Overall Study|Lost to Follow-up|1|||
16241194|NCT00568776|39366310|FG000|Overall Study|Protocol Violation|1|||
16241195|NCT00568776|39366311|FG001|Overall Study|Protocol Violation|0|||
16241196|NCT00568776|39366312|FG002|Overall Study|Protocol Violation|1|||
16241197|NCT00568776|39366313|FG003|Overall Study|Protocol Violation|1|||
16241198|NCT00568776|39366310|FG000|Overall Study|Withdrawal by Subject|13|||
16241199|NCT00568776|39366311|FG001|Overall Study|Withdrawal by Subject|15|||
16241200|NCT00568776|39366312|FG002|Overall Study|Withdrawal by Subject|13|||
16241201|NCT00568776|39366313|FG003|Overall Study|Withdrawal by Subject|7|||
16241202|NCT00568776|39366310|FG000|Overall Study|Loss of Caregiver|0|||
16241203|NCT00568776|39366311|FG001|Overall Study|Loss of Caregiver|2|||
16241204|NCT00568776|39366312|FG002|Overall Study|Loss of Caregiver|1|||
16241205|NCT00568776|39366313|FG003|Overall Study|Loss of Caregiver|2|||
16241206|NCT00568776|39366310|FG000|Overall Study|Sponsor Decision|2|||
16241207|NCT00568776|39366311|FG001|Overall Study|Sponsor Decision|2|||
16241208|NCT00568776|39366312|FG002|Overall Study|Sponsor Decision|41|||
16241209|NCT00568776|39366313|FG003|Overall Study|Sponsor Decision|42|||
16241210|NCT00568776|39366310|FG000|Overall Study|Miscellaeneous|3|||
16241211|NCT00568776|39366311|FG001|Overall Study|Miscellaeneous|3|||
16241212|NCT00568776|39366312|FG002|Overall Study|Miscellaeneous|1|||
16241213|NCT00568776|39366313|FG003|Overall Study|Miscellaeneous|4|||
16241214|NCT01664494|39366315|FG000|Overall Study|Withdrawal by Subject|27|||
16350334|NCT01964989|39769041|FG001|Overall Study|Other|252|||
16350335|NCT00931632|39769042|FG000|Overall Study|Withdrawal by Subject|2|||
16350336|NCT00931632|39769043|FG001|Overall Study|Withdrawal by Subject|3|||
16350337|NCT00931632|39769042|FG000|Overall Study|Adverse Event|19|||
16350338|NCT00931632|39769043|FG001|Overall Study|Adverse Event|15|||
16350339|NCT01077323|39769045|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
16350340|NCT01077323|39769046|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
16124570|NCT01499303|38942256|FG001|Overall Study|Ongoing|1|||
16124571|NCT01499303|38942255|FG000|Overall Study|Withdrawal by Subject|0|||
16124572|NCT01499303|38942256|FG001|Overall Study|Withdrawal by Subject|1|||
16124573|NCT01499303|38942255|FG000|Overall Study|Adverse Event|1|||
16124574|NCT01499303|38942256|FG001|Overall Study|Adverse Event|4|||
16124575|NCT01499303|38942255|FG000|Overall Study|Other|0|||
16124576|NCT01499303|38942256|FG001|Overall Study|Other|1|||
16124577|NCT01283516|38942258|FG000|Overall Study|Adverse Event|0|||
16124578|NCT01283516|38942259|FG001|Overall Study|Adverse Event|0|||
16124579|NCT01283516|38942260|FG002|Overall Study|Adverse Event|0|||
16124580|NCT01283516|38942261|FG003|Overall Study|Adverse Event|0|||
16124581|NCT01283516|38942262|FG004|Overall Study|Adverse Event|0|||
16124582|NCT01283516|38942263|FG005|Overall Study|Adverse Event|0|||
16124583|NCT01283516|38942264|FG006|Overall Study|Adverse Event|2|||
16124584|NCT01283516|38942265|FG007|Overall Study|Adverse Event|0|||
16124585|NCT01283516|38942266|FG008|Overall Study|Adverse Event|28|||
16124586|NCT01283516|38942258|FG000|Overall Study|Death|0|||
16124587|NCT01283516|38942259|FG001|Overall Study|Death|0|||
16124588|NCT01283516|38942260|FG002|Overall Study|Death|0|||
16124589|NCT01283516|38942261|FG003|Overall Study|Death|0|||
16124590|NCT01283516|38942262|FG004|Overall Study|Death|0|||
16124591|NCT01283516|38942263|FG005|Overall Study|Death|1|||
16124592|NCT01283516|38942264|FG006|Overall Study|Death|0|||
16124593|NCT01283516|38942265|FG007|Overall Study|Death|1|||
16124594|NCT01283516|38942266|FG008|Overall Study|Death|12|||
16124595|NCT01283516|38942258|FG000|Overall Study|Disease Progression|2|||
16124596|NCT01283516|38942259|FG001|Overall Study|Disease Progression|2|||
16124597|NCT01283516|38942260|FG002|Overall Study|Disease Progression|3|||
16124598|NCT01283516|38942261|FG003|Overall Study|Disease Progression|3|||
16124599|NCT01283516|38942262|FG004|Overall Study|Disease Progression|13|||
16124600|NCT01283516|38942263|FG005|Overall Study|Disease Progression|8|||
16124601|NCT01283516|38942264|FG006|Overall Study|Disease Progression|6|||
16124602|NCT01283516|38942265|FG007|Overall Study|Disease Progression|3|||
16124603|NCT01283516|38942266|FG008|Overall Study|Disease Progression|139|||
16124604|NCT01283516|38942258|FG000|Overall Study|Withdrawal by Subject|0|||
16124605|NCT01283516|38942259|FG001|Overall Study|Withdrawal by Subject|0|||
16124606|NCT01283516|38942260|FG002|Overall Study|Withdrawal by Subject|0|||
16124607|NCT01283516|38942261|FG003|Overall Study|Withdrawal by Subject|0|||
16124608|NCT01283516|38942262|FG004|Overall Study|Withdrawal by Subject|1|||
16124609|NCT01283516|38942263|FG005|Overall Study|Withdrawal by Subject|0|||
16124610|NCT01283516|38942264|FG006|Overall Study|Withdrawal by Subject|1|||
16124611|NCT01283516|38942265|FG007|Overall Study|Withdrawal by Subject|0|||
16124612|NCT01283516|38942266|FG008|Overall Study|Withdrawal by Subject|36|||
16124613|NCT01283516|38942258|FG000|Overall Study|Administrative problems|0|||
16124614|NCT01283516|38942259|FG001|Overall Study|Administrative problems|0|||
16124615|NCT01283516|38942260|FG002|Overall Study|Administrative problems|0|||
16124616|NCT01283516|38942261|FG003|Overall Study|Administrative problems|0|||
16124617|NCT01283516|38942262|FG004|Overall Study|Administrative problems|0|||
16124618|NCT01283516|38942263|FG005|Overall Study|Administrative problems|1|||
16124619|NCT01283516|38942264|FG006|Overall Study|Administrative problems|1|||
16124620|NCT01283516|38942265|FG007|Overall Study|Administrative problems|1|||
16124621|NCT01283516|38942266|FG008|Overall Study|Administrative problems|39|||
16124622|NCT01283516|38942258|FG000|Overall Study|Lost to Follow-up|0|||
16124623|NCT01283516|38942259|FG001|Overall Study|Lost to Follow-up|0|||
16124624|NCT01283516|38942260|FG002|Overall Study|Lost to Follow-up|0|||
16124625|NCT01283516|38942261|FG003|Overall Study|Lost to Follow-up|0|||
16124626|NCT01283516|38942262|FG004|Overall Study|Lost to Follow-up|0|||
16350341|NCT01077323|39769047|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
16124627|NCT01283516|38942263|FG005|Overall Study|Lost to Follow-up|0|||
16124628|NCT01283516|38942264|FG006|Overall Study|Lost to Follow-up|0|||
16124629|NCT01283516|38942265|FG007|Overall Study|Lost to Follow-up|0|||
16124630|NCT01283516|38942266|FG008|Overall Study|Lost to Follow-up|1|||
16124631|NCT03582943|38942267|FG000|Allocated to Groups|Withdrawal by Subject|1|||
16124632|NCT03582943|38942268|FG001|Allocated to Groups|Withdrawal by Subject|1|||
16124633|NCT03582943|38942267|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
16124634|NCT03582943|38942268|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
16124635|NCT03582943|38942267|FG000|Analyzed|Protocol Violation|4|||
16124636|NCT03582943|38942268|FG001|Analyzed|Protocol Violation|1|||
16124637|NCT00710021|38942269|FG000|Overall Study|Lost to Follow-up|1|||
16124638|NCT00710021|38942270|FG001|Overall Study|Lost to Follow-up|0|||
16124639|NCT00710021|38942271|FG002|Overall Study|Lost to Follow-up|0|||
16124640|NCT00710021|38942269|FG000|Overall Study|Subject's Decision|0|||
16241215|NCT01664494|39366315|FG000|Overall Study|Death|18|||
16241216|NCT01664494|39366315|FG000|Overall Study|Other|49|||
16241217|NCT01664494|39366315|FG000|Overall Study|Lost to Follow-up|99|||
16241218|NCT00950599|39366319|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16241219|NCT00950599|39366320|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16241220|NCT00950599|39366321|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16241221|NCT00950599|39366322|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
16241222|NCT00950599|39366323|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16241223|NCT00950599|39366324|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16241224|NCT00950599|39366325|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16350342|NCT01077323|39769045|FG000|Overall Study|Dispensing of drug in baseline period|0|||
16350343|NCT01077323|39769046|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
16350344|NCT01077323|39769047|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
16350345|NCT01077323|39769045|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
16350346|NCT01077323|39769046|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
16350347|NCT01077323|39769047|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
16350348|NCT02420262|39769048|FG000|Overall Study|Adverse Event|1|||
16350349|NCT02420262|39769049|FG001|Overall Study|Adverse Event|0|||
16350350|NCT02420262|39769048|FG000|Overall Study|Withdrawal by Subject|1|||
16350351|NCT02420262|39769049|FG001|Overall Study|Withdrawal by Subject|4|||
16241225|NCT00950599|39366326|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16241226|NCT00950599|39366327|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16241227|NCT00950599|39366328|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
16241228|NCT00950599|39366319|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16241229|NCT00950599|39366320|FG001|Double-Blind Treatment Period|Adverse Event|1|||
16241230|NCT00950599|39366321|FG002|Double-Blind Treatment Period|Adverse Event|1|||
16241231|NCT00950599|39366322|FG003|Double-Blind Treatment Period|Adverse Event|1|||
16241232|NCT00950599|39366323|FG004|Double-Blind Treatment Period|Adverse Event|1|||
16241233|NCT00950599|39366324|FG005|Double-Blind Treatment Period|Adverse Event|1|||
16241234|NCT00950599|39366325|FG006|Double-Blind Treatment Period|Adverse Event|0|||
16241235|NCT00950599|39366326|FG007|Double-Blind Treatment Period|Adverse Event|0|||
16241236|NCT00950599|39366327|FG008|Double-Blind Treatment Period|Adverse Event|0|||
16241237|NCT00950599|39366328|FG009|Double-Blind Treatment Period|Adverse Event|0|||
16241238|NCT00950599|39366319|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
16241239|NCT00950599|39366320|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
16241240|NCT00950599|39366321|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
16350352|NCT02420262|39769048|FG000|Overall Study|Unclassified|0|||
16350353|NCT02420262|39769049|FG001|Overall Study|Unclassified|1|||
16350354|NCT01093846|39769050|FG000|Overall Study|Adverse Event|0|||
16350355|NCT01093846|39769051|FG001|Overall Study|Adverse Event|0|||
16350356|NCT01093846|39769052|FG002|Overall Study|Adverse Event|1|||
16414475|NCT03242018|39998442|FG000|Overall Study|At the Participant's Own Request|5|||
16414476|NCT03242018|39998443|FG001|Overall Study|At the Participant's Own Request|1|||
16414477|NCT03242018|39998444|FG002|Overall Study|At the Participant's Own Request|4|||
16557589|NCT01106976|40506583|FG000|Overall Study|Lost to Follow-up|8|||
16557590|NCT00003509|40506584|FG000|Overall Study|Not evaluable|5|||
16557591|NCT01225835|40506585|FG000|Overall Study|Completed protocol|2|||
16557592|NCT01225835|40506586|FG001|Overall Study|Completed protocol|1|||
16557593|NCT01225835|40506585|FG000|Overall Study|Did not meet hCG criterion|2|||
16557594|NCT01225835|40506586|FG001|Overall Study|Did not meet hCG criterion|0|||
16557595|NCT01225835|40506585|FG000|Overall Study|Adverse Event|2|||
16557596|NCT01225835|40506586|FG001|Overall Study|Adverse Event|1|||
16557597|NCT01225835|40506585|FG000|Overall Study|Other|1|||
16557598|NCT01225835|40506586|FG001|Overall Study|Other|1|||
16557599|NCT00967018|40506587|FG000|Overall Study|Adverse Event|2|||
16557600|NCT00967018|40506587|FG000|Overall Study|Physician Decision|7|||
16557601|NCT00967018|40506587|FG000|Overall Study|Lost to Follow-up|2|||
16557602|NCT00967018|40506587|FG000|Overall Study|Withdrawal by Subject|1|||
16557603|NCT00967018|40506587|FG000|Overall Study|Miscellaneous Reasons|9|||
16557604|NCT00312858|40506588|FG000|Overall Study|Adverse Event|0|||
16557605|NCT00312858|40506589|FG001|Overall Study|Adverse Event|1|||
16557606|NCT00312858|40506588|FG000|Overall Study|Lost to Follow-up|25|||
16557607|NCT00312858|40506589|FG001|Overall Study|Lost to Follow-up|42|||
16557608|NCT00312858|40506588|FG000|Overall Study|Protocol Violation|3|||
16241241|NCT00950599|39366322|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
16241242|NCT00950599|39366323|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
16241243|NCT00950599|39366324|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
16241244|NCT00950599|39366325|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
16557609|NCT00312858|40506589|FG001|Overall Study|Protocol Violation|8|||
16557610|NCT00312858|40506588|FG000|Overall Study|Withdraw by Participant|20|||
16350357|NCT01093846|39769050|FG000|Overall Study|Lack of Efficacy|0|||
16350358|NCT01093846|39769051|FG001|Overall Study|Lack of Efficacy|0|||
16350359|NCT01093846|39769052|FG002|Overall Study|Lack of Efficacy|4|||
16557611|NCT00312858|40506589|FG001|Overall Study|Withdraw by Participant|20|||
16557612|NCT00312858|40506588|FG000|Overall Study|Participant Moved|11|||
16557613|NCT00312858|40506589|FG001|Overall Study|Participant Moved|10|||
16557614|NCT00312858|40506588|FG000|Overall Study|Other|9|||
16557615|NCT00312858|40506589|FG001|Overall Study|Other|12|||
16557616|NCT02297503|40506590|FG000|Overall Study|Withdrawal by Subject|1|||
16557617|NCT02297503|40506591|FG001|Overall Study|Withdrawal by Subject|1|||
16557618|NCT02297503|40506590|FG000|Overall Study|Protocol Violation|1|||
16557619|NCT02297503|40506591|FG001|Overall Study|Protocol Violation|0|||
16557620|NCT02297503|40506590|FG000|Overall Study|Pregnancy|0|||
16557621|NCT02297503|40506591|FG001|Overall Study|Pregnancy|1|||
16557622|NCT02297503|40506590|FG000|Overall Study|Lost to Follow-up|0|||
16557623|NCT02297503|40506591|FG001|Overall Study|Lost to Follow-up|1|||
16557624|NCT02297503|40506590|FG000|Overall Study|Medical reason|0|||
16557625|NCT02297503|40506591|FG001|Overall Study|Medical reason|1|||
16557626|NCT02420327|40506592|FG000|Overall Study|Adverse Event|7|||
16557627|NCT02420327|40506592|FG000|Overall Study|Pregnancy|1|||
16557628|NCT02420327|40506592|FG000|Overall Study|Withdrawal by Subject|6|||
16557629|NCT02420327|40506592|FG000|Overall Study|Lost to Follow-up|1|||
16557630|NCT02420327|40506592|FG000|Overall Study|Protocol Violation|1|||
16557631|NCT01167179|40506594|FG000|Overall Study|disease recurrence|4|||
16557632|NCT01167179|40506595|FG001|Overall Study|disease recurrence|4|||
16241245|NCT00950599|39366326|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
16241246|NCT00950599|39366327|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
16241247|NCT00950599|39366328|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
16241248|NCT00950599|39366319|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16241249|NCT00950599|39366320|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
16241250|NCT00950599|39366321|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
16241251|NCT00950599|39366322|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
16241252|NCT00950599|39366323|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
16241253|NCT00950599|39366324|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
16241254|NCT00950599|39366325|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
16241255|NCT00950599|39366326|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
16241256|NCT00950599|39366327|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
16241257|NCT00950599|39366328|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
16241258|NCT00950599|39366319|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
16241259|NCT00950599|39366320|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
16241260|NCT00950599|39366321|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16241261|NCT00950599|39366322|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16241262|NCT00950599|39366323|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16241263|NCT00950599|39366324|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16241264|NCT00950599|39366325|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16241265|NCT00950599|39366326|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
16241266|NCT00950599|39366327|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16241267|NCT00950599|39366328|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
16241268|NCT00950599|39366319|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16241269|NCT00950599|39366320|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16241270|NCT00950599|39366321|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16241271|NCT00950599|39366322|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16241272|NCT00950599|39366323|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
16241273|NCT00950599|39366324|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
16241274|NCT00950599|39366325|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16241275|NCT00950599|39366326|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16241276|NCT00950599|39366327|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16241277|NCT00950599|39366328|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
16241278|NCT00950599|39366319|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
16241279|NCT00950599|39366320|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
16241280|NCT00950599|39366321|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
16241281|NCT00950599|39366322|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
16241282|NCT00950599|39366323|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
16241283|NCT00950599|39366324|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
16241284|NCT00950599|39366325|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
16557633|NCT01167179|40506594|FG000|Overall Study|Death|4|||
16557634|NCT01167179|40506595|FG001|Overall Study|Death|10|||
16557635|NCT01167179|40506594|FG000|Overall Study|Withdrawal by Subject|1|||
16557636|NCT01167179|40506595|FG001|Overall Study|Withdrawal by Subject|2|||
16557637|NCT01167179|40506594|FG000|Overall Study|diverse|6|||
16557638|NCT01167179|40506595|FG001|Overall Study|diverse|5|||
16557639|NCT02564055|40506596|FG000|Overall Study|Adverse Event|1|||
16557640|NCT02564055|40506597|FG001|Overall Study|Adverse Event|0|||
16241285|NCT00950599|39366326|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
16241286|NCT00950599|39366327|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
16241287|NCT00950599|39366328|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
16241288|NCT00950599|39366319|FG000|Follow-Up Period|Adverse Event|0|||
16241289|NCT00950599|39366320|FG001|Follow-Up Period|Adverse Event|0|||
16241290|NCT00950599|39366321|FG002|Follow-Up Period|Adverse Event|0|||
16241291|NCT00950599|39366322|FG003|Follow-Up Period|Adverse Event|0|||
16241292|NCT00950599|39366323|FG004|Follow-Up Period|Adverse Event|0|||
16241293|NCT00950599|39366324|FG005|Follow-Up Period|Adverse Event|0|||
16241294|NCT00950599|39366325|FG006|Follow-Up Period|Adverse Event|0|||
16241295|NCT00950599|39366326|FG007|Follow-Up Period|Adverse Event|0|||
16241296|NCT00950599|39366327|FG008|Follow-Up Period|Adverse Event|1|||
16241297|NCT00950599|39366328|FG009|Follow-Up Period|Adverse Event|0|||
16241298|NCT00950599|39366319|FG000|Follow-Up Period|Lack of Efficacy|0|||
16241299|NCT00950599|39366320|FG001|Follow-Up Period|Lack of Efficacy|0|||
16241300|NCT00950599|39366321|FG002|Follow-Up Period|Lack of Efficacy|0|||
16241301|NCT00950599|39366322|FG003|Follow-Up Period|Lack of Efficacy|0|||
16241302|NCT00950599|39366323|FG004|Follow-Up Period|Lack of Efficacy|0|||
16241303|NCT00950599|39366324|FG005|Follow-Up Period|Lack of Efficacy|0|||
16241304|NCT00950599|39366325|FG006|Follow-Up Period|Lack of Efficacy|0|||
16241305|NCT00950599|39366326|FG007|Follow-Up Period|Lack of Efficacy|0|||
16241306|NCT00950599|39366327|FG008|Follow-Up Period|Lack of Efficacy|3|||
16241307|NCT00950599|39366328|FG009|Follow-Up Period|Lack of Efficacy|0|||
16241308|NCT00950599|39366319|FG000|Follow-Up Period|Lost to Follow-up|0|||
16241309|NCT00950599|39366320|FG001|Follow-Up Period|Lost to Follow-up|0|||
16241310|NCT00950599|39366321|FG002|Follow-Up Period|Lost to Follow-up|0|||
16241311|NCT00950599|39366322|FG003|Follow-Up Period|Lost to Follow-up|0|||
16241312|NCT00950599|39366323|FG004|Follow-Up Period|Lost to Follow-up|0|||
16241313|NCT00950599|39366324|FG005|Follow-Up Period|Lost to Follow-up|0|||
16241314|NCT00950599|39366325|FG006|Follow-Up Period|Lost to Follow-up|0|||
16241315|NCT00950599|39366326|FG007|Follow-Up Period|Lost to Follow-up|0|||
16241316|NCT00950599|39366327|FG008|Follow-Up Period|Lost to Follow-up|5|||
16241317|NCT00950599|39366328|FG009|Follow-Up Period|Lost to Follow-up|1|||
16241318|NCT00950599|39366319|FG000|Follow-Up Period|Physician Decision|0|||
16241319|NCT00950599|39366320|FG001|Follow-Up Period|Physician Decision|0|||
16557641|NCT02564055|40506598|FG002|Overall Study|Adverse Event|4|||
16557642|NCT02564055|40506599|FG003|Overall Study|Adverse Event|1|||
16557643|NCT02564055|40506600|FG004|Overall Study|Adverse Event|4|||
16557644|NCT02564055|40506601|FG005|Overall Study|Adverse Event|1|||
16557645|NCT02564055|40506596|FG000|Overall Study|Protocol Violation|1|||
16557646|NCT02564055|40506597|FG001|Overall Study|Protocol Violation|0|||
16557647|NCT02564055|40506598|FG002|Overall Study|Protocol Violation|0|||
16557648|NCT02564055|40506599|FG003|Overall Study|Protocol Violation|0|||
16241320|NCT00950599|39366321|FG002|Follow-Up Period|Physician Decision|0|||
16241321|NCT00950599|39366322|FG003|Follow-Up Period|Physician Decision|0|||
16241322|NCT00950599|39366323|FG004|Follow-Up Period|Physician Decision|0|||
16241323|NCT00950599|39366324|FG005|Follow-Up Period|Physician Decision|0|||
16241324|NCT00950599|39366325|FG006|Follow-Up Period|Physician Decision|0|||
16241325|NCT00950599|39366326|FG007|Follow-Up Period|Physician Decision|0|||
16241326|NCT00950599|39366327|FG008|Follow-Up Period|Physician Decision|1|||
16241327|NCT00950599|39366328|FG009|Follow-Up Period|Physician Decision|0|||
16241328|NCT00950599|39366319|FG000|Follow-Up Period|Poor/Noncompliance|0|||
16241329|NCT00950599|39366320|FG001|Follow-Up Period|Poor/Noncompliance|0|||
16241330|NCT00950599|39366321|FG002|Follow-Up Period|Poor/Noncompliance|0|||
16241331|NCT00950599|39366322|FG003|Follow-Up Period|Poor/Noncompliance|0|||
16241332|NCT00950599|39366323|FG004|Follow-Up Period|Poor/Noncompliance|0|||
16241333|NCT00950599|39366324|FG005|Follow-Up Period|Poor/Noncompliance|0|||
16557649|NCT02564055|40506600|FG004|Overall Study|Protocol Violation|0|||
16557650|NCT02564055|40506601|FG005|Overall Study|Protocol Violation|0|||
16557651|NCT02564055|40506596|FG000|Overall Study|Reached stopping criteria|0|||
16557652|NCT02564055|40506597|FG001|Overall Study|Reached stopping criteria|0|||
16557653|NCT02564055|40506598|FG002|Overall Study|Reached stopping criteria|0|||
16557654|NCT02564055|40506599|FG003|Overall Study|Reached stopping criteria|0|||
16557655|NCT02564055|40506600|FG004|Overall Study|Reached stopping criteria|0|||
16557656|NCT02564055|40506601|FG005|Overall Study|Reached stopping criteria|1|||
16557657|NCT02564055|40506596|FG000|Overall Study|Lost to Follow-up|0|||
16557658|NCT02564055|40506597|FG001|Overall Study|Lost to Follow-up|1|||
16557659|NCT02564055|40506598|FG002|Overall Study|Lost to Follow-up|4|||
16557660|NCT02564055|40506599|FG003|Overall Study|Lost to Follow-up|2|||
16557661|NCT02564055|40506600|FG004|Overall Study|Lost to Follow-up|1|||
16241334|NCT00950599|39366325|FG006|Follow-Up Period|Poor/Noncompliance|0|||
16241335|NCT00950599|39366326|FG007|Follow-Up Period|Poor/Noncompliance|0|||
16241336|NCT00950599|39366327|FG008|Follow-Up Period|Poor/Noncompliance|1|||
16241337|NCT00950599|39366328|FG009|Follow-Up Period|Poor/Noncompliance|0|||
16557662|NCT02564055|40506601|FG005|Overall Study|Lost to Follow-up|0|||
16557663|NCT02564055|40506596|FG000|Overall Study|Physician Decision|0|||
16557664|NCT02564055|40506597|FG001|Overall Study|Physician Decision|0|||
16241338|NCT00950599|39366319|FG000|Follow-Up Period|Subject withdrew Consent|0|||
16241339|NCT00950599|39366320|FG001|Follow-Up Period|Subject withdrew Consent|0|||
16241340|NCT00950599|39366321|FG002|Follow-Up Period|Subject withdrew Consent|0|||
16241341|NCT00950599|39366322|FG003|Follow-Up Period|Subject withdrew Consent|0|||
16241342|NCT00950599|39366323|FG004|Follow-Up Period|Subject withdrew Consent|0|||
16241343|NCT00950599|39366324|FG005|Follow-Up Period|Subject withdrew Consent|0|||
16241344|NCT00950599|39366325|FG006|Follow-Up Period|Subject withdrew Consent|0|||
16241345|NCT00950599|39366326|FG007|Follow-Up Period|Subject withdrew Consent|0|||
16241346|NCT00950599|39366327|FG008|Follow-Up Period|Subject withdrew Consent|2|||
16241347|NCT00950599|39366328|FG009|Follow-Up Period|Subject withdrew Consent|1|||
16241348|NCT02576054|39366329|FG000|Overall Study|Withdrawal by Subject|1|||
16241349|NCT02923115|39366330|FG000|Overall Study|Lost to Follow-up|0|||
16241350|NCT02923115|39366331|FG001|Overall Study|Lost to Follow-up|0|||
16241351|NCT02923115|39366332|FG002|Overall Study|Lost to Follow-up|0|||
16241352|NCT02923115|39366333|FG003|Overall Study|Lost to Follow-up|1|||
16241353|NCT02923115|39366334|FG004|Overall Study|Lost to Follow-up|0|||
16241354|NCT02923115|39366335|FG005|Overall Study|Lost to Follow-up|0|||
16241355|NCT02923115|39366330|FG000|Overall Study|Withdrawal by Subject|0|||
16241356|NCT02923115|39366331|FG001|Overall Study|Withdrawal by Subject|1|||
16241357|NCT02923115|39366332|FG002|Overall Study|Withdrawal by Subject|0|||
16241358|NCT02923115|39366333|FG003|Overall Study|Withdrawal by Subject|0|||
16241359|NCT02923115|39366334|FG004|Overall Study|Withdrawal by Subject|0|||
16241360|NCT02923115|39366335|FG005|Overall Study|Withdrawal by Subject|0|||
16241361|NCT02923115|39366330|FG000|Overall Study|Randomized, but not dosed|0|||
16241362|NCT02923115|39366331|FG001|Overall Study|Randomized, but not dosed|0|||
16241363|NCT02923115|39366332|FG002|Overall Study|Randomized, but not dosed|3|||
16241364|NCT02923115|39366333|FG003|Overall Study|Randomized, but not dosed|1|||
16241365|NCT02923115|39366334|FG004|Overall Study|Randomized, but not dosed|5|||
16241366|NCT02923115|39366335|FG005|Overall Study|Randomized, but not dosed|0|||
16241367|NCT01440647|39366336|FG000|Overall Study|Death|2|||
16241368|NCT01440647|39366337|FG001|Overall Study|Death|3|||
16241369|NCT01829295|39366342|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
16241370|NCT01829295|39366343|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
16241371|NCT01829295|39366344|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
16241372|NCT01829295|39366345|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
16241373|NCT01829295|39366342|FG000|6-12 Months|Adverse Event|0|||
16241374|NCT01829295|39366343|FG001|6-12 Months|Adverse Event|0|||
16241375|NCT01829295|39366344|FG002|6-12 Months|Adverse Event|3|||
16241376|NCT01829295|39366345|FG003|6-12 Months|Adverse Event|2|||
16241377|NCT01829295|39366342|FG000|6-12 Months|Lost to Follow-up|2|||
16241378|NCT01829295|39366343|FG001|6-12 Months|Lost to Follow-up|0|||
16241379|NCT01829295|39366344|FG002|6-12 Months|Lost to Follow-up|0|||
16241380|NCT01829295|39366345|FG003|6-12 Months|Lost to Follow-up|0|||
16241381|NCT01829295|39366342|FG000|6-12 Months|Withdrawal by Subject|2|||
16241382|NCT01829295|39366343|FG001|6-12 Months|Withdrawal by Subject|2|||
16241383|NCT01829295|39366344|FG002|6-12 Months|Withdrawal by Subject|0|||
16241384|NCT01829295|39366345|FG003|6-12 Months|Withdrawal by Subject|0|||
16241385|NCT01764854|39366346|FG000|Overall Study|Adverse Event|0|||
16241386|NCT01764854|39366347|FG001|Overall Study|Adverse Event|0|||
16414478|NCT03242018|39998442|FG000|Overall Study|Reason Not Specified|3|||
16414479|NCT03242018|39998443|FG001|Overall Study|Reason Not Specified|4|||
16414480|NCT03242018|39998444|FG002|Overall Study|Reason Not Specified|1|||
16414481|NCT03242018|39998442|FG000|Overall Study|Study Terminated by Sponsor|1|||
16241387|NCT01764854|39366348|FG002|Overall Study|Adverse Event|2|||
16241388|NCT01764854|39366349|FG003|Overall Study|Adverse Event|0|||
16241389|NCT01764854|39366346|FG000|Overall Study|Withdrawal by Subject|0|||
16241390|NCT01764854|39366347|FG001|Overall Study|Withdrawal by Subject|0|||
16241391|NCT01764854|39366348|FG002|Overall Study|Withdrawal by Subject|1|||
16241392|NCT01764854|39366349|FG003|Overall Study|Withdrawal by Subject|0|||
16241393|NCT01764854|39366346|FG000|Overall Study|relocation|0|||
16241394|NCT01764854|39366347|FG001|Overall Study|relocation|0|||
16414482|NCT03242018|39998443|FG001|Overall Study|Study Terminated by Sponsor|0|||
16414483|NCT03242018|39998444|FG002|Overall Study|Study Terminated by Sponsor|1|||
16414484|NCT01062061|39998448|FG000|Overall Study|Enrolled more than once|2|||
16414485|NCT01062061|39998448|FG000|Overall Study|Investigated before study start|13|||
16414486|NCT01062061|39998448|FG000|Overall Study|Outside chief indications|10|||
16414487|NCT01062061|39998448|FG000|Overall Study|Failed to meet inclusion criteria|2|||
16414488|NCT00895661|39998451|FG000|Overall Study|Death|1|||
16414489|NCT00895661|39998451|FG000|Overall Study|reason unknown|2|||
16414490|NCT02772978|39998455|FG000|Overall Study|Withdrawal by Subject|1|||
16241395|NCT01764854|39366348|FG002|Overall Study|relocation|2|||
16241396|NCT01764854|39366349|FG003|Overall Study|relocation|0|||
16241397|NCT01764854|39366346|FG000|Overall Study|Protocol Violation|0|||
16241398|NCT01764854|39366347|FG001|Overall Study|Protocol Violation|0|||
16241399|NCT01764854|39366348|FG002|Overall Study|Protocol Violation|1|||
16414491|NCT02772978|39998456|FG001|Overall Study|Withdrawal by Subject|1|||
16241400|NCT01764854|39366349|FG003|Overall Study|Protocol Violation|2|||
16241401|NCT02236754|39366350|FG000|Overall Study|Withdrawal by Subject|1|||
16241402|NCT02236754|39366351|FG001|Overall Study|Withdrawal by Subject|0|||
16241403|NCT00579254|39366352|FG000|Overall Study|Lost to Follow-up|39|||
16241404|NCT00579254|39366352|FG000|Overall Study|Discontinued when study terminated|73|||
16241405|NCT01706770|39366355|FG000|Overall Study|Lost to Follow-up|1|||
16241406|NCT01706770|39366356|FG001|Overall Study|Lost to Follow-up|0|||
16241407|NCT01706770|39366355|FG000|Overall Study|Physician Decision|1|||
16241408|NCT01706770|39366356|FG001|Overall Study|Physician Decision|0|||
16241409|NCT01154127|39366357|FG000|Period 1 (21 Days)|Adverse Event|3|||
16241410|NCT01154127|39366358|FG001|Period 1 (21 Days)|Adverse Event|4|||
16241411|NCT01154127|39366357|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
16241412|NCT01154127|39366358|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
16241413|NCT01154127|39366357|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
16241414|NCT01154127|39366358|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
16241415|NCT01154127|39366357|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
16241416|NCT01154127|39366358|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
16241417|NCT01154127|39366357|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
16241418|NCT01154127|39366358|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
16241419|NCT00964223|39366364|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
16241420|NCT02030834|39366365|FG000|Overall Study|Death|4|||
16241421|NCT02030834|39366366|FG001|Overall Study|Death|0|||
16241422|NCT02030834|39366367|FG002|Overall Study|Death|0|||
16241423|NCT02030834|39366365|FG000|Overall Study|Manufacturing failure|2|||
16241424|NCT02030834|39366366|FG001|Overall Study|Manufacturing failure|0|||
16241425|NCT02030834|39366367|FG002|Overall Study|Manufacturing failure|1|||
16241426|NCT02030834|39366365|FG000|Overall Study|Disease progression|2|||
16241427|NCT02030834|39366366|FG001|Overall Study|Disease progression|0|||
16241428|NCT02030834|39366367|FG002|Overall Study|Disease progression|2|||
16241429|NCT02030834|39366365|FG000|Overall Study|Lost to Follow-up|1|||
16241430|NCT02030834|39366366|FG001|Overall Study|Lost to Follow-up|0|||
16241431|NCT02030834|39366367|FG002|Overall Study|Lost to Follow-up|0|||
16241432|NCT02030834|39366365|FG000|Overall Study|Withdrawal by Subject|1|||
16241433|NCT02030834|39366366|FG001|Overall Study|Withdrawal by Subject|0|||
16241434|NCT02030834|39366367|FG002|Overall Study|Withdrawal by Subject|0|||
16241435|NCT02030834|39366365|FG000|Overall Study|Lack of funding|1|||
16241436|NCT02030834|39366366|FG001|Overall Study|Lack of funding|0|||
16241437|NCT02030834|39366367|FG002|Overall Study|Lack of funding|0|||
16241438|NCT00078819|39366369|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
16241439|NCT00078819|39366370|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
16241440|NCT00078819|39366371|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
16241441|NCT00078819|39366372|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
16241442|NCT00078819|39366369|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
16241443|NCT00078819|39366370|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
16241444|NCT00078819|39366371|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
16241445|NCT00078819|39366372|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
16241446|NCT00078819|39366369|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
16241447|NCT00078819|39366370|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
16241448|NCT00078819|39366371|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
16241449|NCT00078819|39366372|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
16241450|NCT00078819|39366369|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
16241451|NCT00078819|39366370|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
16241452|NCT00078819|39366371|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
16241453|NCT00078819|39366372|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
16241454|NCT00078819|39366369|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
16241455|NCT00078819|39366370|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
16241456|NCT00078819|39366371|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
16241457|NCT00078819|39366372|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
16241458|NCT00078819|39366369|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
16241459|NCT00078819|39366370|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
16241460|NCT00078819|39366371|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
16241461|NCT00078819|39366372|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
16241462|NCT00078819|39366369|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
16124641|NCT00710021|38942270|FG001|Overall Study|Subject's Decision|1|||
16241463|NCT00078819|39366370|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
16241464|NCT00078819|39366371|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
16241465|NCT00078819|39366372|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
16241466|NCT00078819|39366369|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
16241467|NCT00078819|39366370|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
16241468|NCT00078819|39366371|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
16241469|NCT00078819|39366372|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
16241470|NCT00569231|39366373|FG000|Overall Study|Study unrelated surgery|1|||
16241471|NCT00569231|39366373|FG000|Overall Study|Airfare expense|2|||
16241472|NCT00569231|39366373|FG000|Overall Study|Withdrawal by Subject|1|||
16241473|NCT00569231|39366373|FG000|Overall Study|Car accident injury|1|||
16241474|NCT00569231|39366373|FG000|Overall Study|Non-compliance|2|||
16241475|NCT01392170|39366374|FG000|Overall Study|Withdrawal by Subject|1|||
16241476|NCT01392170|39366374|FG000|Overall Study|Ineligible|1|||
16241477|NCT00479765|39366375|FG000|Overall Study|study terminated|4|||
16241478|NCT02444182|39366376|FG000|Overall Study|non-compliance|2|||
16241479|NCT02444182|39366377|FG001|Overall Study|non-compliance|1|||
16241480|NCT02444182|39366376|FG000|Overall Study|Lost to Follow-up|0|||
16241481|NCT02444182|39366377|FG001|Overall Study|Lost to Follow-up|4|||
16241482|NCT00344305|39366379|FG000|Overall Study|Lost to Follow-up|2|||
16241483|NCT00344305|39366380|FG001|Overall Study|Lost to Follow-up|0|||
16241484|NCT00344305|39366379|FG000|Overall Study|Participant was not contacted in window|0|||
16241485|NCT00344305|39366380|FG001|Overall Study|Participant was not contacted in window|1|||
16241486|NCT00971204|39366384|FG000|Overall Study|Did not meet all criteria-not treated|14|||
16241487|NCT00971204|39366384|FG000|Overall Study|Lost to Follow-up|10|||
16241488|NCT01128153|39366385|FG000|Overall Study|Adverse Event|1|||
16241489|NCT01128153|39366386|FG001|Overall Study|Adverse Event|3|||
16241490|NCT01128153|39366385|FG000|Overall Study|Condition under investigation worsened|8|||
16241491|NCT01128153|39366386|FG001|Overall Study|Condition under investigation worsened|7|||
16241492|NCT01128153|39366385|FG000|Overall Study|Withdrawal by Subject|2|||
16241493|NCT01128153|39366386|FG001|Overall Study|Withdrawal by Subject|3|||
16241494|NCT01128153|39366385|FG000|Overall Study|Incorrect enrolment to study|2|||
16241495|NCT01128153|39366386|FG001|Overall Study|Incorrect enrolment to study|1|||
16241496|NCT01128153|39366385|FG000|Overall Study|Protocol Violation|2|||
16241497|NCT01128153|39366386|FG001|Overall Study|Protocol Violation|0|||
16241498|NCT01128153|39366385|FG000|Overall Study|Developed discontinuation criteria|1|||
16241499|NCT01128153|39366386|FG001|Overall Study|Developed discontinuation criteria|1|||
16241500|NCT00943384|39366389|FG000|Overall Study|Dispositioned prior to treatment|23|||
16241501|NCT00943384|39366389|FG000|Overall Study|Treated off protocol-protocol violation|5|||
16241502|NCT00943384|39366389|FG000|Overall Study|Lost to Follow-up|16|||
16241503|NCT00943384|39366389|FG000|Overall Study|Withdrawal by Subject|5|||
16241504|NCT01246973|39368625|FG000|Overall Study|Other|38|||
16241505|NCT01246973|39368626|FG001|Overall Study|Other|25|||
16241506|NCT01246973|39368625|FG000|Overall Study|Adverse Event|16|||
16241507|NCT01246973|39368626|FG001|Overall Study|Adverse Event|9|||
16241508|NCT01246973|39368625|FG000|Overall Study|Withdrawal by Subject|7|||
16241509|NCT01246973|39368626|FG001|Overall Study|Withdrawal by Subject|13|||
16241510|NCT01964898|39368627|FG000|Overall Study|ineligible post-randomization|1|||
16241511|NCT01964898|39368628|FG001|Overall Study|ineligible post-randomization|1|||
16241512|NCT01964898|39368627|FG000|Overall Study|did not receive the allocated interventi|2|||
16241513|NCT01964898|39368628|FG001|Overall Study|did not receive the allocated interventi|1|||
16241514|NCT01964898|39368627|FG000|Overall Study|Lost to Follow-up|3|||
16241515|NCT01964898|39368628|FG001|Overall Study|Lost to Follow-up|5|||
16241516|NCT01964898|39368627|FG000|Overall Study|Withdrawal by Subject|1|||
16241517|NCT01964898|39368628|FG001|Overall Study|Withdrawal by Subject|0|||
16241518|NCT00525031|39368629|FG000|Overall Study|Disease Progression|1|||
16241519|NCT00525031|39368630|FG001|Overall Study|Disease Progression|1|||
16241520|NCT00328783|39368632|FG000|Overall Study|Could not tolerate ABC|21|||
16241521|NCT00328783|39368632|FG000|Overall Study|No heart in RT field|4|||
16241522|NCT00328783|39368632|FG000|Overall Study|Withdrawal by Subject|1|||
16241523|NCT04274192|39368636|FG000|Overall Study|Protocol Violation|1|||
16241524|NCT04274192|39368637|FG001|Overall Study|Protocol Violation|0|||
16241525|NCT00065065|39368638|FG000|Overall Study|Adverse Event|3|||
16241526|NCT00065065|39368639|FG001|Overall Study|Adverse Event|2|||
16241527|NCT00065065|39368638|FG000|Overall Study|Withdrawal by Subject|1|||
16241528|NCT00065065|39368639|FG001|Overall Study|Withdrawal by Subject|5|||
16241529|NCT00065065|39368638|FG000|Overall Study|Lack of Efficacy|4|||
16241530|NCT00065065|39368639|FG001|Overall Study|Lack of Efficacy|11|||
16241531|NCT00065065|39368638|FG000|Overall Study|Other|2|||
16241532|NCT00065065|39368639|FG001|Overall Study|Other|2|||
16241533|NCT00409188|39368640|FG000|Overall Study|Ongoing at data cut-off|383|||
16241534|NCT00409188|39368641|FG001|Overall Study|Ongoing at data cut-off|175|||
16241535|NCT00272961|39368643|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
16414492|NCT03191786|39998457|FG000|Overall Study|Death|236|||
16557665|NCT02564055|40506598|FG002|Overall Study|Physician Decision|1|||
16557666|NCT02564055|40506599|FG003|Overall Study|Physician Decision|0|||
16241536|NCT00272961|39368644|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
16241537|NCT00272961|39368645|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
16241538|NCT00272961|39368646|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
16241539|NCT00272961|39368647|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
16241540|NCT00272961|39368643|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
16241541|NCT00272961|39368644|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
16241542|NCT00272961|39368645|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
16241543|NCT00272961|39368646|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
16241544|NCT00272961|39368647|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
16241545|NCT00272961|39368643|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
16241546|NCT00272961|39368644|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
16241547|NCT00272961|39368645|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
16241548|NCT00272961|39368646|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
16241549|NCT00272961|39368647|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
16241550|NCT00272961|39368643|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
16241551|NCT00272961|39368644|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
16241552|NCT00272961|39368645|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
16124642|NCT00710021|38942271|FG002|Overall Study|Subject's Decision|0|||
16241553|NCT00272961|39368646|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
16241554|NCT00272961|39368647|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
16241555|NCT00272961|39368643|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
16241556|NCT00272961|39368644|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
16241557|NCT00272961|39368645|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
16241558|NCT00272961|39368646|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
16241559|NCT00272961|39368647|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
16241560|NCT00272961|39368643|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
16241561|NCT00272961|39368644|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
16241562|NCT00272961|39368645|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
16241563|NCT00272961|39368646|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
16241564|NCT00272961|39368647|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
16241565|NCT00272961|39368643|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
16241566|NCT00272961|39368644|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
16241567|NCT00272961|39368645|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
16241568|NCT00272961|39368646|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
16241569|NCT00272961|39368647|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
16241570|NCT00272961|39368643|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
16241571|NCT00272961|39368644|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
16241572|NCT00272961|39368645|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
16241573|NCT00272961|39368646|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
16241574|NCT00272961|39368647|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
16241575|NCT01462695|39368650|FG000|Overall Study|Adverse Event|1|||
16241576|NCT01462695|39368651|FG001|Overall Study|Adverse Event|1|||
16241577|NCT01462695|39368650|FG000|Overall Study|Death|2|||
16241578|NCT01462695|39368651|FG001|Overall Study|Death|0|||
16241579|NCT01462695|39368650|FG000|Overall Study|Lack of Efficacy|6|||
16241580|NCT01462695|39368651|FG001|Overall Study|Lack of Efficacy|12|||
16241581|NCT01462695|39368650|FG000|Overall Study|Physician Decision|5|||
16241582|NCT01462695|39368651|FG001|Overall Study|Physician Decision|0|||
16241583|NCT01462695|39368650|FG000|Overall Study|Withdrawal by Subject|2|||
16241584|NCT01462695|39368651|FG001|Overall Study|Withdrawal by Subject|0|||
16241585|NCT01462695|39368650|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
16241586|NCT01462695|39368651|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
16241587|NCT03296553|39368652|FG000|Overall Study|Withdrawal by Subject|1|||
16241588|NCT03296553|39368653|FG001|Overall Study|Withdrawal by Subject|1|||
16241589|NCT03296553|39368652|FG000|Overall Study|Death|1|||
16241590|NCT03296553|39368653|FG001|Overall Study|Death|0|||
16241591|NCT02496221|39368654|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
16241592|NCT02496221|39368655|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
16241593|NCT02496221|39368654|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
16241594|NCT02496221|39368655|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
16241595|NCT02496221|39368654|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
16241596|NCT02496221|39368655|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
16241597|NCT04130919|39368656|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
16241598|NCT04130919|39368657|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
16241599|NCT04130919|39368658|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
16241600|NCT04130919|39368659|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
16241601|NCT04130919|39368660|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
16241602|NCT04130919|39368661|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
16241603|NCT04130919|39368656|FG000|Blinded Treatment Phase|Adverse Event|0|||
16241604|NCT04130919|39368657|FG001|Blinded Treatment Phase|Adverse Event|0|||
16241605|NCT04130919|39368658|FG002|Blinded Treatment Phase|Adverse Event|1|||
16241606|NCT04130919|39368659|FG003|Blinded Treatment Phase|Adverse Event|0|||
16241607|NCT04130919|39368660|FG004|Blinded Treatment Phase|Adverse Event|0|||
16241608|NCT04130919|39368661|FG005|Blinded Treatment Phase|Adverse Event|0|||
16350360|NCT01093846|39769050|FG000|Overall Study|Condition no longer required study drug|1|||
16241609|NCT04130919|39368656|FG000|Blinded Treatment Phase|Disease worsening|0|||
16414493|NCT03191786|39998458|FG001|Overall Study|Death|127|||
16557667|NCT02564055|40506600|FG004|Overall Study|Physician Decision|0|||
16557668|NCT02564055|40506601|FG005|Overall Study|Physician Decision|0|||
16557669|NCT02564055|40506596|FG000|Overall Study|Withdrawal by Subject|4|||
16557670|NCT02564055|40506597|FG001|Overall Study|Withdrawal by Subject|4|||
16124643|NCT00710021|38942269|FG000|Overall Study|Subject misrandomized|0|||
16124644|NCT00710021|38942270|FG001|Overall Study|Subject misrandomized|1|||
16124645|NCT00710021|38942271|FG002|Overall Study|Subject misrandomized|1|||
16124646|NCT00710021|38942269|FG000|Overall Study|Physician Decision|0|||
16124647|NCT00710021|38942270|FG001|Overall Study|Physician Decision|1|||
16124648|NCT00710021|38942271|FG002|Overall Study|Physician Decision|0|||
16350361|NCT01093846|39769051|FG001|Overall Study|Condition no longer required study drug|1|||
16350362|NCT01093846|39769052|FG002|Overall Study|Condition no longer required study drug|1|||
16350363|NCT01093846|39769050|FG000|Overall Study|Administrative Problems|18|||
16350364|NCT01093846|39769051|FG001|Overall Study|Administrative Problems|17|||
16350365|NCT01093846|39769052|FG002|Overall Study|Administrative Problems|15|||
16350366|NCT02896569|39769053|FG000|Overall Study|Lost to Follow-up|2|||
16350367|NCT02896569|39769054|FG001|Overall Study|Lost to Follow-up|1|||
16350368|NCT02896569|39769053|FG000|Overall Study|Physician Decision|1|||
16350369|NCT02896569|39769054|FG001|Overall Study|Physician Decision|3|||
16350370|NCT02896569|39769053|FG000|Overall Study|Adverse Event|0|||
16350371|NCT02896569|39769054|FG001|Overall Study|Adverse Event|1|||
16350372|NCT02896569|39769053|FG000|Overall Study|Withdrawal by Subject|1|||
16350373|NCT02896569|39769054|FG001|Overall Study|Withdrawal by Subject|0|||
16350374|NCT00577317|39769057|FG000|Overall Study|Study Terminated|0|||
16350375|NCT00577317|39769058|FG001|Overall Study|Study Terminated|2|||
16350376|NCT00941304|39769059|FG000|Overall Study|Lost to Follow-up|1|||
16350377|NCT00941304|39769060|FG001|Overall Study|Lost to Follow-up|0|||
16350378|NCT00941304|39769061|FG002|Overall Study|Lost to Follow-up|0|||
16350379|NCT00941304|39769062|FG003|Overall Study|Lost to Follow-up|0|||
16350380|NCT00941304|39769063|FG004|Overall Study|Lost to Follow-up|0|||
16350381|NCT01534273|39769065|FG000|Period 1|Physician Decision|0|||
16350382|NCT01534273|39769066|FG001|Period 1|Physician Decision|0|||
16350383|NCT01534273|39769067|FG002|Period 1|Physician Decision|0|||
16350384|NCT01534273|39769068|FG003|Period 1|Physician Decision|1|||
16350385|NCT01534273|39769069|FG004|Period 1|Physician Decision|0|||
16350386|NCT01534273|39769070|FG005|Period 1|Physician Decision|0|||
16350387|NCT01534273|39769071|FG006|Period 1|Physician Decision|0|||
16350388|NCT04030598|39769072|FG000|Overall Study|Voluntary Withdrawal|0|||
16350389|NCT04030598|39769073|FG001|Overall Study|Voluntary Withdrawal|1|||
16350390|NCT04030598|39769074|FG002|Overall Study|Voluntary Withdrawal|0|||
16350391|NCT02131064|39769075|FG000|Overall Study|Death|5|||
16350392|NCT02131064|39769076|FG001|Overall Study|Death|6|||
16350393|NCT02131064|39769075|FG000|Overall Study|Lost to Follow-up|4|||
16350394|NCT02131064|39769076|FG001|Overall Study|Lost to Follow-up|8|||
16350395|NCT02131064|39769075|FG000|Overall Study|Withdrawal by Subject|14|||
16350396|NCT02131064|39769076|FG001|Overall Study|Withdrawal by Subject|18|||
16350397|NCT02131064|39769075|FG000|Overall Study|Other|2|||
16350398|NCT02131064|39769076|FG001|Overall Study|Other|2|||
16350399|NCT02974868|39769077|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
16350400|NCT02974868|39769078|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
16350401|NCT02974868|39769079|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
16350402|NCT02974868|39769080|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
16350403|NCT02974868|39769077|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
16350404|NCT02974868|39769078|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
16350405|NCT02974868|39769079|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
16350406|NCT02974868|39769080|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
16350407|NCT02974868|39769077|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
16350408|NCT02974868|39769078|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
16350409|NCT02974868|39769079|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
16350410|NCT02974868|39769080|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
16350411|NCT02974868|39769077|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
16350412|NCT02974868|39769078|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
16350413|NCT02974868|39769079|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
16350414|NCT02974868|39769080|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
16350415|NCT01059773|39769081|FG000|Overall Study|Adverse Event|2|||
16124649|NCT01593787|38942272|FG000|Overall Study|Adverse Event|1|||
16350416|NCT01059773|39769082|FG001|Overall Study|Adverse Event|2|||
16350417|NCT01059773|39769081|FG000|Overall Study|Withdrawal by Subject|1|||
16350418|NCT01059773|39769082|FG001|Overall Study|Withdrawal by Subject|5|||
16350419|NCT01059773|39769081|FG000|Overall Study|Lost to Follow-up|1|||
16350420|NCT01059773|39769082|FG001|Overall Study|Lost to Follow-up|1|||
16350421|NCT01059773|39769081|FG000|Overall Study|Pregnancy|1|||
16350422|NCT01059773|39769082|FG001|Overall Study|Pregnancy|1|||
16350423|NCT01059773|39769081|FG000|Overall Study|Protocol Violation|6|||
16350424|NCT01059773|39769082|FG001|Overall Study|Protocol Violation|2|||
16557671|NCT02564055|40506598|FG002|Overall Study|Withdrawal by Subject|3|||
16241610|NCT04130919|39368657|FG001|Blinded Treatment Phase|Disease worsening|0|||
16241611|NCT04130919|39368658|FG002|Blinded Treatment Phase|Disease worsening|1|||
16241612|NCT04130919|39368659|FG003|Blinded Treatment Phase|Disease worsening|0|||
16557672|NCT02564055|40506599|FG003|Overall Study|Withdrawal by Subject|3|||
16557673|NCT02564055|40506600|FG004|Overall Study|Withdrawal by Subject|10|||
16557674|NCT02564055|40506601|FG005|Overall Study|Withdrawal by Subject|10|||
16557675|NCT02909101|40506602|FG000|Overall Study|Lost to Follow-up|1|||
16557676|NCT02909101|40506603|FG001|Overall Study|Lost to Follow-up|1|||
16557677|NCT02040090|40506606|FG000|Overall Study|Adverse Event|2|||
16557678|NCT02040090|40506607|FG001|Overall Study|Adverse Event|0|||
16557679|NCT02040090|40506606|FG000|Overall Study|Physician Decision|1|||
16557680|NCT02040090|40506607|FG001|Overall Study|Physician Decision|0|||
16557681|NCT02040090|40506606|FG000|Overall Study|Withdrawal by Subject|0|||
16557682|NCT02040090|40506607|FG001|Overall Study|Withdrawal by Subject|1|||
16557683|NCT02040090|40506606|FG000|Overall Study|Lost to Follow-up|0|||
16557684|NCT02040090|40506607|FG001|Overall Study|Lost to Follow-up|1|||
16557685|NCT01158378|40506614|FG000|Overall Study|Death|4|||
16414494|NCT03191786|39998457|FG000|Overall Study|Lost to Follow-up|9|||
16414495|NCT03191786|39998458|FG001|Overall Study|Lost to Follow-up|3|||
16241613|NCT04130919|39368660|FG004|Blinded Treatment Phase|Disease worsening|0|||
16241614|NCT04130919|39368661|FG005|Blinded Treatment Phase|Disease worsening|0|||
16241615|NCT04130919|39368656|FG000|Blinded Treatment Phase|Investigator's decision|0|||
16241616|NCT04130919|39368657|FG001|Blinded Treatment Phase|Investigator's decision|1|||
16241617|NCT04130919|39368658|FG002|Blinded Treatment Phase|Investigator's decision|0|||
16241618|NCT04130919|39368659|FG003|Blinded Treatment Phase|Investigator's decision|0|||
16241619|NCT04130919|39368660|FG004|Blinded Treatment Phase|Investigator's decision|0|||
16241620|NCT04130919|39368661|FG005|Blinded Treatment Phase|Investigator's decision|0|||
16241621|NCT04130919|39368656|FG000|Blinded Treatment Phase|Withdrew consent|1|||
16241622|NCT04130919|39368657|FG001|Blinded Treatment Phase|Withdrew consent|0|||
16241623|NCT04130919|39368658|FG002|Blinded Treatment Phase|Withdrew consent|0|||
16414496|NCT03191786|39998457|FG000|Overall Study|Physician Decision|1|||
16414497|NCT03191786|39998458|FG001|Overall Study|Physician Decision|0|||
16414498|NCT03191786|39998457|FG000|Overall Study|Study Terminated By Sponsor|15|||
16414499|NCT03191786|39998458|FG001|Overall Study|Study Terminated By Sponsor|5|||
16414500|NCT03191786|39998457|FG000|Overall Study|Withdrawal by Subject|26|||
16414501|NCT03191786|39998458|FG001|Overall Study|Withdrawal by Subject|16|||
16414502|NCT02704689|39998459|FG000|Overall Study|Physician Decision|1|||
16414503|NCT02704689|39998459|FG000|Overall Study|Study device not implanted|2|||
16557686|NCT01158378|40506615|FG001|Overall Study|Death|5|||
16557687|NCT01158378|40506614|FG000|Overall Study|Lost to Follow-up|2|||
16557688|NCT01158378|40506615|FG001|Overall Study|Lost to Follow-up|4|||
16557689|NCT01158378|40506614|FG000|Overall Study|Withdrawal by Subject|4|||
16557690|NCT01158378|40506615|FG001|Overall Study|Withdrawal by Subject|0|||
16557691|NCT04496167|40506620|FG000|Overall Study|Adverse Event|6|||
16557692|NCT04496167|40506621|FG001|Overall Study|Adverse Event|2|||
16557693|NCT04496167|40506620|FG000|Overall Study|Withdrawal by Subject|7|||
16557694|NCT04496167|40506621|FG001|Overall Study|Withdrawal by Subject|6|||
16557695|NCT04496167|40506620|FG000|Overall Study|Lost to Follow-up|3|||
16557696|NCT04496167|40506621|FG001|Overall Study|Lost to Follow-up|5|||
16557697|NCT04496167|40506620|FG000|Overall Study|Not Treated|1|||
16557698|NCT04496167|40506621|FG001|Overall Study|Not Treated|2|||
16557699|NCT04496167|40506620|FG000|Overall Study|Other Than Specified|1|||
16557700|NCT04496167|40506621|FG001|Overall Study|Other Than Specified|1|||
16557701|NCT01007552|40506624|FG000|Overall Study|Withdrawal by Subject|1|||
16557702|NCT01712789|40506626|FG000|Overall Study|Lack of Efficacy|2|||
16557703|NCT01712789|40506626|FG000|Overall Study|Lost to Follow-up|1|||
16557704|NCT01712789|40506626|FG000|Overall Study|Progressive Disease|504|||
16557705|NCT01712789|40506626|FG000|Overall Study|Death|57|||
16557706|NCT01712789|40506626|FG000|Overall Study|Adverse Event|52|||
16241624|NCT04130919|39368659|FG003|Blinded Treatment Phase|Withdrew consent|0|||
16241625|NCT04130919|39368660|FG004|Blinded Treatment Phase|Withdrew consent|0|||
16241626|NCT04130919|39368661|FG005|Blinded Treatment Phase|Withdrew consent|0|||
16241627|NCT04130919|39368656|FG000|Open-label Treatment Phase|Withdrew consent|0|||
16414504|NCT03271047|39998460|FG000|Phase 1b: Dose Finding Period|Death|8|||
16557707|NCT01712789|40506626|FG000|Overall Study|Miscellaneous|31|||
16557708|NCT01712789|40506626|FG000|Overall Study|Withdrawal by Subject|21|||
16557709|NCT01712789|40506626|FG000|Overall Study|Transition to Commercial Treatment|8|||
16557710|NCT01712789|40506626|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
16557711|NCT01815736|40506627|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
16557712|NCT01815736|40506628|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
16557713|NCT01815736|40506627|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
16557714|NCT01815736|40506628|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
16557715|NCT01815736|40506627|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
16241628|NCT04130919|39368657|FG001|Open-label Treatment Phase|Withdrew consent|0|||
16241629|NCT04130919|39368658|FG002|Open-label Treatment Phase|Withdrew consent|0|||
16241630|NCT04130919|39368659|FG003|Open-label Treatment Phase|Withdrew consent|1|||
16241631|NCT04130919|39368660|FG004|Open-label Treatment Phase|Withdrew consent|1|||
16241632|NCT04130919|39368661|FG005|Open-label Treatment Phase|Withdrew consent|1|||
16241633|NCT04130919|39368656|FG000|Open-label Treatment Phase|Disease worsening|0|||
16241634|NCT04130919|39368657|FG001|Open-label Treatment Phase|Disease worsening|0|||
16241635|NCT04130919|39368658|FG002|Open-label Treatment Phase|Disease worsening|0|||
16241636|NCT04130919|39368659|FG003|Open-label Treatment Phase|Disease worsening|1|||
16557716|NCT01815736|40506628|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
16557717|NCT01815736|40506627|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
16557718|NCT01815736|40506628|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
16557719|NCT01815736|40506627|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
16557720|NCT01815736|40506628|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
16557721|NCT01815736|40506627|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
16557722|NCT01815736|40506628|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
16557723|NCT01815736|40506627|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
16557724|NCT01815736|40506628|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
16557725|NCT01815736|40506627|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
16557726|NCT01815736|40506628|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
16557727|NCT01815736|40506627|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
16557728|NCT01815736|40506628|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
16557729|NCT01815736|40506627|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
16557730|NCT01815736|40506628|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
16557731|NCT01815736|40506627|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
16557732|NCT01815736|40506628|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
16557733|NCT01815736|40506627|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
16557734|NCT01815736|40506628|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
16557735|NCT01815736|40506627|FG000|Extension Treatment Phase- After Week 96|Death|1|||
16557736|NCT01815736|40506628|FG001|Extension Treatment Phase- After Week 96|Death|0|||
16557737|NCT00556374|40506629|FG000|Overall Study|Withdrawal by Subject|235|||
16557738|NCT00556374|40506630|FG001|Overall Study|Withdrawal by Subject|205|||
16557739|NCT00556374|40506629|FG000|Overall Study|Death|158|||
16557740|NCT00556374|40506630|FG001|Overall Study|Death|127|||
16557741|NCT00556374|40506629|FG000|Overall Study|Lost to Follow-up|24|||
16557742|NCT00556374|40506630|FG001|Overall Study|Lost to Follow-up|17|||
16241637|NCT04130919|39368660|FG004|Open-label Treatment Phase|Disease worsening|0|||
16241638|NCT04130919|39368661|FG005|Open-label Treatment Phase|Disease worsening|1|||
16241639|NCT04130919|39368656|FG000|Open-label Treatment Phase|Investigator's decision|0|||
16241640|NCT04130919|39368657|FG001|Open-label Treatment Phase|Investigator's decision|0|||
16241641|NCT04130919|39368658|FG002|Open-label Treatment Phase|Investigator's decision|0|||
16241642|NCT04130919|39368659|FG003|Open-label Treatment Phase|Investigator's decision|1|||
16241643|NCT04130919|39368660|FG004|Open-label Treatment Phase|Investigator's decision|0|||
16241644|NCT04130919|39368661|FG005|Open-label Treatment Phase|Investigator's decision|0|||
16241645|NCT04130919|39368656|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
16241646|NCT04130919|39368657|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
16241647|NCT04130919|39368658|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
16241648|NCT04130919|39368659|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
16241649|NCT04130919|39368660|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
16241650|NCT04130919|39368661|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
16241651|NCT04130919|39368656|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
16241652|NCT04130919|39368657|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
16241653|NCT04130919|39368658|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
16241654|NCT04130919|39368659|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
16241655|NCT04130919|39368660|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
16241656|NCT04130919|39368661|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
16350425|NCT01059773|39769081|FG000|Overall Study|Physician Decision|5|||
16350426|NCT01059773|39769082|FG001|Overall Study|Physician Decision|4|||
16350427|NCT01059773|39769081|FG000|Overall Study|Lack of Efficacy|3|||
16350428|NCT01059773|39769082|FG001|Overall Study|Lack of Efficacy|3|||
16350429|NCT01059773|39769081|FG000|Overall Study|Death|0|||
16350430|NCT01059773|39769082|FG001|Overall Study|Death|1|||
16350431|NCT01059773|39769081|FG000|Overall Study|Malignancy including squamous cell skin|0|||
16241657|NCT01408576|39368663|FG000|Overall Study|Lack of Efficacy|17|||
16350432|NCT01059773|39769082|FG001|Overall Study|Malignancy including squamous cell skin|1|||
16241658|NCT01408576|39368664|FG001|Overall Study|Lack of Efficacy|30|||
16350433|NCT01059773|39769081|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
16241659|NCT01408576|39368665|FG002|Overall Study|Lack of Efficacy|48|||
16241660|NCT01408576|39368663|FG000|Overall Study|Protocol Violation|1|||
16414505|NCT03271047|39998461|FG001|Phase 1b: Dose Finding Period|Death|8|||
16414506|NCT03271047|39998462|FG002|Phase 1b: Dose Finding Period|Death|0|||
16414507|NCT03271047|39998463|FG003|Phase 1b: Dose Finding Period|Death|0|||
16414508|NCT03271047|39998460|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
16241661|NCT01408576|39368664|FG001|Overall Study|Protocol Violation|2|||
16241662|NCT01408576|39368665|FG002|Overall Study|Protocol Violation|2|||
16241663|NCT01408576|39368663|FG000|Overall Study|Lost to Follow-up|10|||
16241664|NCT01408576|39368664|FG001|Overall Study|Lost to Follow-up|9|||
16241665|NCT01408576|39368665|FG002|Overall Study|Lost to Follow-up|17|||
16241666|NCT01408576|39368663|FG000|Overall Study|Withdrawal by Subject|34|||
16241667|NCT01408576|39368664|FG001|Overall Study|Withdrawal by Subject|60|||
16241668|NCT01408576|39368665|FG002|Overall Study|Withdrawal by Subject|66|||
16241669|NCT01408576|39368663|FG000|Overall Study|Sponsor terminated study|89|||
16241670|NCT01408576|39368664|FG001|Overall Study|Sponsor terminated study|333|||
16241671|NCT01408576|39368665|FG002|Overall Study|Sponsor terminated study|330|||
16241672|NCT01408576|39368663|FG000|Overall Study|AE, serious fatal|4|||
16241673|NCT01408576|39368664|FG001|Overall Study|AE, serious fatal|4|||
16241674|NCT01408576|39368665|FG002|Overall Study|AE, serious fatal|1|||
16241675|NCT01408576|39368663|FG000|Overall Study|SAE, non-fatal|11|||
16241676|NCT01408576|39368664|FG001|Overall Study|SAE, non-fatal|23|||
16241677|NCT01408576|39368665|FG002|Overall Study|SAE, non-fatal|14|||
16241678|NCT01408576|39368663|FG000|Overall Study|AE, non-serious non-fatal|12|||
16241679|NCT01408576|39368664|FG001|Overall Study|AE, non-serious non-fatal|19|||
16241680|NCT01408576|39368665|FG002|Overall Study|AE, non-serious non-fatal|11|||
16241681|NCT01408576|39368663|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
16241682|NCT01408576|39368664|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16241683|NCT01408576|39368665|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16241684|NCT01408576|39368663|FG000|Overall Study|AE, unknown type|0|||
16241685|NCT01408576|39368664|FG001|Overall Study|AE, unknown type|1|||
16241686|NCT01408576|39368665|FG002|Overall Study|AE, unknown type|0|||
16241687|NCT01408576|39368663|FG000|Overall Study|Other|10|||
16241688|NCT01408576|39368664|FG001|Overall Study|Other|16|||
16241689|NCT01408576|39368665|FG002|Overall Study|Other|18|||
16241690|NCT01361607|39368670|FG000|Overall Study|Adverse Event|38|||
16241691|NCT01361607|39368671|FG001|Overall Study|Adverse Event|29|||
16241692|NCT01361607|39368670|FG000|Overall Study|Withdrawal by Subject|19|||
16241693|NCT01361607|39368671|FG001|Overall Study|Withdrawal by Subject|8|||
16241694|NCT01361607|39368670|FG000|Overall Study|Withdrawal by Investigator|5|||
16241695|NCT01361607|39368671|FG001|Overall Study|Withdrawal by Investigator|3|||
16241696|NCT01361607|39368670|FG000|Overall Study|Lost to Follow-up|1|||
16241697|NCT01361607|39368671|FG001|Overall Study|Lost to Follow-up|0|||
16241698|NCT01361607|39368670|FG000|Overall Study|Met Withdrawal Criteria|1|||
16241699|NCT01361607|39368671|FG001|Overall Study|Met Withdrawal Criteria|1|||
16241700|NCT03726437|39368672|FG000|Overall Study|Lost to Follow-up|85|||
16241701|NCT03726437|39368673|FG001|Overall Study|Lost to Follow-up|76|||
16241702|NCT02239601|39368674|FG000|Overall Study|Withdrawal by Subject|3|||
16241703|NCT02239601|39368675|FG001|Overall Study|Withdrawal by Subject|4|||
16241704|NCT02239601|39368674|FG000|Overall Study|Protocol Violation|4|||
16241705|NCT02239601|39368675|FG001|Overall Study|Protocol Violation|2|||
16241706|NCT01299038|39368676|FG000|Overall Study|Withdrawal by Subject|1|||
16241707|NCT01299038|39368677|FG001|Overall Study|Withdrawal by Subject|0|||
16241708|NCT02476851|39368678|FG000|Overall Study|Protocol Violation|1|||
16241709|NCT02476851|39368679|FG001|Overall Study|Protocol Violation|1|||
16241710|NCT01504867|39368680|FG000|Overall Study|Inclusion criteria not met|2|||
16241711|NCT01504867|39368681|FG001|Overall Study|Inclusion criteria not met|2|||
16241712|NCT01504867|39368680|FG000|Overall Study|Consent revoked|5|||
16241713|NCT01504867|39368681|FG001|Overall Study|Consent revoked|1|||
16241714|NCT00729365|39368684|FG000|Overall Study|Physician Decision|33|||
16241715|NCT00729365|39368685|FG001|Overall Study|Physician Decision|6|||
16414509|NCT03271047|39998461|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
16414510|NCT03271047|39998462|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
16241716|NCT00729365|39368686|FG002|Overall Study|Physician Decision|7|||
16241717|NCT02072174|39368687|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
16241718|NCT02072174|39368688|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
16241719|NCT02072174|39368687|FG000|Overall Study|Protocol Violation|16|||
16241720|NCT02072174|39368688|FG001|Overall Study|Protocol Violation|23|||
16241721|NCT02072174|39368687|FG000|Overall Study|Physician Decision|0|||
16241722|NCT02072174|39368688|FG001|Overall Study|Physician Decision|1|||
16241723|NCT02072174|39368687|FG000|Overall Study|Non-compliance with protocol requirement|2|||
16241724|NCT02072174|39368688|FG001|Overall Study|Non-compliance with protocol requirement|0|||
16241725|NCT01689974|39368689|FG000|Overall Study|Termination of Study|5|||
16241726|NCT01689974|39368690|FG001|Overall Study|Termination of Study|5|||
16241727|NCT00066807|39368691|FG000|Overall Study|Study was terminated early|14|||
16414511|NCT03271047|39998463|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
16241728|NCT00066807|39368692|FG001|Overall Study|Study was terminated early|15|||
16414512|NCT03271047|39998460|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
16414513|NCT03271047|39998461|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
16414514|NCT03271047|39998462|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
16414515|NCT03271047|39998463|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
16414516|NCT03271047|39998460|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
16414517|NCT03271047|39998461|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
16414518|NCT03271047|39998462|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
16414519|NCT03271047|39998463|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
16414520|NCT03271047|39998460|FG000|Randomized Phase 2 Period|Other|0|||
16414521|NCT03271047|39998461|FG001|Randomized Phase 2 Period|Other|0|||
16414522|NCT03271047|39998462|FG002|Randomized Phase 2 Period|Other|0|||
16414523|NCT03271047|39998463|FG003|Randomized Phase 2 Period|Other|1|||
16414524|NCT03271047|39998460|FG000|Randomized Phase 2 Period|Death|0|||
16414525|NCT03271047|39998461|FG001|Randomized Phase 2 Period|Death|0|||
16414526|NCT03271047|39998462|FG002|Randomized Phase 2 Period|Death|20|||
16414527|NCT03271047|39998463|FG003|Randomized Phase 2 Period|Death|21|||
16414528|NCT03271047|39998460|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
16414529|NCT03271047|39998461|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
16414530|NCT03271047|39998462|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
16414531|NCT03271047|39998463|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
16350434|NCT01059773|39769082|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
16124650|NCT01593787|38942273|FG001|Overall Study|Adverse Event|0|||
16124651|NCT01593787|38942274|FG002|Overall Study|Adverse Event|0|||
16350435|NCT01059773|39769081|FG000|Overall Study|Other|1|||
16350436|NCT01059773|39769082|FG001|Overall Study|Other|3|||
16350437|NCT01405898|39769083|FG000|Overall Study|Withdrawal by Subject|2|||
16350438|NCT01405898|39769084|FG001|Overall Study|Withdrawal by Subject|2|||
16350439|NCT02810418|39769086|FG000|Arm A Dose Escalation|Adverse Event|2|||
16350440|NCT02810418|39769087|FG001|Arm A Dose Escalation|Adverse Event|1|||
16350441|NCT02810418|39769088|FG002|Arm A Dose Escalation|Adverse Event|0|||
16350442|NCT02810418|39769089|FG003|Arm A Dose Escalation|Adverse Event|0|||
16350443|NCT02810418|39769090|FG004|Arm A Dose Escalation|Adverse Event|0|||
16350444|NCT02810418|39769091|FG005|Arm A Dose Escalation|Adverse Event|0|||
16350445|NCT02810418|39769092|FG006|Arm A Dose Escalation|Adverse Event|0|||
16350446|NCT02810418|39769086|FG000|Dose Expansion|Adverse Event|0|||
16350447|NCT02810418|39769087|FG001|Dose Expansion|Adverse Event|1|||
16414532|NCT03271047|39998460|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
16414533|NCT03271047|39998461|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
16350448|NCT02810418|39769088|FG002|Dose Expansion|Adverse Event|1|||
16350449|NCT02810418|39769089|FG003|Dose Expansion|Adverse Event|0|||
16124673|NCT02304705|38942278|FG000|Overall Study|Withdrawal by Subject|2|||
16124674|NCT02304705|38942279|FG001|Overall Study|Withdrawal by Subject|0|||
16124675|NCT02304705|38942278|FG000|Overall Study|Physician Decision|2|||
16124676|NCT02304705|38942279|FG001|Overall Study|Physician Decision|4|||
16124677|NCT02304705|38942278|FG000|Overall Study|Death|0|||
16124678|NCT02304705|38942279|FG001|Overall Study|Death|1|||
16124679|NCT02304705|38942278|FG000|Overall Study|Lost to Follow-up|0|||
16124680|NCT02304705|38942279|FG001|Overall Study|Lost to Follow-up|2|||
16124681|NCT00306670|38942280|FG000|Overall Study|patients recruited; Genentech, the st|0|||
16124682|NCT00306670|38942281|FG001|Overall Study|patients recruited; Genentech, the st|2|||
16124683|NCT04510090|38942283|FG000|FE-HS|Withdrawal by Subject|0|||
16124684|NCT04510090|38942284|FG001|FE-HS|Withdrawal by Subject|0|||
16124685|NCT04510090|38942285|FG002|FE-HS|Withdrawal by Subject|0|||
16124686|NCT04510090|38942286|FG003|FE-HS|Withdrawal by Subject|0|||
16124687|NCT04510090|38942287|FG004|FE-HS|Withdrawal by Subject|1|||
16124688|NCT04510090|38942288|FG005|FE-HS|Withdrawal by Subject|0|||
16124689|NCT04510090|38942289|FG006|FE-HS|Withdrawal by Subject|0|||
16124690|NCT04510090|38942290|FG007|FE-HS|Withdrawal by Subject|0|||
16124691|NCT01281839|38942292|FG000|Overall Study|Lost to Follow-up|6|||
16124692|NCT01281839|38942293|FG001|Overall Study|Lost to Follow-up|3|||
16124693|NCT01281839|38942292|FG000|Overall Study|Withdrawal by Subject|4|||
16124694|NCT01281839|38942293|FG001|Overall Study|Withdrawal by Subject|10|||
16124695|NCT01281839|38942292|FG000|Overall Study|Reason not specified|0|||
16124696|NCT01281839|38942293|FG001|Overall Study|Reason not specified|1|||
16124697|NCT01127763|38942294|FG000|Overall Study|Adverse Event|2|||
16124698|NCT01127763|38942294|FG000|Overall Study|Withdrawal by Subject|1|||
16124699|NCT01127763|38942294|FG000|Overall Study|Physician Decision|2|||
16124700|NCT01323972|38942298|FG000|Overall Study|Withdrawal by Subject|1|||
16124701|NCT01323972|38942299|FG001|Overall Study|Withdrawal by Subject|0|||
16124702|NCT01323972|38942300|FG002|Overall Study|Withdrawal by Subject|1|||
16241729|NCT04556838|39368706|FG000|Overall Study|Withdrawal by Subject|3|||
16241730|NCT04556838|39368707|FG001|Overall Study|Withdrawal by Subject|1|||
16241731|NCT04556838|39368708|FG002|Overall Study|Withdrawal by Subject|2|||
16241732|NCT04556838|39368706|FG000|Overall Study|Adverse Event|0|||
16241733|NCT04556838|39368707|FG001|Overall Study|Adverse Event|1|||
16241734|NCT04556838|39368708|FG002|Overall Study|Adverse Event|1|||
16241735|NCT04556838|39368706|FG000|Overall Study|Lost to Follow-up|0|||
16241736|NCT04556838|39368707|FG001|Overall Study|Lost to Follow-up|0|||
16241737|NCT04556838|39368708|FG002|Overall Study|Lost to Follow-up|2|||
16241738|NCT04556838|39368706|FG000|Overall Study|Subject travel|0|||
16124703|NCT01323972|38942301|FG003|Overall Study|Withdrawal by Subject|0|||
16124704|NCT01323972|38942298|FG000|Overall Study|Migrated/moved from study area|1|||
16124705|NCT01323972|38942299|FG001|Overall Study|Migrated/moved from study area|2|||
16124706|NCT01323972|38942300|FG002|Overall Study|Migrated/moved from study area|0|||
16124707|NCT01323972|38942301|FG003|Overall Study|Migrated/moved from study area|0|||
16124708|NCT01323972|38942298|FG000|Overall Study|Lost to Follow-up|0|||
16124709|NCT01323972|38942299|FG001|Overall Study|Lost to Follow-up|1|||
16124710|NCT01323972|38942300|FG002|Overall Study|Lost to Follow-up|1|||
16241739|NCT04556838|39368707|FG001|Overall Study|Subject travel|1|||
16241740|NCT04556838|39368708|FG002|Overall Study|Subject travel|0|||
16241741|NCT04556838|39368706|FG000|Overall Study|Physician Decision|1|||
16350450|NCT02810418|39769090|FG004|Dose Expansion|Adverse Event|0|||
16350451|NCT02810418|39769091|FG005|Dose Expansion|Adverse Event|0|||
16350452|NCT02810418|39769092|FG006|Dose Expansion|Adverse Event|0|||
16350453|NCT02810418|39769086|FG000|Dose Expansion|Physician Decision|0|||
16350454|NCT02810418|39769087|FG001|Dose Expansion|Physician Decision|0|||
16350455|NCT02810418|39769088|FG002|Dose Expansion|Physician Decision|2|||
16350456|NCT02810418|39769089|FG003|Dose Expansion|Physician Decision|0|||
16241742|NCT04556838|39368707|FG001|Overall Study|Physician Decision|0|||
16350457|NCT02810418|39769090|FG004|Dose Expansion|Physician Decision|0|||
16350458|NCT02810418|39769091|FG005|Dose Expansion|Physician Decision|0|||
16350459|NCT02810418|39769092|FG006|Dose Expansion|Physician Decision|0|||
16414534|NCT03271047|39998462|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
16414535|NCT03271047|39998463|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
16414536|NCT03271047|39998460|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
16414537|NCT03271047|39998461|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
16414538|NCT03271047|39998462|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
16414539|NCT03271047|39998463|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
16414540|NCT01267175|39998465|FG000|Overall Study|Withdrawal by Subject|1|||
16414541|NCT01267175|39998465|FG000|Overall Study|Lost to Follow-up|1|||
16414542|NCT02771626|39998466|FG000|Overall Study|Adverse Event|1|||
16414543|NCT02771626|39998467|FG001|Overall Study|Adverse Event|5|||
16414544|NCT02771626|39998468|FG002|Overall Study|Adverse Event|3|||
16414545|NCT02771626|39998469|FG003|Overall Study|Adverse Event|0|||
16414546|NCT02771626|39998470|FG004|Overall Study|Adverse Event|1|||
16414547|NCT02771626|39998471|FG005|Overall Study|Adverse Event|1|||
16414548|NCT02771626|39998466|FG000|Overall Study|Radiologic Disease Progression|6|||
16414549|NCT02771626|39998467|FG001|Overall Study|Radiologic Disease Progression|13|||
16414550|NCT02771626|39998468|FG002|Overall Study|Radiologic Disease Progression|10|||
16414551|NCT02771626|39998469|FG003|Overall Study|Radiologic Disease Progression|7|||
16414552|NCT02771626|39998470|FG004|Overall Study|Radiologic Disease Progression|28|||
16414553|NCT02771626|39998471|FG005|Overall Study|Radiologic Disease Progression|15|||
16414554|NCT02771626|39998466|FG000|Overall Study|Symptomatic Deterioration|0|||
16414555|NCT02771626|39998467|FG001|Overall Study|Symptomatic Deterioration|4|||
16414556|NCT02771626|39998468|FG002|Overall Study|Symptomatic Deterioration|2|||
16414557|NCT02771626|39998469|FG003|Overall Study|Symptomatic Deterioration|0|||
16414558|NCT02771626|39998470|FG004|Overall Study|Symptomatic Deterioration|5|||
16414559|NCT02771626|39998471|FG005|Overall Study|Symptomatic Deterioration|2|||
16414560|NCT02771626|39998466|FG000|Overall Study|Participant Request|0|||
16414561|NCT02771626|39998467|FG001|Overall Study|Participant Request|1|||
16414562|NCT02771626|39998468|FG002|Overall Study|Participant Request|0|||
16414563|NCT02771626|39998469|FG003|Overall Study|Participant Request|2|||
16414564|NCT02771626|39998470|FG004|Overall Study|Participant Request|0|||
16414565|NCT02771626|39998471|FG005|Overall Study|Participant Request|1|||
16414566|NCT02771626|39998466|FG000|Overall Study|Investigator Decision|0|||
16414567|NCT02771626|39998467|FG001|Overall Study|Investigator Decision|1|||
16414568|NCT02771626|39998468|FG002|Overall Study|Investigator Decision|0|||
16414569|NCT02771626|39998469|FG003|Overall Study|Investigator Decision|0|||
16414570|NCT02771626|39998470|FG004|Overall Study|Investigator Decision|1|||
16414571|NCT02771626|39998471|FG005|Overall Study|Investigator Decision|0|||
16414572|NCT02771626|39998466|FG000|Overall Study|Study Termination by Sponsor|0|||
16414573|NCT02771626|39998467|FG001|Overall Study|Study Termination by Sponsor|2|||
16414574|NCT02771626|39998468|FG002|Overall Study|Study Termination by Sponsor|1|||
16414575|NCT02771626|39998469|FG003|Overall Study|Study Termination by Sponsor|0|||
16414576|NCT02771626|39998470|FG004|Overall Study|Study Termination by Sponsor|1|||
16414577|NCT02771626|39998471|FG005|Overall Study|Study Termination by Sponsor|0|||
16414578|NCT02771626|39998466|FG000|Overall Study|Informed Consent Withdrawn|0|||
16414579|NCT02771626|39998467|FG001|Overall Study|Informed Consent Withdrawn|0|||
16414580|NCT02771626|39998468|FG002|Overall Study|Informed Consent Withdrawn|1|||
16414581|NCT02771626|39998469|FG003|Overall Study|Informed Consent Withdrawn|0|||
16414582|NCT02771626|39998470|FG004|Overall Study|Informed Consent Withdrawn|1|||
16414583|NCT02771626|39998471|FG005|Overall Study|Informed Consent Withdrawn|1|||
16414584|NCT02771626|39998466|FG000|Overall Study|Other, Not Specified|1|||
16414585|NCT02771626|39998467|FG001|Overall Study|Other, Not Specified|0|||
16414586|NCT02771626|39998468|FG002|Overall Study|Other, Not Specified|0|||
16414587|NCT02771626|39998469|FG003|Overall Study|Other, Not Specified|0|||
16414588|NCT02771626|39998470|FG004|Overall Study|Other, Not Specified|0|||
16124711|NCT01323972|38942301|FG003|Overall Study|Lost to Follow-up|1|||
16414589|NCT02771626|39998471|FG005|Overall Study|Other, Not Specified|1|||
16414590|NCT03322423|39998472|FG000|Period 1|Subject no longer eligible|0|||
16414591|NCT03322423|39998473|FG001|Period 1|Subject no longer eligible|1|||
16414592|NCT03322423|39998472|FG000|Period 1|Withdrawal by Subject|0|||
16414593|NCT03322423|39998473|FG001|Period 1|Withdrawal by Subject|1|||
16414594|NCT03322423|39998472|FG000|Period 1|Incorrect Lens Dispensed|1|||
16414595|NCT03322423|39998473|FG001|Period 1|Incorrect Lens Dispensed|0|||
16414596|NCT03322423|39998472|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
16414597|NCT03322423|39998473|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
16414598|NCT03322423|39998472|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
16414599|NCT03322423|39998473|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
16414600|NCT03322423|39998472|FG000|Period 2|Protocol Violation|1|||
16414601|NCT03322423|39998473|FG001|Period 2|Protocol Violation|0|||
16414602|NCT03322423|39998472|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
16414603|NCT03322423|39998473|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
16414604|NCT01541917|39998474|FG000|Overall Study|Lost to Follow-up|2|||
16414605|NCT01541917|39998475|FG001|Overall Study|Lost to Follow-up|2|||
16414606|NCT01541917|39998474|FG000|Overall Study|Withdrawal by Subject|13|||
16414607|NCT01541917|39998475|FG001|Overall Study|Withdrawal by Subject|7|||
16414608|NCT00619489|39998476|FG000|Overall Study|Adverse Event|0|||
16414609|NCT00619489|39998477|FG001|Overall Study|Adverse Event|7|||
16350460|NCT02810418|39769086|FG000|Arm B Dose Escalation|Adverse Event|0|||
16350461|NCT02810418|39769087|FG001|Arm B Dose Escalation|Adverse Event|0|||
16414610|NCT00619489|39998476|FG000|Overall Study|Withdrawal by Subject|1|||
16414611|NCT00619489|39998477|FG001|Overall Study|Withdrawal by Subject|1|||
16414612|NCT00619489|39998476|FG000|Overall Study|Lack of Efficacy|0|||
16414613|NCT00619489|39998477|FG001|Overall Study|Lack of Efficacy|11|||
16414614|NCT00619489|39998476|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
16414615|NCT00619489|39998477|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
16414616|NCT00969436|39998478|FG000|Overall Study|Protocol Violation|1|||
16414617|NCT00969436|39998479|FG001|Overall Study|Protocol Violation|3|||
16414618|NCT00969436|39998480|FG002|Overall Study|Protocol Violation|0|||
16414619|NCT00969436|39998478|FG000|Overall Study|Migrated/moved from study area|12|||
16414620|NCT00969436|39998479|FG001|Overall Study|Migrated/moved from study area|10|||
16414621|NCT00969436|39998480|FG002|Overall Study|Migrated/moved from study area|2|||
16414622|NCT00969436|39998478|FG000|Overall Study|Father - serious health problem|0|||
16414623|NCT00969436|39998479|FG001|Overall Study|Father - serious health problem|0|||
16414624|NCT00969436|39998480|FG002|Overall Study|Father - serious health problem|1|||
16414625|NCT00969436|39998478|FG000|Overall Study|Parents personal problem|0|||
16414626|NCT00969436|39998479|FG001|Overall Study|Parents personal problem|0|||
16414627|NCT00969436|39998480|FG002|Overall Study|Parents personal problem|1|||
16414628|NCT00969436|39998478|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
16414629|NCT00969436|39998479|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
16414630|NCT00969436|39998480|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
16414631|NCT00969436|39998478|FG000|Overall Study|Withdrawal by Subject|3|||
16414632|NCT00969436|39998479|FG001|Overall Study|Withdrawal by Subject|0|||
16414633|NCT00969436|39998480|FG002|Overall Study|Withdrawal by Subject|2|||
16414634|NCT00969436|39998478|FG000|Overall Study|Lost to Follow-up|8|||
16414635|NCT00969436|39998479|FG001|Overall Study|Lost to Follow-up|8|||
16414636|NCT00969436|39998480|FG002|Overall Study|Lost to Follow-up|5|||
16414637|NCT02012686|39998481|FG000|Overall Study|muscle contraction|0|||
16414638|NCT02012686|39998482|FG001|Overall Study|muscle contraction|1|||
16414639|NCT02012686|39998481|FG000|Overall Study|electrocardiography monitoring noise|0|||
16350462|NCT02810418|39769088|FG002|Arm B Dose Escalation|Adverse Event|0|||
16350463|NCT02810418|39769089|FG003|Arm B Dose Escalation|Adverse Event|0|||
16350464|NCT02810418|39769090|FG004|Arm B Dose Escalation|Adverse Event|1|||
16350465|NCT02810418|39769091|FG005|Arm B Dose Escalation|Adverse Event|2|||
16350466|NCT02810418|39769092|FG006|Arm B Dose Escalation|Adverse Event|0|||
16350467|NCT00669318|39769097|FG000|Overall Study|Withdrawal by Subject|2|||
16350468|NCT01298700|39769101|FG000|Overall Study|Adverse Event|50|||
16350469|NCT01298700|39769102|FG001|Overall Study|Adverse Event|51|||
16350470|NCT01298700|39769101|FG000|Overall Study|Lack of Efficacy|9|||
16350471|NCT01298700|39769102|FG001|Overall Study|Lack of Efficacy|14|||
16350472|NCT01298700|39769101|FG000|Overall Study|Lost to Follow-up|5|||
16350473|NCT01298700|39769102|FG001|Overall Study|Lost to Follow-up|2|||
16350474|NCT01298700|39769101|FG000|Overall Study|Withdrawal by Subject|12|||
16350475|NCT01298700|39769102|FG001|Overall Study|Withdrawal by Subject|9|||
16350476|NCT01298700|39769101|FG000|Overall Study|Protocol Violation|6|||
16350477|NCT01298700|39769102|FG001|Overall Study|Protocol Violation|4|||
16350478|NCT01298700|39769101|FG000|Overall Study|Other Miscellaneous Reasons|16|||
16350479|NCT01298700|39769102|FG001|Overall Study|Other Miscellaneous Reasons|15|||
16350480|NCT01298700|39769101|FG000|Overall Study|Did not Receive Study Drug|3|||
16350481|NCT01298700|39769102|FG001|Overall Study|Did not Receive Study Drug|5|||
16350482|NCT03225170|39769103|FG000|Overall Study|Lost to Follow-up|4|||
16350483|NCT03225170|39769104|FG001|Overall Study|Lost to Follow-up|4|||
16350484|NCT03225170|39769105|FG002|Overall Study|Lost to Follow-up|0|||
16350485|NCT03225170|39769103|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
16350486|NCT03225170|39769104|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
16414640|NCT02012686|39998482|FG001|Overall Study|electrocardiography monitoring noise|1|||
16414641|NCT02683668|39998491|FG000|Period 2|Withdrawal by Subject|0|||
16414642|NCT02683668|39998492|FG001|Period 2|Withdrawal by Subject|1|||
16414643|NCT02683668|39998493|FG002|Period 2|Withdrawal by Subject|0|||
16124712|NCT01517295|38942302|FG000|Overall Study|Physician Decision|1|||
16350487|NCT03225170|39769105|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
16350488|NCT02849743|39769108|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
16124713|NCT01517295|38942303|FG001|Overall Study|Physician Decision|0|||
16124714|NCT03223662|38942304|FG000|Overall Study|Physician Decision|1|||
16124715|NCT03223662|38942304|FG000|Overall Study|Study closure|1|||
16124716|NCT01242800|38942305|FG000|Overall Study|Patient refusal|0|||
16124717|NCT01242800|38942306|FG001|Overall Study|Patient refusal|10|||
16124718|NCT01242800|38942305|FG000|Overall Study|Physician Decision|0|||
16124719|NCT01242800|38942306|FG001|Overall Study|Physician Decision|1|||
16124720|NCT01242800|38942305|FG000|Overall Study|Disease progression|0|||
16124721|NCT01242800|38942306|FG001|Overall Study|Disease progression|3|||
16124722|NCT01242800|38942305|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
16124723|NCT01242800|38942306|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
16124724|NCT01242800|38942305|FG000|Overall Study|Reasons not reported|0|||
16124725|NCT01242800|38942306|FG001|Overall Study|Reasons not reported|4|||
16124726|NCT03245151|38942307|FG000|Overall Study|Withdrawal by Subject|2|||
16124727|NCT03245151|38942308|FG001|Overall Study|Withdrawal by Subject|0|||
16124728|NCT03245151|38942309|FG002|Overall Study|Withdrawal by Subject|0|||
16124729|NCT03245151|38942310|FG003|Overall Study|Withdrawal by Subject|2|||
16124730|NCT03245151|38942311|FG004|Overall Study|Withdrawal by Subject|1|||
16124731|NCT03245151|38942307|FG000|Overall Study|Death|3|||
16124732|NCT03245151|38942308|FG001|Overall Study|Death|14|||
16124733|NCT03245151|38942309|FG002|Overall Study|Death|9|||
16124734|NCT03245151|38942310|FG003|Overall Study|Death|16|||
16124735|NCT03245151|38942311|FG004|Overall Study|Death|7|||
16241743|NCT04556838|39368708|FG002|Overall Study|Physician Decision|0|||
16241744|NCT00763269|39368709|FG000|Overall Study|Lost to Follow-up|12|||
16124736|NCT03245151|38942307|FG000|Overall Study|Sponsor's decision|0|||
16124737|NCT03245151|38942308|FG001|Overall Study|Sponsor's decision|1|||
16241745|NCT00763269|39368710|FG001|Overall Study|Lost to Follow-up|13|||
16350489|NCT02849743|39769109|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
16350490|NCT02849743|39769108|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
16350491|NCT02849743|39769109|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
16350492|NCT00003471|39769110|FG000|Overall Study|Not evaluable|4|||
16350493|NCT02360280|39769114|FG000|Overall Study|Withdrawal by Subject|2|||
16350494|NCT02360280|39769115|FG001|Overall Study|Withdrawal by Subject|0|||
16350495|NCT02360280|39769114|FG000|Overall Study|Adverse Event|0|||
16350496|NCT02360280|39769115|FG001|Overall Study|Adverse Event|1|||
16350497|NCT02360280|39769114|FG000|Overall Study|Lost to Follow-up|1|||
16350498|NCT02360280|39769115|FG001|Overall Study|Lost to Follow-up|0|||
16350499|NCT00206427|39769120|FG000|Overall Study|Adverse Event|2|||
16414644|NCT01571232|39998500|FG000|Overall Study|Lost to Follow-up|0|||
16414645|NCT01571232|39998501|FG001|Overall Study|Lost to Follow-up|1|||
16414646|NCT01571232|39998500|FG000|Overall Study|Withdrawal by Subject|1|||
16414647|NCT01571232|39998501|FG001|Overall Study|Withdrawal by Subject|0|||
16414648|NCT00295932|39998503|FG000|Overall Study|Not Treated|0|||
16414649|NCT00295932|39998504|FG001|Overall Study|Not Treated|0|||
16414650|NCT00295932|39998505|FG002|Overall Study|Not Treated|0|||
16414651|NCT00295932|39998506|FG003|Overall Study|Not Treated|0|||
16414652|NCT00295932|39998507|FG004|Overall Study|Not Treated|0|||
16414653|NCT00295932|39998508|FG005|Overall Study|Not Treated|0|||
16557743|NCT00556374|40506629|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
16557744|NCT00556374|40506630|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
16557745|NCT01511536|40506631|FG000|Phase 1|Other|0|||
16557746|NCT01511536|40506632|FG001|Phase 1|Other|1|||
16557747|NCT01511536|40506633|FG002|Phase 1|Other|0|||
16124738|NCT03245151|38942309|FG002|Overall Study|Sponsor's decision|0|||
16557748|NCT01511536|40506631|FG000|Phase 2|Other|0|||
16557749|NCT01511536|40506632|FG001|Phase 2|Other|0|||
16557750|NCT01511536|40506633|FG002|Phase 2|Other|9|||
16241746|NCT00758706|39368717|FG000|Overall Study|Adverse Event|4|||
16557751|NCT05199090|40506634|FG000|Overall Study|Adverse Event|1|||
16557752|NCT05199090|40506635|FG001|Overall Study|Adverse Event|4|||
16557753|NCT05199090|40506636|FG002|Overall Study|Adverse Event|0|||
16557754|NCT05199090|40506637|FG003|Overall Study|Adverse Event|0|||
16557755|NCT05199090|40506638|FG004|Overall Study|Adverse Event|0|||
16557756|NCT05199090|40506639|FG005|Overall Study|Adverse Event|0|||
16557757|NCT05199090|40506634|FG000|Overall Study|Lost to Follow-up|1|||
16557758|NCT05199090|40506635|FG001|Overall Study|Lost to Follow-up|0|||
16557759|NCT05199090|40506636|FG002|Overall Study|Lost to Follow-up|1|||
16557760|NCT05199090|40506637|FG003|Overall Study|Lost to Follow-up|4|||
16557761|NCT05199090|40506638|FG004|Overall Study|Lost to Follow-up|0|||
16557762|NCT05199090|40506639|FG005|Overall Study|Lost to Follow-up|5|||
16557763|NCT05199090|40506634|FG000|Overall Study|Physician Decision|0|||
16557764|NCT05199090|40506635|FG001|Overall Study|Physician Decision|0|||
16557765|NCT05199090|40506636|FG002|Overall Study|Physician Decision|0|||
16557766|NCT05199090|40506637|FG003|Overall Study|Physician Decision|0|||
16557767|NCT05199090|40506638|FG004|Overall Study|Physician Decision|0|||
16124739|NCT03245151|38942310|FG003|Overall Study|Sponsor's decision|0|||
16241747|NCT00758706|39368718|FG001|Overall Study|Adverse Event|4|||
16241748|NCT04023994|39368719|FG000|Overall Study|Lost to Follow-up|0|||
16241749|NCT04023994|39368720|FG001|Overall Study|Lost to Follow-up|1|||
16241750|NCT04023994|39368721|FG002|Overall Study|Lost to Follow-up|2|||
16241751|NCT04023994|39368722|FG003|Overall Study|Lost to Follow-up|0|||
16241752|NCT04023994|39368723|FG004|Overall Study|Lost to Follow-up|0|||
16241753|NCT04023994|39368724|FG005|Overall Study|Lost to Follow-up|0|||
16241754|NCT04023994|39368719|FG000|Overall Study|Withdrawal by Subject|0|||
16241755|NCT04023994|39368720|FG001|Overall Study|Withdrawal by Subject|0|||
16241756|NCT04023994|39368721|FG002|Overall Study|Withdrawal by Subject|0|||
16241757|NCT04023994|39368722|FG003|Overall Study|Withdrawal by Subject|1|||
16241758|NCT04023994|39368723|FG004|Overall Study|Withdrawal by Subject|0|||
16241759|NCT04023994|39368724|FG005|Overall Study|Withdrawal by Subject|0|||
16350500|NCT03110354|39769121|FG000|Overall Study|Death|1|||
16350501|NCT03110354|39769122|FG001|Overall Study|Death|0|||
16350502|NCT03110354|39769123|FG002|Overall Study|Death|0|||
16350503|NCT03110354|39769124|FG003|Overall Study|Death|1|||
16350504|NCT03110354|39769125|FG004|Overall Study|Death|0|||
16557768|NCT05199090|40506639|FG005|Overall Study|Physician Decision|1|||
16557769|NCT05199090|40506634|FG000|Overall Study|Study terminated by sponsor|0|||
16124740|NCT03245151|38942311|FG004|Overall Study|Sponsor's decision|0|||
16124741|NCT01008410|38942312|FG000|Overall Study|Adverse Event|13|||
16124742|NCT01008410|38942313|FG001|Overall Study|Adverse Event|7|||
16124743|NCT01008410|38942312|FG000|Overall Study|Withdrawal by Subject|6|||
16124744|NCT01008410|38942313|FG001|Overall Study|Withdrawal by Subject|2|||
16124745|NCT01008410|38942312|FG000|Overall Study|Lost to Follow-up|1|||
16124746|NCT01008410|38942313|FG001|Overall Study|Lost to Follow-up|0|||
16124747|NCT01008410|38942312|FG000|Overall Study|Noncompliance|1|||
16124748|NCT01008410|38942313|FG001|Overall Study|Noncompliance|0|||
16124749|NCT01008410|38942312|FG000|Overall Study|Low Cortisol|2|||
16124750|NCT01008410|38942313|FG001|Overall Study|Low Cortisol|0|||
16124751|NCT01008410|38942312|FG000|Overall Study|Lack of Efficacy|2|||
16124752|NCT01008410|38942313|FG001|Overall Study|Lack of Efficacy|6|||
16124753|NCT01008410|38942312|FG000|Overall Study|Met Exclusion Criterion|0|||
16124754|NCT01008410|38942313|FG001|Overall Study|Met Exclusion Criterion|1|||
16124755|NCT00224887|38942318|FG000|Overall Study|Pregnancy|6|||
16124756|NCT00224887|38942319|FG001|Overall Study|Pregnancy|6|||
16124757|NCT02153073|38942320|FG000|Overall Study|Case Report Forms Uncollected|230|||
16124758|NCT02153073|38942320|FG000|Overall Study|Protocol Deviation|68|||
16124759|NCT04927884|38942321|FG000|Overall Study|Progressive Disease|2|||
16124760|NCT01151410|38942322|FG000|Overall Study|Withdrawal by Subject|3|||
16124761|NCT01151410|38942323|FG001|Overall Study|Withdrawal by Subject|5|||
16124762|NCT01151410|38942322|FG000|Overall Study|Lost to Follow-up|3|||
16124763|NCT01151410|38942323|FG001|Overall Study|Lost to Follow-up|4|||
16124764|NCT01151410|38942322|FG000|Overall Study|Adverse Event|1|||
16124765|NCT01151410|38942323|FG001|Overall Study|Adverse Event|2|||
16124766|NCT01151410|38942322|FG000|Overall Study|Protocol deviation|2|||
16124767|NCT01151410|38942323|FG001|Overall Study|Protocol deviation|1|||
16124768|NCT01151410|38942322|FG000|Overall Study|Administrative problems|1|||
16124769|NCT01151410|38942323|FG001|Overall Study|Administrative problems|1|||
16124770|NCT01151410|38942322|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16124771|NCT01151410|38942323|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16124772|NCT01151410|38942322|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16124773|NCT01151410|38942323|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16124774|NCT03889704|38942325|FG000|Overall Study|Study terminated due to pandemic|1|||
16124775|NCT00126503|38942326|FG000|Overall Study|disease progression|23|||
16124776|NCT00126503|38942327|FG001|Overall Study|disease progression|14|||
16124777|NCT00126503|38942326|FG000|Overall Study|Withdrawal by Subject|0|||
16124778|NCT00126503|38942327|FG001|Overall Study|Withdrawal by Subject|1|||
16124779|NCT00126503|38942326|FG000|Overall Study|alternative therapy|1|||
16124780|NCT00126503|38942327|FG001|Overall Study|alternative therapy|1|||
16124781|NCT00126503|38942326|FG000|Overall Study|other complicating disease|4|||
16124782|NCT00126503|38942327|FG001|Overall Study|other complicating disease|1|||
16124783|NCT00126503|38942326|FG000|Overall Study|Death|3|||
16124784|NCT00126503|38942327|FG001|Overall Study|Death|0|||
16124785|NCT00126503|38942326|FG000|Overall Study|Adverse Event|13|||
16124786|NCT00126503|38942327|FG001|Overall Study|Adverse Event|3|||
16124787|NCT00126503|38942326|FG000|Overall Study|non-compliant|1|||
16124788|NCT00126503|38942327|FG001|Overall Study|non-compliant|0|||
16124789|NCT00126503|38942326|FG000|Overall Study|Physician Decision|2|||
16124790|NCT00126503|38942327|FG001|Overall Study|Physician Decision|1|||
16124791|NCT01283152|38942328|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
16124792|NCT01283152|38942329|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
16124793|NCT01283152|38942328|FG000|Overall Study|Refused HESA|1|||
16124794|NCT01283152|38942329|FG001|Overall Study|Refused HESA|0|||
16241760|NCT03264066|39368725|FG000|Overall Study|Adverse Event|1|||
16124795|NCT00704405|38942331|FG000|Overall Study (NC Population)|Adverse Event|1|||
16124796|NCT00704405|38942332|FG001|Overall Study (NC Population)|Adverse Event|0|||
16124797|NCT00704405|38942333|FG002|Overall Study (NC Population)|Adverse Event|0|||
16124798|NCT00704405|38942334|FG003|Overall Study (NC Population)|Adverse Event|0|||
16124799|NCT00704405|38942335|FG004|Overall Study (NC Population)|Adverse Event|0|||
16124800|NCT00704405|38942331|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
16124801|NCT00704405|38942332|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
16124802|NCT00704405|38942333|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
16124803|NCT00704405|38942334|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
16241761|NCT03264066|39368726|FG001|Overall Study|Adverse Event|1|||
16557770|NCT05199090|40506635|FG001|Overall Study|Study terminated by sponsor|6|||
16557771|NCT05199090|40506636|FG002|Overall Study|Study terminated by sponsor|0|||
16557772|NCT05199090|40506637|FG003|Overall Study|Study terminated by sponsor|0|||
16557773|NCT05199090|40506638|FG004|Overall Study|Study terminated by sponsor|0|||
16557774|NCT05199090|40506639|FG005|Overall Study|Study terminated by sponsor|5|||
16557775|NCT05199090|40506634|FG000|Overall Study|Subject decision|0|||
16557776|NCT05199090|40506635|FG001|Overall Study|Subject decision|4|||
16557777|NCT05199090|40506636|FG002|Overall Study|Subject decision|0|||
16557778|NCT05199090|40506637|FG003|Overall Study|Subject decision|2|||
16557779|NCT05199090|40506638|FG004|Overall Study|Subject decision|5|||
16557780|NCT05199090|40506639|FG005|Overall Study|Subject decision|2|||
16557781|NCT03405662|40506644|FG000|Overall Study|COVID-19 restriction|1|||
16557782|NCT03405662|40506645|FG001|Overall Study|COVID-19 restriction|0|||
16557783|NCT03405662|40506644|FG000|Overall Study|unblinding|0|||
16557784|NCT03405662|40506645|FG001|Overall Study|unblinding|1|||
16557785|NCT03405662|40506644|FG000|Overall Study|placement in memory care facility|0|||
16557786|NCT03405662|40506645|FG001|Overall Study|placement in memory care facility|2|||
16557787|NCT01528709|40506646|FG000|Overall Study|Death|2|||
16557788|NCT01528709|40506647|FG001|Overall Study|Death|0|||
16557789|NCT01528709|40506646|FG000|Overall Study|Withdrawal by Subject|10|||
16557790|NCT01528709|40506647|FG001|Overall Study|Withdrawal by Subject|15|||
16557791|NCT01528709|40506646|FG000|Overall Study|allergy|1|||
16557792|NCT01528709|40506647|FG001|Overall Study|allergy|0|||
16557793|NCT02189863|40509770|FG000|First 2 Weeks|Motion Sickness|4|||
16557794|NCT02189863|40509771|FG001|First 2 Weeks|Motion Sickness|2|||
16557795|NCT03293485|40509772|FG000|Overall Study|Death|1|||
16557796|NCT03293485|40509772|FG000|Overall Study|Screen Failure|2|||
16557797|NCT03293485|40509772|FG000|Overall Study|Withdrawal by Subject|2|||
16557798|NCT01327547|40509773|FG000|Overall Study|Adverse Event|4|||
16557799|NCT01327547|40509774|FG001|Overall Study|Adverse Event|1|||
16557800|NCT01327547|40509773|FG000|Overall Study|Death|1|||
16557801|NCT01327547|40509774|FG001|Overall Study|Death|2|||
16557802|NCT01327547|40509773|FG000|Overall Study|Lost to Follow-up|6|||
16557803|NCT01327547|40509774|FG001|Overall Study|Lost to Follow-up|6|||
16557804|NCT01327547|40509773|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
16557805|NCT01327547|40509774|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
16557806|NCT01327547|40509773|FG000|Overall Study|Withdrawal by Subject|3|||
16557807|NCT01327547|40509774|FG001|Overall Study|Withdrawal by Subject|7|||
16557808|NCT01327547|40509773|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
16557809|NCT01327547|40509774|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
16557810|NCT01327547|40509773|FG000|Overall Study|Protocol Violation|1|||
16557811|NCT01327547|40509774|FG001|Overall Study|Protocol Violation|0|||
16557812|NCT01327547|40509773|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
16557813|NCT01327547|40509774|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
16557814|NCT01327547|40509773|FG000|Overall Study|Required prohibited medication|2|||
16557815|NCT01327547|40509774|FG001|Overall Study|Required prohibited medication|0|||
16557816|NCT01327547|40509773|FG000|Overall Study|Non-compliance with study procedures|1|||
16557817|NCT01327547|40509774|FG001|Overall Study|Non-compliance with study procedures|0|||
16557818|NCT01327547|40509773|FG000|Overall Study|By investigator in subject's interest|0|||
16557819|NCT01327547|40509774|FG001|Overall Study|By investigator in subject's interest|1|||
16557820|NCT00513019|40509775|FG000|Overall Study|Adverse Event|1|||
16557821|NCT00513019|40509776|FG001|Overall Study|Adverse Event|0|||
16557822|NCT00513019|40509775|FG000|Overall Study|Withdrawal by Subject|4|||
16557823|NCT00513019|40509776|FG001|Overall Study|Withdrawal by Subject|5|||
16557824|NCT04963062|40509778|FG000|Overall Study|withdrew by the study team|4|||
16241762|NCT03264066|39368727|FG002|Overall Study|Adverse Event|0|||
16241763|NCT03264066|39368728|FG003|Overall Study|Adverse Event|0|||
16414654|NCT00295932|39998509|FG006|Overall Study|Not Treated|0|||
16414655|NCT00295932|39998510|FG007|Overall Study|Not Treated|0|||
16414656|NCT00295932|39998511|FG008|Overall Study|Not Treated|0|||
16557825|NCT04963062|40509779|FG001|Overall Study|withdrew by the study team|2|||
16557826|NCT03101592|40509780|FG000|Overall Study|participant files could not be located|111|||
16557827|NCT03101592|40509781|FG001|Overall Study|participant files could not be located|170|||
16557828|NCT03101592|40509782|FG002|Overall Study|participant files could not be located|118|||
16557829|NCT01088529|40509785|FG000|Overall Study|Did not receive study treatment|0|||
16557830|NCT01088529|40509786|FG001|Overall Study|Did not receive study treatment|1|||
16124804|NCT00704405|38942335|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
16124805|NCT00704405|38942331|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
16124806|NCT00704405|38942332|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
16124807|NCT00704405|38942333|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
16124808|NCT00704405|38942334|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
16124809|NCT00704405|38942335|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
16124810|NCT00704405|38942331|FG000|Overall Study (NC Population)|Other|0|||
16414657|NCT00295932|39998512|FG009|Overall Study|Not Treated|0|||
16414658|NCT00295932|39998513|FG010|Overall Study|Not Treated|1|||
16414659|NCT00525824|39998514|FG000|Overall Study|Adverse Event|7|||
16414660|NCT00525824|39998515|FG001|Overall Study|Adverse Event|11|||
16414661|NCT00525824|39998516|FG002|Overall Study|Adverse Event|6|||
16414662|NCT00525824|39998517|FG003|Overall Study|Adverse Event|7|||
16414663|NCT00525824|39998514|FG000|Overall Study|Withdrawal by Subject|5|||
16414664|NCT00525824|39998515|FG001|Overall Study|Withdrawal by Subject|9|||
16557831|NCT01770860|40509787|FG000|Overall Study|Withdrawal by Subject|4|||
16557832|NCT01770860|40509787|FG000|Overall Study|Lost to Follow-up|1|||
16124811|NCT00704405|38942332|FG001|Overall Study (NC Population)|Other|0|||
16124812|NCT00704405|38942333|FG002|Overall Study (NC Population)|Other|0|||
16124813|NCT00704405|38942334|FG003|Overall Study (NC Population)|Other|0|||
16124814|NCT00704405|38942335|FG004|Overall Study (NC Population)|Other|1|||
16124815|NCT00704405|38942331|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
16124816|NCT00704405|38942332|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
16124817|NCT00704405|38942333|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
16124818|NCT00704405|38942334|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
16124819|NCT00704405|38942335|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
16124820|NCT00704405|38942331|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
16124821|NCT00704405|38942332|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
16124822|NCT00704405|38942333|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
16124823|NCT00704405|38942334|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
16124824|NCT00704405|38942335|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
16124825|NCT01796548|38942336|FG000|Overall Study|Lost to Follow-up|1|||
16124826|NCT01796548|38942336|FG000|Overall Study|Other|2|||
16124827|NCT03592745|38942337|FG000|Overall Study|Adverse Event|0|||
16124828|NCT03592745|38942338|FG001|Overall Study|Adverse Event|2|||
16350505|NCT03110354|39769121|FG000|Overall Study|Start of new therapy|0|||
16350506|NCT03110354|39769122|FG001|Overall Study|Start of new therapy|0|||
16350507|NCT03110354|39769123|FG002|Overall Study|Start of new therapy|0|||
16350508|NCT03110354|39769124|FG003|Overall Study|Start of new therapy|0|||
16350509|NCT03110354|39769125|FG004|Overall Study|Start of new therapy|1|||
16557833|NCT01770860|40509787|FG000|Overall Study|Administrative decision made by the PI|1|||
16124829|NCT03592745|38942337|FG000|Overall Study|Lost to Follow-up|2|||
16350510|NCT03110354|39769121|FG000|Overall Study|Failure to achieve response|2|||
16350511|NCT03110354|39769122|FG001|Overall Study|Failure to achieve response|3|||
16350512|NCT03110354|39769123|FG002|Overall Study|Failure to achieve response|0|||
16350513|NCT03110354|39769124|FG003|Overall Study|Failure to achieve response|2|||
16350514|NCT03110354|39769125|FG004|Overall Study|Failure to achieve response|1|||
16350515|NCT03110354|39769121|FG000|Overall Study|Progressive disease|1|||
16350516|NCT03110354|39769122|FG001|Overall Study|Progressive disease|1|||
16350517|NCT03110354|39769123|FG002|Overall Study|Progressive disease|3|||
16350518|NCT03110354|39769124|FG003|Overall Study|Progressive disease|4|||
16350519|NCT03110354|39769125|FG004|Overall Study|Progressive disease|2|||
16350520|NCT03110354|39769121|FG000|Overall Study|Adverse Event|0|||
16350521|NCT03110354|39769122|FG001|Overall Study|Adverse Event|0|||
16350522|NCT03110354|39769123|FG002|Overall Study|Adverse Event|0|||
16557834|NCT02081391|40509788|FG000|12-hour Treatment|Withdrawal by Subject|3|||
16124830|NCT03592745|38942338|FG001|Overall Study|Lost to Follow-up|0|||
16124831|NCT03592745|38942337|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
16241764|NCT03264066|39368729|FG004|Overall Study|Adverse Event|0|||
16350523|NCT03110354|39769124|FG003|Overall Study|Adverse Event|2|||
16414665|NCT00525824|39998516|FG002|Overall Study|Withdrawal by Subject|3|||
16557835|NCT02081391|40509789|FG001|12-hour Treatment|Withdrawal by Subject|2|||
16557836|NCT02081391|40509790|FG002|12-hour Treatment|Withdrawal by Subject|0|||
16557837|NCT02081391|40509791|FG003|12-hour Treatment|Withdrawal by Subject|0|||
16557838|NCT02081391|40509788|FG000|12-hour Treatment|Physician Decision|4|||
16557839|NCT02081391|40509789|FG001|12-hour Treatment|Physician Decision|1|||
16557840|NCT02081391|40509790|FG002|12-hour Treatment|Physician Decision|0|||
16557841|NCT02081391|40509791|FG003|12-hour Treatment|Physician Decision|0|||
16557842|NCT02081391|40509788|FG000|12-hour Treatment|Lack of Efficacy|3|||
16557843|NCT02081391|40509789|FG001|12-hour Treatment|Lack of Efficacy|0|||
16557844|NCT02081391|40509790|FG002|12-hour Treatment|Lack of Efficacy|0|||
16557845|NCT02081391|40509791|FG003|12-hour Treatment|Lack of Efficacy|0|||
16557846|NCT02081391|40509788|FG000|12-hour Treatment|Adverse Event|4|||
16557847|NCT02081391|40509789|FG001|12-hour Treatment|Adverse Event|2|||
16557848|NCT02081391|40509790|FG002|12-hour Treatment|Adverse Event|0|||
16557849|NCT02081391|40509791|FG003|12-hour Treatment|Adverse Event|0|||
16557850|NCT02081391|40509788|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
16557851|NCT02081391|40509789|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
16557852|NCT02081391|40509790|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
16557853|NCT02081391|40509791|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
16557854|NCT02081391|40509788|FG000|12-hour Treatment|Further reasons|2|||
16557855|NCT02081391|40509789|FG001|12-hour Treatment|Further reasons|1|||
16557856|NCT02081391|40509790|FG002|12-hour Treatment|Further reasons|0|||
16557857|NCT02081391|40509791|FG003|12-hour Treatment|Further reasons|0|||
16557858|NCT02081391|40509788|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
16557859|NCT02081391|40509789|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
16557860|NCT02081391|40509790|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
16124832|NCT03592745|38942338|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
16124833|NCT03896152|38942339|FG000|Overall Study|Patient/guardian decision|1|||
16124834|NCT03896152|38942340|FG001|Overall Study|Patient/guardian decision|1|||
16124835|NCT03896152|38942339|FG000|Overall Study|Adverse Event|0|||
16124836|NCT03896152|38942340|FG001|Overall Study|Adverse Event|1|||
16124837|NCT03896152|38942339|FG000|Overall Study|Physician Decision|1|||
16124838|NCT03896152|38942340|FG001|Overall Study|Physician Decision|0|||
16124839|NCT03896152|38942339|FG000|Overall Study|Technical problems|1|||
16124840|NCT03896152|38942340|FG001|Overall Study|Technical problems|0|||
16124841|NCT00831129|38942349|FG000|Overall Study|Adverse Event|0|||
16124842|NCT00831129|38942350|FG001|Overall Study|Adverse Event|1|||
16124843|NCT00831129|38942349|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
16124844|NCT00831129|38942350|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
16124845|NCT01302067|38942353|FG000|Overall Study|Death|0|||
16124846|NCT01302067|38942354|FG001|Overall Study|Death|0|||
16124847|NCT01302067|38942355|FG002|Overall Study|Death|1|||
16124848|NCT01302067|38942353|FG000|Overall Study|Physician Decision|9|||
16124849|NCT01302067|38942354|FG001|Overall Study|Physician Decision|5|||
16124850|NCT01302067|38942355|FG002|Overall Study|Physician Decision|14|||
16124851|NCT01302067|38942353|FG000|Overall Study|Lack of Efficacy|8|||
16241765|NCT03264066|39368730|FG005|Overall Study|Adverse Event|0|||
16241766|NCT03264066|39368725|FG000|Overall Study|Death|12|||
16241767|NCT03264066|39368726|FG001|Overall Study|Death|12|||
16241768|NCT03264066|39368727|FG002|Overall Study|Death|8|||
16241769|NCT03264066|39368728|FG003|Overall Study|Death|10|||
16241770|NCT03264066|39368729|FG004|Overall Study|Death|6|||
16241771|NCT03264066|39368730|FG005|Overall Study|Death|1|||
16241772|NCT03264066|39368725|FG000|Overall Study|Lost to Follow-up|1|||
16241773|NCT03264066|39368726|FG001|Overall Study|Lost to Follow-up|0|||
16241774|NCT03264066|39368727|FG002|Overall Study|Lost to Follow-up|0|||
16241775|NCT03264066|39368728|FG003|Overall Study|Lost to Follow-up|0|||
16241776|NCT03264066|39368729|FG004|Overall Study|Lost to Follow-up|0|||
16241777|NCT03264066|39368730|FG005|Overall Study|Lost to Follow-up|0|||
16241778|NCT03264066|39368725|FG000|Overall Study|Progressive Disease|0|||
16241779|NCT03264066|39368726|FG001|Overall Study|Progressive Disease|2|||
16241780|NCT03264066|39368727|FG002|Overall Study|Progressive Disease|1|||
16241781|NCT03264066|39368728|FG003|Overall Study|Progressive Disease|0|||
16241782|NCT03264066|39368729|FG004|Overall Study|Progressive Disease|0|||
16241783|NCT03264066|39368730|FG005|Overall Study|Progressive Disease|0|||
16241784|NCT03264066|39368725|FG000|Overall Study|Study Terminated by Sponsor|5|||
16241785|NCT03264066|39368726|FG001|Overall Study|Study Terminated by Sponsor|5|||
16241786|NCT03264066|39368727|FG002|Overall Study|Study Terminated by Sponsor|8|||
16241787|NCT03264066|39368728|FG003|Overall Study|Study Terminated by Sponsor|5|||
16241788|NCT03264066|39368729|FG004|Overall Study|Study Terminated by Sponsor|1|||
16241789|NCT03264066|39368730|FG005|Overall Study|Study Terminated by Sponsor|2|||
16241790|NCT03264066|39368725|FG000|Overall Study|Withdrawal by Subject|1|||
16241791|NCT03264066|39368726|FG001|Overall Study|Withdrawal by Subject|0|||
16241792|NCT03264066|39368727|FG002|Overall Study|Withdrawal by Subject|0|||
16241793|NCT03264066|39368728|FG003|Overall Study|Withdrawal by Subject|5|||
16241794|NCT03264066|39368729|FG004|Overall Study|Withdrawal by Subject|0|||
16241795|NCT03264066|39368730|FG005|Overall Study|Withdrawal by Subject|0|||
16241796|NCT00860574|39368731|FG000|Overall Study|Death|2|||
16241797|NCT00860574|39368731|FG000|Overall Study|Relapse|1|||
16241798|NCT00709735|39368732|FG000|Overall Study|Lost to Follow-up|1|||
16241799|NCT00709735|39368733|FG001|Overall Study|Lost to Follow-up|1|||
16241800|NCT00709735|39368732|FG000|Overall Study|Relapse into Opioid Abuse|0|||
16241801|NCT00709735|39368733|FG001|Overall Study|Relapse into Opioid Abuse|1|||
16241802|NCT00709735|39368732|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
16241803|NCT00709735|39368733|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
16241804|NCT01142466|39368734|FG000|Overall Study|Adverse Event|2|||
16241805|NCT01142466|39368735|FG001|Overall Study|Adverse Event|1|||
16241806|NCT01142466|39368734|FG000|Overall Study|Withdrawal by Subject|1|||
16241807|NCT01142466|39368735|FG001|Overall Study|Withdrawal by Subject|1|||
16241808|NCT03078192|39368736|FG000|Overall Study|Withdrawal by Subject|2|||
16241809|NCT03078192|39368737|FG001|Overall Study|Withdrawal by Subject|1|||
16241810|NCT03078192|39368736|FG000|Overall Study|screen failure|0|||
16241811|NCT03078192|39368737|FG001|Overall Study|screen failure|3|||
16241812|NCT01364298|39368738|FG000|Overall Study|Adverse Event|3|||
16241813|NCT01364298|39368739|FG001|Overall Study|Adverse Event|4|||
16241814|NCT01364298|39368738|FG000|Overall Study|Lack of adherence to treatment|1|||
16241815|NCT01364298|39368739|FG001|Overall Study|Lack of adherence to treatment|3|||
16241816|NCT01364298|39368738|FG000|Overall Study|Lack of Efficacy|1|||
16241817|NCT01364298|39368739|FG001|Overall Study|Lack of Efficacy|0|||
16241818|NCT01364298|39368738|FG000|Overall Study|Lost to Follow-up|5|||
16241819|NCT01364298|39368739|FG001|Overall Study|Lost to Follow-up|10|||
16241820|NCT01364298|39368738|FG000|Overall Study|Withdrawal by Subject|3|||
16241821|NCT01364298|39368739|FG001|Overall Study|Withdrawal by Subject|3|||
16241822|NCT01364298|39368738|FG000|Overall Study|Other|1|||
16350524|NCT03110354|39769125|FG004|Overall Study|Adverse Event|2|||
16350525|NCT03110354|39769121|FG000|Overall Study|Other|0|||
16350526|NCT03110354|39769122|FG001|Overall Study|Other|0|||
16350527|NCT03110354|39769123|FG002|Overall Study|Other|0|||
16350528|NCT03110354|39769124|FG003|Overall Study|Other|1|||
16350529|NCT03110354|39769125|FG004|Overall Study|Other|1|||
16350530|NCT01026948|39769127|FG000|Overall Study|Physician Decision|8|||
16350531|NCT00101868|39769128|FG000|Overall Study|Death|10|||
16350532|NCT00101868|39769129|FG001|Overall Study|Death|10|||
16350533|NCT00101868|39769128|FG000|Overall Study|Withdrawal by Subject|8|||
16350534|NCT00101868|39769129|FG001|Overall Study|Withdrawal by Subject|9|||
16350535|NCT00101868|39769128|FG000|Overall Study|Protocol Violation|3|||
16241823|NCT01364298|39368739|FG001|Overall Study|Other|3|||
16241824|NCT00103259|39368740|FG000|Overall Study|Death|3|||
16350536|NCT00101868|39769129|FG001|Overall Study|Protocol Violation|0|||
16350537|NCT00101868|39769128|FG000|Overall Study|Lost to Follow-up|8|||
16241825|NCT00103259|39368741|FG001|Overall Study|Death|2|||
16241826|NCT00103259|39368740|FG000|Overall Study|Withdrawal by Subject|2|||
16241827|NCT00103259|39368741|FG001|Overall Study|Withdrawal by Subject|3|||
16241828|NCT00103259|39368740|FG000|Overall Study|alternative therapy|1|||
16241829|NCT00103259|39368741|FG001|Overall Study|alternative therapy|0|||
16241830|NCT00103259|39368740|FG000|Overall Study|other (reasons were not specified)|2|||
16124852|NCT01302067|38942354|FG001|Overall Study|Lack of Efficacy|4|||
16124853|NCT01302067|38942355|FG002|Overall Study|Lack of Efficacy|2|||
16124854|NCT01302067|38942353|FG000|Overall Study|Lost to Follow-up|9|||
16124855|NCT01302067|38942354|FG001|Overall Study|Lost to Follow-up|4|||
16124856|NCT01302067|38942355|FG002|Overall Study|Lost to Follow-up|15|||
16124857|NCT01302067|38942353|FG000|Overall Study|Withdrawal by Subject|13|||
16124858|NCT01302067|38942354|FG001|Overall Study|Withdrawal by Subject|6|||
16124859|NCT01302067|38942355|FG002|Overall Study|Withdrawal by Subject|10|||
16124860|NCT01302067|38942353|FG000|Overall Study|Other|1|||
16124861|NCT01302067|38942354|FG001|Overall Study|Other|1|||
16124862|NCT01302067|38942355|FG002|Overall Study|Other|3|||
16241831|NCT00103259|39368741|FG001|Overall Study|other (reasons were not specified)|1|||
16241832|NCT00103259|39368740|FG000|Overall Study|ineligible/no protocol therapy|4|||
16241833|NCT00103259|39368741|FG001|Overall Study|ineligible/no protocol therapy|6|||
16241834|NCT03262233|39368742|FG000|Overall Study|Withdrawal by Subject|12|||
16241835|NCT03262233|39368743|FG001|Overall Study|Withdrawal by Subject|8|||
16241836|NCT03262233|39368744|FG002|Overall Study|Withdrawal by Subject|21|||
16241837|NCT03262233|39368745|FG003|Overall Study|Withdrawal by Subject|13|||
16241838|NCT03262233|39368742|FG000|Overall Study|Declined due to shock|1|||
16241839|NCT03262233|39368743|FG001|Overall Study|Declined due to shock|2|||
16241840|NCT03262233|39368744|FG002|Overall Study|Declined due to shock|2|||
16241841|NCT03262233|39368745|FG003|Overall Study|Declined due to shock|3|||
16241842|NCT03262233|39368742|FG000|Overall Study|Protocol Violation|5|||
16241843|NCT03262233|39368743|FG001|Overall Study|Protocol Violation|10|||
16241844|NCT03262233|39368744|FG002|Overall Study|Protocol Violation|2|||
16241845|NCT03262233|39368745|FG003|Overall Study|Protocol Violation|13|||
16241846|NCT03262233|39368742|FG000|Overall Study|data collection artifact|0|||
16241847|NCT03262233|39368743|FG001|Overall Study|data collection artifact|1|||
16350538|NCT00101868|39769129|FG001|Overall Study|Lost to Follow-up|13|||
16350539|NCT02219685|39769130|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
16350540|NCT02219685|39769131|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
16124863|NCT01302067|38942353|FG000|Overall Study|Protocol Violation|11|||
16124864|NCT01302067|38942354|FG001|Overall Study|Protocol Violation|0|||
16124865|NCT01302067|38942355|FG002|Overall Study|Protocol Violation|8|||
16124866|NCT01302067|38942353|FG000|Overall Study|Adverse Event|27|||
16124867|NCT01302067|38942354|FG001|Overall Study|Adverse Event|14|||
16124868|NCT01302067|38942355|FG002|Overall Study|Adverse Event|45|||
16124869|NCT01877239|38942358|FG000|Overall Study|Adverse Event|4|||
16124870|NCT01877239|38942358|FG000|Overall Study|Disease Remission|1|||
16124871|NCT01877239|38942358|FG000|Overall Study|Withdrawal by Subject|4|||
16124872|NCT01877239|38942358|FG000|Overall Study|Other|2|||
16124873|NCT01877239|38942358|FG000|Overall Study|Lack of Efficacy|4|||
16124874|NCT01877239|38942358|FG000|Overall Study|Data not available|35|||
16124875|NCT01920932|38942359|FG000|Overall Study|Death|1|||
16124876|NCT01920932|38942359|FG000|Overall Study|Withdrawal of consent|1|||
16241848|NCT03262233|39368744|FG002|Overall Study|data collection artifact|0|||
16241849|NCT03262233|39368745|FG003|Overall Study|data collection artifact|0|||
16350541|NCT02219685|39769130|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
16350542|NCT02219685|39769131|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
16350543|NCT03677869|39769134|FG000|Overall Study|Withdrawal by Subject|1|||
16350544|NCT02595502|39772768|FG000|Period 1|Adverse Event|0|||
16350545|NCT02595502|39772769|FG001|Period 1|Adverse Event|1|||
16350546|NCT02595502|39772768|FG000|Period 1|Withdrawal by Subject|1|||
16350547|NCT02595502|39772769|FG001|Period 1|Withdrawal by Subject|0|||
16350548|NCT02595502|39772768|FG000|Period 1|Lost to Follow-up|0|||
16350549|NCT02595502|39772769|FG001|Period 1|Lost to Follow-up|1|||
16350550|NCT02595502|39772768|FG000|Period 2|Adverse Event|1|||
16350551|NCT02595502|39772769|FG001|Period 2|Adverse Event|1|||
16124877|NCT00928018|38942362|FG000|Overall Study|Withdrawal by Subject|1|||
16124878|NCT00928018|38942363|FG001|Overall Study|Withdrawal by Subject|0|||
16124879|NCT01395888|38942364|FG000|2-week Run-in Period|Adverse Event|2|||
16241850|NCT03063632|39368746|FG000|Overall Study|Death|4|||
16124880|NCT01395888|38942365|FG001|2-week Run-in Period|Adverse Event|0|||
16124881|NCT01395888|38942366|FG002|2-week Run-in Period|Adverse Event|0|||
16124882|NCT01395888|38942364|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
16241851|NCT03063632|39368747|FG001|Overall Study|Death|6|||
16241852|NCT03063632|39368746|FG000|Overall Study|Lost to Follow-up|0|||
16241853|NCT03063632|39368747|FG001|Overall Study|Lost to Follow-up|1|||
16241854|NCT03063632|39368746|FG000|Overall Study|Withdrawal by Subject|0|||
16241855|NCT03063632|39368747|FG001|Overall Study|Withdrawal by Subject|2|||
16241856|NCT03063632|39368746|FG000|Overall Study|Physician Decision|2|||
16241857|NCT03063632|39368747|FG001|Overall Study|Physician Decision|0|||
16241858|NCT03063632|39368746|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
16241859|NCT03063632|39368747|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
16241860|NCT01684722|39368748|FG000|Overall Study|Lost to Follow-up|78|||
16241861|NCT01684722|39368749|FG001|Overall Study|Lost to Follow-up|56|||
16241862|NCT01684722|39368750|FG002|Overall Study|Lost to Follow-up|75|||
16241863|NCT01684722|39368751|FG003|Overall Study|Lost to Follow-up|89|||
16241864|NCT01684722|39368748|FG000|Overall Study|Death|19|||
16241865|NCT01684722|39368749|FG001|Overall Study|Death|21|||
16241866|NCT01684722|39368750|FG002|Overall Study|Death|19|||
16241867|NCT01684722|39368751|FG003|Overall Study|Death|21|||
16241868|NCT02419469|39368755|FG000|Overall Study|Withdrawal by Subject|1|||
16241869|NCT00304954|39368756|FG000|Overall Study|Withdrawal by Subject|0|||
16241870|NCT00304954|39368757|FG001|Overall Study|Withdrawal by Subject|0|||
16241871|NCT00304954|39368758|FG002|Overall Study|Withdrawal by Subject|1|||
16241872|NCT00304954|39368759|FG003|Overall Study|Withdrawal by Subject|0|||
16241873|NCT00304954|39368756|FG000|Overall Study|Adverse Event|1|||
16241874|NCT00304954|39368757|FG001|Overall Study|Adverse Event|0|||
16241875|NCT00304954|39368758|FG002|Overall Study|Adverse Event|0|||
16241876|NCT00304954|39368759|FG003|Overall Study|Adverse Event|0|||
16241877|NCT03636542|39368762|FG000|Overall Study|Lost to Follow-up|1|||
16241878|NCT03636542|39368763|FG001|Overall Study|Lost to Follow-up|1|||
16241879|NCT03636542|39368762|FG000|Overall Study|Physician Decision|0|||
16241880|NCT03636542|39368763|FG001|Overall Study|Physician Decision|1|||
16241881|NCT03636542|39368762|FG000|Overall Study|Withdrawal by Subject|1|||
16241882|NCT03636542|39368763|FG001|Overall Study|Withdrawal by Subject|0|||
16241883|NCT00571922|39368764|FG000|Overall Study|Completion unknown|36|||
16350552|NCT02595502|39772768|FG000|Period 2|Received incorrect lens at Period 1|0|||
16124883|NCT01395888|38942365|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
16241884|NCT00571922|39368765|FG001|Overall Study|Completion unknown|36|||
16241885|NCT00320593|39368768|FG000|Overall Study|Lost to Follow-up|3|||
16241886|NCT00320593|39368769|FG001|Overall Study|Lost to Follow-up|0|||
16241887|NCT00320593|39368768|FG000|Overall Study|Moved to another state|1|||
16124884|NCT01395888|38942366|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
16124885|NCT01395888|38942364|FG000|2-week Run-in Period|Lost to Follow-up|1|||
16124886|NCT01395888|38942365|FG001|2-week Run-in Period|Lost to Follow-up|0|||
16124887|NCT01395888|38942366|FG002|2-week Run-in Period|Lost to Follow-up|0|||
16124888|NCT01395888|38942364|FG000|2-week Run-in Period|Protocol Violation|2|||
16124889|NCT01395888|38942365|FG001|2-week Run-in Period|Protocol Violation|0|||
16124890|NCT01395888|38942366|FG002|2-week Run-in Period|Protocol Violation|0|||
16124891|NCT01395888|38942364|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
16124892|NCT01395888|38942365|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16124893|NCT01395888|38942366|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16124894|NCT01395888|38942364|FG000|Treatment Period (TP)|Adverse Event|0|||
16124895|NCT01395888|38942365|FG001|Treatment Period (TP)|Adverse Event|7|||
16124896|NCT01395888|38942366|FG002|Treatment Period (TP)|Adverse Event|6|||
16124897|NCT01395888|38942364|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
16124898|NCT01395888|38942365|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
16124899|NCT01395888|38942366|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
16124900|NCT01395888|38942364|FG000|Treatment Period (TP)|Protocol Violation|0|||
16124901|NCT01395888|38942365|FG001|Treatment Period (TP)|Protocol Violation|1|||
16124902|NCT01395888|38942366|FG002|Treatment Period (TP)|Protocol Violation|5|||
16124903|NCT01395888|38942364|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
16124904|NCT01395888|38942365|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
16124905|NCT01395888|38942366|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
16124906|NCT01395888|38942364|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
16124907|NCT01395888|38942365|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
16124908|NCT01395888|38942366|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
16124909|NCT01552603|38942367|FG000|Overall Study|Physician Decision|1|||
16124910|NCT03534284|38945968|FG000|Overall Study|Death|2|||
16124911|NCT03534284|38945969|FG001|Overall Study|Death|3|||
16124912|NCT03534284|38945970|FG002|Overall Study|Death|3|||
16124913|NCT03534284|38945968|FG000|Overall Study|Withdrawal by Subject|5|||
16124914|NCT03534284|38945969|FG001|Overall Study|Withdrawal by Subject|0|||
16124915|NCT03534284|38945970|FG002|Overall Study|Withdrawal by Subject|0|||
16124916|NCT02236988|38945971|FG000|Overall Study|Lost to Follow-up|0|||
16124917|NCT02236988|38945972|FG001|Overall Study|Lost to Follow-up|0|||
16124918|NCT02236988|38945973|FG002|Overall Study|Lost to Follow-up|0|||
16124919|NCT02236988|38945974|FG003|Overall Study|Lost to Follow-up|1|||
16124920|NCT02236988|38945971|FG000|Overall Study|Unable to Comply with Study Visits|0|||
16124921|NCT02236988|38945972|FG001|Overall Study|Unable to Comply with Study Visits|0|||
16124922|NCT02236988|38945973|FG002|Overall Study|Unable to Comply with Study Visits|0|||
16124923|NCT02236988|38945974|FG003|Overall Study|Unable to Comply with Study Visits|2|||
16124924|NCT04488770|38945975|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124925|NCT04488770|38945976|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124926|NCT04488770|38945977|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124927|NCT04488770|38945978|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
16124928|NCT04488770|38945979|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124929|NCT04488770|38945980|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124930|NCT04488770|38945981|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124931|NCT04488770|38945982|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124932|NCT04488770|38945983|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124933|NCT04488770|38945984|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124934|NCT04488770|38945985|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124935|NCT04488770|38945986|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124936|NCT04488770|38945987|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
16124937|NCT04488770|38945975|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
16241888|NCT00320593|39368769|FG001|Overall Study|Moved to another state|0|||
16241889|NCT00320593|39368768|FG000|Overall Study|Withdrawal by Subject|2|||
16124938|NCT04488770|38945976|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124939|NCT04488770|38945977|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124940|NCT04488770|38945978|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124941|NCT04488770|38945979|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124942|NCT04488770|38945980|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124943|NCT04488770|38945981|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124944|NCT04488770|38945982|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124945|NCT04488770|38945983|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124946|NCT04488770|38945984|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124947|NCT04488770|38945985|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124948|NCT04488770|38945986|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16124949|NCT04488770|38945987|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
16241890|NCT00320593|39368769|FG001|Overall Study|Withdrawal by Subject|1|||
16241891|NCT00320593|39368768|FG000|Overall Study|Withdrawal by clinical center|1|||
16124950|NCT04488770|38945975|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124951|NCT04488770|38945976|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124952|NCT04488770|38945977|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124953|NCT04488770|38945978|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124954|NCT04488770|38945979|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124955|NCT04488770|38945980|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
16124956|NCT04488770|38945981|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
16124957|NCT04488770|38945982|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124958|NCT04488770|38945983|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124959|NCT04488770|38945984|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124960|NCT04488770|38945985|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124961|NCT04488770|38945986|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124962|NCT04488770|38945987|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
16124963|NCT04488770|38945975|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16124964|NCT04488770|38945976|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16557861|NCT02081391|40509791|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
16557862|NCT02081391|40509788|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
16557863|NCT02081391|40509789|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
16557864|NCT02081391|40509790|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
16557865|NCT02081391|40509791|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
16557866|NCT02081391|40509788|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
16557867|NCT02081391|40509789|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
16557868|NCT02081391|40509790|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
16557869|NCT02081391|40509791|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
16557870|NCT02081391|40509788|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
16557871|NCT02081391|40509789|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
16124965|NCT04488770|38945977|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16124966|NCT04488770|38945978|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16124967|NCT04488770|38945979|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
16124968|NCT04488770|38945980|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16124969|NCT04488770|38945981|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16241892|NCT00320593|39368769|FG001|Overall Study|Withdrawal by clinical center|0|||
16241893|NCT04575038|39368772|FG000|Overall Study|Withdrawal by Subject|1|||
16241894|NCT04575038|39368773|FG001|Overall Study|Withdrawal by Subject|1|||
16241895|NCT00616928|39368774|FG000|Overall Study|Adverse Event|6|||
16241896|NCT00616928|39368775|FG001|Overall Study|Adverse Event|3|||
16241897|NCT00616928|39368776|FG002|Overall Study|Adverse Event|2|||
16241898|NCT00616928|39368777|FG003|Overall Study|Adverse Event|2|||
16241899|NCT00616928|39368774|FG000|Overall Study|Other|51|||
16241900|NCT00616928|39368775|FG001|Overall Study|Other|8|||
16241901|NCT00616928|39368776|FG002|Overall Study|Other|15|||
16241902|NCT00616928|39368777|FG003|Overall Study|Other|5|||
16241903|NCT00616928|39368774|FG000|Overall Study|Lost to Follow-up|5|||
16241904|NCT00616928|39368775|FG001|Overall Study|Lost to Follow-up|7|||
16241905|NCT00616928|39368776|FG002|Overall Study|Lost to Follow-up|0|||
16124970|NCT04488770|38945982|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16124971|NCT04488770|38945983|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16124972|NCT04488770|38945984|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16124973|NCT04488770|38945985|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16124974|NCT04488770|38945986|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16124975|NCT04488770|38945987|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
16124976|NCT03932812|38945989|FG000|Overall Study|Lost to Follow-up|12|||
16124977|NCT03932812|38945990|FG001|Overall Study|Lost to Follow-up|14|||
16124978|NCT03932812|38945989|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
16124979|NCT03932812|38945990|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
16124980|NCT01977677|38945998|FG000|Overall Study|Unrelated Adverse Event|0|||
16124981|NCT01977677|38945999|FG001|Overall Study|Unrelated Adverse Event|0|||
16124982|NCT01977677|38946000|FG002|Overall Study|Unrelated Adverse Event|1|||
16124983|NCT00379288|38946003|FG000|Overall Study|Adverse Event|5|||
16124984|NCT00379288|38946004|FG001|Overall Study|Adverse Event|6|||
16124985|NCT00379288|38946005|FG002|Overall Study|Adverse Event|2|||
16124986|NCT00379288|38946006|FG003|Overall Study|Adverse Event|0|||
16124987|NCT00379288|38946003|FG000|Overall Study|Treatment Failure|0|||
16124988|NCT00379288|38946004|FG001|Overall Study|Treatment Failure|1|||
16124989|NCT00379288|38946005|FG002|Overall Study|Treatment Failure|0|||
16124990|NCT00379288|38946006|FG003|Overall Study|Treatment Failure|1|||
16124991|NCT00379288|38946003|FG000|Overall Study|Lost to Follow-up|3|||
16241906|NCT00616928|39368777|FG003|Overall Study|Lost to Follow-up|0|||
16241907|NCT01335399|39368779|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
16241908|NCT01335399|39368780|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
16241909|NCT01335399|39368779|FG000|Pre-treatment Period|Participant request to discontinue|0|||
16241910|NCT01335399|39368780|FG001|Pre-treatment Period|Participant request to discontinue|1|||
16241911|NCT01335399|39368779|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
16241912|NCT01335399|39368780|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
16241913|NCT01335399|39368779|FG000|Pre-treatment Period|Consent withdrawal|3|||
16241914|NCT01335399|39368780|FG001|Pre-treatment Period|Consent withdrawal|0|||
16241915|NCT01335399|39368779|FG000|Treatment Period|Disease progression|117|||
16241916|NCT01335399|39368780|FG001|Treatment Period|Disease progression|145|||
16241917|NCT01335399|39368779|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
16241918|NCT01335399|39368780|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
16241919|NCT01335399|39368779|FG000|Treatment Period|Study drug toxicity|52|||
16241920|NCT01335399|39368780|FG001|Treatment Period|Study drug toxicity|64|||
16241921|NCT01335399|39368779|FG000|Treatment Period|Participant request to discontinue|30|||
16241922|NCT01335399|39368780|FG001|Treatment Period|Participant request to discontinue|22|||
16241923|NCT01335399|39368779|FG000|Treatment Period|Other reasons|30|||
16241924|NCT01335399|39368780|FG001|Treatment Period|Other reasons|30|||
16241925|NCT01335399|39368779|FG000|Treatment Period|Consent withdrawal|10|||
16241926|NCT01335399|39368780|FG001|Treatment Period|Consent withdrawal|7|||
16241927|NCT01335399|39368779|FG000|Treatment Period|Death|7|||
16241928|NCT01335399|39368780|FG001|Treatment Period|Death|6|||
16241929|NCT01335399|39368779|FG000|Treatment Period|Poor/Non-compliance|3|||
16241930|NCT01335399|39368780|FG001|Treatment Period|Poor/Non-compliance|4|||
16241931|NCT01335399|39368779|FG000|Treatment Period|Lost to Follow-up|2|||
16241932|NCT01335399|39368780|FG001|Treatment Period|Lost to Follow-up|2|||
16241933|NCT01335399|39368779|FG000|Treatment Period|Maximum clinical benefit|1|||
16241934|NCT01335399|39368780|FG001|Treatment Period|Maximum clinical benefit|1|||
16241935|NCT01335399|39368779|FG000|Treatment Period|No longer meet study criteria|1|||
16241936|NCT01335399|39368780|FG001|Treatment Period|No longer meet study criteria|1|||
16241937|NCT01335399|39368779|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
16241938|NCT01335399|39368780|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
16350553|NCT02595502|39772769|FG001|Period 2|Received incorrect lens at Period 1|1|||
16124992|NCT00379288|38946004|FG001|Overall Study|Lost to Follow-up|3|||
16124993|NCT00379288|38946005|FG002|Overall Study|Lost to Follow-up|2|||
16124994|NCT00379288|38946006|FG003|Overall Study|Lost to Follow-up|0|||
16124995|NCT00379288|38946003|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
16241939|NCT02133352|39368782|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
16241940|NCT01697449|39368783|FG000|Overall Study|Disease progression|47|||
16241941|NCT01697449|39368783|FG000|Overall Study|Adverse Event|7|||
16241942|NCT01697449|39368783|FG000|Overall Study|Lost to Follow-up|5|||
16241943|NCT01697449|39368783|FG000|Overall Study|Withdrawal by Subject|2|||
16241944|NCT01697449|39368783|FG000|Overall Study|Physician Decision|1|||
16124996|NCT00379288|38946004|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
16124997|NCT00379288|38946005|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
16124998|NCT00379288|38946006|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
16124999|NCT00379288|38946003|FG000|Overall Study|Subject withdrew-related to study drug|1|||
16125000|NCT00379288|38946004|FG001|Overall Study|Subject withdrew-related to study drug|0|||
16125001|NCT00379288|38946005|FG002|Overall Study|Subject withdrew-related to study drug|0|||
16125002|NCT00379288|38946006|FG003|Overall Study|Subject withdrew-related to study drug|1|||
16125003|NCT00379288|38946003|FG000|Overall Study|Noncompliance with protocol|8|||
16125004|NCT00379288|38946004|FG001|Overall Study|Noncompliance with protocol|6|||
16125005|NCT00379288|38946005|FG002|Overall Study|Noncompliance with protocol|2|||
16125006|NCT00379288|38946006|FG003|Overall Study|Noncompliance with protocol|1|||
16125007|NCT00379288|38946003|FG000|Overall Study|Did not meet protocol eligibility|0|||
16125008|NCT00379288|38946004|FG001|Overall Study|Did not meet protocol eligibility|1|||
16125009|NCT00379288|38946005|FG002|Overall Study|Did not meet protocol eligibility|0|||
16125010|NCT00379288|38946006|FG003|Overall Study|Did not meet protocol eligibility|2|||
16125011|NCT00379288|38946003|FG000|Overall Study|Administrative|2|||
16125012|NCT00379288|38946004|FG001|Overall Study|Administrative|2|||
16125013|NCT00379288|38946005|FG002|Overall Study|Administrative|0|||
16125014|NCT00379288|38946006|FG003|Overall Study|Administrative|1|||
16125015|NCT01901432|38946010|FG000|Overall Study|Adverse Event|0|||
16125016|NCT01901432|38946011|FG001|Overall Study|Adverse Event|1|||
16125017|NCT01901432|38946012|FG002|Overall Study|Adverse Event|1|||
16125018|NCT01901432|38946013|FG003|Overall Study|Adverse Event|0|||
16125019|NCT01901432|38946014|FG004|Overall Study|Adverse Event|1|||
16125020|NCT01901432|38946010|FG000|Overall Study|Withdrawal by Subject|0|||
16125021|NCT01901432|38946011|FG001|Overall Study|Withdrawal by Subject|0|||
16125022|NCT01901432|38946012|FG002|Overall Study|Withdrawal by Subject|1|||
16125023|NCT01901432|38946013|FG003|Overall Study|Withdrawal by Subject|0|||
16125024|NCT01901432|38946014|FG004|Overall Study|Withdrawal by Subject|5|||
16125025|NCT01901432|38946010|FG000|Overall Study|Physician Decision|0|||
16125026|NCT01901432|38946011|FG001|Overall Study|Physician Decision|0|||
16125027|NCT01901432|38946012|FG002|Overall Study|Physician Decision|0|||
16125028|NCT01901432|38946013|FG003|Overall Study|Physician Decision|0|||
16125029|NCT01901432|38946014|FG004|Overall Study|Physician Decision|2|||
16125030|NCT01901432|38946010|FG000|Overall Study|Patient decision to stop study drug|0|||
16125031|NCT01901432|38946011|FG001|Overall Study|Patient decision to stop study drug|0|||
16125032|NCT01901432|38946012|FG002|Overall Study|Patient decision to stop study drug|0|||
16125033|NCT01901432|38946013|FG003|Overall Study|Patient decision to stop study drug|0|||
16125034|NCT01901432|38946014|FG004|Overall Study|Patient decision to stop study drug|1|||
16125035|NCT01036438|38946015|FG000|Overall Study|Adverse Event|7|||
16125036|NCT01036438|38946016|FG001|Overall Study|Adverse Event|8|||
16125037|NCT01036438|38946015|FG000|Overall Study|Death|0|||
16125038|NCT01036438|38946016|FG001|Overall Study|Death|1|||
16125039|NCT01036438|38946015|FG000|Overall Study|No effect of study treatment|3|||
16125040|NCT01036438|38946016|FG001|Overall Study|No effect of study treatment|1|||
16414666|NCT00525824|39998517|FG003|Overall Study|Withdrawal by Subject|4|||
16414667|NCT00525824|39998514|FG000|Overall Study|Lost to Follow-up|4|||
16414668|NCT00525824|39998515|FG001|Overall Study|Lost to Follow-up|2|||
16414669|NCT00525824|39998516|FG002|Overall Study|Lost to Follow-up|4|||
16414670|NCT00525824|39998517|FG003|Overall Study|Lost to Follow-up|0|||
16414671|NCT00525824|39998514|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
16414672|NCT00525824|39998515|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
16414673|NCT00525824|39998516|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
16414674|NCT00525824|39998517|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
16414675|NCT00525824|39998514|FG000|Overall Study|Severe non-compliance|0|||
16414676|NCT00525824|39998515|FG001|Overall Study|Severe non-compliance|1|||
16557872|NCT02081391|40509790|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
16557873|NCT02081391|40509791|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
16125041|NCT01305200|38946017|FG000|Overall Study|Physician Decision|4|||
16125042|NCT01305200|38946018|FG001|Overall Study|Physician Decision|6|||
16125043|NCT01305200|38946019|FG002|Overall Study|Physician Decision|1|||
16125044|NCT01305200|38946017|FG000|Overall Study|Withdrawal by Subject|24|||
16125045|NCT01305200|38946018|FG001|Overall Study|Withdrawal by Subject|21|||
16125046|NCT01305200|38946019|FG002|Overall Study|Withdrawal by Subject|1|||
16125047|NCT01305200|38946017|FG000|Overall Study|Ineligible|1|||
16557874|NCT02081391|40509788|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
16125048|NCT01305200|38946018|FG001|Overall Study|Ineligible|2|||
16125049|NCT01305200|38946019|FG002|Overall Study|Ineligible|1|||
16125050|NCT01305200|38946017|FG000|Overall Study|Death|0|||
16125051|NCT01305200|38946018|FG001|Overall Study|Death|2|||
16125052|NCT01305200|38946019|FG002|Overall Study|Death|0|||
16125053|NCT01789567|38946020|FG000|Overall Study|Death|6|||
16125054|NCT02349425|38946021|FG000|Period 1|Adverse Event|1|||
16125055|NCT02349425|38946022|FG001|Period 1|Adverse Event|1|||
16125056|NCT02349425|38946023|FG002|Period 1|Adverse Event|0|||
16241945|NCT01697449|39368783|FG000|Overall Study|Death|2|||
16241946|NCT01697449|39368783|FG000|Overall Study|Other|1|||
16241947|NCT01697449|39368783|FG000|Overall Study|Missing|25|||
16241948|NCT03070431|39368791|FG000|Overall Study|Withdrawal by Subject|2|||
16241949|NCT03070431|39368791|FG000|Overall Study|Lost to Follow-up|2|||
16241950|NCT01453374|39368792|FG000|Overall Study|Adverse Event|7|||
16241951|NCT01453374|39368792|FG000|Overall Study|Lack of Efficacy|1|||
16241952|NCT01453374|39368792|FG000|Overall Study|Lost to Follow-up|3|||
16241953|NCT01453374|39368792|FG000|Overall Study|Withdrawal by Subject|5|||
16241954|NCT01453374|39368792|FG000|Overall Study|Incarcerated|2|||
16241955|NCT00845026|39368793|FG000|Study Period III|Adverse Event|23|||
16241956|NCT00845026|39368794|FG001|Study Period III|Adverse Event|19|||
16241957|NCT00845026|39368793|FG000|Study Period III|Perceived lack of efficacy|27|||
16125057|NCT02349425|38946024|FG003|Period 1|Adverse Event|0|||
16241958|NCT00845026|39368794|FG001|Study Period III|Perceived lack of efficacy|15|||
16241959|NCT00845026|39368793|FG000|Study Period III|Withdrawal by Subject|19|||
16241960|NCT00845026|39368794|FG001|Study Period III|Withdrawal by Subject|15|||
16241961|NCT00845026|39368793|FG000|Study Period III|Entry Criteria not met|8|||
16241962|NCT00845026|39368794|FG001|Study Period III|Entry Criteria not met|11|||
16241963|NCT00845026|39368793|FG000|Study Period III|Lost to Follow-up|4|||
16241964|NCT00845026|39368794|FG001|Study Period III|Lost to Follow-up|5|||
16241965|NCT00845026|39368793|FG000|Study Period III|Protocol Violation|8|||
16241966|NCT00845026|39368794|FG001|Study Period III|Protocol Violation|1|||
16241967|NCT00845026|39368793|FG000|Study Period III|Scheduled conflict|3|||
16241968|NCT00845026|39368794|FG001|Study Period III|Scheduled conflict|1|||
16241969|NCT00845026|39368793|FG000|Study Period III|Subject is moving or has moved|2|||
16241970|NCT00845026|39368794|FG001|Study Period III|Subject is moving or has moved|4|||
16241971|NCT00845026|39368793|FG000|Study Period III|Transportation issues|1|||
16125058|NCT02349425|38946021|FG000|Period 2|Adverse Event|0|||
16125059|NCT02349425|38946022|FG001|Period 2|Adverse Event|1|||
16241972|NCT00845026|39368794|FG001|Study Period III|Transportation issues|1|||
16241973|NCT00845026|39368793|FG000|Study Period IV|Adverse Event|4|||
16241974|NCT00845026|39368794|FG001|Study Period IV|Adverse Event|0|||
16241975|NCT00845026|39368793|FG000|Study Period IV|Perceived lack of efficacy|2|||
16350554|NCT02595502|39772768|FG000|Period 3|Protocol Violation|0|||
16350555|NCT02595502|39772769|FG001|Period 3|Protocol Violation|1|||
16350556|NCT02595502|39772768|FG000|Period 3|Lost to Follow-up|1|||
16125060|NCT02349425|38946023|FG002|Period 2|Adverse Event|1|||
16125061|NCT02349425|38946024|FG003|Period 2|Adverse Event|0|||
16350557|NCT02595502|39772769|FG001|Period 3|Lost to Follow-up|0|||
16350558|NCT02595502|39772768|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
16350559|NCT02595502|39772769|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
16350560|NCT04386902|39772772|FG000|Overall Study|Withdrawal by Subject|5|||
16350561|NCT04386902|39772772|FG000|Overall Study|Technical problems in the recording|5|||
16350562|NCT00419757|39772773|FG000|Overall Study|Adverse Event|1|||
16350563|NCT00419757|39772774|FG001|Overall Study|Adverse Event|4|||
16350564|NCT00419757|39772773|FG000|Overall Study|Lost to Follow-up|1|||
16350565|NCT00419757|39772774|FG001|Overall Study|Lost to Follow-up|4|||
16350566|NCT00419757|39772773|FG000|Overall Study|Withdrawal by Subject|7|||
16350567|NCT00419757|39772774|FG001|Overall Study|Withdrawal by Subject|1|||
16350568|NCT00419757|39772773|FG000|Overall Study|Protocol Violation|2|||
16350569|NCT00419757|39772774|FG001|Overall Study|Protocol Violation|3|||
16350570|NCT00419757|39772773|FG000|Overall Study|Study specific discontinuation criteria|4|||
16350571|NCT00419757|39772774|FG001|Overall Study|Study specific discontinuation criteria|8|||
16350572|NCT00419757|39772773|FG000|Overall Study|Multiple reasons|3|||
16350573|NCT00419757|39772774|FG001|Overall Study|Multiple reasons|1|||
16350574|NCT01932697|39772775|FG000|Overall Study|Received a different amount of tx|1|||
16350575|NCT01932697|39772776|FG001|Overall Study|Received a different amount of tx|0|||
16241976|NCT00845026|39368794|FG001|Study Period IV|Perceived lack of efficacy|1|||
16241977|NCT00845026|39368793|FG000|Study Period IV|Protocol Violation|3|||
16241978|NCT00845026|39368794|FG001|Study Period IV|Protocol Violation|1|||
16241979|NCT00845026|39368793|FG000|Study Period IV|Lost to Follow-up|1|||
16241980|NCT00845026|39368794|FG001|Study Period IV|Lost to Follow-up|0|||
16241981|NCT00845026|39368793|FG000|Study Period IV|Withdrawal by Subject|4|||
16241982|NCT00845026|39368794|FG001|Study Period IV|Withdrawal by Subject|1|||
16241983|NCT00845026|39368793|FG000|Study Period IV|Entry Criteria Not Met|1|||
16241984|NCT00845026|39368794|FG001|Study Period IV|Entry Criteria Not Met|0|||
16241985|NCT00845026|39368793|FG000|Study Period IV|Subject is moving or has moved|0|||
16241986|NCT00845026|39368794|FG001|Study Period IV|Subject is moving or has moved|1|||
16241987|NCT00845026|39368793|FG000|Study Period IV|Scheduling conflict|1|||
16241988|NCT00845026|39368794|FG001|Study Period IV|Scheduling conflict|0|||
16241989|NCT00751998|39368795|FG000|Overall Study|Lost to Follow-up|7|||
16241990|NCT00751998|39368795|FG000|Overall Study|Death|11|||
16241991|NCT00751998|39368795|FG000|Overall Study|Withdrawal by Subject|2|||
16241992|NCT02018042|39368798|FG000|Overall Study|Withdrawal by Subject|1|||
16241993|NCT00305110|39368799|FG000|Overall Study|Missing data|29|||
16241994|NCT00265083|39368804|FG000|Overall Study|Adverse Event|5|||
16241995|NCT00265083|39368805|FG001|Overall Study|Adverse Event|13|||
16241996|NCT00265083|39368806|FG002|Overall Study|Adverse Event|15|||
16241997|NCT00265083|39368804|FG000|Overall Study|Lost to Follow-up|3|||
16241998|NCT00265083|39368805|FG001|Overall Study|Lost to Follow-up|4|||
16241999|NCT00265083|39368806|FG002|Overall Study|Lost to Follow-up|4|||
16242000|NCT00265083|39368804|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
16242001|NCT00265083|39368805|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
16242002|NCT00265083|39368806|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
16242003|NCT00265083|39368804|FG000|Overall Study|Other|1|||
16242004|NCT00265083|39368805|FG001|Overall Study|Other|12|||
16242005|NCT00265083|39368806|FG002|Overall Study|Other|9|||
16242006|NCT03125629|39368807|FG000|Overall Study|Withdrawal by Subject|2|||
16242007|NCT03125629|39368807|FG000|Overall Study|Equipment malfunction|1|||
16350576|NCT01932697|39772775|FG000|Overall Study|Ineligible|1|||
16350577|NCT01932697|39772776|FG001|Overall Study|Ineligible|0|||
16242008|NCT02629965|39368815|FG000|Period 1|Adverse Event|1|||
16242009|NCT02629965|39368816|FG001|Period 1|Adverse Event|0|||
16242010|NCT02629965|39368815|FG000|Period 1|Unexpected worsening of disease|2|||
16242011|NCT02629965|39368816|FG001|Period 1|Unexpected worsening of disease|0|||
16242012|NCT02629965|39368815|FG000|Period 1|Other than listed above|1|||
16242013|NCT02629965|39368816|FG001|Period 1|Other than listed above|2|||
16242014|NCT02629965|39368815|FG000|Period 2|Adverse Event|1|||
16242015|NCT02629965|39368816|FG001|Period 2|Adverse Event|0|||
16242016|NCT02017535|39368818|FG000|Overall Study|Withdrawal by Subject|1|||
16242017|NCT02017535|39368819|FG001|Overall Study|Withdrawal by Subject|0|||
16242018|NCT02017535|39368820|FG002|Overall Study|Withdrawal by Subject|0|||
16242019|NCT02017535|39368821|FG003|Overall Study|Withdrawal by Subject|0|||
16242020|NCT00534092|39368822|FG000|Overall Study|Lost to Follow-up|1|||
16242021|NCT00534092|39368823|FG001|Overall Study|Lost to Follow-up|0|||
16242022|NCT00534092|39368822|FG000|Overall Study|personal reasons/family concerns|1|||
16242023|NCT00534092|39368823|FG001|Overall Study|personal reasons/family concerns|0|||
16242024|NCT00811070|39368824|FG000|Overall Study|Death|0|||
16242025|NCT00811070|39368825|FG001|Overall Study|Death|0|||
16242026|NCT00811070|39368826|FG002|Overall Study|Death|0|||
16242027|NCT00811070|39368827|FG003|Overall Study|Death|2|||
16242028|NCT00811070|39368828|FG004|Overall Study|Death|5|||
16242029|NCT00811070|39368829|FG005|Overall Study|Death|0|||
16242030|NCT00811070|39368824|FG000|Overall Study|Other|1|||
16242031|NCT00811070|39368825|FG001|Overall Study|Other|0|||
16242032|NCT00811070|39368826|FG002|Overall Study|Other|0|||
16242033|NCT00811070|39368827|FG003|Overall Study|Other|0|||
16242034|NCT00811070|39368828|FG004|Overall Study|Other|0|||
16242035|NCT00811070|39368829|FG005|Overall Study|Other|0|||
16242036|NCT00811070|39368824|FG000|Overall Study|Withdrawal by Subject|0|||
16242037|NCT00811070|39368825|FG001|Overall Study|Withdrawal by Subject|1|||
16242038|NCT00811070|39368826|FG002|Overall Study|Withdrawal by Subject|0|||
16242039|NCT00811070|39368827|FG003|Overall Study|Withdrawal by Subject|0|||
16242040|NCT00811070|39368828|FG004|Overall Study|Withdrawal by Subject|0|||
16242041|NCT00811070|39368829|FG005|Overall Study|Withdrawal by Subject|0|||
16242042|NCT00811070|39368824|FG000|Overall Study|Physician Decision|0|||
16242043|NCT00811070|39368825|FG001|Overall Study|Physician Decision|0|||
16242044|NCT00811070|39368826|FG002|Overall Study|Physician Decision|0|||
16242045|NCT00811070|39368827|FG003|Overall Study|Physician Decision|0|||
16242046|NCT00811070|39368828|FG004|Overall Study|Physician Decision|0|||
16242047|NCT00811070|39368829|FG005|Overall Study|Physician Decision|1|||
16242048|NCT01749033|39368830|FG000|Overall Study|Did not receive allocated intervention|3|||
16242049|NCT01749033|39368831|FG001|Overall Study|Did not receive allocated intervention|3|||
16242050|NCT01749033|39368832|FG002|Overall Study|Did not receive allocated intervention|0|||
16242051|NCT01749033|39368830|FG000|Overall Study|Lost to Follow-up|0|||
16242052|NCT01749033|39368831|FG001|Overall Study|Lost to Follow-up|2|||
16557875|NCT02081391|40509789|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
16557876|NCT02081391|40509790|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
16557877|NCT02081391|40509791|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
16557878|NCT02081391|40509788|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
16557879|NCT02081391|40509789|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
16557880|NCT02081391|40509790|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
16557881|NCT02081391|40509791|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
16557882|NCT01959880|40509803|FG000|Overall Study|Withdrawal by Subject|11|||
16557883|NCT01959880|40509804|FG001|Overall Study|Withdrawal by Subject|13|||
16557884|NCT01959880|40509805|FG002|Overall Study|Withdrawal by Subject|8|||
16557885|NCT01959880|40509806|FG003|Overall Study|Withdrawal by Subject|7|||
16557886|NCT01959880|40509803|FG000|Overall Study|Death|1|||
16125062|NCT03900416|38946025|FG000|Six Week Follow-up|Lost to Follow-up|1|||
16125063|NCT03900416|38946026|FG001|Six Week Follow-up|Lost to Follow-up|0|||
16125064|NCT03900416|38946025|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
16125065|NCT03900416|38946026|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
16125066|NCT03900416|38946025|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
16125067|NCT03900416|38946026|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
16125068|NCT03900416|38946025|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
16125069|NCT03900416|38946026|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
16242053|NCT01749033|39368832|FG002|Overall Study|Lost to Follow-up|1|||
16242054|NCT02230085|39368848|FG000|Overall Study|Physician Decision|1|||
16242055|NCT02230085|39368848|FG000|Overall Study|Withdrawal by Subject|3|||
16242056|NCT04444752|39368854|FG000|Overall Study|Adverse Event|1|||
16242057|NCT04444752|39368855|FG001|Overall Study|Adverse Event|0|||
16242058|NCT04444752|39368856|FG002|Overall Study|Adverse Event|0|||
16242059|NCT04444752|39368857|FG003|Overall Study|Adverse Event|2|||
16242060|NCT04444752|39368854|FG000|Overall Study|Lost to Follow-up|2|||
16242061|NCT04444752|39368855|FG001|Overall Study|Lost to Follow-up|6|||
16242062|NCT04444752|39368856|FG002|Overall Study|Lost to Follow-up|2|||
16242063|NCT04444752|39368857|FG003|Overall Study|Lost to Follow-up|5|||
16557887|NCT01959880|40509804|FG001|Overall Study|Death|10|||
16125070|NCT03900416|38946025|FG000|Twelve Week Follow-up|Adverse Event|1|||
16242064|NCT04444752|39368854|FG000|Overall Study|Physician Decision|0|||
16242065|NCT04444752|39368855|FG001|Overall Study|Physician Decision|0|||
16242066|NCT04444752|39368856|FG002|Overall Study|Physician Decision|0|||
16242067|NCT04444752|39368857|FG003|Overall Study|Physician Decision|2|||
16242068|NCT04444752|39368854|FG000|Overall Study|Pregnancy|0|||
16242069|NCT04444752|39368855|FG001|Overall Study|Pregnancy|0|||
16242070|NCT04444752|39368856|FG002|Overall Study|Pregnancy|0|||
16242071|NCT04444752|39368857|FG003|Overall Study|Pregnancy|1|||
16242072|NCT04444752|39368854|FG000|Overall Study|Withdrawal by Subject|6|||
16242073|NCT04444752|39368855|FG001|Overall Study|Withdrawal by Subject|5|||
16242074|NCT04444752|39368856|FG002|Overall Study|Withdrawal by Subject|3|||
16242075|NCT04444752|39368857|FG003|Overall Study|Withdrawal by Subject|4|||
16242076|NCT04444752|39368854|FG000|Overall Study|Protocol Violation|1|||
16242077|NCT04444752|39368855|FG001|Overall Study|Protocol Violation|1|||
16242078|NCT04444752|39368856|FG002|Overall Study|Protocol Violation|0|||
16242079|NCT04444752|39368857|FG003|Overall Study|Protocol Violation|0|||
16242080|NCT04444752|39368854|FG000|Overall Study|Patient moving out of town|1|||
16242081|NCT04444752|39368855|FG001|Overall Study|Patient moving out of town|0|||
16242082|NCT04444752|39368856|FG002|Overall Study|Patient moving out of town|0|||
16242083|NCT04444752|39368857|FG003|Overall Study|Patient moving out of town|1|||
16242084|NCT04444752|39368854|FG000|Overall Study|Lack of Efficacy|0|||
16242085|NCT04444752|39368855|FG001|Overall Study|Lack of Efficacy|0|||
16242086|NCT04444752|39368856|FG002|Overall Study|Lack of Efficacy|0|||
16242087|NCT04444752|39368857|FG003|Overall Study|Lack of Efficacy|1|||
16242088|NCT04444752|39368854|FG000|Overall Study|Death|0|||
16242089|NCT04444752|39368855|FG001|Overall Study|Death|0|||
16242090|NCT04444752|39368856|FG002|Overall Study|Death|1|||
16242091|NCT04444752|39368857|FG003|Overall Study|Death|0|||
16242092|NCT05028751|39368860|FG000|Overall Study|Study Terminated by Sponsor|3|||
16242093|NCT05028751|39368861|FG001|Overall Study|Study Terminated by Sponsor|0|||
16242094|NCT05028751|39368862|FG002|Overall Study|Study Terminated by Sponsor|0|||
16242095|NCT05028751|39368863|FG003|Overall Study|Study Terminated by Sponsor|0|||
16242096|NCT05028751|39368860|FG000|Overall Study|Death|9|||
16242097|NCT05028751|39368861|FG001|Overall Study|Death|3|||
16242098|NCT05028751|39368862|FG002|Overall Study|Death|2|||
16242099|NCT05028751|39368863|FG003|Overall Study|Death|4|||
16242100|NCT05028751|39368860|FG000|Overall Study|Withdrawal by Subject|0|||
16242101|NCT05028751|39368861|FG001|Overall Study|Withdrawal by Subject|0|||
16242102|NCT05028751|39368862|FG002|Overall Study|Withdrawal by Subject|1|||
16242103|NCT05028751|39368863|FG003|Overall Study|Withdrawal by Subject|0|||
16242104|NCT05028751|39368860|FG000|Overall Study|Miscellaneous|2|||
16242105|NCT05028751|39368861|FG001|Overall Study|Miscellaneous|0|||
16242106|NCT05028751|39368862|FG002|Overall Study|Miscellaneous|0|||
16242107|NCT05028751|39368863|FG003|Overall Study|Miscellaneous|0|||
16242108|NCT01272193|39368864|FG000|Overall Study|Adverse Event|1|||
16350578|NCT03498313|39772779|FG000|Experimental Period 1|Adverse Event|1|||
16350579|NCT03498313|39772780|FG001|Experimental Period 1|Adverse Event|0|||
16242109|NCT01272193|39368865|FG001|Overall Study|Adverse Event|1|||
16242110|NCT01272193|39368864|FG000|Overall Study|Lack of Efficacy|0|||
16242111|NCT01272193|39368865|FG001|Overall Study|Lack of Efficacy|3|||
16242112|NCT01272193|39368864|FG000|Overall Study|Withdrawal Criteria|1|||
16242113|NCT01272193|39368865|FG001|Overall Study|Withdrawal Criteria|1|||
16242114|NCT01272193|39368864|FG000|Overall Study|Unclassified|8|||
16242115|NCT01272193|39368865|FG001|Overall Study|Unclassified|7|||
16350580|NCT03498313|39772781|FG002|Experimental Period 1|Adverse Event|0|||
16350581|NCT03498313|39772782|FG003|Experimental Period 1|Adverse Event|1|||
16350582|NCT03498313|39772783|FG004|Experimental Period 1|Adverse Event|0|||
16350583|NCT03498313|39772784|FG005|Experimental Period 1|Adverse Event|0|||
16350584|NCT03498313|39772779|FG000|Experimental Period 1|Withdrawal by Subject|0|||
16350585|NCT03498313|39772780|FG001|Experimental Period 1|Withdrawal by Subject|1|||
16350586|NCT03498313|39772781|FG002|Experimental Period 1|Withdrawal by Subject|0|||
16350587|NCT03498313|39772782|FG003|Experimental Period 1|Withdrawal by Subject|0|||
16350588|NCT03498313|39772783|FG004|Experimental Period 1|Withdrawal by Subject|0|||
16242116|NCT03877237|39368866|FG000|Overall Study|Adverse Event|1|||
16242117|NCT03877237|39368867|FG001|Overall Study|Adverse Event|2|||
16242118|NCT03877237|39368866|FG000|Overall Study|Death|3|||
16242119|NCT03877237|39368867|FG001|Overall Study|Death|2|||
16242120|NCT03877237|39368866|FG000|Overall Study|Physician Decision|1|||
16242121|NCT03877237|39368867|FG001|Overall Study|Physician Decision|0|||
16242122|NCT03877237|39368866|FG000|Overall Study|Withdrawal by Subject|0|||
16242123|NCT03877237|39368867|FG001|Overall Study|Withdrawal by Subject|2|||
16242124|NCT00080288|39368868|FG000|Overall Study|Adverse Event|7|||
16242125|NCT00080288|39368869|FG001|Overall Study|Adverse Event|4|||
16242126|NCT00080288|39368868|FG000|Overall Study|Lost to Follow-up|3|||
16242127|NCT00080288|39368869|FG001|Overall Study|Lost to Follow-up|5|||
16242128|NCT00080288|39368868|FG000|Overall Study|Physician Decision|6|||
16242129|NCT00080288|39368869|FG001|Overall Study|Physician Decision|2|||
16242130|NCT00080288|39368868|FG000|Overall Study|Withdrawal by Subject|3|||
16242131|NCT00080288|39368869|FG001|Overall Study|Withdrawal by Subject|16|||
16414677|NCT00525824|39998516|FG002|Overall Study|Severe non-compliance|1|||
16414678|NCT00525824|39998517|FG003|Overall Study|Severe non-compliance|1|||
16242132|NCT00080288|39368868|FG000|Overall Study|Miscellaneous|11|||
16242133|NCT00080288|39368869|FG001|Overall Study|Miscellaneous|11|||
16242134|NCT01252238|39368870|FG000|Overall Study|Sponsor terminated study|4|||
16242135|NCT01252238|39368871|FG001|Overall Study|Sponsor terminated study|4|||
16242136|NCT01252238|39368872|FG002|Overall Study|Sponsor terminated study|4|||
16242137|NCT00127192|39368875|FG000|Overall Study|Adverse Event|0|||
16242138|NCT00127192|39368876|FG001|Overall Study|Adverse Event|1|||
16242139|NCT00127192|39368877|FG002|Overall Study|Adverse Event|1|||
16242140|NCT00127192|39368878|FG003|Overall Study|Adverse Event|1|||
16242141|NCT00127192|39368879|FG004|Overall Study|Adverse Event|0|||
16242142|NCT00127192|39368875|FG000|Overall Study|Lack of Efficacy|2|||
16242143|NCT00127192|39368876|FG001|Overall Study|Lack of Efficacy|0|||
16242144|NCT00127192|39368877|FG002|Overall Study|Lack of Efficacy|0|||
16242145|NCT00127192|39368878|FG003|Overall Study|Lack of Efficacy|0|||
16242146|NCT00127192|39368879|FG004|Overall Study|Lack of Efficacy|2|||
16242147|NCT00127192|39368875|FG000|Overall Study|Withdrawal by Subject|0|||
16242148|NCT00127192|39368876|FG001|Overall Study|Withdrawal by Subject|0|||
16242149|NCT00127192|39368877|FG002|Overall Study|Withdrawal by Subject|1|||
16242150|NCT00127192|39368878|FG003|Overall Study|Withdrawal by Subject|0|||
16242151|NCT00127192|39368879|FG004|Overall Study|Withdrawal by Subject|3|||
16242152|NCT00127192|39368875|FG000|Overall Study|Adverse event in pre-treatment period|1|||
16242153|NCT00127192|39368876|FG001|Overall Study|Adverse event in pre-treatment period|0|||
16242154|NCT00127192|39368877|FG002|Overall Study|Adverse event in pre-treatment period|0|||
16242155|NCT00127192|39368878|FG003|Overall Study|Adverse event in pre-treatment period|0|||
16242156|NCT00127192|39368879|FG004|Overall Study|Adverse event in pre-treatment period|0|||
16242157|NCT00833547|39368882|FG000|Overall Study|Withdrawal by Subject|2|||
16242158|NCT00833547|39368883|FG001|Overall Study|Withdrawal by Subject|2|||
16242159|NCT01656967|39368884|FG000|Overall Study|faulty monitor|1|||
16242160|NCT01656967|39368885|FG001|Overall Study|faulty monitor|0|||
16242161|NCT01656967|39368884|FG000|Overall Study|unsuccessful ETT insertion|3|||
16242162|NCT01656967|39368885|FG001|Overall Study|unsuccessful ETT insertion|2|||
16242163|NCT03118765|39368888|FG000|Overall Study|Withdrawal by Subject|0|||
16242164|NCT03118765|39368889|FG001|Overall Study|Withdrawal by Subject|0|||
16242165|NCT03118765|39368890|FG002|Overall Study|Withdrawal by Subject|1|||
16242166|NCT03118765|39368891|FG003|Overall Study|Withdrawal by Subject|0|||
16242167|NCT03118765|39368892|FG004|Overall Study|Withdrawal by Subject|0|||
16242168|NCT03118765|39368888|FG000|Overall Study|Adverse Event|1|||
16242169|NCT03118765|39368889|FG001|Overall Study|Adverse Event|1|||
16242170|NCT03118765|39368890|FG002|Overall Study|Adverse Event|1|||
16242171|NCT03118765|39368891|FG003|Overall Study|Adverse Event|1|||
16242172|NCT03118765|39368892|FG004|Overall Study|Adverse Event|1|||
16242173|NCT03118765|39368888|FG000|Overall Study|Non compliance with Study Procedures|0|||
16242174|NCT03118765|39368889|FG001|Overall Study|Non compliance with Study Procedures|0|||
16242175|NCT03118765|39368890|FG002|Overall Study|Non compliance with Study Procedures|0|||
16242176|NCT03118765|39368891|FG003|Overall Study|Non compliance with Study Procedures|1|||
16242177|NCT03118765|39368892|FG004|Overall Study|Non compliance with Study Procedures|0|||
16242178|NCT03118765|39368888|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
16242179|NCT03118765|39368889|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
16242180|NCT03118765|39368890|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
16242181|NCT03118765|39368891|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
16242182|NCT03118765|39368892|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
16242183|NCT03118765|39368888|FG000|Overall Study|COPD Exacerbation|1|||
16414679|NCT00525824|39998514|FG000|Overall Study|Safety reasons|1|||
16242184|NCT03118765|39368889|FG001|Overall Study|COPD Exacerbation|0|||
16242185|NCT03118765|39368890|FG002|Overall Study|COPD Exacerbation|0|||
16242186|NCT03118765|39368891|FG003|Overall Study|COPD Exacerbation|1|||
16242187|NCT03118765|39368892|FG004|Overall Study|COPD Exacerbation|0|||
16242188|NCT03118765|39368888|FG000|Overall Study|Lost to Follow-up|1|||
16242189|NCT03118765|39368889|FG001|Overall Study|Lost to Follow-up|0|||
16242190|NCT03118765|39368890|FG002|Overall Study|Lost to Follow-up|1|||
16242191|NCT03118765|39368891|FG003|Overall Study|Lost to Follow-up|0|||
16242192|NCT03118765|39368892|FG004|Overall Study|Lost to Follow-up|0|||
16242193|NCT03118765|39368888|FG000|Overall Study|Sponsor Decision|1|||
16242194|NCT03118765|39368889|FG001|Overall Study|Sponsor Decision|0|||
16242195|NCT03118765|39368890|FG002|Overall Study|Sponsor Decision|1|||
16242196|NCT03118765|39368891|FG003|Overall Study|Sponsor Decision|0|||
16242197|NCT03118765|39368892|FG004|Overall Study|Sponsor Decision|1|||
16242198|NCT02016755|39368893|FG000|Overall Study|Major amputation of index limb|2|||
16242199|NCT02016755|39368893|FG000|Overall Study|Adverse Event|2|||
16242200|NCT02016755|39368893|FG000|Overall Study|Physician Decision|1|||
16242201|NCT02016755|39368893|FG000|Overall Study|Death|2|||
16242202|NCT00382291|39371434|FG000|Overall Study|Adverse Event|1|||
16242203|NCT00382291|39371435|FG001|Overall Study|Adverse Event|2|||
16242204|NCT00382291|39371436|FG002|Overall Study|Adverse Event|2|||
16242205|NCT00382291|39371434|FG000|Overall Study|Protocol Violation|1|||
16242206|NCT00382291|39371435|FG001|Overall Study|Protocol Violation|0|||
16242207|NCT00382291|39371436|FG002|Overall Study|Protocol Violation|0|||
16242208|NCT00382291|39371434|FG000|Overall Study|Temporary study suspension|2|||
16242209|NCT00382291|39371435|FG001|Overall Study|Temporary study suspension|2|||
16242210|NCT00382291|39371436|FG002|Overall Study|Temporary study suspension|5|||
16242211|NCT00382291|39371434|FG000|Overall Study|Withdrawal by Subject|0|||
16242212|NCT00382291|39371435|FG001|Overall Study|Withdrawal by Subject|2|||
16242213|NCT00382291|39371436|FG002|Overall Study|Withdrawal by Subject|0|||
16242214|NCT00382291|39371434|FG000|Overall Study|Physician Decision|0|||
16242215|NCT00382291|39371435|FG001|Overall Study|Physician Decision|1|||
16242216|NCT00382291|39371436|FG002|Overall Study|Physician Decision|0|||
16242217|NCT00382291|39371434|FG000|Overall Study|Lack of Efficacy|0|||
16242218|NCT00382291|39371435|FG001|Overall Study|Lack of Efficacy|0|||
16242219|NCT00382291|39371436|FG002|Overall Study|Lack of Efficacy|1|||
16242220|NCT04071626|39371437|FG000|Overall Study|Withdrawal by Subject|1|||
16242221|NCT04071626|39371438|FG001|Overall Study|Withdrawal by Subject|1|||
16242222|NCT04071626|39371437|FG000|Overall Study|Protocol Violation|0|||
16242223|NCT04071626|39371438|FG001|Overall Study|Protocol Violation|1|||
16242224|NCT04318535|39371441|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
16242225|NCT04318535|39371442|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
16242226|NCT04318535|39371443|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
16242227|NCT00006721|39371444|FG000|Overall Study|Adverse Event|0|||
16242228|NCT00006721|39371445|FG001|Overall Study|Adverse Event|4|||
16242229|NCT00006721|39371446|FG002|Overall Study|Adverse Event|4|||
16242230|NCT00006721|39371444|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
16242231|NCT00006721|39371445|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
16242232|NCT00006721|39371446|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
16242233|NCT00006721|39371444|FG000|Overall Study|Progression/Relapse|0|||
16242234|NCT00006721|39371445|FG001|Overall Study|Progression/Relapse|1|||
16242235|NCT00006721|39371446|FG002|Overall Study|Progression/Relapse|2|||
16242236|NCT00006721|39371444|FG000|Overall Study|Death|0|||
16242237|NCT00006721|39371445|FG001|Overall Study|Death|1|||
16242238|NCT00006721|39371446|FG002|Overall Study|Death|2|||
16350589|NCT03498313|39772784|FG005|Experimental Period 1|Withdrawal by Subject|0|||
16350590|NCT03498313|39772779|FG000|Washout Period 1|Anovulation|1|||
16557888|NCT01959880|40509805|FG002|Overall Study|Death|1|||
16125071|NCT03900416|38946026|FG001|Twelve Week Follow-up|Adverse Event|1|||
16242239|NCT00006721|39371444|FG000|Overall Study|Other - Not Protocol Specified|0|||
16242240|NCT00006721|39371445|FG001|Overall Study|Other - Not Protocol Specified|7|||
16242241|NCT00006721|39371446|FG002|Overall Study|Other - Not Protocol Specified|7|||
16242242|NCT00006721|39371444|FG000|Overall Study|Ineligible|2|||
16242243|NCT00006721|39371445|FG001|Overall Study|Ineligible|12|||
16242244|NCT00006721|39371446|FG002|Overall Study|Ineligible|10|||
16242245|NCT00006721|39371444|FG000|Overall Study|Eligible but no Treatment Received|1|||
16242246|NCT00006721|39371445|FG001|Overall Study|Eligible but no Treatment Received|0|||
16242247|NCT00006721|39371446|FG002|Overall Study|Eligible but no Treatment Received|0|||
16125072|NCT03900416|38946025|FG000|Six Month Follow-up|Lost to Follow-up|4|||
16125073|NCT03900416|38946026|FG001|Six Month Follow-up|Lost to Follow-up|3|||
16125074|NCT03900416|38946025|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
16125075|NCT03900416|38946026|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
16125076|NCT01307579|38946028|FG000|Overall Study|Death|3|||
16125077|NCT01307579|38946029|FG001|Overall Study|Death|6|||
16125078|NCT01307579|38946028|FG000|Overall Study|Physician Decision|26|||
16125079|NCT01307579|38946029|FG001|Overall Study|Physician Decision|29|||
16125080|NCT01307579|38946028|FG000|Overall Study|Withdrawal by Subject|7|||
16125081|NCT01307579|38946029|FG001|Overall Study|Withdrawal by Subject|3|||
16125082|NCT01307579|38946028|FG000|Overall Study|Institutional diagnosis of IFD|21|||
16125083|NCT01307579|38946029|FG001|Overall Study|Institutional diagnosis of IFD|36|||
16242248|NCT02962882|39371447|FG000|Overall Study|Adverse Event|2|||
16242249|NCT02962882|39371447|FG000|Overall Study|Withdrawal by Subject|2|||
16414680|NCT00525824|39998515|FG001|Overall Study|Safety reasons|0|||
16242250|NCT02962882|39371447|FG000|Overall Study|Transfer from ICU|32|||
16242251|NCT02191579|39371448|FG000|Treatment 1|Multiple Reasons Specified|27|||
16242252|NCT02191579|39371449|FG001|Treatment 1|Multiple Reasons Specified|58|||
16242253|NCT02191579|39371448|FG000|Treatment 2|Multiple Reasons Specified|0|||
16242254|NCT02191579|39371449|FG001|Treatment 2|Multiple Reasons Specified|25|||
16125084|NCT01307579|38946028|FG000|Overall Study|Begin conditioning for HSCT|42|||
16125085|NCT01307579|38946029|FG001|Overall Study|Begin conditioning for HSCT|44|||
16125086|NCT01307579|38946028|FG000|Overall Study|Refractory or relapsed AML|38|||
16125087|NCT01307579|38946029|FG001|Overall Study|Refractory or relapsed AML|23|||
16125088|NCT01307579|38946028|FG000|Overall Study|Ineligible|3|||
16125089|NCT01307579|38946029|FG001|Overall Study|Ineligible|4|||
16125090|NCT00735475|38946042|FG000|Overall Study|Adverse Event|0|||
16125091|NCT00735475|38946043|FG001|Overall Study|Adverse Event|1|||
16125092|NCT00735475|38946042|FG000|Overall Study|Death|1|||
16125093|NCT00735475|38946043|FG001|Overall Study|Death|1|||
16125094|NCT00735475|38946042|FG000|Overall Study|Lost to Follow-up|3|||
16125095|NCT00735475|38946043|FG001|Overall Study|Lost to Follow-up|3|||
16125096|NCT00735475|38946042|FG000|Overall Study|Physician Decision|0|||
16125097|NCT00735475|38946043|FG001|Overall Study|Physician Decision|1|||
16125098|NCT00735475|38946042|FG000|Overall Study|Withdrawal by Subject|4|||
16125099|NCT00735475|38946043|FG001|Overall Study|Withdrawal by Subject|5|||
16125100|NCT00658788|38946046|FG000|Overall Study|Adverse Event|11|||
16125101|NCT00658788|38946046|FG000|Overall Study|Withdrawal by Subject|13|||
16350591|NCT03498313|39772780|FG001|Washout Period 1|Anovulation|0|||
16350592|NCT03498313|39772781|FG002|Washout Period 1|Anovulation|0|||
16350593|NCT03498313|39772782|FG003|Washout Period 1|Anovulation|0|||
16350594|NCT03498313|39772783|FG004|Washout Period 1|Anovulation|0|||
16350595|NCT03498313|39772784|FG005|Washout Period 1|Anovulation|0|||
16350596|NCT03498313|39772779|FG000|Washout Period 1|Withdrawal by Subject|0|||
16350597|NCT03498313|39772780|FG001|Washout Period 1|Withdrawal by Subject|3|||
16350598|NCT03498313|39772781|FG002|Washout Period 1|Withdrawal by Subject|0|||
16350599|NCT03498313|39772782|FG003|Washout Period 1|Withdrawal by Subject|1|||
16350600|NCT03498313|39772783|FG004|Washout Period 1|Withdrawal by Subject|0|||
16350601|NCT03498313|39772784|FG005|Washout Period 1|Withdrawal by Subject|1|||
16350602|NCT03498313|39772779|FG000|Experimental Period 2|Adverse Event|0|||
16350603|NCT03498313|39772780|FG001|Experimental Period 2|Adverse Event|0|||
16350604|NCT03498313|39772781|FG002|Experimental Period 2|Adverse Event|0|||
16350605|NCT03498313|39772782|FG003|Experimental Period 2|Adverse Event|0|||
16350606|NCT03498313|39772783|FG004|Experimental Period 2|Adverse Event|1|||
16350607|NCT03498313|39772784|FG005|Experimental Period 2|Adverse Event|2|||
16350608|NCT03498313|39772779|FG000|Washout Period 2|Physician Decision|1|||
16350609|NCT03498313|39772780|FG001|Washout Period 2|Physician Decision|0|||
16350610|NCT03498313|39772781|FG002|Washout Period 2|Physician Decision|0|||
16350611|NCT03498313|39772782|FG003|Washout Period 2|Physician Decision|1|||
16350612|NCT03498313|39772783|FG004|Washout Period 2|Physician Decision|0|||
16414681|NCT00525824|39998516|FG002|Overall Study|Safety reasons|1|||
16125102|NCT00658788|38946046|FG000|Overall Study|Lost to Follow-up|18|||
16125103|NCT00658788|38946046|FG000|Overall Study|Treatment Discontinuation|32|||
16242255|NCT00084617|39371450|FG000|Overall Study|Withdrawal by Subject|7|||
16242256|NCT00084617|39371450|FG000|Overall Study|Lack of Efficacy|1|||
16242257|NCT00084617|39371450|FG000|Overall Study|Protocol Violation|1|||
16242258|NCT02046369|39371451|FG000|Overall Study|Adverse Event|3|||
16242259|NCT02046369|39371452|FG001|Overall Study|Adverse Event|3|||
16242260|NCT02046369|39371451|FG000|Overall Study|Lack of Efficacy|3|||
16242261|NCT02046369|39371452|FG001|Overall Study|Lack of Efficacy|3|||
16242262|NCT02046369|39371451|FG000|Overall Study|Lost to Follow-up|3|||
16242263|NCT02046369|39371452|FG001|Overall Study|Lost to Follow-up|3|||
16242264|NCT02046369|39371451|FG000|Overall Study|Protocol Violation|1|||
16242265|NCT02046369|39371452|FG001|Overall Study|Protocol Violation|2|||
16242266|NCT02046369|39371451|FG000|Overall Study|Withdrawal by Subject|3|||
16242267|NCT02046369|39371452|FG001|Overall Study|Withdrawal by Subject|6|||
16242268|NCT02046369|39371451|FG000|Overall Study|never received study drug|0|||
16242269|NCT02046369|39371452|FG001|Overall Study|never received study drug|1|||
16242270|NCT02046369|39371451|FG000|Overall Study|non compliance|1|||
16557889|NCT01959880|40509806|FG003|Overall Study|Death|2|||
16557890|NCT01959880|40509803|FG000|Overall Study|Lost to Follow-up|95|||
16557891|NCT01959880|40509804|FG001|Overall Study|Lost to Follow-up|18|||
16557892|NCT01959880|40509805|FG002|Overall Study|Lost to Follow-up|15|||
16557893|NCT01959880|40509806|FG003|Overall Study|Lost to Follow-up|8|||
16557894|NCT01959880|40509803|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
16557895|NCT01959880|40509804|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
16557896|NCT01959880|40509805|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
16557897|NCT01959880|40509806|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
16557898|NCT01959880|40509803|FG000|Overall Study|Study completed early-FDA approved|1003|||
16557899|NCT01959880|40509804|FG001|Overall Study|Study completed early-FDA approved|311|||
16242271|NCT02046369|39371452|FG001|Overall Study|non compliance|0|||
16242272|NCT00659581|39371453|FG000|Overall Study|Adverse Event|1006|||
16350613|NCT03498313|39772784|FG005|Washout Period 2|Physician Decision|1|||
16125104|NCT02738203|38946062|FG000|Overall Study|Failed IUD Insertion|2|||
16125105|NCT02738203|38946063|FG001|Overall Study|Failed IUD Insertion|2|||
16125106|NCT02738203|38946062|FG000|Overall Study|Protocol Violation|0|||
16125107|NCT02738203|38946063|FG001|Overall Study|Protocol Violation|1|||
16125108|NCT01757197|38946064|FG000|Overall Study|Death|2|||
16125109|NCT02233543|38946067|FG000|Period 1|Withdrawal by Subject|1|||
16125110|NCT02233543|38946068|FG001|Period 1|Withdrawal by Subject|0|||
16242273|NCT00659581|39371453|FG000|Overall Study|Lack of Efficacy|1183|||
16557900|NCT01959880|40509805|FG002|Overall Study|Study completed early-FDA approved|179|||
16557901|NCT01959880|40509806|FG003|Overall Study|Study completed early-FDA approved|152|||
16557902|NCT04537897|40509808|FG000|Overall Study|Other than listed|0|||
16557903|NCT04537897|40509809|FG001|Overall Study|Other than listed|0|||
16557904|NCT04537897|40509810|FG002|Overall Study|Other than listed|0|||
16557905|NCT04537897|40509811|FG003|Overall Study|Other than listed|0|||
16557906|NCT04537897|40509812|FG004|Overall Study|Other than listed|0|||
16557907|NCT04537897|40509813|FG005|Overall Study|Other than listed|0|||
16557908|NCT04537897|40509814|FG006|Overall Study|Other than listed|1|||
16557909|NCT04537897|40509815|FG007|Overall Study|Other than listed|0|||
16557910|NCT04537897|40509816|FG008|Overall Study|Other than listed|0|||
16557911|NCT04537897|40509808|FG000|Overall Study|Adverse Event|0|||
16557912|NCT04537897|40509809|FG001|Overall Study|Adverse Event|0|||
16557913|NCT04537897|40509810|FG002|Overall Study|Adverse Event|0|||
16557914|NCT04537897|40509811|FG003|Overall Study|Adverse Event|1|||
16557915|NCT04537897|40509812|FG004|Overall Study|Adverse Event|0|||
16242274|NCT00659581|39371453|FG000|Overall Study|Other|6393|||
16242275|NCT01537549|39371454|FG000|Overall Study|Lost to Follow-up|1|||
16350614|NCT03498313|39772779|FG000|Washout Period 2|Withdrawal by Subject|3|||
16350615|NCT03498313|39772780|FG001|Washout Period 2|Withdrawal by Subject|2|||
16350616|NCT03498313|39772781|FG002|Washout Period 2|Withdrawal by Subject|0|||
16350617|NCT03498313|39772782|FG003|Washout Period 2|Withdrawal by Subject|0|||
16125111|NCT02233543|38946067|FG000|Period 1|Participants required other treatment.|2|||
16350618|NCT03498313|39772783|FG004|Washout Period 2|Withdrawal by Subject|2|||
16350619|NCT03498313|39772784|FG005|Washout Period 2|Withdrawal by Subject|0|||
16350620|NCT03498313|39772779|FG000|Washout Period 2|Anovulation|0|||
16350621|NCT03498313|39772780|FG001|Washout Period 2|Anovulation|0|||
16350622|NCT03498313|39772781|FG002|Washout Period 2|Anovulation|0|||
16350623|NCT03498313|39772782|FG003|Washout Period 2|Anovulation|0|||
16350624|NCT03498313|39772783|FG004|Washout Period 2|Anovulation|0|||
16350625|NCT03498313|39772784|FG005|Washout Period 2|Anovulation|1|||
16350626|NCT00909844|39772790|FG000|Overall Study|Adverse Event|1|||
16414682|NCT00525824|39998517|FG003|Overall Study|Safety reasons|0|||
16414683|NCT00525824|39998514|FG000|Overall Study|Other|1|||
16414684|NCT00525824|39998515|FG001|Overall Study|Other|3|||
16414685|NCT00525824|39998516|FG002|Overall Study|Other|3|||
16414686|NCT00525824|39998517|FG003|Overall Study|Other|1|||
16414687|NCT02636946|39998518|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
16414688|NCT02636946|39998519|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
16414689|NCT02636946|39998518|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
16414690|NCT02636946|39998519|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
16414691|NCT02636946|39998518|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
16414692|NCT02636946|39998519|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
16414693|NCT02636946|39998518|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
16414694|NCT02636946|39998519|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
16414695|NCT02636946|39998518|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
16242276|NCT01537549|39371454|FG000|Overall Study|Withdrawal by Subject|2|||
16242277|NCT00854620|39371455|FG000|Overall Study|Adverse Event|1|||
16242278|NCT02766400|39371458|FG000|Overall Study|Death|1|||
16242279|NCT02766400|39371459|FG001|Overall Study|Death|2|||
16242280|NCT02766400|39371458|FG000|Overall Study|Withdrawal by Subject|1|||
16242281|NCT02766400|39371459|FG001|Overall Study|Withdrawal by Subject|0|||
16414696|NCT02636946|39998519|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
16557916|NCT04537897|40509813|FG005|Overall Study|Adverse Event|0|||
16557917|NCT04537897|40509814|FG006|Overall Study|Adverse Event|0|||
16557918|NCT04537897|40509815|FG007|Overall Study|Adverse Event|0|||
16557919|NCT04537897|40509816|FG008|Overall Study|Adverse Event|0|||
16557920|NCT04537897|40509808|FG000|Overall Study|Withdrawal by Subject|0|||
16557921|NCT04537897|40509809|FG001|Overall Study|Withdrawal by Subject|1|||
16557922|NCT04537897|40509810|FG002|Overall Study|Withdrawal by Subject|0|||
16557923|NCT04537897|40509811|FG003|Overall Study|Withdrawal by Subject|0|||
16557924|NCT04537897|40509812|FG004|Overall Study|Withdrawal by Subject|0|||
16557925|NCT04537897|40509813|FG005|Overall Study|Withdrawal by Subject|0|||
16557926|NCT04537897|40509814|FG006|Overall Study|Withdrawal by Subject|0|||
16557927|NCT04537897|40509815|FG007|Overall Study|Withdrawal by Subject|0|||
16557928|NCT04537897|40509816|FG008|Overall Study|Withdrawal by Subject|0|||
16557929|NCT00783692|40509817|FG000|Induction Phase|Adverse Event|7|||
16557930|NCT00783692|40509818|FG001|Induction Phase|Adverse Event|9|||
16557931|NCT00783692|40509819|FG002|Induction Phase|Adverse Event|24|||
16242282|NCT03467971|39371460|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16557932|NCT00783692|40509820|FG003|Induction Phase|Adverse Event|0|||
16557933|NCT00783692|40509821|FG004|Induction Phase|Adverse Event|0|||
16557934|NCT00783692|40509822|FG005|Induction Phase|Adverse Event|0|||
16557935|NCT00783692|40509823|FG006|Induction Phase|Adverse Event|0|||
16242283|NCT03467971|39371461|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16557936|NCT00783692|40509817|FG000|Induction Phase|Protocol Violation|0|||
16557937|NCT00783692|40509818|FG001|Induction Phase|Protocol Violation|0|||
16242284|NCT03202511|39371462|FG000|Overall Study|Withdrawal by Subject|1|||
16242285|NCT03202511|39371463|FG001|Overall Study|Withdrawal by Subject|0|||
16242286|NCT01296152|39371466|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
16242287|NCT02544633|39371502|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
16242288|NCT02544633|39371503|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
16242289|NCT02544633|39371504|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
16242290|NCT02544633|39371505|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
16242291|NCT02544633|39371502|FG000|Treatment Period|Adverse Event|7|||
16242292|NCT02544633|39371503|FG001|Treatment Period|Adverse Event|4|||
16242293|NCT02544633|39371504|FG002|Treatment Period|Adverse Event|0|||
16242294|NCT02544633|39371505|FG003|Treatment Period|Adverse Event|5|||
16242295|NCT02544633|39371502|FG000|Treatment Period|Lack of Efficacy|17|||
16242296|NCT02544633|39371503|FG001|Treatment Period|Lack of Efficacy|11|||
16242297|NCT02544633|39371504|FG002|Treatment Period|Lack of Efficacy|5|||
16242298|NCT02544633|39371505|FG003|Treatment Period|Lack of Efficacy|5|||
16242299|NCT02544633|39371502|FG000|Treatment Period|Global Deterioration of Health|3|||
16242300|NCT02544633|39371503|FG001|Treatment Period|Global Deterioration of Health|3|||
16242301|NCT02544633|39371504|FG002|Treatment Period|Global Deterioration of Health|0|||
16242302|NCT02544633|39371505|FG003|Treatment Period|Global Deterioration of Health|1|||
16242303|NCT02544633|39371502|FG000|Treatment Period|Withdrawal by Subject|1|||
16242304|NCT02544633|39371503|FG001|Treatment Period|Withdrawal by Subject|0|||
16242305|NCT02544633|39371504|FG002|Treatment Period|Withdrawal by Subject|0|||
16242306|NCT02544633|39371505|FG003|Treatment Period|Withdrawal by Subject|0|||
16242307|NCT02544633|39371502|FG000|Treatment Period|Lost to Follow-up|0|||
16242308|NCT02544633|39371503|FG001|Treatment Period|Lost to Follow-up|1|||
16242309|NCT02544633|39371504|FG002|Treatment Period|Lost to Follow-up|0|||
16242310|NCT02544633|39371505|FG003|Treatment Period|Lost to Follow-up|0|||
16242311|NCT02544633|39371502|FG000|Treatment Period|Death|0|||
16242312|NCT02544633|39371503|FG001|Treatment Period|Death|0|||
16242313|NCT02544633|39371504|FG002|Treatment Period|Death|1|||
16242314|NCT02544633|39371505|FG003|Treatment Period|Death|0|||
16242315|NCT02544633|39371502|FG000|Treatment Period|Non-compliance|0|||
16242316|NCT02544633|39371503|FG001|Treatment Period|Non-compliance|0|||
16242317|NCT02544633|39371504|FG002|Treatment Period|Non-compliance|1|||
16242318|NCT02544633|39371505|FG003|Treatment Period|Non-compliance|0|||
16242319|NCT02544633|39371502|FG000|Treatment Period|Clinical Disease Progression|0|||
16242320|NCT02544633|39371503|FG001|Treatment Period|Clinical Disease Progression|0|||
16242321|NCT02544633|39371504|FG002|Treatment Period|Clinical Disease Progression|0|||
16242322|NCT02544633|39371505|FG003|Treatment Period|Clinical Disease Progression|1|||
16242323|NCT02544633|39371502|FG000|Survival Follow-up Period|Death|12|||
16242324|NCT02544633|39371503|FG001|Survival Follow-up Period|Death|14|||
16242325|NCT02544633|39371504|FG002|Survival Follow-up Period|Death|3|||
16242326|NCT02544633|39371505|FG003|Survival Follow-up Period|Death|9|||
16242327|NCT02544633|39371502|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
16242328|NCT02544633|39371503|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
16242329|NCT02544633|39371504|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
16242330|NCT02544633|39371505|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
16557938|NCT00783692|40509819|FG002|Induction Phase|Protocol Violation|1|||
16557939|NCT00783692|40509820|FG003|Induction Phase|Protocol Violation|0|||
16557940|NCT00783692|40509821|FG004|Induction Phase|Protocol Violation|0|||
16557941|NCT00783692|40509822|FG005|Induction Phase|Protocol Violation|0|||
16557942|NCT00783692|40509823|FG006|Induction Phase|Protocol Violation|0|||
16242331|NCT02544633|39371502|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
16242332|NCT02544633|39371503|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
16242333|NCT02544633|39371504|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
16242334|NCT02544633|39371505|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
16242335|NCT02544633|39371502|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
16242336|NCT02544633|39371503|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
16242337|NCT02544633|39371504|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
16242338|NCT02544633|39371505|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
16242339|NCT01690520|39371511|FG000|Overall Study|Death|25|||
16242340|NCT01690520|39371512|FG001|Overall Study|Death|21|||
16242341|NCT01690520|39371511|FG000|Overall Study|Lost to Follow-up|2|||
16350627|NCT00909844|39772790|FG000|Overall Study|Withdrawal by Subject|1|||
16557943|NCT00783692|40509817|FG000|Induction Phase|Lack of Efficacy|1|||
16557944|NCT00783692|40509818|FG001|Induction Phase|Lack of Efficacy|3|||
16557945|NCT00783692|40509819|FG002|Induction Phase|Lack of Efficacy|28|||
16557946|NCT00783692|40509820|FG003|Induction Phase|Lack of Efficacy|0|||
16242342|NCT01690520|39371512|FG001|Overall Study|Lost to Follow-up|3|||
16242343|NCT01690520|39371511|FG000|Overall Study|Withdrawal by Subject|2|||
16557947|NCT00783692|40509821|FG004|Induction Phase|Lack of Efficacy|0|||
16557948|NCT00783692|40509822|FG005|Induction Phase|Lack of Efficacy|0|||
16557949|NCT00783692|40509823|FG006|Induction Phase|Lack of Efficacy|0|||
16242344|NCT01690520|39371512|FG001|Overall Study|Withdrawal by Subject|0|||
16242345|NCT01690520|39371511|FG000|Overall Study|Relapse|0|||
16242346|NCT01690520|39371512|FG001|Overall Study|Relapse|1|||
16242347|NCT01690520|39371511|FG000|Overall Study|Other|0|||
16242348|NCT01690520|39371512|FG001|Overall Study|Other|1|||
16242349|NCT01690520|39371511|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
16242350|NCT01690520|39371512|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
16242351|NCT04385199|39371513|FG000|Overall Study|Withdrawal by Subject|1|||
16242352|NCT04385199|39371514|FG001|Overall Study|Withdrawal by Subject|0|||
16242353|NCT00124449|39371515|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
16242354|NCT00124449|39371516|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
16242355|NCT00124449|39371515|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
16242356|NCT00124449|39371516|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
16242357|NCT00124449|39371515|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
16242358|NCT00124449|39371516|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
16242359|NCT00124449|39371515|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
16242360|NCT00124449|39371516|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
16242361|NCT00124449|39371515|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
16242362|NCT00124449|39371516|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
16242363|NCT00124449|39371515|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
16242364|NCT00124449|39371516|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
16242365|NCT00124449|39371515|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
16242366|NCT00124449|39371516|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
16242367|NCT00124449|39371515|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
16242368|NCT00124449|39371516|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
16242369|NCT00124449|39371515|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
16242370|NCT00124449|39371516|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
16242371|NCT00124449|39371515|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
16242372|NCT00124449|39371516|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
16242373|NCT00124449|39371515|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
16242374|NCT00124449|39371516|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
16242375|NCT00124449|39371515|FG000|18-Month Untreated Observation Period|Relocated|1|||
16242376|NCT00124449|39371516|FG001|18-Month Untreated Observation Period|Relocated|0|||
16242377|NCT03763331|39371517|FG000|Overall Study|Lost to Follow-up|1|||
16242378|NCT03763331|39371518|FG001|Overall Study|Lost to Follow-up|0|||
16242379|NCT03763331|39371517|FG000|Overall Study|Withdrawal by Subject|1|||
16242380|NCT03763331|39371518|FG001|Overall Study|Withdrawal by Subject|0|||
16242381|NCT03763331|39371517|FG000|Overall Study|Non-compliance|0|||
16242382|NCT03763331|39371518|FG001|Overall Study|Non-compliance|3|||
16242383|NCT04088734|39371519|FG000|Overall Study|Other, Not Specified|5|||
16242384|NCT00771901|39371547|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
16242385|NCT00771901|39371548|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
16242386|NCT00771901|39371549|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
16242387|NCT03811249|39371556|FG000|Overall Study|Withdrawal by Subject|44|||
16242388|NCT03811249|39371556|FG000|Overall Study|Missed Visit|24|||
16242389|NCT01160198|39371557|FG000|Overall Study|Withdrawal by Subject|2|||
16242390|NCT01160198|39371558|FG001|Overall Study|Withdrawal by Subject|1|||
16242391|NCT01160198|39371559|FG002|Overall Study|Withdrawal by Subject|0|||
16242392|NCT01160198|39371557|FG000|Overall Study|Adverse Event|0|||
16242393|NCT01160198|39371558|FG001|Overall Study|Adverse Event|1|||
16242394|NCT01160198|39371559|FG002|Overall Study|Adverse Event|0|||
16242395|NCT01160198|39371557|FG000|Overall Study|Lost to Follow-up|0|||
16242396|NCT01160198|39371558|FG001|Overall Study|Lost to Follow-up|1|||
16242397|NCT01160198|39371559|FG002|Overall Study|Lost to Follow-up|0|||
16242398|NCT01160198|39371557|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
16350628|NCT00909844|39772790|FG000|Overall Study|Lost to Follow-up|2|||
16350629|NCT03755518|39772791|FG000|Overall Study|Adverse Event|6|||
16350630|NCT03755518|39772791|FG000|Overall Study|Lack of Efficacy|6|||
16350631|NCT03755518|39772791|FG000|Overall Study|Bone Marrow Transplant|4|||
16350632|NCT03755518|39772791|FG000|Overall Study|Withdrawal by participant|4|||
16350633|NCT03755518|39772791|FG000|Overall Study|Progressive Disease|2|||
16350634|NCT03755518|39772791|FG000|Overall Study|Death|1|||
16350635|NCT03755518|39772791|FG000|Overall Study|Physician Decision|1|||
16350636|NCT03755518|39772791|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
16350637|NCT00614874|39772793|FG000|Overall Study|Protocol Violation|1|||
16350638|NCT00614874|39772793|FG000|Overall Study|Withdrawal by Subject|1|||
16350639|NCT00411450|39772794|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
16350640|NCT01255904|39772795|FG000|Overall Study|Physician Decision|1|||
16350641|NCT01255904|39772796|FG001|Overall Study|Physician Decision|4|||
16350642|NCT01367249|39772798|FG000|Overall Study|Withdrawal by Subject|6|||
16242399|NCT01160198|39371558|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
16242400|NCT01160198|39371559|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
16242401|NCT01542736|39371560|FG000|Overall Study|Death|1|||
16242402|NCT04133519|39371561|FG000|Overall Study|Withdrawal by Subject|5|||
16242403|NCT04133519|39371562|FG001|Overall Study|Withdrawal by Subject|4|||
16242404|NCT04133519|39371561|FG000|Overall Study|Protocol Violation|0|||
16242405|NCT04133519|39371562|FG001|Overall Study|Protocol Violation|1|||
16242406|NCT04133519|39371561|FG000|Overall Study|Never started treatment|1|||
16242407|NCT04133519|39371562|FG001|Overall Study|Never started treatment|1|||
16242408|NCT03451331|39371563|FG000|Overall Study|Withdrawal by Subject|1|||
16242409|NCT03451331|39371564|FG001|Overall Study|Withdrawal by Subject|0|||
16242410|NCT03451331|39371563|FG000|Overall Study|Unable to start treatment.|1|||
16242411|NCT03451331|39371564|FG001|Overall Study|Unable to start treatment.|1|||
16242412|NCT01326702|39371568|FG000|Overall Study|Other|1|||
16242413|NCT01326702|39371569|FG001|Overall Study|Other|0|||
16242414|NCT01326702|39371570|FG002|Overall Study|Other|0|||
16557950|NCT00783692|40509817|FG000|Induction Phase|Withdrawal by Subject|3|||
16557951|NCT00783692|40509818|FG001|Induction Phase|Withdrawal by Subject|9|||
16557952|NCT00783692|40509819|FG002|Induction Phase|Withdrawal by Subject|16|||
16557953|NCT00783692|40509820|FG003|Induction Phase|Withdrawal by Subject|0|||
16242415|NCT01326702|39371571|FG003|Overall Study|Other|0|||
16242416|NCT01326702|39371572|FG004|Overall Study|Other|0|||
16242417|NCT01326702|39371573|FG005|Overall Study|Other|1|||
16242418|NCT01326702|39371574|FG006|Overall Study|Other|0|||
16242419|NCT01326702|39371568|FG000|Overall Study|progressive disease|1|||
16242420|NCT01326702|39371569|FG001|Overall Study|progressive disease|1|||
16242421|NCT01326702|39371570|FG002|Overall Study|progressive disease|3|||
16242422|NCT01326702|39371571|FG003|Overall Study|progressive disease|1|||
16242423|NCT01326702|39371572|FG004|Overall Study|progressive disease|3|||
16242424|NCT01326702|39371573|FG005|Overall Study|progressive disease|2|||
16242425|NCT01326702|39371574|FG006|Overall Study|progressive disease|3|||
16242426|NCT01326702|39371568|FG000|Overall Study|Death|0|||
16242427|NCT01326702|39371569|FG001|Overall Study|Death|1|||
16242428|NCT01326702|39371570|FG002|Overall Study|Death|0|||
16242429|NCT01326702|39371571|FG003|Overall Study|Death|0|||
16242430|NCT01326702|39371572|FG004|Overall Study|Death|0|||
16242431|NCT01326702|39371573|FG005|Overall Study|Death|0|||
16242432|NCT01326702|39371574|FG006|Overall Study|Death|0|||
16242433|NCT01326702|39371568|FG000|Overall Study|Adverse Event|0|||
16350643|NCT01367249|39772799|FG001|Overall Study|Withdrawal by Subject|6|||
16350644|NCT01367249|39772798|FG000|Overall Study|Other|3|||
16350645|NCT01367249|39772799|FG001|Overall Study|Other|10|||
16350646|NCT00627497|39772802|FG000|Overall Study|Lost to Follow-up|1|||
16350647|NCT00627497|39772803|FG001|Overall Study|Lost to Follow-up|1|||
16350648|NCT00627497|39772804|FG002|Overall Study|Lost to Follow-up|0|||
16557954|NCT00783692|40509821|FG004|Induction Phase|Withdrawal by Subject|0|||
16125112|NCT02233543|38946068|FG001|Period 1|Participants required other treatment.|3|||
16557955|NCT00783692|40509822|FG005|Induction Phase|Withdrawal by Subject|0|||
16557956|NCT00783692|40509823|FG006|Induction Phase|Withdrawal by Subject|0|||
16557957|NCT00783692|40509817|FG000|Induction Phase|Lost to Follow-up|0|||
16557958|NCT00783692|40509818|FG001|Induction Phase|Lost to Follow-up|0|||
16125113|NCT02233543|38946067|FG000|Period 2|Adverse Event|1|||
16125114|NCT02233543|38946068|FG001|Period 2|Adverse Event|0|||
16125115|NCT02233543|38946067|FG000|Period 2|Participant required other treatment.|0|||
16125116|NCT02233543|38946068|FG001|Period 2|Participant required other treatment.|1|||
16125117|NCT02233543|38946067|FG000|Period 2|COPD exacerbation|1|||
16125118|NCT02233543|38946068|FG001|Period 2|COPD exacerbation|0|||
16125119|NCT00844532|38946069|FG000|Overall Study|Death|16|||
16125120|NCT00844532|38946069|FG000|Overall Study|Withdrawal by Subject|16|||
16125121|NCT00844532|38946069|FG000|Overall Study|Lost to Follow-up|7|||
16125122|NCT02576587|38946070|FG000|Baseline|Equipment failure|0|||
16125123|NCT02576587|38946071|FG001|Baseline|Equipment failure|1|||
16125124|NCT02576587|38946070|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
16125125|NCT02576587|38946071|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
16125126|NCT02576587|38946070|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
16242434|NCT01326702|39371569|FG001|Overall Study|Adverse Event|0|||
16242435|NCT01326702|39371570|FG002|Overall Study|Adverse Event|1|||
16242436|NCT01326702|39371571|FG003|Overall Study|Adverse Event|1|||
16242437|NCT01326702|39371572|FG004|Overall Study|Adverse Event|0|||
16242438|NCT01326702|39371573|FG005|Overall Study|Adverse Event|3|||
16242439|NCT01326702|39371574|FG006|Overall Study|Adverse Event|1|||
16242440|NCT01326702|39371568|FG000|Overall Study|Withdrawal by Subject|0|||
16242441|NCT01326702|39371569|FG001|Overall Study|Withdrawal by Subject|0|||
16350649|NCT00627497|39772805|FG003|Overall Study|Lost to Follow-up|0|||
16557959|NCT00783692|40509819|FG002|Induction Phase|Lost to Follow-up|3|||
16125127|NCT02576587|38946071|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
16242442|NCT01326702|39371570|FG002|Overall Study|Withdrawal by Subject|1|||
16242443|NCT01326702|39371571|FG003|Overall Study|Withdrawal by Subject|0|||
16350650|NCT00249873|39772806|FG000|Overall Study|Not treated|7|||
16557960|NCT00783692|40509820|FG003|Induction Phase|Lost to Follow-up|0|||
16557961|NCT00783692|40509821|FG004|Induction Phase|Lost to Follow-up|0|||
16557962|NCT00783692|40509822|FG005|Induction Phase|Lost to Follow-up|0|||
16557963|NCT00783692|40509823|FG006|Induction Phase|Lost to Follow-up|0|||
16557964|NCT00783692|40509817|FG000|Induction Phase|Other|0|||
16557965|NCT00783692|40509818|FG001|Induction Phase|Other|0|||
16557966|NCT00783692|40509819|FG002|Induction Phase|Other|2|||
16557967|NCT00783692|40509820|FG003|Induction Phase|Other|0|||
16557968|NCT00783692|40509821|FG004|Induction Phase|Other|0|||
16557969|NCT00783692|40509822|FG005|Induction Phase|Other|0|||
16557970|NCT00783692|40509823|FG006|Induction Phase|Other|0|||
16557971|NCT00783692|40509817|FG000|Maintenance Phase|Adverse Event|7|||
16557972|NCT00783692|40509818|FG001|Maintenance Phase|Adverse Event|0|||
16557973|NCT00783692|40509819|FG002|Maintenance Phase|Adverse Event|0|||
16557974|NCT00783692|40509820|FG003|Maintenance Phase|Adverse Event|15|||
16557975|NCT00783692|40509821|FG004|Maintenance Phase|Adverse Event|12|||
16557976|NCT00783692|40509822|FG005|Maintenance Phase|Adverse Event|9|||
16557977|NCT00783692|40509823|FG006|Maintenance Phase|Adverse Event|38|||
16557978|NCT00783692|40509817|FG000|Maintenance Phase|Protocol Violation|0|||
16557979|NCT00783692|40509818|FG001|Maintenance Phase|Protocol Violation|0|||
16557980|NCT00783692|40509819|FG002|Maintenance Phase|Protocol Violation|0|||
16557981|NCT00783692|40509820|FG003|Maintenance Phase|Protocol Violation|1|||
16557982|NCT00783692|40509821|FG004|Maintenance Phase|Protocol Violation|2|||
16557983|NCT00783692|40509822|FG005|Maintenance Phase|Protocol Violation|3|||
16557984|NCT00783692|40509823|FG006|Maintenance Phase|Protocol Violation|4|||
16557985|NCT00783692|40509817|FG000|Maintenance Phase|Lack of Efficacy|79|||
16557986|NCT00783692|40509818|FG001|Maintenance Phase|Lack of Efficacy|0|||
16557987|NCT00783692|40509819|FG002|Maintenance Phase|Lack of Efficacy|0|||
16557988|NCT00783692|40509820|FG003|Maintenance Phase|Lack of Efficacy|64|||
16125128|NCT02576587|38946070|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
16125129|NCT02576587|38946071|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
16350651|NCT00249873|39772807|FG001|Overall Study|Not treated|8|||
16350652|NCT00249873|39772806|FG000|Overall Study|Significant thrombocytopenia|9|||
16350653|NCT00249873|39772807|FG001|Overall Study|Significant thrombocytopenia|8|||
16350654|NCT00249873|39772806|FG000|Overall Study|Severe allergic reaction|8|||
16350655|NCT00249873|39772807|FG001|Overall Study|Severe allergic reaction|1|||
16350656|NCT00249873|39772806|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
16350657|NCT00249873|39772807|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
16350658|NCT00249873|39772806|FG000|Overall Study|Other Serious Adverse Event|86|||
16414697|NCT02636946|39998518|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
16414698|NCT02636946|39998519|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
16414699|NCT03230292|39998524|FG000|Overall Study|Adverse Event|1|||
16414700|NCT03230292|39998524|FG000|Overall Study|Protocol Violation|1|||
16414701|NCT03230292|39998524|FG000|Overall Study|Lost to Follow-up|1|||
16414702|NCT03230292|39998524|FG000|Overall Study|Withdrawal by Subject|3|||
16414703|NCT01198509|39998525|FG000|Overall Study|Withdrawal by Subject|1|||
16414704|NCT01198509|39998526|FG001|Overall Study|Withdrawal by Subject|0|||
16414705|NCT01198509|39998527|FG002|Overall Study|Withdrawal by Subject|0|||
16414706|NCT01198509|39998528|FG003|Overall Study|Withdrawal by Subject|0|||
16414707|NCT01198509|39998529|FG004|Overall Study|Withdrawal by Subject|0|||
16414708|NCT01198509|39998530|FG005|Overall Study|Withdrawal by Subject|0|||
16414709|NCT00701805|39998533|FG000|Overall Study|Withdrawal by Subject|3|||
16414710|NCT00701805|39998534|FG001|Overall Study|Withdrawal by Subject|1|||
16414711|NCT00701805|39998535|FG002|Overall Study|Withdrawal by Subject|4|||
16414712|NCT00701805|39998536|FG003|Overall Study|Withdrawal by Subject|3|||
16414713|NCT00701805|39998533|FG000|Overall Study|Adverse Event|0|||
16414714|NCT00701805|39998534|FG001|Overall Study|Adverse Event|1|||
16414715|NCT00701805|39998535|FG002|Overall Study|Adverse Event|1|||
16414716|NCT00701805|39998536|FG003|Overall Study|Adverse Event|0|||
16414717|NCT00701805|39998533|FG000|Overall Study|Missed 7 consecutive doses|0|||
16414718|NCT00701805|39998534|FG001|Overall Study|Missed 7 consecutive doses|1|||
16414719|NCT00701805|39998535|FG002|Overall Study|Missed 7 consecutive doses|0|||
16414720|NCT00701805|39998536|FG003|Overall Study|Missed 7 consecutive doses|0|||
16414721|NCT00701805|39998533|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
16414722|NCT00701805|39998534|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
16414723|NCT00701805|39998535|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
16414724|NCT00701805|39998536|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
16414725|NCT00701805|39998533|FG000|Overall Study|Physician decision, change of therapy|0|||
16414726|NCT00701805|39998534|FG001|Overall Study|Physician decision, change of therapy|0|||
16414727|NCT00701805|39998535|FG002|Overall Study|Physician decision, change of therapy|0|||
16414728|NCT00701805|39998536|FG003|Overall Study|Physician decision, change of therapy|1|||
16414729|NCT00701805|39998533|FG000|Overall Study|Difficult to travel to dialysis site|0|||
16414730|NCT00701805|39998534|FG001|Overall Study|Difficult to travel to dialysis site|0|||
16414731|NCT00701805|39998535|FG002|Overall Study|Difficult to travel to dialysis site|1|||
16414732|NCT00701805|39998536|FG003|Overall Study|Difficult to travel to dialysis site|0|||
16350659|NCT00249873|39772807|FG001|Overall Study|Other Serious Adverse Event|97|||
16350660|NCT00249873|39772806|FG000|Overall Study|Qualifying condition not present|20|||
16350661|NCT00249873|39772807|FG001|Overall Study|Qualifying condition not present|23|||
16350662|NCT00249873|39772806|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
16350663|NCT00249873|39772807|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
16350664|NCT00249873|39772806|FG000|Overall Study|Withdrawal by Subject|504|||
16350665|NCT00249873|39772807|FG001|Overall Study|Withdrawal by Subject|466|||
16350666|NCT00249873|39772806|FG000|Overall Study|Lost to Follow-up|4|||
16350667|NCT00249873|39772807|FG001|Overall Study|Lost to Follow-up|7|||
16350668|NCT00249873|39772806|FG000|Overall Study|Minor bleeding|99|||
16350669|NCT00249873|39772807|FG001|Overall Study|Minor bleeding|37|||
16350670|NCT00249873|39772806|FG000|Overall Study|Non-compliance|41|||
16350671|NCT00249873|39772807|FG001|Overall Study|Non-compliance|46|||
16350672|NCT00249873|39772806|FG000|Overall Study|Other non serious Adverse Event|112|||
16350673|NCT00249873|39772807|FG001|Overall Study|Other non serious Adverse Event|108|||
16350674|NCT00249873|39772806|FG000|Overall Study|Other contraindicated medication|1|||
16350675|NCT00249873|39772807|FG001|Overall Study|Other contraindicated medication|0|||
16350676|NCT00249873|39772806|FG000|Overall Study|Patient not wish to continue after May08|3|||
16350677|NCT00249873|39772807|FG001|Overall Study|Patient not wish to continue after May08|4|||
16350678|NCT00249873|39772806|FG000|Overall Study|Physician withdrew consent|59|||
16350679|NCT00249873|39772807|FG001|Overall Study|Physician withdrew consent|60|||
16350680|NCT00249873|39772806|FG000|Overall Study|Open label clopidogrel required|31|||
16350681|NCT00249873|39772807|FG001|Overall Study|Open label clopidogrel required|42|||
16414733|NCT00701805|39998533|FG000|Overall Study|Resumption criteria were not met|0|||
16414734|NCT00701805|39998534|FG001|Overall Study|Resumption criteria were not met|1|||
16414735|NCT00701805|39998535|FG002|Overall Study|Resumption criteria were not met|0|||
16414736|NCT00701805|39998536|FG003|Overall Study|Resumption criteria were not met|0|||
16414737|NCT01818492|39998539|FG000|Overall Study|Adverse Event|2|||
16414738|NCT01818492|39998539|FG000|Overall Study|Death|3|||
16414739|NCT01818492|39998539|FG000|Overall Study|Withdrawal by Subject|1|||
16414740|NCT01818492|39998539|FG000|Overall Study|Additional therapy when not allowed PP|4|||
16350682|NCT00249873|39772806|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
16414741|NCT02366767|39998540|FG000|Overall Study|left for home after 1 day at camp|1|||
16414742|NCT02366767|39998541|FG001|Overall Study|left for home after 1 day at camp|0|||
16414743|NCT00637572|39998542|FG000|Overall Study|Adverse Event|1|||
16414744|NCT00637572|39998543|FG001|Overall Study|Adverse Event|2|||
16414745|NCT00637572|39998542|FG000|Overall Study|Death|0|||
16414746|NCT00637572|39998543|FG001|Overall Study|Death|1|||
16414747|NCT00637572|39998542|FG000|Overall Study|Lost to Follow-up|0|||
16414748|NCT00637572|39998543|FG001|Overall Study|Lost to Follow-up|1|||
16414749|NCT00637572|39998542|FG000|Overall Study|Physician Decision|1|||
16414750|NCT00637572|39998543|FG001|Overall Study|Physician Decision|1|||
16414751|NCT00637572|39998542|FG000|Overall Study|Withdrawal by Subject|0|||
16414752|NCT00637572|39998543|FG001|Overall Study|Withdrawal by Subject|2|||
16414753|NCT00637572|39998542|FG000|Overall Study|Illicit Drug Use|1|||
16414754|NCT00637572|39998543|FG001|Overall Study|Illicit Drug Use|0|||
16414755|NCT02713529|39998544|FG000|Overall Study|Withdrawal by Subject|3|||
16414756|NCT02713529|39998545|FG001|Overall Study|Withdrawal by Subject|1|||
16414757|NCT02713529|39998546|FG002|Overall Study|Withdrawal by Subject|4|||
16414758|NCT02713529|39998547|FG003|Overall Study|Withdrawal by Subject|2|||
16414759|NCT02713529|39998548|FG004|Overall Study|Withdrawal by Subject|0|||
16414760|NCT02713529|39998549|FG005|Overall Study|Withdrawal by Subject|1|||
16414761|NCT02713529|39998550|FG006|Overall Study|Withdrawal by Subject|1|||
16414762|NCT02713529|39998544|FG000|Overall Study|Lost to Follow-up|1|||
16414763|NCT02713529|39998545|FG001|Overall Study|Lost to Follow-up|0|||
16414764|NCT02713529|39998546|FG002|Overall Study|Lost to Follow-up|1|||
16414765|NCT02713529|39998547|FG003|Overall Study|Lost to Follow-up|0|||
16414766|NCT02713529|39998548|FG004|Overall Study|Lost to Follow-up|0|||
16414767|NCT02713529|39998549|FG005|Overall Study|Lost to Follow-up|0|||
16414768|NCT02713529|39998550|FG006|Overall Study|Lost to Follow-up|0|||
16414769|NCT02713529|39998544|FG000|Overall Study|Death|3|||
16414770|NCT02713529|39998545|FG001|Overall Study|Death|3|||
16414771|NCT02713529|39998546|FG002|Overall Study|Death|26|||
16414772|NCT02713529|39998547|FG003|Overall Study|Death|27|||
16414773|NCT02713529|39998548|FG004|Overall Study|Death|3|||
16414774|NCT02713529|39998549|FG005|Overall Study|Death|13|||
16414775|NCT02713529|39998550|FG006|Overall Study|Death|3|||
16414776|NCT02119156|39998551|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
16557989|NCT00783692|40509821|FG004|Maintenance Phase|Lack of Efficacy|58|||
16125130|NCT00925353|38946072|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
16125131|NCT03435692|38946073|FG000|Overall Study|Lack of Efficacy|2|||
16125132|NCT03435692|38946074|FG001|Overall Study|Lack of Efficacy|2|||
16125133|NCT03435692|38946075|FG002|Overall Study|Lack of Efficacy|0|||
16125134|NCT00095056|38946086|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
16125135|NCT00095056|38946087|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
16125136|NCT00095056|38946086|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
16125137|NCT00095056|38946087|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
16125138|NCT00095056|38946086|FG000|Phase A (Weeks 0-12)|Death|1|||
16125139|NCT00095056|38946087|FG001|Phase A (Weeks 0-12)|Death|0|||
16125140|NCT00095056|38946086|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
16242444|NCT01326702|39371572|FG004|Overall Study|Withdrawal by Subject|1|||
16242445|NCT01326702|39371573|FG005|Overall Study|Withdrawal by Subject|1|||
16242446|NCT01326702|39371574|FG006|Overall Study|Withdrawal by Subject|3|||
16242447|NCT01326702|39371568|FG000|Overall Study|Not Treated|0|||
16242448|NCT01326702|39371569|FG001|Overall Study|Not Treated|0|||
16242449|NCT01326702|39371570|FG002|Overall Study|Not Treated|0|||
16242450|NCT01326702|39371571|FG003|Overall Study|Not Treated|1|||
16242451|NCT01326702|39371572|FG004|Overall Study|Not Treated|0|||
16242452|NCT01326702|39371573|FG005|Overall Study|Not Treated|1|||
16242453|NCT01326702|39371574|FG006|Overall Study|Not Treated|0|||
16242454|NCT03056352|39371575|FG000|Overall Study|Lost to Follow-up|1|||
16242455|NCT02683187|39371576|FG000|Overall Study|Failed IV access|3|||
16242456|NCT02683187|39371576|FG000|Overall Study|Withdrawal by Subject|5|||
16414777|NCT02119156|39998552|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
16414778|NCT02119156|39998553|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
16414779|NCT02119156|39998551|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
16557990|NCT00783692|40509822|FG005|Maintenance Phase|Lack of Efficacy|48|||
16557991|NCT00783692|40509823|FG006|Maintenance Phase|Lack of Efficacy|177|||
16557992|NCT00783692|40509817|FG000|Maintenance Phase|Withdrawal by Subject|7|||
16557993|NCT00783692|40509818|FG001|Maintenance Phase|Withdrawal by Subject|0|||
16557994|NCT00783692|40509819|FG002|Maintenance Phase|Withdrawal by Subject|0|||
16557995|NCT00783692|40509820|FG003|Maintenance Phase|Withdrawal by Subject|7|||
16557996|NCT00783692|40509821|FG004|Maintenance Phase|Withdrawal by Subject|6|||
16557997|NCT00783692|40509822|FG005|Maintenance Phase|Withdrawal by Subject|9|||
16557998|NCT00783692|40509823|FG006|Maintenance Phase|Withdrawal by Subject|24|||
16557999|NCT00783692|40509817|FG000|Maintenance Phase|Lost to Follow-up|2|||
16558000|NCT00783692|40509818|FG001|Maintenance Phase|Lost to Follow-up|0|||
16558001|NCT00783692|40509819|FG002|Maintenance Phase|Lost to Follow-up|0|||
16242457|NCT03053622|39371577|FG000|Overall Study|Lost to Follow-up|0|||
16242458|NCT03053622|39371578|FG001|Overall Study|Lost to Follow-up|0|||
16242459|NCT03053622|39371579|FG002|Overall Study|Lost to Follow-up|0|||
16242460|NCT03053622|39371580|FG003|Overall Study|Lost to Follow-up|1|||
16558002|NCT00783692|40509820|FG003|Maintenance Phase|Lost to Follow-up|1|||
16242461|NCT00633152|39371581|FG000|Overall Study|Adverse Event|1|||
16242462|NCT00633152|39371582|FG001|Overall Study|Adverse Event|0|||
16242463|NCT00633152|39371581|FG000|Overall Study|Randomized, did not receive study drug|5|||
16242464|NCT00633152|39371582|FG001|Overall Study|Randomized, did not receive study drug|2|||
16242465|NCT00633152|39371581|FG000|Overall Study|Withdrawal by Subject|1|||
16125141|NCT00095056|38946087|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
16125142|NCT00095056|38946086|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
16125143|NCT00095056|38946087|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
16125144|NCT00095056|38946086|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
16125145|NCT00095056|38946087|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
16125146|NCT00095056|38946086|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
16125147|NCT00095056|38946087|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
16125148|NCT00095056|38946086|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
16242466|NCT00633152|39371582|FG001|Overall Study|Withdrawal by Subject|1|||
16558003|NCT00783692|40509821|FG004|Maintenance Phase|Lost to Follow-up|3|||
16125149|NCT00095056|38946087|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
16125150|NCT00095056|38946086|FG000|Phase B (Weeks 12-54)|Death|3|||
16558004|NCT00783692|40509822|FG005|Maintenance Phase|Lost to Follow-up|2|||
16558005|NCT00783692|40509823|FG006|Maintenance Phase|Lost to Follow-up|5|||
16125151|NCT00095056|38946087|FG001|Phase B (Weeks 12-54)|Death|1|||
16242467|NCT00633152|39371581|FG000|Overall Study|Lost to Follow-up|4|||
16242468|NCT00633152|39371582|FG001|Overall Study|Lost to Follow-up|1|||
16558006|NCT00783692|40509817|FG000|Maintenance Phase|Other|0|||
16558007|NCT00783692|40509818|FG001|Maintenance Phase|Other|0|||
16125152|NCT00095056|38946086|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
16125153|NCT00095056|38946087|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
16125154|NCT00095056|38946086|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
16350683|NCT00249873|39772807|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
16350684|NCT00249873|39772806|FG000|Overall Study|Oral anticoagulant required|159|||
16125155|NCT00095056|38946087|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
16125156|NCT03573583|38946088|FG000|Overall Study|Lost to Follow-up|1|||
16125157|NCT03573583|38946089|FG001|Overall Study|Lost to Follow-up|0|||
16125158|NCT03573583|38946088|FG000|Overall Study|Withdrawal by Subject|1|||
16125159|NCT03573583|38946089|FG001|Overall Study|Withdrawal by Subject|1|||
16125160|NCT04165031|38946090|FG000|Overall Study|Adverse Event|1|||
16125161|NCT04165031|38946091|FG001|Overall Study|Adverse Event|1|||
16125162|NCT04165031|38946092|FG002|Overall Study|Adverse Event|0|||
16125163|NCT04165031|38946093|FG003|Overall Study|Adverse Event|0|||
16125164|NCT04165031|38946094|FG004|Overall Study|Adverse Event|0|||
16125165|NCT04165031|38946095|FG005|Overall Study|Adverse Event|0|||
16125166|NCT04165031|38946090|FG000|Overall Study|Withdrawal by Subject|0|||
16125167|NCT04165031|38946091|FG001|Overall Study|Withdrawal by Subject|0|||
16125168|NCT04165031|38946092|FG002|Overall Study|Withdrawal by Subject|1|||
16125169|NCT04165031|38946093|FG003|Overall Study|Withdrawal by Subject|0|||
16125170|NCT04165031|38946094|FG004|Overall Study|Withdrawal by Subject|0|||
16125171|NCT04165031|38946095|FG005|Overall Study|Withdrawal by Subject|0|||
16125172|NCT02187159|38946096|FG000|Overall Study|Protocol Violation|4|||
16125173|NCT02187159|38946097|FG001|Overall Study|Protocol Violation|6|||
16125174|NCT02187159|38946098|FG002|Overall Study|Protocol Violation|3|||
16125175|NCT02187159|38946099|FG003|Overall Study|Protocol Violation|4|||
16350685|NCT00249873|39772807|FG001|Overall Study|Oral anticoagulant required|157|||
16350686|NCT00249873|39772806|FG000|Overall Study|Study drug intolerance|5|||
16350687|NCT00249873|39772807|FG001|Overall Study|Study drug intolerance|0|||
16350688|NCT00249873|39772806|FG000|Overall Study|Surgery/ procedure|9|||
16350689|NCT00249873|39772807|FG001|Overall Study|Surgery/ procedure|9|||
16350690|NCT00249873|39772806|FG000|Overall Study|Event related to cardiac condition|12|||
16350691|NCT00249873|39772807|FG001|Overall Study|Event related to cardiac condition|21|||
16350692|NCT00249873|39772806|FG000|Overall Study|Thromboembolic/outcome event|82|||
16350693|NCT00249873|39772807|FG001|Overall Study|Thromboembolic/outcome event|122|||
16350694|NCT02283658|39772808|FG000|Overall Study|Withdrawal by Subject|1|||
16350695|NCT03492437|39772811|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16350696|NCT03492437|39772812|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16350697|NCT00809445|39772813|FG000|1 Month Follow-up|Lost contact|1|||
16350698|NCT00809445|39772814|FG001|1 Month Follow-up|Lost contact|2|||
16350699|NCT00809445|39772815|FG002|1 Month Follow-up|Lost contact|1|||
16350700|NCT00809445|39772813|FG000|1 Month Follow-up|Withdrew consent|1|||
16350701|NCT00809445|39772814|FG001|1 Month Follow-up|Withdrew consent|1|||
16350702|NCT00809445|39772815|FG002|1 Month Follow-up|Withdrew consent|1|||
16350703|NCT00809445|39772813|FG000|1 Month Follow-up|Death|0|||
16350704|NCT00809445|39772814|FG001|1 Month Follow-up|Death|1|||
16414780|NCT02119156|39998552|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
16414781|NCT02119156|39998553|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
16125176|NCT02187159|38946096|FG000|Overall Study|Lack of Efficacy|10|||
16125177|NCT02187159|38946097|FG001|Overall Study|Lack of Efficacy|5|||
16125178|NCT02187159|38946098|FG002|Overall Study|Lack of Efficacy|4|||
16125179|NCT02187159|38946099|FG003|Overall Study|Lack of Efficacy|7|||
16125180|NCT02187159|38946096|FG000|Overall Study|Adverse Event|28|||
16125181|NCT02187159|38946097|FG001|Overall Study|Adverse Event|33|||
16125182|NCT02187159|38946098|FG002|Overall Study|Adverse Event|42|||
16125183|NCT02187159|38946099|FG003|Overall Study|Adverse Event|50|||
16125184|NCT02187159|38946096|FG000|Overall Study|Withdrawal by Subject|24|||
16125185|NCT02187159|38946097|FG001|Overall Study|Withdrawal by Subject|28|||
16125186|NCT02187159|38946098|FG002|Overall Study|Withdrawal by Subject|25|||
16125187|NCT02187159|38946099|FG003|Overall Study|Withdrawal by Subject|26|||
16125188|NCT02187159|38946096|FG000|Overall Study|Other|3|||
16125189|NCT02187159|38946097|FG001|Overall Study|Other|7|||
16125190|NCT02187159|38946098|FG002|Overall Study|Other|3|||
16125191|NCT02187159|38946099|FG003|Overall Study|Other|9|||
16125192|NCT00189488|38946100|FG000|Overall Study|Ineligibility determined|1|||
16125193|NCT00189488|38946101|FG001|Overall Study|Ineligibility determined|0|||
16125194|NCT00189488|38946100|FG000|Overall Study|Protocol deviation|2|||
16125195|NCT00189488|38946101|FG001|Overall Study|Protocol deviation|1|||
16125196|NCT00189488|38946100|FG000|Overall Study|Adverse Event|2|||
16125197|NCT00189488|38946101|FG001|Overall Study|Adverse Event|1|||
16125198|NCT00189488|38946100|FG000|Overall Study|Withdrawal by Subject|2|||
16125199|NCT00189488|38946101|FG001|Overall Study|Withdrawal by Subject|6|||
16125200|NCT00189488|38946100|FG000|Overall Study|Disease progression|2|||
16125201|NCT00189488|38946101|FG001|Overall Study|Disease progression|4|||
16125202|NCT00189488|38946100|FG000|Overall Study|Administrative Decision|0|||
16414782|NCT02119156|39998551|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
16414783|NCT02119156|39998552|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
16414784|NCT02119156|39998553|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
16414785|NCT02119156|39998551|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
16414786|NCT02119156|39998552|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
16414787|NCT02119156|39998553|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
16414788|NCT02119156|39998551|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
16414789|NCT02119156|39998552|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
16414790|NCT02119156|39998553|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
16558008|NCT00783692|40509819|FG002|Maintenance Phase|Other|0|||
16558009|NCT00783692|40509820|FG003|Maintenance Phase|Other|1|||
16558010|NCT00783692|40509821|FG004|Maintenance Phase|Other|0|||
16558011|NCT00783692|40509822|FG005|Maintenance Phase|Other|1|||
16558012|NCT00783692|40509823|FG006|Maintenance Phase|Other|1|||
16558013|NCT04714216|40509824|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
16558014|NCT04714216|40509824|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
16558015|NCT01628510|40509836|FG000|Overall Study|Withdrawal by Subject|0|||
16558016|NCT01628510|40509837|FG001|Overall Study|Withdrawal by Subject|4|||
16558017|NCT01628510|40509836|FG000|Overall Study|Death|3|||
16558018|NCT01628510|40509837|FG001|Overall Study|Death|1|||
16558019|NCT00439179|40509838|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
16558020|NCT00439179|40509839|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
16558021|NCT00439179|40509840|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
16558022|NCT00439179|40509841|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
16558023|NCT01177813|40509846|FG000|Overall Study|Adverse Event|8|||
16558024|NCT01177813|40509847|FG001|Overall Study|Adverse Event|2|||
16558025|NCT01177813|40509848|FG002|Overall Study|Adverse Event|4|||
16558026|NCT01177813|40509849|FG003|Overall Study|Adverse Event|6|||
16558027|NCT01177813|40509850|FG004|Overall Study|Adverse Event|3|||
16558028|NCT01177813|40509846|FG000|Overall Study|Lack of Efficacy|1|||
16558029|NCT01177813|40509847|FG001|Overall Study|Lack of Efficacy|0|||
16558030|NCT01177813|40509848|FG002|Overall Study|Lack of Efficacy|0|||
16558031|NCT01177813|40509849|FG003|Overall Study|Lack of Efficacy|0|||
16414791|NCT01606787|39998554|FG000|Overall Study|Withdrawal by Subject|4|||
16414792|NCT01606787|39998555|FG001|Overall Study|Withdrawal by Subject|5|||
16414793|NCT01606787|39998554|FG000|Overall Study|Surgery canceled|0|||
16414794|NCT01606787|39998555|FG001|Overall Study|Surgery canceled|2|||
16558032|NCT01177813|40509850|FG004|Overall Study|Lack of Efficacy|0|||
16558033|NCT01177813|40509846|FG000|Overall Study|Protocol Violation|3|||
16558034|NCT01177813|40509847|FG001|Overall Study|Protocol Violation|2|||
16125203|NCT00189488|38946101|FG001|Overall Study|Administrative Decision|2|||
16125204|NCT00189488|38946100|FG000|Overall Study|Death|5|||
16125205|NCT00189488|38946101|FG001|Overall Study|Death|8|||
16125206|NCT00189488|38946100|FG000|Overall Study|Other|1|||
16125207|NCT00189488|38946101|FG001|Overall Study|Other|0|||
16125208|NCT00215137|38946105|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
16125209|NCT00215137|38946106|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
16125210|NCT00215137|38946107|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
16125211|NCT00215137|38946105|FG000|Randomization Period|Lost to Follow-up|0|||
16125212|NCT00215137|38946106|FG001|Randomization Period|Lost to Follow-up|1|||
16414795|NCT02920957|39998556|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
16414796|NCT02920957|39998557|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
16414797|NCT02920957|39998556|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
16414798|NCT02920957|39998557|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
16414799|NCT02920957|39998556|FG000|First Intervention : 1 Month|Adverse Event|1|||
16414800|NCT02920957|39998557|FG001|First Intervention : 1 Month|Adverse Event|0|||
16414801|NCT02920957|39998556|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
16414802|NCT02920957|39998557|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
16414803|NCT05086510|39998558|FG000|Overall Study|Lost to Follow-up|0|||
16414804|NCT05086510|39998559|FG001|Overall Study|Lost to Follow-up|2|||
16414805|NCT05086510|39998558|FG000|Overall Study|Death|0|||
16414806|NCT05086510|39998559|FG001|Overall Study|Death|2|||
16414807|NCT00459537|39998560|FG000|Overall Study|Adverse Event|1|||
16414808|NCT00459537|39998561|FG001|Overall Study|Adverse Event|6|||
16414809|NCT00459537|39998560|FG000|Overall Study|Lack of Efficacy|10|||
16414810|NCT00459537|39998561|FG001|Overall Study|Lack of Efficacy|11|||
16414811|NCT00459537|39998560|FG000|Overall Study|Withdrawal by Subject|20|||
16125213|NCT00215137|38946107|FG002|Randomization Period|Lost to Follow-up|0|||
16125214|NCT00215137|38946105|FG000|Randomization Period|Withdrawal by Subject|0|||
16125215|NCT00215137|38946106|FG001|Randomization Period|Withdrawal by Subject|1|||
16125216|NCT00215137|38946107|FG002|Randomization Period|Withdrawal by Subject|0|||
16125217|NCT01262027|38946108|FG000|Overall Study|Adverse Event|1|||
16125218|NCT01262027|38946108|FG000|Overall Study|Withdrawal by Subject|3|||
16125219|NCT01262027|38946108|FG000|Overall Study|Protocol Violation|1|||
16125220|NCT01484431|38946109|FG000|Period 1: High Dose|Physician Decision|0|||
16125221|NCT01484431|38946110|FG001|Period 1: High Dose|Physician Decision|1|||
16350705|NCT00809445|39772815|FG002|1 Month Follow-up|Death|1|||
16350706|NCT00809445|39772813|FG000|1 Month Follow-up|Incarcerated|0|||
16350707|NCT00809445|39772814|FG001|1 Month Follow-up|Incarcerated|0|||
16350708|NCT00809445|39772815|FG002|1 Month Follow-up|Incarcerated|1|||
16350709|NCT00809445|39772813|FG000|6 Month Follow-up|Lost contact|16|||
16350710|NCT00809445|39772814|FG001|6 Month Follow-up|Lost contact|14|||
16350711|NCT00809445|39772815|FG002|6 Month Follow-up|Lost contact|14|||
16350712|NCT00809445|39772813|FG000|6 Month Follow-up|Death|2|||
16350713|NCT00809445|39772814|FG001|6 Month Follow-up|Death|1|||
16350714|NCT00809445|39772815|FG002|6 Month Follow-up|Death|1|||
16414812|NCT00459537|39998561|FG001|Overall Study|Withdrawal by Subject|26|||
16558035|NCT01177813|40509848|FG002|Overall Study|Protocol Violation|2|||
16558036|NCT01177813|40509849|FG003|Overall Study|Protocol Violation|0|||
16558037|NCT01177813|40509850|FG004|Overall Study|Protocol Violation|1|||
16558038|NCT01177813|40509846|FG000|Overall Study|Lost to Follow-up|12|||
16558039|NCT01177813|40509847|FG001|Overall Study|Lost to Follow-up|5|||
16558040|NCT01177813|40509848|FG002|Overall Study|Lost to Follow-up|6|||
16558041|NCT01177813|40509849|FG003|Overall Study|Lost to Follow-up|3|||
16558042|NCT01177813|40509850|FG004|Overall Study|Lost to Follow-up|0|||
16558043|NCT01177813|40509846|FG000|Overall Study|Withdrawal by Subject|12|||
16558044|NCT01177813|40509847|FG001|Overall Study|Withdrawal by Subject|7|||
16558045|NCT01177813|40509848|FG002|Overall Study|Withdrawal by Subject|6|||
16558046|NCT01177813|40509849|FG003|Overall Study|Withdrawal by Subject|5|||
16558047|NCT01177813|40509850|FG004|Overall Study|Withdrawal by Subject|3|||
16558048|NCT01177813|40509846|FG000|Overall Study|Other reason not defined above|5|||
16558049|NCT01177813|40509847|FG001|Overall Study|Other reason not defined above|2|||
16558050|NCT01177813|40509848|FG002|Overall Study|Other reason not defined above|2|||
16558051|NCT01177813|40509849|FG003|Overall Study|Other reason not defined above|3|||
16558052|NCT01177813|40509850|FG004|Overall Study|Other reason not defined above|2|||
16558053|NCT00798174|40509855|FG000|Overall Study|inability to implant azygos coil|3|||
16558054|NCT00798174|40509856|FG001|Overall Study|inability to implant azygos coil|3|||
16558055|NCT00798174|40509855|FG000|Overall Study|Inability to sedate for DFT testing|1|||
16558056|NCT00798174|40509856|FG001|Overall Study|Inability to sedate for DFT testing|0|||
16558057|NCT03824236|40509857|FG000|Overall Study|Lost to Follow-up|0|||
16558058|NCT03824236|40509858|FG001|Overall Study|Lost to Follow-up|0|||
16558059|NCT03824236|40509859|FG002|Overall Study|Lost to Follow-up|1|||
16558060|NCT02100722|40509860|FG000|Overall Study|Withdrawal pre-procedure|4|||
16558061|NCT02100722|40509861|FG001|Overall Study|Withdrawal pre-procedure|9|||
16558062|NCT02100722|40509860|FG000|Overall Study|Withdrawal post-procedure|0|||
16558063|NCT02100722|40509861|FG001|Overall Study|Withdrawal post-procedure|3|||
16558064|NCT02100722|40509860|FG000|Overall Study|Lost to Follow-up|2|||
16558065|NCT02100722|40509861|FG001|Overall Study|Lost to Follow-up|2|||
16558066|NCT02100722|40509860|FG000|Overall Study|Continuing on study|751|||
16125222|NCT01484431|38946111|FG002|Period 1: High Dose|Physician Decision|0|||
16558067|NCT02100722|40509861|FG001|Overall Study|Continuing on study|729|||
16558068|NCT00885495|40509862|FG000|Overall Study|Adverse Event|1|||
16125223|NCT01484431|38946109|FG000|Period 2|Death|0|||
16125224|NCT01484431|38946110|FG001|Period 2|Death|1|||
16350715|NCT00809445|39772813|FG000|6 Month Follow-up|Incarcerated|6|||
16350716|NCT00809445|39772814|FG001|6 Month Follow-up|Incarcerated|8|||
16558069|NCT00885495|40509863|FG001|Overall Study|Adverse Event|2|||
16125225|NCT01484431|38946111|FG002|Period 2|Death|1|||
16125226|NCT01484431|38946109|FG000|Period 2|Physician Decision|0|||
16125227|NCT01484431|38946110|FG001|Period 2|Physician Decision|0|||
16125228|NCT01484431|38946111|FG002|Period 2|Physician Decision|1|||
16125229|NCT01484431|38946109|FG000|Period 2|Non-Compliance with Study Drug|1|||
16125230|NCT01484431|38946110|FG001|Period 2|Non-Compliance with Study Drug|0|||
16125231|NCT01484431|38946111|FG002|Period 2|Non-Compliance with Study Drug|0|||
16125232|NCT00760474|38946113|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
16125233|NCT00760474|38946114|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
16125234|NCT00760474|38946113|FG000|Placebo Washout Period|Other|0|||
16125235|NCT00760474|38946114|FG001|Placebo Washout Period|Other|1|||
16125236|NCT00760474|38946113|FG000|Period 2 (P2)|Lost to Follow-up|1|||
16125237|NCT00760474|38946114|FG001|Period 2 (P2)|Lost to Follow-up|0|||
16125238|NCT00760474|38946113|FG000|Period 2 (P2)|Adverse Event|0|||
16125239|NCT00760474|38946114|FG001|Period 2 (P2)|Adverse Event|1|||
16125240|NCT03140280|38946115|FG000|Overall Study|Physician Decision|5|||
16125241|NCT03241927|38946121|FG000|Overall Study|study terminated|1|||
16125242|NCT03241927|38946122|FG001|Overall Study|study terminated|0|||
16125243|NCT04958642|38946126|FG000|Overall Study|Transferred to OLEX program|3|||
16125244|NCT04958642|38946127|FG001|Overall Study|Transferred to OLEX program|0|||
16125245|NCT04958642|38946128|FG002|Overall Study|Transferred to OLEX program|5|||
16125246|NCT04958642|38946126|FG000|Overall Study|Death|0|||
16125247|NCT04958642|38946127|FG001|Overall Study|Death|0|||
16125248|NCT04958642|38946128|FG002|Overall Study|Death|1|||
16125249|NCT04958642|38946126|FG000|Overall Study|Withdrawal by Subject|4|||
16125250|NCT04958642|38946127|FG001|Overall Study|Withdrawal by Subject|9|||
16242469|NCT00633152|39371581|FG000|Overall Study|Miscellaneous Other|3|||
16242470|NCT00633152|39371582|FG001|Overall Study|Miscellaneous Other|2|||
16125251|NCT04958642|38946128|FG002|Overall Study|Withdrawal by Subject|13|||
16558070|NCT00885495|40509862|FG000|Overall Study|Protocol Violation|0|||
16558071|NCT00885495|40509863|FG001|Overall Study|Protocol Violation|1|||
16125252|NCT04958642|38946126|FG000|Overall Study|Investigator's Decision|0|||
16125253|NCT04958642|38946127|FG001|Overall Study|Investigator's Decision|0|||
16125254|NCT04958642|38946128|FG002|Overall Study|Investigator's Decision|1|||
16125255|NCT04958642|38946126|FG000|Overall Study|Adverse Event|1|||
16125256|NCT04958642|38946127|FG001|Overall Study|Adverse Event|0|||
16242471|NCT03001011|39371590|FG000|Overall Study|Adverse Event|9|||
16242472|NCT03001011|39371591|FG001|Overall Study|Adverse Event|3|||
16242473|NCT03001011|39371590|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
16242474|NCT03001011|39371591|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
16242475|NCT03001011|39371590|FG000|Overall Study|Other than specified above|3|||
16242476|NCT03001011|39371591|FG001|Overall Study|Other than specified above|8|||
16242477|NCT00423488|39371592|FG000|Overall Study|No evidence of study drug intake|2|||
16242478|NCT00423488|39371593|FG001|Overall Study|No evidence of study drug intake|1|||
16242479|NCT00423488|39371592|FG000|Overall Study|No post baseline data|3|||
16242480|NCT00423488|39371593|FG001|Overall Study|No post baseline data|0|||
16242481|NCT01086215|39371595|FG000|Overall Study|Death|14|||
16558072|NCT00885495|40509862|FG000|Overall Study|Withdrawal by Subject|1|||
16558073|NCT00885495|40509863|FG001|Overall Study|Withdrawal by Subject|0|||
16558074|NCT02748512|40509864|FG000|Overall Study|Lost to Follow-up|1|||
16558075|NCT02748512|40509865|FG001|Overall Study|Lost to Follow-up|1|||
16125257|NCT04958642|38946128|FG002|Overall Study|Adverse Event|1|||
16125258|NCT04958642|38946126|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
16125259|NCT04958642|38946127|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
16125260|NCT04958642|38946128|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
16125261|NCT04958642|38946126|FG000|Overall Study|Lost to Follow-up|1|||
16125262|NCT04958642|38946127|FG001|Overall Study|Lost to Follow-up|0|||
16125263|NCT04958642|38946128|FG002|Overall Study|Lost to Follow-up|0|||
16125264|NCT04958642|38946126|FG000|Overall Study|Transferred to EAP following study termination|0|||
16125265|NCT04958642|38946127|FG001|Overall Study|Transferred to EAP following study termination|0|||
16558076|NCT03606460|40509866|FG000|Overall Study|Lost to Follow-up|1|||
16558077|NCT03606460|40509867|FG001|Overall Study|Lost to Follow-up|8|||
16558078|NCT00051311|40509870|FG000|Overall Study|Starting new study|0|||
16558079|NCT00051311|40509871|FG001|Overall Study|Starting new study|1|||
16558080|NCT00051311|40509870|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
16558081|NCT00051311|40509871|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
16558082|NCT00051311|40509870|FG000|Overall Study|Death of recipient|8|||
16558083|NCT00051311|40509871|FG001|Overall Study|Death of recipient|8|||
16558084|NCT00051311|40509870|FG000|Overall Study|Recipient taken off study|4|||
16558085|NCT00051311|40509871|FG001|Overall Study|Recipient taken off study|4|||
16125266|NCT04958642|38946128|FG002|Overall Study|Transferred to EAP following study termination|1|||
16125267|NCT04958642|38946126|FG000|Overall Study|Transferred to Expanded Access Program|1|||
16125268|NCT04958642|38946127|FG001|Overall Study|Transferred to Expanded Access Program|0|||
16242482|NCT01086215|39371596|FG001|Overall Study|Death|8|||
16558086|NCT01113463|40509875|FG000|Overall Study|Physician Decision|5|||
16558087|NCT03930186|40509876|FG000|Weeks 0 to 16|Adverse Event|6|||
16242483|NCT01086215|39371597|FG002|Overall Study|Death|8|||
16242484|NCT01086215|39371598|FG003|Overall Study|Death|1|||
16242485|NCT01086215|39371595|FG000|Overall Study|Lost to Follow-up|22|||
16242486|NCT01086215|39371596|FG001|Overall Study|Lost to Follow-up|39|||
16242487|NCT01086215|39371597|FG002|Overall Study|Lost to Follow-up|18|||
16242488|NCT01086215|39371598|FG003|Overall Study|Lost to Follow-up|2|||
16242489|NCT01605461|39371601|FG000|Overall Study|Lost to Follow-up|3|||
16242490|NCT01605461|39371601|FG000|Overall Study|Withdrawal by Subject|1|||
16242491|NCT02451670|39371604|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
16242492|NCT02451670|39371605|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
16242493|NCT00879970|39371612|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
16242494|NCT00879970|39371613|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
16242495|NCT00879970|39371614|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
16242496|NCT00879970|39371615|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
16242497|NCT00879970|39371616|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
16242498|NCT00879970|39371612|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
16242499|NCT00879970|39371613|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
16242500|NCT00879970|39371614|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
16242501|NCT00879970|39371615|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
16242502|NCT00879970|39371616|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
16558088|NCT03930186|40509876|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
16558089|NCT03930186|40509876|FG000|Weeks 16 to 32|Adverse Event|1|||
16558090|NCT03930186|40509876|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
16558091|NCT01010217|40509879|FG000|Overall Study|Lost to Follow-up|4|||
16558092|NCT01010217|40509880|FG001|Overall Study|Lost to Follow-up|5|||
16558093|NCT01010217|40509881|FG002|Overall Study|Lost to Follow-up|1|||
16242503|NCT00879970|39371612|FG000|Period 1 TZD Randomization|Death|2|||
16242504|NCT00879970|39371613|FG001|Period 1 TZD Randomization|Death|1|||
16242505|NCT00879970|39371614|FG002|Period 1 TZD Randomization|Death|0|||
16242506|NCT00879970|39371615|FG003|Period 1 TZD Randomization|Death|0|||
16242507|NCT00879970|39371616|FG004|Period 1 TZD Randomization|Death|0|||
16558094|NCT01010217|40509882|FG003|Overall Study|Lost to Follow-up|0|||
16558095|NCT01010217|40509883|FG004|Overall Study|Lost to Follow-up|0|||
16558096|NCT01010217|40509879|FG000|Overall Study|Withdrawal by Subject|1|||
16558097|NCT01010217|40509880|FG001|Overall Study|Withdrawal by Subject|0|||
16558098|NCT01010217|40509881|FG002|Overall Study|Withdrawal by Subject|0|||
16558099|NCT01010217|40509882|FG003|Overall Study|Withdrawal by Subject|0|||
16558100|NCT01010217|40509883|FG004|Overall Study|Withdrawal by Subject|0|||
16558101|NCT01010217|40509879|FG000|Overall Study|Physician Decision|0|||
16558102|NCT01010217|40509880|FG001|Overall Study|Physician Decision|0|||
16558103|NCT01010217|40509881|FG002|Overall Study|Physician Decision|0|||
16558104|NCT01010217|40509882|FG003|Overall Study|Physician Decision|6|||
16558105|NCT01010217|40509883|FG004|Overall Study|Physician Decision|3|||
16242508|NCT00879970|39371612|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
16242509|NCT00879970|39371613|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
16414813|NCT00459537|39998560|FG000|Overall Study|Lost to Follow-up|27|||
16414814|NCT00459537|39998561|FG001|Overall Study|Lost to Follow-up|30|||
16414815|NCT00459537|39998560|FG000|Overall Study|Administrative problems|3|||
16414816|NCT00459537|39998561|FG001|Overall Study|Administrative problems|0|||
16414817|NCT00459537|39998560|FG000|Overall Study|Protocol Violation|4|||
16414818|NCT00459537|39998561|FG001|Overall Study|Protocol Violation|3|||
16414819|NCT00459537|39998560|FG000|Overall Study|Missing|1|||
16558106|NCT01764386|40509885|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
16558107|NCT01764386|40509886|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
16242510|NCT00879970|39371614|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
16558108|NCT01764386|40509885|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
16242511|NCT00879970|39371615|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
16242512|NCT00879970|39371616|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
16414820|NCT00459537|39998561|FG001|Overall Study|Missing|0|||
16414821|NCT02408523|39998562|FG000|Overall Study|Adverse Event|4|||
16242513|NCT00879970|39371612|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
16242514|NCT00879970|39371613|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
16242515|NCT00879970|39371614|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
16242516|NCT00879970|39371615|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
16242517|NCT00879970|39371616|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
16242518|NCT00879970|39371612|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
16242519|NCT00879970|39371613|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
16242520|NCT00879970|39371614|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
16242521|NCT00879970|39371615|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
16414822|NCT02408523|39998563|FG001|Overall Study|Adverse Event|10|||
16414823|NCT02408523|39998562|FG000|Overall Study|Lack of Efficacy|0|||
16242522|NCT00879970|39371616|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
16242523|NCT00879970|39371612|FG000|Period 2 Vitamin D Randomization|Death|0|||
16242524|NCT00879970|39371613|FG001|Period 2 Vitamin D Randomization|Death|0|||
16242525|NCT00879970|39371614|FG002|Period 2 Vitamin D Randomization|Death|0|||
16242526|NCT00879970|39371615|FG003|Period 2 Vitamin D Randomization|Death|2|||
16242527|NCT00879970|39371616|FG004|Period 2 Vitamin D Randomization|Death|0|||
16242528|NCT03332173|39371623|FG000|Overall Study|Death|7|||
16242529|NCT03332173|39371623|FG000|Overall Study|Withdrawal by Subject|6|||
16242530|NCT03332173|39371623|FG000|Overall Study|Lost to Follow-up|2|||
16242531|NCT03332173|39371623|FG000|Overall Study|Transferred to long-term extension study|29|||
16242532|NCT00580983|39371627|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
16242533|NCT02981602|39371629|FG000|Overall Study|Adverse Event|0|||
16242534|NCT02981602|39371630|FG001|Overall Study|Adverse Event|0|||
16242535|NCT02981602|39371631|FG002|Overall Study|Adverse Event|0|||
16242536|NCT02981602|39371632|FG003|Overall Study|Adverse Event|1|||
16242537|NCT02981602|39371633|FG004|Overall Study|Adverse Event|0|||
16242538|NCT01613131|39371634|FG000|Overall Study|Withdrawal by Subject|3|||
16242539|NCT01613131|39371635|FG001|Overall Study|Withdrawal by Subject|5|||
16242540|NCT01901146|39371638|FG000|Neoadjuvant Phase|Death|1|||
16242541|NCT01901146|39371639|FG001|Neoadjuvant Phase|Death|2|||
16242542|NCT01901146|39371640|FG002|Neoadjuvant Phase|Death|0|||
16242543|NCT01901146|39371641|FG003|Neoadjuvant Phase|Death|0|||
16242544|NCT01901146|39371642|FG004|Neoadjuvant Phase|Death|0|||
16242545|NCT01901146|39371638|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
16242546|NCT01901146|39371639|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
16242547|NCT01901146|39371640|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
16242548|NCT01901146|39371641|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
16242549|NCT01901146|39371642|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
16242550|NCT01901146|39371638|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
16242551|NCT01901146|39371639|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
16242552|NCT01901146|39371640|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
16242553|NCT01901146|39371641|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
16242554|NCT01901146|39371642|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
16242555|NCT01901146|39371638|FG000|Neoadjuvant Phase|Physician Decision|1|||
16242556|NCT01901146|39371639|FG001|Neoadjuvant Phase|Physician Decision|2|||
16242557|NCT01901146|39371640|FG002|Neoadjuvant Phase|Physician Decision|0|||
16242558|NCT01901146|39371641|FG003|Neoadjuvant Phase|Physician Decision|0|||
16242559|NCT01901146|39371642|FG004|Neoadjuvant Phase|Physician Decision|0|||
16242560|NCT01901146|39371638|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
16242561|NCT01901146|39371639|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
16242562|NCT01901146|39371640|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
16242563|NCT01901146|39371641|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
16242564|NCT01901146|39371642|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
16242565|NCT01901146|39371638|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
16242566|NCT01901146|39371639|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
16242567|NCT01901146|39371640|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
16242568|NCT01901146|39371641|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
16242569|NCT01901146|39371642|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
16242570|NCT01901146|39371638|FG000|Adjuvant Phase|Other|0|||
16242571|NCT01901146|39371639|FG001|Adjuvant Phase|Other|0|||
16242572|NCT01901146|39371640|FG002|Adjuvant Phase|Other|1|||
16242573|NCT01901146|39371641|FG003|Adjuvant Phase|Other|0|||
16242574|NCT01901146|39371642|FG004|Adjuvant Phase|Other|0|||
16242575|NCT01901146|39371638|FG000|Adjuvant Phase|Death|0|||
16242576|NCT01901146|39371639|FG001|Adjuvant Phase|Death|0|||
16242577|NCT01901146|39371640|FG002|Adjuvant Phase|Death|0|||
16242578|NCT01901146|39371641|FG003|Adjuvant Phase|Death|0|||
16414824|NCT02408523|39998563|FG001|Overall Study|Lack of Efficacy|1|||
16242579|NCT01901146|39371642|FG004|Adjuvant Phase|Death|3|||
16414825|NCT02408523|39998562|FG000|Overall Study|Protocol Violation|1|||
16242580|NCT01901146|39371638|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
16242581|NCT01901146|39371639|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
16414826|NCT02408523|39998563|FG001|Overall Study|Protocol Violation|2|||
16414827|NCT02408523|39998562|FG000|Overall Study|Lost to Follow-up|2|||
16242582|NCT01901146|39371640|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
16242583|NCT01901146|39371641|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
16242584|NCT01901146|39371642|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
16242585|NCT01901146|39371638|FG000|Adjuvant Phase|Physician Decision|0|||
16242586|NCT01901146|39371639|FG001|Adjuvant Phase|Physician Decision|0|||
16242587|NCT01901146|39371640|FG002|Adjuvant Phase|Physician Decision|9|||
16242588|NCT01901146|39371641|FG003|Adjuvant Phase|Physician Decision|2|||
16242589|NCT01901146|39371642|FG004|Adjuvant Phase|Physician Decision|4|||
16242590|NCT01901146|39371638|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
16242591|NCT01901146|39371639|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
16242592|NCT01901146|39371640|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
16242593|NCT01901146|39371641|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
16242594|NCT01901146|39371642|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
16242595|NCT01827371|39371645|FG000|Overall Study|Adverse Event|0|||
16242596|NCT01827371|39371646|FG001|Overall Study|Adverse Event|0|||
16242597|NCT01827371|39371647|FG002|Overall Study|Adverse Event|4|||
16242598|NCT01827371|39371648|FG003|Overall Study|Adverse Event|2|||
16242599|NCT01827371|39371645|FG000|Overall Study|Lost to Follow-up|0|||
16242600|NCT01827371|39371646|FG001|Overall Study|Lost to Follow-up|2|||
16242601|NCT01827371|39371647|FG002|Overall Study|Lost to Follow-up|0|||
16242602|NCT01827371|39371648|FG003|Overall Study|Lost to Follow-up|4|||
16242603|NCT01827371|39371645|FG000|Overall Study|Protocol Violation|1|||
16242604|NCT01827371|39371646|FG001|Overall Study|Protocol Violation|0|||
16242605|NCT01827371|39371647|FG002|Overall Study|Protocol Violation|0|||
16242606|NCT01827371|39371648|FG003|Overall Study|Protocol Violation|0|||
16242607|NCT01827371|39371645|FG000|Overall Study|Withdrawal by Subject|1|||
16242608|NCT01827371|39371646|FG001|Overall Study|Withdrawal by Subject|2|||
16242609|NCT01827371|39371647|FG002|Overall Study|Withdrawal by Subject|2|||
16242610|NCT01827371|39371648|FG003|Overall Study|Withdrawal by Subject|3|||
16242611|NCT01827371|39371645|FG000|Overall Study|Physician Decision|0|||
16242612|NCT01827371|39371646|FG001|Overall Study|Physician Decision|1|||
16242613|NCT01827371|39371647|FG002|Overall Study|Physician Decision|0|||
16242614|NCT01827371|39371648|FG003|Overall Study|Physician Decision|1|||
16242615|NCT01827371|39371645|FG000|Overall Study|Temporary study halt to vaccinations|11|||
16242616|NCT01827371|39371646|FG001|Overall Study|Temporary study halt to vaccinations|2|||
16242617|NCT01827371|39371647|FG002|Overall Study|Temporary study halt to vaccinations|5|||
16242618|NCT01827371|39371648|FG003|Overall Study|Temporary study halt to vaccinations|13|||
16242619|NCT03836729|39371649|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
16242620|NCT03156270|39371650|FG000|Overall Study|Failed pre-treatment screening|1|||
16242621|NCT03156270|39371650|FG000|Overall Study|Lost to Follow-up|1|||
16242622|NCT01255722|39371656|FG000|Overall Study|Adverse Event|0|||
16242623|NCT01255722|39371657|FG001|Overall Study|Adverse Event|1|||
16242624|NCT01255722|39371658|FG002|Overall Study|Adverse Event|1|||
16242625|NCT01255722|39371656|FG000|Overall Study|asymptomatic patient|1|||
16242626|NCT01255722|39371657|FG001|Overall Study|asymptomatic patient|0|||
16242627|NCT01255722|39371658|FG002|Overall Study|asymptomatic patient|0|||
16414828|NCT02408523|39998563|FG001|Overall Study|Lost to Follow-up|3|||
16558109|NCT01764386|40509886|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
16558110|NCT01764386|40509885|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
16558111|NCT01764386|40509886|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
16558112|NCT01764386|40509885|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
16558113|NCT01764386|40509886|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
16558114|NCT01764386|40509885|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
16558115|NCT01764386|40509886|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
16558116|NCT01764386|40509885|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
16558117|NCT01764386|40509886|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
16558118|NCT01764386|40509885|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
16558119|NCT01764386|40509886|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
16558120|NCT01764386|40509885|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
16558121|NCT01764386|40509886|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
16242628|NCT01255722|39371656|FG000|Overall Study|beta-blocker contraindicated|2|||
16242629|NCT01255722|39371657|FG001|Overall Study|beta-blocker contraindicated|0|||
16242630|NCT01255722|39371658|FG002|Overall Study|beta-blocker contraindicated|0|||
16242631|NCT01841359|39371663|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
16558122|NCT01024751|40509887|FG000|Enrolled Participants|Ineligible at baseline|3|||
16558123|NCT01024751|40509888|FG001|Enrolled Participants|Ineligible at baseline|4|||
16558124|NCT01024751|40509887|FG000|Eligible Participants|Withdrawal by Subject|0|||
16558125|NCT01024751|40509888|FG001|Eligible Participants|Withdrawal by Subject|1|||
16558126|NCT01024751|40509887|FG000|Eligible Participants|Lost to Follow-up|0|||
16558127|NCT01024751|40509888|FG001|Eligible Participants|Lost to Follow-up|1|||
16558128|NCT01024751|40509887|FG000|Eligible Participants|Ineligible|0|||
16558129|NCT01024751|40509888|FG001|Eligible Participants|Ineligible|1|||
16558130|NCT04922021|40509889|FG000|Overall Study|Withdrawal by Subject|4|||
16558131|NCT04922021|40509890|FG001|Overall Study|Withdrawal by Subject|10|||
16558132|NCT04922021|40509889|FG000|Overall Study|Adverse Event|2|||
16558133|NCT04922021|40509890|FG001|Overall Study|Adverse Event|2|||
16558134|NCT04922021|40509889|FG000|Overall Study|Lack of Efficacy|0|||
16558135|NCT04922021|40509890|FG001|Overall Study|Lack of Efficacy|1|||
16558136|NCT04922021|40509889|FG000|Overall Study|Multiple reasons|1|||
16558137|NCT04922021|40509890|FG001|Overall Study|Multiple reasons|0|||
16558138|NCT01439711|40509891|FG000|Overall Study|Ineligible|13|||
16558139|NCT01439711|40509891|FG000|Overall Study|Cancel|3|||
16558140|NCT01439711|40509891|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
16558141|NCT01439711|40509891|FG000|Overall Study|Adverse Event|5|||
16558142|NCT01439711|40509891|FG000|Overall Study|Withdrawal by Subject|3|||
16558143|NCT01439711|40509891|FG000|Overall Study|Progression During Active Tx|3|||
16558144|NCT01439711|40509891|FG000|Overall Study|Noncompliance|3|||
16558145|NCT01439711|40509891|FG000|Overall Study|No MRI|9|||
16558146|NCT00280293|40509892|FG000|Overall Study|Protocol Violation|3|||
16558147|NCT00280293|40509893|FG001|Overall Study|Protocol Violation|0|||
16558148|NCT00280293|40509892|FG000|Overall Study|Physician Decision|5|||
16558149|NCT00280293|40509893|FG001|Overall Study|Physician Decision|4|||
16558150|NCT00280293|40509892|FG000|Overall Study|Lost to Follow-up|14|||
16558151|NCT00280293|40509893|FG001|Overall Study|Lost to Follow-up|12|||
16125269|NCT04958642|38946128|FG002|Overall Study|Transferred to Expanded Access Program|0|||
16125270|NCT01699503|38946132|FG000|Overall Study|Death|31|||
16242632|NCT01841359|39371663|FG000|Overall Study|Concommitant medical issues|2|||
16242633|NCT01841359|39371663|FG000|Overall Study|Adverse Event|3|||
16242634|NCT01841359|39371663|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
16242635|NCT01890785|39371666|FG000|Third Intervention|Withdrawal by Subject|0|||
16242636|NCT01890785|39371667|FG001|Third Intervention|Withdrawal by Subject|1|||
16242637|NCT01890785|39371668|FG002|Third Intervention|Withdrawal by Subject|0|||
16242638|NCT01890785|39371669|FG003|Third Intervention|Withdrawal by Subject|0|||
16242639|NCT01890785|39371670|FG004|Third Intervention|Withdrawal by Subject|0|||
16242640|NCT01890785|39371671|FG005|Third Intervention|Withdrawal by Subject|0|||
16242641|NCT00931385|39371672|FG000|Overall Study|Adverse Event|2|||
16242642|NCT00931385|39371673|FG001|Overall Study|Adverse Event|1|||
16242643|NCT00931385|39371674|FG002|Overall Study|Adverse Event|0|||
16350717|NCT00809445|39772815|FG002|6 Month Follow-up|Incarcerated|8|||
16350718|NCT00809445|39772813|FG000|6 Month Follow-up|Withdrew consent|0|||
16350719|NCT00809445|39772814|FG001|6 Month Follow-up|Withdrew consent|0|||
16350720|NCT00809445|39772815|FG002|6 Month Follow-up|Withdrew consent|1|||
16350721|NCT03075267|39772824|FG000|Overall Study|Protocol Violation|1|||
16350722|NCT03075267|39772825|FG001|Overall Study|Protocol Violation|0|||
16350723|NCT03075267|39772826|FG002|Overall Study|Protocol Violation|0|||
16350724|NCT03426345|39772827|FG000|Overall Study|Adverse Event|4|||
16350725|NCT03426345|39772828|FG001|Overall Study|Adverse Event|4|||
16350726|NCT03426345|39772827|FG000|Overall Study|Lack of Efficacy|1|||
16350727|NCT03426345|39772828|FG001|Overall Study|Lack of Efficacy|0|||
16350728|NCT03426345|39772827|FG000|Overall Study|Withdrawal by Subject|5|||
16350729|NCT03426345|39772828|FG001|Overall Study|Withdrawal by Subject|6|||
16350730|NCT03426345|39772827|FG000|Overall Study|Lost to Follow-up|3|||
16350731|NCT03426345|39772828|FG001|Overall Study|Lost to Follow-up|1|||
16350732|NCT03426345|39772827|FG000|Overall Study|Protocol Deviation|3|||
16350733|NCT03426345|39772828|FG001|Overall Study|Protocol Deviation|4|||
16350734|NCT03426345|39772827|FG000|Overall Study|Reason Not Specified|1|||
16350735|NCT03426345|39772828|FG001|Overall Study|Reason Not Specified|2|||
16350736|NCT03426345|39772827|FG000|Overall Study|Missing Completion Status|1|||
16350737|NCT03426345|39772828|FG001|Overall Study|Missing Completion Status|0|||
16350738|NCT00875810|39772831|FG000|Overall Study|Withdrawal by Subject|1|||
16350739|NCT00875810|39772831|FG000|Overall Study|Physician Decision|3|||
16350740|NCT00875810|39772831|FG000|Overall Study|Lost to Follow-up|39|||
16558152|NCT00280293|40509892|FG000|Overall Study|Withdrawal by Subject|3|||
16558153|NCT00280293|40509893|FG001|Overall Study|Withdrawal by Subject|5|||
16558154|NCT00280293|40509892|FG000|Overall Study|Incarceration/Legal Reasons|1|||
16558155|NCT00280293|40509893|FG001|Overall Study|Incarceration/Legal Reasons|1|||
16558156|NCT00280293|40509892|FG000|Overall Study|Adverse Event|0|||
16558157|NCT00280293|40509893|FG001|Overall Study|Adverse Event|1|||
16242644|NCT00931385|39371675|FG003|Overall Study|Adverse Event|3|||
16242645|NCT00931385|39371672|FG000|Overall Study|Protocol Violation|0|||
16350741|NCT00875810|39772831|FG000|Overall Study|Patient enroled but not implanted|2|||
16558158|NCT01818700|40509894|FG000|Overall Study|Adverse Event|67|||
16350742|NCT00875810|39772831|FG000|Overall Study|Device explanted|1|||
16350743|NCT03528551|39772832|FG000|Overall Study|Lost to Follow-up|0|||
16350744|NCT03528551|39772833|FG001|Overall Study|Lost to Follow-up|1|||
16350745|NCT03528551|39772834|FG002|Overall Study|Lost to Follow-up|0|||
16350746|NCT03528551|39772832|FG000|Overall Study|Transferred to other arm/group|2|||
16350747|NCT03528551|39772833|FG001|Overall Study|Transferred to other arm/group|3|||
16242646|NCT00931385|39371673|FG001|Overall Study|Protocol Violation|0|||
16242647|NCT00931385|39371674|FG002|Overall Study|Protocol Violation|1|||
16242648|NCT00931385|39371675|FG003|Overall Study|Protocol Violation|0|||
16242649|NCT00931385|39371672|FG000|Overall Study|Withdrawal by Subject|0|||
16242650|NCT00931385|39371673|FG001|Overall Study|Withdrawal by Subject|1|||
16242651|NCT00931385|39371674|FG002|Overall Study|Withdrawal by Subject|0|||
16242652|NCT00931385|39371675|FG003|Overall Study|Withdrawal by Subject|1|||
16242653|NCT00931385|39371672|FG000|Overall Study|Lost to Follow-up|0|||
16242654|NCT00931385|39371673|FG001|Overall Study|Lost to Follow-up|0|||
16242655|NCT00931385|39371674|FG002|Overall Study|Lost to Follow-up|0|||
16242656|NCT00931385|39371675|FG003|Overall Study|Lost to Follow-up|1|||
16242657|NCT01309828|39371676|FG000|Overall Study|Adverse Event|10|||
16242658|NCT01309828|39371677|FG001|Overall Study|Adverse Event|11|||
16242659|NCT01309828|39371676|FG000|Overall Study|Voluntary Withdrawal|5|||
16242660|NCT01309828|39371677|FG001|Overall Study|Voluntary Withdrawal|4|||
16242661|NCT01309828|39371676|FG000|Overall Study|Major Protocol Deviation|0|||
16242662|NCT01309828|39371677|FG001|Overall Study|Major Protocol Deviation|1|||
16242663|NCT01309828|39371676|FG000|Overall Study|Other|1|||
16242664|NCT01309828|39371677|FG001|Overall Study|Other|0|||
16242665|NCT02970669|39371678|FG000|Double-blind Period|Adverse Event|4|||
16242666|NCT02970669|39371679|FG001|Double-blind Period|Adverse Event|0|||
16242667|NCT02970669|39371678|FG000|Double-blind Period|Death|1|||
16242668|NCT02970669|39371679|FG001|Double-blind Period|Death|0|||
16242669|NCT02970669|39371678|FG000|Double-blind Period|Study terminated by sponsor|1|||
16242670|NCT02970669|39371679|FG001|Double-blind Period|Study terminated by sponsor|2|||
16242671|NCT02970669|39371678|FG000|Double-blind Period|Physician Decision|0|||
16242672|NCT02970669|39371679|FG001|Double-blind Period|Physician Decision|2|||
16242673|NCT02970669|39371678|FG000|Double-blind Period|Withdrawal by Subject|2|||
16242674|NCT02970669|39371679|FG001|Double-blind Period|Withdrawal by Subject|2|||
16242675|NCT02970669|39371678|FG000|Open-label Period|Withdrawal by Subject|2|||
16242676|NCT02970669|39371679|FG001|Open-label Period|Withdrawal by Subject|2|||
16242677|NCT02970669|39371678|FG000|Open-label Period|Adverse Event|1|||
16242678|NCT02970669|39371679|FG001|Open-label Period|Adverse Event|0|||
16242679|NCT02970669|39371678|FG000|Open-label Period|Physician Decision|1|||
16242680|NCT02970669|39371679|FG001|Open-label Period|Physician Decision|0|||
16242681|NCT02464059|39371680|FG000|Overall Study|Lost to Follow-up|6|||
16242682|NCT03439293|39371681|FG000|Overall Study|Death|22|||
16242683|NCT03439293|39371681|FG000|Overall Study|Withdrawal by Subject|8|||
16242684|NCT03439293|39371681|FG000|Overall Study|Lost to Follow-up|2|||
16242685|NCT03439293|39371681|FG000|Overall Study|Reason Not Specified|28|||
16242686|NCT03439293|39371681|FG000|Overall Study|Missing|1|||
16242687|NCT00420849|39371682|FG000|Overall Study|Lack of Efficacy|154|||
16242688|NCT00420849|39371682|FG000|Overall Study|Adverse Event|107|||
16242689|NCT00420849|39371682|FG000|Overall Study|Withdrawal by Subject|28|||
16350748|NCT03528551|39772834|FG002|Overall Study|Transferred to other arm/group|0|||
16350749|NCT03528551|39772832|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16350750|NCT03528551|39772833|FG001|Overall Study|Withdrawal by parent/guardian|5|||
16350751|NCT03528551|39772834|FG002|Overall Study|Withdrawal by parent/guardian|0|||
16350752|NCT03528551|39772832|FG000|Overall Study|Protocol Violation|0|||
16350753|NCT03528551|39772833|FG001|Overall Study|Protocol Violation|3|||
16350754|NCT03528551|39772834|FG002|Overall Study|Protocol Violation|0|||
16350755|NCT03528551|39772832|FG000|Overall Study|Withdrawal by Subject|0|||
16558159|NCT01818700|40509894|FG000|Overall Study|Lack of Efficacy|2|||
16125271|NCT01699503|38946133|FG001|Overall Study|Death|40|||
16125272|NCT01699503|38946132|FG000|Overall Study|Withdrawal by Subject|65|||
16242690|NCT00420849|39371682|FG000|Overall Study|Death|18|||
16350756|NCT03528551|39772833|FG001|Overall Study|Withdrawal by Subject|7|||
16350757|NCT03528551|39772834|FG002|Overall Study|Withdrawal by Subject|0|||
16242691|NCT00420849|39371682|FG000|Overall Study|Other|14|||
16242692|NCT00420849|39371682|FG000|Overall Study|Transplant|8|||
16242693|NCT00420849|39371682|FG000|Overall Study|Protocol Violation|1|||
16242694|NCT00420849|39371682|FG000|Overall Study|Lost to Follow-up|1|||
16242695|NCT03372083|39371683|FG000|Overall Study|Adverse Event|3|||
16242696|NCT03372083|39371683|FG000|Overall Study|Physician Decision|1|||
16242697|NCT03372083|39371683|FG000|Overall Study|Withdrawal by Subject|1|||
16242698|NCT02340078|39371684|FG000|Overall Study|Protocol Violation|1|||
16242699|NCT02477696|39371688|FG000|Overall Study|Death|89|||
16242700|NCT02477696|39371689|FG001|Overall Study|Death|106|||
16242701|NCT02477696|39371688|FG000|Overall Study|Lost to Follow-up|7|||
16242702|NCT02477696|39371689|FG001|Overall Study|Lost to Follow-up|5|||
16242703|NCT02477696|39371688|FG000|Overall Study|Withdrawal by Subject|37|||
16242704|NCT02477696|39371689|FG001|Overall Study|Withdrawal by Subject|34|||
16242705|NCT02477696|39371688|FG000|Overall Study|Physician Decision|7|||
16242706|NCT02477696|39371689|FG001|Overall Study|Physician Decision|9|||
16242707|NCT02477696|39371688|FG000|Overall Study|Study terminated by sponsor|103|||
16242708|NCT02477696|39371689|FG001|Overall Study|Study terminated by sponsor|99|||
16242709|NCT02477696|39371688|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
16242710|NCT02477696|39371689|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
16242711|NCT02477696|39371688|FG000|Overall Study|Missing/Unknown|2|||
16242712|NCT02477696|39371689|FG001|Overall Study|Missing/Unknown|0|||
16242713|NCT00299728|39371690|FG000|Overall Study|Lost to Follow-up|0|||
16242714|NCT00299728|39371691|FG001|Overall Study|Lost to Follow-up|1|||
16242715|NCT00299728|39371690|FG000|Overall Study|Withdrawal by Subject|0|||
16242716|NCT00299728|39371691|FG001|Overall Study|Withdrawal by Subject|1|||
16242717|NCT00299728|39371690|FG000|Overall Study|Progressive disease|0|||
16242718|NCT00299728|39371691|FG001|Overall Study|Progressive disease|1|||
16242719|NCT01463683|39371693|FG000|Overall Study|Adverse Event|2|||
16242720|NCT01463683|39371694|FG001|Overall Study|Adverse Event|0|||
16242721|NCT01463683|39371695|FG002|Overall Study|Adverse Event|0|||
16242722|NCT01463683|39371693|FG000|Overall Study|Lost to Follow-up|10|||
16242723|NCT01463683|39371694|FG001|Overall Study|Lost to Follow-up|9|||
16242724|NCT01463683|39371695|FG002|Overall Study|Lost to Follow-up|7|||
16242725|NCT01463683|39371693|FG000|Overall Study|Physician Decision|0|||
16242726|NCT01463683|39371694|FG001|Overall Study|Physician Decision|3|||
16242727|NCT01463683|39371695|FG002|Overall Study|Physician Decision|1|||
16242728|NCT01463683|39371693|FG000|Overall Study|Pregnancy|2|||
16242729|NCT01463683|39371694|FG001|Overall Study|Pregnancy|2|||
16242730|NCT01463683|39371695|FG002|Overall Study|Pregnancy|1|||
16242731|NCT01463683|39371693|FG000|Overall Study|Withdrawal by Subject|5|||
16242732|NCT01463683|39371694|FG001|Overall Study|Withdrawal by Subject|17|||
16242733|NCT01463683|39371695|FG002|Overall Study|Withdrawal by Subject|2|||
16242734|NCT00379587|39371696|FG000|Overall Study|Lost to Follow-up|2|||
16242735|NCT01039584|39371697|FG000|Overall Study|Withdrawal by Subject|4|||
16242736|NCT01039584|39371698|FG001|Overall Study|Withdrawal by Subject|2|||
16242737|NCT01039584|39371699|FG002|Overall Study|Withdrawal by Subject|1|||
16125273|NCT01699503|38946133|FG001|Overall Study|Withdrawal by Subject|57|||
16125274|NCT01699503|38946132|FG000|Overall Study|Lost to Follow-up|121|||
16242738|NCT01039584|39371697|FG000|Overall Study|Protocol Violation|10|||
16242739|NCT01039584|39371698|FG001|Overall Study|Protocol Violation|4|||
16242740|NCT01039584|39371699|FG002|Overall Study|Protocol Violation|6|||
16242741|NCT01039584|39371697|FG000|Overall Study|Lost to Follow-up|5|||
16242742|NCT01039584|39371698|FG001|Overall Study|Lost to Follow-up|3|||
16242743|NCT01039584|39371699|FG002|Overall Study|Lost to Follow-up|4|||
16242744|NCT01039584|39371697|FG000|Overall Study|Negative Baseline culture for Candida|59|||
16242745|NCT01039584|39371698|FG001|Overall Study|Negative Baseline culture for Candida|59|||
16242746|NCT01039584|39371699|FG002|Overall Study|Negative Baseline culture for Candida|24|||
16242747|NCT01039584|39371697|FG000|Overall Study|Lack of Efficacy|7|||
16242748|NCT01039584|39371698|FG001|Overall Study|Lack of Efficacy|6|||
16242749|NCT01039584|39371699|FG002|Overall Study|Lack of Efficacy|10|||
16242750|NCT01039584|39371697|FG000|Overall Study|other|1|||
16558160|NCT01818700|40509894|FG000|Overall Study|Lost to Follow-up|5|||
16558161|NCT01818700|40509894|FG000|Overall Study|Withdrawal by Subject|27|||
16350758|NCT02869789|39772837|FG000|Overall Study|Disease progression|184|||
16350759|NCT02869789|39772838|FG001|Overall Study|Disease progression|109|||
16350760|NCT02869789|39772839|FG002|Overall Study|Disease progression|260|||
16558162|NCT01818700|40509894|FG000|Overall Study|Protocol Violation|2|||
16558163|NCT01818700|40509894|FG000|Overall Study|Other|1|||
16350761|NCT02869789|39772840|FG003|Overall Study|Disease progression|19|||
16350762|NCT02869789|39772837|FG000|Overall Study|Study drug toxicity|90|||
16350763|NCT02869789|39772838|FG001|Overall Study|Study drug toxicity|32|||
16350764|NCT02869789|39772839|FG002|Overall Study|Study drug toxicity|55|||
16350765|NCT02869789|39772840|FG003|Overall Study|Study drug toxicity|14|||
16350766|NCT02869789|39772837|FG000|Overall Study|Death|7|||
16350767|NCT02869789|39772838|FG001|Overall Study|Death|3|||
16350768|NCT02869789|39772839|FG002|Overall Study|Death|5|||
16350769|NCT02869789|39772840|FG003|Overall Study|Death|1|||
16350770|NCT02869789|39772837|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
16350771|NCT02869789|39772838|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
16350772|NCT02869789|39772839|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
16350773|NCT02869789|39772840|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
16350774|NCT02869789|39772837|FG000|Overall Study|Participant request to discontinue study treatment|10|||
16350775|NCT02869789|39772838|FG001|Overall Study|Participant request to discontinue study treatment|5|||
16350776|NCT02869789|39772839|FG002|Overall Study|Participant request to discontinue study treatment|5|||
16350777|NCT02869789|39772840|FG003|Overall Study|Participant request to discontinue study treatment|3|||
16350778|NCT02869789|39772837|FG000|Overall Study|Withdrawal by Subject|5|||
16350779|NCT02869789|39772838|FG001|Overall Study|Withdrawal by Subject|2|||
16350780|NCT02869789|39772839|FG002|Overall Study|Withdrawal by Subject|7|||
16350781|NCT02869789|39772840|FG003|Overall Study|Withdrawal by Subject|2|||
16350782|NCT02869789|39772837|FG000|Overall Study|Lost to Follow-up|0|||
16350783|NCT02869789|39772838|FG001|Overall Study|Lost to Follow-up|0|||
16350784|NCT02869789|39772839|FG002|Overall Study|Lost to Follow-up|2|||
16350785|NCT02869789|39772840|FG003|Overall Study|Lost to Follow-up|0|||
16350786|NCT02869789|39772837|FG000|Overall Study|Maximum clinical benefit|5|||
16350787|NCT02869789|39772838|FG001|Overall Study|Maximum clinical benefit|2|||
16350788|NCT02869789|39772839|FG002|Overall Study|Maximum clinical benefit|1|||
16350789|NCT02869789|39772840|FG003|Overall Study|Maximum clinical benefit|0|||
16350790|NCT02869789|39772837|FG000|Overall Study|Poor/Non-compliance|0|||
16350791|NCT02869789|39772838|FG001|Overall Study|Poor/Non-compliance|2|||
16350792|NCT02869789|39772839|FG002|Overall Study|Poor/Non-compliance|1|||
16350793|NCT02869789|39772840|FG003|Overall Study|Poor/Non-compliance|0|||
16350794|NCT02869789|39772837|FG000|Overall Study|Participant no longer meets study criteria|0|||
16350795|NCT02869789|39772838|FG001|Overall Study|Participant no longer meets study criteria|1|||
16350796|NCT02869789|39772839|FG002|Overall Study|Participant no longer meets study criteria|1|||
16350797|NCT02869789|39772840|FG003|Overall Study|Participant no longer meets study criteria|0|||
16350798|NCT02869789|39772837|FG000|Overall Study|Administrative reason by sponsor|0|||
16350799|NCT02869789|39772838|FG001|Overall Study|Administrative reason by sponsor|0|||
16350800|NCT02869789|39772839|FG002|Overall Study|Administrative reason by sponsor|1|||
16350801|NCT02869789|39772840|FG003|Overall Study|Administrative reason by sponsor|0|||
16350802|NCT02869789|39772837|FG000|Overall Study|Other reasons|4|||
16350803|NCT02869789|39772838|FG001|Overall Study|Other reasons|8|||
16350804|NCT02869789|39772839|FG002|Overall Study|Other reasons|6|||
16350805|NCT02869789|39772840|FG003|Overall Study|Other reasons|0|||
16350806|NCT01519817|39772841|FG000|Overall Study|Withdrawal by Subject|1|||
16350807|NCT01519817|39772842|FG001|Overall Study|Withdrawal by Subject|0|||
16350808|NCT01519817|39772843|FG002|Overall Study|Withdrawal by Subject|0|||
16414829|NCT02408523|39998562|FG000|Overall Study|Withdrawal by Subject|3|||
16414830|NCT02408523|39998563|FG001|Overall Study|Withdrawal by Subject|1|||
16414831|NCT02408523|39998562|FG000|Overall Study|Sponsor request|1|||
16414832|NCT02408523|39998563|FG001|Overall Study|Sponsor request|0|||
16414833|NCT02408523|39998562|FG000|Overall Study|Did not satisfy extension conditions|0|||
16414834|NCT02408523|39998563|FG001|Overall Study|Did not satisfy extension conditions|1|||
16414835|NCT00432744|39998564|FG000|Months 0-6|Withdrawal by Subject|4|||
16414836|NCT00432744|39998565|FG001|Months 0-6|Withdrawal by Subject|4|||
16350809|NCT01519817|39772844|FG003|Overall Study|Withdrawal by Subject|0|||
16414837|NCT00432744|39998564|FG000|Months 0-6|Too disabled to score|1|||
16414838|NCT00432744|39998565|FG001|Months 0-6|Too disabled to score|0|||
16242751|NCT01039584|39371698|FG001|Overall Study|other|3|||
16242752|NCT01039584|39371699|FG002|Overall Study|other|1|||
16350810|NCT01519817|39772841|FG000|Overall Study|Off study due to infection|0|||
16350811|NCT01519817|39772842|FG001|Overall Study|Off study due to infection|0|||
16350812|NCT01519817|39772843|FG002|Overall Study|Off study due to infection|0|||
16350813|NCT01519817|39772844|FG003|Overall Study|Off study due to infection|1|||
16350814|NCT00919633|39772847|FG000|Overall Study|Adverse Event|1|||
16350815|NCT00919633|39772848|FG001|Overall Study|Adverse Event|9|||
16350816|NCT00919633|39772849|FG002|Overall Study|Adverse Event|12|||
16350817|NCT00919633|39772850|FG003|Overall Study|Adverse Event|10|||
16350818|NCT00919633|39772847|FG000|Overall Study|Death|0|||
16350819|NCT00919633|39772848|FG001|Overall Study|Death|0|||
16350820|NCT00919633|39772849|FG002|Overall Study|Death|2|||
16350821|NCT00919633|39772850|FG003|Overall Study|Death|0|||
16350822|NCT00919633|39772847|FG000|Overall Study|Lack of Efficacy|17|||
16350823|NCT00919633|39772848|FG001|Overall Study|Lack of Efficacy|3|||
16350824|NCT00919633|39772849|FG002|Overall Study|Lack of Efficacy|2|||
16350825|NCT00919633|39772850|FG003|Overall Study|Lack of Efficacy|3|||
16350826|NCT00919633|39772847|FG000|Overall Study|Withdrawal by Subject|1|||
16350827|NCT00919633|39772848|FG001|Overall Study|Withdrawal by Subject|2|||
16350828|NCT00919633|39772849|FG002|Overall Study|Withdrawal by Subject|4|||
16350829|NCT00919633|39772850|FG003|Overall Study|Withdrawal by Subject|3|||
16350830|NCT00919633|39772847|FG000|Overall Study|Lost to Follow-up|3|||
16350831|NCT00919633|39772848|FG001|Overall Study|Lost to Follow-up|1|||
16350832|NCT00919633|39772849|FG002|Overall Study|Lost to Follow-up|0|||
16350833|NCT00919633|39772850|FG003|Overall Study|Lost to Follow-up|2|||
16350834|NCT00919633|39772847|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
16350835|NCT00919633|39772848|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
16350836|NCT00919633|39772849|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
16350837|NCT00919633|39772850|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
16125275|NCT01699503|38946133|FG001|Overall Study|Lost to Follow-up|117|||
16350838|NCT00919633|39772847|FG000|Overall Study|Protocol Violation|0|||
16350839|NCT00919633|39772848|FG001|Overall Study|Protocol Violation|0|||
16350840|NCT00919633|39772849|FG002|Overall Study|Protocol Violation|0|||
16350841|NCT00919633|39772850|FG003|Overall Study|Protocol Violation|1|||
16350842|NCT00919633|39772847|FG000|Overall Study|Physician Decision|0|||
16350843|NCT00919633|39772848|FG001|Overall Study|Physician Decision|0|||
16350844|NCT00919633|39772849|FG002|Overall Study|Physician Decision|0|||
16350845|NCT00919633|39772850|FG003|Overall Study|Physician Decision|1|||
16350846|NCT00919633|39772847|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
16350847|NCT00919633|39772848|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
16350848|NCT00919633|39772849|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
16350849|NCT00919633|39772850|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
16350850|NCT00919633|39772847|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
16350851|NCT00919633|39772848|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
16350852|NCT00919633|39772849|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
16350853|NCT00919633|39772850|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
16350854|NCT01610037|39772853|FG000|All Patients|Adverse Event|27|||
16350855|NCT01610037|39772854|FG001|All Patients|Adverse Event|22|||
16350856|NCT01610037|39772855|FG002|All Patients|Adverse Event|26|||
16350857|NCT01610037|39772853|FG000|All Patients|Withdrawal by Subject|12|||
16350858|NCT01610037|39772854|FG001|All Patients|Withdrawal by Subject|10|||
16350859|NCT01610037|39772855|FG002|All Patients|Withdrawal by Subject|20|||
16350860|NCT01610037|39772853|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
16350861|NCT01610037|39772854|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
16350862|NCT01610037|39772855|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
16350863|NCT01610037|39772853|FG000|All Patients|Death|4|||
16350864|NCT01610037|39772854|FG001|All Patients|Death|2|||
16350865|NCT01610037|39772855|FG002|All Patients|Death|1|||
16350866|NCT01610037|39772853|FG000|All Patients|Protocol deviation|4|||
16350867|NCT01610037|39772854|FG001|All Patients|Protocol deviation|3|||
16350868|NCT01610037|39772855|FG002|All Patients|Protocol deviation|3|||
16350869|NCT01610037|39772853|FG000|All Patients|Abnormal laboratory value|1|||
16350870|NCT01610037|39772854|FG001|All Patients|Abnormal laboratory value|1|||
16350871|NCT01610037|39772855|FG002|All Patients|Abnormal laboratory value|0|||
16350872|NCT01610037|39772853|FG000|All Patients|Administrative problems|1|||
16350873|NCT01610037|39772854|FG001|All Patients|Administrative problems|4|||
16350874|NCT01610037|39772855|FG002|All Patients|Administrative problems|4|||
16350875|NCT01610037|39772853|FG000|All Patients|Lost to Follow-up|1|||
16350876|NCT01610037|39772854|FG001|All Patients|Lost to Follow-up|0|||
16350877|NCT01610037|39772855|FG002|All Patients|Lost to Follow-up|0|||
16350878|NCT01610037|39772853|FG000|All Patients|Abnormal test procedure result(s)|0|||
16350879|NCT01610037|39772854|FG001|All Patients|Abnormal test procedure result(s)|1|||
16350880|NCT01610037|39772855|FG002|All Patients|Abnormal test procedure result(s)|3|||
16350881|NCT01610037|39772853|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
16350882|NCT01610037|39772854|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
16350883|NCT01610037|39772855|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
16350884|NCT01610037|39772853|FG000|Treatment and Follow up Period|Death|10|||
16350885|NCT01610037|39772854|FG001|Treatment and Follow up Period|Death|5|||
16350886|NCT01610037|39772855|FG002|Treatment and Follow up Period|Death|4|||
16414839|NCT00432744|39998564|FG000|Months 7 - 12|Withdrawal by Subject|1|||
16414840|NCT00432744|39998565|FG001|Months 7 - 12|Withdrawal by Subject|0|||
16125276|NCT01699503|38946132|FG000|Overall Study|Excluded due to quality|783|||
16125277|NCT01699503|38946133|FG001|Overall Study|Excluded due to quality|791|||
16125278|NCT02124811|38946136|FG000|Overall Study|Early termination|2|||
16350887|NCT01610037|39772853|FG000|Treatment and Follow up Period|Administrative problems|1|||
16350888|NCT01610037|39772854|FG001|Treatment and Follow up Period|Administrative problems|3|||
16350889|NCT01610037|39772855|FG002|Treatment and Follow up Period|Administrative problems|2|||
16350890|NCT01610037|39772853|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
16350891|NCT01610037|39772854|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
16350892|NCT01610037|39772855|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
16350893|NCT03372798|39772856|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
16350894|NCT03372798|39772857|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
16350895|NCT03372798|39772856|FG000|Overall Study|Failure of imaging probe|0|||
16350896|NCT03372798|39772857|FG001|Overall Study|Failure of imaging probe|1|||
16350897|NCT02230891|39772858|FG000|Baseline|Did not meet inclusion|0|||
16414841|NCT00432744|39998564|FG000|Months 7 - 12|Too disabled to score|0|||
16414842|NCT00432744|39998565|FG001|Months 7 - 12|Too disabled to score|1|||
16414843|NCT03729245|39998586|FG000|Overall Study|Lost to Follow-up|5|||
16414844|NCT03729245|39998587|FG001|Overall Study|Lost to Follow-up|6|||
16414845|NCT03729245|39998586|FG000|Overall Study|Withdrawal by Subject|16|||
16414846|NCT03729245|39998587|FG001|Overall Study|Withdrawal by Subject|19|||
16125279|NCT02124811|38946137|FG001|Overall Study|Early termination|2|||
16125280|NCT02124811|38946136|FG000|Overall Study|Withdrawal by Subject|1|||
16125281|NCT02124811|38946137|FG001|Overall Study|Withdrawal by Subject|0|||
16125282|NCT02412371|38946140|FG000|Overall Study|Withdrawal by Subject|0|||
16125283|NCT02412371|38946141|FG001|Overall Study|Withdrawal by Subject|2|||
16125284|NCT02412371|38946142|FG002|Overall Study|Withdrawal by Subject|0|||
16125285|NCT02412371|38946143|FG003|Overall Study|Withdrawal by Subject|1|||
16125286|NCT02412371|38946144|FG004|Overall Study|Withdrawal by Subject|1|||
16125287|NCT02412371|38946145|FG005|Overall Study|Withdrawal by Subject|0|||
16125288|NCT02412371|38946140|FG000|Overall Study|Sponsor Discontinued Study|1|||
16125289|NCT02412371|38946141|FG001|Overall Study|Sponsor Discontinued Study|4|||
16125290|NCT02412371|38946142|FG002|Overall Study|Sponsor Discontinued Study|6|||
16125291|NCT02412371|38946143|FG003|Overall Study|Sponsor Discontinued Study|4|||
16125292|NCT02412371|38946144|FG004|Overall Study|Sponsor Discontinued Study|5|||
16125293|NCT02412371|38946145|FG005|Overall Study|Sponsor Discontinued Study|0|||
16125294|NCT02412371|38946140|FG000|Overall Study|Death|4|||
16125295|NCT02412371|38946141|FG001|Overall Study|Death|2|||
16125296|NCT02412371|38946142|FG002|Overall Study|Death|1|||
16125297|NCT02412371|38946143|FG003|Overall Study|Death|3|||
16125298|NCT02412371|38946144|FG004|Overall Study|Death|5|||
16125299|NCT02412371|38946145|FG005|Overall Study|Death|2|||
16125300|NCT02412371|38946140|FG000|Overall Study|Other|2|||
16125301|NCT02412371|38946141|FG001|Overall Study|Other|1|||
16125302|NCT02412371|38946142|FG002|Overall Study|Other|0|||
16125303|NCT02412371|38946143|FG003|Overall Study|Other|0|||
16125304|NCT02412371|38946144|FG004|Overall Study|Other|1|||
16125305|NCT02412371|38946145|FG005|Overall Study|Other|3|||
16125306|NCT03541200|38946146|FG000|Overall Study|Adverse Event|19|||
16125307|NCT03541200|38946146|FG000|Overall Study|Death|1|||
16125308|NCT03541200|38946146|FG000|Overall Study|Lost to Follow-up|10|||
16350898|NCT02230891|39772859|FG001|Baseline|Did not meet inclusion|1|||
16350899|NCT02230891|39772860|FG002|Baseline|Did not meet inclusion|1|||
16414847|NCT03729245|39998586|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
16414848|NCT03729245|39998587|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
16558164|NCT04285229|40509895|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
16558165|NCT04285229|40509896|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16558166|NCT04285229|40509897|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16558167|NCT04285229|40509898|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16125309|NCT03541200|38946146|FG000|Overall Study|Physician Decision|1|||
16125310|NCT03541200|38946146|FG000|Overall Study|Protocol Violation|51|||
16414849|NCT02437409|39998590|FG000|Overall Study|Withdrawal by Subject|3|||
16414850|NCT02437409|39998590|FG000|Overall Study|Screening failure|12|||
16414851|NCT01549873|40001433|FG000|Overall Study|Physician Decision|0|||
16414852|NCT01549873|40001434|FG001|Overall Study|Physician Decision|1|||
16125311|NCT03541200|38946146|FG000|Overall Study|Withdrawal by Subject|23|||
16125312|NCT03541200|38946146|FG000|Overall Study|other|8|||
16125313|NCT02004353|38946152|FG000|Overall Study|Voluntary participation|1334|||
16125314|NCT01888900|38946153|FG000|Overall Study|failed treatment|0|||
16125315|NCT01888900|38946154|FG001|Overall Study|failed treatment|2|||
16125316|NCT01004848|38946155|FG000|Overall Study|Lost to Follow-up|55|||
16414853|NCT01711866|40001435|FG000|Overall Study|Noncompliant|3|||
16125317|NCT01004848|38946156|FG001|Overall Study|Lost to Follow-up|45|||
16125318|NCT02766777|38946157|FG000|Overall Study|Adverse Event|12|||
16125319|NCT02766777|38946157|FG000|Overall Study|Lost to Follow-up|16|||
16125320|NCT02766777|38946157|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16125321|NCT02766777|38946157|FG000|Overall Study|Protocol Violation|1|||
16125322|NCT02766777|38946157|FG000|Overall Study|Withdrawal by Subject|4|||
16125323|NCT03056300|38946159|FG000|Overall Study|Surgical reason per study protocol|3|||
16125324|NCT00548262|38946166|FG000|Overall Study|Death|21|||
16125325|NCT00548262|38946166|FG000|Overall Study|Adverse Event|2|||
16125326|NCT00548262|38946166|FG000|Overall Study|Lack of Efficacy|4|||
16125327|NCT00548262|38946166|FG000|Overall Study|Lost to Follow-up|1|||
16125328|NCT00548262|38946166|FG000|Overall Study|Other|3|||
16125329|NCT00548262|38946166|FG000|Overall Study|Withdrawal by Subject|1|||
16242753|NCT01039584|39371697|FG000|Overall Study|Pap smear with significant pathology|10|||
16242754|NCT01039584|39371698|FG001|Overall Study|Pap smear with significant pathology|10|||
16242755|NCT01039584|39371699|FG002|Overall Study|Pap smear with significant pathology|3|||
16242756|NCT01039584|39371697|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
16242757|NCT01039584|39371698|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
16242758|NCT01039584|39371699|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
16242759|NCT00736099|39371700|FG000|Overall Study|Adverse Event|61|||
16242760|NCT00736099|39371701|FG001|Overall Study|Adverse Event|18|||
16242761|NCT00736099|39371700|FG000|Overall Study|Protocol Violation|10|||
16242762|NCT00736099|39371701|FG001|Overall Study|Protocol Violation|4|||
16242763|NCT00736099|39371700|FG000|Overall Study|Lost to Follow-up|12|||
16242764|NCT00736099|39371701|FG001|Overall Study|Lost to Follow-up|5|||
16242765|NCT00736099|39371700|FG000|Overall Study|Withdrawal by Subject|42|||
16242766|NCT00736099|39371701|FG001|Overall Study|Withdrawal by Subject|13|||
16242767|NCT00736099|39371700|FG000|Overall Study|Lack of Efficacy|15|||
16242768|NCT00736099|39371701|FG001|Overall Study|Lack of Efficacy|8|||
16414854|NCT01711866|40001435|FG000|Overall Study|Withdrawal by Subject|3|||
16414855|NCT01711866|40001435|FG000|Overall Study|Adverse Event|2|||
16125330|NCT04276415|38946169|FG000|Overall Study|Adverse Event|0|||
16125331|NCT04276415|38946170|FG001|Overall Study|Adverse Event|0|||
16242769|NCT00736099|39371700|FG000|Overall Study|Other reason|43|||
16242770|NCT00736099|39371701|FG001|Overall Study|Other reason|10|||
16242771|NCT02278952|39371702|FG000|Overall Study|Insufficient Sample|6|||
16242772|NCT01375010|39371703|FG000|Overall Study|Lost to Follow-up|8|||
16125332|NCT04276415|38946171|FG002|Overall Study|Adverse Event|0|||
16125333|NCT04276415|38946172|FG003|Overall Study|Adverse Event|3|||
16125334|NCT04276415|38946173|FG004|Overall Study|Adverse Event|0|||
16125335|NCT04276415|38946174|FG005|Overall Study|Adverse Event|0|||
16125336|NCT04276415|38946169|FG000|Overall Study|Clinical progression|1|||
16125337|NCT04276415|38946170|FG001|Overall Study|Clinical progression|1|||
16558168|NCT04285229|40509899|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16558169|NCT04285229|40509900|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16558170|NCT04285229|40509895|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
16558171|NCT04285229|40509896|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
16558172|NCT04285229|40509897|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
16558173|NCT04285229|40509898|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
16558174|NCT04285229|40509899|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
16558175|NCT04285229|40509900|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
16558176|NCT04285229|40509895|FG000|Extended Treatment Period|Adverse Event|0|||
16558177|NCT04285229|40509896|FG001|Extended Treatment Period|Adverse Event|0|||
16558178|NCT04285229|40509897|FG002|Extended Treatment Period|Adverse Event|0|||
16125338|NCT04276415|38946171|FG002|Overall Study|Clinical progression|0|||
16242773|NCT01375010|39371704|FG001|Overall Study|Lost to Follow-up|2|||
16242774|NCT01375010|39371703|FG000|Overall Study|Withdrawal by Subject|4|||
16242775|NCT01375010|39371704|FG001|Overall Study|Withdrawal by Subject|2|||
16242776|NCT03840135|39371705|FG000|Overall Study|Protocol Violation|6|||
16242777|NCT03840135|39371706|FG001|Overall Study|Protocol Violation|1|||
16242778|NCT03840135|39371705|FG000|Overall Study|Withdrawal by Subject|1|||
16242779|NCT03840135|39371706|FG001|Overall Study|Withdrawal by Subject|0|||
16242780|NCT00520494|39371707|FG000|Overall Study|Withdrawal by Subject|1|||
16242781|NCT01416142|39371708|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
16242782|NCT01416142|39371709|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
16242783|NCT01416142|39371710|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
16125339|NCT04276415|38946172|FG003|Overall Study|Clinical progression|0|||
16125340|NCT04276415|38946173|FG004|Overall Study|Clinical progression|1|||
16350900|NCT02230891|39772858|FG000|2 Week|Withdrawal by Subject|2|||
16350901|NCT02230891|39772859|FG001|2 Week|Withdrawal by Subject|2|||
16350902|NCT02230891|39772860|FG002|2 Week|Withdrawal by Subject|0|||
16350903|NCT02230891|39772858|FG000|2 Week|Consent withdrawn|1|||
16350904|NCT02230891|39772859|FG001|2 Week|Consent withdrawn|0|||
16350905|NCT02230891|39772860|FG002|2 Week|Consent withdrawn|0|||
16350906|NCT02230891|39772858|FG000|6 Month|Withdrawal by Subject|1|||
16350907|NCT02230891|39772859|FG001|6 Month|Withdrawal by Subject|1|||
16350908|NCT02230891|39772860|FG002|6 Month|Withdrawal by Subject|1|||
16350909|NCT02230891|39772858|FG000|6 Month|Physician Decision|0|||
16350910|NCT02230891|39772859|FG001|6 Month|Physician Decision|2|||
16350911|NCT02230891|39772860|FG002|6 Month|Physician Decision|0|||
16350912|NCT02230891|39772858|FG000|12 Month|Death|1|||
16350913|NCT02230891|39772859|FG001|12 Month|Death|0|||
16350914|NCT02230891|39772860|FG002|12 Month|Death|0|||
16350915|NCT02230891|39772858|FG000|12 Month|Lost to Follow-up|0|||
16350916|NCT02230891|39772859|FG001|12 Month|Lost to Follow-up|1|||
16350917|NCT02230891|39772860|FG002|12 Month|Lost to Follow-up|0|||
16350918|NCT02230891|39772858|FG000|12 Month|Withdrawal by Subject|0|||
16350919|NCT02230891|39772859|FG001|12 Month|Withdrawal by Subject|2|||
16350920|NCT02230891|39772860|FG002|12 Month|Withdrawal by Subject|0|||
16350921|NCT02230891|39772858|FG000|18 Month End of Study|Death|0|||
16558179|NCT04285229|40509898|FG003|Extended Treatment Period|Adverse Event|1|||
16558180|NCT04285229|40509899|FG004|Extended Treatment Period|Adverse Event|0|||
16558181|NCT04285229|40509900|FG005|Extended Treatment Period|Adverse Event|0|||
16558182|NCT04285229|40509895|FG000|Extended Treatment Period|Physician Decision|0|||
16558183|NCT04285229|40509896|FG001|Extended Treatment Period|Physician Decision|0|||
16558184|NCT04285229|40509897|FG002|Extended Treatment Period|Physician Decision|1|||
16558185|NCT04285229|40509898|FG003|Extended Treatment Period|Physician Decision|0|||
16558186|NCT04285229|40509899|FG004|Extended Treatment Period|Physician Decision|0|||
16558187|NCT04285229|40509900|FG005|Extended Treatment Period|Physician Decision|0|||
16558188|NCT04285229|40509895|FG000|Follow-up Period|Adverse Event|0|||
16558189|NCT04285229|40509896|FG001|Follow-up Period|Adverse Event|0|||
16558190|NCT04285229|40509897|FG002|Follow-up Period|Adverse Event|0|||
16558191|NCT04285229|40509898|FG003|Follow-up Period|Adverse Event|0|||
16558192|NCT04285229|40509899|FG004|Follow-up Period|Adverse Event|1|||
16558193|NCT04285229|40509900|FG005|Follow-up Period|Adverse Event|4|||
16558194|NCT04285229|40509895|FG000|Follow-up Period|Withdrawal by Subject|0|||
16558195|NCT04285229|40509896|FG001|Follow-up Period|Withdrawal by Subject|0|||
16558196|NCT04285229|40509897|FG002|Follow-up Period|Withdrawal by Subject|0|||
16558197|NCT04285229|40509898|FG003|Follow-up Period|Withdrawal by Subject|0|||
16558198|NCT04285229|40509899|FG004|Follow-up Period|Withdrawal by Subject|0|||
16414856|NCT00958217|40001439|FG000|Overall Study|Death|2|||
16414857|NCT00958217|40001440|FG001|Overall Study|Death|1|||
16414858|NCT00958217|40001439|FG000|Overall Study|Withdrawal by Subject|4|||
16125341|NCT04276415|38946174|FG005|Overall Study|Clinical progression|0|||
16125342|NCT04276415|38946169|FG000|Overall Study|Other|0|||
16125343|NCT04276415|38946170|FG001|Overall Study|Other|0|||
16125344|NCT04276415|38946171|FG002|Overall Study|Other|0|||
16125345|NCT04276415|38946172|FG003|Overall Study|Other|1|||
16125346|NCT04276415|38946173|FG004|Overall Study|Other|0|||
16125347|NCT04276415|38946174|FG005|Overall Study|Other|0|||
16125348|NCT04276415|38946169|FG000|Overall Study|Physician Decision|0|||
16125349|NCT04276415|38946170|FG001|Overall Study|Physician Decision|0|||
16125350|NCT04276415|38946171|FG002|Overall Study|Physician Decision|1|||
16125351|NCT04276415|38946172|FG003|Overall Study|Physician Decision|3|||
16125352|NCT04276415|38946173|FG004|Overall Study|Physician Decision|2|||
16125353|NCT04276415|38946174|FG005|Overall Study|Physician Decision|0|||
16125354|NCT04276415|38946169|FG000|Overall Study|Progressive disease|3|||
16125355|NCT04276415|38946170|FG001|Overall Study|Progressive disease|3|||
16125356|NCT04276415|38946171|FG002|Overall Study|Progressive disease|4|||
16414859|NCT00958217|40001440|FG001|Overall Study|Withdrawal by Subject|3|||
16558199|NCT04285229|40509900|FG005|Follow-up Period|Withdrawal by Subject|5|||
16558200|NCT04285229|40509895|FG000|Follow-up Period|Covid-19|0|||
16125357|NCT04276415|38946172|FG003|Overall Study|Progressive disease|5|||
16125358|NCT04276415|38946173|FG004|Overall Study|Progressive disease|1|||
16125359|NCT04276415|38946174|FG005|Overall Study|Progressive disease|2|||
16125360|NCT04276415|38946169|FG000|Overall Study|Withdrawal by patient|0|||
16125361|NCT04276415|38946170|FG001|Overall Study|Withdrawal by patient|0|||
16125362|NCT04276415|38946171|FG002|Overall Study|Withdrawal by patient|0|||
16125363|NCT04276415|38946172|FG003|Overall Study|Withdrawal by patient|1|||
16125364|NCT04276415|38946173|FG004|Overall Study|Withdrawal by patient|2|||
16125365|NCT04276415|38946174|FG005|Overall Study|Withdrawal by patient|0|||
16125366|NCT02544451|38946175|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
16125367|NCT02544451|38946176|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
16125368|NCT02544451|38946177|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
16125369|NCT02544451|38946178|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
16125370|NCT02544451|38946175|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
16125371|NCT02544451|38946176|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
16125372|NCT02544451|38946177|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
16414860|NCT00958217|40001439|FG000|Overall Study|Lost to Follow-up|17|||
16173323|NCT01287104|39111176|FG000|Overall Study|NK cells did not meet release criteria|0|||
16350922|NCT02230891|39772859|FG001|18 Month End of Study|Death|0|||
16350923|NCT02230891|39772860|FG002|18 Month End of Study|Death|1|||
16125373|NCT02544451|38946178|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
16125374|NCT02544451|38946175|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
16558201|NCT04285229|40509896|FG001|Follow-up Period|Covid-19|0|||
16558202|NCT04285229|40509897|FG002|Follow-up Period|Covid-19|0|||
16558203|NCT04285229|40509898|FG003|Follow-up Period|Covid-19|0|||
16125375|NCT02544451|38946176|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
16125376|NCT02544451|38946177|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
16125377|NCT02544451|38946178|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
16414861|NCT00958217|40001440|FG001|Overall Study|Lost to Follow-up|19|||
16125378|NCT02544451|38946175|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
16125379|NCT02544451|38946176|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
16125380|NCT02544451|38946177|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
16125381|NCT02544451|38946178|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
16125382|NCT02544451|38946175|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
16125383|NCT02544451|38946176|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
16125384|NCT02544451|38946177|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
16125385|NCT02544451|38946178|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
16125386|NCT02544451|38946175|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
16125387|NCT02544451|38946176|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
16125388|NCT02544451|38946177|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
16125389|NCT02544451|38946178|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
16125390|NCT02030002|38946182|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
16125391|NCT02030002|38946182|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
16125392|NCT02030002|38946182|FG000|Follow-up|Lost to Follow-up|2|||
16125393|NCT01160289|38946185|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
16125394|NCT01160289|38946186|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
16125395|NCT01160289|38946187|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
16125396|NCT01160289|38946188|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
16125397|NCT01160289|38946189|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
16125398|NCT01160289|38946190|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
16125399|NCT01160289|38946185|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
16125400|NCT01160289|38946186|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
16125401|NCT01160289|38946187|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
16125402|NCT01160289|38946188|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
16125403|NCT01160289|38946189|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
16125404|NCT01160289|38946190|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
16125405|NCT01160289|38946185|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
16125406|NCT01160289|38946186|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
16125407|NCT01160289|38946187|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
16125408|NCT01160289|38946188|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
16125409|NCT01160289|38946189|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
16125410|NCT01160289|38946190|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
16125411|NCT01160289|38946185|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
16125412|NCT01160289|38946186|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
16125413|NCT01160289|38946187|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
16125414|NCT01160289|38946188|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
16125415|NCT01160289|38946189|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
16125416|NCT01160289|38946190|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
16125417|NCT01160289|38946185|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
16125418|NCT01160289|38946186|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
16125419|NCT01160289|38946187|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
16125420|NCT01160289|38946188|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
16125421|NCT01160289|38946189|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
16125422|NCT01160289|38946190|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
16125423|NCT01160289|38946185|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
16125424|NCT01160289|38946186|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
16125425|NCT01160289|38946187|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
16125426|NCT01160289|38946188|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
16125427|NCT01160289|38946189|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
16125428|NCT01160289|38946190|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
16125429|NCT01160289|38946185|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
16125430|NCT01160289|38946186|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
16414862|NCT00958217|40001439|FG000|Overall Study|Moved out of area|1|||
16414863|NCT00958217|40001440|FG001|Overall Study|Moved out of area|1|||
16414864|NCT00958217|40001439|FG000|Overall Study|Inpatient hospitalization|0|||
16558204|NCT04285229|40509899|FG004|Follow-up Period|Covid-19|0|||
16558205|NCT04285229|40509900|FG005|Follow-up Period|Covid-19|2|||
16242784|NCT00481871|39371711|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
16242785|NCT00481871|39371712|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
16242786|NCT00481871|39371713|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
16242787|NCT00481871|39371714|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
16242788|NCT00481871|39371715|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
16558206|NCT04285229|40509895|FG000|Follow-up Period|Physician Decision|0|||
16558207|NCT04285229|40509896|FG001|Follow-up Period|Physician Decision|0|||
16242789|NCT05476679|39374770|FG000|Overall Study|Withdrawal by Subject|0|||
16242790|NCT05476679|39374771|FG001|Overall Study|Withdrawal by Subject|0|||
16558208|NCT04285229|40509897|FG002|Follow-up Period|Physician Decision|0|||
16558209|NCT04285229|40509898|FG003|Follow-up Period|Physician Decision|0|||
16558210|NCT04285229|40509899|FG004|Follow-up Period|Physician Decision|0|||
16558211|NCT04285229|40509900|FG005|Follow-up Period|Physician Decision|1|||
16558212|NCT02478359|40509901|FG000|Overall Study|Disenrolled from health plan|106|||
16558213|NCT02478359|40509902|FG001|Overall Study|Disenrolled from health plan|65|||
16558214|NCT00003377|40509905|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
16558215|NCT00003377|40509906|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
16558216|NCT00003377|40509907|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
16558217|NCT00003377|40509908|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
16558218|NCT00003377|40509909|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
16242791|NCT05476679|39374772|FG002|Overall Study|Withdrawal by Subject|0|||
16242792|NCT05476679|39374773|FG003|Overall Study|Withdrawal by Subject|1|||
16242793|NCT05476679|39374774|FG004|Overall Study|Withdrawal by Subject|0|||
16242794|NCT05476679|39374770|FG000|Overall Study|Lost to Follow-up|0|||
16242795|NCT05476679|39374771|FG001|Overall Study|Lost to Follow-up|0|||
16242796|NCT05476679|39374772|FG002|Overall Study|Lost to Follow-up|0|||
16242797|NCT05476679|39374773|FG003|Overall Study|Lost to Follow-up|1|||
16242798|NCT05476679|39374774|FG004|Overall Study|Lost to Follow-up|0|||
16242799|NCT01013792|39374785|FG000|Overall Study|Study suspended|2|||
16242800|NCT01013792|39374786|FG001|Overall Study|Study suspended|1|||
16242801|NCT01013792|39374785|FG000|Overall Study|Adverse Event|0|||
16242802|NCT01013792|39374786|FG001|Overall Study|Adverse Event|3|||
16242803|NCT01013792|39374785|FG000|Overall Study|Lost to Follow-up|0|||
16242804|NCT01013792|39374786|FG001|Overall Study|Lost to Follow-up|1|||
16242805|NCT03751020|39374791|FG000|Overall Study|Withdrawal by Subject|2|||
16242806|NCT03751020|39374792|FG001|Overall Study|Withdrawal by Subject|0|||
16242807|NCT03751020|39374793|FG002|Overall Study|Withdrawal by Subject|0|||
16242808|NCT03751020|39374791|FG000|Overall Study|Lost to Follow-up|7|||
16242809|NCT03751020|39374792|FG001|Overall Study|Lost to Follow-up|4|||
16242810|NCT03751020|39374793|FG002|Overall Study|Lost to Follow-up|10|||
16242811|NCT01814137|39374798|FG000|Overall Study|Adverse Event|0|||
16242812|NCT01814137|39374799|FG001|Overall Study|Adverse Event|1|||
16242813|NCT01814137|39374798|FG000|Overall Study|Withdrawal by Subject|2|||
16242814|NCT01814137|39374799|FG001|Overall Study|Withdrawal by Subject|2|||
16242815|NCT01814137|39374798|FG000|Overall Study|Physician Decision|1|||
16242816|NCT01814137|39374799|FG001|Overall Study|Physician Decision|1|||
16242817|NCT01814137|39374798|FG000|Overall Study|Unclassified|2|||
16242818|NCT01814137|39374799|FG001|Overall Study|Unclassified|1|||
16242819|NCT01201356|39374800|FG000|Overall Study|Adverse Event|170|||
16242820|NCT01201356|39374800|FG000|Overall Study|Abnormal laboratory value(s)|51|||
16242821|NCT01201356|39374800|FG000|Overall Study|Abnormal test procedure result(s)|3|||
16242822|NCT01201356|39374800|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
16242823|NCT01201356|39374800|FG000|Overall Study|Condition no longer requires study drug|12|||
16242824|NCT01201356|39374800|FG000|Overall Study|Withdrawal by Subject|144|||
16242825|NCT01201356|39374800|FG000|Overall Study|Lost to Follow-up|50|||
16558219|NCT00003377|40509905|FG000|Period II|Ureteral stent complications|0|||
16242826|NCT01201356|39374800|FG000|Overall Study|administrative problems|74|||
16242827|NCT01201356|39374800|FG000|Overall Study|Death|16|||
16558220|NCT00003377|40509906|FG001|Period II|Ureteral stent complications|0|||
16558221|NCT00003377|40509907|FG002|Period II|Ureteral stent complications|0|||
16558222|NCT00003377|40509908|FG003|Period II|Ureteral stent complications|0|||
16125431|NCT01160289|38946187|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
16125432|NCT01160289|38946188|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
16125433|NCT01160289|38946189|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
16125434|NCT01160289|38946190|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
16125435|NCT01160289|38946185|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
16125436|NCT01160289|38946186|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
16125437|NCT01160289|38946187|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
16125438|NCT01160289|38946188|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
16125439|NCT01160289|38946189|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
16125440|NCT01160289|38946190|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
16125441|NCT01160289|38946185|FG000|Post-Randomization Period|Adverse Event|0|||
16125442|NCT01160289|38946186|FG001|Post-Randomization Period|Adverse Event|4|||
16125443|NCT01160289|38946187|FG002|Post-Randomization Period|Adverse Event|4|||
16125444|NCT01160289|38946188|FG003|Post-Randomization Period|Adverse Event|2|||
16125445|NCT01160289|38946189|FG004|Post-Randomization Period|Adverse Event|0|||
16125446|NCT01160289|38946190|FG005|Post-Randomization Period|Adverse Event|0|||
16125447|NCT01160289|38946185|FG000|Post-Randomization Period|Death|0|||
16125448|NCT01160289|38946186|FG001|Post-Randomization Period|Death|0|||
16125449|NCT01160289|38946187|FG002|Post-Randomization Period|Death|0|||
16125450|NCT01160289|38946188|FG003|Post-Randomization Period|Death|1|||
16125451|NCT01160289|38946189|FG004|Post-Randomization Period|Death|0|||
16125452|NCT01160289|38946190|FG005|Post-Randomization Period|Death|0|||
16125453|NCT01160289|38946185|FG000|Post-Randomization Period|Lack of Efficacy|0|||
16125454|NCT01160289|38946186|FG001|Post-Randomization Period|Lack of Efficacy|1|||
16125455|NCT01160289|38946187|FG002|Post-Randomization Period|Lack of Efficacy|0|||
16125456|NCT01160289|38946188|FG003|Post-Randomization Period|Lack of Efficacy|3|||
16125457|NCT01160289|38946189|FG004|Post-Randomization Period|Lack of Efficacy|0|||
16125458|NCT01160289|38946190|FG005|Post-Randomization Period|Lack of Efficacy|0|||
16125459|NCT01160289|38946185|FG000|Post-Randomization Period|Lost to Follow-up|0|||
16125460|NCT01160289|38946186|FG001|Post-Randomization Period|Lost to Follow-up|3|||
16125461|NCT01160289|38946187|FG002|Post-Randomization Period|Lost to Follow-up|2|||
16125462|NCT01160289|38946188|FG003|Post-Randomization Period|Lost to Follow-up|5|||
16125463|NCT01160289|38946189|FG004|Post-Randomization Period|Lost to Follow-up|3|||
16125464|NCT01160289|38946190|FG005|Post-Randomization Period|Lost to Follow-up|4|||
16125465|NCT01160289|38946185|FG000|Post-Randomization Period|Physician Decision|0|||
16125466|NCT01160289|38946186|FG001|Post-Randomization Period|Physician Decision|0|||
16125467|NCT01160289|38946187|FG002|Post-Randomization Period|Physician Decision|1|||
16125468|NCT01160289|38946188|FG003|Post-Randomization Period|Physician Decision|0|||
16125469|NCT01160289|38946189|FG004|Post-Randomization Period|Physician Decision|0|||
16125470|NCT01160289|38946190|FG005|Post-Randomization Period|Physician Decision|0|||
16125471|NCT01160289|38946185|FG000|Post-Randomization Period|Protocol Violation|0|||
16125472|NCT01160289|38946186|FG001|Post-Randomization Period|Protocol Violation|4|||
16125473|NCT01160289|38946187|FG002|Post-Randomization Period|Protocol Violation|2|||
16125474|NCT01160289|38946188|FG003|Post-Randomization Period|Protocol Violation|0|||
16125475|NCT01160289|38946189|FG004|Post-Randomization Period|Protocol Violation|1|||
16125476|NCT01160289|38946190|FG005|Post-Randomization Period|Protocol Violation|3|||
16125477|NCT01160289|38946185|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
16125478|NCT01160289|38946186|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
16125479|NCT01160289|38946187|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
16125480|NCT01160289|38946188|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
16125481|NCT01160289|38946189|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
16125482|NCT01160289|38946190|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
16125483|NCT01160289|38946185|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
16125484|NCT01160289|38946186|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
16125485|NCT01160289|38946187|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
16125486|NCT01160289|38946188|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
16125487|NCT01160289|38946189|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
16125488|NCT01160289|38946190|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
16125489|NCT01160289|38946185|FG000|Post-Randomization Period|Sponsor Decision|0|||
16125490|NCT01160289|38946186|FG001|Post-Randomization Period|Sponsor Decision|1|||
16125491|NCT01160289|38946187|FG002|Post-Randomization Period|Sponsor Decision|0|||
16125492|NCT01160289|38946188|FG003|Post-Randomization Period|Sponsor Decision|0|||
16125493|NCT01160289|38946189|FG004|Post-Randomization Period|Sponsor Decision|0|||
16125494|NCT01160289|38946190|FG005|Post-Randomization Period|Sponsor Decision|0|||
16125495|NCT00616902|38946192|FG000|Overall Study|Termination of study|6|||
16125496|NCT00616902|38946193|FG001|Overall Study|Termination of study|6|||
16125497|NCT01518153|38946196|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
16125498|NCT01518153|38946197|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
16125499|NCT01518153|38946198|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
16125500|NCT01518153|38946196|FG000|Stem Cell Transplant|Death|2|||
16414865|NCT00958217|40001440|FG001|Overall Study|Inpatient hospitalization|1|||
16558223|NCT00003377|40509909|FG004|Period II|Ureteral stent complications|1|||
16125501|NCT01518153|38946197|FG001|Stem Cell Transplant|Death|0|||
16125502|NCT01518153|38946198|FG002|Stem Cell Transplant|Death|0|||
16125503|NCT01518153|38946196|FG000|Stem Cell Transplant|Secondary graft failure|1|||
16125504|NCT01518153|38946197|FG001|Stem Cell Transplant|Secondary graft failure|0|||
16125505|NCT01518153|38946198|FG002|Stem Cell Transplant|Secondary graft failure|0|||
16125506|NCT01518153|38946196|FG000|Stem Cell Transplant|Adverse Event|1|||
16125507|NCT01518153|38946197|FG001|Stem Cell Transplant|Adverse Event|0|||
16125508|NCT01518153|38946198|FG002|Stem Cell Transplant|Adverse Event|0|||
16125509|NCT01518153|38946196|FG000|Donor Lymphocyte Infusion|Death|0|||
16125510|NCT01518153|38946197|FG001|Donor Lymphocyte Infusion|Death|2|||
16125511|NCT01518153|38946198|FG002|Donor Lymphocyte Infusion|Death|1|||
16125512|NCT00006011|38946199|FG000|Overall Study|Disease progression|13|||
16125513|NCT00006011|38946200|FG001|Overall Study|Disease progression|6|||
16125514|NCT00006011|38946201|FG002|Overall Study|Disease progression|26|||
16125515|NCT00006011|38946199|FG000|Overall Study|Refused further treatment|15|||
16125516|NCT00006011|38946200|FG001|Overall Study|Refused further treatment|13|||
16125517|NCT00006011|38946201|FG002|Overall Study|Refused further treatment|26|||
16125518|NCT00006011|38946199|FG000|Overall Study|Adverse Event|15|||
16125519|NCT00006011|38946200|FG001|Overall Study|Adverse Event|39|||
16125520|NCT00006011|38946201|FG002|Overall Study|Adverse Event|5|||
16125521|NCT00006011|38946199|FG000|Overall Study|Death|0|||
16125522|NCT00006011|38946200|FG001|Overall Study|Death|1|||
16125523|NCT00006011|38946201|FG002|Overall Study|Death|2|||
16125524|NCT00006011|38946199|FG000|Overall Study|Other|4|||
16125525|NCT00006011|38946200|FG001|Overall Study|Other|2|||
16125526|NCT00006011|38946201|FG002|Overall Study|Other|5|||
16125527|NCT00006011|38946199|FG000|Overall Study|Ineligible|18|||
16125528|NCT00006011|38946200|FG001|Overall Study|Ineligible|16|||
16125529|NCT00006011|38946201|FG002|Overall Study|Ineligible|9|||
16125530|NCT00439231|38946202|FG000|Overall Study|Lack of Efficacy|28|||
16125531|NCT00132873|38946205|FG000|Overall Study|Adverse Event|3|||
16125532|NCT00132873|38946205|FG000|Overall Study|Lost to Follow-up|1|||
16125533|NCT00132873|38946205|FG000|Overall Study|Lack of Efficacy|1|||
16125534|NCT00132873|38946205|FG000|Overall Study|Withdrawal by Subject|3|||
16125535|NCT00132873|38946205|FG000|Overall Study|Planned Pregnancy|1|||
16125536|NCT04032613|38946210|FG000|Overall Study|Did not complete post-program assessment|5|||
16125537|NCT04032613|38946211|FG001|Overall Study|Did not complete post-program assessment|2|||
16125538|NCT01050790|38946212|FG000|Overall Study|Adverse Event|1|||
16125539|NCT03333876|38946213|FG000|Screening Period|Screen Failure|4|||
16125540|NCT03333876|38946213|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
16125541|NCT03333876|38946213|FG000|Mandibular Advancement|Adverse Event|2|||
16125542|NCT03333876|38946213|FG000|Mandibular Advancement|Product Damage|2|||
16125543|NCT01605916|38946214|FG000|Overall Study|Adverse Event|1|||
16125544|NCT01605916|38946215|FG001|Overall Study|Adverse Event|0|||
16125545|NCT01605916|38946216|FG002|Overall Study|Adverse Event|0|||
16125546|NCT01605916|38946217|FG003|Overall Study|Adverse Event|1|||
16125547|NCT01605916|38946218|FG004|Overall Study|Adverse Event|0|||
16125548|NCT01605916|38946214|FG000|Overall Study|Lack of Efficacy|2|||
16125549|NCT01605916|38946215|FG001|Overall Study|Lack of Efficacy|3|||
16125550|NCT01605916|38946216|FG002|Overall Study|Lack of Efficacy|3|||
16125551|NCT01605916|38946217|FG003|Overall Study|Lack of Efficacy|5|||
16125552|NCT01605916|38946218|FG004|Overall Study|Lack of Efficacy|4|||
16125553|NCT01605916|38946214|FG000|Overall Study|Withdrawal by Subject|1|||
16125554|NCT01605916|38946215|FG001|Overall Study|Withdrawal by Subject|1|||
16125555|NCT01605916|38946216|FG002|Overall Study|Withdrawal by Subject|0|||
16125556|NCT01605916|38946217|FG003|Overall Study|Withdrawal by Subject|0|||
16125557|NCT01605916|38946218|FG004|Overall Study|Withdrawal by Subject|2|||
16125558|NCT00998790|38946223|FG000|Overall Study|Withdrawal by Subject|21|||
16125559|NCT03762200|38946234|FG000|Overall Study|Death|2|||
16125560|NCT04043143|38946235|FG000|Overall Study|Lost to Follow-up|5|||
16125561|NCT04043143|38946236|FG001|Overall Study|Lost to Follow-up|5|||
16125562|NCT04043143|38946235|FG000|Overall Study|screen failure|1|||
16414866|NCT01114360|40001445|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
16414867|NCT01114360|40001446|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
16125563|NCT04043143|38946236|FG001|Overall Study|screen failure|0|||
16125564|NCT01940939|38946237|FG000|Overall Study|Withdrawal by Subject|2|||
16125565|NCT01940939|38946238|FG001|Overall Study|Withdrawal by Subject|8|||
16125566|NCT00444275|38946240|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
16125567|NCT00444275|38946241|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
16125568|NCT00444275|38946242|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
16125569|NCT00444275|38946243|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
16125570|NCT00444275|38946244|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
16125571|NCT00444275|38946240|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
16125572|NCT00444275|38946241|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
16125573|NCT00444275|38946242|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
16350924|NCT02230891|39772858|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
16350925|NCT02230891|39772859|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
16125574|NCT00444275|38946243|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
16125575|NCT00444275|38946244|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
16125576|NCT00444275|38946240|FG000|Maintenance Treatment Phase|Adverse Event|0|||
16125577|NCT00444275|38946241|FG001|Maintenance Treatment Phase|Adverse Event|0|||
16125578|NCT00444275|38946242|FG002|Maintenance Treatment Phase|Adverse Event|3|||
16125579|NCT00444275|38946243|FG003|Maintenance Treatment Phase|Adverse Event|2|||
16125580|NCT00444275|38946244|FG004|Maintenance Treatment Phase|Adverse Event|13|||
16125581|NCT00444275|38946240|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
16125582|NCT00444275|38946241|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
16125583|NCT00444275|38946242|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
16125584|NCT00444275|38946243|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
16125585|NCT00444275|38946244|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
16125586|NCT00444275|38946240|FG000|Maintenance Treatment Phase|Patient's wish|0|||
16125587|NCT00444275|38946241|FG001|Maintenance Treatment Phase|Patient's wish|0|||
16125588|NCT00444275|38946242|FG002|Maintenance Treatment Phase|Patient's wish|19|||
16125589|NCT00444275|38946243|FG003|Maintenance Treatment Phase|Patient's wish|9|||
16125590|NCT00444275|38946244|FG004|Maintenance Treatment Phase|Patient's wish|20|||
16125591|NCT00444275|38946240|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
16125592|NCT00444275|38946241|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
16125593|NCT00444275|38946242|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
16125594|NCT00444275|38946243|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
16125595|NCT00444275|38946244|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
16125596|NCT00444275|38946240|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
16125597|NCT00444275|38946241|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
16125598|NCT00444275|38946242|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
16125599|NCT00444275|38946243|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
16125600|NCT00444275|38946244|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
16125601|NCT00653523|38946245|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
16125602|NCT00653523|38946245|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
16125603|NCT00653523|38946245|FG000|Overall Study|Adverse Event|7|||
16125604|NCT00653523|38946245|FG000|Overall Study|Withdrawal by Subject|6|||
16125605|NCT00653523|38946245|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
16125606|NCT00653523|38946245|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
16125607|NCT01445301|38946248|FG000|Overall Study|Adverse Event|15|||
16125608|NCT01445301|38946249|FG001|Overall Study|Adverse Event|25|||
16125609|NCT01445301|38946250|FG002|Overall Study|Adverse Event|4|||
16125610|NCT01445301|38946248|FG000|Overall Study|Lack of Efficacy|0|||
16125611|NCT01445301|38946249|FG001|Overall Study|Lack of Efficacy|1|||
16125612|NCT01445301|38946250|FG002|Overall Study|Lack of Efficacy|0|||
16125613|NCT01445301|38946248|FG000|Overall Study|Protocol Violation|1|||
16125614|NCT01445301|38946249|FG001|Overall Study|Protocol Violation|0|||
16125615|NCT01445301|38946250|FG002|Overall Study|Protocol Violation|0|||
16125616|NCT01445301|38946248|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
16125617|NCT01445301|38946249|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
16125618|NCT01445301|38946250|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
16125619|NCT01445301|38946248|FG000|Overall Study|Physician Decision|0|||
16125620|NCT01445301|38946249|FG001|Overall Study|Physician Decision|2|||
16125621|NCT01445301|38946250|FG002|Overall Study|Physician Decision|0|||
16125622|NCT01445301|38946248|FG000|Overall Study|Withdrawal by Subject|5|||
16125623|NCT01445301|38946249|FG001|Overall Study|Withdrawal by Subject|6|||
16125624|NCT01445301|38946250|FG002|Overall Study|Withdrawal by Subject|4|||
16125625|NCT03207451|38946255|FG000|Overall Study|scheduling conflict|1|||
16125626|NCT03207451|38946256|FG001|Overall Study|scheduling conflict|0|||
16125627|NCT03207451|38946257|FG002|Overall Study|scheduling conflict|2|||
16125628|NCT03207451|38946258|FG003|Overall Study|scheduling conflict|2|||
16125629|NCT03207451|38946255|FG000|Overall Study|Adverse Event|0|||
16125630|NCT03207451|38946256|FG001|Overall Study|Adverse Event|0|||
16350926|NCT02230891|39772860|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
16350927|NCT02446691|39772861|FG000|Overall Study|Withdrawal by Subject|2|||
16350928|NCT02446691|39772861|FG000|Overall Study|Lost to Follow-up|8|||
16125631|NCT03207451|38946257|FG002|Overall Study|Adverse Event|0|||
16125632|NCT03207451|38946258|FG003|Overall Study|Adverse Event|1|||
16125633|NCT04138576|38946262|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
16125634|NCT01056718|38946264|FG000|Overall Study|Withdrawal by Subject|2|||
16350929|NCT02446691|39772861|FG000|Overall Study|Protocol Violation|1|||
16350930|NCT00846586|39772862|FG000|Overall Study|Adverse Event|20|||
16350931|NCT00846586|39772863|FG001|Overall Study|Adverse Event|10|||
16350932|NCT00846586|39772862|FG000|Overall Study|Subject withdrew consent|8|||
16350933|NCT00846586|39772863|FG001|Overall Study|Subject withdrew consent|10|||
16350934|NCT00846586|39772862|FG000|Overall Study|Administrative problems|5|||
16350935|NCT00846586|39772863|FG001|Overall Study|Administrative problems|4|||
16350936|NCT00846586|39772862|FG000|Overall Study|Death|2|||
16414868|NCT00885482|40001449|FG000|Overall Study|Pregnancy|1|||
16414869|NCT00885482|40001449|FG000|Overall Study|Lack of Efficacy|1|||
16414870|NCT00885482|40001449|FG000|Overall Study|Death|1|||
16414871|NCT00885482|40001449|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
16414872|NCT01167907|40001450|FG000|Overall Study|Protocol Violation|1|||
16414873|NCT01167907|40001451|FG001|Overall Study|Protocol Violation|0|||
16414874|NCT01167907|40001450|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
16414875|NCT01167907|40001451|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
16414876|NCT01969721|40001452|FG000|Overall Study|Adverse Event|3|||
16414877|NCT01969721|40001453|FG001|Overall Study|Adverse Event|8|||
16414878|NCT01969721|40001454|FG002|Overall Study|Adverse Event|3|||
16414879|NCT01969721|40001455|FG003|Overall Study|Adverse Event|2|||
16414880|NCT01969721|40001452|FG000|Overall Study|Lack of Efficacy|0|||
16125635|NCT01056718|38946264|FG000|Overall Study|Ischemia on baseline stress test|1|||
16125636|NCT03705832|38946265|FG000|Overall Study|Physician Decision|0|||
16125637|NCT03705832|38946266|FG001|Overall Study|Physician Decision|1|||
16125638|NCT03705832|38946265|FG000|Overall Study|Withdrawal by Subject|1|||
16125639|NCT03705832|38946266|FG001|Overall Study|Withdrawal by Subject|0|||
16125640|NCT00688870|38946267|FG000|Infant Series|Parent or legal guardian request|4|||
16125641|NCT00688870|38946268|FG001|Infant Series|Parent or legal guardian request|0|||
16125642|NCT01639560|38946269|FG000|Overall Study|Withdrawal by Subject|9|||
16125643|NCT01639560|38946270|FG001|Overall Study|Withdrawal by Subject|14|||
16125644|NCT01639560|38946269|FG000|Overall Study|Lack of Efficacy|1|||
16125645|NCT01639560|38946270|FG001|Overall Study|Lack of Efficacy|2|||
16125646|NCT01639560|38946269|FG000|Overall Study|Lost to Follow-up|9|||
16125647|NCT01639560|38946270|FG001|Overall Study|Lost to Follow-up|11|||
16125648|NCT01639560|38946269|FG000|Overall Study|Adverse Event|0|||
16125649|NCT01639560|38946270|FG001|Overall Study|Adverse Event|2|||
16125650|NCT02399254|38946271|FG000|Overall Study|Physician Decision|2|||
16125651|NCT00446043|38946272|FG000|Overall Study|Adverse Event|9|||
16125652|NCT00446043|38946272|FG000|Overall Study|Withdrawal by Subject|70|||
16125653|NCT00446043|38946272|FG000|Overall Study|Protocol Violation|2|||
16125654|NCT00446043|38946272|FG000|Overall Study|Lost to Follow-up|42|||
16125655|NCT00446043|38946272|FG000|Overall Study|Pregnancy|2|||
16125656|NCT00532493|38946273|FG000|Overall Study|Death|1|||
16125657|NCT00532493|38946274|FG001|Overall Study|Death|1|||
16125658|NCT00532493|38946273|FG000|Overall Study|Lost to Follow-up|10|||
16414881|NCT01969721|40001453|FG001|Overall Study|Lack of Efficacy|0|||
16414882|NCT01969721|40001454|FG002|Overall Study|Lack of Efficacy|1|||
16414883|NCT01969721|40001455|FG003|Overall Study|Lack of Efficacy|0|||
16414884|NCT01969721|40001452|FG000|Overall Study|Non compliant with protocol|1|||
16125659|NCT00532493|38946274|FG001|Overall Study|Lost to Follow-up|7|||
16125660|NCT00532493|38946273|FG000|Overall Study|Withdrawal by Subject|7|||
16125661|NCT00532493|38946274|FG001|Overall Study|Withdrawal by Subject|9|||
16125662|NCT00532493|38946273|FG000|Overall Study|Physician Decision|1|||
16125663|NCT00532493|38946274|FG001|Overall Study|Physician Decision|6|||
16350937|NCT00846586|39772863|FG001|Overall Study|Death|0|||
16350938|NCT00846586|39772862|FG000|Overall Study|Protocol deviation|2|||
16350939|NCT00846586|39772863|FG001|Overall Study|Protocol deviation|6|||
16414885|NCT01969721|40001453|FG001|Overall Study|Non compliant with protocol|1|||
16414886|NCT01969721|40001454|FG002|Overall Study|Non compliant with protocol|0|||
16242828|NCT01201356|39374800|FG000|Overall Study|Protocol Violation|12|||
16242829|NCT02270983|39374801|FG000|Overall Study|Adverse Event|3|||
16242830|NCT02270983|39374802|FG001|Overall Study|Adverse Event|2|||
16242831|NCT02270983|39374803|FG002|Overall Study|Adverse Event|6|||
16242832|NCT02270983|39374801|FG000|Overall Study|Lack of Efficacy|2|||
16242833|NCT02270983|39374802|FG001|Overall Study|Lack of Efficacy|1|||
16242834|NCT02270983|39374803|FG002|Overall Study|Lack of Efficacy|1|||
16242835|NCT02270983|39374801|FG000|Overall Study|Withdrawal by Subject|1|||
16242836|NCT02270983|39374802|FG001|Overall Study|Withdrawal by Subject|0|||
16242837|NCT02270983|39374803|FG002|Overall Study|Withdrawal by Subject|2|||
16242838|NCT02270983|39374801|FG000|Overall Study|Lost to Follow-up|1|||
16242839|NCT02270983|39374802|FG001|Overall Study|Lost to Follow-up|1|||
16242840|NCT02270983|39374803|FG002|Overall Study|Lost to Follow-up|2|||
16242841|NCT02270983|39374801|FG000|Overall Study|Protocol Violation|1|||
16350940|NCT00846586|39772862|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16350941|NCT00846586|39772863|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16350942|NCT00846586|39772862|FG000|Overall Study|Lost to Follow-up|1|||
16350943|NCT00846586|39772863|FG001|Overall Study|Lost to Follow-up|4|||
16350944|NCT00846586|39772862|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16350945|NCT00846586|39772863|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16350946|NCT02224625|39772865|FG000|Irritation|Adverse Event|6|||
16350947|NCT02224625|39772865|FG000|Sensitization|Adverse Event|55|||
16350948|NCT02364388|39772871|FG000|Overall Study|Protocol Violation|1|||
16350949|NCT02364388|39772871|FG000|Overall Study|Technical Failure|3|||
16350950|NCT02364388|39772871|FG000|Overall Study|No OA/US data|2|||
16350951|NCT02364388|39772871|FG000|Overall Study|No Biopsy|2|||
16350952|NCT02710084|39772872|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
16350953|NCT02710084|39772873|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
16350954|NCT03904420|39772876|FG000|Overall Study|Study terminated|2|||
16350955|NCT03904420|39772877|FG001|Overall Study|Study terminated|2|||
16350956|NCT05117060|39772878|FG000|Overall Study|Adverse Event|3|||
16350957|NCT05117060|39772879|FG001|Overall Study|Adverse Event|5|||
16350958|NCT05117060|39772880|FG002|Overall Study|Adverse Event|6|||
16350959|NCT05117060|39772881|FG003|Overall Study|Adverse Event|1|||
16350960|NCT05117060|39772878|FG000|Overall Study|Lost to Follow-up|0|||
16350961|NCT05117060|39772879|FG001|Overall Study|Lost to Follow-up|0|||
16350962|NCT05117060|39772880|FG002|Overall Study|Lost to Follow-up|0|||
16350963|NCT05117060|39772881|FG003|Overall Study|Lost to Follow-up|1|||
16414887|NCT01969721|40001455|FG003|Overall Study|Non compliant with protocol|2|||
16414888|NCT01969721|40001452|FG000|Overall Study|Other not defined above|0|||
16414889|NCT01969721|40001453|FG001|Overall Study|Other not defined above|2|||
16414890|NCT01969721|40001454|FG002|Overall Study|Other not defined above|0|||
16414891|NCT01969721|40001455|FG003|Overall Study|Other not defined above|0|||
16414892|NCT01969721|40001452|FG000|Overall Study|Discontinued during washout periods.|0|||
16414893|NCT01969721|40001453|FG001|Overall Study|Discontinued during washout periods.|1|||
16414894|NCT01969721|40001454|FG002|Overall Study|Discontinued during washout periods.|1|||
16414895|NCT01969721|40001455|FG003|Overall Study|Discontinued during washout periods.|2|||
16414896|NCT01300260|40001456|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
16414897|NCT01300260|40001457|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
16414898|NCT01300260|40001456|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
16414899|NCT01300260|40001457|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
16414900|NCT01300260|40001456|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
16414901|NCT01300260|40001457|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
16414902|NCT00771615|40001458|FG000|Overall Study|Withdrawal by Subject|0|||
16414903|NCT00771615|40001459|FG001|Overall Study|Withdrawal by Subject|1|||
16414904|NCT00771615|40001460|FG002|Overall Study|Withdrawal by Subject|0|||
16414905|NCT00771615|40001461|FG003|Overall Study|Withdrawal by Subject|0|||
16414906|NCT00771615|40001462|FG004|Overall Study|Withdrawal by Subject|0|||
16242842|NCT02270983|39374802|FG001|Overall Study|Protocol Violation|1|||
16242843|NCT02270983|39374803|FG002|Overall Study|Protocol Violation|1|||
16242844|NCT02270983|39374801|FG000|Overall Study|family emergency|0|||
16242845|NCT02270983|39374802|FG001|Overall Study|family emergency|1|||
16242846|NCT02270983|39374803|FG002|Overall Study|family emergency|0|||
16242847|NCT02270983|39374801|FG000|Overall Study|study procedure non-compliance|1|||
16350964|NCT05117060|39772878|FG000|Overall Study|Lack of Efficacy|4|||
16350965|NCT05117060|39772879|FG001|Overall Study|Lack of Efficacy|5|||
16350966|NCT05117060|39772880|FG002|Overall Study|Lack of Efficacy|2|||
16350967|NCT05117060|39772881|FG003|Overall Study|Lack of Efficacy|6|||
16350968|NCT05117060|39772878|FG000|Overall Study|Withdrawal by Subject|8|||
16350969|NCT05117060|39772879|FG001|Overall Study|Withdrawal by Subject|5|||
16125664|NCT00532493|38946273|FG000|Overall Study|Adverse Event|6|||
16125665|NCT00532493|38946274|FG001|Overall Study|Adverse Event|5|||
16125666|NCT00532493|38946273|FG000|Overall Study|Protocol Deviation|1|||
16125667|NCT00532493|38946274|FG001|Overall Study|Protocol Deviation|0|||
16125668|NCT00532493|38946273|FG000|Overall Study|Subject Moved Away|3|||
16125669|NCT00532493|38946274|FG001|Overall Study|Subject Moved Away|1|||
16125670|NCT00532493|38946273|FG000|Overall Study|Contraindicative Medication|1|||
16414907|NCT00771615|40001463|FG005|Overall Study|Withdrawal by Subject|0|||
16414908|NCT00771615|40001464|FG006|Overall Study|Withdrawal by Subject|0|||
16414909|NCT00771615|40001465|FG007|Overall Study|Withdrawal by Subject|1|||
16414910|NCT00771615|40001466|FG008|Overall Study|Withdrawal by Subject|0|||
16414911|NCT00771615|40001458|FG000|Overall Study|Lost to Follow-up|1|||
16414912|NCT00771615|40001459|FG001|Overall Study|Lost to Follow-up|1|||
16125671|NCT00532493|38946274|FG001|Overall Study|Contraindicative Medication|0|||
16125672|NCT01901341|38946278|FG000|Overall Study|Adverse Event|4|||
16125673|NCT01901341|38946279|FG001|Overall Study|Adverse Event|2|||
16125674|NCT01901341|38946278|FG000|Overall Study|Lack of Efficacy|0|||
16125675|NCT01901341|38946279|FG001|Overall Study|Lack of Efficacy|2|||
16125676|NCT01901341|38946278|FG000|Overall Study|Lost to Follow-up|0|||
16414913|NCT00771615|40001460|FG002|Overall Study|Lost to Follow-up|1|||
16414914|NCT00771615|40001461|FG003|Overall Study|Lost to Follow-up|1|||
16414915|NCT00771615|40001462|FG004|Overall Study|Lost to Follow-up|0|||
16414916|NCT00771615|40001463|FG005|Overall Study|Lost to Follow-up|1|||
16414917|NCT00771615|40001464|FG006|Overall Study|Lost to Follow-up|1|||
16414918|NCT00771615|40001465|FG007|Overall Study|Lost to Follow-up|0|||
16414919|NCT00771615|40001466|FG008|Overall Study|Lost to Follow-up|0|||
16414920|NCT00946322|40001467|FG000|Pre-treatment|participant failure to follow up|1|||
16414921|NCT00946322|40001467|FG000|Post-treatment|participant failure to follow up|2|||
16414922|NCT00581360|40001468|FG000|Overall Study|Withdrawal by Subject|1|||
16125677|NCT01901341|38946279|FG001|Overall Study|Lost to Follow-up|1|||
16125678|NCT01901341|38946278|FG000|Overall Study|Protocol Violation|2|||
16125679|NCT01901341|38946279|FG001|Overall Study|Protocol Violation|0|||
16125680|NCT01901341|38946278|FG000|Overall Study|Study Terminated by Sponsor|13|||
16125681|NCT01901341|38946279|FG001|Overall Study|Study Terminated by Sponsor|15|||
16125682|NCT01901341|38946278|FG000|Overall Study|Withdrawal by Subject|1|||
16125683|NCT01901341|38946279|FG001|Overall Study|Withdrawal by Subject|1|||
16125684|NCT01239043|38946281|FG000|Overall Study|Protocol Violation|2|||
16125685|NCT01239043|38946282|FG001|Overall Study|Protocol Violation|1|||
16125686|NCT00589121|38946283|FG000|Overall Study|Protocol Violation|2|||
16125687|NCT00589121|38946284|FG001|Overall Study|Protocol Violation|6|||
16125688|NCT00589121|38946283|FG000|Overall Study|No protocol treatment received|0|||
16414923|NCT01030874|40001469|FG000|Overall Study|Withdrawal by Subject|1|||
16414924|NCT01030874|40001470|FG001|Overall Study|Withdrawal by Subject|0|||
16558224|NCT02886728|40509910|FG000|Overall Study|Withdrew Consent|31|||
16125689|NCT00589121|38946284|FG001|Overall Study|No protocol treatment received|1|||
16125690|NCT05180500|38949460|FG000|Overall Study|Adverse Event|1|||
16125691|NCT05180500|38949461|FG001|Overall Study|Adverse Event|0|||
16414925|NCT01030874|40001469|FG000|Overall Study|Discharged in first 2 weeks|17|||
16414926|NCT01030874|40001470|FG001|Overall Study|Discharged in first 2 weeks|16|||
16414927|NCT01985360|40001473|FG000|Overall Study|Withdrawal by Subject|4|||
16125692|NCT05180500|38949460|FG000|Overall Study|Withdrawal by Subject|2|||
16125693|NCT05180500|38949461|FG001|Overall Study|Withdrawal by Subject|0|||
16125694|NCT00151281|38949464|FG000|Overall Study|Not evaluable|3|||
16125695|NCT02641496|38949465|FG000|Overall Study|Lost to Follow-up|13|||
16125696|NCT02641496|38949466|FG001|Overall Study|Lost to Follow-up|12|||
16125697|NCT02641496|38949465|FG000|Overall Study|Withdrawal by Subject|1|||
16125698|NCT02641496|38949466|FG001|Overall Study|Withdrawal by Subject|0|||
16125699|NCT00923260|38949470|FG000|Overall Study|Lost to Follow-up|1|||
16125700|NCT00923260|38949471|FG001|Overall Study|Lost to Follow-up|1|||
16125701|NCT01156792|38949472|FG000|Overall Study|Adverse Event|1|||
16125702|NCT01156792|38949472|FG000|Overall Study|Lack of Efficacy|36|||
16125703|NCT01156792|38949472|FG000|Overall Study|Protocol Violation|6|||
16125704|NCT01156792|38949472|FG000|Overall Study|Lost to Follow-up|3|||
16125705|NCT01156792|38949472|FG000|Overall Study|Physician Decision|3|||
16125706|NCT01156792|38949472|FG000|Overall Study|Withdrawal by Subject|9|||
16125707|NCT01156792|38949472|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
16125708|NCT01076153|38949473|FG000|Overall Study|Symptoms improved/resolved|10|||
16125709|NCT01076153|38949473|FG000|Overall Study|Adverse Event|1|||
16125710|NCT05062759|38949474|FG000|Overall Study|Death|0|||
16125711|NCT05062759|38949475|FG001|Overall Study|Death|1|||
16125712|NCT05062759|38949474|FG000|Overall Study|Lost to Follow-up|1|||
16125713|NCT05062759|38949475|FG001|Overall Study|Lost to Follow-up|0|||
16125714|NCT00903006|38949476|FG000|Overall Study|Withdrawal by Subject|2|||
16125715|NCT00903006|38949477|FG001|Overall Study|Withdrawal by Subject|0|||
16125716|NCT00903006|38949478|FG002|Overall Study|Withdrawal by Subject|0|||
16125717|NCT00903006|38949479|FG003|Overall Study|Withdrawal by Subject|0|||
16125718|NCT00903006|38949476|FG000|Overall Study|Progressive Disease|0|||
16125719|NCT00903006|38949477|FG001|Overall Study|Progressive Disease|3|||
16125720|NCT00903006|38949478|FG002|Overall Study|Progressive Disease|1|||
16125721|NCT00903006|38949479|FG003|Overall Study|Progressive Disease|0|||
16125722|NCT02859324|38949480|FG000|Overall Study|Death|4|||
16242848|NCT02270983|39374802|FG001|Overall Study|study procedure non-compliance|0|||
16242849|NCT02270983|39374803|FG002|Overall Study|study procedure non-compliance|0|||
16125723|NCT02859324|38949481|FG001|Overall Study|Death|6|||
16125724|NCT02859324|38949482|FG002|Overall Study|Death|5|||
16125725|NCT02859324|38949480|FG000|Overall Study|Other reasons|3|||
16242850|NCT02270983|39374801|FG000|Overall Study|moved away from study site|0|||
16242851|NCT02270983|39374802|FG001|Overall Study|moved away from study site|1|||
16125726|NCT02859324|38949481|FG001|Overall Study|Other reasons|3|||
16125727|NCT02859324|38949482|FG002|Overall Study|Other reasons|0|||
16125728|NCT00436852|38949483|FG000|Overall Study|Death|23|||
16125729|NCT00436852|38949484|FG001|Overall Study|Death|34|||
16125730|NCT00436852|38949483|FG000|Overall Study|Lack of Efficacy|9|||
16125731|NCT00436852|38949484|FG001|Overall Study|Lack of Efficacy|7|||
16125732|NCT00436852|38949483|FG000|Overall Study|Withdrawal by Subject|2|||
16125733|NCT00436852|38949484|FG001|Overall Study|Withdrawal by Subject|4|||
16125734|NCT00436852|38949483|FG000|Overall Study|Ineligible|1|||
16125735|NCT00436852|38949484|FG001|Overall Study|Ineligible|0|||
16125736|NCT00888927|38949485|FG000|Overall Study|Adverse Event|0|||
16125737|NCT00888927|38949486|FG001|Overall Study|Adverse Event|0|||
16125738|NCT00888927|38949487|FG002|Overall Study|Adverse Event|0|||
16125739|NCT00888927|38949488|FG003|Overall Study|Adverse Event|1|||
16125740|NCT00888927|38949485|FG000|Overall Study|Withdrawal of consent|0|||
16125741|NCT00888927|38949486|FG001|Overall Study|Withdrawal of consent|0|||
16125742|NCT00888927|38949487|FG002|Overall Study|Withdrawal of consent|0|||
16125743|NCT00888927|38949488|FG003|Overall Study|Withdrawal of consent|1|||
16125744|NCT03756129|38949489|FG000|Overall Study|Adverse Event|1|||
16125745|NCT03756129|38949490|FG001|Overall Study|Adverse Event|1|||
16125746|NCT03756129|38949491|FG002|Overall Study|Adverse Event|0|||
16125747|NCT03756129|38949492|FG003|Overall Study|Adverse Event|2|||
16125748|NCT03756129|38949493|FG004|Overall Study|Adverse Event|0|||
16125749|NCT03756129|38949494|FG005|Overall Study|Adverse Event|0|||
16125750|NCT03756129|38949489|FG000|Overall Study|Withdrawal by Subject|2|||
16125751|NCT03756129|38949490|FG001|Overall Study|Withdrawal by Subject|1|||
16125752|NCT03756129|38949491|FG002|Overall Study|Withdrawal by Subject|3|||
16125753|NCT03756129|38949492|FG003|Overall Study|Withdrawal by Subject|1|||
16125754|NCT03756129|38949493|FG004|Overall Study|Withdrawal by Subject|1|||
16125755|NCT03756129|38949494|FG005|Overall Study|Withdrawal by Subject|3|||
16125756|NCT03756129|38949489|FG000|Overall Study|Lost to Follow-up|0|||
16125757|NCT03756129|38949490|FG001|Overall Study|Lost to Follow-up|0|||
16125758|NCT03756129|38949491|FG002|Overall Study|Lost to Follow-up|0|||
16125759|NCT03756129|38949492|FG003|Overall Study|Lost to Follow-up|0|||
16242852|NCT02270983|39374803|FG002|Overall Study|moved away from study site|0|||
16350970|NCT05117060|39772880|FG002|Overall Study|Withdrawal by Subject|5|||
16350971|NCT05117060|39772881|FG003|Overall Study|Withdrawal by Subject|6|||
16350972|NCT05117060|39772878|FG000|Overall Study|Other|2|||
16350973|NCT05117060|39772879|FG001|Overall Study|Other|1|||
16350974|NCT05117060|39772880|FG002|Overall Study|Other|3|||
16350975|NCT05117060|39772881|FG003|Overall Study|Other|1|||
16350976|NCT01657162|39772882|FG000|Overall Study|Adverse Event|26|||
16350977|NCT01657162|39772883|FG001|Overall Study|Adverse Event|36|||
16350978|NCT01657162|39772882|FG000|Overall Study|Withdrawal by Subject|13|||
16350979|NCT01657162|39772883|FG001|Overall Study|Withdrawal by Subject|13|||
16350980|NCT01657162|39772882|FG000|Overall Study|Continuing Significant Deterioration|9|||
16350981|NCT01657162|39772883|FG001|Overall Study|Continuing Significant Deterioration|3|||
16350982|NCT01657162|39772882|FG000|Overall Study|Refusal of Treatment|4|||
16350983|NCT01657162|39772883|FG001|Overall Study|Refusal of Treatment|6|||
16350984|NCT01657162|39772882|FG000|Overall Study|Lost to Follow-up|3|||
16350985|NCT01657162|39772883|FG001|Overall Study|Lost to Follow-up|4|||
16350986|NCT01657162|39772882|FG000|Overall Study|Death|2|||
16350987|NCT01657162|39772883|FG001|Overall Study|Death|3|||
16350988|NCT01657162|39772882|FG000|Overall Study|Inability to Complete Study Procedures|1|||
16350989|NCT01657162|39772883|FG001|Overall Study|Inability to Complete Study Procedures|7|||
16350990|NCT01657162|39772882|FG000|Overall Study|Protocol Violation|1|||
16350991|NCT01657162|39772883|FG001|Overall Study|Protocol Violation|0|||
16350992|NCT01657162|39772882|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
16350993|NCT01657162|39772883|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
16350994|NCT01657162|39772882|FG000|Overall Study|Other than Specified|0|||
16350995|NCT01657162|39772883|FG001|Overall Study|Other than Specified|2|||
16350996|NCT01251952|39772884|FG000|Overall Study|Adverse Event|1|||
16350997|NCT00751140|39772890|FG000|Overall Study|benign angioma excluded from analysis|1|||
16125760|NCT03756129|38949493|FG004|Overall Study|Lost to Follow-up|0|||
16125761|NCT03756129|38949494|FG005|Overall Study|Lost to Follow-up|1|||
16125762|NCT03756129|38949489|FG000|Overall Study|Physician Decision|0|||
16414928|NCT01985360|40001474|FG001|Overall Study|Withdrawal by Subject|0|||
16414929|NCT01985360|40001473|FG000|Overall Study|Lost to Follow-up|5|||
16414930|NCT01985360|40001474|FG001|Overall Study|Lost to Follow-up|3|||
16125763|NCT03756129|38949490|FG001|Overall Study|Physician Decision|0|||
16125764|NCT03756129|38949491|FG002|Overall Study|Physician Decision|0|||
16125765|NCT03756129|38949492|FG003|Overall Study|Physician Decision|0|||
16125766|NCT03756129|38949493|FG004|Overall Study|Physician Decision|0|||
16125767|NCT03756129|38949494|FG005|Overall Study|Physician Decision|1|||
16125768|NCT00297427|38949495|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
16125769|NCT00297427|38949496|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
16125770|NCT00297427|38949495|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
16125771|NCT00297427|38949496|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
16125772|NCT00297427|38949495|FG000|Phase 1: Initial Intervention|Death|0|||
16125773|NCT00297427|38949496|FG001|Phase 1: Initial Intervention|Death|1|||
16125774|NCT00297427|38949495|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
16125775|NCT00297427|38949496|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
16125776|NCT00297427|38949495|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
16125777|NCT00297427|38949496|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
16125778|NCT00297427|38949495|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
16125779|NCT00297427|38949496|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
16125780|NCT00297427|38949495|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
16125781|NCT00297427|38949496|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
16125782|NCT00297427|38949495|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
16125783|NCT00297427|38949496|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
16125784|NCT02366468|38949497|FG000|Overall Study|Adverse Event|2|||
16125785|NCT02366468|38949498|FG001|Overall Study|Adverse Event|0|||
16125786|NCT02366468|38949497|FG000|Overall Study|Withdrawal by Subject|1|||
16125787|NCT02366468|38949498|FG001|Overall Study|Withdrawal by Subject|5|||
16125788|NCT02366468|38949497|FG000|Overall Study|Lost to Follow-up|2|||
16125789|NCT02366468|38949498|FG001|Overall Study|Lost to Follow-up|0|||
16125790|NCT02366468|38949497|FG000|Overall Study|Death|1|||
16125791|NCT02366468|38949498|FG001|Overall Study|Death|2|||
16125792|NCT02366468|38949497|FG000|Overall Study|Other|0|||
16125793|NCT02366468|38949498|FG001|Overall Study|Other|2|||
16125794|NCT00836745|38949499|FG000|Overall Study|Death|2|||
16125795|NCT00836745|38949499|FG000|Overall Study|Lost to Follow-up|10|||
16125796|NCT00836745|38949499|FG000|Overall Study|Adverse Event|3|||
16125797|NCT00836745|38949499|FG000|Overall Study|Objective progression or relapse|4|||
16125798|NCT00836745|38949499|FG000|Overall Study|Other|2|||
16125799|NCT00116753|38949503|FG000|Overall Study|Adverse Event|16|||
16125800|NCT00116753|38949504|FG001|Overall Study|Adverse Event|10|||
16125801|NCT00116753|38949505|FG002|Overall Study|Adverse Event|7|||
16125802|NCT00116753|38949503|FG000|Overall Study|Withdrawal by Subject|11|||
16125803|NCT00116753|38949504|FG001|Overall Study|Withdrawal by Subject|12|||
16125804|NCT00116753|38949505|FG002|Overall Study|Withdrawal by Subject|8|||
16125805|NCT00116753|38949503|FG000|Overall Study|Lost to Follow-up|0|||
16125806|NCT00116753|38949504|FG001|Overall Study|Lost to Follow-up|2|||
16125807|NCT00116753|38949505|FG002|Overall Study|Lost to Follow-up|1|||
16125808|NCT00116753|38949503|FG000|Overall Study|Protocol Violation|0|||
16125809|NCT00116753|38949504|FG001|Overall Study|Protocol Violation|0|||
16125810|NCT00116753|38949505|FG002|Overall Study|Protocol Violation|1|||
16125811|NCT00116753|38949503|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
16125812|NCT00116753|38949504|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
16125813|NCT00116753|38949505|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
16125814|NCT00116753|38949503|FG000|Overall Study|Disease Progression|3|||
16125815|NCT00116753|38949504|FG001|Overall Study|Disease Progression|4|||
16125816|NCT00116753|38949505|FG002|Overall Study|Disease Progression|3|||
16125817|NCT00116753|38949503|FG000|Overall Study|Abnormal Echocardiogram|0|||
16125818|NCT00116753|38949504|FG001|Overall Study|Abnormal Echocardiogram|0|||
16125819|NCT00116753|38949505|FG002|Overall Study|Abnormal Echocardiogram|1|||
16125820|NCT00116753|38949503|FG000|Overall Study|Progressive Parkinson's Disease|1|||
16125821|NCT00116753|38949504|FG001|Overall Study|Progressive Parkinson's Disease|0|||
16125822|NCT00116753|38949505|FG002|Overall Study|Progressive Parkinson's Disease|0|||
16350998|NCT00737100|39772895|FG000|Overall Study|Adverse Event|6|||
16350999|NCT00737100|39772896|FG001|Overall Study|Adverse Event|5|||
16351000|NCT00737100|39772897|FG002|Overall Study|Adverse Event|3|||
16351001|NCT00737100|39772895|FG000|Overall Study|Lost to Follow-up|0|||
16351002|NCT00737100|39772896|FG001|Overall Study|Lost to Follow-up|1|||
16351003|NCT00737100|39772897|FG002|Overall Study|Lost to Follow-up|0|||
16351004|NCT00737100|39772895|FG000|Overall Study|Withdrawal by Subject|0|||
16351005|NCT00737100|39772896|FG001|Overall Study|Withdrawal by Subject|0|||
16125823|NCT00116753|38949503|FG000|Overall Study|Dosing Error|0|||
16125824|NCT00116753|38949504|FG001|Overall Study|Dosing Error|1|||
16125825|NCT00116753|38949505|FG002|Overall Study|Dosing Error|0|||
16125826|NCT04772898|38949506|FG000|Overall Study|Withdrawal by Subject|0|||
16351006|NCT00737100|39772897|FG002|Overall Study|Withdrawal by Subject|3|||
16351007|NCT00737100|39772895|FG000|Overall Study|Reason discontinued not explained above|1|||
16125827|NCT04772898|38949507|FG001|Overall Study|Withdrawal by Subject|1|||
16125828|NCT03682302|38949508|FG000|Overall Study|Lost to Follow-up|1|||
16125829|NCT03682302|38949509|FG001|Overall Study|Lost to Follow-up|2|||
16125830|NCT03682302|38949510|FG002|Overall Study|Lost to Follow-up|0|||
16125831|NCT03682302|38949511|FG003|Overall Study|Lost to Follow-up|1|||
16125832|NCT03682302|38949508|FG000|Overall Study|Study drug was not administered|0|||
16125833|NCT03682302|38949509|FG001|Overall Study|Study drug was not administered|0|||
16125834|NCT03682302|38949510|FG002|Overall Study|Study drug was not administered|1|||
16125835|NCT03682302|38949511|FG003|Overall Study|Study drug was not administered|1|||
16125836|NCT02663518|38949513|FG000|Part 1: Phase 1a Escalation|Death|0|||
16125837|NCT02663518|38949514|FG001|Part 1: Phase 1a Escalation|Death|0|||
16125838|NCT02663518|38949515|FG002|Part 1: Phase 1a Escalation|Death|1|||
16125839|NCT02663518|38949516|FG003|Part 1: Phase 1a Escalation|Death|0|||
16125840|NCT02663518|38949517|FG004|Part 1: Phase 1a Escalation|Death|0|||
16125841|NCT02663518|38949518|FG005|Part 1: Phase 1a Escalation|Death|0|||
16125842|NCT02663518|38949519|FG006|Part 1: Phase 1a Escalation|Death|0|||
16125843|NCT02663518|38949520|FG007|Part 1: Phase 1a Escalation|Death|0|||
16125844|NCT02663518|38949521|FG008|Part 1: Phase 1a Escalation|Death|0|||
16125845|NCT02663518|38949522|FG009|Part 1: Phase 1a Escalation|Death|0|||
16125846|NCT02663518|38949523|FG010|Part 1: Phase 1a Escalation|Death|0|||
16125847|NCT02663518|38949524|FG011|Part 1: Phase 1a Escalation|Death|0|||
16125848|NCT02663518|38949525|FG012|Part 1: Phase 1a Escalation|Death|0|||
16125849|NCT02663518|38949526|FG013|Part 1: Phase 1a Escalation|Death|0|||
16125850|NCT02663518|38949513|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125851|NCT02663518|38949514|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125852|NCT02663518|38949515|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
16125853|NCT02663518|38949516|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125854|NCT02663518|38949517|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125855|NCT02663518|38949518|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125856|NCT02663518|38949519|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16351008|NCT00737100|39772896|FG001|Overall Study|Reason discontinued not explained above|1|||
16351009|NCT00737100|39772897|FG002|Overall Study|Reason discontinued not explained above|1|||
16351010|NCT02667301|39772898|FG000|Overall Study|Adverse Event|1|||
16351011|NCT02667301|39772898|FG000|Overall Study|Lack of Efficacy|1|||
16351012|NCT01348139|39772899|FG000|Period 1|Adverse Event|1|||
16414931|NCT03602885|40001476|FG000|Overall Study|Lost to Follow-up|3|||
16125857|NCT02663518|38949520|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125858|NCT02663518|38949521|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125859|NCT02663518|38949522|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125860|NCT02663518|38949523|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125861|NCT02663518|38949524|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125862|NCT02663518|38949525|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125863|NCT02663518|38949526|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
16125864|NCT02663518|38949513|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
16125865|NCT02663518|38949514|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
16125866|NCT02663518|38949515|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
16125867|NCT02663518|38949516|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
16125868|NCT02663518|38949517|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
16125869|NCT02663518|38949518|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
16125870|NCT02663518|38949519|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
16125871|NCT02663518|38949520|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
16125872|NCT02663518|38949521|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
16125873|NCT02663518|38949522|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
16125874|NCT02663518|38949523|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
16125875|NCT02663518|38949524|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
16125876|NCT02663518|38949525|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
16125877|NCT02663518|38949526|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
16125878|NCT02663518|38949513|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
16125879|NCT02663518|38949514|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16125880|NCT02663518|38949515|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
16125881|NCT02663518|38949516|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
16125882|NCT02663518|38949517|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16351013|NCT01348139|39772900|FG001|Period 1|Adverse Event|0|||
16351014|NCT01348139|39772901|FG002|Period 1|Adverse Event|0|||
16351015|NCT01348139|39772902|FG003|Period 1|Adverse Event|0|||
16125883|NCT02663518|38949518|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16125884|NCT02663518|38949519|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16125885|NCT02663518|38949520|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16125886|NCT02663518|38949521|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16125887|NCT02663518|38949522|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16125888|NCT02663518|38949523|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16125889|NCT02663518|38949524|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16125890|NCT02663518|38949525|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16351016|NCT01348139|39772903|FG004|Period 1|Adverse Event|0|||
16125891|NCT02663518|38949526|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
16125892|NCT02663518|38949513|FG000|Part 1: Phase 1a Escalation|Other|0|||
16125893|NCT02663518|38949514|FG001|Part 1: Phase 1a Escalation|Other|0|||
16125894|NCT02663518|38949515|FG002|Part 1: Phase 1a Escalation|Other|2|||
16125895|NCT02663518|38949516|FG003|Part 1: Phase 1a Escalation|Other|0|||
16125896|NCT02663518|38949517|FG004|Part 1: Phase 1a Escalation|Other|0|||
16125897|NCT02663518|38949518|FG005|Part 1: Phase 1a Escalation|Other|0|||
16125898|NCT02663518|38949519|FG006|Part 1: Phase 1a Escalation|Other|0|||
16125899|NCT02663518|38949520|FG007|Part 1: Phase 1a Escalation|Other|0|||
16125900|NCT02663518|38949521|FG008|Part 1: Phase 1a Escalation|Other|0|||
16125901|NCT02663518|38949522|FG009|Part 1: Phase 1a Escalation|Other|0|||
16125902|NCT02663518|38949523|FG010|Part 1: Phase 1a Escalation|Other|0|||
16125903|NCT02663518|38949524|FG011|Part 1: Phase 1a Escalation|Other|0|||
16125904|NCT02663518|38949525|FG012|Part 1: Phase 1a Escalation|Other|0|||
16125905|NCT02663518|38949526|FG013|Part 1: Phase 1a Escalation|Other|0|||
16125906|NCT02663518|38949513|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125907|NCT02663518|38949514|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125908|NCT02663518|38949515|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125909|NCT02663518|38949516|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125910|NCT02663518|38949517|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
16125911|NCT02663518|38949518|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125912|NCT02663518|38949519|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
16125913|NCT02663518|38949520|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
16125914|NCT02663518|38949521|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125915|NCT02663518|38949522|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125916|NCT02663518|38949523|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125917|NCT02663518|38949524|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125918|NCT02663518|38949525|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125919|NCT02663518|38949526|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
16125920|NCT02663518|38949513|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125921|NCT02663518|38949514|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125922|NCT02663518|38949515|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125923|NCT02663518|38949516|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125924|NCT02663518|38949517|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
16125925|NCT02663518|38949518|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125926|NCT02663518|38949519|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
16125927|NCT02663518|38949520|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
16125928|NCT02663518|38949521|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125929|NCT02663518|38949522|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125930|NCT02663518|38949523|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125931|NCT02663518|38949524|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125932|NCT02663518|38949525|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125933|NCT02663518|38949526|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
16125934|NCT02663518|38949513|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125935|NCT02663518|38949514|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125936|NCT02663518|38949515|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125937|NCT02663518|38949516|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125938|NCT02663518|38949517|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
16125939|NCT02663518|38949518|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125940|NCT02663518|38949519|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125941|NCT02663518|38949520|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125942|NCT02663518|38949521|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125943|NCT02663518|38949522|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125944|NCT02663518|38949523|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125945|NCT02663518|38949524|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125946|NCT02663518|38949525|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125947|NCT02663518|38949526|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
16125948|NCT02663518|38949513|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
16125949|NCT02663518|38949514|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
16125950|NCT02663518|38949515|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
16242853|NCT00526890|39374804|FG000|Overall Study|Adverse Event|2|||
16125951|NCT02663518|38949516|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
16125952|NCT02663518|38949517|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
16125953|NCT02663518|38949518|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
16125954|NCT02663518|38949519|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
16125955|NCT02663518|38949520|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
16125956|NCT02663518|38949521|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
16125957|NCT02663518|38949522|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
16125958|NCT02663518|38949523|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
16242854|NCT00871169|39374805|FG000|Overall Study|Protocol Violation|1|||
16414932|NCT03602885|40001477|FG001|Overall Study|Lost to Follow-up|0|||
16414933|NCT00025155|40001478|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
16414934|NCT00025155|40001478|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
16414935|NCT00758589|40001480|FG000|Overall Study|Adverse Event|3|||
16414936|NCT00758589|40001481|FG001|Overall Study|Adverse Event|2|||
16414937|NCT00758589|40001482|FG002|Overall Study|Adverse Event|5|||
16414938|NCT00758589|40001483|FG003|Overall Study|Adverse Event|4|||
16125959|NCT02663518|38949524|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
16125960|NCT02663518|38949525|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
16125961|NCT02663518|38949526|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
16125962|NCT02663518|38949513|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125963|NCT02663518|38949514|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125964|NCT02663518|38949515|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125965|NCT02663518|38949516|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125966|NCT02663518|38949517|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
16125967|NCT02663518|38949518|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125968|NCT02663518|38949519|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
16125969|NCT02663518|38949520|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125970|NCT02663518|38949521|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125971|NCT02663518|38949522|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125972|NCT02663518|38949523|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125973|NCT02663518|38949524|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125974|NCT02663518|38949525|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125975|NCT02663518|38949526|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
16125976|NCT02663518|38949513|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125977|NCT02663518|38949514|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125978|NCT02663518|38949515|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125979|NCT02663518|38949516|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125980|NCT02663518|38949517|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125981|NCT02663518|38949518|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125982|NCT02663518|38949519|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
16125983|NCT02663518|38949520|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125984|NCT02663518|38949521|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125985|NCT02663518|38949522|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16414939|NCT00758589|40001480|FG000|Overall Study|Withdrawal by Subject|0|||
16558225|NCT02886728|40509911|FG001|Overall Study|Withdrew Consent|13|||
16125986|NCT02663518|38949523|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125987|NCT02663518|38949524|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16351017|NCT01348139|39772904|FG005|Period 1|Adverse Event|0|||
16351018|NCT00471497|39772909|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
16414940|NCT00758589|40001481|FG001|Overall Study|Withdrawal by Subject|1|||
16414941|NCT00758589|40001482|FG002|Overall Study|Withdrawal by Subject|1|||
16414942|NCT00758589|40001483|FG003|Overall Study|Withdrawal by Subject|1|||
16414943|NCT00758589|40001480|FG000|Overall Study|Palm stopped to work|0|||
16414944|NCT00758589|40001481|FG001|Overall Study|Palm stopped to work|0|||
16414945|NCT00758589|40001482|FG002|Overall Study|Palm stopped to work|0|||
16414946|NCT00758589|40001483|FG003|Overall Study|Palm stopped to work|1|||
16414947|NCT01422824|40001484|FG000|Overall Study|Case record form not evaluated|1|||
16414948|NCT01422824|40001484|FG000|Overall Study|Lost to Follow-up|37|||
16414949|NCT02966015|40001485|FG000|Inclusion Visit|did not answer questionnaire|8|||
16351019|NCT00471497|39772910|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
16351020|NCT00471497|39772911|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
16351021|NCT00471497|39772909|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
16351022|NCT00471497|39772910|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
16351023|NCT00471497|39772911|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
16351024|NCT00471497|39772909|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
16351025|NCT00471497|39772910|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
16351026|NCT00471497|39772911|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
16351027|NCT00471497|39772909|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
16351028|NCT00471497|39772910|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
16351029|NCT00471497|39772911|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
16351030|NCT00471497|39772909|FG000|Core Treatment Phase|Lost to Follow-up|6|||
16414950|NCT02966015|40001486|FG001|Inclusion Visit|did not answer questionnaire|3|||
16414951|NCT01948063|40001493|FG000|Overall Study|Boston MCI halted research protocol|0|||
16414952|NCT01948063|40001494|FG001|Overall Study|Boston MCI halted research protocol|1|||
16414953|NCT01948063|40001493|FG000|Overall Study|Discovered an enrollment in other study|0|||
16414954|NCT01948063|40001494|FG001|Overall Study|Discovered an enrollment in other study|1|||
16414955|NCT01948063|40001493|FG000|Overall Study|Blood samples were accidentally thawed|1|||
16414956|NCT01948063|40001494|FG001|Overall Study|Blood samples were accidentally thawed|0|||
16414957|NCT02265796|40001500|FG000|Overall Study|Death|1|||
16414958|NCT02265796|40001501|FG001|Overall Study|Death|0|||
16414959|NCT02265796|40001500|FG000|Overall Study|started on excluded medication|1|||
16414960|NCT02265796|40001501|FG001|Overall Study|started on excluded medication|0|||
16414961|NCT02265796|40001500|FG000|Overall Study|Withdrawal by Subject|1|||
16414962|NCT02265796|40001501|FG001|Overall Study|Withdrawal by Subject|1|||
16351031|NCT00471497|39772910|FG001|Core Treatment Phase|Lost to Follow-up|6|||
16351032|NCT00471497|39772911|FG002|Core Treatment Phase|Lost to Follow-up|3|||
16351033|NCT00471497|39772909|FG000|Core Treatment Phase|Death|3|||
16351034|NCT00471497|39772910|FG001|Core Treatment Phase|Death|9|||
16351035|NCT00471497|39772911|FG002|Core Treatment Phase|Death|3|||
16351036|NCT00471497|39772909|FG000|Core Treatment Phase|Disease Progression|10|||
16351037|NCT00471497|39772910|FG001|Core Treatment Phase|Disease Progression|2|||
16351038|NCT00471497|39772911|FG002|Core Treatment Phase|Disease Progression|4|||
16351039|NCT00471497|39772909|FG000|Core Treatment Phase|Protocol Violation|6|||
16351040|NCT00471497|39772910|FG001|Core Treatment Phase|Protocol Violation|15|||
16351041|NCT00471497|39772911|FG002|Core Treatment Phase|Protocol Violation|11|||
16351042|NCT00471497|39772909|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
16351043|NCT00471497|39772910|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
16351044|NCT00471497|39772911|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
16351045|NCT00471497|39772909|FG000|Core Treatment Phase|Administrative problems|14|||
16351046|NCT00471497|39772910|FG001|Core Treatment Phase|Administrative problems|14|||
16351047|NCT00471497|39772911|FG002|Core Treatment Phase|Administrative problems|12|||
16351048|NCT00471497|39772909|FG000|Core Treatment Phase|Adverse Event|43|||
16414963|NCT03582813|40001504|FG000|Overall Study|Lost to Follow-up|18|||
16414964|NCT03582813|40001505|FG001|Overall Study|Lost to Follow-up|21|||
16414965|NCT03582813|40001504|FG000|Overall Study|Withdrawal by Subject|1|||
16414966|NCT03582813|40001505|FG001|Overall Study|Withdrawal by Subject|0|||
16351049|NCT00471497|39772910|FG001|Core Treatment Phase|Adverse Event|53|||
16414967|NCT02271945|40001506|FG000|Overall Study|Death|3|||
16242855|NCT00871169|39374805|FG000|Overall Study|Patient did not receive study treatment|2|||
16242856|NCT03760510|39374806|FG000|Overall Study|Not ventilated for 24 hours|105|||
16242857|NCT03760510|39374807|FG001|Overall Study|Not ventilated for 24 hours|97|||
16242858|NCT02280356|39374810|FG000|Overall Study|Not Treated|2|||
16242859|NCT02280356|39374810|FG000|Overall Study|Withdrawal by Subject|1|||
16242860|NCT02280356|39374810|FG000|Overall Study|Not evaluable|2|||
16242861|NCT01427803|39374819|FG000|Overall Study|Lost to Follow-up|32|||
16242862|NCT01427803|39374820|FG001|Overall Study|Lost to Follow-up|26|||
16242863|NCT01427803|39374819|FG000|Overall Study|Withdrawal by Subject|20|||
16242864|NCT01427803|39374820|FG001|Overall Study|Withdrawal by Subject|0|||
16242865|NCT01427803|39374819|FG000|Overall Study|Unable to complete full treatment period|6|||
16242866|NCT01427803|39374820|FG001|Overall Study|Unable to complete full treatment period|0|||
16242867|NCT01427803|39374819|FG000|Overall Study|Protocol Violation|1|||
16242868|NCT01427803|39374820|FG001|Overall Study|Protocol Violation|0|||
16242869|NCT01427803|39374819|FG000|Overall Study|Physician Decision|3|||
16242870|NCT01427803|39374820|FG001|Overall Study|Physician Decision|0|||
16242871|NCT01427803|39374819|FG000|Overall Study|did not take product|1|||
16242872|NCT01427803|39374820|FG001|Overall Study|did not take product|0|||
16242873|NCT03101293|39374824|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
16242874|NCT03101293|39374825|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
16242875|NCT01440595|39374826|FG000|Overall Study|Lost to Follow-up|0|||
16242876|NCT01440595|39374827|FG001|Overall Study|Lost to Follow-up|1|||
16242877|NCT01440595|39374828|FG002|Overall Study|Lost to Follow-up|0|||
16242878|NCT01440595|39374826|FG000|Overall Study|Study terminated by sponsor.|1|||
16242879|NCT01440595|39374827|FG001|Overall Study|Study terminated by sponsor.|2|||
16242880|NCT01440595|39374828|FG002|Overall Study|Study terminated by sponsor.|1|||
16242881|NCT01716754|39374829|FG000|Overall Study|Death|0|||
16242882|NCT01716754|39374830|FG001|Overall Study|Death|0|||
16242883|NCT01716754|39374831|FG002|Overall Study|Death|0|||
16242884|NCT01716754|39374832|FG003|Overall Study|Death|1|||
16242885|NCT01716754|39374829|FG000|Overall Study|Protocol deviation|0|||
16242886|NCT01716754|39374830|FG001|Overall Study|Protocol deviation|2|||
16242887|NCT01716754|39374831|FG002|Overall Study|Protocol deviation|7|||
16242888|NCT01716754|39374832|FG003|Overall Study|Protocol deviation|2|||
16242889|NCT01716754|39374829|FG000|Overall Study|Non-compliance with study treatment|0|||
16242890|NCT01716754|39374830|FG001|Overall Study|Non-compliance with study treatment|0|||
16242891|NCT01716754|39374831|FG002|Overall Study|Non-compliance with study treatment|1|||
16242892|NCT01716754|39374832|FG003|Overall Study|Non-compliance with study treatment|0|||
16242893|NCT01716754|39374829|FG000|Overall Study|Physician Decision|1|||
16242894|NCT01716754|39374830|FG001|Overall Study|Physician Decision|0|||
16242895|NCT01716754|39374831|FG002|Overall Study|Physician Decision|0|||
16242896|NCT01716754|39374832|FG003|Overall Study|Physician Decision|0|||
16242897|NCT01716754|39374829|FG000|Overall Study|Lost to Follow-up|1|||
16242898|NCT01716754|39374830|FG001|Overall Study|Lost to Follow-up|0|||
16242899|NCT01716754|39374831|FG002|Overall Study|Lost to Follow-up|0|||
16242900|NCT01716754|39374832|FG003|Overall Study|Lost to Follow-up|1|||
16242901|NCT01716754|39374829|FG000|Overall Study|Adverse Event|4|||
16242902|NCT01716754|39374830|FG001|Overall Study|Adverse Event|2|||
16242903|NCT01716754|39374831|FG002|Overall Study|Adverse Event|2|||
16242904|NCT01716754|39374832|FG003|Overall Study|Adverse Event|1|||
16242905|NCT01716754|39374829|FG000|Overall Study|Withdrawal by Subject|5|||
16242906|NCT01716754|39374830|FG001|Overall Study|Withdrawal by Subject|0|||
16242907|NCT01716754|39374831|FG002|Overall Study|Withdrawal by Subject|4|||
16242908|NCT01716754|39374832|FG003|Overall Study|Withdrawal by Subject|3|||
16242909|NCT03124381|39374833|FG000|Overall Study|Lost to Follow-up|1|||
16242910|NCT03124381|39374834|FG001|Overall Study|Lost to Follow-up|1|||
16242911|NCT03124381|39374833|FG000|Overall Study|Withdrawal by Subject|6|||
16242912|NCT03124381|39374834|FG001|Overall Study|Withdrawal by Subject|3|||
16242913|NCT03124381|39374833|FG000|Overall Study|Protocol Violation|0|||
16242914|NCT03124381|39374834|FG001|Overall Study|Protocol Violation|1|||
16242915|NCT03124381|39374833|FG000|Overall Study|Adverse Event|1|||
16242916|NCT03124381|39374834|FG001|Overall Study|Adverse Event|1|||
16242917|NCT03124381|39374833|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
16242918|NCT03124381|39374834|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
16242919|NCT01306253|39374835|FG000|Overall Study|Lost to Follow-up|1|||
16242920|NCT01306253|39374836|FG001|Overall Study|Lost to Follow-up|1|||
16242921|NCT03085485|39374837|FG000|Overall Study|Death|1|||
16242922|NCT03085485|39374838|FG001|Overall Study|Death|0|||
16242923|NCT03085485|39374837|FG000|Overall Study|Lost to Follow-up|1|||
16242924|NCT03085485|39374838|FG001|Overall Study|Lost to Follow-up|0|||
16242925|NCT02253654|39374839|FG000|Overall Study|Withdrawal by Subject|12|||
16242926|NCT02253654|39374840|FG001|Overall Study|Withdrawal by Subject|4|||
16242927|NCT02253654|39374839|FG000|Overall Study|Decision by Sponsor|1|||
16242928|NCT02253654|39374840|FG001|Overall Study|Decision by Sponsor|1|||
16242929|NCT02253654|39374839|FG000|Overall Study|Lost to Follow-up|2|||
16242930|NCT02253654|39374840|FG001|Overall Study|Lost to Follow-up|5|||
16242931|NCT02253654|39374839|FG000|Overall Study|Death|4|||
16242932|NCT02253654|39374840|FG001|Overall Study|Death|7|||
16242933|NCT02253654|39374839|FG000|Overall Study|Did Not Receive Study Treatment|4|||
16242934|NCT02253654|39374840|FG001|Overall Study|Did Not Receive Study Treatment|1|||
16242935|NCT04313283|39374841|FG000|Overall Study|did not complete intervention|4|||
16242936|NCT03705169|39374842|FG000|Overall Study|Lost to Follow-up|0|||
16242937|NCT03705169|39374843|FG001|Overall Study|Lost to Follow-up|0|||
16242938|NCT03705169|39374844|FG002|Overall Study|Lost to Follow-up|0|||
16242939|NCT03705169|39374845|FG003|Overall Study|Lost to Follow-up|2|||
16242940|NCT03705169|39374846|FG004|Overall Study|Lost to Follow-up|0|||
16242941|NCT03705169|39374847|FG005|Overall Study|Lost to Follow-up|2|||
16242942|NCT03705169|39374848|FG006|Overall Study|Lost to Follow-up|1|||
16242943|NCT03705169|39374849|FG007|Overall Study|Lost to Follow-up|0|||
16242944|NCT03705169|39374850|FG008|Overall Study|Lost to Follow-up|0|||
16242945|NCT03705169|39374851|FG009|Overall Study|Lost to Follow-up|1|||
16242946|NCT03705169|39374842|FG000|Overall Study|Adverse Event|0|||
16242947|NCT03705169|39374843|FG001|Overall Study|Adverse Event|0|||
16242948|NCT03705169|39374844|FG002|Overall Study|Adverse Event|0|||
16242949|NCT03705169|39374845|FG003|Overall Study|Adverse Event|1|||
16242950|NCT03705169|39374846|FG004|Overall Study|Adverse Event|0|||
16242951|NCT03705169|39374847|FG005|Overall Study|Adverse Event|0|||
16242952|NCT03705169|39374848|FG006|Overall Study|Adverse Event|0|||
16242953|NCT03705169|39374849|FG007|Overall Study|Adverse Event|0|||
16242954|NCT03705169|39374850|FG008|Overall Study|Adverse Event|0|||
16242955|NCT03705169|39374851|FG009|Overall Study|Adverse Event|0|||
16242956|NCT03705169|39374842|FG000|Overall Study|Site Closure|0|||
16242957|NCT03705169|39374843|FG001|Overall Study|Site Closure|0|||
16242958|NCT03705169|39374844|FG002|Overall Study|Site Closure|0|||
16242959|NCT03705169|39374845|FG003|Overall Study|Site Closure|1|||
16242960|NCT03705169|39374846|FG004|Overall Study|Site Closure|0|||
16242961|NCT03705169|39374847|FG005|Overall Study|Site Closure|0|||
16242962|NCT03705169|39374848|FG006|Overall Study|Site Closure|0|||
16242963|NCT03705169|39374849|FG007|Overall Study|Site Closure|0|||
16242964|NCT03705169|39374850|FG008|Overall Study|Site Closure|0|||
16242965|NCT03705169|39374851|FG009|Overall Study|Site Closure|0|||
16242966|NCT03705169|39374842|FG000|Overall Study|Did not receive study treatment|0|||
16242967|NCT03705169|39374843|FG001|Overall Study|Did not receive study treatment|0|||
16242968|NCT03705169|39374844|FG002|Overall Study|Did not receive study treatment|0|||
16242969|NCT03705169|39374845|FG003|Overall Study|Did not receive study treatment|1|||
16242970|NCT03705169|39374846|FG004|Overall Study|Did not receive study treatment|0|||
16242971|NCT03705169|39374847|FG005|Overall Study|Did not receive study treatment|0|||
16242972|NCT03705169|39374848|FG006|Overall Study|Did not receive study treatment|0|||
16242973|NCT03705169|39374849|FG007|Overall Study|Did not receive study treatment|0|||
16242974|NCT03705169|39374850|FG008|Overall Study|Did not receive study treatment|0|||
16242975|NCT03705169|39374851|FG009|Overall Study|Did not receive study treatment|0|||
16242976|NCT03705169|39374842|FG000|Overall Study|Concerns about study visit compliance|0|||
16242977|NCT03705169|39374843|FG001|Overall Study|Concerns about study visit compliance|0|||
16242978|NCT03705169|39374844|FG002|Overall Study|Concerns about study visit compliance|0|||
16242979|NCT03705169|39374845|FG003|Overall Study|Concerns about study visit compliance|1|||
16242980|NCT03705169|39374846|FG004|Overall Study|Concerns about study visit compliance|0|||
16242981|NCT03705169|39374847|FG005|Overall Study|Concerns about study visit compliance|0|||
16242982|NCT03705169|39374848|FG006|Overall Study|Concerns about study visit compliance|0|||
16242983|NCT03705169|39374849|FG007|Overall Study|Concerns about study visit compliance|0|||
16242984|NCT03705169|39374850|FG008|Overall Study|Concerns about study visit compliance|0|||
16242985|NCT03705169|39374851|FG009|Overall Study|Concerns about study visit compliance|0|||
16414968|NCT02271945|40001507|FG001|Overall Study|Death|3|||
16242986|NCT02957682|39374854|FG000|Overall Study|Adverse Event|64|||
16242987|NCT02957682|39374855|FG001|Overall Study|Adverse Event|67|||
16242988|NCT02957682|39374854|FG000|Overall Study|Poor Compliance to Protocol|30|||
16242989|NCT02957682|39374855|FG001|Overall Study|Poor Compliance to Protocol|26|||
16242990|NCT02957682|39374854|FG000|Overall Study|Physician Decision|4|||
16242991|NCT02957682|39374855|FG001|Overall Study|Physician Decision|4|||
16242992|NCT02957682|39374854|FG000|Overall Study|Study Terminated by Sponsor|4|||
16242993|NCT02957682|39374855|FG001|Overall Study|Study Terminated by Sponsor|3|||
16414969|NCT02271945|40001506|FG000|Overall Study|Withdrawal by Subject|1|||
16242994|NCT02957682|39374854|FG000|Overall Study|Subject Moved|10|||
16242995|NCT02957682|39374855|FG001|Overall Study|Subject Moved|16|||
16242996|NCT02957682|39374854|FG000|Overall Study|Withdrawal by Subject|64|||
16242997|NCT02957682|39374855|FG001|Overall Study|Withdrawal by Subject|33|||
16242998|NCT02957682|39374854|FG000|Overall Study|Related to IMP Administration|3|||
16242999|NCT02957682|39374855|FG001|Overall Study|Related to IMP Administration|6|||
16243000|NCT02957682|39374854|FG000|Overall Study|Non-disclosed|16|||
16243001|NCT02957682|39374855|FG001|Overall Study|Non-disclosed|12|||
16243002|NCT02957682|39374854|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
16243003|NCT02957682|39374855|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
16243004|NCT03705351|39374856|FG000|Overall Study|Study termination|3|||
16243005|NCT03705351|39374856|FG000|Overall Study|Death|1|||
16243006|NCT03705351|39374856|FG000|Overall Study|Lack of Efficacy|2|||
16243007|NCT03705351|39374856|FG000|Overall Study|Withdrawal by Subject|1|||
16351050|NCT00471497|39772911|FG002|Core Treatment Phase|Adverse Event|89|||
16351051|NCT00471497|39772909|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
16351052|NCT00471497|39772910|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
16351053|NCT00471497|39772911|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
16351054|NCT00471497|39772909|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
16351055|NCT00471497|39772910|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
16351056|NCT00471497|39772911|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
16351057|NCT00471497|39772909|FG000|Extension Phase|Adverse Event|9|||
16351058|NCT00471497|39772910|FG001|Extension Phase|Adverse Event|5|||
16351059|NCT00471497|39772911|FG002|Extension Phase|Adverse Event|1|||
16351060|NCT00471497|39772909|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
16351061|NCT00471497|39772910|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
16351062|NCT00471497|39772911|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
16351063|NCT00471497|39772909|FG000|Extension Phase|Withdrawal by Subject|3|||
16351064|NCT00471497|39772910|FG001|Extension Phase|Withdrawal by Subject|1|||
16351065|NCT00471497|39772911|FG002|Extension Phase|Withdrawal by Subject|0|||
16351066|NCT00471497|39772909|FG000|Extension Phase|Lost to Follow-up|2|||
16351067|NCT00471497|39772910|FG001|Extension Phase|Lost to Follow-up|0|||
16351068|NCT00471497|39772911|FG002|Extension Phase|Lost to Follow-up|0|||
16351069|NCT00471497|39772909|FG000|Extension Phase|Death|1|||
16351070|NCT00471497|39772910|FG001|Extension Phase|Death|0|||
16351071|NCT00471497|39772911|FG002|Extension Phase|Death|0|||
16351072|NCT00471497|39772909|FG000|Extension Phase|Disease progression|2|||
16351073|NCT00471497|39772910|FG001|Extension Phase|Disease progression|0|||
16414970|NCT02271945|40001507|FG001|Overall Study|Withdrawal by Subject|1|||
16414971|NCT02271945|40001506|FG000|Overall Study|Other|1|||
16414972|NCT02271945|40001507|FG001|Overall Study|Other|1|||
16414973|NCT02925741|40001508|FG000|Overall Study|Withdrawal by Subject|11|||
16414974|NCT02925741|40001509|FG001|Overall Study|Withdrawal by Subject|0|||
16414975|NCT00391391|40001510|FG000|Overall Study|Adverse Event|0|||
16414976|NCT00391391|40001511|FG001|Overall Study|Adverse Event|0|||
16414977|NCT00391391|40001512|FG002|Overall Study|Adverse Event|0|||
16414978|NCT00391391|40001513|FG003|Overall Study|Adverse Event|1|||
16414979|NCT00391391|40001510|FG000|Overall Study|Lost to Follow-up|1|||
16414980|NCT00391391|40001511|FG001|Overall Study|Lost to Follow-up|3|||
16414981|NCT00391391|40001512|FG002|Overall Study|Lost to Follow-up|7|||
16414982|NCT00391391|40001513|FG003|Overall Study|Lost to Follow-up|4|||
16414983|NCT00391391|40001510|FG000|Overall Study|Protocol Violation|2|||
16414984|NCT00391391|40001511|FG001|Overall Study|Protocol Violation|3|||
16414985|NCT00391391|40001512|FG002|Overall Study|Protocol Violation|6|||
16414986|NCT00391391|40001513|FG003|Overall Study|Protocol Violation|7|||
16414987|NCT00391391|40001510|FG000|Overall Study|Withdrawal by Subject|6|||
16558226|NCT02886728|40509912|FG002|Overall Study|Withdrew Consent|11|||
16243008|NCT03012815|39374864|FG000|Overall Study|Lost to Follow-up|1|||
16243009|NCT03012815|39374865|FG001|Overall Study|Lost to Follow-up|0|||
16243010|NCT03012815|39374864|FG000|Overall Study|Physician Decision|3|||
16243011|NCT03012815|39374865|FG001|Overall Study|Physician Decision|2|||
16243012|NCT03012815|39374864|FG000|Overall Study|Adverse Event|1|||
16243013|NCT03012815|39374865|FG001|Overall Study|Adverse Event|0|||
16243014|NCT02402933|39374866|FG000|Overall Study|Withdrawal by Subject|4|||
16243015|NCT02402933|39374866|FG000|Overall Study|Discontinued; Site Termination|10|||
16243016|NCT01677910|39374870|FG000|Double-Blind Treatment Period|Adverse Event|6|||
16243017|NCT01677910|39374871|FG001|Double-Blind Treatment Period|Adverse Event|2|||
16243018|NCT01677910|39374872|FG002|Double-Blind Treatment Period|Adverse Event|3|||
16243019|NCT01677910|39374873|FG003|Double-Blind Treatment Period|Adverse Event|0|||
16243020|NCT01677910|39374870|FG000|Double-Blind Treatment Period|Physician Decision|0|||
16243021|NCT01677910|39374871|FG001|Double-Blind Treatment Period|Physician Decision|0|||
16243022|NCT01677910|39374872|FG002|Double-Blind Treatment Period|Physician Decision|1|||
16243023|NCT01677910|39374873|FG003|Double-Blind Treatment Period|Physician Decision|0|||
16243024|NCT01677910|39374870|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
16243025|NCT01677910|39374871|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
16243026|NCT01677910|39374872|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
16243027|NCT01677910|39374873|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
16414988|NCT00391391|40001511|FG001|Overall Study|Withdrawal by Subject|4|||
16414989|NCT00391391|40001512|FG002|Overall Study|Withdrawal by Subject|10|||
16414990|NCT00391391|40001513|FG003|Overall Study|Withdrawal by Subject|7|||
16414991|NCT01753401|40001514|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
16414992|NCT01753401|40001515|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
16414993|NCT01753401|40001516|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
16414994|NCT01753401|40001517|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
16414995|NCT01753401|40001514|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
16414996|NCT01753401|40001515|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
16414997|NCT01753401|40001516|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
16414998|NCT01753401|40001517|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
16414999|NCT01753401|40001514|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
16415000|NCT01753401|40001515|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
16415001|NCT01753401|40001516|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
16415002|NCT01753401|40001517|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
16415003|NCT01753401|40001514|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
16415004|NCT01753401|40001515|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
16415005|NCT01753401|40001516|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
16415006|NCT01753401|40001517|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
16415007|NCT01753401|40001514|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
16415008|NCT01753401|40001515|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
16243028|NCT01677910|39374870|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
16415009|NCT01753401|40001516|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
16415010|NCT01753401|40001517|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
16415011|NCT01753401|40001514|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
16415012|NCT01753401|40001515|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
16415013|NCT01753401|40001516|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
16415014|NCT01753401|40001517|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
16415015|NCT01753401|40001514|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
16415016|NCT01753401|40001515|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
16415017|NCT01753401|40001516|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
16415018|NCT01753401|40001517|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
16415019|NCT03773107|40001520|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
16558227|NCT02886728|40509913|FG003|Overall Study|Withdrew Consent|47|||
16558228|NCT02886728|40509910|FG000|Overall Study|Lost to Follow-up|12|||
16558229|NCT02886728|40509911|FG001|Overall Study|Lost to Follow-up|6|||
16558230|NCT02886728|40509912|FG002|Overall Study|Lost to Follow-up|13|||
16558231|NCT02886728|40509913|FG003|Overall Study|Lost to Follow-up|12|||
16558232|NCT02886728|40509910|FG000|Overall Study|Adverse Event|13|||
16558233|NCT02886728|40509911|FG001|Overall Study|Adverse Event|5|||
16558234|NCT02886728|40509912|FG002|Overall Study|Adverse Event|5|||
16558235|NCT02886728|40509913|FG003|Overall Study|Adverse Event|11|||
16558236|NCT02886728|40509910|FG000|Overall Study|Investigator's Discretion|11|||
16558237|NCT02886728|40509911|FG001|Overall Study|Investigator's Discretion|7|||
16558238|NCT02886728|40509912|FG002|Overall Study|Investigator's Discretion|5|||
16243029|NCT01677910|39374871|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
16243030|NCT01677910|39374872|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
16243031|NCT01677910|39374873|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
16243032|NCT01677910|39374870|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
16243033|NCT01677910|39374871|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
16243034|NCT01677910|39374872|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
16243035|NCT01677910|39374873|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
16243036|NCT01677910|39374870|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
16243037|NCT01677910|39374871|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
16243038|NCT01677910|39374872|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
16243039|NCT01677910|39374873|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
16243040|NCT01677910|39374870|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
16243041|NCT01677910|39374871|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
16243042|NCT01677910|39374872|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
16243043|NCT01677910|39374873|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
16243044|NCT01677910|39374870|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
16243045|NCT01677910|39374871|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
16243046|NCT01677910|39374872|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
16243047|NCT01677910|39374873|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
16243048|NCT01677910|39374870|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
16243049|NCT01677910|39374871|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
16243050|NCT01677910|39374872|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
16243051|NCT01677910|39374873|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
16243052|NCT01677910|39374870|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
16243053|NCT01677910|39374871|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
16243054|NCT01677910|39374872|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
16243055|NCT01677910|39374873|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
16243056|NCT02971605|39374874|FG000|Overall Study|Withdrawal by Subject|1|||
16243057|NCT00948025|39374876|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
16243058|NCT00948025|39374877|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
16243059|NCT00948025|39374876|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
16243060|NCT00948025|39374877|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
16243061|NCT00948025|39374876|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
16243062|NCT00948025|39374877|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
16243063|NCT00871728|39374878|FG000|Overall Study|Adverse Event|1|||
16243064|NCT00871728|39374878|FG000|Overall Study|Protocol Violation|7|||
16243065|NCT00871728|39374878|FG000|Overall Study|Lost to Follow-up|2|||
16243066|NCT00871728|39374878|FG000|Overall Study|Failed to Visit Hospital|4|||
16243067|NCT00871728|39374878|FG000|Overall Study|Participant Non-compliance|1|||
16243068|NCT00871728|39374878|FG000|Overall Study|Withdrawal of Informed Consent|5|||
16243069|NCT02414854|39374879|FG000|Overall Study|Adverse Event|9|||
16243070|NCT02414854|39374880|FG001|Overall Study|Adverse Event|7|||
16243071|NCT02414854|39374881|FG002|Overall Study|Adverse Event|1|||
16243072|NCT02414854|39374882|FG003|Overall Study|Adverse Event|12|||
16243073|NCT02414854|39374879|FG000|Overall Study|Poor compliance to protocol|1|||
16243074|NCT02414854|39374880|FG001|Overall Study|Poor compliance to protocol|1|||
16243075|NCT02414854|39374881|FG002|Overall Study|Poor compliance to protocol|2|||
16243076|NCT02414854|39374882|FG003|Overall Study|Poor compliance to protocol|2|||
16243077|NCT02414854|39374879|FG000|Overall Study|Other than specified above|12|||
16243078|NCT02414854|39374880|FG001|Overall Study|Other than specified above|37|||
16243079|NCT02414854|39374881|FG002|Overall Study|Other than specified above|17|||
16243080|NCT02414854|39374882|FG003|Overall Study|Other than specified above|37|||
16243081|NCT02323295|39374885|FG000|Overall Study|Adverse Event|0|||
16243082|NCT02323295|39374886|FG001|Overall Study|Adverse Event|1|||
16243083|NCT02323295|39374885|FG000|Overall Study|Withdrawal by Subject|0|||
16243084|NCT02323295|39374886|FG001|Overall Study|Withdrawal by Subject|1|||
16243085|NCT02323295|39374885|FG000|Overall Study|Patient did not have surgery as planned.|0|||
16243086|NCT02323295|39374886|FG001|Overall Study|Patient did not have surgery as planned.|1|||
16243087|NCT03670537|39374889|FG000|Overall Study|Protocol Violation|1|||
16473134|NCT00098475|40210743|FG003|Step 1|Criteria to continue treatment not met|0|||
16558239|NCT02886728|40509913|FG003|Overall Study|Investigator's Discretion|11|||
16125988|NCT02663518|38949525|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125989|NCT02663518|38949526|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
16125990|NCT02663518|38949513|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
16125991|NCT02663518|38949514|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
16125992|NCT02663518|38949515|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
16125993|NCT02663518|38949516|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
16125994|NCT02663518|38949517|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
16125995|NCT02663518|38949518|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
16125996|NCT02663518|38949519|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
16125997|NCT02663518|38949520|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
16125998|NCT02663518|38949521|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
16125999|NCT02663518|38949522|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
16126000|NCT02663518|38949523|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
16126001|NCT02663518|38949524|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
16126002|NCT02663518|38949525|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
16126003|NCT02663518|38949526|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
16126004|NCT02663518|38949513|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126005|NCT02663518|38949514|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126006|NCT02663518|38949515|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126007|NCT02663518|38949516|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126008|NCT02663518|38949517|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126009|NCT02663518|38949518|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126010|NCT02663518|38949519|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16558240|NCT02886728|40509910|FG000|Overall Study|Death|3|||
16558241|NCT02886728|40509911|FG001|Overall Study|Death|1|||
16558242|NCT02886728|40509912|FG002|Overall Study|Death|0|||
16558243|NCT02886728|40509913|FG003|Overall Study|Death|0|||
16558244|NCT02886728|40509910|FG000|Overall Study|Protocol Violation|0|||
16558245|NCT02886728|40509911|FG001|Overall Study|Protocol Violation|0|||
16558246|NCT02886728|40509912|FG002|Overall Study|Protocol Violation|0|||
16558247|NCT02886728|40509913|FG003|Overall Study|Protocol Violation|4|||
16558248|NCT02886728|40509910|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16558249|NCT02886728|40509911|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16558250|NCT02886728|40509912|FG002|Overall Study|Non-Compliance with Study Drug|1|||
16558251|NCT02886728|40509913|FG003|Overall Study|Non-Compliance with Study Drug|0|||
16558252|NCT02886728|40509910|FG000|Overall Study|Pregnancy|0|||
16126011|NCT02663518|38949520|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126012|NCT02663518|38949521|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126013|NCT02663518|38949522|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126014|NCT02663518|38949523|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16243088|NCT01796860|39374890|FG000|Overall Study|Withdrawal by Subject|3|||
16243089|NCT04363736|39374891|FG000|Overall Study|Withdrawal by Subject|1|||
16243090|NCT04363736|39374892|FG001|Overall Study|Withdrawal by Subject|0|||
16243091|NCT04363736|39374891|FG000|Overall Study|Lost to Follow-up|10|||
16243092|NCT04363736|39374892|FG001|Overall Study|Lost to Follow-up|7|||
16243093|NCT04363736|39374891|FG000|Overall Study|Death|8|||
16243094|NCT04363736|39374892|FG001|Overall Study|Death|6|||
16558253|NCT02886728|40509911|FG001|Overall Study|Pregnancy|0|||
16558254|NCT02886728|40509912|FG002|Overall Study|Pregnancy|1|||
16558255|NCT02886728|40509913|FG003|Overall Study|Pregnancy|0|||
16558256|NCT02886728|40509910|FG000|Overall Study|Randomized but Not Dosed|1|||
16558257|NCT02886728|40509911|FG001|Overall Study|Randomized but Not Dosed|0|||
16558258|NCT02886728|40509912|FG002|Overall Study|Randomized but Not Dosed|0|||
16558259|NCT02886728|40509913|FG003|Overall Study|Randomized but Not Dosed|2|||
16558260|NCT00777803|40509917|FG000|Overall Study|Lost to Follow-up|12|||
16243095|NCT01446913|39374894|FG000|Overall Study|Significant illness|1|||
16243096|NCT01446913|39374895|FG001|Overall Study|Significant illness|1|||
16243097|NCT01446913|39374896|FG002|Overall Study|Significant illness|1|||
16243098|NCT01446913|39374894|FG000|Overall Study|Withdrawal by Subject|5|||
16243099|NCT01446913|39374895|FG001|Overall Study|Withdrawal by Subject|3|||
16243100|NCT01446913|39374896|FG002|Overall Study|Withdrawal by Subject|5|||
16243101|NCT01446913|39374894|FG000|Overall Study|Physician Decision|0|||
16243102|NCT01446913|39374895|FG001|Overall Study|Physician Decision|0|||
16351074|NCT00471497|39772911|FG002|Extension Phase|Disease progression|0|||
16351075|NCT00471497|39772909|FG000|Extension Phase|Protocol Violation|2|||
16558261|NCT00777803|40509918|FG001|Overall Study|Lost to Follow-up|5|||
16558262|NCT00777803|40509917|FG000|Overall Study|Adverse Event|1|||
16558263|NCT00777803|40509918|FG001|Overall Study|Adverse Event|0|||
16558264|NCT00777803|40509917|FG000|Overall Study|Non-compliance|2|||
16558265|NCT00777803|40509918|FG001|Overall Study|Non-compliance|2|||
16558266|NCT00680056|40509924|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
16558267|NCT00680056|40509925|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
16558268|NCT00680056|40509924|FG000|Second Intervention|Protocol Violation|3|||
16558269|NCT00680056|40509925|FG001|Second Intervention|Protocol Violation|1|||
16558270|NCT00577720|40509926|FG000|Overall Study|Adverse Event|2|||
16558271|NCT00577720|40509927|FG001|Overall Study|Adverse Event|1|||
16351076|NCT00471497|39772910|FG001|Extension Phase|Protocol Violation|2|||
16351077|NCT00471497|39772911|FG002|Extension Phase|Protocol Violation|0|||
16351078|NCT02723188|39772912|FG000|Overall Study|Withdrawal by Subject|1|||
16351079|NCT02723188|39772913|FG001|Overall Study|Withdrawal by Subject|0|||
16351080|NCT02723188|39772914|FG002|Overall Study|Withdrawal by Subject|0|||
16351081|NCT04794751|39772915|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
16351082|NCT04794751|39772916|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
16243103|NCT01446913|39374896|FG002|Overall Study|Physician Decision|2|||
16243104|NCT01446913|39374894|FG000|Overall Study|Lost to Follow-up|3|||
16351083|NCT04794751|39772915|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
16558272|NCT00577720|40509928|FG002|Overall Study|Adverse Event|0|||
16558273|NCT00577720|40509929|FG003|Overall Study|Adverse Event|4|||
16558274|NCT00577720|40509926|FG000|Overall Study|Lost to Follow-up|0|||
16558275|NCT00577720|40509927|FG001|Overall Study|Lost to Follow-up|0|||
16558276|NCT00577720|40509928|FG002|Overall Study|Lost to Follow-up|1|||
16351084|NCT04794751|39772916|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
16351085|NCT04794751|39772915|FG000|Period 1|Protocol Violation|0|||
16351086|NCT04794751|39772916|FG001|Period 1|Protocol Violation|2|||
16351087|NCT04794751|39772915|FG000|Period 1|Withdrawal by Subject|0|||
16351088|NCT04794751|39772916|FG001|Period 1|Withdrawal by Subject|1|||
16351089|NCT04794751|39772915|FG000|Period 2|Withdrawal by Subject|0|||
16558277|NCT00577720|40509929|FG003|Overall Study|Lost to Follow-up|0|||
16558278|NCT00577720|40509926|FG000|Overall Study|Protocol Violation|0|||
16558279|NCT00577720|40509927|FG001|Overall Study|Protocol Violation|0|||
16558280|NCT00577720|40509928|FG002|Overall Study|Protocol Violation|0|||
16558281|NCT00577720|40509929|FG003|Overall Study|Protocol Violation|1|||
16558282|NCT00577720|40509926|FG000|Overall Study|Withdrawal by Subject|2|||
16558283|NCT00577720|40509927|FG001|Overall Study|Withdrawal by Subject|0|||
16558284|NCT00577720|40509928|FG002|Overall Study|Withdrawal by Subject|0|||
16558285|NCT00577720|40509929|FG003|Overall Study|Withdrawal by Subject|2|||
16351090|NCT04794751|39772916|FG001|Period 2|Withdrawal by Subject|1|||
16351091|NCT04794751|39772915|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
16351092|NCT04794751|39772916|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
16351093|NCT04794751|39772915|FG000|Period 2|Protocol Violation|1|||
16351094|NCT04794751|39772916|FG001|Period 2|Protocol Violation|0|||
16351095|NCT03489343|39772917|FG000|Overall Study|Documented progressive disease|1|||
16351096|NCT03489343|39772918|FG001|Overall Study|Documented progressive disease|0|||
16351097|NCT03489343|39772919|FG002|Overall Study|Documented progressive disease|3|||
16351098|NCT03489343|39772920|FG003|Overall Study|Documented progressive disease|1|||
16351099|NCT03489343|39772921|FG004|Overall Study|Documented progressive disease|3|||
16351100|NCT03489343|39772922|FG005|Overall Study|Documented progressive disease|5|||
16351101|NCT03489343|39772923|FG006|Overall Study|Documented progressive disease|4|||
16351102|NCT03489343|39772917|FG000|Overall Study|Adverse Event|0|||
16351103|NCT03489343|39772918|FG001|Overall Study|Adverse Event|1|||
16351104|NCT03489343|39772919|FG002|Overall Study|Adverse Event|0|||
16351105|NCT03489343|39772920|FG003|Overall Study|Adverse Event|0|||
16351106|NCT03489343|39772921|FG004|Overall Study|Adverse Event|0|||
16351107|NCT03489343|39772922|FG005|Overall Study|Adverse Event|1|||
16351108|NCT03489343|39772923|FG006|Overall Study|Adverse Event|0|||
16351109|NCT03489343|39772917|FG000|Overall Study|Withdrawal by Subject|0|||
16351110|NCT03489343|39772918|FG001|Overall Study|Withdrawal by Subject|0|||
16351111|NCT03489343|39772919|FG002|Overall Study|Withdrawal by Subject|0|||
16351112|NCT03489343|39772920|FG003|Overall Study|Withdrawal by Subject|1|||
16351113|NCT03489343|39772921|FG004|Overall Study|Withdrawal by Subject|0|||
16351114|NCT03489343|39772922|FG005|Overall Study|Withdrawal by Subject|1|||
16351115|NCT03489343|39772923|FG006|Overall Study|Withdrawal by Subject|1|||
16351116|NCT03489343|39772917|FG000|Overall Study|Clinical progression|0|||
16351117|NCT03489343|39772918|FG001|Overall Study|Clinical progression|0|||
16351118|NCT03489343|39772919|FG002|Overall Study|Clinical progression|0|||
16351119|NCT03489343|39772920|FG003|Overall Study|Clinical progression|1|||
16351120|NCT03489343|39772921|FG004|Overall Study|Clinical progression|0|||
16351121|NCT03489343|39772922|FG005|Overall Study|Clinical progression|0|||
16351122|NCT03489343|39772923|FG006|Overall Study|Clinical progression|1|||
16351123|NCT01095835|39772924|FG000|Overall Study|Adverse Event|8|||
16351124|NCT01095835|39772925|FG001|Overall Study|Adverse Event|6|||
16351125|NCT01095835|39772926|FG002|Overall Study|Adverse Event|6|||
16351126|NCT01095835|39772924|FG000|Overall Study|Lack of Efficacy|0|||
16351127|NCT01095835|39772925|FG001|Overall Study|Lack of Efficacy|1|||
16351128|NCT01095835|39772926|FG002|Overall Study|Lack of Efficacy|0|||
16351129|NCT01095835|39772924|FG000|Overall Study|Physician Decision|0|||
16351130|NCT01095835|39772925|FG001|Overall Study|Physician Decision|0|||
16351131|NCT01095835|39772926|FG002|Overall Study|Physician Decision|1|||
16351132|NCT01095835|39772924|FG000|Overall Study|Withdrawal by Subject|1|||
16351133|NCT01095835|39772925|FG001|Overall Study|Withdrawal by Subject|3|||
16351134|NCT01095835|39772926|FG002|Overall Study|Withdrawal by Subject|0|||
16351135|NCT01095835|39772924|FG000|Overall Study|Non study compliance|0|||
16351136|NCT01095835|39772925|FG001|Overall Study|Non study compliance|0|||
16351137|NCT01095835|39772926|FG002|Overall Study|Non study compliance|1|||
16558286|NCT01012973|40509930|FG000|Overall Study|Adverse Event|5|||
16351138|NCT01095835|39772924|FG000|Overall Study|Protocol Violation|1|||
16351139|NCT01095835|39772925|FG001|Overall Study|Protocol Violation|2|||
16351140|NCT01095835|39772926|FG002|Overall Study|Protocol Violation|0|||
16351141|NCT00496769|39772927|FG000|Double Blind|>=1 reason assigned per patient|558|||
16351142|NCT00496769|39772928|FG001|Double Blind|>=1 reason assigned per patient|649|||
16351143|NCT00496769|39772929|FG002|Double Blind|>=1 reason assigned per patient|0|||
16351144|NCT00496769|39772927|FG000|Open Label|>=1 reason assigned per patient|0|||
16351145|NCT00496769|39772928|FG001|Open Label|>=1 reason assigned per patient|0|||
16351146|NCT00496769|39772929|FG002|Open Label|>=1 reason assigned per patient|1011|||
16351147|NCT01198002|39772930|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
16558287|NCT01012973|40509931|FG001|Overall Study|Adverse Event|5|||
16351148|NCT01198002|39772931|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
16351149|NCT01198002|39772932|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
16351150|NCT01198002|39772930|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
16351151|NCT01198002|39772931|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
16351152|NCT01198002|39772932|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
16351153|NCT01198002|39772930|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
16351154|NCT01198002|39772931|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
16351155|NCT01198002|39772932|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
16351156|NCT01198002|39772930|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
16351157|NCT01198002|39772931|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
16351158|NCT01198002|39772932|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
16351159|NCT01198002|39772930|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
16351160|NCT01198002|39772931|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
16351161|NCT01198002|39772932|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
16351162|NCT01198002|39772930|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
16351163|NCT01198002|39772931|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
16351164|NCT01198002|39772932|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
16351165|NCT01198002|39772930|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
16351166|NCT01198002|39772931|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
16351167|NCT01198002|39772932|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
16351168|NCT01198002|39772930|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
16351169|NCT01198002|39772931|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
16351170|NCT01198002|39772932|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
16351171|NCT01198002|39772930|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
16351172|NCT01198002|39772931|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
16351173|NCT01198002|39772932|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
16351174|NCT01198002|39772930|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
16351175|NCT01198002|39772931|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
16351176|NCT01198002|39772932|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
16351177|NCT01198002|39772930|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
16351178|NCT01198002|39772931|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
16351179|NCT01198002|39772932|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
16351180|NCT01198002|39772930|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
16351181|NCT01198002|39772931|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
16351182|NCT01198002|39772932|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
16351183|NCT01198002|39772930|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
16351184|NCT01198002|39772931|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
16351185|NCT01198002|39772932|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
16351186|NCT01198002|39772930|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
16351187|NCT01198002|39772931|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
16351188|NCT01198002|39772932|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
16351189|NCT01198002|39772930|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
16351190|NCT01198002|39772931|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
16351191|NCT01198002|39772932|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
16415020|NCT03773107|40001521|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
16351192|NCT00161213|39772935|FG000|Overall Study|Withdrawal by Subject|1|||
16415021|NCT03773107|40001522|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
16415022|NCT03773107|40001523|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
16415023|NCT02690649|40001525|FG000|Overall Study|Withdrawal by Subject|1|||
16415024|NCT02690649|40001526|FG001|Overall Study|Withdrawal by Subject|1|||
16415025|NCT02690649|40001525|FG000|Overall Study|Protocol Violation|0|||
16415026|NCT02690649|40001526|FG001|Overall Study|Protocol Violation|3|||
16415027|NCT01176565|40001529|FG000|Overall Study|Lost to Follow-up|12|||
16415028|NCT01176565|40001530|FG001|Overall Study|Lost to Follow-up|16|||
16415029|NCT01176565|40001529|FG000|Overall Study|Withdrawal by Subject|7|||
16351193|NCT00161213|39772935|FG000|Overall Study|Evaluable for toxicity but not response|1|||
16415030|NCT01176565|40001530|FG001|Overall Study|Withdrawal by Subject|1|||
16415031|NCT01176565|40001529|FG000|Overall Study|Not Analyzed (any other reason)|1|||
16415032|NCT01176565|40001530|FG001|Overall Study|Not Analyzed (any other reason)|2|||
16415033|NCT00635089|40001539|FG000|Overall Study|Adverse Event|7|||
16415034|NCT00635089|40001539|FG000|Overall Study|Lack of Efficacy|28|||
16415035|NCT00635089|40001539|FG000|Overall Study|Protocol Deviation|4|||
16351194|NCT03205150|39772936|FG000|Overall Study|Protocol deviation|1|||
16126015|NCT02663518|38949524|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126016|NCT02663518|38949525|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
16126017|NCT02663518|38949526|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
16126018|NCT02663518|38949513|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126019|NCT02663518|38949514|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126020|NCT02663518|38949515|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126021|NCT02663518|38949516|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126022|NCT02663518|38949517|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126023|NCT02663518|38949518|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126024|NCT02663518|38949519|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126025|NCT02663518|38949520|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126026|NCT02663518|38949521|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126027|NCT02663518|38949522|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126028|NCT02663518|38949523|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126029|NCT02663518|38949524|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
16126030|NCT02663518|38949525|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126031|NCT02663518|38949526|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
16126032|NCT02663518|38949513|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
16126033|NCT02663518|38949514|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
16126034|NCT02663518|38949515|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
16126035|NCT02663518|38949516|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
16126036|NCT02663518|38949517|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
16126037|NCT02663518|38949518|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
16126038|NCT02663518|38949519|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
16126039|NCT02663518|38949520|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
16126040|NCT02663518|38949521|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
16126041|NCT02663518|38949522|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
16126042|NCT02663518|38949523|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
16126043|NCT02663518|38949524|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
16126044|NCT02663518|38949525|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
16126045|NCT02663518|38949526|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
16126046|NCT02663518|38949513|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
16126047|NCT02663518|38949514|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
16126048|NCT02663518|38949515|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
16126049|NCT02663518|38949516|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
16126050|NCT02663518|38949517|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
16126051|NCT02663518|38949518|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
16126052|NCT02663518|38949519|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
16126053|NCT02663518|38949520|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
16126054|NCT02663518|38949521|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
16126055|NCT02663518|38949522|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
16126056|NCT02663518|38949523|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
16126057|NCT02663518|38949524|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
16126058|NCT02663518|38949525|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
16126059|NCT02663518|38949526|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
16126060|NCT02663518|38949513|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126061|NCT02663518|38949514|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126062|NCT02663518|38949515|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126063|NCT02663518|38949516|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126064|NCT02663518|38949517|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126065|NCT02663518|38949518|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126066|NCT02663518|38949519|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16351195|NCT03205150|39772937|FG001|Overall Study|Protocol deviation|3|||
16126067|NCT02663518|38949520|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126068|NCT02663518|38949521|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126069|NCT02663518|38949522|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126070|NCT02663518|38949523|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126071|NCT02663518|38949524|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126072|NCT02663518|38949525|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
16126073|NCT02663518|38949526|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
16126074|NCT01769326|38949527|FG000|Overall Study|Lost to Follow-up|1|||
16126075|NCT01769326|38949528|FG001|Overall Study|Lost to Follow-up|2|||
16126076|NCT01769326|38949529|FG002|Overall Study|Lost to Follow-up|0|||
16126077|NCT01769326|38949530|FG003|Overall Study|Lost to Follow-up|0|||
16126078|NCT01769326|38949527|FG000|Overall Study|unrelated injry|1|||
16126079|NCT01769326|38949528|FG001|Overall Study|unrelated injry|1|||
16126080|NCT01769326|38949529|FG002|Overall Study|unrelated injry|0|||
16126081|NCT01769326|38949530|FG003|Overall Study|unrelated injry|0|||
16126082|NCT01769326|38949527|FG000|Overall Study|got a job|0|||
16126083|NCT01769326|38949528|FG001|Overall Study|got a job|1|||
16126084|NCT01769326|38949529|FG002|Overall Study|got a job|0|||
16126085|NCT01769326|38949530|FG003|Overall Study|got a job|0|||
16126086|NCT01769326|38949527|FG000|Overall Study|Got sick and could not complete study|0|||
16126087|NCT01769326|38949528|FG001|Overall Study|Got sick and could not complete study|0|||
16126088|NCT01769326|38949529|FG002|Overall Study|Got sick and could not complete study|1|||
16126089|NCT01769326|38949530|FG003|Overall Study|Got sick and could not complete study|0|||
16126090|NCT01879722|38949531|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16126091|NCT01879722|38949532|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
16126092|NCT01879722|38949533|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16126093|NCT01879722|38949534|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
16126094|NCT01879722|38949535|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
16126095|NCT01879722|38949536|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
16126096|NCT01879722|38949537|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
16126097|NCT01879722|38949538|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
16126098|NCT01879722|38949539|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
16126099|NCT01879722|38949540|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
16126100|NCT01879722|38949531|FG000|Overall Study|Voluntary Withdrawal|0|||
16126101|NCT01879722|38949532|FG001|Overall Study|Voluntary Withdrawal|0|||
16126102|NCT01879722|38949533|FG002|Overall Study|Voluntary Withdrawal|0|||
16558288|NCT01012973|40509930|FG000|Overall Study|Lack of Efficacy|0|||
16558289|NCT01012973|40509931|FG001|Overall Study|Lack of Efficacy|5|||
16558290|NCT01012973|40509930|FG000|Overall Study|Lost to Follow-up|1|||
16558291|NCT01012973|40509931|FG001|Overall Study|Lost to Follow-up|0|||
16558292|NCT01012973|40509930|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
16558293|NCT01012973|40509931|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
16558294|NCT01012973|40509930|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
16558295|NCT01012973|40509931|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
16558296|NCT01012973|40509930|FG000|Overall Study|Protocol Violation|5|||
16558297|NCT01012973|40509931|FG001|Overall Study|Protocol Violation|2|||
16558298|NCT01012973|40509930|FG000|Overall Study|Withdrawal by Subject|4|||
16558299|NCT01012973|40509931|FG001|Overall Study|Withdrawal by Subject|6|||
16558300|NCT01991197|40509933|FG000|Overall Study|Lost to Follow-up|1|||
16558301|NCT01991197|40509934|FG001|Overall Study|Lost to Follow-up|1|||
16558302|NCT01991197|40509933|FG000|Overall Study|Physician Decision|0|||
16558303|NCT01991197|40509934|FG001|Overall Study|Physician Decision|2|||
16558304|NCT01991197|40509933|FG000|Overall Study|Withdrawal by Subject|2|||
16558305|NCT01991197|40509934|FG001|Overall Study|Withdrawal by Subject|0|||
16558306|NCT00386308|40509935|FG000|Overall Study|Adverse Event|3|||
16558307|NCT00386308|40509936|FG001|Overall Study|Adverse Event|3|||
16558308|NCT00386308|40509935|FG000|Overall Study|Protocol Violation|2|||
16558309|NCT00386308|40509936|FG001|Overall Study|Protocol Violation|5|||
16558310|NCT00386308|40509935|FG000|Overall Study|Lack of Efficacy|0|||
16558311|NCT00386308|40509936|FG001|Overall Study|Lack of Efficacy|2|||
16126103|NCT01879722|38949534|FG003|Overall Study|Voluntary Withdrawal|0|||
16126104|NCT01879722|38949535|FG004|Overall Study|Voluntary Withdrawal|0|||
16126105|NCT01879722|38949536|FG005|Overall Study|Voluntary Withdrawal|0|||
16558312|NCT00386308|40509935|FG000|Overall Study|Lost to Follow-up|10|||
16558313|NCT00386308|40509936|FG001|Overall Study|Lost to Follow-up|6|||
16558314|NCT00386308|40509935|FG000|Overall Study|Withdrawal by Subject|6|||
16558315|NCT00386308|40509936|FG001|Overall Study|Withdrawal by Subject|2|||
16558316|NCT00386308|40509935|FG000|Overall Study|Other Event|8|||
16126106|NCT01879722|38949537|FG006|Overall Study|Voluntary Withdrawal|0|||
16126107|NCT01879722|38949538|FG007|Overall Study|Voluntary Withdrawal|0|||
16126108|NCT01879722|38949539|FG008|Overall Study|Voluntary Withdrawal|1|||
16126109|NCT01879722|38949540|FG009|Overall Study|Voluntary Withdrawal|0|||
16126110|NCT03020576|38949551|FG000|Overall Study|Withdrawal by Subject|1|||
16126111|NCT03020576|38949552|FG001|Overall Study|Withdrawal by Subject|2|||
16126112|NCT00994682|38949554|FG000|Double Bilnd|Withdrawal by Subject|5|||
16126113|NCT00994682|38949555|FG001|Double Bilnd|Withdrawal by Subject|6|||
16126114|NCT00994682|38949554|FG000|Double Bilnd|Lost to Follow-up|3|||
16126115|NCT00994682|38949555|FG001|Double Bilnd|Lost to Follow-up|3|||
16126116|NCT00994682|38949554|FG000|Double Bilnd|Adverse Event|1|||
16126117|NCT00994682|38949555|FG001|Double Bilnd|Adverse Event|0|||
16126118|NCT00994682|38949554|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
16126119|NCT00994682|38949555|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
16126120|NCT00994682|38949554|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
16126121|NCT00994682|38949555|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
16126122|NCT00994682|38949554|FG000|Pioglitazone Open Label|Physician Decision|6|||
16126123|NCT00994682|38949555|FG001|Pioglitazone Open Label|Physician Decision|1|||
16126124|NCT01679405|38949556|FG000|Overall Study|Death|2|||
16126125|NCT01679405|38949557|FG001|Overall Study|Death|5|||
16126126|NCT00287690|38949558|FG000|Overall Study|Protocol Violation|20|||
16126127|NCT00287690|38949559|FG001|Overall Study|Protocol Violation|26|||
16126128|NCT05033080|38949560|FG000|Overall Study|Adverse Event|4|||
16126129|NCT05033080|38949561|FG001|Overall Study|Adverse Event|4|||
16126130|NCT05033080|38949560|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
16126131|NCT05033080|38949561|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
16126132|NCT05033080|38949560|FG000|Overall Study|Lost to Follow-up|1|||
16126133|NCT05033080|38949561|FG001|Overall Study|Lost to Follow-up|0|||
16126134|NCT05033080|38949560|FG000|Overall Study|Other non-compliance|0|||
16126135|NCT05033080|38949561|FG001|Overall Study|Other non-compliance|1|||
16126136|NCT05033080|38949560|FG000|Overall Study|Physician Decision|0|||
16126137|NCT05033080|38949561|FG001|Overall Study|Physician Decision|1|||
16126138|NCT05033080|38949560|FG000|Overall Study|Other|1|||
16126139|NCT05033080|38949561|FG001|Overall Study|Other|1|||
16126140|NCT01470001|38949566|FG000|Overall Study|Lost to Follow-up|1|||
16126141|NCT01470001|38949567|FG001|Overall Study|Lost to Follow-up|1|||
16126142|NCT01470001|38949566|FG000|Overall Study|Physician Decision|2|||
16126143|NCT01470001|38949567|FG001|Overall Study|Physician Decision|0|||
16126144|NCT01470001|38949566|FG000|Overall Study|Withdrawal by Subject|2|||
16126145|NCT01470001|38949567|FG001|Overall Study|Withdrawal by Subject|1|||
16126146|NCT03694275|38949568|FG000|Overall Study|Adverse Event|0|||
16126147|NCT03694275|38949569|FG001|Overall Study|Adverse Event|1|||
16126148|NCT03694275|38949568|FG000|Overall Study|Reason not Specified|0|||
16126149|NCT03694275|38949569|FG001|Overall Study|Reason not Specified|1|||
16126150|NCT00626990|38949572|FG000|Overall Study|Lack of Efficacy|6|||
16126151|NCT00626990|38949573|FG001|Overall Study|Lack of Efficacy|7|||
16126152|NCT00626990|38949574|FG002|Overall Study|Lack of Efficacy|49|||
16126153|NCT00626990|38949575|FG003|Overall Study|Lack of Efficacy|40|||
16126154|NCT00626990|38949572|FG000|Overall Study|Adverse Event|1|||
16126155|NCT00626990|38949573|FG001|Overall Study|Adverse Event|7|||
16126156|NCT00626990|38949574|FG002|Overall Study|Adverse Event|14|||
16126157|NCT00626990|38949575|FG003|Overall Study|Adverse Event|28|||
16351196|NCT03205150|39772938|FG002|Overall Study|Protocol deviation|0|||
16351197|NCT03205150|39772936|FG000|Overall Study|Patient/guardian decision|0|||
16351198|NCT03205150|39772937|FG001|Overall Study|Patient/guardian decision|3|||
16415036|NCT00635089|40001539|FG000|Overall Study|Lost to Follow-up|8|||
16126158|NCT00626990|38949572|FG000|Overall Study|Death|0|||
16126159|NCT00626990|38949573|FG001|Overall Study|Death|1|||
16126160|NCT00626990|38949574|FG002|Overall Study|Death|0|||
16126161|NCT00626990|38949575|FG003|Overall Study|Death|0|||
16126162|NCT00626990|38949572|FG000|Overall Study|Withdrawal by Subject|3|||
16126163|NCT00626990|38949573|FG001|Overall Study|Withdrawal by Subject|1|||
16126164|NCT00626990|38949574|FG002|Overall Study|Withdrawal by Subject|5|||
16126165|NCT00626990|38949575|FG003|Overall Study|Withdrawal by Subject|11|||
16126166|NCT00626990|38949572|FG000|Overall Study|Protocol Violation|0|||
16126167|NCT00626990|38949573|FG001|Overall Study|Protocol Violation|1|||
16126168|NCT00626990|38949574|FG002|Overall Study|Protocol Violation|1|||
16126169|NCT00626990|38949575|FG003|Overall Study|Protocol Violation|0|||
16126170|NCT00626990|38949572|FG000|Overall Study|Various different reasons/missing|4|||
16126171|NCT00626990|38949573|FG001|Overall Study|Various different reasons/missing|8|||
16126172|NCT00626990|38949574|FG002|Overall Study|Various different reasons/missing|8|||
16351199|NCT03205150|39772938|FG002|Overall Study|Patient/guardian decision|0|||
16351200|NCT03205150|39772936|FG000|Overall Study|Adverse Event|1|||
16351201|NCT03205150|39772937|FG001|Overall Study|Adverse Event|1|||
16351202|NCT03205150|39772938|FG002|Overall Study|Adverse Event|1|||
16351203|NCT03205150|39772936|FG000|Overall Study|Lost to Follow-up|0|||
16351204|NCT03205150|39772937|FG001|Overall Study|Lost to Follow-up|0|||
16351205|NCT03205150|39772938|FG002|Overall Study|Lost to Follow-up|1|||
16351206|NCT02417753|39772939|FG000|Overall Study|Death|1|||
16351207|NCT01806168|39772940|FG000|Overall Study|Adverse Event|1|||
16351208|NCT01806168|39772941|FG001|Overall Study|Adverse Event|0|||
16351209|NCT01806168|39772942|FG002|Overall Study|Adverse Event|0|||
16415037|NCT00635089|40001539|FG000|Overall Study|Other|31|||
16415038|NCT04021524|40001540|FG000|Overall Study|Change in surgical intervention|0|||
16415039|NCT04021524|40001541|FG001|Overall Study|Change in surgical intervention|1|||
16415040|NCT01814670|40001544|FG000|Overall Study|Protocol Violation|12|||
16415041|NCT03344172|40001545|FG000|Overall Study|Received <1 dose of treatment|1|||
16415042|NCT03344172|40001546|FG001|Overall Study|Received <1 dose of treatment|0|||
16415043|NCT01554514|40001551|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
16415044|NCT01554514|40001551|FG000|Overall Study|Physician Decision|1|||
16415045|NCT02963701|40001552|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
16415046|NCT02963701|40001553|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
16415047|NCT01739803|40001554|FG000|Overall Study|Lost to Follow-up|9|||
16415048|NCT01739803|40001555|FG001|Overall Study|Lost to Follow-up|6|||
16415049|NCT02091284|40001556|FG000|Overall Study|Withdrawal by Subject|2|||
16415050|NCT02091284|40001557|FG001|Overall Study|Withdrawal by Subject|1|||
16415051|NCT02091284|40001556|FG000|Overall Study|unreliable data|1|||
16415052|NCT02091284|40001557|FG001|Overall Study|unreliable data|0|||
16415053|NCT00290498|40001562|FG000|Overall Study|Death|2|||
16415054|NCT00290498|40001563|FG001|Overall Study|Death|0|||
16415055|NCT00290498|40001562|FG000|Overall Study|Physician Decision|1|||
16415056|NCT00290498|40001563|FG001|Overall Study|Physician Decision|0|||
16415057|NCT00290498|40001562|FG000|Overall Study|Withdrawal by Subject|1|||
16415058|NCT00290498|40001563|FG001|Overall Study|Withdrawal by Subject|0|||
16415059|NCT00290498|40001562|FG000|Overall Study|Ineligible|3|||
16415060|NCT00290498|40001563|FG001|Overall Study|Ineligible|0|||
16415061|NCT00290498|40001562|FG000|Overall Study|Non-Compliance|1|||
16126173|NCT00626990|38949575|FG003|Overall Study|Various different reasons/missing|16|||
16126174|NCT02581631|38949576|FG000|Overall Study|Disease progression|29|||
16126175|NCT02581631|38949577|FG001|Overall Study|Disease progression|19|||
16126176|NCT02581631|38949578|FG002|Overall Study|Disease progression|13|||
16415062|NCT00290498|40001563|FG001|Overall Study|Non-Compliance|0|||
16126177|NCT02581631|38949579|FG003|Overall Study|Disease progression|5|||
16415063|NCT03847909|40001564|FG000|Overall Study|Withdrawal by Subject|1|||
16415064|NCT03847909|40001565|FG001|Overall Study|Withdrawal by Subject|1|||
16415065|NCT01177969|40001568|FG000|Overall Study|Protocol Violation|2|||
16351210|NCT01806168|39772940|FG000|Overall Study|Withdrawal by Subject|0|||
16415066|NCT01177969|40001569|FG001|Overall Study|Protocol Violation|1|||
16126178|NCT02581631|38949580|FG004|Overall Study|Disease progression|8|||
16351211|NCT01806168|39772941|FG001|Overall Study|Withdrawal by Subject|1|||
16126179|NCT02581631|38949576|FG000|Overall Study|Study drug toxicity|4|||
16126180|NCT02581631|38949577|FG001|Overall Study|Study drug toxicity|6|||
16126181|NCT02581631|38949578|FG002|Overall Study|Study drug toxicity|7|||
16126182|NCT02581631|38949579|FG003|Overall Study|Study drug toxicity|0|||
16126183|NCT02581631|38949580|FG004|Overall Study|Study drug toxicity|3|||
16126184|NCT02581631|38949576|FG000|Overall Study|AE unrelated to study drug|3|||
16126185|NCT02581631|38949577|FG001|Overall Study|AE unrelated to study drug|1|||
16126186|NCT02581631|38949578|FG002|Overall Study|AE unrelated to study drug|1|||
16126187|NCT02581631|38949579|FG003|Overall Study|AE unrelated to study drug|0|||
16126188|NCT02581631|38949580|FG004|Overall Study|AE unrelated to study drug|2|||
16126189|NCT02581631|38949576|FG000|Overall Study|Request to discontinue|1|||
16126190|NCT02581631|38949577|FG001|Overall Study|Request to discontinue|0|||
16126191|NCT02581631|38949578|FG002|Overall Study|Request to discontinue|3|||
16126192|NCT02581631|38949579|FG003|Overall Study|Request to discontinue|0|||
16126193|NCT02581631|38949580|FG004|Overall Study|Request to discontinue|1|||
16126194|NCT02581631|38949576|FG000|Overall Study|participant withdrew consent|3|||
16126195|NCT02581631|38949577|FG001|Overall Study|participant withdrew consent|0|||
16126196|NCT02581631|38949578|FG002|Overall Study|participant withdrew consent|1|||
16126197|NCT02581631|38949579|FG003|Overall Study|participant withdrew consent|0|||
16126198|NCT02581631|38949580|FG004|Overall Study|participant withdrew consent|0|||
16126199|NCT02581631|38949576|FG000|Overall Study|Maximum clinical benefit|1|||
16126200|NCT02581631|38949577|FG001|Overall Study|Maximum clinical benefit|7|||
16126201|NCT02581631|38949578|FG002|Overall Study|Maximum clinical benefit|1|||
16126202|NCT02581631|38949579|FG003|Overall Study|Maximum clinical benefit|3|||
16126203|NCT02581631|38949580|FG004|Overall Study|Maximum clinical benefit|13|||
16126204|NCT02581631|38949576|FG000|Overall Study|Other Reasons|1|||
16126205|NCT02581631|38949577|FG001|Overall Study|Other Reasons|0|||
16126206|NCT02581631|38949578|FG002|Overall Study|Other Reasons|2|||
16126207|NCT02581631|38949579|FG003|Overall Study|Other Reasons|2|||
16126208|NCT02581631|38949580|FG004|Overall Study|Other Reasons|3|||
16126209|NCT02581631|38949576|FG000|Overall Study|Poor/Non-Compliance|0|||
16126210|NCT02581631|38949577|FG001|Overall Study|Poor/Non-Compliance|0|||
16126211|NCT02581631|38949578|FG002|Overall Study|Poor/Non-Compliance|1|||
16126212|NCT02581631|38949579|FG003|Overall Study|Poor/Non-Compliance|0|||
16126213|NCT02581631|38949580|FG004|Overall Study|Poor/Non-Compliance|0|||
16126214|NCT01080716|38949581|FG000|Part 1|Physician Decision|1|||
16126215|NCT01080716|38949582|FG001|Part 1|Physician Decision|0|||
16126216|NCT01080716|38949583|FG002|Part 1|Physician Decision|0|||
16126217|NCT01080716|38949584|FG003|Part 1|Physician Decision|0|||
16126218|NCT03538301|38949589|FG000|Overall Study|Adverse Event|1|||
16126219|NCT03538301|38949590|FG001|Overall Study|Adverse Event|4|||
16126220|NCT03538301|38949591|FG002|Overall Study|Adverse Event|4|||
16126221|NCT03538301|38949589|FG000|Overall Study|Death|1|||
16126222|NCT03538301|38949590|FG001|Overall Study|Death|1|||
16126223|NCT03538301|38949591|FG002|Overall Study|Death|0|||
16126224|NCT03538301|38949589|FG000|Overall Study|Physician Decision|0|||
16126225|NCT03538301|38949590|FG001|Overall Study|Physician Decision|1|||
16126226|NCT03538301|38949591|FG002|Overall Study|Physician Decision|0|||
16126227|NCT03538301|38949589|FG000|Overall Study|Protocol Violation|0|||
16126228|NCT03538301|38949590|FG001|Overall Study|Protocol Violation|0|||
16126229|NCT03538301|38949591|FG002|Overall Study|Protocol Violation|1|||
16126230|NCT03538301|38949589|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
16126231|NCT03538301|38949590|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
16126232|NCT03538301|38949591|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
16126233|NCT04797650|38949592|FG000|Overall Study|Reason Not Specified|5|||
16126234|NCT04797650|38949593|FG001|Overall Study|Reason Not Specified|12|||
16126235|NCT04797650|38949594|FG002|Overall Study|Reason Not Specified|5|||
16243105|NCT01446913|39374895|FG001|Overall Study|Lost to Follow-up|5|||
16415067|NCT01177969|40001568|FG000|Overall Study|Withdrawal by Subject|1|||
16415068|NCT01177969|40001569|FG001|Overall Study|Withdrawal by Subject|2|||
16415069|NCT03927404|40001573|FG000|Overall Study|Withdrawal by Subject|1|||
16415070|NCT01283542|40001581|FG000|Main Phase|Acute or progressive vision loss|1|||
16415071|NCT01283542|40001581|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
16415072|NCT01283542|40001581|FG000|Main Phase|abnormal laboratory values|5|||
16415073|NCT01283542|40001581|FG000|Extension Phase|Physician Decision|1|||
16126236|NCT04797650|38949592|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
16126237|NCT04797650|38949593|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
16126238|NCT04797650|38949594|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
16126239|NCT04797650|38949592|FG000|Overall Study|Lack of Efficacy|1|||
16126240|NCT04797650|38949593|FG001|Overall Study|Lack of Efficacy|0|||
16126241|NCT04797650|38949594|FG002|Overall Study|Lack of Efficacy|1|||
16126242|NCT04797650|38949592|FG000|Overall Study|Non-compliance with Study Drug|0|||
16126243|NCT04797650|38949593|FG001|Overall Study|Non-compliance with Study Drug|0|||
16126244|NCT04797650|38949594|FG002|Overall Study|Non-compliance with Study Drug|2|||
16243106|NCT01446913|39374896|FG002|Overall Study|Lost to Follow-up|3|||
16415074|NCT01283542|40001581|FG000|Extension Phase|Adverse Event|1|||
16126245|NCT04797650|38949592|FG000|Overall Study|Lost to Follow-up|4|||
16126246|NCT04797650|38949593|FG001|Overall Study|Lost to Follow-up|6|||
16126247|NCT04797650|38949594|FG002|Overall Study|Lost to Follow-up|1|||
16126248|NCT03446781|38949595|FG000|Overall Study|Lost to Follow-up|11|||
16126249|NCT03446781|38949596|FG001|Overall Study|Lost to Follow-up|5|||
16126250|NCT03446781|38949595|FG000|Overall Study|Withdrawal by Subject|9|||
16126251|NCT03446781|38949596|FG001|Overall Study|Withdrawal by Subject|7|||
16126252|NCT03446781|38949595|FG000|Overall Study|Adverse Event|8|||
16351212|NCT01806168|39772942|FG002|Overall Study|Withdrawal by Subject|2|||
16351213|NCT01806168|39772940|FG000|Overall Study|Protocol Violation|0|||
16351214|NCT01806168|39772941|FG001|Overall Study|Protocol Violation|0|||
16351215|NCT01806168|39772942|FG002|Overall Study|Protocol Violation|1|||
16351216|NCT00305227|39772944|FG000|Overall Study|Lost to Follow-up|7|||
16126253|NCT03446781|38949596|FG001|Overall Study|Adverse Event|2|||
16351217|NCT00305227|39772945|FG001|Overall Study|Lost to Follow-up|6|||
16126254|NCT03446781|38949595|FG000|Overall Study|Protocol Violation|0|||
16126255|NCT03446781|38949596|FG001|Overall Study|Protocol Violation|3|||
16126256|NCT00371683|38949597|FG000|DB Treatment Period-Randomized Patients|Death|1|||
16126257|NCT00371683|38949598|FG001|DB Treatment Period-Randomized Patients|Death|1|||
16126258|NCT00371683|38949597|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
16126259|NCT00371683|38949598|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
16126260|NCT00371683|38949597|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
16126261|NCT00371683|38949598|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
16126262|NCT00371683|38949597|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
16126263|NCT00371683|38949598|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
16126264|NCT00371683|38949597|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
16126265|NCT00371683|38949598|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
16126266|NCT00371683|38949597|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
16126267|NCT00371683|38949598|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
16126268|NCT00371683|38949597|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
16126269|NCT00371683|38949598|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
16126270|NCT00371683|38949597|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
16126271|NCT00371683|38949598|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
16126272|NCT00371683|38949597|FG000|Follow-Up Period - Randomized Patients|Death|0|||
16126273|NCT00371683|38949598|FG001|Follow-Up Period - Randomized Patients|Death|2|||
16126274|NCT00371683|38949597|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
16126275|NCT00371683|38949598|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
16126276|NCT00371683|38949597|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
16126277|NCT00371683|38949598|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
16126278|NCT00201643|38949601|FG000|Overall Study|Withdrawal by Subject|5|||
16126279|NCT00201643|38949602|FG001|Overall Study|Withdrawal by Subject|4|||
16126280|NCT00734097|38949603|FG000|Screening|Protocol Violation|12|||
16126281|NCT00734097|38949603|FG000|Screening|Withdrawal by Subject|5|||
16126282|NCT00734097|38949603|FG000|Screening|Lost to Follow-up|2|||
16126283|NCT00734097|38949603|FG000|Screening|Unconfirmed pregnancy|1|||
16126284|NCT00734097|38949603|FG000|Open Label|Lost to Follow-up|7|||
16126285|NCT00734097|38949603|FG000|Open Label|Withdrawal by Subject|5|||
16126286|NCT00734097|38949603|FG000|Open Label|Protocol Violation|4|||
16126287|NCT01691768|38949604|FG000|Overall Study|Death|0|||
16126288|NCT01691768|38949605|FG001|Overall Study|Death|2|||
16126289|NCT01691768|38949604|FG000|Overall Study|Lost to Follow-up|4|||
16126290|NCT01691768|38949605|FG001|Overall Study|Lost to Follow-up|3|||
16126291|NCT01691768|38949604|FG000|Overall Study|Withdrawal by Subject|10|||
16126292|NCT01691768|38949605|FG001|Overall Study|Withdrawal by Subject|9|||
16126293|NCT01691768|38949604|FG000|Overall Study|Relocated|0|||
16126294|NCT01691768|38949605|FG001|Overall Study|Relocated|1|||
16126295|NCT01691768|38949604|FG000|Overall Study|Investigator decision|1|||
16126296|NCT01691768|38949605|FG001|Overall Study|Investigator decision|1|||
16126297|NCT01536015|38949606|FG000|Overall Study|Adverse Event|1|||
16126298|NCT01536015|38949607|FG001|Overall Study|Adverse Event|4|||
16126299|NCT01536015|38949606|FG000|Overall Study|Lost to Follow-up|0|||
16126300|NCT01536015|38949607|FG001|Overall Study|Lost to Follow-up|1|||
16126301|NCT01536015|38949606|FG000|Overall Study|Inclusion Criterion not met|2|||
16126302|NCT01536015|38949607|FG001|Overall Study|Inclusion Criterion not met|0|||
16126303|NCT01536015|38949606|FG000|Overall Study|Study closure|5|||
16126304|NCT01536015|38949607|FG001|Overall Study|Study closure|5|||
16126305|NCT00345293|38949609|FG000|Overall Study|Unable to access line for sample|1|||
16126306|NCT00345293|38949610|FG001|Overall Study|Unable to access line for sample|0|||
16126307|NCT00345293|38949609|FG000|Overall Study|Withdrawal by Subject|1|||
16126308|NCT00345293|38949610|FG001|Overall Study|Withdrawal by Subject|0|||
16126309|NCT00833833|38949611|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
16126310|NCT00833833|38949612|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
16126311|NCT00833833|38949613|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
16126312|NCT00833833|38949614|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
16126313|NCT00833833|38949615|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
16126314|NCT00833833|38949616|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
16126315|NCT00833833|38949611|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
16126316|NCT00833833|38949612|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
16126317|NCT00833833|38949613|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
16126318|NCT00833833|38949614|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
16243107|NCT00446654|39374897|FG000|Overall Study|Withdrawal by Subject|1|||
16351218|NCT01704755|39772946|FG000|Overall Study|Adverse Event|4|||
16126319|NCT00833833|38949615|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
16126320|NCT00833833|38949616|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
16126321|NCT00833833|38949611|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
16126322|NCT00833833|38949612|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
16126323|NCT00833833|38949613|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
16126324|NCT00833833|38949614|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
16415075|NCT01283542|40001581|FG000|Extension Phase|Administrative problems|1|||
16415076|NCT02644356|40001582|FG000|Overall Study|Withdrawal by Subject|2|||
16415077|NCT02365285|40001590|FG000|Overall Study|Physician Decision|0|||
16415078|NCT02365285|40001591|FG001|Overall Study|Physician Decision|1|||
16415079|NCT02365285|40001592|FG002|Overall Study|Physician Decision|1|||
16415080|NCT02365285|40001593|FG003|Overall Study|Physician Decision|0|||
16415081|NCT02365285|40001590|FG000|Overall Study|Adverse Event|0|||
16415082|NCT02365285|40001591|FG001|Overall Study|Adverse Event|0|||
16415083|NCT02365285|40001592|FG002|Overall Study|Adverse Event|0|||
16415084|NCT02365285|40001593|FG003|Overall Study|Adverse Event|2|||
16415085|NCT00820222|40001596|FG000|Overall Study|Lost to Follow-up|10|||
16415086|NCT00820222|40001597|FG001|Overall Study|Lost to Follow-up|9|||
16415087|NCT00820222|40001596|FG000|Overall Study|Withdrawal by Subject|19|||
16415088|NCT00820222|40001597|FG001|Overall Study|Withdrawal by Subject|21|||
16415089|NCT00820222|40001596|FG000|Overall Study|Physician Decision|93|||
16415090|NCT00820222|40001597|FG001|Overall Study|Physician Decision|88|||
16126325|NCT00833833|38949615|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
16126326|NCT00833833|38949616|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
16126327|NCT00833833|38949611|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
16126328|NCT00833833|38949612|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
16126329|NCT00833833|38949613|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
16126330|NCT00833833|38949614|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
16126331|NCT00833833|38949615|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
16126332|NCT00833833|38949616|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
16126333|NCT00833833|38949611|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
16126334|NCT00833833|38949612|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16126335|NCT00833833|38949613|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
16126336|NCT00833833|38949614|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16415091|NCT00820222|40001596|FG000|Overall Study|Sponsor Terminated Study|43|||
16415092|NCT00820222|40001597|FG001|Overall Study|Sponsor Terminated Study|65|||
16415093|NCT00820222|40001596|FG000|Overall Study|Unkown|11|||
16126337|NCT00833833|38949615|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16415094|NCT00820222|40001597|FG001|Overall Study|Unkown|7|||
16415095|NCT01276223|40001601|FG000|Overall Study|Adverse Event|7|||
16415096|NCT01276223|40001602|FG001|Overall Study|Adverse Event|4|||
16415097|NCT01276223|40001603|FG002|Overall Study|Adverse Event|1|||
16415098|NCT01276223|40001601|FG000|Overall Study|Lost to Follow-up|0|||
16415099|NCT01276223|40001602|FG001|Overall Study|Lost to Follow-up|0|||
16415100|NCT01276223|40001603|FG002|Overall Study|Lost to Follow-up|1|||
16415101|NCT01276223|40001601|FG000|Overall Study|Other|0|||
16415102|NCT01276223|40001602|FG001|Overall Study|Other|0|||
16415103|NCT01276223|40001603|FG002|Overall Study|Other|1|||
16415104|NCT01276223|40001601|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
16415105|NCT01276223|40001602|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
16415106|NCT01276223|40001603|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
16415107|NCT01276223|40001601|FG000|Overall Study|Protocol Violation|1|||
16415108|NCT01276223|40001602|FG001|Overall Study|Protocol Violation|0|||
16558317|NCT00386308|40509936|FG001|Overall Study|Other Event|1|||
16558318|NCT01500226|40509939|FG000|Overall Study|Adverse Event|31|||
16558319|NCT01500226|40509940|FG001|Overall Study|Adverse Event|38|||
16126338|NCT00833833|38949616|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16126339|NCT00833833|38949611|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
16126340|NCT00833833|38949612|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
16558320|NCT01500226|40509939|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
16126341|NCT00833833|38949613|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
16126342|NCT00833833|38949614|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
16126343|NCT00833833|38949615|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
16126344|NCT00833833|38949616|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
16415109|NCT01276223|40001603|FG002|Overall Study|Protocol Violation|0|||
16558321|NCT01500226|40509940|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
16558322|NCT01500226|40509939|FG000|Overall Study|Withdrawal by Subject|93|||
16558323|NCT01500226|40509940|FG001|Overall Study|Withdrawal by Subject|96|||
16558324|NCT01500226|40509939|FG000|Overall Study|Death|12|||
16558325|NCT01500226|40509940|FG001|Overall Study|Death|4|||
16558326|NCT01500226|40509939|FG000|Overall Study|Disease Progression|16|||
16558327|NCT01500226|40509940|FG001|Overall Study|Disease Progression|14|||
16558328|NCT01500226|40509939|FG000|Overall Study|Protocol Violation|53|||
16558329|NCT01500226|40509940|FG001|Overall Study|Protocol Violation|39|||
16558330|NCT01500226|40509939|FG000|Overall Study|Physician Decision|17|||
16558331|NCT01500226|40509940|FG001|Overall Study|Physician Decision|15|||
16558332|NCT01500226|40509939|FG000|Overall Study|Lack of Efficacy|14|||
16558333|NCT01500226|40509940|FG001|Overall Study|Lack of Efficacy|30|||
16558334|NCT01500226|40509939|FG000|Overall Study|Lost to Follow-up|9|||
16558335|NCT01500226|40509940|FG001|Overall Study|Lost to Follow-up|5|||
16558336|NCT01500226|40509939|FG000|Overall Study|Other Reasons|19|||
16558337|NCT01500226|40509940|FG001|Overall Study|Other Reasons|16|||
16415110|NCT05059977|40001604|FG000|Overall Study|Withdrawal by Subject|0|||
16558338|NCT02337361|40509941|FG000|3-month Follow-up|Lost to Follow-up|19|||
16126345|NCT00833833|38949611|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
16415111|NCT05059977|40001605|FG001|Overall Study|Withdrawal by Subject|0|||
16415112|NCT05059977|40001606|FG002|Overall Study|Withdrawal by Subject|1|||
16415113|NCT00881504|40001607|FG000|Overall Study|Withdrawal by Subject|1|||
16558339|NCT02337361|40509942|FG001|3-month Follow-up|Lost to Follow-up|14|||
16558340|NCT02337361|40509941|FG000|6-month Follow-up|Lost to Follow-up|2|||
16558341|NCT02337361|40509942|FG001|6-month Follow-up|Lost to Follow-up|4|||
16558342|NCT01190176|40509945|FG000|Overall Study|Withdrawal by Subject|1|||
16126346|NCT00833833|38949612|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
16126347|NCT00833833|38949613|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
16126348|NCT00833833|38949614|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
16126349|NCT00833833|38949615|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
16126350|NCT00833833|38949616|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
16126351|NCT00833833|38949611|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
16126352|NCT00833833|38949612|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
16126353|NCT00833833|38949613|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
16126354|NCT00833833|38949614|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
16126355|NCT00833833|38949615|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
16126356|NCT00833833|38949616|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
16126357|NCT00833833|38949611|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
16126358|NCT00833833|38949612|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
16126359|NCT00833833|38949613|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
16126360|NCT00833833|38949614|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
16126361|NCT00833833|38949615|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
16126362|NCT00833833|38949616|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
16126363|NCT00833833|38949611|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16126364|NCT00833833|38949612|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16126365|NCT00833833|38949613|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16126366|NCT00833833|38949614|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
16126367|NCT00833833|38949615|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
16126368|NCT00833833|38949616|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
16126369|NCT00833833|38949611|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
16126370|NCT00833833|38949612|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
16126371|NCT00833833|38949613|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
16126372|NCT00833833|38949614|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
16126373|NCT00833833|38949615|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
16126374|NCT00833833|38949616|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
16126375|NCT00833833|38949611|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
16126376|NCT00833833|38949612|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
16126377|NCT00833833|38949613|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
16126378|NCT00833833|38949614|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
16126379|NCT00833833|38949615|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
16126380|NCT00833833|38949616|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
16126381|NCT00833833|38949611|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
16126382|NCT00833833|38949612|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
16126383|NCT00833833|38949613|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
16126384|NCT00833833|38949614|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
16126385|NCT00833833|38949615|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
16126386|NCT00833833|38949616|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
16126387|NCT02019667|38949617|FG000|First Intervention (6 Months)|Adverse Event|0|||
16126388|NCT02019667|38949618|FG001|First Intervention (6 Months)|Adverse Event|1|||
16126389|NCT02019667|38949617|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
16126390|NCT02019667|38949618|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
16126391|NCT02019667|38949617|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
16126392|NCT02019667|38949618|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
16126393|NCT01204710|38949619|FG000|Randomization Treatment|Lost to Follow-up|1|||
16126394|NCT01204710|38949620|FG001|Randomization Treatment|Lost to Follow-up|0|||
16126395|NCT01204710|38949619|FG000|Randomization Treatment|Withdrawal by Subject|6|||
16126396|NCT01204710|38949620|FG001|Randomization Treatment|Withdrawal by Subject|5|||
16126397|NCT01204710|38949619|FG000|Randomization Treatment|Physician Decision|3|||
16126398|NCT01204710|38949620|FG001|Randomization Treatment|Physician Decision|2|||
16126399|NCT01204710|38949619|FG000|Randomization Treatment|Entry criteria not met|0|||
16415114|NCT02117349|40001608|FG000|Overall Study|Withdrawal by Subject|1|||
16415115|NCT02117349|40001609|FG001|Overall Study|Withdrawal by Subject|0|||
16415116|NCT02117349|40001608|FG000|Overall Study|Lost to Follow-up|1|||
16415117|NCT02117349|40001609|FG001|Overall Study|Lost to Follow-up|1|||
16415118|NCT02117349|40001608|FG000|Overall Study|Death|1|||
16415119|NCT02117349|40001609|FG001|Overall Study|Death|0|||
16415120|NCT00351273|40001610|FG000|Overall Study|Lost to Follow-up|1|||
16415121|NCT00351273|40001611|FG001|Overall Study|Lost to Follow-up|2|||
16415122|NCT00351273|40001612|FG002|Overall Study|Lost to Follow-up|5|||
16415123|NCT00489736|40001620|FG000|Overall Study|Lack of Efficacy|53|||
16415124|NCT00489736|40001621|FG001|Overall Study|Lack of Efficacy|14|||
16415125|NCT00489736|40001620|FG000|Overall Study|Adverse Event|32|||
16415126|NCT00489736|40001621|FG001|Overall Study|Adverse Event|45|||
16415127|NCT00489736|40001620|FG000|Overall Study|Poor compliance|6|||
16126400|NCT01204710|38949620|FG001|Randomization Treatment|Entry criteria not met|1|||
16126401|NCT01204710|38949619|FG000|Randomization Treatment|Adverse Event|4|||
16126402|NCT01204710|38949620|FG001|Randomization Treatment|Adverse Event|2|||
16415128|NCT00489736|40001621|FG001|Overall Study|Poor compliance|2|||
16351219|NCT01704755|39772947|FG001|Overall Study|Adverse Event|1|||
16351220|NCT01704755|39772946|FG000|Overall Study|Lost to Follow-up|3|||
16351221|NCT01704755|39772947|FG001|Overall Study|Lost to Follow-up|4|||
16351222|NCT01704755|39772946|FG000|Overall Study|Withdrew consent|1|||
16351223|NCT01704755|39772947|FG001|Overall Study|Withdrew consent|1|||
16351224|NCT01704755|39772946|FG000|Overall Study|Other (not specified)|3|||
16351225|NCT01704755|39772947|FG001|Overall Study|Other (not specified)|1|||
16351226|NCT01704755|39772946|FG000|Overall Study|Withdrew consent and personal issues|1|||
16351227|NCT01704755|39772947|FG001|Overall Study|Withdrew consent and personal issues|0|||
16351228|NCT01607593|39772951|FG000|Overall Study|Adverse Event|15|||
16351229|NCT01607593|39772951|FG000|Overall Study|Lack of Efficacy|16|||
16351230|NCT01607593|39772951|FG000|Overall Study|Lost to Follow-up|25|||
16351231|NCT01607593|39772951|FG000|Overall Study|Continuation|33|||
16351232|NCT01607593|39772951|FG000|Overall Study|Other|4|||
16351233|NCT00126594|39772952|FG000|Overall Study|Ineligible|2|||
16351234|NCT00126594|39772953|FG001|Overall Study|Ineligible|0|||
16415129|NCT00489736|40001620|FG000|Overall Study|Not coded/ Not pre-specified|5|||
16415130|NCT00489736|40001621|FG001|Overall Study|Not coded/ Not pre-specified|8|||
16415131|NCT03689712|40001622|FG000|Overall Study|Adverse Event|1|||
16415132|NCT03689712|40001623|FG001|Overall Study|Adverse Event|0|||
16415133|NCT03689712|40001622|FG000|Overall Study|Death|20|||
16415134|NCT03689712|40001623|FG001|Overall Study|Death|10|||
16415135|NCT03689712|40001622|FG000|Overall Study|Lost to Follow-up|6|||
16415136|NCT03689712|40001623|FG001|Overall Study|Lost to Follow-up|6|||
16415137|NCT03689712|40001622|FG000|Overall Study|Other|1|||
16415138|NCT03689712|40001623|FG001|Overall Study|Other|0|||
16415139|NCT03689712|40001622|FG000|Overall Study|Patient Non-Compliance|0|||
16415140|NCT03689712|40001623|FG001|Overall Study|Patient Non-Compliance|1|||
16415141|NCT03689712|40001622|FG000|Overall Study|Withdrawal by Subject|20|||
16415142|NCT03689712|40001623|FG001|Overall Study|Withdrawal by Subject|4|||
16558343|NCT01190176|40509945|FG000|Overall Study|Lost to Follow-up|1|||
16558344|NCT00654940|40509946|FG000|Period 1|Adverse Event|0|||
16558345|NCT00654940|40509947|FG001|Period 1|Adverse Event|1|||
16351235|NCT00126594|39772952|FG000|Overall Study|Withdrawal by Subject|0|||
16351236|NCT00126594|39772953|FG001|Overall Study|Withdrawal by Subject|4|||
16351237|NCT00126594|39772952|FG000|Overall Study|Physician Decision|1|||
16351238|NCT00126594|39772953|FG001|Overall Study|Physician Decision|3|||
16351239|NCT00126594|39772952|FG000|Overall Study|Adverse Event|7|||
16351240|NCT00126594|39772953|FG001|Overall Study|Adverse Event|5|||
16351241|NCT00126594|39772952|FG000|Overall Study|Non-compliance|0|||
16351242|NCT00126594|39772953|FG001|Overall Study|Non-compliance|1|||
16351243|NCT00126594|39772952|FG000|Overall Study|Disease Progression|29|||
16351244|NCT00126594|39772953|FG001|Overall Study|Disease Progression|24|||
16351245|NCT02783170|39772954|FG000|Overall Study|Randomized but not Vaccinated|1|||
16351246|NCT02783170|39772955|FG001|Overall Study|Randomized but not Vaccinated|0|||
16351247|NCT01222104|39772956|FG000|Overall Study|Lost to Follow-up|37|||
16351248|NCT01222104|39772956|FG000|Overall Study|Death|10|||
16351249|NCT02370511|39772957|FG000|Overall Study|Death|10|||
16351250|NCT02370511|39772958|FG001|Overall Study|Death|7|||
16558346|NCT00654940|40509946|FG000|Period 1|Intolerable Pain Level|1|||
16558347|NCT00654940|40509947|FG001|Period 1|Intolerable Pain Level|0|||
16351251|NCT02370511|39772959|FG002|Overall Study|Death|1|||
16351252|NCT02370511|39772957|FG000|Overall Study|Withdrawal by Subject|2|||
16351253|NCT02370511|39772958|FG001|Overall Study|Withdrawal by Subject|0|||
16558348|NCT01316692|40509951|FG000|Overall Study|Adverse Event|5|||
16558349|NCT01316692|40509951|FG000|Overall Study|Disease Progression|7|||
16558350|NCT00830947|40509954|FG000|Overall Study|Lost to Follow-up|4|||
16558351|NCT00830947|40509955|FG001|Overall Study|Lost to Follow-up|4|||
16558352|NCT02139982|40509956|FG000|Overall Study|Lack of Efficacy|0|||
16126403|NCT01204710|38949619|FG000|Randomization Treatment|Sponsor Decision|0|||
16126404|NCT01204710|38949620|FG001|Randomization Treatment|Sponsor Decision|1|||
16126405|NCT01204710|38949619|FG000|Randomization Treatment|Worsening of General condition|0|||
16126406|NCT01204710|38949620|FG001|Randomization Treatment|Worsening of General condition|1|||
16126407|NCT01204710|38949619|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
16126408|NCT01204710|38949620|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
16126409|NCT01204710|38949619|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
16351254|NCT02370511|39772959|FG002|Overall Study|Withdrawal by Subject|0|||
16351255|NCT02370511|39772957|FG000|Overall Study|Lost to Follow-up|0|||
16351256|NCT02370511|39772958|FG001|Overall Study|Lost to Follow-up|4|||
16351257|NCT02370511|39772959|FG002|Overall Study|Lost to Follow-up|0|||
16351258|NCT04396626|39772962|FG000|Overall Study|Premature termination of study|975|||
16351259|NCT01817075|39772963|FG000|Overall Study|Adverse Event|7|||
16351260|NCT01817075|39772964|FG001|Overall Study|Adverse Event|5|||
16126410|NCT01204710|38949620|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
16126411|NCT01204710|38949619|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
16126412|NCT01204710|38949620|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
16126413|NCT01204710|38949619|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
16126414|NCT01204710|38949620|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
16126415|NCT01859988|38949623|FG000|Overall Study|Withdrawal by Subject|6|||
16126416|NCT01859988|38949624|FG001|Overall Study|Withdrawal by Subject|3|||
16126417|NCT01859988|38949625|FG002|Overall Study|Withdrawal by Subject|4|||
16351261|NCT01817075|39772963|FG000|Overall Study|Physician Decision|9|||
16351262|NCT01817075|39772964|FG001|Overall Study|Physician Decision|12|||
16351263|NCT01817075|39772963|FG000|Overall Study|Withdrawal by Subject|31|||
16351264|NCT01817075|39772964|FG001|Overall Study|Withdrawal by Subject|15|||
16351265|NCT01817075|39772963|FG000|Overall Study|Received Sorafenib after enrollment|0|||
16415143|NCT03689712|40001622|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
16415144|NCT03689712|40001623|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
16558353|NCT02139982|40509957|FG001|Overall Study|Lack of Efficacy|1|||
16558354|NCT02139982|40509958|FG002|Overall Study|Lack of Efficacy|0|||
16351266|NCT01817075|39772964|FG001|Overall Study|Received Sorafenib after enrollment|1|||
16415145|NCT03689712|40001622|FG000|Overall Study|Randomized but not Treated|13|||
16558355|NCT02139982|40509959|FG003|Overall Study|Lack of Efficacy|1|||
16126418|NCT01859988|38949626|FG003|Overall Study|Withdrawal by Subject|3|||
16126419|NCT01859988|38949627|FG004|Overall Study|Withdrawal by Subject|2|||
16126420|NCT01859988|38949628|FG005|Overall Study|Withdrawal by Subject|2|||
16126421|NCT01859988|38949623|FG000|Overall Study|Lack of Efficacy|1|||
16126422|NCT01859988|38949624|FG001|Overall Study|Lack of Efficacy|1|||
16126423|NCT01859988|38949625|FG002|Overall Study|Lack of Efficacy|5|||
16126424|NCT01859988|38949626|FG003|Overall Study|Lack of Efficacy|0|||
16126425|NCT01859988|38949627|FG004|Overall Study|Lack of Efficacy|7|||
16126426|NCT01859988|38949628|FG005|Overall Study|Lack of Efficacy|9|||
16126427|NCT01859988|38949623|FG000|Overall Study|Physician Decision|1|||
16126428|NCT01859988|38949624|FG001|Overall Study|Physician Decision|3|||
16126429|NCT01859988|38949625|FG002|Overall Study|Physician Decision|1|||
16126430|NCT01859988|38949626|FG003|Overall Study|Physician Decision|3|||
16126431|NCT01859988|38949627|FG004|Overall Study|Physician Decision|4|||
16126432|NCT01859988|38949628|FG005|Overall Study|Physician Decision|1|||
16126433|NCT01859988|38949623|FG000|Overall Study|Adverse Event|2|||
16558356|NCT02139982|40509960|FG004|Overall Study|Lack of Efficacy|0|||
16558357|NCT02139982|40509961|FG005|Overall Study|Lack of Efficacy|0|||
16558358|NCT02139982|40509962|FG006|Overall Study|Lack of Efficacy|0|||
16558359|NCT02139982|40509963|FG007|Overall Study|Lack of Efficacy|0|||
16558360|NCT02139982|40509964|FG008|Overall Study|Lack of Efficacy|0|||
16558361|NCT02139982|40509965|FG009|Overall Study|Lack of Efficacy|0|||
16558362|NCT02998528|40509966|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
16558363|NCT02998528|40509967|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
16558364|NCT02998528|40509968|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
16126434|NCT01859988|38949624|FG001|Overall Study|Adverse Event|1|||
16126435|NCT01859988|38949625|FG002|Overall Study|Adverse Event|3|||
16243108|NCT00446654|39374898|FG001|Overall Study|Withdrawal by Subject|0|||
16243109|NCT00446654|39374897|FG000|Overall Study|Adverse Event|1|||
16243110|NCT00446654|39374898|FG001|Overall Study|Adverse Event|0|||
16243111|NCT01484028|39374900|FG000|Period 1|Lost to Follow-up|0|||
16243112|NCT01484028|39374901|FG001|Period 1|Lost to Follow-up|1|||
16243113|NCT01484028|39374902|FG002|Period 1|Lost to Follow-up|0|||
16243114|NCT01484028|39374903|FG003|Period 1|Lost to Follow-up|0|||
16243115|NCT01484028|39374900|FG000|Period 1|Non-Compliance to Protocol|0|||
16243116|NCT01484028|39374901|FG001|Period 1|Non-Compliance to Protocol|1|||
16243117|NCT01484028|39374902|FG002|Period 1|Non-Compliance to Protocol|0|||
16558365|NCT02998528|40509966|FG000|Randomization Period|Participant withdrew consent|0|||
16558366|NCT02998528|40509967|FG001|Randomization Period|Participant withdrew consent|3|||
16558367|NCT02998528|40509968|FG002|Randomization Period|Participant withdrew consent|0|||
16558368|NCT02998528|40509966|FG000|Randomization Period|Participant no longer meets study criteria|1|||
16558369|NCT02998528|40509967|FG001|Randomization Period|Participant no longer meets study criteria|3|||
16558370|NCT02998528|40509968|FG002|Randomization Period|Participant no longer meets study criteria|2|||
16558371|NCT02998528|40509966|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
16558372|NCT02998528|40509967|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
16558373|NCT02998528|40509968|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
16558374|NCT02998528|40509966|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
16558375|NCT02998528|40509967|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
16558376|NCT02998528|40509968|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
16558377|NCT02998528|40509966|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
16558378|NCT02998528|40509967|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
16558379|NCT02998528|40509968|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
16558380|NCT02998528|40509966|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
16558381|NCT02998528|40509967|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
16558382|NCT02998528|40509968|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
16558383|NCT02998528|40509966|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
16558384|NCT02998528|40509967|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
16558385|NCT02998528|40509968|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
16558386|NCT02998528|40509966|FG000|Neoadjuvant Treatment Period|Death|1|||
16558387|NCT02998528|40509967|FG001|Neoadjuvant Treatment Period|Death|0|||
16558388|NCT02998528|40509968|FG002|Neoadjuvant Treatment Period|Death|0|||
16558389|NCT02998528|40509966|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
16558390|NCT02998528|40509967|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
16558391|NCT02998528|40509968|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
16558392|NCT02998528|40509966|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
16558393|NCT02998528|40509967|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
16558394|NCT02998528|40509968|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
16243118|NCT01484028|39374903|FG003|Period 1|Non-Compliance to Protocol|1|||
16243119|NCT01484028|39374900|FG000|Period 1|Lens Discomfort|0|||
16126436|NCT01859988|38949626|FG003|Overall Study|Adverse Event|1|||
16243120|NCT01484028|39374901|FG001|Period 1|Lens Discomfort|1|||
16126437|NCT01859988|38949627|FG004|Overall Study|Adverse Event|2|||
16126438|NCT01859988|38949628|FG005|Overall Study|Adverse Event|2|||
16126439|NCT01859988|38949623|FG000|Overall Study|Lost to Follow-up|1|||
16126440|NCT01859988|38949624|FG001|Overall Study|Lost to Follow-up|2|||
16126441|NCT01859988|38949625|FG002|Overall Study|Lost to Follow-up|3|||
16126442|NCT01859988|38949626|FG003|Overall Study|Lost to Follow-up|0|||
16126443|NCT01859988|38949627|FG004|Overall Study|Lost to Follow-up|3|||
16126444|NCT01859988|38949628|FG005|Overall Study|Lost to Follow-up|2|||
16126445|NCT01859988|38949623|FG000|Overall Study|Protocol Violation|0|||
16126446|NCT01859988|38949624|FG001|Overall Study|Protocol Violation|0|||
16126447|NCT01859988|38949625|FG002|Overall Study|Protocol Violation|1|||
16126448|NCT01859988|38949626|FG003|Overall Study|Protocol Violation|0|||
16126449|NCT01859988|38949627|FG004|Overall Study|Protocol Violation|0|||
16126450|NCT01859988|38949628|FG005|Overall Study|Protocol Violation|0|||
16126451|NCT01859988|38949623|FG000|Overall Study|Other than specified above|0|||
16126452|NCT01859988|38949624|FG001|Overall Study|Other than specified above|2|||
16126453|NCT01859988|38949625|FG002|Overall Study|Other than specified above|11|||
16126454|NCT01859988|38949626|FG003|Overall Study|Other than specified above|3|||
16126455|NCT01859988|38949627|FG004|Overall Study|Other than specified above|5|||
16126456|NCT01859988|38949628|FG005|Overall Study|Other than specified above|3|||
16126457|NCT00291642|38949629|FG000|Overall Study|Adverse Event|1|||
16126458|NCT00291642|38949630|FG001|Overall Study|Adverse Event|0|||
16126459|NCT00291642|38949631|FG002|Overall Study|Adverse Event|1|||
16126460|NCT00291642|38949632|FG003|Overall Study|Adverse Event|0|||
16126461|NCT00291642|38949633|FG004|Overall Study|Adverse Event|1|||
16126462|NCT00291642|38949629|FG000|Overall Study|Patient missed visit|0|||
16126463|NCT00291642|38949630|FG001|Overall Study|Patient missed visit|0|||
16126464|NCT00291642|38949631|FG002|Overall Study|Patient missed visit|1|||
16126465|NCT00291642|38949632|FG003|Overall Study|Patient missed visit|0|||
16126466|NCT00291642|38949633|FG004|Overall Study|Patient missed visit|0|||
16126467|NCT00291642|38949629|FG000|Overall Study|Intake of prohibited medication|1|||
16126468|NCT00291642|38949630|FG001|Overall Study|Intake of prohibited medication|0|||
16126469|NCT00291642|38949631|FG002|Overall Study|Intake of prohibited medication|0|||
16126470|NCT00291642|38949632|FG003|Overall Study|Intake of prohibited medication|0|||
16126471|NCT00291642|38949633|FG004|Overall Study|Intake of prohibited medication|0|||
16126472|NCT01895101|38949634|FG000|Overall Study|OPCAB procedure|1|||
16126473|NCT01895101|38949635|FG001|Overall Study|OPCAB procedure|1|||
16126474|NCT01895101|38949636|FG002|Overall Study|OPCAB procedure|3|||
16126475|NCT01895101|38949634|FG000|Overall Study|Withdrawal by Subject|0|||
16126476|NCT01895101|38949635|FG001|Overall Study|Withdrawal by Subject|1|||
16126477|NCT01895101|38949636|FG002|Overall Study|Withdrawal by Subject|2|||
16126478|NCT01895101|38949634|FG000|Overall Study|another study, enrolled in other study|0|||
16126479|NCT01895101|38949635|FG001|Overall Study|another study, enrolled in other study|1|||
16126480|NCT01895101|38949636|FG002|Overall Study|another study, enrolled in other study|0|||
16126481|NCT01895101|38949634|FG000|Overall Study|Death|0|||
16126482|NCT01895101|38949635|FG001|Overall Study|Death|1|||
16126483|NCT01895101|38949636|FG002|Overall Study|Death|0|||
16126484|NCT01895101|38949634|FG000|Overall Study|coagulation disorder|0|||
16126485|NCT01895101|38949635|FG001|Overall Study|coagulation disorder|1|||
16126486|NCT01895101|38949636|FG002|Overall Study|coagulation disorder|0|||
16126487|NCT02731690|38949639|FG000|Overall Study|Adverse Event|1|||
16126488|NCT02731690|38949639|FG000|Overall Study|Withdrawal by Subject|3|||
16126489|NCT02731690|38949639|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
16126490|NCT02008877|38949643|FG000|Overall Study|Inevaluable|0|||
16126491|NCT02008877|38949644|FG001|Overall Study|Inevaluable|1|||
16126492|NCT02008877|38949645|FG002|Overall Study|Inevaluable|0|||
16126493|NCT01177800|38949649|FG000|Overall Study|Adverse Event|9|||
16126494|NCT01177800|38949650|FG001|Overall Study|Adverse Event|3|||
16126495|NCT01177800|38949649|FG000|Overall Study|Protocol Violation|0|||
16126496|NCT01177800|38949650|FG001|Overall Study|Protocol Violation|1|||
16126497|NCT01177800|38949649|FG000|Overall Study|Physician Decision|1|||
16126498|NCT01177800|38949650|FG001|Overall Study|Physician Decision|0|||
16126499|NCT01177800|38949649|FG000|Overall Study|Withdrawal of informed consent|0|||
16126500|NCT01177800|38949650|FG001|Overall Study|Withdrawal of informed consent|1|||
16126501|NCT01493427|38949657|FG000|Overall Study|Adverse Event|10|||
16126502|NCT01493427|38949657|FG000|Overall Study|Personal Reasons|4|||
16126503|NCT01493427|38949657|FG000|Overall Study|Lost to Follow-up|2|||
16126504|NCT01493427|38949657|FG000|Overall Study|Inability to Follow Instructions|2|||
16126505|NCT01493427|38949657|FG000|Overall Study|Other|2|||
16126506|NCT01712659|38949658|FG000|Dose Escalation|Physician Decision|0|||
16126507|NCT01712659|38949659|FG001|Dose Escalation|Physician Decision|1|||
16126508|NCT01712659|38949660|FG002|Dose Escalation|Physician Decision|0|||
16126509|NCT01712659|38949661|FG003|Dose Escalation|Physician Decision|0|||
16126510|NCT01712659|38949662|FG004|Dose Escalation|Physician Decision|0|||
16126511|NCT01712659|38949658|FG000|Dose Escalation|Unable to take study drug|0|||
16126512|NCT01712659|38949659|FG001|Dose Escalation|Unable to take study drug|1|||
16126513|NCT01712659|38949660|FG002|Dose Escalation|Unable to take study drug|0|||
16126514|NCT01712659|38949661|FG003|Dose Escalation|Unable to take study drug|0|||
16126515|NCT01712659|38949662|FG004|Dose Escalation|Unable to take study drug|0|||
16126516|NCT01712659|38949658|FG000|Dose Expansion|Early disease progression|1|||
16126517|NCT01712659|38949659|FG001|Dose Expansion|Early disease progression|0|||
16126518|NCT01712659|38949660|FG002|Dose Expansion|Early disease progression|0|||
16126519|NCT01712659|38949661|FG003|Dose Expansion|Early disease progression|0|||
16126520|NCT01712659|38949662|FG004|Dose Expansion|Early disease progression|0|||
16126521|NCT01712659|38949658|FG000|Dose Expansion|Physician Decision|1|||
16126522|NCT01712659|38949659|FG001|Dose Expansion|Physician Decision|0|||
16126523|NCT01712659|38949660|FG002|Dose Expansion|Physician Decision|0|||
16126524|NCT01712659|38949661|FG003|Dose Expansion|Physician Decision|0|||
16126525|NCT01712659|38949662|FG004|Dose Expansion|Physician Decision|0|||
16126526|NCT00935818|38949671|FG000|Overall Study|Withdrawal by Subject|45|||
16126527|NCT00935818|38949672|FG001|Overall Study|Withdrawal by Subject|50|||
16126528|NCT00935818|38949671|FG000|Overall Study|Lost to Follow-up|40|||
16126529|NCT00935818|38949672|FG001|Overall Study|Lost to Follow-up|42|||
16126530|NCT00935818|38949671|FG000|Overall Study|Adverse Event|6|||
16126531|NCT00935818|38949672|FG001|Overall Study|Adverse Event|7|||
16126532|NCT00935818|38949671|FG000|Overall Study|Physician Decision|0|||
16126533|NCT00935818|38949672|FG001|Overall Study|Physician Decision|1|||
16126534|NCT02914275|38949674|FG000|Overall Study|Lost to Follow-up|84|||
16126535|NCT02914275|38949675|FG001|Overall Study|Lost to Follow-up|29|||
16558395|NCT02998528|40509966|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
16558396|NCT02998528|40509967|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
16558397|NCT02998528|40509968|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
16558398|NCT02998528|40509966|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
16558399|NCT02998528|40509967|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
16558400|NCT02998528|40509968|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
16558401|NCT02998528|40509966|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
16558402|NCT02998528|40509967|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
16558403|NCT02998528|40509968|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
16558404|NCT02998528|40509966|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
16558405|NCT02998528|40509967|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
16558406|NCT02998528|40509968|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
16558407|NCT00467142|40509974|FG000|Overall Study|Withdrawal by Subject|1|||
16558408|NCT00467142|40509974|FG000|Overall Study|Adverse Event|1|||
16558409|NCT00467142|40509974|FG000|Overall Study|Protocol Violation|1|||
16558410|NCT00502996|40509977|FG000|Overall Study|Lost to Follow-up|9|||
16558411|NCT00502996|40509977|FG000|Overall Study|Protocol Violation|2|||
16558412|NCT00502996|40509977|FG000|Overall Study|Treatment failure|25|||
16558413|NCT00502996|40509977|FG000|Overall Study|Withdrawal Informed Consent|6|||
16558414|NCT00502996|40509977|FG000|Overall Study|Adverse Event|2|||
16558415|NCT03135548|40509978|FG000|Overall Study|Lost to Follow-up|3|||
16558416|NCT03135548|40509979|FG001|Overall Study|Lost to Follow-up|0|||
16558417|NCT03135548|40509980|FG002|Overall Study|Lost to Follow-up|0|||
16558418|NCT03135548|40509978|FG000|Overall Study|Withdrawal by Subject|2|||
16558419|NCT03135548|40509979|FG001|Overall Study|Withdrawal by Subject|2|||
16558420|NCT03135548|40509980|FG002|Overall Study|Withdrawal by Subject|1|||
16558421|NCT03135548|40509978|FG000|Overall Study|Other than listed|0|||
16558422|NCT03135548|40509979|FG001|Overall Study|Other than listed|2|||
16558423|NCT03135548|40509980|FG002|Overall Study|Other than listed|2|||
16558424|NCT00877851|40509983|FG000|Overall Study|Lost to Follow-up|5|||
16558425|NCT00877851|40509984|FG001|Overall Study|Lost to Follow-up|5|||
16558426|NCT00877851|40509983|FG000|Overall Study|computer problem|3|||
16558427|NCT00877851|40509984|FG001|Overall Study|computer problem|0|||
16558428|NCT00877851|40509983|FG000|Overall Study|no longer interested in participating|1|||
16558429|NCT00877851|40509984|FG001|Overall Study|no longer interested in participating|0|||
16558430|NCT00663117|40509988|FG000|Overall Study|Lack of Efficacy|1|||
16558431|NCT00663117|40509989|FG001|Overall Study|Lack of Efficacy|0|||
16126536|NCT02914275|38949674|FG000|Overall Study|Withdrawal by Subject|26|||
16126537|NCT02914275|38949675|FG001|Overall Study|Withdrawal by Subject|10|||
16126538|NCT02914275|38949674|FG000|Overall Study|Protocol Violation|1|||
16126539|NCT02914275|38949675|FG001|Overall Study|Protocol Violation|1|||
16126540|NCT02914275|38949674|FG000|Overall Study|Physician Decision|3|||
16126541|NCT02914275|38949675|FG001|Overall Study|Physician Decision|1|||
16126542|NCT02914275|38949674|FG000|Overall Study|Other|4|||
16126543|NCT02914275|38949675|FG001|Overall Study|Other|1|||
16126544|NCT02914275|38949674|FG000|Overall Study|Excluded due to invalid informed consent|3|||
16126545|NCT02914275|38949675|FG001|Overall Study|Excluded due to invalid informed consent|0|||
16126546|NCT01775475|38949676|FG000|Overall Study|Death|3|||
16126547|NCT01775475|38949677|FG001|Overall Study|Death|3|||
16126548|NCT01077271|38949678|FG000|Overall Study|Parental desire|8|||
16126549|NCT01077271|38949678|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
16126550|NCT01077271|38949678|FG000|Overall Study|Noncompliance|2|||
16126551|NCT01077271|38949678|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
16126552|NCT01077271|38949678|FG000|Overall Study|Changed doctors|2|||
16126553|NCT01077271|38949678|FG000|Overall Study|Parents thought too many injections|2|||
16126554|NCT01077271|38949678|FG000|Overall Study|End of RSV season nearly reached|1|||
16126555|NCT01077271|38949678|FG000|Overall Study|Mother unconvinced of the necessity|1|||
16126556|NCT03292432|38949679|FG000|Overall Study|Lost to Follow-up|11|||
16126557|NCT03292432|38949680|FG001|Overall Study|Lost to Follow-up|8|||
16126558|NCT03292432|38949679|FG000|Overall Study|Death|2|||
16126559|NCT03292432|38949680|FG001|Overall Study|Death|1|||
16126560|NCT03292432|38949679|FG000|Overall Study|Withdrawal by Subject|1|||
16126561|NCT03292432|38949680|FG001|Overall Study|Withdrawal by Subject|2|||
16126562|NCT03292432|38949679|FG000|Overall Study|Site closed before any data collected|1|||
16126563|NCT03292432|38949680|FG001|Overall Study|Site closed before any data collected|0|||
16126564|NCT01276379|38949683|FG000|Overall Study|Screening failure|40|||
16126565|NCT04677179|38949684|FG000|Induction Treatment Period|Adverse Event|1|||
16126566|NCT04677179|38949685|FG001|Induction Treatment Period|Adverse Event|0|||
16126567|NCT04677179|38949686|FG002|Induction Treatment Period|Adverse Event|0|||
16126568|NCT04677179|38949687|FG003|Induction Treatment Period|Adverse Event|0|||
16126569|NCT04677179|38949688|FG004|Induction Treatment Period|Adverse Event|0|||
16126570|NCT04677179|38949689|FG005|Induction Treatment Period|Adverse Event|0|||
16126571|NCT04677179|38949690|FG006|Induction Treatment Period|Adverse Event|0|||
16126572|NCT04677179|38949691|FG007|Induction Treatment Period|Adverse Event|0|||
16126573|NCT04677179|38949692|FG008|Induction Treatment Period|Adverse Event|0|||
16351267|NCT01817075|39772963|FG000|Overall Study|Ineligible|0|||
16351268|NCT01817075|39772964|FG001|Overall Study|Ineligible|2|||
16351269|NCT03139552|39772969|FG000|Overall Study|unable to attend tasting due to schedule|3|||
16558432|NCT00422799|40509990|FG000|Overall Study|Withdrawal by Subject|6|||
16558433|NCT00422799|40509990|FG000|Overall Study|Adverse Event|7|||
16558434|NCT00333788|40509997|FG000|Overall Study|Adverse Event|44|||
16558435|NCT00333788|40509997|FG000|Overall Study|Lack of Efficacy|80|||
16558436|NCT00333788|40509997|FG000|Overall Study|Lost to Follow-up|2|||
16558437|NCT00333788|40509997|FG000|Overall Study|Withdrawal by Subject|24|||
16558438|NCT00333788|40509997|FG000|Overall Study|Other: Non-compliance|2|||
16558439|NCT00333788|40509997|FG000|Overall Study|Other: Moved|2|||
16558440|NCT00333788|40509997|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
16558441|NCT00333788|40509997|FG000|Overall Study|Other: Investigator decision|1|||
16558442|NCT00333788|40509997|FG000|Overall Study|Other: Quality of life concern|1|||
16558443|NCT00333788|40509997|FG000|Overall Study|Other: Sponsor decision|1|||
16558444|NCT00333788|40509997|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
16558445|NCT00333788|40509997|FG000|Overall Study|Other: Medical monitor decision|1|||
16558446|NCT00333788|40509997|FG000|Overall Study|Other: Physician decision|1|||
16558447|NCT00333788|40509997|FG000|Overall Study|Other: Signed consent for another study|1|||
16558448|NCT00007475|40509998|FG000|Overall Study|Withdrawal by Subject|1|||
16558449|NCT00007475|40509999|FG001|Overall Study|Withdrawal by Subject|0|||
16558450|NCT00007475|40510000|FG002|Overall Study|Withdrawal by Subject|0|||
16558451|NCT00007475|40510001|FG003|Overall Study|Withdrawal by Subject|0|||
16558452|NCT00007475|40509998|FG000|Overall Study|Adverse Event|3|||
16558453|NCT00007475|40509999|FG001|Overall Study|Adverse Event|0|||
16558454|NCT00007475|40510000|FG002|Overall Study|Adverse Event|0|||
16558455|NCT00007475|40510001|FG003|Overall Study|Adverse Event|0|||
16558456|NCT01994720|40510002|FG000|Overall Study|Withdrawal by Subject|46|||
16558457|NCT01994720|40510003|FG001|Overall Study|Withdrawal by Subject|56|||
16558458|NCT00146640|40510005|FG000|Overall Study|Adverse Event|12|||
16558459|NCT00146640|40510006|FG001|Overall Study|Adverse Event|10|||
16126574|NCT04677179|38949693|FG009|Induction Treatment Period|Adverse Event|0|||
16558460|NCT00146640|40510005|FG000|Overall Study|Medical Reasons|3|||
16351270|NCT01316575|39772970|FG000|Overall Study|Withdrawal by Subject|2|||
16351271|NCT01316575|39772971|FG001|Overall Study|Withdrawal by Subject|0|||
16351272|NCT01316575|39772970|FG000|Overall Study|Required alternate treatment|0|||
16126575|NCT04677179|38949684|FG000|Induction Treatment Period|Physician Decision|1|||
16126576|NCT04677179|38949685|FG001|Induction Treatment Period|Physician Decision|0|||
16126577|NCT04677179|38949686|FG002|Induction Treatment Period|Physician Decision|1|||
16126578|NCT04677179|38949687|FG003|Induction Treatment Period|Physician Decision|0|||
16126579|NCT04677179|38949688|FG004|Induction Treatment Period|Physician Decision|0|||
16126580|NCT04677179|38949689|FG005|Induction Treatment Period|Physician Decision|0|||
16126581|NCT04677179|38949690|FG006|Induction Treatment Period|Physician Decision|0|||
16126582|NCT04677179|38949691|FG007|Induction Treatment Period|Physician Decision|0|||
16126583|NCT04677179|38949692|FG008|Induction Treatment Period|Physician Decision|0|||
16126584|NCT04677179|38949693|FG009|Induction Treatment Period|Physician Decision|0|||
16126585|NCT04677179|38949684|FG000|Induction Treatment Period|Protocol Violation|0|||
16126586|NCT04677179|38949685|FG001|Induction Treatment Period|Protocol Violation|1|||
16126587|NCT04677179|38949686|FG002|Induction Treatment Period|Protocol Violation|0|||
16126588|NCT04677179|38949687|FG003|Induction Treatment Period|Protocol Violation|0|||
16351273|NCT01316575|39772971|FG001|Overall Study|Required alternate treatment|1|||
16351274|NCT03327324|39772976|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351275|NCT03327324|39772977|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
16126589|NCT04677179|38949688|FG004|Induction Treatment Period|Protocol Violation|0|||
16126590|NCT04677179|38949689|FG005|Induction Treatment Period|Protocol Violation|0|||
16351276|NCT03327324|39772978|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351277|NCT03327324|39772979|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
16351278|NCT03327324|39772980|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351279|NCT03327324|39772981|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
16351280|NCT03327324|39772976|FG000|Baseline (Month 0-Month 3)|Refused|0|||
16351281|NCT03327324|39772977|FG001|Baseline (Month 0-Month 3)|Refused|0|||
16351282|NCT03327324|39772978|FG002|Baseline (Month 0-Month 3)|Refused|0|||
16351283|NCT03327324|39772979|FG003|Baseline (Month 0-Month 3)|Refused|0|||
16351284|NCT03327324|39772980|FG004|Baseline (Month 0-Month 3)|Refused|1|||
16351285|NCT03327324|39772981|FG005|Baseline (Month 0-Month 3)|Refused|0|||
16351286|NCT03327324|39772976|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
16351287|NCT03327324|39772977|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
16351288|NCT03327324|39772978|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
16351289|NCT03327324|39772979|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
16351290|NCT03327324|39772980|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
16351291|NCT03327324|39772981|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
16351292|NCT03327324|39772976|FG000|Baseline (Month 0-Month 3)|Death|0|||
16351293|NCT03327324|39772977|FG001|Baseline (Month 0-Month 3)|Death|0|||
16351294|NCT03327324|39772978|FG002|Baseline (Month 0-Month 3)|Death|0|||
16351295|NCT03327324|39772979|FG003|Baseline (Month 0-Month 3)|Death|0|||
16351296|NCT03327324|39772980|FG004|Baseline (Month 0-Month 3)|Death|1|||
16351297|NCT03327324|39772981|FG005|Baseline (Month 0-Month 3)|Death|0|||
16351298|NCT03327324|39772976|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351299|NCT03327324|39772977|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351300|NCT03327324|39772978|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16415146|NCT03689712|40001623|FG001|Overall Study|Randomized but not Treated|7|||
16415147|NCT03689712|40001622|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
16558461|NCT00146640|40510006|FG001|Overall Study|Medical Reasons|0|||
16126591|NCT04677179|38949690|FG006|Induction Treatment Period|Protocol Violation|0|||
16126592|NCT04677179|38949691|FG007|Induction Treatment Period|Protocol Violation|0|||
16126593|NCT04677179|38949692|FG008|Induction Treatment Period|Protocol Violation|0|||
16126594|NCT04677179|38949693|FG009|Induction Treatment Period|Protocol Violation|0|||
16126595|NCT04677179|38949684|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
16126596|NCT04677179|38949685|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
16126597|NCT04677179|38949686|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
16126598|NCT04677179|38949687|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
16126599|NCT04677179|38949688|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
16126600|NCT04677179|38949689|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
16126601|NCT04677179|38949690|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
16558462|NCT00146640|40510005|FG000|Overall Study|Non-Medical Reasons|8|||
16558463|NCT00146640|40510006|FG001|Overall Study|Non-Medical Reasons|4|||
16558464|NCT01244763|40510007|FG000|Overall Study|Adverse Event|1|||
16558465|NCT01244763|40510008|FG001|Overall Study|Adverse Event|0|||
16558466|NCT01244763|40510009|FG002|Overall Study|Adverse Event|0|||
16558467|NCT01244763|40510010|FG003|Overall Study|Adverse Event|0|||
16558468|NCT01244763|40510011|FG004|Overall Study|Adverse Event|0|||
16558469|NCT01244763|40510012|FG005|Overall Study|Adverse Event|1|||
16558470|NCT01244763|40510007|FG000|Overall Study|Death|1|||
16558471|NCT01244763|40510008|FG001|Overall Study|Death|0|||
16558472|NCT01244763|40510009|FG002|Overall Study|Death|1|||
16558473|NCT01244763|40510010|FG003|Overall Study|Death|0|||
16558474|NCT01244763|40510011|FG004|Overall Study|Death|2|||
16558475|NCT01244763|40510012|FG005|Overall Study|Death|0|||
16558476|NCT01244763|40510007|FG000|Overall Study|Physician Decision|0|||
16558477|NCT01244763|40510008|FG001|Overall Study|Physician Decision|0|||
16558478|NCT01244763|40510009|FG002|Overall Study|Physician Decision|1|||
16558479|NCT01244763|40510010|FG003|Overall Study|Physician Decision|0|||
16126602|NCT04677179|38949691|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
16126603|NCT04677179|38949692|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
16558480|NCT01244763|40510011|FG004|Overall Study|Physician Decision|0|||
16558481|NCT01244763|40510012|FG005|Overall Study|Physician Decision|0|||
16558482|NCT01244763|40510007|FG000|Overall Study|Withdrawal by Subject|1|||
16558483|NCT01244763|40510008|FG001|Overall Study|Withdrawal by Subject|2|||
16558484|NCT01244763|40510009|FG002|Overall Study|Withdrawal by Subject|0|||
16558485|NCT01244763|40510010|FG003|Overall Study|Withdrawal by Subject|1|||
16558486|NCT01244763|40510011|FG004|Overall Study|Withdrawal by Subject|1|||
16558487|NCT01244763|40510012|FG005|Overall Study|Withdrawal by Subject|2|||
16558488|NCT01244763|40510007|FG000|Overall Study|Lost to Follow-up|0|||
16558489|NCT01244763|40510008|FG001|Overall Study|Lost to Follow-up|1|||
16558490|NCT01244763|40510009|FG002|Overall Study|Lost to Follow-up|0|||
16558491|NCT01244763|40510010|FG003|Overall Study|Lost to Follow-up|0|||
16558492|NCT01244763|40510011|FG004|Overall Study|Lost to Follow-up|0|||
16558493|NCT01244763|40510012|FG005|Overall Study|Lost to Follow-up|0|||
16558494|NCT01244763|40510007|FG000|Overall Study|Enrolled into the Extension Study|0|||
16558495|NCT01244763|40510008|FG001|Overall Study|Enrolled into the Extension Study|0|||
16558496|NCT01244763|40510009|FG002|Overall Study|Enrolled into the Extension Study|0|||
16558497|NCT01244763|40510010|FG003|Overall Study|Enrolled into the Extension Study|0|||
16558498|NCT01244763|40510011|FG004|Overall Study|Enrolled into the Extension Study|0|||
16558499|NCT01244763|40510012|FG005|Overall Study|Enrolled into the Extension Study|1|||
16558500|NCT03073005|40510015|FG000|Overall Study|Death|6|||
16558501|NCT03073005|40510016|FG001|Overall Study|Death|0|||
16558502|NCT03073005|40510017|FG002|Overall Study|Death|7|||
16558503|NCT03073005|40510018|FG003|Overall Study|Death|0|||
16558504|NCT03073005|40510015|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
16558505|NCT03073005|40510016|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
16558506|NCT03073005|40510017|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
16558507|NCT03073005|40510018|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
16558508|NCT03073005|40510015|FG000|Overall Study|Lost to Follow-up|2|||
16558509|NCT03073005|40510016|FG001|Overall Study|Lost to Follow-up|2|||
16558510|NCT03073005|40510017|FG002|Overall Study|Lost to Follow-up|1|||
16558511|NCT03073005|40510018|FG003|Overall Study|Lost to Follow-up|2|||
16558512|NCT03073005|40510015|FG000|Overall Study|Withdrawal by Subject|0|||
16558513|NCT03073005|40510016|FG001|Overall Study|Withdrawal by Subject|4|||
16558514|NCT03073005|40510017|FG002|Overall Study|Withdrawal by Subject|4|||
16558515|NCT03073005|40510018|FG003|Overall Study|Withdrawal by Subject|4|||
16558516|NCT00683449|40510019|FG000|Overall Study|Lost to Follow-up|0|||
16558517|NCT00683449|40510020|FG001|Overall Study|Lost to Follow-up|1|||
16558518|NCT00683449|40510021|FG002|Overall Study|Lost to Follow-up|0|||
16126604|NCT04677179|38949693|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
16126605|NCT04677179|38949684|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
16126606|NCT04677179|38949685|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
16126607|NCT04677179|38949686|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
16126608|NCT04677179|38949687|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
16126609|NCT04677179|38949688|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
16126610|NCT04677179|38949689|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
16126611|NCT04677179|38949690|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
16126612|NCT04677179|38949691|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
16126613|NCT04677179|38949692|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
16558519|NCT00683449|40510022|FG003|Overall Study|Lost to Follow-up|0|||
16558520|NCT00683449|40510023|FG004|Overall Study|Lost to Follow-up|0|||
16558521|NCT01625910|40510024|FG000|Overall Study|Lost to Follow-up|3|||
16558522|NCT01625910|40510025|FG001|Overall Study|Lost to Follow-up|4|||
16126614|NCT04677179|38949693|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
16126615|NCT04677179|38949684|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
16126616|NCT04677179|38949685|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
16558523|NCT00335153|40510027|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
16126617|NCT04677179|38949686|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
16126618|NCT04677179|38949687|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
16126619|NCT04677179|38949688|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
16126620|NCT04677179|38949689|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
16126621|NCT04677179|38949690|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
16126622|NCT04677179|38949691|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
16126623|NCT04677179|38949692|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
16243121|NCT01484028|39374902|FG002|Period 1|Lens Discomfort|0|||
16243122|NCT01484028|39374903|FG003|Period 1|Lens Discomfort|0|||
16243123|NCT02024698|39374907|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
16243124|NCT02024698|39374908|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
16243125|NCT03208933|39374909|FG000|Overall Study|Death|3|||
16243126|NCT03208933|39374909|FG000|Overall Study|Withdrawal by Subject|3|||
16243127|NCT03208933|39374909|FG000|Overall Study|Adverse Event|1|||
16243128|NCT03208933|39374909|FG000|Overall Study|Lost to Follow-up|2|||
16243129|NCT03208933|39374909|FG000|Overall Study|Physician Decision|3|||
16243130|NCT03208933|39374909|FG000|Overall Study|Protocol Violation|1|||
16243131|NCT01021137|39374910|FG000|Overall Study|Lost to Follow-up|9|||
16243132|NCT01021137|39374911|FG001|Overall Study|Lost to Follow-up|4|||
16243133|NCT01021137|39374912|FG002|Overall Study|Lost to Follow-up|2|||
16243134|NCT01021137|39374913|FG003|Overall Study|Lost to Follow-up|6|||
16243135|NCT01021137|39374910|FG000|Overall Study|Withdrawal by Subject|1|||
16243136|NCT01021137|39374911|FG001|Overall Study|Withdrawal by Subject|0|||
16243137|NCT01021137|39374912|FG002|Overall Study|Withdrawal by Subject|0|||
16243138|NCT01021137|39374913|FG003|Overall Study|Withdrawal by Subject|3|||
16243139|NCT00881959|39374914|FG000|Overall Study|Lost to Follow-up|2|||
16243140|NCT00881959|39374915|FG001|Overall Study|Lost to Follow-up|4|||
16243141|NCT02094937|39374916|FG000|8 Weeks in Period 1|Adverse Event|9|||
16243142|NCT02094937|39374917|FG001|8 Weeks in Period 1|Adverse Event|0|||
16243143|NCT02094937|39374918|FG002|8 Weeks in Period 1|Adverse Event|0|||
16243144|NCT02094937|39374919|FG003|8 Weeks in Period 1|Adverse Event|0|||
16243145|NCT02094937|39374916|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
16243146|NCT02094937|39374917|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
16243147|NCT02094937|39374918|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
16243148|NCT02094937|39374919|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
16243149|NCT02094937|39374916|FG000|8 Weeks in Period 1|Protocol Violation|2|||
16243150|NCT02094937|39374917|FG001|8 Weeks in Period 1|Protocol Violation|0|||
16243151|NCT02094937|39374918|FG002|8 Weeks in Period 1|Protocol Violation|0|||
16243152|NCT02094937|39374919|FG003|8 Weeks in Period 1|Protocol Violation|0|||
16243153|NCT02094937|39374916|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
16243154|NCT02094937|39374917|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
16243155|NCT02094937|39374918|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
16243156|NCT02094937|39374919|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
16243157|NCT02094937|39374916|FG000|8 Weeks in Period 1|Physician Decision|1|||
16415148|NCT03689712|40001623|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
16415149|NCT00590577|40001625|FG000|Overall Study|Lack of Efficacy|31|||
16415150|NCT00590577|40001626|FG001|Overall Study|Lack of Efficacy|28|||
16415151|NCT00590577|40001627|FG002|Overall Study|Lack of Efficacy|23|||
16415152|NCT00590577|40001628|FG003|Overall Study|Lack of Efficacy|45|||
16415153|NCT00590577|40001625|FG000|Overall Study|Withdrawal by Subject|23|||
16415154|NCT00590577|40001626|FG001|Overall Study|Withdrawal by Subject|28|||
16415155|NCT00590577|40001627|FG002|Overall Study|Withdrawal by Subject|30|||
16415156|NCT00590577|40001628|FG003|Overall Study|Withdrawal by Subject|26|||
16415157|NCT00590577|40001625|FG000|Overall Study|Adverse Event|10|||
16415158|NCT00590577|40001626|FG001|Overall Study|Adverse Event|10|||
16415159|NCT00590577|40001627|FG002|Overall Study|Adverse Event|13|||
16415160|NCT00590577|40001628|FG003|Overall Study|Adverse Event|11|||
16415161|NCT00590577|40001625|FG000|Overall Study|Lost to Follow-up|12|||
16415162|NCT00590577|40001626|FG001|Overall Study|Lost to Follow-up|6|||
16126624|NCT04677179|38949693|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
16415163|NCT00590577|40001627|FG002|Overall Study|Lost to Follow-up|6|||
16243158|NCT02094937|39374917|FG001|8 Weeks in Period 1|Physician Decision|0|||
16243159|NCT02094937|39374918|FG002|8 Weeks in Period 1|Physician Decision|0|||
16243160|NCT02094937|39374919|FG003|8 Weeks in Period 1|Physician Decision|0|||
16243161|NCT02094937|39374916|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
16243162|NCT02094937|39374917|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
16243163|NCT02094937|39374918|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
16243164|NCT02094937|39374919|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
16243165|NCT02094937|39374916|FG000|12 Weeks in Period 2|Adverse Event|0|||
16243166|NCT02094937|39374917|FG001|12 Weeks in Period 2|Adverse Event|2|||
16243167|NCT02094937|39374918|FG002|12 Weeks in Period 2|Adverse Event|4|||
16243168|NCT02094937|39374919|FG003|12 Weeks in Period 2|Adverse Event|1|||
16243169|NCT02094937|39374916|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
16243170|NCT02094937|39374917|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
16243171|NCT02094937|39374918|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
16243172|NCT02094937|39374919|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
16243173|NCT02094937|39374916|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
16243174|NCT02094937|39374917|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
16243175|NCT02094937|39374918|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
16243176|NCT02094937|39374919|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
16243177|NCT02094937|39374916|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
16243178|NCT02094937|39374917|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
16243179|NCT02094937|39374918|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
16243180|NCT02094937|39374919|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
16243181|NCT02094937|39374916|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
16243182|NCT02094937|39374917|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
16243183|NCT02094937|39374918|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
16243184|NCT02094937|39374919|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
16243185|NCT00911859|39374925|FG000|Treatment Period|Adverse Event|3|||
16243186|NCT00911859|39374926|FG001|Treatment Period|Adverse Event|3|||
16243187|NCT00911859|39374927|FG002|Treatment Period|Adverse Event|7|||
16243188|NCT00911859|39374925|FG000|Treatment Period|Death|1|||
16243189|NCT00911859|39374926|FG001|Treatment Period|Death|3|||
16243190|NCT00911859|39374927|FG002|Treatment Period|Death|5|||
16243191|NCT00911859|39374925|FG000|Treatment Period|Lack of Efficacy|1|||
16243192|NCT00911859|39374926|FG001|Treatment Period|Lack of Efficacy|7|||
16243193|NCT00911859|39374927|FG002|Treatment Period|Lack of Efficacy|5|||
16243194|NCT00911859|39374925|FG000|Treatment Period|Physician Decision|3|||
16243195|NCT00911859|39374926|FG001|Treatment Period|Physician Decision|3|||
16243196|NCT00911859|39374927|FG002|Treatment Period|Physician Decision|3|||
16243197|NCT00911859|39374925|FG000|Treatment Period|Withdrawal by Subject|0|||
16243198|NCT00911859|39374926|FG001|Treatment Period|Withdrawal by Subject|4|||
16243199|NCT00911859|39374927|FG002|Treatment Period|Withdrawal by Subject|5|||
16243200|NCT00911859|39374925|FG000|Treatment Period|Did not receive study treatment|0|||
16243201|NCT00911859|39374926|FG001|Treatment Period|Did not receive study treatment|1|||
16243202|NCT00911859|39374927|FG002|Treatment Period|Did not receive study treatment|0|||
16243203|NCT00911859|39374925|FG000|Maintainance Period|Lack of Efficacy|0|||
16243204|NCT00911859|39374926|FG001|Maintainance Period|Lack of Efficacy|0|||
16243205|NCT00911859|39374927|FG002|Maintainance Period|Lack of Efficacy|9|||
16243206|NCT00911859|39374925|FG000|Maintainance Period|Physician Decision|0|||
16243207|NCT00911859|39374926|FG001|Maintainance Period|Physician Decision|0|||
16243208|NCT00911859|39374927|FG002|Maintainance Period|Physician Decision|9|||
16243209|NCT00911859|39374925|FG000|Maintainance Period|Withdrawal by Subject|0|||
16243210|NCT00911859|39374926|FG001|Maintainance Period|Withdrawal by Subject|0|||
16243211|NCT00911859|39374927|FG002|Maintainance Period|Withdrawal by Subject|3|||
16243212|NCT00911859|39374925|FG000|Follow-up Period|Death|5|||
16243213|NCT00911859|39374926|FG001|Follow-up Period|Death|8|||
16243214|NCT00911859|39374927|FG002|Follow-up Period|Death|10|||
16243215|NCT00911859|39374925|FG000|Follow-up Period|Lost to Follow-up|1|||
16243216|NCT00911859|39374926|FG001|Follow-up Period|Lost to Follow-up|1|||
16243217|NCT00911859|39374927|FG002|Follow-up Period|Lost to Follow-up|0|||
16351301|NCT03327324|39772979|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351302|NCT03327324|39772980|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351303|NCT03327324|39772981|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
16351304|NCT03327324|39772976|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351305|NCT03327324|39772977|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351306|NCT03327324|39772978|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
16351307|NCT03327324|39772979|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351308|NCT03327324|39772980|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351309|NCT03327324|39772981|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351310|NCT03327324|39772976|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
16351311|NCT03327324|39772977|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
16243218|NCT00911859|39374925|FG000|Follow-up Period|Withdrawal by Subject|0|||
16243219|NCT00911859|39374926|FG001|Follow-up Period|Withdrawal by Subject|4|||
16243220|NCT00911859|39374927|FG002|Follow-up Period|Withdrawal by Subject|4|||
16243221|NCT00911859|39374925|FG000|Follow-up Period|Study terminated by sponsor|5|||
16243222|NCT00911859|39374926|FG001|Follow-up Period|Study terminated by sponsor|33|||
16243223|NCT00911859|39374927|FG002|Follow-up Period|Study terminated by sponsor|27|||
16243224|NCT00575328|39374928|FG000|Overall Study|Adverse Event|1|||
16415164|NCT00590577|40001628|FG003|Overall Study|Lost to Follow-up|9|||
16415165|NCT00590577|40001625|FG000|Overall Study|Pregnancy|0|||
16415166|NCT00590577|40001626|FG001|Overall Study|Pregnancy|1|||
16415167|NCT00590577|40001627|FG002|Overall Study|Pregnancy|0|||
16415168|NCT00590577|40001628|FG003|Overall Study|Pregnancy|0|||
16415169|NCT00590577|40001625|FG000|Overall Study|Various reasons|1|||
16415170|NCT00590577|40001626|FG001|Overall Study|Various reasons|3|||
16415171|NCT00590577|40001627|FG002|Overall Study|Various reasons|1|||
16415172|NCT00590577|40001628|FG003|Overall Study|Various reasons|2|||
16415173|NCT04496453|40001638|FG000|Overall Study|Lost to Follow-up|6|||
16415174|NCT00845065|40001639|FG000|Overall Study|Adverse Event|3|||
16415175|NCT00845065|40001640|FG001|Overall Study|Adverse Event|23|||
16415176|NCT00845065|40001639|FG000|Overall Study|Lack of Efficacy|43|||
16415177|NCT00845065|40001640|FG001|Overall Study|Lack of Efficacy|21|||
16415178|NCT00845065|40001639|FG000|Overall Study|Non-Medical Reasons|1|||
16415179|NCT00845065|40001640|FG001|Overall Study|Non-Medical Reasons|11|||
16415180|NCT00521222|40001651|FG000|Overall Study|Lost to Follow-up|0|||
16415181|NCT00521222|40001652|FG001|Overall Study|Lost to Follow-up|0|||
16415182|NCT00521222|40001653|FG002|Overall Study|Lost to Follow-up|1|||
16415183|NCT00521222|40001654|FG003|Overall Study|Lost to Follow-up|1|||
16415184|NCT00521222|40001651|FG000|Overall Study|Withdrawal by Subject|0|||
16415185|NCT00521222|40001652|FG001|Overall Study|Withdrawal by Subject|0|||
16415186|NCT00521222|40001653|FG002|Overall Study|Withdrawal by Subject|2|||
16415187|NCT00521222|40001654|FG003|Overall Study|Withdrawal by Subject|0|||
16415188|NCT00521222|40001651|FG000|Overall Study|Physician Decision|0|||
16415189|NCT00521222|40001652|FG001|Overall Study|Physician Decision|1|||
16415190|NCT00521222|40001653|FG002|Overall Study|Physician Decision|0|||
16415191|NCT00521222|40001654|FG003|Overall Study|Physician Decision|1|||
16415192|NCT01424566|40001655|FG000|Single-blind Treatment|Adverse Event|71|||
16415193|NCT01424566|40001656|FG001|Single-blind Treatment|Adverse Event|0|||
16415194|NCT01424566|40001657|FG002|Single-blind Treatment|Adverse Event|0|||
16415195|NCT01424566|40001655|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
16415196|NCT01424566|40001656|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
16415197|NCT01424566|40001657|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
16415198|NCT01424566|40001655|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
16415199|NCT01424566|40001656|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
16415200|NCT01424566|40001657|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
16415201|NCT01424566|40001655|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
16415202|NCT01424566|40001656|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
16415203|NCT01424566|40001657|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
16415204|NCT01424566|40001655|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
16415205|NCT01424566|40001656|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
16415206|NCT01424566|40001657|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
16415207|NCT01424566|40001655|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
16415208|NCT01424566|40001656|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
16415209|NCT01424566|40001657|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
16415210|NCT01424566|40001655|FG000|Double-blind Treatment|Adverse Event|0|||
16415211|NCT01424566|40001656|FG001|Double-blind Treatment|Adverse Event|21|||
16415212|NCT01424566|40001657|FG002|Double-blind Treatment|Adverse Event|13|||
16415213|NCT01424566|40001655|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
16415214|NCT01424566|40001656|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
16415215|NCT01424566|40001657|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
16415216|NCT01424566|40001655|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
16415217|NCT01424566|40001656|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
16415218|NCT01424566|40001657|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
16415219|NCT01424566|40001655|FG000|Double-blind Treatment|Lack of Efficacy|0|||
16415220|NCT01424566|40001656|FG001|Double-blind Treatment|Lack of Efficacy|1|||
16415221|NCT01424566|40001657|FG002|Double-blind Treatment|Lack of Efficacy|1|||
16415222|NCT04881747|40001658|FG000|Period 2 Washout|Adverse Event|1|||
16415223|NCT04881747|40001659|FG001|Period 2 Washout|Adverse Event|0|||
16415224|NCT04881747|40001660|FG002|Period 2 Washout|Adverse Event|0|||
16415225|NCT04881747|40001661|FG003|Period 2 Washout|Adverse Event|0|||
16243225|NCT00575328|39374929|FG001|Overall Study|Adverse Event|1|||
16415226|NCT04881747|40001662|FG004|Period 2 Washout|Adverse Event|1|||
16415227|NCT04881747|40001663|FG005|Period 2 Washout|Adverse Event|0|||
16415228|NCT04881747|40001658|FG000|Period 2 Washout|Withdrawal by Subject|1|||
16415229|NCT04881747|40001659|FG001|Period 2 Washout|Withdrawal by Subject|0|||
16415230|NCT04881747|40001660|FG002|Period 2 Washout|Withdrawal by Subject|0|||
16415231|NCT04881747|40001661|FG003|Period 2 Washout|Withdrawal by Subject|1|||
16415232|NCT04881747|40001662|FG004|Period 2 Washout|Withdrawal by Subject|0|||
16415233|NCT04881747|40001663|FG005|Period 2 Washout|Withdrawal by Subject|0|||
16415234|NCT00286221|40001668|FG000|Overall Study|Protocol Violation|2|||
16415235|NCT00286221|40001669|FG001|Overall Study|Protocol Violation|1|||
16415236|NCT00286221|40001670|FG002|Overall Study|Protocol Violation|6|||
16415237|NCT00286221|40001671|FG003|Overall Study|Protocol Violation|4|||
16415238|NCT00286221|40001668|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
16415239|NCT00286221|40001669|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
16415240|NCT00286221|40001670|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
16415241|NCT00286221|40001671|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
16415242|NCT00286221|40001668|FG000|Overall Study|Inability to trigger PCA|2|||
16415243|NCT00286221|40001669|FG001|Overall Study|Inability to trigger PCA|0|||
16415244|NCT00286221|40001670|FG002|Overall Study|Inability to trigger PCA|0|||
16415245|NCT00286221|40001671|FG003|Overall Study|Inability to trigger PCA|0|||
16415246|NCT00286221|40001668|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
16415247|NCT00286221|40001669|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
16415248|NCT00286221|40001670|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
16415249|NCT00286221|40001671|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
16415250|NCT02558400|40001674|FG000|Overall Study|Adverse Event|47|||
16415251|NCT02558400|40001675|FG001|Overall Study|Adverse Event|53|||
16415252|NCT02558400|40001676|FG002|Overall Study|Adverse Event|4|||
16415253|NCT02558400|40001674|FG000|Overall Study|Withdrawal by Subject|13|||
16415254|NCT02558400|40001675|FG001|Overall Study|Withdrawal by Subject|9|||
16415255|NCT02558400|40001676|FG002|Overall Study|Withdrawal by Subject|8|||
16415256|NCT02558400|40001674|FG000|Overall Study|Non-Compliant|0|||
16415257|NCT02558400|40001675|FG001|Overall Study|Non-Compliant|1|||
16415258|NCT02558400|40001676|FG002|Overall Study|Non-Compliant|3|||
16415259|NCT02558400|40001674|FG000|Overall Study|Lost to Follow-up|5|||
16415260|NCT02558400|40001675|FG001|Overall Study|Lost to Follow-up|5|||
16415261|NCT02558400|40001676|FG002|Overall Study|Lost to Follow-up|4|||
16415262|NCT02558400|40001674|FG000|Overall Study|Lack of Efficacy|0|||
16415263|NCT02558400|40001675|FG001|Overall Study|Lack of Efficacy|13|||
16415264|NCT02558400|40001676|FG002|Overall Study|Lack of Efficacy|1|||
16415265|NCT02558400|40001674|FG000|Overall Study|Disallowed Concurrent Medication|6|||
16415266|NCT02558400|40001675|FG001|Overall Study|Disallowed Concurrent Medication|7|||
16415267|NCT02558400|40001676|FG002|Overall Study|Disallowed Concurrent Medication|5|||
16415268|NCT02558400|40001674|FG000|Overall Study|Physician Decision|2|||
16415269|NCT02558400|40001675|FG001|Overall Study|Physician Decision|2|||
16415270|NCT02558400|40001676|FG002|Overall Study|Physician Decision|0|||
16415271|NCT02558400|40001674|FG000|Overall Study|Protocol Violation|6|||
16415272|NCT02558400|40001675|FG001|Overall Study|Protocol Violation|3|||
16415273|NCT02558400|40001676|FG002|Overall Study|Protocol Violation|8|||
16415274|NCT02558400|40001674|FG000|Overall Study|Death|0|||
16415275|NCT02558400|40001675|FG001|Overall Study|Death|1|||
16415276|NCT02558400|40001676|FG002|Overall Study|Death|0|||
16415277|NCT02558400|40001674|FG000|Overall Study|Ineligible for the study|0|||
16415278|NCT02558400|40001675|FG001|Overall Study|Ineligible for the study|2|||
16415279|NCT02558400|40001676|FG002|Overall Study|Ineligible for the study|0|||
16415280|NCT02177838|40001677|FG000|Overall Study|Withdrawal by Subject|1|||
16415281|NCT02177838|40001677|FG000|Overall Study|Physician Decision|1|||
16415282|NCT02177838|40001677|FG000|Overall Study|Death|1|||
16415283|NCT03134183|40001678|FG000|Overall Study|Withdrawal by Subject|1|||
16243226|NCT00575328|39374928|FG000|Overall Study|Lost to Follow-up|2|||
16243227|NCT00575328|39374929|FG001|Overall Study|Lost to Follow-up|1|||
16243228|NCT01020305|39374930|FG000|Overall Study|Adverse Event|2|||
16243229|NCT00543439|39374931|FG000|Period 1|Adverse Event|0|||
16243230|NCT00543439|39374932|FG001|Period 1|Adverse Event|2|||
16415284|NCT03134183|40001679|FG001|Overall Study|Withdrawal by Subject|1|||
16415285|NCT00350623|40001680|FG000|Overall Study|Lost to Follow-up|8|||
16415286|NCT00350623|40001681|FG001|Overall Study|Lost to Follow-up|3|||
16415287|NCT00350623|40001682|FG002|Overall Study|Lost to Follow-up|4|||
16415288|NCT00350623|40001680|FG000|Overall Study|Withdrawal by Subject|0|||
16415289|NCT00350623|40001681|FG001|Overall Study|Withdrawal by Subject|1|||
16415290|NCT00350623|40001682|FG002|Overall Study|Withdrawal by Subject|1|||
16415291|NCT00350623|40001680|FG000|Overall Study|patient traveling outside the country|0|||
16415292|NCT00350623|40001681|FG001|Overall Study|patient traveling outside the country|0|||
16415293|NCT00350623|40001682|FG002|Overall Study|patient traveling outside the country|1|||
16415294|NCT03769311|40001685|FG000|Overall Study|Withdrawal by Subject|1|||
16415295|NCT02914561|40001686|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
16415296|NCT02914561|40001687|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
16243231|NCT00543439|39374933|FG002|Period 1|Adverse Event|1|||
16243232|NCT00543439|39374931|FG000|Period 1|Withdrawal by Subject|1|||
16415297|NCT02914561|40001688|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
16415298|NCT02914561|40001689|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
16415299|NCT02914561|40001690|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
16415300|NCT02914561|40001691|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
16243233|NCT00543439|39374932|FG001|Period 1|Withdrawal by Subject|1|||
16243234|NCT00543439|39374933|FG002|Period 1|Withdrawal by Subject|0|||
16243235|NCT00543439|39374931|FG000|Period 1|Physician Decision|0|||
16243236|NCT00543439|39374932|FG001|Period 1|Physician Decision|0|||
16243237|NCT00543439|39374933|FG002|Period 1|Physician Decision|1|||
16351312|NCT03327324|39772978|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
16243238|NCT00543439|39374931|FG000|Period 2|Protocol Violation|1|||
16126625|NCT04677179|38949684|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
16126626|NCT04677179|38949685|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
16126627|NCT04677179|38949686|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
16126628|NCT04677179|38949687|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
16126629|NCT04677179|38949688|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
16126630|NCT04677179|38949689|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
16126631|NCT04677179|38949690|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
16126632|NCT04677179|38949691|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
16126633|NCT04677179|38949692|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
16126634|NCT04677179|38949693|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
16126635|NCT04677179|38949684|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
16126636|NCT04677179|38949685|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
16126637|NCT04677179|38949686|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
16126638|NCT04677179|38949687|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
16126639|NCT04677179|38949688|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
16126640|NCT04677179|38949689|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
16126641|NCT04677179|38949690|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
16126642|NCT04677179|38949691|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
16126643|NCT04677179|38949692|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
16126644|NCT04677179|38949693|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
16126645|NCT04677179|38949684|FG000|Extension Treatment Period|Lack of Efficacy|0|||
16126646|NCT04677179|38949685|FG001|Extension Treatment Period|Lack of Efficacy|0|||
16126647|NCT04677179|38949686|FG002|Extension Treatment Period|Lack of Efficacy|0|||
16126648|NCT04677179|38949687|FG003|Extension Treatment Period|Lack of Efficacy|0|||
16126649|NCT04677179|38949688|FG004|Extension Treatment Period|Lack of Efficacy|0|||
16126650|NCT04677179|38949689|FG005|Extension Treatment Period|Lack of Efficacy|0|||
16126651|NCT04677179|38949690|FG006|Extension Treatment Period|Lack of Efficacy|6|||
16126652|NCT04677179|38949691|FG007|Extension Treatment Period|Lack of Efficacy|0|||
16126653|NCT04677179|38949692|FG008|Extension Treatment Period|Lack of Efficacy|0|||
16126654|NCT04677179|38949693|FG009|Extension Treatment Period|Lack of Efficacy|0|||
16126655|NCT04677179|38949684|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
16126656|NCT04677179|38949685|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
16126657|NCT04677179|38949686|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
16126658|NCT04677179|38949687|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
16126659|NCT04677179|38949688|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
16126660|NCT04677179|38949689|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
16126661|NCT04677179|38949690|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
16126662|NCT04677179|38949691|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
16243239|NCT00543439|39374932|FG001|Period 2|Protocol Violation|0|||
16126663|NCT04677179|38949692|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
16126664|NCT04677179|38949693|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
16126665|NCT04677179|38949684|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
16126666|NCT04677179|38949685|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
16126667|NCT04677179|38949686|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
16126668|NCT04677179|38949687|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
16126669|NCT04677179|38949688|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
16126670|NCT04677179|38949689|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
16126671|NCT04677179|38949690|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
16126672|NCT04677179|38949691|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
16126673|NCT04677179|38949692|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
16126674|NCT04677179|38949693|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
16126675|NCT04677179|38949684|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
16126676|NCT04677179|38949685|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
16126677|NCT04677179|38949686|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
16126678|NCT04677179|38949687|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
16126679|NCT04677179|38949688|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
16126680|NCT04677179|38949689|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
16126681|NCT04677179|38949690|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
16126682|NCT04677179|38949691|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
16126683|NCT04677179|38949692|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
16126684|NCT04677179|38949693|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
16126685|NCT04677179|38949684|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
16126686|NCT04677179|38949685|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
16126687|NCT04677179|38949686|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
16126688|NCT04677179|38949687|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
16126689|NCT04677179|38949688|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
16126690|NCT04677179|38949689|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
16126691|NCT04677179|38949690|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
16126692|NCT04677179|38949691|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
16126693|NCT04677179|38949692|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
16126694|NCT04677179|38949693|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
16126695|NCT04677179|38949684|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16126696|NCT04677179|38949685|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16126697|NCT04677179|38949686|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16126698|NCT04677179|38949687|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16126699|NCT04677179|38949688|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16126700|NCT04677179|38949689|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16126701|NCT04677179|38949690|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16126702|NCT04677179|38949691|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
16126703|NCT04677179|38949692|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16126704|NCT04677179|38949693|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16126705|NCT04677179|38949684|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16415301|NCT02914561|40001692|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
16415302|NCT02914561|40001693|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
16126706|NCT04677179|38949685|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16243240|NCT00543439|39374933|FG002|Period 2|Protocol Violation|1|||
16415303|NCT02914561|40001694|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
16415304|NCT02914561|40001695|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
16415305|NCT02914561|40001696|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
16415306|NCT02914561|40001686|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
16558524|NCT00335153|40510027|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
16558525|NCT00335153|40510027|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
16558526|NCT00335153|40510027|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
16558527|NCT00335153|40510027|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
16558528|NCT00335153|40510027|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
16558529|NCT00335153|40510027|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
16558530|NCT00335153|40510027|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
16558531|NCT00335153|40510027|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
16558532|NCT00335153|40510027|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
16558533|NCT00738530|40510028|FG000|Overall Study|Death|220|||
16558534|NCT00738530|40510029|FG001|Overall Study|Death|224|||
16558535|NCT00738530|40510028|FG000|Overall Study|Lost to Follow-up|8|||
16558536|NCT00738530|40510029|FG001|Overall Study|Lost to Follow-up|6|||
16558537|NCT00738530|40510028|FG000|Overall Study|Withdrawal by Subject|6|||
16558538|NCT00738530|40510029|FG001|Overall Study|Withdrawal by Subject|8|||
16558539|NCT01627340|40510037|FG000|Overall Study|Adverse Event|1|||
16558540|NCT01627340|40510038|FG001|Overall Study|Adverse Event|0|||
16558541|NCT01627340|40510037|FG000|Overall Study|Lost to Follow-up|8|||
16558542|NCT01627340|40510038|FG001|Overall Study|Lost to Follow-up|4|||
16558543|NCT01627340|40510037|FG000|Overall Study|Pregnancy|1|||
16558544|NCT01627340|40510038|FG001|Overall Study|Pregnancy|0|||
16558545|NCT01627340|40510037|FG000|Overall Study|Withdrawal by Subject|2|||
16558546|NCT01627340|40510038|FG001|Overall Study|Withdrawal by Subject|0|||
16558547|NCT00802659|40510039|FG000|Overall Study|Physician Decision|0|||
16558548|NCT00802659|40510040|FG001|Overall Study|Physician Decision|1|||
16558549|NCT00802659|40510041|FG002|Overall Study|Physician Decision|0|||
16558550|NCT00802659|40510042|FG003|Overall Study|Physician Decision|0|||
16558551|NCT03056040|40510043|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
16558552|NCT03056040|40510044|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
16558553|NCT03056040|40510043|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
16558554|NCT03056040|40510044|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
16415307|NCT02914561|40001687|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
16415308|NCT02914561|40001688|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
16415309|NCT02914561|40001689|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
16415310|NCT02914561|40001690|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
16415311|NCT02914561|40001691|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
16415312|NCT02914561|40001692|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
16415313|NCT02914561|40001693|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
16415314|NCT02914561|40001694|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
16415315|NCT02914561|40001695|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
16415316|NCT02914561|40001696|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
16415317|NCT02914561|40001686|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
16415318|NCT02914561|40001687|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
16415319|NCT02914561|40001688|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
16415320|NCT02914561|40001689|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
16415321|NCT02914561|40001690|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
16415322|NCT02914561|40001691|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
16415323|NCT02914561|40001692|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
16415324|NCT02914561|40001693|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
16415325|NCT02914561|40001694|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
16243241|NCT00543439|39374931|FG000|Period 2|Adverse Event|0|||
16558555|NCT03056040|40510043|FG000|Primary Evaluation Period|Pregnancy|0|||
16126707|NCT04677179|38949686|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16415326|NCT02914561|40001695|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
16415327|NCT02914561|40001696|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
16415328|NCT02914561|40001686|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
16415329|NCT02914561|40001687|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
16415330|NCT02914561|40001688|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
16415331|NCT02914561|40001689|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
16415332|NCT02914561|40001690|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
16415333|NCT02914561|40001691|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
16415334|NCT02914561|40001692|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
16415335|NCT02914561|40001693|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
16415336|NCT02914561|40001694|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
16415337|NCT02914561|40001695|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
16415338|NCT02914561|40001696|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
16415339|NCT02914561|40001686|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
16415340|NCT02914561|40001687|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
16415341|NCT02914561|40001688|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
16415342|NCT02914561|40001689|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
16415343|NCT02914561|40001690|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
16415344|NCT02914561|40001691|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
16415345|NCT02914561|40001692|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
16415346|NCT02914561|40001693|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
16415347|NCT02914561|40001694|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
16415348|NCT02914561|40001695|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
16415349|NCT02914561|40001696|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
16415350|NCT02914561|40001686|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
16415351|NCT02914561|40001687|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
16415352|NCT02914561|40001688|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
16415353|NCT02914561|40001689|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
16415354|NCT02914561|40001690|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
16415355|NCT02914561|40001691|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
16415356|NCT02914561|40001692|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
16415357|NCT02914561|40001693|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
16415358|NCT02914561|40001694|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
16415359|NCT02914561|40001695|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
16415360|NCT02914561|40001696|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
16415361|NCT02914561|40001686|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
16415362|NCT02914561|40001687|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
16415363|NCT02914561|40001688|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
16415364|NCT02914561|40001689|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
16415365|NCT02914561|40001690|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
16415366|NCT02914561|40001691|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
16415367|NCT02914561|40001692|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
16415368|NCT02914561|40001693|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
16415369|NCT02914561|40001694|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
16415370|NCT02914561|40001695|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
16415371|NCT02914561|40001696|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
16415372|NCT02914561|40001686|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
16415373|NCT02914561|40001687|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
16415374|NCT02914561|40001688|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
16415375|NCT02914561|40001689|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
16415376|NCT02914561|40001690|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
16415377|NCT02914561|40001691|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
16415378|NCT02914561|40001692|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
16415379|NCT02914561|40001693|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
16415380|NCT02914561|40001694|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
16415381|NCT02914561|40001695|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
16415382|NCT02914561|40001696|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
16415383|NCT02914561|40001686|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
16415384|NCT02914561|40001687|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
16415385|NCT02914561|40001688|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
16415386|NCT02914561|40001689|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
16415387|NCT02914561|40001690|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
16415388|NCT02914561|40001691|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
16415389|NCT02914561|40001692|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
16415390|NCT02914561|40001693|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
16415391|NCT02914561|40001694|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
16415392|NCT02914561|40001695|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
16415393|NCT02914561|40001696|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
16415394|NCT02914561|40001686|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
16415395|NCT02914561|40001687|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
16415396|NCT02914561|40001688|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
16415397|NCT02914561|40001689|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
16415398|NCT02914561|40001690|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
16415399|NCT02914561|40001691|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
16415400|NCT02914561|40001692|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
16415401|NCT02914561|40001693|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
16415402|NCT02914561|40001694|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
16415403|NCT02914561|40001695|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
16415404|NCT02914561|40001696|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
16415405|NCT02914561|40001686|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
16415406|NCT02914561|40001687|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
16415407|NCT02914561|40001688|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
16415408|NCT02914561|40001689|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
16415409|NCT02914561|40001690|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
16415410|NCT02914561|40001691|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
16415411|NCT02914561|40001692|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
16415412|NCT02914561|40001693|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
16415413|NCT02914561|40001694|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
16415414|NCT02914561|40001695|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
16415415|NCT02914561|40001696|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
16415416|NCT02914561|40001686|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
16415417|NCT02914561|40001687|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
16415418|NCT02914561|40001688|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
16415419|NCT02914561|40001689|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
16415420|NCT02914561|40001690|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
16415421|NCT02914561|40001691|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
16415422|NCT02914561|40001692|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
16415423|NCT02914561|40001693|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
16415424|NCT02914561|40001694|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
16415425|NCT02914561|40001695|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
16415426|NCT02914561|40001696|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
16415427|NCT02914561|40001686|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
16415428|NCT02914561|40001687|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
16415429|NCT02914561|40001688|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
16415430|NCT02914561|40001689|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
16415431|NCT02914561|40001690|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
16415432|NCT02914561|40001691|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
16415433|NCT02914561|40001692|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
16415434|NCT02914561|40001693|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
16415435|NCT02914561|40001694|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
16415436|NCT02914561|40001695|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
16415437|NCT02914561|40001696|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
16415438|NCT02914561|40001686|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
16415439|NCT02914561|40001687|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
16415440|NCT02914561|40001688|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
16415441|NCT02914561|40001689|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
16415442|NCT02914561|40001690|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
16415443|NCT02914561|40001691|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
16415444|NCT02914561|40001692|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
16415445|NCT02914561|40001693|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
16415446|NCT02914561|40001694|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
16415447|NCT02914561|40001695|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
16415448|NCT02914561|40001696|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
16415449|NCT02914561|40001686|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
16415450|NCT02914561|40001687|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
16415451|NCT02914561|40001688|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
16415452|NCT02914561|40001689|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
16415453|NCT02914561|40001690|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
16415454|NCT02914561|40001691|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
16415455|NCT02914561|40001692|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
16415456|NCT02914561|40001693|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
16415457|NCT02914561|40001694|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
16415458|NCT02914561|40001695|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
16415459|NCT02914561|40001696|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
16415460|NCT02914561|40001686|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
16415461|NCT02914561|40001687|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
16415462|NCT02914561|40001688|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
16415463|NCT02914561|40001689|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
16415464|NCT02914561|40001690|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
16415465|NCT02914561|40001691|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
16415466|NCT02914561|40001692|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
16415467|NCT02914561|40001693|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
16415468|NCT02914561|40001694|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
16415469|NCT02914561|40001695|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
16415470|NCT02914561|40001696|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
16415471|NCT02914561|40001686|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
16415472|NCT02914561|40001687|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
16415473|NCT02914561|40001688|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
16415474|NCT02914561|40001689|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
16415475|NCT02914561|40001690|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
16415476|NCT02914561|40001691|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
16415477|NCT02914561|40001692|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
16126708|NCT04677179|38949687|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16415478|NCT02914561|40001693|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
16415479|NCT02914561|40001694|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
16415480|NCT02914561|40001695|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
16415481|NCT02914561|40001696|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
16415482|NCT02759315|40001699|FG000|Overall Study|Adverse Event|0|||
16415483|NCT02759315|40001700|FG001|Overall Study|Adverse Event|0|||
16415484|NCT02759315|40001701|FG002|Overall Study|Adverse Event|0|||
16415485|NCT02759315|40001702|FG003|Overall Study|Adverse Event|1|||
16415486|NCT02759315|40001703|FG004|Overall Study|Adverse Event|0|||
16126709|NCT04677179|38949688|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16126710|NCT04677179|38949689|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16126711|NCT04677179|38949690|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16126712|NCT04677179|38949691|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
16126713|NCT04677179|38949692|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
16126714|NCT04677179|38949693|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16126715|NCT04677179|38949684|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
16126716|NCT04677179|38949685|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
16126717|NCT04677179|38949686|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
16126718|NCT04677179|38949687|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
16126719|NCT04677179|38949688|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
16126720|NCT04677179|38949689|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
16126721|NCT04677179|38949690|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
16126722|NCT04677179|38949691|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
16126723|NCT04677179|38949692|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
16126724|NCT04677179|38949693|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
16126725|NCT02495792|38949694|FG000|Overall Study|Lost to Follow-up|5|||
16126726|NCT02495792|38949695|FG001|Overall Study|Lost to Follow-up|9|||
16126727|NCT02495792|38949694|FG000|Overall Study|Protocol Violation|32|||
16126728|NCT02495792|38949695|FG001|Overall Study|Protocol Violation|31|||
16126729|NCT02081417|38949696|FG000|Overall Study|Lost to Follow-up|26|||
16126730|NCT02081417|38949697|FG001|Overall Study|Lost to Follow-up|23|||
16126731|NCT02081417|38949696|FG000|Overall Study|Moved Away|1|||
16126732|NCT02081417|38949697|FG001|Overall Study|Moved Away|2|||
16126733|NCT02081417|38949696|FG000|Overall Study|Incarcerated|2|||
16126734|NCT02081417|38949697|FG001|Overall Study|Incarcerated|2|||
16126735|NCT02081417|38949696|FG000|Overall Study|Death|4|||
16126736|NCT02081417|38949697|FG001|Overall Study|Death|3|||
16126737|NCT02081417|38949696|FG000|Overall Study|Withdrawal by Subject|4|||
16126738|NCT02081417|38949697|FG001|Overall Study|Withdrawal by Subject|0|||
16126739|NCT02081417|38949696|FG000|Overall Study|Admitted to Residential Treatment|2|||
16126740|NCT02081417|38949697|FG001|Overall Study|Admitted to Residential Treatment|0|||
16126741|NCT02081417|38949696|FG000|Overall Study|Did not start treatment|17|||
16126742|NCT02081417|38949697|FG001|Overall Study|Did not start treatment|21|||
16126743|NCT03482466|38949698|FG000|Overall Study|Protocol Violation|2|||
16126744|NCT00621777|38949701|FG000|Open Phase|Adverse Event|20|||
16126745|NCT00621777|38949702|FG001|Open Phase|Adverse Event|0|||
16126746|NCT00621777|38949701|FG000|Open Phase|Did not abstain during open phase|56|||
16126747|NCT00621777|38949702|FG001|Open Phase|Did not abstain during open phase|0|||
16126748|NCT00621777|38949701|FG000|Open Phase|Withdrawal by Subject|17|||
16126749|NCT00621777|38949702|FG001|Open Phase|Withdrawal by Subject|0|||
16126750|NCT00621777|38949701|FG000|Open Phase|administrative|13|||
16126751|NCT00621777|38949702|FG001|Open Phase|administrative|0|||
16126752|NCT00621777|38949701|FG000|Open Phase|Lost to Follow-up|10|||
16126753|NCT00621777|38949702|FG001|Open Phase|Lost to Follow-up|0|||
16126754|NCT00621777|38949701|FG000|Randomized Phase|Adverse Event|3|||
16126755|NCT00621777|38949702|FG001|Randomized Phase|Adverse Event|3|||
16126756|NCT00621777|38949701|FG000|Randomized Phase|Lost to Follow-up|3|||
16126757|NCT00621777|38949702|FG001|Randomized Phase|Lost to Follow-up|3|||
16126758|NCT00621777|38949701|FG000|Randomized Phase|Withdrawal by Subject|1|||
16126759|NCT00621777|38949702|FG001|Randomized Phase|Withdrawal by Subject|9|||
16126760|NCT00621777|38949701|FG000|Randomized Phase|administrative|0|||
16126761|NCT00621777|38949702|FG001|Randomized Phase|administrative|3|||
16126762|NCT00621777|38949701|FG000|Randomized Phase|Death|0|||
16126763|NCT00621777|38949702|FG001|Randomized Phase|Death|1|||
16126764|NCT02003573|38949710|FG000|Overall Study|Progressive disease|2|||
16126765|NCT02003573|38949711|FG001|Overall Study|Progressive disease|0|||
16126766|NCT02003573|38949712|FG002|Overall Study|Progressive disease|1|||
16126767|NCT02003573|38949710|FG000|Overall Study|Other Adverse event|0|||
16126768|NCT02003573|38949711|FG001|Overall Study|Other Adverse event|1|||
16126769|NCT02003573|38949712|FG002|Overall Study|Other Adverse event|1|||
16126770|NCT02003573|38949710|FG000|Overall Study|Refuse to take trial medication|0|||
16126771|NCT02003573|38949711|FG001|Overall Study|Refuse to take trial medication|1|||
16126772|NCT02003573|38949712|FG002|Overall Study|Refuse to take trial medication|1|||
16126773|NCT02003573|38949710|FG000|Overall Study|Other than specified|1|||
16126774|NCT02003573|38949711|FG001|Overall Study|Other than specified|2|||
16126775|NCT02003573|38949712|FG002|Overall Study|Other than specified|3|||
16126776|NCT00618618|38949713|FG000|Overall Study|Patient Request|0|||
16126777|NCT00618618|38949714|FG001|Overall Study|Patient Request|0|||
16243242|NCT00543439|39374932|FG001|Period 2|Adverse Event|1|||
16243243|NCT00543439|39374933|FG002|Period 2|Adverse Event|1|||
16243244|NCT00789828|39374934|FG000|Core Period (48 Weeks)|Administrative problems|0|||
16243245|NCT00789828|39374935|FG001|Core Period (48 Weeks)|Administrative problems|1|||
16243246|NCT00789828|39374934|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
16243247|NCT00789828|39374935|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
16243248|NCT00789828|39374934|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
16415487|NCT02759315|40001699|FG000|Overall Study|Death|0|||
16415488|NCT02759315|40001700|FG001|Overall Study|Death|0|||
16415489|NCT02759315|40001701|FG002|Overall Study|Death|1|||
16415490|NCT02759315|40001702|FG003|Overall Study|Death|0|||
16415491|NCT02759315|40001703|FG004|Overall Study|Death|0|||
16415492|NCT02759315|40001699|FG000|Overall Study|Lost to Follow-up|2|||
16415493|NCT02759315|40001700|FG001|Overall Study|Lost to Follow-up|0|||
16415494|NCT02759315|40001701|FG002|Overall Study|Lost to Follow-up|4|||
16415495|NCT02759315|40001702|FG003|Overall Study|Lost to Follow-up|0|||
16415496|NCT02759315|40001703|FG004|Overall Study|Lost to Follow-up|0|||
16415497|NCT02759315|40001699|FG000|Overall Study|Protocol Violation|0|||
16415498|NCT02759315|40001700|FG001|Overall Study|Protocol Violation|1|||
16415499|NCT02759315|40001701|FG002|Overall Study|Protocol Violation|0|||
16415500|NCT02759315|40001702|FG003|Overall Study|Protocol Violation|0|||
16415501|NCT02759315|40001703|FG004|Overall Study|Protocol Violation|0|||
16415502|NCT02759315|40001699|FG000|Overall Study|Study terminated prior to completion|2|||
16243249|NCT00789828|39374935|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
16243250|NCT00789828|39374934|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
16243251|NCT00789828|39374935|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
16243252|NCT00789828|39374934|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
16243253|NCT00789828|39374935|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
16243254|NCT00789828|39374934|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
16415503|NCT02759315|40001700|FG001|Overall Study|Study terminated prior to completion|0|||
16558556|NCT03056040|40510044|FG001|Primary Evaluation Period|Pregnancy|1|||
16558557|NCT03056040|40510043|FG000|Extension Period|Physician Decision|3|||
16558558|NCT03056040|40510044|FG001|Extension Period|Physician Decision|3|||
16558559|NCT03056040|40510043|FG000|Extension Period|Lost to Follow-up|0|||
16558560|NCT03056040|40510044|FG001|Extension Period|Lost to Follow-up|1|||
16558561|NCT03056040|40510043|FG000|Extension Period|Death|0|||
16558562|NCT03056040|40510044|FG001|Extension Period|Death|3|||
16558563|NCT03056040|40510043|FG000|Extension Period|Withdrawal by Subject|1|||
16558564|NCT03056040|40510044|FG001|Extension Period|Withdrawal by Subject|0|||
16558565|NCT01473420|40510045|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
16558566|NCT01473420|40510046|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
16558567|NCT01473420|40510045|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
16558568|NCT01473420|40510046|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
16558569|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
16558570|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
16558571|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
16558572|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
16558573|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
16558574|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
16558575|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
16558576|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
16558577|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
16558578|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
16558579|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
16558580|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
16126778|NCT00618618|38949715|FG002|Overall Study|Patient Request|2|||
16126779|NCT00618618|38949716|FG003|Overall Study|Patient Request|0|||
16243255|NCT00789828|39374935|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
16126780|NCT00618618|38949713|FG000|Overall Study|Inability to Complete Study Procedures|0|||
16243256|NCT00789828|39374934|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
16415504|NCT02759315|40001701|FG002|Overall Study|Study terminated prior to completion|5|||
16243257|NCT00789828|39374935|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
16243258|NCT00789828|39374934|FG000|Open-label Extension Period (4 Years)|Death|1|||
16243259|NCT00789828|39374935|FG001|Open-label Extension Period (4 Years)|Death|0|||
16243260|NCT00789828|39374934|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
16243261|NCT00789828|39374935|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
16243262|NCT00789828|39374934|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
16243263|NCT00789828|39374935|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
16243264|NCT02499354|39374936|FG000|Overall Study|Withdrawal by Subject|1|||
16243265|NCT02499354|39374937|FG001|Overall Study|Withdrawal by Subject|0|||
16243266|NCT02984683|39374938|FG000|Overall Study|Adverse Event|3|||
16243267|NCT02984683|39374939|FG001|Overall Study|Adverse Event|3|||
16243268|NCT02984683|39374938|FG000|Overall Study|Withdrawal by Subject|1|||
16415505|NCT02759315|40001702|FG003|Overall Study|Study terminated prior to completion|0|||
16415506|NCT02759315|40001703|FG004|Overall Study|Study terminated prior to completion|1|||
16415507|NCT02535416|40001708|FG000|Overall Study|Family bereavement overseas|1|||
16415508|NCT02535416|40001709|FG001|Overall Study|Family bereavement overseas|0|||
16415509|NCT02535416|40001710|FG002|Overall Study|Family bereavement overseas|0|||
16558581|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
16558582|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
16558583|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
16558584|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
16558585|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
16558586|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
16558587|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
16558588|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
16558589|NCT01473420|40510045|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
16558590|NCT01473420|40510046|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
16558591|NCT03523871|40510049|FG000|Overall Study|Death|1|||
16558592|NCT03398356|40510050|FG000|Before Treatment|Lost to Follow-up|1|||
16558593|NCT03398356|40510051|FG001|Before Treatment|Lost to Follow-up|2|||
16558594|NCT03398356|40510052|FG002|Before Treatment|Lost to Follow-up|0|||
16558595|NCT03398356|40510050|FG000|Before Treatment|drug intolerance|2|||
16558596|NCT03398356|40510051|FG001|Before Treatment|drug intolerance|1|||
16558597|NCT03398356|40510052|FG002|Before Treatment|drug intolerance|0|||
16558598|NCT03398356|40510050|FG000|Before Treatment|Withdrawal by Subject|0|||
16558599|NCT03398356|40510051|FG001|Before Treatment|Withdrawal by Subject|5|||
16558600|NCT03398356|40510052|FG002|Before Treatment|Withdrawal by Subject|0|||
16558601|NCT03398356|40510050|FG000|Before Treatment|Physician Decision|0|||
16558602|NCT03398356|40510051|FG001|Before Treatment|Physician Decision|0|||
16558603|NCT03398356|40510052|FG002|Before Treatment|Physician Decision|11|||
16558604|NCT03398356|40510050|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
16558605|NCT03398356|40510051|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
16558606|NCT03398356|40510052|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
16558607|NCT01004263|40510053|FG000|Overall Study|Adverse Event|15|||
16558608|NCT01004263|40510053|FG000|Overall Study|Withdrawal by Subject|58|||
16558609|NCT01004263|40510053|FG000|Overall Study|Protocol Violation|10|||
16558610|NCT01004263|40510053|FG000|Overall Study|Lost to Follow-up|64|||
16558611|NCT01004263|40510053|FG000|Overall Study|Lack of Efficacy|13|||
16558612|NCT01004263|40510053|FG000|Overall Study|Pregnancy|2|||
16558613|NCT01004263|40510053|FG000|Overall Study|Physician Decision|15|||
16558614|NCT01004263|40510053|FG000|Overall Study|Lack of Qualifying Event|2|||
16558615|NCT02240680|40510056|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
16558616|NCT02240680|40510057|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
16558617|NCT02240680|40510058|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
16558618|NCT02240680|40510059|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
16558619|NCT02240680|40510056|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
16558620|NCT02240680|40510057|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
16558621|NCT02240680|40510058|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
16558622|NCT02240680|40510059|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
16415510|NCT02535416|40001711|FG003|Overall Study|Family bereavement overseas|0|||
16415511|NCT02535416|40001712|FG004|Overall Study|Family bereavement overseas|0|||
16415512|NCT02535416|40001713|FG005|Overall Study|Family bereavement overseas|0|||
16415513|NCT02535416|40001714|FG006|Overall Study|Family bereavement overseas|0|||
16415514|NCT02535416|40001715|FG007|Overall Study|Family bereavement overseas|0|||
16415515|NCT02535416|40001716|FG008|Overall Study|Family bereavement overseas|0|||
16558623|NCT02240680|40510056|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
16558624|NCT02240680|40510057|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
16243269|NCT02984683|39374939|FG001|Overall Study|Withdrawal by Subject|0|||
16243270|NCT02984683|39374938|FG000|Overall Study|Disease progression|7|||
16243271|NCT02984683|39374939|FG001|Overall Study|Disease progression|9|||
16243272|NCT00461500|39374940|FG000|Overall Study|Adverse Event|1|||
16243273|NCT00461500|39374941|FG001|Overall Study|Adverse Event|0|||
16243274|NCT00461500|39374940|FG000|Overall Study|Lack of Efficacy|0|||
16243275|NCT00461500|39374941|FG001|Overall Study|Lack of Efficacy|1|||
16243276|NCT00461500|39374940|FG000|Overall Study|Expired Drug Treatment|1|||
16243277|NCT00461500|39374941|FG001|Overall Study|Expired Drug Treatment|1|||
16243278|NCT00461500|39374940|FG000|Overall Study|Study Stopped|1|||
16243279|NCT00461500|39374941|FG001|Overall Study|Study Stopped|2|||
16243280|NCT00461500|39374940|FG000|Overall Study|Drug Treatment Misuse|1|||
16243281|NCT00461500|39374941|FG001|Overall Study|Drug Treatment Misuse|0|||
16243282|NCT00461500|39374940|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
16243283|NCT00461500|39374941|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
16243284|NCT00461500|39374940|FG000|Overall Study|Lost to Follow-up|2|||
16243285|NCT00461500|39374941|FG001|Overall Study|Lost to Follow-up|2|||
16243286|NCT02092961|39374942|FG000|Overall Study|Not reported|1|||
16243287|NCT02092961|39374943|FG001|Overall Study|Not reported|0|||
16243288|NCT02092961|39374944|FG002|Overall Study|Not reported|1|||
16243289|NCT02092961|39374942|FG000|Overall Study|Study stopped|13|||
16243290|NCT02092961|39374943|FG001|Overall Study|Study stopped|9|||
16243291|NCT02092961|39374944|FG002|Overall Study|Study stopped|12|||
16243292|NCT02092961|39374942|FG000|Overall Study|Lack of therapeutic response|2|||
16243293|NCT02092961|39374943|FG001|Overall Study|Lack of therapeutic response|1|||
16243294|NCT02092961|39374944|FG002|Overall Study|Lack of therapeutic response|3|||
16243295|NCT02092961|39374942|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
16243296|NCT02092961|39374943|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
16558625|NCT02240680|40510058|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
16558626|NCT02240680|40510059|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
16558627|NCT02240680|40510056|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
16558628|NCT02240680|40510057|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
16558629|NCT02240680|40510058|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
16243297|NCT02092961|39374944|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
16243298|NCT02092961|39374942|FG000|Overall Study|Adverse Event|2|||
16243299|NCT02092961|39374943|FG001|Overall Study|Adverse Event|4|||
16243300|NCT02092961|39374944|FG002|Overall Study|Adverse Event|0|||
16243301|NCT03521999|39374945|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
16243302|NCT03521999|39374946|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
16243303|NCT03521999|39374945|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
16243304|NCT03521999|39374946|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
16243305|NCT03521999|39374945|FG000|Completed 3 Month Follow up|Death|0|||
16243306|NCT03521999|39374946|FG001|Completed 3 Month Follow up|Death|1|||
16415516|NCT03160885|40001717|FG000|Initial Treatment Period|Not dosed|2|||
16126781|NCT00618618|38949714|FG001|Overall Study|Inability to Complete Study Procedures|1|||
16243307|NCT03521999|39374945|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
16243308|NCT03521999|39374946|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
16243309|NCT01835132|39374952|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
16243310|NCT01489956|39374953|FG000|Overall Study|Lost to Follow-up|1|||
16243311|NCT01489956|39374954|FG001|Overall Study|Lost to Follow-up|0|||
16243312|NCT01489956|39374955|FG002|Overall Study|Lost to Follow-up|0|||
16243313|NCT01489956|39374953|FG000|Overall Study|Withdrawal by Subject|0|||
16243314|NCT01489956|39374954|FG001|Overall Study|Withdrawal by Subject|0|||
16243315|NCT01489956|39374955|FG002|Overall Study|Withdrawal by Subject|1|||
16243316|NCT02217345|39374956|FG000|Overall Study|Lost to Follow-up|2|||
16243317|NCT02217345|39374957|FG001|Overall Study|Lost to Follow-up|1|||
16243318|NCT02217345|39374956|FG000|Overall Study|Withdrawal by Subject|3|||
16243319|NCT02217345|39374957|FG001|Overall Study|Withdrawal by Subject|2|||
16243320|NCT02217345|39374956|FG000|Overall Study|Adverse Event|2|||
16243321|NCT02217345|39374957|FG001|Overall Study|Adverse Event|1|||
16243322|NCT02217345|39374956|FG000|Overall Study|Physician Decision|0|||
16243323|NCT02217345|39374957|FG001|Overall Study|Physician Decision|1|||
16243324|NCT00095199|39374958|FG000|Overall Study|Adverse Event|40|||
16243325|NCT00095199|39374959|FG001|Overall Study|Adverse Event|22|||
16243326|NCT00095199|39374960|FG002|Overall Study|Adverse Event|26|||
16243327|NCT00095199|39374961|FG003|Overall Study|Adverse Event|11|||
16243328|NCT00095199|39374958|FG000|Overall Study|Progressive disease|213|||
16243329|NCT00095199|39374959|FG001|Overall Study|Progressive disease|179|||
16243330|NCT00095199|39374960|FG002|Overall Study|Progressive disease|105|||
16243331|NCT00095199|39374961|FG003|Overall Study|Progressive disease|98|||
16243332|NCT00095199|39374958|FG000|Overall Study|Death|10|||
16243333|NCT00095199|39374959|FG001|Overall Study|Death|6|||
16243334|NCT00095199|39374960|FG002|Overall Study|Death|11|||
16243335|NCT00095199|39374961|FG003|Overall Study|Death|9|||
16243336|NCT00095199|39374958|FG000|Overall Study|Withdrawal by Subject|21|||
16243337|NCT00095199|39374959|FG001|Overall Study|Withdrawal by Subject|16|||
16243338|NCT00095199|39374960|FG002|Overall Study|Withdrawal by Subject|13|||
16243339|NCT00095199|39374961|FG003|Overall Study|Withdrawal by Subject|22|||
16243340|NCT00095199|39374958|FG000|Overall Study|Protocol Violation|4|||
16243341|NCT00095199|39374959|FG001|Overall Study|Protocol Violation|4|||
16243342|NCT00095199|39374960|FG002|Overall Study|Protocol Violation|2|||
16243343|NCT00095199|39374961|FG003|Overall Study|Protocol Violation|0|||
16351313|NCT03327324|39772979|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
16558630|NCT02240680|40510059|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
16558631|NCT02240680|40510056|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
16558632|NCT02240680|40510057|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
16558633|NCT02240680|40510058|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
16558634|NCT02240680|40510059|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
16558635|NCT02240680|40510056|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
16558636|NCT02240680|40510057|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
16558637|NCT02240680|40510058|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
16558638|NCT02240680|40510059|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
16558639|NCT02240680|40510056|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
16558640|NCT02240680|40510057|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
16558641|NCT02240680|40510058|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
16351314|NCT03327324|39772980|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
16351315|NCT03327324|39772981|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
16351316|NCT03327324|39772976|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
16351317|NCT03327324|39772977|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
16351318|NCT03327324|39772978|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
16351319|NCT03327324|39772979|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
16558642|NCT02240680|40510059|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
16558643|NCT02240680|40510056|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
16558644|NCT02240680|40510057|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
16243344|NCT00095199|39374958|FG000|Overall Study|Liver function test results elevated|0|||
16243345|NCT00095199|39374959|FG001|Overall Study|Liver function test results elevated|0|||
16243346|NCT00095199|39374960|FG002|Overall Study|Liver function test results elevated|1|||
16243347|NCT00095199|39374961|FG003|Overall Study|Liver function test results elevated|1|||
16243348|NCT00095199|39374958|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
16243349|NCT00095199|39374959|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
16243350|NCT00095199|39374960|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
16243351|NCT00095199|39374961|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
16243352|NCT00095199|39374958|FG000|Overall Study|Physician Decision|5|||
16243353|NCT00095199|39374959|FG001|Overall Study|Physician Decision|6|||
16243354|NCT00095199|39374960|FG002|Overall Study|Physician Decision|1|||
16243355|NCT00095199|39374961|FG003|Overall Study|Physician Decision|1|||
16243356|NCT00095199|39374958|FG000|Overall Study|Not eligible|1|||
16243357|NCT00095199|39374959|FG001|Overall Study|Not eligible|7|||
16243358|NCT00095199|39374960|FG002|Overall Study|Not eligible|0|||
16243359|NCT00095199|39374961|FG003|Overall Study|Not eligible|1|||
16243360|NCT00095199|39374958|FG000|Overall Study|Started Palliative Radiotherapy|1|||
16243361|NCT00095199|39374959|FG001|Overall Study|Started Palliative Radiotherapy|0|||
16243362|NCT00095199|39374960|FG002|Overall Study|Started Palliative Radiotherapy|0|||
16243363|NCT00095199|39374961|FG003|Overall Study|Started Palliative Radiotherapy|0|||
16243364|NCT00095199|39374958|FG000|Overall Study|Started radiotherapy regimen|0|||
16243365|NCT00095199|39374959|FG001|Overall Study|Started radiotherapy regimen|1|||
16243366|NCT00095199|39374960|FG002|Overall Study|Started radiotherapy regimen|0|||
16243367|NCT00095199|39374961|FG003|Overall Study|Started radiotherapy regimen|0|||
16243368|NCT00095199|39374958|FG000|Overall Study|Primary tumor removed in other surgery|0|||
16243369|NCT00095199|39374959|FG001|Overall Study|Primary tumor removed in other surgery|1|||
16243370|NCT00095199|39374960|FG002|Overall Study|Primary tumor removed in other surgery|0|||
16243371|NCT00095199|39374961|FG003|Overall Study|Primary tumor removed in other surgery|0|||
16243372|NCT00095199|39374958|FG000|Overall Study|Data inadvertently lost by site|1|||
16243373|NCT00095199|39374959|FG001|Overall Study|Data inadvertently lost by site|0|||
16243374|NCT00095199|39374960|FG002|Overall Study|Data inadvertently lost by site|0|||
16243375|NCT00095199|39374961|FG003|Overall Study|Data inadvertently lost by site|0|||
16243376|NCT01965652|39374962|FG000|Overall Study|Adverse Event|40|||
16243377|NCT01965652|39374963|FG001|Overall Study|Adverse Event|37|||
16243378|NCT01965652|39374962|FG000|Overall Study|Withdrawal by Subject|62|||
16243379|NCT01965652|39374963|FG001|Overall Study|Withdrawal by Subject|69|||
16243380|NCT01965652|39374962|FG000|Overall Study|Lost to Follow-up|53|||
16243381|NCT01965652|39374963|FG001|Overall Study|Lost to Follow-up|40|||
16243382|NCT01965652|39374962|FG000|Overall Study|Protocol Violation|34|||
16243383|NCT01965652|39374963|FG001|Overall Study|Protocol Violation|38|||
16243384|NCT01965652|39374962|FG000|Overall Study|Death|3|||
16243385|NCT01965652|39374963|FG001|Overall Study|Death|4|||
16243386|NCT01965652|39374962|FG000|Overall Study|Other - Miscellaneous|18|||
16243387|NCT01965652|39374963|FG001|Overall Study|Other - Miscellaneous|21|||
16243388|NCT01965652|39374962|FG000|Overall Study|Pregnancy|0|||
16243389|NCT01965652|39374963|FG001|Overall Study|Pregnancy|1|||
16243390|NCT02454972|39374964|FG000|Overall Study|Progressive disease|17|||
16243391|NCT02454972|39374965|FG001|Overall Study|Progressive disease|16|||
16243392|NCT02454972|39374966|FG002|Overall Study|Progressive disease|59|||
16243393|NCT02454972|39374967|FG003|Overall Study|Progressive disease|23|||
16243394|NCT02454972|39374968|FG004|Overall Study|Progressive disease|16|||
16243395|NCT02454972|39374969|FG005|Overall Study|Progressive disease|12|||
16243396|NCT02454972|39374970|FG006|Overall Study|Progressive disease|19|||
16243397|NCT02454972|39374971|FG007|Overall Study|Progressive disease|27|||
16243398|NCT02454972|39374972|FG008|Overall Study|Progressive disease|0|||
16243399|NCT02454972|39374964|FG000|Overall Study|Death|0|||
16243400|NCT02454972|39374965|FG001|Overall Study|Death|0|||
16243401|NCT02454972|39374966|FG002|Overall Study|Death|5|||
16243402|NCT02454972|39374967|FG003|Overall Study|Death|1|||
16243403|NCT02454972|39374968|FG004|Overall Study|Death|0|||
16243404|NCT02454972|39374969|FG005|Overall Study|Death|0|||
16243405|NCT02454972|39374970|FG006|Overall Study|Death|0|||
16243406|NCT02454972|39374971|FG007|Overall Study|Death|0|||
16243407|NCT02454972|39374972|FG008|Overall Study|Death|95|||
16243408|NCT02454972|39374964|FG000|Overall Study|Physician Decision|0|||
16243409|NCT02454972|39374965|FG001|Overall Study|Physician Decision|1|||
16243410|NCT02454972|39374966|FG002|Overall Study|Physician Decision|2|||
16243411|NCT02454972|39374967|FG003|Overall Study|Physician Decision|1|||
16243412|NCT02454972|39374968|FG004|Overall Study|Physician Decision|2|||
16243413|NCT02454972|39374969|FG005|Overall Study|Physician Decision|0|||
16243414|NCT02454972|39374970|FG006|Overall Study|Physician Decision|0|||
16415517|NCT03160885|40001718|FG001|Initial Treatment Period|Not dosed|0|||
16243415|NCT02454972|39374971|FG007|Overall Study|Physician Decision|1|||
16243416|NCT02454972|39374972|FG008|Overall Study|Physician Decision|0|||
16243417|NCT02454972|39374964|FG000|Overall Study|Non treatment-related adverse event|2|||
16243418|NCT02454972|39374965|FG001|Overall Study|Non treatment-related adverse event|0|||
16243419|NCT02454972|39374966|FG002|Overall Study|Non treatment-related adverse event|1|||
16243420|NCT02454972|39374967|FG003|Overall Study|Non treatment-related adverse event|0|||
16243421|NCT02454972|39374968|FG004|Overall Study|Non treatment-related adverse event|0|||
16243422|NCT02454972|39374969|FG005|Overall Study|Non treatment-related adverse event|1|||
16243423|NCT02454972|39374970|FG006|Overall Study|Non treatment-related adverse event|0|||
16243424|NCT02454972|39374971|FG007|Overall Study|Non treatment-related adverse event|1|||
16243425|NCT02454972|39374972|FG008|Overall Study|Non treatment-related adverse event|0|||
16243426|NCT02454972|39374964|FG000|Overall Study|Treatment-related adverse events|0|||
16243427|NCT02454972|39374965|FG001|Overall Study|Treatment-related adverse events|1|||
16243428|NCT02454972|39374966|FG002|Overall Study|Treatment-related adverse events|1|||
16243429|NCT02454972|39374967|FG003|Overall Study|Treatment-related adverse events|0|||
16243430|NCT02454972|39374968|FG004|Overall Study|Treatment-related adverse events|2|||
16243431|NCT02454972|39374969|FG005|Overall Study|Treatment-related adverse events|0|||
16243432|NCT02454972|39374970|FG006|Overall Study|Treatment-related adverse events|0|||
16243433|NCT02454972|39374971|FG007|Overall Study|Treatment-related adverse events|2|||
16243434|NCT02454972|39374972|FG008|Overall Study|Treatment-related adverse events|0|||
16243435|NCT02454972|39374964|FG000|Overall Study|Patient moves to compassionate use|0|||
16243436|NCT02454972|39374965|FG001|Overall Study|Patient moves to compassionate use|0|||
16243437|NCT02454972|39374966|FG002|Overall Study|Patient moves to compassionate use|0|||
16243438|NCT02454972|39374967|FG003|Overall Study|Patient moves to compassionate use|0|||
16243439|NCT02454972|39374968|FG004|Overall Study|Patient moves to compassionate use|0|||
16243440|NCT02454972|39374969|FG005|Overall Study|Patient moves to compassionate use|0|||
16243441|NCT02454972|39374970|FG006|Overall Study|Patient moves to compassionate use|2|||
16243442|NCT02454972|39374971|FG007|Overall Study|Patient moves to compassionate use|0|||
16243443|NCT02454972|39374972|FG008|Overall Study|Patient moves to compassionate use|0|||
16243444|NCT02454972|39374964|FG000|Overall Study|Withdrawal by Subject|0|||
16243445|NCT02454972|39374965|FG001|Overall Study|Withdrawal by Subject|1|||
16243446|NCT02454972|39374966|FG002|Overall Study|Withdrawal by Subject|5|||
16243447|NCT02454972|39374967|FG003|Overall Study|Withdrawal by Subject|2|||
16243448|NCT02454972|39374968|FG004|Overall Study|Withdrawal by Subject|3|||
16243449|NCT02454972|39374969|FG005|Overall Study|Withdrawal by Subject|2|||
16243450|NCT02454972|39374970|FG006|Overall Study|Withdrawal by Subject|0|||
16243451|NCT02454972|39374971|FG007|Overall Study|Withdrawal by Subject|1|||
16243452|NCT02454972|39374972|FG008|Overall Study|Withdrawal by Subject|2|||
16243453|NCT02454972|39374964|FG000|Overall Study|Multiple delay/holds on treatment|0|||
16243454|NCT02454972|39374965|FG001|Overall Study|Multiple delay/holds on treatment|0|||
16243455|NCT02454972|39374966|FG002|Overall Study|Multiple delay/holds on treatment|0|||
16243456|NCT02454972|39374967|FG003|Overall Study|Multiple delay/holds on treatment|1|||
16243457|NCT02454972|39374968|FG004|Overall Study|Multiple delay/holds on treatment|0|||
16243458|NCT02454972|39374969|FG005|Overall Study|Multiple delay/holds on treatment|0|||
16243459|NCT02454972|39374970|FG006|Overall Study|Multiple delay/holds on treatment|0|||
16243460|NCT02454972|39374971|FG007|Overall Study|Multiple delay/holds on treatment|0|||
16243461|NCT02454972|39374972|FG008|Overall Study|Multiple delay/holds on treatment|0|||
16243462|NCT02454972|39374964|FG000|Overall Study|Never treated|0|||
16243463|NCT02454972|39374965|FG001|Overall Study|Never treated|0|||
16243464|NCT02454972|39374966|FG002|Overall Study|Never treated|3|||
16243465|NCT02454972|39374967|FG003|Overall Study|Never treated|1|||
16243466|NCT02454972|39374968|FG004|Overall Study|Never treated|1|||
16243467|NCT02454972|39374969|FG005|Overall Study|Never treated|0|||
16243468|NCT02454972|39374970|FG006|Overall Study|Never treated|0|||
16243469|NCT02454972|39374971|FG007|Overall Study|Never treated|0|||
16243470|NCT02454972|39374972|FG008|Overall Study|Never treated|5|||
16243471|NCT02454972|39374964|FG000|Overall Study|Lost to Follow-up|0|||
16243472|NCT02454972|39374965|FG001|Overall Study|Lost to Follow-up|0|||
16243473|NCT02454972|39374966|FG002|Overall Study|Lost to Follow-up|0|||
16243474|NCT02454972|39374967|FG003|Overall Study|Lost to Follow-up|0|||
16243475|NCT02454972|39374968|FG004|Overall Study|Lost to Follow-up|0|||
16243476|NCT02454972|39374969|FG005|Overall Study|Lost to Follow-up|0|||
16243477|NCT02454972|39374970|FG006|Overall Study|Lost to Follow-up|0|||
16243478|NCT02454972|39374971|FG007|Overall Study|Lost to Follow-up|0|||
16243479|NCT02454972|39374972|FG008|Overall Study|Lost to Follow-up|2|||
16243480|NCT02454972|39374964|FG000|Overall Study|Study termination|0|||
16243481|NCT02454972|39374965|FG001|Overall Study|Study termination|0|||
16243482|NCT02454972|39374966|FG002|Overall Study|Study termination|0|||
16243483|NCT02454972|39374967|FG003|Overall Study|Study termination|0|||
16243484|NCT02454972|39374968|FG004|Overall Study|Study termination|0|||
16243485|NCT02454972|39374969|FG005|Overall Study|Study termination|0|||
16243486|NCT02454972|39374970|FG006|Overall Study|Study termination|0|||
16243487|NCT02454972|39374971|FG007|Overall Study|Study termination|0|||
16243488|NCT02454972|39374972|FG008|Overall Study|Study termination|6|||
16243489|NCT00736333|39374978|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
16243490|NCT00736333|39374978|FG000|Overall Study|Data Missing|2|||
16243491|NCT00736333|39374978|FG000|Overall Study|Tumor Progression|75|||
16243492|NCT00736333|39374978|FG000|Overall Study|Toxicity|6|||
16243493|NCT00736333|39374978|FG000|Overall Study|Withdrawal by Subject|10|||
16243494|NCT00736333|39374978|FG000|Overall Study|Death|7|||
16243495|NCT00736333|39374978|FG000|Overall Study|Other|4|||
16126782|NCT00618618|38949715|FG002|Overall Study|Inability to Complete Study Procedures|0|||
16126783|NCT00618618|38949716|FG003|Overall Study|Inability to Complete Study Procedures|0|||
16126784|NCT00618618|38949713|FG000|Overall Study|Lost to Follow-up|3|||
16126785|NCT00618618|38949714|FG001|Overall Study|Lost to Follow-up|0|||
16126786|NCT00618618|38949715|FG002|Overall Study|Lost to Follow-up|0|||
16126787|NCT00618618|38949716|FG003|Overall Study|Lost to Follow-up|1|||
16126788|NCT00618618|38949713|FG000|Overall Study|Non-compliance|1|||
16126789|NCT00618618|38949714|FG001|Overall Study|Non-compliance|1|||
16126790|NCT00618618|38949715|FG002|Overall Study|Non-compliance|0|||
16126791|NCT00618618|38949716|FG003|Overall Study|Non-compliance|0|||
16126792|NCT00618618|38949713|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
16126793|NCT00618618|38949714|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
16126794|NCT00618618|38949715|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
16126795|NCT00618618|38949716|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
16126796|NCT00618618|38949713|FG000|Overall Study|Death|0|||
16126797|NCT00618618|38949714|FG001|Overall Study|Death|1|||
16126798|NCT00618618|38949715|FG002|Overall Study|Death|0|||
16126799|NCT00618618|38949716|FG003|Overall Study|Death|0|||
16126800|NCT03291288|38949718|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
16126801|NCT03291288|38949719|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
16126802|NCT03291288|38949718|FG000|Drug-drug Interaction Phase|Disease progression|1|||
16126803|NCT03291288|38949719|FG001|Drug-drug Interaction Phase|Disease progression|0|||
16126804|NCT03291288|38949718|FG000|Drug-drug Interaction Phase|Other|3|||
16126805|NCT03291288|38949719|FG001|Drug-drug Interaction Phase|Other|0|||
16126806|NCT03291288|38949718|FG000|Pexidartinib Only|Ongoing|0|||
16126807|NCT03291288|38949719|FG001|Pexidartinib Only|Ongoing|2|||
16126808|NCT00766363|38949720|FG000|Overall Study|Withdrawal by Subject|1|||
16126809|NCT00766363|38949721|FG001|Overall Study|Withdrawal by Subject|0|||
16126810|NCT00766363|38949722|FG002|Overall Study|Withdrawal by Subject|0|||
16126811|NCT00766363|38949723|FG003|Overall Study|Withdrawal by Subject|0|||
16558645|NCT02240680|40510058|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
16126812|NCT00766363|38949720|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
16558646|NCT02240680|40510059|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
16558647|NCT00958009|40510060|FG000|Overall Study|Adverse Event|1|||
16558648|NCT00958009|40510060|FG000|Overall Study|Subject found device difficult to use|1|||
16558649|NCT02080520|40510061|FG000|Overall Study|Self-reported symptoms|5|||
16558650|NCT02080520|40510062|FG001|Overall Study|Self-reported symptoms|6|||
16558651|NCT02080520|40510061|FG000|Overall Study|Unable to contact|2|||
16558652|NCT02080520|40510062|FG001|Overall Study|Unable to contact|1|||
16558653|NCT02080520|40510061|FG000|Overall Study|Initiated aspirin|2|||
16558654|NCT02080520|40510062|FG001|Overall Study|Initiated aspirin|0|||
16558655|NCT02080520|40510061|FG000|Overall Study|Atrial fibrillation|1|||
16558656|NCT02080520|40510062|FG001|Overall Study|Atrial fibrillation|1|||
16558657|NCT02080520|40510061|FG000|Overall Study|Cancer|1|||
16558658|NCT02080520|40510062|FG001|Overall Study|Cancer|2|||
16558659|NCT02080520|40510061|FG000|Overall Study|Not interested in study|1|||
16126813|NCT00766363|38949721|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
16126814|NCT00766363|38949722|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
16126815|NCT00766363|38949723|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
16126816|NCT01631227|38949724|FG000|Overall Study|withdrawn consent|27|||
16126817|NCT01631227|38949725|FG001|Overall Study|withdrawn consent|21|||
16126818|NCT01631227|38949724|FG000|Overall Study|Adverse Event|1|||
16126819|NCT01631227|38949725|FG001|Overall Study|Adverse Event|0|||
16126820|NCT01631227|38949724|FG000|Overall Study|administrative|2|||
16126821|NCT01631227|38949725|FG001|Overall Study|administrative|1|||
16126822|NCT02150343|38949728|FG000|Overall Study|Adverse Event|2|||
16126823|NCT02150343|38949729|FG001|Overall Study|Adverse Event|0|||
16126824|NCT02150343|38949730|FG002|Overall Study|Adverse Event|1|||
16126825|NCT02150343|38949731|FG003|Overall Study|Adverse Event|1|||
16126826|NCT02150343|38949728|FG000|Overall Study|Withdrawal by Subject|13|||
16126827|NCT02150343|38949729|FG001|Overall Study|Withdrawal by Subject|10|||
16126828|NCT02150343|38949730|FG002|Overall Study|Withdrawal by Subject|9|||
16126829|NCT02150343|38949731|FG003|Overall Study|Withdrawal by Subject|4|||
16126830|NCT02150343|38949728|FG000|Overall Study|Lost to Follow-up|4|||
16126831|NCT02150343|38949729|FG001|Overall Study|Lost to Follow-up|4|||
16126832|NCT02150343|38949730|FG002|Overall Study|Lost to Follow-up|2|||
16126833|NCT02150343|38949731|FG003|Overall Study|Lost to Follow-up|3|||
16126834|NCT02150343|38949728|FG000|Overall Study|Other|2|||
16126835|NCT02150343|38949729|FG001|Overall Study|Other|6|||
16126836|NCT02150343|38949730|FG002|Overall Study|Other|0|||
16126837|NCT02150343|38949731|FG003|Overall Study|Other|2|||
16126838|NCT01049217|38949732|FG000|Overall Study|Adverse Event|2|||
16126839|NCT01049217|38949733|FG001|Overall Study|Adverse Event|1|||
16126840|NCT01049217|38949732|FG000|Overall Study|Lack of Efficacy|1|||
16126841|NCT01049217|38949733|FG001|Overall Study|Lack of Efficacy|1|||
16126842|NCT01049217|38949732|FG000|Overall Study|Lost to Follow-up|3|||
16126843|NCT01049217|38949733|FG001|Overall Study|Lost to Follow-up|8|||
16126844|NCT01049217|38949732|FG000|Overall Study|Withdrawal by Subject|4|||
16126845|NCT01049217|38949733|FG001|Overall Study|Withdrawal by Subject|3|||
16126846|NCT01049217|38949732|FG000|Overall Study|Protocol Violation|1|||
16126847|NCT01049217|38949733|FG001|Overall Study|Protocol Violation|3|||
16126848|NCT01049217|38949732|FG000|Overall Study|Pregnancy|1|||
16126849|NCT01049217|38949733|FG001|Overall Study|Pregnancy|0|||
16126850|NCT01049217|38949732|FG000|Overall Study|Study Terminated by Sponsor|43|||
16126851|NCT01049217|38949733|FG001|Overall Study|Study Terminated by Sponsor|43|||
16126852|NCT01049217|38949732|FG000|Overall Study|Other|1|||
16126853|NCT01049217|38949733|FG001|Overall Study|Other|2|||
16126854|NCT01049217|38949732|FG000|Overall Study|Randomized but not Treated|0|||
16126855|NCT01049217|38949733|FG001|Overall Study|Randomized but not Treated|2|||
16126856|NCT00680901|38949734|FG000|Overall Study|Lost to Follow-up|8|||
16126857|NCT00680901|38949735|FG001|Overall Study|Lost to Follow-up|8|||
16126858|NCT00680901|38949734|FG000|Overall Study|Withdrawal by Subject|4|||
16126859|NCT00680901|38949735|FG001|Overall Study|Withdrawal by Subject|13|||
16415518|NCT03160885|40001719|FG002|Initial Treatment Period|Not dosed|0|||
16415519|NCT03160885|40001720|FG003|Initial Treatment Period|Not dosed|0|||
16415520|NCT03160885|40001721|FG004|Initial Treatment Period|Not dosed|0|||
16415521|NCT03160885|40001722|FG005|Initial Treatment Period|Not dosed|0|||
16415522|NCT03160885|40001723|FG006|Initial Treatment Period|Not dosed|0|||
16415523|NCT03160885|40001717|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
16415524|NCT03160885|40001718|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
16415525|NCT03160885|40001719|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16415526|NCT03160885|40001720|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16415527|NCT03160885|40001721|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16415528|NCT03160885|40001722|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16415529|NCT03160885|40001723|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
16415530|NCT03160885|40001717|FG000|Open-label Treatment|Not dosed|0|||
16415531|NCT03160885|40001718|FG001|Open-label Treatment|Not dosed|0|||
16415532|NCT03160885|40001719|FG002|Open-label Treatment|Not dosed|0|||
16126860|NCT00680901|38949734|FG000|Overall Study|Physician Decision|0|||
16126861|NCT00680901|38949735|FG001|Overall Study|Physician Decision|1|||
16126862|NCT00680901|38949734|FG000|Overall Study|Ongoing: On Study Treatment|16|||
16126863|NCT00680901|38949735|FG001|Overall Study|Ongoing: On Study Treatment|13|||
16126864|NCT00680901|38949734|FG000|Overall Study|Ongoing: In Follow Up|45|||
16126865|NCT00680901|38949735|FG001|Overall Study|Ongoing: In Follow Up|41|||
16126866|NCT01144052|38949736|FG000|Overall Study|Withdrawal by Subject|1|||
16126867|NCT01144052|38949737|FG001|Overall Study|Withdrawal by Subject|1|||
16126868|NCT00777088|38949738|FG000|Overall Study|PED Treatment not attempted|1|||
16173324|NCT01287104|39111177|FG001|Overall Study|NK cells did not meet release criteria|1|||
16173325|NCT01287104|39111178|FG002|Overall Study|NK cells did not meet release criteria|0|||
16173326|NCT01287104|39111179|FG003|Overall Study|NK cells did not meet release criteria|0|||
16173327|NCT00282243|39111180|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
16173328|NCT00282243|39111180|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
16351320|NCT03327324|39772980|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
16173329|NCT00282243|39111180|FG000|Extension Treatment Period|Adverse Event|15|||
16173330|NCT00282243|39111180|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
16173331|NCT00282243|39111180|FG000|Extension Treatment Period|Non-compliance|2|||
16173332|NCT00282243|39111180|FG000|Extension Treatment Period|Physician Decision|1|||
16173333|NCT01856114|39111181|FG000|Overall Study|Withdrawal by Subject|1|||
16173334|NCT01856114|39111182|FG001|Overall Study|Withdrawal by Subject|0|||
16173335|NCT01856114|39111181|FG000|Overall Study|Adverse Event|1|||
16173336|NCT01856114|39111182|FG001|Overall Study|Adverse Event|0|||
16173337|NCT01822561|39111184|FG000|Overall Study|Withdrawal by Subject|2|||
16173338|NCT03157531|39111189|FG000|Overall Study|Death|2|||
16173339|NCT03157531|39111189|FG000|Overall Study|Lost to Follow-up|4|||
16173340|NCT00623831|39111190|FG000|Overall Study|Withdrawal by Subject|1|||
16173341|NCT00623831|39111191|FG001|Overall Study|Withdrawal by Subject|0|||
16173342|NCT00623831|39111190|FG000|Overall Study|Progressive Disease|0|||
16173343|NCT00623831|39111191|FG001|Overall Study|Progressive Disease|1|||
16173344|NCT01147809|39111194|FG000|Phase I (168 Days)|Adverse Event|0|||
16173345|NCT01147809|39111195|FG001|Phase I (168 Days)|Adverse Event|0|||
16351321|NCT03327324|39772981|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
16351322|NCT03327324|39772976|FG000|Intervention (Month 3-Month 6)|Death|1|||
16173346|NCT01147809|39111196|FG002|Phase I (168 Days)|Adverse Event|0|||
16173347|NCT01147809|39111197|FG003|Phase I (168 Days)|Adverse Event|1|||
16351323|NCT03327324|39772977|FG001|Intervention (Month 3-Month 6)|Death|0|||
16173348|NCT01147809|39111198|FG004|Phase I (168 Days)|Adverse Event|0|||
16351324|NCT03327324|39772978|FG002|Intervention (Month 3-Month 6)|Death|1|||
16351325|NCT03327324|39772979|FG003|Intervention (Month 3-Month 6)|Death|1|||
16351326|NCT03327324|39772980|FG004|Intervention (Month 3-Month 6)|Death|1|||
16351327|NCT03327324|39772981|FG005|Intervention (Month 3-Month 6)|Death|0|||
16351328|NCT03327324|39772976|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351329|NCT03327324|39772977|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16126869|NCT01012817|38951533|FG000|Overall Study|Withdrawal by Subject|0|||
16126870|NCT01012817|38951534|FG001|Overall Study|Withdrawal by Subject|0|||
16126871|NCT01012817|38951535|FG002|Overall Study|Withdrawal by Subject|0|||
16126872|NCT01012817|38951536|FG003|Overall Study|Withdrawal by Subject|1|||
16126873|NCT01012817|38951537|FG004|Overall Study|Withdrawal by Subject|0|||
16126874|NCT01012817|38951538|FG005|Overall Study|Withdrawal by Subject|0|||
16126875|NCT01012817|38951539|FG006|Overall Study|Withdrawal by Subject|0|||
16126876|NCT01012817|38951540|FG007|Overall Study|Withdrawal by Subject|1|||
16126877|NCT01012817|38951541|FG008|Overall Study|Withdrawal by Subject|0|||
16126878|NCT01012817|38951542|FG009|Overall Study|Withdrawal by Subject|0|||
16126879|NCT01012817|38951543|FG010|Overall Study|Withdrawal by Subject|1|||
16126880|NCT01012817|38951544|FG011|Overall Study|Withdrawal by Subject|1|||
16126881|NCT01012817|38951545|FG012|Overall Study|Withdrawal by Subject|0|||
16126882|NCT01012817|38951546|FG013|Overall Study|Withdrawal by Subject|1|||
16126883|NCT01012817|38951533|FG000|Overall Study|Adverse Event|0|||
16126884|NCT01012817|38951534|FG001|Overall Study|Adverse Event|0|||
16126885|NCT01012817|38951535|FG002|Overall Study|Adverse Event|0|||
16126886|NCT01012817|38951536|FG003|Overall Study|Adverse Event|0|||
16126887|NCT01012817|38951537|FG004|Overall Study|Adverse Event|0|||
16126888|NCT01012817|38951538|FG005|Overall Study|Adverse Event|1|||
16126889|NCT01012817|38951539|FG006|Overall Study|Adverse Event|0|||
16126890|NCT01012817|38951540|FG007|Overall Study|Adverse Event|0|||
16415533|NCT03160885|40001720|FG003|Open-label Treatment|Not dosed|0|||
16415534|NCT03160885|40001721|FG004|Open-label Treatment|Not dosed|0|||
16415535|NCT03160885|40001722|FG005|Open-label Treatment|Not dosed|0|||
16415536|NCT03160885|40001723|FG006|Open-label Treatment|Not dosed|2|||
16415537|NCT03160885|40001717|FG000|Open-label Treatment|Discontinued IMP|0|||
16126891|NCT01012817|38951541|FG008|Overall Study|Adverse Event|0|||
16126892|NCT01012817|38951542|FG009|Overall Study|Adverse Event|0|||
16126893|NCT01012817|38951543|FG010|Overall Study|Adverse Event|1|||
16415538|NCT03160885|40001718|FG001|Open-label Treatment|Discontinued IMP|0|||
16415539|NCT03160885|40001719|FG002|Open-label Treatment|Discontinued IMP|0|||
16415540|NCT03160885|40001720|FG003|Open-label Treatment|Discontinued IMP|0|||
16415541|NCT03160885|40001721|FG004|Open-label Treatment|Discontinued IMP|0|||
16415542|NCT03160885|40001722|FG005|Open-label Treatment|Discontinued IMP|0|||
16415543|NCT03160885|40001723|FG006|Open-label Treatment|Discontinued IMP|131|||
16415544|NCT03160885|40001717|FG000|Open-label Treatment|Completed Week 50|0|||
16415545|NCT03160885|40001718|FG001|Open-label Treatment|Completed Week 50|0|||
16415546|NCT03160885|40001719|FG002|Open-label Treatment|Completed Week 50|0|||
16415547|NCT03160885|40001720|FG003|Open-label Treatment|Completed Week 50|0|||
16415548|NCT03160885|40001721|FG004|Open-label Treatment|Completed Week 50|0|||
16415549|NCT03160885|40001722|FG005|Open-label Treatment|Completed Week 50|0|||
16415550|NCT03160885|40001723|FG006|Open-label Treatment|Completed Week 50|4|||
16126894|NCT01012817|38951544|FG011|Overall Study|Adverse Event|0|||
16126895|NCT01012817|38951545|FG012|Overall Study|Adverse Event|0|||
16126896|NCT01012817|38951546|FG013|Overall Study|Adverse Event|1|||
16126897|NCT03940703|38951549|FG000|Overall Study|Still under treatment|31|||
16126898|NCT03940703|38951550|FG001|Overall Study|Still under treatment|0|||
16126899|NCT04152200|38951551|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
16126900|NCT04152200|38951552|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
16126901|NCT03828747|38951553|FG000|Double-Blind Treatment Period|Adverse Event|6|||
16126902|NCT03828747|38951554|FG001|Double-Blind Treatment Period|Adverse Event|6|||
16126903|NCT03828747|38951553|FG000|Double-Blind Treatment Period|Death|1|||
16126904|NCT03828747|38951554|FG001|Double-Blind Treatment Period|Death|1|||
16126905|NCT03828747|38951553|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16126906|NCT03828747|38951554|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
16126907|NCT03828747|38951553|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
16126908|NCT03828747|38951554|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
16126909|NCT03828747|38951553|FG000|Double-Blind Treatment Period|Physician Decision|1|||
16126910|NCT03828747|38951554|FG001|Double-Blind Treatment Period|Physician Decision|4|||
16126911|NCT03828747|38951553|FG000|Double-Blind Treatment Period|Various reasons|5|||
16126912|NCT03828747|38951554|FG001|Double-Blind Treatment Period|Various reasons|3|||
16126913|NCT03828747|38951553|FG000|Open-Label Extension|Adverse Event|9|||
16126914|NCT03828747|38951554|FG001|Open-Label Extension|Adverse Event|7|||
16415551|NCT03160885|40001717|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
16415552|NCT03160885|40001718|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
16126915|NCT03828747|38951553|FG000|Open-Label Extension|Death|0|||
16126916|NCT03828747|38951554|FG001|Open-Label Extension|Death|2|||
16126917|NCT03828747|38951553|FG000|Open-Label Extension|Lost to Follow-up|4|||
16126918|NCT03828747|38951554|FG001|Open-Label Extension|Lost to Follow-up|0|||
16126919|NCT03828747|38951553|FG000|Open-Label Extension|Withdrawal by Subject|31|||
16126920|NCT03828747|38951554|FG001|Open-Label Extension|Withdrawal by Subject|30|||
16126921|NCT03828747|38951553|FG000|Open-Label Extension|Various reasons|4|||
16415553|NCT03160885|40001719|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
16126922|NCT03828747|38951554|FG001|Open-Label Extension|Various reasons|4|||
16126923|NCT03828747|38951553|FG000|Open-Label Extension|Physician Decision|6|||
16126924|NCT03828747|38951554|FG001|Open-Label Extension|Physician Decision|2|||
16126925|NCT04871711|38951559|FG000|Overall Study|Withdrawal by Subject|11|||
16126926|NCT04871711|38951560|FG001|Overall Study|Withdrawal by Subject|5|||
16126927|NCT04871711|38951559|FG000|Overall Study|Lack of Efficacy|5|||
16126928|NCT04871711|38951560|FG001|Overall Study|Lack of Efficacy|7|||
16126929|NCT04871711|38951559|FG000|Overall Study|Adverse Event|2|||
16126930|NCT04871711|38951560|FG001|Overall Study|Adverse Event|6|||
16126931|NCT04871711|38951559|FG000|Overall Study|Various reasons|2|||
16126932|NCT04871711|38951560|FG001|Overall Study|Various reasons|1|||
16126933|NCT04871711|38951559|FG000|Overall Study|Lost to Follow-up|0|||
16126934|NCT04871711|38951560|FG001|Overall Study|Lost to Follow-up|2|||
16126935|NCT04279392|38951562|FG000|Overall Study|Physician Decision|1|||
16126936|NCT04279392|38951563|FG001|Overall Study|Physician Decision|0|||
16126937|NCT01171807|38951564|FG000|Overall Study|Treatment failure|2|||
16126938|NCT01171807|38951565|FG001|Overall Study|Treatment failure|4|||
16126939|NCT01171807|38951564|FG000|Overall Study|Non compliance|1|||
16126940|NCT01171807|38951565|FG001|Overall Study|Non compliance|0|||
16126941|NCT01171807|38951564|FG000|Overall Study|Lost to Follow-up|3|||
16126942|NCT01171807|38951565|FG001|Overall Study|Lost to Follow-up|0|||
16126943|NCT04833127|38951566|FG000|Overall Study|Lost to Follow-up|1|||
16126944|NCT04833127|38951567|FG001|Overall Study|Lost to Follow-up|1|||
16126945|NCT00700258|38951568|FG000|Overall Study|Premature discontinuation of documentation|136|||
16126946|NCT00700258|38951568|FG000|Overall Study|Type of study end not documented|1|||
16126947|NCT00700258|38951568|FG000|Overall Study|Lost to Follow-up|81|||
16126948|NCT00700258|38951568|FG000|Overall Study|Premature discontinuation of therapy|1013|||
16126949|NCT04606771|38951569|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
16126950|NCT04606771|38951570|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
16126951|NCT04606771|38951569|FG000|Overall Study|Death|5|||
16126952|NCT04606771|38951570|FG001|Overall Study|Death|6|||
16126953|NCT04606771|38951569|FG000|Overall Study|Wrong randomisation|0|||
16126954|NCT04606771|38951570|FG001|Overall Study|Wrong randomisation|1|||
16126955|NCT05398237|38951571|FG000|Overall Study|Withdrawal by Subject|1|||
16126956|NCT04988867|38951572|FG000|Overall Study|Study terminated by Sponsor|12|||
16126957|NCT04988867|38951572|FG000|Overall Study|Adverse Event|2|||
16126958|NCT04988867|38951572|FG000|Overall Study|Study drug noncompliance|1|||
16126959|NCT01621568|38951580|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
16126960|NCT01621568|38951581|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
16126961|NCT01621568|38951580|FG000|Week 5-6 No Treatment|Death|1|||
16126962|NCT01621568|38951581|FG001|Week 5-6 No Treatment|Death|0|||
16126963|NCT04971681|38951590|FG000|Followup|Lost to Follow-up|1|||
16126964|NCT04971681|38951591|FG001|Followup|Lost to Follow-up|0|||
16126965|NCT01293487|38951592|FG000|Overall Study|Lost to Follow-up|0|||
16126966|NCT01293487|38951593|FG001|Overall Study|Lost to Follow-up|0|||
16126967|NCT01293487|38951594|FG002|Overall Study|Lost to Follow-up|0|||
16126968|NCT01293487|38951595|FG003|Overall Study|Lost to Follow-up|1|||
16126969|NCT01293487|38951596|FG004|Overall Study|Lost to Follow-up|0|||
16126970|NCT01293487|38951597|FG005|Overall Study|Lost to Follow-up|0|||
16126971|NCT01293487|38951598|FG006|Overall Study|Lost to Follow-up|0|||
16126972|NCT01293487|38951599|FG007|Overall Study|Lost to Follow-up|0|||
16126973|NCT01293487|38951592|FG000|Overall Study|Withdrawal by Subject|0|||
16126974|NCT01293487|38951593|FG001|Overall Study|Withdrawal by Subject|0|||
16126975|NCT01293487|38951594|FG002|Overall Study|Withdrawal by Subject|0|||
16126976|NCT01293487|38951595|FG003|Overall Study|Withdrawal by Subject|0|||
16126977|NCT01293487|38951596|FG004|Overall Study|Withdrawal by Subject|0|||
16126978|NCT01293487|38951597|FG005|Overall Study|Withdrawal by Subject|0|||
16126979|NCT01293487|38951598|FG006|Overall Study|Withdrawal by Subject|0|||
16126980|NCT01293487|38951599|FG007|Overall Study|Withdrawal by Subject|2|||
16126981|NCT02003222|38951602|FG000|Induction|Never started treatment|0|||
16126982|NCT02003222|38951603|FG001|Induction|Never started treatment|0|||
16126983|NCT02003222|38951604|FG002|Induction|Never started treatment|0|||
16126984|NCT02003222|38951605|FG003|Induction|Never started treatment|0|||
16126985|NCT02003222|38951606|FG004|Induction|Never started treatment|8|||
16126986|NCT02003222|38951602|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
16126987|NCT02003222|38951603|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
16243496|NCT02082912|39374981|FG000|Overall Study|Physician Decision|0|||
16173349|NCT01147809|39111199|FG005|Phase I (168 Days)|Adverse Event|0|||
16126988|NCT02003222|38951604|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
16126989|NCT02003222|38951605|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
16126990|NCT02003222|38951606|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
16126991|NCT02003222|38951602|FG000|Induction|Adverse Event|0|||
16126992|NCT02003222|38951603|FG001|Induction|Adverse Event|0|||
16126993|NCT02003222|38951604|FG002|Induction|Adverse Event|0|||
16126994|NCT02003222|38951605|FG003|Induction|Adverse Event|0|||
16126995|NCT02003222|38951606|FG004|Induction|Adverse Event|13|||
16126996|NCT02003222|38951602|FG000|Induction|Alternative therapy|0|||
16126997|NCT02003222|38951603|FG001|Induction|Alternative therapy|0|||
16126998|NCT02003222|38951604|FG002|Induction|Alternative therapy|0|||
16126999|NCT02003222|38951605|FG003|Induction|Alternative therapy|0|||
16127000|NCT02003222|38951606|FG004|Induction|Alternative therapy|12|||
16127001|NCT02003222|38951602|FG000|Induction|Disease progression|0|||
16127002|NCT02003222|38951603|FG001|Induction|Disease progression|0|||
16127003|NCT02003222|38951604|FG002|Induction|Disease progression|0|||
16127004|NCT02003222|38951605|FG003|Induction|Disease progression|0|||
16127005|NCT02003222|38951606|FG004|Induction|Disease progression|22|||
16127006|NCT02003222|38951602|FG000|Induction|Death|0|||
16127007|NCT02003222|38951603|FG001|Induction|Death|0|||
16415554|NCT03160885|40001720|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
16415555|NCT03160885|40001721|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
16415556|NCT03160885|40001722|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
16415557|NCT03160885|40001723|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
16415558|NCT03160885|40001717|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
16415559|NCT03160885|40001718|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
16415560|NCT03160885|40001719|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
16415561|NCT03160885|40001720|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
16415562|NCT03160885|40001721|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
16415563|NCT03160885|40001722|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
16415564|NCT03160885|40001723|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
16415565|NCT03160885|40001717|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
16415566|NCT03160885|40001718|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
16415567|NCT03160885|40001719|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
16415568|NCT03160885|40001720|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
16415569|NCT03160885|40001721|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
16415570|NCT03160885|40001722|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
16415571|NCT03160885|40001723|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
16415572|NCT03160885|40001717|FG000|Maintenance Treatment Period|Completed Week 50|0|||
16127008|NCT02003222|38951604|FG002|Induction|Death|0|||
16127009|NCT02003222|38951605|FG003|Induction|Death|0|||
16127010|NCT02003222|38951606|FG004|Induction|Death|3|||
16127011|NCT02003222|38951602|FG000|Induction|Withdrawal by Subject|0|||
16127012|NCT02003222|38951603|FG001|Induction|Withdrawal by Subject|0|||
16127013|NCT02003222|38951604|FG002|Induction|Withdrawal by Subject|0|||
16127014|NCT02003222|38951605|FG003|Induction|Withdrawal by Subject|0|||
16127015|NCT02003222|38951606|FG004|Induction|Withdrawal by Subject|8|||
16127016|NCT02003222|38951602|FG000|Induction|Other reasons|0|||
16127017|NCT02003222|38951603|FG001|Induction|Other reasons|0|||
16127018|NCT02003222|38951604|FG002|Induction|Other reasons|0|||
16127019|NCT02003222|38951605|FG003|Induction|Other reasons|0|||
16127020|NCT02003222|38951606|FG004|Induction|Other reasons|22|||
16127021|NCT02003222|38951602|FG000|Intensification|Never started treatment|0|||
16127022|NCT02003222|38951603|FG001|Intensification|Never started treatment|0|||
16127023|NCT02003222|38951604|FG002|Intensification|Never started treatment|0|||
16127024|NCT02003222|38951605|FG003|Intensification|Never started treatment|0|||
16127025|NCT02003222|38951606|FG004|Intensification|Never started treatment|2|||
16127026|NCT02003222|38951602|FG000|Intensification|Adverse Event|0|||
16127027|NCT02003222|38951603|FG001|Intensification|Adverse Event|0|||
16127028|NCT02003222|38951604|FG002|Intensification|Adverse Event|0|||
16127029|NCT02003222|38951605|FG003|Intensification|Adverse Event|0|||
16127030|NCT02003222|38951606|FG004|Intensification|Adverse Event|6|||
16127031|NCT02003222|38951602|FG000|Intensification|Alternative therapy|0|||
16127032|NCT02003222|38951603|FG001|Intensification|Alternative therapy|0|||
16127033|NCT02003222|38951604|FG002|Intensification|Alternative therapy|0|||
16127034|NCT02003222|38951605|FG003|Intensification|Alternative therapy|0|||
16127035|NCT02003222|38951606|FG004|Intensification|Alternative therapy|8|||
16127036|NCT02003222|38951602|FG000|Intensification|Disease progression|0|||
16127037|NCT02003222|38951603|FG001|Intensification|Disease progression|0|||
16243497|NCT02082912|39374982|FG001|Overall Study|Physician Decision|1|||
16243498|NCT01347879|39374983|FG000|Overall Study|Adverse Event|0|||
16243499|NCT01347879|39374984|FG001|Overall Study|Adverse Event|12|||
16243500|NCT01347879|39374983|FG000|Overall Study|Lost to Follow-up|2|||
16243501|NCT01347879|39374984|FG001|Overall Study|Lost to Follow-up|0|||
16558660|NCT02080520|40510062|FG001|Overall Study|Not interested in study|3|||
16558661|NCT02080520|40510061|FG000|Overall Study|Too busy|1|||
16558662|NCT02080520|40510062|FG001|Overall Study|Too busy|1|||
16558663|NCT02080520|40510061|FG000|Overall Study|Work-related injury|1|||
16558664|NCT02080520|40510062|FG001|Overall Study|Work-related injury|0|||
16558665|NCT02080520|40510061|FG000|Overall Study|Personal reasons|0|||
16558666|NCT02080520|40510062|FG001|Overall Study|Personal reasons|3|||
16558667|NCT01333943|40510063|FG000|Overall Study|Known neuropathy|1|||
16558668|NCT01333943|40510064|FG001|Overall Study|Known neuropathy|0|||
16558669|NCT03369951|40510066|FG000|Overall Study|Withdrawal by Subject|3|||
16558670|NCT03369951|40510066|FG000|Overall Study|Death|1|||
16558671|NCT03369951|40510066|FG000|Overall Study|Lost to Follow-up|1|||
16558672|NCT03369951|40510066|FG000|Overall Study|Protocol Violation|1|||
16558673|NCT04812548|40510067|FG000|Overall Study|Adverse Event|2|||
16558674|NCT04812548|40510068|FG001|Overall Study|Adverse Event|7|||
16558675|NCT04812548|40510067|FG000|Overall Study|HSCT Planned|2|||
16558676|NCT04812548|40510068|FG001|Overall Study|HSCT Planned|3|||
16558677|NCT04812548|40510067|FG000|Overall Study|Progressive Disease|0|||
16558678|NCT04812548|40510068|FG001|Overall Study|Progressive Disease|2|||
16558679|NCT04812548|40510067|FG000|Overall Study|Death|0|||
16558680|NCT04812548|40510068|FG001|Overall Study|Death|1|||
16558681|NCT04812548|40510067|FG000|Overall Study|Post Study Access to Treatment|0|||
16127038|NCT02003222|38951604|FG002|Intensification|Disease progression|0|||
16127039|NCT02003222|38951605|FG003|Intensification|Disease progression|0|||
16127040|NCT02003222|38951606|FG004|Intensification|Disease progression|18|||
16127041|NCT02003222|38951602|FG000|Intensification|Withdrawal by Subject|0|||
16243502|NCT01347879|39374983|FG000|Overall Study|Withdrawal by Subject|3|||
16243503|NCT01347879|39374984|FG001|Overall Study|Withdrawal by Subject|2|||
16127042|NCT02003222|38951603|FG001|Intensification|Withdrawal by Subject|0|||
16127043|NCT02003222|38951604|FG002|Intensification|Withdrawal by Subject|0|||
16127044|NCT02003222|38951605|FG003|Intensification|Withdrawal by Subject|0|||
16243504|NCT01347879|39374983|FG000|Overall Study|Other|2|||
16558682|NCT04812548|40510068|FG001|Overall Study|Post Study Access to Treatment|1|||
16558683|NCT04812548|40510067|FG000|Overall Study|Withdrawal by Subject|0|||
16558684|NCT04812548|40510068|FG001|Overall Study|Withdrawal by Subject|1|||
16558685|NCT04812548|40510067|FG000|Overall Study|Physician Decision|1|||
16127045|NCT02003222|38951606|FG004|Intensification|Withdrawal by Subject|5|||
16127046|NCT02003222|38951602|FG000|Intensification|Other reasons|0|||
16243505|NCT01347879|39374984|FG001|Overall Study|Other|3|||
16415573|NCT03160885|40001718|FG001|Maintenance Treatment Period|Completed Week 50|0|||
16558686|NCT04812548|40510068|FG001|Overall Study|Physician Decision|0|||
16558687|NCT00219141|40510072|FG000|Overall Study|Adverse Event|4|||
16558688|NCT00219141|40510073|FG001|Overall Study|Adverse Event|10|||
16558689|NCT00219141|40510074|FG002|Overall Study|Adverse Event|5|||
16558690|NCT00219141|40510072|FG000|Overall Study|Lack of Efficacy|3|||
16558691|NCT00219141|40510073|FG001|Overall Study|Lack of Efficacy|2|||
16558692|NCT00219141|40510074|FG002|Overall Study|Lack of Efficacy|0|||
16127047|NCT02003222|38951603|FG001|Intensification|Other reasons|0|||
16127048|NCT02003222|38951604|FG002|Intensification|Other reasons|0|||
16127049|NCT02003222|38951605|FG003|Intensification|Other reasons|0|||
16127050|NCT02003222|38951606|FG004|Intensification|Other reasons|8|||
16558693|NCT00219141|40510072|FG000|Overall Study|Administrative problems|0|||
16558694|NCT00219141|40510073|FG001|Overall Study|Administrative problems|1|||
16558695|NCT00219141|40510074|FG002|Overall Study|Administrative problems|0|||
16558696|NCT00219141|40510072|FG000|Overall Study|Lost to Follow-up|2|||
16558697|NCT00219141|40510073|FG001|Overall Study|Lost to Follow-up|4|||
16558698|NCT00219141|40510074|FG002|Overall Study|Lost to Follow-up|1|||
16558699|NCT00219141|40510072|FG000|Overall Study|Protocol Violation|3|||
16558700|NCT00219141|40510073|FG001|Overall Study|Protocol Violation|1|||
16558701|NCT00219141|40510074|FG002|Overall Study|Protocol Violation|1|||
16415574|NCT03160885|40001719|FG002|Maintenance Treatment Period|Completed Week 50|1|||
16351330|NCT03327324|39772978|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351331|NCT03327324|39772979|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351332|NCT03327324|39772980|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351333|NCT03327324|39772981|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
16351334|NCT03327324|39772976|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
16351335|NCT03327324|39772977|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16415575|NCT03160885|40001720|FG003|Maintenance Treatment Period|Completed Week 50|0|||
16415576|NCT03160885|40001721|FG004|Maintenance Treatment Period|Completed Week 50|0|||
16415577|NCT03160885|40001722|FG005|Maintenance Treatment Period|Completed Week 50|0|||
16415578|NCT03160885|40001723|FG006|Maintenance Treatment Period|Completed Week 50|0|||
16415579|NCT02014584|40001725|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
16415580|NCT02014584|40001726|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
16415581|NCT02014584|40001727|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
16415582|NCT02014584|40001728|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
16415583|NCT02014584|40001729|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
16415584|NCT02014584|40001730|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
16415585|NCT02014584|40001725|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
16415586|NCT02014584|40001726|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
16415587|NCT02014584|40001727|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
16558702|NCT00219141|40510072|FG000|Overall Study|Withdrawal by Subject|1|||
16558703|NCT00219141|40510073|FG001|Overall Study|Withdrawal by Subject|3|||
16558704|NCT00219141|40510074|FG002|Overall Study|Withdrawal by Subject|5|||
16558705|NCT00219141|40510072|FG000|Overall Study|Condition no longer requires study drug|1|||
16558706|NCT00219141|40510073|FG001|Overall Study|Condition no longer requires study drug|0|||
16558707|NCT00219141|40510074|FG002|Overall Study|Condition no longer requires study drug|0|||
16558708|NCT01836458|40510075|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
16558709|NCT01836458|40510076|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16558710|NCT01836458|40510077|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
16558711|NCT01836458|40510078|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
16558712|NCT01489020|40510081|FG000|Overall Study|Withdrawal by Subject|1|||
16558713|NCT01489020|40510082|FG001|Overall Study|Withdrawal by Subject|0|||
16558714|NCT01489020|40510083|FG002|Overall Study|Withdrawal by Subject|0|||
16127051|NCT01737827|38951607|FG000|Overall Study|Adverse Event|3|||
16127052|NCT01737827|38951608|FG001|Overall Study|Adverse Event|6|||
16127053|NCT01737827|38951609|FG002|Overall Study|Adverse Event|0|||
16127054|NCT01737827|38951607|FG000|Overall Study|Lost to Follow-up|0|||
16127055|NCT01737827|38951608|FG001|Overall Study|Lost to Follow-up|1|||
16558715|NCT01489020|40510084|FG003|Overall Study|Withdrawal by Subject|0|||
16558716|NCT01489020|40510085|FG004|Overall Study|Withdrawal by Subject|0|||
16558717|NCT01489020|40510086|FG005|Overall Study|Withdrawal by Subject|0|||
16558718|NCT01489020|40510081|FG000|Overall Study|Adverse Event|0|||
16558719|NCT01489020|40510082|FG001|Overall Study|Adverse Event|0|||
16558720|NCT01489020|40510083|FG002|Overall Study|Adverse Event|3|||
16127056|NCT01737827|38951609|FG002|Overall Study|Lost to Follow-up|0|||
16127057|NCT01737827|38951607|FG000|Overall Study|Physician Decision|0|||
16127058|NCT01737827|38951608|FG001|Overall Study|Physician Decision|2|||
16127059|NCT01737827|38951609|FG002|Overall Study|Physician Decision|0|||
16558721|NCT01489020|40510084|FG003|Overall Study|Adverse Event|0|||
16558722|NCT01489020|40510085|FG004|Overall Study|Adverse Event|3|||
16127060|NCT01737827|38951607|FG000|Overall Study|Progressive Disease|5|||
16558723|NCT01489020|40510086|FG005|Overall Study|Adverse Event|0|||
16558724|NCT01489020|40510081|FG000|Overall Study|Concomitant disease|0|||
16558725|NCT01489020|40510082|FG001|Overall Study|Concomitant disease|0|||
16558726|NCT01489020|40510083|FG002|Overall Study|Concomitant disease|0|||
16558727|NCT01489020|40510084|FG003|Overall Study|Concomitant disease|0|||
16558728|NCT01489020|40510085|FG004|Overall Study|Concomitant disease|3|||
16558729|NCT01489020|40510086|FG005|Overall Study|Concomitant disease|0|||
16558730|NCT00097370|40513169|FG000|Stage 1|Adverse Event|3|||
16558731|NCT00097370|40513169|FG000|Stage 1|Withdrawal by Subject|1|||
16558732|NCT00097370|40513169|FG000|Stage 1|Lack of Efficacy|2|||
16127061|NCT01737827|38951608|FG001|Overall Study|Progressive Disease|16|||
16127062|NCT01737827|38951609|FG002|Overall Study|Progressive Disease|2|||
16127063|NCT01737827|38951607|FG000|Overall Study|Study Terminated by Sponsor|0|||
16351336|NCT03327324|39772978|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16415588|NCT02014584|40001728|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
16415589|NCT02014584|40001729|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
16415590|NCT02014584|40001730|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
16415591|NCT02014584|40001725|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
16415592|NCT02014584|40001726|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
16415593|NCT02014584|40001727|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
16351337|NCT03327324|39772979|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351338|NCT03327324|39772980|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351339|NCT03327324|39772981|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
16351340|NCT03327324|39772976|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
16351341|NCT03327324|39772977|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
16351342|NCT03327324|39772978|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
16351343|NCT03327324|39772979|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
16351344|NCT03327324|39772980|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
16351345|NCT03327324|39772981|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
16351346|NCT03327324|39772976|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
16351347|NCT03327324|39772977|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
16351348|NCT03327324|39772978|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
16351349|NCT03327324|39772979|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
16351350|NCT03327324|39772980|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
16351351|NCT03327324|39772981|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
16351352|NCT03327324|39772976|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351353|NCT03327324|39772977|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351354|NCT03327324|39772978|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351355|NCT03327324|39772979|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
16351356|NCT03327324|39772980|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
16351357|NCT03327324|39772981|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
16351358|NCT03327324|39772976|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
16415594|NCT02014584|40001728|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
16415595|NCT02014584|40001729|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
16415596|NCT02014584|40001730|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
16415597|NCT02014584|40001725|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
16415598|NCT02014584|40001726|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
16415599|NCT02014584|40001727|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
16415600|NCT02014584|40001728|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
16415601|NCT02014584|40001729|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
16415602|NCT02014584|40001730|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
16415603|NCT02014584|40001725|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
16415604|NCT02014584|40001726|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
16415605|NCT02014584|40001727|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
16415606|NCT02014584|40001728|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
16415607|NCT02014584|40001729|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
16415608|NCT02014584|40001730|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
16415609|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
16415610|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
16558733|NCT00097370|40513169|FG000|Stage 2|Adverse Event|5|||
16558734|NCT00097370|40513169|FG000|Stage 2|Withdrawal by Subject|1|||
16558735|NCT00097370|40513169|FG000|Stage 2|Lack of Efficacy|3|||
16558736|NCT00097370|40513169|FG000|Stage 2|Pregnancy|1|||
16558737|NCT00097370|40513169|FG000|Stage 2|Sponsor Terminated Study|2|||
16558738|NCT00097370|40513169|FG000|Stage 2|Lost to Follow-up|1|||
16558739|NCT00097370|40513169|FG000|Stage 3|Adverse Event|2|||
16558740|NCT00097370|40513169|FG000|Stage 3|Withdrawal by Subject|3|||
16558741|NCT00097370|40513169|FG000|Stage 3|Lack of Efficacy|1|||
16558742|NCT00097370|40513169|FG000|Stage 3|Sponsor Terminated Study|52|||
16558743|NCT00097370|40513169|FG000|Stage 3|Lost to Follow-up|1|||
16558744|NCT02956967|40513186|FG000|Overall Study|Adverse Event|3|||
16558745|NCT02956967|40513186|FG000|Overall Study|Reason non-related to neutropenia|10|||
16558746|NCT02956967|40513186|FG000|Overall Study|Lost to Follow-up|5|||
16558747|NCT02956967|40513186|FG000|Overall Study|Missing|1|||
16558748|NCT02956967|40513186|FG000|Overall Study|Termination of Nivestim administration|29|||
16558749|NCT03285711|40513187|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
16558750|NCT03285711|40513188|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
16558751|NCT03285711|40513189|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
16558752|NCT03285711|40513190|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
16558753|NCT03285711|40513187|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
16558754|NCT03285711|40513188|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
16558755|NCT03285711|40513189|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
16558756|NCT03285711|40513190|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
16558757|NCT03285711|40513187|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
16558758|NCT03285711|40513188|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
16558759|NCT03285711|40513189|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
16243506|NCT00566098|39374985|FG000|Collection of MILs|Withdrawal by Subject|1|||
16243507|NCT00566098|39374985|FG000|Collection of MILs|Relapsed|1|||
16243508|NCT00566098|39374985|FG000|Generation of MILs Product|Relapsed|1|||
16243509|NCT00566098|39374985|FG000|Administration of ASCT+MILs|Death|10|||
16243510|NCT00566098|39374985|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
16243511|NCT00671879|39374988|FG000|Overall Study|Withdrawal by Subject|0|||
16243512|NCT00671879|39374989|FG001|Overall Study|Withdrawal by Subject|4|||
16243513|NCT00671879|39374990|FG002|Overall Study|Withdrawal by Subject|6|||
16243514|NCT03990389|39374991|FG000|Overall Study|Lost to Follow-up|3|||
16243515|NCT03990389|39374992|FG001|Overall Study|Lost to Follow-up|0|||
16243516|NCT01991977|39374993|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
16243517|NCT01991977|39374993|FG000|Overall Study|Withdrew after start of treatment|5|||
16243518|NCT04908722|39374994|FG000|Overall Study|Protocol deviation|1|||
16243519|NCT04908722|39374995|FG001|Overall Study|Protocol deviation|0|||
16243520|NCT04908722|39374996|FG002|Overall Study|Protocol deviation|0|||
16243521|NCT04908722|39374997|FG003|Overall Study|Protocol deviation|0|||
16243522|NCT04908722|39374998|FG004|Overall Study|Protocol deviation|0|||
16243523|NCT04908722|39374999|FG005|Overall Study|Protocol deviation|1|||
16243524|NCT04908722|39374994|FG000|Overall Study|Lost to Follow-up|33|||
16243525|NCT04908722|39374995|FG001|Overall Study|Lost to Follow-up|33|||
16243526|NCT04908722|39374996|FG002|Overall Study|Lost to Follow-up|36|||
16243527|NCT04908722|39374997|FG003|Overall Study|Lost to Follow-up|30|||
16127064|NCT01737827|38951608|FG001|Overall Study|Study Terminated by Sponsor|1|||
16243528|NCT04908722|39374998|FG004|Overall Study|Lost to Follow-up|32|||
16243529|NCT04908722|39374999|FG005|Overall Study|Lost to Follow-up|34|||
16243530|NCT04908722|39374994|FG000|Overall Study|Physician Decision|1|||
16351359|NCT03327324|39772977|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
16243531|NCT04908722|39374995|FG001|Overall Study|Physician Decision|1|||
16351360|NCT03327324|39772978|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
16351361|NCT03327324|39772979|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
16351362|NCT03327324|39772980|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
16351363|NCT03327324|39772981|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
16351364|NCT03327324|39772976|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
16351365|NCT03327324|39772977|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
16351366|NCT03327324|39772978|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
16351367|NCT03327324|39772979|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
16351368|NCT03327324|39772980|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
16351369|NCT03327324|39772981|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
16351370|NCT01365130|39772982|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
16351371|NCT02486692|39772983|FG000|Overall Study|did not login for randomization|4|||
16351372|NCT02486692|39772984|FG001|Overall Study|did not login for randomization|7|||
16351373|NCT00689338|39772985|FG000|Overall Study|Death|65|||
16351374|NCT00689338|39772985|FG000|Overall Study|Adverse Event|13|||
16351375|NCT00689338|39772985|FG000|Overall Study|Insufficient Clinical Response|1|||
16351376|NCT00689338|39772985|FG000|Overall Study|Lack of Efficacy|6|||
16351377|NCT00689338|39772985|FG000|Overall Study|Other|8|||
16351378|NCT00689338|39772985|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
16351379|NCT00689338|39772985|FG000|Overall Study|Lost to Follow-up|5|||
16351380|NCT00689338|39772985|FG000|Overall Study|Withdrawal by Subject|3|||
16351381|NCT00689338|39772985|FG000|Overall Study|Protocol Violation|15|||
16351382|NCT01065818|39772988|FG000|Overall Study|Withdrawal by Subject|1|||
16415611|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
16415612|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
16415613|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
16415614|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
16415615|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
16415616|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
16415617|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
16415618|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
16415619|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
16415620|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
16415621|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
16415622|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
16415623|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
16415624|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
16415625|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
16415626|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
16415627|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
16415628|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
16415629|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
16415630|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
16415631|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
16415632|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
16415633|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
16415634|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
16415635|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
16415636|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
16415637|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
16415638|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
16415639|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
16415640|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
16415641|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
16415642|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
16415643|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
16351383|NCT01065818|39772988|FG000|Overall Study|Not a candidate for surgery|1|||
16351384|NCT01598610|39772993|FG000|Overall Study|Adverse Event|1|||
16351385|NCT02915159|39772994|FG000|Overall Study|Participant no longer meets criteria|2|||
16351386|NCT02915159|39772995|FG001|Overall Study|Participant no longer meets criteria|0|||
16351387|NCT02915159|39772994|FG000|Overall Study|poor/non-compliance|1|||
16351388|NCT02915159|39772995|FG001|Overall Study|poor/non-compliance|0|||
16351389|NCT02915159|39772994|FG000|Overall Study|Participant withdrew consent|5|||
16351390|NCT02915159|39772995|FG001|Overall Study|Participant withdrew consent|1|||
16351391|NCT02915159|39772994|FG000|Overall Study|Request to discontinue treatment|1|||
16351392|NCT02915159|39772995|FG001|Overall Study|Request to discontinue treatment|2|||
16351393|NCT02915159|39772994|FG000|Overall Study|Adverse Event|2|||
16351394|NCT02915159|39772995|FG001|Overall Study|Adverse Event|2|||
16415644|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
16127065|NCT01737827|38951609|FG002|Overall Study|Study Terminated by Sponsor|0|||
16127066|NCT01737827|38951607|FG000|Overall Study|Subject/Guardian Decision|0|||
16351395|NCT02915159|39772994|FG000|Overall Study|Lack of Efficacy|0|||
16351396|NCT02915159|39772995|FG001|Overall Study|Lack of Efficacy|3|||
16351397|NCT01719380|39772996|FG000|Overall Study|Adverse Event|0|||
16351398|NCT01719380|39772997|FG001|Overall Study|Adverse Event|0|||
16351399|NCT01719380|39772998|FG002|Overall Study|Adverse Event|1|||
16351400|NCT01719380|39772999|FG003|Overall Study|Adverse Event|2|||
16351401|NCT01719380|39773000|FG004|Overall Study|Adverse Event|0|||
16558760|NCT03285711|40513190|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
16558761|NCT03285711|40513187|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
16558762|NCT03285711|40513188|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
16558763|NCT03285711|40513189|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
16558764|NCT03285711|40513190|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
16558765|NCT04545619|40513191|FG000|Overall Study|due to equipment challenges|1|||
16558766|NCT01729728|40513192|FG000|Overall Study|Adverse Event|0|||
16127067|NCT01737827|38951608|FG001|Overall Study|Subject/Guardian Decision|2|||
16127068|NCT01737827|38951609|FG002|Overall Study|Subject/Guardian Decision|0|||
16127069|NCT02112708|38951615|FG000|Baseline|Physician Decision|16|||
16127070|NCT02112708|38951616|FG001|Baseline|Physician Decision|11|||
16127071|NCT02112708|38951615|FG000|Baseline|Lost to Follow-up|12|||
16127072|NCT02112708|38951616|FG001|Baseline|Lost to Follow-up|0|||
16127073|NCT02112708|38951615|FG000|4 Month|Death|0|||
16127074|NCT02112708|38951616|FG001|4 Month|Death|1|||
16127075|NCT02112708|38951615|FG000|4 Month|Withdrawal by Subject|12|||
16127076|NCT02112708|38951616|FG001|4 Month|Withdrawal by Subject|0|||
16127077|NCT03965689|38951617|FG000|Overall Study|Too sick to get study intervention|2|||
16127078|NCT03248492|38951618|FG000|Overall Study|Ongoing|23|||
16127079|NCT03248492|38951619|FG001|Overall Study|Ongoing|26|||
16127080|NCT03248492|38951620|FG002|Overall Study|Ongoing|3|||
16127081|NCT03248492|38951621|FG003|Overall Study|Ongoing|85|||
16127082|NCT03248492|38951622|FG004|Overall Study|Ongoing|2|||
16127083|NCT03248492|38951618|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
16127084|NCT03248492|38951619|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
16127085|NCT03248492|38951620|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
16127086|NCT03248492|38951621|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
16127087|NCT03248492|38951622|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
16127088|NCT03248492|38951618|FG000|Overall Study|Adverse Event|6|||
16127089|NCT03248492|38951619|FG001|Overall Study|Adverse Event|6|||
16127090|NCT03248492|38951620|FG002|Overall Study|Adverse Event|8|||
16127091|NCT03248492|38951621|FG003|Overall Study|Adverse Event|8|||
16127092|NCT03248492|38951622|FG004|Overall Study|Adverse Event|1|||
16127093|NCT03248492|38951618|FG000|Overall Study|Withdrawal by Subject|3|||
16127094|NCT03248492|38951619|FG001|Overall Study|Withdrawal by Subject|3|||
16127095|NCT03248492|38951620|FG002|Overall Study|Withdrawal by Subject|0|||
16127096|NCT03248492|38951621|FG003|Overall Study|Withdrawal by Subject|3|||
16127097|NCT03248492|38951622|FG004|Overall Study|Withdrawal by Subject|1|||
16127098|NCT03248492|38951618|FG000|Overall Study|Physician Decision|1|||
16127099|NCT03248492|38951619|FG001|Overall Study|Physician Decision|0|||
16127100|NCT03248492|38951620|FG002|Overall Study|Physician Decision|1|||
16127101|NCT03248492|38951621|FG003|Overall Study|Physician Decision|2|||
16127102|NCT03248492|38951622|FG004|Overall Study|Physician Decision|0|||
16127103|NCT03248492|38951618|FG000|Overall Study|Death|1|||
16127104|NCT03248492|38951619|FG001|Overall Study|Death|0|||
16127105|NCT03248492|38951620|FG002|Overall Study|Death|0|||
16127106|NCT03248492|38951621|FG003|Overall Study|Death|6|||
16127107|NCT03248492|38951622|FG004|Overall Study|Death|0|||
16127108|NCT03248492|38951618|FG000|Overall Study|Other|0|||
16127109|NCT03248492|38951619|FG001|Overall Study|Other|1|||
16127110|NCT03248492|38951620|FG002|Overall Study|Other|0|||
16127111|NCT03248492|38951621|FG003|Overall Study|Other|4|||
16127112|NCT03248492|38951622|FG004|Overall Study|Other|0|||
16127113|NCT05543187|38951624|FG000|Overall Study|Ongoing|3|||
16351402|NCT01719380|39773001|FG005|Overall Study|Adverse Event|1|||
16351403|NCT01719380|39773002|FG006|Overall Study|Adverse Event|0|||
16351404|NCT01719380|39773003|FG007|Overall Study|Adverse Event|1|||
16351405|NCT01719380|39773004|FG008|Overall Study|Adverse Event|4|||
16351406|NCT01719380|39773005|FG009|Overall Study|Adverse Event|3|||
16351407|NCT01719380|39772996|FG000|Overall Study|Death|0|||
16415645|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
16415646|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
16351408|NCT01719380|39772997|FG001|Overall Study|Death|1|||
16351409|NCT01719380|39772998|FG002|Overall Study|Death|0|||
16415647|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
16127114|NCT05543187|38951625|FG001|Overall Study|Ongoing|2|||
16351410|NCT01719380|39772999|FG003|Overall Study|Death|0|||
16351411|NCT01719380|39773000|FG004|Overall Study|Death|0|||
16127115|NCT05330312|38951626|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
16127116|NCT05330312|38951627|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
16127117|NCT05330312|38951628|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
16127118|NCT05330312|38951626|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
16127119|NCT05330312|38951627|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
16243532|NCT04908722|39374996|FG002|Overall Study|Physician Decision|1|||
16127120|NCT05330312|38951628|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
16351412|NCT01719380|39773001|FG005|Overall Study|Death|0|||
16351413|NCT01719380|39773002|FG006|Overall Study|Death|0|||
16127121|NCT05330312|38951626|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
16127122|NCT05330312|38951627|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
16127123|NCT05330312|38951628|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
16243533|NCT04908722|39374997|FG003|Overall Study|Physician Decision|2|||
16243534|NCT04908722|39374998|FG004|Overall Study|Physician Decision|0|||
16243535|NCT04908722|39374999|FG005|Overall Study|Physician Decision|0|||
16243536|NCT04908722|39374994|FG000|Overall Study|Death|1|||
16243537|NCT04908722|39374995|FG001|Overall Study|Death|0|||
16243538|NCT04908722|39374996|FG002|Overall Study|Death|0|||
16243539|NCT04908722|39374997|FG003|Overall Study|Death|0|||
16243540|NCT04908722|39374998|FG004|Overall Study|Death|0|||
16243541|NCT04908722|39374999|FG005|Overall Study|Death|1|||
16351414|NCT01719380|39773003|FG007|Overall Study|Death|0|||
16351415|NCT01719380|39773004|FG008|Overall Study|Death|3|||
16351416|NCT01719380|39773005|FG009|Overall Study|Death|3|||
16558767|NCT01729728|40513193|FG001|Overall Study|Adverse Event|6|||
16351417|NCT01719380|39772996|FG000|Overall Study|Participant/Guardian Decision|0|||
16558768|NCT01729728|40513194|FG002|Overall Study|Adverse Event|0|||
16558769|NCT01729728|40513192|FG000|Overall Study|Protocol Violation|1|||
16558770|NCT01729728|40513193|FG001|Overall Study|Protocol Violation|0|||
16558771|NCT01729728|40513194|FG002|Overall Study|Protocol Violation|1|||
16558772|NCT00372528|40513195|FG000|Overall Study|Lack of Efficacy|1|||
16558773|NCT00372528|40513195|FG000|Overall Study|Adverse Event|1|||
16558774|NCT00372528|40513195|FG000|Overall Study|Study Terminated by Sponsor|18|||
16558775|NCT00372528|40513195|FG000|Overall Study|Other|1|||
16558776|NCT04242875|40513196|FG000|Overall Study|Adverse Event|2|||
16558777|NCT00900627|40513199|FG000|Overall Study|Condition under investigation worsened|4|||
16351418|NCT01719380|39772997|FG001|Overall Study|Participant/Guardian Decision|0|||
16351419|NCT01719380|39772998|FG002|Overall Study|Participant/Guardian Decision|1|||
16351420|NCT01719380|39772999|FG003|Overall Study|Participant/Guardian Decision|0|||
16351421|NCT01719380|39773000|FG004|Overall Study|Participant/Guardian Decision|0|||
16351422|NCT01719380|39773001|FG005|Overall Study|Participant/Guardian Decision|0|||
16558778|NCT00900627|40513200|FG001|Overall Study|Condition under investigation worsened|0|||
16558779|NCT00900627|40513201|FG002|Overall Study|Condition under investigation worsened|5|||
16558780|NCT00900627|40513202|FG003|Overall Study|Condition under investigation worsened|3|||
16558781|NCT00900627|40513203|FG004|Overall Study|Condition under investigation worsened|0|||
16558782|NCT00900627|40513204|FG005|Overall Study|Condition under investigation worsened|0|||
16558783|NCT00900627|40513199|FG000|Overall Study|Withdrawal by Subject|1|||
16558784|NCT00900627|40513200|FG001|Overall Study|Withdrawal by Subject|0|||
16558785|NCT00900627|40513201|FG002|Overall Study|Withdrawal by Subject|1|||
16558786|NCT00900627|40513202|FG003|Overall Study|Withdrawal by Subject|0|||
16558787|NCT00900627|40513203|FG004|Overall Study|Withdrawal by Subject|1|||
16558788|NCT00900627|40513204|FG005|Overall Study|Withdrawal by Subject|2|||
16558789|NCT00900627|40513199|FG000|Overall Study|Adverse Event|1|||
16558790|NCT00900627|40513200|FG001|Overall Study|Adverse Event|2|||
16558791|NCT00900627|40513201|FG002|Overall Study|Adverse Event|0|||
16558792|NCT00900627|40513202|FG003|Overall Study|Adverse Event|3|||
16558793|NCT00900627|40513203|FG004|Overall Study|Adverse Event|0|||
16127124|NCT05330312|38951626|FG000|Pivotal Investigation - Part 2|Death|1|||
16127125|NCT05330312|38951627|FG001|Pivotal Investigation - Part 2|Death|4|||
16127126|NCT05330312|38951628|FG002|Pivotal Investigation - Part 2|Death|0|||
16127127|NCT02766465|38951630|FG000|Overall Study|Withdrawal by Subject|0|||
16127128|NCT02766465|38951631|FG001|Overall Study|Withdrawal by Subject|10|||
16127129|NCT03316300|38951632|FG000|Overall Study|Withdrawal by Subject|3|||
16127130|NCT03316300|38951633|FG001|Overall Study|Withdrawal by Subject|2|||
16127131|NCT03316300|38951632|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
16127132|NCT03316300|38951633|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
16127133|NCT03316300|38951632|FG000|Overall Study|Adverse Event|1|||
16127134|NCT03316300|38951633|FG001|Overall Study|Adverse Event|0|||
16127135|NCT03316300|38951632|FG000|Overall Study|COVID-19|0|||
16127136|NCT03316300|38951633|FG001|Overall Study|COVID-19|1|||
16127137|NCT05326815|38951634|FG000|Overall Study|Withdrawal by Subject|3|||
16127138|NCT05326815|38951634|FG000|Overall Study|Did not complete required labs|6|||
16127139|NCT05326815|38951634|FG000|Overall Study|Screen fail- abnormal labs|5|||
16127140|NCT04737187|38951635|FG000|Overall Study|Switched to marketed drug|32|||
16127141|NCT04737187|38951636|FG001|Overall Study|Switched to marketed drug|4|||
16243542|NCT04908722|39374994|FG000|Overall Study|Withdrawal by Subject|12|||
16243543|NCT04908722|39374995|FG001|Overall Study|Withdrawal by Subject|8|||
16351423|NCT01719380|39773002|FG006|Overall Study|Participant/Guardian Decision|0|||
16351424|NCT01719380|39773003|FG007|Overall Study|Participant/Guardian Decision|0|||
16558794|NCT00900627|40513204|FG005|Overall Study|Adverse Event|0|||
16558795|NCT00900627|40513199|FG000|Overall Study|Death|0|||
16558796|NCT00900627|40513200|FG001|Overall Study|Death|0|||
16127142|NCT04737187|38951635|FG000|Overall Study|Radiological Progressive Disease|145|||
16243544|NCT04908722|39374996|FG002|Overall Study|Withdrawal by Subject|7|||
16243545|NCT04908722|39374997|FG003|Overall Study|Withdrawal by Subject|6|||
16558797|NCT00900627|40513201|FG002|Overall Study|Death|0|||
16558798|NCT00900627|40513202|FG003|Overall Study|Death|0|||
16558799|NCT00900627|40513203|FG004|Overall Study|Death|28|||
16558800|NCT00900627|40513204|FG005|Overall Study|Death|24|||
16243546|NCT04908722|39374998|FG004|Overall Study|Withdrawal by Subject|12|||
16243547|NCT04908722|39374999|FG005|Overall Study|Withdrawal by Subject|14|||
16243548|NCT04908722|39374994|FG000|Overall Study|Other|3|||
16243549|NCT04908722|39374995|FG001|Overall Study|Other|1|||
16243550|NCT04908722|39374996|FG002|Overall Study|Other|3|||
16243551|NCT04908722|39374997|FG003|Overall Study|Other|2|||
16243552|NCT04908722|39374998|FG004|Overall Study|Other|4|||
16243553|NCT04908722|39374999|FG005|Overall Study|Other|1|||
16243554|NCT04908722|39374994|FG000|Overall Study|Initiated prohibited medication|0|||
16243555|NCT04908722|39374995|FG001|Overall Study|Initiated prohibited medication|0|||
16243556|NCT04908722|39374996|FG002|Overall Study|Initiated prohibited medication|0|||
16243557|NCT04908722|39374997|FG003|Overall Study|Initiated prohibited medication|1|||
16243558|NCT04908722|39374998|FG004|Overall Study|Initiated prohibited medication|0|||
16243559|NCT04908722|39374999|FG005|Overall Study|Initiated prohibited medication|1|||
16243560|NCT04908722|39374994|FG000|Overall Study|Randomized but not vaccinated|3|||
16243561|NCT04908722|39374995|FG001|Overall Study|Randomized but not vaccinated|1|||
16243562|NCT04908722|39374996|FG002|Overall Study|Randomized but not vaccinated|2|||
16243563|NCT04908722|39374997|FG003|Overall Study|Randomized but not vaccinated|2|||
16243564|NCT04908722|39374998|FG004|Overall Study|Randomized but not vaccinated|3|||
16243565|NCT04908722|39374999|FG005|Overall Study|Randomized but not vaccinated|4|||
16243566|NCT03433001|39375002|FG000|Overall Study|Lack of Efficacy|109|||
16243567|NCT03433001|39375002|FG000|Overall Study|Adverse Event|69|||
16243568|NCT03433001|39375002|FG000|Overall Study|Withdrawal by Subject|10|||
16243569|NCT03433001|39375002|FG000|Overall Study|Death|12|||
16243570|NCT03433001|39375002|FG000|Overall Study|Lost to Follow-up|4|||
16243571|NCT03433001|39375002|FG000|Overall Study|Other|25|||
16243572|NCT02390219|39375003|FG000|Overall Study|Death|1|||
16243573|NCT02390219|39375003|FG000|Overall Study|Physician Decision|1|||
16243574|NCT02390219|39375003|FG000|Overall Study|Adverse Event|6|||
16243575|NCT02390219|39375003|FG000|Overall Study|Withdrawal by Subject|1|||
16243576|NCT02390219|39375003|FG000|Overall Study|Lost to Follow-up|2|||
16243577|NCT02390219|39375003|FG000|Overall Study|Other|2|||
16558801|NCT01651403|40513209|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
16558802|NCT01651403|40513210|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
16558803|NCT01651403|40513209|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
16558804|NCT01651403|40513210|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
16558805|NCT01651403|40513209|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
16558806|NCT01651403|40513210|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
16558807|NCT01651403|40513209|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
16243578|NCT00593333|39375004|FG000|Overall Study|Lost to Follow-up|10|||
16243579|NCT00593333|39375005|FG001|Overall Study|Lost to Follow-up|11|||
16243580|NCT01155063|39375006|FG000|Overall Study|Adverse Event|1|||
16243581|NCT01155063|39375006|FG000|Overall Study|Withdrawal by Subject|1|||
16243582|NCT01155063|39375006|FG000|Overall Study|Study terminated by sponsor|87|||
16243583|NCT00856778|39375015|FG000|Overall Study|Adverse Event|7|||
16243584|NCT00856778|39375015|FG000|Overall Study|Withdrawal by Subject|10|||
16243585|NCT00856778|39375015|FG000|Overall Study|Study deviation|2|||
16243586|NCT00856778|39375015|FG000|Overall Study|Lost to Follow-up|5|||
16243587|NCT01473758|39375016|FG000|Cycle 1|Adverse Event|10|||
16243588|NCT01473758|39375017|FG001|Cycle 1|Adverse Event|2|||
16243589|NCT01473758|39375018|FG002|Cycle 1|Adverse Event|0|||
16243590|NCT01473758|39375019|FG003|Cycle 1|Adverse Event|0|||
16243591|NCT01473758|39375016|FG000|Cycle 1|Withdrawal by Subject|1|||
16243592|NCT01473758|39375017|FG001|Cycle 1|Withdrawal by Subject|1|||
16243593|NCT01473758|39375018|FG002|Cycle 1|Withdrawal by Subject|0|||
16243594|NCT01473758|39375019|FG003|Cycle 1|Withdrawal by Subject|0|||
16243595|NCT01473758|39375016|FG000|Cycle 2|Adverse Event|0|||
16243596|NCT01473758|39375017|FG001|Cycle 2|Adverse Event|0|||
16243597|NCT01473758|39375018|FG002|Cycle 2|Adverse Event|5|||
16243598|NCT01473758|39375019|FG003|Cycle 2|Adverse Event|0|||
16243599|NCT01377233|39375020|FG000|Open-label|Adverse Event|1|||
16243600|NCT01377233|39375021|FG001|Open-label|Adverse Event|0|||
16243601|NCT01377233|39375022|FG002|Open-label|Adverse Event|0|||
16243602|NCT01377233|39375023|FG003|Open-label|Adverse Event|0|||
16243603|NCT01377233|39375024|FG004|Open-label|Adverse Event|0|||
16243604|NCT01377233|39375020|FG000|Open-label|Withdrawal by Subject|3|||
16243605|NCT01377233|39375021|FG001|Open-label|Withdrawal by Subject|0|||
16558808|NCT01651403|40513210|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
16243606|NCT01377233|39375022|FG002|Open-label|Withdrawal by Subject|0|||
16243607|NCT01377233|39375023|FG003|Open-label|Withdrawal by Subject|0|||
16243608|NCT01377233|39375024|FG004|Open-label|Withdrawal by Subject|0|||
16243609|NCT01377233|39375020|FG000|Double-blind|Adverse Event|0|||
16243610|NCT01377233|39375021|FG001|Double-blind|Adverse Event|1|||
16243611|NCT01377233|39375022|FG002|Double-blind|Adverse Event|2|||
16243612|NCT01377233|39375023|FG003|Double-blind|Adverse Event|2|||
16243613|NCT01377233|39375024|FG004|Double-blind|Adverse Event|0|||
16243614|NCT01377233|39375020|FG000|Double-blind|Protocol Violation|0|||
16243615|NCT01377233|39375021|FG001|Double-blind|Protocol Violation|0|||
16243616|NCT01377233|39375022|FG002|Double-blind|Protocol Violation|0|||
16243617|NCT01377233|39375023|FG003|Double-blind|Protocol Violation|0|||
16243618|NCT01377233|39375024|FG004|Double-blind|Protocol Violation|1|||
16243619|NCT01377233|39375020|FG000|Double-blind|Withdrawal by Subject|0|||
16243620|NCT01377233|39375021|FG001|Double-blind|Withdrawal by Subject|0|||
16243621|NCT01377233|39375022|FG002|Double-blind|Withdrawal by Subject|0|||
16243622|NCT01377233|39375023|FG003|Double-blind|Withdrawal by Subject|1|||
16243623|NCT01377233|39375024|FG004|Double-blind|Withdrawal by Subject|0|||
16243624|NCT01377233|39375020|FG000|Double-blind|Administrative or other|0|||
16243625|NCT01377233|39375021|FG001|Double-blind|Administrative or other|0|||
16243626|NCT01377233|39375022|FG002|Double-blind|Administrative or other|0|||
16243627|NCT01377233|39375023|FG003|Double-blind|Administrative or other|1|||
16243628|NCT01377233|39375024|FG004|Double-blind|Administrative or other|1|||
16243629|NCT00096382|39375029|FG000|Overall Study|Not treated|1|||
16243630|NCT00096382|39375030|FG001|Overall Study|Not treated|0|||
16243631|NCT00096382|39375029|FG000|Overall Study|Death during treatment|1|||
16243632|NCT00096382|39375030|FG001|Overall Study|Death during treatment|0|||
16243633|NCT02109133|39375031|FG000|Overall Study|Lost to Follow-up|1|||
16243634|NCT02109133|39375032|FG001|Overall Study|Lost to Follow-up|0|||
16243635|NCT04470622|39375034|FG000|Overall Study|Withdrawal by Subject|0|||
16243636|NCT04470622|39375035|FG001|Overall Study|Withdrawal by Subject|1|||
16243637|NCT04470622|39375034|FG000|Overall Study|Screen Failure|0|||
16243638|NCT04470622|39375035|FG001|Overall Study|Screen Failure|1|||
16243639|NCT04470622|39375034|FG000|Overall Study|Death|0|||
16243640|NCT04470622|39375035|FG001|Overall Study|Death|1|||
16243641|NCT01169649|39375036|FG000|Overall Study|Patient Not Treated|3|||
16243642|NCT02557672|39375037|FG000|Overall Study|Withdrawal by Subject|4|||
16243643|NCT02557672|39375038|FG001|Overall Study|Withdrawal by Subject|2|||
16243644|NCT04428502|39375039|FG000|Overall Study|Did not meet entrance criteria|14|||
16243645|NCT00936884|39375041|FG000|Double-blind|Withdrawal by Subject|6|||
16243646|NCT00936884|39375042|FG001|Double-blind|Withdrawal by Subject|4|||
16243647|NCT00936884|39375043|FG002|Double-blind|Withdrawal by Subject|0|||
16243648|NCT00936884|39375041|FG000|Double-blind|Death|2|||
16243649|NCT00936884|39375042|FG001|Double-blind|Death|1|||
16243650|NCT00936884|39375043|FG002|Double-blind|Death|0|||
16243651|NCT00936884|39375041|FG000|Double-blind|Lack of Efficacy|1|||
16243652|NCT00936884|39375042|FG001|Double-blind|Lack of Efficacy|1|||
16243653|NCT00936884|39375043|FG002|Double-blind|Lack of Efficacy|0|||
16243654|NCT00936884|39375041|FG000|Double-blind|Adverse Event|1|||
16243655|NCT00936884|39375042|FG001|Double-blind|Adverse Event|0|||
16243656|NCT00936884|39375043|FG002|Double-blind|Adverse Event|0|||
16243657|NCT00936884|39375041|FG000|Double-blind|Physician Decision|1|||
16243658|NCT00936884|39375042|FG001|Double-blind|Physician Decision|0|||
16243659|NCT00936884|39375043|FG002|Double-blind|Physician Decision|0|||
16243660|NCT00936884|39375041|FG000|Double-blind|No post baseline diary entry|1|||
16243661|NCT00936884|39375042|FG001|Double-blind|No post baseline diary entry|0|||
16243662|NCT00936884|39375043|FG002|Double-blind|No post baseline diary entry|0|||
16243663|NCT00936884|39375041|FG000|Double-blind|Did not receive study drug|0|||
16243664|NCT00936884|39375042|FG001|Double-blind|Did not receive study drug|1|||
16243665|NCT00936884|39375043|FG002|Double-blind|Did not receive study drug|0|||
16243666|NCT03568500|39375044|FG000|Overall Study|Lost to Follow-up|1|||
16243667|NCT03568500|39375045|FG001|Overall Study|Lost to Follow-up|1|||
16243668|NCT03568500|39375046|FG002|Overall Study|Lost to Follow-up|2|||
16243669|NCT03568500|39375044|FG000|Overall Study|Adverse Event|1|||
16243670|NCT03568500|39375045|FG001|Overall Study|Adverse Event|1|||
16243671|NCT03568500|39375046|FG002|Overall Study|Adverse Event|2|||
16243672|NCT03568500|39375044|FG000|Overall Study|Physician Decision|1|||
16243673|NCT03568500|39375045|FG001|Overall Study|Physician Decision|0|||
16243674|NCT03568500|39375046|FG002|Overall Study|Physician Decision|0|||
16243675|NCT03568500|39375044|FG000|Overall Study|Withdrawal by Subject|4|||
16243676|NCT03568500|39375045|FG001|Overall Study|Withdrawal by Subject|2|||
16243677|NCT03568500|39375046|FG002|Overall Study|Withdrawal by Subject|0|||
16243678|NCT03568500|39375044|FG000|Overall Study|Technical Problems|2|||
16243679|NCT03568500|39375045|FG001|Overall Study|Technical Problems|1|||
16243680|NCT03568500|39375046|FG002|Overall Study|Technical Problems|0|||
16351425|NCT01719380|39773004|FG008|Overall Study|Participant/Guardian Decision|2|||
16243681|NCT03568500|39375044|FG000|Overall Study|Participant Noncompliance|1|||
16243682|NCT03568500|39375045|FG001|Overall Study|Participant Noncompliance|1|||
16243683|NCT03568500|39375046|FG002|Overall Study|Participant Noncompliance|0|||
16351426|NCT01719380|39773005|FG009|Overall Study|Participant/Guardian Decision|2|||
16351427|NCT01719380|39772996|FG000|Overall Study|Physician Decision|0|||
16243684|NCT01681771|39375047|FG000|Overall Study|Lost to Follow-up|4|||
16243685|NCT01681771|39375048|FG001|Overall Study|Lost to Follow-up|2|||
16243686|NCT03361956|39375049|FG000|Overall Study|Adverse Event|1|||
16243687|NCT03361956|39375050|FG001|Overall Study|Adverse Event|0|||
16243688|NCT03361956|39375051|FG002|Overall Study|Adverse Event|1|||
16243689|NCT03361956|39375052|FG003|Overall Study|Adverse Event|1|||
16243690|NCT03361956|39375053|FG004|Overall Study|Adverse Event|0|||
16243691|NCT03361956|39375049|FG000|Overall Study|Other|0|||
16243692|NCT03361956|39375050|FG001|Overall Study|Other|0|||
16243693|NCT03361956|39375051|FG002|Overall Study|Other|0|||
16243694|NCT03361956|39375052|FG003|Overall Study|Other|1|||
16243695|NCT03361956|39375053|FG004|Overall Study|Other|0|||
16243696|NCT03361956|39375049|FG000|Overall Study|Withdrawal by Subject|2|||
16243697|NCT03361956|39375050|FG001|Overall Study|Withdrawal by Subject|2|||
16243698|NCT03361956|39375051|FG002|Overall Study|Withdrawal by Subject|2|||
16243699|NCT03361956|39375052|FG003|Overall Study|Withdrawal by Subject|0|||
16243700|NCT03361956|39375053|FG004|Overall Study|Withdrawal by Subject|3|||
16243701|NCT03361956|39375049|FG000|Overall Study|Disease Relapse|0|||
16243702|NCT03361956|39375050|FG001|Overall Study|Disease Relapse|0|||
16243703|NCT03361956|39375051|FG002|Overall Study|Disease Relapse|1|||
16243704|NCT03361956|39375052|FG003|Overall Study|Disease Relapse|0|||
16243705|NCT03361956|39375053|FG004|Overall Study|Disease Relapse|0|||
16243706|NCT03361956|39375049|FG000|Overall Study|Physician Decision|0|||
16243707|NCT03361956|39375050|FG001|Overall Study|Physician Decision|2|||
16243708|NCT03361956|39375051|FG002|Overall Study|Physician Decision|0|||
16243709|NCT03361956|39375052|FG003|Overall Study|Physician Decision|1|||
16243710|NCT03361956|39375053|FG004|Overall Study|Physician Decision|0|||
16243711|NCT03361956|39375049|FG000|Overall Study|Lost to Follow-up|0|||
16243712|NCT03361956|39375050|FG001|Overall Study|Lost to Follow-up|0|||
16243713|NCT03361956|39375051|FG002|Overall Study|Lost to Follow-up|1|||
16243714|NCT03361956|39375052|FG003|Overall Study|Lost to Follow-up|1|||
16243715|NCT03361956|39375053|FG004|Overall Study|Lost to Follow-up|2|||
16243716|NCT00986154|39375054|FG000|Overall Study|Death|136|||
16351428|NCT01719380|39772997|FG001|Overall Study|Physician Decision|0|||
16351429|NCT01719380|39772998|FG002|Overall Study|Physician Decision|2|||
16351430|NCT01719380|39772999|FG003|Overall Study|Physician Decision|0|||
16351431|NCT01719380|39773000|FG004|Overall Study|Physician Decision|0|||
16351432|NCT01719380|39773001|FG005|Overall Study|Physician Decision|0|||
16351433|NCT01719380|39773002|FG006|Overall Study|Physician Decision|0|||
16351434|NCT01719380|39773003|FG007|Overall Study|Physician Decision|0|||
16351435|NCT01719380|39773004|FG008|Overall Study|Physician Decision|1|||
16351436|NCT01719380|39773005|FG009|Overall Study|Physician Decision|1|||
16351437|NCT01719380|39772996|FG000|Overall Study|Lack of Efficacy|2|||
16351438|NCT01719380|39772997|FG001|Overall Study|Lack of Efficacy|6|||
16351439|NCT01719380|39772998|FG002|Overall Study|Lack of Efficacy|5|||
16351440|NCT01719380|39772999|FG003|Overall Study|Lack of Efficacy|6|||
16243717|NCT00986154|39375055|FG001|Overall Study|Death|127|||
16243718|NCT00986154|39375054|FG000|Overall Study|Lost to Follow-up|7|||
16243719|NCT00986154|39375055|FG001|Overall Study|Lost to Follow-up|4|||
16243720|NCT00986154|39375054|FG000|Overall Study|Withdrawal by Subject|32|||
16243721|NCT00986154|39375055|FG001|Overall Study|Withdrawal by Subject|33|||
16243722|NCT00986154|39375054|FG000|Overall Study|investigator/subject decide not continue|6|||
16243723|NCT00986154|39375055|FG001|Overall Study|investigator/subject decide not continue|3|||
16243724|NCT00986154|39375054|FG000|Overall Study|never received study drug|25|||
16243725|NCT00986154|39375055|FG001|Overall Study|never received study drug|27|||
16558809|NCT01651403|40513209|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
16558810|NCT01651403|40513210|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
16558811|NCT01651403|40513209|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
16558812|NCT01651403|40513210|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
16558813|NCT00031447|40513212|FG000|Overall Study|Lost to Follow-up|0|||
16558814|NCT00031447|40513213|FG001|Overall Study|Lost to Follow-up|1|||
16558815|NCT00031447|40513212|FG000|Overall Study|Non-compliant|1|||
16558816|NCT00031447|40513213|FG001|Overall Study|Non-compliant|1|||
16243726|NCT01625845|39375060|FG000|Overall Study|Adverse Event|1|||
16243727|NCT01625845|39375061|FG001|Overall Study|Adverse Event|2|||
16243728|NCT01625845|39375060|FG000|Overall Study|Lost to Follow-up|2|||
16243729|NCT01625845|39375061|FG001|Overall Study|Lost to Follow-up|1|||
16243730|NCT01625845|39375060|FG000|Overall Study|Withdrawal by Subject|2|||
16243731|NCT01625845|39375061|FG001|Overall Study|Withdrawal by Subject|0|||
16243732|NCT00289458|39375062|FG000|Overall Study|Death|1|||
16351441|NCT01719380|39773000|FG004|Overall Study|Lack of Efficacy|3|||
16351442|NCT01719380|39773001|FG005|Overall Study|Lack of Efficacy|7|||
16351443|NCT01719380|39773002|FG006|Overall Study|Lack of Efficacy|10|||
16558817|NCT00031447|40513212|FG000|Overall Study|Re-activation of Disease|2|||
16243733|NCT00289458|39375063|FG001|Overall Study|Death|0|||
16243734|NCT00289458|39375064|FG002|Overall Study|Death|0|||
16243735|NCT00289458|39375062|FG000|Overall Study|Physician Decision|3|||
16558818|NCT00031447|40513213|FG001|Overall Study|Re-activation of Disease|1|||
16558819|NCT00031447|40513212|FG000|Overall Study|Disruption of blinded study drug supply|7|||
16558820|NCT00031447|40513213|FG001|Overall Study|Disruption of blinded study drug supply|4|||
16558821|NCT02419755|40513214|FG000|Overall Study|Death|1|||
16558822|NCT02419755|40513215|FG001|Overall Study|Death|3|||
16558823|NCT02419755|40513214|FG000|Overall Study|Relapse|0|||
16558824|NCT02419755|40513215|FG001|Overall Study|Relapse|1|||
16558825|NCT02419755|40513214|FG000|Overall Study|Ineligible|1|||
16558826|NCT02419755|40513215|FG001|Overall Study|Ineligible|0|||
16558827|NCT02419755|40513214|FG000|Overall Study|Withdrawal by Subject|1|||
16558828|NCT02419755|40513215|FG001|Overall Study|Withdrawal by Subject|0|||
16558829|NCT00670540|40513216|FG000|Overall Study|ineligible|17|||
16558830|NCT00670540|40513216|FG000|Overall Study|not living in France|348|||
16558831|NCT00670540|40513216|FG000|Overall Study|refused to participate|189|||
16351444|NCT01719380|39773003|FG007|Overall Study|Lack of Efficacy|6|||
16351445|NCT01719380|39773004|FG008|Overall Study|Lack of Efficacy|39|||
16127143|NCT04737187|38951636|FG001|Overall Study|Radiological Progressive Disease|146|||
16127144|NCT04737187|38951635|FG000|Overall Study|Clinical Progressive Disease|20|||
16127145|NCT04737187|38951636|FG001|Overall Study|Clinical Progressive Disease|20|||
16127146|NCT04737187|38951635|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
16127147|NCT04737187|38951636|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
16127148|NCT04737187|38951635|FG000|Overall Study|Adverse Event|16|||
16127149|NCT04737187|38951636|FG001|Overall Study|Adverse Event|16|||
16127150|NCT04737187|38951635|FG000|Overall Study|Physician Decision|2|||
16127151|NCT04737187|38951636|FG001|Overall Study|Physician Decision|0|||
16127152|NCT04737187|38951635|FG000|Overall Study|Withdrawal by Subject|5|||
16127153|NCT04737187|38951636|FG001|Overall Study|Withdrawal by Subject|8|||
16127154|NCT03567434|38951640|FG000|Overall Study|Lost to Follow-up|1|||
16351446|NCT01719380|39773005|FG009|Overall Study|Lack of Efficacy|42|||
16351447|NCT01719380|39772996|FG000|Overall Study|Progressive Disease|0|||
16351448|NCT01719380|39772997|FG001|Overall Study|Progressive Disease|0|||
16351449|NCT01719380|39772998|FG002|Overall Study|Progressive Disease|0|||
16351450|NCT01719380|39772999|FG003|Overall Study|Progressive Disease|0|||
16127155|NCT03567434|38951641|FG001|Overall Study|Lost to Follow-up|3|||
16127156|NCT03432260|38951643|FG000|Overall Study|Lost to Follow-up|1|||
16127157|NCT03432260|38951644|FG001|Overall Study|Lost to Follow-up|1|||
16127158|NCT03432260|38951645|FG002|Overall Study|Lost to Follow-up|0|||
16351451|NCT01719380|39773000|FG004|Overall Study|Progressive Disease|0|||
16351452|NCT01719380|39773001|FG005|Overall Study|Progressive Disease|0|||
16351453|NCT01719380|39773002|FG006|Overall Study|Progressive Disease|0|||
16351454|NCT01719380|39773003|FG007|Overall Study|Progressive Disease|0|||
16351455|NCT01719380|39773004|FG008|Overall Study|Progressive Disease|1|||
16351456|NCT01719380|39773005|FG009|Overall Study|Progressive Disease|0|||
16351457|NCT04805671|39773006|FG000|Overall Study|Death|2|||
16351458|NCT04805671|39773007|FG001|Overall Study|Death|7|||
16351459|NCT04805671|39773006|FG000|Overall Study|Lost to Follow-up|1|||
16351460|NCT04805671|39773007|FG001|Overall Study|Lost to Follow-up|0|||
16351461|NCT04805671|39773006|FG000|Overall Study|Withdrawal by Subject|9|||
16243736|NCT00289458|39375063|FG001|Overall Study|Physician Decision|4|||
16351462|NCT04805671|39773007|FG001|Overall Study|Withdrawal by Subject|7|||
16558832|NCT00670540|40513216|FG000|Overall Study|controls randomised for no follow up|2770|||
16127159|NCT03432260|38951646|FG003|Overall Study|Lost to Follow-up|0|||
16127160|NCT03432260|38951647|FG004|Overall Study|Lost to Follow-up|1|||
16351463|NCT04805671|39773006|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
16558833|NCT00670540|40513216|FG000|Overall Study|missing information inclusion criteria|1|||
16558834|NCT03432533|40513219|FG000|Overall Study|Lost to Follow-up|1|||
16127161|NCT03330847|38951648|FG000|Overall Study|Patients ongoing study|62|||
16127162|NCT03330847|38951649|FG001|Overall Study|Patients ongoing study|65|||
16127163|NCT03330847|38951650|FG002|Overall Study|Patients ongoing study|15|||
16127164|NCT03319849|38951652|FG000|Overall Study|Adverse Event|1|||
16127165|NCT03319849|38951653|FG001|Overall Study|Adverse Event|0|||
16127166|NCT03319849|38951652|FG000|Overall Study|Physician Decision|0|||
16127167|NCT03319849|38951653|FG001|Overall Study|Physician Decision|1|||
16127168|NCT03319849|38951652|FG000|Overall Study|Withdrawal by Subject|0|||
16127169|NCT03319849|38951653|FG001|Overall Study|Withdrawal by Subject|1|||
16127170|NCT03319849|38951652|FG000|Overall Study|COVID-19|0|||
16127171|NCT03319849|38951653|FG001|Overall Study|COVID-19|1|||
16127172|NCT03319849|38951652|FG000|Overall Study|Other|1|||
16127173|NCT03319849|38951653|FG001|Overall Study|Other|2|||
16127174|NCT03319849|38951652|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
16127175|NCT03319849|38951653|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
16127176|NCT03319849|38951652|FG000|Overall Study|Lost to Follow-up|0|||
16127177|NCT03319849|38951653|FG001|Overall Study|Lost to Follow-up|2|||
16127178|NCT05593445|38951655|FG000|12-Week DBVC Period|Adverse Event|1|||
16127179|NCT05593445|38951656|FG001|12-Week DBVC Period|Adverse Event|0|||
16127180|NCT05593445|38951657|FG002|12-Week DBVC Period|Adverse Event|0|||
16127181|NCT05593445|38951658|FG003|12-Week DBVC Period|Adverse Event|0|||
16127182|NCT05593445|38951655|FG000|12-Week DBVC Period|Physician Decision|0|||
16558835|NCT03432533|40513220|FG001|Overall Study|Lost to Follow-up|2|||
16558836|NCT03432533|40513219|FG000|Overall Study|Withdrawal by Subject|14|||
16558837|NCT03432533|40513220|FG001|Overall Study|Withdrawal by Subject|9|||
16558838|NCT02926937|40513221|FG000|Overall Study|Adverse Event|0|||
16558839|NCT02926937|40513222|FG001|Overall Study|Adverse Event|1|||
16558840|NCT02926937|40513223|FG002|Overall Study|Adverse Event|1|||
16558841|NCT02926937|40513221|FG000|Overall Study|Poor Compliance to Protocol|1|||
16558842|NCT02926937|40513222|FG001|Overall Study|Poor Compliance to Protocol|0|||
16558843|NCT02926937|40513223|FG002|Overall Study|Poor Compliance to Protocol|0|||
16558844|NCT02926937|40513221|FG000|Overall Study|Lost to Follow-up|4|||
16558845|NCT02926937|40513222|FG001|Overall Study|Lost to Follow-up|5|||
16558846|NCT02926937|40513223|FG002|Overall Study|Lost to Follow-up|0|||
16558847|NCT02926937|40513221|FG000|Overall Study|At the Participant's own Request|11|||
16558848|NCT02926937|40513222|FG001|Overall Study|At the Participant's own Request|5|||
16558849|NCT02926937|40513223|FG002|Overall Study|At the Participant's own Request|8|||
16558850|NCT02926937|40513221|FG000|Overall Study|Reason not Specified|3|||
16558851|NCT02926937|40513222|FG001|Overall Study|Reason not Specified|4|||
16558852|NCT02926937|40513223|FG002|Overall Study|Reason not Specified|2|||
16558853|NCT02781506|40513224|FG000|Overall Study|Adverse Event|5|||
16558854|NCT04640571|40513225|FG000|Overall Study|Withdrawal by Subject|0|||
16558855|NCT04640571|40513226|FG001|Overall Study|Withdrawal by Subject|0|||
16558856|NCT04640571|40513227|FG002|Overall Study|Withdrawal by Subject|0|||
16558857|NCT04640571|40513228|FG003|Overall Study|Withdrawal by Subject|0|||
16558858|NCT04640571|40513229|FG004|Overall Study|Withdrawal by Subject|0|||
16558859|NCT04640571|40513230|FG005|Overall Study|Withdrawal by Subject|2|||
16558860|NCT00919893|40513246|FG000|Overall Study|Protocol Violation|19|||
16558861|NCT00919893|40513247|FG001|Overall Study|Protocol Violation|9|||
16558862|NCT00604721|40513250|FG000|Overall Study|Physician Decision|1|||
16558863|NCT00604721|40513250|FG000|Overall Study|Withdrawal by Subject|1|||
16558864|NCT03055832|40513251|FG000|Week 2|Withdrawal by Subject|1|||
16558865|NCT03055832|40513252|FG001|Week 2|Withdrawal by Subject|0|||
16558866|NCT00262743|40513253|FG000|Overall Study|Adverse Event|0|||
16558867|NCT00262743|40513254|FG001|Overall Study|Adverse Event|9|||
16558868|NCT00262743|40513253|FG000|Overall Study|Disease progression|0|||
16558869|NCT00262743|40513254|FG001|Overall Study|Disease progression|3|||
16558870|NCT00665561|40513255|FG000|Overall Study|Death recorded on subject summary pages|75|||
16558871|NCT00665561|40513256|FG001|Overall Study|Death recorded on subject summary pages|75|||
16558872|NCT00665561|40513255|FG000|Overall Study|Does not meet entrance criteria|19|||
16558873|NCT00665561|40513256|FG001|Overall Study|Does not meet entrance criteria|21|||
16558874|NCT00665561|40513255|FG000|Overall Study|Lost to Follow-up|203|||
16558875|NCT00665561|40513256|FG001|Overall Study|Lost to Follow-up|264|||
16558876|NCT00665561|40513255|FG000|Overall Study|Withdrawal by Subject|74|||
16558877|NCT00665561|40513256|FG001|Overall Study|Withdrawal by Subject|65|||
16558878|NCT00665561|40513255|FG000|Overall Study|Other|123|||
16558879|NCT00665561|40513256|FG001|Overall Study|Other|108|||
16558880|NCT00665561|40513255|FG000|Overall Study|Site closed|8|||
16558881|NCT00665561|40513256|FG001|Overall Study|Site closed|0|||
16558882|NCT00665561|40513255|FG000|Overall Study|Withdrawn due to pregnancy|0|||
16558883|NCT00665561|40513256|FG001|Overall Study|Withdrawn due to pregnancy|1|||
16558884|NCT00429793|40513257|FG000|Overall Study|Improper pre-protocol treatment|3|||
16558885|NCT00429793|40513257|FG000|Overall Study|Required test not done|1|||
16558886|NCT00429793|40513257|FG000|Overall Study|Never treated|1|||
16558887|NCT00429793|40513257|FG000|Overall Study|Non-measurable|1|||
16558888|NCT01603121|40513258|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
16127183|NCT05593445|38951656|FG001|12-Week DBVC Period|Physician Decision|1|||
16127184|NCT05593445|38951657|FG002|12-Week DBVC Period|Physician Decision|0|||
16127185|NCT05593445|38951658|FG003|12-Week DBVC Period|Physician Decision|0|||
16127186|NCT05593445|38951655|FG000|12-Week DBVC Period|Protocol Violation|0|||
16127187|NCT05593445|38951656|FG001|12-Week DBVC Period|Protocol Violation|1|||
16127188|NCT05593445|38951657|FG002|12-Week DBVC Period|Protocol Violation|0|||
16127189|NCT05593445|38951658|FG003|12-Week DBVC Period|Protocol Violation|0|||
16127190|NCT05593445|38951655|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
16127191|NCT05593445|38951656|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
16127192|NCT05593445|38951657|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
16127193|NCT05593445|38951658|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
16127194|NCT05593445|38951655|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
16127195|NCT05593445|38951656|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
16127196|NCT05593445|38951657|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
16127197|NCT05593445|38951658|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
16127198|NCT05593445|38951655|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
16127199|NCT05593445|38951656|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
16127200|NCT05593445|38951657|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
16127201|NCT05593445|38951658|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
16127202|NCT05593445|38951655|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
16127203|NCT05593445|38951656|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
16127204|NCT05593445|38951657|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
16127205|NCT05593445|38951658|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
16127206|NCT05593445|38951655|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
16127207|NCT05593445|38951656|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
16127208|NCT05593445|38951657|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
16127209|NCT05593445|38951658|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
16127210|NCT05559476|38951659|FG000|Overall Study|Adverse Event|2|||
16127211|NCT05559476|38951660|FG001|Overall Study|Adverse Event|0|||
16127212|NCT05559476|38951659|FG000|Overall Study|Lost to Follow-up|13|||
16127213|NCT05559476|38951660|FG001|Overall Study|Lost to Follow-up|12|||
16127214|NCT05559476|38951659|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
16127215|NCT05559476|38951660|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
16127216|NCT05559476|38951659|FG000|Overall Study|Other|0|||
16127217|NCT05559476|38951660|FG001|Overall Study|Other|2|||
16127218|NCT03727438|38951662|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
16127219|NCT03727438|38951663|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
16415648|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
16415649|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
16415650|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
16415651|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
16127220|NCT03727438|38951662|FG000|Intervention Period|Excluded (health)|1|||
16415652|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
16558889|NCT01603121|40513259|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
16127221|NCT03727438|38951663|FG001|Intervention Period|Excluded (health)|0|||
16243737|NCT00289458|39375064|FG002|Overall Study|Physician Decision|2|||
16127222|NCT03727438|38951662|FG000|Intervention Period|Withdrawal by Subject|3|||
16127223|NCT03727438|38951663|FG001|Intervention Period|Withdrawal by Subject|1|||
16127224|NCT03727438|38951662|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
16127225|NCT03727438|38951663|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
16127226|NCT03727438|38951662|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
16127227|NCT03727438|38951663|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
16127228|NCT03727438|38951662|FG000|8 Week Assessment|Withdrawal by Subject|6|||
16127229|NCT03727438|38951663|FG001|8 Week Assessment|Withdrawal by Subject|1|||
16127230|NCT03727438|38951662|FG000|6 mo Assessment|did not complete assessment|10|||
16127231|NCT03727438|38951663|FG001|6 mo Assessment|did not complete assessment|11|||
16127232|NCT00924027|38951664|FG000|Overall Study|Lost to Further Follow-Up|4|||
16127233|NCT00924027|38951665|FG001|Overall Study|Lost to Further Follow-Up|0|||
16127234|NCT00924027|38951666|FG002|Overall Study|Lost to Further Follow-Up|0|||
16127235|NCT00924027|38951667|FG003|Overall Study|Lost to Further Follow-Up|0|||
16127236|NCT00924027|38951664|FG000|Overall Study|Physician Decision|1|||
16127237|NCT00924027|38951665|FG001|Overall Study|Physician Decision|0|||
16127238|NCT00924027|38951666|FG002|Overall Study|Physician Decision|0|||
16127239|NCT00924027|38951667|FG003|Overall Study|Physician Decision|1|||
16127240|NCT00924027|38951664|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
16127241|NCT00924027|38951665|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
16127242|NCT00924027|38951666|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
16127243|NCT00924027|38951667|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
16127244|NCT00924027|38951664|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
16127245|NCT00924027|38951665|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
16127246|NCT00924027|38951666|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
16127247|NCT00924027|38951667|FG003|Overall Study|Withdrawal: Refused to start treatment|1|||
16127248|NCT00924027|38951664|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
16127249|NCT00924027|38951665|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
16127250|NCT00924027|38951666|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
16127251|NCT00924027|38951667|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
16173350|NCT01147809|39111194|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
16173351|NCT01147809|39111195|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
16173352|NCT01147809|39111196|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
16173353|NCT01147809|39111197|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
16173354|NCT01147809|39111198|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
16173355|NCT01147809|39111199|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
16173356|NCT01147809|39111194|FG000|Phase I (168 Days)|Physician Decision|0|||
16173357|NCT01147809|39111195|FG001|Phase I (168 Days)|Physician Decision|1|||
16173358|NCT01147809|39111196|FG002|Phase I (168 Days)|Physician Decision|2|||
16173359|NCT01147809|39111197|FG003|Phase I (168 Days)|Physician Decision|0|||
16173360|NCT01147809|39111198|FG004|Phase I (168 Days)|Physician Decision|0|||
16173361|NCT01147809|39111199|FG005|Phase I (168 Days)|Physician Decision|0|||
16173362|NCT01147809|39111194|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
16173363|NCT01147809|39111195|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
16173364|NCT01147809|39111196|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
16173365|NCT01147809|39111197|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
16173366|NCT01147809|39111198|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
16173367|NCT01147809|39111199|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
16173368|NCT01147809|39111194|FG000|Phase II (168 Days)|Adverse Event|0|||
16173369|NCT01147809|39111195|FG001|Phase II (168 Days)|Adverse Event|0|||
16173370|NCT01147809|39111196|FG002|Phase II (168 Days)|Adverse Event|0|||
16173371|NCT01147809|39111197|FG003|Phase II (168 Days)|Adverse Event|0|||
16173372|NCT01147809|39111198|FG004|Phase II (168 Days)|Adverse Event|3|||
16558890|NCT01636362|40513260|FG000|Overall Study|Physician Decision|6|||
16173373|NCT01147809|39111199|FG005|Phase II (168 Days)|Adverse Event|6|||
16351464|NCT04805671|39773007|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
16351465|NCT01151345|39773008|FG000|First Intervention Period|Protocol Violation|0|||
16558891|NCT01636362|40513260|FG000|Overall Study|Subject healed, not returning|1|||
16558892|NCT01636362|40513260|FG000|Overall Study|Withdrawal by Subject|1|||
16558893|NCT00742274|40513266|FG000|Overall Study|Death|1|||
16558894|NCT00742274|40513267|FG001|Overall Study|Death|0|||
16558895|NCT00742274|40513266|FG000|Overall Study|Withdrawal by Subject|1|||
16558896|NCT00742274|40513267|FG001|Overall Study|Withdrawal by Subject|2|||
16558897|NCT00742274|40513266|FG000|Overall Study|Removed for medical reasons|1|||
16558898|NCT00742274|40513267|FG001|Overall Study|Removed for medical reasons|1|||
16558899|NCT00725010|40513275|FG000|Overall Study|Toxicity|9|||
16558900|NCT00725010|40513275|FG000|Overall Study|Tumor Progression|7|||
16173374|NCT01147809|39111194|FG000|Phase II (168 Days)|Protocol Violation|0|||
16173375|NCT01147809|39111195|FG001|Phase II (168 Days)|Protocol Violation|0|||
16558901|NCT00725010|40513275|FG000|Overall Study|Withdrawal by Subject|2|||
16558902|NCT00725010|40513275|FG000|Overall Study|Death|1|||
16558903|NCT00725010|40513275|FG000|Overall Study|Lost to Follow-up|1|||
16558904|NCT00725010|40513275|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
16127252|NCT00774930|38954321|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
16127253|NCT00774930|38954322|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
16127254|NCT00774930|38954321|FG000|DB Phase|Adverse Event|1|||
16127255|NCT00774930|38954322|FG001|DB Phase|Adverse Event|2|||
16127256|NCT00774930|38954321|FG000|DB Phase|Subject Decision|1|||
16127257|NCT00774930|38954322|FG001|DB Phase|Subject Decision|5|||
16127258|NCT00774930|38954321|FG000|DB Phase|Sponsor Decision|0|||
16127259|NCT00774930|38954322|FG001|DB Phase|Sponsor Decision|1|||
16127260|NCT00774930|38954321|FG000|DB Phase|Disease Progression|1|||
16127261|NCT00774930|38954322|FG001|DB Phase|Disease Progression|1|||
16127262|NCT00774930|38954321|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
16127263|NCT00774930|38954322|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
16127264|NCT00774930|38954321|FG000|IOL Phase|Adverse Event|1|||
16127265|NCT00774930|38954322|FG001|IOL Phase|Adverse Event|1|||
16127266|NCT00774930|38954321|FG000|IOL Phase|Subject Decision|4|||
16127267|NCT00774930|38954322|FG001|IOL Phase|Subject Decision|3|||
16127268|NCT00774930|38954321|FG000|IOL Phase|Physician Decision|3|||
16127269|NCT00774930|38954322|FG001|IOL Phase|Physician Decision|2|||
16127270|NCT00774930|38954321|FG000|IOL Phase|Sponsor Decision|1|||
16127271|NCT00774930|38954322|FG001|IOL Phase|Sponsor Decision|0|||
16127272|NCT00774930|38954321|FG000|IOL Phase|Disease Progression|2|||
16127273|NCT00774930|38954322|FG001|IOL Phase|Disease Progression|1|||
16127274|NCT00774930|38954321|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
16127275|NCT00774930|38954322|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
16127276|NCT00774930|38954321|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
16127277|NCT00774930|38954322|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
16127278|NCT00774930|38954321|FG000|IOL Phase|Other|1|||
16127279|NCT00774930|38954322|FG001|IOL Phase|Other|0|||
16127280|NCT00774930|38954321|FG000|IOL Phase|Brain radiation|0|||
16127281|NCT00774930|38954322|FG001|IOL Phase|Brain radiation|1|||
16127282|NCT00774930|38954321|FG000|LTOLE Phase|Adverse Event|7|||
16127283|NCT00774930|38954322|FG001|LTOLE Phase|Adverse Event|3|||
16127284|NCT00774930|38954321|FG000|LTOLE Phase|Subject decision|0|||
16127285|NCT00774930|38954322|FG001|LTOLE Phase|Subject decision|5|||
16127286|NCT00774930|38954321|FG000|LTOLE Phase|Physician Decision|4|||
16127287|NCT00774930|38954322|FG001|LTOLE Phase|Physician Decision|1|||
16127288|NCT00774930|38954321|FG000|LTOLE Phase|Sponsor decision|2|||
16127289|NCT00774930|38954322|FG001|LTOLE Phase|Sponsor decision|1|||
16127290|NCT00774930|38954321|FG000|LTOLE Phase|Disease Progression|2|||
16127291|NCT00774930|38954322|FG001|LTOLE Phase|Disease Progression|5|||
16127292|NCT00774930|38954321|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
16127293|NCT00774930|38954322|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
16127294|NCT00774930|38954321|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
16127295|NCT00774930|38954322|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
16127296|NCT02297139|38954334|FG000|Overall Study|Disease progression|0|||
16127297|NCT02297139|38954335|FG001|Overall Study|Disease progression|1|||
16127298|NCT02297139|38954334|FG000|Overall Study|Study drug toxicity|0|||
16127299|NCT02297139|38954335|FG001|Overall Study|Study drug toxicity|4|||
16127300|NCT02297139|38954334|FG000|Overall Study|Participant request to discontinue study treatment|0|||
16127301|NCT02297139|38954335|FG001|Overall Study|Participant request to discontinue study treatment|1|||
16127302|NCT02297139|38954334|FG000|Overall Study|Maximum clinical benefit|1|||
16127303|NCT02297139|38954335|FG001|Overall Study|Maximum clinical benefit|0|||
16127304|NCT02297139|38954334|FG000|Overall Study|Administrative reason by sponsor|0|||
16127305|NCT02297139|38954335|FG001|Overall Study|Administrative reason by sponsor|2|||
16127306|NCT02297139|38954334|FG000|Overall Study|Other reasons|0|||
16127307|NCT02297139|38954335|FG001|Overall Study|Other reasons|8|||
16127308|NCT00872989|38954336|FG000|Overall Study|Adverse Event|7|||
16127309|NCT00872989|38954337|FG001|Overall Study|Adverse Event|15|||
16127310|NCT00872989|38954336|FG000|Overall Study|Withdrawal by Subject|8|||
16127311|NCT00872989|38954337|FG001|Overall Study|Withdrawal by Subject|5|||
16127312|NCT00872989|38954336|FG000|Overall Study|Progression/relapse|47|||
16127313|NCT00872989|38954337|FG001|Overall Study|Progression/relapse|35|||
16127314|NCT00872989|38954336|FG000|Overall Study|Not protocol specified|3|||
16127315|NCT00872989|38954337|FG001|Overall Study|Not protocol specified|8|||
16127316|NCT04552899|38954338|FG000|Overall Study|Adverse Event|4|||
16127317|NCT04552899|38954339|FG001|Overall Study|Adverse Event|3|||
16127318|NCT04552899|38954338|FG000|Overall Study|Death|4|||
16127319|NCT04552899|38954339|FG001|Overall Study|Death|4|||
16127320|NCT04552899|38954338|FG000|Overall Study|Lost to Follow-up|8|||
16127321|NCT04552899|38954339|FG001|Overall Study|Lost to Follow-up|13|||
16127322|NCT04552899|38954338|FG000|Overall Study|Lung Transplant|4|||
16127323|NCT04552899|38954339|FG001|Overall Study|Lung Transplant|3|||
16127324|NCT04552899|38954338|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
16127325|NCT04552899|38954339|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
16127326|NCT04552899|38954338|FG000|Overall Study|Physician Decision|3|||
16127327|NCT04552899|38954339|FG001|Overall Study|Physician Decision|4|||
16127328|NCT04552899|38954338|FG000|Overall Study|Study Terminated By Sponsor|237|||
16127329|NCT04552899|38954339|FG001|Overall Study|Study Terminated By Sponsor|239|||
16415653|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
16415654|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
16415655|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
16415656|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
16415657|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
16415658|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
16415659|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
16415660|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
16415661|NCT02008357|40001735|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
16415662|NCT02008357|40001736|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
16415663|NCT02008357|40001735|FG000|Open-label Extension Period|Adverse Event|8|||
16415664|NCT02008357|40001736|FG001|Open-label Extension Period|Adverse Event|7|||
16415665|NCT02008357|40001735|FG000|Open-label Extension Period|Death|7|||
16415666|NCT02008357|40001736|FG001|Open-label Extension Period|Death|4|||
16415667|NCT02008357|40001735|FG000|Open-label Extension Period|Lack of Efficacy|9|||
16415668|NCT02008357|40001736|FG001|Open-label Extension Period|Lack of Efficacy|5|||
16415669|NCT02008357|40001735|FG000|Open-label Extension Period|Lost to Follow-up|2|||
16415670|NCT02008357|40001736|FG001|Open-label Extension Period|Lost to Follow-up|2|||
16415671|NCT02008357|40001735|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
16415672|NCT02008357|40001736|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
16415673|NCT02008357|40001735|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
16415674|NCT02008357|40001736|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
16415675|NCT02008357|40001735|FG000|Open-label Extension Period|Safety Risk|2|||
16415676|NCT02008357|40001736|FG001|Open-label Extension Period|Safety Risk|1|||
16415677|NCT02008357|40001735|FG000|Open-label Extension Period|Non-Compliance|0|||
16415678|NCT02008357|40001736|FG001|Open-label Extension Period|Non-Compliance|1|||
16415679|NCT02008357|40001735|FG000|Open-label Extension Period|Investigator Recommendation|0|||
16415680|NCT02008357|40001736|FG001|Open-label Extension Period|Investigator Recommendation|1|||
16415681|NCT02008357|40001735|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
16415682|NCT02008357|40001736|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
16415683|NCT02008357|40001735|FG000|Open-label Extension Period|Coordinating Center Request|2|||
16415684|NCT02008357|40001736|FG001|Open-label Extension Period|Coordinating Center Request|4|||
16415685|NCT02008357|40001735|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
16243738|NCT00289458|39375062|FG000|Overall Study|Withdrawal by Subject|2|||
16243739|NCT00289458|39375063|FG001|Overall Study|Withdrawal by Subject|2|||
16243740|NCT00289458|39375064|FG002|Overall Study|Withdrawal by Subject|4|||
16243741|NCT01512979|39375078|FG000|Overall Study|Adverse Event|2|||
16243742|NCT01512979|39375079|FG001|Overall Study|Adverse Event|2|||
16243743|NCT01512979|39375078|FG000|Overall Study|Protocol Violation|1|||
16243744|NCT01512979|39375079|FG001|Overall Study|Protocol Violation|4|||
16243745|NCT01512979|39375078|FG000|Overall Study|Lost to Follow-up|2|||
16243746|NCT01512979|39375079|FG001|Overall Study|Lost to Follow-up|5|||
16243747|NCT01512979|39375078|FG000|Overall Study|Withdrawal by Subject|1|||
16243748|NCT01512979|39375079|FG001|Overall Study|Withdrawal by Subject|2|||
16243749|NCT01512979|39375078|FG000|Overall Study|Reason other than stated above|13|||
16243750|NCT01512979|39375079|FG001|Overall Study|Reason other than stated above|9|||
16243751|NCT01084603|39375082|FG000|Baseline|Withdrawal by Subject|2|||
16243752|NCT01084603|39375082|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
16243753|NCT01084603|39375082|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
16243754|NCT01084603|39375082|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
16243755|NCT01084603|39375082|FG000|Washout Period 4|Adverse Event|1|||
16243756|NCT02741271|39375083|FG000|Overall Study|Lost to Follow-up|2|||
16243757|NCT02741271|39375084|FG001|Overall Study|Lost to Follow-up|0|||
16243758|NCT02741271|39375083|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16243759|NCT02741271|39375084|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
16243760|NCT03066440|39377814|FG000|Overall Study|Physician Decision|1|||
16243761|NCT03066440|39377815|FG001|Overall Study|Physician Decision|1|||
16243762|NCT03066440|39377814|FG000|Overall Study|Protocol Violation|0|||
16243763|NCT03066440|39377815|FG001|Overall Study|Protocol Violation|2|||
16243764|NCT02378506|39377826|FG000|Overall Study|Lack of Efficacy|3|||
16351466|NCT01151345|39773009|FG001|First Intervention Period|Protocol Violation|1|||
16351467|NCT01005901|39773010|FG000|Overall Study|Withdrawal by Subject|38|||
16351468|NCT01005901|39773011|FG001|Overall Study|Withdrawal by Subject|14|||
16351469|NCT01005901|39773010|FG000|Overall Study|Adverse Event|30|||
16351470|NCT01005901|39773011|FG001|Overall Study|Adverse Event|16|||
16351471|NCT01005901|39773010|FG000|Overall Study|Administrative problems|21|||
16351472|NCT01005901|39773011|FG001|Overall Study|Administrative problems|13|||
16351473|NCT01005901|39773010|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
16351474|NCT01005901|39773011|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
16351475|NCT01005901|39773010|FG000|Overall Study|Protocol Violation|4|||
16127330|NCT04552899|38954338|FG000|Overall Study|Withdrawal by Subject|15|||
16127331|NCT04552899|38954339|FG001|Overall Study|Withdrawal by Subject|17|||
16127332|NCT02270515|38954340|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
16127333|NCT02270515|38954340|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
16127334|NCT02270515|38954340|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
16127335|NCT02270515|38954340|FG000|Intervention Period 1: 0-6 Months|Death|7|||
16127336|NCT02270515|38954340|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
16127337|NCT02270515|38954340|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
16127338|NCT02270515|38954340|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
16127339|NCT02270515|38954340|FG000|Intervention Period 2: 6-12 Months|Death|5|||
16127340|NCT02270515|38954340|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
16127341|NCT02270515|38954340|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
16127342|NCT02270515|38954340|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
16127343|NCT02270515|38954340|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
16127344|NCT02270515|38954340|FG000|Intervention Period 3: 12-18 Months|Death|3|||
16127345|NCT02270515|38954340|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
16127346|NCT02721732|38954341|FG000|Overall Study|Adverse Event|2|||
16127347|NCT02721732|38954342|FG001|Overall Study|Adverse Event|0|||
16127348|NCT02721732|38954343|FG002|Overall Study|Adverse Event|2|||
16127349|NCT02721732|38954344|FG003|Overall Study|Adverse Event|0|||
16127350|NCT02721732|38954345|FG004|Overall Study|Adverse Event|1|||
16243765|NCT02378506|39377826|FG000|Overall Study|Withdrawal by Subject|4|||
16127351|NCT02721732|38954346|FG005|Overall Study|Adverse Event|0|||
16127352|NCT02721732|38954347|FG006|Overall Study|Adverse Event|1|||
16127353|NCT02721732|38954348|FG007|Overall Study|Adverse Event|0|||
16351476|NCT01005901|39773011|FG001|Overall Study|Protocol Violation|3|||
16127354|NCT02721732|38954349|FG008|Overall Study|Adverse Event|1|||
16127355|NCT02721732|38954350|FG009|Overall Study|Adverse Event|1|||
16127356|NCT02721732|38954341|FG000|Overall Study|Death|0|||
16127357|NCT02721732|38954342|FG001|Overall Study|Death|0|||
16127358|NCT02721732|38954343|FG002|Overall Study|Death|0|||
16127359|NCT02721732|38954344|FG003|Overall Study|Death|0|||
16127360|NCT02721732|38954345|FG004|Overall Study|Death|1|||
16127361|NCT02721732|38954346|FG005|Overall Study|Death|0|||
16127362|NCT02721732|38954347|FG006|Overall Study|Death|1|||
16127363|NCT02721732|38954348|FG007|Overall Study|Death|0|||
16127364|NCT02721732|38954349|FG008|Overall Study|Death|0|||
16127365|NCT02721732|38954350|FG009|Overall Study|Death|1|||
16127366|NCT02721732|38954341|FG000|Overall Study|Lack of Efficacy|12|||
16127367|NCT02721732|38954342|FG001|Overall Study|Lack of Efficacy|11|||
16127368|NCT02721732|38954343|FG002|Overall Study|Lack of Efficacy|18|||
16127369|NCT02721732|38954344|FG003|Overall Study|Lack of Efficacy|5|||
16127370|NCT02721732|38954345|FG004|Overall Study|Lack of Efficacy|21|||
16127371|NCT02721732|38954346|FG005|Overall Study|Lack of Efficacy|2|||
16127372|NCT02721732|38954347|FG006|Overall Study|Lack of Efficacy|8|||
16127373|NCT02721732|38954348|FG007|Overall Study|Lack of Efficacy|11|||
16127374|NCT02721732|38954349|FG008|Overall Study|Lack of Efficacy|10|||
16127375|NCT02721732|38954350|FG009|Overall Study|Lack of Efficacy|20|||
16127376|NCT02721732|38954341|FG000|Overall Study|Physician Decision|0|||
16127377|NCT02721732|38954342|FG001|Overall Study|Physician Decision|0|||
16127378|NCT02721732|38954343|FG002|Overall Study|Physician Decision|1|||
16127379|NCT02721732|38954344|FG003|Overall Study|Physician Decision|0|||
16127380|NCT02721732|38954345|FG004|Overall Study|Physician Decision|0|||
16127381|NCT02721732|38954346|FG005|Overall Study|Physician Decision|0|||
16127382|NCT02721732|38954347|FG006|Overall Study|Physician Decision|0|||
16415686|NCT02008357|40001736|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
16127383|NCT02721732|38954348|FG007|Overall Study|Physician Decision|0|||
16127384|NCT02721732|38954349|FG008|Overall Study|Physician Decision|0|||
16127385|NCT02721732|38954350|FG009|Overall Study|Physician Decision|0|||
16127386|NCT02721732|38954341|FG000|Overall Study|Withdrawal by Subject|1|||
16127387|NCT02721732|38954342|FG001|Overall Study|Withdrawal by Subject|0|||
16127388|NCT02721732|38954343|FG002|Overall Study|Withdrawal by Subject|0|||
16127389|NCT02721732|38954344|FG003|Overall Study|Withdrawal by Subject|0|||
16127390|NCT02721732|38954345|FG004|Overall Study|Withdrawal by Subject|3|||
16127391|NCT02721732|38954346|FG005|Overall Study|Withdrawal by Subject|0|||
16127392|NCT02721732|38954347|FG006|Overall Study|Withdrawal by Subject|1|||
16127393|NCT02721732|38954348|FG007|Overall Study|Withdrawal by Subject|1|||
16127394|NCT02721732|38954349|FG008|Overall Study|Withdrawal by Subject|0|||
16127395|NCT02721732|38954350|FG009|Overall Study|Withdrawal by Subject|1|||
16127396|NCT02721732|38954341|FG000|Overall Study|Participant Choice|1|||
16127397|NCT02721732|38954342|FG001|Overall Study|Participant Choice|0|||
16127398|NCT02721732|38954343|FG002|Overall Study|Participant Choice|0|||
16127399|NCT02721732|38954344|FG003|Overall Study|Participant Choice|0|||
16127400|NCT02721732|38954345|FG004|Overall Study|Participant Choice|0|||
16127401|NCT02721732|38954346|FG005|Overall Study|Participant Choice|0|||
16127402|NCT02721732|38954347|FG006|Overall Study|Participant Choice|0|||
16127403|NCT02721732|38954348|FG007|Overall Study|Participant Choice|0|||
16127404|NCT02721732|38954349|FG008|Overall Study|Participant Choice|0|||
16127405|NCT02721732|38954350|FG009|Overall Study|Participant Choice|1|||
16127406|NCT02721732|38954341|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
16127407|NCT02721732|38954342|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
16127408|NCT02721732|38954343|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
16127409|NCT02721732|38954344|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
16127410|NCT02721732|38954345|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
16127411|NCT02721732|38954346|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
16127412|NCT02721732|38954347|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
16127413|NCT02721732|38954348|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
16127414|NCT02721732|38954349|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
16127415|NCT02721732|38954350|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
16127416|NCT02721732|38954341|FG000|Overall Study|Progression and withdrew consent|1|||
16127417|NCT02721732|38954342|FG001|Overall Study|Progression and withdrew consent|1|||
16127418|NCT02721732|38954343|FG002|Overall Study|Progression and withdrew consent|0|||
16415687|NCT02008357|40001735|FG000|Open-label Extension Period|Study Ended|20|||
16415688|NCT02008357|40001736|FG001|Open-label Extension Period|Study Ended|25|||
16127419|NCT02721732|38954344|FG003|Overall Study|Progression and withdrew consent|0|||
16127420|NCT02721732|38954345|FG004|Overall Study|Progression and withdrew consent|0|||
16127421|NCT02721732|38954346|FG005|Overall Study|Progression and withdrew consent|0|||
16127422|NCT02721732|38954347|FG006|Overall Study|Progression and withdrew consent|0|||
16127423|NCT02721732|38954348|FG007|Overall Study|Progression and withdrew consent|0|||
16243766|NCT02378506|39377826|FG000|Overall Study|Protocol Violation|2|||
16127424|NCT02721732|38954349|FG008|Overall Study|Progression and withdrew consent|0|||
16127425|NCT02721732|38954350|FG009|Overall Study|Progression and withdrew consent|1|||
16127426|NCT02721732|38954341|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
16127427|NCT02721732|38954342|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
16127428|NCT02721732|38954343|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
16127429|NCT02721732|38954344|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
16127430|NCT02721732|38954345|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
16127431|NCT02721732|38954346|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
16127432|NCT02721732|38954347|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
16127433|NCT02721732|38954348|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
16127434|NCT02721732|38954349|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
16127435|NCT02721732|38954350|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
16127436|NCT00581555|38954355|FG000|Overall Study|Adverse Event|4|||
16127437|NCT00581555|38954356|FG001|Overall Study|Adverse Event|3|||
16127438|NCT00581555|38954355|FG000|Overall Study|Physician Decision|3|||
16127439|NCT00581555|38954356|FG001|Overall Study|Physician Decision|2|||
16127440|NCT00581555|38954355|FG000|Overall Study|Withdrawal by Subject|18|||
16127441|NCT00581555|38954356|FG001|Overall Study|Withdrawal by Subject|9|||
16127442|NCT00581555|38954355|FG000|Overall Study|Lost to Follow-up|2|||
16127443|NCT00581555|38954356|FG001|Overall Study|Lost to Follow-up|2|||
16127444|NCT00581555|38954355|FG000|Overall Study|Other reasons|16|||
16127445|NCT00581555|38954356|FG001|Overall Study|Other reasons|4|||
16127446|NCT01014143|38954357|FG000|Second Intervention|Lost to Follow-up|2|||
16127447|NCT01014143|38954358|FG001|Second Intervention|Lost to Follow-up|0|||
16127448|NCT01014143|38954359|FG002|Second Intervention|Lost to Follow-up|0|||
16127449|NCT00232544|38954360|FG000|Overall Study|Lost to Follow-up|20|||
16127450|NCT00232544|38954361|FG001|Overall Study|Lost to Follow-up|15|||
16127451|NCT01346475|38954362|FG000|First Intervention|Lost to Follow-up|4|||
16127452|NCT01346475|38954363|FG001|First Intervention|Lost to Follow-up|3|||
16127453|NCT00895154|38954364|FG000|Overall Study|Lost to Follow-up|1|||
16127454|NCT00895154|38954365|FG001|Overall Study|Lost to Follow-up|1|||
16127455|NCT00895154|38954364|FG000|Overall Study|Withdrawal by Subject|0|||
16127456|NCT00895154|38954365|FG001|Overall Study|Withdrawal by Subject|1|||
16127457|NCT01200589|38954369|FG000|Overall Study|Withdrawal by Subject|13|||
16127458|NCT01200589|38954370|FG001|Overall Study|Withdrawal by Subject|11|||
16127459|NCT01200589|38954369|FG000|Overall Study|Physician Decision|2|||
16127460|NCT01200589|38954370|FG001|Overall Study|Physician Decision|2|||
16127461|NCT01200589|38954369|FG000|Overall Study|Lost to Follow-up|5|||
16127462|NCT01200589|38954370|FG001|Overall Study|Lost to Follow-up|4|||
16127463|NCT01200589|38954369|FG000|Overall Study|Study terminated|170|||
16127464|NCT01200589|38954370|FG001|Overall Study|Study terminated|172|||
16127465|NCT03282240|38954371|FG000|Overall Study|Adverse Event|2|||
16127466|NCT03282240|38954372|FG001|Overall Study|Adverse Event|2|||
16127467|NCT03282240|38954373|FG002|Overall Study|Adverse Event|0|||
16127468|NCT03282240|38954371|FG000|Overall Study|Lost to Follow-up|3|||
16558905|NCT00725010|40513275|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
16558906|NCT00725010|40513275|FG000|Overall Study|No further documentation|1|||
16558907|NCT00725010|40513275|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
16558908|NCT02462083|40513281|FG000|Overall Study|Sponsor request|39|||
16558909|NCT02462083|40513281|FG000|Overall Study|Withdrawal by Subject|87|||
16127469|NCT03282240|38954372|FG001|Overall Study|Lost to Follow-up|0|||
16127470|NCT03282240|38954373|FG002|Overall Study|Lost to Follow-up|0|||
16127471|NCT03282240|38954371|FG000|Overall Study|Protocol Deviation|4|||
16127472|NCT03282240|38954372|FG001|Overall Study|Protocol Deviation|1|||
16351477|NCT01005901|39773010|FG000|Overall Study|Death|2|||
16351478|NCT01005901|39773011|FG001|Overall Study|Death|3|||
16351479|NCT01005901|39773010|FG000|Overall Study|Lost to Follow-up|1|||
16351480|NCT01005901|39773011|FG001|Overall Study|Lost to Follow-up|2|||
16558910|NCT02462083|40513281|FG000|Overall Study|Lost to Follow-up|41|||
16558911|NCT02462083|40513281|FG000|Overall Study|Lack of Efficacy|151|||
16558912|NCT02462083|40513281|FG000|Overall Study|Pregnancy|1|||
16558913|NCT02462083|40513281|FG000|Overall Study|Protocol Violation|6|||
16558914|NCT02462083|40513281|FG000|Overall Study|Adverse Event|33|||
16558915|NCT02462083|40513281|FG000|Overall Study|Worsening condition|16|||
16558916|NCT02462083|40513281|FG000|Overall Study|Other than specified|45|||
16127473|NCT03282240|38954373|FG002|Overall Study|Protocol Deviation|2|||
16127474|NCT03282240|38954371|FG000|Overall Study|Withdrawal by Subject|1|||
16558917|NCT01925170|40513298|FG000|Overall Study|Unverified cancer status|53|||
16127475|NCT03282240|38954372|FG001|Overall Study|Withdrawal by Subject|0|||
16127476|NCT03282240|38954373|FG002|Overall Study|Withdrawal by Subject|1|||
16127477|NCT03189745|38954374|FG000|Overall Study|Conflict in work schedule of participant|1|||
16127478|NCT03189745|38954375|FG001|Overall Study|Conflict in work schedule of participant|1|||
16127479|NCT00998335|38954379|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
16243767|NCT02378506|39377826|FG000|Overall Study|Death|1|||
16351481|NCT01005901|39773010|FG000|Overall Study|Patient's inability to use the device|1|||
16243768|NCT02378506|39377826|FG000|Overall Study|Adverse Event|14|||
16243769|NCT02378506|39377826|FG000|Overall Study|Randomized But Not Treated|1|||
16243770|NCT03707522|39377827|FG000|Overall Study|Lost to Follow-up|24|||
16243771|NCT03707522|39377828|FG001|Overall Study|Lost to Follow-up|27|||
16243772|NCT03707522|39377829|FG002|Overall Study|Lost to Follow-up|41|||
16243773|NCT03707522|39377830|FG003|Overall Study|Lost to Follow-up|36|||
16243774|NCT00700310|39377831|FG000|Overall Study|Adverse Event|6|||
16243775|NCT00700310|39377832|FG001|Overall Study|Adverse Event|10|||
16243776|NCT00700310|39377833|FG002|Overall Study|Adverse Event|5|||
16243777|NCT00700310|39377834|FG003|Overall Study|Adverse Event|11|||
16243778|NCT00700310|39377831|FG000|Overall Study|Lost to Follow-up|4|||
16243779|NCT00700310|39377832|FG001|Overall Study|Lost to Follow-up|1|||
16243780|NCT00700310|39377833|FG002|Overall Study|Lost to Follow-up|0|||
16243781|NCT00700310|39377834|FG003|Overall Study|Lost to Follow-up|1|||
16243782|NCT00700310|39377831|FG000|Overall Study|Withdrawal by Subject|8|||
16243783|NCT00700310|39377832|FG001|Overall Study|Withdrawal by Subject|9|||
16558918|NCT05124899|40513299|FG000|Overall Study|Lost to Follow-up|3|||
16558919|NCT02431533|40513300|FG000|Overall Study|Withdrawal by Subject|1|||
16558920|NCT02431533|40513301|FG001|Overall Study|Withdrawal by Subject|3|||
16558921|NCT02431533|40513300|FG000|Overall Study|Developed Exclusionary criteria|1|||
16558922|NCT02431533|40513301|FG001|Overall Study|Developed Exclusionary criteria|0|||
16558923|NCT00235495|40513302|FG000|Overall Study|Death|52|||
16558924|NCT00235495|40513303|FG001|Overall Study|Death|42|||
16558925|NCT00235495|40513302|FG000|Overall Study|Withdrawal by Subject|5|||
16558926|NCT00235495|40513303|FG001|Overall Study|Withdrawal by Subject|3|||
16558927|NCT00235495|40513302|FG000|Overall Study|Lost to Follow-up|11|||
16558928|NCT00235495|40513303|FG001|Overall Study|Lost to Follow-up|13|||
16558929|NCT00235495|40513302|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
16558930|NCT00235495|40513303|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
16243784|NCT00700310|39377833|FG002|Overall Study|Withdrawal by Subject|8|||
16243785|NCT00700310|39377834|FG003|Overall Study|Withdrawal by Subject|8|||
16243786|NCT00700310|39377831|FG000|Overall Study|Lack of Efficacy|0|||
16243787|NCT00700310|39377832|FG001|Overall Study|Lack of Efficacy|3|||
16243788|NCT00700310|39377833|FG002|Overall Study|Lack of Efficacy|0|||
16243789|NCT00700310|39377834|FG003|Overall Study|Lack of Efficacy|1|||
16243790|NCT00700310|39377831|FG000|Overall Study|Administrative/Other|1|||
16243791|NCT00700310|39377832|FG001|Overall Study|Administrative/Other|3|||
16243792|NCT00700310|39377833|FG002|Overall Study|Administrative/Other|1|||
16243793|NCT00700310|39377834|FG003|Overall Study|Administrative/Other|3|||
16243794|NCT00700310|39377831|FG000|Overall Study|Randomized, Not Treated|2|||
16243795|NCT00700310|39377832|FG001|Overall Study|Randomized, Not Treated|0|||
16243796|NCT00700310|39377833|FG002|Overall Study|Randomized, Not Treated|2|||
16243797|NCT00700310|39377834|FG003|Overall Study|Randomized, Not Treated|2|||
16243798|NCT00528879|39377836|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
16243799|NCT00528879|39377837|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
16243800|NCT00528879|39377838|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
16415689|NCT02008357|40001735|FG000|Open-label Extension Period|Personal Reasons|0|||
16558931|NCT03300817|40513304|FG000|Overall Study|Withdrawal by Subject|1|||
16243801|NCT00528879|39377839|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
16243802|NCT00528879|39377836|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
16243803|NCT00528879|39377837|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
16243804|NCT00528879|39377838|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
16243805|NCT00528879|39377839|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
16243806|NCT00528879|39377836|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
16243807|NCT00528879|39377837|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
16243808|NCT00528879|39377838|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
16243809|NCT00528879|39377839|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
16243810|NCT00528879|39377836|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
16243811|NCT00528879|39377837|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
16243812|NCT00528879|39377838|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
16243813|NCT00528879|39377839|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
16243814|NCT00528879|39377836|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
16243815|NCT00528879|39377837|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
16243816|NCT00528879|39377838|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
16243817|NCT00528879|39377839|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
16243818|NCT00528879|39377836|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
16243819|NCT00528879|39377837|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
16243820|NCT00528879|39377838|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
16243821|NCT00528879|39377839|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
16243822|NCT00528879|39377836|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
16243823|NCT00528879|39377837|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
16243824|NCT00528879|39377838|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
16243825|NCT00528879|39377839|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
16243826|NCT00528879|39377836|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
16243827|NCT00528879|39377837|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
16243828|NCT00528879|39377838|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
16243829|NCT00528879|39377839|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
16243830|NCT00528879|39377836|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
16243831|NCT00528879|39377837|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
16243832|NCT00528879|39377838|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
16243833|NCT00528879|39377839|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
16243834|NCT00528879|39377836|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
16243835|NCT00528879|39377837|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
16243836|NCT00528879|39377838|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
16243837|NCT00528879|39377839|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
16243838|NCT00528879|39377836|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
16243839|NCT00528879|39377837|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
16243840|NCT00528879|39377838|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
16243841|NCT00528879|39377839|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
16243842|NCT00528879|39377836|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
16243843|NCT00528879|39377837|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
16243844|NCT00528879|39377838|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
16243845|NCT00528879|39377839|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
16243846|NCT00528879|39377836|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
16243847|NCT00528879|39377837|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
16243848|NCT00528879|39377838|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
16243849|NCT00528879|39377839|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
16243850|NCT00528879|39377836|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
16243851|NCT00528879|39377837|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
16243852|NCT00528879|39377838|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
16243853|NCT00528879|39377839|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
16243854|NCT00528879|39377836|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
16243855|NCT00528879|39377837|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
16243856|NCT00528879|39377838|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
16243857|NCT00528879|39377839|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
16243858|NCT00528879|39377836|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
16243859|NCT00528879|39377837|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
16243860|NCT00528879|39377838|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
16243861|NCT00528879|39377839|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
16243862|NCT02762565|39377844|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
16243863|NCT02622074|39377845|FG000|Overall Study|Death|4|||
16243864|NCT02622074|39377846|FG001|Overall Study|Death|0|||
16243865|NCT02622074|39377847|FG002|Overall Study|Death|0|||
16415690|NCT02008357|40001736|FG001|Open-label Extension Period|Personal Reasons|1|||
16415691|NCT02008357|40001735|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
16415692|NCT02008357|40001736|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
16415693|NCT02008357|40001735|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
16243866|NCT02622074|39377848|FG003|Overall Study|Death|1|||
16243867|NCT02622074|39377849|FG004|Overall Study|Death|1|||
16243868|NCT02622074|39377850|FG005|Overall Study|Death|0|||
16243869|NCT02622074|39377845|FG000|Overall Study|Withdrawal by Subject|0|||
16415694|NCT02008357|40001736|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
16243870|NCT02622074|39377846|FG001|Overall Study|Withdrawal by Subject|1|||
16243871|NCT02622074|39377847|FG002|Overall Study|Withdrawal by Subject|0|||
16243872|NCT02622074|39377848|FG003|Overall Study|Withdrawal by Subject|0|||
16243873|NCT02622074|39377849|FG004|Overall Study|Withdrawal by Subject|0|||
16243874|NCT02622074|39377850|FG005|Overall Study|Withdrawal by Subject|0|||
16243875|NCT02354976|39377851|FG000|Overall Study|Other - reason not specified|1|||
16243876|NCT02354976|39377852|FG001|Overall Study|Other - reason not specified|0|||
16243877|NCT02354976|39377853|FG002|Overall Study|Other - reason not specified|1|||
16243878|NCT02354976|39377851|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
16243879|NCT02354976|39377852|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
16243880|NCT02354976|39377853|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
16243881|NCT02354976|39377851|FG000|Overall Study|Adverse Event|1|||
16243882|NCT02354976|39377852|FG001|Overall Study|Adverse Event|0|||
16243883|NCT02354976|39377853|FG002|Overall Study|Adverse Event|2|||
16243884|NCT02624518|39377854|FG000|Overall Study|Physician Decision|1|||
16243885|NCT02196506|39377857|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
16243886|NCT02196506|39377858|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
16243887|NCT02196506|39377859|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
16243888|NCT02196506|39377860|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
16243889|NCT02196506|39377857|FG000|Phase A|Withdrawal by Subject|34|||
16243890|NCT02196506|39377858|FG001|Phase A|Withdrawal by Subject|0|||
16243891|NCT02196506|39377859|FG002|Phase A|Withdrawal by Subject|0|||
16243892|NCT02196506|39377860|FG003|Phase A|Withdrawal by Subject|0|||
16243893|NCT02196506|39377857|FG000|Phase A|Adverse Event|22|||
16243894|NCT02196506|39377858|FG001|Phase A|Adverse Event|0|||
16243895|NCT02196506|39377859|FG002|Phase A|Adverse Event|0|||
16243896|NCT02196506|39377860|FG003|Phase A|Adverse Event|0|||
16243897|NCT02196506|39377857|FG000|Phase A|Lost to Follow-up|9|||
16243898|NCT02196506|39377858|FG001|Phase A|Lost to Follow-up|0|||
16243899|NCT02196506|39377859|FG002|Phase A|Lost to Follow-up|0|||
16243900|NCT02196506|39377860|FG003|Phase A|Lost to Follow-up|0|||
16243901|NCT02196506|39377857|FG000|Phase A|Protocol deviation|12|||
16243902|NCT02196506|39377858|FG001|Phase A|Protocol deviation|0|||
16243903|NCT02196506|39377859|FG002|Phase A|Protocol deviation|0|||
16243904|NCT02196506|39377860|FG003|Phase A|Protocol deviation|0|||
16243905|NCT02196506|39377857|FG000|Phase A|Participant withdrawn by investigator|10|||
16243906|NCT02196506|39377858|FG001|Phase A|Participant withdrawn by investigator|0|||
16243907|NCT02196506|39377859|FG002|Phase A|Participant withdrawn by investigator|0|||
16243908|NCT02196506|39377860|FG003|Phase A|Participant withdrawn by investigator|0|||
16243909|NCT02196506|39377857|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
16243910|NCT02196506|39377858|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
16243911|NCT02196506|39377859|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
16243912|NCT02196506|39377860|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
16243913|NCT02196506|39377857|FG000|Phase B|Lack of Efficacy|0|||
16243914|NCT02196506|39377858|FG001|Phase B|Lack of Efficacy|1|||
16243915|NCT02196506|39377859|FG002|Phase B|Lack of Efficacy|2|||
16243916|NCT02196506|39377860|FG003|Phase B|Lack of Efficacy|0|||
16558932|NCT03300817|40513304|FG000|Overall Study|Adverse Event|1|||
16558933|NCT03300817|40513304|FG000|Overall Study|Subject Found to be Ineligible|2|||
16243917|NCT02196506|39377857|FG000|Phase B|Withdrawal by Participant|0|||
16243918|NCT02196506|39377858|FG001|Phase B|Withdrawal by Participant|8|||
16243919|NCT02196506|39377859|FG002|Phase B|Withdrawal by Participant|1|||
16243920|NCT02196506|39377860|FG003|Phase B|Withdrawal by Participant|0|||
16243921|NCT02196506|39377857|FG000|Phase B|Adverse Event|0|||
16243922|NCT02196506|39377858|FG001|Phase B|Adverse Event|4|||
16243923|NCT02196506|39377859|FG002|Phase B|Adverse Event|1|||
16243924|NCT02196506|39377860|FG003|Phase B|Adverse Event|0|||
16243925|NCT02196506|39377857|FG000|Phase B|Lost to Follow-up|0|||
16415695|NCT02008357|40001735|FG000|Open-label Extension Period|Other|2|||
16558934|NCT00329719|40513305|FG000|Overall Study|Lost to Follow-up|0|||
16558935|NCT00329719|40513306|FG001|Overall Study|Lost to Follow-up|0|||
16558936|NCT00329719|40513307|FG002|Overall Study|Lost to Follow-up|0|||
16558937|NCT00329719|40513308|FG003|Overall Study|Lost to Follow-up|1|||
16558938|NCT01237678|40513309|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
16558939|NCT01237678|40513310|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
16558940|NCT01237678|40513311|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
16558941|NCT01237678|40513309|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
16558942|NCT01237678|40513310|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
16558943|NCT01237678|40513311|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
16558944|NCT01237678|40513309|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
16558945|NCT01237678|40513310|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
16558946|NCT01237678|40513311|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
16243926|NCT02196506|39377858|FG001|Phase B|Lost to Follow-up|2|||
16243927|NCT02196506|39377859|FG002|Phase B|Lost to Follow-up|1|||
16243928|NCT02196506|39377860|FG003|Phase B|Lost to Follow-up|0|||
16243929|NCT02196506|39377857|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
16243930|NCT02196506|39377858|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
16243931|NCT02196506|39377859|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
16243932|NCT02196506|39377860|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
16243933|NCT02196506|39377857|FG000|Phase A+|Withdrawal by Participant|0|||
16243934|NCT02196506|39377858|FG001|Phase A+|Withdrawal by Participant|0|||
16243935|NCT02196506|39377859|FG002|Phase A+|Withdrawal by Participant|0|||
16243936|NCT02196506|39377860|FG003|Phase A+|Withdrawal by Participant|5|||
16243937|NCT02196506|39377857|FG000|Phase A+|Adverse Event|0|||
16243938|NCT02196506|39377858|FG001|Phase A+|Adverse Event|0|||
16243939|NCT02196506|39377859|FG002|Phase A+|Adverse Event|0|||
16243940|NCT02196506|39377860|FG003|Phase A+|Adverse Event|1|||
16243941|NCT02196506|39377857|FG000|Phase A+|Lost to Follow-up|0|||
16243942|NCT02196506|39377858|FG001|Phase A+|Lost to Follow-up|0|||
16243943|NCT02196506|39377859|FG002|Phase A+|Lost to Follow-up|0|||
16243944|NCT02196506|39377860|FG003|Phase A+|Lost to Follow-up|6|||
16243945|NCT02196506|39377857|FG000|Phase A+|Participant withdrawn by investigator|0|||
16243946|NCT02196506|39377858|FG001|Phase A+|Participant withdrawn by investigator|0|||
16243947|NCT02196506|39377859|FG002|Phase A+|Participant withdrawn by investigator|0|||
16243948|NCT02196506|39377860|FG003|Phase A+|Participant withdrawn by investigator|1|||
16243949|NCT04345471|39377864|FG000|Overall Study|Adverse Event|8|||
16243950|NCT04345471|39377865|FG001|Overall Study|Adverse Event|5|||
16243951|NCT04345471|39377866|FG002|Overall Study|Adverse Event|6|||
16243952|NCT04345471|39377864|FG000|Overall Study|Lack of Efficacy|1|||
16243953|NCT04345471|39377865|FG001|Overall Study|Lack of Efficacy|1|||
16243954|NCT04345471|39377866|FG002|Overall Study|Lack of Efficacy|0|||
16243955|NCT04345471|39377864|FG000|Overall Study|Protocol Violation|0|||
16243956|NCT04345471|39377865|FG001|Overall Study|Protocol Violation|1|||
16243957|NCT04345471|39377866|FG002|Overall Study|Protocol Violation|2|||
16243958|NCT04345471|39377864|FG000|Overall Study|Withdrawal by Subject|10|||
16243959|NCT04345471|39377865|FG001|Overall Study|Withdrawal by Subject|5|||
16243960|NCT04345471|39377866|FG002|Overall Study|Withdrawal by Subject|10|||
16243961|NCT00295620|39377867|FG000|Overall Study|Lost to Follow-up|9|||
16243962|NCT00295620|39377868|FG001|Overall Study|Lost to Follow-up|5|||
16243963|NCT00295620|39377867|FG000|Overall Study|Withdrawal by Subject|37|||
16243964|NCT00295620|39377868|FG001|Overall Study|Withdrawal by Subject|50|||
16243965|NCT00295620|39377867|FG000|Overall Study|Death|206|||
16243966|NCT00295620|39377868|FG001|Overall Study|Death|207|||
16243967|NCT00295620|39377867|FG000|Overall Study|Other reasons|10|||
16243968|NCT00295620|39377868|FG001|Overall Study|Other reasons|9|||
16243969|NCT00295620|39377867|FG000|Overall Study|Discontinuation by sponsor|580|||
16243970|NCT00295620|39377868|FG001|Overall Study|Discontinuation by sponsor|593|||
16243971|NCT00295620|39377867|FG000|Overall Study|Protocol Violation|30|||
16243972|NCT00295620|39377868|FG001|Overall Study|Protocol Violation|32|||
16243973|NCT00520351|39377869|FG000|First Intervention|Withdrawal by Subject|1|||
16243974|NCT00520351|39377870|FG001|First Intervention|Withdrawal by Subject|1|||
16243975|NCT00947011|39377873|FG000|Overall Study|Study was terminated,PI left institution|12|||
16243976|NCT02424565|39377874|FG000|Period 1 (D0)|Protocol Violation|0|||
16243977|NCT02424565|39377875|FG001|Period 1 (D0)|Protocol Violation|1|||
16243978|NCT03989115|39377876|FG000|Overall Study|Withdrawal by Subject|2|||
16243979|NCT03989115|39377877|FG001|Overall Study|Withdrawal by Subject|1|||
16243980|NCT03989115|39377878|FG002|Overall Study|Withdrawal by Subject|3|||
16243981|NCT03989115|39377879|FG003|Overall Study|Withdrawal by Subject|0|||
16243982|NCT03989115|39377880|FG004|Overall Study|Withdrawal by Subject|17|||
16243983|NCT03989115|39377881|FG005|Overall Study|Withdrawal by Subject|1|||
16243984|NCT03989115|39377882|FG006|Overall Study|Withdrawal by Subject|0|||
16243985|NCT03989115|39377883|FG007|Overall Study|Withdrawal by Subject|0|||
16243986|NCT03989115|39377876|FG000|Overall Study|Sponsor decision to terminate the study|1|||
16243987|NCT03989115|39377877|FG001|Overall Study|Sponsor decision to terminate the study|1|||
16243988|NCT03989115|39377878|FG002|Overall Study|Sponsor decision to terminate the study|0|||
16415696|NCT02008357|40001736|FG001|Open-label Extension Period|Other|0|||
16415697|NCT01751139|40001737|FG000|Overall Study|Other|135|||
16415698|NCT01751139|40001737|FG000|Overall Study|Sponsor study termination|1609|||
16243989|NCT03989115|39377879|FG003|Overall Study|Sponsor decision to terminate the study|1|||
16243990|NCT03989115|39377880|FG004|Overall Study|Sponsor decision to terminate the study|11|||
16243991|NCT03989115|39377881|FG005|Overall Study|Sponsor decision to terminate the study|0|||
16243992|NCT03989115|39377882|FG006|Overall Study|Sponsor decision to terminate the study|2|||
16243993|NCT03989115|39377883|FG007|Overall Study|Sponsor decision to terminate the study|1|||
16243994|NCT03989115|39377876|FG000|Overall Study|Lost to Follow-up|2|||
16243995|NCT03989115|39377877|FG001|Overall Study|Lost to Follow-up|0|||
16415699|NCT01751139|40001737|FG000|Overall Study|Lost to Follow-up|240|||
16415700|NCT01751139|40001737|FG000|Overall Study|Withdrawal by Subject|251|||
16415701|NCT01751139|40001737|FG000|Overall Study|Adverse Event|1|||
16415702|NCT01751139|40001737|FG000|Overall Study|Death|31|||
16415703|NCT01009086|40001743|FG000|Overall Study|Lack of Efficacy|16|||
16243996|NCT03989115|39377878|FG002|Overall Study|Lost to Follow-up|0|||
16243997|NCT03989115|39377879|FG003|Overall Study|Lost to Follow-up|0|||
16243998|NCT03989115|39377880|FG004|Overall Study|Lost to Follow-up|1|||
16415704|NCT01009086|40001744|FG001|Overall Study|Lack of Efficacy|15|||
16415705|NCT01009086|40001745|FG002|Overall Study|Lack of Efficacy|9|||
16415706|NCT01009086|40001743|FG000|Overall Study|Lost to Follow-up|4|||
16415707|NCT01009086|40001744|FG001|Overall Study|Lost to Follow-up|5|||
16415708|NCT01009086|40001745|FG002|Overall Study|Lost to Follow-up|3|||
16415709|NCT01009086|40001743|FG000|Overall Study|Adverse Event|12|||
16415710|NCT01009086|40001744|FG001|Overall Study|Adverse Event|11|||
16415711|NCT01009086|40001745|FG002|Overall Study|Adverse Event|8|||
16415712|NCT01009086|40001743|FG000|Overall Study|Withdrawal by Subject|9|||
16415713|NCT01009086|40001744|FG001|Overall Study|Withdrawal by Subject|11|||
16243999|NCT03989115|39377881|FG005|Overall Study|Lost to Follow-up|0|||
16244000|NCT03989115|39377882|FG006|Overall Study|Lost to Follow-up|0|||
16244001|NCT03989115|39377883|FG007|Overall Study|Lost to Follow-up|0|||
16244002|NCT03989115|39377876|FG000|Overall Study|Death|2|||
16244003|NCT03989115|39377877|FG001|Overall Study|Death|2|||
16558947|NCT01237678|40513309|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
16558948|NCT01237678|40513310|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
16558949|NCT01237678|40513311|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
16558950|NCT01237678|40513309|FG000|Phase II|Adverse Event|0|||
16415714|NCT01009086|40001745|FG002|Overall Study|Withdrawal by Subject|13|||
16558951|NCT01237678|40513310|FG001|Phase II|Adverse Event|39|||
16244004|NCT03989115|39377878|FG002|Overall Study|Death|9|||
16244005|NCT03989115|39377879|FG003|Overall Study|Death|6|||
16244006|NCT03989115|39377880|FG004|Overall Study|Death|31|||
16244007|NCT03989115|39377881|FG005|Overall Study|Death|6|||
16244008|NCT03989115|39377882|FG006|Overall Study|Death|2|||
16244009|NCT03989115|39377883|FG007|Overall Study|Death|3|||
16244010|NCT03989115|39377876|FG000|Overall Study|Other|1|||
16244011|NCT03989115|39377877|FG001|Overall Study|Other|2|||
16244012|NCT03989115|39377878|FG002|Overall Study|Other|0|||
16558952|NCT01237678|40513311|FG002|Phase II|Adverse Event|9|||
16558953|NCT01237678|40513309|FG000|Phase II|Death|0|||
16558954|NCT01237678|40513310|FG001|Phase II|Death|0|||
16244013|NCT03989115|39377879|FG003|Overall Study|Other|0|||
16244014|NCT03989115|39377880|FG004|Overall Study|Other|5|||
16244015|NCT03989115|39377881|FG005|Overall Study|Other|0|||
16558955|NCT01237678|40513311|FG002|Phase II|Death|2|||
16558956|NCT01237678|40513309|FG000|Phase II|Lack of Efficacy|0|||
16244016|NCT03989115|39377882|FG006|Overall Study|Other|0|||
16244017|NCT03989115|39377883|FG007|Overall Study|Other|0|||
16244018|NCT04126733|39377888|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
16244019|NCT04126733|39377888|FG000|Treatment Period|Adverse Event|8|||
16244020|NCT04126733|39377888|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
16244021|NCT04126733|39377888|FG000|Treatment Period|Physician Decision|5|||
16244022|NCT04126733|39377888|FG000|Treatment Period|Death|1|||
16244023|NCT04126733|39377888|FG000|Treatment Period|Other Reasons|2|||
16244024|NCT04126733|39377888|FG000|Active Follow-up Period|Death|13|||
16244025|NCT04126733|39377888|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
16244026|NCT04126733|39377888|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
16244027|NCT04126733|39377888|FG000|Active Follow-up Period|Other Reasons|1|||
16244028|NCT04126733|39377888|FG000|Long-term Follow-up Period|Death|22|||
16244029|NCT04126733|39377888|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
16244030|NCT04126733|39377888|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
16558957|NCT01237678|40513310|FG001|Phase II|Lack of Efficacy|25|||
16558958|NCT01237678|40513311|FG002|Phase II|Lack of Efficacy|3|||
16558959|NCT01237678|40513309|FG000|Phase II|Withdrawal by Subject|0|||
16558960|NCT01237678|40513310|FG001|Phase II|Withdrawal by Subject|1|||
16244031|NCT02065791|39377892|FG000|Overall Study|Closed Site|1|||
16244032|NCT02065791|39377893|FG001|Overall Study|Closed Site|1|||
16244033|NCT02065791|39377892|FG000|Overall Study|Withdrawal by Subject|11|||
16244034|NCT02065791|39377893|FG001|Overall Study|Withdrawal by Subject|5|||
16244035|NCT02065791|39377892|FG000|Overall Study|Lost to Follow-up|13|||
16244036|NCT02065791|39377893|FG001|Overall Study|Lost to Follow-up|9|||
16415715|NCT01009086|40001743|FG000|Overall Study|Other|3|||
16415716|NCT01009086|40001744|FG001|Overall Study|Other|5|||
16415717|NCT01009086|40001745|FG002|Overall Study|Other|1|||
16415718|NCT03369431|40001750|FG000|Overall Study|Lost to Follow-up|1|||
16415719|NCT03369431|40001751|FG001|Overall Study|Lost to Follow-up|3|||
16244037|NCT00399490|39377894|FG000|Overall Study|Adverse Event|19|||
16244038|NCT00399490|39377894|FG000|Overall Study|Lack of Efficacy|31|||
16244039|NCT00399490|39377894|FG000|Overall Study|Lost to Follow-up|5|||
16415720|NCT03369431|40001750|FG000|Overall Study|Withdrawal by Subject|2|||
16244040|NCT00399490|39377894|FG000|Overall Study|Withdrawal by Subject|18|||
16244041|NCT00399490|39377894|FG000|Overall Study|Other|25|||
16558961|NCT01237678|40513311|FG002|Phase II|Withdrawal by Subject|5|||
16558962|NCT01237678|40513309|FG000|Phase II|Completed Cycles 4-6|0|||
16558963|NCT01237678|40513310|FG001|Phase II|Completed Cycles 4-6|11|||
16558964|NCT01237678|40513311|FG002|Phase II|Completed Cycles 4-6|21|||
16558965|NCT01237678|40513309|FG000|Phase II|Sponsor Decision/Study Closed|0|||
16558966|NCT01237678|40513310|FG001|Phase II|Sponsor Decision/Study Closed|18|||
16415721|NCT03369431|40001751|FG001|Overall Study|Withdrawal by Subject|3|||
16415722|NCT03369431|40001750|FG000|Overall Study|Protocol Violation|1|||
16415723|NCT03369431|40001751|FG001|Overall Study|Protocol Violation|1|||
16415724|NCT01270256|40001752|FG000|Overall Study|Withdrawal by Subject|1|||
16415725|NCT01270256|40001753|FG001|Overall Study|Withdrawal by Subject|0|||
16415726|NCT00903331|40001754|FG000|Overall Study|Death|4|||
16415727|NCT00903331|40001755|FG001|Overall Study|Death|8|||
16415728|NCT00903331|40001754|FG000|Overall Study|Withdrawal of consent|1|||
16415729|NCT00903331|40001755|FG001|Overall Study|Withdrawal of consent|8|||
16415730|NCT00903331|40001754|FG000|Overall Study|Lung transplant|0|||
16415731|NCT00903331|40001755|FG001|Overall Study|Lung transplant|2|||
16415732|NCT00989781|40001756|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
16415733|NCT00989781|40001757|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
16415734|NCT01075984|40004541|FG000|Treatment Phase|Adverse Event|0|||
16415735|NCT01075984|40004542|FG001|Treatment Phase|Adverse Event|1|||
16415736|NCT01075984|40004543|FG002|Treatment Phase|Adverse Event|3|||
16415737|NCT01075984|40004544|FG003|Treatment Phase|Adverse Event|7|||
16415738|NCT01075984|40004545|FG004|Treatment Phase|Adverse Event|35|||
16415739|NCT01075984|40004541|FG000|Treatment Phase|Protocol Violation|0|||
16415740|NCT01075984|40004542|FG001|Treatment Phase|Protocol Violation|0|||
16244042|NCT04292171|39377897|FG000|Overall Study|Pharmacy error|2|||
16244043|NCT04292171|39377898|FG001|Overall Study|Pharmacy error|0|||
16244044|NCT04292171|39377897|FG000|Overall Study|Delivered prior to procedure|0|||
16244045|NCT04292171|39377898|FG001|Overall Study|Delivered prior to procedure|1|||
16244046|NCT00475852|39377899|FG000|Overall Study|Death|444|||
16244047|NCT00475852|39377900|FG001|Overall Study|Death|456|||
16244048|NCT00475852|39377899|FG000|Overall Study|Withdrawal by Subject|19|||
16244049|NCT00475852|39377900|FG001|Overall Study|Withdrawal by Subject|24|||
16415741|NCT01075984|40004543|FG002|Treatment Phase|Protocol Violation|1|||
16415742|NCT01075984|40004544|FG003|Treatment Phase|Protocol Violation|0|||
16558967|NCT01237678|40513311|FG002|Phase II|Sponsor Decision/Study Closed|7|||
16558968|NCT01237678|40513309|FG000|Phase II|Randomized but were not treated|0|||
16558969|NCT01237678|40513310|FG001|Phase II|Randomized but were not treated|4|||
16558970|NCT01237678|40513311|FG002|Phase II|Randomized but were not treated|3|||
16558971|NCT01196104|40513312|FG000|Overall Study|Lost to Follow-up|1|||
16558972|NCT01196104|40513313|FG001|Overall Study|Lost to Follow-up|0|||
16558973|NCT01196104|40513312|FG000|Overall Study|Physician Decision|0|||
16558974|NCT01196104|40513313|FG001|Overall Study|Physician Decision|1|||
16558975|NCT01196104|40513312|FG000|Overall Study|Withdrawal by Subject|3|||
16558976|NCT01196104|40513313|FG001|Overall Study|Withdrawal by Subject|3|||
16558977|NCT01196104|40513312|FG000|Overall Study|Various|0|||
16558978|NCT01196104|40513313|FG001|Overall Study|Various|1|||
16558979|NCT01809210|40513314|FG000|Overall Study|Withdrawal by Subject|0|||
16558980|NCT01809210|40513315|FG001|Overall Study|Withdrawal by Subject|0|||
16558981|NCT01809210|40513316|FG002|Overall Study|Withdrawal by Subject|1|||
16558982|NCT01809210|40513317|FG003|Overall Study|Withdrawal by Subject|1|||
16558983|NCT01809210|40513318|FG004|Overall Study|Withdrawal by Subject|1|||
16558984|NCT01809210|40513319|FG005|Overall Study|Withdrawal by Subject|0|||
16244050|NCT00475852|39377899|FG000|Overall Study|Lost to Follow-up|54|||
16244051|NCT00475852|39377900|FG001|Overall Study|Lost to Follow-up|68|||
16244052|NCT02611752|39377903|FG000|Overall Study|Adverse Event|0|||
16244053|NCT02611752|39377904|FG001|Overall Study|Adverse Event|1|||
16244054|NCT01076166|39377908|FG000|Overall Study|Adverse Event|3|||
16244055|NCT01076166|39377908|FG000|Overall Study|Symptoms improved/resolved|6|||
16244056|NCT00068237|39377909|FG000|Overall Study|Ineligible|3|||
16244057|NCT00068237|39377909|FG000|Overall Study|No protocol treatment received|2|||
16244058|NCT02657356|39377910|FG000|Overall Study|Death|1|||
16244059|NCT02657356|39377911|FG001|Overall Study|Death|0|||
16244060|NCT02657356|39377910|FG000|Overall Study|Withdrawal by Subject|5|||
16244061|NCT02657356|39377911|FG001|Overall Study|Withdrawal by Subject|6|||
16244062|NCT02657356|39377910|FG000|Overall Study|Terminated by Sponsor|8|||
16244063|NCT02657356|39377911|FG001|Overall Study|Terminated by Sponsor|5|||
16415743|NCT01075984|40004545|FG004|Treatment Phase|Protocol Violation|3|||
16558985|NCT01809210|40513320|FG006|Overall Study|Withdrawal by Subject|4|||
16415744|NCT01075984|40004541|FG000|Treatment Phase|Withdrawal by Subject|0|||
16415745|NCT01075984|40004542|FG001|Treatment Phase|Withdrawal by Subject|0|||
16415746|NCT01075984|40004543|FG002|Treatment Phase|Withdrawal by Subject|2|||
16415747|NCT01075984|40004544|FG003|Treatment Phase|Withdrawal by Subject|0|||
16415748|NCT01075984|40004545|FG004|Treatment Phase|Withdrawal by Subject|15|||
16415749|NCT01075984|40004541|FG000|Treatment Phase|Treatment Failure|0|||
16415750|NCT01075984|40004542|FG001|Treatment Phase|Treatment Failure|0|||
16415751|NCT01075984|40004543|FG002|Treatment Phase|Treatment Failure|1|||
16415752|NCT01075984|40004544|FG003|Treatment Phase|Treatment Failure|0|||
16415753|NCT01075984|40004545|FG004|Treatment Phase|Treatment Failure|5|||
16415754|NCT01075984|40004541|FG000|Treatment Phase|Progression of disease|0|||
16415755|NCT01075984|40004542|FG001|Treatment Phase|Progression of disease|0|||
16415756|NCT01075984|40004543|FG002|Treatment Phase|Progression of disease|0|||
16415757|NCT01075984|40004544|FG003|Treatment Phase|Progression of disease|0|||
16415758|NCT01075984|40004545|FG004|Treatment Phase|Progression of disease|2|||
16415759|NCT01075984|40004541|FG000|Follow-up Phase|Protocol Violation|0|||
16415760|NCT01075984|40004542|FG001|Follow-up Phase|Protocol Violation|0|||
16415761|NCT01075984|40004543|FG002|Follow-up Phase|Protocol Violation|1|||
16415762|NCT01075984|40004544|FG003|Follow-up Phase|Protocol Violation|0|||
16415763|NCT01075984|40004545|FG004|Follow-up Phase|Protocol Violation|3|||
16415764|NCT01075984|40004541|FG000|Follow-up Phase|Adverse Event|0|||
16415765|NCT01075984|40004542|FG001|Follow-up Phase|Adverse Event|0|||
16415766|NCT01075984|40004543|FG002|Follow-up Phase|Adverse Event|0|||
16415767|NCT01075984|40004544|FG003|Follow-up Phase|Adverse Event|2|||
16415768|NCT01075984|40004545|FG004|Follow-up Phase|Adverse Event|27|||
16415769|NCT01075984|40004541|FG000|Follow-up Phase|Administrative|0|||
16415770|NCT01075984|40004542|FG001|Follow-up Phase|Administrative|0|||
16415771|NCT01075984|40004543|FG002|Follow-up Phase|Administrative|0|||
16415772|NCT01075984|40004544|FG003|Follow-up Phase|Administrative|0|||
16244064|NCT02657356|39377910|FG000|Overall Study|Rolled over to EAP study|6|||
16244065|NCT02657356|39377911|FG001|Overall Study|Rolled over to EAP study|4|||
16244066|NCT03586830|39377912|FG000|Overall Study|Site terminated by Sponsor|1|||
16244067|NCT03586830|39377913|FG001|Overall Study|Site terminated by Sponsor|4|||
16244068|NCT03586830|39377914|FG002|Overall Study|Site terminated by Sponsor|3|||
16244069|NCT03586830|39377915|FG003|Overall Study|Site terminated by Sponsor|3|||
16244070|NCT03586830|39377912|FG000|Overall Study|Lost to Follow-up|0|||
16244071|NCT03586830|39377913|FG001|Overall Study|Lost to Follow-up|2|||
16244072|NCT03586830|39377914|FG002|Overall Study|Lost to Follow-up|2|||
16244073|NCT03586830|39377915|FG003|Overall Study|Lost to Follow-up|1|||
16244074|NCT03586830|39377912|FG000|Overall Study|Withdrawal by Subject|1|||
16244075|NCT03586830|39377913|FG001|Overall Study|Withdrawal by Subject|0|||
16244076|NCT03586830|39377914|FG002|Overall Study|Withdrawal by Subject|3|||
16244077|NCT03586830|39377915|FG003|Overall Study|Withdrawal by Subject|1|||
16244078|NCT01034137|39377916|FG000|Overall Study|Adverse Event|9|||
16244079|NCT01034137|39377917|FG001|Overall Study|Adverse Event|10|||
16244080|NCT01034137|39377918|FG002|Overall Study|Adverse Event|8|||
16244081|NCT01034137|39377916|FG000|Overall Study|Withdrawal by Subject|4|||
16244082|NCT01034137|39377917|FG001|Overall Study|Withdrawal by Subject|3|||
16244083|NCT01034137|39377918|FG002|Overall Study|Withdrawal by Subject|3|||
16244084|NCT01034137|39377916|FG000|Overall Study|Lack of Efficacy|9|||
16244085|NCT01034137|39377917|FG001|Overall Study|Lack of Efficacy|4|||
16244086|NCT01034137|39377918|FG002|Overall Study|Lack of Efficacy|13|||
16244087|NCT01034137|39377916|FG000|Overall Study|Protocol Violation|2|||
16244088|NCT01034137|39377917|FG001|Overall Study|Protocol Violation|2|||
16244089|NCT01034137|39377918|FG002|Overall Study|Protocol Violation|1|||
16244090|NCT01034137|39377916|FG000|Overall Study|Refused treatment or did not cooperate|2|||
16244091|NCT01034137|39377917|FG001|Overall Study|Refused treatment or did not cooperate|0|||
16244092|NCT01034137|39377918|FG002|Overall Study|Refused treatment or did not cooperate|1|||
16244093|NCT01034137|39377916|FG000|Overall Study|Administrative or other|2|||
16244094|NCT01034137|39377917|FG001|Overall Study|Administrative or other|3|||
16244095|NCT01034137|39377918|FG002|Overall Study|Administrative or other|4|||
16244096|NCT01348542|39377919|FG000|Overall Study|Withdrawal by Subject|3|||
16244097|NCT01348542|39377920|FG001|Overall Study|Withdrawal by Subject|0|||
16244098|NCT03016078|39377921|FG000|Overall Study|Protocol Violation|1|||
16244099|NCT03016078|39377921|FG000|Overall Study|Protocol Violation|1|||
16244100|NCT00673790|39377925|FG000|Overall Study|Adverse Event|23|||
16244101|NCT00673790|39377926|FG001|Overall Study|Adverse Event|14|||
16244102|NCT00673790|39377927|FG002|Overall Study|Adverse Event|2|||
16244103|NCT00673790|39377925|FG000|Overall Study|Lack of Efficacy|2|||
16244104|NCT00673790|39377926|FG001|Overall Study|Lack of Efficacy|2|||
16244105|NCT00673790|39377927|FG002|Overall Study|Lack of Efficacy|2|||
16244106|NCT00673790|39377925|FG000|Overall Study|Protocol Violation|6|||
16415773|NCT01075984|40004545|FG004|Follow-up Phase|Administrative|1|||
16415774|NCT01075984|40004541|FG000|Follow-up Phase|Withdrawal by Subject|0|||
16415775|NCT01075984|40004542|FG001|Follow-up Phase|Withdrawal by Subject|0|||
16415776|NCT01075984|40004543|FG002|Follow-up Phase|Withdrawal by Subject|0|||
16415777|NCT01075984|40004544|FG003|Follow-up Phase|Withdrawal by Subject|0|||
16127480|NCT00998335|38954380|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
16127481|NCT02245737|38954383|FG000|Overall Study|Adverse Event|23|||
16127482|NCT02245737|38954384|FG001|Overall Study|Adverse Event|26|||
16127483|NCT02245737|38954385|FG002|Overall Study|Adverse Event|33|||
16127484|NCT02245737|38954383|FG000|Overall Study|Condition Worsened|9|||
16127485|NCT02245737|38954384|FG001|Overall Study|Condition Worsened|10|||
16127486|NCT02245737|38954385|FG002|Overall Study|Condition Worsened|9|||
16127487|NCT02245737|38954383|FG000|Overall Study|Death|2|||
16127488|NCT02245737|38954384|FG001|Overall Study|Death|4|||
16127489|NCT02245737|38954385|FG002|Overall Study|Death|4|||
16127490|NCT02245737|38954383|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
16127491|NCT02245737|38954384|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
16127492|NCT02245737|38954385|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
16127493|NCT02245737|38954383|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
16127494|NCT02245737|38954384|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
16127495|NCT02245737|38954385|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
16127496|NCT02245737|38954383|FG000|Overall Study|Lost to Follow-up|2|||
16127497|NCT02245737|38954384|FG001|Overall Study|Lost to Follow-up|5|||
16127498|NCT02245737|38954385|FG002|Overall Study|Lost to Follow-up|4|||
16127499|NCT02245737|38954383|FG000|Overall Study|Other-determined by Investigator|9|||
16127500|NCT02245737|38954384|FG001|Overall Study|Other-determined by Investigator|10|||
16127501|NCT02245737|38954385|FG002|Overall Study|Other-determined by Investigator|10|||
16127502|NCT02245737|38954383|FG000|Overall Study|Physician Decision|6|||
16127503|NCT02245737|38954384|FG001|Overall Study|Physician Decision|3|||
16127504|NCT02245737|38954385|FG002|Overall Study|Physician Decision|6|||
16127505|NCT02245737|38954383|FG000|Overall Study|Protocol Violation|3|||
16127506|NCT02245737|38954384|FG001|Overall Study|Protocol Violation|2|||
16127507|NCT02245737|38954385|FG002|Overall Study|Protocol Violation|3|||
16127508|NCT02245737|38954383|FG000|Overall Study|Withdrawal by Subject|40|||
16127509|NCT02245737|38954384|FG001|Overall Study|Withdrawal by Subject|41|||
16127510|NCT02245737|38954385|FG002|Overall Study|Withdrawal by Subject|44|||
16127511|NCT02245737|38954383|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
16127512|NCT02245737|38954384|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
16127513|NCT02245737|38954385|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
16127514|NCT02245737|38954383|FG000|Overall Study|Sponsor Decision|445|||
16127515|NCT02245737|38954384|FG001|Overall Study|Sponsor Decision|430|||
16127516|NCT02245737|38954385|FG002|Overall Study|Sponsor Decision|432|||
16127517|NCT02787044|38954386|FG000|Overall Study|Lost to Follow-up|15|||
16127518|NCT02787044|38954387|FG001|Overall Study|Lost to Follow-up|19|||
16127519|NCT00384189|38954388|FG000|Overall Study|Reason Not Specified|50|||
16127520|NCT00384189|38954389|FG001|Overall Study|Reason Not Specified|57|||
16415778|NCT01075984|40004545|FG004|Follow-up Phase|Withdrawal by Subject|10|||
16558986|NCT01809210|40513314|FG000|Overall Study|Death|1|||
16558987|NCT01809210|40513315|FG001|Overall Study|Death|1|||
16558988|NCT01809210|40513316|FG002|Overall Study|Death|2|||
16558989|NCT01809210|40513317|FG003|Overall Study|Death|0|||
16558990|NCT01809210|40513318|FG004|Overall Study|Death|1|||
16558991|NCT01809210|40513319|FG005|Overall Study|Death|3|||
16558992|NCT01809210|40513320|FG006|Overall Study|Death|1|||
16558993|NCT00197028|40513321|FG000|Overall Study|Adverse Event|2|||
16558994|NCT00197028|40513322|FG001|Overall Study|Adverse Event|2|||
16558995|NCT00197028|40513321|FG000|Overall Study|Protocol Violation|2|||
16558996|NCT00197028|40513322|FG001|Overall Study|Protocol Violation|1|||
16558997|NCT00197028|40513321|FG000|Overall Study|Withdrawal by Subject|8|||
16558998|NCT00197028|40513322|FG001|Overall Study|Withdrawal by Subject|12|||
16558999|NCT00197028|40513321|FG000|Overall Study|Lost to Follow-up|1|||
16559000|NCT00197028|40513322|FG001|Overall Study|Lost to Follow-up|0|||
16559001|NCT00197028|40513321|FG000|Overall Study|Other|3|||
16559002|NCT00197028|40513322|FG001|Overall Study|Other|6|||
16559003|NCT00372060|40513323|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
16559004|NCT00372060|40513324|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
16559005|NCT00372060|40513323|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
16559006|NCT00372060|40513324|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
16559007|NCT00372060|40513323|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
16559008|NCT00372060|40513324|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
16559009|NCT00372060|40513323|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
16559010|NCT00372060|40513324|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
16559011|NCT00372060|40513323|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
16559012|NCT00372060|40513324|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
16127521|NCT00384189|38954390|FG002|Overall Study|Reason Not Specified|58|||
16127522|NCT00384189|38954391|FG003|Overall Study|Reason Not Specified|40|||
16127523|NCT00744757|38954392|FG000|Overall Study|Objective disease progression|7|||
16127524|NCT00744757|38954392|FG000|Overall Study|Physician Decision|5|||
16559013|NCT00372060|40513323|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
16559014|NCT00372060|40513324|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
16415779|NCT01075984|40004541|FG000|Follow-up Phase|Progression of disease|0|||
16351482|NCT01005901|39773011|FG001|Overall Study|Patient's inability to use the device|1|||
16127525|NCT00744757|38954392|FG000|Overall Study|Withdrawal by Subject|1|||
16127526|NCT00744757|38954392|FG000|Overall Study|Death|6|||
16127527|NCT00744757|38954392|FG000|Overall Study|Adverse Event|2|||
16127528|NCT00528645|38954393|FG000|Overall Study|Adverse Event|3|||
16127529|NCT02217501|38954394|FG000|Overall Study|Death|3|||
16127530|NCT02217501|38954395|FG001|Overall Study|Death|4|||
16127531|NCT03256851|38954403|FG000|Overall Study|Withdrawal by Subject|1|||
16127532|NCT03256851|38954404|FG001|Overall Study|Withdrawal by Subject|0|||
16127533|NCT05086276|38954405|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
16127534|NCT05086276|38954406|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
16127535|NCT01776541|38954407|FG000|Overall Study|Administrative Reason|6|||
16127536|NCT01776541|38954408|FG001|Overall Study|Administrative Reason|2|||
16127537|NCT01776541|38954407|FG000|Overall Study|Death|4|||
16127538|NCT01776541|38954408|FG001|Overall Study|Death|0|||
16127539|NCT01776541|38954407|FG000|Overall Study|Lost to Follow-up|27|||
16127540|NCT01776541|38954408|FG001|Overall Study|Lost to Follow-up|48|||
16127541|NCT01776541|38954407|FG000|Overall Study|Unclassified|5|||
16127542|NCT01776541|38954408|FG001|Overall Study|Unclassified|4|||
16127543|NCT01776541|38954407|FG000|Overall Study|Protocol Violation|2|||
16127544|NCT01776541|38954408|FG001|Overall Study|Protocol Violation|1|||
16127545|NCT01776541|38954407|FG000|Overall Study|Withdrawal by Subject|12|||
16127546|NCT01776541|38954408|FG001|Overall Study|Withdrawal by Subject|20|||
16127547|NCT03836716|38954409|FG000|Overall Study|Adverse Event|3|||
16127548|NCT03836716|38954409|FG000|Overall Study|Death|22|||
16127549|NCT03836716|38954409|FG000|Overall Study|Withdrawal by Subject|8|||
16127550|NCT03836716|38954409|FG000|Overall Study|Study terminated by sponsor|87|||
16127551|NCT03625895|38954410|FG000|Overall Study|Protocol Violation|585|||
16127552|NCT05007080|38954411|FG000|Overall Study|Lost to Follow-up|0|||
16351483|NCT01005901|39773010|FG000|Overall Study|No longer requires study drug|0|||
16351484|NCT01005901|39773011|FG001|Overall Study|No longer requires study drug|1|||
16351485|NCT00327340|39773012|FG000|Overall Study|Withdrawal by Subject|1|||
16351486|NCT00327340|39773013|FG001|Overall Study|Withdrawal by Subject|5|||
16351487|NCT00327340|39773012|FG000|Overall Study|Physician Decision|1|||
16351488|NCT00327340|39773013|FG001|Overall Study|Physician Decision|1|||
16351489|NCT00327340|39773012|FG000|Overall Study|Disease Progression|10|||
16351490|NCT00327340|39773013|FG001|Overall Study|Disease Progression|19|||
16351491|NCT00327340|39773012|FG000|Overall Study|Symptomatic Disease|0|||
16351492|NCT00327340|39773013|FG001|Overall Study|Symptomatic Disease|2|||
16351493|NCT00327340|39773012|FG000|Overall Study|Adverse Event|3|||
16351494|NCT00327340|39773013|FG001|Overall Study|Adverse Event|3|||
16351495|NCT01724177|39773014|FG000|Overall Study|Adverse Event|8|||
16351496|NCT01724177|39773014|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
16127553|NCT05007080|38954412|FG001|Overall Study|Lost to Follow-up|1|||
16127554|NCT05007080|38954413|FG002|Overall Study|Lost to Follow-up|0|||
16127555|NCT05007080|38954414|FG003|Overall Study|Lost to Follow-up|1|||
16415780|NCT01075984|40004542|FG001|Follow-up Phase|Progression of disease|0|||
16127556|NCT05007080|38954415|FG004|Overall Study|Lost to Follow-up|1|||
16127557|NCT05007080|38954416|FG005|Overall Study|Lost to Follow-up|1|||
16351497|NCT01724177|39773014|FG000|Overall Study|Nervous participant|1|||
16415781|NCT01075984|40004543|FG002|Follow-up Phase|Progression of disease|0|||
16127558|NCT05007080|38954411|FG000|Overall Study|Death|0|||
16127559|NCT05007080|38954412|FG001|Overall Study|Death|1|||
16415782|NCT01075984|40004544|FG003|Follow-up Phase|Progression of disease|0|||
16415783|NCT01075984|40004545|FG004|Follow-up Phase|Progression of disease|2|||
16415784|NCT01075984|40004541|FG000|Follow-up Phase|Treatment failure|0|||
16415785|NCT01075984|40004542|FG001|Follow-up Phase|Treatment failure|0|||
16415786|NCT01075984|40004543|FG002|Follow-up Phase|Treatment failure|0|||
16415787|NCT01075984|40004544|FG003|Follow-up Phase|Treatment failure|0|||
16415788|NCT01075984|40004545|FG004|Follow-up Phase|Treatment failure|4|||
16415789|NCT01375608|40004547|FG000|Overall Study|Withdrawal by Subject|2|||
16415790|NCT01581619|40004554|FG000|Overall Study|Withdrawal by Subject|1|||
16415791|NCT01581619|40004554|FG000|Overall Study|Lost to Follow-up|1|||
16415792|NCT00454181|40004555|FG000|Overall Study|Adverse Event|1|||
16415793|NCT00454181|40004556|FG001|Overall Study|Adverse Event|1|||
16415794|NCT00454181|40004555|FG000|Overall Study|Lost to Follow-up|11|||
16415795|NCT00454181|40004556|FG001|Overall Study|Lost to Follow-up|1|||
16559015|NCT03424239|40513327|FG000|Overall Study|Withdrawal by Subject|2|||
16559016|NCT00311155|40513328|FG000|Overall Study|Adverse Event|21|||
16559017|NCT00311155|40513328|FG000|Overall Study|Withdrawal by Subject|17|||
16559018|NCT00311155|40513328|FG000|Overall Study|Did not meet entry criteria|55|||
16127560|NCT05007080|38954413|FG002|Overall Study|Death|0|||
16127561|NCT05007080|38954414|FG003|Overall Study|Death|0|||
16127562|NCT05007080|38954415|FG004|Overall Study|Death|0|||
16559019|NCT01619787|40513329|FG000|Overall Study|Lost to Follow-up|5|||
16559020|NCT00057811|40513330|FG000|Overall Study|Lack of Efficacy|1|||
16559021|NCT00057811|40513331|FG001|Overall Study|Lack of Efficacy|4|||
16559022|NCT00057811|40513330|FG000|Overall Study|Physician Decision|1|||
16559023|NCT00057811|40513331|FG001|Overall Study|Physician Decision|0|||
16559024|NCT00057811|40513330|FG000|Overall Study|Withdrawal by Subject|3|||
16559025|NCT00057811|40513331|FG001|Overall Study|Withdrawal by Subject|4|||
16127563|NCT05007080|38954416|FG005|Overall Study|Death|0|||
16415796|NCT00454181|40004555|FG000|Overall Study|Protocol Violation|1|||
16415797|NCT00454181|40004556|FG001|Overall Study|Protocol Violation|1|||
16415798|NCT00454181|40004555|FG000|Overall Study|Withdrawal by Subject|2|||
16415799|NCT00454181|40004556|FG001|Overall Study|Withdrawal by Subject|0|||
16415800|NCT01291277|40004557|FG000|Overall Study|Death|2|||
16415801|NCT01291277|40004558|FG001|Overall Study|Death|2|||
16415802|NCT01291277|40004557|FG000|Overall Study|Lost to Follow-up|3|||
16415803|NCT01291277|40004558|FG001|Overall Study|Lost to Follow-up|1|||
16415804|NCT00737633|40004562|FG000|Overall Study|Study terminated by sponsor|44|||
16415805|NCT00737633|40004563|FG001|Overall Study|Study terminated by sponsor|55|||
16415806|NCT00737633|40004562|FG000|Overall Study|Lost to Follow-up|0|||
16415807|NCT00737633|40004563|FG001|Overall Study|Lost to Follow-up|1|||
16415808|NCT00737633|40004562|FG000|Overall Study|protocol non-compliance|0|||
16415809|NCT00737633|40004563|FG001|Overall Study|protocol non-compliance|1|||
16415810|NCT00565136|40004564|FG000|Overall Study|Lost to Follow-up|1|||
16415811|NCT00565136|40004564|FG000|Overall Study|Withdrawal by Subject|1|||
16415812|NCT00565136|40004564|FG000|Overall Study|Protocol Violation|1|||
16415813|NCT01026220|40004567|FG000|Induction|Death|1|||
16415814|NCT01026220|40004568|FG001|Induction|Death|0|||
16127564|NCT05007080|38954411|FG000|Overall Study|Withdrawal by Subject|1|||
16127565|NCT05007080|38954412|FG001|Overall Study|Withdrawal by Subject|2|||
16127566|NCT05007080|38954413|FG002|Overall Study|Withdrawal by Subject|0|||
16351498|NCT01724177|39773014|FG000|Overall Study|Serious Adverse Event Related|1|||
16351499|NCT00928434|39773026|FG000|Overall Study|Adverse Event|14|||
16351500|NCT00928434|39773027|FG001|Overall Study|Adverse Event|5|||
16351501|NCT00928434|39773028|FG002|Overall Study|Adverse Event|18|||
16351502|NCT00928434|39773026|FG000|Overall Study|Protocol Violation|5|||
16351503|NCT00928434|39773027|FG001|Overall Study|Protocol Violation|0|||
16351504|NCT00928434|39773028|FG002|Overall Study|Protocol Violation|8|||
16351505|NCT00928434|39773026|FG000|Overall Study|Physician Decision|2|||
16351506|NCT00928434|39773027|FG001|Overall Study|Physician Decision|0|||
16351507|NCT00928434|39773028|FG002|Overall Study|Physician Decision|3|||
16351508|NCT00928434|39773026|FG000|Overall Study|Lost to Follow-up|1|||
16351509|NCT00928434|39773027|FG001|Overall Study|Lost to Follow-up|0|||
16351510|NCT00928434|39773028|FG002|Overall Study|Lost to Follow-up|3|||
16351511|NCT00928434|39773026|FG000|Overall Study|Withdrawal by Subject|5|||
16351512|NCT00928434|39773027|FG001|Overall Study|Withdrawal by Subject|3|||
16415815|NCT01026220|40004569|FG002|Induction|Death|0|||
16415816|NCT01026220|40004567|FG000|Induction|Lack of Efficacy|2|||
16415817|NCT01026220|40004568|FG001|Induction|Lack of Efficacy|0|||
16415818|NCT01026220|40004569|FG002|Induction|Lack of Efficacy|0|||
16559026|NCT00057811|40513330|FG000|Overall Study|Ineligible|4|||
16559027|NCT00057811|40513331|FG001|Overall Study|Ineligible|2|||
16127567|NCT05007080|38954414|FG003|Overall Study|Withdrawal by Subject|2|||
16351513|NCT00928434|39773028|FG002|Overall Study|Withdrawal by Subject|2|||
16415819|NCT01026220|40004567|FG000|Induction|Physician Decision|12|||
16127568|NCT05007080|38954415|FG004|Overall Study|Withdrawal by Subject|1|||
16415820|NCT01026220|40004568|FG001|Induction|Physician Decision|0|||
16415821|NCT01026220|40004569|FG002|Induction|Physician Decision|0|||
16415822|NCT01026220|40004567|FG000|Induction|Withdrawal by Subject|9|||
16127569|NCT05007080|38954416|FG005|Overall Study|Withdrawal by Subject|1|||
16127570|NCT05007080|38954411|FG000|Overall Study|Other|1|||
16127571|NCT05007080|38954412|FG001|Overall Study|Other|0|||
16127572|NCT05007080|38954413|FG002|Overall Study|Other|1|||
16127573|NCT05007080|38954414|FG003|Overall Study|Other|1|||
16127574|NCT05007080|38954415|FG004|Overall Study|Other|0|||
16127575|NCT05007080|38954416|FG005|Overall Study|Other|2|||
16127576|NCT05007080|38954411|FG000|Overall Study|Randomized not vaccinated|0|||
16127577|NCT05007080|38954412|FG001|Overall Study|Randomized not vaccinated|0|||
16127578|NCT05007080|38954413|FG002|Overall Study|Randomized not vaccinated|0|||
16127579|NCT05007080|38954414|FG003|Overall Study|Randomized not vaccinated|0|||
16127580|NCT05007080|38954415|FG004|Overall Study|Randomized not vaccinated|0|||
16127581|NCT05007080|38954416|FG005|Overall Study|Randomized not vaccinated|1|||
16127582|NCT02929329|38954417|FG000|Overall Study|Withdrawal by Subject|24|||
16127583|NCT02929329|38954418|FG001|Overall Study|Withdrawal by Subject|21|||
16127584|NCT02929329|38954417|FG000|Overall Study|Lost to Follow-up|26|||
16127585|NCT02929329|38954418|FG001|Overall Study|Lost to Follow-up|20|||
16127586|NCT02929329|38954417|FG000|Overall Study|Death|1054|||
16127587|NCT02929329|38954418|FG001|Overall Study|Death|1051|||
16127588|NCT02432196|38954419|FG000|Overall Study|Exit - did not receive study device|1|||
16127589|NCT02432196|38954419|FG000|Overall Study|Death|2|||
16127590|NCT02432196|38954419|FG000|Overall Study|Reoperation|3|||
16127591|NCT01262677|38954420|FG000|Overall Study|Does not meet entrance criteria|0|||
16127592|NCT01262677|38954421|FG001|Overall Study|Does not meet entrance criteria|2|||
16127593|NCT01262677|38954422|FG002|Overall Study|Does not meet entrance criteria|0|||
16127594|NCT01262677|38954420|FG000|Overall Study|Insufficient clinical response|0|||
16127595|NCT01262677|38954421|FG001|Overall Study|Insufficient clinical response|0|||
16127596|NCT01262677|38954422|FG002|Overall Study|Insufficient clinical response|1|||
16127597|NCT01262677|38954420|FG000|Overall Study|Lost to Follow-up|1|||
16127598|NCT01262677|38954421|FG001|Overall Study|Lost to Follow-up|0|||
16127599|NCT01262677|38954422|FG002|Overall Study|Lost to Follow-up|2|||
16127600|NCT01262677|38954420|FG000|Overall Study|No longer willing to participate|3|||
16127601|NCT01262677|38954421|FG001|Overall Study|No longer willing to participate|3|||
16127602|NCT01262677|38954422|FG002|Overall Study|No longer willing to participate|2|||
16127603|NCT01262677|38954420|FG000|Overall Study|Reason not provided|2|||
16127604|NCT01262677|38954421|FG001|Overall Study|Reason not provided|1|||
16415823|NCT01026220|40004568|FG001|Induction|Withdrawal by Subject|0|||
16415824|NCT01026220|40004569|FG002|Induction|Withdrawal by Subject|0|||
16415825|NCT01026220|40004567|FG000|Induction|Ineligible|1|||
16415826|NCT01026220|40004568|FG001|Induction|Ineligible|0|||
16415827|NCT01026220|40004569|FG002|Induction|Ineligible|0|||
16415828|NCT01026220|40004567|FG000|Consolidation Maintenance|Death|0|||
16415829|NCT01026220|40004568|FG001|Consolidation Maintenance|Death|1|||
16415830|NCT01026220|40004569|FG002|Consolidation Maintenance|Death|0|||
16415831|NCT01026220|40004567|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
16415832|NCT01026220|40004568|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
16415833|NCT01026220|40004569|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
16415834|NCT01026220|40004567|FG000|Consolidation Maintenance|Physician Decision|0|||
16415835|NCT01026220|40004568|FG001|Consolidation Maintenance|Physician Decision|2|||
16415836|NCT01026220|40004569|FG002|Consolidation Maintenance|Physician Decision|7|||
16415837|NCT01026220|40004567|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
16415838|NCT01026220|40004568|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
16415839|NCT01026220|40004569|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
16415840|NCT00257660|40004572|FG000|Overall Study|Lack of Efficacy|5|||
16415841|NCT00257660|40004573|FG001|Overall Study|Lack of Efficacy|23|||
16415842|NCT00257660|40004572|FG000|Overall Study|Withdrawal by Subject|2|||
16415843|NCT00257660|40004573|FG001|Overall Study|Withdrawal by Subject|0|||
16415844|NCT00257660|40004572|FG000|Overall Study|Lost to Follow-up|1|||
16415845|NCT00257660|40004573|FG001|Overall Study|Lost to Follow-up|0|||
16415846|NCT00257660|40004572|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
16415847|NCT00257660|40004573|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
16415848|NCT00257660|40004572|FG000|Overall Study|No longer wanted to do blood draws|1|||
16415849|NCT00257660|40004573|FG001|Overall Study|No longer wanted to do blood draws|0|||
16415850|NCT00548717|40004574|FG000|Overall Study|Death|5|||
16415851|NCT00548717|40004575|FG001|Overall Study|Death|2|||
16415852|NCT00548717|40004574|FG000|Overall Study|Relapse|3|||
16415853|NCT00548717|40004575|FG001|Overall Study|Relapse|0|||
16415854|NCT00548717|40004574|FG000|Overall Study|Alternative treatment for GVHD|1|||
16415855|NCT00548717|40004575|FG001|Overall Study|Alternative treatment for GVHD|0|||
16415856|NCT01716104|40004577|FG000|Overall Study|Do not meet inclusion criteria|6|||
16415857|NCT01716104|40004578|FG001|Overall Study|Do not meet inclusion criteria|7|||
16415858|NCT03131596|40004580|FG000|Overall Study|Protocol Violation|3|||
16415859|NCT03131596|40004581|FG001|Overall Study|Protocol Violation|3|||
16415860|NCT03131596|40004580|FG000|Overall Study|Lost to Follow-up|3|||
16415861|NCT03131596|40004581|FG001|Overall Study|Lost to Follow-up|0|||
16415862|NCT00109577|40004582|FG000|Overall Study|Withdrawal by Subject|3|||
16415863|NCT00109577|40004583|FG001|Overall Study|Withdrawal by Subject|3|||
16415864|NCT02404649|40004584|FG000|Overall Study|Adverse Event|1|||
16415865|NCT02404649|40004585|FG001|Overall Study|Adverse Event|2|||
16415866|NCT00377364|40004586|FG000|Overall Study|Lost to Follow-up|1|||
16415867|NCT00377364|40004587|FG001|Overall Study|Lost to Follow-up|0|||
16415868|NCT00377364|40004586|FG000|Overall Study|Withdrawal by Subject|1|||
16559028|NCT00057811|40513330|FG000|Overall Study|Inevaluable|1|||
16559029|NCT00057811|40513331|FG001|Overall Study|Inevaluable|2|||
16559030|NCT04212169|40513335|FG000|Overall Study|Adverse Event|0|||
16559031|NCT04212169|40513336|FG001|Overall Study|Adverse Event|0|||
16559032|NCT04212169|40513337|FG002|Overall Study|Adverse Event|0|||
16559033|NCT04212169|40513338|FG003|Overall Study|Adverse Event|2|||
16559034|NCT04212169|40513335|FG000|Overall Study|Lost to Follow-up|1|||
16559035|NCT04212169|40513336|FG001|Overall Study|Lost to Follow-up|0|||
16559036|NCT04212169|40513337|FG002|Overall Study|Lost to Follow-up|0|||
16559037|NCT04212169|40513338|FG003|Overall Study|Lost to Follow-up|2|||
16559038|NCT04212169|40513335|FG000|Overall Study|Withdrawal by Subject|10|||
16559039|NCT04212169|40513336|FG001|Overall Study|Withdrawal by Subject|2|||
16559040|NCT04212169|40513337|FG002|Overall Study|Withdrawal by Subject|5|||
16559041|NCT04212169|40513338|FG003|Overall Study|Withdrawal by Subject|7|||
16559042|NCT04212169|40513335|FG000|Overall Study|Other reason, unspecified|3|||
16559043|NCT04212169|40513336|FG001|Overall Study|Other reason, unspecified|1|||
16559044|NCT04212169|40513337|FG002|Overall Study|Other reason, unspecified|0|||
16559045|NCT04212169|40513338|FG003|Overall Study|Other reason, unspecified|2|||
16559046|NCT01154036|40513340|FG000|Phase I|Physician Decision|0|||
16559047|NCT01154036|40513341|FG001|Phase I|Physician Decision|1|||
16559048|NCT01154036|40513342|FG002|Phase I|Physician Decision|0|||
16559049|NCT01154036|40513343|FG003|Phase I|Physician Decision|0|||
16559050|NCT01154036|40513344|FG004|Phase I|Physician Decision|0|||
16559051|NCT01154036|40513345|FG005|Phase I|Physician Decision|0|||
16559052|NCT01154036|40513346|FG006|Phase I|Physician Decision|0|||
16559053|NCT01154036|40513347|FG007|Phase I|Physician Decision|0|||
16559054|NCT01154036|40513340|FG000|Phase I|Lost to Follow-up|0|||
16559055|NCT01154036|40513341|FG001|Phase I|Lost to Follow-up|3|||
16559056|NCT01154036|40513342|FG002|Phase I|Lost to Follow-up|6|||
16559057|NCT01154036|40513343|FG003|Phase I|Lost to Follow-up|0|||
16559058|NCT01154036|40513344|FG004|Phase I|Lost to Follow-up|0|||
16559059|NCT01154036|40513345|FG005|Phase I|Lost to Follow-up|0|||
16559060|NCT01154036|40513346|FG006|Phase I|Lost to Follow-up|0|||
16559061|NCT01154036|40513347|FG007|Phase I|Lost to Follow-up|0|||
16559062|NCT01154036|40513340|FG000|Phase I|Protocol Violation|0|||
16244107|NCT00673790|39377926|FG001|Overall Study|Protocol Violation|9|||
16244108|NCT00673790|39377927|FG002|Overall Study|Protocol Violation|1|||
16244109|NCT00673790|39377925|FG000|Overall Study|Withdrawal by Subject|7|||
16244110|NCT00673790|39377926|FG001|Overall Study|Withdrawal by Subject|4|||
16244111|NCT00673790|39377927|FG002|Overall Study|Withdrawal by Subject|1|||
16244112|NCT00673790|39377925|FG000|Overall Study|Lost to Follow-up|6|||
16244113|NCT00673790|39377926|FG001|Overall Study|Lost to Follow-up|6|||
16244114|NCT00673790|39377927|FG002|Overall Study|Lost to Follow-up|5|||
16415869|NCT00377364|40004587|FG001|Overall Study|Withdrawal by Subject|0|||
16415870|NCT01331291|40004588|FG000|Overall Study|Lack of Efficacy|2|||
16415871|NCT01331291|40004589|FG001|Overall Study|Lack of Efficacy|8|||
16415872|NCT01331291|40004588|FG000|Overall Study|Death|0|||
16415873|NCT01331291|40004589|FG001|Overall Study|Death|1|||
16415874|NCT02648217|40004590|FG000|Overall Study|Adverse Event|0|||
16415875|NCT02648217|40004591|FG001|Overall Study|Adverse Event|1|||
16415876|NCT02648217|40004590|FG000|Overall Study|Lost to Follow-up|1|||
16415877|NCT02648217|40004591|FG001|Overall Study|Lost to Follow-up|1|||
16415878|NCT02648217|40004590|FG000|Overall Study|Withdrawal by Subject|4|||
16415879|NCT02648217|40004591|FG001|Overall Study|Withdrawal by Subject|3|||
16559063|NCT01154036|40513341|FG001|Phase I|Protocol Violation|3|||
16559064|NCT01154036|40513342|FG002|Phase I|Protocol Violation|9|||
16559065|NCT01154036|40513343|FG003|Phase I|Protocol Violation|0|||
16559066|NCT01154036|40513344|FG004|Phase I|Protocol Violation|0|||
16559067|NCT01154036|40513345|FG005|Phase I|Protocol Violation|0|||
16244115|NCT00673790|39377925|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
16244116|NCT00673790|39377926|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
16559068|NCT01154036|40513346|FG006|Phase I|Protocol Violation|0|||
16559069|NCT01154036|40513347|FG007|Phase I|Protocol Violation|0|||
16559070|NCT01154036|40513340|FG000|Phase I|Withdrawal by Subject|2|||
16559071|NCT01154036|40513341|FG001|Phase I|Withdrawal by Subject|10|||
16559072|NCT01154036|40513342|FG002|Phase I|Withdrawal by Subject|29|||
16559073|NCT01154036|40513343|FG003|Phase I|Withdrawal by Subject|0|||
16559074|NCT01154036|40513344|FG004|Phase I|Withdrawal by Subject|0|||
16559075|NCT01154036|40513345|FG005|Phase I|Withdrawal by Subject|0|||
16559076|NCT01154036|40513346|FG006|Phase I|Withdrawal by Subject|0|||
16559077|NCT01154036|40513347|FG007|Phase I|Withdrawal by Subject|0|||
16559078|NCT01154036|40513340|FG000|Phase I|Adverse Event|1|||
16559079|NCT01154036|40513341|FG001|Phase I|Adverse Event|11|||
16559080|NCT01154036|40513342|FG002|Phase I|Adverse Event|12|||
16559081|NCT01154036|40513343|FG003|Phase I|Adverse Event|0|||
16559082|NCT01154036|40513344|FG004|Phase I|Adverse Event|0|||
16559083|NCT01154036|40513345|FG005|Phase I|Adverse Event|0|||
16559084|NCT01154036|40513346|FG006|Phase I|Adverse Event|0|||
16559085|NCT01154036|40513347|FG007|Phase I|Adverse Event|0|||
16559086|NCT01154036|40513340|FG000|Phase II|Adverse Event|0|||
16559087|NCT01154036|40513341|FG001|Phase II|Adverse Event|0|||
16559088|NCT01154036|40513342|FG002|Phase II|Adverse Event|0|||
16559089|NCT01154036|40513343|FG003|Phase II|Adverse Event|0|||
16559090|NCT01154036|40513344|FG004|Phase II|Adverse Event|1|||
16559091|NCT01154036|40513345|FG005|Phase II|Adverse Event|1|||
16244117|NCT00673790|39377927|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
16244118|NCT00673790|39377925|FG000|Overall Study|Poor compliance|1|||
16244119|NCT00673790|39377926|FG001|Overall Study|Poor compliance|0|||
16244120|NCT00673790|39377927|FG002|Overall Study|Poor compliance|0|||
16244121|NCT00673790|39377925|FG000|Overall Study|Participated in two Nebivolol studies|0|||
16244122|NCT00673790|39377926|FG001|Overall Study|Participated in two Nebivolol studies|0|||
16244123|NCT00673790|39377927|FG002|Overall Study|Participated in two Nebivolol studies|1|||
16244124|NCT00673790|39377925|FG000|Overall Study|Unconfirmed pregnancy|0|||
16244125|NCT00673790|39377926|FG001|Overall Study|Unconfirmed pregnancy|1|||
16559092|NCT01154036|40513346|FG006|Phase II|Adverse Event|1|||
16244126|NCT00673790|39377927|FG002|Overall Study|Unconfirmed pregnancy|0|||
16244127|NCT00673790|39377925|FG000|Overall Study|Randomization criteria not met|0|||
16559093|NCT01154036|40513347|FG007|Phase II|Adverse Event|1|||
16415880|NCT02648217|40004590|FG000|Overall Study|Unclassified|5|||
16415881|NCT02648217|40004591|FG001|Overall Study|Unclassified|0|||
16415882|NCT04896593|40004592|FG000|Overall Study|Withdrawal by Subject|2|||
16559094|NCT01154036|40513340|FG000|Phase II|Physician Decision|0|||
16559095|NCT01154036|40513341|FG001|Phase II|Physician Decision|0|||
16559096|NCT01154036|40513342|FG002|Phase II|Physician Decision|0|||
16559097|NCT01154036|40513343|FG003|Phase II|Physician Decision|0|||
16559098|NCT01154036|40513344|FG004|Phase II|Physician Decision|0|||
16244128|NCT00673790|39377926|FG001|Overall Study|Randomization criteria not met|1|||
16244129|NCT00673790|39377927|FG002|Overall Study|Randomization criteria not met|0|||
16244130|NCT01335464|39377928|FG000|Overall Study|Adverse Event|15|||
16559099|NCT01154036|40513345|FG005|Phase II|Physician Decision|0|||
16559100|NCT01154036|40513346|FG006|Phase II|Physician Decision|1|||
16559101|NCT01154036|40513347|FG007|Phase II|Physician Decision|0|||
16559102|NCT01154036|40513340|FG000|Phase II|Lost to Follow-up|0|||
16559103|NCT01154036|40513341|FG001|Phase II|Lost to Follow-up|0|||
16559104|NCT01154036|40513342|FG002|Phase II|Lost to Follow-up|0|||
16559105|NCT01154036|40513343|FG003|Phase II|Lost to Follow-up|1|||
16559106|NCT01154036|40513344|FG004|Phase II|Lost to Follow-up|2|||
16559107|NCT01154036|40513345|FG005|Phase II|Lost to Follow-up|0|||
16127605|NCT01262677|38954422|FG002|Overall Study|Reason not provided|3|||
16244131|NCT01335464|39377929|FG001|Overall Study|Adverse Event|25|||
16244132|NCT01335464|39377928|FG000|Overall Study|Non compliant with protocol|2|||
16244133|NCT01335464|39377929|FG001|Overall Study|Non compliant with protocol|0|||
16244134|NCT01335464|39377928|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
16244135|NCT01335464|39377929|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
16244136|NCT01335464|39377928|FG000|Overall Study|Not treated|2|||
16244137|NCT01335464|39377929|FG001|Overall Study|Not treated|0|||
16244138|NCT01335464|39377928|FG000|Overall Study|Reason other than those stated above|1|||
16244139|NCT01335464|39377929|FG001|Overall Study|Reason other than those stated above|1|||
16244140|NCT01313728|39377942|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
16244141|NCT01405950|39377943|FG000|Overall Study|Withdrawal by Subject|1|||
16244142|NCT01405950|39377944|FG001|Overall Study|Withdrawal by Subject|0|||
16244143|NCT01405950|39377945|FG002|Overall Study|Withdrawal by Subject|0|||
16244144|NCT01405950|39377946|FG003|Overall Study|Withdrawal by Subject|0|||
16244145|NCT01325532|39377949|FG000|Overall Study|Withdrawal by Subject|2|||
16244146|NCT01325532|39377950|FG001|Overall Study|Withdrawal by Subject|0|||
16244147|NCT02063698|39377951|FG000|Overall Study|did not complete booklet for days 2-8|1|||
16244148|NCT02063698|39377952|FG001|Overall Study|did not complete booklet for days 2-8|2|||
16244149|NCT02904200|39377958|FG000|Overall Study|Withdrawal by Subject|1|||
16244150|NCT02904200|39377959|FG001|Overall Study|Withdrawal by Subject|0|||
16244151|NCT03549130|39377960|FG000|Overall Study|Adverse Event|0|||
16244152|NCT03549130|39377961|FG001|Overall Study|Adverse Event|1|||
16244153|NCT03549130|39377960|FG000|Overall Study|Lost to Follow-up|0|||
16244154|NCT03549130|39377961|FG001|Overall Study|Lost to Follow-up|1|||
16244155|NCT03555890|39377962|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16244156|NCT03555890|39377963|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16244157|NCT03555890|39377964|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16244158|NCT03555890|39377965|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
16244159|NCT02780700|39377966|FG000|Overall Study|Progressive disease|1|||
16244160|NCT00410410|39377973|FG000|Induction Period (IP)|Death|1|||
16244161|NCT00410410|39377974|FG001|Induction Period (IP)|Death|0|||
16244162|NCT00410410|39377975|FG002|Induction Period (IP)|Death|0|||
16244163|NCT00410410|39377976|FG003|Induction Period (IP)|Death|0|||
16244164|NCT00410410|39377977|FG004|Induction Period (IP)|Death|0|||
16244165|NCT00410410|39377978|FG005|Induction Period (IP)|Death|0|||
16244166|NCT00410410|39377979|FG006|Induction Period (IP)|Death|0|||
16244167|NCT00410410|39377980|FG007|Induction Period (IP)|Death|0|||
16244168|NCT00410410|39377981|FG008|Induction Period (IP)|Death|0|||
16244169|NCT00410410|39377973|FG000|Induction Period (IP)|Adverse Event|3|||
16244170|NCT00410410|39377974|FG001|Induction Period (IP)|Adverse Event|4|||
16244171|NCT00410410|39377975|FG002|Induction Period (IP)|Adverse Event|2|||
16415883|NCT04896593|40004592|FG000|Overall Study|Lost to Follow-up|1|||
16415884|NCT04896593|40004592|FG000|Overall Study|Did not complete onboarding|2|||
16415885|NCT01839656|40004594|FG000|Overall Study|Withdrawal by Subject|1|||
16415886|NCT01839656|40004595|FG001|Overall Study|Withdrawal by Subject|1|||
16415887|NCT01839656|40004594|FG000|Overall Study|Adverse event, serious fatal|1|||
16415888|NCT01839656|40004595|FG001|Overall Study|Adverse event, serious fatal|4|||
16415889|NCT01839656|40004594|FG000|Overall Study|Early study closure|0|||
16415890|NCT01839656|40004595|FG001|Overall Study|Early study closure|11|||
16415891|NCT01839656|40004594|FG000|Overall Study|Adverse Event|1|||
16415892|NCT01839656|40004595|FG001|Overall Study|Adverse Event|0|||
16244172|NCT00410410|39377976|FG003|Induction Period (IP)|Adverse Event|4|||
16244173|NCT00410410|39377977|FG004|Induction Period (IP)|Adverse Event|1|||
16415893|NCT01406015|40004598|FG000|Overall Study|Withdrawal by Subject|3|||
16244174|NCT00410410|39377978|FG005|Induction Period (IP)|Adverse Event|0|||
16244175|NCT00410410|39377979|FG006|Induction Period (IP)|Adverse Event|0|||
16244176|NCT00410410|39377980|FG007|Induction Period (IP)|Adverse Event|0|||
16415894|NCT01406015|40004599|FG001|Overall Study|Withdrawal by Subject|3|||
16415895|NCT00908037|40004602|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16559108|NCT01154036|40513346|FG006|Phase II|Lost to Follow-up|2|||
16559109|NCT01154036|40513347|FG007|Phase II|Lost to Follow-up|1|||
16559110|NCT01154036|40513340|FG000|Phase II|Protocol Violation|0|||
16559111|NCT01154036|40513341|FG001|Phase II|Protocol Violation|0|||
16415896|NCT00908037|40004603|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16415897|NCT00908037|40004604|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16559112|NCT01154036|40513342|FG002|Phase II|Protocol Violation|0|||
16559113|NCT01154036|40513343|FG003|Phase II|Protocol Violation|0|||
16559114|NCT01154036|40513344|FG004|Phase II|Protocol Violation|1|||
16559115|NCT01154036|40513345|FG005|Phase II|Protocol Violation|2|||
16415898|NCT00908037|40004605|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16415899|NCT00908037|40004606|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
16415900|NCT00908037|40004607|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16415901|NCT00908037|40004608|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
16415902|NCT00908037|40004609|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16415903|NCT00908037|40004610|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
16415904|NCT00908037|40004611|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16415905|NCT00908037|40004612|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16127606|NCT01262677|38954420|FG000|Overall Study|Protocol Violation|0|||
16127607|NCT01262677|38954421|FG001|Overall Study|Protocol Violation|1|||
16127608|NCT01262677|38954422|FG002|Overall Study|Protocol Violation|1|||
16415906|NCT00908037|40004613|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
16415907|NCT00908037|40004602|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16415908|NCT00908037|40004603|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16415909|NCT00908037|40004604|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16415910|NCT00908037|40004605|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16415911|NCT00908037|40004606|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
16415912|NCT00908037|40004607|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16415913|NCT00908037|40004608|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16415914|NCT00908037|40004609|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16415915|NCT00908037|40004610|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
16415916|NCT00908037|40004611|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16415917|NCT00908037|40004612|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16415918|NCT00908037|40004613|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
16415919|NCT00908037|40004602|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16415920|NCT00908037|40004603|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16415921|NCT00908037|40004604|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16415922|NCT00908037|40004605|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
16559116|NCT01154036|40513346|FG006|Phase II|Protocol Violation|0|||
16559117|NCT01154036|40513347|FG007|Phase II|Protocol Violation|0|||
16559118|NCT01154036|40513340|FG000|Phase II|Withdrawal by Subject|0|||
16559119|NCT01154036|40513341|FG001|Phase II|Withdrawal by Subject|0|||
16559120|NCT01154036|40513342|FG002|Phase II|Withdrawal by Subject|0|||
16559121|NCT01154036|40513343|FG003|Phase II|Withdrawal by Subject|0|||
16559122|NCT01154036|40513344|FG004|Phase II|Withdrawal by Subject|4|||
16559123|NCT01154036|40513345|FG005|Phase II|Withdrawal by Subject|2|||
16559124|NCT01154036|40513346|FG006|Phase II|Withdrawal by Subject|5|||
16559125|NCT01154036|40513347|FG007|Phase II|Withdrawal by Subject|4|||
16559126|NCT01657682|40513350|FG000|Overall Study|Lost to Follow-up|1|||
16559127|NCT01657682|40513351|FG001|Overall Study|Lost to Follow-up|0|||
16559128|NCT01657682|40513352|FG002|Overall Study|Lost to Follow-up|0|||
16559129|NCT01657682|40513350|FG000|Overall Study|Withdrawal by Subject|0|||
16127609|NCT01262677|38954420|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
16127610|NCT01262677|38954421|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
16127611|NCT01262677|38954422|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
16559130|NCT01657682|40513351|FG001|Overall Study|Withdrawal by Subject|1|||
16559131|NCT01657682|40513352|FG002|Overall Study|Withdrawal by Subject|1|||
16559132|NCT01657682|40513350|FG000|Overall Study|Adverse Event|0|||
16559133|NCT01657682|40513351|FG001|Overall Study|Adverse Event|1|||
16559134|NCT01657682|40513352|FG002|Overall Study|Adverse Event|0|||
16559135|NCT02291289|40513359|FG000|Induction Treatment|Withdrawal by Subject|0|||
16559136|NCT02291289|40513360|FG001|Induction Treatment|Withdrawal by Subject|0|||
16244177|NCT00410410|39377981|FG008|Induction Period (IP)|Adverse Event|0|||
16244178|NCT00410410|39377973|FG000|Induction Period (IP)|Lack of Efficacy|26|||
16244179|NCT00410410|39377974|FG001|Induction Period (IP)|Lack of Efficacy|24|||
16244180|NCT00410410|39377975|FG002|Induction Period (IP)|Lack of Efficacy|8|||
16244181|NCT00410410|39377976|FG003|Induction Period (IP)|Lack of Efficacy|8|||
16244182|NCT00410410|39377977|FG004|Induction Period (IP)|Lack of Efficacy|7|||
16559137|NCT02291289|40513361|FG002|Induction Treatment|Withdrawal by Subject|0|||
16559138|NCT02291289|40513362|FG003|Induction Treatment|Withdrawal by Subject|24|||
16559139|NCT02291289|40513363|FG004|Induction Treatment|Withdrawal by Subject|0|||
16559140|NCT02291289|40513364|FG005|Induction Treatment|Withdrawal by Subject|0|||
16559141|NCT02291289|40513365|FG006|Induction Treatment|Withdrawal by Subject|0|||
16559142|NCT02291289|40513366|FG007|Induction Treatment|Withdrawal by Subject|0|||
16559143|NCT02291289|40513367|FG008|Induction Treatment|Withdrawal by Subject|0|||
16559144|NCT02291289|40513368|FG009|Induction Treatment|Withdrawal by Subject|18|||
16559145|NCT02291289|40513369|FG010|Induction Treatment|Withdrawal by Subject|0|||
16244183|NCT00410410|39377978|FG005|Induction Period (IP)|Lack of Efficacy|7|||
16244184|NCT00410410|39377979|FG006|Induction Period (IP)|Lack of Efficacy|0|||
16244185|NCT00410410|39377980|FG007|Induction Period (IP)|Lack of Efficacy|0|||
16244186|NCT00410410|39377981|FG008|Induction Period (IP)|Lack of Efficacy|0|||
16244187|NCT00410410|39377973|FG000|Induction Period (IP)|Lost to Follow-up|2|||
16244188|NCT00410410|39377974|FG001|Induction Period (IP)|Lost to Follow-up|2|||
16244189|NCT00410410|39377975|FG002|Induction Period (IP)|Lost to Follow-up|2|||
16244190|NCT00410410|39377976|FG003|Induction Period (IP)|Lost to Follow-up|3|||
16244191|NCT00410410|39377977|FG004|Induction Period (IP)|Lost to Follow-up|0|||
16244192|NCT00410410|39377978|FG005|Induction Period (IP)|Lost to Follow-up|1|||
16244193|NCT00410410|39377979|FG006|Induction Period (IP)|Lost to Follow-up|0|||
16244194|NCT00410410|39377980|FG007|Induction Period (IP)|Lost to Follow-up|0|||
16244195|NCT00410410|39377981|FG008|Induction Period (IP)|Lost to Follow-up|0|||
16244196|NCT00410410|39377973|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
16244197|NCT00410410|39377974|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
16244198|NCT00410410|39377975|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
16244199|NCT00410410|39377976|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
16244200|NCT00410410|39377977|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
16244201|NCT00410410|39377978|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
16244202|NCT00410410|39377979|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
16244203|NCT00410410|39377980|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
16244204|NCT00410410|39377981|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
16244205|NCT00410410|39377973|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
16244206|NCT00410410|39377974|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
16244207|NCT00410410|39377975|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
16244208|NCT00410410|39377976|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
16244209|NCT00410410|39377977|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
16244210|NCT00410410|39377978|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
16244211|NCT00410410|39377979|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
16244212|NCT00410410|39377980|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
16244213|NCT00410410|39377981|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
16244214|NCT00410410|39377973|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
16244215|NCT00410410|39377974|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
16244216|NCT00410410|39377975|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
16244217|NCT00410410|39377976|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
16351514|NCT00928434|39773026|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
16351515|NCT00928434|39773027|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
16351516|NCT00928434|39773028|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
16244218|NCT00410410|39377977|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
16244219|NCT00410410|39377978|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
16559146|NCT02291289|40513370|FG011|Induction Treatment|Withdrawal by Subject|0|||
16559147|NCT02291289|40513371|FG012|Induction Treatment|Withdrawal by Subject|0|||
16244220|NCT00410410|39377979|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
16244221|NCT00410410|39377980|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
16244222|NCT00410410|39377981|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
16244223|NCT00410410|39377973|FG000|Induction Period (IP)|Other|0|||
16244224|NCT00410410|39377974|FG001|Induction Period (IP)|Other|0|||
16244225|NCT00410410|39377975|FG002|Induction Period (IP)|Other|1|||
16244226|NCT00410410|39377976|FG003|Induction Period (IP)|Other|0|||
16244227|NCT00410410|39377977|FG004|Induction Period (IP)|Other|0|||
16244228|NCT00410410|39377978|FG005|Induction Period (IP)|Other|0|||
16244229|NCT00410410|39377979|FG006|Induction Period (IP)|Other|0|||
16244230|NCT00410410|39377980|FG007|Induction Period (IP)|Other|0|||
16244231|NCT00410410|39377981|FG008|Induction Period (IP)|Other|0|||
16244232|NCT00410410|39377973|FG000|Maintenance Period (MP)|Death|0|||
16244233|NCT00410410|39377974|FG001|Maintenance Period (MP)|Death|0|||
16244234|NCT00410410|39377975|FG002|Maintenance Period (MP)|Death|0|||
16244235|NCT00410410|39377976|FG003|Maintenance Period (MP)|Death|0|||
16244236|NCT00410410|39377977|FG004|Maintenance Period (MP)|Death|0|||
16244237|NCT00410410|39377978|FG005|Maintenance Period (MP)|Death|0|||
16244238|NCT00410410|39377979|FG006|Maintenance Period (MP)|Death|1|||
16244239|NCT00410410|39377980|FG007|Maintenance Period (MP)|Death|0|||
16244240|NCT00410410|39377981|FG008|Maintenance Period (MP)|Death|0|||
16244241|NCT00410410|39377973|FG000|Maintenance Period (MP)|Adverse Event|0|||
16244242|NCT00410410|39377974|FG001|Maintenance Period (MP)|Adverse Event|0|||
16244243|NCT00410410|39377975|FG002|Maintenance Period (MP)|Adverse Event|0|||
16244244|NCT00410410|39377976|FG003|Maintenance Period (MP)|Adverse Event|0|||
16244245|NCT00410410|39377977|FG004|Maintenance Period (MP)|Adverse Event|0|||
16244246|NCT00410410|39377978|FG005|Maintenance Period (MP)|Adverse Event|0|||
16244247|NCT00410410|39377979|FG006|Maintenance Period (MP)|Adverse Event|1|||
16244248|NCT00410410|39377980|FG007|Maintenance Period (MP)|Adverse Event|3|||
16244249|NCT00410410|39377981|FG008|Maintenance Period (MP)|Adverse Event|0|||
16244250|NCT00410410|39377973|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
16244251|NCT00410410|39377974|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
16244252|NCT00410410|39377975|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
16351517|NCT00928434|39773026|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
16559148|NCT02291289|40513359|FG000|Induction Treatment|Adverse Event|0|||
16559149|NCT02291289|40513360|FG001|Induction Treatment|Adverse Event|0|||
16559150|NCT02291289|40513361|FG002|Induction Treatment|Adverse Event|0|||
16559151|NCT02291289|40513362|FG003|Induction Treatment|Adverse Event|3|||
16559152|NCT02291289|40513363|FG004|Induction Treatment|Adverse Event|0|||
16559153|NCT02291289|40513364|FG005|Induction Treatment|Adverse Event|0|||
16559154|NCT02291289|40513365|FG006|Induction Treatment|Adverse Event|0|||
16559155|NCT02291289|40513366|FG007|Induction Treatment|Adverse Event|0|||
16559156|NCT02291289|40513367|FG008|Induction Treatment|Adverse Event|0|||
16559157|NCT02291289|40513368|FG009|Induction Treatment|Adverse Event|1|||
16559158|NCT02291289|40513369|FG010|Induction Treatment|Adverse Event|0|||
16559159|NCT02291289|40513370|FG011|Induction Treatment|Adverse Event|0|||
16559160|NCT02291289|40513371|FG012|Induction Treatment|Adverse Event|0|||
16559161|NCT02291289|40513359|FG000|Induction Treatment|Death|25|||
16559162|NCT02291289|40513360|FG001|Induction Treatment|Death|0|||
16559163|NCT02291289|40513361|FG002|Induction Treatment|Death|0|||
16559164|NCT02291289|40513362|FG003|Induction Treatment|Death|111|||
16559165|NCT02291289|40513363|FG004|Induction Treatment|Death|0|||
16559166|NCT02291289|40513364|FG005|Induction Treatment|Death|0|||
16559167|NCT02291289|40513365|FG006|Induction Treatment|Death|1|||
16559168|NCT02291289|40513366|FG007|Induction Treatment|Death|0|||
16559169|NCT02291289|40513367|FG008|Induction Treatment|Death|0|||
16559170|NCT02291289|40513368|FG009|Induction Treatment|Death|82|||
16559171|NCT02291289|40513369|FG010|Induction Treatment|Death|0|||
16244253|NCT00410410|39377976|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
16244254|NCT00410410|39377977|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
16244255|NCT00410410|39377978|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
16244256|NCT00410410|39377979|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
16244257|NCT00410410|39377980|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
16244258|NCT00410410|39377981|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
16351518|NCT00928434|39773027|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
16351519|NCT00928434|39773028|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
16559172|NCT02291289|40513370|FG011|Induction Treatment|Death|0|||
16559173|NCT02291289|40513371|FG012|Induction Treatment|Death|0|||
16559174|NCT02291289|40513359|FG000|Induction Treatment|Lost to Follow-up|1|||
16244259|NCT00410410|39377973|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
16244260|NCT00410410|39377974|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
16351520|NCT00928434|39773026|FG000|Overall Study|Other (not meeting above criteria)|5|||
16351521|NCT00928434|39773027|FG001|Overall Study|Other (not meeting above criteria)|1|||
16351522|NCT00928434|39773028|FG002|Overall Study|Other (not meeting above criteria)|2|||
16351523|NCT00887484|39773029|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
16351524|NCT00887484|39773029|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
16351525|NCT00887484|39773029|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
16351526|NCT01499810|39773033|FG000|Overall Study|Lost to Follow-up|10|||
16351527|NCT01499810|39773033|FG000|Overall Study|Protocol Violation|1|||
16351528|NCT01499810|39773033|FG000|Overall Study|Withdrawal by Subject|1|||
16351529|NCT02157519|39773035|FG000|Overall Study|Death|3|||
16351530|NCT02157519|39773036|FG001|Overall Study|Death|1|||
16351531|NCT02157519|39773035|FG000|Overall Study|Withdrawal by Subject|7|||
16351532|NCT02157519|39773036|FG001|Overall Study|Withdrawal by Subject|0|||
16351533|NCT02157519|39773035|FG000|Overall Study|Lost to Follow-up|1|||
16351534|NCT02157519|39773036|FG001|Overall Study|Lost to Follow-up|0|||
16351535|NCT03044314|39773037|FG000|Overall Study|Physician Decision|2|||
16415923|NCT00908037|40004606|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16415924|NCT00908037|40004607|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16415925|NCT00908037|40004608|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
16415926|NCT00908037|40004609|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16415927|NCT00908037|40004610|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16415928|NCT00908037|40004611|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16415929|NCT00908037|40004612|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16415930|NCT00908037|40004613|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
16415931|NCT00908037|40004602|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16415932|NCT00908037|40004603|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16415933|NCT00908037|40004604|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16415934|NCT00908037|40004605|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16351536|NCT03044314|39773037|FG000|Overall Study|Withdrawal by Subject|1|||
16351537|NCT03044314|39773037|FG000|Overall Study|Connector tubing not available|1|||
16351538|NCT03234465|39773045|FG000|Overall Study|Adverse Event|4|||
16351539|NCT03234465|39773046|FG001|Overall Study|Adverse Event|2|||
16351540|NCT03234465|39773045|FG000|Overall Study|Death|0|||
16415935|NCT00908037|40004606|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16415936|NCT00908037|40004607|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16415937|NCT00908037|40004608|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16415938|NCT00908037|40004609|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16415939|NCT00908037|40004610|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16415940|NCT00908037|40004611|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16415941|NCT00908037|40004612|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
16415942|NCT00908037|40004613|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
16415943|NCT00908037|40004602|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16415944|NCT00908037|40004603|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16415945|NCT00908037|40004604|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16415946|NCT00908037|40004605|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16415947|NCT00908037|40004606|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16415948|NCT00908037|40004607|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16415949|NCT00908037|40004608|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16415950|NCT00908037|40004609|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16415951|NCT00908037|40004610|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16415952|NCT00908037|40004611|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
16415953|NCT00908037|40004612|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
16415954|NCT00908037|40004613|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
16415955|NCT00908037|40004602|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415956|NCT00908037|40004603|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415957|NCT00908037|40004604|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415958|NCT00908037|40004605|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415959|NCT00908037|40004606|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415960|NCT00908037|40004607|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415961|NCT00908037|40004608|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415962|NCT00908037|40004609|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415963|NCT00908037|40004610|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415964|NCT00908037|40004611|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
16415965|NCT00908037|40004612|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415966|NCT00908037|40004613|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
16415967|NCT00908037|40004602|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16415968|NCT00908037|40004603|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16415969|NCT00908037|40004604|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16415970|NCT00908037|40004605|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16415971|NCT00908037|40004606|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16127612|NCT03339583|38954423|FG000|First Intervention (14 Days)|Adverse Event|1|||
16127613|NCT03339583|38954424|FG001|First Intervention (14 Days)|Adverse Event|0|||
16127614|NCT03339583|38954423|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
16127615|NCT03339583|38954424|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
16127616|NCT03339583|38954423|FG000|Second Intervention (14 Days)|Adverse Event|0|||
16127617|NCT03339583|38954424|FG001|Second Intervention (14 Days)|Adverse Event|1|||
16127618|NCT03339583|38954423|FG000|Follow-up (14 Days)|Physician Decision|6|||
16127619|NCT03339583|38954424|FG001|Follow-up (14 Days)|Physician Decision|3|||
16127620|NCT00309959|38954428|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
16127621|NCT03412747|38954430|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
16127622|NCT03412747|38954431|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
16127623|NCT03412747|38954432|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
16127624|NCT03412747|38954430|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
16127625|NCT03412747|38954431|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
16127626|NCT03412747|38954432|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
16127627|NCT03412747|38954430|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
16127628|NCT03412747|38954431|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
16127629|NCT03412747|38954432|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
16127630|NCT03412747|38954430|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
16127631|NCT03412747|38954431|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
16127632|NCT03412747|38954432|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
16127633|NCT03412747|38954430|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
16127634|NCT03412747|38954431|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
16127635|NCT03412747|38954432|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
16127636|NCT03412747|38954430|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
16127637|NCT03412747|38954431|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
16127638|NCT03412747|38954432|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
16127639|NCT03412747|38954430|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
16127640|NCT03412747|38954431|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
16127641|NCT03412747|38954432|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
16127642|NCT03412747|38954430|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
16127643|NCT03412747|38954431|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
16127644|NCT03412747|38954432|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
16127645|NCT03412747|38954430|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
16127646|NCT03412747|38954431|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
16127647|NCT03412747|38954432|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
16127648|NCT03412747|38954430|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
16127649|NCT03412747|38954431|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
16127650|NCT03412747|38954432|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
16127651|NCT03412747|38954430|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
16127652|NCT03412747|38954431|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
16127653|NCT03412747|38954432|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
16127654|NCT03412747|38954430|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
16127655|NCT03412747|38954431|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
16127656|NCT03412747|38954432|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
16127657|NCT03412747|38954430|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
16127658|NCT03412747|38954431|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
16127659|NCT03412747|38954432|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
16127660|NCT03412747|38954430|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
16127661|NCT03412747|38954431|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
16559175|NCT02291289|40513360|FG001|Induction Treatment|Lost to Follow-up|0|||
16559176|NCT02291289|40513361|FG002|Induction Treatment|Lost to Follow-up|0|||
16559177|NCT02291289|40513362|FG003|Induction Treatment|Lost to Follow-up|12|||
16559178|NCT02291289|40513363|FG004|Induction Treatment|Lost to Follow-up|0|||
16559179|NCT02291289|40513364|FG005|Induction Treatment|Lost to Follow-up|0|||
16127662|NCT03412747|38954432|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
16127663|NCT03412747|38954430|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
16127664|NCT03412747|38954431|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
16127665|NCT03412747|38954432|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
16127666|NCT03412747|38954430|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
16127667|NCT03412747|38954431|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
16127668|NCT03412747|38954432|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
16127669|NCT00743431|38954433|FG000|Overall Study|Toxicity|6|||
16127670|NCT00743431|38954433|FG000|Overall Study|Tumor progression|56|||
16127671|NCT00743431|38954433|FG000|Overall Study|Withdrawal by Subject|13|||
16127672|NCT00743431|38954433|FG000|Overall Study|Death|9|||
16127673|NCT00743431|38954433|FG000|Overall Study|Reason for discontinuation not specified|29|||
16127674|NCT00743431|38954433|FG000|Overall Study|No documentation available|13|||
16127675|NCT03702231|38954435|FG000|Overall Study|Withdrawal by Subject|1|||
16127676|NCT03702231|38954436|FG001|Overall Study|Withdrawal by Subject|0|||
16127677|NCT03702231|38954437|FG002|Overall Study|Withdrawal by Subject|0|||
16127678|NCT03702231|38954435|FG000|Overall Study|Protocol Violation|0|||
16127679|NCT03702231|38954436|FG001|Overall Study|Protocol Violation|0|||
16127680|NCT03702231|38954437|FG002|Overall Study|Protocol Violation|1|||
16127681|NCT03702231|38954435|FG000|Overall Study|Change in CLL Treatment|0|||
16127682|NCT03702231|38954436|FG001|Overall Study|Change in CLL Treatment|0|||
16127683|NCT03702231|38954437|FG002|Overall Study|Change in CLL Treatment|1|||
16127684|NCT03702231|38954435|FG000|Overall Study|COVID Pandemic|1|||
16127685|NCT03702231|38954436|FG001|Overall Study|COVID Pandemic|4|||
16415972|NCT00908037|40004607|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16415973|NCT00908037|40004608|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16415974|NCT00908037|40004609|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16415975|NCT00908037|40004610|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16559180|NCT02291289|40513365|FG006|Induction Treatment|Lost to Follow-up|0|||
16559181|NCT02291289|40513366|FG007|Induction Treatment|Lost to Follow-up|0|||
16559182|NCT02291289|40513367|FG008|Induction Treatment|Lost to Follow-up|0|||
16559183|NCT02291289|40513368|FG009|Induction Treatment|Lost to Follow-up|9|||
16559184|NCT02291289|40513369|FG010|Induction Treatment|Lost to Follow-up|0|||
16415976|NCT00908037|40004611|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16415977|NCT00908037|40004612|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
16415978|NCT00908037|40004613|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
16415979|NCT00908037|40004602|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16415980|NCT00908037|40004603|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16415981|NCT00908037|40004604|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16559185|NCT02291289|40513370|FG011|Induction Treatment|Lost to Follow-up|0|||
16559186|NCT02291289|40513371|FG012|Induction Treatment|Lost to Follow-up|0|||
16559187|NCT02291289|40513359|FG000|Induction Treatment|Non-Compliance|0|||
16351541|NCT03234465|39773046|FG001|Overall Study|Death|1|||
16351542|NCT03234465|39773045|FG000|Overall Study|Lost to Follow-up|1|||
16351543|NCT03234465|39773046|FG001|Overall Study|Lost to Follow-up|1|||
16351544|NCT03234465|39773045|FG000|Overall Study|Withdrawal by Subject|12|||
16351545|NCT03234465|39773046|FG001|Overall Study|Withdrawal by Subject|27|||
16351546|NCT03234465|39773045|FG000|Overall Study|Symptomatic deterioration|0|||
16351547|NCT03234465|39773046|FG001|Overall Study|Symptomatic deterioration|1|||
16351548|NCT03234465|39773045|FG000|Overall Study|Non-compliance|2|||
16351549|NCT03234465|39773046|FG001|Overall Study|Non-compliance|0|||
16351550|NCT03234465|39773045|FG000|Overall Study|Other|14|||
16351551|NCT03234465|39773046|FG001|Overall Study|Other|8|||
16351552|NCT03718429|39773047|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
16351553|NCT03718429|39773048|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
16351554|NCT03718429|39773049|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
16351555|NCT03718429|39773050|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
16351556|NCT02662569|39773052|FG000|Overall Study|Withdrawal by Subject|6|||
16351557|NCT02662569|39773053|FG001|Overall Study|Withdrawal by Subject|1|||
16127686|NCT03702231|38954437|FG002|Overall Study|COVID Pandemic|1|||
16127687|NCT03702231|38954435|FG000|Overall Study|Non-compliance|0|||
16127688|NCT03702231|38954436|FG001|Overall Study|Non-compliance|0|||
16127689|NCT03702231|38954437|FG002|Overall Study|Non-compliance|1|||
16127690|NCT00608868|38954438|FG000|Overall Study|Withdrawal by Subject|7|||
16127691|NCT00608868|38954438|FG000|Overall Study|Protocol Violation|3|||
16127692|NCT00608868|38954438|FG000|Overall Study|Lost to Follow-up|2|||
16127693|NCT00608868|38954438|FG000|Overall Study|Adverse Event|1|||
16127694|NCT00608868|38954438|FG000|Overall Study|Physician Decision|2|||
16127695|NCT00864253|38954439|FG000|Overall Study|Adverse Event|56|||
16127696|NCT00864253|38954440|FG001|Overall Study|Adverse Event|11|||
16127697|NCT00864253|38954439|FG000|Overall Study|Unrelated Adverse Event|3|||
16127698|NCT00864253|38954440|FG001|Overall Study|Unrelated Adverse Event|1|||
16127699|NCT00864253|38954439|FG000|Overall Study|Physician Decision|11|||
16127700|NCT00864253|38954440|FG001|Overall Study|Physician Decision|15|||
16127701|NCT00864253|38954439|FG000|Overall Study|Protocol Violation|0|||
16127702|NCT00864253|38954440|FG001|Overall Study|Protocol Violation|2|||
16127703|NCT00864253|38954439|FG000|Overall Study|Lost to Follow-up|1|||
16127704|NCT00864253|38954440|FG001|Overall Study|Lost to Follow-up|1|||
16127705|NCT00864253|38954439|FG000|Overall Study|Withdrawal by Subject|18|||
16127706|NCT00864253|38954440|FG001|Overall Study|Withdrawal by Subject|18|||
16127707|NCT00864253|38954439|FG000|Overall Study|Death|1|||
16127708|NCT00864253|38954440|FG001|Overall Study|Death|0|||
16127709|NCT00864253|38954439|FG000|Overall Study|Ongoing|2|||
16127710|NCT00864253|38954440|FG001|Overall Study|Ongoing|3|||
16127711|NCT00864253|38954439|FG000|Overall Study|Untreated|7|||
16127712|NCT00864253|38954440|FG001|Overall Study|Untreated|7|||
16127713|NCT05087979|38954441|FG000|Overall Study|Converted to general anesthesia|1|||
16127714|NCT05087979|38954442|FG001|Overall Study|Converted to general anesthesia|0|||
16127715|NCT01465347|38954443|FG000|Overall Study|Withdrawal by Subject|1|||
16127716|NCT01465347|38954444|FG001|Overall Study|Withdrawal by Subject|1|||
16127717|NCT01465347|38954443|FG000|Overall Study|Physician Decision|0|||
16127718|NCT01465347|38954444|FG001|Overall Study|Physician Decision|1|||
16127719|NCT01465347|38954443|FG000|Overall Study|Admitted to hospice|0|||
16127720|NCT01465347|38954444|FG001|Overall Study|Admitted to hospice|1|||
16127721|NCT01656200|38954447|FG000|Overall Study|Withdrawal by Subject|1|||
16127722|NCT00356408|38954448|FG000|Overall Study|Adverse Event|9|||
16127723|NCT00356408|38954448|FG000|Overall Study|Lack of Efficacy|36|||
16127724|NCT00356408|38954448|FG000|Overall Study|Lost to Follow-up|2|||
16127725|NCT00356408|38954448|FG000|Overall Study|Withdrawal by Subject|6|||
16127726|NCT00356408|38954448|FG000|Overall Study|Other: Principal investigator discretion|3|||
16127727|NCT00356408|38954448|FG000|Overall Study|Other: Sponsor request|1|||
16127728|NCT00356408|38954448|FG000|Overall Study|Other: Azathioprine stopped|1|||
16127729|NCT00356408|38954448|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
16127730|NCT00356408|38954448|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
16127731|NCT00730275|38954449|FG000|Overall Study|Withdrawal by Subject|0|||
16127732|NCT00730275|38954450|FG001|Overall Study|Withdrawal by Subject|0|||
16127733|NCT00730275|38954451|FG002|Overall Study|Withdrawal by Subject|0|||
16127734|NCT00730275|38954452|FG003|Overall Study|Withdrawal by Subject|1|||
16127735|NCT01153321|38954453|FG000|Overall Study|Development of study withdrawal criteria|0|||
16127736|NCT01153321|38954454|FG001|Overall Study|Development of study withdrawal criteria|1|||
16127737|NCT01153321|38954453|FG000|Overall Study|Withdrawal by Subject|0|||
16127738|NCT01153321|38954454|FG001|Overall Study|Withdrawal by Subject|1|||
16127739|NCT01153321|38954453|FG000|Overall Study|Adverse Event|1|||
16127740|NCT01153321|38954454|FG001|Overall Study|Adverse Event|1|||
16127741|NCT01081132|38954459|FG000|Overall Study|Lack of Efficacy|25|||
16127742|NCT01081132|38954460|FG001|Overall Study|Lack of Efficacy|9|||
16127743|NCT01081132|38954459|FG000|Overall Study|Withdrawal by Subject|13|||
16127744|NCT01081132|38954460|FG001|Overall Study|Withdrawal by Subject|16|||
16127745|NCT01081132|38954459|FG000|Overall Study|Lost to Follow-up|4|||
16127746|NCT01081132|38954460|FG001|Overall Study|Lost to Follow-up|11|||
16127747|NCT01081132|38954459|FG000|Overall Study|Adverse Event|3|||
16127748|NCT01081132|38954460|FG001|Overall Study|Adverse Event|9|||
16127749|NCT01081132|38954459|FG000|Overall Study|Non Compliance|4|||
16127750|NCT01081132|38954460|FG001|Overall Study|Non Compliance|2|||
16127751|NCT01081132|38954459|FG000|Overall Study|Lack Of Compliance|0|||
16127752|NCT01081132|38954460|FG001|Overall Study|Lack Of Compliance|1|||
16127753|NCT01081132|38954459|FG000|Overall Study|Missed Visits|1|||
16127754|NCT01081132|38954460|FG001|Overall Study|Missed Visits|1|||
16127755|NCT01081132|38954459|FG000|Overall Study|Stopped Taking Meds|2|||
16127756|NCT01081132|38954460|FG001|Overall Study|Stopped Taking Meds|0|||
16127757|NCT01081132|38954459|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
16127758|NCT01081132|38954460|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
16127759|NCT01081132|38954459|FG000|Overall Study|Declined Taper Phase|0|||
16127760|NCT01081132|38954460|FG001|Overall Study|Declined Taper Phase|1|||
16127761|NCT01081132|38954459|FG000|Overall Study|Protocol Violation|3|||
16127762|NCT01081132|38954460|FG001|Overall Study|Protocol Violation|1|||
16127763|NCT01248065|38954463|FG000|Overall Study|Lost to Follow-up|3|||
16127764|NCT01248065|38954464|FG001|Overall Study|Lost to Follow-up|5|||
16127765|NCT01248065|38954463|FG000|Overall Study|Withdrawal by Subject|14|||
16244261|NCT00410410|39377975|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
16127766|NCT01248065|38954464|FG001|Overall Study|Withdrawal by Subject|11|||
16244262|NCT00410410|39377976|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
16127767|NCT01248065|38954463|FG000|Overall Study|Adverse Event|3|||
16127768|NCT01248065|38954464|FG001|Overall Study|Adverse Event|0|||
16127769|NCT01248065|38954463|FG000|Overall Study|Third treatment failure event|3|||
16127770|NCT01248065|38954464|FG001|Overall Study|Third treatment failure event|1|||
16127771|NCT01248065|38954463|FG000|Overall Study|Other|3|||
16415982|NCT00908037|40004605|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16415983|NCT00908037|40004606|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16415984|NCT00908037|40004607|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16415985|NCT00908037|40004608|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16415986|NCT00908037|40004609|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16415987|NCT00908037|40004610|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16415988|NCT00908037|40004611|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
16415989|NCT00908037|40004612|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16415990|NCT00908037|40004613|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
16415991|NCT00908037|40004602|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16415992|NCT00908037|40004603|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16415993|NCT00908037|40004604|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16415994|NCT00908037|40004605|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16415995|NCT00908037|40004606|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16415996|NCT00908037|40004607|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16415997|NCT00908037|40004608|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16415998|NCT00908037|40004609|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16415999|NCT00908037|40004610|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16416000|NCT00908037|40004611|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16416001|NCT00908037|40004612|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
16416002|NCT00908037|40004613|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
16416003|NCT01141478|40004614|FG000|Overall Study|Withdrawal by Subject|1|||
16416004|NCT01141478|40004615|FG001|Overall Study|Withdrawal by Subject|1|||
16559188|NCT02291289|40513360|FG001|Induction Treatment|Non-Compliance|0|||
16559189|NCT02291289|40513361|FG002|Induction Treatment|Non-Compliance|0|||
16127772|NCT01248065|38954464|FG001|Overall Study|Other|5|||
16127773|NCT01489891|38954466|FG000|Overall Study|Endoscopy failure|1|||
16127774|NCT01489891|38954467|FG001|Overall Study|Endoscopy failure|0|||
16127775|NCT02549196|38954468|FG000|Overall Study|Protocol Violation|0|||
16127776|NCT02549196|38954469|FG001|Overall Study|Protocol Violation|0|||
16559190|NCT02291289|40513362|FG003|Induction Treatment|Non-Compliance|1|||
16559191|NCT02291289|40513363|FG004|Induction Treatment|Non-Compliance|0|||
16559192|NCT02291289|40513364|FG005|Induction Treatment|Non-Compliance|0|||
16559193|NCT02291289|40513365|FG006|Induction Treatment|Non-Compliance|0|||
16559194|NCT02291289|40513366|FG007|Induction Treatment|Non-Compliance|0|||
16559195|NCT02291289|40513367|FG008|Induction Treatment|Non-Compliance|0|||
16559196|NCT02291289|40513368|FG009|Induction Treatment|Non-Compliance|1|||
16559197|NCT02291289|40513369|FG010|Induction Treatment|Non-Compliance|0|||
16559198|NCT02291289|40513370|FG011|Induction Treatment|Non-Compliance|0|||
16559199|NCT02291289|40513371|FG012|Induction Treatment|Non-Compliance|0|||
16559200|NCT02291289|40513359|FG000|Induction Treatment|Reason Not Specified|0|||
16559201|NCT02291289|40513360|FG001|Induction Treatment|Reason Not Specified|0|||
16559202|NCT02291289|40513361|FG002|Induction Treatment|Reason Not Specified|0|||
16559203|NCT02291289|40513362|FG003|Induction Treatment|Reason Not Specified|4|||
16559204|NCT02291289|40513363|FG004|Induction Treatment|Reason Not Specified|0|||
16559205|NCT02291289|40513364|FG005|Induction Treatment|Reason Not Specified|0|||
16559206|NCT02291289|40513365|FG006|Induction Treatment|Reason Not Specified|0|||
16559207|NCT02291289|40513366|FG007|Induction Treatment|Reason Not Specified|0|||
16559208|NCT02291289|40513367|FG008|Induction Treatment|Reason Not Specified|0|||
16127777|NCT02549196|38954470|FG002|Overall Study|Protocol Violation|0|||
16127778|NCT02549196|38954471|FG003|Overall Study|Protocol Violation|1|||
16127779|NCT02549196|38954468|FG000|Overall Study|Withdrawal by Subject|1|||
16127780|NCT02549196|38954469|FG001|Overall Study|Withdrawal by Subject|0|||
16127781|NCT02549196|38954470|FG002|Overall Study|Withdrawal by Subject|1|||
16127782|NCT02549196|38954471|FG003|Overall Study|Withdrawal by Subject|0|||
16127783|NCT00440999|38954472|FG000|Overall Study|Adverse Event|0|||
16127784|NCT00440999|38954473|FG001|Overall Study|Adverse Event|2|||
16127785|NCT00440999|38954472|FG000|Overall Study|Lack of Efficacy|6|||
16127786|NCT00440999|38954473|FG001|Overall Study|Lack of Efficacy|7|||
16244263|NCT00410410|39377977|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
16244264|NCT00410410|39377978|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
16244265|NCT00410410|39377979|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
16244266|NCT00410410|39377980|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
16559209|NCT02291289|40513368|FG009|Induction Treatment|Reason Not Specified|7|||
16559210|NCT02291289|40513369|FG010|Induction Treatment|Reason Not Specified|0|||
16559211|NCT02291289|40513370|FG011|Induction Treatment|Reason Not Specified|0|||
16244267|NCT00410410|39377981|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
16244268|NCT00410410|39377973|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
16244269|NCT00410410|39377974|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
16244270|NCT00410410|39377975|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
16244271|NCT00410410|39377976|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
16244272|NCT00410410|39377977|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
16244273|NCT00410410|39377978|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
16244274|NCT00410410|39377979|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
16244275|NCT00410410|39377980|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
16244276|NCT00410410|39377981|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
16244277|NCT00410410|39377973|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
16244278|NCT00410410|39377974|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
16559212|NCT02291289|40513371|FG012|Induction Treatment|Reason Not Specified|0|||
16559213|NCT02291289|40513359|FG000|Induction Treatment|Physician Decision|0|||
16244279|NCT00410410|39377975|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
16244280|NCT00410410|39377976|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
16244281|NCT00410410|39377977|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
16244282|NCT00410410|39377978|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
16244283|NCT00410410|39377979|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
16244284|NCT00410410|39377980|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
16244285|NCT00410410|39377981|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
16244286|NCT00410410|39377973|FG000|Open-Label Period (OL)|Death|0|||
16244287|NCT00410410|39377974|FG001|Open-Label Period (OL)|Death|0|||
16244288|NCT00410410|39377975|FG002|Open-Label Period (OL)|Death|0|||
16244289|NCT00410410|39377976|FG003|Open-Label Period (OL)|Death|0|||
16244290|NCT00410410|39377977|FG004|Open-Label Period (OL)|Death|0|||
16244291|NCT00410410|39377978|FG005|Open-Label Period (OL)|Death|0|||
16244292|NCT00410410|39377979|FG006|Open-Label Period (OL)|Death|0|||
16244293|NCT00410410|39377980|FG007|Open-Label Period (OL)|Death|0|||
16244294|NCT00410410|39377981|FG008|Open-Label Period (OL)|Death|1|||
16244295|NCT00410410|39377973|FG000|Open-Label Period (OL)|Adverse Event|0|||
16244296|NCT00410410|39377974|FG001|Open-Label Period (OL)|Adverse Event|0|||
16244297|NCT00410410|39377975|FG002|Open-Label Period (OL)|Adverse Event|0|||
16244298|NCT00410410|39377976|FG003|Open-Label Period (OL)|Adverse Event|0|||
16244299|NCT00410410|39377977|FG004|Open-Label Period (OL)|Adverse Event|0|||
16244300|NCT00410410|39377978|FG005|Open-Label Period (OL)|Adverse Event|0|||
16244301|NCT00410410|39377979|FG006|Open-Label Period (OL)|Adverse Event|0|||
16244302|NCT00410410|39377980|FG007|Open-Label Period (OL)|Adverse Event|0|||
16244303|NCT00410410|39377981|FG008|Open-Label Period (OL)|Adverse Event|10|||
16244304|NCT00410410|39377973|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
16244305|NCT00410410|39377974|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
16244306|NCT00410410|39377975|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
16244307|NCT00410410|39377976|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
16244308|NCT00410410|39377977|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
16244309|NCT00410410|39377978|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
16244310|NCT00410410|39377979|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
16559214|NCT02291289|40513360|FG001|Induction Treatment|Physician Decision|0|||
16559215|NCT02291289|40513361|FG002|Induction Treatment|Physician Decision|0|||
16416005|NCT04268173|40004616|FG000|Overall Study|Lost to Follow-up|75|||
16559216|NCT02291289|40513362|FG003|Induction Treatment|Physician Decision|3|||
16244311|NCT00410410|39377980|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
16244312|NCT00410410|39377981|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
16244313|NCT00410410|39377973|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
16244314|NCT00410410|39377974|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
16244315|NCT00410410|39377975|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
16244316|NCT00410410|39377976|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
16244317|NCT00410410|39377977|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
16244318|NCT00410410|39377978|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
16244319|NCT00410410|39377979|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
16244320|NCT00410410|39377980|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
16244321|NCT00410410|39377981|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
16244322|NCT00410410|39377973|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
16244323|NCT00410410|39377974|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
16244324|NCT00410410|39377975|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
16244325|NCT00410410|39377976|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
16244326|NCT00410410|39377977|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
16244327|NCT00410410|39377978|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
16244328|NCT00410410|39377979|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
16244329|NCT00410410|39377980|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
16244330|NCT00410410|39377981|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
16244331|NCT00410410|39377973|FG000|Open-Label Period (OL)|Pregnancy|0|||
16244332|NCT00410410|39377974|FG001|Open-Label Period (OL)|Pregnancy|0|||
16244333|NCT00410410|39377975|FG002|Open-Label Period (OL)|Pregnancy|0|||
16244334|NCT00410410|39377976|FG003|Open-Label Period (OL)|Pregnancy|0|||
16244335|NCT00410410|39377977|FG004|Open-Label Period (OL)|Pregnancy|0|||
16244336|NCT00410410|39377978|FG005|Open-Label Period (OL)|Pregnancy|0|||
16244337|NCT00410410|39377979|FG006|Open-Label Period (OL)|Pregnancy|0|||
16244338|NCT00410410|39377980|FG007|Open-Label Period (OL)|Pregnancy|0|||
16244339|NCT00410410|39377981|FG008|Open-Label Period (OL)|Pregnancy|1|||
16244340|NCT00410410|39377973|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
16244341|NCT00410410|39377974|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
16244342|NCT00410410|39377975|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
16244343|NCT00410410|39377976|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
16244344|NCT00410410|39377977|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
16244345|NCT00410410|39377978|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
16244346|NCT00410410|39377979|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
16244347|NCT00410410|39377980|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
16244348|NCT00410410|39377981|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
16244349|NCT00410410|39377973|FG000|Open-Label Period (OL)|Other|0|||
16244350|NCT00410410|39377974|FG001|Open-Label Period (OL)|Other|0|||
16244351|NCT00410410|39377975|FG002|Open-Label Period (OL)|Other|0|||
16244352|NCT00410410|39377976|FG003|Open-Label Period (OL)|Other|0|||
16244353|NCT00410410|39377977|FG004|Open-Label Period (OL)|Other|0|||
16244354|NCT00410410|39377978|FG005|Open-Label Period (OL)|Other|0|||
16244355|NCT00410410|39377979|FG006|Open-Label Period (OL)|Other|0|||
16244356|NCT00410410|39377980|FG007|Open-Label Period (OL)|Other|0|||
16244357|NCT00410410|39377981|FG008|Open-Label Period (OL)|Other|7|||
16244358|NCT03077828|39377982|FG000|Treatment Cycles|Death|1|||
16244359|NCT03077828|39377982|FG000|Treatment Cycles|Withdrawal by Subject|1|||
16244360|NCT03077828|39377982|FG000|Treatment Cycles|Screen Fail|2|||
16244361|NCT03077828|39377982|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
16244362|NCT03077828|39377982|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
16244363|NCT03077828|39377982|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
16244364|NCT03077828|39377982|FG000|Follow-up|Patients still in follow-up|15|||
16244365|NCT04335110|39377984|FG000|Overall Study|Withdrawal by Subject|1|||
16244366|NCT04335110|39377985|FG001|Overall Study|Withdrawal by Subject|1|||
16244367|NCT04335110|39377984|FG000|Overall Study|Death|0|||
16127787|NCT00440999|38954472|FG000|Overall Study|Lost to Follow-up|19|||
16127788|NCT00440999|38954473|FG001|Overall Study|Lost to Follow-up|12|||
16127789|NCT00440999|38954472|FG000|Overall Study|Protocol Violation|1|||
16127790|NCT00440999|38954473|FG001|Overall Study|Protocol Violation|0|||
16127791|NCT00440999|38954472|FG000|Overall Study|Withdrawal by Subject|2|||
16127792|NCT00440999|38954473|FG001|Overall Study|Withdrawal by Subject|5|||
16127793|NCT00440999|38954472|FG000|Overall Study|Subjets missed the visit|1|||
16127794|NCT00440999|38954473|FG001|Overall Study|Subjets missed the visit|0|||
16127795|NCT00440999|38954472|FG000|Overall Study|Mixed infection at entry|1|||
16127796|NCT00440999|38954473|FG001|Overall Study|Mixed infection at entry|0|||
16244368|NCT04335110|39377985|FG001|Overall Study|Death|1|||
16244369|NCT01612156|39377986|FG000|Overall Study|Protocol Violation|2|||
16244370|NCT01612156|39377987|FG001|Overall Study|Protocol Violation|0|||
16244371|NCT01859390|39377988|FG000|Overall Study|Insufficient Sputum Collected|1|||
16244372|NCT01859390|39377989|FG001|Overall Study|Insufficient Sputum Collected|3|||
16244373|NCT01859390|39377988|FG000|Overall Study|Sample Missing Collection Date|0|||
16244374|NCT01859390|39377989|FG001|Overall Study|Sample Missing Collection Date|1|||
16127797|NCT00440999|38954472|FG000|Overall Study|P. falciparum malaria|5|||
16244375|NCT01859390|39377988|FG000|Overall Study|Tube Cracked|0|||
16244376|NCT01859390|39377989|FG001|Overall Study|Tube Cracked|2|||
16244377|NCT01859390|39377988|FG000|Overall Study|Shipment Error|0|||
16244378|NCT01859390|39377989|FG001|Overall Study|Shipment Error|1|||
16244379|NCT02437890|39377993|FG000|Overall Study|Non-compliance to study drug|0|||
16244380|NCT02437890|39377994|FG001|Overall Study|Non-compliance to study drug|1|||
16244381|NCT02437890|39377995|FG002|Overall Study|Non-compliance to study drug|0|||
16244382|NCT02437890|39377996|FG003|Overall Study|Non-compliance to study drug|0|||
16244383|NCT02437890|39377997|FG004|Overall Study|Non-compliance to study drug|1|||
16244384|NCT02437890|39377993|FG000|Overall Study|Sponsor's decision|1|||
16244385|NCT02437890|39377994|FG001|Overall Study|Sponsor's decision|1|||
16244386|NCT02437890|39377995|FG002|Overall Study|Sponsor's decision|4|||
16244387|NCT02437890|39377996|FG003|Overall Study|Sponsor's decision|0|||
16244388|NCT02437890|39377997|FG004|Overall Study|Sponsor's decision|2|||
16244389|NCT02437890|39377993|FG000|Overall Study|Physician Decision|0|||
16244390|NCT02437890|39377994|FG001|Overall Study|Physician Decision|0|||
16244391|NCT02437890|39377995|FG002|Overall Study|Physician Decision|0|||
16244392|NCT02437890|39377996|FG003|Overall Study|Physician Decision|1|||
16244393|NCT02437890|39377997|FG004|Overall Study|Physician Decision|0|||
16244394|NCT02437890|39377993|FG000|Overall Study|Unable to attend visit(s)|1|||
16244395|NCT02437890|39377994|FG001|Overall Study|Unable to attend visit(s)|0|||
16244396|NCT02437890|39377995|FG002|Overall Study|Unable to attend visit(s)|0|||
16244397|NCT02437890|39377996|FG003|Overall Study|Unable to attend visit(s)|0|||
16244398|NCT02437890|39377997|FG004|Overall Study|Unable to attend visit(s)|0|||
16244399|NCT02437890|39377993|FG000|Overall Study|Lack of Efficacy|1|||
16244400|NCT02437890|39377994|FG001|Overall Study|Lack of Efficacy|3|||
16244401|NCT02437890|39377995|FG002|Overall Study|Lack of Efficacy|0|||
16244402|NCT02437890|39377996|FG003|Overall Study|Lack of Efficacy|3|||
16244403|NCT02437890|39377997|FG004|Overall Study|Lack of Efficacy|1|||
16244404|NCT02437890|39377993|FG000|Overall Study|Adverse Event|4|||
16244405|NCT02437890|39377994|FG001|Overall Study|Adverse Event|9|||
16244406|NCT02437890|39377995|FG002|Overall Study|Adverse Event|5|||
16244407|NCT02437890|39377996|FG003|Overall Study|Adverse Event|11|||
16244408|NCT02437890|39377997|FG004|Overall Study|Adverse Event|7|||
16244409|NCT02437890|39377993|FG000|Overall Study|Withdrawal by Subject|1|||
16244410|NCT02437890|39377994|FG001|Overall Study|Withdrawal by Subject|2|||
16244411|NCT02437890|39377995|FG002|Overall Study|Withdrawal by Subject|6|||
16244412|NCT02437890|39377996|FG003|Overall Study|Withdrawal by Subject|5|||
16244413|NCT02437890|39377997|FG004|Overall Study|Withdrawal by Subject|5|||
16244414|NCT02437890|39377993|FG000|Overall Study|Death|0|||
16244415|NCT02437890|39377994|FG001|Overall Study|Death|0|||
16244416|NCT02437890|39377995|FG002|Overall Study|Death|0|||
16244417|NCT02437890|39377996|FG003|Overall Study|Death|2|||
16244418|NCT02437890|39377997|FG004|Overall Study|Death|0|||
16244419|NCT01084005|39377999|FG000|Overall Study|Adverse Event|1|||
16244420|NCT01084005|39378000|FG001|Overall Study|Adverse Event|8|||
16244421|NCT01084005|39377999|FG000|Overall Study|Protocol Violation|3|||
16244422|NCT01084005|39378000|FG001|Overall Study|Protocol Violation|7|||
16244423|NCT01084005|39377999|FG000|Overall Study|Withdrawal by Subject|1|||
16244424|NCT01084005|39378000|FG001|Overall Study|Withdrawal by Subject|1|||
16244425|NCT04448561|39378005|FG000|Overall Study|Noncompliance|1|||
16244426|NCT04448561|39378006|FG001|Overall Study|Noncompliance|0|||
16244427|NCT00863057|39378007|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
16244428|NCT00863057|39378008|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
16244429|NCT00863057|39378009|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
16244430|NCT00863057|39378010|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
16244431|NCT00863057|39378007|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
16244432|NCT00863057|39378008|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
16244433|NCT00863057|39378009|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
16244434|NCT00863057|39378010|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
16244435|NCT00863057|39378007|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
16244436|NCT00863057|39378008|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
16244437|NCT00863057|39378009|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
16244438|NCT00863057|39378010|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
16244439|NCT00863057|39378007|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
16244440|NCT00863057|39378008|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
16244441|NCT00863057|39378009|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
16244442|NCT00863057|39378010|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
16244443|NCT03083132|39378016|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
16244444|NCT03083132|39378017|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
16244445|NCT03083132|39378016|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
16244446|NCT03083132|39378017|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
16244447|NCT03083132|39378016|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
16244448|NCT03083132|39378017|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
16244449|NCT00772577|39378018|FG000|Overall Study|Adverse Event|6|||
16244450|NCT00772577|39378019|FG001|Overall Study|Adverse Event|3|||
16244451|NCT00772577|39378018|FG000|Overall Study|Abnormal laboratory values|0|||
16244452|NCT00772577|39378019|FG001|Overall Study|Abnormal laboratory values|1|||
16244453|NCT00772577|39378018|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16244454|NCT00772577|39378019|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
16244455|NCT00772577|39378018|FG000|Overall Study|Patient withdrew consent|8|||
16244456|NCT00772577|39378019|FG001|Overall Study|Patient withdrew consent|5|||
16244457|NCT00772577|39378018|FG000|Overall Study|Lost to Follow-up|4|||
16244458|NCT00772577|39378019|FG001|Overall Study|Lost to Follow-up|3|||
16244459|NCT00772577|39378018|FG000|Overall Study|Administrative problems|2|||
16244460|NCT00772577|39378019|FG001|Overall Study|Administrative problems|1|||
16244461|NCT00772577|39378018|FG000|Overall Study|Protocol Deviation|3|||
16244462|NCT00772577|39378019|FG001|Overall Study|Protocol Deviation|2|||
16244463|NCT01200394|39378027|FG000|Overall Study|Adverse Event|0|||
16244464|NCT01200394|39378028|FG001|Overall Study|Adverse Event|14|||
16244465|NCT01200394|39378027|FG000|Overall Study|Death|1|||
16244466|NCT01200394|39378028|FG001|Overall Study|Death|0|||
16244467|NCT01200394|39378027|FG000|Overall Study|Lost to Follow-up|0|||
16244468|NCT01200394|39378028|FG001|Overall Study|Lost to Follow-up|1|||
16244469|NCT01200394|39378027|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
16244470|NCT01200394|39378028|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
16244471|NCT01200394|39378027|FG000|Overall Study|Protocol Violation|0|||
16244472|NCT01200394|39378028|FG001|Overall Study|Protocol Violation|3|||
16244473|NCT01200394|39378027|FG000|Overall Study|Withdrawal by Subject|0|||
16244474|NCT01200394|39378028|FG001|Overall Study|Withdrawal by Subject|5|||
16244475|NCT01200394|39378027|FG000|Overall Study|Other|0|||
16244476|NCT01200394|39378028|FG001|Overall Study|Other|1|||
16244477|NCT03493698|39378029|FG000|Treatment Period C|Adverse Event|1|||
16244478|NCT03493698|39378029|FG000|Treatment Period C|Withdrawal by Subject|1|||
16244479|NCT01637961|39378034|FG000|Overall Study|Ineligible: wrong primary|1|||
16244480|NCT01637961|39378034|FG000|Overall Study|Ineligible: inadequate pathology|1|||
16244481|NCT01155583|39378040|FG000|Phase I|Screen failure - did not start treatment|0|||
16244482|NCT01155583|39378041|FG001|Phase I|Screen failure - did not start treatment|0|||
16244483|NCT01155583|39378042|FG002|Phase I|Screen failure - did not start treatment|0|||
16244484|NCT01155583|39378043|FG003|Phase I|Screen failure - did not start treatment|0|||
16244485|NCT01155583|39378044|FG004|Phase I|Screen failure - did not start treatment|1|||
16244486|NCT01155583|39378045|FG005|Phase I|Screen failure - did not start treatment|0|||
16244487|NCT01155583|39378046|FG006|Phase I|Screen failure - did not start treatment|0|||
16244488|NCT01155583|39378047|FG007|Phase I|Screen failure - did not start treatment|2|||
16244489|NCT01155583|39378048|FG008|Phase I|Screen failure - did not start treatment|0|||
16244490|NCT01155583|39378040|FG000|Phase I|Withdrawal by Subject|0|||
16351558|NCT02662569|39773054|FG002|Overall Study|Withdrawal by Subject|6|||
16351559|NCT02662569|39773055|FG003|Overall Study|Withdrawal by Subject|4|||
16351560|NCT02662569|39773052|FG000|Overall Study|Lost to Follow-up|1|||
16351561|NCT02662569|39773053|FG001|Overall Study|Lost to Follow-up|0|||
16351562|NCT02662569|39773054|FG002|Overall Study|Lost to Follow-up|0|||
16351563|NCT02662569|39773055|FG003|Overall Study|Lost to Follow-up|0|||
16351564|NCT00901342|39773057|FG000|Overall Study|Adverse Event|1|||
16351565|NCT00901342|39773057|FG000|Overall Study|Death|4|||
16351566|NCT00901342|39773057|FG000|Overall Study|Disease progression|1|||
16351567|NCT00901342|39773057|FG000|Overall Study|Withdrawal by Subject|9|||
16351568|NCT01841970|39773058|FG000|Overall Study|Withdrawal by Subject|1|||
16351569|NCT01841970|39773058|FG000|Overall Study|Physician Decision|2|||
16351570|NCT01841970|39773058|FG000|Overall Study|Lost to Follow-up|8|||
16351571|NCT03713684|39773059|FG000|Overall Study|Adverse Event|1|||
16351572|NCT03713684|39773060|FG001|Overall Study|Adverse Event|3|||
16351573|NCT03713684|39773061|FG002|Overall Study|Adverse Event|1|||
16351574|NCT03713684|39773062|FG003|Overall Study|Adverse Event|0|||
16351575|NCT03713684|39773059|FG000|Overall Study|Poor compliance to protocol|2|||
16351576|NCT03713684|39773060|FG001|Overall Study|Poor compliance to protocol|1|||
16351577|NCT03713684|39773061|FG002|Overall Study|Poor compliance to protocol|0|||
16351578|NCT03713684|39773062|FG003|Overall Study|Poor compliance to protocol|1|||
16351579|NCT03713684|39773059|FG000|Overall Study|Withdrawal by Subject|14|||
16351580|NCT03713684|39773060|FG001|Overall Study|Withdrawal by Subject|6|||
16351581|NCT03713684|39773061|FG002|Overall Study|Withdrawal by Subject|14|||
16351582|NCT03713684|39773062|FG003|Overall Study|Withdrawal by Subject|16|||
16351583|NCT03713684|39773059|FG000|Overall Study|Other than specified|69|||
16244491|NCT01155583|39378041|FG001|Phase I|Withdrawal by Subject|0|||
16244492|NCT01155583|39378042|FG002|Phase I|Withdrawal by Subject|0|||
16244493|NCT01155583|39378043|FG003|Phase I|Withdrawal by Subject|0|||
16351584|NCT03713684|39773060|FG001|Overall Study|Other than specified|77|||
16351585|NCT03713684|39773061|FG002|Overall Study|Other than specified|73|||
16351586|NCT03713684|39773062|FG003|Overall Study|Other than specified|70|||
16351587|NCT02762084|39773063|FG000|Overall Study|Withdrawal by Subject|1|||
16351588|NCT02762084|39773064|FG001|Overall Study|Withdrawal by Subject|0|||
16351589|NCT02762084|39773065|FG002|Overall Study|Withdrawal by Subject|0|||
16351590|NCT02762084|39773063|FG000|Overall Study|Adverse Event|0|||
16351591|NCT02762084|39773064|FG001|Overall Study|Adverse Event|0|||
16351592|NCT02762084|39773065|FG002|Overall Study|Adverse Event|1|||
16351593|NCT00483652|39773066|FG000|Double-blind Treatment Period|Protocol Violation|2|||
16244494|NCT01155583|39378044|FG004|Phase I|Withdrawal by Subject|0|||
16244495|NCT01155583|39378045|FG005|Phase I|Withdrawal by Subject|0|||
16244496|NCT01155583|39378046|FG006|Phase I|Withdrawal by Subject|0|||
16244497|NCT01155583|39378047|FG007|Phase I|Withdrawal by Subject|1|||
16244498|NCT01155583|39378048|FG008|Phase I|Withdrawal by Subject|0|||
16244499|NCT00626925|39378050|FG000|Overall Study|Lost to Follow-up|1|||
16244500|NCT00626925|39378051|FG001|Overall Study|Lost to Follow-up|2|||
16244501|NCT00626925|39378050|FG000|Overall Study|relapse|1|||
16244502|NCT00626925|39378051|FG001|Overall Study|relapse|0|||
16244503|NCT00626925|39378050|FG000|Overall Study|Adverse effect|6|||
16244504|NCT00626925|39378051|FG001|Overall Study|Adverse effect|2|||
16244505|NCT00626925|39378050|FG000|Overall Study|Lack of Efficacy|1|||
16244506|NCT00626925|39378051|FG001|Overall Study|Lack of Efficacy|4|||
16244507|NCT00626925|39378050|FG000|Overall Study|Time constraints|3|||
16244508|NCT00626925|39378051|FG001|Overall Study|Time constraints|1|||
16244509|NCT01862328|39378052|FG000|Overall Study|Progressive Disease|3|||
16244510|NCT01862328|39378053|FG001|Overall Study|Progressive Disease|11|||
16244511|NCT01862328|39378054|FG002|Overall Study|Progressive Disease|5|||
16244512|NCT01862328|39378055|FG003|Overall Study|Progressive Disease|6|||
16244513|NCT01862328|39378056|FG004|Overall Study|Progressive Disease|7|||
16244514|NCT01862328|39378057|FG005|Overall Study|Progressive Disease|4|||
16244515|NCT01862328|39378058|FG006|Overall Study|Progressive Disease|3|||
16244516|NCT01862328|39378052|FG000|Overall Study|Adverse Event|0|||
16244517|NCT01862328|39378053|FG001|Overall Study|Adverse Event|4|||
16244518|NCT01862328|39378054|FG002|Overall Study|Adverse Event|0|||
16244519|NCT01862328|39378055|FG003|Overall Study|Adverse Event|1|||
16244520|NCT01862328|39378056|FG004|Overall Study|Adverse Event|0|||
16244521|NCT01862328|39378057|FG005|Overall Study|Adverse Event|2|||
16244522|NCT01862328|39378058|FG006|Overall Study|Adverse Event|4|||
16244523|NCT01862328|39378052|FG000|Overall Study|Other|0|||
16244524|NCT01862328|39378053|FG001|Overall Study|Other|2|||
16244525|NCT01862328|39378054|FG002|Overall Study|Other|1|||
16244526|NCT01862328|39378055|FG003|Overall Study|Other|0|||
16244527|NCT01862328|39378056|FG004|Overall Study|Other|4|||
16244528|NCT01862328|39378057|FG005|Overall Study|Other|0|||
16244529|NCT01862328|39378058|FG006|Overall Study|Other|1|||
16244530|NCT01862328|39378052|FG000|Overall Study|Withdrawal by Subject|1|||
16244531|NCT01862328|39378053|FG001|Overall Study|Withdrawal by Subject|1|||
16127798|NCT00440999|38954473|FG001|Overall Study|P. falciparum malaria|14|||
16127799|NCT00440999|38954472|FG000|Overall Study|Subj left hosp without inform staff|0|||
16127800|NCT00440999|38954473|FG001|Overall Study|Subj left hosp without inform staff|1|||
16127801|NCT00700427|38954474|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
16127802|NCT00700427|38954475|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
16127803|NCT00700427|38954476|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
16127804|NCT00700427|38954477|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
16127805|NCT00700427|38954478|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
16127806|NCT00700427|38954474|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
16244532|NCT01862328|39378054|FG002|Overall Study|Withdrawal by Subject|0|||
16244533|NCT01862328|39378055|FG003|Overall Study|Withdrawal by Subject|0|||
16244534|NCT01862328|39378056|FG004|Overall Study|Withdrawal by Subject|1|||
16351594|NCT00483652|39773067|FG001|Double-blind Treatment Period|Protocol Violation|1|||
16351595|NCT00483652|39773066|FG000|Double-blind Treatment Period|Adverse Event|3|||
16351596|NCT00483652|39773067|FG001|Double-blind Treatment Period|Adverse Event|4|||
16351597|NCT00483652|39773066|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
16351598|NCT00483652|39773067|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
16351599|NCT00483652|39773066|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
16351600|NCT00483652|39773067|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
16351601|NCT00970489|39773070|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
16416006|NCT04268173|40004617|FG001|Overall Study|Lost to Follow-up|108|||
16127807|NCT00700427|38954475|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
16244535|NCT01862328|39378057|FG005|Overall Study|Withdrawal by Subject|1|||
16244536|NCT01862328|39378058|FG006|Overall Study|Withdrawal by Subject|1|||
16244537|NCT01862328|39378052|FG000|Overall Study|Symptomatic Deterioration|0|||
16244538|NCT01862328|39378053|FG001|Overall Study|Symptomatic Deterioration|0|||
16244539|NCT01862328|39378054|FG002|Overall Study|Symptomatic Deterioration|0|||
16244540|NCT01862328|39378055|FG003|Overall Study|Symptomatic Deterioration|0|||
16244541|NCT01862328|39378056|FG004|Overall Study|Symptomatic Deterioration|0|||
16244542|NCT01862328|39378057|FG005|Overall Study|Symptomatic Deterioration|0|||
16244543|NCT01862328|39378058|FG006|Overall Study|Symptomatic Deterioration|1|||
16244544|NCT03196791|39381332|FG000|Overall Study|Protocol Violation|7|||
16244545|NCT03196791|39381333|FG001|Overall Study|Protocol Violation|3|||
16244546|NCT03196791|39381332|FG000|Overall Study|Withdrawal by Subject|3|||
16244547|NCT03196791|39381333|FG001|Overall Study|Withdrawal by Subject|2|||
16244548|NCT01814761|39381334|FG000|Overall Study|Other Reasons|1|||
16351602|NCT00970489|39773071|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
16351603|NCT03131167|39773072|FG000|Overall Study|Other (Unspecified)|0|||
16351604|NCT03131167|39773073|FG001|Overall Study|Other (Unspecified)|0|||
16351605|NCT03131167|39773074|FG002|Overall Study|Other (Unspecified)|0|||
16351606|NCT03131167|39773075|FG003|Overall Study|Other (Unspecified)|0|||
16351607|NCT03131167|39773076|FG004|Overall Study|Other (Unspecified)|0|||
16351608|NCT03131167|39773077|FG005|Overall Study|Other (Unspecified)|1|||
16351609|NCT03131167|39773078|FG006|Overall Study|Other (Unspecified)|0|||
16351610|NCT03131167|39773079|FG007|Overall Study|Other (Unspecified)|0|||
16351611|NCT03131167|39773080|FG008|Overall Study|Other (Unspecified)|0|||
16351612|NCT03131167|39773081|FG009|Overall Study|Other (Unspecified)|0|||
16351613|NCT03131167|39773082|FG010|Overall Study|Other (Unspecified)|0|||
16416007|NCT02658656|40004620|FG000|Screening|Failed eligibility criteria|0|||
16416008|NCT02658656|40004621|FG001|Screening|Failed eligibility criteria|0|||
16416009|NCT02658656|40004622|FG002|Screening|Failed eligibility criteria|263|||
16351614|NCT03131167|39773083|FG011|Overall Study|Other (Unspecified)|0|||
16351615|NCT03131167|39773084|FG012|Overall Study|Other (Unspecified)|0|||
16351616|NCT01468454|39776446|FG000|Overall Study|Did not have surgery after PET|9|||
16351617|NCT00297167|39776448|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
16351618|NCT00297167|39776449|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
16351619|NCT00297167|39776450|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
16351620|NCT00297167|39776448|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
16351621|NCT00297167|39776449|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
16351622|NCT00297167|39776450|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
16351623|NCT03299101|39776453|FG000|Overall Study|Lost to Follow-up|1|||
16351624|NCT03299101|39776453|FG000|Overall Study|Withdrawal by Subject|5|||
16351625|NCT03299101|39776453|FG000|Overall Study|Surgery was changed|3|||
16351626|NCT03299101|39776453|FG000|Overall Study|Not enough time to complete prehab|1|||
16351627|NCT02021292|39776454|FG000|Overall Study|Physician Decision|0|||
16351628|NCT02021292|39776455|FG001|Overall Study|Physician Decision|1|||
16351629|NCT02021292|39776454|FG000|Overall Study|Lost to Follow-up|0|||
16351630|NCT02021292|39776455|FG001|Overall Study|Lost to Follow-up|1|||
16351631|NCT02021292|39776454|FG000|Overall Study|Death|0|||
16351632|NCT02021292|39776455|FG001|Overall Study|Death|1|||
16351633|NCT03118518|39776456|FG000|Overall Study|Early Exit after treatment|2|||
16351634|NCT03118518|39776457|FG001|Overall Study|Early Exit after treatment|8|||
16351635|NCT03118518|39776456|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
16351636|NCT03118518|39776457|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
16351637|NCT01896193|39776462|FG000|Overall Study|Lack of Efficacy|20|||
16351638|NCT01896193|39776463|FG001|Overall Study|Lack of Efficacy|11|||
16351639|NCT01896193|39776462|FG000|Overall Study|Protocol Violation|0|||
16351640|NCT01896193|39776463|FG001|Overall Study|Protocol Violation|1|||
16351641|NCT01896193|39776462|FG000|Overall Study|Withdrew Consent|1|||
16351642|NCT01896193|39776463|FG001|Overall Study|Withdrew Consent|0|||
16351643|NCT03902613|39776464|FG000|Overall Study|Physician Decision|1|||
16351644|NCT02329847|39776469|FG000|Overall Study|Death|4|||
16351645|NCT02329847|39776470|FG001|Overall Study|Death|4|||
16351646|NCT02329847|39776471|FG002|Overall Study|Death|22|||
16351647|NCT02329847|39776472|FG003|Overall Study|Death|12|||
16351648|NCT02329847|39776473|FG004|Overall Study|Death|20|||
16351649|NCT02329847|39776474|FG005|Overall Study|Death|13|||
16351650|NCT02329847|39776469|FG000|Overall Study|Lost to Follow-up|0|||
16351651|NCT02329847|39776470|FG001|Overall Study|Lost to Follow-up|0|||
16351652|NCT02329847|39776471|FG002|Overall Study|Lost to Follow-up|2|||
16351653|NCT02329847|39776472|FG003|Overall Study|Lost to Follow-up|3|||
16351654|NCT02329847|39776473|FG004|Overall Study|Lost to Follow-up|0|||
16351655|NCT02329847|39776474|FG005|Overall Study|Lost to Follow-up|1|||
16351656|NCT02329847|39776469|FG000|Overall Study|Physician Decision|0|||
16351657|NCT02329847|39776470|FG001|Overall Study|Physician Decision|0|||
16351658|NCT02329847|39776471|FG002|Overall Study|Physician Decision|0|||
16351659|NCT02329847|39776472|FG003|Overall Study|Physician Decision|0|||
16351660|NCT02329847|39776473|FG004|Overall Study|Physician Decision|1|||
16351661|NCT02329847|39776474|FG005|Overall Study|Physician Decision|0|||
16351662|NCT02329847|39776469|FG000|Overall Study|Withdrawal by Subject|2|||
16351663|NCT02329847|39776470|FG001|Overall Study|Withdrawal by Subject|1|||
16351664|NCT02329847|39776471|FG002|Overall Study|Withdrawal by Subject|5|||
16351665|NCT02329847|39776472|FG003|Overall Study|Withdrawal by Subject|7|||
16351666|NCT02329847|39776473|FG004|Overall Study|Withdrawal by Subject|8|||
16416010|NCT02658656|40004620|FG000|Randomization|Withdrawal by Subject|8|||
16351667|NCT02329847|39776474|FG005|Overall Study|Withdrawal by Subject|3|||
16351668|NCT02329847|39776469|FG000|Overall Study|Other|1|||
16351669|NCT02329847|39776470|FG001|Overall Study|Other|2|||
16416011|NCT02658656|40004621|FG001|Randomization|Withdrawal by Subject|7|||
16351670|NCT02329847|39776471|FG002|Overall Study|Other|6|||
16351671|NCT02329847|39776472|FG003|Overall Study|Other|13|||
16351672|NCT02329847|39776473|FG004|Overall Study|Other|10|||
16351673|NCT02329847|39776474|FG005|Overall Study|Other|3|||
16351674|NCT00971867|39776475|FG000|Overall Study|Adverse Event|4|||
16351675|NCT00971867|39776475|FG000|Overall Study|Participant Withdrew Consent|1|||
16351676|NCT00971867|39776475|FG000|Overall Study|Disease Progression|6|||
16351677|NCT01687218|39776485|FG000|Overall Study|Withdrawal by Subject|2|||
16351678|NCT01687218|39776486|FG001|Overall Study|Withdrawal by Subject|3|||
16351679|NCT01687218|39776487|FG002|Overall Study|Withdrawal by Subject|0|||
16351680|NCT01687218|39776488|FG003|Overall Study|Withdrawal by Subject|1|||
16351681|NCT01687218|39776489|FG004|Overall Study|Withdrawal by Subject|1|||
16351682|NCT01687218|39776490|FG005|Overall Study|Withdrawal by Subject|0|||
16351683|NCT01687218|39776485|FG000|Overall Study|Relocated, no follow-up planned|1|||
16351684|NCT01687218|39776486|FG001|Overall Study|Relocated, no follow-up planned|0|||
16351685|NCT01687218|39776487|FG002|Overall Study|Relocated, no follow-up planned|1|||
16351686|NCT01687218|39776488|FG003|Overall Study|Relocated, no follow-up planned|1|||
16351687|NCT01687218|39776489|FG004|Overall Study|Relocated, no follow-up planned|0|||
16351688|NCT01687218|39776490|FG005|Overall Study|Relocated, no follow-up planned|0|||
16351689|NCT01064479|39776492|FG000|Overall Study|Death|10|||
16351690|NCT01064479|39776493|FG001|Overall Study|Death|11|||
16351691|NCT01064479|39776492|FG000|Overall Study|Withdrawal by Subject|2|||
16351692|NCT01064479|39776493|FG001|Overall Study|Withdrawal by Subject|2|||
16351693|NCT01064479|39776492|FG000|Overall Study|Disease progression|1|||
16351694|NCT01064479|39776493|FG001|Overall Study|Disease progression|1|||
16351695|NCT01064479|39776492|FG000|Overall Study|Toxicity|1|||
16351696|NCT01064479|39776493|FG001|Overall Study|Toxicity|1|||
16351697|NCT01064479|39776492|FG000|Overall Study|Other|1|||
16351698|NCT01064479|39776493|FG001|Overall Study|Other|2|||
16351699|NCT01663402|39776494|FG000|Overall Study|Randomized but not treated|19|||
16351700|NCT01663402|39776495|FG001|Overall Study|Randomized but not treated|11|||
16351701|NCT01663402|39776494|FG000|Overall Study|Adverse Event|347|||
16351702|NCT01663402|39776495|FG001|Overall Study|Adverse Event|362|||
16351703|NCT01663402|39776494|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
16351704|NCT01663402|39776495|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
16351705|NCT01663402|39776494|FG000|Overall Study|Poor compliance to protocol|529|||
16351706|NCT01663402|39776495|FG001|Overall Study|Poor compliance to protocol|454|||
16351707|NCT01663402|39776494|FG000|Overall Study|Physician Decision|77|||
16351708|NCT01663402|39776495|FG001|Overall Study|Physician Decision|62|||
16351709|NCT01663402|39776494|FG000|Overall Study|Site terminated by sponsor|1|||
16351710|NCT01663402|39776495|FG001|Overall Study|Site terminated by sponsor|3|||
16351711|NCT01663402|39776494|FG000|Overall Study|Participant moved|139|||
16351712|NCT01663402|39776495|FG001|Overall Study|Participant moved|104|||
16351713|NCT01663402|39776494|FG000|Overall Study|Withdrawal by Subject|118|||
16351714|NCT01663402|39776495|FG001|Overall Study|Withdrawal by Subject|91|||
16351715|NCT01663402|39776494|FG000|Overall Study|Related to study drug administration|96|||
16351716|NCT01663402|39776495|FG001|Overall Study|Related to study drug administration|105|||
16351717|NCT01663402|39776494|FG000|Overall Study|Lost to Follow-up|17|||
16351718|NCT01663402|39776495|FG001|Overall Study|Lost to Follow-up|15|||
16351719|NCT01663402|39776494|FG000|Overall Study|Other than specified above|172|||
16351720|NCT01663402|39776495|FG001|Overall Study|Other than specified above|147|||
16416012|NCT02658656|40004622|FG002|Randomization|Withdrawal by Subject|0|||
16416013|NCT02658656|40004620|FG000|Randomization|Lost to Follow-up|1|||
16416014|NCT02658656|40004621|FG001|Randomization|Lost to Follow-up|3|||
16416015|NCT02658656|40004622|FG002|Randomization|Lost to Follow-up|0|||
16416016|NCT02658656|40004620|FG000|Randomization|Adverse Event|4|||
16416017|NCT02658656|40004621|FG001|Randomization|Adverse Event|0|||
16416018|NCT02658656|40004622|FG002|Randomization|Adverse Event|0|||
16416019|NCT02658656|40004620|FG000|Randomization|Administrative Termination|3|||
16416020|NCT02658656|40004621|FG001|Randomization|Administrative Termination|1|||
16416021|NCT02658656|40004622|FG002|Randomization|Administrative Termination|0|||
16416022|NCT02658656|40004620|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
16416023|NCT02658656|40004621|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
16416024|NCT02658656|40004622|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
16416025|NCT02658656|40004620|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
16416026|NCT02658656|40004621|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
16416027|NCT02658656|40004622|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
16416028|NCT02658656|40004620|FG000|Randomization|Not eligible for Randomization|1|||
16351721|NCT00447772|39776496|FG000|Overall Study|Lack of Efficacy|3|||
16351722|NCT00447772|39776496|FG000|Overall Study|Insufficient compliance|6|||
16351723|NCT00447772|39776496|FG000|Overall Study|Discontinuation of drug therapy|1|||
16351724|NCT00447772|39776496|FG000|Overall Study|Lost to Follow-up|9|||
16351725|NCT00447772|39776496|FG000|Overall Study|Withdrawal by Subject|1|||
16351726|NCT00447772|39776496|FG000|Overall Study|Unable to attend all study visits|2|||
16351727|NCT00447772|39776496|FG000|Overall Study|Adverse Event|1|||
16351728|NCT00447772|39776496|FG000|Overall Study|Patient relocated|1|||
16351729|NCT00447772|39776496|FG000|Overall Study|Incomplete documentation at visit 1|1|||
16351730|NCT00447772|39776496|FG000|Overall Study|Chemotherapy for lung cancer|1|||
16127808|NCT00700427|38954476|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
16127809|NCT00700427|38954477|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
16127810|NCT00700427|38954478|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
16127811|NCT00700427|38954474|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
16127812|NCT00700427|38954475|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
16127813|NCT00700427|38954476|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
16127814|NCT00700427|38954477|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
16127815|NCT00700427|38954478|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
16127816|NCT00700427|38954474|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
16127817|NCT00700427|38954475|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
16127818|NCT00700427|38954476|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
16127819|NCT00700427|38954477|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
16127820|NCT00700427|38954478|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
16127821|NCT00700427|38954474|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
16127822|NCT00700427|38954475|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
16127823|NCT00700427|38954476|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
16127824|NCT00700427|38954477|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
16127825|NCT00700427|38954478|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
16127826|NCT00700427|38954474|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
16127827|NCT00700427|38954475|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
16127828|NCT00700427|38954476|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
16127829|NCT00700427|38954477|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
16351731|NCT00447772|39776496|FG000|Overall Study|Premature re-injection required|1|||
16351732|NCT00902577|39776497|FG000|Overall Study|Withdrawal by Subject|6|||
16559217|NCT02291289|40513363|FG004|Induction Treatment|Physician Decision|0|||
16559218|NCT02291289|40513364|FG005|Induction Treatment|Physician Decision|0|||
16559219|NCT02291289|40513365|FG006|Induction Treatment|Physician Decision|0|||
16559220|NCT02291289|40513366|FG007|Induction Treatment|Physician Decision|0|||
16559221|NCT02291289|40513367|FG008|Induction Treatment|Physician Decision|0|||
16559222|NCT02291289|40513368|FG009|Induction Treatment|Physician Decision|1|||
16559223|NCT02291289|40513369|FG010|Induction Treatment|Physician Decision|0|||
16559224|NCT02291289|40513370|FG011|Induction Treatment|Physician Decision|0|||
16559225|NCT02291289|40513371|FG012|Induction Treatment|Physician Decision|0|||
16559226|NCT02291289|40513359|FG000|Induction Treatment|Protocol Violation|0|||
16559227|NCT02291289|40513360|FG001|Induction Treatment|Protocol Violation|0|||
16559228|NCT02291289|40513361|FG002|Induction Treatment|Protocol Violation|0|||
16559229|NCT02291289|40513362|FG003|Induction Treatment|Protocol Violation|3|||
16559230|NCT02291289|40513363|FG004|Induction Treatment|Protocol Violation|0|||
16559231|NCT02291289|40513364|FG005|Induction Treatment|Protocol Violation|0|||
16351733|NCT00902577|39776497|FG000|Overall Study|FMISO production failure|2|||
16351734|NCT00780975|39776498|FG000|Overall Study|Progressive disease|3|||
16351735|NCT00780975|39776498|FG000|Overall Study|Toxicity|5|||
16351736|NCT03410992|39776499|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
16351737|NCT03410992|39776500|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
16416029|NCT02658656|40004621|FG001|Randomization|Not eligible for Randomization|0|||
16416030|NCT02658656|40004622|FG002|Randomization|Not eligible for Randomization|0|||
16416031|NCT02658656|40004620|FG000|Randomization|Protocol Violation|1|||
16416032|NCT02658656|40004621|FG001|Randomization|Protocol Violation|0|||
16416033|NCT02658656|40004622|FG002|Randomization|Protocol Violation|0|||
16416034|NCT01805037|40004624|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
16416035|NCT01805037|40004625|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
16416036|NCT01805037|40004624|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
16416037|NCT01805037|40004625|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
16416038|NCT01805037|40004624|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
16559232|NCT02291289|40513365|FG006|Induction Treatment|Protocol Violation|0|||
16559233|NCT02291289|40513366|FG007|Induction Treatment|Protocol Violation|0|||
16559234|NCT02291289|40513367|FG008|Induction Treatment|Protocol Violation|0|||
16559235|NCT02291289|40513368|FG009|Induction Treatment|Protocol Violation|2|||
16559236|NCT02291289|40513369|FG010|Induction Treatment|Protocol Violation|0|||
16559237|NCT02291289|40513370|FG011|Induction Treatment|Protocol Violation|0|||
16559238|NCT02291289|40513371|FG012|Induction Treatment|Protocol Violation|0|||
16559239|NCT02291289|40513359|FG000|Induction Treatment|Missing|4|||
16127830|NCT00700427|38954478|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
16127831|NCT00700427|38954474|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
16127832|NCT00700427|38954475|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
16127833|NCT00700427|38954476|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
16127834|NCT00700427|38954477|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
16127835|NCT00700427|38954478|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
16351738|NCT03410992|39776501|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
16351739|NCT03410992|39776502|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
16559240|NCT02291289|40513360|FG001|Induction Treatment|Missing|0|||
16559241|NCT02291289|40513361|FG002|Induction Treatment|Missing|0|||
16559242|NCT02291289|40513362|FG003|Induction Treatment|Missing|14|||
16559243|NCT02291289|40513363|FG004|Induction Treatment|Missing|0|||
16559244|NCT02291289|40513364|FG005|Induction Treatment|Missing|0|||
16559245|NCT02291289|40513365|FG006|Induction Treatment|Missing|0|||
16559246|NCT02291289|40513366|FG007|Induction Treatment|Missing|0|||
16559247|NCT02291289|40513367|FG008|Induction Treatment|Missing|0|||
16559248|NCT02291289|40513368|FG009|Induction Treatment|Missing|54|||
16559249|NCT02291289|40513369|FG010|Induction Treatment|Missing|0|||
16559250|NCT02291289|40513370|FG011|Induction Treatment|Missing|0|||
16559251|NCT02291289|40513371|FG012|Induction Treatment|Missing|0|||
16127836|NCT00700427|38954474|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
16351740|NCT03410992|39776503|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
16351741|NCT03410992|39776504|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
16351742|NCT03410992|39776505|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
16351743|NCT03410992|39776506|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
16351744|NCT03410992|39776507|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
16351745|NCT03410992|39776508|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
16559252|NCT02291289|40513359|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16559253|NCT02291289|40513360|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16559254|NCT02291289|40513361|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16559255|NCT02291289|40513362|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16416039|NCT01805037|40004625|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
16416040|NCT01805037|40004624|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
16416041|NCT01805037|40004625|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
16416042|NCT01805037|40004624|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
16416043|NCT01805037|40004625|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
16416044|NCT01805037|40004624|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
16127837|NCT00700427|38954475|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
16127838|NCT00700427|38954476|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
16127839|NCT00700427|38954477|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
16127840|NCT00700427|38954478|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
16127841|NCT00700427|38954474|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
16127842|NCT00700427|38954475|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
16127843|NCT00700427|38954476|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
16127844|NCT00700427|38954477|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
16127845|NCT00700427|38954478|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
16127846|NCT00700427|38954474|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
16127847|NCT00700427|38954475|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
16127848|NCT00700427|38954476|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
16127849|NCT00700427|38954477|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
16127850|NCT00700427|38954478|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
16127851|NCT00700427|38954474|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
16127852|NCT00700427|38954475|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
16127853|NCT00700427|38954476|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
16127854|NCT00700427|38954477|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
16127855|NCT00700427|38954478|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
16127856|NCT00700427|38954474|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
16127857|NCT00700427|38954475|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
16127858|NCT00700427|38954476|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
16127859|NCT00700427|38954477|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
16127860|NCT00700427|38954478|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
16127861|NCT00700427|38954474|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
16127862|NCT00700427|38954475|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
16127863|NCT00700427|38954476|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
16127864|NCT00700427|38954477|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
16127865|NCT00700427|38954478|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
16127866|NCT00700427|38954474|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
16127867|NCT00700427|38954475|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
16127868|NCT00700427|38954476|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
16127869|NCT00700427|38954477|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
16127870|NCT00700427|38954478|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
16127871|NCT00700427|38954474|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
16127872|NCT00700427|38954475|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
16127873|NCT00700427|38954476|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
16127874|NCT00700427|38954477|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
16127875|NCT00700427|38954478|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
16127876|NCT00700427|38954474|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
16127877|NCT00700427|38954475|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
16127878|NCT00700427|38954476|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
16127879|NCT00700427|38954477|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
16127880|NCT00700427|38954478|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
16127881|NCT00700427|38954474|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
16127882|NCT00700427|38954475|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
16127883|NCT00700427|38954476|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
16416045|NCT01805037|40004625|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
16559256|NCT02291289|40513363|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
16416046|NCT01805037|40004624|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
16416047|NCT01805037|40004625|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
16416048|NCT01805037|40004624|FG000|Follow Up (up to 3 Years)|Death|0|||
16127884|NCT00700427|38954477|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
16127885|NCT00700427|38954478|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
16127886|NCT00700427|38954474|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
16127887|NCT00700427|38954475|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
16127888|NCT00700427|38954476|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
16127889|NCT00700427|38954477|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
16127890|NCT00700427|38954478|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
16127891|NCT00700427|38954474|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
16416049|NCT01805037|40004625|FG001|Follow Up (up to 3 Years)|Death|2|||
16416050|NCT01805037|40004624|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
16416051|NCT01805037|40004625|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
16416052|NCT01805037|40004624|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
16416053|NCT01805037|40004625|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
16416054|NCT01306656|40004626|FG000|Overall Study|Lost to Follow-up|1|||
16416055|NCT01306656|40004627|FG001|Overall Study|Lost to Follow-up|0|||
16416056|NCT00551291|40004628|FG000|Overall Study|Physician Decision|1|||
16416057|NCT02717130|40004629|FG000|Overall Study|Withdrawal by Subject|1|||
16416058|NCT02717130|40004629|FG000|Overall Study|Adverse Event|1|||
16416059|NCT02717130|40004629|FG000|Overall Study|Physician Decision|1|||
16416060|NCT02717130|40004629|FG000|Overall Study|Study Closure|4|||
16416061|NCT01490294|40004630|FG000|Overall Study|Prematurely discontinuation|4|||
16416062|NCT01490294|40004631|FG001|Overall Study|Prematurely discontinuation|0|||
16416063|NCT01490294|40004632|FG002|Overall Study|Prematurely discontinuation|1|||
16416064|NCT01490294|40004633|FG003|Overall Study|Prematurely discontinuation|1|||
16416065|NCT01490294|40004630|FG000|Overall Study|Adverse Event|1|||
16416066|NCT01490294|40004631|FG001|Overall Study|Adverse Event|0|||
16416067|NCT01490294|40004632|FG002|Overall Study|Adverse Event|0|||
16416068|NCT01490294|40004633|FG003|Overall Study|Adverse Event|0|||
16416069|NCT03429543|40004635|FG000|Overall Study|Adverse Event|1|||
16559257|NCT02291289|40513364|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
16559258|NCT02291289|40513365|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16559259|NCT02291289|40513366|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16559260|NCT02291289|40513367|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16559261|NCT02291289|40513368|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16559262|NCT02291289|40513369|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
16559263|NCT02291289|40513370|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
16559264|NCT02291289|40513371|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16559265|NCT02291289|40513359|FG000|Maintenance Treatment Phase|Death|0|||
16559266|NCT02291289|40513360|FG001|Maintenance Treatment Phase|Death|29|||
16416070|NCT03429543|40004636|FG001|Overall Study|Adverse Event|1|||
16416071|NCT03429543|40004637|FG002|Overall Study|Adverse Event|0|||
16416072|NCT03429543|40004638|FG003|Overall Study|Adverse Event|0|||
16416073|NCT03429543|40004639|FG004|Overall Study|Adverse Event|0|||
16416074|NCT03429543|40004640|FG005|Overall Study|Adverse Event|2|||
16127892|NCT00700427|38954475|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
16127893|NCT00700427|38954476|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
16127894|NCT00700427|38954477|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
16127895|NCT00700427|38954478|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
16127896|NCT00700427|38954474|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
16127897|NCT00700427|38954475|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
16127898|NCT00700427|38954476|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
16127899|NCT00700427|38954477|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
16127900|NCT00700427|38954478|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
16127901|NCT00700427|38954474|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
16127902|NCT00700427|38954475|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
16127903|NCT00700427|38954476|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
16127904|NCT00700427|38954477|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
16127905|NCT00700427|38954478|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
16127906|NCT00700427|38954474|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
16127907|NCT00700427|38954475|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
16127908|NCT00700427|38954476|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
16127909|NCT00700427|38954477|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
16127910|NCT00700427|38954478|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
16127911|NCT00700427|38954474|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
16127912|NCT00700427|38954475|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
16127913|NCT00700427|38954476|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
16127914|NCT00700427|38954477|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
16127915|NCT00700427|38954478|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
16127916|NCT00700427|38954474|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
16127917|NCT00700427|38954475|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
16127918|NCT00700427|38954476|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
16127919|NCT00700427|38954477|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
16127920|NCT00700427|38954478|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
16127921|NCT00700427|38954474|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
16127922|NCT00700427|38954475|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
16127923|NCT00700427|38954476|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
16127924|NCT00700427|38954477|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
16127925|NCT00700427|38954478|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
16127926|NCT00700427|38954474|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
16127927|NCT00700427|38954475|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
16127928|NCT00700427|38954476|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
16127929|NCT00700427|38954477|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
16127930|NCT00700427|38954478|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
16127931|NCT00700427|38954474|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
16351746|NCT03410992|39776509|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
16351747|NCT03410992|39776499|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
16559267|NCT02291289|40513361|FG002|Maintenance Treatment Phase|Death|16|||
16559268|NCT02291289|40513362|FG003|Maintenance Treatment Phase|Death|0|||
16559269|NCT02291289|40513363|FG004|Maintenance Treatment Phase|Death|188|||
16559270|NCT02291289|40513364|FG005|Maintenance Treatment Phase|Death|107|||
16559271|NCT02291289|40513365|FG006|Maintenance Treatment Phase|Death|0|||
16559272|NCT02291289|40513366|FG007|Maintenance Treatment Phase|Death|1|||
16559273|NCT02291289|40513367|FG008|Maintenance Treatment Phase|Death|1|||
16559274|NCT02291289|40513368|FG009|Maintenance Treatment Phase|Death|0|||
16559275|NCT02291289|40513369|FG010|Maintenance Treatment Phase|Death|46|||
16559276|NCT02291289|40513370|FG011|Maintenance Treatment Phase|Death|19|||
16559277|NCT02291289|40513371|FG012|Maintenance Treatment Phase|Death|0|||
16559278|NCT02291289|40513359|FG000|Maintenance Treatment Phase|Adverse Event|0|||
16559279|NCT02291289|40513360|FG001|Maintenance Treatment Phase|Adverse Event|0|||
16559280|NCT02291289|40513361|FG002|Maintenance Treatment Phase|Adverse Event|0|||
16559281|NCT02291289|40513362|FG003|Maintenance Treatment Phase|Adverse Event|0|||
16559282|NCT02291289|40513363|FG004|Maintenance Treatment Phase|Adverse Event|1|||
16559283|NCT02291289|40513364|FG005|Maintenance Treatment Phase|Adverse Event|1|||
16559284|NCT02291289|40513365|FG006|Maintenance Treatment Phase|Adverse Event|0|||
16559285|NCT02291289|40513366|FG007|Maintenance Treatment Phase|Adverse Event|0|||
16559286|NCT02291289|40513367|FG008|Maintenance Treatment Phase|Adverse Event|0|||
16559287|NCT02291289|40513368|FG009|Maintenance Treatment Phase|Adverse Event|0|||
16559288|NCT02291289|40513369|FG010|Maintenance Treatment Phase|Adverse Event|0|||
16559289|NCT02291289|40513370|FG011|Maintenance Treatment Phase|Adverse Event|0|||
16559290|NCT02291289|40513371|FG012|Maintenance Treatment Phase|Adverse Event|0|||
16559291|NCT02291289|40513359|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
16559292|NCT02291289|40513360|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
16127932|NCT00700427|38954475|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
16127933|NCT00700427|38954476|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
16127934|NCT00700427|38954477|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
16127935|NCT00700427|38954478|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
16127936|NCT00700427|38954474|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
16127937|NCT00700427|38954475|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
16127938|NCT00700427|38954476|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
16127939|NCT00700427|38954477|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
16127940|NCT00700427|38954478|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
16127941|NCT00700427|38954474|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
16127942|NCT00700427|38954475|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
16127943|NCT00700427|38954476|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
16127944|NCT00700427|38954477|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
16127945|NCT00700427|38954478|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
16127946|NCT00700427|38954474|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
16416075|NCT03429543|40004641|FG006|Overall Study|Adverse Event|0|||
16416076|NCT03429543|40004635|FG000|Overall Study|Lost to Follow-up|1|||
16416077|NCT03429543|40004636|FG001|Overall Study|Lost to Follow-up|0|||
16416078|NCT03429543|40004637|FG002|Overall Study|Lost to Follow-up|0|||
16416079|NCT03429543|40004638|FG003|Overall Study|Lost to Follow-up|0|||
16416080|NCT03429543|40004639|FG004|Overall Study|Lost to Follow-up|1|||
16416081|NCT03429543|40004640|FG005|Overall Study|Lost to Follow-up|0|||
16416082|NCT03429543|40004641|FG006|Overall Study|Lost to Follow-up|0|||
16416083|NCT03429543|40004635|FG000|Overall Study|Withdrawal by Subject|5|||
16416084|NCT03429543|40004636|FG001|Overall Study|Withdrawal by Subject|0|||
16416085|NCT03429543|40004637|FG002|Overall Study|Withdrawal by Subject|1|||
16416086|NCT03429543|40004638|FG003|Overall Study|Withdrawal by Subject|2|||
16416087|NCT03429543|40004639|FG004|Overall Study|Withdrawal by Subject|6|||
16416088|NCT03429543|40004640|FG005|Overall Study|Withdrawal by Subject|3|||
16416089|NCT03429543|40004641|FG006|Overall Study|Withdrawal by Subject|1|||
16416090|NCT03429543|40004635|FG000|Overall Study|Other reason than listed|0|||
16416091|NCT03429543|40004636|FG001|Overall Study|Other reason than listed|1|||
16416092|NCT03429543|40004637|FG002|Overall Study|Other reason than listed|0|||
16416093|NCT03429543|40004638|FG003|Overall Study|Other reason than listed|0|||
16416094|NCT03429543|40004639|FG004|Overall Study|Other reason than listed|4|||
16416095|NCT03429543|40004640|FG005|Overall Study|Other reason than listed|4|||
16416096|NCT03429543|40004641|FG006|Overall Study|Other reason than listed|0|||
16416097|NCT03429543|40004635|FG000|Overall Study|Not treated|0|||
16244549|NCT01814761|39381335|FG001|Overall Study|Other Reasons|10|||
16416098|NCT03429543|40004636|FG001|Overall Study|Not treated|0|||
16416099|NCT03429543|40004637|FG002|Overall Study|Not treated|0|||
16416100|NCT03429543|40004638|FG003|Overall Study|Not treated|0|||
16416101|NCT03429543|40004639|FG004|Overall Study|Not treated|1|||
16416102|NCT03429543|40004640|FG005|Overall Study|Not treated|0|||
16416103|NCT03429543|40004641|FG006|Overall Study|Not treated|0|||
16416104|NCT02445573|40004642|FG000|Overall Study|Withdrawal by Subject|1|||
16416105|NCT02445573|40004643|FG001|Overall Study|Withdrawal by Subject|1|||
16416106|NCT02445573|40004642|FG000|Overall Study|Lost to Follow-up|0|||
16416107|NCT02445573|40004643|FG001|Overall Study|Lost to Follow-up|1|||
16416108|NCT03581292|40004644|FG000|Overall Study|Physician Decision|9|||
16416109|NCT03581292|40004645|FG001|Overall Study|Physician Decision|5|||
16416110|NCT03581292|40004644|FG000|Overall Study|Withdrawal by Subject|3|||
16416111|NCT03581292|40004645|FG001|Overall Study|Withdrawal by Subject|0|||
16416112|NCT03581292|40004644|FG000|Overall Study|Withdrawal before Therapy Start|1|||
16416113|NCT03581292|40004645|FG001|Overall Study|Withdrawal before Therapy Start|0|||
16416114|NCT00932165|40004646|FG000|Overall Study|Lost to Follow-up|1|||
16416115|NCT00454584|40004647|FG000|Controlled Period|Adverse Event|5|||
16416116|NCT00454584|40004648|FG001|Controlled Period|Adverse Event|2|||
16416117|NCT00454584|40004649|FG002|Controlled Period|Adverse Event|1|||
16416118|NCT00454584|40004650|FG003|Controlled Period|Adverse Event|0|||
16416119|NCT00454584|40004651|FG004|Controlled Period|Adverse Event|0|||
16416120|NCT00454584|40004652|FG005|Controlled Period|Adverse Event|0|||
16416121|NCT00454584|40004647|FG000|Controlled Period|Lost to Follow-up|1|||
16416122|NCT00454584|40004648|FG001|Controlled Period|Lost to Follow-up|2|||
16416123|NCT00454584|40004649|FG002|Controlled Period|Lost to Follow-up|2|||
16416124|NCT00454584|40004650|FG003|Controlled Period|Lost to Follow-up|0|||
16416125|NCT00454584|40004651|FG004|Controlled Period|Lost to Follow-up|0|||
16416126|NCT00454584|40004652|FG005|Controlled Period|Lost to Follow-up|0|||
16416127|NCT00454584|40004647|FG000|Controlled Period|Other|5|||
16416128|NCT00454584|40004648|FG001|Controlled Period|Other|4|||
16416129|NCT00454584|40004649|FG002|Controlled Period|Other|2|||
16416130|NCT00454584|40004650|FG003|Controlled Period|Other|0|||
16416131|NCT00454584|40004651|FG004|Controlled Period|Other|0|||
16416132|NCT00454584|40004652|FG005|Controlled Period|Other|0|||
16416133|NCT00454584|40004647|FG000|After Controlled Period|Adverse Event|0|||
16416134|NCT00454584|40004648|FG001|After Controlled Period|Adverse Event|0|||
16416135|NCT00454584|40004649|FG002|After Controlled Period|Adverse Event|0|||
16416136|NCT00454584|40004650|FG003|After Controlled Period|Adverse Event|9|||
16416137|NCT00454584|40004651|FG004|After Controlled Period|Adverse Event|3|||
16416138|NCT00454584|40004652|FG005|After Controlled Period|Adverse Event|9|||
16559293|NCT02291289|40513361|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
16559294|NCT02291289|40513362|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
16559295|NCT02291289|40513363|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
16559296|NCT02291289|40513364|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
16559297|NCT02291289|40513365|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
16559298|NCT02291289|40513366|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
16559299|NCT02291289|40513367|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
16559300|NCT02291289|40513368|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
16559301|NCT02291289|40513369|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
16559302|NCT02291289|40513370|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
16559303|NCT02291289|40513371|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
16559304|NCT02291289|40513359|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
16416139|NCT00454584|40004647|FG000|After Controlled Period|Lack of Efficacy|0|||
16416140|NCT00454584|40004648|FG001|After Controlled Period|Lack of Efficacy|0|||
16416141|NCT00454584|40004649|FG002|After Controlled Period|Lack of Efficacy|0|||
16416142|NCT00454584|40004650|FG003|After Controlled Period|Lack of Efficacy|1|||
16416143|NCT00454584|40004651|FG004|After Controlled Period|Lack of Efficacy|0|||
16416144|NCT00454584|40004652|FG005|After Controlled Period|Lack of Efficacy|0|||
16244550|NCT01814761|39381334|FG000|Overall Study|Ocular Adverse Event|6|||
16416145|NCT00454584|40004647|FG000|After Controlled Period|Lost to Follow-up|0|||
16416146|NCT00454584|40004648|FG001|After Controlled Period|Lost to Follow-up|0|||
16416147|NCT00454584|40004649|FG002|After Controlled Period|Lost to Follow-up|0|||
16416148|NCT00454584|40004650|FG003|After Controlled Period|Lost to Follow-up|2|||
16416149|NCT00454584|40004651|FG004|After Controlled Period|Lost to Follow-up|4|||
16416150|NCT00454584|40004652|FG005|After Controlled Period|Lost to Follow-up|6|||
16416151|NCT00454584|40004647|FG000|After Controlled Period|Other|0|||
16416152|NCT00454584|40004648|FG001|After Controlled Period|Other|0|||
16416153|NCT00454584|40004649|FG002|After Controlled Period|Other|0|||
16416154|NCT00454584|40004650|FG003|After Controlled Period|Other|1|||
16416155|NCT00454584|40004651|FG004|After Controlled Period|Other|0|||
16416156|NCT00454584|40004652|FG005|After Controlled Period|Other|0|||
16244551|NCT01814761|39381335|FG001|Overall Study|Ocular Adverse Event|15|||
16244552|NCT01814761|39381334|FG000|Overall Study|Lost to Follow-up|1|||
16244553|NCT01814761|39381335|FG001|Overall Study|Lost to Follow-up|5|||
16244554|NCT01507896|39381337|FG000|Overall Study|Withdrawal by Subject|1|||
16244555|NCT01507896|39381337|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
16244556|NCT02884206|39381341|FG000|Valsartan Run-in Period|Death|1|||
16244557|NCT02884206|39381342|FG001|Valsartan Run-in Period|Death|0|||
16244558|NCT02884206|39381343|FG002|Valsartan Run-in Period|Death|0|||
16244559|NCT02884206|39381341|FG000|Valsartan Run-in Period|Adverse Event|31|||
16244560|NCT02884206|39381342|FG001|Valsartan Run-in Period|Adverse Event|0|||
16244561|NCT02884206|39381343|FG002|Valsartan Run-in Period|Adverse Event|0|||
16244562|NCT02884206|39381341|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
16244563|NCT02884206|39381342|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
16244564|NCT02884206|39381343|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
16244565|NCT02884206|39381341|FG000|Valsartan Run-in Period|Protocol deviation|4|||
16244566|NCT02884206|39381342|FG001|Valsartan Run-in Period|Protocol deviation|0|||
16244567|NCT02884206|39381343|FG002|Valsartan Run-in Period|Protocol deviation|0|||
16244568|NCT02884206|39381341|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
16244569|NCT02884206|39381342|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
16244570|NCT02884206|39381343|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
16244571|NCT02884206|39381341|FG000|Valsartan Run-in Period|Physician Decision|1|||
16244572|NCT02884206|39381342|FG001|Valsartan Run-in Period|Physician Decision|0|||
16244573|NCT02884206|39381343|FG002|Valsartan Run-in Period|Physician Decision|0|||
16244574|NCT02884206|39381341|FG000|LCZ696 Run-in Period|Adverse Event|38|||
16244575|NCT02884206|39381342|FG001|LCZ696 Run-in Period|Adverse Event|0|||
16244576|NCT02884206|39381343|FG002|LCZ696 Run-in Period|Adverse Event|0|||
16244577|NCT02884206|39381341|FG000|LCZ696 Run-in Period|Death|2|||
16244578|NCT02884206|39381342|FG001|LCZ696 Run-in Period|Death|0|||
16244579|NCT02884206|39381343|FG002|LCZ696 Run-in Period|Death|0|||
16244580|NCT02884206|39381341|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
16244581|NCT02884206|39381342|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
16244582|NCT02884206|39381343|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
16244583|NCT02884206|39381341|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
16244584|NCT02884206|39381342|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
16244585|NCT02884206|39381343|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
16244586|NCT02884206|39381341|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
16244587|NCT02884206|39381342|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
16244588|NCT02884206|39381343|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
16244589|NCT02884206|39381341|FG000|LCZ696 Run-in Period|Physician Decision|1|||
16244590|NCT02884206|39381342|FG001|LCZ696 Run-in Period|Physician Decision|0|||
16244591|NCT02884206|39381343|FG002|LCZ696 Run-in Period|Physician Decision|0|||
16244592|NCT02884206|39381341|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
16244593|NCT02884206|39381342|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
16244594|NCT02884206|39381343|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
16244595|NCT02884206|39381341|FG000|Double-Blind Period|Death|0|||
16244596|NCT02884206|39381342|FG001|Double-Blind Period|Death|28|||
16244597|NCT02884206|39381343|FG002|Double-Blind Period|Death|39|||
16244598|NCT02884206|39381341|FG000|Double-Blind Period|Patient/guardian decision|0|||
16244599|NCT02884206|39381342|FG001|Double-Blind Period|Patient/guardian decision|10|||
16244600|NCT02884206|39381343|FG002|Double-Blind Period|Patient/guardian decision|13|||
16244601|NCT02884206|39381341|FG000|Double-Blind Period|Lost to Follow-up|0|||
16244602|NCT02884206|39381342|FG001|Double-Blind Period|Lost to Follow-up|4|||
16244603|NCT02884206|39381343|FG002|Double-Blind Period|Lost to Follow-up|4|||
16244604|NCT02884206|39381341|FG000|Double-Blind Period|Physician Decision|0|||
16244605|NCT02884206|39381342|FG001|Double-Blind Period|Physician Decision|2|||
16244606|NCT02884206|39381343|FG002|Double-Blind Period|Physician Decision|0|||
16244607|NCT02884206|39381341|FG000|Double-Blind Period|Adverse Event|0|||
16244608|NCT02884206|39381342|FG001|Double-Blind Period|Adverse Event|0|||
16244609|NCT02884206|39381343|FG002|Double-Blind Period|Adverse Event|3|||
16244610|NCT02884206|39381341|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
16244611|NCT02884206|39381342|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
16244612|NCT02884206|39381343|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
16244613|NCT01626885|39381344|FG000|Overall Study|Adverse Event|8|||
16244614|NCT01626885|39381344|FG000|Overall Study|Withdrawal by Subject|4|||
16416157|NCT00454584|40004647|FG000|After Controlled Period|Other|0|||
16244615|NCT02791659|39381369|FG000|Overall Study|Protocol Violation|0|||
16244616|NCT02791659|39381370|FG001|Overall Study|Protocol Violation|1|||
16244617|NCT00384033|39381371|FG000|Overall Study|Adverse Event|10|||
16244618|NCT00384033|39381372|FG001|Overall Study|Adverse Event|8|||
16244619|NCT00384033|39381373|FG002|Overall Study|Adverse Event|11|||
16244620|NCT00384033|39381374|FG003|Overall Study|Adverse Event|20|||
16244621|NCT00384033|39381371|FG000|Overall Study|Failed to return|1|||
16244622|NCT00384033|39381372|FG001|Overall Study|Failed to return|3|||
16244623|NCT00384033|39381373|FG002|Overall Study|Failed to return|2|||
16244624|NCT00384033|39381374|FG003|Overall Study|Failed to return|2|||
16244625|NCT00384033|39381371|FG000|Overall Study|Physician Decision|1|||
16244626|NCT00384033|39381372|FG001|Overall Study|Physician Decision|0|||
16244627|NCT00384033|39381373|FG002|Overall Study|Physician Decision|0|||
16244628|NCT00384033|39381374|FG003|Overall Study|Physician Decision|0|||
16244629|NCT00384033|39381371|FG000|Overall Study|Lost to Follow-up|6|||
16351748|NCT03410992|39776500|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
16351749|NCT03410992|39776501|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
16351750|NCT03410992|39776502|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
16351751|NCT03410992|39776503|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
16351752|NCT03410992|39776504|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
16351753|NCT03410992|39776505|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
16351754|NCT03410992|39776506|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
16351755|NCT03410992|39776507|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
16351756|NCT03410992|39776508|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
16351757|NCT03410992|39776509|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
16351758|NCT03410992|39776499|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
16351759|NCT03410992|39776500|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
16351760|NCT03410992|39776501|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
16351761|NCT03410992|39776502|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
16351762|NCT03410992|39776503|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
16351763|NCT03410992|39776504|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
16351764|NCT03410992|39776505|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
16351765|NCT03410992|39776506|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
16351766|NCT03410992|39776507|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
16351767|NCT03410992|39776508|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
16351768|NCT03410992|39776509|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
16351769|NCT03410992|39776499|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
16351770|NCT03410992|39776500|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
16351771|NCT03410992|39776501|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
16351772|NCT03410992|39776502|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
16351773|NCT03410992|39776503|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
16351774|NCT03410992|39776504|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
16351775|NCT03410992|39776505|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
16351776|NCT03410992|39776506|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
16351777|NCT03410992|39776507|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
16351778|NCT03410992|39776508|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
16351779|NCT03410992|39776509|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
16351780|NCT03410992|39776499|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
16351781|NCT03410992|39776500|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
16351782|NCT03410992|39776501|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
16351783|NCT03410992|39776502|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
16351784|NCT03410992|39776503|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
16351785|NCT03410992|39776504|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
16351786|NCT03410992|39776505|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
16351787|NCT03410992|39776506|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
16351788|NCT03410992|39776507|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
16351789|NCT03410992|39776508|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
16351790|NCT03410992|39776509|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
16351791|NCT03410992|39776499|FG000|Week 16 Assessment|Incorrect escapers|0|||
16416158|NCT00454584|40004648|FG001|After Controlled Period|Other|0|||
16416159|NCT00454584|40004649|FG002|After Controlled Period|Other|0|||
16416160|NCT00454584|40004650|FG003|After Controlled Period|Other|13|||
16416161|NCT00454584|40004651|FG004|After Controlled Period|Other|5|||
16416162|NCT00454584|40004652|FG005|After Controlled Period|Other|17|||
16416163|NCT02279498|40004653|FG000|Overall Study|Adverse Event|3|||
16416164|NCT02279498|40004654|FG001|Overall Study|Adverse Event|0|||
16416165|NCT02279498|40004653|FG000|Overall Study|Lack of Efficacy|4|||
16416166|NCT02279498|40004654|FG001|Overall Study|Lack of Efficacy|0|||
16559305|NCT02291289|40513360|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
16351792|NCT03410992|39776500|FG001|Week 16 Assessment|Incorrect escapers|6|||
16416167|NCT02279498|40004653|FG000|Overall Study|Lost to Follow-up|0|||
16244630|NCT00384033|39381372|FG001|Overall Study|Lost to Follow-up|12|||
16244631|NCT00384033|39381373|FG002|Overall Study|Lost to Follow-up|7|||
16244632|NCT00384033|39381374|FG003|Overall Study|Lost to Follow-up|7|||
16244633|NCT00384033|39381371|FG000|Overall Study|Other|2|||
16244634|NCT00384033|39381372|FG001|Overall Study|Other|0|||
16244635|NCT00384033|39381373|FG002|Overall Study|Other|0|||
16244636|NCT00384033|39381374|FG003|Overall Study|Other|0|||
16244637|NCT00384033|39381371|FG000|Overall Study|Protocol Violation|5|||
16244638|NCT00384033|39381372|FG001|Overall Study|Protocol Violation|0|||
16244639|NCT00384033|39381373|FG002|Overall Study|Protocol Violation|5|||
16244640|NCT00384033|39381374|FG003|Overall Study|Protocol Violation|6|||
16244641|NCT00384033|39381371|FG000|Overall Study|Withdrawal by Subject|6|||
16244642|NCT00384033|39381372|FG001|Overall Study|Withdrawal by Subject|2|||
16244643|NCT00384033|39381373|FG002|Overall Study|Withdrawal by Subject|5|||
16244644|NCT00384033|39381374|FG003|Overall Study|Withdrawal by Subject|2|||
16244645|NCT00384033|39381371|FG000|Overall Study|Lack of Efficacy|7|||
16244646|NCT00384033|39381372|FG001|Overall Study|Lack of Efficacy|3|||
16244647|NCT00384033|39381373|FG002|Overall Study|Lack of Efficacy|3|||
16244648|NCT00384033|39381374|FG003|Overall Study|Lack of Efficacy|1|||
16244649|NCT00384033|39381371|FG000|Overall Study|Randomized but not treated|3|||
16244650|NCT00384033|39381372|FG001|Overall Study|Randomized but not treated|7|||
16244651|NCT00384033|39381373|FG002|Overall Study|Randomized but not treated|10|||
16244652|NCT00384033|39381374|FG003|Overall Study|Randomized but not treated|2|||
16244653|NCT00437281|39381375|FG000|Overall Study|Adverse Event|0|||
16244654|NCT00437281|39381376|FG001|Overall Study|Adverse Event|0|||
16244655|NCT00437281|39381377|FG002|Overall Study|Adverse Event|0|||
16244656|NCT00437281|39381378|FG003|Overall Study|Adverse Event|1|||
16559306|NCT02291289|40513361|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
16559307|NCT02291289|40513362|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
16559308|NCT02291289|40513363|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
16559309|NCT02291289|40513364|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
16559310|NCT02291289|40513365|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
16559311|NCT02291289|40513366|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
16559312|NCT02291289|40513367|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
16559313|NCT02291289|40513368|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
16559314|NCT02291289|40513369|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
16244657|NCT00437281|39381379|FG004|Overall Study|Adverse Event|0|||
16244658|NCT00437281|39381380|FG005|Overall Study|Adverse Event|1|||
16559315|NCT02291289|40513370|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
16559316|NCT02291289|40513371|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
16559317|NCT02291289|40513359|FG000|Maintenance Treatment Phase|Physician Decision|0|||
16559318|NCT02291289|40513360|FG001|Maintenance Treatment Phase|Physician Decision|2|||
16559319|NCT02291289|40513361|FG002|Maintenance Treatment Phase|Physician Decision|0|||
16559320|NCT02291289|40513362|FG003|Maintenance Treatment Phase|Physician Decision|0|||
16559321|NCT02291289|40513363|FG004|Maintenance Treatment Phase|Physician Decision|3|||
16559322|NCT02291289|40513364|FG005|Maintenance Treatment Phase|Physician Decision|0|||
16559323|NCT02291289|40513365|FG006|Maintenance Treatment Phase|Physician Decision|0|||
16559324|NCT02291289|40513366|FG007|Maintenance Treatment Phase|Physician Decision|0|||
16416168|NCT02279498|40004654|FG001|Overall Study|Lost to Follow-up|1|||
16416169|NCT02279498|40004653|FG000|Overall Study|Withdrawal by Subject|9|||
16416170|NCT02279498|40004654|FG001|Overall Study|Withdrawal by Subject|2|||
16416171|NCT02279498|40004653|FG000|Overall Study|Undefined|2|||
16244659|NCT00437281|39381381|FG006|Overall Study|Adverse Event|0|||
16244660|NCT00437281|39381382|FG007|Overall Study|Adverse Event|0|||
16244661|NCT00437281|39381383|FG008|Overall Study|Adverse Event|0|||
16244662|NCT00437281|39381384|FG009|Overall Study|Adverse Event|1|||
16416172|NCT02279498|40004654|FG001|Overall Study|Undefined|1|||
16244663|NCT00437281|39381385|FG010|Overall Study|Adverse Event|0|||
16244664|NCT00437281|39381386|FG011|Overall Study|Adverse Event|0|||
16244665|NCT00437281|39381387|FG012|Overall Study|Adverse Event|0|||
16416173|NCT00870194|40004655|FG000|Overall Study|Adverse Event|10|||
16244666|NCT00437281|39381388|FG013|Overall Study|Adverse Event|1|||
16244667|NCT00437281|39381389|FG014|Overall Study|Adverse Event|1|||
16244668|NCT00437281|39381390|FG015|Overall Study|Adverse Event|0|||
16416174|NCT00870194|40004656|FG001|Overall Study|Adverse Event|5|||
16416175|NCT00870194|40004655|FG000|Overall Study|Lack of Efficacy|0|||
16416176|NCT00870194|40004656|FG001|Overall Study|Lack of Efficacy|1|||
16416177|NCT00870194|40004655|FG000|Overall Study|Lost to Follow-up|2|||
16416178|NCT00870194|40004656|FG001|Overall Study|Lost to Follow-up|0|||
16559325|NCT02291289|40513367|FG008|Maintenance Treatment Phase|Physician Decision|0|||
16244669|NCT00437281|39381391|FG016|Overall Study|Adverse Event|0|||
16244670|NCT00437281|39381392|FG017|Overall Study|Adverse Event|0|||
16559326|NCT02291289|40513368|FG009|Maintenance Treatment Phase|Physician Decision|0|||
16559327|NCT02291289|40513369|FG010|Maintenance Treatment Phase|Physician Decision|1|||
16244671|NCT00437281|39381393|FG018|Overall Study|Adverse Event|1|||
16244672|NCT00437281|39381394|FG019|Overall Study|Adverse Event|0|||
16244673|NCT00437281|39381375|FG000|Overall Study|Lost to Follow-up|0|||
16244674|NCT00437281|39381376|FG001|Overall Study|Lost to Follow-up|0|||
16244675|NCT00437281|39381377|FG002|Overall Study|Lost to Follow-up|0|||
16244676|NCT00437281|39381378|FG003|Overall Study|Lost to Follow-up|0|||
16244677|NCT00437281|39381379|FG004|Overall Study|Lost to Follow-up|0|||
16244678|NCT00437281|39381380|FG005|Overall Study|Lost to Follow-up|0|||
16244679|NCT00437281|39381381|FG006|Overall Study|Lost to Follow-up|0|||
16244680|NCT00437281|39381382|FG007|Overall Study|Lost to Follow-up|0|||
16244681|NCT00437281|39381383|FG008|Overall Study|Lost to Follow-up|0|||
16244682|NCT00437281|39381384|FG009|Overall Study|Lost to Follow-up|0|||
16244683|NCT00437281|39381385|FG010|Overall Study|Lost to Follow-up|0|||
16244684|NCT00437281|39381386|FG011|Overall Study|Lost to Follow-up|0|||
16244685|NCT00437281|39381387|FG012|Overall Study|Lost to Follow-up|0|||
16244686|NCT00437281|39381388|FG013|Overall Study|Lost to Follow-up|0|||
16244687|NCT00437281|39381389|FG014|Overall Study|Lost to Follow-up|0|||
16244688|NCT00437281|39381390|FG015|Overall Study|Lost to Follow-up|0|||
16244689|NCT00437281|39381391|FG016|Overall Study|Lost to Follow-up|0|||
16244690|NCT00437281|39381392|FG017|Overall Study|Lost to Follow-up|0|||
16244691|NCT00437281|39381393|FG018|Overall Study|Lost to Follow-up|0|||
16244692|NCT00437281|39381394|FG019|Overall Study|Lost to Follow-up|1|||
16244693|NCT04304950|39381395|FG000|Overall Study|Lost to Follow-up|1|||
16244694|NCT04304950|39381396|FG001|Overall Study|Lost to Follow-up|1|||
16244695|NCT04006847|39381397|FG000|Overall Study|Product issue|1|||
16244696|NCT00638157|39381398|FG000|Overall Study|Adverse Event|0|||
16244697|NCT00638157|39381399|FG001|Overall Study|Adverse Event|1|||
16244698|NCT00638157|39381398|FG000|Overall Study|Clinical (symptomatic) failure|1|||
16244699|NCT00638157|39381399|FG001|Overall Study|Clinical (symptomatic) failure|1|||
16244700|NCT00638157|39381398|FG000|Overall Study|Microbiological failure|1|||
16244701|NCT00638157|39381399|FG001|Overall Study|Microbiological failure|0|||
16244702|NCT00638157|39381398|FG000|Overall Study|Lost to Follow-up|1|||
16244703|NCT00638157|39381399|FG001|Overall Study|Lost to Follow-up|0|||
16244704|NCT00638157|39381398|FG000|Overall Study|Physician Decision|1|||
16244705|NCT00638157|39381399|FG001|Overall Study|Physician Decision|0|||
16244706|NCT00638157|39381398|FG000|Overall Study|Other|1|||
16244707|NCT00638157|39381399|FG001|Overall Study|Other|2|||
16244708|NCT00638157|39381398|FG000|Overall Study|Randomized, not treated|2|||
16244709|NCT00638157|39381399|FG001|Overall Study|Randomized, not treated|0|||
16244710|NCT04014959|39381402|FG000|Baseline MRI and Assessments|Physician Decision|2|||
16244711|NCT04014959|39381402|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
16244712|NCT04014959|39381402|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
16244713|NCT01456052|39381405|FG000|Overall Study|Adverse Event|1|||
16244714|NCT01456052|39381406|FG001|Overall Study|Adverse Event|1|||
16244715|NCT01456052|39381407|FG002|Overall Study|Adverse Event|2|||
16244716|NCT01456052|39381405|FG000|Overall Study|Consent withdrawn|0|||
16244717|NCT01456052|39381406|FG001|Overall Study|Consent withdrawn|2|||
16244718|NCT01456052|39381407|FG002|Overall Study|Consent withdrawn|1|||
16244719|NCT01456052|39381405|FG000|Overall Study|Protocol Violation|0|||
16244720|NCT01456052|39381406|FG001|Overall Study|Protocol Violation|1|||
16244721|NCT01456052|39381407|FG002|Overall Study|Protocol Violation|0|||
16244722|NCT01456052|39381405|FG000|Overall Study|Physician Decision|1|||
16244723|NCT01456052|39381406|FG001|Overall Study|Physician Decision|0|||
16244724|NCT01456052|39381407|FG002|Overall Study|Physician Decision|1|||
16244725|NCT01456052|39381405|FG000|Overall Study|Treatment Failure|0|||
16244726|NCT01456052|39381406|FG001|Overall Study|Treatment Failure|1|||
16416179|NCT00870194|40004655|FG000|Overall Study|Physician Decision|3|||
16244727|NCT01456052|39381407|FG002|Overall Study|Treatment Failure|1|||
16244728|NCT02151461|39381408|FG000|Overall Study|Adverse Event|5|||
16244729|NCT02151461|39381409|FG001|Overall Study|Adverse Event|1|||
16244730|NCT02151461|39381410|FG002|Overall Study|Adverse Event|0|||
16244731|NCT02151461|39381411|FG003|Overall Study|Adverse Event|2|||
16244732|NCT02151461|39381408|FG000|Overall Study|Lost to Follow-up|0|||
16244733|NCT02151461|39381409|FG001|Overall Study|Lost to Follow-up|0|||
16244734|NCT02151461|39381410|FG002|Overall Study|Lost to Follow-up|1|||
16244735|NCT02151461|39381411|FG003|Overall Study|Lost to Follow-up|1|||
16416180|NCT00870194|40004656|FG001|Overall Study|Physician Decision|1|||
16416181|NCT00870194|40004655|FG000|Overall Study|Protocol Violation|3|||
16244736|NCT02151461|39381408|FG000|Overall Study|Withdrawal by Subject|1|||
16244737|NCT02151461|39381409|FG001|Overall Study|Withdrawal by Subject|0|||
16244738|NCT02151461|39381410|FG002|Overall Study|Withdrawal by Subject|1|||
16244739|NCT02151461|39381411|FG003|Overall Study|Withdrawal by Subject|1|||
16244740|NCT02151461|39381408|FG000|Overall Study|Treatment discontinuation|0|||
16244741|NCT02151461|39381409|FG001|Overall Study|Treatment discontinuation|0|||
16244742|NCT02151461|39381410|FG002|Overall Study|Treatment discontinuation|1|||
16244743|NCT02151461|39381411|FG003|Overall Study|Treatment discontinuation|0|||
16244744|NCT01967888|39381412|FG000|Overall Study|Lost to Follow-up|6|||
16244745|NCT01967888|39381413|FG001|Overall Study|Lost to Follow-up|4|||
16244746|NCT01967888|39381412|FG000|Overall Study|Withdrawal by Subject|1|||
16244747|NCT01967888|39381413|FG001|Overall Study|Withdrawal by Subject|1|||
16244748|NCT01967888|39381412|FG000|Overall Study|Did Not Have Transplant|1|||
16244749|NCT01967888|39381413|FG001|Overall Study|Did Not Have Transplant|0|||
16244750|NCT01967888|39381412|FG000|Overall Study|Research visit not done, data recorded|1|||
16244751|NCT01967888|39381413|FG001|Overall Study|Research visit not done, data recorded|0|||
16244752|NCT01967888|39381412|FG000|Overall Study|Subject excluded after randomization|1|||
16244753|NCT01967888|39381413|FG001|Overall Study|Subject excluded after randomization|0|||
16244754|NCT01967888|39381412|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
16244755|NCT01967888|39381413|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
16244756|NCT01967888|39381412|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
16244757|NCT01967888|39381413|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
16244758|NCT02102490|39381414|FG000|Overall Study|Death|6|||
16244759|NCT02102490|39381414|FG000|Overall Study|Lost to Follow-up|1|||
16244760|NCT00408876|39381415|FG000|Overall Study|Adverse Event|9|||
16244761|NCT00408876|39381416|FG001|Overall Study|Adverse Event|17|||
16244762|NCT00408876|39381417|FG002|Overall Study|Adverse Event|27|||
16244763|NCT00408876|39381418|FG003|Overall Study|Adverse Event|10|||
16244764|NCT00408876|39381415|FG000|Overall Study|Withdrawal by Subject|3|||
16244765|NCT00408876|39381416|FG001|Overall Study|Withdrawal by Subject|6|||
16244766|NCT00408876|39381417|FG002|Overall Study|Withdrawal by Subject|6|||
16244767|NCT00408876|39381418|FG003|Overall Study|Withdrawal by Subject|14|||
16244768|NCT00408876|39381415|FG000|Overall Study|Lack of Efficacy|2|||
16244769|NCT00408876|39381416|FG001|Overall Study|Lack of Efficacy|4|||
16244770|NCT00408876|39381417|FG002|Overall Study|Lack of Efficacy|5|||
16416182|NCT00870194|40004656|FG001|Overall Study|Protocol Violation|3|||
16416183|NCT00870194|40004655|FG000|Overall Study|Entry Criteria Not Met|1|||
16416184|NCT00870194|40004656|FG001|Overall Study|Entry Criteria Not Met|2|||
16416185|NCT00870194|40004655|FG000|Overall Study|Subject Decision|7|||
16416186|NCT00870194|40004656|FG001|Overall Study|Subject Decision|2|||
16416187|NCT04094584|40004659|FG000|Overall Study|No interest in study|88|||
16416188|NCT04094584|40004659|FG000|Overall Study|Unwilling to undergo screening tests|36|||
16416189|NCT04094584|40004659|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
16416190|NCT04094584|40004659|FG000|Overall Study|Opioid use|7|||
16416191|NCT04094584|40004659|FG000|Overall Study|Need for major surgery in study period|4|||
16416192|NCT04094584|40004659|FG000|Overall Study|eligible but declined enrollment|4|||
16416193|NCT04094584|40004659|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
16416194|NCT04094584|40004659|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
16416195|NCT04094584|40004659|FG000|Overall Study|Lost to Follow-up|3|||
16416196|NCT04094584|40004659|FG000|Overall Study|Withdrawal by Subject|2|||
16416197|NCT02553538|40004660|FG000|Overall Study|Could Not Reach by Telephone|133|||
16416198|NCT02553538|40004661|FG001|Overall Study|Could Not Reach by Telephone|0|||
16416199|NCT02553538|40004660|FG000|Overall Study|Died or Left Network|54|||
16416200|NCT02553538|40004661|FG001|Overall Study|Died or Left Network|56|||
16416201|NCT01423916|40004662|FG000|Overall Study|Adverse Event|5|||
16416202|NCT01423916|40004663|FG001|Overall Study|Adverse Event|9|||
16244771|NCT00408876|39381418|FG003|Overall Study|Lack of Efficacy|6|||
16244772|NCT00408876|39381415|FG000|Overall Study|Lost to Follow-up|1|||
16244773|NCT00408876|39381416|FG001|Overall Study|Lost to Follow-up|6|||
16244774|NCT00408876|39381417|FG002|Overall Study|Lost to Follow-up|5|||
16244775|NCT00408876|39381418|FG003|Overall Study|Lost to Follow-up|2|||
16244776|NCT00408876|39381415|FG000|Overall Study|Protocol Violation|0|||
16244777|NCT00408876|39381416|FG001|Overall Study|Protocol Violation|3|||
16244778|NCT00408876|39381417|FG002|Overall Study|Protocol Violation|4|||
16416203|NCT01423916|40004664|FG002|Overall Study|Adverse Event|2|||
16244779|NCT00408876|39381418|FG003|Overall Study|Protocol Violation|3|||
16244780|NCT00408876|39381415|FG000|Overall Study|Physician Decision|1|||
16244781|NCT00408876|39381416|FG001|Overall Study|Physician Decision|0|||
16244782|NCT00408876|39381417|FG002|Overall Study|Physician Decision|3|||
16244783|NCT00408876|39381418|FG003|Overall Study|Physician Decision|0|||
16416204|NCT01423916|40004662|FG000|Overall Study|Met Withdrawal Criteria|1|||
16416205|NCT01423916|40004663|FG001|Overall Study|Met Withdrawal Criteria|1|||
16244784|NCT00450216|39381421|FG000|Overall Study|Adverse Event|38|||
16244785|NCT00450216|39381422|FG001|Overall Study|Adverse Event|23|||
16244786|NCT00450216|39381421|FG000|Overall Study|Withdrawal by Subject|48|||
16244787|NCT00450216|39381422|FG001|Overall Study|Withdrawal by Subject|26|||
16244788|NCT00450216|39381421|FG000|Overall Study|Lost to Follow-up|16|||
16244789|NCT00450216|39381422|FG001|Overall Study|Lost to Follow-up|9|||
16244790|NCT00450216|39381421|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
16244791|NCT00450216|39381422|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
16244792|NCT00450216|39381421|FG000|Overall Study|misc|21|||
16244793|NCT00450216|39381422|FG001|Overall Study|misc|20|||
16244794|NCT01907087|39381423|FG000|Overall Study|Withdrawal by Subject|1|||
16559328|NCT02291289|40513370|FG011|Maintenance Treatment Phase|Physician Decision|3|||
16559329|NCT02291289|40513371|FG012|Maintenance Treatment Phase|Physician Decision|0|||
16244795|NCT02675426|39381424|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
16244796|NCT02675426|39381425|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
16244797|NCT02675426|39381426|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
16559330|NCT02291289|40513359|FG000|Maintenance Treatment Phase|Not Treated|0|||
16559331|NCT02291289|40513360|FG001|Maintenance Treatment Phase|Not Treated|0|||
16559332|NCT02291289|40513361|FG002|Maintenance Treatment Phase|Not Treated|2|||
16559333|NCT02291289|40513362|FG003|Maintenance Treatment Phase|Not Treated|0|||
16559334|NCT02291289|40513363|FG004|Maintenance Treatment Phase|Not Treated|0|||
16559335|NCT02291289|40513364|FG005|Maintenance Treatment Phase|Not Treated|0|||
16559336|NCT02291289|40513365|FG006|Maintenance Treatment Phase|Not Treated|0|||
16559337|NCT02291289|40513366|FG007|Maintenance Treatment Phase|Not Treated|0|||
16559338|NCT02291289|40513367|FG008|Maintenance Treatment Phase|Not Treated|0|||
16244798|NCT02675426|39381427|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
16244799|NCT02675426|39381424|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
16244800|NCT02675426|39381425|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
16244801|NCT02675426|39381426|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
16244802|NCT02675426|39381427|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
16244803|NCT02675426|39381424|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
16244804|NCT02675426|39381425|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
16244805|NCT02675426|39381426|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
16244806|NCT02675426|39381427|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
16244807|NCT02675426|39381424|FG000|Period 1: Week 1 to Week 12|Other|2|||
16559339|NCT02291289|40513368|FG009|Maintenance Treatment Phase|Not Treated|0|||
16559340|NCT02291289|40513369|FG010|Maintenance Treatment Phase|Not Treated|0|||
16559341|NCT02291289|40513370|FG011|Maintenance Treatment Phase|Not Treated|0|||
16559342|NCT02291289|40513371|FG012|Maintenance Treatment Phase|Not Treated|0|||
16559343|NCT02291289|40513359|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559344|NCT02291289|40513360|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
16559345|NCT02291289|40513361|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559346|NCT02291289|40513362|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559347|NCT02291289|40513363|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559348|NCT02291289|40513364|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559349|NCT02291289|40513365|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559350|NCT02291289|40513366|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16244808|NCT02675426|39381425|FG001|Period 1: Week 1 to Week 12|Other|1|||
16244809|NCT02675426|39381426|FG002|Period 1: Week 1 to Week 12|Other|0|||
16244810|NCT02675426|39381427|FG003|Period 1: Week 1 to Week 12|Other|2|||
16244811|NCT02675426|39381424|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
16244812|NCT02675426|39381425|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
16244813|NCT02675426|39381426|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
16244814|NCT02675426|39381427|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
16244815|NCT02675426|39381424|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
16244816|NCT02675426|39381425|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
16244817|NCT02675426|39381426|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
16244818|NCT02675426|39381427|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
16244819|NCT02675426|39381424|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
16559351|NCT02291289|40513367|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559352|NCT02291289|40513368|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559353|NCT02291289|40513369|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559354|NCT02291289|40513370|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559355|NCT02291289|40513371|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
16559356|NCT02291289|40513359|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
16559357|NCT02291289|40513360|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
16559358|NCT02291289|40513361|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
16559359|NCT02291289|40513362|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
16244820|NCT02675426|39381425|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
16559360|NCT02291289|40513363|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
16559361|NCT02291289|40513364|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
16244821|NCT02675426|39381426|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
16244822|NCT02675426|39381427|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
16559362|NCT02291289|40513365|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
16559363|NCT02291289|40513366|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
16416206|NCT01423916|40004664|FG002|Overall Study|Met Withdrawal Criteria|1|||
16416207|NCT01423916|40004662|FG000|Overall Study|Physician Decision|1|||
16416208|NCT01423916|40004663|FG001|Overall Study|Physician Decision|0|||
16416209|NCT01423916|40004664|FG002|Overall Study|Physician Decision|1|||
16416210|NCT01423916|40004662|FG000|Overall Study|Withdrawal by Subject|3|||
16416211|NCT01423916|40004663|FG001|Overall Study|Withdrawal by Subject|10|||
16416212|NCT01423916|40004664|FG002|Overall Study|Withdrawal by Subject|3|||
16416213|NCT01423916|40004662|FG000|Overall Study|Protocol Deviation|1|||
16416214|NCT01423916|40004663|FG001|Overall Study|Protocol Deviation|0|||
16416215|NCT01423916|40004664|FG002|Overall Study|Protocol Deviation|0|||
16416216|NCT00778895|40004665|FG000|Active Phase|Adverse Event|3|||
16416217|NCT00778895|40004666|FG001|Active Phase|Adverse Event|1|||
16416218|NCT00778895|40004667|FG002|Active Phase|Adverse Event|0|||
16416219|NCT00778895|40004665|FG000|Active Phase|Withdrawal by Subject|1|||
16416220|NCT00778895|40004666|FG001|Active Phase|Withdrawal by Subject|4|||
16416221|NCT00778895|40004667|FG002|Active Phase|Withdrawal by Subject|0|||
16416222|NCT00778895|40004665|FG000|Active Phase|Lost to Follow-up|1|||
16416223|NCT00778895|40004666|FG001|Active Phase|Lost to Follow-up|1|||
16416224|NCT00778895|40004667|FG002|Active Phase|Lost to Follow-up|0|||
16416225|NCT00778895|40004665|FG000|Active Phase|Other|2|||
16416226|NCT00778895|40004666|FG001|Active Phase|Other|0|||
16416227|NCT00778895|40004667|FG002|Active Phase|Other|0|||
16416228|NCT00778895|40004665|FG000|ESFU Phase|Adverse Event|2|||
16416229|NCT00778895|40004666|FG001|ESFU Phase|Adverse Event|1|||
16416230|NCT00778895|40004667|FG002|ESFU Phase|Adverse Event|0|||
16559364|NCT02291289|40513367|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
16559365|NCT02291289|40513368|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
16559366|NCT02291289|40513369|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
16559367|NCT02291289|40513370|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
16559368|NCT02291289|40513371|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
16559369|NCT02291289|40513359|FG000|Early Disease Progression|Death|0|||
16559370|NCT02291289|40513360|FG001|Early Disease Progression|Death|0|||
16559371|NCT02291289|40513361|FG002|Early Disease Progression|Death|0|||
16559372|NCT02291289|40513362|FG003|Early Disease Progression|Death|0|||
16559373|NCT02291289|40513363|FG004|Early Disease Progression|Death|0|||
16559374|NCT02291289|40513364|FG005|Early Disease Progression|Death|0|||
16559375|NCT02291289|40513365|FG006|Early Disease Progression|Death|0|||
16559376|NCT02291289|40513366|FG007|Early Disease Progression|Death|0|||
16559377|NCT02291289|40513367|FG008|Early Disease Progression|Death|0|||
16559378|NCT02291289|40513368|FG009|Early Disease Progression|Death|0|||
16559379|NCT02291289|40513369|FG010|Early Disease Progression|Death|0|||
16559380|NCT02291289|40513370|FG011|Early Disease Progression|Death|0|||
16559381|NCT02291289|40513371|FG012|Early Disease Progression|Death|10|||
16559382|NCT02291289|40513359|FG000|Early Disease Progression|Lost to Follow-up|0|||
16559383|NCT02291289|40513360|FG001|Early Disease Progression|Lost to Follow-up|0|||
16559384|NCT02291289|40513361|FG002|Early Disease Progression|Lost to Follow-up|0|||
16559385|NCT02291289|40513362|FG003|Early Disease Progression|Lost to Follow-up|0|||
16559386|NCT02291289|40513363|FG004|Early Disease Progression|Lost to Follow-up|0|||
16559387|NCT02291289|40513364|FG005|Early Disease Progression|Lost to Follow-up|0|||
16559388|NCT02291289|40513365|FG006|Early Disease Progression|Lost to Follow-up|0|||
16416231|NCT00778895|40004665|FG000|ESFU Phase|Withdrawal by Subject|1|||
16559389|NCT02291289|40513366|FG007|Early Disease Progression|Lost to Follow-up|0|||
16559390|NCT02291289|40513367|FG008|Early Disease Progression|Lost to Follow-up|0|||
16559391|NCT02291289|40513368|FG009|Early Disease Progression|Lost to Follow-up|0|||
16559392|NCT02291289|40513369|FG010|Early Disease Progression|Lost to Follow-up|0|||
16559393|NCT02291289|40513370|FG011|Early Disease Progression|Lost to Follow-up|0|||
16559394|NCT02291289|40513371|FG012|Early Disease Progression|Lost to Follow-up|1|||
16559395|NCT02507219|40513372|FG000|Overall Study|Physician Decision|1|||
16559396|NCT02507219|40513373|FG001|Overall Study|Physician Decision|0|||
16559397|NCT02507219|40513374|FG002|Overall Study|Physician Decision|0|||
16559398|NCT02507219|40513375|FG003|Overall Study|Physician Decision|0|||
16559399|NCT02507219|40513376|FG004|Overall Study|Physician Decision|0|||
16416232|NCT00778895|40004666|FG001|ESFU Phase|Withdrawal by Subject|4|||
16416233|NCT00778895|40004667|FG002|ESFU Phase|Withdrawal by Subject|0|||
16416234|NCT00778895|40004665|FG000|ESFU Phase|Lost to Follow-up|6|||
16416235|NCT00778895|40004666|FG001|ESFU Phase|Lost to Follow-up|7|||
16416236|NCT00778895|40004667|FG002|ESFU Phase|Lost to Follow-up|2|||
16416237|NCT00778895|40004665|FG000|ESFU Phase|Other|2|||
16416238|NCT00778895|40004666|FG001|ESFU Phase|Other|0|||
16559400|NCT02507219|40513377|FG005|Overall Study|Physician Decision|0|||
16559401|NCT02507219|40513372|FG000|Overall Study|Withdrawal by Subject|0|||
16559402|NCT02507219|40513373|FG001|Overall Study|Withdrawal by Subject|0|||
16559403|NCT02507219|40513374|FG002|Overall Study|Withdrawal by Subject|0|||
16559404|NCT02507219|40513375|FG003|Overall Study|Withdrawal by Subject|0|||
16559405|NCT02507219|40513376|FG004|Overall Study|Withdrawal by Subject|1|||
16416239|NCT00778895|40004667|FG002|ESFU Phase|Other|0|||
16559406|NCT02507219|40513377|FG005|Overall Study|Withdrawal by Subject|0|||
16559407|NCT02107443|40513378|FG000|Overall Study|Death|42|||
16559408|NCT02107443|40513379|FG001|Overall Study|Death|30|||
16559409|NCT02107443|40513378|FG000|Overall Study|Study Protocol Violation|3|||
16559410|NCT02107443|40513379|FG001|Overall Study|Study Protocol Violation|1|||
16559411|NCT02107443|40513378|FG000|Overall Study|Registered but Not Eligible|0|||
16559412|NCT02107443|40513379|FG001|Overall Study|Registered but Not Eligible|1|||
16559413|NCT02107443|40513378|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
16559414|NCT02107443|40513379|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
16559415|NCT02107443|40513378|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
16559416|NCT02107443|40513379|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
16559417|NCT02107443|40513378|FG000|Overall Study|Withdrawal: Changed Mind|2|||
16127947|NCT00700427|38954475|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
16416240|NCT01300455|40004669|FG000|Washout|Withdrawal by Subject|1|||
16416241|NCT01300455|40004670|FG001|Washout|Withdrawal by Subject|0|||
16416242|NCT00849108|40004671|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
16416243|NCT00849108|40004672|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
16416244|NCT00849108|40004671|FG000|Cohort 2 Efficacy|Adverse Event|0|||
16416245|NCT00849108|40004672|FG001|Cohort 2 Efficacy|Adverse Event|1|||
16416246|NCT00849108|40004671|FG000|Cohort 2 Efficacy|Other|0|||
16416247|NCT00849108|40004672|FG001|Cohort 2 Efficacy|Other|9|||
16416248|NCT01272869|40004678|FG000|Period 2 (14 Days)|Adverse Event|1|||
16416249|NCT01272869|40004679|FG001|Period 2 (14 Days)|Adverse Event|0|||
16559418|NCT02107443|40513379|FG001|Overall Study|Withdrawal: Changed Mind|0|||
16559419|NCT02107443|40513378|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
16127948|NCT00700427|38954476|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
16127949|NCT00700427|38954477|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
16127950|NCT00700427|38954478|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
16127951|NCT00700427|38954474|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
16127952|NCT00700427|38954475|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
16127953|NCT00700427|38954476|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
16127954|NCT00700427|38954477|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
16127955|NCT00700427|38954478|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
16127956|NCT00700427|38954474|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
16127957|NCT00700427|38954475|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
16127958|NCT00700427|38954476|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
16127959|NCT00700427|38954477|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
16127960|NCT00700427|38954478|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
16127961|NCT00700427|38954474|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
16127962|NCT00700427|38954475|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
16127963|NCT00700427|38954476|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
16127964|NCT00700427|38954477|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
16127965|NCT00700427|38954478|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
16127966|NCT00700427|38954474|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
16127967|NCT00700427|38954475|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
16127968|NCT00700427|38954476|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
16127969|NCT00700427|38954477|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
16127970|NCT00700427|38954478|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
16127971|NCT00700427|38954474|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
16127972|NCT00700427|38954475|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
16127973|NCT00700427|38954476|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
16127974|NCT00700427|38954477|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
16127975|NCT00700427|38954478|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
16127976|NCT00700427|38954474|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
16127977|NCT00700427|38954475|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
16127978|NCT00700427|38954476|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
16127979|NCT00700427|38954477|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
16127980|NCT00700427|38954478|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
16127981|NCT00700427|38954474|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
16127982|NCT00700427|38954475|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
16127983|NCT00700427|38954476|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
16127984|NCT00700427|38954477|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
16127985|NCT00700427|38954478|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
16127986|NCT00700427|38954474|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
16127987|NCT00700427|38954475|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
16127988|NCT00700427|38954476|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
16416250|NCT02210091|40004680|FG000|Overall Study|Physician Decision|0|||
16416251|NCT02210091|40004681|FG001|Overall Study|Physician Decision|1|||
16559420|NCT02107443|40513379|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
16416252|NCT02210091|40004680|FG000|Overall Study|Withdrawal by Sponsor|0|||
16416253|NCT02210091|40004681|FG001|Overall Study|Withdrawal by Sponsor|1|||
16416254|NCT03443427|40004682|FG000|Overall Study|Adverse Event|2|||
16416255|NCT03443427|40004683|FG001|Overall Study|Adverse Event|3|||
16416256|NCT03443427|40004682|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
16416257|NCT03443427|40004683|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
16416258|NCT03443427|40004682|FG000|Overall Study|Other|4|||
16416259|NCT03443427|40004683|FG001|Overall Study|Other|6|||
16416260|NCT00541346|40004684|FG000|Follow-up|Adverse Event|1|||
16416261|NCT04030247|40004685|FG000|Overall Study|Withdrawal by Subject|4|||
16416262|NCT04030247|40004685|FG000|Overall Study|Lost to Follow-up|13|||
16416263|NCT02455076|40004686|FG000|Inpatient|Withdrawal by Subject|1|||
16416264|NCT02455076|40004687|FG001|Inpatient|Withdrawal by Subject|0|||
16416265|NCT02455076|40004688|FG002|Inpatient|Withdrawal by Subject|0|||
16416266|NCT02455076|40004689|FG003|Inpatient|Withdrawal by Subject|0|||
16416267|NCT02455076|40004690|FG004|Inpatient|Withdrawal by Subject|0|||
16416268|NCT02455076|40004686|FG000|Inpatient|Discharged <24 h after admission|0|||
16416269|NCT02455076|40004687|FG001|Inpatient|Discharged <24 h after admission|1|||
16416270|NCT02455076|40004688|FG002|Inpatient|Discharged <24 h after admission|0|||
16416271|NCT02455076|40004689|FG003|Inpatient|Discharged <24 h after admission|0|||
16416272|NCT02455076|40004690|FG004|Inpatient|Discharged <24 h after admission|0|||
16416273|NCT02455076|40004686|FG000|Inpatient|Adverse Event|3|||
16416274|NCT02455076|40004687|FG001|Inpatient|Adverse Event|0|||
16416275|NCT02455076|40004688|FG002|Inpatient|Adverse Event|0|||
16416276|NCT02455076|40004689|FG003|Inpatient|Adverse Event|0|||
16416277|NCT02455076|40004690|FG004|Inpatient|Adverse Event|0|||
16416278|NCT02455076|40004686|FG000|Outpatient|Adverse Event|0|||
16416279|NCT02455076|40004687|FG001|Outpatient|Adverse Event|0|||
16416280|NCT02455076|40004688|FG002|Outpatient|Adverse Event|0|||
16416281|NCT02455076|40004689|FG003|Outpatient|Adverse Event|5|||
16416282|NCT02455076|40004690|FG004|Outpatient|Adverse Event|0|||
16416283|NCT02455076|40004686|FG000|Outpatient|Lost to Follow-up|0|||
16416284|NCT02455076|40004687|FG001|Outpatient|Lost to Follow-up|0|||
16416285|NCT02455076|40004688|FG002|Outpatient|Lost to Follow-up|0|||
16416286|NCT02455076|40004689|FG003|Outpatient|Lost to Follow-up|1|||
16416287|NCT02455076|40004690|FG004|Outpatient|Lost to Follow-up|12|||
16416288|NCT02228096|40004691|FG000|Overall Study|Study terminated by Sponsor|24|||
16416289|NCT02228096|40004691|FG000|Overall Study|Lack of Efficacy|18|||
16416290|NCT02228096|40004691|FG000|Overall Study|Death|12|||
16416291|NCT02228096|40004691|FG000|Overall Study|Physician Decision|3|||
16416292|NCT02228096|40004691|FG000|Overall Study|Subject/guardian decision|2|||
16416293|NCT02228096|40004691|FG000|Overall Study|New therapy for study indication|1|||
16416294|NCT02228096|40004691|FG000|Overall Study|Enrolled, not infused|11|||
16416295|NCT00599638|40004692|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
16416296|NCT00599638|40004693|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
16416297|NCT00599638|40004694|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
16416298|NCT00599638|40004695|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
16416299|NCT00599638|40004692|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
16416300|NCT00599638|40004693|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
16416301|NCT00599638|40004694|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
16416302|NCT00599638|40004695|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
16416303|NCT00599638|40004692|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
16416304|NCT00599638|40004693|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
16416305|NCT00599638|40004694|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
16416306|NCT00599638|40004695|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
16416307|NCT00599638|40004692|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
16416308|NCT00599638|40004693|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
16416309|NCT00599638|40004694|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
16416310|NCT00599638|40004695|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
16416311|NCT00599638|40004692|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
16416312|NCT00599638|40004693|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
16416313|NCT00599638|40004694|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
16416314|NCT00599638|40004695|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
16416315|NCT00599638|40004692|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
16416316|NCT00599638|40004693|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
16416317|NCT00599638|40004694|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
16559421|NCT02107443|40513378|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
16559422|NCT02107443|40513379|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
16416318|NCT00599638|40004695|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
16416319|NCT00599638|40004692|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
16416320|NCT00599638|40004693|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
16416321|NCT00599638|40004694|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
16416322|NCT00599638|40004695|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
16416323|NCT00599638|40004692|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
16416324|NCT00599638|40004693|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
16416325|NCT00599638|40004694|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
16416326|NCT00599638|40004695|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
16416327|NCT00599638|40004692|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
16416328|NCT00599638|40004693|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
16416329|NCT00599638|40004694|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
16416330|NCT00599638|40004695|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
16416331|NCT03149029|40004697|FG000|Overall Study|Adverse Event|2|||
16416332|NCT03149029|40004698|FG001|Overall Study|Adverse Event|0|||
16416333|NCT02273960|40004699|FG000|Short Term Period|Lost to Follow-up|1|||
16416334|NCT02273960|40004700|FG001|Short Term Period|Lost to Follow-up|0|||
16416335|NCT02273960|40004701|FG002|Short Term Period|Lost to Follow-up|0|||
16416336|NCT02273960|40004702|FG003|Short Term Period|Lost to Follow-up|0|||
16416337|NCT02273960|40004699|FG000|Short Term Period|Lack of Efficacy|0|||
16416338|NCT02273960|40004700|FG001|Short Term Period|Lack of Efficacy|0|||
16416339|NCT02273960|40004701|FG002|Short Term Period|Lack of Efficacy|0|||
16416340|NCT02273960|40004702|FG003|Short Term Period|Lack of Efficacy|1|||
16416341|NCT02273960|40004699|FG000|Short Term Period|ST complete, not entering LTE|4|||
16416342|NCT02273960|40004700|FG001|Short Term Period|ST complete, not entering LTE|6|||
16416343|NCT02273960|40004701|FG002|Short Term Period|ST complete, not entering LTE|4|||
16416344|NCT02273960|40004702|FG003|Short Term Period|ST complete, not entering LTE|5|||
16416345|NCT02273960|40004699|FG000|Long Term Extension|Death|0|||
16416346|NCT02273960|40004700|FG001|Long Term Extension|Death|0|||
16416347|NCT02273960|40004701|FG002|Long Term Extension|Death|0|||
16416348|NCT02273960|40004702|FG003|Long Term Extension|Death|1|||
16416349|NCT01012323|40004704|FG000|Overall Study|Investigator Judgment|1|||
16416350|NCT00387647|40004705|FG000|Overall Study|Death|18|||
16416351|NCT01278407|40004706|FG000|Confirmatory Phase|Adverse Event|5|||
16416352|NCT01278407|40004707|FG001|Confirmatory Phase|Adverse Event|10|||
16416353|NCT01278407|40004708|FG002|Confirmatory Phase|Adverse Event|1|||
16416354|NCT01278407|40004709|FG003|Confirmatory Phase|Adverse Event|0|||
16416355|NCT01278407|40004710|FG004|Confirmatory Phase|Adverse Event|0|||
16416356|NCT01278407|40004706|FG000|Confirmatory Phase|Participant's Choice|3|||
16416357|NCT01278407|40004707|FG001|Confirmatory Phase|Participant's Choice|5|||
16416358|NCT01278407|40004708|FG002|Confirmatory Phase|Participant's Choice|3|||
16416359|NCT01278407|40004709|FG003|Confirmatory Phase|Participant's Choice|0|||
16416360|NCT01278407|40004710|FG004|Confirmatory Phase|Participant's Choice|0|||
16416361|NCT01278407|40004706|FG000|Confirmatory Phase|Other|1|||
16416362|NCT01278407|40004707|FG001|Confirmatory Phase|Other|1|||
16416363|NCT01278407|40004708|FG002|Confirmatory Phase|Other|2|||
16416364|NCT01278407|40004709|FG003|Confirmatory Phase|Other|0|||
16416365|NCT01278407|40004710|FG004|Confirmatory Phase|Other|0|||
16416366|NCT01278407|40004706|FG000|Extension Phase|Adverse Event|0|||
16416367|NCT01278407|40004707|FG001|Extension Phase|Adverse Event|0|||
16416368|NCT01278407|40004708|FG002|Extension Phase|Adverse Event|0|||
16416369|NCT01278407|40004709|FG003|Extension Phase|Adverse Event|7|||
16416370|NCT01278407|40004710|FG004|Extension Phase|Adverse Event|16|||
16416371|NCT01278407|40004706|FG000|Extension Phase|Participant's Choice|0|||
16416372|NCT01278407|40004707|FG001|Extension Phase|Participant's Choice|0|||
16416373|NCT01278407|40004708|FG002|Extension Phase|Participant's Choice|0|||
16559423|NCT02107443|40513378|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
16559424|NCT02107443|40513379|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
16559425|NCT02107443|40513378|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
16559426|NCT02107443|40513379|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
16244823|NCT02675426|39381424|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
16244824|NCT02675426|39381425|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
16244825|NCT02675426|39381426|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
16244826|NCT02675426|39381427|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
16244827|NCT02675426|39381424|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
16244828|NCT02675426|39381425|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
16244829|NCT02675426|39381426|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
16244830|NCT02675426|39381427|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
16416374|NCT01278407|40004709|FG003|Extension Phase|Participant's Choice|4|||
16416375|NCT01278407|40004710|FG004|Extension Phase|Participant's Choice|11|||
16416376|NCT01278407|40004706|FG000|Extension Phase|Other|0|||
16559427|NCT02107443|40513378|FG000|Overall Study|Withdrawal: Other Medical|9|||
16559428|NCT02107443|40513379|FG001|Overall Study|Withdrawal: Other Medical|5|||
16559429|NCT02107443|40513378|FG000|Overall Study|Withdrawal: Disease Progression|4|||
16416377|NCT01278407|40004707|FG001|Extension Phase|Other|0|||
16416378|NCT01278407|40004708|FG002|Extension Phase|Other|0|||
16416379|NCT01278407|40004709|FG003|Extension Phase|Other|1|||
16416380|NCT01278407|40004710|FG004|Extension Phase|Other|3|||
16416381|NCT01896271|40004712|FG000|Overall Study|Physician Decision|10|||
16559430|NCT02107443|40513379|FG001|Overall Study|Withdrawal: Disease Progression|2|||
16559431|NCT02107443|40513378|FG000|Overall Study|Withdrawal: Personal Issues|0|||
16559432|NCT02107443|40513379|FG001|Overall Study|Withdrawal: Personal Issues|3|||
16559433|NCT03212365|40513380|FG000|Overall Study|Discharged prior to Xa level|12|||
16559434|NCT03212365|40513381|FG001|Overall Study|Discharged prior to Xa level|8|||
16559435|NCT03212365|40513380|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
16559436|NCT03212365|40513381|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
16559437|NCT03212365|40513380|FG000|Overall Study|Refused study medication|3|||
16559438|NCT03212365|40513381|FG001|Overall Study|Refused study medication|0|||
16559439|NCT03212365|40513380|FG000|Overall Study|Initiated heparin infusion on floor|1|||
16559440|NCT03212365|40513381|FG001|Overall Study|Initiated heparin infusion on floor|1|||
16559441|NCT03212365|40513380|FG000|Overall Study|Unexpected return to OR|1|||
16559442|NCT03212365|40513381|FG001|Overall Study|Unexpected return to OR|1|||
16559443|NCT03212365|40513380|FG000|Overall Study|Medication distribution error|1|||
16559444|NCT03212365|40513381|FG001|Overall Study|Medication distribution error|0|||
16559445|NCT03212365|40513380|FG000|Overall Study|Required epidural placement|1|||
16559446|NCT03212365|40513381|FG001|Overall Study|Required epidural placement|0|||
16559447|NCT03212365|40513380|FG000|Overall Study|Withdrawal by Subject|0|||
16559448|NCT03212365|40513381|FG001|Overall Study|Withdrawal by Subject|1|||
16559449|NCT03212365|40513380|FG000|Overall Study|developed acute renal failure|0|||
16559450|NCT03212365|40513381|FG001|Overall Study|developed acute renal failure|1|||
16559451|NCT00419003|40513382|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
16559452|NCT00419003|40513383|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
16559453|NCT00419003|40513382|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
16559454|NCT00419003|40513383|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
16559455|NCT03658811|40513385|FG000|Overall Study|Lost to Follow-up|3|||
16559456|NCT00605319|40513386|FG000|Overall Study|Adverse Event|6|||
16559457|NCT01403987|40513388|FG000|Overall Study|Residents forgot their secret PIN|18|||
16559458|NCT01403987|40513389|FG001|Overall Study|Residents forgot their secret PIN|17|||
16416382|NCT01729208|40004713|FG000|Baseline|Physician Decision|5|||
16416383|NCT01729208|40004714|FG001|Baseline|Physician Decision|4|||
16416384|NCT01729208|40004713|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
16416385|NCT01729208|40004714|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
16416386|NCT01729208|40004713|FG000|12 Months Follow-up|Lost to Follow-up|3|||
16416387|NCT01729208|40004714|FG001|12 Months Follow-up|Lost to Follow-up|3|||
16416388|NCT01729208|40004713|FG000|24 Months Follow-up|Lost to Follow-up|3|||
16416389|NCT01729208|40004714|FG001|24 Months Follow-up|Lost to Follow-up|0|||
16416390|NCT01729208|40004713|FG000|36 Months Follow-up|Physician Decision|1|||
16416391|NCT01729208|40004714|FG001|36 Months Follow-up|Physician Decision|0|||
16416392|NCT01729208|40004713|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
16416393|NCT01729208|40004714|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
16416394|NCT00619099|40004715|FG000|Overall Study|Progressive Disease|7|||
16416395|NCT00619099|40004716|FG001|Overall Study|Progressive Disease|5|||
16127989|NCT00700427|38954477|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
16127990|NCT00700427|38954478|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
16127991|NCT01850446|38954481|FG000|Overall Study|Lack of Efficacy|1|||
16127992|NCT01850446|38954482|FG001|Overall Study|Lack of Efficacy|0|||
16416396|NCT00619099|40004715|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
16559459|NCT01403987|40513390|FG002|Overall Study|Residents forgot their secret PIN|18|||
16559460|NCT02322775|40513393|FG000|Overall Study|Adverse Event|1|||
16559461|NCT02322775|40513394|FG001|Overall Study|Adverse Event|0|||
16559462|NCT02322775|40513393|FG000|Overall Study|Lost to Follow-up|0|||
16244831|NCT02675426|39381424|FG000|Period 2: Week 12 to Week 260|Other|8|||
16244832|NCT02675426|39381425|FG001|Period 2: Week 12 to Week 260|Other|12|||
16416397|NCT00619099|40004716|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
16416398|NCT00619099|40004715|FG000|Overall Study|Adverse Event|4|||
16416399|NCT00619099|40004716|FG001|Overall Study|Adverse Event|3|||
16416400|NCT00619099|40004715|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
16416401|NCT00619099|40004716|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
16416402|NCT00619099|40004715|FG000|Overall Study|Withdrawal by Subject|10|||
16416403|NCT00619099|40004716|FG001|Overall Study|Withdrawal by Subject|2|||
16416404|NCT00619099|40004715|FG000|Overall Study|Physician Decision|9|||
16416405|NCT00619099|40004716|FG001|Overall Study|Physician Decision|6|||
16416406|NCT03199391|40004717|FG000|Overall Study|Death|1|||
16416407|NCT03199391|40004717|FG000|Overall Study|Lost to Follow-up|3|||
16416408|NCT03199391|40004717|FG000|Overall Study|Adverse Event|2|||
16416409|NCT03199391|40004717|FG000|Overall Study|Withdrawal by Subject|10|||
16416410|NCT03667690|40004720|FG000|Overall Study|Adverse Event|0|||
16416411|NCT03667690|40004721|FG001|Overall Study|Adverse Event|3|||
16416412|NCT03667690|40004720|FG000|Overall Study|Death|22|||
16416413|NCT03667690|40004721|FG001|Overall Study|Death|21|||
16416414|NCT03667690|40004720|FG000|Overall Study|Lost to Follow-up|4|||
16416415|NCT03667690|40004721|FG001|Overall Study|Lost to Follow-up|5|||
16559463|NCT02322775|40513394|FG001|Overall Study|Lost to Follow-up|1|||
16559464|NCT02322775|40513393|FG000|Overall Study|Protocol Violation|1|||
16559465|NCT02322775|40513394|FG001|Overall Study|Protocol Violation|0|||
16559466|NCT02322775|40513393|FG000|Overall Study|Withdrawal by Subject|3|||
16559467|NCT02322775|40513394|FG001|Overall Study|Withdrawal by Subject|4|||
16559468|NCT02322775|40513393|FG000|Overall Study|Not willing to perform all FU visits|0|||
16559469|NCT02322775|40513394|FG001|Overall Study|Not willing to perform all FU visits|1|||
16244833|NCT02675426|39381426|FG002|Period 2: Week 12 to Week 260|Other|23|||
16244834|NCT02675426|39381427|FG003|Period 2: Week 12 to Week 260|Other|15|||
16244835|NCT03237611|39381429|FG000|Overall Study|Withdrawal by Subject|1|||
16244836|NCT03237611|39381429|FG000|Overall Study|Ineligible|1|||
16244837|NCT00373685|39381430|FG000|Overall Study|Death|2|||
16244838|NCT00373685|39381431|FG001|Overall Study|Death|1|||
16244839|NCT00373685|39381430|FG000|Overall Study|Adverse Event|278|||
16244840|NCT00373685|39381431|FG001|Overall Study|Adverse Event|253|||
16244841|NCT00373685|39381430|FG000|Overall Study|Insufficient clinical response|169|||
16244842|NCT00373685|39381431|FG001|Overall Study|Insufficient clinical response|119|||
16244843|NCT00373685|39381430|FG000|Overall Study|Did not meet entrance criteria|167|||
16244844|NCT00373685|39381431|FG001|Overall Study|Did not meet entrance criteria|184|||
16244845|NCT00373685|39381430|FG000|Overall Study|Lost to follow up|83|||
16244846|NCT00373685|39381431|FG001|Overall Study|Lost to follow up|103|||
16244847|NCT00373685|39381430|FG000|Overall Study|No longer willing to participate|337|||
16244848|NCT00373685|39381431|FG001|Overall Study|No longer willing to participate|352|||
16244849|NCT00373685|39381430|FG000|Overall Study|Other|149|||
16244850|NCT00373685|39381431|FG001|Overall Study|Other|146|||
16244851|NCT00373685|39381430|FG000|Overall Study|Protocol Violation|191|||
16244852|NCT00373685|39381431|FG001|Overall Study|Protocol Violation|182|||
16244853|NCT00373685|39381430|FG000|Overall Study|Final Status Unknown|12|||
16416416|NCT03667690|40004720|FG000|Overall Study|Withdrawal by Subject|7|||
16416417|NCT03667690|40004721|FG001|Overall Study|Withdrawal by Subject|8|||
16559470|NCT01152554|40513397|FG000|Overall Study|Withdrawal by Subject|73|||
16559471|NCT01152554|40513398|FG001|Overall Study|Withdrawal by Subject|28|||
16244854|NCT00373685|39381431|FG001|Overall Study|Final Status Unknown|4|||
16244855|NCT00373685|39381430|FG000|Overall Study|Randomized, not treated|51|||
16244856|NCT00373685|39381431|FG001|Overall Study|Randomized, not treated|77|||
16416418|NCT03667690|40004720|FG000|Overall Study|Subject could not return for additional investigational product|1|||
16416419|NCT03667690|40004721|FG001|Overall Study|Subject could not return for additional investigational product|0|||
16416420|NCT03667690|40004720|FG000|Overall Study|Subject discharged to hospice care|2|||
16416421|NCT03667690|40004721|FG001|Overall Study|Subject discharged to hospice care|0|||
16416422|NCT03667690|40004720|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
16416423|NCT03667690|40004721|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
16416424|NCT03667690|40004720|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
16416425|NCT03667690|40004721|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
16416426|NCT03667690|40004720|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
16416427|NCT03667690|40004721|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
16416428|NCT03667690|40004720|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
16416429|NCT03667690|40004721|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
16416430|NCT03667690|40004720|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
16416431|NCT03667690|40004721|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
16416432|NCT00084487|40004722|FG000|Overall Study|Death|1|||
16416433|NCT01079936|40004723|FG000|Phase I: MTD|First Remission Status|2|||
16416434|NCT01079936|40004724|FG001|Phase I: MTD|First Remission Status|0|||
16416435|NCT01079936|40004725|FG002|Phase I: MTD|First Remission Status|0|||
16416436|NCT01079936|40004726|FG003|Phase I: MTD|First Remission Status|0|||
16416437|NCT01079936|40004727|FG004|Phase I: MTD|First Remission Status|0|||
16416438|NCT01079936|40004723|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
16416439|NCT01079936|40004724|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
16244857|NCT02521948|39381432|FG000|Overall Study|Adverse Event|2|||
16127993|NCT01850446|38954481|FG000|Overall Study|Withdrawal by Subject|4|||
16127994|NCT01850446|38954482|FG001|Overall Study|Withdrawal by Subject|0|||
16127995|NCT01850446|38954481|FG000|Overall Study|Protocol Violation|0|||
16127996|NCT01850446|38954482|FG001|Overall Study|Protocol Violation|2|||
16127997|NCT00910689|38954483|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
16127998|NCT00910689|38954484|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
16127999|NCT00910689|38954485|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
16128000|NCT00910689|38954486|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
16128001|NCT00910689|38954483|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
16128002|NCT00910689|38954484|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
16128003|NCT00910689|38954485|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
16128004|NCT00910689|38954486|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
16128005|NCT00910689|38954483|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
16128006|NCT00910689|38954484|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
16128007|NCT00910689|38954485|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
16128008|NCT00910689|38954486|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
16128009|NCT00910689|38954483|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
16128010|NCT00910689|38954484|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
16128011|NCT00910689|38954485|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
16128012|NCT00910689|38954486|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
16128013|NCT00910689|38954483|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
16128014|NCT00910689|38954484|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
16128015|NCT00910689|38954485|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
16128016|NCT00910689|38954486|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
16128017|NCT00910689|38954483|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
16128018|NCT00910689|38954484|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
16128019|NCT00910689|38954485|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
16128020|NCT00910689|38954486|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
16128021|NCT00910689|38954483|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
16128022|NCT00910689|38954484|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
16128023|NCT00910689|38954485|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
16128024|NCT00910689|38954486|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
16128025|NCT00910689|38954483|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
16128026|NCT00910689|38954484|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
16128027|NCT00910689|38954485|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
16128028|NCT00910689|38954486|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
16128029|NCT00910689|38954483|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
16351793|NCT03410992|39776501|FG002|Week 16 Assessment|Incorrect escapers|0|||
16351794|NCT03410992|39776502|FG003|Week 16 Assessment|Incorrect escapers|0|||
16351795|NCT03410992|39776503|FG004|Week 16 Assessment|Incorrect escapers|0|||
16351796|NCT03410992|39776504|FG005|Week 16 Assessment|Incorrect escapers|0|||
16351797|NCT03410992|39776505|FG006|Week 16 Assessment|Incorrect escapers|0|||
16128030|NCT00910689|38954484|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
16128031|NCT00910689|38954485|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
16128032|NCT00910689|38954486|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
16128033|NCT00910689|38954483|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
16128034|NCT00910689|38954484|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
16128035|NCT00910689|38954485|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
16128036|NCT00910689|38954486|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
16128037|NCT00910689|38954483|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
16128038|NCT00910689|38954484|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
16128039|NCT00910689|38954485|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
16128040|NCT00910689|38954486|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
16244858|NCT02521948|39381432|FG000|Overall Study|Death|4|||
16244859|NCT02521948|39381432|FG000|Overall Study|Lost to Follow-up|1|||
16244860|NCT02521948|39381432|FG000|Overall Study|Did not attend one or both follow-ups|6|||
16244861|NCT02725671|39381435|FG000|Overall Study|Lost to Follow-up|1|||
16244862|NCT04132232|39381436|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
16244863|NCT04132232|39381437|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
16244864|NCT04132232|39381436|FG000|Overall Study|Lost to Follow-up|6|||
16244865|NCT04132232|39381437|FG001|Overall Study|Lost to Follow-up|7|||
16244866|NCT01223196|39381438|FG000|Overall Study|Lost to Follow-up|2|||
16244867|NCT01223196|39381439|FG001|Overall Study|Lost to Follow-up|0|||
16244868|NCT01223196|39381438|FG000|Overall Study|Physician Decision|1|||
16559472|NCT01152554|40513397|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
16559473|NCT01152554|40513398|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
16559474|NCT01152554|40513397|FG000|Overall Study|Adverse Event|67|||
16244869|NCT01223196|39381439|FG001|Overall Study|Physician Decision|0|||
16559475|NCT01152554|40513398|FG001|Overall Study|Adverse Event|14|||
16559476|NCT01152554|40513397|FG000|Overall Study|Severe non-compliance to protocol|36|||
16559477|NCT01152554|40513398|FG001|Overall Study|Severe non-compliance to protocol|14|||
16559478|NCT01152554|40513397|FG000|Overall Study|Condition under investigation worsened|5|||
16559479|NCT01152554|40513398|FG001|Overall Study|Condition under investigation worsened|2|||
16559480|NCT01152554|40513397|FG000|Overall Study|Lack of Efficacy|20|||
16559481|NCT01152554|40513398|FG001|Overall Study|Lack of Efficacy|3|||
16559482|NCT01152554|40513397|FG000|Overall Study|Study-specific withdrawal criteria|17|||
16559483|NCT01152554|40513398|FG001|Overall Study|Study-specific withdrawal criteria|8|||
16559484|NCT01152554|40513397|FG000|Overall Study|Lost to Follow-up|87|||
16559485|NCT01152554|40513398|FG001|Overall Study|Lost to Follow-up|32|||
16559486|NCT01152554|40513397|FG000|Overall Study|Other|28|||
16559487|NCT01152554|40513398|FG001|Overall Study|Other|8|||
16559488|NCT01152554|40513397|FG000|Overall Study|Death|1|||
16559489|NCT01152554|40513398|FG001|Overall Study|Death|1|||
16559490|NCT02391038|40513399|FG000|Overall Study|Progressive disease|3|||
16559491|NCT02391038|40513400|FG001|Overall Study|Progressive disease|3|||
16559492|NCT02391038|40513401|FG002|Overall Study|Progressive disease|6|||
16559493|NCT01458249|40513402|FG000|Overall Study|Not treated|1|||
16559494|NCT01458249|40513402|FG000|Overall Study|Adverse Event|4|||
16244870|NCT01223196|39381438|FG000|Overall Study|Withdrawal by Subject|1|||
16244871|NCT01223196|39381439|FG001|Overall Study|Withdrawal by Subject|0|||
16244872|NCT00544557|39381447|FG000|Overall Study|Adverse Event|140|||
16244873|NCT00544557|39381447|FG000|Overall Study|Lack of Efficacy|196|||
16244874|NCT00544557|39381447|FG000|Overall Study|Other|98|||
16244875|NCT01792284|39381448|FG000|Lead-in Period|Adverse Event|15|||
16351798|NCT03410992|39776506|FG007|Week 16 Assessment|Incorrect escapers|0|||
16351799|NCT03410992|39776507|FG008|Week 16 Assessment|Incorrect escapers|0|||
16351800|NCT03410992|39776508|FG009|Week 16 Assessment|Incorrect escapers|0|||
16351801|NCT03410992|39776509|FG010|Week 16 Assessment|Incorrect escapers|0|||
16351802|NCT03410992|39776499|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
16351803|NCT03410992|39776500|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
16351804|NCT03410992|39776501|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
16351805|NCT03410992|39776502|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
16351806|NCT03410992|39776503|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
16351807|NCT03410992|39776504|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
16351808|NCT03410992|39776505|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
16351809|NCT03410992|39776506|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
16244876|NCT01792284|39381449|FG001|Lead-in Period|Adverse Event|0|||
16351810|NCT03410992|39776507|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
16351811|NCT03410992|39776508|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
16351812|NCT03410992|39776509|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
16351813|NCT03410992|39776499|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
16559495|NCT01458249|40513402|FG000|Overall Study|Other|2|||
16559496|NCT01458249|40513402|FG000|Overall Study|Ongoing|1|||
16559497|NCT01702428|40513403|FG000|Overall Study|Adverse Event|2|||
16559498|NCT01702428|40513404|FG001|Overall Study|Adverse Event|0|||
16244877|NCT01792284|39381450|FG002|Lead-in Period|Adverse Event|0|||
16559499|NCT01702428|40513405|FG002|Overall Study|Adverse Event|0|||
16559500|NCT01702428|40513406|FG003|Overall Study|Adverse Event|0|||
16128041|NCT00910689|38954483|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
16128042|NCT00910689|38954484|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
16559501|NCT01702428|40513403|FG000|Overall Study|Lost to Follow-up|33|||
16559502|NCT01702428|40513404|FG001|Overall Study|Lost to Follow-up|41|||
16559503|NCT01702428|40513405|FG002|Overall Study|Lost to Follow-up|37|||
16559504|NCT01702428|40513406|FG003|Overall Study|Lost to Follow-up|44|||
16128043|NCT00910689|38954485|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
16128044|NCT00910689|38954486|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
16128045|NCT00910689|38954483|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
16128046|NCT00910689|38954484|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
16128047|NCT00910689|38954485|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
16128048|NCT00910689|38954486|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
16128049|NCT00910689|38954483|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
16128050|NCT00910689|38954484|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
16128051|NCT00910689|38954485|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
16128052|NCT00910689|38954486|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
16128053|NCT00910689|38954483|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
16128054|NCT00910689|38954484|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
16128055|NCT00910689|38954485|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
16244878|NCT01792284|39381448|FG000|Lead-in Period|Lost to Follow-up|2|||
16244879|NCT01792284|39381449|FG001|Lead-in Period|Lost to Follow-up|0|||
16244880|NCT01792284|39381450|FG002|Lead-in Period|Lost to Follow-up|0|||
16559505|NCT01702428|40513403|FG000|Overall Study|Parents cannot assist to site|1|||
16559506|NCT01702428|40513404|FG001|Overall Study|Parents cannot assist to site|0|||
16559507|NCT01702428|40513405|FG002|Overall Study|Parents cannot assist to site|1|||
16559508|NCT01702428|40513406|FG003|Overall Study|Parents cannot assist to site|0|||
16559509|NCT01702428|40513403|FG000|Overall Study|Lost Coverage|0|||
16559510|NCT01702428|40513404|FG001|Overall Study|Lost Coverage|0|||
16559511|NCT01702428|40513405|FG002|Overall Study|Lost Coverage|0|||
16559512|NCT01702428|40513406|FG003|Overall Study|Lost Coverage|1|||
16559513|NCT01702428|40513403|FG000|Overall Study|Lost Health Plan|3|||
16559514|NCT01702428|40513404|FG001|Overall Study|Lost Health Plan|5|||
16559515|NCT01702428|40513405|FG002|Overall Study|Lost Health Plan|0|||
16559516|NCT01702428|40513406|FG003|Overall Study|Lost Health Plan|2|||
16559517|NCT01702428|40513403|FG000|Overall Study|Mother transferred care|0|||
16559518|NCT01702428|40513404|FG001|Overall Study|Mother transferred care|1|||
16559519|NCT01702428|40513405|FG002|Overall Study|Mother transferred care|0|||
16559520|NCT01702428|40513406|FG003|Overall Study|Mother transferred care|0|||
16559521|NCT01702428|40513403|FG000|Overall Study|Parents too busy|1|||
16559522|NCT01702428|40513404|FG001|Overall Study|Parents too busy|0|||
16559523|NCT01702428|40513405|FG002|Overall Study|Parents too busy|0|||
16559524|NCT01702428|40513406|FG003|Overall Study|Parents too busy|0|||
16559525|NCT01702428|40513403|FG000|Overall Study|Protocol Violation|3|||
16559526|NCT01702428|40513404|FG001|Overall Study|Protocol Violation|0|||
16559527|NCT01702428|40513405|FG002|Overall Study|Protocol Violation|1|||
16559528|NCT01702428|40513406|FG003|Overall Study|Protocol Violation|0|||
16128056|NCT00910689|38954486|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
16128057|NCT00910689|38954483|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
16559529|NCT01702428|40513403|FG000|Overall Study|Withdrawal by Subject|21|||
16559530|NCT01702428|40513404|FG001|Overall Study|Withdrawal by Subject|23|||
16559531|NCT01702428|40513405|FG002|Overall Study|Withdrawal by Subject|14|||
16559532|NCT01702428|40513406|FG003|Overall Study|Withdrawal by Subject|10|||
16559533|NCT02059161|40513408|FG000|Overall Study|Pregnancy|0|||
16559534|NCT02059161|40513409|FG001|Overall Study|Pregnancy|2|||
16559535|NCT02059161|40513408|FG000|Overall Study|Adverse Event|2|||
16559536|NCT02059161|40513409|FG001|Overall Study|Adverse Event|6|||
16559537|NCT02059161|40513408|FG000|Overall Study|Lost to Follow-up|20|||
16416440|NCT01079936|40004725|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
16416441|NCT01079936|40004726|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
16416442|NCT01079936|40004727|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
16416443|NCT01079936|40004723|FG000|Phase II|Adverse Event|0|||
16559538|NCT02059161|40513409|FG001|Overall Study|Lost to Follow-up|12|||
16559539|NCT02059161|40513408|FG000|Overall Study|Physician Decision|4|||
16559540|NCT02059161|40513409|FG001|Overall Study|Physician Decision|4|||
16559541|NCT02059161|40513408|FG000|Overall Study|Protocol Violation|1|||
16559542|NCT02059161|40513409|FG001|Overall Study|Protocol Violation|1|||
16559543|NCT02059161|40513408|FG000|Overall Study|Withdrawal by Subject|16|||
16559544|NCT02059161|40513409|FG001|Overall Study|Withdrawal by Subject|13|||
16559545|NCT02059161|40513408|FG000|Overall Study|Randomized in error, no study drug|0|||
16559546|NCT02059161|40513409|FG001|Overall Study|Randomized in error, no study drug|1|||
16244881|NCT01792284|39381448|FG000|Lead-in Period|Protocol Violation|1|||
16416444|NCT01079936|40004724|FG001|Phase II|Adverse Event|0|||
16559547|NCT02059161|40513408|FG000|Overall Study|Non-compliance with study drug|6|||
16416445|NCT01079936|40004725|FG002|Phase II|Adverse Event|1|||
16416446|NCT01079936|40004726|FG003|Phase II|Adverse Event|0|||
16559548|NCT02059161|40513409|FG001|Overall Study|Non-compliance with study drug|2|||
16559549|NCT02839681|40513410|FG000|Overall Study|Death|2|||
16559550|NCT01656759|40513411|FG000|Overall Study|Protocol Violation|2|||
16559551|NCT01656759|40513412|FG001|Overall Study|Protocol Violation|3|||
16559552|NCT01232556|40513417|FG000|Overall Study|Withdrawal by Subject|21|||
16128058|NCT00910689|38954484|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
16128059|NCT00910689|38954485|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
16128060|NCT00910689|38954486|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
16128061|NCT00910689|38954483|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
16128062|NCT00910689|38954484|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
16128063|NCT00910689|38954485|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
16128064|NCT00910689|38954486|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
16128065|NCT00910689|38954483|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
16128066|NCT00910689|38954484|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
16128067|NCT00910689|38954485|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
16128068|NCT00910689|38954486|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
16128069|NCT00910689|38954483|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
16128070|NCT00910689|38954484|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
16128071|NCT00910689|38954485|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
16128072|NCT00910689|38954486|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
16128073|NCT00910689|38954483|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
16128074|NCT00910689|38954484|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
16128075|NCT00910689|38954485|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
16128076|NCT00910689|38954486|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
16128077|NCT00910689|38954483|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
16128078|NCT00910689|38954484|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
16128079|NCT00910689|38954485|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
16128080|NCT00910689|38954486|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
16128081|NCT01034176|38954488|FG000|Overall Study|Physician Decision|2|||
16128082|NCT01034176|38954489|FG001|Overall Study|Physician Decision|0|||
16244882|NCT01792284|39381449|FG001|Lead-in Period|Protocol Violation|0|||
16244883|NCT01792284|39381450|FG002|Lead-in Period|Protocol Violation|0|||
16244884|NCT01792284|39381448|FG000|Lead-in Period|Withdrawal by Subject|10|||
16244885|NCT01792284|39381449|FG001|Lead-in Period|Withdrawal by Subject|0|||
16244886|NCT01792284|39381450|FG002|Lead-in Period|Withdrawal by Subject|0|||
16244887|NCT01792284|39381448|FG000|Lead-in Period|Physician Decision|1|||
16244888|NCT01792284|39381449|FG001|Lead-in Period|Physician Decision|0|||
16244889|NCT01792284|39381450|FG002|Lead-in Period|Physician Decision|0|||
16244890|NCT01792284|39381448|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
16244891|NCT01792284|39381449|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
16416447|NCT01079936|40004727|FG004|Phase II|Adverse Event|0|||
16416448|NCT01079936|40004723|FG000|Phase II|Insurance Issue|0|||
16416449|NCT01079936|40004724|FG001|Phase II|Insurance Issue|0|||
16416450|NCT01079936|40004725|FG002|Phase II|Insurance Issue|0|||
16416451|NCT01079936|40004726|FG003|Phase II|Insurance Issue|0|||
16416452|NCT01079936|40004727|FG004|Phase II|Insurance Issue|1|||
16416453|NCT00588094|40004728|FG000|Overall Study|Adverse Event|3|||
16416454|NCT00588094|40004728|FG000|Overall Study|Progression of Disease|2|||
16416455|NCT00694304|40004729|FG000|Overall Study|Adverse Event|42|||
16416456|NCT00694304|40004729|FG000|Overall Study|Lack of Efficacy|35|||
16416457|NCT00694304|40004729|FG000|Overall Study|Non-compliance With Study Product|16|||
16416458|NCT00694304|40004729|FG000|Overall Study|Protocol Violation|6|||
16416459|NCT00694304|40004729|FG000|Overall Study|Withdrawal of Consent|61|||
16416460|NCT00694304|40004729|FG000|Overall Study|Lost to Follow-up|15|||
16416461|NCT00694304|40004729|FG000|Overall Study|Administrative or Other Reasons|32|||
16559553|NCT01232556|40513418|FG001|Overall Study|Withdrawal by Subject|17|||
16559554|NCT01232556|40513417|FG000|Overall Study|Death|97|||
16559555|NCT01232556|40513418|FG001|Overall Study|Death|97|||
16559556|NCT01232556|40513417|FG000|Overall Study|Lost to Follow-up|0|||
16244892|NCT01792284|39381450|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
16416462|NCT00249613|40004732|FG000|12 Month Follow-up|Death|1|||
16416463|NCT00249613|40004733|FG001|12 Month Follow-up|Death|1|||
16416464|NCT00249613|40004732|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
16416465|NCT00249613|40004733|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
16559557|NCT01232556|40513418|FG001|Overall Study|Lost to Follow-up|2|||
16559558|NCT01232556|40513417|FG000|Overall Study|Terminated by Sponsor|35|||
16559559|NCT01232556|40513418|FG001|Overall Study|Terminated by Sponsor|51|||
16559560|NCT01232556|40513417|FG000|Overall Study|Other|6|||
16416466|NCT00249613|40004732|FG000|12 Month Follow-up|Lost to Follow-up|10|||
16559561|NCT01232556|40513418|FG001|Overall Study|Other|4|||
16559562|NCT02234310|40513419|FG000|Overall Study|Physician Decision|1|||
16559563|NCT02234310|40513419|FG000|Overall Study|Adverse Event|1|||
16559564|NCT02234310|40513419|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
16128083|NCT01034176|38954488|FG000|Overall Study|Withdrawal by Subject|0|||
16128084|NCT01034176|38954489|FG001|Overall Study|Withdrawal by Subject|1|||
16128085|NCT01034176|38954488|FG000|Overall Study|Lost to Follow-up|0|||
16559565|NCT02234310|40513419|FG000|Overall Study|Withdrawal by Subject|2|||
16559566|NCT03697460|40513420|FG000|Overall Study|Withdrawal by Subject|3|||
16559567|NCT01661881|40513421|FG000|Overall Study|Disease Progression|1|||
16559568|NCT03660943|40513422|FG000|Overall Study|Adverse Event|5|||
16559569|NCT03660943|40513423|FG001|Overall Study|Adverse Event|3|||
16559570|NCT03660943|40513422|FG000|Overall Study|Death|0|||
16559571|NCT03660943|40513423|FG001|Overall Study|Death|2|||
16559572|NCT03660943|40513422|FG000|Overall Study|Lost to Follow-up|7|||
16559573|NCT03660943|40513423|FG001|Overall Study|Lost to Follow-up|3|||
16244893|NCT01792284|39381448|FG000|Randomization Period 1|Withdrawal by Subject|0|||
16244894|NCT01792284|39381449|FG001|Randomization Period 1|Withdrawal by Subject|1|||
16244895|NCT01792284|39381450|FG002|Randomization Period 1|Withdrawal by Subject|1|||
16244896|NCT01792284|39381448|FG000|Randomization Period 1|Physician Decision|0|||
16244897|NCT01792284|39381449|FG001|Randomization Period 1|Physician Decision|1|||
16244898|NCT01792284|39381450|FG002|Randomization Period 1|Physician Decision|1|||
16244899|NCT01792284|39381448|FG000|Randomization Period 1|Adverse Event|0|||
16244900|NCT01792284|39381449|FG001|Randomization Period 1|Adverse Event|0|||
16244901|NCT01792284|39381450|FG002|Randomization Period 1|Adverse Event|2|||
16244902|NCT01792284|39381448|FG000|Randomization Period 1|Lost to Follow-up|0|||
16244903|NCT01792284|39381449|FG001|Randomization Period 1|Lost to Follow-up|0|||
16244904|NCT01792284|39381450|FG002|Randomization Period 1|Lost to Follow-up|1|||
16244905|NCT01792284|39381448|FG000|Randomization Period 2|Protocol Violation|0|||
16244906|NCT01792284|39381449|FG001|Randomization Period 2|Protocol Violation|1|||
16244907|NCT01792284|39381450|FG002|Randomization Period 2|Protocol Violation|0|||
16244908|NCT01792284|39381448|FG000|Randomization Period 2|Withdrawal by Subject|0|||
16244909|NCT01792284|39381449|FG001|Randomization Period 2|Withdrawal by Subject|2|||
16244910|NCT01792284|39381450|FG002|Randomization Period 2|Withdrawal by Subject|0|||
16244911|NCT03627195|39381451|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
16244912|NCT03627195|39381452|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
16244913|NCT03627195|39381453|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
16244914|NCT03627195|39381454|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
16244915|NCT03627195|39381455|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
16244916|NCT03627195|39381456|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
16244917|NCT03862625|39381457|FG000|Overall Study|Lost to Follow-up|0|||
16244918|NCT03862625|39381458|FG001|Overall Study|Lost to Follow-up|1|||
16244919|NCT04527471|39381459|FG000|Overall Study|Adverse Event|1|||
16244920|NCT04527471|39381460|FG001|Overall Study|Adverse Event|0|||
16244921|NCT04527471|39381459|FG000|Overall Study|Lost to Follow-up|1|||
16244922|NCT04527471|39381460|FG001|Overall Study|Lost to Follow-up|0|||
16244923|NCT04633837|39381461|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
16244924|NCT04633837|39381462|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
16244925|NCT02168270|39381463|FG000|Overall Study|Lack of Efficacy|4|||
16244926|NCT01590433|39381464|FG000|Overall Study|Lost to Follow-up|20|||
16244927|NCT01590433|39381465|FG001|Overall Study|Lost to Follow-up|8|||
16416467|NCT00249613|40004733|FG001|12 Month Follow-up|Lost to Follow-up|8|||
16559574|NCT03660943|40513422|FG000|Overall Study|Protocol Violation|3|||
16244928|NCT01590433|39381464|FG000|Overall Study|Withdrawal by Subject|21|||
16244929|NCT01590433|39381465|FG001|Overall Study|Withdrawal by Subject|11|||
16244930|NCT01590433|39381464|FG000|Overall Study|Adverse Event|11|||
16244931|NCT01590433|39381465|FG001|Overall Study|Adverse Event|3|||
16244932|NCT00323609|39381466|FG000|Overall Study|Death|16|||
16244933|NCT00323609|39381467|FG001|Overall Study|Death|21|||
16416468|NCT00552760|40004735|FG000|Overall Study|Adverse Event|3|||
16559575|NCT03660943|40513423|FG001|Overall Study|Protocol Violation|5|||
16244934|NCT00323609|39381468|FG002|Overall Study|Death|0|||
16244935|NCT00323609|39381469|FG003|Overall Study|Death|0|||
16244936|NCT00323609|39381466|FG000|Overall Study|Lost to Follow-up|9|||
16244937|NCT00323609|39381467|FG001|Overall Study|Lost to Follow-up|10|||
16244938|NCT00323609|39381468|FG002|Overall Study|Lost to Follow-up|0|||
16244939|NCT00323609|39381469|FG003|Overall Study|Lost to Follow-up|0|||
16244940|NCT00323609|39381466|FG000|Overall Study|Physician Decision|2|||
16244941|NCT00323609|39381467|FG001|Overall Study|Physician Decision|0|||
16244942|NCT00323609|39381468|FG002|Overall Study|Physician Decision|0|||
16244943|NCT00323609|39381469|FG003|Overall Study|Physician Decision|1|||
16244944|NCT00323609|39381466|FG000|Overall Study|Withdrawal by Subject|11|||
16351814|NCT03410992|39776500|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
16351815|NCT03410992|39776501|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
16351816|NCT03410992|39776502|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
16351817|NCT03410992|39776503|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
16244945|NCT00323609|39381467|FG001|Overall Study|Withdrawal by Subject|23|||
16244946|NCT00323609|39381468|FG002|Overall Study|Withdrawal by Subject|4|||
16244947|NCT00323609|39381469|FG003|Overall Study|Withdrawal by Subject|4|||
16244948|NCT00323609|39381466|FG000|Overall Study|Other non-VCF-related medical condition|3|||
16351818|NCT03410992|39776504|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
16351819|NCT03410992|39776505|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
16351820|NCT03410992|39776506|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
16244949|NCT00323609|39381467|FG001|Overall Study|Other non-VCF-related medical condition|2|||
16244950|NCT00323609|39381468|FG002|Overall Study|Other non-VCF-related medical condition|0|||
16244951|NCT00323609|39381469|FG003|Overall Study|Other non-VCF-related medical condition|0|||
16244952|NCT00323609|39381466|FG000|Overall Study|Sponsor discontinued trial|29|||
16244953|NCT00323609|39381467|FG001|Overall Study|Sponsor discontinued trial|29|||
16244954|NCT00323609|39381468|FG002|Overall Study|Sponsor discontinued trial|0|||
16244955|NCT00323609|39381469|FG003|Overall Study|Sponsor discontinued trial|0|||
16244956|NCT00323609|39381466|FG000|Overall Study|Unrelenting or severe back pain|1|||
16244957|NCT00323609|39381467|FG001|Overall Study|Unrelenting or severe back pain|1|||
16244958|NCT00323609|39381468|FG002|Overall Study|Unrelenting or severe back pain|0|||
16244959|NCT00323609|39381469|FG003|Overall Study|Unrelenting or severe back pain|0|||
16244960|NCT00323609|39381466|FG000|Overall Study|Logistical withdrawal|9|||
16244961|NCT00323609|39381467|FG001|Overall Study|Logistical withdrawal|5|||
16244962|NCT00323609|39381468|FG002|Overall Study|Logistical withdrawal|0|||
16244963|NCT00323609|39381469|FG003|Overall Study|Logistical withdrawal|1|||
16244964|NCT00323609|39381466|FG000|Overall Study|Other reason|11|||
16244965|NCT00323609|39381467|FG001|Overall Study|Other reason|8|||
16559576|NCT03660943|40513422|FG000|Overall Study|Withdrawal by Subject|8|||
16559577|NCT03660943|40513423|FG001|Overall Study|Withdrawal by Subject|15|||
16128086|NCT01034176|38954489|FG001|Overall Study|Lost to Follow-up|1|||
16128087|NCT00195091|38954490|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
16128088|NCT02387970|38954495|FG000|Overall Study|Did not complete 1-year follow up|1|||
16128089|NCT02387970|38954496|FG001|Overall Study|Did not complete 1-year follow up|2|||
16128090|NCT04410523|38954497|FG000|Overall Study|Study terminated by sponsor|1|||
16128091|NCT04410523|38954498|FG001|Overall Study|Study terminated by sponsor|3|||
16128092|NCT04410523|38954499|FG002|Overall Study|Study terminated by sponsor|2|||
16128093|NCT04410523|38954500|FG003|Overall Study|Study terminated by sponsor|6|||
16128094|NCT04410523|38954501|FG004|Overall Study|Study terminated by sponsor|3|||
16128095|NCT04410523|38954502|FG005|Overall Study|Study terminated by sponsor|4|||
16244966|NCT00323609|39381468|FG002|Overall Study|Other reason|4|||
16244967|NCT00323609|39381469|FG003|Overall Study|Other reason|9|||
16559578|NCT03660943|40513422|FG000|Overall Study|Lack of Efficacy|9|||
16244968|NCT01663714|39381471|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
16244969|NCT01663714|39381471|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
16244970|NCT01663714|39381471|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
16244971|NCT01663714|39381471|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
16244972|NCT01663714|39381471|FG000|Long-Term Follow-Up|Death|4|||
16244973|NCT01663714|39381471|FG000|Long-Term Follow-Up|Non-compliance|1|||
16244974|NCT02370784|39381474|FG000|Overall Study|Patient started prohibited medication|0|||
16244975|NCT02370784|39381475|FG001|Overall Study|Patient started prohibited medication|1|||
16244976|NCT01214603|39381476|FG000|Overall Study|Adverse Event|0|||
16244977|NCT01214603|39381477|FG001|Overall Study|Adverse Event|0|||
16244978|NCT01214603|39381478|FG002|Overall Study|Adverse Event|1|||
16244979|NCT01214603|39381476|FG000|Overall Study|Death|1|||
16244980|NCT01214603|39381477|FG001|Overall Study|Death|0|||
16244981|NCT01214603|39381478|FG002|Overall Study|Death|0|||
16244982|NCT01214603|39381476|FG000|Overall Study|Progressive Disease|4|||
16244983|NCT01214603|39381477|FG001|Overall Study|Progressive Disease|1|||
16244984|NCT01214603|39381478|FG002|Overall Study|Progressive Disease|3|||
16244985|NCT00219557|39381479|FG000|Phase 1|Lack of Efficacy|3|||
16244986|NCT00219557|39381480|FG001|Phase 1|Lack of Efficacy|0|||
16244987|NCT00219557|39381481|FG002|Phase 1|Lack of Efficacy|0|||
16244988|NCT00219557|39381479|FG000|Phase 1|Adverse Event|2|||
16244989|NCT00219557|39381480|FG001|Phase 1|Adverse Event|0|||
16244990|NCT00219557|39381481|FG002|Phase 1|Adverse Event|0|||
16559579|NCT03660943|40513423|FG001|Overall Study|Lack of Efficacy|12|||
16559580|NCT03660943|40513422|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
16559581|NCT03660943|40513423|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
16559582|NCT00765362|40513424|FG000|Overall Study|Death|9|||
16559583|NCT00765362|40513424|FG000|Overall Study|Adverse Event|2|||
16559584|NCT00765362|40513424|FG000|Overall Study|Protocol Violation|18|||
16559585|NCT00765362|40513424|FG000|Overall Study|Withdrawal by Subject|13|||
16559586|NCT00765362|40513424|FG000|Overall Study|Lost to Follow-up|95|||
16128096|NCT04410523|38954497|FG000|Overall Study|Adverse Event|1|||
16128097|NCT04410523|38954498|FG001|Overall Study|Adverse Event|0|||
16244991|NCT00219557|39381479|FG000|Phase 1|Withdrawal by Subject|1|||
16244992|NCT00219557|39381480|FG001|Phase 1|Withdrawal by Subject|0|||
16244993|NCT00219557|39381481|FG002|Phase 1|Withdrawal by Subject|0|||
16244994|NCT00219557|39381479|FG000|Phase 1|Started chemotherapy at other institute|1|||
16244995|NCT00219557|39381480|FG001|Phase 1|Started chemotherapy at other institute|0|||
16244996|NCT00219557|39381481|FG002|Phase 1|Started chemotherapy at other institute|0|||
16244997|NCT00219557|39381479|FG000|Phase 2|Lack of Efficacy|0|||
16244998|NCT00219557|39381480|FG001|Phase 2|Lack of Efficacy|21|||
16244999|NCT00219557|39381481|FG002|Phase 2|Lack of Efficacy|15|||
16245000|NCT00219557|39381479|FG000|Phase 2|Adverse Event|0|||
16245001|NCT00219557|39381480|FG001|Phase 2|Adverse Event|22|||
16245002|NCT00219557|39381481|FG002|Phase 2|Adverse Event|2|||
16245003|NCT00219557|39381479|FG000|Phase 2|Death|0|||
16245004|NCT00219557|39381480|FG001|Phase 2|Death|8|||
16245005|NCT00219557|39381481|FG002|Phase 2|Death|2|||
16245006|NCT00219557|39381479|FG000|Phase 2|Other|0|||
16245007|NCT00219557|39381480|FG001|Phase 2|Other|8|||
16245008|NCT00219557|39381481|FG002|Phase 2|Other|6|||
16245009|NCT00219557|39381479|FG000|Phase 2|Withdrawal by Subject|0|||
16245010|NCT00219557|39381480|FG001|Phase 2|Withdrawal by Subject|9|||
16245011|NCT00219557|39381481|FG002|Phase 2|Withdrawal by Subject|5|||
16245012|NCT00219557|39381479|FG000|Phase 2|Treatment not received|0|||
16245013|NCT00219557|39381480|FG001|Phase 2|Treatment not received|1|||
16245014|NCT00219557|39381481|FG002|Phase 2|Treatment not received|3|||
16245015|NCT03551730|39381482|FG000|Overall Study|Adverse Event|1|||
16245016|NCT03551730|39381483|FG001|Overall Study|Adverse Event|0|||
16245017|NCT03551730|39381484|FG002|Overall Study|Adverse Event|0|||
16245018|NCT03551730|39381485|FG003|Overall Study|Adverse Event|0|||
16245019|NCT03210259|39381486|FG000|12-Week Run-in Period|Adverse Event|1|||
16245020|NCT03210259|39381487|FG001|12-Week Run-in Period|Adverse Event|0|||
16245021|NCT03210259|39381488|FG002|12-Week Run-in Period|Adverse Event|0|||
16245022|NCT03210259|39381486|FG000|12-Week Run-in Period|Death|1|||
16245023|NCT03210259|39381487|FG001|12-Week Run-in Period|Death|0|||
16245024|NCT03210259|39381488|FG002|12-Week Run-in Period|Death|0|||
16245025|NCT03210259|39381486|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
16245026|NCT03210259|39381487|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
16245027|NCT03210259|39381488|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
16245028|NCT03210259|39381486|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
16245029|NCT03210259|39381487|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
16245030|NCT03210259|39381488|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
16245031|NCT03210259|39381486|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
16245032|NCT03210259|39381487|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
16245033|NCT03210259|39381488|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
16245034|NCT03210259|39381486|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
16245035|NCT03210259|39381487|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
16245036|NCT03210259|39381488|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
16245037|NCT03210259|39381486|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
16245038|NCT03210259|39381487|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
16245039|NCT03210259|39381488|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
16245040|NCT03210259|39381486|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
16245041|NCT03210259|39381487|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
16245042|NCT03210259|39381488|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
16245043|NCT03210259|39381486|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
16245044|NCT03210259|39381487|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
16245045|NCT03210259|39381488|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
16245046|NCT03210259|39381486|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
16245047|NCT03210259|39381487|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
16245048|NCT03210259|39381488|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
16245049|NCT03210259|39381486|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
16245050|NCT03210259|39381487|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
16245051|NCT03210259|39381488|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
16245052|NCT01261325|39381489|FG000|Overall Study|Lack of Efficacy|1|||
16245053|NCT01261325|39381490|FG001|Overall Study|Lack of Efficacy|1|||
16245054|NCT01261325|39381491|FG002|Overall Study|Lack of Efficacy|0|||
16245055|NCT01261325|39381489|FG000|Overall Study|Withdrawal by Subject|2|||
16245056|NCT01261325|39381490|FG001|Overall Study|Withdrawal by Subject|2|||
16245057|NCT01261325|39381491|FG002|Overall Study|Withdrawal by Subject|4|||
16245058|NCT01261325|39381489|FG000|Overall Study|SAE, non-fatal|1|||
16245059|NCT01261325|39381490|FG001|Overall Study|SAE, non-fatal|5|||
16351821|NCT03410992|39776507|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
16351822|NCT03410992|39776508|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
16351823|NCT03410992|39776509|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
16351824|NCT03410992|39776499|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
16351825|NCT03410992|39776500|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
16351826|NCT03410992|39776501|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
16351827|NCT03410992|39776502|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
16351828|NCT03410992|39776503|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
16351829|NCT03410992|39776504|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
16351830|NCT03410992|39776505|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
16351831|NCT03410992|39776506|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
16128098|NCT04410523|38954499|FG002|Overall Study|Adverse Event|0|||
16245060|NCT01261325|39381491|FG002|Overall Study|SAE, non-fatal|1|||
16245061|NCT01261325|39381489|FG000|Overall Study|AE, non-serious non-fatal|9|||
16245062|NCT01261325|39381490|FG001|Overall Study|AE, non-serious non-fatal|15|||
16245063|NCT01261325|39381491|FG002|Overall Study|AE, non-serious non-fatal|13|||
16245064|NCT01261325|39381489|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
16245065|NCT01261325|39381490|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16245066|NCT01261325|39381491|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
16245067|NCT01261325|39381489|FG000|Overall Study|Non Compliance|2|||
16245068|NCT01261325|39381490|FG001|Overall Study|Non Compliance|0|||
16245069|NCT01261325|39381491|FG002|Overall Study|Non Compliance|0|||
16245070|NCT01261325|39381489|FG000|Overall Study|Patient Randomized by Mistake|0|||
16245071|NCT01261325|39381490|FG001|Overall Study|Patient Randomized by Mistake|1|||
16245072|NCT01261325|39381491|FG002|Overall Study|Patient Randomized by Mistake|0|||
16245073|NCT01261325|39381489|FG000|Overall Study|Erroneously Randomized|1|||
16245074|NCT01261325|39381490|FG001|Overall Study|Erroneously Randomized|0|||
16245075|NCT01261325|39381491|FG002|Overall Study|Erroneously Randomized|0|||
16245076|NCT01261325|39381489|FG000|Overall Study|Screen Failure|1|||
16245077|NCT01261325|39381490|FG001|Overall Study|Screen Failure|0|||
16128099|NCT04410523|38954500|FG003|Overall Study|Adverse Event|0|||
16128100|NCT04410523|38954501|FG004|Overall Study|Adverse Event|0|||
16245078|NCT01261325|39381491|FG002|Overall Study|Screen Failure|0|||
16245079|NCT01261325|39381489|FG000|Overall Study|Randomized in Error|0|||
16245080|NCT01261325|39381490|FG001|Overall Study|Randomized in Error|0|||
16245081|NCT01261325|39381491|FG002|Overall Study|Randomized in Error|1|||
16559587|NCT02397460|40513425|FG000|Treatment Period 2|Adverse Event|0|||
16559588|NCT02397460|40513426|FG001|Treatment Period 2|Adverse Event|0|||
16559589|NCT02397460|40513427|FG002|Treatment Period 2|Adverse Event|0|||
16559590|NCT02397460|40513428|FG003|Treatment Period 2|Adverse Event|0|||
16559591|NCT02397460|40513429|FG004|Treatment Period 2|Adverse Event|0|||
16559592|NCT02397460|40513430|FG005|Treatment Period 2|Adverse Event|0|||
16559593|NCT02397460|40513431|FG006|Treatment Period 2|Adverse Event|0|||
16559594|NCT02397460|40513432|FG007|Treatment Period 2|Adverse Event|1|||
16559595|NCT02397460|40513425|FG000|Treatment Period 4|Adverse Event|0|||
16559596|NCT02397460|40513426|FG001|Treatment Period 4|Adverse Event|1|||
16559597|NCT02397460|40513427|FG002|Treatment Period 4|Adverse Event|0|||
16245082|NCT01261325|39381489|FG000|Overall Study|Protocol Violation|0|||
16245083|NCT01261325|39381490|FG001|Overall Study|Protocol Violation|3|||
16245084|NCT01261325|39381491|FG002|Overall Study|Protocol Violation|1|||
16245085|NCT01261325|39381489|FG000|Overall Study|Lost to Follow-up|0|||
16245086|NCT01261325|39381490|FG001|Overall Study|Lost to Follow-up|1|||
16245087|NCT01261325|39381491|FG002|Overall Study|Lost to Follow-up|3|||
16245088|NCT01261325|39381489|FG000|Overall Study|AE, serious fatal|0|||
16245089|NCT01261325|39381490|FG001|Overall Study|AE, serious fatal|0|||
16351832|NCT03410992|39776507|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
16351833|NCT03410992|39776508|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
16351834|NCT03410992|39776509|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
16351835|NCT03410992|39776499|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
16351836|NCT03410992|39776500|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
16351837|NCT03410992|39776501|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
16351838|NCT03410992|39776502|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
16351839|NCT03410992|39776503|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
16351840|NCT03410992|39776504|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
16351841|NCT03410992|39776505|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
16351842|NCT03410992|39776506|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
16351843|NCT03410992|39776507|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
16351844|NCT03410992|39776508|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
16351845|NCT03410992|39776509|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
16351846|NCT03410992|39776499|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
16351847|NCT03410992|39776500|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
16351848|NCT03410992|39776501|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
16351849|NCT03410992|39776502|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
16351850|NCT03410992|39776503|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
16351851|NCT03410992|39776504|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
16351852|NCT03410992|39776505|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
16351853|NCT03410992|39776506|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
16351854|NCT03410992|39776507|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
16351855|NCT03410992|39776508|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
16351856|NCT03410992|39776509|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
16351857|NCT03410992|39776499|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
16351858|NCT03410992|39776500|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
16351859|NCT03410992|39776501|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
16351860|NCT03410992|39776502|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
16351861|NCT03410992|39776503|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
16351862|NCT03410992|39776504|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
16351863|NCT03410992|39776505|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
16351864|NCT03410992|39776506|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
16351865|NCT03410992|39776507|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
16351866|NCT03410992|39776508|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
16351867|NCT03410992|39776509|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
16351868|NCT00243919|39776513|FG000|Overall Study|Death|3|||
16351869|NCT00243919|39776514|FG001|Overall Study|Death|4|||
16351870|NCT00243919|39776515|FG002|Overall Study|Death|6|||
16351871|NCT00243919|39776513|FG000|Overall Study|Withdrawal by Subject|6|||
16351872|NCT00243919|39776514|FG001|Overall Study|Withdrawal by Subject|6|||
16351873|NCT00243919|39776515|FG002|Overall Study|Withdrawal by Subject|2|||
16559598|NCT02397460|40513428|FG003|Treatment Period 4|Adverse Event|0|||
16559599|NCT02397460|40513429|FG004|Treatment Period 4|Adverse Event|0|||
16559600|NCT02397460|40513430|FG005|Treatment Period 4|Adverse Event|0|||
16245090|NCT01261325|39381491|FG002|Overall Study|AE, serious fatal|2|||
16245091|NCT04378010|39381495|FG000|Overall Study|Adverse Event|8|||
16245092|NCT04378010|39381496|FG001|Overall Study|Adverse Event|14|||
16245093|NCT04378010|39381497|FG002|Overall Study|Adverse Event|4|||
16245094|NCT04378010|39381495|FG000|Overall Study|Withdrawal by Subject|0|||
16245095|NCT04378010|39381496|FG001|Overall Study|Withdrawal by Subject|2|||
16245096|NCT04378010|39381497|FG002|Overall Study|Withdrawal by Subject|1|||
16245097|NCT04378010|39381495|FG000|Overall Study|Protocol Violation|2|||
16245098|NCT04378010|39381496|FG001|Overall Study|Protocol Violation|1|||
16245099|NCT04378010|39381497|FG002|Overall Study|Protocol Violation|4|||
16245100|NCT04378010|39381495|FG000|Overall Study|Study terminated by Sponsor|22|||
16245101|NCT04378010|39381496|FG001|Overall Study|Study terminated by Sponsor|16|||
16245102|NCT04378010|39381497|FG002|Overall Study|Study terminated by Sponsor|22|||
16245103|NCT04378010|39381495|FG000|Overall Study|Subject inability to complete study visit|0|||
16245104|NCT04378010|39381496|FG001|Overall Study|Subject inability to complete study visit|0|||
16245105|NCT04378010|39381497|FG002|Overall Study|Subject inability to complete study visit|1|||
16245106|NCT04378010|39381495|FG000|Overall Study|Subject never dosed|0|||
16245107|NCT04378010|39381496|FG001|Overall Study|Subject never dosed|1|||
16245108|NCT04378010|39381497|FG002|Overall Study|Subject never dosed|0|||
16245109|NCT01259401|39381498|FG000|4-month Follow-up|Death|0|||
16245110|NCT01259401|39381499|FG001|4-month Follow-up|Death|1|||
16245111|NCT01259401|39381498|FG000|4-month Follow-up|Lost to Follow-up|0|||
16245112|NCT01259401|39381499|FG001|4-month Follow-up|Lost to Follow-up|1|||
16245113|NCT00463866|39381501|FG000|Overall Study|Adverse Event|70|||
16245114|NCT00463866|39381502|FG001|Overall Study|Adverse Event|93|||
16245115|NCT00463866|39381501|FG000|Overall Study|Withdrawal by Subject|81|||
16245116|NCT00463866|39381502|FG001|Overall Study|Withdrawal by Subject|79|||
16245117|NCT00463866|39381501|FG000|Overall Study|Lost to Follow-up|46|||
16245118|NCT00463866|39381502|FG001|Overall Study|Lost to Follow-up|55|||
16245119|NCT00463866|39381501|FG000|Overall Study|Incorrect Enrolment|64|||
16245120|NCT00463866|39381502|FG001|Overall Study|Incorrect Enrolment|66|||
16245121|NCT00463866|39381501|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
16245122|NCT00463866|39381502|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
16245123|NCT00463866|39381501|FG000|Overall Study|Safety Reason|1|||
16245124|NCT00463866|39381502|FG001|Overall Study|Safety Reason|3|||
16559601|NCT02397460|40513431|FG006|Treatment Period 4|Adverse Event|0|||
16559602|NCT02397460|40513432|FG007|Treatment Period 4|Adverse Event|0|||
16559603|NCT02397460|40513425|FG000|Treatment Period 4|Physician Decision|0|||
16559604|NCT02397460|40513426|FG001|Treatment Period 4|Physician Decision|0|||
16245125|NCT00463866|39381501|FG000|Overall Study|Mis-Randomization of subject|0|||
16245126|NCT00463866|39381502|FG001|Overall Study|Mis-Randomization of subject|1|||
16245127|NCT00463866|39381501|FG000|Overall Study|Other|22|||
16245128|NCT00463866|39381502|FG001|Overall Study|Other|22|||
16245129|NCT01620489|39381503|FG000|Overall Study|Adverse Event|17|||
16245130|NCT01620489|39381504|FG001|Overall Study|Adverse Event|4|||
16245131|NCT01620489|39381503|FG000|Overall Study|Protocol Violation|0|||
16245132|NCT01620489|39381504|FG001|Overall Study|Protocol Violation|3|||
16245133|NCT01620489|39381503|FG000|Overall Study|Withdrawal Criteria|17|||
16245134|NCT01620489|39381504|FG001|Overall Study|Withdrawal Criteria|25|||
16245135|NCT01620489|39381503|FG000|Overall Study|Unclassified|1|||
16245136|NCT01620489|39381504|FG001|Overall Study|Unclassified|2|||
16245137|NCT01025193|39381505|FG000|Overall Study|Protocol Violation|1|||
16245138|NCT01025193|39381505|FG000|Overall Study|Adverse Event|3|||
16245139|NCT02290028|39381506|FG000|Overall Study|Death|217|||
16245140|NCT02290028|39381506|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
16245141|NCT02290028|39381506|FG000|Overall Study|No longer under care of study physician|76|||
16245142|NCT02290028|39381506|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
16245143|NCT02290028|39381506|FG000|Overall Study|Withdrawal by Subject|52|||
16245144|NCT02290028|39381506|FG000|Overall Study|Study site closure|44|||
16245145|NCT02290028|39381506|FG000|Overall Study|Lost to Follow-up|34|||
16245146|NCT02290028|39381506|FG000|Overall Study|Miscellaneous|10|||
16245147|NCT02290028|39381506|FG000|Overall Study|Transition to EP PASSION|1295|||
16245148|NCT02290028|39381506|FG000|Overall Study|Planned study completion at 12 months|257|||
16245149|NCT01664052|39381510|FG000|Phase 1|No device placement|6|||
16245150|NCT01664052|39381511|FG001|Phase 1|No device placement|0|||
16245151|NCT01664052|39381510|FG000|Phase 1|No HSG 1 hr post placement|1|||
16245152|NCT01664052|39381511|FG001|Phase 1|No HSG 1 hr post placement|0|||
16245153|NCT01664052|39381510|FG000|Phase 2|No device placement|0|||
16245154|NCT01664052|39381511|FG001|Phase 2|No device placement|4|||
16245155|NCT02513459|39381513|FG000|Overall Study|Adverse Event|7|||
16245156|NCT02513459|39381513|FG000|Overall Study|Withdrew consent|5|||
16245157|NCT02513459|39381513|FG000|Overall Study|Loss of efficacy|2|||
16245158|NCT02513459|39381513|FG000|Overall Study|Pregnancy|2|||
16559605|NCT02397460|40513427|FG002|Treatment Period 4|Physician Decision|0|||
16559606|NCT02397460|40513428|FG003|Treatment Period 4|Physician Decision|0|||
16245159|NCT02513459|39381513|FG000|Overall Study|Subject decision|2|||
16351874|NCT00243919|39776513|FG000|Overall Study|Lost to Follow-up|6|||
16245160|NCT02513459|39381513|FG000|Overall Study|Lack of response|1|||
16245161|NCT02513459|39381513|FG000|Overall Study|Reproductive plans|1|||
16351875|NCT00243919|39776514|FG001|Overall Study|Lost to Follow-up|7|||
16351876|NCT00243919|39776515|FG002|Overall Study|Lost to Follow-up|3|||
16245162|NCT02513459|39381513|FG000|Overall Study|Surgery planned-- not done|1|||
16245163|NCT00409578|39381515|FG000|Overall Study|Adverse Event|27|||
16245164|NCT00409578|39381516|FG001|Overall Study|Adverse Event|37|||
16245165|NCT00409578|39381517|FG002|Overall Study|Adverse Event|25|||
16245166|NCT00409578|39381518|FG003|Overall Study|Adverse Event|33|||
16245167|NCT00409578|39381515|FG000|Overall Study|Abnormal laboratory value(s)|2|||
16245168|NCT00409578|39381516|FG001|Overall Study|Abnormal laboratory value(s)|2|||
16245169|NCT00409578|39381517|FG002|Overall Study|Abnormal laboratory value(s)|2|||
16245170|NCT00409578|39381518|FG003|Overall Study|Abnormal laboratory value(s)|4|||
16245171|NCT00409578|39381515|FG000|Overall Study|Lack of Efficacy|0|||
16245172|NCT00409578|39381516|FG001|Overall Study|Lack of Efficacy|0|||
16245173|NCT00409578|39381517|FG002|Overall Study|Lack of Efficacy|0|||
16245174|NCT00409578|39381518|FG003|Overall Study|Lack of Efficacy|2|||
16245175|NCT00409578|39381515|FG000|Overall Study|Subject no longer requires study drug|0|||
16245176|NCT00409578|39381516|FG001|Overall Study|Subject no longer requires study drug|0|||
16559607|NCT02397460|40513429|FG004|Treatment Period 4|Physician Decision|1|||
16559608|NCT02397460|40513430|FG005|Treatment Period 4|Physician Decision|0|||
16559609|NCT02397460|40513431|FG006|Treatment Period 4|Physician Decision|0|||
16559610|NCT02397460|40513432|FG007|Treatment Period 4|Physician Decision|0|||
16559611|NCT03639675|40513436|FG000|Overall Study|Withdrawal by Subject|1|||
16559612|NCT03000673|40513438|FG000|Overall Study|Withdrawal by Subject|1|||
16559613|NCT03000673|40513439|FG001|Overall Study|Withdrawal by Subject|0|||
16559614|NCT03000673|40513440|FG002|Overall Study|Withdrawal by Subject|0|||
16245177|NCT00409578|39381517|FG002|Overall Study|Subject no longer requires study drug|0|||
16245178|NCT00409578|39381518|FG003|Overall Study|Subject no longer requires study drug|1|||
16245179|NCT00409578|39381515|FG000|Overall Study|Withdrawal by Subject|8|||
16245180|NCT00409578|39381516|FG001|Overall Study|Withdrawal by Subject|15|||
16245181|NCT00409578|39381517|FG002|Overall Study|Withdrawal by Subject|16|||
16351877|NCT00243919|39776513|FG000|Overall Study|Administrative Error|1|||
16351878|NCT00243919|39776514|FG001|Overall Study|Administrative Error|0|||
16351879|NCT00243919|39776515|FG002|Overall Study|Administrative Error|0|||
16351880|NCT00243919|39776513|FG000|Overall Study|Physician Decision|1|||
16351881|NCT00243919|39776514|FG001|Overall Study|Physician Decision|1|||
16351882|NCT00243919|39776515|FG002|Overall Study|Physician Decision|0|||
16351883|NCT01656395|39776517|FG000|Overall Study|Adverse Event|1|||
16351884|NCT01656395|39776518|FG001|Overall Study|Adverse Event|14|||
16351885|NCT01656395|39776519|FG002|Overall Study|Adverse Event|5|||
16351886|NCT01656395|39776520|FG003|Overall Study|Adverse Event|4|||
16351887|NCT01656395|39776521|FG004|Overall Study|Adverse Event|5|||
16351888|NCT01656395|39776522|FG005|Overall Study|Adverse Event|7|||
16351889|NCT01656395|39776523|FG006|Overall Study|Adverse Event|0|||
16351890|NCT01656395|39776524|FG007|Overall Study|Adverse Event|0|||
16351891|NCT01656395|39776517|FG000|Overall Study|Lack of Efficacy|1|||
16351892|NCT01656395|39776518|FG001|Overall Study|Lack of Efficacy|8|||
16351893|NCT01656395|39776519|FG002|Overall Study|Lack of Efficacy|6|||
16351894|NCT01656395|39776520|FG003|Overall Study|Lack of Efficacy|1|||
16351895|NCT01656395|39776521|FG004|Overall Study|Lack of Efficacy|1|||
16351896|NCT01656395|39776522|FG005|Overall Study|Lack of Efficacy|6|||
16351897|NCT01656395|39776523|FG006|Overall Study|Lack of Efficacy|0|||
16351898|NCT01656395|39776524|FG007|Overall Study|Lack of Efficacy|0|||
16351899|NCT01656395|39776517|FG000|Overall Study|Lost to Follow-up|1|||
16351900|NCT01656395|39776518|FG001|Overall Study|Lost to Follow-up|0|||
16351901|NCT01656395|39776519|FG002|Overall Study|Lost to Follow-up|0|||
16351902|NCT01656395|39776520|FG003|Overall Study|Lost to Follow-up|0|||
16351903|NCT01656395|39776521|FG004|Overall Study|Lost to Follow-up|0|||
16351904|NCT01656395|39776522|FG005|Overall Study|Lost to Follow-up|0|||
16351905|NCT01656395|39776523|FG006|Overall Study|Lost to Follow-up|0|||
16351906|NCT01656395|39776524|FG007|Overall Study|Lost to Follow-up|0|||
16351907|NCT01656395|39776517|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16245182|NCT00409578|39381518|FG003|Overall Study|Withdrawal by Subject|17|||
16351908|NCT01656395|39776518|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16351909|NCT01656395|39776519|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16351910|NCT01656395|39776520|FG003|Overall Study|Non-Compliance with Study Drug|0|||
16559615|NCT03000673|40513441|FG003|Overall Study|Withdrawal by Subject|0|||
16245183|NCT00409578|39381515|FG000|Overall Study|Lost to Follow-up|2|||
16245184|NCT00409578|39381516|FG001|Overall Study|Lost to Follow-up|0|||
16245185|NCT00409578|39381517|FG002|Overall Study|Lost to Follow-up|2|||
16351911|NCT01656395|39776521|FG004|Overall Study|Non-Compliance with Study Drug|1|||
16351912|NCT01656395|39776522|FG005|Overall Study|Non-Compliance with Study Drug|1|||
16351913|NCT01656395|39776523|FG006|Overall Study|Non-Compliance with Study Drug|0|||
16559616|NCT01115998|40513442|FG000|Overall Study|Lost to Follow-up|6|||
16128101|NCT04410523|38954502|FG005|Overall Study|Adverse Event|2|||
16128102|NCT04410523|38954497|FG000|Overall Study|Lost to Follow-up|0|||
16128103|NCT04410523|38954498|FG001|Overall Study|Lost to Follow-up|1|||
16128104|NCT04410523|38954499|FG002|Overall Study|Lost to Follow-up|0|||
16128105|NCT04410523|38954500|FG003|Overall Study|Lost to Follow-up|0|||
16128106|NCT04410523|38954501|FG004|Overall Study|Lost to Follow-up|0|||
16128107|NCT04410523|38954502|FG005|Overall Study|Lost to Follow-up|0|||
16128108|NCT04410523|38954497|FG000|Overall Study|Physician Decision|0|||
16128109|NCT04410523|38954498|FG001|Overall Study|Physician Decision|1|||
16128110|NCT04410523|38954499|FG002|Overall Study|Physician Decision|0|||
16128111|NCT04410523|38954500|FG003|Overall Study|Physician Decision|0|||
16128112|NCT04410523|38954501|FG004|Overall Study|Physician Decision|0|||
16128113|NCT04410523|38954502|FG005|Overall Study|Physician Decision|0|||
16416469|NCT00552760|40004736|FG001|Overall Study|Adverse Event|5|||
16416470|NCT00552760|40004735|FG000|Overall Study|Relapsed- Depressed Event|10|||
16416471|NCT00552760|40004736|FG001|Overall Study|Relapsed- Depressed Event|16|||
16416472|NCT00552760|40004735|FG000|Overall Study|Relapse- Manic Event|3|||
16416473|NCT00552760|40004736|FG001|Overall Study|Relapse- Manic Event|3|||
16416474|NCT00552760|40004735|FG000|Overall Study|Relapsed- Mixed Event|3|||
16416475|NCT00552760|40004736|FG001|Overall Study|Relapsed- Mixed Event|5|||
16128114|NCT04410523|38954497|FG000|Overall Study|Pregnancy|0|||
16128115|NCT04410523|38954498|FG001|Overall Study|Pregnancy|0|||
16128116|NCT04410523|38954499|FG002|Overall Study|Pregnancy|0|||
16128117|NCT04410523|38954500|FG003|Overall Study|Pregnancy|0|||
16128118|NCT04410523|38954501|FG004|Overall Study|Pregnancy|0|||
16128119|NCT04410523|38954502|FG005|Overall Study|Pregnancy|1|||
16128120|NCT04410523|38954497|FG000|Overall Study|Protocol deviation|0|||
16128121|NCT04410523|38954498|FG001|Overall Study|Protocol deviation|0|||
16128122|NCT04410523|38954499|FG002|Overall Study|Protocol deviation|0|||
16128123|NCT04410523|38954500|FG003|Overall Study|Protocol deviation|0|||
16128124|NCT04410523|38954501|FG004|Overall Study|Protocol deviation|0|||
16128125|NCT04410523|38954502|FG005|Overall Study|Protocol deviation|2|||
16128126|NCT04410523|38954497|FG000|Overall Study|Subject decision|2|||
16128127|NCT04410523|38954498|FG001|Overall Study|Subject decision|0|||
16128128|NCT04410523|38954499|FG002|Overall Study|Subject decision|0|||
16128129|NCT04410523|38954500|FG003|Overall Study|Subject decision|1|||
16128130|NCT04410523|38954501|FG004|Overall Study|Subject decision|0|||
16128131|NCT04410523|38954502|FG005|Overall Study|Subject decision|1|||
16128132|NCT01204398|38954503|FG000|Overall Study|Adverse Event|1|||
16128133|NCT01281969|38954504|FG000|Overall Study|not randomized didn't meet criteria|0|||
16128134|NCT01281969|38954505|FG001|Overall Study|not randomized didn't meet criteria|0|||
16128135|NCT01281969|38954506|FG002|Overall Study|not randomized didn't meet criteria|7|||
16128136|NCT01281969|38954504|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
16128137|NCT01281969|38954505|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
16128138|NCT01281969|38954506|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
16128139|NCT01281969|38954504|FG000|Overall Study|not randomized, child consent not given|0|||
16128140|NCT01281969|38954505|FG001|Overall Study|not randomized, child consent not given|0|||
16128141|NCT01281969|38954506|FG002|Overall Study|not randomized, child consent not given|2|||
16128142|NCT02442336|38954507|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
16128143|NCT02442336|38954507|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
16128144|NCT02442336|38954507|FG000|Overall Study|Lost to Follow-up|11|||
16128145|NCT02947087|38954508|FG000|Overall Study|Withdrawal by Subject|3|||
16128146|NCT02947087|38954509|FG001|Overall Study|Withdrawal by Subject|2|||
16128147|NCT00948766|38954510|FG000|Core Study|Adverse Event|73|||
16128148|NCT00948766|38954511|FG001|Core Study|Adverse Event|51|||
16245186|NCT00409578|39381518|FG003|Overall Study|Lost to Follow-up|2|||
16351914|NCT01656395|39776524|FG007|Overall Study|Non-Compliance with Study Drug|0|||
16351915|NCT01656395|39776517|FG000|Overall Study|Other|0|||
16351916|NCT01656395|39776518|FG001|Overall Study|Other|0|||
16128149|NCT00948766|38954510|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
16128150|NCT00948766|38954511|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
16128151|NCT00948766|38954510|FG000|Core Study|Patient Withdrew Consent|27|||
16128152|NCT00948766|38954511|FG001|Core Study|Patient Withdrew Consent|46|||
16128153|NCT00948766|38954510|FG000|Core Study|Lost to Follow-up|3|||
16351917|NCT01656395|39776519|FG002|Overall Study|Other|1|||
16128154|NCT00948766|38954511|FG001|Core Study|Lost to Follow-up|2|||
16128155|NCT00948766|38954510|FG000|Core Study|Administrative Problems|2|||
16128156|NCT00948766|38954511|FG001|Core Study|Administrative Problems|2|||
16128157|NCT00948766|38954510|FG000|Core Study|Death|1|||
16128158|NCT00948766|38954511|FG001|Core Study|Death|1|||
16128159|NCT00948766|38954510|FG000|Core Study|Protocol Deviation|8|||
16128160|NCT00948766|38954511|FG001|Core Study|Protocol Deviation|10|||
16128161|NCT00948766|38954510|FG000|Extension Study|Adverse Event|43|||
16128162|NCT00948766|38954511|FG001|Extension Study|Adverse Event|0|||
16128163|NCT00948766|38954510|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
16128164|NCT00948766|38954511|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
16128165|NCT00948766|38954510|FG000|Extension Study|Study Drug No Longer Required|1|||
16128166|NCT00948766|38954511|FG001|Extension Study|Study Drug No Longer Required|0|||
16128167|NCT00948766|38954510|FG000|Extension Study|Patient Withdrew Consent|32|||
16128168|NCT00948766|38954511|FG001|Extension Study|Patient Withdrew Consent|0|||
16128169|NCT00948766|38954510|FG000|Extension Study|Lost to Follow-up|8|||
16128170|NCT00948766|38954511|FG001|Extension Study|Lost to Follow-up|0|||
16128171|NCT00948766|38954510|FG000|Extension Study|Administrative Problems|1|||
16128172|NCT00948766|38954511|FG001|Extension Study|Administrative Problems|0|||
16128173|NCT00948766|38954510|FG000|Extension Study|Death|4|||
16128174|NCT00948766|38954511|FG001|Extension Study|Death|0|||
16128175|NCT03075410|38954512|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
16128176|NCT03075410|38954513|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
16128177|NCT03075410|38954514|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
16128178|NCT03075410|38954515|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
16128179|NCT03075410|38954516|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
16128180|NCT03075410|38954517|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
16128181|NCT03075410|38954518|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
16128182|NCT03075410|38954519|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
16128183|NCT03075410|38954520|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
16128184|NCT03075410|38954512|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
16128185|NCT03075410|38954513|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
16128186|NCT03075410|38954514|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
16128187|NCT03075410|38954515|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
16128188|NCT03075410|38954516|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
16128189|NCT03075410|38954517|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
16128190|NCT03075410|38954518|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
16128191|NCT03075410|38954519|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
16128192|NCT03075410|38954520|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
16128193|NCT01157676|38954521|FG000|Randomization|Death|1|||
16128194|NCT01157676|38954522|FG001|Randomization|Death|1|||
16128195|NCT01157676|38954521|FG000|Randomization|unresectable|2|||
16128196|NCT01157676|38954522|FG001|Randomization|unresectable|3|||
16416476|NCT00552760|40004735|FG000|Overall Study|Protocol Violation|0|||
16416477|NCT00552760|40004736|FG001|Overall Study|Protocol Violation|1|||
16416478|NCT00552760|40004735|FG000|Overall Study|Lost to Follow-up|1|||
16416479|NCT00552760|40004736|FG001|Overall Study|Lost to Follow-up|1|||
16416480|NCT00552760|40004735|FG000|Overall Study|Non-compliance|1|||
16416481|NCT00552760|40004736|FG001|Overall Study|Non-compliance|1|||
16416482|NCT00552760|40004735|FG000|Overall Study|Medical Condition|1|||
16559617|NCT01115998|40513443|FG001|Overall Study|Lost to Follow-up|6|||
16559618|NCT00737061|40513446|FG000|Waiting Period|Lost to Follow-up|6|||
16128197|NCT01157676|38954521|FG000|Randomization|Withdrawal by Subject|17|||
16416483|NCT00552760|40004736|FG001|Overall Study|Medical Condition|1|||
16416484|NCT00552760|40004735|FG000|Overall Study|Withdrawal by Subject|3|||
16416485|NCT00552760|40004736|FG001|Overall Study|Withdrawal by Subject|0|||
16416486|NCT00552760|40004735|FG000|Overall Study|Medication Change|1|||
16416487|NCT00552760|40004736|FG001|Overall Study|Medication Change|0|||
16416488|NCT01953913|40004737|FG000|Overall Study|Disease Progression|349|||
16416489|NCT01953913|40004737|FG000|Overall Study|Worsening of underlying cancer|22|||
16416490|NCT01953913|40004737|FG000|Overall Study|Adverse Event|20|||
16416491|NCT01953913|40004737|FG000|Overall Study|Protocol Violation|6|||
16416492|NCT01953913|40004737|FG000|Overall Study|Lost to Follow-up|4|||
16416493|NCT01953913|40004737|FG000|Overall Study|Withdrawal by Subject|32|||
16416494|NCT01953913|40004737|FG000|Overall Study|Other than listed|108|||
16416495|NCT01953913|40004737|FG000|Overall Study|Not Treated|1|||
16416496|NCT03734029|40004738|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
16416497|NCT03734029|40004739|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
16559619|NCT00737061|40513446|FG000|Waiting Period|Withdrawal by Subject|1|||
16128198|NCT01157676|38954522|FG001|Randomization|Withdrawal by Subject|13|||
16128199|NCT01157676|38954521|FG000|Randomization|Physician Decision|1|||
16128200|NCT01157676|38954522|FG001|Randomization|Physician Decision|0|||
16128201|NCT01157676|38954521|FG000|Surgery|underwent open cystectomy|0|||
16128202|NCT01157676|38954522|FG001|Surgery|underwent open cystectomy|4|||
16128203|NCT01157676|38954521|FG000|Surgery|converted to open procedure|0|||
16416498|NCT03734029|40004738|FG000|Overall Study|Adverse Event|60|||
16416499|NCT03734029|40004739|FG001|Overall Study|Adverse Event|14|||
16416500|NCT03734029|40004738|FG000|Overall Study|Withdrawal by Subject|12|||
16416501|NCT03734029|40004739|FG001|Overall Study|Withdrawal by Subject|11|||
16416502|NCT03734029|40004738|FG000|Overall Study|Clinical progression by investigator|10|||
16416503|NCT03734029|40004739|FG001|Overall Study|Clinical progression by investigator|8|||
16416504|NCT03734029|40004738|FG000|Overall Study|Death|5|||
16416505|NCT03734029|40004739|FG001|Overall Study|Death|2|||
16416506|NCT03734029|40004738|FG000|Overall Study|Physician Decision|4|||
16416507|NCT03734029|40004739|FG001|Overall Study|Physician Decision|3|||
16416508|NCT03734029|40004738|FG000|Overall Study|Other|2|||
16416509|NCT03734029|40004739|FG001|Overall Study|Other|0|||
16416510|NCT03734029|40004738|FG000|Overall Study|Lost to Follow-up|0|||
16416511|NCT03734029|40004739|FG001|Overall Study|Lost to Follow-up|1|||
16416512|NCT03734029|40004738|FG000|Overall Study|Randomized, but not treated|2|||
16416513|NCT03734029|40004739|FG001|Overall Study|Randomized, but not treated|12|||
16416514|NCT00952614|40004741|FG000|Overall Study|Death|3|||
16416515|NCT00952614|40004741|FG000|Overall Study|Lost to Follow-up|3|||
16416516|NCT00952614|40004741|FG000|Overall Study|other reason|1|||
16416517|NCT04577651|40004742|FG000|Overall Study|Screen Failure|7|||
16245187|NCT00409578|39381515|FG000|Overall Study|Administrative problems|8|||
16245188|NCT00409578|39381516|FG001|Overall Study|Administrative problems|9|||
16245189|NCT00409578|39381517|FG002|Overall Study|Administrative problems|2|||
16245190|NCT00409578|39381518|FG003|Overall Study|Administrative problems|4|||
16416518|NCT04577651|40004742|FG000|Overall Study|Adverse Event|1|||
16416519|NCT04577651|40004742|FG000|Overall Study|Death|1|||
16416520|NCT04577651|40004742|FG000|Overall Study|Physician Decision|1|||
16416521|NCT04577651|40004742|FG000|Overall Study|Withdrawal by Subject|3|||
16416522|NCT00330668|40004743|FG000|BID Dosing Period|Adverse Event|1|||
16416523|NCT00330668|40004743|FG000|BID Dosing Period|Lost to Follow-up|7|||
16416524|NCT00330668|40004743|FG000|BID Dosing Period|Non-Compliance|5|||
16416525|NCT00330668|40004743|FG000|BID Dosing Period|Withdrawal by Subject|19|||
16416526|NCT00330668|40004743|FG000|BID Dosing Period|Sponsor's decision|1|||
16416527|NCT00330668|40004743|FG000|BID Dosing Period|Other|3|||
16416528|NCT00330668|40004743|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
16416529|NCT00330668|40004743|FG000|QD Dosing Period|Other|1|||
16416530|NCT00330668|40004743|FG000|QD Dosing Period|Withdrawal by Subject|1|||
16416531|NCT00330668|40004743|FG000|QD Dosing Period|Lost to Follow-up|2|||
16416532|NCT03203291|40004745|FG000|Overall Study|Withdrawal by Subject|1|||
16416533|NCT00395850|40004746|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
16416534|NCT00395850|40004747|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
16416535|NCT00395850|40004748|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
16416536|NCT00395850|40004749|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
16416537|NCT00395850|40004746|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
16416538|NCT00395850|40004747|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
16416539|NCT00395850|40004748|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
16128204|NCT01157676|38954522|FG001|Surgery|converted to open procedure|5|||
16128205|NCT01157676|38954521|FG000|Surgery|underwent robotic cystectomy|1|||
16245191|NCT00409578|39381515|FG000|Overall Study|Death|2|||
16245192|NCT00409578|39381516|FG001|Overall Study|Death|4|||
16245193|NCT00409578|39381517|FG002|Overall Study|Death|4|||
16245194|NCT00409578|39381518|FG003|Overall Study|Death|2|||
16245195|NCT00409578|39381515|FG000|Overall Study|Protocol Violation|3|||
16245196|NCT00409578|39381516|FG001|Overall Study|Protocol Violation|2|||
16245197|NCT00409578|39381517|FG002|Overall Study|Protocol Violation|3|||
16245198|NCT00409578|39381518|FG003|Overall Study|Protocol Violation|1|||
16245199|NCT00409578|39381515|FG000|Overall Study|Missing|0|||
16245200|NCT00409578|39381516|FG001|Overall Study|Missing|1|||
16559620|NCT00737061|40513446|FG000|Waiting Period|Bilateral placement failure|34|||
16559621|NCT00737061|40513446|FG000|Waiting Period|Deemed patent following HSG|26|||
16559622|NCT00737061|40513446|FG000|Waiting Period|Alternative contraception failure|3|||
16559623|NCT00737061|40513446|FG000|Waiting Period|Elected surgical tubal ligation|5|||
16559624|NCT00737061|40513446|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
16245201|NCT00409578|39381517|FG002|Overall Study|Missing|0|||
16245202|NCT00409578|39381518|FG003|Overall Study|Missing|1|||
16245203|NCT01186978|39381519|FG000|Overall Study|Withdrawal by Subject|1|||
16245204|NCT02770716|39381524|FG000|Overall Study|Death|101|||
16559625|NCT00737061|40513446|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
16559626|NCT00737061|40513446|FG000|1 Year Wearing Period|Discontinued reilance|3|||
16559627|NCT00737061|40513446|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
16245205|NCT02770716|39381525|FG001|Overall Study|Death|45|||
16128206|NCT01157676|38954522|FG001|Surgery|underwent robotic cystectomy|0|||
16245206|NCT02770716|39381524|FG000|Overall Study|Withdrawal by Subject|4|||
16245207|NCT02770716|39381525|FG001|Overall Study|Withdrawal by Subject|2|||
16128207|NCT01959334|38954524|FG000|Second Dose|Adverse Event|1|||
16128208|NCT01959334|38954525|FG001|Second Dose|Adverse Event|0|||
16128209|NCT01959334|38954524|FG000|Third Dose|Adverse Event|0|||
16128210|NCT01959334|38954525|FG001|Third Dose|Adverse Event|1|||
16128211|NCT04476251|38954526|FG000|Overall Study|Not treated|1|||
16128212|NCT03035201|38954527|FG000|Overall Study|Death|9|||
16128213|NCT03035201|38954528|FG001|Overall Study|Death|12|||
16128214|NCT03035201|38954529|FG002|Overall Study|Death|9|||
16128215|NCT03035201|38954530|FG003|Overall Study|Death|10|||
16128216|NCT03035201|38954527|FG000|Overall Study|Withdrawal by Subject|51|||
16128217|NCT03035201|38954528|FG001|Overall Study|Withdrawal by Subject|49|||
16128218|NCT03035201|38954529|FG002|Overall Study|Withdrawal by Subject|37|||
16128219|NCT03035201|38954530|FG003|Overall Study|Withdrawal by Subject|46|||
16128220|NCT03035201|38954527|FG000|Overall Study|Lost to Follow-up|67|||
16128221|NCT03035201|38954528|FG001|Overall Study|Lost to Follow-up|51|||
16128222|NCT03035201|38954529|FG002|Overall Study|Lost to Follow-up|64|||
16128223|NCT03035201|38954530|FG003|Overall Study|Lost to Follow-up|69|||
16128224|NCT03261700|38954540|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
16128225|NCT03261700|38954541|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
16128226|NCT02040259|38954542|FG000|Overall Study|Death|280|||
16128227|NCT02040259|38954542|FG000|Overall Study|Lost to Follow-up|76|||
16128228|NCT02040259|38954542|FG000|Overall Study|Assessment not completed|3|||
16128229|NCT02040259|38954542|FG000|Overall Study|Withdrawal by Subject|4|||
16128230|NCT02075073|38954543|FG000|Overall Study|Withdrawal by Subject|0|||
16128231|NCT02075073|38954544|FG001|Overall Study|Withdrawal by Subject|1|||
16128232|NCT02075073|38954545|FG002|Overall Study|Withdrawal by Subject|0|||
16128233|NCT01820585|38954546|FG000|Overall Study|Adverse Event|9|||
16128234|NCT01820585|38954547|FG001|Overall Study|Adverse Event|13|||
16128235|NCT01820585|38954548|FG002|Overall Study|Adverse Event|23|||
16128236|NCT01820585|38954549|FG003|Overall Study|Adverse Event|34|||
16128237|NCT01820585|38954546|FG000|Overall Study|Lack of Efficacy|9|||
16128238|NCT01820585|38954547|FG001|Overall Study|Lack of Efficacy|7|||
16128239|NCT01820585|38954548|FG002|Overall Study|Lack of Efficacy|5|||
16128240|NCT01820585|38954549|FG003|Overall Study|Lack of Efficacy|1|||
16128241|NCT01820585|38954546|FG000|Overall Study|Withdrawal by Subject|3|||
16128242|NCT01820585|38954547|FG001|Overall Study|Withdrawal by Subject|7|||
16128243|NCT01820585|38954548|FG002|Overall Study|Withdrawal by Subject|3|||
16559628|NCT00136916|40513447|FG000|Overall Study|Never received study treatment|3|||
16559629|NCT00136916|40513448|FG001|Overall Study|Never received study treatment|5|||
16559630|NCT00136916|40513447|FG000|Overall Study|Death|1|||
16559631|NCT00136916|40513448|FG001|Overall Study|Death|3|||
16128244|NCT01820585|38954549|FG003|Overall Study|Withdrawal by Subject|8|||
16559632|NCT00136916|40513447|FG000|Overall Study|Adverse Event|27|||
16559633|NCT00136916|40513448|FG001|Overall Study|Adverse Event|8|||
16559634|NCT00136916|40513447|FG000|Overall Study|Laboratory abnormality|0|||
16559635|NCT00136916|40513448|FG001|Overall Study|Laboratory abnormality|1|||
16559636|NCT00136916|40513447|FG000|Overall Study|Lack of Efficacy|13|||
16559637|NCT00136916|40513448|FG001|Overall Study|Lack of Efficacy|3|||
16559638|NCT00136916|40513447|FG000|Overall Study|Lost to Follow-up|12|||
16559639|NCT00136916|40513448|FG001|Overall Study|Lost to Follow-up|14|||
16559640|NCT00136916|40513447|FG000|Overall Study|Withdrawal by Subject|44|||
16559641|NCT00136916|40513448|FG001|Overall Study|Withdrawal by Subject|46|||
16559642|NCT00136916|40513447|FG000|Overall Study|Other|22|||
16559643|NCT00136916|40513448|FG001|Overall Study|Other|24|||
16559644|NCT00136916|40513447|FG000|Overall Study|Discontinued in follow up period|3|||
16559645|NCT00136916|40513448|FG001|Overall Study|Discontinued in follow up period|0|||
16559646|NCT01256476|40513449|FG000|Overall Study|Adverse Event|2|||
16559647|NCT01256476|40513450|FG001|Overall Study|Adverse Event|1|||
16559648|NCT01256476|40513449|FG000|Overall Study|Withdrawal by Subject|2|||
16559649|NCT01256476|40513450|FG001|Overall Study|Withdrawal by Subject|1|||
16559650|NCT01256476|40513449|FG000|Overall Study|Lost to Follow-up|1|||
16559651|NCT01256476|40513450|FG001|Overall Study|Lost to Follow-up|2|||
16559652|NCT01256476|40513449|FG000|Overall Study|Persistent ALT or AST elevation|1|||
16559653|NCT01256476|40513450|FG001|Overall Study|Persistent ALT or AST elevation|0|||
16559654|NCT01256476|40513449|FG000|Overall Study|Physician Decision|0|||
16559655|NCT01256476|40513450|FG001|Overall Study|Physician Decision|1|||
16559656|NCT01256476|40513449|FG000|Overall Study|Subject non-compliance|0|||
16559657|NCT01256476|40513450|FG001|Overall Study|Subject non-compliance|1|||
16559658|NCT01256476|40513449|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
16559659|NCT01256476|40513450|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
16128245|NCT01820585|38954546|FG000|Overall Study|Lost to Follow-up|3|||
16128246|NCT01820585|38954547|FG001|Overall Study|Lost to Follow-up|3|||
16128247|NCT01820585|38954548|FG002|Overall Study|Lost to Follow-up|0|||
16128248|NCT01820585|38954549|FG003|Overall Study|Lost to Follow-up|3|||
16128249|NCT01820585|38954546|FG000|Overall Study|Protocol Violation|3|||
16559660|NCT04296942|40513451|FG000|Overall Study|Study closure by sponsor|1|||
16559661|NCT04296942|40513452|FG001|Overall Study|Study closure by sponsor|0|||
16559662|NCT04296942|40513453|FG002|Overall Study|Study closure by sponsor|0|||
16128250|NCT01820585|38954547|FG001|Overall Study|Protocol Violation|1|||
16128251|NCT01820585|38954548|FG002|Overall Study|Protocol Violation|1|||
16128252|NCT01820585|38954549|FG003|Overall Study|Protocol Violation|1|||
16128253|NCT01820585|38954546|FG000|Overall Study|Subject non-compliance|0|||
16128254|NCT01820585|38954547|FG001|Overall Study|Subject non-compliance|0|||
16128255|NCT01820585|38954548|FG002|Overall Study|Subject non-compliance|1|||
16128256|NCT01820585|38954549|FG003|Overall Study|Subject non-compliance|2|||
16128257|NCT01820585|38954546|FG000|Overall Study|at sponsor request|0|||
16128258|NCT01820585|38954547|FG001|Overall Study|at sponsor request|0|||
16128259|NCT01820585|38954548|FG002|Overall Study|at sponsor request|1|||
16128260|NCT01820585|38954549|FG003|Overall Study|at sponsor request|0|||
16128261|NCT01820585|38954546|FG000|Overall Study|Pregnancy|0|||
16128262|NCT01820585|38954547|FG001|Overall Study|Pregnancy|1|||
16128263|NCT01820585|38954548|FG002|Overall Study|Pregnancy|0|||
16128264|NCT01820585|38954549|FG003|Overall Study|Pregnancy|0|||
16128265|NCT02045875|38954550|FG000|Overall Study|Lost to Follow-up|3|||
16128266|NCT02045875|38954551|FG001|Overall Study|Lost to Follow-up|0|||
16128267|NCT02045875|38954550|FG000|Overall Study|Withdrawal by Subject|4|||
16128268|NCT02045875|38954551|FG001|Overall Study|Withdrawal by Subject|3|||
16128269|NCT00473265|38954552|FG000|Overall Study|Unrelated adverse event|5|||
16128270|NCT00473265|38954552|FG000|Overall Study|Off treatment early|15|||
16128271|NCT02729753|38954553|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
16128272|NCT02729753|38954554|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
16128273|NCT02874924|38954555|FG000|Overall Study|Adverse Event|2|||
16128274|NCT02874924|38954556|FG001|Overall Study|Adverse Event|0|||
16128275|NCT02874924|38954557|FG002|Overall Study|Adverse Event|0|||
16128276|NCT02874924|38954555|FG000|Overall Study|Withdrawal by Subject|1|||
16128277|NCT02874924|38954556|FG001|Overall Study|Withdrawal by Subject|0|||
16128278|NCT02874924|38954557|FG002|Overall Study|Withdrawal by Subject|0|||
16128279|NCT01474434|38954558|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
16128280|NCT01474434|38954559|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
16128281|NCT01474434|38954560|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
16128282|NCT01474434|38954561|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
16128283|NCT01474434|38954558|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
16128284|NCT01474434|38954559|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
16128285|NCT01474434|38954560|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
16128286|NCT01474434|38954561|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
16128287|NCT01474434|38954558|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
16128288|NCT01474434|38954559|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
16128289|NCT01474434|38954560|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
16245208|NCT02770716|39381524|FG000|Overall Study|Lost to Follow-up|1|||
16351918|NCT01656395|39776520|FG003|Overall Study|Other|0|||
16351919|NCT01656395|39776521|FG004|Overall Study|Other|0|||
16351920|NCT01656395|39776522|FG005|Overall Study|Other|1|||
16245209|NCT02770716|39381525|FG001|Overall Study|Lost to Follow-up|0|||
16245210|NCT02770716|39381524|FG000|Overall Study|Various reasons|6|||
16245211|NCT02770716|39381525|FG001|Overall Study|Various reasons|2|||
16245212|NCT02265952|39381535|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
16245213|NCT02265952|39381536|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
16245214|NCT02265952|39381535|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
16245215|NCT02265952|39381536|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
16245216|NCT00003782|39381540|FG000|Overall Study|No follow up data|30|||
16245217|NCT00003782|39381541|FG001|Overall Study|No follow up data|31|||
16245218|NCT00003782|39381542|FG002|Overall Study|No follow up data|26|||
16245219|NCT02711956|39381546|FG000|Overall Study|Adverse Event|0|||
16245220|NCT02711956|39381547|FG001|Overall Study|Adverse Event|0|||
16245221|NCT02711956|39381548|FG002|Overall Study|Adverse Event|0|||
16245222|NCT02711956|39381549|FG003|Overall Study|Adverse Event|1|||
16245223|NCT02711956|39381550|FG004|Overall Study|Adverse Event|2|||
16245224|NCT02711956|39381551|FG005|Overall Study|Adverse Event|0|||
16245225|NCT02711956|39381552|FG006|Overall Study|Adverse Event|0|||
16245226|NCT02711956|39381553|FG007|Overall Study|Adverse Event|1|||
16245227|NCT02711956|39381554|FG008|Overall Study|Adverse Event|1|||
16245228|NCT02711956|39381555|FG009|Overall Study|Adverse Event|1|||
16416540|NCT00395850|40004749|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
16416541|NCT00395850|40004746|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
16416542|NCT00395850|40004747|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
16416543|NCT00395850|40004748|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
16416544|NCT00395850|40004749|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
16416545|NCT00395850|40004746|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
16416546|NCT00395850|40004747|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
16416547|NCT00395850|40004748|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
16416548|NCT00395850|40004749|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
16416549|NCT00395850|40004746|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
16416550|NCT00395850|40004747|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
16416551|NCT00395850|40004748|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
16416552|NCT00395850|40004749|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
16245229|NCT02711956|39381556|FG010|Overall Study|Adverse Event|1|||
16245230|NCT02711956|39381557|FG011|Overall Study|Adverse Event|0|||
16245231|NCT02711956|39381558|FG012|Overall Study|Adverse Event|0|||
16245232|NCT02711956|39381559|FG013|Overall Study|Adverse Event|0|||
16128290|NCT01474434|38954561|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
16128291|NCT01656733|38954563|FG000|Overall Study|No permission to collect birth outcomes|0|||
16128292|NCT01656733|38954564|FG001|Overall Study|No permission to collect birth outcomes|1|||
16128293|NCT01656733|38954563|FG000|Overall Study|Delivery at another hospital|0|||
16128294|NCT01656733|38954564|FG001|Overall Study|Delivery at another hospital|2|||
16128295|NCT01656733|38954563|FG000|Overall Study|Spontaneous abortion|0|||
16128296|NCT01656733|38954564|FG001|Overall Study|Spontaneous abortion|1|||
16128297|NCT02207569|38954565|FG000|1-Month|Death|6|||
16128298|NCT02207569|38954565|FG000|1-Month|Withdrawal by Subject|2|||
16128299|NCT02207569|38954565|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
16128300|NCT02207569|38954565|FG000|6-Month|Death|8|||
16128301|NCT02207569|38954565|FG000|6-Month|Withdrawal by Subject|2|||
16128302|NCT02207569|38954565|FG000|12-Month|Death|14|||
16128303|NCT02207569|38954565|FG000|12-Month|Withdrawal by Subject|2|||
16128304|NCT02207569|38954565|FG000|24-Month|Death|23|||
16128305|NCT02207569|38954565|FG000|24-Month|Withdrawal by Subject|3|||
16128306|NCT02207569|38954565|FG000|36-Month|Death|23|||
16128307|NCT02207569|38954565|FG000|36-Month|Withdrawal by Subject|4|||
16128308|NCT02207569|38954565|FG000|48-Month|Death|25|||
16128309|NCT02207569|38954565|FG000|48-Month|Withdrawal by Subject|2|||
16128310|NCT02207569|38954565|FG000|48-Month|Lost to Follow-up|4|||
16128311|NCT02207569|38954565|FG000|60-Month|Death|1|||
16128312|NCT02207569|38954565|FG000|60-Month|Lost to Follow-up|1|||
16128313|NCT02207569|38954565|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
16128314|NCT02207569|38954565|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
16128315|NCT03459443|38954566|FG000|Overall Study|Lack of Efficacy|3|||
16128316|NCT03459443|38954566|FG000|Overall Study|Adverse Event|1|||
16128317|NCT03459443|38954566|FG000|Overall Study|Sponsor's decision to close the study|18|||
16128318|NCT04602221|38954567|FG000|Overall Study|Discontinuation of trial treatment|0|||
16128319|NCT04602221|38954568|FG001|Overall Study|Discontinuation of trial treatment|0|||
16128320|NCT04602221|38954569|FG002|Overall Study|Discontinuation of trial treatment|1|||
16128321|NCT04602221|38954570|FG003|Overall Study|Discontinuation of trial treatment|0|||
16128322|NCT04602221|38954571|FG004|Overall Study|Discontinuation of trial treatment|0|||
16128323|NCT04602221|38954572|FG005|Overall Study|Discontinuation of trial treatment|0|||
16128324|NCT04602221|38954573|FG006|Overall Study|Discontinuation of trial treatment|0|||
16128325|NCT04602221|38954574|FG007|Overall Study|Discontinuation of trial treatment|0|||
16128326|NCT04602221|38954575|FG008|Overall Study|Discontinuation of trial treatment|0|||
16128327|NCT04602221|38954576|FG009|Overall Study|Discontinuation of trial treatment|0|||
16128328|NCT04602221|38954577|FG010|Overall Study|Discontinuation of trial treatment|0|||
16128329|NCT04602221|38954578|FG011|Overall Study|Discontinuation of trial treatment|0|||
16128330|NCT04602221|38954579|FG012|Overall Study|Discontinuation of trial treatment|0|||
16128331|NCT04602221|38954580|FG013|Overall Study|Discontinuation of trial treatment|0|||
16128332|NCT04602221|38954581|FG014|Overall Study|Discontinuation of trial treatment|0|||
16128333|NCT04602221|38954582|FG015|Overall Study|Discontinuation of trial treatment|0|||
16128334|NCT04602221|38954583|FG016|Overall Study|Discontinuation of trial treatment|0|||
16128335|NCT04602221|38954584|FG017|Overall Study|Discontinuation of trial treatment|0|||
16128336|NCT04602221|38954567|FG000|Overall Study|Other than listed|0|||
16128337|NCT04602221|38954568|FG001|Overall Study|Other than listed|0|||
16128338|NCT04602221|38954569|FG002|Overall Study|Other than listed|0|||
16128339|NCT04602221|38954570|FG003|Overall Study|Other than listed|0|||
16128340|NCT04602221|38954571|FG004|Overall Study|Other than listed|0|||
16128341|NCT04602221|38954572|FG005|Overall Study|Other than listed|0|||
16128342|NCT04602221|38954573|FG006|Overall Study|Other than listed|0|||
16128343|NCT04602221|38954574|FG007|Overall Study|Other than listed|0|||
16128344|NCT04602221|38954575|FG008|Overall Study|Other than listed|0|||
16351921|NCT01656395|39776523|FG006|Overall Study|Other|0|||
16245233|NCT02711956|39381560|FG014|Overall Study|Adverse Event|2|||
16245234|NCT02711956|39381546|FG000|Overall Study|Physician Decision|0|||
16245235|NCT02711956|39381547|FG001|Overall Study|Physician Decision|0|||
16245236|NCT02711956|39381548|FG002|Overall Study|Physician Decision|0|||
16245237|NCT02711956|39381549|FG003|Overall Study|Physician Decision|2|||
16245238|NCT02711956|39381550|FG004|Overall Study|Physician Decision|0|||
16245239|NCT02711956|39381551|FG005|Overall Study|Physician Decision|0|||
16245240|NCT02711956|39381552|FG006|Overall Study|Physician Decision|0|||
16245241|NCT02711956|39381553|FG007|Overall Study|Physician Decision|0|||
16245242|NCT02711956|39381554|FG008|Overall Study|Physician Decision|0|||
16245243|NCT02711956|39381555|FG009|Overall Study|Physician Decision|0|||
16245244|NCT02711956|39381556|FG010|Overall Study|Physician Decision|0|||
16245245|NCT02711956|39381557|FG011|Overall Study|Physician Decision|0|||
16245246|NCT02711956|39381558|FG012|Overall Study|Physician Decision|0|||
16245247|NCT02711956|39381559|FG013|Overall Study|Physician Decision|0|||
16245248|NCT02711956|39381560|FG014|Overall Study|Physician Decision|0|||
16245249|NCT02711956|39381546|FG000|Overall Study|Withdrawal by Subject|0|||
16245250|NCT02711956|39381547|FG001|Overall Study|Withdrawal by Subject|0|||
16245251|NCT02711956|39381548|FG002|Overall Study|Withdrawal by Subject|0|||
16245252|NCT02711956|39381549|FG003|Overall Study|Withdrawal by Subject|0|||
16245253|NCT02711956|39381550|FG004|Overall Study|Withdrawal by Subject|0|||
16245254|NCT02711956|39381551|FG005|Overall Study|Withdrawal by Subject|0|||
16245255|NCT02711956|39381552|FG006|Overall Study|Withdrawal by Subject|1|||
16245256|NCT02711956|39381553|FG007|Overall Study|Withdrawal by Subject|0|||
16245257|NCT02711956|39381554|FG008|Overall Study|Withdrawal by Subject|0|||
16245258|NCT02711956|39381555|FG009|Overall Study|Withdrawal by Subject|0|||
16245259|NCT02711956|39381556|FG010|Overall Study|Withdrawal by Subject|0|||
16245260|NCT02711956|39381557|FG011|Overall Study|Withdrawal by Subject|1|||
16245261|NCT02711956|39381558|FG012|Overall Study|Withdrawal by Subject|6|||
16245262|NCT02711956|39381559|FG013|Overall Study|Withdrawal by Subject|0|||
16245263|NCT02711956|39381560|FG014|Overall Study|Withdrawal by Subject|1|||
16245264|NCT02711956|39381546|FG000|Overall Study|Clinical progression|1|||
16245265|NCT02711956|39381547|FG001|Overall Study|Clinical progression|0|||
16245266|NCT02711956|39381548|FG002|Overall Study|Clinical progression|0|||
16245267|NCT02711956|39381549|FG003|Overall Study|Clinical progression|0|||
16245268|NCT02711956|39381550|FG004|Overall Study|Clinical progression|0|||
16245269|NCT02711956|39381551|FG005|Overall Study|Clinical progression|0|||
16245270|NCT02711956|39381552|FG006|Overall Study|Clinical progression|1|||
16245271|NCT02711956|39381553|FG007|Overall Study|Clinical progression|0|||
16245272|NCT02711956|39381554|FG008|Overall Study|Clinical progression|1|||
16245273|NCT02711956|39381555|FG009|Overall Study|Clinical progression|0|||
16245274|NCT02711956|39381556|FG010|Overall Study|Clinical progression|0|||
16245275|NCT02711956|39381557|FG011|Overall Study|Clinical progression|2|||
16245276|NCT02711956|39381558|FG012|Overall Study|Clinical progression|4|||
16245277|NCT02711956|39381559|FG013|Overall Study|Clinical progression|1|||
16245278|NCT02711956|39381560|FG014|Overall Study|Clinical progression|1|||
16245279|NCT02711956|39381546|FG000|Overall Study|Radiographic progression|1|||
16245280|NCT02711956|39381547|FG001|Overall Study|Radiographic progression|1|||
16245281|NCT02711956|39381548|FG002|Overall Study|Radiographic progression|2|||
16245282|NCT02711956|39381549|FG003|Overall Study|Radiographic progression|0|||
16245283|NCT02711956|39381550|FG004|Overall Study|Radiographic progression|1|||
16245284|NCT02711956|39381551|FG005|Overall Study|Radiographic progression|0|||
16245285|NCT02711956|39381552|FG006|Overall Study|Radiographic progression|0|||
16245286|NCT02711956|39381553|FG007|Overall Study|Radiographic progression|0|||
16245287|NCT02711956|39381554|FG008|Overall Study|Radiographic progression|2|||
16245288|NCT02711956|39381555|FG009|Overall Study|Radiographic progression|1|||
16245289|NCT02711956|39381556|FG010|Overall Study|Radiographic progression|0|||
16245290|NCT02711956|39381557|FG011|Overall Study|Radiographic progression|5|||
16245291|NCT02711956|39381558|FG012|Overall Study|Radiographic progression|3|||
16245292|NCT02711956|39381559|FG013|Overall Study|Radiographic progression|0|||
16245293|NCT02711956|39381560|FG014|Overall Study|Radiographic progression|1|||
16245294|NCT02711956|39381546|FG000|Overall Study|PSA progression with clinical progression|0|||
16245295|NCT02711956|39381547|FG001|Overall Study|PSA progression with clinical progression|0|||
16245296|NCT02711956|39381548|FG002|Overall Study|PSA progression with clinical progression|0|||
16245297|NCT02711956|39381549|FG003|Overall Study|PSA progression with clinical progression|0|||
16245298|NCT02711956|39381550|FG004|Overall Study|PSA progression with clinical progression|1|||
16245299|NCT02711956|39381551|FG005|Overall Study|PSA progression with clinical progression|0|||
16245300|NCT02711956|39381552|FG006|Overall Study|PSA progression with clinical progression|0|||
16245301|NCT02711956|39381553|FG007|Overall Study|PSA progression with clinical progression|0|||
16245302|NCT02711956|39381554|FG008|Overall Study|PSA progression with clinical progression|0|||
16351922|NCT01656395|39776524|FG007|Overall Study|Other|0|||
16245303|NCT02711956|39381555|FG009|Overall Study|PSA progression with clinical progression|0|||
16351923|NCT01656395|39776517|FG000|Overall Study|Physician Decision|2|||
16245304|NCT02711956|39381556|FG010|Overall Study|PSA progression with clinical progression|0|||
16351924|NCT01656395|39776518|FG001|Overall Study|Physician Decision|3|||
16245305|NCT02711956|39381557|FG011|Overall Study|PSA progression with clinical progression|0|||
16245306|NCT02711956|39381558|FG012|Overall Study|PSA progression with clinical progression|1|||
16245307|NCT02711956|39381559|FG013|Overall Study|PSA progression with clinical progression|1|||
16245308|NCT02711956|39381560|FG014|Overall Study|PSA progression with clinical progression|0|||
16245309|NCT02711956|39381546|FG000|Overall Study|PSA progression with radiographic progression|0|||
16245310|NCT02711956|39381547|FG001|Overall Study|PSA progression with radiographic progression|1|||
16245311|NCT02711956|39381548|FG002|Overall Study|PSA progression with radiographic progression|0|||
16245312|NCT02711956|39381549|FG003|Overall Study|PSA progression with radiographic progression|0|||
16245313|NCT02711956|39381550|FG004|Overall Study|PSA progression with radiographic progression|0|||
16245314|NCT02711956|39381551|FG005|Overall Study|PSA progression with radiographic progression|2|||
16245315|NCT02711956|39381552|FG006|Overall Study|PSA progression with radiographic progression|2|||
16245316|NCT02711956|39381553|FG007|Overall Study|PSA progression with radiographic progression|1|||
16245317|NCT02711956|39381554|FG008|Overall Study|PSA progression with radiographic progression|0|||
16245318|NCT02711956|39381555|FG009|Overall Study|PSA progression with radiographic progression|1|||
16245319|NCT02711956|39381556|FG010|Overall Study|PSA progression with radiographic progression|0|||
16245320|NCT02711956|39381557|FG011|Overall Study|PSA progression with radiographic progression|1|||
16245321|NCT02711956|39381558|FG012|Overall Study|PSA progression with radiographic progression|2|||
16245322|NCT02711956|39381559|FG013|Overall Study|PSA progression with radiographic progression|3|||
16245323|NCT02711956|39381560|FG014|Overall Study|PSA progression with radiographic progression|3|||
16245324|NCT04071366|39381561|FG000|Part 1: Open-label (29 Days)|Death|4|||
16245325|NCT04071366|39381562|FG001|Part 1: Open-label (29 Days)|Death|2|||
16245326|NCT04071366|39381563|FG002|Part 1: Open-label (29 Days)|Death|8|||
16245327|NCT04071366|39381564|FG003|Part 1: Open-label (29 Days)|Death|0|||
16245328|NCT04071366|39381565|FG004|Part 1: Open-label (29 Days)|Death|0|||
16245329|NCT04071366|39381561|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
16245330|NCT04071366|39381562|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
16245331|NCT04071366|39381563|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
16245332|NCT04071366|39381564|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
16245333|NCT04071366|39381565|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
16245334|NCT04071366|39381561|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
16245335|NCT04071366|39381562|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
16245336|NCT04071366|39381563|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
16245337|NCT04071366|39381564|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
16245338|NCT04071366|39381565|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
16245339|NCT04071366|39381561|FG000|Part 2: Randomized (29 Days)|Death|0|||
16245340|NCT04071366|39381562|FG001|Part 2: Randomized (29 Days)|Death|0|||
16245341|NCT04071366|39381563|FG002|Part 2: Randomized (29 Days)|Death|0|||
16245342|NCT04071366|39381564|FG003|Part 2: Randomized (29 Days)|Death|2|||
16245343|NCT04071366|39381565|FG004|Part 2: Randomized (29 Days)|Death|2|||
16245344|NCT04071366|39381561|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
16245345|NCT04071366|39381562|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
16245346|NCT04071366|39381563|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
16245347|NCT04071366|39381564|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
16245348|NCT04071366|39381565|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
16245349|NCT04071366|39381561|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
16245350|NCT04071366|39381562|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
16245351|NCT04071366|39381563|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
16245352|NCT04071366|39381564|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
16245353|NCT04071366|39381565|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
16245354|NCT04071366|39381561|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
16245355|NCT04071366|39381562|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
16245356|NCT04071366|39381563|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
16245357|NCT04071366|39381564|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
16245358|NCT04071366|39381565|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
16245359|NCT04071366|39381561|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
16245360|NCT04071366|39381562|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
16245361|NCT04071366|39381563|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
16245362|NCT04071366|39381564|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
16245363|NCT04071366|39381565|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
16245364|NCT04071366|39381561|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
16245365|NCT04071366|39381562|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
16245366|NCT04071366|39381563|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
16416553|NCT00395850|40004746|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
16245367|NCT04071366|39381564|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
16245368|NCT04071366|39381565|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
16245369|NCT04071366|39381561|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
16245370|NCT04071366|39381562|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
16245371|NCT04071366|39381563|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
16245372|NCT04071366|39381564|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
16245373|NCT04071366|39381565|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
16245374|NCT01098240|39381573|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
16245375|NCT01098240|39381574|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
16245376|NCT01098240|39381575|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
16245377|NCT01098240|39381573|FG000|Open-Label Phase|Protocol Violation|4|||
16245378|NCT01098240|39381574|FG001|Open-Label Phase|Protocol Violation|0|||
16245379|NCT01098240|39381575|FG002|Open-Label Phase|Protocol Violation|0|||
16245380|NCT01098240|39381573|FG000|Open-Label Phase|Lost to Follow-up|13|||
16245381|NCT01098240|39381574|FG001|Open-Label Phase|Lost to Follow-up|0|||
16245382|NCT01098240|39381575|FG002|Open-Label Phase|Lost to Follow-up|0|||
16245383|NCT01098240|39381573|FG000|Open-Label Phase|Other|19|||
16245384|NCT01098240|39381574|FG001|Open-Label Phase|Other|0|||
16245385|NCT01098240|39381575|FG002|Open-Label Phase|Other|0|||
16245386|NCT01098240|39381573|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
16245387|NCT01098240|39381574|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
16245388|NCT01098240|39381575|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
16245389|NCT01098240|39381573|FG000|Open-Label Phase|Pregnancy|1|||
16245390|NCT01098240|39381574|FG001|Open-Label Phase|Pregnancy|0|||
16245391|NCT01098240|39381575|FG002|Open-Label Phase|Pregnancy|0|||
16245392|NCT01098240|39381573|FG000|Open-Label Phase|Withdrawal by Subject|9|||
16245393|NCT01098240|39381574|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16245394|NCT01098240|39381575|FG002|Open-Label Phase|Withdrawal by Subject|0|||
16245395|NCT01098240|39381573|FG000|Open-Label Phase|Adverse Event|12|||
16245396|NCT01098240|39381574|FG001|Open-Label Phase|Adverse Event|0|||
16245397|NCT01098240|39381575|FG002|Open-Label Phase|Adverse Event|0|||
16245398|NCT01098240|39381573|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
16245399|NCT01098240|39381574|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
16245400|NCT01098240|39381575|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
16245401|NCT01098240|39381573|FG000|Double-Blind Phase|Protocol Violation|0|||
16245402|NCT01098240|39381574|FG001|Double-Blind Phase|Protocol Violation|2|||
16245403|NCT01098240|39381575|FG002|Double-Blind Phase|Protocol Violation|4|||
16128345|NCT04602221|38954576|FG009|Overall Study|Other than listed|0|||
16245404|NCT01098240|39381573|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16245405|NCT01098240|39381574|FG001|Double-Blind Phase|Lost to Follow-up|2|||
16245406|NCT01098240|39381575|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16245407|NCT01098240|39381573|FG000|Double-Blind Phase|Other|0|||
16245408|NCT01098240|39381574|FG001|Double-Blind Phase|Other|2|||
16245409|NCT01098240|39381575|FG002|Double-Blind Phase|Other|2|||
16245410|NCT01098240|39381573|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
16245411|NCT01098240|39381574|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
16245412|NCT01098240|39381575|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
16245413|NCT01098240|39381573|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
16245414|NCT01098240|39381574|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
16245415|NCT01098240|39381575|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
16245416|NCT01098240|39381573|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
16245417|NCT01098240|39381574|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
16245418|NCT01098240|39381575|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
16245419|NCT01098240|39381573|FG000|Double-Blind Phase|Adverse Event|0|||
16559663|NCT00742885|40513455|FG000|Overall Study|Lost to Follow-up|1|||
16245420|NCT01098240|39381574|FG001|Double-Blind Phase|Adverse Event|3|||
16245421|NCT01098240|39381575|FG002|Double-Blind Phase|Adverse Event|3|||
16245422|NCT01872689|39381576|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
16245423|NCT01872689|39381577|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
16245424|NCT01872689|39381578|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
16245425|NCT01872689|39381579|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
16245426|NCT01872689|39381576|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
16245427|NCT01872689|39381577|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
16245428|NCT01872689|39381578|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
16245429|NCT01872689|39381579|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
16245430|NCT01872689|39381576|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
16245431|NCT01872689|39381577|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
16245432|NCT01872689|39381578|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
16245433|NCT01872689|39381579|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
16245434|NCT01872689|39381576|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
16245435|NCT01872689|39381577|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
16245436|NCT01872689|39381578|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
16245437|NCT01872689|39381579|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
16245438|NCT01872689|39381576|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
16245439|NCT01872689|39381577|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
16245440|NCT01872689|39381578|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
16245441|NCT01872689|39381579|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
16245442|NCT01872689|39381576|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
16245443|NCT01872689|39381577|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
16245444|NCT01872689|39381578|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
16245445|NCT01872689|39381579|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
16245446|NCT01872689|39381576|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
16245447|NCT01872689|39381577|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
16245448|NCT01872689|39381578|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
16245449|NCT01872689|39381579|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
16245450|NCT01872689|39381576|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
16245451|NCT01872689|39381577|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
16245452|NCT01872689|39381578|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
16245453|NCT01872689|39381579|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
16245454|NCT01872689|39381576|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
16245455|NCT01872689|39381577|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
16245456|NCT01872689|39381578|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
16245457|NCT01872689|39381579|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
16245458|NCT01872689|39381576|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
16245459|NCT01872689|39381577|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
16245460|NCT01872689|39381578|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
16245461|NCT01872689|39381579|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
16245462|NCT01872689|39381576|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
16245463|NCT01872689|39381577|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
16245464|NCT01872689|39381578|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
16245465|NCT01872689|39381579|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
16245466|NCT01872689|39381576|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
16245467|NCT01872689|39381577|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
16245468|NCT01872689|39381578|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
16245469|NCT01872689|39381579|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
16245470|NCT01872689|39381576|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
16245471|NCT01872689|39381577|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
16245472|NCT01872689|39381578|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
16245473|NCT01872689|39381579|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
16245474|NCT01872689|39381576|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
16245475|NCT01872689|39381577|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
16245476|NCT01872689|39381578|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
16245477|NCT01872689|39381579|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
16245478|NCT03712228|39381580|FG000|Treatment Period 1|Lack of Efficacy|0|||
16245479|NCT03712228|39381581|FG001|Treatment Period 1|Lack of Efficacy|0|||
16245480|NCT03712228|39381582|FG002|Treatment Period 1|Lack of Efficacy|0|||
16245481|NCT03712228|39381583|FG003|Treatment Period 1|Lack of Efficacy|0|||
16245482|NCT03712228|39381584|FG004|Treatment Period 1|Lack of Efficacy|0|||
16245483|NCT03712228|39381585|FG005|Treatment Period 1|Lack of Efficacy|1|||
16245484|NCT03712228|39381580|FG000|Treatment Period 2|Pregnancy|0|||
16245485|NCT03712228|39381581|FG001|Treatment Period 2|Pregnancy|0|||
16245486|NCT03712228|39381582|FG002|Treatment Period 2|Pregnancy|0|||
16245487|NCT03712228|39381583|FG003|Treatment Period 2|Pregnancy|1|||
16245488|NCT03712228|39381584|FG004|Treatment Period 2|Pregnancy|0|||
16245489|NCT03712228|39381585|FG005|Treatment Period 2|Pregnancy|0|||
16245490|NCT03712228|39381580|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16245491|NCT03712228|39381581|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16245492|NCT03712228|39381582|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16245493|NCT03712228|39381583|FG003|Treatment Period 2|Withdrawal by Subject|1|||
16245494|NCT03712228|39381584|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16559664|NCT00742885|40513456|FG001|Overall Study|Lost to Follow-up|0|||
16559665|NCT01349829|40513457|FG000|Overall Study|Lost to Follow-up|4|||
16245495|NCT03712228|39381585|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16245496|NCT00660790|39381586|FG000|Baseline to 3 Months|Death|1|||
16245497|NCT00660790|39381586|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
16245498|NCT00660790|39381586|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
16245499|NCT03835975|39381589|FG000|Overall Study|Lost to Follow-up|1|||
16245500|NCT03835975|39381590|FG001|Overall Study|Lost to Follow-up|1|||
16245501|NCT03835975|39381591|FG002|Overall Study|Lost to Follow-up|0|||
16245502|NCT03835975|39381592|FG003|Overall Study|Lost to Follow-up|0|||
16245503|NCT03835975|39381593|FG004|Overall Study|Lost to Follow-up|0|||
16245504|NCT03835975|39381589|FG000|Overall Study|No longer met eligibility criteria|0|||
16245505|NCT03835975|39381590|FG001|Overall Study|No longer met eligibility criteria|1|||
16416554|NCT00395850|40004747|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
16416555|NCT00395850|40004748|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
16559666|NCT01349829|40513458|FG001|Overall Study|Lost to Follow-up|8|||
16559667|NCT01349829|40513457|FG000|Overall Study|Consent withdrawal|3|||
16559668|NCT01349829|40513458|FG001|Overall Study|Consent withdrawal|8|||
16559669|NCT01349829|40513457|FG000|Overall Study|Migrated/moved|2|||
16559670|NCT01349829|40513458|FG001|Overall Study|Migrated/moved|7|||
16559671|NCT00231179|40517291|FG000|Overall Study|Lost to Follow-up|21|||
16245506|NCT03835975|39381591|FG002|Overall Study|No longer met eligibility criteria|0|||
16245507|NCT03835975|39381592|FG003|Overall Study|No longer met eligibility criteria|0|||
16245508|NCT03835975|39381593|FG004|Overall Study|No longer met eligibility criteria|0|||
16245509|NCT03835975|39381589|FG000|Overall Study|Protocol Violation|1|||
16245510|NCT03835975|39381590|FG001|Overall Study|Protocol Violation|1|||
16245511|NCT03835975|39381591|FG002|Overall Study|Protocol Violation|2|||
16245512|NCT03835975|39381592|FG003|Overall Study|Protocol Violation|0|||
16245513|NCT03835975|39381593|FG004|Overall Study|Protocol Violation|0|||
16245514|NCT03835975|39381589|FG000|Overall Study|Withdrawal by Subject|1|||
16245515|NCT03835975|39381590|FG001|Overall Study|Withdrawal by Subject|0|||
16245516|NCT03835975|39381591|FG002|Overall Study|Withdrawal by Subject|1|||
16245517|NCT03835975|39381592|FG003|Overall Study|Withdrawal by Subject|1|||
16245518|NCT03835975|39381593|FG004|Overall Study|Withdrawal by Subject|0|||
16245519|NCT02535000|39381594|FG000|Overall Study|Cancellation of surgery.|1|||
16245520|NCT02535000|39381595|FG001|Overall Study|Cancellation of surgery.|2|||
16245521|NCT01102777|39381601|FG000|Overall Study|Death|2|||
16245522|NCT01102777|39381602|FG001|Overall Study|Death|6|||
16245523|NCT01102777|39381601|FG000|Overall Study|Lost to Follow-up|7|||
16416556|NCT00395850|40004749|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
16559672|NCT00231179|40517292|FG001|Overall Study|Lost to Follow-up|21|||
16245524|NCT01102777|39381602|FG001|Overall Study|Lost to Follow-up|10|||
16245525|NCT00217971|39381603|FG000|Overall Study|Adverse Event|1|||
16245526|NCT00217971|39381604|FG001|Overall Study|Adverse Event|1|||
16245527|NCT00217971|39381603|FG000|Overall Study|Lost to Follow-up|15|||
16245528|NCT00217971|39381604|FG001|Overall Study|Lost to Follow-up|19|||
16245529|NCT00217971|39381603|FG000|Overall Study|Physician Decision|0|||
16559673|NCT00231179|40517291|FG000|Overall Study|Withdrawal by Subject|3|||
16245530|NCT00217971|39381604|FG001|Overall Study|Physician Decision|1|||
16245531|NCT00217971|39381603|FG000|Overall Study|Withdrawal by Subject|7|||
16245532|NCT00217971|39381604|FG001|Overall Study|Withdrawal by Subject|12|||
16245533|NCT00217971|39381603|FG000|Overall Study|non compliant|1|||
16245534|NCT00217971|39381604|FG001|Overall Study|non compliant|0|||
16245535|NCT01798485|39381609|FG000|Overall Study|Adverse Event|32|||
16245536|NCT01798485|39381610|FG001|Overall Study|Adverse Event|40|||
16245537|NCT01798485|39381609|FG000|Overall Study|Withdrawal by Subject|27|||
16245538|NCT01798485|39381610|FG001|Overall Study|Withdrawal by Subject|31|||
16245539|NCT01798485|39381609|FG000|Overall Study|Lost to Follow-up|0|||
16245540|NCT01798485|39381610|FG001|Overall Study|Lost to Follow-up|3|||
16245541|NCT01798485|39381609|FG000|Overall Study|Physician Decision|14|||
16245542|NCT01798485|39381610|FG001|Overall Study|Physician Decision|10|||
16245543|NCT01798485|39381609|FG000|Overall Study|Objective Disease Progression|152|||
16245544|NCT01798485|39381610|FG001|Overall Study|Objective Disease Progression|106|||
16245545|NCT01798485|39381609|FG000|Overall Study|Death|25|||
16245546|NCT01798485|39381610|FG001|Overall Study|Death|22|||
16245547|NCT01798485|39381609|FG000|Overall Study|Sponsor Decision|61|||
16245548|NCT01798485|39381610|FG001|Overall Study|Sponsor Decision|54|||
16245549|NCT01798485|39381609|FG000|Overall Study|Clinical Progression|35|||
16245550|NCT01798485|39381610|FG001|Overall Study|Clinical Progression|24|||
16245551|NCT02480010|39381611|FG000|Overall Study|Adverse Event|3|||
16245552|NCT02480010|39381612|FG001|Overall Study|Adverse Event|1|||
16245553|NCT02480010|39381611|FG000|Overall Study|Death|1|||
16245554|NCT02480010|39381612|FG001|Overall Study|Death|0|||
16245555|NCT02480010|39381611|FG000|Overall Study|Insufficient therapeutic response|31|||
16245556|NCT02480010|39381612|FG001|Overall Study|Insufficient therapeutic response|29|||
16245557|NCT02480010|39381611|FG000|Overall Study|Refused Treatment|0|||
16245558|NCT02480010|39381612|FG001|Overall Study|Refused Treatment|3|||
16245559|NCT01017029|39381613|FG000|Overall Study|Lost to Follow-up|1|||
16245560|NCT01017029|39381614|FG001|Overall Study|Lost to Follow-up|0|||
16245561|NCT01017029|39381613|FG000|Overall Study|Administrative problem|0|||
16245562|NCT01017029|39381614|FG001|Overall Study|Administrative problem|1|||
16245563|NCT01017029|39381613|FG000|Overall Study|Death|3|||
16245564|NCT01017029|39381614|FG001|Overall Study|Death|1|||
16245565|NCT01225991|39381615|FG000|Overall Study|Withdrawal by Subject|6|||
16245566|NCT01121900|39381616|FG000|First Intervention Period|Adverse Event|1|||
16245567|NCT01121900|39381617|FG001|First Intervention Period|Adverse Event|1|||
16245568|NCT01121900|39381616|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
16245569|NCT01121900|39381617|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16245570|NCT05016765|39381618|FG000|Overall Study|Lost to Follow-up|4|||
16351925|NCT01656395|39776519|FG002|Overall Study|Physician Decision|3|||
16351926|NCT01656395|39776520|FG003|Overall Study|Physician Decision|2|||
16351927|NCT01656395|39776521|FG004|Overall Study|Physician Decision|3|||
16351928|NCT01656395|39776522|FG005|Overall Study|Physician Decision|3|||
16245571|NCT03137082|39381624|FG000|Overall Study|Withdrawal by Subject|1|||
16245572|NCT03137082|39381625|FG001|Overall Study|Withdrawal by Subject|1|||
16245573|NCT03137082|39381624|FG000|Overall Study|Lost to Follow-up|1|||
16245574|NCT03137082|39381625|FG001|Overall Study|Lost to Follow-up|0|||
16245575|NCT02789111|39381626|FG000|Overall Study|Withdrawal by Subject|1|||
16245576|NCT02789111|39381627|FG001|Overall Study|Withdrawal by Subject|4|||
16351929|NCT01656395|39776523|FG006|Overall Study|Physician Decision|0|||
16351930|NCT01656395|39776524|FG007|Overall Study|Physician Decision|0|||
16351931|NCT01656395|39776517|FG000|Overall Study|Pregnancy|0|||
16351932|NCT01656395|39776518|FG001|Overall Study|Pregnancy|0|||
16351933|NCT01656395|39776519|FG002|Overall Study|Pregnancy|1|||
16351934|NCT01656395|39776520|FG003|Overall Study|Pregnancy|0|||
16351935|NCT01656395|39776521|FG004|Overall Study|Pregnancy|0|||
16351936|NCT01656395|39776522|FG005|Overall Study|Pregnancy|0|||
16351937|NCT01656395|39776523|FG006|Overall Study|Pregnancy|0|||
16351938|NCT01656395|39776524|FG007|Overall Study|Pregnancy|0|||
16351939|NCT01656395|39776517|FG000|Overall Study|Progressive Disease|0|||
16351940|NCT01656395|39776518|FG001|Overall Study|Progressive Disease|0|||
16351941|NCT01656395|39776519|FG002|Overall Study|Progressive Disease|0|||
16351942|NCT01656395|39776520|FG003|Overall Study|Progressive Disease|0|||
16351943|NCT01656395|39776521|FG004|Overall Study|Progressive Disease|0|||
16559674|NCT00231179|40517292|FG001|Overall Study|Withdrawal by Subject|3|||
16559675|NCT04004208|40517293|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16559676|NCT04004208|40517294|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16559677|NCT04004208|40517293|FG000|Overall Study|Death|3|||
16559678|NCT04004208|40517294|FG001|Overall Study|Death|0|||
16559679|NCT04004208|40517293|FG000|Overall Study|COVID-19 pandemic|1|||
16559680|NCT04004208|40517294|FG001|Overall Study|COVID-19 pandemic|0|||
16559681|NCT04004208|40517293|FG000|Overall Study|Physician Decision|1|||
16559682|NCT04004208|40517294|FG001|Overall Study|Physician Decision|0|||
16559683|NCT04004208|40517293|FG000|Overall Study|Adverse Event|1|||
16559684|NCT04004208|40517294|FG001|Overall Study|Adverse Event|1|||
16559685|NCT00986102|40517295|FG000|Overall Study|Lost to Follow-up|0|||
16559686|NCT00986102|40517296|FG001|Overall Study|Lost to Follow-up|1|||
16559687|NCT00986102|40517297|FG002|Overall Study|Lost to Follow-up|0|||
16351944|NCT01656395|39776522|FG005|Overall Study|Progressive Disease|1|||
16351945|NCT01656395|39776523|FG006|Overall Study|Progressive Disease|0|||
16351946|NCT01656395|39776524|FG007|Overall Study|Progressive Disease|0|||
16351947|NCT01656395|39776517|FG000|Overall Study|Protocol Violation|6|||
16351948|NCT01656395|39776518|FG001|Overall Study|Protocol Violation|6|||
16351949|NCT01656395|39776519|FG002|Overall Study|Protocol Violation|9|||
16351950|NCT01656395|39776520|FG003|Overall Study|Protocol Violation|2|||
16351951|NCT01656395|39776521|FG004|Overall Study|Protocol Violation|4|||
16351952|NCT01656395|39776522|FG005|Overall Study|Protocol Violation|10|||
16351953|NCT01656395|39776523|FG006|Overall Study|Protocol Violation|0|||
16351954|NCT01656395|39776524|FG007|Overall Study|Protocol Violation|0|||
16351955|NCT01656395|39776517|FG000|Overall Study|Screen Failure|2|||
16351956|NCT01656395|39776518|FG001|Overall Study|Screen Failure|1|||
16351957|NCT01656395|39776519|FG002|Overall Study|Screen Failure|7|||
16351958|NCT01656395|39776520|FG003|Overall Study|Screen Failure|1|||
16351959|NCT01656395|39776521|FG004|Overall Study|Screen Failure|0|||
16351960|NCT01656395|39776522|FG005|Overall Study|Screen Failure|8|||
16351961|NCT01656395|39776523|FG006|Overall Study|Screen Failure|0|||
16351962|NCT01656395|39776524|FG007|Overall Study|Screen Failure|0|||
16351963|NCT01656395|39776517|FG000|Overall Study|Withdrawal by Subject|3|||
16351964|NCT01656395|39776518|FG001|Overall Study|Withdrawal by Subject|1|||
16351965|NCT01656395|39776519|FG002|Overall Study|Withdrawal by Subject|4|||
16351966|NCT01656395|39776520|FG003|Overall Study|Withdrawal by Subject|2|||
16351967|NCT01656395|39776521|FG004|Overall Study|Withdrawal by Subject|0|||
16351968|NCT01656395|39776522|FG005|Overall Study|Withdrawal by Subject|3|||
16351969|NCT01656395|39776523|FG006|Overall Study|Withdrawal by Subject|0|||
16351970|NCT01656395|39776524|FG007|Overall Study|Withdrawal by Subject|0|||
16351971|NCT02340000|39776525|FG000|Time Period 1|Withdrawal by Subject|6|||
16559688|NCT00986102|40517298|FG003|Overall Study|Lost to Follow-up|1|||
16351972|NCT02340000|39776526|FG001|Time Period 1|Withdrawal by Subject|8|||
16559689|NCT00986102|40517295|FG000|Overall Study|Withdrawal by Subject|1|||
16559690|NCT00986102|40517296|FG001|Overall Study|Withdrawal by Subject|1|||
16351973|NCT02340000|39776525|FG000|Time Period 1|Lost to Follow-up|6|||
16351974|NCT02340000|39776526|FG001|Time Period 1|Lost to Follow-up|7|||
16351975|NCT02340000|39776525|FG000|Time Period 2|Withdrawal by Subject|9|||
16351976|NCT02340000|39776526|FG001|Time Period 2|Withdrawal by Subject|7|||
16559691|NCT00986102|40517297|FG002|Overall Study|Withdrawal by Subject|0|||
16416557|NCT00395850|40004746|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
16351977|NCT02340000|39776525|FG000|Time Period 2|Lost to Follow-up|10|||
16351978|NCT02340000|39776526|FG001|Time Period 2|Lost to Follow-up|8|||
16351979|NCT02457195|39776527|FG000|Overall Study|Adverse Event|3|||
16351980|NCT02457195|39776527|FG000|Overall Study|Protocol Violation|2|||
16351981|NCT02457195|39776527|FG000|Overall Study|Withdrawal by Subject|4|||
16351982|NCT00666211|39776528|FG000|Overall Study|Withdrawal by Subject|10|||
16351983|NCT00666211|39776529|FG001|Overall Study|Withdrawal by Subject|13|||
16351984|NCT00666211|39776528|FG000|Overall Study|went off medication, no more pain|1|||
16351985|NCT00666211|39776529|FG001|Overall Study|went off medication, no more pain|0|||
16351986|NCT00666211|39776528|FG000|Overall Study|patient non-compliant|6|||
16351987|NCT00666211|39776529|FG001|Overall Study|patient non-compliant|6|||
16351988|NCT00666211|39776528|FG000|Overall Study|disease progression|1|||
16351989|NCT00666211|39776529|FG001|Overall Study|disease progression|8|||
16351990|NCT00666211|39776528|FG000|Overall Study|Lost to Follow-up|2|||
16351991|NCT00666211|39776529|FG001|Overall Study|Lost to Follow-up|0|||
16351992|NCT00666211|39776528|FG000|Overall Study|toxicity|0|||
16351993|NCT00666211|39776529|FG001|Overall Study|toxicity|2|||
16351994|NCT00666211|39776528|FG000|Overall Study|hospital admission|0|||
16128346|NCT04602221|38954577|FG010|Overall Study|Other than listed|0|||
16351995|NCT00666211|39776529|FG001|Overall Study|hospital admission|5|||
16351996|NCT00666211|39776528|FG000|Overall Study|Death|0|||
16351997|NCT00666211|39776529|FG001|Overall Study|Death|2|||
16416558|NCT00395850|40004747|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
16416559|NCT00395850|40004748|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
16416560|NCT00395850|40004749|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
16416561|NCT01827332|40004750|FG000|Overall Study|Lost to Follow-up|2|||
16416562|NCT01827332|40004751|FG001|Overall Study|Lost to Follow-up|1|||
16416563|NCT02943915|40004752|FG000|Overall Study|Withdrawal by Subject|2|||
16416564|NCT02943915|40004753|FG001|Overall Study|Withdrawal by Subject|1|||
16416565|NCT02943915|40004754|FG002|Overall Study|Withdrawal by Subject|0|||
16416566|NCT02943915|40004755|FG003|Overall Study|Withdrawal by Subject|0|||
16416567|NCT02943915|40004752|FG000|Overall Study|Lost to Follow-up|3|||
16416568|NCT02943915|40004753|FG001|Overall Study|Lost to Follow-up|1|||
16416569|NCT02943915|40004754|FG002|Overall Study|Lost to Follow-up|0|||
16416570|NCT02943915|40004755|FG003|Overall Study|Lost to Follow-up|0|||
16416571|NCT02943915|40004752|FG000|Overall Study|excluded|0|||
16416572|NCT02943915|40004753|FG001|Overall Study|excluded|1|||
16416573|NCT02943915|40004754|FG002|Overall Study|excluded|0|||
16416574|NCT02943915|40004755|FG003|Overall Study|excluded|0|||
16416575|NCT01704456|40004759|FG000|Overall Study|Lost to Follow-up|8|||
16416576|NCT01704456|40004760|FG001|Overall Study|Lost to Follow-up|14|||
16416577|NCT00462748|40004761|FG000|Overall Study|Adverse Event|7|||
16416578|NCT00462748|40004762|FG001|Overall Study|Adverse Event|5|||
16416579|NCT00462748|40004763|FG002|Overall Study|Adverse Event|9|||
16416580|NCT00462748|40004761|FG000|Overall Study|Protocol Violation|0|||
16416581|NCT00462748|40004762|FG001|Overall Study|Protocol Violation|2|||
16416582|NCT00462748|40004763|FG002|Overall Study|Protocol Violation|1|||
16128347|NCT04602221|38954578|FG011|Overall Study|Other than listed|0|||
16128348|NCT04602221|38954579|FG012|Overall Study|Other than listed|0|||
16351998|NCT00666211|39776528|FG000|Overall Study|off tx for other complicating disease|0|||
16416583|NCT00462748|40004761|FG000|Overall Study|Withdrew consent|3|||
16351999|NCT00666211|39776529|FG001|Overall Study|off tx for other complicating disease|1|||
16128349|NCT04602221|38954580|FG013|Overall Study|Other than listed|0|||
16128350|NCT04602221|38954581|FG014|Overall Study|Other than listed|0|||
16128351|NCT04602221|38954582|FG015|Overall Study|Other than listed|1|||
16128352|NCT04602221|38954583|FG016|Overall Study|Other than listed|0|||
16128353|NCT04602221|38954584|FG017|Overall Study|Other than listed|1|||
16128354|NCT04602221|38954567|FG000|Overall Study|Withdrawal by Subject|0|||
16128355|NCT04602221|38954568|FG001|Overall Study|Withdrawal by Subject|0|||
16128356|NCT04602221|38954569|FG002|Overall Study|Withdrawal by Subject|0|||
16128357|NCT04602221|38954570|FG003|Overall Study|Withdrawal by Subject|0|||
16128358|NCT04602221|38954571|FG004|Overall Study|Withdrawal by Subject|0|||
16128359|NCT04602221|38954572|FG005|Overall Study|Withdrawal by Subject|0|||
16128360|NCT04602221|38954573|FG006|Overall Study|Withdrawal by Subject|0|||
16128361|NCT04602221|38954574|FG007|Overall Study|Withdrawal by Subject|0|||
16128362|NCT04602221|38954575|FG008|Overall Study|Withdrawal by Subject|0|||
16128363|NCT04602221|38954576|FG009|Overall Study|Withdrawal by Subject|0|||
16128364|NCT04602221|38954577|FG010|Overall Study|Withdrawal by Subject|0|||
16128365|NCT04602221|38954578|FG011|Overall Study|Withdrawal by Subject|0|||
16128366|NCT04602221|38954579|FG012|Overall Study|Withdrawal by Subject|1|||
16128367|NCT04602221|38954580|FG013|Overall Study|Withdrawal by Subject|0|||
16128368|NCT04602221|38954581|FG014|Overall Study|Withdrawal by Subject|0|||
16128369|NCT04602221|38954582|FG015|Overall Study|Withdrawal by Subject|0|||
16128370|NCT04602221|38954583|FG016|Overall Study|Withdrawal by Subject|0|||
16128371|NCT04602221|38954584|FG017|Overall Study|Withdrawal by Subject|0|||
16128372|NCT04602221|38954567|FG000|Overall Study|Lost to Follow-up|0|||
16128373|NCT04602221|38954568|FG001|Overall Study|Lost to Follow-up|0|||
16128374|NCT04602221|38954569|FG002|Overall Study|Lost to Follow-up|0|||
16128375|NCT04602221|38954570|FG003|Overall Study|Lost to Follow-up|0|||
16128376|NCT04602221|38954571|FG004|Overall Study|Lost to Follow-up|0|||
16128377|NCT04602221|38954572|FG005|Overall Study|Lost to Follow-up|1|||
16128378|NCT04602221|38954573|FG006|Overall Study|Lost to Follow-up|0|||
16128379|NCT04602221|38954574|FG007|Overall Study|Lost to Follow-up|0|||
16128380|NCT04602221|38954575|FG008|Overall Study|Lost to Follow-up|0|||
16128381|NCT04602221|38954576|FG009|Overall Study|Lost to Follow-up|0|||
16128382|NCT04602221|38954577|FG010|Overall Study|Lost to Follow-up|0|||
16128383|NCT04602221|38954578|FG011|Overall Study|Lost to Follow-up|0|||
16128384|NCT04602221|38954579|FG012|Overall Study|Lost to Follow-up|0|||
16128385|NCT04602221|38954580|FG013|Overall Study|Lost to Follow-up|0|||
16128386|NCT04602221|38954581|FG014|Overall Study|Lost to Follow-up|0|||
16128387|NCT04602221|38954582|FG015|Overall Study|Lost to Follow-up|0|||
16128388|NCT04602221|38954583|FG016|Overall Study|Lost to Follow-up|0|||
16128389|NCT04602221|38954584|FG017|Overall Study|Lost to Follow-up|0|||
16128390|NCT03606668|38954588|FG000|Overall Study|Screen Failure|1|||
16128391|NCT03606668|38954588|FG000|Overall Study|Lost to Follow-up|1|||
16128392|NCT01090427|38954589|FG000|After Controlled Period|Death|0|||
16128393|NCT01090427|38954590|FG001|After Controlled Period|Death|0|||
16128394|NCT01090427|38954591|FG002|After Controlled Period|Death|0|||
16128395|NCT01090427|38954592|FG003|After Controlled Period|Death|0|||
16128396|NCT01090427|38954593|FG004|After Controlled Period|Death|0|||
16128397|NCT01090427|38954594|FG005|After Controlled Period|Death|1|||
16128398|NCT01090427|38954595|FG006|After Controlled Period|Death|0|||
16128399|NCT01090427|38954589|FG000|After Controlled Period|Lack of Efficacy|0|||
16128400|NCT01090427|38954590|FG001|After Controlled Period|Lack of Efficacy|0|||
16128401|NCT01090427|38954591|FG002|After Controlled Period|Lack of Efficacy|0|||
16128402|NCT01090427|38954592|FG003|After Controlled Period|Lack of Efficacy|0|||
16128403|NCT01090427|38954593|FG004|After Controlled Period|Lack of Efficacy|0|||
16128404|NCT01090427|38954594|FG005|After Controlled Period|Lack of Efficacy|3|||
16352000|NCT00666211|39776528|FG000|Overall Study|Physician Decision|0|||
16128405|NCT01090427|38954595|FG006|After Controlled Period|Lack of Efficacy|2|||
16128406|NCT01090427|38954589|FG000|After Controlled Period|Adverse Event|0|||
16128407|NCT01090427|38954590|FG001|After Controlled Period|Adverse Event|0|||
16128408|NCT01090427|38954591|FG002|After Controlled Period|Adverse Event|0|||
16128409|NCT01090427|38954592|FG003|After Controlled Period|Adverse Event|2|||
16128410|NCT01090427|38954593|FG004|After Controlled Period|Adverse Event|0|||
16128411|NCT01090427|38954594|FG005|After Controlled Period|Adverse Event|1|||
16128412|NCT01090427|38954595|FG006|After Controlled Period|Adverse Event|0|||
16559692|NCT00986102|40517298|FG003|Overall Study|Withdrawal by Subject|0|||
16128413|NCT05132127|38954597|FG000|Overall Study|Adverse Event|1|||
16128414|NCT01146782|38954598|FG000|Screening Cohort|Screen Failure|187|||
16128415|NCT01146782|38954598|FG000|Screening Cohort|Lost to Follow-up|4|||
16128416|NCT01146782|38954598|FG000|Screening Cohort|Physician Decision|1|||
16128417|NCT01146782|38954598|FG000|Screening Cohort|Withdrawal by Subject|29|||
16128418|NCT01146782|38954598|FG000|Safety Cohort|Screen Failure|61|||
16128419|NCT01146782|38954598|FG000|Safety Cohort|Withdrawal by Subject|4|||
16128420|NCT01146782|38954598|FG000|Safety Cohort|Control AHI <5|4|||
16128421|NCT01146782|38954598|FG000|Safety Cohort|TST <4 hrs|14|||
16128422|NCT01146782|38954598|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
16128423|NCT01146782|38954598|FG000|Primary Endpoint Cohort|Physician Decision|1|||
16128424|NCT00194987|38954599|FG000|Overall Study|Withdrawal by Subject|0|||
16128425|NCT00194987|38954600|FG001|Overall Study|Withdrawal by Subject|3|||
16128426|NCT01775124|38954601|FG000|Core Period|Disease Progression|0|||
16128427|NCT01775124|38954602|FG001|Core Period|Disease Progression|1|||
16128428|NCT01775124|38954601|FG000|Core Period|Physician Decision|1|||
16128429|NCT01775124|38954602|FG001|Core Period|Physician Decision|1|||
16128430|NCT01775124|38954601|FG000|Core Period|Death|0|||
16128431|NCT01775124|38954602|FG001|Core Period|Death|1|||
16128432|NCT01775124|38954601|FG000|Core Period|Administrative problems|1|||
16128433|NCT01775124|38954602|FG001|Core Period|Administrative problems|0|||
16128434|NCT01775124|38954601|FG000|Core Period|Withdrawal by Subject|4|||
16128435|NCT01775124|38954602|FG001|Core Period|Withdrawal by Subject|2|||
16128436|NCT01775124|38954601|FG000|Core Period|Adverse Event|5|||
16128437|NCT01775124|38954602|FG001|Core Period|Adverse Event|5|||
16245577|NCT02995837|39381631|FG000|Overall Study|Lost to Follow-up|9|||
16245578|NCT02995837|39381632|FG001|Overall Study|Lost to Follow-up|8|||
16128438|NCT01775124|38954601|FG000|Extension Period|Adverse Event|3|||
16128439|NCT01775124|38954602|FG001|Extension Period|Adverse Event|2|||
16128440|NCT01775124|38954601|FG000|Extension Period|Physician Decision|0|||
16128441|NCT01775124|38954602|FG001|Extension Period|Physician Decision|2|||
16128442|NCT01775124|38954601|FG000|Extension Period|Administrative problems|0|||
16128443|NCT01775124|38954602|FG001|Extension Period|Administrative problems|1|||
16128444|NCT01775124|38954601|FG000|Extension Period|Lost to Follow-up|0|||
16128445|NCT01775124|38954602|FG001|Extension Period|Lost to Follow-up|1|||
16128446|NCT01775124|38954601|FG000|Extension Period|Withdrawal by Subject|9|||
16128447|NCT01775124|38954602|FG001|Extension Period|Withdrawal by Subject|12|||
16128448|NCT01946438|38958619|FG000|Overall Study|Adverse Event|0|||
16128449|NCT01946438|38958620|FG001|Overall Study|Adverse Event|0|||
16128450|NCT01946438|38958621|FG002|Overall Study|Adverse Event|0|||
16559693|NCT02955277|40517303|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
16559694|NCT02955277|40517304|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
16559695|NCT02955277|40517303|FG000|Post to Follow-up|Lost to Follow-up|8|||
16559696|NCT02955277|40517304|FG001|Post to Follow-up|Lost to Follow-up|11|||
16128451|NCT01946438|38958622|FG003|Overall Study|Adverse Event|1|||
16128452|NCT01946438|38958619|FG000|Overall Study|Serious Adverse event|1|||
16128453|NCT01946438|38958620|FG001|Overall Study|Serious Adverse event|0|||
16559697|NCT03268590|40517305|FG000|Overall Study|Previously unknown exclusion criteria|1|||
16559698|NCT02851511|40517306|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
16559699|NCT02851511|40517307|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
16559700|NCT02851511|40517308|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
16559701|NCT02851511|40517309|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
16559702|NCT02851511|40517306|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
16559703|NCT02851511|40517307|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
16559704|NCT02851511|40517308|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
16559705|NCT02851511|40517309|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
16559706|NCT02851511|40517306|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
16559707|NCT02851511|40517307|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
16559708|NCT02851511|40517308|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
16559709|NCT02851511|40517309|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
16559710|NCT02851511|40517306|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
16559711|NCT02851511|40517307|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
16559712|NCT02851511|40517308|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
16559713|NCT02851511|40517309|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
16559714|NCT02851511|40517306|FG000|Phase I|Physician Decision|0|||
16559715|NCT02851511|40517307|FG001|Phase I|Physician Decision|0|||
16559716|NCT02851511|40517308|FG002|Phase I|Physician Decision|0|||
16559717|NCT02851511|40517309|FG003|Phase I|Physician Decision|1|||
16128454|NCT01946438|38958621|FG002|Overall Study|Serious Adverse event|0|||
16559718|NCT02851511|40517306|FG000|Phase I|Withdrawal by Subject|2|||
16128455|NCT01946438|38958622|FG003|Overall Study|Serious Adverse event|0|||
16128456|NCT01946438|38958619|FG000|Overall Study|Protocol Violation|0|||
16128457|NCT01946438|38958620|FG001|Overall Study|Protocol Violation|0|||
16128458|NCT01946438|38958621|FG002|Overall Study|Protocol Violation|1|||
16128459|NCT01946438|38958622|FG003|Overall Study|Protocol Violation|0|||
16128460|NCT01946438|38958619|FG000|Overall Study|Withdrawal by Subject|1|||
16128461|NCT01946438|38958620|FG001|Overall Study|Withdrawal by Subject|0|||
16128462|NCT01946438|38958621|FG002|Overall Study|Withdrawal by Subject|0|||
16128463|NCT01946438|38958622|FG003|Overall Study|Withdrawal by Subject|0|||
16128464|NCT01642251|38958623|FG000|Overall Study|Progressive disease|0|||
16128465|NCT01642251|38958624|FG001|Overall Study|Progressive disease|0|||
16128466|NCT01642251|38958625|FG002|Overall Study|Progressive disease|3|||
16128467|NCT01642251|38958626|FG003|Overall Study|Progressive disease|3|||
16128468|NCT01642251|38958623|FG000|Overall Study|Adverse Event|0|||
16128469|NCT01642251|38958624|FG001|Overall Study|Adverse Event|0|||
16128470|NCT01642251|38958625|FG002|Overall Study|Adverse Event|5|||
16128471|NCT01642251|38958626|FG003|Overall Study|Adverse Event|4|||
16128472|NCT01642251|38958623|FG000|Overall Study|Death|0|||
16128473|NCT01642251|38958624|FG001|Overall Study|Death|0|||
16128474|NCT01642251|38958625|FG002|Overall Study|Death|1|||
16128475|NCT01642251|38958626|FG003|Overall Study|Death|3|||
16559719|NCT02851511|40517307|FG001|Phase I|Withdrawal by Subject|1|||
16559720|NCT02851511|40517308|FG002|Phase I|Withdrawal by Subject|0|||
16559721|NCT02851511|40517309|FG003|Phase I|Withdrawal by Subject|3|||
16559722|NCT02851511|40517306|FG000|Phase II|Physician Decision|18|||
16559723|NCT02851511|40517307|FG001|Phase II|Physician Decision|16|||
16559724|NCT02851511|40517308|FG002|Phase II|Physician Decision|0|||
16559725|NCT02851511|40517309|FG003|Phase II|Physician Decision|0|||
16559726|NCT02851511|40517306|FG000|Phase II|Withdrawal by Subject|18|||
16559727|NCT02851511|40517307|FG001|Phase II|Withdrawal by Subject|16|||
16559728|NCT02851511|40517308|FG002|Phase II|Withdrawal by Subject|0|||
16559729|NCT02851511|40517309|FG003|Phase II|Withdrawal by Subject|0|||
16559730|NCT02851511|40517306|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
16559731|NCT02851511|40517307|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
16559732|NCT02851511|40517308|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
16559733|NCT02851511|40517309|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
16559734|NCT02851511|40517306|FG000|Phase II|Lost to Follow-up|0|||
16559735|NCT02851511|40517307|FG001|Phase II|Lost to Follow-up|1|||
16559736|NCT02851511|40517308|FG002|Phase II|Lost to Follow-up|0|||
16559737|NCT02851511|40517309|FG003|Phase II|Lost to Follow-up|0|||
16559738|NCT01723826|40517310|FG000|Overall Study|Adverse Event|4|||
16559739|NCT01723826|40517311|FG001|Overall Study|Adverse Event|1|||
16559740|NCT01723826|40517312|FG002|Overall Study|Adverse Event|4|||
16559741|NCT01723826|40517313|FG003|Overall Study|Adverse Event|5|||
16559742|NCT01723826|40517310|FG000|Overall Study|Death according to AE eCRF|2|||
16559743|NCT01723826|40517311|FG001|Overall Study|Death according to AE eCRF|3|||
16559744|NCT01723826|40517312|FG002|Overall Study|Death according to AE eCRF|3|||
16559745|NCT01723826|40517313|FG003|Overall Study|Death according to AE eCRF|7|||
16559746|NCT01723826|40517310|FG000|Overall Study|Lost to Follow-up|1|||
16559747|NCT01723826|40517311|FG001|Overall Study|Lost to Follow-up|3|||
16559748|NCT01723826|40517312|FG002|Overall Study|Lost to Follow-up|1|||
16559749|NCT01723826|40517313|FG003|Overall Study|Lost to Follow-up|1|||
16559750|NCT01723826|40517310|FG000|Overall Study|Non-compliance|0|||
16559751|NCT01723826|40517311|FG001|Overall Study|Non-compliance|1|||
16559752|NCT01723826|40517312|FG002|Overall Study|Non-compliance|3|||
16559753|NCT01723826|40517313|FG003|Overall Study|Non-compliance|3|||
16559754|NCT01723826|40517310|FG000|Overall Study|Non-compliance With Study Drug|0|||
16559755|NCT01723826|40517311|FG001|Overall Study|Non-compliance With Study Drug|1|||
16559756|NCT01723826|40517312|FG002|Overall Study|Non-compliance With Study Drug|0|||
16559757|NCT01723826|40517313|FG003|Overall Study|Non-compliance With Study Drug|0|||
16559758|NCT01723826|40517310|FG000|Overall Study|Other Reason|8|||
16559759|NCT01723826|40517311|FG001|Overall Study|Other Reason|6|||
16559760|NCT01723826|40517312|FG002|Overall Study|Other Reason|12|||
16559761|NCT01723826|40517313|FG003|Overall Study|Other Reason|14|||
16559762|NCT01723826|40517310|FG000|Overall Study|Physician Decision|1|||
16559763|NCT01723826|40517311|FG001|Overall Study|Physician Decision|3|||
16559764|NCT01723826|40517312|FG002|Overall Study|Physician Decision|4|||
16559765|NCT01723826|40517313|FG003|Overall Study|Physician Decision|11|||
16559766|NCT01723826|40517310|FG000|Overall Study|Protocol Violation|1|||
16559767|NCT01723826|40517311|FG001|Overall Study|Protocol Violation|1|||
16559768|NCT01723826|40517312|FG002|Overall Study|Protocol Violation|3|||
16559769|NCT01723826|40517313|FG003|Overall Study|Protocol Violation|1|||
16559770|NCT01723826|40517310|FG000|Overall Study|Withdrawal by Subject|10|||
16559771|NCT01723826|40517311|FG001|Overall Study|Withdrawal by Subject|17|||
16559772|NCT01723826|40517312|FG002|Overall Study|Withdrawal by Subject|27|||
16559773|NCT01723826|40517313|FG003|Overall Study|Withdrawal by Subject|48|||
16559774|NCT00610675|40517314|FG000|Overall Study|Untreated|4|||
16559775|NCT00610675|40517314|FG000|Overall Study|Adverse Event|67|||
16559776|NCT00610675|40517314|FG000|Overall Study|Insufficient Effect|31|||
16559777|NCT00610675|40517314|FG000|Overall Study|Withdrawal by Subject|28|||
16559778|NCT00610675|40517314|FG000|Overall Study|Reasons unrelated to trial|27|||
16559779|NCT00610675|40517314|FG000|Overall Study|Lack of Compliance|7|||
16559780|NCT00610675|40517314|FG000|Overall Study|Lost to Follow-up|31|||
16559781|NCT00610675|40517314|FG000|Overall Study|Other reason (not specified)|25|||
16559782|NCT04990440|40517315|FG000|Overall Study|Sponsor's Decision|0|||
16559783|NCT04990440|40517316|FG001|Overall Study|Sponsor's Decision|0|||
16559784|NCT04990440|40517317|FG002|Overall Study|Sponsor's Decision|1|||
16559785|NCT03290079|40517322|FG000|Overall Study|Death|2|||
16559786|NCT01782326|40517323|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
16559787|NCT01782326|40517324|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
16559788|NCT01782326|40517323|FG000|Planned Treatment Epoch|Death|29|||
16559789|NCT01782326|40517324|FG001|Planned Treatment Epoch|Death|30|||
16559790|NCT01782326|40517323|FG000|Planned Treatment Epoch|Physician Decision|18|||
16559791|NCT01782326|40517324|FG001|Planned Treatment Epoch|Physician Decision|16|||
16559792|NCT01782326|40517323|FG000|Planned Treatment Epoch|Protocol deviation|2|||
16559793|NCT01782326|40517324|FG001|Planned Treatment Epoch|Protocol deviation|3|||
16559794|NCT01782326|40517323|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
16559795|NCT01782326|40517324|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
16128476|NCT01642251|38958623|FG000|Overall Study|Withdrawal by Subject|0|||
16128477|NCT01642251|38958624|FG001|Overall Study|Withdrawal by Subject|0|||
16128478|NCT01642251|38958625|FG002|Overall Study|Withdrawal by Subject|1|||
16128479|NCT01642251|38958626|FG003|Overall Study|Withdrawal by Subject|3|||
16128480|NCT01642251|38958623|FG000|Overall Study|Alternative therapy|0|||
16128481|NCT01642251|38958624|FG001|Overall Study|Alternative therapy|0|||
16128482|NCT01642251|38958625|FG002|Overall Study|Alternative therapy|0|||
16128483|NCT01642251|38958626|FG003|Overall Study|Alternative therapy|2|||
16128484|NCT01642251|38958623|FG000|Overall Study|Other complicating disease|0|||
16128485|NCT01642251|38958624|FG001|Overall Study|Other complicating disease|0|||
16128486|NCT01642251|38958625|FG002|Overall Study|Other complicating disease|1|||
16128487|NCT01642251|38958626|FG003|Overall Study|Other complicating disease|0|||
16128488|NCT01642251|38958623|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
16128489|NCT01642251|38958624|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
16128490|NCT01642251|38958625|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
16128491|NCT01642251|38958626|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
16128492|NCT00819390|38958629|FG000|Overall Study|Lost to Follow-up|1|||
16128493|NCT00819390|38958630|FG001|Overall Study|Lost to Follow-up|1|||
16128494|NCT00819390|38958631|FG002|Overall Study|Lost to Follow-up|0|||
16128495|NCT00819390|38958632|FG003|Overall Study|Lost to Follow-up|0|||
16128496|NCT00819390|38958629|FG000|Overall Study|Withdrawal by Subject|2|||
16128497|NCT00819390|38958630|FG001|Overall Study|Withdrawal by Subject|0|||
16128498|NCT00819390|38958631|FG002|Overall Study|Withdrawal by Subject|0|||
16128499|NCT00819390|38958632|FG003|Overall Study|Withdrawal by Subject|0|||
16128500|NCT00819390|38958629|FG000|Overall Study|Adverse Event|0|||
16128501|NCT00819390|38958630|FG001|Overall Study|Adverse Event|0|||
16128502|NCT00819390|38958631|FG002|Overall Study|Adverse Event|1|||
16128503|NCT00819390|38958632|FG003|Overall Study|Adverse Event|0|||
16128504|NCT03212989|38958633|FG000|Overall Study|Physician Decision|8|||
16128505|NCT01759368|38958645|FG000|Overall Study|Lost to Follow-up|1|||
16128506|NCT01759368|38958646|FG001|Overall Study|Lost to Follow-up|0|||
16128507|NCT00446992|38958647|FG000|Overall Study|Adverse Event|11|||
16128508|NCT00446992|38958647|FG000|Overall Study|Lost to Follow-up|5|||
16128509|NCT03656510|38958650|FG000|Overall Study|Lost to Follow-up|1|||
16128510|NCT03656510|38958651|FG001|Overall Study|Lost to Follow-up|0|||
16128511|NCT03656510|38958652|FG002|Overall Study|Lost to Follow-up|0|||
16128512|NCT03656510|38958653|FG003|Overall Study|Lost to Follow-up|0|||
16128513|NCT03656510|38958654|FG004|Overall Study|Lost to Follow-up|0|||
16128514|NCT03656510|38958655|FG005|Overall Study|Lost to Follow-up|0|||
16128515|NCT03656510|38958650|FG000|Overall Study|Withdrawal by Subject|1|||
16128516|NCT03656510|38958651|FG001|Overall Study|Withdrawal by Subject|1|||
16128517|NCT03656510|38958652|FG002|Overall Study|Withdrawal by Subject|0|||
16128518|NCT03656510|38958653|FG003|Overall Study|Withdrawal by Subject|1|||
16128519|NCT03656510|38958654|FG004|Overall Study|Withdrawal by Subject|0|||
16128520|NCT03656510|38958655|FG005|Overall Study|Withdrawal by Subject|0|||
16128521|NCT02781844|38958656|FG000|Treatment Period 1|Adverse Event|0|||
16128522|NCT02781844|38958657|FG001|Treatment Period 1|Adverse Event|0|||
16128523|NCT02781844|38958658|FG002|Treatment Period 1|Adverse Event|0|||
16128524|NCT02781844|38958659|FG003|Treatment Period 1|Adverse Event|0|||
16128525|NCT02781844|38958660|FG004|Treatment Period 1|Adverse Event|0|||
16128526|NCT02781844|38958661|FG005|Treatment Period 1|Adverse Event|1|||
16128527|NCT02781844|38958662|FG006|Treatment Period 1|Adverse Event|0|||
16128528|NCT02781844|38958663|FG007|Treatment Period 1|Adverse Event|0|||
16128529|NCT00336895|38958676|FG000|Overall Study|diarrhea|1|||
16128530|NCT00336895|38958676|FG000|Overall Study|nausea and upset stomach|1|||
16128531|NCT00336895|38958676|FG000|Overall Study|Physician Decision|1|||
16128532|NCT00336895|38958676|FG000|Overall Study|screen failed|1|||
16128533|NCT02783768|38958677|FG000|Overall Study|Lost to Follow-up|1|||
16128534|NCT02783768|38958678|FG001|Overall Study|Lost to Follow-up|0|||
16128535|NCT04275089|38958682|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
16128536|NCT00346632|38958683|FG000|Overall Study|Progressive Disease|2|||
16128537|NCT00346632|38958684|FG001|Overall Study|Progressive Disease|2|||
16128538|NCT00346632|38958685|FG002|Overall Study|Progressive Disease|4|||
16128539|NCT00346632|38958686|FG003|Overall Study|Progressive Disease|3|||
16416584|NCT00462748|40004762|FG001|Overall Study|Withdrew consent|3|||
16416585|NCT00462748|40004763|FG002|Overall Study|Withdrew consent|0|||
16416586|NCT00462748|40004761|FG000|Overall Study|Lost to Follow-up|1|||
16416587|NCT00462748|40004762|FG001|Overall Study|Lost to Follow-up|1|||
16416588|NCT00462748|40004763|FG002|Overall Study|Lost to Follow-up|1|||
16416589|NCT00462748|40004761|FG000|Overall Study|Discontinued after 41 days Rx|1|||
16416590|NCT00462748|40004762|FG001|Overall Study|Discontinued after 41 days Rx|0|||
16416591|NCT00462748|40004763|FG002|Overall Study|Discontinued after 41 days Rx|0|||
16416592|NCT01600053|40004764|FG000|Overall Study|Adverse Event|2|||
16416593|NCT01600053|40004764|FG000|Overall Study|trial will not meet the interim endpoint|9|||
16416594|NCT04208087|40004767|FG000|Overall Study|Adverse Event|1|||
16416595|NCT04208087|40004768|FG001|Overall Study|Adverse Event|0|||
16416596|NCT04208087|40004769|FG002|Overall Study|Adverse Event|0|||
16416597|NCT04208087|40004770|FG003|Overall Study|Adverse Event|0|||
16416598|NCT04208087|40004771|FG004|Overall Study|Adverse Event|0|||
16416599|NCT04208087|40004767|FG000|Overall Study|Withdrawal by Subject|0|||
16416600|NCT04208087|40004768|FG001|Overall Study|Withdrawal by Subject|0|||
16416601|NCT04208087|40004769|FG002|Overall Study|Withdrawal by Subject|1|||
16416602|NCT04208087|40004770|FG003|Overall Study|Withdrawal by Subject|0|||
16416603|NCT04208087|40004771|FG004|Overall Study|Withdrawal by Subject|0|||
16416604|NCT04208087|40004767|FG000|Overall Study|Other|0|||
16416605|NCT04208087|40004768|FG001|Overall Study|Other|0|||
16416606|NCT04208087|40004769|FG002|Overall Study|Other|0|||
16416607|NCT04208087|40004770|FG003|Overall Study|Other|0|||
16416608|NCT04208087|40004771|FG004|Overall Study|Other|1|||
16416609|NCT02726945|40004773|FG000|Overall Study|Withdrawal by Subject|0|||
16416610|NCT02726945|40004774|FG001|Overall Study|Withdrawal by Subject|0|||
16416611|NCT02726945|40004775|FG002|Overall Study|Withdrawal by Subject|1|||
16416612|NCT02726945|40004773|FG000|Overall Study|Elected to have total knee replacement|0|||
16416613|NCT02726945|40004774|FG001|Overall Study|Elected to have total knee replacement|1|||
16559796|NCT01782326|40517323|FG000|Planned Treatment Epoch|Technical problems|0|||
16559797|NCT01782326|40517324|FG001|Planned Treatment Epoch|Technical problems|4|||
16559798|NCT01782326|40517323|FG000|Double-blind Treatment|Adverse Event|129|||
16559799|NCT01782326|40517324|FG001|Double-blind Treatment|Adverse Event|145|||
16559800|NCT01782326|40517323|FG000|Double-blind Treatment|Subject/guardian decision|111|||
16559801|NCT01782326|40517324|FG001|Double-blind Treatment|Subject/guardian decision|125|||
16559802|NCT01782326|40517323|FG000|Double-blind Treatment|Lack of Efficacy|17|||
16559803|NCT01782326|40517324|FG001|Double-blind Treatment|Lack of Efficacy|22|||
16559804|NCT01782326|40517323|FG000|Double-blind Treatment|Physician Decision|13|||
16559805|NCT01782326|40517324|FG001|Double-blind Treatment|Physician Decision|16|||
16559806|NCT01782326|40517323|FG000|Double-blind Treatment|Protocol deviation|8|||
16559807|NCT01782326|40517324|FG001|Double-blind Treatment|Protocol deviation|7|||
16559808|NCT01782326|40517323|FG000|Double-blind Treatment|Technical problems|0|||
16559809|NCT01782326|40517324|FG001|Double-blind Treatment|Technical problems|5|||
16559810|NCT02015195|40517327|FG000|Overall Study|Adverse Event|0|||
16128540|NCT00346632|38958687|FG004|Overall Study|Progressive Disease|3|||
16416614|NCT02726945|40004775|FG002|Overall Study|Elected to have total knee replacement|0|||
16128541|NCT00346632|38958688|FG005|Overall Study|Progressive Disease|1|||
16128542|NCT00346632|38958689|FG006|Overall Study|Progressive Disease|2|||
16559811|NCT02015195|40517328|FG001|Overall Study|Adverse Event|0|||
16352001|NCT00666211|39776529|FG001|Overall Study|Physician Decision|1|||
16352002|NCT02791269|39776530|FG000|Overall Study|Lost to Follow-up|0|||
16352003|NCT02791269|39776531|FG001|Overall Study|Lost to Follow-up|1|||
16352004|NCT02781324|39776534|FG000|Overall Study|Withdrawal by Subject|1|||
16352005|NCT02781324|39776535|FG001|Overall Study|Withdrawal by Subject|0|||
16352006|NCT02781324|39776534|FG000|Overall Study|Physician Decision|1|||
16352007|NCT02781324|39776535|FG001|Overall Study|Physician Decision|2|||
16352008|NCT03082729|39776536|FG000|Overall Study|Lost to Follow-up|7|||
16352009|NCT03082729|39776536|FG000|Overall Study|Physician Decision|2|||
16352010|NCT03082729|39776536|FG000|Overall Study|Withdrawal by Subject|1|||
16352011|NCT03082729|39776536|FG000|Overall Study|Lack of Efficacy|9|||
16352012|NCT03082729|39776536|FG000|Overall Study|Adverse Event|4|||
16352013|NCT03082729|39776536|FG000|Overall Study|Protocol Violation|6|||
16352014|NCT03082729|39776536|FG000|Overall Study|Fear of study procedure|1|||
16352015|NCT03082729|39776536|FG000|Overall Study|Scheduling conflict|1|||
16352016|NCT00379834|39776537|FG000|Overall Study|Time constraints|2|||
16352017|NCT02427841|39776539|FG000|Overall Study|Lack of Efficacy|5|||
16352018|NCT02427841|39776539|FG000|Overall Study|Physician Decision|2|||
16352019|NCT02427841|39776539|FG000|Overall Study|Withdrawal by Subject|1|||
16352020|NCT01316224|39776540|FG000|Overall Study|Protocol Violation|3|||
16352021|NCT01316224|39776540|FG000|Overall Study|Adverse Event|3|||
16352022|NCT01316224|39776540|FG000|Overall Study|Lack of Efficacy|1|||
16352023|NCT01316224|39776540|FG000|Overall Study|Withdrawal by Subject|1|||
16352024|NCT01316224|39776540|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
16352025|NCT01316224|39776540|FG000|Overall Study|Other|1|||
16352026|NCT03804268|39776541|FG000|Overall Study|Adverse Event|2|||
16352027|NCT03804268|39776542|FG001|Overall Study|Adverse Event|2|||
16352028|NCT03804268|39776541|FG000|Overall Study|Withdrawal by Subject|2|||
16352029|NCT03804268|39776542|FG001|Overall Study|Withdrawal by Subject|0|||
16352030|NCT03804268|39776541|FG000|Overall Study|Lost to Follow-up|1|||
16352031|NCT03804268|39776542|FG001|Overall Study|Lost to Follow-up|0|||
16352032|NCT03804268|39776541|FG000|Overall Study|Physician Decision|2|||
16352033|NCT03804268|39776542|FG001|Overall Study|Physician Decision|0|||
16352034|NCT02121210|39776543|FG000|Overall Study|Adverse Event|5|||
16352035|NCT02121210|39776544|FG001|Overall Study|Adverse Event|7|||
16352036|NCT02121210|39776543|FG000|Overall Study|Lack of Efficacy|2|||
16559812|NCT02015195|40517329|FG002|Overall Study|Adverse Event|0|||
16128543|NCT00346632|38958690|FG007|Overall Study|Progressive Disease|2|||
16128544|NCT00346632|38958691|FG008|Overall Study|Progressive Disease|2|||
16128545|NCT00346632|38958692|FG009|Overall Study|Progressive Disease|2|||
16128546|NCT00346632|38958683|FG000|Overall Study|Adverse Event|0|||
16559813|NCT02015195|40517330|FG003|Overall Study|Adverse Event|1|||
16559814|NCT02015195|40517331|FG004|Overall Study|Adverse Event|0|||
16559815|NCT02015195|40517332|FG005|Overall Study|Adverse Event|0|||
16559816|NCT02015195|40517333|FG006|Overall Study|Adverse Event|0|||
16559817|NCT01101165|40517334|FG000|Period 1|Adverse Event|1|||
16559818|NCT01101165|40517335|FG001|Period 1|Adverse Event|2|||
16559819|NCT01101165|40517334|FG000|Period 1|Withdrawal by Subject|0|||
16559820|NCT01101165|40517335|FG001|Period 1|Withdrawal by Subject|2|||
16559821|NCT01101165|40517334|FG000|Period 1|Positive Drug Screen|0|||
16559822|NCT01101165|40517335|FG001|Period 1|Positive Drug Screen|1|||
16559823|NCT01101165|40517334|FG000|Period 1|Lost to Follow-up|1|||
16559824|NCT01101165|40517335|FG001|Period 1|Lost to Follow-up|0|||
16559825|NCT01101165|40517334|FG000|Period 2|Withdrawal by Subject|3|||
16559826|NCT01101165|40517335|FG001|Period 2|Withdrawal by Subject|1|||
16559827|NCT01101165|40517334|FG000|Period 2|Adverse Event|1|||
16559828|NCT01101165|40517335|FG001|Period 2|Adverse Event|0|||
16559829|NCT02412761|40517340|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16559830|NCT02412761|40517341|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
16559831|NCT02412761|40517342|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
16559832|NCT02412761|40517343|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16559833|NCT02412761|40517344|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
16559834|NCT02412761|40517345|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
16559835|NCT02015663|40517348|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
16559836|NCT02015663|40517349|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
16559837|NCT02015663|40517348|FG000|Overall Study|Withdrawal by Subject|1|||
16559838|NCT02015663|40517349|FG001|Overall Study|Withdrawal by Subject|0|||
16559839|NCT02015663|40517348|FG000|Overall Study|Protocol Violation|0|||
16559840|NCT02015663|40517349|FG001|Overall Study|Protocol Violation|1|||
16559841|NCT02015663|40517348|FG000|Overall Study|Adverse Event|3|||
16559842|NCT02015663|40517349|FG001|Overall Study|Adverse Event|0|||
16559843|NCT02015663|40517348|FG000|Overall Study|Administrative problems|10|||
16559844|NCT02015663|40517349|FG001|Overall Study|Administrative problems|11|||
16559845|NCT01394991|40517350|FG000|Overall Study|Adverse Event|0|||
16559846|NCT01394991|40517351|FG001|Overall Study|Adverse Event|4|||
16559847|NCT01394991|40517350|FG000|Overall Study|Lack of Efficacy|5|||
16128547|NCT00346632|38958684|FG001|Overall Study|Adverse Event|0|||
16559848|NCT01394991|40517351|FG001|Overall Study|Lack of Efficacy|7|||
16559849|NCT01394991|40517350|FG000|Overall Study|Lost to Follow-up|6|||
16559850|NCT01394991|40517351|FG001|Overall Study|Lost to Follow-up|8|||
16128548|NCT00346632|38958685|FG002|Overall Study|Adverse Event|0|||
16128549|NCT00346632|38958686|FG003|Overall Study|Adverse Event|0|||
16128550|NCT00346632|38958687|FG004|Overall Study|Adverse Event|1|||
16128551|NCT00346632|38958688|FG005|Overall Study|Adverse Event|1|||
16128552|NCT00346632|38958689|FG006|Overall Study|Adverse Event|1|||
16128553|NCT00346632|38958690|FG007|Overall Study|Adverse Event|0|||
16128554|NCT00346632|38958691|FG008|Overall Study|Adverse Event|0|||
16128555|NCT00346632|38958692|FG009|Overall Study|Adverse Event|0|||
16128556|NCT00346632|38958683|FG000|Overall Study|Death|0|||
16128557|NCT00346632|38958684|FG001|Overall Study|Death|0|||
16128558|NCT00346632|38958685|FG002|Overall Study|Death|1|||
16128559|NCT00346632|38958686|FG003|Overall Study|Death|0|||
16128560|NCT00346632|38958687|FG004|Overall Study|Death|0|||
16128561|NCT00346632|38958688|FG005|Overall Study|Death|0|||
16128562|NCT00346632|38958689|FG006|Overall Study|Death|0|||
16128563|NCT00346632|38958690|FG007|Overall Study|Death|0|||
16128564|NCT00346632|38958691|FG008|Overall Study|Death|0|||
16128565|NCT00346632|38958692|FG009|Overall Study|Death|0|||
16128566|NCT00346632|38958683|FG000|Overall Study|Protocol Violation|0|||
16128567|NCT00346632|38958684|FG001|Overall Study|Protocol Violation|0|||
16128568|NCT00346632|38958685|FG002|Overall Study|Protocol Violation|0|||
16128569|NCT00346632|38958686|FG003|Overall Study|Protocol Violation|0|||
16128570|NCT00346632|38958687|FG004|Overall Study|Protocol Violation|0|||
16128571|NCT00346632|38958688|FG005|Overall Study|Protocol Violation|0|||
16128572|NCT00346632|38958689|FG006|Overall Study|Protocol Violation|1|||
16128573|NCT00346632|38958690|FG007|Overall Study|Protocol Violation|0|||
16128574|NCT00346632|38958691|FG008|Overall Study|Protocol Violation|0|||
16128575|NCT00346632|38958692|FG009|Overall Study|Protocol Violation|0|||
16128576|NCT00346632|38958683|FG000|Overall Study|Withdrawal by Subject|0|||
16128577|NCT00346632|38958684|FG001|Overall Study|Withdrawal by Subject|0|||
16128578|NCT00346632|38958685|FG002|Overall Study|Withdrawal by Subject|0|||
16128579|NCT00346632|38958686|FG003|Overall Study|Withdrawal by Subject|0|||
16245579|NCT02082262|39381633|FG000|Overall Study|Withdrawal by Subject|3|||
16245580|NCT02082262|39381633|FG000|Overall Study|Adverse Event|48|||
16245581|NCT03273387|39381635|FG000|Overall Study|Death|2|||
16245582|NCT03273387|39381636|FG001|Overall Study|Death|2|||
16245583|NCT03273387|39381635|FG000|Overall Study|Withdrawal by Subject|1|||
16245584|NCT03273387|39381636|FG001|Overall Study|Withdrawal by Subject|1|||
16245585|NCT01154153|39381637|FG000|Overall Study|Poor compliance to protocol|2|||
16245586|NCT01154153|39381638|FG001|Overall Study|Poor compliance to protocol|0|||
16245587|NCT01154153|39381637|FG000|Overall Study|Unable to use labs|2|||
16245588|NCT01154153|39381638|FG001|Overall Study|Unable to use labs|3|||
16245589|NCT01154153|39381637|FG000|Overall Study|Withdrew consent|1|||
16245590|NCT01154153|39381638|FG001|Overall Study|Withdrew consent|0|||
16245591|NCT00775983|39381644|FG000|Overall Study|Protocol Violation|1|||
16245592|NCT00775983|39381645|FG001|Overall Study|Protocol Violation|2|||
16245593|NCT01138150|39381646|FG000|Overall Study|blood unable to be processed|0|||
16245594|NCT01138150|39381647|FG001|Overall Study|blood unable to be processed|1|||
16245595|NCT01138150|39381646|FG000|Overall Study|Physician Decision|1|||
16245596|NCT01138150|39381647|FG001|Overall Study|Physician Decision|0|||
16245597|NCT05017493|39381648|FG000|Overall Study|Withdrawal by Subject|26|||
16245598|NCT05017493|39381649|FG001|Overall Study|Withdrawal by Subject|0|||
16245599|NCT05017493|39381648|FG000|Overall Study|Physician Decision|15|||
16245600|NCT05017493|39381649|FG001|Overall Study|Physician Decision|0|||
16245601|NCT05017493|39381648|FG000|Overall Study|Protocol Violation|81|||
16245602|NCT05017493|39381649|FG001|Overall Study|Protocol Violation|0|||
16245603|NCT03812679|39381650|FG000|Overall Study|Adverse Event|2|||
16352037|NCT02121210|39776544|FG001|Overall Study|Lack of Efficacy|0|||
16352038|NCT02121210|39776543|FG000|Overall Study|Other than specified above|0|||
16352039|NCT02121210|39776544|FG001|Overall Study|Other than specified above|2|||
16352040|NCT03006562|39776549|FG000|Overall Study|Lost to Follow-up|0|||
16352041|NCT03006562|39776550|FG001|Overall Study|Lost to Follow-up|1|||
16352042|NCT01630135|39776554|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
16352043|NCT01630135|39776555|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
16352044|NCT00974311|39776556|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
16352045|NCT00974311|39776557|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
16559851|NCT01394991|40517350|FG000|Overall Study|Physician Decision|1|||
16128580|NCT00346632|38958687|FG004|Overall Study|Withdrawal by Subject|0|||
16245604|NCT03812679|39381650|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
16245605|NCT03812679|39381650|FG000|Overall Study|Renal transplant|1|||
16128581|NCT00346632|38958688|FG005|Overall Study|Withdrawal by Subject|0|||
16128582|NCT00346632|38958689|FG006|Overall Study|Withdrawal by Subject|1|||
16128583|NCT00346632|38958690|FG007|Overall Study|Withdrawal by Subject|0|||
16128584|NCT00346632|38958691|FG008|Overall Study|Withdrawal by Subject|0|||
16128585|NCT00346632|38958692|FG009|Overall Study|Withdrawal by Subject|0|||
16245606|NCT03812679|39381650|FG000|Overall Study|Withdrawal by Subject|1|||
16245607|NCT03812679|39381650|FG000|Overall Study|Termination of study|2|||
16245608|NCT03812679|39381650|FG000|Overall Study|Water device replacement|1|||
16245609|NCT01623830|39381651|FG000|Overall Study|Withdrawal by Subject|6|||
16245610|NCT01623830|39381652|FG001|Overall Study|Withdrawal by Subject|7|||
16245611|NCT01623830|39381651|FG000|Overall Study|Exclusion from Study|1|||
16245612|NCT01623830|39381652|FG001|Overall Study|Exclusion from Study|2|||
16245613|NCT02629133|39381653|FG000|Overall Study|Lost to Follow-up|3|||
16245614|NCT02629133|39381654|FG001|Overall Study|Lost to Follow-up|1|||
16245615|NCT02629133|39381653|FG000|Overall Study|Withdrawal by Subject|1|||
16245616|NCT02629133|39381654|FG001|Overall Study|Withdrawal by Subject|1|||
16245617|NCT00123487|39381660|FG000|Randomized|Death prior to starting treatment|0|||
16245618|NCT00123487|39381661|FG001|Randomized|Death prior to starting treatment|1|||
16245619|NCT00123487|39381660|FG000|Randomized|SAE prior to starting treatment|1|||
16245620|NCT00123487|39381661|FG001|Randomized|SAE prior to starting treatment|0|||
16245621|NCT00123487|39381660|FG000|Treated With Study Drug|Adverse Event|23|||
16245622|NCT00123487|39381661|FG001|Treated With Study Drug|Adverse Event|22|||
16245623|NCT00123487|39381660|FG000|Treated With Study Drug|Disease Progression|141|||
16245624|NCT00123487|39381661|FG001|Treated With Study Drug|Disease Progression|122|||
16245625|NCT00123487|39381660|FG000|Treated With Study Drug|Physician Decision|8|||
16245626|NCT00123487|39381661|FG001|Treated With Study Drug|Physician Decision|9|||
16245627|NCT00123487|39381660|FG000|Treated With Study Drug|Other|59|||
16245628|NCT00123487|39381661|FG001|Treated With Study Drug|Other|58|||
16245629|NCT00123487|39381660|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
16245630|NCT00123487|39381661|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
16245631|NCT00123487|39381660|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
16245632|NCT00123487|39381661|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
16245633|NCT00123487|39381660|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
16245634|NCT00123487|39381661|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
16245635|NCT01851590|39381662|FG000|Overall Study|Withdrawal by Subject|0|||
16245636|NCT01851590|39381663|FG001|Overall Study|Withdrawal by Subject|0|||
16245637|NCT01851590|39381664|FG002|Overall Study|Withdrawal by Subject|1|||
16245638|NCT01851590|39381662|FG000|Overall Study|Adverse Event|0|||
16245639|NCT01851590|39381663|FG001|Overall Study|Adverse Event|0|||
16245640|NCT01851590|39381664|FG002|Overall Study|Adverse Event|2|||
16245641|NCT01851590|39381662|FG000|Overall Study|Lack of Efficacy|0|||
16245642|NCT01851590|39381663|FG001|Overall Study|Lack of Efficacy|1|||
16245643|NCT01851590|39381664|FG002|Overall Study|Lack of Efficacy|0|||
16245644|NCT01388647|39381665|FG000|Overall Study|Adverse Event|1|||
16245645|NCT01388647|39381666|FG001|Overall Study|Adverse Event|2|||
16273129|NCT00529763|39484415|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
16273130|NCT00529763|39484416|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
16273131|NCT00529763|39484417|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
16273132|NCT00529763|39484415|FG000|Overall Study|Death|1|||
16273133|NCT00529763|39484416|FG001|Overall Study|Death|1|||
16273134|NCT00529763|39484417|FG002|Overall Study|Death|1|||
16273135|NCT00529763|39484415|FG000|Overall Study|Disease Progression|10|||
16273136|NCT00529763|39484416|FG001|Overall Study|Disease Progression|16|||
16273137|NCT00529763|39484417|FG002|Overall Study|Disease Progression|11|||
16273138|NCT00529763|39484415|FG000|Overall Study|Lost to Follow-up|1|||
16273139|NCT00529763|39484416|FG001|Overall Study|Lost to Follow-up|2|||
16273140|NCT00529763|39484417|FG002|Overall Study|Lost to Follow-up|3|||
16273141|NCT00529763|39484415|FG000|Overall Study|Stem Cell Transplant|0|||
16273142|NCT00529763|39484416|FG001|Overall Study|Stem Cell Transplant|3|||
16273143|NCT00529763|39484417|FG002|Overall Study|Stem Cell Transplant|1|||
16273144|NCT00529763|39484415|FG000|Overall Study|Study Drug Toxicity|3|||
16273145|NCT00529763|39484416|FG001|Overall Study|Study Drug Toxicity|6|||
16273146|NCT00529763|39484417|FG002|Overall Study|Study Drug Toxicity|4|||
16273147|NCT00529763|39484415|FG000|Overall Study|Participant Withdrew Consent|2|||
16273148|NCT00529763|39484416|FG001|Overall Study|Participant Withdrew Consent|3|||
16273149|NCT00529763|39484417|FG002|Overall Study|Participant Withdrew Consent|4|||
16273150|NCT00529763|39484415|FG000|Overall Study|Other reasons|2|||
16273151|NCT00529763|39484416|FG001|Overall Study|Other reasons|0|||
16273152|NCT00529763|39484417|FG002|Overall Study|Other reasons|2|||
16273153|NCT00529763|39484415|FG000|Overall Study|Participant request to discontinue treatment|1|||
16273154|NCT00529763|39484416|FG001|Overall Study|Participant request to discontinue treatment|1|||
16273155|NCT00529763|39484417|FG002|Overall Study|Participant request to discontinue treatment|3|||
16273156|NCT03067987|39484423|FG000|Overall Study|Lost to Follow-up|7|||
16273157|NCT03067987|39484424|FG001|Overall Study|Lost to Follow-up|10|||
16273158|NCT03067987|39484423|FG000|Overall Study|Protocol Violation|1|||
16273159|NCT03067987|39484424|FG001|Overall Study|Protocol Violation|2|||
16273160|NCT03067987|39484423|FG000|Overall Study|Withdrawal by Subject|2|||
16273161|NCT03067987|39484424|FG001|Overall Study|Withdrawal by Subject|1|||
16273162|NCT02858037|39484427|FG000|Overall Study|Death|1|||
16273163|NCT02858037|39484427|FG000|Overall Study|Withdrawal by Subject|18|||
16273164|NCT02858037|39484427|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
16273165|NCT02858037|39484427|FG000|Overall Study|Lost to Follow-up|3|||
16273166|NCT02858037|39484427|FG000|Overall Study|Other|4|||
16352046|NCT00974311|39776556|FG000|DB Phase (up to 24 Months)|Death|561|||
16245646|NCT00969332|39385278|FG000|Overall Study|Physician Decision|8|||
16245647|NCT00969332|39385278|FG000|Overall Study|Withdrawal by Subject|3|||
16245648|NCT02175966|39385279|FG000|Follow-up Period|Lack of Efficacy|10|||
16245649|NCT02175966|39385280|FG001|Follow-up Period|Lack of Efficacy|6|||
16245650|NCT00319449|39385281|FG000|Overall Study|Subject did not wish to continue|1|||
16245651|NCT00319449|39385282|FG001|Overall Study|Subject did not wish to continue|0|||
16245652|NCT00319449|39385281|FG000|Overall Study|Noncompliance with the protocol|1|||
16245653|NCT00319449|39385282|FG001|Overall Study|Noncompliance with the protocol|0|||
16245654|NCT02668783|39385283|FG000|Overall Study|Pregnancy|0|||
16245655|NCT02668783|39385284|FG001|Overall Study|Pregnancy|1|||
16245656|NCT02668783|39385283|FG000|Overall Study|Protocol Violation|2|||
16245657|NCT02668783|39385284|FG001|Overall Study|Protocol Violation|1|||
16245658|NCT02668783|39385283|FG000|Overall Study|Study terminated by sponsor|9|||
16245659|NCT02668783|39385284|FG001|Overall Study|Study terminated by sponsor|10|||
16245660|NCT02668783|39385283|FG000|Overall Study|Subject moved|1|||
16245661|NCT02668783|39385284|FG001|Overall Study|Subject moved|0|||
16245662|NCT02668783|39385283|FG000|Overall Study|Withdrawal by Subject|1|||
16245663|NCT02668783|39385284|FG001|Overall Study|Withdrawal by Subject|0|||
16245664|NCT01889862|39385285|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
16245665|NCT01889862|39385286|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
16245666|NCT01889862|39385287|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
16245667|NCT01889862|39385288|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
16245668|NCT01889862|39385289|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
16245669|NCT01889862|39385285|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
16245670|NCT01889862|39385286|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
16245671|NCT01889862|39385287|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
16245672|NCT01889862|39385288|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
16245673|NCT01889862|39385289|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
16245674|NCT01889862|39385285|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
16245675|NCT01889862|39385286|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
16245676|NCT01889862|39385287|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
16245677|NCT01889862|39385288|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
16245678|NCT01889862|39385289|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
16245679|NCT01889862|39385285|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
16245680|NCT01889862|39385286|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
16245681|NCT01889862|39385287|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
16245682|NCT01889862|39385288|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
16245683|NCT01889862|39385289|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
16245684|NCT01889862|39385285|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
16245685|NCT01889862|39385286|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
16245686|NCT01889862|39385287|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
16245687|NCT01889862|39385288|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
16245688|NCT01889862|39385289|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
16245689|NCT01889862|39385285|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
16245690|NCT01889862|39385286|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
16245691|NCT01889862|39385287|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
16245692|NCT01889862|39385288|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
16245693|NCT01889862|39385289|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
16245694|NCT01889862|39385285|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
16245695|NCT01889862|39385286|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
16245696|NCT01889862|39385287|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
16245697|NCT01889862|39385288|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
16245698|NCT01889862|39385289|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
16245699|NCT01889862|39385285|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
16245700|NCT01889862|39385286|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
16245701|NCT01889862|39385287|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
16245702|NCT01889862|39385288|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
16245703|NCT01889862|39385289|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
16245704|NCT01889862|39385285|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
16245705|NCT01889862|39385286|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
16245706|NCT01889862|39385287|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
16245707|NCT01889862|39385288|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
16245708|NCT01889862|39385289|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
16245709|NCT01889862|39385285|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
16245710|NCT01889862|39385286|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
16245711|NCT01889862|39385287|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
16245712|NCT01889862|39385288|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
16245713|NCT01889862|39385289|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
16245714|NCT01312779|39385290|FG000|Overall Study|Withdrawal by Subject|2|||
16245715|NCT01312779|39385290|FG000|Overall Study|Death|3|||
16245716|NCT01312779|39385290|FG000|Overall Study|Not Implanted with Device|27|||
16245717|NCT02038634|39385291|FG000|Overall Study|Lost to Follow-up|0|||
16245718|NCT02038634|39385292|FG001|Overall Study|Lost to Follow-up|1|||
16416615|NCT04566692|40004776|FG000|Overall Study|Adverse Event|2|||
16245719|NCT02739984|39385293|FG000|Overall Study|Sponsor Decision|1|||
16245720|NCT02739984|39385294|FG001|Overall Study|Sponsor Decision|0|||
16245721|NCT02739984|39385293|FG000|Overall Study|Withdrawal by Subject|1|||
16245722|NCT02739984|39385294|FG001|Overall Study|Withdrawal by Subject|1|||
16352047|NCT00974311|39776557|FG001|DB Phase (up to 24 Months)|Death|298|||
16352048|NCT00974311|39776556|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
16352049|NCT00974311|39776557|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
16352050|NCT00974311|39776556|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
16352051|NCT00974311|39776557|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
16352052|NCT00974311|39776556|FG000|DB Phase (up to 24 Months)|Other|1|||
16352053|NCT00974311|39776557|FG001|DB Phase (up to 24 Months)|Other|0|||
16352054|NCT00974311|39776556|FG000|OLE Phase (up to 77 Months)|Death|14|||
16352055|NCT00974311|39776557|FG001|OLE Phase (up to 77 Months)|Death|21|||
16352056|NCT00974311|39776556|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
16352057|NCT00974311|39776557|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
16352058|NCT00974311|39776556|FG000|OLE Phase (up to 77 Months)|Other|15|||
16352059|NCT00974311|39776557|FG001|OLE Phase (up to 77 Months)|Other|2|||
16352060|NCT00974311|39776556|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
16352061|NCT00974311|39776557|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
16352062|NCT05556148|39776558|FG000|Overall Study|Early Termination|29|||
16352063|NCT05556148|39776558|FG000|Overall Study|Baseline Tasks Expired|4|||
16352064|NCT05556148|39776558|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
16352065|NCT05556148|39776558|FG000|Overall Study|No Longer Wished to Participate|1|||
16559852|NCT01394991|40517351|FG001|Overall Study|Physician Decision|3|||
16245723|NCT02739984|39385293|FG000|Overall Study|Death|0|||
16245724|NCT02739984|39385294|FG001|Overall Study|Death|1|||
16245725|NCT02739984|39385293|FG000|Overall Study|Lost to Follow-up|3|||
16245726|NCT02739984|39385294|FG001|Overall Study|Lost to Follow-up|0|||
16245727|NCT01875445|39385297|FG000|Overall Study|Lost to Follow-up|5|||
16245728|NCT01875445|39385298|FG001|Overall Study|Lost to Follow-up|0|||
16245729|NCT01875445|39385297|FG000|Overall Study|Withdrawal by Subject|2|||
16245730|NCT01875445|39385298|FG001|Overall Study|Withdrawal by Subject|0|||
16245731|NCT03740698|39385300|FG000|Overall Study|Physician Decision|0|||
16245732|NCT03740698|39385301|FG001|Overall Study|Physician Decision|1|||
16245733|NCT03740698|39385302|FG002|Overall Study|Physician Decision|1|||
16245734|NCT02482805|39385303|FG000|Overall Study|Lost to Follow-up|4|||
16245735|NCT02482805|39385304|FG001|Overall Study|Lost to Follow-up|4|||
16245736|NCT02482805|39385305|FG002|Overall Study|Lost to Follow-up|0|||
16245737|NCT02533999|39385306|FG000|Overall Study|Lost to Follow-up|3|||
16245738|NCT02533999|39385307|FG001|Overall Study|Lost to Follow-up|5|||
16245739|NCT02533999|39385306|FG000|Overall Study|Protocol Violation|3|||
16245740|NCT02533999|39385307|FG001|Overall Study|Protocol Violation|0|||
16245741|NCT02533999|39385306|FG000|Overall Study|Adverse Event|0|||
16245742|NCT02533999|39385307|FG001|Overall Study|Adverse Event|1|||
16245743|NCT02533999|39385306|FG000|Overall Study|Randomized but intervention not received|0|||
16245744|NCT02533999|39385307|FG001|Overall Study|Randomized but intervention not received|1|||
16245745|NCT02004847|39385308|FG000|Overall Study|Protocol Violation|1|||
16245746|NCT02004847|39385309|FG001|Overall Study|Protocol Violation|1|||
16245747|NCT01113710|39385310|FG000|Overall Study|Adverse Event|64|||
16245748|NCT01113710|39385310|FG000|Overall Study|Lack of Efficacy|41|||
16245749|NCT01113710|39385310|FG000|Overall Study|No Information Available|40|||
16245750|NCT01113710|39385310|FG000|Overall Study|Withdrawal by Subject|28|||
16245751|NCT01113710|39385310|FG000|Overall Study|Lost to Follow-up|20|||
16245752|NCT01113710|39385310|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
16245753|NCT01113710|39385310|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
16245754|NCT01113710|39385310|FG000|Overall Study|Lack of Patient's Compliance|8|||
16245755|NCT01113710|39385310|FG000|Overall Study|Other|7|||
16245756|NCT01113710|39385310|FG000|Overall Study|Adverse Event/Other|5|||
16245757|NCT01113710|39385310|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
16245758|NCT01113710|39385310|FG000|Overall Study|Lack of Efficacy/Other|4|||
16245759|NCT01113710|39385310|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
16245760|NCT01113710|39385310|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
16352066|NCT05556148|39776558|FG000|Overall Study|Bacterial Conjunctivitis|1|||
16352067|NCT01418339|39776559|FG000|Overall Study|Adverse Event|5|||
16352068|NCT01418339|39776560|FG001|Overall Study|Adverse Event|2|||
16245761|NCT01113710|39385310|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
16245762|NCT01113710|39385310|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
16245763|NCT01113710|39385310|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
16245764|NCT01113710|39385310|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
16352069|NCT01418339|39776559|FG000|Overall Study|Subject Withdrew Consent|1|||
16245765|NCT01113710|39385310|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
16245766|NCT01113710|39385310|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
16245767|NCT01113710|39385310|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
16352070|NCT01418339|39776560|FG001|Overall Study|Subject Withdrew Consent|2|||
16416616|NCT04566692|40004777|FG001|Overall Study|Adverse Event|0|||
16352071|NCT01418339|39776559|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
16352072|NCT01418339|39776560|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
16352073|NCT01061606|39776561|FG000|Overall Study|Adverse Event|1|||
16352074|NCT01061606|39776561|FG000|Overall Study|Death|1|||
16352075|NCT01061606|39776561|FG000|Overall Study|Disease Progression|4|||
16352076|NCT01061606|39776561|FG000|Overall Study|alternative therapy|2|||
16352077|NCT01029262|39776562|FG000|Overall Study|Adverse Event|9|||
16352078|NCT01029262|39776563|FG001|Overall Study|Adverse Event|52|||
16352079|NCT01029262|39776562|FG000|Overall Study|Lack of therapeutic effect|57|||
16352080|NCT01029262|39776563|FG001|Overall Study|Lack of therapeutic effect|76|||
16352081|NCT01029262|39776562|FG000|Overall Study|Withdrawal by Subject|10|||
16352082|NCT01029262|39776563|FG001|Overall Study|Withdrawal by Subject|17|||
16352083|NCT01029262|39776562|FG000|Overall Study|Protocol Violation|2|||
16352084|NCT01029262|39776563|FG001|Overall Study|Protocol Violation|3|||
16352085|NCT01029262|39776562|FG000|Overall Study|Miscellaneous|1|||
16352086|NCT01029262|39776563|FG001|Overall Study|Miscellaneous|9|||
16352087|NCT01029262|39776562|FG000|Overall Study|Death|0|||
16352088|NCT01029262|39776563|FG001|Overall Study|Death|3|||
16352089|NCT01181167|39776564|FG000|Overall Study|Adverse Event|11|||
16352090|NCT01181167|39776565|FG001|Overall Study|Adverse Event|21|||
16352091|NCT01181167|39776564|FG000|Overall Study|Lost to Follow-up|1|||
16352092|NCT01181167|39776565|FG001|Overall Study|Lost to Follow-up|0|||
16352093|NCT01181167|39776564|FG000|Overall Study|Physician Decision|2|||
16352094|NCT01181167|39776565|FG001|Overall Study|Physician Decision|3|||
16352095|NCT01181167|39776564|FG000|Overall Study|Protocol Violation|3|||
16352096|NCT01181167|39776565|FG001|Overall Study|Protocol Violation|0|||
16352097|NCT01181167|39776564|FG000|Overall Study|Withdrawal by Subject|6|||
16352098|NCT01181167|39776565|FG001|Overall Study|Withdrawal by Subject|8|||
16559853|NCT01394991|40517350|FG000|Overall Study|Protocol Violation|1|||
16559854|NCT01394991|40517351|FG001|Overall Study|Protocol Violation|1|||
16128586|NCT00346632|38958683|FG000|Overall Study|Switched to alternative treatment|0|||
16128587|NCT00346632|38958684|FG001|Overall Study|Switched to alternative treatment|0|||
16128588|NCT00346632|38958685|FG002|Overall Study|Switched to alternative treatment|1|||
16128589|NCT00346632|38958686|FG003|Overall Study|Switched to alternative treatment|0|||
16559855|NCT01394991|40517350|FG000|Overall Study|Withdrawal by Subject|20|||
16128590|NCT00346632|38958687|FG004|Overall Study|Switched to alternative treatment|0|||
16128591|NCT00346632|38958688|FG005|Overall Study|Switched to alternative treatment|0|||
16128592|NCT00346632|38958689|FG006|Overall Study|Switched to alternative treatment|0|||
16128593|NCT00346632|38958690|FG007|Overall Study|Switched to alternative treatment|0|||
16128594|NCT00346632|38958691|FG008|Overall Study|Switched to alternative treatment|0|||
16128595|NCT00346632|38958692|FG009|Overall Study|Switched to alternative treatment|0|||
16128596|NCT00346632|38958683|FG000|Overall Study|Not Stated|1|||
16128597|NCT00346632|38958684|FG001|Overall Study|Not Stated|1|||
16128598|NCT00346632|38958685|FG002|Overall Study|Not Stated|0|||
16128599|NCT00346632|38958686|FG003|Overall Study|Not Stated|0|||
16128600|NCT00346632|38958687|FG004|Overall Study|Not Stated|0|||
16128601|NCT00346632|38958688|FG005|Overall Study|Not Stated|0|||
16128602|NCT00346632|38958689|FG006|Overall Study|Not Stated|0|||
16128603|NCT00346632|38958690|FG007|Overall Study|Not Stated|2|||
16128604|NCT00346632|38958691|FG008|Overall Study|Not Stated|2|||
16128605|NCT00346632|38958692|FG009|Overall Study|Not Stated|1|||
16128606|NCT02502799|38958695|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
16128607|NCT02502799|38958696|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
16128608|NCT02502799|38958697|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
16128609|NCT02502799|38958698|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
16128610|NCT02502799|38958695|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
16128611|NCT02502799|38958696|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
16128612|NCT02502799|38958697|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
16128613|NCT02502799|38958698|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
16128614|NCT02502799|38958695|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
16128615|NCT02502799|38958696|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
16128616|NCT02502799|38958697|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
16128617|NCT02502799|38958698|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
16128618|NCT02502799|38958695|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
16128619|NCT02502799|38958696|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
16352099|NCT03874013|39776566|FG000|Overall Study|Adverse Event|0|||
16352100|NCT03874013|39776567|FG001|Overall Study|Adverse Event|1|||
16352101|NCT01286129|39776570|FG000|Overall Study|Withdrawal by Subject|4|||
16559856|NCT01394991|40517351|FG001|Overall Study|Withdrawal by Subject|17|||
16128620|NCT02502799|38958697|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
16128621|NCT02502799|38958698|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
16128622|NCT02502799|38958695|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
16128623|NCT02502799|38958696|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
16352102|NCT01286129|39776571|FG001|Overall Study|Withdrawal by Subject|1|||
16559857|NCT01394991|40517350|FG000|Overall Study|Chemotherapy Termination|10|||
16352103|NCT01286129|39776570|FG000|Overall Study|Could not comply with study requirements|4|||
16352104|NCT01286129|39776571|FG001|Overall Study|Could not comply with study requirements|4|||
16352105|NCT02801331|39776572|FG000|Overall Study|Transferred to another hospital|8|||
16352106|NCT02801331|39776573|FG001|Overall Study|Transferred to another hospital|7|||
16352107|NCT02801331|39776572|FG000|Overall Study|Withdrawal by Subject|0|||
16352108|NCT02801331|39776573|FG001|Overall Study|Withdrawal by Subject|4|||
16352109|NCT02801331|39776572|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
16352110|NCT02801331|39776573|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
16352111|NCT01791985|39776574|FG000|Overall Study|Adverse Event|7|||
16352112|NCT01791985|39776574|FG000|Overall Study|Withdrawal by Subject|1|||
16559858|NCT01394991|40517351|FG001|Overall Study|Chemotherapy Termination|15|||
16245768|NCT01113710|39385310|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
16245769|NCT01113710|39385310|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
16245770|NCT01113710|39385310|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
16245771|NCT01113710|39385310|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
16245772|NCT01907737|39385316|FG000|Overall Study|Withdrawal by Subject|1|||
16245773|NCT01722266|39385317|FG000|Overall Study|Withdrawal by Subject|1|||
16245774|NCT01722266|39385318|FG001|Overall Study|Withdrawal by Subject|2|||
16245775|NCT01722266|39385319|FG002|Overall Study|Withdrawal by Subject|0|||
16245776|NCT01722266|39385320|FG003|Overall Study|Withdrawal by Subject|0|||
16245777|NCT01722266|39385317|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
16245778|NCT01722266|39385318|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
16245779|NCT01722266|39385319|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
16245780|NCT01722266|39385320|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
16245781|NCT01722266|39385317|FG000|Overall Study|Dropped out due to Nausea|0|||
16245782|NCT01722266|39385318|FG001|Overall Study|Dropped out due to Nausea|0|||
16245783|NCT01722266|39385319|FG002|Overall Study|Dropped out due to Nausea|2|||
16245784|NCT01722266|39385320|FG003|Overall Study|Dropped out due to Nausea|0|||
16245785|NCT02295774|39385321|FG000|Overall Study|Physician Decision|1|||
16245786|NCT02295774|39385321|FG000|Overall Study|Withdrawal by Subject|2|||
16245787|NCT02040428|39385322|FG000|Overall Study|Death|4|||
16245788|NCT02040428|39385323|FG001|Overall Study|Death|3|||
16245789|NCT02040428|39385322|FG000|Overall Study|Withdrawal by Subject|1|||
16245790|NCT02040428|39385323|FG001|Overall Study|Withdrawal by Subject|1|||
16245791|NCT01806597|39385324|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
16245792|NCT01806597|39385325|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
16245793|NCT01806597|39385326|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
16245794|NCT01806597|39385327|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
16245795|NCT01806597|39385328|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
16245796|NCT01806597|39385329|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
16245797|NCT01806597|39385324|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
16245798|NCT01806597|39385325|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
16245799|NCT01806597|39385326|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
16245800|NCT01806597|39385327|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
16245801|NCT01806597|39385328|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
16245802|NCT01806597|39385329|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
16245803|NCT01806597|39385324|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
16245804|NCT01806597|39385325|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
16245805|NCT01806597|39385326|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
16245806|NCT01806597|39385327|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
16559859|NCT01394991|40517350|FG000|Overall Study|Disease Progression|7|||
16352113|NCT03118934|39776575|FG000|Overall Study|Adverse Event|0|||
16352114|NCT03118934|39776576|FG001|Overall Study|Adverse Event|0|||
16352115|NCT03118934|39776577|FG002|Overall Study|Adverse Event|0|||
16352116|NCT03118934|39776578|FG003|Overall Study|Adverse Event|0|||
16352117|NCT03118934|39776579|FG004|Overall Study|Adverse Event|0|||
16352118|NCT03118934|39776580|FG005|Overall Study|Adverse Event|1|||
16352119|NCT03118934|39776575|FG000|Overall Study|Physician Decision|0|||
16352120|NCT03118934|39776576|FG001|Overall Study|Physician Decision|0|||
16352121|NCT03118934|39776577|FG002|Overall Study|Physician Decision|0|||
16352122|NCT03118934|39776578|FG003|Overall Study|Physician Decision|0|||
16128624|NCT02502799|38958697|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
16128625|NCT02502799|38958698|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
16128626|NCT00461032|38958699|FG000|Overall Study|Adverse Event|5|||
16128627|NCT00461032|38958700|FG001|Overall Study|Adverse Event|6|||
16128628|NCT00461032|38958699|FG000|Overall Study|Lack of Efficacy|5|||
16128629|NCT00461032|38958700|FG001|Overall Study|Lack of Efficacy|1|||
16128630|NCT00461032|38958699|FG000|Overall Study|Lost to Follow-up|7|||
16128631|NCT00461032|38958700|FG001|Overall Study|Lost to Follow-up|12|||
16128632|NCT00461032|38958699|FG000|Overall Study|Protocol Violation|4|||
16128633|NCT00461032|38958700|FG001|Overall Study|Protocol Violation|4|||
16128634|NCT00461032|38958699|FG000|Overall Study|Withdrawal by Subject|7|||
16128635|NCT00461032|38958700|FG001|Overall Study|Withdrawal by Subject|15|||
16128636|NCT00461032|38958699|FG000|Overall Study|Patient Moved or Relocated|2|||
16128637|NCT00461032|38958700|FG001|Overall Study|Patient Moved or Relocated|1|||
16128638|NCT00461032|38958699|FG000|Overall Study|Other|7|||
16128639|NCT00461032|38958700|FG001|Overall Study|Other|5|||
16128640|NCT02337751|38958701|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
16245807|NCT01806597|39385328|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
16245808|NCT01806597|39385329|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
16245809|NCT01806597|39385324|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
16245810|NCT01806597|39385325|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
16245811|NCT01806597|39385326|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
16245812|NCT01806597|39385327|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
16245813|NCT01806597|39385328|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
16245814|NCT01806597|39385329|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
16245815|NCT01806597|39385324|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
16245816|NCT01806597|39385325|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
16245817|NCT01806597|39385326|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
16245818|NCT01806597|39385327|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
16245819|NCT01806597|39385328|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
16245820|NCT01806597|39385329|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
16245821|NCT01806597|39385324|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
16245822|NCT01806597|39385325|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
16245823|NCT01806597|39385326|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
16245824|NCT01806597|39385327|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
16245825|NCT01806597|39385328|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
16245826|NCT01806597|39385329|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
16245827|NCT01806597|39385324|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
16245828|NCT01806597|39385325|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
16245829|NCT01806597|39385326|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
16245830|NCT01806597|39385327|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
16245831|NCT01806597|39385328|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
16128641|NCT02337751|38958702|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
16245832|NCT01806597|39385329|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
16245833|NCT01806597|39385324|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
16128642|NCT02337751|38958701|FG000|Overall Study|Voluntary Withdrawal|6|||
16128643|NCT02337751|38958702|FG001|Overall Study|Voluntary Withdrawal|8|||
16128644|NCT02337751|38958701|FG000|Overall Study|Lack of Efficacy|2|||
16128645|NCT02337751|38958702|FG001|Overall Study|Lack of Efficacy|5|||
16128646|NCT02337751|38958701|FG000|Overall Study|Investigator's Judgement|1|||
16128647|NCT02337751|38958702|FG001|Overall Study|Investigator's Judgement|0|||
16128648|NCT02724969|38958703|FG000|Overall Study|Lost to Follow-up|12|||
16128649|NCT02724969|38958704|FG001|Overall Study|Lost to Follow-up|6|||
16128650|NCT02724969|38958703|FG000|Overall Study|Withdrawal by Subject|3|||
16128651|NCT02724969|38958704|FG001|Overall Study|Withdrawal by Subject|3|||
16128652|NCT02724969|38958703|FG000|Overall Study|Infant demise|0|||
16128653|NCT02724969|38958704|FG001|Overall Study|Infant demise|2|||
16128654|NCT00768079|38958709|FG000|Overall Study|Lost to Follow-up|2|||
16128655|NCT00768079|38958710|FG001|Overall Study|Lost to Follow-up|0|||
16128656|NCT00768079|38958711|FG002|Overall Study|Lost to Follow-up|4|||
16128657|NCT00768079|38958709|FG000|Overall Study|Participant incarcerated|0|||
16128658|NCT00768079|38958710|FG001|Overall Study|Participant incarcerated|1|||
16128659|NCT00768079|38958711|FG002|Overall Study|Participant incarcerated|0|||
16128660|NCT01236534|38958712|FG000|Overall Study|Adverse Event|3|||
16128661|NCT01236534|38958713|FG001|Overall Study|Adverse Event|0|||
16128662|NCT03484273|38958714|FG000|Overall Study|Equipment Malfunction|1|||
16128663|NCT03484273|38958714|FG000|Overall Study|Data excluded from analysis|1|||
16128664|NCT00738894|38958716|FG000|Overall Study|Lost to Follow-up|23|||
16128665|NCT00738894|38958717|FG001|Overall Study|Lost to Follow-up|13|||
16128666|NCT00738894|38958716|FG000|Overall Study|Withdrawal by Subject|10|||
16128667|NCT00738894|38958717|FG001|Overall Study|Withdrawal by Subject|15|||
16128668|NCT00738894|38958716|FG000|Overall Study|Physician Decision|4|||
16128669|NCT00738894|38958717|FG001|Overall Study|Physician Decision|5|||
16128670|NCT00738894|38958716|FG000|Overall Study|Death|2|||
16128671|NCT00738894|38958717|FG001|Overall Study|Death|0|||
16128672|NCT01065844|38958719|FG000|Overall Study|Adverse Event|5|||
16245834|NCT01806597|39385325|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
16128673|NCT00477334|38958720|FG000|Overall Study|Discontinued prior to taking study drug|106|||
16128674|NCT00477334|38958721|FG001|Overall Study|Discontinued prior to taking study drug|53|||
16128675|NCT00477334|38958720|FG000|Overall Study|Adverse Event|1|||
16128676|NCT00477334|38958721|FG001|Overall Study|Adverse Event|2|||
16128677|NCT00477334|38958720|FG000|Overall Study|Withdrawal by Subject|2|||
16128678|NCT00477334|38958721|FG001|Overall Study|Withdrawal by Subject|1|||
16128679|NCT00477334|38958720|FG000|Overall Study|Lost to Follow-up|15|||
16128680|NCT00477334|38958721|FG001|Overall Study|Lost to Follow-up|4|||
16128681|NCT00477334|38958720|FG000|Overall Study|Administrative Problems|39|||
16128682|NCT00477334|38958721|FG001|Overall Study|Administrative Problems|15|||
16128683|NCT00477334|38958720|FG000|Overall Study|Protocol Violation|7|||
16128684|NCT00477334|38958721|FG001|Overall Study|Protocol Violation|1|||
16128685|NCT01676909|38958724|FG000|Overall Study|Withdrawal by Subject|3|||
16128686|NCT01676909|38958725|FG001|Overall Study|Withdrawal by Subject|5|||
16128687|NCT01676909|38958724|FG000|Overall Study|Lost to Follow-up|15|||
16128688|NCT01676909|38958725|FG001|Overall Study|Lost to Follow-up|9|||
16128689|NCT02317432|38958728|FG000|Overall Study|Death|4|||
16128690|NCT02317432|38958729|FG001|Overall Study|Death|1|||
16128691|NCT02317432|38958728|FG000|Overall Study|Lost to Follow-up|0|||
16128692|NCT02317432|38958729|FG001|Overall Study|Lost to Follow-up|5|||
16128693|NCT02317432|38958728|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
16128694|NCT02317432|38958729|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
16128695|NCT00069108|38958730|FG000|Overall Study|Withdrawal by Subject|5|||
16352123|NCT03118934|39776579|FG004|Overall Study|Physician Decision|0|||
16352124|NCT03118934|39776580|FG005|Overall Study|Physician Decision|1|||
16352125|NCT03118934|39776575|FG000|Overall Study|Discontinued prior to exposure|0|||
16352126|NCT03118934|39776576|FG001|Overall Study|Discontinued prior to exposure|1|||
16128696|NCT00069108|38958731|FG001|Overall Study|Withdrawal by Subject|9|||
16128697|NCT00069108|38958730|FG000|Overall Study|Adverse Event|64|||
16352127|NCT03118934|39776577|FG002|Overall Study|Discontinued prior to exposure|1|||
16352128|NCT03118934|39776578|FG003|Overall Study|Discontinued prior to exposure|1|||
16352129|NCT03118934|39776579|FG004|Overall Study|Discontinued prior to exposure|2|||
16352130|NCT03118934|39776580|FG005|Overall Study|Discontinued prior to exposure|0|||
16352131|NCT03154086|39776581|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16559860|NCT01394991|40517351|FG001|Overall Study|Disease Progression|7|||
16128698|NCT00069108|38958731|FG001|Overall Study|Adverse Event|42|||
16128699|NCT00069108|38958730|FG000|Overall Study|Death|6|||
16128700|NCT00069108|38958731|FG001|Overall Study|Death|6|||
16128701|NCT00069108|38958730|FG000|Overall Study|Administration|15|||
16128702|NCT00069108|38958731|FG001|Overall Study|Administration|4|||
16128703|NCT00069108|38958730|FG000|Overall Study|Insufficient therapy|117|||
16128704|NCT00069108|38958731|FG001|Overall Study|Insufficient therapy|144|||
16128705|NCT00069108|38958730|FG000|Overall Study|Violation criteria|1|||
16128706|NCT00069108|38958731|FG001|Overall Study|Violation criteria|4|||
16128707|NCT00069108|38958730|FG000|Overall Study|Refused treatment|5|||
16128708|NCT00069108|38958731|FG001|Overall Study|Refused treatment|10|||
16128709|NCT02101385|38958732|FG000|Study Treatment|Disease Progression|9|||
16128710|NCT02101385|38958733|FG001|Study Treatment|Disease Progression|3|||
16128711|NCT02101385|38958732|FG000|Study Treatment|Alternative therapy|0|||
16128712|NCT02101385|38958733|FG001|Study Treatment|Alternative therapy|1|||
16128713|NCT02101385|38958732|FG000|Study Treatment|No treatment, per protocol criteria|0|||
16128714|NCT02101385|38958733|FG001|Study Treatment|No treatment, per protocol criteria|4|||
16128715|NCT02101385|38958732|FG000|Study Treatment|Patient Non compliance|0|||
16128716|NCT02101385|38958733|FG001|Study Treatment|Patient Non compliance|2|||
16128717|NCT02101385|38958732|FG000|Study Treatment|Withdrawal by Subject|5|||
16128718|NCT02101385|38958733|FG001|Study Treatment|Withdrawal by Subject|2|||
16128719|NCT02101385|38958732|FG000|Study Treatment|screen failure|1|||
16128720|NCT02101385|38958733|FG001|Study Treatment|screen failure|0|||
16128721|NCT02101385|38958732|FG000|Study Treatment|AE/Side Effects/Complications|8|||
16128722|NCT02101385|38958733|FG001|Study Treatment|AE/Side Effects/Complications|0|||
16128723|NCT02101385|38958732|FG000|Study Treatment|Lost to Follow-up|1|||
16128724|NCT02101385|38958733|FG001|Study Treatment|Lost to Follow-up|0|||
16352132|NCT03154086|39776582|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16352133|NCT03154086|39776583|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16352134|NCT03154086|39776584|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
16352135|NCT03154086|39776585|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16128725|NCT02101385|38958732|FG000|Study Treatment|Disease Progression before treatment|1|||
16128726|NCT02101385|38958733|FG001|Study Treatment|Disease Progression before treatment|0|||
16128727|NCT02101385|38958732|FG000|Study Treatment|Death|1|||
16128728|NCT02101385|38958733|FG001|Study Treatment|Death|0|||
16128729|NCT02101385|38958732|FG000|Follow up|Lost to Follow-up|4|||
16128730|NCT02101385|38958733|FG001|Follow up|Lost to Follow-up|9|||
16352136|NCT03154086|39776586|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16352137|NCT03154086|39776587|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16352138|NCT03154086|39776588|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16352139|NCT03154086|39776589|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16352140|NCT03154086|39776590|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16352141|NCT03154086|39776591|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16352142|NCT03154086|39776592|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16128731|NCT02101385|38958732|FG000|Follow up|Refused to follow up|5|||
16128732|NCT02101385|38958733|FG001|Follow up|Refused to follow up|4|||
16128733|NCT02101385|38958732|FG000|Follow up|Death|21|||
16128734|NCT02101385|38958733|FG001|Follow up|Death|39|||
16128735|NCT02101385|38958732|FG000|Follow up|study completed|33|||
16128736|NCT02101385|38958733|FG001|Follow up|study completed|52|||
16128737|NCT02101385|38958732|FG000|Follow up|screen failure|2|||
16128738|NCT02101385|38958733|FG001|Follow up|screen failure|0|||
16128739|NCT02101385|38958732|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
16128740|NCT02101385|38958733|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
16128741|NCT02101385|38958732|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
16128742|NCT02101385|38958733|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
16128743|NCT02101385|38958732|FG000|Follow up|Withdrawal by Subject|2|||
16128744|NCT02101385|38958733|FG001|Follow up|Withdrawal by Subject|2|||
16128745|NCT02101385|38958732|FG000|Follow up|PI requested closure of site|0|||
16128746|NCT02101385|38958733|FG001|Follow up|PI requested closure of site|5|||
16128747|NCT01081665|38958734|FG000|Overall Study|Death|41|||
16128748|NCT01081665|38958734|FG000|Overall Study|Lost to Follow-up|18|||
16128749|NCT01081665|38958734|FG000|Overall Study|Withdrawal by Subject|17|||
16128750|NCT01081665|38958734|FG000|Overall Study|Change of dialysis unit|10|||
16128751|NCT01081665|38958734|FG000|Overall Study|Regulation of iPTH|5|||
16128752|NCT01081665|38958734|FG000|Overall Study|Change in renal replacement therapy|2|||
16128753|NCT01081665|38958734|FG000|Overall Study|Adverse Event|1|||
16128754|NCT01081665|38958734|FG000|Overall Study|Lack of Efficacy|1|||
16128755|NCT00166712|38958735|FG000|Overall Study|Death|0|||
16128756|NCT00166712|38958736|FG001|Overall Study|Death|1|||
16128757|NCT00166712|38958735|FG000|Overall Study|Adverse Event|1|||
16128758|NCT00166712|38958736|FG001|Overall Study|Adverse Event|0|||
16128759|NCT00166712|38958735|FG000|Overall Study|Withdrawal by Subject|1|||
16128760|NCT00166712|38958736|FG001|Overall Study|Withdrawal by Subject|2|||
16128761|NCT00166712|38958735|FG000|Overall Study|Physician Decision|0|||
16128762|NCT00166712|38958736|FG001|Overall Study|Physician Decision|2|||
16128763|NCT00297232|38958737|FG000|Overall Study|Lack of Efficacy|7|||
16128764|NCT00297232|38958737|FG000|Overall Study|Lost to Follow-up|10|||
16128765|NCT00297232|38958737|FG000|Overall Study|Adverse Event|63|||
16128766|NCT00297232|38958737|FG000|Overall Study|Voluntary Withdrawal|120|||
16128767|NCT00297232|38958737|FG000|Overall Study|Subject was Noncompliant|9|||
16128768|NCT00297232|38958737|FG000|Overall Study|Death|9|||
16128769|NCT00297232|38958737|FG000|Overall Study|Anti-natalizumab Positive|8|||
16128770|NCT00297232|38958737|FG000|Overall Study|Switched to Commercial Tysabri|22|||
16128771|NCT00297232|38958737|FG000|Overall Study|Disease Progression|8|||
16128772|NCT00297232|38958737|FG000|Overall Study|Fear of PML|10|||
16128773|NCT00297232|38958737|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
16128774|NCT00297232|38958737|FG000|Overall Study|Miscellaneous|5|||
16128775|NCT00297232|38958737|FG000|Overall Study|Sponsor Decision|34|||
16128776|NCT00297232|38958737|FG000|Overall Study|Subject Relocated|7|||
16128777|NCT00297232|38958737|FG000|Overall Study|Subject Withdrew Consent|37|||
16128778|NCT00297232|38958737|FG000|Overall Study|Persistently Positive Antibodies|11|||
16128779|NCT00297232|38958737|FG000|Overall Study|Investigator Withdrew From Program|19|||
16128780|NCT00297232|38958737|FG000|Overall Study|Did Not Enroll to Week 264|34|||
16352143|NCT03154086|39776593|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16352144|NCT03154086|39776594|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16128781|NCT00297232|38958737|FG000|Overall Study|Did Not Enroll to Week 480|17|||
16128782|NCT00297232|38958737|FG000|Overall Study|No data available after Week 264|161|||
16128783|NCT00297232|38958737|FG000|Overall Study|Other|1|||
16128784|NCT01022268|38958738|FG000|Overall Study|Withdrawal by Subject|1|||
16128785|NCT01022268|38958739|FG001|Overall Study|Withdrawal by Subject|0|||
16128786|NCT01022268|38958738|FG000|Overall Study|Withdrawal by Subject|1|||
16128787|NCT01022268|38958739|FG001|Overall Study|Withdrawal by Subject|0|||
16128788|NCT00918580|38958740|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
16128789|NCT00918580|38958740|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
16128790|NCT00918580|38958740|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
16128791|NCT00918580|38958740|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
16128792|NCT00918580|38958740|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
16128793|NCT00918580|38958740|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
16128794|NCT00918580|38958740|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
16128795|NCT01981473|38958749|FG000|Overall Study|Incorrect diagnosis of RA|0|||
16128796|NCT01981473|38958750|FG001|Overall Study|Incorrect diagnosis of RA|0|||
16128797|NCT01981473|38958751|FG002|Overall Study|Incorrect diagnosis of RA|1|||
16128798|NCT01981473|38958749|FG000|Overall Study|Received treatment for < 6 months|0|||
16128799|NCT01981473|38958750|FG001|Overall Study|Received treatment for < 6 months|0|||
16128800|NCT01981473|38958751|FG002|Overall Study|Received treatment for < 6 months|1|||
16128801|NCT01981473|38958749|FG000|Overall Study|Received treatment for >24 months|2|||
16128802|NCT01981473|38958750|FG001|Overall Study|Received treatment for >24 months|0|||
16128803|NCT01981473|38958751|FG002|Overall Study|Received treatment for >24 months|6|||
16128804|NCT02585232|38958752|FG000|Overall Study|Lost to Follow-up|8|||
16128805|NCT02585232|38958753|FG001|Overall Study|Lost to Follow-up|8|||
16128806|NCT02585232|38958752|FG000|Overall Study|Withdrawal by Subject|4|||
16128807|NCT02585232|38958753|FG001|Overall Study|Withdrawal by Subject|8|||
16128808|NCT00721149|38958754|FG000|Overall Study|Physician Decision|1|||
16128809|NCT01238900|38958758|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
16128810|NCT01238900|38958758|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
16128811|NCT01236365|38958759|FG000|Overall Study|Lost to Follow-up|0|||
16128812|NCT01236365|38958760|FG001|Overall Study|Lost to Follow-up|2|||
16128813|NCT01236365|38958759|FG000|Overall Study|Moved Out of State|1|||
16245835|NCT01806597|39385326|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
16245836|NCT01806597|39385327|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
16245837|NCT01806597|39385328|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
16245838|NCT01806597|39385329|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
16245839|NCT01806597|39385324|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
16245840|NCT01806597|39385325|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
16245841|NCT01806597|39385326|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
16245842|NCT01806597|39385327|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
16416617|NCT04566692|40004776|FG000|Overall Study|Withdrawal by Subject|1|||
16416618|NCT04566692|40004777|FG001|Overall Study|Withdrawal by Subject|1|||
16416619|NCT00840060|40004778|FG000|Overall Study|Withdrawal by Subject|1|||
16416620|NCT00840060|40004779|FG001|Overall Study|Withdrawal by Subject|0|||
16416621|NCT00840060|40004778|FG000|Overall Study|Change in emotional/behavioral status|0|||
16416622|NCT00840060|40004779|FG001|Overall Study|Change in emotional/behavioral status|1|||
16416623|NCT00612508|40004782|FG000|Overall Study|Withdrawal by Subject|3|||
16416624|NCT00612508|40004783|FG001|Overall Study|Withdrawal by Subject|4|||
16416625|NCT03157037|40004784|FG000|Overall Study|Death|1|||
16416626|NCT00558272|40004785|FG000|Overall Study|Adverse Event|10|||
16416627|NCT00558272|40004786|FG001|Overall Study|Adverse Event|0|||
16416628|NCT00558272|40004785|FG000|Overall Study|Death|1|||
16416629|NCT00558272|40004786|FG001|Overall Study|Death|0|||
16416630|NCT00558272|40004785|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
16416631|NCT00558272|40004786|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
16416632|NCT00558272|40004785|FG000|Overall Study|AZ study team decision|0|||
16416633|NCT00558272|40004786|FG001|Overall Study|AZ study team decision|1|||
16416634|NCT00558272|40004785|FG000|Overall Study|Incorrectly enrolled|1|||
16416635|NCT00558272|40004786|FG001|Overall Study|Incorrectly enrolled|0|||
16416636|NCT00558272|40004785|FG000|Overall Study|Withdrawal by Subject|0|||
16416637|NCT00558272|40004786|FG001|Overall Study|Withdrawal by Subject|1|||
16416638|NCT02383433|40004787|FG000|Overall Study|Disease progression|2|||
16416639|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
16416640|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
16416641|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
16416642|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
16416643|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
16416644|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
16416645|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
16416646|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
16416647|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
16416648|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
16416649|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
16416650|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
16416651|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
16416652|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
16416653|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
16416654|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
16416655|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
16416656|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
16416657|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
16416658|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
16416659|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
16416660|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
16416661|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
16416662|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
16416663|NCT01532869|40004788|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
16416664|NCT01532869|40004789|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
16416665|NCT01532869|40004788|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
16416666|NCT01532869|40004789|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
16416667|NCT01532869|40004788|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
16416668|NCT01532869|40004789|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
16416669|NCT01532869|40004788|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
16416670|NCT01532869|40004789|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
16416671|NCT01532869|40004788|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
16416672|NCT01532869|40004789|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
16416673|NCT01641822|40004790|FG000|Run-in Phase|Noncompliance with study drug|1|||
16416674|NCT01641822|40004791|FG001|Run-in Phase|Noncompliance with study drug|0|||
16245843|NCT01806597|39385328|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
16128814|NCT01236365|38958760|FG001|Overall Study|Moved Out of State|0|||
16128815|NCT01236365|38958759|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
16128816|NCT01236365|38958760|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
16128817|NCT01127893|38958761|FG000|Overall Study|Study Termination by the Sponsor|1|||
16128818|NCT00598273|38958762|FG000|Overall Study|Adverse Event|4|||
16128819|NCT00598273|38958763|FG001|Overall Study|Adverse Event|5|||
16128820|NCT00598273|38958764|FG002|Overall Study|Adverse Event|2|||
16128821|NCT00598273|38958762|FG000|Overall Study|Death|6|||
16128822|NCT00598273|38958763|FG001|Overall Study|Death|12|||
16128823|NCT00598273|38958764|FG002|Overall Study|Death|8|||
16128824|NCT00598273|38958762|FG000|Overall Study|Lost to Follow-up|8|||
16128825|NCT00598273|38958763|FG001|Overall Study|Lost to Follow-up|3|||
16128826|NCT00598273|38958764|FG002|Overall Study|Lost to Follow-up|5|||
16128827|NCT00598273|38958762|FG000|Overall Study|Physician Decision|0|||
16128828|NCT00598273|38958763|FG001|Overall Study|Physician Decision|0|||
16128829|NCT00598273|38958764|FG002|Overall Study|Physician Decision|1|||
16128830|NCT00598273|38958762|FG000|Overall Study|Withdrawal by Subject|12|||
16128831|NCT00598273|38958763|FG001|Overall Study|Withdrawal by Subject|10|||
16128832|NCT00598273|38958764|FG002|Overall Study|Withdrawal by Subject|10|||
16128833|NCT00598273|38958762|FG000|Overall Study|Noncompliance|3|||
16128834|NCT00598273|38958763|FG001|Overall Study|Noncompliance|2|||
16128835|NCT00598273|38958764|FG002|Overall Study|Noncompliance|3|||
16128836|NCT00598273|38958762|FG000|Overall Study|Relocation|0|||
16128837|NCT00598273|38958763|FG001|Overall Study|Relocation|2|||
16128838|NCT00598273|38958764|FG002|Overall Study|Relocation|4|||
16128839|NCT00598273|38958762|FG000|Overall Study|Renal transplant|1|||
16128840|NCT00598273|38958763|FG001|Overall Study|Renal transplant|0|||
16128841|NCT00598273|38958764|FG002|Overall Study|Renal transplant|1|||
16128842|NCT00598273|38958762|FG000|Overall Study|Site elected to close|1|||
16128843|NCT00598273|38958763|FG001|Overall Study|Site elected to close|0|||
16128844|NCT00598273|38958764|FG002|Overall Study|Site elected to close|0|||
16128845|NCT00598273|38958762|FG000|Overall Study|Started dialysis|6|||
16128846|NCT00598273|38958763|FG001|Overall Study|Started dialysis|4|||
16128847|NCT00598273|38958764|FG002|Overall Study|Started dialysis|5|||
16128848|NCT01142232|38958765|FG000|Overall Study|Adverse Event|1|||
16128849|NCT01142232|38958766|FG001|Overall Study|Adverse Event|2|||
16128850|NCT01142232|38958767|FG002|Overall Study|Adverse Event|1|||
16128851|NCT01142232|38958768|FG003|Overall Study|Adverse Event|0|||
16128852|NCT01142232|38958769|FG004|Overall Study|Adverse Event|4|||
16128853|NCT01142232|38958765|FG000|Overall Study|Death|0|||
16128854|NCT01142232|38958766|FG001|Overall Study|Death|0|||
16128855|NCT01142232|38958767|FG002|Overall Study|Death|0|||
16128856|NCT01142232|38958768|FG003|Overall Study|Death|0|||
16128857|NCT01142232|38958769|FG004|Overall Study|Death|1|||
16128858|NCT01142232|38958765|FG000|Overall Study|Disease Progression|2|||
16128859|NCT01142232|38958766|FG001|Overall Study|Disease Progression|0|||
16128860|NCT01142232|38958767|FG002|Overall Study|Disease Progression|1|||
16128861|NCT01142232|38958768|FG003|Overall Study|Disease Progression|2|||
16128862|NCT01142232|38958769|FG004|Overall Study|Disease Progression|12|||
16128863|NCT01142232|38958765|FG000|Overall Study|Withdrawal by Subject|0|||
16128864|NCT01142232|38958766|FG001|Overall Study|Withdrawal by Subject|0|||
16128865|NCT01142232|38958767|FG002|Overall Study|Withdrawal by Subject|0|||
16128866|NCT01142232|38958768|FG003|Overall Study|Withdrawal by Subject|1|||
16128867|NCT01142232|38958769|FG004|Overall Study|Withdrawal by Subject|3|||
16128868|NCT01142232|38958765|FG000|Overall Study|Physician Decision|0|||
16128869|NCT01142232|38958766|FG001|Overall Study|Physician Decision|1|||
16128870|NCT01142232|38958767|FG002|Overall Study|Physician Decision|0|||
16128871|NCT01142232|38958768|FG003|Overall Study|Physician Decision|2|||
16128872|NCT01142232|38958769|FG004|Overall Study|Physician Decision|10|||
16128873|NCT01142232|38958765|FG000|Overall Study|Alternative Therapy|0|||
16128874|NCT01142232|38958766|FG001|Overall Study|Alternative Therapy|1|||
16128875|NCT01142232|38958767|FG002|Overall Study|Alternative Therapy|1|||
16128876|NCT01142232|38958768|FG003|Overall Study|Alternative Therapy|0|||
16128877|NCT01142232|38958769|FG004|Overall Study|Alternative Therapy|1|||
16128878|NCT01142232|38958765|FG000|Overall Study|Off Trt for other complicating disease|0|||
16128879|NCT01142232|38958766|FG001|Overall Study|Off Trt for other complicating disease|0|||
16128880|NCT01142232|38958767|FG002|Overall Study|Off Trt for other complicating disease|0|||
16128881|NCT01142232|38958768|FG003|Overall Study|Off Trt for other complicating disease|0|||
16128882|NCT01142232|38958769|FG004|Overall Study|Off Trt for other complicating disease|1|||
16128883|NCT01142232|38958765|FG000|Overall Study|Noncompliance|0|||
16128884|NCT01142232|38958766|FG001|Overall Study|Noncompliance|0|||
16128885|NCT01142232|38958767|FG002|Overall Study|Noncompliance|0|||
16128886|NCT01142232|38958768|FG003|Overall Study|Noncompliance|0|||
16128887|NCT01142232|38958769|FG004|Overall Study|Noncompliance|2|||
16128888|NCT05114473|38958770|FG000|Overall Study|Lost to Follow-up|2|||
16128889|NCT05114473|38958771|FG001|Overall Study|Lost to Follow-up|2|||
16128890|NCT05114473|38958772|FG002|Overall Study|Lost to Follow-up|0|||
16128891|NCT00603304|38958774|FG000|Overall Study|Lost to Follow-up|5|||
16128892|NCT00603304|38958775|FG001|Overall Study|Lost to Follow-up|7|||
16128893|NCT00603304|38958774|FG000|Overall Study|Withdrawal by Subject|8|||
16128894|NCT00603304|38958775|FG001|Overall Study|Withdrawal by Subject|5|||
16128895|NCT00603304|38958774|FG000|Overall Study|Protocol Violation|1|||
16128896|NCT00603304|38958775|FG001|Overall Study|Protocol Violation|0|||
16128897|NCT00603304|38958774|FG000|Overall Study|Adverse Event|4|||
16128898|NCT00603304|38958775|FG001|Overall Study|Adverse Event|2|||
16128899|NCT00603304|38958774|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
16128900|NCT00603304|38958775|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
16128901|NCT00603304|38958774|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
16128902|NCT00603304|38958775|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
16128903|NCT00603304|38958774|FG000|Overall Study|Exclusionary Medication|2|||
16128904|NCT00603304|38958775|FG001|Overall Study|Exclusionary Medication|3|||
16128905|NCT00603304|38958774|FG000|Overall Study|Non-Compliant|0|||
16128906|NCT00603304|38958775|FG001|Overall Study|Non-Compliant|1|||
16128907|NCT00603304|38958774|FG000|Overall Study|Moved Away|0|||
16128908|NCT00603304|38958775|FG001|Overall Study|Moved Away|2|||
16128909|NCT00603304|38958774|FG000|Overall Study|Other|2|||
16128910|NCT00603304|38958775|FG001|Overall Study|Other|0|||
16128911|NCT00603304|38958774|FG000|Overall Study|Patient Decision|2|||
16128912|NCT00603304|38958775|FG001|Overall Study|Patient Decision|0|||
16128913|NCT00558259|38958776|FG000|Overall Study|Adverse Event|50|||
16128914|NCT00558259|38958777|FG001|Overall Study|Adverse Event|81|||
16128915|NCT00558259|38958776|FG000|Overall Study|Protocol Violation|9|||
16128916|NCT00558259|38958777|FG001|Overall Study|Protocol Violation|5|||
16128917|NCT00558259|38958776|FG000|Overall Study|Withdrawal by Subject|12|||
16128918|NCT00558259|38958777|FG001|Overall Study|Withdrawal by Subject|13|||
16128919|NCT00540046|38958778|FG000|Overall Study|Lost to Follow-up|33|||
16128920|NCT00540046|38958779|FG001|Overall Study|Lost to Follow-up|23|||
16128921|NCT00657020|38958780|FG000|PERIOD 1|Adverse Event|0|||
16128922|NCT00657020|38958781|FG001|PERIOD 1|Adverse Event|1|||
16128923|NCT01021215|38958782|FG000|Overall Study|Lost to Follow-up|3|||
16128924|NCT01021215|38958783|FG001|Overall Study|Lost to Follow-up|0|||
16128925|NCT03938545|38958784|FG000|Overall Study|Lost to Follow-up|0|||
16128926|NCT03938545|38958785|FG001|Overall Study|Lost to Follow-up|0|||
16128927|NCT03938545|38958786|FG002|Overall Study|Lost to Follow-up|0|||
16128928|NCT03938545|38958787|FG003|Overall Study|Lost to Follow-up|1|||
16128929|NCT03938545|38958784|FG000|Overall Study|Non-compliance with study drug|0|||
16128930|NCT03938545|38958785|FG001|Overall Study|Non-compliance with study drug|0|||
16128931|NCT03938545|38958786|FG002|Overall Study|Non-compliance with study drug|1|||
16128932|NCT03938545|38958787|FG003|Overall Study|Non-compliance with study drug|0|||
16128933|NCT03938545|38958784|FG000|Overall Study|Pregnancy|1|||
16128934|NCT03938545|38958785|FG001|Overall Study|Pregnancy|0|||
16128935|NCT03938545|38958786|FG002|Overall Study|Pregnancy|0|||
16128936|NCT03938545|38958787|FG003|Overall Study|Pregnancy|0|||
16128937|NCT03938545|38958784|FG000|Overall Study|Study terminated by sponsor|6|||
16128938|NCT03938545|38958785|FG001|Overall Study|Study terminated by sponsor|4|||
16128939|NCT03938545|38958786|FG002|Overall Study|Study terminated by sponsor|2|||
16128940|NCT03938545|38958787|FG003|Overall Study|Study terminated by sponsor|4|||
16128941|NCT03938545|38958784|FG000|Overall Study|Withdrawal by Subject|0|||
16128942|NCT03938545|38958785|FG001|Overall Study|Withdrawal by Subject|1|||
16128943|NCT03938545|38958786|FG002|Overall Study|Withdrawal by Subject|0|||
16128944|NCT03938545|38958787|FG003|Overall Study|Withdrawal by Subject|0|||
16128945|NCT03938545|38958784|FG000|Overall Study|Adverse Event|1|||
16128946|NCT03938545|38958785|FG001|Overall Study|Adverse Event|0|||
16128947|NCT03938545|38958786|FG002|Overall Study|Adverse Event|0|||
16128948|NCT03938545|38958787|FG003|Overall Study|Adverse Event|0|||
16128949|NCT00925132|38958788|FG000|Overall Study|Withdrawal by Subject|2|||
16128950|NCT00925132|38958789|FG001|Overall Study|Withdrawal by Subject|0|||
16128951|NCT00925132|38958790|FG002|Overall Study|Withdrawal by Subject|0|||
16128952|NCT00925132|38958791|FG003|Overall Study|Withdrawal by Subject|0|||
16128953|NCT00925132|38958792|FG004|Overall Study|Withdrawal by Subject|1|||
16128954|NCT00925132|38958788|FG000|Overall Study|Removed due to disease progression|0|||
16128955|NCT00925132|38958789|FG001|Overall Study|Removed due to disease progression|0|||
16128956|NCT00925132|38958790|FG002|Overall Study|Removed due to disease progression|0|||
16128957|NCT00925132|38958791|FG003|Overall Study|Removed due to disease progression|0|||
16128958|NCT00925132|38958792|FG004|Overall Study|Removed due to disease progression|4|||
16352145|NCT03154086|39776595|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
16352146|NCT03154086|39776581|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352147|NCT03154086|39776582|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
16352148|NCT03154086|39776583|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352149|NCT03154086|39776584|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352150|NCT03154086|39776585|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352151|NCT03154086|39776586|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352152|NCT03154086|39776587|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16128959|NCT01198756|38958796|FG000|Overall Study|Adverse Event|0|||
16128960|NCT01198756|38958797|FG001|Overall Study|Adverse Event|0|||
16128961|NCT01198756|38958798|FG002|Overall Study|Adverse Event|0|||
16128962|NCT01198756|38958799|FG003|Overall Study|Adverse Event|1|||
16128963|NCT01198756|38958796|FG000|Overall Study|Protocol Violation|0|||
16128964|NCT01198756|38958797|FG001|Overall Study|Protocol Violation|0|||
16128965|NCT01198756|38958798|FG002|Overall Study|Protocol Violation|0|||
16416675|NCT01641822|40004792|FG002|Run-in Phase|Noncompliance with study drug|0|||
16416676|NCT01641822|40004790|FG000|Run-in Phase|Adverse Event|3|||
16416677|NCT01641822|40004791|FG001|Run-in Phase|Adverse Event|0|||
16128966|NCT01198756|38958799|FG003|Overall Study|Protocol Violation|2|||
16128967|NCT01198756|38958796|FG000|Overall Study|Withdrawal by Subject|9|||
16128968|NCT01198756|38958797|FG001|Overall Study|Withdrawal by Subject|4|||
16128969|NCT01198756|38958798|FG002|Overall Study|Withdrawal by Subject|7|||
16128970|NCT01198756|38958799|FG003|Overall Study|Withdrawal by Subject|5|||
16128971|NCT01198756|38958796|FG000|Overall Study|Lost to Follow-up|29|||
16128972|NCT01198756|38958797|FG001|Overall Study|Lost to Follow-up|36|||
16128973|NCT01198756|38958798|FG002|Overall Study|Lost to Follow-up|23|||
16128974|NCT01198756|38958799|FG003|Overall Study|Lost to Follow-up|18|||
16128975|NCT00752557|38958800|FG000|Overall Study|Withdrawal by Subject|4|||
16128976|NCT00752557|38958801|FG001|Overall Study|Withdrawal by Subject|3|||
16128977|NCT00752557|38958802|FG002|Overall Study|Withdrawal by Subject|3|||
16128978|NCT00752557|38958800|FG000|Overall Study|Unspecified resaons|0|||
16128979|NCT00752557|38958801|FG001|Overall Study|Unspecified resaons|2|||
16128980|NCT00752557|38958802|FG002|Overall Study|Unspecified resaons|2|||
16128981|NCT00752557|38958800|FG000|Overall Study|Lost to Follow-up|1|||
16128982|NCT00752557|38958801|FG001|Overall Study|Lost to Follow-up|0|||
16128983|NCT00752557|38958802|FG002|Overall Study|Lost to Follow-up|1|||
16128984|NCT01993927|38958803|FG000|Overall Study|Case Report Forms Uncollected|18|||
16416678|NCT01641822|40004792|FG002|Run-in Phase|Adverse Event|0|||
16128985|NCT01993927|38958803|FG000|Overall Study|Protocol Violation|11|||
16128986|NCT01052103|38958804|FG000|Overall Study|Adverse Event|10|||
16128987|NCT01052103|38958805|FG001|Overall Study|Adverse Event|6|||
16128988|NCT01052103|38958804|FG000|Overall Study|Entry Criteria Not Met|3|||
16128989|NCT01052103|38958805|FG001|Overall Study|Entry Criteria Not Met|1|||
16128990|NCT01052103|38958804|FG000|Overall Study|Lost to Follow-up|3|||
16128991|NCT01052103|38958805|FG001|Overall Study|Lost to Follow-up|5|||
16128992|NCT01052103|38958804|FG000|Overall Study|Protocol Violation|10|||
16128993|NCT01052103|38958805|FG001|Overall Study|Protocol Violation|4|||
16128994|NCT01052103|38958804|FG000|Overall Study|Scheduling conflict|2|||
16128995|NCT01052103|38958805|FG001|Overall Study|Scheduling conflict|1|||
16128996|NCT01052103|38958804|FG000|Overall Study|Sponsor Decision|2|||
16128997|NCT01052103|38958805|FG001|Overall Study|Sponsor Decision|0|||
16128998|NCT01052103|38958804|FG000|Overall Study|Withdrawal by Subject|3|||
16128999|NCT01052103|38958805|FG001|Overall Study|Withdrawal by Subject|6|||
16129000|NCT01052103|38958804|FG000|Overall Study|Perceived Lack of Efficacy|1|||
16416679|NCT01641822|40004790|FG000|Run-in Phase|Withdrew consent|1|||
16416680|NCT01641822|40004791|FG001|Run-in Phase|Withdrew consent|0|||
16416681|NCT01641822|40004792|FG002|Run-in Phase|Withdrew consent|0|||
16416682|NCT01641822|40004790|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
16416683|NCT01641822|40004791|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
16559861|NCT01394991|40517350|FG000|Overall Study|Prematurely Termination of Trial|9|||
16559862|NCT01394991|40517351|FG001|Overall Study|Prematurely Termination of Trial|10|||
16559863|NCT00373295|40517354|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
16559864|NCT00373295|40517355|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
16559865|NCT00373295|40517356|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
16559866|NCT00373295|40517357|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
16559867|NCT00373295|40517358|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
16559868|NCT00373295|40517359|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
16416684|NCT01641822|40004792|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
16416685|NCT01641822|40004790|FG000|Comparative Phase|Noncompliance with study drug|0|||
16416686|NCT01641822|40004791|FG001|Comparative Phase|Noncompliance with study drug|1|||
16559869|NCT03168438|40517360|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
16559870|NCT03168438|40517361|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
16559871|NCT01657032|40517362|FG000|Overall Study|Lost to Follow-up|0|||
16559872|NCT01657032|40517363|FG001|Overall Study|Lost to Follow-up|7|||
16559873|NCT03389893|40517364|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
16129001|NCT01052103|38958805|FG001|Overall Study|Perceived Lack of Efficacy|0|||
16416687|NCT01641822|40004792|FG002|Comparative Phase|Noncompliance with study drug|0|||
16416688|NCT01641822|40004790|FG000|Comparative Phase|Investigator's discretion|0|||
16416689|NCT01641822|40004791|FG001|Comparative Phase|Investigator's discretion|0|||
16129002|NCT04371198|38958807|FG000|Overall Study|inadequate sample|4|||
16129003|NCT02040584|38958814|FG000|Overall Study|Adverse Event|13|||
16129004|NCT02040584|38958815|FG001|Overall Study|Adverse Event|6|||
16559874|NCT03389893|40517365|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
16559875|NCT03389893|40517366|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
16129005|NCT02040584|38958814|FG000|Overall Study|Protocol Violation|9|||
16129006|NCT02040584|38958815|FG001|Overall Study|Protocol Violation|11|||
16559876|NCT03389893|40517367|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
16129007|NCT02040584|38958814|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16129008|NCT02040584|38958815|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16129009|NCT02040584|38958814|FG000|Overall Study|Death|6|||
16129010|NCT02040584|38958815|FG001|Overall Study|Death|3|||
16129011|NCT02040584|38958814|FG000|Overall Study|Transplant rejection/retransplant|0|||
16129012|NCT02040584|38958815|FG001|Overall Study|Transplant rejection/retransplant|1|||
16129013|NCT02040584|38958814|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
16129014|NCT02040584|38958815|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
16129015|NCT02518490|38958821|FG000|Overall Study|Withdrawal by Subject|1|||
16129016|NCT02518490|38958822|FG001|Overall Study|Withdrawal by Subject|1|||
16129017|NCT00296400|38958823|FG000|Overall Study|Adverse Event|7|||
16129018|NCT00296400|38958824|FG001|Overall Study|Adverse Event|7|||
16129019|NCT00296400|38958825|FG002|Overall Study|Adverse Event|7|||
16129020|NCT00296400|38958823|FG000|Overall Study|Withdrawal by Subject|5|||
16129021|NCT00296400|38958824|FG001|Overall Study|Withdrawal by Subject|6|||
16129022|NCT00296400|38958825|FG002|Overall Study|Withdrawal by Subject|2|||
16129023|NCT00296400|38958823|FG000|Overall Study|Incorrect enrollment|2|||
16129024|NCT00296400|38958824|FG001|Overall Study|Incorrect enrollment|0|||
16129025|NCT00296400|38958825|FG002|Overall Study|Incorrect enrollment|0|||
16416690|NCT01641822|40004792|FG002|Comparative Phase|Investigator's discretion|1|||
16416691|NCT01641822|40004790|FG000|Comparative Phase|Pregnancy|0|||
16416692|NCT01641822|40004791|FG001|Comparative Phase|Pregnancy|0|||
16416693|NCT01641822|40004792|FG002|Comparative Phase|Pregnancy|1|||
16416694|NCT01641822|40004790|FG000|Comparative Phase|Adverse event, serious fatal|0|||
16416695|NCT01641822|40004791|FG001|Comparative Phase|Adverse event, serious fatal|1|||
16416696|NCT01641822|40004792|FG002|Comparative Phase|Adverse event, serious fatal|0|||
16416697|NCT01641822|40004790|FG000|Comparative Phase|Withdrew consent|0|||
16129026|NCT00296400|38958823|FG000|Overall Study|Protocol Violation|1|||
16129027|NCT00296400|38958824|FG001|Overall Study|Protocol Violation|1|||
16129028|NCT00296400|38958825|FG002|Overall Study|Protocol Violation|1|||
16129029|NCT00296400|38958823|FG000|Overall Study|Lost to Follow-up|1|||
16129030|NCT00296400|38958824|FG001|Overall Study|Lost to Follow-up|1|||
16129031|NCT00296400|38958825|FG002|Overall Study|Lost to Follow-up|2|||
16129032|NCT00296400|38958823|FG000|Overall Study|Study specific discontinuation criteria|0|||
16129033|NCT00296400|38958824|FG001|Overall Study|Study specific discontinuation criteria|0|||
16129034|NCT00296400|38958825|FG002|Overall Study|Study specific discontinuation criteria|1|||
16129035|NCT00296400|38958823|FG000|Overall Study|Visit 10 was performed earlier|0|||
16129036|NCT00296400|38958824|FG001|Overall Study|Visit 10 was performed earlier|1|||
16129037|NCT00296400|38958825|FG002|Overall Study|Visit 10 was performed earlier|0|||
16416698|NCT01641822|40004791|FG001|Comparative Phase|Withdrew consent|3|||
16416699|NCT01641822|40004792|FG002|Comparative Phase|Withdrew consent|7|||
16416700|NCT01641822|40004790|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
16416701|NCT01641822|40004791|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
16416702|NCT01641822|40004792|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
16416703|NCT03006887|40004796|FG000|Overall Study|Adverse Event|1|||
16416704|NCT02544373|40004797|FG000|Overall Study|Lost to Follow-up|5|||
16416705|NCT02544373|40004798|FG001|Overall Study|Lost to Follow-up|3|||
16416706|NCT02544373|40004797|FG000|Overall Study|Withdrawal by Subject|8|||
16416707|NCT02544373|40004798|FG001|Overall Study|Withdrawal by Subject|2|||
16416708|NCT01424228|40004799|FG000|Overall Study|Withdrawal by Subject|27|||
16416709|NCT01424228|40004800|FG001|Overall Study|Withdrawal by Subject|11|||
16416710|NCT01424228|40004799|FG000|Overall Study|Adverse Event|10|||
16416711|NCT01424228|40004800|FG001|Overall Study|Adverse Event|14|||
16129038|NCT00296400|38958823|FG000|Overall Study|Pregnancy|1|||
16129039|NCT00296400|38958824|FG001|Overall Study|Pregnancy|2|||
16129040|NCT00296400|38958825|FG002|Overall Study|Pregnancy|0|||
16129041|NCT01967147|38958826|FG000|Overall Study|Adverse Event|5|||
16129042|NCT01967147|38958827|FG001|Overall Study|Adverse Event|2|||
16129043|NCT01967147|38958826|FG000|Overall Study|Lack of Efficacy|1|||
16416712|NCT01424228|40004799|FG000|Overall Study|Sponsor's decision|9|||
16416713|NCT01424228|40004800|FG001|Overall Study|Sponsor's decision|12|||
16416714|NCT01424228|40004799|FG000|Overall Study|Lack of Efficacy|5|||
16416715|NCT01424228|40004800|FG001|Overall Study|Lack of Efficacy|7|||
16129044|NCT01967147|38958827|FG001|Overall Study|Lack of Efficacy|4|||
16129045|NCT01967147|38958826|FG000|Overall Study|Lost to Follow-up|1|||
16129046|NCT01967147|38958827|FG001|Overall Study|Lost to Follow-up|2|||
16129047|NCT01967147|38958826|FG000|Overall Study|Withdrawal by Subject|2|||
16129048|NCT01967147|38958827|FG001|Overall Study|Withdrawal by Subject|4|||
16129049|NCT01967147|38958826|FG000|Overall Study|Non-compliance with Study Drug|0|||
16245844|NCT01806597|39385329|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
16245845|NCT01806597|39385324|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
16245846|NCT01806597|39385325|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
16245847|NCT01806597|39385326|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
16245848|NCT01806597|39385327|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
16245849|NCT01806597|39385328|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
16245850|NCT01806597|39385329|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
16245851|NCT01806597|39385324|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
16245852|NCT01806597|39385325|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
16245853|NCT01806597|39385326|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
16245854|NCT01806597|39385327|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
16245855|NCT01806597|39385328|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
16245856|NCT01806597|39385329|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
16245857|NCT01806597|39385324|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
16245858|NCT01806597|39385325|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
16245859|NCT01806597|39385326|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
16245860|NCT01806597|39385327|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
16245861|NCT01806597|39385328|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
16245862|NCT01806597|39385329|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
16245863|NCT01806597|39385324|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
16245864|NCT01806597|39385325|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
16245865|NCT01806597|39385326|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
16245866|NCT01806597|39385327|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
16416716|NCT01424228|40004799|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
16416717|NCT01424228|40004800|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
16416718|NCT01424228|40004799|FG000|Overall Study|Non-compliance|2|||
16416719|NCT01424228|40004800|FG001|Overall Study|Non-compliance|0|||
16416720|NCT01424228|40004799|FG000|Overall Study|Worsening of symptoms|1|||
16416721|NCT01424228|40004800|FG001|Overall Study|Worsening of symptoms|0|||
16416722|NCT01424228|40004799|FG000|Overall Study|Unplanned journey|0|||
16416723|NCT01424228|40004800|FG001|Overall Study|Unplanned journey|1|||
16416724|NCT02049138|40004801|FG000|Overall Study|Adverse Event|46|||
16416725|NCT02049138|40004802|FG001|Overall Study|Adverse Event|25|||
16416726|NCT02049138|40004803|FG002|Overall Study|Adverse Event|1|||
16416727|NCT02049138|40004801|FG000|Overall Study|Withdrawal by Subject|57|||
16416728|NCT02049138|40004802|FG001|Overall Study|Withdrawal by Subject|21|||
16416729|NCT02049138|40004803|FG002|Overall Study|Withdrawal by Subject|5|||
16416730|NCT02049138|40004801|FG000|Overall Study|Lost to Follow-up|18|||
16416731|NCT02049138|40004802|FG001|Overall Study|Lost to Follow-up|5|||
16416732|NCT02049138|40004803|FG002|Overall Study|Lost to Follow-up|1|||
16416733|NCT02049138|40004801|FG000|Overall Study|Lack of Efficacy|10|||
16416734|NCT02049138|40004802|FG001|Overall Study|Lack of Efficacy|26|||
16416735|NCT02049138|40004803|FG002|Overall Study|Lack of Efficacy|1|||
16416736|NCT02049138|40004801|FG000|Overall Study|Non-Compliance|15|||
16416737|NCT02049138|40004802|FG001|Overall Study|Non-Compliance|6|||
16416738|NCT02049138|40004803|FG002|Overall Study|Non-Compliance|0|||
16416739|NCT02049138|40004801|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
16416740|NCT02049138|40004802|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
16416741|NCT02049138|40004803|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
16416742|NCT02049138|40004801|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
16416743|NCT02049138|40004802|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
16416744|NCT02049138|40004803|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
16416745|NCT02049138|40004801|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
16416746|NCT02049138|40004802|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
16416747|NCT02049138|40004803|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
16416748|NCT02049138|40004801|FG000|Overall Study|Other|15|||
16416749|NCT02049138|40004802|FG001|Overall Study|Other|13|||
16416750|NCT02049138|40004803|FG002|Overall Study|Other|0|||
16416751|NCT02049138|40004801|FG000|Overall Study|Missing|0|||
16416752|NCT02049138|40004802|FG001|Overall Study|Missing|1|||
16416753|NCT02049138|40004803|FG002|Overall Study|Missing|0|||
16416754|NCT01345682|40008330|FG000|Overall Study|Progressive disease per RECIST|226|||
16416755|NCT01345682|40008331|FG001|Overall Study|Progressive disease per RECIST|93|||
16416756|NCT01345682|40008330|FG000|Overall Study|Worsening of underlying cancer disease|23|||
16416757|NCT01345682|40008331|FG001|Overall Study|Worsening of underlying cancer disease|12|||
16416758|NCT01345682|40008330|FG000|Overall Study|Adverse Event|51|||
16416759|NCT01345682|40008331|FG001|Overall Study|Adverse Event|41|||
16416760|NCT01345682|40008330|FG000|Overall Study|Non-compliance with protocol|0|||
16416761|NCT01345682|40008331|FG001|Overall Study|Non-compliance with protocol|1|||
16245867|NCT01806597|39385328|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
16245868|NCT01806597|39385329|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
16245869|NCT01806597|39385324|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
16245870|NCT01806597|39385325|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
16245871|NCT01806597|39385326|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
16245872|NCT01806597|39385327|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
16245873|NCT01806597|39385328|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
16245874|NCT01806597|39385329|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
16245875|NCT01806597|39385324|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
16245876|NCT01806597|39385325|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
16245877|NCT01806597|39385326|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
16245878|NCT01806597|39385327|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
16245879|NCT01806597|39385328|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
16245880|NCT01806597|39385329|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
16245881|NCT01806597|39385324|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
16245882|NCT01806597|39385325|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
16245883|NCT01806597|39385326|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
16245884|NCT01806597|39385327|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
16245885|NCT01806597|39385328|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
16245886|NCT01806597|39385329|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
16245887|NCT01806597|39385324|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
16245888|NCT01806597|39385325|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
16245889|NCT01806597|39385326|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
16245890|NCT01806597|39385327|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
16245891|NCT01806597|39385328|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
16245892|NCT01806597|39385329|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
16245893|NCT01806597|39385324|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
16245894|NCT01806597|39385325|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
16245895|NCT01806597|39385326|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
16245896|NCT01806597|39385327|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
16245897|NCT01806597|39385328|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
16245898|NCT01806597|39385329|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
16245899|NCT01806597|39385324|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
16245900|NCT01806597|39385325|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
16245901|NCT01806597|39385326|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
16245902|NCT01806597|39385327|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
16245903|NCT01806597|39385328|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
16245904|NCT01806597|39385329|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
16245905|NCT02436135|39385334|FG000|Overall Study|Progressive Disease|3|||
16245906|NCT02436135|39385335|FG001|Overall Study|Progressive Disease|1|||
16245907|NCT02436135|39385334|FG000|Overall Study|Investigator Discretion|1|||
16245908|NCT02436135|39385335|FG001|Overall Study|Investigator Discretion|2|||
16245909|NCT02436135|39385334|FG000|Overall Study|Adverse Event|1|||
16245910|NCT02436135|39385335|FG001|Overall Study|Adverse Event|0|||
16245911|NCT02436135|39385334|FG000|Overall Study|Withdrawal by Participant|1|||
16245912|NCT02436135|39385335|FG001|Overall Study|Withdrawal by Participant|0|||
16245913|NCT02436135|39385334|FG000|Overall Study|Study Terminated By Sponsor|0|||
16245914|NCT02436135|39385335|FG001|Overall Study|Study Terminated By Sponsor|1|||
16245915|NCT00130520|39385336|FG000|Overall Study|Adverse Event|11|||
16245916|NCT00130520|39385336|FG000|Overall Study|Death|1|||
16245917|NCT00130520|39385336|FG000|Overall Study|Physician Decision|1|||
16245918|NCT00130520|39385336|FG000|Overall Study|Withdrawal by Subject|1|||
16245919|NCT00130520|39385336|FG000|Overall Study|Disease Progression|23|||
16245920|NCT00130520|39385336|FG000|Overall Study|Protocol non-compliance|1|||
16245921|NCT00130520|39385336|FG000|Overall Study|Did not meet re-treatment criteria|1|||
16245922|NCT00415532|39385337|FG000|Treatment Period|Adverse Event|2|||
16245923|NCT00415532|39385338|FG001|Treatment Period|Adverse Event|3|||
16245924|NCT00415532|39385337|FG000|Treatment Period|Death|2|||
16245925|NCT00415532|39385338|FG001|Treatment Period|Death|1|||
16245926|NCT00415532|39385337|FG000|Treatment Period|Lost to Follow-up|1|||
16245927|NCT00415532|39385338|FG001|Treatment Period|Lost to Follow-up|1|||
16245928|NCT00415532|39385337|FG000|Treatment Period|Protocol Violation|1|||
16245929|NCT00415532|39385338|FG001|Treatment Period|Protocol Violation|0|||
16245930|NCT00415532|39385337|FG000|Treatment Period|Withdrawal by Subject|6|||
16416762|NCT01345682|40008330|FG000|Overall Study|Lost to Follow-up|0|||
16416763|NCT01345682|40008331|FG001|Overall Study|Lost to Follow-up|1|||
16416764|NCT01345682|40008330|FG000|Overall Study|Refused to continue trial medication|16|||
16416765|NCT01345682|40008331|FG001|Overall Study|Refused to continue trial medication|9|||
16416766|NCT01345682|40008330|FG000|Overall Study|Not treated|2|||
16416767|NCT01345682|40008331|FG001|Overall Study|Not treated|1|||
16245931|NCT00415532|39385338|FG001|Treatment Period|Withdrawal by Subject|6|||
16245932|NCT00415532|39385337|FG000|Treatment Period|Other|2|||
16245933|NCT00415532|39385338|FG001|Treatment Period|Other|2|||
16245934|NCT00415532|39385337|FG000|Treatment Period|Ineligibility determined|1|||
16245935|NCT00415532|39385338|FG001|Treatment Period|Ineligibility determined|1|||
16416768|NCT01345682|40008330|FG000|Overall Study|Reason other than those specified above|4|||
16416769|NCT01345682|40008331|FG001|Overall Study|Reason other than those specified above|3|||
16416770|NCT01457846|40008338|FG000|Overall Study|Death before treatment|1|||
16559877|NCT03389893|40517364|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
16559878|NCT03389893|40517365|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
16559879|NCT03389893|40517366|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
16559880|NCT03389893|40517367|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
16559881|NCT03389893|40517364|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
16416771|NCT01457846|40008339|FG001|Overall Study|Death before treatment|2|||
16416772|NCT01457846|40008338|FG000|Overall Study|Did not receive treatment|0|||
16416773|NCT01457846|40008339|FG001|Overall Study|Did not receive treatment|1|||
16416774|NCT01457846|40008338|FG000|Overall Study|Death|27|||
16416775|NCT01457846|40008339|FG001|Overall Study|Death|16|||
16416776|NCT01457846|40008338|FG000|Overall Study|Unclassified reason for not completed|11|||
16416777|NCT01457846|40008339|FG001|Overall Study|Unclassified reason for not completed|10|||
16416778|NCT01457846|40008338|FG000|Overall Study|Withdrawal by Subject|1|||
16416779|NCT01457846|40008339|FG001|Overall Study|Withdrawal by Subject|1|||
16416780|NCT01457846|40008338|FG000|Overall Study|Lost to Follow-up|1|||
16416781|NCT01457846|40008339|FG001|Overall Study|Lost to Follow-up|0|||
16416782|NCT03629912|40008343|FG000|Overall Study|Lost to Follow-up|19|||
16416783|NCT03629912|40008344|FG001|Overall Study|Lost to Follow-up|7|||
16416784|NCT03629912|40008345|FG002|Overall Study|Lost to Follow-up|5|||
16416785|NCT03629912|40008346|FG003|Overall Study|Lost to Follow-up|1|||
16416786|NCT03629912|40008343|FG000|Overall Study|Withdrawal by Subject|6|||
16416787|NCT03629912|40008344|FG001|Overall Study|Withdrawal by Subject|0|||
16416788|NCT03629912|40008345|FG002|Overall Study|Withdrawal by Subject|1|||
16416789|NCT03629912|40008346|FG003|Overall Study|Withdrawal by Subject|2|||
16416790|NCT03629912|40008343|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
16416791|NCT03629912|40008344|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
16416792|NCT03629912|40008345|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
16416793|NCT03629912|40008346|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
16416794|NCT03629912|40008343|FG000|Overall Study|Death|1|||
16416795|NCT03629912|40008344|FG001|Overall Study|Death|0|||
16416796|NCT03629912|40008345|FG002|Overall Study|Death|0|||
16416797|NCT03629912|40008346|FG003|Overall Study|Death|0|||
16416798|NCT04405245|40008349|FG000|Overall Study|Adverse Event|0|||
16416799|NCT04405245|40008350|FG001|Overall Study|Adverse Event|1|||
16416800|NCT04405245|40008351|FG002|Overall Study|Adverse Event|0|||
16416801|NCT00924443|40008352|FG000|Overall Study|Physician Decision|2|||
16416802|NCT00924443|40008352|FG000|Overall Study|Protocol Violation|1|||
16416803|NCT01147848|40008353|FG000|Run-in Period|Screen Failure|623|||
16416804|NCT01147848|40008354|FG001|Run-in Period|Screen Failure|0|||
16416805|NCT01147848|40008355|FG002|Run-in Period|Screen Failure|0|||
16416806|NCT01147848|40008353|FG000|Run-in Period|Run-in Failure|135|||
16416807|NCT01147848|40008354|FG001|Run-in Period|Run-in Failure|0|||
16416808|NCT01147848|40008355|FG002|Run-in Period|Run-in Failure|0|||
16416809|NCT01147848|40008353|FG000|Randomized Phase|Adverse Event|0|||
16416810|NCT01147848|40008354|FG001|Randomized Phase|Adverse Event|6|||
16416811|NCT01147848|40008355|FG002|Randomized Phase|Adverse Event|8|||
16416812|NCT01147848|40008353|FG000|Randomized Phase|Lack of Efficacy|0|||
16416813|NCT01147848|40008354|FG001|Randomized Phase|Lack of Efficacy|20|||
16416814|NCT01147848|40008355|FG002|Randomized Phase|Lack of Efficacy|11|||
16416815|NCT01147848|40008353|FG000|Randomized Phase|Protocol Violation|0|||
16416816|NCT01147848|40008354|FG001|Randomized Phase|Protocol Violation|7|||
16416817|NCT01147848|40008355|FG002|Randomized Phase|Protocol Violation|10|||
16416818|NCT01147848|40008353|FG000|Randomized Phase|Lost to Follow-up|0|||
16416819|NCT01147848|40008354|FG001|Randomized Phase|Lost to Follow-up|5|||
16416820|NCT01147848|40008355|FG002|Randomized Phase|Lost to Follow-up|7|||
16416821|NCT01147848|40008353|FG000|Randomized Phase|Physician Decision|0|||
16416822|NCT01147848|40008354|FG001|Randomized Phase|Physician Decision|0|||
16245936|NCT00415532|39385337|FG000|Treatment Period|Noncompliance|1|||
16416823|NCT01147848|40008355|FG002|Randomized Phase|Physician Decision|1|||
16416824|NCT01147848|40008353|FG000|Randomized Phase|Withdrawal by Subject|0|||
16416825|NCT01147848|40008354|FG001|Randomized Phase|Withdrawal by Subject|7|||
16416826|NCT01147848|40008355|FG002|Randomized Phase|Withdrawal by Subject|9|||
16416827|NCT05096312|40008366|FG000|Overall Study|Lost to Follow-up|2|||
16416828|NCT05096312|40008367|FG001|Overall Study|Lost to Follow-up|4|||
16416829|NCT05096312|40008366|FG000|Overall Study|Adverse Event|1|||
16416830|NCT05096312|40008367|FG001|Overall Study|Adverse Event|0|||
16416831|NCT02891382|40008368|FG000|Overall Study|Lost to Follow-up|3|||
16352153|NCT03154086|39776588|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352154|NCT03154086|39776589|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352155|NCT03154086|39776590|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352156|NCT03154086|39776591|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352157|NCT03154086|39776592|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352158|NCT03154086|39776593|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352159|NCT03154086|39776594|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352160|NCT03154086|39776595|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
16352161|NCT03154086|39776581|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352162|NCT03154086|39776582|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352163|NCT03154086|39776583|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
16352164|NCT03154086|39776584|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352165|NCT03154086|39776585|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352166|NCT03154086|39776586|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352167|NCT03154086|39776587|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352168|NCT03154086|39776588|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352169|NCT03154086|39776589|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352170|NCT03154086|39776590|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352171|NCT03154086|39776591|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352172|NCT03154086|39776592|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352173|NCT03154086|39776593|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352174|NCT03154086|39776594|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352175|NCT03154086|39776595|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
16352176|NCT03154086|39776581|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
16352177|NCT03154086|39776582|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352178|NCT03154086|39776583|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352179|NCT03154086|39776584|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352180|NCT03154086|39776585|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16416832|NCT02891382|40008369|FG001|Overall Study|Lost to Follow-up|4|||
16416833|NCT02891382|40008370|FG002|Overall Study|Lost to Follow-up|5|||
16416834|NCT02891382|40008371|FG003|Overall Study|Lost to Follow-up|3|||
16416835|NCT02891382|40008372|FG004|Overall Study|Lost to Follow-up|4|||
16416836|NCT05098509|40008373|FG000|Overall Study|Withdrawal by Subject|0|||
16416837|NCT05098509|40008374|FG001|Overall Study|Withdrawal by Subject|0|||
16129050|NCT01967147|38958827|FG001|Overall Study|Non-compliance with Study Drug|3|||
16129051|NCT01967147|38958826|FG000|Overall Study|Other|4|||
16129052|NCT01967147|38958827|FG001|Overall Study|Other|5|||
16129053|NCT00996476|38958828|FG000|Overall Study|Withdrawal by Subject|1|||
16129054|NCT00996476|38958829|FG001|Overall Study|Withdrawal by Subject|2|||
16129055|NCT00996476|38958830|FG002|Overall Study|Withdrawal by Subject|1|||
16129056|NCT00996476|38958831|FG003|Overall Study|Withdrawal by Subject|0|||
16129057|NCT00996476|38958832|FG004|Overall Study|Withdrawal by Subject|1|||
16129058|NCT00996476|38958828|FG000|Overall Study|Adverse Event|0|||
16129059|NCT00996476|38958829|FG001|Overall Study|Adverse Event|1|||
16129060|NCT00996476|38958830|FG002|Overall Study|Adverse Event|0|||
16129061|NCT00996476|38958831|FG003|Overall Study|Adverse Event|0|||
16129062|NCT00996476|38958832|FG004|Overall Study|Adverse Event|1|||
16129063|NCT02533531|38958834|FG000|Overall Study|Device did not turn on|1|||
16129064|NCT00412061|38958835|FG000|Double Blind Phase|Disease Progression|101|||
16129065|NCT00412061|38958836|FG001|Double Blind Phase|Disease Progression|154|||
16129066|NCT00412061|38958835|FG000|Double Blind Phase|Adverse Event|61|||
16129067|NCT00412061|38958836|FG001|Double Blind Phase|Adverse Event|16|||
16129068|NCT00412061|38958835|FG000|Double Blind Phase|Final Primary Analysis|26|||
16129069|NCT00412061|38958836|FG001|Double Blind Phase|Final Primary Analysis|14|||
16129070|NCT00412061|38958835|FG000|Double Blind Phase|Withdrawal by Subject|18|||
16129071|NCT00412061|38958836|FG001|Double Blind Phase|Withdrawal by Subject|20|||
16129072|NCT00412061|38958835|FG000|Double Blind Phase|Death|6|||
16129073|NCT00412061|38958836|FG001|Double Blind Phase|Death|3|||
16129074|NCT00412061|38958835|FG000|Double Blind Phase|Protocol Violation|3|||
16129075|NCT00412061|38958836|FG001|Double Blind Phase|Protocol Violation|4|||
16129076|NCT00412061|38958835|FG000|Double Blind Phase|New Cander Therapy|1|||
16129077|NCT00412061|38958836|FG001|Double Blind Phase|New Cander Therapy|1|||
16129078|NCT00412061|38958835|FG000|Double Blind Phase|Lost to Follow-up|0|||
16129079|NCT00412061|38958836|FG001|Double Blind Phase|Lost to Follow-up|1|||
16129080|NCT00412061|38958835|FG000|Open Label Phase|Disease Progression|0|||
16129081|NCT00412061|38958836|FG001|Open Label Phase|Disease Progression|86|||
16129082|NCT00412061|38958835|FG000|Open Label Phase|Adverse Event|0|||
16129083|NCT00412061|38958836|FG001|Open Label Phase|Adverse Event|46|||
16129084|NCT00412061|38958835|FG000|Open Label Phase|Withdrawal by Subject|0|||
16352181|NCT03154086|39776586|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352182|NCT03154086|39776587|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16416838|NCT05098509|40008375|FG002|Overall Study|Withdrawal by Subject|1|||
16352183|NCT03154086|39776588|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352184|NCT03154086|39776589|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352185|NCT03154086|39776590|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352186|NCT03154086|39776591|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352187|NCT03154086|39776592|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352188|NCT03154086|39776593|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352189|NCT03154086|39776594|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352190|NCT03154086|39776595|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
16352191|NCT03154086|39776581|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352192|NCT03154086|39776582|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352193|NCT03154086|39776583|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352194|NCT03154086|39776584|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352195|NCT03154086|39776585|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352196|NCT03154086|39776586|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352197|NCT03154086|39776587|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352198|NCT03154086|39776588|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352199|NCT03154086|39776589|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
16352200|NCT03154086|39776590|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352201|NCT03154086|39776591|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352202|NCT03154086|39776592|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352203|NCT03154086|39776593|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352204|NCT03154086|39776594|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352205|NCT03154086|39776595|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
16352206|NCT03154086|39776581|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352207|NCT03154086|39776582|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352208|NCT03154086|39776583|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352209|NCT03154086|39776584|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352210|NCT03154086|39776585|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352211|NCT03154086|39776586|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352212|NCT03154086|39776587|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352213|NCT03154086|39776588|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
16352214|NCT03154086|39776589|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352215|NCT03154086|39776590|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352216|NCT03154086|39776591|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352217|NCT03154086|39776592|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352218|NCT03154086|39776593|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352219|NCT03154086|39776594|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16416839|NCT05098509|40008376|FG003|Overall Study|Withdrawal by Subject|0|||
16416840|NCT05098509|40008373|FG000|Overall Study|Early study termination|1|||
16416841|NCT05098509|40008374|FG001|Overall Study|Early study termination|1|||
16559882|NCT03389893|40517365|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
16559883|NCT03389893|40517366|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
16559884|NCT03389893|40517367|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
16559885|NCT03389893|40517364|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
16559886|NCT03389893|40517365|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
16559887|NCT03389893|40517366|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
16559888|NCT03389893|40517367|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
16559889|NCT04562779|40517385|FG000|Overall Study|Lost to Follow-up|7|||
16559890|NCT04562779|40517386|FG001|Overall Study|Lost to Follow-up|5|||
16559891|NCT04562779|40517387|FG002|Overall Study|Lost to Follow-up|10|||
16559892|NCT04562779|40517385|FG000|Overall Study|Protocol Violation|2|||
16559893|NCT04562779|40517386|FG001|Overall Study|Protocol Violation|2|||
16559894|NCT04562779|40517387|FG002|Overall Study|Protocol Violation|0|||
16559895|NCT04179461|40517388|FG000|Overall Study|Lost to Follow-up|4|||
16559896|NCT02687919|40517393|FG000|Overall Study|Withdrawal by Subject|6|||
16559897|NCT02687919|40517394|FG001|Overall Study|Withdrawal by Subject|6|||
16559898|NCT02687919|40517393|FG000|Overall Study|Protocol Violation|2|||
16559899|NCT02687919|40517394|FG001|Overall Study|Protocol Violation|0|||
16559900|NCT03619174|40517397|FG000|Overall Study|Lost to Follow-up|3|||
16559901|NCT03619174|40517398|FG001|Overall Study|Lost to Follow-up|0|||
16559902|NCT03619174|40517397|FG000|Overall Study|Withdrawal by Subject|4|||
16559903|NCT03619174|40517398|FG001|Overall Study|Withdrawal by Subject|3|||
16559904|NCT03619174|40517397|FG000|Overall Study|Pregnancy|1|||
16559905|NCT03619174|40517398|FG001|Overall Study|Pregnancy|1|||
16559906|NCT03619174|40517397|FG000|Overall Study|Discomfort during treatment|1|||
16559907|NCT03619174|40517398|FG001|Overall Study|Discomfort during treatment|0|||
16559908|NCT00770211|40517401|FG000|Overall Study|Lost to Follow-up|1|||
16559909|NCT00770211|40517402|FG001|Overall Study|Lost to Follow-up|0|||
16559910|NCT00770211|40517401|FG000|Overall Study|Withdrawal by Subject|0|||
16416842|NCT05098509|40008375|FG002|Overall Study|Early study termination|1|||
16416843|NCT05098509|40008376|FG003|Overall Study|Early study termination|0|||
16416844|NCT02540265|40008379|FG000|Overall Study|Lost to Follow-up|0|||
16416845|NCT02540265|40008380|FG001|Overall Study|Lost to Follow-up|0|||
16416846|NCT02540265|40008381|FG002|Overall Study|Lost to Follow-up|1|||
16416847|NCT01438177|40008382|FG000|Overall Study|Withdrawal by Subject|1|||
16416848|NCT01438177|40008382|FG000|Overall Study|Initiation of new therapy|1|||
16129085|NCT00412061|38958836|FG001|Open Label Phase|Withdrawal by Subject|15|||
16129086|NCT00412061|38958835|FG000|Open Label Phase|Administrative Problems|0|||
16129087|NCT00412061|38958836|FG001|Open Label Phase|Administrative Problems|13|||
16129088|NCT00412061|38958835|FG000|Open Label Phase|Death|0|||
16129089|NCT00412061|38958836|FG001|Open Label Phase|Death|7|||
16129090|NCT00412061|38958835|FG000|Open Label Phase|Lost to Follow-up|0|||
16129091|NCT00412061|38958836|FG001|Open Label Phase|Lost to Follow-up|2|||
16129092|NCT00412061|38958835|FG000|Open Label Phase|New Cancer Therapy|0|||
16129093|NCT00412061|38958836|FG001|Open Label Phase|New Cancer Therapy|1|||
16129094|NCT01012713|38958839|FG000|Overall Study|Lack of Efficacy|3|||
16129095|NCT02146326|38958848|FG000|Overall Study|Lost to Follow-up|3|||
16129096|NCT02146326|38958849|FG001|Overall Study|Lost to Follow-up|3|||
16129097|NCT02146326|38958850|FG002|Overall Study|Lost to Follow-up|11|||
16129098|NCT02146326|38958851|FG003|Overall Study|Lost to Follow-up|19|||
16129099|NCT02146326|38958848|FG000|Overall Study|Withdrawal by Subject|2|||
16352220|NCT03154086|39776595|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
16352221|NCT03154086|39776581|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
16352222|NCT03154086|39776582|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
16352223|NCT03154086|39776583|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
16352224|NCT03154086|39776584|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
16352225|NCT03154086|39776585|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
16352226|NCT03154086|39776586|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
16352227|NCT03154086|39776587|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
16352228|NCT03154086|39776588|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
16352229|NCT03154086|39776589|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
16352230|NCT03154086|39776590|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
16352231|NCT03154086|39776591|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
16352232|NCT03154086|39776592|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
16352233|NCT03154086|39776593|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
16352234|NCT03154086|39776594|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
16352235|NCT03154086|39776595|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
16352236|NCT01919164|39776596|FG000|Overall Study|Adverse Event|6|||
16352237|NCT01919164|39776597|FG001|Overall Study|Adverse Event|4|||
16352238|NCT01919164|39776598|FG002|Overall Study|Adverse Event|9|||
16352239|NCT01919164|39776599|FG003|Overall Study|Adverse Event|3|||
16352240|NCT01919164|39776600|FG004|Overall Study|Adverse Event|2|||
16352241|NCT01919164|39776596|FG000|Overall Study|Lost to Follow-up|2|||
16352242|NCT01919164|39776597|FG001|Overall Study|Lost to Follow-up|2|||
16352243|NCT01919164|39776598|FG002|Overall Study|Lost to Follow-up|2|||
16352244|NCT01919164|39776599|FG003|Overall Study|Lost to Follow-up|0|||
16352245|NCT01919164|39776600|FG004|Overall Study|Lost to Follow-up|4|||
16352246|NCT01919164|39776596|FG000|Overall Study|Death|1|||
16352247|NCT01919164|39776597|FG001|Overall Study|Death|0|||
16352248|NCT01919164|39776598|FG002|Overall Study|Death|0|||
16352249|NCT01919164|39776599|FG003|Overall Study|Death|0|||
16352250|NCT01919164|39776600|FG004|Overall Study|Death|0|||
16352251|NCT01919164|39776596|FG000|Overall Study|Protocol Violation|6|||
16352252|NCT01919164|39776597|FG001|Overall Study|Protocol Violation|0|||
16352253|NCT01919164|39776598|FG002|Overall Study|Protocol Violation|3|||
16352254|NCT01919164|39776599|FG003|Overall Study|Protocol Violation|2|||
16352255|NCT01919164|39776600|FG004|Overall Study|Protocol Violation|2|||
16352256|NCT01919164|39776596|FG000|Overall Study|Disease progression|2|||
16352257|NCT01919164|39776597|FG001|Overall Study|Disease progression|2|||
16352258|NCT01919164|39776598|FG002|Overall Study|Disease progression|1|||
16352259|NCT01919164|39776599|FG003|Overall Study|Disease progression|2|||
16352260|NCT01919164|39776600|FG004|Overall Study|Disease progression|1|||
16352261|NCT01919164|39776596|FG000|Overall Study|Withdrew consent|13|||
16352262|NCT01919164|39776597|FG001|Overall Study|Withdrew consent|13|||
16352263|NCT01919164|39776598|FG002|Overall Study|Withdrew consent|14|||
16416849|NCT00444067|40008387|FG000|Overall Study|Lost to Follow-up|0|||
16352264|NCT01919164|39776599|FG003|Overall Study|Withdrew consent|14|||
16416850|NCT00444067|40008388|FG001|Overall Study|Lost to Follow-up|1|||
16416851|NCT03688555|40008391|FG000|Treatment Period|Adverse Event|0|||
16416852|NCT03688555|40008392|FG001|Treatment Period|Adverse Event|0|||
16129100|NCT02146326|38958849|FG001|Overall Study|Withdrawal by Subject|1|||
16129101|NCT02146326|38958850|FG002|Overall Study|Withdrawal by Subject|15|||
16129102|NCT02146326|38958851|FG003|Overall Study|Withdrawal by Subject|11|||
16129103|NCT02146326|38958848|FG000|Overall Study|Separated from mental health center|23|||
16352265|NCT01919164|39776600|FG004|Overall Study|Withdrew consent|9|||
16352266|NCT01919164|39776596|FG000|Overall Study|Other Un-specified|13|||
16352267|NCT01919164|39776597|FG001|Overall Study|Other Un-specified|9|||
16352268|NCT01919164|39776598|FG002|Overall Study|Other Un-specified|8|||
16416853|NCT03688555|40008393|FG002|Treatment Period|Adverse Event|1|||
16416854|NCT00098306|40008394|FG000|Double Blind|Randomized, not treated|9|||
16416855|NCT00098306|40008395|FG001|Double Blind|Randomized, not treated|5|||
16416856|NCT00098306|40008396|FG002|Double Blind|Randomized, not treated|2|||
16416857|NCT00098306|40008397|FG003|Double Blind|Randomized, not treated|0|||
16416858|NCT00098306|40008398|FG004|Double Blind|Randomized, not treated|0|||
16416859|NCT00098306|40008399|FG005|Double Blind|Randomized, not treated|0|||
16416860|NCT00098306|40008400|FG006|Double Blind|Randomized, not treated|0|||
16416861|NCT00098306|40008394|FG000|Double Blind|Ongoing at cut-off date|151|||
16416862|NCT00098306|40008395|FG001|Double Blind|Ongoing at cut-off date|166|||
16416863|NCT00098306|40008396|FG002|Double Blind|Ongoing at cut-off date|72|||
16416864|NCT00098306|40008397|FG003|Double Blind|Ongoing at cut-off date|0|||
16416865|NCT00098306|40008398|FG004|Double Blind|Ongoing at cut-off date|0|||
16416866|NCT00098306|40008399|FG005|Double Blind|Ongoing at cut-off date|0|||
16416867|NCT00098306|40008400|FG006|Double Blind|Ongoing at cut-off date|0|||
16416868|NCT00098306|40008394|FG000|Double Blind|Adverse Event|11|||
16416869|NCT00098306|40008395|FG001|Double Blind|Adverse Event|10|||
16416870|NCT00098306|40008396|FG002|Double Blind|Adverse Event|6|||
16416871|NCT00098306|40008397|FG003|Double Blind|Adverse Event|0|||
16416872|NCT00098306|40008398|FG004|Double Blind|Adverse Event|0|||
16416873|NCT00098306|40008399|FG005|Double Blind|Adverse Event|0|||
16416874|NCT00098306|40008400|FG006|Double Blind|Adverse Event|0|||
16416875|NCT00098306|40008394|FG000|Double Blind|Lack of Efficacy|43|||
16416876|NCT00098306|40008395|FG001|Double Blind|Lack of Efficacy|34|||
16416877|NCT00098306|40008396|FG002|Double Blind|Lack of Efficacy|17|||
16416878|NCT00098306|40008397|FG003|Double Blind|Lack of Efficacy|0|||
16129104|NCT02146326|38958849|FG001|Overall Study|Separated from mental health center|33|||
16129105|NCT02146326|38958850|FG002|Overall Study|Separated from mental health center|0|||
16129106|NCT02146326|38958851|FG003|Overall Study|Separated from mental health center|0|||
16129107|NCT02146326|38958848|FG000|Overall Study|Incarcerated|0|||
16129108|NCT02146326|38958849|FG001|Overall Study|Incarcerated|0|||
16129109|NCT02146326|38958850|FG002|Overall Study|Incarcerated|3|||
16129110|NCT02146326|38958851|FG003|Overall Study|Incarcerated|8|||
16129111|NCT02146326|38958848|FG000|Overall Study|Death|0|||
16129112|NCT02146326|38958849|FG001|Overall Study|Death|0|||
16129113|NCT02146326|38958850|FG002|Overall Study|Death|4|||
16129114|NCT02146326|38958851|FG003|Overall Study|Death|4|||
16129115|NCT02146326|38958848|FG000|Overall Study|Unable to complete interview|0|||
16129116|NCT02146326|38958849|FG001|Overall Study|Unable to complete interview|0|||
16129117|NCT02146326|38958850|FG002|Overall Study|Unable to complete interview|10|||
16129118|NCT02146326|38958851|FG003|Overall Study|Unable to complete interview|6|||
16129119|NCT00979134|38958852|FG000|Overall Study|Disease progression|18|||
16129120|NCT00979134|38958853|FG001|Overall Study|Disease progression|2|||
16129121|NCT00979134|38958854|FG002|Overall Study|Disease progression|5|||
16129122|NCT00979134|38958852|FG000|Overall Study|Adverse Event|0|||
16129123|NCT00979134|38958853|FG001|Overall Study|Adverse Event|0|||
16129124|NCT00979134|38958854|FG002|Overall Study|Adverse Event|2|||
16129125|NCT00979134|38958852|FG000|Overall Study|Withdrawal by Subject|1|||
16129126|NCT00979134|38958853|FG001|Overall Study|Withdrawal by Subject|1|||
16129127|NCT00979134|38958854|FG002|Overall Study|Withdrawal by Subject|2|||
16129128|NCT00979134|38958852|FG000|Overall Study|Lost to Follow-up|2|||
16129129|NCT00979134|38958853|FG001|Overall Study|Lost to Follow-up|2|||
16129130|NCT00979134|38958854|FG002|Overall Study|Lost to Follow-up|0|||
16129131|NCT00979134|38958852|FG000|Overall Study|Death|4|||
16129132|NCT00979134|38958853|FG001|Overall Study|Death|0|||
16129133|NCT00979134|38958854|FG002|Overall Study|Death|26|||
16129134|NCT00979134|38958852|FG000|Overall Study|Other|8|||
16129135|NCT00979134|38958853|FG001|Overall Study|Other|1|||
16129136|NCT00979134|38958854|FG002|Overall Study|Other|5|||
16129137|NCT01590082|38958857|FG000|Overall Study|Withdrawal by Subject|1|||
16129138|NCT01590082|38958858|FG001|Overall Study|Withdrawal by Subject|0|||
16129139|NCT01590082|38958857|FG000|Overall Study|Ineligible|1|||
16129140|NCT01590082|38958858|FG001|Overall Study|Ineligible|0|||
16129141|NCT00192647|38958861|FG000|Overall Study|Death|1|||
16416879|NCT00098306|40008398|FG004|Double Blind|Lack of Efficacy|0|||
16129142|NCT00192647|38958862|FG001|Overall Study|Death|1|||
16416880|NCT00098306|40008399|FG005|Double Blind|Lack of Efficacy|0|||
16416881|NCT00098306|40008400|FG006|Double Blind|Lack of Efficacy|0|||
16129143|NCT00192647|38958861|FG000|Overall Study|Adverse Event|35|||
16129144|NCT00192647|38958862|FG001|Overall Study|Adverse Event|29|||
16129145|NCT00192647|38958861|FG000|Overall Study|Laboratory Test Abnormality|4|||
16129146|NCT00192647|38958862|FG001|Overall Study|Laboratory Test Abnormality|2|||
16129147|NCT00192647|38958861|FG000|Overall Study|Insufficient Therapeutic Response|53|||
16129148|NCT00192647|38958862|FG001|Overall Study|Insufficient Therapeutic Response|83|||
16129149|NCT00192647|38958861|FG000|Overall Study|Entry Criteria Violation|6|||
16129150|NCT00192647|38958862|FG001|Overall Study|Entry Criteria Violation|6|||
16129151|NCT00192647|38958861|FG000|Overall Study|Protocol Violation|3|||
16416882|NCT00098306|40008394|FG000|Double Blind|Death|1|||
16416883|NCT00098306|40008395|FG001|Double Blind|Death|4|||
16129152|NCT00192647|38958862|FG001|Overall Study|Protocol Violation|1|||
16129153|NCT00192647|38958861|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
16129154|NCT00192647|38958862|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
16129155|NCT00192647|38958861|FG000|Overall Study|Failure to Return|11|||
16129156|NCT00192647|38958862|FG001|Overall Study|Failure to Return|13|||
16129157|NCT00192647|38958861|FG000|Overall Study|Other/Administrative|5|||
16129158|NCT00192647|38958862|FG001|Overall Study|Other/Administrative|3|||
16129159|NCT00545051|38958863|FG000|Overall Study|Adverse Event|7|||
16129160|NCT00545051|38958864|FG001|Overall Study|Adverse Event|3|||
16129161|NCT00545051|38958863|FG000|Overall Study|Death|1|||
16129162|NCT00545051|38958864|FG001|Overall Study|Death|0|||
16129163|NCT00545051|38958863|FG000|Overall Study|Violation of inclusion/exclusion|0|||
16129164|NCT00545051|38958864|FG001|Overall Study|Violation of inclusion/exclusion|2|||
16129165|NCT00545051|38958863|FG000|Overall Study|Protocol Violation|1|||
16129166|NCT00545051|38958864|FG001|Overall Study|Protocol Violation|0|||
16129167|NCT00545051|38958863|FG000|Overall Study|Withdrawal by Subject|0|||
16129168|NCT00545051|38958864|FG001|Overall Study|Withdrawal by Subject|1|||
16129169|NCT00545051|38958863|FG000|Overall Study|Administrative reasons|0|||
16129170|NCT00545051|38958864|FG001|Overall Study|Administrative reasons|1|||
16129171|NCT03981861|38958867|FG000|Overall Study|Withdrawal by Subject|3|||
16129172|NCT02414932|38958871|FG000|Overall Study|Withdrawal by Subject|2|||
16129173|NCT02414932|38958872|FG001|Overall Study|Withdrawal by Subject|3|||
16129174|NCT02414932|38958871|FG000|Overall Study|Adverse Event|1|||
16129175|NCT02414932|38958872|FG001|Overall Study|Adverse Event|0|||
16129176|NCT01880528|38958873|FG000|Overall Study|Other|1|||
16352269|NCT01919164|39776599|FG003|Overall Study|Other Un-specified|7|||
16129177|NCT01880528|38958874|FG001|Overall Study|Other|1|||
16129178|NCT04493502|38958875|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
16129179|NCT04493502|38958876|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
16129180|NCT04493502|38958875|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
16129181|NCT04493502|38958876|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
16352270|NCT01919164|39776600|FG004|Overall Study|Other Un-specified|15|||
16352271|NCT03586050|39776610|FG000|Overall Study|Death|3|||
16352272|NCT03586050|39776610|FG000|Overall Study|Withdrawal by Subject|2|||
16352273|NCT00141518|39776611|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
16352274|NCT00141518|39776612|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
16352275|NCT00141518|39776613|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
16352276|NCT00141518|39776611|FG000|Overall Study|Adverse Event|7|||
16352277|NCT00141518|39776612|FG001|Overall Study|Adverse Event|5|||
16352278|NCT00141518|39776613|FG002|Overall Study|Adverse Event|2|||
16352279|NCT00141518|39776611|FG000|Overall Study|Withdrawal by Subject|2|||
16352280|NCT00141518|39776612|FG001|Overall Study|Withdrawal by Subject|0|||
16352281|NCT00141518|39776613|FG002|Overall Study|Withdrawal by Subject|2|||
16352282|NCT00141518|39776611|FG000|Overall Study|Protocol Violation|1|||
16352283|NCT00141518|39776612|FG001|Overall Study|Protocol Violation|1|||
16352284|NCT00141518|39776613|FG002|Overall Study|Protocol Violation|2|||
16352285|NCT00141518|39776611|FG000|Overall Study|Lack of Efficacy|5|||
16352286|NCT00141518|39776612|FG001|Overall Study|Lack of Efficacy|0|||
16352287|NCT00141518|39776613|FG002|Overall Study|Lack of Efficacy|0|||
16352288|NCT00964028|39776616|FG000|Overall Study|Withdrawal by Subject|0|||
16352289|NCT00964028|39776617|FG001|Overall Study|Withdrawal by Subject|1|||
16352290|NCT01839916|39776618|FG000|Overall Study|Death|9|||
16352291|NCT01839916|39776618|FG000|Overall Study|Physician Decision|17|||
16352292|NCT01839916|39776618|FG000|Overall Study|Relapse|12|||
16352293|NCT01839916|39776618|FG000|Overall Study|GVHD|2|||
16352294|NCT01839916|39776618|FG000|Overall Study|Graft Failure|1|||
16352295|NCT00297648|39776623|FG000|Overall Study|Adverse Event|13|||
16352296|NCT00297648|39776623|FG000|Overall Study|Lack of Efficacy|18|||
16352297|NCT00297648|39776623|FG000|Overall Study|Lost to Follow-up|1|||
16352298|NCT00297648|39776623|FG000|Overall Study|Withdrawal by Subject|3|||
16352299|NCT00297648|39776623|FG000|Overall Study|Other: Incompliance|1|||
16352300|NCT03428100|39776624|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
16352301|NCT03428100|39776625|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352302|NCT03428100|39776626|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
16352303|NCT03428100|39776627|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
16352304|NCT03428100|39776628|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352305|NCT03428100|39776629|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352306|NCT03428100|39776630|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352307|NCT03428100|39776631|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352308|NCT03428100|39776632|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352309|NCT03428100|39776633|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352310|NCT03428100|39776634|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352311|NCT03428100|39776635|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352312|NCT03428100|39776636|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16129182|NCT04493502|38958875|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
16129183|NCT04493502|38958876|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
16129184|NCT04493502|38958875|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
16129185|NCT04493502|38958876|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
16129186|NCT04493502|38958875|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
16129187|NCT04493502|38958876|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
16129188|NCT04493502|38958875|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
16129189|NCT04493502|38958876|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
16129190|NCT04493502|38958875|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
16129191|NCT04493502|38958876|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
16129192|NCT04493502|38958875|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
16352313|NCT03428100|39776637|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352314|NCT03428100|39776638|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16559911|NCT00770211|40517402|FG001|Overall Study|Withdrawal by Subject|2|||
16559912|NCT00811187|40517403|FG000|Overall Study|Unable to place device / procedure abort|3|||
16559913|NCT00811187|40517404|FG001|Overall Study|Unable to place device / procedure abort|3|||
16559914|NCT01982760|40517405|FG000|Overall Study|Physician Decision|1|||
16559915|NCT01982760|40517406|FG001|Overall Study|Physician Decision|0|||
16559916|NCT03704298|40517407|FG000|Overall Study|Death|3|||
16559917|NCT03704298|40517408|FG001|Overall Study|Death|1|||
16559918|NCT03704298|40517409|FG002|Overall Study|Death|1|||
16559919|NCT03704298|40517410|FG003|Overall Study|Death|0|||
16559920|NCT03704298|40517407|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
16559921|NCT03704298|40517408|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
16559922|NCT03704298|40517409|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
16559923|NCT03704298|40517410|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
16559924|NCT03704298|40517407|FG000|Overall Study|Withdrawal by Subject|1|||
16559925|NCT03704298|40517408|FG001|Overall Study|Withdrawal by Subject|0|||
16559926|NCT03704298|40517409|FG002|Overall Study|Withdrawal by Subject|0|||
16559927|NCT03704298|40517410|FG003|Overall Study|Withdrawal by Subject|0|||
16559928|NCT03704298|40517407|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
16559929|NCT03704298|40517408|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
16559930|NCT03704298|40517409|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
16559931|NCT03704298|40517410|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
16559932|NCT01683994|40517411|FG000|Overall Study|Withdrawal by Subject|1|||
16559933|NCT01683994|40517412|FG001|Overall Study|Withdrawal by Subject|0|||
16559934|NCT01683994|40517413|FG002|Overall Study|Withdrawal by Subject|0|||
16559935|NCT01683994|40517414|FG003|Overall Study|Withdrawal by Subject|1|||
16559936|NCT01683994|40517415|FG004|Overall Study|Withdrawal by Subject|0|||
16559937|NCT01683994|40517411|FG000|Overall Study|Intercurrent illness|0|||
16559938|NCT01683994|40517412|FG001|Overall Study|Intercurrent illness|0|||
16559939|NCT01683994|40517413|FG002|Overall Study|Intercurrent illness|0|||
16559940|NCT01683994|40517414|FG003|Overall Study|Intercurrent illness|2|||
16559941|NCT01683994|40517415|FG004|Overall Study|Intercurrent illness|1|||
16559942|NCT03220737|40517416|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
16559943|NCT03220737|40517417|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
16559944|NCT03220737|40517418|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
16559945|NCT03220737|40517419|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
16559946|NCT03220737|40517420|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
16559947|NCT03220737|40517421|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
16559948|NCT03220737|40517422|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
16559949|NCT03220737|40517416|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
16559950|NCT03220737|40517417|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
16559951|NCT03220737|40517418|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
16559952|NCT03220737|40517419|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
16559953|NCT03220737|40517420|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
16559954|NCT03220737|40517421|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
16559955|NCT03220737|40517422|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
16129193|NCT04493502|38958876|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
16129194|NCT04493502|38958875|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
16559956|NCT03220737|40517416|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
16559957|NCT03220737|40517417|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
16559958|NCT03220737|40517418|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
16559959|NCT03220737|40517419|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
16559960|NCT03220737|40517420|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
16559961|NCT03220737|40517421|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
16559962|NCT03220737|40517422|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
16559963|NCT03220737|40517416|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
16559964|NCT03220737|40517417|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
16559965|NCT03220737|40517418|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
16559966|NCT03220737|40517419|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
16559967|NCT03220737|40517420|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
16559968|NCT03220737|40517421|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
16559969|NCT03220737|40517422|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
16559970|NCT03220737|40517416|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
16559971|NCT03220737|40517417|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
16559972|NCT03220737|40517418|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
16559973|NCT03220737|40517419|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
16559974|NCT03220737|40517420|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
16559975|NCT03220737|40517421|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
16559976|NCT03220737|40517422|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
16559977|NCT03220737|40517416|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
16559978|NCT03220737|40517417|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
16559979|NCT03220737|40517418|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
16559980|NCT03220737|40517419|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
16559981|NCT03220737|40517420|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
16559982|NCT03220737|40517421|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
16559983|NCT03220737|40517422|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
16559984|NCT03220737|40517416|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
16559985|NCT03220737|40517417|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
16559986|NCT03220737|40517418|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
16559987|NCT03220737|40517419|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
16559988|NCT03220737|40517420|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
16559989|NCT03220737|40517421|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
16559990|NCT03220737|40517422|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
16559991|NCT03220737|40517416|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
16559992|NCT03220737|40517417|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
16559993|NCT03220737|40517418|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
16559994|NCT03220737|40517419|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
16559995|NCT03220737|40517420|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
16559996|NCT03220737|40517421|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
16559997|NCT03220737|40517422|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
16559998|NCT00593554|40517423|FG000|Overall Study|Death|1|||
16559999|NCT00593554|40517424|FG001|Overall Study|Death|2|||
16560000|NCT00593554|40517423|FG000|Overall Study|Physician Decision|0|||
16560001|NCT00593554|40517424|FG001|Overall Study|Physician Decision|1|||
16560002|NCT00593554|40517423|FG000|Overall Study|Withdrawal by Subject|1|||
16560003|NCT00593554|40517424|FG001|Overall Study|Withdrawal by Subject|0|||
16560004|NCT00593554|40517423|FG000|Overall Study|Disease Progression|1|||
16560005|NCT00593554|40517424|FG001|Overall Study|Disease Progression|2|||
16560006|NCT00121199|40517428|FG000|Overall Study|Adverse Event|11|||
16560007|NCT00121199|40517428|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
16560008|NCT00121199|40517428|FG000|Overall Study|Progression/Relapse|1|||
16416884|NCT00098306|40008396|FG002|Double Blind|Death|1|||
16416885|NCT00098306|40008397|FG003|Double Blind|Death|0|||
16416886|NCT00098306|40008398|FG004|Double Blind|Death|0|||
16416887|NCT00098306|40008399|FG005|Double Blind|Death|0|||
16416888|NCT00098306|40008400|FG006|Double Blind|Death|0|||
16416889|NCT00098306|40008394|FG000|Double Blind|Participant defaulted|19|||
16416890|NCT00098306|40008395|FG001|Double Blind|Participant defaulted|18|||
16416891|NCT00098306|40008396|FG002|Double Blind|Participant defaulted|11|||
16416892|NCT00098306|40008397|FG003|Double Blind|Participant defaulted|0|||
16416893|NCT00098306|40008398|FG004|Double Blind|Participant defaulted|0|||
16416894|NCT00098306|40008399|FG005|Double Blind|Participant defaulted|0|||
16560009|NCT00121199|40517428|FG000|Overall Study|Death|3|||
16560010|NCT00121199|40517428|FG000|Overall Study|Other - Not Protocol Specified|3|||
16560011|NCT00121199|40517428|FG000|Overall Study|Ineligible|9|||
16560012|NCT01866917|40517429|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
16416895|NCT00098306|40008400|FG006|Double Blind|Participant defaulted|0|||
16416896|NCT00098306|40008394|FG000|Double Blind|Un-specified|7|||
16416897|NCT00098306|40008395|FG001|Double Blind|Un-specified|3|||
16560013|NCT01866917|40517430|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
16560014|NCT00972179|40517434|FG000|Overall Study|Noncompliance|1|||
16560015|NCT00972179|40517435|FG001|Overall Study|Noncompliance|0|||
16245937|NCT00415532|39385338|FG001|Treatment Period|Noncompliance|1|||
16560016|NCT00972179|40517436|FG002|Overall Study|Noncompliance|0|||
16560017|NCT00972179|40517437|FG003|Overall Study|Noncompliance|0|||
16560018|NCT00972179|40517438|FG004|Overall Study|Noncompliance|1|||
16560019|NCT00972179|40517439|FG005|Overall Study|Noncompliance|0|||
16560020|NCT00972179|40517440|FG006|Overall Study|Noncompliance|1|||
16560021|NCT00972179|40517434|FG000|Overall Study|Withdrawal by Subject|0|||
16560022|NCT00972179|40517435|FG001|Overall Study|Withdrawal by Subject|3|||
16560023|NCT00972179|40517436|FG002|Overall Study|Withdrawal by Subject|0|||
16245938|NCT00415532|39385337|FG000|Treatment Period|Requirement for alternative therapy|1|||
16245939|NCT00415532|39385338|FG001|Treatment Period|Requirement for alternative therapy|0|||
16245940|NCT00415532|39385337|FG000|Safety Follow Up Period|Adverse Event|1|||
16245941|NCT00415532|39385338|FG001|Safety Follow Up Period|Adverse Event|3|||
16352315|NCT03428100|39776639|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16560024|NCT00972179|40517437|FG003|Overall Study|Withdrawal by Subject|1|||
16560025|NCT00972179|40517438|FG004|Overall Study|Withdrawal by Subject|0|||
16560026|NCT00972179|40517439|FG005|Overall Study|Withdrawal by Subject|0|||
16560027|NCT00972179|40517440|FG006|Overall Study|Withdrawal by Subject|2|||
16560028|NCT00972179|40517434|FG000|Overall Study|Administrative Decision|0|||
16560029|NCT00972179|40517435|FG001|Overall Study|Administrative Decision|0|||
16560030|NCT00972179|40517436|FG002|Overall Study|Administrative Decision|0|||
16560031|NCT00972179|40517437|FG003|Overall Study|Administrative Decision|0|||
16560032|NCT00972179|40517438|FG004|Overall Study|Administrative Decision|1|||
16560033|NCT00972179|40517439|FG005|Overall Study|Administrative Decision|0|||
16560034|NCT00972179|40517440|FG006|Overall Study|Administrative Decision|0|||
16560035|NCT00972179|40517434|FG000|Overall Study|Lost to Follow-up|0|||
16560036|NCT00972179|40517435|FG001|Overall Study|Lost to Follow-up|0|||
16560037|NCT00972179|40517436|FG002|Overall Study|Lost to Follow-up|1|||
16560038|NCT00972179|40517437|FG003|Overall Study|Lost to Follow-up|0|||
16560039|NCT00972179|40517438|FG004|Overall Study|Lost to Follow-up|0|||
16560040|NCT00972179|40517439|FG005|Overall Study|Lost to Follow-up|3|||
16560041|NCT00972179|40517440|FG006|Overall Study|Lost to Follow-up|1|||
16560042|NCT01400893|40517441|FG000|Overall Study|Death|27|||
16560043|NCT01400893|40517442|FG001|Overall Study|Death|21|||
16560044|NCT01400893|40517441|FG000|Overall Study|Lost to Follow-up|0|||
16560045|NCT01400893|40517442|FG001|Overall Study|Lost to Follow-up|6|||
16560046|NCT00901485|40517443|FG000|Overall Study|Lack of Efficacy|0|||
16352316|NCT03428100|39776640|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352317|NCT03428100|39776641|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352318|NCT03428100|39776642|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
16352319|NCT03428100|39776624|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
16352320|NCT03428100|39776625|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
16352321|NCT03428100|39776626|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
16352322|NCT03428100|39776627|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
16352323|NCT03428100|39776628|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352324|NCT03428100|39776629|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352325|NCT03428100|39776630|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352326|NCT03428100|39776631|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16416898|NCT00098306|40008396|FG002|Double Blind|Un-specified|11|||
16416899|NCT00098306|40008397|FG003|Double Blind|Un-specified|0|||
16416900|NCT00098306|40008398|FG004|Double Blind|Un-specified|0|||
16416901|NCT00098306|40008399|FG005|Double Blind|Un-specified|0|||
16416902|NCT00098306|40008400|FG006|Double Blind|Un-specified|0|||
16560047|NCT00901485|40517444|FG001|Overall Study|Lack of Efficacy|2|||
16560048|NCT00901485|40517443|FG000|Overall Study|Withdrawal by Subject|1|||
16560049|NCT00901485|40517444|FG001|Overall Study|Withdrawal by Subject|2|||
16560050|NCT00965484|40517445|FG000|Overall Study|Protocol Violation|1|||
16560051|NCT00965484|40517445|FG000|Overall Study|Withdrawal by Subject|1|||
16560052|NCT00322868|40517451|FG000|Overall Study|disease progression|1|||
16560053|NCT03018106|40517453|FG000|Overall Study|Lost to Follow-up|0|||
16560054|NCT03018106|40517454|FG001|Overall Study|Lost to Follow-up|1|||
16560055|NCT00333138|40517455|FG000|Core Study (6 Months)|Adverse Event|4|||
16560056|NCT00333138|40517456|FG001|Core Study (6 Months)|Adverse Event|5|||
16560057|NCT00333138|40517457|FG002|Core Study (6 Months)|Adverse Event|8|||
16560058|NCT00333138|40517455|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
16560059|NCT00333138|40517456|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
16560060|NCT00333138|40517457|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
16560061|NCT00333138|40517455|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
16560062|NCT00333138|40517456|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
16560063|NCT00333138|40517457|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
16560064|NCT00333138|40517455|FG000|Core Study (6 Months)|Protocol Violation|1|||
16560065|NCT00333138|40517456|FG001|Core Study (6 Months)|Protocol Violation|0|||
16560066|NCT00333138|40517457|FG002|Core Study (6 Months)|Protocol Violation|1|||
16560067|NCT00333138|40517455|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
16560068|NCT00333138|40517456|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
16560069|NCT00333138|40517457|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
16560070|NCT00333138|40517455|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
16560071|NCT00333138|40517456|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
16560072|NCT00333138|40517457|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
16560073|NCT00333138|40517455|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
16560074|NCT00333138|40517456|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
16560075|NCT00333138|40517457|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
16560076|NCT00333138|40517455|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
16560077|NCT00333138|40517456|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
16560078|NCT00333138|40517457|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
16560079|NCT00333138|40517455|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
16560080|NCT00333138|40517456|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
16560081|NCT00333138|40517457|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
16560082|NCT00333138|40517455|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
16560083|NCT00333138|40517456|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
16560084|NCT00333138|40517457|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
16560085|NCT00333138|40517455|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
16560086|NCT00333138|40517456|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
16560087|NCT00333138|40517457|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
16560088|NCT00333138|40517455|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
16560089|NCT00333138|40517456|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
16560090|NCT00333138|40517457|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
16560091|NCT00333138|40517455|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
16560092|NCT00333138|40517456|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
16560093|NCT00333138|40517457|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
16560094|NCT00333138|40517455|FG000|Extension Study (Month6 to End of Study)|Death|0|||
16560095|NCT00333138|40517456|FG001|Extension Study (Month6 to End of Study)|Death|1|||
16560096|NCT00333138|40517457|FG002|Extension Study (Month6 to End of Study)|Death|0|||
16560097|NCT02025205|40517463|FG000|Overall Study|Withdrawal by Subject|1|||
16560098|NCT02025205|40517464|FG001|Overall Study|Withdrawal by Subject|1|||
16560099|NCT02025205|40517463|FG000|Overall Study|Protocol Violation|2|||
16416903|NCT00098306|40008394|FG000|Open Label|Lack of Efficacy|0|||
16416904|NCT00098306|40008395|FG001|Open Label|Lack of Efficacy|0|||
16560100|NCT02025205|40517464|FG001|Overall Study|Protocol Violation|1|||
16560101|NCT02025205|40517463|FG000|Overall Study|Death|0|||
16560102|NCT02025205|40517464|FG001|Overall Study|Death|1|||
16560103|NCT02819479|40517465|FG000|Overall Study|Adverse Event|2|||
16560104|NCT01575860|40517468|FG000|Overall Study|Withdrawal by Subject|1|||
16560105|NCT01575860|40517468|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
16560106|NCT00590980|40517469|FG000|Overall Study|Did not meet all inclusion criteria|10|||
16560107|NCT02696785|40517470|FG000|Blinded Treatment Period|Adverse Event|0|||
16560108|NCT02696785|40517471|FG001|Blinded Treatment Period|Adverse Event|1|||
16560109|NCT02696785|40517472|FG002|Blinded Treatment Period|Adverse Event|3|||
16560110|NCT02696785|40517473|FG003|Blinded Treatment Period|Adverse Event|0|||
16560111|NCT02696785|40517470|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
16560112|NCT02696785|40517471|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
16560113|NCT02696785|40517472|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
16560114|NCT02696785|40517473|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
16560115|NCT02696785|40517470|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
16560116|NCT02696785|40517471|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
16560117|NCT02696785|40517472|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
16560118|NCT02696785|40517473|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
16560119|NCT02696785|40517470|FG000|Blinded Treatment Period|Screen Failure|1|||
16560120|NCT02696785|40517471|FG001|Blinded Treatment Period|Screen Failure|0|||
16560121|NCT02696785|40517472|FG002|Blinded Treatment Period|Screen Failure|0|||
16560122|NCT02696785|40517473|FG003|Blinded Treatment Period|Screen Failure|0|||
16560123|NCT02696785|40517470|FG000|Washout Period|Withdrawal by Subject|0|||
16560124|NCT02696785|40517471|FG001|Washout Period|Withdrawal by Subject|1|||
16560125|NCT02696785|40517472|FG002|Washout Period|Withdrawal by Subject|0|||
16560126|NCT02696785|40517473|FG003|Washout Period|Withdrawal by Subject|0|||
16560127|NCT02696785|40517470|FG000|Washout Period|Lack of Efficacy|0|||
16560128|NCT02696785|40517471|FG001|Washout Period|Lack of Efficacy|1|||
16560129|NCT02696785|40517472|FG002|Washout Period|Lack of Efficacy|0|||
16560130|NCT02696785|40517473|FG003|Washout Period|Lack of Efficacy|0|||
16560131|NCT02696785|40517470|FG000|Extended Treatment Period|Adverse Event|2|||
16560132|NCT02696785|40517471|FG001|Extended Treatment Period|Adverse Event|3|||
16560133|NCT02696785|40517472|FG002|Extended Treatment Period|Adverse Event|2|||
16560134|NCT02696785|40517473|FG003|Extended Treatment Period|Adverse Event|1|||
16560135|NCT02696785|40517470|FG000|Extended Treatment Period|Lack of Efficacy|0|||
16560136|NCT02696785|40517471|FG001|Extended Treatment Period|Lack of Efficacy|1|||
16560137|NCT02696785|40517472|FG002|Extended Treatment Period|Lack of Efficacy|0|||
16560138|NCT02696785|40517473|FG003|Extended Treatment Period|Lack of Efficacy|0|||
16560139|NCT02696785|40517470|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
16560140|NCT02696785|40517471|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
16560141|NCT02696785|40517472|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
16560142|NCT02696785|40517473|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
16560143|NCT02696785|40517470|FG000|Follow-up Period|Adverse Event|0|||
16560144|NCT02696785|40517471|FG001|Follow-up Period|Adverse Event|0|||
16560145|NCT02696785|40517472|FG002|Follow-up Period|Adverse Event|8|||
16560146|NCT02696785|40517473|FG003|Follow-up Period|Adverse Event|2|||
16560147|NCT02696785|40517470|FG000|Follow-up Period|Lost to Follow-up|0|||
16560148|NCT02696785|40517471|FG001|Follow-up Period|Lost to Follow-up|0|||
16560149|NCT02696785|40517472|FG002|Follow-up Period|Lost to Follow-up|0|||
16560150|NCT02696785|40517473|FG003|Follow-up Period|Lost to Follow-up|1|||
16560151|NCT02696785|40517470|FG000|Follow-up Period|Lack of Efficacy|0|||
16560152|NCT02696785|40517471|FG001|Follow-up Period|Lack of Efficacy|0|||
16560153|NCT02696785|40517472|FG002|Follow-up Period|Lack of Efficacy|0|||
16560154|NCT02696785|40517473|FG003|Follow-up Period|Lack of Efficacy|1|||
16560155|NCT02696785|40517470|FG000|Follow-up Period|Withdrawal by Subject|1|||
16560156|NCT02696785|40517471|FG001|Follow-up Period|Withdrawal by Subject|0|||
16560157|NCT02696785|40517472|FG002|Follow-up Period|Withdrawal by Subject|5|||
16560158|NCT02696785|40517473|FG003|Follow-up Period|Withdrawal by Subject|4|||
16560159|NCT02276547|40517474|FG000|Overall Study|Death|2|||
16560160|NCT02276547|40517474|FG000|Overall Study|Explant|2|||
16560161|NCT01094743|40517477|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
16560162|NCT02692235|40517478|FG000|Overall Study|Withdrawal by Subject|2|||
16560163|NCT02692235|40517479|FG001|Overall Study|Withdrawal by Subject|1|||
16560164|NCT02692235|40517478|FG000|Overall Study|Adverse Event|1|||
16560165|NCT02692235|40517479|FG001|Overall Study|Adverse Event|2|||
16560166|NCT02013687|40517487|FG000|Overall Study|Lost to Follow-up|0|||
16245942|NCT00415532|39385337|FG000|Safety Follow Up Period|Death|3|||
16560167|NCT02013687|40517488|FG001|Overall Study|Lost to Follow-up|0|||
16560168|NCT02013687|40517489|FG002|Overall Study|Lost to Follow-up|1|||
16560169|NCT02013687|40517490|FG003|Overall Study|Lost to Follow-up|0|||
16560170|NCT02013687|40517487|FG000|Overall Study|Protocol Violation|0|||
16560171|NCT02013687|40517488|FG001|Overall Study|Protocol Violation|0|||
16560172|NCT02013687|40517489|FG002|Overall Study|Protocol Violation|0|||
16560173|NCT02013687|40517490|FG003|Overall Study|Protocol Violation|1|||
16560174|NCT02013687|40517487|FG000|Overall Study|Withdrawal by Subject|0|||
16560175|NCT02013687|40517488|FG001|Overall Study|Withdrawal by Subject|0|||
16560176|NCT02013687|40517489|FG002|Overall Study|Withdrawal by Subject|0|||
16560177|NCT02013687|40517490|FG003|Overall Study|Withdrawal by Subject|1|||
16560178|NCT02013687|40517487|FG000|Overall Study|Missed visits due to patient travel|0|||
16560179|NCT02013687|40517488|FG001|Overall Study|Missed visits due to patient travel|0|||
16416905|NCT00098306|40008396|FG002|Open Label|Lack of Efficacy|0|||
16416906|NCT00098306|40008397|FG003|Open Label|Lack of Efficacy|13|||
16416907|NCT00098306|40008398|FG004|Open Label|Lack of Efficacy|0|||
16416908|NCT00098306|40008399|FG005|Open Label|Lack of Efficacy|0|||
16416909|NCT00098306|40008400|FG006|Open Label|Lack of Efficacy|0|||
16416910|NCT00098306|40008394|FG000|Open Label|Adverse Event|0|||
16416911|NCT00098306|40008395|FG001|Open Label|Adverse Event|0|||
16416912|NCT00098306|40008396|FG002|Open Label|Adverse Event|0|||
16416913|NCT00098306|40008397|FG003|Open Label|Adverse Event|2|||
16416914|NCT00098306|40008398|FG004|Open Label|Adverse Event|0|||
16416915|NCT00098306|40008399|FG005|Open Label|Adverse Event|0|||
16416916|NCT00098306|40008400|FG006|Open Label|Adverse Event|0|||
16416917|NCT00098306|40008394|FG000|Open Label|Death|0|||
16416918|NCT00098306|40008395|FG001|Open Label|Death|0|||
16416919|NCT00098306|40008396|FG002|Open Label|Death|0|||
16416920|NCT00098306|40008397|FG003|Open Label|Death|4|||
16416921|NCT00098306|40008398|FG004|Open Label|Death|0|||
16416922|NCT00098306|40008399|FG005|Open Label|Death|0|||
16416923|NCT00098306|40008400|FG006|Open Label|Death|0|||
16416924|NCT00098306|40008394|FG000|Open Label|Participant defaulted|0|||
16416925|NCT00098306|40008395|FG001|Open Label|Participant defaulted|0|||
16416926|NCT00098306|40008396|FG002|Open Label|Participant defaulted|0|||
16416927|NCT00098306|40008397|FG003|Open Label|Participant defaulted|24|||
16416928|NCT00098306|40008398|FG004|Open Label|Participant defaulted|0|||
16416929|NCT00098306|40008399|FG005|Open Label|Participant defaulted|0|||
16416930|NCT00098306|40008400|FG006|Open Label|Participant defaulted|0|||
16416931|NCT00098306|40008394|FG000|Open Label|Un-specified|0|||
16416932|NCT00098306|40008395|FG001|Open Label|Un-specified|0|||
16416933|NCT00098306|40008396|FG002|Open Label|Un-specified|0|||
16416934|NCT00098306|40008397|FG003|Open Label|Un-specified|15|||
16416935|NCT00098306|40008398|FG004|Open Label|Un-specified|0|||
16416936|NCT00098306|40008399|FG005|Open Label|Un-specified|0|||
16416937|NCT00098306|40008400|FG006|Open Label|Un-specified|0|||
16416938|NCT00098306|40008394|FG000|Open Label|Ongoing at cut-off date|0|||
16416939|NCT00098306|40008395|FG001|Open Label|Ongoing at cut-off date|0|||
16416940|NCT00098306|40008396|FG002|Open Label|Ongoing at cut-off date|0|||
16416941|NCT00098306|40008397|FG003|Open Label|Ongoing at cut-off date|269|||
16416942|NCT00098306|40008398|FG004|Open Label|Ongoing at cut-off date|62|||
16416943|NCT00098306|40008399|FG005|Open Label|Ongoing at cut-off date|0|||
16416944|NCT00098306|40008400|FG006|Open Label|Ongoing at cut-off date|0|||
16416945|NCT00098306|40008394|FG000|Observational Phase|Death|0|||
16416946|NCT00098306|40008395|FG001|Observational Phase|Death|0|||
16416947|NCT00098306|40008396|FG002|Observational Phase|Death|0|||
16416948|NCT00098306|40008397|FG003|Observational Phase|Death|0|||
16416949|NCT00098306|40008398|FG004|Observational Phase|Death|0|||
16416950|NCT00098306|40008399|FG005|Observational Phase|Death|5|||
16416951|NCT00098306|40008400|FG006|Observational Phase|Death|4|||
16416952|NCT00098306|40008394|FG000|Observational Phase|Participant defaulted|0|||
16416953|NCT00098306|40008395|FG001|Observational Phase|Participant defaulted|0|||
16416954|NCT00098306|40008396|FG002|Observational Phase|Participant defaulted|0|||
16416955|NCT00098306|40008397|FG003|Observational Phase|Participant defaulted|0|||
16416956|NCT00098306|40008398|FG004|Observational Phase|Participant defaulted|0|||
16416957|NCT00098306|40008399|FG005|Observational Phase|Participant defaulted|34|||
16416958|NCT00098306|40008400|FG006|Observational Phase|Participant defaulted|18|||
16416959|NCT00098306|40008394|FG000|Observational Phase|Un-specified|0|||
16416960|NCT00098306|40008395|FG001|Observational Phase|Un-specified|0|||
16416961|NCT00098306|40008396|FG002|Observational Phase|Un-specified|0|||
16416962|NCT00098306|40008397|FG003|Observational Phase|Un-specified|0|||
16416963|NCT00098306|40008398|FG004|Observational Phase|Un-specified|0|||
16416964|NCT00098306|40008399|FG005|Observational Phase|Un-specified|7|||
16416965|NCT00098306|40008400|FG006|Observational Phase|Un-specified|4|||
16416966|NCT01147900|40008401|FG000|At Year 10|Lost to Follow-up|0|||
16416967|NCT01147900|40008402|FG001|At Year 10|Lost to Follow-up|1|||
16416968|NCT01147900|40008403|FG002|At Year 10|Lost to Follow-up|0|||
16416969|NCT02392403|40008405|FG000|Overall Study|Adverse Event|1|||
16416970|NCT02392403|40008405|FG000|Overall Study|Death|1|||
16416971|NCT02392403|40008405|FG000|Overall Study|Withdrawal by Subject|1|||
16416972|NCT03688100|40008406|FG000|Overall Study|Lost to Follow-up|21|||
16416973|NCT03688100|40008407|FG001|Overall Study|Lost to Follow-up|15|||
16416974|NCT03688100|40008408|FG002|Overall Study|Lost to Follow-up|15|||
16416975|NCT03688100|40008409|FG003|Overall Study|Lost to Follow-up|18|||
16416976|NCT03688100|40008406|FG000|Overall Study|Withdrawal by Subject|19|||
16416977|NCT03688100|40008407|FG001|Overall Study|Withdrawal by Subject|16|||
16416978|NCT03688100|40008408|FG002|Overall Study|Withdrawal by Subject|0|||
16416979|NCT03688100|40008409|FG003|Overall Study|Withdrawal by Subject|0|||
16416980|NCT03688100|40008406|FG000|Overall Study|Death|36|||
16416981|NCT03688100|40008407|FG001|Overall Study|Death|27|||
16416982|NCT03688100|40008408|FG002|Overall Study|Death|0|||
16416983|NCT03688100|40008409|FG003|Overall Study|Death|0|||
16416984|NCT01440881|40008418|FG000|Overall Study|Death|0|||
16416985|NCT01440881|40008419|FG001|Overall Study|Death|1|||
16129195|NCT04493502|38958876|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
16129196|NCT04493502|38958875|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
16129197|NCT04493502|38958876|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
16560180|NCT02013687|40517489|FG002|Overall Study|Missed visits due to patient travel|1|||
16560181|NCT02013687|40517490|FG003|Overall Study|Missed visits due to patient travel|0|||
16560182|NCT04012814|40517491|FG000|Overall Study|Lost to Follow-up|4|||
16560183|NCT04012814|40517491|FG000|Overall Study|Withdrawal by Subject|2|||
16560184|NCT04012814|40517491|FG000|Overall Study|Protocol Violation|1|||
16560185|NCT04012814|40517491|FG000|Overall Study|Adverse Event|1|||
16560186|NCT03023332|40517494|FG000|Overall Study|Withdrawal by Subject|10|||
16560187|NCT03023332|40517495|FG001|Overall Study|Withdrawal by Subject|5|||
16416986|NCT03908476|40008420|FG000|Overall Study|Death|3|||
16416987|NCT03908476|40008421|FG001|Overall Study|Death|0|||
16416988|NCT03908476|40008420|FG000|Overall Study|Lost to Follow-up|3|||
16416989|NCT03908476|40008421|FG001|Overall Study|Lost to Follow-up|1|||
16416990|NCT03908476|40008420|FG000|Overall Study|Withdrawal by Subject|7|||
16416991|NCT03908476|40008421|FG001|Overall Study|Withdrawal by Subject|1|||
16416992|NCT03908476|40008420|FG000|Overall Study|Physician Decision|2|||
16560188|NCT03023332|40517496|FG002|Overall Study|Withdrawal by Subject|4|||
16560189|NCT03023332|40517497|FG003|Overall Study|Withdrawal by Subject|7|||
16560190|NCT03023332|40517494|FG000|Overall Study|Lost to Follow-up|13|||
16560191|NCT03023332|40517495|FG001|Overall Study|Lost to Follow-up|16|||
16560192|NCT03023332|40517496|FG002|Overall Study|Lost to Follow-up|8|||
16560193|NCT03023332|40517497|FG003|Overall Study|Lost to Follow-up|13|||
16560194|NCT03023332|40517494|FG000|Overall Study|Death|1|||
16560195|NCT03023332|40517495|FG001|Overall Study|Death|0|||
16560196|NCT03023332|40517496|FG002|Overall Study|Death|0|||
16560197|NCT03023332|40517497|FG003|Overall Study|Death|0|||
16560198|NCT01349907|40517498|FG000|Overall Study|Adverse Event|37|||
16560199|NCT01349907|40517499|FG001|Overall Study|Adverse Event|11|||
16560200|NCT01349907|40517498|FG000|Overall Study|Treatment failure|13|||
16560201|NCT01349907|40517499|FG001|Overall Study|Treatment failure|4|||
16560202|NCT01349907|40517498|FG000|Overall Study|Lost to Follow-up|25|||
16560203|NCT01349907|40517499|FG001|Overall Study|Lost to Follow-up|6|||
16560204|NCT01349907|40517498|FG000|Overall Study|Withdrawal by Subject|30|||
16560205|NCT01349907|40517499|FG001|Overall Study|Withdrawal by Subject|8|||
16560206|NCT01349907|40517498|FG000|Overall Study|Protocol Violation|33|||
16560207|NCT01349907|40517499|FG001|Overall Study|Protocol Violation|13|||
16560208|NCT01349907|40517498|FG000|Overall Study|Administrative|1|||
16560209|NCT01349907|40517499|FG001|Overall Study|Administrative|1|||
16560210|NCT01880515|40517500|FG000|Overall Study|Lost to Follow-up|3|||
16560211|NCT01880515|40517501|FG001|Overall Study|Lost to Follow-up|2|||
16560212|NCT01880515|40517500|FG000|Overall Study|Disease Progression|5|||
16129198|NCT04493502|38958875|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
16129199|NCT04493502|38958876|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
16129200|NCT04493502|38958875|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
16129201|NCT04493502|38958876|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
16129202|NCT04493502|38958875|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
16129203|NCT04493502|38958876|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
16129204|NCT00470366|38958877|FG000|Overall Study|Adverse Event|3|||
16129205|NCT00470366|38958877|FG000|Overall Study|Poor compliance|1|||
16245943|NCT00415532|39385338|FG001|Safety Follow Up Period|Death|0|||
16416993|NCT03908476|40008421|FG001|Overall Study|Physician Decision|0|||
16416994|NCT03908476|40008420|FG000|Overall Study|System Explanted and not Replaced|4|||
16416995|NCT03908476|40008421|FG001|Overall Study|System Explanted and not Replaced|0|||
16560213|NCT01880515|40517501|FG001|Overall Study|Disease Progression|7|||
16560214|NCT01853254|40517503|FG000|Overall Study|Abnormal Laboratory Test|1|||
16560215|NCT01853254|40517503|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
16245944|NCT00415532|39385337|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
16245945|NCT00415532|39385338|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
16245946|NCT00415532|39385337|FG000|Safety Follow Up Period|Other|1|||
16245947|NCT00415532|39385338|FG001|Safety Follow Up Period|Other|4|||
16245948|NCT00415532|39385337|FG000|Safety Follow Up Period|Ineligibility determined|1|||
16245949|NCT00415532|39385338|FG001|Safety Follow Up Period|Ineligibility determined|1|||
16245950|NCT00415532|39385337|FG000|Safety Follow Up Period|Noncompliance|1|||
16245951|NCT00415532|39385338|FG001|Safety Follow Up Period|Noncompliance|0|||
16245952|NCT00415532|39385337|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
16245953|NCT00415532|39385338|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
16245954|NCT04079842|39385356|FG000|Overall Study|Request of subject|2|||
16245955|NCT04079842|39385356|FG000|Overall Study|Unable to draw Arterial samples|1|||
16245956|NCT01789281|39385357|FG000|Overall Study|Disease progression|15|||
16245957|NCT01789281|39385358|FG001|Overall Study|Disease progression|4|||
16245958|NCT01789281|39385357|FG000|Overall Study|Adverse Event|5|||
16245959|NCT01789281|39385358|FG001|Overall Study|Adverse Event|5|||
16245960|NCT01789281|39385357|FG000|Overall Study|Withdrawal by Subject|1|||
16245961|NCT01789281|39385358|FG001|Overall Study|Withdrawal by Subject|0|||
16245962|NCT01789281|39385357|FG000|Overall Study|Lost to Follow-up|1|||
16245963|NCT01789281|39385358|FG001|Overall Study|Lost to Follow-up|0|||
16352327|NCT03428100|39776632|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352328|NCT03428100|39776633|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16560216|NCT01853254|40517503|FG000|Overall Study|Death|1|||
16560217|NCT01853254|40517503|FG000|Overall Study|Failure to Return|43|||
16560218|NCT01853254|40517503|FG000|Overall Study|Insufficient Therapeutic Response|22|||
16560219|NCT01853254|40517503|FG000|Overall Study|Refusal of Treatment|1|||
16560220|NCT01853254|40517503|FG000|Overall Study|Other Protocol Violation|1|||
16560221|NCT01853254|40517503|FG000|Overall Study|Withdrawal of Consent|16|||
16560222|NCT01853254|40517503|FG000|Overall Study|Administrative/Other|16|||
16560223|NCT00506285|40517508|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
16560224|NCT00506285|40517509|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
16560225|NCT00506285|40517508|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
16560226|NCT00506285|40517509|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
16560227|NCT00506285|40517508|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
16560228|NCT00506285|40517509|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
16560229|NCT00506285|40517508|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
16245964|NCT01789281|39385357|FG000|Overall Study|Administrative problems|0|||
16245965|NCT01789281|39385358|FG001|Overall Study|Administrative problems|1|||
16352329|NCT03428100|39776634|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352330|NCT03428100|39776635|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352331|NCT03428100|39776636|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352332|NCT03428100|39776637|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352333|NCT03428100|39776638|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352334|NCT03428100|39776639|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352335|NCT03428100|39776640|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352336|NCT03428100|39776641|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16416996|NCT03908476|40008420|FG000|Overall Study|Intrathecal Pump|1|||
16416997|NCT03908476|40008421|FG001|Overall Study|Intrathecal Pump|0|||
16416998|NCT03908476|40008420|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
16416999|NCT03908476|40008421|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
16417000|NCT01732913|40008422|FG000|Overall Study|Study Terminated by Sponsor|105|||
16417001|NCT01732913|40008423|FG001|Overall Study|Study Terminated by Sponsor|55|||
16417002|NCT01732913|40008422|FG000|Overall Study|Withdrawal by Subject|27|||
16417003|NCT01732913|40008423|FG001|Overall Study|Withdrawal by Subject|4|||
16417004|NCT01732913|40008422|FG000|Overall Study|Physician Decision|14|||
16417005|NCT01732913|40008423|FG001|Overall Study|Physician Decision|7|||
16417006|NCT01732913|40008422|FG000|Overall Study|Other|7|||
16417007|NCT01732913|40008423|FG001|Overall Study|Other|1|||
16417008|NCT01732913|40008422|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
16417009|NCT01732913|40008423|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
16417010|NCT01972789|40008424|FG000|Overall Study|Adverse Event|11|||
16417011|NCT01972789|40008425|FG001|Overall Study|Adverse Event|4|||
16417012|NCT01972789|40008424|FG000|Overall Study|Subject withdrew consent|14|||
16417013|NCT01972789|40008425|FG001|Overall Study|Subject withdrew consent|12|||
16417014|NCT01972789|40008424|FG000|Overall Study|Lost to Follow-up|4|||
16417015|NCT01972789|40008425|FG001|Overall Study|Lost to Follow-up|7|||
16417016|NCT01972789|40008424|FG000|Overall Study|Death|7|||
16417017|NCT01972789|40008425|FG001|Overall Study|Death|5|||
16417018|NCT01972789|40008424|FG000|Overall Study|Protocol deviation|1|||
16417019|NCT01972789|40008425|FG001|Overall Study|Protocol deviation|0|||
16417020|NCT01972789|40008424|FG000|Overall Study|Physician Decision|3|||
16417021|NCT01972789|40008425|FG001|Overall Study|Physician Decision|2|||
16417022|NCT01504204|40008433|FG000|Overall Study|Lost to Follow-up|1|||
16417023|NCT01504204|40008434|FG001|Overall Study|Lost to Follow-up|1|||
16417024|NCT04311463|40008435|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
16417025|NCT04311463|40008436|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
16417026|NCT04311463|40008435|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
16417027|NCT04311463|40008436|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
16417028|NCT04311463|40008435|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
16417029|NCT04311463|40008436|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
16417030|NCT03480009|40008437|FG000|Overall Study|Lost to Follow-up|4|||
16417031|NCT03480009|40008438|FG001|Overall Study|Lost to Follow-up|5|||
16417032|NCT03480009|40008439|FG002|Overall Study|Lost to Follow-up|4|||
16417033|NCT03480009|40008440|FG003|Overall Study|Lost to Follow-up|0|||
16417034|NCT01939366|40008443|FG000|Overall Study|Adverse Event|8|||
16417035|NCT01939366|40008444|FG001|Overall Study|Adverse Event|17|||
16417036|NCT01939366|40008445|FG002|Overall Study|Adverse Event|30|||
16417037|NCT01939366|40008446|FG003|Overall Study|Adverse Event|8|||
16417038|NCT01939366|40008447|FG004|Overall Study|Adverse Event|5|||
16417039|NCT01939366|40008443|FG000|Overall Study|Lack of Efficacy|2|||
16417040|NCT01939366|40008444|FG001|Overall Study|Lack of Efficacy|1|||
16417041|NCT01939366|40008445|FG002|Overall Study|Lack of Efficacy|1|||
16417042|NCT01939366|40008446|FG003|Overall Study|Lack of Efficacy|1|||
16417043|NCT01939366|40008447|FG004|Overall Study|Lack of Efficacy|3|||
16417044|NCT01939366|40008443|FG000|Overall Study|Lost to Follow-up|1|||
16417045|NCT01939366|40008444|FG001|Overall Study|Lost to Follow-up|1|||
16417046|NCT01939366|40008445|FG002|Overall Study|Lost to Follow-up|0|||
16417047|NCT01939366|40008446|FG003|Overall Study|Lost to Follow-up|0|||
16417048|NCT01939366|40008447|FG004|Overall Study|Lost to Follow-up|0|||
16417049|NCT01939366|40008443|FG000|Overall Study|Withdrawal by Subject|1|||
16417050|NCT01939366|40008444|FG001|Overall Study|Withdrawal by Subject|0|||
16417051|NCT01939366|40008445|FG002|Overall Study|Withdrawal by Subject|2|||
16417052|NCT01939366|40008446|FG003|Overall Study|Withdrawal by Subject|2|||
16417053|NCT01939366|40008447|FG004|Overall Study|Withdrawal by Subject|3|||
16417054|NCT01939366|40008443|FG000|Overall Study|Inclusion criteria not met|0|||
16417055|NCT01939366|40008444|FG001|Overall Study|Inclusion criteria not met|1|||
16417056|NCT01939366|40008445|FG002|Overall Study|Inclusion criteria not met|1|||
16417057|NCT01939366|40008446|FG003|Overall Study|Inclusion criteria not met|0|||
16417058|NCT01939366|40008447|FG004|Overall Study|Inclusion criteria not met|1|||
16417059|NCT01939366|40008443|FG000|Overall Study|Other|0|||
16417060|NCT01939366|40008444|FG001|Overall Study|Other|0|||
16417061|NCT01939366|40008445|FG002|Overall Study|Other|2|||
16417062|NCT01939366|40008446|FG003|Overall Study|Other|2|||
16417063|NCT01939366|40008447|FG004|Overall Study|Other|1|||
16417064|NCT01939366|40008443|FG000|Overall Study|Protocol Violation|0|||
16417065|NCT01939366|40008444|FG001|Overall Study|Protocol Violation|0|||
16417066|NCT01939366|40008445|FG002|Overall Study|Protocol Violation|0|||
16417067|NCT01939366|40008446|FG003|Overall Study|Protocol Violation|1|||
16417068|NCT01939366|40008447|FG004|Overall Study|Protocol Violation|0|||
16417069|NCT01939366|40008443|FG000|Overall Study|Sponsor decision|0|||
16417070|NCT01939366|40008444|FG001|Overall Study|Sponsor decision|0|||
16417071|NCT01939366|40008445|FG002|Overall Study|Sponsor decision|0|||
16417072|NCT01939366|40008446|FG003|Overall Study|Sponsor decision|0|||
16417073|NCT01939366|40008447|FG004|Overall Study|Sponsor decision|2|||
16417074|NCT01939366|40008443|FG000|Overall Study|GCP non-compliance at site|2|||
16417075|NCT01939366|40008444|FG001|Overall Study|GCP non-compliance at site|3|||
16417076|NCT01939366|40008445|FG002|Overall Study|GCP non-compliance at site|2|||
16417077|NCT01939366|40008446|FG003|Overall Study|GCP non-compliance at site|3|||
16417078|NCT01939366|40008447|FG004|Overall Study|GCP non-compliance at site|3|||
16417079|NCT05026853|40008451|FG000|Overall Study|Cancelled appointment|1|||
16417080|NCT05026853|40008452|FG001|Overall Study|Cancelled appointment|0|||
16560230|NCT00506285|40517509|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
16560231|NCT00506285|40517508|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
16560232|NCT00506285|40517509|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
16560233|NCT01653743|40517510|FG000|Overall Study|Withdrawal by Subject|1|||
16560234|NCT01653743|40517511|FG001|Overall Study|Withdrawal by Subject|0|||
16417081|NCT05026853|40008451|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
16417082|NCT05026853|40008452|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
16417083|NCT05026853|40008451|FG000|Overall Study|Did not complete 12-week survey|16|||
16417084|NCT05026853|40008452|FG001|Overall Study|Did not complete 12-week survey|16|||
16246015|NCT05751629|39385366|FG000|Overall Study|Withdrawal by Subject|6|||
16246016|NCT05751629|39385366|FG000|Overall Study|Death|25|||
16246017|NCT05751629|39385366|FG000|Overall Study|Study Site Closed|9|||
16246018|NCT05751629|39385366|FG000|Overall Study|Physician Decision|1|||
16246019|NCT01698320|39385370|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
16246020|NCT01698320|39385371|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
16246021|NCT01698320|39385372|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
16246022|NCT01698320|39385370|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
16246023|NCT01698320|39385371|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
16246024|NCT01698320|39385372|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
16246025|NCT01698320|39385370|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
16129206|NCT00185965|38958878|FG000|Overall Study|Adverse Event|0|||
16129207|NCT00185965|38958879|FG001|Overall Study|Adverse Event|1|||
16129208|NCT02891837|38958880|FG000|Overall Study|Lost to Follow-up|2|||
16129209|NCT02891837|38958881|FG001|Overall Study|Lost to Follow-up|0|||
16246026|NCT01698320|39385371|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
16246027|NCT01698320|39385372|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
16246028|NCT01698320|39385370|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
16246029|NCT01698320|39385371|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
16246030|NCT01698320|39385372|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
16246031|NCT01698320|39385370|FG000|12-Week Double-Blind Period|Adverse Event|0|||
16246032|NCT01698320|39385371|FG001|12-Week Double-Blind Period|Adverse Event|1|||
16246033|NCT01698320|39385372|FG002|12-Week Double-Blind Period|Adverse Event|1|||
16246034|NCT01698320|39385370|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
16246035|NCT01698320|39385371|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
16129210|NCT02891837|38958880|FG000|Overall Study|Withdrawal by Subject|1|||
16129211|NCT02891837|38958881|FG001|Overall Study|Withdrawal by Subject|0|||
16129212|NCT00095498|38958882|FG000|Overall Study|Physician Decision|9|||
16129213|NCT00095498|38958883|FG001|Overall Study|Physician Decision|10|||
16129214|NCT00095498|38958884|FG002|Overall Study|Physician Decision|8|||
16129215|NCT00095498|38958882|FG000|Overall Study|Adverse Event|1|||
16129216|NCT00095498|38958883|FG001|Overall Study|Adverse Event|0|||
16129217|NCT00095498|38958884|FG002|Overall Study|Adverse Event|1|||
16129218|NCT00095498|38958882|FG000|Overall Study|Withdrawal by Subject|15|||
16129219|NCT00095498|38958883|FG001|Overall Study|Withdrawal by Subject|16|||
16129220|NCT00095498|38958884|FG002|Overall Study|Withdrawal by Subject|15|||
16129221|NCT00095498|38958882|FG000|Overall Study|Disease progression|0|||
16129222|NCT00095498|38958883|FG001|Overall Study|Disease progression|1|||
16129223|NCT00095498|38958884|FG002|Overall Study|Disease progression|1|||
16129224|NCT00095498|38958882|FG000|Overall Study|Ineligibility determined|3|||
16129225|NCT00095498|38958883|FG001|Overall Study|Ineligibility determined|0|||
16246036|NCT01698320|39385372|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
16246037|NCT01698320|39385370|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
16246038|NCT01698320|39385371|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
16246039|NCT01698320|39385372|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
16246040|NCT01698320|39385370|FG000|12-Week Double-Blind Period|Pregnancy|0|||
16246041|NCT01698320|39385371|FG001|12-Week Double-Blind Period|Pregnancy|1|||
16246042|NCT01698320|39385372|FG002|12-Week Double-Blind Period|Pregnancy|1|||
16129226|NCT00095498|38958884|FG002|Overall Study|Ineligibility determined|2|||
16129227|NCT00095498|38958882|FG000|Overall Study|Lost to Follow-up|1|||
16129228|NCT00095498|38958883|FG001|Overall Study|Lost to Follow-up|1|||
16246043|NCT01698320|39385370|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
16246044|NCT01698320|39385371|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
16246045|NCT01698320|39385372|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
16246046|NCT01698320|39385370|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
16246047|NCT01698320|39385371|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
16246048|NCT01698320|39385372|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
16246049|NCT01698320|39385370|FG000|40-Week Open-Label Period|Adverse Event|0|||
16246050|NCT01698320|39385371|FG001|40-Week Open-Label Period|Adverse Event|3|||
16246051|NCT01698320|39385372|FG002|40-Week Open-Label Period|Adverse Event|2|||
16246052|NCT01698320|39385370|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
16352337|NCT03428100|39776642|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
16352338|NCT03428100|39776624|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352339|NCT03428100|39776625|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
16352340|NCT03428100|39776626|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
16352341|NCT03428100|39776627|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352342|NCT03428100|39776628|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352343|NCT03428100|39776629|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16246053|NCT01698320|39385371|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
16246054|NCT01698320|39385372|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
16246055|NCT01698320|39385370|FG000|40-Week Open-Label Period|Pregnancy|0|||
16246056|NCT01698320|39385371|FG001|40-Week Open-Label Period|Pregnancy|2|||
16246057|NCT01698320|39385372|FG002|40-Week Open-Label Period|Pregnancy|1|||
16246058|NCT01698320|39385370|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
16246059|NCT01698320|39385371|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
16246060|NCT01698320|39385372|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
16246061|NCT01698320|39385370|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
16246062|NCT01698320|39385371|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
16246063|NCT01698320|39385372|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
16246064|NCT01159769|39385373|FG000|Overall Study|Adverse Event|1|||
16246065|NCT00326885|39385377|FG000|Overall Study|Adverse Event|1|||
16246066|NCT00326885|39385377|FG000|Overall Study|Withdrawal by Subject|3|||
16246067|NCT00326885|39385377|FG000|Overall Study|Physician Decision|1|||
16246068|NCT00326885|39385377|FG000|Overall Study|Hospice withdrew consent|2|||
16246069|NCT01688037|39385378|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
16246070|NCT01688037|39385379|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
16246071|NCT01688037|39385380|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
16246072|NCT01688037|39385378|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
16246073|NCT01688037|39385379|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
16246074|NCT01688037|39385380|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
16246075|NCT01688037|39385378|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
16246076|NCT01688037|39385379|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
16352344|NCT03428100|39776630|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352345|NCT03428100|39776631|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352346|NCT03428100|39776632|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352347|NCT03428100|39776633|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352348|NCT03428100|39776634|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352349|NCT03428100|39776635|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352350|NCT03428100|39776636|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352351|NCT03428100|39776637|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352352|NCT03428100|39776638|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352353|NCT03428100|39776639|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352354|NCT03428100|39776640|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352355|NCT03428100|39776641|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352356|NCT03428100|39776642|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
16352357|NCT03428100|39776624|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
16352358|NCT03428100|39776625|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352359|NCT03428100|39776626|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352360|NCT03428100|39776627|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352361|NCT03428100|39776628|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352362|NCT03428100|39776629|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352363|NCT03428100|39776630|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352364|NCT03428100|39776631|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352365|NCT03428100|39776632|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352366|NCT03428100|39776633|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352367|NCT03428100|39776634|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16246077|NCT01688037|39385380|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
16246078|NCT01688037|39385378|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
16246079|NCT01688037|39385379|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
16246080|NCT01688037|39385380|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
16246081|NCT01688037|39385378|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
16246082|NCT01688037|39385379|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
16246083|NCT01688037|39385380|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
16246084|NCT01688037|39385378|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
16246085|NCT01688037|39385379|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
16246086|NCT01688037|39385380|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
16246087|NCT01688037|39385378|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
16246088|NCT01688037|39385379|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
16560235|NCT01653743|40517510|FG000|Overall Study|Investigator discretion|3|||
16560236|NCT01653743|40517511|FG001|Overall Study|Investigator discretion|0|||
16560237|NCT03615482|40517519|FG000|Overall Study|Death|1|||
16560238|NCT03615482|40517520|FG001|Overall Study|Death|0|||
16560239|NCT03615482|40517519|FG000|Overall Study|Lost to Follow-up|7|||
16560240|NCT03615482|40517520|FG001|Overall Study|Lost to Follow-up|7|||
16560241|NCT03615482|40517519|FG000|Overall Study|Physician Decision|2|||
16560242|NCT03615482|40517520|FG001|Overall Study|Physician Decision|3|||
16560243|NCT03615482|40517519|FG000|Overall Study|Withdrawal by Subject|7|||
16560244|NCT03615482|40517520|FG001|Overall Study|Withdrawal by Subject|7|||
16560245|NCT03005288|40517521|FG000|Overall Study|Withdrawal by Subject|7|||
16560246|NCT03005288|40517522|FG001|Overall Study|Withdrawal by Subject|5|||
16560247|NCT03005288|40517521|FG000|Overall Study|Lost to Follow-up|0|||
16560248|NCT03005288|40517522|FG001|Overall Study|Lost to Follow-up|1|||
16560249|NCT03005288|40517521|FG000|Overall Study|Adverse Event|5|||
16246089|NCT01688037|39385380|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
16246090|NCT01688037|39385378|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
16246091|NCT01688037|39385379|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
16246092|NCT01688037|39385380|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
16246093|NCT01688037|39385378|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
16246094|NCT01688037|39385379|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
16246095|NCT01688037|39385380|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
16246096|NCT01688037|39385378|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
16246097|NCT01688037|39385379|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
16246098|NCT01688037|39385380|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
16246099|NCT03840811|39385381|FG000|Overall Study|Lost to Follow-up|0|||
16246100|NCT03840811|39385382|FG001|Overall Study|Lost to Follow-up|0|||
16246101|NCT03840811|39385383|FG002|Overall Study|Lost to Follow-up|1|||
16246102|NCT01960816|39385385|FG000|Overall Study|Lost to Follow-up|1|||
16417085|NCT00897390|40008453|FG000|Overall Study|Adverse Event|2|||
16417086|NCT00897390|40008453|FG000|Overall Study|No Longer Met Study Criteria|1|||
16417087|NCT00897390|40008453|FG000|Overall Study|Personal Reasons|1|||
16417088|NCT00897390|40008453|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
16417089|NCT01455220|40008454|FG000|Overall Study|screen fail|30|||
16417090|NCT00079677|40008455|FG000|Overall Study|Adverse Event|5|||
16417091|NCT00079677|40008456|FG001|Overall Study|Adverse Event|6|||
16417092|NCT00079677|40008455|FG000|Overall Study|Lack of Efficacy|1|||
16417093|NCT00079677|40008456|FG001|Overall Study|Lack of Efficacy|0|||
16417094|NCT00079677|40008455|FG000|Overall Study|Lost to Follow-up|2|||
16417095|NCT00079677|40008456|FG001|Overall Study|Lost to Follow-up|2|||
16417096|NCT00079677|40008455|FG000|Overall Study|Physician Decision|3|||
16417097|NCT00079677|40008456|FG001|Overall Study|Physician Decision|0|||
16417098|NCT00079677|40008455|FG000|Overall Study|Protocol Violation|2|||
16417099|NCT00079677|40008456|FG001|Overall Study|Protocol Violation|3|||
16417100|NCT00079677|40008455|FG000|Overall Study|Withdrawal by Subject|5|||
16417101|NCT00079677|40008456|FG001|Overall Study|Withdrawal by Subject|3|||
16560250|NCT03005288|40517522|FG001|Overall Study|Adverse Event|0|||
16560251|NCT03005288|40517521|FG000|Overall Study|Protocol deviation|0|||
16246103|NCT00597584|39385386|FG000|Overall Study|Adverse Event|4|||
16246104|NCT00597584|39385387|FG001|Overall Study|Adverse Event|2|||
16246105|NCT00597584|39385386|FG000|Overall Study|Death|53|||
16246106|NCT00597584|39385387|FG001|Overall Study|Death|30|||
16246107|NCT00597584|39385386|FG000|Overall Study|Lack of Efficacy|1|||
16246108|NCT00597584|39385387|FG001|Overall Study|Lack of Efficacy|0|||
16246109|NCT00597584|39385386|FG000|Overall Study|Lost to Follow-up|2|||
16246110|NCT00597584|39385387|FG001|Overall Study|Lost to Follow-up|4|||
16246111|NCT00597584|39385386|FG000|Overall Study|Physician Decision|3|||
16246112|NCT00597584|39385387|FG001|Overall Study|Physician Decision|0|||
16352368|NCT03428100|39776635|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352369|NCT03428100|39776636|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352370|NCT03428100|39776637|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352371|NCT03428100|39776638|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352372|NCT03428100|39776639|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352373|NCT03428100|39776640|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352374|NCT03428100|39776641|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352375|NCT03428100|39776642|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
16352376|NCT03428100|39776624|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352377|NCT03428100|39776625|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
16352378|NCT03428100|39776626|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352379|NCT03428100|39776627|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352380|NCT03428100|39776628|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352381|NCT03428100|39776629|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352382|NCT03428100|39776630|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352383|NCT03428100|39776631|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352384|NCT03428100|39776632|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352385|NCT03428100|39776633|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352386|NCT03428100|39776634|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352387|NCT03428100|39776635|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352388|NCT03428100|39776636|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352389|NCT03428100|39776637|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352390|NCT03428100|39776638|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352391|NCT03428100|39776639|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352392|NCT03428100|39776640|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16352393|NCT03428100|39776641|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16417102|NCT00079677|40008455|FG000|Overall Study|Miscellaneous|2|||
16417103|NCT00079677|40008456|FG001|Overall Study|Miscellaneous|0|||
16417104|NCT00330681|40008460|FG000|Overall Study|Adverse Event|3|||
16417105|NCT00330681|40008461|FG001|Overall Study|Adverse Event|6|||
16417106|NCT00330681|40008460|FG000|Overall Study|Protocol Violation|0|||
16417107|NCT00330681|40008461|FG001|Overall Study|Protocol Violation|1|||
16352394|NCT03428100|39776642|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
16129229|NCT00095498|38958884|FG002|Overall Study|Lost to Follow-up|2|||
16129230|NCT00095498|38958882|FG000|Overall Study|Noncompliance|1|||
16129231|NCT00095498|38958883|FG001|Overall Study|Noncompliance|0|||
16129232|NCT00095498|38958884|FG002|Overall Study|Noncompliance|1|||
16129233|NCT00095498|38958882|FG000|Overall Study|Other|6|||
16129234|NCT00095498|38958883|FG001|Overall Study|Other|7|||
16129235|NCT00095498|38958884|FG002|Overall Study|Other|6|||
16129236|NCT00095498|38958882|FG000|Overall Study|Protocol Violation|0|||
16129237|NCT00095498|38958883|FG001|Overall Study|Protocol Violation|0|||
16129238|NCT00095498|38958884|FG002|Overall Study|Protocol Violation|1|||
16129239|NCT00095498|38958882|FG000|Overall Study|Requirement for alternative therapy|1|||
16129240|NCT00095498|38958883|FG001|Overall Study|Requirement for alternative therapy|0|||
16129241|NCT00095498|38958884|FG002|Overall Study|Requirement for alternative therapy|2|||
16129242|NCT01983254|38958885|FG000|Overall Study|Death|6|||
16129243|NCT01983254|38958886|FG001|Overall Study|Death|6|||
16129244|NCT01983254|38958885|FG000|Overall Study|Lost to Follow-up|17|||
16129245|NCT01983254|38958886|FG001|Overall Study|Lost to Follow-up|16|||
16129246|NCT01983254|38958885|FG000|Overall Study|too ill|11|||
16129247|NCT01983254|38958886|FG001|Overall Study|too ill|8|||
16129248|NCT01191268|38958887|FG000|Overall Study|Withdrawal by Subject|19|||
16246113|NCT00597584|39385386|FG000|Overall Study|Pregnancy|2|||
16246114|NCT00597584|39385387|FG001|Overall Study|Pregnancy|0|||
16246115|NCT00597584|39385386|FG000|Overall Study|Withdrawal by Subject|44|||
16352395|NCT03428100|39776624|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
16129249|NCT01191268|38958888|FG001|Overall Study|Withdrawal by Subject|25|||
16129250|NCT01191268|38958889|FG002|Overall Study|Withdrawal by Subject|21|||
16129251|NCT01191268|38958887|FG000|Overall Study|Adverse Event|21|||
16129252|NCT01191268|38958888|FG001|Overall Study|Adverse Event|13|||
16246116|NCT00597584|39385387|FG001|Overall Study|Withdrawal by Subject|12|||
16246117|NCT00597584|39385386|FG000|Overall Study|Discontinued Dialysis|0|||
16246118|NCT00597584|39385387|FG001|Overall Study|Discontinued Dialysis|1|||
16246119|NCT00597584|39385386|FG000|Overall Study|Lost ability to consent|1|||
16129253|NCT01191268|38958889|FG002|Overall Study|Adverse Event|8|||
16246120|NCT00597584|39385387|FG001|Overall Study|Lost ability to consent|1|||
16246121|NCT00597584|39385386|FG000|Overall Study|Never dosed|1|||
16246122|NCT00597584|39385387|FG001|Overall Study|Never dosed|0|||
16246123|NCT00597584|39385386|FG000|Overall Study|Relocation|8|||
16246124|NCT00597584|39385387|FG001|Overall Study|Relocation|6|||
16246125|NCT00597584|39385386|FG000|Overall Study|Renal transplant|9|||
16246126|NCT00597584|39385387|FG001|Overall Study|Renal transplant|7|||
16246127|NCT02328547|39385391|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
16129254|NCT01191268|38958887|FG000|Overall Study|Physician Decision|6|||
16129255|NCT01191268|38958888|FG001|Overall Study|Physician Decision|8|||
16246128|NCT02328547|39385392|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
16246129|NCT02328547|39385391|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
16246130|NCT02328547|39385392|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
16246131|NCT00717756|39385393|FG000|Overall Study|Withdrawal by Subject|1|||
16246132|NCT00686374|39385402|FG000|Overall Study|Lack of Efficacy|10|||
16246133|NCT00686374|39385402|FG000|Overall Study|Adverse Event|8|||
16246134|NCT00686374|39385402|FG000|Overall Study|Withdrew consent|5|||
16246135|NCT00686374|39385402|FG000|Overall Study|Lost to Follow-up|1|||
16129256|NCT01191268|38958889|FG002|Overall Study|Physician Decision|9|||
16129257|NCT01191268|38958887|FG000|Overall Study|Lost to Follow-up|8|||
16129258|NCT01191268|38958888|FG001|Overall Study|Lost to Follow-up|5|||
16129259|NCT01191268|38958889|FG002|Overall Study|Lost to Follow-up|9|||
16129260|NCT01191268|38958887|FG000|Overall Study|Entry Criteria Not Met|3|||
16129261|NCT01191268|38958888|FG001|Overall Study|Entry Criteria Not Met|1|||
16129262|NCT01191268|38958889|FG002|Overall Study|Entry Criteria Not Met|1|||
16129263|NCT01191268|38958887|FG000|Overall Study|Death|0|||
16129264|NCT01191268|38958888|FG001|Overall Study|Death|1|||
16129265|NCT01191268|38958889|FG002|Overall Study|Death|3|||
16129266|NCT01191268|38958887|FG000|Overall Study|Protocol Violation|1|||
16129267|NCT01191268|38958888|FG001|Overall Study|Protocol Violation|0|||
16129268|NCT01191268|38958889|FG002|Overall Study|Protocol Violation|1|||
16129269|NCT01191268|38958887|FG000|Overall Study|Sponsor Decision|0|||
16129270|NCT01191268|38958888|FG001|Overall Study|Sponsor Decision|2|||
16129271|NCT01191268|38958889|FG002|Overall Study|Sponsor Decision|0|||
16129272|NCT02413333|38958896|FG000|Period 1|Adverse Event|1|||
16129273|NCT02413333|38958897|FG001|Period 1|Adverse Event|0|||
16129274|NCT02413333|38958896|FG000|Period 1|Reason Not Specified|0|||
16129275|NCT02413333|38958897|FG001|Period 1|Reason Not Specified|1|||
16246136|NCT00686374|39385402|FG000|Overall Study|Missing reason|33|||
16246137|NCT00686374|39385402|FG000|Overall Study|Other, not specified|4|||
16246138|NCT00770315|39385406|FG000|Overall Study|Adverse Event|11|||
16246139|NCT00770315|39385407|FG001|Overall Study|Adverse Event|17|||
16246140|NCT00770315|39385408|FG002|Overall Study|Adverse Event|16|||
16246141|NCT00770315|39385409|FG003|Overall Study|Adverse Event|6|||
16246142|NCT00770315|39385406|FG000|Overall Study|Lost to Follow-up|9|||
16246143|NCT00770315|39385407|FG001|Overall Study|Lost to Follow-up|5|||
16246144|NCT00770315|39385408|FG002|Overall Study|Lost to Follow-up|10|||
16246145|NCT00770315|39385409|FG003|Overall Study|Lost to Follow-up|3|||
16246146|NCT00770315|39385406|FG000|Overall Study|Withdrawal by Subject|13|||
16246147|NCT00770315|39385407|FG001|Overall Study|Withdrawal by Subject|17|||
16129276|NCT02413333|38958896|FG000|Period 2|Protocol Deviation|1|||
16246148|NCT00770315|39385408|FG002|Overall Study|Withdrawal by Subject|24|||
16246149|NCT00770315|39385409|FG003|Overall Study|Withdrawal by Subject|20|||
16246150|NCT00770315|39385406|FG000|Overall Study|Noncompliance with Protocol|7|||
16246151|NCT00770315|39385407|FG001|Overall Study|Noncompliance with Protocol|4|||
16246152|NCT00770315|39385408|FG002|Overall Study|Noncompliance with Protocol|7|||
16246153|NCT00770315|39385409|FG003|Overall Study|Noncompliance with Protocol|9|||
16129277|NCT02413333|38958897|FG001|Period 2|Protocol Deviation|0|||
16129278|NCT00978627|38958899|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
16129279|NCT00978627|38958900|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
16129280|NCT00978627|38958899|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
16129281|NCT00978627|38958900|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
16129282|NCT00978627|38958899|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
16129283|NCT00978627|38958900|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
16129284|NCT00978627|38958899|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
16129285|NCT00978627|38958900|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
16129286|NCT00978627|38958899|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
16129287|NCT00978627|38958900|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
16129288|NCT00978627|38958899|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
16129289|NCT00978627|38958900|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
16129290|NCT00978627|38958899|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
16129291|NCT00978627|38958900|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
16129292|NCT00978627|38958899|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
16129293|NCT00978627|38958900|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
16129294|NCT00978627|38958899|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
16129295|NCT00978627|38958900|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
16129296|NCT02390245|38958901|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
16129297|NCT02390245|38958902|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
16129298|NCT02390245|38958903|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
16129299|NCT02390245|38958901|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
16129300|NCT02390245|38958902|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
16129301|NCT02390245|38958903|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
16129302|NCT00911937|38958904|FG000|Overall Study|Death|1|||
16129303|NCT00911937|38958905|FG001|Overall Study|Death|0|||
16129304|NCT00911937|38958904|FG000|Overall Study|Lost to Follow-up|8|||
16129305|NCT00911937|38958905|FG001|Overall Study|Lost to Follow-up|5|||
16129306|NCT00911937|38958904|FG000|Overall Study|Withdrawal by Subject|10|||
16129307|NCT00911937|38958905|FG001|Overall Study|Withdrawal by Subject|7|||
16129308|NCT00911937|38958904|FG000|Overall Study|Withdrawn due to pregnancy|1|||
16129309|NCT00911937|38958905|FG001|Overall Study|Withdrawn due to pregnancy|0|||
16129310|NCT00911937|38958904|FG000|Overall Study|Adverse Event|11|||
16129311|NCT00911937|38958905|FG001|Overall Study|Adverse Event|25|||
16129312|NCT00911937|38958904|FG000|Overall Study|Lack of Efficacy|11|||
16129313|NCT00911937|38958905|FG001|Overall Study|Lack of Efficacy|6|||
16129314|NCT00911937|38958904|FG000|Overall Study|Did not meet inclusion criteria|9|||
16129315|NCT00911937|38958905|FG001|Overall Study|Did not meet inclusion criteria|11|||
16129316|NCT00911937|38958904|FG000|Overall Study|Protocol Violation|14|||
16129317|NCT00911937|38958905|FG001|Overall Study|Protocol Violation|23|||
16129318|NCT00911937|38958904|FG000|Overall Study|Randomized but not treated|13|||
16129319|NCT00911937|38958905|FG001|Overall Study|Randomized but not treated|13|||
16129320|NCT00911937|38958904|FG000|Overall Study|Other|9|||
16129321|NCT00911937|38958905|FG001|Overall Study|Other|5|||
16129322|NCT04343872|38958906|FG000|Overall Study|Lost to Follow-up|6|||
16129323|NCT04343872|38958907|FG001|Overall Study|Lost to Follow-up|3|||
16129324|NCT03590366|38958908|FG000|Overall Study|Adverse Event|0|||
16129325|NCT03590366|38958909|FG001|Overall Study|Adverse Event|3|||
16129326|NCT03590366|38958908|FG000|Overall Study|Lost to Follow-up|3|||
16129327|NCT03590366|38958909|FG001|Overall Study|Lost to Follow-up|3|||
16129328|NCT03590366|38958908|FG000|Overall Study|Withdrawal by Subject|0|||
16129329|NCT03590366|38958909|FG001|Overall Study|Withdrawal by Subject|2|||
16129330|NCT02053792|38958910|FG000|Overall Study|Physician Decision|0|||
16129331|NCT02053792|38958911|FG001|Overall Study|Physician Decision|1|||
16246154|NCT02280421|39385410|FG000|Washout (2 Weeks)|Adverse Event|0|||
16129332|NCT02053792|38958910|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
16246155|NCT02280421|39385411|FG001|Washout (2 Weeks)|Adverse Event|1|||
16246156|NCT02280421|39385410|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
16246157|NCT02280421|39385411|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
16129333|NCT02053792|38958911|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
16129334|NCT02053792|38958910|FG000|Overall Study|Lack of Efficacy|1|||
16129335|NCT02053792|38958911|FG001|Overall Study|Lack of Efficacy|0|||
16129336|NCT02053792|38958910|FG000|Overall Study|Adverse Event|1|||
16129337|NCT02053792|38958911|FG001|Overall Study|Adverse Event|0|||
16129338|NCT02053792|38958910|FG000|Overall Study|Withdrawal by Subject|2|||
16129339|NCT02053792|38958911|FG001|Overall Study|Withdrawal by Subject|2|||
16129340|NCT02053792|38958910|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
16129341|NCT02053792|38958911|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
16129342|NCT02053792|38958910|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
16129343|NCT02053792|38958911|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
16129344|NCT00467285|38958913|FG000|Overall Study|Lost to Follow-up|4|||
16129345|NCT00467285|38958914|FG001|Overall Study|Lost to Follow-up|4|||
16129346|NCT00847808|38958920|FG000|Overall Study|Adverse Event|7|||
16129347|NCT00847808|38958920|FG000|Overall Study|Protocol Violation|1|||
16129348|NCT00847808|38958920|FG000|Overall Study|Lost to Follow-up|1|||
16129349|NCT00847808|38958920|FG000|Overall Study|Withdrawal by Subject|4|||
16129350|NCT00847808|38958920|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
16129351|NCT00847808|38958920|FG000|Overall Study|Participant Took Excluded Medication|1|||
16129352|NCT00211185|38958921|FG000|Overall Study|Death|2|||
16129353|NCT00211185|38958921|FG000|Overall Study|Disease progression|7|||
16129354|NCT00211185|38958921|FG000|Overall Study|Withdrawal by Subject|6|||
16129355|NCT00211185|38958921|FG000|Overall Study|Physician Decision|5|||
16129356|NCT04289051|38958922|FG000|Overall Study|Lost to Follow-up|0|||
16129357|NCT04289051|38958923|FG001|Overall Study|Lost to Follow-up|0|||
16129358|NCT04289051|38958924|FG002|Overall Study|Lost to Follow-up|2|||
16129359|NCT03309813|38958926|FG000|Main Randomized Study|Withdrawal by Subject|1|||
16129360|NCT03309813|38958927|FG001|Main Randomized Study|Withdrawal by Subject|0|||
16129361|NCT01007448|38962131|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
16129362|NCT01007448|38962132|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
16129363|NCT01007448|38962131|FG000|Overall Study|Staph Skin Infection Flare|1|||
16129364|NCT01007448|38962132|FG001|Overall Study|Staph Skin Infection Flare|0|||
16129365|NCT01007448|38962131|FG000|Overall Study|Participant Leaving the Country|1|||
16129366|NCT01007448|38962132|FG001|Overall Study|Participant Leaving the Country|0|||
16129367|NCT01007448|38962131|FG000|Overall Study|Participant Given Prohibited Medication|1|||
16129368|NCT01007448|38962132|FG001|Overall Study|Participant Given Prohibited Medication|0|||
16129369|NCT01007448|38962131|FG000|Overall Study|Progressive Disease|1|||
16129370|NCT01007448|38962132|FG001|Overall Study|Progressive Disease|2|||
16129371|NCT01007448|38962131|FG000|Overall Study|Lack of Efficacy|2|||
16129372|NCT01007448|38962132|FG001|Overall Study|Lack of Efficacy|0|||
16129373|NCT01007448|38962131|FG000|Overall Study|Withdrawal by Subject|2|||
16129374|NCT01007448|38962132|FG001|Overall Study|Withdrawal by Subject|3|||
16129375|NCT01007448|38962131|FG000|Overall Study|Adverse Event|1|||
16129376|NCT01007448|38962132|FG001|Overall Study|Adverse Event|4|||
16129377|NCT02729831|38962134|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
16129378|NCT02729831|38962135|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
16129379|NCT02729831|38962136|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
16129380|NCT02729831|38962137|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
16129381|NCT02729831|38962134|FG000|1 Week Post-visit|Lost to Follow-up|43|||
16129382|NCT02729831|38962135|FG001|1 Week Post-visit|Lost to Follow-up|40|||
16129383|NCT02729831|38962136|FG002|1 Week Post-visit|Lost to Follow-up|38|||
16129384|NCT02729831|38962137|FG003|1 Week Post-visit|Lost to Follow-up|36|||
16129385|NCT02729831|38962134|FG000|6 Month Follow-up|Lost to Follow-up|54|||
16129386|NCT02729831|38962135|FG001|6 Month Follow-up|Lost to Follow-up|51|||
16129387|NCT02729831|38962136|FG002|6 Month Follow-up|Lost to Follow-up|48|||
16129388|NCT02729831|38962137|FG003|6 Month Follow-up|Lost to Follow-up|42|||
16129389|NCT02729831|38962134|FG000|6 Month Follow-up|Death|1|||
16129390|NCT02729831|38962135|FG001|6 Month Follow-up|Death|3|||
16129391|NCT02729831|38962136|FG002|6 Month Follow-up|Death|0|||
16129392|NCT02729831|38962137|FG003|6 Month Follow-up|Death|1|||
16129393|NCT02910739|38962138|FG000|Overall Study|Adverse Event|1|||
16129394|NCT02910739|38962139|FG001|Overall Study|Adverse Event|0|||
16129395|NCT02910739|38962140|FG002|Overall Study|Adverse Event|0|||
16129396|NCT02910739|38962141|FG003|Overall Study|Adverse Event|0|||
16129397|NCT04227704|38962142|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
16129398|NCT04227704|38962143|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
16129399|NCT04227704|38962144|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
16129400|NCT04227704|38962142|FG000|Overall Study|due to C/S being cancelled|1|||
16129401|NCT04227704|38962143|FG001|Overall Study|due to C/S being cancelled|0|||
16129402|NCT04227704|38962144|FG002|Overall Study|due to C/S being cancelled|0|||
16129403|NCT00572039|38962145|FG000|Overall Study|Withdrawal by Subject|9|||
16129404|NCT00572039|38962146|FG001|Overall Study|Withdrawal by Subject|6|||
16129405|NCT00572039|38962145|FG000|Overall Study|Death|2|||
16129406|NCT00572039|38962146|FG001|Overall Study|Death|3|||
16129407|NCT00572039|38962145|FG000|Overall Study|Ill|5|||
16129408|NCT00572039|38962146|FG001|Overall Study|Ill|1|||
16129409|NCT01970345|38962147|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
16129410|NCT01970345|38962148|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
16129411|NCT01970345|38962147|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
16129412|NCT01970345|38962148|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
16129413|NCT03053518|38962149|FG000|Overall Study|Withdrawal by Subject|3|||
16129414|NCT03053518|38962149|FG000|Overall Study|Lost to Follow-up|2|||
16129415|NCT03053518|38962149|FG000|Overall Study|Ineligible|5|||
16129416|NCT01048671|38962150|FG000|Overall Study|Protocol Violation|0|||
16129417|NCT01048671|38962151|FG001|Overall Study|Protocol Violation|1|||
16129418|NCT01048671|38962152|FG002|Overall Study|Protocol Violation|1|||
16129419|NCT01060540|38962153|FG000|Overall Study|Withdrawal by Subject|10|||
16129420|NCT01060540|38962154|FG001|Overall Study|Withdrawal by Subject|20|||
16352396|NCT03428100|39776625|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
16352397|NCT03428100|39776626|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
16352398|NCT03428100|39776627|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
16352399|NCT03428100|39776628|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
16352400|NCT03428100|39776629|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
16352401|NCT03428100|39776630|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
16417108|NCT00330681|40008460|FG000|Overall Study|Withdrawal by Subject|5|||
16417109|NCT00330681|40008461|FG001|Overall Study|Withdrawal by Subject|5|||
16417110|NCT00330681|40008460|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
16417111|NCT00330681|40008461|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
16417112|NCT01639755|40008462|FG000|Overall Study|Study Ongoing|15|||
16129421|NCT01060540|38962153|FG000|Overall Study|Lost to Follow-up|52|||
16129422|NCT01060540|38962154|FG001|Overall Study|Lost to Follow-up|43|||
16129423|NCT01060540|38962153|FG000|Overall Study|Death|2|||
16129424|NCT01060540|38962154|FG001|Overall Study|Death|1|||
16129425|NCT01060540|38962153|FG000|Overall Study|Physician Decision|0|||
16129426|NCT01060540|38962154|FG001|Overall Study|Physician Decision|1|||
16129427|NCT00993668|38962155|FG000|Single-Blind Period|Adverse Event|1|||
16129428|NCT00993668|38962156|FG001|Single-Blind Period|Adverse Event|1|||
16129429|NCT00993668|38962155|FG000|Single-Blind Period|Lack of Efficacy|0|||
16129430|NCT00993668|38962156|FG001|Single-Blind Period|Lack of Efficacy|1|||
16129431|NCT00993668|38962155|FG000|Single-Blind Period|Lost to Follow-up|3|||
16129432|NCT00993668|38962156|FG001|Single-Blind Period|Lost to Follow-up|1|||
16129433|NCT00993668|38962155|FG000|Open-Label Period|Adverse Event|9|||
16129434|NCT00993668|38962156|FG001|Open-Label Period|Adverse Event|8|||
16129435|NCT00993668|38962155|FG000|Open-Label Period|Lack of Efficacy|4|||
16129436|NCT00993668|38962156|FG001|Open-Label Period|Lack of Efficacy|3|||
16129437|NCT00993668|38962155|FG000|Open-Label Period|Withdrawal by Subject|4|||
16129438|NCT00993668|38962156|FG001|Open-Label Period|Withdrawal by Subject|3|||
16129439|NCT00993668|38962155|FG000|Open-Label Period|Lost to Follow-up|6|||
16129440|NCT00993668|38962156|FG001|Open-Label Period|Lost to Follow-up|1|||
16129441|NCT04075994|38962164|FG000|Overall Study|Withdrawal by Subject|8|||
16129442|NCT04075994|38962165|FG001|Overall Study|Withdrawal by Subject|9|||
16129443|NCT04075994|38962164|FG000|Overall Study|Adverse Event|2|||
16129444|NCT04075994|38962165|FG001|Overall Study|Adverse Event|2|||
16129445|NCT04075994|38962164|FG000|Overall Study|Investigator withdrew|3|||
16129446|NCT04075994|38962165|FG001|Overall Study|Investigator withdrew|1|||
16129447|NCT00906945|38962171|FG000|Overall Study|Found to be not eligible|0|||
16129448|NCT00906945|38962172|FG001|Overall Study|Found to be not eligible|0|||
16129449|NCT00906945|38962173|FG002|Overall Study|Found to be not eligible|0|||
16129450|NCT00906945|38962174|FG003|Overall Study|Found to be not eligible|1|||
16246158|NCT00759148|39385414|FG000|Overall Study|Adverse Event|1|||
16417113|NCT01639755|40008462|FG000|Overall Study|Patient had device explantation|4|||
16129451|NCT00906945|38962175|FG004|Overall Study|Found to be not eligible|1|||
16417114|NCT00094107|40008465|FG000|Overall Study|Lack of Efficacy|23|||
16129452|NCT00906945|38962176|FG005|Overall Study|Found to be not eligible|1|||
16129453|NCT00906945|38962171|FG000|Overall Study|Physician Decision|0|||
16129454|NCT00906945|38962172|FG001|Overall Study|Physician Decision|0|||
16129455|NCT00906945|38962173|FG002|Overall Study|Physician Decision|0|||
16129456|NCT00906945|38962174|FG003|Overall Study|Physician Decision|0|||
16129457|NCT00906945|38962175|FG004|Overall Study|Physician Decision|0|||
16129458|NCT00906945|38962176|FG005|Overall Study|Physician Decision|1|||
16129459|NCT02319759|38962179|FG000|Week 0 - 16|Lack of Efficacy|1|||
16129460|NCT02319759|38962180|FG001|Week 0 - 16|Lack of Efficacy|0|||
16129461|NCT02319759|38962181|FG002|Week 0 - 16|Lack of Efficacy|0|||
16129462|NCT02319759|38962182|FG003|Week 0 - 16|Lack of Efficacy|0|||
16129463|NCT02319759|38962183|FG004|Week 0 - 16|Lack of Efficacy|0|||
16129464|NCT02319759|38962179|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
16129465|NCT02319759|38962180|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
16129466|NCT02319759|38962181|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
16129467|NCT02319759|38962182|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
16129468|NCT02319759|38962183|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
16129469|NCT02319759|38962179|FG000|Week 16 - 24|Lack of Efficacy|1|||
16129470|NCT02319759|38962180|FG001|Week 16 - 24|Lack of Efficacy|0|||
16129471|NCT02319759|38962181|FG002|Week 16 - 24|Lack of Efficacy|1|||
16129472|NCT02319759|38962182|FG003|Week 16 - 24|Lack of Efficacy|0|||
16129473|NCT02319759|38962183|FG004|Week 16 - 24|Lack of Efficacy|0|||
16129474|NCT02319759|38962179|FG000|Week 16 - 24|Lost to Follow-up|1|||
16129475|NCT02319759|38962180|FG001|Week 16 - 24|Lost to Follow-up|0|||
16129476|NCT02319759|38962181|FG002|Week 16 - 24|Lost to Follow-up|0|||
16129477|NCT02319759|38962182|FG003|Week 16 - 24|Lost to Follow-up|0|||
16129478|NCT02319759|38962183|FG004|Week 16 - 24|Lost to Follow-up|0|||
16129479|NCT02319759|38962179|FG000|Week 16 - 24|Withdrawal by Subject|0|||
16129480|NCT02319759|38962180|FG001|Week 16 - 24|Withdrawal by Subject|0|||
16129481|NCT02319759|38962181|FG002|Week 16 - 24|Withdrawal by Subject|2|||
16129482|NCT02319759|38962182|FG003|Week 16 - 24|Withdrawal by Subject|0|||
16129483|NCT02319759|38962183|FG004|Week 16 - 24|Withdrawal by Subject|0|||
16246159|NCT00759148|39385415|FG001|Overall Study|Adverse Event|6|||
16246160|NCT00759148|39385414|FG000|Overall Study|Withdrawal by Subject|3|||
16246161|NCT00759148|39385415|FG001|Overall Study|Withdrawal by Subject|7|||
16129484|NCT02319759|38962179|FG000|Week 24 - 56|Adverse Event|0|||
16129485|NCT02319759|38962180|FG001|Week 24 - 56|Adverse Event|0|||
16129486|NCT02319759|38962181|FG002|Week 24 - 56|Adverse Event|2|||
16129487|NCT02319759|38962182|FG003|Week 24 - 56|Adverse Event|0|||
16129488|NCT02319759|38962183|FG004|Week 24 - 56|Adverse Event|0|||
16129489|NCT02319759|38962179|FG000|Week 24 - 56|Lack of Efficacy|0|||
16129490|NCT02319759|38962180|FG001|Week 24 - 56|Lack of Efficacy|0|||
16129491|NCT02319759|38962181|FG002|Week 24 - 56|Lack of Efficacy|0|||
16129492|NCT02319759|38962182|FG003|Week 24 - 56|Lack of Efficacy|2|||
16246162|NCT00759148|39385414|FG000|Overall Study|Lost to Follow-up|3|||
16246163|NCT00759148|39385415|FG001|Overall Study|Lost to Follow-up|9|||
16246164|NCT00759148|39385414|FG000|Overall Study|Treatment Failure|6|||
16246165|NCT00759148|39385415|FG001|Overall Study|Treatment Failure|10|||
16246166|NCT00759148|39385414|FG000|Overall Study|Reason not given|1|||
16246167|NCT00759148|39385415|FG001|Overall Study|Reason not given|0|||
16246168|NCT00905489|39385416|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
16246169|NCT00905489|39385416|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
16246170|NCT00905489|39385416|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
16246171|NCT01783496|39385419|FG000|Overall Study|Lost to Follow-up|0|||
16246172|NCT01783496|39385420|FG001|Overall Study|Lost to Follow-up|0|||
16246173|NCT01783496|39385421|FG002|Overall Study|Lost to Follow-up|0|||
16246174|NCT01783496|39385422|FG003|Overall Study|Lost to Follow-up|2|||
16246175|NCT01783496|39385423|FG004|Overall Study|Lost to Follow-up|0|||
16246176|NCT01783496|39385424|FG005|Overall Study|Lost to Follow-up|1|||
16246177|NCT01783496|39385419|FG000|Overall Study|Withdrawal by Subject|1|||
16246178|NCT01783496|39385420|FG001|Overall Study|Withdrawal by Subject|0|||
16246179|NCT01783496|39385421|FG002|Overall Study|Withdrawal by Subject|0|||
16246180|NCT01783496|39385422|FG003|Overall Study|Withdrawal by Subject|0|||
16246181|NCT01783496|39385423|FG004|Overall Study|Withdrawal by Subject|0|||
16246182|NCT01783496|39385424|FG005|Overall Study|Withdrawal by Subject|0|||
16246183|NCT00207714|39385426|FG000|Overall Study|Adverse Event|6|||
16246184|NCT00207714|39385427|FG001|Overall Study|Adverse Event|2|||
16246185|NCT00207714|39385428|FG002|Overall Study|Adverse Event|4|||
16246186|NCT00207714|39385429|FG003|Overall Study|Adverse Event|3|||
16246187|NCT00207714|39385430|FG004|Overall Study|Adverse Event|1|||
16246188|NCT00207714|39385426|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
16246189|NCT00207714|39385427|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16246190|NCT00207714|39385428|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
16246191|NCT00207714|39385429|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
16246192|NCT00207714|39385430|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
16246193|NCT00207714|39385426|FG000|Overall Study|Other|3|||
16246194|NCT00207714|39385427|FG001|Overall Study|Other|2|||
16246195|NCT00207714|39385428|FG002|Overall Study|Other|5|||
16246196|NCT00207714|39385429|FG003|Overall Study|Other|1|||
16246197|NCT00207714|39385430|FG004|Overall Study|Other|0|||
16246198|NCT00310856|39385431|FG000|Overall Study|Withdrawal by Subject|2|||
16246199|NCT00310856|39385432|FG001|Overall Study|Withdrawal by Subject|2|||
16246200|NCT00310856|39385433|FG002|Overall Study|Withdrawal by Subject|2|||
16246201|NCT00310856|39385431|FG000|Overall Study|Lost to Follow-up|1|||
16246202|NCT00310856|39385432|FG001|Overall Study|Lost to Follow-up|2|||
16246203|NCT00310856|39385433|FG002|Overall Study|Lost to Follow-up|6|||
16246204|NCT00310856|39385431|FG000|Overall Study|Inappropriate enrollment|1|||
16246205|NCT00310856|39385432|FG001|Overall Study|Inappropriate enrollment|1|||
16246206|NCT00310856|39385433|FG002|Overall Study|Inappropriate enrollment|0|||
16246207|NCT00310856|39385431|FG000|Overall Study|Unable to classify|1|||
16246208|NCT00310856|39385432|FG001|Overall Study|Unable to classify|0|||
16246209|NCT00310856|39385433|FG002|Overall Study|Unable to classify|0|||
16246210|NCT01023269|39385434|FG000|Overall Study|early termination of the study|2|||
16246211|NCT01023269|39385435|FG001|Overall Study|early termination of the study|0|||
16246212|NCT04741503|39385438|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
16246213|NCT04741503|39385439|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
16246214|NCT04741503|39385440|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
16246215|NCT04741503|39385438|FG000|Initial Enrollment|Overquotas removed|0|||
16246216|NCT04741503|39385439|FG001|Initial Enrollment|Overquotas removed|0|||
16246217|NCT04741503|39385440|FG002|Initial Enrollment|Overquotas removed|186|||
16246218|NCT04741503|39385438|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
16246219|NCT04741503|39385439|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
16246220|NCT04741503|39385440|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
16246221|NCT00926289|39385444|FG000|Overall Study|Adverse Event|9|||
16246222|NCT00926289|39385445|FG001|Overall Study|Adverse Event|11|||
16246223|NCT00926289|39385444|FG000|Overall Study|Protocol Violation|8|||
16246224|NCT00926289|39385445|FG001|Overall Study|Protocol Violation|12|||
16246225|NCT00926289|39385444|FG000|Overall Study|Lost to Follow-up|3|||
16246226|NCT00926289|39385445|FG001|Overall Study|Lost to Follow-up|6|||
16246227|NCT00926289|39385444|FG000|Overall Study|Withdrawal by Subject|4|||
16246228|NCT00926289|39385445|FG001|Overall Study|Withdrawal by Subject|4|||
16246229|NCT00926289|39385444|FG000|Overall Study|Other|1|||
16246230|NCT00926289|39385445|FG001|Overall Study|Other|3|||
16417115|NCT00094107|40008465|FG000|Overall Study|Death|5|||
16246231|NCT02139306|39385446|FG000|Overall Study|Withdrawal by Subject|4|||
16246232|NCT02139306|39385447|FG001|Overall Study|Withdrawal by Subject|6|||
16246233|NCT02139306|39385446|FG000|Overall Study|Adverse Event|3|||
16246234|NCT02139306|39385447|FG001|Overall Study|Adverse Event|4|||
16246235|NCT02139306|39385446|FG000|Overall Study|Physician Decision|0|||
16129493|NCT02319759|38962183|FG004|Week 24 - 56|Lack of Efficacy|1|||
16129494|NCT02319759|38962179|FG000|Week 24 - 56|Withdrawal by Subject|0|||
16129495|NCT02319759|38962180|FG001|Week 24 - 56|Withdrawal by Subject|1|||
16129496|NCT02319759|38962181|FG002|Week 24 - 56|Withdrawal by Subject|0|||
16129497|NCT02319759|38962182|FG003|Week 24 - 56|Withdrawal by Subject|0|||
16129498|NCT02319759|38962183|FG004|Week 24 - 56|Withdrawal by Subject|0|||
16129499|NCT02319759|38962179|FG000|Week 24 - 56|Lost to Follow-up|0|||
16129500|NCT02319759|38962180|FG001|Week 24 - 56|Lost to Follow-up|0|||
16129501|NCT02319759|38962181|FG002|Week 24 - 56|Lost to Follow-up|0|||
16129502|NCT02319759|38962182|FG003|Week 24 - 56|Lost to Follow-up|0|||
16129503|NCT02319759|38962183|FG004|Week 24 - 56|Lost to Follow-up|1|||
16129504|NCT01237587|38962184|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
16129505|NCT01237587|38962185|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
16129506|NCT01237587|38962184|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
16129507|NCT01237587|38962185|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
16129508|NCT01237587|38962184|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
16129509|NCT01237587|38962185|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
16129510|NCT01237587|38962184|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
16129511|NCT01237587|38962185|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
16129512|NCT01237587|38962184|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
16129513|NCT01237587|38962185|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
16129514|NCT01237587|38962184|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
16129515|NCT01237587|38962185|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
16129516|NCT01237587|38962184|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
16129517|NCT01237587|38962185|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
16129518|NCT01237587|38962184|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
16129519|NCT01237587|38962185|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
16129520|NCT01237587|38962184|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
16246236|NCT02139306|39385447|FG001|Overall Study|Physician Decision|1|||
16246237|NCT02139306|39385446|FG000|Overall Study|Other Unspecified|2|||
16246238|NCT02139306|39385447|FG001|Overall Study|Other Unspecified|3|||
16246239|NCT02139306|39385446|FG000|Overall Study|Protocol Violation|4|||
16246240|NCT02139306|39385447|FG001|Overall Study|Protocol Violation|0|||
16246241|NCT02763579|39385450|FG000|Global Period|Death|167|||
16246242|NCT02763579|39385451|FG001|Global Period|Death|151|||
16246243|NCT02763579|39385452|FG002|Global Period|Death|0|||
16246244|NCT02763579|39385453|FG003|Global Period|Death|0|||
16246245|NCT02763579|39385450|FG000|Global Period|Lost to Follow-up|2|||
16246246|NCT02763579|39385451|FG001|Global Period|Lost to Follow-up|4|||
16246247|NCT02763579|39385452|FG002|Global Period|Lost to Follow-up|0|||
16246248|NCT02763579|39385453|FG003|Global Period|Lost to Follow-up|0|||
16246249|NCT02763579|39385450|FG000|Global Period|Physician Decision|0|||
16246250|NCT02763579|39385451|FG001|Global Period|Physician Decision|2|||
16246251|NCT02763579|39385452|FG002|Global Period|Physician Decision|0|||
16246252|NCT02763579|39385453|FG003|Global Period|Physician Decision|0|||
16246253|NCT02763579|39385450|FG000|Global Period|Study Terminated By Sponsor|21|||
16246254|NCT02763579|39385451|FG001|Global Period|Study Terminated By Sponsor|26|||
16246255|NCT02763579|39385452|FG002|Global Period|Study Terminated By Sponsor|0|||
16246256|NCT02763579|39385453|FG003|Global Period|Study Terminated By Sponsor|0|||
16246257|NCT02763579|39385450|FG000|Global Period|Withdrawal by Subject|12|||
16246258|NCT02763579|39385451|FG001|Global Period|Withdrawal by Subject|18|||
16246259|NCT02763579|39385452|FG002|Global Period|Withdrawal by Subject|0|||
16246260|NCT02763579|39385453|FG003|Global Period|Withdrawal by Subject|0|||
16246261|NCT02763579|39385450|FG000|China Period|Death|0|||
16246262|NCT02763579|39385451|FG001|China Period|Death|0|||
16246263|NCT02763579|39385452|FG002|China Period|Death|46|||
16129521|NCT01237587|38962185|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
16129522|NCT01237587|38962184|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
16246264|NCT02763579|39385453|FG003|China Period|Death|48|||
16246265|NCT02763579|39385450|FG000|China Period|Lost to Follow-up|0|||
16246266|NCT02763579|39385451|FG001|China Period|Lost to Follow-up|0|||
16246267|NCT02763579|39385452|FG002|China Period|Lost to Follow-up|1|||
16246268|NCT02763579|39385453|FG003|China Period|Lost to Follow-up|1|||
16246269|NCT02763579|39385450|FG000|China Period|Physician Decision|0|||
16246270|NCT02763579|39385451|FG001|China Period|Physician Decision|0|||
16246271|NCT02763579|39385452|FG002|China Period|Physician Decision|0|||
16246272|NCT02763579|39385453|FG003|China Period|Physician Decision|1|||
16129523|NCT01237587|38962185|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
16129524|NCT01237587|38962184|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
16129525|NCT01237587|38962185|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
16129526|NCT01237587|38962184|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
16129527|NCT01237587|38962185|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
16129528|NCT01237587|38962184|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
16129529|NCT01237587|38962185|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
16129530|NCT01237587|38962184|FG000|Taper Phase|Adverse Event|0|||
16129531|NCT01237587|38962185|FG001|Taper Phase|Adverse Event|2|||
16129532|NCT01237587|38962184|FG000|Taper Phase|Protocol Violation|2|||
16129533|NCT01237587|38962185|FG001|Taper Phase|Protocol Violation|0|||
16129534|NCT01237587|38962184|FG000|Taper Phase|Lack of Efficacy|2|||
16129535|NCT01237587|38962185|FG001|Taper Phase|Lack of Efficacy|5|||
16246273|NCT02763579|39385450|FG000|China Period|Study Terminated By Sponsor|0|||
16246274|NCT02763579|39385451|FG001|China Period|Study Terminated By Sponsor|0|||
16246275|NCT02763579|39385452|FG002|China Period|Study Terminated By Sponsor|3|||
16246276|NCT02763579|39385453|FG003|China Period|Study Terminated By Sponsor|4|||
16246277|NCT02763579|39385450|FG000|China Period|Withdrawal by Subject|0|||
16246278|NCT02763579|39385451|FG001|China Period|Withdrawal by Subject|0|||
16246279|NCT02763579|39385452|FG002|China Period|Withdrawal by Subject|3|||
16246280|NCT02763579|39385453|FG003|China Period|Withdrawal by Subject|3|||
16246281|NCT00876733|39385456|FG000|Overall Study|Adverse Event|34|||
16246282|NCT00876733|39385457|FG001|Overall Study|Adverse Event|20|||
16246283|NCT00876733|39385458|FG002|Overall Study|Adverse Event|10|||
16246284|NCT00876733|39385459|FG003|Overall Study|Adverse Event|3|||
16246285|NCT00876733|39385456|FG000|Overall Study|Lack of Efficacy|17|||
16246286|NCT00876733|39385457|FG001|Overall Study|Lack of Efficacy|9|||
16246287|NCT00876733|39385458|FG002|Overall Study|Lack of Efficacy|10|||
16246288|NCT00876733|39385459|FG003|Overall Study|Lack of Efficacy|1|||
16246289|NCT00876733|39385456|FG000|Overall Study|Lost to Follow-up|26|||
16246290|NCT00876733|39385457|FG001|Overall Study|Lost to Follow-up|10|||
16246291|NCT00876733|39385458|FG002|Overall Study|Lost to Follow-up|3|||
16246292|NCT00876733|39385459|FG003|Overall Study|Lost to Follow-up|2|||
16246293|NCT00876733|39385456|FG000|Overall Study|Data not available|14|||
16246294|NCT00876733|39385457|FG001|Overall Study|Data not available|3|||
16246295|NCT00876733|39385458|FG002|Overall Study|Data not available|7|||
16246296|NCT00876733|39385459|FG003|Overall Study|Data not available|1|||
16246297|NCT01785875|39385460|FG000|Overall Study|Withdrawal by Subject|41|||
16246298|NCT01785875|39385461|FG001|Overall Study|Withdrawal by Subject|34|||
16246299|NCT01785875|39385462|FG002|Overall Study|Withdrawal by Subject|36|||
16246300|NCT01785875|39385460|FG000|Overall Study|Lost to Follow-up|19|||
16246301|NCT01785875|39385461|FG001|Overall Study|Lost to Follow-up|22|||
16246302|NCT01785875|39385462|FG002|Overall Study|Lost to Follow-up|6|||
16246303|NCT01785875|39385460|FG000|Overall Study|Death|27|||
16246304|NCT01785875|39385461|FG001|Overall Study|Death|16|||
16246305|NCT01785875|39385462|FG002|Overall Study|Death|7|||
16246306|NCT01785875|39385460|FG000|Overall Study|Sponsor Decision|0|||
16246307|NCT01785875|39385461|FG001|Overall Study|Sponsor Decision|2|||
16246308|NCT01785875|39385462|FG002|Overall Study|Sponsor Decision|0|||
16246309|NCT01785875|39385460|FG000|Overall Study|Protocol Specified Criteria|207|||
16246310|NCT01785875|39385461|FG001|Overall Study|Protocol Specified Criteria|214|||
16246311|NCT01785875|39385462|FG002|Overall Study|Protocol Specified Criteria|55|||
16246312|NCT01785875|39385460|FG000|Overall Study|Missing|0|||
16246313|NCT01785875|39385461|FG001|Overall Study|Missing|1|||
16246314|NCT01785875|39385462|FG002|Overall Study|Missing|3|||
16246315|NCT04242186|39385463|FG000|Overall Study|Death|5|||
16246316|NCT02418910|39385466|FG000|Overall Study|Lost to Follow-up|3|||
16246317|NCT02418910|39385466|FG000|Overall Study|Withdrawal by Subject|4|||
16246318|NCT01244815|39385467|FG000|Overall Study|Not Treated|0|||
16246319|NCT01244815|39385468|FG001|Overall Study|Not Treated|1|||
16246320|NCT01244815|39385469|FG002|Overall Study|Not Treated|0|||
16246321|NCT01244815|39385470|FG003|Overall Study|Not Treated|0|||
16246322|NCT01244815|39385467|FG000|Overall Study|Adverse Event|4|||
16246323|NCT01244815|39385468|FG001|Overall Study|Adverse Event|7|||
16246324|NCT01244815|39385469|FG002|Overall Study|Adverse Event|5|||
16246325|NCT01244815|39385470|FG003|Overall Study|Adverse Event|5|||
16246326|NCT01244815|39385467|FG000|Overall Study|Treatment Failure|0|||
16246327|NCT01244815|39385468|FG001|Overall Study|Treatment Failure|0|||
16246328|NCT01244815|39385469|FG002|Overall Study|Treatment Failure|0|||
16246329|NCT01244815|39385470|FG003|Overall Study|Treatment Failure|1|||
16246330|NCT01244815|39385467|FG000|Overall Study|Lost to Follow-up|3|||
16246331|NCT01244815|39385468|FG001|Overall Study|Lost to Follow-up|2|||
16246332|NCT01244815|39385469|FG002|Overall Study|Lost to Follow-up|3|||
16417116|NCT00094107|40008465|FG000|Overall Study|Adverse Event|3|||
16246333|NCT01244815|39385470|FG003|Overall Study|Lost to Follow-up|2|||
16246334|NCT01244815|39385467|FG000|Overall Study|Withdrawal by Subject|0|||
16417117|NCT00094107|40008465|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
16246335|NCT01244815|39385468|FG001|Overall Study|Withdrawal by Subject|2|||
16246336|NCT01244815|39385469|FG002|Overall Study|Withdrawal by Subject|0|||
16246337|NCT01244815|39385470|FG003|Overall Study|Withdrawal by Subject|3|||
16246338|NCT01244815|39385467|FG000|Overall Study|Protocol Violation|7|||
16246339|NCT01244815|39385468|FG001|Overall Study|Protocol Violation|4|||
16246340|NCT01244815|39385469|FG002|Overall Study|Protocol Violation|3|||
16246341|NCT01244815|39385470|FG003|Overall Study|Protocol Violation|1|||
16246342|NCT01244815|39385467|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
16246343|NCT01244815|39385468|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
16246344|NCT01244815|39385469|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
16352402|NCT03428100|39776631|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
16129536|NCT01237587|38962184|FG000|Taper Phase|Parent/Guardian Decision|0|||
16129537|NCT01237587|38962185|FG001|Taper Phase|Parent/Guardian Decision|2|||
16129538|NCT01237587|38962184|FG000|Taper Phase|Sponsor Decision|1|||
16129539|NCT01237587|38962185|FG001|Taper Phase|Sponsor Decision|0|||
16129540|NCT01237587|38962184|FG000|Taper Phase|Withdrawal by Subject|0|||
16129541|NCT01237587|38962185|FG001|Taper Phase|Withdrawal by Subject|1|||
16129542|NCT02294227|38962186|FG000|Overall Study|Death|0|||
16129543|NCT02294227|38962187|FG001|Overall Study|Death|0|||
16129544|NCT02294227|38962188|FG002|Overall Study|Death|1|||
16129545|NCT02294227|38962186|FG000|Overall Study|Subject/Guardian Decision|6|||
16129546|NCT02294227|38962187|FG001|Overall Study|Subject/Guardian Decision|3|||
16129547|NCT02294227|38962188|FG002|Overall Study|Subject/Guardian Decision|7|||
16129548|NCT02294227|38962186|FG000|Overall Study|Physician Decision|1|||
16129549|NCT02294227|38962187|FG001|Overall Study|Physician Decision|2|||
16129550|NCT02294227|38962188|FG002|Overall Study|Physician Decision|1|||
16129551|NCT02294227|38962186|FG000|Overall Study|Lost to Follow-up|1|||
16129552|NCT02294227|38962187|FG001|Overall Study|Lost to Follow-up|0|||
16129553|NCT02294227|38962188|FG002|Overall Study|Lost to Follow-up|0|||
16129554|NCT02294227|38962186|FG000|Overall Study|Lack of Efficacy|11|||
16129555|NCT02294227|38962187|FG001|Overall Study|Lack of Efficacy|12|||
16129556|NCT02294227|38962188|FG002|Overall Study|Lack of Efficacy|8|||
16129557|NCT02294227|38962186|FG000|Overall Study|Adverse Event|6|||
16129558|NCT02294227|38962187|FG001|Overall Study|Adverse Event|8|||
16129559|NCT02294227|38962188|FG002|Overall Study|Adverse Event|2|||
16129560|NCT02447172|38962189|FG000|Overall Study|Adverse Event|11|||
16129561|NCT02447172|38962190|FG001|Overall Study|Adverse Event|8|||
16129562|NCT02447172|38962191|FG002|Overall Study|Adverse Event|7|||
16129563|NCT02447172|38962189|FG000|Overall Study|Death|3|||
16129564|NCT02447172|38962190|FG001|Overall Study|Death|1|||
16129565|NCT02447172|38962191|FG002|Overall Study|Death|0|||
16129566|NCT02447172|38962189|FG000|Overall Study|Protocol Violation|2|||
16129567|NCT02447172|38962190|FG001|Overall Study|Protocol Violation|1|||
16129568|NCT02447172|38962191|FG002|Overall Study|Protocol Violation|2|||
16129569|NCT02447172|38962189|FG000|Overall Study|Lost to Follow-up|7|||
16129570|NCT02447172|38962190|FG001|Overall Study|Lost to Follow-up|4|||
16129571|NCT02447172|38962191|FG002|Overall Study|Lost to Follow-up|4|||
16129572|NCT02447172|38962189|FG000|Overall Study|Withdrawal by Subject|5|||
16129573|NCT02447172|38962190|FG001|Overall Study|Withdrawal by Subject|1|||
16129574|NCT02447172|38962191|FG002|Overall Study|Withdrawal by Subject|3|||
16129575|NCT02447172|38962189|FG000|Overall Study|protocol specific treatment unrelated|3|||
16129576|NCT02447172|38962190|FG001|Overall Study|protocol specific treatment unrelated|0|||
16129577|NCT02447172|38962191|FG002|Overall Study|protocol specific treatment unrelated|2|||
16129578|NCT01675479|38962211|FG000|Overall Study|Lost to Follow-up|11|||
16129579|NCT01844687|38962215|FG000|Visit 1|Protocol Violation|3|||
16129580|NCT01844687|38962215|FG000|Visit 1|Lost to Follow-up|5|||
16129581|NCT01844687|38962215|FG000|Visit 2|Withdrawal by Subject|1|||
16129582|NCT01844687|38962215|FG000|Visit 2|Protocol Violation|1|||
16246345|NCT01244815|39385470|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
16246346|NCT01904383|39385471|FG000|Overall Study|CRF not collected|117|||
16246347|NCT01904383|39385471|FG000|Overall Study|Reason not listed|147|||
16246348|NCT01904383|39385471|FG000|Overall Study|Lost to Follow-up|674|||
16246349|NCT01904383|39385471|FG000|Overall Study|Lack of Efficacy|370|||
16246350|NCT01904383|39385471|FG000|Overall Study|Improvement|141|||
16246351|NCT01904383|39385471|FG000|Overall Study|Adverse Event|271|||
16246352|NCT01904383|39385471|FG000|Overall Study|No patient visit after entry|54|||
16246353|NCT00472446|39385472|FG000|Overall Study|Protocol Violation|0|||
16246354|NCT00472446|39385473|FG001|Overall Study|Protocol Violation|0|||
16246355|NCT00472446|39385474|FG002|Overall Study|Protocol Violation|0|||
16246356|NCT00472446|39385475|FG003|Overall Study|Protocol Violation|1|||
16246357|NCT00472446|39385472|FG000|Overall Study|Reintervention|0|||
16417118|NCT04732949|40008466|FG000|Overall Study|Withdrawal by Subject|23|||
16246358|NCT00472446|39385473|FG001|Overall Study|Reintervention|0|||
16246359|NCT00472446|39385474|FG002|Overall Study|Reintervention|1|||
16246360|NCT00472446|39385475|FG003|Overall Study|Reintervention|1|||
16246361|NCT00472446|39385472|FG000|Overall Study|Questionnaires not returned|5|||
16246362|NCT00472446|39385473|FG001|Overall Study|Questionnaires not returned|6|||
16246363|NCT00472446|39385474|FG002|Overall Study|Questionnaires not returned|6|||
16246364|NCT00472446|39385475|FG003|Overall Study|Questionnaires not returned|4|||
16246365|NCT03770000|39385476|FG000|Overall Study|Premature discontinuation due to PD|0|||
16246366|NCT03770000|39385477|FG001|Overall Study|Premature discontinuation due to PD|0|||
16246367|NCT03770000|39385478|FG002|Overall Study|Premature discontinuation due to PD|1|||
16246368|NCT03770000|39385479|FG003|Overall Study|Premature discontinuation due to PD|3|||
16246369|NCT03770000|39385480|FG004|Overall Study|Premature discontinuation due to PD|2|||
16246370|NCT00909727|39385481|FG000|Overall Study|Adverse Event|1|||
16246371|NCT00909727|39385482|FG001|Overall Study|Adverse Event|0|||
16246372|NCT00909727|39385481|FG000|Overall Study|Wrong Genotype|1|||
16246373|NCT00909727|39385482|FG001|Overall Study|Wrong Genotype|0|||
16246374|NCT00909727|39385481|FG000|Overall Study|Withdrawal of Consent|1|||
16246375|NCT00909727|39385482|FG001|Overall Study|Withdrawal of Consent|0|||
16246376|NCT00909727|39385481|FG000|Overall Study|Prohibited Medication|1|||
16246377|NCT00909727|39385482|FG001|Overall Study|Prohibited Medication|0|||
16246378|NCT00614055|39385483|FG000|Overall Study|Adverse Event|1|||
16246379|NCT00614055|39385484|FG001|Overall Study|Adverse Event|0|||
16246380|NCT00614055|39385485|FG002|Overall Study|Adverse Event|0|||
16246381|NCT00614055|39385483|FG000|Overall Study|Protocol Violation|2|||
16352403|NCT03428100|39776632|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
16352404|NCT03428100|39776633|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
16352405|NCT03428100|39776634|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
16352406|NCT03428100|39776635|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
16352407|NCT03428100|39776636|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
16352408|NCT03428100|39776637|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
16352409|NCT03428100|39776638|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
16352410|NCT03428100|39776639|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
16352411|NCT03428100|39776640|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
16352412|NCT03428100|39776641|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
16352413|NCT03428100|39776642|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
16352414|NCT03428100|39776624|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
16352415|NCT03428100|39776625|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
16352416|NCT03428100|39776626|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
16352417|NCT03428100|39776627|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
16352418|NCT03428100|39776628|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
16352419|NCT03428100|39776629|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
16417119|NCT04732949|40008467|FG001|Overall Study|Withdrawal by Subject|27|||
16417120|NCT04732949|40008466|FG000|Overall Study|Protocol Violation|0|||
16417121|NCT04732949|40008467|FG001|Overall Study|Protocol Violation|1|||
16417122|NCT04732949|40008466|FG000|Overall Study|Non-compliance|0|||
16417123|NCT04732949|40008467|FG001|Overall Study|Non-compliance|2|||
16417124|NCT04732949|40008466|FG000|Overall Study|Physician Decision|2|||
16417125|NCT04732949|40008467|FG001|Overall Study|Physician Decision|1|||
16417126|NCT04732949|40008466|FG000|Overall Study|Serious adverse event (Fatal)|16|||
16417127|NCT04732949|40008467|FG001|Overall Study|Serious adverse event (Fatal)|18|||
16417128|NCT04732949|40008466|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
16417129|NCT04732949|40008467|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
16417130|NCT04732949|40008466|FG000|Overall Study|Non-serious adverse event|1|||
16417131|NCT04732949|40008467|FG001|Overall Study|Non-serious adverse event|3|||
16417132|NCT04732949|40008466|FG000|Overall Study|Lost to Follow-up|26|||
16417133|NCT04732949|40008467|FG001|Overall Study|Lost to Follow-up|27|||
16417134|NCT04732949|40008466|FG000|Overall Study|Other|6|||
16246382|NCT00614055|39385484|FG001|Overall Study|Protocol Violation|2|||
16246383|NCT00614055|39385485|FG002|Overall Study|Protocol Violation|1|||
16246384|NCT00614055|39385483|FG000|Overall Study|Lack of Efficacy|0|||
16246385|NCT00614055|39385484|FG001|Overall Study|Lack of Efficacy|0|||
16352420|NCT03428100|39776630|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
16246386|NCT00614055|39385485|FG002|Overall Study|Lack of Efficacy|2|||
16246387|NCT00614055|39385483|FG000|Overall Study|Unclassified|1|||
16246388|NCT00614055|39385484|FG001|Overall Study|Unclassified|4|||
16246389|NCT00614055|39385485|FG002|Overall Study|Unclassified|2|||
16417135|NCT04732949|40008467|FG001|Overall Study|Other|3|||
16417136|NCT00494507|40008470|FG000|Double-Blind Phase|Adverse Event|2|||
16417137|NCT00494507|40008471|FG001|Double-Blind Phase|Adverse Event|0|||
16417138|NCT00494507|40008472|FG002|Double-Blind Phase|Adverse Event|1|||
16417139|NCT00494507|40008473|FG003|Double-Blind Phase|Adverse Event|0|||
16417140|NCT00494507|40008470|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
16417141|NCT00494507|40008471|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
16417142|NCT00494507|40008472|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
16417143|NCT00494507|40008473|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
16417144|NCT00494507|40008470|FG000|Double-Blind Phase|Subject Non-compliance|0|||
16417145|NCT00494507|40008471|FG001|Double-Blind Phase|Subject Non-compliance|0|||
16417146|NCT00494507|40008472|FG002|Double-Blind Phase|Subject Non-compliance|1|||
16417147|NCT00494507|40008473|FG003|Double-Blind Phase|Subject Non-compliance|0|||
16417148|NCT00494507|40008470|FG000|Double-Blind Phase|Negative DNA test|0|||
16417149|NCT00494507|40008471|FG001|Double-Blind Phase|Negative DNA test|0|||
16417150|NCT00494507|40008472|FG002|Double-Blind Phase|Negative DNA test|0|||
16417151|NCT00494507|40008473|FG003|Double-Blind Phase|Negative DNA test|1|||
16417152|NCT00494507|40008470|FG000|Open-Label Phase|Adverse Event|0|||
16417153|NCT00494507|40008471|FG001|Open-Label Phase|Adverse Event|1|||
16417154|NCT00494507|40008472|FG002|Open-Label Phase|Adverse Event|5|||
16417155|NCT00494507|40008473|FG003|Open-Label Phase|Adverse Event|3|||
16417156|NCT00494507|40008470|FG000|Open-Label Phase|Worsening Disease|0|||
16417157|NCT00494507|40008471|FG001|Open-Label Phase|Worsening Disease|0|||
16417158|NCT00494507|40008472|FG002|Open-Label Phase|Worsening Disease|0|||
16417159|NCT00494507|40008473|FG003|Open-Label Phase|Worsening Disease|2|||
16417160|NCT00456599|40008474|FG000|Overall Study|Non-compliance|1|||
16417161|NCT00456599|40008474|FG000|Overall Study|Withdrawal by Subject|2|||
16417162|NCT01825941|40008476|FG000|Overall Study|Lost to Follow-up|4|||
16417163|NCT01825941|40008477|FG001|Overall Study|Lost to Follow-up|1|||
16417164|NCT00837759|40008479|FG000|Overall Study|Protocol Violation|3|||
16417165|NCT00837759|40008479|FG000|Overall Study|Lost to Follow-up|1|||
16417166|NCT00734071|40008480|FG000|Overall Study|Adverse Event|4|||
16417167|NCT00734071|40008481|FG001|Overall Study|Adverse Event|3|||
16417168|NCT00734071|40008480|FG000|Overall Study|Lack of Efficacy|3|||
16417169|NCT00734071|40008481|FG001|Overall Study|Lack of Efficacy|1|||
16417170|NCT00734071|40008480|FG000|Overall Study|Noncompliance|2|||
16417171|NCT00734071|40008481|FG001|Overall Study|Noncompliance|2|||
16417172|NCT00734071|40008480|FG000|Overall Study|Protocol Deviations|3|||
16417173|NCT00734071|40008481|FG001|Overall Study|Protocol Deviations|4|||
16417174|NCT00734071|40008480|FG000|Overall Study|Voluntary Withdrawal|9|||
16417175|NCT00734071|40008481|FG001|Overall Study|Voluntary Withdrawal|7|||
16417176|NCT00734071|40008480|FG000|Overall Study|Lost to Follow-up|16|||
16417177|NCT00734071|40008481|FG001|Overall Study|Lost to Follow-up|8|||
16417178|NCT00734071|40008480|FG000|Overall Study|Other|1|||
16417179|NCT00734071|40008481|FG001|Overall Study|Other|2|||
16417180|NCT03040986|40008483|FG000|Overall Study|Hospice|1|||
16417181|NCT03040986|40008484|FG001|Overall Study|Hospice|0|||
16417182|NCT03040986|40008483|FG000|Overall Study|Adverse Event|2|||
16417183|NCT03040986|40008484|FG001|Overall Study|Adverse Event|1|||
16417184|NCT03040986|40008483|FG000|Overall Study|Disease progression on study|3|||
16417185|NCT03040986|40008484|FG001|Overall Study|Disease progression on study|1|||
16560252|NCT03005288|40517522|FG001|Overall Study|Protocol deviation|1|||
16560253|NCT03005288|40517521|FG000|Overall Study|Physician Decision|0|||
16560254|NCT03005288|40517522|FG001|Overall Study|Physician Decision|1|||
16560255|NCT03499600|40517535|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
16560256|NCT03499600|40517536|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
16246390|NCT00455533|39385486|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
16246391|NCT00455533|39385487|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
16246392|NCT00455533|39385488|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
16246393|NCT00455533|39385486|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
16246394|NCT00455533|39385487|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
16246395|NCT00455533|39385488|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
16246396|NCT00455533|39385486|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
16246397|NCT00455533|39385487|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
16246398|NCT00455533|39385488|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
16246399|NCT00455533|39385486|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
16246400|NCT00455533|39385487|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
16246401|NCT00455533|39385488|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
16417186|NCT00940485|40008485|FG000|Overall Study|HBeAb positive at Baseline|3|||
16417187|NCT00940485|40008486|FG001|Overall Study|HBeAb positive at Baseline|2|||
16417188|NCT00940485|40008485|FG000|Overall Study|Lost to Follow-up|2|||
16417189|NCT00940485|40008486|FG001|Overall Study|Lost to Follow-up|3|||
16129583|NCT01844687|38962215|FG000|Visit 3|Lost to Follow-up|1|||
16129584|NCT01844687|38962215|FG000|Visit 3|Withdrawal by Subject|3|||
16129585|NCT01844687|38962215|FG000|Visit 3|child care problems|1|||
16129586|NCT01844687|38962215|FG000|Visit 4|Pregnancy|1|||
16129587|NCT01844687|38962215|FG000|Visit 4|Lost to Follow-up|1|||
16129588|NCT01844687|38962215|FG000|Visit 4|Withdrawal by Subject|2|||
16129589|NCT00468104|38962216|FG000|First Intervention|Protocol Violation|2|||
16129590|NCT00468104|38962217|FG001|First Intervention|Protocol Violation|1|||
16129591|NCT00468104|38962216|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
16129592|NCT00468104|38962217|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
16129593|NCT00468104|38962216|FG000|First Intervention|died within 3 weeks|1|||
16129594|NCT00468104|38962217|FG001|First Intervention|died within 3 weeks|0|||
16129595|NCT00468104|38962216|FG000|First Intervention|malposition/blocked chest tube tube|2|||
16129596|NCT00468104|38962217|FG001|First Intervention|malposition/blocked chest tube tube|0|||
16129597|NCT00468104|38962216|FG000|First Intervention|large lung mass with minimal effusion|1|||
16129598|NCT00468104|38962217|FG001|First Intervention|large lung mass with minimal effusion|0|||
16129599|NCT00468104|38962216|FG000|First Intervention|associated prolonged pneumothorax|1|||
16129600|NCT00468104|38962217|FG001|First Intervention|associated prolonged pneumothorax|0|||
16129601|NCT00468104|38962216|FG000|First Intervention|trapped lung|1|||
16129602|NCT00468104|38962217|FG001|First Intervention|trapped lung|0|||
16129603|NCT00468104|38962216|FG000|Second Intervention|Withdrawal by Subject|5|||
16129604|NCT00468104|38962217|FG001|Second Intervention|Withdrawal by Subject|2|||
16129605|NCT00468104|38962216|FG000|Second Intervention|discarded for malposition of chest tube|0|||
16129606|NCT00468104|38962217|FG001|Second Intervention|discarded for malposition of chest tube|2|||
16129607|NCT01323647|38962218|FG000|Overall Study|Migrated/moved from study area|2|||
16129608|NCT01323647|38962219|FG001|Overall Study|Migrated/moved from study area|0|||
16129609|NCT01323647|38962218|FG000|Overall Study|Withdrawal by Subject|5|||
16129610|NCT01323647|38962219|FG001|Overall Study|Withdrawal by Subject|0|||
16129611|NCT01323647|38962218|FG000|Overall Study|Lost to Follow-up|2|||
16129612|NCT01323647|38962219|FG001|Overall Study|Lost to Follow-up|0|||
16129613|NCT00818649|38962220|FG000|Overall Study|Declining performance status|2|||
16129614|NCT00818649|38962220|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
16129615|NCT00818649|38962220|FG000|Overall Study|Adverse Event|1|||
16129616|NCT01942590|38962222|FG000|Overall Study|Withdrawal by Subject|0|||
16129617|NCT01942590|38962223|FG001|Overall Study|Withdrawal by Subject|1|||
16129618|NCT01942590|38962222|FG000|Overall Study|Adverse Event|1|||
16129619|NCT01942590|38962223|FG001|Overall Study|Adverse Event|0|||
16129620|NCT01183234|38962227|FG000|First Intervention|Adverse Event|1|||
16129621|NCT01183234|38962228|FG001|First Intervention|Adverse Event|0|||
16129622|NCT01328717|38962229|FG000|Overall Study|Adverse Event|1|||
16129623|NCT00370682|38962230|FG000|Overall Study|Moved from area|0|||
16129624|NCT00370682|38962231|FG001|Overall Study|Moved from area|2|||
16129625|NCT00370682|38962232|FG002|Overall Study|Moved from area|0|||
16129626|NCT00370682|38962230|FG000|Overall Study|Lost to Follow-up|0|||
16129627|NCT00370682|38962231|FG001|Overall Study|Lost to Follow-up|1|||
16129628|NCT00370682|38962232|FG002|Overall Study|Lost to Follow-up|1|||
16129629|NCT02374671|38962233|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
16129630|NCT02374671|38962234|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
16129631|NCT02374671|38962235|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
16129632|NCT02374671|38962233|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
16129633|NCT02374671|38962234|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
16417190|NCT00940485|40008485|FG000|Overall Study|Adverse Event|8|||
16417191|NCT00940485|40008486|FG001|Overall Study|Adverse Event|0|||
16417192|NCT00940485|40008485|FG000|Overall Study|Withdrawal by Subject|1|||
16417193|NCT00940485|40008486|FG001|Overall Study|Withdrawal by Subject|1|||
16417194|NCT00940485|40008485|FG000|Overall Study|Others|1|||
16417195|NCT00940485|40008486|FG001|Overall Study|Others|1|||
16417196|NCT02345330|40008487|FG000|Overall Study|Death|1|||
16417197|NCT02345330|40008487|FG000|Overall Study|Progressive Disease|2|||
16417198|NCT01105377|40008488|FG000|Overall Study|Withdrawal by Subject|0|||
16417199|NCT01105377|40008489|FG001|Overall Study|Withdrawal by Subject|1|||
16417200|NCT03233438|40008490|FG000|Overall Study|Lost to Follow-up|4|||
16417201|NCT03233438|40008491|FG001|Overall Study|Lost to Follow-up|9|||
16417202|NCT03233438|40008490|FG000|Overall Study|Withdrawal by Subject|2|||
16417203|NCT03233438|40008491|FG001|Overall Study|Withdrawal by Subject|1|||
16417204|NCT03233438|40008490|FG000|Overall Study|No recording of dalbavancin|0|||
16417205|NCT03233438|40008491|FG001|Overall Study|No recording of dalbavancin|1|||
16417206|NCT00710385|40008492|FG000|Overall Study|Did not qualify|1|||
16417207|NCT00710385|40008492|FG000|Overall Study|Withdrawal by Subject|1|||
16417208|NCT00710385|40008492|FG000|Overall Study|Undisclosed back pain|1|||
16417209|NCT00710385|40008492|FG000|Overall Study|Physician Decision|1|||
16417210|NCT00710385|40008492|FG000|Overall Study|Undisclosed excessive methadone use|1|||
16417211|NCT03442296|40008493|FG000|3 Month Follow-up|Death|3|||
16417212|NCT03442296|40008494|FG001|3 Month Follow-up|Death|1|||
16417213|NCT03442296|40008493|FG000|3 Month Follow-up|Lost to Follow-up|1|||
16417214|NCT03442296|40008494|FG001|3 Month Follow-up|Lost to Follow-up|1|||
16417215|NCT03442296|40008493|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
16417216|NCT03442296|40008494|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
16417217|NCT03442296|40008493|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
16417218|NCT03442296|40008494|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
16417219|NCT03442296|40008493|FG000|12 Month Follow-up|Incomplete measurement|1|||
16417220|NCT03442296|40008494|FG001|12 Month Follow-up|Incomplete measurement|1|||
16417221|NCT00300365|40008495|FG000|Overall Study|Lost to Follow-up|1|||
16417222|NCT00300365|40008496|FG001|Overall Study|Lost to Follow-up|0|||
16417223|NCT00300365|40008495|FG000|Overall Study|Physician Decision|2|||
16417224|NCT00300365|40008496|FG001|Overall Study|Physician Decision|0|||
16417225|NCT00300365|40008495|FG000|Overall Study|Withdrawal by Subject|1|||
16417226|NCT00300365|40008496|FG001|Overall Study|Withdrawal by Subject|0|||
16417227|NCT00300365|40008495|FG000|Overall Study|Adverse Event|0|||
16417228|NCT00300365|40008496|FG001|Overall Study|Adverse Event|2|||
16417229|NCT02925728|40008497|FG000|Overall Study|Death|3|||
16417230|NCT02925728|40008498|FG001|Overall Study|Death|5|||
16417231|NCT02925728|40008497|FG000|Overall Study|Physician Decision|1|||
16417232|NCT02925728|40008498|FG001|Overall Study|Physician Decision|0|||
16417233|NCT02925728|40008497|FG000|Overall Study|Withdrawal by Subject|1|||
16417234|NCT02925728|40008498|FG001|Overall Study|Withdrawal by Subject|0|||
16417235|NCT04038567|40008499|FG000|Overall Study|Lost to Follow-up|6|||
16417236|NCT04038567|40008500|FG001|Overall Study|Lost to Follow-up|4|||
16417237|NCT04038567|40008501|FG002|Overall Study|Lost to Follow-up|5|||
16417238|NCT04038567|40008502|FG003|Overall Study|Lost to Follow-up|4|||
16417239|NCT04038567|40008503|FG004|Overall Study|Lost to Follow-up|6|||
16417240|NCT04038567|40008504|FG005|Overall Study|Lost to Follow-up|4|||
16417241|NCT04038567|40008505|FG006|Overall Study|Lost to Follow-up|4|||
16560257|NCT02325713|40517537|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560258|NCT02325713|40517538|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560259|NCT02325713|40517539|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560260|NCT02325713|40517540|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560261|NCT02325713|40517541|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560262|NCT02325713|40517542|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560263|NCT02325713|40517543|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560264|NCT02325713|40517544|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560265|NCT02325713|40517545|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16417242|NCT04038567|40008506|FG007|Overall Study|Lost to Follow-up|1|||
16129634|NCT02374671|38962235|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
16129635|NCT02374671|38962233|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
16129636|NCT02374671|38962234|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
16129637|NCT02374671|38962235|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
16129638|NCT02374671|38962233|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
16129639|NCT02374671|38962234|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
16129640|NCT02374671|38962235|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
16129641|NCT02374671|38962233|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
16129642|NCT02374671|38962234|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
16129643|NCT02374671|38962235|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
16129644|NCT01182194|38962236|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
16129645|NCT01182194|38962237|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
16129646|NCT02481947|38962238|FG000|Overall Study|Withdrawal by Subject|24|||
16129647|NCT02481947|38962239|FG001|Overall Study|Withdrawal by Subject|10|||
16129648|NCT02481947|38962238|FG000|Overall Study|Lost to Follow-up|11|||
16129649|NCT02481947|38962239|FG001|Overall Study|Lost to Follow-up|5|||
16129650|NCT02481947|38962238|FG000|Overall Study|Adverse Event|6|||
16129651|NCT02481947|38962239|FG001|Overall Study|Adverse Event|11|||
16129652|NCT02481947|38962238|FG000|Overall Study|Physician Decision|4|||
16129653|NCT02481947|38962239|FG001|Overall Study|Physician Decision|5|||
16129654|NCT02481947|38962238|FG000|Overall Study|Protocol Violation|1|||
16129655|NCT02481947|38962239|FG001|Overall Study|Protocol Violation|5|||
16129656|NCT02292927|38962240|FG000|Overall Study|Protocol Violation|13|||
16129657|NCT02292927|38962241|FG001|Overall Study|Protocol Violation|7|||
16129658|NCT02572882|38962242|FG000|Overall Study|Withdrawal by Subject|1|||
16129659|NCT02572882|38962242|FG000|Overall Study|Participant received kidney transplant|1|||
16352421|NCT03428100|39776631|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
16129660|NCT01278173|38962244|FG000|Overall Study|Lack of Efficacy|13|||
16129661|NCT01278173|38962244|FG000|Overall Study|Adverse Event|8|||
16129662|NCT01278173|38962244|FG000|Overall Study|Administrative or other reason|4|||
16129663|NCT01278173|38962244|FG000|Overall Study|Protocol Violation|1|||
16129664|NCT01278173|38962244|FG000|Overall Study|Withdrawal by Subject|1|||
16129665|NCT02457559|38962245|FG000|Overall Study|Progressive Disease|1|||
16129666|NCT02457559|38962246|FG001|Overall Study|Progressive Disease|2|||
16129667|NCT02457559|38962247|FG002|Overall Study|Progressive Disease|3|||
16129668|NCT02457559|38962248|FG003|Overall Study|Progressive Disease|0|||
16129669|NCT02457559|38962249|FG004|Overall Study|Progressive Disease|0|||
16129670|NCT02457559|38962250|FG005|Overall Study|Progressive Disease|2|||
16129671|NCT02457559|38962251|FG006|Overall Study|Progressive Disease|1|||
16129672|NCT02457559|38962252|FG007|Overall Study|Progressive Disease|0|||
16129673|NCT02457559|38962253|FG008|Overall Study|Progressive Disease|1|||
16129674|NCT02457559|38962254|FG009|Overall Study|Progressive Disease|1|||
16129675|NCT02457559|38962255|FG010|Overall Study|Progressive Disease|1|||
16129676|NCT02457559|38962245|FG000|Overall Study|Investigator's Discretion|0|||
16129677|NCT02457559|38962246|FG001|Overall Study|Investigator's Discretion|0|||
16129678|NCT02457559|38962247|FG002|Overall Study|Investigator's Discretion|2|||
16129679|NCT02457559|38962248|FG003|Overall Study|Investigator's Discretion|0|||
16129680|NCT02457559|38962249|FG004|Overall Study|Investigator's Discretion|1|||
16129681|NCT02457559|38962250|FG005|Overall Study|Investigator's Discretion|0|||
16129682|NCT02457559|38962251|FG006|Overall Study|Investigator's Discretion|1|||
16129683|NCT02457559|38962252|FG007|Overall Study|Investigator's Discretion|0|||
16129684|NCT02457559|38962253|FG008|Overall Study|Investigator's Discretion|1|||
16129685|NCT02457559|38962254|FG009|Overall Study|Investigator's Discretion|0|||
16129686|NCT02457559|38962255|FG010|Overall Study|Investigator's Discretion|1|||
16129687|NCT02457559|38962245|FG000|Overall Study|Adverse Event|0|||
16129688|NCT02457559|38962246|FG001|Overall Study|Adverse Event|1|||
16129689|NCT02457559|38962247|FG002|Overall Study|Adverse Event|2|||
16129690|NCT02457559|38962248|FG003|Overall Study|Adverse Event|0|||
16129691|NCT02457559|38962249|FG004|Overall Study|Adverse Event|0|||
16129692|NCT02457559|38962250|FG005|Overall Study|Adverse Event|0|||
16129693|NCT02457559|38962251|FG006|Overall Study|Adverse Event|0|||
16129694|NCT02457559|38962252|FG007|Overall Study|Adverse Event|0|||
16129695|NCT02457559|38962253|FG008|Overall Study|Adverse Event|0|||
16129696|NCT02457559|38962254|FG009|Overall Study|Adverse Event|0|||
16129697|NCT02457559|38962255|FG010|Overall Study|Adverse Event|0|||
16129698|NCT02457559|38962245|FG000|Overall Study|Reason not Specified|1|||
16129699|NCT02457559|38962246|FG001|Overall Study|Reason not Specified|0|||
16129700|NCT02457559|38962247|FG002|Overall Study|Reason not Specified|0|||
16129701|NCT02457559|38962248|FG003|Overall Study|Reason not Specified|0|||
16129702|NCT02457559|38962249|FG004|Overall Study|Reason not Specified|0|||
16129703|NCT02457559|38962250|FG005|Overall Study|Reason not Specified|0|||
16129704|NCT02457559|38962251|FG006|Overall Study|Reason not Specified|0|||
16129705|NCT02457559|38962252|FG007|Overall Study|Reason not Specified|0|||
16129706|NCT02457559|38962253|FG008|Overall Study|Reason not Specified|0|||
16129707|NCT02457559|38962254|FG009|Overall Study|Reason not Specified|2|||
16129708|NCT02457559|38962255|FG010|Overall Study|Reason not Specified|0|||
16129709|NCT02457559|38962245|FG000|Overall Study|Death|0|||
16129710|NCT02457559|38962246|FG001|Overall Study|Death|0|||
16417243|NCT04038567|40008499|FG000|Overall Study|Withdrawal by Subject|2|||
16417244|NCT04038567|40008500|FG001|Overall Study|Withdrawal by Subject|1|||
16417245|NCT04038567|40008501|FG002|Overall Study|Withdrawal by Subject|1|||
16417246|NCT04038567|40008502|FG003|Overall Study|Withdrawal by Subject|1|||
16417247|NCT04038567|40008503|FG004|Overall Study|Withdrawal by Subject|4|||
16129711|NCT02457559|38962247|FG002|Overall Study|Death|0|||
16129712|NCT02457559|38962248|FG003|Overall Study|Death|0|||
16129713|NCT02457559|38962249|FG004|Overall Study|Death|0|||
16129714|NCT02457559|38962250|FG005|Overall Study|Death|0|||
16129715|NCT02457559|38962251|FG006|Overall Study|Death|0|||
16129716|NCT02457559|38962252|FG007|Overall Study|Death|0|||
16129717|NCT02457559|38962253|FG008|Overall Study|Death|1|||
16129718|NCT02457559|38962254|FG009|Overall Study|Death|1|||
16129719|NCT02457559|38962255|FG010|Overall Study|Death|0|||
16129720|NCT02679573|38962261|FG000|Overall Study|Adverse Event|13|||
16129721|NCT02679573|38962262|FG001|Overall Study|Adverse Event|6|||
16129722|NCT02679573|38962261|FG000|Overall Study|Lack of Efficacy|12|||
16129723|NCT02679573|38962262|FG001|Overall Study|Lack of Efficacy|15|||
16129724|NCT02679573|38962261|FG000|Overall Study|Could not complete required study visits|6|||
16129725|NCT02679573|38962262|FG001|Overall Study|Could not complete required study visits|2|||
16129726|NCT02679573|38962261|FG000|Overall Study|Withdrawal by Subject|2|||
16129727|NCT02679573|38962262|FG001|Overall Study|Withdrawal by Subject|9|||
16129728|NCT02679573|38962261|FG000|Overall Study|Death|2|||
16129729|NCT02679573|38962262|FG001|Overall Study|Death|0|||
16129730|NCT02679573|38962261|FG000|Overall Study|Physician Decision|2|||
16129731|NCT02679573|38962262|FG001|Overall Study|Physician Decision|4|||
16129732|NCT02679573|38962261|FG000|Overall Study|Lost to Follow-up|0|||
16129733|NCT02679573|38962262|FG001|Overall Study|Lost to Follow-up|3|||
16129734|NCT01313689|38962263|FG000|24-Week Randomization 1|Adverse Event|10|||
16129735|NCT01313689|38962264|FG001|24-Week Randomization 1|Adverse Event|5|||
16129736|NCT01313689|38962265|FG002|24-Week Randomization 1|Adverse Event|0|||
16129737|NCT01313689|38962266|FG003|24-Week Randomization 1|Adverse Event|0|||
16129738|NCT01313689|38962267|FG004|24-Week Randomization 1|Adverse Event|0|||
16129739|NCT01313689|38962263|FG000|24-Week Randomization 1|Physician Decision|4|||
16129740|NCT01313689|38962264|FG001|24-Week Randomization 1|Physician Decision|5|||
16129741|NCT01313689|38962265|FG002|24-Week Randomization 1|Physician Decision|0|||
16129742|NCT01313689|38962266|FG003|24-Week Randomization 1|Physician Decision|0|||
16129743|NCT01313689|38962267|FG004|24-Week Randomization 1|Physician Decision|0|||
16246402|NCT00455533|39385486|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
16246403|NCT00455533|39385487|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
16352422|NCT03428100|39776632|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
16352423|NCT03428100|39776633|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
16352424|NCT03428100|39776634|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
16352425|NCT03428100|39776635|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
16352426|NCT03428100|39776636|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
16352427|NCT03428100|39776637|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
16129744|NCT01313689|38962263|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
16129745|NCT01313689|38962264|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
16129746|NCT01313689|38962265|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
16352428|NCT03428100|39776638|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
16129747|NCT01313689|38962266|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
16129748|NCT01313689|38962267|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
16129749|NCT01313689|38962263|FG000|24-Week Randomization 2|Adverse Event|0|||
16129750|NCT01313689|38962264|FG001|24-Week Randomization 2|Adverse Event|0|||
16129751|NCT01313689|38962265|FG002|24-Week Randomization 2|Adverse Event|2|||
16129752|NCT01313689|38962266|FG003|24-Week Randomization 2|Adverse Event|0|||
16129753|NCT01313689|38962267|FG004|24-Week Randomization 2|Adverse Event|8|||
16129754|NCT01313689|38962263|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
16129755|NCT01313689|38962264|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
16129756|NCT01313689|38962265|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
16560266|NCT02325713|40517546|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560267|NCT02325713|40517547|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
16560268|NCT02325713|40517548|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560269|NCT02325713|40517549|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560270|NCT02325713|40517550|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560271|NCT02325713|40517551|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560272|NCT02325713|40517552|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
16560273|NCT02325713|40517537|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
16560274|NCT02325713|40517538|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560275|NCT02325713|40517539|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560276|NCT02325713|40517540|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560277|NCT02325713|40517541|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560278|NCT02325713|40517542|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560279|NCT02325713|40517543|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560280|NCT02325713|40517544|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560281|NCT02325713|40517545|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560282|NCT02325713|40517546|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560283|NCT02325713|40517547|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560284|NCT02325713|40517548|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560285|NCT02325713|40517549|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560286|NCT02325713|40517550|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560287|NCT02325713|40517551|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560288|NCT02325713|40517552|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
16560289|NCT02325713|40517537|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560290|NCT02325713|40517538|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560291|NCT02325713|40517539|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560292|NCT02325713|40517540|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560293|NCT02325713|40517541|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560294|NCT02325713|40517542|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560295|NCT02325713|40517543|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560296|NCT02325713|40517544|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560297|NCT02325713|40517545|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560298|NCT02325713|40517546|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
16560299|NCT02325713|40517547|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560300|NCT02325713|40517548|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560301|NCT02325713|40517549|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560302|NCT02325713|40517550|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560303|NCT02325713|40517551|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560304|NCT02325713|40517552|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
16560305|NCT00224133|40517555|FG000|Overall Study|Adverse Event|93|||
16560306|NCT00224133|40517555|FG000|Overall Study|Protocol Violation|6|||
16560307|NCT00224133|40517555|FG000|Overall Study|Withdrawal by Subject|33|||
16560308|NCT00224133|40517555|FG000|Overall Study|Lack of Efficacy|58|||
16560309|NCT00224133|40517555|FG000|Overall Study|Lost to Follow-up|21|||
16560310|NCT00224133|40517555|FG000|Overall Study|Physician Decision|1|||
16560311|NCT00224133|40517555|FG000|Overall Study|Other|14|||
16560312|NCT02408549|40517556|FG000|Overall Study|Adverse Event|15|||
16560313|NCT02408549|40517556|FG000|Overall Study|Death|4|||
16560314|NCT02408549|40517556|FG000|Overall Study|Lack of Efficacy|17|||
16560315|NCT02408549|40517556|FG000|Overall Study|Protocol Violation|4|||
16560316|NCT02408549|40517556|FG000|Overall Study|Lost to Follow-up|6|||
16560317|NCT02408549|40517556|FG000|Overall Study|Consent withdrawn|30|||
16129757|NCT01313689|38962266|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
16129758|NCT01313689|38962267|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
16129759|NCT01313689|38962263|FG000|24-Week Randomization 2|Physician Decision|0|||
16129760|NCT01313689|38962264|FG001|24-Week Randomization 2|Physician Decision|0|||
16129761|NCT01313689|38962265|FG002|24-Week Randomization 2|Physician Decision|0|||
16129762|NCT01313689|38962266|FG003|24-Week Randomization 2|Physician Decision|0|||
16560318|NCT02408549|40517556|FG000|Overall Study|Neurology research program closing at site|1|||
16560319|NCT02408549|40517556|FG000|Overall Study|Site closure|1|||
16560320|NCT02408549|40517556|FG000|Overall Study|Pregnancy|1|||
16560321|NCT02408549|40517556|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
16560322|NCT02408549|40517556|FG000|Overall Study|Subject moved to another place, far from site|1|||
16560323|NCT02408549|40517556|FG000|Overall Study|Study terminated at site|1|||
16560324|NCT03459729|40517557|FG000|Overall Study|Physician Decision|2|||
16560325|NCT00432159|40517558|FG000|Overall Study|Death|0|||
16560326|NCT00432159|40517559|FG001|Overall Study|Death|1|||
16560327|NCT00432159|40517560|FG002|Overall Study|Death|0|||
16129763|NCT01313689|38962267|FG004|24-Week Randomization 2|Physician Decision|4|||
16129764|NCT03271021|38962268|FG000|Overall Study|Adverse Event|3|||
16129765|NCT03271021|38962269|FG001|Overall Study|Adverse Event|2|||
16129766|NCT03271021|38962268|FG000|Overall Study|Withdrawal by Subject|36|||
16129767|NCT03271021|38962269|FG001|Overall Study|Withdrawal by Subject|53|||
16129768|NCT03271021|38962268|FG000|Overall Study|Lost to Follow-up|34|||
16129769|NCT03271021|38962269|FG001|Overall Study|Lost to Follow-up|39|||
16129770|NCT03271021|38962268|FG000|Overall Study|Protocol Violation|6|||
16129771|NCT03271021|38962269|FG001|Overall Study|Protocol Violation|4|||
16129772|NCT03271021|38962268|FG000|Overall Study|Abnormal Lab Results|1|||
16129773|NCT03271021|38962269|FG001|Overall Study|Abnormal Lab Results|0|||
16129774|NCT03271021|38962268|FG000|Overall Study|Miscellaneous|9|||
16129775|NCT03271021|38962269|FG001|Overall Study|Miscellaneous|8|||
16129776|NCT04684394|38962270|FG000|Overall Study|Death|1|||
16129777|NCT04684394|38962271|FG001|Overall Study|Death|2|||
16560328|NCT00432159|40517561|FG003|Overall Study|Death|0|||
16560329|NCT00432159|40517562|FG004|Overall Study|Death|0|||
16560330|NCT00432159|40517558|FG000|Overall Study|Failure|9|||
16560331|NCT00432159|40517559|FG001|Overall Study|Failure|5|||
16560332|NCT00432159|40517560|FG002|Overall Study|Failure|3|||
16246404|NCT00455533|39385488|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
16246405|NCT00455533|39385486|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
16246406|NCT00455533|39385487|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
16129778|NCT04684394|38962270|FG000|Overall Study|Lost to Follow-up|1|||
16129779|NCT04684394|38962271|FG001|Overall Study|Lost to Follow-up|0|||
16246407|NCT00455533|39385488|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
16246408|NCT00455533|39385486|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
16129780|NCT04684394|38962270|FG000|Overall Study|Withdrawal by Subject|2|||
16129781|NCT04684394|38962271|FG001|Overall Study|Withdrawal by Subject|0|||
16129782|NCT04684394|38962270|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
16129783|NCT04684394|38962271|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
16246409|NCT00455533|39385487|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
16560333|NCT00432159|40517561|FG003|Overall Study|Failure|2|||
16560334|NCT00432159|40517562|FG004|Overall Study|Failure|3|||
16246410|NCT00455533|39385488|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
16246411|NCT00455533|39385486|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
16246412|NCT00455533|39385487|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
16246413|NCT00455533|39385488|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
16246414|NCT00455533|39385486|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
16246415|NCT00455533|39385487|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
16246416|NCT00455533|39385488|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
16246417|NCT00455533|39385486|FG000|Period Two: Randomized Period|Death|0|||
16246418|NCT00455533|39385487|FG001|Period Two: Randomized Period|Death|0|||
16246419|NCT00455533|39385488|FG002|Period Two: Randomized Period|Death|3|||
16246420|NCT00455533|39385486|FG000|Period Two: Randomized Period|Disease Progression|0|||
16246421|NCT00455533|39385487|FG001|Period Two: Randomized Period|Disease Progression|1|||
16246422|NCT00455533|39385488|FG002|Period Two: Randomized Period|Disease Progression|1|||
16246423|NCT00455533|39385486|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
16246424|NCT00455533|39385487|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
16246425|NCT00455533|39385488|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
16246426|NCT00455533|39385486|FG000|Period Two: Randomized Period|Other - need reasons|0|||
16246427|NCT00455533|39385487|FG001|Period Two: Randomized Period|Other - need reasons|1|||
16246428|NCT00455533|39385488|FG002|Period Two: Randomized Period|Other - need reasons|0|||
16246429|NCT00455533|39385486|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
16246430|NCT00455533|39385487|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
16246431|NCT00455533|39385488|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
16246432|NCT00455533|39385486|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
16246433|NCT00455533|39385487|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
16246434|NCT00455533|39385488|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
16246435|NCT04409002|39385489|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
16246436|NCT01070394|39385490|FG000|Overall Study|Adverse Event|6|||
16246437|NCT01070394|39385490|FG000|Overall Study|Withdrawal by Subject|1|||
16246438|NCT01619085|39385493|FG000|Overall Study|Adverse Event|231|||
16246439|NCT01619085|39385493|FG000|Overall Study|Protocol Violation|4|||
16246440|NCT01619085|39385493|FG000|Overall Study|Lost to Follow-up|3|||
16246441|NCT01619085|39385493|FG000|Overall Study|Withdrawal by Subject|45|||
16246442|NCT01619085|39385493|FG000|Overall Study|Other than specified|96|||
16246443|NCT01619085|39385493|FG000|Overall Study|Not treated|1|||
16246444|NCT01619085|39385493|FG000|Overall Study|Death|145|||
16417248|NCT04038567|40008504|FG005|Overall Study|Withdrawal by Subject|1|||
16417249|NCT04038567|40008505|FG006|Overall Study|Withdrawal by Subject|1|||
16560335|NCT00432159|40517558|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
16560336|NCT00432159|40517559|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
16560337|NCT00432159|40517560|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
16560338|NCT00432159|40517561|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
16560339|NCT00432159|40517562|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
16560340|NCT01719861|40517565|FG000|Cycle 1|Death|4|||
16560341|NCT01719861|40517565|FG000|Cycle 2|Death|1|||
16560342|NCT02451930|40517566|FG000|Overall Study|Death|0|||
16560343|NCT02451930|40517567|FG001|Overall Study|Death|15|||
16560344|NCT02451930|40517566|FG000|Overall Study|Lost to Follow-up|0|||
16560345|NCT02451930|40517567|FG001|Overall Study|Lost to Follow-up|3|||
16560346|NCT02451930|40517566|FG000|Overall Study|Sponsor Decision|2|||
16560347|NCT02451930|40517567|FG001|Overall Study|Sponsor Decision|10|||
16560348|NCT02451930|40517566|FG000|Overall Study|Withdrawal by Subject|0|||
16246445|NCT00836927|39385496|FG000|Overall Study|Progressive disease|2|||
16246446|NCT00836927|39385497|FG001|Overall Study|Progressive disease|0|||
16246447|NCT00836927|39385498|FG002|Overall Study|Progressive disease|0|||
16246448|NCT00836927|39385499|FG003|Overall Study|Progressive disease|1|||
16560349|NCT02451930|40517567|FG001|Overall Study|Withdrawal by Subject|1|||
16560350|NCT02451930|40517566|FG000|Overall Study|Other|0|||
16560351|NCT02451930|40517567|FG001|Overall Study|Other|1|||
16560352|NCT03738241|40517570|FG000|Overall Study|Withdrawal by Subject|0|||
16560353|NCT03738241|40517571|FG001|Overall Study|Withdrawal by Subject|0|||
16560354|NCT03738241|40517572|FG002|Overall Study|Withdrawal by Subject|0|||
16560355|NCT03738241|40517573|FG003|Overall Study|Withdrawal by Subject|0|||
16560356|NCT03738241|40517574|FG004|Overall Study|Withdrawal by Subject|0|||
16560357|NCT03738241|40517575|FG005|Overall Study|Withdrawal by Subject|0|||
16560358|NCT03738241|40517576|FG006|Overall Study|Withdrawal by Subject|0|||
16560359|NCT03738241|40517577|FG007|Overall Study|Withdrawal by Subject|0|||
16560360|NCT03738241|40517578|FG008|Overall Study|Withdrawal by Subject|0|||
16560361|NCT03738241|40517579|FG009|Overall Study|Withdrawal by Subject|1|||
16560362|NCT03738241|40517570|FG000|Overall Study|Physician Decision|0|||
16560363|NCT03738241|40517571|FG001|Overall Study|Physician Decision|0|||
16560364|NCT03738241|40517572|FG002|Overall Study|Physician Decision|0|||
16560365|NCT03738241|40517573|FG003|Overall Study|Physician Decision|0|||
16560366|NCT03738241|40517574|FG004|Overall Study|Physician Decision|0|||
16246449|NCT00836927|39385500|FG004|Overall Study|Progressive disease|1|||
16246450|NCT00836927|39385496|FG000|Overall Study|Withdrawal by Subject|1|||
16246451|NCT00836927|39385497|FG001|Overall Study|Withdrawal by Subject|0|||
16246452|NCT00836927|39385498|FG002|Overall Study|Withdrawal by Subject|0|||
16246453|NCT00836927|39385499|FG003|Overall Study|Withdrawal by Subject|0|||
16246454|NCT00836927|39385500|FG004|Overall Study|Withdrawal by Subject|0|||
16246455|NCT02410837|39385501|FG000|Overall Study|Death|387|||
16246456|NCT02410837|39385501|FG000|Overall Study|Lost to Follow-up|50|||
16246457|NCT02410837|39385501|FG000|Overall Study|Withdrawal by Subject|44|||
16246458|NCT02410837|39385501|FG000|Overall Study|Physician Decision|6|||
16246459|NCT02410837|39385501|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
16246460|NCT01588106|39385502|FG000|Overall Study|Withdrawal by Subject|5|||
16246461|NCT01588106|39385503|FG001|Overall Study|Withdrawal by Subject|4|||
16246462|NCT01759537|39385506|FG000|Overall Study|Death|1|||
16246463|NCT01759537|39385507|FG001|Overall Study|Death|1|||
16246464|NCT01759537|39385506|FG000|Overall Study|Pregnancy|1|||
16560367|NCT03738241|40517575|FG005|Overall Study|Physician Decision|0|||
16560368|NCT03738241|40517576|FG006|Overall Study|Physician Decision|0|||
16560369|NCT03738241|40517577|FG007|Overall Study|Physician Decision|0|||
16560370|NCT03738241|40517578|FG008|Overall Study|Physician Decision|1|||
16560371|NCT03738241|40517579|FG009|Overall Study|Physician Decision|0|||
16560372|NCT03738241|40517570|FG000|Overall Study|Adverse Event|1|||
16246465|NCT01759537|39385507|FG001|Overall Study|Pregnancy|1|||
16246466|NCT01759537|39385506|FG000|Overall Study|Lost to Follow-up|9|||
16246467|NCT01759537|39385507|FG001|Overall Study|Lost to Follow-up|9|||
16246468|NCT01759537|39385506|FG000|Overall Study|Accident involving jaw fracture|1|||
16246469|NCT01759537|39385507|FG001|Overall Study|Accident involving jaw fracture|1|||
16246470|NCT01759537|39385506|FG000|Overall Study|Subcrestal implant too coronal|1|||
16246471|NCT01759537|39385507|FG001|Overall Study|Subcrestal implant too coronal|1|||
16246472|NCT02666430|39385509|FG000|Period 1|Lost to Follow-up|1|||
16246473|NCT02666430|39385510|FG001|Period 1|Lost to Follow-up|0|||
16246474|NCT02666430|39385509|FG000|Period 1|Adverse Event|0|||
16352429|NCT03428100|39776639|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
16352430|NCT03428100|39776640|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
16352431|NCT03428100|39776641|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
16352432|NCT03428100|39776642|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
16352433|NCT03428100|39776624|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
16352434|NCT03428100|39776625|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
16352435|NCT03428100|39776626|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
16352436|NCT03428100|39776627|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
16352437|NCT03428100|39776628|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
16352438|NCT03428100|39776629|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
16352439|NCT03428100|39776630|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
16352440|NCT03428100|39776631|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
16352441|NCT03428100|39776632|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
16352442|NCT03428100|39776633|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
16417250|NCT04038567|40008506|FG007|Overall Study|Withdrawal by Subject|1|||
16417251|NCT04038567|40008499|FG000|Overall Study|missed survey window|1|||
16417252|NCT04038567|40008500|FG001|Overall Study|missed survey window|2|||
16417253|NCT04038567|40008501|FG002|Overall Study|missed survey window|0|||
16417254|NCT04038567|40008502|FG003|Overall Study|missed survey window|0|||
16417255|NCT04038567|40008503|FG004|Overall Study|missed survey window|1|||
16560373|NCT03738241|40517571|FG001|Overall Study|Adverse Event|0|||
16246475|NCT02666430|39385510|FG001|Period 1|Adverse Event|1|||
16246476|NCT02666430|39385509|FG000|Period 2|Withdrawal by Subject|1|||
16246477|NCT02666430|39385510|FG001|Period 2|Withdrawal by Subject|4|||
16560374|NCT03738241|40517572|FG002|Overall Study|Adverse Event|0|||
16246478|NCT02666430|39385509|FG000|Period 3|Lost to Follow-up|1|||
16246479|NCT02666430|39385510|FG001|Period 3|Lost to Follow-up|0|||
16246480|NCT03558997|39385511|FG000|Overall Study|Adverse Event|0|||
16246481|NCT03558997|39385512|FG001|Overall Study|Adverse Event|2|||
16246482|NCT03558997|39385513|FG002|Overall Study|Adverse Event|5|||
16246483|NCT03558997|39385514|FG003|Overall Study|Adverse Event|1|||
16246484|NCT03558997|39385511|FG000|Overall Study|Physician Decision|0|||
16246485|NCT03558997|39385512|FG001|Overall Study|Physician Decision|0|||
16246486|NCT03558997|39385513|FG002|Overall Study|Physician Decision|1|||
16246487|NCT03558997|39385514|FG003|Overall Study|Physician Decision|0|||
16246488|NCT03558997|39385511|FG000|Overall Study|Withdrawal by Subject|1|||
16246489|NCT03558997|39385512|FG001|Overall Study|Withdrawal by Subject|0|||
16246490|NCT03558997|39385513|FG002|Overall Study|Withdrawal by Subject|1|||
16246491|NCT03558997|39385514|FG003|Overall Study|Withdrawal by Subject|1|||
16246492|NCT03558997|39385511|FG000|Overall Study|Lost to Follow-up|0|||
16246493|NCT03558997|39385512|FG001|Overall Study|Lost to Follow-up|0|||
16246494|NCT03558997|39385513|FG002|Overall Study|Lost to Follow-up|1|||
16246495|NCT03558997|39385514|FG003|Overall Study|Lost to Follow-up|0|||
16246496|NCT03349333|39385516|FG000|Overall Study|Progression of Disease|36|||
16246497|NCT03349333|39385516|FG000|Overall Study|Adverse Event|11|||
16246498|NCT03349333|39385516|FG000|Overall Study|Other|6|||
16246499|NCT03349333|39385516|FG000|Overall Study|Withdrawal by Subject|5|||
16246500|NCT03349333|39385516|FG000|Overall Study|Conditions interfere with participation|2|||
16246501|NCT03349333|39385516|FG000|Overall Study|Physician Decision|2|||
16246502|NCT03349333|39385516|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
16246503|NCT03349333|39385516|FG000|Overall Study|Patients in treatment less than 24 month|8|||
16246504|NCT00185211|39385517|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
16246505|NCT00185211|39385518|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
16246506|NCT00185211|39385517|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
16246507|NCT00185211|39385518|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
16246508|NCT00185211|39385517|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
16246509|NCT00185211|39385518|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
16246510|NCT00185211|39385517|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
16246511|NCT00185211|39385518|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
16246512|NCT00185211|39385517|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
16246513|NCT00185211|39385518|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
16246514|NCT00185211|39385517|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
16246515|NCT00185211|39385518|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
16246516|NCT00185211|39385517|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
16246517|NCT00185211|39385518|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
16246518|NCT00185211|39385517|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
16246519|NCT00185211|39385518|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
16246520|NCT00185211|39385517|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
16246521|NCT00185211|39385518|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
16352443|NCT03428100|39776634|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
16417256|NCT04038567|40008504|FG005|Overall Study|missed survey window|1|||
16352444|NCT03428100|39776635|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
16352445|NCT03428100|39776636|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
16352446|NCT03428100|39776637|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
16352447|NCT03428100|39776638|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
16352448|NCT03428100|39776639|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
16352449|NCT03428100|39776640|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
16352450|NCT03428100|39776641|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
16352451|NCT03428100|39776642|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
16417257|NCT04038567|40008505|FG006|Overall Study|missed survey window|2|||
16246522|NCT00185211|39385517|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
16246523|NCT00185211|39385518|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
16417258|NCT04038567|40008506|FG007|Overall Study|missed survey window|2|||
16129784|NCT00883051|38962274|FG000|Overall Study|Lost to Follow-up|0|||
16352452|NCT03428100|39776624|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352453|NCT03428100|39776625|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352454|NCT03428100|39776626|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352455|NCT03428100|39776627|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352456|NCT03428100|39776628|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352457|NCT03428100|39776629|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352458|NCT03428100|39776630|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352459|NCT03428100|39776631|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
16352460|NCT03428100|39776632|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352461|NCT03428100|39776633|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352462|NCT03428100|39776634|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352463|NCT03428100|39776635|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
16352464|NCT03428100|39776636|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
16352465|NCT03428100|39776637|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16417259|NCT04038567|40008499|FG000|Overall Study|technical issues|0|||
16417260|NCT04038567|40008500|FG001|Overall Study|technical issues|0|||
16417261|NCT04038567|40008501|FG002|Overall Study|technical issues|0|||
16417262|NCT04038567|40008502|FG003|Overall Study|technical issues|0|||
16417263|NCT04038567|40008503|FG004|Overall Study|technical issues|0|||
16417264|NCT04038567|40008504|FG005|Overall Study|technical issues|0|||
16417265|NCT04038567|40008505|FG006|Overall Study|technical issues|1|||
16417266|NCT04038567|40008506|FG007|Overall Study|technical issues|0|||
16417267|NCT04038567|40008499|FG000|Overall Study|Medical issues (i.e., illness)|0|||
16417268|NCT04038567|40008500|FG001|Overall Study|Medical issues (i.e., illness)|1|||
16417269|NCT04038567|40008501|FG002|Overall Study|Medical issues (i.e., illness)|2|||
16417270|NCT04038567|40008502|FG003|Overall Study|Medical issues (i.e., illness)|1|||
16417271|NCT04038567|40008503|FG004|Overall Study|Medical issues (i.e., illness)|1|||
16417272|NCT04038567|40008504|FG005|Overall Study|Medical issues (i.e., illness)|1|||
16417273|NCT04038567|40008505|FG006|Overall Study|Medical issues (i.e., illness)|0|||
16417274|NCT04038567|40008506|FG007|Overall Study|Medical issues (i.e., illness)|0|||
16417275|NCT04038567|40008499|FG000|Overall Study|Death|0|||
16417276|NCT04038567|40008500|FG001|Overall Study|Death|0|||
16417277|NCT04038567|40008501|FG002|Overall Study|Death|0|||
16417278|NCT04038567|40008502|FG003|Overall Study|Death|1|||
16560375|NCT03738241|40517573|FG003|Overall Study|Adverse Event|0|||
16560376|NCT03738241|40517574|FG004|Overall Study|Adverse Event|0|||
16352466|NCT03428100|39776638|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
16352467|NCT03428100|39776639|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352468|NCT03428100|39776640|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352469|NCT03428100|39776641|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
16352470|NCT03428100|39776642|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
16352471|NCT03428100|39776624|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
16417279|NCT04038567|40008503|FG004|Overall Study|Death|1|||
16417280|NCT04038567|40008504|FG005|Overall Study|Death|0|||
16417281|NCT04038567|40008505|FG006|Overall Study|Death|0|||
16560377|NCT03738241|40517575|FG005|Overall Study|Adverse Event|0|||
16560378|NCT03738241|40517576|FG006|Overall Study|Adverse Event|0|||
16560379|NCT03738241|40517577|FG007|Overall Study|Adverse Event|0|||
16560380|NCT03738241|40517578|FG008|Overall Study|Adverse Event|0|||
16417282|NCT04038567|40008506|FG007|Overall Study|Death|1|||
16417283|NCT03022981|40008507|FG000|Overall Study|Adverse Event|0|||
16417284|NCT03022981|40008508|FG001|Overall Study|Adverse Event|1|||
16417285|NCT03022981|40008509|FG002|Overall Study|Adverse Event|0|||
16417286|NCT03022981|40008507|FG000|Overall Study|Investigator's Discretion|0|||
16417287|NCT03022981|40008508|FG001|Overall Study|Investigator's Discretion|1|||
16417288|NCT03022981|40008509|FG002|Overall Study|Investigator's Discretion|2|||
16417289|NCT03022981|40008507|FG000|Overall Study|Lost to Follow-up|6|||
16417290|NCT03022981|40008508|FG001|Overall Study|Lost to Follow-up|2|||
16417291|NCT03022981|40008509|FG002|Overall Study|Lost to Follow-up|1|||
16417292|NCT03022981|40008507|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16417293|NCT03022981|40008508|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16417294|NCT03022981|40008509|FG002|Overall Study|Non-Compliance With Study Drug|2|||
16417295|NCT03022981|40008507|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
16417296|NCT03022981|40008508|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
16417297|NCT03022981|40008509|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
16417298|NCT01600092|40008515|FG000|Overall Study|Adverse Event|2|||
16417299|NCT01600092|40008516|FG001|Overall Study|Adverse Event|0|||
16417300|NCT01600092|40008515|FG000|Overall Study|Lost to Follow-up|4|||
16417301|NCT01600092|40008516|FG001|Overall Study|Lost to Follow-up|6|||
16417302|NCT01600092|40008515|FG000|Overall Study|Withdrawal by parent/guardian|8|||
16352472|NCT03428100|39776625|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
16417303|NCT01600092|40008516|FG001|Overall Study|Withdrawal by parent/guardian|6|||
16560381|NCT03738241|40517579|FG009|Overall Study|Adverse Event|0|||
16560382|NCT01347645|40517607|FG000|Overall Study|Death|1|||
16352473|NCT03428100|39776626|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
16352474|NCT03428100|39776627|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
16352475|NCT03428100|39776628|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
16352476|NCT03428100|39776629|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
16352477|NCT03428100|39776630|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
16352478|NCT03428100|39776631|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
16352479|NCT03428100|39776632|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
16352480|NCT03428100|39776633|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
16352481|NCT03428100|39776634|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
16352482|NCT03428100|39776635|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
16352483|NCT03428100|39776636|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
16352484|NCT03428100|39776637|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
16352485|NCT03428100|39776638|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
16352486|NCT03428100|39776639|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
16352487|NCT03428100|39776640|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
16352488|NCT03428100|39776641|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
16352489|NCT03428100|39776642|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
16352490|NCT03428100|39776624|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352491|NCT03428100|39776625|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352492|NCT03428100|39776626|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352493|NCT03428100|39776627|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352494|NCT03428100|39776628|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352495|NCT03428100|39776629|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352496|NCT03428100|39776630|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
16352497|NCT03428100|39776631|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352498|NCT03428100|39776632|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352499|NCT03428100|39776633|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352500|NCT03428100|39776634|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352501|NCT03428100|39776635|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352502|NCT03428100|39776636|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352503|NCT03428100|39776637|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352504|NCT03428100|39776638|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352505|NCT03428100|39776639|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352506|NCT03428100|39776640|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352507|NCT03428100|39776641|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
16352508|NCT03428100|39776642|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
16352509|NCT03428100|39776624|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
16352510|NCT03428100|39776625|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
16352511|NCT03428100|39776626|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
16352512|NCT03428100|39776627|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
16352513|NCT03428100|39776628|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
16352514|NCT03428100|39776629|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
16352515|NCT03428100|39776630|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
16352516|NCT03428100|39776631|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
16129785|NCT00883051|38962275|FG001|Overall Study|Lost to Follow-up|0|||
16129786|NCT00883051|38962276|FG002|Overall Study|Lost to Follow-up|0|||
16129787|NCT00883051|38962277|FG003|Overall Study|Lost to Follow-up|0|||
16129788|NCT00883051|38962278|FG004|Overall Study|Lost to Follow-up|1|||
16129789|NCT00883051|38962274|FG000|Overall Study|Did not use study medication|24|||
16129790|NCT00883051|38962275|FG001|Overall Study|Did not use study medication|22|||
16352517|NCT03428100|39776632|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
16352518|NCT03428100|39776633|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
16352519|NCT03428100|39776634|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
16352520|NCT03428100|39776635|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
16352521|NCT03428100|39776636|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
16352522|NCT03428100|39776637|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
16352523|NCT03428100|39776638|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
16352524|NCT03428100|39776639|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
16352525|NCT03428100|39776640|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
16352526|NCT03428100|39776641|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
16352527|NCT03428100|39776642|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
16352528|NCT03428100|39776624|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
16352529|NCT03428100|39776625|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
16352530|NCT03428100|39776626|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
16129791|NCT00883051|38962276|FG002|Overall Study|Did not use study medication|29|||
16129792|NCT00883051|38962277|FG003|Overall Study|Did not use study medication|29|||
16129793|NCT00883051|38962278|FG004|Overall Study|Did not use study medication|17|||
16129794|NCT02523599|38962279|FG000|Overall Study|Adverse Event|1|||
16129795|NCT02523599|38962280|FG001|Overall Study|Adverse Event|0|||
16129796|NCT02523599|38962279|FG000|Overall Study|Physician Decision|1|||
16129797|NCT02523599|38962280|FG001|Overall Study|Physician Decision|0|||
16129798|NCT02523599|38962279|FG000|Overall Study|Lost to Follow-up|4|||
16129799|NCT02523599|38962280|FG001|Overall Study|Lost to Follow-up|1|||
16129800|NCT02523599|38962279|FG000|Overall Study|Did not return for Day 30 visit|2|||
16129801|NCT02523599|38962280|FG001|Overall Study|Did not return for Day 30 visit|0|||
16129802|NCT02424734|38962281|FG000|Overall Study|Treatment stopped to be discharged home|2|||
16129803|NCT02424734|38962282|FG001|Overall Study|Treatment stopped to be discharged home|2|||
16129804|NCT02424734|38962283|FG002|Overall Study|Treatment stopped to be discharged home|0|||
16129805|NCT02288247|38962284|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
16129806|NCT02288247|38962285|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
16129807|NCT02288247|38962284|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
16129808|NCT02288247|38962285|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
16129809|NCT02288247|38962284|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
16129810|NCT02288247|38962285|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
16129811|NCT02288247|38962284|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
16129812|NCT02288247|38962285|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
16129813|NCT02288247|38962284|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
16129814|NCT02288247|38962285|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
16129815|NCT02288247|38962284|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
16129816|NCT02288247|38962285|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
16129817|NCT02288247|38962284|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
16129818|NCT02288247|38962285|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
16129819|NCT02288247|38962284|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
16129820|NCT02288247|38962285|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
16129821|NCT02288247|38962284|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
16129822|NCT02288247|38962285|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
16129823|NCT02288247|38962284|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
16129824|NCT02288247|38962285|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
16129825|NCT02288247|38962284|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
16129826|NCT02288247|38962285|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
16129827|NCT02288247|38962284|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
16129828|NCT02288247|38962285|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
16129829|NCT02288247|38962284|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
16129830|NCT02288247|38962285|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
16129831|NCT02288247|38962284|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
16129832|NCT02288247|38962285|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
16129833|NCT02288247|38962284|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
16129834|NCT02288247|38962285|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
16129835|NCT02407990|38962289|FG000|Overall Study|Death|2|||
16129836|NCT02407990|38962290|FG001|Overall Study|Death|22|||
16129837|NCT02407990|38962291|FG002|Overall Study|Death|23|||
16129838|NCT02407990|38962292|FG003|Overall Study|Death|7|||
16129839|NCT02407990|38962293|FG004|Overall Study|Death|17|||
16129840|NCT02407990|38962294|FG005|Overall Study|Death|16|||
16417304|NCT01600092|40008515|FG000|Overall Study|Physician Decision|1|||
16417305|NCT01600092|40008516|FG001|Overall Study|Physician Decision|1|||
16417306|NCT01600092|40008515|FG000|Overall Study|Randomized but not vaccinated|3|||
16417307|NCT01600092|40008516|FG001|Overall Study|Randomized but not vaccinated|3|||
16417308|NCT02409719|40008517|FG000|Overall Study|Lost to Follow-up|3|||
16417309|NCT02409719|40008518|FG001|Overall Study|Lost to Follow-up|3|||
16417310|NCT01620528|40008519|FG000|Treatment Period|Did Not Receive Study Drug|0|||
16417311|NCT01620528|40008520|FG001|Treatment Period|Did Not Receive Study Drug|0|||
16417312|NCT01620528|40008521|FG002|Treatment Period|Did Not Receive Study Drug|1|||
16417313|NCT01620528|40008519|FG000|Treatment Period|Withdrawal by Subject|35|||
16417314|NCT01620528|40008520|FG001|Treatment Period|Withdrawal by Subject|21|||
16417315|NCT01620528|40008521|FG002|Treatment Period|Withdrawal by Subject|16|||
16417316|NCT01620528|40008519|FG000|Treatment Period|Adverse Event|17|||
16129841|NCT02407990|38962295|FG006|Overall Study|Death|10|||
16129842|NCT02407990|38962296|FG007|Overall Study|Death|248|||
16129843|NCT02407990|38962289|FG000|Overall Study|Lost to Follow-up|0|||
16129844|NCT02407990|38962290|FG001|Overall Study|Lost to Follow-up|1|||
16129845|NCT02407990|38962291|FG002|Overall Study|Lost to Follow-up|0|||
16129846|NCT02407990|38962292|FG003|Overall Study|Lost to Follow-up|0|||
16417317|NCT01620528|40008520|FG001|Treatment Period|Adverse Event|13|||
16417318|NCT01620528|40008521|FG002|Treatment Period|Adverse Event|21|||
16352531|NCT03428100|39776627|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
16352532|NCT03428100|39776628|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
16352533|NCT03428100|39776629|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
16352534|NCT03428100|39776630|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
16352535|NCT03428100|39776631|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
16352536|NCT03428100|39776632|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
16352537|NCT03428100|39776633|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
16352538|NCT03428100|39776634|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
16352539|NCT03428100|39776635|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
16352540|NCT03428100|39776636|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
16352541|NCT03428100|39776637|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
16352542|NCT03428100|39776638|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
16352543|NCT03428100|39776639|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
16352544|NCT03428100|39776640|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
16352545|NCT03428100|39776641|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
16352546|NCT03428100|39776642|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
16352547|NCT02062437|39776643|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
16352548|NCT02062437|39776643|FG000|Overall Study|Patient not available for the 2y visit|18|||
16352549|NCT02062437|39776643|FG000|Overall Study|Death|2|||
16352550|NCT02062437|39776643|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
16352551|NCT04085601|39776644|FG000|Overall Study|Lost to Follow-up|1|||
16352552|NCT04085601|39776645|FG001|Overall Study|Lost to Follow-up|0|||
16352553|NCT04085601|39776644|FG000|Overall Study|Death|1|||
16352554|NCT04085601|39776645|FG001|Overall Study|Death|1|||
16352555|NCT02982863|39776646|FG000|Overall Study|Not eligible patients|809|||
16352556|NCT02982863|39776647|FG001|Overall Study|Not eligible patients|4261|||
16352557|NCT02982863|39776648|FG002|Overall Study|Not eligible patients|1852|||
16352558|NCT02982863|39776649|FG003|Overall Study|Not eligible patients|1400|||
16352559|NCT02982863|39776650|FG004|Overall Study|Not eligible patients|492|||
16352560|NCT00072410|39776653|FG000|Overall Study|Progressive disease|0|||
16352561|NCT00072410|39776654|FG001|Overall Study|Progressive disease|3|||
16352562|NCT01484951|39776655|FG000|Overall Study|Adverse Event|3|||
16352563|NCT01484951|39776655|FG000|Overall Study|Personal Reasons|1|||
16352564|NCT01484951|39776655|FG000|Overall Study|Non-Compliance|1|||
16352565|NCT03217591|39776661|FG000|Overall Study|Adverse Event|1|||
16352566|NCT03217591|39776662|FG001|Overall Study|Adverse Event|2|||
16352567|NCT03217591|39776663|FG002|Overall Study|Adverse Event|6|||
16352568|NCT03217591|39776661|FG000|Overall Study|Withdrawal by Subject|0|||
16352569|NCT03217591|39776662|FG001|Overall Study|Withdrawal by Subject|1|||
16352570|NCT03217591|39776663|FG002|Overall Study|Withdrawal by Subject|3|||
16352571|NCT03217591|39776661|FG000|Overall Study|Lost to Follow-up|1|||
16352572|NCT03217591|39776662|FG001|Overall Study|Lost to Follow-up|0|||
16352573|NCT03217591|39776663|FG002|Overall Study|Lost to Follow-up|0|||
16352574|NCT03217591|39776661|FG000|Overall Study|Protocol Violation|1|||
16352575|NCT03217591|39776662|FG001|Overall Study|Protocol Violation|0|||
16352576|NCT03217591|39776663|FG002|Overall Study|Protocol Violation|1|||
16352577|NCT04435808|39776666|FG000|Overall Study|Study stopped by DSMB|0|||
16352578|NCT04435808|39776667|FG001|Overall Study|Study stopped by DSMB|1|||
16352579|NCT00749398|39776668|FG000|Overall Study|Lack of Efficacy|7|||
16352580|NCT00749398|39776668|FG000|Overall Study|Adverse Event|4|||
16352581|NCT00749398|39776668|FG000|Overall Study|Serious adverse event|11|||
16352582|NCT00749398|39776668|FG000|Overall Study|Withdrawal by Subject|17|||
16352583|NCT00749398|39776668|FG000|Overall Study|Lost to Follow-up|11|||
16352584|NCT00749398|39776668|FG000|Overall Study|Reason not specified|2|||
16352585|NCT00749398|39776668|FG000|Overall Study|Unknown reason|1|||
16352586|NCT01566604|39776669|FG000|Overall Study|Patient's inability to use the device|1|||
16352587|NCT01566604|39776670|FG001|Overall Study|Patient's inability to use the device|0|||
16352588|NCT01566604|39776669|FG000|Overall Study|Administrative problems|1|||
16352589|NCT01566604|39776670|FG001|Overall Study|Administrative problems|0|||
16352590|NCT01566604|39776669|FG000|Overall Study|Lack of Efficacy|1|||
16352591|NCT01566604|39776670|FG001|Overall Study|Lack of Efficacy|2|||
16352592|NCT01566604|39776669|FG000|Overall Study|Protocol deviation|2|||
16352593|NCT01566604|39776670|FG001|Overall Study|Protocol deviation|0|||
16352594|NCT01566604|39776669|FG000|Overall Study|Abnormal laboratory value|2|||
16352595|NCT01566604|39776670|FG001|Overall Study|Abnormal laboratory value|0|||
16352596|NCT01566604|39776669|FG000|Overall Study|Death|4|||
16352597|NCT01566604|39776670|FG001|Overall Study|Death|1|||
16352598|NCT01566604|39776669|FG000|Overall Study|Adverse Event|4|||
16352599|NCT01566604|39776670|FG001|Overall Study|Adverse Event|2|||
16352600|NCT01566604|39776669|FG000|Overall Study|Withdrawal by Subject|9|||
16352601|NCT01566604|39776670|FG001|Overall Study|Withdrawal by Subject|6|||
16352602|NCT02155699|39776671|FG000|Overall Study|Withdrawal by Subject|0|||
16352603|NCT02155699|39776672|FG001|Overall Study|Withdrawal by Subject|3|||
16352604|NCT02155699|39776673|FG002|Overall Study|Withdrawal by Subject|6|||
16352605|NCT02155699|39776674|FG003|Overall Study|Withdrawal by Subject|1|||
16352606|NCT02155699|39776671|FG000|Overall Study|Lost to Follow-up|0|||
16352607|NCT02155699|39776672|FG001|Overall Study|Lost to Follow-up|0|||
16352608|NCT02155699|39776673|FG002|Overall Study|Lost to Follow-up|0|||
16352609|NCT02155699|39776674|FG003|Overall Study|Lost to Follow-up|3|||
16417319|NCT01620528|40008519|FG000|Treatment Period|Lost to Follow-up|16|||
16417320|NCT01620528|40008520|FG001|Treatment Period|Lost to Follow-up|8|||
16417321|NCT01620528|40008521|FG002|Treatment Period|Lost to Follow-up|14|||
16417322|NCT01620528|40008519|FG000|Treatment Period|Other|9|||
16417323|NCT01620528|40008520|FG001|Treatment Period|Other|5|||
16417324|NCT01620528|40008521|FG002|Treatment Period|Other|7|||
16417325|NCT01620528|40008519|FG000|Treatment Period|Subject Noncompliant|11|||
16417326|NCT01620528|40008520|FG001|Treatment Period|Subject Noncompliant|2|||
16417327|NCT01620528|40008521|FG002|Treatment Period|Subject Noncompliant|2|||
16417328|NCT01620528|40008519|FG000|Treatment Period|Pregnancy|7|||
16417329|NCT01620528|40008520|FG001|Treatment Period|Pregnancy|2|||
16417330|NCT01620528|40008521|FG002|Treatment Period|Pregnancy|2|||
16417331|NCT01620528|40008519|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
16352610|NCT02155699|39776671|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
16352611|NCT02155699|39776672|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
16352612|NCT02155699|39776673|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
16352613|NCT02155699|39776674|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
16352614|NCT00230048|39776678|FG000|Overall Study|Lost to Follow-up|13|||
16352615|NCT00230048|39776679|FG001|Overall Study|Lost to Follow-up|18|||
16352616|NCT01705080|39776680|FG000|Overall Study|Missed visit|10|||
16352617|NCT01705080|39776681|FG001|Overall Study|Missed visit|4|||
16352618|NCT01705080|39776682|FG002|Overall Study|Missed visit|1|||
16352619|NCT01705080|39776680|FG000|Overall Study|Death|4|||
16352620|NCT01705080|39776681|FG001|Overall Study|Death|4|||
16352621|NCT01705080|39776682|FG002|Overall Study|Death|6|||
16352622|NCT01705080|39776680|FG000|Overall Study|Withdrawal by Subject|61|||
16352623|NCT01705080|39776681|FG001|Overall Study|Withdrawal by Subject|44|||
16352624|NCT01705080|39776682|FG002|Overall Study|Withdrawal by Subject|9|||
16352625|NCT02899065|39776683|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
16352626|NCT02899065|39776684|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
16352627|NCT02899065|39776683|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
16352628|NCT02899065|39776684|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
16352629|NCT02899065|39776683|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
16352630|NCT02899065|39776684|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
16352631|NCT05133323|39776685|FG000|Overall Study|Lack of Efficacy|0|||
16352632|NCT05133323|39776686|FG001|Overall Study|Lack of Efficacy|0|||
16352633|NCT05133323|39776687|FG002|Overall Study|Lack of Efficacy|1|||
16352634|NCT05133323|39776685|FG000|Overall Study|Withdrawal by Subject|2|||
16352635|NCT05133323|39776686|FG001|Overall Study|Withdrawal by Subject|1|||
16352636|NCT05133323|39776687|FG002|Overall Study|Withdrawal by Subject|0|||
16352637|NCT02346708|39776689|FG000|Overall Study|Adverse Event|2|||
16352638|NCT02346708|39776690|FG001|Overall Study|Adverse Event|0|||
16352639|NCT02346708|39776689|FG000|Overall Study|Protocol Violation|0|||
16352640|NCT02346708|39776690|FG001|Overall Study|Protocol Violation|1|||
16352641|NCT01048541|39776693|FG000|Overall Study|Withdrawal by Subject|1|||
16352642|NCT01048541|39776694|FG001|Overall Study|Withdrawal by Subject|0|||
16352643|NCT02254772|39776696|FG000|Overall Study|Ineligible|1|||
16352644|NCT02254772|39776696|FG000|Overall Study|Withdrawal by Subject|1|||
16352645|NCT03102762|39776699|FG000|Overall Study|Lost to Follow-up|1|||
16352646|NCT03102762|39776700|FG001|Overall Study|Lost to Follow-up|0|||
16352647|NCT03074695|39776701|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
16352648|NCT03074695|39776702|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
16352649|NCT03074695|39776701|FG000|Overall Study|Research staff not available|1|||
16352650|NCT03074695|39776702|FG001|Overall Study|Research staff not available|2|||
16352651|NCT03074695|39776701|FG000|Overall Study|Did not receive neuraxial block|2|||
16352652|NCT03074695|39776702|FG001|Overall Study|Did not receive neuraxial block|2|||
16352653|NCT00528424|39776706|FG000|Overall Study|Lost to Follow-up|13|||
16352654|NCT00528424|39776706|FG000|Overall Study|Withdrew consent|2|||
16352655|NCT00528424|39776706|FG000|Overall Study|Administrative reason|2|||
16129847|NCT02407990|38962293|FG004|Overall Study|Lost to Follow-up|0|||
16352656|NCT00528424|39776706|FG000|Overall Study|Other|12|||
16352657|NCT00956839|39776707|FG000|Overall Study|Lost to Follow-up|3|||
16352658|NCT00956839|39776708|FG001|Overall Study|Lost to Follow-up|0|||
16352659|NCT00956839|39776709|FG002|Overall Study|Lost to Follow-up|3|||
16352660|NCT01274351|39776710|FG000|Overall Study|Lost to Follow-up|1|||
16352661|NCT01274351|39776710|FG000|Overall Study|patient not compliant with the protocol|1|||
16352662|NCT01274351|39776710|FG000|Overall Study|Pregnancy|1|||
16352663|NCT01274351|39776710|FG000|Overall Study|Death|2|||
16417332|NCT01620528|40008520|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
16417333|NCT01620528|40008521|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
16352664|NCT01274351|39776710|FG000|Overall Study|Withdrawal by Subject|3|||
16352665|NCT01274351|39776710|FG000|Overall Study|Adverse Event|8|||
16352666|NCT01274351|39776710|FG000|Overall Study|progression of disease|3|||
16352667|NCT01274351|39776710|FG000|Overall Study|hospitalization|1|||
16352668|NCT00116688|39776714|FG000|Overall Study|Protocol deviation|1|||
16352669|NCT00116688|39776715|FG001|Overall Study|Protocol deviation|0|||
16352670|NCT00116688|39776714|FG000|Overall Study|Noncompliance|3|||
16352671|NCT00116688|39776715|FG001|Overall Study|Noncompliance|1|||
16352672|NCT00116688|39776714|FG000|Overall Study|Adverse Event|11|||
16352673|NCT00116688|39776715|FG001|Overall Study|Adverse Event|0|||
16352674|NCT00116688|39776714|FG000|Overall Study|Withdrawal by Subject|26|||
16352675|NCT00116688|39776715|FG001|Overall Study|Withdrawal by Subject|2|||
16352676|NCT00116688|39776714|FG000|Overall Study|Requirement for alternative therapy|11|||
16352677|NCT00116688|39776715|FG001|Overall Study|Requirement for alternative therapy|1|||
16352678|NCT00116688|39776714|FG000|Overall Study|Physician Decision|7|||
16352679|NCT00116688|39776715|FG001|Overall Study|Physician Decision|0|||
16560383|NCT01347645|40517608|FG001|Overall Study|Death|5|||
16560384|NCT01347645|40517609|FG002|Overall Study|Death|2|||
16560385|NCT01347645|40517610|FG003|Overall Study|Death|7|||
16560386|NCT01347645|40517611|FG004|Overall Study|Death|7|||
16352680|NCT00116688|39776714|FG000|Overall Study|Lost to Follow-up|3|||
16352681|NCT00116688|39776715|FG001|Overall Study|Lost to Follow-up|0|||
16352682|NCT00116688|39776714|FG000|Overall Study|Death|15|||
16352683|NCT00116688|39776715|FG001|Overall Study|Death|0|||
16352684|NCT00116688|39776714|FG000|Overall Study|Protocol-specified criteria|3|||
16352685|NCT00116688|39776715|FG001|Overall Study|Protocol-specified criteria|0|||
16352686|NCT00116688|39776714|FG000|Overall Study|Pregnancy|1|||
16352687|NCT00116688|39776715|FG001|Overall Study|Pregnancy|0|||
16352688|NCT00116688|39776714|FG000|Overall Study|Other|11|||
16352689|NCT00116688|39776715|FG001|Overall Study|Other|0|||
16352690|NCT00465517|39776716|FG000|Overall Study|Adverse Event|7|||
16352691|NCT00465517|39776717|FG001|Overall Study|Adverse Event|3|||
16352692|NCT00465517|39776716|FG000|Overall Study|Lost to Follow-up|1|||
16352693|NCT00465517|39776717|FG001|Overall Study|Lost to Follow-up|0|||
16352694|NCT00465517|39776716|FG000|Overall Study|Withdrawal by Subject|4|||
16352695|NCT00465517|39776717|FG001|Overall Study|Withdrawal by Subject|1|||
16352696|NCT04460326|39780230|FG000|Completed at Least 4 Meals|Early discharge|5|||
16352697|NCT04460326|39780231|FG001|Completed at Least 4 Meals|Early discharge|5|||
16352698|NCT04460326|39780230|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
16352699|NCT04460326|39780231|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
16352700|NCT04460326|39780230|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
16352701|NCT04460326|39780231|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
16352702|NCT04460326|39780230|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
16352703|NCT04460326|39780231|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
16352704|NCT04460326|39780230|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
16352705|NCT04460326|39780231|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
16352706|NCT04460326|39780230|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
16352707|NCT04460326|39780231|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
16352708|NCT01604785|39780234|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
16352709|NCT01604785|39780235|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
16352710|NCT01705977|39780242|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
16352711|NCT01705977|39780243|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
16352712|NCT01705977|39780242|FG000|Treatment Period (Year 1)|Adverse Event|57|||
16352713|NCT01705977|39780243|FG001|Treatment Period (Year 1)|Adverse Event|49|||
16352714|NCT01705977|39780242|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
16352715|NCT01705977|39780243|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
16352716|NCT01705977|39780242|FG000|Treatment Period (Year 1)|Site closure|3|||
16352717|NCT01705977|39780243|FG001|Treatment Period (Year 1)|Site closure|2|||
16352718|NCT01705977|39780242|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
16352719|NCT01705977|39780243|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
16352720|NCT01705977|39780242|FG000|Treatment Period (Year 1)|Physician Decision|48|||
16352721|NCT01705977|39780243|FG001|Treatment Period (Year 1)|Physician Decision|38|||
16352722|NCT01705977|39780242|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
16352723|NCT01705977|39780243|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
16352724|NCT01705977|39780242|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
16352725|NCT01705977|39780243|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
16560387|NCT01347645|40517607|FG000|Overall Study|Lost to Follow-up|1|||
16129848|NCT02407990|38962294|FG005|Overall Study|Lost to Follow-up|0|||
16352726|NCT01705977|39780242|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
16352727|NCT01705977|39780243|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
16352728|NCT01705977|39780242|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
16352729|NCT01705977|39780243|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
16560388|NCT01347645|40517608|FG001|Overall Study|Lost to Follow-up|1|||
16560389|NCT01347645|40517609|FG002|Overall Study|Lost to Follow-up|0|||
16560390|NCT01347645|40517610|FG003|Overall Study|Lost to Follow-up|1|||
16352730|NCT01705977|39780242|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
16352731|NCT01705977|39780243|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
16352732|NCT01705977|39780242|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
16352733|NCT01705977|39780243|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
16352734|NCT01063855|39780244|FG000|Overall Study|Adverse Event|4|||
16352735|NCT01063855|39780245|FG001|Overall Study|Adverse Event|4|||
16352736|NCT01063855|39780244|FG000|Overall Study|Death|0|||
16352737|NCT01063855|39780245|FG001|Overall Study|Death|1|||
16417334|NCT01620528|40008519|FG000|Treatment Period|Exclusionary Medication Received|0|||
16417335|NCT01620528|40008520|FG001|Treatment Period|Exclusionary Medication Received|1|||
16129849|NCT02407990|38962295|FG006|Overall Study|Lost to Follow-up|0|||
16129850|NCT02407990|38962296|FG007|Overall Study|Lost to Follow-up|17|||
16417336|NCT01620528|40008521|FG002|Treatment Period|Exclusionary Medication Received|0|||
16417337|NCT01620528|40008519|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
16417338|NCT01620528|40008520|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
16129851|NCT02407990|38962289|FG000|Overall Study|Progressive Disease|0|||
16129852|NCT02407990|38962290|FG001|Overall Study|Progressive Disease|0|||
16417339|NCT01620528|40008521|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
16417340|NCT01620528|40008519|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
16417341|NCT01620528|40008520|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
16129853|NCT02407990|38962291|FG002|Overall Study|Progressive Disease|0|||
16129854|NCT02407990|38962292|FG003|Overall Study|Progressive Disease|0|||
16417342|NCT01620528|40008521|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
16417343|NCT01620528|40008519|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
16417344|NCT01620528|40008520|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
16417345|NCT01620528|40008521|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
16417346|NCT01620528|40008519|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
16417347|NCT01620528|40008520|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
16417348|NCT01620528|40008521|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
16129855|NCT02407990|38962293|FG004|Overall Study|Progressive Disease|0|||
16129856|NCT02407990|38962294|FG005|Overall Study|Progressive Disease|0|||
16129857|NCT02407990|38962295|FG006|Overall Study|Progressive Disease|0|||
16129858|NCT02407990|38962296|FG007|Overall Study|Progressive Disease|1|||
16129859|NCT02407990|38962289|FG000|Overall Study|Withdrawal by Subject|0|||
16129860|NCT02407990|38962290|FG001|Overall Study|Withdrawal by Subject|0|||
16417349|NCT01620528|40008519|FG000|Post-Treatment Follow-Up Period|Other|6|||
16417350|NCT01620528|40008520|FG001|Post-Treatment Follow-Up Period|Other|4|||
16417351|NCT01620528|40008521|FG002|Post-Treatment Follow-Up Period|Other|2|||
16417352|NCT04349033|40008522|FG000|Overall Study|Lost to Follow-up|3|||
16417353|NCT04349033|40008523|FG001|Overall Study|Lost to Follow-up|1|||
16417354|NCT04349033|40008524|FG002|Overall Study|Lost to Follow-up|1|||
16417355|NCT00500760|40008528|FG000|Overall Study|Death|32|||
16417356|NCT00500760|40008529|FG001|Overall Study|Death|15|||
16417357|NCT00500760|40008528|FG000|Overall Study|Withdrawal by Subject|5|||
16417358|NCT00500760|40008529|FG001|Overall Study|Withdrawal by Subject|7|||
16417359|NCT00500760|40008528|FG000|Overall Study|Administrative decision|2|||
16417360|NCT00500760|40008529|FG001|Overall Study|Administrative decision|0|||
16129861|NCT02407990|38962291|FG002|Overall Study|Withdrawal by Subject|0|||
16129862|NCT02407990|38962292|FG003|Overall Study|Withdrawal by Subject|0|||
16129863|NCT02407990|38962293|FG004|Overall Study|Withdrawal by Subject|1|||
16129864|NCT02407990|38962294|FG005|Overall Study|Withdrawal by Subject|0|||
16352738|NCT01063855|39780244|FG000|Overall Study|Lost to Follow-up|8|||
16352739|NCT01063855|39780245|FG001|Overall Study|Lost to Follow-up|4|||
16417361|NCT00500760|40008528|FG000|Overall Study|Lost to Follow-up|3|||
16417362|NCT00500760|40008529|FG001|Overall Study|Lost to Follow-up|0|||
16417363|NCT00500760|40008528|FG000|Overall Study|Other|1|||
16129865|NCT02407990|38962295|FG006|Overall Study|Withdrawal by Subject|0|||
16129866|NCT02407990|38962296|FG007|Overall Study|Withdrawal by Subject|30|||
16129867|NCT02407990|38962289|FG000|Overall Study|Study Terminated by Sponsor|1|||
16129868|NCT02407990|38962290|FG001|Overall Study|Study Terminated by Sponsor|3|||
16129869|NCT02407990|38962291|FG002|Overall Study|Study Terminated by Sponsor|3|||
16129870|NCT02407990|38962292|FG003|Overall Study|Study Terminated by Sponsor|0|||
16129871|NCT02407990|38962293|FG004|Overall Study|Study Terminated by Sponsor|3|||
16129872|NCT02407990|38962294|FG005|Overall Study|Study Terminated by Sponsor|4|||
16129873|NCT02407990|38962295|FG006|Overall Study|Study Terminated by Sponsor|3|||
16129874|NCT02407990|38962296|FG007|Overall Study|Study Terminated by Sponsor|37|||
16129875|NCT02407990|38962289|FG000|Overall Study|Logistics|0|||
16129876|NCT02407990|38962290|FG001|Overall Study|Logistics|0|||
16129877|NCT02407990|38962291|FG002|Overall Study|Logistics|0|||
16129878|NCT02407990|38962292|FG003|Overall Study|Logistics|0|||
16129879|NCT02407990|38962293|FG004|Overall Study|Logistics|0|||
16129880|NCT02407990|38962294|FG005|Overall Study|Logistics|0|||
16129881|NCT02407990|38962295|FG006|Overall Study|Logistics|0|||
16129882|NCT02407990|38962296|FG007|Overall Study|Logistics|1|||
16129883|NCT02407990|38962289|FG000|Overall Study|Rolled into long-term extension study|0|||
16129884|NCT02407990|38962290|FG001|Overall Study|Rolled into long-term extension study|0|||
16129885|NCT02407990|38962291|FG002|Overall Study|Rolled into long-term extension study|0|||
16129886|NCT02407990|38962292|FG003|Overall Study|Rolled into long-term extension study|0|||
16129887|NCT02407990|38962293|FG004|Overall Study|Rolled into long-term extension study|0|||
16129888|NCT02407990|38962294|FG005|Overall Study|Rolled into long-term extension study|0|||
16129889|NCT02407990|38962295|FG006|Overall Study|Rolled into long-term extension study|0|||
16129890|NCT02407990|38962296|FG007|Overall Study|Rolled into long-term extension study|1|||
16129891|NCT03010176|38962297|FG000|Overall Study|Death|21|||
16129892|NCT03010176|38962298|FG001|Overall Study|Death|35|||
16129893|NCT03010176|38962299|FG002|Overall Study|Death|19|||
16129894|NCT03010176|38962300|FG003|Overall Study|Death|19|||
16129895|NCT03010176|38962301|FG004|Overall Study|Death|14|||
16129896|NCT03010176|38962302|FG005|Overall Study|Death|0|||
16129897|NCT03010176|38962297|FG000|Overall Study|Lost to Follow-up|0|||
16129898|NCT03010176|38962298|FG001|Overall Study|Lost to Follow-up|0|||
16129899|NCT03010176|38962299|FG002|Overall Study|Lost to Follow-up|0|||
16129900|NCT03010176|38962300|FG003|Overall Study|Lost to Follow-up|0|||
16129901|NCT03010176|38962301|FG004|Overall Study|Lost to Follow-up|1|||
16129902|NCT03010176|38962302|FG005|Overall Study|Lost to Follow-up|0|||
16129903|NCT03010176|38962297|FG000|Overall Study|Physician Decision|0|||
16129904|NCT03010176|38962298|FG001|Overall Study|Physician Decision|4|||
16129905|NCT03010176|38962299|FG002|Overall Study|Physician Decision|0|||
16129906|NCT03010176|38962300|FG003|Overall Study|Physician Decision|1|||
16129907|NCT03010176|38962301|FG004|Overall Study|Physician Decision|0|||
16129908|NCT03010176|38962302|FG005|Overall Study|Physician Decision|0|||
16129909|NCT03010176|38962297|FG000|Overall Study|Sponsor Decision|0|||
16129910|NCT03010176|38962298|FG001|Overall Study|Sponsor Decision|4|||
16129911|NCT03010176|38962299|FG002|Overall Study|Sponsor Decision|4|||
16129912|NCT03010176|38962300|FG003|Overall Study|Sponsor Decision|1|||
16129913|NCT03010176|38962301|FG004|Overall Study|Sponsor Decision|6|||
16129914|NCT03010176|38962302|FG005|Overall Study|Sponsor Decision|0|||
16129915|NCT03010176|38962297|FG000|Overall Study|Withdrawal by Subject|11|||
16129916|NCT03010176|38962298|FG001|Overall Study|Withdrawal by Subject|9|||
16129917|NCT03010176|38962299|FG002|Overall Study|Withdrawal by Subject|3|||
16129918|NCT03010176|38962300|FG003|Overall Study|Withdrawal by Subject|0|||
16129919|NCT03010176|38962301|FG004|Overall Study|Withdrawal by Subject|4|||
16246524|NCT00185211|39385517|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
16246525|NCT00185211|39385518|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
16246526|NCT00185211|39385517|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
16246527|NCT00185211|39385518|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
16246528|NCT02742181|39385519|FG000|Overall Study|Physician Decision|1|||
16246529|NCT02742181|39385520|FG001|Overall Study|Physician Decision|0|||
16246530|NCT01620983|39385521|FG000|Overall Study|Lost to Follow-up|8|||
16352740|NCT01063855|39780244|FG000|Overall Study|Pregnancy|1|||
16352741|NCT01063855|39780245|FG001|Overall Study|Pregnancy|0|||
16129920|NCT03010176|38962302|FG005|Overall Study|Withdrawal by Subject|0|||
16129921|NCT00178126|38962303|FG000|Overall Study|Lost to Follow-up|21|||
16129922|NCT00178126|38962304|FG001|Overall Study|Lost to Follow-up|21|||
16129923|NCT00178126|38962303|FG000|Overall Study|did not receive intervention|4|||
16129924|NCT00178126|38962304|FG001|Overall Study|did not receive intervention|6|||
16129925|NCT00658684|38962305|FG000|Overall Study|Adverse Event|10|||
16129926|NCT00658684|38962306|FG001|Overall Study|Adverse Event|8|||
16129927|NCT00658684|38962307|FG002|Overall Study|Adverse Event|2|||
16129928|NCT00658684|38962308|FG003|Overall Study|Adverse Event|0|||
16129929|NCT00658684|38962305|FG000|Overall Study|Withdrawal by Subject|6|||
16129930|NCT00658684|38962306|FG001|Overall Study|Withdrawal by Subject|4|||
16129931|NCT00658684|38962307|FG002|Overall Study|Withdrawal by Subject|1|||
16129932|NCT00658684|38962308|FG003|Overall Study|Withdrawal by Subject|1|||
16417364|NCT00500760|40008529|FG001|Overall Study|Other|2|||
16417365|NCT01918332|40008530|FG000|Overall Study|Adverse Event|0|||
16417366|NCT01918332|40008531|FG001|Overall Study|Adverse Event|0|||
16417367|NCT01918332|40008532|FG002|Overall Study|Adverse Event|0|||
16417368|NCT01918332|40008533|FG003|Overall Study|Adverse Event|1|||
16417369|NCT01918332|40008530|FG000|Overall Study|Withdrawal by Subject|2|||
16417370|NCT01918332|40008531|FG001|Overall Study|Withdrawal by Subject|3|||
16417371|NCT01918332|40008532|FG002|Overall Study|Withdrawal by Subject|2|||
16417372|NCT01918332|40008533|FG003|Overall Study|Withdrawal by Subject|3|||
16417373|NCT01918332|40008530|FG000|Overall Study|Protocol Violation|6|||
16417374|NCT01918332|40008531|FG001|Overall Study|Protocol Violation|2|||
16417375|NCT01918332|40008532|FG002|Overall Study|Protocol Violation|6|||
16417376|NCT01918332|40008533|FG003|Overall Study|Protocol Violation|3|||
16417377|NCT01918332|40008530|FG000|Overall Study|lipid result by central lab did not meet|0|||
16417378|NCT01918332|40008531|FG001|Overall Study|lipid result by central lab did not meet|0|||
16417379|NCT01918332|40008532|FG002|Overall Study|lipid result by central lab did not meet|1|||
16417380|NCT01918332|40008533|FG003|Overall Study|lipid result by central lab did not meet|0|||
16417381|NCT00576472|40008534|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
16352742|NCT01063855|39780244|FG000|Overall Study|Lack of Efficacy|0|||
16352743|NCT01063855|39780245|FG001|Overall Study|Lack of Efficacy|1|||
16352744|NCT01063855|39780244|FG000|Overall Study|Withdrawal by Subject|11|||
16352745|NCT01063855|39780245|FG001|Overall Study|Withdrawal by Subject|8|||
16352746|NCT01063855|39780244|FG000|Overall Study|Reason not specified|13|||
16352747|NCT01063855|39780245|FG001|Overall Study|Reason not specified|11|||
16417382|NCT00576472|40008535|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417383|NCT00576472|40008536|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417384|NCT00576472|40008537|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
16417385|NCT00576472|40008538|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417386|NCT00576472|40008539|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417387|NCT00576472|40008540|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417388|NCT00576472|40008541|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417389|NCT00576472|40008542|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417390|NCT00576472|40008543|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417391|NCT00576472|40008544|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417392|NCT00576472|40008545|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417393|NCT00576472|40008546|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417394|NCT00576472|40008547|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417395|NCT00576472|40008548|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
16417396|NCT00576472|40008534|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
16417397|NCT00576472|40008535|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
16417398|NCT00576472|40008536|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
16417399|NCT00576472|40008537|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
16417400|NCT00576472|40008538|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
16417401|NCT00576472|40008539|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
16417402|NCT00576472|40008540|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
16417403|NCT00576472|40008541|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
16417404|NCT00576472|40008542|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
16417405|NCT00576472|40008543|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
16417406|NCT00576472|40008544|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
16417407|NCT00576472|40008545|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
16417408|NCT00576472|40008546|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
16417409|NCT00576472|40008547|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
16417410|NCT00576472|40008548|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
16417411|NCT00576472|40008534|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16417412|NCT00576472|40008535|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16352748|NCT00249834|39780246|FG000|Overall Study|Ovarian stimulation failed|1|||
16352749|NCT00249834|39780247|FG001|Overall Study|Ovarian stimulation failed|0|||
16352750|NCT00249834|39780248|FG002|Overall Study|Ovarian stimulation failed|0|||
16352751|NCT00249834|39780249|FG003|Overall Study|Ovarian stimulation failed|0|||
16417413|NCT00576472|40008536|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16417414|NCT00576472|40008537|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
16417415|NCT00576472|40008538|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16417416|NCT00576472|40008539|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16417417|NCT00576472|40008540|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16129933|NCT00658684|38962305|FG000|Overall Study|Lack of Efficacy|1|||
16417418|NCT00576472|40008541|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16417419|NCT00576472|40008542|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16417420|NCT00576472|40008543|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16417421|NCT00576472|40008544|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16417422|NCT00576472|40008545|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16417423|NCT00576472|40008546|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16129934|NCT00658684|38962306|FG001|Overall Study|Lack of Efficacy|1|||
16129935|NCT00658684|38962307|FG002|Overall Study|Lack of Efficacy|0|||
16417424|NCT00576472|40008547|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16129936|NCT00658684|38962308|FG003|Overall Study|Lack of Efficacy|0|||
16129937|NCT00658684|38962305|FG000|Overall Study|Protocol Violation|1|||
16129938|NCT00658684|38962306|FG001|Overall Study|Protocol Violation|1|||
16129939|NCT00658684|38962307|FG002|Overall Study|Protocol Violation|0|||
16129940|NCT00658684|38962308|FG003|Overall Study|Protocol Violation|0|||
16129941|NCT00658684|38962305|FG000|Overall Study|Pregnancy|1|||
16129942|NCT00658684|38962306|FG001|Overall Study|Pregnancy|1|||
16129943|NCT00658684|38962307|FG002|Overall Study|Pregnancy|0|||
16129944|NCT00658684|38962308|FG003|Overall Study|Pregnancy|0|||
16129945|NCT05249829|38962309|FG000|Overall Study|Participant Relocation|0|||
16129946|NCT05249829|38962310|FG001|Overall Study|Participant Relocation|1|||
16129947|NCT05249829|38962311|FG002|Overall Study|Participant Relocation|2|||
16129948|NCT05249829|38962312|FG003|Overall Study|Participant Relocation|2|||
16129949|NCT05249829|38962309|FG000|Overall Study|Withdrawal by Subject|9|||
16129950|NCT05249829|38962310|FG001|Overall Study|Withdrawal by Subject|17|||
16129951|NCT05249829|38962311|FG002|Overall Study|Withdrawal by Subject|40|||
16129952|NCT05249829|38962312|FG003|Overall Study|Withdrawal by Subject|35|||
16129953|NCT05249829|38962309|FG000|Overall Study|Physician Decision|1|||
16129954|NCT05249829|38962310|FG001|Overall Study|Physician Decision|0|||
16129955|NCT05249829|38962311|FG002|Overall Study|Physician Decision|0|||
16129956|NCT05249829|38962312|FG003|Overall Study|Physician Decision|0|||
16129957|NCT05249829|38962309|FG000|Overall Study|Lost to Follow-up|16|||
16129958|NCT05249829|38962310|FG001|Overall Study|Lost to Follow-up|16|||
16129959|NCT05249829|38962311|FG002|Overall Study|Lost to Follow-up|57|||
16129960|NCT05249829|38962312|FG003|Overall Study|Lost to Follow-up|60|||
16129961|NCT05249829|38962309|FG000|Overall Study|Adverse Event|2|||
16129962|NCT05249829|38962310|FG001|Overall Study|Adverse Event|2|||
16129963|NCT05249829|38962311|FG002|Overall Study|Adverse Event|2|||
16129964|NCT05249829|38962312|FG003|Overall Study|Adverse Event|2|||
16129965|NCT05249829|38962309|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
16129966|NCT05249829|38962310|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
16129967|NCT05249829|38962311|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
16129968|NCT05249829|38962312|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
16129969|NCT05249829|38962309|FG000|Overall Study|Protocol Violation|2|||
16129970|NCT05249829|38962310|FG001|Overall Study|Protocol Violation|0|||
16129971|NCT05249829|38962311|FG002|Overall Study|Protocol Violation|5|||
16129972|NCT05249829|38962312|FG003|Overall Study|Protocol Violation|3|||
16129973|NCT05249829|38962309|FG000|Overall Study|Death|0|||
16129974|NCT05249829|38962310|FG001|Overall Study|Death|1|||
16129975|NCT05249829|38962311|FG002|Overall Study|Death|2|||
16129976|NCT05249829|38962312|FG003|Overall Study|Death|4|||
16129977|NCT03527550|38962314|FG000|Overall Study|Lost to Follow-up|4|||
16129978|NCT03527550|38962315|FG001|Overall Study|Lost to Follow-up|2|||
16129979|NCT03527550|38962314|FG000|Overall Study|Withdrawal by Subject|4|||
16129980|NCT03527550|38962315|FG001|Overall Study|Withdrawal by Subject|1|||
16129981|NCT03527550|38962314|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
16129982|NCT03527550|38962315|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
16129983|NCT00775463|38962318|FG000|Overall Study|Withdrawal by Subject|0|||
16129984|NCT00775463|38962319|FG001|Overall Study|Withdrawal by Subject|1|||
16129985|NCT00775463|38962318|FG000|Overall Study|Adverse Event|7|||
16129986|NCT00775463|38962319|FG001|Overall Study|Adverse Event|9|||
16129987|NCT00775463|38962318|FG000|Overall Study|Protocol Violation|2|||
16129988|NCT00775463|38962319|FG001|Overall Study|Protocol Violation|2|||
16129989|NCT00775463|38962318|FG000|Overall Study|Lost to Follow-up|1|||
16129990|NCT00775463|38962319|FG001|Overall Study|Lost to Follow-up|0|||
16417425|NCT00576472|40008548|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
16129991|NCT00775463|38962318|FG000|Overall Study|Lack of Efficacy|1|||
16129992|NCT00775463|38962319|FG001|Overall Study|Lack of Efficacy|1|||
16129993|NCT05323396|38962320|FG000|Overall Study|Lost to Follow-up|1|||
16129994|NCT05323396|38962321|FG001|Overall Study|Lost to Follow-up|31|||
16129995|NCT05323396|38962320|FG000|Overall Study|Pregnancy|1|||
16129996|NCT05323396|38962321|FG001|Overall Study|Pregnancy|0|||
16129997|NCT01668667|38962322|FG000|Overall Study|Adverse Event|3|||
16129998|NCT01668667|38962323|FG001|Overall Study|Adverse Event|6|||
16129999|NCT01668667|38962324|FG002|Overall Study|Adverse Event|4|||
16130000|NCT01668667|38962325|FG003|Overall Study|Adverse Event|4|||
16130001|NCT01668667|38962322|FG000|Overall Study|Lack of Efficacy|3|||
16130002|NCT01668667|38962323|FG001|Overall Study|Lack of Efficacy|2|||
16130003|NCT01668667|38962324|FG002|Overall Study|Lack of Efficacy|2|||
16130004|NCT01668667|38962325|FG003|Overall Study|Lack of Efficacy|3|||
16130005|NCT01668667|38962322|FG000|Overall Study|Protocol Violation|6|||
16130006|NCT01668667|38962323|FG001|Overall Study|Protocol Violation|10|||
16130007|NCT01668667|38962324|FG002|Overall Study|Protocol Violation|12|||
16130008|NCT01668667|38962325|FG003|Overall Study|Protocol Violation|5|||
16417426|NCT00576472|40008534|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
16417427|NCT00576472|40008535|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
16417428|NCT00576472|40008536|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
16417429|NCT00576472|40008537|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
16417430|NCT00576472|40008538|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
16417431|NCT00576472|40008539|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
16417432|NCT00576472|40008540|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
16417433|NCT00576472|40008541|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
16417434|NCT00576472|40008542|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
16417435|NCT00576472|40008543|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
16417436|NCT00576472|40008544|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
16417437|NCT00576472|40008545|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
16417438|NCT00576472|40008546|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
16417439|NCT00576472|40008547|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
16417440|NCT00576472|40008548|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
16417441|NCT00576472|40008534|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417442|NCT00576472|40008535|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417443|NCT00576472|40008536|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417444|NCT00576472|40008537|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
16417445|NCT00576472|40008538|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
16560391|NCT01347645|40517611|FG004|Overall Study|Lost to Follow-up|1|||
16560392|NCT01347645|40517607|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
16417446|NCT00576472|40008539|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417447|NCT00576472|40008540|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
16560393|NCT01347645|40517608|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
16560394|NCT01347645|40517609|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
16560395|NCT01347645|40517610|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
16130009|NCT01668667|38962322|FG000|Overall Study|Lost to Follow-up|9|||
16130010|NCT01668667|38962323|FG001|Overall Study|Lost to Follow-up|4|||
16130011|NCT01668667|38962324|FG002|Overall Study|Lost to Follow-up|7|||
16417448|NCT00576472|40008541|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
16130012|NCT01668667|38962325|FG003|Overall Study|Lost to Follow-up|6|||
16130013|NCT01668667|38962322|FG000|Overall Study|Physician Decision|3|||
16130014|NCT01668667|38962323|FG001|Overall Study|Physician Decision|0|||
16130015|NCT01668667|38962324|FG002|Overall Study|Physician Decision|1|||
16130016|NCT01668667|38962325|FG003|Overall Study|Physician Decision|0|||
16130017|NCT01668667|38962322|FG000|Overall Study|Withdrawal by Subject|7|||
16130018|NCT01668667|38962323|FG001|Overall Study|Withdrawal by Subject|4|||
16130019|NCT01668667|38962324|FG002|Overall Study|Withdrawal by Subject|5|||
16130020|NCT01668667|38962325|FG003|Overall Study|Withdrawal by Subject|5|||
16130021|NCT02121301|38962326|FG000|Overall Study|Protocol Violation|1|||
16130022|NCT02121301|38962327|FG001|Overall Study|Protocol Violation|4|||
16130023|NCT02121301|38962328|FG002|Overall Study|Protocol Violation|1|||
16130024|NCT01723254|38962329|FG000|Overall Study|Conflict with work schedule|0|||
16130025|NCT01723254|38962330|FG001|Overall Study|Conflict with work schedule|0|||
16130026|NCT01723254|38962331|FG002|Overall Study|Conflict with work schedule|0|||
16130027|NCT01723254|38962332|FG003|Overall Study|Conflict with work schedule|0|||
16130028|NCT01723254|38962333|FG004|Overall Study|Conflict with work schedule|0|||
16130029|NCT01723254|38962334|FG005|Overall Study|Conflict with work schedule|0|||
16130030|NCT01723254|38962335|FG006|Overall Study|Conflict with work schedule|0|||
16130031|NCT01723254|38962336|FG007|Overall Study|Conflict with work schedule|1|||
16130032|NCT01723254|38962329|FG000|Overall Study|Personal issues|0|||
16130033|NCT01723254|38962330|FG001|Overall Study|Personal issues|0|||
16130034|NCT01723254|38962331|FG002|Overall Study|Personal issues|0|||
16130035|NCT01723254|38962332|FG003|Overall Study|Personal issues|0|||
16130036|NCT01723254|38962333|FG004|Overall Study|Personal issues|0|||
16130037|NCT01723254|38962334|FG005|Overall Study|Personal issues|1|||
16130038|NCT01723254|38962335|FG006|Overall Study|Personal issues|0|||
16130039|NCT01723254|38962336|FG007|Overall Study|Personal issues|0|||
16130040|NCT01723254|38962329|FG000|Overall Study|No longer have time to participate|0|||
16130041|NCT01723254|38962330|FG001|Overall Study|No longer have time to participate|0|||
16130042|NCT01723254|38962331|FG002|Overall Study|No longer have time to participate|0|||
16130043|NCT01723254|38962332|FG003|Overall Study|No longer have time to participate|1|||
16130044|NCT01723254|38962333|FG004|Overall Study|No longer have time to participate|0|||
16130045|NCT01723254|38962334|FG005|Overall Study|No longer have time to participate|0|||
16130046|NCT01723254|38962335|FG006|Overall Study|No longer have time to participate|0|||
16130047|NCT01723254|38962336|FG007|Overall Study|No longer have time to participate|0|||
16130048|NCT01723254|38962329|FG000|Overall Study|Move/Left to another country/city|0|||
16130049|NCT01723254|38962330|FG001|Overall Study|Move/Left to another country/city|0|||
16130050|NCT01723254|38962331|FG002|Overall Study|Move/Left to another country/city|2|||
16130051|NCT01723254|38962332|FG003|Overall Study|Move/Left to another country/city|1|||
16130052|NCT01723254|38962333|FG004|Overall Study|Move/Left to another country/city|1|||
16130053|NCT01723254|38962334|FG005|Overall Study|Move/Left to another country/city|0|||
16130054|NCT01723254|38962335|FG006|Overall Study|Move/Left to another country/city|0|||
16130055|NCT01723254|38962336|FG007|Overall Study|Move/Left to another country/city|0|||
16130056|NCT01723254|38962329|FG000|Overall Study|Protocol Violation|0|||
16130057|NCT01723254|38962330|FG001|Overall Study|Protocol Violation|1|||
16130058|NCT01723254|38962331|FG002|Overall Study|Protocol Violation|0|||
16130059|NCT01723254|38962332|FG003|Overall Study|Protocol Violation|0|||
16130060|NCT01723254|38962333|FG004|Overall Study|Protocol Violation|0|||
16130061|NCT01723254|38962334|FG005|Overall Study|Protocol Violation|0|||
16130062|NCT01723254|38962335|FG006|Overall Study|Protocol Violation|0|||
16130063|NCT01723254|38962336|FG007|Overall Study|Protocol Violation|0|||
16130064|NCT01723254|38962329|FG000|Overall Study|Withdrawal by Subject|1|||
16130065|NCT01723254|38962330|FG001|Overall Study|Withdrawal by Subject|2|||
16130066|NCT01723254|38962331|FG002|Overall Study|Withdrawal by Subject|1|||
16130067|NCT01723254|38962332|FG003|Overall Study|Withdrawal by Subject|0|||
16130068|NCT01723254|38962333|FG004|Overall Study|Withdrawal by Subject|1|||
16130069|NCT01723254|38962334|FG005|Overall Study|Withdrawal by Subject|1|||
16130070|NCT01723254|38962335|FG006|Overall Study|Withdrawal by Subject|1|||
16130071|NCT01723254|38962336|FG007|Overall Study|Withdrawal by Subject|2|||
16130072|NCT02924428|38962337|FG000|Overall Study|Adverse Event|1|||
16130073|NCT02924428|38962338|FG001|Overall Study|Adverse Event|0|||
16130074|NCT02924428|38962337|FG000|Overall Study|Physician Decision|1|||
16130075|NCT02924428|38962338|FG001|Overall Study|Physician Decision|0|||
16130076|NCT02924428|38962337|FG000|Overall Study|Lost to Follow-up|2|||
16130077|NCT02924428|38962338|FG001|Overall Study|Lost to Follow-up|4|||
16130078|NCT02924428|38962337|FG000|Overall Study|Pregnancy|0|||
16130079|NCT02924428|38962338|FG001|Overall Study|Pregnancy|1|||
16130080|NCT01867333|38962342|FG000|Overall Study|Withdrawal by Subject|1|||
16130081|NCT01867333|38962343|FG001|Overall Study|Withdrawal by Subject|0|||
16130082|NCT01867333|38962342|FG000|Overall Study|Adverse Event|1|||
16130083|NCT01867333|38962343|FG001|Overall Study|Adverse Event|0|||
16130084|NCT01867333|38962342|FG000|Overall Study|Participant choice|1|||
16130085|NCT01867333|38962343|FG001|Overall Study|Participant choice|2|||
16130086|NCT01867333|38962342|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
16130087|NCT01867333|38962343|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
16130088|NCT01867333|38962342|FG000|Overall Study|Death|0|||
16130089|NCT01867333|38962343|FG001|Overall Study|Death|1|||
16130090|NCT01867333|38962342|FG000|Overall Study|Physician Decision|3|||
16130091|NCT01867333|38962343|FG001|Overall Study|Physician Decision|2|||
16130092|NCT01867333|38962342|FG000|Overall Study|Switched to alternative treatment|1|||
16130093|NCT01867333|38962343|FG001|Overall Study|Switched to alternative treatment|0|||
16130094|NCT00552240|38962345|FG000|Overall Study|Adverse Event|9|||
16130095|NCT00552240|38962346|FG001|Overall Study|Adverse Event|9|||
16130096|NCT00552240|38962345|FG000|Overall Study|Protocol Violation|1|||
16130097|NCT00552240|38962346|FG001|Overall Study|Protocol Violation|1|||
16130098|NCT00552240|38962345|FG000|Overall Study|Lost to Follow-up|5|||
16130099|NCT00552240|38962346|FG001|Overall Study|Lost to Follow-up|6|||
16130100|NCT00552240|38962345|FG000|Overall Study|Withdrawal by Subject|2|||
16130101|NCT00552240|38962346|FG001|Overall Study|Withdrawal by Subject|2|||
16130102|NCT00552240|38962345|FG000|Overall Study|Lack of Efficacy|6|||
16130103|NCT00552240|38962346|FG001|Overall Study|Lack of Efficacy|0|||
16130104|NCT00552240|38962345|FG000|Overall Study|Other|1|||
16130105|NCT00552240|38962346|FG001|Overall Study|Other|0|||
16130106|NCT00249002|38962347|FG000|Overall Study|Adverse Event|2|||
16130107|NCT00249002|38962347|FG000|Overall Study|Study cancellation|3|||
16130108|NCT00249002|38962347|FG000|Overall Study|Other|2|||
16130109|NCT00112047|38962350|FG000|Randomized Phase|Lost to Follow-up|26|||
16130110|NCT00112047|38962351|FG001|Randomized Phase|Lost to Follow-up|33|||
16130111|NCT00112047|38962350|FG000|Randomized Phase|Adverse Event|10|||
16130112|NCT00112047|38962351|FG001|Randomized Phase|Adverse Event|10|||
16130113|NCT00112047|38962350|FG000|Randomized Phase|Withrawal of consent|10|||
16130114|NCT00112047|38962351|FG001|Randomized Phase|Withrawal of consent|18|||
16130115|NCT00112047|38962350|FG000|Randomized Phase|Sub-optimal virological response|3|||
16130116|NCT00112047|38962351|FG001|Randomized Phase|Sub-optimal virological response|13|||
16130117|NCT00112047|38962350|FG000|Randomized Phase|Noncompliance|8|||
16130118|NCT00112047|38962351|FG001|Randomized Phase|Noncompliance|4|||
16130119|NCT00112047|38962350|FG000|Randomized Phase|Protocol Violation|2|||
16130120|NCT00112047|38962351|FG001|Randomized Phase|Protocol Violation|0|||
16130121|NCT00112047|38962350|FG000|Randomized Phase|Pregnancy|3|||
16130122|NCT00112047|38962351|FG001|Randomized Phase|Pregnancy|1|||
16130123|NCT00112047|38962350|FG000|Randomized Phase|Death|1|||
16130124|NCT00112047|38962351|FG001|Randomized Phase|Death|3|||
16130125|NCT00112047|38962350|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
16130126|NCT00112047|38962351|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
16130127|NCT00112047|38962350|FG000|Randomized Phase|Inability to swallow pills|0|||
16130128|NCT00112047|38962351|FG001|Randomized Phase|Inability to swallow pills|1|||
16130129|NCT00112047|38962350|FG000|Randomized Phase|Incarceration|3|||
16130130|NCT00112047|38962351|FG001|Randomized Phase|Incarceration|2|||
16130131|NCT00112047|38962350|FG000|Randomized Phase|Moved out of State|0|||
16130132|NCT00112047|38962351|FG001|Randomized Phase|Moved out of State|1|||
16130133|NCT00112047|38962350|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
16130134|NCT00112047|38962351|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
16130135|NCT00112047|38962350|FG000|Randomized Phase|High Hepatitis B DNA|0|||
16130136|NCT00112047|38962351|FG001|Randomized Phase|High Hepatitis B DNA|1|||
16130137|NCT00112047|38962350|FG000|Atripla Phase|Adverse Event|2|||
16130138|NCT00112047|38962351|FG001|Atripla Phase|Adverse Event|1|||
16130139|NCT00112047|38962350|FG000|Atripla Phase|Lost to Follow-up|5|||
16130140|NCT00112047|38962351|FG001|Atripla Phase|Lost to Follow-up|7|||
16130141|NCT00112047|38962350|FG000|Atripla Phase|Pregnancy|0|||
16130142|NCT00112047|38962351|FG001|Atripla Phase|Pregnancy|1|||
16130143|NCT00112047|38962350|FG000|Atripla Phase|Death|0|||
16130144|NCT00112047|38962351|FG001|Atripla Phase|Death|2|||
16130145|NCT00112047|38962350|FG000|Atripla Phase|Withdrew consent|7|||
16130146|NCT00112047|38962351|FG001|Atripla Phase|Withdrew consent|7|||
16130147|NCT00112047|38962350|FG000|Atripla Phase|Sub-optimal virological response|0|||
16130148|NCT00112047|38962351|FG001|Atripla Phase|Sub-optimal virological response|1|||
16130149|NCT00112047|38962350|FG000|Atripla Phase|Non-compliance|1|||
16130150|NCT00112047|38962351|FG001|Atripla Phase|Non-compliance|0|||
16130151|NCT00112047|38962350|FG000|Atripla Phase|Other|3|||
16130152|NCT00112047|38962351|FG001|Atripla Phase|Other|1|||
16130153|NCT00903682|38962352|FG000|Overall Study|Adverse Event|6|||
16130154|NCT00903682|38962353|FG001|Overall Study|Adverse Event|13|||
16130155|NCT00903682|38962352|FG000|Overall Study|Lost to Follow-up|1|||
16130156|NCT00903682|38962353|FG001|Overall Study|Lost to Follow-up|0|||
16130157|NCT00903682|38962352|FG000|Overall Study|Withdrawal by Subject|5|||
16130158|NCT00903682|38962353|FG001|Overall Study|Withdrawal by Subject|0|||
16130159|NCT00903682|38962352|FG000|Overall Study|Pregnancy|0|||
16417449|NCT00576472|40008542|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417450|NCT00576472|40008543|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417451|NCT00576472|40008544|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417452|NCT00576472|40008545|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417453|NCT00576472|40008546|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417454|NCT00576472|40008547|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417455|NCT00576472|40008548|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
16417456|NCT00576472|40008534|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
16130160|NCT00903682|38962353|FG001|Overall Study|Pregnancy|1|||
16130161|NCT00903682|38962352|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
16130162|NCT00903682|38962353|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
16130163|NCT00903682|38962352|FG000|Overall Study|Subject Non-Compliant|1|||
16130164|NCT00903682|38962353|FG001|Overall Study|Subject Non-Compliant|0|||
16130165|NCT00903682|38962352|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
16130166|NCT00903682|38962353|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
16130167|NCT00903682|38962352|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
16130168|NCT00903682|38962353|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
16130169|NCT02980731|38962354|FG000|Overall Study|Death|63|||
16130170|NCT02980731|38962354|FG000|Overall Study|Withdrawal by Subject|6|||
16130171|NCT02980731|38962354|FG000|Overall Study|Lost to Follow-up|5|||
16352752|NCT00249834|39780250|FG004|Overall Study|Ovarian stimulation failed|0|||
16352753|NCT00249834|39780251|FG005|Overall Study|Ovarian stimulation failed|0|||
16352754|NCT00249834|39780252|FG006|Overall Study|Ovarian stimulation failed|0|||
16352755|NCT00249834|39780253|FG007|Overall Study|Ovarian stimulation failed|0|||
16417457|NCT00576472|40008535|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417458|NCT00576472|40008536|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
16352756|NCT00249834|39780246|FG000|Overall Study|Failure of down-regulation|0|||
16352757|NCT00249834|39780247|FG001|Overall Study|Failure of down-regulation|0|||
16352758|NCT00249834|39780248|FG002|Overall Study|Failure of down-regulation|0|||
16352759|NCT00249834|39780249|FG003|Overall Study|Failure of down-regulation|0|||
16352760|NCT00249834|39780250|FG004|Overall Study|Failure of down-regulation|0|||
16352761|NCT00249834|39780251|FG005|Overall Study|Failure of down-regulation|0|||
16352762|NCT00249834|39780252|FG006|Overall Study|Failure of down-regulation|1|||
16352763|NCT00249834|39780253|FG007|Overall Study|Failure of down-regulation|0|||
16352764|NCT00249834|39780246|FG000|Overall Study|Protocol Violation|0|||
16352765|NCT00249834|39780247|FG001|Overall Study|Protocol Violation|19|||
16352766|NCT00249834|39780248|FG002|Overall Study|Protocol Violation|14|||
16352767|NCT00249834|39780249|FG003|Overall Study|Protocol Violation|8|||
16352768|NCT00249834|39780250|FG004|Overall Study|Protocol Violation|5|||
16352769|NCT00249834|39780251|FG005|Overall Study|Protocol Violation|2|||
16352770|NCT00249834|39780252|FG006|Overall Study|Protocol Violation|0|||
16352771|NCT00249834|39780253|FG007|Overall Study|Protocol Violation|0|||
16352772|NCT01157845|39780254|FG000|Overall Study|Lost to Follow-up|5|||
16352773|NCT01157845|39780254|FG000|Overall Study|Withdrawal by Subject|12|||
16352774|NCT01157845|39780254|FG000|Overall Study|Physician Decision|3|||
16130172|NCT02980731|38962354|FG000|Overall Study|Study terminated by Sponsor|4|||
16352775|NCT01157845|39780254|FG000|Overall Study|Protocol Violation|13|||
16352776|NCT01157845|39780254|FG000|Overall Study|Study was ended|1|||
16352777|NCT01157845|39780254|FG000|Overall Study|Device malfunction|1|||
16560396|NCT01347645|40517611|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
16560397|NCT01347645|40517607|FG000|Overall Study|Other|1|||
16560398|NCT01347645|40517608|FG001|Overall Study|Other|0|||
16560399|NCT01347645|40517609|FG002|Overall Study|Other|0|||
16560400|NCT01347645|40517610|FG003|Overall Study|Other|0|||
16560401|NCT01347645|40517611|FG004|Overall Study|Other|1|||
16560402|NCT01347645|40517607|FG000|Overall Study|Withdrawal by Subject|0|||
16560403|NCT01347645|40517608|FG001|Overall Study|Withdrawal by Subject|0|||
16560404|NCT01347645|40517609|FG002|Overall Study|Withdrawal by Subject|0|||
16560405|NCT01347645|40517610|FG003|Overall Study|Withdrawal by Subject|3|||
16560406|NCT01347645|40517611|FG004|Overall Study|Withdrawal by Subject|3|||
16560407|NCT01347645|40517607|FG000|Overall Study|Physician Decision|0|||
16560408|NCT01347645|40517608|FG001|Overall Study|Physician Decision|0|||
16560409|NCT01347645|40517609|FG002|Overall Study|Physician Decision|0|||
16560410|NCT01347645|40517610|FG003|Overall Study|Physician Decision|0|||
16560411|NCT01347645|40517611|FG004|Overall Study|Physician Decision|1|||
16560412|NCT01347645|40517607|FG000|Overall Study|Adverse Event|0|||
16560413|NCT01347645|40517608|FG001|Overall Study|Adverse Event|0|||
16560414|NCT01347645|40517609|FG002|Overall Study|Adverse Event|0|||
16560415|NCT01347645|40517610|FG003|Overall Study|Adverse Event|1|||
16560416|NCT01347645|40517611|FG004|Overall Study|Adverse Event|1|||
16560417|NCT01222247|40517613|FG000|Overall Study|Lost to Follow-up|2|||
16560418|NCT01222247|40517614|FG001|Overall Study|Lost to Follow-up|2|||
16560419|NCT04707391|40517615|FG000|Overall Study|Adverse Event|5|||
16560420|NCT04707391|40517616|FG001|Overall Study|Adverse Event|8|||
16560421|NCT04707391|40517615|FG000|Overall Study|Lost to Follow-up|44|||
16560422|NCT04707391|40517616|FG001|Overall Study|Lost to Follow-up|31|||
16560423|NCT04707391|40517615|FG000|Overall Study|Protocol Violation|1|||
16560424|NCT04707391|40517616|FG001|Overall Study|Protocol Violation|5|||
16560425|NCT04707391|40517615|FG000|Overall Study|Withdrawal by Subject|27|||
16560426|NCT04707391|40517616|FG001|Overall Study|Withdrawal by Subject|25|||
16560427|NCT04707391|40517615|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
16417459|NCT00576472|40008537|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417460|NCT00576472|40008538|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417461|NCT00576472|40008539|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417462|NCT00576472|40008540|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
16417463|NCT00576472|40008541|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417464|NCT00576472|40008542|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417465|NCT00576472|40008543|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417466|NCT00576472|40008544|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417467|NCT00576472|40008545|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417468|NCT00576472|40008546|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417469|NCT00576472|40008547|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417470|NCT00576472|40008548|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
16417471|NCT00576472|40008534|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
16417472|NCT00576472|40008535|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
16417473|NCT00576472|40008536|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
16417474|NCT00576472|40008537|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
16417475|NCT00576472|40008538|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
16417476|NCT00576472|40008539|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
16417477|NCT00576472|40008540|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
16417478|NCT00576472|40008541|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
16417479|NCT00576472|40008542|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
16417480|NCT00576472|40008543|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
16417481|NCT00576472|40008544|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
16560428|NCT04707391|40517616|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
16560429|NCT04707391|40517615|FG000|Overall Study|Other|0|||
16560430|NCT04707391|40517616|FG001|Overall Study|Other|2|||
16560431|NCT01559090|40517617|FG000|Stage I|Withdrawal by Subject|2|||
16560432|NCT01559090|40517618|FG001|Stage I|Withdrawal by Subject|2|||
16560433|NCT01559090|40517619|FG002|Stage I|Withdrawal by Subject|3|||
16560434|NCT01559090|40517617|FG000|Stage II|Withdrawal by Subject|1|||
16560435|NCT01559090|40517618|FG001|Stage II|Withdrawal by Subject|0|||
16560436|NCT01559090|40517619|FG002|Stage II|Withdrawal by Subject|0|||
16560437|NCT00801242|40517620|FG000|Overall Study|Adverse Event|10|||
16560438|NCT00801242|40517620|FG000|Overall Study|Withdrawal by Subject|13|||
16417482|NCT00576472|40008545|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
16417483|NCT00576472|40008546|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
16417484|NCT00576472|40008547|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
16417485|NCT00576472|40008548|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
16560439|NCT00801242|40517620|FG000|Overall Study|Protocol Violation|5|||
16560440|NCT00801242|40517620|FG000|Overall Study|Physician Decision|3|||
16560441|NCT00801242|40517620|FG000|Overall Study|Lost to Follow-up|1|||
16560442|NCT00801242|40517620|FG000|Overall Study|Miscellaneous reasons|20|||
16560443|NCT01712685|40517622|FG000|Overall Study|pt declined to participate before trmt|1|||
16560444|NCT02427646|40517623|FG000|Overall Study|Lack of Efficacy|2|||
16560445|NCT02427646|40517624|FG001|Overall Study|Lack of Efficacy|3|||
16560446|NCT02427646|40517623|FG000|Overall Study|Physician Decision|1|||
16560447|NCT02427646|40517624|FG001|Overall Study|Physician Decision|4|||
16560448|NCT02427646|40517623|FG000|Overall Study|Protocol Violation|3|||
16560449|NCT02427646|40517624|FG001|Overall Study|Protocol Violation|3|||
16560450|NCT02427646|40517623|FG000|Overall Study|Bothersome hand weakness|2|||
16560451|NCT02427646|40517624|FG001|Overall Study|Bothersome hand weakness|4|||
16560452|NCT00178256|40517638|FG000|Overall Study|Adverse Event|2|||
16560453|NCT00178256|40517639|FG001|Overall Study|Adverse Event|0|||
16560454|NCT00178256|40517640|FG002|Overall Study|Adverse Event|0|||
16560455|NCT00178256|40517641|FG003|Overall Study|Adverse Event|0|||
16560456|NCT00178256|40517638|FG000|Overall Study|Death|0|||
16560457|NCT00178256|40517639|FG001|Overall Study|Death|1|||
16560458|NCT00178256|40517640|FG002|Overall Study|Death|0|||
16560459|NCT00178256|40517641|FG003|Overall Study|Death|1|||
16560460|NCT00178256|40517638|FG000|Overall Study|Cancer progression|2|||
16560461|NCT00178256|40517639|FG001|Overall Study|Cancer progression|0|||
16560462|NCT00178256|40517640|FG002|Overall Study|Cancer progression|0|||
16560463|NCT00178256|40517641|FG003|Overall Study|Cancer progression|1|||
16560464|NCT02790606|40517646|FG000|Overall Study|Death|27|||
16560465|NCT02790606|40517646|FG000|Overall Study|Lost to Follow-up|4|||
16560466|NCT02790606|40517646|FG000|Overall Study|Physician Decision|3|||
16560467|NCT02790606|40517646|FG000|Overall Study|Withdrawal by Subject|1|||
16560468|NCT02176928|40517651|FG000|Overall Study|Lost to Follow-up|2|||
16560469|NCT02176928|40517652|FG001|Overall Study|Lost to Follow-up|4|||
16560470|NCT02531438|40517653|FG000|Overall Study|Adverse Event|7|||
16560471|NCT02531438|40517654|FG001|Overall Study|Adverse Event|9|||
16560472|NCT02531438|40517653|FG000|Overall Study|Lost to Follow-up|0|||
16560473|NCT02531438|40517654|FG001|Overall Study|Lost to Follow-up|3|||
16560474|NCT02531438|40517653|FG000|Overall Study|Withdrawal by Subject|7|||
16560475|NCT02531438|40517654|FG001|Overall Study|Withdrawal by Subject|8|||
16560476|NCT02531438|40517653|FG000|Overall Study|Physician Decision|0|||
16560477|NCT02531438|40517654|FG001|Overall Study|Physician Decision|1|||
16560478|NCT02531438|40517653|FG000|Overall Study|Death|6|||
16560479|NCT02531438|40517654|FG001|Overall Study|Death|3|||
16560480|NCT02531438|40517653|FG000|Overall Study|Randomized, but Not Treated|4|||
16560481|NCT02531438|40517654|FG001|Overall Study|Randomized, but Not Treated|0|||
16560482|NCT02531438|40517653|FG000|Overall Study|Missed EOT/PTE Visit|5|||
16560483|NCT02531438|40517654|FG001|Overall Study|Missed EOT/PTE Visit|2|||
16352778|NCT02121795|39780255|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
16352779|NCT02121795|39780256|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
16352780|NCT02121795|39780255|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
16352781|NCT02121795|39780256|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
16352782|NCT02121795|39780255|FG000|Double-Blind Phase|Lost to Follow-up|7|||
16352783|NCT02121795|39780256|FG001|Double-Blind Phase|Lost to Follow-up|4|||
16352784|NCT02121795|39780255|FG000|Double-Blind Phase|Physician Decision|2|||
16352785|NCT02121795|39780256|FG001|Double-Blind Phase|Physician Decision|5|||
16352786|NCT02121795|39780255|FG000|Double-Blind Phase|Adverse Event|5|||
16352787|NCT02121795|39780256|FG001|Double-Blind Phase|Adverse Event|0|||
16352788|NCT02121795|39780255|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
16352789|NCT02121795|39780256|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
16352790|NCT02121795|39780255|FG000|Double-Blind Phase|Protocol Violation|0|||
16352791|NCT02121795|39780256|FG001|Double-Blind Phase|Protocol Violation|3|||
16352792|NCT02121795|39780255|FG000|Double-Blind Phase|Death|1|||
16352793|NCT02121795|39780256|FG001|Double-Blind Phase|Death|1|||
16352794|NCT02121795|39780255|FG000|Open-Label Phase|Physician Decision|8|||
16352795|NCT02121795|39780256|FG001|Open-Label Phase|Physician Decision|8|||
16417486|NCT00576472|40008534|FG000|MPH Cross Over Phase|Physician Decision|0|||
16417487|NCT00576472|40008535|FG001|MPH Cross Over Phase|Physician Decision|0|||
16417488|NCT00576472|40008536|FG002|MPH Cross Over Phase|Physician Decision|0|||
16560484|NCT02531438|40517653|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
16352796|NCT02121795|39780255|FG000|Open-Label Phase|Withdrawal by Subject|3|||
16352797|NCT02121795|39780256|FG001|Open-Label Phase|Withdrawal by Subject|2|||
16352798|NCT02121795|39780255|FG000|Open-Label Phase|Lost to Follow-up|1|||
16352799|NCT02121795|39780256|FG001|Open-Label Phase|Lost to Follow-up|0|||
16352800|NCT01051921|39780257|FG000|Overall Study|Physician Decision|9|||
16352801|NCT01051921|39780257|FG000|Overall Study|Adverse Event|8|||
16352802|NCT01051921|39780257|FG000|Overall Study|Withdrawal by Subject|7|||
16352803|NCT01051921|39780257|FG000|Overall Study|Lost to Follow-up|4|||
16352804|NCT01051921|39780257|FG000|Overall Study|virological failure|1|||
16352805|NCT01051921|39780257|FG000|Overall Study|patient moved|1|||
16352806|NCT01128296|39780258|FG000|Overall Study|Physician Decision|0|||
16352807|NCT01128296|39780259|FG001|Overall Study|Physician Decision|0|||
16352808|NCT01128296|39780260|FG002|Overall Study|Physician Decision|0|||
16352809|NCT01128296|39780261|FG003|Overall Study|Physician Decision|0|||
16352810|NCT01128296|39780262|FG004|Overall Study|Physician Decision|0|||
16352811|NCT01128296|39780263|FG005|Overall Study|Physician Decision|3|||
16352812|NCT01128296|39780258|FG000|Overall Study|Withdrawal by Subject|0|||
16352813|NCT01128296|39780259|FG001|Overall Study|Withdrawal by Subject|0|||
16352814|NCT01128296|39780260|FG002|Overall Study|Withdrawal by Subject|0|||
16352815|NCT01128296|39780261|FG003|Overall Study|Withdrawal by Subject|0|||
16352816|NCT01128296|39780262|FG004|Overall Study|Withdrawal by Subject|0|||
16352817|NCT01128296|39780263|FG005|Overall Study|Withdrawal by Subject|2|||
16352818|NCT02308046|39780268|FG000|Overall Study|Negative yeast culture at Baseline|32|||
16352819|NCT02308046|39780269|FG001|Overall Study|Negative yeast culture at Baseline|33|||
16352820|NCT02308046|39780268|FG000|Overall Study|Positive for STD at Baseline|1|||
16352821|NCT02308046|39780269|FG001|Overall Study|Positive for STD at Baseline|2|||
16352822|NCT02308046|39780268|FG000|Overall Study|Lost to Follow-up|1|||
16352823|NCT02308046|39780269|FG001|Overall Study|Lost to Follow-up|3|||
16352824|NCT00863707|39780270|FG000|Overall Study|Randomized, but drug not received|4|||
16352825|NCT00863707|39780271|FG001|Overall Study|Randomized, but drug not received|3|||
16352826|NCT02143414|39780272|FG000|Induction|Adverse Event|1|||
16352827|NCT02143414|39780273|FG001|Induction|Adverse Event|2|||
16352828|NCT02143414|39780272|FG000|Induction|Death|1|||
16417489|NCT00576472|40008537|FG003|MPH Cross Over Phase|Physician Decision|0|||
16417490|NCT00576472|40008538|FG004|MPH Cross Over Phase|Physician Decision|0|||
16417491|NCT00576472|40008539|FG005|MPH Cross Over Phase|Physician Decision|0|||
16560485|NCT02531438|40517654|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
16560486|NCT03677375|40517655|FG000|Overall Study|Incomplete procedure|8|||
16560487|NCT03677375|40517655|FG000|Overall Study|Adverse Event|3|||
16560488|NCT03677375|40517655|FG000|Overall Study|Physician Decision|1|||
16560489|NCT02733042|40517656|FG000|Overall Study|Adverse Event|1|||
16130173|NCT02980731|38962354|FG000|Overall Study|Completed survival follow-up period|65|||
16130174|NCT02980731|38962354|FG000|Overall Study|COVID-19 infection|1|||
16130175|NCT02980731|38962354|FG000|Overall Study|Other, not specified|66|||
16130176|NCT01771107|38962355|FG000|Overall Study|Adverse Event|1|||
16130177|NCT01771107|38962356|FG001|Overall Study|Adverse Event|3|||
16130178|NCT01771107|38962355|FG000|Overall Study|Withdrawal by Subject|0|||
16417492|NCT00576472|40008540|FG006|MPH Cross Over Phase|Physician Decision|4|||
16352829|NCT02143414|39780273|FG001|Induction|Death|2|||
16352830|NCT02143414|39780272|FG000|Induction|Patient refusal|1|||
16352831|NCT02143414|39780273|FG001|Induction|Patient refusal|1|||
16352832|NCT02143414|39780272|FG000|Induction|Refractory|1|||
16417493|NCT00576472|40008541|FG007|MPH Cross Over Phase|Physician Decision|0|||
16352833|NCT02143414|39780273|FG001|Induction|Refractory|0|||
16352834|NCT02143414|39780272|FG000|Induction|Began alternative treatment|1|||
16130179|NCT01771107|38962356|FG001|Overall Study|Withdrawal by Subject|2|||
16130180|NCT01771107|38962355|FG000|Overall Study|Lost to Follow-up|0|||
16130181|NCT01771107|38962356|FG001|Overall Study|Lost to Follow-up|1|||
16130182|NCT01771107|38962355|FG000|Overall Study|participant moved|0|||
16130183|NCT01771107|38962356|FG001|Overall Study|participant moved|1|||
16130184|NCT01771107|38962355|FG000|Overall Study|Other|0|||
16130185|NCT01771107|38962356|FG001|Overall Study|Other|1|||
16130186|NCT00986973|38962357|FG000|Overall Study|Withdrawn by study team|1|||
16130187|NCT02751320|38962358|FG000|Overall Study|Adverse Event|2|||
16130188|NCT02751320|38962358|FG000|Overall Study|Withdrawal by Subject|1|||
16130189|NCT01014533|38962359|FG000|Overall Study|Protocol Violation|3|||
16246531|NCT01620983|39385522|FG001|Overall Study|Lost to Follow-up|4|||
16246532|NCT01620983|39385523|FG002|Overall Study|Lost to Follow-up|9|||
16246533|NCT01620983|39385521|FG000|Overall Study|Withdrawal by Subject|6|||
16246534|NCT01620983|39385522|FG001|Overall Study|Withdrawal by Subject|8|||
16560490|NCT02733042|40517657|FG001|Overall Study|Adverse Event|0|||
16560491|NCT02733042|40517658|FG002|Overall Study|Adverse Event|1|||
16560492|NCT02733042|40517659|FG003|Overall Study|Adverse Event|1|||
16560493|NCT02733042|40517660|FG004|Overall Study|Adverse Event|0|||
16560494|NCT02733042|40517661|FG005|Overall Study|Adverse Event|0|||
16560495|NCT02733042|40517662|FG006|Overall Study|Adverse Event|0|||
16246535|NCT01620983|39385523|FG002|Overall Study|Withdrawal by Subject|1|||
16246536|NCT01620983|39385521|FG000|Overall Study|Death|2|||
16246537|NCT01620983|39385522|FG001|Overall Study|Death|0|||
16246538|NCT01620983|39385523|FG002|Overall Study|Death|0|||
16246539|NCT01620983|39385521|FG000|Overall Study|Physician Decision|3|||
16246540|NCT01620983|39385522|FG001|Overall Study|Physician Decision|10|||
16246541|NCT01620983|39385523|FG002|Overall Study|Physician Decision|5|||
16246542|NCT04535583|39385524|FG000|Overall Study|Lost to Follow-up|1|||
16246543|NCT04535583|39385524|FG000|Overall Study|Physician Decision|1|||
16246544|NCT04535583|39385524|FG000|Overall Study|Withdrawal by Subject|1|||
16246545|NCT04049552|39385536|FG000|Overall Study|Lost to Follow-up|1|||
16560496|NCT02733042|40517663|FG007|Overall Study|Adverse Event|0|||
16560497|NCT02733042|40517664|FG008|Overall Study|Adverse Event|0|||
16246546|NCT01254045|39385537|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
16246547|NCT01254045|39385538|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
16246548|NCT01254045|39385539|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
16246549|NCT01254045|39385540|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
16246550|NCT01254045|39385541|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
16246551|NCT01254045|39385542|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
16246552|NCT03377556|39385544|FG000|Overall Study|Adverse Event|5|||
16246553|NCT03377556|39385544|FG000|Overall Study|Refusal unrelated to adverse events|1|||
16246554|NCT03377556|39385544|FG000|Overall Study|Progression/relapse|38|||
16246555|NCT03377556|39385544|FG000|Overall Study|Death|3|||
16246556|NCT01337050|39385545|FG000|Overall Study|Death|0|||
16246557|NCT01337050|39385546|FG001|Overall Study|Death|0|||
16246558|NCT01337050|39385547|FG002|Overall Study|Death|4|||
16246559|NCT01337050|39385545|FG000|Overall Study|Other|4|||
16246560|NCT01337050|39385546|FG001|Overall Study|Other|6|||
16246561|NCT01337050|39385547|FG002|Overall Study|Other|8|||
16560498|NCT02733042|40517665|FG009|Overall Study|Adverse Event|0|||
16560499|NCT02733042|40517666|FG010|Overall Study|Adverse Event|2|||
16560500|NCT02733042|40517667|FG011|Overall Study|Adverse Event|2|||
16560501|NCT02733042|40517668|FG012|Overall Study|Adverse Event|0|||
16560502|NCT02733042|40517669|FG013|Overall Study|Adverse Event|2|||
16560503|NCT02733042|40517670|FG014|Overall Study|Adverse Event|0|||
16130190|NCT01014533|38962360|FG001|Overall Study|Protocol Violation|2|||
16130191|NCT01014533|38962359|FG000|Overall Study|Withdrawal by Subject|2|||
16130192|NCT01014533|38962360|FG001|Overall Study|Withdrawal by Subject|0|||
16246562|NCT01337050|39385545|FG000|Overall Study|Participants refused further follow-up|0|||
16560504|NCT02733042|40517671|FG015|Overall Study|Adverse Event|0|||
16130193|NCT01014533|38962359|FG000|Overall Study|unable to come to appointment|0|||
16246563|NCT01337050|39385546|FG001|Overall Study|Participants refused further follow-up|7|||
16246564|NCT01337050|39385547|FG002|Overall Study|Participants refused further follow-up|7|||
16246565|NCT01738581|39385548|FG000|Overall Study|Lost to Follow-up|1|||
16560505|NCT02733042|40517672|FG016|Overall Study|Adverse Event|0|||
16560506|NCT02733042|40517673|FG017|Overall Study|Adverse Event|1|||
16246566|NCT01738581|39385549|FG001|Overall Study|Lost to Follow-up|0|||
16246567|NCT02965820|39385550|FG000|Period 2, Second 30 Days|Adverse Event|1|||
16417494|NCT00576472|40008542|FG008|MPH Cross Over Phase|Physician Decision|0|||
16417495|NCT00576472|40008543|FG009|MPH Cross Over Phase|Physician Decision|0|||
16560507|NCT02733042|40517674|FG018|Overall Study|Adverse Event|0|||
16560508|NCT02733042|40517656|FG000|Overall Study|Progressive Disease|2|||
16417496|NCT00576472|40008544|FG010|MPH Cross Over Phase|Physician Decision|0|||
16417497|NCT00576472|40008545|FG011|MPH Cross Over Phase|Physician Decision|0|||
16417498|NCT00576472|40008546|FG012|MPH Cross Over Phase|Physician Decision|0|||
16417499|NCT00576472|40008547|FG013|MPH Cross Over Phase|Physician Decision|0|||
16417500|NCT00576472|40008548|FG014|MPH Cross Over Phase|Physician Decision|0|||
16417501|NCT00576472|40008534|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
16417502|NCT00576472|40008535|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
16417503|NCT00576472|40008536|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
16246568|NCT02965820|39385551|FG001|Period 2, Second 30 Days|Adverse Event|1|||
16246569|NCT03731182|39385552|FG000|Overall Study|Lost to Follow-up|2|||
16246570|NCT03731182|39385553|FG001|Overall Study|Lost to Follow-up|0|||
16246571|NCT03731182|39385552|FG000|Overall Study|Physician Decision|1|||
16246572|NCT03731182|39385553|FG001|Overall Study|Physician Decision|0|||
16246573|NCT03731182|39385552|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
16246574|NCT03731182|39385553|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
16246575|NCT00618774|39385560|FG000|Overall Study|Adverse Event|5|||
16246576|NCT00618774|39385561|FG001|Overall Study|Adverse Event|3|||
16417504|NCT00576472|40008537|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
16417505|NCT00576472|40008538|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
16417506|NCT00576472|40008539|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
16417507|NCT00576472|40008540|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
16560509|NCT02733042|40517657|FG001|Overall Study|Progressive Disease|1|||
16560510|NCT02733042|40517658|FG002|Overall Study|Progressive Disease|3|||
16560511|NCT02733042|40517659|FG003|Overall Study|Progressive Disease|1|||
16560512|NCT02733042|40517660|FG004|Overall Study|Progressive Disease|2|||
16246577|NCT00618774|39385560|FG000|Overall Study|Withdrawal by Subject|1|||
16560513|NCT02733042|40517661|FG005|Overall Study|Progressive Disease|3|||
16560514|NCT02733042|40517662|FG006|Overall Study|Progressive Disease|0|||
16560515|NCT02733042|40517663|FG007|Overall Study|Progressive Disease|3|||
16560516|NCT02733042|40517664|FG008|Overall Study|Progressive Disease|3|||
16560517|NCT02733042|40517665|FG009|Overall Study|Progressive Disease|2|||
16560518|NCT02733042|40517666|FG010|Overall Study|Progressive Disease|2|||
16560519|NCT02733042|40517667|FG011|Overall Study|Progressive Disease|2|||
16560520|NCT02733042|40517668|FG012|Overall Study|Progressive Disease|8|||
16560521|NCT02733042|40517669|FG013|Overall Study|Progressive Disease|1|||
16560522|NCT02733042|40517670|FG014|Overall Study|Progressive Disease|4|||
16560523|NCT02733042|40517671|FG015|Overall Study|Progressive Disease|7|||
16560524|NCT02733042|40517672|FG016|Overall Study|Progressive Disease|2|||
16560525|NCT02733042|40517673|FG017|Overall Study|Progressive Disease|3|||
16560526|NCT02733042|40517674|FG018|Overall Study|Progressive Disease|4|||
16560527|NCT02733042|40517656|FG000|Overall Study|Withdrawal by Subject|0|||
16560528|NCT02733042|40517657|FG001|Overall Study|Withdrawal by Subject|1|||
16560529|NCT02733042|40517658|FG002|Overall Study|Withdrawal by Subject|2|||
16560530|NCT02733042|40517659|FG003|Overall Study|Withdrawal by Subject|1|||
16560531|NCT02733042|40517660|FG004|Overall Study|Withdrawal by Subject|1|||
16246578|NCT00618774|39385561|FG001|Overall Study|Withdrawal by Subject|0|||
16246579|NCT01452529|39385562|FG000|Run-in Period|Adverse Event|96|||
16246580|NCT01452529|39385563|FG001|Run-in Period|Adverse Event|0|||
16246581|NCT01452529|39385564|FG002|Run-in Period|Adverse Event|0|||
16246582|NCT01452529|39385562|FG000|Run-in Period|Withdrawal by Subject|49|||
16246583|NCT01452529|39385563|FG001|Run-in Period|Withdrawal by Subject|0|||
16246584|NCT01452529|39385564|FG002|Run-in Period|Withdrawal by Subject|0|||
16246585|NCT01452529|39385562|FG000|Run-in Period|Lost to Follow-up|19|||
16560532|NCT02733042|40517661|FG005|Overall Study|Withdrawal by Subject|0|||
16560533|NCT02733042|40517662|FG006|Overall Study|Withdrawal by Subject|0|||
16560534|NCT02733042|40517663|FG007|Overall Study|Withdrawal by Subject|0|||
16560535|NCT02733042|40517664|FG008|Overall Study|Withdrawal by Subject|1|||
16246586|NCT01452529|39385563|FG001|Run-in Period|Lost to Follow-up|0|||
16246587|NCT01452529|39385564|FG002|Run-in Period|Lost to Follow-up|0|||
16560536|NCT02733042|40517665|FG009|Overall Study|Withdrawal by Subject|1|||
16560537|NCT02733042|40517666|FG010|Overall Study|Withdrawal by Subject|0|||
16560538|NCT02733042|40517667|FG011|Overall Study|Withdrawal by Subject|2|||
16246588|NCT01452529|39385562|FG000|Run-in Period|Lack of Efficacy|46|||
16246589|NCT01452529|39385563|FG001|Run-in Period|Lack of Efficacy|0|||
16417508|NCT00576472|40008541|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
16417509|NCT00576472|40008542|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
16417510|NCT00576472|40008543|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
16417511|NCT00576472|40008544|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
16417512|NCT00576472|40008545|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
16417513|NCT00576472|40008546|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
16417514|NCT00576472|40008547|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
16417515|NCT00576472|40008548|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
16417516|NCT00576472|40008534|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16130194|NCT01014533|38962360|FG001|Overall Study|unable to come to appointment|3|||
16130195|NCT03207009|38962361|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
16130196|NCT01535560|38962363|FG000|Overall Study|Adverse Event|12|||
16130197|NCT01535560|38962364|FG001|Overall Study|Adverse Event|7|||
16130198|NCT01535560|38962363|FG000|Overall Study|Lost to Follow-up|1|||
16130199|NCT01535560|38962364|FG001|Overall Study|Lost to Follow-up|3|||
16130200|NCT01535560|38962363|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
16130201|NCT01535560|38962364|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
16130202|NCT01535560|38962363|FG000|Overall Study|Treatment Failure|21|||
16130203|NCT01535560|38962364|FG001|Overall Study|Treatment Failure|83|||
16130204|NCT01535560|38962363|FG000|Overall Study|Other|0|||
16130205|NCT01535560|38962364|FG001|Overall Study|Other|1|||
16130206|NCT01535560|38962363|FG000|Overall Study|Randomized in Error|0|||
16130207|NCT01535560|38962364|FG001|Overall Study|Randomized in Error|1|||
16130208|NCT01427751|38962365|FG000|Overall Study|Adverse Event|18|||
16130209|NCT01427751|38962366|FG001|Overall Study|Adverse Event|2|||
16417517|NCT00576472|40008535|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16417518|NCT00576472|40008536|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16417519|NCT00576472|40008537|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16417520|NCT00576472|40008538|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16417521|NCT00576472|40008539|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16417522|NCT00576472|40008540|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16417523|NCT00576472|40008541|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16130210|NCT01427751|38962365|FG000|Overall Study|No further treatment benefit expected|5|||
16417524|NCT00576472|40008542|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16560539|NCT02733042|40517668|FG012|Overall Study|Withdrawal by Subject|1|||
16560540|NCT02733042|40517669|FG013|Overall Study|Withdrawal by Subject|1|||
16560541|NCT02733042|40517670|FG014|Overall Study|Withdrawal by Subject|0|||
16560542|NCT02733042|40517671|FG015|Overall Study|Withdrawal by Subject|0|||
16560543|NCT02733042|40517672|FG016|Overall Study|Withdrawal by Subject|0|||
16560544|NCT02733042|40517673|FG017|Overall Study|Withdrawal by Subject|0|||
16560545|NCT02733042|40517674|FG018|Overall Study|Withdrawal by Subject|0|||
16560546|NCT02733042|40517656|FG000|Overall Study|Other Reasons|0|||
16560547|NCT02733042|40517657|FG001|Overall Study|Other Reasons|0|||
16560548|NCT02733042|40517658|FG002|Overall Study|Other Reasons|1|||
16560549|NCT02733042|40517659|FG003|Overall Study|Other Reasons|0|||
16560550|NCT02733042|40517660|FG004|Overall Study|Other Reasons|0|||
16560551|NCT02733042|40517661|FG005|Overall Study|Other Reasons|0|||
16130211|NCT01427751|38962366|FG001|Overall Study|No further treatment benefit expected|1|||
16560552|NCT02733042|40517662|FG006|Overall Study|Other Reasons|0|||
16560553|NCT02733042|40517663|FG007|Overall Study|Other Reasons|0|||
16560554|NCT02733042|40517664|FG008|Overall Study|Other Reasons|0|||
16560555|NCT02733042|40517665|FG009|Overall Study|Other Reasons|1|||
16130212|NCT01427751|38962365|FG000|Overall Study|Lost to Follow-up|3|||
16130213|NCT01427751|38962366|FG001|Overall Study|Lost to Follow-up|1|||
16130214|NCT01427751|38962365|FG000|Overall Study|Withdrawal of consent|2|||
16130215|NCT01427751|38962366|FG001|Overall Study|Withdrawal of consent|2|||
16130216|NCT01427751|38962365|FG000|Overall Study|Protocol Violation|6|||
16130217|NCT01427751|38962366|FG001|Overall Study|Protocol Violation|4|||
16130218|NCT01427751|38962365|FG000|Overall Study|Death|2|||
16130219|NCT01427751|38962366|FG001|Overall Study|Death|0|||
16130220|NCT01427751|38962365|FG000|Overall Study|Other miscellaneous reasons|6|||
16130221|NCT01427751|38962366|FG001|Overall Study|Other miscellaneous reasons|4|||
16130222|NCT02988622|38962369|FG000|Overall Study|Lost to Follow-up|17|||
16130223|NCT00321373|38962370|FG000|Overall Study|Adverse Event|0|||
16130224|NCT00321373|38962371|FG001|Overall Study|Adverse Event|0|||
16130225|NCT00321373|38962372|FG002|Overall Study|Adverse Event|1|||
16246590|NCT01452529|39385564|FG002|Run-in Period|Lack of Efficacy|0|||
16560556|NCT02733042|40517666|FG010|Overall Study|Other Reasons|1|||
16130226|NCT00321373|38962370|FG000|Overall Study|Lost to Follow-up|1|||
16130227|NCT00321373|38962371|FG001|Overall Study|Lost to Follow-up|0|||
16130228|NCT00321373|38962372|FG002|Overall Study|Lost to Follow-up|1|||
16560557|NCT02733042|40517667|FG011|Overall Study|Other Reasons|0|||
16130229|NCT00321373|38962370|FG000|Overall Study|Withdrawal by Subject|1|||
16560558|NCT02733042|40517668|FG012|Overall Study|Other Reasons|0|||
16560559|NCT02733042|40517669|FG013|Overall Study|Other Reasons|0|||
16560560|NCT02733042|40517670|FG014|Overall Study|Other Reasons|0|||
16560561|NCT02733042|40517671|FG015|Overall Study|Other Reasons|1|||
16560562|NCT02733042|40517672|FG016|Overall Study|Other Reasons|0|||
16560563|NCT02733042|40517673|FG017|Overall Study|Other Reasons|1|||
16560564|NCT02733042|40517674|FG018|Overall Study|Other Reasons|0|||
16560565|NCT02733042|40517656|FG000|Overall Study|Death|0|||
16560566|NCT02733042|40517657|FG001|Overall Study|Death|0|||
16560567|NCT02733042|40517658|FG002|Overall Study|Death|0|||
16560568|NCT02733042|40517659|FG003|Overall Study|Death|0|||
16560569|NCT02733042|40517660|FG004|Overall Study|Death|0|||
16560570|NCT02733042|40517661|FG005|Overall Study|Death|0|||
16560571|NCT02733042|40517662|FG006|Overall Study|Death|1|||
16560572|NCT02733042|40517663|FG007|Overall Study|Death|0|||
16560573|NCT02733042|40517664|FG008|Overall Study|Death|1|||
16560574|NCT02733042|40517665|FG009|Overall Study|Death|0|||
16560575|NCT02733042|40517666|FG010|Overall Study|Death|1|||
16560576|NCT02733042|40517667|FG011|Overall Study|Death|0|||
16560577|NCT02733042|40517668|FG012|Overall Study|Death|0|||
16560578|NCT02733042|40517669|FG013|Overall Study|Death|0|||
16560579|NCT02733042|40517670|FG014|Overall Study|Death|1|||
16560580|NCT02733042|40517671|FG015|Overall Study|Death|2|||
16560581|NCT02733042|40517672|FG016|Overall Study|Death|0|||
16560582|NCT02733042|40517673|FG017|Overall Study|Death|0|||
16560583|NCT02733042|40517674|FG018|Overall Study|Death|0|||
16560584|NCT03726879|40517675|FG000|Overall Study|Death|6|||
16560585|NCT03726879|40517676|FG001|Overall Study|Death|4|||
16560586|NCT03726879|40517675|FG000|Overall Study|Physician Decision|0|||
16560587|NCT03726879|40517676|FG001|Overall Study|Physician Decision|2|||
16560588|NCT03726879|40517675|FG000|Overall Study|Protocol Violation|0|||
16130230|NCT00321373|38962371|FG001|Overall Study|Withdrawal by Subject|0|||
16130231|NCT00321373|38962372|FG002|Overall Study|Withdrawal by Subject|0|||
16352835|NCT02143414|39780273|FG001|Induction|Began alternative treatment|0|||
16352836|NCT02143414|39780272|FG000|Induction|Ineligible for postremission|5|||
16352837|NCT02143414|39780273|FG001|Induction|Ineligible for postremission|1|||
16352838|NCT02143414|39780272|FG000|Post-remission|Adverse Event|0|||
16352839|NCT02143414|39780273|FG001|Post-remission|Adverse Event|2|||
16352840|NCT02143414|39780272|FG000|Post-remission|Disease progression/relapse|5|||
16352841|NCT02143414|39780273|FG001|Post-remission|Disease progression/relapse|0|||
16352842|NCT02143414|39780272|FG000|Maintenance|Adverse Event|4|||
16352843|NCT02143414|39780273|FG001|Maintenance|Adverse Event|6|||
16352844|NCT02143414|39780272|FG000|Maintenance|Disease progression/relapse|3|||
16352845|NCT02143414|39780273|FG001|Maintenance|Disease progression/relapse|2|||
16352846|NCT02143414|39780272|FG000|Maintenance|Patient refusal|2|||
16352847|NCT02143414|39780273|FG001|Maintenance|Patient refusal|1|||
16352848|NCT02143414|39780272|FG000|Maintenance|Physician Decision|1|||
16352849|NCT02143414|39780273|FG001|Maintenance|Physician Decision|0|||
16352850|NCT02143414|39780272|FG000|Maintenance|Death|0|||
16352851|NCT02143414|39780273|FG001|Maintenance|Death|1|||
16352852|NCT02143414|39780272|FG000|Maintenance|On protocol treatment|0|||
16352853|NCT02143414|39780273|FG001|Maintenance|On protocol treatment|6|||
16352854|NCT01401322|39780274|FG000|Overall Study|Withdrawal by Subject|1|||
16352855|NCT01401322|39780274|FG000|Overall Study|Physician Decision|1|||
16352856|NCT01307787|39780275|FG000|Overall Study|Withdrawal by Subject|2|||
16352857|NCT01307787|39780276|FG001|Overall Study|Withdrawal by Subject|0|||
16352858|NCT04609514|39780279|FG000|Overall Study|Lost to Follow-up|5|||
16352859|NCT04609514|39780280|FG001|Overall Study|Lost to Follow-up|4|||
16352860|NCT04609514|39780279|FG000|Overall Study|Withdrawal by PI|0|||
16352861|NCT04609514|39780280|FG001|Overall Study|Withdrawal by PI|2|||
16352862|NCT03248037|39780281|FG000|Overall Study|Withdrawal by Subject|6|||
16352863|NCT03248037|39780282|FG001|Overall Study|Withdrawal by Subject|9|||
16352864|NCT03248037|39780281|FG000|Overall Study|Adverse Event|15|||
16352865|NCT03248037|39780282|FG001|Overall Study|Adverse Event|0|||
16352866|NCT00606307|39780283|FG000|Overall Study|Adverse Event|2|||
16352867|NCT00606307|39780283|FG000|Overall Study|Withdrawal by Subject|2|||
16352868|NCT00606307|39780283|FG000|Overall Study|Disease progression|6|||
16560589|NCT03726879|40517676|FG001|Overall Study|Protocol Violation|1|||
16560590|NCT03726879|40517675|FG000|Overall Study|Withdrawal by Subject|5|||
16130232|NCT00321373|38962370|FG000|Overall Study|Other|0|||
16246591|NCT01452529|39385562|FG000|Run-in Period|Confirmed or suspected diversion|23|||
16352869|NCT00606307|39780283|FG000|Overall Study|QTc prolongation|1|||
16352870|NCT03608826|39780286|FG000|Overall Study|Death|3|||
16352871|NCT03608826|39780286|FG000|Overall Study|Heart Transplant|3|||
16560591|NCT03726879|40517676|FG001|Overall Study|Withdrawal by Subject|5|||
16560592|NCT03726879|40517675|FG000|Overall Study|TSH result is unstable|0|||
16352872|NCT03608826|39780286|FG000|Overall Study|Physician Decision|4|||
16352873|NCT00577772|39780287|FG000|Overall Study|Lost to Follow-up|0|||
16352874|NCT00577772|39780288|FG001|Overall Study|Lost to Follow-up|1|||
16352875|NCT00676403|39780291|FG000|Overall Study|Adverse Event|1|||
16352876|NCT00676403|39780292|FG001|Overall Study|Adverse Event|2|||
16560593|NCT03726879|40517676|FG001|Overall Study|TSH result is unstable|1|||
16352877|NCT00676403|39780293|FG002|Overall Study|Adverse Event|0|||
16352878|NCT00676403|39780294|FG003|Overall Study|Adverse Event|5|||
16352879|NCT00676403|39780295|FG004|Overall Study|Adverse Event|1|||
16352880|NCT00676403|39780296|FG005|Overall Study|Adverse Event|2|||
16352881|NCT00676403|39780291|FG000|Overall Study|Lost to Follow-up|0|||
16352882|NCT00676403|39780292|FG001|Overall Study|Lost to Follow-up|0|||
16560594|NCT03726879|40517675|FG000|Overall Study|Continuing on Study|215|||
16560595|NCT03726879|40517676|FG001|Overall Study|Continuing on Study|215|||
16352883|NCT00676403|39780293|FG002|Overall Study|Lost to Follow-up|0|||
16352884|NCT00676403|39780294|FG003|Overall Study|Lost to Follow-up|0|||
16352885|NCT00676403|39780295|FG004|Overall Study|Lost to Follow-up|0|||
16352886|NCT00676403|39780296|FG005|Overall Study|Lost to Follow-up|1|||
16352887|NCT00676403|39780291|FG000|Overall Study|Reason Unspecified|1|||
16560596|NCT01871285|40517677|FG000|First Intervention (1 Day)|Adverse Event|1|||
16560597|NCT01871285|40517678|FG001|First Intervention (1 Day)|Adverse Event|0|||
16560598|NCT01871285|40517679|FG002|First Intervention (1 Day)|Adverse Event|0|||
16560599|NCT01871285|40517680|FG003|First Intervention (1 Day)|Adverse Event|0|||
16560600|NCT01871285|40517677|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
16560601|NCT01871285|40517678|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
16560602|NCT01871285|40517679|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
16560603|NCT01871285|40517680|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
16560604|NCT03785340|40517682|FG000|Overall Study|Lost to Follow-up|2|||
16560605|NCT03785340|40517683|FG001|Overall Study|Lost to Follow-up|0|||
16560606|NCT03785340|40517682|FG000|Overall Study|Adverse Event|1|||
16560607|NCT03785340|40517683|FG001|Overall Study|Adverse Event|0|||
16560608|NCT00848211|40517686|FG000|Overall Study|Protocol Violation|0|||
16560609|NCT00848211|40517687|FG001|Overall Study|Protocol Violation|1|||
16560610|NCT00848211|40517688|FG002|Overall Study|Protocol Violation|1|||
16560611|NCT00848211|40517689|FG003|Overall Study|Protocol Violation|0|||
16560612|NCT00848211|40517686|FG000|Overall Study|Adverse Event|0|||
16560613|NCT00848211|40517687|FG001|Overall Study|Adverse Event|0|||
16560614|NCT00848211|40517688|FG002|Overall Study|Adverse Event|0|||
16560615|NCT00848211|40517689|FG003|Overall Study|Adverse Event|0|||
16560616|NCT00810641|40517690|FG000|Overall Study|Withdrawal by Subject|0|||
16560617|NCT00810641|40517691|FG001|Overall Study|Withdrawal by Subject|1|||
16560618|NCT00810641|40517692|FG002|Overall Study|Withdrawal by Subject|2|||
16560619|NCT01036087|40517693|FG000|Overall Study|Adverse Event|2|||
16560620|NCT01036087|40517693|FG000|Overall Study|Lack of Efficacy|1|||
16560621|NCT00647348|40517694|FG000|Overall Study|Lost to Follow-up|3|||
16560622|NCT00647348|40517695|FG001|Overall Study|Lost to Follow-up|6|||
16560623|NCT00619151|40521609|FG000|Overall Study|Study terminated prior to followup|1|||
16560624|NCT00619151|40521610|FG001|Overall Study|Study terminated prior to followup|0|||
16560625|NCT02761629|40521611|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
16560626|NCT02761629|40521612|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
16560627|NCT02761629|40521611|FG000|Overall Study|Insufficient Therapeutic Response|2|||
16560628|NCT02761629|40521612|FG001|Overall Study|Insufficient Therapeutic Response|7|||
16560629|NCT02761629|40521611|FG000|Overall Study|Failure to Return|2|||
16560630|NCT02761629|40521612|FG001|Overall Study|Failure to Return|4|||
16560631|NCT02761629|40521611|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
16560632|NCT02761629|40521612|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
16560633|NCT02761629|40521611|FG000|Overall Study|Protocol Violation|2|||
16560634|NCT02761629|40521612|FG001|Overall Study|Protocol Violation|2|||
16560635|NCT02761629|40521611|FG000|Overall Study|Withdrawal by Subject|0|||
16560636|NCT02761629|40521612|FG001|Overall Study|Withdrawal by Subject|3|||
16560637|NCT02761629|40521611|FG000|Overall Study|Other|0|||
16560638|NCT02761629|40521612|FG001|Overall Study|Other|2|||
16560639|NCT02761629|40521611|FG000|Overall Study|Lost to Follow-up|4|||
16560640|NCT02761629|40521612|FG001|Overall Study|Lost to Follow-up|1|||
16560641|NCT02761629|40521611|FG000|Overall Study|Randomized But Not Treated|8|||
16560642|NCT02761629|40521612|FG001|Overall Study|Randomized But Not Treated|4|||
16560643|NCT01720797|40521613|FG000|Overall Study|Withdrawal by Subject|3|||
16560644|NCT01720797|40521614|FG001|Overall Study|Withdrawal by Subject|0|||
16560645|NCT01348854|40521617|FG000|Overall Study|Lost to Follow-up|2|||
16560646|NCT01348854|40521618|FG001|Overall Study|Lost to Follow-up|1|||
16560647|NCT01348854|40521617|FG000|Overall Study|Withdrawal by Subject|1|||
16560648|NCT01348854|40521618|FG001|Overall Study|Withdrawal by Subject|0|||
16560649|NCT01290094|40521619|FG000|Overall Study|Withdrawal by Subject|1|||
16560650|NCT01290094|40521619|FG000|Overall Study|Lost to Follow-up|5|||
16352888|NCT00676403|39780292|FG001|Overall Study|Reason Unspecified|0|||
16352889|NCT00676403|39780293|FG002|Overall Study|Reason Unspecified|1|||
16560651|NCT01543685|40521620|FG000|Overall Study|Lack of Efficacy|1|||
16560652|NCT01543685|40521621|FG001|Overall Study|Lack of Efficacy|2|||
16560653|NCT01543685|40521622|FG002|Overall Study|Lack of Efficacy|2|||
16560654|NCT01543685|40521623|FG003|Overall Study|Lack of Efficacy|0|||
16560655|NCT01543685|40521624|FG004|Overall Study|Lack of Efficacy|2|||
16560656|NCT01543685|40521620|FG000|Overall Study|Adverse Event|2|||
16352890|NCT00676403|39780294|FG003|Overall Study|Reason Unspecified|0|||
16352891|NCT00676403|39780295|FG004|Overall Study|Reason Unspecified|0|||
16560657|NCT01543685|40521621|FG001|Overall Study|Adverse Event|1|||
16560658|NCT01543685|40521622|FG002|Overall Study|Adverse Event|0|||
16560659|NCT01543685|40521623|FG003|Overall Study|Adverse Event|0|||
16560660|NCT01543685|40521624|FG004|Overall Study|Adverse Event|2|||
16560661|NCT03759366|40521625|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
16560662|NCT03759366|40521625|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
16246592|NCT01452529|39385563|FG001|Run-in Period|Confirmed or suspected diversion|0|||
16246593|NCT01452529|39385564|FG002|Run-in Period|Confirmed or suspected diversion|0|||
16246594|NCT01452529|39385562|FG000|Run-in Period|Administrative|21|||
16246595|NCT01452529|39385563|FG001|Run-in Period|Administrative|0|||
16560663|NCT02559817|40521626|FG000|Treatment Period|Adverse Event|1|||
16560664|NCT02559817|40521627|FG001|Treatment Period|Adverse Event|0|||
16560665|NCT02559817|40521628|FG002|Treatment Period|Adverse Event|1|||
16560666|NCT02559817|40521629|FG003|Treatment Period|Adverse Event|0|||
16246596|NCT01452529|39385564|FG002|Run-in Period|Administrative|0|||
16246597|NCT01452529|39385562|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
16246598|NCT01452529|39385563|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
16246599|NCT01452529|39385564|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
16246600|NCT01452529|39385562|FG000|Double-blind (DB) Period|Adverse Event|0|||
16246601|NCT01452529|39385563|FG001|Double-blind (DB) Period|Adverse Event|18|||
16246602|NCT01452529|39385564|FG002|Double-blind (DB) Period|Adverse Event|11|||
16246603|NCT01452529|39385562|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
16246604|NCT01452529|39385563|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
16246605|NCT01452529|39385564|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
16246606|NCT01452529|39385562|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
16246607|NCT01452529|39385563|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
16246608|NCT01452529|39385564|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
16246609|NCT01452529|39385562|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
16246610|NCT01452529|39385563|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
16246611|NCT01452529|39385564|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
16246612|NCT01452529|39385562|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
16352892|NCT00676403|39780296|FG005|Overall Study|Reason Unspecified|1|||
16352893|NCT00676403|39780291|FG000|Overall Study|Withdrawal by Subject|0|||
16352894|NCT00676403|39780292|FG001|Overall Study|Withdrawal by Subject|0|||
16352895|NCT00676403|39780293|FG002|Overall Study|Withdrawal by Subject|0|||
16352896|NCT00676403|39780294|FG003|Overall Study|Withdrawal by Subject|0|||
16352897|NCT00676403|39780295|FG004|Overall Study|Withdrawal by Subject|0|||
16352898|NCT00676403|39780296|FG005|Overall Study|Withdrawal by Subject|1|||
16560667|NCT02559817|40521630|FG004|Treatment Period|Adverse Event|0|||
16560668|NCT02559817|40521626|FG000|Treatment Period|Lack of Efficacy|0|||
16246613|NCT01452529|39385563|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
16246614|NCT01452529|39385564|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
16560669|NCT02559817|40521627|FG001|Treatment Period|Lack of Efficacy|1|||
16246615|NCT01452529|39385562|FG000|Double-blind (DB) Period|Administrative|0|||
16352899|NCT01396083|39780297|FG000|Overall Study|Adverse Event|2|||
16352900|NCT01396083|39780298|FG001|Overall Study|Adverse Event|28|||
16352901|NCT01396083|39780297|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16352902|NCT01396083|39780298|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
16352903|NCT01396083|39780297|FG000|Overall Study|Consent withdrawn|4|||
16352904|NCT01396083|39780298|FG001|Overall Study|Consent withdrawn|5|||
16352905|NCT01396083|39780297|FG000|Overall Study|Protocol deviation(s)|0|||
16352906|NCT01396083|39780298|FG001|Overall Study|Protocol deviation(s)|1|||
16352907|NCT01396083|39780297|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16352908|NCT01396083|39780298|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16352909|NCT01396083|39780297|FG000|Overall Study|Administrative problems|1|||
16352910|NCT01396083|39780298|FG001|Overall Study|Administrative problems|0|||
16352911|NCT01396083|39780297|FG000|Overall Study|Lost to Follow-up|1|||
16352912|NCT01396083|39780298|FG001|Overall Study|Lost to Follow-up|0|||
16352913|NCT02771275|39780300|FG000|Overall Study|Reoperation|3|||
16352914|NCT02771275|39780300|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
16352915|NCT00281697|39780306|FG000|Overall Study|> 60 days since last dose of study drug|4|||
16352916|NCT00281697|39780307|FG001|Overall Study|> 60 days since last dose of study drug|4|||
16352917|NCT00281697|39780306|FG000|Overall Study|Adverse Event|54|||
16352918|NCT00281697|39780307|FG001|Overall Study|Adverse Event|15|||
16352919|NCT00281697|39780306|FG000|Overall Study|Death|8|||
16352920|NCT00281697|39780307|FG001|Overall Study|Death|3|||
16352921|NCT00281697|39780306|FG000|Overall Study|Disease progression|279|||
16352922|NCT00281697|39780307|FG001|Overall Study|Disease progression|149|||
16352923|NCT00281697|39780306|FG000|Overall Study|Other|5|||
16352924|NCT00281697|39780307|FG001|Overall Study|Other|6|||
16352925|NCT00281697|39780306|FG000|Overall Study|Physician's decision to withdraw|15|||
16352926|NCT00281697|39780307|FG001|Overall Study|Physician's decision to withdraw|12|||
16352927|NCT00281697|39780306|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
16352928|NCT00281697|39780307|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
16352929|NCT00281697|39780306|FG000|Overall Study|Did not receive study drug|3|||
16352930|NCT00281697|39780307|FG001|Overall Study|Did not receive study drug|2|||
16352931|NCT00823264|39780310|FG000|Overall Study|Protocol Violation|2|||
16352932|NCT00823264|39780311|FG001|Overall Study|Protocol Violation|0|||
16352933|NCT00111761|39780312|FG000|Part 1|Physician Decision|0|||
16352934|NCT00111761|39780313|FG001|Part 1|Physician Decision|1|||
16352935|NCT00111761|39780312|FG000|Part 1|Death|0|||
16352936|NCT00111761|39780313|FG001|Part 1|Death|2|||
16352937|NCT00111761|39780312|FG000|Part 1|Other|0|||
16352938|NCT00111761|39780313|FG001|Part 1|Other|1|||
16352939|NCT00111761|39780312|FG000|Part 1|Withdrawal by Subject|0|||
16352940|NCT00111761|39780313|FG001|Part 1|Withdrawal by Subject|1|||
16352941|NCT00111761|39780312|FG000|Part 2|Adverse Event|1|||
16352942|NCT00111761|39780313|FG001|Part 2|Adverse Event|0|||
16352943|NCT00111761|39780312|FG000|Part 2|Physician Decision|1|||
16352944|NCT00111761|39780313|FG001|Part 2|Physician Decision|0|||
16352945|NCT00111761|39780312|FG000|Part 2|Death|1|||
16352946|NCT00111761|39780313|FG001|Part 2|Death|0|||
16352947|NCT00111761|39780312|FG000|Part 2|Disease progression|3|||
16352948|NCT00111761|39780313|FG001|Part 2|Disease progression|0|||
16352949|NCT00111761|39780312|FG000|Part 2|Protocol-specified criteria|1|||
16352950|NCT00111761|39780313|FG001|Part 2|Protocol-specified criteria|0|||
16352951|NCT00111761|39780312|FG000|Part 2|Other|1|||
16352952|NCT00111761|39780313|FG001|Part 2|Other|0|||
16352953|NCT01278342|39780316|FG000|Overall Study|Physician Decision|0|||
16352954|NCT01278342|39780317|FG001|Overall Study|Physician Decision|1|||
16560670|NCT02559817|40521628|FG002|Treatment Period|Lack of Efficacy|0|||
16560671|NCT02559817|40521629|FG003|Treatment Period|Lack of Efficacy|0|||
16352955|NCT01278342|39780318|FG002|Overall Study|Physician Decision|0|||
16352956|NCT01278342|39780316|FG000|Overall Study|Lost to Follow-up|1|||
16352957|NCT01278342|39780317|FG001|Overall Study|Lost to Follow-up|0|||
16352958|NCT01278342|39780318|FG002|Overall Study|Lost to Follow-up|0|||
16352959|NCT01278342|39780316|FG000|Overall Study|Administrative problems|2|||
16352960|NCT01278342|39780317|FG001|Overall Study|Administrative problems|0|||
16352961|NCT01278342|39780318|FG002|Overall Study|Administrative problems|0|||
16352962|NCT01278342|39780316|FG000|Overall Study|Other|1|||
16352963|NCT01278342|39780317|FG001|Overall Study|Other|0|||
16352964|NCT01278342|39780318|FG002|Overall Study|Other|0|||
16352965|NCT01462630|39780321|FG000|Overall Study|Did not initiate therapy|3|||
16352966|NCT01462630|39780321|FG000|Overall Study|Death|1|||
16352967|NCT01462630|39780321|FG000|Overall Study|Protocol Violation|2|||
16352968|NCT01462630|39780321|FG000|Overall Study|Adverse Event|1|||
16352969|NCT01232790|39780322|FG000|Randomization|Withdrawal by Subject|2|||
16352970|NCT01232790|39780323|FG001|Randomization|Withdrawal by Subject|0|||
16352971|NCT01232790|39780322|FG000|Randomization|Protocol Violation|0|||
16352972|NCT01232790|39780323|FG001|Randomization|Protocol Violation|1|||
16352973|NCT01232790|39780322|FG000|Randomization|Physician Decision|0|||
16352974|NCT01232790|39780323|FG001|Randomization|Physician Decision|1|||
16352975|NCT01232790|39780322|FG000|Initial Assessment|Withdrawal by Subject|0|||
16352976|NCT01232790|39780323|FG001|Initial Assessment|Withdrawal by Subject|1|||
16352977|NCT01232790|39780322|FG000|First Crossover|Withdrawal by Subject|1|||
16352978|NCT01232790|39780323|FG001|First Crossover|Withdrawal by Subject|0|||
16352979|NCT01232790|39780322|FG000|Second Crossover|Withdrawal by Subject|1|||
16352980|NCT01232790|39780323|FG001|Second Crossover|Withdrawal by Subject|2|||
16352981|NCT00735007|39780324|FG000|Overall Study|Adverse Event|4|||
16352982|NCT00735007|39780324|FG000|Overall Study|Protocol Violation|1|||
16352983|NCT03322293|39780325|FG000|Overall Study|Lost to Follow-up|0|||
16352984|NCT03322293|39780326|FG001|Overall Study|Lost to Follow-up|0|||
16352985|NCT03322293|39780327|FG002|Overall Study|Lost to Follow-up|1|||
16352986|NCT02849587|39780328|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
16352987|NCT02849587|39780329|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
16352988|NCT02849587|39780330|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
16352989|NCT02849587|39780328|FG000|Overall Study|Withdrawal by Subject|0|||
16352990|NCT02849587|39780329|FG001|Overall Study|Withdrawal by Subject|1|||
16352991|NCT02849587|39780330|FG002|Overall Study|Withdrawal by Subject|0|||
16352992|NCT03478371|39780331|FG000|Overall Study|non-compliance|1|||
16352993|NCT03478371|39780331|FG000|Overall Study|Lost to Follow-up|4|||
16352994|NCT04356937|39780332|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
16352995|NCT04356937|39780333|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
16352996|NCT00010257|39780334|FG000|Overall Study|Withdrawal by Subject|1|||
16352997|NCT00010257|39780335|FG001|Overall Study|Withdrawal by Subject|0|||
16352998|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
16352999|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
16353000|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
16353001|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
16353002|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
16353003|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
16353004|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
16353005|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
16353006|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
16353007|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
16353008|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
16353009|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
16353010|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
16353011|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
16353012|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
16353013|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
16353014|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
16353015|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
16353016|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
16353017|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
16353018|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
16353019|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
16353020|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
16353021|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
16353022|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
16353023|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
16353024|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
16353025|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
16353026|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
16353027|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
16353028|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
16353029|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
16353030|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
16353031|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
16353032|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
16353033|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
16353034|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
16353035|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
16353036|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
16353037|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
16353038|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
16417525|NCT00576472|40008543|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16353039|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
16353040|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
16353041|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
16353042|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
16353043|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
16353044|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
16353045|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
16353046|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
16353047|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
16353048|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
16353049|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
16353050|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
16353051|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
16353052|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
16353053|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
16353054|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
16353055|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
16353056|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
16353057|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
16353058|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
16353059|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
16353060|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
16353061|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
16353062|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
16353063|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
16353064|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
16353065|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
16353066|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
16353067|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
16353068|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
16353069|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
16353070|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
16353071|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
16560672|NCT02559817|40521630|FG004|Treatment Period|Lack of Efficacy|0|||
16560673|NCT02559817|40521626|FG000|Treatment Period|Lost to Follow-up|0|||
16130233|NCT00321373|38962371|FG001|Overall Study|Other|0|||
16130234|NCT00321373|38962372|FG002|Overall Study|Other|1|||
16130235|NCT03545503|38962373|FG000|Overall Study|Protocol Violation|14|||
16130236|NCT03545503|38962374|FG001|Overall Study|Protocol Violation|16|||
16130237|NCT02047903|38962375|FG000|Overall Study|Adverse Event|14|||
16130238|NCT02047903|38962375|FG000|Overall Study|Serious adverse event|10|||
16130239|NCT02047903|38962375|FG000|Overall Study|Withdrawal by Subject|16|||
16130240|NCT02047903|38962375|FG000|Overall Study|Lost to Follow-up|4|||
16130241|NCT02047903|38962375|FG000|Overall Study|Reason not listed|6|||
16130242|NCT02047903|38962375|FG000|Overall Study|Not Treated|9|||
16130243|NCT01097707|38962376|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16130244|NCT01097707|38962377|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
16130245|NCT01097707|38962378|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16130246|NCT01097707|38962379|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16130247|NCT01097707|38962380|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
16130248|NCT01097707|38962376|FG000|Overall Study|Adverse Event|4|||
16130249|NCT01097707|38962377|FG001|Overall Study|Adverse Event|2|||
16130250|NCT01097707|38962378|FG002|Overall Study|Adverse Event|3|||
16130251|NCT01097707|38962379|FG003|Overall Study|Adverse Event|1|||
16130252|NCT01097707|38962380|FG004|Overall Study|Adverse Event|3|||
16130253|NCT01097707|38962376|FG000|Overall Study|Entry Criteria Not Met|2|||
16130254|NCT01097707|38962377|FG001|Overall Study|Entry Criteria Not Met|1|||
16130255|NCT01097707|38962378|FG002|Overall Study|Entry Criteria Not Met|1|||
16130256|NCT01097707|38962379|FG003|Overall Study|Entry Criteria Not Met|0|||
16130257|NCT01097707|38962380|FG004|Overall Study|Entry Criteria Not Met|1|||
16130258|NCT01097707|38962376|FG000|Overall Study|Lack of Efficacy|1|||
16130259|NCT01097707|38962377|FG001|Overall Study|Lack of Efficacy|0|||
16130260|NCT01097707|38962378|FG002|Overall Study|Lack of Efficacy|0|||
16130261|NCT01097707|38962379|FG003|Overall Study|Lack of Efficacy|1|||
16130262|NCT01097707|38962380|FG004|Overall Study|Lack of Efficacy|0|||
16130263|NCT01097707|38962376|FG000|Overall Study|Lost to Follow-up|1|||
16130264|NCT01097707|38962377|FG001|Overall Study|Lost to Follow-up|1|||
16130265|NCT01097707|38962378|FG002|Overall Study|Lost to Follow-up|2|||
16130266|NCT01097707|38962379|FG003|Overall Study|Lost to Follow-up|0|||
16130267|NCT01097707|38962380|FG004|Overall Study|Lost to Follow-up|3|||
16130268|NCT01097707|38962376|FG000|Overall Study|Protocol Violation|2|||
16130269|NCT01097707|38962377|FG001|Overall Study|Protocol Violation|2|||
16130270|NCT01097707|38962378|FG002|Overall Study|Protocol Violation|3|||
16130271|NCT01097707|38962379|FG003|Overall Study|Protocol Violation|2|||
16130272|NCT01097707|38962380|FG004|Overall Study|Protocol Violation|2|||
16130273|NCT01097707|38962376|FG000|Overall Study|Sponsor Decision|31|||
16130274|NCT01097707|38962377|FG001|Overall Study|Sponsor Decision|31|||
16130275|NCT01097707|38962378|FG002|Overall Study|Sponsor Decision|34|||
16353072|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
16130276|NCT01097707|38962379|FG003|Overall Study|Sponsor Decision|35|||
16353073|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
16353074|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
16353075|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
16353076|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
16353077|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
16353078|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
16417526|NCT00576472|40008544|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16417527|NCT00576472|40008545|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16417528|NCT00576472|40008546|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16417529|NCT00576472|40008547|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
16417530|NCT00576472|40008548|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
16417531|NCT00576472|40008534|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
16417532|NCT00576472|40008535|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
16417533|NCT00576472|40008536|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
16417534|NCT00576472|40008537|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
16417535|NCT00576472|40008538|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
16417536|NCT00576472|40008539|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
16417537|NCT00576472|40008540|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
16417538|NCT00576472|40008541|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
16560674|NCT02559817|40521627|FG001|Treatment Period|Lost to Follow-up|1|||
16560675|NCT02559817|40521628|FG002|Treatment Period|Lost to Follow-up|0|||
16560676|NCT02559817|40521629|FG003|Treatment Period|Lost to Follow-up|1|||
16560677|NCT02559817|40521630|FG004|Treatment Period|Lost to Follow-up|0|||
16560678|NCT02559817|40521626|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
16560679|NCT02559817|40521627|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
16560680|NCT02559817|40521628|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
16560681|NCT02559817|40521629|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
16560682|NCT02559817|40521630|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
16560683|NCT02559817|40521626|FG000|Treatment Period|Protocol Violation|0|||
16560684|NCT02559817|40521627|FG001|Treatment Period|Protocol Violation|0|||
16560685|NCT02559817|40521628|FG002|Treatment Period|Protocol Violation|0|||
16560686|NCT02559817|40521629|FG003|Treatment Period|Protocol Violation|1|||
16560687|NCT02559817|40521630|FG004|Treatment Period|Protocol Violation|0|||
16560688|NCT00131911|40521631|FG000|Overall Study|Withdrawal by Subject|1|||
16560689|NCT00131911|40521632|FG001|Overall Study|Withdrawal by Subject|0|||
16560690|NCT02711995|40521633|FG000|Washout (90 Days)|Conflicting medication|1|||
16560691|NCT00318656|40521634|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
16560692|NCT00318656|40521635|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
16560693|NCT00318656|40521634|FG000|Overall Study|Did not receive any treatment|0|||
16560694|NCT00318656|40521635|FG001|Overall Study|Did not receive any treatment|1|||
16560695|NCT00764868|40521636|FG000|Overall Study|Adverse Event|18|||
16417539|NCT00576472|40008542|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
16417540|NCT00576472|40008543|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
16417541|NCT00576472|40008544|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
16417542|NCT00576472|40008545|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
16417543|NCT00576472|40008546|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
16417544|NCT00576472|40008547|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
16417545|NCT00576472|40008548|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
16417546|NCT00576472|40008534|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
16417547|NCT00576472|40008535|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
16417548|NCT00576472|40008536|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
16417549|NCT00576472|40008537|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
16417550|NCT00576472|40008538|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
16417551|NCT00576472|40008539|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
16417552|NCT00576472|40008540|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
16417553|NCT00576472|40008541|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
16417554|NCT00576472|40008542|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
16130277|NCT01097707|38962380|FG004|Overall Study|Sponsor Decision|36|||
16130278|NCT01097707|38962376|FG000|Overall Study|Withdrawal by Subject|3|||
16130279|NCT01097707|38962377|FG001|Overall Study|Withdrawal by Subject|6|||
16130280|NCT01097707|38962378|FG002|Overall Study|Withdrawal by Subject|1|||
16130281|NCT01097707|38962379|FG003|Overall Study|Withdrawal by Subject|4|||
16130282|NCT01097707|38962380|FG004|Overall Study|Withdrawal by Subject|3|||
16130283|NCT01097707|38962376|FG000|Overall Study|Reason unknown|0|||
16130284|NCT01097707|38962377|FG001|Overall Study|Reason unknown|0|||
16130285|NCT01097707|38962378|FG002|Overall Study|Reason unknown|0|||
16130286|NCT01097707|38962379|FG003|Overall Study|Reason unknown|0|||
16130287|NCT01097707|38962380|FG004|Overall Study|Reason unknown|1|||
16130288|NCT01853644|38962383|FG000|Registration and Treatment Start|Did not start treatment|1|||
16130289|NCT01853644|38962383|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
16130290|NCT01853644|38962383|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
16130291|NCT01853644|38962383|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
16130292|NCT01853644|38962383|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
16130293|NCT01853644|38962383|FG000|Continued Treatment After First Response|Adverse Event|2|||
16130294|NCT01853644|38962383|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
16130295|NCT01910181|38962384|FG000|Overall Study|Death|37|||
16417555|NCT00576472|40008543|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
16417556|NCT00576472|40008544|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
16130296|NCT01910181|38962384|FG000|Overall Study|Lost to Follow-up|3|||
16246616|NCT01452529|39385563|FG001|Double-blind (DB) Period|Administrative|11|||
16246617|NCT01452529|39385564|FG002|Double-blind (DB) Period|Administrative|7|||
16246618|NCT02257632|39385565|FG000|Overall Study|Withdrawal by Subject|0|||
16246619|NCT02257632|39385566|FG001|Overall Study|Withdrawal by Subject|1|||
16246620|NCT02257632|39385565|FG000|Overall Study|Adverse Event|1|||
16246621|NCT02257632|39385566|FG001|Overall Study|Adverse Event|2|||
16246622|NCT00910858|39385573|FG000|Pharmacokinetic Phase|Adverse Event|1|||
16246623|NCT00910858|39385574|FG001|Pharmacokinetic Phase|Adverse Event|0|||
16246624|NCT00910858|39385575|FG002|Pharmacokinetic Phase|Adverse Event|0|||
16246625|NCT00910858|39385573|FG000|Monotherapy Phase|Adverse Event|3|||
16246626|NCT00910858|39385574|FG001|Monotherapy Phase|Adverse Event|2|||
16246627|NCT00910858|39385575|FG002|Monotherapy Phase|Adverse Event|0|||
16246628|NCT00910858|39385573|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
16246629|NCT00910858|39385574|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
16246630|NCT00910858|39385575|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
16246631|NCT00910858|39385573|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
16246632|NCT00910858|39385574|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
16246633|NCT00910858|39385575|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
16246634|NCT00910858|39385573|FG000|Monotherapy Phase|Protocol Violation|1|||
16246635|NCT00910858|39385574|FG001|Monotherapy Phase|Protocol Violation|0|||
16246636|NCT00910858|39385575|FG002|Monotherapy Phase|Protocol Violation|0|||
16246637|NCT00910858|39385573|FG000|Monotherapy Phase|Other|3|||
16246638|NCT00910858|39385574|FG001|Monotherapy Phase|Other|4|||
16246639|NCT00910858|39385575|FG002|Monotherapy Phase|Other|2|||
16246640|NCT00910858|39385573|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
16246641|NCT00910858|39385574|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
16246642|NCT00910858|39385575|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
16560696|NCT00764868|40521636|FG000|Overall Study|Withdrawal by Subject|31|||
16560697|NCT00764868|40521636|FG000|Overall Study|Non-compliance|16|||
16560698|NCT00764868|40521636|FG000|Overall Study|Lost to Follow-up|25|||
16560699|NCT00764868|40521636|FG000|Overall Study|Lack of Efficacy|5|||
16560700|NCT00764868|40521636|FG000|Overall Study|Subject moved|7|||
16560701|NCT00764868|40521636|FG000|Overall Study|Pregnancy|3|||
16560702|NCT00764868|40521636|FG000|Overall Study|Prohibited medication|1|||
16560703|NCT00764868|40521636|FG000|Overall Study|Out of town|1|||
16560704|NCT00764868|40521636|FG000|Overall Study|Misuse and compliance of study drug|1|||
16560705|NCT00764868|40521636|FG000|Overall Study|Subject sent to boarding school|1|||
16560706|NCT00764868|40521636|FG000|Overall Study|Met an exclusion criteria|1|||
16560707|NCT00764868|40521636|FG000|Overall Study|Positive drug screen|2|||
16560708|NCT00764868|40521636|FG000|Overall Study|Sponsor requested withdrawal|1|||
16560709|NCT02449044|40521637|FG000|Overall Study|Lost to Follow-up|2|||
16560710|NCT02449044|40521637|FG000|Overall Study|Withdrawal by Subject|13|||
16560711|NCT02449044|40521637|FG000|Overall Study|Adverse Event|30|||
16560712|NCT02449044|40521637|FG000|Overall Study|Met Withdrawal Criteria|7|||
16560713|NCT02449044|40521637|FG000|Overall Study|Physician Decision|9|||
16560714|NCT02449044|40521637|FG000|Overall Study|Sponsor Discontinued Trial|3|||
16560715|NCT02264574|40521638|FG000|Overall Study|Death|21|||
16560716|NCT02264574|40521639|FG001|Overall Study|Death|21|||
16560717|NCT02264574|40521638|FG000|Overall Study|Withdrawal by Subject|8|||
16560718|NCT02264574|40521639|FG001|Overall Study|Withdrawal by Subject|6|||
16560719|NCT02264574|40521638|FG000|Overall Study|Other, Not Specified|0|||
16560720|NCT02264574|40521639|FG001|Overall Study|Other, Not Specified|3|||
16560721|NCT03670602|40521647|FG000|Overall Study|Lost to Follow-up|1|||
16560722|NCT03670602|40521648|FG001|Overall Study|Lost to Follow-up|0|||
16560723|NCT03670602|40521647|FG000|Overall Study|Withdrawal by Subject|0|||
16560724|NCT03670602|40521648|FG001|Overall Study|Withdrawal by Subject|3|||
16560725|NCT01417000|40521651|FG000|Overall Study|Death|59|||
16560726|NCT01417000|40521652|FG001|Overall Study|Death|28|||
16560727|NCT01417000|40521651|FG000|Overall Study|Lost to Follow-up|1|||
16560728|NCT01417000|40521652|FG001|Overall Study|Lost to Follow-up|0|||
16560729|NCT01417000|40521651|FG000|Overall Study|Study Terminated by Sponsor|1|||
16560730|NCT01417000|40521652|FG001|Overall Study|Study Terminated by Sponsor|1|||
16560731|NCT02886936|40521654|FG000|Overall Study|Lost to Follow-up|4|||
16560732|NCT02886936|40521655|FG001|Overall Study|Lost to Follow-up|3|||
16246643|NCT00910858|39385573|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
16246644|NCT00910858|39385574|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
16560733|NCT02886936|40521656|FG002|Overall Study|Lost to Follow-up|0|||
16560734|NCT01767129|40521659|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
16560735|NCT01767129|40521660|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
16560736|NCT00107380|40521661|FG000|Overall Study|Adverse Event|7|||
16560737|NCT00107380|40521661|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
16560738|NCT00107380|40521661|FG000|Overall Study|Progression/relapse|4|||
16560739|NCT00107380|40521661|FG000|Overall Study|Death|3|||
16560740|NCT00107380|40521661|FG000|Overall Study|Other - not protocol specified|7|||
16560741|NCT00107380|40521661|FG000|Overall Study|Ineligible|2|||
16560742|NCT01813422|40521662|FG000|Overall Study|Withdrawal by Subject|14|||
16560743|NCT01813422|40521663|FG001|Overall Study|Withdrawal by Subject|8|||
16560744|NCT01813422|40521662|FG000|Overall Study|Death|2|||
16560745|NCT01813422|40521663|FG001|Overall Study|Death|3|||
16246645|NCT00910858|39385575|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
16560746|NCT01813422|40521662|FG000|Overall Study|Sponsor Decision|2|||
16560747|NCT01813422|40521663|FG001|Overall Study|Sponsor Decision|1|||
16560748|NCT01813422|40521662|FG000|Overall Study|Lost to Follow-up|2|||
16560749|NCT01813422|40521663|FG001|Overall Study|Lost to Follow-up|4|||
16560750|NCT02068885|40521667|FG000|Overall Study|Withdrew|3|||
16560751|NCT02068885|40521668|FG001|Overall Study|Withdrew|5|||
16560752|NCT02068885|40521669|FG002|Overall Study|Withdrew|8|||
16560753|NCT02448719|40521670|FG000|Overall Study|Withdrawal by Subject|0|||
16560754|NCT02448719|40521671|FG001|Overall Study|Withdrawal by Subject|0|||
16560755|NCT02448719|40521672|FG002|Overall Study|Withdrawal by Subject|0|||
16560756|NCT02448719|40521673|FG003|Overall Study|Withdrawal by Subject|0|||
16560757|NCT02448719|40521674|FG004|Overall Study|Withdrawal by Subject|1|||
16560758|NCT02448719|40521675|FG005|Overall Study|Withdrawal by Subject|0|||
16560759|NCT02448719|40521676|FG006|Overall Study|Withdrawal by Subject|0|||
16560760|NCT02448719|40521677|FG007|Overall Study|Withdrawal by Subject|0|||
16560761|NCT02448719|40521678|FG008|Overall Study|Withdrawal by Subject|0|||
16560762|NCT02448719|40521679|FG009|Overall Study|Withdrawal by Subject|0|||
16560763|NCT02448719|40521680|FG010|Overall Study|Withdrawal by Subject|0|||
16560764|NCT01140347|40521687|FG000|Overall Study|Lost to Follow-up|5|||
16560765|NCT01140347|40521688|FG001|Overall Study|Lost to Follow-up|6|||
16560766|NCT01140347|40521687|FG000|Overall Study|Withdrawal by Subject|13|||
16560767|NCT01140347|40521688|FG001|Overall Study|Withdrawal by Subject|8|||
16560768|NCT01272011|40521689|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
16560769|NCT01272011|40521690|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
16560770|NCT01272011|40521691|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
16560771|NCT02491411|40521692|FG000|Overall Study|Physician Decision|4|||
16560772|NCT01318811|40521693|FG000|Overall Study|Physician Decision|1|||
16560773|NCT01318811|40521694|FG001|Overall Study|Physician Decision|1|||
16560774|NCT01318811|40521693|FG000|Overall Study|CRRT stopped for head CT|0|||
16560775|NCT01318811|40521694|FG001|Overall Study|CRRT stopped for head CT|1|||
16560776|NCT01318811|40521693|FG000|Overall Study|Death|0|||
16560777|NCT01318811|40521694|FG001|Overall Study|Death|1|||
16560778|NCT01318811|40521693|FG000|Overall Study|CRRT stopped for head MRI|0|||
16560779|NCT01318811|40521694|FG001|Overall Study|CRRT stopped for head MRI|1|||
16560780|NCT02162732|40521697|FG000|Overall Study|Biopsy not performed.|18|||
16560781|NCT02414828|40521698|FG000|Overall Study|Lost to Follow-up|0|||
16560782|NCT02414828|40521699|FG001|Overall Study|Lost to Follow-up|1|||
16560783|NCT02414828|40521700|FG002|Overall Study|Lost to Follow-up|1|||
16560784|NCT02414828|40521701|FG003|Overall Study|Lost to Follow-up|2|||
16560785|NCT00708097|40521702|FG000|Period 1|Protocol Violation|0|||
16560786|NCT00708097|40521703|FG001|Period 1|Protocol Violation|1|||
16560787|NCT00708097|40521704|FG002|Period 1|Protocol Violation|0|||
16560788|NCT00708097|40521705|FG003|Period 1|Protocol Violation|2|||
16560789|NCT00708097|40521706|FG004|Period 1|Protocol Violation|0|||
16560790|NCT00708097|40521702|FG000|Period 1|Other Reason|0|||
16560791|NCT00708097|40521703|FG001|Period 1|Other Reason|0|||
16560792|NCT00708097|40521704|FG002|Period 1|Other Reason|0|||
16560793|NCT00708097|40521705|FG003|Period 1|Other Reason|0|||
16560794|NCT00708097|40521706|FG004|Period 1|Other Reason|1|||
16560795|NCT00708097|40521702|FG000|Period 2|Protocol Violation|0|||
16560796|NCT00708097|40521703|FG001|Period 2|Protocol Violation|1|||
16560797|NCT00708097|40521704|FG002|Period 2|Protocol Violation|1|||
16560798|NCT00708097|40521705|FG003|Period 2|Protocol Violation|1|||
16560799|NCT00708097|40521706|FG004|Period 2|Protocol Violation|0|||
16560800|NCT00114959|40521707|FG000|Overall Study|Lack of Efficacy|6|||
16560801|NCT00114959|40521707|FG000|Overall Study|Physician Decision|1|||
16560802|NCT00114959|40521707|FG000|Overall Study|Death|1|||
16560803|NCT01375959|40521708|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
16560804|NCT01375959|40521709|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
16560805|NCT01375959|40521708|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
16130297|NCT01910181|38962384|FG000|Overall Study|Study Terminated by Sponsor|6|||
16130298|NCT01290029|38962390|FG000|Overall Study|Other|2|||
16130299|NCT00381615|38962393|FG000|Overall Study|Withdrawal by Subject|1|||
16130300|NCT00381615|38962394|FG001|Overall Study|Withdrawal by Subject|3|||
16130301|NCT00381615|38962395|FG002|Overall Study|Withdrawal by Subject|0|||
16130302|NCT00381615|38962396|FG003|Overall Study|Withdrawal by Subject|1|||
16130303|NCT00381615|38962393|FG000|Overall Study|Lost to Follow-up|3|||
16130304|NCT00381615|38962394|FG001|Overall Study|Lost to Follow-up|2|||
16130305|NCT00381615|38962395|FG002|Overall Study|Lost to Follow-up|0|||
16130306|NCT00381615|38962396|FG003|Overall Study|Lost to Follow-up|1|||
16130307|NCT00381615|38962393|FG000|Overall Study|Protocol Violation|0|||
16130308|NCT00381615|38962394|FG001|Overall Study|Protocol Violation|0|||
16130309|NCT00381615|38962395|FG002|Overall Study|Protocol Violation|1|||
16130310|NCT00381615|38962396|FG003|Overall Study|Protocol Violation|0|||
16130311|NCT04256629|38962401|FG000|Overall Study|Adverse Event|0|||
16417557|NCT00576472|40008545|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
16417558|NCT00576472|40008546|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
16417559|NCT00576472|40008547|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
16417560|NCT00576472|40008548|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
16417561|NCT00576472|40008534|FG000|MPH Home Maintenance Phase|Side effects|0|||
16417562|NCT00576472|40008535|FG001|MPH Home Maintenance Phase|Side effects|0|||
16417563|NCT00576472|40008536|FG002|MPH Home Maintenance Phase|Side effects|0|||
16417564|NCT00576472|40008537|FG003|MPH Home Maintenance Phase|Side effects|0|||
16417565|NCT00576472|40008538|FG004|MPH Home Maintenance Phase|Side effects|0|||
16417566|NCT00576472|40008539|FG005|MPH Home Maintenance Phase|Side effects|0|||
16417567|NCT00576472|40008540|FG006|MPH Home Maintenance Phase|Side effects|0|||
16417568|NCT00576472|40008541|FG007|MPH Home Maintenance Phase|Side effects|0|||
16417569|NCT00576472|40008542|FG008|MPH Home Maintenance Phase|Side effects|0|||
16417570|NCT00576472|40008543|FG009|MPH Home Maintenance Phase|Side effects|0|||
16417571|NCT00576472|40008544|FG010|MPH Home Maintenance Phase|Side effects|0|||
16417572|NCT00576472|40008545|FG011|MPH Home Maintenance Phase|Side effects|0|||
16130312|NCT04256629|38962402|FG001|Overall Study|Adverse Event|0|||
16130313|NCT04256629|38962403|FG002|Overall Study|Adverse Event|0|||
16130314|NCT04256629|38962404|FG003|Overall Study|Adverse Event|0|||
16130315|NCT04256629|38962405|FG004|Overall Study|Adverse Event|0|||
16130316|NCT04256629|38962406|FG005|Overall Study|Adverse Event|1|||
16130317|NCT04256629|38962401|FG000|Overall Study|Protocol Violation|0|||
16130318|NCT04256629|38962402|FG001|Overall Study|Protocol Violation|1|||
16130319|NCT04256629|38962403|FG002|Overall Study|Protocol Violation|0|||
16130320|NCT04256629|38962404|FG003|Overall Study|Protocol Violation|0|||
16246646|NCT00910858|39385573|FG000|Combined Treatment Phase|Protocol Violation|1|||
16246647|NCT00910858|39385574|FG001|Combined Treatment Phase|Protocol Violation|0|||
16417573|NCT00576472|40008546|FG012|MPH Home Maintenance Phase|Side effects|0|||
16417574|NCT00576472|40008547|FG013|MPH Home Maintenance Phase|Side effects|0|||
16560806|NCT01375959|40521709|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
16560807|NCT01375959|40521708|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
16560808|NCT01375959|40521709|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
16560809|NCT00681811|40521710|FG000|Overall Study|Adverse Event|1|||
16560810|NCT00681811|40521711|FG001|Overall Study|Adverse Event|1|||
16560811|NCT00681811|40521710|FG000|Overall Study|Withdrawal by Subject|2|||
16560812|NCT00681811|40521711|FG001|Overall Study|Withdrawal by Subject|2|||
16560813|NCT00681811|40521710|FG000|Overall Study|Non-compliance|0|||
16560814|NCT00681811|40521711|FG001|Overall Study|Non-compliance|1|||
16560815|NCT03929302|40521712|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
16560816|NCT03929302|40521713|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
16560817|NCT03929302|40521714|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
16417575|NCT00576472|40008548|FG014|MPH Home Maintenance Phase|Side effects|8|||
16130321|NCT04256629|38962405|FG004|Overall Study|Protocol Violation|0|||
16417576|NCT00576472|40008534|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16130322|NCT04256629|38962406|FG005|Overall Study|Protocol Violation|0|||
16130323|NCT00816400|38962407|FG000|Overall Study|Death|2|||
16560818|NCT03929302|40521712|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
16560819|NCT03929302|40521713|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
16560820|NCT03929302|40521714|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
16560821|NCT03929302|40521712|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
16560822|NCT03929302|40521713|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
16560823|NCT03929302|40521714|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
16560824|NCT00997243|40521718|FG000|Overall Study|Early termination of study by sponsor|7|||
16560825|NCT00761774|40521719|FG000|Overall Study|Adverse Event|17|||
16560826|NCT00761774|40521719|FG000|Overall Study|Lack of Efficacy|37|||
16560827|NCT00761774|40521719|FG000|Overall Study|Lost to Follow-up|2|||
16560828|NCT00761774|40521719|FG000|Overall Study|Withdrawal by Subject|9|||
16560829|NCT00761774|40521719|FG000|Overall Study|Non-compliance|4|||
16560830|NCT00761774|40521719|FG000|Overall Study|End of study|2|||
16560831|NCT00761774|40521719|FG000|Overall Study|Reclassification of seizures|1|||
16560832|NCT00761774|40521719|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
16560833|NCT00761774|40521719|FG000|Overall Study|Sponsor decision|1|||
16246648|NCT00910858|39385575|FG002|Combined Treatment Phase|Protocol Violation|0|||
16246649|NCT00910858|39385573|FG000|Combined Treatment Phase|Other|0|||
16246650|NCT00910858|39385574|FG001|Combined Treatment Phase|Other|2|||
16246651|NCT00910858|39385575|FG002|Combined Treatment Phase|Other|1|||
16246652|NCT00275028|39385576|FG000|Overall Study|Withdrew consent before treatment began|1|||
16246653|NCT00275028|39385576|FG000|Overall Study|Withdrawal by Subject|5|||
16246654|NCT00275028|39385576|FG000|Overall Study|Adverse Event|9|||
16246655|NCT00275028|39385576|FG000|Overall Study|Progressive Disease|30|||
16246656|NCT00275028|39385576|FG000|Overall Study|Physician Decision|2|||
16246657|NCT04317781|39385577|FG000|Overall Study|Adverse Event|1|||
16246658|NCT04317781|39385577|FG000|Overall Study|Disease relapse|1|||
16246659|NCT04317781|39385577|FG000|Overall Study|Withdrawal by Subject|1|||
16353079|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
16353080|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
16353081|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
16353082|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
16353083|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
16353084|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
16353085|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
16353086|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
16353087|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
16353088|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
16353089|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
16353090|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
16353091|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
16353092|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
16417577|NCT00576472|40008535|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417578|NCT00576472|40008536|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417579|NCT00576472|40008537|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417580|NCT00576472|40008538|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417581|NCT00576472|40008539|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417582|NCT00576472|40008540|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16246660|NCT00345683|39385578|FG000|Overall Study|Lost to Follow-up|19|||
16246661|NCT00345683|39385579|FG001|Overall Study|Lost to Follow-up|7|||
16246662|NCT00345683|39385578|FG000|Overall Study|Other|6|||
16246663|NCT00345683|39385579|FG001|Overall Study|Other|2|||
16246664|NCT02266706|39385580|FG000|Overall Study|Withdrawal by Subject|0|||
16246665|NCT02266706|39385581|FG001|Overall Study|Withdrawal by Subject|1|||
16246666|NCT02266706|39385582|FG002|Overall Study|Withdrawal by Subject|1|||
16130324|NCT00816400|38962408|FG001|Overall Study|Death|3|||
16130325|NCT00816400|38962409|FG002|Overall Study|Death|3|||
16130326|NCT00816400|38962410|FG003|Overall Study|Death|3|||
16130327|NCT00816400|38962411|FG004|Overall Study|Death|2|||
16130328|NCT00816400|38962412|FG005|Overall Study|Death|3|||
16130329|NCT00816400|38962413|FG006|Overall Study|Death|2|||
16130330|NCT00816400|38962414|FG007|Overall Study|Death|5|||
16130331|NCT00816400|38962415|FG008|Overall Study|Death|6|||
16130332|NCT00816400|38962407|FG000|Overall Study|In hospice care at the end of the study|0|||
16246667|NCT02266706|39385583|FG003|Overall Study|Withdrawal by Subject|0|||
16130333|NCT00816400|38962408|FG001|Overall Study|In hospice care at the end of the study|0|||
16353093|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
16353094|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
16353095|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
16353096|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
16353097|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
16353098|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
16353099|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
16353100|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
16353101|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
16353102|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
16353103|NCT02717195|39780336|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
16353104|NCT02717195|39780337|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
16353105|NCT02717195|39780338|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
16353106|NCT02717195|39780339|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
16353107|NCT02717195|39780340|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
16353108|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
16353109|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
16353110|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
16353111|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
16130334|NCT00816400|38962409|FG002|Overall Study|In hospice care at the end of the study|2|||
16130335|NCT00816400|38962410|FG003|Overall Study|In hospice care at the end of the study|0|||
16130336|NCT00816400|38962411|FG004|Overall Study|In hospice care at the end of the study|0|||
16130337|NCT00816400|38962412|FG005|Overall Study|In hospice care at the end of the study|0|||
16130338|NCT00816400|38962413|FG006|Overall Study|In hospice care at the end of the study|0|||
16130339|NCT00816400|38962414|FG007|Overall Study|In hospice care at the end of the study|0|||
16130340|NCT00816400|38962415|FG008|Overall Study|In hospice care at the end of the study|0|||
16246668|NCT02266706|39385584|FG004|Overall Study|Withdrawal by Subject|0|||
16353112|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
16353113|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
16353114|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
16353115|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
16353116|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
16353117|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
16353118|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
16353119|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
16353120|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
16353121|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
16353122|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
16353123|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
16353124|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
16353125|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
16353126|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
16353127|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
16353128|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
16353129|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
16353130|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
16417583|NCT00576472|40008541|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417584|NCT00576472|40008542|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417585|NCT00576472|40008543|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417586|NCT00576472|40008544|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417587|NCT00576472|40008545|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417588|NCT00576472|40008546|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417589|NCT00576472|40008547|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
16417590|NCT00576472|40008548|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
16417591|NCT00576472|40008534|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
16417592|NCT00576472|40008535|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
16417593|NCT00576472|40008536|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
16130341|NCT00434213|38966998|FG000|Overall Study|Adverse Event|12|||
16417594|NCT00576472|40008537|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
16353131|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
16353132|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
16353133|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
16353134|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
16353135|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
16353136|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
16353137|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
16353138|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
16130342|NCT00434213|38966998|FG000|Overall Study|Lack of Efficacy|9|||
16130343|NCT00434213|38966998|FG000|Overall Study|Lost to Follow-up|14|||
16130344|NCT00434213|38966998|FG000|Overall Study|Withdrawal by Subject|7|||
16130345|NCT00434213|38966998|FG000|Overall Study|Protocol Violation|3|||
16130346|NCT00434213|38966998|FG000|Overall Study|Unable to comply with study visit window|2|||
16130347|NCT00434213|38966998|FG000|Overall Study|Application site reaction|1|||
16130348|NCT00434213|38966998|FG000|Overall Study|Non-compliant to study schedule|1|||
16130349|NCT01415531|38966999|FG000|Overall Study|Adverse Event|7|||
16130350|NCT01415531|38967000|FG001|Overall Study|Adverse Event|10|||
16130351|NCT01415531|38966999|FG000|Overall Study|Lack of Efficacy|3|||
16130352|NCT01415531|38967000|FG001|Overall Study|Lack of Efficacy|2|||
16130353|NCT01415531|38966999|FG000|Overall Study|Protocol Violation|0|||
16130354|NCT01415531|38967000|FG001|Overall Study|Protocol Violation|1|||
16130355|NCT01415531|38966999|FG000|Overall Study|Withdrawal by Subject|5|||
16130356|NCT01415531|38967000|FG001|Overall Study|Withdrawal by Subject|4|||
16130357|NCT01415531|38966999|FG000|Overall Study|Lost to Follow-up|6|||
16130358|NCT01415531|38967000|FG001|Overall Study|Lost to Follow-up|14|||
16130359|NCT01415531|38966999|FG000|Overall Study|Lack of Compliance|1|||
16130360|NCT01415531|38967000|FG001|Overall Study|Lack of Compliance|4|||
16130361|NCT01415531|38966999|FG000|Overall Study|Other Reasons|3|||
16130362|NCT01415531|38967000|FG001|Overall Study|Other Reasons|2|||
16130363|NCT00324675|38967001|FG000|Overall Study|Adverse Event|1|||
16130364|NCT00324675|38967002|FG001|Overall Study|Adverse Event|0|||
16130365|NCT01263665|38967003|FG000|Overall Study|Withdrew Consent|1|||
16130366|NCT01263665|38967003|FG000|Overall Study|Lost to Follow-up|3|||
16130367|NCT01263665|38967003|FG000|Overall Study|Death|2|||
16130368|NCT01263665|38967003|FG000|Overall Study|Amputation above the ankle|1|||
16130369|NCT01263665|38967003|FG000|Overall Study|Surgical Bypass|2|||
16130370|NCT03814187|38967004|FG000|Overall Study|Sponsor's Administrative Decision|0|||
16130371|NCT03814187|38967005|FG001|Overall Study|Sponsor's Administrative Decision|0|||
16130372|NCT03814187|38967006|FG002|Overall Study|Sponsor's Administrative Decision|272|||
16130373|NCT03814187|38967004|FG000|Overall Study|Death|80|||
16130374|NCT03814187|38967005|FG001|Overall Study|Death|81|||
16130375|NCT03814187|38967006|FG002|Overall Study|Death|4|||
16130376|NCT03814187|38967004|FG000|Overall Study|Withdrew Consent|77|||
16130377|NCT03814187|38967005|FG001|Overall Study|Withdrew Consent|78|||
16130378|NCT03814187|38967006|FG002|Overall Study|Withdrew Consent|2|||
16130379|NCT03814187|38967004|FG000|Overall Study|Lost to Follow-up|47|||
16130380|NCT03814187|38967005|FG001|Overall Study|Lost to Follow-up|52|||
16130381|NCT03814187|38967006|FG002|Overall Study|Lost to Follow-up|1|||
16130382|NCT03814187|38967004|FG000|Overall Study|Adverse Event|22|||
16130383|NCT03814187|38967005|FG001|Overall Study|Adverse Event|23|||
16130384|NCT03814187|38967006|FG002|Overall Study|Adverse Event|0|||
16130385|NCT03814187|38967004|FG000|Overall Study|Physician Decision|7|||
16130386|NCT03814187|38967005|FG001|Overall Study|Physician Decision|4|||
16130387|NCT03814187|38967006|FG002|Overall Study|Physician Decision|2|||
16130388|NCT03814187|38967004|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
16130389|NCT03814187|38967005|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
16130390|NCT03814187|38967006|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
16130391|NCT03814187|38967004|FG000|Overall Study|Other reasons|34|||
16130392|NCT03814187|38967005|FG001|Overall Study|Other reasons|40|||
16130393|NCT03814187|38967006|FG002|Overall Study|Other reasons|2|||
16130394|NCT02673515|38967009|FG000|Overall Study|Lack of motivation|2|||
16130395|NCT02673515|38967010|FG001|Overall Study|Lack of motivation|1|||
16130396|NCT01054170|38967011|FG000|Overall Study|Protocol Violation|1|||
16130397|NCT01054170|38967012|FG001|Overall Study|Protocol Violation|0|||
16130398|NCT01054170|38967011|FG000|Overall Study|Withdrawal by Subject|3|||
16130399|NCT01054170|38967012|FG001|Overall Study|Withdrawal by Subject|2|||
16130400|NCT01054170|38967011|FG000|Overall Study|Adverse Event|0|||
16130401|NCT01054170|38967012|FG001|Overall Study|Adverse Event|4|||
16130402|NCT05056987|38967013|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
16130403|NCT05056987|38967014|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
16130404|NCT05056987|38967013|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
16130405|NCT05056987|38967014|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
16130406|NCT03110185|38967015|FG000|Overall Study|Death|0|||
16130407|NCT03110185|38967016|FG001|Overall Study|Death|1|||
16130408|NCT03110185|38967015|FG000|Overall Study|Withdrawal by Subject|2|||
16130409|NCT03110185|38967016|FG001|Overall Study|Withdrawal by Subject|7|||
16417595|NCT00576472|40008538|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
16417596|NCT00576472|40008539|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
16417597|NCT00576472|40008540|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
16417598|NCT00576472|40008541|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
16417599|NCT00576472|40008542|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
16417600|NCT00576472|40008543|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
16417601|NCT00576472|40008544|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
16417602|NCT00576472|40008545|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
16417603|NCT00576472|40008546|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
16417604|NCT00576472|40008547|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
16417605|NCT00576472|40008548|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
16417606|NCT00576472|40008534|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16417607|NCT00576472|40008535|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16417608|NCT00576472|40008536|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16417609|NCT00576472|40008537|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16417610|NCT00576472|40008538|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16417611|NCT00576472|40008539|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16417612|NCT00576472|40008540|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16417613|NCT00576472|40008541|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16417614|NCT00576472|40008542|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16417615|NCT00576472|40008543|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16417616|NCT00576472|40008544|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16130410|NCT03110185|38967015|FG000|Overall Study|Time Constraints|0|||
16130411|NCT03110185|38967016|FG001|Overall Study|Time Constraints|6|||
16130412|NCT03110185|38967015|FG000|Overall Study|Conflict with care|5|||
16130413|NCT03110185|38967016|FG001|Overall Study|Conflict with care|12|||
16130414|NCT03110185|38967015|FG000|Overall Study|Protocol Violation|1|||
16130415|NCT03110185|38967016|FG001|Overall Study|Protocol Violation|4|||
16130416|NCT03110185|38967015|FG000|Overall Study|MRI Incompatible|2|||
16130417|NCT03110185|38967016|FG001|Overall Study|MRI Incompatible|0|||
16130418|NCT03110185|38967015|FG000|Overall Study|Patient Refusal|0|||
16130419|NCT03110185|38967016|FG001|Overall Study|Patient Refusal|1|||
16130420|NCT02963610|38967017|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
16130421|NCT00812331|38967018|FG000|Overall Study|Adverse Event|1|||
16130422|NCT00812331|38967019|FG001|Overall Study|Adverse Event|0|||
16130423|NCT00812331|38967020|FG002|Overall Study|Adverse Event|0|||
16130424|NCT00812331|38967021|FG003|Overall Study|Adverse Event|0|||
16130425|NCT00812331|38967022|FG004|Overall Study|Adverse Event|0|||
16130426|NCT05020327|38967023|FG000|Overall Study|Physician Decision|3|||
16130427|NCT05020327|38967024|FG001|Overall Study|Physician Decision|0|||
16130428|NCT05020327|38967025|FG002|Overall Study|Physician Decision|0|||
16130429|NCT05020327|38967023|FG000|Overall Study|Withdrawal by Subject|1|||
16130430|NCT05020327|38967024|FG001|Overall Study|Withdrawal by Subject|1|||
16130431|NCT05020327|38967025|FG002|Overall Study|Withdrawal by Subject|0|||
16130432|NCT05020327|38967023|FG000|Overall Study|personal/cultural, ineligible|12|||
16130433|NCT05020327|38967024|FG001|Overall Study|personal/cultural, ineligible|0|||
16130434|NCT05020327|38967025|FG002|Overall Study|personal/cultural, ineligible|0|||
16130435|NCT01337115|38967026|FG000|Overall Study|Protocol Violation|2|||
16130436|NCT01337115|38967027|FG001|Overall Study|Protocol Violation|0|||
16130437|NCT03581825|38967030|FG000|Period 1|Lens Discomfort|1|||
16130438|NCT03581825|38967031|FG001|Period 1|Lens Discomfort|0|||
16130439|NCT03581825|38967030|FG000|Period 2|Unsatisfactory Vision to Test|0|||
16130440|NCT03581825|38967031|FG001|Period 2|Unsatisfactory Vision to Test|1|||
16130441|NCT00709852|38967032|FG000|Period 1|Adverse Event|2|||
16130442|NCT00709852|38967033|FG001|Period 1|Adverse Event|0|||
16130443|NCT00709852|38967032|FG000|Period 1|Withdrawal by Subject|4|||
16130444|NCT00709852|38967033|FG001|Period 1|Withdrawal by Subject|2|||
16130445|NCT00709852|38967032|FG000|Period 1|Protocol Violation|1|||
16130446|NCT00709852|38967033|FG001|Period 1|Protocol Violation|0|||
16130447|NCT00709852|38967032|FG000|Period 1|Defective scanner|0|||
16130448|NCT00709852|38967033|FG001|Period 1|Defective scanner|1|||
16130449|NCT00709852|38967032|FG000|Period 1|Lost to Follow-up|1|||
16130450|NCT00709852|38967033|FG001|Period 1|Lost to Follow-up|0|||
16130451|NCT00709852|38967032|FG000|Period 2|Protocol Violation|4|||
16130452|NCT00709852|38967033|FG001|Period 2|Protocol Violation|1|||
16130453|NCT00709852|38967032|FG000|Period 2|Adverse Event|1|||
16130454|NCT00709852|38967033|FG001|Period 2|Adverse Event|1|||
16130455|NCT00709852|38967032|FG000|Period 2|Lost to Follow-up|1|||
16130456|NCT00709852|38967033|FG001|Period 2|Lost to Follow-up|0|||
16130457|NCT00709852|38967032|FG000|Period 2|No 72-hour follow-up|3|||
16130458|NCT00709852|38967033|FG001|Period 2|No 72-hour follow-up|0|||
16130459|NCT00432666|38967034|FG000|Main Period|Adverse Event|1|||
16130460|NCT00432666|38967035|FG001|Main Period|Adverse Event|1|||
16130461|NCT00432666|38967034|FG000|Main Period|Consent Withdrawn|1|||
16130462|NCT00432666|38967035|FG001|Main Period|Consent Withdrawn|0|||
16130463|NCT00432666|38967034|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
16130464|NCT00432666|38967035|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
16130465|NCT00432666|38967034|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
16130466|NCT00432666|38967035|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
16130467|NCT00432666|38967034|FG000|Open-Label Extension Period|Adverse Event|5|||
16130468|NCT00432666|38967035|FG001|Open-Label Extension Period|Adverse Event|0|||
16130469|NCT00432666|38967034|FG000|Open-Label Extension Period|Consent withdrawn|10|||
16130470|NCT00432666|38967035|FG001|Open-Label Extension Period|Consent withdrawn|0|||
16130471|NCT00432666|38967034|FG000|Open-Label Extension Period|Physician Decision|3|||
16130472|NCT00432666|38967035|FG001|Open-Label Extension Period|Physician Decision|0|||
16130473|NCT02996474|38967036|FG000|Overall Study|Physician Decision|5|||
16130474|NCT01210664|38967041|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
16130475|NCT01210664|38967042|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
16130476|NCT01210664|38967043|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
16130477|NCT01210664|38967044|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
16130478|NCT01210664|38967041|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
16130479|NCT01210664|38967042|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
16130480|NCT01210664|38967043|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
16130481|NCT01210664|38967044|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
16130482|NCT01210664|38967041|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
16130483|NCT01210664|38967042|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
16246669|NCT02266706|39385585|FG005|Overall Study|Withdrawal by Subject|1|||
16353139|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
16353140|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
16353141|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
16353142|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
16353143|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
16353144|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
16353145|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
16353146|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
16353147|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
16353148|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
16353149|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
16353150|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
16353151|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
16353152|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
16353153|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
16353154|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
16353155|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
16353156|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
16353157|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
16353158|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
16353159|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
16353160|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
16353161|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
16353162|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
16353163|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
16353164|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
16353165|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
16353166|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
16353167|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
16353168|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
16353169|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
16353170|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
16353171|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
16353172|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
16353173|NCT02717195|39780336|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
16353174|NCT02717195|39780337|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
16353175|NCT02717195|39780338|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
16353176|NCT02717195|39780339|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
16353177|NCT02717195|39780340|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
16353178|NCT03234036|39780341|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
16353179|NCT03234036|39780342|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
16353180|NCT03234036|39780343|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
16353181|NCT03234036|39780344|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
16353182|NCT00808067|39780345|FG000|Overall Study|Major/minor bleed|30|||
16353183|NCT00808067|39780346|FG001|Overall Study|Major/minor bleed|44|||
16353184|NCT00808067|39780345|FG000|Overall Study|Outcome event - other|33|||
16353185|NCT00808067|39780346|FG001|Overall Study|Outcome event - other|25|||
16353186|NCT00808067|39780345|FG000|Overall Study|Adverse Event|111|||
16353187|NCT00808067|39780346|FG001|Overall Study|Adverse Event|121|||
16353188|NCT00808067|39780345|FG000|Overall Study|Hospitalization (not including surgery)|18|||
16246670|NCT02266706|39385586|FG006|Overall Study|Withdrawal by Subject|0|||
16246671|NCT02266706|39385587|FG007|Overall Study|Withdrawal by Subject|0|||
16353189|NCT00808067|39780346|FG001|Overall Study|Hospitalization (not including surgery)|17|||
16353190|NCT00808067|39780345|FG000|Overall Study|Hospitalization due to surgery|37|||
16353191|NCT00808067|39780346|FG001|Overall Study|Hospitalization due to surgery|40|||
16353192|NCT00808067|39780345|FG000|Overall Study|Reduced creatinine clearance|53|||
16353193|NCT00808067|39780346|FG001|Overall Study|Reduced creatinine clearance|55|||
16353194|NCT00808067|39780345|FG000|Overall Study|Elevated LFT results|7|||
16353195|NCT00808067|39780346|FG001|Overall Study|Elevated LFT results|3|||
16353196|NCT00808067|39780345|FG000|Overall Study|Patient refused to take study medication|65|||
16353197|NCT00808067|39780346|FG001|Overall Study|Patient refused to take study medication|76|||
16353198|NCT00808067|39780345|FG000|Overall Study|Missing|1|||
16353199|NCT00808067|39780346|FG001|Overall Study|Missing|0|||
16353200|NCT00808067|39780345|FG000|Overall Study|Death|1|||
16353201|NCT00808067|39780346|FG001|Overall Study|Death|1|||
16353202|NCT00808067|39780345|FG000|Overall Study|Procedure|6|||
16246672|NCT02266706|39385588|FG008|Overall Study|Withdrawal by Subject|0|||
16353203|NCT00808067|39780346|FG001|Overall Study|Procedure|7|||
16353204|NCT00808067|39780345|FG000|Overall Study|Withdrawal by Subject|21|||
16353205|NCT00808067|39780346|FG001|Overall Study|Withdrawal by Subject|25|||
16353206|NCT00808067|39780345|FG000|Overall Study|Site closed|4|||
16353207|NCT00808067|39780346|FG001|Overall Study|Site closed|3|||
16353208|NCT00808067|39780345|FG000|Overall Study|Physician Decision|47|||
16353209|NCT00808067|39780346|FG001|Overall Study|Physician Decision|38|||
16353210|NCT00808067|39780345|FG000|Overall Study|Protocol Violation|3|||
16353211|NCT00808067|39780346|FG001|Overall Study|Protocol Violation|11|||
16353212|NCT00808067|39780345|FG000|Overall Study|Patient elected|7|||
16353213|NCT00808067|39780346|FG001|Overall Study|Patient elected|9|||
16353214|NCT00808067|39780345|FG000|Overall Study|Site closed for cause|19|||
16353215|NCT00808067|39780346|FG001|Overall Study|Site closed for cause|19|||
16353216|NCT00808067|39780345|FG000|Overall Study|Other reason not defined above|5|||
16353217|NCT00808067|39780346|FG001|Overall Study|Other reason not defined above|5|||
16353218|NCT00808067|39780345|FG000|Overall Study|Excluded from analysis|13|||
16353219|NCT00808067|39780346|FG001|Overall Study|Excluded from analysis|19|||
16353220|NCT02260817|39780347|FG000|Overall Study|Lost to Follow-up|0|||
16353221|NCT02260817|39780348|FG001|Overall Study|Lost to Follow-up|14|||
16353222|NCT02260817|39780347|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
16353223|NCT02260817|39780348|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
16353224|NCT02260817|39780347|FG000|Overall Study|Observation, no biopsy|0|||
16353225|NCT02260817|39780348|FG001|Overall Study|Observation, no biopsy|1|||
16353226|NCT02260817|39780347|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
16353227|NCT02260817|39780348|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
16353228|NCT02260817|39780347|FG000|Overall Study|Protocol Violation|0|||
16353229|NCT02260817|39780348|FG001|Overall Study|Protocol Violation|14|||
16353230|NCT01001429|39780349|FG000|Overall Study|surgery cancelled|0|||
16353231|NCT01001429|39780350|FG001|Overall Study|surgery cancelled|1|||
16353232|NCT03016169|39780351|FG000|Overall Study|Lost to Follow-up|4|||
16353233|NCT03016169|39780351|FG000|Overall Study|Death|54|||
16353234|NCT03016169|39780351|FG000|Overall Study|Device Explant|11|||
16353235|NCT03016169|39780351|FG000|Overall Study|Withdrawal by Subject|19|||
16353236|NCT03016169|39780351|FG000|Overall Study|Other Reasons|1|||
16130484|NCT01210664|38967043|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
16130485|NCT01210664|38967044|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
16130486|NCT02545933|38967045|FG000|Overall Study|Adverse Event|3|||
16353237|NCT05002972|39780352|FG000|Overall Study|Withdrawal by Subject|2|||
16353238|NCT03087058|39780353|FG000|Overall Study|Withdrawal by Subject|2|||
16353239|NCT03087058|39780354|FG001|Overall Study|Withdrawal by Subject|0|||
16130487|NCT02545933|38967046|FG001|Overall Study|Adverse Event|0|||
16130488|NCT02545933|38967047|FG002|Overall Study|Adverse Event|0|||
16130489|NCT02545933|38967045|FG000|Overall Study|Withdrawal by Subject|2|||
16130490|NCT02545933|38967046|FG001|Overall Study|Withdrawal by Subject|3|||
16130491|NCT02545933|38967047|FG002|Overall Study|Withdrawal by Subject|3|||
16130492|NCT02545933|38967045|FG000|Overall Study|Protocol Violation|1|||
16130493|NCT02545933|38967046|FG001|Overall Study|Protocol Violation|0|||
16130494|NCT02545933|38967047|FG002|Overall Study|Protocol Violation|1|||
16130495|NCT00196976|38967049|FG000|Primary Study|Migrated from study area|0|||
16130496|NCT00196976|38967050|FG001|Primary Study|Migrated from study area|0|||
16246673|NCT02266706|39385580|FG000|Overall Study|Screen failure|0|||
16246674|NCT02266706|39385581|FG001|Overall Study|Screen failure|0|||
16130497|NCT00196976|38967051|FG002|Primary Study|Migrated from study area|0|||
16130498|NCT00196976|38967052|FG003|Primary Study|Migrated from study area|0|||
16246675|NCT02266706|39385582|FG002|Overall Study|Screen failure|0|||
16246676|NCT02266706|39385583|FG003|Overall Study|Screen failure|0|||
16130499|NCT00196976|38967053|FG004|Primary Study|Migrated from study area|0|||
16130500|NCT00196976|38967054|FG005|Primary Study|Migrated from study area|0|||
16130501|NCT00196976|38967055|FG006|Primary Study|Migrated from study area|0|||
16130502|NCT00196976|38967056|FG007|Primary Study|Migrated from study area|1|||
16130503|NCT00196976|38967057|FG008|Primary Study|Migrated from study area|0|||
16130504|NCT00196976|38967058|FG009|Primary Study|Migrated from study area|0|||
16353240|NCT03087058|39780355|FG002|Overall Study|Withdrawal by Subject|0|||
16353241|NCT01714544|39780358|FG000|Overall Study|Lost to Follow-up|1|||
16353242|NCT01714544|39780358|FG000|Overall Study|Physician Decision|1|||
16353243|NCT01714544|39780358|FG000|Overall Study|Withdrawal by Subject|1|||
16353244|NCT01075048|39780367|FG000|Overall Study|Death|4|||
16353245|NCT01075048|39780368|FG001|Overall Study|Death|17|||
16353246|NCT01075048|39780369|FG002|Overall Study|Death|12|||
16353247|NCT01075048|39780367|FG000|Overall Study|Start of other or new therapy|4|||
16353248|NCT01075048|39780368|FG001|Overall Study|Start of other or new therapy|36|||
16353249|NCT01075048|39780369|FG002|Overall Study|Start of other or new therapy|46|||
16246677|NCT02266706|39385584|FG004|Overall Study|Screen failure|0|||
16130505|NCT00196976|38967059|FG010|Primary Study|Migrated from study area|0|||
16130506|NCT00196976|38967060|FG011|Primary Study|Migrated from study area|0|||
16130507|NCT00196976|38967061|FG012|Primary Study|Migrated from study area|0|||
16130508|NCT00196976|38967062|FG013|Primary Study|Migrated from study area|0|||
16353250|NCT01075048|39780367|FG000|Overall Study|Withdrawal by Subject|1|||
16353251|NCT01075048|39780368|FG001|Overall Study|Withdrawal by Subject|6|||
16353252|NCT01075048|39780369|FG002|Overall Study|Withdrawal by Subject|3|||
16353253|NCT01075048|39780367|FG000|Overall Study|Lost to Follow-up|0|||
16353254|NCT01075048|39780368|FG001|Overall Study|Lost to Follow-up|1|||
16353255|NCT01075048|39780369|FG002|Overall Study|Lost to Follow-up|1|||
16353256|NCT00869960|39780378|FG000|Overall Study|Lost to Follow-up|2|||
16353257|NCT02089347|39780380|FG000|Overall Study|Protocol Violation|1|||
16353258|NCT02089347|39780381|FG001|Overall Study|Protocol Violation|0|||
16353259|NCT01789047|39780382|FG000|Overall Study|Adverse Event|3|||
16353260|NCT01789047|39780383|FG001|Overall Study|Adverse Event|2|||
16353261|NCT01789047|39780382|FG000|Overall Study|Withdrawal by Subject|1|||
16353262|NCT01789047|39780383|FG001|Overall Study|Withdrawal by Subject|2|||
16353263|NCT03316586|39780384|FG000|Overall Study|Adverse Event|2|||
16353264|NCT03316586|39780384|FG000|Overall Study|Physician Decision|3|||
16353265|NCT03316586|39780384|FG000|Overall Study|Lack of Efficacy|10|||
16353266|NCT03316586|39780384|FG000|Overall Study|still on treatment|1|||
16353267|NCT03316586|39780384|FG000|Overall Study|Patient needed radiation therapy|1|||
16353268|NCT03316586|39780384|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
16353269|NCT03091192|39780385|FG000|Overall Study|Study terminated by sponsor|21|||
16353270|NCT03091192|39780386|FG001|Overall Study|Study terminated by sponsor|14|||
16353271|NCT03091192|39780385|FG000|Overall Study|Death|9|||
16353272|NCT03091192|39780386|FG001|Overall Study|Death|13|||
16353273|NCT03091192|39780385|FG000|Overall Study|Withdrawal by Subject|2|||
16353274|NCT03091192|39780386|FG001|Overall Study|Withdrawal by Subject|0|||
16353275|NCT03091192|39780385|FG000|Overall Study|Lost to Follow-up|1|||
16353276|NCT03091192|39780386|FG001|Overall Study|Lost to Follow-up|0|||
16353277|NCT02515630|39780387|FG000|Overall Study|Withdrawal by Subject|5|||
16353278|NCT02515630|39780387|FG000|Overall Study|Adverse Event|4|||
16353279|NCT02515630|39780387|FG000|Overall Study|Physician Decision|4|||
16353280|NCT02515630|39780387|FG000|Overall Study|Death|2|||
16353281|NCT02515630|39780387|FG000|Overall Study|Disease Progression|1|||
16353282|NCT00643760|39780390|FG000|Overall Study|Adverse Event|11|||
16353283|NCT00643760|39780391|FG001|Overall Study|Adverse Event|5|||
16353284|NCT00643760|39780392|FG002|Overall Study|Adverse Event|12|||
16353285|NCT00643760|39780393|FG003|Overall Study|Adverse Event|21|||
16353286|NCT00643760|39780394|FG004|Overall Study|Adverse Event|6|||
16353287|NCT00643760|39780390|FG000|Overall Study|Lack of Efficacy|3|||
16353288|NCT00643760|39780391|FG001|Overall Study|Lack of Efficacy|1|||
16353289|NCT00643760|39780392|FG002|Overall Study|Lack of Efficacy|0|||
16353290|NCT00643760|39780393|FG003|Overall Study|Lack of Efficacy|4|||
16353291|NCT00643760|39780394|FG004|Overall Study|Lack of Efficacy|3|||
16353292|NCT00643760|39780390|FG000|Overall Study|Protocol Violation|7|||
16353293|NCT00643760|39780391|FG001|Overall Study|Protocol Violation|6|||
16353294|NCT00643760|39780392|FG002|Overall Study|Protocol Violation|4|||
16353295|NCT00643760|39780393|FG003|Overall Study|Protocol Violation|4|||
16353296|NCT00643760|39780394|FG004|Overall Study|Protocol Violation|6|||
16353297|NCT00643760|39780390|FG000|Overall Study|Lost to Follow-up|6|||
16353298|NCT00643760|39780391|FG001|Overall Study|Lost to Follow-up|2|||
16353299|NCT00643760|39780392|FG002|Overall Study|Lost to Follow-up|1|||
16353300|NCT00643760|39780393|FG003|Overall Study|Lost to Follow-up|3|||
16353301|NCT00643760|39780394|FG004|Overall Study|Lost to Follow-up|3|||
16353302|NCT00643760|39780390|FG000|Overall Study|Investigator Discretion|0|||
16353303|NCT00643760|39780391|FG001|Overall Study|Investigator Discretion|0|||
16353304|NCT00643760|39780392|FG002|Overall Study|Investigator Discretion|0|||
16353305|NCT00643760|39780393|FG003|Overall Study|Investigator Discretion|2|||
16353306|NCT00643760|39780394|FG004|Overall Study|Investigator Discretion|0|||
16353307|NCT00643760|39780390|FG000|Overall Study|Withdrawal by Subject|3|||
16353308|NCT00643760|39780391|FG001|Overall Study|Withdrawal by Subject|1|||
16353309|NCT00643760|39780392|FG002|Overall Study|Withdrawal by Subject|2|||
16353310|NCT00643760|39780393|FG003|Overall Study|Withdrawal by Subject|4|||
16353311|NCT00643760|39780394|FG004|Overall Study|Withdrawal by Subject|1|||
16353312|NCT00570401|39780395|FG000|Overall Study|Adverse Event|2|||
16353313|NCT00617279|39780396|FG000|Overall Study|Study terminated by Sponsor|10|||
16353314|NCT00617279|39780397|FG001|Overall Study|Study terminated by Sponsor|15|||
16353315|NCT00617279|39780396|FG000|Overall Study|Graft abandonment|2|||
16353316|NCT00617279|39780397|FG001|Overall Study|Graft abandonment|0|||
16353317|NCT00617279|39780396|FG000|Overall Study|Lost to Follow-up|1|||
16353318|NCT00617279|39780397|FG001|Overall Study|Lost to Follow-up|0|||
16353319|NCT00617279|39780396|FG000|Overall Study|Death|1|||
16353320|NCT00617279|39780397|FG001|Overall Study|Death|2|||
16353321|NCT00735709|39780400|FG000|Overall Study|Adverse Event|2|||
16353322|NCT00735709|39780401|FG001|Overall Study|Adverse Event|3|||
16353323|NCT00735709|39780402|FG002|Overall Study|Adverse Event|1|||
16353324|NCT00735709|39780403|FG003|Overall Study|Adverse Event|5|||
16353325|NCT00735709|39780400|FG000|Overall Study|Lack of Efficacy|8|||
16353326|NCT00735709|39780401|FG001|Overall Study|Lack of Efficacy|4|||
16353327|NCT00735709|39780402|FG002|Overall Study|Lack of Efficacy|2|||
16353328|NCT00735709|39780403|FG003|Overall Study|Lack of Efficacy|3|||
16353329|NCT00735709|39780400|FG000|Overall Study|Noncompliance|0|||
16353330|NCT00735709|39780401|FG001|Overall Study|Noncompliance|0|||
16353331|NCT00735709|39780402|FG002|Overall Study|Noncompliance|1|||
16353332|NCT00735709|39780403|FG003|Overall Study|Noncompliance|0|||
16353333|NCT00735709|39780400|FG000|Overall Study|Protocol deviations|1|||
16353334|NCT00735709|39780401|FG001|Overall Study|Protocol deviations|2|||
16353335|NCT00735709|39780402|FG002|Overall Study|Protocol deviations|1|||
16353336|NCT00735709|39780403|FG003|Overall Study|Protocol deviations|1|||
16353337|NCT00735709|39780400|FG000|Overall Study|Voluntary Withdrawal|1|||
16353338|NCT00735709|39780401|FG001|Overall Study|Voluntary Withdrawal|3|||
16353339|NCT00735709|39780402|FG002|Overall Study|Voluntary Withdrawal|5|||
16353340|NCT00735709|39780403|FG003|Overall Study|Voluntary Withdrawal|7|||
16353341|NCT00735709|39780400|FG000|Overall Study|Lost to Follow-up|0|||
16353342|NCT00735709|39780401|FG001|Overall Study|Lost to Follow-up|1|||
16353343|NCT00735709|39780402|FG002|Overall Study|Lost to Follow-up|1|||
16353344|NCT00735709|39780403|FG003|Overall Study|Lost to Follow-up|1|||
16353345|NCT00735709|39780400|FG000|Overall Study|Excluded medication|1|||
16353346|NCT00735709|39780401|FG001|Overall Study|Excluded medication|0|||
16353347|NCT00735709|39780402|FG002|Overall Study|Excluded medication|0|||
16353348|NCT00735709|39780403|FG003|Overall Study|Excluded medication|1|||
16353349|NCT02403674|39780414|FG000|Overall Study|Adverse Event|10|||
16353350|NCT02403674|39780415|FG001|Overall Study|Adverse Event|23|||
16353351|NCT02403674|39780414|FG000|Overall Study|Death|1|||
16353352|NCT02403674|39780415|FG001|Overall Study|Death|3|||
16353353|NCT02403674|39780414|FG000|Overall Study|Lack of Efficacy|18|||
16353354|NCT02403674|39780415|FG001|Overall Study|Lack of Efficacy|10|||
16353355|NCT02403674|39780414|FG000|Overall Study|Lost to Follow-up|6|||
16353356|NCT02403674|39780415|FG001|Overall Study|Lost to Follow-up|7|||
16353357|NCT02403674|39780414|FG000|Overall Study|Noncompliance with study drug|1|||
16353358|NCT02403674|39780415|FG001|Overall Study|Noncompliance with study drug|2|||
16353359|NCT02403674|39780414|FG000|Overall Study|Withdrawal by Subject|8|||
16353360|NCT02403674|39780415|FG001|Overall Study|Withdrawal by Subject|11|||
16353361|NCT02403674|39780414|FG000|Overall Study|Physician Decision|2|||
16353362|NCT02403674|39780415|FG001|Overall Study|Physician Decision|2|||
16353363|NCT02403674|39780414|FG000|Overall Study|Not treated with study drug|4|||
16246678|NCT02266706|39385585|FG005|Overall Study|Screen failure|1|||
16246679|NCT02266706|39385586|FG006|Overall Study|Screen failure|1|||
16246680|NCT02266706|39385587|FG007|Overall Study|Screen failure|0|||
16246681|NCT02266706|39385588|FG008|Overall Study|Screen failure|0|||
16246682|NCT02266706|39385580|FG000|Overall Study|Enrollment in another study|0|||
16246683|NCT02266706|39385581|FG001|Overall Study|Enrollment in another study|0|||
16246684|NCT02266706|39385582|FG002|Overall Study|Enrollment in another study|0|||
16560834|NCT00761774|40521719|FG000|Overall Study|Investigator clinical judgement|1|||
16560835|NCT00761774|40521719|FG000|Overall Study|Patient moved out of study area|1|||
16560836|NCT00761774|40521719|FG000|Overall Study|Coordinator leaving site|1|||
16560837|NCT00761774|40521719|FG000|Overall Study|Subject IP non-compliance|1|||
16560838|NCT00761774|40521719|FG000|Overall Study|IP stopped by hospital physician|1|||
16560839|NCT00087490|40521727|FG000|Overall Study|Death|6|||
16560840|NCT00087490|40521728|FG001|Overall Study|Death|4|||
16560841|NCT00087490|40521727|FG000|Overall Study|Adverse Event|3|||
16560842|NCT00087490|40521728|FG001|Overall Study|Adverse Event|8|||
16560843|NCT00087490|40521727|FG000|Overall Study|Lack of Efficacy|0|||
16560844|NCT00087490|40521728|FG001|Overall Study|Lack of Efficacy|2|||
16560845|NCT00087490|40521727|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
16560846|NCT00087490|40521728|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
16560847|NCT00087490|40521727|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
16560848|NCT00087490|40521728|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
16560849|NCT00087490|40521727|FG000|Overall Study|Randomized but not treated|7|||
16560850|NCT00087490|40521728|FG001|Overall Study|Randomized but not treated|18|||
16560851|NCT01653847|40521729|FG000|Overall Study|Withdrawal by Subject|1|||
16560852|NCT01653847|40521730|FG001|Overall Study|Withdrawal by Subject|0|||
16560853|NCT01642186|40521731|FG000|Overall Study|Death|0|||
16560854|NCT01642186|40521732|FG001|Overall Study|Death|2|||
16353364|NCT02403674|39780415|FG001|Overall Study|Not treated with study drug|2|||
16353365|NCT02403674|39780414|FG000|Overall Study|Pregnancy|1|||
16353366|NCT02403674|39780415|FG001|Overall Study|Pregnancy|1|||
16353367|NCT02403674|39780414|FG000|Overall Study|Protocol Violation|4|||
16353368|NCT02403674|39780415|FG001|Overall Study|Protocol Violation|2|||
16353369|NCT00274742|39780416|FG000|Overall Study|Adverse Event|0|||
16353370|NCT00274742|39780417|FG001|Overall Study|Adverse Event|4|||
16353371|NCT00274742|39780418|FG002|Overall Study|Adverse Event|1|||
16353372|NCT00274742|39780419|FG003|Overall Study|Adverse Event|4|||
16353373|NCT00274742|39780420|FG004|Overall Study|Adverse Event|12|||
16353374|NCT00274742|39780421|FG005|Overall Study|Adverse Event|3|||
16353375|NCT00274742|39780416|FG000|Overall Study|Lost to Follow-up|0|||
16560855|NCT01642186|40521733|FG002|Overall Study|Death|2|||
16560856|NCT01642186|40521731|FG000|Overall Study|Lost to Follow-up|0|||
16560857|NCT01642186|40521732|FG001|Overall Study|Lost to Follow-up|0|||
16560858|NCT01642186|40521733|FG002|Overall Study|Lost to Follow-up|1|||
16560859|NCT02485353|40521740|FG000|Overall Study|Death|1|||
16560860|NCT02485353|40521740|FG000|Overall Study|Disease Progression|1|||
16560861|NCT03029780|40521741|FG000|Overall Study|Disease Progression|20|||
16560862|NCT03029780|40521742|FG001|Overall Study|Disease Progression|22|||
16560863|NCT03029780|40521741|FG000|Overall Study|Study Drug Toxicity|15|||
16560864|NCT03029780|40521742|FG001|Overall Study|Study Drug Toxicity|11|||
16560865|NCT03029780|40521741|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
16560866|NCT03029780|40521742|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
16560867|NCT03029780|40521741|FG000|Overall Study|Participant request to discontinue study treatment|4|||
16560868|NCT03029780|40521742|FG001|Overall Study|Participant request to discontinue study treatment|1|||
16560869|NCT03029780|40521741|FG000|Overall Study|Maximum clinical benefit|1|||
16560870|NCT03029780|40521742|FG001|Overall Study|Maximum clinical benefit|0|||
16560871|NCT03029780|40521741|FG000|Overall Study|Participant no longer meets study criteria|0|||
16560872|NCT03029780|40521742|FG001|Overall Study|Participant no longer meets study criteria|1|||
16560873|NCT03029780|40521741|FG000|Overall Study|Other reasons|6|||
16560874|NCT03029780|40521742|FG001|Overall Study|Other reasons|6|||
16560875|NCT03029780|40521741|FG000|Overall Study|Not reported|1|||
16560876|NCT03029780|40521742|FG001|Overall Study|Not reported|1|||
16560877|NCT03029780|40521741|FG000|Overall Study|Death|2|||
16560878|NCT03029780|40521742|FG001|Overall Study|Death|6|||
16560879|NCT00062868|40521753|FG000|Dose Level 1|Death|2|||
16560880|NCT00062868|40521754|FG001|Dose Level 1|Death|0|||
16560881|NCT00062868|40521755|FG002|Dose Level 1|Death|0|||
16560882|NCT00062868|40521756|FG003|Dose Level 1|Death|2|||
16560883|NCT00062868|40521757|FG004|Dose Level 1|Death|0|||
16560884|NCT00062868|40521758|FG005|Dose Level 1|Death|0|||
16560885|NCT00062868|40521759|FG006|Dose Level 1|Death|3|||
16560886|NCT00062868|40521760|FG007|Dose Level 1|Death|0|||
16560887|NCT00062868|40521761|FG008|Dose Level 1|Death|0|||
16560888|NCT00062868|40521762|FG009|Dose Level 1|Death|0|||
16560889|NCT00062868|40521763|FG010|Dose Level 1|Death|0|||
16560890|NCT00062868|40521764|FG011|Dose Level 1|Death|0|||
16560891|NCT00062868|40521765|FG012|Dose Level 1|Death|0|||
16560892|NCT00062868|40521766|FG013|Dose Level 1|Death|0|||
16560893|NCT00062868|40521767|FG014|Dose Level 1|Death|0|||
16560894|NCT00062868|40521768|FG015|Dose Level 1|Death|0|||
16560895|NCT00062868|40521769|FG016|Dose Level 1|Death|0|||
16560896|NCT00062868|40521770|FG017|Dose Level 1|Death|0|||
16560897|NCT00062868|40521771|FG018|Dose Level 1|Death|7|||
16560898|NCT00062868|40521772|FG019|Dose Level 1|Death|0|||
16560899|NCT00062868|40521773|FG020|Dose Level 1|Death|1|||
16560900|NCT00062868|40521753|FG000|Dose Level 1|Lost to Follow-up|0|||
16560901|NCT00062868|40521754|FG001|Dose Level 1|Lost to Follow-up|0|||
16560902|NCT00062868|40521755|FG002|Dose Level 1|Lost to Follow-up|0|||
16560903|NCT00062868|40521756|FG003|Dose Level 1|Lost to Follow-up|0|||
16560904|NCT00062868|40521757|FG004|Dose Level 1|Lost to Follow-up|0|||
16560905|NCT00062868|40521758|FG005|Dose Level 1|Lost to Follow-up|0|||
16560906|NCT00062868|40521759|FG006|Dose Level 1|Lost to Follow-up|0|||
16560907|NCT00062868|40521760|FG007|Dose Level 1|Lost to Follow-up|0|||
16560908|NCT00062868|40521761|FG008|Dose Level 1|Lost to Follow-up|0|||
16560909|NCT00062868|40521762|FG009|Dose Level 1|Lost to Follow-up|0|||
16560910|NCT00062868|40521763|FG010|Dose Level 1|Lost to Follow-up|0|||
16560911|NCT00062868|40521764|FG011|Dose Level 1|Lost to Follow-up|0|||
16560912|NCT00062868|40521765|FG012|Dose Level 1|Lost to Follow-up|1|||
16560913|NCT00062868|40521766|FG013|Dose Level 1|Lost to Follow-up|0|||
16560914|NCT00062868|40521767|FG014|Dose Level 1|Lost to Follow-up|0|||
16560915|NCT00062868|40521768|FG015|Dose Level 1|Lost to Follow-up|0|||
16560916|NCT00062868|40521769|FG016|Dose Level 1|Lost to Follow-up|0|||
16560917|NCT00062868|40521770|FG017|Dose Level 1|Lost to Follow-up|0|||
16560918|NCT00062868|40521771|FG018|Dose Level 1|Lost to Follow-up|2|||
16560919|NCT00062868|40521772|FG019|Dose Level 1|Lost to Follow-up|0|||
16560920|NCT00062868|40521773|FG020|Dose Level 1|Lost to Follow-up|1|||
16560921|NCT00062868|40521753|FG000|Dose Level 2|Death|0|||
16560922|NCT00062868|40521754|FG001|Dose Level 2|Death|3|||
16560923|NCT00062868|40521755|FG002|Dose Level 2|Death|0|||
16560924|NCT00062868|40521756|FG003|Dose Level 2|Death|0|||
16560925|NCT00062868|40521757|FG004|Dose Level 2|Death|2|||
16560926|NCT00062868|40521758|FG005|Dose Level 2|Death|0|||
16560927|NCT00062868|40521759|FG006|Dose Level 2|Death|0|||
16560928|NCT00062868|40521760|FG007|Dose Level 2|Death|0|||
16560929|NCT00062868|40521761|FG008|Dose Level 2|Death|0|||
16560930|NCT00062868|40521762|FG009|Dose Level 2|Death|0|||
16560931|NCT00062868|40521763|FG010|Dose Level 2|Death|1|||
16560932|NCT00062868|40521764|FG011|Dose Level 2|Death|0|||
16560933|NCT00062868|40521765|FG012|Dose Level 2|Death|0|||
16560934|NCT00062868|40521766|FG013|Dose Level 2|Death|0|||
16560935|NCT00062868|40521767|FG014|Dose Level 2|Death|0|||
16353376|NCT00274742|39780417|FG001|Overall Study|Lost to Follow-up|0|||
16353377|NCT00274742|39780418|FG002|Overall Study|Lost to Follow-up|0|||
16353378|NCT00274742|39780419|FG003|Overall Study|Lost to Follow-up|0|||
16353379|NCT00274742|39780420|FG004|Overall Study|Lost to Follow-up|1|||
16353380|NCT00274742|39780421|FG005|Overall Study|Lost to Follow-up|0|||
16353381|NCT00274742|39780416|FG000|Overall Study|End of Study|0|||
16353382|NCT00274742|39780417|FG001|Overall Study|End of Study|0|||
16353383|NCT00274742|39780418|FG002|Overall Study|End of Study|0|||
16353384|NCT00274742|39780419|FG003|Overall Study|End of Study|1|||
16353385|NCT00274742|39780420|FG004|Overall Study|End of Study|0|||
16353386|NCT00274742|39780421|FG005|Overall Study|End of Study|0|||
16353387|NCT00274742|39780416|FG000|Overall Study|Disease Progression|0|||
16353388|NCT00274742|39780417|FG001|Overall Study|Disease Progression|1|||
16353389|NCT00274742|39780418|FG002|Overall Study|Disease Progression|1|||
16353390|NCT00274742|39780419|FG003|Overall Study|Disease Progression|0|||
16353391|NCT00274742|39780420|FG004|Overall Study|Disease Progression|1|||
16353392|NCT00274742|39780421|FG005|Overall Study|Disease Progression|0|||
16353393|NCT00274742|39780416|FG000|Overall Study|Other|0|||
16353394|NCT00274742|39780417|FG001|Overall Study|Other|3|||
16353395|NCT00274742|39780418|FG002|Overall Study|Other|0|||
16353396|NCT00274742|39780419|FG003|Overall Study|Other|0|||
16353397|NCT00274742|39780420|FG004|Overall Study|Other|2|||
16353398|NCT00274742|39780421|FG005|Overall Study|Other|0|||
16353399|NCT00264147|39780428|FG000|Treatment I Period|Adverse Event|3|||
16353400|NCT00264147|39780429|FG001|Treatment I Period|Adverse Event|6|||
16353401|NCT00264147|39780430|FG002|Treatment I Period|Adverse Event|3|||
16353402|NCT00264147|39780431|FG003|Treatment I Period|Adverse Event|5|||
16353403|NCT00264147|39780432|FG004|Treatment I Period|Adverse Event|7|||
16353404|NCT00264147|39780433|FG005|Treatment I Period|Adverse Event|0|||
16353405|NCT00264147|39780428|FG000|Treatment I Period|Laboratory Adverse Event|0|||
16353406|NCT00264147|39780429|FG001|Treatment I Period|Laboratory Adverse Event|0|||
16353407|NCT00264147|39780430|FG002|Treatment I Period|Laboratory Adverse Event|0|||
16353408|NCT00264147|39780431|FG003|Treatment I Period|Laboratory Adverse Event|1|||
16353409|NCT00264147|39780432|FG004|Treatment I Period|Laboratory Adverse Event|0|||
16353410|NCT00264147|39780433|FG005|Treatment I Period|Laboratory Adverse Event|0|||
16353411|NCT00264147|39780428|FG000|Treatment I Period|Lack of Efficacy|6|||
16353412|NCT00264147|39780429|FG001|Treatment I Period|Lack of Efficacy|2|||
16353413|NCT00264147|39780430|FG002|Treatment I Period|Lack of Efficacy|8|||
16353414|NCT00264147|39780431|FG003|Treatment I Period|Lack of Efficacy|0|||
16353415|NCT00264147|39780432|FG004|Treatment I Period|Lack of Efficacy|1|||
16353416|NCT00264147|39780433|FG005|Treatment I Period|Lack of Efficacy|0|||
16353417|NCT00264147|39780428|FG000|Treatment I Period|Lost to Follow-up|1|||
16353418|NCT00264147|39780429|FG001|Treatment I Period|Lost to Follow-up|0|||
16353419|NCT00264147|39780430|FG002|Treatment I Period|Lost to Follow-up|0|||
16353420|NCT00264147|39780431|FG003|Treatment I Period|Lost to Follow-up|1|||
16353421|NCT00264147|39780432|FG004|Treatment I Period|Lost to Follow-up|1|||
16353422|NCT00264147|39780433|FG005|Treatment I Period|Lost to Follow-up|0|||
16353423|NCT00264147|39780428|FG000|Treatment I Period|Protocol Violation|2|||
16353424|NCT00264147|39780429|FG001|Treatment I Period|Protocol Violation|2|||
16353425|NCT00264147|39780430|FG002|Treatment I Period|Protocol Violation|0|||
16353426|NCT00264147|39780431|FG003|Treatment I Period|Protocol Violation|0|||
16353427|NCT00264147|39780432|FG004|Treatment I Period|Protocol Violation|0|||
16353428|NCT00264147|39780433|FG005|Treatment I Period|Protocol Violation|0|||
16353429|NCT00264147|39780428|FG000|Treatment I Period|Withdrawal by Subject|2|||
16353430|NCT00264147|39780429|FG001|Treatment I Period|Withdrawal by Subject|0|||
16353431|NCT00264147|39780430|FG002|Treatment I Period|Withdrawal by Subject|0|||
16353432|NCT00264147|39780431|FG003|Treatment I Period|Withdrawal by Subject|2|||
16353433|NCT00264147|39780432|FG004|Treatment I Period|Withdrawal by Subject|2|||
16353434|NCT00264147|39780433|FG005|Treatment I Period|Withdrawal by Subject|0|||
16353435|NCT00264147|39780428|FG000|Treatment I Period|Patient out of town for an extended time|0|||
16353436|NCT00264147|39780429|FG001|Treatment I Period|Patient out of town for an extended time|1|||
16353437|NCT00264147|39780430|FG002|Treatment I Period|Patient out of town for an extended time|0|||
16353438|NCT00264147|39780431|FG003|Treatment I Period|Patient out of town for an extended time|0|||
16353439|NCT00264147|39780432|FG004|Treatment I Period|Patient out of town for an extended time|0|||
16353440|NCT00264147|39780433|FG005|Treatment I Period|Patient out of town for an extended time|0|||
16353441|NCT00264147|39780428|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
16353442|NCT00264147|39780429|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
16353443|NCT00264147|39780430|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
16353444|NCT00264147|39780431|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
16353445|NCT00264147|39780432|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
16353446|NCT00264147|39780433|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
16353447|NCT00264147|39780428|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
16353448|NCT00264147|39780429|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
16353449|NCT00264147|39780430|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
16560936|NCT00062868|40521768|FG015|Dose Level 2|Death|0|||
16353450|NCT00264147|39780431|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
16353451|NCT00264147|39780432|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
16353452|NCT00264147|39780433|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
16353453|NCT00264147|39780428|FG000|Treatment II Period|Adverse Event|0|||
16353454|NCT00264147|39780429|FG001|Treatment II Period|Adverse Event|0|||
16353455|NCT00264147|39780430|FG002|Treatment II Period|Adverse Event|0|||
16353456|NCT00264147|39780431|FG003|Treatment II Period|Adverse Event|0|||
16353457|NCT00264147|39780432|FG004|Treatment II Period|Adverse Event|9|||
16353458|NCT00264147|39780433|FG005|Treatment II Period|Adverse Event|9|||
16353459|NCT00264147|39780428|FG000|Treatment II Period|Laboratory Adverse Event|0|||
16353460|NCT00264147|39780429|FG001|Treatment II Period|Laboratory Adverse Event|0|||
16353461|NCT00264147|39780430|FG002|Treatment II Period|Laboratory Adverse Event|0|||
16353462|NCT00264147|39780431|FG003|Treatment II Period|Laboratory Adverse Event|0|||
16353463|NCT00264147|39780432|FG004|Treatment II Period|Laboratory Adverse Event|0|||
16353464|NCT00264147|39780433|FG005|Treatment II Period|Laboratory Adverse Event|1|||
16353465|NCT00264147|39780428|FG000|Treatment II Period|Lack of Efficacy|0|||
16353466|NCT00264147|39780429|FG001|Treatment II Period|Lack of Efficacy|0|||
16353467|NCT00264147|39780430|FG002|Treatment II Period|Lack of Efficacy|0|||
16353468|NCT00264147|39780431|FG003|Treatment II Period|Lack of Efficacy|0|||
16353469|NCT00264147|39780432|FG004|Treatment II Period|Lack of Efficacy|20|||
16353470|NCT00264147|39780433|FG005|Treatment II Period|Lack of Efficacy|19|||
16353471|NCT00264147|39780428|FG000|Treatment II Period|Lost to Follow-up|0|||
16353472|NCT00264147|39780429|FG001|Treatment II Period|Lost to Follow-up|0|||
16353473|NCT00264147|39780430|FG002|Treatment II Period|Lost to Follow-up|0|||
16353474|NCT00264147|39780431|FG003|Treatment II Period|Lost to Follow-up|0|||
16353475|NCT00264147|39780432|FG004|Treatment II Period|Lost to Follow-up|1|||
16353476|NCT00264147|39780433|FG005|Treatment II Period|Lost to Follow-up|1|||
16353477|NCT00264147|39780428|FG000|Treatment II Period|Withdrawal by Subject|0|||
16353478|NCT00264147|39780429|FG001|Treatment II Period|Withdrawal by Subject|0|||
16353479|NCT00264147|39780430|FG002|Treatment II Period|Withdrawal by Subject|0|||
16353480|NCT00264147|39780431|FG003|Treatment II Period|Withdrawal by Subject|0|||
16353481|NCT00264147|39780432|FG004|Treatment II Period|Withdrawal by Subject|3|||
16353482|NCT00264147|39780433|FG005|Treatment II Period|Withdrawal by Subject|2|||
16353483|NCT00264147|39780428|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
16353484|NCT00264147|39780429|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
16353485|NCT00264147|39780430|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
16353486|NCT00264147|39780431|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
16353487|NCT00264147|39780432|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
16353488|NCT00264147|39780433|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
16353489|NCT00715403|39780436|FG000|Overall Study|Progressive disease|0|||
16353490|NCT00715403|39780437|FG001|Overall Study|Progressive disease|1|||
16353491|NCT00715403|39780438|FG002|Overall Study|Progressive disease|3|||
16353492|NCT00715403|39780439|FG003|Overall Study|Progressive disease|9|||
16353493|NCT00715403|39780440|FG004|Overall Study|Progressive disease|5|||
16353494|NCT00715403|39780441|FG005|Overall Study|Progressive disease|14|||
16353495|NCT00715403|39780442|FG006|Overall Study|Progressive disease|1|||
16353496|NCT00715403|39780436|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
16353497|NCT00715403|39780437|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
16353498|NCT00715403|39780438|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
16246685|NCT02266706|39385583|FG003|Overall Study|Enrollment in another study|1|||
16246686|NCT02266706|39385584|FG004|Overall Study|Enrollment in another study|0|||
16246687|NCT02266706|39385585|FG005|Overall Study|Enrollment in another study|0|||
16246688|NCT02266706|39385586|FG006|Overall Study|Enrollment in another study|0|||
16246689|NCT02266706|39385587|FG007|Overall Study|Enrollment in another study|0|||
16246690|NCT02266706|39385588|FG008|Overall Study|Enrollment in another study|0|||
16246691|NCT00601484|39385589|FG000|Overall Study|Adverse Event|0|||
16246692|NCT00601484|39385590|FG001|Overall Study|Adverse Event|1|||
16246693|NCT00601484|39385589|FG000|Overall Study|Lost to Follow-up|4|||
16246694|NCT00601484|39385590|FG001|Overall Study|Lost to Follow-up|3|||
16246695|NCT00601484|39385589|FG000|Overall Study|Lack of Efficacy|0|||
16246696|NCT00601484|39385590|FG001|Overall Study|Lack of Efficacy|2|||
16246697|NCT00601484|39385589|FG000|Overall Study|Withdrawal by Subject|1|||
16246698|NCT00601484|39385590|FG001|Overall Study|Withdrawal by Subject|1|||
16246699|NCT00601484|39385589|FG000|Overall Study|Randomized, but not treated|0|||
16246700|NCT00601484|39385590|FG001|Overall Study|Randomized, but not treated|1|||
16246701|NCT01214330|39385593|FG000|Overall Study|Withdrawal by Subject|2|||
16246702|NCT01214330|39385593|FG000|Overall Study|Withdrawal by Subject|2|||
16246703|NCT00686920|39385599|FG000|Overall Study|Death|45|||
16246704|NCT00686920|39385600|FG001|Overall Study|Death|14|||
16246705|NCT00686920|39385599|FG000|Overall Study|Liver Transplant|23|||
16246706|NCT00686920|39385600|FG001|Overall Study|Liver Transplant|8|||
16353499|NCT00715403|39780439|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
16353500|NCT00715403|39780440|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
16417617|NCT00576472|40008545|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16353501|NCT00715403|39780441|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
16353502|NCT00715403|39780442|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
16353503|NCT00715403|39780436|FG000|Overall Study|Other Adverse Event than DLT|1|||
16353504|NCT00715403|39780437|FG001|Overall Study|Other Adverse Event than DLT|0|||
16353505|NCT00715403|39780438|FG002|Overall Study|Other Adverse Event than DLT|0|||
16353506|NCT00715403|39780439|FG003|Overall Study|Other Adverse Event than DLT|0|||
16353507|NCT00715403|39780440|FG004|Overall Study|Other Adverse Event than DLT|0|||
16353508|NCT00715403|39780441|FG005|Overall Study|Other Adverse Event than DLT|2|||
16353509|NCT00715403|39780442|FG006|Overall Study|Other Adverse Event than DLT|0|||
16353510|NCT00715403|39780436|FG000|Overall Study|Protocol Violation|0|||
16353511|NCT00715403|39780437|FG001|Overall Study|Protocol Violation|0|||
16353512|NCT00715403|39780438|FG002|Overall Study|Protocol Violation|0|||
16353513|NCT00715403|39780439|FG003|Overall Study|Protocol Violation|0|||
16353514|NCT00715403|39780440|FG004|Overall Study|Protocol Violation|0|||
16353515|NCT00715403|39780441|FG005|Overall Study|Protocol Violation|1|||
16353516|NCT00715403|39780442|FG006|Overall Study|Protocol Violation|0|||
16353517|NCT00715403|39780436|FG000|Overall Study|Other reason not defined above|0|||
16353518|NCT00715403|39780437|FG001|Overall Study|Other reason not defined above|0|||
16353519|NCT00715403|39780438|FG002|Overall Study|Other reason not defined above|1|||
16353520|NCT00715403|39780439|FG003|Overall Study|Other reason not defined above|0|||
16353521|NCT00715403|39780440|FG004|Overall Study|Other reason not defined above|1|||
16353522|NCT00715403|39780441|FG005|Overall Study|Other reason not defined above|1|||
16353523|NCT00715403|39780442|FG006|Overall Study|Other reason not defined above|0|||
16353524|NCT05222880|39780443|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
16353525|NCT05222880|39780443|FG000|Overall Study|Withdrew Consent during Study|1|||
16353526|NCT05222880|39780443|FG000|Overall Study|COVID-19 Related|1|||
16353527|NCT00716456|39780444|FG000|Overall Study|Adverse Event|0|||
16353528|NCT00716456|39780445|FG001|Overall Study|Adverse Event|2|||
16353529|NCT00716456|39780446|FG002|Overall Study|Adverse Event|0|||
16353530|NCT02100839|39780447|FG000|Multiple Ascending Dose|Adverse Event|2|||
16353531|NCT02100839|39780448|FG001|Multiple Ascending Dose|Adverse Event|0|||
16353532|NCT02100839|39780447|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
16353533|NCT02100839|39780448|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
16353534|NCT00511810|39780449|FG000|Overall Study|Lost to Follow-up|1|||
16353535|NCT00511810|39780450|FG001|Overall Study|Lost to Follow-up|2|||
16353536|NCT00511810|39780449|FG000|Overall Study|Lack of Efficacy|0|||
16353537|NCT00511810|39780450|FG001|Overall Study|Lack of Efficacy|2|||
16353538|NCT00511810|39780449|FG000|Overall Study|Refused second scn|0|||
16353539|NCT00511810|39780450|FG001|Overall Study|Refused second scn|1|||
16353540|NCT01774591|39780453|FG000|Overall Study|Physician Decision|1|||
16353541|NCT01774591|39780454|FG001|Overall Study|Physician Decision|1|||
16353542|NCT01774591|39780453|FG000|Overall Study|Withdrawal by Subject|0|||
16353543|NCT01774591|39780454|FG001|Overall Study|Withdrawal by Subject|1|||
16353544|NCT01774591|39780453|FG000|Overall Study|Adverse Event|0|||
16353545|NCT01774591|39780454|FG001|Overall Study|Adverse Event|2|||
16353546|NCT01089127|39780455|FG000|Overall Study|Adverse Event|5|||
16353547|NCT01089127|39780456|FG001|Overall Study|Adverse Event|1|||
16353548|NCT01089127|39780457|FG002|Overall Study|Adverse Event|1|||
16353549|NCT01089127|39780458|FG003|Overall Study|Adverse Event|0|||
16353550|NCT01089127|39780459|FG004|Overall Study|Adverse Event|0|||
16353551|NCT01089127|39780460|FG005|Overall Study|Adverse Event|1|||
16353552|NCT01089127|39780455|FG000|Overall Study|Subject withdrew consent|0|||
16353553|NCT01089127|39780456|FG001|Overall Study|Subject withdrew consent|1|||
16353554|NCT01089127|39780457|FG002|Overall Study|Subject withdrew consent|1|||
16353555|NCT01089127|39780458|FG003|Overall Study|Subject withdrew consent|1|||
16353556|NCT01089127|39780459|FG004|Overall Study|Subject withdrew consent|0|||
16353557|NCT01089127|39780460|FG005|Overall Study|Subject withdrew consent|2|||
16353558|NCT01089127|39780455|FG000|Overall Study|Abnormal test procedure result(s)|2|||
16353559|NCT01089127|39780456|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16353560|NCT01089127|39780457|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16353561|NCT01089127|39780458|FG003|Overall Study|Abnormal test procedure result(s)|0|||
16353562|NCT01089127|39780459|FG004|Overall Study|Abnormal test procedure result(s)|0|||
16353563|NCT01089127|39780460|FG005|Overall Study|Abnormal test procedure result(s)|0|||
16353564|NCT01089127|39780455|FG000|Overall Study|Lost to Follow-up|1|||
16353565|NCT01089127|39780456|FG001|Overall Study|Lost to Follow-up|1|||
16353566|NCT01089127|39780457|FG002|Overall Study|Lost to Follow-up|0|||
16353567|NCT01089127|39780458|FG003|Overall Study|Lost to Follow-up|0|||
16353568|NCT01089127|39780459|FG004|Overall Study|Lost to Follow-up|1|||
16353569|NCT01089127|39780460|FG005|Overall Study|Lost to Follow-up|0|||
16353570|NCT01089127|39780455|FG000|Overall Study|Protocol deviation|0|||
16353571|NCT01089127|39780456|FG001|Overall Study|Protocol deviation|1|||
16353572|NCT01089127|39780457|FG002|Overall Study|Protocol deviation|0|||
16353573|NCT01089127|39780458|FG003|Overall Study|Protocol deviation|0|||
16353574|NCT01089127|39780459|FG004|Overall Study|Protocol deviation|1|||
16353575|NCT01089127|39780460|FG005|Overall Study|Protocol deviation|0|||
16353576|NCT03769649|39780461|FG000|Overall Study|Lost to Follow-up|4|||
16353577|NCT01494818|39780463|FG000|Overall Study|Relocation|1|||
16353578|NCT01494818|39780464|FG001|Overall Study|Relocation|2|||
16353579|NCT01494818|39780463|FG000|Overall Study|Lost to Follow-up|1|||
16353580|NCT01494818|39780464|FG001|Overall Study|Lost to Follow-up|0|||
16353581|NCT04155463|39780465|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
16353582|NCT04155463|39780466|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
16353583|NCT03644017|39780468|FG000|Overall Study|Access Abandonment|5|||
16353584|NCT03644017|39780468|FG000|Overall Study|Kidney Transplant|2|||
16353585|NCT01884597|39780471|FG000|Overall Study|Adverse Event|0|||
16353586|NCT01884597|39780472|FG001|Overall Study|Adverse Event|0|||
16353587|NCT01884597|39780473|FG002|Overall Study|Adverse Event|1|||
16353588|NCT01884597|39780471|FG000|Overall Study|Lack of Efficacy|1|||
16353589|NCT01884597|39780472|FG001|Overall Study|Lack of Efficacy|0|||
16353590|NCT01884597|39780473|FG002|Overall Study|Lack of Efficacy|0|||
16353591|NCT01884597|39780471|FG000|Overall Study|Death|0|||
16353592|NCT01884597|39780472|FG001|Overall Study|Death|1|||
16353593|NCT01884597|39780473|FG002|Overall Study|Death|0|||
16353594|NCT00232557|39780474|FG000|Overall Study|Lost to Follow-up|3|||
16353595|NCT00232557|39780475|FG001|Overall Study|Lost to Follow-up|5|||
16353596|NCT01228591|39780476|FG000|Baseline|Lack of Efficacy|1|||
16353597|NCT01228591|39780477|FG001|Baseline|Lack of Efficacy|2|||
16353598|NCT01746862|39780481|FG000|Overall Study|Withdrawal by Subject|1|||
16560937|NCT00062868|40521769|FG016|Dose Level 2|Death|2|||
16560938|NCT00062868|40521770|FG017|Dose Level 2|Death|0|||
16560939|NCT00062868|40521771|FG018|Dose Level 2|Death|0|||
16560940|NCT00062868|40521772|FG019|Dose Level 2|Death|0|||
16560941|NCT00062868|40521773|FG020|Dose Level 2|Death|0|||
16560942|NCT00062868|40521753|FG000|Dose Level 2|Lost to Follow-up|0|||
16560943|NCT00062868|40521754|FG001|Dose Level 2|Lost to Follow-up|0|||
16560944|NCT00062868|40521755|FG002|Dose Level 2|Lost to Follow-up|0|||
16560945|NCT00062868|40521756|FG003|Dose Level 2|Lost to Follow-up|0|||
16560946|NCT00062868|40521757|FG004|Dose Level 2|Lost to Follow-up|0|||
16560947|NCT00062868|40521758|FG005|Dose Level 2|Lost to Follow-up|0|||
16560948|NCT00062868|40521759|FG006|Dose Level 2|Lost to Follow-up|0|||
16560949|NCT00062868|40521760|FG007|Dose Level 2|Lost to Follow-up|0|||
16560950|NCT00062868|40521761|FG008|Dose Level 2|Lost to Follow-up|0|||
16560951|NCT00062868|40521762|FG009|Dose Level 2|Lost to Follow-up|0|||
16560952|NCT00062868|40521763|FG010|Dose Level 2|Lost to Follow-up|0|||
16560953|NCT00062868|40521764|FG011|Dose Level 2|Lost to Follow-up|0|||
16560954|NCT00062868|40521765|FG012|Dose Level 2|Lost to Follow-up|0|||
16560955|NCT00062868|40521766|FG013|Dose Level 2|Lost to Follow-up|1|||
16560956|NCT00062868|40521767|FG014|Dose Level 2|Lost to Follow-up|0|||
16560957|NCT00062868|40521768|FG015|Dose Level 2|Lost to Follow-up|0|||
16560958|NCT00062868|40521769|FG016|Dose Level 2|Lost to Follow-up|1|||
16560959|NCT00062868|40521770|FG017|Dose Level 2|Lost to Follow-up|0|||
16246707|NCT00686920|39385599|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
16246708|NCT00686920|39385600|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
16246709|NCT00686920|39385599|FG000|Overall Study|Withdrawal by Subject|23|||
16246710|NCT00686920|39385600|FG001|Overall Study|Withdrawal by Subject|5|||
16246711|NCT00686920|39385599|FG000|Overall Study|Protocol Violation|2|||
16246712|NCT00686920|39385600|FG001|Overall Study|Protocol Violation|1|||
16246713|NCT00686920|39385599|FG000|Overall Study|Adverse Event|10|||
16246714|NCT00686920|39385600|FG001|Overall Study|Adverse Event|2|||
16246715|NCT00686920|39385599|FG000|Overall Study|Personal Reason|0|||
16246716|NCT00686920|39385600|FG001|Overall Study|Personal Reason|1|||
16246717|NCT00686920|39385599|FG000|Overall Study|Lost to Follow-up|15|||
16246718|NCT00686920|39385600|FG001|Overall Study|Lost to Follow-up|3|||
16246719|NCT00686920|39385599|FG000|Overall Study|Moved to Another State|1|||
16246720|NCT00686920|39385600|FG001|Overall Study|Moved to Another State|0|||
16246721|NCT00686920|39385599|FG000|Overall Study|Transferred to Nursing Home|1|||
16246722|NCT00686920|39385600|FG001|Overall Study|Transferred to Nursing Home|0|||
16246723|NCT00686920|39385599|FG000|Overall Study|Noncompliance|9|||
16246724|NCT00686920|39385600|FG001|Overall Study|Noncompliance|0|||
16246725|NCT00686920|39385599|FG000|Overall Study|Principal Investigator Decision|2|||
16246726|NCT00686920|39385600|FG001|Overall Study|Principal Investigator Decision|0|||
16246727|NCT03280537|39385601|FG000|Overall Study|Withdrawal by Subject|2|||
16246728|NCT03280537|39385602|FG001|Overall Study|Withdrawal by Subject|4|||
16246729|NCT02308111|39385608|FG000|Overall Study|Adverse Event|31|||
16246730|NCT02308111|39385609|FG001|Overall Study|Adverse Event|19|||
16246731|NCT02308111|39385608|FG000|Overall Study|Death|9|||
16246732|NCT02308111|39385609|FG001|Overall Study|Death|6|||
16353599|NCT01746862|39780482|FG001|Overall Study|Withdrawal by Subject|1|||
16353600|NCT01746862|39780481|FG000|Overall Study|Protocol Violation|1|||
16353601|NCT01746862|39780482|FG001|Overall Study|Protocol Violation|0|||
16560960|NCT00062868|40521771|FG018|Dose Level 2|Lost to Follow-up|0|||
16560961|NCT00062868|40521772|FG019|Dose Level 2|Lost to Follow-up|0|||
16353602|NCT01746862|39780481|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
16353603|NCT01746862|39780482|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
16560962|NCT00062868|40521773|FG020|Dose Level 2|Lost to Follow-up|0|||
16560963|NCT00062868|40521753|FG000|Dose Level 3|Death|0|||
16560964|NCT00062868|40521754|FG001|Dose Level 3|Death|0|||
16560965|NCT00062868|40521755|FG002|Dose Level 3|Death|0|||
16560966|NCT00062868|40521756|FG003|Dose Level 3|Death|0|||
16560967|NCT00062868|40521757|FG004|Dose Level 3|Death|0|||
16560968|NCT00062868|40521758|FG005|Dose Level 3|Death|0|||
16560969|NCT00062868|40521759|FG006|Dose Level 3|Death|0|||
16560970|NCT00062868|40521760|FG007|Dose Level 3|Death|0|||
16560971|NCT00062868|40521761|FG008|Dose Level 3|Death|0|||
16560972|NCT00062868|40521762|FG009|Dose Level 3|Death|0|||
16560973|NCT00062868|40521763|FG010|Dose Level 3|Death|0|||
16560974|NCT00062868|40521764|FG011|Dose Level 3|Death|1|||
16560975|NCT00062868|40521765|FG012|Dose Level 3|Death|0|||
16560976|NCT00062868|40521766|FG013|Dose Level 3|Death|0|||
16560977|NCT00062868|40521767|FG014|Dose Level 3|Death|0|||
16353604|NCT01746862|39780481|FG000|Overall Study|Entered puberty during the study|1|||
16353605|NCT01746862|39780482|FG001|Overall Study|Entered puberty during the study|0|||
16353606|NCT00315445|39780483|FG000|Overall Study|Adverse Event|7|||
16353607|NCT00315445|39780484|FG001|Overall Study|Adverse Event|12|||
16353608|NCT00315445|39780485|FG002|Overall Study|Adverse Event|15|||
16353609|NCT00315445|39780483|FG000|Overall Study|Lack of Efficacy|16|||
16353610|NCT00315445|39780484|FG001|Overall Study|Lack of Efficacy|1|||
16353611|NCT00315445|39780485|FG002|Overall Study|Lack of Efficacy|7|||
16353612|NCT00315445|39780483|FG000|Overall Study|Lost to Follow-up|1|||
16353613|NCT00315445|39780484|FG001|Overall Study|Lost to Follow-up|0|||
16353614|NCT00315445|39780485|FG002|Overall Study|Lost to Follow-up|1|||
16353615|NCT00315445|39780483|FG000|Overall Study|Protocol Violation|2|||
16353616|NCT00315445|39780484|FG001|Overall Study|Protocol Violation|0|||
16353617|NCT00315445|39780485|FG002|Overall Study|Protocol Violation|1|||
16353618|NCT00315445|39780483|FG000|Overall Study|Other|1|||
16353619|NCT00315445|39780484|FG001|Overall Study|Other|3|||
16353620|NCT00315445|39780485|FG002|Overall Study|Other|0|||
16353621|NCT03200548|39780486|FG000|Overall Study|Withdrawal by Subject|5|||
16353622|NCT03200548|39780487|FG001|Overall Study|Withdrawal by Subject|11|||
16353623|NCT03200548|39780488|FG002|Overall Study|Withdrawal by Subject|7|||
16353624|NCT03200548|39780489|FG003|Overall Study|Withdrawal by Subject|6|||
16353625|NCT01001910|39780494|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
16353626|NCT00871234|39780495|FG000|Overall Study|Adverse Event|2|||
16353627|NCT00871234|39780495|FG000|Overall Study|Lost to Follow-up|3|||
16353628|NCT02700048|39780501|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
16353629|NCT02700048|39780502|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
16353630|NCT00909870|39780503|FG000|Overall Study|Adverse Event|13|||
16353631|NCT00909870|39780504|FG001|Overall Study|Adverse Event|7|||
16353632|NCT00909870|39780503|FG000|Overall Study|Protocol Violation|1|||
16353633|NCT00909870|39780504|FG001|Overall Study|Protocol Violation|2|||
16353634|NCT00909870|39780503|FG000|Overall Study|Withdrawal by Subject|5|||
16353635|NCT00909870|39780504|FG001|Overall Study|Withdrawal by Subject|8|||
16353636|NCT00909870|39780503|FG000|Overall Study|Lost to Follow-up|3|||
16353637|NCT00909870|39780504|FG001|Overall Study|Lost to Follow-up|3|||
16353638|NCT00909870|39780503|FG000|Overall Study|Physician Decision|0|||
16353639|NCT00909870|39780504|FG001|Overall Study|Physician Decision|2|||
16353640|NCT00909870|39780503|FG000|Overall Study|Other|1|||
16353641|NCT00909870|39780504|FG001|Overall Study|Other|5|||
16353642|NCT00977197|39780506|FG000|Overall Study|Withdrawal by Subject|3|||
16353643|NCT00977197|39780507|FG001|Overall Study|Withdrawal by Subject|4|||
16353644|NCT00977197|39780506|FG000|Overall Study|Adverse Event|3|||
16130509|NCT00196976|38967049|FG000|Primary Study|Protocol Violation|0|||
16130510|NCT00196976|38967050|FG001|Primary Study|Protocol Violation|1|||
16353645|NCT00977197|39780507|FG001|Overall Study|Adverse Event|1|||
16353646|NCT00977197|39780506|FG000|Overall Study|Lack of Efficacy|1|||
16353647|NCT00977197|39780507|FG001|Overall Study|Lack of Efficacy|0|||
16353648|NCT00977197|39780506|FG000|Overall Study|Lost to Follow-up|1|||
16560978|NCT00062868|40521768|FG015|Dose Level 3|Death|0|||
16560979|NCT00062868|40521769|FG016|Dose Level 3|Death|0|||
16560980|NCT00062868|40521770|FG017|Dose Level 3|Death|1|||
16560981|NCT00062868|40521771|FG018|Dose Level 3|Death|0|||
16130511|NCT00196976|38967051|FG002|Primary Study|Protocol Violation|1|||
16130512|NCT00196976|38967052|FG003|Primary Study|Protocol Violation|0|||
16353649|NCT00977197|39780507|FG001|Overall Study|Lost to Follow-up|3|||
16353650|NCT00977197|39780506|FG000|Overall Study|Nonadherence|1|||
16353651|NCT00977197|39780507|FG001|Overall Study|Nonadherence|1|||
16353652|NCT04210986|39780508|FG000|Overall Study|Lost to Follow-up|5|||
16353653|NCT04210986|39780509|FG001|Overall Study|Lost to Follow-up|2|||
16353654|NCT04210986|39780508|FG000|Overall Study|Withdrawal by Subject|3|||
16353655|NCT04210986|39780509|FG001|Overall Study|Withdrawal by Subject|1|||
16560982|NCT00062868|40521772|FG019|Dose Level 3|Death|0|||
16130513|NCT00196976|38967053|FG004|Primary Study|Protocol Violation|0|||
16353656|NCT04210986|39780508|FG000|Overall Study|Protocol Violation|1|||
16353657|NCT04210986|39780509|FG001|Overall Study|Protocol Violation|1|||
16560983|NCT00062868|40521773|FG020|Dose Level 3|Death|0|||
16560984|NCT00062868|40521753|FG000|Dose Level 3|Lost to Follow-up|0|||
16560985|NCT00062868|40521754|FG001|Dose Level 3|Lost to Follow-up|0|||
16560986|NCT00062868|40521755|FG002|Dose Level 3|Lost to Follow-up|0|||
16560987|NCT00062868|40521756|FG003|Dose Level 3|Lost to Follow-up|0|||
16560988|NCT00062868|40521757|FG004|Dose Level 3|Lost to Follow-up|0|||
16560989|NCT00062868|40521758|FG005|Dose Level 3|Lost to Follow-up|0|||
16560990|NCT00062868|40521759|FG006|Dose Level 3|Lost to Follow-up|0|||
16560991|NCT00062868|40521760|FG007|Dose Level 3|Lost to Follow-up|0|||
16560992|NCT00062868|40521761|FG008|Dose Level 3|Lost to Follow-up|0|||
16560993|NCT00062868|40521762|FG009|Dose Level 3|Lost to Follow-up|0|||
16560994|NCT00062868|40521763|FG010|Dose Level 3|Lost to Follow-up|0|||
16560995|NCT00062868|40521764|FG011|Dose Level 3|Lost to Follow-up|0|||
16560996|NCT00062868|40521765|FG012|Dose Level 3|Lost to Follow-up|0|||
16560997|NCT00062868|40521766|FG013|Dose Level 3|Lost to Follow-up|0|||
16560998|NCT00062868|40521767|FG014|Dose Level 3|Lost to Follow-up|1|||
16560999|NCT00062868|40521768|FG015|Dose Level 3|Lost to Follow-up|0|||
16561000|NCT00062868|40521769|FG016|Dose Level 3|Lost to Follow-up|0|||
16561001|NCT00062868|40521770|FG017|Dose Level 3|Lost to Follow-up|0|||
16561002|NCT00062868|40521771|FG018|Dose Level 3|Lost to Follow-up|0|||
16561003|NCT00062868|40521772|FG019|Dose Level 3|Lost to Follow-up|0|||
16561004|NCT00062868|40521773|FG020|Dose Level 3|Lost to Follow-up|0|||
16561005|NCT00062868|40521753|FG000|Dose Level 3|Withdrew|0|||
16561006|NCT00062868|40521754|FG001|Dose Level 3|Withdrew|0|||
16561007|NCT00062868|40521755|FG002|Dose Level 3|Withdrew|2|||
16561008|NCT00062868|40521756|FG003|Dose Level 3|Withdrew|0|||
16561009|NCT00062868|40521757|FG004|Dose Level 3|Withdrew|0|||
16561010|NCT00062868|40521758|FG005|Dose Level 3|Withdrew|0|||
16561011|NCT00062868|40521759|FG006|Dose Level 3|Withdrew|0|||
16561012|NCT00062868|40521760|FG007|Dose Level 3|Withdrew|0|||
16561013|NCT00062868|40521761|FG008|Dose Level 3|Withdrew|0|||
16561014|NCT00062868|40521762|FG009|Dose Level 3|Withdrew|0|||
16561015|NCT00062868|40521763|FG010|Dose Level 3|Withdrew|0|||
16561016|NCT00062868|40521764|FG011|Dose Level 3|Withdrew|0|||
16561017|NCT00062868|40521765|FG012|Dose Level 3|Withdrew|0|||
16561018|NCT00062868|40521766|FG013|Dose Level 3|Withdrew|0|||
16561019|NCT00062868|40521767|FG014|Dose Level 3|Withdrew|0|||
16561020|NCT00062868|40521768|FG015|Dose Level 3|Withdrew|0|||
16561021|NCT00062868|40521769|FG016|Dose Level 3|Withdrew|0|||
16561022|NCT00062868|40521770|FG017|Dose Level 3|Withdrew|0|||
16561023|NCT00062868|40521771|FG018|Dose Level 3|Withdrew|0|||
16561024|NCT00062868|40521772|FG019|Dose Level 3|Withdrew|0|||
16561025|NCT00062868|40521773|FG020|Dose Level 3|Withdrew|0|||
16561026|NCT01390857|40521777|FG000|Overall Study|Protocol Violation|2|||
16561027|NCT01390857|40521777|FG000|Overall Study|Lost to Follow-up|1|||
16561028|NCT01390857|40521777|FG000|Overall Study|No Visit after the First Visit|7|||
16561029|NCT00946647|40521780|FG000|Phase 1 Part|Adverse Event|2|||
16561030|NCT00946647|40521781|FG001|Phase 1 Part|Adverse Event|5|||
16561031|NCT00946647|40521782|FG002|Phase 1 Part|Adverse Event|3|||
16561032|NCT00946647|40521783|FG003|Phase 1 Part|Adverse Event|0|||
16561033|NCT00946647|40521784|FG004|Phase 1 Part|Adverse Event|0|||
16561034|NCT00946647|40521780|FG000|Phase 1 Part|Disease progression|3|||
16561035|NCT00946647|40521781|FG001|Phase 1 Part|Disease progression|6|||
16353658|NCT04210986|39780508|FG000|Overall Study|Physician Decision|0|||
16353659|NCT04210986|39780509|FG001|Overall Study|Physician Decision|1|||
16353660|NCT01776554|39780510|FG000|Overall Study|Adverse Event|1|||
16353661|NCT01776554|39780511|FG001|Overall Study|Adverse Event|0|||
16353662|NCT01776554|39780510|FG000|Overall Study|Withdrawal by Subject|3|||
16353663|NCT01776554|39780511|FG001|Overall Study|Withdrawal by Subject|8|||
16353664|NCT01776554|39780510|FG000|Overall Study|Lost to Follow-up|6|||
16353665|NCT01776554|39780511|FG001|Overall Study|Lost to Follow-up|9|||
16353666|NCT01776554|39780510|FG000|Overall Study|Administrative Reason|2|||
16353667|NCT01776554|39780511|FG001|Overall Study|Administrative Reason|5|||
16353668|NCT01776554|39780510|FG000|Overall Study|Protocol Violation|1|||
16353669|NCT01776554|39780511|FG001|Overall Study|Protocol Violation|0|||
16353670|NCT01776554|39780510|FG000|Overall Study|Unclassified|4|||
16353671|NCT01776554|39780511|FG001|Overall Study|Unclassified|1|||
16353672|NCT02438280|39780513|FG000|Overall Study|Physician Decision|1|||
16353673|NCT02438280|39780514|FG001|Overall Study|Physician Decision|0|||
16353674|NCT01716806|39780523|FG000|Overall Study|Patient withdrawal of consent|4|||
16353675|NCT01716806|39780524|FG001|Overall Study|Patient withdrawal of consent|2|||
16353676|NCT01716806|39780525|FG002|Overall Study|Patient withdrawal of consent|4|||
16353677|NCT01716806|39780526|FG003|Overall Study|Patient withdrawal of consent|3|||
16353678|NCT01716806|39780527|FG004|Overall Study|Patient withdrawal of consent|2|||
16353679|NCT01716806|39780528|FG005|Overall Study|Patient withdrawal of consent|0|||
16353680|NCT01716806|39780523|FG000|Overall Study|Lost to Follow-up|3|||
16353681|NCT01716806|39780524|FG001|Overall Study|Lost to Follow-up|3|||
16353682|NCT01716806|39780525|FG002|Overall Study|Lost to Follow-up|0|||
16353683|NCT01716806|39780526|FG003|Overall Study|Lost to Follow-up|2|||
16353684|NCT01716806|39780527|FG004|Overall Study|Lost to Follow-up|1|||
16353685|NCT01716806|39780528|FG005|Overall Study|Lost to Follow-up|0|||
16353686|NCT01716806|39780523|FG000|Overall Study|Death|13|||
16353687|NCT01716806|39780524|FG001|Overall Study|Death|9|||
16353688|NCT01716806|39780525|FG002|Overall Study|Death|12|||
16353689|NCT01716806|39780526|FG003|Overall Study|Death|4|||
16353690|NCT01716806|39780527|FG004|Overall Study|Death|10|||
16353691|NCT01716806|39780528|FG005|Overall Study|Death|5|||
16353692|NCT01716806|39780523|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
16353693|NCT01716806|39780524|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
16353694|NCT01716806|39780525|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
16353695|NCT01716806|39780526|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
16353696|NCT01716806|39780527|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
16353697|NCT01716806|39780528|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
16353698|NCT01716806|39780523|FG000|Overall Study|PI decision|0|||
16353699|NCT01716806|39780524|FG001|Overall Study|PI decision|0|||
16353700|NCT01716806|39780525|FG002|Overall Study|PI decision|0|||
16353701|NCT01716806|39780526|FG003|Overall Study|PI decision|0|||
16353702|NCT01716806|39780527|FG004|Overall Study|PI decision|1|||
16353703|NCT01716806|39780528|FG005|Overall Study|PI decision|0|||
16353704|NCT01716806|39780523|FG000|Overall Study|Change in performance status|1|||
16353705|NCT01716806|39780524|FG001|Overall Study|Change in performance status|0|||
16353706|NCT01716806|39780525|FG002|Overall Study|Change in performance status|0|||
16353707|NCT01716806|39780526|FG003|Overall Study|Change in performance status|0|||
16353708|NCT01716806|39780527|FG004|Overall Study|Change in performance status|0|||
16353709|NCT01716806|39780528|FG005|Overall Study|Change in performance status|0|||
16353710|NCT01716806|39780523|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
16353711|NCT01716806|39780524|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
16353712|NCT01716806|39780525|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
16353713|NCT01716806|39780526|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
16353714|NCT01716806|39780527|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
16353715|NCT01716806|39780528|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
16353716|NCT01716806|39780523|FG000|Overall Study|Sponsor direction|7|||
16353717|NCT01716806|39780524|FG001|Overall Study|Sponsor direction|8|||
16353718|NCT01716806|39780525|FG002|Overall Study|Sponsor direction|5|||
16353719|NCT01716806|39780526|FG003|Overall Study|Sponsor direction|12|||
16353720|NCT01716806|39780527|FG004|Overall Study|Sponsor direction|16|||
16353721|NCT01716806|39780528|FG005|Overall Study|Sponsor direction|1|||
16353722|NCT03106077|39780532|FG000|Overall Study|Screen Failure|94|||
16353723|NCT03106077|39780533|FG001|Overall Study|Screen Failure|0|||
16353724|NCT02100124|39780537|FG000|Overall Study|Lost to Follow-up|5|||
16353725|NCT02100124|39780538|FG001|Overall Study|Lost to Follow-up|11|||
16417618|NCT00576472|40008546|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16353726|NCT02100124|39780539|FG002|Overall Study|Lost to Follow-up|3|||
16353727|NCT02100124|39780537|FG000|Overall Study|Withdrawal by Subject|1|||
16353728|NCT02100124|39780538|FG001|Overall Study|Withdrawal by Subject|0|||
16353729|NCT02100124|39780539|FG002|Overall Study|Withdrawal by Subject|0|||
16353730|NCT01783743|39780540|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
16353731|NCT01783743|39780541|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
16353732|NCT01783743|39780540|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
16353733|NCT01783743|39780541|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
16353734|NCT01783743|39780540|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
16353735|NCT01783743|39780541|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
16353736|NCT01022203|39780542|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
16353737|NCT01022203|39780543|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
16353738|NCT01022203|39780542|FG000|Post Treatment Assessment|Physician Decision|2|||
16353739|NCT01022203|39780543|FG001|Post Treatment Assessment|Physician Decision|0|||
16353740|NCT01022203|39780542|FG000|Post Treatment Assessment|Adverse Event|0|||
16353741|NCT01022203|39780543|FG001|Post Treatment Assessment|Adverse Event|2|||
16353742|NCT01022203|39780542|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
16353743|NCT01022203|39780543|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
16353744|NCT03934216|39780546|FG000|Overall Study|Other Reasons|5|||
16353745|NCT03934216|39780547|FG001|Overall Study|Other Reasons|5|||
16353746|NCT03934216|39780546|FG000|Overall Study|Adverse Event|22|||
16353747|NCT03934216|39780547|FG001|Overall Study|Adverse Event|11|||
16353748|NCT03934216|39780546|FG000|Overall Study|Lack of Efficacy|8|||
16353749|NCT03934216|39780547|FG001|Overall Study|Lack of Efficacy|7|||
16353750|NCT03934216|39780546|FG000|Overall Study|Lost to Follow-up|2|||
16353751|NCT03934216|39780547|FG001|Overall Study|Lost to Follow-up|0|||
16353752|NCT03934216|39780546|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16353753|NCT03934216|39780547|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16353754|NCT03934216|39780546|FG000|Overall Study|Pregnancy|1|||
16353755|NCT03934216|39780547|FG001|Overall Study|Pregnancy|0|||
16353756|NCT03934216|39780546|FG000|Overall Study|Withdrawal by Subject|18|||
16353757|NCT03934216|39780547|FG001|Overall Study|Withdrawal by Subject|6|||
16353758|NCT03934216|39780546|FG000|Overall Study|Randomized but not treated|1|||
16353759|NCT03934216|39780547|FG001|Overall Study|Randomized but not treated|1|||
16353760|NCT01123655|39780548|FG000|Overall Study|Medication for RA had to be changed|1|||
16353761|NCT01123655|39780549|FG001|Overall Study|Medication for RA had to be changed|0|||
16353762|NCT01123655|39780550|FG002|Overall Study|Medication for RA had to be changed|0|||
16353763|NCT01123655|39780548|FG000|Overall Study|new illness|0|||
16353764|NCT01123655|39780549|FG001|Overall Study|new illness|1|||
16353765|NCT01123655|39780550|FG002|Overall Study|new illness|0|||
16353766|NCT01123655|39780548|FG000|Overall Study|began prohibitive drug|0|||
16353767|NCT01123655|39780549|FG001|Overall Study|began prohibitive drug|0|||
16353768|NCT01123655|39780550|FG002|Overall Study|began prohibitive drug|1|||
16353769|NCT01325350|39780559|FG000|Overall Study|Adverse Event|3|||
16353770|NCT01325350|39780560|FG001|Overall Study|Adverse Event|3|||
16353771|NCT01325350|39780561|FG002|Overall Study|Adverse Event|3|||
16353772|NCT01325350|39780562|FG003|Overall Study|Adverse Event|1|||
16353773|NCT01325350|39780563|FG004|Overall Study|Adverse Event|2|||
16353774|NCT01325350|39780559|FG000|Overall Study|Pregnancy|0|||
16353775|NCT01325350|39780560|FG001|Overall Study|Pregnancy|0|||
16353776|NCT01325350|39780561|FG002|Overall Study|Pregnancy|1|||
16353777|NCT01325350|39780562|FG003|Overall Study|Pregnancy|0|||
16353778|NCT01325350|39780563|FG004|Overall Study|Pregnancy|1|||
16353779|NCT01325350|39780559|FG000|Overall Study|Lost to Follow-up|1|||
16353780|NCT01325350|39780560|FG001|Overall Study|Lost to Follow-up|0|||
16353781|NCT01325350|39780561|FG002|Overall Study|Lost to Follow-up|5|||
16353782|NCT01325350|39780562|FG003|Overall Study|Lost to Follow-up|1|||
16353783|NCT01325350|39780563|FG004|Overall Study|Lost to Follow-up|5|||
16353784|NCT01325350|39780559|FG000|Overall Study|Personal Reasons|2|||
16353785|NCT01325350|39780560|FG001|Overall Study|Personal Reasons|1|||
16353786|NCT01325350|39780561|FG002|Overall Study|Personal Reasons|6|||
16353787|NCT01325350|39780562|FG003|Overall Study|Personal Reasons|5|||
16353788|NCT01325350|39780563|FG004|Overall Study|Personal Reasons|3|||
16353789|NCT01325350|39780559|FG000|Overall Study|Protocol Violation|0|||
16353790|NCT01325350|39780560|FG001|Overall Study|Protocol Violation|0|||
16353791|NCT01325350|39780561|FG002|Overall Study|Protocol Violation|0|||
16353792|NCT01325350|39780562|FG003|Overall Study|Protocol Violation|1|||
16353793|NCT01325350|39780563|FG004|Overall Study|Protocol Violation|0|||
16353794|NCT01325350|39780559|FG000|Overall Study|Withdrawal by Subject|0|||
16353795|NCT01325350|39780560|FG001|Overall Study|Withdrawal by Subject|0|||
16353796|NCT01325350|39780561|FG002|Overall Study|Withdrawal by Subject|1|||
16353797|NCT01325350|39780562|FG003|Overall Study|Withdrawal by Subject|1|||
16353798|NCT01325350|39780563|FG004|Overall Study|Withdrawal by Subject|0|||
16353799|NCT01325350|39780559|FG000|Overall Study|Did Not Receive Treatment|0|||
16353800|NCT01325350|39780560|FG001|Overall Study|Did Not Receive Treatment|1|||
16561036|NCT00946647|40521782|FG002|Phase 1 Part|Disease progression|1|||
16353801|NCT01325350|39780561|FG002|Overall Study|Did Not Receive Treatment|1|||
16353802|NCT01325350|39780562|FG003|Overall Study|Did Not Receive Treatment|0|||
16561037|NCT00946647|40521783|FG003|Phase 1 Part|Disease progression|0|||
16353803|NCT01325350|39780563|FG004|Overall Study|Did Not Receive Treatment|1|||
16353804|NCT01296412|39780564|FG000|Overall Study|Adverse Event|8|||
16353805|NCT01296412|39780565|FG001|Overall Study|Adverse Event|29|||
16353806|NCT01296412|39780564|FG000|Overall Study|Lack of Efficacy|1|||
16353807|NCT01296412|39780565|FG001|Overall Study|Lack of Efficacy|0|||
16353808|NCT01296412|39780564|FG000|Overall Study|Lost to Follow-up|10|||
16353809|NCT01296412|39780565|FG001|Overall Study|Lost to Follow-up|7|||
16353810|NCT01296412|39780564|FG000|Overall Study|Non-compliance with study drug|1|||
16353811|NCT01296412|39780565|FG001|Overall Study|Non-compliance with study drug|2|||
16353812|NCT01296412|39780564|FG000|Overall Study|Other reason not specified|20|||
16353813|NCT01296412|39780565|FG001|Overall Study|Other reason not specified|15|||
16353814|NCT01296412|39780564|FG000|Overall Study|Physician Decision|1|||
16353815|NCT01296412|39780565|FG001|Overall Study|Physician Decision|3|||
16353816|NCT01296412|39780564|FG000|Overall Study|Pregnancy|0|||
16353817|NCT01296412|39780565|FG001|Overall Study|Pregnancy|1|||
16353818|NCT01296412|39780564|FG000|Overall Study|Withdrawal by Subject|10|||
16353819|NCT01296412|39780565|FG001|Overall Study|Withdrawal by Subject|13|||
16353820|NCT01545388|39780566|FG000|Overall Study|Adverse Event|2|||
16353821|NCT01545388|39780567|FG001|Overall Study|Adverse Event|4|||
16353822|NCT01545388|39780568|FG002|Overall Study|Adverse Event|1|||
16353823|NCT01545388|39780566|FG000|Overall Study|Lack of Efficacy|3|||
16353824|NCT01545388|39780567|FG001|Overall Study|Lack of Efficacy|2|||
16353825|NCT01545388|39780568|FG002|Overall Study|Lack of Efficacy|5|||
16353826|NCT01545388|39780566|FG000|Overall Study|Participant moved or relocated|1|||
16353827|NCT01545388|39780567|FG001|Overall Study|Participant moved or relocated|0|||
16353828|NCT01545388|39780568|FG002|Overall Study|Participant moved or relocated|0|||
16353829|NCT01545388|39780566|FG000|Overall Study|Withdrawal by Subject|1|||
16353830|NCT01545388|39780567|FG001|Overall Study|Withdrawal by Subject|4|||
16353831|NCT01545388|39780568|FG002|Overall Study|Withdrawal by Subject|2|||
16353832|NCT01545388|39780566|FG000|Overall Study|Other|1|||
16353833|NCT01545388|39780567|FG001|Overall Study|Other|1|||
16353834|NCT01545388|39780568|FG002|Overall Study|Other|0|||
16353835|NCT00102596|39780569|FG000|Part A|Screen failures|6|||
16353836|NCT00102596|39780570|FG001|Part A|Screen failures|0|||
16353837|NCT00102596|39780569|FG000|Part A|Adverse Event|1|||
16353838|NCT00102596|39780570|FG001|Part A|Adverse Event|0|||
16353839|NCT04644029|39780571|FG000|Overall Study|Death|1|||
16353840|NCT04644029|39780572|FG001|Overall Study|Death|0|||
16353841|NCT04644029|39780571|FG000|Overall Study|Physician Decision|1|||
16353842|NCT04644029|39780572|FG001|Overall Study|Physician Decision|2|||
16353843|NCT04644029|39780571|FG000|Overall Study|Withdrawal by Subject|21|||
16353844|NCT04644029|39780572|FG001|Overall Study|Withdrawal by Subject|19|||
16353845|NCT04644029|39780571|FG000|Overall Study|Lost to Follow-up|31|||
16353846|NCT04644029|39780572|FG001|Overall Study|Lost to Follow-up|34|||
16353847|NCT04644029|39780571|FG000|Overall Study|Study Terminated by Sponsor|305|||
16353848|NCT04644029|39780572|FG001|Overall Study|Study Terminated by Sponsor|301|||
16353849|NCT04644029|39780571|FG000|Overall Study|Status Not Recorded|3|||
16561038|NCT00946647|40521784|FG004|Phase 1 Part|Disease progression|0|||
16561039|NCT00946647|40521780|FG000|Phase 1 Part|Withdrawal by Subject|1|||
16561040|NCT00946647|40521781|FG001|Phase 1 Part|Withdrawal by Subject|4|||
16561041|NCT00946647|40521782|FG002|Phase 1 Part|Withdrawal by Subject|3|||
16246733|NCT02308111|39385608|FG000|Overall Study|Lost to Follow-up|2|||
16353850|NCT04644029|39780572|FG001|Overall Study|Status Not Recorded|8|||
16353851|NCT04644029|39780571|FG000|Overall Study|Randomized in Error|2|||
16353852|NCT04644029|39780572|FG001|Overall Study|Randomized in Error|1|||
16353853|NCT04644029|39780571|FG000|Overall Study|Other|0|||
16353854|NCT04644029|39780572|FG001|Overall Study|Other|1|||
16353855|NCT00994110|39780575|FG000|Overall Study|Withdrawal by Subject|9|||
16353856|NCT00994110|39780576|FG001|Overall Study|Withdrawal by Subject|9|||
16353857|NCT00994110|39780575|FG000|Overall Study|Not Treated|4|||
16353858|NCT00994110|39780576|FG001|Overall Study|Not Treated|8|||
16353859|NCT00994110|39780575|FG000|Overall Study|Adverse Event|1|||
16353860|NCT00994110|39780576|FG001|Overall Study|Adverse Event|0|||
16353861|NCT00994110|39780575|FG000|Overall Study|Patient not resected|41|||
16561042|NCT00946647|40521783|FG003|Phase 1 Part|Withdrawal by Subject|0|||
16561043|NCT00946647|40521784|FG004|Phase 1 Part|Withdrawal by Subject|0|||
16561044|NCT00946647|40521780|FG000|Phase 1 Part|Abnormal values|0|||
16561045|NCT00946647|40521781|FG001|Phase 1 Part|Abnormal values|2|||
16561046|NCT00946647|40521782|FG002|Phase 1 Part|Abnormal values|0|||
16561047|NCT00946647|40521783|FG003|Phase 1 Part|Abnormal values|0|||
16561048|NCT00946647|40521784|FG004|Phase 1 Part|Abnormal values|0|||
16561049|NCT00946647|40521780|FG000|Phase 1 Part|Reason missing|0|||
16561050|NCT00946647|40521781|FG001|Phase 1 Part|Reason missing|1|||
16561051|NCT00946647|40521782|FG002|Phase 1 Part|Reason missing|0|||
16561052|NCT00946647|40521783|FG003|Phase 1 Part|Reason missing|0|||
16130514|NCT00196976|38967054|FG005|Primary Study|Protocol Violation|0|||
16353862|NCT00994110|39780576|FG001|Overall Study|Patient not resected|52|||
16353863|NCT00994110|39780575|FG000|Overall Study|Pt not eligible|10|||
16353864|NCT00994110|39780576|FG001|Overall Study|Pt not eligible|5|||
16353865|NCT03704064|39780577|FG000|Overall Study|Lost to Follow-up|8|||
16353866|NCT03704064|39780578|FG001|Overall Study|Lost to Follow-up|4|||
16353867|NCT03704064|39780577|FG000|Overall Study|Withdrawal by Subject|1|||
16353868|NCT03704064|39780578|FG001|Overall Study|Withdrawal by Subject|1|||
16353869|NCT03704064|39780577|FG000|Overall Study|No longer available for study visits|0|||
16353870|NCT03704064|39780578|FG001|Overall Study|No longer available for study visits|1|||
16353871|NCT03704064|39780577|FG000|Overall Study|Censoring event|1|||
16353872|NCT03704064|39780578|FG001|Overall Study|Censoring event|0|||
16353873|NCT00875563|39780579|FG000|Overall Study|Death|4|||
16353874|NCT00875563|39780579|FG000|Overall Study|Withdrawal by Subject|7|||
16353875|NCT00875563|39780579|FG000|Overall Study|No long-term (3-5 year) consent|6|||
16353876|NCT00875563|39780579|FG000|Overall Study|Still be eligible for follow-up|7|||
16353877|NCT01619865|39780580|FG000|Overall Study|Adverse Event|1|||
16353878|NCT01619865|39780580|FG000|Overall Study|Death|2|||
16353879|NCT01619865|39780580|FG000|Overall Study|subject not able to comply|1|||
16353880|NCT02812186|39780581|FG000|Period 1|Post randomization screen failure|5|||
16353881|NCT02812186|39780582|FG001|Period 1|Post randomization screen failure|9|||
16353882|NCT02812186|39780581|FG000|Period 1|nonevaluable data sets|6|||
16353883|NCT02812186|39780582|FG001|Period 1|nonevaluable data sets|6|||
16353884|NCT02567188|39780585|FG000|Overall Study|Death|10|||
16353885|NCT02567188|39780585|FG000|Overall Study|Terminated Mircera Treatment|9|||
16353886|NCT02567188|39780585|FG000|Overall Study|Lost to Follow-up|5|||
16353887|NCT02567188|39780585|FG000|Overall Study|Adverse Event|1|||
16353888|NCT02567188|39780585|FG000|Overall Study|Withdrawal by Subject|1|||
16353889|NCT02567188|39780585|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
16353890|NCT02567188|39780585|FG000|Overall Study|Moved and Changed Clinic|1|||
16353891|NCT02567188|39780585|FG000|Overall Study|Started Hemodialysis|2|||
16353892|NCT02567188|39780585|FG000|Overall Study|Protocol Violation|5|||
16353893|NCT02087774|39780586|FG000|Overall Study|Were absent day of data collection|8|||
16353894|NCT02087774|39780587|FG001|Overall Study|Were absent day of data collection|20|||
16353895|NCT01573000|39784183|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
16353896|NCT01573000|39784184|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
16353897|NCT01573000|39784183|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
16353898|NCT01573000|39784184|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
16353899|NCT01573000|39784183|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
16353900|NCT01573000|39784184|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
16353901|NCT01573000|39784183|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
16353902|NCT01573000|39784184|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
16353903|NCT01573000|39784183|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
16353904|NCT01573000|39784184|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
16353905|NCT01573000|39784183|FG000|Crossover Phase|Lack of Efficacy|0|||
16353906|NCT01573000|39784184|FG001|Crossover Phase|Lack of Efficacy|13|||
16353907|NCT01573000|39784183|FG000|Crossover Phase|Lost to Follow-up|0|||
16353908|NCT01573000|39784184|FG001|Crossover Phase|Lost to Follow-up|2|||
16353909|NCT01573000|39784183|FG000|Crossover Phase|Death|0|||
16353910|NCT01573000|39784184|FG001|Crossover Phase|Death|3|||
16353911|NCT01573000|39784183|FG000|Long-Term Follow-Up|Death|3|||
16353912|NCT01573000|39784184|FG001|Long-Term Follow-Up|Death|0|||
16353913|NCT01573000|39784183|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
16353914|NCT01573000|39784184|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
16353915|NCT01204671|39784190|FG000|Overall Study|Adverse Event|4|||
16561053|NCT00946647|40521784|FG004|Phase 1 Part|Reason missing|0|||
16561054|NCT00946647|40521780|FG000|Phase ll Part|Untreated|0|||
16561055|NCT00946647|40521781|FG001|Phase ll Part|Untreated|0|||
16353916|NCT01204671|39784191|FG001|Overall Study|Adverse Event|3|||
16353917|NCT01204671|39784192|FG002|Overall Study|Adverse Event|3|||
16353918|NCT01204671|39784193|FG003|Overall Study|Adverse Event|3|||
16353919|NCT01204671|39784194|FG004|Overall Study|Adverse Event|1|||
16353920|NCT01204671|39784190|FG000|Overall Study|Withdrawal by Subject|2|||
16353921|NCT01204671|39784191|FG001|Overall Study|Withdrawal by Subject|3|||
16353922|NCT01204671|39784192|FG002|Overall Study|Withdrawal by Subject|4|||
16353923|NCT01204671|39784193|FG003|Overall Study|Withdrawal by Subject|5|||
16353924|NCT01204671|39784194|FG004|Overall Study|Withdrawal by Subject|3|||
16353925|NCT01204671|39784190|FG000|Overall Study|Lost to Follow-up|7|||
16353926|NCT01204671|39784191|FG001|Overall Study|Lost to Follow-up|8|||
16353927|NCT01204671|39784192|FG002|Overall Study|Lost to Follow-up|6|||
16353928|NCT01204671|39784193|FG003|Overall Study|Lost to Follow-up|4|||
16353929|NCT01204671|39784194|FG004|Overall Study|Lost to Follow-up|0|||
16353930|NCT01204671|39784190|FG000|Overall Study|Unknown Completion Status|1|||
16353931|NCT01204671|39784191|FG001|Overall Study|Unknown Completion Status|1|||
16353932|NCT01204671|39784192|FG002|Overall Study|Unknown Completion Status|0|||
16353933|NCT01204671|39784193|FG003|Overall Study|Unknown Completion Status|0|||
16353934|NCT01204671|39784194|FG004|Overall Study|Unknown Completion Status|0|||
16353935|NCT01204671|39784190|FG000|Overall Study|Physician Decision|0|||
16353936|NCT01204671|39784191|FG001|Overall Study|Physician Decision|0|||
16353937|NCT01204671|39784192|FG002|Overall Study|Physician Decision|0|||
16353938|NCT01204671|39784193|FG003|Overall Study|Physician Decision|1|||
16353939|NCT01204671|39784194|FG004|Overall Study|Physician Decision|0|||
16130515|NCT00196976|38967055|FG006|Primary Study|Protocol Violation|0|||
16130516|NCT00196976|38967056|FG007|Primary Study|Protocol Violation|0|||
16130517|NCT00196976|38967057|FG008|Primary Study|Protocol Violation|0|||
16130518|NCT00196976|38967058|FG009|Primary Study|Protocol Violation|0|||
16130519|NCT00196976|38967059|FG010|Primary Study|Protocol Violation|0|||
16130520|NCT00196976|38967060|FG011|Primary Study|Protocol Violation|0|||
16130521|NCT00196976|38967061|FG012|Primary Study|Protocol Violation|0|||
16130522|NCT00196976|38967062|FG013|Primary Study|Protocol Violation|0|||
16130523|NCT00196976|38967049|FG000|Primary Study|Withdrawal by Subject|1|||
16130524|NCT00196976|38967050|FG001|Primary Study|Withdrawal by Subject|0|||
16130525|NCT00196976|38967051|FG002|Primary Study|Withdrawal by Subject|1|||
16130526|NCT00196976|38967052|FG003|Primary Study|Withdrawal by Subject|1|||
16130527|NCT00196976|38967053|FG004|Primary Study|Withdrawal by Subject|2|||
16130528|NCT00196976|38967054|FG005|Primary Study|Withdrawal by Subject|1|||
16130529|NCT00196976|38967055|FG006|Primary Study|Withdrawal by Subject|0|||
16130530|NCT00196976|38967056|FG007|Primary Study|Withdrawal by Subject|0|||
16130531|NCT00196976|38967057|FG008|Primary Study|Withdrawal by Subject|0|||
16130532|NCT00196976|38967058|FG009|Primary Study|Withdrawal by Subject|1|||
16130533|NCT00196976|38967059|FG010|Primary Study|Withdrawal by Subject|0|||
16130534|NCT00196976|38967060|FG011|Primary Study|Withdrawal by Subject|0|||
16130535|NCT00196976|38967061|FG012|Primary Study|Withdrawal by Subject|0|||
16130536|NCT00196976|38967062|FG013|Primary Study|Withdrawal by Subject|0|||
16130537|NCT00196976|38967049|FG000|Primary Study|Lost to Follow-up|0|||
16130538|NCT00196976|38967050|FG001|Primary Study|Lost to Follow-up|0|||
16130539|NCT00196976|38967051|FG002|Primary Study|Lost to Follow-up|0|||
16130540|NCT00196976|38967052|FG003|Primary Study|Lost to Follow-up|0|||
16130541|NCT00196976|38967053|FG004|Primary Study|Lost to Follow-up|1|||
16130542|NCT00196976|38967054|FG005|Primary Study|Lost to Follow-up|1|||
16130543|NCT00196976|38967055|FG006|Primary Study|Lost to Follow-up|0|||
16130544|NCT00196976|38967056|FG007|Primary Study|Lost to Follow-up|2|||
16130545|NCT00196976|38967057|FG008|Primary Study|Lost to Follow-up|0|||
16130546|NCT00196976|38967058|FG009|Primary Study|Lost to Follow-up|0|||
16130547|NCT00196976|38967059|FG010|Primary Study|Lost to Follow-up|0|||
16130548|NCT00196976|38967060|FG011|Primary Study|Lost to Follow-up|0|||
16130549|NCT00196976|38967061|FG012|Primary Study|Lost to Follow-up|0|||
16130550|NCT00196976|38967062|FG013|Primary Study|Lost to Follow-up|0|||
16353940|NCT00372424|39784195|FG000|Overall Study|Adverse Event|2|||
16353941|NCT00372424|39784195|FG000|Overall Study|Withdrawal by Subject|1|||
16353942|NCT00372424|39784195|FG000|Overall Study|Death|1|||
16353943|NCT00372424|39784195|FG000|Overall Study|Objective Progression or Relapse|14|||
16353944|NCT00372424|39784195|FG000|Overall Study|Other|7|||
16353945|NCT00372424|39784195|FG000|Overall Study|Enrolled, Not Treated|1|||
16561056|NCT00946647|40521782|FG002|Phase ll Part|Untreated|0|||
16130551|NCT00196976|38967049|FG000|Primary Study|Other|0|||
16130552|NCT00196976|38967050|FG001|Primary Study|Other|0|||
16130553|NCT00196976|38967051|FG002|Primary Study|Other|2|||
16130554|NCT00196976|38967052|FG003|Primary Study|Other|0|||
16130555|NCT00196976|38967053|FG004|Primary Study|Other|0|||
16130556|NCT00196976|38967054|FG005|Primary Study|Other|0|||
16353946|NCT03055013|39784196|FG000|Overall Study|Adverse Event|78|||
16353947|NCT03055013|39784197|FG001|Overall Study|Adverse Event|0|||
16353948|NCT03055013|39784196|FG000|Overall Study|Death|6|||
16353949|NCT03055013|39784197|FG001|Overall Study|Death|0|||
16353950|NCT03055013|39784196|FG000|Overall Study|Disease relapse|33|||
16353951|NCT03055013|39784197|FG001|Overall Study|Disease relapse|0|||
16353952|NCT03055013|39784196|FG000|Overall Study|Withdrawal by Subject|28|||
16353953|NCT03055013|39784197|FG001|Overall Study|Withdrawal by Subject|0|||
16353954|NCT03055013|39784196|FG000|Overall Study|Other complicating disease|5|||
16353955|NCT03055013|39784197|FG001|Overall Study|Other complicating disease|0|||
16353956|NCT03055013|39784196|FG000|Overall Study|Physician Decision|1|||
16353957|NCT03055013|39784197|FG001|Overall Study|Physician Decision|0|||
16353958|NCT03055013|39784196|FG000|Overall Study|Benign mass/non-RCC|4|||
16353959|NCT03055013|39784197|FG001|Overall Study|Benign mass/non-RCC|0|||
16353960|NCT03055013|39784196|FG000|Overall Study|Enrolled in another trial|1|||
16353961|NCT03055013|39784197|FG001|Overall Study|Enrolled in another trial|0|||
16353962|NCT03055013|39784196|FG000|Overall Study|Non-protocol therapy|1|||
16353963|NCT03055013|39784197|FG001|Overall Study|Non-protocol therapy|0|||
16353964|NCT03055013|39784196|FG000|Overall Study|Incompliance|1|||
16353965|NCT03055013|39784197|FG001|Overall Study|Incompliance|0|||
16353966|NCT03055013|39784196|FG000|Overall Study|Insurance issues|1|||
16353967|NCT03055013|39784197|FG001|Overall Study|Insurance issues|0|||
16353968|NCT03055013|39784196|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
16353969|NCT03055013|39784197|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
16353970|NCT03055013|39784196|FG000|Overall Study|Did not receive nivolumab|10|||
16353971|NCT03055013|39784197|FG001|Overall Study|Did not receive nivolumab|0|||
16353972|NCT03055013|39784196|FG000|Overall Study|Did not receive surgery|0|||
16353973|NCT03055013|39784197|FG001|Overall Study|Did not receive surgery|28|||
16353974|NCT00619827|39784198|FG000|Overall Study|Adverse Event|1|||
16353975|NCT00619827|39784199|FG001|Overall Study|Adverse Event|2|||
16353976|NCT00619827|39784198|FG000|Overall Study|Withdrawal by Subject|2|||
16353977|NCT00619827|39784199|FG001|Overall Study|Withdrawal by Subject|2|||
16353978|NCT01265498|39784200|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
16353979|NCT01265498|39784201|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
16353980|NCT04006145|39784204|FG000|Overall Study|Lost to Follow-up|0|||
16353981|NCT04006145|39784205|FG001|Overall Study|Lost to Follow-up|1|||
16353982|NCT04006145|39784204|FG000|Overall Study|Other|1|||
16353983|NCT04006145|39784205|FG001|Overall Study|Other|2|||
16353984|NCT02104895|39784206|FG000|Overall Study|Withdrawal by Subject|0|||
16353985|NCT02104895|39784207|FG001|Overall Study|Withdrawal by Subject|14|||
16353986|NCT01774981|39784208|FG000|Overall Study|Adverse Event|0|||
16353987|NCT01774981|39784209|FG001|Overall Study|Adverse Event|0|||
16353988|NCT01774981|39784210|FG002|Overall Study|Adverse Event|0|||
16353989|NCT01774981|39784211|FG003|Overall Study|Adverse Event|0|||
16353990|NCT01774981|39784212|FG004|Overall Study|Adverse Event|0|||
16353991|NCT01774981|39784213|FG005|Overall Study|Adverse Event|1|||
16353992|NCT01774981|39784214|FG006|Overall Study|Adverse Event|0|||
16353993|NCT01774981|39784215|FG007|Overall Study|Adverse Event|0|||
16353994|NCT01774981|39784208|FG000|Overall Study|Withdrawal by Subject|0|||
16353995|NCT01774981|39784209|FG001|Overall Study|Withdrawal by Subject|0|||
16353996|NCT01774981|39784210|FG002|Overall Study|Withdrawal by Subject|0|||
16353997|NCT01774981|39784211|FG003|Overall Study|Withdrawal by Subject|0|||
16353998|NCT01774981|39784212|FG004|Overall Study|Withdrawal by Subject|0|||
16353999|NCT01774981|39784213|FG005|Overall Study|Withdrawal by Subject|0|||
16354000|NCT01774981|39784214|FG006|Overall Study|Withdrawal by Subject|0|||
16354001|NCT01774981|39784215|FG007|Overall Study|Withdrawal by Subject|1|||
16354002|NCT01774981|39784208|FG000|Overall Study|Death|0|||
16354003|NCT01774981|39784209|FG001|Overall Study|Death|0|||
16354004|NCT01774981|39784210|FG002|Overall Study|Death|0|||
16246734|NCT02308111|39385609|FG001|Overall Study|Lost to Follow-up|7|||
16354005|NCT01774981|39784211|FG003|Overall Study|Death|0|||
16354006|NCT01774981|39784212|FG004|Overall Study|Death|1|||
16354007|NCT01774981|39784213|FG005|Overall Study|Death|0|||
16354008|NCT01774981|39784214|FG006|Overall Study|Death|0|||
16354009|NCT01774981|39784215|FG007|Overall Study|Death|0|||
16354010|NCT00838097|39784216|FG000|Overall Study|Ineligibility determined|6|||
16354011|NCT00838097|39784216|FG000|Overall Study|Adverse Event|2|||
16354012|NCT00838097|39784216|FG000|Overall Study|Withdrawal by Subject|3|||
16354013|NCT00838097|39784216|FG000|Overall Study|Requirement for alternative therapy|2|||
16354014|NCT00838097|39784216|FG000|Overall Study|Physician Decision|4|||
16354015|NCT00838097|39784216|FG000|Overall Study|Lost to Follow-up|11|||
16354016|NCT00838097|39784216|FG000|Overall Study|Death|6|||
16354017|NCT00838097|39784216|FG000|Overall Study|Protocol-specified criteria|142|||
16354018|NCT01053741|39784217|FG000|2nd Study Intervention|Physician Decision|0|||
16354019|NCT01053741|39784218|FG001|2nd Study Intervention|Physician Decision|1|||
16561057|NCT00946647|40521783|FG003|Phase ll Part|Untreated|0|||
16561058|NCT00946647|40521784|FG004|Phase ll Part|Untreated|2|||
16561059|NCT00946647|40521780|FG000|Phase ll Part|Adverse Event|0|||
16561060|NCT00946647|40521781|FG001|Phase ll Part|Adverse Event|0|||
16561061|NCT00946647|40521782|FG002|Phase ll Part|Adverse Event|0|||
16561062|NCT00946647|40521783|FG003|Phase ll Part|Adverse Event|10|||
16561063|NCT00946647|40521784|FG004|Phase ll Part|Adverse Event|6|||
16561064|NCT00946647|40521780|FG000|Phase ll Part|Withdrawal by Subject|0|||
16561065|NCT00946647|40521781|FG001|Phase ll Part|Withdrawal by Subject|0|||
16561066|NCT00946647|40521782|FG002|Phase ll Part|Withdrawal by Subject|0|||
16561067|NCT00946647|40521783|FG003|Phase ll Part|Withdrawal by Subject|8|||
16561068|NCT00946647|40521784|FG004|Phase ll Part|Withdrawal by Subject|6|||
16561069|NCT00946647|40521780|FG000|Phase ll Part|Administrative problems|0|||
16561070|NCT00946647|40521781|FG001|Phase ll Part|Administrative problems|0|||
16561071|NCT00946647|40521782|FG002|Phase ll Part|Administrative problems|0|||
16561072|NCT00946647|40521783|FG003|Phase ll Part|Administrative problems|3|||
16561073|NCT00946647|40521784|FG004|Phase ll Part|Administrative problems|8|||
16561074|NCT00946647|40521780|FG000|Phase ll Part|Death|0|||
16561075|NCT00946647|40521781|FG001|Phase ll Part|Death|0|||
16561076|NCT00946647|40521782|FG002|Phase ll Part|Death|0|||
16561077|NCT00946647|40521783|FG003|Phase ll Part|Death|7|||
16561078|NCT00946647|40521784|FG004|Phase ll Part|Death|4|||
16561079|NCT00946647|40521780|FG000|Phase ll Part|Disease progression|0|||
16561080|NCT00946647|40521781|FG001|Phase ll Part|Disease progression|0|||
16561081|NCT00946647|40521782|FG002|Phase ll Part|Disease progression|0|||
16561082|NCT00946647|40521783|FG003|Phase ll Part|Disease progression|6|||
16561083|NCT00946647|40521784|FG004|Phase ll Part|Disease progression|14|||
16561084|NCT00946647|40521780|FG000|Phase ll Part|Protocol Violation|0|||
16561085|NCT00946647|40521781|FG001|Phase ll Part|Protocol Violation|0|||
16561086|NCT00946647|40521782|FG002|Phase ll Part|Protocol Violation|0|||
16561087|NCT00946647|40521783|FG003|Phase ll Part|Protocol Violation|4|||
16561088|NCT00946647|40521784|FG004|Phase ll Part|Protocol Violation|2|||
16561089|NCT00946647|40521780|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
16561090|NCT00946647|40521781|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
16561091|NCT00946647|40521782|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
16561092|NCT00946647|40521783|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
16561093|NCT00946647|40521784|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
16561094|NCT02718417|40521785|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
16561095|NCT02718417|40521786|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
16561096|NCT02718417|40521787|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
16561097|NCT02718417|40521785|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
16561098|NCT02718417|40521786|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
16561099|NCT02718417|40521787|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
16561100|NCT02718417|40521785|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
16561101|NCT02718417|40521786|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
16561102|NCT02718417|40521787|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
16561103|NCT02718417|40521785|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
16561104|NCT02718417|40521786|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
16561105|NCT02718417|40521787|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
16561106|NCT02718417|40521785|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
16561107|NCT02718417|40521786|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
16561108|NCT02718417|40521787|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
16561109|NCT02718417|40521785|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
16561110|NCT02718417|40521786|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
16561111|NCT02718417|40521787|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
16561112|NCT02718417|40521785|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
16561113|NCT02718417|40521786|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
16561114|NCT02718417|40521787|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
16561115|NCT02718417|40521785|FG000|Chemotherapy Phase (CP)|Other|2|||
16561116|NCT02718417|40521786|FG001|Chemotherapy Phase (CP)|Other|0|||
16561117|NCT02718417|40521787|FG002|Chemotherapy Phase (CP)|Other|1|||
16561118|NCT02718417|40521785|FG000|Maintenance Phase (MP)|Adverse Event|21|||
16561119|NCT02718417|40521786|FG001|Maintenance Phase (MP)|Adverse Event|26|||
16561120|NCT02718417|40521787|FG002|Maintenance Phase (MP)|Adverse Event|0|||
16561121|NCT02718417|40521785|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
16561122|NCT02718417|40521786|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
16561123|NCT02718417|40521787|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
16561124|NCT02718417|40521785|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
16561125|NCT02718417|40521786|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
16561126|NCT02718417|40521787|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
16561127|NCT02718417|40521785|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
16561128|NCT02718417|40521786|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
16417619|NCT00576472|40008547|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
16561129|NCT02718417|40521787|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
16561130|NCT02718417|40521785|FG000|Maintenance Phase (MP)|Physician's decision|6|||
16561131|NCT02718417|40521786|FG001|Maintenance Phase (MP)|Physician's decision|7|||
16561132|NCT02718417|40521787|FG002|Maintenance Phase (MP)|Physician's decision|0|||
16561133|NCT02718417|40521785|FG000|Maintenance Phase (MP)|Progressive disease|100|||
16561134|NCT02718417|40521786|FG001|Maintenance Phase (MP)|Progressive disease|88|||
16561135|NCT02718417|40521787|FG002|Maintenance Phase (MP)|Progressive disease|0|||
16561136|NCT02718417|40521785|FG000|Maintenance Phase (MP)|Other|2|||
16561137|NCT02718417|40521786|FG001|Maintenance Phase (MP)|Other|1|||
16561138|NCT02718417|40521787|FG002|Maintenance Phase (MP)|Other|0|||
16561139|NCT02718417|40521785|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
16561140|NCT02718417|40521786|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
16561141|NCT02718417|40521787|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
16561142|NCT02718417|40521785|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
16561143|NCT02718417|40521786|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
16561144|NCT02718417|40521787|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
16561145|NCT02718417|40521785|FG000|Observation Phase (OP)|Adverse Event|0|||
16561146|NCT02718417|40521786|FG001|Observation Phase (OP)|Adverse Event|0|||
16561147|NCT02718417|40521787|FG002|Observation Phase (OP)|Adverse Event|1|||
16561148|NCT02718417|40521785|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
16561149|NCT02718417|40521786|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
16561150|NCT02718417|40521787|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
16561151|NCT02718417|40521785|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
16561152|NCT02718417|40521786|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
16561153|NCT02718417|40521787|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
16246735|NCT02308111|39385608|FG000|Overall Study|Physician Decision|6|||
16246736|NCT02308111|39385609|FG001|Overall Study|Physician Decision|17|||
16246737|NCT02308111|39385608|FG000|Overall Study|Protocol Violation|0|||
16417620|NCT00576472|40008548|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
16417621|NCT02104947|40008549|FG000|Overall Study|Withdrawal by Subject|10|||
16417622|NCT02104947|40008550|FG001|Overall Study|Withdrawal by Subject|3|||
16417623|NCT02104947|40008549|FG000|Overall Study|Lost to Follow-up|4|||
16417624|NCT02104947|40008550|FG001|Overall Study|Lost to Follow-up|4|||
16417625|NCT02104947|40008549|FG000|Overall Study|Protocol Violation|6|||
16417626|NCT02104947|40008550|FG001|Overall Study|Protocol Violation|8|||
16417627|NCT02104947|40008549|FG000|Overall Study|Adverse Event|57|||
16417628|NCT02104947|40008550|FG001|Overall Study|Adverse Event|38|||
16417629|NCT02104947|40008549|FG000|Overall Study|Other than stated above|2|||
16417630|NCT02104947|40008550|FG001|Overall Study|Other than stated above|3|||
16417631|NCT00847015|40008553|FG000|Overall Study|Withdrawal by Subject|1|||
16417632|NCT00847015|40008553|FG000|Overall Study|declined any surgery|1|||
16417633|NCT00847015|40008553|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
16417634|NCT00844558|40008554|FG000|Overall Study|Withdrawal by Subject|9|||
16417635|NCT00844558|40008555|FG001|Overall Study|Withdrawal by Subject|2|||
16417636|NCT00844558|40008554|FG000|Overall Study|Death|1|||
16417637|NCT00844558|40008555|FG001|Overall Study|Death|0|||
16417638|NCT00844558|40008554|FG000|Overall Study|Protocol Violation|1|||
16417639|NCT00844558|40008555|FG001|Overall Study|Protocol Violation|1|||
16417640|NCT00844558|40008554|FG000|Overall Study|Lost to Follow-up|0|||
16417641|NCT00844558|40008555|FG001|Overall Study|Lost to Follow-up|1|||
16417642|NCT00844558|40008554|FG000|Overall Study|Physician Decision|1|||
16561154|NCT02718417|40521785|FG000|Observation Phase (OP)|Physician Decision|0|||
16561155|NCT02718417|40521786|FG001|Observation Phase (OP)|Physician Decision|0|||
16246738|NCT02308111|39385609|FG001|Overall Study|Protocol Violation|1|||
16417643|NCT00844558|40008555|FG001|Overall Study|Physician Decision|0|||
16417644|NCT03596450|40008567|FG000|Overall Study|Death|9|||
16246739|NCT02308111|39385608|FG000|Overall Study|Withdrawal by Subject|28|||
16246740|NCT02308111|39385609|FG001|Overall Study|Withdrawal by Subject|38|||
16246741|NCT02308111|39385608|FG000|Overall Study|Study Terminated by Sponsor|72|||
16246742|NCT02308111|39385609|FG001|Overall Study|Study Terminated by Sponsor|61|||
16246743|NCT02308111|39385608|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
16246744|NCT02308111|39385609|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
16246745|NCT02308111|39385608|FG000|Overall Study|Site Closure|3|||
16246746|NCT02308111|39385609|FG001|Overall Study|Site Closure|3|||
16246747|NCT02308111|39385608|FG000|Overall Study|Non-compliance with Study Drug|3|||
16246748|NCT02308111|39385609|FG001|Overall Study|Non-compliance with Study Drug|1|||
16246749|NCT02308111|39385608|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
16246750|NCT02308111|39385609|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
16246751|NCT02308111|39385608|FG000|Overall Study|Liver Transplant|3|||
16246752|NCT02308111|39385609|FG001|Overall Study|Liver Transplant|3|||
16246753|NCT02308111|39385608|FG000|Overall Study|Liver Transplant Waitlist|2|||
16246754|NCT02308111|39385609|FG001|Overall Study|Liver Transplant Waitlist|2|||
16246755|NCT02308111|39385608|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
16246756|NCT02308111|39385609|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
16246757|NCT02041494|39385611|FG000|Overall Study|Death|1|||
16246758|NCT02041494|39385612|FG001|Overall Study|Death|3|||
16246759|NCT02041494|39385611|FG000|Overall Study|Lost to Follow-up|2|||
16246760|NCT02041494|39385612|FG001|Overall Study|Lost to Follow-up|6|||
16246761|NCT02041494|39385611|FG000|Overall Study|study terminated|16|||
16246762|NCT02041494|39385612|FG001|Overall Study|study terminated|11|||
16246763|NCT00697112|39385613|FG000|Overall Study|Adverse Event|8|||
16246764|NCT00697112|39385613|FG000|Overall Study|Lost to Follow-up|1|||
16246765|NCT00697112|39385613|FG000|Overall Study|Did not meet inclusion criteria|1|||
16246766|NCT02268045|39385617|FG000|Overall Study|Death|4|||
16246767|NCT02268045|39385618|FG001|Overall Study|Death|4|||
16246768|NCT02268045|39385617|FG000|Overall Study|Disease Progression|2|||
16246769|NCT02268045|39385618|FG001|Overall Study|Disease Progression|1|||
16246770|NCT02268045|39385617|FG000|Overall Study|Adverse Event|7|||
16246771|NCT02268045|39385618|FG001|Overall Study|Adverse Event|7|||
16246772|NCT02268045|39385617|FG000|Overall Study|Withdrawal by Subject|2|||
16246773|NCT02268045|39385618|FG001|Overall Study|Withdrawal by Subject|6|||
16246774|NCT02268045|39385617|FG000|Overall Study|Physician Decision|0|||
16246775|NCT02268045|39385618|FG001|Overall Study|Physician Decision|1|||
16246776|NCT02268045|39385617|FG000|Overall Study|Protocol Violation|1|||
16246777|NCT02268045|39385618|FG001|Overall Study|Protocol Violation|1|||
16561156|NCT02718417|40521787|FG002|Observation Phase (OP)|Physician Decision|9|||
16246778|NCT02497391|39387979|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
16246779|NCT02497391|39387980|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
16246780|NCT02497391|39387981|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
16246781|NCT02497391|39387982|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
16246782|NCT02497391|39387983|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
16246783|NCT02497391|39387984|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
16246784|NCT02497391|39387979|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
16246785|NCT02497391|39387980|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
16246786|NCT02497391|39387981|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
16246787|NCT02497391|39387982|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
16246788|NCT02497391|39387983|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
16246789|NCT02497391|39387984|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
16246790|NCT02497391|39387979|FG000|Period 3 (14 Days)|Adverse Event|0|||
16246791|NCT02497391|39387980|FG001|Period 3 (14 Days)|Adverse Event|1|||
16246792|NCT02497391|39387981|FG002|Period 3 (14 Days)|Adverse Event|0|||
16246793|NCT02497391|39387982|FG003|Period 3 (14 Days)|Adverse Event|0|||
16246794|NCT02497391|39387983|FG004|Period 3 (14 Days)|Adverse Event|0|||
16246795|NCT02497391|39387984|FG005|Period 3 (14 Days)|Adverse Event|0|||
16246796|NCT02497391|39387979|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
16246797|NCT02497391|39387980|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
16246798|NCT02497391|39387981|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
16246799|NCT02497391|39387982|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
16246800|NCT02497391|39387983|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
16246801|NCT02497391|39387984|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
16246802|NCT02497391|39387979|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
16246803|NCT02497391|39387980|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
16246804|NCT02497391|39387981|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
16246805|NCT02497391|39387982|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
16246806|NCT02497391|39387983|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
16246807|NCT02497391|39387984|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
16246808|NCT00706706|39387987|FG000|Overall Study|Death|53|||
16246809|NCT00706706|39387987|FG000|Overall Study|Lost to Follow-up|7|||
16246810|NCT00706706|39387987|FG000|Overall Study|Study endpoint had reached|45|||
16246811|NCT00467818|39387988|FG000|Overall Study|Adverse Event|1|||
16246812|NCT00467818|39387989|FG001|Overall Study|Adverse Event|0|||
16561157|NCT02718417|40521785|FG000|Observation Phase (OP)|Progressive disease|0|||
16354020|NCT03630393|39784220|FG000|Overall Study|Death|1|||
16354021|NCT03630393|39784221|FG001|Overall Study|Death|0|||
16354022|NCT01100853|39784222|FG000|Overall Study|Lost to Follow-up|11|||
16354023|NCT01100853|39784223|FG001|Overall Study|Lost to Follow-up|6|||
16354024|NCT01100853|39784222|FG000|Overall Study|Received <4 study injections|10|||
16354025|NCT01100853|39784223|FG001|Overall Study|Received <4 study injections|13|||
16354026|NCT01100853|39784222|FG000|Overall Study|Withdrawal by Subject|6|||
16354027|NCT01100853|39784223|FG001|Overall Study|Withdrawal by Subject|4|||
16354028|NCT02806713|39784224|FG000|Overall Study|Urethral injury during procedure|1|||
16354029|NCT02806713|39784225|FG001|Overall Study|Urethral injury during procedure|0|||
16354030|NCT02806713|39784224|FG000|Overall Study|cancelled surgery|1|||
16354031|NCT02806713|39784225|FG001|Overall Study|cancelled surgery|2|||
16354032|NCT00617357|39784226|FG000|Overall Study|Lost to Follow-up|7|||
16354033|NCT00617357|39784226|FG000|Overall Study|Death|5|||
16354034|NCT00617357|39784226|FG000|Overall Study|insurance concerns|2|||
16354035|NCT00617357|39784226|FG000|Overall Study|Withdrawal by Subject|1|||
16354036|NCT00617357|39784226|FG000|Overall Study|Physician Decision|1|||
16354037|NCT01924533|39784232|FG000|Overall Study|Death|181|||
16354038|NCT01924533|39784233|FG001|Overall Study|Death|200|||
16354039|NCT01924533|39784232|FG000|Overall Study|Lost to Follow-up|0|||
16354040|NCT01924533|39784233|FG001|Overall Study|Lost to Follow-up|1|||
16354041|NCT01924533|39784232|FG000|Overall Study|Withdrawal by Subject|7|||
16354042|NCT01924533|39784233|FG001|Overall Study|Withdrawal by Subject|3|||
16354043|NCT01924533|39784232|FG000|Overall Study|Other Eligibility criteria|1|||
16354044|NCT01924533|39784233|FG001|Overall Study|Other Eligibility criteria|1|||
16354045|NCT02897349|39784234|FG000|Overall Study|Lost to Follow-up|2|||
16354046|NCT02897349|39784235|FG001|Overall Study|Lost to Follow-up|2|||
16354047|NCT02897349|39784234|FG000|Overall Study|Adverse Event|3|||
16354048|NCT02897349|39784235|FG001|Overall Study|Adverse Event|3|||
16354049|NCT02897349|39784234|FG000|Overall Study|Other than listed above|0|||
16354050|NCT02897349|39784235|FG001|Overall Study|Other than listed above|1|||
16354051|NCT03103503|39784238|FG000|Overall Study|Death|64|||
16354052|NCT03103503|39784238|FG000|Overall Study|Physician Decision|57|||
16354053|NCT03103503|39784238|FG000|Overall Study|Withdrawal by Subject|10|||
16354054|NCT03103503|39784238|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
16354055|NCT03103503|39784238|FG000|Overall Study|Lost to Follow-up|3|||
16354056|NCT03103503|39784238|FG000|Overall Study|Study Closure|757|||
16354057|NCT00879658|39784239|FG000|Overall Study|Abnormal laboratory value(s)|3|||
16354058|NCT00879658|39784240|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16354059|NCT00879658|39784241|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16354060|NCT00879658|39784242|FG003|Overall Study|Abnormal laboratory value(s)|1|||
16354061|NCT00879658|39784243|FG004|Overall Study|Abnormal laboratory value(s)|0|||
16354062|NCT00879658|39784244|FG005|Overall Study|Abnormal laboratory value(s)|0|||
16354063|NCT00879658|39784245|FG006|Overall Study|Abnormal laboratory value(s)|0|||
16354064|NCT00879658|39784239|FG000|Overall Study|Administrative problems|2|||
16354065|NCT00879658|39784240|FG001|Overall Study|Administrative problems|1|||
16354066|NCT00879658|39784241|FG002|Overall Study|Administrative problems|0|||
16354067|NCT00879658|39784242|FG003|Overall Study|Administrative problems|1|||
16354068|NCT00879658|39784243|FG004|Overall Study|Administrative problems|0|||
16354069|NCT00879658|39784244|FG005|Overall Study|Administrative problems|0|||
16354070|NCT00879658|39784245|FG006|Overall Study|Administrative problems|0|||
16354071|NCT00879658|39784239|FG000|Overall Study|Adverse Event|6|||
16561158|NCT02718417|40521786|FG001|Observation Phase (OP)|Progressive disease|0|||
16561159|NCT02718417|40521787|FG002|Observation Phase (OP)|Progressive disease|92|||
16561160|NCT02718417|40521785|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
16561161|NCT02718417|40521786|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
16561162|NCT02718417|40521787|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
16561163|NCT02718417|40521785|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
16561164|NCT02718417|40521786|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
16561165|NCT02718417|40521787|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
16561166|NCT02718417|40521785|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
16561167|NCT02718417|40521786|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
16561168|NCT02718417|40521787|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
16561169|NCT02718417|40521785|FG000|Observation Phase (OP)|Other|0|||
16561170|NCT02718417|40521786|FG001|Observation Phase (OP)|Other|0|||
16354072|NCT00879658|39784240|FG001|Overall Study|Adverse Event|4|||
16354073|NCT00879658|39784241|FG002|Overall Study|Adverse Event|3|||
16354074|NCT00879658|39784242|FG003|Overall Study|Adverse Event|1|||
16354075|NCT00879658|39784243|FG004|Overall Study|Adverse Event|2|||
16354076|NCT00879658|39784244|FG005|Overall Study|Adverse Event|0|||
16354077|NCT00879658|39784245|FG006|Overall Study|Adverse Event|0|||
16354078|NCT00879658|39784239|FG000|Overall Study|Protocol Violation|1|||
16354079|NCT00879658|39784240|FG001|Overall Study|Protocol Violation|0|||
16561171|NCT02718417|40521787|FG002|Observation Phase (OP)|Other|7|||
16561172|NCT02718417|40521785|FG000|Follow-up Phase|Adverse Event|3|||
16354080|NCT00879658|39784241|FG002|Overall Study|Protocol Violation|0|||
16354081|NCT00879658|39784242|FG003|Overall Study|Protocol Violation|0|||
16354082|NCT00879658|39784243|FG004|Overall Study|Protocol Violation|0|||
16354083|NCT00879658|39784244|FG005|Overall Study|Protocol Violation|0|||
16354084|NCT00879658|39784245|FG006|Overall Study|Protocol Violation|0|||
16354085|NCT00879658|39784239|FG000|Overall Study|Withdrawal by Subject|3|||
16354086|NCT00879658|39784240|FG001|Overall Study|Withdrawal by Subject|0|||
16354087|NCT00879658|39784241|FG002|Overall Study|Withdrawal by Subject|2|||
16354088|NCT00879658|39784242|FG003|Overall Study|Withdrawal by Subject|0|||
16354089|NCT00879658|39784243|FG004|Overall Study|Withdrawal by Subject|0|||
16354090|NCT00879658|39784244|FG005|Overall Study|Withdrawal by Subject|1|||
16354091|NCT00879658|39784245|FG006|Overall Study|Withdrawal by Subject|0|||
16354092|NCT00879658|39784239|FG000|Overall Study|Lack of Efficacy|0|||
16354093|NCT00879658|39784240|FG001|Overall Study|Lack of Efficacy|0|||
16354094|NCT00879658|39784241|FG002|Overall Study|Lack of Efficacy|2|||
16354095|NCT00879658|39784242|FG003|Overall Study|Lack of Efficacy|0|||
16354096|NCT00879658|39784243|FG004|Overall Study|Lack of Efficacy|0|||
16354097|NCT00879658|39784244|FG005|Overall Study|Lack of Efficacy|0|||
16354098|NCT00879658|39784245|FG006|Overall Study|Lack of Efficacy|0|||
16354099|NCT00879658|39784239|FG000|Overall Study|misrandomized (never received study med)|0|||
16354100|NCT00879658|39784240|FG001|Overall Study|misrandomized (never received study med)|0|||
16354101|NCT00879658|39784241|FG002|Overall Study|misrandomized (never received study med)|0|||
16354102|NCT00879658|39784242|FG003|Overall Study|misrandomized (never received study med)|1|||
16354103|NCT00879658|39784243|FG004|Overall Study|misrandomized (never received study med)|0|||
16354104|NCT00879658|39784244|FG005|Overall Study|misrandomized (never received study med)|0|||
16354105|NCT00879658|39784245|FG006|Overall Study|misrandomized (never received study med)|0|||
16354106|NCT03573297|39784246|FG000|Open Label Treatment Period|Adverse Event|67|||
16246813|NCT00467818|39387988|FG000|Overall Study|Lost to Follow-up|2|||
16246814|NCT00467818|39387989|FG001|Overall Study|Lost to Follow-up|2|||
16246815|NCT00901628|39387992|FG000|Overall Study|disconnection of catheter|4|||
16246816|NCT00901628|39387993|FG001|Overall Study|disconnection of catheter|8|||
16246817|NCT00901628|39387992|FG000|Overall Study|disconnection of drain|0|||
16246818|NCT00901628|39387993|FG001|Overall Study|disconnection of drain|1|||
16246819|NCT00901628|39387992|FG000|Overall Study|peroneal nerve palsy|0|||
16246820|NCT00901628|39387993|FG001|Overall Study|peroneal nerve palsy|1|||
16246821|NCT01381900|39388004|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
16246822|NCT01381900|39388005|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
16246823|NCT01381900|39388006|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
16246824|NCT01381900|39388004|FG000|Overall Study|Adverse Event|4|||
16246825|NCT01381900|39388005|FG001|Overall Study|Adverse Event|6|||
16246826|NCT01381900|39388006|FG002|Overall Study|Adverse Event|7|||
16246827|NCT01381900|39388004|FG000|Overall Study|Noncompliance with study drug|0|||
16246828|NCT01381900|39388005|FG001|Overall Study|Noncompliance with study drug|0|||
16246829|NCT01381900|39388006|FG002|Overall Study|Noncompliance with study drug|1|||
16246830|NCT01381900|39388004|FG000|Overall Study|Physician Decision|0|||
16246831|NCT01381900|39388005|FG001|Overall Study|Physician Decision|1|||
16246832|NCT01381900|39388006|FG002|Overall Study|Physician Decision|1|||
16246833|NCT01381900|39388004|FG000|Overall Study|Protocol Violation|0|||
16246834|NCT01381900|39388005|FG001|Overall Study|Protocol Violation|1|||
16246835|NCT01381900|39388006|FG002|Overall Study|Protocol Violation|1|||
16246836|NCT01381900|39388004|FG000|Overall Study|Withdrawal by Subject|0|||
16246837|NCT01381900|39388005|FG001|Overall Study|Withdrawal by Subject|0|||
16246838|NCT01381900|39388006|FG002|Overall Study|Withdrawal by Subject|1|||
16246839|NCT01381900|39388004|FG000|Overall Study|Early withdraw|3|||
16246840|NCT01381900|39388005|FG001|Overall Study|Early withdraw|1|||
16246841|NCT01381900|39388006|FG002|Overall Study|Early withdraw|1|||
16246842|NCT03769181|39388007|FG000|Overall Study|Adverse Event|1|||
16246843|NCT03769181|39388008|FG001|Overall Study|Adverse Event|0|||
16246844|NCT03769181|39388009|FG002|Overall Study|Adverse Event|2|||
16246845|NCT03769181|39388010|FG003|Overall Study|Adverse Event|4|||
16246846|NCT03769181|39388007|FG000|Overall Study|Withdrawal by Subject|1|||
16246847|NCT03769181|39388008|FG001|Overall Study|Withdrawal by Subject|0|||
16246848|NCT03769181|39388009|FG002|Overall Study|Withdrawal by Subject|2|||
16246849|NCT03769181|39388010|FG003|Overall Study|Withdrawal by Subject|1|||
16246850|NCT03769181|39388007|FG000|Overall Study|Progressive disease|9|||
16246851|NCT03769181|39388008|FG001|Overall Study|Progressive disease|7|||
16246852|NCT03769181|39388009|FG002|Overall Study|Progressive disease|13|||
16246853|NCT03769181|39388010|FG003|Overall Study|Progressive disease|6|||
16246854|NCT03769181|39388007|FG000|Overall Study|Other - Unspecified|2|||
16246855|NCT03769181|39388008|FG001|Overall Study|Other - Unspecified|1|||
16246856|NCT03769181|39388009|FG002|Overall Study|Other - Unspecified|0|||
16246857|NCT03769181|39388010|FG003|Overall Study|Other - Unspecified|0|||
16246858|NCT00290745|39388011|FG000|Overall Study|Withdrawal by Subject|4|||
16246859|NCT00290745|39388011|FG000|Overall Study|Physician Decision|2|||
16246860|NCT00290745|39388011|FG000|Overall Study|Surgery after 3 months for progression|3|||
16246861|NCT00290745|39388011|FG000|Overall Study|Baseline MRI not available|3|||
16246862|NCT01298596|39388012|FG000|Overall Study|Withdrawal by Subject|1|||
16246863|NCT01298596|39388013|FG001|Overall Study|Withdrawal by Subject|1|||
16246864|NCT01298596|39388012|FG000|Overall Study|Death|5|||
16246865|NCT01298596|39388013|FG001|Overall Study|Death|3|||
16246866|NCT01298596|39388012|FG000|Overall Study|Lost to Follow-up|6|||
16246867|NCT01298596|39388013|FG001|Overall Study|Lost to Follow-up|14|||
16246868|NCT01298596|39388012|FG000|Overall Study|Referred for further management|16|||
16246869|NCT01298596|39388013|FG001|Overall Study|Referred for further management|15|||
16246870|NCT00252187|39388014|FG000|Overall Study|Adverse Event|3|||
16246871|NCT00252187|39388015|FG001|Overall Study|Adverse Event|1|||
16246872|NCT00252187|39388014|FG000|Overall Study|Withdrawal by Subject|1|||
16246873|NCT00252187|39388015|FG001|Overall Study|Withdrawal by Subject|0|||
16246874|NCT02753400|39388021|FG000|Overall Study|Adverse Event|3|||
16246875|NCT02753400|39388022|FG001|Overall Study|Adverse Event|0|||
16246876|NCT02753400|39388021|FG000|Overall Study|Withdrawal by Subject|2|||
16246877|NCT02753400|39388022|FG001|Overall Study|Withdrawal by Subject|1|||
16246878|NCT02049359|39388023|FG000|Overall Study|Lost to Follow-up|26|||
16246879|NCT02049359|39388024|FG001|Overall Study|Lost to Follow-up|19|||
16246880|NCT01751412|39388031|FG000|Overall Study|Disease Progression Before Treatment|1|||
16246881|NCT01606137|39388036|FG000|Overall Study|Adverse Event|85|||
16246882|NCT01606137|39388036|FG000|Overall Study|Withdrawal by Subject|74|||
16246883|NCT01606137|39388036|FG000|Overall Study|Lack of Efficacy|56|||
16246884|NCT01606137|39388036|FG000|Overall Study|Lost to Follow-up|15|||
16246885|NCT01606137|39388036|FG000|Overall Study|Protocol Violation|1|||
16246886|NCT01606137|39388036|FG000|Overall Study|Patient non-compliance|9|||
16246887|NCT01606137|39388036|FG000|Overall Study|Death|1|||
16246888|NCT01606137|39388036|FG000|Overall Study|Decreased/no pain|4|||
16246889|NCT01606137|39388036|FG000|Overall Study|Issues with driving|4|||
16246890|NCT01606137|39388036|FG000|Overall Study|multiple sclerosis less stable|1|||
16246891|NCT01606137|39388036|FG000|Overall Study|Increased bilirubin|1|||
16246892|NCT01606137|39388036|FG000|Overall Study|Spray causes nausea|1|||
16246893|NCT01606137|39388036|FG000|Overall Study|Not enough improvement|4|||
16246894|NCT01606137|39388036|FG000|Overall Study|Wanted to try another treatment|1|||
16246895|NCT01606137|39388036|FG000|Overall Study|Patient leaving country|1|||
16246896|NCT01606137|39388036|FG000|Overall Study|Personal reasons|1|||
16246897|NCT01606137|39388036|FG000|Overall Study|Unable to tolerate study med. taste|1|||
16246898|NCT01606137|39388036|FG000|Overall Study|Patient moving|1|||
16246899|NCT01606137|39388036|FG000|Overall Study|Unable to collect consistent data|1|||
16246900|NCT01314703|39388039|FG000|Overall Study|screen failure and closed enrollment|8|||
16246901|NCT02035137|39388040|FG000|Overall Study|Physician Decision|0|||
16246902|NCT02035137|39388041|FG001|Overall Study|Physician Decision|0|||
16246903|NCT02035137|39388042|FG002|Overall Study|Physician Decision|1|||
16246904|NCT02035137|39388040|FG000|Overall Study|Withdrawal by Subject|0|||
16246905|NCT02035137|39388041|FG001|Overall Study|Withdrawal by Subject|1|||
16246906|NCT02035137|39388042|FG002|Overall Study|Withdrawal by Subject|2|||
16246907|NCT02035137|39388040|FG000|Overall Study|Ineligible|0|||
16246908|NCT02035137|39388041|FG001|Overall Study|Ineligible|1|||
16246909|NCT02035137|39388042|FG002|Overall Study|Ineligible|2|||
16246910|NCT02035137|39388040|FG000|Overall Study|Disease progression prior to treatment start|2|||
16246911|NCT02035137|39388041|FG001|Overall Study|Disease progression prior to treatment start|0|||
16354107|NCT03573297|39784247|FG001|Open Label Treatment Period|Adverse Event|0|||
16354108|NCT03573297|39784248|FG002|Open Label Treatment Period|Adverse Event|0|||
16354109|NCT03573297|39784249|FG003|Open Label Treatment Period|Adverse Event|0|||
16354110|NCT03573297|39784246|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
16354111|NCT03573297|39784247|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
16354112|NCT03573297|39784248|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
16354113|NCT03573297|39784249|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
16354114|NCT03573297|39784246|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
16354115|NCT03573297|39784247|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
16354116|NCT03573297|39784248|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
16354117|NCT03573297|39784249|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
16354118|NCT03573297|39784246|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
16354119|NCT03573297|39784247|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
16354120|NCT03573297|39784248|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
16354121|NCT03573297|39784249|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
16354122|NCT03573297|39784246|FG000|Open Label Treatment Period|Pregnancy|1|||
16354123|NCT03573297|39784247|FG001|Open Label Treatment Period|Pregnancy|0|||
16354124|NCT03573297|39784248|FG002|Open Label Treatment Period|Pregnancy|0|||
16354125|NCT03573297|39784249|FG003|Open Label Treatment Period|Pregnancy|0|||
16354126|NCT03573297|39784246|FG000|Open Label Treatment Period|Protocol Violation|17|||
16354127|NCT03573297|39784247|FG001|Open Label Treatment Period|Protocol Violation|0|||
16354128|NCT03573297|39784248|FG002|Open Label Treatment Period|Protocol Violation|0|||
16354129|NCT03573297|39784249|FG003|Open Label Treatment Period|Protocol Violation|0|||
16354130|NCT03573297|39784246|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
16354131|NCT03573297|39784247|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
16354132|NCT03573297|39784248|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
16354133|NCT03573297|39784249|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
16354134|NCT03573297|39784246|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
16354135|NCT03573297|39784247|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
16354136|NCT03573297|39784248|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
16354137|NCT03573297|39784249|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
16354138|NCT03573297|39784246|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
16354139|NCT03573297|39784247|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
16354140|NCT03573297|39784248|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
16354141|NCT03573297|39784249|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
16354142|NCT03573297|39784246|FG000|Open Label Treatment Period|Other, Not Specified|7|||
16354143|NCT03573297|39784247|FG001|Open Label Treatment Period|Other, Not Specified|0|||
16354144|NCT03573297|39784248|FG002|Open Label Treatment Period|Other, Not Specified|0|||
16354145|NCT03573297|39784249|FG003|Open Label Treatment Period|Other, Not Specified|0|||
16354146|NCT03573297|39784246|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
16354147|NCT03573297|39784247|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
16354148|NCT03573297|39784248|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
16354149|NCT03573297|39784249|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
16354150|NCT03573297|39784246|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16354151|NCT03573297|39784247|FG001|Double-Blind Treatment Period|Adverse Event|1|||
16354152|NCT03573297|39784248|FG002|Double-Blind Treatment Period|Adverse Event|5|||
16354153|NCT03573297|39784249|FG003|Double-Blind Treatment Period|Adverse Event|1|||
16354154|NCT03573297|39784246|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
16561173|NCT02718417|40521786|FG001|Follow-up Phase|Adverse Event|1|||
16561174|NCT02718417|40521787|FG002|Follow-up Phase|Adverse Event|1|||
16561175|NCT02718417|40521785|FG000|Follow-up Phase|Other|4|||
16561176|NCT02718417|40521786|FG001|Follow-up Phase|Other|6|||
16561177|NCT02718417|40521787|FG002|Follow-up Phase|Other|4|||
16561178|NCT02718417|40521785|FG000|Follow-up Phase|Withdrawal by Subject|19|||
16561179|NCT02718417|40521786|FG001|Follow-up Phase|Withdrawal by Subject|17|||
16561180|NCT02718417|40521787|FG002|Follow-up Phase|Withdrawal by Subject|5|||
16561181|NCT02718417|40521785|FG000|Follow-up Phase|Study terminated by sponsor|100|||
16561182|NCT02718417|40521786|FG001|Follow-up Phase|Study terminated by sponsor|138|||
16561183|NCT02718417|40521787|FG002|Follow-up Phase|Study terminated by sponsor|6|||
16561184|NCT02718417|40521785|FG000|Follow-up Phase|Lost to Follow-up|2|||
16561185|NCT02718417|40521786|FG001|Follow-up Phase|Lost to Follow-up|3|||
16561186|NCT02718417|40521787|FG002|Follow-up Phase|Lost to Follow-up|0|||
16561187|NCT02718417|40521785|FG000|Follow-up Phase|Death leading to discontinuation|7|||
16561188|NCT02718417|40521786|FG001|Follow-up Phase|Death leading to discontinuation|7|||
16561189|NCT02718417|40521787|FG002|Follow-up Phase|Death leading to discontinuation|3|||
16561190|NCT02718417|40521785|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
16561191|NCT02718417|40521786|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
16561192|NCT02718417|40521787|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
16561193|NCT02718417|40521785|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
16246912|NCT02035137|39388042|FG002|Overall Study|Disease progression prior to treatment start|0|||
16246913|NCT02764489|39388050|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
16246914|NCT02764489|39388051|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
16246915|NCT02764489|39388050|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
16246916|NCT02764489|39388051|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
16246917|NCT02764489|39388050|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
16246918|NCT02764489|39388051|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
16246919|NCT02764489|39388050|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
16246920|NCT02764489|39388051|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
16246921|NCT03507439|39388058|FG000|Overall Study|Other|2|||
16246922|NCT03507439|39388059|FG001|Overall Study|Other|1|||
16246923|NCT03507439|39388058|FG000|Overall Study|Withdrawal by Subject|1|||
16246924|NCT03507439|39388059|FG001|Overall Study|Withdrawal by Subject|0|||
16246925|NCT03507439|39388058|FG000|Overall Study|Death|1|||
16246926|NCT03507439|39388059|FG001|Overall Study|Death|1|||
16246927|NCT00608205|39388060|FG000|Overall Study|Adverse Event|3|||
16246928|NCT00608205|39388061|FG001|Overall Study|Adverse Event|2|||
16246929|NCT00608205|39388060|FG000|Overall Study|Patient non-compliant|0|||
16246930|NCT00608205|39388061|FG001|Overall Study|Patient non-compliant|1|||
16246931|NCT02853929|39388062|FG000|Overall Study|Lost to Follow-up|3|||
16246932|NCT02853929|39388063|FG001|Overall Study|Lost to Follow-up|0|||
16246933|NCT02853929|39388062|FG000|Overall Study|Withdrawal by Subject|1|||
16246934|NCT02853929|39388063|FG001|Overall Study|Withdrawal by Subject|0|||
16246935|NCT02853929|39388062|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
16246936|NCT02853929|39388063|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
16246937|NCT00297479|39388064|FG000|Overall Study|Lost to Follow-up|37|||
16246938|NCT00297479|39388065|FG001|Overall Study|Lost to Follow-up|54|||
16246939|NCT00297479|39388066|FG002|Overall Study|Lost to Follow-up|51|||
16246940|NCT01294592|39388067|FG000|Overall Study|Adverse Event|28|||
16246941|NCT01294592|39388068|FG001|Overall Study|Adverse Event|13|||
16246942|NCT01294592|39388067|FG000|Overall Study|Lack of Efficacy|7|||
16246943|NCT01294592|39388068|FG001|Overall Study|Lack of Efficacy|5|||
16246944|NCT01294592|39388067|FG000|Overall Study|Protocol Violation|1|||
16246945|NCT01294592|39388068|FG001|Overall Study|Protocol Violation|7|||
16246946|NCT01294592|39388067|FG000|Overall Study|Lost to Follow-up|7|||
16246947|NCT01294592|39388068|FG001|Overall Study|Lost to Follow-up|9|||
16246948|NCT01294592|39388067|FG000|Overall Study|Physician Decision|6|||
16246949|NCT01294592|39388068|FG001|Overall Study|Physician Decision|11|||
16246950|NCT01294592|39388067|FG000|Overall Study|Withdrawal by Subject|28|||
16246951|NCT01294592|39388068|FG001|Overall Study|Withdrawal by Subject|28|||
16246952|NCT00814658|39388069|FG000|Overall Study|Lost to Follow-up|0|||
16246953|NCT00814658|39388070|FG001|Overall Study|Lost to Follow-up|1|||
16246954|NCT00814658|39388069|FG000|Overall Study|Physician Decision|1|||
16246955|NCT00814658|39388070|FG001|Overall Study|Physician Decision|0|||
16246956|NCT00814658|39388069|FG000|Overall Study|Adverse Event|3|||
16246957|NCT00814658|39388070|FG001|Overall Study|Adverse Event|3|||
16246958|NCT01725113|39388071|FG000|Overall Study|Kidney Transplant|1|||
16246959|NCT01725113|39388072|FG001|Overall Study|Kidney Transplant|1|||
16246960|NCT01725113|39388071|FG000|Overall Study|Withdrawal by Subject|0|||
16246961|NCT01725113|39388072|FG001|Overall Study|Withdrawal by Subject|1|||
16246962|NCT02614703|39388073|FG000|Overall Study|Withdrawal by Subject|7|||
16246963|NCT02614703|39388074|FG001|Overall Study|Withdrawal by Subject|1|||
16246964|NCT02750761|39388075|FG000|Overall Study|Lost to Follow-up|0|||
16246965|NCT02750761|39388076|FG001|Overall Study|Lost to Follow-up|0|||
16246966|NCT02750761|39388077|FG002|Overall Study|Lost to Follow-up|1|||
16246967|NCT02750761|39388078|FG003|Overall Study|Lost to Follow-up|0|||
16246968|NCT02750761|39388079|FG004|Overall Study|Lost to Follow-up|0|||
16246969|NCT02750761|39388080|FG005|Overall Study|Lost to Follow-up|0|||
16246970|NCT00319956|39388086|FG000|Overall Study|Death|20|||
16246971|NCT00319956|39388087|FG001|Overall Study|Death|24|||
16246972|NCT01886300|39388093|FG000|Overall Study|Trial terminated by sponsor|16|||
16246973|NCT00679783|39388098|FG000|Overall Study|Adverse Event|0|||
16246974|NCT00679783|39388099|FG001|Overall Study|Adverse Event|0|||
16246975|NCT00679783|39388100|FG002|Overall Study|Adverse Event|0|||
16246976|NCT00679783|39388101|FG003|Overall Study|Adverse Event|3|||
16354155|NCT03573297|39784247|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
16354156|NCT03573297|39784248|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
16354157|NCT03573297|39784249|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
16246977|NCT00679783|39388102|FG004|Overall Study|Adverse Event|0|||
16246978|NCT00679783|39388103|FG005|Overall Study|Adverse Event|0|||
16246979|NCT00679783|39388104|FG006|Overall Study|Adverse Event|1|||
16246980|NCT00679783|39388098|FG000|Overall Study|Lack of Efficacy|0|||
16246981|NCT00679783|39388099|FG001|Overall Study|Lack of Efficacy|1|||
16246982|NCT00679783|39388100|FG002|Overall Study|Lack of Efficacy|0|||
16246983|NCT00679783|39388101|FG003|Overall Study|Lack of Efficacy|2|||
16246984|NCT00679783|39388102|FG004|Overall Study|Lack of Efficacy|0|||
16246985|NCT00679783|39388103|FG005|Overall Study|Lack of Efficacy|0|||
16246986|NCT00679783|39388104|FG006|Overall Study|Lack of Efficacy|0|||
16354158|NCT03573297|39784246|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16354159|NCT03573297|39784247|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
16354160|NCT03573297|39784248|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
16354161|NCT03573297|39784249|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
16354162|NCT03573297|39784246|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16354163|NCT03573297|39784247|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
16354164|NCT03573297|39784248|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
16354165|NCT03573297|39784249|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
16354166|NCT03573297|39784246|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
16354167|NCT03573297|39784247|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
16354168|NCT03573297|39784248|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
16354169|NCT03573297|39784249|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
16354170|NCT03573297|39784246|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
16354171|NCT03573297|39784247|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
16354172|NCT03573297|39784248|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
16354173|NCT03573297|39784249|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
16354174|NCT03573297|39784246|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
16354175|NCT03573297|39784247|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
16354176|NCT03573297|39784248|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
16354177|NCT03573297|39784249|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
16354178|NCT01433159|39784256|FG000|Overall Study|Adverse Event|1|||
16354179|NCT01433159|39784257|FG001|Overall Study|Adverse Event|0|||
16354180|NCT01433159|39784256|FG000|Overall Study|Physician Decision|1|||
16354181|NCT01433159|39784257|FG001|Overall Study|Physician Decision|0|||
16354182|NCT01433159|39784256|FG000|Overall Study|Protocol Violation|0|||
16354183|NCT01433159|39784257|FG001|Overall Study|Protocol Violation|1|||
16354184|NCT01867008|39784262|FG000|Overall Study|Withdrawal by Subject|1|||
16354185|NCT05081388|39784263|FG000|Overall Study|Adverse Event|1|||
16354186|NCT05081388|39784264|FG001|Overall Study|Adverse Event|0|||
16354187|NCT05081388|39784265|FG002|Overall Study|Adverse Event|0|||
16354188|NCT05081388|39784266|FG003|Overall Study|Adverse Event|0|||
16354189|NCT05081388|39784267|FG004|Overall Study|Adverse Event|0|||
16354190|NCT05081388|39784263|FG000|Overall Study|Lost to Follow-up|0|||
16130557|NCT00196976|38967055|FG006|Primary Study|Other|0|||
16354191|NCT05081388|39784264|FG001|Overall Study|Lost to Follow-up|1|||
16354192|NCT05081388|39784265|FG002|Overall Study|Lost to Follow-up|0|||
16354193|NCT05081388|39784266|FG003|Overall Study|Lost to Follow-up|0|||
16354194|NCT05081388|39784267|FG004|Overall Study|Lost to Follow-up|0|||
16354195|NCT05081388|39784263|FG000|Overall Study|Subject decision|0|||
16354196|NCT05081388|39784264|FG001|Overall Study|Subject decision|0|||
16354197|NCT05081388|39784265|FG002|Overall Study|Subject decision|0|||
16354198|NCT05081388|39784266|FG003|Overall Study|Subject decision|1|||
16354199|NCT05081388|39784267|FG004|Overall Study|Subject decision|0|||
16354200|NCT00492297|39784270|FG000|Treatment|Death|2|||
16354201|NCT00492297|39784270|FG000|Treatment|Study terminated by sponsor|3|||
16354202|NCT00492297|39784270|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
16354203|NCT00492297|39784270|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
16354204|NCT00492297|39784270|FG000|Survival Only Follow-up|Death|46|||
16354205|NCT00492297|39784270|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
16354206|NCT00492297|39784270|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
16354207|NCT03575702|39784271|FG000|Overall Study|Withdrawal by Subject|1|||
16354208|NCT03575702|39784272|FG001|Overall Study|Withdrawal by Subject|1|||
16354209|NCT03575702|39784271|FG000|Overall Study|Lost to Follow-up|1|||
16354210|NCT03575702|39784272|FG001|Overall Study|Lost to Follow-up|2|||
16354211|NCT03575702|39784271|FG000|Overall Study|Protocol Violation|0|||
16354212|NCT03575702|39784272|FG001|Overall Study|Protocol Violation|1|||
16354213|NCT03575702|39784271|FG000|Overall Study|Patient non compliance|4|||
16354214|NCT03575702|39784272|FG001|Overall Study|Patient non compliance|0|||
16354215|NCT04161391|39784275|FG000|Overall Study|Adverse Event|0|||
16354216|NCT04161391|39784276|FG001|Overall Study|Adverse Event|1|||
16354217|NCT04161391|39784277|FG002|Overall Study|Adverse Event|0|||
16354218|NCT04161391|39784278|FG003|Overall Study|Adverse Event|1|||
16354219|NCT04161391|39784279|FG004|Overall Study|Adverse Event|0|||
16130558|NCT00196976|38967056|FG007|Primary Study|Other|0|||
16354220|NCT04161391|39784280|FG005|Overall Study|Adverse Event|0|||
16354221|NCT04161391|39784281|FG006|Overall Study|Adverse Event|0|||
16354222|NCT04161391|39784282|FG007|Overall Study|Adverse Event|3|||
16354223|NCT04161391|39784283|FG008|Overall Study|Adverse Event|0|||
16354224|NCT04161391|39784275|FG000|Overall Study|Death|0|||
16354225|NCT04161391|39784276|FG001|Overall Study|Death|0|||
16130559|NCT00196976|38967057|FG008|Primary Study|Other|0|||
16354226|NCT04161391|39784277|FG002|Overall Study|Death|0|||
16354227|NCT04161391|39784278|FG003|Overall Study|Death|0|||
16354228|NCT04161391|39784279|FG004|Overall Study|Death|0|||
16354229|NCT04161391|39784280|FG005|Overall Study|Death|0|||
16354230|NCT04161391|39784281|FG006|Overall Study|Death|0|||
16354231|NCT04161391|39784282|FG007|Overall Study|Death|1|||
16354232|NCT04161391|39784283|FG008|Overall Study|Death|0|||
16354233|NCT04161391|39784275|FG000|Overall Study|Physician Decision|0|||
16354234|NCT04161391|39784276|FG001|Overall Study|Physician Decision|0|||
16354235|NCT04161391|39784277|FG002|Overall Study|Physician Decision|1|||
16354236|NCT04161391|39784278|FG003|Overall Study|Physician Decision|2|||
16354237|NCT04161391|39784279|FG004|Overall Study|Physician Decision|0|||
16354238|NCT04161391|39784280|FG005|Overall Study|Physician Decision|0|||
16354239|NCT04161391|39784281|FG006|Overall Study|Physician Decision|2|||
16354240|NCT04161391|39784282|FG007|Overall Study|Physician Decision|0|||
16354241|NCT04161391|39784283|FG008|Overall Study|Physician Decision|0|||
16354242|NCT04161391|39784275|FG000|Overall Study|Progressive Disease|4|||
16354243|NCT04161391|39784276|FG001|Overall Study|Progressive Disease|3|||
16354244|NCT04161391|39784277|FG002|Overall Study|Progressive Disease|3|||
16354245|NCT04161391|39784278|FG003|Overall Study|Progressive Disease|5|||
16354246|NCT04161391|39784279|FG004|Overall Study|Progressive Disease|3|||
16354247|NCT04161391|39784280|FG005|Overall Study|Progressive Disease|3|||
16354248|NCT04161391|39784281|FG006|Overall Study|Progressive Disease|5|||
16354249|NCT04161391|39784282|FG007|Overall Study|Progressive Disease|2|||
16354250|NCT04161391|39784283|FG008|Overall Study|Progressive Disease|2|||
16354251|NCT00666237|39784284|FG000|Overall Study|Death|5|||
16354252|NCT00666237|39784285|FG001|Overall Study|Death|5|||
16354253|NCT00666237|39784284|FG000|Overall Study|Lost to Follow-up|29|||
16354254|NCT00666237|39784285|FG001|Overall Study|Lost to Follow-up|25|||
16354255|NCT02027025|39784287|FG000|Overall Study|Adverse Event|0|||
16354256|NCT02027025|39784288|FG001|Overall Study|Adverse Event|1|||
16354257|NCT02027025|39784289|FG002|Overall Study|Adverse Event|1|||
16354258|NCT02027025|39784287|FG000|Overall Study|Protocol Violation|1|||
16354259|NCT02027025|39784288|FG001|Overall Study|Protocol Violation|0|||
16354260|NCT02027025|39784289|FG002|Overall Study|Protocol Violation|0|||
16354261|NCT02027025|39784287|FG000|Overall Study|Lost to Follow-up|0|||
16354262|NCT02027025|39784288|FG001|Overall Study|Lost to Follow-up|2|||
16354263|NCT02027025|39784289|FG002|Overall Study|Lost to Follow-up|0|||
16354264|NCT02027025|39784287|FG000|Overall Study|Withdrawal by Subject|0|||
16354265|NCT02027025|39784288|FG001|Overall Study|Withdrawal by Subject|1|||
16354266|NCT02027025|39784289|FG002|Overall Study|Withdrawal by Subject|0|||
16354267|NCT02027025|39784287|FG000|Overall Study|Sponsor's decision|0|||
16417645|NCT03596450|40008568|FG001|Overall Study|Death|9|||
16417646|NCT03596450|40008567|FG000|Overall Study|Protocol Violation|18|||
16354268|NCT02027025|39784288|FG001|Overall Study|Sponsor's decision|1|||
16354269|NCT02027025|39784289|FG002|Overall Study|Sponsor's decision|0|||
16354270|NCT04275336|39784292|FG000|Overall Study|First venipuncture failed|4|||
16354271|NCT04275336|39784293|FG001|Overall Study|First venipuncture failed|6|||
16417647|NCT03596450|40008568|FG001|Overall Study|Protocol Violation|26|||
16417648|NCT03596450|40008567|FG000|Overall Study|Lost to Follow-up|50|||
16354272|NCT04275336|39784294|FG002|Overall Study|First venipuncture failed|5|||
16354273|NCT04275336|39784292|FG000|Overall Study|Unscheduled venipuncture|9|||
16130560|NCT00196976|38967058|FG009|Primary Study|Other|0|||
16354274|NCT04275336|39784293|FG001|Overall Study|Unscheduled venipuncture|13|||
16354275|NCT04275336|39784294|FG002|Overall Study|Unscheduled venipuncture|7|||
16354276|NCT04275336|39784292|FG000|Overall Study|Failed specimen of saliva|4|||
16354277|NCT04275336|39784293|FG001|Overall Study|Failed specimen of saliva|3|||
16354278|NCT04275336|39784294|FG002|Overall Study|Failed specimen of saliva|4|||
16354279|NCT02063672|39784295|FG000|Overall Study|Ongoing Follow-up|27|||
16354280|NCT02063672|39784296|FG001|Overall Study|Ongoing Follow-up|14|||
16354281|NCT02063672|39784295|FG000|Overall Study|Death|5|||
16354282|NCT02063672|39784296|FG001|Overall Study|Death|3|||
16354283|NCT02063672|39784295|FG000|Overall Study|Lost to Follow-up|1|||
16354284|NCT02063672|39784296|FG001|Overall Study|Lost to Follow-up|3|||
16354285|NCT02063672|39784295|FG000|Overall Study|Withdrawal by Subject|2|||
16354286|NCT02063672|39784296|FG001|Overall Study|Withdrawal by Subject|2|||
16354287|NCT00385840|39784297|FG000|Overall Study|Adverse Event|1|||
16354288|NCT00385840|39784298|FG001|Overall Study|Adverse Event|1|||
16354289|NCT00385840|39784297|FG000|Overall Study|Lost to Follow-up|3|||
16354290|NCT00385840|39784298|FG001|Overall Study|Lost to Follow-up|13|||
16354291|NCT01814007|39784299|FG000|Overall Study|Withdrawal by Subject|1|||
16354292|NCT00667563|39784300|FG000|Overall Study|Protocol Violation|24|||
16354293|NCT00661089|39784301|FG000|Overall Study|1 subject withdrawal|0|||
16354294|NCT00661089|39784302|FG001|Overall Study|1 subject withdrawal|1|||
16354295|NCT00661089|39784301|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
16354296|NCT00661089|39784302|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
16354297|NCT00113295|39784303|FG000|Overall Study|Adverse Event|4|||
16354298|NCT00113295|39784304|FG001|Overall Study|Adverse Event|1|||
16354299|NCT00113295|39784303|FG000|Overall Study|Unrelated Medical Illness|1|||
16354300|NCT00113295|39784304|FG001|Overall Study|Unrelated Medical Illness|0|||
16354301|NCT02187783|39784305|FG000|Overall Study|Adverse Event|8|||
16354302|NCT02187783|39784305|FG000|Overall Study|Death|3|||
16354303|NCT02187783|39784305|FG000|Overall Study|Progressive disease|80|||
16354304|NCT02187783|39784305|FG000|Overall Study|Protocol Violation|3|||
16354305|NCT02187783|39784305|FG000|Overall Study|Physician Decision|2|||
16354306|NCT02187783|39784305|FG000|Overall Study|Withdrawal by Subject|9|||
16354307|NCT02187783|39784305|FG000|Overall Study|Study terminated by sponsor|1|||
16354308|NCT01483118|39784310|FG000|Overall Study|Lost to Follow-up|12|||
16354309|NCT01483118|39784311|FG001|Overall Study|Lost to Follow-up|16|||
16354310|NCT00427908|39784314|FG000|Primary Phase|Lost to Follow-up|4|||
16561194|NCT02718417|40521786|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
16561195|NCT02718417|40521787|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
16561196|NCT02718417|40521785|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
16561197|NCT02718417|40521786|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
16561198|NCT02718417|40521787|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
16561199|NCT02718417|40521785|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
16561200|NCT02718417|40521786|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
16246987|NCT00679783|39388098|FG000|Overall Study|Withdrawal by Subject|0|||
16246988|NCT00679783|39388099|FG001|Overall Study|Withdrawal by Subject|0|||
16246989|NCT00679783|39388100|FG002|Overall Study|Withdrawal by Subject|1|||
16246990|NCT00679783|39388101|FG003|Overall Study|Withdrawal by Subject|1|||
16246991|NCT00679783|39388102|FG004|Overall Study|Withdrawal by Subject|0|||
16246992|NCT00679783|39388103|FG005|Overall Study|Withdrawal by Subject|0|||
16246993|NCT00679783|39388104|FG006|Overall Study|Withdrawal by Subject|0|||
16246994|NCT00679783|39388098|FG000|Overall Study|Not Captured|0|||
16246995|NCT00679783|39388099|FG001|Overall Study|Not Captured|0|||
16246996|NCT00679783|39388100|FG002|Overall Study|Not Captured|0|||
16246997|NCT00679783|39388101|FG003|Overall Study|Not Captured|5|||
16246998|NCT00679783|39388102|FG004|Overall Study|Not Captured|0|||
16246999|NCT00679783|39388103|FG005|Overall Study|Not Captured|0|||
16247000|NCT00679783|39388104|FG006|Overall Study|Not Captured|0|||
16247001|NCT00679783|39388098|FG000|Overall Study|Ongoing at data cut-off|2|||
16247002|NCT00679783|39388099|FG001|Overall Study|Ongoing at data cut-off|2|||
16354311|NCT00427908|39784315|FG001|Primary Phase|Lost to Follow-up|0|||
16354312|NCT00427908|39784316|FG002|Primary Phase|Lost to Follow-up|2|||
16354313|NCT00427908|39784317|FG003|Primary Phase|Lost to Follow-up|0|||
16561201|NCT02718417|40521787|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
16561202|NCT02718417|40521785|FG000|Long-term Follow-up Phase|Other|0|||
16561203|NCT02718417|40521786|FG001|Long-term Follow-up Phase|Other|2|||
16561204|NCT02718417|40521787|FG002|Long-term Follow-up Phase|Other|0|||
16561205|NCT02487446|40521788|FG000|Period 1|Physician Decision|0|||
16561206|NCT02487446|40521789|FG001|Period 1|Physician Decision|1|||
16561207|NCT02487446|40521788|FG000|Period 1|Lack of Efficacy|1|||
16561208|NCT02487446|40521789|FG001|Period 1|Lack of Efficacy|0|||
16561209|NCT02487446|40521788|FG000|Period 1|Protocol deviation|3|||
16247003|NCT00679783|39388100|FG002|Overall Study|Ongoing at data cut-off|0|||
16247004|NCT00679783|39388101|FG003|Overall Study|Ongoing at data cut-off|9|||
16247005|NCT00679783|39388102|FG004|Overall Study|Ongoing at data cut-off|1|||
16354314|NCT00427908|39784314|FG000|Primary Phase|Withdrawal by Subject|1|||
16354315|NCT00427908|39784315|FG001|Primary Phase|Withdrawal by Subject|2|||
16354316|NCT00427908|39784316|FG002|Primary Phase|Withdrawal by Subject|1|||
16354317|NCT00427908|39784317|FG003|Primary Phase|Withdrawal by Subject|0|||
16561210|NCT02487446|40521789|FG001|Period 1|Protocol deviation|2|||
16247006|NCT00679783|39388103|FG005|Overall Study|Ongoing at data cut-off|0|||
16354318|NCT00427908|39784314|FG000|Primary Phase|Adverse Event|0|||
16354319|NCT00427908|39784315|FG001|Primary Phase|Adverse Event|1|||
16354320|NCT00427908|39784316|FG002|Primary Phase|Adverse Event|0|||
16354321|NCT00427908|39784317|FG003|Primary Phase|Adverse Event|0|||
16354322|NCT03506477|39784318|FG000|Overall Study|Withdrawal by Subject|1|||
16354323|NCT03506477|39784319|FG001|Overall Study|Withdrawal by Subject|0|||
16354324|NCT01973218|39784320|FG000|Overall Study|Adverse Event|1|||
16354325|NCT01973218|39784321|FG001|Overall Study|Adverse Event|0|||
16354326|NCT01973218|39784320|FG000|Overall Study|Withdrawal by Subject|1|||
16354327|NCT01973218|39784321|FG001|Overall Study|Withdrawal by Subject|0|||
16354328|NCT00087178|39784322|FG000|Overall Study|No follow up data|5|||
16354329|NCT00087178|39784323|FG001|Overall Study|No follow up data|15|||
16354330|NCT00087178|39784322|FG000|Overall Study|No clinical assessment|1|||
16354331|NCT00087178|39784323|FG001|Overall Study|No clinical assessment|2|||
16354332|NCT00087178|39784322|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
16354333|NCT00087178|39784323|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
16354334|NCT04076917|39784328|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
16354335|NCT04076917|39784328|FG000|Overall Study|Study closure|13|||
16354336|NCT04076917|39784328|FG000|Overall Study|Physician Decision|3|||
16354337|NCT04076917|39784328|FG000|Overall Study|Death|1|||
16354338|NCT04076917|39784328|FG000|Overall Study|Lost to Follow-up|1|||
16354339|NCT04076917|39784328|FG000|Overall Study|Withdrawal by Subject|1|||
16354340|NCT04076917|39784328|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
16354341|NCT00885118|39784329|FG000|Overall Study|Adverse Event|1|||
16354342|NCT00885118|39784330|FG001|Overall Study|Adverse Event|0|||
16354343|NCT00885118|39784331|FG002|Overall Study|Adverse Event|0|||
16354344|NCT00885118|39784332|FG003|Overall Study|Adverse Event|0|||
16354345|NCT00885118|39784333|FG004|Overall Study|Adverse Event|0|||
16354346|NCT00885118|39784329|FG000|Overall Study|Withdrawal by Subject|0|||
16354347|NCT00885118|39784330|FG001|Overall Study|Withdrawal by Subject|0|||
16354348|NCT00885118|39784331|FG002|Overall Study|Withdrawal by Subject|0|||
16354349|NCT00885118|39784332|FG003|Overall Study|Withdrawal by Subject|0|||
16354350|NCT00885118|39784333|FG004|Overall Study|Withdrawal by Subject|1|||
16354351|NCT00885118|39784329|FG000|Overall Study|Other reason not defined above|0|||
16354352|NCT00885118|39784330|FG001|Overall Study|Other reason not defined above|0|||
16354353|NCT00885118|39784331|FG002|Overall Study|Other reason not defined above|1|||
16354354|NCT00885118|39784332|FG003|Overall Study|Other reason not defined above|0|||
16354355|NCT00885118|39784333|FG004|Overall Study|Other reason not defined above|0|||
16354356|NCT01309386|39784334|FG000|Overall Study|Other|2|||
16354357|NCT01309386|39784335|FG001|Overall Study|Other|0|||
16354358|NCT01309386|39784334|FG000|Overall Study|Withdrawal by Subject|2|||
16354359|NCT01309386|39784335|FG001|Overall Study|Withdrawal by Subject|0|||
16354360|NCT01309386|39784334|FG000|Overall Study|Progressive disease|9|||
16354361|NCT01309386|39784335|FG001|Overall Study|Progressive disease|11|||
16354362|NCT01309386|39784334|FG000|Overall Study|Physician Decision|1|||
16354363|NCT01309386|39784335|FG001|Overall Study|Physician Decision|1|||
16354364|NCT01309386|39784334|FG000|Overall Study|Lack of Efficacy|3|||
16354365|NCT01309386|39784335|FG001|Overall Study|Lack of Efficacy|1|||
16354366|NCT01309386|39784334|FG000|Overall Study|Adverse Event|5|||
16354367|NCT01309386|39784335|FG001|Overall Study|Adverse Event|8|||
16354368|NCT03885908|39784336|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
16354369|NCT03885908|39784337|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
16354370|NCT03885908|39784336|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
16354371|NCT03885908|39784337|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
16354372|NCT03885908|39784336|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
16354373|NCT03885908|39784337|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
16354374|NCT03885908|39784336|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
16354375|NCT03885908|39784337|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
16354376|NCT02163395|39784339|FG000|Overall Study|Withdrawal by Subject|1|||
16354377|NCT02163395|39784339|FG000|Overall Study|Lost to Follow-up|3|||
16354378|NCT02163395|39784339|FG000|Overall Study|Adverse Event|1|||
16354379|NCT01111565|39784340|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
16354380|NCT01111565|39784341|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
16354381|NCT01111565|39784342|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
16354382|NCT01111565|39784343|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
16354383|NCT01111565|39784344|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
16354384|NCT01111565|39784340|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
16354385|NCT01111565|39784341|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
16354386|NCT01111565|39784342|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
16354387|NCT01111565|39784343|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
16354388|NCT01111565|39784344|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
16354389|NCT01111565|39784340|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
16354390|NCT01111565|39784341|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
16354391|NCT01111565|39784342|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
16354392|NCT01111565|39784343|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
16354393|NCT01111565|39784344|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
16354394|NCT01111565|39784340|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
16354395|NCT01111565|39784341|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
16354396|NCT01111565|39784342|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
16354397|NCT01111565|39784343|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
16354398|NCT01111565|39784344|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
16354399|NCT01111565|39784340|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
16354400|NCT01111565|39784341|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
16354401|NCT01111565|39784342|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
16354402|NCT01111565|39784343|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
16354403|NCT01111565|39784344|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
16354404|NCT01111565|39784340|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
16354405|NCT01111565|39784341|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
16354406|NCT01111565|39784342|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
16354407|NCT01111565|39784343|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
16354408|NCT01111565|39784344|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
16354409|NCT01111565|39784340|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
16354410|NCT01111565|39784341|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
16354411|NCT01111565|39784342|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
16354412|NCT01111565|39784343|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
16354413|NCT01111565|39784344|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
16354414|NCT01111565|39784340|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16354415|NCT01111565|39784341|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16354416|NCT01111565|39784342|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16354417|NCT01111565|39784343|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
16354418|NCT01111565|39784344|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
16354419|NCT01111565|39784340|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16354420|NCT01111565|39784341|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16354421|NCT01111565|39784342|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
16354422|NCT01111565|39784343|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16354423|NCT01111565|39784344|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
16354424|NCT01111565|39784340|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
16354425|NCT01111565|39784341|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
16354426|NCT01111565|39784342|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
16354427|NCT01111565|39784343|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
16354428|NCT01111565|39784344|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
16354429|NCT01111565|39784340|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
16354430|NCT01111565|39784341|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
16354431|NCT01111565|39784342|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
16354432|NCT01111565|39784343|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
16354433|NCT01111565|39784344|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
16354434|NCT01111565|39784340|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
16354435|NCT01111565|39784341|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
16354436|NCT01111565|39784342|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
16354437|NCT01111565|39784343|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
16354438|NCT01111565|39784344|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
16354439|NCT02557295|39784345|FG000|Overall Study|Withdrawal by Subject|9|||
16354440|NCT02557295|39784346|FG001|Overall Study|Withdrawal by Subject|2|||
16354441|NCT02557295|39784347|FG002|Overall Study|Withdrawal by Subject|4|||
16354442|NCT02557295|39784348|FG003|Overall Study|Withdrawal by Subject|0|||
16354443|NCT02557295|39784349|FG004|Overall Study|Withdrawal by Subject|0|||
16354444|NCT02557295|39784350|FG005|Overall Study|Withdrawal by Subject|0|||
16354445|NCT02557295|39784351|FG006|Overall Study|Withdrawal by Subject|15|||
16354446|NCT02557295|39784352|FG007|Overall Study|Withdrawal by Subject|1|||
16354447|NCT02557295|39784353|FG008|Overall Study|Withdrawal by Subject|3|||
16354448|NCT02557295|39784345|FG000|Overall Study|Disease Progression|0|||
16354449|NCT02557295|39784346|FG001|Overall Study|Disease Progression|0|||
16354450|NCT02557295|39784347|FG002|Overall Study|Disease Progression|0|||
16354451|NCT02557295|39784348|FG003|Overall Study|Disease Progression|0|||
16354452|NCT02557295|39784349|FG004|Overall Study|Disease Progression|0|||
16354453|NCT02557295|39784350|FG005|Overall Study|Disease Progression|0|||
16354454|NCT02557295|39784351|FG006|Overall Study|Disease Progression|1|||
16354455|NCT02557295|39784352|FG007|Overall Study|Disease Progression|0|||
16354456|NCT02557295|39784353|FG008|Overall Study|Disease Progression|0|||
16354457|NCT02557295|39784345|FG000|Overall Study|Lack of Efficacy|24|||
16417649|NCT03596450|40008568|FG001|Overall Study|Lost to Follow-up|56|||
16417650|NCT03596450|40008567|FG000|Overall Study|Adverse Event|14|||
16417651|NCT03596450|40008568|FG001|Overall Study|Adverse Event|7|||
16417652|NCT03596450|40008567|FG000|Overall Study|Withdrawal by Subject|38|||
16417653|NCT03596450|40008568|FG001|Overall Study|Withdrawal by Subject|36|||
16417654|NCT03596450|40008567|FG000|Overall Study|Accidentally Randomized|2|||
16417655|NCT03596450|40008568|FG001|Overall Study|Accidentally Randomized|0|||
16417656|NCT03596450|40008567|FG000|Overall Study|Other reasons|48|||
16561211|NCT02487446|40521788|FG000|Period 1|Lost to Follow-up|2|||
16561212|NCT02487446|40521789|FG001|Period 1|Lost to Follow-up|0|||
16561213|NCT02487446|40521788|FG000|Period 1|Withdrawal by Subject|2|||
16561214|NCT02487446|40521789|FG001|Period 1|Withdrawal by Subject|0|||
16561215|NCT02487446|40521788|FG000|Period 1|Adverse Event|5|||
16561216|NCT02487446|40521789|FG001|Period 1|Adverse Event|5|||
16561217|NCT02487446|40521788|FG000|Washout|Lost to Follow-up|0|||
16561218|NCT02487446|40521789|FG001|Washout|Lost to Follow-up|2|||
16561219|NCT02487446|40521788|FG000|Washout|Withdrawal by Subject|1|||
16561220|NCT02487446|40521789|FG001|Washout|Withdrawal by Subject|4|||
16561221|NCT02487446|40521788|FG000|Washout|Adverse Event|2|||
16561222|NCT02487446|40521789|FG001|Washout|Adverse Event|2|||
16561223|NCT02487446|40521788|FG000|Period 2|Protocol deviation|0|||
16561224|NCT02487446|40521789|FG001|Period 2|Protocol deviation|1|||
16561225|NCT02487446|40521788|FG000|Period 2|Lost to Follow-up|1|||
16561226|NCT02487446|40521789|FG001|Period 2|Lost to Follow-up|1|||
16561227|NCT02487446|40521788|FG000|Period 2|Withdrawal by Subject|1|||
16561228|NCT02487446|40521789|FG001|Period 2|Withdrawal by Subject|1|||
16561229|NCT02487446|40521788|FG000|Period 2|Adverse Event|6|||
16561230|NCT02487446|40521789|FG001|Period 2|Adverse Event|2|||
16561231|NCT04523181|40521790|FG000|Overall Study|Withdrawal by Subject|4|||
16561232|NCT04523181|40521791|FG001|Overall Study|Withdrawal by Subject|5|||
16561233|NCT04523181|40521790|FG000|Overall Study|Lost to Follow-up|2|||
16561234|NCT04523181|40521791|FG001|Overall Study|Lost to Follow-up|3|||
16417657|NCT03596450|40008568|FG001|Overall Study|Other reasons|53|||
16417658|NCT03596450|40008567|FG000|Overall Study|Pregnancy|2|||
16417659|NCT03596450|40008568|FG001|Overall Study|Pregnancy|0|||
16354458|NCT02557295|39784346|FG001|Overall Study|Lack of Efficacy|1|||
16354459|NCT02557295|39784347|FG002|Overall Study|Lack of Efficacy|3|||
16354460|NCT02557295|39784348|FG003|Overall Study|Lack of Efficacy|0|||
16561235|NCT04523181|40521790|FG000|Overall Study|Physician Decision|1|||
16561236|NCT04523181|40521791|FG001|Overall Study|Physician Decision|0|||
16561237|NCT04523181|40521790|FG000|Overall Study|Transferred to external facility.|1|||
16561238|NCT04523181|40521791|FG001|Overall Study|Transferred to external facility.|1|||
16561239|NCT01268059|40521792|FG000|Overall Study|Lost to Follow-up|0|||
16354461|NCT02557295|39784349|FG004|Overall Study|Lack of Efficacy|0|||
16247007|NCT00679783|39388104|FG006|Overall Study|Ongoing at data cut-off|0|||
16247008|NCT00254397|39388105|FG000|Overall Study|Disease Progression|4|||
16247009|NCT00254397|39388106|FG001|Overall Study|Disease Progression|1|||
16247010|NCT00254397|39388107|FG002|Overall Study|Disease Progression|16|||
16247011|NCT00254397|39388108|FG003|Overall Study|Disease Progression|23|||
16247012|NCT00254397|39388105|FG000|Overall Study|Non-Compliant|0|||
16247013|NCT00254397|39388106|FG001|Overall Study|Non-Compliant|0|||
16247014|NCT00254397|39388107|FG002|Overall Study|Non-Compliant|0|||
16247015|NCT00254397|39388108|FG003|Overall Study|Non-Compliant|1|||
16247016|NCT00254397|39388105|FG000|Overall Study|Adverse Event|2|||
16247017|NCT00254397|39388106|FG001|Overall Study|Adverse Event|0|||
16247018|NCT00254397|39388107|FG002|Overall Study|Adverse Event|3|||
16247019|NCT00254397|39388108|FG003|Overall Study|Adverse Event|1|||
16247020|NCT02087059|39388109|FG000|Overall Study|Disease Progression|1|||
16247021|NCT02087059|39388109|FG000|Overall Study|Adverse Event|5|||
16247022|NCT02087059|39388109|FG000|Overall Study|Lost to Follow-up|1|||
16247023|NCT02123459|39388114|FG000|Washout Period (1 Day)|Adverse Event|1|||
16247024|NCT02123459|39388115|FG001|Washout Period (1 Day)|Adverse Event|0|||
16247025|NCT05216978|39388121|FG000|Overall Study|Withdrawal by Subject|3|||
16247026|NCT05216978|39388121|FG000|Overall Study|Lost to Follow-up|5|||
16247027|NCT02708277|39388122|FG000|Overall Study|Lost to Follow-up|7|||
16247028|NCT02708277|39388123|FG001|Overall Study|Lost to Follow-up|4|||
16247029|NCT02742090|39388124|FG000|Overall Study|Adverse Event|10|||
16247030|NCT02742090|39388124|FG000|Overall Study|Death|3|||
16247031|NCT02742090|39388124|FG000|Overall Study|Disease Progression|25|||
16247032|NCT02742090|39388124|FG000|Overall Study|Investigator's Decision|1|||
16247033|NCT02742090|39388124|FG000|Overall Study|Lost to Follow-up|1|||
16247034|NCT02742090|39388124|FG000|Overall Study|Non-compliance with Study|1|||
16354462|NCT02557295|39784350|FG005|Overall Study|Lack of Efficacy|0|||
16354463|NCT02557295|39784351|FG006|Overall Study|Lack of Efficacy|12|||
16354464|NCT02557295|39784352|FG007|Overall Study|Lack of Efficacy|1|||
16354465|NCT02557295|39784353|FG008|Overall Study|Lack of Efficacy|0|||
16354466|NCT02557295|39784345|FG000|Overall Study|Adverse Event|16|||
16354467|NCT02557295|39784346|FG001|Overall Study|Adverse Event|2|||
16354468|NCT02557295|39784347|FG002|Overall Study|Adverse Event|3|||
16354469|NCT02557295|39784348|FG003|Overall Study|Adverse Event|0|||
16354470|NCT02557295|39784349|FG004|Overall Study|Adverse Event|0|||
16354471|NCT02557295|39784350|FG005|Overall Study|Adverse Event|0|||
16354472|NCT02557295|39784351|FG006|Overall Study|Adverse Event|2|||
16417660|NCT01400412|40008571|FG000|Overall Study|Lost to Follow-up|4|||
16247035|NCT02742090|39388124|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
16247036|NCT02742090|39388124|FG000|Overall Study|Withdrawal by Subject|4|||
16354473|NCT02557295|39784352|FG007|Overall Study|Adverse Event|1|||
16354474|NCT02557295|39784353|FG008|Overall Study|Adverse Event|1|||
16247037|NCT02742090|39388124|FG000|Overall Study|Reason Not Specified|1|||
16247038|NCT02143947|39388126|FG000|Overall Study|Lost to Follow-up|4|||
16247039|NCT02143947|39388127|FG001|Overall Study|Lost to Follow-up|2|||
16247040|NCT00003102|39388128|FG000|Overall Study|Physician Decision|1|||
16247041|NCT00003102|39388129|FG001|Overall Study|Physician Decision|1|||
16247042|NCT00003102|39388130|FG002|Overall Study|Physician Decision|0|||
16247043|NCT00003102|39388128|FG000|Overall Study|Progressive Disease|0|||
16247044|NCT00003102|39388129|FG001|Overall Study|Progressive Disease|1|||
16247045|NCT00003102|39388130|FG002|Overall Study|Progressive Disease|0|||
16247046|NCT00003102|39388128|FG000|Overall Study|Adverse Event|0|||
16247047|NCT00003102|39388129|FG001|Overall Study|Adverse Event|1|||
16247048|NCT00003102|39388130|FG002|Overall Study|Adverse Event|1|||
16247049|NCT00003102|39388128|FG000|Overall Study|Death|0|||
16247050|NCT00003102|39388129|FG001|Overall Study|Death|0|||
16247051|NCT00003102|39388130|FG002|Overall Study|Death|1|||
16247052|NCT00417027|39388131|FG000|Overall Study|Protocol Violation|0|||
16247053|NCT00417027|39388132|FG001|Overall Study|Protocol Violation|5|||
16247054|NCT00417027|39388133|FG002|Overall Study|Protocol Violation|5|||
16247055|NCT02006147|39388134|FG000|Overall Study|Protocol Violation|1|||
16247056|NCT02006147|39388135|FG001|Overall Study|Protocol Violation|1|||
16247057|NCT02006147|39388136|FG002|Overall Study|Protocol Violation|0|||
16247058|NCT02006147|39388137|FG003|Overall Study|Protocol Violation|0|||
16561240|NCT01268059|40521793|FG001|Overall Study|Lost to Follow-up|1|||
16561241|NCT01268059|40521794|FG002|Overall Study|Lost to Follow-up|0|||
16561242|NCT01268059|40521795|FG003|Overall Study|Lost to Follow-up|0|||
16561243|NCT01268059|40521792|FG000|Overall Study|Withdrawal by Subject|7|||
16247059|NCT02006147|39388134|FG000|Overall Study|Withdrawal by Subject|0|||
16247060|NCT02006147|39388135|FG001|Overall Study|Withdrawal by Subject|1|||
16561244|NCT01268059|40521793|FG001|Overall Study|Withdrawal by Subject|4|||
16561245|NCT01268059|40521794|FG002|Overall Study|Withdrawal by Subject|0|||
16561246|NCT01268059|40521795|FG003|Overall Study|Withdrawal by Subject|0|||
16561247|NCT01268059|40521792|FG000|Overall Study|Death|20|||
16561248|NCT01268059|40521793|FG001|Overall Study|Death|30|||
16561249|NCT01268059|40521794|FG002|Overall Study|Death|3|||
16561250|NCT01268059|40521795|FG003|Overall Study|Death|5|||
16247061|NCT02006147|39388136|FG002|Overall Study|Withdrawal by Subject|0|||
16247062|NCT02006147|39388137|FG003|Overall Study|Withdrawal by Subject|0|||
16247063|NCT02006147|39388134|FG000|Overall Study|Withdrawal by Sponsor|1|||
16247064|NCT02006147|39388135|FG001|Overall Study|Withdrawal by Sponsor|0|||
16247065|NCT02006147|39388136|FG002|Overall Study|Withdrawal by Sponsor|0|||
16247066|NCT02006147|39388137|FG003|Overall Study|Withdrawal by Sponsor|0|||
16247067|NCT01464827|39388138|FG000|Overall Study|Adverse Event|0|||
16247068|NCT01464827|39388139|FG001|Overall Study|Adverse Event|0|||
16247069|NCT01464827|39388140|FG002|Overall Study|Adverse Event|0|||
16247070|NCT01464827|39388141|FG003|Overall Study|Adverse Event|0|||
16247071|NCT01464827|39388142|FG004|Overall Study|Adverse Event|0|||
16247072|NCT01464827|39388143|FG005|Overall Study|Adverse Event|0|||
16247073|NCT01464827|39388144|FG006|Overall Study|Adverse Event|0|||
16247074|NCT01464827|39388145|FG007|Overall Study|Adverse Event|0|||
16247075|NCT01464827|39388146|FG008|Overall Study|Adverse Event|0|||
16247076|NCT01464827|39388147|FG009|Overall Study|Adverse Event|0|||
16247077|NCT01464827|39388148|FG010|Overall Study|Adverse Event|0|||
16247078|NCT01464827|39388149|FG011|Overall Study|Adverse Event|0|||
16247079|NCT01464827|39388150|FG012|Overall Study|Adverse Event|1|||
16247080|NCT01464827|39388151|FG013|Overall Study|Adverse Event|0|||
16247081|NCT01464827|39388138|FG000|Overall Study|Withdrawal by Subject|1|||
16247082|NCT01464827|39388139|FG001|Overall Study|Withdrawal by Subject|0|||
16247083|NCT01464827|39388140|FG002|Overall Study|Withdrawal by Subject|0|||
16247084|NCT01464827|39388141|FG003|Overall Study|Withdrawal by Subject|0|||
16247085|NCT01464827|39388142|FG004|Overall Study|Withdrawal by Subject|1|||
16247086|NCT01464827|39388143|FG005|Overall Study|Withdrawal by Subject|0|||
16247087|NCT01464827|39388144|FG006|Overall Study|Withdrawal by Subject|0|||
16247088|NCT01464827|39388145|FG007|Overall Study|Withdrawal by Subject|1|||
16247089|NCT01464827|39388146|FG008|Overall Study|Withdrawal by Subject|0|||
16247090|NCT01464827|39388147|FG009|Overall Study|Withdrawal by Subject|0|||
16247091|NCT01464827|39388148|FG010|Overall Study|Withdrawal by Subject|0|||
16417661|NCT01400412|40008572|FG001|Overall Study|Lost to Follow-up|7|||
16561251|NCT01268059|40521792|FG000|Overall Study|Progression of disease|1|||
16247092|NCT01464827|39388149|FG011|Overall Study|Withdrawal by Subject|0|||
16247093|NCT01464827|39388150|FG012|Overall Study|Withdrawal by Subject|0|||
16561252|NCT01268059|40521793|FG001|Overall Study|Progression of disease|0|||
16561253|NCT01268059|40521794|FG002|Overall Study|Progression of disease|0|||
16354475|NCT02557295|39784345|FG000|Overall Study|Lost to Follow-up|4|||
16354476|NCT02557295|39784346|FG001|Overall Study|Lost to Follow-up|0|||
16354477|NCT02557295|39784347|FG002|Overall Study|Lost to Follow-up|0|||
16354478|NCT02557295|39784348|FG003|Overall Study|Lost to Follow-up|0|||
16354479|NCT02557295|39784349|FG004|Overall Study|Lost to Follow-up|0|||
16354480|NCT02557295|39784350|FG005|Overall Study|Lost to Follow-up|0|||
16354481|NCT02557295|39784351|FG006|Overall Study|Lost to Follow-up|9|||
16354482|NCT02557295|39784352|FG007|Overall Study|Lost to Follow-up|0|||
16354483|NCT02557295|39784353|FG008|Overall Study|Lost to Follow-up|0|||
16354484|NCT02557295|39784345|FG000|Overall Study|Study Close|54|||
16354485|NCT02557295|39784346|FG001|Overall Study|Study Close|3|||
16354486|NCT02557295|39784347|FG002|Overall Study|Study Close|5|||
16354487|NCT02557295|39784348|FG003|Overall Study|Study Close|3|||
16354488|NCT02557295|39784349|FG004|Overall Study|Study Close|0|||
16354489|NCT02557295|39784350|FG005|Overall Study|Study Close|0|||
16354490|NCT02557295|39784351|FG006|Overall Study|Study Close|37|||
16354491|NCT02557295|39784352|FG007|Overall Study|Study Close|3|||
16354492|NCT02557295|39784353|FG008|Overall Study|Study Close|19|||
16354493|NCT02557295|39784345|FG000|Overall Study|except for study close|4|||
16354494|NCT02557295|39784346|FG001|Overall Study|except for study close|0|||
16354495|NCT02557295|39784347|FG002|Overall Study|except for study close|0|||
16354496|NCT02557295|39784348|FG003|Overall Study|except for study close|0|||
16354497|NCT02557295|39784349|FG004|Overall Study|except for study close|0|||
16354498|NCT02557295|39784350|FG005|Overall Study|except for study close|0|||
16354499|NCT02557295|39784351|FG006|Overall Study|except for study close|5|||
16354500|NCT02557295|39784352|FG007|Overall Study|except for study close|1|||
16247094|NCT01464827|39388151|FG013|Overall Study|Withdrawal by Subject|0|||
16354501|NCT02557295|39784353|FG008|Overall Study|except for study close|0|||
16354502|NCT02456727|39784354|FG000|Overall Study|Lost to Follow-up|63|||
16354503|NCT02456727|39784355|FG001|Overall Study|Lost to Follow-up|65|||
16354504|NCT02456727|39784354|FG000|Overall Study|Death|2|||
16354505|NCT02456727|39784355|FG001|Overall Study|Death|1|||
16354506|NCT02456727|39784354|FG000|Overall Study|Withdrawal by Subject|1|||
16354507|NCT02456727|39784355|FG001|Overall Study|Withdrawal by Subject|10|||
16354508|NCT02456727|39784354|FG000|Overall Study|Never Initiated Treatment|43|||
16354509|NCT02456727|39784355|FG001|Overall Study|Never Initiated Treatment|30|||
16354510|NCT01305564|39784356|FG000|Overall Study|Death|21|||
16354511|NCT01305564|39784356|FG000|Overall Study|Lost to Follow-up|12|||
16247095|NCT01464827|39388138|FG000|Overall Study|Lost to Follow-up|0|||
16247096|NCT01464827|39388139|FG001|Overall Study|Lost to Follow-up|2|||
16247097|NCT01464827|39388140|FG002|Overall Study|Lost to Follow-up|0|||
16247098|NCT01464827|39388141|FG003|Overall Study|Lost to Follow-up|2|||
16247099|NCT01464827|39388142|FG004|Overall Study|Lost to Follow-up|3|||
16247100|NCT01464827|39388143|FG005|Overall Study|Lost to Follow-up|1|||
16247101|NCT01464827|39388144|FG006|Overall Study|Lost to Follow-up|2|||
16247102|NCT01464827|39388145|FG007|Overall Study|Lost to Follow-up|2|||
16247103|NCT01464827|39388146|FG008|Overall Study|Lost to Follow-up|0|||
16247104|NCT01464827|39388147|FG009|Overall Study|Lost to Follow-up|0|||
16247105|NCT01464827|39388148|FG010|Overall Study|Lost to Follow-up|0|||
16247106|NCT01464827|39388149|FG011|Overall Study|Lost to Follow-up|1|||
16247107|NCT01464827|39388150|FG012|Overall Study|Lost to Follow-up|0|||
16354512|NCT01305564|39784356|FG000|Overall Study|Withdrawal by Subject|1|||
16354513|NCT01305564|39784356|FG000|Overall Study|Physician Decision|3|||
16354514|NCT00269152|39784357|FG000|Overall Study|Adverse Event|9|||
16354515|NCT00269152|39784358|FG001|Overall Study|Adverse Event|3|||
16354516|NCT00269152|39784357|FG000|Overall Study|Withdrawal by Subject|7|||
16354517|NCT00269152|39784358|FG001|Overall Study|Withdrawal by Subject|3|||
16247108|NCT01464827|39388151|FG013|Overall Study|Lost to Follow-up|1|||
16247109|NCT01464827|39388138|FG000|Overall Study|Other|2|||
16247110|NCT01464827|39388139|FG001|Overall Study|Other|3|||
16247111|NCT01464827|39388140|FG002|Overall Study|Other|0|||
16354518|NCT00269152|39784357|FG000|Overall Study|Physician Decision|2|||
16354519|NCT00269152|39784358|FG001|Overall Study|Physician Decision|3|||
16354520|NCT00269152|39784357|FG000|Overall Study|Protocol Violation|0|||
16354521|NCT00269152|39784358|FG001|Overall Study|Protocol Violation|1|||
16354522|NCT00789321|39784359|FG000|Overall Study|Adverse Event|0|||
16354523|NCT00789321|39784360|FG001|Overall Study|Adverse Event|1|||
16354524|NCT01447407|39784365|FG000|Overall Study|Withdrawal by Subject|2|||
16354525|NCT01447407|39784366|FG001|Overall Study|Withdrawal by Subject|0|||
16354526|NCT01447407|39784367|FG002|Overall Study|Withdrawal by Subject|0|||
16354527|NCT01447407|39784368|FG003|Overall Study|Withdrawal by Subject|1|||
16354528|NCT01447407|39784365|FG000|Overall Study|Physician Decision|0|||
16354529|NCT01447407|39784366|FG001|Overall Study|Physician Decision|0|||
16354530|NCT01447407|39784367|FG002|Overall Study|Physician Decision|1|||
16354531|NCT01447407|39784368|FG003|Overall Study|Physician Decision|1|||
16354532|NCT02563899|39784369|FG000|Overall Study|Protocol Violation|1|||
16354533|NCT02563899|39784370|FG001|Overall Study|Protocol Violation|0|||
16354534|NCT02563899|39784371|FG002|Overall Study|Protocol Violation|0|||
16354535|NCT02563899|39784372|FG003|Overall Study|Protocol Violation|0|||
16354536|NCT02563899|39784369|FG000|Overall Study|Withdrawal by Subject|0|||
16354537|NCT02563899|39784370|FG001|Overall Study|Withdrawal by Subject|0|||
16354538|NCT02563899|39784371|FG002|Overall Study|Withdrawal by Subject|1|||
16354539|NCT02563899|39784372|FG003|Overall Study|Withdrawal by Subject|0|||
16354540|NCT00830128|39784373|FG000|Overall Study|Adverse Event|5|||
16354541|NCT00830128|39784373|FG000|Overall Study|Lack of Efficacy|7|||
16354542|NCT00830128|39784373|FG000|Overall Study|Protocol Violation|1|||
16354543|NCT00830128|39784373|FG000|Overall Study|Withdrawal by Subject|2|||
16354544|NCT00830128|39784373|FG000|Overall Study|Family obligation|1|||
16354545|NCT00830128|39784373|FG000|Overall Study|Relocation|1|||
16354546|NCT00830128|39784373|FG000|Overall Study|Work obligation|1|||
16354547|NCT00830128|39784373|FG000|Overall Study|Operating a vehicle|1|||
16354548|NCT03368664|39784380|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
16354549|NCT03368664|39784380|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
16354550|NCT03368664|39784380|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
16354551|NCT03368664|39784380|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
16354552|NCT02048722|39784382|FG000|2 Cycles of Treatment|Adverse Event|2|||
16354553|NCT02048722|39784382|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
16354554|NCT02048722|39784382|FG000|2 Cycles of Treatment|Progressive Disease|2|||
16354555|NCT02048722|39784382|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
16354556|NCT02048722|39784382|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
16354557|NCT02048722|39784382|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
16354558|NCT00641056|39784383|FG000|Overall Study|Adverse Event|12|||
16354559|NCT00641056|39784384|FG001|Overall Study|Adverse Event|2|||
16354560|NCT00641056|39784383|FG000|Overall Study|Lost to Follow-up|2|||
16354561|NCT00641056|39784384|FG001|Overall Study|Lost to Follow-up|1|||
16354562|NCT00641056|39784383|FG000|Overall Study|Physician Decision|3|||
16354563|NCT00641056|39784384|FG001|Overall Study|Physician Decision|1|||
16354564|NCT00641056|39784383|FG000|Overall Study|Protocol Violation|2|||
16354565|NCT00641056|39784384|FG001|Overall Study|Protocol Violation|0|||
16354566|NCT00641056|39784383|FG000|Overall Study|Entry Criteria Not Met|3|||
16354567|NCT00641056|39784384|FG001|Overall Study|Entry Criteria Not Met|0|||
16354568|NCT00641056|39784383|FG000|Overall Study|Subject Decision|6|||
16354569|NCT00641056|39784384|FG001|Overall Study|Subject Decision|19|||
16354570|NCT00641056|39784383|FG000|Overall Study|Sponsor Decision|1|||
16354571|NCT00641056|39784384|FG001|Overall Study|Sponsor Decision|2|||
16354572|NCT01287936|39784387|FG000|Overall Study|Lost to Follow-up|0|||
16354573|NCT01287936|39784388|FG001|Overall Study|Lost to Follow-up|1|||
16247112|NCT01464827|39388141|FG003|Overall Study|Other|2|||
16247113|NCT01464827|39388142|FG004|Overall Study|Other|3|||
16247114|NCT01464827|39388143|FG005|Overall Study|Other|0|||
16247115|NCT01464827|39388144|FG006|Overall Study|Other|1|||
16247116|NCT01464827|39388145|FG007|Overall Study|Other|0|||
16247117|NCT01464827|39388146|FG008|Overall Study|Other|3|||
16247118|NCT01464827|39388147|FG009|Overall Study|Other|1|||
16247119|NCT01464827|39388148|FG010|Overall Study|Other|2|||
16247120|NCT01464827|39388149|FG011|Overall Study|Other|0|||
16354574|NCT01287936|39784389|FG002|Overall Study|Lost to Follow-up|1|||
16354575|NCT01614470|39784390|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
16354576|NCT01614470|39784391|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
16354577|NCT01614470|39784392|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
16354578|NCT01614470|39784390|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
16247121|NCT01464827|39388150|FG012|Overall Study|Other|1|||
16354579|NCT01614470|39784391|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
16354580|NCT01614470|39784392|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
16354581|NCT03054428|39784393|FG000|Overall Study|Physician Decision|0|||
16354582|NCT03054428|39784394|FG001|Overall Study|Physician Decision|1|||
16354583|NCT03054428|39784395|FG002|Overall Study|Physician Decision|1|||
16354584|NCT03054428|39784393|FG000|Overall Study|Lack of Efficacy|3|||
16354585|NCT03054428|39784394|FG001|Overall Study|Lack of Efficacy|1|||
16354586|NCT03054428|39784395|FG002|Overall Study|Lack of Efficacy|0|||
16354587|NCT03054428|39784393|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
16247122|NCT01464827|39388151|FG013|Overall Study|Other|0|||
16247123|NCT01464827|39388138|FG000|Overall Study|Not Treated|0|||
16247124|NCT01464827|39388139|FG001|Overall Study|Not Treated|2|||
16354588|NCT03054428|39784394|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
16354589|NCT03054428|39784395|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
16354590|NCT03054428|39784393|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
16354591|NCT03054428|39784394|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
16354592|NCT03054428|39784395|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
16354593|NCT03054428|39784393|FG000|Overall Study|Transitioned to OLE study|76|||
16354594|NCT03054428|39784394|FG001|Overall Study|Transitioned to OLE study|76|||
16354595|NCT03054428|39784395|FG002|Overall Study|Transitioned to OLE study|73|||
16354596|NCT03054428|39784393|FG000|Overall Study|Withdrawal by Subject|3|||
16354597|NCT03054428|39784394|FG001|Overall Study|Withdrawal by Subject|2|||
16354598|NCT03054428|39784395|FG002|Overall Study|Withdrawal by Subject|3|||
16354599|NCT03054428|39784393|FG000|Overall Study|Lost to Follow-up|0|||
16354600|NCT03054428|39784394|FG001|Overall Study|Lost to Follow-up|0|||
16354601|NCT03054428|39784395|FG002|Overall Study|Lost to Follow-up|1|||
16354602|NCT02074514|39784396|FG000|Overall Study|Lack of Efficacy|3|||
16354603|NCT02074514|39784397|FG001|Overall Study|Lack of Efficacy|2|||
16354604|NCT02074514|39784396|FG000|Overall Study|Lost to Follow-up|0|||
16354605|NCT02074514|39784397|FG001|Overall Study|Lost to Follow-up|1|||
16354606|NCT02074514|39784396|FG000|Overall Study|Withdrew Consent|0|||
16354607|NCT02074514|39784397|FG001|Overall Study|Withdrew Consent|1|||
16354608|NCT01285518|39784398|FG000|Overall Study|Lost to Follow-up|0|||
16354609|NCT01285518|39784399|FG001|Overall Study|Lost to Follow-up|0|||
16354610|NCT01285518|39784400|FG002|Overall Study|Lost to Follow-up|0|||
16354611|NCT01285518|39784401|FG003|Overall Study|Lost to Follow-up|0|||
16354612|NCT01285518|39784402|FG004|Overall Study|Lost to Follow-up|0|||
16354613|NCT01285518|39784403|FG005|Overall Study|Lost to Follow-up|1|||
16354614|NCT01285518|39784404|FG006|Overall Study|Lost to Follow-up|0|||
16354615|NCT01285518|39784405|FG007|Overall Study|Lost to Follow-up|0|||
16354616|NCT00705757|39784406|FG000|Overall Study|Lack of Efficacy|5|||
16354617|NCT00705757|39784407|FG001|Overall Study|Lack of Efficacy|1|||
16354618|NCT00705757|39784408|FG002|Overall Study|Lack of Efficacy|3|||
16354619|NCT00705757|39784406|FG000|Overall Study|Lost to Follow-up|7|||
16354620|NCT00705757|39784407|FG001|Overall Study|Lost to Follow-up|6|||
16130561|NCT00196976|38967059|FG010|Primary Study|Other|0|||
16247125|NCT01464827|39388140|FG002|Overall Study|Not Treated|0|||
16247126|NCT01464827|39388141|FG003|Overall Study|Not Treated|0|||
16247127|NCT01464827|39388142|FG004|Overall Study|Not Treated|1|||
16247128|NCT01464827|39388143|FG005|Overall Study|Not Treated|0|||
16247129|NCT01464827|39388144|FG006|Overall Study|Not Treated|1|||
16247130|NCT01464827|39388145|FG007|Overall Study|Not Treated|0|||
16247131|NCT01464827|39388146|FG008|Overall Study|Not Treated|0|||
16247132|NCT01464827|39388147|FG009|Overall Study|Not Treated|2|||
16247133|NCT01464827|39388148|FG010|Overall Study|Not Treated|0|||
16247134|NCT01464827|39388149|FG011|Overall Study|Not Treated|1|||
16247135|NCT01464827|39388150|FG012|Overall Study|Not Treated|0|||
16247136|NCT01464827|39388151|FG013|Overall Study|Not Treated|2|||
16247137|NCT03384745|39388152|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
16247138|NCT03384745|39388153|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
16247139|NCT03384745|39388154|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
16247140|NCT03384745|39388155|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
16247141|NCT03384745|39388156|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
16247142|NCT03384745|39388157|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
16247143|NCT03384745|39388152|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
16247144|NCT03384745|39388153|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
16247145|NCT03384745|39388154|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
16247146|NCT03384745|39388155|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
16247147|NCT03384745|39388156|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
16247148|NCT03384745|39388157|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
16247149|NCT03384745|39388152|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
16247150|NCT03384745|39388153|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
16247151|NCT03384745|39388154|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
16354621|NCT00705757|39784408|FG002|Overall Study|Lost to Follow-up|6|||
16354622|NCT00705757|39784406|FG000|Overall Study|Withdrawal by Subject|1|||
16354623|NCT00705757|39784407|FG001|Overall Study|Withdrawal by Subject|1|||
16354624|NCT00705757|39784408|FG002|Overall Study|Withdrawal by Subject|2|||
16354625|NCT02498678|39784409|FG000|Overall Study|interference from the surgical team|0|||
16354626|NCT02498678|39784410|FG001|Overall Study|interference from the surgical team|2|||
16354627|NCT03555149|39784430|FG000|Overall Study|Death|18|||
16354628|NCT03555149|39784431|FG001|Overall Study|Death|15|||
16354629|NCT03555149|39784432|FG002|Overall Study|Death|15|||
16354630|NCT03555149|39784433|FG003|Overall Study|Death|4|||
16354631|NCT03555149|39784434|FG004|Overall Study|Death|4|||
16354632|NCT03555149|39784435|FG005|Overall Study|Death|11|||
16354633|NCT03555149|39784436|FG006|Overall Study|Death|12|||
16354634|NCT03555149|39784437|FG007|Overall Study|Death|1|||
16354635|NCT03555149|39784430|FG000|Overall Study|Lost to Follow-up|1|||
16354636|NCT03555149|39784431|FG001|Overall Study|Lost to Follow-up|0|||
16354637|NCT03555149|39784432|FG002|Overall Study|Lost to Follow-up|0|||
16354638|NCT03555149|39784433|FG003|Overall Study|Lost to Follow-up|0|||
16354639|NCT03555149|39784434|FG004|Overall Study|Lost to Follow-up|0|||
16354640|NCT03555149|39784435|FG005|Overall Study|Lost to Follow-up|1|||
16354641|NCT03555149|39784436|FG006|Overall Study|Lost to Follow-up|0|||
16354642|NCT03555149|39784437|FG007|Overall Study|Lost to Follow-up|0|||
16354643|NCT03555149|39784430|FG000|Overall Study|Physician Decision|1|||
16354644|NCT03555149|39784431|FG001|Overall Study|Physician Decision|0|||
16354645|NCT03555149|39784432|FG002|Overall Study|Physician Decision|0|||
16354646|NCT03555149|39784433|FG003|Overall Study|Physician Decision|0|||
16354647|NCT03555149|39784434|FG004|Overall Study|Physician Decision|0|||
16354648|NCT03555149|39784435|FG005|Overall Study|Physician Decision|0|||
16354649|NCT03555149|39784436|FG006|Overall Study|Physician Decision|0|||
16354650|NCT03555149|39784437|FG007|Overall Study|Physician Decision|0|||
16354651|NCT03555149|39784430|FG000|Overall Study|Study Terminated By Sponsor|1|||
16354652|NCT03555149|39784431|FG001|Overall Study|Study Terminated By Sponsor|0|||
16354653|NCT03555149|39784432|FG002|Overall Study|Study Terminated By Sponsor|0|||
16354654|NCT03555149|39784433|FG003|Overall Study|Study Terminated By Sponsor|0|||
16354655|NCT03555149|39784434|FG004|Overall Study|Study Terminated By Sponsor|0|||
16354656|NCT03555149|39784435|FG005|Overall Study|Study Terminated By Sponsor|2|||
16354657|NCT03555149|39784436|FG006|Overall Study|Study Terminated By Sponsor|3|||
16354658|NCT03555149|39784437|FG007|Overall Study|Study Terminated By Sponsor|1|||
16354659|NCT03555149|39784430|FG000|Overall Study|Withdrawal by Subject|3|||
16247152|NCT03384745|39388155|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
16247153|NCT03384745|39388156|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
16247154|NCT03384745|39388157|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
16247155|NCT03384745|39388152|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
16247156|NCT03384745|39388153|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
16247157|NCT03384745|39388154|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
16247158|NCT03384745|39388155|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
16247159|NCT03384745|39388156|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
16247160|NCT03384745|39388157|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
16247161|NCT03384745|39388152|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
16247162|NCT03384745|39388153|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
16247163|NCT03384745|39388154|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
16247164|NCT03384745|39388155|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
16247165|NCT03384745|39388156|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
16247166|NCT03384745|39388157|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
16247167|NCT03384745|39388152|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
16247168|NCT03384745|39388153|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
16247169|NCT03384745|39388154|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
16247170|NCT03384745|39388155|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
16247171|NCT03384745|39388156|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
16247172|NCT03384745|39388157|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
16247173|NCT03384745|39388152|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
16247174|NCT03384745|39388153|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
16247175|NCT03384745|39388154|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
16247176|NCT03384745|39388155|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
16247177|NCT03384745|39388156|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
16247178|NCT03384745|39388157|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
16247179|NCT03384745|39388152|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
16247180|NCT03384745|39388153|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
16247181|NCT03384745|39388154|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
16247182|NCT03384745|39388155|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
16354660|NCT03555149|39784431|FG001|Overall Study|Withdrawal by Subject|0|||
16354661|NCT03555149|39784432|FG002|Overall Study|Withdrawal by Subject|0|||
16354662|NCT03555149|39784433|FG003|Overall Study|Withdrawal by Subject|2|||
16354663|NCT03555149|39784434|FG004|Overall Study|Withdrawal by Subject|0|||
16354664|NCT03555149|39784435|FG005|Overall Study|Withdrawal by Subject|1|||
16354665|NCT03555149|39784436|FG006|Overall Study|Withdrawal by Subject|0|||
16354666|NCT03555149|39784437|FG007|Overall Study|Withdrawal by Subject|0|||
16354667|NCT00468585|39784438|FG000|Overall Study|Patient not treated|1|||
16354668|NCT00468585|39784439|FG001|Overall Study|Patient not treated|0|||
16354669|NCT00468585|39784440|FG002|Overall Study|Patient not treated|1|||
16354670|NCT00468585|39784441|FG003|Overall Study|Patient not treated|0|||
16354671|NCT00468585|39784438|FG000|Overall Study|Patient found to be ineligible|0|||
16354672|NCT00468585|39784439|FG001|Overall Study|Patient found to be ineligible|0|||
16354673|NCT00468585|39784440|FG002|Overall Study|Patient found to be ineligible|1|||
16354674|NCT00468585|39784441|FG003|Overall Study|Patient found to be ineligible|0|||
16354675|NCT00468585|39784438|FG000|Overall Study|Adverse Event|0|||
16354676|NCT00468585|39784439|FG001|Overall Study|Adverse Event|0|||
16247183|NCT03384745|39388156|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
16247184|NCT03384745|39388157|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
16247185|NCT03384745|39388152|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
16247186|NCT03384745|39388153|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
16247187|NCT03384745|39388154|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
16247188|NCT03384745|39388155|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
16247189|NCT03384745|39388156|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
16247190|NCT03384745|39388157|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
16247191|NCT03384745|39388152|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
16247192|NCT03384745|39388153|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
16247193|NCT03384745|39388154|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
16247194|NCT03384745|39388155|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
16247195|NCT03384745|39388156|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
16247196|NCT03384745|39388157|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
16247197|NCT03384745|39388152|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
16247198|NCT03384745|39388153|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
16247199|NCT03384745|39388154|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
16247200|NCT03384745|39388155|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
16247201|NCT03384745|39388156|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
16247202|NCT03384745|39388157|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
16247203|NCT02472977|39388158|FG000|Overall Study|Disease progression|4|||
16247204|NCT02472977|39388159|FG001|Overall Study|Disease progression|25|||
16247205|NCT02472977|39388160|FG002|Overall Study|Disease progression|6|||
16247206|NCT02472977|39388158|FG000|Overall Study|Withdrawal by Subject|0|||
16247207|NCT02472977|39388159|FG001|Overall Study|Withdrawal by Subject|1|||
16247208|NCT02472977|39388160|FG002|Overall Study|Withdrawal by Subject|0|||
16247209|NCT02472977|39388158|FG000|Overall Study|Study drug toxicity|2|||
16247210|NCT02472977|39388159|FG001|Overall Study|Study drug toxicity|0|||
16247211|NCT02472977|39388160|FG002|Overall Study|Study drug toxicity|2|||
16247212|NCT02472977|39388158|FG000|Overall Study|Subject request to discontinue treatment|0|||
16247213|NCT02472977|39388159|FG001|Overall Study|Subject request to discontinue treatment|1|||
16247214|NCT02472977|39388160|FG002|Overall Study|Subject request to discontinue treatment|0|||
16561254|NCT01268059|40521795|FG003|Overall Study|Progression of disease|0|||
16561255|NCT01641861|40521796|FG000|Overall Study|Lost to Follow-up|21|||
16561256|NCT01641861|40521797|FG001|Overall Study|Lost to Follow-up|16|||
16561257|NCT01641861|40521796|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
16561258|NCT01641861|40521797|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
16561259|NCT01641861|40521796|FG000|Overall Study|Died due to drowning|0|||
16247215|NCT01564758|39388162|FG000|Overall Study|Death|8|||
16247216|NCT01564758|39388162|FG000|Overall Study|Adverse Event|3|||
16247217|NCT01564758|39388162|FG000|Overall Study|Other|3|||
16247218|NCT00106028|39388166|FG000|Overall Study|Adverse Event|3|||
16247219|NCT00106028|39388167|FG001|Overall Study|Adverse Event|2|||
16247220|NCT00106028|39388166|FG000|Overall Study|Protocol Violation|1|||
16247221|NCT00106028|39388167|FG001|Overall Study|Protocol Violation|1|||
16247222|NCT00106028|39388166|FG000|Overall Study|Withdrawal by Subject|2|||
16247223|NCT00106028|39388167|FG001|Overall Study|Withdrawal by Subject|8|||
16247224|NCT00106028|39388166|FG000|Overall Study|Lost to Follow-up|0|||
16247225|NCT00106028|39388167|FG001|Overall Study|Lost to Follow-up|1|||
16247226|NCT00832078|39388169|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
16247227|NCT00832078|39388170|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
16247228|NCT00832078|39388169|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
16247229|NCT00832078|39388170|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
16247230|NCT02577354|39388172|FG000|Overall Study|Lack of Efficacy|4|||
16247231|NCT02577354|39388173|FG001|Overall Study|Lack of Efficacy|4|||
16247232|NCT02577354|39388172|FG000|Overall Study|Lost to Follow-up|3|||
16247233|NCT02577354|39388173|FG001|Overall Study|Lost to Follow-up|1|||
16247234|NCT02577354|39388172|FG000|Overall Study|Missed Visit|4|||
16247235|NCT02577354|39388173|FG001|Overall Study|Missed Visit|3|||
16247236|NCT02577354|39388172|FG000|Overall Study|Adverse Event|4|||
16247237|NCT02577354|39388173|FG001|Overall Study|Adverse Event|5|||
16247238|NCT00395083|39388174|FG000|Overall Study|Withdrawal by Subject|6|||
16247239|NCT00395083|39388175|FG001|Overall Study|Withdrawal by Subject|5|||
16247240|NCT00395083|39388174|FG000|Overall Study|Developed another disease|4|||
16417662|NCT01400412|40008571|FG000|Overall Study|Withdrawal by Subject|3|||
16417663|NCT01400412|40008572|FG001|Overall Study|Withdrawal by Subject|4|||
16417664|NCT01400412|40008571|FG000|Overall Study|Unable to complete|3|||
16417665|NCT01400412|40008572|FG001|Overall Study|Unable to complete|3|||
16417666|NCT01400412|40008571|FG000|Overall Study|Never started study treatment|0|||
16417667|NCT01400412|40008572|FG001|Overall Study|Never started study treatment|3|||
16417668|NCT03517566|40008573|FG000|Overall Study|Adverse Event|5|||
16417669|NCT03517566|40008574|FG001|Overall Study|Adverse Event|2|||
16417670|NCT03517566|40008575|FG002|Overall Study|Adverse Event|2|||
16417671|NCT03517566|40008576|FG003|Overall Study|Adverse Event|8|||
16417672|NCT03517566|40008577|FG004|Overall Study|Adverse Event|7|||
16417673|NCT03517566|40008573|FG000|Overall Study|Lack of Efficacy|3|||
16417674|NCT03517566|40008574|FG001|Overall Study|Lack of Efficacy|2|||
16417675|NCT03517566|40008575|FG002|Overall Study|Lack of Efficacy|1|||
16417676|NCT03517566|40008576|FG003|Overall Study|Lack of Efficacy|1|||
16417677|NCT03517566|40008577|FG004|Overall Study|Lack of Efficacy|4|||
16417678|NCT03517566|40008573|FG000|Overall Study|Lost to Follow-up|3|||
16417679|NCT03517566|40008574|FG001|Overall Study|Lost to Follow-up|1|||
16417680|NCT03517566|40008575|FG002|Overall Study|Lost to Follow-up|1|||
16417681|NCT03517566|40008576|FG003|Overall Study|Lost to Follow-up|1|||
16417682|NCT03517566|40008577|FG004|Overall Study|Lost to Follow-up|0|||
16417683|NCT03517566|40008573|FG000|Overall Study|Physician Decision|1|||
16417684|NCT03517566|40008574|FG001|Overall Study|Physician Decision|1|||
16417685|NCT03517566|40008575|FG002|Overall Study|Physician Decision|0|||
16417686|NCT03517566|40008576|FG003|Overall Study|Physician Decision|1|||
16417687|NCT03517566|40008577|FG004|Overall Study|Physician Decision|0|||
16417688|NCT03517566|40008573|FG000|Overall Study|Pregnancy|0|||
16417689|NCT03517566|40008574|FG001|Overall Study|Pregnancy|1|||
16417690|NCT03517566|40008575|FG002|Overall Study|Pregnancy|0|||
16417691|NCT03517566|40008576|FG003|Overall Study|Pregnancy|0|||
16417692|NCT03517566|40008577|FG004|Overall Study|Pregnancy|0|||
16417693|NCT03517566|40008573|FG000|Overall Study|Protocol Deviation|0|||
16417694|NCT03517566|40008574|FG001|Overall Study|Protocol Deviation|1|||
16417695|NCT03517566|40008575|FG002|Overall Study|Protocol Deviation|0|||
16417696|NCT03517566|40008576|FG003|Overall Study|Protocol Deviation|1|||
16247241|NCT00395083|39388175|FG001|Overall Study|Developed another disease|3|||
16247242|NCT01625377|39388176|FG000|Overall Study|Death|1|||
16247243|NCT01625377|39388177|FG001|Overall Study|Death|1|||
16247244|NCT01625377|39388176|FG000|Overall Study|Administrative Problem|1|||
16247245|NCT01625377|39388177|FG001|Overall Study|Administrative Problem|1|||
16247246|NCT01625377|39388176|FG000|Overall Study|Protocol Violation|0|||
16247247|NCT01625377|39388177|FG001|Overall Study|Protocol Violation|3|||
16247248|NCT01625377|39388176|FG000|Overall Study|Adverse Event|3|||
16247249|NCT01625377|39388177|FG001|Overall Study|Adverse Event|16|||
16247250|NCT01625377|39388176|FG000|Overall Study|Graft loss|1|||
16247251|NCT01625377|39388177|FG001|Overall Study|Graft loss|0|||
16247252|NCT01625377|39388176|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16247253|NCT01625377|39388177|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16247254|NCT01625377|39388176|FG000|Overall Study|Abnormal laboratory values|1|||
16247255|NCT01625377|39388177|FG001|Overall Study|Abnormal laboratory values|0|||
16247256|NCT02140164|39388180|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
16247257|NCT02444533|39388181|FG000|Overall Study|Not able to complete forms|0|||
16247258|NCT02444533|39388182|FG001|Overall Study|Not able to complete forms|2|||
16247259|NCT02444533|39388181|FG000|Overall Study|Only gave post-procedure complications|2|||
16247260|NCT02444533|39388182|FG001|Overall Study|Only gave post-procedure complications|2|||
16247261|NCT02752776|39388183|FG000|Overall Study|Adverse Event|15|||
16247262|NCT02752776|39388184|FG001|Overall Study|Adverse Event|23|||
16247263|NCT02752776|39388185|FG002|Overall Study|Adverse Event|11|||
16247264|NCT02752776|39388183|FG000|Overall Study|Lack of Efficacy|2|||
16247265|NCT02752776|39388184|FG001|Overall Study|Lack of Efficacy|6|||
16247266|NCT02752776|39388185|FG002|Overall Study|Lack of Efficacy|14|||
16247267|NCT02752776|39388183|FG000|Overall Study|Lost to Follow-up|11|||
16247268|NCT02752776|39388184|FG001|Overall Study|Lost to Follow-up|12|||
16247269|NCT02752776|39388185|FG002|Overall Study|Lost to Follow-up|4|||
16247270|NCT02752776|39388183|FG000|Overall Study|Non-compliance with study treatment|0|||
16247271|NCT02752776|39388184|FG001|Overall Study|Non-compliance with study treatment|0|||
16417697|NCT03517566|40008577|FG004|Overall Study|Protocol Deviation|1|||
16417698|NCT03517566|40008573|FG000|Overall Study|Study terminated by Sponsor|11|||
16417699|NCT03517566|40008574|FG001|Overall Study|Study terminated by Sponsor|5|||
16417700|NCT03517566|40008575|FG002|Overall Study|Study terminated by Sponsor|6|||
16417701|NCT03517566|40008576|FG003|Overall Study|Study terminated by Sponsor|14|||
16417702|NCT03517566|40008577|FG004|Overall Study|Study terminated by Sponsor|12|||
16417703|NCT03517566|40008573|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
16417704|NCT03517566|40008574|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
16247272|NCT02752776|39388185|FG002|Overall Study|Non-compliance with study treatment|1|||
16247273|NCT02752776|39388183|FG000|Overall Study|Physician Decision|2|||
16247274|NCT02752776|39388184|FG001|Overall Study|Physician Decision|6|||
16247275|NCT02752776|39388185|FG002|Overall Study|Physician Decision|2|||
16247276|NCT02752776|39388183|FG000|Overall Study|Pregnancy|1|||
16247277|NCT02752776|39388184|FG001|Overall Study|Pregnancy|6|||
16247278|NCT02752776|39388185|FG002|Overall Study|Pregnancy|3|||
16247279|NCT02752776|39388183|FG000|Overall Study|Protocol Violation|10|||
16247280|NCT02752776|39388184|FG001|Overall Study|Protocol Violation|13|||
16247281|NCT02752776|39388185|FG002|Overall Study|Protocol Violation|6|||
16417705|NCT03517566|40008575|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
16417706|NCT03517566|40008576|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
16417707|NCT03517566|40008577|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
16417708|NCT01831817|40008578|FG000|Overall Study|Lost to Follow-up|1|||
16417709|NCT01831817|40008579|FG001|Overall Study|Lost to Follow-up|0|||
16417710|NCT01831817|40008580|FG002|Overall Study|Lost to Follow-up|0|||
16417711|NCT01831817|40008581|FG003|Overall Study|Lost to Follow-up|0|||
16417712|NCT01831817|40008578|FG000|Overall Study|Withdrawl of Consent|3|||
16417713|NCT01831817|40008579|FG001|Overall Study|Withdrawl of Consent|0|||
16417714|NCT01831817|40008580|FG002|Overall Study|Withdrawl of Consent|0|||
16417715|NCT01831817|40008581|FG003|Overall Study|Withdrawl of Consent|0|||
16561260|NCT01641861|40521797|FG001|Overall Study|Died due to drowning|1|||
16561261|NCT01668147|40521799|FG000|Overall Study|Withdrawal by Subject|6|||
16561262|NCT00691028|40521800|FG000|Open-label Period|Adverse Event|0|||
16561263|NCT00691028|40521801|FG001|Open-label Period|Adverse Event|0|||
16561264|NCT00691028|40521802|FG002|Open-label Period|Adverse Event|0|||
16561265|NCT00691028|40521803|FG003|Open-label Period|Adverse Event|16|||
16561266|NCT00691028|40521800|FG000|Open-label Period|Withdrawal by Subject|0|||
16561267|NCT00691028|40521801|FG001|Open-label Period|Withdrawal by Subject|0|||
16561268|NCT00691028|40521802|FG002|Open-label Period|Withdrawal by Subject|0|||
16561269|NCT00691028|40521803|FG003|Open-label Period|Withdrawal by Subject|3|||
16561270|NCT00691028|40521800|FG000|Open-label Period|not come to a hospital|0|||
16561271|NCT00691028|40521801|FG001|Open-label Period|not come to a hospital|0|||
16561272|NCT00691028|40521802|FG002|Open-label Period|not come to a hospital|0|||
16561273|NCT00691028|40521803|FG003|Open-label Period|not come to a hospital|1|||
16561274|NCT00691028|40521800|FG000|Double-blind Period|Adverse Event|8|||
16561275|NCT00691028|40521801|FG001|Double-blind Period|Adverse Event|9|||
16561276|NCT00691028|40521802|FG002|Double-blind Period|Adverse Event|6|||
16561277|NCT00691028|40521803|FG003|Double-blind Period|Adverse Event|0|||
16561278|NCT00691028|40521800|FG000|Double-blind Period|Lack of Efficacy|4|||
16561279|NCT00691028|40521801|FG001|Double-blind Period|Lack of Efficacy|3|||
16561280|NCT00691028|40521802|FG002|Double-blind Period|Lack of Efficacy|2|||
16561281|NCT00691028|40521803|FG003|Double-blind Period|Lack of Efficacy|0|||
16561282|NCT00691028|40521800|FG000|Double-blind Period|Withdrawal by Subject|1|||
16561283|NCT00691028|40521801|FG001|Double-blind Period|Withdrawal by Subject|0|||
16561284|NCT00691028|40521802|FG002|Double-blind Period|Withdrawal by Subject|1|||
16561285|NCT00691028|40521803|FG003|Double-blind Period|Withdrawal by Subject|0|||
16247282|NCT02752776|39388183|FG000|Overall Study|Subject/guardian decision|8|||
16247283|NCT02752776|39388184|FG001|Overall Study|Subject/guardian decision|6|||
16417716|NCT01624090|40008584|FG000|Overall Study|DLT, taken off therapy|0|||
16417717|NCT01624090|40008585|FG001|Overall Study|DLT, taken off therapy|1|||
16561286|NCT00691028|40521800|FG000|Double-blind Period|not come to a hospital.|0|||
16561287|NCT00691028|40521801|FG001|Double-blind Period|not come to a hospital.|1|||
16561288|NCT00691028|40521802|FG002|Double-blind Period|not come to a hospital.|0|||
16561289|NCT00691028|40521803|FG003|Double-blind Period|not come to a hospital.|0|||
16561290|NCT04530344|40521806|FG000|Overall Study|Lost to Follow-up|3|||
16561291|NCT04530344|40521807|FG001|Overall Study|Lost to Follow-up|3|||
16417718|NCT01624090|40008586|FG002|Overall Study|DLT, taken off therapy|0|||
16417719|NCT01624090|40008587|FG003|Overall Study|DLT, taken off therapy|0|||
16417720|NCT01624090|40008584|FG000|Overall Study|Withdrew prior to treatment|0|||
16417721|NCT01624090|40008585|FG001|Overall Study|Withdrew prior to treatment|1|||
16417722|NCT01624090|40008586|FG002|Overall Study|Withdrew prior to treatment|0|||
16417723|NCT01624090|40008587|FG003|Overall Study|Withdrew prior to treatment|0|||
16417724|NCT01624090|40008584|FG000|Overall Study|Died on study|0|||
16561292|NCT04530344|40521808|FG002|Overall Study|Lost to Follow-up|3|||
16561293|NCT04530344|40521809|FG003|Overall Study|Lost to Follow-up|10|||
16561294|NCT04530344|40521806|FG000|Overall Study|Withdrawal by Subject|14|||
16561295|NCT04530344|40521807|FG001|Overall Study|Withdrawal by Subject|5|||
16561296|NCT04530344|40521808|FG002|Overall Study|Withdrawal by Subject|18|||
16561297|NCT04530344|40521809|FG003|Overall Study|Withdrawal by Subject|33|||
16561298|NCT04530344|40521806|FG000|Overall Study|Adverse Event|0|||
16561299|NCT04530344|40521807|FG001|Overall Study|Adverse Event|0|||
16561300|NCT04530344|40521808|FG002|Overall Study|Adverse Event|0|||
16561301|NCT04530344|40521809|FG003|Overall Study|Adverse Event|1|||
16561302|NCT04530344|40521806|FG000|Overall Study|Lack of Efficacy|0|||
16561303|NCT04530344|40521807|FG001|Overall Study|Lack of Efficacy|0|||
16561304|NCT04530344|40521808|FG002|Overall Study|Lack of Efficacy|0|||
16561305|NCT04530344|40521809|FG003|Overall Study|Lack of Efficacy|1|||
16561306|NCT04530344|40521806|FG000|Overall Study|Physician Decision|0|||
16561307|NCT04530344|40521807|FG001|Overall Study|Physician Decision|0|||
16561308|NCT04530344|40521808|FG002|Overall Study|Physician Decision|1|||
16561309|NCT04530344|40521809|FG003|Overall Study|Physician Decision|1|||
16561310|NCT04530344|40521806|FG000|Overall Study|Pregnancy|0|||
16561311|NCT04530344|40521807|FG001|Overall Study|Pregnancy|0|||
16561312|NCT04530344|40521808|FG002|Overall Study|Pregnancy|2|||
16561313|NCT04530344|40521809|FG003|Overall Study|Pregnancy|1|||
16561314|NCT04530344|40521806|FG000|Overall Study|Protocol Violation|0|||
16561315|NCT04530344|40521807|FG001|Overall Study|Protocol Violation|0|||
16561316|NCT04530344|40521808|FG002|Overall Study|Protocol Violation|0|||
16561317|NCT04530344|40521809|FG003|Overall Study|Protocol Violation|1|||
16561318|NCT04530344|40521806|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
16561319|NCT04530344|40521807|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
16561320|NCT04530344|40521808|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
16561321|NCT04530344|40521809|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
16561322|NCT04530344|40521806|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
16561323|NCT04530344|40521807|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
16561324|NCT04530344|40521808|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
16561325|NCT04530344|40521809|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
16561326|NCT04530344|40521806|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
16561327|NCT04530344|40521807|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
16561328|NCT04530344|40521808|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
16561329|NCT04530344|40521809|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
16561330|NCT04530344|40521806|FG000|Overall Study|Personal Reasons|0|||
16561331|NCT04530344|40521807|FG001|Overall Study|Personal Reasons|0|||
16561332|NCT04530344|40521808|FG002|Overall Study|Personal Reasons|0|||
16561333|NCT04530344|40521809|FG003|Overall Study|Personal Reasons|1|||
16561334|NCT04530344|40521806|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
16561335|NCT04530344|40521807|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
16561336|NCT04530344|40521808|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
16561337|NCT04530344|40521809|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
16561338|NCT02268396|40521810|FG000|Overall Study|Adverse Event|3|||
16561339|NCT02268396|40521810|FG000|Overall Study|Administrative|2|||
16561340|NCT02268396|40521810|FG000|Overall Study|Withdrawal by Subject|1|||
16561341|NCT02268396|40521810|FG000|Overall Study|Lost to Follow-up|2|||
16561342|NCT02268396|40521810|FG000|Overall Study|Protocol-Specified Criteria|2|||
16561343|NCT02268396|40521810|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
16561344|NCT00388362|40521812|FG000|Enrolled|Ineligible|1|||
16561345|NCT00388362|40521812|FG000|Enrolled|Adverse Event|9|||
16561346|NCT00388362|40521812|FG000|Enrolled|Death|1|||
16561347|NCT00388362|40521812|FG000|Enrolled|Loss insurance|1|||
16561348|NCT00388362|40521812|FG000|Enrolled|Withdrawal by Subject|1|||
16561349|NCT00388362|40521812|FG000|Remained on Study Median of 514 Days|Death|2|||
16561350|NCT02303574|40521813|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16417725|NCT01624090|40008585|FG001|Overall Study|Died on study|0|||
16417726|NCT01624090|40008586|FG002|Overall Study|Died on study|2|||
16561351|NCT02303574|40521814|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16561352|NCT02303574|40521815|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
16561353|NCT02303574|40521816|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16561354|NCT02303574|40521817|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16561355|NCT02303574|40521818|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16561356|NCT02303574|40521819|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16561357|NCT02303574|40521820|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16561358|NCT02303574|40521821|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16130562|NCT00196976|38967060|FG011|Primary Study|Other|0|||
16247284|NCT02752776|39388185|FG002|Overall Study|Subject/guardian decision|4|||
16247285|NCT02752776|39388183|FG000|Overall Study|Death|0|||
16247286|NCT02752776|39388184|FG001|Overall Study|Death|0|||
16247287|NCT02752776|39388185|FG002|Overall Study|Death|1|||
16247288|NCT02752776|39388183|FG000|Overall Study|Withdrawal by Subject|3|||
16247289|NCT02752776|39388184|FG001|Overall Study|Withdrawal by Subject|4|||
16247290|NCT02752776|39388185|FG002|Overall Study|Withdrawal by Subject|2|||
16417727|NCT01624090|40008587|FG003|Overall Study|Died on study|0|||
16417728|NCT01624090|40008584|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
16417729|NCT01624090|40008585|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
16417730|NCT01624090|40008586|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
16417731|NCT01624090|40008587|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
16417732|NCT01624090|40008584|FG000|Overall Study|Dose escalated|0|||
16417733|NCT01624090|40008585|FG001|Overall Study|Dose escalated|0|||
16417734|NCT01624090|40008586|FG002|Overall Study|Dose escalated|3|||
16417735|NCT01624090|40008587|FG003|Overall Study|Dose escalated|0|||
16561359|NCT02303574|40521822|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
16561360|NCT02303574|40521813|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16561361|NCT02303574|40521814|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16561362|NCT02303574|40521815|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16561363|NCT02303574|40521816|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16561364|NCT02303574|40521817|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16561365|NCT02303574|40521818|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16561366|NCT02303574|40521819|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16561367|NCT02303574|40521820|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
16561368|NCT02303574|40521821|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16561369|NCT02303574|40521822|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
16561370|NCT03330119|40521824|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
16561371|NCT03330119|40521825|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
16561372|NCT02788656|40521826|FG000|Overall Study|Withdrawal by Subject|1|||
16561373|NCT02788656|40521827|FG001|Overall Study|Withdrawal by Subject|0|||
16561374|NCT00557505|40521828|FG000|Overall Study|Death|0|||
16561375|NCT00557505|40521829|FG001|Overall Study|Death|0|||
16561376|NCT00557505|40521830|FG002|Overall Study|Death|0|||
16561377|NCT00557505|40521831|FG003|Overall Study|Death|0|||
16561378|NCT00557505|40521832|FG004|Overall Study|Death|0|||
16561379|NCT00557505|40521833|FG005|Overall Study|Death|0|||
16561380|NCT00557505|40521834|FG006|Overall Study|Death|0|||
16561381|NCT00557505|40521835|FG007|Overall Study|Death|0|||
16561382|NCT00557505|40521836|FG008|Overall Study|Death|1|||
16561383|NCT00557505|40521828|FG000|Overall Study|Adverse Event|0|||
16561384|NCT00557505|40521829|FG001|Overall Study|Adverse Event|0|||
16561385|NCT00557505|40521830|FG002|Overall Study|Adverse Event|1|||
16561386|NCT00557505|40521831|FG003|Overall Study|Adverse Event|0|||
16561387|NCT00557505|40521832|FG004|Overall Study|Adverse Event|0|||
16561388|NCT00557505|40521833|FG005|Overall Study|Adverse Event|0|||
16561389|NCT00557505|40521834|FG006|Overall Study|Adverse Event|1|||
16561390|NCT00557505|40521835|FG007|Overall Study|Adverse Event|0|||
16561391|NCT00557505|40521836|FG008|Overall Study|Adverse Event|0|||
16561392|NCT00557505|40521828|FG000|Overall Study|Global deterioration of health|1|||
16561393|NCT00557505|40521829|FG001|Overall Study|Global deterioration of health|0|||
16561394|NCT00557505|40521830|FG002|Overall Study|Global deterioration of health|0|||
16561395|NCT00557505|40521831|FG003|Overall Study|Global deterioration of health|0|||
16561396|NCT00557505|40521832|FG004|Overall Study|Global deterioration of health|0|||
16561397|NCT00557505|40521833|FG005|Overall Study|Global deterioration of health|0|||
16561398|NCT00557505|40521834|FG006|Overall Study|Global deterioration of health|0|||
16561399|NCT00557505|40521835|FG007|Overall Study|Global deterioration of health|0|||
16247291|NCT00613574|39388188|FG000|Overall Study|Adverse Event|3|||
16247292|NCT00613574|39388188|FG000|Overall Study|Lost to Follow-up|2|||
16247293|NCT00613574|39388188|FG000|Overall Study|Other|1|||
16247294|NCT01498484|39388189|FG000|Overall Study|Death|6|||
16247295|NCT01498484|39388190|FG001|Overall Study|Death|3|||
16247296|NCT01498484|39388191|FG002|Overall Study|Death|1|||
16247297|NCT01498484|39388192|FG003|Overall Study|Death|1|||
16247298|NCT01498484|39388193|FG004|Overall Study|Death|0|||
16561400|NCT00557505|40521836|FG008|Overall Study|Global deterioration of health|0|||
16561401|NCT00557505|40521828|FG000|Overall Study|Objective progression or relapse|2|||
16561402|NCT00557505|40521829|FG001|Overall Study|Objective progression or relapse|3|||
16247299|NCT01498484|39388194|FG005|Overall Study|Death|0|||
16247300|NCT01498484|39388195|FG006|Overall Study|Death|10|||
16247301|NCT01498484|39388196|FG007|Overall Study|Death|1|||
16247302|NCT01498484|39388197|FG008|Overall Study|Death|0|||
16354677|NCT00468585|39784440|FG002|Overall Study|Adverse Event|1|||
16354678|NCT00468585|39784441|FG003|Overall Study|Adverse Event|0|||
16354679|NCT00468585|39784438|FG000|Overall Study|Withdrawal by Subject|0|||
16354680|NCT00468585|39784439|FG001|Overall Study|Withdrawal by Subject|0|||
16354681|NCT00468585|39784440|FG002|Overall Study|Withdrawal by Subject|2|||
16354682|NCT00468585|39784441|FG003|Overall Study|Withdrawal by Subject|1|||
16354683|NCT03191799|39784442|FG000|Overall Study|Withdrawal by Subject|4|||
16354684|NCT03191799|39784442|FG000|Overall Study|Physician Decision|2|||
16354685|NCT03191799|39784442|FG000|Overall Study|Lost to Follow-up|1|||
16354686|NCT03191799|39784442|FG000|Overall Study|Death|2|||
16354687|NCT02668640|39784443|FG000|Overall Study|Lost to Follow-up|13|||
16354688|NCT02668640|39784443|FG000|Overall Study|Other, not specified|1|||
16354689|NCT02532374|39784444|FG000|Overall Study|Withdrawal by Subject|1|||
16354690|NCT02532374|39784444|FG000|Overall Study|Physician Decision|1|||
16354691|NCT02033759|39784450|FG000|Overall Study|Withdrawal by Subject|2|||
16354692|NCT02033759|39784451|FG001|Overall Study|Withdrawal by Subject|1|||
16354693|NCT02033759|39784450|FG000|Overall Study|Protocol Violation|1|||
16354694|NCT02033759|39784451|FG001|Overall Study|Protocol Violation|1|||
16354695|NCT01041859|39784452|FG000|Open-Label Titration|Adverse Event|69|||
16354696|NCT01041859|39784453|FG001|Open-Label Titration|Adverse Event|0|||
16354697|NCT01041859|39784454|FG002|Open-Label Titration|Adverse Event|0|||
16354698|NCT01041859|39784452|FG000|Open-Label Titration|Lack of Efficacy|3|||
16354699|NCT01041859|39784453|FG001|Open-Label Titration|Lack of Efficacy|0|||
16354700|NCT01041859|39784454|FG002|Open-Label Titration|Lack of Efficacy|0|||
16354701|NCT01041859|39784452|FG000|Open-Label Titration|Lost to Follow-up|1|||
16354702|NCT01041859|39784453|FG001|Open-Label Titration|Lost to Follow-up|0|||
16354703|NCT01041859|39784454|FG002|Open-Label Titration|Lost to Follow-up|0|||
16354704|NCT01041859|39784452|FG000|Open-Label Titration|Physician Decision|1|||
16354705|NCT01041859|39784453|FG001|Open-Label Titration|Physician Decision|0|||
16354706|NCT01041859|39784454|FG002|Open-Label Titration|Physician Decision|0|||
16354707|NCT01041859|39784452|FG000|Open-Label Titration|Protocol Violation|1|||
16354708|NCT01041859|39784453|FG001|Open-Label Titration|Protocol Violation|0|||
16354709|NCT01041859|39784454|FG002|Open-Label Titration|Protocol Violation|0|||
16354710|NCT01041859|39784452|FG000|Open-Label Titration|Other|7|||
16561403|NCT00557505|40521830|FG002|Overall Study|Objective progression or relapse|3|||
16561404|NCT00557505|40521831|FG003|Overall Study|Objective progression or relapse|2|||
16561405|NCT00557505|40521832|FG004|Overall Study|Objective progression or relapse|2|||
16561406|NCT00557505|40521833|FG005|Overall Study|Objective progression or relapse|3|||
16561407|NCT00557505|40521834|FG006|Overall Study|Objective progression or relapse|2|||
16561408|NCT00557505|40521835|FG007|Overall Study|Objective progression or relapse|5|||
16561409|NCT00557505|40521836|FG008|Overall Study|Objective progression or relapse|15|||
16561410|NCT00557505|40521828|FG000|Overall Study|Withdrawal by Subject|0|||
16561411|NCT00557505|40521829|FG001|Overall Study|Withdrawal by Subject|0|||
16561412|NCT00557505|40521830|FG002|Overall Study|Withdrawal by Subject|0|||
16561413|NCT00557505|40521831|FG003|Overall Study|Withdrawal by Subject|1|||
16561414|NCT00557505|40521832|FG004|Overall Study|Withdrawal by Subject|0|||
16561415|NCT00557505|40521833|FG005|Overall Study|Withdrawal by Subject|0|||
16561416|NCT00557505|40521834|FG006|Overall Study|Withdrawal by Subject|0|||
16561417|NCT00557505|40521835|FG007|Overall Study|Withdrawal by Subject|0|||
16561418|NCT00557505|40521836|FG008|Overall Study|Withdrawal by Subject|1|||
16561419|NCT00983619|40521840|FG000|Overall Study|Lost to Follow-up|0|||
16561420|NCT00983619|40521841|FG001|Overall Study|Lost to Follow-up|1|||
16561421|NCT00983619|40521842|FG002|Overall Study|Lost to Follow-up|0|||
16561422|NCT00983619|40521843|FG003|Overall Study|Lost to Follow-up|0|||
16561423|NCT00983619|40521844|FG004|Overall Study|Lost to Follow-up|0|||
16561424|NCT00983619|40521845|FG005|Overall Study|Lost to Follow-up|2|||
16561425|NCT00983619|40521846|FG006|Overall Study|Lost to Follow-up|0|||
16561426|NCT00983619|40521847|FG007|Overall Study|Lost to Follow-up|0|||
16561427|NCT00983619|40521848|FG008|Overall Study|Lost to Follow-up|0|||
16561428|NCT00983619|40521849|FG009|Overall Study|Lost to Follow-up|0|||
16561429|NCT00983619|40521850|FG010|Overall Study|Lost to Follow-up|0|||
16561430|NCT00983619|40521851|FG011|Overall Study|Lost to Follow-up|2|||
16561431|NCT00983619|40521840|FG000|Overall Study|Withdrawal by Subject|2|||
16561432|NCT00983619|40521841|FG001|Overall Study|Withdrawal by Subject|1|||
16561433|NCT00983619|40521842|FG002|Overall Study|Withdrawal by Subject|1|||
16561434|NCT00983619|40521843|FG003|Overall Study|Withdrawal by Subject|3|||
16561435|NCT00983619|40521844|FG004|Overall Study|Withdrawal by Subject|1|||
16561436|NCT00983619|40521845|FG005|Overall Study|Withdrawal by Subject|23|||
16561437|NCT00983619|40521846|FG006|Overall Study|Withdrawal by Subject|0|||
16561438|NCT00983619|40521847|FG007|Overall Study|Withdrawal by Subject|0|||
16561439|NCT00983619|40521848|FG008|Overall Study|Withdrawal by Subject|0|||
16561440|NCT00983619|40521849|FG009|Overall Study|Withdrawal by Subject|0|||
16561441|NCT00983619|40521850|FG010|Overall Study|Withdrawal by Subject|1|||
16561442|NCT00983619|40521851|FG011|Overall Study|Withdrawal by Subject|1|||
16561443|NCT00983619|40521840|FG000|Overall Study|Death|0|||
16561444|NCT00983619|40521841|FG001|Overall Study|Death|2|||
16561445|NCT00983619|40521842|FG002|Overall Study|Death|2|||
16354711|NCT01041859|39784453|FG001|Open-Label Titration|Other|0|||
16354712|NCT01041859|39784454|FG002|Open-Label Titration|Other|0|||
16354713|NCT01041859|39784452|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
16354714|NCT01041859|39784453|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
16561446|NCT00983619|40521843|FG003|Overall Study|Death|1|||
16561447|NCT00983619|40521844|FG004|Overall Study|Death|2|||
16561448|NCT00983619|40521845|FG005|Overall Study|Death|30|||
16354715|NCT01041859|39784454|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
16354716|NCT01041859|39784452|FG000|Open-Label Titration|Withdrawal by Subject|11|||
16354717|NCT01041859|39784453|FG001|Open-Label Titration|Withdrawal by Subject|0|||
16354718|NCT01041859|39784454|FG002|Open-Label Titration|Withdrawal by Subject|0|||
16354719|NCT01041859|39784452|FG000|Double-Blind Maintenance|Adverse Event|0|||
16354720|NCT01041859|39784453|FG001|Double-Blind Maintenance|Adverse Event|23|||
16354721|NCT01041859|39784454|FG002|Double-Blind Maintenance|Adverse Event|13|||
16354722|NCT01041859|39784452|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
16354723|NCT01041859|39784453|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
16354724|NCT01041859|39784454|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
16354725|NCT01041859|39784452|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
16354726|NCT01041859|39784453|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
16354727|NCT01041859|39784454|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
16354728|NCT01041859|39784452|FG000|Double-Blind Maintenance|Physician Decision|0|||
16354729|NCT01041859|39784453|FG001|Double-Blind Maintenance|Physician Decision|2|||
16354730|NCT01041859|39784454|FG002|Double-Blind Maintenance|Physician Decision|1|||
16354731|NCT01041859|39784452|FG000|Double-Blind Maintenance|Protocol Violation|0|||
16354732|NCT01041859|39784453|FG001|Double-Blind Maintenance|Protocol Violation|1|||
16354733|NCT01041859|39784454|FG002|Double-Blind Maintenance|Protocol Violation|3|||
16354734|NCT01041859|39784452|FG000|Double-Blind Maintenance|Other|0|||
16354735|NCT01041859|39784453|FG001|Double-Blind Maintenance|Other|6|||
16354736|NCT01041859|39784454|FG002|Double-Blind Maintenance|Other|2|||
16417736|NCT00924404|40008591|FG000|Overall Study|Lost to Follow-up|6|||
16417737|NCT00924404|40008592|FG001|Overall Study|Lost to Follow-up|4|||
16417738|NCT02598128|40008593|FG000|Period A: Days -7 to -1|Adverse Event|1|||
16417739|NCT02598128|40008594|FG001|Period A: Days -7 to -1|Adverse Event|0|||
16417740|NCT02598128|40008595|FG002|Period A: Days -7 to -1|Adverse Event|0|||
16417741|NCT02598128|40008596|FG003|Period A: Days -7 to -1|Adverse Event|0|||
16417742|NCT01299116|40008599|FG000|Overall Study|Lost to Follow-up|65|||
16417743|NCT01299116|40008600|FG001|Overall Study|Lost to Follow-up|9|||
16417744|NCT01299116|40008601|FG002|Overall Study|Lost to Follow-up|11|||
16417745|NCT00545103|40008605|FG000|Overall Study|Lack of Efficacy|48|||
16561449|NCT00983619|40521846|FG006|Overall Study|Death|1|||
16561450|NCT00983619|40521847|FG007|Overall Study|Death|0|||
16561451|NCT00983619|40521848|FG008|Overall Study|Death|1|||
16561452|NCT00983619|40521849|FG009|Overall Study|Death|2|||
16561453|NCT00983619|40521850|FG010|Overall Study|Death|9|||
16561454|NCT00983619|40521851|FG011|Overall Study|Death|8|||
16561455|NCT00983619|40521840|FG000|Overall Study|Other|1|||
16561456|NCT00983619|40521841|FG001|Overall Study|Other|0|||
16561457|NCT00983619|40521842|FG002|Overall Study|Other|0|||
16561458|NCT00983619|40521843|FG003|Overall Study|Other|1|||
16561459|NCT00983619|40521844|FG004|Overall Study|Other|0|||
16561460|NCT00983619|40521845|FG005|Overall Study|Other|12|||
16561461|NCT00983619|40521846|FG006|Overall Study|Other|2|||
16561462|NCT00983619|40521847|FG007|Overall Study|Other|2|||
16561463|NCT00983619|40521848|FG008|Overall Study|Other|0|||
16561464|NCT00983619|40521849|FG009|Overall Study|Other|1|||
16561465|NCT00983619|40521850|FG010|Overall Study|Other|1|||
16561466|NCT00983619|40521851|FG011|Overall Study|Other|0|||
16561467|NCT00163215|40521852|FG000|Overall Study|Lack of Efficacy|3|||
16561468|NCT00163215|40521852|FG000|Overall Study|Withdrawal by Subject|5|||
16561469|NCT00163215|40521852|FG000|Overall Study|Other|7|||
16561470|NCT03633903|40521853|FG000|Overall Study|Withdrawal by Subject|1|||
16561471|NCT03633903|40521854|FG001|Overall Study|Withdrawal by Subject|2|||
16561472|NCT03633903|40521853|FG000|Overall Study|Lost to Follow-up|5|||
16561473|NCT03633903|40521854|FG001|Overall Study|Lost to Follow-up|5|||
16561474|NCT00813488|40521856|FG000|Titration Period 1|Adverse Event|6|||
16561475|NCT00813488|40521857|FG001|Titration Period 1|Adverse Event|1|||
16561476|NCT00813488|40521856|FG000|Titration Period 1|Lack of Efficacy|9|||
16561477|NCT00813488|40521857|FG001|Titration Period 1|Lack of Efficacy|7|||
16561478|NCT00813488|40521856|FG000|Titration Period 1|Withdrawal by Subject|2|||
16561479|NCT00813488|40521857|FG001|Titration Period 1|Withdrawal by Subject|2|||
16561480|NCT00813488|40521856|FG000|Titration Period 1|Protocol Violation|4|||
16561481|NCT00813488|40521857|FG001|Titration Period 1|Protocol Violation|3|||
16354737|NCT01041859|39784452|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
16417746|NCT00545103|40008606|FG001|Overall Study|Lack of Efficacy|45|||
16561482|NCT00813488|40521856|FG000|Titration Period 1|Non-compliance to study medication|4|||
16561483|NCT00813488|40521857|FG001|Titration Period 1|Non-compliance to study medication|1|||
16417747|NCT00545103|40008607|FG002|Overall Study|Lack of Efficacy|31|||
16417748|NCT00545103|40008608|FG003|Overall Study|Lack of Efficacy|27|||
16417749|NCT00545103|40008605|FG000|Overall Study|Withdrawal by Subject|6|||
16561484|NCT00813488|40521856|FG000|Titration Period 1|Non-compliance to study procedures|2|||
16561485|NCT00813488|40521857|FG001|Titration Period 1|Non-compliance to study procedures|2|||
16561486|NCT00813488|40521856|FG000|Titration Period 1|Technical Difficulties|0|||
16561487|NCT00813488|40521857|FG001|Titration Period 1|Technical Difficulties|1|||
16561488|NCT00813488|40521856|FG000|Titration Period 2|Adverse Event|2|||
16561489|NCT00813488|40521857|FG001|Titration Period 2|Adverse Event|3|||
16417750|NCT00545103|40008606|FG001|Overall Study|Withdrawal by Subject|10|||
16417751|NCT00545103|40008607|FG002|Overall Study|Withdrawal by Subject|18|||
16417752|NCT00545103|40008608|FG003|Overall Study|Withdrawal by Subject|22|||
16417753|NCT00545103|40008605|FG000|Overall Study|Adverse Event|11|||
16417754|NCT00545103|40008606|FG001|Overall Study|Adverse Event|12|||
16417755|NCT00545103|40008607|FG002|Overall Study|Adverse Event|17|||
16417756|NCT00545103|40008608|FG003|Overall Study|Adverse Event|10|||
16417757|NCT00545103|40008605|FG000|Overall Study|Lost to Follow-up|4|||
16417758|NCT00545103|40008606|FG001|Overall Study|Lost to Follow-up|6|||
16417759|NCT00545103|40008607|FG002|Overall Study|Lost to Follow-up|3|||
16417760|NCT00545103|40008608|FG003|Overall Study|Lost to Follow-up|4|||
16417761|NCT00545103|40008605|FG000|Overall Study|Protocol Violation|1|||
16417762|NCT00545103|40008606|FG001|Overall Study|Protocol Violation|2|||
16417763|NCT00545103|40008607|FG002|Overall Study|Protocol Violation|3|||
16417764|NCT00545103|40008608|FG003|Overall Study|Protocol Violation|0|||
16417765|NCT00545103|40008605|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
16417766|NCT00545103|40008606|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
16417767|NCT00545103|40008607|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
16417768|NCT00545103|40008608|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
16417769|NCT00545103|40008605|FG000|Overall Study|Difficult to open package|0|||
16417770|NCT00545103|40008606|FG001|Overall Study|Difficult to open package|0|||
16417771|NCT00545103|40008607|FG002|Overall Study|Difficult to open package|0|||
16417772|NCT00545103|40008608|FG003|Overall Study|Difficult to open package|1|||
16417773|NCT00545103|40008605|FG000|Overall Study|Investigational product not taken|1|||
16354738|NCT01041859|39784453|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
16354739|NCT01041859|39784454|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
16354740|NCT01041859|39784452|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
16354741|NCT01041859|39784453|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
16354742|NCT01041859|39784454|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
16354743|NCT00969228|39784474|FG000|Overall Study|Adverse Event|1|||
16354744|NCT00969228|39784475|FG001|Overall Study|Adverse Event|0|||
16354745|NCT00969228|39784474|FG000|Overall Study|Withdrawal by Subject|4|||
16354746|NCT00969228|39784475|FG001|Overall Study|Withdrawal by Subject|0|||
16354747|NCT00969228|39784474|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
16354748|NCT00969228|39784475|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
16354749|NCT03353792|39784478|FG000|Overall Study|Lost to Follow-up|1|||
16354750|NCT03353792|39784479|FG001|Overall Study|Lost to Follow-up|0|||
16354751|NCT03353792|39784478|FG000|Overall Study|Participant Unable to Manage Device|1|||
16354752|NCT03353792|39784479|FG001|Overall Study|Participant Unable to Manage Device|0|||
16354753|NCT01159574|39784482|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
16417774|NCT00545103|40008606|FG001|Overall Study|Investigational product not taken|0|||
16417775|NCT00545103|40008607|FG002|Overall Study|Investigational product not taken|0|||
16417776|NCT00545103|40008608|FG003|Overall Study|Investigational product not taken|1|||
16417777|NCT00545103|40008605|FG000|Overall Study|Wish to start a family|0|||
16561490|NCT00813488|40521856|FG000|Titration Period 2|Lack of Efficacy|8|||
16561491|NCT00813488|40521857|FG001|Titration Period 2|Lack of Efficacy|4|||
16561492|NCT00813488|40521856|FG000|Titration Period 2|Protocol Violation|3|||
16561493|NCT00813488|40521857|FG001|Titration Period 2|Protocol Violation|2|||
16561494|NCT00813488|40521856|FG000|Titration Period 2|Lost to Follow-up|1|||
16561495|NCT00813488|40521857|FG001|Titration Period 2|Lost to Follow-up|0|||
16561496|NCT00813488|40521856|FG000|Titration Period 2|Non-compliance with study procedures|2|||
16561497|NCT00813488|40521857|FG001|Titration Period 2|Non-compliance with study procedures|1|||
16561498|NCT00813488|40521856|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
16561499|NCT00813488|40521857|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
16561500|NCT00813488|40521856|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
16561501|NCT00813488|40521857|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
16561502|NCT00813488|40521856|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
16561503|NCT00813488|40521857|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
16561504|NCT00813488|40521856|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
16561505|NCT00813488|40521857|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
16561506|NCT00813488|40521856|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
16561507|NCT00813488|40521857|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
16417778|NCT00545103|40008606|FG001|Overall Study|Wish to start a family|0|||
16417779|NCT00545103|40008607|FG002|Overall Study|Wish to start a family|0|||
16417780|NCT00545103|40008608|FG003|Overall Study|Wish to start a family|1|||
16417781|NCT00545103|40008605|FG000|Overall Study|Diverticulitis crisis|0|||
16417782|NCT00545103|40008606|FG001|Overall Study|Diverticulitis crisis|0|||
16417783|NCT00545103|40008607|FG002|Overall Study|Diverticulitis crisis|0|||
16417784|NCT00545103|40008608|FG003|Overall Study|Diverticulitis crisis|1|||
16247303|NCT01498484|39388189|FG000|Overall Study|Physician Decision|3|||
16354754|NCT01159574|39784482|FG000|Treatment Phase|Adverse Event|3|||
16354755|NCT01159574|39784482|FG000|Treatment Phase|Death|6|||
16417785|NCT00545103|40008605|FG000|Overall Study|Personal reasons|1|||
16417786|NCT00545103|40008606|FG001|Overall Study|Personal reasons|0|||
16561508|NCT00813488|40521856|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
16354756|NCT01159574|39784482|FG000|Treatment Phase|Physician Decision|2|||
16354757|NCT01159574|39784482|FG000|Treatment Phase|Withdrawal by Subject|7|||
16354758|NCT01159574|39784482|FG000|Treatment Phase|still on treatment|2|||
16354759|NCT01159574|39784482|FG000|Follow Up Phase|Lost to Follow-up|2|||
16354760|NCT01159574|39784482|FG000|Follow Up Phase|still being followed for overall surviva|18|||
16354761|NCT03498521|39784483|FG000|Overall Study|Death|191|||
16354762|NCT03498521|39784484|FG001|Overall Study|Death|64|||
16354763|NCT03498521|39784485|FG002|Overall Study|Death|72|||
16354764|NCT03498521|39784483|FG000|Overall Study|Exclusion criteria|1|||
16354765|NCT03498521|39784484|FG001|Overall Study|Exclusion criteria|0|||
16354766|NCT03498521|39784485|FG002|Overall Study|Exclusion criteria|0|||
16354767|NCT03498521|39784483|FG000|Overall Study|Lost to Follow-up|3|||
16354768|NCT03498521|39784484|FG001|Overall Study|Lost to Follow-up|3|||
16354769|NCT03498521|39784485|FG002|Overall Study|Lost to Follow-up|3|||
16354770|NCT03498521|39784483|FG000|Overall Study|No profile due to technical failure|1|||
16354771|NCT03498521|39784484|FG001|Overall Study|No profile due to technical failure|0|||
16354772|NCT03498521|39784485|FG002|Overall Study|No profile due to technical failure|0|||
16354773|NCT03498521|39784483|FG000|Overall Study|Physician Decision|0|||
16354774|NCT03498521|39784484|FG001|Overall Study|Physician Decision|1|||
16354775|NCT03498521|39784485|FG002|Overall Study|Physician Decision|0|||
16354776|NCT03498521|39784483|FG000|Overall Study|Withdrawal by Subject|9|||
16354777|NCT03498521|39784484|FG001|Overall Study|Withdrawal by Subject|6|||
16354778|NCT03498521|39784485|FG002|Overall Study|Withdrawal by Subject|2|||
16354779|NCT03498521|39784483|FG000|Overall Study|Study ongoing|121|||
16354780|NCT03498521|39784484|FG001|Overall Study|Study ongoing|36|||
16354781|NCT03498521|39784485|FG002|Overall Study|Study ongoing|15|||
16354782|NCT00671788|39784486|FG000|Overall Study|Adverse Event|8|||
16354783|NCT00671788|39784486|FG000|Overall Study|Refused further treatment|3|||
16354784|NCT00671788|39784486|FG000|Overall Study|Ineligible|1|||
16354785|NCT00671788|39784486|FG000|Overall Study|MD Decision|1|||
16354786|NCT00671788|39784486|FG000|Overall Study|Other|1|||
16354787|NCT02154139|39784489|FG000|Overall Study|Injection not administered|2|||
16354788|NCT02154139|39784489|FG000|Overall Study|Other|2|||
16354789|NCT02154139|39784489|FG000|Overall Study|Investigator transferred|3|||
16354790|NCT00192114|39784490|FG000|Overall Study|Objective Tumor Progression|19|||
16354791|NCT00192114|39784490|FG000|Overall Study|Adverse Event|2|||
16354792|NCT00192114|39784490|FG000|Overall Study|Clinical Progression|2|||
16354793|NCT00192114|39784490|FG000|Overall Study|Death|1|||
16354794|NCT03122171|39784493|FG000|Overall Study|Withdrawal by Subject|1|||
16354795|NCT00452439|39784496|FG000|Overall Study|Lost to Follow-up|1|||
16354796|NCT00452439|39784497|FG001|Overall Study|Lost to Follow-up|1|||
16354797|NCT00452439|39784496|FG000|Overall Study|Refused Treatment|4|||
16354798|NCT00452439|39784497|FG001|Overall Study|Refused Treatment|3|||
16354799|NCT00452439|39784496|FG000|Overall Study|Death|3|||
16354800|NCT00452439|39784497|FG001|Overall Study|Death|1|||
16354801|NCT00452439|39784496|FG000|Overall Study|Bone Marrow Transplant|0|||
16354802|NCT00452439|39784497|FG001|Overall Study|Bone Marrow Transplant|1|||
16354803|NCT00452439|39784496|FG000|Overall Study|Too Ill to Continue|0|||
16354804|NCT00452439|39784497|FG001|Overall Study|Too Ill to Continue|1|||
16354805|NCT00452439|39784496|FG000|Overall Study|Failed to achieve complete response|2|||
16354806|NCT00452439|39784497|FG001|Overall Study|Failed to achieve complete response|0|||
16354807|NCT00452439|39784496|FG000|Overall Study|Relapse|3|||
16417787|NCT00545103|40008607|FG002|Overall Study|Personal reasons|0|||
16354808|NCT00452439|39784497|FG001|Overall Study|Relapse|0|||
16354809|NCT00452439|39784496|FG000|Overall Study|Fracture|1|||
16354810|NCT00452439|39784497|FG001|Overall Study|Fracture|0|||
16354811|NCT02692586|39784498|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
16354812|NCT02692586|39784498|FG000|Overall Study|Received adjunctive thrombolytics|2|||
16354813|NCT02709746|39784501|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
16354814|NCT02709746|39784502|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
16354815|NCT02709746|39784503|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
16354816|NCT02709746|39784504|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
16354817|NCT02709746|39784505|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
16354818|NCT02709746|39784501|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
16354819|NCT02709746|39784502|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
16354820|NCT02709746|39784503|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
16354821|NCT02709746|39784504|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
16354822|NCT02709746|39784505|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
16354823|NCT02709746|39784501|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
16561509|NCT00813488|40521857|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
16561510|NCT00813488|40521856|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
16561511|NCT00813488|40521857|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
16561512|NCT00813488|40521856|FG000|Double-blind Treatment Period 2|Other|1|||
16561513|NCT00813488|40521857|FG001|Double-blind Treatment Period 2|Other|0|||
16561514|NCT00813488|40521856|FG000|Open-label Extension|Adverse Event|1|||
16561515|NCT00813488|40521857|FG001|Open-label Extension|Adverse Event|2|||
16354824|NCT02709746|39784502|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
16354825|NCT02709746|39784503|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
16354826|NCT02709746|39784504|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
16354827|NCT02709746|39784505|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
16354828|NCT02709746|39784501|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
16354829|NCT02709746|39784502|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
16354830|NCT02709746|39784503|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
16354831|NCT02709746|39784504|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
16354832|NCT02709746|39784505|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
16354833|NCT02709746|39784501|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
16354834|NCT02709746|39784502|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
16354835|NCT02709746|39784503|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
16354836|NCT02709746|39784504|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
16354837|NCT02709746|39784505|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
16354838|NCT02709746|39784501|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
16354839|NCT02709746|39784502|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
16354840|NCT02709746|39784503|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
16354841|NCT02709746|39784504|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
16354842|NCT02709746|39784505|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
16354843|NCT02709746|39784501|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
16354844|NCT02709746|39784502|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
16354845|NCT02709746|39784503|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
16354846|NCT02709746|39784504|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
16417788|NCT00545103|40008608|FG003|Overall Study|Personal reasons|0|||
16417789|NCT00545103|40008605|FG000|Overall Study|Subject's decision|1|||
16417790|NCT00545103|40008606|FG001|Overall Study|Subject's decision|0|||
16417791|NCT00545103|40008607|FG002|Overall Study|Subject's decision|0|||
16417792|NCT00545103|40008608|FG003|Overall Study|Subject's decision|0|||
16417793|NCT00545103|40008605|FG000|Overall Study|Noncompliance|0|||
16417794|NCT00545103|40008606|FG001|Overall Study|Noncompliance|1|||
16417795|NCT00545103|40008607|FG002|Overall Study|Noncompliance|0|||
16130563|NCT00196976|38967061|FG012|Primary Study|Other|0|||
16417796|NCT00545103|40008608|FG003|Overall Study|Noncompliance|0|||
16417797|NCT00545103|40008605|FG000|Overall Study|Investigator decision|0|||
16417798|NCT00545103|40008606|FG001|Overall Study|Investigator decision|0|||
16417799|NCT00545103|40008607|FG002|Overall Study|Investigator decision|1|||
16417800|NCT00545103|40008608|FG003|Overall Study|Investigator decision|0|||
16417801|NCT00545103|40008605|FG000|Overall Study|Subject moved|0|||
16417802|NCT00545103|40008606|FG001|Overall Study|Subject moved|1|||
16417803|NCT00545103|40008607|FG002|Overall Study|Subject moved|0|||
16417804|NCT00545103|40008608|FG003|Overall Study|Subject moved|0|||
16417805|NCT00545103|40008605|FG000|Overall Study|Use of prohibited medication|0|||
16417806|NCT00545103|40008606|FG001|Overall Study|Use of prohibited medication|0|||
16417807|NCT00545103|40008607|FG002|Overall Study|Use of prohibited medication|1|||
16417808|NCT00545103|40008608|FG003|Overall Study|Use of prohibited medication|0|||
16417809|NCT00545103|40008605|FG000|Overall Study|Does not want to take study drug anymore|1|||
16247304|NCT01498484|39388190|FG001|Overall Study|Physician Decision|2|||
16354847|NCT02709746|39784505|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
16354848|NCT02709746|39784501|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
16354849|NCT02709746|39784502|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
16354850|NCT02709746|39784503|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
16354851|NCT02709746|39784504|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
16354852|NCT02709746|39784505|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
16354853|NCT02709746|39784501|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
16354854|NCT02709746|39784502|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
16354855|NCT02709746|39784503|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
16354856|NCT02709746|39784504|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
16354857|NCT02709746|39784505|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
16354858|NCT02709746|39784501|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
16354859|NCT02709746|39784502|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
16354860|NCT02709746|39784503|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
16354861|NCT02709746|39784504|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
16354862|NCT02709746|39784505|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
16354863|NCT02709746|39784501|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
16354864|NCT02709746|39784502|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
16354865|NCT02709746|39784503|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
16354866|NCT02709746|39784504|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
16354867|NCT02709746|39784505|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
16354868|NCT02709746|39784501|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
16354869|NCT02709746|39784502|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
16354870|NCT02709746|39784503|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
16354871|NCT02709746|39784504|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
16354872|NCT02709746|39784505|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
16354873|NCT02709746|39784501|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
16354874|NCT02709746|39784502|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
16354875|NCT02709746|39784503|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
16354876|NCT02709746|39784504|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
16354877|NCT02709746|39784505|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
16354878|NCT02709746|39784501|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
16354879|NCT02709746|39784502|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
16354880|NCT02709746|39784503|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
16354881|NCT02709746|39784504|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
16354882|NCT02709746|39784505|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
16354883|NCT02709746|39784501|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
16354884|NCT02709746|39784502|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
16354885|NCT02709746|39784503|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
16354886|NCT02709746|39784504|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
16354887|NCT02709746|39784505|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
16354888|NCT02709746|39784501|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
16354889|NCT02709746|39784502|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
16354890|NCT02709746|39784503|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
16354891|NCT02709746|39784504|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
16354892|NCT02709746|39784505|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
16354893|NCT02709746|39784501|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
16354894|NCT02709746|39784502|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
16354895|NCT02709746|39784503|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
16354896|NCT02709746|39784504|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
16354897|NCT02709746|39784505|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
16354898|NCT01775670|39784508|FG000|Overall Study|Lost to Follow-up|1|||
16354899|NCT01775670|39784509|FG001|Overall Study|Lost to Follow-up|1|||
16354900|NCT02175225|39784510|FG000|Overall Study|Withdrawal by Subject|1|||
16417810|NCT00545103|40008606|FG001|Overall Study|Does not want to take study drug anymore|0|||
16417811|NCT00545103|40008607|FG002|Overall Study|Does not want to take study drug anymore|1|||
16417812|NCT00545103|40008608|FG003|Overall Study|Does not want to take study drug anymore|0|||
16417813|NCT00545103|40008605|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
16417814|NCT00545103|40008606|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
16417815|NCT00545103|40008607|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
16417816|NCT00545103|40008608|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
16417817|NCT00545103|40008605|FG000|Overall Study|Death|0|||
16417818|NCT00545103|40008606|FG001|Overall Study|Death|1|||
16417819|NCT00545103|40008607|FG002|Overall Study|Death|0|||
16417820|NCT00545103|40008608|FG003|Overall Study|Death|0|||
16417821|NCT00082381|40008609|FG000|Overall Study|Adverse Event|27|||
16417822|NCT00082381|40008610|FG001|Overall Study|Adverse Event|2|||
16417823|NCT00082381|40008609|FG000|Overall Study|Lost to Follow-up|5|||
16417824|NCT00082381|40008610|FG001|Overall Study|Lost to Follow-up|7|||
16417825|NCT00082381|40008609|FG000|Overall Study|Patient Decision|8|||
16417826|NCT00082381|40008610|FG001|Overall Study|Patient Decision|4|||
16417827|NCT00082381|40008609|FG000|Overall Study|Physician Decision|1|||
16417828|NCT00082381|40008610|FG001|Overall Study|Physician Decision|2|||
16417829|NCT00082381|40008609|FG000|Overall Study|Protocol Violation|10|||
16417830|NCT00082381|40008610|FG001|Overall Study|Protocol Violation|11|||
16417831|NCT00082381|40008609|FG000|Overall Study|Loss of Glucose Control|4|||
16417832|NCT00082381|40008610|FG001|Overall Study|Loss of Glucose Control|0|||
16417833|NCT01183468|40008611|FG000|Overall Study|Lost to Follow-up|2|||
16417834|NCT01183468|40008612|FG001|Overall Study|Lost to Follow-up|1|||
16417835|NCT01183468|40008613|FG002|Overall Study|Lost to Follow-up|0|||
16417836|NCT01183468|40008614|FG003|Overall Study|Lost to Follow-up|0|||
16417837|NCT01183468|40008611|FG000|Overall Study|Physician Decision|1|||
16417838|NCT01183468|40008612|FG001|Overall Study|Physician Decision|0|||
16417839|NCT01183468|40008613|FG002|Overall Study|Physician Decision|0|||
16417840|NCT01183468|40008614|FG003|Overall Study|Physician Decision|0|||
16417841|NCT01183468|40008611|FG000|Overall Study|Withdrawal by Subject|0|||
16417842|NCT01183468|40008612|FG001|Overall Study|Withdrawal by Subject|1|||
16417843|NCT01183468|40008613|FG002|Overall Study|Withdrawal by Subject|0|||
16561516|NCT00813488|40521856|FG000|Open-label Extension|Lack of Efficacy|3|||
16561517|NCT00813488|40521857|FG001|Open-label Extension|Lack of Efficacy|0|||
16561518|NCT00813488|40521856|FG000|Open-label Extension|Withdrawal by Subject|0|||
16561519|NCT00813488|40521857|FG001|Open-label Extension|Withdrawal by Subject|2|||
16561520|NCT00813488|40521856|FG000|Open-label Extension|Protocol Violation|1|||
16561521|NCT00813488|40521857|FG001|Open-label Extension|Protocol Violation|2|||
16561522|NCT00813488|40521856|FG000|Open-label Extension|Non-compliance study medication|4|||
16561523|NCT00813488|40521857|FG001|Open-label Extension|Non-compliance study medication|0|||
16247305|NCT01498484|39388191|FG002|Overall Study|Physician Decision|1|||
16247306|NCT01498484|39388192|FG003|Overall Study|Physician Decision|1|||
16417844|NCT01183468|40008614|FG003|Overall Study|Withdrawal by Subject|0|||
16417845|NCT00528996|40008615|FG000|Overall Study|Other reasons than listing|6|||
16417846|NCT00528996|40008616|FG001|Overall Study|Other reasons than listing|7|||
16417847|NCT00528996|40008617|FG002|Overall Study|Other reasons than listing|14|||
16417848|NCT00528996|40008618|FG003|Overall Study|Other reasons than listing|11|||
16247307|NCT01498484|39388193|FG004|Overall Study|Physician Decision|0|||
16247308|NCT01498484|39388194|FG005|Overall Study|Physician Decision|0|||
16247309|NCT01498484|39388195|FG006|Overall Study|Physician Decision|8|||
16247310|NCT01498484|39388196|FG007|Overall Study|Physician Decision|13|||
16247311|NCT01498484|39388197|FG008|Overall Study|Physician Decision|1|||
16247312|NCT01498484|39388189|FG000|Overall Study|Adverse Event|0|||
16247313|NCT01498484|39388190|FG001|Overall Study|Adverse Event|0|||
16247314|NCT01498484|39388191|FG002|Overall Study|Adverse Event|0|||
16247315|NCT01498484|39388192|FG003|Overall Study|Adverse Event|0|||
16247316|NCT01498484|39388193|FG004|Overall Study|Adverse Event|0|||
16247317|NCT01498484|39388194|FG005|Overall Study|Adverse Event|1|||
16247318|NCT01498484|39388195|FG006|Overall Study|Adverse Event|0|||
16247319|NCT01498484|39388196|FG007|Overall Study|Adverse Event|0|||
16247320|NCT01498484|39388197|FG008|Overall Study|Adverse Event|0|||
16247321|NCT01498484|39388189|FG000|Overall Study|Withdrawal by Subject|0|||
16247322|NCT01498484|39388190|FG001|Overall Study|Withdrawal by Subject|0|||
16247323|NCT01498484|39388191|FG002|Overall Study|Withdrawal by Subject|0|||
16247324|NCT01498484|39388192|FG003|Overall Study|Withdrawal by Subject|1|||
16247325|NCT01498484|39388193|FG004|Overall Study|Withdrawal by Subject|0|||
16247326|NCT01498484|39388194|FG005|Overall Study|Withdrawal by Subject|0|||
16247327|NCT01498484|39388195|FG006|Overall Study|Withdrawal by Subject|1|||
16247328|NCT01498484|39388196|FG007|Overall Study|Withdrawal by Subject|0|||
16247329|NCT01498484|39388197|FG008|Overall Study|Withdrawal by Subject|0|||
16247330|NCT01498484|39388189|FG000|Overall Study|Other|5|||
16247331|NCT01498484|39388190|FG001|Overall Study|Other|2|||
16247332|NCT01498484|39388191|FG002|Overall Study|Other|0|||
16247333|NCT01498484|39388192|FG003|Overall Study|Other|0|||
16247334|NCT01498484|39388193|FG004|Overall Study|Other|1|||
16247335|NCT01498484|39388194|FG005|Overall Study|Other|0|||
16247336|NCT01498484|39388195|FG006|Overall Study|Other|3|||
16417849|NCT00528996|40008619|FG004|Overall Study|Other reasons than listing|5|||
16417850|NCT00528996|40008615|FG000|Overall Study|Refused continue medication|16|||
16417851|NCT00528996|40008616|FG001|Overall Study|Refused continue medication|0|||
16417852|NCT00528996|40008617|FG002|Overall Study|Refused continue medication|3|||
16417853|NCT00528996|40008618|FG003|Overall Study|Refused continue medication|3|||
16561524|NCT00813488|40521856|FG000|Open-label Extension|Non-compliance study procedures|2|||
16354901|NCT02175225|39784511|FG001|Overall Study|Withdrawal by Subject|2|||
16354902|NCT02175225|39784510|FG000|Overall Study|Lost to Follow-up|6|||
16354903|NCT02175225|39784511|FG001|Overall Study|Lost to Follow-up|7|||
16354904|NCT02175225|39784510|FG000|Overall Study|Study drug not administered|1|||
16354905|NCT02175225|39784511|FG001|Overall Study|Study drug not administered|2|||
16354906|NCT00073918|39784512|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
16354907|NCT00073918|39784512|FG000|Overall Study|Rapid disease progression|2|||
16354908|NCT00073918|39784512|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
16354909|NCT00830765|39784517|FG000|Overall Study|Protocol Violation|3|||
16354910|NCT00830765|39784518|FG001|Overall Study|Protocol Violation|2|||
16354911|NCT01811238|39787299|FG000|Overall Study|Withdrawal by Subject|42|||
16354912|NCT01811238|39787299|FG000|Overall Study|Adverse Event|25|||
16354913|NCT01811238|39787299|FG000|Overall Study|Protocol Violation|4|||
16354914|NCT01811238|39787299|FG000|Overall Study|Lack of Efficacy|4|||
16354915|NCT01811238|39787299|FG000|Overall Study|subject refused study medication|6|||
16354916|NCT01408706|39787300|FG000|Overall Study|Physician Decision|1|||
16354917|NCT01408706|39787301|FG001|Overall Study|Physician Decision|0|||
16354918|NCT01926028|39787304|FG000|Overall Study|Lost to Follow-up|7|||
16354919|NCT01926028|39787305|FG001|Overall Study|Lost to Follow-up|6|||
16354920|NCT01926028|39787306|FG002|Overall Study|Lost to Follow-up|0|||
16354921|NCT01926028|39787304|FG000|Overall Study|Physician Decision|1|||
16354922|NCT01926028|39787305|FG001|Overall Study|Physician Decision|5|||
16354923|NCT01926028|39787306|FG002|Overall Study|Physician Decision|0|||
16354924|NCT01926028|39787304|FG000|Overall Study|Withdrawal by Subject|9|||
16354925|NCT01926028|39787305|FG001|Overall Study|Withdrawal by Subject|9|||
16354926|NCT01926028|39787306|FG002|Overall Study|Withdrawal by Subject|2|||
16354927|NCT01926028|39787304|FG000|Overall Study|Non compliance or other reasons|4|||
16354928|NCT01926028|39787305|FG001|Overall Study|Non compliance or other reasons|2|||
16354929|NCT01926028|39787306|FG002|Overall Study|Non compliance or other reasons|0|||
16354930|NCT01299909|39787307|FG000|Overall Study|Lost to Follow-up|22|||
16354931|NCT01299909|39787308|FG001|Overall Study|Lost to Follow-up|18|||
16354932|NCT01299909|39787309|FG002|Overall Study|Lost to Follow-up|17|||
16354933|NCT01674725|39787318|FG000|Overall Study|Adverse Event|1|||
16354934|NCT01674725|39787319|FG001|Overall Study|Adverse Event|0|||
16354935|NCT01674725|39787318|FG000|Overall Study|Did not receive study drug|1|||
16354936|NCT01674725|39787319|FG001|Overall Study|Did not receive study drug|0|||
16354937|NCT01674725|39787318|FG000|Overall Study|Withdrawal by Subject|1|||
16354938|NCT01674725|39787319|FG001|Overall Study|Withdrawal by Subject|0|||
16354939|NCT01674725|39787318|FG000|Overall Study|Lost to Follow-up|0|||
16354940|NCT01674725|39787319|FG001|Overall Study|Lost to Follow-up|1|||
16354941|NCT04494646|39787323|FG000|Overall Study|Adverse Event|0|||
16354942|NCT04494646|39787324|FG001|Overall Study|Adverse Event|1|||
16354943|NCT04494646|39787323|FG000|Overall Study|Withdrawal by Subject|0|||
16354944|NCT04494646|39787324|FG001|Overall Study|Withdrawal by Subject|1|||
16354945|NCT00960193|39787326|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
16354946|NCT01064414|39787327|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
16354947|NCT01064414|39787328|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
16354948|NCT01064414|39787329|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
16354949|NCT01064414|39787327|FG000|Core Period: Baseline to Week 26|Death|0|||
16354950|NCT01064414|39787328|FG001|Core Period: Baseline to Week 26|Death|1|||
16354951|NCT01064414|39787329|FG002|Core Period: Baseline to Week 26|Death|0|||
16354952|NCT01064414|39787327|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
16354953|NCT01064414|39787328|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
16354954|NCT01064414|39787329|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
16354955|NCT01064414|39787327|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
16354956|NCT01064414|39787328|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
16354957|NCT01064414|39787329|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
16354958|NCT01064414|39787327|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16354959|NCT01064414|39787328|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
16354960|NCT01064414|39787329|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16354961|NCT01064414|39787327|FG000|Core Period: Baseline to Week 26|Other|4|||
16354962|NCT01064414|39787328|FG001|Core Period: Baseline to Week 26|Other|7|||
16354963|NCT01064414|39787329|FG002|Core Period: Baseline to Week 26|Other|2|||
16354964|NCT01064414|39787327|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
16354965|NCT01064414|39787328|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
16354966|NCT01064414|39787329|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
16354967|NCT01064414|39787327|FG000|Extension Period: Week 26 to Week 52|Death|0|||
16354968|NCT01064414|39787328|FG001|Extension Period: Week 26 to Week 52|Death|1|||
16354969|NCT01064414|39787329|FG002|Extension Period: Week 26 to Week 52|Death|0|||
16354970|NCT01064414|39787327|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
16417854|NCT00528996|40008619|FG004|Overall Study|Refused continue medication|6|||
16354971|NCT01064414|39787328|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16354972|NCT01064414|39787329|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16354973|NCT01064414|39787327|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
16354974|NCT01064414|39787328|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16354975|NCT01064414|39787329|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16354976|NCT01064414|39787327|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16354977|NCT01064414|39787328|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16354978|NCT01064414|39787329|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16354979|NCT01064414|39787327|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
16354980|NCT01064414|39787328|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
16354981|NCT01064414|39787329|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
16354982|NCT01064414|39787327|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
16354983|NCT01064414|39787328|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
16354984|NCT01064414|39787329|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
16354985|NCT01064414|39787327|FG000|Extension Period: Week 26 to Week 52|Other|5|||
16354986|NCT01064414|39787328|FG001|Extension Period: Week 26 to Week 52|Other|2|||
16354987|NCT01064414|39787329|FG002|Extension Period: Week 26 to Week 52|Other|1|||
16354988|NCT00104052|39787330|FG000|Overall Study|Adverse Event|1|||
16354989|NCT00104052|39787330|FG000|Overall Study|Lack of Efficacy|26|||
16354990|NCT00104052|39787330|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
16354991|NCT00521365|39787331|FG000|Overall Study|Adverse Event|3|||
16354992|NCT00521365|39787331|FG000|Overall Study|Lost to Follow-up|6|||
16354993|NCT00521365|39787331|FG000|Overall Study|Protocol deviation|2|||
16354994|NCT00521365|39787331|FG000|Overall Study|Drug compliance|3|||
16354995|NCT00521365|39787331|FG000|Overall Study|Usage of not allowed drugs|6|||
16354996|NCT02900352|39787332|FG000|Overall Study|Lost to Follow-up|28|||
16354997|NCT02900352|39787333|FG001|Overall Study|Lost to Follow-up|17|||
16354998|NCT00741611|39787334|FG000|Overall Study|Death|0|||
16354999|NCT00741611|39787335|FG001|Overall Study|Death|0|||
16355000|NCT00741611|39787336|FG002|Overall Study|Death|1|||
16355001|NCT00741611|39787334|FG000|Overall Study|Withdrawal by Subject|0|||
16355002|NCT00741611|39787335|FG001|Overall Study|Withdrawal by Subject|2|||
16355003|NCT00741611|39787336|FG002|Overall Study|Withdrawal by Subject|2|||
16355004|NCT02823470|39787340|FG000|Overall Study|Adverse Event|1|||
16355005|NCT02823470|39787341|FG001|Overall Study|Adverse Event|0|||
16355006|NCT02823470|39787340|FG000|Overall Study|Study terminated by sponsor|8|||
16355007|NCT02823470|39787341|FG001|Overall Study|Study terminated by sponsor|15|||
16355008|NCT05379920|39787346|FG000|Overall Study|Lost to Follow-up|0|||
16355009|NCT05379920|39787347|FG001|Overall Study|Lost to Follow-up|5|||
16355010|NCT05379920|39787348|FG002|Overall Study|Lost to Follow-up|0|||
16355011|NCT05379920|39787349|FG003|Overall Study|Lost to Follow-up|0|||
16355012|NCT01302899|39787350|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
16355013|NCT01302899|39787351|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
16355014|NCT01302899|39787350|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
16355015|NCT01302899|39787351|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
16355016|NCT02984982|39787360|FG000|Overall Study|Adverse Event|2|||
16355017|NCT02984982|39787361|FG001|Overall Study|Adverse Event|5|||
16355018|NCT02984982|39787360|FG000|Overall Study|Poor Compliance to Protocol|4|||
16355019|NCT02984982|39787361|FG001|Overall Study|Poor Compliance to Protocol|4|||
16355020|NCT02984982|39787360|FG000|Overall Study|Withdrawal by Subject|2|||
16355021|NCT02984982|39787361|FG001|Overall Study|Withdrawal by Subject|0|||
16355022|NCT02984982|39787360|FG000|Overall Study|Randomized but not treated|0|||
16355023|NCT02984982|39787361|FG001|Overall Study|Randomized but not treated|1|||
16355024|NCT00386334|39787367|FG000|Double Blind Period|Adverse Event|9|||
16355025|NCT00386334|39787368|FG001|Double Blind Period|Adverse Event|14|||
16355026|NCT00386334|39787367|FG000|Double Blind Period|Protocol Violation|1|||
16355027|NCT00386334|39787368|FG001|Double Blind Period|Protocol Violation|1|||
16355028|NCT00386334|39787367|FG000|Double Blind Period|Withdrawal by Subject|9|||
16355029|NCT00386334|39787368|FG001|Double Blind Period|Withdrawal by Subject|13|||
16355030|NCT00386334|39787367|FG000|Double Blind Period|Lack of Efficacy|20|||
16355031|NCT00386334|39787368|FG001|Double Blind Period|Lack of Efficacy|11|||
16355032|NCT00386334|39787367|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
16355033|NCT00386334|39787368|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
16355034|NCT00386334|39787367|FG000|Double Blind Period|Other|3|||
16355035|NCT00386334|39787368|FG001|Double Blind Period|Other|3|||
16355036|NCT00386334|39787367|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
16355037|NCT00386334|39787368|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
16355038|NCT03712280|39787373|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
16355039|NCT03712280|39787374|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
16355040|NCT03712280|39787375|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
16355041|NCT03712280|39787376|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
16355042|NCT03712280|39787373|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
16355043|NCT03712280|39787374|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
16355044|NCT03712280|39787375|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
16355045|NCT03712280|39787376|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
16355046|NCT03712280|39787373|FG000|Overall Study|Adverse Event|0|||
16247337|NCT01498484|39388196|FG007|Overall Study|Other|0|||
16247338|NCT01498484|39388197|FG008|Overall Study|Other|1|||
16247339|NCT02400905|39388201|FG000|Overall Study|Death|24|||
16247340|NCT02400905|39388201|FG000|Overall Study|Lost to Follow-up|18|||
16247341|NCT02400905|39388201|FG000|Overall Study|Withdrawal by Subject|16|||
16247342|NCT02400905|39388201|FG000|Overall Study|Physician Decision|4|||
16247343|NCT02400905|39388201|FG000|Overall Study|Other|1|||
16247344|NCT00368537|39388202|FG000|Randomization|No study drug dosed|13|||
16247345|NCT00368537|39388203|FG001|Randomization|No study drug dosed|6|||
16247346|NCT00368537|39388202|FG000|Baseline Participants|Lost to Follow-up|16|||
16247347|NCT00368537|39388203|FG001|Baseline Participants|Lost to Follow-up|17|||
16247348|NCT00368537|39388202|FG000|Baseline Participants|Withdrawal by Subject|6|||
16247349|NCT00368537|39388203|FG001|Baseline Participants|Withdrawal by Subject|4|||
16247350|NCT00368537|39388202|FG000|Baseline Participants|Death|1|||
16247351|NCT00368537|39388203|FG001|Baseline Participants|Death|2|||
16247352|NCT00368537|39388202|FG000|Baseline Participants|No susceptibility|1|||
16247353|NCT00368537|39388203|FG001|Baseline Participants|No susceptibility|0|||
16247354|NCT00368537|39388202|FG000|Baseline Participants|Patient uncompliant|0|||
16247355|NCT00368537|39388203|FG001|Baseline Participants|Patient uncompliant|1|||
16247356|NCT01965535|39388207|FG000|Overall Study|Lack of Efficacy|2|||
16247357|NCT01965535|39388208|FG001|Overall Study|Lack of Efficacy|1|||
16247358|NCT01141283|39388209|FG000|Overall Study|Adverse Event|56|||
16247359|NCT01141283|39388209|FG000|Overall Study|Lost to Follow-up|4|||
16247360|NCT01141283|39388209|FG000|Overall Study|Withdrawal by Subject|14|||
16247361|NCT01141283|39388209|FG000|Overall Study|Administrative|4|||
16247362|NCT01141283|39388209|FG000|Overall Study|Lack of Efficacy|10|||
16247363|NCT03008460|39388210|FG000|Overall Study|Protocol deviation|0|||
16247364|NCT03008460|39388211|FG001|Overall Study|Protocol deviation|2|||
16247365|NCT03008460|39388210|FG000|Overall Study|Study drug not dispensed|0|||
16247366|NCT03008460|39388211|FG001|Overall Study|Study drug not dispensed|1|||
16247367|NCT03008460|39388210|FG000|Overall Study|Adverse Event|0|||
16247368|NCT03008460|39388211|FG001|Overall Study|Adverse Event|1|||
16247369|NCT03008460|39388210|FG000|Overall Study|Withdrawal by Subject|5|||
16247370|NCT03008460|39388211|FG001|Overall Study|Withdrawal by Subject|6|||
16247371|NCT03008460|39388210|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
16355047|NCT03712280|39787374|FG001|Overall Study|Adverse Event|0|||
16355048|NCT03712280|39787375|FG002|Overall Study|Adverse Event|1|||
16355049|NCT03712280|39787376|FG003|Overall Study|Adverse Event|0|||
16355050|NCT01035138|39787384|FG000|Overall Study|Adverse Event|4|||
16355051|NCT01035138|39787385|FG001|Overall Study|Adverse Event|0|||
16355052|NCT01035138|39787386|FG002|Overall Study|Adverse Event|2|||
16355053|NCT01035138|39787384|FG000|Overall Study|Caregiver Decision|2|||
16355054|NCT01035138|39787385|FG001|Overall Study|Caregiver Decision|0|||
16355055|NCT01035138|39787386|FG002|Overall Study|Caregiver Decision|1|||
16355056|NCT01035138|39787384|FG000|Overall Study|Withdrawal by Subject|1|||
16355057|NCT01035138|39787385|FG001|Overall Study|Withdrawal by Subject|0|||
16355058|NCT01035138|39787386|FG002|Overall Study|Withdrawal by Subject|0|||
16355059|NCT01035138|39787384|FG000|Overall Study|Physician Decision|0|||
16355060|NCT01035138|39787385|FG001|Overall Study|Physician Decision|0|||
16355061|NCT01035138|39787386|FG002|Overall Study|Physician Decision|1|||
16355062|NCT01035138|39787384|FG000|Overall Study|Sponsor Decision|66|||
16355063|NCT01035138|39787385|FG001|Overall Study|Sponsor Decision|60|||
16355064|NCT01035138|39787386|FG002|Overall Study|Sponsor Decision|42|||
16355065|NCT01035138|39787384|FG000|Overall Study|Lost to Follow-up|0|||
16355066|NCT01035138|39787385|FG001|Overall Study|Lost to Follow-up|0|||
16355067|NCT01035138|39787386|FG002|Overall Study|Lost to Follow-up|1|||
16355068|NCT00402831|39787396|FG000|Overall Study|Lost to Follow-up|1|||
16355069|NCT00402831|39787397|FG001|Overall Study|Lost to Follow-up|2|||
16355070|NCT00402831|39787396|FG000|Overall Study|Non-compliance with protocol|0|||
16355071|NCT00402831|39787397|FG001|Overall Study|Non-compliance with protocol|1|||
16355072|NCT01618968|39787398|FG000|Overall Study|Adverse Event|1|||
16355073|NCT01618968|39787399|FG001|Overall Study|Adverse Event|0|||
16355074|NCT01618968|39787400|FG002|Overall Study|Adverse Event|0|||
16247372|NCT03008460|39388211|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
16247373|NCT03008460|39388210|FG000|Overall Study|End of study visit outside permitted time window|0|||
16247374|NCT03008460|39388211|FG001|Overall Study|End of study visit outside permitted time window|1|||
16247375|NCT03008460|39388210|FG000|Overall Study|Lost to Follow-up|1|||
16247376|NCT03008460|39388211|FG001|Overall Study|Lost to Follow-up|3|||
16247377|NCT00686790|39388212|FG000|Overall Study|Adverse Event|2|||
16247378|NCT00686790|39388212|FG000|Overall Study|Withdrawal by Subject|1|||
16247379|NCT00686790|39388212|FG000|Overall Study|Death|1|||
16247380|NCT00686790|39388212|FG000|Overall Study|Lost to Follow-up|12|||
16247381|NCT01797120|39388213|FG000|Overall Study|Disesae progression|37|||
16247382|NCT01797120|39388214|FG001|Overall Study|Disesae progression|49|||
16355075|NCT01618968|39787401|FG003|Overall Study|Adverse Event|0|||
16355076|NCT01618968|39787398|FG000|Overall Study|Death|0|||
16355077|NCT01618968|39787399|FG001|Overall Study|Death|0|||
16355078|NCT01618968|39787400|FG002|Overall Study|Death|0|||
16355079|NCT01618968|39787401|FG003|Overall Study|Death|1|||
16355080|NCT01206764|39787406|FG000|Overall Study|Adverse Event|20|||
16355081|NCT01206764|39787406|FG000|Overall Study|Abnormal laboratory value|2|||
16355082|NCT01206764|39787406|FG000|Overall Study|Abnormal test procedure result|1|||
16355083|NCT01206764|39787406|FG000|Overall Study|Patient withdrew consent|5|||
16355084|NCT01206764|39787406|FG000|Overall Study|Lost to Follow-up|6|||
16355085|NCT01206764|39787406|FG000|Overall Study|Death|11|||
16355086|NCT01206764|39787406|FG000|Overall Study|New cancer therapy|2|||
16355087|NCT01206764|39787406|FG000|Overall Study|Disease progression|88|||
16355088|NCT01206764|39787406|FG000|Overall Study|Protocol deviation|3|||
16355089|NCT02999789|39787410|FG000|Overall Study|Withdrawal by Subject|0|||
16355090|NCT02999789|39787411|FG001|Overall Study|Withdrawal by Subject|1|||
16355091|NCT02999789|39787410|FG000|Overall Study|Became ineligible|1|||
16355092|NCT02999789|39787411|FG001|Overall Study|Became ineligible|2|||
16355093|NCT01692119|39787412|FG000|Overall Study|Protocol Violation|3|||
16355094|NCT01692119|39787413|FG001|Overall Study|Protocol Violation|1|||
16355095|NCT01692119|39787412|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
16355096|NCT01692119|39787413|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
16355097|NCT03652818|39787414|FG000|Overall Study|Adverse Event|1|||
16355098|NCT03652818|39787415|FG001|Overall Study|Adverse Event|0|||
16355099|NCT03652818|39787416|FG002|Overall Study|Adverse Event|0|||
16355100|NCT03652818|39787417|FG003|Overall Study|Adverse Event|0|||
16355101|NCT03652818|39787418|FG004|Overall Study|Adverse Event|0|||
16355102|NCT03652818|39787414|FG000|Overall Study|Physician Decision|1|||
16355103|NCT03652818|39787415|FG001|Overall Study|Physician Decision|0|||
16355104|NCT03652818|39787416|FG002|Overall Study|Physician Decision|0|||
16355105|NCT03652818|39787417|FG003|Overall Study|Physician Decision|0|||
16355106|NCT03652818|39787418|FG004|Overall Study|Physician Decision|0|||
16355107|NCT03652818|39787414|FG000|Overall Study|Lost to Follow-up|0|||
16355108|NCT03652818|39787415|FG001|Overall Study|Lost to Follow-up|1|||
16355109|NCT03652818|39787416|FG002|Overall Study|Lost to Follow-up|2|||
16355110|NCT03652818|39787417|FG003|Overall Study|Lost to Follow-up|1|||
16355111|NCT03652818|39787418|FG004|Overall Study|Lost to Follow-up|1|||
16355112|NCT03669588|39787421|FG000|Overall Study|Adverse Event|1|||
16355113|NCT03669588|39787422|FG001|Overall Study|Adverse Event|0|||
16355114|NCT03669588|39787421|FG000|Overall Study|Physician Decision|0|||
16355115|NCT03669588|39787422|FG001|Overall Study|Physician Decision|1|||
16355116|NCT03669588|39787421|FG000|Overall Study|Protocol Violation|1|||
16355117|NCT03669588|39787422|FG001|Overall Study|Protocol Violation|0|||
16355118|NCT03669588|39787421|FG000|Overall Study|Sponsor Decision|1|||
16355119|NCT03669588|39787422|FG001|Overall Study|Sponsor Decision|1|||
16355120|NCT03669588|39787421|FG000|Overall Study|Withdrawal by Subject|1|||
16355121|NCT03669588|39787422|FG001|Overall Study|Withdrawal by Subject|4|||
16355122|NCT03669588|39787421|FG000|Overall Study|Rescue Therapy Needed|0|||
16355123|NCT03669588|39787422|FG001|Overall Study|Rescue Therapy Needed|1|||
16355124|NCT03342001|39787424|FG000|Overall Study|Adverse Event|1|||
16355125|NCT03342001|39787424|FG000|Overall Study|Lost to Follow-up|1|||
16417855|NCT00528996|40008615|FG000|Overall Study|Lost to Follow-up|2|||
16417856|NCT00528996|40008616|FG001|Overall Study|Lost to Follow-up|0|||
16417857|NCT00528996|40008617|FG002|Overall Study|Lost to Follow-up|4|||
16417858|NCT00528996|40008618|FG003|Overall Study|Lost to Follow-up|1|||
16417859|NCT00528996|40008619|FG004|Overall Study|Lost to Follow-up|3|||
16355126|NCT01232283|39787437|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
16355127|NCT01232283|39787438|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
16355128|NCT01232283|39787439|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16355129|NCT01232283|39787440|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16355130|NCT01232283|39787441|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16355131|NCT01232283|39787442|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16355132|NCT01232283|39787443|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16355133|NCT01232283|39787444|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16355134|NCT01232283|39787445|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16355135|NCT01232283|39787446|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
16355136|NCT01232283|39787437|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
16355137|NCT01232283|39787438|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
16355138|NCT01232283|39787439|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16355139|NCT01232283|39787440|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16355140|NCT01232283|39787441|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16355141|NCT01232283|39787442|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16355142|NCT01232283|39787443|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16355143|NCT01232283|39787444|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16355144|NCT01232283|39787445|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16355145|NCT01232283|39787446|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
16417860|NCT00528996|40008615|FG000|Overall Study|Protocol Violation|1|||
16355146|NCT01232283|39787437|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
16355147|NCT01232283|39787438|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16355148|NCT01232283|39787439|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16355149|NCT01232283|39787440|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16355150|NCT01232283|39787441|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16355151|NCT01232283|39787442|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16355152|NCT01232283|39787443|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16355153|NCT01232283|39787444|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16355154|NCT01232283|39787445|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16355155|NCT01232283|39787446|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
16355156|NCT01232283|39787437|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
16355157|NCT01232283|39787438|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
16355158|NCT01232283|39787439|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16355159|NCT01232283|39787440|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16355160|NCT01232283|39787441|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16355161|NCT01232283|39787442|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16355162|NCT01232283|39787443|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16355163|NCT01232283|39787444|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16355164|NCT01232283|39787445|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16355165|NCT01232283|39787446|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
16355166|NCT01232283|39787437|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
16355167|NCT01232283|39787438|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
16355168|NCT01232283|39787439|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16355169|NCT01232283|39787440|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16355170|NCT01232283|39787441|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16355171|NCT01232283|39787442|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16355172|NCT01232283|39787443|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16355173|NCT01232283|39787444|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16355174|NCT01232283|39787445|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16355175|NCT01232283|39787446|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
16355176|NCT01232283|39787437|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
16355177|NCT01232283|39787438|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
16355178|NCT01232283|39787439|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16355179|NCT01232283|39787440|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16355180|NCT01232283|39787441|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16355181|NCT01232283|39787442|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16355182|NCT01232283|39787443|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16355183|NCT01232283|39787444|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16355184|NCT01232283|39787445|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16355185|NCT01232283|39787446|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
16355186|NCT01232283|39787437|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
16355187|NCT01232283|39787438|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
16355188|NCT01232283|39787439|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16355189|NCT01232283|39787440|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16355190|NCT01232283|39787441|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16355191|NCT01232283|39787442|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16355192|NCT01232283|39787443|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16355193|NCT01232283|39787444|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16355194|NCT01232283|39787445|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16355195|NCT01232283|39787446|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
16417861|NCT00528996|40008616|FG001|Overall Study|Protocol Violation|2|||
16417862|NCT00528996|40008617|FG002|Overall Study|Protocol Violation|3|||
16417863|NCT00528996|40008618|FG003|Overall Study|Protocol Violation|3|||
16417864|NCT00528996|40008619|FG004|Overall Study|Protocol Violation|2|||
16417865|NCT00528996|40008615|FG000|Overall Study|Lack of Efficacy|7|||
16417866|NCT00528996|40008616|FG001|Overall Study|Lack of Efficacy|2|||
16417867|NCT00528996|40008617|FG002|Overall Study|Lack of Efficacy|1|||
16417868|NCT00528996|40008618|FG003|Overall Study|Lack of Efficacy|3|||
16417869|NCT00528996|40008619|FG004|Overall Study|Lack of Efficacy|3|||
16417870|NCT00528996|40008615|FG000|Overall Study|Adverse Event|32|||
16417871|NCT00528996|40008616|FG001|Overall Study|Adverse Event|13|||
16417872|NCT00528996|40008617|FG002|Overall Study|Adverse Event|18|||
16417873|NCT00528996|40008618|FG003|Overall Study|Adverse Event|29|||
16417874|NCT00528996|40008619|FG004|Overall Study|Adverse Event|18|||
16417875|NCT01229449|40008620|FG000|Overall Study|Withdrawal by Subject|0|||
16417876|NCT01229449|40008621|FG001|Overall Study|Withdrawal by Subject|3|||
16417877|NCT01229449|40008622|FG002|Overall Study|Withdrawal by Subject|0|||
16355196|NCT01232283|39787437|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16355197|NCT01232283|39787438|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16355198|NCT01232283|39787439|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
16355199|NCT01232283|39787440|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
16355200|NCT01232283|39787441|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16355201|NCT01232283|39787442|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16355202|NCT01232283|39787443|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16355203|NCT01232283|39787444|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16355204|NCT01232283|39787445|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16355205|NCT01232283|39787446|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
16355206|NCT01232283|39787437|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16355207|NCT01232283|39787438|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16355208|NCT01232283|39787439|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
16355209|NCT01232283|39787440|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
16355210|NCT01232283|39787441|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16355211|NCT01232283|39787442|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16355212|NCT01232283|39787443|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16355213|NCT01232283|39787444|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16355214|NCT01232283|39787445|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16355215|NCT01232283|39787446|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
16355216|NCT01232283|39787437|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16355217|NCT01232283|39787438|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16355218|NCT01232283|39787439|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
16355219|NCT01232283|39787440|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16355220|NCT01232283|39787441|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16355221|NCT01232283|39787442|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16355222|NCT01232283|39787443|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16355223|NCT01232283|39787444|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16355224|NCT01232283|39787445|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16355225|NCT01232283|39787446|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
16355226|NCT01232283|39787437|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16355227|NCT01232283|39787438|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16355228|NCT01232283|39787439|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
16355229|NCT01232283|39787440|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
16355230|NCT01232283|39787441|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16355231|NCT01232283|39787442|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16355232|NCT01232283|39787443|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16355233|NCT01232283|39787444|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16355234|NCT01232283|39787445|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16355235|NCT01232283|39787446|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
16355236|NCT01232283|39787437|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16355237|NCT01232283|39787438|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16355238|NCT01232283|39787439|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
16355239|NCT01232283|39787440|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
16355240|NCT01232283|39787441|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16355241|NCT01232283|39787442|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16355242|NCT01232283|39787443|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16417878|NCT01229449|40008623|FG003|Overall Study|Withdrawal by Subject|1|||
16417879|NCT01229449|40008624|FG004|Overall Study|Withdrawal by Subject|1|||
16247383|NCT01797120|39388213|FG000|Overall Study|Adverse Event|13|||
16247384|NCT01797120|39388214|FG001|Overall Study|Adverse Event|5|||
16247385|NCT01797120|39388213|FG000|Overall Study|Withdrawal by Subject|6|||
16247386|NCT01797120|39388214|FG001|Overall Study|Withdrawal by Subject|6|||
16247387|NCT01797120|39388213|FG000|Overall Study|Symptomatic progression|2|||
16247388|NCT01797120|39388214|FG001|Overall Study|Symptomatic progression|1|||
16247389|NCT01797120|39388213|FG000|Overall Study|Non-compliance|1|||
16247390|NCT01797120|39388214|FG001|Overall Study|Non-compliance|0|||
16247391|NCT01797120|39388213|FG000|Overall Study|Physician Decision|3|||
16247392|NCT01797120|39388214|FG001|Overall Study|Physician Decision|0|||
16247393|NCT01797120|39388213|FG000|Overall Study|still on treatment|2|||
16247394|NCT01797120|39388214|FG001|Overall Study|still on treatment|4|||
16247395|NCT01797120|39388213|FG000|Overall Study|never start protocol therapy|2|||
16247396|NCT01797120|39388214|FG001|Overall Study|never start protocol therapy|0|||
16247397|NCT02110706|39388215|FG000|Overall Study|Adverse Event|2|||
16247398|NCT02110706|39388216|FG001|Overall Study|Adverse Event|3|||
16247399|NCT02110706|39388215|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
16417880|NCT01229449|40008620|FG000|Overall Study|Lost to Follow-up|1|||
16247400|NCT02110706|39388216|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
16247401|NCT01078623|39388219|FG000|Treatment Period 1|Adverse Event|1|||
16247402|NCT01078623|39388220|FG001|Treatment Period 1|Adverse Event|1|||
16417881|NCT01229449|40008621|FG001|Overall Study|Lost to Follow-up|1|||
16417882|NCT01229449|40008622|FG002|Overall Study|Lost to Follow-up|1|||
16417883|NCT01229449|40008623|FG003|Overall Study|Lost to Follow-up|0|||
16417884|NCT01229449|40008624|FG004|Overall Study|Lost to Follow-up|0|||
16417885|NCT01229449|40008620|FG000|Overall Study|Physician Decision|0|||
16417886|NCT01229449|40008621|FG001|Overall Study|Physician Decision|0|||
16417887|NCT01229449|40008622|FG002|Overall Study|Physician Decision|1|||
16247403|NCT01078623|39388221|FG002|Treatment Period 1|Adverse Event|1|||
16247404|NCT01078623|39388222|FG003|Treatment Period 1|Adverse Event|0|||
16247405|NCT01078623|39388223|FG004|Treatment Period 1|Adverse Event|0|||
16247406|NCT01078623|39388224|FG005|Treatment Period 1|Adverse Event|0|||
16247407|NCT01078623|39388225|FG006|Treatment Period 1|Adverse Event|1|||
16247408|NCT01078623|39388226|FG007|Treatment Period 1|Adverse Event|0|||
16247409|NCT01078623|39388227|FG008|Treatment Period 1|Adverse Event|1|||
16247410|NCT01078623|39388228|FG009|Treatment Period 1|Adverse Event|1|||
16247411|NCT01078623|39388229|FG010|Treatment Period 1|Adverse Event|0|||
16247412|NCT01078623|39388230|FG011|Treatment Period 1|Adverse Event|0|||
16247413|NCT01078623|39388231|FG012|Treatment Period 1|Adverse Event|0|||
16247414|NCT01078623|39388232|FG013|Treatment Period 1|Adverse Event|0|||
16247415|NCT01078623|39388233|FG014|Treatment Period 1|Adverse Event|0|||
16247416|NCT01078623|39388234|FG015|Treatment Period 1|Adverse Event|0|||
16247417|NCT01078623|39388235|FG016|Treatment Period 1|Adverse Event|0|||
16247418|NCT01078623|39388236|FG017|Treatment Period 1|Adverse Event|0|||
16247419|NCT01078623|39388237|FG018|Treatment Period 1|Adverse Event|0|||
16247420|NCT01078623|39388238|FG019|Treatment Period 1|Adverse Event|0|||
16247421|NCT01078623|39388219|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16247422|NCT01078623|39388220|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16247423|NCT01078623|39388221|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16247424|NCT01078623|39388222|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16247425|NCT01078623|39388223|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16247426|NCT01078623|39388224|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16247427|NCT01078623|39388225|FG006|Treatment Period 1|Withdrawal by Subject|0|||
16247428|NCT01078623|39388226|FG007|Treatment Period 1|Withdrawal by Subject|1|||
16247429|NCT01078623|39388227|FG008|Treatment Period 1|Withdrawal by Subject|0|||
16247430|NCT01078623|39388228|FG009|Treatment Period 1|Withdrawal by Subject|0|||
16247431|NCT01078623|39388229|FG010|Treatment Period 1|Withdrawal by Subject|1|||
16247432|NCT01078623|39388230|FG011|Treatment Period 1|Withdrawal by Subject|0|||
16247433|NCT01078623|39388231|FG012|Treatment Period 1|Withdrawal by Subject|0|||
16247434|NCT01078623|39388232|FG013|Treatment Period 1|Withdrawal by Subject|0|||
16247435|NCT01078623|39388233|FG014|Treatment Period 1|Withdrawal by Subject|0|||
16247436|NCT01078623|39388234|FG015|Treatment Period 1|Withdrawal by Subject|0|||
16247437|NCT01078623|39388235|FG016|Treatment Period 1|Withdrawal by Subject|0|||
16247438|NCT01078623|39388236|FG017|Treatment Period 1|Withdrawal by Subject|0|||
16247439|NCT01078623|39388237|FG018|Treatment Period 1|Withdrawal by Subject|0|||
16247440|NCT01078623|39388238|FG019|Treatment Period 1|Withdrawal by Subject|0|||
16247441|NCT01078623|39388219|FG000|Treatment Period 1|Protocol Violation|0|||
16417888|NCT01229449|40008623|FG003|Overall Study|Physician Decision|0|||
16355243|NCT01232283|39787444|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16355244|NCT01232283|39787445|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16355245|NCT01232283|39787446|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
16355246|NCT01232283|39787437|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
16355247|NCT01232283|39787438|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
16355248|NCT01232283|39787439|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
16355249|NCT01232283|39787440|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
16355250|NCT01232283|39787441|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
16355251|NCT01232283|39787442|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
16355252|NCT01232283|39787443|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
16355253|NCT01232283|39787444|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
16355254|NCT01232283|39787445|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
16417889|NCT01229449|40008624|FG004|Overall Study|Physician Decision|0|||
16417890|NCT01545050|40008625|FG000|Overall Study|Lack of Efficacy|0|||
16417891|NCT01545050|40008626|FG001|Overall Study|Lack of Efficacy|0|||
16417892|NCT01545050|40008627|FG002|Overall Study|Lack of Efficacy|0|||
16417893|NCT01545050|40008628|FG003|Overall Study|Lack of Efficacy|3|||
16417894|NCT01545050|40008629|FG004|Overall Study|Lack of Efficacy|2|||
16417895|NCT01545050|40008625|FG000|Overall Study|Adverse Event|1|||
16417896|NCT01545050|40008626|FG001|Overall Study|Adverse Event|1|||
16417897|NCT01545050|40008627|FG002|Overall Study|Adverse Event|2|||
16417898|NCT01545050|40008628|FG003|Overall Study|Adverse Event|2|||
16417899|NCT01545050|40008629|FG004|Overall Study|Adverse Event|0|||
16417900|NCT01545050|40008625|FG000|Overall Study|Discontinued study treatment|1|||
16417901|NCT01545050|40008626|FG001|Overall Study|Discontinued study treatment|0|||
16417902|NCT01545050|40008627|FG002|Overall Study|Discontinued study treatment|0|||
16417903|NCT01545050|40008628|FG003|Overall Study|Discontinued study treatment|0|||
16417904|NCT01545050|40008629|FG004|Overall Study|Discontinued study treatment|0|||
16417905|NCT01545050|40008625|FG000|Overall Study|Withdrawal by Subject|1|||
16417906|NCT01545050|40008626|FG001|Overall Study|Withdrawal by Subject|0|||
16417907|NCT01545050|40008627|FG002|Overall Study|Withdrawal by Subject|0|||
16417908|NCT01545050|40008628|FG003|Overall Study|Withdrawal by Subject|2|||
16417909|NCT01545050|40008629|FG004|Overall Study|Withdrawal by Subject|1|||
16417910|NCT01545050|40008625|FG000|Overall Study|Participant no longer meets study criteria|0|||
16417911|NCT01545050|40008626|FG001|Overall Study|Participant no longer meets study criteria|2|||
16417912|NCT01545050|40008627|FG002|Overall Study|Participant no longer meets study criteria|0|||
16417913|NCT01545050|40008628|FG003|Overall Study|Participant no longer meets study criteria|0|||
16417914|NCT01545050|40008629|FG004|Overall Study|Participant no longer meets study criteria|1|||
16417915|NCT01545050|40008625|FG000|Overall Study|Administrative reason by sponsor|4|||
16417916|NCT01545050|40008626|FG001|Overall Study|Administrative reason by sponsor|2|||
16417917|NCT01545050|40008627|FG002|Overall Study|Administrative reason by sponsor|3|||
16417918|NCT01545050|40008628|FG003|Overall Study|Administrative reason by sponsor|5|||
16417919|NCT01545050|40008629|FG004|Overall Study|Administrative reason by sponsor|5|||
16417920|NCT00760838|40008638|FG000|Overall Study|Adverse Event|1|||
16417921|NCT00760838|40008639|FG001|Overall Study|Adverse Event|1|||
16417922|NCT00760838|40008638|FG000|Overall Study|Lack of Efficacy|1|||
16417923|NCT00760838|40008639|FG001|Overall Study|Lack of Efficacy|0|||
16417924|NCT00760838|40008638|FG000|Overall Study|Lost to Follow-up|2|||
16417925|NCT00760838|40008639|FG001|Overall Study|Lost to Follow-up|0|||
16417926|NCT00760838|40008638|FG000|Overall Study|Withdrawal by Subject|1|||
16417927|NCT00760838|40008639|FG001|Overall Study|Withdrawal by Subject|1|||
16417928|NCT02976103|40008641|FG000|Overall Study|Withdrawal by Subject|1|||
16417929|NCT02976103|40008642|FG001|Overall Study|Withdrawal by Subject|0|||
16355255|NCT01232283|39787446|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
16355256|NCT01232283|39787437|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16355257|NCT01232283|39787438|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16355258|NCT01232283|39787439|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16355259|NCT01232283|39787440|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16355260|NCT01232283|39787441|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
16355261|NCT01232283|39787442|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
16355262|NCT01232283|39787443|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16355263|NCT01232283|39787444|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
16355264|NCT01232283|39787445|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16355265|NCT01232283|39787446|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
16355266|NCT01232283|39787437|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16355267|NCT01232283|39787438|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16355268|NCT01232283|39787439|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16417930|NCT02976103|40008641|FG000|Overall Study|Lost to Follow-up|12|||
16417931|NCT02976103|40008642|FG001|Overall Study|Lost to Follow-up|8|||
16417932|NCT01789606|40011707|FG000|Overall Study|Participant not Purchased the Product|0|||
16417933|NCT01789606|40011708|FG001|Overall Study|Participant not Purchased the Product|20|||
16561525|NCT00813488|40521857|FG001|Open-label Extension|Non-compliance study procedures|1|||
16130564|NCT00196976|38967062|FG013|Primary Study|Other|0|||
16417934|NCT01789606|40011707|FG000|Overall Study|Withdrawal by Subject|0|||
16417935|NCT01789606|40011708|FG001|Overall Study|Withdrawal by Subject|1|||
16417936|NCT01789606|40011707|FG000|Overall Study|Ineligible|6|||
16417937|NCT01789606|40011708|FG001|Overall Study|Ineligible|2|||
16355269|NCT01232283|39787440|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16355270|NCT01232283|39787441|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
16355271|NCT01232283|39787442|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16355272|NCT01232283|39787443|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
16355273|NCT01232283|39787444|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
16355274|NCT01232283|39787445|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16355275|NCT01232283|39787446|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
16355276|NCT01232283|39787437|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16355277|NCT01232283|39787438|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16355278|NCT01232283|39787439|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16355279|NCT01232283|39787440|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16355280|NCT01232283|39787441|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
16355281|NCT01232283|39787442|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
16355282|NCT01232283|39787443|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
16355283|NCT01232283|39787444|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
16355284|NCT01232283|39787445|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16355285|NCT01232283|39787446|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
16355286|NCT01232283|39787437|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16355287|NCT01232283|39787438|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16355288|NCT01232283|39787439|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16355289|NCT01232283|39787440|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16355290|NCT01232283|39787441|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
16355291|NCT01232283|39787442|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16355292|NCT01232283|39787443|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16355293|NCT01232283|39787444|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16355294|NCT01232283|39787445|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16355295|NCT01232283|39787446|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
16355296|NCT01232283|39787437|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16355297|NCT01232283|39787438|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16355298|NCT01232283|39787439|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16355299|NCT01232283|39787440|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16355300|NCT01232283|39787441|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
16355301|NCT01232283|39787442|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16355302|NCT01232283|39787443|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
16355303|NCT01232283|39787444|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
16355304|NCT01232283|39787445|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16355305|NCT01232283|39787446|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
16355306|NCT01232283|39787437|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16355307|NCT01232283|39787438|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16355308|NCT01232283|39787439|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16355309|NCT01232283|39787440|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16355310|NCT01232283|39787441|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16355311|NCT01232283|39787442|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16355312|NCT01232283|39787443|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16355313|NCT01232283|39787444|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
16355314|NCT01232283|39787445|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16355315|NCT01232283|39787446|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
16355316|NCT01232283|39787437|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16355317|NCT01232283|39787438|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16355318|NCT01232283|39787439|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16355319|NCT01232283|39787440|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16355320|NCT01232283|39787441|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16355321|NCT01232283|39787442|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
16355322|NCT01232283|39787443|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16417938|NCT01789606|40011707|FG000|Overall Study|Administrative Reasons|17|||
16417939|NCT01789606|40011708|FG001|Overall Study|Administrative Reasons|6|||
16561526|NCT00813488|40521856|FG000|Open-label Extension|Other|1|||
16561527|NCT00813488|40521857|FG001|Open-label Extension|Other|0|||
16561528|NCT03712098|40521858|FG000|Overall Study|Lost to Follow-up|3|||
16247442|NCT01078623|39388220|FG001|Treatment Period 1|Protocol Violation|0|||
16355323|NCT01232283|39787444|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16355324|NCT01232283|39787445|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16355325|NCT01232283|39787446|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
16355326|NCT01232283|39787437|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16355327|NCT01232283|39787438|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16355328|NCT01232283|39787439|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16355329|NCT01232283|39787440|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16355330|NCT01232283|39787441|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16355331|NCT01232283|39787442|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16355332|NCT01232283|39787443|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16355333|NCT01232283|39787444|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
16355334|NCT01232283|39787445|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
16417940|NCT01789606|40011707|FG000|Overall Study|No Study Medication Taken|0|||
16417941|NCT01789606|40011708|FG001|Overall Study|No Study Medication Taken|1|||
16417942|NCT01789606|40011707|FG000|Overall Study|Protocol Violation|0|||
16417943|NCT01789606|40011708|FG001|Overall Study|Protocol Violation|55|||
16417944|NCT01789606|40011707|FG000|Overall Study|Adverse Event|0|||
16417945|NCT01789606|40011708|FG001|Overall Study|Adverse Event|3|||
16417946|NCT01789606|40011707|FG000|Overall Study|Lost to Follow-up|0|||
16417947|NCT01789606|40011708|FG001|Overall Study|Lost to Follow-up|14|||
16417948|NCT01789606|40011707|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
16417949|NCT01789606|40011708|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
16417950|NCT00752726|40011709|FG000|Overall Study|Lost to Follow-up|2|||
16417951|NCT00752726|40011710|FG001|Overall Study|Lost to Follow-up|1|||
16417952|NCT00752726|40011709|FG000|Overall Study|Adverse Event|3|||
16417953|NCT00752726|40011710|FG001|Overall Study|Adverse Event|0|||
16417954|NCT00752726|40011709|FG000|Overall Study|Withdrawal by Subject|5|||
16417955|NCT00752726|40011710|FG001|Overall Study|Withdrawal by Subject|10|||
16417956|NCT00752726|40011709|FG000|Overall Study|Other Reason|1|||
16417957|NCT00752726|40011710|FG001|Overall Study|Other Reason|2|||
16417958|NCT01329939|40011711|FG000|Overall Study|Lost to Follow-up|3|||
16417959|NCT01329939|40011712|FG001|Overall Study|Lost to Follow-up|0|||
16417960|NCT01329939|40011713|FG002|Overall Study|Lost to Follow-up|1|||
16417961|NCT01329939|40011714|FG003|Overall Study|Lost to Follow-up|2|||
16417962|NCT01329939|40011711|FG000|Overall Study|Withdrawal by Subject|0|||
16417963|NCT01329939|40011712|FG001|Overall Study|Withdrawal by Subject|1|||
16417964|NCT01329939|40011713|FG002|Overall Study|Withdrawal by Subject|0|||
16417965|NCT01329939|40011714|FG003|Overall Study|Withdrawal by Subject|0|||
16561529|NCT03712098|40521859|FG001|Overall Study|Lost to Follow-up|7|||
16561530|NCT03712098|40521858|FG000|Overall Study|Withdrawal by Subject|9|||
16561531|NCT03712098|40521859|FG001|Overall Study|Withdrawal by Subject|4|||
16561532|NCT03712098|40521858|FG000|Overall Study|Protocol Violation|2|||
16561533|NCT03712098|40521859|FG001|Overall Study|Protocol Violation|1|||
16561534|NCT00814489|40521860|FG000|Overall Study|Other|2|||
16561535|NCT00814489|40521861|FG001|Overall Study|Other|0|||
16561536|NCT00814489|40521862|FG002|Overall Study|Other|1|||
16561537|NCT02061761|40521863|FG000|Overall Study|Disease progression|2|||
16561538|NCT02061761|40521864|FG001|Overall Study|Disease progression|8|||
16561539|NCT02061761|40521865|FG002|Overall Study|Disease progression|4|||
16561540|NCT02061761|40521866|FG003|Overall Study|Disease progression|5|||
16561541|NCT02061761|40521867|FG004|Overall Study|Disease progression|9|||
16561542|NCT02061761|40521868|FG005|Overall Study|Disease progression|3|||
16561543|NCT02061761|40521869|FG006|Overall Study|Disease progression|1|||
16561544|NCT02061761|40521870|FG007|Overall Study|Disease progression|2|||
16561545|NCT02061761|40521871|FG008|Overall Study|Disease progression|28|||
16561546|NCT02061761|40521863|FG000|Overall Study|Study Drug toxicity|0|||
16561547|NCT02061761|40521864|FG001|Overall Study|Study Drug toxicity|0|||
16561548|NCT02061761|40521865|FG002|Overall Study|Study Drug toxicity|0|||
16561549|NCT02061761|40521866|FG003|Overall Study|Study Drug toxicity|0|||
16561550|NCT02061761|40521867|FG004|Overall Study|Study Drug toxicity|0|||
16561551|NCT02061761|40521868|FG005|Overall Study|Study Drug toxicity|1|||
16561552|NCT02061761|40521869|FG006|Overall Study|Study Drug toxicity|0|||
16561553|NCT02061761|40521870|FG007|Overall Study|Study Drug toxicity|2|||
16561554|NCT02061761|40521871|FG008|Overall Study|Study Drug toxicity|6|||
16561555|NCT02061761|40521863|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
16247443|NCT01078623|39388221|FG002|Treatment Period 1|Protocol Violation|0|||
16247444|NCT01078623|39388222|FG003|Treatment Period 1|Protocol Violation|0|||
16247445|NCT01078623|39388223|FG004|Treatment Period 1|Protocol Violation|0|||
16247446|NCT01078623|39388224|FG005|Treatment Period 1|Protocol Violation|1|||
16247447|NCT01078623|39388225|FG006|Treatment Period 1|Protocol Violation|0|||
16247448|NCT01078623|39388226|FG007|Treatment Period 1|Protocol Violation|0|||
16247449|NCT01078623|39388227|FG008|Treatment Period 1|Protocol Violation|0|||
16247450|NCT01078623|39388228|FG009|Treatment Period 1|Protocol Violation|0|||
16247451|NCT01078623|39388229|FG010|Treatment Period 1|Protocol Violation|0|||
16247452|NCT01078623|39388230|FG011|Treatment Period 1|Protocol Violation|0|||
16247453|NCT01078623|39388231|FG012|Treatment Period 1|Protocol Violation|0|||
16247454|NCT01078623|39388232|FG013|Treatment Period 1|Protocol Violation|0|||
16247455|NCT01078623|39388233|FG014|Treatment Period 1|Protocol Violation|0|||
16561556|NCT02061761|40521864|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
16561557|NCT02061761|40521865|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
16561558|NCT02061761|40521866|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
16561559|NCT02061761|40521867|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
16561560|NCT02061761|40521868|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
16417966|NCT01329939|40011711|FG000|Overall Study|Adverse Event|0|||
16417967|NCT01329939|40011712|FG001|Overall Study|Adverse Event|0|||
16247456|NCT01078623|39388234|FG015|Treatment Period 1|Protocol Violation|0|||
16247457|NCT01078623|39388235|FG016|Treatment Period 1|Protocol Violation|0|||
16247458|NCT01078623|39388236|FG017|Treatment Period 1|Protocol Violation|0|||
16247459|NCT01078623|39388237|FG018|Treatment Period 1|Protocol Violation|0|||
16247460|NCT01078623|39388238|FG019|Treatment Period 1|Protocol Violation|0|||
16247461|NCT01078623|39388219|FG000|Treatment Period 2|Adverse Event|0|||
16247462|NCT01078623|39388220|FG001|Treatment Period 2|Adverse Event|0|||
16247463|NCT01078623|39388221|FG002|Treatment Period 2|Adverse Event|0|||
16247464|NCT01078623|39388222|FG003|Treatment Period 2|Adverse Event|0|||
16247465|NCT01078623|39388223|FG004|Treatment Period 2|Adverse Event|0|||
16247466|NCT01078623|39388224|FG005|Treatment Period 2|Adverse Event|0|||
16247467|NCT01078623|39388225|FG006|Treatment Period 2|Adverse Event|1|||
16247468|NCT01078623|39388226|FG007|Treatment Period 2|Adverse Event|0|||
16247469|NCT01078623|39388227|FG008|Treatment Period 2|Adverse Event|0|||
16247470|NCT01078623|39388228|FG009|Treatment Period 2|Adverse Event|0|||
16247471|NCT01078623|39388229|FG010|Treatment Period 2|Adverse Event|0|||
16247472|NCT01078623|39388230|FG011|Treatment Period 2|Adverse Event|0|||
16247473|NCT01078623|39388231|FG012|Treatment Period 2|Adverse Event|0|||
16247474|NCT01078623|39388232|FG013|Treatment Period 2|Adverse Event|0|||
16247475|NCT01078623|39388233|FG014|Treatment Period 2|Adverse Event|0|||
16247476|NCT01078623|39388234|FG015|Treatment Period 2|Adverse Event|0|||
16247477|NCT01078623|39388235|FG016|Treatment Period 2|Adverse Event|0|||
16247478|NCT01078623|39388236|FG017|Treatment Period 2|Adverse Event|0|||
16247479|NCT01078623|39388237|FG018|Treatment Period 2|Adverse Event|1|||
16247480|NCT01078623|39388238|FG019|Treatment Period 2|Adverse Event|0|||
16247481|NCT01078623|39388219|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16247482|NCT01078623|39388220|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16247483|NCT01078623|39388221|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16247484|NCT01078623|39388222|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16247485|NCT01078623|39388223|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16247486|NCT01078623|39388224|FG005|Treatment Period 2|Withdrawal by Subject|1|||
16247487|NCT01078623|39388225|FG006|Treatment Period 2|Withdrawal by Subject|0|||
16247488|NCT01078623|39388226|FG007|Treatment Period 2|Withdrawal by Subject|0|||
16561561|NCT02061761|40521869|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
16247489|NCT01078623|39388227|FG008|Treatment Period 2|Withdrawal by Subject|0|||
16247490|NCT01078623|39388228|FG009|Treatment Period 2|Withdrawal by Subject|0|||
16247491|NCT01078623|39388229|FG010|Treatment Period 2|Withdrawal by Subject|0|||
16247492|NCT01078623|39388230|FG011|Treatment Period 2|Withdrawal by Subject|0|||
16247493|NCT01078623|39388231|FG012|Treatment Period 2|Withdrawal by Subject|0|||
16247494|NCT01078623|39388232|FG013|Treatment Period 2|Withdrawal by Subject|0|||
16417968|NCT01329939|40011713|FG002|Overall Study|Adverse Event|0|||
16561562|NCT02061761|40521870|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
16561563|NCT02061761|40521871|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
16561564|NCT02061761|40521863|FG000|Overall Study|Participant request to discontinue study treatment|0|||
16561565|NCT02061761|40521864|FG001|Overall Study|Participant request to discontinue study treatment|0|||
16561566|NCT02061761|40521865|FG002|Overall Study|Participant request to discontinue study treatment|2|||
16561567|NCT02061761|40521866|FG003|Overall Study|Participant request to discontinue study treatment|2|||
16247495|NCT01078623|39388233|FG014|Treatment Period 2|Withdrawal by Subject|0|||
16247496|NCT01078623|39388234|FG015|Treatment Period 2|Withdrawal by Subject|0|||
16247497|NCT01078623|39388235|FG016|Treatment Period 2|Withdrawal by Subject|0|||
16247498|NCT01078623|39388236|FG017|Treatment Period 2|Withdrawal by Subject|0|||
16247499|NCT01078623|39388237|FG018|Treatment Period 2|Withdrawal by Subject|0|||
16247500|NCT01078623|39388238|FG019|Treatment Period 2|Withdrawal by Subject|0|||
16247501|NCT01078623|39388219|FG000|Treatment Period 3|Adverse Event|0|||
16247502|NCT01078623|39388220|FG001|Treatment Period 3|Adverse Event|0|||
16355335|NCT01232283|39787446|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
16355336|NCT01232283|39787437|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16355337|NCT01232283|39787438|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16355338|NCT01232283|39787439|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16355339|NCT01232283|39787440|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16355340|NCT01232283|39787441|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16355341|NCT01232283|39787442|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16355342|NCT01232283|39787443|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16355343|NCT01232283|39787444|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
16355344|NCT01232283|39787445|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
16355345|NCT01232283|39787446|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
16355346|NCT01232283|39787437|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16355347|NCT01232283|39787438|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16355348|NCT01232283|39787439|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16355349|NCT01232283|39787440|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16355350|NCT01232283|39787441|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16355351|NCT01232283|39787442|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16355352|NCT01232283|39787443|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16355353|NCT01232283|39787444|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
16355354|NCT01232283|39787445|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
16355355|NCT01232283|39787446|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
16355356|NCT01232283|39787437|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16355357|NCT01232283|39787438|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16355358|NCT01232283|39787439|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16355359|NCT01232283|39787440|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16355360|NCT01232283|39787441|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16355361|NCT01232283|39787442|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16355362|NCT01232283|39787443|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16355363|NCT01232283|39787444|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
16355364|NCT01232283|39787445|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
16355365|NCT01232283|39787446|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
16355366|NCT01232283|39787437|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16561568|NCT02061761|40521867|FG004|Overall Study|Participant request to discontinue study treatment|0|||
16561569|NCT02061761|40521868|FG005|Overall Study|Participant request to discontinue study treatment|1|||
16561570|NCT02061761|40521869|FG006|Overall Study|Participant request to discontinue study treatment|0|||
16561571|NCT02061761|40521870|FG007|Overall Study|Participant request to discontinue study treatment|0|||
16561572|NCT02061761|40521871|FG008|Overall Study|Participant request to discontinue study treatment|2|||
16561573|NCT02061761|40521863|FG000|Overall Study|Withdrawal by Subject|0|||
16130565|NCT00196976|38967049|FG000|Booster Study|Withdrawal by Subject|0|||
16247503|NCT01078623|39388221|FG002|Treatment Period 3|Adverse Event|0|||
16247504|NCT01078623|39388222|FG003|Treatment Period 3|Adverse Event|0|||
16247505|NCT01078623|39388223|FG004|Treatment Period 3|Adverse Event|1|||
16247506|NCT01078623|39388224|FG005|Treatment Period 3|Adverse Event|0|||
16247507|NCT01078623|39388225|FG006|Treatment Period 3|Adverse Event|0|||
16247508|NCT01078623|39388226|FG007|Treatment Period 3|Adverse Event|0|||
16247509|NCT01078623|39388227|FG008|Treatment Period 3|Adverse Event|0|||
16247510|NCT01078623|39388228|FG009|Treatment Period 3|Adverse Event|0|||
16247511|NCT01078623|39388229|FG010|Treatment Period 3|Adverse Event|0|||
16247512|NCT01078623|39388230|FG011|Treatment Period 3|Adverse Event|0|||
16247513|NCT01078623|39388231|FG012|Treatment Period 3|Adverse Event|0|||
16247514|NCT01078623|39388232|FG013|Treatment Period 3|Adverse Event|1|||
16247515|NCT01078623|39388233|FG014|Treatment Period 3|Adverse Event|0|||
16247516|NCT01078623|39388234|FG015|Treatment Period 3|Adverse Event|0|||
16247517|NCT01078623|39388235|FG016|Treatment Period 3|Adverse Event|0|||
16247518|NCT01078623|39388236|FG017|Treatment Period 3|Adverse Event|0|||
16247519|NCT01078623|39388237|FG018|Treatment Period 3|Adverse Event|0|||
16247520|NCT01078623|39388238|FG019|Treatment Period 3|Adverse Event|0|||
16247521|NCT01078623|39388219|FG000|Treatment Period 4|Adverse Event|0|||
16247522|NCT01078623|39388220|FG001|Treatment Period 4|Adverse Event|0|||
16247523|NCT01078623|39388221|FG002|Treatment Period 4|Adverse Event|1|||
16247524|NCT01078623|39388222|FG003|Treatment Period 4|Adverse Event|0|||
16247525|NCT01078623|39388223|FG004|Treatment Period 4|Adverse Event|0|||
16247526|NCT01078623|39388224|FG005|Treatment Period 4|Adverse Event|0|||
16247527|NCT01078623|39388225|FG006|Treatment Period 4|Adverse Event|0|||
16247528|NCT01078623|39388226|FG007|Treatment Period 4|Adverse Event|0|||
16247529|NCT01078623|39388227|FG008|Treatment Period 4|Adverse Event|0|||
16247530|NCT01078623|39388228|FG009|Treatment Period 4|Adverse Event|0|||
16247531|NCT01078623|39388229|FG010|Treatment Period 4|Adverse Event|0|||
16247532|NCT01078623|39388230|FG011|Treatment Period 4|Adverse Event|0|||
16247533|NCT01078623|39388231|FG012|Treatment Period 4|Adverse Event|0|||
16247534|NCT01078623|39388232|FG013|Treatment Period 4|Adverse Event|0|||
16247535|NCT01078623|39388233|FG014|Treatment Period 4|Adverse Event|0|||
16247536|NCT01078623|39388234|FG015|Treatment Period 4|Adverse Event|0|||
16247537|NCT01078623|39388235|FG016|Treatment Period 4|Adverse Event|0|||
16247538|NCT01078623|39388236|FG017|Treatment Period 4|Adverse Event|0|||
16247539|NCT01078623|39388237|FG018|Treatment Period 4|Adverse Event|0|||
16247540|NCT01078623|39388238|FG019|Treatment Period 4|Adverse Event|0|||
16561574|NCT02061761|40521864|FG001|Overall Study|Withdrawal by Subject|0|||
16561575|NCT02061761|40521865|FG002|Overall Study|Withdrawal by Subject|0|||
16561576|NCT02061761|40521866|FG003|Overall Study|Withdrawal by Subject|0|||
16355367|NCT01232283|39787438|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16355368|NCT01232283|39787439|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16355369|NCT01232283|39787440|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16355370|NCT01232283|39787441|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16355371|NCT01232283|39787442|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16355372|NCT01232283|39787443|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16355373|NCT01232283|39787444|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
16355374|NCT01232283|39787445|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
16355375|NCT01232283|39787446|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
16355376|NCT01232283|39787437|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16355377|NCT01232283|39787438|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16355378|NCT01232283|39787439|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16355379|NCT01232283|39787440|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16355380|NCT01232283|39787441|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16355381|NCT01232283|39787442|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16417969|NCT01329939|40011714|FG003|Overall Study|Adverse Event|3|||
16417970|NCT01183065|40011715|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
16417971|NCT05079477|40011717|FG000|Overall Study|Lost to Follow-up|2|||
16417972|NCT05079477|40011718|FG001|Overall Study|Lost to Follow-up|0|||
16417973|NCT05079477|40011717|FG000|Overall Study|Withdrawal by Subject|1|||
16417974|NCT05079477|40011718|FG001|Overall Study|Withdrawal by Subject|0|||
16417975|NCT05079477|40011717|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
16417976|NCT05079477|40011718|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
16417977|NCT05079477|40011717|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
16417978|NCT05079477|40011718|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
16417979|NCT00718770|40011719|FG000|Overall Study|Adverse Event|1|||
16417980|NCT00718770|40011719|FG000|Overall Study|Lack of Efficacy|1|||
16417981|NCT00718770|40011719|FG000|Overall Study|Lack of Efficacy|1|||
16417982|NCT00718770|40011719|FG000|Overall Study|Adverse Event|1|||
16417983|NCT00718770|40011719|FG000|Overall Study|Lack of Efficacy|1|||
16417984|NCT00718770|40011719|FG000|Overall Study|Adverse Event|1|||
16417985|NCT00718770|40011719|FG000|Overall Study|Lack of Efficacy|1|||
16417986|NCT00718770|40011719|FG000|Overall Study|Adverse Event|1|||
16417987|NCT03238924|40011720|FG000|Overall Study|Withdrawal by Subject|2|||
16417988|NCT03238924|40011721|FG001|Overall Study|Withdrawal by Subject|2|||
16561577|NCT02061761|40521867|FG004|Overall Study|Withdrawal by Subject|0|||
16561578|NCT02061761|40521868|FG005|Overall Study|Withdrawal by Subject|0|||
16561579|NCT02061761|40521869|FG006|Overall Study|Withdrawal by Subject|0|||
16561580|NCT02061761|40521870|FG007|Overall Study|Withdrawal by Subject|0|||
16355382|NCT01232283|39787443|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16355383|NCT01232283|39787444|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16355384|NCT01232283|39787445|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
16355385|NCT01232283|39787446|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
16355386|NCT01232283|39787437|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16355387|NCT01232283|39787438|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16355388|NCT01232283|39787439|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16417989|NCT00931801|40011723|FG000|Overall Study|Adverse Event|0|||
16561581|NCT02061761|40521871|FG008|Overall Study|Withdrawal by Subject|2|||
16561582|NCT02061761|40521863|FG000|Overall Study|Maximum clinical benefit|0|||
16561583|NCT02061761|40521864|FG001|Overall Study|Maximum clinical benefit|0|||
16561584|NCT02061761|40521865|FG002|Overall Study|Maximum clinical benefit|0|||
16561585|NCT02061761|40521866|FG003|Overall Study|Maximum clinical benefit|1|||
16561586|NCT02061761|40521867|FG004|Overall Study|Maximum clinical benefit|0|||
16561587|NCT02061761|40521868|FG005|Overall Study|Maximum clinical benefit|0|||
16561588|NCT02061761|40521869|FG006|Overall Study|Maximum clinical benefit|0|||
16561589|NCT02061761|40521870|FG007|Overall Study|Maximum clinical benefit|0|||
16561590|NCT02061761|40521871|FG008|Overall Study|Maximum clinical benefit|6|||
16561591|NCT02061761|40521863|FG000|Overall Study|Participant no longer meets study criteria|0|||
16561592|NCT02061761|40521864|FG001|Overall Study|Participant no longer meets study criteria|0|||
16561593|NCT02061761|40521865|FG002|Overall Study|Participant no longer meets study criteria|0|||
16561594|NCT02061761|40521866|FG003|Overall Study|Participant no longer meets study criteria|0|||
16561595|NCT02061761|40521867|FG004|Overall Study|Participant no longer meets study criteria|0|||
16561596|NCT02061761|40521868|FG005|Overall Study|Participant no longer meets study criteria|0|||
16561597|NCT02061761|40521869|FG006|Overall Study|Participant no longer meets study criteria|0|||
16561598|NCT02061761|40521870|FG007|Overall Study|Participant no longer meets study criteria|0|||
16355389|NCT01232283|39787440|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16561599|NCT02061761|40521871|FG008|Overall Study|Participant no longer meets study criteria|1|||
16561600|NCT02061761|40521863|FG000|Overall Study|Other reasons|0|||
16561601|NCT02061761|40521864|FG001|Overall Study|Other reasons|0|||
16561602|NCT02061761|40521865|FG002|Overall Study|Other reasons|0|||
16561603|NCT02061761|40521866|FG003|Overall Study|Other reasons|0|||
16561604|NCT02061761|40521867|FG004|Overall Study|Other reasons|2|||
16561605|NCT02061761|40521868|FG005|Overall Study|Other reasons|0|||
16561606|NCT02061761|40521869|FG006|Overall Study|Other reasons|0|||
16355390|NCT01232283|39787441|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16355391|NCT01232283|39787442|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16355392|NCT01232283|39787443|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16355393|NCT01232283|39787444|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16355394|NCT01232283|39787445|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
16355395|NCT01232283|39787446|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
16355396|NCT01232283|39787437|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16355397|NCT01232283|39787438|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16355398|NCT01232283|39787439|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16355399|NCT01232283|39787440|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16355400|NCT01232283|39787441|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16355401|NCT01232283|39787442|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16355402|NCT01232283|39787443|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16355403|NCT01232283|39787444|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
16355404|NCT01232283|39787445|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
16355405|NCT01232283|39787446|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
16355406|NCT03903172|39787447|FG000|Overall Study|screen fail|4|||
16355407|NCT03903172|39787448|FG001|Overall Study|screen fail|1|||
16355408|NCT01165307|39787451|FG000|Overall Study|Lost to Follow-up|11|||
16355409|NCT01165307|39787452|FG001|Overall Study|Lost to Follow-up|3|||
16355410|NCT01165307|39787451|FG000|Overall Study|Withdrawal by Subject|2|||
16355411|NCT01165307|39787452|FG001|Overall Study|Withdrawal by Subject|0|||
16355412|NCT01165307|39787451|FG000|Overall Study|Subject not available for contact|1|||
16355413|NCT01165307|39787452|FG001|Overall Study|Subject not available for contact|0|||
16417990|NCT00931801|40011724|FG001|Overall Study|Adverse Event|0|||
16417991|NCT00931801|40011725|FG002|Overall Study|Adverse Event|1|||
16417992|NCT00931801|40011723|FG000|Overall Study|Lost to Follow-up|0|||
16417993|NCT00931801|40011724|FG001|Overall Study|Lost to Follow-up|1|||
16417994|NCT00931801|40011725|FG002|Overall Study|Lost to Follow-up|0|||
16417995|NCT00931801|40011723|FG000|Overall Study|Withdrawal by Subject|1|||
16355414|NCT00828711|39787453|FG000|Overall Study|Lost to Follow-up|1|||
16355415|NCT00828711|39787454|FG001|Overall Study|Lost to Follow-up|0|||
16355416|NCT00828711|39787455|FG002|Overall Study|Lost to Follow-up|0|||
16355417|NCT04350827|39787456|FG000|Overall Study|Lost to Follow-up|1|||
16355418|NCT04350827|39787457|FG001|Overall Study|Lost to Follow-up|2|||
16355419|NCT01914393|39787461|FG000|Overall Study|Protocol Violation|11|||
16355420|NCT01914393|39787462|FG001|Overall Study|Protocol Violation|3|||
16355421|NCT01914393|39787463|FG002|Overall Study|Protocol Violation|19|||
16355422|NCT01914393|39787461|FG000|Overall Study|Lack of Efficacy|11|||
16355423|NCT01914393|39787462|FG001|Overall Study|Lack of Efficacy|16|||
16355424|NCT01914393|39787463|FG002|Overall Study|Lack of Efficacy|5|||
16355425|NCT01914393|39787461|FG000|Overall Study|no reason given|14|||
16355426|NCT01914393|39787462|FG001|Overall Study|no reason given|8|||
16355427|NCT01914393|39787463|FG002|Overall Study|no reason given|16|||
16355428|NCT01914393|39787461|FG000|Overall Study|Adverse Event|29|||
16355429|NCT01914393|39787462|FG001|Overall Study|Adverse Event|18|||
16355430|NCT01914393|39787463|FG002|Overall Study|Adverse Event|31|||
16355431|NCT01914393|39787461|FG000|Overall Study|Withdrawal by Subject|38|||
16355432|NCT01914393|39787462|FG001|Overall Study|Withdrawal by Subject|20|||
16355433|NCT01914393|39787463|FG002|Overall Study|Withdrawal by Subject|47|||
16355434|NCT01914393|39787461|FG000|Overall Study|Lost to Follow-up|12|||
16355435|NCT01914393|39787462|FG001|Overall Study|Lost to Follow-up|6|||
16355436|NCT01914393|39787463|FG002|Overall Study|Lost to Follow-up|19|||
16355437|NCT01914393|39787461|FG000|Overall Study|subject never dosed|0|||
16355438|NCT01914393|39787462|FG001|Overall Study|subject never dosed|0|||
16355439|NCT01914393|39787463|FG002|Overall Study|subject never dosed|1|||
16355440|NCT00505921|39787464|FG000|Overall Study|Ineligible|1|||
16355441|NCT00505921|39787464|FG000|Overall Study|Failed to Mobilize|8|||
16355442|NCT02008526|39787470|FG000|Overall Study|Death|0|||
16355443|NCT02008526|39787471|FG001|Overall Study|Death|2|||
16355444|NCT02008526|39787472|FG002|Overall Study|Death|1|||
16417996|NCT00931801|40011724|FG001|Overall Study|Withdrawal by Subject|0|||
16417997|NCT00931801|40011725|FG002|Overall Study|Withdrawal by Subject|0|||
16561607|NCT02061761|40521870|FG007|Overall Study|Other reasons|0|||
16561608|NCT02061761|40521871|FG008|Overall Study|Other reasons|6|||
16561609|NCT02056119|40521875|FG000|Overall Study|Death|1|||
16561610|NCT02056119|40521876|FG001|Overall Study|Death|2|||
16247541|NCT01078623|39388219|FG000|Treatment Period 4|Withdrawal by Subject|0|||
16247542|NCT01078623|39388220|FG001|Treatment Period 4|Withdrawal by Subject|0|||
16247543|NCT01078623|39388221|FG002|Treatment Period 4|Withdrawal by Subject|0|||
16247544|NCT01078623|39388222|FG003|Treatment Period 4|Withdrawal by Subject|0|||
16247545|NCT01078623|39388223|FG004|Treatment Period 4|Withdrawal by Subject|0|||
16247546|NCT01078623|39388224|FG005|Treatment Period 4|Withdrawal by Subject|0|||
16247547|NCT01078623|39388225|FG006|Treatment Period 4|Withdrawal by Subject|0|||
16247548|NCT01078623|39388226|FG007|Treatment Period 4|Withdrawal by Subject|0|||
16247549|NCT01078623|39388227|FG008|Treatment Period 4|Withdrawal by Subject|0|||
16247550|NCT01078623|39388228|FG009|Treatment Period 4|Withdrawal by Subject|0|||
16247551|NCT01078623|39388229|FG010|Treatment Period 4|Withdrawal by Subject|0|||
16247552|NCT01078623|39388230|FG011|Treatment Period 4|Withdrawal by Subject|0|||
16247553|NCT01078623|39388231|FG012|Treatment Period 4|Withdrawal by Subject|0|||
16247554|NCT01078623|39388232|FG013|Treatment Period 4|Withdrawal by Subject|0|||
16247555|NCT01078623|39388233|FG014|Treatment Period 4|Withdrawal by Subject|0|||
16247556|NCT01078623|39388234|FG015|Treatment Period 4|Withdrawal by Subject|1|||
16247557|NCT01078623|39388235|FG016|Treatment Period 4|Withdrawal by Subject|0|||
16247558|NCT01078623|39388236|FG017|Treatment Period 4|Withdrawal by Subject|0|||
16247559|NCT01078623|39388237|FG018|Treatment Period 4|Withdrawal by Subject|0|||
16561611|NCT02056119|40521875|FG000|Overall Study|Intubated for less than 24 hrs|2|||
16561612|NCT02056119|40521876|FG001|Overall Study|Intubated for less than 24 hrs|7|||
16561613|NCT02056119|40521875|FG000|Overall Study|No aerosol treatments were given.|3|||
16561614|NCT02056119|40521876|FG001|Overall Study|No aerosol treatments were given.|2|||
16561615|NCT02056119|40521875|FG000|Overall Study|Received Metaneb treatment|0|||
16247560|NCT01078623|39388238|FG019|Treatment Period 4|Withdrawal by Subject|0|||
16247561|NCT00720122|39388239|FG000|Overall Study|Lost to Follow-up|1|||
16247562|NCT00720122|39388239|FG000|Overall Study|Physician Decision|1|||
16247563|NCT00720122|39388239|FG000|Overall Study|Withdrawal by Subject|7|||
16247564|NCT00490061|39388240|FG000|Overall Study|Physician Decision|1|||
16247565|NCT01859702|39388247|FG000|Overall Study|Protocol deviation|3|||
16247566|NCT01859702|39388247|FG000|Overall Study|Adverse Event|2|||
16247567|NCT03031899|39388248|FG000|Overall Study|Protocol Violation|1|||
16247568|NCT03031899|39388248|FG000|Overall Study|lesion disappeared after stopping habit|1|||
16247569|NCT01896297|39388249|FG000|Overall Study|Died in post treatment phase|1|||
16247570|NCT01238822|39388250|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
16247571|NCT04947579|39388251|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
16247572|NCT04947579|39388252|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
16247573|NCT04947579|39388253|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
16247574|NCT04947579|39388254|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
16247575|NCT04947579|39388255|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
16247576|NCT04947579|39388256|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
16247577|NCT04947579|39388251|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
16247578|NCT04947579|39388252|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
16247579|NCT04947579|39388253|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
16247580|NCT04947579|39388254|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
16247581|NCT04947579|39388255|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
16247582|NCT04947579|39388256|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
16247583|NCT04947579|39388251|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
16247584|NCT04947579|39388252|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
16247585|NCT04947579|39388253|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
16247586|NCT04947579|39388254|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
16247587|NCT04947579|39388255|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
16247588|NCT04947579|39388256|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
16247589|NCT04947579|39388251|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
16247590|NCT04947579|39388252|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
16247591|NCT04947579|39388253|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
16247592|NCT04947579|39388254|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
16247593|NCT04947579|39388255|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
16561616|NCT02056119|40521876|FG001|Overall Study|Received Metaneb treatment|2|||
16561617|NCT02056119|40521875|FG000|Overall Study|Protocol Violation|4|||
16561618|NCT02056119|40521876|FG001|Overall Study|Protocol Violation|7|||
16247594|NCT04947579|39388256|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
16247595|NCT04947579|39388251|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
16417998|NCT00931801|40011723|FG000|Overall Study|Confirmed Virologic Failure|0|||
16247596|NCT04947579|39388252|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
16247597|NCT04947579|39388253|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
16247598|NCT04947579|39388254|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
16247599|NCT04947579|39388255|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
16247600|NCT04947579|39388256|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
16561619|NCT00945477|40521878|FG000|Overall Study|Adverse Event|3|||
16561620|NCT00945477|40521878|FG000|Overall Study|Lack of Efficacy|2|||
16561621|NCT00945477|40521878|FG000|Overall Study|Withdrawal by Subject|1|||
16561622|NCT02271594|40521883|FG000|Overall Study|Study closed; recruiting failure|19|||
16561623|NCT02271594|40521884|FG001|Overall Study|Study closed; recruiting failure|12|||
16561624|NCT00231894|40521885|FG000|Overall Study|Withdrawal by Subject|1|||
16561625|NCT00231894|40521886|FG001|Overall Study|Withdrawal by Subject|1|||
16561626|NCT02501811|40521896|FG000|Overall Study|Death|1|||
16561627|NCT02501811|40521897|FG001|Overall Study|Death|3|||
16561628|NCT02501811|40521898|FG002|Overall Study|Death|2|||
16561629|NCT02501811|40521899|FG003|Overall Study|Death|3|||
16561630|NCT02501811|40521896|FG000|Overall Study|Withdrawal by Subject|3|||
16561631|NCT02501811|40521897|FG001|Overall Study|Withdrawal by Subject|3|||
16561632|NCT02501811|40521898|FG002|Overall Study|Withdrawal by Subject|2|||
16561633|NCT02501811|40521899|FG003|Overall Study|Withdrawal by Subject|3|||
16561634|NCT02501811|40521896|FG000|Overall Study|Lost to Follow-up|0|||
16561635|NCT02501811|40521897|FG001|Overall Study|Lost to Follow-up|0|||
16561636|NCT02501811|40521898|FG002|Overall Study|Lost to Follow-up|2|||
16561637|NCT02501811|40521899|FG003|Overall Study|Lost to Follow-up|1|||
16561638|NCT03100838|40521900|FG000|Overall Study|Adverse Event|1|||
16561639|NCT03100838|40521901|FG001|Overall Study|Adverse Event|0|||
16561640|NCT03100838|40521902|FG002|Overall Study|Adverse Event|0|||
16561641|NCT03100838|40521903|FG003|Overall Study|Adverse Event|0|||
16561642|NCT03100838|40521900|FG000|Overall Study|Physician Decision|1|||
16561643|NCT03100838|40521901|FG001|Overall Study|Physician Decision|1|||
16561644|NCT03100838|40521902|FG002|Overall Study|Physician Decision|1|||
16561645|NCT03100838|40521903|FG003|Overall Study|Physician Decision|1|||
16561646|NCT03100838|40521900|FG000|Overall Study|Pregnancy|0|||
16561647|NCT03100838|40521901|FG001|Overall Study|Pregnancy|1|||
16561648|NCT03100838|40521902|FG002|Overall Study|Pregnancy|0|||
16561649|NCT03100838|40521903|FG003|Overall Study|Pregnancy|0|||
16247601|NCT04947579|39388251|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
16247602|NCT04947579|39388252|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
16247603|NCT04947579|39388253|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
16247604|NCT04947579|39388254|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
16247605|NCT04947579|39388255|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
16247606|NCT04947579|39388256|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
16247607|NCT04947579|39388251|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
16247608|NCT04947579|39388252|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
16417999|NCT00931801|40011724|FG001|Overall Study|Confirmed Virologic Failure|0|||
16418000|NCT00931801|40011725|FG002|Overall Study|Confirmed Virologic Failure|3|||
16247609|NCT04947579|39388253|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
16247610|NCT04947579|39388254|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
16247611|NCT04947579|39388255|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
16247612|NCT04947579|39388256|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
16247613|NCT04947579|39388251|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
16418001|NCT03101085|40011729|FG000|Overall Study|Lost to Follow-up|0|||
16418002|NCT03101085|40011730|FG001|Overall Study|Lost to Follow-up|1|||
16561650|NCT03100838|40521900|FG000|Overall Study|Lost to Follow-up|0|||
16561651|NCT03100838|40521901|FG001|Overall Study|Lost to Follow-up|0|||
16561652|NCT03100838|40521902|FG002|Overall Study|Lost to Follow-up|1|||
16561653|NCT03100838|40521903|FG003|Overall Study|Lost to Follow-up|0|||
16561654|NCT01449929|40521904|FG000|Randomization Phase 96 Week|Adverse Event|5|||
16561655|NCT01449929|40521905|FG001|Randomization Phase 96 Week|Adverse Event|13|||
16561656|NCT01449929|40521906|FG002|Randomization Phase 96 Week|Adverse Event|0|||
16561657|NCT01449929|40521904|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
16561658|NCT01449929|40521905|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
16355445|NCT02008526|39787470|FG000|Overall Study|Withdrawal by Subject|3|||
16355446|NCT02008526|39787471|FG001|Overall Study|Withdrawal by Subject|3|||
16355447|NCT02008526|39787472|FG002|Overall Study|Withdrawal by Subject|2|||
16355448|NCT02008526|39787470|FG000|Overall Study|Lost to Follow-up|5|||
16355449|NCT02008526|39787471|FG001|Overall Study|Lost to Follow-up|9|||
16355450|NCT02008526|39787472|FG002|Overall Study|Lost to Follow-up|6|||
16355451|NCT01883895|39787473|FG000|Overall Study|Lost to Follow-up|2|||
16355452|NCT00888654|39787478|FG000|Overall Study|Problems swallowing oral meds.|1|||
16355453|NCT00888654|39787478|FG000|Overall Study|Not enough oral meds before surgery|3|||
16355454|NCT00888654|39787478|FG000|Overall Study|Surgery aborted|2|||
16355455|NCT00888654|39787478|FG000|Overall Study|Withdrawal by Subject|1|||
16355456|NCT00888654|39787478|FG000|Overall Study|Inelig. due to contraindication of med|1|||
16355457|NCT00888654|39787478|FG000|Overall Study|Change in surg date|1|||
16355458|NCT00888654|39787478|FG000|Overall Study|Stopped meds due to headaches|1|||
16355459|NCT00001566|39787479|FG000|Overall Study|patients' choice to discontinue protocol|3|||
16355460|NCT00001566|39787479|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
16355461|NCT00001566|39787479|FG000|Overall Study|Death|13|||
16355462|NCT00001566|39787479|FG000|Overall Study|Lost to Follow-up|1|||
16355463|NCT00001566|39787479|FG000|Overall Study|unable to complete initial apheresis|1|||
16355464|NCT00975416|39787480|FG000|Overall Study|early discharge from tx|3|||
16355465|NCT00975416|39787481|FG001|Overall Study|early discharge from tx|5|||
16355466|NCT01172873|39787482|FG000|Overall Study|Withdrawal by Subject|3|||
16355467|NCT01172873|39787483|FG001|Overall Study|Withdrawal by Subject|2|||
16355468|NCT03292016|39787484|FG000|Second Washout|Adverse Event|0|||
16355469|NCT03292016|39787485|FG001|Second Washout|Adverse Event|1|||
16355470|NCT03292016|39787486|FG002|Second Washout|Adverse Event|0|||
16355471|NCT03292016|39787487|FG003|Second Washout|Adverse Event|0|||
16355472|NCT03292016|39787488|FG004|Second Washout|Adverse Event|0|||
16355473|NCT03292016|39787489|FG005|Second Washout|Adverse Event|0|||
16355474|NCT02460289|39787490|FG000|Overall Study|Adverse Event|1|||
16355475|NCT02460289|39787490|FG000|Overall Study|Withdrawal by Subject|8|||
16355476|NCT02460289|39787490|FG000|Overall Study|Lost to Follow-up|1|||
16355477|NCT01603277|39787491|FG000|Overall Study|Adverse Event|1|||
16355478|NCT01603277|39787492|FG001|Overall Study|Adverse Event|2|||
16355479|NCT01603277|39787491|FG000|Overall Study|Physician Decision|0|||
16355480|NCT01603277|39787492|FG001|Overall Study|Physician Decision|1|||
16355481|NCT01603277|39787491|FG000|Overall Study|Protocol Violation|6|||
16355482|NCT01603277|39787492|FG001|Overall Study|Protocol Violation|10|||
16355483|NCT01603277|39787491|FG000|Overall Study|Withdrawal by Subject|5|||
16355484|NCT01603277|39787492|FG001|Overall Study|Withdrawal by Subject|4|||
16355485|NCT01603277|39787491|FG000|Overall Study|Non-Compliance|2|||
16355486|NCT01603277|39787492|FG001|Overall Study|Non-Compliance|1|||
16355487|NCT01386606|39787499|FG000|Overall Study|Adverse Event|0|||
16355488|NCT01386606|39787500|FG001|Overall Study|Adverse Event|1|||
16355489|NCT01386606|39787501|FG002|Overall Study|Adverse Event|0|||
16355490|NCT01386606|39787502|FG003|Overall Study|Adverse Event|0|||
16355491|NCT01386606|39787499|FG000|Overall Study|Withdrawal by Subject|0|||
16355492|NCT01386606|39787500|FG001|Overall Study|Withdrawal by Subject|1|||
16355493|NCT01386606|39787501|FG002|Overall Study|Withdrawal by Subject|1|||
16355494|NCT01386606|39787502|FG003|Overall Study|Withdrawal by Subject|0|||
16355495|NCT01386606|39787499|FG000|Overall Study|Protocol Violation|1|||
16355496|NCT01386606|39787500|FG001|Overall Study|Protocol Violation|0|||
16355497|NCT01386606|39787501|FG002|Overall Study|Protocol Violation|1|||
16355498|NCT01386606|39787502|FG003|Overall Study|Protocol Violation|1|||
16355499|NCT01386606|39787499|FG000|Overall Study|Lost to Follow-up|2|||
16355500|NCT01386606|39787500|FG001|Overall Study|Lost to Follow-up|0|||
16355501|NCT01386606|39787501|FG002|Overall Study|Lost to Follow-up|0|||
16355502|NCT01386606|39787502|FG003|Overall Study|Lost to Follow-up|0|||
16355503|NCT01386606|39787499|FG000|Overall Study|Subject incarcerated|0|||
16355504|NCT01386606|39787500|FG001|Overall Study|Subject incarcerated|1|||
16355505|NCT01386606|39787501|FG002|Overall Study|Subject incarcerated|0|||
16355506|NCT01386606|39787502|FG003|Overall Study|Subject incarcerated|0|||
16355507|NCT01386606|39787499|FG000|Overall Study|Unable to draw PK|1|||
16355508|NCT01386606|39787500|FG001|Overall Study|Unable to draw PK|0|||
16355509|NCT01386606|39787501|FG002|Overall Study|Unable to draw PK|0|||
16355510|NCT01386606|39787502|FG003|Overall Study|Unable to draw PK|0|||
16355511|NCT01386606|39787499|FG000|Overall Study|T levels too high|0|||
16355512|NCT01386606|39787500|FG001|Overall Study|T levels too high|1|||
16355513|NCT01386606|39787501|FG002|Overall Study|T levels too high|1|||
16355514|NCT01386606|39787502|FG003|Overall Study|T levels too high|0|||
16355515|NCT01855958|39787505|FG000|Overall Study|Withdrawal by Subject|1|||
16355516|NCT01855958|39787506|FG001|Overall Study|Withdrawal by Subject|0|||
16355517|NCT05512949|39787509|FG000|Overall Study|Lost to Follow-up|4|||
16355518|NCT05512949|39787510|FG001|Overall Study|Lost to Follow-up|6|||
16355519|NCT05512949|39787511|FG002|Overall Study|Lost to Follow-up|2|||
16355520|NCT05512949|39787509|FG000|Overall Study|Protocol Violation|0|||
16355521|NCT05512949|39787510|FG001|Overall Study|Protocol Violation|0|||
16355522|NCT05512949|39787511|FG002|Overall Study|Protocol Violation|1|||
16561659|NCT01449929|40521906|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
16247614|NCT04947579|39388252|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
16247615|NCT04947579|39388253|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
16247616|NCT04947579|39388254|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
16561660|NCT01449929|40521904|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
16561661|NCT01449929|40521905|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
16561662|NCT01449929|40521906|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
16561663|NCT01449929|40521904|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
16561664|NCT01449929|40521905|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
16561665|NCT01449929|40521906|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
16561666|NCT01449929|40521904|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
16561667|NCT01449929|40521905|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
16561668|NCT01449929|40521906|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
16561669|NCT01449929|40521904|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
16561670|NCT01449929|40521905|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
16561671|NCT01449929|40521906|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
16561672|NCT01449929|40521904|FG000|Randomization Phase 96 Week|Physician Decision|2|||
16561673|NCT01449929|40521905|FG001|Randomization Phase 96 Week|Physician Decision|3|||
16561674|NCT01449929|40521906|FG002|Randomization Phase 96 Week|Physician Decision|0|||
16561675|NCT01449929|40521904|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
16561676|NCT01449929|40521905|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
16561677|NCT01449929|40521906|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
16561678|NCT01449929|40521904|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
16561679|NCT01449929|40521905|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
16561680|NCT01449929|40521906|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
16561681|NCT01449929|40521904|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
16561682|NCT01449929|40521905|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
16561683|NCT01449929|40521906|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
16561684|NCT01449929|40521904|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
16561685|NCT01449929|40521905|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
16561686|NCT01449929|40521906|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
16561687|NCT02034435|40521909|FG000|Overall Study|Withdrawal by Subject|1|||
16561688|NCT02034435|40521910|FG001|Overall Study|Withdrawal by Subject|0|||
16561689|NCT02034435|40521911|FG002|Overall Study|Withdrawal by Subject|0|||
16561690|NCT02034435|40521912|FG003|Overall Study|Withdrawal by Subject|0|||
16561691|NCT02034435|40521909|FG000|Overall Study|Illness|0|||
16561692|NCT02034435|40521910|FG001|Overall Study|Illness|2|||
16561693|NCT02034435|40521911|FG002|Overall Study|Illness|0|||
16561694|NCT02034435|40521912|FG003|Overall Study|Illness|0|||
16561695|NCT02034435|40521909|FG000|Overall Study|Inadequate IV access|1|||
16561696|NCT02034435|40521910|FG001|Overall Study|Inadequate IV access|0|||
16561697|NCT02034435|40521911|FG002|Overall Study|Inadequate IV access|0|||
16561698|NCT02034435|40521912|FG003|Overall Study|Inadequate IV access|1|||
16561699|NCT00558753|40521918|FG000|Overall Study|Lost to Follow-up|5|||
16561700|NCT00558753|40521919|FG001|Overall Study|Lost to Follow-up|7|||
16561701|NCT02459587|40521920|FG000|3-Month Follow-up Assessment|Death|0|||
16561702|NCT02459587|40521921|FG001|3-Month Follow-up Assessment|Death|2|||
16561703|NCT02459587|40521920|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
16247617|NCT04947579|39388255|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
16247618|NCT04947579|39388256|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
16561704|NCT02459587|40521921|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
16561705|NCT02459587|40521920|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
16561706|NCT02459587|40521921|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
16561707|NCT02459587|40521920|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
16355523|NCT05512949|39787509|FG000|Overall Study|Withdrawal by Subject|1|||
16355524|NCT05512949|39787510|FG001|Overall Study|Withdrawal by Subject|1|||
16355525|NCT05512949|39787511|FG002|Overall Study|Withdrawal by Subject|2|||
16355526|NCT05512949|39787509|FG000|Overall Study|Completion status unknown|1|||
16355527|NCT05512949|39787510|FG001|Overall Study|Completion status unknown|3|||
16355528|NCT05512949|39787511|FG002|Overall Study|Completion status unknown|0|||
16355529|NCT01294423|39787512|FG000|Overall Study|Adverse Event|1|||
16355530|NCT01294423|39787513|FG001|Overall Study|Adverse Event|2|||
16355531|NCT01294423|39787514|FG002|Overall Study|Adverse Event|3|||
16355532|NCT01294423|39787512|FG000|Overall Study|Withdrawal by Subject|1|||
16355533|NCT01294423|39787513|FG001|Overall Study|Withdrawal by Subject|2|||
16355534|NCT01294423|39787514|FG002|Overall Study|Withdrawal by Subject|2|||
16355535|NCT01294423|39787512|FG000|Overall Study|subject no longer meets study criteria|2|||
16355536|NCT01294423|39787513|FG001|Overall Study|subject no longer meets study criteria|5|||
16355537|NCT01294423|39787514|FG002|Overall Study|subject no longer meets study criteria|2|||
16355538|NCT01294423|39787512|FG000|Overall Study|poor/non-compliance|1|||
16355539|NCT01294423|39787513|FG001|Overall Study|poor/non-compliance|0|||
16355540|NCT01294423|39787514|FG002|Overall Study|poor/non-compliance|1|||
16355541|NCT00726609|39787519|FG000|Overall Study|Adverse Event|10|||
16355542|NCT00726609|39787519|FG000|Overall Study|Withdrawal by Subject|2|||
16355543|NCT00726609|39787519|FG000|Overall Study|Lack of Efficacy|25|||
16355544|NCT00726609|39787519|FG000|Overall Study|Other|16|||
16355545|NCT00726609|39787519|FG000|Overall Study|Missing|42|||
16355546|NCT00726609|39787519|FG000|Overall Study|Other|3|||
16355547|NCT01118052|39787520|FG000|Overall Study|Never treated|2|||
16355548|NCT01079780|39787538|FG000|Overall Study|Disease progression|43|||
16355549|NCT01079780|39787539|FG001|Overall Study|Disease progression|7|||
16355550|NCT01079780|39787540|FG002|Overall Study|Disease progression|31|||
16355551|NCT01079780|39787538|FG000|Overall Study|Adverse Event|13|||
16355552|NCT01079780|39787539|FG001|Overall Study|Adverse Event|5|||
16355553|NCT01079780|39787540|FG002|Overall Study|Adverse Event|7|||
16355554|NCT01079780|39787538|FG000|Overall Study|Death|2|||
16355555|NCT01079780|39787539|FG001|Overall Study|Death|0|||
16355556|NCT01079780|39787540|FG002|Overall Study|Death|2|||
16355557|NCT01079780|39787538|FG000|Overall Study|Withdrawal by Subject|6|||
16355558|NCT01079780|39787539|FG001|Overall Study|Withdrawal by Subject|4|||
16355559|NCT01079780|39787540|FG002|Overall Study|Withdrawal by Subject|4|||
16355560|NCT01079780|39787538|FG000|Overall Study|Alternative therapy|2|||
16355561|NCT01079780|39787539|FG001|Overall Study|Alternative therapy|0|||
16355562|NCT01079780|39787540|FG002|Overall Study|Alternative therapy|2|||
16355563|NCT01079780|39787538|FG000|Overall Study|Physician Decision|1|||
16355564|NCT01079780|39787539|FG001|Overall Study|Physician Decision|0|||
16355565|NCT01079780|39787540|FG002|Overall Study|Physician Decision|1|||
16355566|NCT01079780|39787538|FG000|Overall Study|Error made in lesion measurement|1|||
16355567|NCT01079780|39787539|FG001|Overall Study|Error made in lesion measurement|0|||
16355568|NCT01079780|39787540|FG002|Overall Study|Error made in lesion measurement|0|||
16355569|NCT01079780|39787538|FG000|Overall Study|Patient had surgery|1|||
16355570|NCT01079780|39787539|FG001|Overall Study|Patient had surgery|0|||
16355571|NCT01079780|39787540|FG002|Overall Study|Patient had surgery|0|||
16355572|NCT01079780|39787538|FG000|Overall Study|Treatment cycle delay|0|||
16355573|NCT01079780|39787539|FG001|Overall Study|Treatment cycle delay|0|||
16355574|NCT01079780|39787540|FG002|Overall Study|Treatment cycle delay|1|||
16355575|NCT01079780|39787538|FG000|Overall Study|Never started treatment|1|||
16355576|NCT01079780|39787539|FG001|Overall Study|Never started treatment|0|||
16355577|NCT01079780|39787540|FG002|Overall Study|Never started treatment|2|||
16355578|NCT01676701|39787541|FG000|Overall Study|Protocol Violation|1|||
16355579|NCT01676701|39787542|FG001|Overall Study|Protocol Violation|0|||
16355580|NCT01676701|39787541|FG000|Overall Study|Sponsor Decision|3|||
16355581|NCT01676701|39787542|FG001|Overall Study|Sponsor Decision|4|||
16355582|NCT01239797|39787543|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
16355583|NCT01239797|39787544|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
16355584|NCT01239797|39787543|FG000|Randomized Participants|Participant withdrew consent|1|||
16355585|NCT01239797|39787544|FG001|Randomized Participants|Participant withdrew consent|7|||
16355586|NCT01239797|39787543|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
16355587|NCT01239797|39787544|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
16355588|NCT01239797|39787543|FG000|Treated Participants|Disease progression|185|||
16355589|NCT01239797|39787544|FG001|Treated Participants|Disease progression|185|||
16355590|NCT01239797|39787543|FG000|Treated Participants|Study drug toxicity|39|||
16355591|NCT01239797|39787544|FG001|Treated Participants|Study drug toxicity|45|||
16355592|NCT01239797|39787543|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
16355593|NCT01239797|39787544|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
16355594|NCT01239797|39787543|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
16355595|NCT01239797|39787544|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
16355596|NCT01239797|39787543|FG000|Treated Participants|Administrative reason by sponsor|13|||
16355597|NCT01239797|39787544|FG001|Treated Participants|Administrative reason by sponsor|4|||
16355598|NCT01239797|39787543|FG000|Treated Participants|Other reasons|14|||
16355599|NCT01239797|39787544|FG001|Treated Participants|Other reasons|14|||
16355600|NCT01239797|39787543|FG000|Treated Participants|Participant withdrew consent|6|||
16355601|NCT01239797|39787544|FG001|Treated Participants|Participant withdrew consent|11|||
16355602|NCT01239797|39787543|FG000|Treated Participants|Death|1|||
16355603|NCT01239797|39787544|FG001|Treated Participants|Death|1|||
16355604|NCT01239797|39787543|FG000|Treated Participants|Participant no longer meets study criteria|1|||
16355605|NCT01239797|39787544|FG001|Treated Participants|Participant no longer meets study criteria|1|||
16355606|NCT01239797|39787543|FG000|Treated Participants|Poor/non-compliance|0|||
16355607|NCT01239797|39787544|FG001|Treated Participants|Poor/non-compliance|1|||
16355608|NCT03321721|39787545|FG000|Overall Study|Lost to Follow-up|4|||
16355609|NCT03321721|39787546|FG001|Overall Study|Lost to Follow-up|8|||
16355610|NCT03321721|39787547|FG002|Overall Study|Lost to Follow-up|11|||
16355611|NCT01965327|39787548|FG000|Overall Study|Physician Decision|2|||
16355612|NCT01149655|39787549|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
16355613|NCT01149655|39787550|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
16355614|NCT01149655|39787551|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
16355615|NCT01149655|39787552|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
16355616|NCT01149655|39787549|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
16355617|NCT01149655|39787550|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
16355618|NCT01149655|39787551|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
16355619|NCT01149655|39787552|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
16355620|NCT01149655|39787549|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
16355621|NCT01149655|39787550|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
16355622|NCT01149655|39787551|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
16355623|NCT01149655|39787552|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
16355624|NCT01149655|39787549|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
16355625|NCT01149655|39787550|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
16355626|NCT01149655|39787551|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
16355627|NCT01149655|39787552|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
16355628|NCT01149655|39787549|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
16355629|NCT01149655|39787550|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
16355630|NCT01149655|39787551|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
16355631|NCT01149655|39787552|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
16355632|NCT01149655|39787549|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
16355633|NCT01149655|39787550|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
16355634|NCT01149655|39787551|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
16355635|NCT01149655|39787552|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
16418003|NCT03316950|40011732|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
16418004|NCT03316950|40011733|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
16418005|NCT03316950|40011734|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
16418006|NCT03316950|40011735|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
16418007|NCT03316950|40011732|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
16355636|NCT01149655|39787549|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
16355637|NCT01149655|39787550|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
16355638|NCT01149655|39787551|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
16355639|NCT01149655|39787552|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
16418008|NCT03316950|40011733|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
16561708|NCT02459587|40521921|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
16561709|NCT02459587|40521920|FG000|6-month Follow-up Assessment|Death|2|||
16561710|NCT02459587|40521921|FG001|6-month Follow-up Assessment|Death|1|||
16561711|NCT02459587|40521920|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
16561712|NCT02459587|40521921|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
16561713|NCT02459587|40521920|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
16561714|NCT02459587|40521921|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
16561715|NCT02459587|40521920|FG000|12-month Follow-up Assessment|Death|2|||
16561716|NCT02459587|40521921|FG001|12-month Follow-up Assessment|Death|0|||
16561717|NCT02459587|40521920|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
16561718|NCT02459587|40521921|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
16561719|NCT02459587|40521920|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
16561720|NCT02459587|40521921|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
16561721|NCT02459587|40521920|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
16561722|NCT02459587|40521921|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
16561723|NCT01822821|40521925|FG000|Overall Study|Eligible surgery cancelled|1|||
16561724|NCT01822821|40521926|FG001|Overall Study|Eligible surgery cancelled|1|||
16561725|NCT01822821|40521925|FG000|Overall Study|Other reasons|1|||
16561726|NCT01822821|40521926|FG001|Overall Study|Other reasons|0|||
16561727|NCT03019458|40521927|FG000|Overall Study|Death|0|||
16561728|NCT03019458|40521928|FG001|Overall Study|Death|1|||
16561729|NCT01354938|40521929|FG000|Overall Study|Lost to Follow-up|1|||
16561730|NCT01446003|40521934|FG000|Period 1|Protocol Violation|2|||
16247619|NCT04947579|39388251|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
16247620|NCT04947579|39388252|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
16247621|NCT04947579|39388253|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
16561731|NCT01446003|40521935|FG001|Period 1|Protocol Violation|0|||
16561732|NCT01446003|40521934|FG000|Period 2|Adverse Event|1|||
16561733|NCT01446003|40521935|FG001|Period 2|Adverse Event|0|||
16561734|NCT02401529|40521936|FG000|Overall Study|Lost to Follow-up|2|||
16247622|NCT04947579|39388254|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
16247623|NCT04947579|39388255|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
16247624|NCT04947579|39388256|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
16247625|NCT04947579|39388251|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
16247626|NCT04947579|39388252|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
16247627|NCT04947579|39388253|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
16247628|NCT04947579|39388254|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
16247629|NCT04947579|39388255|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
16561735|NCT02401529|40521937|FG001|Overall Study|Lost to Follow-up|1|||
16561736|NCT02401529|40521936|FG000|Overall Study|Physician Decision|2|||
16561737|NCT02401529|40521937|FG001|Overall Study|Physician Decision|6|||
16561738|NCT02401529|40521936|FG000|Overall Study|Protocol Violation|5|||
16561739|NCT02401529|40521937|FG001|Overall Study|Protocol Violation|0|||
16561740|NCT00795132|40521962|FG000|Overall Study|Death|1|||
16561741|NCT00795132|40521962|FG000|Overall Study|Relapse|2|||
16561742|NCT00504348|40521963|FG000|Overall Study|Adverse Event|3|||
16247630|NCT04947579|39388256|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
16247631|NCT04947579|39388251|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
16247632|NCT04947579|39388252|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
16247633|NCT04947579|39388253|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
16247634|NCT04947579|39388254|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
16247635|NCT04947579|39388255|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
16247636|NCT04947579|39388256|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
16247637|NCT00787566|39388259|FG000|Overall Study|AE related to chemotherapy|0|||
16247638|NCT00787566|39388260|FG001|Overall Study|AE related to chemotherapy|1|||
16247639|NCT00787566|39388261|FG002|Overall Study|AE related to chemotherapy|0|||
16247640|NCT00707174|39388262|FG000|Overall Study|Adverse Event|1|||
16247641|NCT00707174|39388263|FG001|Overall Study|Adverse Event|6|||
16247642|NCT00707174|39388262|FG000|Overall Study|Withdrawal by Subject|4|||
16247643|NCT00707174|39388263|FG001|Overall Study|Withdrawal by Subject|1|||
16247644|NCT02826603|39388264|FG000|Overall Study|Adverse Event|17|||
16247645|NCT02826603|39388265|FG001|Overall Study|Adverse Event|9|||
16247646|NCT02826603|39388264|FG000|Overall Study|Lack of Efficacy|4|||
16561743|NCT00504348|40521963|FG000|Overall Study|Lack of Efficacy|4|||
16561744|NCT00504348|40521963|FG000|Overall Study|Physician Decision|1|||
16561745|NCT01077024|40525178|FG000|Overall Study|Lost to Follow-up|20|||
16561746|NCT01077024|40525179|FG001|Overall Study|Lost to Follow-up|14|||
16561747|NCT01077024|40525178|FG000|Overall Study|Withdrawal by Subject|0|||
16561748|NCT01077024|40525179|FG001|Overall Study|Withdrawal by Subject|2|||
16561749|NCT01077024|40525178|FG000|Overall Study|Incarcerated|7|||
16561750|NCT01077024|40525179|FG001|Overall Study|Incarcerated|8|||
16561751|NCT01077024|40525178|FG000|Overall Study|Other|4|||
16561752|NCT01077024|40525179|FG001|Overall Study|Other|4|||
16355640|NCT01149655|39787549|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
16355641|NCT01149655|39787550|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
16355642|NCT01149655|39787551|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
16355643|NCT01149655|39787552|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
16355644|NCT01149655|39787549|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
16355645|NCT01149655|39787550|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
16355646|NCT01149655|39787551|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
16355647|NCT01149655|39787552|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
16355648|NCT01149655|39787549|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
16355649|NCT01149655|39787550|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
16355650|NCT01149655|39787551|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
16355651|NCT01149655|39787552|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
16355652|NCT01149655|39787549|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
16355653|NCT01149655|39787550|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
16355654|NCT01149655|39787551|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
16355655|NCT01149655|39787552|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
16355656|NCT01149655|39787549|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
16418009|NCT03316950|40011734|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
16418010|NCT03316950|40011735|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
16418011|NCT03316950|40011732|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
16418012|NCT03316950|40011733|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
16418013|NCT03316950|40011734|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
16418014|NCT03316950|40011735|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
16418015|NCT02900170|40011736|FG000|Overall Study|Lost to Follow-up|8|||
16418016|NCT03615066|40011739|FG000|Main Study|Withdrew Consent|0|||
16418017|NCT03615066|40011740|FG001|Main Study|Withdrew Consent|1|||
16418018|NCT03615066|40011741|FG002|Main Study|Withdrew Consent|1|||
16418019|NCT03615066|40011739|FG000|Main Study|Lost to Follow-up|0|||
16418020|NCT03615066|40011740|FG001|Main Study|Lost to Follow-up|0|||
16418021|NCT03615066|40011741|FG002|Main Study|Lost to Follow-up|1|||
16418022|NCT03615066|40011739|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
16418023|NCT03615066|40011740|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
16418024|NCT03615066|40011741|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
16418025|NCT03615066|40011739|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
16418026|NCT03615066|40011740|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
16418027|NCT03615066|40011741|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
16561753|NCT02084082|40525180|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
16561754|NCT02084082|40525181|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
16561755|NCT02084082|40525182|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
16561756|NCT02084082|40525183|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
16561757|NCT02084082|40525180|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16561758|NCT02084082|40525181|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16561759|NCT02084082|40525182|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16561760|NCT02084082|40525183|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
16561761|NCT02300311|40525184|FG000|Overall Study|Other than the reason specified|1|||
16561762|NCT02300311|40525185|FG001|Overall Study|Other than the reason specified|0|||
16561763|NCT02300311|40525184|FG000|Overall Study|Refused to continue taking medication|18|||
16561764|NCT02300311|40525185|FG001|Overall Study|Refused to continue taking medication|0|||
16247647|NCT02826603|39388265|FG001|Overall Study|Lack of Efficacy|9|||
16247648|NCT02826603|39388264|FG000|Overall Study|Lost to Follow-up|13|||
16247649|NCT02826603|39388265|FG001|Overall Study|Lost to Follow-up|12|||
16247650|NCT02826603|39388264|FG000|Overall Study|Noncompliance with treatment|0|||
16247651|NCT02826603|39388265|FG001|Overall Study|Noncompliance with treatment|2|||
16247652|NCT02826603|39388264|FG000|Overall Study|Physician Decision|1|||
16247653|NCT02826603|39388265|FG001|Overall Study|Physician Decision|7|||
16247654|NCT02826603|39388264|FG000|Overall Study|Pregnancy|1|||
16561765|NCT00821236|40525186|FG000|Overall Study|Lost to Follow-up|3|||
16561766|NCT01648283|40525192|FG000|Overall Study|Withdrawal by Subject|14|||
16561767|NCT00495469|40525193|FG000|Overall Study|Adverse Event|0|||
16561768|NCT00495469|40525194|FG001|Overall Study|Adverse Event|1|||
16561769|NCT00495469|40525195|FG002|Overall Study|Adverse Event|3|||
16561770|NCT00495469|40525196|FG003|Overall Study|Adverse Event|0|||
16561771|NCT00495469|40525197|FG004|Overall Study|Adverse Event|1|||
16561772|NCT00495469|40525198|FG005|Overall Study|Adverse Event|1|||
16355657|NCT01149655|39787550|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
16355658|NCT01149655|39787551|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
16418028|NCT03615066|40011739|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
16418029|NCT03615066|40011740|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
16561773|NCT00495469|40525199|FG006|Overall Study|Adverse Event|1|||
16561774|NCT00495469|40525193|FG000|Overall Study|Lost to Follow-up|1|||
16247655|NCT02826603|39388265|FG001|Overall Study|Pregnancy|2|||
16247656|NCT02826603|39388264|FG000|Overall Study|Protocol Violation|3|||
16247657|NCT02826603|39388265|FG001|Overall Study|Protocol Violation|3|||
16247658|NCT02826603|39388264|FG000|Overall Study|Withdrawal by Subject|20|||
16247659|NCT02826603|39388265|FG001|Overall Study|Withdrawal by Subject|19|||
16247660|NCT02826603|39388264|FG000|Overall Study|Death|2|||
16247661|NCT02826603|39388265|FG001|Overall Study|Death|0|||
16247662|NCT02826603|39388264|FG000|Overall Study|New therapy for study indication|0|||
16247663|NCT02826603|39388265|FG001|Overall Study|New therapy for study indication|1|||
16247664|NCT03387059|39388266|FG000|Overall Study|Study termination|5|||
16247665|NCT03387059|39388267|FG001|Overall Study|Study termination|4|||
16247666|NCT00444795|39388270|FG000|Overall Study|Not Treated|1|||
16247667|NCT00444795|39388270|FG000|Overall Study|Treated Prior to the Contract Date|2|||
16247668|NCT03372369|39391580|FG000|Qualification Period|Withdrawal by Subject|16|||
16247669|NCT03372369|39391581|FG001|Qualification Period|Withdrawal by Subject|13|||
16247670|NCT03372369|39391580|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
16247671|NCT03372369|39391581|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
16247672|NCT03372369|39391580|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
16247673|NCT03372369|39391581|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
16247674|NCT01336894|39391594|FG000|Follow-up|Study terminated prematurely|2|||
16247675|NCT01336894|39391595|FG001|Follow-up|Study terminated prematurely|7|||
16247676|NCT01133392|39391598|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
16247677|NCT01133392|39391599|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
16247678|NCT01133392|39391598|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
16247679|NCT01133392|39391599|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
16247680|NCT01015612|39391602|FG000|Overall Study|Death|113|||
16247681|NCT01015612|39391602|FG000|Overall Study|Withdrawal by Subject|40|||
16247682|NCT02732561|39391604|FG000|Overall Study|Lost to Follow-up|1|||
16247683|NCT02732561|39391605|FG001|Overall Study|Lost to Follow-up|1|||
16247684|NCT02732561|39391604|FG000|Overall Study|Withdrawal by Subject|1|||
16247685|NCT02732561|39391605|FG001|Overall Study|Withdrawal by Subject|0|||
16247686|NCT00331630|39391606|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
16247687|NCT00331630|39391606|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
16247688|NCT00331630|39391606|FG000|Follow up for 5 Years|Death|5|||
16247689|NCT00331630|39391606|FG000|Follow up for 5 Years|Data collection was stopped|24|||
16247690|NCT00606684|39391607|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
16247691|NCT00606684|39391608|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
16247692|NCT00606684|39391609|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
16247693|NCT00606684|39391610|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
16247694|NCT00606684|39391611|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
16247695|NCT00606684|39391612|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
16247696|NCT00606684|39391613|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
16247697|NCT00606684|39391607|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
16247698|NCT00606684|39391608|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
16247699|NCT00606684|39391609|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
16247700|NCT00606684|39391610|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
16247701|NCT00606684|39391611|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
16247702|NCT00606684|39391612|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
16247703|NCT00606684|39391613|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
16247704|NCT00606684|39391607|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
16247705|NCT00606684|39391608|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
16247706|NCT00606684|39391609|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
16247707|NCT00606684|39391610|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
16247708|NCT00606684|39391611|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
16247709|NCT00606684|39391612|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
16247710|NCT00606684|39391613|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
16247711|NCT00606684|39391607|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
16247712|NCT00606684|39391608|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
16247713|NCT00606684|39391609|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
16130566|NCT00196976|38967050|FG001|Booster Study|Withdrawal by Subject|0|||
16247714|NCT00606684|39391610|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
16247715|NCT00606684|39391611|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
16247716|NCT00606684|39391612|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
16247717|NCT00606684|39391613|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
16247718|NCT00606684|39391607|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
16247719|NCT00606684|39391608|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
16355659|NCT01149655|39787552|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
16355660|NCT01149655|39787549|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
16355661|NCT01149655|39787550|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
16355662|NCT01149655|39787551|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
16355663|NCT01149655|39787552|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
16355664|NCT01149655|39787549|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
16355665|NCT01149655|39787550|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
16355666|NCT01149655|39787551|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
16355667|NCT01149655|39787552|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
16355668|NCT01149655|39787549|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
16355669|NCT01149655|39787550|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
16355670|NCT01149655|39787551|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
16355671|NCT01149655|39787552|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
16355672|NCT01149655|39787549|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
16355673|NCT01149655|39787550|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
16355674|NCT01149655|39787551|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
16355675|NCT01149655|39787552|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
16355676|NCT01586195|39787553|FG000|Overall Study|Death|11|||
16355677|NCT01586195|39787553|FG000|Overall Study|Withdrawal of Consent|5|||
16418030|NCT03615066|40011741|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
16418031|NCT02440789|40011742|FG000|Overall Study|Withdrawal by Subject|3|||
16418032|NCT02440789|40011742|FG000|Overall Study|Not willing to adhere to reqs|1|||
16418033|NCT04232215|40011743|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
16418034|NCT04232215|40011744|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
16418035|NCT03263780|40011746|FG000|Overall Study|Withdrawal by Subject|3|||
16418036|NCT03263780|40011746|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
16418037|NCT02294734|40011747|FG000|Overall Study|Adverse Event|5|||
16418038|NCT02294734|40011748|FG001|Overall Study|Adverse Event|5|||
16418039|NCT02294734|40011747|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
16418040|NCT02294734|40011748|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
16418041|NCT02294734|40011747|FG000|Overall Study|Lost to Follow-up|2|||
16418042|NCT02294734|40011748|FG001|Overall Study|Lost to Follow-up|0|||
16418043|NCT02294734|40011747|FG000|Overall Study|Physician Decision|2|||
16418044|NCT02294734|40011748|FG001|Overall Study|Physician Decision|1|||
16418045|NCT02294734|40011747|FG000|Overall Study|Withdrawal by Subject|4|||
16418046|NCT02294734|40011748|FG001|Overall Study|Withdrawal by Subject|2|||
16418047|NCT01943552|40011751|FG000|Overall Study|Adverse Event|3|||
16418048|NCT01943552|40011752|FG001|Overall Study|Adverse Event|2|||
16418049|NCT01943552|40011751|FG000|Overall Study|Withdrawal by Subject|6|||
16418050|NCT01943552|40011752|FG001|Overall Study|Withdrawal by Subject|6|||
16418051|NCT01943552|40011751|FG000|Overall Study|Other Reasons|16|||
16418052|NCT01943552|40011752|FG001|Overall Study|Other Reasons|17|||
16418053|NCT01727336|40011753|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
16418054|NCT01727336|40011754|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
16418055|NCT01727336|40011755|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
16418056|NCT01727336|40011756|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
16418057|NCT01727336|40011757|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
16418058|NCT01727336|40011758|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
16418059|NCT01727336|40011753|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
16418060|NCT01727336|40011754|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
16418061|NCT01727336|40011755|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
16418062|NCT01727336|40011756|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
16418063|NCT01727336|40011757|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
16418064|NCT01727336|40011758|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
16418065|NCT01727336|40011753|FG000|Part 2 Blinded|Death|0|||
16418066|NCT01727336|40011754|FG001|Part 2 Blinded|Death|0|||
16418067|NCT01727336|40011755|FG002|Part 2 Blinded|Death|0|||
16418068|NCT01727336|40011756|FG003|Part 2 Blinded|Death|0|||
16418069|NCT01727336|40011757|FG004|Part 2 Blinded|Death|20|||
16418070|NCT01727336|40011758|FG005|Part 2 Blinded|Death|16|||
16355678|NCT01586195|39787553|FG000|Overall Study|Started new anti-melanoma therapy|1|||
16418071|NCT01727336|40011753|FG000|Part 2 Blinded|Lack of Efficacy|0|||
16418072|NCT01727336|40011754|FG001|Part 2 Blinded|Lack of Efficacy|0|||
16418073|NCT01727336|40011755|FG002|Part 2 Blinded|Lack of Efficacy|0|||
16247720|NCT00606684|39391609|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
16247721|NCT00606684|39391610|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
16247722|NCT00606684|39391611|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
16247723|NCT00606684|39391612|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
16247724|NCT00606684|39391613|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
16247725|NCT00606684|39391607|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
16247726|NCT00606684|39391608|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
16247727|NCT00606684|39391609|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
16247728|NCT00606684|39391610|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
16247729|NCT00606684|39391611|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
16247730|NCT00606684|39391612|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
16247731|NCT00606684|39391613|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
16247732|NCT00606684|39391607|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
16247733|NCT00606684|39391608|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
16247734|NCT00606684|39391609|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
16247735|NCT00606684|39391610|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
16247736|NCT00606684|39391611|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
16247737|NCT00606684|39391612|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
16247738|NCT00606684|39391613|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
16247739|NCT00606684|39391607|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16247740|NCT00606684|39391608|FG001|Double-Blind Treatment Period|Adverse Event|3|||
16247741|NCT00606684|39391609|FG002|Double-Blind Treatment Period|Adverse Event|2|||
16247742|NCT00606684|39391610|FG003|Double-Blind Treatment Period|Adverse Event|4|||
16247743|NCT00606684|39391611|FG004|Double-Blind Treatment Period|Adverse Event|2|||
16247744|NCT00606684|39391612|FG005|Double-Blind Treatment Period|Adverse Event|0|||
16247745|NCT00606684|39391613|FG006|Double-Blind Treatment Period|Adverse Event|1|||
16247746|NCT00606684|39391607|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
16247747|NCT00606684|39391608|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
16247748|NCT00606684|39391609|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
16247749|NCT00606684|39391610|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
16247750|NCT00606684|39391611|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
16247751|NCT00606684|39391612|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
16247752|NCT00606684|39391613|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
16247753|NCT00606684|39391607|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
16247754|NCT00606684|39391608|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
16247755|NCT00606684|39391609|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
16247756|NCT00606684|39391610|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
16247757|NCT00606684|39391611|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
16247758|NCT00606684|39391612|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
16247759|NCT00606684|39391613|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
16247760|NCT00606684|39391607|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
16247761|NCT00606684|39391608|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
16247762|NCT00606684|39391609|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
16247763|NCT00606684|39391610|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
16247764|NCT00606684|39391611|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
16247765|NCT00606684|39391612|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
16247766|NCT00606684|39391613|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
16247767|NCT00606684|39391607|FG000|Double-Blind Treatment Period|Physician Decision|0|||
16247768|NCT00606684|39391608|FG001|Double-Blind Treatment Period|Physician Decision|5|||
16247769|NCT00606684|39391609|FG002|Double-Blind Treatment Period|Physician Decision|1|||
16247770|NCT00606684|39391610|FG003|Double-Blind Treatment Period|Physician Decision|0|||
16247771|NCT00606684|39391611|FG004|Double-Blind Treatment Period|Physician Decision|3|||
16247772|NCT00606684|39391612|FG005|Double-Blind Treatment Period|Physician Decision|1|||
16247773|NCT00606684|39391613|FG006|Double-Blind Treatment Period|Physician Decision|2|||
16247774|NCT00606684|39391607|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16247775|NCT00606684|39391608|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16247776|NCT00606684|39391609|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16247777|NCT00606684|39391610|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
16247778|NCT00606684|39391611|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16247779|NCT00606684|39391612|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
16247780|NCT00606684|39391613|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16247781|NCT01709383|39391614|FG000|Overall Study|Lost to Follow-up|1|||
16247782|NCT01709383|39391615|FG001|Overall Study|Lost to Follow-up|0|||
16247783|NCT03111147|39391616|FG000|Overall Study|Lost to Follow-up|2|||
16247784|NCT03111147|39391617|FG001|Overall Study|Lost to Follow-up|5|||
16247785|NCT03111147|39391616|FG000|Overall Study|Withdrawal by Subject|4|||
16247786|NCT03111147|39391617|FG001|Overall Study|Withdrawal by Subject|3|||
16418074|NCT01727336|40011756|FG003|Part 2 Blinded|Lack of Efficacy|0|||
16418075|NCT01727336|40011757|FG004|Part 2 Blinded|Lack of Efficacy|42|||
16418076|NCT01727336|40011758|FG005|Part 2 Blinded|Lack of Efficacy|44|||
16418077|NCT01727336|40011753|FG000|Part 2 Blinded|Lost to Follow-up|0|||
16418078|NCT01727336|40011754|FG001|Part 2 Blinded|Lost to Follow-up|0|||
16418079|NCT01727336|40011755|FG002|Part 2 Blinded|Lost to Follow-up|0|||
16418080|NCT01727336|40011756|FG003|Part 2 Blinded|Lost to Follow-up|0|||
16418081|NCT01727336|40011757|FG004|Part 2 Blinded|Lost to Follow-up|0|||
16418082|NCT01727336|40011758|FG005|Part 2 Blinded|Lost to Follow-up|1|||
16418083|NCT01727336|40011753|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
16418084|NCT01727336|40011754|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
16418085|NCT01727336|40011755|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
16418086|NCT01727336|40011756|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
16418087|NCT01727336|40011757|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
16418088|NCT01727336|40011758|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
16418089|NCT01727336|40011753|FG000|Part 2 Blinded|use of prohibited medications|0|||
16418090|NCT01727336|40011754|FG001|Part 2 Blinded|use of prohibited medications|0|||
16418091|NCT01727336|40011755|FG002|Part 2 Blinded|use of prohibited medications|0|||
16418092|NCT01727336|40011756|FG003|Part 2 Blinded|use of prohibited medications|0|||
16418093|NCT01727336|40011757|FG004|Part 2 Blinded|use of prohibited medications|1|||
16418094|NCT01727336|40011758|FG005|Part 2 Blinded|use of prohibited medications|3|||
16418095|NCT02102399|40011759|FG000|Overall Study|Withdrawal by Subject|6|||
16418096|NCT02102399|40011760|FG001|Overall Study|Withdrawal by Subject|4|||
16418097|NCT02713867|40011761|FG000|Randomization|Other Reason|2|||
16418098|NCT02713867|40011762|FG001|Randomization|Other Reason|1|||
16418099|NCT02713867|40011761|FG000|Randomization|Participant Withdrew consent|0|||
16418100|NCT02713867|40011762|FG001|Randomization|Participant Withdrew consent|2|||
16418101|NCT02713867|40011761|FG000|Treatment Period|Other Reasons|22|||
16418102|NCT02713867|40011762|FG001|Treatment Period|Other Reasons|28|||
16418103|NCT02713867|40011761|FG000|Treatment Period|Administrative reason by sponsor|21|||
16418104|NCT02713867|40011762|FG001|Treatment Period|Administrative reason by sponsor|16|||
16418105|NCT02713867|40011761|FG000|Treatment Period|No longer meets study criteria|2|||
16418106|NCT02713867|40011762|FG001|Treatment Period|No longer meets study criteria|1|||
16418107|NCT02713867|40011761|FG000|Treatment Period|Poor/Non Compliance|1|||
16418108|NCT02713867|40011762|FG001|Treatment Period|Poor/Non Compliance|0|||
16418109|NCT02713867|40011761|FG000|Treatment Period|Maximum Clinical Benefit|5|||
16418110|NCT02713867|40011762|FG001|Treatment Period|Maximum Clinical Benefit|6|||
16418111|NCT02713867|40011761|FG000|Treatment Period|Withdrew consent|3|||
16418112|NCT02713867|40011762|FG001|Treatment Period|Withdrew consent|6|||
16418113|NCT02713867|40011761|FG000|Treatment Period|Requested to Discontinue|8|||
16418114|NCT02713867|40011762|FG001|Treatment Period|Requested to Discontinue|8|||
16418115|NCT02713867|40011761|FG000|Treatment Period|AE unrelated to Study Drug|11|||
16418116|NCT02713867|40011762|FG001|Treatment Period|AE unrelated to Study Drug|10|||
16418117|NCT02713867|40011761|FG000|Treatment Period|Death|7|||
16418118|NCT02713867|40011762|FG001|Treatment Period|Death|3|||
16418119|NCT02713867|40011761|FG000|Treatment Period|Study Drug Toxicity|16|||
16418120|NCT02713867|40011762|FG001|Treatment Period|Study Drug Toxicity|19|||
16418121|NCT02713867|40011761|FG000|Treatment Period|Disease Progression|82|||
16418122|NCT02713867|40011762|FG001|Treatment Period|Disease Progression|83|||
16418123|NCT02456857|40011763|FG000|Overall Study|Disease Progression|4|||
16418124|NCT01563172|40011764|FG000|Overall Study|Adverse Event|5|||
16418125|NCT01563172|40011764|FG000|Overall Study|Lost to Follow-up|2|||
16418126|NCT01563172|40011764|FG000|Overall Study|Other (Protocol deviation)|5|||
16418127|NCT01563172|40011764|FG000|Overall Study|Other (Not specified)|1|||
16418128|NCT00950742|40011765|FG000|Overall Study|Other Adverse Event|1|||
16418129|NCT00950742|40011766|FG001|Overall Study|Other Adverse Event|0|||
16418130|NCT00950742|40011765|FG000|Overall Study|Withdrawal by Subject|3|||
16418131|NCT00950742|40011766|FG001|Overall Study|Withdrawal by Subject|0|||
16418132|NCT00950742|40011765|FG000|Overall Study|Progressive Disease|6|||
16418133|NCT00950742|40011766|FG001|Overall Study|Progressive Disease|2|||
16418134|NCT00950742|40011765|FG000|Overall Study|Dose limiting toxicity|6|||
16418135|NCT00950742|40011766|FG001|Overall Study|Dose limiting toxicity|0|||
16418136|NCT02453555|40011767|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
16418137|NCT02453555|40011768|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
16418138|NCT02453555|40011769|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
16418139|NCT02453555|40011770|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
16418140|NCT02453555|40011771|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
16418141|NCT02453555|40011772|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
16418142|NCT02453555|40011767|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
16418143|NCT02453555|40011768|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
16418144|NCT02453555|40011769|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
16418145|NCT02453555|40011770|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
16418146|NCT02453555|40011771|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
16418147|NCT02453555|40011772|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
16418148|NCT02453555|40011767|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
16418149|NCT02453555|40011768|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
16418150|NCT02453555|40011769|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16418151|NCT02453555|40011770|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16418152|NCT02453555|40011771|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16418153|NCT02453555|40011772|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16418154|NCT02453555|40011767|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
16418155|NCT02453555|40011768|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
16418156|NCT02453555|40011769|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
16418157|NCT02453555|40011770|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
16418158|NCT02453555|40011771|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
16418159|NCT02453555|40011772|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
16418160|NCT02453555|40011767|FG000|Extension Period|Adverse Event|0|||
16418161|NCT02453555|40011768|FG001|Extension Period|Adverse Event|0|||
16418162|NCT02453555|40011769|FG002|Extension Period|Adverse Event|1|||
16418163|NCT02453555|40011770|FG003|Extension Period|Adverse Event|2|||
16418164|NCT02453555|40011771|FG004|Extension Period|Adverse Event|1|||
16418165|NCT02453555|40011772|FG005|Extension Period|Adverse Event|1|||
16418166|NCT02453555|40011767|FG000|Extension Period|Protocol Violation|0|||
16418167|NCT02453555|40011768|FG001|Extension Period|Protocol Violation|0|||
16418168|NCT02453555|40011769|FG002|Extension Period|Protocol Violation|1|||
16418169|NCT02453555|40011770|FG003|Extension Period|Protocol Violation|0|||
16418170|NCT02453555|40011771|FG004|Extension Period|Protocol Violation|0|||
16418171|NCT02453555|40011772|FG005|Extension Period|Protocol Violation|0|||
16418172|NCT02453555|40011767|FG000|Extension Period|Withdrawal by Subject|0|||
16418173|NCT02453555|40011768|FG001|Extension Period|Withdrawal by Subject|0|||
16418174|NCT02453555|40011769|FG002|Extension Period|Withdrawal by Subject|1|||
16418175|NCT02453555|40011770|FG003|Extension Period|Withdrawal by Subject|0|||
16418176|NCT02453555|40011771|FG004|Extension Period|Withdrawal by Subject|0|||
16418177|NCT02453555|40011772|FG005|Extension Period|Withdrawal by Subject|0|||
16418178|NCT01966445|40011775|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
16418179|NCT01966445|40011776|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
16418180|NCT01966445|40011777|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
16418181|NCT01966445|40011778|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
16418182|NCT01966445|40011779|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
16418183|NCT01966445|40011780|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
16418184|NCT01966445|40011781|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
16418185|NCT01966445|40011775|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
16418186|NCT01966445|40011776|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
16418187|NCT01966445|40011777|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
16418188|NCT01966445|40011778|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
16418189|NCT01966445|40011779|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
16418190|NCT01966445|40011780|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
16418191|NCT01966445|40011781|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
16418192|NCT01966445|40011775|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
16418193|NCT01966445|40011776|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
16418194|NCT01966445|40011777|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
16418195|NCT01966445|40011778|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
16355679|NCT01586195|39787553|FG000|Overall Study|Reason not specified|9|||
16355680|NCT00449163|39787556|FG000|Overall Study|Physician Decision|3|||
16355681|NCT01825200|39787559|FG000|Overall Study|Lost to Follow-up|5|||
16355682|NCT01825200|39787560|FG001|Overall Study|Lost to Follow-up|6|||
16355683|NCT01825200|39787559|FG000|Overall Study|Withdrawal by Subject|0|||
16355684|NCT01825200|39787560|FG001|Overall Study|Withdrawal by Subject|1|||
16355685|NCT00785356|39787563|FG000|Overall Study|Study prematurely terminated|8|||
16355686|NCT00728494|39787564|FG000|Overall Study|Adverse Event|7|||
16355687|NCT00728494|39787565|FG001|Overall Study|Adverse Event|0|||
16355688|NCT00728494|39787564|FG000|Overall Study|Withdrawal by Subject|0|||
16355689|NCT00728494|39787565|FG001|Overall Study|Withdrawal by Subject|2|||
16355690|NCT00728494|39787564|FG000|Overall Study|Lack of Efficacy|2|||
16355691|NCT00728494|39787565|FG001|Overall Study|Lack of Efficacy|4|||
16355692|NCT00728494|39787564|FG000|Overall Study|No data available|0|||
16355693|NCT00728494|39787565|FG001|Overall Study|No data available|1|||
16418196|NCT01966445|40011779|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
16355694|NCT01114724|39787566|FG000|Overall Study|Death|8|||
16355695|NCT01114724|39787566|FG000|Overall Study|Lost to Follow-up|1|||
16355696|NCT01114724|39787566|FG000|Overall Study|Withdrawal by Subject|1|||
16247787|NCT03111147|39391616|FG000|Overall Study|Protocol Violation|2|||
16247788|NCT03111147|39391617|FG001|Overall Study|Protocol Violation|1|||
16247789|NCT03111147|39391616|FG000|Overall Study|Death|1|||
16247790|NCT03111147|39391617|FG001|Overall Study|Death|1|||
16247791|NCT03083483|39391620|FG000|Overall Study|Adverse Event|1|||
16247792|NCT03083483|39391621|FG001|Overall Study|Adverse Event|1|||
16247793|NCT03083483|39391622|FG002|Overall Study|Adverse Event|1|||
16247794|NCT03083483|39391620|FG000|Overall Study|Lost to Follow-up|2|||
16247795|NCT03083483|39391621|FG001|Overall Study|Lost to Follow-up|1|||
16247796|NCT03083483|39391622|FG002|Overall Study|Lost to Follow-up|1|||
16247797|NCT03083483|39391620|FG000|Overall Study|technological issues|1|||
16247798|NCT03083483|39391621|FG001|Overall Study|technological issues|0|||
16247799|NCT03083483|39391622|FG002|Overall Study|technological issues|1|||
16247800|NCT00928252|39391623|FG000|Overall Study|Physician Decision|3|||
16247801|NCT03692676|39391624|FG000|Overall Study|exclude patients with prior use|4424|||
16247802|NCT03692676|39391625|FG001|Overall Study|exclude patients with prior use|24726|||
16247803|NCT03692676|39391626|FG002|Overall Study|exclude patients with prior use|0|||
16247804|NCT03692676|39391627|FG003|Overall Study|exclude patients with prior use|0|||
16247805|NCT03692676|39391624|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
16247806|NCT03692676|39391625|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
16247807|NCT03692676|39391626|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
16247808|NCT03692676|39391627|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
16247809|NCT03692676|39391624|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
16247810|NCT03692676|39391625|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
16247811|NCT03692676|39391626|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
16247812|NCT03692676|39391627|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
16247813|NCT03692676|39391624|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
16247814|NCT03692676|39391625|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
16247815|NCT03692676|39391626|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
16247816|NCT03692676|39391627|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
16247817|NCT03692676|39391624|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
16247818|NCT03692676|39391625|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
16247819|NCT03692676|39391626|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
16247820|NCT03692676|39391627|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
16247821|NCT03692676|39391624|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
16247822|NCT03692676|39391625|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
16247823|NCT03692676|39391626|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
16247824|NCT03692676|39391627|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
16247825|NCT03692676|39391624|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
16247826|NCT03692676|39391625|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
16247827|NCT03692676|39391626|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
16247828|NCT03692676|39391627|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
16247829|NCT03692676|39391624|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
16247830|NCT03692676|39391625|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
16247831|NCT03692676|39391626|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
16247832|NCT03692676|39391627|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
16247833|NCT03692676|39391624|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
16247834|NCT03692676|39391625|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
16247835|NCT03692676|39391626|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
16247836|NCT03692676|39391627|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
16247837|NCT03692676|39391624|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
16247838|NCT03692676|39391625|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
16247839|NCT03692676|39391626|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
16247840|NCT03692676|39391627|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
16247841|NCT03692676|39391624|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
16247842|NCT03692676|39391625|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
16247843|NCT03692676|39391626|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
16247844|NCT03692676|39391627|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
16418197|NCT01966445|40011780|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
16418198|NCT01966445|40011781|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
16418199|NCT01966445|40011775|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16418200|NCT01966445|40011776|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16418201|NCT01966445|40011777|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16418202|NCT01966445|40011778|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16418203|NCT01966445|40011779|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16418204|NCT01966445|40011780|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
16418205|NCT01966445|40011781|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
16418206|NCT01966445|40011775|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16418207|NCT01966445|40011776|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16355697|NCT03368807|39787571|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
16355698|NCT03368807|39787571|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
16355699|NCT03368807|39787571|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
16355700|NCT03368807|39787571|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
16355701|NCT02378662|39787573|FG000|Overall Study|Early Discontinuation|2|||
16355702|NCT02378662|39787574|FG001|Overall Study|Early Discontinuation|0|||
16355703|NCT02229084|39787575|FG000|Overall Study|Adverse Event|1|||
16355704|NCT02229084|39787576|FG001|Overall Study|Adverse Event|0|||
16355705|NCT02229084|39787577|FG002|Overall Study|Adverse Event|0|||
16355706|NCT02229084|39787578|FG003|Overall Study|Adverse Event|0|||
16355707|NCT02229084|39787579|FG004|Overall Study|Adverse Event|0|||
16355708|NCT02229084|39787580|FG005|Overall Study|Adverse Event|0|||
16355709|NCT02229084|39787581|FG006|Overall Study|Adverse Event|0|||
16355710|NCT02229084|39787575|FG000|Overall Study|Lost to Follow-up|0|||
16355711|NCT02229084|39787576|FG001|Overall Study|Lost to Follow-up|0|||
16355712|NCT02229084|39787577|FG002|Overall Study|Lost to Follow-up|1|||
16355713|NCT02229084|39787578|FG003|Overall Study|Lost to Follow-up|1|||
16355714|NCT02229084|39787579|FG004|Overall Study|Lost to Follow-up|0|||
16355715|NCT02229084|39787580|FG005|Overall Study|Lost to Follow-up|0|||
16355716|NCT02229084|39787581|FG006|Overall Study|Lost to Follow-up|1|||
16355717|NCT02229084|39787575|FG000|Overall Study|Physician Decision|0|||
16355718|NCT02229084|39787576|FG001|Overall Study|Physician Decision|0|||
16355719|NCT02229084|39787577|FG002|Overall Study|Physician Decision|0|||
16355720|NCT02229084|39787578|FG003|Overall Study|Physician Decision|1|||
16355721|NCT02229084|39787579|FG004|Overall Study|Physician Decision|3|||
16355722|NCT02229084|39787580|FG005|Overall Study|Physician Decision|0|||
16355723|NCT02229084|39787581|FG006|Overall Study|Physician Decision|1|||
16355724|NCT02229084|39787575|FG000|Overall Study|Withdrawal by Subject|0|||
16355725|NCT02229084|39787576|FG001|Overall Study|Withdrawal by Subject|0|||
16355726|NCT02229084|39787577|FG002|Overall Study|Withdrawal by Subject|1|||
16355727|NCT02229084|39787578|FG003|Overall Study|Withdrawal by Subject|0|||
16355728|NCT02229084|39787579|FG004|Overall Study|Withdrawal by Subject|1|||
16418208|NCT01966445|40011777|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16418209|NCT01966445|40011778|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16418210|NCT01966445|40011779|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16418211|NCT01966445|40011780|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
16418212|NCT01966445|40011781|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
16418213|NCT00129961|40011782|FG000|Overall Study|Adverse Event|1|||
16418214|NCT00129961|40011783|FG001|Overall Study|Adverse Event|0|||
16418215|NCT00129961|40011782|FG000|Overall Study|Death|1|||
16418216|NCT00129961|40011783|FG001|Overall Study|Death|1|||
16418217|NCT00129961|40011782|FG000|Overall Study|Withdrawal by Sponsor|14|||
16561775|NCT00495469|40525194|FG001|Overall Study|Lost to Follow-up|1|||
16561776|NCT00495469|40525195|FG002|Overall Study|Lost to Follow-up|3|||
16561777|NCT00495469|40525196|FG003|Overall Study|Lost to Follow-up|1|||
16561778|NCT00495469|40525197|FG004|Overall Study|Lost to Follow-up|0|||
16561779|NCT00495469|40525198|FG005|Overall Study|Lost to Follow-up|0|||
16561780|NCT00495469|40525199|FG006|Overall Study|Lost to Follow-up|0|||
16561781|NCT00495469|40525193|FG000|Overall Study|Protocol Violation|0|||
16561782|NCT00495469|40525194|FG001|Overall Study|Protocol Violation|0|||
16561783|NCT00495469|40525195|FG002|Overall Study|Protocol Violation|0|||
16561784|NCT00495469|40525196|FG003|Overall Study|Protocol Violation|0|||
16561785|NCT00495469|40525197|FG004|Overall Study|Protocol Violation|1|||
16355729|NCT02229084|39787580|FG005|Overall Study|Withdrawal by Subject|1|||
16355730|NCT02229084|39787581|FG006|Overall Study|Withdrawal by Subject|1|||
16355731|NCT02229084|39787575|FG000|Overall Study|Death|0|||
16355732|NCT02229084|39787576|FG001|Overall Study|Death|0|||
16355733|NCT02229084|39787577|FG002|Overall Study|Death|0|||
16355734|NCT02229084|39787578|FG003|Overall Study|Death|0|||
16418218|NCT00129961|40011783|FG001|Overall Study|Withdrawal by Sponsor|20|||
16561786|NCT00495469|40525198|FG005|Overall Study|Protocol Violation|2|||
16561787|NCT00495469|40525199|FG006|Overall Study|Protocol Violation|0|||
16561788|NCT00495469|40525193|FG000|Overall Study|Withdrawal by Subject|5|||
16355735|NCT02229084|39787579|FG004|Overall Study|Death|0|||
16355736|NCT02229084|39787580|FG005|Overall Study|Death|0|||
16418219|NCT00129961|40011782|FG000|Overall Study|Physician Decision|1|||
16418220|NCT00129961|40011783|FG001|Overall Study|Physician Decision|0|||
16418221|NCT00129961|40011782|FG000|Overall Study|Withdrawal by Subject|2|||
16418222|NCT00129961|40011783|FG001|Overall Study|Withdrawal by Subject|1|||
16418223|NCT00129961|40011782|FG000|Overall Study|Missing Record|0|||
16418224|NCT00129961|40011783|FG001|Overall Study|Missing Record|1|||
16418225|NCT02895945|40011785|FG000|Overall Study|Physician Decision|2|||
16418226|NCT02895945|40011786|FG001|Overall Study|Physician Decision|1|||
16418227|NCT02708355|40011788|FG000|Overall Study|Adverse Event|1|||
16418228|NCT02708355|40011789|FG001|Overall Study|Adverse Event|0|||
16418229|NCT02708355|40011790|FG002|Overall Study|Adverse Event|0|||
16418230|NCT02191605|40011793|FG000|Overall Study|Lost to Follow-up|9|||
16418231|NCT02191605|40011794|FG001|Overall Study|Lost to Follow-up|4|||
16418232|NCT02191605|40011795|FG002|Overall Study|Lost to Follow-up|7|||
16418233|NCT02191605|40011796|FG003|Overall Study|Lost to Follow-up|3|||
16418234|NCT02191605|40011797|FG004|Overall Study|Lost to Follow-up|4|||
16418235|NCT02479139|40011798|FG000|Overall Study|Lost to Follow-up|2|||
16418236|NCT02479139|40011799|FG001|Overall Study|Lost to Follow-up|4|||
16418237|NCT02479139|40011800|FG002|Overall Study|Lost to Follow-up|4|||
16418238|NCT02479139|40011801|FG003|Overall Study|Lost to Follow-up|2|||
16418239|NCT02479139|40011802|FG004|Overall Study|Lost to Follow-up|3|||
16418240|NCT02479139|40011803|FG005|Overall Study|Lost to Follow-up|5|||
16418241|NCT02479139|40011798|FG000|Overall Study|Withdrew Consent|5|||
16418242|NCT02479139|40011799|FG001|Overall Study|Withdrew Consent|6|||
16418243|NCT02479139|40011800|FG002|Overall Study|Withdrew Consent|1|||
16418244|NCT02479139|40011801|FG003|Overall Study|Withdrew Consent|4|||
16418245|NCT02479139|40011802|FG004|Overall Study|Withdrew Consent|1|||
16418246|NCT02479139|40011803|FG005|Overall Study|Withdrew Consent|1|||
16418247|NCT02479139|40011798|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
16418248|NCT02479139|40011799|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
16418249|NCT02479139|40011800|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
16418250|NCT02479139|40011801|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
16418251|NCT02479139|40011802|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
16247845|NCT03692676|39391624|FG000|Overall Study|Other|0|||
16247846|NCT03692676|39391625|FG001|Overall Study|Other|805|||
16247847|NCT03692676|39391626|FG002|Overall Study|Other|758|||
16247848|NCT03692676|39391627|FG003|Overall Study|Other|277|||
16247849|NCT03692676|39391624|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
16247850|NCT03692676|39391625|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
16247851|NCT03692676|39391626|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
16247852|NCT03692676|39391627|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
16247853|NCT02660242|39391628|FG000|Glucose Tabs|Lost to Follow-up|1|||
16247854|NCT02660242|39391628|FG000|Glucagon Injection|Lost to Follow-up|1|||
16247855|NCT00783796|39391631|FG000|Overall Study|Did not receive any stent|4|||
16247856|NCT00783796|39391631|FG000|Overall Study|Received non-XIENCE V stent|1|||
16247857|NCT00783796|39391631|FG000|Overall Study|Received commercial XIENCE V stent|1|||
16247858|NCT03118739|39391640|FG000|Overall Study|Physician Decision|0|||
16247859|NCT03118739|39391641|FG001|Overall Study|Physician Decision|1|||
16247860|NCT03118739|39391640|FG000|Overall Study|Withdrawal by Subject|5|||
16247861|NCT03118739|39391641|FG001|Overall Study|Withdrawal by Subject|3|||
16247862|NCT03118739|39391640|FG000|Overall Study|Lost to Follow-up|2|||
16247863|NCT03118739|39391641|FG001|Overall Study|Lost to Follow-up|0|||
16247864|NCT03572933|39391642|FG000|Overall Study|Adverse Event|4|||
16247865|NCT03572933|39391643|FG001|Overall Study|Adverse Event|1|||
16247866|NCT03572933|39391642|FG000|Overall Study|Withdrawal by Subject|0|||
16247867|NCT03572933|39391643|FG001|Overall Study|Withdrawal by Subject|1|||
16247868|NCT03937466|39391644|FG000|Overall Study|not eligbile after the 2-week diary|9|||
16247869|NCT03937466|39391644|FG000|Overall Study|never returned their diary|6|||
16247870|NCT03937466|39391644|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
16247871|NCT03937466|39391644|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
16247872|NCT01830920|39391645|FG000|Overall Study|Adverse Event|1|||
16247873|NCT01830920|39391646|FG001|Overall Study|Adverse Event|0|||
16247874|NCT01830920|39391647|FG002|Overall Study|Adverse Event|1|||
16247875|NCT01830920|39391648|FG003|Overall Study|Adverse Event|0|||
16247876|NCT01830920|39391649|FG004|Overall Study|Adverse Event|0|||
16247877|NCT01830920|39391645|FG000|Overall Study|Withdrawal by Subject|2|||
16247878|NCT01830920|39391646|FG001|Overall Study|Withdrawal by Subject|2|||
16247879|NCT01830920|39391647|FG002|Overall Study|Withdrawal by Subject|1|||
16418252|NCT02479139|40011803|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
16418253|NCT02479139|40011798|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16418254|NCT02479139|40011799|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16418255|NCT02479139|40011800|FG002|Overall Study|Other Miscellaneous Reasons|1|||
16418256|NCT02479139|40011801|FG003|Overall Study|Other Miscellaneous Reasons|1|||
16418257|NCT02479139|40011802|FG004|Overall Study|Other Miscellaneous Reasons|1|||
16247880|NCT01830920|39391648|FG003|Overall Study|Withdrawal by Subject|7|||
16418258|NCT02479139|40011803|FG005|Overall Study|Other Miscellaneous Reasons|0|||
16355737|NCT02229084|39787581|FG006|Overall Study|Death|1|||
16355738|NCT01928771|39787584|FG000|Overall Study|Adverse Event|6|||
16355739|NCT01928771|39787585|FG001|Overall Study|Adverse Event|5|||
16355740|NCT01928771|39787586|FG002|Overall Study|Adverse Event|1|||
16355741|NCT01928771|39787584|FG000|Overall Study|Death|2|||
16355742|NCT01928771|39787585|FG001|Overall Study|Death|2|||
16355743|NCT01928771|39787586|FG002|Overall Study|Death|2|||
16355744|NCT01928771|39787584|FG000|Overall Study|Lost to Follow-up|5|||
16355745|NCT01928771|39787585|FG001|Overall Study|Lost to Follow-up|6|||
16355746|NCT01928771|39787586|FG002|Overall Study|Lost to Follow-up|3|||
16355747|NCT01928771|39787584|FG000|Overall Study|Withdrawal by Subject|20|||
16355748|NCT01928771|39787585|FG001|Overall Study|Withdrawal by Subject|15|||
16355749|NCT01928771|39787586|FG002|Overall Study|Withdrawal by Subject|17|||
16355750|NCT01928771|39787584|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
16355751|NCT01928771|39787585|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
16418259|NCT01403116|40011807|FG000|Overall Study|Adverse Event|7|||
16418260|NCT01403116|40011808|FG001|Overall Study|Adverse Event|4|||
16418261|NCT01403116|40011807|FG000|Overall Study|Lost to Follow-up|7|||
16418262|NCT01403116|40011808|FG001|Overall Study|Lost to Follow-up|5|||
16418263|NCT01403116|40011807|FG000|Overall Study|Withdrawal by Subject|12|||
16418264|NCT01403116|40011808|FG001|Overall Study|Withdrawal by Subject|15|||
16355752|NCT01928771|39787586|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
16355753|NCT01928771|39787584|FG000|Overall Study|Other Reasons|9|||
16355754|NCT01928771|39787585|FG001|Overall Study|Other Reasons|9|||
16355755|NCT01928771|39787586|FG002|Overall Study|Other Reasons|14|||
16355756|NCT01928771|39787584|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
16355757|NCT01928771|39787585|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
16355758|NCT01928771|39787586|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
16355759|NCT00492726|39787587|FG000|Overall Study|Adverse Event|10|||
16355760|NCT00492726|39787588|FG001|Overall Study|Adverse Event|6|||
16355761|NCT00492726|39787587|FG000|Overall Study|Death|7|||
16355762|NCT00492726|39787588|FG001|Overall Study|Death|2|||
16355763|NCT00492726|39787587|FG000|Overall Study|Lack of Efficacy|0|||
16355764|NCT00492726|39787588|FG001|Overall Study|Lack of Efficacy|2|||
16418265|NCT01403116|40011807|FG000|Overall Study|Non-compliance of study drug|3|||
16418266|NCT01403116|40011808|FG001|Overall Study|Non-compliance of study drug|0|||
16418267|NCT01403116|40011807|FG000|Overall Study|Protocol Violation|0|||
16418268|NCT01403116|40011808|FG001|Overall Study|Protocol Violation|1|||
16418269|NCT01403116|40011807|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
16418270|NCT01403116|40011808|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
16418271|NCT01403116|40011807|FG000|Overall Study|Hct >54%|2|||
16418272|NCT01403116|40011808|FG001|Overall Study|Hct >54%|0|||
16418273|NCT01403116|40011807|FG000|Overall Study|unable to keep appointments|0|||
16355765|NCT00492726|39787587|FG000|Overall Study|Lost to Follow-up|27|||
16355766|NCT00492726|39787588|FG001|Overall Study|Lost to Follow-up|19|||
16418274|NCT01403116|40011808|FG001|Overall Study|unable to keep appointments|2|||
16247881|NCT01830920|39391649|FG004|Overall Study|Withdrawal by Subject|1|||
16247882|NCT01830920|39391645|FG000|Overall Study|Death|3|||
16247883|NCT01830920|39391646|FG001|Overall Study|Death|3|||
16247884|NCT01830920|39391647|FG002|Overall Study|Death|5|||
16355767|NCT00492726|39787587|FG000|Overall Study|Physician Decision|0|||
16355768|NCT00492726|39787588|FG001|Overall Study|Physician Decision|1|||
16355769|NCT00492726|39787587|FG000|Overall Study|Withdrawal by Subject|6|||
16355770|NCT00492726|39787588|FG001|Overall Study|Withdrawal by Subject|3|||
16355771|NCT00492726|39787587|FG000|Overall Study|Non compliant with study medication|0|||
16355772|NCT00492726|39787588|FG001|Overall Study|Non compliant with study medication|3|||
16355773|NCT01190891|39787589|FG000|Overall Study|Protocol Violation|1|||
16355774|NCT01190891|39787590|FG001|Overall Study|Protocol Violation|0|||
16355775|NCT01190891|39787589|FG000|Overall Study|Withdrawal by Subject|5|||
16355776|NCT01190891|39787590|FG001|Overall Study|Withdrawal by Subject|0|||
16355777|NCT01324102|39787592|FG000|Overall Study|illness|1|||
16355778|NCT01324102|39787593|FG001|Overall Study|illness|6|||
16355779|NCT02497469|39787594|FG000|Overall Study|Randomized but not Treated|0|||
16355780|NCT02497469|39787595|FG001|Overall Study|Randomized but not Treated|2|||
16355781|NCT02497469|39787594|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
16355782|NCT02497469|39787595|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
16355783|NCT02497469|39787594|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
16355784|NCT02497469|39787595|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
16355785|NCT02497469|39787594|FG000|Overall Study|Significant Protocol Deviation|4|||
16355786|NCT02497469|39787595|FG001|Overall Study|Significant Protocol Deviation|5|||
16355787|NCT02497469|39787594|FG000|Overall Study|Lost to Follow-up|14|||
16355788|NCT02497469|39787595|FG001|Overall Study|Lost to Follow-up|4|||
16355789|NCT02497469|39787594|FG000|Overall Study|Voluntary Withdrawal|39|||
16355790|NCT02497469|39787595|FG001|Overall Study|Voluntary Withdrawal|41|||
16355791|NCT02497469|39787594|FG000|Overall Study|Pregnancy|1|||
16355792|NCT02497469|39787595|FG001|Overall Study|Pregnancy|1|||
16355793|NCT02497469|39787594|FG000|Overall Study|Lack of Efficacy|86|||
16355794|NCT02497469|39787595|FG001|Overall Study|Lack of Efficacy|40|||
16355795|NCT02497469|39787594|FG000|Overall Study|Reason not Specified|6|||
16355796|NCT02497469|39787595|FG001|Overall Study|Reason not Specified|6|||
16355797|NCT02701634|39787596|FG000|Overall Study|Adverse Event|2|||
16355798|NCT02701634|39787597|FG001|Overall Study|Adverse Event|3|||
16355799|NCT02701634|39787596|FG000|Overall Study|Death|1|||
16355800|NCT02701634|39787597|FG001|Overall Study|Death|0|||
16355801|NCT02701634|39787596|FG000|Overall Study|Investigator's Discretion|7|||
16355802|NCT02701634|39787597|FG001|Overall Study|Investigator's Discretion|4|||
16355803|NCT02701634|39787596|FG000|Overall Study|Study terminated by Sponsor|15|||
16355804|NCT02701634|39787597|FG001|Overall Study|Study terminated by Sponsor|17|||
16355805|NCT02701634|39787596|FG000|Overall Study|Withdrew Consent|6|||
16355806|NCT02701634|39787597|FG001|Overall Study|Withdrew Consent|7|||
16247885|NCT01830920|39391648|FG003|Overall Study|Death|4|||
16247886|NCT01830920|39391649|FG004|Overall Study|Death|4|||
16355807|NCT02701634|39787596|FG000|Overall Study|Randomized but not treated|1|||
16355808|NCT02701634|39787597|FG001|Overall Study|Randomized but not treated|0|||
16355809|NCT00551369|39787598|FG000|Overall Study|Protocol Violation|5|||
16355810|NCT00551369|39787598|FG000|Overall Study|Withdrawal by Subject|1|||
16355811|NCT00551369|39787598|FG000|Overall Study|Not treated per protocol and re|1|||
16355812|NCT01100502|39787599|FG000|Overall Study|Withdrawal by Subject|18|||
16418275|NCT02540291|40011809|FG000|Overall Study|Death|7|||
16247887|NCT01830920|39391645|FG000|Overall Study|Other|15|||
16247888|NCT01830920|39391646|FG001|Overall Study|Other|1|||
16247889|NCT01830920|39391647|FG002|Overall Study|Other|1|||
16355813|NCT01100502|39787600|FG001|Overall Study|Withdrawal by Subject|25|||
16355814|NCT01100502|39787599|FG000|Overall Study|Lost to Follow-up|13|||
16355815|NCT01100502|39787600|FG001|Overall Study|Lost to Follow-up|28|||
16418276|NCT02540291|40011810|FG001|Overall Study|Death|7|||
16355816|NCT01100502|39787599|FG000|Overall Study|Site request to end participation in study|0|||
16355817|NCT01100502|39787600|FG001|Overall Study|Site request to end participation in study|1|||
16355818|NCT01100502|39787599|FG000|Overall Study|Death|45|||
16355819|NCT01100502|39787600|FG001|Overall Study|Death|40|||
16355820|NCT01701245|39787606|FG000|Overall Study|Protocol Violation|1|||
16355821|NCT01701245|39787607|FG001|Overall Study|Protocol Violation|3|||
16355822|NCT01701245|39787606|FG000|Overall Study|Did not complete the open label period|11|||
16355823|NCT01701245|39787607|FG001|Overall Study|Did not complete the open label period|12|||
16355824|NCT00325416|39787609|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
16355825|NCT00325416|39787610|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
16355826|NCT00325416|39787609|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
16355827|NCT00325416|39787610|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
16355828|NCT00325416|39787609|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
16355829|NCT00325416|39787610|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
16355830|NCT00325416|39787609|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
16355831|NCT00325416|39787610|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
16355832|NCT00325416|39787609|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
16355833|NCT00325416|39787610|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
16355834|NCT00325416|39787609|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
16355835|NCT00325416|39787610|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
16355836|NCT02792504|39790434|FG000|Overall Study|Lost to Follow-up|24|||
16355837|NCT02792504|39790434|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
16355838|NCT01548404|39790435|FG000|Overall Study|Adverse Event|3|||
16355839|NCT01548404|39790436|FG001|Overall Study|Adverse Event|1|||
16355840|NCT01548404|39790435|FG000|Overall Study|Physician Decision|2|||
16355841|NCT01548404|39790436|FG001|Overall Study|Physician Decision|1|||
16355842|NCT01548404|39790435|FG000|Overall Study|Inadequate response to study treatment|23|||
16355843|NCT01548404|39790436|FG001|Overall Study|Inadequate response to study treatment|7|||
16355844|NCT01548404|39790435|FG000|Overall Study|Lost to Follow-up|2|||
16355845|NCT01548404|39790436|FG001|Overall Study|Lost to Follow-up|0|||
16355846|NCT01548404|39790435|FG000|Overall Study|Withdrawal by Subject|0|||
16355847|NCT01548404|39790436|FG001|Overall Study|Withdrawal by Subject|3|||
16355848|NCT01548404|39790435|FG000|Overall Study|Other than specified above|0|||
16355849|NCT01548404|39790436|FG001|Overall Study|Other than specified above|2|||
16355850|NCT01384877|39790437|FG000|Treatment 2|Lost to Follow-up|2|||
16355851|NCT01384877|39790438|FG001|Treatment 2|Lost to Follow-up|2|||
16355852|NCT00296517|39790443|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
16355853|NCT00296517|39790444|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
16355854|NCT00296517|39790443|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
16355855|NCT00296517|39790444|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
16355856|NCT00296517|39790443|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
16418277|NCT02540291|40011811|FG002|Overall Study|Death|5|||
16247890|NCT01830920|39391648|FG003|Overall Study|Other|5|||
16247891|NCT01830920|39391649|FG004|Overall Study|Other|3|||
16247892|NCT01783483|39391650|FG000|Overall Study|Death|3|||
16247893|NCT01783483|39391651|FG001|Overall Study|Death|3|||
16247894|NCT01783483|39391650|FG000|Overall Study|Lost to Follow-up|14|||
16247895|NCT01783483|39391651|FG001|Overall Study|Lost to Follow-up|10|||
16247896|NCT01783483|39391650|FG000|Overall Study|Withdrawal by Subject|2|||
16247897|NCT01783483|39391651|FG001|Overall Study|Withdrawal by Subject|1|||
16247898|NCT01783483|39391650|FG000|Overall Study|Physician Decision|1|||
16247899|NCT01783483|39391651|FG001|Overall Study|Physician Decision|1|||
16247900|NCT03567057|39391658|FG000|Overall Study|Adverse Event|56|||
16247901|NCT03567057|39391659|FG001|Overall Study|Adverse Event|53|||
16247902|NCT03567057|39391660|FG002|Overall Study|Adverse Event|28|||
16247903|NCT03567057|39391658|FG000|Overall Study|Withdrawal by Subject|22|||
16247904|NCT03567057|39391659|FG001|Overall Study|Withdrawal by Subject|24|||
16247905|NCT03567057|39391660|FG002|Overall Study|Withdrawal by Subject|13|||
16247906|NCT03567057|39391658|FG000|Overall Study|Lost to Follow-up|3|||
16247907|NCT03567057|39391659|FG001|Overall Study|Lost to Follow-up|5|||
16247908|NCT03567057|39391660|FG002|Overall Study|Lost to Follow-up|2|||
16247909|NCT03567057|39391658|FG000|Overall Study|COVID-19 pandemic|4|||
16247910|NCT03567057|39391659|FG001|Overall Study|COVID-19 pandemic|3|||
16247911|NCT03567057|39391660|FG002|Overall Study|COVID-19 pandemic|0|||
16247912|NCT03567057|39391658|FG000|Overall Study|Non-compliance with study drug|4|||
16247913|NCT03567057|39391659|FG001|Overall Study|Non-compliance with study drug|2|||
16247914|NCT03567057|39391660|FG002|Overall Study|Non-compliance with study drug|0|||
16247915|NCT03567057|39391658|FG000|Overall Study|Lack of Efficacy|3|||
16247916|NCT03567057|39391659|FG001|Overall Study|Lack of Efficacy|0|||
16247917|NCT03567057|39391660|FG002|Overall Study|Lack of Efficacy|1|||
16247918|NCT03567057|39391658|FG000|Overall Study|Death|1|||
16247919|NCT03567057|39391659|FG001|Overall Study|Death|0|||
16247920|NCT03567057|39391660|FG002|Overall Study|Death|0|||
16247921|NCT03567057|39391658|FG000|Overall Study|Physician Decision|1|||
16247922|NCT03567057|39391659|FG001|Overall Study|Physician Decision|0|||
16355857|NCT00296517|39790444|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
16355858|NCT00296517|39790443|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
16355859|NCT00296517|39790444|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
16355860|NCT00296517|39790443|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
16355861|NCT00296517|39790444|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
16355862|NCT00296517|39790443|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
16355863|NCT00296517|39790444|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
16355864|NCT00296517|39790443|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
16355865|NCT00296517|39790444|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
16355866|NCT00296517|39790443|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
16355867|NCT00296517|39790444|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
16355868|NCT00296517|39790443|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
16355869|NCT00296517|39790444|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
16355870|NCT01145482|39790446|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
16355871|NCT01145482|39790447|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
16355872|NCT00239720|39790451|FG000|Overall Study|Adverse Event|1|||
16355873|NCT00239720|39790452|FG001|Overall Study|Adverse Event|0|||
16355874|NCT00239720|39790451|FG000|Overall Study|Lost to Follow-up|0|||
16355875|NCT00239720|39790452|FG001|Overall Study|Lost to Follow-up|1|||
16355876|NCT00834041|39790453|FG000|Overall Study|Withdrawal by Subject|1|||
16355877|NCT00834041|39790454|FG001|Overall Study|Withdrawal by Subject|0|||
16355878|NCT00834041|39790453|FG000|Overall Study|Lost to Follow-up|0|||
16355879|NCT00834041|39790454|FG001|Overall Study|Lost to Follow-up|1|||
16355880|NCT01765296|39790455|FG000|Overall Study|Protocol Violation|0|||
16355881|NCT01765296|39790456|FG001|Overall Study|Protocol Violation|5|||
16355882|NCT01765296|39790457|FG002|Overall Study|Protocol Violation|4|||
16355883|NCT01765296|39790455|FG000|Overall Study|Withdrawal by Subject|4|||
16355884|NCT01765296|39790456|FG001|Overall Study|Withdrawal by Subject|2|||
16355885|NCT01765296|39790457|FG002|Overall Study|Withdrawal by Subject|2|||
16355886|NCT01765296|39790455|FG000|Overall Study|Adverse Event|1|||
16355887|NCT01765296|39790456|FG001|Overall Study|Adverse Event|13|||
16355888|NCT01765296|39790457|FG002|Overall Study|Adverse Event|5|||
16355889|NCT01765296|39790455|FG000|Overall Study|Lack of Efficacy|0|||
16355890|NCT01765296|39790456|FG001|Overall Study|Lack of Efficacy|0|||
16355891|NCT01765296|39790457|FG002|Overall Study|Lack of Efficacy|2|||
16355892|NCT01631214|39790458|FG000|Overall Study|Withdrawal by Subject|276|||
16355893|NCT01631214|39790459|FG001|Overall Study|Withdrawal by Subject|290|||
16355894|NCT01631214|39790458|FG000|Overall Study|Death|113|||
16355895|NCT01631214|39790459|FG001|Overall Study|Death|106|||
16355896|NCT01631214|39790458|FG000|Overall Study|Lost to Follow-up|54|||
16355897|NCT01631214|39790459|FG001|Overall Study|Lost to Follow-up|40|||
16355898|NCT01631214|39790458|FG000|Overall Study|Adverse Event|45|||
16355899|NCT01631214|39790459|FG001|Overall Study|Adverse Event|45|||
16355900|NCT01631214|39790458|FG000|Overall Study|Other|22|||
16355901|NCT01631214|39790459|FG001|Overall Study|Other|19|||
16355902|NCT01631214|39790458|FG000|Overall Study|Noncompliance|16|||
16355903|NCT01631214|39790459|FG001|Overall Study|Noncompliance|15|||
16355904|NCT01631214|39790458|FG000|Overall Study|Requirement for Alternative Therapy|8|||
16355905|NCT01631214|39790459|FG001|Overall Study|Requirement for Alternative Therapy|3|||
16355906|NCT01631214|39790458|FG000|Overall Study|Protocol Deviation|4|||
16355907|NCT01631214|39790459|FG001|Overall Study|Protocol Deviation|3|||
16355908|NCT01631214|39790458|FG000|Overall Study|Ineligibility determined|5|||
16355909|NCT01631214|39790459|FG001|Overall Study|Ineligibility determined|2|||
16355910|NCT01631214|39790458|FG000|Overall Study|Administrative Decision|1|||
16355911|NCT01631214|39790459|FG001|Overall Study|Administrative Decision|0|||
16355912|NCT03163446|39790469|FG000|Overall Study|Unable to return for Day 180 visit|2|||
16355913|NCT03163446|39790470|FG001|Overall Study|Unable to return for Day 180 visit|0|||
16355914|NCT03163446|39790469|FG000|Overall Study|Withdrawal by Subject|2|||
16355915|NCT03163446|39790470|FG001|Overall Study|Withdrawal by Subject|6|||
16355916|NCT03163446|39790469|FG000|Overall Study|Death|16|||
16355917|NCT03163446|39790470|FG001|Overall Study|Death|5|||
16355918|NCT03163446|39790469|FG000|Overall Study|Lost to Follow-up|6|||
16355919|NCT03163446|39790470|FG001|Overall Study|Lost to Follow-up|5|||
16355920|NCT03163446|39790469|FG000|Overall Study|Physician Decision|1|||
16355921|NCT03163446|39790470|FG001|Overall Study|Physician Decision|1|||
16355922|NCT03163446|39790469|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
16355923|NCT03163446|39790470|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
16355924|NCT03439137|39790471|FG000|Overall Study|Adverse Event|16|||
16355925|NCT03439137|39790472|FG001|Overall Study|Adverse Event|12|||
16355926|NCT03439137|39790471|FG000|Overall Study|Physician Decision|0|||
16355927|NCT03439137|39790472|FG001|Overall Study|Physician Decision|5|||
16355928|NCT03439137|39790471|FG000|Overall Study|Withdrawal by Subject|14|||
16355929|NCT03439137|39790472|FG001|Overall Study|Withdrawal by Subject|4|||
16355930|NCT03439137|39790471|FG000|Overall Study|Conducting rescue therapy|2|||
16355931|NCT03439137|39790472|FG001|Overall Study|Conducting rescue therapy|1|||
16355932|NCT03439137|39790471|FG000|Overall Study|Difficult to control Hb|10|||
16355933|NCT03439137|39790472|FG001|Overall Study|Difficult to control Hb|2|||
16355934|NCT03439137|39790471|FG000|Overall Study|Initiation of a renal transplant|0|||
16355935|NCT03439137|39790472|FG001|Overall Study|Initiation of a renal transplant|2|||
16355936|NCT01317641|39790473|FG000|Overall Study|Not treated|0|||
16355937|NCT01317641|39790474|FG001|Overall Study|Not treated|0|||
16355938|NCT01317641|39790475|FG002|Overall Study|Not treated|0|||
16355939|NCT01317641|39790476|FG003|Overall Study|Not treated|0|||
16355940|NCT01317641|39790477|FG004|Overall Study|Not treated|0|||
16355941|NCT01317641|39790478|FG005|Overall Study|Not treated|0|||
16355942|NCT01317641|39790479|FG006|Overall Study|Not treated|0|||
16355943|NCT01317641|39790480|FG007|Overall Study|Not treated|1|||
16355944|NCT01317641|39790481|FG008|Overall Study|Not treated|1|||
16355945|NCT01317641|39790473|FG000|Overall Study|Adverse Event|0|||
16355946|NCT01317641|39790474|FG001|Overall Study|Adverse Event|1|||
16355947|NCT01317641|39790475|FG002|Overall Study|Adverse Event|0|||
16355948|NCT01317641|39790476|FG003|Overall Study|Adverse Event|1|||
16355949|NCT01317641|39790477|FG004|Overall Study|Adverse Event|0|||
16355950|NCT01317641|39790478|FG005|Overall Study|Adverse Event|0|||
16355951|NCT01317641|39790479|FG006|Overall Study|Adverse Event|2|||
16355952|NCT01317641|39790480|FG007|Overall Study|Adverse Event|1|||
16355953|NCT01317641|39790481|FG008|Overall Study|Adverse Event|0|||
16355954|NCT01317641|39790473|FG000|Overall Study|Protocol Violation|1|||
16355955|NCT01317641|39790474|FG001|Overall Study|Protocol Violation|0|||
16355956|NCT01317641|39790475|FG002|Overall Study|Protocol Violation|0|||
16355957|NCT01317641|39790476|FG003|Overall Study|Protocol Violation|0|||
16355958|NCT01317641|39790477|FG004|Overall Study|Protocol Violation|0|||
16355959|NCT01317641|39790478|FG005|Overall Study|Protocol Violation|0|||
16355960|NCT01317641|39790479|FG006|Overall Study|Protocol Violation|0|||
16355961|NCT01317641|39790480|FG007|Overall Study|Protocol Violation|0|||
16355962|NCT01317641|39790481|FG008|Overall Study|Protocol Violation|0|||
16355963|NCT01317641|39790473|FG000|Overall Study|Disease progression|0|||
16355964|NCT01317641|39790474|FG001|Overall Study|Disease progression|0|||
16355965|NCT01317641|39790475|FG002|Overall Study|Disease progression|0|||
16355966|NCT01317641|39790476|FG003|Overall Study|Disease progression|0|||
16355967|NCT01317641|39790477|FG004|Overall Study|Disease progression|0|||
16355968|NCT01317641|39790478|FG005|Overall Study|Disease progression|0|||
16355969|NCT01317641|39790479|FG006|Overall Study|Disease progression|0|||
16355970|NCT01317641|39790480|FG007|Overall Study|Disease progression|3|||
16355971|NCT01317641|39790481|FG008|Overall Study|Disease progression|4|||
16355972|NCT01317641|39790473|FG000|Overall Study|Withdrawal by Subject|0|||
16355973|NCT01317641|39790474|FG001|Overall Study|Withdrawal by Subject|0|||
16355974|NCT01317641|39790475|FG002|Overall Study|Withdrawal by Subject|0|||
16355975|NCT01317641|39790476|FG003|Overall Study|Withdrawal by Subject|0|||
16355976|NCT01317641|39790477|FG004|Overall Study|Withdrawal by Subject|0|||
16355977|NCT01317641|39790478|FG005|Overall Study|Withdrawal by Subject|0|||
16355978|NCT01317641|39790479|FG006|Overall Study|Withdrawal by Subject|1|||
16355979|NCT01317641|39790480|FG007|Overall Study|Withdrawal by Subject|0|||
16355980|NCT01317641|39790481|FG008|Overall Study|Withdrawal by Subject|0|||
16355981|NCT02314728|39790486|FG000|Overall Study|Protocol Violation|1|||
16355982|NCT02314728|39790487|FG001|Overall Study|Protocol Violation|0|||
16355983|NCT02314728|39790486|FG000|Overall Study|Lost to Follow-up|0|||
16355984|NCT02314728|39790487|FG001|Overall Study|Lost to Follow-up|1|||
16355985|NCT01268267|39790488|FG000|Overall Study|Protocol Violation|1|||
16355986|NCT01443858|39790489|FG000|Overall Study|Withdrawal by Subject|9|||
16355987|NCT01443858|39790490|FG001|Overall Study|Withdrawal by Subject|8|||
16355988|NCT01443858|39790491|FG002|Overall Study|Withdrawal by Subject|5|||
16355989|NCT01443858|39790489|FG000|Overall Study|Lack of Efficacy|1|||
16355990|NCT01443858|39790490|FG001|Overall Study|Lack of Efficacy|0|||
16355991|NCT01443858|39790491|FG002|Overall Study|Lack of Efficacy|0|||
16355992|NCT01443858|39790489|FG000|Overall Study|Lost to Follow-up|5|||
16355993|NCT01443858|39790490|FG001|Overall Study|Lost to Follow-up|5|||
16355994|NCT01443858|39790491|FG002|Overall Study|Lost to Follow-up|2|||
16355995|NCT00472420|39790492|FG000|Induction Treatment Period|Physician Decision|9|||
16355996|NCT00472420|39790492|FG000|Induction Treatment Period|Adverse Event|3|||
16355997|NCT00472420|39790492|FG000|Induction Treatment Period|Non-compliance|1|||
16355998|NCT00472420|39790492|FG000|Induction Treatment Period|Death|3|||
16355999|NCT00472420|39790492|FG000|Follow-up Period|Death|5|||
16356000|NCT00472420|39790492|FG000|Follow-up Period|Physician Decision|9|||
16356001|NCT00472420|39790492|FG000|Follow-up Period|Lost to Follow-up|2|||
16356002|NCT00472420|39790492|FG000|Follow-up Period|Protocol Violation|1|||
16356003|NCT00611806|39790493|FG000|Overall Study|Withdrawal by Subject|8|||
16356004|NCT00611806|39790494|FG001|Overall Study|Withdrawal by Subject|2|||
16356005|NCT00611806|39790493|FG000|Overall Study|Adverse Event|2|||
16356006|NCT00611806|39790494|FG001|Overall Study|Adverse Event|1|||
16356007|NCT00611806|39790493|FG000|Overall Study|Lost to Follow-up|6|||
16356008|NCT00611806|39790494|FG001|Overall Study|Lost to Follow-up|0|||
16356009|NCT01811732|39790496|FG000|Overall Study|Lost to Follow-up|24|||
16356010|NCT01811732|39790497|FG001|Overall Study|Lost to Follow-up|30|||
16356011|NCT01811732|39790496|FG000|Overall Study|Withdrawal by Subject|16|||
16356012|NCT01811732|39790497|FG001|Overall Study|Withdrawal by Subject|10|||
16356013|NCT01811732|39790496|FG000|Overall Study|Adverse Event|3|||
16356014|NCT01811732|39790497|FG001|Overall Study|Adverse Event|9|||
16356015|NCT01811732|39790496|FG000|Overall Study|Lack of Efficacy|3|||
16356016|NCT01811732|39790497|FG001|Overall Study|Lack of Efficacy|1|||
16356017|NCT01811732|39790496|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
16356018|NCT01811732|39790497|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
16356019|NCT01811732|39790496|FG000|Overall Study|Physician Decision|2|||
16356020|NCT01811732|39790497|FG001|Overall Study|Physician Decision|0|||
16356021|NCT01811732|39790496|FG000|Overall Study|Death|1|||
16356022|NCT01811732|39790497|FG001|Overall Study|Death|1|||
16356023|NCT01811732|39790496|FG000|Overall Study|Insufficient venous access|0|||
16356024|NCT01811732|39790497|FG001|Overall Study|Insufficient venous access|1|||
16356025|NCT01811732|39790496|FG000|Overall Study|Protocol Violation|0|||
16356026|NCT01811732|39790497|FG001|Overall Study|Protocol Violation|1|||
16356027|NCT01811732|39790496|FG000|Overall Study|Subject incarcerated|1|||
16356028|NCT01811732|39790497|FG001|Overall Study|Subject incarcerated|2|||
16356029|NCT01811732|39790496|FG000|Overall Study|Admitted to another facility|1|||
16356030|NCT01811732|39790497|FG001|Overall Study|Admitted to another facility|0|||
16356031|NCT01811732|39790496|FG000|Overall Study|Correct study drug not available on site|1|||
16356032|NCT01811732|39790497|FG001|Overall Study|Correct study drug not available on site|0|||
16356033|NCT01710020|39790498|FG000|Period 1|Protocol Violation|1|||
16356034|NCT00630916|39790499|FG000|Overall Study|Death|110|||
16356035|NCT00630916|39790499|FG000|Overall Study|Explant|8|||
16356036|NCT00630916|39790499|FG000|Overall Study|Lost to Follow-up|5|||
16356037|NCT00630916|39790499|FG000|Overall Study|Withdrawal by Subject|30|||
16356038|NCT00630916|39790499|FG000|Overall Study|Protocol Violation|7|||
16356039|NCT00630916|39790499|FG000|Overall Study|Physician Decision|47|||
16356040|NCT00630916|39790499|FG000|Overall Study|Lack of Efficacy|3|||
16356041|NCT04239924|39790500|FG000|Overall Study|Lost to Follow-up|2|||
16356042|NCT02051296|39790507|FG000|Overall Study|Lost to Follow-up|1|||
16356043|NCT02051296|39790508|FG001|Overall Study|Lost to Follow-up|2|||
16356044|NCT02051296|39790507|FG000|Overall Study|withdraw prior to treatment|7|||
16356045|NCT02051296|39790508|FG001|Overall Study|withdraw prior to treatment|7|||
16356046|NCT02737722|39790511|FG000|Overall Study|Physician Decision|0|||
16356047|NCT02737722|39790512|FG001|Overall Study|Physician Decision|0|||
16356048|NCT02737722|39790513|FG002|Overall Study|Physician Decision|1|||
16356049|NCT02737722|39790514|FG003|Overall Study|Physician Decision|0|||
16356050|NCT01832766|39790518|FG000|Washout|Lost to Follow-up|0|||
16356051|NCT01832766|39790519|FG001|Washout|Lost to Follow-up|1|||
16356052|NCT03238417|39790520|FG000|Overall|non-response|955|||
16356053|NCT03238417|39790521|FG001|Overall|non-response|1920|||
16356054|NCT03238417|39790520|FG000|Overall|partial completion|48|||
16356055|NCT03238417|39790521|FG001|Overall|partial completion|68|||
16356056|NCT03238417|39790520|FG000|Baseline|Partial completion|17|||
16356057|NCT03238417|39790521|FG001|Baseline|Partial completion|48|||
16356058|NCT03238417|39790520|FG000|Baseline|non-response|372|||
16356059|NCT03238417|39790521|FG001|Baseline|non-response|669|||
16356060|NCT03238417|39790520|FG000|12-month|non-response|296|||
16356061|NCT03238417|39790521|FG001|12-month|non-response|669|||
16356062|NCT03238417|39790520|FG000|12-month|partial completion|23|||
16356063|NCT03238417|39790521|FG001|12-month|partial completion|37|||
16356064|NCT03238417|39790520|FG000|24-month|non-response|287|||
16356065|NCT03238417|39790521|FG001|24-month|non-response|594|||
16356066|NCT03238417|39790520|FG000|24-month|partial completion|8|||
16356067|NCT03238417|39790521|FG001|24-month|partial completion|31|||
16356068|NCT02127658|39790522|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
16356069|NCT02127658|39790523|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
16356070|NCT02127658|39790522|FG000|Overall Study|Withdrawal by Subject|0|||
16356071|NCT02127658|39790523|FG001|Overall Study|Withdrawal by Subject|2|||
16356072|NCT02127658|39790522|FG000|Overall Study|Physician Decision|0|||
16356073|NCT02127658|39790523|FG001|Overall Study|Physician Decision|1|||
16356074|NCT02592824|39790527|FG000|Overall Study|Protocol Violation|5|||
16356075|NCT02592824|39790528|FG001|Overall Study|Protocol Violation|3|||
16356076|NCT02592824|39790527|FG000|Overall Study|Lost to Follow-up|2|||
16356077|NCT02592824|39790528|FG001|Overall Study|Lost to Follow-up|1|||
16356078|NCT00983372|39790533|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
16356079|NCT00983372|39790533|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
16356080|NCT00983372|39790533|FG000|Diltiazem ER Alone|Adverse Event|1|||
16356081|NCT01245101|39790534|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
16356082|NCT01245101|39790535|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
16356083|NCT01245101|39790534|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
16356084|NCT01245101|39790535|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
16356085|NCT01245101|39790534|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
16356086|NCT01245101|39790535|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
16356087|NCT03638128|39790538|FG000|Overall Study|Withdrawal by Subject|1|||
16356088|NCT03638128|39790539|FG001|Overall Study|Withdrawal by Subject|7|||
16356089|NCT03638128|39790540|FG002|Overall Study|Withdrawal by Subject|6|||
16356090|NCT03638128|39790538|FG000|Overall Study|Sponsor Decision|15|||
16356091|NCT03638128|39790539|FG001|Overall Study|Sponsor Decision|12|||
16356092|NCT03638128|39790540|FG002|Overall Study|Sponsor Decision|19|||
16356093|NCT03638128|39790538|FG000|Overall Study|Lost to Follow-up|0|||
16356094|NCT03638128|39790539|FG001|Overall Study|Lost to Follow-up|0|||
16356095|NCT03638128|39790540|FG002|Overall Study|Lost to Follow-up|1|||
16356096|NCT00408499|39790541|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
16356097|NCT00408499|39790542|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
16356098|NCT00408499|39790543|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
16356099|NCT00408499|39790544|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
16356100|NCT00408499|39790545|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
16356101|NCT00408499|39790541|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
16356102|NCT00408499|39790542|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
16356103|NCT00408499|39790543|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
16356104|NCT00408499|39790544|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
16356105|NCT00408499|39790545|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
16356106|NCT00408499|39790541|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
16356107|NCT00408499|39790542|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
16356108|NCT00408499|39790543|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
16356109|NCT00408499|39790544|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
16356110|NCT00408499|39790545|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
16356111|NCT00408499|39790541|FG000|Phase II- MTD Expansion|Adverse Event|0|||
16356112|NCT00408499|39790542|FG001|Phase II- MTD Expansion|Adverse Event|0|||
16356113|NCT00408499|39790543|FG002|Phase II- MTD Expansion|Adverse Event|0|||
16356114|NCT00408499|39790544|FG003|Phase II- MTD Expansion|Adverse Event|0|||
16356115|NCT00408499|39790545|FG004|Phase II- MTD Expansion|Adverse Event|9|||
16356116|NCT00408499|39790541|FG000|Phase II- MTD Expansion|Death|0|||
16356117|NCT00408499|39790542|FG001|Phase II- MTD Expansion|Death|0|||
16356118|NCT00408499|39790543|FG002|Phase II- MTD Expansion|Death|0|||
16356119|NCT00408499|39790544|FG003|Phase II- MTD Expansion|Death|0|||
16356120|NCT00408499|39790545|FG004|Phase II- MTD Expansion|Death|2|||
16356121|NCT00408499|39790541|FG000|Phase II- MTD Expansion|Physician Decision|0|||
16356122|NCT00408499|39790542|FG001|Phase II- MTD Expansion|Physician Decision|0|||
16356123|NCT00408499|39790543|FG002|Phase II- MTD Expansion|Physician Decision|0|||
16356124|NCT00408499|39790544|FG003|Phase II- MTD Expansion|Physician Decision|0|||
16356125|NCT00408499|39790545|FG004|Phase II- MTD Expansion|Physician Decision|1|||
16356126|NCT00408499|39790541|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
16356127|NCT00408499|39790542|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
16356128|NCT00408499|39790543|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
16356129|NCT00408499|39790544|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
16356130|NCT00408499|39790545|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
16356131|NCT00408499|39790541|FG000|Phase II- MTD Expansion|treatment delay|0|||
16356132|NCT00408499|39790542|FG001|Phase II- MTD Expansion|treatment delay|0|||
16356133|NCT00408499|39790543|FG002|Phase II- MTD Expansion|treatment delay|0|||
16356134|NCT00408499|39790544|FG003|Phase II- MTD Expansion|treatment delay|0|||
16356135|NCT00408499|39790545|FG004|Phase II- MTD Expansion|treatment delay|3|||
16356136|NCT03964207|39790546|FG000|First Treatment|Withdrawal by Subject|1|||
16356137|NCT03964207|39790547|FG001|First Treatment|Withdrawal by Subject|2|||
16356138|NCT03964207|39790546|FG000|First Treatment|Protocol Violation|1|||
16356139|NCT03964207|39790547|FG001|First Treatment|Protocol Violation|0|||
16356140|NCT03964207|39790546|FG000|First Treatment|Lost to Follow-up|1|||
16356141|NCT03964207|39790547|FG001|First Treatment|Lost to Follow-up|0|||
16356142|NCT03964207|39790546|FG000|Second Treatment|Lost to Follow-up|0|||
16356143|NCT03964207|39790547|FG001|Second Treatment|Lost to Follow-up|1|||
16356144|NCT03964207|39790546|FG000|Second Treatment|Adverse Event|1|||
16356145|NCT03964207|39790547|FG001|Second Treatment|Adverse Event|2|||
16356146|NCT01178294|39790548|FG000|Overall Study|Adverse Event|4|||
16356147|NCT01178294|39790548|FG000|Overall Study|Lost to Follow-up|2|||
16356148|NCT01178294|39790548|FG000|Overall Study|Lack of Efficacy|1|||
16356149|NCT01178294|39790548|FG000|Overall Study|Death|1|||
16356150|NCT01178294|39790548|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
16356151|NCT01178294|39790548|FG000|Overall Study|Subject status is terminal|1|||
16356152|NCT01178294|39790548|FG000|Overall Study|Completion status could not be verified|1|||
16356153|NCT02204917|39790554|FG000|Overall Study|Protocol Violation|1|||
16356154|NCT03093181|39790555|FG000|Overall Study|Withdrawal by Subject|2|||
16356155|NCT03093181|39790556|FG001|Overall Study|Withdrawal by Subject|1|||
16356156|NCT03093181|39790557|FG002|Overall Study|Withdrawal by Subject|2|||
16356157|NCT03093181|39790555|FG000|Overall Study|Other (Not specified)|1|||
16356158|NCT03093181|39790556|FG001|Overall Study|Other (Not specified)|0|||
16418278|NCT02540291|40011812|FG003|Overall Study|Death|7|||
16418279|NCT02540291|40011809|FG000|Overall Study|Lost to Follow-up|0|||
16418280|NCT02540291|40011810|FG001|Overall Study|Lost to Follow-up|0|||
16418281|NCT02540291|40011811|FG002|Overall Study|Lost to Follow-up|1|||
16418282|NCT02540291|40011812|FG003|Overall Study|Lost to Follow-up|0|||
16418283|NCT02540291|40011809|FG000|Overall Study|Withdrawal Of Consent|0|||
16418284|NCT02540291|40011810|FG001|Overall Study|Withdrawal Of Consent|1|||
16418285|NCT02540291|40011811|FG002|Overall Study|Withdrawal Of Consent|0|||
16418286|NCT02540291|40011812|FG003|Overall Study|Withdrawal Of Consent|0|||
16418287|NCT02540291|40011809|FG000|Overall Study|Study Terminated By Sponsor|1|||
16418288|NCT02540291|40011810|FG001|Overall Study|Study Terminated By Sponsor|0|||
16418289|NCT02540291|40011811|FG002|Overall Study|Study Terminated By Sponsor|0|||
16418290|NCT02540291|40011812|FG003|Overall Study|Study Terminated By Sponsor|0|||
16418291|NCT02540291|40011809|FG000|Overall Study|Other|0|||
16418292|NCT02540291|40011810|FG001|Overall Study|Other|0|||
16418293|NCT02540291|40011811|FG002|Overall Study|Other|1|||
16418294|NCT02540291|40011812|FG003|Overall Study|Other|0|||
16418295|NCT01266317|40011819|FG000|Overall Study|Withdrawal by Subject|2|||
16418296|NCT01792518|40011821|FG000|Overall Study|Adverse Event|3|||
16418297|NCT01792518|40011822|FG001|Overall Study|Adverse Event|4|||
16418298|NCT01792518|40011821|FG000|Overall Study|Protocol Violation|0|||
16418299|NCT01792518|40011822|FG001|Overall Study|Protocol Violation|1|||
16418300|NCT01792518|40011821|FG000|Overall Study|Lost to Follow-up|3|||
16418301|NCT01792518|40011822|FG001|Overall Study|Lost to Follow-up|1|||
16418302|NCT01792518|40011821|FG000|Overall Study|Withdrawal by Subject|2|||
16418303|NCT01792518|40011822|FG001|Overall Study|Withdrawal by Subject|0|||
16356159|NCT03093181|39790557|FG002|Overall Study|Other (Not specified)|0|||
16356160|NCT03093181|39790555|FG000|Overall Study|Adverse Event|0|||
16356161|NCT03093181|39790556|FG001|Overall Study|Adverse Event|1|||
16356162|NCT03093181|39790557|FG002|Overall Study|Adverse Event|0|||
16356163|NCT03093181|39790555|FG000|Overall Study|Other (Protocol violation)|0|||
16356164|NCT03093181|39790556|FG001|Overall Study|Other (Protocol violation)|0|||
16356165|NCT03093181|39790557|FG002|Overall Study|Other (Protocol violation)|1|||
16356166|NCT01405560|39790558|FG000|Overall Study|Physician Decision|1|||
16356167|NCT00830219|39790559|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16356168|NCT00830219|39790560|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
16356169|NCT00739648|39790561|FG000|Overall Study|Adverse Event|3|||
16356170|NCT00739648|39790562|FG001|Overall Study|Adverse Event|15|||
16356171|NCT00739648|39790561|FG000|Overall Study|Withdrawal by Subject|13|||
16356172|NCT00739648|39790562|FG001|Overall Study|Withdrawal by Subject|25|||
16356173|NCT00739648|39790561|FG000|Overall Study|Lost to Follow-up|4|||
16356174|NCT00739648|39790562|FG001|Overall Study|Lost to Follow-up|7|||
16418304|NCT01792518|40011821|FG000|Overall Study|Other Reason|0|||
16356175|NCT00739648|39790561|FG000|Overall Study|Death|2|||
16356176|NCT00739648|39790562|FG001|Overall Study|Death|0|||
16356177|NCT00739648|39790561|FG000|Overall Study|Do not know|4|||
16356178|NCT00739648|39790562|FG001|Overall Study|Do not know|6|||
16356179|NCT00731822|39790563|FG000|Overall Study|Adverse Event|2|||
16356180|NCT00731822|39790564|FG001|Overall Study|Adverse Event|1|||
16356181|NCT00731822|39790563|FG000|Overall Study|Protocol Violation|1|||
16356182|NCT00731822|39790564|FG001|Overall Study|Protocol Violation|0|||
16356183|NCT00731822|39790563|FG000|Overall Study|Lost to Follow-up|1|||
16356184|NCT00731822|39790564|FG001|Overall Study|Lost to Follow-up|0|||
16356185|NCT00171249|39790565|FG000|Overall Study|Withdrawal by Subject|2|||
16356186|NCT00171249|39790566|FG001|Overall Study|Withdrawal by Subject|0|||
16356187|NCT00171249|39790567|FG002|Overall Study|Withdrawal by Subject|0|||
16356188|NCT00171249|39790568|FG003|Overall Study|Withdrawal by Subject|6|||
16356189|NCT00171249|39790569|FG004|Overall Study|Withdrawal by Subject|0|||
16356190|NCT00171249|39790570|FG005|Overall Study|Withdrawal by Subject|0|||
16356191|NCT00171249|39790571|FG006|Overall Study|Withdrawal by Subject|0|||
16356192|NCT00171249|39790565|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
16356193|NCT00171249|39790566|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16356194|NCT00171249|39790567|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
16356195|NCT00171249|39790568|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
16356196|NCT00171249|39790569|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16356197|NCT00171249|39790570|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
16356198|NCT00171249|39790571|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
16418305|NCT01792518|40011822|FG001|Overall Study|Other Reason|1|||
16247923|NCT03567057|39391660|FG002|Overall Study|Physician Decision|0|||
16418310|NCT02879578|40011827|FG000|Overall Study|Adverse Event|1|||
16356199|NCT00171249|39790565|FG000|Overall Study|Death|7|||
16356200|NCT00171249|39790566|FG001|Overall Study|Death|1|||
16356201|NCT00171249|39790567|FG002|Overall Study|Death|0|||
16356202|NCT00171249|39790568|FG003|Overall Study|Death|4|||
16418311|NCT02879578|40011828|FG001|Overall Study|Adverse Event|2|||
16356203|NCT00171249|39790569|FG004|Overall Study|Death|0|||
16356204|NCT00171249|39790570|FG005|Overall Study|Death|3|||
16356205|NCT00171249|39790571|FG006|Overall Study|Death|1|||
16356206|NCT00171249|39790565|FG000|Overall Study|Other|10|||
16356207|NCT00171249|39790566|FG001|Overall Study|Other|0|||
16356208|NCT00171249|39790567|FG002|Overall Study|Other|0|||
16356209|NCT00171249|39790568|FG003|Overall Study|Other|43|||
16356210|NCT00171249|39790569|FG004|Overall Study|Other|0|||
16356211|NCT00171249|39790570|FG005|Overall Study|Other|2|||
16356212|NCT00171249|39790571|FG006|Overall Study|Other|0|||
16356213|NCT00171249|39790565|FG000|Overall Study|No Longer Requires Study Drug|4|||
16356214|NCT00171249|39790566|FG001|Overall Study|No Longer Requires Study Drug|0|||
16356215|NCT00171249|39790567|FG002|Overall Study|No Longer Requires Study Drug|0|||
16356216|NCT00171249|39790568|FG003|Overall Study|No Longer Requires Study Drug|3|||
16356217|NCT00171249|39790569|FG004|Overall Study|No Longer Requires Study Drug|0|||
16356218|NCT00171249|39790570|FG005|Overall Study|No Longer Requires Study Drug|5|||
16356219|NCT00171249|39790571|FG006|Overall Study|No Longer Requires Study Drug|0|||
16356220|NCT00171249|39790565|FG000|Overall Study|Administrative Problems|1|||
16356221|NCT00171249|39790566|FG001|Overall Study|Administrative Problems|0|||
16356222|NCT00171249|39790567|FG002|Overall Study|Administrative Problems|0|||
16356223|NCT00171249|39790568|FG003|Overall Study|Administrative Problems|2|||
16356224|NCT00171249|39790569|FG004|Overall Study|Administrative Problems|0|||
16356225|NCT00171249|39790570|FG005|Overall Study|Administrative Problems|0|||
16356226|NCT00171249|39790571|FG006|Overall Study|Administrative Problems|0|||
16356227|NCT00171249|39790565|FG000|Overall Study|Adverse Event|3|||
16356228|NCT00171249|39790566|FG001|Overall Study|Adverse Event|1|||
16356229|NCT00171249|39790567|FG002|Overall Study|Adverse Event|0|||
16356230|NCT00171249|39790568|FG003|Overall Study|Adverse Event|15|||
16356231|NCT00171249|39790569|FG004|Overall Study|Adverse Event|0|||
16356232|NCT00171249|39790570|FG005|Overall Study|Adverse Event|2|||
16356233|NCT00171249|39790571|FG006|Overall Study|Adverse Event|0|||
16356234|NCT00171249|39790565|FG000|Overall Study|Lost to Follow-up|5|||
16356235|NCT00171249|39790566|FG001|Overall Study|Lost to Follow-up|0|||
16356236|NCT00171249|39790567|FG002|Overall Study|Lost to Follow-up|0|||
16356237|NCT00171249|39790568|FG003|Overall Study|Lost to Follow-up|9|||
16356238|NCT00171249|39790569|FG004|Overall Study|Lost to Follow-up|0|||
16356239|NCT00171249|39790570|FG005|Overall Study|Lost to Follow-up|0|||
16356240|NCT00171249|39790571|FG006|Overall Study|Lost to Follow-up|0|||
16356241|NCT01033136|39790576|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
16356242|NCT01033136|39790577|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
16356243|NCT00848497|39790582|FG000|Overall Study|Screen failure|2|||
16356244|NCT00848497|39790583|FG001|Overall Study|Screen failure|0|||
16356245|NCT00848497|39790582|FG000|Overall Study|Withdrawal by Subject|0|||
16356246|NCT00848497|39790583|FG001|Overall Study|Withdrawal by Subject|1|||
16356247|NCT01274533|39790588|FG000|Overall Study|Withdrawal by Subject|1|||
16356248|NCT01274533|39790588|FG000|Overall Study|Non-compliance|1|||
16356249|NCT01274533|39790588|FG000|Overall Study|Disease progression|2|||
16356250|NCT00106002|39790589|FG000|Overall Study|Did not take any study drug|1|||
16356251|NCT00106002|39790589|FG000|Overall Study|Ineligible after Registration|1|||
16356252|NCT03435055|39790590|FG000|Screening|Physician Decision|2|||
16356253|NCT03435055|39790590|FG000|Received Intervention|Did not complete nitrous administration|3|||
16356254|NCT03191552|39790591|FG000|Overall Study|Lost to Follow-up|1|||
16356255|NCT03191552|39790592|FG001|Overall Study|Lost to Follow-up|0|||
16356256|NCT03191552|39790593|FG002|Overall Study|Lost to Follow-up|0|||
16356257|NCT03191552|39790591|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
16356258|NCT03191552|39790592|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
16356259|NCT03191552|39790593|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
16356260|NCT01900444|39790602|FG000|Overall Study|Protocol Violation|2|||
16356261|NCT01900444|39790602|FG000|Overall Study|Lost to Follow-up|1|||
16356262|NCT03470922|39790603|FG000|Overall Study|Death|107|||
16356263|NCT03470922|39790604|FG001|Overall Study|Death|118|||
16356264|NCT03470922|39790603|FG000|Overall Study|Lost to Follow-up|5|||
16356265|NCT03470922|39790604|FG001|Overall Study|Lost to Follow-up|5|||
16356266|NCT03470922|39790603|FG000|Overall Study|Participant Withdrew Consent|4|||
16356267|NCT03470922|39790604|FG001|Overall Study|Participant Withdrew Consent|9|||
16356268|NCT03470922|39790603|FG000|Overall Study|Other reasons|1|||
16356269|NCT03470922|39790604|FG001|Overall Study|Other reasons|0|||
16356270|NCT03470922|39790603|FG000|Overall Study|Not reported|1|||
16356271|NCT03470922|39790604|FG001|Overall Study|Not reported|0|||
16356272|NCT01787552|39790605|FG000|Overall Study|Withdrawal by Subject|2|||
16356273|NCT01787552|39790606|FG001|Overall Study|Withdrawal by Subject|0|||
16356274|NCT01787552|39790607|FG002|Overall Study|Withdrawal by Subject|0|||
16356275|NCT01787552|39790608|FG003|Overall Study|Withdrawal by Subject|4|||
16356276|NCT01787552|39790605|FG000|Overall Study|Physician Decision|2|||
16356277|NCT01787552|39790606|FG001|Overall Study|Physician Decision|2|||
16356278|NCT01787552|39790607|FG002|Overall Study|Physician Decision|1|||
16356279|NCT01787552|39790608|FG003|Overall Study|Physician Decision|2|||
16356280|NCT01787552|39790605|FG000|Overall Study|Death|0|||
16418312|NCT02879578|40011829|FG002|Overall Study|Adverse Event|14|||
16418313|NCT02879578|40011827|FG000|Overall Study|Protocol Violation|0|||
16418314|NCT02879578|40011828|FG001|Overall Study|Protocol Violation|1|||
16418315|NCT02879578|40011829|FG002|Overall Study|Protocol Violation|1|||
16418316|NCT02879578|40011827|FG000|Overall Study|Withdrawal by Subject|8|||
16356281|NCT01787552|39790606|FG001|Overall Study|Death|0|||
16356282|NCT01787552|39790607|FG002|Overall Study|Death|0|||
16356283|NCT01787552|39790608|FG003|Overall Study|Death|1|||
16356284|NCT01787552|39790605|FG000|Overall Study|Adverse Event|2|||
16356285|NCT01787552|39790606|FG001|Overall Study|Adverse Event|5|||
16356286|NCT01787552|39790607|FG002|Overall Study|Adverse Event|2|||
16356287|NCT01787552|39790608|FG003|Overall Study|Adverse Event|16|||
16356288|NCT01787552|39790605|FG000|Overall Study|Study terminated by Sponsor|0|||
16356289|NCT01787552|39790606|FG001|Overall Study|Study terminated by Sponsor|0|||
16356290|NCT01787552|39790607|FG002|Overall Study|Study terminated by Sponsor|1|||
16561789|NCT00495469|40525194|FG001|Overall Study|Withdrawal by Subject|3|||
16561790|NCT00495469|40525195|FG002|Overall Study|Withdrawal by Subject|1|||
16561791|NCT00495469|40525196|FG003|Overall Study|Withdrawal by Subject|3|||
16561792|NCT00495469|40525197|FG004|Overall Study|Withdrawal by Subject|3|||
16561793|NCT00495469|40525198|FG005|Overall Study|Withdrawal by Subject|2|||
16561794|NCT00495469|40525199|FG006|Overall Study|Withdrawal by Subject|3|||
16356291|NCT01787552|39790608|FG003|Overall Study|Study terminated by Sponsor|3|||
16356292|NCT01787552|39790605|FG000|Overall Study|Progressive Disease|2|||
16356293|NCT01787552|39790606|FG001|Overall Study|Progressive Disease|2|||
16418317|NCT02879578|40011828|FG001|Overall Study|Withdrawal by Subject|6|||
16418318|NCT02879578|40011829|FG002|Overall Study|Withdrawal by Subject|9|||
16418319|NCT02879578|40011827|FG000|Overall Study|Lost to Follow-up|1|||
16418320|NCT02879578|40011828|FG001|Overall Study|Lost to Follow-up|0|||
16418321|NCT02879578|40011829|FG002|Overall Study|Lost to Follow-up|4|||
16418322|NCT02879578|40011827|FG000|Overall Study|Physician Decision|0|||
16418323|NCT02879578|40011828|FG001|Overall Study|Physician Decision|0|||
16418324|NCT02879578|40011829|FG002|Overall Study|Physician Decision|4|||
16418325|NCT00470418|40011830|FG000|Overall Study|Withdrawal by Subject|1|||
16418326|NCT00470418|40011831|FG001|Overall Study|Withdrawal by Subject|0|||
16418327|NCT02915978|40011832|FG000|Overall Study|Adverse Event|2|||
16418328|NCT02915978|40011833|FG001|Overall Study|Adverse Event|1|||
16418329|NCT02915978|40011834|FG002|Overall Study|Adverse Event|0|||
16418330|NCT00902174|40011835|FG000|Overall Study|Adverse Event|27|||
16418331|NCT00902174|40011836|FG001|Overall Study|Adverse Event|7|||
16418332|NCT00902174|40011835|FG000|Overall Study|Lack of Efficacy|1|||
16418333|NCT00902174|40011836|FG001|Overall Study|Lack of Efficacy|5|||
16418334|NCT00902174|40011835|FG000|Overall Study|Death|2|||
16418335|NCT00902174|40011836|FG001|Overall Study|Death|2|||
16418336|NCT00902174|40011835|FG000|Overall Study|Withdrawal by Subject|2|||
16418337|NCT00902174|40011836|FG001|Overall Study|Withdrawal by Subject|1|||
16418338|NCT00902174|40011835|FG000|Overall Study|Abnormal labs|1|||
16418339|NCT00902174|40011836|FG001|Overall Study|Abnormal labs|1|||
16418340|NCT00902174|40011835|FG000|Overall Study|Protocol Violation|1|||
16418341|NCT00902174|40011836|FG001|Overall Study|Protocol Violation|1|||
16418342|NCT00902174|40011835|FG000|Overall Study|Administration problem|0|||
16418343|NCT00902174|40011836|FG001|Overall Study|Administration problem|1|||
16418344|NCT00095173|40011837|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
16418345|NCT00095173|40011838|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
16418346|NCT00095173|40011839|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
16418347|NCT00095173|40011840|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
16418348|NCT00095173|40011841|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
16561795|NCT00495469|40525193|FG000|Overall Study|Lack of Efficacy|0|||
16561796|NCT00495469|40525194|FG001|Overall Study|Lack of Efficacy|0|||
16561797|NCT00495469|40525195|FG002|Overall Study|Lack of Efficacy|0|||
16561798|NCT00495469|40525196|FG003|Overall Study|Lack of Efficacy|0|||
16561799|NCT00495469|40525197|FG004|Overall Study|Lack of Efficacy|0|||
16561800|NCT00495469|40525198|FG005|Overall Study|Lack of Efficacy|0|||
16561801|NCT00495469|40525199|FG006|Overall Study|Lack of Efficacy|1|||
16247924|NCT03567057|39391658|FG000|Overall Study|Unstable medical condition|1|||
16247925|NCT03567057|39391659|FG001|Overall Study|Unstable medical condition|0|||
16247926|NCT03567057|39391660|FG002|Overall Study|Unstable medical condition|0|||
16247927|NCT03567057|39391658|FG000|Overall Study|Medical history event|0|||
16247928|NCT03567057|39391659|FG001|Overall Study|Medical history event|0|||
16247929|NCT03567057|39391660|FG002|Overall Study|Medical history event|1|||
16247930|NCT03567057|39391658|FG000|Overall Study|Other|0|||
16418349|NCT00095173|40011842|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
16561802|NCT00495469|40525193|FG000|Overall Study|Liver function test abnormality|0|||
16561803|NCT00495469|40525194|FG001|Overall Study|Liver function test abnormality|1|||
16561804|NCT00495469|40525195|FG002|Overall Study|Liver function test abnormality|0|||
16356294|NCT01787552|39790607|FG002|Overall Study|Progressive Disease|1|||
16356295|NCT01787552|39790608|FG003|Overall Study|Progressive Disease|1|||
16418350|NCT00095173|40011837|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
16418351|NCT00095173|40011838|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
16356296|NCT03409744|39790609|FG000|Overall Study|Death|2|||
16356297|NCT03409744|39790609|FG000|Overall Study|Physician Decision|5|||
16356298|NCT03409744|39790609|FG000|Overall Study|Pregnancy|1|||
16356299|NCT03409744|39790609|FG000|Overall Study|Lost to Follow-up|1|||
16356300|NCT03409744|39790609|FG000|Overall Study|Protocol Violation|1|||
16356301|NCT03176771|39790610|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
16356302|NCT03176771|39790611|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
16356303|NCT03176771|39790612|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
16356304|NCT03176771|39790613|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
16356305|NCT03176771|39790614|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
16356306|NCT03176771|39790610|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
16356307|NCT03176771|39790611|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
16356308|NCT03176771|39790612|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
16356309|NCT03176771|39790613|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
16356310|NCT03176771|39790614|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
16356311|NCT03176771|39790610|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
16356312|NCT03176771|39790611|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
16356313|NCT03176771|39790612|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
16356314|NCT03176771|39790613|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
16356315|NCT03176771|39790614|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
16356316|NCT03176771|39790610|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
16356317|NCT03176771|39790611|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
16356318|NCT03176771|39790612|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
16356319|NCT03176771|39790613|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
16356320|NCT03176771|39790614|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
16356321|NCT03176771|39790610|FG000|Double-Blind Extension Period|Adverse Event|0|||
16356322|NCT03176771|39790611|FG001|Double-Blind Extension Period|Adverse Event|0|||
16356323|NCT03176771|39790612|FG002|Double-Blind Extension Period|Adverse Event|0|||
16356324|NCT03176771|39790613|FG003|Double-Blind Extension Period|Adverse Event|15|||
16356325|NCT03176771|39790614|FG004|Double-Blind Extension Period|Adverse Event|18|||
16356326|NCT03176771|39790610|FG000|Double-Blind Extension Period|Death|0|||
16356327|NCT03176771|39790611|FG001|Double-Blind Extension Period|Death|0|||
16356328|NCT03176771|39790612|FG002|Double-Blind Extension Period|Death|0|||
16356329|NCT03176771|39790613|FG003|Double-Blind Extension Period|Death|3|||
16356330|NCT03176771|39790614|FG004|Double-Blind Extension Period|Death|4|||
16356331|NCT03176771|39790610|FG000|Double-Blind Extension Period|Physician Decision|0|||
16356332|NCT03176771|39790611|FG001|Double-Blind Extension Period|Physician Decision|0|||
16356333|NCT03176771|39790612|FG002|Double-Blind Extension Period|Physician Decision|0|||
16356334|NCT03176771|39790613|FG003|Double-Blind Extension Period|Physician Decision|3|||
16356335|NCT03176771|39790614|FG004|Double-Blind Extension Period|Physician Decision|1|||
16356336|NCT03176771|39790610|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
16356337|NCT03176771|39790611|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
16356338|NCT03176771|39790612|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
16356339|NCT03176771|39790613|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
16356340|NCT03176771|39790614|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
16356341|NCT01162343|39790617|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
16356342|NCT01162343|39790617|FG000|Overall Study|Refused psychiatrist assessment|12|||
16356343|NCT03353220|39790618|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
16356344|NCT03353220|39790619|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
16356345|NCT02736617|39790620|FG000|Treatment|Adverse Event|1|||
16356346|NCT02736617|39790620|FG000|Treatment|Lack of Efficacy|1|||
16356347|NCT02736617|39790620|FG000|Treatment|Withdrawal by Subject|1|||
16356348|NCT02736617|39790620|FG000|Maintenance|Lack of Efficacy|4|||
16356349|NCT02736617|39790620|FG000|Maintenance|Physician Decision|1|||
16356350|NCT03713281|39790623|FG000|Overall Study|Lens handling difficuluties|2|||
16356351|NCT03713281|39790623|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
16356352|NCT03363906|39790625|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
16356353|NCT03363906|39790626|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
16356354|NCT03363906|39790625|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
16356355|NCT03363906|39790626|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
16356356|NCT03363906|39790625|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
16356357|NCT03363906|39790626|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
16356358|NCT03363906|39790625|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
16356359|NCT03363906|39790626|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
16418352|NCT00095173|40011839|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
16356360|NCT02683109|39790627|FG000|Overall Study|Adverse Event|1|||
16356361|NCT02683109|39790628|FG001|Overall Study|Adverse Event|0|||
16356362|NCT01192178|39790629|FG000|Overall Study|Withdrawal by Subject|6|||
16356363|NCT01192178|39790630|FG001|Overall Study|Withdrawal by Subject|10|||
16356364|NCT01192178|39790629|FG000|Overall Study|Protocol Violation|10|||
16356365|NCT01192178|39790630|FG001|Overall Study|Protocol Violation|3|||
16356366|NCT01192178|39790629|FG000|Overall Study|Physician Decision|2|||
16356367|NCT01192178|39790630|FG001|Overall Study|Physician Decision|4|||
16356368|NCT01192178|39790629|FG000|Overall Study|Lost to Follow-up|3|||
16356369|NCT01192178|39790630|FG001|Overall Study|Lost to Follow-up|3|||
16356370|NCT01192178|39790629|FG000|Overall Study|Adverse Event|2|||
16356371|NCT01192178|39790630|FG001|Overall Study|Adverse Event|1|||
16356372|NCT01192178|39790629|FG000|Overall Study|Lack of Efficacy|1|||
16356373|NCT01192178|39790630|FG001|Overall Study|Lack of Efficacy|2|||
16356374|NCT02499328|39790632|FG000|Overall Study|Withdrawal by Subject|1|||
16356375|NCT02499328|39790633|FG001|Overall Study|Withdrawal by Subject|1|||
16356376|NCT02499328|39790634|FG002|Overall Study|Withdrawal by Subject|5|||
16356377|NCT02499328|39790635|FG003|Overall Study|Withdrawal by Subject|3|||
16356378|NCT02499328|39790636|FG004|Overall Study|Withdrawal by Subject|5|||
16356379|NCT02499328|39790637|FG005|Overall Study|Withdrawal by Subject|0|||
16356380|NCT02499328|39790638|FG006|Overall Study|Withdrawal by Subject|0|||
16356381|NCT02499328|39790639|FG007|Overall Study|Withdrawal by Subject|0|||
16356382|NCT02499328|39790640|FG008|Overall Study|Withdrawal by Subject|2|||
16356383|NCT02499328|39790641|FG009|Overall Study|Withdrawal by Subject|2|||
16356384|NCT02499328|39790642|FG010|Overall Study|Withdrawal by Subject|0|||
16356385|NCT02499328|39790643|FG011|Overall Study|Withdrawal by Subject|3|||
16356386|NCT02499328|39790644|FG012|Overall Study|Withdrawal by Subject|7|||
16356387|NCT02499328|39790645|FG013|Overall Study|Withdrawal by Subject|3|||
16356388|NCT02499328|39790646|FG014|Overall Study|Withdrawal by Subject|1|||
16356389|NCT02499328|39790647|FG015|Overall Study|Withdrawal by Subject|0|||
16356390|NCT02499328|39790648|FG016|Overall Study|Withdrawal by Subject|0|||
16356391|NCT02499328|39790649|FG017|Overall Study|Withdrawal by Subject|3|||
16356392|NCT02499328|39790650|FG018|Overall Study|Withdrawal by Subject|0|||
16356393|NCT02499328|39790632|FG000|Overall Study|Lost to Follow-up|0|||
16356394|NCT02499328|39790633|FG001|Overall Study|Lost to Follow-up|1|||
16356395|NCT02499328|39790634|FG002|Overall Study|Lost to Follow-up|1|||
16356396|NCT02499328|39790635|FG003|Overall Study|Lost to Follow-up|2|||
16356397|NCT02499328|39790636|FG004|Overall Study|Lost to Follow-up|0|||
16356398|NCT02499328|39790637|FG005|Overall Study|Lost to Follow-up|0|||
16356399|NCT02499328|39790638|FG006|Overall Study|Lost to Follow-up|0|||
16356400|NCT02499328|39790639|FG007|Overall Study|Lost to Follow-up|2|||
16356401|NCT02499328|39790640|FG008|Overall Study|Lost to Follow-up|3|||
16356402|NCT02499328|39790641|FG009|Overall Study|Lost to Follow-up|0|||
16356403|NCT02499328|39790642|FG010|Overall Study|Lost to Follow-up|0|||
16356404|NCT02499328|39790643|FG011|Overall Study|Lost to Follow-up|0|||
16356405|NCT02499328|39790644|FG012|Overall Study|Lost to Follow-up|0|||
16356406|NCT02499328|39790645|FG013|Overall Study|Lost to Follow-up|0|||
16356407|NCT02499328|39790646|FG014|Overall Study|Lost to Follow-up|0|||
16356408|NCT02499328|39790647|FG015|Overall Study|Lost to Follow-up|0|||
16356409|NCT02499328|39790648|FG016|Overall Study|Lost to Follow-up|0|||
16356410|NCT02499328|39790649|FG017|Overall Study|Lost to Follow-up|0|||
16356411|NCT02499328|39790650|FG018|Overall Study|Lost to Follow-up|1|||
16356412|NCT02499328|39790632|FG000|Overall Study|Death|0|||
16356413|NCT02499328|39790633|FG001|Overall Study|Death|3|||
16356414|NCT02499328|39790634|FG002|Overall Study|Death|3|||
16356415|NCT02499328|39790635|FG003|Overall Study|Death|2|||
16356416|NCT02499328|39790636|FG004|Overall Study|Death|4|||
16356417|NCT02499328|39790637|FG005|Overall Study|Death|7|||
16356418|NCT02499328|39790638|FG006|Overall Study|Death|3|||
16356419|NCT02499328|39790639|FG007|Overall Study|Death|0|||
16356420|NCT02499328|39790640|FG008|Overall Study|Death|2|||
16356421|NCT02499328|39790641|FG009|Overall Study|Death|6|||
16356422|NCT02499328|39790642|FG010|Overall Study|Death|6|||
16356423|NCT02499328|39790643|FG011|Overall Study|Death|20|||
16356424|NCT02499328|39790644|FG012|Overall Study|Death|9|||
16356425|NCT02499328|39790645|FG013|Overall Study|Death|7|||
16356426|NCT02499328|39790646|FG014|Overall Study|Death|3|||
16356427|NCT02499328|39790647|FG015|Overall Study|Death|1|||
16356428|NCT02499328|39790648|FG016|Overall Study|Death|1|||
16356429|NCT02499328|39790649|FG017|Overall Study|Death|16|||
16356430|NCT02499328|39790650|FG018|Overall Study|Death|5|||
16356431|NCT02499328|39790632|FG000|Overall Study|"Other"|2|||
16356432|NCT02499328|39790633|FG001|Overall Study|"Other"|2|||
16356433|NCT02499328|39790634|FG002|Overall Study|"Other"|1|||
16356434|NCT02499328|39790635|FG003|Overall Study|"Other"|3|||
16356435|NCT02499328|39790636|FG004|Overall Study|"Other"|6|||
16356436|NCT02499328|39790637|FG005|Overall Study|"Other"|2|||
16356437|NCT02499328|39790638|FG006|Overall Study|"Other"|3|||
16356438|NCT02499328|39790639|FG007|Overall Study|"Other"|4|||
16356439|NCT02499328|39790640|FG008|Overall Study|"Other"|6|||
16356440|NCT02499328|39790641|FG009|Overall Study|"Other"|16|||
16356441|NCT02499328|39790642|FG010|Overall Study|"Other"|13|||
16356442|NCT02499328|39790643|FG011|Overall Study|"Other"|31|||
16356443|NCT02499328|39790644|FG012|Overall Study|"Other"|8|||
16356444|NCT02499328|39790645|FG013|Overall Study|"Other"|7|||
16356445|NCT02499328|39790646|FG014|Overall Study|"Other"|6|||
16356446|NCT02499328|39790647|FG015|Overall Study|"Other"|0|||
16356447|NCT02499328|39790648|FG016|Overall Study|"Other"|0|||
16356448|NCT02499328|39790649|FG017|Overall Study|"Other"|34|||
16356449|NCT02499328|39790650|FG018|Overall Study|"Other"|43|||
16356450|NCT02499328|39790632|FG000|Overall Study|Disease Progression|0|||
16356451|NCT02499328|39790633|FG001|Overall Study|Disease Progression|0|||
16356452|NCT02499328|39790634|FG002|Overall Study|Disease Progression|0|||
16356453|NCT02499328|39790635|FG003|Overall Study|Disease Progression|0|||
16356454|NCT02499328|39790636|FG004|Overall Study|Disease Progression|0|||
16356455|NCT02499328|39790637|FG005|Overall Study|Disease Progression|0|||
16356456|NCT02499328|39790638|FG006|Overall Study|Disease Progression|1|||
16356457|NCT02499328|39790639|FG007|Overall Study|Disease Progression|0|||
16356458|NCT02499328|39790640|FG008|Overall Study|Disease Progression|1|||
16356459|NCT02499328|39790641|FG009|Overall Study|Disease Progression|0|||
16356460|NCT02499328|39790642|FG010|Overall Study|Disease Progression|1|||
16356461|NCT02499328|39790643|FG011|Overall Study|Disease Progression|0|||
16356462|NCT02499328|39790644|FG012|Overall Study|Disease Progression|0|||
16356463|NCT02499328|39790645|FG013|Overall Study|Disease Progression|0|||
16356464|NCT02499328|39790646|FG014|Overall Study|Disease Progression|0|||
16356465|NCT02499328|39790647|FG015|Overall Study|Disease Progression|0|||
16356466|NCT02499328|39790648|FG016|Overall Study|Disease Progression|0|||
16356467|NCT02499328|39790649|FG017|Overall Study|Disease Progression|2|||
16356468|NCT02499328|39790650|FG018|Overall Study|Disease Progression|0|||
16356469|NCT02499328|39790632|FG000|Overall Study|Adverse Event|1|||
16356470|NCT02499328|39790633|FG001|Overall Study|Adverse Event|0|||
16356471|NCT02499328|39790634|FG002|Overall Study|Adverse Event|0|||
16356472|NCT02499328|39790635|FG003|Overall Study|Adverse Event|1|||
16356473|NCT02499328|39790636|FG004|Overall Study|Adverse Event|0|||
16356474|NCT02499328|39790637|FG005|Overall Study|Adverse Event|0|||
16356475|NCT02499328|39790638|FG006|Overall Study|Adverse Event|0|||
16356476|NCT02499328|39790639|FG007|Overall Study|Adverse Event|0|||
16356477|NCT02499328|39790640|FG008|Overall Study|Adverse Event|0|||
16356478|NCT02499328|39790641|FG009|Overall Study|Adverse Event|0|||
16356479|NCT02499328|39790642|FG010|Overall Study|Adverse Event|0|||
16356480|NCT02499328|39790643|FG011|Overall Study|Adverse Event|0|||
16356481|NCT02499328|39790644|FG012|Overall Study|Adverse Event|1|||
16356482|NCT02499328|39790645|FG013|Overall Study|Adverse Event|0|||
16356483|NCT02499328|39790646|FG014|Overall Study|Adverse Event|0|||
16356484|NCT02499328|39790647|FG015|Overall Study|Adverse Event|0|||
16356485|NCT02499328|39790648|FG016|Overall Study|Adverse Event|0|||
16356486|NCT02499328|39790649|FG017|Overall Study|Adverse Event|0|||
16356487|NCT02499328|39790650|FG018|Overall Study|Adverse Event|0|||
16356488|NCT00266708|39790653|FG000|Overall Study|No renal function|1|||
16356489|NCT00266708|39790654|FG001|Overall Study|No renal function|1|||
16356490|NCT00266708|39790653|FG000|Overall Study|Refused biopsy|3|||
16356491|NCT00266708|39790654|FG001|Overall Study|Refused biopsy|6|||
16356492|NCT00266708|39790653|FG000|Overall Study|Asthma|0|||
16356493|NCT00266708|39790654|FG001|Overall Study|Asthma|2|||
16356494|NCT03533751|39790662|FG000|Overall Study|Withdrawal by Subject|12|||
16356495|NCT03533751|39790663|FG001|Overall Study|Withdrawal by Subject|6|||
16356496|NCT03533751|39790664|FG002|Overall Study|Withdrawal by Subject|11|||
16356497|NCT03533751|39790665|FG003|Overall Study|Withdrawal by Subject|9|||
16356498|NCT03533751|39790666|FG004|Overall Study|Withdrawal by Subject|10|||
16356499|NCT03533751|39790662|FG000|Overall Study|Adverse Event|4|||
16356500|NCT03533751|39790663|FG001|Overall Study|Adverse Event|7|||
16356501|NCT03533751|39790664|FG002|Overall Study|Adverse Event|2|||
16356502|NCT03533751|39790665|FG003|Overall Study|Adverse Event|4|||
16356503|NCT03533751|39790666|FG004|Overall Study|Adverse Event|5|||
16356504|NCT03533751|39790662|FG000|Overall Study|Physician Decision|0|||
16356505|NCT03533751|39790663|FG001|Overall Study|Physician Decision|2|||
16356506|NCT03533751|39790664|FG002|Overall Study|Physician Decision|1|||
16356507|NCT03533751|39790665|FG003|Overall Study|Physician Decision|2|||
16356508|NCT03533751|39790666|FG004|Overall Study|Physician Decision|1|||
16356509|NCT03533751|39790662|FG000|Overall Study|Sponsor Decision|0|||
16356510|NCT03533751|39790663|FG001|Overall Study|Sponsor Decision|0|||
16356511|NCT03533751|39790664|FG002|Overall Study|Sponsor Decision|1|||
16356512|NCT03533751|39790665|FG003|Overall Study|Sponsor Decision|1|||
16356513|NCT03533751|39790666|FG004|Overall Study|Sponsor Decision|0|||
16356514|NCT03533751|39790662|FG000|Overall Study|Lost to Follow-up|3|||
16356515|NCT03533751|39790663|FG001|Overall Study|Lost to Follow-up|7|||
16356516|NCT03533751|39790664|FG002|Overall Study|Lost to Follow-up|6|||
16356517|NCT03533751|39790665|FG003|Overall Study|Lost to Follow-up|4|||
16356518|NCT03533751|39790666|FG004|Overall Study|Lost to Follow-up|3|||
16356519|NCT03533751|39790662|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
16247931|NCT03567057|39391659|FG001|Overall Study|Other|0|||
16247932|NCT03567057|39391660|FG002|Overall Study|Other|1|||
16247933|NCT04820842|39391661|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
16247934|NCT04820842|39391662|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
16247935|NCT04820842|39391663|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
16247936|NCT04820842|39391664|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
16247937|NCT04820842|39391665|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
16247938|NCT04820842|39391666|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
16247939|NCT04820842|39391667|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
16247940|NCT04820842|39391661|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
16247941|NCT04820842|39391662|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
16247942|NCT04820842|39391663|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
16356520|NCT03533751|39790663|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
16356521|NCT03533751|39790664|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
16356522|NCT03533751|39790665|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
16356523|NCT03533751|39790666|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
16356524|NCT03533751|39790662|FG000|Overall Study|Other|0|||
16356525|NCT03533751|39790663|FG001|Overall Study|Other|2|||
16418353|NCT00095173|40011840|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
16418354|NCT00095173|40011841|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
16418355|NCT00095173|40011842|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
16418356|NCT00095173|40011837|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
16418357|NCT00095173|40011838|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
16418358|NCT00095173|40011839|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
16418359|NCT00095173|40011840|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
16418360|NCT00095173|40011841|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
16418361|NCT00095173|40011842|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
16418362|NCT00095173|40011837|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
16418363|NCT00095173|40011838|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
16418364|NCT00095173|40011839|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
16418365|NCT00095173|40011840|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
16418366|NCT00095173|40011841|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
16418367|NCT00095173|40011842|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
16418368|NCT00095173|40011837|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
16418369|NCT00095173|40011838|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
16418370|NCT00095173|40011839|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
16418371|NCT00095173|40011840|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
16418372|NCT00095173|40011841|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
16561805|NCT00495469|40525196|FG003|Overall Study|Liver function test abnormality|0|||
16561806|NCT00495469|40525197|FG004|Overall Study|Liver function test abnormality|0|||
16561807|NCT00495469|40525198|FG005|Overall Study|Liver function test abnormality|0|||
16561808|NCT00495469|40525199|FG006|Overall Study|Liver function test abnormality|0|||
16130567|NCT00196976|38967051|FG002|Booster Study|Withdrawal by Subject|0|||
16356526|NCT03533751|39790664|FG002|Overall Study|Other|1|||
16356527|NCT03533751|39790665|FG003|Overall Study|Other|0|||
16356528|NCT03533751|39790666|FG004|Overall Study|Other|3|||
16356529|NCT02997163|39790671|FG000|Overall Study|Adverse Event|1|||
16356530|NCT02997163|39790672|FG001|Overall Study|Adverse Event|0|||
16356531|NCT02997163|39790673|FG002|Overall Study|Adverse Event|0|||
16356532|NCT02997163|39790674|FG003|Overall Study|Adverse Event|1|||
16356533|NCT02914834|39790675|FG000|Overall Study|Study halted due to COVID|1|||
16356534|NCT02914834|39790676|FG001|Overall Study|Study halted due to COVID|1|||
16356535|NCT02914834|39790675|FG000|Overall Study|1 subject withdrew|0|||
16356536|NCT02914834|39790676|FG001|Overall Study|1 subject withdrew|1|||
16356537|NCT00313846|39790677|FG000|Overall Study|Withdrawal by Subject|2|||
16356538|NCT00313846|39790678|FG001|Overall Study|Withdrawal by Subject|0|||
16356539|NCT00313846|39790677|FG000|Overall Study|Adverse Event|1|||
16356540|NCT00313846|39790678|FG001|Overall Study|Adverse Event|8|||
16356541|NCT00313846|39790677|FG000|Overall Study|Administrative|2|||
16356542|NCT00313846|39790678|FG001|Overall Study|Administrative|3|||
16356543|NCT01241279|39790679|FG000|Overall Study|Lost to Follow-up|0|||
16356544|NCT01241279|39790680|FG001|Overall Study|Lost to Follow-up|1|||
16356545|NCT02579629|39790681|FG000|Overall Study|Withdrawal by Subject|0|||
16356546|NCT02579629|39790682|FG001|Overall Study|Withdrawal by Subject|1|||
16356547|NCT02579629|39790683|FG002|Overall Study|Withdrawal by Subject|0|||
16561809|NCT00495469|40525193|FG000|Overall Study|ST depression at randomisation in ECG|0|||
16561810|NCT00495469|40525194|FG001|Overall Study|ST depression at randomisation in ECG|1|||
16356548|NCT02579629|39790681|FG000|Overall Study|Screen Failure|2|||
16356549|NCT02579629|39790682|FG001|Overall Study|Screen Failure|0|||
16418373|NCT00095173|40011842|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
16561811|NCT00495469|40525195|FG002|Overall Study|ST depression at randomisation in ECG|0|||
16561812|NCT00495469|40525196|FG003|Overall Study|ST depression at randomisation in ECG|0|||
16561813|NCT00495469|40525197|FG004|Overall Study|ST depression at randomisation in ECG|0|||
16561814|NCT00495469|40525198|FG005|Overall Study|ST depression at randomisation in ECG|0|||
16561815|NCT00495469|40525199|FG006|Overall Study|ST depression at randomisation in ECG|0|||
16561816|NCT01143077|40525200|FG000|Overall Study|Lack of Efficacy|0|||
16561817|NCT01143077|40525201|FG001|Overall Study|Lack of Efficacy|2|||
16561818|NCT01143077|40525202|FG002|Overall Study|Lack of Efficacy|1|||
16561819|NCT01143077|40525200|FG000|Overall Study|Adverse Event|5|||
16561820|NCT01143077|40525201|FG001|Overall Study|Adverse Event|6|||
16561821|NCT01143077|40525202|FG002|Overall Study|Adverse Event|5|||
16561822|NCT01143077|40525200|FG000|Overall Study|Lost to Follow-up|2|||
16561823|NCT01143077|40525201|FG001|Overall Study|Lost to Follow-up|3|||
16561824|NCT01143077|40525202|FG002|Overall Study|Lost to Follow-up|4|||
16561825|NCT01143077|40525200|FG000|Overall Study|Protocol Violation|2|||
16561826|NCT01143077|40525201|FG001|Overall Study|Protocol Violation|0|||
16561827|NCT01143077|40525202|FG002|Overall Study|Protocol Violation|0|||
16561828|NCT01143077|40525200|FG000|Overall Study|Withdrawal by Subject|4|||
16561829|NCT01143077|40525201|FG001|Overall Study|Withdrawal by Subject|3|||
16247943|NCT04820842|39391664|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
16247944|NCT04820842|39391665|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
16247945|NCT04820842|39391666|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
16273167|NCT01751087|39484428|FG000|Overall Study|Withdrawal by Subject|1|||
16418374|NCT00095173|40011837|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
16418375|NCT00095173|40011838|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
16418376|NCT00095173|40011839|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
16418377|NCT00095173|40011840|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
16418378|NCT00095173|40011841|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
16418379|NCT00095173|40011842|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
16418380|NCT00095173|40011837|FG000|Open-Label Extension Phase (Period C)|Death|0|||
16418381|NCT00095173|40011838|FG001|Open-Label Extension Phase (Period C)|Death|0|||
16418382|NCT00095173|40011839|FG002|Open-Label Extension Phase (Period C)|Death|0|||
16418383|NCT00095173|40011840|FG003|Open-Label Extension Phase (Period C)|Death|0|||
16418384|NCT00095173|40011841|FG004|Open-Label Extension Phase (Period C)|Death|0|||
16418385|NCT00095173|40011842|FG005|Open-Label Extension Phase (Period C)|Death|1|||
16418386|NCT00095173|40011837|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
16418387|NCT00095173|40011838|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
16418388|NCT00095173|40011839|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
16418389|NCT00095173|40011840|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
16418390|NCT00095173|40011841|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
16418391|NCT00095173|40011842|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
16418392|NCT00095173|40011837|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
16418393|NCT00095173|40011838|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
16418394|NCT00095173|40011839|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
16418395|NCT00095173|40011840|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
16418396|NCT00095173|40011841|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
16418397|NCT00095173|40011842|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
16418398|NCT00095173|40011837|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
16418399|NCT00095173|40011838|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
16418400|NCT00095173|40011839|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
16418401|NCT00095173|40011840|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
16418402|NCT00095173|40011841|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
16418403|NCT00095173|40011842|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
16561830|NCT01143077|40525202|FG002|Overall Study|Withdrawal by Subject|3|||
16561831|NCT01143077|40525200|FG000|Overall Study|Non-compliance with study drug|0|||
16561832|NCT01143077|40525201|FG001|Overall Study|Non-compliance with study drug|1|||
16561833|NCT01143077|40525202|FG002|Overall Study|Non-compliance with study drug|1|||
16356550|NCT02579629|39790683|FG002|Overall Study|Screen Failure|2|||
16356551|NCT01147822|39790684|FG000|Overall Study|Death|66|||
16356552|NCT01147822|39790685|FG001|Overall Study|Death|59|||
16356553|NCT01147822|39790684|FG000|Overall Study|Protocol Violation|0|||
16356554|NCT01147822|39790685|FG001|Overall Study|Protocol Violation|1|||
16356555|NCT01147822|39790684|FG000|Overall Study|Lost to Follow-up|3|||
16356556|NCT01147822|39790685|FG001|Overall Study|Lost to Follow-up|2|||
16356557|NCT01147822|39790684|FG000|Overall Study|Physician Decision|0|||
16356558|NCT01147822|39790685|FG001|Overall Study|Physician Decision|2|||
16356559|NCT01147822|39790684|FG000|Overall Study|Withdrawal by Subject|8|||
16356560|NCT01147822|39790685|FG001|Overall Study|Withdrawal by Subject|13|||
16356561|NCT01147822|39790684|FG000|Overall Study|Not Completed/Ongoing|111|||
16356562|NCT01147822|39790685|FG001|Overall Study|Not Completed/Ongoing|102|||
16356563|NCT00794664|39790686|FG000|Treatment Period|Withdrawal by Subject|0|||
16356564|NCT00794664|39790687|FG001|Treatment Period|Withdrawal by Subject|2|||
16356565|NCT00794664|39790686|FG000|Treatment Period|Protocol non-compliance|0|||
16418404|NCT00095173|40011837|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
16418405|NCT00095173|40011838|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
16418406|NCT00095173|40011839|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
16418407|NCT00095173|40011840|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
16356566|NCT00794664|39790687|FG001|Treatment Period|Protocol non-compliance|1|||
16356567|NCT00794664|39790686|FG000|Treatment Period|Other|0|||
16356568|NCT00794664|39790687|FG001|Treatment Period|Other|1|||
16356569|NCT00794664|39790686|FG000|Treatment Period|Adverse Event|1|||
16356570|NCT00794664|39790687|FG001|Treatment Period|Adverse Event|8|||
16356571|NCT00794664|39790686|FG000|Follow-up Period|Other|1|||
16356572|NCT00794664|39790687|FG001|Follow-up Period|Other|2|||
16356573|NCT00794664|39790686|FG000|Follow-up Period|Withdrawal by Subject|0|||
16356574|NCT00794664|39790687|FG001|Follow-up Period|Withdrawal by Subject|2|||
16356575|NCT00794664|39790686|FG000|Follow-up Period|Protocol non-compliance|0|||
16356576|NCT00794664|39790687|FG001|Follow-up Period|Protocol non-compliance|1|||
16356577|NCT03150082|39790690|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
16356578|NCT03150082|39790691|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
16356579|NCT04018066|39790692|FG000|Overall Study|participants started taking medications during the study period|3|||
16356580|NCT04018066|39790692|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
16356581|NCT03074500|39790693|FG000|Overall Study|Lost to Follow-up|1|||
16356582|NCT03074500|39790694|FG001|Overall Study|Lost to Follow-up|0|||
16356583|NCT03074500|39790695|FG002|Overall Study|Lost to Follow-up|0|||
16356584|NCT03074500|39790693|FG000|Overall Study|Lack of Efficacy|0|||
16356585|NCT03074500|39790694|FG001|Overall Study|Lack of Efficacy|1|||
16356586|NCT03074500|39790695|FG002|Overall Study|Lack of Efficacy|0|||
16356587|NCT03074500|39790693|FG000|Overall Study|Adverse Event|0|||
16356588|NCT03074500|39790694|FG001|Overall Study|Adverse Event|0|||
16356589|NCT03074500|39790695|FG002|Overall Study|Adverse Event|1|||
16356590|NCT00086190|39790696|FG000|Overall Study|Adverse Event|6|||
16356591|NCT00086190|39790697|FG001|Overall Study|Adverse Event|2|||
16356592|NCT00086190|39790698|FG002|Overall Study|Adverse Event|2|||
16356593|NCT00086190|39790696|FG000|Overall Study|Withdrawal by Subject|0|||
16356594|NCT00086190|39790697|FG001|Overall Study|Withdrawal by Subject|2|||
16356595|NCT00086190|39790698|FG002|Overall Study|Withdrawal by Subject|2|||
16356596|NCT00086190|39790696|FG000|Overall Study|Protocol Violation|1|||
16356597|NCT00086190|39790697|FG001|Overall Study|Protocol Violation|0|||
16356598|NCT00086190|39790698|FG002|Overall Study|Protocol Violation|0|||
16356599|NCT00086190|39790696|FG000|Overall Study|Moved|1|||
16356600|NCT00086190|39790697|FG001|Overall Study|Moved|0|||
16356601|NCT00086190|39790698|FG002|Overall Study|Moved|0|||
16356602|NCT00086190|39790696|FG000|Overall Study|Worsening depression|0|||
16356603|NCT00086190|39790697|FG001|Overall Study|Worsening depression|0|||
16356604|NCT00086190|39790698|FG002|Overall Study|Worsening depression|2|||
16356605|NCT02785939|39790699|FG000|Overall Study|Progression|25|||
16356606|NCT02785939|39790700|FG001|Overall Study|Progression|8|||
16356607|NCT02785939|39790699|FG000|Overall Study|Adverse Event|3|||
16356608|NCT02785939|39790700|FG001|Overall Study|Adverse Event|1|||
16356609|NCT02785939|39790699|FG000|Overall Study|Death|1|||
16356610|NCT02785939|39790700|FG001|Overall Study|Death|0|||
16418408|NCT00095173|40011841|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
16418409|NCT00095173|40011842|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
16356611|NCT02785939|39790699|FG000|Overall Study|Refusal|1|||
16356612|NCT02785939|39790700|FG001|Overall Study|Refusal|0|||
16356613|NCT02785939|39790699|FG000|Overall Study|Deteriorating health|1|||
16356614|NCT02785939|39790700|FG001|Overall Study|Deteriorating health|0|||
16356615|NCT02785939|39790699|FG000|Overall Study|Not protocol specified|0|||
16356616|NCT02785939|39790700|FG001|Overall Study|Not protocol specified|1|||
16356617|NCT01107925|39790701|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
16356618|NCT01107925|39790702|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
16356619|NCT01107925|39790703|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
16356620|NCT01107925|39790704|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
16356621|NCT01107925|39790705|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
16356622|NCT01107925|39790706|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
16356623|NCT01107925|39790701|FG000|Period 2|Withdrawal by Subject|0|||
16356624|NCT01107925|39790702|FG001|Period 2|Withdrawal by Subject|1|||
16356625|NCT01107925|39790703|FG002|Period 2|Withdrawal by Subject|0|||
16356626|NCT01107925|39790704|FG003|Period 2|Withdrawal by Subject|0|||
16356627|NCT01107925|39790705|FG004|Period 2|Withdrawal by Subject|0|||
16356628|NCT01107925|39790706|FG005|Period 2|Withdrawal by Subject|1|||
16356629|NCT01186770|39790711|FG000|Overall Study|Ineligibility|0|||
16356630|NCT01186770|39790712|FG001|Overall Study|Ineligibility|0|||
16356631|NCT01186770|39790713|FG002|Overall Study|Ineligibility|2|||
16356632|NCT01186770|39790714|FG003|Overall Study|Ineligibility|0|||
16356633|NCT01186770|39790711|FG000|Overall Study|Protocol Violation|7|||
16356634|NCT01186770|39790712|FG001|Overall Study|Protocol Violation|9|||
16356635|NCT01186770|39790713|FG002|Overall Study|Protocol Violation|12|||
16356636|NCT01186770|39790714|FG003|Overall Study|Protocol Violation|14|||
16356637|NCT01186770|39790711|FG000|Overall Study|Adverse Event|2|||
16418410|NCT00095173|40011837|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
16418411|NCT00095173|40011838|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
16418412|NCT00095173|40011839|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
16418413|NCT00095173|40011840|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
16418414|NCT00095173|40011841|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
16418415|NCT00095173|40011842|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
16418416|NCT00095173|40011837|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
16418417|NCT00095173|40011838|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
16418418|NCT00095173|40011839|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
16418419|NCT00095173|40011840|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
16418420|NCT00095173|40011841|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
16418421|NCT00095173|40011842|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
16418422|NCT00095173|40011837|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
16418423|NCT00095173|40011838|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
16418424|NCT00095173|40011839|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
16418425|NCT00095173|40011840|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
16418426|NCT00095173|40011841|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
16418427|NCT00095173|40011842|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
16418428|NCT00095173|40011837|FG000|Open-Label Extension Phase (Period C)|Other|0|||
16418429|NCT00095173|40011838|FG001|Open-Label Extension Phase (Period C)|Other|0|||
16418430|NCT00095173|40011839|FG002|Open-Label Extension Phase (Period C)|Other|0|||
16418431|NCT00095173|40011840|FG003|Open-Label Extension Phase (Period C)|Other|4|||
16418432|NCT00095173|40011841|FG004|Open-Label Extension Phase (Period C)|Other|6|||
16418433|NCT00095173|40011842|FG005|Open-Label Extension Phase (Period C)|Other|8|||
16418434|NCT00896649|40011843|FG000|Overall Study|Physician Decision|1|||
16418435|NCT00896649|40011843|FG000|Overall Study|Pregnancy|1|||
16418436|NCT00896649|40011843|FG000|Overall Study|missing documentation|1|||
16418437|NCT00896649|40011843|FG000|Overall Study|technical difficulties|2|||
16418438|NCT00764673|40011847|FG000|Overall Study|Death|1|||
16418439|NCT00764673|40011847|FG000|Overall Study|Lost to Follow-up|3|||
16418440|NCT00764673|40011847|FG000|Overall Study|Withdrawal by Subject|6|||
16418441|NCT00764673|40011847|FG000|Overall Study|Revision of Device|2|||
16418442|NCT01336023|40011848|FG000|Week 0 to Week 26|Adverse Event|8|||
16418443|NCT01336023|40011849|FG001|Week 0 to Week 26|Adverse Event|10|||
16418444|NCT01336023|40011850|FG002|Week 0 to Week 26|Adverse Event|24|||
16418445|NCT01336023|40011848|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
16418446|NCT01336023|40011849|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
16418447|NCT01336023|40011850|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
16418448|NCT01336023|40011848|FG000|Week 0 to Week 26|Protocol Violation|1|||
16418449|NCT01336023|40011849|FG001|Week 0 to Week 26|Protocol Violation|2|||
16418450|NCT01336023|40011850|FG002|Week 0 to Week 26|Protocol Violation|0|||
16418451|NCT01336023|40011848|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
16418452|NCT01336023|40011849|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
16418453|NCT01336023|40011850|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
16418454|NCT01336023|40011848|FG000|Week 0 to Week 26|Unclassified|5|||
16418455|NCT01336023|40011849|FG001|Week 0 to Week 26|Unclassified|16|||
16418456|NCT01336023|40011850|FG002|Week 0 to Week 26|Unclassified|9|||
16418457|NCT01336023|40011848|FG000|Week 27 to 52|Adverse Event|1|||
16418458|NCT01336023|40011849|FG001|Week 27 to 52|Adverse Event|5|||
16418459|NCT01336023|40011850|FG002|Week 27 to 52|Adverse Event|2|||
16418460|NCT01336023|40011848|FG000|Week 27 to 52|Protocol Violation|0|||
16130568|NCT00196976|38967052|FG003|Booster Study|Withdrawal by Subject|0|||
16356638|NCT01186770|39790712|FG001|Overall Study|Adverse Event|9|||
16418461|NCT01336023|40011849|FG001|Week 27 to 52|Protocol Violation|2|||
16418462|NCT01336023|40011850|FG002|Week 27 to 52|Protocol Violation|1|||
16418463|NCT01336023|40011848|FG000|Week 27 to 52|Withdrawal Criteria|14|||
16418464|NCT01336023|40011849|FG001|Week 27 to 52|Withdrawal Criteria|19|||
16418465|NCT01336023|40011850|FG002|Week 27 to 52|Withdrawal Criteria|16|||
16418466|NCT01336023|40011848|FG000|Week 27 to 52|Unclassified|13|||
16418467|NCT01336023|40011849|FG001|Week 27 to 52|Unclassified|18|||
16418468|NCT01336023|40011850|FG002|Week 27 to 52|Unclassified|9|||
16418469|NCT01353911|40011854|FG000|Overall Study|Lost to Follow-up|2|||
16418470|NCT01353911|40011855|FG001|Overall Study|Lost to Follow-up|6|||
16418471|NCT01353911|40011856|FG002|Overall Study|Lost to Follow-up|4|||
16418472|NCT01353911|40011857|FG003|Overall Study|Lost to Follow-up|0|||
16418473|NCT01353911|40011858|FG004|Overall Study|Lost to Follow-up|4|||
16418474|NCT01353911|40011859|FG005|Overall Study|Lost to Follow-up|4|||
16418475|NCT01353911|40011860|FG006|Overall Study|Lost to Follow-up|3|||
16418476|NCT01353911|40011861|FG007|Overall Study|Lost to Follow-up|6|||
16418477|NCT01353911|40011854|FG000|Overall Study|Withdrawal by Subject|2|||
16418478|NCT01353911|40011855|FG001|Overall Study|Withdrawal by Subject|3|||
16418479|NCT01353911|40011856|FG002|Overall Study|Withdrawal by Subject|4|||
16418480|NCT01353911|40011857|FG003|Overall Study|Withdrawal by Subject|2|||
16418481|NCT01353911|40011858|FG004|Overall Study|Withdrawal by Subject|2|||
16418482|NCT01353911|40011859|FG005|Overall Study|Withdrawal by Subject|3|||
16418483|NCT01353911|40011860|FG006|Overall Study|Withdrawal by Subject|3|||
16418484|NCT01353911|40011861|FG007|Overall Study|Withdrawal by Subject|9|||
16418485|NCT01353911|40011854|FG000|Overall Study|Status Not Recorded|4|||
16418486|NCT01353911|40011855|FG001|Overall Study|Status Not Recorded|0|||
16418487|NCT01353911|40011856|FG002|Overall Study|Status Not Recorded|1|||
16418488|NCT01353911|40011857|FG003|Overall Study|Status Not Recorded|0|||
16418489|NCT01353911|40011858|FG004|Overall Study|Status Not Recorded|0|||
16418490|NCT01353911|40011859|FG005|Overall Study|Status Not Recorded|0|||
16418491|NCT01353911|40011860|FG006|Overall Study|Status Not Recorded|0|||
16418492|NCT01353911|40011861|FG007|Overall Study|Status Not Recorded|0|||
16418493|NCT00490776|40011869|FG000|Overall Study|Withdrawal by Subject|1|||
16418494|NCT00490776|40011869|FG000|Overall Study|Administrative Problems|1|||
16418495|NCT00490776|40011869|FG000|Overall Study|Death|1|||
16418496|NCT00490776|40011869|FG000|Overall Study|New Cancer Therapy|1|||
16418497|NCT00490776|40011869|FG000|Overall Study|Disease Progression|5|||
16418498|NCT01452919|40011870|FG000|Open-Label Treatment|Adverse Event|5|||
16418499|NCT01452919|40011871|FG001|Open-Label Treatment|Adverse Event|0|||
16418500|NCT01452919|40011872|FG002|Open-Label Treatment|Adverse Event|0|||
16418501|NCT01452919|40011870|FG000|Open-Label Treatment|Lost to Follow-up|4|||
16418502|NCT01452919|40011871|FG001|Open-Label Treatment|Lost to Follow-up|0|||
16418503|NCT01452919|40011872|FG002|Open-Label Treatment|Lost to Follow-up|0|||
16418504|NCT01452919|40011870|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
16418505|NCT01452919|40011871|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
16418506|NCT01452919|40011872|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
16418507|NCT01452919|40011870|FG000|Open-Label Treatment|Protocol Violation|4|||
16418508|NCT01452919|40011871|FG001|Open-Label Treatment|Protocol Violation|0|||
16418509|NCT01452919|40011872|FG002|Open-Label Treatment|Protocol Violation|0|||
16418510|NCT01452919|40011870|FG000|Open-Label Treatment|Sponsor Decision|1|||
16356639|NCT01186770|39790713|FG002|Overall Study|Adverse Event|7|||
16356640|NCT01186770|39790714|FG003|Overall Study|Adverse Event|9|||
16356641|NCT01186770|39790711|FG000|Overall Study|Withdrawal by Subject|15|||
16356642|NCT01186770|39790712|FG001|Overall Study|Withdrawal by Subject|13|||
16356643|NCT01186770|39790713|FG002|Overall Study|Withdrawal by Subject|11|||
16356644|NCT01186770|39790714|FG003|Overall Study|Withdrawal by Subject|17|||
16356645|NCT01186770|39790711|FG000|Overall Study|Lost to Follow-up|10|||
16356646|NCT01186770|39790712|FG001|Overall Study|Lost to Follow-up|6|||
16356647|NCT01186770|39790713|FG002|Overall Study|Lost to Follow-up|14|||
16356648|NCT01186770|39790714|FG003|Overall Study|Lost to Follow-up|9|||
16356649|NCT01186770|39790711|FG000|Overall Study|Insufficient response to treatment|7|||
16356650|NCT01186770|39790712|FG001|Overall Study|Insufficient response to treatment|8|||
16356651|NCT01186770|39790713|FG002|Overall Study|Insufficient response to treatment|5|||
16356652|NCT01186770|39790714|FG003|Overall Study|Insufficient response to treatment|7|||
16356653|NCT01186770|39790711|FG000|Overall Study|Other than specified|0|||
16356654|NCT01186770|39790712|FG001|Overall Study|Other than specified|1|||
16356655|NCT01186770|39790713|FG002|Overall Study|Other than specified|1|||
16418511|NCT01452919|40011871|FG001|Open-Label Treatment|Sponsor Decision|0|||
16418512|NCT01452919|40011872|FG002|Open-Label Treatment|Sponsor Decision|0|||
16418513|NCT01452919|40011870|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
16418514|NCT01452919|40011871|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
16418515|NCT01452919|40011872|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
16418516|NCT01452919|40011870|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
16418517|NCT01452919|40011871|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
16418518|NCT01452919|40011872|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
16418519|NCT01452919|40011870|FG000|Randomization Treatment|Adverse Event|0|||
16561834|NCT01143077|40525200|FG000|Overall Study|Administrative|1|||
16356656|NCT01186770|39790714|FG003|Overall Study|Other than specified|2|||
16356657|NCT01718483|39790715|FG000|Overall Study|Withdrawal by Subject|14|||
16356658|NCT01718483|39790716|FG001|Overall Study|Withdrawal by Subject|12|||
16356659|NCT01718483|39790715|FG000|Overall Study|Adverse Event|5|||
16356660|NCT01718483|39790716|FG001|Overall Study|Adverse Event|12|||
16356661|NCT01718483|39790715|FG000|Overall Study|Lost to Follow-up|8|||
16356662|NCT01718483|39790716|FG001|Overall Study|Lost to Follow-up|3|||
16356663|NCT01718483|39790715|FG000|Overall Study|Protocol Violation|4|||
16356664|NCT01718483|39790716|FG001|Overall Study|Protocol Violation|2|||
16356665|NCT01718483|39790715|FG000|Overall Study|Other|1|||
16356666|NCT01718483|39790716|FG001|Overall Study|Other|4|||
16356667|NCT01718483|39790715|FG000|Overall Study|Pregnancy|1|||
16356668|NCT01718483|39790716|FG001|Overall Study|Pregnancy|1|||
16356669|NCT01718483|39790715|FG000|Overall Study|Lack of Efficacy|1|||
16356670|NCT01718483|39790716|FG001|Overall Study|Lack of Efficacy|0|||
16356671|NCT02247466|39790721|FG000|Overall Study|Procedure changed to open surgery|0|||
16356672|NCT02247466|39790722|FG001|Overall Study|Procedure changed to open surgery|3|||
16356673|NCT00072384|39790723|FG000|Overall Study|Physician Decision|1|||
16356674|NCT00072384|39790723|FG000|Overall Study|Ineligible|8|||
16356675|NCT03558516|39790724|FG000|Overall Study|Protocol Violation|2|||
16356676|NCT03558516|39790725|FG001|Overall Study|Protocol Violation|2|||
16356677|NCT01829347|39790726|FG000|VTI-210|Death|5|||
16356678|NCT01829347|39790727|FG001|VTI-210|Death|3|||
16356679|NCT01829347|39790726|FG000|VTI-210|Withdrawal by Subject|1|||
16356680|NCT01829347|39790727|FG001|VTI-210|Withdrawal by Subject|0|||
16418520|NCT01452919|40011871|FG001|Randomization Treatment|Adverse Event|0|||
16418521|NCT01452919|40011872|FG002|Randomization Treatment|Adverse Event|2|||
16356681|NCT01829347|39790726|FG000|VTI-210E|Death|2|||
16356682|NCT01829347|39790727|FG001|VTI-210E|Death|1|||
16356683|NCT01829347|39790726|FG000|VTI-210E|Study terminated prematurely|1|||
16356684|NCT01829347|39790727|FG001|VTI-210E|Study terminated prematurely|5|||
16356685|NCT02000921|39790731|FG000|Overall Study|Withdrawal by Subject|3|||
16356686|NCT02000921|39790732|FG001|Overall Study|Withdrawal by Subject|10|||
16356687|NCT02000921|39790733|FG002|Overall Study|Withdrawal by Subject|5|||
16356688|NCT02000921|39790731|FG000|Overall Study|Lost to Follow-up|2|||
16356689|NCT02000921|39790732|FG001|Overall Study|Lost to Follow-up|4|||
16356690|NCT02000921|39790733|FG002|Overall Study|Lost to Follow-up|5|||
16356691|NCT02000921|39790731|FG000|Overall Study|Physician Decision|0|||
16356692|NCT02000921|39790732|FG001|Overall Study|Physician Decision|2|||
16356693|NCT02000921|39790733|FG002|Overall Study|Physician Decision|0|||
16356694|NCT02783066|39793599|FG000|Overall Study|Withdrawal by Subject|13|||
16356695|NCT00099437|39793600|FG000|Overall Study|Lost to Follow-up|30|||
16356696|NCT00099437|39793601|FG001|Overall Study|Lost to Follow-up|33|||
16356697|NCT00099437|39793600|FG000|Overall Study|Death|293|||
16356698|NCT00099437|39793601|FG001|Overall Study|Death|261|||
16356699|NCT00099437|39793600|FG000|Overall Study|Withdrawal by Subject|6|||
16356700|NCT00099437|39793601|FG001|Overall Study|Withdrawal by Subject|10|||
16356701|NCT00099437|39793600|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
16356702|NCT00099437|39793601|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
16356703|NCT02160626|39793604|FG000|Overall Study|Adverse Event|1|||
16356704|NCT02160626|39793605|FG001|Overall Study|Adverse Event|0|||
16356705|NCT02160626|39793606|FG002|Overall Study|Adverse Event|0|||
16356706|NCT02160626|39793604|FG000|Overall Study|Schedule not conducive to study visits|0|||
16356707|NCT02160626|39793605|FG001|Overall Study|Schedule not conducive to study visits|0|||
16356708|NCT02160626|39793606|FG002|Overall Study|Schedule not conducive to study visits|1|||
16356709|NCT02160626|39793604|FG000|Overall Study|Withdrawal by Subject|0|||
16356710|NCT02160626|39793605|FG001|Overall Study|Withdrawal by Subject|1|||
16356711|NCT02160626|39793606|FG002|Overall Study|Withdrawal by Subject|0|||
16356712|NCT02410629|39793607|FG000|Overall Study|Family cannot commit to the study|2|||
16356713|NCT02410629|39793608|FG001|Overall Study|Family cannot commit to the study|1|||
16356714|NCT02410629|39793607|FG000|Overall Study|Subject returned to work|1|||
16356715|NCT02410629|39793608|FG001|Overall Study|Subject returned to work|0|||
16356716|NCT02410629|39793607|FG000|Overall Study|Subject moved back to home country|0|||
16356717|NCT02410629|39793608|FG001|Overall Study|Subject moved back to home country|1|||
16356718|NCT02410629|39793607|FG000|Overall Study|Subject underwent heart surgery|0|||
16356719|NCT02410629|39793608|FG001|Overall Study|Subject underwent heart surgery|1|||
16356720|NCT00703534|39793609|FG000|Overall Study|Adverse Event|14|||
16356721|NCT00703534|39793610|FG001|Overall Study|Adverse Event|3|||
16418522|NCT01452919|40011870|FG000|Randomization Treatment|Sponsor Decision|0|||
16356722|NCT00703534|39793609|FG000|Overall Study|Withdrawal by Subject|8|||
16356723|NCT00703534|39793610|FG001|Overall Study|Withdrawal by Subject|7|||
16356724|NCT00703534|39793609|FG000|Overall Study|Incorrect Enrollment|6|||
16356725|NCT00703534|39793610|FG001|Overall Study|Incorrect Enrollment|6|||
16356726|NCT00703534|39793609|FG000|Overall Study|Lost to Follow-up|1|||
16356727|NCT00703534|39793610|FG001|Overall Study|Lost to Follow-up|4|||
16356728|NCT00703534|39793609|FG000|Overall Study|Severe Non Compliance|1|||
16356729|NCT00703534|39793610|FG001|Overall Study|Severe Non Compliance|5|||
16356730|NCT03627832|39793613|FG000|Overall Study|Withdrawal by Subject|10|||
16356731|NCT03627832|39793614|FG001|Overall Study|Withdrawal by Subject|1|||
16356732|NCT04465422|39793615|FG000|Overall Study|Lost to Follow-up|0|||
16356733|NCT04465422|39793616|FG001|Overall Study|Lost to Follow-up|2|||
16356734|NCT01225549|39793617|FG000|Period 4 - Washout|Disallowed medication|0|||
16356735|NCT01225549|39793618|FG001|Period 4 - Washout|Disallowed medication|1|||
16356736|NCT01225549|39793619|FG002|Period 4 - Washout|Disallowed medication|0|||
16356737|NCT01225549|39793620|FG003|Period 4 - Washout|Disallowed medication|0|||
16356738|NCT01225549|39793621|FG004|Period 4 - Washout|Disallowed medication|0|||
16356739|NCT01225549|39793622|FG005|Period 4 - Washout|Disallowed medication|0|||
16356740|NCT01225549|39793623|FG006|Period 4 - Washout|Disallowed medication|0|||
16356741|NCT01225549|39793624|FG007|Period 4 - Washout|Disallowed medication|0|||
16356742|NCT01225549|39793625|FG008|Period 4 - Washout|Disallowed medication|0|||
16356743|NCT01225549|39793626|FG009|Period 4 - Washout|Disallowed medication|0|||
16356744|NCT01225549|39793617|FG000|Period 6 - Washout|Disallowed medication|0|||
16356745|NCT01225549|39793618|FG001|Period 6 - Washout|Disallowed medication|0|||
16356746|NCT01225549|39793619|FG002|Period 6 - Washout|Disallowed medication|0|||
16418523|NCT01452919|40011871|FG001|Randomization Treatment|Sponsor Decision|1|||
16418524|NCT01452919|40011872|FG002|Randomization Treatment|Sponsor Decision|0|||
16418525|NCT01452919|40011870|FG000|Randomization Treatment|Withdrawal by Subject|0|||
16418526|NCT01452919|40011871|FG001|Randomization Treatment|Withdrawal by Subject|1|||
16418527|NCT01452919|40011872|FG002|Randomization Treatment|Withdrawal by Subject|0|||
16418528|NCT01452919|40011870|FG000|Randomization Treatment|Subject is moving or has moved|0|||
16418529|NCT01452919|40011871|FG001|Randomization Treatment|Subject is moving or has moved|1|||
16418530|NCT01452919|40011872|FG002|Randomization Treatment|Subject is moving or has moved|0|||
16418531|NCT00871923|40011873|FG000|Overall Study|Death|1|||
16418532|NCT00871923|40011873|FG000|Overall Study|Withdrawal by Subject|1|||
16418533|NCT03281304|40011874|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
16418534|NCT03281304|40011875|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
16418535|NCT03281304|40011874|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
16418536|NCT03281304|40011875|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
16418537|NCT03281304|40011874|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
16418538|NCT03281304|40011875|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
16418539|NCT03281304|40011874|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
16418540|NCT03281304|40011875|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
16356747|NCT01225549|39793620|FG003|Period 6 - Washout|Disallowed medication|1|||
16356748|NCT01225549|39793621|FG004|Period 6 - Washout|Disallowed medication|0|||
16356749|NCT01225549|39793622|FG005|Period 6 - Washout|Disallowed medication|0|||
16356750|NCT01225549|39793623|FG006|Period 6 - Washout|Disallowed medication|0|||
16356751|NCT01225549|39793624|FG007|Period 6 - Washout|Disallowed medication|0|||
16356752|NCT01225549|39793625|FG008|Period 6 - Washout|Disallowed medication|0|||
16356753|NCT01225549|39793626|FG009|Period 6 - Washout|Disallowed medication|0|||
16356754|NCT02164916|39793627|FG000|Overall Study|Adverse Event|3|||
16356755|NCT02164916|39793628|FG001|Overall Study|Adverse Event|8|||
16356756|NCT02164916|39793627|FG000|Overall Study|Death|1|||
16356757|NCT02164916|39793628|FG001|Overall Study|Death|1|||
16356758|NCT02164916|39793627|FG000|Overall Study|Refusal unrelated to adverse event|3|||
16356759|NCT02164916|39793628|FG001|Overall Study|Refusal unrelated to adverse event|7|||
16356760|NCT02164916|39793627|FG000|Overall Study|Progression|37|||
16356761|NCT02164916|39793628|FG001|Overall Study|Progression|26|||
16356762|NCT02164916|39793627|FG000|Overall Study|Not protocol specified|5|||
16356763|NCT02164916|39793628|FG001|Overall Study|Not protocol specified|1|||
16356764|NCT02164916|39793627|FG000|Overall Study|Reason under review|1|||
16356765|NCT02164916|39793628|FG001|Overall Study|Reason under review|6|||
16356766|NCT02164916|39793627|FG000|Overall Study|Not eligible|2|||
16356767|NCT02164916|39793628|FG001|Overall Study|Not eligible|5|||
16356768|NCT00720499|39793629|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
16356769|NCT00720499|39793630|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
16356770|NCT00720499|39793629|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
16356771|NCT00720499|39793630|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
16356772|NCT00720499|39793629|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
16356773|NCT00720499|39793630|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
16356774|NCT00113607|39793631|FG000|Overall Study|Adverse Event|40|||
16356775|NCT00113607|39793632|FG001|Overall Study|Adverse Event|71|||
16356776|NCT00113607|39793631|FG000|Overall Study|Death|8|||
16356777|NCT00113607|39793632|FG001|Overall Study|Death|8|||
16418541|NCT03281304|40011874|FG000|Treatment Phase (up to 42 Months)|Death|0|||
16418542|NCT03281304|40011875|FG001|Treatment Phase (up to 42 Months)|Death|1|||
16418543|NCT03281304|40011874|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
16356778|NCT00113607|39793631|FG000|Overall Study|Withdrawal by Subject|50|||
16356779|NCT00113607|39793632|FG001|Overall Study|Withdrawal by Subject|58|||
16356780|NCT00113607|39793631|FG000|Overall Study|Lost to Follow-up|0|||
16356781|NCT00113607|39793632|FG001|Overall Study|Lost to Follow-up|2|||
16356782|NCT00113607|39793631|FG000|Overall Study|Disease Progression|180|||
16356783|NCT00113607|39793632|FG001|Overall Study|Disease Progression|142|||
16356784|NCT00113607|39793631|FG000|Overall Study|Complete Response (Confirmed)|14|||
16418544|NCT03281304|40011875|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
16418545|NCT03281304|40011874|FG000|Treatment Phase (up to 42 Months)|Other|0|||
16418546|NCT03281304|40011875|FG001|Treatment Phase (up to 42 Months)|Other|2|||
16418547|NCT03281304|40011874|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
16418548|NCT03281304|40011875|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
16418549|NCT00483002|40011878|FG000|Overall Study|Adverse Event|68|||
16418550|NCT00483002|40011878|FG000|Overall Study|Lack of Efficacy|555|||
16418551|NCT00483002|40011878|FG000|Overall Study|Lost to Follow-up|962|||
16418552|NCT00483002|40011878|FG000|Overall Study|Other|2|||
16418553|NCT00483002|40011878|FG000|Overall Study|Other|967|||
16418554|NCT01895309|40011879|FG000|Overall Study|Adverse Event|13|||
16418555|NCT01895309|40011880|FG001|Overall Study|Adverse Event|17|||
16418556|NCT01895309|40011879|FG000|Overall Study|Protocol Violation|1|||
16418557|NCT01895309|40011880|FG001|Overall Study|Protocol Violation|0|||
16418558|NCT01895309|40011879|FG000|Overall Study|Lack of Efficacy|1|||
16356785|NCT00113607|39793632|FG001|Overall Study|Complete Response (Confirmed)|24|||
16356786|NCT00113607|39793631|FG000|Overall Study|Other|43|||
16356787|NCT00113607|39793632|FG001|Overall Study|Other|32|||
16356788|NCT02251275|39793637|FG000|Overall Study|Adverse Event|23|||
16356789|NCT02251275|39793638|FG001|Overall Study|Adverse Event|60|||
16356790|NCT02251275|39793639|FG002|Overall Study|Adverse Event|28|||
16356791|NCT02251275|39793640|FG003|Overall Study|Adverse Event|0|||
16356792|NCT02251275|39793641|FG004|Overall Study|Adverse Event|0|||
16356793|NCT02251275|39793637|FG000|Overall Study|Lost to Follow-up|5|||
16356794|NCT02251275|39793638|FG001|Overall Study|Lost to Follow-up|6|||
16418559|NCT01895309|40011880|FG001|Overall Study|Lack of Efficacy|3|||
16418560|NCT01895309|40011879|FG000|Overall Study|Lost to Follow-up|1|||
16418561|NCT01895309|40011880|FG001|Overall Study|Lost to Follow-up|3|||
16418562|NCT01895309|40011879|FG000|Overall Study|Physician Decision|15|||
16418563|NCT01895309|40011880|FG001|Overall Study|Physician Decision|10|||
16418564|NCT01895309|40011879|FG000|Overall Study|Withdrawal by Subject|9|||
16418565|NCT01895309|40011880|FG001|Overall Study|Withdrawal by Subject|18|||
16418566|NCT02066129|40011881|FG000|Overall Study|Lost to Follow-up|13|||
16418567|NCT02066129|40011882|FG001|Overall Study|Lost to Follow-up|12|||
16418568|NCT02066129|40011881|FG000|Overall Study|Withdrawal by Subject|7|||
16418569|NCT02066129|40011882|FG001|Overall Study|Withdrawal by Subject|10|||
16418570|NCT02066129|40011881|FG000|Overall Study|Lack of Efficacy|8|||
16356795|NCT02251275|39793639|FG002|Overall Study|Lost to Follow-up|4|||
16356796|NCT02251275|39793640|FG003|Overall Study|Lost to Follow-up|0|||
16356797|NCT02251275|39793641|FG004|Overall Study|Lost to Follow-up|0|||
16356798|NCT02251275|39793637|FG000|Overall Study|Physician Decision|19|||
16356799|NCT02251275|39793638|FG001|Overall Study|Physician Decision|30|||
16356800|NCT02251275|39793639|FG002|Overall Study|Physician Decision|26|||
16356801|NCT02251275|39793640|FG003|Overall Study|Physician Decision|0|||
16356802|NCT02251275|39793641|FG004|Overall Study|Physician Decision|1|||
16356803|NCT02251275|39793637|FG000|Overall Study|Protocol Deviation|0|||
16356804|NCT02251275|39793638|FG001|Overall Study|Protocol Deviation|0|||
16356805|NCT02251275|39793639|FG002|Overall Study|Protocol Deviation|1|||
16356806|NCT02251275|39793640|FG003|Overall Study|Protocol Deviation|0|||
16418571|NCT02066129|40011882|FG001|Overall Study|Lack of Efficacy|10|||
16418572|NCT02066129|40011881|FG000|Overall Study|Physician Decision|1|||
16418573|NCT02066129|40011882|FG001|Overall Study|Physician Decision|1|||
16418574|NCT02540668|40011883|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
16418575|NCT02540668|40011884|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
16418576|NCT04033068|40011885|FG000|Overall Study|Withdrawal by Subject|0|||
16418577|NCT04033068|40011886|FG001|Overall Study|Withdrawal by Subject|0|||
16418578|NCT04033068|40011887|FG002|Overall Study|Withdrawal by Subject|1|||
16418579|NCT04033068|40011888|FG003|Overall Study|Withdrawal by Subject|0|||
16418580|NCT04033068|40011885|FG000|Overall Study|Lost to Follow-up|0|||
16418581|NCT04033068|40011886|FG001|Overall Study|Lost to Follow-up|1|||
16356807|NCT02251275|39793641|FG004|Overall Study|Protocol Deviation|0|||
16356808|NCT02251275|39793637|FG000|Overall Study|Withdrawal by Subject|25|||
16418582|NCT04033068|40011887|FG002|Overall Study|Lost to Follow-up|0|||
16418583|NCT04033068|40011888|FG003|Overall Study|Lost to Follow-up|0|||
16356809|NCT02251275|39793638|FG001|Overall Study|Withdrawal by Subject|51|||
16356810|NCT02251275|39793639|FG002|Overall Study|Withdrawal by Subject|35|||
16356811|NCT02251275|39793640|FG003|Overall Study|Withdrawal by Subject|1|||
16356812|NCT02251275|39793641|FG004|Overall Study|Withdrawal by Subject|0|||
16356813|NCT00473655|39793642|FG000|Overall Study|Lost to Follow-up|9|||
16418584|NCT04033068|40011885|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
16418585|NCT04033068|40011886|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
16418586|NCT04033068|40011887|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
16356814|NCT00473655|39793643|FG001|Overall Study|Lost to Follow-up|5|||
16356815|NCT00473655|39793644|FG002|Overall Study|Lost to Follow-up|8|||
16418587|NCT04033068|40011888|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
16418588|NCT01571453|40011894|FG000|Overall Study|Adverse Event|14|||
16418589|NCT01571453|40011895|FG001|Overall Study|Adverse Event|32|||
16418590|NCT01571453|40011894|FG000|Overall Study|Lack of Efficacy|8|||
16418591|NCT01571453|40011895|FG001|Overall Study|Lack of Efficacy|3|||
16418592|NCT01571453|40011894|FG000|Overall Study|Non-compliance|2|||
16418593|NCT01571453|40011895|FG001|Overall Study|Non-compliance|4|||
16418594|NCT01571453|40011894|FG000|Overall Study|Protocol Violation|1|||
16418595|NCT01571453|40011895|FG001|Overall Study|Protocol Violation|5|||
16418596|NCT01571453|40011894|FG000|Overall Study|Withdrawal of consent|5|||
16418597|NCT01571453|40011895|FG001|Overall Study|Withdrawal of consent|13|||
16418598|NCT01571453|40011894|FG000|Overall Study|Lost to Follow-up|4|||
16418599|NCT01571453|40011895|FG001|Overall Study|Lost to Follow-up|2|||
16418600|NCT01571453|40011894|FG000|Overall Study|Administrative or other reason(s)|4|||
16418601|NCT01571453|40011895|FG001|Overall Study|Administrative or other reason(s)|3|||
16418602|NCT01638559|40011897|FG000|Overall Study|Lost to Follow-up|1|||
16418603|NCT01638559|40011897|FG000|Overall Study|Withdrawal by Subject|1|||
16418604|NCT01638559|40011897|FG000|Overall Study|Subject declined to travel for biopsy|1|||
16418605|NCT00279812|40011900|FG000|Overall Study|Protocol Violation|1|||
16418606|NCT00279812|40011901|FG001|Overall Study|Protocol Violation|1|||
16418607|NCT00279812|40011902|FG002|Overall Study|Protocol Violation|0|||
16561835|NCT01143077|40525201|FG001|Overall Study|Administrative|0|||
16247946|NCT04820842|39391667|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
16247947|NCT04820842|39391661|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
16247948|NCT04820842|39391662|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
16247949|NCT04820842|39391663|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
16247950|NCT04820842|39391664|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
16247951|NCT04820842|39391665|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
16247952|NCT04820842|39391666|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
16247953|NCT04820842|39391667|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
16247954|NCT04820842|39391661|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
16247955|NCT04820842|39391662|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
16561836|NCT01143077|40525202|FG002|Overall Study|Administrative|0|||
16561837|NCT01143077|40525200|FG000|Overall Study|Principal Investigator Decision|2|||
16561838|NCT01143077|40525201|FG001|Overall Study|Principal Investigator Decision|0|||
16561839|NCT01143077|40525202|FG002|Overall Study|Principal Investigator Decision|1|||
16247956|NCT04820842|39391663|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
16561840|NCT03382821|40525203|FG000|Overall Study|Did not receive allocated intervention.|0|||
16561841|NCT03382821|40525204|FG001|Overall Study|Did not receive allocated intervention.|3|||
16561842|NCT03699124|40525208|FG000|Overall Study|Adverse Event|6|||
16561843|NCT03699124|40525209|FG001|Overall Study|Adverse Event|5|||
16561844|NCT03699124|40525210|FG002|Overall Study|Adverse Event|2|||
16561845|NCT03699124|40525208|FG000|Overall Study|Death|0|||
16561846|NCT03699124|40525209|FG001|Overall Study|Death|2|||
16561847|NCT03699124|40525210|FG002|Overall Study|Death|0|||
16247957|NCT04820842|39391664|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
16247958|NCT04820842|39391665|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
16247959|NCT04820842|39391666|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
16247960|NCT04820842|39391667|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
16247961|NCT01508936|39391677|FG000|Overall Study|Adverse Event|11|||
16247962|NCT01508936|39391678|FG001|Overall Study|Adverse Event|32|||
16418608|NCT00279812|40011903|FG003|Overall Study|Protocol Violation|0|||
16418609|NCT00279812|40011904|FG004|Overall Study|Protocol Violation|1|||
16418610|NCT00279812|40011905|FG005|Overall Study|Protocol Violation|0|||
16418611|NCT00279812|40011900|FG000|Overall Study|Withdrawal by Subject|0|||
16418612|NCT00279812|40011901|FG001|Overall Study|Withdrawal by Subject|4|||
16418613|NCT00279812|40011902|FG002|Overall Study|Withdrawal by Subject|2|||
16247963|NCT01508936|39391677|FG000|Overall Study|Lack of Efficacy|0|||
16247964|NCT01508936|39391678|FG001|Overall Study|Lack of Efficacy|1|||
16247965|NCT01508936|39391677|FG000|Overall Study|Withdrawal by Subject|4|||
16247966|NCT01508936|39391678|FG001|Overall Study|Withdrawal by Subject|18|||
16418614|NCT00279812|40011903|FG003|Overall Study|Withdrawal by Subject|0|||
16418615|NCT00279812|40011904|FG004|Overall Study|Withdrawal by Subject|0|||
16418616|NCT00279812|40011905|FG005|Overall Study|Withdrawal by Subject|0|||
16418617|NCT00279812|40011900|FG000|Overall Study|Adverse Event|0|||
16561848|NCT03699124|40525208|FG000|Overall Study|Lost to Follow-up|20|||
16561849|NCT03699124|40525209|FG001|Overall Study|Lost to Follow-up|16|||
16561850|NCT03699124|40525210|FG002|Overall Study|Lost to Follow-up|15|||
16561851|NCT03699124|40525208|FG000|Overall Study|Protocol Violation|1|||
16356816|NCT00288912|39793646|FG000|Overall Study|Developed exclusion criterion|4|||
16356817|NCT00288912|39793647|FG001|Overall Study|Developed exclusion criterion|6|||
16356818|NCT00288912|39793648|FG002|Overall Study|Developed exclusion criterion|7|||
16356819|NCT00288912|39793646|FG000|Overall Study|Lost to Follow-up|9|||
16356820|NCT00288912|39793647|FG001|Overall Study|Lost to Follow-up|6|||
16356821|NCT00288912|39793648|FG002|Overall Study|Lost to Follow-up|9|||
16356822|NCT00288912|39793646|FG000|Overall Study|Withdrawal by Subject|4|||
16356823|NCT00288912|39793647|FG001|Overall Study|Withdrawal by Subject|5|||
16356824|NCT00288912|39793648|FG002|Overall Study|Withdrawal by Subject|12|||
16356825|NCT01094288|39793649|FG000|Overall Study|Adverse Event|0|||
16356826|NCT01094288|39793650|FG001|Overall Study|Adverse Event|3|||
16356827|NCT01094288|39793651|FG002|Overall Study|Adverse Event|1|||
16356828|NCT01094288|39793652|FG003|Overall Study|Adverse Event|1|||
16356829|NCT01094288|39793653|FG004|Overall Study|Adverse Event|0|||
16356830|NCT01094288|39793654|FG005|Overall Study|Adverse Event|0|||
16356831|NCT01094288|39793655|FG006|Overall Study|Adverse Event|0|||
16356832|NCT01094288|39793656|FG007|Overall Study|Adverse Event|0|||
16356833|NCT01094288|39793649|FG000|Overall Study|Withdrawal by Subject|0|||
16356834|NCT01094288|39793650|FG001|Overall Study|Withdrawal by Subject|1|||
16356835|NCT01094288|39793651|FG002|Overall Study|Withdrawal by Subject|2|||
16356836|NCT01094288|39793652|FG003|Overall Study|Withdrawal by Subject|0|||
16356837|NCT01094288|39793653|FG004|Overall Study|Withdrawal by Subject|0|||
16356838|NCT01094288|39793654|FG005|Overall Study|Withdrawal by Subject|0|||
16356839|NCT01094288|39793655|FG006|Overall Study|Withdrawal by Subject|0|||
16356840|NCT01094288|39793656|FG007|Overall Study|Withdrawal by Subject|2|||
16356841|NCT01094288|39793649|FG000|Overall Study|Initiation of Alternative Therapy|0|||
16356842|NCT01094288|39793650|FG001|Overall Study|Initiation of Alternative Therapy|0|||
16356843|NCT01094288|39793651|FG002|Overall Study|Initiation of Alternative Therapy|1|||
16356844|NCT01094288|39793652|FG003|Overall Study|Initiation of Alternative Therapy|0|||
16356845|NCT01094288|39793653|FG004|Overall Study|Initiation of Alternative Therapy|0|||
16356846|NCT01094288|39793654|FG005|Overall Study|Initiation of Alternative Therapy|0|||
16356847|NCT01094288|39793655|FG006|Overall Study|Initiation of Alternative Therapy|0|||
16356848|NCT01094288|39793656|FG007|Overall Study|Initiation of Alternative Therapy|0|||
16356849|NCT01094288|39793649|FG000|Overall Study|Reason not Specified|2|||
16356850|NCT01094288|39793650|FG001|Overall Study|Reason not Specified|3|||
16356851|NCT01094288|39793651|FG002|Overall Study|Reason not Specified|0|||
16356852|NCT01094288|39793652|FG003|Overall Study|Reason not Specified|1|||
16356853|NCT01094288|39793653|FG004|Overall Study|Reason not Specified|0|||
16356854|NCT01094288|39793654|FG005|Overall Study|Reason not Specified|0|||
16418618|NCT00279812|40011901|FG001|Overall Study|Adverse Event|1|||
16418619|NCT00279812|40011902|FG002|Overall Study|Adverse Event|1|||
16418620|NCT00279812|40011903|FG003|Overall Study|Adverse Event|0|||
16418621|NCT00279812|40011904|FG004|Overall Study|Adverse Event|2|||
16418622|NCT00279812|40011905|FG005|Overall Study|Adverse Event|1|||
16418623|NCT02666105|40011910|FG000|Overall Study|Death|1|||
16418624|NCT04068519|40011911|FG000|Dose Verification|Death|15|||
16418625|NCT04068519|40011911|FG000|Dose Verification|Withdrawal by Subject|1|||
16418626|NCT04068519|40011911|FG000|Pharmacokinetic Sub-study|Death|35|||
16418627|NCT04068519|40011911|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
16418628|NCT04068519|40011911|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
16418629|NCT04068519|40011911|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
16418630|NCT04068519|40011911|FG000|Indication Expansion|Death|152|||
16418631|NCT04068519|40011911|FG000|Indication Expansion|Withdrawal by Subject|10|||
16418632|NCT04068519|40011911|FG000|Indication Expansion|Lost to Follow-up|7|||
16418633|NCT01455194|40011912|FG000|Overall Study|Screen Failure|20|||
16418634|NCT01455194|40011913|FG001|Overall Study|Screen Failure|0|||
16418635|NCT01455194|40011914|FG002|Overall Study|Screen Failure|0|||
16418636|NCT01455194|40011915|FG003|Overall Study|Screen Failure|0|||
16418637|NCT01455194|40011912|FG000|Overall Study|Randomisation Failure|90|||
16418638|NCT01455194|40011913|FG001|Overall Study|Randomisation Failure|0|||
16418639|NCT01455194|40011914|FG002|Overall Study|Randomisation Failure|0|||
16418640|NCT01455194|40011915|FG003|Overall Study|Randomisation Failure|0|||
16418641|NCT01455194|40011912|FG000|Overall Study|Deterioration in asthma|12|||
16418642|NCT01455194|40011913|FG001|Overall Study|Deterioration in asthma|6|||
16418643|NCT01455194|40011914|FG002|Overall Study|Deterioration in asthma|14|||
16418644|NCT01455194|40011915|FG003|Overall Study|Deterioration in asthma|9|||
16130569|NCT00196976|38967053|FG004|Booster Study|Withdrawal by Subject|0|||
16130570|NCT00196976|38967054|FG005|Booster Study|Withdrawal by Subject|0|||
16418645|NCT01455194|40011912|FG000|Overall Study|Adverse Event|1|||
16356855|NCT01094288|39793655|FG006|Overall Study|Reason not Specified|0|||
16356856|NCT01094288|39793656|FG007|Overall Study|Reason not Specified|0|||
16356857|NCT01094288|39793649|FG000|Overall Study|Ongoing Participants|0|||
16418646|NCT01455194|40011913|FG001|Overall Study|Adverse Event|1|||
16418647|NCT01455194|40011914|FG002|Overall Study|Adverse Event|1|||
16418648|NCT01455194|40011915|FG003|Overall Study|Adverse Event|3|||
16418649|NCT01455194|40011912|FG000|Overall Study|Withdrawal by Subject|21|||
16418650|NCT01455194|40011913|FG001|Overall Study|Withdrawal by Subject|16|||
16418651|NCT01455194|40011914|FG002|Overall Study|Withdrawal by Subject|12|||
16418652|NCT01455194|40011915|FG003|Overall Study|Withdrawal by Subject|9|||
16418653|NCT01455194|40011912|FG000|Overall Study|Lost to Follow-up|2|||
16356858|NCT01094288|39793650|FG001|Overall Study|Ongoing Participants|3|||
16356859|NCT01094288|39793651|FG002|Overall Study|Ongoing Participants|0|||
16356860|NCT01094288|39793652|FG003|Overall Study|Ongoing Participants|0|||
16356861|NCT01094288|39793653|FG004|Overall Study|Ongoing Participants|0|||
16356862|NCT01094288|39793654|FG005|Overall Study|Ongoing Participants|0|||
16356863|NCT01094288|39793655|FG006|Overall Study|Ongoing Participants|0|||
16418654|NCT01455194|40011913|FG001|Overall Study|Lost to Follow-up|0|||
16418655|NCT01455194|40011914|FG002|Overall Study|Lost to Follow-up|1|||
16418656|NCT01455194|40011915|FG003|Overall Study|Lost to Follow-up|1|||
16418657|NCT01455194|40011912|FG000|Overall Study|Pregnancy|0|||
16418658|NCT01455194|40011913|FG001|Overall Study|Pregnancy|1|||
16418659|NCT01455194|40011914|FG002|Overall Study|Pregnancy|1|||
16418660|NCT01455194|40011915|FG003|Overall Study|Pregnancy|0|||
16418661|NCT01455194|40011912|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
16418662|NCT01455194|40011913|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
16418663|NCT01455194|40011914|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
16561852|NCT03699124|40525209|FG001|Overall Study|Protocol Violation|0|||
16561853|NCT03699124|40525210|FG002|Overall Study|Protocol Violation|0|||
16561854|NCT03699124|40525208|FG000|Overall Study|Withdrawal by Subject|13|||
16561855|NCT03699124|40525209|FG001|Overall Study|Withdrawal by Subject|14|||
16561856|NCT03699124|40525210|FG002|Overall Study|Withdrawal by Subject|13|||
16561857|NCT03699124|40525208|FG000|Overall Study|Other reasons|5|||
16561858|NCT03699124|40525209|FG001|Overall Study|Other reasons|3|||
16561859|NCT03699124|40525210|FG002|Overall Study|Other reasons|10|||
16561860|NCT02554513|40525211|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
16130571|NCT00196976|38967055|FG006|Booster Study|Withdrawal by Subject|0|||
16356864|NCT01094288|39793656|FG007|Overall Study|Ongoing Participants|0|||
16356865|NCT03257436|39793659|FG000|Overall Study|Withdrawal by Subject|76|||
16356866|NCT03257436|39793659|FG000|Overall Study|Death|19|||
16356867|NCT01712178|39793660|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
16356868|NCT01712178|39793661|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
16356869|NCT01712178|39793660|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
16356870|NCT01712178|39793661|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
16356871|NCT01712178|39793660|FG000|Overall Study|Lost to Follow-up|0|||
16356872|NCT01712178|39793661|FG001|Overall Study|Lost to Follow-up|1|||
16356873|NCT03980223|39793662|FG000|Overall Study|Lost to Follow-up|3|||
16356874|NCT03980223|39793663|FG001|Overall Study|Lost to Follow-up|7|||
16356875|NCT03980223|39793664|FG002|Overall Study|Lost to Follow-up|10|||
16356876|NCT03980223|39793665|FG003|Overall Study|Lost to Follow-up|8|||
16356877|NCT03980223|39793662|FG000|Overall Study|Withdrawal by Subject|0|||
16356878|NCT03980223|39793663|FG001|Overall Study|Withdrawal by Subject|0|||
16356879|NCT03980223|39793664|FG002|Overall Study|Withdrawal by Subject|1|||
16356880|NCT03980223|39793665|FG003|Overall Study|Withdrawal by Subject|2|||
16356881|NCT03980223|39793662|FG000|Overall Study|Physician Decision|0|||
16356882|NCT03980223|39793663|FG001|Overall Study|Physician Decision|0|||
16356883|NCT03980223|39793664|FG002|Overall Study|Physician Decision|1|||
16356884|NCT03980223|39793665|FG003|Overall Study|Physician Decision|0|||
16356885|NCT03980223|39793662|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
16356886|NCT03980223|39793663|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
16356887|NCT03980223|39793664|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
16356888|NCT03980223|39793665|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
16356889|NCT01026493|39793668|FG000|Overall Study|Protocol Violation|0|||
16356890|NCT01026493|39793669|FG001|Overall Study|Protocol Violation|1|||
16356891|NCT01026493|39793670|FG002|Overall Study|Protocol Violation|0|||
16356892|NCT01026493|39793671|FG003|Overall Study|Protocol Violation|0|||
16356893|NCT01026493|39793672|FG004|Overall Study|Protocol Violation|2|||
16356894|NCT01026493|39793673|FG005|Overall Study|Protocol Violation|3|||
16356895|NCT01026493|39793674|FG006|Overall Study|Protocol Violation|4|||
16356896|NCT01026493|39793675|FG007|Overall Study|Protocol Violation|1|||
16356897|NCT02295644|39793676|FG000|Overall Study|Did not meet inclusion criterion|0|||
16356898|NCT02295644|39793677|FG001|Overall Study|Did not meet inclusion criterion|0|||
16356899|NCT02295644|39793678|FG002|Overall Study|Did not meet inclusion criterion|1|||
16356900|NCT02295644|39793679|FG003|Overall Study|Did not meet inclusion criterion|2|||
16356901|NCT01764841|39793680|FG000|Overall Study|Logistical Difficulties|0|||
16561861|NCT02554513|40525212|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
16561862|NCT01244984|40525213|FG000|Overall Study|Adverse Event|2|||
16561863|NCT01244984|40525214|FG001|Overall Study|Adverse Event|11|||
16561864|NCT01244984|40525215|FG002|Overall Study|Adverse Event|2|||
16561865|NCT01244984|40525213|FG000|Overall Study|Protocol Violation|1|||
16561866|NCT01244984|40525214|FG001|Overall Study|Protocol Violation|0|||
16561867|NCT01244984|40525215|FG002|Overall Study|Protocol Violation|0|||
16561868|NCT01244984|40525213|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
16561869|NCT01244984|40525214|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
16561870|NCT01244984|40525215|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
16561871|NCT01244984|40525213|FG000|Overall Study|Withdrawal by Subject|1|||
16561872|NCT01244984|40525214|FG001|Overall Study|Withdrawal by Subject|2|||
16561873|NCT01244984|40525215|FG002|Overall Study|Withdrawal by Subject|2|||
16561874|NCT02825043|40525216|FG000|Overall Study|Lost to Follow-up|4|||
16561875|NCT00551213|40525217|FG000|Overall Study|Adverse Event|6|||
16561876|NCT00551213|40525218|FG001|Overall Study|Adverse Event|3|||
16561877|NCT00551213|40525217|FG000|Overall Study|Progressive Disease|41|||
16561878|NCT00551213|40525218|FG001|Overall Study|Progressive Disease|12|||
16561879|NCT00551213|40525217|FG000|Overall Study|Withdrawal by Subject|2|||
16561880|NCT00551213|40525218|FG001|Overall Study|Withdrawal by Subject|0|||
16561881|NCT00551213|40525217|FG000|Overall Study|Not Treated|1|||
16561882|NCT00551213|40525218|FG001|Overall Study|Not Treated|2|||
16561883|NCT00561574|40525225|FG000|Overall Study|Adverse Event|21|||
16561884|NCT00561574|40525226|FG001|Overall Study|Adverse Event|24|||
16561885|NCT00561574|40525225|FG000|Overall Study|Lack of Efficacy|11|||
16561886|NCT00561574|40525226|FG001|Overall Study|Lack of Efficacy|21|||
16561887|NCT00561574|40525225|FG000|Overall Study|Withdrawal by Subject|4|||
16561888|NCT00561574|40525226|FG001|Overall Study|Withdrawal by Subject|4|||
16561889|NCT00561574|40525225|FG000|Overall Study|Reason Unrelated to Trial|6|||
16561890|NCT00561574|40525226|FG001|Overall Study|Reason Unrelated to Trial|2|||
16561891|NCT00561574|40525225|FG000|Overall Study|Lost to Follow-up|1|||
16561892|NCT00561574|40525226|FG001|Overall Study|Lost to Follow-up|0|||
16561893|NCT00561574|40525225|FG000|Overall Study|Other|5|||
16561894|NCT00561574|40525226|FG001|Overall Study|Other|7|||
16561895|NCT04668144|40525227|FG000|Overall Study|Protocol Violation|0|||
16561896|NCT04668144|40525228|FG001|Overall Study|Protocol Violation|1|||
16356902|NCT01764841|39793681|FG001|Overall Study|Logistical Difficulties|1|||
16356903|NCT01764841|39793682|FG002|Overall Study|Logistical Difficulties|0|||
16356904|NCT01764841|39793683|FG003|Overall Study|Logistical Difficulties|0|||
16356905|NCT01764841|39793680|FG000|Overall Study|Death|3|||
16356906|NCT01764841|39793681|FG001|Overall Study|Death|0|||
16356907|NCT01764841|39793682|FG002|Overall Study|Death|1|||
16356908|NCT01764841|39793683|FG003|Overall Study|Death|4|||
16356909|NCT01764841|39793680|FG000|Overall Study|No Follow Up|1|||
16418664|NCT01455194|40011915|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
16418665|NCT01455194|40011912|FG000|Overall Study|Miscellaneous|4|||
16418666|NCT01455194|40011913|FG001|Overall Study|Miscellaneous|5|||
16418667|NCT01455194|40011914|FG002|Overall Study|Miscellaneous|1|||
16561897|NCT04668144|40525229|FG002|Overall Study|Protocol Violation|2|||
16561898|NCT01251614|40525234|FG000|Overall Study|Adverse Event|1|||
16561899|NCT01251614|40525235|FG001|Overall Study|Adverse Event|0|||
16561900|NCT01251614|40525236|FG002|Overall Study|Adverse Event|1|||
16130572|NCT00196976|38967056|FG007|Booster Study|Withdrawal by Subject|0|||
16356910|NCT01764841|39793681|FG001|Overall Study|No Follow Up|0|||
16356911|NCT01764841|39793682|FG002|Overall Study|No Follow Up|1|||
16356912|NCT01764841|39793683|FG003|Overall Study|No Follow Up|0|||
16356913|NCT01764841|39793680|FG000|Overall Study|Protocol Violation|0|||
16356914|NCT01764841|39793681|FG001|Overall Study|Protocol Violation|1|||
16356915|NCT01764841|39793682|FG002|Overall Study|Protocol Violation|0|||
16356916|NCT01764841|39793683|FG003|Overall Study|Protocol Violation|0|||
16356917|NCT01764841|39793680|FG000|Overall Study|Withdrawal by Subject|16|||
16356918|NCT01764841|39793681|FG001|Overall Study|Withdrawal by Subject|24|||
16356919|NCT01764841|39793682|FG002|Overall Study|Withdrawal by Subject|11|||
16356920|NCT01764841|39793683|FG003|Overall Study|Withdrawal by Subject|15|||
16356921|NCT01764841|39793680|FG000|Overall Study|Lost to Follow-up|3|||
16356922|NCT01764841|39793681|FG001|Overall Study|Lost to Follow-up|0|||
16356923|NCT01764841|39793682|FG002|Overall Study|Lost to Follow-up|1|||
16356924|NCT01764841|39793683|FG003|Overall Study|Lost to Follow-up|0|||
16356925|NCT00368108|39793686|FG000|Overall Study|Adverse Event|38|||
16356926|NCT00368108|39793687|FG001|Overall Study|Adverse Event|26|||
16356927|NCT00368108|39793688|FG002|Overall Study|Adverse Event|44|||
16356928|NCT00368108|39793686|FG000|Overall Study|Abnormal Laboratory Value|0|||
16356929|NCT00368108|39793687|FG001|Overall Study|Abnormal Laboratory Value|0|||
16356930|NCT00368108|39793688|FG002|Overall Study|Abnormal Laboratory Value|3|||
16356931|NCT00368108|39793686|FG000|Overall Study|Protocol Violation|5|||
16356932|NCT00368108|39793687|FG001|Overall Study|Protocol Violation|9|||
16356933|NCT00368108|39793688|FG002|Overall Study|Protocol Violation|9|||
16356934|NCT00368108|39793686|FG000|Overall Study|Withdrawal by Subject|9|||
16356935|NCT00368108|39793687|FG001|Overall Study|Withdrawal by Subject|3|||
16356936|NCT00368108|39793688|FG002|Overall Study|Withdrawal by Subject|5|||
16356937|NCT00368108|39793686|FG000|Overall Study|Lack of Efficacy|7|||
16356938|NCT00368108|39793687|FG001|Overall Study|Lack of Efficacy|8|||
16356939|NCT00368108|39793688|FG002|Overall Study|Lack of Efficacy|5|||
16356940|NCT00368108|39793686|FG000|Overall Study|Physician Decision|2|||
16356941|NCT00368108|39793687|FG001|Overall Study|Physician Decision|0|||
16356942|NCT00368108|39793688|FG002|Overall Study|Physician Decision|1|||
16356943|NCT00368108|39793686|FG000|Overall Study|Other|3|||
16356944|NCT00368108|39793687|FG001|Overall Study|Other|7|||
16561901|NCT01251614|40525234|FG000|Overall Study|Lack of Efficacy|1|||
16356945|NCT00368108|39793688|FG002|Overall Study|Other|1|||
16356946|NCT02147626|39793689|FG000|Overall Study|Lost to Follow-up|4|||
16418668|NCT01455194|40011915|FG003|Overall Study|Miscellaneous|4|||
16561902|NCT01251614|40525235|FG001|Overall Study|Lack of Efficacy|9|||
16356947|NCT02147626|39793690|FG001|Overall Study|Lost to Follow-up|4|||
16356948|NCT02147626|39793689|FG000|Overall Study|Pregnancy|1|||
16561903|NCT01251614|40525236|FG002|Overall Study|Lack of Efficacy|4|||
16561904|NCT01251614|40525234|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
16356949|NCT02147626|39793690|FG001|Overall Study|Pregnancy|2|||
16356950|NCT02147626|39793689|FG000|Overall Study|Withdrawal by Subject|0|||
16356951|NCT02147626|39793690|FG001|Overall Study|Withdrawal by Subject|1|||
16356952|NCT00891813|39793697|FG000|Overall Study|Adverse Event|3|||
16356953|NCT00891813|39793697|FG000|Overall Study|Withdrawal by Subject|1|||
16356954|NCT00891813|39793697|FG000|Overall Study|Patient Noncompliance|6|||
16356955|NCT00891813|39793697|FG000|Overall Study|Protocol Violation|2|||
16356956|NCT00721799|39793700|FG000|Overall Study|Withdrawal by Subject|7|||
16356957|NCT00721799|39793700|FG000|Overall Study|withdraw by subject after scan 1|1|||
16356958|NCT02425904|39793701|FG000|Overall Study|Lost to Follow-up|1|||
16356959|NCT02425904|39793702|FG001|Overall Study|Lost to Follow-up|0|||
16356960|NCT02425904|39793701|FG000|Overall Study|Withdrawal by Subject|2|||
16356961|NCT02425904|39793702|FG001|Overall Study|Withdrawal by Subject|0|||
16356962|NCT02425904|39793701|FG000|Overall Study|Death|0|||
16356963|NCT02425904|39793702|FG001|Overall Study|Death|3|||
16356964|NCT03834350|39793705|FG000|Overall Study|Withdrawal by Subject|1|||
16356965|NCT01673386|39793706|FG000|Overall Study|Study terminated by sponsor|16|||
16356966|NCT01673386|39793707|FG001|Overall Study|Study terminated by sponsor|22|||
16356967|NCT01673386|39793706|FG000|Overall Study|Adverse Event|5|||
16356968|NCT01673386|39793707|FG001|Overall Study|Adverse Event|2|||
16356969|NCT01673386|39793706|FG000|Overall Study|Progressive disease|4|||
16356970|NCT01673386|39793707|FG001|Overall Study|Progressive disease|1|||
16356971|NCT01673386|39793706|FG000|Overall Study|Withdrawal by Subject|0|||
16356972|NCT01673386|39793707|FG001|Overall Study|Withdrawal by Subject|2|||
16356973|NCT01977846|39793708|FG000|Total Study - Prospective|Death|0|||
16356974|NCT01977846|39793709|FG001|Total Study - Prospective|Death|1|||
16356975|NCT01977846|39793708|FG000|Total Study - Prospective|Lost to Follow-up|0|||
16356976|NCT01977846|39793709|FG001|Total Study - Prospective|Lost to Follow-up|8|||
16356977|NCT01977846|39793708|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
16356978|NCT01977846|39793709|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
16356979|NCT01977846|39793708|FG000|Total Study - Prospective|Not available at time of visit|0|||
16356980|NCT01977846|39793709|FG001|Total Study - Prospective|Not available at time of visit|5|||
16356981|NCT01977846|39793708|FG000|Total Study - Prospective|No show|0|||
16356982|NCT01977846|39793709|FG001|Total Study - Prospective|No show|1|||
16356983|NCT01977846|39793708|FG000|Total Study - Prospective|Protocol Violation|0|||
16356984|NCT01977846|39793709|FG001|Total Study - Prospective|Protocol Violation|1|||
16356985|NCT00746551|39793711|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
16356986|NCT00746551|39793712|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
16356987|NCT00746551|39793711|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
16356988|NCT00746551|39793712|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
16356989|NCT00746551|39793711|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
16356990|NCT00746551|39793712|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
16356991|NCT02273167|39793717|FG000|Overall Study|Adverse Event|1|||
16356992|NCT02273167|39793718|FG001|Overall Study|Adverse Event|0|||
16356993|NCT02273167|39793719|FG002|Overall Study|Adverse Event|0|||
16356994|NCT02273167|39793717|FG000|Overall Study|Protocol Violation|3|||
16356995|NCT02273167|39793718|FG001|Overall Study|Protocol Violation|1|||
16356996|NCT02273167|39793719|FG002|Overall Study|Protocol Violation|1|||
16356997|NCT02273167|39793717|FG000|Overall Study|Lost to Follow-up|0|||
16356998|NCT02273167|39793718|FG001|Overall Study|Lost to Follow-up|1|||
16356999|NCT02273167|39793719|FG002|Overall Study|Lost to Follow-up|1|||
16357000|NCT02273167|39793717|FG000|Overall Study|Withdrawal by Subject|10|||
16357001|NCT02273167|39793718|FG001|Overall Study|Withdrawal by Subject|12|||
16357002|NCT02273167|39793719|FG002|Overall Study|Withdrawal by Subject|11|||
16357003|NCT02273167|39793717|FG000|Overall Study|Various|10|||
16357004|NCT02273167|39793718|FG001|Overall Study|Various|9|||
16357005|NCT02273167|39793719|FG002|Overall Study|Various|8|||
16247967|NCT01508936|39391677|FG000|Overall Study|Protocol Violation|2|||
16247968|NCT01508936|39391678|FG001|Overall Study|Protocol Violation|3|||
16247969|NCT01508936|39391677|FG000|Overall Study|Lost to Follow-up|2|||
16247970|NCT01508936|39391678|FG001|Overall Study|Lost to Follow-up|9|||
16247971|NCT01508936|39391677|FG000|Overall Study|Other|0|||
16247972|NCT01508936|39391678|FG001|Overall Study|Other|5|||
16247973|NCT01508936|39391677|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
16247974|NCT01508936|39391678|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
16247975|NCT03734237|39391679|FG000|Overall Study|Lost to Follow-up|1|||
16247976|NCT03734237|39391680|FG001|Overall Study|Lost to Follow-up|3|||
16247977|NCT03734237|39391681|FG002|Overall Study|Lost to Follow-up|0|||
16247978|NCT03734237|39391679|FG000|Overall Study|Withdrawal by Subject|7|||
16247979|NCT03734237|39391680|FG001|Overall Study|Withdrawal by Subject|9|||
16247980|NCT03734237|39391681|FG002|Overall Study|Withdrawal by Subject|10|||
16247981|NCT01333033|39391684|FG000|Overall Study|Ineligible|0|||
16247982|NCT01333033|39391685|FG001|Overall Study|Ineligible|0|||
16247983|NCT01333033|39391686|FG002|Overall Study|Ineligible|0|||
16247984|NCT01333033|39391687|FG003|Overall Study|Ineligible|0|||
16247985|NCT01333033|39391688|FG004|Overall Study|Ineligible|6|||
16247986|NCT01333033|39391689|FG005|Overall Study|Ineligible|8|||
16247987|NCT01333033|39391684|FG000|Overall Study|Withdrawal by Subject|0|||
16247988|NCT01333033|39391685|FG001|Overall Study|Withdrawal by Subject|0|||
16247989|NCT01333033|39391686|FG002|Overall Study|Withdrawal by Subject|0|||
16247990|NCT01333033|39391687|FG003|Overall Study|Withdrawal by Subject|0|||
16247991|NCT01333033|39391688|FG004|Overall Study|Withdrawal by Subject|4|||
16247992|NCT01333033|39391689|FG005|Overall Study|Withdrawal by Subject|2|||
16247993|NCT01333033|39391684|FG000|Overall Study|PET inevaluable|0|||
16247994|NCT01333033|39391685|FG001|Overall Study|PET inevaluable|0|||
16247995|NCT01333033|39391686|FG002|Overall Study|PET inevaluable|0|||
16247996|NCT01333033|39391687|FG003|Overall Study|PET inevaluable|0|||
16247997|NCT01333033|39391688|FG004|Overall Study|PET inevaluable|2|||
16247998|NCT01333033|39391689|FG005|Overall Study|PET inevaluable|4|||
16247999|NCT01333033|39391684|FG000|Overall Study|Adverse Event|0|||
16248000|NCT01333033|39391685|FG001|Overall Study|Adverse Event|0|||
16248001|NCT01333033|39391686|FG002|Overall Study|Adverse Event|0|||
16248002|NCT01333033|39391687|FG003|Overall Study|Adverse Event|0|||
16248003|NCT01333033|39391688|FG004|Overall Study|Adverse Event|2|||
16248004|NCT01333033|39391689|FG005|Overall Study|Adverse Event|1|||
16248005|NCT01333033|39391684|FG000|Overall Study|Progression|0|||
16248006|NCT01333033|39391685|FG001|Overall Study|Progression|0|||
16248007|NCT01333033|39391686|FG002|Overall Study|Progression|0|||
16248008|NCT01333033|39391687|FG003|Overall Study|Progression|0|||
16248009|NCT01333033|39391688|FG004|Overall Study|Progression|0|||
16248010|NCT01333033|39391689|FG005|Overall Study|Progression|1|||
16248011|NCT01333033|39391684|FG000|Overall Study|MD Decision|0|||
16248012|NCT01333033|39391685|FG001|Overall Study|MD Decision|0|||
16248013|NCT01333033|39391686|FG002|Overall Study|MD Decision|0|||
16248014|NCT01333033|39391687|FG003|Overall Study|MD Decision|0|||
16248015|NCT01333033|39391688|FG004|Overall Study|MD Decision|0|||
16248016|NCT01333033|39391689|FG005|Overall Study|MD Decision|2|||
16248017|NCT00767325|39391690|FG000|Overall Study|Lack of Efficacy|2|||
16248018|NCT00767325|39391690|FG000|Overall Study|Adverse Event|7|||
16248019|NCT00767325|39391690|FG000|Overall Study|Lost to Follow-up|3|||
16248020|NCT00767325|39391690|FG000|Overall Study|No longer met study criteria|2|||
16248021|NCT00767325|39391690|FG000|Overall Study|Missed visit due to family reasons|1|||
16248022|NCT00481247|39391711|FG000|Overall Study|Death|0|||
16248023|NCT00481247|39391712|FG001|Overall Study|Death|1|||
16248024|NCT00481247|39391711|FG000|Overall Study|Disease progression|18|||
16248025|NCT00481247|39391712|FG001|Overall Study|Disease progression|22|||
16248026|NCT00481247|39391711|FG000|Overall Study|Intolerance|42|||
16248027|NCT00481247|39391712|FG001|Overall Study|Intolerance|17|||
16248028|NCT00481247|39391711|FG000|Overall Study|Treatment failure|10|||
16248029|NCT00481247|39391712|FG001|Overall Study|Treatment failure|14|||
16248030|NCT00481247|39391711|FG000|Overall Study|AE unrelated to study drug|13|||
16248031|NCT00481247|39391712|FG001|Overall Study|AE unrelated to study drug|4|||
16248032|NCT00481247|39391711|FG000|Overall Study|Withdrawal by Subject|8|||
16248033|NCT00481247|39391712|FG001|Overall Study|Withdrawal by Subject|13|||
16248034|NCT00481247|39391711|FG000|Overall Study|Pregnancy|2|||
16248035|NCT00481247|39391712|FG001|Overall Study|Pregnancy|1|||
16248036|NCT00481247|39391711|FG000|Overall Study|Lost to Follow-up|1|||
16248037|NCT00481247|39391712|FG001|Overall Study|Lost to Follow-up|2|||
16248038|NCT00481247|39391711|FG000|Overall Study|Poor compliance/noncompliance|1|||
16357006|NCT01101178|39793727|FG000|Period 1|Withdrawal by Subject|1|||
16357007|NCT01101178|39793728|FG001|Period 1|Withdrawal by Subject|2|||
16357008|NCT01101178|39793727|FG000|Period 1|Positive drug screen|1|||
16357009|NCT01101178|39793728|FG001|Period 1|Positive drug screen|1|||
16357010|NCT01101178|39793727|FG000|Period 1|Adverse Event|2|||
16357011|NCT01101178|39793728|FG001|Period 1|Adverse Event|1|||
16357012|NCT01101178|39793727|FG000|Period 2|Withdrawal by Subject|0|||
16357013|NCT01101178|39793728|FG001|Period 2|Withdrawal by Subject|1|||
16357014|NCT01721798|39793732|FG000|Overall Study|Death|0|||
16357015|NCT01721798|39793733|FG001|Overall Study|Death|0|||
16357016|NCT01721798|39793734|FG002|Overall Study|Death|1|||
16357017|NCT01721798|39793735|FG003|Overall Study|Death|1|||
16357018|NCT01721798|39793732|FG000|Overall Study|Lost to Follow-up|2|||
16357019|NCT01721798|39793733|FG001|Overall Study|Lost to Follow-up|2|||
16418669|NCT01999218|40011916|FG000|Overall Study|Hyperglycemia|18|||
16418670|NCT01999218|40011917|FG001|Overall Study|Hyperglycemia|17|||
16418671|NCT01999218|40011918|FG002|Overall Study|Hyperglycemia|17|||
16418672|NCT01999218|40011916|FG000|Overall Study|Lack of Efficacy|1|||
16418673|NCT01999218|40011917|FG001|Overall Study|Lack of Efficacy|0|||
16418674|NCT01999218|40011918|FG002|Overall Study|Lack of Efficacy|1|||
16418675|NCT01999218|40011916|FG000|Overall Study|Lost to Follow-up|22|||
16418676|NCT01999218|40011917|FG001|Overall Study|Lost to Follow-up|17|||
16357020|NCT01721798|39793734|FG002|Overall Study|Lost to Follow-up|9|||
16357021|NCT01721798|39793735|FG003|Overall Study|Lost to Follow-up|9|||
16357022|NCT01721798|39793732|FG000|Overall Study|Pregnancy|0|||
16357023|NCT01721798|39793733|FG001|Overall Study|Pregnancy|0|||
16357024|NCT01721798|39793734|FG002|Overall Study|Pregnancy|1|||
16357025|NCT01721798|39793735|FG003|Overall Study|Pregnancy|1|||
16357026|NCT01721798|39793732|FG000|Overall Study|Withdrawal by Subject|1|||
16357027|NCT01721798|39793733|FG001|Overall Study|Withdrawal by Subject|0|||
16357028|NCT01721798|39793734|FG002|Overall Study|Withdrawal by Subject|2|||
16357029|NCT01721798|39793735|FG003|Overall Study|Withdrawal by Subject|1|||
16357030|NCT01721798|39793732|FG000|Overall Study|Not eligible for 24 month visit|1|||
16357031|NCT01721798|39793733|FG001|Overall Study|Not eligible for 24 month visit|0|||
16357032|NCT01721798|39793734|FG002|Overall Study|Not eligible for 24 month visit|8|||
16357033|NCT01721798|39793735|FG003|Overall Study|Not eligible for 24 month visit|7|||
16357034|NCT00142415|39793737|FG000|Overall Study|Physician Decision|0|||
16418677|NCT01999218|40011918|FG002|Overall Study|Lost to Follow-up|18|||
16357035|NCT00142415|39793738|FG001|Overall Study|Physician Decision|0|||
16357036|NCT00142415|39793739|FG002|Overall Study|Physician Decision|0|||
16357037|NCT00142415|39793740|FG003|Overall Study|Physician Decision|0|||
16357038|NCT00142415|39793741|FG004|Overall Study|Physician Decision|1|||
16357039|NCT00142415|39793742|FG005|Overall Study|Physician Decision|2|||
16418678|NCT01999218|40011916|FG000|Overall Study|Non-Compliance With Study Drug|6|||
16357040|NCT02466399|39793743|FG000|Overall Study|Adverse Event|1|||
16357041|NCT02466399|39793744|FG001|Overall Study|Adverse Event|0|||
16357042|NCT02466399|39793743|FG000|Overall Study|Early exit due to family emergency|1|||
16357043|NCT02466399|39793744|FG001|Overall Study|Early exit due to family emergency|0|||
16357044|NCT01474486|39793746|FG000|Overall Study|Death|2|||
16357045|NCT01474486|39793746|FG000|Overall Study|Withdrawal by Subject|4|||
16357046|NCT01474486|39793746|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
16357047|NCT00737048|39793747|FG000|Overall Study|Physician Decision|0|||
16357048|NCT00737048|39793748|FG001|Overall Study|Physician Decision|0|||
16357049|NCT00737048|39793749|FG002|Overall Study|Physician Decision|1|||
16418679|NCT01999218|40011917|FG001|Overall Study|Non-Compliance With Study Drug|4|||
16418680|NCT01999218|40011918|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16418681|NCT01999218|40011916|FG000|Overall Study|Physician Decision|1|||
16418682|NCT01999218|40011917|FG001|Overall Study|Physician Decision|4|||
16357050|NCT00737048|39793747|FG000|Overall Study|Adverse Event|0|||
16357051|NCT00737048|39793748|FG001|Overall Study|Adverse Event|1|||
16357052|NCT00737048|39793749|FG002|Overall Study|Adverse Event|0|||
16357053|NCT00737048|39793747|FG000|Overall Study|Worsening of the symptoms|3|||
16357054|NCT00737048|39793748|FG001|Overall Study|Worsening of the symptoms|5|||
16357055|NCT00737048|39793749|FG002|Overall Study|Worsening of the symptoms|3|||
16357056|NCT02631941|39793750|FG000|Overall Study|Physician Decision|0|||
16357057|NCT02631941|39793751|FG001|Overall Study|Physician Decision|1|||
16357058|NCT02631941|39793752|FG002|Overall Study|Physician Decision|0|||
16357059|NCT02631941|39793753|FG003|Overall Study|Physician Decision|0|||
16357060|NCT02631941|39793754|FG004|Overall Study|Physician Decision|0|||
16357061|NCT02631941|39793755|FG005|Overall Study|Physician Decision|0|||
16357062|NCT02631941|39793756|FG006|Overall Study|Physician Decision|0|||
16357063|NCT02631941|39793757|FG007|Overall Study|Physician Decision|0|||
16357064|NCT02631941|39793758|FG008|Overall Study|Physician Decision|0|||
16418683|NCT01999218|40011918|FG002|Overall Study|Physician Decision|6|||
16418684|NCT01999218|40011916|FG000|Overall Study|Protocol Violation|4|||
16418685|NCT01999218|40011917|FG001|Overall Study|Protocol Violation|5|||
16418686|NCT01999218|40011918|FG002|Overall Study|Protocol Violation|4|||
16418687|NCT01999218|40011916|FG000|Overall Study|Screen failure|0|||
16418688|NCT01999218|40011917|FG001|Overall Study|Screen failure|1|||
16418689|NCT01999218|40011918|FG002|Overall Study|Screen failure|0|||
16418690|NCT01999218|40011916|FG000|Overall Study|Study Terminated By Sponsor|7|||
16418691|NCT01999218|40011917|FG001|Overall Study|Study Terminated By Sponsor|5|||
16418692|NCT01999218|40011918|FG002|Overall Study|Study Terminated By Sponsor|12|||
16357065|NCT02631941|39793759|FG009|Overall Study|Physician Decision|0|||
16357066|NCT02631941|39793750|FG000|Overall Study|Adverse Event|0|||
16357067|NCT02631941|39793751|FG001|Overall Study|Adverse Event|1|||
16357068|NCT02631941|39793752|FG002|Overall Study|Adverse Event|0|||
16357069|NCT02631941|39793753|FG003|Overall Study|Adverse Event|0|||
16357070|NCT02631941|39793754|FG004|Overall Study|Adverse Event|0|||
16357071|NCT02631941|39793755|FG005|Overall Study|Adverse Event|0|||
16357072|NCT02631941|39793756|FG006|Overall Study|Adverse Event|0|||
16357073|NCT02631941|39793757|FG007|Overall Study|Adverse Event|0|||
16357074|NCT02631941|39793758|FG008|Overall Study|Adverse Event|0|||
16357075|NCT02631941|39793759|FG009|Overall Study|Adverse Event|0|||
16357076|NCT02631941|39793750|FG000|Overall Study|Withdrawal by Subject|0|||
16357077|NCT02631941|39793751|FG001|Overall Study|Withdrawal by Subject|0|||
16357078|NCT02631941|39793752|FG002|Overall Study|Withdrawal by Subject|0|||
16357079|NCT02631941|39793753|FG003|Overall Study|Withdrawal by Subject|0|||
16357080|NCT02631941|39793754|FG004|Overall Study|Withdrawal by Subject|1|||
16357081|NCT02631941|39793755|FG005|Overall Study|Withdrawal by Subject|0|||
16357082|NCT02631941|39793756|FG006|Overall Study|Withdrawal by Subject|0|||
16357083|NCT02631941|39793757|FG007|Overall Study|Withdrawal by Subject|1|||
16357084|NCT02631941|39793758|FG008|Overall Study|Withdrawal by Subject|0|||
16357085|NCT02631941|39793759|FG009|Overall Study|Withdrawal by Subject|0|||
16357086|NCT02631941|39793750|FG000|Overall Study|Lost to Follow-up|0|||
16357087|NCT02631941|39793751|FG001|Overall Study|Lost to Follow-up|0|||
16357088|NCT02631941|39793752|FG002|Overall Study|Lost to Follow-up|0|||
16357089|NCT02631941|39793753|FG003|Overall Study|Lost to Follow-up|0|||
16357090|NCT02631941|39793754|FG004|Overall Study|Lost to Follow-up|0|||
16357091|NCT02631941|39793755|FG005|Overall Study|Lost to Follow-up|0|||
16357092|NCT02631941|39793756|FG006|Overall Study|Lost to Follow-up|0|||
16357093|NCT02631941|39793757|FG007|Overall Study|Lost to Follow-up|0|||
16357094|NCT02631941|39793758|FG008|Overall Study|Lost to Follow-up|1|||
16357095|NCT02631941|39793759|FG009|Overall Study|Lost to Follow-up|0|||
16357096|NCT01663623|39793762|FG000|Overall Study|Adverse Event|3|||
16357097|NCT01663623|39793763|FG001|Overall Study|Adverse Event|7|||
16357098|NCT01663623|39793762|FG000|Overall Study|Lack of Efficacy|5|||
16357099|NCT01663623|39793763|FG001|Overall Study|Lack of Efficacy|6|||
16357100|NCT01663623|39793762|FG000|Overall Study|Protocol Violation|0|||
16357101|NCT01663623|39793763|FG001|Overall Study|Protocol Violation|1|||
16357102|NCT01663623|39793762|FG000|Overall Study|Other-Study closed/terminated|1|||
16357103|NCT01663623|39793763|FG001|Overall Study|Other-Study closed/terminated|1|||
16357104|NCT01663623|39793762|FG000|Overall Study|Physician Decision|1|||
16357105|NCT01663623|39793763|FG001|Overall Study|Physician Decision|4|||
16357106|NCT01663623|39793762|FG000|Overall Study|Withdrawal by Subject|2|||
16357107|NCT01663623|39793763|FG001|Overall Study|Withdrawal by Subject|1|||
16418693|NCT01999218|40011916|FG000|Overall Study|Participant moves|2|||
16357108|NCT02452047|39793764|FG000|Overall Study|Adverse Event|0|||
16357109|NCT02452047|39793765|FG001|Overall Study|Adverse Event|1|||
16357110|NCT02452047|39793766|FG002|Overall Study|Adverse Event|1|||
16357111|NCT02452047|39793764|FG000|Overall Study|Death|1|||
16418694|NCT01999218|40011917|FG001|Overall Study|Participant moves|5|||
16418695|NCT01999218|40011918|FG002|Overall Study|Participant moves|3|||
16418696|NCT01999218|40011916|FG000|Overall Study|Withdrawal by Subject|28|||
16357112|NCT02452047|39793765|FG001|Overall Study|Death|3|||
16357113|NCT02452047|39793766|FG002|Overall Study|Death|1|||
16357114|NCT02452047|39793764|FG000|Overall Study|Physician Decision|1|||
16357115|NCT02452047|39793765|FG001|Overall Study|Physician Decision|0|||
16357116|NCT02452047|39793766|FG002|Overall Study|Physician Decision|0|||
16357117|NCT02452047|39793764|FG000|Overall Study|Lost to Follow-up|1|||
16418697|NCT01999218|40011917|FG001|Overall Study|Withdrawal by Subject|29|||
16418698|NCT01999218|40011918|FG002|Overall Study|Withdrawal by Subject|34|||
16418699|NCT01999218|40011916|FG000|Overall Study|Creatinine/eGFR|0|||
16418700|NCT01999218|40011917|FG001|Overall Study|Creatinine/eGFR|0|||
16418701|NCT01999218|40011918|FG002|Overall Study|Creatinine/eGFR|1|||
16357118|NCT02452047|39793765|FG001|Overall Study|Lost to Follow-up|1|||
16357119|NCT02452047|39793766|FG002|Overall Study|Lost to Follow-up|0|||
16357120|NCT02452047|39793764|FG000|Overall Study|Withdrawal by Subject|1|||
16357121|NCT02452047|39793765|FG001|Overall Study|Withdrawal by Subject|0|||
16357122|NCT02452047|39793766|FG002|Overall Study|Withdrawal by Subject|0|||
16357123|NCT02870868|39793773|FG000|Overall Study|Withdrawal by Subject|2|||
16357124|NCT02870868|39793774|FG001|Overall Study|Withdrawal by Subject|1|||
16357125|NCT03933449|39793775|FG000|Overall Study|Adverse Event|6|||
16357126|NCT03933449|39793776|FG001|Overall Study|Adverse Event|4|||
16357127|NCT03933449|39793775|FG000|Overall Study|Death|55|||
16418702|NCT01999218|40011916|FG000|Overall Study|Death|7|||
16418703|NCT01999218|40011917|FG001|Overall Study|Death|1|||
16418704|NCT01999218|40011918|FG002|Overall Study|Death|2|||
16418705|NCT01999218|40011916|FG000|Overall Study|Excluded Medication|1|||
16418706|NCT01999218|40011917|FG001|Overall Study|Excluded Medication|1|||
16418707|NCT01999218|40011918|FG002|Overall Study|Excluded Medication|2|||
16418708|NCT01999218|40011916|FG000|Overall Study|Adverse Event|9|||
16418709|NCT01999218|40011917|FG001|Overall Study|Adverse Event|7|||
16418710|NCT01999218|40011918|FG002|Overall Study|Adverse Event|7|||
16418711|NCT01999218|40011916|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
16418712|NCT01999218|40011917|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
16418713|NCT01999218|40011918|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
16357128|NCT03933449|39793776|FG001|Overall Study|Death|57|||
16357129|NCT03933449|39793775|FG000|Overall Study|Sponsor Decision|1|||
16357130|NCT03933449|39793776|FG001|Overall Study|Sponsor Decision|0|||
16357131|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
16357132|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16357133|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16357134|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16357135|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16357136|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16357137|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
16357138|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
16357139|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16357140|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16357141|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16357142|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16357143|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16418714|NCT04583956|40011927|FG000|Overall Study|Death|9|||
16418715|NCT04583956|40011928|FG001|Overall Study|Death|11|||
16418716|NCT04583956|40011927|FG000|Overall Study|Lost to Follow-up|7|||
16418717|NCT04583956|40011928|FG001|Overall Study|Lost to Follow-up|9|||
16418718|NCT04583956|40011927|FG000|Overall Study|Protocol Violation|2|||
16418719|NCT04583956|40011928|FG001|Overall Study|Protocol Violation|0|||
16418720|NCT04583956|40011927|FG000|Overall Study|Withdrawal by Subject|0|||
16357144|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
16357145|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16357146|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
16418721|NCT04583956|40011928|FG001|Overall Study|Withdrawal by Subject|2|||
16418722|NCT04583956|40011927|FG000|Overall Study|Randomized but not dosed|2|||
16357147|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16357148|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16357149|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16357150|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16357151|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
16357152|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16357153|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16357154|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
16357155|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16357156|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16357157|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16357158|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
16357159|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16357160|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16418723|NCT04583956|40011928|FG001|Overall Study|Randomized but not dosed|3|||
16418724|NCT04583956|40011927|FG000|Overall Study|Withdrawal of consent before product administration|1|||
16418725|NCT04583956|40011928|FG001|Overall Study|Withdrawal of consent before product administration|0|||
16418726|NCT03689855|40011931|FG000|Overall Study|Adverse Event|3|||
16418727|NCT03689855|40011931|FG000|Overall Study|Withdrawal by Subject|1|||
16418728|NCT02175368|40011932|FG000|Overall Study|Lost to Follow-up|1|||
16418729|NCT02951429|40011933|FG000|Overall Study|Adverse Event|3|||
16418730|NCT02951429|40011934|FG001|Overall Study|Adverse Event|7|||
16418731|NCT02951429|40011933|FG000|Overall Study|Death|28|||
16418732|NCT02951429|40011934|FG001|Overall Study|Death|36|||
16418733|NCT02951429|40011933|FG000|Overall Study|Lack of Efficacy|0|||
16418734|NCT02951429|40011934|FG001|Overall Study|Lack of Efficacy|1|||
16418735|NCT02951429|40011933|FG000|Overall Study|Lost to Follow-up|0|||
16418736|NCT02951429|40011934|FG001|Overall Study|Lost to Follow-up|1|||
16418737|NCT02951429|40011933|FG000|Overall Study|Lung Transplantation|9|||
16418738|NCT02951429|40011934|FG001|Overall Study|Lung Transplantation|6|||
16418739|NCT02951429|40011933|FG000|Overall Study|Other|1|||
16418740|NCT02951429|40011934|FG001|Overall Study|Other|3|||
16418741|NCT02951429|40011933|FG000|Overall Study|Progressive Disease|1|||
16418742|NCT02951429|40011934|FG001|Overall Study|Progressive Disease|1|||
16418743|NCT02951429|40011933|FG000|Overall Study|Withdrawal by Subject|7|||
16418744|NCT02951429|40011934|FG001|Overall Study|Withdrawal by Subject|11|||
16418745|NCT02951429|40011933|FG000|Overall Study|Participant ongoing in the study|23|||
16418746|NCT02951429|40011934|FG001|Overall Study|Participant ongoing in the study|17|||
16418747|NCT02723175|40011935|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
16418748|NCT02723175|40011936|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
16418749|NCT02723175|40011935|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
16418750|NCT02723175|40011936|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
16418751|NCT03684694|40011937|FG000|Phase 1|Withdrawal by Subject|1|||
16418752|NCT03684694|40011938|FG001|Phase 1|Withdrawal by Subject|0|||
16418753|NCT03684694|40011939|FG002|Phase 1|Withdrawal by Subject|0|||
16418754|NCT03684694|40011940|FG003|Phase 1|Withdrawal by Subject|0|||
16418755|NCT03684694|40011941|FG004|Phase 1|Withdrawal by Subject|0|||
16418756|NCT03684694|40011942|FG005|Phase 1|Withdrawal by Subject|0|||
16418757|NCT03684694|40011937|FG000|Phase 1|Investigator/Sponsor Decision|12|||
16418758|NCT03684694|40011938|FG001|Phase 1|Investigator/Sponsor Decision|2|||
16418759|NCT03684694|40011939|FG002|Phase 1|Investigator/Sponsor Decision|1|||
16418760|NCT03684694|40011940|FG003|Phase 1|Investigator/Sponsor Decision|0|||
16418761|NCT03684694|40011941|FG004|Phase 1|Investigator/Sponsor Decision|0|||
16418762|NCT03684694|40011942|FG005|Phase 1|Investigator/Sponsor Decision|0|||
16418763|NCT03684694|40011937|FG000|Phase 1|Death|24|||
16418764|NCT03684694|40011938|FG001|Phase 1|Death|0|||
16418765|NCT03684694|40011939|FG002|Phase 1|Death|3|||
16418766|NCT03684694|40011940|FG003|Phase 1|Death|0|||
16418767|NCT03684694|40011941|FG004|Phase 1|Death|0|||
16418768|NCT03684694|40011942|FG005|Phase 1|Death|0|||
16418769|NCT03684694|40011937|FG000|Phase 1|Lost to Follow-up|0|||
16418770|NCT03684694|40011938|FG001|Phase 1|Lost to Follow-up|0|||
16418771|NCT03684694|40011939|FG002|Phase 1|Lost to Follow-up|1|||
16418772|NCT03684694|40011940|FG003|Phase 1|Lost to Follow-up|0|||
16418773|NCT03684694|40011941|FG004|Phase 1|Lost to Follow-up|0|||
16418774|NCT03684694|40011942|FG005|Phase 1|Lost to Follow-up|0|||
16418775|NCT03684694|40011937|FG000|Phase 1|Miscellaneous|0|||
16418776|NCT03684694|40011938|FG001|Phase 1|Miscellaneous|1|||
16418777|NCT03684694|40011939|FG002|Phase 1|Miscellaneous|0|||
16418778|NCT03684694|40011940|FG003|Phase 1|Miscellaneous|0|||
16418779|NCT03684694|40011941|FG004|Phase 1|Miscellaneous|0|||
16418780|NCT03684694|40011942|FG005|Phase 1|Miscellaneous|0|||
16418781|NCT03684694|40011937|FG000|Phase 2|Withdrawal by Subject|0|||
16418782|NCT03684694|40011938|FG001|Phase 2|Withdrawal by Subject|0|||
16418783|NCT03684694|40011939|FG002|Phase 2|Withdrawal by Subject|0|||
16418784|NCT03684694|40011940|FG003|Phase 2|Withdrawal by Subject|0|||
16418785|NCT03684694|40011941|FG004|Phase 2|Withdrawal by Subject|0|||
16418786|NCT03684694|40011942|FG005|Phase 2|Withdrawal by Subject|1|||
16418787|NCT03684694|40011937|FG000|Phase 2|Investigator/Sponsor Decision|0|||
16418788|NCT03684694|40011938|FG001|Phase 2|Investigator/Sponsor Decision|0|||
16418789|NCT03684694|40011939|FG002|Phase 2|Investigator/Sponsor Decision|0|||
16418790|NCT03684694|40011940|FG003|Phase 2|Investigator/Sponsor Decision|17|||
16418791|NCT03684694|40011941|FG004|Phase 2|Investigator/Sponsor Decision|16|||
16418792|NCT03684694|40011942|FG005|Phase 2|Investigator/Sponsor Decision|6|||
16418793|NCT03684694|40011937|FG000|Phase 2|Death|0|||
16418794|NCT03684694|40011938|FG001|Phase 2|Death|0|||
16418795|NCT03684694|40011939|FG002|Phase 2|Death|0|||
16418796|NCT03684694|40011940|FG003|Phase 2|Death|28|||
16418797|NCT03684694|40011941|FG004|Phase 2|Death|14|||
16418798|NCT03684694|40011942|FG005|Phase 2|Death|3|||
16418799|NCT03684694|40011937|FG000|Phase 2|Lost to Follow-up|0|||
16418800|NCT03684694|40011938|FG001|Phase 2|Lost to Follow-up|0|||
16418801|NCT03684694|40011939|FG002|Phase 2|Lost to Follow-up|0|||
16418802|NCT03684694|40011940|FG003|Phase 2|Lost to Follow-up|1|||
16418803|NCT03684694|40011941|FG004|Phase 2|Lost to Follow-up|0|||
16418804|NCT03684694|40011942|FG005|Phase 2|Lost to Follow-up|0|||
16418805|NCT03684694|40011937|FG000|Phase 2|Miscellaneous|0|||
16418806|NCT03684694|40011938|FG001|Phase 2|Miscellaneous|0|||
16418807|NCT03684694|40011939|FG002|Phase 2|Miscellaneous|0|||
16418808|NCT03684694|40011940|FG003|Phase 2|Miscellaneous|3|||
16418809|NCT03684694|40011941|FG004|Phase 2|Miscellaneous|0|||
16418810|NCT03684694|40011942|FG005|Phase 2|Miscellaneous|0|||
16418811|NCT05392803|40011945|FG000|Overall Study|Lost to Follow-up|0|||
16418812|NCT05392803|40011946|FG001|Overall Study|Lost to Follow-up|2|||
16418813|NCT01274429|40011951|FG000|Overall Study|Study closed do to lack of funding|5|||
16418814|NCT00324233|40011952|FG000|First Period|unable to insert catheter|1|||
16418815|NCT00324233|40011953|FG001|First Period|unable to insert catheter|0|||
16418816|NCT00324233|40011952|FG000|Second Period|unable to insert catheter|1|||
16418817|NCT00324233|40011953|FG001|Second Period|unable to insert catheter|1|||
16418818|NCT00324233|40011952|FG000|Second Period|Protocol Violation|4|||
16418819|NCT00324233|40011953|FG001|Second Period|Protocol Violation|6|||
16418820|NCT00086411|40011954|FG000|Overall Study|Lost to Follow-up|11|||
16418821|NCT00086411|40011955|FG001|Overall Study|Lost to Follow-up|11|||
16418822|NCT00086411|40011956|FG002|Overall Study|Lost to Follow-up|13|||
16418823|NCT00086411|40011957|FG003|Overall Study|Lost to Follow-up|12|||
16418824|NCT03235089|40011958|FG000|Overall Study|Lost to Follow-up|1|||
16418825|NCT03235089|40011959|FG001|Overall Study|Lost to Follow-up|1|||
16418826|NCT03235089|40011958|FG000|Overall Study|Physician Decision|2|||
16418827|NCT03235089|40011959|FG001|Overall Study|Physician Decision|2|||
16418828|NCT00471887|40011960|FG000|Overall Study|Adverse Event|9|||
16418829|NCT02690714|40011961|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
16418830|NCT02690714|40011961|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
16418831|NCT01220180|40011978|FG000|Overall Study|Lost to Follow-up|76|||
16418832|NCT01220180|40011978|FG000|Overall Study|Other|72|||
16418833|NCT01220180|40011978|FG000|Overall Study|Adverse Event|35|||
16418834|NCT01220180|40011978|FG000|Overall Study|Lack of Efficacy|22|||
16418835|NCT01220180|40011978|FG000|Overall Study|Death|1|||
16418836|NCT01220180|40011978|FG000|Overall Study|Randomized but not treated|1|||
16418837|NCT00042666|40011979|FG000|Overall Study|Adverse Event|2|||
16418838|NCT00042666|40011979|FG000|Overall Study|Death|4|||
16418839|NCT00042666|40011979|FG000|Overall Study|Protocol Violation|1|||
16418840|NCT00042666|40011979|FG000|Overall Study|Participant/Physician Perception|1|||
16418841|NCT00042666|40011979|FG000|Overall Study|Progressive Disease|41|||
16248039|NCT00481247|39391712|FG001|Overall Study|Poor compliance/noncompliance|7|||
16418842|NCT00042666|40011979|FG000|Overall Study|Other|1|||
16418843|NCT00042666|40011979|FG000|Overall Study|Other|4|||
16418844|NCT03159104|40011988|FG000|Overall Study|Violation of inclusion criteria|1|||
16418845|NCT03159104|40011989|FG001|Overall Study|Violation of inclusion criteria|2|||
16418846|NCT02708485|40011990|FG000|Overall Study|Withdrawal by Subject|3|||
16418847|NCT02708485|40011991|FG001|Overall Study|Withdrawal by Subject|2|||
16418848|NCT03238248|40011998|FG000|Overall Study|Death|5|||
16418849|NCT03238248|40011998|FG000|Overall Study|Withdrawal by Subject|7|||
16418850|NCT03238248|40011998|FG000|Overall Study|Participant proceeding to transplant|10|||
16418851|NCT03238248|40011998|FG000|Overall Study|Lack of Efficacy|4|||
16418852|NCT03238248|40011998|FG000|Overall Study|Physician Decision|3|||
16418853|NCT03238248|40011998|FG000|Overall Study|Transitioning to another study|1|||
16418854|NCT03238248|40011998|FG000|Overall Study|No longer benefiting|1|||
16418855|NCT03238248|40011998|FG000|Overall Study|Other complicating disease|1|||
16418856|NCT03238248|40011998|FG000|Overall Study|Adverse Event|5|||
16418857|NCT03238248|40011998|FG000|Overall Study|Disease progression|26|||
16418858|NCT03238248|40011998|FG000|Overall Study|N/A participant is still on treatment|1|||
16418859|NCT03238248|40011998|FG000|Overall Study|Decline in condition|1|||
16418860|NCT03238248|40011998|FG000|Overall Study|Alternative therapy|2|||
16418861|NCT02202538|40015344|FG000|Overall Study|Withdrawal by Subject|5|||
16418862|NCT02202538|40015344|FG000|Overall Study|Did not meet all inclusion criteria|2|||
16418863|NCT02202538|40015344|FG000|Overall Study|Investigator Decision|1|||
16418864|NCT00679172|40015347|FG000|Overall Study|Non-compliance|1|||
16357161|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
16357162|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16357163|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16357164|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16357165|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
16357166|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16357167|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16357168|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
16357169|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16357170|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16357171|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16357172|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
16357173|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16357174|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16357175|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16357176|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
16418865|NCT00679172|40015348|FG001|Overall Study|Non-compliance|1|||
16418866|NCT00679172|40015349|FG002|Overall Study|Non-compliance|0|||
16418867|NCT00679172|40015350|FG003|Overall Study|Non-compliance|1|||
16418868|NCT00679172|40015351|FG004|Overall Study|Non-compliance|0|||
16418869|NCT00679172|40015347|FG000|Overall Study|Other not specified|0|||
16418870|NCT00679172|40015348|FG001|Overall Study|Other not specified|0|||
16418871|NCT00679172|40015349|FG002|Overall Study|Other not specified|1|||
16418872|NCT00679172|40015350|FG003|Overall Study|Other not specified|0|||
16418873|NCT00679172|40015351|FG004|Overall Study|Other not specified|0|||
16418874|NCT02301624|40015354|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
16418875|NCT02301624|40015355|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
16418876|NCT02301624|40015354|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
16418877|NCT02301624|40015355|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
16418878|NCT02301624|40015354|FG000|Open-label Maintenance Phase|Adverse Event|2|||
16561905|NCT01251614|40525235|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
16561906|NCT01251614|40525236|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
16561907|NCT01251614|40525234|FG000|Overall Study|Pregnancy|0|||
16561908|NCT01251614|40525235|FG001|Overall Study|Pregnancy|0|||
16561909|NCT01251614|40525236|FG002|Overall Study|Pregnancy|2|||
16561910|NCT01251614|40525234|FG000|Overall Study|Loss of Disease Control|0|||
16561911|NCT01251614|40525235|FG001|Overall Study|Loss of Disease Control|1|||
16357177|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16357178|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16357179|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
16357180|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16357181|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16357182|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16357183|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
16357184|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16357185|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16357186|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
16357187|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16357188|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16357189|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16357190|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16357191|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
16357192|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16357193|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
16357194|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16357195|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16418879|NCT02301624|40015355|FG001|Open-label Maintenance Phase|Adverse Event|5|||
16418880|NCT02301624|40015354|FG000|Open-label Maintenance Phase|Physician Decision|3|||
16418881|NCT02301624|40015355|FG001|Open-label Maintenance Phase|Physician Decision|3|||
16418882|NCT02301624|40015354|FG000|Open-label Maintenance Phase|Death|2|||
16561912|NCT01251614|40525236|FG002|Overall Study|Loss of Disease Control|0|||
16561913|NCT01251614|40525234|FG000|Overall Study|Withdrawal by Subject|0|||
16561914|NCT01251614|40525235|FG001|Overall Study|Withdrawal by Subject|2|||
16561915|NCT01251614|40525236|FG002|Overall Study|Withdrawal by Subject|1|||
16561916|NCT01251614|40525234|FG000|Overall Study|Lost to Follow-up|0|||
16561917|NCT01251614|40525235|FG001|Overall Study|Lost to Follow-up|1|||
16561918|NCT01251614|40525236|FG002|Overall Study|Lost to Follow-up|0|||
16561919|NCT00372567|40525237|FG000|Phase 3 Study|Adverse Event|5|||
16561920|NCT00372567|40525238|FG001|Phase 3 Study|Adverse Event|1|||
16561921|NCT00372567|40525239|FG002|Phase 3 Study|Adverse Event|1|||
16357196|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16357197|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16357198|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
16357199|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16357200|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
16357201|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16357202|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16357203|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16357204|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16357205|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
16357206|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16357207|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
16357208|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16357209|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16357210|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16357211|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16357212|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
16357213|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16357214|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
16357215|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16357216|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16357217|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16357218|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16357219|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16357220|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
16357221|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
16357222|NCT01791595|39793778|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16357223|NCT01791595|39793779|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16357224|NCT01791595|39793780|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16357225|NCT01791595|39793781|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16357226|NCT01791595|39793782|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16357227|NCT01791595|39793783|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
16357228|NCT01791595|39793784|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
16357229|NCT01791595|39793778|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16357230|NCT01791595|39793779|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16357231|NCT01791595|39793780|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16357232|NCT01791595|39793781|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16357233|NCT01791595|39793782|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16357234|NCT01791595|39793783|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
16357235|NCT01791595|39793784|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
16357236|NCT01791595|39793778|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16357237|NCT01791595|39793779|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16357238|NCT01791595|39793780|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16357239|NCT01791595|39793781|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16357240|NCT01791595|39793782|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16357241|NCT01791595|39793783|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
16357242|NCT01791595|39793784|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
16357243|NCT01791595|39793778|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16357244|NCT01791595|39793779|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16357245|NCT01791595|39793780|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16357246|NCT01791595|39793781|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16357247|NCT01791595|39793782|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16357248|NCT01791595|39793783|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
16357249|NCT01791595|39793784|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
16357250|NCT01791595|39793778|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16357251|NCT01791595|39793779|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16357252|NCT01791595|39793780|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16357253|NCT01791595|39793781|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16357254|NCT01791595|39793782|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16357255|NCT01791595|39793783|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
16357256|NCT01791595|39793784|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
16357257|NCT02017717|39793785|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16357258|NCT02017717|39793786|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16357259|NCT02017717|39793787|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16357260|NCT02017717|39793788|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
16357261|NCT02017717|39793789|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16357262|NCT02017717|39793790|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16357263|NCT02017717|39793791|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16357264|NCT02017717|39793792|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16357265|NCT02017717|39793793|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
16418883|NCT02301624|40015355|FG001|Open-label Maintenance Phase|Death|1|||
16418884|NCT02301624|40015354|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
16418885|NCT02301624|40015355|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
16418886|NCT01309269|40015356|FG000|Overall Study|Adverse Event|56|||
16418887|NCT01309269|40015356|FG000|Overall Study|Withdrawal by Subject|25|||
16418888|NCT01309269|40015356|FG000|Overall Study|Lack of Acceptance|15|||
16418889|NCT01309269|40015356|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
16418890|NCT01309269|40015356|FG000|Overall Study|Kidney Transplant|25|||
16418891|NCT01309269|40015356|FG000|Overall Study|Administrative Problems|141|||
16357266|NCT02017717|39793785|FG000|Before Treatment Period|Participant request to stop therapy|0|||
16357267|NCT02017717|39793786|FG001|Before Treatment Period|Participant request to stop therapy|0|||
16357268|NCT02017717|39793787|FG002|Before Treatment Period|Participant request to stop therapy|0|||
16357269|NCT02017717|39793788|FG003|Before Treatment Period|Participant request to stop therapy|0|||
16357270|NCT02017717|39793789|FG004|Before Treatment Period|Participant request to stop therapy|5|||
16357271|NCT02017717|39793790|FG005|Before Treatment Period|Participant request to stop therapy|0|||
16357272|NCT02017717|39793791|FG006|Before Treatment Period|Participant request to stop therapy|0|||
16357273|NCT02017717|39793792|FG007|Before Treatment Period|Participant request to stop therapy|0|||
16357274|NCT02017717|39793793|FG008|Before Treatment Period|Participant request to stop therapy|0|||
16357275|NCT02017717|39793785|FG000|Before Treatment Period|Participant withdrew consent|0|||
16357276|NCT02017717|39793786|FG001|Before Treatment Period|Participant withdrew consent|0|||
16357277|NCT02017717|39793787|FG002|Before Treatment Period|Participant withdrew consent|0|||
16357278|NCT02017717|39793788|FG003|Before Treatment Period|Participant withdrew consent|0|||
16357279|NCT02017717|39793789|FG004|Before Treatment Period|Participant withdrew consent|11|||
16357280|NCT02017717|39793790|FG005|Before Treatment Period|Participant withdrew consent|0|||
16357281|NCT02017717|39793791|FG006|Before Treatment Period|Participant withdrew consent|0|||
16357282|NCT02017717|39793792|FG007|Before Treatment Period|Participant withdrew consent|0|||
16357283|NCT02017717|39793793|FG008|Before Treatment Period|Participant withdrew consent|2|||
16357284|NCT02017717|39793785|FG000|Before Treatment Period|Lost to Follow-up|0|||
16357285|NCT02017717|39793786|FG001|Before Treatment Period|Lost to Follow-up|0|||
16357286|NCT02017717|39793787|FG002|Before Treatment Period|Lost to Follow-up|0|||
16357287|NCT02017717|39793788|FG003|Before Treatment Period|Lost to Follow-up|0|||
16357288|NCT02017717|39793789|FG004|Before Treatment Period|Lost to Follow-up|1|||
16357289|NCT02017717|39793790|FG005|Before Treatment Period|Lost to Follow-up|0|||
16357290|NCT02017717|39793791|FG006|Before Treatment Period|Lost to Follow-up|0|||
16357291|NCT02017717|39793792|FG007|Before Treatment Period|Lost to Follow-up|0|||
16357292|NCT02017717|39793793|FG008|Before Treatment Period|Lost to Follow-up|0|||
16357293|NCT02017717|39793785|FG000|Before Treatment Period|Participant no longer met criteria|0|||
16357294|NCT02017717|39793786|FG001|Before Treatment Period|Participant no longer met criteria|0|||
16357295|NCT02017717|39793787|FG002|Before Treatment Period|Participant no longer met criteria|0|||
16357296|NCT02017717|39793788|FG003|Before Treatment Period|Participant no longer met criteria|1|||
16357297|NCT02017717|39793789|FG004|Before Treatment Period|Participant no longer met criteria|2|||
16357298|NCT02017717|39793790|FG005|Before Treatment Period|Participant no longer met criteria|0|||
16418892|NCT01309269|40015356|FG000|Overall Study|Other|256|||
16357299|NCT02017717|39793791|FG006|Before Treatment Period|Participant no longer met criteria|0|||
16418893|NCT01309269|40015356|FG000|Overall Study|Other|1|||
16418894|NCT01309269|40015356|FG000|Overall Study|Study Completion Data Not Recorded|95|||
16418895|NCT01309269|40015356|FG000|Overall Study|Enrolled but not Treated|107|||
16418896|NCT01263015|40015360|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
16418897|NCT01263015|40015361|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
16418898|NCT01263015|40015360|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
16357300|NCT02017717|39793792|FG007|Before Treatment Period|Participant no longer met criteria|1|||
16357301|NCT02017717|39793793|FG008|Before Treatment Period|Participant no longer met criteria|0|||
16357302|NCT02017717|39793785|FG000|Before Treatment Period|other reason|0|||
16357303|NCT02017717|39793786|FG001|Before Treatment Period|other reason|0|||
16357304|NCT02017717|39793787|FG002|Before Treatment Period|other reason|0|||
16357305|NCT02017717|39793788|FG003|Before Treatment Period|other reason|0|||
16357306|NCT02017717|39793789|FG004|Before Treatment Period|other reason|1|||
16357307|NCT02017717|39793790|FG005|Before Treatment Period|other reason|0|||
16357308|NCT02017717|39793791|FG006|Before Treatment Period|other reason|0|||
16357309|NCT02017717|39793792|FG007|Before Treatment Period|other reason|0|||
16357310|NCT02017717|39793793|FG008|Before Treatment Period|other reason|0|||
16357311|NCT02017717|39793785|FG000|Treatment Period|Disease progression|7|||
16357312|NCT02017717|39793786|FG001|Treatment Period|Disease progression|9|||
16357313|NCT02017717|39793787|FG002|Treatment Period|Disease progression|12|||
16357314|NCT02017717|39793788|FG003|Treatment Period|Disease progression|165|||
16357315|NCT02017717|39793789|FG004|Treatment Period|Disease progression|134|||
16357316|NCT02017717|39793790|FG005|Treatment Period|Disease progression|20|||
16357317|NCT02017717|39793791|FG006|Treatment Period|Disease progression|26|||
16357318|NCT02017717|39793792|FG007|Treatment Period|Disease progression|17|||
16357319|NCT02017717|39793793|FG008|Treatment Period|Disease progression|22|||
16357320|NCT02017717|39793785|FG000|Treatment Period|Study drug toxicity|3|||
16357321|NCT02017717|39793786|FG001|Treatment Period|Study drug toxicity|0|||
16357322|NCT02017717|39793787|FG002|Treatment Period|Study drug toxicity|1|||
16357323|NCT02017717|39793788|FG003|Treatment Period|Study drug toxicity|7|||
16357324|NCT02017717|39793789|FG004|Treatment Period|Study drug toxicity|11|||
16357325|NCT02017717|39793790|FG005|Treatment Period|Study drug toxicity|4|||
16357326|NCT02017717|39793791|FG006|Treatment Period|Study drug toxicity|4|||
16357327|NCT02017717|39793792|FG007|Treatment Period|Study drug toxicity|5|||
16357328|NCT02017717|39793793|FG008|Treatment Period|Study drug toxicity|3|||
16357329|NCT02017717|39793785|FG000|Treatment Period|Death|0|||
16357330|NCT02017717|39793786|FG001|Treatment Period|Death|0|||
16357331|NCT02017717|39793787|FG002|Treatment Period|Death|1|||
16418899|NCT01263015|40015361|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
16357332|NCT02017717|39793788|FG003|Treatment Period|Death|0|||
16357333|NCT02017717|39793789|FG004|Treatment Period|Death|0|||
16357334|NCT02017717|39793790|FG005|Treatment Period|Death|0|||
16357335|NCT02017717|39793791|FG006|Treatment Period|Death|0|||
16357336|NCT02017717|39793792|FG007|Treatment Period|Death|1|||
16357337|NCT02017717|39793793|FG008|Treatment Period|Death|0|||
16357338|NCT02017717|39793785|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
16357339|NCT02017717|39793786|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
16357340|NCT02017717|39793787|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
16357341|NCT02017717|39793788|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
16357342|NCT02017717|39793789|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
16357343|NCT02017717|39793790|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
16357344|NCT02017717|39793791|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
16357345|NCT02017717|39793792|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
16357346|NCT02017717|39793793|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
16357347|NCT02017717|39793785|FG000|Treatment Period|Participant request to stop therapy|0|||
16418900|NCT01263015|40015360|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
16418901|NCT01263015|40015361|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
16418902|NCT01263015|40015360|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
16418903|NCT01263015|40015361|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
16418904|NCT01263015|40015360|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
16418905|NCT01263015|40015361|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
16418906|NCT01263015|40015360|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
16418907|NCT01263015|40015361|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
16357348|NCT02017717|39793786|FG001|Treatment Period|Participant request to stop therapy|0|||
16357349|NCT02017717|39793787|FG002|Treatment Period|Participant request to stop therapy|3|||
16357350|NCT02017717|39793788|FG003|Treatment Period|Participant request to stop therapy|4|||
16357351|NCT02017717|39793789|FG004|Treatment Period|Participant request to stop therapy|7|||
16357352|NCT02017717|39793790|FG005|Treatment Period|Participant request to stop therapy|5|||
16357353|NCT02017717|39793791|FG006|Treatment Period|Participant request to stop therapy|0|||
16357354|NCT02017717|39793792|FG007|Treatment Period|Participant request to stop therapy|2|||
16357355|NCT02017717|39793793|FG008|Treatment Period|Participant request to stop therapy|1|||
16357356|NCT02017717|39793785|FG000|Treatment Period|Participant withdrew consent|0|||
16357357|NCT02017717|39793786|FG001|Treatment Period|Participant withdrew consent|0|||
16357358|NCT02017717|39793787|FG002|Treatment Period|Participant withdrew consent|1|||
16357359|NCT02017717|39793788|FG003|Treatment Period|Participant withdrew consent|1|||
16357360|NCT02017717|39793789|FG004|Treatment Period|Participant withdrew consent|4|||
16357361|NCT02017717|39793790|FG005|Treatment Period|Participant withdrew consent|0|||
16357362|NCT02017717|39793791|FG006|Treatment Period|Participant withdrew consent|0|||
16357363|NCT02017717|39793792|FG007|Treatment Period|Participant withdrew consent|2|||
16357364|NCT02017717|39793793|FG008|Treatment Period|Participant withdrew consent|0|||
16357365|NCT02017717|39793785|FG000|Treatment Period|Participant no longer met criteria|0|||
16357366|NCT02017717|39793786|FG001|Treatment Period|Participant no longer met criteria|0|||
16357367|NCT02017717|39793787|FG002|Treatment Period|Participant no longer met criteria|0|||
16357368|NCT02017717|39793788|FG003|Treatment Period|Participant no longer met criteria|0|||
16357369|NCT02017717|39793789|FG004|Treatment Period|Participant no longer met criteria|1|||
16357370|NCT02017717|39793790|FG005|Treatment Period|Participant no longer met criteria|0|||
16418908|NCT01263015|40015360|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
16418909|NCT01263015|40015361|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
16418910|NCT01263015|40015360|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
16418911|NCT01263015|40015361|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
16418912|NCT01263015|40015360|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
16418913|NCT01263015|40015361|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
16418914|NCT01263015|40015360|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
16418915|NCT01263015|40015361|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
16357371|NCT02017717|39793791|FG006|Treatment Period|Participant no longer met criteria|0|||
16357372|NCT02017717|39793792|FG007|Treatment Period|Participant no longer met criteria|0|||
16357373|NCT02017717|39793793|FG008|Treatment Period|Participant no longer met criteria|0|||
16357374|NCT02017717|39793785|FG000|Treatment Period|other reasons|0|||
16357375|NCT02017717|39793786|FG001|Treatment Period|other reasons|0|||
16357376|NCT02017717|39793787|FG002|Treatment Period|other reasons|0|||
16357377|NCT02017717|39793788|FG003|Treatment Period|other reasons|0|||
16357378|NCT02017717|39793789|FG004|Treatment Period|other reasons|1|||
16357379|NCT02017717|39793790|FG005|Treatment Period|other reasons|0|||
16357380|NCT02017717|39793791|FG006|Treatment Period|other reasons|0|||
16357381|NCT02017717|39793792|FG007|Treatment Period|other reasons|1|||
16357382|NCT02017717|39793793|FG008|Treatment Period|other reasons|1|||
16357383|NCT02017717|39793785|FG000|Treatment Period|Maximum clinical benefit|0|||
16357384|NCT02017717|39793786|FG001|Treatment Period|Maximum clinical benefit|0|||
16357385|NCT02017717|39793787|FG002|Treatment Period|Maximum clinical benefit|0|||
16357386|NCT02017717|39793788|FG003|Treatment Period|Maximum clinical benefit|0|||
16357387|NCT02017717|39793789|FG004|Treatment Period|Maximum clinical benefit|1|||
16357388|NCT02017717|39793790|FG005|Treatment Period|Maximum clinical benefit|0|||
16357389|NCT02017717|39793791|FG006|Treatment Period|Maximum clinical benefit|0|||
16357390|NCT02017717|39793792|FG007|Treatment Period|Maximum clinical benefit|0|||
16357391|NCT02017717|39793793|FG008|Treatment Period|Maximum clinical benefit|0|||
16357392|NCT01190813|39793794|FG000|Overall Study|Lost to Follow-up|1|||
16357393|NCT01190813|39793795|FG001|Overall Study|Lost to Follow-up|2|||
16357394|NCT01190813|39793794|FG000|Overall Study|Withdrawal by Subject|2|||
16357395|NCT01190813|39793795|FG001|Overall Study|Withdrawal by Subject|1|||
16357396|NCT01190813|39793794|FG000|Overall Study|Refused study treatment after randomized|1|||
16357397|NCT01190813|39793795|FG001|Overall Study|Refused study treatment after randomized|0|||
16357398|NCT01190813|39793794|FG000|Overall Study|Adverse Event|0|||
16357399|NCT01190813|39793795|FG001|Overall Study|Adverse Event|1|||
16357400|NCT01130272|39793797|FG000|Overall Study|Adverse Event|2|||
16357401|NCT01130272|39793798|FG001|Overall Study|Adverse Event|5|||
16357402|NCT01130272|39793799|FG002|Overall Study|Adverse Event|6|||
16357403|NCT01130272|39793800|FG003|Overall Study|Adverse Event|22|||
16357404|NCT01130272|39793801|FG004|Overall Study|Adverse Event|7|||
16357405|NCT01130272|39793797|FG000|Overall Study|IVRS-confirmed constipation|0|||
16357406|NCT01130272|39793798|FG001|Overall Study|IVRS-confirmed constipation|1|||
16357407|NCT01130272|39793799|FG002|Overall Study|IVRS-confirmed constipation|1|||
16357408|NCT01130272|39793800|FG003|Overall Study|IVRS-confirmed constipation|2|||
16357409|NCT01130272|39793801|FG004|Overall Study|IVRS-confirmed constipation|0|||
16357410|NCT01130272|39793797|FG000|Overall Study|Rescue medications due to diarrhea|3|||
16357411|NCT01130272|39793798|FG001|Overall Study|Rescue medications due to diarrhea|5|||
16357412|NCT01130272|39793799|FG002|Overall Study|Rescue medications due to diarrhea|8|||
16357413|NCT01130272|39793800|FG003|Overall Study|Rescue medications due to diarrhea|8|||
16357414|NCT01130272|39793801|FG004|Overall Study|Rescue medications due to diarrhea|6|||
16357415|NCT01130272|39793797|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
16357416|NCT01130272|39793798|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
16357417|NCT01130272|39793799|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
16357418|NCT01130272|39793800|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
16357419|NCT01130272|39793801|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
16357420|NCT01130272|39793797|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
16357421|NCT01130272|39793798|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
16357422|NCT01130272|39793799|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
16357423|NCT01130272|39793800|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
16357424|NCT01130272|39793801|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
16357425|NCT01130272|39793797|FG000|Overall Study|Protocol Violation|0|||
16357426|NCT01130272|39793798|FG001|Overall Study|Protocol Violation|0|||
16357427|NCT01130272|39793799|FG002|Overall Study|Protocol Violation|3|||
16357428|NCT01130272|39793800|FG003|Overall Study|Protocol Violation|5|||
16357429|NCT01130272|39793801|FG004|Overall Study|Protocol Violation|5|||
16357430|NCT01130272|39793797|FG000|Overall Study|Lost to Follow-up|4|||
16357431|NCT01130272|39793798|FG001|Overall Study|Lost to Follow-up|3|||
16357432|NCT01130272|39793799|FG002|Overall Study|Lost to Follow-up|4|||
16357433|NCT01130272|39793800|FG003|Overall Study|Lost to Follow-up|7|||
16357434|NCT01130272|39793801|FG004|Overall Study|Lost to Follow-up|6|||
16357435|NCT01130272|39793797|FG000|Overall Study|Withdrawal by Subject|4|||
16357436|NCT01130272|39793798|FG001|Overall Study|Withdrawal by Subject|11|||
16248040|NCT00481247|39391711|FG000|Overall Study|Administrative reason by sponsor|157|||
16357437|NCT01130272|39793799|FG002|Overall Study|Withdrawal by Subject|10|||
16357438|NCT01130272|39793800|FG003|Overall Study|Withdrawal by Subject|9|||
16357439|NCT01130272|39793801|FG004|Overall Study|Withdrawal by Subject|8|||
16357440|NCT01130272|39793797|FG000|Overall Study|Physician Decision|1|||
16357441|NCT01130272|39793798|FG001|Overall Study|Physician Decision|1|||
16357442|NCT01130272|39793799|FG002|Overall Study|Physician Decision|0|||
16357443|NCT01130272|39793800|FG003|Overall Study|Physician Decision|1|||
16357444|NCT01130272|39793801|FG004|Overall Study|Physician Decision|2|||
16357445|NCT01130272|39793797|FG000|Overall Study|Sponsor decision|6|||
16357446|NCT01130272|39793798|FG001|Overall Study|Sponsor decision|15|||
16357447|NCT01130272|39793799|FG002|Overall Study|Sponsor decision|16|||
16357448|NCT01130272|39793800|FG003|Overall Study|Sponsor decision|13|||
16357449|NCT01130272|39793801|FG004|Overall Study|Sponsor decision|16|||
16357450|NCT01130272|39793797|FG000|Overall Study|Study arm discontinued|38|||
16357451|NCT01130272|39793798|FG001|Overall Study|Study arm discontinued|0|||
16357452|NCT01130272|39793799|FG002|Overall Study|Study arm discontinued|0|||
16357453|NCT01130272|39793800|FG003|Overall Study|Study arm discontinued|0|||
16357454|NCT01130272|39793801|FG004|Overall Study|Study arm discontinued|0|||
16357455|NCT03817528|39793802|FG000|Overall Study|Withdrawal by Subject|1|||
16357456|NCT03817528|39793802|FG000|Overall Study|Adverse Event|2|||
16357457|NCT00427934|39793803|FG000|Overall Study|Adverse Event|1|||
16357458|NCT00427934|39793804|FG001|Overall Study|Adverse Event|0|||
16357459|NCT00427934|39793805|FG002|Overall Study|Adverse Event|5|||
16357460|NCT00427934|39793806|FG003|Overall Study|Adverse Event|4|||
16357461|NCT00427934|39793803|FG000|Overall Study|Lack of Efficacy|0|||
16357462|NCT00427934|39793804|FG001|Overall Study|Lack of Efficacy|0|||
16357463|NCT00427934|39793805|FG002|Overall Study|Lack of Efficacy|5|||
16357464|NCT00427934|39793806|FG003|Overall Study|Lack of Efficacy|2|||
16357465|NCT00427934|39793803|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
16357466|NCT00427934|39793804|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
16357467|NCT00427934|39793805|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
16357468|NCT00427934|39793806|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
16357469|NCT00427934|39793803|FG000|Overall Study|Other|0|||
16357470|NCT00427934|39793804|FG001|Overall Study|Other|0|||
16357471|NCT00427934|39793805|FG002|Overall Study|Other|11|||
16357472|NCT00427934|39793806|FG003|Overall Study|Other|5|||
16357473|NCT00427934|39793803|FG000|Overall Study|Withdrawal by Subject|0|||
16418916|NCT01263015|40015360|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
16418917|NCT01263015|40015361|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
16418918|NCT01263015|40015360|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
16418919|NCT01263015|40015361|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
16418920|NCT03565237|40015362|FG000|Overall Study|Non-compliance of Investigational Product|1|||
16418921|NCT03565237|40015362|FG000|Overall Study|Physician Decision|1|||
16418922|NCT00293020|40015363|FG000|Overall Study|Withdrawal by Subject|34|||
16418923|NCT00293020|40015363|FG000|Overall Study|Adverse Event|30|||
16418924|NCT00293020|40015363|FG000|Overall Study|Death|32|||
16418925|NCT00293020|40015363|FG000|Overall Study|Lack of Efficacy|12|||
16418926|NCT00293020|40015363|FG000|Overall Study|Lost to Follow-up|4|||
16418927|NCT00293020|40015363|FG000|Overall Study|Protocol Violation|6|||
16418928|NCT00293020|40015363|FG000|Overall Study|Physician Decision|21|||
16418929|NCT00293020|40015363|FG000|Overall Study|Other Reason|22|||
16418930|NCT00293020|40015363|FG000|Overall Study|No dose taken|1|||
16418931|NCT02335424|40015364|FG000|Overall Study|Withdrawal by Subject|19|||
16418932|NCT02335424|40015364|FG000|Overall Study|Adverse Event|25|||
16418933|NCT02335424|40015364|FG000|Overall Study|Death|273|||
16418934|NCT02335424|40015364|FG000|Overall Study|Lost to Follow-up|3|||
16418935|NCT02335424|40015364|FG000|Overall Study|Physician Decision|13|||
16418936|NCT02335424|40015364|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
16418937|NCT02335424|40015364|FG000|Overall Study|Protocol Violation|1|||
16418938|NCT02335424|40015364|FG000|Overall Study|Screen failure|1|||
16418939|NCT00267150|40015365|FG000|Overall Study|Adverse Event|1|||
16418940|NCT03966885|40015372|FG000|Overall Study|Death|1|||
16418941|NCT03966885|40015373|FG001|Overall Study|Death|0|||
16418942|NCT03966885|40015372|FG000|Overall Study|Lost to Follow-up|1|||
16418943|NCT03966885|40015373|FG001|Overall Study|Lost to Follow-up|2|||
16418944|NCT03966885|40015372|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
16418945|NCT03966885|40015373|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
16418946|NCT03966885|40015372|FG000|Overall Study|Moved from study area.|0|||
16418947|NCT03966885|40015373|FG001|Overall Study|Moved from study area.|2|||
16418948|NCT05327361|40015374|FG000|Overall Study|Lost to Follow-up|4|||
16418949|NCT01174173|40015376|FG000|Overall Study|drug-drug interaction|1|||
16418950|NCT01078168|40015381|FG000|Overall Study|Physician Decision|0|||
16357474|NCT00427934|39793804|FG001|Overall Study|Withdrawal by Subject|0|||
16357475|NCT00427934|39793805|FG002|Overall Study|Withdrawal by Subject|1|||
16357476|NCT00427934|39793806|FG003|Overall Study|Withdrawal by Subject|3|||
16357477|NCT01582451|39793817|FG000|Overall Study|Adverse Event|1|||
16357478|NCT01582451|39793818|FG001|Overall Study|Adverse Event|3|||
16357479|NCT01582451|39793817|FG000|Overall Study|Death|3|||
16357480|NCT01582451|39793818|FG001|Overall Study|Death|3|||
16357481|NCT01582451|39793817|FG000|Overall Study|Lost to Follow-up|0|||
16248041|NCT00481247|39391712|FG001|Overall Study|Administrative reason by sponsor|162|||
16248042|NCT00481247|39391711|FG000|Overall Study|Varied|6|||
16248043|NCT00481247|39391712|FG001|Overall Study|Varied|15|||
16248044|NCT00481247|39391711|FG000|Overall Study|Did not receive treatment|1|||
16248045|NCT00481247|39391712|FG001|Overall Study|Did not receive treatment|2|||
16248046|NCT00936975|39391713|FG000|Overall Study|Withdrawal by Subject|1|||
16248047|NCT00936975|39391713|FG000|Overall Study|Disease progression|3|||
16248048|NCT00936975|39391713|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
16248049|NCT02019979|39391714|FG000|Overall Study|study terminated|14|||
16248050|NCT00693784|39391715|FG000|Overall Study|Lost to Follow-up|2|||
16248051|NCT00693784|39391715|FG000|Overall Study|Withdrawal by Subject|2|||
16248052|NCT03404206|39391716|FG000|Overall Study|Withdrawal by Subject|1|||
16248053|NCT03404206|39391717|FG001|Overall Study|Withdrawal by Subject|1|||
16248054|NCT03404206|39391718|FG002|Overall Study|Withdrawal by Subject|0|||
16248055|NCT03404206|39391716|FG000|Overall Study|Lost to Follow-up|3|||
16248056|NCT03404206|39391717|FG001|Overall Study|Lost to Follow-up|1|||
16248057|NCT03404206|39391718|FG002|Overall Study|Lost to Follow-up|0|||
16248058|NCT00798889|39391719|FG000|Overall Study|Adverse Event|53|||
16248059|NCT00798889|39391719|FG000|Overall Study|Protocol Violation|2|||
16248060|NCT00798889|39391719|FG000|Overall Study|Withdrawal by Subject|31|||
16248061|NCT00798889|39391719|FG000|Overall Study|Lost to Follow-up|1|||
16248062|NCT00798889|39391719|FG000|Overall Study|Lack of Efficacy|213|||
16248063|NCT00798889|39391719|FG000|Overall Study|Decision of Sponsor|11|||
16248064|NCT00798889|39391719|FG000|Overall Study|Enrolled, Not treated|3|||
16248065|NCT01736553|39391723|FG000|Overall Study|Death|12|||
16248066|NCT01736553|39391724|FG001|Overall Study|Death|0|||
16248067|NCT01736553|39391723|FG000|Overall Study|Withdrawal by Subject|5|||
16248068|NCT01736553|39391724|FG001|Overall Study|Withdrawal by Subject|2|||
16248069|NCT01736553|39391723|FG000|Overall Study|Lost to Follow-up|2|||
16248070|NCT01736553|39391724|FG001|Overall Study|Lost to Follow-up|2|||
16248071|NCT03072459|39391725|FG000|Overall Study|Device revised/removed|1|||
16248072|NCT03072459|39391725|FG000|Overall Study|Subject not able to return|1|||
16248073|NCT01717456|39391726|FG000|End of Treatment|Physician Decision|0|||
16248074|NCT01717456|39391727|FG001|End of Treatment|Physician Decision|1|||
16248075|NCT01717456|39391726|FG000|End of Treatment|Lost to Follow-up|0|||
16248076|NCT01717456|39391727|FG001|End of Treatment|Lost to Follow-up|1|||
16357482|NCT01582451|39793818|FG001|Overall Study|Lost to Follow-up|2|||
16357483|NCT01582451|39793817|FG000|Overall Study|Protocol Violation|11|||
16357484|NCT01582451|39793818|FG001|Overall Study|Protocol Violation|3|||
16357485|NCT01582451|39793817|FG000|Overall Study|Withdrawal by Subject|13|||
16357486|NCT01582451|39793818|FG001|Overall Study|Withdrawal by Subject|9|||
16357487|NCT01582451|39793817|FG000|Overall Study|Physician Decision|3|||
16357488|NCT01582451|39793818|FG001|Overall Study|Physician Decision|0|||
16357489|NCT01582451|39793817|FG000|Overall Study|Sponsor Decision|1|||
16357490|NCT01582451|39793818|FG001|Overall Study|Sponsor Decision|0|||
16357491|NCT01619852|39793819|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
16357492|NCT01619852|39793820|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
16357493|NCT01619852|39793819|FG000|3 Month Follow up|Lost to Follow-up|31|||
16357494|NCT01619852|39793820|FG001|3 Month Follow up|Lost to Follow-up|34|||
16357495|NCT03722576|39793821|FG000|Overall Study|Withdrawal by Subject|3|||
16357496|NCT03722576|39793821|FG000|Overall Study|Adverse Event|2|||
16357497|NCT03722576|39793821|FG000|Overall Study|Physician Decision|1|||
16357498|NCT03722576|39793821|FG000|Overall Study|Lost to Follow-up|1|||
16357499|NCT00465179|39793822|FG000|Overall Study|Adverse Event|4|||
16357500|NCT00465179|39793822|FG000|Overall Study|Withdrawal by Subject|2|||
16357501|NCT00465179|39793822|FG000|Overall Study|Progression of Disease|47|||
16357502|NCT02696616|39793824|FG000|Overall Study|Adverse Event|0|||
16357503|NCT02696616|39793825|FG001|Overall Study|Adverse Event|1|||
16357504|NCT02696616|39793826|FG002|Overall Study|Adverse Event|0|||
16357505|NCT02696616|39793827|FG003|Overall Study|Adverse Event|0|||
16357506|NCT02696616|39793828|FG004|Overall Study|Adverse Event|0|||
16357507|NCT02696616|39793829|FG005|Overall Study|Adverse Event|0|||
16357508|NCT02696616|39793830|FG006|Overall Study|Adverse Event|0|||
16357509|NCT00853762|39793832|FG000|Overall Study|Premature Termination|16|||
16357510|NCT00853762|39793833|FG001|Overall Study|Premature Termination|15|||
16357511|NCT00853762|39793834|FG002|Overall Study|Premature Termination|14|||
16357512|NCT00853762|39793835|FG003|Overall Study|Premature Termination|21|||
16357513|NCT00853762|39793832|FG000|Overall Study|Protocol Violation|0|||
16357514|NCT00853762|39793833|FG001|Overall Study|Protocol Violation|0|||
16357515|NCT00853762|39793834|FG002|Overall Study|Protocol Violation|0|||
16357516|NCT00853762|39793835|FG003|Overall Study|Protocol Violation|1|||
16418951|NCT01078168|40015382|FG001|Overall Study|Physician Decision|1|||
16418952|NCT01073930|40015383|FG000|Overall Study|Withdrawal by Subject|3|||
16418953|NCT01073930|40015384|FG001|Overall Study|Withdrawal by Subject|2|||
16418954|NCT01073930|40015383|FG000|Overall Study|Lost to Follow-up|0|||
16418955|NCT01073930|40015384|FG001|Overall Study|Lost to Follow-up|1|||
16418956|NCT01073930|40015383|FG000|Overall Study|Adverse Event|0|||
16418957|NCT01073930|40015384|FG001|Overall Study|Adverse Event|1|||
16418958|NCT01073930|40015383|FG000|Overall Study|Noncompliance with study drug|0|||
16418959|NCT01073930|40015384|FG001|Overall Study|Noncompliance with study drug|1|||
16418960|NCT01073930|40015383|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
16418961|NCT01073930|40015384|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
16418962|NCT01264770|40015385|FG000|Overall Study|Not reported|0|||
16418963|NCT01264770|40015386|FG001|Overall Study|Not reported|0|||
16418964|NCT01264770|40015387|FG002|Overall Study|Not reported|1|||
16418965|NCT01264770|40015388|FG003|Overall Study|Not reported|0|||
16418966|NCT01264770|40015389|FG004|Overall Study|Not reported|0|||
16418967|NCT01264770|40015390|FG005|Overall Study|Not reported|0|||
16418968|NCT01264770|40015385|FG000|Overall Study|e.g., change in circumstances|8|||
16418969|NCT01264770|40015386|FG001|Overall Study|e.g., change in circumstances|3|||
16418970|NCT01264770|40015387|FG002|Overall Study|e.g., change in circumstances|3|||
16418971|NCT01264770|40015388|FG003|Overall Study|e.g., change in circumstances|3|||
16418972|NCT01264770|40015389|FG004|Overall Study|e.g., change in circumstances|4|||
16418973|NCT01264770|40015390|FG005|Overall Study|e.g., change in circumstances|4|||
16418974|NCT01264770|40015385|FG000|Overall Study|Severe non-compliance to protocol|0|||
16418975|NCT01264770|40015386|FG001|Overall Study|Severe non-compliance to protocol|0|||
16357517|NCT00853762|39793832|FG000|Overall Study|Withdrawal by Subject|0|||
16357518|NCT00853762|39793833|FG001|Overall Study|Withdrawal by Subject|0|||
16357519|NCT00853762|39793834|FG002|Overall Study|Withdrawal by Subject|1|||
16357520|NCT00853762|39793835|FG003|Overall Study|Withdrawal by Subject|0|||
16357521|NCT00853762|39793832|FG000|Overall Study|Other|0|||
16357522|NCT00853762|39793833|FG001|Overall Study|Other|2|||
16357523|NCT00853762|39793834|FG002|Overall Study|Other|0|||
16357524|NCT00853762|39793835|FG003|Overall Study|Other|0|||
16357525|NCT00853762|39793832|FG000|Overall Study|Randomised but not Treated|0|||
16357526|NCT00853762|39793833|FG001|Overall Study|Randomised but not Treated|2|||
16357527|NCT00853762|39793834|FG002|Overall Study|Randomised but not Treated|2|||
16357528|NCT00853762|39793835|FG003|Overall Study|Randomised but not Treated|0|||
16357529|NCT00424008|39793838|FG000|Overall Study|Adverse Event|8|||
16357530|NCT00424008|39793839|FG001|Overall Study|Adverse Event|6|||
16357531|NCT00424008|39793838|FG000|Overall Study|Lack of Efficacy|40|||
16357532|NCT00424008|39793839|FG001|Overall Study|Lack of Efficacy|34|||
16357533|NCT00424008|39793838|FG000|Overall Study|Lost to Follow-up|1|||
16357534|NCT00424008|39793839|FG001|Overall Study|Lost to Follow-up|2|||
16357535|NCT00424008|39793838|FG000|Overall Study|Withdrawal by Subject|5|||
16357536|NCT00424008|39793839|FG001|Overall Study|Withdrawal by Subject|8|||
16357537|NCT00424008|39793838|FG000|Overall Study|Noncompliance with protocol|13|||
16418976|NCT01264770|40015387|FG002|Overall Study|Severe non-compliance to protocol|1|||
16418977|NCT01264770|40015388|FG003|Overall Study|Severe non-compliance to protocol|1|||
16418978|NCT01264770|40015389|FG004|Overall Study|Severe non-compliance to protocol|0|||
16418979|NCT01264770|40015390|FG005|Overall Study|Severe non-compliance to protocol|0|||
16357538|NCT00424008|39793839|FG001|Overall Study|Noncompliance with protocol|7|||
16357539|NCT00424008|39793838|FG000|Overall Study|Did not meet protocol eligibility|16|||
16357540|NCT00424008|39793839|FG001|Overall Study|Did not meet protocol eligibility|21|||
16357541|NCT00424008|39793838|FG000|Overall Study|Administrative|266|||
16357542|NCT00424008|39793839|FG001|Overall Study|Administrative|257|||
16357543|NCT00368251|39793840|FG000|Overall Study|SAE, non-fatal|1|||
16357544|NCT00368251|39793841|FG001|Overall Study|SAE, non-fatal|0|||
16357545|NCT00368251|39793842|FG002|Overall Study|SAE, non-fatal|0|||
16357546|NCT00368251|39793840|FG000|Overall Study|AE, non-serious non-fatal|0|||
16357547|NCT00368251|39793841|FG001|Overall Study|AE, non-serious non-fatal|0|||
16418980|NCT01264770|40015385|FG000|Overall Study|Lack of therapeutic response|1|||
16418981|NCT01264770|40015386|FG001|Overall Study|Lack of therapeutic response|0|||
16418982|NCT01264770|40015387|FG002|Overall Study|Lack of therapeutic response|2|||
16418983|NCT01264770|40015388|FG003|Overall Study|Lack of therapeutic response|1|||
16357548|NCT00368251|39793842|FG002|Overall Study|AE, non-serious non-fatal|1|||
16357549|NCT02659943|39793843|FG000|Overall Study|Switched to alternative treatment|1|||
16357550|NCT02659943|39793844|FG001|Overall Study|Switched to alternative treatment|1|||
16357551|NCT02659943|39793845|FG002|Overall Study|Switched to alternative treatment|0|||
16357552|NCT02659943|39793846|FG003|Overall Study|Switched to alternative treatment|2|||
16357553|NCT02659943|39793847|FG004|Overall Study|Switched to alternative treatment|1|||
16357554|NCT02659943|39793848|FG005|Overall Study|Switched to alternative treatment|0|||
16357555|NCT02659943|39793849|FG006|Overall Study|Switched to alternative treatment|1|||
16357556|NCT02659943|39793843|FG000|Overall Study|Disease progression on study|0|||
16357557|NCT02659943|39793844|FG001|Overall Study|Disease progression on study|1|||
16357558|NCT02659943|39793845|FG002|Overall Study|Disease progression on study|1|||
16357559|NCT02659943|39793846|FG003|Overall Study|Disease progression on study|1|||
16357560|NCT02659943|39793847|FG004|Overall Study|Disease progression on study|1|||
16357561|NCT02659943|39793848|FG005|Overall Study|Disease progression on study|4|||
16357562|NCT02659943|39793849|FG006|Overall Study|Disease progression on study|0|||
16357563|NCT02659943|39793843|FG000|Overall Study|Patient's condition per principal investigator|0|||
16561922|NCT00372567|40525237|FG000|Phase 3 Study|Death|1|||
16561923|NCT00372567|40525238|FG001|Phase 3 Study|Death|1|||
16561924|NCT00372567|40525239|FG002|Phase 3 Study|Death|0|||
16561925|NCT00372567|40525237|FG000|Phase 3 Study|Protocol Violation|0|||
16561926|NCT00372567|40525238|FG001|Phase 3 Study|Protocol Violation|0|||
16561927|NCT00372567|40525239|FG002|Phase 3 Study|Protocol Violation|1|||
16561928|NCT00372567|40525237|FG000|Phase 3 Study|Objective progression or relapse|10|||
16561929|NCT00372567|40525238|FG001|Phase 3 Study|Objective progression or relapse|13|||
16561930|NCT00372567|40525239|FG002|Phase 3 Study|Objective progression or relapse|4|||
16561931|NCT00372567|40525237|FG000|Phase 3 Study|Global deterioration of health status|0|||
16561932|NCT00372567|40525238|FG001|Phase 3 Study|Global deterioration of health status|1|||
16561933|NCT00372567|40525239|FG002|Phase 3 Study|Global deterioration of health status|0|||
16357564|NCT02659943|39793844|FG001|Overall Study|Patient's condition per principal investigator|0|||
16561934|NCT00372567|40525237|FG000|Phase 3 Study|Other|2|||
16130573|NCT00196976|38967057|FG008|Booster Study|Withdrawal by Subject|0|||
16130574|NCT00196976|38967058|FG009|Booster Study|Withdrawal by Subject|0|||
16130575|NCT00196976|38967059|FG010|Booster Study|Withdrawal by Subject|1|||
16130576|NCT00196976|38967060|FG011|Booster Study|Withdrawal by Subject|0|||
16130577|NCT00196976|38967061|FG012|Booster Study|Withdrawal by Subject|0|||
16130578|NCT00196976|38967062|FG013|Booster Study|Withdrawal by Subject|0|||
16130579|NCT00196976|38967049|FG000|Booster Study|Lost to Follow-up|0|||
16130580|NCT00196976|38967050|FG001|Booster Study|Lost to Follow-up|0|||
16130581|NCT00196976|38967051|FG002|Booster Study|Lost to Follow-up|0|||
16130582|NCT00196976|38967052|FG003|Booster Study|Lost to Follow-up|0|||
16130583|NCT00196976|38967053|FG004|Booster Study|Lost to Follow-up|0|||
16130584|NCT00196976|38967054|FG005|Booster Study|Lost to Follow-up|0|||
16130585|NCT00196976|38967055|FG006|Booster Study|Lost to Follow-up|0|||
16130586|NCT00196976|38967056|FG007|Booster Study|Lost to Follow-up|0|||
16130587|NCT00196976|38967057|FG008|Booster Study|Lost to Follow-up|0|||
16130588|NCT00196976|38967058|FG009|Booster Study|Lost to Follow-up|0|||
16130589|NCT00196976|38967059|FG010|Booster Study|Lost to Follow-up|1|||
16130590|NCT00196976|38967060|FG011|Booster Study|Lost to Follow-up|2|||
16130591|NCT00196976|38967061|FG012|Booster Study|Lost to Follow-up|0|||
16418984|NCT01264770|40015389|FG004|Overall Study|Lack of therapeutic response|1|||
16357565|NCT02659943|39793845|FG002|Overall Study|Patient's condition per principal investigator|0|||
16357566|NCT02659943|39793846|FG003|Overall Study|Patient's condition per principal investigator|0|||
16357567|NCT02659943|39793847|FG004|Overall Study|Patient's condition per principal investigator|0|||
16357568|NCT02659943|39793848|FG005|Overall Study|Patient's condition per principal investigator|1|||
16357569|NCT02659943|39793849|FG006|Overall Study|Patient's condition per principal investigator|0|||
16130592|NCT00196976|38967062|FG013|Booster Study|Lost to Follow-up|0|||
16130593|NCT00190749|38967063|FG000|Overall Study|Lost to Follow-up|8|||
16130594|NCT00190749|38967064|FG001|Overall Study|Lost to Follow-up|11|||
16130595|NCT00190749|38967063|FG000|Overall Study|Withdrawal by Subject|10|||
16130596|NCT00190749|38967064|FG001|Overall Study|Withdrawal by Subject|6|||
16130597|NCT00190749|38967063|FG000|Overall Study|Protocol Violation|5|||
16130598|NCT00190749|38967064|FG001|Overall Study|Protocol Violation|4|||
16130599|NCT00190749|38967063|FG000|Overall Study|Adverse Event|0|||
16130600|NCT00190749|38967064|FG001|Overall Study|Adverse Event|5|||
16357570|NCT02659943|39793843|FG000|Overall Study|Ineligible|0|||
16357571|NCT02659943|39793844|FG001|Overall Study|Ineligible|0|||
16357572|NCT02659943|39793845|FG002|Overall Study|Ineligible|0|||
16418985|NCT01264770|40015390|FG005|Overall Study|Lack of therapeutic response|0|||
16418986|NCT01264770|40015385|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
16418987|NCT01264770|40015386|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
16418988|NCT01264770|40015387|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
16418989|NCT01264770|40015388|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
16418990|NCT01264770|40015389|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
16418991|NCT01264770|40015390|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
16418992|NCT01264770|40015385|FG000|Overall Study|Lost to Follow-up|0|||
16418993|NCT01264770|40015386|FG001|Overall Study|Lost to Follow-up|0|||
16418994|NCT01264770|40015387|FG002|Overall Study|Lost to Follow-up|1|||
16418995|NCT01264770|40015388|FG003|Overall Study|Lost to Follow-up|1|||
16418996|NCT01264770|40015389|FG004|Overall Study|Lost to Follow-up|0|||
16418997|NCT01264770|40015390|FG005|Overall Study|Lost to Follow-up|0|||
16418998|NCT01264770|40015385|FG000|Overall Study|Adverse Event|7|||
16418999|NCT01264770|40015386|FG001|Overall Study|Adverse Event|7|||
16419000|NCT01264770|40015387|FG002|Overall Study|Adverse Event|8|||
16419001|NCT01264770|40015388|FG003|Overall Study|Adverse Event|0|||
16419002|NCT01264770|40015389|FG004|Overall Study|Adverse Event|2|||
16419003|NCT01264770|40015390|FG005|Overall Study|Adverse Event|1|||
16419004|NCT01620762|40015391|FG000|Overall Study|Protocol Violation|1|||
16561935|NCT00372567|40525238|FG001|Phase 3 Study|Other|2|||
16357573|NCT02659943|39793846|FG003|Overall Study|Ineligible|0|||
16357574|NCT02659943|39793847|FG004|Overall Study|Ineligible|0|||
16357575|NCT02659943|39793848|FG005|Overall Study|Ineligible|0|||
16357576|NCT02659943|39793849|FG006|Overall Study|Ineligible|1|||
16357577|NCT02659943|39793843|FG000|Overall Study|No longer meets eligibility|0|||
16419005|NCT01620762|40015392|FG001|Overall Study|Protocol Violation|1|||
16419006|NCT01620762|40015393|FG002|Overall Study|Protocol Violation|1|||
16419007|NCT01620762|40015391|FG000|Overall Study|Adverse Event|9|||
16419008|NCT01620762|40015392|FG001|Overall Study|Adverse Event|5|||
16419009|NCT01620762|40015393|FG002|Overall Study|Adverse Event|2|||
16419010|NCT01620762|40015391|FG000|Overall Study|Withdrawal by Subject|23|||
16419011|NCT01620762|40015392|FG001|Overall Study|Withdrawal by Subject|26|||
16419012|NCT01620762|40015393|FG002|Overall Study|Withdrawal by Subject|27|||
16419013|NCT01620762|40015391|FG000|Overall Study|Lost to Follow-up|11|||
16419014|NCT01620762|40015392|FG001|Overall Study|Lost to Follow-up|17|||
16419015|NCT01620762|40015393|FG002|Overall Study|Lost to Follow-up|10|||
16419016|NCT01620762|40015391|FG000|Overall Study|Protocol deviation|1|||
16419017|NCT01620762|40015392|FG001|Overall Study|Protocol deviation|1|||
16419018|NCT01620762|40015393|FG002|Overall Study|Protocol deviation|6|||
16130601|NCT00190749|38967063|FG000|Overall Study|Lack of Efficacy|2|||
16130602|NCT00190749|38967064|FG001|Overall Study|Lack of Efficacy|3|||
16130603|NCT00190749|38967063|FG000|Overall Study|Reason Not Specified|0|||
16130604|NCT00190749|38967064|FG001|Overall Study|Reason Not Specified|2|||
16357578|NCT02659943|39793844|FG001|Overall Study|No longer meets eligibility|0|||
16357579|NCT02659943|39793845|FG002|Overall Study|No longer meets eligibility|0|||
16419019|NCT01620762|40015391|FG000|Overall Study|Subject deterioration|0|||
16419020|NCT01620762|40015392|FG001|Overall Study|Subject deterioration|1|||
16419021|NCT01620762|40015393|FG002|Overall Study|Subject deterioration|1|||
16419022|NCT01620762|40015391|FG000|Overall Study|Non-specified|3|||
16419023|NCT01620762|40015392|FG001|Overall Study|Non-specified|6|||
16561936|NCT00372567|40525239|FG002|Phase 3 Study|Other|1|||
16357580|NCT02659943|39793846|FG003|Overall Study|No longer meets eligibility|0|||
16357581|NCT02659943|39793847|FG004|Overall Study|No longer meets eligibility|0|||
16357582|NCT02659943|39793848|FG005|Overall Study|No longer meets eligibility|0|||
16357583|NCT02659943|39793849|FG006|Overall Study|No longer meets eligibility|1|||
16357584|NCT02659943|39793843|FG000|Overall Study|No treatment, per protocol|0|||
16357585|NCT02659943|39793844|FG001|Overall Study|No treatment, per protocol|0|||
16419024|NCT01620762|40015393|FG002|Overall Study|Non-specified|5|||
16419025|NCT01620762|40015391|FG000|Overall Study|Use of prohibted therapies|0|||
16419026|NCT01620762|40015392|FG001|Overall Study|Use of prohibted therapies|1|||
16419027|NCT01620762|40015393|FG002|Overall Study|Use of prohibted therapies|1|||
16419028|NCT02905006|40015394|FG000|Overall Study|Adverse Event|1|||
16419029|NCT02905006|40015395|FG001|Overall Study|Adverse Event|1|||
16419030|NCT02905006|40015396|FG002|Overall Study|Adverse Event|1|||
16419031|NCT02905006|40015397|FG003|Overall Study|Adverse Event|1|||
16419032|NCT02905006|40015398|FG004|Overall Study|Adverse Event|0|||
16419033|NCT02905006|40015399|FG005|Overall Study|Adverse Event|1|||
16419034|NCT02905006|40015394|FG000|Overall Study|Lack of Efficacy|1|||
16419035|NCT02905006|40015395|FG001|Overall Study|Lack of Efficacy|0|||
16561937|NCT00372567|40525237|FG000|Phase 3 Study|study terminated by sponsor|13|||
16561938|NCT00372567|40525238|FG001|Phase 3 Study|study terminated by sponsor|8|||
16561939|NCT00372567|40525239|FG002|Phase 3 Study|study terminated by sponsor|5|||
16561940|NCT01163149|40525240|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
16561941|NCT01163149|40525241|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
16561942|NCT01163149|40525242|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
16561943|NCT01163149|40525240|FG000|Extension Treatment Period|Adverse Event|0|||
16561944|NCT01163149|40525241|FG001|Extension Treatment Period|Adverse Event|1|||
16561945|NCT01163149|40525242|FG002|Extension Treatment Period|Adverse Event|0|||
16561946|NCT01163149|40525240|FG000|Extension Treatment Period|Noncompliance|0|||
16561947|NCT01163149|40525241|FG001|Extension Treatment Period|Noncompliance|0|||
16248077|NCT01717456|39391726|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
16248078|NCT01717456|39391727|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
16248079|NCT01759381|39391728|FG000|Overall Study|Death|1|||
16248080|NCT01759381|39391729|FG001|Overall Study|Death|0|||
16248081|NCT02891200|39391733|FG000|Overall Study|Lost to Follow-up|31|||
16248082|NCT02891200|39391734|FG001|Overall Study|Lost to Follow-up|36|||
16248083|NCT02891200|39391733|FG000|Overall Study|Death|10|||
16248084|NCT02891200|39391734|FG001|Overall Study|Death|9|||
16248085|NCT02891200|39391733|FG000|Overall Study|Withdrawal by Subject|1|||
16248086|NCT02891200|39391734|FG001|Overall Study|Withdrawal by Subject|4|||
16248087|NCT00906347|39391735|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
16248088|NCT00906347|39391736|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
16248089|NCT00906347|39391735|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
16248090|NCT00906347|39391736|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
16248091|NCT00906347|39391735|FG000|Received Study Drug|Refused study drug|1|||
16248092|NCT00906347|39391736|FG001|Received Study Drug|Refused study drug|0|||
16248093|NCT00906347|39391735|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
16248094|NCT00906347|39391736|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
16248095|NCT01579474|39391744|FG000|Overall Study|Adverse Event|1|||
16248096|NCT01579474|39391745|FG001|Overall Study|Adverse Event|13|||
16248097|NCT01579474|39391746|FG002|Overall Study|Adverse Event|2|||
16248098|NCT01579474|39391747|FG003|Overall Study|Adverse Event|0|||
16248099|NCT01579474|39391748|FG004|Overall Study|Adverse Event|0|||
16248100|NCT01579474|39391749|FG005|Overall Study|Adverse Event|1|||
16248101|NCT01579474|39391744|FG000|Overall Study|Lack of Efficacy|1|||
16248102|NCT01579474|39391745|FG001|Overall Study|Lack of Efficacy|0|||
16248103|NCT01579474|39391746|FG002|Overall Study|Lack of Efficacy|0|||
16248104|NCT01579474|39391747|FG003|Overall Study|Lack of Efficacy|0|||
16561948|NCT01163149|40525242|FG002|Extension Treatment Period|Noncompliance|1|||
16561949|NCT04541186|40525246|FG000|Main Study|Adverse Event|0|||
16248105|NCT01579474|39391748|FG004|Overall Study|Lack of Efficacy|1|||
16248106|NCT01579474|39391749|FG005|Overall Study|Lack of Efficacy|0|||
16248107|NCT01579474|39391744|FG000|Overall Study|Withdrawal by Subject|1|||
16248108|NCT01579474|39391745|FG001|Overall Study|Withdrawal by Subject|0|||
16248109|NCT01579474|39391746|FG002|Overall Study|Withdrawal by Subject|0|||
16248110|NCT01579474|39391747|FG003|Overall Study|Withdrawal by Subject|0|||
16248111|NCT01579474|39391748|FG004|Overall Study|Withdrawal by Subject|0|||
16357586|NCT02659943|39793845|FG002|Overall Study|No treatment, per protocol|0|||
16357587|NCT02659943|39793846|FG003|Overall Study|No treatment, per protocol|0|||
16357588|NCT02659943|39793847|FG004|Overall Study|No treatment, per protocol|0|||
16357589|NCT02659943|39793848|FG005|Overall Study|No treatment, per protocol|0|||
16357590|NCT02659943|39793849|FG006|Overall Study|No treatment, per protocol|3|||
16357591|NCT00336544|39793850|FG000|Overall Study|Lack of Efficacy|8|||
16357592|NCT00336544|39793851|FG001|Overall Study|Lack of Efficacy|5|||
16357593|NCT00336544|39793850|FG000|Overall Study|Adverse Event|4|||
16561950|NCT04541186|40525247|FG001|Main Study|Adverse Event|0|||
16561951|NCT04541186|40525248|FG002|Main Study|Adverse Event|4|||
16561952|NCT04541186|40525249|FG003|Main Study|Adverse Event|0|||
16419036|NCT02905006|40015396|FG002|Overall Study|Lack of Efficacy|0|||
16419037|NCT02905006|40015397|FG003|Overall Study|Lack of Efficacy|0|||
16419038|NCT02905006|40015398|FG004|Overall Study|Lack of Efficacy|0|||
16419039|NCT02905006|40015399|FG005|Overall Study|Lack of Efficacy|0|||
16419040|NCT02905006|40015394|FG000|Overall Study|Protocol Violation|2|||
16419041|NCT02905006|40015395|FG001|Overall Study|Protocol Violation|0|||
16419042|NCT02905006|40015396|FG002|Overall Study|Protocol Violation|0|||
16419043|NCT02905006|40015397|FG003|Overall Study|Protocol Violation|0|||
16419044|NCT02905006|40015398|FG004|Overall Study|Protocol Violation|0|||
16419045|NCT02905006|40015399|FG005|Overall Study|Protocol Violation|0|||
16419046|NCT02905006|40015394|FG000|Overall Study|Lost to Follow-up|0|||
16419047|NCT02905006|40015395|FG001|Overall Study|Lost to Follow-up|0|||
16419048|NCT02905006|40015396|FG002|Overall Study|Lost to Follow-up|0|||
16419049|NCT02905006|40015397|FG003|Overall Study|Lost to Follow-up|1|||
16419050|NCT02905006|40015398|FG004|Overall Study|Lost to Follow-up|1|||
16419051|NCT02905006|40015399|FG005|Overall Study|Lost to Follow-up|0|||
16419052|NCT02905006|40015394|FG000|Overall Study|Withdrawal by Subject|0|||
16419053|NCT02905006|40015395|FG001|Overall Study|Withdrawal by Subject|0|||
16419054|NCT02905006|40015396|FG002|Overall Study|Withdrawal by Subject|1|||
16419055|NCT02905006|40015397|FG003|Overall Study|Withdrawal by Subject|1|||
16419056|NCT02905006|40015398|FG004|Overall Study|Withdrawal by Subject|0|||
16419057|NCT02905006|40015399|FG005|Overall Study|Withdrawal by Subject|1|||
16419058|NCT02905006|40015394|FG000|Overall Study|Screening exclusion criteria met|1|||
16419059|NCT02905006|40015395|FG001|Overall Study|Screening exclusion criteria met|0|||
16419060|NCT02905006|40015396|FG002|Overall Study|Screening exclusion criteria met|0|||
16419061|NCT02905006|40015397|FG003|Overall Study|Screening exclusion criteria met|0|||
16419062|NCT02905006|40015398|FG004|Overall Study|Screening exclusion criteria met|0|||
16419063|NCT02905006|40015399|FG005|Overall Study|Screening exclusion criteria met|0|||
16419064|NCT02905006|40015394|FG000|Overall Study|Lab withdrawal criterion met|0|||
16419065|NCT02905006|40015395|FG001|Overall Study|Lab withdrawal criterion met|1|||
16419066|NCT02905006|40015396|FG002|Overall Study|Lab withdrawal criterion met|2|||
16419067|NCT02905006|40015397|FG003|Overall Study|Lab withdrawal criterion met|2|||
16419068|NCT02905006|40015398|FG004|Overall Study|Lab withdrawal criterion met|2|||
16419069|NCT02905006|40015399|FG005|Overall Study|Lab withdrawal criterion met|1|||
16419070|NCT02905006|40015394|FG000|Overall Study|Positive for Tuberculosis|0|||
16419071|NCT02905006|40015395|FG001|Overall Study|Positive for Tuberculosis|1|||
16419072|NCT02905006|40015396|FG002|Overall Study|Positive for Tuberculosis|0|||
16419073|NCT02905006|40015397|FG003|Overall Study|Positive for Tuberculosis|0|||
16561953|NCT04541186|40525250|FG004|Main Study|Adverse Event|0|||
16357594|NCT00336544|39793851|FG001|Overall Study|Adverse Event|9|||
16357595|NCT00336544|39793850|FG000|Overall Study|Withdrawal by Subject|4|||
16357596|NCT00336544|39793851|FG001|Overall Study|Withdrawal by Subject|3|||
16357597|NCT00336544|39793850|FG000|Overall Study|Other|3|||
16357598|NCT00336544|39793851|FG001|Overall Study|Other|5|||
16357599|NCT01317940|39793852|FG000|Overall Study|Death|1|||
16357600|NCT01317940|39793853|FG001|Overall Study|Death|0|||
16357601|NCT01317940|39793854|FG002|Overall Study|Death|1|||
16357602|NCT01317940|39793855|FG003|Overall Study|Death|0|||
16357603|NCT01317940|39793856|FG004|Overall Study|Death|0|||
16561954|NCT04541186|40525246|FG000|Main Study|Investigator Decision|0|||
16561955|NCT04541186|40525247|FG001|Main Study|Investigator Decision|0|||
16561956|NCT04541186|40525248|FG002|Main Study|Investigator Decision|1|||
16130605|NCT00190749|38967063|FG000|Overall Study|Sponsor Decision|1|||
16130606|NCT00190749|38967064|FG001|Overall Study|Sponsor Decision|0|||
16130607|NCT02656823|38967070|FG000|Overall Study|Adverse Event|3|||
16561957|NCT04541186|40525249|FG003|Main Study|Investigator Decision|1|||
16561958|NCT04541186|40525250|FG004|Main Study|Investigator Decision|0|||
16561959|NCT04541186|40525246|FG000|Main Study|Withdrawal by Subject|1|||
16561960|NCT04541186|40525247|FG001|Main Study|Withdrawal by Subject|1|||
16561961|NCT04541186|40525248|FG002|Main Study|Withdrawal by Subject|0|||
16561962|NCT04541186|40525249|FG003|Main Study|Withdrawal by Subject|0|||
16561963|NCT04541186|40525250|FG004|Main Study|Withdrawal by Subject|0|||
16561964|NCT04541186|40525246|FG000|Main Study|COVID-19-related Dose Interruption|0|||
16561965|NCT04541186|40525247|FG001|Main Study|COVID-19-related Dose Interruption|0|||
16561966|NCT04541186|40525248|FG002|Main Study|COVID-19-related Dose Interruption|0|||
16561967|NCT04541186|40525249|FG003|Main Study|COVID-19-related Dose Interruption|0|||
16561968|NCT04541186|40525250|FG004|Main Study|COVID-19-related Dose Interruption|1|||
16561969|NCT04541186|40525246|FG000|Main Study|Randomized in Error Not Treated|0|||
16130608|NCT02656823|38967070|FG000|Overall Study|Lost to Follow-up|2|||
16130609|NCT00513604|38967071|FG000|Overall Study|Not treated|2|||
16130610|NCT00513604|38967072|FG001|Overall Study|Not treated|0|||
16561970|NCT04541186|40525247|FG001|Main Study|Randomized in Error Not Treated|0|||
16561971|NCT04541186|40525248|FG002|Main Study|Randomized in Error Not Treated|1|||
16561972|NCT04541186|40525249|FG003|Main Study|Randomized in Error Not Treated|0|||
16561973|NCT04541186|40525250|FG004|Main Study|Randomized in Error Not Treated|0|||
16130611|NCT00513604|38967073|FG002|Overall Study|Not treated|1|||
16130612|NCT00513604|38967074|FG003|Overall Study|Not treated|0|||
16130613|NCT00513604|38967075|FG004|Overall Study|Not treated|0|||
16130614|NCT00513604|38967071|FG000|Overall Study|Death during treatment|0|||
16130615|NCT00513604|38967072|FG001|Overall Study|Death during treatment|3|||
16130616|NCT00513604|38967073|FG002|Overall Study|Death during treatment|2|||
16130617|NCT00513604|38967074|FG003|Overall Study|Death during treatment|0|||
16561974|NCT04541186|40525246|FG000|Fibrate Expansion Study|Other than Specified|0|||
16561975|NCT04541186|40525247|FG001|Fibrate Expansion Study|Other than Specified|0|||
16357604|NCT01317940|39793857|FG005|Overall Study|Death|0|||
16357605|NCT01317940|39793852|FG000|Overall Study|Lost to Follow-up|0|||
16419074|NCT02905006|40015398|FG004|Overall Study|Positive for Tuberculosis|0|||
16130618|NCT00513604|38967075|FG004|Overall Study|Death during treatment|0|||
16357606|NCT01317940|39793853|FG001|Overall Study|Lost to Follow-up|0|||
16357607|NCT01317940|39793854|FG002|Overall Study|Lost to Follow-up|1|||
16357608|NCT01317940|39793855|FG003|Overall Study|Lost to Follow-up|1|||
16357609|NCT01317940|39793856|FG004|Overall Study|Lost to Follow-up|1|||
16357610|NCT01317940|39793857|FG005|Overall Study|Lost to Follow-up|0|||
16357611|NCT01317940|39793852|FG000|Overall Study|Change in therapy plan|0|||
16357612|NCT01317940|39793853|FG001|Overall Study|Change in therapy plan|0|||
16357613|NCT01317940|39793854|FG002|Overall Study|Change in therapy plan|3|||
16419075|NCT02905006|40015399|FG005|Overall Study|Positive for Tuberculosis|0|||
16419076|NCT02905006|40015394|FG000|Overall Study|Subject positive for Hep B|0|||
16419077|NCT02905006|40015395|FG001|Overall Study|Subject positive for Hep B|0|||
16130619|NCT02704754|38967076|FG000|Overall Study|Lost to Follow-up|1|||
16130620|NCT02704754|38967077|FG001|Overall Study|Lost to Follow-up|1|||
16130621|NCT02704754|38967076|FG000|Overall Study|Lack of Efficacy|1|||
16130622|NCT02704754|38967077|FG001|Overall Study|Lack of Efficacy|0|||
16130623|NCT02704754|38967076|FG000|Overall Study|Withdrawal by Subject|1|||
16130624|NCT02704754|38967077|FG001|Overall Study|Withdrawal by Subject|0|||
16130625|NCT00833261|38967085|FG000|Overall Study|Withdrawal by Subject|4|||
16130626|NCT02951767|38967086|FG000|Overall Study|Study Terminated By Sponsor|9|||
16130627|NCT02951767|38967086|FG000|Overall Study|Withdrawal by Subject|11|||
16130628|NCT02951767|38967086|FG000|Overall Study|Death|96|||
16130629|NCT02951767|38967086|FG000|Overall Study|Lost to Follow-up|2|||
16130630|NCT02951767|38967086|FG000|Overall Study|Physician Decision|1|||
16130631|NCT01154010|38967090|FG000|Overall Study|Lost to Follow-up|0|||
16130632|NCT01154010|38967091|FG001|Overall Study|Lost to Follow-up|1|||
16130633|NCT01659853|38967092|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
16130634|NCT01659853|38967093|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
16130635|NCT01659853|38967092|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
16130636|NCT01659853|38967093|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
16130637|NCT00690443|38967094|FG000|Overall Study|Adverse Event|1|||
16130638|NCT00690443|38967095|FG001|Overall Study|Adverse Event|2|||
16130639|NCT00484289|38967097|FG000|Long Term Phase|Adverse Event|1|||
16130640|NCT00484289|38967098|FG001|Long Term Phase|Adverse Event|17|||
16130641|NCT00484289|38967099|FG002|Long Term Phase|Adverse Event|5|||
16130642|NCT00484289|38967097|FG000|Long Term Phase|Withdrawal by Subject|0|||
16130643|NCT00484289|38967098|FG001|Long Term Phase|Withdrawal by Subject|7|||
16130644|NCT00484289|38967099|FG002|Long Term Phase|Withdrawal by Subject|6|||
16130645|NCT00484289|38967097|FG000|Long Term Phase|Inadequate response|2|||
16130646|NCT00484289|38967098|FG001|Long Term Phase|Inadequate response|7|||
16130647|NCT00484289|38967099|FG002|Long Term Phase|Inadequate response|4|||
16130648|NCT00484289|38967097|FG000|Long Term Phase|Other Reason|0|||
16130649|NCT00484289|38967098|FG001|Long Term Phase|Other Reason|5|||
16130650|NCT00484289|38967099|FG002|Long Term Phase|Other Reason|1|||
16130651|NCT00484289|38967097|FG000|Post Marketing Phase|Adverse Event|0|||
16130652|NCT00484289|38967098|FG001|Post Marketing Phase|Adverse Event|1|||
16130653|NCT00484289|38967099|FG002|Post Marketing Phase|Adverse Event|0|||
16130654|NCT02842827|38967100|FG000|Overall Study|Adverse Event|0|||
16130655|NCT02842827|38967101|FG001|Overall Study|Adverse Event|1|||
16130656|NCT02842827|38967102|FG002|Overall Study|Adverse Event|0|||
16130657|NCT02842827|38967103|FG003|Overall Study|Adverse Event|1|||
16130658|NCT02842827|38967104|FG004|Overall Study|Adverse Event|0|||
16130659|NCT02842827|38967105|FG005|Overall Study|Adverse Event|1|||
16130660|NCT02842827|38967106|FG006|Overall Study|Adverse Event|0|||
16130661|NCT02842827|38967107|FG007|Overall Study|Adverse Event|0|||
16130662|NCT02842827|38967100|FG000|Overall Study|Death|1|||
16130663|NCT02842827|38967101|FG001|Overall Study|Death|0|||
16130664|NCT02842827|38967102|FG002|Overall Study|Death|2|||
16130665|NCT02842827|38967103|FG003|Overall Study|Death|3|||
16130666|NCT02842827|38967104|FG004|Overall Study|Death|2|||
16130667|NCT02842827|38967105|FG005|Overall Study|Death|1|||
16130668|NCT02842827|38967106|FG006|Overall Study|Death|0|||
16130669|NCT02842827|38967107|FG007|Overall Study|Death|4|||
16130670|NCT02842827|38967100|FG000|Overall Study|Physician Decision|1|||
16130671|NCT02842827|38967101|FG001|Overall Study|Physician Decision|3|||
16130672|NCT02842827|38967102|FG002|Overall Study|Physician Decision|0|||
16130673|NCT02842827|38967103|FG003|Overall Study|Physician Decision|0|||
16130674|NCT02842827|38967104|FG004|Overall Study|Physician Decision|1|||
16130675|NCT02842827|38967105|FG005|Overall Study|Physician Decision|4|||
16357614|NCT01317940|39793855|FG003|Overall Study|Change in therapy plan|0|||
16130676|NCT02842827|38967106|FG006|Overall Study|Physician Decision|2|||
16130677|NCT02842827|38967107|FG007|Overall Study|Physician Decision|1|||
16130678|NCT02842827|38967100|FG000|Overall Study|Protocol Defined Disease Progression|0|||
16357615|NCT01317940|39793856|FG004|Overall Study|Change in therapy plan|0|||
16357616|NCT01317940|39793857|FG005|Overall Study|Change in therapy plan|0|||
16130679|NCT02842827|38967101|FG001|Overall Study|Protocol Defined Disease Progression|0|||
16130680|NCT02842827|38967102|FG002|Overall Study|Protocol Defined Disease Progression|0|||
16357617|NCT02674516|39793858|FG000|Overall Study|Lost to Follow-up|3|||
16419078|NCT02905006|40015396|FG002|Overall Study|Subject positive for Hep B|1|||
16419079|NCT02905006|40015397|FG003|Overall Study|Subject positive for Hep B|0|||
16419080|NCT02905006|40015398|FG004|Overall Study|Subject positive for Hep B|0|||
16419081|NCT02905006|40015399|FG005|Overall Study|Subject positive for Hep B|0|||
16419082|NCT02905006|40015394|FG000|Overall Study|Patient moved abroad|0|||
16419083|NCT02905006|40015395|FG001|Overall Study|Patient moved abroad|0|||
16419084|NCT02905006|40015396|FG002|Overall Study|Patient moved abroad|0|||
16419085|NCT02905006|40015397|FG003|Overall Study|Patient moved abroad|1|||
16357618|NCT02674516|39793859|FG001|Overall Study|Lost to Follow-up|0|||
16357619|NCT02674516|39793858|FG000|Overall Study|Protocol Violation|0|||
16357620|NCT02674516|39793859|FG001|Overall Study|Protocol Violation|4|||
16357621|NCT02674516|39793858|FG000|Overall Study|Knowledge of study hypothesis|1|||
16357622|NCT02674516|39793859|FG001|Overall Study|Knowledge of study hypothesis|0|||
16357623|NCT04584788|39793860|FG000|Overall Study|Physician Decision|8|||
16357624|NCT04584788|39793860|FG000|Overall Study|Withdrawal by Subject|1|||
16357625|NCT04584788|39793860|FG000|Overall Study|Adverse Event|3|||
16357626|NCT00499122|39793861|FG000|Overall Study|Withdrawal by Subject|2|||
16357627|NCT02351934|39793864|FG000|Allocation|POD weight<pre-op weight|3|||
16357628|NCT02351934|39793865|FG001|Allocation|POD weight<pre-op weight|0|||
16357629|NCT02351934|39793864|FG000|Allocation|Hypotension preventing administration|2|||
16357630|NCT02351934|39793865|FG001|Allocation|Hypotension preventing administration|0|||
16357631|NCT02351934|39793864|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
16357632|NCT02351934|39793865|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
16357633|NCT02351934|39793864|FG000|Follow-Up|POD weight<pre-op weight|3|||
16357634|NCT02351934|39793865|FG001|Follow-Up|POD weight<pre-op weight|0|||
16357635|NCT02351934|39793864|FG000|Follow-Up|Acute Kidney Injury|1|||
16357636|NCT02351934|39793865|FG001|Follow-Up|Acute Kidney Injury|0|||
16357637|NCT02351934|39793864|FG000|Follow-Up|Early dismissal|3|||
16357638|NCT02351934|39793865|FG001|Follow-Up|Early dismissal|0|||
16357639|NCT02351934|39793864|FG000|Follow-Up|Hypotension|3|||
16357640|NCT02351934|39793865|FG001|Follow-Up|Hypotension|0|||
16357641|NCT02351934|39793864|FG000|Follow-Up|No documentation|2|||
16357642|NCT02351934|39793865|FG001|Follow-Up|No documentation|0|||
16357643|NCT02351934|39793864|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
16357644|NCT02351934|39793865|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
16357645|NCT02351934|39793864|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
16357646|NCT02351934|39793865|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
16357647|NCT02481050|39793868|FG000|Overall Study|Adverse Event|1|||
16357648|NCT02481050|39793868|FG000|Overall Study|Disease Progression|47|||
16357649|NCT02481050|39793868|FG000|Overall Study|Withdrawal by Subject|7|||
16357650|NCT02481050|39793868|FG000|Overall Study|Other|3|||
16357651|NCT01930539|39793872|FG000|Overall Study|Withdrawal by Subject|2|||
16357652|NCT01930539|39793873|FG001|Overall Study|Withdrawal by Subject|2|||
16357653|NCT01027949|39793876|FG000|Overall Study|Death|174|||
16357654|NCT01027949|39793876|FG000|Overall Study|Progressive Disease|163|||
16357655|NCT01027949|39793876|FG000|Overall Study|Adverse Event|172|||
16357656|NCT01027949|39793876|FG000|Overall Study|Withdrawal by Subject|113|||
16357657|NCT01027949|39793876|FG000|Overall Study|Lost to Follow-up|17|||
16357658|NCT01027949|39793876|FG000|Overall Study|Protocol Violation|13|||
16357659|NCT01027949|39793876|FG000|Overall Study|PI Decision|8|||
16357660|NCT01027949|39793876|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
16357661|NCT01027949|39793876|FG000|Overall Study|Non-compliance with Study Procedures|7|||
16357662|NCT01027949|39793876|FG000|Overall Study|Lung Transplant|5|||
16357663|NCT01027949|39793876|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
16357664|NCT01027949|39793876|FG000|Overall Study|Use of Excluded Medication|2|||
16357665|NCT01027949|39793876|FG000|Overall Study|Patient Self-discontinuation|1|||
16357666|NCT01027949|39793876|FG000|Overall Study|Pregnancy|1|||
16357667|NCT01027949|39793876|FG000|Overall Study|Surgery|1|||
16357668|NCT01670292|39793877|FG000|Overall Study|Lost to Follow-up|14|||
16357669|NCT01387269|39793878|FG000|Overall Study|Death|38|||
16357670|NCT01387269|39793879|FG001|Overall Study|Death|20|||
16357671|NCT01387269|39793878|FG000|Overall Study|Other|8|||
16357672|NCT01387269|39793879|FG001|Overall Study|Other|7|||
16357673|NCT01387269|39793878|FG000|Overall Study|Unrelated AE|12|||
16357674|NCT01387269|39793879|FG001|Overall Study|Unrelated AE|3|||
16357675|NCT01387269|39793878|FG000|Overall Study|Withdrawal by patient|32|||
16357676|NCT01387269|39793879|FG001|Overall Study|Withdrawal by patient|10|||
16357677|NCT01387269|39793878|FG000|Overall Study|Study drug-related AE|1|||
16419086|NCT02905006|40015398|FG004|Overall Study|Patient moved abroad|0|||
16419087|NCT02905006|40015399|FG005|Overall Study|Patient moved abroad|0|||
16419088|NCT02905006|40015394|FG000|Overall Study|Patient randomized by mistake|0|||
16357678|NCT01387269|39793879|FG001|Overall Study|Study drug-related AE|0|||
16357679|NCT01387269|39793878|FG000|Overall Study|Lost to Follow-up|1|||
16357680|NCT01387269|39793879|FG001|Overall Study|Lost to Follow-up|0|||
16357681|NCT04919317|39793888|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
16357682|NCT04919317|39793889|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
16357683|NCT04919317|39793888|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
16357684|NCT04919317|39793889|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
16357685|NCT02078817|39793894|FG000|Overall Study|Withdrawal by Subject|1|||
16357686|NCT00744939|39793895|FG000|Overall Study|Withdrawal by Subject|9|||
16357687|NCT00744939|39793895|FG000|Overall Study|Protocol Violation|13|||
16357688|NCT00744939|39793895|FG000|Overall Study|Death|24|||
16357689|NCT00744939|39793895|FG000|Overall Study|distance|4|||
16357690|NCT00744939|39793895|FG000|Overall Study|Lost to Follow-up|12|||
16357691|NCT00744939|39793895|FG000|Overall Study|Medical history exclusionary|1|||
16357692|NCT00744939|39793895|FG000|Overall Study|Did not receive Magnevist|7|||
16357693|NCT00744939|39793895|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
16357694|NCT00744939|39793895|FG000|Overall Study|coma|1|||
16357695|NCT00744939|39793895|FG000|Overall Study|incorrect race|1|||
16357696|NCT01420536|39793898|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
16357697|NCT01420536|39793899|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
16357698|NCT01103323|39793900|FG000|Without/Before Drug Switch|Adverse Event|50|||
16357699|NCT01103323|39793901|FG001|Without/Before Drug Switch|Adverse Event|7|||
16357700|NCT01103323|39793900|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
16419089|NCT02905006|40015395|FG001|Overall Study|Patient randomized by mistake|0|||
16419090|NCT02905006|40015396|FG002|Overall Study|Patient randomized by mistake|0|||
16419091|NCT02905006|40015397|FG003|Overall Study|Patient randomized by mistake|0|||
16419092|NCT02905006|40015398|FG004|Overall Study|Patient randomized by mistake|0|||
16419093|NCT02905006|40015399|FG005|Overall Study|Patient randomized by mistake|1|||
16419094|NCT00866814|40015400|FG000|Overall Study|Lost to Follow-up|12|||
16419095|NCT00866814|40015400|FG000|Overall Study|Adverse Event|2|||
16419096|NCT00866814|40015400|FG000|Overall Study|Physician Decision|1|||
16419097|NCT00866814|40015400|FG000|Overall Study|Death|1|||
16419098|NCT00866814|40015400|FG000|Overall Study|No longer wished to participate|1|||
16357701|NCT01103323|39793901|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
16357702|NCT01103323|39793900|FG000|Without/Before Drug Switch|Protocol Violation|2|||
16357703|NCT01103323|39793901|FG001|Without/Before Drug Switch|Protocol Violation|0|||
16357704|NCT01103323|39793900|FG000|Without/Before Drug Switch|Physician Decision|2|||
16357705|NCT01103323|39793901|FG001|Without/Before Drug Switch|Physician Decision|0|||
16357706|NCT01103323|39793900|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
16357707|NCT01103323|39793901|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
16357708|NCT01103323|39793900|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
16357709|NCT01103323|39793901|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
16357710|NCT01103323|39793900|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
16357711|NCT01103323|39793901|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
16357712|NCT03886272|39793902|FG000|Period 1|Withdrawal by Subject|0|||
16357713|NCT03886272|39793903|FG001|Period 1|Withdrawal by Subject|0|||
16357714|NCT03886272|39793904|FG002|Period 1|Withdrawal by Subject|0|||
16357715|NCT03886272|39793905|FG003|Period 1|Withdrawal by Subject|0|||
16357716|NCT03886272|39793906|FG004|Period 1|Withdrawal by Subject|0|||
16357717|NCT03886272|39793907|FG005|Period 1|Withdrawal by Subject|1|||
16357718|NCT03886272|39793908|FG006|Period 1|Withdrawal by Subject|0|||
16357719|NCT00797563|39793909|FG000|Overall Study|Adverse Event|1|||
16419099|NCT00866814|40015400|FG000|Overall Study|Unable to meet follow-up requirements|2|||
16419100|NCT00866814|40015400|FG000|Overall Study|Moved to area without study site|1|||
16419101|NCT03129360|40015401|FG000|Overall Study|Did not meet entry criteria|0|||
16419102|NCT03129360|40015402|FG001|Overall Study|Did not meet entry criteria|2|||
16419103|NCT03129360|40015403|FG002|Overall Study|Did not meet entry criteria|1|||
16419104|NCT03129360|40015401|FG000|Overall Study|Excluded due to motion in scanner|1|||
16357720|NCT03080935|39793914|FG000|Overall Study|Death|34|||
16357721|NCT03080935|39793915|FG001|Overall Study|Death|50|||
16357722|NCT03080935|39793914|FG000|Overall Study|Lost to Follow-up|5|||
16357723|NCT03080935|39793915|FG001|Overall Study|Lost to Follow-up|4|||
16357724|NCT03080935|39793914|FG000|Overall Study|Withdrawal by Subject|11|||
16357725|NCT03080935|39793915|FG001|Overall Study|Withdrawal by Subject|15|||
16357726|NCT01677741|39793919|FG000|Overall Study|Death|0|||
16561976|NCT04541186|40525248|FG002|Fibrate Expansion Study|Other than Specified|0|||
16248112|NCT01579474|39391749|FG005|Overall Study|Withdrawal by Subject|0|||
16248113|NCT00673361|39391756|FG000|Overall Study|Screen Failure|2|||
16248114|NCT03487796|39391761|FG000|Overall Study|Lost to Follow-up|18|||
16248115|NCT03487796|39391762|FG001|Overall Study|Lost to Follow-up|6|||
16248116|NCT04828161|39391763|FG000|Overall Study|Withdrawal by Subject|0|||
16248117|NCT04828161|39391764|FG001|Overall Study|Withdrawal by Subject|3|||
16248118|NCT04828161|39391765|FG002|Overall Study|Withdrawal by Subject|3|||
16248119|NCT04828161|39391766|FG003|Overall Study|Withdrawal by Subject|4|||
16248120|NCT04828161|39391763|FG000|Overall Study|Lost to Follow-up|1|||
16248121|NCT04828161|39391764|FG001|Overall Study|Lost to Follow-up|4|||
16248122|NCT04828161|39391765|FG002|Overall Study|Lost to Follow-up|2|||
16248123|NCT04828161|39391766|FG003|Overall Study|Lost to Follow-up|2|||
16248124|NCT04828161|39391763|FG000|Overall Study|Other|2|||
16248125|NCT04828161|39391764|FG001|Overall Study|Other|0|||
16248126|NCT04828161|39391765|FG002|Overall Study|Other|2|||
16248127|NCT04828161|39391766|FG003|Overall Study|Other|0|||
16248128|NCT04828161|39391763|FG000|Overall Study|Death|0|||
16248129|NCT04828161|39391764|FG001|Overall Study|Death|0|||
16248130|NCT04828161|39391765|FG002|Overall Study|Death|0|||
16248131|NCT04828161|39391766|FG003|Overall Study|Death|2|||
16248132|NCT00210626|39391767|FG000|Overall Study|Adverse Event|1|||
16248133|NCT00210626|39391768|FG001|Overall Study|Adverse Event|2|||
16248134|NCT00210626|39391767|FG000|Overall Study|Protocol Violation|1|||
16248135|NCT00210626|39391768|FG001|Overall Study|Protocol Violation|5|||
16248136|NCT00210626|39391767|FG000|Overall Study|Lost to Follow-up|11|||
16248137|NCT00210626|39391768|FG001|Overall Study|Lost to Follow-up|11|||
16248138|NCT00210626|39391767|FG000|Overall Study|Death|1|||
16248139|NCT00210626|39391768|FG001|Overall Study|Death|0|||
16248140|NCT00210626|39391767|FG000|Overall Study|Withdrawal by Subject|29|||
16248141|NCT00210626|39391768|FG001|Overall Study|Withdrawal by Subject|20|||
16248142|NCT00210626|39391767|FG000|Overall Study|Physician Decision|0|||
16248143|NCT00210626|39391768|FG001|Overall Study|Physician Decision|2|||
16248144|NCT00210626|39391767|FG000|Overall Study|Sponser Request|1|||
16248145|NCT00210626|39391768|FG001|Overall Study|Sponser Request|0|||
16248146|NCT00210626|39391767|FG000|Overall Study|Other|4|||
16248147|NCT00210626|39391768|FG001|Overall Study|Other|5|||
16248148|NCT02701283|39391769|FG000|Overall Study|Death|25|||
16248149|NCT02701283|39391770|FG001|Overall Study|Death|29|||
16248150|NCT02701283|39391771|FG002|Overall Study|Death|19|||
16248151|NCT02701283|39391769|FG000|Overall Study|Lost to Follow-up|3|||
16248152|NCT02701283|39391770|FG001|Overall Study|Lost to Follow-up|8|||
16248153|NCT02701283|39391771|FG002|Overall Study|Lost to Follow-up|1|||
16248154|NCT02701283|39391769|FG000|Overall Study|Withdrawal by Subject|12|||
16248155|NCT02701283|39391770|FG001|Overall Study|Withdrawal by Subject|41|||
16248156|NCT02701283|39391771|FG002|Overall Study|Withdrawal by Subject|1|||
16248157|NCT02701283|39391769|FG000|Overall Study|Missed 2-year visit|22|||
16248158|NCT02701283|39391770|FG001|Overall Study|Missed 2-year visit|27|||
16248159|NCT02701283|39391771|FG002|Overall Study|Missed 2-year visit|0|||
16248160|NCT02701283|39391769|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
16248161|NCT02701283|39391770|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
16248162|NCT02701283|39391771|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
16248163|NCT01073020|39391772|FG000|Overall Study|Withdrawal by Subject|6|||
16248164|NCT01073020|39391773|FG001|Overall Study|Withdrawal by Subject|4|||
16248165|NCT01073020|39391774|FG002|Overall Study|Withdrawal by Subject|1|||
16248166|NCT01073020|39391775|FG003|Overall Study|Withdrawal by Subject|2|||
16248167|NCT01073020|39391772|FG000|Overall Study|Physician Decision|1|||
16248168|NCT01073020|39391773|FG001|Overall Study|Physician Decision|0|||
16248169|NCT01073020|39391774|FG002|Overall Study|Physician Decision|2|||
16248170|NCT01073020|39391775|FG003|Overall Study|Physician Decision|0|||
16248171|NCT01073020|39391772|FG000|Overall Study|Death|0|||
16248172|NCT01073020|39391773|FG001|Overall Study|Death|1|||
16248173|NCT01073020|39391774|FG002|Overall Study|Death|0|||
16248174|NCT01073020|39391775|FG003|Overall Study|Death|0|||
16248175|NCT03538756|39391776|FG000|Long-Term Follow-up|Adverse Event|0|||
16248176|NCT03538756|39391777|FG001|Long-Term Follow-up|Adverse Event|0|||
16248177|NCT03538756|39391778|FG002|Long-Term Follow-up|Adverse Event|6|||
16248178|NCT03538756|39391776|FG000|Long-Term Follow-up|Death|0|||
16357727|NCT01677741|39793920|FG001|Overall Study|Death|0|||
16357728|NCT01677741|39793921|FG002|Overall Study|Death|0|||
16357729|NCT01677741|39793922|FG003|Overall Study|Death|1|||
16357730|NCT01677741|39793923|FG004|Overall Study|Death|0|||
16357731|NCT01677741|39793924|FG005|Overall Study|Death|1|||
16357732|NCT01677741|39793925|FG006|Overall Study|Death|0|||
16357733|NCT01677741|39793926|FG007|Overall Study|Death|0|||
16357734|NCT01677741|39793919|FG000|Overall Study|Withdrawal by Subject|2|||
16357735|NCT01677741|39793920|FG001|Overall Study|Withdrawal by Subject|7|||
16357736|NCT01677741|39793921|FG002|Overall Study|Withdrawal by Subject|5|||
16357737|NCT01677741|39793922|FG003|Overall Study|Withdrawal by Subject|4|||
16357738|NCT01677741|39793923|FG004|Overall Study|Withdrawal by Subject|11|||
16357739|NCT01677741|39793924|FG005|Overall Study|Withdrawal by Subject|20|||
16357740|NCT01677741|39793925|FG006|Overall Study|Withdrawal by Subject|4|||
16357741|NCT01677741|39793926|FG007|Overall Study|Withdrawal by Subject|2|||
16357742|NCT01677741|39793919|FG000|Overall Study|Enrolled in a rollover study|0|||
16357743|NCT01677741|39793920|FG001|Overall Study|Enrolled in a rollover study|3|||
16357744|NCT01677741|39793921|FG002|Overall Study|Enrolled in a rollover study|2|||
16357745|NCT01677741|39793922|FG003|Overall Study|Enrolled in a rollover study|1|||
16357746|NCT01677741|39793923|FG004|Overall Study|Enrolled in a rollover study|6|||
16357747|NCT01677741|39793924|FG005|Overall Study|Enrolled in a rollover study|6|||
16357748|NCT01677741|39793925|FG006|Overall Study|Enrolled in a rollover study|7|||
16357749|NCT01677741|39793926|FG007|Overall Study|Enrolled in a rollover study|0|||
16357750|NCT01677741|39793919|FG000|Overall Study|Progressive disease|1|||
16357751|NCT01677741|39793920|FG001|Overall Study|Progressive disease|0|||
16357752|NCT01677741|39793921|FG002|Overall Study|Progressive disease|1|||
16357753|NCT01677741|39793922|FG003|Overall Study|Progressive disease|0|||
16357754|NCT01677741|39793923|FG004|Overall Study|Progressive disease|0|||
16357755|NCT01677741|39793924|FG005|Overall Study|Progressive disease|1|||
16357756|NCT01677741|39793925|FG006|Overall Study|Progressive disease|0|||
16357757|NCT01677741|39793926|FG007|Overall Study|Progressive disease|0|||
16357758|NCT01290718|39793931|FG000|Overall Study|Early termination of the study|4|||
16357759|NCT00947544|39793934|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
16357760|NCT00947544|39793935|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
16357761|NCT02666222|39793936|FG000|Overall Study|Death|2|||
16357762|NCT03311555|39797061|FG000|Overall Study|Adverse Event|1|||
16357763|NCT02340949|39797063|FG000|Overall Study|Adverse Event|4|||
16248179|NCT03538756|39391777|FG001|Long-Term Follow-up|Death|0|||
16248180|NCT03538756|39391778|FG002|Long-Term Follow-up|Death|1|||
16248181|NCT03538756|39391776|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
16248182|NCT03538756|39391777|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
16248183|NCT03538756|39391778|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
16248184|NCT03538756|39391776|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
16248185|NCT03538756|39391777|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
16248186|NCT03538756|39391778|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
16248187|NCT03538756|39391776|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
16248188|NCT03538756|39391777|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
16248189|NCT03538756|39391778|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
16248190|NCT04896385|39391779|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
16248191|NCT04896385|39391780|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
16248192|NCT04896385|39391781|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
16248193|NCT04896385|39391782|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
16248194|NCT04896385|39391779|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
16248195|NCT04896385|39391780|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
16248196|NCT04896385|39391781|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
16248197|NCT04896385|39391782|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
16248198|NCT04896385|39391779|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
16248199|NCT04896385|39391780|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
16248200|NCT04896385|39391781|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
16248201|NCT04896385|39391782|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
16248202|NCT04896385|39391779|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
16248203|NCT04896385|39391780|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
16248204|NCT04896385|39391781|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
16248205|NCT04896385|39391782|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
16248206|NCT04896385|39391779|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
16248207|NCT04896385|39391780|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
16357764|NCT02340949|39797064|FG001|Overall Study|Adverse Event|2|||
16561977|NCT04541186|40525249|FG003|Fibrate Expansion Study|Other than Specified|0|||
16248208|NCT04896385|39391781|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
16248209|NCT04896385|39391782|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
16357765|NCT02340949|39797063|FG000|Overall Study|Withdrawal by Subject|2|||
16357766|NCT02340949|39797064|FG001|Overall Study|Withdrawal by Subject|0|||
16357767|NCT02340949|39797063|FG000|Overall Study|Progression disease|6|||
16357768|NCT02340949|39797064|FG001|Overall Study|Progression disease|2|||
16357769|NCT02340949|39797063|FG000|Overall Study|Death|3|||
16357770|NCT02340949|39797064|FG001|Overall Study|Death|0|||
16357771|NCT02340949|39797063|FG000|Overall Study|Physician Decision|1|||
16357772|NCT02340949|39797064|FG001|Overall Study|Physician Decision|0|||
16248210|NCT04896385|39391779|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
16248211|NCT04896385|39391780|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
16248212|NCT04896385|39391781|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
16248213|NCT04896385|39391782|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
16248214|NCT00752791|39391783|FG000|Overall Study|Adverse Event|7|||
16248215|NCT00752791|39391783|FG000|Overall Study|Withdrawal by Subject|1|||
16248216|NCT00752791|39391783|FG000|Overall Study|Physician Decision|1|||
16248217|NCT00752791|39391783|FG000|Overall Study|Death|1|||
16248218|NCT00752791|39391783|FG000|Overall Study|Renal transplant|3|||
16248219|NCT00752791|39391783|FG000|Overall Study|Switched to hemodialysis|2|||
16248220|NCT00752791|39391783|FG000|Overall Study|Protocol deviation|1|||
16248221|NCT02919475|39391784|FG000|Overall Study|Adverse Event|3|||
16248222|NCT02919475|39391785|FG001|Overall Study|Adverse Event|3|||
16248223|NCT02919475|39391786|FG002|Overall Study|Adverse Event|3|||
16248224|NCT02919475|39391787|FG003|Overall Study|Adverse Event|9|||
16248225|NCT02919475|39391788|FG004|Overall Study|Adverse Event|2|||
16248226|NCT02919475|39391784|FG000|Overall Study|Death|0|||
16248227|NCT02919475|39391785|FG001|Overall Study|Death|1|||
16248228|NCT02919475|39391786|FG002|Overall Study|Death|0|||
16248229|NCT02919475|39391787|FG003|Overall Study|Death|0|||
16248230|NCT02919475|39391788|FG004|Overall Study|Death|0|||
16248231|NCT02919475|39391784|FG000|Overall Study|Lost to Follow-up|0|||
16248232|NCT02919475|39391785|FG001|Overall Study|Lost to Follow-up|0|||
16248233|NCT02919475|39391786|FG002|Overall Study|Lost to Follow-up|0|||
16248234|NCT02919475|39391787|FG003|Overall Study|Lost to Follow-up|1|||
16248235|NCT02919475|39391788|FG004|Overall Study|Lost to Follow-up|0|||
16248236|NCT02919475|39391784|FG000|Overall Study|Withdrawal by Subject|2|||
16248237|NCT02919475|39391785|FG001|Overall Study|Withdrawal by Subject|3|||
16357773|NCT03502798|39797072|FG000|Overall Study|equipment failure|0|||
16357774|NCT03502798|39797073|FG001|Overall Study|equipment failure|7|||
16357775|NCT00183430|39797074|FG000|Overall Study|Adverse Event|1|||
16357776|NCT00183430|39797075|FG001|Overall Study|Adverse Event|0|||
16357777|NCT00183430|39797074|FG000|Overall Study|Lost to Follow-up|3|||
16357778|NCT00183430|39797075|FG001|Overall Study|Lost to Follow-up|0|||
16357779|NCT00183430|39797074|FG000|Overall Study|did not meet inclusion criteria|1|||
16357780|NCT00183430|39797075|FG001|Overall Study|did not meet inclusion criteria|0|||
16357781|NCT00183430|39797074|FG000|Overall Study|Withdrawal by Subject|1|||
16357782|NCT00183430|39797075|FG001|Overall Study|Withdrawal by Subject|0|||
16357783|NCT01326871|39797076|FG000|Overall Study|Major surgery|0|||
16357784|NCT01326871|39797077|FG001|Overall Study|Major surgery|1|||
16357785|NCT01326871|39797078|FG002|Overall Study|Major surgery|0|||
16357786|NCT01326871|39797076|FG000|Overall Study|SAE and death|0|||
16357787|NCT01326871|39797077|FG001|Overall Study|SAE and death|2|||
16357788|NCT01326871|39797078|FG002|Overall Study|SAE and death|0|||
16357789|NCT01326871|39797076|FG000|Overall Study|Physician decision and decreased performance status|0|||
16357790|NCT01326871|39797077|FG001|Overall Study|Physician decision and decreased performance status|1|||
16357791|NCT01326871|39797078|FG002|Overall Study|Physician decision and decreased performance status|0|||
16357792|NCT01326871|39797076|FG000|Overall Study|Disease progression|0|||
16357793|NCT01326871|39797077|FG001|Overall Study|Disease progression|11|||
16357794|NCT01326871|39797078|FG002|Overall Study|Disease progression|5|||
16357795|NCT01326871|39797076|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
16357796|NCT01326871|39797077|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
16357797|NCT01326871|39797078|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
16357798|NCT01326871|39797076|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
16357799|NCT01326871|39797077|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
16357800|NCT01326871|39797078|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
16419105|NCT03129360|40015402|FG001|Overall Study|Excluded due to motion in scanner|0|||
16419106|NCT03129360|40015403|FG002|Overall Study|Excluded due to motion in scanner|0|||
16419107|NCT00498355|40015404|FG000|Overall Study|Lost to Follow-up|1|||
16419108|NCT03688620|40015407|FG000|Overall Study|Other|0|||
16419109|NCT03688620|40015408|FG001|Overall Study|Other|0|||
16419110|NCT03688620|40015409|FG002|Overall Study|Other|1|||
16419111|NCT03688620|40015407|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
16561978|NCT04541186|40525250|FG004|Fibrate Expansion Study|Other than Specified|1|||
16248238|NCT02919475|39391786|FG002|Overall Study|Withdrawal by Subject|1|||
16248239|NCT02919475|39391787|FG003|Overall Study|Withdrawal by Subject|2|||
16248240|NCT02919475|39391788|FG004|Overall Study|Withdrawal by Subject|2|||
16248241|NCT02919475|39391784|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
16248242|NCT02919475|39391785|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
16248243|NCT02919475|39391786|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
16248244|NCT02919475|39391787|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
16248245|NCT02919475|39391788|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16419112|NCT03688620|40015408|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
16419113|NCT03688620|40015409|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
16419114|NCT03688620|40015407|FG000|Overall Study|Lost to Follow-up|16|||
16357801|NCT01326871|39797076|FG000|Overall Study|Withdrawal by Subject|0|||
16357802|NCT01326871|39797077|FG001|Overall Study|Withdrawal by Subject|1|||
16357803|NCT01326871|39797078|FG002|Overall Study|Withdrawal by Subject|0|||
16357804|NCT01326871|39797076|FG000|Overall Study|DLT|0|||
16357805|NCT01326871|39797077|FG001|Overall Study|DLT|2|||
16357806|NCT01326871|39797078|FG002|Overall Study|DLT|0|||
16357807|NCT01326871|39797076|FG000|Overall Study|SAE, disease progression and subject decision|0|||
16357808|NCT01326871|39797077|FG001|Overall Study|SAE, disease progression and subject decision|1|||
16357809|NCT01326871|39797078|FG002|Overall Study|SAE, disease progression and subject decision|0|||
16357810|NCT01326871|39797076|FG000|Overall Study|Death|0|||
16357811|NCT01326871|39797077|FG001|Overall Study|Death|1|||
16357812|NCT01326871|39797078|FG002|Overall Study|Death|0|||
16357813|NCT01326871|39797076|FG000|Overall Study|Other|0|||
16357814|NCT01326871|39797077|FG001|Overall Study|Other|3|||
16357815|NCT01326871|39797078|FG002|Overall Study|Other|0|||
16357816|NCT01326871|39797076|FG000|Overall Study|SAE and disease progression|0|||
16357817|NCT01326871|39797077|FG001|Overall Study|SAE and disease progression|0|||
16357818|NCT01326871|39797078|FG002|Overall Study|SAE and disease progression|1|||
16357819|NCT01326871|39797076|FG000|Overall Study|SAE and physician decision|0|||
16357820|NCT01326871|39797077|FG001|Overall Study|SAE and physician decision|0|||
16357821|NCT01326871|39797078|FG002|Overall Study|SAE and physician decision|1|||
16357822|NCT01326871|39797076|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
16357823|NCT01326871|39797077|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
16357824|NCT01326871|39797078|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
16419115|NCT03688620|40015408|FG001|Overall Study|Lost to Follow-up|0|||
16561979|NCT04305912|40525251|FG000|First Intervention|COVID-19 Suspension|2|||
16561980|NCT04305912|40525252|FG001|First Intervention|COVID-19 Suspension|0|||
16561981|NCT04305912|40525251|FG000|First Intervention|Withdrawal by Subject|0|||
16561982|NCT04305912|40525252|FG001|First Intervention|Withdrawal by Subject|1|||
16561983|NCT04305912|40525251|FG000|Second Intervention|Adverse Event|0|||
16561984|NCT04305912|40525252|FG001|Second Intervention|Adverse Event|1|||
16561985|NCT01518257|40525258|FG000|Overall Study|Lost to Follow-up|1|||
16561986|NCT01518257|40525259|FG001|Overall Study|Lost to Follow-up|0|||
16561987|NCT01518257|40525258|FG000|Overall Study|Other Miscellaneous Reason|1|||
16561988|NCT01518257|40525259|FG001|Overall Study|Other Miscellaneous Reason|0|||
16561989|NCT03673098|40525262|FG000|Overall Study|Lost to Follow-up|2|||
16561990|NCT03673098|40525263|FG001|Overall Study|Lost to Follow-up|3|||
16561991|NCT03673098|40525262|FG000|Overall Study|Withdrawal by Subject|6|||
16561992|NCT03673098|40525263|FG001|Overall Study|Withdrawal by Subject|1|||
16561993|NCT03673098|40525262|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
16561994|NCT03673098|40525263|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
16561995|NCT03379233|40525269|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
16561996|NCT03379233|40525270|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
16561997|NCT01561079|40525271|FG000|Overall Study|Physician Decision|17|||
16561998|NCT01561079|40525271|FG000|Overall Study|Withdrawal by Subject|59|||
16561999|NCT01561079|40525271|FG000|Overall Study|Protocol Violation|2|||
16562000|NCT00256308|40525272|FG000|Overall Study|Death|2|||
16562001|NCT01929993|40525273|FG000|Overall Study|Protocol Violation|4|||
16562002|NCT01929993|40525274|FG001|Overall Study|Protocol Violation|6|||
16562003|NCT01929993|40525273|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
16562004|NCT01929993|40525274|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
16562005|NCT00859014|40525279|FG000|Overall Study|Death|4|||
16562006|NCT00859014|40525279|FG000|Overall Study|Lost to Follow-up|1|||
16562007|NCT00924664|40525286|FG000|Overall Study|Adverse Event|23|||
16562008|NCT00924664|40525287|FG001|Overall Study|Adverse Event|39|||
16562009|NCT00924664|40525286|FG000|Overall Study|Lack of Efficacy|10|||
16562010|NCT00924664|40525287|FG001|Overall Study|Lack of Efficacy|15|||
16562011|NCT00924664|40525286|FG000|Overall Study|Lost to Follow-up|10|||
16562012|NCT00924664|40525287|FG001|Overall Study|Lost to Follow-up|12|||
16562013|NCT00924664|40525286|FG000|Overall Study|Withdrawal by Subject|47|||
16562014|NCT00924664|40525287|FG001|Overall Study|Withdrawal by Subject|71|||
16562015|NCT00924664|40525286|FG000|Overall Study|Protocol Violation|2|||
16562016|NCT00924664|40525287|FG001|Overall Study|Protocol Violation|5|||
16562017|NCT00924664|40525286|FG000|Overall Study|Pregnancy|1|||
16562018|NCT00924664|40525287|FG001|Overall Study|Pregnancy|1|||
16562019|NCT00924664|40525286|FG000|Overall Study|Death|0|||
16562020|NCT00924664|40525287|FG001|Overall Study|Death|2|||
16562021|NCT00924664|40525286|FG000|Overall Study|Study terminated by sponsor|199|||
16562022|NCT00924664|40525287|FG001|Overall Study|Study terminated by sponsor|330|||
16562023|NCT00924664|40525286|FG000|Overall Study|Other|29|||
16248246|NCT01890707|39391789|FG000|Overall Study|Lost to Follow-up|1|||
16248247|NCT01890707|39391790|FG001|Overall Study|Lost to Follow-up|1|||
16248248|NCT01580020|39391791|FG000|Overall Study|Lack of Efficacy|0|||
16248249|NCT01580020|39391792|FG001|Overall Study|Lack of Efficacy|5|||
16248250|NCT01580020|39391793|FG002|Overall Study|Lack of Efficacy|0|||
16248251|NCT01580020|39391794|FG003|Overall Study|Lack of Efficacy|1|||
16248252|NCT01580020|39391791|FG000|Overall Study|Withdrawal by Subject|0|||
16248253|NCT01580020|39391792|FG001|Overall Study|Withdrawal by Subject|1|||
16562024|NCT00924664|40525287|FG001|Overall Study|Other|52|||
16248254|NCT01580020|39391793|FG002|Overall Study|Withdrawal by Subject|1|||
16248255|NCT01580020|39391794|FG003|Overall Study|Withdrawal by Subject|0|||
16562025|NCT00924664|40525286|FG000|Overall Study|Randomized but not Treated|1|||
16562026|NCT00924664|40525287|FG001|Overall Study|Randomized but not Treated|0|||
16562027|NCT02091869|40525297|FG000|Overall Study|Withdrawal by Subject|0|||
16562028|NCT02091869|40525298|FG001|Overall Study|Withdrawal by Subject|3|||
16562029|NCT02397889|40525299|FG000|Overall Study|Physician Decision|1|||
16562030|NCT02397889|40525300|FG001|Overall Study|Physician Decision|0|||
16562031|NCT01598987|40525301|FG000|Baseline to Month 12|Administrative problems|2|||
16562032|NCT01598987|40525301|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
16562033|NCT01598987|40525301|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
16562034|NCT01598987|40525301|FG000|Baseline to 24 Month|Administrative problems|2|||
16562035|NCT01598987|40525301|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
16562036|NCT02501629|40525302|FG000|Overall Study|Death|0|||
16562037|NCT02501629|40525303|FG001|Overall Study|Death|1|||
16562038|NCT02501629|40525302|FG000|Overall Study|Withdrawn from study by sponsor|1|||
16562039|NCT02501629|40525303|FG001|Overall Study|Withdrawn from study by sponsor|0|||
16562040|NCT02501629|40525302|FG000|Overall Study|Early termination by sponsor|1|||
16562041|NCT02501629|40525303|FG001|Overall Study|Early termination by sponsor|0|||
16562042|NCT02501629|40525302|FG000|Overall Study|Withdrawal by Subject|3|||
16562043|NCT02501629|40525303|FG001|Overall Study|Withdrawal by Subject|5|||
16248256|NCT01580020|39391791|FG000|Overall Study|Adverse Event|1|||
16248257|NCT01580020|39391792|FG001|Overall Study|Adverse Event|1|||
16248258|NCT01580020|39391793|FG002|Overall Study|Adverse Event|1|||
16562044|NCT02501629|40525302|FG000|Overall Study|Subject did not return to site|0|||
16562045|NCT02501629|40525303|FG001|Overall Study|Subject did not return to site|1|||
16357825|NCT01326871|39797076|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
16357826|NCT01326871|39797077|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
16357827|NCT01326871|39797078|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
16357828|NCT01326871|39797076|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
16357829|NCT01326871|39797077|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
16357830|NCT01326871|39797078|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
16357831|NCT01326871|39797076|FG000|Overall Study|Physician Decision|0|||
16357832|NCT01326871|39797077|FG001|Overall Study|Physician Decision|0|||
16357833|NCT01326871|39797078|FG002|Overall Study|Physician Decision|1|||
16357834|NCT01326871|39797076|FG000|Overall Study|SAE|0|||
16357835|NCT01326871|39797077|FG001|Overall Study|SAE|0|||
16357836|NCT01326871|39797078|FG002|Overall Study|SAE|1|||
16357837|NCT01326871|39797076|FG000|Overall Study|Disease progression and death|0|||
16357838|NCT01326871|39797077|FG001|Overall Study|Disease progression and death|0|||
16357839|NCT01326871|39797078|FG002|Overall Study|Disease progression and death|1|||
16357840|NCT01326871|39797076|FG000|Overall Study|Subject decision|0|||
16357841|NCT01326871|39797077|FG001|Overall Study|Subject decision|0|||
16357842|NCT01326871|39797078|FG002|Overall Study|Subject decision|1|||
16357843|NCT00997334|39797079|FG000|Overall Study|still on therapy|12|||
16357844|NCT00997334|39797079|FG000|Overall Study|Adverse Event|3|||
16357845|NCT00997334|39797079|FG000|Overall Study|Patient non-compliance|1|||
16357846|NCT00997334|39797079|FG000|Overall Study|Withdrawal by Subject|3|||
16357847|NCT00997334|39797079|FG000|Overall Study|Death|2|||
16357848|NCT00997334|39797079|FG000|Overall Study|Urgent Palliative Care|2|||
16357849|NCT00997334|39797079|FG000|Overall Study|No lesion amenable|1|||
16357850|NCT00997334|39797079|FG000|Overall Study|Ineligible|1|||
16357851|NCT02814526|39797080|FG000|Overall Study|Adverse Event|4|||
16357852|NCT02814526|39797081|FG001|Overall Study|Adverse Event|3|||
16357853|NCT02814526|39797080|FG000|Overall Study|Death|1|||
16357854|NCT02814526|39797081|FG001|Overall Study|Death|1|||
16357855|NCT02814526|39797080|FG000|Overall Study|Lost to Follow-up|3|||
16357856|NCT02814526|39797081|FG001|Overall Study|Lost to Follow-up|4|||
16357857|NCT02814526|39797080|FG000|Overall Study|non site physician decision|1|||
16357858|NCT02814526|39797081|FG001|Overall Study|non site physician decision|0|||
16357859|NCT02814526|39797080|FG000|Overall Study|participant noncompliance|1|||
16357860|NCT02814526|39797081|FG001|Overall Study|participant noncompliance|1|||
16357861|NCT02814526|39797080|FG000|Overall Study|Withdrawal by Subject|20|||
16357862|NCT02814526|39797081|FG001|Overall Study|Withdrawal by Subject|14|||
16357863|NCT02814526|39797080|FG000|Overall Study|safety risk|2|||
16357864|NCT02814526|39797081|FG001|Overall Study|safety risk|1|||
16357865|NCT02814526|39797080|FG000|Overall Study|early termination-study terminated|1|||
16357866|NCT02814526|39797081|FG001|Overall Study|early termination-study terminated|2|||
16357867|NCT02814526|39797080|FG000|Overall Study|Other|0|||
16357868|NCT02814526|39797081|FG001|Overall Study|Other|4|||
16357869|NCT00296244|39797082|FG000|Overall Study|Underwent retransplant|0|||
16357870|NCT00296244|39797083|FG001|Overall Study|Underwent retransplant|1|||
16357871|NCT00003537|39797084|FG000|Overall Study|Not evalauable|1|||
16357872|NCT02472353|39797085|FG000|Overall Study|Lost to Follow-up|1|||
16357873|NCT02472353|39797086|FG001|Overall Study|Lost to Follow-up|1|||
16357874|NCT02472353|39797085|FG000|Overall Study|Withdrawal by Subject|2|||
16357875|NCT02472353|39797086|FG001|Overall Study|Withdrawal by Subject|1|||
16357876|NCT02472353|39797085|FG000|Overall Study|Study Termination|1|||
16357877|NCT02472353|39797086|FG001|Overall Study|Study Termination|4|||
16357878|NCT00843492|39797089|FG000|Overall Study|Adverse Event|0|||
16357879|NCT00843492|39797090|FG001|Overall Study|Adverse Event|3|||
16357880|NCT00843492|39797089|FG000|Overall Study|Lost to Follow-up|4|||
16357881|NCT00843492|39797090|FG001|Overall Study|Lost to Follow-up|4|||
16357882|NCT00843492|39797089|FG000|Overall Study|Withdrawal by Subject|0|||
16357883|NCT00843492|39797090|FG001|Overall Study|Withdrawal by Subject|4|||
16357884|NCT00843492|39797089|FG000|Overall Study|Immobilization Stopped|1|||
16357885|NCT00843492|39797090|FG001|Overall Study|Immobilization Stopped|0|||
16357886|NCT00843492|39797089|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
16357887|NCT00843492|39797090|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
16357888|NCT00843492|39797089|FG000|Overall Study|Orthopedic Surgery|0|||
16357889|NCT00843492|39797090|FG001|Overall Study|Orthopedic Surgery|2|||
16357890|NCT00843492|39797089|FG000|Overall Study|Visit Not Performed|1|||
16357891|NCT00843492|39797090|FG001|Overall Study|Visit Not Performed|0|||
16357892|NCT00843492|39797089|FG000|Overall Study|Deep-vein Thrombosis|1|||
16357893|NCT00843492|39797090|FG001|Overall Study|Deep-vein Thrombosis|0|||
16357894|NCT01200329|39797091|FG000|Overall Study|Lack of financial coverage|2|||
16562046|NCT03169361|40525306|FG000|Overall Study|Protocol Violation|32|||
16357895|NCT01200329|39797091|FG000|Overall Study|Progressive disease|1|||
16357896|NCT02966834|39797094|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
16357897|NCT02966834|39797095|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
16357898|NCT02966834|39797096|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
16357899|NCT02966834|39797097|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
16357900|NCT02966834|39797098|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
16357901|NCT02966834|39797099|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
16357902|NCT02966834|39797094|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
16357903|NCT02966834|39797095|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
16357904|NCT02966834|39797096|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
16357905|NCT02966834|39797097|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
16357906|NCT02966834|39797098|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
16357907|NCT02966834|39797099|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
16357908|NCT02966834|39797094|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
16357909|NCT02966834|39797095|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
16357910|NCT02966834|39797096|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
16357911|NCT02966834|39797097|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
16357912|NCT02966834|39797098|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
16357913|NCT02966834|39797099|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
16357914|NCT02966834|39797094|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
16357915|NCT02966834|39797095|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
16357916|NCT02966834|39797096|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
16357917|NCT02966834|39797097|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
16357918|NCT02966834|39797098|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
16562047|NCT00490555|40525307|FG000|Overall Study|noncompliant with drug administration|0|||
16562048|NCT00490555|40525308|FG001|Overall Study|noncompliant with drug administration|0|||
16562049|NCT00490555|40525309|FG002|Overall Study|noncompliant with drug administration|2|||
16562050|NCT00490555|40525310|FG003|Overall Study|noncompliant with drug administration|0|||
16562051|NCT04172987|40525313|FG000|Lead In Period|Adverse Event|1|||
16562052|NCT04172987|40525313|FG000|Lead In Period|Protocol Violation|1|||
16562053|NCT04172987|40525313|FG000|Period 1|Physician Decision|1|||
16562054|NCT04172987|40525313|FG000|Period 2|Adverse Event|5|||
16562055|NCT04172987|40525313|FG000|Period 2|Dosing Termination by Sponsor|4|||
16562056|NCT01023308|40525314|FG000|Overall Study|Abnormal test proceedure results|3|||
16562057|NCT01023308|40525315|FG001|Overall Study|Abnormal test proceedure results|8|||
16562058|NCT01023308|40525314|FG000|Overall Study|Administrative problems|2|||
16562059|NCT01023308|40525315|FG001|Overall Study|Administrative problems|1|||
16562060|NCT01023308|40525314|FG000|Overall Study|Adverse Event|130|||
16562061|NCT01023308|40525315|FG001|Overall Study|Adverse Event|66|||
16562062|NCT01023308|40525314|FG000|Overall Study|Death|21|||
16248259|NCT01580020|39391794|FG003|Overall Study|Adverse Event|1|||
16357919|NCT02966834|39797099|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
16357920|NCT02966834|39797094|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
16357921|NCT02966834|39797095|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
16357922|NCT02966834|39797096|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
16419116|NCT03688620|40015409|FG002|Overall Study|Lost to Follow-up|1|||
16419117|NCT03688620|40015407|FG000|Overall Study|Withdrawal by Subject|0|||
16419118|NCT03688620|40015408|FG001|Overall Study|Withdrawal by Subject|0|||
16419119|NCT03688620|40015409|FG002|Overall Study|Withdrawal by Subject|6|||
16419120|NCT00695864|40015418|FG000|Placebo|Withdrawal by Subject|1|||
16419121|NCT00695864|40015418|FG000|Placebo|Physician Decision|4|||
16419122|NCT02262754|40015419|FG000|Overall Study|Adverse Event|3|||
16419123|NCT02262754|40015420|FG001|Overall Study|Adverse Event|4|||
16419124|NCT02262754|40015421|FG002|Overall Study|Adverse Event|0|||
16419125|NCT02262754|40015419|FG000|Overall Study|Lack of Efficacy|2|||
16562063|NCT01023308|40525315|FG001|Overall Study|Death|17|||
16562064|NCT01023308|40525314|FG000|Overall Study|Disease progression|82|||
16357923|NCT02966834|39797097|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
16357924|NCT02966834|39797098|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
16357925|NCT02966834|39797099|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
16357926|NCT02966834|39797094|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
16357927|NCT02966834|39797095|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
16357928|NCT02966834|39797096|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
16419126|NCT02262754|40015420|FG001|Overall Study|Lack of Efficacy|0|||
16419127|NCT02262754|40015421|FG002|Overall Study|Lack of Efficacy|1|||
16419128|NCT02262754|40015419|FG000|Overall Study|Lost to Follow-up|0|||
16419129|NCT02262754|40015420|FG001|Overall Study|Lost to Follow-up|0|||
16419130|NCT02262754|40015421|FG002|Overall Study|Lost to Follow-up|1|||
16419131|NCT02262754|40015419|FG000|Overall Study|No longer meets eligibility criteria|0|||
16419132|NCT02262754|40015420|FG001|Overall Study|No longer meets eligibility criteria|1|||
16419133|NCT02262754|40015421|FG002|Overall Study|No longer meets eligibility criteria|0|||
16419134|NCT02262754|40015419|FG000|Overall Study|Study terminated by sponsor|5|||
16357929|NCT02966834|39797097|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
16419135|NCT02262754|40015420|FG001|Overall Study|Study terminated by sponsor|4|||
16419136|NCT02262754|40015421|FG002|Overall Study|Study terminated by sponsor|4|||
16419137|NCT02262754|40015419|FG000|Overall Study|Protocol Violation|1|||
16419138|NCT02262754|40015420|FG001|Overall Study|Protocol Violation|0|||
16419139|NCT02262754|40015421|FG002|Overall Study|Protocol Violation|0|||
16357930|NCT02966834|39797098|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
16357931|NCT02966834|39797099|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
16357932|NCT00701363|39797100|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
16357933|NCT00701363|39797101|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
16357934|NCT00701363|39797102|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
16357935|NCT00701363|39797103|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
16357936|NCT00701363|39797100|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
16357937|NCT00701363|39797101|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
16357938|NCT00701363|39797102|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
16357939|NCT00701363|39797103|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
16357940|NCT00701363|39797100|FG000|Treatment Phase 1|Adverse Event|7|||
16357941|NCT00701363|39797101|FG001|Treatment Phase 1|Adverse Event|0|||
16357942|NCT00701363|39797102|FG002|Treatment Phase 1|Adverse Event|0|||
16357943|NCT00701363|39797103|FG003|Treatment Phase 1|Adverse Event|0|||
16357944|NCT00701363|39797100|FG000|Treatment Phase 1|Protocol Violation|1|||
16357945|NCT00701363|39797101|FG001|Treatment Phase 1|Protocol Violation|0|||
16357946|NCT00701363|39797102|FG002|Treatment Phase 1|Protocol Violation|0|||
16357947|NCT00701363|39797103|FG003|Treatment Phase 1|Protocol Violation|0|||
16357948|NCT00701363|39797100|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
16357949|NCT00701363|39797101|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
16357950|NCT00701363|39797102|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
16357951|NCT00701363|39797103|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
16357952|NCT00701363|39797100|FG000|Treatment Phase 1|Lack of Efficacy|1|||
16357953|NCT00701363|39797101|FG001|Treatment Phase 1|Lack of Efficacy|0|||
16357954|NCT00701363|39797102|FG002|Treatment Phase 1|Lack of Efficacy|0|||
16357955|NCT00701363|39797103|FG003|Treatment Phase 1|Lack of Efficacy|0|||
16357956|NCT00701363|39797100|FG000|Treatment Phase 2|Adverse Event|0|||
16357957|NCT00701363|39797101|FG001|Treatment Phase 2|Adverse Event|0|||
16357958|NCT00701363|39797102|FG002|Treatment Phase 2|Adverse Event|1|||
16357959|NCT00701363|39797103|FG003|Treatment Phase 2|Adverse Event|0|||
16357960|NCT00701363|39797100|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
16357961|NCT00701363|39797101|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
16357962|NCT00701363|39797102|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
16357963|NCT00701363|39797103|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
16357964|NCT00486044|39797104|FG000|Overall Study|Withdrawal by Subject|2|||
16357965|NCT00486044|39797105|FG001|Overall Study|Withdrawal by Subject|1|||
16357966|NCT00486044|39797104|FG000|Overall Study|Adverse Event|0|||
16357967|NCT00486044|39797105|FG001|Overall Study|Adverse Event|1|||
16357968|NCT00486044|39797104|FG000|Overall Study|Lost to Follow-up|0|||
16357969|NCT00486044|39797105|FG001|Overall Study|Lost to Follow-up|1|||
16357970|NCT04219189|39797106|FG000|Overall Study|Withdrawal by Subject|1|||
16357971|NCT04219189|39797107|FG001|Overall Study|Withdrawal by Subject|2|||
16357972|NCT04219189|39797106|FG000|Overall Study|Protocol Violation|0|||
16357973|NCT04219189|39797107|FG001|Overall Study|Protocol Violation|1|||
16357974|NCT04219189|39797106|FG000|Overall Study|Lost to Follow-up|0|||
16357975|NCT04219189|39797107|FG001|Overall Study|Lost to Follow-up|1|||
16357976|NCT04219189|39797106|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
16357977|NCT04219189|39797107|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
16357978|NCT01155570|39797108|FG000|Overall Study|Adverse Event|39|||
16357979|NCT01155570|39797108|FG000|Overall Study|Lack of Efficacy|46|||
16357980|NCT01155570|39797108|FG000|Overall Study|Participant's Economic Reasons|17|||
16357981|NCT01155570|39797108|FG000|Overall Study|No Hospital Visits|7|||
16357982|NCT01155570|39797108|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
16357983|NCT01155570|39797108|FG000|Overall Study|Adverse Event + Other Reasons|7|||
16357984|NCT01155570|39797108|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
16357985|NCT01155570|39797108|FG000|Overall Study|Other Reasons|23|||
16357986|NCT00301834|39797113|FG000|Overall Study|Death|1|||
16357987|NCT03040726|39797114|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
16357988|NCT03040726|39797115|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
16357989|NCT03040726|39797114|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
16357990|NCT03040726|39797115|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
16357991|NCT03040726|39797114|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
16419140|NCT02262754|40015419|FG000|Overall Study|Withdrawal by Subject|1|||
16419141|NCT02262754|40015420|FG001|Overall Study|Withdrawal by Subject|0|||
16419142|NCT02262754|40015421|FG002|Overall Study|Withdrawal by Subject|1|||
16419143|NCT02262754|40015419|FG000|Overall Study|Other|4|||
16419144|NCT02262754|40015420|FG001|Overall Study|Other|0|||
16248260|NCT01580020|39391791|FG000|Overall Study|Administrative Problems|0|||
16248261|NCT01580020|39391792|FG001|Overall Study|Administrative Problems|0|||
16248262|NCT01580020|39391793|FG002|Overall Study|Administrative Problems|1|||
16248263|NCT01580020|39391794|FG003|Overall Study|Administrative Problems|0|||
16248264|NCT01580020|39391791|FG000|Overall Study|Lost to Follow-up|0|||
16248265|NCT01580020|39391792|FG001|Overall Study|Lost to Follow-up|0|||
16248266|NCT01580020|39391793|FG002|Overall Study|Lost to Follow-up|1|||
16248267|NCT01580020|39391794|FG003|Overall Study|Lost to Follow-up|0|||
16248268|NCT01766778|39391795|FG000|Overall Study|Adverse Event|4|||
16248269|NCT01766778|39391796|FG001|Overall Study|Adverse Event|4|||
16248270|NCT01766778|39391795|FG000|Overall Study|Withdrawal by Subject|1|||
16248271|NCT01766778|39391796|FG001|Overall Study|Withdrawal by Subject|0|||
16248272|NCT00669955|39391797|FG000|Overall Study|Adverse Event|3|||
16248273|NCT00669955|39391798|FG001|Overall Study|Adverse Event|5|||
16248274|NCT00669955|39391797|FG000|Overall Study|Death|0|||
16248275|NCT00669955|39391798|FG001|Overall Study|Death|1|||
16248276|NCT00669955|39391797|FG000|Overall Study|Withdrawal by Subject|2|||
16248277|NCT00669955|39391798|FG001|Overall Study|Withdrawal by Subject|3|||
16248278|NCT00669955|39391797|FG000|Overall Study|Lost to Follow-up|5|||
16248279|NCT00669955|39391798|FG001|Overall Study|Lost to Follow-up|7|||
16248280|NCT00669955|39391797|FG000|Overall Study|Protocol Violation|2|||
16248281|NCT00669955|39391798|FG001|Overall Study|Protocol Violation|7|||
16248282|NCT00669955|39391797|FG000|Overall Study|Investigator Sponsor Judgement|0|||
16248283|NCT00669955|39391798|FG001|Overall Study|Investigator Sponsor Judgement|1|||
16248284|NCT00669955|39391797|FG000|Overall Study|not compliant with study drug/visit|2|||
16248285|NCT00669955|39391798|FG001|Overall Study|not compliant with study drug/visit|3|||
16248286|NCT04120194|39391802|FG000|Overall Study|Lost to Follow-up|11|||
16248287|NCT04120194|39391803|FG001|Overall Study|Lost to Follow-up|8|||
16248288|NCT04120194|39391802|FG000|Overall Study|Adverse Event|4|||
16248289|NCT04120194|39391803|FG001|Overall Study|Adverse Event|5|||
16248290|NCT04120194|39391802|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
16248291|NCT04120194|39391803|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
16248292|NCT04120194|39391802|FG000|Overall Study|Miscellaneous|4|||
16248293|NCT04120194|39391803|FG001|Overall Study|Miscellaneous|5|||
16248294|NCT04104646|39391805|FG000|Overall Study|Withdrawal by Subject|1|||
16248295|NCT04104646|39391806|FG001|Overall Study|Withdrawal by Subject|1|||
16248296|NCT04104646|39391805|FG000|Overall Study|Lost to Follow-up|1|||
16248297|NCT04104646|39391806|FG001|Overall Study|Lost to Follow-up|0|||
16248298|NCT04104646|39391805|FG000|Overall Study|Physician Decision|2|||
16248299|NCT04104646|39391806|FG001|Overall Study|Physician Decision|0|||
16248300|NCT01070966|39391807|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
16248301|NCT01070966|39391807|FG000|Participants for Safety Evaluation|Off-label use|9|||
16248302|NCT01070966|39391807|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
16248303|NCT01070966|39391807|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
16248304|NCT01070966|39391807|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
16248305|NCT01070966|39391807|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
16248306|NCT01070966|39391807|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
16248307|NCT01070966|39391807|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
16248308|NCT01488578|39391808|FG000|Overall Study|Protocol Violation|1836|||
16248309|NCT02598193|39391809|FG000|Overall Study|Adverse Event|13|||
16248310|NCT02598193|39391809|FG000|Overall Study|Withdrawal by Subject|1|||
16248311|NCT02598193|39391809|FG000|Overall Study|Listed in active lung transplant list|1|||
16248312|NCT02598193|39391809|FG000|Overall Study|Does not want to take Nintedanib|1|||
16248313|NCT02974114|39391814|FG000|Overall Study|Other (Not specified)|0|||
16248314|NCT02974114|39391815|FG001|Overall Study|Other (Not specified)|1|||
16248315|NCT02974114|39391816|FG002|Overall Study|Other (Not specified)|2|||
16248316|NCT01007916|39391817|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
16248317|NCT01007916|39391818|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
16248318|NCT01007916|39391817|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
16248319|NCT01007916|39391818|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
16248320|NCT02231710|39391819|FG000|Overall Study|Physician Decision|1|||
16248321|NCT01829477|39391820|FG000|Overall Study|Study Terminated by Sponsor|15|||
16248322|NCT01829477|39391821|FG001|Overall Study|Study Terminated by Sponsor|15|||
16248323|NCT01829477|39391820|FG000|Overall Study|Withdrawal by Subject|1|||
16248324|NCT01829477|39391821|FG001|Overall Study|Withdrawal by Subject|0|||
16248325|NCT00598559|39391822|FG000|Overall Study|Adverse Event|11|||
16248326|NCT00598559|39391823|FG001|Overall Study|Adverse Event|7|||
16248327|NCT00598559|39391824|FG002|Overall Study|Adverse Event|0|||
16248328|NCT00598559|39391822|FG000|Overall Study|Withdrawal by Subject|2|||
16248329|NCT00598559|39391823|FG001|Overall Study|Withdrawal by Subject|2|||
16248330|NCT00598559|39391824|FG002|Overall Study|Withdrawal by Subject|0|||
16248331|NCT00598559|39391822|FG000|Overall Study|Protocol Non-compliance|1|||
16248332|NCT00598559|39391823|FG001|Overall Study|Protocol Non-compliance|0|||
16248333|NCT00598559|39391824|FG002|Overall Study|Protocol Non-compliance|0|||
16357992|NCT03040726|39797115|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
16357993|NCT03040726|39797114|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
16357994|NCT03040726|39797115|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
16357995|NCT03040726|39797114|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
16357996|NCT03040726|39797115|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
16357997|NCT02153918|39797125|FG000|Overall Study|Refused further treatment|1|||
16357998|NCT05412134|39797126|FG000|Overall Study|Lost to Follow-up|2|||
16357999|NCT05412134|39797127|FG001|Overall Study|Lost to Follow-up|0|||
16358000|NCT03427411|39797129|FG000|Overall Study|Screen failure - platelets too low|0|||
16358001|NCT03427411|39797130|FG001|Overall Study|Screen failure - platelets too low|1|||
16358002|NCT02765035|39797131|FG000|First Intervention (90 Days)|Adverse Event|1|||
16358003|NCT02765035|39797132|FG001|First Intervention (90 Days)|Adverse Event|1|||
16358004|NCT02765035|39797131|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
16358005|NCT02765035|39797132|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
16358006|NCT00972478|39797133|FG000|Overall Study|Adverse Event|3|||
16358007|NCT00972478|39797134|FG001|Overall Study|Adverse Event|16|||
16358008|NCT00972478|39797133|FG000|Overall Study|Withdrawal by Subject|1|||
16358009|NCT00972478|39797134|FG001|Overall Study|Withdrawal by Subject|8|||
16358010|NCT00972478|39797133|FG000|Overall Study|Progression/Relapse|0|||
16419145|NCT02262754|40015421|FG002|Overall Study|Other|2|||
16419146|NCT00527319|40015422|FG000|Overall Study|Withdrawal by Subject|5|||
16419147|NCT00527319|40015423|FG001|Overall Study|Withdrawal by Subject|0|||
16419148|NCT00527319|40015424|FG002|Overall Study|Withdrawal by Subject|1|||
16419149|NCT00527319|40015422|FG000|Overall Study|Lost to Follow-up|1|||
16419150|NCT00527319|40015423|FG001|Overall Study|Lost to Follow-up|0|||
16419151|NCT00527319|40015424|FG002|Overall Study|Lost to Follow-up|0|||
16419152|NCT00527319|40015422|FG000|Overall Study|Death|0|||
16419153|NCT00527319|40015423|FG001|Overall Study|Death|3|||
16419154|NCT00527319|40015424|FG002|Overall Study|Death|1|||
16419155|NCT00527319|40015422|FG000|Overall Study|Intercurrent Medical Illness|0|||
16419156|NCT00527319|40015423|FG001|Overall Study|Intercurrent Medical Illness|1|||
16419157|NCT00527319|40015424|FG002|Overall Study|Intercurrent Medical Illness|3|||
16419158|NCT00527319|40015422|FG000|Overall Study|Adverse Event|0|||
16419159|NCT00527319|40015423|FG001|Overall Study|Adverse Event|0|||
16419160|NCT00527319|40015424|FG002|Overall Study|Adverse Event|1|||
16419161|NCT02986854|40015425|FG000|Overall Study|Withdrawal by Subject|0|||
16419162|NCT02986854|40015426|FG001|Overall Study|Withdrawal by Subject|1|||
16419163|NCT02986854|40015427|FG002|Overall Study|Withdrawal by Subject|1|||
16419164|NCT02986854|40015425|FG000|Overall Study|Lost to Follow-up|3|||
16419165|NCT02986854|40015426|FG001|Overall Study|Lost to Follow-up|11|||
16419166|NCT02986854|40015427|FG002|Overall Study|Lost to Follow-up|2|||
16419167|NCT03995355|40015430|FG000|Overall Study|Adverse Event|1|||
16419168|NCT03995355|40015431|FG001|Overall Study|Adverse Event|0|||
16419169|NCT03995355|40015430|FG000|Overall Study|Withdrawal by Subject|1|||
16419170|NCT03995355|40015431|FG001|Overall Study|Withdrawal by Subject|0|||
16419171|NCT03995355|40015430|FG000|Overall Study|Scheduling Issues|0|||
16419172|NCT03995355|40015431|FG001|Overall Study|Scheduling Issues|1|||
16419173|NCT02212678|40015438|FG000|Overall Study|Adverse Event|1|||
16419174|NCT02198235|40015440|FG000|Overall Study|Lost to Follow-up|3|||
16419175|NCT02198235|40015441|FG001|Overall Study|Lost to Follow-up|2|||
16419176|NCT02198235|40015442|FG002|Overall Study|Lost to Follow-up|2|||
16419177|NCT01196416|40015446|FG000|Overall Study|Withdrawal by Subject|2|||
16358011|NCT00972478|39797134|FG001|Overall Study|Progression/Relapse|2|||
16358012|NCT00972478|39797133|FG000|Overall Study|Death|0|||
16358013|NCT00972478|39797134|FG001|Overall Study|Death|2|||
16358014|NCT00972478|39797133|FG000|Overall Study|Not protocol specified|1|||
16358015|NCT00972478|39797134|FG001|Overall Study|Not protocol specified|1|||
16358016|NCT00972478|39797133|FG000|Overall Study|Ineligible|1|||
16358017|NCT00972478|39797134|FG001|Overall Study|Ineligible|7|||
16358018|NCT00972478|39797133|FG000|Overall Study|Not start protocol treatment|1|||
16358019|NCT00972478|39797134|FG001|Overall Study|Not start protocol treatment|2|||
16358020|NCT02858401|39797137|FG000|Overall Study|Withdrew Consent|0|||
16358021|NCT02858401|39797138|FG001|Overall Study|Withdrew Consent|0|||
16419178|NCT01649869|40015447|FG000|Overall Study|Family member illness|1|||
16419179|NCT01649869|40015448|FG001|Overall Study|Family member illness|0|||
16419180|NCT01649869|40015447|FG000|Overall Study|Required treatment outside protocol|1|||
16419181|NCT01649869|40015448|FG001|Overall Study|Required treatment outside protocol|0|||
16358022|NCT02858401|39797139|FG002|Overall Study|Withdrew Consent|0|||
16358023|NCT02858401|39797140|FG003|Overall Study|Withdrew Consent|0|||
16358024|NCT02858401|39797141|FG004|Overall Study|Withdrew Consent|0|||
16358025|NCT02858401|39797142|FG005|Overall Study|Withdrew Consent|1|||
16358026|NCT02858401|39797143|FG006|Overall Study|Withdrew Consent|0|||
16358027|NCT02858401|39797137|FG000|Overall Study|Lost to Follow-up|0|||
16358028|NCT02858401|39797138|FG001|Overall Study|Lost to Follow-up|1|||
16419182|NCT01649869|40015447|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
16358029|NCT02858401|39797139|FG002|Overall Study|Lost to Follow-up|0|||
16358030|NCT02858401|39797140|FG003|Overall Study|Lost to Follow-up|0|||
16358031|NCT02858401|39797141|FG004|Overall Study|Lost to Follow-up|0|||
16358032|NCT02858401|39797142|FG005|Overall Study|Lost to Follow-up|0|||
16358033|NCT02858401|39797143|FG006|Overall Study|Lost to Follow-up|0|||
16358034|NCT00284856|39797148|FG000|Overall Study|Adverse Event|3|||
16358035|NCT00284856|39797149|FG001|Overall Study|Adverse Event|3|||
16358036|NCT00284856|39797150|FG002|Overall Study|Adverse Event|3|||
16358037|NCT00284856|39797148|FG000|Overall Study|Lack of Efficacy|2|||
16358038|NCT00284856|39797149|FG001|Overall Study|Lack of Efficacy|1|||
16358039|NCT00284856|39797150|FG002|Overall Study|Lack of Efficacy|8|||
16358040|NCT00284856|39797148|FG000|Overall Study|Lost to Follow-up|25|||
16358041|NCT00284856|39797149|FG001|Overall Study|Lost to Follow-up|21|||
16358042|NCT00284856|39797150|FG002|Overall Study|Lost to Follow-up|22|||
16358043|NCT00284856|39797148|FG000|Overall Study|Protocol Violation|5|||
16358044|NCT00284856|39797149|FG001|Overall Study|Protocol Violation|4|||
16358045|NCT00284856|39797150|FG002|Overall Study|Protocol Violation|5|||
16358046|NCT00284856|39797148|FG000|Overall Study|Withdrawal by Subject|12|||
16358047|NCT00284856|39797149|FG001|Overall Study|Withdrawal by Subject|16|||
16358048|NCT00284856|39797150|FG002|Overall Study|Withdrawal by Subject|18|||
16358049|NCT00284856|39797148|FG000|Overall Study|Other|4|||
16358050|NCT00284856|39797149|FG001|Overall Study|Other|5|||
16358051|NCT00284856|39797150|FG002|Overall Study|Other|4|||
16358052|NCT01922934|39797151|FG000|Eligible Patients|Death|0|||
16358053|NCT01922934|39797152|FG001|Eligible Patients|Death|7|||
16358054|NCT01922934|39797151|FG000|Eligible Patients|Physician Decision|17|||
16358055|NCT01922934|39797152|FG001|Eligible Patients|Physician Decision|0|||
16358056|NCT01922934|39797151|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
16358057|NCT01922934|39797152|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
16358058|NCT01922934|39797151|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
16358059|NCT01922934|39797152|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
16358060|NCT01922934|39797151|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
16358061|NCT01922934|39797152|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
16358062|NCT01922934|39797151|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
16358063|NCT01922934|39797152|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
16358064|NCT01850641|39797153|FG000|Overall Study|Physician Decision|1|||
16358065|NCT01850641|39797153|FG000|Overall Study|Decrease in serum phosphorus|1|||
16358066|NCT01850641|39797153|FG000|Overall Study|Decrease in serum calcium|2|||
16358067|NCT01850641|39797153|FG000|Overall Study|Increase in serum ferritin|1|||
16358068|NCT03538041|39797154|FG000|12-Week Treatment Period|Adverse Event|1|||
16358069|NCT03538041|39797155|FG001|12-Week Treatment Period|Adverse Event|1|||
16358070|NCT03538041|39797154|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
16358071|NCT03538041|39797155|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
16358072|NCT03538041|39797154|FG000|Treatment Extension Period|Adverse Event|4|||
16358073|NCT03538041|39797155|FG001|Treatment Extension Period|Adverse Event|0|||
16358074|NCT03538041|39797154|FG000|Treatment Extension Period|Physician Decision|1|||
16358075|NCT03538041|39797155|FG001|Treatment Extension Period|Physician Decision|0|||
16358076|NCT03538041|39797154|FG000|Treatment Extension Period|Lack of Efficacy|1|||
16358077|NCT03538041|39797155|FG001|Treatment Extension Period|Lack of Efficacy|3|||
16358078|NCT03538041|39797154|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
16358079|NCT03538041|39797155|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
16358080|NCT00961064|39797156|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
16358081|NCT00961064|39797156|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
16358082|NCT00961064|39797156|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
16358083|NCT00961064|39797156|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
16358084|NCT00961064|39797156|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
16562065|NCT01023308|40525315|FG001|Overall Study|Disease progression|153|||
16130681|NCT02842827|38967103|FG003|Overall Study|Protocol Defined Disease Progression|0|||
16358085|NCT00961064|39797156|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
16358086|NCT00961064|39797156|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
16358087|NCT00961064|39797156|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
16358088|NCT00706004|39797160|FG000|Overall Study|Did not meet eligibility criteria|2|||
16358089|NCT01142336|39797161|FG000|Overall Study|Adverse Event|1|||
16358090|NCT01142336|39797162|FG001|Overall Study|Adverse Event|1|||
16358091|NCT01142336|39797161|FG000|Overall Study|Lost to Follow-up|0|||
16358092|NCT01142336|39797162|FG001|Overall Study|Lost to Follow-up|1|||
16358093|NCT02611882|39797163|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
16358094|NCT02611882|39797164|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
16358095|NCT02611882|39797165|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
16358096|NCT01140906|39797168|FG000|Overall Study|Adverse Event|7|||
16358097|NCT01140906|39797169|FG001|Overall Study|Adverse Event|10|||
16358098|NCT01140906|39797170|FG002|Overall Study|Adverse Event|17|||
16358099|NCT01140906|39797171|FG003|Overall Study|Adverse Event|7|||
16358100|NCT01140906|39797168|FG000|Overall Study|Lack of Efficacy|6|||
16358101|NCT01140906|39797169|FG001|Overall Study|Lack of Efficacy|8|||
16358102|NCT01140906|39797170|FG002|Overall Study|Lack of Efficacy|2|||
16358103|NCT01140906|39797171|FG003|Overall Study|Lack of Efficacy|1|||
16358104|NCT01140906|39797168|FG000|Overall Study|Non-compliance|0|||
16358105|NCT01140906|39797169|FG001|Overall Study|Non-compliance|1|||
16358106|NCT01140906|39797170|FG002|Overall Study|Non-compliance|0|||
16358107|NCT01140906|39797171|FG003|Overall Study|Non-compliance|1|||
16358108|NCT01140906|39797168|FG000|Overall Study|Protocol Violation|5|||
16358109|NCT01140906|39797169|FG001|Overall Study|Protocol Violation|3|||
16358110|NCT01140906|39797170|FG002|Overall Study|Protocol Violation|2|||
16358111|NCT01140906|39797171|FG003|Overall Study|Protocol Violation|1|||
16358112|NCT01140906|39797168|FG000|Overall Study|Withdrawal of consent|6|||
16358113|NCT01140906|39797169|FG001|Overall Study|Withdrawal of consent|6|||
16358114|NCT01140906|39797170|FG002|Overall Study|Withdrawal of consent|2|||
16358115|NCT01140906|39797171|FG003|Overall Study|Withdrawal of consent|2|||
16358116|NCT01140906|39797168|FG000|Overall Study|Lost to Follow-up|1|||
16358117|NCT01140906|39797169|FG001|Overall Study|Lost to Follow-up|1|||
16358118|NCT01140906|39797170|FG002|Overall Study|Lost to Follow-up|0|||
16358119|NCT01140906|39797171|FG003|Overall Study|Lost to Follow-up|2|||
16358120|NCT01140906|39797168|FG000|Overall Study|Administrative or other reason|0|||
16358121|NCT01140906|39797169|FG001|Overall Study|Administrative or other reason|5|||
16358122|NCT01140906|39797170|FG002|Overall Study|Administrative or other reason|3|||
16358123|NCT01140906|39797171|FG003|Overall Study|Administrative or other reason|2|||
16358124|NCT03642990|39797182|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
16358125|NCT03642990|39797182|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
16358126|NCT00323063|39797185|FG000|Overall Study|Adverse Event|1|||
16358127|NCT00323063|39797186|FG001|Overall Study|Adverse Event|0|||
16358128|NCT00323063|39797185|FG000|Overall Study|brain mets discovered prior to treatment|1|||
16358129|NCT00323063|39797186|FG001|Overall Study|brain mets discovered prior to treatment|0|||
16358130|NCT00374868|39797188|FG000|Overall Study|Adverse Event|12|||
16358131|NCT00374868|39797188|FG000|Overall Study|Progressive Disease|7|||
16358132|NCT00374868|39797188|FG000|Overall Study|Physician Decision|13|||
16358133|NCT00374868|39797188|FG000|Overall Study|Lost to Follow-up|1|||
16358134|NCT00374868|39797188|FG000|Overall Study|Death|2|||
16358135|NCT00374868|39797188|FG000|Overall Study|Other - Not Specified|1|||
16358136|NCT00076570|39797191|FG000|Overall Study|Drug intolerance|8|||
16358137|NCT00076570|39797192|FG001|Overall Study|Drug intolerance|8|||
16358138|NCT00856180|39797198|FG000|Overall Study|Adverse Event|4|||
16358139|NCT00856180|39797198|FG000|Overall Study|Progressive Disease|16|||
16358140|NCT00529035|39797205|FG000|Overall Study|Withdrawal by Subject|1|||
16358141|NCT01699750|39797206|FG000|Overall Study|Withdrew Consent|0|||
16358142|NCT01699750|39797207|FG001|Overall Study|Withdrew Consent|1|||
16358143|NCT01699750|39797206|FG000|Overall Study|Other|0|||
16358144|NCT01699750|39797207|FG001|Overall Study|Other|2|||
16358145|NCT02265510|39797211|FG000|Overall Study|Withdrawal by Subject|1|||
16358146|NCT02265510|39797212|FG001|Overall Study|Withdrawal by Subject|1|||
16358147|NCT02265510|39797213|FG002|Overall Study|Withdrawal by Subject|2|||
16358148|NCT02265510|39797214|FG003|Overall Study|Withdrawal by Subject|1|||
16358149|NCT02265510|39797215|FG004|Overall Study|Withdrawal by Subject|0|||
16358150|NCT02265510|39797216|FG005|Overall Study|Withdrawal by Subject|2|||
16358151|NCT02265510|39797217|FG006|Overall Study|Withdrawal by Subject|0|||
16358152|NCT02265510|39797218|FG007|Overall Study|Withdrawal by Subject|2|||
16358153|NCT02265510|39797219|FG008|Overall Study|Withdrawal by Subject|0|||
16358154|NCT02265510|39797220|FG009|Overall Study|Withdrawal by Subject|0|||
16358155|NCT02265510|39797221|FG010|Overall Study|Withdrawal by Subject|0|||
16419183|NCT01649869|40015448|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
16419184|NCT04356352|40015453|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
16358156|NCT02265510|39797222|FG011|Overall Study|Withdrawal by Subject|0|||
16358157|NCT02265510|39797223|FG012|Overall Study|Withdrawal by Subject|1|||
16358158|NCT02265510|39797224|FG013|Overall Study|Withdrawal by Subject|0|||
16358159|NCT02265510|39797211|FG000|Overall Study|Disease Progression|0|||
16358160|NCT02265510|39797212|FG001|Overall Study|Disease Progression|1|||
16358161|NCT02265510|39797213|FG002|Overall Study|Disease Progression|2|||
16358162|NCT02265510|39797214|FG003|Overall Study|Disease Progression|1|||
16358163|NCT02265510|39797215|FG004|Overall Study|Disease Progression|1|||
16358164|NCT02265510|39797216|FG005|Overall Study|Disease Progression|0|||
16358165|NCT02265510|39797217|FG006|Overall Study|Disease Progression|0|||
16358166|NCT02265510|39797218|FG007|Overall Study|Disease Progression|0|||
16358167|NCT02265510|39797219|FG008|Overall Study|Disease Progression|0|||
16358168|NCT02265510|39797220|FG009|Overall Study|Disease Progression|0|||
16358169|NCT02265510|39797221|FG010|Overall Study|Disease Progression|0|||
16248334|NCT00598559|39391822|FG000|Overall Study|Early discharge from hospital|9|||
16248335|NCT00598559|39391823|FG001|Overall Study|Early discharge from hospital|12|||
16248336|NCT00598559|39391824|FG002|Overall Study|Early discharge from hospital|3|||
16248337|NCT00598559|39391822|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
16248338|NCT00598559|39391823|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
16248339|NCT00598559|39391824|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
16248340|NCT00753714|39391825|FG000|Overall Study|Lack of Efficacy|21|||
16248341|NCT00753714|39391826|FG001|Overall Study|Lack of Efficacy|34|||
16248342|NCT00753714|39391825|FG000|Overall Study|Adverse Event|26|||
16248343|NCT00753714|39391826|FG001|Overall Study|Adverse Event|18|||
16248344|NCT00753714|39391825|FG000|Overall Study|Protocol Violation|1|||
16248345|NCT00753714|39391826|FG001|Overall Study|Protocol Violation|0|||
16248346|NCT00753714|39391825|FG000|Overall Study|Lost to Follow-up|0|||
16248347|NCT00753714|39391826|FG001|Overall Study|Lost to Follow-up|1|||
16248348|NCT00753714|39391825|FG000|Overall Study|Withdrawal by Subject|2|||
16248349|NCT00753714|39391826|FG001|Overall Study|Withdrawal by Subject|1|||
16248350|NCT00753714|39391825|FG000|Overall Study|Death|3|||
16248351|NCT00753714|39391826|FG001|Overall Study|Death|3|||
16248352|NCT00753714|39391825|FG000|Overall Study|Other|7|||
16248353|NCT00753714|39391826|FG001|Overall Study|Other|5|||
16248354|NCT00583596|39391830|FG000|Overall Study|Lost to Follow-up|110|||
16248355|NCT00583596|39391830|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
16248356|NCT00583596|39391830|FG000|Overall Study|Death|2|||
16248357|NCT00583596|39391830|FG000|Overall Study|Withdrawal by Subject|6|||
16248358|NCT00583596|39391830|FG000|Overall Study|Lost to Follow-up|94|||
16248359|NCT00583596|39391830|FG000|Overall Study|Data not complete|1|||
16248360|NCT00583596|39391830|FG000|Overall Study|Not consented|15|||
16248361|NCT00583596|39391830|FG000|Overall Study|Outside f-up window|26|||
16248362|NCT02100956|39391833|FG000|At Least One Week Between Injections|Adverse Event|0|||
16248363|NCT02100956|39391834|FG001|At Least One Week Between Injections|Adverse Event|1|||
16248364|NCT03682536|39391835|FG000|Randomization|Withdrawal by Subject|0|||
16248365|NCT03682536|39391836|FG001|Randomization|Withdrawal by Subject|2|||
16248366|NCT03682536|39391835|FG000|Treatment|Other Reasons|8|||
16248367|NCT03682536|39391836|FG001|Treatment|Other Reasons|7|||
16248368|NCT03682536|39391835|FG000|Treatment|Physician Decision|5|||
16248369|NCT03682536|39391836|FG001|Treatment|Physician Decision|5|||
16248370|NCT03682536|39391835|FG000|Treatment|Protocol Violation|1|||
16248371|NCT03682536|39391836|FG001|Treatment|Protocol Violation|0|||
16248372|NCT03682536|39391835|FG000|Treatment|Study Terminated by Sponsor|1|||
16248373|NCT03682536|39391836|FG001|Treatment|Study Terminated by Sponsor|2|||
16248374|NCT03682536|39391835|FG000|Treatment|Lost to Follow-up|0|||
16248375|NCT03682536|39391836|FG001|Treatment|Lost to Follow-up|1|||
16248376|NCT03682536|39391835|FG000|Treatment|Withdrawal by Subject|16|||
16248377|NCT03682536|39391836|FG001|Treatment|Withdrawal by Subject|18|||
16248378|NCT03682536|39391835|FG000|Treatment|Lack of Efficacy|41|||
16248379|NCT03682536|39391836|FG001|Treatment|Lack of Efficacy|68|||
16248380|NCT03682536|39391835|FG000|Treatment|Disease Progression|9|||
16248381|NCT03682536|39391836|FG001|Treatment|Disease Progression|7|||
16248382|NCT03682536|39391835|FG000|Treatment|Adverse Event|9|||
16248383|NCT03682536|39391836|FG001|Treatment|Adverse Event|5|||
16248384|NCT03682536|39391835|FG000|Treatment|Death|14|||
16248385|NCT03682536|39391836|FG001|Treatment|Death|13|||
16248386|NCT00634179|39391837|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
16248387|NCT01059071|39391838|FG000|Overall Study|Lack of Efficacy|1|||
16248388|NCT01059071|39391839|FG001|Overall Study|Lack of Efficacy|4|||
16248389|NCT01059071|39391840|FG002|Overall Study|Lack of Efficacy|2|||
16248390|NCT01059071|39391841|FG003|Overall Study|Lack of Efficacy|3|||
16248391|NCT01059071|39391838|FG000|Overall Study|Withdrawal by Subject|1|||
16248392|NCT01059071|39391839|FG001|Overall Study|Withdrawal by Subject|0|||
16248393|NCT01059071|39391840|FG002|Overall Study|Withdrawal by Subject|0|||
16248394|NCT01059071|39391841|FG003|Overall Study|Withdrawal by Subject|2|||
16248395|NCT01059071|39391838|FG000|Overall Study|Physician Decision|0|||
16248396|NCT01059071|39391839|FG001|Overall Study|Physician Decision|0|||
16248397|NCT01059071|39391840|FG002|Overall Study|Physician Decision|0|||
16248398|NCT01059071|39391841|FG003|Overall Study|Physician Decision|1|||
16248399|NCT01966042|39391842|FG000|Overall Study|Death|2|||
16248400|NCT01208402|39391845|FG000|Overall Study|Withdrawal by Subject|1|||
16248401|NCT01208402|39391846|FG001|Overall Study|Withdrawal by Subject|0|||
16248402|NCT02415959|39391847|FG000|Overall Study|Adverse Event|0|||
16248403|NCT02415959|39391848|FG001|Overall Study|Adverse Event|1|||
16358170|NCT02265510|39797222|FG011|Overall Study|Disease Progression|0|||
16248404|NCT02415959|39391849|FG002|Overall Study|Adverse Event|0|||
16248405|NCT02415959|39391850|FG003|Overall Study|Adverse Event|0|||
16248406|NCT02415959|39391851|FG004|Overall Study|Adverse Event|0|||
16248407|NCT02415959|39391847|FG000|Overall Study|Protocol Violation|0|||
16248408|NCT02415959|39391848|FG001|Overall Study|Protocol Violation|0|||
16248409|NCT02415959|39391849|FG002|Overall Study|Protocol Violation|0|||
16358171|NCT02265510|39797223|FG012|Overall Study|Disease Progression|0|||
16358172|NCT02265510|39797224|FG013|Overall Study|Disease Progression|0|||
16419185|NCT04356352|40015454|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
16419186|NCT04356352|40015455|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
16419187|NCT04356352|40015453|FG000|Overall Study|Protocol Violation|0|||
16419188|NCT04356352|40015454|FG001|Overall Study|Protocol Violation|3|||
16419189|NCT04356352|40015455|FG002|Overall Study|Protocol Violation|1|||
16419190|NCT01008449|40015456|FG000|Overall Study|Lost to Follow-up|29|||
16419191|NCT01008449|40015457|FG001|Overall Study|Lost to Follow-up|19|||
16419192|NCT00077649|40015458|FG000|Overall Study|Adverse Event|5|||
16419193|NCT00077649|40015459|FG001|Overall Study|Adverse Event|1|||
16419194|NCT00077649|40015460|FG002|Overall Study|Adverse Event|7|||
16419195|NCT00077649|40015461|FG003|Overall Study|Adverse Event|9|||
16419196|NCT00077649|40015458|FG000|Overall Study|Lack of Efficacy|5|||
16419197|NCT00077649|40015459|FG001|Overall Study|Lack of Efficacy|3|||
16419198|NCT00077649|40015460|FG002|Overall Study|Lack of Efficacy|3|||
16419199|NCT00077649|40015461|FG003|Overall Study|Lack of Efficacy|2|||
16419200|NCT00077649|40015458|FG000|Overall Study|Withdrawal by Subject|0|||
16419201|NCT00077649|40015459|FG001|Overall Study|Withdrawal by Subject|1|||
16419202|NCT00077649|40015460|FG002|Overall Study|Withdrawal by Subject|1|||
16419203|NCT00077649|40015461|FG003|Overall Study|Withdrawal by Subject|2|||
16419204|NCT00077649|40015458|FG000|Overall Study|Lost to Follow-up|2|||
16419205|NCT00077649|40015459|FG001|Overall Study|Lost to Follow-up|2|||
16419206|NCT00077649|40015460|FG002|Overall Study|Lost to Follow-up|3|||
16419207|NCT00077649|40015461|FG003|Overall Study|Lost to Follow-up|2|||
16419208|NCT00077649|40015458|FG000|Overall Study|Abnormality of Laboratory Test|1|||
16419209|NCT00077649|40015459|FG001|Overall Study|Abnormality of Laboratory Test|2|||
16419210|NCT00077649|40015460|FG002|Overall Study|Abnormality of Laboratory Test|1|||
16419211|NCT00077649|40015461|FG003|Overall Study|Abnormality of Laboratory Test|2|||
16419212|NCT00077649|40015458|FG000|Overall Study|Randomized but never dosed|1|||
16419213|NCT00077649|40015459|FG001|Overall Study|Randomized but never dosed|0|||
16419214|NCT00077649|40015460|FG002|Overall Study|Randomized but never dosed|0|||
16419215|NCT00077649|40015461|FG003|Overall Study|Randomized but never dosed|0|||
16358173|NCT02265510|39797211|FG000|Overall Study|Death|2|||
16358174|NCT02265510|39797212|FG001|Overall Study|Death|0|||
16358175|NCT02265510|39797213|FG002|Overall Study|Death|2|||
16358176|NCT02265510|39797214|FG003|Overall Study|Death|2|||
16358177|NCT02265510|39797215|FG004|Overall Study|Death|1|||
16358178|NCT02265510|39797216|FG005|Overall Study|Death|3|||
16358179|NCT02265510|39797217|FG006|Overall Study|Death|2|||
16358180|NCT02265510|39797218|FG007|Overall Study|Death|1|||
16358181|NCT02265510|39797219|FG008|Overall Study|Death|3|||
16358182|NCT02265510|39797220|FG009|Overall Study|Death|3|||
16419216|NCT00705146|40015462|FG000|Overall Study|Lost to Follow-up|1|||
16419217|NCT00705146|40015463|FG001|Overall Study|Lost to Follow-up|1|||
16419218|NCT00852241|40015473|FG000|Overall Study|Physician Decision|18|||
16419219|NCT03214406|40015474|FG000|Overall Study|did not meet enrollment criteria|9|||
16419220|NCT03214406|40015475|FG001|Overall Study|did not meet enrollment criteria|13|||
16419221|NCT03214406|40015474|FG000|Overall Study|Withdrawal by Subject|1|||
16358183|NCT02265510|39797221|FG010|Overall Study|Death|4|||
16419222|NCT03214406|40015475|FG001|Overall Study|Withdrawal by Subject|0|||
16419223|NCT03214406|40015474|FG000|Overall Study|Lost to Follow-up|0|||
16419224|NCT03214406|40015475|FG001|Overall Study|Lost to Follow-up|2|||
16419225|NCT01818284|40015480|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
16358184|NCT02265510|39797222|FG011|Overall Study|Death|12|||
16358185|NCT02265510|39797223|FG012|Overall Study|Death|7|||
16358186|NCT02265510|39797224|FG013|Overall Study|Death|6|||
16358187|NCT02265510|39797211|FG000|Overall Study|Lost to Follow-up|0|||
16358188|NCT02265510|39797212|FG001|Overall Study|Lost to Follow-up|0|||
16358189|NCT02265510|39797213|FG002|Overall Study|Lost to Follow-up|0|||
16358190|NCT02265510|39797214|FG003|Overall Study|Lost to Follow-up|0|||
16358191|NCT02265510|39797215|FG004|Overall Study|Lost to Follow-up|1|||
16358192|NCT02265510|39797216|FG005|Overall Study|Lost to Follow-up|0|||
16358193|NCT02265510|39797217|FG006|Overall Study|Lost to Follow-up|0|||
16358194|NCT02265510|39797218|FG007|Overall Study|Lost to Follow-up|0|||
16358195|NCT02265510|39797219|FG008|Overall Study|Lost to Follow-up|0|||
16358196|NCT02265510|39797220|FG009|Overall Study|Lost to Follow-up|2|||
16419226|NCT01818284|40015481|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
16419227|NCT01818284|40015480|FG000|Overall Study|Death|0|||
16419228|NCT01818284|40015481|FG001|Overall Study|Death|2|||
16248410|NCT02415959|39391850|FG003|Overall Study|Protocol Violation|1|||
16358197|NCT02265510|39797221|FG010|Overall Study|Lost to Follow-up|0|||
16358198|NCT02265510|39797222|FG011|Overall Study|Lost to Follow-up|0|||
16358199|NCT02265510|39797223|FG012|Overall Study|Lost to Follow-up|0|||
16358200|NCT02265510|39797224|FG013|Overall Study|Lost to Follow-up|2|||
16358201|NCT02265510|39797211|FG000|Overall Study|Other|0|||
16358202|NCT02265510|39797212|FG001|Overall Study|Other|1|||
16358203|NCT02265510|39797213|FG002|Overall Study|Other|0|||
16358204|NCT02265510|39797214|FG003|Overall Study|Other|0|||
16358205|NCT02265510|39797215|FG004|Overall Study|Other|0|||
16358206|NCT02265510|39797216|FG005|Overall Study|Other|0|||
16358207|NCT02265510|39797217|FG006|Overall Study|Other|0|||
16358208|NCT02265510|39797218|FG007|Overall Study|Other|0|||
16358209|NCT02265510|39797219|FG008|Overall Study|Other|0|||
16358210|NCT02265510|39797220|FG009|Overall Study|Other|0|||
16358211|NCT02265510|39797221|FG010|Overall Study|Other|0|||
16358212|NCT02265510|39797222|FG011|Overall Study|Other|0|||
16358213|NCT02265510|39797223|FG012|Overall Study|Other|0|||
16358214|NCT02265510|39797224|FG013|Overall Study|Other|0|||
16358215|NCT02265510|39797211|FG000|Overall Study|Study Terminated by Sponsor|0|||
16358216|NCT02265510|39797212|FG001|Overall Study|Study Terminated by Sponsor|0|||
16358217|NCT02265510|39797213|FG002|Overall Study|Study Terminated by Sponsor|0|||
16358218|NCT02265510|39797214|FG003|Overall Study|Study Terminated by Sponsor|0|||
16358219|NCT02265510|39797215|FG004|Overall Study|Study Terminated by Sponsor|0|||
16358220|NCT02265510|39797216|FG005|Overall Study|Study Terminated by Sponsor|1|||
16358221|NCT02265510|39797217|FG006|Overall Study|Study Terminated by Sponsor|1|||
16358222|NCT02265510|39797218|FG007|Overall Study|Study Terminated by Sponsor|1|||
16358223|NCT02265510|39797219|FG008|Overall Study|Study Terminated by Sponsor|1|||
16358224|NCT02265510|39797220|FG009|Overall Study|Study Terminated by Sponsor|2|||
16358225|NCT02265510|39797221|FG010|Overall Study|Study Terminated by Sponsor|1|||
16358226|NCT02265510|39797222|FG011|Overall Study|Study Terminated by Sponsor|4|||
16358227|NCT02265510|39797223|FG012|Overall Study|Study Terminated by Sponsor|1|||
16358228|NCT02265510|39797224|FG013|Overall Study|Study Terminated by Sponsor|2|||
16358229|NCT02349386|39797227|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
16358230|NCT02349386|39797228|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
16358231|NCT02349386|39797229|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
16358232|NCT02349386|39797230|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
16358233|NCT02349386|39797227|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
16358234|NCT02349386|39797228|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
16358235|NCT02349386|39797229|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
16358236|NCT02349386|39797230|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
16358237|NCT02349386|39797227|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
16358238|NCT02349386|39797228|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
16358239|NCT02349386|39797229|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
16358240|NCT02349386|39797230|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
16358241|NCT02349386|39797227|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
16358242|NCT02349386|39797228|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
16358243|NCT02349386|39797229|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
16358244|NCT02349386|39797230|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
16419229|NCT04856904|40015482|FG000|Overall Study|Physician Decision|1|||
16419230|NCT04856904|40015483|FG001|Overall Study|Physician Decision|1|||
16419231|NCT04856904|40015482|FG000|Overall Study|Withdrawal by Subject|13|||
16419232|NCT04856904|40015483|FG001|Overall Study|Withdrawal by Subject|13|||
16419233|NCT04856904|40015482|FG000|Overall Study|Adverse Event|1|||
16419234|NCT04856904|40015483|FG001|Overall Study|Adverse Event|1|||
16419235|NCT04856904|40015482|FG000|Overall Study|Non-compliance with study drug|1|||
16419236|NCT04856904|40015483|FG001|Overall Study|Non-compliance with study drug|1|||
16419237|NCT04856904|40015482|FG000|Overall Study|Lost to Follow-up|4|||
16419238|NCT04856904|40015483|FG001|Overall Study|Lost to Follow-up|4|||
16419239|NCT04856904|40015482|FG000|Overall Study|Withdrawal by Subject|1|||
16419240|NCT04856904|40015483|FG001|Overall Study|Withdrawal by Subject|1|||
16419241|NCT04856904|40015482|FG000|Overall Study|Protocol Violation|1|||
16419242|NCT04856904|40015483|FG001|Overall Study|Protocol Violation|1|||
16419243|NCT02798471|40015484|FG000|Overall Study|Adverse Event|7|||
16419244|NCT02798471|40015485|FG001|Overall Study|Adverse Event|2|||
16419245|NCT02798471|40015484|FG000|Overall Study|Physician Decision|3|||
16419246|NCT02798471|40015485|FG001|Overall Study|Physician Decision|7|||
16419247|NCT02798471|40015484|FG000|Overall Study|Death|2|||
16419248|NCT02798471|40015485|FG001|Overall Study|Death|3|||
16419249|NCT02798471|40015484|FG000|Overall Study|Lost to Follow-up|0|||
16419250|NCT02798471|40015485|FG001|Overall Study|Lost to Follow-up|1|||
16419251|NCT02798471|40015484|FG000|Overall Study|Other|5|||
16419252|NCT02798471|40015485|FG001|Overall Study|Other|3|||
16419253|NCT02798471|40015484|FG000|Overall Study|Subject withdrew consent|0|||
16419254|NCT02798471|40015485|FG001|Overall Study|Subject withdrew consent|6|||
16419255|NCT02798471|40015484|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
16419256|NCT02798471|40015485|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
16419257|NCT02798471|40015484|FG000|Overall Study|Randomized, but not treated|0|||
16419258|NCT02798471|40015485|FG001|Overall Study|Randomized, but not treated|2|||
16419259|NCT04268745|40015488|FG000|Overall Study|Lost to Follow-up|2|||
16419260|NCT04268745|40015489|FG001|Overall Study|Lost to Follow-up|3|||
16419261|NCT04268745|40015488|FG000|Overall Study|Withdrawal by Subject|4|||
16419262|NCT04268745|40015489|FG001|Overall Study|Withdrawal by Subject|2|||
16358245|NCT02349386|39797227|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
16358246|NCT02349386|39797228|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
16248411|NCT02415959|39391851|FG004|Overall Study|Protocol Violation|0|||
16248412|NCT02224391|39391853|FG000|Overall Study|Lost to Follow-up|26|||
16248413|NCT02224391|39391854|FG001|Overall Study|Lost to Follow-up|19|||
16248414|NCT02224391|39391853|FG000|Overall Study|Withdrawal by Subject|6|||
16248415|NCT02224391|39391854|FG001|Overall Study|Withdrawal by Subject|5|||
16248416|NCT02576990|39391855|FG000|Overall Study|Death|29|||
16248417|NCT02576990|39391856|FG001|Overall Study|Death|18|||
16248418|NCT02576990|39391855|FG000|Overall Study|Physician Decision|1|||
16248419|NCT02576990|39391856|FG001|Overall Study|Physician Decision|0|||
16248420|NCT02576990|39391855|FG000|Overall Study|Screen failure|2|||
16248421|NCT02576990|39391856|FG001|Overall Study|Screen failure|0|||
16248422|NCT02576990|39391855|FG000|Overall Study|Sponsor's decision|24|||
16248423|NCT02576990|39391856|FG001|Overall Study|Sponsor's decision|4|||
16248424|NCT02576990|39391855|FG000|Overall Study|Withdrawal by Subject|0|||
16248425|NCT02576990|39391856|FG001|Overall Study|Withdrawal by Subject|2|||
16248426|NCT00306384|39391859|FG000|Overall Study|Adverse Event|103|||
16248427|NCT00306384|39391860|FG001|Overall Study|Adverse Event|87|||
16248428|NCT00306384|39391861|FG002|Overall Study|Adverse Event|40|||
16248429|NCT00306384|39391859|FG000|Overall Study|Major protocol deviation|43|||
16248430|NCT00306384|39391860|FG001|Overall Study|Major protocol deviation|51|||
16248431|NCT00306384|39391861|FG002|Overall Study|Major protocol deviation|18|||
16248432|NCT00306384|39391859|FG000|Overall Study|Lost to Follow-up|57|||
16248433|NCT00306384|39391860|FG001|Overall Study|Lost to Follow-up|41|||
16248434|NCT00306384|39391861|FG002|Overall Study|Lost to Follow-up|35|||
16248435|NCT00306384|39391859|FG000|Overall Study|Voluntary withdrawal|199|||
16248436|NCT00306384|39391860|FG001|Overall Study|Voluntary withdrawal|187|||
16248437|NCT00306384|39391861|FG002|Overall Study|Voluntary withdrawal|91|||
16248438|NCT00306384|39391859|FG000|Overall Study|Study termination|1|||
16248439|NCT00306384|39391860|FG001|Overall Study|Study termination|0|||
16248440|NCT00306384|39391861|FG002|Overall Study|Study termination|1|||
16248441|NCT00306384|39391859|FG000|Overall Study|Pregnancy|3|||
16248442|NCT00306384|39391860|FG001|Overall Study|Pregnancy|1|||
16248443|NCT00306384|39391861|FG002|Overall Study|Pregnancy|1|||
16248444|NCT00306384|39391859|FG000|Overall Study|Lack of Efficacy|26|||
16248445|NCT00306384|39391860|FG001|Overall Study|Lack of Efficacy|40|||
16248446|NCT00306384|39391861|FG002|Overall Study|Lack of Efficacy|38|||
16248447|NCT00306384|39391859|FG000|Overall Study|Investigator discretion|28|||
16248448|NCT00306384|39391860|FG001|Overall Study|Investigator discretion|31|||
16248449|NCT00306384|39391861|FG002|Overall Study|Investigator discretion|21|||
16248450|NCT00306384|39391859|FG000|Overall Study|Other|80|||
16248451|NCT00306384|39391860|FG001|Overall Study|Other|70|||
16248452|NCT00306384|39391861|FG002|Overall Study|Other|32|||
16248453|NCT00306384|39391859|FG000|Overall Study|Site closure|2|||
16248454|NCT00306384|39391860|FG001|Overall Study|Site closure|0|||
16248455|NCT00306384|39391861|FG002|Overall Study|Site closure|0|||
16248456|NCT01193517|39391863|FG000|Overall Study|Early Progression|1|||
16248457|NCT01193517|39391864|FG001|Overall Study|Early Progression|0|||
16248458|NCT01193517|39391865|FG002|Overall Study|Early Progression|0|||
16248459|NCT03650400|39391873|FG000|Overall Study|Study terminated by sponsor|0|||
16248460|NCT03650400|39391874|FG001|Overall Study|Study terminated by sponsor|5|||
16248461|NCT03652961|39391891|FG000|Overall Study|Lost to Follow-up|3|||
16248462|NCT03652961|39391891|FG000|Overall Study|Screen Failure|1|||
16248463|NCT00623623|39391892|FG000|Overall Study|Previous enrolment into this study|1|||
16248464|NCT00623623|39391893|FG001|Overall Study|Previous enrolment into this study|1|||
16248465|NCT03459846|39391896|FG000|Overall Study|Death|52|||
16248466|NCT03459846|39391897|FG001|Overall Study|Death|46|||
16248467|NCT03459846|39391896|FG000|Overall Study|Study terminated by sponsor|24|||
16248468|NCT03459846|39391897|FG001|Overall Study|Study terminated by sponsor|28|||
16248469|NCT03459846|39391896|FG000|Overall Study|Withdrawal by Subject|2|||
16248470|NCT03459846|39391897|FG001|Overall Study|Withdrawal by Subject|2|||
16248471|NCT04147715|39391900|FG000|Overall Study|Adverse Event|0|||
16248472|NCT04147715|39391901|FG001|Overall Study|Adverse Event|0|||
16248473|NCT04147715|39391902|FG002|Overall Study|Adverse Event|0|||
16248474|NCT04147715|39391903|FG003|Overall Study|Adverse Event|0|||
16248475|NCT04147715|39391904|FG004|Overall Study|Adverse Event|0|||
16248476|NCT04147715|39391905|FG005|Overall Study|Adverse Event|0|||
16248477|NCT04147715|39391906|FG006|Overall Study|Adverse Event|0|||
16419263|NCT04268745|40015488|FG000|Overall Study|Death in the family|1|||
16248478|NCT04147715|39391907|FG007|Overall Study|Adverse Event|2|||
16248479|NCT04147715|39391908|FG008|Overall Study|Adverse Event|1|||
16248480|NCT04147715|39391909|FG009|Overall Study|Adverse Event|0|||
16248481|NCT04147715|39391910|FG010|Overall Study|Adverse Event|0|||
16248482|NCT04147715|39391911|FG011|Overall Study|Adverse Event|0|||
16248483|NCT00321711|39391912|FG000|Part A|Adverse Event|3|||
16248484|NCT00321711|39391913|FG001|Part A|Adverse Event|3|||
16248485|NCT00321711|39391914|FG002|Part A|Adverse Event|2|||
16248486|NCT00321711|39391915|FG003|Part A|Adverse Event|0|||
16248487|NCT00321711|39391916|FG004|Part A|Adverse Event|0|||
16248488|NCT00321711|39391912|FG000|Part A|Withdrawal by Subject|1|||
16248489|NCT00321711|39391913|FG001|Part A|Withdrawal by Subject|1|||
16248490|NCT00321711|39391914|FG002|Part A|Withdrawal by Subject|1|||
16358247|NCT02349386|39797229|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
16358248|NCT02349386|39797230|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
16358249|NCT02349386|39797227|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
16358250|NCT02349386|39797228|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
16358251|NCT02349386|39797229|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
16358252|NCT02349386|39797230|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
16358253|NCT04456686|39797236|FG000|Overall Study|Adverse Event|2|||
16358254|NCT04456686|39797237|FG001|Overall Study|Adverse Event|1|||
16358255|NCT04456686|39797236|FG000|Overall Study|Lack of Efficacy|3|||
16358256|NCT04456686|39797237|FG001|Overall Study|Lack of Efficacy|1|||
16358257|NCT04456686|39797236|FG000|Overall Study|Withdrew consent|3|||
16358258|NCT04456686|39797237|FG001|Overall Study|Withdrew consent|1|||
16358259|NCT04456686|39797236|FG000|Overall Study|Physician Decision|2|||
16358260|NCT04456686|39797237|FG001|Overall Study|Physician Decision|2|||
16358261|NCT04456686|39797236|FG000|Overall Study|Withdrawal by Subject|5|||
16358262|NCT04456686|39797237|FG001|Overall Study|Withdrawal by Subject|1|||
16358263|NCT04456686|39797236|FG000|Overall Study|Protocol Violation|0|||
16358264|NCT04456686|39797237|FG001|Overall Study|Protocol Violation|1|||
16358265|NCT01004614|39797238|FG000|Washout|Withdrawal by Subject|0|||
16358266|NCT01004614|39797239|FG001|Washout|Withdrawal by Subject|1|||
16358267|NCT01004614|39797240|FG002|Washout|Withdrawal by Subject|0|||
16358268|NCT01004614|39797241|FG003|Washout|Withdrawal by Subject|0|||
16358269|NCT03444584|39797242|FG000|Overall Study|Withdrawal by Subject|0|||
16358270|NCT03444584|39797243|FG001|Overall Study|Withdrawal by Subject|1|||
16358271|NCT03444584|39797242|FG000|Overall Study|Other|0|||
16358272|NCT03444584|39797243|FG001|Overall Study|Other|1|||
16358273|NCT02988661|39797244|FG000|Overall Study|Death|2|||
16358274|NCT02988661|39797245|FG001|Overall Study|Death|18|||
16358275|NCT02988661|39797244|FG000|Overall Study|Lost to Follow-up|0|||
16358276|NCT02988661|39797245|FG001|Overall Study|Lost to Follow-up|33|||
16358277|NCT02988661|39797244|FG000|Overall Study|Withdrawal by Subject|0|||
16358278|NCT02988661|39797245|FG001|Overall Study|Withdrawal by Subject|6|||
16358279|NCT02988661|39797244|FG000|Overall Study|Unable to complete the 18-month survey|1|||
16358280|NCT02988661|39797245|FG001|Overall Study|Unable to complete the 18-month survey|27|||
16358281|NCT01255163|39797251|FG000|Overall Study|Withdrawal by Subject|1|||
16358282|NCT01255163|39797252|FG001|Overall Study|Withdrawal by Subject|0|||
16358283|NCT01255163|39797251|FG000|Overall Study|Lost to Follow-up|2|||
16358284|NCT01255163|39797252|FG001|Overall Study|Lost to Follow-up|0|||
16358285|NCT01255163|39797251|FG000|Overall Study|Adverse Event|0|||
16358286|NCT01255163|39797252|FG001|Overall Study|Adverse Event|2|||
16358287|NCT01255163|39797251|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
16358288|NCT01255163|39797252|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
16358289|NCT02371616|39797253|FG000|Overall Study|Protocol Violation|2|||
16358290|NCT02371616|39797254|FG001|Overall Study|Protocol Violation|1|||
16358291|NCT02371616|39797253|FG000|Overall Study|Adverse Event|0|||
16358292|NCT02371616|39797254|FG001|Overall Study|Adverse Event|1|||
16358293|NCT02371616|39797253|FG000|Overall Study|Withdrawal of Consent|1|||
16358294|NCT02371616|39797254|FG001|Overall Study|Withdrawal of Consent|0|||
16358295|NCT02371616|39797253|FG000|Overall Study|Other (Not specified)|1|||
16358296|NCT02371616|39797254|FG001|Overall Study|Other (Not specified)|5|||
16358297|NCT00656617|39797255|FG000|Overall Study|Adverse Event|1|||
16358298|NCT00656617|39797255|FG000|Overall Study|Death|2|||
16358299|NCT00656617|39797255|FG000|Overall Study|Insurance Issues|2|||
16358300|NCT00656617|39797255|FG000|Overall Study|Move to different clinical trial|2|||
16358301|NCT03641508|39797256|FG000|First Injection|Lost to Follow-up|2|||
16358302|NCT03641508|39797257|FG001|First Injection|Lost to Follow-up|0|||
16358303|NCT02194465|39797258|FG000|Overall Study|Adverse Event|6|||
16358304|NCT02194465|39797259|FG001|Overall Study|Adverse Event|1|||
16358305|NCT02194465|39797260|FG002|Overall Study|Adverse Event|4|||
16419264|NCT04268745|40015489|FG001|Overall Study|Death in the family|0|||
16358306|NCT02194465|39797261|FG003|Overall Study|Adverse Event|4|||
16358307|NCT02194465|39797262|FG004|Overall Study|Adverse Event|4|||
16562066|NCT01023308|40525314|FG000|Overall Study|New Cancer therapy|4|||
16562067|NCT01023308|40525315|FG001|Overall Study|New Cancer therapy|7|||
16562068|NCT01023308|40525314|FG000|Overall Study|Protocol Violation|3|||
16562069|NCT01023308|40525315|FG001|Overall Study|Protocol Violation|4|||
16562070|NCT01023308|40525314|FG000|Overall Study|Untreated|5|||
16562071|NCT01023308|40525315|FG001|Overall Study|Untreated|5|||
16562072|NCT01023308|40525314|FG000|Overall Study|Lost to Follow-up|1|||
16562073|NCT01023308|40525315|FG001|Overall Study|Lost to Follow-up|0|||
16562074|NCT01023308|40525314|FG000|Overall Study|Withdrawal by Subject|34|||
16562075|NCT01023308|40525315|FG001|Overall Study|Withdrawal by Subject|18|||
16562076|NCT01645111|40525316|FG000|Overall Study|Did not require Clevidipine|15|||
16562077|NCT02338609|40525318|FG000|Overall Study|Physician Decision|1|||
16562078|NCT02338609|40525318|FG000|Overall Study|Death|1|||
16562079|NCT03289455|40525319|FG000|Overall Study|Death|1|||
16562080|NCT03289455|40525320|FG001|Overall Study|Death|0|||
16562081|NCT03289455|40525321|FG002|Overall Study|Death|0|||
16562082|NCT03289455|40525319|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
16562083|NCT03289455|40525320|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
16562084|NCT03289455|40525321|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
16562085|NCT03289455|40525319|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
16562086|NCT03289455|40525320|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
16562087|NCT03289455|40525321|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
16562088|NCT03289455|40525319|FG000|Overall Study|Progressive disease|3|||
16562089|NCT03289455|40525320|FG001|Overall Study|Progressive disease|4|||
16562090|NCT03289455|40525321|FG002|Overall Study|Progressive disease|5|||
16562091|NCT01118962|40525322|FG000|Overall Study|Adverse Event|2|||
16562092|NCT01118962|40525322|FG000|Overall Study|Lack of Efficacy|1|||
16562093|NCT01118962|40525322|FG000|Overall Study|Protocol Violation|1|||
16562094|NCT01118962|40525322|FG000|Overall Study|Withdrawal by Subject|4|||
16562095|NCT01118962|40525322|FG000|Overall Study|Pregnancy|1|||
16562096|NCT01118962|40525322|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
16562097|NCT00409708|40525328|FG000|Treatment|Abnormal test procedure result(s)|1|||
16562098|NCT00409708|40525329|FG001|Treatment|Abnormal test procedure result(s)|0|||
16562099|NCT00409708|40525328|FG000|Treatment|Lack of Efficacy|0|||
16562100|NCT00409708|40525329|FG001|Treatment|Lack of Efficacy|1|||
16562101|NCT00409708|40525328|FG000|Treatment|Protocol Violation|6|||
16562102|NCT00409708|40525329|FG001|Treatment|Protocol Violation|2|||
16562103|NCT00409708|40525328|FG000|Treatment|Withdrawal by Subject|3|||
16562104|NCT00409708|40525329|FG001|Treatment|Withdrawal by Subject|8|||
16562105|NCT00409708|40525328|FG000|Treatment|Lost to Follow-up|0|||
16562106|NCT00409708|40525329|FG001|Treatment|Lost to Follow-up|6|||
16562107|NCT00409708|40525328|FG000|Treatment|Administrative problems|5|||
16562108|NCT00409708|40525329|FG001|Treatment|Administrative problems|0|||
16562109|NCT00409708|40525328|FG000|Washout|Lack of Efficacy|9|||
16562110|NCT00409708|40525329|FG001|Washout|Lack of Efficacy|1|||
16562111|NCT00409708|40525328|FG000|Washout|Protocol Violation|0|||
16562112|NCT00409708|40525329|FG001|Washout|Protocol Violation|1|||
16562113|NCT00409708|40525328|FG000|Washout|Withdrawal by Subject|11|||
16562114|NCT00409708|40525329|FG001|Washout|Withdrawal by Subject|5|||
16562115|NCT00409708|40525328|FG000|Washout|Lost to Follow-up|1|||
16562116|NCT00409708|40525329|FG001|Washout|Lost to Follow-up|3|||
16562117|NCT01555762|40525342|FG000|Overall Study|No information on Bevacizumab intake|11|||
16562118|NCT01555762|40525342|FG000|Overall Study|Missing start date of infusion|8|||
16562119|NCT01555762|40525342|FG000|Overall Study|75 years old or more ticked No|1|||
16562120|NCT01555762|40525342|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
16248491|NCT00321711|39391915|FG003|Part A|Withdrawal by Subject|0|||
16562121|NCT01555762|40525342|FG000|Overall Study|Death linked to progression of disease|165|||
16562122|NCT01555762|40525342|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
16562123|NCT01555762|40525342|FG000|Overall Study|Investigator's decision|10|||
16562124|NCT01555762|40525342|FG000|Overall Study|Participant not wishing to continue|5|||
16562125|NCT01555762|40525342|FG000|Overall Study|Missing data|1|||
16562126|NCT01555762|40525342|FG000|Overall Study|Death linked to an adverse event|14|||
16562127|NCT00664521|40525345|FG000|Overall Study|Adverse Event|4|||
16562128|NCT00664521|40525346|FG001|Overall Study|Adverse Event|1|||
16562129|NCT00664521|40525345|FG000|Overall Study|Lost to Follow-up|1|||
16562130|NCT00664521|40525346|FG001|Overall Study|Lost to Follow-up|0|||
16562131|NCT00664521|40525345|FG000|Overall Study|Other|1|||
16358308|NCT02194465|39797263|FG005|Overall Study|Adverse Event|2|||
16358309|NCT02194465|39797264|FG006|Overall Study|Adverse Event|0|||
16358310|NCT02194465|39797258|FG000|Overall Study|Lost to Follow-up|0|||
16358311|NCT02194465|39797259|FG001|Overall Study|Lost to Follow-up|0|||
16358312|NCT02194465|39797260|FG002|Overall Study|Lost to Follow-up|0|||
16358313|NCT02194465|39797261|FG003|Overall Study|Lost to Follow-up|1|||
16358314|NCT02194465|39797262|FG004|Overall Study|Lost to Follow-up|0|||
16419265|NCT01302054|40015494|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
16419266|NCT01302054|40015495|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
16419267|NCT01302054|40015496|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
16419268|NCT01302054|40015494|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
16419269|NCT01302054|40015495|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
16562132|NCT00664521|40525346|FG001|Overall Study|Other|0|||
16562133|NCT01833065|40525347|FG000|Overall Study|Adverse Event|6|||
16562134|NCT01833065|40525348|FG001|Overall Study|Adverse Event|1|||
16562135|NCT01833065|40525349|FG002|Overall Study|Adverse Event|0|||
16562136|NCT01833065|40525350|FG003|Overall Study|Adverse Event|2|||
16562137|NCT01833065|40525351|FG004|Overall Study|Adverse Event|3|||
16562138|NCT01833065|40525347|FG000|Overall Study|Protocol Violation|1|||
16562139|NCT01833065|40525348|FG001|Overall Study|Protocol Violation|0|||
16562140|NCT01833065|40525349|FG002|Overall Study|Protocol Violation|0|||
16562141|NCT01833065|40525350|FG003|Overall Study|Protocol Violation|0|||
16562142|NCT01833065|40525351|FG004|Overall Study|Protocol Violation|2|||
16562143|NCT01833065|40525347|FG000|Overall Study|Lost to Follow-up|1|||
16562144|NCT01833065|40525348|FG001|Overall Study|Lost to Follow-up|0|||
16562145|NCT01833065|40525349|FG002|Overall Study|Lost to Follow-up|0|||
16562146|NCT01833065|40525350|FG003|Overall Study|Lost to Follow-up|0|||
16562147|NCT01833065|40525351|FG004|Overall Study|Lost to Follow-up|3|||
16419270|NCT01302054|40015496|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
16419271|NCT01302054|40015494|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
16419272|NCT01302054|40015495|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
16419273|NCT01302054|40015496|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
16419274|NCT01302054|40015494|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
16419275|NCT01302054|40015495|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
16419276|NCT01302054|40015496|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
16419277|NCT01302054|40015494|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
16419278|NCT01302054|40015495|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
16419279|NCT01302054|40015496|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
16419280|NCT01302054|40015494|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
16419281|NCT01302054|40015495|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
16419282|NCT01302054|40015496|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
16419283|NCT01302054|40015494|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
16419284|NCT01302054|40015495|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
16419285|NCT01302054|40015496|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
16419286|NCT01302054|40015494|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
16419287|NCT01302054|40015495|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
16419288|NCT01302054|40015496|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
16419289|NCT01302054|40015494|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
16419290|NCT01302054|40015495|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
16419291|NCT01302054|40015496|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
16419292|NCT01302054|40015494|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16419293|NCT01302054|40015495|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
16419294|NCT01302054|40015496|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
16419295|NCT01302054|40015494|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
16419296|NCT01302054|40015495|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
16419297|NCT01302054|40015496|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
16419298|NCT01302054|40015494|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
16419299|NCT01302054|40015495|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
16562148|NCT01833065|40525347|FG000|Overall Study|Withdrawal by Subject|6|||
16562149|NCT01833065|40525348|FG001|Overall Study|Withdrawal by Subject|2|||
16562150|NCT01833065|40525349|FG002|Overall Study|Withdrawal by Subject|4|||
16358315|NCT02194465|39797263|FG005|Overall Study|Lost to Follow-up|1|||
16358316|NCT02194465|39797264|FG006|Overall Study|Lost to Follow-up|0|||
16358317|NCT02194465|39797258|FG000|Overall Study|Physician Decision|1|||
16562151|NCT01833065|40525350|FG003|Overall Study|Withdrawal by Subject|3|||
16562152|NCT01833065|40525351|FG004|Overall Study|Withdrawal by Subject|11|||
16562153|NCT01833065|40525347|FG000|Overall Study|Subject's substantial non-compliance|0|||
16358318|NCT02194465|39797259|FG001|Overall Study|Physician Decision|0|||
16358319|NCT02194465|39797260|FG002|Overall Study|Physician Decision|0|||
16248492|NCT00321711|39391916|FG004|Part A|Withdrawal by Subject|0|||
16248493|NCT00321711|39391912|FG000|Part A|Disease progression|0|||
16562154|NCT01833065|40525348|FG001|Overall Study|Subject's substantial non-compliance|1|||
16562155|NCT01833065|40525349|FG002|Overall Study|Subject's substantial non-compliance|0|||
16562156|NCT01833065|40525350|FG003|Overall Study|Subject's substantial non-compliance|0|||
16562157|NCT01833065|40525351|FG004|Overall Study|Subject's substantial non-compliance|0|||
16562158|NCT01833065|40525347|FG000|Overall Study|Trial terminated by sponsor|8|||
16562159|NCT01833065|40525348|FG001|Overall Study|Trial terminated by sponsor|8|||
16562160|NCT01833065|40525349|FG002|Overall Study|Trial terminated by sponsor|7|||
16562161|NCT01833065|40525350|FG003|Overall Study|Trial terminated by sponsor|3|||
16562162|NCT01833065|40525351|FG004|Overall Study|Trial terminated by sponsor|13|||
16562163|NCT01833065|40525347|FG000|Overall Study|Others|2|||
16562164|NCT01833065|40525348|FG001|Overall Study|Others|1|||
16562165|NCT01833065|40525349|FG002|Overall Study|Others|1|||
16562166|NCT01833065|40525350|FG003|Overall Study|Others|1|||
16562167|NCT01833065|40525351|FG004|Overall Study|Others|4|||
16562168|NCT04822298|40525355|FG000|Overall Study|Death|3|||
16562169|NCT00601640|40525356|FG000|Overall Study|Withdrawal by Subject|3|||
16562170|NCT00601640|40525357|FG001|Overall Study|Withdrawal by Subject|0|||
16562171|NCT00601640|40525358|FG002|Overall Study|Withdrawal by Subject|7|||
16562172|NCT00601640|40525356|FG000|Overall Study|Death|1|||
16562173|NCT00601640|40525357|FG001|Overall Study|Death|0|||
16562174|NCT00601640|40525358|FG002|Overall Study|Death|0|||
16562175|NCT00601640|40525356|FG000|Overall Study|Adverse Event|0|||
16562176|NCT00601640|40525357|FG001|Overall Study|Adverse Event|4|||
16562177|NCT00601640|40525358|FG002|Overall Study|Adverse Event|2|||
16562178|NCT00601640|40525356|FG000|Overall Study|intercurrent illness|1|||
16562179|NCT00601640|40525357|FG001|Overall Study|intercurrent illness|0|||
16562180|NCT00601640|40525358|FG002|Overall Study|intercurrent illness|0|||
16562181|NCT00601640|40525356|FG000|Overall Study|change in eligibility status|0|||
16562182|NCT00601640|40525357|FG001|Overall Study|change in eligibility status|1|||
16562183|NCT00601640|40525358|FG002|Overall Study|change in eligibility status|1|||
16562184|NCT00701311|40525359|FG000|Overall Study|Lack of Efficacy|3|||
16562185|NCT00701311|40525359|FG000|Overall Study|Adverse Event|3|||
16562186|NCT00701311|40525359|FG000|Overall Study|Withdrawal by Subject|2|||
16562187|NCT04610684|40525360|FG000|Study Treatment|Withdrawal by Subject|1|||
16562188|NCT04610684|40525360|FG000|Study Treatment|Disease Progression|2|||
16562189|NCT04610684|40525360|FG000|Follow up|Death|2|||
16562190|NCT04610684|40525360|FG000|Follow up|Withdrawal by Subject|1|||
16562191|NCT01932996|40525361|FG000|Overall Study|Protocol Violation|2|||
16562192|NCT01932996|40525362|FG001|Overall Study|Protocol Violation|0|||
16562193|NCT00630539|40525363|FG000|Overall Study|Adverse Event|1|||
16562194|NCT00630539|40525364|FG001|Overall Study|Adverse Event|3|||
16562195|NCT00630539|40525365|FG002|Overall Study|Adverse Event|1|||
16562196|NCT00630539|40525366|FG003|Overall Study|Adverse Event|2|||
16562197|NCT00630539|40525363|FG000|Overall Study|Withdrawal by Subject|0|||
16562198|NCT00630539|40525364|FG001|Overall Study|Withdrawal by Subject|1|||
16562199|NCT00630539|40525365|FG002|Overall Study|Withdrawal by Subject|0|||
16562200|NCT00630539|40525366|FG003|Overall Study|Withdrawal by Subject|1|||
16562201|NCT01089556|40525367|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
16562202|NCT01089556|40525368|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
16562203|NCT01089556|40525369|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
16562204|NCT01089556|40525370|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
16562205|NCT01089556|40525371|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
16562206|NCT01089556|40525372|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
16562207|NCT01089556|40525367|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
16562208|NCT01089556|40525368|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
16562209|NCT01089556|40525369|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
16562210|NCT01089556|40525370|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
16130682|NCT02842827|38967104|FG004|Overall Study|Protocol Defined Disease Progression|0|||
16130683|NCT02842827|38967105|FG005|Overall Study|Protocol Defined Disease Progression|1|||
16130684|NCT02842827|38967106|FG006|Overall Study|Protocol Defined Disease Progression|0|||
16130685|NCT02842827|38967107|FG007|Overall Study|Protocol Defined Disease Progression|0|||
16130686|NCT02842827|38967100|FG000|Overall Study|Participant Withdrawal of Consent|1|||
16130687|NCT02842827|38967101|FG001|Overall Study|Participant Withdrawal of Consent|2|||
16130688|NCT02842827|38967102|FG002|Overall Study|Participant Withdrawal of Consent|2|||
16130689|NCT02842827|38967103|FG003|Overall Study|Participant Withdrawal of Consent|2|||
16248494|NCT00321711|39391913|FG001|Part A|Disease progression|1|||
16248495|NCT00321711|39391914|FG002|Part A|Disease progression|0|||
16358320|NCT02194465|39797261|FG003|Overall Study|Physician Decision|0|||
16358321|NCT02194465|39797262|FG004|Overall Study|Physician Decision|0|||
16562211|NCT01089556|40525371|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
16562212|NCT01089556|40525372|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
16562213|NCT01089556|40525367|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
16562214|NCT01089556|40525368|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
16419300|NCT01302054|40015496|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
16419301|NCT01302054|40015494|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
16419302|NCT01302054|40015495|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
16419303|NCT01302054|40015496|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
16419304|NCT01302054|40015494|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
16419305|NCT01302054|40015495|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
16419306|NCT01302054|40015496|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
16419307|NCT01302054|40015494|FG000|Double-Blind Treatment Phase|Other|0|||
16419308|NCT01302054|40015495|FG001|Double-Blind Treatment Phase|Other|4|||
16562215|NCT01089556|40525369|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
16562216|NCT01089556|40525370|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
16562217|NCT01089556|40525371|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
16358322|NCT02194465|39797263|FG005|Overall Study|Physician Decision|0|||
16130690|NCT02842827|38967104|FG004|Overall Study|Participant Withdrawal of Consent|2|||
16358323|NCT02194465|39797264|FG006|Overall Study|Physician Decision|0|||
16358324|NCT02194465|39797258|FG000|Overall Study|Protocol Violation|1|||
16358325|NCT02194465|39797259|FG001|Overall Study|Protocol Violation|1|||
16358326|NCT02194465|39797260|FG002|Overall Study|Protocol Violation|2|||
16358327|NCT02194465|39797261|FG003|Overall Study|Protocol Violation|1|||
16358328|NCT02194465|39797262|FG004|Overall Study|Protocol Violation|1|||
16358329|NCT02194465|39797263|FG005|Overall Study|Protocol Violation|0|||
16358330|NCT02194465|39797264|FG006|Overall Study|Protocol Violation|0|||
16358331|NCT02194465|39797258|FG000|Overall Study|Withdrawal by Subject|1|||
16358332|NCT02194465|39797259|FG001|Overall Study|Withdrawal by Subject|3|||
16358333|NCT02194465|39797260|FG002|Overall Study|Withdrawal by Subject|1|||
16358334|NCT02194465|39797261|FG003|Overall Study|Withdrawal by Subject|2|||
16358335|NCT02194465|39797262|FG004|Overall Study|Withdrawal by Subject|2|||
16358336|NCT02194465|39797263|FG005|Overall Study|Withdrawal by Subject|1|||
16358337|NCT02194465|39797264|FG006|Overall Study|Withdrawal by Subject|2|||
16358338|NCT02194465|39797258|FG000|Overall Study|Discontinued follow-up period|0|||
16358339|NCT02194465|39797259|FG001|Overall Study|Discontinued follow-up period|2|||
16358340|NCT02194465|39797260|FG002|Overall Study|Discontinued follow-up period|1|||
16358341|NCT02194465|39797261|FG003|Overall Study|Discontinued follow-up period|0|||
16358342|NCT02194465|39797262|FG004|Overall Study|Discontinued follow-up period|2|||
16358343|NCT02194465|39797263|FG005|Overall Study|Discontinued follow-up period|0|||
16358344|NCT02194465|39797264|FG006|Overall Study|Discontinued follow-up period|0|||
16358345|NCT02737358|39797265|FG000|Overall Study|Withdrawal by Subject|7|||
16358346|NCT02737358|39797266|FG001|Overall Study|Withdrawal by Subject|12|||
16358347|NCT02737358|39797265|FG000|Overall Study|Lost to Follow-up|2|||
16358348|NCT02737358|39797266|FG001|Overall Study|Lost to Follow-up|3|||
16358349|NCT02732639|39797271|FG000|Overall Study|Lost to Follow-up|1|||
16358350|NCT01787838|39797275|FG000|Overall Study|refused|1413|||
16358351|NCT01715831|39797276|FG000|Overall Study|Adverse Event|1|||
16358352|NCT03091439|39797277|FG000|Overall Study|Study Terminated by the Sponsor|1|||
16358353|NCT03091439|39797278|FG001|Overall Study|Study Terminated by the Sponsor|0|||
16358354|NCT01529606|39797284|FG000|Overall Study|Lost to Follow-up|21|||
16358355|NCT01529606|39797285|FG001|Overall Study|Lost to Follow-up|18|||
16358356|NCT00715208|39797288|FG000|Overall Study|Withdrawal by Subject|1|||
16358357|NCT00715208|39797289|FG001|Overall Study|Withdrawal by Subject|1|||
16358358|NCT00715208|39797288|FG000|Overall Study|Adverse Event|0|||
16358359|NCT00715208|39797289|FG001|Overall Study|Adverse Event|6|||
16562218|NCT01089556|40525372|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
16562219|NCT01089556|40525367|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
16562220|NCT01089556|40525368|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
16562221|NCT01089556|40525369|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
16562222|NCT01089556|40525370|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
16562223|NCT01089556|40525371|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
16562224|NCT01089556|40525372|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
16562225|NCT01089556|40525367|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
16358360|NCT00715208|39797288|FG000|Overall Study|Lack of Efficacy|0|||
16358361|NCT00715208|39797289|FG001|Overall Study|Lack of Efficacy|2|||
16358362|NCT00719901|39797292|FG000|Overall Study|Adverse Event|5|||
16419309|NCT01302054|40015496|FG002|Double-Blind Treatment Phase|Other|9|||
16419310|NCT03178669|40015497|FG000|Overall Study|Adverse Event|4|||
16358363|NCT00719901|39797292|FG000|Overall Study|Withdrawal by Subject|1|||
16358364|NCT00719901|39797292|FG000|Overall Study|Alternate Treatment|1|||
16358365|NCT00719901|39797292|FG000|Overall Study|Disease Progression|3|||
16358366|NCT00719901|39797292|FG000|Overall Study|Availability of Study Drug|1|||
16358367|NCT02765165|39797294|FG000|Treatment Period|Progressive disease|3|||
16358368|NCT02765165|39797295|FG001|Treatment Period|Progressive disease|2|||
16358369|NCT02765165|39797296|FG002|Treatment Period|Progressive disease|3|||
16358370|NCT02765165|39797297|FG003|Treatment Period|Progressive disease|3|||
16358371|NCT02765165|39797298|FG004|Treatment Period|Progressive disease|4|||
16358372|NCT02765165|39797299|FG005|Treatment Period|Progressive disease|2|||
16358373|NCT02765165|39797300|FG006|Treatment Period|Progressive disease|2|||
16358374|NCT02765165|39797294|FG000|Treatment Period|Physician Decision|0|||
16358375|NCT02765165|39797295|FG001|Treatment Period|Physician Decision|1|||
16358376|NCT02765165|39797296|FG002|Treatment Period|Physician Decision|0|||
16358377|NCT02765165|39797297|FG003|Treatment Period|Physician Decision|0|||
16358378|NCT02765165|39797298|FG004|Treatment Period|Physician Decision|0|||
16358379|NCT02765165|39797299|FG005|Treatment Period|Physician Decision|0|||
16358380|NCT02765165|39797300|FG006|Treatment Period|Physician Decision|0|||
16358381|NCT02765165|39797294|FG000|Treatment Period|Adverse Event|0|||
16358382|NCT02765165|39797295|FG001|Treatment Period|Adverse Event|1|||
16358383|NCT02765165|39797296|FG002|Treatment Period|Adverse Event|0|||
16358384|NCT02765165|39797297|FG003|Treatment Period|Adverse Event|0|||
16358385|NCT02765165|39797298|FG004|Treatment Period|Adverse Event|0|||
16358386|NCT02765165|39797299|FG005|Treatment Period|Adverse Event|0|||
16358387|NCT02765165|39797300|FG006|Treatment Period|Adverse Event|0|||
16358388|NCT02765165|39797294|FG000|Treatment Period|Withdrawal by Subject|0|||
16358389|NCT02765165|39797295|FG001|Treatment Period|Withdrawal by Subject|0|||
16358390|NCT02765165|39797296|FG002|Treatment Period|Withdrawal by Subject|0|||
16358391|NCT02765165|39797297|FG003|Treatment Period|Withdrawal by Subject|0|||
16358392|NCT02765165|39797298|FG004|Treatment Period|Withdrawal by Subject|2|||
16358393|NCT02765165|39797299|FG005|Treatment Period|Withdrawal by Subject|0|||
16358394|NCT02765165|39797300|FG006|Treatment Period|Withdrawal by Subject|0|||
16358395|NCT02765165|39797294|FG000|Treatment Period|Study terminated|0|||
16358396|NCT02765165|39797295|FG001|Treatment Period|Study terminated|0|||
16358397|NCT02765165|39797296|FG002|Treatment Period|Study terminated|0|||
16358398|NCT02765165|39797297|FG003|Treatment Period|Study terminated|0|||
16358399|NCT02765165|39797298|FG004|Treatment Period|Study terminated|0|||
16358400|NCT02765165|39797299|FG005|Treatment Period|Study terminated|1|||
16358401|NCT02765165|39797300|FG006|Treatment Period|Study terminated|2|||
16358402|NCT02765165|39797294|FG000|Post-treatment Follow-up|Death|1|||
16358403|NCT02765165|39797295|FG001|Post-treatment Follow-up|Death|2|||
16358404|NCT02765165|39797296|FG002|Post-treatment Follow-up|Death|1|||
16358405|NCT02765165|39797297|FG003|Post-treatment Follow-up|Death|1|||
16358406|NCT02765165|39797298|FG004|Post-treatment Follow-up|Death|1|||
16358407|NCT02765165|39797299|FG005|Post-treatment Follow-up|Death|1|||
16358408|NCT02765165|39797300|FG006|Post-treatment Follow-up|Death|0|||
16358409|NCT02765165|39797294|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
16358410|NCT02765165|39797295|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
16358411|NCT02765165|39797296|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
16358412|NCT02765165|39797297|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
16358413|NCT02765165|39797298|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
16358414|NCT02765165|39797299|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
16358415|NCT02765165|39797300|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
16358416|NCT02765165|39797294|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
16419311|NCT03178669|40015498|FG001|Overall Study|Adverse Event|1|||
16358417|NCT02765165|39797295|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
16358418|NCT02765165|39797296|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
16358419|NCT02765165|39797297|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
16358420|NCT02765165|39797298|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
16358421|NCT02765165|39797299|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
16358422|NCT02765165|39797300|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
16358423|NCT02765165|39797294|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
16358424|NCT02765165|39797295|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
16358425|NCT02765165|39797296|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
16358426|NCT02765165|39797297|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
16358427|NCT02765165|39797298|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
16358428|NCT02765165|39797299|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
16358429|NCT02765165|39797300|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
16358430|NCT02765165|39797294|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
16358431|NCT02765165|39797295|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
16358432|NCT02765165|39797296|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
16358433|NCT02765165|39797297|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
16358434|NCT02765165|39797298|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
16358435|NCT02765165|39797299|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
16419312|NCT03178669|40015499|FG002|Overall Study|Adverse Event|4|||
16248496|NCT00321711|39391915|FG003|Part A|Disease progression|0|||
16248497|NCT00321711|39391916|FG004|Part A|Disease progression|0|||
16248498|NCT00321711|39391912|FG000|Part A|Requirement for alternative therapy|0|||
16248499|NCT00321711|39391913|FG001|Part A|Requirement for alternative therapy|2|||
16248500|NCT00321711|39391914|FG002|Part A|Requirement for alternative therapy|1|||
16248501|NCT00321711|39391915|FG003|Part A|Requirement for alternative therapy|0|||
16248502|NCT00321711|39391916|FG004|Part A|Requirement for alternative therapy|0|||
16248503|NCT00321711|39391912|FG000|Part A|Physician Decision|0|||
16248504|NCT00321711|39391913|FG001|Part A|Physician Decision|1|||
16248505|NCT00321711|39391914|FG002|Part A|Physician Decision|3|||
16248506|NCT00321711|39391915|FG003|Part A|Physician Decision|0|||
16248507|NCT00321711|39391916|FG004|Part A|Physician Decision|0|||
16248508|NCT00321711|39391912|FG000|Part A|Other|1|||
16248509|NCT00321711|39391913|FG001|Part A|Other|2|||
16248510|NCT00321711|39391914|FG002|Part A|Other|3|||
16248511|NCT00321711|39391915|FG003|Part A|Other|0|||
16248512|NCT00321711|39391916|FG004|Part A|Other|0|||
16248513|NCT00321711|39391912|FG000|Part A|Protocol deviation|0|||
16248514|NCT00321711|39391913|FG001|Part A|Protocol deviation|0|||
16248515|NCT00321711|39391914|FG002|Part A|Protocol deviation|1|||
16248516|NCT00321711|39391915|FG003|Part A|Protocol deviation|0|||
16248517|NCT00321711|39391916|FG004|Part A|Protocol deviation|0|||
16248518|NCT00321711|39391912|FG000|Part B|Noncompliance|0|||
16248519|NCT00321711|39391913|FG001|Part B|Noncompliance|0|||
16248520|NCT00321711|39391914|FG002|Part B|Noncompliance|0|||
16248521|NCT00321711|39391915|FG003|Part B|Noncompliance|0|||
16248522|NCT00321711|39391916|FG004|Part B|Noncompliance|1|||
16248523|NCT00321711|39391912|FG000|Part B|Adverse Event|0|||
16248524|NCT00321711|39391913|FG001|Part B|Adverse Event|0|||
16248525|NCT00321711|39391914|FG002|Part B|Adverse Event|0|||
16248526|NCT00321711|39391915|FG003|Part B|Adverse Event|2|||
16248527|NCT00321711|39391916|FG004|Part B|Adverse Event|1|||
16248528|NCT00321711|39391912|FG000|Part B|Disease progression|0|||
16248529|NCT00321711|39391913|FG001|Part B|Disease progression|0|||
16248530|NCT00321711|39391914|FG002|Part B|Disease progression|0|||
16248531|NCT00321711|39391915|FG003|Part B|Disease progression|1|||
16248532|NCT00321711|39391916|FG004|Part B|Disease progression|0|||
16248533|NCT00321711|39391912|FG000|Part B|Physician Decision|0|||
16248534|NCT00321711|39391913|FG001|Part B|Physician Decision|0|||
16248535|NCT00321711|39391914|FG002|Part B|Physician Decision|0|||
16248536|NCT00321711|39391915|FG003|Part B|Physician Decision|1|||
16248537|NCT00321711|39391916|FG004|Part B|Physician Decision|2|||
16248538|NCT00321711|39391912|FG000|Part B|Death|0|||
16248539|NCT00321711|39391913|FG001|Part B|Death|0|||
16248540|NCT00321711|39391914|FG002|Part B|Death|0|||
16248541|NCT00321711|39391915|FG003|Part B|Death|2|||
16248542|NCT00321711|39391916|FG004|Part B|Death|1|||
16248543|NCT01132118|39391920|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
16248544|NCT01132118|39391921|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
16248545|NCT01132118|39391920|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
16248546|NCT01132118|39391921|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
16248547|NCT01132118|39391920|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
16248548|NCT01132118|39391921|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
16248549|NCT03982433|39391924|FG000|Overall Study|Lost to Follow-up|1|||
16248550|NCT01415921|39391926|FG000|Overall Study|Adverse Event|0|||
16248551|NCT01415921|39391927|FG001|Overall Study|Adverse Event|1|||
16248552|NCT01415921|39391926|FG000|Overall Study|Physician Decision|1|||
16248553|NCT01415921|39391927|FG001|Overall Study|Physician Decision|1|||
16248554|NCT01415921|39391926|FG000|Overall Study|Withdrawal by Subject|0|||
16248555|NCT01415921|39391927|FG001|Overall Study|Withdrawal by Subject|1|||
16248556|NCT01415921|39391926|FG000|Overall Study|Other|2|||
16248557|NCT01415921|39391927|FG001|Overall Study|Other|0|||
16248558|NCT01368276|39391933|FG000|Overall Study|Death|1|||
16248559|NCT01368276|39391934|FG001|Overall Study|Death|10|||
16248560|NCT00303316|39391935|FG000|Overall Study|Protocol Violation|1|||
16248561|NCT00303316|39391936|FG001|Overall Study|Protocol Violation|0|||
16248562|NCT00303316|39391935|FG000|Overall Study|Lost to Follow-up|0|||
16248563|NCT00303316|39391936|FG001|Overall Study|Lost to Follow-up|1|||
16248564|NCT00303316|39391935|FG000|Overall Study|Withdrawal by Subject|1|||
16248565|NCT00303316|39391936|FG001|Overall Study|Withdrawal by Subject|2|||
16248566|NCT03035227|39391937|FG000|Overall Study|study stopped due to PI leaving institut|1|||
16248567|NCT03035227|39391938|FG001|Overall Study|study stopped due to PI leaving institut|1|||
16248568|NCT00927810|39391939|FG000|Overall Study|Withdrawal by Subject|0|||
16248569|NCT00927810|39391940|FG001|Overall Study|Withdrawal by Subject|3|||
16248570|NCT00927810|39391941|FG002|Overall Study|Withdrawal by Subject|0|||
16248571|NCT00927810|39391942|FG003|Overall Study|Withdrawal by Subject|1|||
16562226|NCT01089556|40525368|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
16248572|NCT00927810|39391939|FG000|Overall Study|Lost to Follow-up|0|||
16248573|NCT00927810|39391940|FG001|Overall Study|Lost to Follow-up|2|||
16248574|NCT00927810|39391941|FG002|Overall Study|Lost to Follow-up|1|||
16248575|NCT00927810|39391942|FG003|Overall Study|Lost to Follow-up|1|||
16248576|NCT00927810|39391939|FG000|Overall Study|Death|0|||
16358436|NCT02765165|39797300|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
16358437|NCT02765165|39797294|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
16358438|NCT02765165|39797295|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
16358439|NCT02765165|39797296|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
16358440|NCT02765165|39797297|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
16358441|NCT02765165|39797298|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
16358442|NCT02765165|39797299|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
16358443|NCT02765165|39797300|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
16358444|NCT03810183|39797301|FG000|Overall Study|Study terminated by Sponsor|2|||
16358445|NCT03810183|39797302|FG001|Overall Study|Study terminated by Sponsor|1|||
16358446|NCT00262119|39797309|FG000|Overall Study|Lost to Follow-up|38|||
16358447|NCT00262119|39797310|FG001|Overall Study|Lost to Follow-up|51|||
16358448|NCT00262119|39797311|FG002|Overall Study|Lost to Follow-up|42|||
16358449|NCT00262119|39797309|FG000|Overall Study|Death|20|||
16358450|NCT00262119|39797310|FG001|Overall Study|Death|19|||
16358451|NCT00262119|39797311|FG002|Overall Study|Death|16|||
16358452|NCT01863771|39797313|FG000|Induction Phase|Adverse Event|9|||
16358453|NCT01863771|39797314|FG001|Induction Phase|Adverse Event|0|||
16358454|NCT01863771|39797315|FG002|Induction Phase|Adverse Event|0|||
16358455|NCT01863771|39797316|FG003|Induction Phase|Adverse Event|0|||
16358456|NCT01863771|39797313|FG000|Induction Phase|Lack of Efficacy|10|||
16358457|NCT01863771|39797314|FG001|Induction Phase|Lack of Efficacy|0|||
16358458|NCT01863771|39797315|FG002|Induction Phase|Lack of Efficacy|0|||
16358459|NCT01863771|39797316|FG003|Induction Phase|Lack of Efficacy|0|||
16358460|NCT01863771|39797313|FG000|Induction Phase|Withdrawal by Subject|2|||
16358461|NCT01863771|39797314|FG001|Induction Phase|Withdrawal by Subject|0|||
16358462|NCT01863771|39797315|FG002|Induction Phase|Withdrawal by Subject|0|||
16358463|NCT01863771|39797316|FG003|Induction Phase|Withdrawal by Subject|0|||
16358464|NCT01863771|39797313|FG000|Maintenance Phase|Adverse Event|0|||
16358465|NCT01863771|39797314|FG001|Maintenance Phase|Adverse Event|0|||
16358466|NCT01863771|39797315|FG002|Maintenance Phase|Adverse Event|1|||
16358467|NCT01863771|39797316|FG003|Maintenance Phase|Adverse Event|1|||
16358468|NCT01863771|39797313|FG000|Maintenance Phase|Lack of Efficacy|0|||
16358469|NCT01863771|39797314|FG001|Maintenance Phase|Lack of Efficacy|3|||
16358470|NCT01863771|39797315|FG002|Maintenance Phase|Lack of Efficacy|7|||
16248577|NCT00927810|39391940|FG001|Overall Study|Death|2|||
16248578|NCT00927810|39391941|FG002|Overall Study|Death|0|||
16248579|NCT00927810|39391942|FG003|Overall Study|Death|0|||
16248580|NCT00927810|39391939|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16248581|NCT00927810|39391940|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16248582|NCT00927810|39391941|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16248583|NCT00927810|39391942|FG003|Overall Study|Abnormal laboratory value(s)|0|||
16248584|NCT00979628|39391945|FG000|Overall Study|received regimen < 24 hours|7|||
16248585|NCT00979628|39391946|FG001|Overall Study|received regimen < 24 hours|6|||
16248586|NCT00979628|39391947|FG002|Overall Study|received regimen < 24 hours|5|||
16248587|NCT00979628|39391945|FG000|Overall Study|received steroids|1|||
16248588|NCT00979628|39391946|FG001|Overall Study|received steroids|1|||
16248589|NCT00979628|39391947|FG002|Overall Study|received steroids|0|||
16248590|NCT00979628|39391945|FG000|Overall Study|transferred to ICU|1|||
16248591|NCT00979628|39391946|FG001|Overall Study|transferred to ICU|2|||
16248592|NCT00979628|39391947|FG002|Overall Study|transferred to ICU|1|||
16248593|NCT00947427|39391949|FG000|Overall Study|Withdrawal by Subject|1|||
16248594|NCT00947427|39391950|FG001|Overall Study|Withdrawal by Subject|3|||
16248595|NCT00947427|39391949|FG000|Overall Study|Protocol Violation|0|||
16248596|NCT00947427|39391950|FG001|Overall Study|Protocol Violation|1|||
16248597|NCT00988169|39391953|FG000|Overall Study|Withdrawal by Subject|1|||
16248598|NCT01165684|39395200|FG000|Overall Study|Adverse Event|1|||
16248599|NCT01165684|39395201|FG001|Overall Study|Adverse Event|1|||
16248600|NCT01165684|39395200|FG000|Overall Study|Lack of Efficacy|2|||
16248601|NCT01165684|39395201|FG001|Overall Study|Lack of Efficacy|1|||
16358471|NCT01863771|39797316|FG003|Maintenance Phase|Lack of Efficacy|38|||
16358472|NCT01863771|39797313|FG000|Maintenance Phase|Physician Decision|0|||
16358473|NCT01863771|39797314|FG001|Maintenance Phase|Physician Decision|0|||
16358474|NCT01863771|39797315|FG002|Maintenance Phase|Physician Decision|2|||
16248602|NCT01165684|39395200|FG000|Overall Study|Protocol Violation|7|||
16248603|NCT01165684|39395201|FG001|Overall Study|Protocol Violation|15|||
16248604|NCT01165684|39395200|FG000|Overall Study|Withdrawal Criteria|2|||
16358475|NCT01863771|39797316|FG003|Maintenance Phase|Physician Decision|1|||
16358476|NCT01863771|39797313|FG000|Maintenance Phase|Pregnancy|0|||
16358477|NCT01863771|39797314|FG001|Maintenance Phase|Pregnancy|1|||
16358478|NCT01863771|39797315|FG002|Maintenance Phase|Pregnancy|0|||
16358479|NCT01863771|39797316|FG003|Maintenance Phase|Pregnancy|0|||
16358480|NCT01863771|39797313|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16358481|NCT01863771|39797314|FG001|Maintenance Phase|Withdrawal by Subject|1|||
16358482|NCT01863771|39797315|FG002|Maintenance Phase|Withdrawal by Subject|2|||
16358483|NCT01863771|39797316|FG003|Maintenance Phase|Withdrawal by Subject|3|||
16358484|NCT02382939|39797319|FG000|Overall Study|Adverse Event|1|||
16358485|NCT02382939|39797320|FG001|Overall Study|Adverse Event|1|||
16358486|NCT02382939|39797319|FG000|Overall Study|Withdrawal by Subject|2|||
16358487|NCT02382939|39797320|FG001|Overall Study|Withdrawal by Subject|2|||
16419313|NCT03178669|40015500|FG003|Overall Study|Adverse Event|2|||
16419314|NCT03178669|40015501|FG004|Overall Study|Adverse Event|2|||
16419315|NCT03178669|40015497|FG000|Overall Study|Lack of Efficacy|0|||
16419316|NCT03178669|40015498|FG001|Overall Study|Lack of Efficacy|0|||
16419317|NCT03178669|40015499|FG002|Overall Study|Lack of Efficacy|2|||
16130691|NCT02842827|38967105|FG005|Overall Study|Participant Withdrawal of Consent|1|||
16130692|NCT02842827|38967106|FG006|Overall Study|Participant Withdrawal of Consent|2|||
16130693|NCT02842827|38967107|FG007|Overall Study|Participant Withdrawal of Consent|1|||
16130694|NCT01598311|38967108|FG000|Overall Study|Physician Decision|4|||
16419318|NCT03178669|40015500|FG003|Overall Study|Lack of Efficacy|0|||
16419319|NCT03178669|40015501|FG004|Overall Study|Lack of Efficacy|1|||
16419320|NCT03178669|40015497|FG000|Overall Study|Physician Decision|0|||
16419321|NCT03178669|40015498|FG001|Overall Study|Physician Decision|0|||
16419322|NCT03178669|40015499|FG002|Overall Study|Physician Decision|0|||
16419323|NCT03178669|40015500|FG003|Overall Study|Physician Decision|0|||
16419324|NCT03178669|40015501|FG004|Overall Study|Physician Decision|1|||
16419325|NCT03178669|40015497|FG000|Overall Study|Withdrawal by Subject|1|||
16419326|NCT03178669|40015498|FG001|Overall Study|Withdrawal by Subject|0|||
16419327|NCT03178669|40015499|FG002|Overall Study|Withdrawal by Subject|1|||
16419328|NCT03178669|40015500|FG003|Overall Study|Withdrawal by Subject|1|||
16419329|NCT03178669|40015501|FG004|Overall Study|Withdrawal by Subject|0|||
16419330|NCT03178669|40015497|FG000|Overall Study|Lost to Follow-up|0|||
16419331|NCT03178669|40015498|FG001|Overall Study|Lost to Follow-up|0|||
16419332|NCT03178669|40015499|FG002|Overall Study|Lost to Follow-up|0|||
16419333|NCT03178669|40015500|FG003|Overall Study|Lost to Follow-up|1|||
16419334|NCT03178669|40015501|FG004|Overall Study|Lost to Follow-up|0|||
16419335|NCT00559988|40015517|FG000|Overall Study|Death|147|||
16358488|NCT01576575|39797334|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
16358489|NCT01576575|39797334|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
16358490|NCT01576575|39797334|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
16419336|NCT00559988|40015518|FG001|Overall Study|Death|140|||
16419337|NCT00559988|40015517|FG000|Overall Study|Withdrawal by Subject|152|||
16419338|NCT00559988|40015518|FG001|Overall Study|Withdrawal by Subject|139|||
16419339|NCT00559988|40015517|FG000|Overall Study|Lost to Follow-up|42|||
16419340|NCT00559988|40015518|FG001|Overall Study|Lost to Follow-up|56|||
16419341|NCT00559988|40015517|FG000|Overall Study|ICD device explanted|10|||
16419342|NCT00559988|40015518|FG001|Overall Study|ICD device explanted|17|||
16419343|NCT03262441|40015519|FG000|Overall Study|Withdrawal by Subject|1|||
16419344|NCT02516228|40015522|FG000|Overall Study|Lost to Follow-up|1|||
16419345|NCT02516228|40015522|FG000|Overall Study|Withdrawal by Subject|1|||
16419346|NCT02516228|40015522|FG000|Overall Study|Physician Decision|1|||
16419347|NCT04384523|40015523|FG000|Overall Study|Lost to Follow-up|0|||
16419348|NCT04384523|40015524|FG001|Overall Study|Lost to Follow-up|0|||
16419349|NCT04384523|40015525|FG002|Overall Study|Lost to Follow-up|0|||
16419350|NCT04384523|40015526|FG003|Overall Study|Lost to Follow-up|0|||
16419351|NCT04384523|40015527|FG004|Overall Study|Lost to Follow-up|0|||
16419352|NCT04384523|40015528|FG005|Overall Study|Lost to Follow-up|1|||
16419353|NCT04384523|40015523|FG000|Overall Study|Protocol Violation|0|||
16419354|NCT04384523|40015524|FG001|Overall Study|Protocol Violation|1|||
16419355|NCT04384523|40015525|FG002|Overall Study|Protocol Violation|0|||
16419356|NCT04384523|40015526|FG003|Overall Study|Protocol Violation|0|||
16419357|NCT04384523|40015527|FG004|Overall Study|Protocol Violation|0|||
16419358|NCT04384523|40015528|FG005|Overall Study|Protocol Violation|0|||
16419359|NCT04384523|40015523|FG000|Overall Study|Withdrawal by Subject|1|||
16419360|NCT04384523|40015524|FG001|Overall Study|Withdrawal by Subject|0|||
16419361|NCT04384523|40015525|FG002|Overall Study|Withdrawal by Subject|0|||
16419362|NCT04384523|40015526|FG003|Overall Study|Withdrawal by Subject|0|||
16419363|NCT04384523|40015527|FG004|Overall Study|Withdrawal by Subject|0|||
16419364|NCT04384523|40015528|FG005|Overall Study|Withdrawal by Subject|0|||
16419365|NCT04023682|40015531|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
16419366|NCT01990859|40015532|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
16419367|NCT01990859|40015532|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
16419368|NCT03597061|40015533|FG000|Overall Study|Lost to Follow-up|1|||
16419369|NCT03597061|40015534|FG001|Overall Study|Lost to Follow-up|0|||
16419370|NCT03597061|40015533|FG000|Overall Study|Protocol Violation|0|||
16419371|NCT03597061|40015534|FG001|Overall Study|Protocol Violation|1|||
16419372|NCT04058886|40015535|FG000|Overall Study|Withdrawal by Subject|4|||
16419373|NCT04058886|40015535|FG000|Overall Study|Inadequate deafness interpreter service|1|||
16419374|NCT01870726|40015540|FG000|Overall Study|Withdrawal of informed consent|0|||
16419375|NCT01870726|40015541|FG001|Overall Study|Withdrawal of informed consent|0|||
16419376|NCT01870726|40015542|FG002|Overall Study|Withdrawal of informed consent|0|||
16419377|NCT01870726|40015543|FG003|Overall Study|Withdrawal of informed consent|1|||
16358491|NCT01189266|39797335|FG000|Overall Study|Adverse Event|1|||
16358492|NCT01189266|39797336|FG001|Overall Study|Adverse Event|0|||
16419378|NCT01870726|40015544|FG004|Overall Study|Withdrawal of informed consent|0|||
16419379|NCT01870726|40015545|FG005|Overall Study|Withdrawal of informed consent|0|||
16419380|NCT01870726|40015546|FG006|Overall Study|Withdrawal of informed consent|0|||
16419381|NCT01870726|40015540|FG000|Overall Study|Withdrawal by Subject|0|||
16358493|NCT01189266|39797337|FG002|Overall Study|Adverse Event|5|||
16358494|NCT01189266|39797335|FG000|Overall Study|Death|0|||
16358495|NCT01189266|39797336|FG001|Overall Study|Death|0|||
16358496|NCT01189266|39797337|FG002|Overall Study|Death|5|||
16358497|NCT01189266|39797335|FG000|Overall Study|Lack of Efficacy|4|||
16358498|NCT01189266|39797336|FG001|Overall Study|Lack of Efficacy|5|||
16358499|NCT01189266|39797337|FG002|Overall Study|Lack of Efficacy|44|||
16358500|NCT01189266|39797335|FG000|Overall Study|Physician Decision|0|||
16358501|NCT01189266|39797336|FG001|Overall Study|Physician Decision|0|||
16358502|NCT01189266|39797337|FG002|Overall Study|Physician Decision|1|||
16358503|NCT01189266|39797335|FG000|Overall Study|Protocol Violation|0|||
16358504|NCT01189266|39797336|FG001|Overall Study|Protocol Violation|1|||
16358505|NCT01189266|39797337|FG002|Overall Study|Protocol Violation|1|||
16358506|NCT01189266|39797335|FG000|Overall Study|Withdrawal by Subject|0|||
16358507|NCT01189266|39797336|FG001|Overall Study|Withdrawal by Subject|0|||
16358508|NCT01189266|39797337|FG002|Overall Study|Withdrawal by Subject|1|||
16358509|NCT01189266|39797335|FG000|Overall Study|Patient refuses further therapy|1|||
16419382|NCT01870726|40015541|FG001|Overall Study|Withdrawal by Subject|1|||
16419383|NCT01870726|40015542|FG002|Overall Study|Withdrawal by Subject|0|||
16419384|NCT01870726|40015543|FG003|Overall Study|Withdrawal by Subject|0|||
16419385|NCT01870726|40015544|FG004|Overall Study|Withdrawal by Subject|0|||
16419386|NCT01870726|40015545|FG005|Overall Study|Withdrawal by Subject|0|||
16562227|NCT01089556|40525369|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
16358510|NCT01189266|39797336|FG001|Overall Study|Patient refuses further therapy|0|||
16419387|NCT01870726|40015546|FG006|Overall Study|Withdrawal by Subject|0|||
16419388|NCT01870726|40015540|FG000|Overall Study|Adverse Event|0|||
16419389|NCT01870726|40015541|FG001|Overall Study|Adverse Event|0|||
16419390|NCT01870726|40015542|FG002|Overall Study|Adverse Event|0|||
16358511|NCT01189266|39797337|FG002|Overall Study|Patient refuses further therapy|7|||
16358512|NCT01189266|39797335|FG000|Overall Study|No treatment|0|||
16358513|NCT01189266|39797336|FG001|Overall Study|No treatment|0|||
16358514|NCT01189266|39797337|FG002|Overall Study|No treatment|1|||
16358515|NCT00921024|39797346|FG000|Overall Study|Lost to Follow-up|2|||
16358516|NCT00921024|39797347|FG001|Overall Study|Lost to Follow-up|0|||
16358517|NCT00921024|39797346|FG000|Overall Study|Received concomittant therapy|2|||
16358518|NCT00921024|39797347|FG001|Overall Study|Received concomittant therapy|0|||
16358519|NCT00921024|39797346|FG000|Overall Study|Withdrawal by Subject|0|||
16358520|NCT00921024|39797347|FG001|Overall Study|Withdrawal by Subject|3|||
16358521|NCT02111083|39797351|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
16358522|NCT02111083|39797352|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
16358523|NCT03805841|39797353|FG000|Overall Study|Clinical Progression|2|||
16358524|NCT03805841|39797354|FG001|Overall Study|Clinical Progression|0|||
16358525|NCT03805841|39797355|FG002|Overall Study|Clinical Progression|0|||
16358526|NCT03805841|39797353|FG000|Overall Study|Death|0|||
16358527|NCT03805841|39797354|FG001|Overall Study|Death|3|||
16358528|NCT03805841|39797355|FG002|Overall Study|Death|1|||
16358529|NCT03805841|39797353|FG000|Overall Study|Lost to Follow-up|0|||
16358530|NCT03805841|39797354|FG001|Overall Study|Lost to Follow-up|0|||
16358531|NCT03805841|39797355|FG002|Overall Study|Lost to Follow-up|1|||
16358532|NCT03805841|39797353|FG000|Overall Study|Withdrawal by Subject|2|||
16358533|NCT03805841|39797354|FG001|Overall Study|Withdrawal by Subject|3|||
16358534|NCT03805841|39797355|FG002|Overall Study|Withdrawal by Subject|0|||
16358535|NCT03805841|39797353|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
16358536|NCT03805841|39797354|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
16358537|NCT03805841|39797355|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
16358538|NCT02207608|39797356|FG000|Overall Study|Adverse Event|1|||
16358539|NCT02207608|39797357|FG001|Overall Study|Adverse Event|0|||
16358540|NCT01933594|39797358|FG000|Overall Study|Lost to Follow-up|1|||
16358541|NCT01933594|39797359|FG001|Overall Study|Lost to Follow-up|0|||
16358542|NCT01933594|39797360|FG002|Overall Study|Lost to Follow-up|0|||
16358543|NCT01933594|39797361|FG003|Overall Study|Lost to Follow-up|0|||
16358544|NCT01933594|39797362|FG004|Overall Study|Lost to Follow-up|1|||
16358545|NCT01933594|39797363|FG005|Overall Study|Lost to Follow-up|0|||
16358546|NCT01933594|39797358|FG000|Overall Study|Ineligible for subsequent study step|0|||
16358547|NCT01933594|39797359|FG001|Overall Study|Ineligible for subsequent study step|0|||
16358548|NCT01933594|39797360|FG002|Overall Study|Ineligible for subsequent study step|0|||
16358549|NCT01933594|39797361|FG003|Overall Study|Ineligible for subsequent study step|0|||
16358550|NCT01933594|39797362|FG004|Overall Study|Ineligible for subsequent study step|1|||
16358551|NCT01933594|39797363|FG005|Overall Study|Ineligible for subsequent study step|0|||
16358552|NCT00410163|39800262|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
16358553|NCT00410163|39800263|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
16358554|NCT00410163|39800262|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
16358555|NCT00410163|39800263|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
16358556|NCT00410163|39800262|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
16358557|NCT00410163|39800263|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
16358558|NCT00410163|39800262|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
16358559|NCT00410163|39800263|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
16358560|NCT00410163|39800262|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
16358561|NCT00410163|39800263|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
16358562|NCT00410163|39800262|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
16358563|NCT00410163|39800263|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
16358564|NCT00410163|39800262|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
16358565|NCT00410163|39800263|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
16358566|NCT00410163|39800262|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
16358567|NCT00410163|39800263|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
16358568|NCT00410163|39800262|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
16419391|NCT01870726|40015543|FG003|Overall Study|Adverse Event|0|||
16248605|NCT01165684|39395201|FG001|Overall Study|Withdrawal Criteria|13|||
16248606|NCT01165684|39395200|FG000|Overall Study|Unclassified|16|||
16419392|NCT01870726|40015544|FG004|Overall Study|Adverse Event|1|||
16358569|NCT00410163|39800263|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
16419393|NCT01870726|40015545|FG005|Overall Study|Adverse Event|1|||
16419394|NCT01870726|40015546|FG006|Overall Study|Adverse Event|0|||
16419395|NCT01870726|40015540|FG000|Overall Study|Progressive disease|5|||
16419396|NCT01870726|40015541|FG001|Overall Study|Progressive disease|5|||
16419397|NCT01870726|40015542|FG002|Overall Study|Progressive disease|4|||
16419398|NCT01870726|40015543|FG003|Overall Study|Progressive disease|5|||
16419399|NCT01870726|40015544|FG004|Overall Study|Progressive disease|6|||
16419400|NCT01870726|40015545|FG005|Overall Study|Progressive disease|4|||
16358570|NCT00410163|39800262|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
16358571|NCT00410163|39800263|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
16358572|NCT00410163|39800262|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
16358573|NCT00410163|39800263|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
16358574|NCT00410163|39800262|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
16358575|NCT00410163|39800263|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
16358576|NCT00410163|39800262|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
16358577|NCT00410163|39800263|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
16358578|NCT00410163|39800262|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
16358579|NCT00410163|39800263|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
16358580|NCT00321763|39800264|FG000|Overall Study|Adverse Event|1|||
16419401|NCT01870726|40015546|FG006|Overall Study|Progressive disease|10|||
16419402|NCT00186901|40015547|FG000|Overall Study|Pregnancy|6|||
16419403|NCT00186901|40015548|FG001|Overall Study|Pregnancy|3|||
16419404|NCT00186901|40015549|FG002|Overall Study|Pregnancy|0|||
16419405|NCT00186901|40015547|FG000|Overall Study|Lost to Follow-up|6|||
16419406|NCT00186901|40015548|FG001|Overall Study|Lost to Follow-up|3|||
16419407|NCT00186901|40015549|FG002|Overall Study|Lost to Follow-up|0|||
16419408|NCT00186901|40015547|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
16419409|NCT00186901|40015548|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
16358581|NCT00321763|39800265|FG001|Overall Study|Adverse Event|1|||
16358582|NCT00321763|39800266|FG002|Overall Study|Adverse Event|0|||
16358583|NCT00321763|39800267|FG003|Overall Study|Adverse Event|1|||
16358584|NCT00321763|39800264|FG000|Overall Study|Withdrawal by Subject|2|||
16358585|NCT00321763|39800265|FG001|Overall Study|Withdrawal by Subject|0|||
16358586|NCT00321763|39800266|FG002|Overall Study|Withdrawal by Subject|1|||
16358587|NCT00321763|39800267|FG003|Overall Study|Withdrawal by Subject|0|||
16358588|NCT00321763|39800264|FG000|Overall Study|Lost to Follow-up|3|||
16358589|NCT00321763|39800265|FG001|Overall Study|Lost to Follow-up|1|||
16358590|NCT00321763|39800266|FG002|Overall Study|Lost to Follow-up|5|||
16358591|NCT00321763|39800267|FG003|Overall Study|Lost to Follow-up|4|||
16358592|NCT00827567|39800268|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
16358593|NCT01030900|39800269|FG000|Overall Study|Not treated due to congestive heart failure|1|||
16358594|NCT01030900|39800269|FG000|Overall Study|Not treated due to rapid disease|1|||
16358595|NCT01277861|39800275|FG000|Overall Study|Physician Decision|2|||
16419410|NCT00186901|40015549|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
16419411|NCT00186901|40015547|FG000|Overall Study|ALL relapse or second malignancy|1|||
16358596|NCT01277861|39800276|FG001|Overall Study|Physician Decision|2|||
16358597|NCT01860989|39800277|FG000|Overall Study|Unsatisfactory therapeutic|5|||
16358598|NCT05259917|39800280|FG000|Overall Study|Protocol Violation|0|||
16562228|NCT01089556|40525370|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
16358599|NCT05259917|39800281|FG001|Overall Study|Protocol Violation|0|||
16358600|NCT05259917|39800282|FG002|Overall Study|Protocol Violation|1|||
16358601|NCT05259917|39800283|FG003|Overall Study|Protocol Violation|0|||
16358602|NCT05259917|39800284|FG004|Overall Study|Protocol Violation|0|||
16358603|NCT05259917|39800285|FG005|Overall Study|Protocol Violation|0|||
16358604|NCT05259917|39800280|FG000|Overall Study|Lost to Follow-up|0|||
16358605|NCT05259917|39800281|FG001|Overall Study|Lost to Follow-up|0|||
16358606|NCT05259917|39800282|FG002|Overall Study|Lost to Follow-up|1|||
16358607|NCT05259917|39800283|FG003|Overall Study|Lost to Follow-up|0|||
16358608|NCT05259917|39800284|FG004|Overall Study|Lost to Follow-up|0|||
16358609|NCT05259917|39800285|FG005|Overall Study|Lost to Follow-up|1|||
16358610|NCT05259917|39800280|FG000|Overall Study|Physician Decision|0|||
16358611|NCT05259917|39800281|FG001|Overall Study|Physician Decision|1|||
16358612|NCT05259917|39800282|FG002|Overall Study|Physician Decision|0|||
16358613|NCT05259917|39800283|FG003|Overall Study|Physician Decision|0|||
16358614|NCT05259917|39800284|FG004|Overall Study|Physician Decision|0|||
16358615|NCT05259917|39800285|FG005|Overall Study|Physician Decision|0|||
16358616|NCT05259917|39800280|FG000|Overall Study|Withdrawal by Subject|0|||
16358617|NCT05259917|39800281|FG001|Overall Study|Withdrawal by Subject|1|||
16358618|NCT05259917|39800282|FG002|Overall Study|Withdrawal by Subject|0|||
16358619|NCT05259917|39800283|FG003|Overall Study|Withdrawal by Subject|0|||
16358620|NCT05259917|39800284|FG004|Overall Study|Withdrawal by Subject|1|||
16358621|NCT05259917|39800285|FG005|Overall Study|Withdrawal by Subject|1|||
16358622|NCT05259917|39800280|FG000|Overall Study|Trial Termination by Sponsor|7|||
16358623|NCT05259917|39800281|FG001|Overall Study|Trial Termination by Sponsor|2|||
16358624|NCT05259917|39800282|FG002|Overall Study|Trial Termination by Sponsor|3|||
16358625|NCT05259917|39800283|FG003|Overall Study|Trial Termination by Sponsor|5|||
16358626|NCT05259917|39800284|FG004|Overall Study|Trial Termination by Sponsor|11|||
16358627|NCT05259917|39800285|FG005|Overall Study|Trial Termination by Sponsor|4|||
16358628|NCT05259917|39800280|FG000|Overall Study|Other|1|||
16358629|NCT05259917|39800281|FG001|Overall Study|Other|0|||
16358630|NCT05259917|39800282|FG002|Overall Study|Other|2|||
16358631|NCT05259917|39800283|FG003|Overall Study|Other|0|||
16358632|NCT05259917|39800284|FG004|Overall Study|Other|0|||
16358633|NCT05259917|39800285|FG005|Overall Study|Other|0|||
16358634|NCT00069264|39800288|FG000|Overall Study|Adverse Event|3|||
16358635|NCT00069264|39800288|FG000|Overall Study|Progressive Disease|23|||
16358636|NCT00069264|39800288|FG000|Overall Study|Withdrawal by Subject|3|||
16358637|NCT00069264|39800288|FG000|Overall Study|Discon Therapy|3|||
16358638|NCT00314145|39800293|FG000|Overall Study|Withdrawal by Subject|8|||
16358639|NCT00314145|39800294|FG001|Overall Study|Withdrawal by Subject|10|||
16358640|NCT00314145|39800293|FG000|Overall Study|Lost to Follow-up|5|||
16358641|NCT00314145|39800294|FG001|Overall Study|Lost to Follow-up|12|||
16358642|NCT00314145|39800293|FG000|Overall Study|Physician Decision|3|||
16358643|NCT00314145|39800294|FG001|Overall Study|Physician Decision|4|||
16358644|NCT00314145|39800293|FG000|Overall Study|Adverse Event|0|||
16358645|NCT00314145|39800294|FG001|Overall Study|Adverse Event|3|||
16358646|NCT00314145|39800293|FG000|Overall Study|Protocol Violation|3|||
16358647|NCT00314145|39800294|FG001|Overall Study|Protocol Violation|0|||
16358648|NCT00314145|39800293|FG000|Overall Study|Sponsor Decision|2|||
16358649|NCT00314145|39800294|FG001|Overall Study|Sponsor Decision|0|||
16358650|NCT00490035|39800312|FG000|Overall Study|AE, non-serious non-fatal|3|||
16358651|NCT00490035|39800313|FG001|Overall Study|AE, non-serious non-fatal|4|||
16358652|NCT00490035|39800314|FG002|Overall Study|AE, non-serious non-fatal|4|||
16358653|NCT00490035|39800315|FG003|Overall Study|AE, non-serious non-fatal|5|||
16358654|NCT00490035|39800312|FG000|Overall Study|Lost to Follow-up|2|||
16358655|NCT00490035|39800313|FG001|Overall Study|Lost to Follow-up|0|||
16358656|NCT00490035|39800314|FG002|Overall Study|Lost to Follow-up|1|||
16358657|NCT00490035|39800315|FG003|Overall Study|Lost to Follow-up|0|||
16358658|NCT00490035|39800312|FG000|Overall Study|Withdrawal by Subject|2|||
16358659|NCT00490035|39800313|FG001|Overall Study|Withdrawal by Subject|1|||
16358660|NCT00490035|39800314|FG002|Overall Study|Withdrawal by Subject|1|||
16358661|NCT00490035|39800315|FG003|Overall Study|Withdrawal by Subject|0|||
16358662|NCT00490035|39800312|FG000|Overall Study|Other reason|0|||
16358663|NCT00490035|39800313|FG001|Overall Study|Other reason|1|||
16358664|NCT00490035|39800314|FG002|Overall Study|Other reason|3|||
16358665|NCT00490035|39800315|FG003|Overall Study|Other reason|1|||
16358666|NCT00490035|39800312|FG000|Overall Study|AE, serious fatal|1|||
16358667|NCT00490035|39800313|FG001|Overall Study|AE, serious fatal|0|||
16358668|NCT00490035|39800314|FG002|Overall Study|AE, serious fatal|0|||
16358669|NCT00490035|39800315|FG003|Overall Study|AE, serious fatal|0|||
16358670|NCT00490035|39800312|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
16358671|NCT00490035|39800313|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
16358672|NCT00490035|39800314|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
16358673|NCT00490035|39800315|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
16358674|NCT00490035|39800312|FG000|Overall Study|AE of unknown type|0|||
16419412|NCT00186901|40015548|FG001|Overall Study|ALL relapse or second malignancy|2|||
16419413|NCT00186901|40015549|FG002|Overall Study|ALL relapse or second malignancy|0|||
16419414|NCT00186901|40015547|FG000|Overall Study|Withdrawal by Subject|4|||
16419415|NCT00186901|40015548|FG001|Overall Study|Withdrawal by Subject|5|||
16419416|NCT00186901|40015549|FG002|Overall Study|Withdrawal by Subject|0|||
16419417|NCT00186901|40015547|FG000|Overall Study|Open label|3|||
16419418|NCT00186901|40015548|FG001|Overall Study|Open label|2|||
16419419|NCT00186901|40015549|FG002|Overall Study|Open label|0|||
16419420|NCT00186901|40015547|FG000|Overall Study|Limited adherence to study requirements|20|||
16419421|NCT00186901|40015548|FG001|Overall Study|Limited adherence to study requirements|23|||
16419422|NCT00186901|40015549|FG002|Overall Study|Limited adherence to study requirements|0|||
16419423|NCT00186901|40015547|FG000|Overall Study|Bone Mineral Density > 0|0|||
16419424|NCT00186901|40015548|FG001|Overall Study|Bone Mineral Density > 0|0|||
16419425|NCT00186901|40015549|FG002|Overall Study|Bone Mineral Density > 0|149|||
16419426|NCT01844778|40015554|FG000|Overall Study|Protocol deviation|0|||
16419427|NCT01844778|40015555|FG001|Overall Study|Protocol deviation|1|||
16419428|NCT01844778|40015556|FG002|Overall Study|Protocol deviation|2|||
16419429|NCT01844778|40015554|FG000|Overall Study|Withdrawal by Subject|2|||
16419430|NCT01844778|40015555|FG001|Overall Study|Withdrawal by Subject|0|||
16419431|NCT01844778|40015556|FG002|Overall Study|Withdrawal by Subject|0|||
16419432|NCT01844778|40015554|FG000|Overall Study|Adverse Event|0|||
16419433|NCT01844778|40015555|FG001|Overall Study|Adverse Event|2|||
16358675|NCT00490035|39800313|FG001|Overall Study|AE of unknown type|0|||
16419434|NCT01844778|40015556|FG002|Overall Study|Adverse Event|2|||
16419435|NCT01008904|40015557|FG000|Overall Study|Lost to Follow-up|1|||
16419436|NCT01008904|40015557|FG000|Overall Study|Adverse Event|2|||
16419437|NCT01008904|40015557|FG000|Overall Study|unexpected unrelated surgery|1|||
16419438|NCT03216746|40015559|FG000|Overall Study|Lost to Follow-up|6|||
16419439|NCT03216746|40015560|FG001|Overall Study|Lost to Follow-up|8|||
16419440|NCT03216746|40015561|FG002|Overall Study|Lost to Follow-up|5|||
16419441|NCT03216746|40015562|FG003|Overall Study|Lost to Follow-up|6|||
16419442|NCT02032407|40015563|FG000|Overall Study|Lost to Follow-up|2|||
16358676|NCT00490035|39800314|FG002|Overall Study|AE of unknown type|2|||
16358677|NCT00490035|39800315|FG003|Overall Study|AE of unknown type|0|||
16358678|NCT02119299|39800316|FG000|Overall Study|Withdrawal by Subject|7|||
16358679|NCT02119299|39800316|FG000|Overall Study|Lack of Efficacy|1|||
16358680|NCT02119299|39800316|FG000|Overall Study|Pregnancy|1|||
16358681|NCT02020941|39800319|FG000|Overall Study|Adverse Event|1|||
16358682|NCT02020941|39800319|FG000|Overall Study|Physician Decision|2|||
16358683|NCT02020941|39800319|FG000|Overall Study|Withdrawal by Subject|1|||
16358684|NCT02020941|39800319|FG000|Overall Study|Disease Progression|4|||
16358685|NCT00846365|39800320|FG000|Overall Study|Adverse Event|20|||
16358686|NCT00846365|39800321|FG001|Overall Study|Adverse Event|30|||
16358687|NCT00846365|39800322|FG002|Overall Study|Adverse Event|11|||
16358688|NCT00846365|39800320|FG000|Overall Study|Protocol Violation|5|||
16358689|NCT00846365|39800321|FG001|Overall Study|Protocol Violation|4|||
16358690|NCT00846365|39800322|FG002|Overall Study|Protocol Violation|0|||
16358691|NCT00846365|39800320|FG000|Overall Study|Lost to Follow-up|8|||
16358692|NCT00846365|39800321|FG001|Overall Study|Lost to Follow-up|2|||
16358693|NCT00846365|39800322|FG002|Overall Study|Lost to Follow-up|5|||
16358694|NCT00846365|39800320|FG000|Overall Study|Withdrawal by Subject|11|||
16358695|NCT00846365|39800321|FG001|Overall Study|Withdrawal by Subject|11|||
16419443|NCT02032407|40015563|FG000|Overall Study|Pregnancy|1|||
16419444|NCT02032407|40015563|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16419445|NCT03848949|40015564|FG000|Overall Study|Lost to Follow-up|5|||
16419446|NCT03848949|40015565|FG001|Overall Study|Lost to Follow-up|7|||
16419447|NCT01067469|40015566|FG000|Overall Study|Withdrawal by Subject|0|||
16419448|NCT01067469|40015567|FG001|Overall Study|Withdrawal by Subject|1|||
16419449|NCT01067469|40015566|FG000|Overall Study|Disease Progression|0|||
16562229|NCT01089556|40525371|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
16358696|NCT00846365|39800322|FG002|Overall Study|Withdrawal by Subject|9|||
16358697|NCT00846365|39800320|FG000|Overall Study|Pregnancy|1|||
16358698|NCT00846365|39800321|FG001|Overall Study|Pregnancy|0|||
16358699|NCT00846365|39800322|FG002|Overall Study|Pregnancy|0|||
16358700|NCT00846365|39800320|FG000|Overall Study|Lack of Efficacy|1|||
16358701|NCT00846365|39800321|FG001|Overall Study|Lack of Efficacy|1|||
16358702|NCT00846365|39800322|FG002|Overall Study|Lack of Efficacy|2|||
16358703|NCT00846365|39800320|FG000|Overall Study|Other|9|||
16358704|NCT00846365|39800321|FG001|Overall Study|Other|1|||
16358705|NCT00846365|39800322|FG002|Overall Study|Other|6|||
16358706|NCT00630292|39800325|FG000|Overall Study|Withdrawal by Subject|1|||
16358707|NCT01868646|39800328|FG000|Overall Study|Do not meet inclusion criteria|3|||
16358708|NCT01868646|39800329|FG001|Overall Study|Do not meet inclusion criteria|5|||
16358709|NCT00984867|39800334|FG000|Overall Study|Adverse Event|3|||
16358710|NCT00984867|39800335|FG001|Overall Study|Adverse Event|7|||
16358711|NCT00984867|39800334|FG000|Overall Study|Death|1|||
16358712|NCT00984867|39800335|FG001|Overall Study|Death|0|||
16358713|NCT00984867|39800334|FG000|Overall Study|Withdrawal by Subject|13|||
16358714|NCT00984867|39800335|FG001|Overall Study|Withdrawal by Subject|4|||
16358715|NCT00984867|39800334|FG000|Overall Study|Lost to Follow-up|3|||
16358716|NCT00984867|39800335|FG001|Overall Study|Lost to Follow-up|4|||
16358717|NCT00984867|39800334|FG000|Overall Study|Poor/non-compliance|0|||
16358718|NCT00984867|39800335|FG001|Overall Study|Poor/non-compliance|1|||
16358719|NCT00984867|39800334|FG000|Overall Study|Subject no longer meets study criteria|1|||
16419450|NCT01067469|40015567|FG001|Overall Study|Disease Progression|1|||
16419451|NCT02726022|40015568|FG000|Overall Study|Adverse Event|14|||
16562230|NCT01089556|40525372|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
16419452|NCT02726022|40015568|FG000|Overall Study|Treatment Failure|8|||
16419453|NCT02726022|40015568|FG000|Overall Study|Poor Compliance|13|||
16419454|NCT02726022|40015568|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
16419455|NCT00383162|40015569|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
16419456|NCT00383162|40015570|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
16419457|NCT00383162|40015569|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
16419458|NCT00383162|40015570|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
16419459|NCT00383162|40015569|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
16419460|NCT00383162|40015570|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
16562231|NCT01089556|40525367|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
16248607|NCT01165684|39395201|FG001|Overall Study|Unclassified|22|||
16358720|NCT00984867|39800335|FG001|Overall Study|Subject no longer meets study criteria|1|||
16562232|NCT01089556|40525368|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
16358721|NCT00984867|39800334|FG000|Overall Study|site closing|1|||
16358722|NCT00984867|39800335|FG001|Overall Study|site closing|0|||
16358723|NCT00984867|39800334|FG000|Overall Study|lack of efficacy and subject compliance|1|||
16358724|NCT00984867|39800335|FG001|Overall Study|lack of efficacy and subject compliance|0|||
16358725|NCT02722967|39800337|FG000|Overall Study|Adverse Event|1|||
16562233|NCT01089556|40525369|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
16248608|NCT01393990|39395202|FG000|Overall Study|Adverse Event|0|||
16562234|NCT01089556|40525370|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
16562235|NCT01089556|40525371|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
16562236|NCT01089556|40525372|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
16562237|NCT01089556|40525367|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
16562238|NCT01089556|40525368|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
16562239|NCT01089556|40525369|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
16562240|NCT01089556|40525370|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
16562241|NCT01089556|40525371|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
16562242|NCT01089556|40525372|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
16562243|NCT01089556|40525367|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
16562244|NCT01089556|40525368|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
16562245|NCT01089556|40525369|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
16562246|NCT01089556|40525370|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
16562247|NCT01089556|40525371|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
16562248|NCT01089556|40525372|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
16562249|NCT01089556|40525367|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
16130695|NCT01598311|38967109|FG001|Overall Study|Physician Decision|5|||
16358726|NCT02722967|39800338|FG001|Overall Study|Adverse Event|0|||
16419461|NCT00383162|40015569|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
16419462|NCT00383162|40015570|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
16419463|NCT00383162|40015569|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
16419464|NCT00383162|40015570|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
16419465|NCT00383162|40015569|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
16419466|NCT00383162|40015570|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
16419467|NCT00383162|40015569|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
16419468|NCT00383162|40015570|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
16419469|NCT00383162|40015569|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
16419470|NCT00383162|40015570|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
16419471|NCT00383162|40015569|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
16419472|NCT00383162|40015570|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
16419473|NCT00830180|40015571|FG000|Overall Study|Adverse Event|6|||
16419474|NCT00830180|40015571|FG000|Overall Study|Death|11|||
16419475|NCT00830180|40015571|FG000|Overall Study|Insufficient clinical response|1|||
16419476|NCT00830180|40015571|FG000|Overall Study|Withdrawal by Subject|5|||
16419477|NCT00830180|40015571|FG000|Overall Study|Progressive disease|2|||
16419478|NCT00830180|40015571|FG000|Overall Study|Other - Unspecified|1|||
16419479|NCT04544683|40015581|FG000|Overall Study|Lost to Follow-up|2|||
16419480|NCT04544683|40015581|FG000|Overall Study|Underwent cervical spine surgery|6|||
16419481|NCT02437084|40015587|FG000|Overall Study|Withdrawal by Subject|2|||
16419482|NCT02437084|40015587|FG000|Overall Study|Physician Decision|1|||
16419483|NCT02828020|40015588|FG000|Treatment Period|Adverse Event|3|||
16419484|NCT02828020|40015589|FG001|Treatment Period|Adverse Event|1|||
16419485|NCT02828020|40015590|FG002|Treatment Period|Adverse Event|1|||
16419486|NCT02828020|40015588|FG000|Treatment Period|Withdrawal of Consent|10|||
16419487|NCT02828020|40015589|FG001|Treatment Period|Withdrawal of Consent|14|||
16419488|NCT02828020|40015590|FG002|Treatment Period|Withdrawal of Consent|9|||
16419489|NCT02828020|40015588|FG000|Treatment Period|Lost to Follow-up|21|||
16419490|NCT02828020|40015589|FG001|Treatment Period|Lost to Follow-up|24|||
16419491|NCT02828020|40015590|FG002|Treatment Period|Lost to Follow-up|18|||
16419492|NCT02828020|40015588|FG000|Treatment Period|Lack of Qualifying Event|44|||
16419493|NCT02828020|40015589|FG001|Treatment Period|Lack of Qualifying Event|53|||
16419494|NCT02828020|40015590|FG002|Treatment Period|Lack of Qualifying Event|43|||
16419495|NCT02828020|40015588|FG000|Treatment Period|Pregnancy|0|||
16419496|NCT02828020|40015589|FG001|Treatment Period|Pregnancy|2|||
16419497|NCT02828020|40015590|FG002|Treatment Period|Pregnancy|0|||
16419498|NCT02828020|40015588|FG000|Treatment Period|Protocol Violation|2|||
16419499|NCT02828020|40015589|FG001|Treatment Period|Protocol Violation|4|||
16419500|NCT02828020|40015590|FG002|Treatment Period|Protocol Violation|7|||
16419501|NCT02828020|40015588|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
16419502|NCT02828020|40015589|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
16419503|NCT02828020|40015590|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
16419504|NCT02828020|40015588|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
16419505|NCT02828020|40015589|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
16419506|NCT02828020|40015590|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
16419507|NCT02828020|40015588|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
16419508|NCT02828020|40015589|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
16419509|NCT02828020|40015590|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
16419510|NCT02828020|40015588|FG000|Safety Follow-up Period|Protocol Violation|0|||
16419511|NCT02828020|40015589|FG001|Safety Follow-up Period|Protocol Violation|2|||
16419512|NCT02828020|40015590|FG002|Safety Follow-up Period|Protocol Violation|1|||
16419513|NCT02828020|40015588|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
16419514|NCT02828020|40015589|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
16419515|NCT02828020|40015590|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
16419516|NCT00687531|40015591|FG000|Overall Study|Did not meet protocol eligibility|104|||
16358727|NCT02722967|39800339|FG002|Overall Study|Adverse Event|0|||
16358728|NCT02722967|39800337|FG000|Overall Study|Lost to Follow-up|0|||
16358729|NCT02722967|39800338|FG001|Overall Study|Lost to Follow-up|1|||
16358730|NCT02722967|39800339|FG002|Overall Study|Lost to Follow-up|0|||
16358731|NCT02722967|39800337|FG000|Overall Study|Non-compliance with patch wearing|2|||
16358732|NCT02722967|39800338|FG001|Overall Study|Non-compliance with patch wearing|1|||
16358733|NCT02722967|39800339|FG002|Overall Study|Non-compliance with patch wearing|1|||
16419517|NCT00687531|40015591|FG000|Overall Study|Adverse Event|5|||
16419518|NCT00687531|40015591|FG000|Overall Study|Lost to Follow-up|26|||
16419519|NCT03652675|40015603|FG000|Overall Study|Lost to Follow-up|4|||
16419520|NCT03652675|40015604|FG001|Overall Study|Lost to Follow-up|4|||
16419521|NCT01439373|40015607|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
16419522|NCT01439373|40015608|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
16562250|NCT01089556|40525368|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
16358734|NCT02722967|39800337|FG000|Overall Study|Withdrawal by Subject|1|||
16248609|NCT01393990|39395203|FG001|Overall Study|Adverse Event|0|||
16248610|NCT01393990|39395204|FG002|Overall Study|Adverse Event|0|||
16248611|NCT01393990|39395205|FG003|Overall Study|Adverse Event|0|||
16248612|NCT01393990|39395206|FG004|Overall Study|Adverse Event|0|||
16248613|NCT01393990|39395207|FG005|Overall Study|Adverse Event|0|||
16248614|NCT01393990|39395208|FG006|Overall Study|Adverse Event|0|||
16248615|NCT01393990|39395209|FG007|Overall Study|Adverse Event|0|||
16248616|NCT01393990|39395210|FG008|Overall Study|Adverse Event|0|||
16248617|NCT01393990|39395211|FG009|Overall Study|Adverse Event|0|||
16248618|NCT01393990|39395212|FG010|Overall Study|Adverse Event|0|||
16248619|NCT01393990|39395213|FG011|Overall Study|Adverse Event|0|||
16248620|NCT01393990|39395214|FG012|Overall Study|Adverse Event|0|||
16248621|NCT01393990|39395215|FG013|Overall Study|Adverse Event|0|||
16248622|NCT01393990|39395216|FG014|Overall Study|Adverse Event|1|||
16248623|NCT01393990|39395217|FG015|Overall Study|Adverse Event|1|||
16248624|NCT01393990|39395218|FG016|Overall Study|Adverse Event|0|||
16248625|NCT01393990|39395219|FG017|Overall Study|Adverse Event|0|||
16248626|NCT01393990|39395202|FG000|Overall Study|Progressive Disease|1|||
16248627|NCT01393990|39395203|FG001|Overall Study|Progressive Disease|0|||
16248628|NCT01393990|39395204|FG002|Overall Study|Progressive Disease|0|||
16248629|NCT01393990|39395205|FG003|Overall Study|Progressive Disease|1|||
16248630|NCT01393990|39395206|FG004|Overall Study|Progressive Disease|1|||
16248631|NCT01393990|39395207|FG005|Overall Study|Progressive Disease|1|||
16248632|NCT01393990|39395208|FG006|Overall Study|Progressive Disease|1|||
16248633|NCT01393990|39395209|FG007|Overall Study|Progressive Disease|1|||
16248634|NCT01393990|39395210|FG008|Overall Study|Progressive Disease|3|||
16248635|NCT01393990|39395211|FG009|Overall Study|Progressive Disease|1|||
16248636|NCT01393990|39395212|FG010|Overall Study|Progressive Disease|0|||
16248637|NCT01393990|39395213|FG011|Overall Study|Progressive Disease|0|||
16248638|NCT01393990|39395214|FG012|Overall Study|Progressive Disease|0|||
16248639|NCT01393990|39395215|FG013|Overall Study|Progressive Disease|1|||
16248640|NCT01393990|39395216|FG014|Overall Study|Progressive Disease|6|||
16248641|NCT01393990|39395217|FG015|Overall Study|Progressive Disease|1|||
16248642|NCT01393990|39395218|FG016|Overall Study|Progressive Disease|0|||
16248643|NCT01393990|39395219|FG017|Overall Study|Progressive Disease|0|||
16248644|NCT01393990|39395202|FG000|Overall Study|Death|0|||
16248645|NCT01393990|39395203|FG001|Overall Study|Death|0|||
16248646|NCT01393990|39395204|FG002|Overall Study|Death|0|||
16248647|NCT01393990|39395205|FG003|Overall Study|Death|0|||
16248648|NCT01393990|39395206|FG004|Overall Study|Death|1|||
16248649|NCT01393990|39395207|FG005|Overall Study|Death|0|||
16248650|NCT01393990|39395208|FG006|Overall Study|Death|0|||
16248651|NCT01393990|39395209|FG007|Overall Study|Death|0|||
16248652|NCT01393990|39395210|FG008|Overall Study|Death|0|||
16248653|NCT01393990|39395211|FG009|Overall Study|Death|0|||
16248654|NCT01393990|39395212|FG010|Overall Study|Death|0|||
16248655|NCT01393990|39395213|FG011|Overall Study|Death|0|||
16248656|NCT01393990|39395214|FG012|Overall Study|Death|0|||
16248657|NCT01393990|39395215|FG013|Overall Study|Death|1|||
16248658|NCT01393990|39395216|FG014|Overall Study|Death|1|||
16248659|NCT01393990|39395217|FG015|Overall Study|Death|0|||
16248660|NCT01393990|39395218|FG016|Overall Study|Death|0|||
16248661|NCT01393990|39395219|FG017|Overall Study|Death|0|||
16248662|NCT01393990|39395202|FG000|Overall Study|Withdrawal by Subject|0|||
16248663|NCT01393990|39395203|FG001|Overall Study|Withdrawal by Subject|0|||
16248664|NCT01393990|39395204|FG002|Overall Study|Withdrawal by Subject|0|||
16248665|NCT01393990|39395205|FG003|Overall Study|Withdrawal by Subject|0|||
16248666|NCT01393990|39395206|FG004|Overall Study|Withdrawal by Subject|0|||
16248667|NCT01393990|39395207|FG005|Overall Study|Withdrawal by Subject|0|||
16248668|NCT01393990|39395208|FG006|Overall Study|Withdrawal by Subject|0|||
16248669|NCT01393990|39395209|FG007|Overall Study|Withdrawal by Subject|0|||
16248670|NCT01393990|39395210|FG008|Overall Study|Withdrawal by Subject|0|||
16248671|NCT01393990|39395211|FG009|Overall Study|Withdrawal by Subject|0|||
16248672|NCT01393990|39395212|FG010|Overall Study|Withdrawal by Subject|0|||
16248673|NCT01393990|39395213|FG011|Overall Study|Withdrawal by Subject|0|||
16248674|NCT01393990|39395214|FG012|Overall Study|Withdrawal by Subject|0|||
16248675|NCT01393990|39395215|FG013|Overall Study|Withdrawal by Subject|0|||
16248676|NCT01393990|39395216|FG014|Overall Study|Withdrawal by Subject|1|||
16419523|NCT01439373|40015607|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
16248677|NCT01393990|39395217|FG015|Overall Study|Withdrawal by Subject|1|||
16248678|NCT01393990|39395218|FG016|Overall Study|Withdrawal by Subject|0|||
16248679|NCT01393990|39395219|FG017|Overall Study|Withdrawal by Subject|0|||
16248680|NCT02207621|39395220|FG000|Overall Study|Adverse Event|71|||
16248681|NCT02207621|39395221|FG001|Overall Study|Adverse Event|15|||
16248682|NCT02207621|39395222|FG002|Overall Study|Adverse Event|132|||
16248683|NCT02207621|39395220|FG000|Overall Study|Withdrawal by Subject|9|||
16248684|NCT02207621|39395221|FG001|Overall Study|Withdrawal by Subject|9|||
16248685|NCT02207621|39395222|FG002|Overall Study|Withdrawal by Subject|13|||
16248686|NCT02207621|39395220|FG000|Overall Study|Non-Compliant|3|||
16248687|NCT02207621|39395221|FG001|Overall Study|Non-Compliant|3|||
16358735|NCT02722967|39800338|FG001|Overall Study|Withdrawal by Subject|0|||
16419524|NCT01439373|40015608|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
16419525|NCT01746173|40015610|FG000|Overall Study|Disease Progression|2|||
16419526|NCT02461745|40015611|FG000|Overall Study|Lack of Efficacy|9|||
16358736|NCT02722967|39800339|FG002|Overall Study|Withdrawal by Subject|1|||
16358737|NCT02722967|39800337|FG000|Overall Study|Physician Decision|1|||
16358738|NCT02722967|39800338|FG001|Overall Study|Physician Decision|0|||
16358739|NCT02722967|39800339|FG002|Overall Study|Physician Decision|0|||
16358740|NCT02722967|39800337|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
16358741|NCT02722967|39800338|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
16358742|NCT02722967|39800339|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
16358743|NCT03312738|39800342|FG000|Overall Study|Progressive disease|58|||
16358744|NCT03312738|39800343|FG001|Overall Study|Progressive disease|67|||
16358745|NCT03312738|39800342|FG000|Overall Study|Patient/guardian decision|13|||
16358746|NCT03312738|39800343|FG001|Overall Study|Patient/guardian decision|5|||
16358747|NCT03312738|39800342|FG000|Overall Study|Adverse Event|5|||
16358748|NCT03312738|39800343|FG001|Overall Study|Adverse Event|3|||
16358749|NCT03312738|39800342|FG000|Overall Study|Protocol deviation|2|||
16358750|NCT03312738|39800343|FG001|Overall Study|Protocol deviation|0|||
16358751|NCT03312738|39800342|FG000|Overall Study|Technical problems|0|||
16358752|NCT03312738|39800343|FG001|Overall Study|Technical problems|1|||
16358753|NCT03312738|39800342|FG000|Overall Study|Physician Decision|2|||
16358754|NCT03312738|39800343|FG001|Overall Study|Physician Decision|3|||
16358755|NCT01668797|39800346|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
16358756|NCT01668797|39800347|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
16358757|NCT01668797|39800348|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
16358758|NCT01668797|39800349|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
16358759|NCT01668797|39800346|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
16358760|NCT01668797|39800347|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
16358761|NCT01668797|39800348|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
16358762|NCT01668797|39800349|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
16358763|NCT01668797|39800346|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
16358764|NCT01668797|39800347|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
16358765|NCT01668797|39800348|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
16358766|NCT01668797|39800349|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
16358767|NCT01668797|39800346|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
16358768|NCT01668797|39800347|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
16358769|NCT01668797|39800348|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
16358770|NCT01668797|39800349|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
16358771|NCT01668797|39800346|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
16358772|NCT01668797|39800347|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
16358773|NCT01668797|39800348|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
16358774|NCT01668797|39800349|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
16358775|NCT01668797|39800346|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
16358776|NCT01668797|39800347|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
16358777|NCT01668797|39800348|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
16419527|NCT02461745|40015612|FG001|Overall Study|Lack of Efficacy|1|||
16562251|NCT01089556|40525369|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
16358778|NCT01668797|39800349|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
16419528|NCT02461745|40015611|FG000|Overall Study|Lost to Follow-up|2|||
16358779|NCT01668797|39800346|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
16358780|NCT01668797|39800347|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
16358781|NCT01668797|39800348|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
16358782|NCT01668797|39800349|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
16358783|NCT01668797|39800346|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
16358784|NCT01668797|39800347|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
16358785|NCT01668797|39800348|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
16358786|NCT01668797|39800349|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
16358787|NCT01668797|39800346|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
16358788|NCT01668797|39800347|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
16358789|NCT01668797|39800348|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
16358790|NCT01668797|39800349|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
16358791|NCT01668797|39800346|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
16358792|NCT01668797|39800347|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
16358793|NCT01668797|39800348|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
16358794|NCT01668797|39800349|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
16358795|NCT01668797|39800346|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
16358796|NCT01668797|39800347|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
16358797|NCT01668797|39800348|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
16358798|NCT01668797|39800349|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
16358799|NCT01668797|39800346|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
16358800|NCT01668797|39800347|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
16358801|NCT01668797|39800348|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
16358802|NCT01668797|39800349|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
16358803|NCT01668797|39800346|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
16358804|NCT01668797|39800347|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
16358805|NCT01668797|39800348|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
16358806|NCT01668797|39800349|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
16358807|NCT01668797|39800346|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
16358808|NCT01668797|39800347|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
16358809|NCT01668797|39800348|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
16358810|NCT01668797|39800349|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
16358811|NCT01668797|39800346|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
16358812|NCT01668797|39800347|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
16358813|NCT01668797|39800348|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
16358814|NCT01668797|39800349|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
16358815|NCT01668797|39800346|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
16358816|NCT01668797|39800347|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
16358817|NCT01668797|39800348|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
16358818|NCT01668797|39800349|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
16358819|NCT01668797|39800346|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
16248688|NCT02207621|39395222|FG002|Overall Study|Non-Compliant|1|||
16248689|NCT02207621|39395220|FG000|Overall Study|Lost to Follow-up|1|||
16248690|NCT02207621|39395221|FG001|Overall Study|Lost to Follow-up|0|||
16248691|NCT02207621|39395222|FG002|Overall Study|Lost to Follow-up|3|||
16248692|NCT02207621|39395220|FG000|Overall Study|Lack of Efficacy|10|||
16419529|NCT02461745|40015612|FG001|Overall Study|Lost to Follow-up|2|||
16419530|NCT02461745|40015611|FG000|Overall Study|Withdrawal by Subject|3|||
16419531|NCT02461745|40015612|FG001|Overall Study|Withdrawal by Subject|1|||
16419532|NCT02428205|40015613|FG000|Overall Study|Lack of Efficacy|1|||
16419533|NCT02428205|40015614|FG001|Overall Study|Lack of Efficacy|0|||
16419534|NCT02428205|40015613|FG000|Overall Study|Lost to Follow-up|1|||
16419535|NCT02428205|40015614|FG001|Overall Study|Lost to Follow-up|1|||
16419536|NCT02428205|40015613|FG000|Overall Study|Worse behavior|0|||
16419537|NCT02428205|40015614|FG001|Overall Study|Worse behavior|1|||
16419538|NCT02607228|40015617|FG000|Overall Study|Progressive Disease|4|||
16419539|NCT02607228|40015618|FG001|Overall Study|Progressive Disease|3|||
16419540|NCT02607228|40015619|FG002|Overall Study|Progressive Disease|1|||
16419541|NCT02607228|40015620|FG003|Overall Study|Progressive Disease|5|||
16248693|NCT02207621|39395221|FG001|Overall Study|Lack of Efficacy|2|||
16248694|NCT02207621|39395222|FG002|Overall Study|Lack of Efficacy|4|||
16248695|NCT02207621|39395220|FG000|Overall Study|Disallowed Concurrent Medication|2|||
16248696|NCT02207621|39395221|FG001|Overall Study|Disallowed Concurrent Medication|5|||
16419542|NCT02607228|40015621|FG004|Overall Study|Progressive Disease|4|||
16419543|NCT02607228|40015622|FG005|Overall Study|Progressive Disease|3|||
16419544|NCT02607228|40015623|FG006|Overall Study|Progressive Disease|1|||
16248697|NCT02207621|39395222|FG002|Overall Study|Disallowed Concurrent Medication|2|||
16248698|NCT02207621|39395220|FG000|Overall Study|Physician Decision|1|||
16248699|NCT02207621|39395221|FG001|Overall Study|Physician Decision|2|||
16248700|NCT02207621|39395222|FG002|Overall Study|Physician Decision|2|||
16248701|NCT02207621|39395220|FG000|Overall Study|Protocol Violation|4|||
16248702|NCT02207621|39395221|FG001|Overall Study|Protocol Violation|10|||
16248703|NCT02207621|39395222|FG002|Overall Study|Protocol Violation|6|||
16248704|NCT02207621|39395220|FG000|Overall Study|Death|2|||
16248705|NCT02207621|39395221|FG001|Overall Study|Death|0|||
16248706|NCT02207621|39395222|FG002|Overall Study|Death|0|||
16248707|NCT02207621|39395220|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
16248708|NCT02207621|39395221|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
16248709|NCT02207621|39395222|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
16248710|NCT03565211|39395223|FG000|Overall Study|Withdrawal by Subject|2|||
16248711|NCT03565211|39395223|FG000|Overall Study|Lost to Follow-up|1|||
16248712|NCT03565211|39395223|FG000|Overall Study|Adverse Event|44|||
16248713|NCT03565211|39395223|FG000|Overall Study|Personal issues|1|||
16248714|NCT00329602|39395224|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
16248715|NCT00329602|39395225|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
16248716|NCT00329602|39395226|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
16419545|NCT02607228|40015617|FG000|Overall Study|Adverse Event|1|||
16419546|NCT02607228|40015618|FG001|Overall Study|Adverse Event|0|||
16419547|NCT02607228|40015619|FG002|Overall Study|Adverse Event|1|||
16419548|NCT02607228|40015620|FG003|Overall Study|Adverse Event|0|||
16130696|NCT01598311|38967108|FG000|Overall Study|Adverse Event|9|||
16248717|NCT00329602|39395224|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
16248718|NCT00329602|39395225|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
16248719|NCT00329602|39395226|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
16248720|NCT00329602|39395224|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
16419549|NCT02607228|40015621|FG004|Overall Study|Adverse Event|1|||
16248721|NCT00329602|39395225|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
16358820|NCT01668797|39800347|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
16358821|NCT01668797|39800348|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
16358822|NCT01668797|39800349|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
16358823|NCT01668797|39800346|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
16358824|NCT01668797|39800347|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
16358825|NCT01668797|39800348|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
16358826|NCT01668797|39800349|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
16358827|NCT01668797|39800346|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
16358828|NCT01668797|39800347|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
16358829|NCT01668797|39800348|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
16358830|NCT01668797|39800349|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
16358831|NCT01668797|39800346|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
16358832|NCT01668797|39800347|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
16358833|NCT01668797|39800348|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
16358834|NCT01668797|39800349|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
16358835|NCT01668797|39800346|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
16358836|NCT01668797|39800347|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
16358837|NCT01668797|39800348|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
16358838|NCT01668797|39800349|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
16358839|NCT01668797|39800346|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
16358840|NCT01668797|39800347|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
16358841|NCT01668797|39800348|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
16358842|NCT01668797|39800349|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
16358843|NCT01668797|39800346|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
16358844|NCT01668797|39800347|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
16358845|NCT01668797|39800348|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
16358846|NCT01668797|39800349|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
16358847|NCT01668797|39800346|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
16358848|NCT01668797|39800347|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
16358849|NCT01668797|39800348|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
16358850|NCT01668797|39800349|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
16358851|NCT01668797|39800346|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
16358852|NCT01668797|39800347|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
16358853|NCT01668797|39800348|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
16358854|NCT01668797|39800349|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
16358855|NCT00062166|39800352|FG000|Overall Study|Withdrawal by Subject|6|||
16358856|NCT01369433|39800354|FG000|Overall Study|Adverse Event|31|||
16358857|NCT01369433|39800355|FG001|Overall Study|Adverse Event|1|||
16358858|NCT01369433|39800354|FG000|Overall Study|Required significant surgical procedure|1|||
16358859|NCT01369433|39800355|FG001|Overall Study|Required significant surgical procedure|0|||
16358860|NCT01369433|39800354|FG000|Overall Study|Non-compliance|1|||
16358861|NCT01369433|39800355|FG001|Overall Study|Non-compliance|0|||
16358862|NCT01369433|39800354|FG000|Overall Study|Withdrawal by Subject|5|||
16358863|NCT01369433|39800355|FG001|Overall Study|Withdrawal by Subject|2|||
16358864|NCT01369433|39800354|FG000|Overall Study|Study terminated by Sponsor|67|||
16358865|NCT01369433|39800355|FG001|Overall Study|Study terminated by Sponsor|0|||
16358866|NCT01369433|39800354|FG000|Overall Study|Lost to Follow-up|1|||
16358867|NCT01369433|39800355|FG001|Overall Study|Lost to Follow-up|0|||
16358868|NCT01369433|39800354|FG000|Overall Study|Death|5|||
16358869|NCT01369433|39800355|FG001|Overall Study|Death|0|||
16358870|NCT01369433|39800354|FG000|Overall Study|Investigator discretion|6|||
16358871|NCT01369433|39800355|FG001|Overall Study|Investigator discretion|1|||
16358872|NCT01369433|39800354|FG000|Overall Study|Progressive Disease|92|||
16358873|NCT01369433|39800355|FG001|Overall Study|Progressive Disease|12|||
16358874|NCT03504917|39800366|FG000|Blinded Treatment Period|Protocol Violation|1|||
16358875|NCT03504917|39800367|FG001|Blinded Treatment Period|Protocol Violation|0|||
16358876|NCT03504917|39800366|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
16358877|NCT03504917|39800367|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
16358878|NCT03504917|39800366|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
16358879|NCT03504917|39800367|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
16358880|NCT03504917|39800366|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
16358881|NCT03504917|39800367|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
16358882|NCT03504917|39800366|FG000|Blinded Treatment Period|Adverse Event|4|||
16358883|NCT03504917|39800367|FG001|Blinded Treatment Period|Adverse Event|4|||
16358884|NCT03504917|39800366|FG000|Blinded Treatment Period|Physician Decision|1|||
16358885|NCT03504917|39800367|FG001|Blinded Treatment Period|Physician Decision|0|||
16358886|NCT03504917|39800366|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
16358887|NCT03504917|39800367|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
16358888|NCT03504917|39800366|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
16358889|NCT03504917|39800367|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
16358890|NCT03504917|39800366|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
16358891|NCT03504917|39800367|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
16358892|NCT03504917|39800366|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
16358893|NCT03504917|39800367|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
16358894|NCT03504917|39800366|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
16358895|NCT03504917|39800367|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
16358896|NCT03504917|39800366|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
16358897|NCT03504917|39800367|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
16358898|NCT03504917|39800366|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
16358899|NCT03504917|39800367|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
16358900|NCT03504917|39800366|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
16358901|NCT03504917|39800367|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
16358902|NCT03504917|39800366|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
16358903|NCT03504917|39800367|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
16358904|NCT03504917|39800366|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
16358905|NCT03504917|39800367|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
16358906|NCT00487188|39800369|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
16358907|NCT00487188|39800370|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
16358908|NCT00487188|39800371|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
16358909|NCT00487188|39800369|FG000|Induction Phase|Adverse Event|5|||
16358910|NCT00487188|39800370|FG001|Induction Phase|Adverse Event|0|||
16358911|NCT00487188|39800371|FG002|Induction Phase|Adverse Event|0|||
16358912|NCT00487188|39800369|FG000|Induction Phase|Lack of Efficacy|0|||
16358913|NCT00487188|39800370|FG001|Induction Phase|Lack of Efficacy|1|||
16358914|NCT00487188|39800371|FG002|Induction Phase|Lack of Efficacy|0|||
16358915|NCT00487188|39800369|FG000|Induction Phase|Protocol Violation|1|||
16358916|NCT00487188|39800370|FG001|Induction Phase|Protocol Violation|0|||
16358917|NCT00487188|39800371|FG002|Induction Phase|Protocol Violation|0|||
16358918|NCT00487188|39800369|FG000|Induction Phase|Refused Treatment|1|||
16358919|NCT00487188|39800370|FG001|Induction Phase|Refused Treatment|2|||
16358920|NCT00487188|39800371|FG002|Induction Phase|Refused Treatment|0|||
16358921|NCT00487188|39800369|FG000|Induction Phase|Lost to Follow-up|2|||
16358922|NCT00487188|39800370|FG001|Induction Phase|Lost to Follow-up|2|||
16358923|NCT00487188|39800371|FG002|Induction Phase|Lost to Follow-up|0|||
16358924|NCT00487188|39800369|FG000|Induction Phase|Administrative|0|||
16358925|NCT00487188|39800370|FG001|Induction Phase|Administrative|1|||
16358926|NCT00487188|39800371|FG002|Induction Phase|Administrative|0|||
16358927|NCT00487188|39800369|FG000|Maintenance Phase|Adverse Event|1|||
16358928|NCT00487188|39800370|FG001|Maintenance Phase|Adverse Event|0|||
16358929|NCT00487188|39800371|FG002|Maintenance Phase|Adverse Event|0|||
16358930|NCT00487188|39800369|FG000|Maintenance Phase|Death|1|||
16358931|NCT00487188|39800370|FG001|Maintenance Phase|Death|0|||
16358932|NCT00487188|39800371|FG002|Maintenance Phase|Death|0|||
16358933|NCT00487188|39800369|FG000|Maintenance Phase|Lost to Follow-up|1|||
16358934|NCT00487188|39800370|FG001|Maintenance Phase|Lost to Follow-up|0|||
16358935|NCT00487188|39800371|FG002|Maintenance Phase|Lost to Follow-up|0|||
16358936|NCT00487188|39800369|FG000|Maintenance Phase|Administrative|0|||
16358937|NCT00487188|39800370|FG001|Maintenance Phase|Administrative|0|||
16358938|NCT00487188|39800371|FG002|Maintenance Phase|Administrative|1|||
16358939|NCT00537277|39800372|FG000|Overall Study|Adverse Event|1|||
16358940|NCT00537277|39800372|FG000|Overall Study|Lack of Efficacy|2|||
16358941|NCT00537277|39800372|FG000|Overall Study|Lost to Follow-up|12|||
16358942|NCT00537277|39800372|FG000|Overall Study|Protocol Violation|11|||
16358943|NCT00537277|39800372|FG000|Overall Study|Unclassified|4|||
16358944|NCT00537277|39800372|FG000|Overall Study|Inability to tolerate trial medication|4|||
16358945|NCT00537277|39800372|FG000|Overall Study|Non-compliance with trial procedures|15|||
16358946|NCT04889040|39800373|FG000|Overall Study|Withdrawal by Subject|3|||
16358947|NCT04889040|39800374|FG001|Overall Study|Withdrawal by Subject|3|||
16358948|NCT04889040|39800373|FG000|Overall Study|Lost to Follow-up|0|||
16419550|NCT02607228|40015622|FG005|Overall Study|Adverse Event|1|||
16419551|NCT02607228|40015623|FG006|Overall Study|Adverse Event|1|||
16419552|NCT02607228|40015617|FG000|Overall Study|Investigator's Discretion|0|||
16358949|NCT04889040|39800374|FG001|Overall Study|Lost to Follow-up|1|||
16358950|NCT04889040|39800373|FG000|Overall Study|Adverse Event|2|||
16358951|NCT04889040|39800374|FG001|Overall Study|Adverse Event|1|||
16358952|NCT00626639|39800377|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
16358953|NCT00626639|39800378|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
16358954|NCT01981616|39800379|FG000|Overall Study|Adverse Event|0|||
16358955|NCT01981616|39800380|FG001|Overall Study|Adverse Event|1|||
16358956|NCT01981616|39800379|FG000|Overall Study|Protocol Violation|1|||
16358957|NCT01981616|39800380|FG001|Overall Study|Protocol Violation|0|||
16358958|NCT01240382|39800381|FG000|Overall Study|Adverse Event|2|||
16358959|NCT01240382|39800382|FG001|Overall Study|Adverse Event|1|||
16358960|NCT01240382|39800381|FG000|Overall Study|Lack of Efficacy|0|||
16358961|NCT01240382|39800382|FG001|Overall Study|Lack of Efficacy|2|||
16358962|NCT01240382|39800381|FG000|Overall Study|Fear of adverse events|0|||
16358963|NCT01240382|39800382|FG001|Overall Study|Fear of adverse events|1|||
16358964|NCT02550795|39800383|FG000|Overall Study|Physician Decision|0|||
16358965|NCT02550795|39800384|FG001|Overall Study|Physician Decision|1|||
16358966|NCT02550795|39800385|FG002|Overall Study|Physician Decision|0|||
16358967|NCT00729586|39800386|FG000|Overall Study|Ineligible|0|||
16358968|NCT00729586|39800387|FG001|Overall Study|Ineligible|1|||
16358969|NCT00729586|39800386|FG000|Overall Study|never treated|1|||
16358970|NCT00729586|39800387|FG001|Overall Study|never treated|0|||
16358971|NCT03329885|39800394|FG000|Overall Study|Sponsor discontinued the study early|0|||
16358972|NCT03329885|39800395|FG001|Overall Study|Sponsor discontinued the study early|0|||
16358973|NCT03329885|39800396|FG002|Overall Study|Sponsor discontinued the study early|0|||
16358974|NCT03329885|39800397|FG003|Overall Study|Sponsor discontinued the study early|0|||
16358975|NCT03329885|39800398|FG004|Overall Study|Sponsor discontinued the study early|0|||
16358976|NCT03329885|39800399|FG005|Overall Study|Sponsor discontinued the study early|0|||
16358977|NCT03329885|39800400|FG006|Overall Study|Sponsor discontinued the study early|1|||
16358978|NCT03329885|39800401|FG007|Overall Study|Sponsor discontinued the study early|1|||
16358979|NCT03329885|39800402|FG008|Overall Study|Sponsor discontinued the study early|0|||
16358980|NCT01316614|39800403|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
16358981|NCT01316614|39800403|FG000|Overall Study|Cytology slides not available for review|4|||
16358982|NCT01316614|39800403|FG000|Overall Study|Cystic lesion|5|||
16358983|NCT01316614|39800403|FG000|Overall Study|Inadequate number of passes|2|||
16358984|NCT01316614|39800403|FG000|Overall Study|Medically unstable|1|||
16358985|NCT00748241|39800404|FG000|Overall Study|Implant failure|1|||
16358986|NCT00748241|39800404|FG000|Overall Study|Lost to Follow-up|5|||
16358987|NCT00748241|39800404|FG000|Overall Study|Death|2|||
16358988|NCT01184872|39800405|FG000|Overall Study|Adverse Event|3|||
16358989|NCT01184872|39800406|FG001|Overall Study|Adverse Event|4|||
16358990|NCT01184872|39800405|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
16358991|NCT01184872|39800406|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16358992|NCT01184872|39800405|FG000|Overall Study|Withdrawal by Subject|2|||
16358993|NCT01184872|39800406|FG001|Overall Study|Withdrawal by Subject|0|||
16358994|NCT01184872|39800405|FG000|Overall Study|Lost to Follow-up|0|||
16358995|NCT01184872|39800406|FG001|Overall Study|Lost to Follow-up|1|||
16358996|NCT01184872|39800405|FG000|Overall Study|Administrative problems|1|||
16358997|NCT01184872|39800406|FG001|Overall Study|Administrative problems|1|||
16358998|NCT01184872|39800405|FG000|Overall Study|Protocol deviation|1|||
16358999|NCT01184872|39800406|FG001|Overall Study|Protocol deviation|0|||
16359000|NCT03863353|39800407|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
16359001|NCT03863353|39800408|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
16359002|NCT03738696|39800409|FG000|Overall Study|Withdrawal by Subject|0|||
16359003|NCT03738696|39800410|FG001|Overall Study|Withdrawal by Subject|1|||
16359004|NCT03738696|39800409|FG000|Overall Study|Lost to Follow-up|8|||
16359005|NCT03738696|39800410|FG001|Overall Study|Lost to Follow-up|14|||
16359006|NCT00094445|39800420|FG000|Overall Study|Withdrawal by Subject|3|||
16359007|NCT00094445|39800420|FG000|Overall Study|Lost to Follow-up|1|||
16359008|NCT00094445|39800420|FG000|Overall Study|Progressive Disease|2|||
16359009|NCT00671749|39800421|FG000|Overall Study|Adverse Event|2|||
16359010|NCT00671749|39800421|FG000|Overall Study|Withdrawal by Subject|4|||
16359011|NCT00671749|39800421|FG000|Overall Study|Protocol Violation|1|||
16359012|NCT00671749|39800421|FG000|Overall Study|Lost to Follow-up|1|||
16359013|NCT03451045|39800422|FG000|Overall Study|Lack of Efficacy|3|||
16359014|NCT03451045|39800423|FG001|Overall Study|Lack of Efficacy|2|||
16359015|NCT03451045|39800424|FG002|Overall Study|Lack of Efficacy|2|||
16359016|NCT03451045|39800422|FG000|Overall Study|Physician Decision|1|||
16359017|NCT03451045|39800423|FG001|Overall Study|Physician Decision|1|||
16359018|NCT03451045|39800424|FG002|Overall Study|Physician Decision|1|||
16359019|NCT03451045|39800422|FG000|Overall Study|Withdrawal by Subject|4|||
16359020|NCT03451045|39800423|FG001|Overall Study|Withdrawal by Subject|0|||
16359021|NCT03451045|39800424|FG002|Overall Study|Withdrawal by Subject|5|||
16419553|NCT02607228|40015618|FG001|Overall Study|Investigator's Discretion|0|||
16419554|NCT02607228|40015619|FG002|Overall Study|Investigator's Discretion|1|||
16359022|NCT03451045|39800422|FG000|Overall Study|Pregnancy|0|||
16359023|NCT03451045|39800423|FG001|Overall Study|Pregnancy|0|||
16359024|NCT03451045|39800424|FG002|Overall Study|Pregnancy|2|||
16359025|NCT03451045|39800422|FG000|Overall Study|Adverse Event|7|||
16359026|NCT03451045|39800423|FG001|Overall Study|Adverse Event|1|||
16359027|NCT03451045|39800424|FG002|Overall Study|Adverse Event|3|||
16359028|NCT03451045|39800422|FG000|Overall Study|Non-compliance with study|2|||
16359029|NCT03451045|39800423|FG001|Overall Study|Non-compliance with study|0|||
16359030|NCT03451045|39800424|FG002|Overall Study|Non-compliance with study|1|||
16359031|NCT03451045|39800422|FG000|Overall Study|any other reason|10|||
16359032|NCT03451045|39800423|FG001|Overall Study|any other reason|2|||
16359033|NCT03451045|39800424|FG002|Overall Study|any other reason|13|||
16359034|NCT00764790|39800430|FG000|Overall Study|Protocol Violation|0|||
16359035|NCT00764790|39800431|FG001|Overall Study|Protocol Violation|0|||
16359036|NCT00764790|39800432|FG002|Overall Study|Protocol Violation|1|||
16359037|NCT00764790|39800430|FG000|Overall Study|Withdrawal by Subject|10|||
16359038|NCT00764790|39800431|FG001|Overall Study|Withdrawal by Subject|12|||
16359039|NCT00764790|39800432|FG002|Overall Study|Withdrawal by Subject|6|||
16359040|NCT00764790|39800430|FG000|Overall Study|Lost to Follow-up|28|||
16359041|NCT00764790|39800431|FG001|Overall Study|Lost to Follow-up|29|||
16359042|NCT00764790|39800432|FG002|Overall Study|Lost to Follow-up|23|||
16359043|NCT00300053|39800433|FG000|Overall Study|Patient/Caregiver Preference|2|||
16359044|NCT00300053|39800434|FG001|Overall Study|Patient/Caregiver Preference|2|||
16359045|NCT00300053|39800435|FG002|Overall Study|Patient/Caregiver Preference|3|||
16359046|NCT00300053|39800433|FG000|Overall Study|Death|0|||
16359047|NCT00300053|39800434|FG001|Overall Study|Death|0|||
16359048|NCT00300053|39800435|FG002|Overall Study|Death|3|||
16359049|NCT00300053|39800433|FG000|Overall Study|Lost to Follow-up|0|||
16359050|NCT00300053|39800434|FG001|Overall Study|Lost to Follow-up|1|||
16359051|NCT00300053|39800435|FG002|Overall Study|Lost to Follow-up|0|||
16359052|NCT00420745|39800436|FG000|Overall Study|Adverse Event|2|||
16359053|NCT00420745|39800437|FG001|Overall Study|Adverse Event|2|||
16359054|NCT00420745|39800436|FG000|Overall Study|Lost to Follow-up|10|||
16359055|NCT00420745|39800437|FG001|Overall Study|Lost to Follow-up|2|||
16359056|NCT00420745|39800436|FG000|Overall Study|Protocol Violation|1|||
16359057|NCT00420745|39800437|FG001|Overall Study|Protocol Violation|0|||
16359058|NCT00420745|39800436|FG000|Overall Study|Physician Decision|1|||
16359059|NCT00420745|39800437|FG001|Overall Study|Physician Decision|1|||
16359060|NCT00420745|39800436|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
16359061|NCT00420745|39800437|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
16359062|NCT00420745|39800436|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
16359063|NCT00420745|39800437|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
16359064|NCT03167242|39800438|FG000|Overall Study|Patient/Guardian Decision|0|||
16359065|NCT03167242|39800439|FG001|Overall Study|Patient/Guardian Decision|1|||
16359066|NCT03167242|39800440|FG002|Overall Study|Patient/Guardian Decision|2|||
16359067|NCT03167242|39800441|FG003|Overall Study|Patient/Guardian Decision|1|||
16359068|NCT03167242|39800442|FG004|Overall Study|Patient/Guardian Decision|1|||
16359069|NCT03167242|39800443|FG005|Overall Study|Patient/Guardian Decision|1|||
16359070|NCT03167242|39800444|FG006|Overall Study|Patient/Guardian Decision|0|||
16359071|NCT03167242|39800445|FG007|Overall Study|Patient/Guardian Decision|0|||
16359072|NCT03167242|39800446|FG008|Overall Study|Patient/Guardian Decision|0|||
16359073|NCT03167242|39800447|FG009|Overall Study|Patient/Guardian Decision|0|||
16359074|NCT03167242|39800448|FG010|Overall Study|Patient/Guardian Decision|1|||
16359075|NCT03167242|39800449|FG011|Overall Study|Patient/Guardian Decision|0|||
16359076|NCT03167242|39800438|FG000|Overall Study|Lost to Follow-up|0|||
16359077|NCT03167242|39800439|FG001|Overall Study|Lost to Follow-up|0|||
16359078|NCT03167242|39800440|FG002|Overall Study|Lost to Follow-up|1|||
16359079|NCT03167242|39800441|FG003|Overall Study|Lost to Follow-up|0|||
16359080|NCT03167242|39800442|FG004|Overall Study|Lost to Follow-up|0|||
16359081|NCT03167242|39800443|FG005|Overall Study|Lost to Follow-up|1|||
16359082|NCT03167242|39800444|FG006|Overall Study|Lost to Follow-up|2|||
16359083|NCT03167242|39800445|FG007|Overall Study|Lost to Follow-up|1|||
16359084|NCT03167242|39800446|FG008|Overall Study|Lost to Follow-up|0|||
16359085|NCT03167242|39800447|FG009|Overall Study|Lost to Follow-up|0|||
16359086|NCT03167242|39800448|FG010|Overall Study|Lost to Follow-up|1|||
16359087|NCT03167242|39800449|FG011|Overall Study|Lost to Follow-up|1|||
16359088|NCT03167242|39800438|FG000|Overall Study|Reason not provided|0|||
16359089|NCT03167242|39800439|FG001|Overall Study|Reason not provided|0|||
16359090|NCT03167242|39800440|FG002|Overall Study|Reason not provided|0|||
16359091|NCT03167242|39800441|FG003|Overall Study|Reason not provided|0|||
16359092|NCT03167242|39800442|FG004|Overall Study|Reason not provided|0|||
16359093|NCT03167242|39800443|FG005|Overall Study|Reason not provided|0|||
16359094|NCT03167242|39800444|FG006|Overall Study|Reason not provided|0|||
16359095|NCT03167242|39800445|FG007|Overall Study|Reason not provided|0|||
16359096|NCT03167242|39800446|FG008|Overall Study|Reason not provided|1|||
16359097|NCT03167242|39800447|FG009|Overall Study|Reason not provided|0|||
16359098|NCT03167242|39800448|FG010|Overall Study|Reason not provided|0|||
16359099|NCT03167242|39800449|FG011|Overall Study|Reason not provided|0|||
16359100|NCT02471339|39800452|FG000|Overall Study|Did not provide follow-up data|2|||
16359101|NCT02471339|39800453|FG001|Overall Study|Did not provide follow-up data|0|||
16359102|NCT00251758|39800454|FG000|Overall Study|Adverse Event|7|||
16359103|NCT00251758|39800455|FG001|Overall Study|Adverse Event|9|||
16359104|NCT00251758|39800456|FG002|Overall Study|Adverse Event|11|||
16359105|NCT00251758|39800454|FG000|Overall Study|Lost to Follow-up|4|||
16359106|NCT00251758|39800455|FG001|Overall Study|Lost to Follow-up|2|||
16359107|NCT00251758|39800456|FG002|Overall Study|Lost to Follow-up|5|||
16359108|NCT00251758|39800454|FG000|Overall Study|Withdrawal by Subject|13|||
16359109|NCT00251758|39800455|FG001|Overall Study|Withdrawal by Subject|7|||
16359110|NCT00251758|39800456|FG002|Overall Study|Withdrawal by Subject|3|||
16359111|NCT00251758|39800454|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
16359112|NCT00251758|39800455|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
16359113|NCT00251758|39800456|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
16359114|NCT00251758|39800454|FG000|Overall Study|Lack of Efficacy|3|||
16359115|NCT00251758|39800455|FG001|Overall Study|Lack of Efficacy|0|||
16359116|NCT00251758|39800456|FG002|Overall Study|Lack of Efficacy|0|||
16359117|NCT00251758|39800454|FG000|Overall Study|Noncompliant|0|||
16359118|NCT00251758|39800455|FG001|Overall Study|Noncompliant|2|||
16359119|NCT00251758|39800456|FG002|Overall Study|Noncompliant|2|||
16359120|NCT00251758|39800454|FG000|Overall Study|Pregnancy|0|||
16359121|NCT00251758|39800455|FG001|Overall Study|Pregnancy|1|||
16359122|NCT00251758|39800456|FG002|Overall Study|Pregnancy|0|||
16359123|NCT00251758|39800454|FG000|Overall Study|Per Subject Request|0|||
16359124|NCT00251758|39800455|FG001|Overall Study|Per Subject Request|0|||
16359125|NCT00251758|39800456|FG002|Overall Study|Per Subject Request|1|||
16359126|NCT00251758|39800454|FG000|Overall Study|Per Investigator Request|1|||
16359127|NCT00251758|39800455|FG001|Overall Study|Per Investigator Request|0|||
16359128|NCT00251758|39800456|FG002|Overall Study|Per Investigator Request|0|||
16359129|NCT01704261|39800457|FG000|Overall Study|Withdrawal by Subject|12|||
16359130|NCT01704261|39800458|FG001|Overall Study|Withdrawal by Subject|15|||
16359131|NCT01704261|39800457|FG000|Overall Study|Lost to Follow-up|1|||
16359132|NCT01704261|39800458|FG001|Overall Study|Lost to Follow-up|0|||
16359133|NCT03257267|39800460|FG000|Overall Study|Adverse Event|17|||
16359134|NCT03257267|39800461|FG001|Overall Study|Adverse Event|7|||
16359135|NCT03257267|39800460|FG000|Overall Study|Death|96|||
16359136|NCT03257267|39800461|FG001|Overall Study|Death|98|||
16359137|NCT03257267|39800460|FG000|Overall Study|Lost to Follow-up|2|||
16359138|NCT03257267|39800461|FG001|Overall Study|Lost to Follow-up|2|||
16359139|NCT03257267|39800460|FG000|Overall Study|Non-compliance with Study Drug|0|||
16359140|NCT03257267|39800461|FG001|Overall Study|Non-compliance with Study Drug|2|||
16359141|NCT03257267|39800460|FG000|Overall Study|Participant Decision|35|||
16359142|NCT03257267|39800461|FG001|Overall Study|Participant Decision|43|||
16359143|NCT03257267|39800460|FG000|Overall Study|Sponsor Decision|1|||
16359144|NCT03257267|39800461|FG001|Overall Study|Sponsor Decision|0|||
16359145|NCT03257267|39800460|FG000|Overall Study|Physician Decision|1|||
16359146|NCT03257267|39800461|FG001|Overall Study|Physician Decision|3|||
16359147|NCT03257267|39800460|FG000|Overall Study|Disease Progression|109|||
16359148|NCT03257267|39800461|FG001|Overall Study|Disease Progression|121|||
16359149|NCT03257267|39800460|FG000|Overall Study|Withdrawal by Subject|8|||
16359150|NCT03257267|39800461|FG001|Overall Study|Withdrawal by Subject|26|||
16359151|NCT03257267|39800460|FG000|Overall Study|Other|0|||
16359152|NCT03257267|39800461|FG001|Overall Study|Other|2|||
16359153|NCT00717886|39800464|FG000|Overall Study|Withdrawal by Subject|3|||
16359154|NCT00717886|39800464|FG000|Overall Study|Treatment Failure|1|||
16359155|NCT01715285|39800465|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
16359156|NCT01715285|39800466|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
16419555|NCT02607228|40015620|FG003|Overall Study|Investigator's Discretion|0|||
16419556|NCT02607228|40015621|FG004|Overall Study|Investigator's Discretion|0|||
16419557|NCT02607228|40015622|FG005|Overall Study|Investigator's Discretion|1|||
16419558|NCT02607228|40015623|FG006|Overall Study|Investigator's Discretion|0|||
16419559|NCT02607228|40015617|FG000|Overall Study|Withdrew Consent|0|||
16419560|NCT02607228|40015618|FG001|Overall Study|Withdrew Consent|1|||
16419561|NCT02607228|40015619|FG002|Overall Study|Withdrew Consent|0|||
16359157|NCT01715285|39800467|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
16359158|NCT01715285|39800465|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
16359159|NCT01715285|39800466|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
16359160|NCT01715285|39800467|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
16359161|NCT01715285|39800465|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
16419562|NCT02607228|40015620|FG003|Overall Study|Withdrew Consent|0|||
16419563|NCT02607228|40015621|FG004|Overall Study|Withdrew Consent|0|||
16359162|NCT01715285|39800466|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
16419564|NCT02607228|40015622|FG005|Overall Study|Withdrew Consent|1|||
16419565|NCT02607228|40015623|FG006|Overall Study|Withdrew Consent|0|||
16419566|NCT02607228|40015617|FG000|Overall Study|Study Terminated by Sponsor|0|||
16419567|NCT02607228|40015618|FG001|Overall Study|Study Terminated by Sponsor|0|||
16419568|NCT02607228|40015619|FG002|Overall Study|Study Terminated by Sponsor|0|||
16419569|NCT02607228|40015620|FG003|Overall Study|Study Terminated by Sponsor|1|||
16419570|NCT02607228|40015621|FG004|Overall Study|Study Terminated by Sponsor|0|||
16419571|NCT02607228|40015622|FG005|Overall Study|Study Terminated by Sponsor|0|||
16419572|NCT02607228|40015623|FG006|Overall Study|Study Terminated by Sponsor|0|||
16419573|NCT03244826|40015624|FG000|Overall Study|Withdrawal by Subject|2|||
16562252|NCT01089556|40525370|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
16562253|NCT01089556|40525371|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
16562254|NCT01089556|40525372|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
16562255|NCT01089556|40525367|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
16562256|NCT01089556|40525368|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
16562257|NCT01089556|40525369|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
16130697|NCT01598311|38967109|FG001|Overall Study|Adverse Event|13|||
16130698|NCT01598311|38967108|FG000|Overall Study|Lost to Follow-up|7|||
16130699|NCT01598311|38967109|FG001|Overall Study|Lost to Follow-up|12|||
16130700|NCT01598311|38967108|FG000|Overall Study|Withdrawal by Subject|9|||
16130701|NCT01598311|38967109|FG001|Overall Study|Withdrawal by Subject|13|||
16130702|NCT01598311|38967108|FG000|Overall Study|No reason provided.|0|||
16130703|NCT01598311|38967109|FG001|Overall Study|No reason provided.|5|||
16130704|NCT01598311|38967108|FG000|Overall Study|Randomized but never treated|8|||
16130705|NCT01598311|38967109|FG001|Overall Study|Randomized but never treated|5|||
16130706|NCT01598311|38967108|FG000|Overall Study|Treated but no confirmed CDAD|9|||
16130707|NCT01598311|38967109|FG001|Overall Study|Treated but no confirmed CDAD|8|||
16130708|NCT01598311|38967108|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
16130709|NCT01598311|38967109|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
16130710|NCT03426605|38967110|FG000|Overall Study|AML relapse or progression|2|||
16130711|NCT03426605|38967111|FG001|Overall Study|AML relapse or progression|1|||
16130712|NCT03426605|38967112|FG002|Overall Study|AML relapse or progression|2|||
16130713|NCT03426605|38967113|FG003|Overall Study|AML relapse or progression|2|||
16130714|NCT03426605|38967110|FG000|Overall Study|Treatment failure|3|||
16130715|NCT03426605|38967111|FG001|Overall Study|Treatment failure|2|||
16130716|NCT03426605|38967112|FG002|Overall Study|Treatment failure|0|||
16130717|NCT03426605|38967113|FG003|Overall Study|Treatment failure|0|||
16562258|NCT01089556|40525370|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
16562259|NCT01089556|40525371|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
16562260|NCT01089556|40525372|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
16130718|NCT03426605|38967110|FG000|Overall Study|Adverse Event|1|||
16130719|NCT03426605|38967111|FG001|Overall Study|Adverse Event|0|||
16130720|NCT03426605|38967112|FG002|Overall Study|Adverse Event|1|||
16130721|NCT03426605|38967113|FG003|Overall Study|Adverse Event|1|||
16130722|NCT03426605|38967110|FG000|Overall Study|Withdrawal by Subject|0|||
16130723|NCT03426605|38967111|FG001|Overall Study|Withdrawal by Subject|0|||
16130724|NCT03426605|38967112|FG002|Overall Study|Withdrawal by Subject|1|||
16130725|NCT03426605|38967113|FG003|Overall Study|Withdrawal by Subject|1|||
16130726|NCT01139580|38967120|FG000|Overall Study|Adverse Event|5|||
16130727|NCT01139580|38967121|FG001|Overall Study|Adverse Event|4|||
16130728|NCT01139580|38967120|FG000|Overall Study|Lost to Follow-up|9|||
16130729|NCT01139580|38967121|FG001|Overall Study|Lost to Follow-up|1|||
16130730|NCT01139580|38967120|FG000|Overall Study|Lack of Efficacy|0|||
16130731|NCT01139580|38967121|FG001|Overall Study|Lack of Efficacy|2|||
16130732|NCT01139580|38967120|FG000|Overall Study|Withdrawal by Subject|6|||
16130733|NCT01139580|38967121|FG001|Overall Study|Withdrawal by Subject|9|||
16130734|NCT01139580|38967120|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
16130735|NCT01139580|38967121|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
16130736|NCT01139580|38967120|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
16130737|NCT01139580|38967121|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
16130738|NCT01139580|38967120|FG000|Overall Study|Misrandomized|1|||
16130739|NCT01139580|38967121|FG001|Overall Study|Misrandomized|0|||
16130740|NCT01139580|38967120|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
16130741|NCT01139580|38967121|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
16130742|NCT01139580|38967120|FG000|Overall Study|Participant Randomization in Error|0|||
16130743|NCT01139580|38967121|FG001|Overall Study|Participant Randomization in Error|1|||
16130744|NCT00985153|38967122|FG000|Overall Study|Lost to Follow-up|16|||
16130745|NCT00985153|38967123|FG001|Overall Study|Lost to Follow-up|19|||
16130746|NCT00985153|38967124|FG002|Overall Study|Lost to Follow-up|17|||
16130747|NCT00985153|38967125|FG003|Overall Study|Lost to Follow-up|20|||
16130748|NCT00985153|38967122|FG000|Overall Study|Protocol Violation|3|||
16130749|NCT00985153|38967123|FG001|Overall Study|Protocol Violation|2|||
16248722|NCT00329602|39395226|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
16419574|NCT03244826|40015625|FG001|Overall Study|Withdrawal by Subject|0|||
16419575|NCT03244826|40015624|FG000|Overall Study|Transplant delayed or withdrawn|12|||
16419576|NCT03244826|40015625|FG001|Overall Study|Transplant delayed or withdrawn|10|||
16419577|NCT02831933|40015628|FG000|Overall Study|Physician Decision|11|||
16562261|NCT01089556|40525367|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
16248723|NCT00329602|39395224|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
16359163|NCT01715285|39800467|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
16359164|NCT01715285|39800465|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
16359165|NCT01715285|39800466|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
16359166|NCT01715285|39800467|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
16359167|NCT01715285|39800465|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
16359168|NCT01715285|39800466|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
16359169|NCT01715285|39800467|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
16359170|NCT01715285|39800465|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
16359171|NCT01715285|39800466|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
16359172|NCT01715285|39800467|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
16359173|NCT01715285|39800465|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
16359174|NCT01715285|39800466|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
16359175|NCT01715285|39800467|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
16359176|NCT01715285|39800465|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
16359177|NCT01715285|39800466|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
16359178|NCT01715285|39800467|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
16359179|NCT01715285|39800465|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
16359180|NCT01715285|39800466|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
16359181|NCT01715285|39800467|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
16359182|NCT01715285|39800465|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
16359183|NCT01715285|39800466|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
16359184|NCT01715285|39800467|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
16359185|NCT01715285|39800465|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
16359186|NCT01715285|39800466|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
16359187|NCT01715285|39800467|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
16359188|NCT01715285|39800465|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
16359189|NCT01715285|39800466|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
16359190|NCT01715285|39800467|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
16359191|NCT01715285|39800465|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
16359192|NCT01715285|39800466|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
16359193|NCT01715285|39800467|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
16359194|NCT01715285|39800465|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
16359195|NCT01715285|39800466|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
16359196|NCT01715285|39800467|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
16359197|NCT00547339|39800468|FG000|Overall Study|Physician Decision|0|||
16359198|NCT00547339|39800469|FG001|Overall Study|Physician Decision|0|||
16359199|NCT00547339|39800470|FG002|Overall Study|Physician Decision|1|||
16359200|NCT00547339|39800471|FG003|Overall Study|Physician Decision|0|||
16359201|NCT01569022|39800474|FG000|First Intervention|Lost to Follow-up|2|||
16359202|NCT01569022|39800475|FG001|First Intervention|Lost to Follow-up|1|||
16359203|NCT01569022|39800474|FG000|Second Intervention|Lost to Follow-up|2|||
16359204|NCT01569022|39800475|FG001|Second Intervention|Lost to Follow-up|2|||
16359205|NCT01739335|39800476|FG000|Overall Study|Lost to Follow-up|7|||
16359206|NCT01739335|39800477|FG001|Overall Study|Lost to Follow-up|4|||
16359207|NCT01739335|39800476|FG000|Overall Study|Ineligible patient randomized|0|||
16359208|NCT01739335|39800477|FG001|Overall Study|Ineligible patient randomized|1|||
16359209|NCT01020123|39800478|FG000|Main Period|Withdrawal by Subject|6|||
16359210|NCT01020123|39800479|FG001|Main Period|Withdrawal by Subject|5|||
16359211|NCT01020123|39800480|FG002|Main Period|Withdrawal by Subject|3|||
16359212|NCT01020123|39800481|FG003|Main Period|Withdrawal by Subject|1|||
16359213|NCT01020123|39800482|FG004|Main Period|Withdrawal by Subject|6|||
16359214|NCT01020123|39800483|FG005|Main Period|Withdrawal by Subject|3|||
16359215|NCT01020123|39800484|FG006|Main Period|Withdrawal by Subject|2|||
16359216|NCT01020123|39800478|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
16359217|NCT01020123|39800479|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
16359218|NCT01020123|39800480|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
16359219|NCT01020123|39800481|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
16359220|NCT01020123|39800482|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
16359221|NCT01020123|39800483|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
16359222|NCT01020123|39800484|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
16359223|NCT01020123|39800478|FG000|Main Period|Adverse Event|5|||
16359224|NCT01020123|39800479|FG001|Main Period|Adverse Event|2|||
16359225|NCT01020123|39800480|FG002|Main Period|Adverse Event|2|||
16359226|NCT01020123|39800481|FG003|Main Period|Adverse Event|1|||
16359227|NCT01020123|39800482|FG004|Main Period|Adverse Event|1|||
16359228|NCT01020123|39800483|FG005|Main Period|Adverse Event|2|||
16359229|NCT01020123|39800484|FG006|Main Period|Adverse Event|1|||
16359230|NCT01020123|39800478|FG000|Main Period|Protocol Violation|4|||
16419578|NCT03916484|40015630|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
16419579|NCT03916484|40015631|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
16419580|NCT03916484|40015632|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
16419581|NCT03916484|40015633|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
16419582|NCT03916484|40015630|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
16419583|NCT03916484|40015631|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
16419584|NCT03916484|40015632|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
16419585|NCT03916484|40015633|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
16130750|NCT00985153|38967124|FG002|Overall Study|Protocol Violation|4|||
16130751|NCT00985153|38967125|FG003|Overall Study|Protocol Violation|3|||
16130752|NCT00985153|38967122|FG000|Overall Study|Withdrawal by Subject|6|||
16130753|NCT00985153|38967123|FG001|Overall Study|Withdrawal by Subject|11|||
16130754|NCT00985153|38967124|FG002|Overall Study|Withdrawal by Subject|11|||
16419586|NCT01264419|40015634|FG000|Overall Study|Lost to Follow-up|3|||
16419587|NCT02651220|40015635|FG000|Overall Study|Adverse Event|1|||
16419588|NCT02651220|40015636|FG001|Overall Study|Adverse Event|5|||
16419589|NCT02651220|40015637|FG002|Overall Study|Adverse Event|1|||
16419590|NCT02651220|40015635|FG000|Overall Study|Lost to Follow-up|8|||
16419591|NCT02651220|40015636|FG001|Overall Study|Lost to Follow-up|14|||
16419592|NCT02651220|40015637|FG002|Overall Study|Lost to Follow-up|14|||
16419593|NCT02651220|40015635|FG000|Overall Study|Non-Compliance with Study Drug|4|||
16419594|NCT02651220|40015636|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16130755|NCT00985153|38967125|FG003|Overall Study|Withdrawal by Subject|10|||
16130756|NCT00985153|38967122|FG000|Overall Study|Missed One or More Bleeds|7|||
16130757|NCT00985153|38967123|FG001|Overall Study|Missed One or More Bleeds|7|||
16130758|NCT00985153|38967124|FG002|Overall Study|Missed One or More Bleeds|8|||
16130759|NCT00985153|38967125|FG003|Overall Study|Missed One or More Bleeds|10|||
16130760|NCT00985153|38967122|FG000|Overall Study|Incomplete Safety Follow-up|3|||
16359231|NCT01020123|39800479|FG001|Main Period|Protocol Violation|4|||
16359232|NCT01020123|39800480|FG002|Main Period|Protocol Violation|2|||
16359233|NCT01020123|39800481|FG003|Main Period|Protocol Violation|5|||
16359234|NCT01020123|39800482|FG004|Main Period|Protocol Violation|2|||
16359235|NCT01020123|39800483|FG005|Main Period|Protocol Violation|3|||
16359236|NCT01020123|39800484|FG006|Main Period|Protocol Violation|2|||
16359237|NCT01020123|39800478|FG000|Main Period|Lost to Follow-up|0|||
16359238|NCT01020123|39800479|FG001|Main Period|Lost to Follow-up|2|||
16359239|NCT01020123|39800480|FG002|Main Period|Lost to Follow-up|0|||
16359240|NCT01020123|39800481|FG003|Main Period|Lost to Follow-up|0|||
16359241|NCT01020123|39800482|FG004|Main Period|Lost to Follow-up|0|||
16359242|NCT01020123|39800483|FG005|Main Period|Lost to Follow-up|0|||
16359243|NCT01020123|39800484|FG006|Main Period|Lost to Follow-up|0|||
16359244|NCT01020123|39800478|FG000|Main Period|Unclasified|2|||
16359245|NCT01020123|39800479|FG001|Main Period|Unclasified|0|||
16359246|NCT01020123|39800480|FG002|Main Period|Unclasified|1|||
16359247|NCT01020123|39800481|FG003|Main Period|Unclasified|0|||
16359248|NCT01020123|39800482|FG004|Main Period|Unclasified|1|||
16359249|NCT01020123|39800483|FG005|Main Period|Unclasified|3|||
16359250|NCT01020123|39800484|FG006|Main Period|Unclasified|6|||
16359251|NCT01020123|39800478|FG000|Extention Period|Withdrawal by Subject|2|||
16359252|NCT01020123|39800479|FG001|Extention Period|Withdrawal by Subject|1|||
16359253|NCT01020123|39800480|FG002|Extention Period|Withdrawal by Subject|1|||
16359254|NCT01020123|39800481|FG003|Extention Period|Withdrawal by Subject|0|||
16359255|NCT01020123|39800482|FG004|Extention Period|Withdrawal by Subject|0|||
16359256|NCT01020123|39800483|FG005|Extention Period|Withdrawal by Subject|0|||
16359257|NCT01020123|39800484|FG006|Extention Period|Withdrawal by Subject|0|||
16359258|NCT01020123|39800478|FG000|Extention Period|Adverse Event|0|||
16419595|NCT02651220|40015637|FG002|Overall Study|Non-Compliance with Study Drug|1|||
16419596|NCT02651220|40015635|FG000|Overall Study|Pregnancy|1|||
16419597|NCT02651220|40015636|FG001|Overall Study|Pregnancy|0|||
16419598|NCT02651220|40015637|FG002|Overall Study|Pregnancy|1|||
16419599|NCT02651220|40015635|FG000|Overall Study|Protocol Violation|0|||
16419600|NCT02651220|40015636|FG001|Overall Study|Protocol Violation|0|||
16130761|NCT00985153|38967123|FG001|Overall Study|Incomplete Safety Follow-up|5|||
16359259|NCT01020123|39800479|FG001|Extention Period|Adverse Event|0|||
16359260|NCT01020123|39800480|FG002|Extention Period|Adverse Event|0|||
16359261|NCT01020123|39800481|FG003|Extention Period|Adverse Event|1|||
16359262|NCT01020123|39800482|FG004|Extention Period|Adverse Event|0|||
16359263|NCT01020123|39800483|FG005|Extention Period|Adverse Event|0|||
16359264|NCT01020123|39800484|FG006|Extention Period|Adverse Event|0|||
16359265|NCT01020123|39800478|FG000|Extention Period|Protocol Violation|1|||
16359266|NCT01020123|39800479|FG001|Extention Period|Protocol Violation|1|||
16359267|NCT01020123|39800480|FG002|Extention Period|Protocol Violation|1|||
16359268|NCT01020123|39800481|FG003|Extention Period|Protocol Violation|0|||
16359269|NCT01020123|39800482|FG004|Extention Period|Protocol Violation|0|||
16359270|NCT01020123|39800483|FG005|Extention Period|Protocol Violation|0|||
16359271|NCT01020123|39800484|FG006|Extention Period|Protocol Violation|1|||
16359272|NCT01020123|39800478|FG000|Extention Period|Lost to Follow-up|0|||
16359273|NCT01020123|39800479|FG001|Extention Period|Lost to Follow-up|0|||
16359274|NCT01020123|39800480|FG002|Extention Period|Lost to Follow-up|0|||
16359275|NCT01020123|39800481|FG003|Extention Period|Lost to Follow-up|0|||
16359276|NCT01020123|39800482|FG004|Extention Period|Lost to Follow-up|0|||
16359277|NCT01020123|39800483|FG005|Extention Period|Lost to Follow-up|2|||
16359278|NCT01020123|39800484|FG006|Extention Period|Lost to Follow-up|0|||
16359279|NCT03499795|39800488|FG000|Overall Study|Adverse Event|1|||
16359280|NCT03499795|39800488|FG000|Overall Study|Lost to Follow-up|1|||
16359281|NCT03883386|39800490|FG000|First Assignment|Lost to Follow-up|1|||
16359282|NCT03883386|39800491|FG001|First Assignment|Lost to Follow-up|0|||
16359283|NCT03883386|39800490|FG000|First Assignment|Withdrawal by Subject|1|||
16359284|NCT03883386|39800491|FG001|First Assignment|Withdrawal by Subject|1|||
16359285|NCT01299584|39800494|FG000|Overall Study|Protocol Violation|9|||
16359286|NCT00896493|39800495|FG000|Overall Study|Early disease relapse|3|||
16359287|NCT00761319|39800496|FG000|Overall Study|Protocol Violation|21|||
16359288|NCT00761319|39800497|FG001|Overall Study|Protocol Violation|14|||
16359289|NCT00761319|39800496|FG000|Overall Study|Adverse Event|11|||
16359290|NCT00761319|39800497|FG001|Overall Study|Adverse Event|7|||
16359291|NCT00761319|39800496|FG000|Overall Study|Withdrawal by Subject|8|||
16359292|NCT00761319|39800497|FG001|Overall Study|Withdrawal by Subject|7|||
16359293|NCT00761319|39800496|FG000|Overall Study|Noncompliance|4|||
16359294|NCT00761319|39800497|FG001|Overall Study|Noncompliance|3|||
16359295|NCT00761319|39800496|FG000|Overall Study|Lost to Follow-up|1|||
16359296|NCT00761319|39800497|FG001|Overall Study|Lost to Follow-up|1|||
16359297|NCT00761319|39800496|FG000|Overall Study|Nonspecified|2|||
16359298|NCT00761319|39800497|FG001|Overall Study|Nonspecified|2|||
16359299|NCT00761319|39800496|FG000|Overall Study|Missing|1|||
16359300|NCT00761319|39800497|FG001|Overall Study|Missing|0|||
16359301|NCT00317369|39800500|FG000|Overall Study|Adverse Event|2|||
16359302|NCT00317369|39800501|FG001|Overall Study|Adverse Event|1|||
16359303|NCT00317369|39800502|FG002|Overall Study|Adverse Event|0|||
16359304|NCT00317369|39800500|FG000|Overall Study|Lack of Efficacy|0|||
16359305|NCT00317369|39800501|FG001|Overall Study|Lack of Efficacy|1|||
16359306|NCT00317369|39800502|FG002|Overall Study|Lack of Efficacy|1|||
16359307|NCT00317369|39800500|FG000|Overall Study|Withdrawal by Subject|0|||
16359308|NCT00317369|39800501|FG001|Overall Study|Withdrawal by Subject|0|||
16359309|NCT00317369|39800502|FG002|Overall Study|Withdrawal by Subject|1|||
16359310|NCT01411852|39800503|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
16359311|NCT01411852|39800504|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
16359312|NCT01411852|39800503|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
16359313|NCT01411852|39800504|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
16359314|NCT01411852|39800503|FG000|Prehospital Intervention Phase|Found to be under age|0|||
16359315|NCT01411852|39800504|FG001|Prehospital Intervention Phase|Found to be under age|1|||
16130762|NCT00985153|38967124|FG002|Overall Study|Incomplete Safety Follow-up|4|||
16130763|NCT00985153|38967125|FG003|Overall Study|Incomplete Safety Follow-up|4|||
16359316|NCT01411852|39800503|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
16359317|NCT01411852|39800504|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
16359318|NCT01411852|39800503|FG000|Hospital Intervention Phase|Severe head injury|5|||
16359319|NCT01411852|39800504|FG001|Hospital Intervention Phase|Severe head injury|4|||
16359320|NCT01411852|39800503|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
16419601|NCT02651220|40015637|FG002|Overall Study|Protocol Violation|1|||
16359321|NCT01411852|39800504|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
16359322|NCT01411852|39800503|FG000|Hospital Intervention Phase|Miscommunication error|1|||
16359323|NCT01411852|39800504|FG001|Hospital Intervention Phase|Miscommunication error|2|||
16359324|NCT01411852|39800503|FG000|Hospital Intervention Phase|CPR administered|3|||
16359325|NCT01411852|39800504|FG001|Hospital Intervention Phase|CPR administered|1|||
16359326|NCT01411852|39800503|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
16359327|NCT01411852|39800504|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
16359328|NCT01411852|39800503|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
16359329|NCT01411852|39800504|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
16359330|NCT01411852|39800503|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
16359331|NCT01411852|39800504|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
16359332|NCT01411852|39800503|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
16359333|NCT01411852|39800504|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
16359334|NCT01411852|39800503|FG000|Hospital Intervention Phase|Other ineligible|2|||
16359335|NCT01411852|39800504|FG001|Hospital Intervention Phase|Other ineligible|2|||
16359336|NCT01411852|39800503|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
16359337|NCT01411852|39800504|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
16359338|NCT01411852|39800503|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
16359339|NCT01411852|39800504|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
16359340|NCT01411852|39800503|FG000|Hospital Intervention Phase|Vascular access failed|1|||
16359341|NCT01411852|39800504|FG001|Hospital Intervention Phase|Vascular access failed|0|||
16359342|NCT02669849|39800506|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
16359343|NCT02669849|39800507|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
16359344|NCT02669849|39800508|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
16359345|NCT02669849|39800506|FG000|Overall Study|Lost to Follow-up|1|||
16359346|NCT02669849|39800507|FG001|Overall Study|Lost to Follow-up|0|||
16359347|NCT02669849|39800508|FG002|Overall Study|Lost to Follow-up|3|||
16359348|NCT02669849|39800506|FG000|Overall Study|Death|1|||
16359349|NCT02669849|39800507|FG001|Overall Study|Death|1|||
16359350|NCT02669849|39800508|FG002|Overall Study|Death|2|||
16248724|NCT00329602|39395225|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
16248725|NCT00329602|39395226|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
16248726|NCT00329602|39395224|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
16248727|NCT00329602|39395225|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
16248728|NCT00329602|39395226|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
16248729|NCT00329602|39395224|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
16248730|NCT00329602|39395225|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
16248731|NCT00329602|39395226|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
16248732|NCT02518685|39395227|FG000|Overall Study|Adverse Event|29|||
16248733|NCT02518685|39395228|FG001|Overall Study|Adverse Event|1|||
16248734|NCT02518685|39395227|FG000|Overall Study|Withdrawal by Subject|10|||
16248735|NCT02518685|39395228|FG001|Overall Study|Withdrawal by Subject|3|||
16248736|NCT02518685|39395227|FG000|Overall Study|relocation, study fatigue|7|||
16248737|NCT02518685|39395228|FG001|Overall Study|relocation, study fatigue|2|||
16248738|NCT02518685|39395227|FG000|Overall Study|Pregnancy|1|||
16248739|NCT02518685|39395228|FG001|Overall Study|Pregnancy|0|||
16248740|NCT02518685|39395227|FG000|Overall Study|Physician Decision|1|||
16248741|NCT02518685|39395228|FG001|Overall Study|Physician Decision|0|||
16248742|NCT02518685|39395227|FG000|Overall Study|Lost to Follow-up|1|||
16248743|NCT02518685|39395228|FG001|Overall Study|Lost to Follow-up|4|||
16248744|NCT00433381|39395229|FG000|Overall Study|Ineligible / no protocol treatment|3|||
16248745|NCT00433381|39395230|FG001|Overall Study|Ineligible / no protocol treatment|3|||
16248746|NCT00936390|39395231|FG000|Overall Study|Protocol Violation|21|||
16248747|NCT00936390|39395232|FG001|Overall Study|Protocol Violation|25|||
16248748|NCT01298570|39395233|FG000|Overall Study|Disease progression, relapse during acti|64|||
16248749|NCT01298570|39395234|FG001|Overall Study|Disease progression, relapse during acti|40|||
16248750|NCT01298570|39395233|FG000|Overall Study|Adverse Event|20|||
16248751|NCT01298570|39395234|FG001|Overall Study|Adverse Event|2|||
16248752|NCT01298570|39395233|FG000|Overall Study|Withdrawal by Subject|21|||
16248753|NCT01298570|39395234|FG001|Overall Study|Withdrawal by Subject|6|||
16248754|NCT01298570|39395233|FG000|Overall Study|Treatment delay > 4 weeks|4|||
16248755|NCT01298570|39395234|FG001|Overall Study|Treatment delay > 4 weeks|5|||
16248756|NCT01298570|39395233|FG000|Overall Study|Physician Decision|4|||
16248757|NCT01298570|39395234|FG001|Overall Study|Physician Decision|2|||
16248758|NCT01298570|39395233|FG000|Overall Study|Other complicating disease|2|||
16248759|NCT01298570|39395234|FG001|Overall Study|Other complicating disease|1|||
16248760|NCT01298570|39395233|FG000|Overall Study|Surgery|2|||
16248761|NCT01298570|39395234|FG001|Overall Study|Surgery|1|||
16248762|NCT01298570|39395233|FG000|Overall Study|Symptomatic progression/deterioration|3|||
16248763|NCT01298570|39395234|FG001|Overall Study|Symptomatic progression/deterioration|2|||
16248764|NCT01298570|39395233|FG000|Overall Study|Death|0|||
16248765|NCT01298570|39395234|FG001|Overall Study|Death|1|||
16248766|NCT01298570|39395233|FG000|Overall Study|Ineligibility|0|||
16248767|NCT01298570|39395234|FG001|Overall Study|Ineligibility|1|||
16248768|NCT00686036|39395239|FG000|Overall Study|Adverse Event|3|||
16248769|NCT00686036|39395240|FG001|Overall Study|Adverse Event|0|||
16248770|NCT00686036|39395239|FG000|Overall Study|Withdrawal by Subject|3|||
16248771|NCT00686036|39395240|FG001|Overall Study|Withdrawal by Subject|1|||
16248772|NCT00686036|39395239|FG000|Overall Study|Study terminated by AstraZeneca|2|||
16248773|NCT00686036|39395240|FG001|Overall Study|Study terminated by AstraZeneca|1|||
16248774|NCT00686036|39395239|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
16248775|NCT00686036|39395240|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
16248776|NCT00686036|39395239|FG000|Overall Study|Other reasons not identified|0|||
16248777|NCT00686036|39395240|FG001|Overall Study|Other reasons not identified|4|||
16248778|NCT00952484|39395244|FG000|Overall Study|Withdrawal by Subject|0|||
16248779|NCT00952484|39395245|FG001|Overall Study|Withdrawal by Subject|1|||
16248780|NCT00952484|39395246|FG002|Overall Study|Withdrawal by Subject|0|||
16248781|NCT02688400|39395247|FG000|Overall Study|Protocol Violation|2|||
16248782|NCT02688400|39395248|FG001|Overall Study|Protocol Violation|5|||
16248783|NCT02688400|39395247|FG000|Overall Study|Lack of Efficacy|7|||
16248784|NCT02688400|39395248|FG001|Overall Study|Lack of Efficacy|7|||
16248785|NCT02688400|39395247|FG000|Overall Study|Adverse Event|21|||
16248786|NCT02688400|39395248|FG001|Overall Study|Adverse Event|12|||
16248787|NCT02688400|39395247|FG000|Overall Study|Withdrawal by Subject|15|||
16248788|NCT02688400|39395248|FG001|Overall Study|Withdrawal by Subject|13|||
16248789|NCT02688400|39395247|FG000|Overall Study|No study medication intake|1|||
16248790|NCT02688400|39395248|FG001|Overall Study|No study medication intake|4|||
16248791|NCT02688400|39395247|FG000|Overall Study|Lost to Follow-up|0|||
16359351|NCT02669849|39800506|FG000|Overall Study|Study terminated by sponsor|16|||
16359352|NCT02669849|39800507|FG001|Overall Study|Study terminated by sponsor|1|||
16359353|NCT02669849|39800508|FG002|Overall Study|Study terminated by sponsor|14|||
16359354|NCT02669849|39800506|FG000|Overall Study|Other|0|||
16248792|NCT02688400|39395248|FG001|Overall Study|Lost to Follow-up|3|||
16248793|NCT00458302|39395249|FG000|Overall Study|Adverse Event|4|||
16248794|NCT00458302|39395250|FG001|Overall Study|Adverse Event|14|||
16248795|NCT00458302|39395249|FG000|Overall Study|Pregnancy|2|||
16359355|NCT02669849|39800507|FG001|Overall Study|Other|0|||
16359356|NCT02669849|39800508|FG002|Overall Study|Other|2|||
16359357|NCT03183908|39800511|FG000|Overall Study|Missing Symptom Diary Data|0|||
16359358|NCT03183908|39800512|FG001|Overall Study|Missing Symptom Diary Data|2|||
16359359|NCT03307174|39800513|FG000|Overall Study|Unplanned ICU Administrion|5|||
16359360|NCT03307174|39800514|FG001|Overall Study|Unplanned ICU Administrion|3|||
16359361|NCT03307174|39800513|FG000|Overall Study|Aborted Surgery|1|||
16359362|NCT03307174|39800514|FG001|Overall Study|Aborted Surgery|2|||
16359363|NCT03307174|39800513|FG000|Overall Study|Hypotension|6|||
16359364|NCT03307174|39800514|FG001|Overall Study|Hypotension|0|||
16419602|NCT02651220|40015635|FG000|Overall Study|Withdrawal by Subject|5|||
16419603|NCT02651220|40015636|FG001|Overall Study|Withdrawal by Subject|6|||
16419604|NCT02651220|40015637|FG002|Overall Study|Withdrawal by Subject|8|||
16419605|NCT02651220|40015635|FG000|Overall Study|Miscellaneous|4|||
16419606|NCT02651220|40015636|FG001|Overall Study|Miscellaneous|1|||
16419607|NCT02651220|40015637|FG002|Overall Study|Miscellaneous|2|||
16419608|NCT02651220|40015635|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16419609|NCT02651220|40015636|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16419610|NCT02651220|40015637|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
16419611|NCT01300572|40015641|FG000|Overall Study|HAMA + post dosimetry|1|||
16419612|NCT03369236|40018691|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
16419613|NCT03369236|40018692|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
16419614|NCT03369236|40018691|FG000|Open-label Extension Period|Lack of Efficacy|2|||
16419615|NCT03369236|40018692|FG001|Open-label Extension Period|Lack of Efficacy|1|||
16419616|NCT03369236|40018691|FG000|Open-label Extension Period|Adverse Event|0|||
16419617|NCT03369236|40018692|FG001|Open-label Extension Period|Adverse Event|1|||
16419618|NCT03369236|40018691|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
16419619|NCT03369236|40018692|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
16419620|NCT04576897|40018693|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
16419621|NCT02008773|40018694|FG000|Overall Study|Adverse Event|3|||
16419622|NCT02008773|40018695|FG001|Overall Study|Adverse Event|3|||
16419623|NCT02008773|40018696|FG002|Overall Study|Adverse Event|1|||
16419624|NCT02008773|40018697|FG003|Overall Study|Adverse Event|2|||
16419625|NCT02008773|40018694|FG000|Overall Study|Medication Non-compliance|2|||
16419626|NCT02008773|40018695|FG001|Overall Study|Medication Non-compliance|1|||
16419627|NCT02008773|40018696|FG002|Overall Study|Medication Non-compliance|3|||
16419628|NCT02008773|40018697|FG003|Overall Study|Medication Non-compliance|2|||
16419629|NCT02008773|40018694|FG000|Overall Study|Withdrawal by Subject|8|||
16419630|NCT02008773|40018695|FG001|Overall Study|Withdrawal by Subject|4|||
16419631|NCT02008773|40018696|FG002|Overall Study|Withdrawal by Subject|7|||
16419632|NCT02008773|40018697|FG003|Overall Study|Withdrawal by Subject|6|||
16419633|NCT02008773|40018694|FG000|Overall Study|Lost to Follow-up|0|||
16419634|NCT02008773|40018695|FG001|Overall Study|Lost to Follow-up|1|||
16419635|NCT02008773|40018696|FG002|Overall Study|Lost to Follow-up|3|||
16419636|NCT02008773|40018697|FG003|Overall Study|Lost to Follow-up|2|||
16419637|NCT01298765|40018698|FG000|Titration Period|Adverse Event|26|||
16419638|NCT01298765|40018698|FG000|Titration Period|Death|1|||
16419639|NCT01298765|40018698|FG000|Titration Period|Lack of Efficacy|21|||
16419640|NCT01298765|40018698|FG000|Titration Period|Lost to Follow-up|9|||
16562262|NCT01089556|40525368|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
16419641|NCT01298765|40018698|FG000|Titration Period|Physician Decision|1|||
16419642|NCT01298765|40018698|FG000|Titration Period|Withdrawal by Subject|10|||
16419643|NCT01298765|40018698|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
16419644|NCT01298765|40018698|FG000|Long-Term Treatment Period|Adverse Event|19|||
16419645|NCT01298765|40018698|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
16359365|NCT03307174|39800513|FG000|Overall Study|Nonfunctional epidural|1|||
16359366|NCT03307174|39800514|FG001|Overall Study|Nonfunctional epidural|1|||
16359367|NCT03307174|39800513|FG000|Overall Study|Planned epidural removal|1|||
16419646|NCT01298765|40018698|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
16419647|NCT01298765|40018698|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
16419648|NCT01298765|40018698|FG000|Long-Term Treatment Period|Physician Decision|1|||
16419649|NCT01298765|40018698|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
16419650|NCT02305238|40018699|FG000|Overall Study|Death|2|||
16419651|NCT02305238|40018700|FG001|Overall Study|Death|1|||
16419652|NCT02305238|40018701|FG002|Overall Study|Death|0|||
16419653|NCT02305238|40018699|FG000|Overall Study|Progressive disease|4|||
16419654|NCT02305238|40018700|FG001|Overall Study|Progressive disease|4|||
16419655|NCT02305238|40018701|FG002|Overall Study|Progressive disease|0|||
16419656|NCT02305238|40018699|FG000|Overall Study|Logistical difficulties|1|||
16419657|NCT02305238|40018700|FG001|Overall Study|Logistical difficulties|3|||
16419658|NCT02305238|40018701|FG002|Overall Study|Logistical difficulties|0|||
16419659|NCT02305238|40018699|FG000|Overall Study|Protocol Violation|0|||
16419660|NCT02305238|40018700|FG001|Overall Study|Protocol Violation|3|||
16419661|NCT02305238|40018701|FG002|Overall Study|Protocol Violation|0|||
16419662|NCT02305238|40018699|FG000|Overall Study|Physician Decision|2|||
16419663|NCT02305238|40018700|FG001|Overall Study|Physician Decision|1|||
16419664|NCT02305238|40018701|FG002|Overall Study|Physician Decision|0|||
16419665|NCT02305238|40018699|FG000|Overall Study|Adverse Event|4|||
16419666|NCT02305238|40018700|FG001|Overall Study|Adverse Event|2|||
16419667|NCT02305238|40018701|FG002|Overall Study|Adverse Event|0|||
16419668|NCT02305238|40018699|FG000|Overall Study|Withdrawal by Subject|3|||
16419669|NCT02305238|40018700|FG001|Overall Study|Withdrawal by Subject|4|||
16419670|NCT02305238|40018701|FG002|Overall Study|Withdrawal by Subject|0|||
16419671|NCT02305238|40018699|FG000|Overall Study|Randomized failure|0|||
16419672|NCT02305238|40018700|FG001|Overall Study|Randomized failure|0|||
16419673|NCT02305238|40018701|FG002|Overall Study|Randomized failure|8|||
16419674|NCT02305238|40018699|FG000|Overall Study|Required procedure failed|0|||
16419675|NCT02305238|40018700|FG001|Overall Study|Required procedure failed|1|||
16419676|NCT02305238|40018701|FG002|Overall Study|Required procedure failed|0|||
16419677|NCT04699461|40018709|FG000|Overall Study|Withdrawal by Subject|1|||
16419678|NCT04699461|40018710|FG001|Overall Study|Withdrawal by Subject|0|||
16419679|NCT04699461|40018709|FG000|Overall Study|Study termination by sponsor|2|||
16419680|NCT04699461|40018710|FG001|Overall Study|Study termination by sponsor|1|||
16419681|NCT04699461|40018709|FG000|Overall Study|Death|1|||
16359368|NCT03307174|39800514|FG001|Overall Study|Planned epidural removal|0|||
16359369|NCT03307174|39800513|FG000|Overall Study|Intrathecal catheter placement|0|||
16359370|NCT03307174|39800514|FG001|Overall Study|Intrathecal catheter placement|1|||
16359371|NCT01249131|39800515|FG000|Washout Period of 10 Days|Adverse Event|0|||
16359372|NCT01249131|39800516|FG001|Washout Period of 10 Days|Adverse Event|0|||
16359373|NCT01249131|39800517|FG002|Washout Period of 10 Days|Adverse Event|0|||
16359374|NCT01249131|39800518|FG003|Washout Period of 10 Days|Adverse Event|0|||
16359375|NCT01249131|39800519|FG004|Washout Period of 10 Days|Adverse Event|1|||
16359376|NCT01249131|39800520|FG005|Washout Period of 10 Days|Adverse Event|0|||
16359377|NCT00964782|39800521|FG000|Overall Study|Lost to Follow-up|1|||
16359378|NCT00964782|39800522|FG001|Overall Study|Lost to Follow-up|0|||
16359379|NCT00997893|39800523|FG000|Overall Study|Adverse Event|1|||
16359380|NCT00997893|39800524|FG001|Overall Study|Adverse Event|0|||
16359381|NCT00997893|39800525|FG002|Overall Study|Adverse Event|0|||
16359382|NCT00997893|39800523|FG000|Overall Study|Unable to meet study timelines|1|||
16359383|NCT00997893|39800524|FG001|Overall Study|Unable to meet study timelines|0|||
16359384|NCT00997893|39800525|FG002|Overall Study|Unable to meet study timelines|0|||
16359385|NCT00997893|39800523|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
16359386|NCT00997893|39800524|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
16359387|NCT00997893|39800525|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
16359388|NCT04009837|39800528|FG000|Overall Study|Withdrawal by Subject|5|||
16359389|NCT04009837|39800529|FG001|Overall Study|Withdrawal by Subject|4|||
16359390|NCT04009837|39800528|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
16359391|NCT04009837|39800529|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
16419682|NCT04699461|40018710|FG001|Overall Study|Death|0|||
16419683|NCT04699461|40018709|FG000|Overall Study|Radiographic progression|0|||
16359392|NCT01649765|39800530|FG000|Overall Study|Adverse Event|5|||
16359393|NCT01649765|39800531|FG001|Overall Study|Adverse Event|3|||
16419684|NCT04699461|40018710|FG001|Overall Study|Radiographic progression|1|||
16419685|NCT01019369|40018711|FG000|Overall Study|Lost to Follow-up|10|||
16130764|NCT02240693|38967126|FG000|Overall Study|Adverse Event|0|||
16130765|NCT02240693|38967127|FG001|Overall Study|Adverse Event|0|||
16130766|NCT02240693|38967128|FG002|Overall Study|Adverse Event|0|||
16130767|NCT02240693|38967129|FG003|Overall Study|Adverse Event|0|||
16130768|NCT02240693|38967130|FG004|Overall Study|Adverse Event|1|||
16130769|NCT02240693|38967126|FG000|Overall Study|Withdrawal by Subject|0|||
16130770|NCT02240693|38967127|FG001|Overall Study|Withdrawal by Subject|0|||
16130771|NCT02240693|38967128|FG002|Overall Study|Withdrawal by Subject|2|||
16130772|NCT02240693|38967129|FG003|Overall Study|Withdrawal by Subject|1|||
16130773|NCT02240693|38967130|FG004|Overall Study|Withdrawal by Subject|0|||
16130774|NCT02240693|38967126|FG000|Overall Study|Other than specified|0|||
16130775|NCT02240693|38967127|FG001|Overall Study|Other than specified|0|||
16130776|NCT02240693|38967128|FG002|Overall Study|Other than specified|2|||
16130777|NCT02240693|38967129|FG003|Overall Study|Other than specified|0|||
16130778|NCT02240693|38967130|FG004|Overall Study|Other than specified|0|||
16130779|NCT01506453|38967133|FG000|Overall Study|Withdrawal prior to treatment|0|||
16130780|NCT01506453|38967134|FG001|Overall Study|Withdrawal prior to treatment|2|||
16130781|NCT00825825|38967136|FG000|First Medication Period (14 Days)|Adverse Event|1|||
16130782|NCT00825825|38967137|FG001|First Medication Period (14 Days)|Adverse Event|0|||
16130783|NCT00825825|38967138|FG002|First Medication Period (14 Days)|Adverse Event|0|||
16130784|NCT00825825|38967139|FG003|First Medication Period (14 Days)|Adverse Event|0|||
16562263|NCT01089556|40525369|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
16562264|NCT01089556|40525370|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
16562265|NCT01089556|40525371|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
16562266|NCT01089556|40525372|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
16562267|NCT01089556|40525367|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
16562268|NCT01089556|40525368|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
16562269|NCT01089556|40525369|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
16562270|NCT01089556|40525370|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
16562271|NCT01089556|40525371|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
16562272|NCT01089556|40525372|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
16562273|NCT01089556|40525367|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
16562274|NCT01089556|40525368|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
16562275|NCT01089556|40525369|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
16562276|NCT01089556|40525370|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
16562277|NCT01089556|40525371|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
16562278|NCT01089556|40525372|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
16562279|NCT01089556|40525367|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
16562280|NCT01089556|40525368|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
16562281|NCT01089556|40525369|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
16562282|NCT01089556|40525370|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
16130785|NCT00825825|38967140|FG004|First Medication Period (14 Days)|Adverse Event|0|||
16130786|NCT00825825|38967141|FG005|First Medication Period (14 Days)|Adverse Event|1|||
16130787|NCT00825825|38967136|FG000|First Medication Period (14 Days)|Physician Decision|2|||
16130788|NCT00825825|38967137|FG001|First Medication Period (14 Days)|Physician Decision|0|||
16130789|NCT00825825|38967138|FG002|First Medication Period (14 Days)|Physician Decision|1|||
16562283|NCT01089556|40525371|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
16562284|NCT01089556|40525372|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
16130790|NCT00825825|38967139|FG003|First Medication Period (14 Days)|Physician Decision|0|||
16130791|NCT00825825|38967140|FG004|First Medication Period (14 Days)|Physician Decision|0|||
16130792|NCT00825825|38967141|FG005|First Medication Period (14 Days)|Physician Decision|1|||
16130793|NCT00825825|38967136|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
16130794|NCT00825825|38967137|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
16130795|NCT00825825|38967138|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
16130796|NCT00825825|38967139|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
16130797|NCT00825825|38967140|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
16130798|NCT00825825|38967141|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
16130799|NCT00825825|38967136|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
16130800|NCT00825825|38967137|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
16130801|NCT00825825|38967138|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
16130802|NCT00825825|38967139|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
16130803|NCT00825825|38967140|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
16130804|NCT00825825|38967141|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
16130805|NCT00825825|38967136|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
16130806|NCT00825825|38967137|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
16130807|NCT00825825|38967138|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
16130808|NCT00825825|38967139|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
16130809|NCT00825825|38967140|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
16130810|NCT00825825|38967141|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
16419686|NCT01019369|40018712|FG001|Overall Study|Lost to Follow-up|6|||
16419687|NCT01019369|40018711|FG000|Overall Study|Withdrawal by Subject|0|||
16419688|NCT01019369|40018712|FG001|Overall Study|Withdrawal by Subject|1|||
16419689|NCT01620944|40018721|FG000|Overall Study|Early termination of Study|2|||
16419690|NCT01620944|40018722|FG001|Overall Study|Early termination of Study|1|||
16419691|NCT00991406|40018723|FG000|Overall Study|One participant did not respond to FES.|1|||
16419692|NCT03180307|40018724|FG000|Overall Study|Lost to Follow-up|2|||
16419693|NCT03180307|40018725|FG001|Overall Study|Lost to Follow-up|0|||
16419694|NCT03180307|40018724|FG000|Overall Study|Death|1|||
16419695|NCT03180307|40018725|FG001|Overall Study|Death|0|||
16419696|NCT03180307|40018724|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
16419697|NCT03180307|40018725|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
16419698|NCT04046250|40018726|FG000|Overall Study|Death|0|||
16419699|NCT04046250|40018727|FG001|Overall Study|Death|1|||
16419700|NCT04046250|40018726|FG000|Overall Study|Withdrawal by Subject|3|||
16419701|NCT04046250|40018727|FG001|Overall Study|Withdrawal by Subject|3|||
16419702|NCT01092663|40018731|FG000|Overall Study|Withdrawal by Subject|3|||
16419703|NCT01092663|40018732|FG001|Overall Study|Withdrawal by Subject|2|||
16419704|NCT01092663|40018731|FG000|Overall Study|Glucose >300mg/dL|1|||
16419705|NCT01092663|40018732|FG001|Overall Study|Glucose >300mg/dL|0|||
16419706|NCT01092663|40018731|FG000|Overall Study|High fasting triglyceride|2|||
16419707|NCT01092663|40018732|FG001|Overall Study|High fasting triglyceride|0|||
16419708|NCT01092663|40018731|FG000|Overall Study|Adverse Event|1|||
16419709|NCT01092663|40018732|FG001|Overall Study|Adverse Event|1|||
16419710|NCT01092663|40018731|FG000|Overall Study|Protocol Violation|0|||
16419711|NCT01092663|40018732|FG001|Overall Study|Protocol Violation|1|||
16419712|NCT03624127|40018737|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
16419713|NCT03624127|40018738|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
16419714|NCT03624127|40018739|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
16419715|NCT03624127|40018737|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
16419716|NCT03624127|40018738|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
16419717|NCT03624127|40018739|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
16359394|NCT01649765|39800530|FG000|Overall Study|Lack of Efficacy|1|||
16359395|NCT01649765|39800531|FG001|Overall Study|Lack of Efficacy|1|||
16359396|NCT01649765|39800530|FG000|Overall Study|Physician Decision|0|||
16359397|NCT01649765|39800531|FG001|Overall Study|Physician Decision|3|||
16359398|NCT01649765|39800530|FG000|Overall Study|Protocol Violation|1|||
16359399|NCT01649765|39800531|FG001|Overall Study|Protocol Violation|0|||
16359400|NCT01649765|39800530|FG000|Overall Study|Withdrawal by Subject|2|||
16359401|NCT01649765|39800531|FG001|Overall Study|Withdrawal by Subject|1|||
16359402|NCT00375752|39804107|FG000|Overall Study|Lack of Efficacy|4|||
16359403|NCT00375752|39804108|FG001|Overall Study|Lack of Efficacy|4|||
16359404|NCT00375752|39804107|FG000|Overall Study|Adverse Event|1|||
16359405|NCT00375752|39804108|FG001|Overall Study|Adverse Event|6|||
16359406|NCT00375752|39804107|FG000|Overall Study|Withdrawal by Subject|6|||
16359407|NCT00375752|39804108|FG001|Overall Study|Withdrawal by Subject|1|||
16359408|NCT00375752|39804107|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
16359409|NCT00375752|39804108|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
16359410|NCT00375752|39804107|FG000|Overall Study|Protocol Violation|0|||
16359411|NCT00375752|39804108|FG001|Overall Study|Protocol Violation|2|||
16359412|NCT00375752|39804107|FG000|Overall Study|Administrative Problems|0|||
16359413|NCT00375752|39804108|FG001|Overall Study|Administrative Problems|1|||
16419718|NCT03624127|40018737|FG000|Treatment Week 0 - Week 16|Death|0|||
16359414|NCT00143507|39804109|FG000|Overall Study|Death|572|||
16419719|NCT03624127|40018738|FG001|Treatment Week 0 - Week 16|Death|1|||
16419720|NCT03624127|40018739|FG002|Treatment Week 0 - Week 16|Death|0|||
16359415|NCT00143507|39804110|FG001|Overall Study|Death|547|||
16359416|NCT00143507|39804109|FG000|Overall Study|Withdrawal by Subject|114|||
16419721|NCT03624127|40018737|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
16419722|NCT03624127|40018738|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
16419723|NCT03624127|40018739|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
16419724|NCT03624127|40018737|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
16419725|NCT03624127|40018738|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
16419726|NCT03624127|40018739|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
16419727|NCT03624127|40018737|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
16419728|NCT03624127|40018738|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
16419729|NCT03624127|40018739|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
16419730|NCT03624127|40018737|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
16419731|NCT03624127|40018738|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
16419732|NCT03624127|40018739|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
16419733|NCT03624127|40018737|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
16419734|NCT03624127|40018738|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
16419735|NCT03624127|40018739|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
16419736|NCT03624127|40018737|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
16419737|NCT03624127|40018738|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
16419738|NCT03624127|40018739|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
16419739|NCT03624127|40018737|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
16419740|NCT03624127|40018738|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
16419741|NCT03624127|40018739|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
16419742|NCT03624127|40018737|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
16419743|NCT03624127|40018738|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
16419744|NCT03624127|40018739|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
16419745|NCT03624127|40018737|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
16419746|NCT03624127|40018738|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
16419747|NCT03624127|40018739|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
16419748|NCT03624127|40018737|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
16419749|NCT03624127|40018738|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
16419750|NCT03624127|40018739|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
16419751|NCT03624127|40018737|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
16419752|NCT03624127|40018738|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
16419753|NCT03624127|40018739|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
16419754|NCT03624127|40018737|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
16419755|NCT03624127|40018738|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
16419756|NCT03624127|40018739|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
16419757|NCT03624127|40018737|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
16419758|NCT03624127|40018738|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
16419759|NCT03624127|40018739|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
16419760|NCT03624127|40018737|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
16419761|NCT03624127|40018738|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
16419762|NCT03624127|40018739|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
16419763|NCT03624127|40018737|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
16419764|NCT03624127|40018738|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
16419765|NCT03624127|40018739|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
16419766|NCT03624127|40018737|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
16419767|NCT03624127|40018738|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
16419768|NCT03624127|40018739|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
16419769|NCT03624127|40018737|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
16419770|NCT03624127|40018738|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
16419771|NCT03624127|40018739|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
16419772|NCT03624127|40018737|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
16419773|NCT03624127|40018738|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
16419774|NCT03624127|40018739|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
16419775|NCT03675737|40018740|FG000|Overall Study|Death|593|||
16419776|NCT03675737|40018741|FG001|Overall Study|Death|660|||
16419777|NCT03675737|40018740|FG000|Overall Study|Lost to Follow-up|1|||
16419778|NCT03675737|40018741|FG001|Overall Study|Lost to Follow-up|5|||
16419779|NCT03675737|40018740|FG000|Overall Study|Physician Decision|1|||
16419780|NCT03675737|40018741|FG001|Overall Study|Physician Decision|0|||
16419781|NCT03675737|40018740|FG000|Overall Study|Withdrawal by Subject|14|||
16419782|NCT03675737|40018741|FG001|Overall Study|Withdrawal by Subject|12|||
16419783|NCT03675737|40018740|FG000|Overall Study|Ongoing in Study|181|||
16419784|NCT03675737|40018741|FG001|Overall Study|Ongoing in Study|112|||
16419785|NCT00360568|40018744|FG000|Overall Study|Adverse Event|1|||
16419786|NCT00360568|40018745|FG001|Overall Study|Adverse Event|2|||
16419787|NCT00360568|40018744|FG000|Overall Study|Lack of Efficacy|1|||
16419788|NCT00360568|40018745|FG001|Overall Study|Lack of Efficacy|0|||
16419789|NCT00360568|40018744|FG000|Overall Study|Withdrawal by Subject|0|||
16419790|NCT00360568|40018745|FG001|Overall Study|Withdrawal by Subject|3|||
16419791|NCT00148941|40018748|FG000|Overall Study|Lost to Follow-up|17|||
16419792|NCT00148941|40018749|FG001|Overall Study|Lost to Follow-up|24|||
16419793|NCT00148941|40018750|FG002|Overall Study|Lost to Follow-up|18|||
16419794|NCT00148941|40018751|FG003|Overall Study|Lost to Follow-up|22|||
16419795|NCT00148941|40018748|FG000|Overall Study|Withdrawal by Subject|1|||
16419796|NCT00148941|40018749|FG001|Overall Study|Withdrawal by Subject|0|||
16419797|NCT00148941|40018750|FG002|Overall Study|Withdrawal by Subject|1|||
16419798|NCT00148941|40018751|FG003|Overall Study|Withdrawal by Subject|0|||
16419799|NCT00148941|40018748|FG000|Overall Study|Other|0|||
16419800|NCT00148941|40018749|FG001|Overall Study|Other|0|||
16419801|NCT00148941|40018750|FG002|Overall Study|Other|1|||
16419802|NCT00148941|40018751|FG003|Overall Study|Other|2|||
16419803|NCT03908970|40018752|FG000|Overall Study|Adverse Event|7|||
16419804|NCT03908970|40018753|FG001|Overall Study|Adverse Event|21|||
16419805|NCT03908970|40018752|FG000|Overall Study|Physician Decision|1|||
16419806|NCT03908970|40018753|FG001|Overall Study|Physician Decision|4|||
16419807|NCT03908970|40018752|FG000|Overall Study|Withdrawal by Subject|9|||
16419808|NCT03908970|40018753|FG001|Overall Study|Withdrawal by Subject|22|||
16419809|NCT04356040|40018754|FG000|Overall Study|Death|2|||
16419810|NCT04356040|40018755|FG001|Overall Study|Death|0|||
16419811|NCT04356040|40018754|FG000|Overall Study|Lost to Follow-up|1|||
16419812|NCT04356040|40018755|FG001|Overall Study|Lost to Follow-up|0|||
16419813|NCT04356040|40018754|FG000|Overall Study|Physician Decision|0|||
16419814|NCT04356040|40018755|FG001|Overall Study|Physician Decision|1|||
16419815|NCT04356040|40018754|FG000|Overall Study|Withdrawal by Subject|13|||
16419816|NCT04356040|40018755|FG001|Overall Study|Withdrawal by Subject|1|||
16419817|NCT04356040|40018754|FG000|Overall Study|Enrollment Pause|10|||
16359417|NCT00143507|39804110|FG001|Overall Study|Withdrawal by Subject|102|||
16359418|NCT00143507|39804109|FG000|Overall Study|Lost to Follow-up|1|||
16359419|NCT00143507|39804110|FG001|Overall Study|Lost to Follow-up|0|||
16359420|NCT00143507|39804109|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
16359421|NCT00143507|39804110|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
16359422|NCT00091819|39804111|FG000|Overall Study|Adverse Event|1|||
16359423|NCT00091819|39804112|FG001|Overall Study|Adverse Event|1|||
16359424|NCT00091819|39804111|FG000|Overall Study|Death|4|||
16359425|NCT00091819|39804112|FG001|Overall Study|Death|5|||
16359426|NCT00091819|39804111|FG000|Overall Study|Lost to Follow-up|26|||
16359427|NCT00091819|39804112|FG001|Overall Study|Lost to Follow-up|23|||
16359428|NCT00091819|39804111|FG000|Overall Study|Withdrawal by Subject|5|||
16359429|NCT00091819|39804112|FG001|Overall Study|Withdrawal by Subject|8|||
16359430|NCT00091819|39804111|FG000|Overall Study|Protocol Violation|1|||
16359431|NCT00091819|39804112|FG001|Overall Study|Protocol Violation|2|||
16359432|NCT00091819|39804111|FG000|Overall Study|Other|2|||
16359433|NCT00091819|39804112|FG001|Overall Study|Other|3|||
16359434|NCT00091819|39804111|FG000|Overall Study|Never received study treatment|3|||
16419818|NCT04356040|40018755|FG001|Overall Study|Enrollment Pause|0|||
16419819|NCT04356040|40018754|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
16419820|NCT04356040|40018755|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
16419821|NCT04356040|40018754|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
16419822|NCT04356040|40018755|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
16419823|NCT04356040|40018754|FG000|Overall Study|PI left institution|3|||
16419824|NCT04356040|40018755|FG001|Overall Study|PI left institution|0|||
16419825|NCT02478255|40018760|FG000|Overall Study|Physician Decision|6|||
16419826|NCT02478255|40018761|FG001|Overall Study|Physician Decision|0|||
16419827|NCT02478255|40018760|FG000|Overall Study|Withdrawal by Subject|2|||
16419828|NCT02478255|40018761|FG001|Overall Study|Withdrawal by Subject|0|||
16419829|NCT00604695|40018764|FG000|Overall Study|Did not receive first bolus.|0|||
16419830|NCT00604695|40018765|FG001|Overall Study|Did not receive first bolus.|4|||
16419831|NCT00802893|40018769|FG000|Overall Study|study terminated|3|||
16419832|NCT04006392|40018775|FG000|Overall Study|Lost to Follow-up|0|||
16419833|NCT04006392|40018776|FG001|Overall Study|Lost to Follow-up|1|||
16419834|NCT03722524|40018777|FG000|Overall Study|Protocol Violation|86|||
16419835|NCT03722524|40018777|FG000|Overall Study|Adverse Event|7|||
16419836|NCT03722524|40018777|FG000|Overall Study|Lost to Follow-up|1|||
16419837|NCT03722524|40018777|FG000|Overall Study|Reason is not stated|1|||
16419838|NCT03722524|40018777|FG000|Overall Study|Physician Decision|1|||
16419839|NCT03722524|40018777|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
16419840|NCT00772109|40018778|FG000|Overall Study|Serious adverse event|1|||
16419841|NCT00772109|40018779|FG001|Overall Study|Serious adverse event|0|||
16419842|NCT00772109|40018780|FG002|Overall Study|Serious adverse event|1|||
16419843|NCT00772109|40018781|FG003|Overall Study|Serious adverse event|0|||
16419844|NCT00772109|40018778|FG000|Overall Study|Protocol Violation|5|||
16419845|NCT00772109|40018779|FG001|Overall Study|Protocol Violation|8|||
16419846|NCT00772109|40018780|FG002|Overall Study|Protocol Violation|7|||
16419847|NCT00772109|40018781|FG003|Overall Study|Protocol Violation|6|||
16419848|NCT00772109|40018778|FG000|Overall Study|Lost to Follow-up|7|||
16419849|NCT00772109|40018779|FG001|Overall Study|Lost to Follow-up|3|||
16419850|NCT00772109|40018780|FG002|Overall Study|Lost to Follow-up|5|||
16419851|NCT00772109|40018781|FG003|Overall Study|Lost to Follow-up|9|||
16248796|NCT00458302|39395250|FG001|Overall Study|Pregnancy|1|||
16359435|NCT00091819|39804112|FG001|Overall Study|Never received study treatment|4|||
16359436|NCT01541748|39804116|FG000|Overall Study|Lost to Follow-up|17|||
16419852|NCT00772109|40018778|FG000|Overall Study|Withdrawal by Subject|8|||
16419853|NCT00772109|40018779|FG001|Overall Study|Withdrawal by Subject|8|||
16419854|NCT00772109|40018780|FG002|Overall Study|Withdrawal by Subject|6|||
16419855|NCT00772109|40018781|FG003|Overall Study|Withdrawal by Subject|16|||
16419856|NCT01563185|40018786|FG000|Overall Study|Withdrawal by Subject|1|||
16419857|NCT01563185|40018786|FG000|Overall Study|Non-Compliance with study drug|1|||
16419858|NCT01712204|40018789|FG000|Overall Study|Adverse Event|3|||
16419859|NCT01712204|40018790|FG001|Overall Study|Adverse Event|1|||
16419860|NCT01712204|40018789|FG000|Overall Study|Withdrawal by Subject|3|||
16419861|NCT01712204|40018790|FG001|Overall Study|Withdrawal by Subject|3|||
16419862|NCT01712204|40018789|FG000|Overall Study|Lost to Follow-up|1|||
16419863|NCT01712204|40018790|FG001|Overall Study|Lost to Follow-up|0|||
16419864|NCT01712204|40018789|FG000|Overall Study|Protocol Violation|1|||
16419865|NCT01712204|40018790|FG001|Overall Study|Protocol Violation|1|||
16419866|NCT01113580|40018791|FG000|Overall Study|Protocol Violation|1|||
16419867|NCT01113580|40018792|FG001|Overall Study|Protocol Violation|0|||
16419868|NCT00629798|40018793|FG000|Overall Study|Not Treated|4|||
16419869|NCT02974842|40018801|FG000|Overall Study|Withdrawal by Subject|4|||
16419870|NCT02974842|40018801|FG000|Overall Study|Screen failures|4|||
16419871|NCT02322190|40018802|FG000|Overall Study|Death on study|1|||
16359437|NCT01541748|39804116|FG000|Overall Study|Moved out of state|1|||
16359438|NCT01541748|39804116|FG000|Overall Study|Withdrawal by Subject|7|||
16359439|NCT01541748|39804116|FG000|Overall Study|Screen failure|5|||
16359440|NCT01541748|39804116|FG000|Overall Study|Did not receive study device|1|||
16359441|NCT00639509|39804117|FG000|Overall Study|Death|1|||
16359442|NCT02029417|39804118|FG000|Overall Study|Death|1|||
16359443|NCT02029417|39804118|FG000|Overall Study|Adverse Event|1|||
16359444|NCT00644059|39804119|FG000|Overall Study|Lost to Follow-up|37|||
16359445|NCT00644059|39804120|FG001|Overall Study|Lost to Follow-up|34|||
16359446|NCT00644059|39804121|FG002|Overall Study|Lost to Follow-up|16|||
16359447|NCT00644059|39804119|FG000|Overall Study|Withdrawal by Subject|52|||
16359448|NCT00644059|39804120|FG001|Overall Study|Withdrawal by Subject|60|||
16359449|NCT00644059|39804121|FG002|Overall Study|Withdrawal by Subject|30|||
16359450|NCT00644059|39804119|FG000|Overall Study|Adverse Event|8|||
16419872|NCT02322190|40018803|FG001|Overall Study|Death on study|0|||
16419873|NCT00923845|40018810|FG000|Induction Therapy|Poor performance status|0|||
16419874|NCT00923845|40018811|FG001|Induction Therapy|Poor performance status|2|||
16419875|NCT00504894|40018812|FG000|Overall Study|fMRI technical problems|1|||
16419876|NCT00504894|40018813|FG001|Overall Study|fMRI technical problems|1|||
16419877|NCT00504894|40018814|FG002|Overall Study|fMRI technical problems|0|||
16419878|NCT00504894|40018812|FG000|Overall Study|Withdrawal by Subject|0|||
16419879|NCT00504894|40018813|FG001|Overall Study|Withdrawal by Subject|1|||
16419880|NCT00504894|40018814|FG002|Overall Study|Withdrawal by Subject|0|||
16419881|NCT00504894|40018812|FG000|Overall Study|Infusion technical problems|0|||
16419882|NCT00504894|40018813|FG001|Overall Study|Infusion technical problems|1|||
16419883|NCT00504894|40018814|FG002|Overall Study|Infusion technical problems|0|||
16419884|NCT00504894|40018812|FG000|Overall Study|poor subject data|2|||
16419885|NCT00504894|40018813|FG001|Overall Study|poor subject data|0|||
16419886|NCT00504894|40018814|FG002|Overall Study|poor subject data|0|||
16419887|NCT00666965|40018815|FG000|Overall Study|Adverse Event|0|||
16419888|NCT00666965|40018816|FG001|Overall Study|Adverse Event|2|||
16419889|NCT00666965|40018817|FG002|Overall Study|Adverse Event|1|||
16419890|NCT00666965|40018818|FG003|Overall Study|Adverse Event|9|||
16419891|NCT00666965|40018815|FG000|Overall Study|Lack of Efficacy|1|||
16419892|NCT00666965|40018816|FG001|Overall Study|Lack of Efficacy|1|||
16419893|NCT00666965|40018817|FG002|Overall Study|Lack of Efficacy|0|||
16419894|NCT00666965|40018818|FG003|Overall Study|Lack of Efficacy|0|||
16419895|NCT00666965|40018815|FG000|Overall Study|Protocol Violation|0|||
16419896|NCT00666965|40018816|FG001|Overall Study|Protocol Violation|0|||
16419897|NCT00666965|40018817|FG002|Overall Study|Protocol Violation|0|||
16419898|NCT00666965|40018818|FG003|Overall Study|Protocol Violation|2|||
16419899|NCT00666965|40018815|FG000|Overall Study|Discontinuation criteria|2|||
16419900|NCT00666965|40018816|FG001|Overall Study|Discontinuation criteria|1|||
16419901|NCT00666965|40018817|FG002|Overall Study|Discontinuation criteria|1|||
16359451|NCT00644059|39804120|FG001|Overall Study|Adverse Event|5|||
16419902|NCT00666965|40018818|FG003|Overall Study|Discontinuation criteria|2|||
16419903|NCT00666965|40018815|FG000|Overall Study|Withdrawal by Subject|0|||
16419904|NCT00666965|40018816|FG001|Overall Study|Withdrawal by Subject|0|||
16419905|NCT00666965|40018817|FG002|Overall Study|Withdrawal by Subject|0|||
16419906|NCT00666965|40018818|FG003|Overall Study|Withdrawal by Subject|2|||
16359452|NCT00644059|39804121|FG002|Overall Study|Adverse Event|1|||
16419907|NCT01894022|40018819|FG000|Overall Study|Death|1|||
16248797|NCT00458302|39395249|FG000|Overall Study|Protocol Violation|0|||
16359453|NCT00644059|39804119|FG000|Overall Study|Inappropriate Enrollment|1|||
16359454|NCT00644059|39804120|FG001|Overall Study|Inappropriate Enrollment|3|||
16419908|NCT01894022|40018820|FG001|Overall Study|Death|0|||
16419909|NCT01894022|40018819|FG000|Overall Study|Adverse Event, non-fatal|1|||
16419910|NCT01894022|40018820|FG001|Overall Study|Adverse Event, non-fatal|0|||
16419911|NCT01894022|40018819|FG000|Overall Study|Study Closed/terminated|7|||
16419912|NCT01894022|40018820|FG001|Overall Study|Study Closed/terminated|10|||
16419913|NCT02039856|40018821|FG000|Overall Study|Death|5|||
16419914|NCT02039856|40018822|FG001|Overall Study|Death|3|||
16419915|NCT02039856|40018821|FG000|Overall Study|Partial survey completion|61|||
16419916|NCT02039856|40018822|FG001|Overall Study|Partial survey completion|26|||
16419917|NCT02039856|40018821|FG000|Overall Study|Lost to Follow-up|388|||
16419918|NCT02039856|40018822|FG001|Overall Study|Lost to Follow-up|206|||
16419919|NCT02039856|40018821|FG000|Overall Study|Withdrawal by Subject|1573|||
16419920|NCT02039856|40018822|FG001|Overall Study|Withdrawal by Subject|618|||
16419921|NCT00527982|40018824|FG000|Overall Study|Physician Decision|1|||
16419922|NCT00527982|40018825|FG001|Overall Study|Physician Decision|0|||
16419923|NCT00812565|40018826|FG000|Overall Study|Did Not Receive Study Medication|1|||
16419924|NCT00812565|40018827|FG001|Overall Study|Did Not Receive Study Medication|1|||
16419925|NCT00812565|40018828|FG002|Overall Study|Did Not Receive Study Medication|0|||
16419926|NCT00812565|40018829|FG003|Overall Study|Did Not Receive Study Medication|0|||
16419927|NCT00812565|40018830|FG004|Overall Study|Did Not Receive Study Medication|0|||
16419928|NCT00812565|40018831|FG005|Overall Study|Did Not Receive Study Medication|0|||
16419929|NCT00812565|40018832|FG006|Overall Study|Did Not Receive Study Medication|0|||
16419930|NCT00812565|40018833|FG007|Overall Study|Did Not Receive Study Medication|0|||
16419931|NCT00812565|40018826|FG000|Overall Study|Adverse Event|0|||
16419932|NCT00812565|40018827|FG001|Overall Study|Adverse Event|0|||
16419933|NCT00812565|40018828|FG002|Overall Study|Adverse Event|0|||
16419934|NCT00812565|40018829|FG003|Overall Study|Adverse Event|2|||
16419935|NCT00812565|40018830|FG004|Overall Study|Adverse Event|0|||
16419936|NCT00812565|40018831|FG005|Overall Study|Adverse Event|0|||
16419937|NCT00812565|40018832|FG006|Overall Study|Adverse Event|0|||
16419938|NCT00812565|40018833|FG007|Overall Study|Adverse Event|1|||
16419939|NCT00812565|40018826|FG000|Overall Study|Did Not Come to Study Visit|1|||
16419940|NCT00812565|40018827|FG001|Overall Study|Did Not Come to Study Visit|0|||
16419941|NCT00812565|40018828|FG002|Overall Study|Did Not Come to Study Visit|0|||
16419942|NCT00812565|40018829|FG003|Overall Study|Did Not Come to Study Visit|0|||
16419943|NCT00812565|40018830|FG004|Overall Study|Did Not Come to Study Visit|0|||
16419944|NCT00812565|40018831|FG005|Overall Study|Did Not Come to Study Visit|0|||
16419945|NCT00812565|40018832|FG006|Overall Study|Did Not Come to Study Visit|0|||
16419946|NCT00812565|40018833|FG007|Overall Study|Did Not Come to Study Visit|0|||
16419947|NCT00812565|40018826|FG000|Overall Study|Withdrawal of Consent|1|||
16419948|NCT00812565|40018827|FG001|Overall Study|Withdrawal of Consent|0|||
16419949|NCT00812565|40018828|FG002|Overall Study|Withdrawal of Consent|0|||
16419950|NCT00812565|40018829|FG003|Overall Study|Withdrawal of Consent|0|||
16419951|NCT00812565|40018830|FG004|Overall Study|Withdrawal of Consent|1|||
16419952|NCT00812565|40018831|FG005|Overall Study|Withdrawal of Consent|0|||
16419953|NCT00812565|40018832|FG006|Overall Study|Withdrawal of Consent|0|||
16419954|NCT00812565|40018833|FG007|Overall Study|Withdrawal of Consent|0|||
16419955|NCT00812565|40018826|FG000|Overall Study|Reason Not Specified|0|||
16419956|NCT00812565|40018827|FG001|Overall Study|Reason Not Specified|0|||
16419957|NCT00812565|40018828|FG002|Overall Study|Reason Not Specified|0|||
16419958|NCT00812565|40018829|FG003|Overall Study|Reason Not Specified|0|||
16419959|NCT00812565|40018830|FG004|Overall Study|Reason Not Specified|0|||
16419960|NCT00812565|40018831|FG005|Overall Study|Reason Not Specified|1|||
16419961|NCT00812565|40018832|FG006|Overall Study|Reason Not Specified|0|||
16419962|NCT00812565|40018833|FG007|Overall Study|Reason Not Specified|0|||
16419963|NCT00064792|40018834|FG000|Overall Study|Withdrawal by Subject|2|||
16419964|NCT00064792|40018835|FG001|Overall Study|Withdrawal by Subject|0|||
16419965|NCT00064792|40018834|FG000|Overall Study|Adverse Event|3|||
16419966|NCT00064792|40018835|FG001|Overall Study|Adverse Event|0|||
16419967|NCT00428844|40018836|FG000|Completed Study Drug Treatment|Adverse Event|2|||
16419968|NCT00428844|40018837|FG001|Completed Study Drug Treatment|Adverse Event|4|||
16419969|NCT00428844|40018838|FG002|Completed Study Drug Treatment|Adverse Event|4|||
16419970|NCT00428844|40018836|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
16419971|NCT00428844|40018837|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
16419972|NCT00428844|40018838|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
16419973|NCT00428844|40018836|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
16419974|NCT00428844|40018837|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
16419975|NCT00428844|40018838|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
16419976|NCT00428844|40018836|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
16419977|NCT00428844|40018837|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
16419978|NCT00428844|40018838|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
16419979|NCT00428844|40018836|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
16419980|NCT00428844|40018837|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
16419981|NCT00428844|40018838|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
16419982|NCT00428844|40018836|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
16419983|NCT00428844|40018837|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
16419984|NCT00428844|40018838|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
16419985|NCT00428844|40018836|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
16419986|NCT00428844|40018837|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
16419987|NCT00428844|40018838|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
16419988|NCT00428844|40018836|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
16419989|NCT00428844|40018837|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
16419990|NCT00428844|40018838|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
16419991|NCT00428844|40018836|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
16419992|NCT00428844|40018837|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
16419993|NCT00428844|40018838|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
16419994|NCT03657095|40018839|FG000|Overall Study|Withdrawal by Subject|1|||
16419995|NCT03657095|40018840|FG001|Overall Study|Withdrawal by Subject|1|||
16419996|NCT03657095|40018839|FG000|Overall Study|Adverse Event|0|||
16419997|NCT03657095|40018840|FG001|Overall Study|Adverse Event|3|||
16419998|NCT03657095|40018839|FG000|Overall Study|Study Terminated by Sponsor|58|||
16419999|NCT03657095|40018840|FG001|Overall Study|Study Terminated by Sponsor|49|||
16420000|NCT01114438|40018843|FG000|Overall Study|Adverse Event|10|||
16420001|NCT01114438|40018843|FG000|Overall Study|concomitant medication|1|||
16420002|NCT01114438|40018843|FG000|Overall Study|Physician Decision|1|||
16420003|NCT01114438|40018843|FG000|Overall Study|Withdrawal by Subject|2|||
16420004|NCT01736618|40018844|FG000|Overall Study|Death|294|||
16420005|NCT01736618|40018844|FG000|Overall Study|Lost to Follow-up|193|||
16420006|NCT01736618|40018844|FG000|Overall Study|Withdrawal by Subject|54|||
16420007|NCT01736618|40018844|FG000|Overall Study|Subject unable to be followed at study location|223|||
16420008|NCT01736618|40018844|FG000|Overall Study|Physician Decision|33|||
16420009|NCT01736618|40018844|FG000|Overall Study|Transplant or removal of target organ|19|||
16420010|NCT01736618|40018844|FG000|Overall Study|Change in indication or condition|78|||
16420011|NCT01736618|40018844|FG000|Overall Study|Study device explant|103|||
16420012|NCT01736618|40018844|FG000|Overall Study|Unable to complete implant|2|||
16420013|NCT00195663|40018845|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
16420014|NCT00195663|40018846|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
16420015|NCT00195663|40018847|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
16420016|NCT00195663|40018845|FG000|2-year Double-blind Treatment Period|Death|0|||
16420017|NCT00195663|40018846|FG001|2-year Double-blind Treatment Period|Death|2|||
16420018|NCT00195663|40018847|FG002|2-year Double-blind Treatment Period|Death|0|||
16359455|NCT00644059|39804121|FG002|Overall Study|Inappropriate Enrollment|0|||
16359456|NCT00644059|39804119|FG000|Overall Study|Protocol Deviation/violation|20|||
16359457|NCT00644059|39804120|FG001|Overall Study|Protocol Deviation/violation|19|||
16359458|NCT00644059|39804121|FG002|Overall Study|Protocol Deviation/violation|15|||
16359459|NCT00644059|39804119|FG000|Overall Study|Unable to classify|6|||
16359460|NCT00644059|39804120|FG001|Overall Study|Unable to classify|2|||
16359461|NCT00644059|39804121|FG002|Overall Study|Unable to classify|3|||
16359462|NCT00390013|39804124|FG000|Phase 1|tired|0|||
16359463|NCT00390013|39804125|FG001|Phase 1|tired|0|||
16359464|NCT00390013|39804126|FG002|Phase 1|tired|0|||
16359465|NCT00390013|39804127|FG003|Phase 1|tired|1|||
16359466|NCT00390013|39804124|FG000|Phase 2 First Treatment|tired|1|||
16359467|NCT00390013|39804125|FG001|Phase 2 First Treatment|tired|0|||
16359468|NCT00390013|39804126|FG002|Phase 2 First Treatment|tired|0|||
16359469|NCT00390013|39804127|FG003|Phase 2 First Treatment|tired|0|||
16359470|NCT00390013|39804124|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
16359471|NCT00390013|39804125|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
16359472|NCT00390013|39804126|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
16359473|NCT00390013|39804127|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
16359474|NCT03095287|39804128|FG000|Overall Study|Treatment Failure|1|||
16359475|NCT03095287|39804128|FG000|Overall Study|Adverse Event|1|||
16359476|NCT01125930|39804129|FG000|Overall Study|Adverse Event|0|||
16359477|NCT01125930|39804130|FG001|Overall Study|Adverse Event|1|||
16359478|NCT01125930|39804129|FG000|Overall Study|Withdrawal by Subject|1|||
16359479|NCT01125930|39804130|FG001|Overall Study|Withdrawal by Subject|6|||
16359480|NCT01125930|39804129|FG000|Overall Study|Protocol Violation|0|||
16420019|NCT00195663|40018845|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
16359481|NCT01125930|39804130|FG001|Overall Study|Protocol Violation|1|||
16359482|NCT01125930|39804129|FG000|Overall Study|Lost to Follow-up|0|||
16359483|NCT01125930|39804130|FG001|Overall Study|Lost to Follow-up|2|||
16359484|NCT00903968|39804131|FG000|Overall Study|Adverse Event|0|||
16359485|NCT00903968|39804132|FG001|Overall Study|Adverse Event|0|||
16359486|NCT00903968|39804133|FG002|Overall Study|Adverse Event|0|||
16359487|NCT00903968|39804134|FG003|Overall Study|Adverse Event|0|||
16359488|NCT00903968|39804135|FG004|Overall Study|Adverse Event|0|||
16359489|NCT00903968|39804136|FG005|Overall Study|Adverse Event|0|||
16359490|NCT00903968|39804137|FG006|Overall Study|Adverse Event|1|||
16359491|NCT00903968|39804138|FG007|Overall Study|Adverse Event|8|||
16359492|NCT00903968|39804131|FG000|Overall Study|DLT|0|||
16359493|NCT00903968|39804132|FG001|Overall Study|DLT|0|||
16359494|NCT00903968|39804133|FG002|Overall Study|DLT|0|||
16359495|NCT00903968|39804134|FG003|Overall Study|DLT|0|||
16359496|NCT00903968|39804135|FG004|Overall Study|DLT|0|||
16359497|NCT00903968|39804136|FG005|Overall Study|DLT|0|||
16359498|NCT00903968|39804137|FG006|Overall Study|DLT|2|||
16359499|NCT00903968|39804138|FG007|Overall Study|DLT|0|||
16359500|NCT00903968|39804131|FG000|Overall Study|Withdrawal by Subject|1|||
16359501|NCT00903968|39804132|FG001|Overall Study|Withdrawal by Subject|0|||
16359502|NCT00903968|39804133|FG002|Overall Study|Withdrawal by Subject|1|||
16359503|NCT00903968|39804134|FG003|Overall Study|Withdrawal by Subject|0|||
16359504|NCT00903968|39804135|FG004|Overall Study|Withdrawal by Subject|1|||
16359505|NCT00903968|39804136|FG005|Overall Study|Withdrawal by Subject|1|||
16359506|NCT00903968|39804137|FG006|Overall Study|Withdrawal by Subject|0|||
16359507|NCT00903968|39804138|FG007|Overall Study|Withdrawal by Subject|4|||
16359508|NCT00903968|39804131|FG000|Overall Study|Non-Compliance|0|||
16359509|NCT00903968|39804132|FG001|Overall Study|Non-Compliance|0|||
16359510|NCT00903968|39804133|FG002|Overall Study|Non-Compliance|0|||
16359511|NCT00903968|39804134|FG003|Overall Study|Non-Compliance|0|||
16359512|NCT00903968|39804135|FG004|Overall Study|Non-Compliance|0|||
16359513|NCT00903968|39804136|FG005|Overall Study|Non-Compliance|1|||
16420020|NCT00195663|40018846|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
16420021|NCT00195663|40018847|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
16420022|NCT00195663|40018845|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
16420023|NCT00195663|40018846|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
16420024|NCT00195663|40018847|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
16420025|NCT00195663|40018845|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
16420026|NCT00195663|40018846|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
16420027|NCT00195663|40018847|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
16420028|NCT00195663|40018845|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
16420029|NCT00195663|40018846|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
16420030|NCT00195663|40018847|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
16420031|NCT00195663|40018845|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
16420032|NCT00195663|40018846|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
16420033|NCT00195663|40018847|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
16420034|NCT00195663|40018845|FG000|2-year Double-blind Treatment Period|Recovery|1|||
16420035|NCT00195663|40018846|FG001|2-year Double-blind Treatment Period|Recovery|0|||
16420036|NCT00195663|40018847|FG002|2-year Double-blind Treatment Period|Recovery|1|||
16420037|NCT00195663|40018845|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
16420038|NCT00195663|40018846|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
16420039|NCT00195663|40018847|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
16420040|NCT00195663|40018845|FG000|Open-Label Extension Period|Adverse Event|21|||
16420041|NCT00195663|40018846|FG001|Open-Label Extension Period|Adverse Event|32|||
16420042|NCT00195663|40018847|FG002|Open-Label Extension Period|Adverse Event|36|||
16420043|NCT00195663|40018845|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
16420044|NCT00195663|40018846|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
16420045|NCT00195663|40018847|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
16420046|NCT00195663|40018845|FG000|Open-Label Extension Period|Recovery|0|||
16420047|NCT00195663|40018846|FG001|Open-Label Extension Period|Recovery|2|||
16420048|NCT00195663|40018847|FG002|Open-Label Extension Period|Recovery|2|||
16420049|NCT00195663|40018845|FG000|Open-Label Extension Period|Protocol Violation|3|||
16420050|NCT00195663|40018846|FG001|Open-Label Extension Period|Protocol Violation|4|||
16420051|NCT00195663|40018847|FG002|Open-Label Extension Period|Protocol Violation|4|||
16420052|NCT00195663|40018845|FG000|Open-Label Extension Period|Death|2|||
16420053|NCT00195663|40018846|FG001|Open-Label Extension Period|Death|2|||
16420054|NCT00195663|40018847|FG002|Open-Label Extension Period|Death|2|||
16562285|NCT01089556|40525367|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
16562286|NCT01089556|40525368|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
16562287|NCT01089556|40525369|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
16562288|NCT01089556|40525370|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
16562289|NCT01089556|40525371|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
16359514|NCT00903968|39804137|FG006|Overall Study|Non-Compliance|0|||
16359515|NCT00903968|39804138|FG007|Overall Study|Non-Compliance|0|||
16359516|NCT00903968|39804131|FG000|Overall Study|Physician Decision|0|||
16359517|NCT00903968|39804132|FG001|Overall Study|Physician Decision|0|||
16359518|NCT00903968|39804133|FG002|Overall Study|Physician Decision|0|||
16359519|NCT00903968|39804134|FG003|Overall Study|Physician Decision|0|||
16359520|NCT00903968|39804135|FG004|Overall Study|Physician Decision|0|||
16359521|NCT00903968|39804136|FG005|Overall Study|Physician Decision|1|||
16420055|NCT00195663|40018845|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
16420056|NCT00195663|40018846|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
16420057|NCT00195663|40018847|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
16420058|NCT00195663|40018845|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
16420059|NCT00195663|40018846|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
16420060|NCT00195663|40018847|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
16420061|NCT00195663|40018845|FG000|Open-Label Extension Period|Administrative reasons|11|||
16420062|NCT00195663|40018846|FG001|Open-Label Extension Period|Administrative reasons|11|||
16420063|NCT00195663|40018847|FG002|Open-Label Extension Period|Administrative reasons|13|||
16420064|NCT02396589|40018848|FG000|Intervention|Lost to Follow-up|1|||
16420065|NCT02396589|40018849|FG001|Intervention|Lost to Follow-up|0|||
16420066|NCT02396589|40018848|FG000|6 Month Follow-up|change in health status|0|||
16420067|NCT02396589|40018849|FG001|6 Month Follow-up|change in health status|1|||
16420068|NCT02396589|40018848|FG000|9 Month Follow-up|Death|0|||
16420069|NCT02396589|40018849|FG001|9 Month Follow-up|Death|1|||
16420070|NCT02396589|40018848|FG000|12 Month Follow up|Lost to Follow-up|0|||
16420071|NCT02396589|40018849|FG001|12 Month Follow up|Lost to Follow-up|2|||
16420072|NCT02161757|40018850|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
16420073|NCT02161757|40018851|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
16420074|NCT02161757|40018852|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
16420075|NCT02161757|40018850|FG000|Treatment Through Study Completion|Adverse Event|1|||
16420076|NCT02161757|40018851|FG001|Treatment Through Study Completion|Adverse Event|1|||
16420077|NCT02161757|40018852|FG002|Treatment Through Study Completion|Adverse Event|0|||
16420078|NCT02161757|40018850|FG000|Treatment Through Study Completion|Protocol Violation|0|||
16420079|NCT02161757|40018851|FG001|Treatment Through Study Completion|Protocol Violation|1|||
16420080|NCT02161757|40018852|FG002|Treatment Through Study Completion|Protocol Violation|2|||
16420081|NCT02161757|40018850|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
16420082|NCT02161757|40018851|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
16420083|NCT02161757|40018852|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
16420084|NCT02161757|40018850|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
16420085|NCT02161757|40018851|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
16420086|NCT02161757|40018852|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
16420087|NCT02161757|40018850|FG000|Treatment Through Study Completion|Other|20|||
16420088|NCT02161757|40018851|FG001|Treatment Through Study Completion|Other|19|||
16420089|NCT02161757|40018852|FG002|Treatment Through Study Completion|Other|12|||
16420090|NCT02161757|40018850|FG000|Treatment Through Study Completion|Death|2|||
16420091|NCT02161757|40018851|FG001|Treatment Through Study Completion|Death|1|||
16420092|NCT02161757|40018852|FG002|Treatment Through Study Completion|Death|1|||
16420093|NCT02678923|40018853|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
16420094|NCT02678923|40018854|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
16420095|NCT02678923|40018853|FG000|Overall Study|Withdrawal by Subject|3|||
16420096|NCT02678923|40018854|FG001|Overall Study|Withdrawal by Subject|2|||
16420097|NCT02678923|40018853|FG000|Overall Study|Lost to Follow-up|1|||
16420098|NCT02678923|40018854|FG001|Overall Study|Lost to Follow-up|0|||
16420099|NCT02678923|40018853|FG000|Overall Study|Did Not Return for Study Visits|1|||
16420100|NCT02678923|40018854|FG001|Overall Study|Did Not Return for Study Visits|0|||
16420101|NCT02119663|40018856|FG000|Overall Study|Disease progression|26|||
16420102|NCT02119663|40018857|FG001|Overall Study|Disease progression|27|||
16420103|NCT02119663|40018856|FG000|Overall Study|Adverse Event|5|||
16420104|NCT02119663|40018857|FG001|Overall Study|Adverse Event|5|||
16420105|NCT02119663|40018856|FG000|Overall Study|Death|3|||
16420106|NCT02119663|40018857|FG001|Overall Study|Death|2|||
16420107|NCT02119663|40018856|FG000|Overall Study|Physician Decision|1|||
16420108|NCT02119663|40018857|FG001|Overall Study|Physician Decision|2|||
16420109|NCT02119663|40018856|FG000|Overall Study|Other unspecified|2|||
16420110|NCT02119663|40018857|FG001|Overall Study|Other unspecified|0|||
16420111|NCT02119663|40018856|FG000|Overall Study|Subject decision|0|||
16420112|NCT02119663|40018857|FG001|Overall Study|Subject decision|1|||
16420113|NCT02119663|40018856|FG000|Overall Study|Study Terminated by the Sponsor|3|||
16420114|NCT02119663|40018857|FG001|Overall Study|Study Terminated by the Sponsor|4|||
16420115|NCT00167310|40018858|FG000|Overall Study|Protocol Violation|5|||
16420116|NCT00167310|40018859|FG001|Overall Study|Protocol Violation|3|||
16420117|NCT00167310|40018858|FG000|Overall Study|Withdrawal by Subject|3|||
16420118|NCT00167310|40018859|FG001|Overall Study|Withdrawal by Subject|7|||
16420119|NCT01959243|40018868|FG000|Overall Study|Investigator Decision|3|||
16420120|NCT01959243|40018869|FG001|Overall Study|Investigator Decision|0|||
16420121|NCT01959243|40018868|FG000|Overall Study|Adverse Event|5|||
16420122|NCT01959243|40018869|FG001|Overall Study|Adverse Event|2|||
16420123|NCT01959243|40018868|FG000|Overall Study|Administrative reasons|2|||
16420124|NCT01959243|40018869|FG001|Overall Study|Administrative reasons|1|||
16420125|NCT01959243|40018868|FG000|Overall Study|Lost to Follow-up|3|||
16420126|NCT01959243|40018869|FG001|Overall Study|Lost to Follow-up|1|||
16420127|NCT01192412|40018872|FG000|Overall Study|Lost to Follow-up|2|||
16420128|NCT01192412|40018873|FG001|Overall Study|Lost to Follow-up|1|||
16420129|NCT01192412|40018872|FG000|Overall Study|Withdrawal by Subject|2|||
16420130|NCT01192412|40018873|FG001|Overall Study|Withdrawal by Subject|1|||
16420131|NCT03664765|40018883|FG000|Overall Study|Withdrawal by Subject|4|||
16420132|NCT03664765|40018884|FG001|Overall Study|Withdrawal by Subject|1|||
16420133|NCT03664765|40018883|FG000|Overall Study|Lost to Follow-up|0|||
16420134|NCT03664765|40018884|FG001|Overall Study|Lost to Follow-up|1|||
16420135|NCT00727558|40018885|FG000|Overall Study|Lens issue|0|||
16420136|NCT00727558|40018886|FG001|Overall Study|Lens issue|1|||
16420137|NCT00727558|40018885|FG000|Overall Study|Adverse Event|0|||
16420138|NCT00727558|40018886|FG001|Overall Study|Adverse Event|1|||
16420139|NCT00727558|40018885|FG000|Overall Study|Subject unable to return for follow-up|1|||
16420140|NCT00727558|40018886|FG001|Overall Study|Subject unable to return for follow-up|1|||
16420141|NCT00727558|40018885|FG000|Overall Study|Lost to Follow-up|1|||
16420142|NCT00727558|40018886|FG001|Overall Study|Lost to Follow-up|0|||
16420143|NCT02126839|40018887|FG000|Overall Study|Adverse Event|0|||
16420144|NCT02126839|40018888|FG001|Overall Study|Adverse Event|1|||
16420145|NCT02126839|40018887|FG000|Overall Study|Withdrawal by Subject|1|||
16420146|NCT02126839|40018888|FG001|Overall Study|Withdrawal by Subject|0|||
16420147|NCT02126839|40018887|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16420148|NCT02126839|40018888|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16420149|NCT02126839|40018887|FG000|Overall Study|Protocol Violation|2|||
16420150|NCT02126839|40018888|FG001|Overall Study|Protocol Violation|3|||
16420151|NCT02126839|40018887|FG000|Overall Study|Sponsor request|0|||
16420152|NCT02126839|40018888|FG001|Overall Study|Sponsor request|1|||
16420153|NCT02126839|40018887|FG000|Overall Study|Lost to Follow-up|1|||
16420154|NCT02126839|40018888|FG001|Overall Study|Lost to Follow-up|4|||
16420155|NCT02126839|40018887|FG000|Overall Study|Other|5|||
16420156|NCT02126839|40018888|FG001|Overall Study|Other|5|||
16420157|NCT02554981|40018889|FG000|Overall Study|Adverse Event|1|||
16420158|NCT02554981|40018889|FG000|Overall Study|Administrative Reasons|1|||
16420159|NCT02554981|40018889|FG000|Overall Study|Other Miscellaneous Reasons|3|||
16420160|NCT02669121|40018890|FG000|Overall Study|Adverse Event|4|||
16420161|NCT02669121|40018891|FG001|Overall Study|Adverse Event|5|||
16420162|NCT02669121|40018890|FG000|Overall Study|Lost to Follow-up|15|||
16420163|NCT02669121|40018891|FG001|Overall Study|Lost to Follow-up|27|||
16420164|NCT02669121|40018890|FG000|Overall Study|Withdrawal by Subject|132|||
16420165|NCT02669121|40018891|FG001|Overall Study|Withdrawal by Subject|140|||
16130811|NCT00825825|38967136|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
16130812|NCT00825825|38967137|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
16130813|NCT00825825|38967138|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
16130814|NCT00825825|38967139|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
16130815|NCT00825825|38967140|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
16130816|NCT00825825|38967141|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
16130817|NCT00825825|38967136|FG000|Third Medication Period (14 Days)|poor data quality|0|||
16420166|NCT02669121|40018890|FG000|Overall Study|Pregnancy|0|||
16420167|NCT02669121|40018891|FG001|Overall Study|Pregnancy|1|||
16420168|NCT02669121|40018890|FG000|Overall Study|Discharged from US Military Active Service|117|||
16420169|NCT02669121|40018891|FG001|Overall Study|Discharged from US Military Active Service|91|||
16420170|NCT02669121|40018890|FG000|Overall Study|Reason not Specified|22|||
16420171|NCT02669121|40018891|FG001|Overall Study|Reason not Specified|18|||
16420172|NCT03755661|40018893|FG000|Overall Study|Lost to Follow-up|1|||
16420173|NCT03755661|40018894|FG001|Overall Study|Lost to Follow-up|0|||
16420174|NCT00398320|40018895|FG000|Overall Study|Death|1|||
16420175|NCT00398320|40018895|FG000|Overall Study|Adverse Event|4|||
16420176|NCT00398320|40018895|FG000|Overall Study|Physician Decision|1|||
16420177|NCT00348309|40018896|FG000|Overall Study|Adverse Event|56|||
16420178|NCT00348309|40018897|FG001|Overall Study|Adverse Event|28|||
16420179|NCT00348309|40018898|FG002|Overall Study|Adverse Event|63|||
16420180|NCT00348309|40018896|FG000|Overall Study|Lost to Follow-up|6|||
16420181|NCT00348309|40018897|FG001|Overall Study|Lost to Follow-up|7|||
16420182|NCT00348309|40018898|FG002|Overall Study|Lost to Follow-up|4|||
16420183|NCT00348309|40018896|FG000|Overall Study|Protocol Violation|7|||
16420184|NCT00348309|40018897|FG001|Overall Study|Protocol Violation|12|||
16420185|NCT00348309|40018898|FG002|Overall Study|Protocol Violation|7|||
16420186|NCT00348309|40018896|FG000|Overall Study|Withdrawal by Subject|33|||
16420187|NCT00348309|40018897|FG001|Overall Study|Withdrawal by Subject|37|||
16420188|NCT00348309|40018898|FG002|Overall Study|Withdrawal by Subject|40|||
16420189|NCT00348309|40018896|FG000|Overall Study|Non-compliance|8|||
16420190|NCT00348309|40018897|FG001|Overall Study|Non-compliance|6|||
16420191|NCT00348309|40018898|FG002|Overall Study|Non-compliance|8|||
16420192|NCT00348309|40018896|FG000|Overall Study|Death of caregiver|1|||
16420193|NCT00348309|40018897|FG001|Overall Study|Death of caregiver|0|||
16420194|NCT00348309|40018898|FG002|Overall Study|Death of caregiver|1|||
16420195|NCT00348309|40018896|FG000|Overall Study|Lack of insight, dementia|1|||
16420196|NCT00348309|40018897|FG001|Overall Study|Lack of insight, dementia|0|||
16420197|NCT00348309|40018898|FG002|Overall Study|Lack of insight, dementia|0|||
16420198|NCT00348309|40018896|FG000|Overall Study|Wrong bottle allocated|1|||
16420199|NCT00348309|40018897|FG001|Overall Study|Wrong bottle allocated|0|||
16420200|NCT00348309|40018898|FG002|Overall Study|Wrong bottle allocated|0|||
16420201|NCT00348309|40018896|FG000|Overall Study|Caregiver sick|1|||
16420202|NCT00348309|40018897|FG001|Overall Study|Caregiver sick|0|||
16420203|NCT00348309|40018898|FG002|Overall Study|Caregiver sick|0|||
16420204|NCT00348309|40018896|FG000|Overall Study|Use of prohibited medication|5|||
16420205|NCT00348309|40018897|FG001|Overall Study|Use of prohibited medication|2|||
16420206|NCT00348309|40018898|FG002|Overall Study|Use of prohibited medication|2|||
16420207|NCT00348309|40018896|FG000|Overall Study|Caregiver withdrawal|3|||
16420208|NCT00348309|40018897|FG001|Overall Study|Caregiver withdrawal|0|||
16420209|NCT00348309|40018898|FG002|Overall Study|Caregiver withdrawal|7|||
16420210|NCT00348309|40018896|FG000|Overall Study|Unable to complete ET visit|1|||
16420211|NCT00348309|40018897|FG001|Overall Study|Unable to complete ET visit|0|||
16420212|NCT00348309|40018898|FG002|Overall Study|Unable to complete ET visit|0|||
16420213|NCT00348309|40018896|FG000|Overall Study|PI closing medical practice|1|||
16420214|NCT00348309|40018897|FG001|Overall Study|PI closing medical practice|0|||
16420215|NCT00348309|40018898|FG002|Overall Study|PI closing medical practice|0|||
16420216|NCT00348309|40018896|FG000|Overall Study|Principal investigator's decision|1|||
16420217|NCT00348309|40018897|FG001|Overall Study|Principal investigator's decision|0|||
16420218|NCT00348309|40018898|FG002|Overall Study|Principal investigator's decision|0|||
16420219|NCT00348309|40018896|FG000|Overall Study|No disponibility of medication|1|||
16420220|NCT00348309|40018897|FG001|Overall Study|No disponibility of medication|0|||
16420221|NCT00348309|40018898|FG002|Overall Study|No disponibility of medication|0|||
16420222|NCT00348309|40018896|FG000|Overall Study|Worsened neurodegenerative disease|1|||
16420223|NCT00348309|40018897|FG001|Overall Study|Worsened neurodegenerative disease|0|||
16420224|NCT00348309|40018898|FG002|Overall Study|Worsened neurodegenerative disease|0|||
16420225|NCT00348309|40018896|FG000|Overall Study|Cognitive and behaviour worsening|2|||
16420226|NCT00348309|40018897|FG001|Overall Study|Cognitive and behaviour worsening|0|||
16420227|NCT00348309|40018898|FG002|Overall Study|Cognitive and behaviour worsening|0|||
16420228|NCT00348309|40018896|FG000|Overall Study|Worsening of alzheimer|1|||
16420229|NCT00348309|40018897|FG001|Overall Study|Worsening of alzheimer|0|||
16420230|NCT00348309|40018898|FG002|Overall Study|Worsening of alzheimer|1|||
16420231|NCT00348309|40018896|FG000|Overall Study|Did not appear in time for Visit 3|1|||
16420232|NCT00348309|40018897|FG001|Overall Study|Did not appear in time for Visit 3|0|||
16420233|NCT00348309|40018898|FG002|Overall Study|Did not appear in time for Visit 3|0|||
16420234|NCT00348309|40018896|FG000|Overall Study|Participant died|2|||
16420235|NCT00348309|40018897|FG001|Overall Study|Participant died|1|||
16420236|NCT00348309|40018898|FG002|Overall Study|Participant died|1|||
16420237|NCT00348309|40018896|FG000|Overall Study|Decision of sponsor|1|||
16420238|NCT00348309|40018897|FG001|Overall Study|Decision of sponsor|0|||
16420239|NCT00348309|40018898|FG002|Overall Study|Decision of sponsor|0|||
16420240|NCT00348309|40018896|FG000|Overall Study|Ineffectiveness of treatment|0|||
16420241|NCT00348309|40018897|FG001|Overall Study|Ineffectiveness of treatment|1|||
16420242|NCT00348309|40018898|FG002|Overall Study|Ineffectiveness of treatment|0|||
16420243|NCT00348309|40018896|FG000|Overall Study|A foul of exclusion criteria|0|||
16420244|NCT00348309|40018897|FG001|Overall Study|A foul of exclusion criteria|1|||
16420245|NCT00348309|40018898|FG002|Overall Study|A foul of exclusion criteria|0|||
16420246|NCT00348309|40018896|FG000|Overall Study|Participant was hospitalized|0|||
16420247|NCT00348309|40018897|FG001|Overall Study|Participant was hospitalized|1|||
16420248|NCT00348309|40018898|FG002|Overall Study|Participant was hospitalized|0|||
16420249|NCT00348309|40018896|FG000|Overall Study|Sponsor refuseal|0|||
16420250|NCT00348309|40018897|FG001|Overall Study|Sponsor refuseal|1|||
16420251|NCT00348309|40018898|FG002|Overall Study|Sponsor refuseal|1|||
16420252|NCT00348309|40018896|FG000|Overall Study|Forgot often medication|0|||
16420253|NCT00348309|40018897|FG001|Overall Study|Forgot often medication|1|||
16420254|NCT00348309|40018898|FG002|Overall Study|Forgot often medication|0|||
16420255|NCT00348309|40018896|FG000|Overall Study|Medical Monitor decision|0|||
16420256|NCT00348309|40018897|FG001|Overall Study|Medical Monitor decision|0|||
16420257|NCT00348309|40018898|FG002|Overall Study|Medical Monitor decision|1|||
16420258|NCT00348309|40018896|FG000|Overall Study|Increased dose of Aricept|0|||
16420259|NCT00348309|40018897|FG001|Overall Study|Increased dose of Aricept|0|||
16420260|NCT00348309|40018898|FG002|Overall Study|Increased dose of Aricept|1|||
16420261|NCT00348309|40018896|FG000|Overall Study|Site closure|0|||
16420262|NCT00348309|40018897|FG001|Overall Study|Site closure|0|||
16420263|NCT00348309|40018898|FG002|Overall Study|Site closure|1|||
16420264|NCT00348309|40018896|FG000|Overall Study|Adverse event not attended|0|||
16420265|NCT00348309|40018897|FG001|Overall Study|Adverse event not attended|0|||
16420266|NCT00348309|40018898|FG002|Overall Study|Adverse event not attended|1|||
16420267|NCT00348309|40018896|FG000|Overall Study|ECG abnormal|0|||
16420268|NCT00348309|40018897|FG001|Overall Study|ECG abnormal|0|||
16420269|NCT00348309|40018898|FG002|Overall Study|ECG abnormal|2|||
16420270|NCT00348309|40018896|FG000|Overall Study|Cardiologist recommendations|0|||
16420271|NCT00348309|40018897|FG001|Overall Study|Cardiologist recommendations|0|||
16420272|NCT00348309|40018898|FG002|Overall Study|Cardiologist recommendations|1|||
16420273|NCT00348309|40018896|FG000|Overall Study|HCV career|0|||
16420274|NCT00348309|40018897|FG001|Overall Study|HCV career|0|||
16420275|NCT00348309|40018898|FG002|Overall Study|HCV career|1|||
16420276|NCT03197376|40018899|FG000|Primary and Booster Phase|Adverse Event|0|||
16420277|NCT03197376|40018900|FG001|Primary and Booster Phase|Adverse Event|0|||
16420278|NCT03197376|40018901|FG002|Primary and Booster Phase|Adverse Event|0|||
16562290|NCT01089556|40525372|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
16420279|NCT03197376|40018902|FG003|Primary and Booster Phase|Adverse Event|1|||
16420280|NCT03197376|40018899|FG000|Primary and Booster Phase|Death|1|||
16420281|NCT03197376|40018900|FG001|Primary and Booster Phase|Death|0|||
16420282|NCT03197376|40018901|FG002|Primary and Booster Phase|Death|0|||
16420283|NCT03197376|40018902|FG003|Primary and Booster Phase|Death|2|||
16420284|NCT03197376|40018899|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
16420285|NCT03197376|40018900|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
16420286|NCT03197376|40018901|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
16420287|NCT03197376|40018902|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
16420288|NCT03197376|40018899|FG000|Primary and Booster Phase|Physician Decision|1|||
16562291|NCT03850444|40525373|FG000|Overall Study|Adverse Event|16|||
16562292|NCT03850444|40525374|FG001|Overall Study|Adverse Event|10|||
16420289|NCT03197376|40018900|FG001|Primary and Booster Phase|Physician Decision|0|||
16420290|NCT03197376|40018901|FG002|Primary and Booster Phase|Physician Decision|1|||
16562293|NCT03850444|40525373|FG000|Overall Study|Death|87|||
16420291|NCT03197376|40018902|FG003|Primary and Booster Phase|Physician Decision|3|||
16420292|NCT03197376|40018899|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
16420293|NCT03197376|40018900|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
16420294|NCT03197376|40018901|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
16420295|NCT03197376|40018902|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
16420296|NCT03197376|40018899|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
16420297|NCT03197376|40018900|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
16420298|NCT03197376|40018901|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
16420299|NCT03197376|40018902|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
16420300|NCT03197376|40018899|FG000|Primary and Booster Phase|Not vaccine related|1|||
16420301|NCT03197376|40018900|FG001|Primary and Booster Phase|Not vaccine related|2|||
16420302|NCT03197376|40018901|FG002|Primary and Booster Phase|Not vaccine related|0|||
16420303|NCT03197376|40018902|FG003|Primary and Booster Phase|Not vaccine related|6|||
16420304|NCT03197376|40018899|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
16420305|NCT03197376|40018900|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
16420306|NCT03197376|40018901|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
16420307|NCT03197376|40018902|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
16420308|NCT03197376|40018899|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
16420309|NCT03197376|40018900|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
16420310|NCT03197376|40018901|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
16420311|NCT03197376|40018902|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
16420312|NCT03197376|40018899|FG000|Immune Persistence Phase|Not vaccine related|1|||
16420313|NCT03197376|40018900|FG001|Immune Persistence Phase|Not vaccine related|0|||
16420314|NCT03197376|40018901|FG002|Immune Persistence Phase|Not vaccine related|1|||
16420315|NCT03197376|40018902|FG003|Immune Persistence Phase|Not vaccine related|1|||
16420316|NCT02292706|40018904|FG000|Overall Study|Lost to Follow-up|20|||
16420317|NCT02292706|40018905|FG001|Overall Study|Lost to Follow-up|44|||
16420318|NCT02292706|40018906|FG002|Overall Study|Lost to Follow-up|24|||
16420319|NCT02292706|40018907|FG003|Overall Study|Lost to Follow-up|61|||
16420320|NCT02292706|40018908|FG004|Overall Study|Lost to Follow-up|21|||
16420321|NCT02292706|40018909|FG005|Overall Study|Lost to Follow-up|52|||
16420322|NCT02292706|40018910|FG006|Overall Study|Lost to Follow-up|25|||
16420323|NCT02292706|40018911|FG007|Overall Study|Lost to Follow-up|0|||
16420324|NCT02292706|40018904|FG000|Overall Study|Withdrew consent|15|||
16420325|NCT02292706|40018905|FG001|Overall Study|Withdrew consent|56|||
16420326|NCT02292706|40018906|FG002|Overall Study|Withdrew consent|43|||
16420327|NCT02292706|40018907|FG003|Overall Study|Withdrew consent|36|||
16420328|NCT02292706|40018908|FG004|Overall Study|Withdrew consent|13|||
16420329|NCT02292706|40018909|FG005|Overall Study|Withdrew consent|51|||
16420330|NCT02292706|40018910|FG006|Overall Study|Withdrew consent|20|||
16420331|NCT02292706|40018911|FG007|Overall Study|Withdrew consent|0|||
16420332|NCT02292706|40018904|FG000|Overall Study|Death|3|||
16420333|NCT02292706|40018905|FG001|Overall Study|Death|11|||
16420334|NCT02292706|40018906|FG002|Overall Study|Death|16|||
16420335|NCT02292706|40018907|FG003|Overall Study|Death|22|||
16420336|NCT02292706|40018908|FG004|Overall Study|Death|8|||
16420337|NCT02292706|40018909|FG005|Overall Study|Death|17|||
16420338|NCT02292706|40018910|FG006|Overall Study|Death|3|||
16420339|NCT02292706|40018911|FG007|Overall Study|Death|0|||
16420340|NCT02292706|40018904|FG000|Overall Study|Study terminated by sponsor|0|||
16420341|NCT02292706|40018905|FG001|Overall Study|Study terminated by sponsor|9|||
16420342|NCT02292706|40018906|FG002|Overall Study|Study terminated by sponsor|4|||
16420343|NCT02292706|40018907|FG003|Overall Study|Study terminated by sponsor|21|||
16420344|NCT02292706|40018908|FG004|Overall Study|Study terminated by sponsor|11|||
16420345|NCT02292706|40018909|FG005|Overall Study|Study terminated by sponsor|13|||
16420346|NCT02292706|40018910|FG006|Overall Study|Study terminated by sponsor|3|||
16420347|NCT02292706|40018911|FG007|Overall Study|Study terminated by sponsor|0|||
16420348|NCT02292706|40018904|FG000|Overall Study|Investigator's discretion|4|||
16420349|NCT02292706|40018905|FG001|Overall Study|Investigator's discretion|9|||
16420350|NCT02292706|40018906|FG002|Overall Study|Investigator's discretion|7|||
16420351|NCT02292706|40018907|FG003|Overall Study|Investigator's discretion|11|||
16420352|NCT02292706|40018908|FG004|Overall Study|Investigator's discretion|4|||
16420353|NCT02292706|40018909|FG005|Overall Study|Investigator's discretion|10|||
16420354|NCT02292706|40018910|FG006|Overall Study|Investigator's discretion|1|||
16248798|NCT00458302|39395250|FG001|Overall Study|Protocol Violation|2|||
16420355|NCT02292706|40018911|FG007|Overall Study|Investigator's discretion|0|||
16420356|NCT02292706|40018904|FG000|Overall Study|Liver transplant|1|||
16420357|NCT02292706|40018905|FG001|Overall Study|Liver transplant|1|||
16420358|NCT02292706|40018906|FG002|Overall Study|Liver transplant|11|||
16420359|NCT02292706|40018907|FG003|Overall Study|Liver transplant|16|||
16420360|NCT02292706|40018908|FG004|Overall Study|Liver transplant|5|||
16420361|NCT02292706|40018909|FG005|Overall Study|Liver transplant|6|||
16420362|NCT02292706|40018910|FG006|Overall Study|Liver transplant|5|||
16420363|NCT02292706|40018911|FG007|Overall Study|Liver transplant|0|||
16420364|NCT02292706|40018904|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
16562294|NCT03850444|40525374|FG001|Overall Study|Death|107|||
16420365|NCT02292706|40018905|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
16420366|NCT02292706|40018906|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
16420367|NCT02292706|40018907|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
16420368|NCT02292706|40018908|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
16420369|NCT02292706|40018909|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
16420370|NCT02292706|40018910|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
16420371|NCT02292706|40018911|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
16420372|NCT02292706|40018904|FG000|Overall Study|Subject terminated by sponsor|1|||
16420373|NCT02292706|40018905|FG001|Overall Study|Subject terminated by sponsor|0|||
16420374|NCT02292706|40018906|FG002|Overall Study|Subject terminated by sponsor|0|||
16420375|NCT02292706|40018907|FG003|Overall Study|Subject terminated by sponsor|2|||
16420376|NCT02292706|40018908|FG004|Overall Study|Subject terminated by sponsor|1|||
16420377|NCT02292706|40018909|FG005|Overall Study|Subject terminated by sponsor|0|||
16420378|NCT02292706|40018910|FG006|Overall Study|Subject terminated by sponsor|0|||
16420379|NCT02292706|40018911|FG007|Overall Study|Subject terminated by sponsor|0|||
16420380|NCT02292706|40018904|FG000|Overall Study|Missing|0|||
16420381|NCT02292706|40018905|FG001|Overall Study|Missing|0|||
16420382|NCT02292706|40018906|FG002|Overall Study|Missing|1|||
16420383|NCT02292706|40018907|FG003|Overall Study|Missing|1|||
16420384|NCT02292706|40018908|FG004|Overall Study|Missing|0|||
16420385|NCT02292706|40018909|FG005|Overall Study|Missing|1|||
16420386|NCT02292706|40018910|FG006|Overall Study|Missing|0|||
16420387|NCT02292706|40018911|FG007|Overall Study|Missing|0|||
16420388|NCT02292706|40018904|FG000|Overall Study|Virologic relapse or reinfection|1|||
16420389|NCT02292706|40018905|FG001|Overall Study|Virologic relapse or reinfection|0|||
16420390|NCT02292706|40018906|FG002|Overall Study|Virologic relapse or reinfection|0|||
16420391|NCT02292706|40018907|FG003|Overall Study|Virologic relapse or reinfection|1|||
16420392|NCT02292706|40018908|FG004|Overall Study|Virologic relapse or reinfection|0|||
16420393|NCT02292706|40018909|FG005|Overall Study|Virologic relapse or reinfection|1|||
16420394|NCT02292706|40018910|FG006|Overall Study|Virologic relapse or reinfection|0|||
16420395|NCT02292706|40018911|FG007|Overall Study|Virologic relapse or reinfection|0|||
16420396|NCT02252965|40018912|FG000|Overall Study|Adverse Event|9|||
16420397|NCT02252965|40018913|FG001|Overall Study|Adverse Event|14|||
16420398|NCT02252965|40018912|FG000|Overall Study|Lost to Follow-up|16|||
16420399|NCT02252965|40018913|FG001|Overall Study|Lost to Follow-up|8|||
16420400|NCT02252965|40018912|FG000|Overall Study|Protocol Violation|4|||
16420401|NCT02252965|40018913|FG001|Overall Study|Protocol Violation|5|||
16420402|NCT02252965|40018912|FG000|Overall Study|Lack of Efficacy|0|||
16420403|NCT02252965|40018913|FG001|Overall Study|Lack of Efficacy|2|||
16420404|NCT02252965|40018912|FG000|Overall Study|Withdrawal by Subject|7|||
16420405|NCT02252965|40018913|FG001|Overall Study|Withdrawal by Subject|9|||
16420406|NCT02252965|40018912|FG000|Overall Study|Other|4|||
16420407|NCT02252965|40018913|FG001|Overall Study|Other|5|||
16420408|NCT02777827|40018914|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
16420409|NCT02777827|40018915|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
16420410|NCT02777827|40018916|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
16420411|NCT02777827|40018917|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
16420412|NCT02777827|40018918|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
16420413|NCT02777827|40018919|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
16420414|NCT01153698|40018920|FG000|Overall Study|Adverse Event|12|||
16420415|NCT01153698|40018920|FG000|Overall Study|Lost to Follow-up|4|||
16420416|NCT01153698|40018920|FG000|Overall Study|Withdrawal by Subject|2|||
16420417|NCT01153698|40018920|FG000|Overall Study|Switch to other anticoagulants|4|||
16420418|NCT01153698|40018920|FG000|Overall Study|Other|2|||
16420419|NCT01153698|40018920|FG000|Overall Study|Not treated with Pradaxa|5|||
16420420|NCT02980133|40018923|FG000|Overall Study|Other than specified|1|||
16420421|NCT02980133|40018924|FG001|Overall Study|Other than specified|1|||
16420422|NCT02980133|40018925|FG002|Overall Study|Other than specified|2|||
16420423|NCT02980133|40018926|FG003|Overall Study|Other than specified|2|||
16420424|NCT02980133|40018923|FG000|Overall Study|Lost to Follow-up|0|||
16420425|NCT02980133|40018924|FG001|Overall Study|Lost to Follow-up|0|||
16420426|NCT02980133|40018925|FG002|Overall Study|Lost to Follow-up|1|||
16420427|NCT02980133|40018926|FG003|Overall Study|Lost to Follow-up|3|||
16420428|NCT02980133|40018923|FG000|Overall Study|Protocol Violation|0|||
16420429|NCT02980133|40018924|FG001|Overall Study|Protocol Violation|1|||
16420430|NCT02980133|40018925|FG002|Overall Study|Protocol Violation|0|||
16420431|NCT02980133|40018926|FG003|Overall Study|Protocol Violation|0|||
16420432|NCT02980133|40018923|FG000|Overall Study|Withdrawal by parent/guardian|6|||
16420433|NCT02980133|40018924|FG001|Overall Study|Withdrawal by parent/guardian|3|||
16420434|NCT02980133|40018925|FG002|Overall Study|Withdrawal by parent/guardian|3|||
16420435|NCT02980133|40018926|FG003|Overall Study|Withdrawal by parent/guardian|1|||
16420436|NCT02980133|40018923|FG000|Overall Study|Withdrawal by Subject|0|||
16420437|NCT02980133|40018924|FG001|Overall Study|Withdrawal by Subject|0|||
16420438|NCT02980133|40018925|FG002|Overall Study|Withdrawal by Subject|1|||
16420439|NCT02980133|40018926|FG003|Overall Study|Withdrawal by Subject|0|||
16420440|NCT01153724|40018927|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16420441|NCT01153724|40018927|FG000|Treatment Period 2|Adverse Event|1|||
16420442|NCT01153724|40018927|FG000|Treatment Period 2|Other reason not defined above|1|||
16420443|NCT02429791|40018928|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
16420444|NCT02429791|40018929|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
16420445|NCT02429791|40018928|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
16420446|NCT02429791|40018929|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
16420447|NCT02429791|40018928|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
16420448|NCT02429791|40018929|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
16420449|NCT02429791|40018928|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
16420450|NCT02429791|40018929|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
16420451|NCT02429791|40018928|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
16420452|NCT02429791|40018929|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
16420453|NCT02429791|40018928|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
16420454|NCT02429791|40018929|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
16420455|NCT02429791|40018928|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
16420456|NCT02429791|40018929|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
16420457|NCT02429791|40018928|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
16420458|NCT02429791|40018929|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
16420459|NCT02429791|40018928|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
16420460|NCT02429791|40018929|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
16420461|NCT02429791|40018928|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
16420462|NCT02429791|40018929|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
16420463|NCT02429791|40018928|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
16420464|NCT02429791|40018929|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
16420465|NCT02429791|40018928|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
16420466|NCT02429791|40018929|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
16420467|NCT02429791|40018928|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
16562295|NCT03850444|40525373|FG000|Overall Study|Lost to Follow-up|1|||
16248799|NCT00458302|39395249|FG000|Overall Study|Withdrawal by Subject|6|||
16248800|NCT00458302|39395250|FG001|Overall Study|Withdrawal by Subject|4|||
16248801|NCT00458302|39395249|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
16248802|NCT00458302|39395250|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
16248803|NCT00458302|39395249|FG000|Overall Study|Study Termination By Sponsor|1|||
16248804|NCT00458302|39395250|FG001|Overall Study|Study Termination By Sponsor|0|||
16248805|NCT00458302|39395249|FG000|Overall Study|Lost to Follow-up|2|||
16248806|NCT00458302|39395250|FG001|Overall Study|Lost to Follow-up|0|||
16248807|NCT00458302|39395249|FG000|Overall Study|Other|4|||
16248808|NCT00458302|39395250|FG001|Overall Study|Other|2|||
16248809|NCT02260492|39395257|FG000|Overall Study|Adverse Event|6|||
16359522|NCT00903968|39804137|FG006|Overall Study|Physician Decision|0|||
16248810|NCT02260492|39395258|FG001|Overall Study|Adverse Event|1|||
16248811|NCT02260492|39395259|FG002|Overall Study|Adverse Event|2|||
16248812|NCT02260492|39395257|FG000|Overall Study|Death|0|||
16420468|NCT02429791|40018929|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
16420469|NCT02429791|40018928|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
16420470|NCT02429791|40018929|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
16420471|NCT02429791|40018928|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
16420472|NCT02429791|40018929|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
16420473|NCT02429791|40018928|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
16420474|NCT02429791|40018929|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
16420475|NCT02429791|40018928|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
16420476|NCT02429791|40018929|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
16420477|NCT02429791|40018928|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
16420478|NCT02429791|40018929|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
16420479|NCT01374178|40018932|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
16420480|NCT01374178|40018933|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
16420481|NCT01374178|40018932|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
16420482|NCT01374178|40018933|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
16420483|NCT02409342|40018934|FG000|Overall Study|Death|211|||
16420484|NCT02409342|40018935|FG001|Overall Study|Death|201|||
16420485|NCT02409342|40018934|FG000|Overall Study|Withdrawal by Subject|24|||
16420486|NCT02409342|40018935|FG001|Overall Study|Withdrawal by Subject|17|||
16420487|NCT02409342|40018934|FG000|Overall Study|Study Terminated By Sponsor|48|||
16420488|NCT02409342|40018935|FG001|Overall Study|Study Terminated By Sponsor|59|||
16420489|NCT02409342|40018934|FG000|Overall Study|Lost to Follow-up|3|||
16420490|NCT02409342|40018935|FG001|Overall Study|Lost to Follow-up|5|||
16420491|NCT02409342|40018934|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
16420492|NCT02409342|40018935|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
16420493|NCT02409342|40018934|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
16420494|NCT02409342|40018935|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
16420495|NCT02409342|40018934|FG000|Overall Study|Sponsor Decision|1|||
16248813|NCT02260492|39395258|FG001|Overall Study|Death|1|||
16248814|NCT02260492|39395259|FG002|Overall Study|Death|0|||
16420496|NCT02409342|40018935|FG001|Overall Study|Sponsor Decision|0|||
16420497|NCT01045694|40018936|FG000|Overall Study|Withdrawal by Subject|2|||
16420498|NCT02999633|40018937|FG000|Overall Study|Adverse Event|2|||
16420499|NCT02999633|40018937|FG000|Overall Study|Progressive disease|12|||
16420500|NCT02220712|40018942|FG000|Overall Study|Adverse Event|1|||
16420501|NCT02220712|40018942|FG000|Overall Study|Withdrawal by Subject|2|||
16420502|NCT02220712|40018942|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
16420503|NCT01711645|40018943|FG000|Overall Study|Withdrawal by Subject|8|||
16420504|NCT01711645|40018943|FG000|Overall Study|Lost to Follow-up|6|||
16420505|NCT01711645|40018943|FG000|Overall Study|Physician Decision|5|||
16420506|NCT02577016|40018944|FG000|Overall Study|Adverse Event|2|||
16420507|NCT02577016|40018945|FG001|Overall Study|Adverse Event|1|||
16420508|NCT02577016|40018944|FG000|Overall Study|Physician Decision|0|||
16420509|NCT02577016|40018945|FG001|Overall Study|Physician Decision|1|||
16420510|NCT03270891|40018946|FG000|Overall Study|Lost to Follow-up|3|||
16420511|NCT03270891|40018947|FG001|Overall Study|Lost to Follow-up|6|||
16562296|NCT03850444|40525374|FG001|Overall Study|Lost to Follow-up|1|||
16562297|NCT03850444|40525373|FG000|Overall Study|Withdrawal by Subject|1|||
16562298|NCT03850444|40525374|FG001|Overall Study|Withdrawal by Subject|5|||
16562299|NCT03850444|40525373|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
16562300|NCT03850444|40525374|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
16562301|NCT03315754|40525375|FG000|Overall Study|COVID-19 complications leading to death|1|||
16562302|NCT03315754|40525375|FG000|Overall Study|insurance coverage issue|1|||
16562303|NCT02018861|40525376|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
16562304|NCT02018861|40525377|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
16562305|NCT02018861|40525378|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
16562306|NCT02018861|40525379|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
16562307|NCT02018861|40525380|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
16248815|NCT02260492|39395257|FG000|Overall Study|Lost to Follow-up|12|||
16248816|NCT02260492|39395258|FG001|Overall Study|Lost to Follow-up|9|||
16420512|NCT03270891|40018948|FG002|Overall Study|Lost to Follow-up|0|||
16420513|NCT03270891|40018946|FG000|Overall Study|Withdrawal by Subject|1|||
16420514|NCT03270891|40018947|FG001|Overall Study|Withdrawal by Subject|0|||
16420515|NCT03270891|40018948|FG002|Overall Study|Withdrawal by Subject|0|||
16420516|NCT03270891|40018946|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
16420517|NCT03270891|40018947|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
16420518|NCT03270891|40018948|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
16420519|NCT02508428|40018949|FG000|Overall Study|Death|32|||
16420520|NCT02508428|40018950|FG001|Overall Study|Death|33|||
16420521|NCT02508428|40018949|FG000|Overall Study|Liner revised|3|||
16420522|NCT02508428|40018950|FG001|Overall Study|Liner revised|19|||
16420523|NCT02508428|40018949|FG000|Overall Study|Incomplete follow-up|17|||
16420524|NCT02508428|40018950|FG001|Overall Study|Incomplete follow-up|15|||
16420525|NCT04207060|40018951|FG000|Overall Study|Lost to Follow-up|2|||
16420526|NCT04207060|40018952|FG001|Overall Study|Lost to Follow-up|0|||
16420527|NCT02353728|40018957|FG000|Overall Study|Subject non-compliance|1|||
16420528|NCT02873338|40018958|FG000|Overall Study|Adverse Event|0|||
16420529|NCT02873338|40018959|FG001|Overall Study|Adverse Event|2|||
16420530|NCT02873338|40018960|FG002|Overall Study|Adverse Event|1|||
16420531|NCT02873338|40018958|FG000|Overall Study|Death|2|||
16420532|NCT02873338|40018959|FG001|Overall Study|Death|1|||
16420533|NCT02873338|40018960|FG002|Overall Study|Death|1|||
16420534|NCT02873338|40018958|FG000|Overall Study|Withdrawal by Subject|2|||
16420535|NCT02873338|40018959|FG001|Overall Study|Withdrawal by Subject|1|||
16420536|NCT02873338|40018960|FG002|Overall Study|Withdrawal by Subject|3|||
16420537|NCT02873338|40018958|FG000|Overall Study|Lack of Efficacy|0|||
16420538|NCT02873338|40018959|FG001|Overall Study|Lack of Efficacy|2|||
16420539|NCT02873338|40018960|FG002|Overall Study|Lack of Efficacy|0|||
16420540|NCT02873338|40018958|FG000|Overall Study|Other or Missing|14|||
16420541|NCT02873338|40018959|FG001|Overall Study|Other or Missing|15|||
16420542|NCT02873338|40018960|FG002|Overall Study|Other or Missing|13|||
16420543|NCT01811186|40018961|FG000|Overall Study|Adverse Event|54|||
16420544|NCT01811186|40018962|FG001|Overall Study|Adverse Event|38|||
16420545|NCT01811186|40018961|FG000|Overall Study|Protocol Violation|5|||
16420546|NCT01811186|40018962|FG001|Overall Study|Protocol Violation|6|||
16420547|NCT01811186|40018961|FG000|Overall Study|Withdrawal by Subject|5|||
16420548|NCT01811186|40018962|FG001|Overall Study|Withdrawal by Subject|10|||
16420549|NCT01811186|40018961|FG000|Overall Study|Lack of Efficacy|3|||
16420550|NCT01811186|40018962|FG001|Overall Study|Lack of Efficacy|6|||
16420551|NCT01811186|40018961|FG000|Overall Study|Lost to Follow-up|4|||
16420552|NCT01811186|40018962|FG001|Overall Study|Lost to Follow-up|2|||
16420553|NCT02783599|40018963|FG000|Overall Study|Progressive disease|23|||
16420554|NCT02783599|40018963|FG000|Overall Study|Surgical Resection|10|||
16420555|NCT02783599|40018963|FG000|Overall Study|Adverse Event|4|||
16420556|NCT02783599|40018963|FG000|Overall Study|Physician Decision|2|||
16420557|NCT02783599|40018963|FG000|Overall Study|Death|1|||
16420558|NCT04891107|40018964|FG000|Overall Study|Physician Decision|1|||
16420559|NCT04891107|40018964|FG000|Overall Study|Withdrawal by Subject|1|||
16420560|NCT04891107|40018964|FG000|Overall Study|Screen failure after consent|1|||
16420561|NCT01673620|40018965|FG000|Overall Study|Adverse Event|1|||
16420562|NCT01673620|40018966|FG001|Overall Study|Adverse Event|0|||
16420563|NCT00417963|40018967|FG000|Overall Study|Lost to Follow-up|3|||
16420564|NCT00417963|40018967|FG000|Overall Study|Withdrawal by Subject|18|||
16420565|NCT00417963|40018967|FG000|Overall Study|Death|17|||
16420566|NCT00417963|40018967|FG000|Overall Study|Study device could not be deployed|3|||
16420567|NCT03576716|40018968|FG000|Overall Study|Withdrawal by Subject|0|||
16420568|NCT03576716|40018969|FG001|Overall Study|Withdrawal by Subject|1|||
16420569|NCT01090063|40018973|FG000|Screen|Screen Failed|4|||
16420570|NCT01090063|40018973|FG000|Treatment|Withdrawal by Subject|4|||
16420571|NCT02677896|40018974|FG000|Double Blind Period (up to 35 Months)|Death|113|||
16420572|NCT02677896|40018975|FG001|Double Blind Period (up to 35 Months)|Death|189|||
16420573|NCT02677896|40018974|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
16420574|NCT02677896|40018975|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
16420575|NCT02677896|40018974|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
16420576|NCT02677896|40018975|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
16420577|NCT02677896|40018974|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
16420578|NCT02677896|40018975|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
16420579|NCT02677896|40018974|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
16420580|NCT02677896|40018975|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
16420581|NCT02677896|40018974|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
16420582|NCT02677896|40018975|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
16420583|NCT02677896|40018974|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
16420584|NCT02677896|40018975|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
16420585|NCT02677896|40018974|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
16420586|NCT02677896|40018975|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
16420587|NCT02677896|40018974|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
16420588|NCT02677896|40018975|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
16420589|NCT02677896|40018974|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
16420590|NCT02677896|40018975|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
16420591|NCT02677896|40018974|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
16420592|NCT02677896|40018975|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
16420593|NCT02677896|40018974|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
16420594|NCT02677896|40018975|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
16420595|NCT02677896|40018974|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
16420596|NCT02677896|40018975|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
16420597|NCT02677896|40018974|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
16420598|NCT02677896|40018975|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
16420599|NCT00835341|40018976|FG000|Overall Study|Lost to Follow-up|3|||
16420600|NCT00835341|40018977|FG001|Overall Study|Lost to Follow-up|12|||
16420601|NCT03824587|40018978|FG000|Run-in Period|Screen Failure|0|||
16420602|NCT03824587|40018979|FG001|Run-in Period|Screen Failure|275|||
16420603|NCT03824587|40018978|FG000|Treatment Period|Adverse Event|4|||
16420604|NCT03824587|40018979|FG001|Treatment Period|Adverse Event|1|||
16420605|NCT03824587|40018978|FG000|Treatment Period|Withdrawal by Subject|0|||
16420606|NCT03824587|40018979|FG001|Treatment Period|Withdrawal by Subject|1|||
16420607|NCT03824587|40018978|FG000|Treatment Period|Kidney Transplant|1|||
16420608|NCT03824587|40018979|FG001|Treatment Period|Kidney Transplant|1|||
16420609|NCT01555125|40018980|FG000|Induction Period|Lost to Follow-up|0|||
16420610|NCT01555125|40018981|FG001|Induction Period|Lost to Follow-up|2|||
16420611|NCT01555125|40018982|FG002|Induction Period|Lost to Follow-up|0|||
16420612|NCT01555125|40018983|FG003|Induction Period|Lost to Follow-up|0|||
16420613|NCT01555125|40018984|FG004|Induction Period|Lost to Follow-up|0|||
16420614|NCT01555125|40018980|FG000|Induction Period|Adverse Event|0|||
16420615|NCT01555125|40018981|FG001|Induction Period|Adverse Event|1|||
16420616|NCT01555125|40018982|FG002|Induction Period|Adverse Event|0|||
16420617|NCT01555125|40018983|FG003|Induction Period|Adverse Event|0|||
16420618|NCT01555125|40018984|FG004|Induction Period|Adverse Event|1|||
16420619|NCT01555125|40018980|FG000|Induction Period|Subject / guardian decision|0|||
16420620|NCT01555125|40018981|FG001|Induction Period|Subject / guardian decision|0|||
16420621|NCT01555125|40018982|FG002|Induction Period|Subject / guardian decision|0|||
16420622|NCT01555125|40018983|FG003|Induction Period|Subject / guardian decision|0|||
16420623|NCT01555125|40018984|FG004|Induction Period|Subject / guardian decision|2|||
16420624|NCT01555125|40018980|FG000|Induction Period|Death|1|||
16420625|NCT01555125|40018981|FG001|Induction Period|Death|0|||
16420626|NCT01555125|40018982|FG002|Induction Period|Death|0|||
16420627|NCT01555125|40018983|FG003|Induction Period|Death|0|||
16420628|NCT01555125|40018984|FG004|Induction Period|Death|0|||
16420629|NCT01555125|40018980|FG000|Maintenance Period|Adverse Event|1|||
16420630|NCT01555125|40018981|FG001|Maintenance Period|Adverse Event|1|||
16420631|NCT01555125|40018982|FG002|Maintenance Period|Adverse Event|0|||
16420632|NCT01555125|40018983|FG003|Maintenance Period|Adverse Event|0|||
16420633|NCT01555125|40018984|FG004|Maintenance Period|Adverse Event|0|||
16420634|NCT01555125|40018980|FG000|Maintenance Period|Subject / guardian decision|1|||
16420635|NCT01555125|40018981|FG001|Maintenance Period|Subject / guardian decision|2|||
16420636|NCT01555125|40018982|FG002|Maintenance Period|Subject / guardian decision|0|||
16420637|NCT01555125|40018983|FG003|Maintenance Period|Subject / guardian decision|0|||
16420638|NCT01555125|40018984|FG004|Maintenance Period|Subject / guardian decision|0|||
16420639|NCT01555125|40018980|FG000|Maintenance Period|Lost to Follow-up|2|||
16420640|NCT01555125|40018981|FG001|Maintenance Period|Lost to Follow-up|0|||
16420641|NCT01555125|40018982|FG002|Maintenance Period|Lost to Follow-up|0|||
16420642|NCT01555125|40018983|FG003|Maintenance Period|Lost to Follow-up|1|||
16420643|NCT01555125|40018984|FG004|Maintenance Period|Lost to Follow-up|0|||
16420644|NCT01555125|40018980|FG000|Maintenance Period|Lack of Efficacy|6|||
16420645|NCT01555125|40018981|FG001|Maintenance Period|Lack of Efficacy|1|||
16420646|NCT01555125|40018982|FG002|Maintenance Period|Lack of Efficacy|3|||
16420647|NCT01555125|40018983|FG003|Maintenance Period|Lack of Efficacy|0|||
16420648|NCT01555125|40018984|FG004|Maintenance Period|Lack of Efficacy|0|||
16420649|NCT01555125|40018980|FG000|Maintenance Period|Physician Decision|0|||
16420650|NCT01555125|40018981|FG001|Maintenance Period|Physician Decision|0|||
16420651|NCT01555125|40018982|FG002|Maintenance Period|Physician Decision|1|||
16420652|NCT01555125|40018983|FG003|Maintenance Period|Physician Decision|0|||
16420653|NCT01555125|40018984|FG004|Maintenance Period|Physician Decision|0|||
16420654|NCT01555125|40018980|FG000|Maintenance Period|Death|0|||
16420655|NCT01555125|40018981|FG001|Maintenance Period|Death|0|||
16420656|NCT01555125|40018982|FG002|Maintenance Period|Death|0|||
16562308|NCT02018861|40525381|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
16420657|NCT01555125|40018983|FG003|Maintenance Period|Death|1|||
16420658|NCT01555125|40018984|FG004|Maintenance Period|Death|0|||
16420659|NCT01555125|40018980|FG000|Extension|Adverse Event|1|||
16420660|NCT01555125|40018981|FG001|Extension|Adverse Event|2|||
16420661|NCT01555125|40018982|FG002|Extension|Adverse Event|1|||
16420662|NCT01555125|40018983|FG003|Extension|Adverse Event|1|||
16420663|NCT01555125|40018984|FG004|Extension|Adverse Event|0|||
16420664|NCT01555125|40018980|FG000|Extension|Protocol deviation|1|||
16359523|NCT00903968|39804138|FG007|Overall Study|Physician Decision|0|||
16359524|NCT00903968|39804131|FG000|Overall Study|Progressive Disease|2|||
16359525|NCT00903968|39804132|FG001|Overall Study|Progressive Disease|3|||
16359526|NCT00903968|39804133|FG002|Overall Study|Progressive Disease|2|||
16359527|NCT00903968|39804134|FG003|Overall Study|Progressive Disease|3|||
16359528|NCT00903968|39804135|FG004|Overall Study|Progressive Disease|3|||
16359529|NCT00903968|39804136|FG005|Overall Study|Progressive Disease|3|||
16359530|NCT00903968|39804137|FG006|Overall Study|Progressive Disease|0|||
16359531|NCT00903968|39804138|FG007|Overall Study|Progressive Disease|18|||
16359532|NCT00903968|39804131|FG000|Overall Study|Lack of Efficacy|0|||
16359533|NCT00903968|39804132|FG001|Overall Study|Lack of Efficacy|0|||
16359534|NCT00903968|39804133|FG002|Overall Study|Lack of Efficacy|0|||
16359535|NCT00903968|39804134|FG003|Overall Study|Lack of Efficacy|0|||
16359536|NCT00903968|39804135|FG004|Overall Study|Lack of Efficacy|0|||
16359537|NCT00903968|39804136|FG005|Overall Study|Lack of Efficacy|0|||
16359538|NCT00903968|39804137|FG006|Overall Study|Lack of Efficacy|0|||
16359539|NCT00903968|39804138|FG007|Overall Study|Lack of Efficacy|3|||
16359540|NCT00207740|39804139|FG000|Overall Study|Adverse Event|4|||
16359541|NCT00207740|39804140|FG001|Overall Study|Adverse Event|14|||
16359542|NCT00207740|39804141|FG002|Overall Study|Adverse Event|14|||
16359543|NCT00207740|39804142|FG003|Overall Study|Adverse Event|11|||
16359544|NCT00207740|39804139|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16359545|NCT00207740|39804140|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16359546|NCT00207740|39804141|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
16359547|NCT00207740|39804142|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
16359548|NCT00207740|39804139|FG000|Overall Study|Lost to Follow-up|0|||
16359549|NCT00207740|39804140|FG001|Overall Study|Lost to Follow-up|2|||
16359550|NCT00207740|39804141|FG002|Overall Study|Lost to Follow-up|1|||
16359551|NCT00207740|39804142|FG003|Overall Study|Lost to Follow-up|1|||
16359552|NCT00207740|39804139|FG000|Overall Study|Death|0|||
16359553|NCT00207740|39804140|FG001|Overall Study|Death|0|||
16359554|NCT00207740|39804141|FG002|Overall Study|Death|0|||
16359555|NCT00207740|39804142|FG003|Overall Study|Death|1|||
16359556|NCT00207740|39804139|FG000|Overall Study|Sponsor Directive|22|||
16359557|NCT00207740|39804140|FG001|Overall Study|Sponsor Directive|15|||
16359558|NCT00207740|39804141|FG002|Overall Study|Sponsor Directive|16|||
16359559|NCT00207740|39804142|FG003|Overall Study|Sponsor Directive|21|||
16359560|NCT00207740|39804139|FG000|Overall Study|Other|2|||
16359561|NCT00207740|39804140|FG001|Overall Study|Other|10|||
16359562|NCT00207740|39804141|FG002|Overall Study|Other|7|||
16359563|NCT00207740|39804142|FG003|Overall Study|Other|5|||
16359564|NCT03585270|39804143|FG000|Overall Study|Withdrawal by Subject|2|||
16359565|NCT03585270|39804144|FG001|Overall Study|Withdrawal by Subject|6|||
16359566|NCT03585270|39804143|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
16359567|NCT03585270|39804144|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
16359568|NCT03585270|39804143|FG000|Overall Study|Adverse Event|5|||
16359569|NCT03585270|39804144|FG001|Overall Study|Adverse Event|2|||
16359570|NCT03585270|39804143|FG000|Overall Study|Lost to Follow-up|1|||
16359571|NCT03585270|39804144|FG001|Overall Study|Lost to Follow-up|4|||
16359572|NCT03585270|39804143|FG000|Overall Study|Death|5|||
16359573|NCT03585270|39804144|FG001|Overall Study|Death|3|||
16359574|NCT03585270|39804143|FG000|Overall Study|Other reasons|2|||
16359575|NCT03585270|39804144|FG001|Overall Study|Other reasons|2|||
16359576|NCT03329989|39804145|FG000|Overall Study|Withdrawal by Subject|9|||
16359577|NCT03329989|39804145|FG000|Overall Study|Lost to Follow-up|8|||
16359578|NCT03329989|39804145|FG000|Overall Study|Adverse Event|5|||
16359579|NCT03329989|39804145|FG000|Overall Study|Protocol Violation|1|||
16359580|NCT01529268|39804146|FG000|Overall Study|Lost to Follow-up|9|||
16359581|NCT01529268|39804147|FG001|Overall Study|Lost to Follow-up|3|||
16359582|NCT01529268|39804146|FG000|Overall Study|Moved|3|||
16359583|NCT01529268|39804147|FG001|Overall Study|Moved|0|||
16359584|NCT03979313|39804148|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
16359585|NCT03979313|39804149|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
16359586|NCT03979313|39804148|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
16359587|NCT03979313|39804149|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
16359588|NCT03979313|39804148|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
16359589|NCT03979313|39804149|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
16359590|NCT03979313|39804148|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
16359591|NCT03979313|39804149|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
16359592|NCT03979313|39804148|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
16359593|NCT03979313|39804149|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
16359594|NCT03979313|39804148|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
16359595|NCT03979313|39804149|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
16420665|NCT01555125|40018981|FG001|Extension|Protocol deviation|0|||
16420666|NCT01555125|40018982|FG002|Extension|Protocol deviation|0|||
16420667|NCT01555125|40018983|FG003|Extension|Protocol deviation|0|||
16420668|NCT01555125|40018984|FG004|Extension|Protocol deviation|0|||
16420669|NCT01555125|40018980|FG000|Extension|Lack of Efficacy|7|||
16420670|NCT01555125|40018981|FG001|Extension|Lack of Efficacy|6|||
16420671|NCT01555125|40018982|FG002|Extension|Lack of Efficacy|3|||
16420672|NCT01555125|40018983|FG003|Extension|Lack of Efficacy|0|||
16420673|NCT01555125|40018984|FG004|Extension|Lack of Efficacy|0|||
16420674|NCT01555125|40018980|FG000|Extension|Lost to Follow-up|2|||
16420675|NCT01555125|40018981|FG001|Extension|Lost to Follow-up|1|||
16420676|NCT01555125|40018982|FG002|Extension|Lost to Follow-up|2|||
16420677|NCT01555125|40018983|FG003|Extension|Lost to Follow-up|0|||
16420678|NCT01555125|40018984|FG004|Extension|Lost to Follow-up|0|||
16420679|NCT01555125|40018980|FG000|Extension|Study terminated by sponsor|32|||
16420680|NCT01555125|40018981|FG001|Extension|Study terminated by sponsor|33|||
16420681|NCT01555125|40018982|FG002|Extension|Study terminated by sponsor|16|||
16420682|NCT01555125|40018983|FG003|Extension|Study terminated by sponsor|20|||
16420683|NCT01555125|40018984|FG004|Extension|Study terminated by sponsor|0|||
16420684|NCT01555125|40018980|FG000|Extension|Subject/guardian decision|1|||
16420685|NCT01555125|40018981|FG001|Extension|Subject/guardian decision|9|||
16420686|NCT01555125|40018982|FG002|Extension|Subject/guardian decision|1|||
16420687|NCT01555125|40018983|FG003|Extension|Subject/guardian decision|0|||
16420688|NCT01555125|40018984|FG004|Extension|Subject/guardian decision|0|||
16420689|NCT01555125|40018980|FG000|Extension|Technical Problems|1|||
16420690|NCT01555125|40018981|FG001|Extension|Technical Problems|0|||
16420691|NCT01555125|40018982|FG002|Extension|Technical Problems|0|||
16420692|NCT01555125|40018983|FG003|Extension|Technical Problems|1|||
16420693|NCT01555125|40018984|FG004|Extension|Technical Problems|0|||
16420694|NCT01555125|40018980|FG000|Follow-Up Period|Lost to Follow-up|1|||
16420695|NCT01555125|40018981|FG001|Follow-Up Period|Lost to Follow-up|0|||
16420696|NCT01555125|40018982|FG002|Follow-Up Period|Lost to Follow-up|0|||
16420697|NCT01555125|40018983|FG003|Follow-Up Period|Lost to Follow-up|0|||
16420698|NCT01555125|40018984|FG004|Follow-Up Period|Lost to Follow-up|0|||
16420699|NCT01555125|40018980|FG000|Follow-Up Period|Subject / guardian decision|3|||
16420700|NCT01555125|40018981|FG001|Follow-Up Period|Subject / guardian decision|1|||
16420701|NCT01555125|40018982|FG002|Follow-Up Period|Subject / guardian decision|1|||
16420702|NCT01555125|40018983|FG003|Follow-Up Period|Subject / guardian decision|1|||
16420703|NCT01555125|40018984|FG004|Follow-Up Period|Subject / guardian decision|0|||
16420704|NCT02540993|40018985|FG000|Overall Study|Lost to Follow-up|5|||
16420705|NCT02540993|40018986|FG001|Overall Study|Lost to Follow-up|3|||
16420706|NCT02540993|40018985|FG000|Overall Study|Withdrawal by Subject|4|||
16420707|NCT02540993|40018986|FG001|Overall Study|Withdrawal by Subject|6|||
16420708|NCT02540993|40018985|FG000|Overall Study|GCP violations|33|||
16420709|NCT02540993|40018986|FG001|Overall Study|GCP violations|27|||
16473135|NCT00098475|40210740|FG000|Step 1|Misinterpretation of lab data|0|||
16473136|NCT00098475|40210741|FG001|Step 1|Misinterpretation of lab data|1|||
16473137|NCT00098475|40210742|FG002|Step 1|Misinterpretation of lab data|0|||
16473138|NCT00098475|40210743|FG003|Step 1|Misinterpretation of lab data|0|||
16473139|NCT00098475|40210740|FG000|Step 1|Patient fell with fracture|1|||
16473140|NCT00098475|40210741|FG001|Step 1|Patient fell with fracture|0|||
16473141|NCT00098475|40210742|FG002|Step 1|Patient fell with fracture|0|||
16473142|NCT00098475|40210743|FG003|Step 1|Patient fell with fracture|0|||
16473143|NCT00098475|40210740|FG000|Step 1|Not documented|0|||
16473144|NCT00098475|40210741|FG001|Step 1|Not documented|1|||
16473145|NCT00098475|40210742|FG002|Step 1|Not documented|0|||
16473146|NCT00098475|40210743|FG003|Step 1|Not documented|0|||
16473147|NCT00098475|40210740|FG000|Step 2|Disease progression|1|||
16473148|NCT00098475|40210741|FG001|Step 2|Disease progression|4|||
16473149|NCT00098475|40210742|FG002|Step 2|Disease progression|0|||
16473150|NCT00098475|40210743|FG003|Step 2|Disease progression|0|||
16473151|NCT00098475|40210740|FG000|Step 2|Adverse Event|2|||
16473152|NCT00098475|40210741|FG001|Step 2|Adverse Event|0|||
16473153|NCT00098475|40210742|FG002|Step 2|Adverse Event|0|||
16473154|NCT00098475|40210743|FG003|Step 2|Adverse Event|0|||
16473155|NCT00098475|40210740|FG000|Step 2|Withdrawal by Subject|0|||
16473156|NCT00098475|40210741|FG001|Step 2|Withdrawal by Subject|2|||
16473157|NCT00098475|40210742|FG002|Step 2|Withdrawal by Subject|0|||
16473158|NCT00098475|40210743|FG003|Step 2|Withdrawal by Subject|0|||
16473159|NCT00098475|40210740|FG000|Step 2|Physician Decision|0|||
16473160|NCT00098475|40210741|FG001|Step 2|Physician Decision|1|||
16473161|NCT00098475|40210742|FG002|Step 2|Physician Decision|0|||
16473162|NCT00098475|40210743|FG003|Step 2|Physician Decision|0|||
16473163|NCT00098475|40210740|FG000|Step 2|Alternative therapy|1|||
16473164|NCT00098475|40210741|FG001|Step 2|Alternative therapy|2|||
16473165|NCT00098475|40210742|FG002|Step 2|Alternative therapy|0|||
16473166|NCT00098475|40210743|FG003|Step 2|Alternative therapy|0|||
16473167|NCT00098475|40210740|FG000|Step 2|Never started treatment|1|||
16473168|NCT00098475|40210741|FG001|Step 2|Never started treatment|1|||
16473169|NCT00098475|40210742|FG002|Step 2|Never started treatment|0|||
16473170|NCT00098475|40210743|FG003|Step 2|Never started treatment|0|||
16420710|NCT02921087|40021945|FG000|Overall Study|Withdrawal by Subject|0|||
16420711|NCT02921087|40021946|FG001|Overall Study|Withdrawal by Subject|1|||
16420712|NCT03802396|40021949|FG000|Overall Study|Withdrawal by Subject|2|||
16420713|NCT03802396|40021950|FG001|Overall Study|Withdrawal by Subject|0|||
16420714|NCT03802396|40021949|FG000|Overall Study|Surgery Cancelled|1|||
16420715|NCT03802396|40021950|FG001|Overall Study|Surgery Cancelled|0|||
16420716|NCT00455143|40021951|FG000|Overall Study|Physician Decision|1|||
16420717|NCT00455143|40021951|FG000|Overall Study|Withdrawal by Subject|1|||
16420718|NCT00455143|40021951|FG000|Overall Study|Staff was not avail to follow patient|2|||
16420719|NCT00455143|40021951|FG000|Overall Study|No longer met Inclusion Criteria|1|||
16420720|NCT00455143|40021951|FG000|Overall Study|Surgical time, staff not available|1|||
16420721|NCT00766051|40021956|FG000|Overall Study|Withdrawal by Subject|2|||
16420722|NCT00766051|40021957|FG001|Overall Study|Withdrawal by Subject|0|||
16420723|NCT03946670|40021960|FG000|Overall Study|Progressive Disease|26|||
16420724|NCT03946670|40021961|FG001|Overall Study|Progressive Disease|23|||
16420725|NCT03946670|40021960|FG000|Overall Study|Adverse Event|7|||
16420726|NCT03946670|40021961|FG001|Overall Study|Adverse Event|9|||
16420727|NCT03946670|40021960|FG000|Overall Study|Death|5|||
16420728|NCT03946670|40021961|FG001|Overall Study|Death|6|||
16420729|NCT03946670|40021960|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
16420730|NCT03946670|40021961|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
16420731|NCT03946670|40021960|FG000|Overall Study|Subject Decision|4|||
16420732|NCT03946670|40021961|FG001|Overall Study|Subject Decision|4|||
16420733|NCT03946670|40021960|FG000|Overall Study|Physician Decision|3|||
16420734|NCT03946670|40021961|FG001|Overall Study|Physician Decision|3|||
16420735|NCT03946670|40021960|FG000|Overall Study|New Therapy for Study Indication|1|||
16420736|NCT03946670|40021961|FG001|Overall Study|New Therapy for Study Indication|0|||
16420737|NCT03946670|40021960|FG000|Overall Study|Not treated|1|||
16420738|NCT03946670|40021961|FG001|Overall Study|Not treated|1|||
16420739|NCT01868477|40021962|FG000|Overall Study|Adverse Event|2|||
16420740|NCT01868477|40021963|FG001|Overall Study|Adverse Event|4|||
16420741|NCT01868477|40021962|FG000|Overall Study|Disease progression|1|||
16420742|NCT01868477|40021963|FG001|Overall Study|Disease progression|1|||
16420743|NCT01868477|40021962|FG000|Overall Study|Withdrawal by Subject|1|||
16420744|NCT01868477|40021963|FG001|Overall Study|Withdrawal by Subject|0|||
16420745|NCT00211887|40021964|FG000|Overall Study|Adverse Event|8|||
16420746|NCT00211887|40021965|FG001|Overall Study|Adverse Event|4|||
16420747|NCT00211887|40021966|FG002|Overall Study|Adverse Event|6|||
16420748|NCT00211887|40021964|FG000|Overall Study|Death|1|||
16420749|NCT00211887|40021965|FG001|Overall Study|Death|1|||
16130818|NCT00825825|38967137|FG001|Third Medication Period (14 Days)|poor data quality|1|||
16420750|NCT00211887|40021966|FG002|Overall Study|Death|1|||
16420751|NCT00211887|40021964|FG000|Overall Study|Lost to Follow-up|28|||
16420752|NCT00211887|40021965|FG001|Overall Study|Lost to Follow-up|13|||
16420753|NCT00211887|40021966|FG002|Overall Study|Lost to Follow-up|9|||
16420754|NCT00211887|40021964|FG000|Overall Study|Non-medical reason|31|||
16420755|NCT00211887|40021965|FG001|Overall Study|Non-medical reason|14|||
16130819|NCT00825825|38967138|FG002|Third Medication Period (14 Days)|poor data quality|0|||
16130820|NCT00825825|38967139|FG003|Third Medication Period (14 Days)|poor data quality|0|||
16359596|NCT03979313|39804148|FG000|All Subjects|Any Other Reason|16|||
16420756|NCT00211887|40021966|FG002|Overall Study|Non-medical reason|8|||
16420757|NCT00211887|40021964|FG000|Overall Study|Other medical reason|15|||
16420758|NCT00211887|40021965|FG001|Overall Study|Other medical reason|11|||
16420759|NCT00211887|40021966|FG002|Overall Study|Other medical reason|7|||
16420760|NCT00211887|40021964|FG000|Overall Study|Side effects|19|||
16420761|NCT00211887|40021965|FG001|Overall Study|Side effects|13|||
16420762|NCT00211887|40021966|FG002|Overall Study|Side effects|5|||
16420763|NCT00042991|40021967|FG000|Overall Study|Adverse Event|1|||
16420764|NCT00042991|40021968|FG001|Overall Study|Adverse Event|4|||
16420765|NCT00042991|40021969|FG002|Overall Study|Adverse Event|2|||
16420766|NCT00042991|40021970|FG003|Overall Study|Adverse Event|0|||
16420767|NCT00042991|40021971|FG004|Overall Study|Adverse Event|0|||
16420768|NCT00042991|40021972|FG005|Overall Study|Adverse Event|1|||
16420769|NCT00042991|40021973|FG006|Overall Study|Adverse Event|0|||
16420770|NCT00042991|40021967|FG000|Overall Study|Withdrawal by Subject|0|||
16420771|NCT00042991|40021968|FG001|Overall Study|Withdrawal by Subject|7|||
16420772|NCT00042991|40021969|FG002|Overall Study|Withdrawal by Subject|2|||
16420773|NCT00042991|40021970|FG003|Overall Study|Withdrawal by Subject|0|||
16420774|NCT00042991|40021971|FG004|Overall Study|Withdrawal by Subject|1|||
16420775|NCT00042991|40021972|FG005|Overall Study|Withdrawal by Subject|0|||
16420776|NCT00042991|40021973|FG006|Overall Study|Withdrawal by Subject|0|||
16420777|NCT00042991|40021967|FG000|Overall Study|Disease Progression|5|||
16420778|NCT00042991|40021968|FG001|Overall Study|Disease Progression|29|||
16420779|NCT00042991|40021969|FG002|Overall Study|Disease Progression|2|||
16420780|NCT00042991|40021970|FG003|Overall Study|Disease Progression|2|||
16420781|NCT00042991|40021971|FG004|Overall Study|Disease Progression|1|||
16420782|NCT00042991|40021972|FG005|Overall Study|Disease Progression|4|||
16420783|NCT00042991|40021973|FG006|Overall Study|Disease Progression|2|||
16420784|NCT00042991|40021967|FG000|Overall Study|Alternative Therapy|0|||
16420785|NCT00042991|40021968|FG001|Overall Study|Alternative Therapy|0|||
16420786|NCT00042991|40021969|FG002|Overall Study|Alternative Therapy|0|||
16359597|NCT03979313|39804149|FG001|All Subjects|Any Other Reason|23|||
16359598|NCT03979313|39804148|FG000|All Subjects|Covid-19|1|||
16359599|NCT03979313|39804149|FG001|All Subjects|Covid-19|3|||
16359600|NCT03979313|39804148|FG000|All Subjects|Withdrawal by Subject|35|||
16359601|NCT03979313|39804149|FG001|All Subjects|Withdrawal by Subject|44|||
16359602|NCT03979313|39804148|FG000|All Subjects|Death|0|||
16359603|NCT03979313|39804149|FG001|All Subjects|Death|5|||
16359604|NCT03979313|39804148|FG000|All Subjects|Lost to Follow-up|28|||
16359605|NCT03979313|39804149|FG001|All Subjects|Lost to Follow-up|61|||
16359606|NCT04919161|39804151|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
16359607|NCT04919161|39804152|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
16359608|NCT04919161|39804151|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
16359609|NCT04919161|39804152|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
16359610|NCT04919161|39804151|FG000|Overall Study|Acute ankle sprain after session 1|0|||
16359611|NCT04919161|39804152|FG001|Overall Study|Acute ankle sprain after session 1|1|||
16359612|NCT03407482|39804161|FG000|Overall Study|Adverse Event|12|||
16359613|NCT03407482|39804161|FG000|Overall Study|Disease Relapse|1|||
16359614|NCT03407482|39804161|FG000|Overall Study|Lost to Follow-up|1|||
16359615|NCT03407482|39804161|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16359616|NCT03407482|39804161|FG000|Overall Study|Pregnancy|2|||
16359617|NCT03407482|39804161|FG000|Overall Study|Protocol Violation|1|||
16359618|NCT03407482|39804161|FG000|Overall Study|Study Terminated By Sponsor|106|||
16359619|NCT03407482|39804161|FG000|Overall Study|Withdrawal by Subject|6|||
16359620|NCT03407482|39804161|FG000|Overall Study|Data Entry Error|1|||
16359621|NCT01349595|39804163|FG000|Overall Study|Lack of funding|2|||
16359622|NCT01349595|39804164|FG001|Overall Study|Lack of funding|2|||
16359623|NCT02475369|39804167|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
16359624|NCT02475369|39804168|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
16359625|NCT02014272|39804169|FG000|Intervention Period 1|Withdrawal by Subject|1|||
16359626|NCT02014272|39804170|FG001|Intervention Period 1|Withdrawal by Subject|0|||
16359627|NCT02014272|39804169|FG000|Intervention Period 1|Adverse Event|0|||
16359628|NCT02014272|39804170|FG001|Intervention Period 1|Adverse Event|1|||
16359629|NCT03055936|39804171|FG000|Overall Study|Adverse Event|0|||
16359630|NCT03055936|39804172|FG001|Overall Study|Adverse Event|1|||
16359631|NCT03055936|39804173|FG002|Overall Study|Adverse Event|1|||
16359632|NCT03055936|39804174|FG003|Overall Study|Adverse Event|1|||
16420787|NCT00042991|40021970|FG003|Overall Study|Alternative Therapy|0|||
16420788|NCT00042991|40021971|FG004|Overall Study|Alternative Therapy|1|||
16420789|NCT00042991|40021972|FG005|Overall Study|Alternative Therapy|0|||
16420790|NCT00042991|40021973|FG006|Overall Study|Alternative Therapy|0|||
16359633|NCT03055936|39804171|FG000|Overall Study|Personal reason|2|||
16359634|NCT03055936|39804172|FG001|Overall Study|Personal reason|0|||
16420791|NCT00477152|40021976|FG000|Overall Study|Parent withdrew consent|2|||
16420792|NCT00477152|40021976|FG000|Overall Study|Adverse Event|1|||
16420793|NCT03834220|40021977|FG000|Overall Study|Adverse Event|1|||
16420794|NCT03834220|40021978|FG001|Overall Study|Adverse Event|0|||
16420795|NCT03834220|40021979|FG002|Overall Study|Adverse Event|0|||
16420796|NCT03834220|40021977|FG000|Overall Study|Death|8|||
16420797|NCT03834220|40021978|FG001|Overall Study|Death|1|||
16420798|NCT03834220|40021979|FG002|Overall Study|Death|17|||
16420799|NCT03834220|40021977|FG000|Overall Study|Reason not Specified|9|||
16420800|NCT03834220|40021978|FG001|Overall Study|Reason not Specified|0|||
16420801|NCT03834220|40021979|FG002|Overall Study|Reason not Specified|6|||
16420802|NCT03834220|40021977|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
16420803|NCT03834220|40021978|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
16420804|NCT03834220|40021979|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
16420805|NCT03834220|40021977|FG000|Overall Study|Withdrawal of Consent|2|||
16420806|NCT03834220|40021978|FG001|Overall Study|Withdrawal of Consent|2|||
16420807|NCT03834220|40021979|FG002|Overall Study|Withdrawal of Consent|2|||
16420808|NCT03052816|40021982|FG000|Overall Study|Withdrawal by Subject|1|||
16420809|NCT03052816|40021983|FG001|Overall Study|Withdrawal by Subject|0|||
16420810|NCT03052816|40021982|FG000|Overall Study|Desired opioids|2|||
16420811|NCT03052816|40021983|FG001|Overall Study|Desired opioids|0|||
16420812|NCT00788710|40021985|FG000|Overall Study|Adverse Event|1|||
16420813|NCT00788710|40021986|FG001|Overall Study|Adverse Event|3|||
16420814|NCT00788710|40021987|FG002|Overall Study|Adverse Event|4|||
16420815|NCT00788710|40021985|FG000|Overall Study|Lack of Efficacy|0|||
16420816|NCT00788710|40021986|FG001|Overall Study|Lack of Efficacy|0|||
16420817|NCT00788710|40021987|FG002|Overall Study|Lack of Efficacy|1|||
16420818|NCT00788710|40021985|FG000|Overall Study|Lost to Follow-up|0|||
16420819|NCT00788710|40021986|FG001|Overall Study|Lost to Follow-up|1|||
16420820|NCT00788710|40021987|FG002|Overall Study|Lost to Follow-up|0|||
16420821|NCT00788710|40021985|FG000|Overall Study|Physician Decision|2|||
16420822|NCT00788710|40021986|FG001|Overall Study|Physician Decision|1|||
16420823|NCT00788710|40021987|FG002|Overall Study|Physician Decision|0|||
16420824|NCT00788710|40021985|FG000|Overall Study|Protocol Violation|0|||
16420825|NCT00788710|40021986|FG001|Overall Study|Protocol Violation|1|||
16420826|NCT00788710|40021987|FG002|Overall Study|Protocol Violation|1|||
16420827|NCT00788710|40021985|FG000|Overall Study|Withdrawal by Subject|2|||
16420828|NCT00788710|40021986|FG001|Overall Study|Withdrawal by Subject|2|||
16420829|NCT00788710|40021987|FG002|Overall Study|Withdrawal by Subject|0|||
16420830|NCT04294147|40021994|FG000|Overall Study|Protocol Violation|2|||
16420831|NCT04294147|40021995|FG001|Overall Study|Protocol Violation|0|||
16420832|NCT01123707|40021998|FG000|Overall Study|Lost to Follow-up|3|||
16420833|NCT01123707|40021999|FG001|Overall Study|Lost to Follow-up|1|||
16420834|NCT01123707|40022000|FG002|Overall Study|Lost to Follow-up|3|||
16420835|NCT01123707|40022001|FG003|Overall Study|Lost to Follow-up|2|||
16420836|NCT01123707|40021998|FG000|Overall Study|Adverse Event|5|||
16420837|NCT01123707|40021999|FG001|Overall Study|Adverse Event|7|||
16420838|NCT01123707|40022000|FG002|Overall Study|Adverse Event|5|||
16420839|NCT01123707|40022001|FG003|Overall Study|Adverse Event|3|||
16420840|NCT01123707|40021998|FG000|Overall Study|Sponsor Discontinued Study|30|||
16420841|NCT01123707|40021999|FG001|Overall Study|Sponsor Discontinued Study|24|||
16420842|NCT01123707|40022000|FG002|Overall Study|Sponsor Discontinued Study|25|||
16420843|NCT01123707|40022001|FG003|Overall Study|Sponsor Discontinued Study|40|||
16420844|NCT01123707|40021998|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
16420845|NCT01123707|40021999|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
16420846|NCT01123707|40022000|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
16420847|NCT01123707|40022001|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
16420848|NCT01123707|40021998|FG000|Overall Study|Investigator Withdrew Participant|0|||
16420849|NCT01123707|40021999|FG001|Overall Study|Investigator Withdrew Participant|1|||
16420850|NCT01123707|40022000|FG002|Overall Study|Investigator Withdrew Participant|1|||
16420851|NCT01123707|40022001|FG003|Overall Study|Investigator Withdrew Participant|1|||
16420852|NCT01123707|40021998|FG000|Overall Study|Subject Withdrew Consent|4|||
16420853|NCT01123707|40021999|FG001|Overall Study|Subject Withdrew Consent|5|||
16420854|NCT01123707|40022000|FG002|Overall Study|Subject Withdrew Consent|1|||
16420855|NCT01123707|40022001|FG003|Overall Study|Subject Withdrew Consent|2|||
16420856|NCT01123707|40021998|FG000|Overall Study|Lack of Efficacy|1|||
16420857|NCT01123707|40021999|FG001|Overall Study|Lack of Efficacy|2|||
16420858|NCT01123707|40022000|FG002|Overall Study|Lack of Efficacy|1|||
16420859|NCT01123707|40022001|FG003|Overall Study|Lack of Efficacy|0|||
16420860|NCT01123707|40021998|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
16420861|NCT01123707|40021999|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
16420862|NCT01123707|40022000|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
16420863|NCT01123707|40022001|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
16420864|NCT00408434|40022002|FG000|Overall Study|Adverse Event|0|||
16420865|NCT00408434|40022003|FG001|Overall Study|Adverse Event|0|||
16420866|NCT00408434|40022004|FG002|Overall Study|Adverse Event|1|||
16420867|NCT00408434|40022005|FG003|Overall Study|Adverse Event|0|||
16420868|NCT00408434|40022006|FG004|Overall Study|Adverse Event|0|||
16420869|NCT00408434|40022007|FG005|Overall Study|Adverse Event|0|||
16420870|NCT00408434|40022008|FG006|Overall Study|Adverse Event|0|||
16420871|NCT00408434|40022002|FG000|Overall Study|Progressive disease|6|||
16420872|NCT00408434|40022003|FG001|Overall Study|Progressive disease|3|||
16420873|NCT00408434|40022004|FG002|Overall Study|Progressive disease|4|||
16420874|NCT00408434|40022005|FG003|Overall Study|Progressive disease|3|||
16420875|NCT00408434|40022006|FG004|Overall Study|Progressive disease|3|||
16420876|NCT00408434|40022007|FG005|Overall Study|Progressive disease|1|||
16420877|NCT00408434|40022008|FG006|Overall Study|Progressive disease|4|||
16420878|NCT00408434|40022002|FG000|Overall Study|Other|0|||
16420879|NCT00408434|40022003|FG001|Overall Study|Other|0|||
16420880|NCT00408434|40022004|FG002|Overall Study|Other|1|||
16420881|NCT00408434|40022005|FG003|Overall Study|Other|0|||
16420882|NCT00408434|40022006|FG004|Overall Study|Other|2|||
16420883|NCT00408434|40022007|FG005|Overall Study|Other|1|||
16420884|NCT00408434|40022008|FG006|Overall Study|Other|0|||
16420885|NCT00408434|40022002|FG000|Overall Study|Terminated by Investigator|0|||
16420886|NCT00408434|40022003|FG001|Overall Study|Terminated by Investigator|0|||
16420887|NCT00408434|40022004|FG002|Overall Study|Terminated by Investigator|0|||
16420888|NCT00408434|40022005|FG003|Overall Study|Terminated by Investigator|0|||
16420889|NCT00408434|40022006|FG004|Overall Study|Terminated by Investigator|1|||
16420890|NCT00408434|40022007|FG005|Overall Study|Terminated by Investigator|1|||
16420891|NCT00408434|40022008|FG006|Overall Study|Terminated by Investigator|0|||
16420892|NCT02936284|40022011|FG000|Overall Study|Withdrawal by Subject|3|||
16420893|NCT02936284|40022012|FG001|Overall Study|Withdrawal by Subject|1|||
16420894|NCT02936284|40022011|FG000|Overall Study|Lost to Follow-up|7|||
16420895|NCT02936284|40022012|FG001|Overall Study|Lost to Follow-up|8|||
16420896|NCT00994643|40022013|FG000|Overall Study|Withdrawal by Subject|1|||
16420897|NCT01817959|40022020|FG000|Overall Study|Graft loss|1|||
16420898|NCT01817959|40022021|FG001|Overall Study|Graft loss|1|||
16420899|NCT01817959|40022020|FG000|Overall Study|forbidden medication|1|||
16420900|NCT01817959|40022021|FG001|Overall Study|forbidden medication|1|||
16420901|NCT01817959|40022020|FG000|Overall Study|Adverse Event|1|||
16420902|NCT01817959|40022021|FG001|Overall Study|Adverse Event|0|||
16420903|NCT01817959|40022020|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
16420904|NCT01817959|40022021|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
16420905|NCT02713828|40022024|FG000|Overall Study|Death|2|||
16420906|NCT02713828|40022025|FG001|Overall Study|Death|0|||
16420907|NCT02713828|40022024|FG000|Overall Study|Withdrawal by Subject|1|||
16420908|NCT02713828|40022025|FG001|Overall Study|Withdrawal by Subject|0|||
16420909|NCT02713828|40022024|FG000|Overall Study|study terminated but patient allowed to|2|||
16420910|NCT02713828|40022025|FG001|Overall Study|study terminated but patient allowed to|0|||
16420911|NCT02593825|40022026|FG000|Intervention|Lost to Follow-up|10|||
16420912|NCT02593825|40022027|FG001|Intervention|Lost to Follow-up|12|||
16420913|NCT01832532|40022028|FG000|Overall Study|Withdrawal by Subject|5|||
16420914|NCT01832532|40022029|FG001|Overall Study|Withdrawal by Subject|2|||
16420915|NCT02868229|40022032|FG000|Overall Study|Adverse Event|1|||
16420916|NCT02868229|40022033|FG001|Overall Study|Adverse Event|0|||
16420917|NCT02868229|40022034|FG002|Overall Study|Adverse Event|0|||
16420918|NCT02868229|40022035|FG003|Overall Study|Adverse Event|1|||
16420919|NCT02868229|40022032|FG000|Overall Study|Death|0|||
16420920|NCT02868229|40022033|FG001|Overall Study|Death|0|||
16420921|NCT02868229|40022034|FG002|Overall Study|Death|1|||
16420922|NCT02868229|40022035|FG003|Overall Study|Death|1|||
16420923|NCT02868229|40022032|FG000|Overall Study|Missed dose|0|||
16420924|NCT02868229|40022033|FG001|Overall Study|Missed dose|0|||
16420925|NCT02868229|40022034|FG002|Overall Study|Missed dose|0|||
16420926|NCT02868229|40022035|FG003|Overall Study|Missed dose|3|||
16420927|NCT03319212|40022037|FG000|Overall Study|Discontinued as moving out of local area|0|||
16420928|NCT03319212|40022038|FG001|Overall Study|Discontinued as moving out of local area|1|||
16420929|NCT03319212|40022037|FG000|Overall Study|Adverse Event|2|||
16420930|NCT03319212|40022038|FG001|Overall Study|Adverse Event|2|||
16420931|NCT03319212|40022037|FG000|Overall Study|Withdrawal by Subject|0|||
16420932|NCT03319212|40022038|FG001|Overall Study|Withdrawal by Subject|1|||
16420933|NCT03319212|40022037|FG000|Overall Study|Lost to Follow-up|0|||
16420934|NCT03319212|40022038|FG001|Overall Study|Lost to Follow-up|1|||
16420935|NCT03319212|40022037|FG000|Overall Study|Physician Decision|1|||
16420936|NCT03319212|40022038|FG001|Overall Study|Physician Decision|0|||
16420937|NCT02249182|40022044|FG000|Treatment Phase|Lost to Follow-up|4|||
16420938|NCT02249182|40022045|FG001|Treatment Phase|Lost to Follow-up|0|||
16420939|NCT02249182|40022046|FG002|Treatment Phase|Lost to Follow-up|0|||
16420940|NCT02249182|40022047|FG003|Treatment Phase|Lost to Follow-up|0|||
16420941|NCT02249182|40022048|FG004|Treatment Phase|Lost to Follow-up|0|||
16420942|NCT03477838|40022049|FG000|Overall Study|Lost to Follow-up|14|||
16420943|NCT00428389|40022050|FG000|Core Phase|Adverse Event|6|||
16420944|NCT00428389|40022051|FG001|Core Phase|Adverse Event|4|||
16420945|NCT00428389|40022050|FG000|Core Phase|Lack of Efficacy|2|||
16420946|NCT00428389|40022051|FG001|Core Phase|Lack of Efficacy|0|||
16420947|NCT00428389|40022050|FG000|Core Phase|Abnormal test procedure result(s)|0|||
16420948|NCT00428389|40022051|FG001|Core Phase|Abnormal test procedure result(s)|1|||
16420949|NCT00428389|40022050|FG000|Core Phase|Withdrawal by Subject|3|||
16420950|NCT00428389|40022051|FG001|Core Phase|Withdrawal by Subject|4|||
16420951|NCT00428389|40022050|FG000|Core Phase|Protocol deviation|0|||
16420952|NCT00428389|40022051|FG001|Core Phase|Protocol deviation|2|||
16420953|NCT00428389|40022050|FG000|Extension Phase|Adverse Event|17|||
16420954|NCT00428389|40022051|FG001|Extension Phase|Adverse Event|11|||
16420955|NCT00428389|40022050|FG000|Extension Phase|Lack of Efficacy|4|||
16420956|NCT00428389|40022051|FG001|Extension Phase|Lack of Efficacy|3|||
16420957|NCT00428389|40022050|FG000|Extension Phase|Withdrawal by Subject|6|||
16420958|NCT00428389|40022051|FG001|Extension Phase|Withdrawal by Subject|6|||
16420959|NCT00428389|40022050|FG000|Extension Phase|Lost to Follow-up|0|||
16420960|NCT00428389|40022051|FG001|Extension Phase|Lost to Follow-up|3|||
16420961|NCT00428389|40022050|FG000|Extension Phase|Death|1|||
16420962|NCT00428389|40022051|FG001|Extension Phase|Death|0|||
16420963|NCT00428389|40022050|FG000|Extension Phase|Protocol Violation|3|||
16420964|NCT00428389|40022051|FG001|Extension Phase|Protocol Violation|2|||
16420965|NCT00428389|40022050|FG000|Extension Phase|Administrative problems|1|||
16420966|NCT00428389|40022051|FG001|Extension Phase|Administrative problems|1|||
16420967|NCT02513472|40022052|FG000|Overall Study|Radiological Disease Progression|45|||
16420968|NCT02513472|40022053|FG001|Overall Study|Radiological Disease Progression|57|||
16420969|NCT02513472|40022052|FG000|Overall Study|Clinical Disease Progression|5|||
16420970|NCT02513472|40022053|FG001|Overall Study|Clinical Disease Progression|13|||
16420971|NCT02513472|40022052|FG000|Overall Study|Adverse Event|8|||
16420972|NCT02513472|40022053|FG001|Overall Study|Adverse Event|11|||
16420973|NCT02513472|40022052|FG000|Overall Study|Withdrawal by Subject|0|||
16420974|NCT02513472|40022053|FG001|Overall Study|Withdrawal by Subject|4|||
16420975|NCT02513472|40022052|FG000|Overall Study|Subject Choice|2|||
16420976|NCT02513472|40022053|FG001|Overall Study|Subject Choice|7|||
16359635|NCT03055936|39804173|FG002|Overall Study|Personal reason|1|||
16359636|NCT03055936|39804174|FG003|Overall Study|Personal reason|0|||
16359637|NCT00606008|39804175|FG000|Overall Study|Adverse Event|1|||
16359638|NCT00606008|39804175|FG000|Overall Study|Withdrawal by Subject|4|||
16359639|NCT01461551|39804176|FG000|Overall Study|Physician Decision|2|||
16359640|NCT01461551|39804177|FG001|Overall Study|Physician Decision|1|||
16359641|NCT01461551|39804178|FG002|Overall Study|Physician Decision|2|||
16359642|NCT01991314|39804179|FG000|Overall Study|Adverse Event|5|||
16359643|NCT01991314|39804180|FG001|Overall Study|Adverse Event|1|||
16359644|NCT01991314|39804179|FG000|Overall Study|Lost to Follow-up|6|||
16359645|NCT01991314|39804180|FG001|Overall Study|Lost to Follow-up|10|||
16359646|NCT01122173|39804184|FG000|Overall Study|Lost to Follow-up|3|||
16359647|NCT01122173|39804184|FG000|Overall Study|Withdrawal by Subject|3|||
16359648|NCT01122173|39804184|FG000|Overall Study|Left study for other reasons|3|||
16359649|NCT02404545|39804186|FG000|Overall Study|Sponsor Termination|6|||
16359650|NCT02404545|39804187|FG001|Overall Study|Sponsor Termination|6|||
16359651|NCT01664091|39804188|FG000|Overall Study|Death|1|||
16359652|NCT01664091|39804188|FG000|Overall Study|Disease Progression|2|||
16359653|NCT01664091|39804188|FG000|Overall Study|Lost to Follow-up|2|||
16359654|NCT01664091|39804188|FG000|Overall Study|Withdrawal by Subject|1|||
16359655|NCT02948400|39804189|FG000|Overall Study|Withdrawal by Subject|17|||
16359656|NCT02948400|39804190|FG001|Overall Study|Withdrawal by Subject|10|||
16359657|NCT02948400|39804189|FG000|Overall Study|failed to attend appointments|47|||
16359658|NCT02948400|39804190|FG001|Overall Study|failed to attend appointments|34|||
16359659|NCT02948400|39804189|FG000|Overall Study|COVID-related closure|6|||
16359660|NCT02948400|39804190|FG001|Overall Study|COVID-related closure|2|||
16359661|NCT02948400|39804189|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
16359662|NCT02948400|39804190|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
16359663|NCT02948400|39804189|FG000|Overall Study|motion sickness in virtual reality|2|||
16359664|NCT02948400|39804190|FG001|Overall Study|motion sickness in virtual reality|0|||
16359665|NCT00700635|39804191|FG000|Overall Study|Adverse Event|1|||
16359666|NCT00700635|39804192|FG001|Overall Study|Adverse Event|0|||
16359667|NCT00700635|39804193|FG002|Overall Study|Adverse Event|0|||
16359668|NCT00700635|39804191|FG000|Overall Study|Lost to Follow-up|1|||
16359669|NCT00700635|39804192|FG001|Overall Study|Lost to Follow-up|3|||
16359670|NCT00700635|39804193|FG002|Overall Study|Lost to Follow-up|0|||
16359671|NCT00700635|39804191|FG000|Overall Study|Protocol Violation|2|||
16359672|NCT00700635|39804192|FG001|Overall Study|Protocol Violation|2|||
16359673|NCT00700635|39804193|FG002|Overall Study|Protocol Violation|0|||
16359674|NCT00700635|39804191|FG000|Overall Study|Withdrawal by Subject|7|||
16359675|NCT00700635|39804192|FG001|Overall Study|Withdrawal by Subject|3|||
16420977|NCT02513472|40022052|FG000|Overall Study|Treatment Completed as per Protocol|3|||
16420978|NCT02513472|40022053|FG001|Overall Study|Treatment Completed as per Protocol|3|||
16420979|NCT02513472|40022052|FG000|Overall Study|Other|3|||
16359676|NCT00700635|39804193|FG002|Overall Study|Withdrawal by Subject|1|||
16359677|NCT04539275|39804195|FG000|Overall Study|Death|2|||
16359678|NCT04539275|39804196|FG001|Overall Study|Death|4|||
16420980|NCT02513472|40022053|FG001|Overall Study|Other|6|||
16420981|NCT05320393|40022054|FG000|Overall Study|Withdrawal by Subject|1|||
16420982|NCT05320393|40022055|FG001|Overall Study|Withdrawal by Subject|0|||
16420983|NCT05320393|40022056|FG002|Overall Study|Withdrawal by Subject|2|||
16420984|NCT05320393|40022054|FG000|Overall Study|Lost to Follow-up|1|||
16420985|NCT05320393|40022055|FG001|Overall Study|Lost to Follow-up|2|||
16420986|NCT05320393|40022056|FG002|Overall Study|Lost to Follow-up|1|||
16420987|NCT05320393|40022054|FG000|Overall Study|Moved; too much driving|0|||
16420988|NCT05320393|40022055|FG001|Overall Study|Moved; too much driving|0|||
16420989|NCT05320393|40022056|FG002|Overall Study|Moved; too much driving|2|||
16420990|NCT05320393|40022054|FG000|Overall Study|Did not receive treatment|0|||
16248817|NCT02260492|39395259|FG002|Overall Study|Lost to Follow-up|0|||
16248818|NCT02260492|39395257|FG000|Overall Study|Physician Decision|2|||
16420991|NCT05320393|40022055|FG001|Overall Study|Did not receive treatment|0|||
16420992|NCT05320393|40022056|FG002|Overall Study|Did not receive treatment|1|||
16420993|NCT00488826|40022061|FG000|Overall Study|Withdrawal by Subject|40|||
16420994|NCT00488826|40022062|FG001|Overall Study|Withdrawal by Subject|35|||
16420995|NCT00488826|40022063|FG002|Overall Study|Withdrawal by Subject|19|||
16420996|NCT00488826|40022061|FG000|Overall Study|Protocol Violation|0|||
16420997|NCT00488826|40022062|FG001|Overall Study|Protocol Violation|0|||
16420998|NCT00488826|40022063|FG002|Overall Study|Protocol Violation|2|||
16420999|NCT00488826|40022061|FG000|Overall Study|Adverse Event|9|||
16421000|NCT00488826|40022062|FG001|Overall Study|Adverse Event|15|||
16421001|NCT00488826|40022063|FG002|Overall Study|Adverse Event|4|||
16421002|NCT00488826|40022061|FG000|Overall Study|Lost to Follow-up|5|||
16421003|NCT00488826|40022062|FG001|Overall Study|Lost to Follow-up|1|||
16421004|NCT00488826|40022063|FG002|Overall Study|Lost to Follow-up|0|||
16421005|NCT00488826|40022061|FG000|Overall Study|Protocol Deviations|2|||
16421006|NCT00488826|40022062|FG001|Overall Study|Protocol Deviations|1|||
16421007|NCT00488826|40022063|FG002|Overall Study|Protocol Deviations|1|||
16421008|NCT02673684|40022066|FG000|Overall Study|Study not completed d/t loss of funding|9|||
16421009|NCT02673684|40022067|FG001|Overall Study|Study not completed d/t loss of funding|8|||
16421010|NCT00231413|40022070|FG000|Overall Study|Non-serious AE|0|||
16421011|NCT00231413|40022071|FG001|Overall Study|Non-serious AE|0|||
16421012|NCT00231413|40022072|FG002|Overall Study|Non-serious AE|1|||
16421013|NCT00231413|40022073|FG003|Overall Study|Non-serious AE|0|||
16421014|NCT00231413|40022074|FG004|Overall Study|Non-serious AE|0|||
16421015|NCT00231413|40022075|FG005|Overall Study|Non-serious AE|0|||
16421016|NCT00231413|40022076|FG006|Overall Study|Non-serious AE|1|||
16421017|NCT00231413|40022070|FG000|Overall Study|Withdrawal by Subject|3|||
16421018|NCT00231413|40022071|FG001|Overall Study|Withdrawal by Subject|1|||
16421019|NCT00231413|40022072|FG002|Overall Study|Withdrawal by Subject|4|||
16421020|NCT00231413|40022073|FG003|Overall Study|Withdrawal by Subject|2|||
16421021|NCT00231413|40022074|FG004|Overall Study|Withdrawal by Subject|2|||
16421022|NCT00231413|40022075|FG005|Overall Study|Withdrawal by Subject|0|||
16421023|NCT00231413|40022076|FG006|Overall Study|Withdrawal by Subject|3|||
16421024|NCT00231413|40022070|FG000|Overall Study|Migrated/moved from study area|0|||
16421025|NCT00231413|40022071|FG001|Overall Study|Migrated/moved from study area|0|||
16421026|NCT00231413|40022072|FG002|Overall Study|Migrated/moved from study area|1|||
16421027|NCT00231413|40022073|FG003|Overall Study|Migrated/moved from study area|0|||
16421028|NCT00231413|40022074|FG004|Overall Study|Migrated/moved from study area|0|||
16421029|NCT00231413|40022075|FG005|Overall Study|Migrated/moved from study area|1|||
16421030|NCT00231413|40022076|FG006|Overall Study|Migrated/moved from study area|0|||
16421031|NCT00231413|40022070|FG000|Overall Study|Lost to Follow-up|4|||
16421032|NCT00231413|40022071|FG001|Overall Study|Lost to Follow-up|4|||
16421033|NCT00231413|40022072|FG002|Overall Study|Lost to Follow-up|1|||
16421034|NCT00231413|40022073|FG003|Overall Study|Lost to Follow-up|1|||
16421035|NCT00231413|40022074|FG004|Overall Study|Lost to Follow-up|1|||
16421036|NCT00231413|40022075|FG005|Overall Study|Lost to Follow-up|4|||
16421037|NCT00231413|40022076|FG006|Overall Study|Lost to Follow-up|0|||
16421038|NCT00231413|40022070|FG000|Overall Study|Pregnancy|1|||
16421039|NCT00231413|40022071|FG001|Overall Study|Pregnancy|0|||
16421040|NCT00231413|40022072|FG002|Overall Study|Pregnancy|0|||
16421041|NCT00231413|40022073|FG003|Overall Study|Pregnancy|0|||
16421042|NCT00231413|40022074|FG004|Overall Study|Pregnancy|0|||
16421043|NCT00231413|40022075|FG005|Overall Study|Pregnancy|0|||
16421044|NCT00231413|40022076|FG006|Overall Study|Pregnancy|0|||
16421045|NCT01192568|40022080|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
16421046|NCT01192568|40022081|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
16421047|NCT01192568|40022082|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
16421048|NCT01192568|40022083|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
16421049|NCT01192568|40022080|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
16421050|NCT01192568|40022081|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
16421051|NCT01192568|40022082|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
16421052|NCT01192568|40022083|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
16421053|NCT03997825|40022084|FG000|Overall Study|Death|3|||
16421054|NCT03997825|40022084|FG000|Overall Study|Lost to Follow-up|10|||
16421055|NCT03997825|40022084|FG000|Overall Study|Withdrawal by Subject|3|||
16421056|NCT03997825|40022084|FG000|Overall Study|Refused participation|1|||
16248819|NCT02260492|39395258|FG001|Overall Study|Physician Decision|0|||
16248820|NCT02260492|39395259|FG002|Overall Study|Physician Decision|1|||
16248821|NCT02260492|39395257|FG000|Overall Study|Withdrawal by Subject|3|||
16248822|NCT02260492|39395258|FG001|Overall Study|Withdrawal by Subject|2|||
16248823|NCT02260492|39395259|FG002|Overall Study|Withdrawal by Subject|2|||
16248824|NCT01346410|39395263|FG000|Overall Study|Death|1|||
16248825|NCT01165996|39395264|FG000|Overall Study|Death|1|||
16248826|NCT01165996|39395264|FG000|Overall Study|Physician Decision|1|||
16248827|NCT02087046|39395265|FG000|Overall Study|Adverse Event|4|||
16248828|NCT02087046|39395265|FG000|Overall Study|Death|1|||
16248829|NCT02087046|39395265|FG000|Overall Study|Lost to Follow-up|3|||
16248830|NCT02087046|39395265|FG000|Overall Study|Withdrawal by Subject|2|||
16248831|NCT02087046|39395265|FG000|Overall Study|Physician Decision|1|||
16248832|NCT00685919|39395266|FG000|Overall Study|Withdrawal by Subject|0|||
16248833|NCT00685919|39395267|FG001|Overall Study|Withdrawal by Subject|0|||
16248834|NCT00685919|39395268|FG002|Overall Study|Withdrawal by Subject|1|||
16248835|NCT00685919|39395269|FG003|Overall Study|Withdrawal by Subject|0|||
16248836|NCT00685919|39395266|FG000|Overall Study|Physician Decision|1|||
16248837|NCT00685919|39395267|FG001|Overall Study|Physician Decision|0|||
16248838|NCT00685919|39395268|FG002|Overall Study|Physician Decision|0|||
16248839|NCT00685919|39395269|FG003|Overall Study|Physician Decision|0|||
16248840|NCT01165242|39395273|FG000|Overall Study|Unreachable Subjects|1|||
16248841|NCT01165242|39395274|FG001|Overall Study|Unreachable Subjects|0|||
16248842|NCT01165242|39395275|FG002|Overall Study|Unreachable Subjects|0|||
16248843|NCT01165242|39395273|FG000|Overall Study|Incarcerated Subjects|0|||
16248844|NCT01165242|39395274|FG001|Overall Study|Incarcerated Subjects|1|||
16248845|NCT01165242|39395275|FG002|Overall Study|Incarcerated Subjects|0|||
16248846|NCT01165242|39395273|FG000|Overall Study|Visit 2 Declined by Subject|0|||
16248847|NCT01165242|39395274|FG001|Overall Study|Visit 2 Declined by Subject|0|||
16248848|NCT01165242|39395275|FG002|Overall Study|Visit 2 Declined by Subject|1|||
16248849|NCT01165242|39395273|FG000|Overall Study|Withdrawal by Subject|0|||
16248850|NCT01165242|39395274|FG001|Overall Study|Withdrawal by Subject|2|||
16248851|NCT01165242|39395275|FG002|Overall Study|Withdrawal by Subject|2|||
16248852|NCT01165242|39395273|FG000|Overall Study|Extended Holiday|0|||
16248853|NCT01165242|39395274|FG001|Overall Study|Extended Holiday|0|||
16248854|NCT01165242|39395275|FG002|Overall Study|Extended Holiday|1|||
16248855|NCT01165242|39395273|FG000|Overall Study|Lost to Follow-up|9|||
16248856|NCT01165242|39395274|FG001|Overall Study|Lost to Follow-up|7|||
16248857|NCT01165242|39395275|FG002|Overall Study|Lost to Follow-up|10|||
16248858|NCT01001169|39395276|FG000|Overall Study|Withdrawal by Subject|2|||
16248859|NCT01001169|39395277|FG001|Overall Study|Withdrawal by Subject|1|||
16248860|NCT03271528|39395278|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
16248861|NCT03271528|39395279|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
16248862|NCT03271528|39395278|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
16248863|NCT03271528|39395279|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
16248864|NCT03271528|39395278|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
16248865|NCT03271528|39395279|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
16248866|NCT03271528|39395278|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
16248867|NCT03271528|39395279|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
16248868|NCT03271528|39395278|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
16248869|NCT03271528|39395279|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
16248870|NCT03271528|39395278|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
16248871|NCT03271528|39395279|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
16248872|NCT03271528|39395278|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
16248873|NCT03271528|39395279|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
16248874|NCT01066052|39395280|FG000|Overall Study|Enrolled But Not Treated|3|||
16248875|NCT01066052|39395281|FG001|Overall Study|Enrolled But Not Treated|0|||
16248876|NCT01618305|39395286|FG000|Overall Study|Death|0|||
16248877|NCT01618305|39395287|FG001|Overall Study|Death|1|||
16248878|NCT01618305|39395286|FG000|Overall Study|Lost to Follow-up|11|||
16248879|NCT01618305|39395287|FG001|Overall Study|Lost to Follow-up|7|||
16248880|NCT01618305|39395286|FG000|Overall Study|Protocol Violation|1|||
16248881|NCT01618305|39395287|FG001|Overall Study|Protocol Violation|0|||
16248882|NCT01618305|39395286|FG000|Overall Study|Withdrawal by Subject|3|||
16248883|NCT01618305|39395287|FG001|Overall Study|Withdrawal by Subject|2|||
16248884|NCT03896490|39395288|FG000|Overall Study|Withdrawal by Subject|1|||
16248885|NCT03896490|39395289|FG001|Overall Study|Withdrawal by Subject|1|||
16248886|NCT00441584|39395290|FG000|Overall Study|Lack of Efficacy|79|||
16248887|NCT00441584|39395290|FG000|Overall Study|Withdrawal by Subject|8|||
16248888|NCT00441584|39395290|FG000|Overall Study|Adverse Event|6|||
16359679|NCT04539275|39804195|FG000|Overall Study|Lost to Follow-up|1|||
16359680|NCT04539275|39804196|FG001|Overall Study|Lost to Follow-up|1|||
16359681|NCT04539275|39804195|FG000|Overall Study|Withdrawal by Subject|3|||
16359682|NCT04539275|39804196|FG001|Overall Study|Withdrawal by Subject|0|||
16130821|NCT00825825|38967140|FG004|Third Medication Period (14 Days)|poor data quality|0|||
16130822|NCT00825825|38967141|FG005|Third Medication Period (14 Days)|poor data quality|0|||
16130823|NCT00842985|38967142|FG000|Screening|Did not meet entrance requirements|27|||
16130824|NCT00842985|38967142|FG000|First Intervention|Withdrawal by Subject|3|||
16130825|NCT00842985|38967142|FG000|First Intervention|Protocol Violation|3|||
16130826|NCT00842985|38967142|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
16130827|NCT00842985|38967142|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
16130828|NCT02689518|38967143|FG000|Overall Study|Withdrawal by Subject|3|||
16130829|NCT03616977|38967144|FG000|Period 1|Physician Decision|0|||
16130830|NCT03616977|38967145|FG001|Period 1|Physician Decision|1|||
16130831|NCT03616977|38967144|FG000|Period 3|Adverse Event|1|||
16130832|NCT03616977|38967145|FG001|Period 3|Adverse Event|1|||
16130833|NCT01103362|38967146|FG000|Overall Study|study terminated|596|||
16130834|NCT01498679|38967147|FG000|Overall Study|Adverse Event|1|||
16130835|NCT01498679|38967148|FG001|Overall Study|Adverse Event|4|||
16130836|NCT01498679|38967147|FG000|Overall Study|Lack of Efficacy|72|||
16130837|NCT01498679|38967148|FG001|Overall Study|Lack of Efficacy|12|||
16130838|NCT01498679|38967147|FG000|Overall Study|Protocol Violation|4|||
16130839|NCT01498679|38967148|FG001|Overall Study|Protocol Violation|0|||
16130840|NCT01498679|38967147|FG000|Overall Study|Physician Decision|0|||
16130841|NCT01498679|38967148|FG001|Overall Study|Physician Decision|2|||
16130842|NCT01498679|38967147|FG000|Overall Study|Withdrawal by Subject|12|||
16130843|NCT01498679|38967148|FG001|Overall Study|Withdrawal by Subject|4|||
16130844|NCT00600886|38967149|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
16130845|NCT00600886|38967150|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
16130846|NCT00600886|38967149|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
16130847|NCT00600886|38967150|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
16130848|NCT00600886|38967149|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
16130849|NCT00600886|38967150|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
16130850|NCT00600886|38967149|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
16130851|NCT00600886|38967150|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
16130852|NCT00600886|38967149|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
16130853|NCT00600886|38967150|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
16130854|NCT00600886|38967149|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
16130855|NCT00600886|38967150|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
16130856|NCT00600886|38967149|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
16130857|NCT00600886|38967150|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
16130858|NCT00600886|38967149|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
16130859|NCT00600886|38967150|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
16130860|NCT00600886|38967149|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
16130861|NCT00600886|38967150|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
16130862|NCT00600886|38967149|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
16130863|NCT00600886|38967150|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
16130864|NCT00600886|38967149|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
16130865|NCT00600886|38967150|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
16130866|NCT00600886|38967149|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
16130867|NCT00600886|38967150|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
16130868|NCT00600886|38967149|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
16130869|NCT00600886|38967150|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
16130870|NCT00600886|38967149|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
16130871|NCT00600886|38967150|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
16130872|NCT00600886|38967149|FG000|Extension - Same Treatment (FAS)|Death|1|||
16130873|NCT00600886|38967150|FG001|Extension - Same Treatment (FAS)|Death|1|||
16130874|NCT00600886|38967149|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
16130875|NCT00600886|38967150|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
16130876|NCT00600886|38967149|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
16130877|NCT00600886|38967150|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
16130878|NCT00600886|38967149|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
16248889|NCT00441584|39395290|FG000|Overall Study|Protocol Violation|5|||
16248890|NCT00441584|39395290|FG000|Overall Study|Lost to Follow-up|4|||
16248891|NCT00441584|39395290|FG000|Overall Study|Failure to meet eligibility criteria|3|||
16248892|NCT03465891|39395291|FG000|Overall Study|Withdrawal by Subject|0|||
16421057|NCT00391625|40022085|FG000|Month 14|Withdrawal by Subject|1|||
16421058|NCT00391625|40022085|FG000|Month 50|Physician Decision|1|||
16130879|NCT00600886|38967150|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
16130880|NCT00600886|38967149|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
16130881|NCT00600886|38967150|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
16248893|NCT03465891|39395292|FG001|Overall Study|Withdrawal by Subject|1|||
16421059|NCT02277119|40022086|FG000|Overall Study|Lack of Efficacy|1|||
16421060|NCT02277119|40022087|FG001|Overall Study|Lack of Efficacy|1|||
16421061|NCT02277119|40022088|FG002|Overall Study|Lack of Efficacy|1|||
16421062|NCT02277119|40022086|FG000|Overall Study|Protocol Violation|2|||
16421063|NCT02277119|40022087|FG001|Overall Study|Protocol Violation|3|||
16421064|NCT02277119|40022088|FG002|Overall Study|Protocol Violation|7|||
16421065|NCT03193736|40022102|FG000|Overall Study|Death|2|||
16421066|NCT03193736|40022102|FG000|Overall Study|Withdrawal by Subject|1|||
16421067|NCT03193736|40022102|FG000|Overall Study|Lost to Follow-up|1|||
16421068|NCT03193736|40022102|FG000|Overall Study|implant not received|1|||
16421069|NCT01361178|40022103|FG000|Overall Study|Death|13|||
16421070|NCT01361178|40022104|FG001|Overall Study|Death|0|||
16421071|NCT02253316|40022111|FG000|Consolidation|Progression|4|||
16421072|NCT02253316|40022112|FG001|Consolidation|Progression|0|||
16421073|NCT02253316|40022113|FG002|Consolidation|Progression|0|||
16421074|NCT02253316|40022111|FG000|Consolidation|Non-Compliance|1|||
16421075|NCT02253316|40022112|FG001|Consolidation|Non-Compliance|0|||
16421076|NCT02253316|40022113|FG002|Consolidation|Non-Compliance|0|||
16421077|NCT02253316|40022111|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
16421078|NCT02253316|40022112|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
16421079|NCT02253316|40022113|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
16421080|NCT02253316|40022111|FG000|Consolidation|Secondary Malignancy|2|||
16421081|NCT02253316|40022112|FG001|Consolidation|Secondary Malignancy|0|||
16421082|NCT02253316|40022113|FG002|Consolidation|Secondary Malignancy|0|||
16421083|NCT02253316|40022111|FG000|Consolidation|Adverse Event|7|||
16421084|NCT02253316|40022112|FG001|Consolidation|Adverse Event|0|||
16421085|NCT02253316|40022113|FG002|Consolidation|Adverse Event|0|||
16421086|NCT02253316|40022111|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
16421087|NCT02253316|40022112|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
16421088|NCT02253316|40022113|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
16421089|NCT02253316|40022111|FG000|Maintenance|Physician Decision|0|||
16421090|NCT02253316|40022112|FG001|Maintenance|Physician Decision|7|||
16421091|NCT02253316|40022113|FG002|Maintenance|Physician Decision|16|||
16421092|NCT02253316|40022111|FG000|Maintenance|Non-Compliance|0|||
16421093|NCT02253316|40022112|FG001|Maintenance|Non-Compliance|1|||
16421094|NCT02253316|40022113|FG002|Maintenance|Non-Compliance|1|||
16421095|NCT02253316|40022111|FG000|Maintenance|Secondary Malignancy|0|||
16421096|NCT02253316|40022112|FG001|Maintenance|Secondary Malignancy|2|||
16421097|NCT02253316|40022113|FG002|Maintenance|Secondary Malignancy|6|||
16421098|NCT02253316|40022111|FG000|Maintenance|Adverse Event|0|||
16421099|NCT02253316|40022112|FG001|Maintenance|Adverse Event|8|||
16421100|NCT02253316|40022113|FG002|Maintenance|Adverse Event|12|||
16421101|NCT02253316|40022111|FG000|Maintenance|Still receiving active treatment|0|||
16421102|NCT02253316|40022112|FG001|Maintenance|Still receiving active treatment|5|||
16421103|NCT02253316|40022113|FG002|Maintenance|Still receiving active treatment|0|||
16421104|NCT02429830|40022116|FG000|Overall Study|Lost to Follow-up|1|||
16421105|NCT02429830|40022116|FG000|Overall Study|Device Explant|2|||
16421106|NCT00915551|40022117|FG000|Overall Study|Withdrawal by Subject|0|||
16421107|NCT00915551|40022118|FG001|Overall Study|Withdrawal by Subject|1|||
16421108|NCT04186871|40022121|FG000|Overall Study|Lack of Efficacy|0|||
16421109|NCT04186871|40022122|FG001|Overall Study|Lack of Efficacy|1|||
16421110|NCT04186871|40022123|FG002|Overall Study|Lack of Efficacy|0|||
16421111|NCT04186871|40022124|FG003|Overall Study|Lack of Efficacy|0|||
16421112|NCT04186871|40022125|FG004|Overall Study|Lack of Efficacy|1|||
16421113|NCT04186871|40022126|FG005|Overall Study|Lack of Efficacy|1|||
16421114|NCT04186871|40022121|FG000|Overall Study|Adverse Event|1|||
16421115|NCT04186871|40022122|FG001|Overall Study|Adverse Event|1|||
16421116|NCT04186871|40022123|FG002|Overall Study|Adverse Event|0|||
16421117|NCT04186871|40022124|FG003|Overall Study|Adverse Event|0|||
16421118|NCT04186871|40022125|FG004|Overall Study|Adverse Event|0|||
16421119|NCT04186871|40022126|FG005|Overall Study|Adverse Event|2|||
16421120|NCT04186871|40022121|FG000|Overall Study|Study terminated by sponsor|1|||
16421121|NCT04186871|40022122|FG001|Overall Study|Study terminated by sponsor|2|||
16421122|NCT04186871|40022123|FG002|Overall Study|Study terminated by sponsor|0|||
16421123|NCT04186871|40022124|FG003|Overall Study|Study terminated by sponsor|1|||
16421124|NCT04186871|40022125|FG004|Overall Study|Study terminated by sponsor|0|||
16421125|NCT04186871|40022126|FG005|Overall Study|Study terminated by sponsor|0|||
16421126|NCT04186871|40022121|FG000|Overall Study|Other reasons|0|||
16421127|NCT04186871|40022122|FG001|Overall Study|Other reasons|0|||
16421128|NCT04186871|40022123|FG002|Overall Study|Other reasons|0|||
16421129|NCT04186871|40022124|FG003|Overall Study|Other reasons|0|||
16421130|NCT04186871|40022125|FG004|Overall Study|Other reasons|0|||
16421131|NCT04186871|40022126|FG005|Overall Study|Other reasons|1|||
16421132|NCT04186871|40022121|FG000|Overall Study|Withdrawal by Subject|0|||
16421133|NCT04186871|40022122|FG001|Overall Study|Withdrawal by Subject|0|||
16421134|NCT04186871|40022123|FG002|Overall Study|Withdrawal by Subject|0|||
16421135|NCT04186871|40022124|FG003|Overall Study|Withdrawal by Subject|0|||
16421136|NCT04186871|40022125|FG004|Overall Study|Withdrawal by Subject|0|||
16421137|NCT04186871|40022126|FG005|Overall Study|Withdrawal by Subject|1|||
16421138|NCT04186871|40022121|FG000|Overall Study|Lost to Follow-up|0|||
16421139|NCT04186871|40022122|FG001|Overall Study|Lost to Follow-up|0|||
16421140|NCT04186871|40022123|FG002|Overall Study|Lost to Follow-up|0|||
16421141|NCT04186871|40022124|FG003|Overall Study|Lost to Follow-up|0|||
16421142|NCT04186871|40022125|FG004|Overall Study|Lost to Follow-up|0|||
16421143|NCT04186871|40022126|FG005|Overall Study|Lost to Follow-up|1|||
16421144|NCT00400569|40022127|FG000|Overall Study|Death|1|||
16421145|NCT00106353|40022131|FG000|Part 1|Disease progression|3|||
16421146|NCT00106353|40022132|FG001|Part 1|Disease progression|4|||
16421147|NCT00106353|40022133|FG002|Part 1|Disease progression|1|||
16421148|NCT00106353|40022134|FG003|Part 1|Disease progression|3|||
16421149|NCT00106353|40022135|FG004|Part 1|Disease progression|0|||
16421150|NCT00106353|40022136|FG005|Part 1|Disease progression|0|||
16421151|NCT00106353|40022137|FG006|Part 1|Disease progression|0|||
16421152|NCT00106353|40022131|FG000|Part 1|Withdrawal by Subject|0|||
16421153|NCT00106353|40022132|FG001|Part 1|Withdrawal by Subject|0|||
16421154|NCT00106353|40022133|FG002|Part 1|Withdrawal by Subject|1|||
16421155|NCT00106353|40022134|FG003|Part 1|Withdrawal by Subject|2|||
16421156|NCT00106353|40022135|FG004|Part 1|Withdrawal by Subject|0|||
16421157|NCT00106353|40022136|FG005|Part 1|Withdrawal by Subject|0|||
16421158|NCT00106353|40022137|FG006|Part 1|Withdrawal by Subject|0|||
16421159|NCT00106353|40022131|FG000|Part 1|Symptomatic deterioration|0|||
16421160|NCT00106353|40022132|FG001|Part 1|Symptomatic deterioration|0|||
16421161|NCT00106353|40022133|FG002|Part 1|Symptomatic deterioration|1|||
16421162|NCT00106353|40022134|FG003|Part 1|Symptomatic deterioration|0|||
16421163|NCT00106353|40022135|FG004|Part 1|Symptomatic deterioration|0|||
16421164|NCT00106353|40022136|FG005|Part 1|Symptomatic deterioration|0|||
16421165|NCT00106353|40022137|FG006|Part 1|Symptomatic deterioration|0|||
16421166|NCT00106353|40022131|FG000|Part 1|Entered follow-up phase|1|||
16421167|NCT00106353|40022132|FG001|Part 1|Entered follow-up phase|1|||
16421168|NCT00106353|40022133|FG002|Part 1|Entered follow-up phase|0|||
16421169|NCT00106353|40022134|FG003|Part 1|Entered follow-up phase|1|||
16421170|NCT00106353|40022135|FG004|Part 1|Entered follow-up phase|0|||
16421171|NCT00106353|40022136|FG005|Part 1|Entered follow-up phase|0|||
16421172|NCT00106353|40022137|FG006|Part 1|Entered follow-up phase|0|||
16421173|NCT00106353|40022131|FG000|Part 1|Adverse Event|0|||
16421174|NCT00106353|40022132|FG001|Part 1|Adverse Event|0|||
16421175|NCT00106353|40022133|FG002|Part 1|Adverse Event|0|||
16421176|NCT00106353|40022134|FG003|Part 1|Adverse Event|1|||
16421177|NCT00106353|40022135|FG004|Part 1|Adverse Event|0|||
16421178|NCT00106353|40022136|FG005|Part 1|Adverse Event|0|||
16421179|NCT00106353|40022137|FG006|Part 1|Adverse Event|0|||
16421180|NCT00106353|40022131|FG000|Part 2|Disease progression|0|||
16421181|NCT00106353|40022132|FG001|Part 2|Disease progression|0|||
16421182|NCT00106353|40022133|FG002|Part 2|Disease progression|0|||
16421183|NCT00106353|40022134|FG003|Part 2|Disease progression|0|||
16421184|NCT00106353|40022135|FG004|Part 2|Disease progression|8|||
16421185|NCT00106353|40022136|FG005|Part 2|Disease progression|14|||
16421186|NCT00106353|40022137|FG006|Part 2|Disease progression|13|||
16421187|NCT00106353|40022131|FG000|Part 2|Death|0|||
16421188|NCT00106353|40022132|FG001|Part 2|Death|0|||
16421189|NCT00106353|40022133|FG002|Part 2|Death|0|||
16421190|NCT00106353|40022134|FG003|Part 2|Death|0|||
16421191|NCT00106353|40022135|FG004|Part 2|Death|3|||
16421192|NCT00106353|40022136|FG005|Part 2|Death|0|||
16421193|NCT00106353|40022137|FG006|Part 2|Death|1|||
16421194|NCT00106353|40022131|FG000|Part 2|Symptomatic deterioration|0|||
16421195|NCT00106353|40022132|FG001|Part 2|Symptomatic deterioration|0|||
16421196|NCT00106353|40022133|FG002|Part 2|Symptomatic deterioration|0|||
16421197|NCT00106353|40022134|FG003|Part 2|Symptomatic deterioration|0|||
16248894|NCT03465891|39395291|FG000|Overall Study|Disease progression|1|||
16421198|NCT00106353|40022135|FG004|Part 2|Symptomatic deterioration|3|||
16421199|NCT00106353|40022136|FG005|Part 2|Symptomatic deterioration|0|||
16421200|NCT00106353|40022137|FG006|Part 2|Symptomatic deterioration|0|||
16421201|NCT00106353|40022131|FG000|Part 2|Adverse Event|0|||
16421202|NCT00106353|40022132|FG001|Part 2|Adverse Event|0|||
16421203|NCT00106353|40022133|FG002|Part 2|Adverse Event|0|||
16421204|NCT00106353|40022134|FG003|Part 2|Adverse Event|0|||
16421205|NCT00106353|40022135|FG004|Part 2|Adverse Event|0|||
16421206|NCT00106353|40022136|FG005|Part 2|Adverse Event|2|||
16421207|NCT00106353|40022137|FG006|Part 2|Adverse Event|1|||
16421208|NCT00106353|40022131|FG000|Part 2|Other|0|||
16421209|NCT00106353|40022132|FG001|Part 2|Other|0|||
16421210|NCT00106353|40022133|FG002|Part 2|Other|0|||
16421211|NCT00106353|40022134|FG003|Part 2|Other|0|||
16421212|NCT00106353|40022135|FG004|Part 2|Other|1|||
16421213|NCT00106353|40022136|FG005|Part 2|Other|1|||
16421214|NCT00106353|40022137|FG006|Part 2|Other|1|||
16130882|NCT00600886|38967149|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
16421215|NCT00106353|40022131|FG000|Part 2|Withdrawal by Subject|0|||
16421216|NCT00106353|40022132|FG001|Part 2|Withdrawal by Subject|0|||
16421217|NCT00106353|40022133|FG002|Part 2|Withdrawal by Subject|0|||
16421218|NCT00106353|40022134|FG003|Part 2|Withdrawal by Subject|0|||
16421219|NCT00106353|40022135|FG004|Part 2|Withdrawal by Subject|1|||
16421220|NCT00106353|40022136|FG005|Part 2|Withdrawal by Subject|0|||
16421221|NCT00106353|40022137|FG006|Part 2|Withdrawal by Subject|0|||
16421222|NCT00106353|40022131|FG000|Part 2|Physician Decision|0|||
16421223|NCT00106353|40022132|FG001|Part 2|Physician Decision|0|||
16421224|NCT00106353|40022133|FG002|Part 2|Physician Decision|0|||
16421225|NCT00106353|40022134|FG003|Part 2|Physician Decision|0|||
16421226|NCT00106353|40022135|FG004|Part 2|Physician Decision|0|||
16421227|NCT00106353|40022136|FG005|Part 2|Physician Decision|1|||
16421228|NCT00106353|40022137|FG006|Part 2|Physician Decision|0|||
16421229|NCT01793883|40022140|FG000|Overall Study|Withdrawal by Subject|3|||
16421230|NCT01793883|40022141|FG001|Overall Study|Withdrawal by Subject|7|||
16421231|NCT01793883|40022142|FG002|Overall Study|Withdrawal by Subject|3|||
16421232|NCT01793883|40022140|FG000|Overall Study|Subject noncompliance|0|||
16421233|NCT01793883|40022141|FG001|Overall Study|Subject noncompliance|1|||
16421234|NCT01793883|40022142|FG002|Overall Study|Subject noncompliance|1|||
16421235|NCT01793883|40022140|FG000|Overall Study|Lost to Follow-up|5|||
16421236|NCT01793883|40022141|FG001|Overall Study|Lost to Follow-up|1|||
16421237|NCT01793883|40022142|FG002|Overall Study|Lost to Follow-up|3|||
16421238|NCT01793883|40022140|FG000|Overall Study|Randomized in error|1|||
16421239|NCT01793883|40022141|FG001|Overall Study|Randomized in error|0|||
16421240|NCT01793883|40022142|FG002|Overall Study|Randomized in error|0|||
16421241|NCT01793883|40022140|FG000|Overall Study|Unable to complete spriometry|1|||
16421242|NCT01793883|40022141|FG001|Overall Study|Unable to complete spriometry|0|||
16421243|NCT01793883|40022142|FG002|Overall Study|Unable to complete spriometry|0|||
16421244|NCT01793883|40022140|FG000|Overall Study|Unable to complete measurements|1|||
16421245|NCT01793883|40022141|FG001|Overall Study|Unable to complete measurements|0|||
16421246|NCT01793883|40022142|FG002|Overall Study|Unable to complete measurements|0|||
16421247|NCT01793883|40022140|FG000|Overall Study|Met exclusion criteria|1|||
16421248|NCT01793883|40022141|FG001|Overall Study|Met exclusion criteria|0|||
16421249|NCT01793883|40022142|FG002|Overall Study|Met exclusion criteria|0|||
16421250|NCT01793883|40022140|FG000|Overall Study|Dosing error|0|||
16421251|NCT01793883|40022141|FG001|Overall Study|Dosing error|1|||
16421252|NCT01793883|40022142|FG002|Overall Study|Dosing error|0|||
16421253|NCT01793883|40022140|FG000|Overall Study|Respiratory distress during spirometry|0|||
16421254|NCT01793883|40022141|FG001|Overall Study|Respiratory distress during spirometry|0|||
16421255|NCT01793883|40022142|FG002|Overall Study|Respiratory distress during spirometry|1|||
16421256|NCT02464410|40022143|FG000|Overall Study|Death|3|||
16421257|NCT02464410|40022144|FG001|Overall Study|Death|4|||
16421258|NCT02464410|40022143|FG000|Overall Study|Lost to Follow-up|7|||
16421259|NCT02464410|40022144|FG001|Overall Study|Lost to Follow-up|9|||
16421260|NCT02464410|40022143|FG000|Overall Study|Withdrawal by Subject|12|||
16421261|NCT02464410|40022144|FG001|Overall Study|Withdrawal by Subject|3|||
16421262|NCT02702414|40022146|FG000|Overall Study|Death|96|||
16421263|NCT02702414|40022147|FG001|Overall Study|Death|42|||
16421264|NCT02702414|40022146|FG000|Overall Study|Lost to Follow-up|0|||
16421265|NCT02702414|40022147|FG001|Overall Study|Lost to Follow-up|1|||
16421266|NCT02702414|40022146|FG000|Overall Study|Withdrawal by Subject|0|||
16421267|NCT02702414|40022147|FG001|Overall Study|Withdrawal by Subject|1|||
16421268|NCT02702414|40022146|FG000|Overall Study|Protocol Violation|1|||
16421269|NCT02702414|40022147|FG001|Overall Study|Protocol Violation|0|||
16421270|NCT02702414|40022146|FG000|Overall Study|Sponsor Decision|8|||
16421271|NCT02702414|40022147|FG001|Overall Study|Sponsor Decision|7|||
16421272|NCT03194438|40022149|FG000|Overall Study|Withdrawal by Subject|2|||
16421273|NCT01088399|40022150|FG000|Overall Study|Adverse Event|211|||
16421274|NCT01088399|40022151|FG001|Overall Study|Adverse Event|16|||
16421275|NCT01088399|40022152|FG002|Overall Study|Adverse Event|0|||
16421276|NCT01088399|40022150|FG000|Overall Study|Death|204|||
16421277|NCT01088399|40022151|FG001|Overall Study|Death|45|||
16421278|NCT01088399|40022152|FG002|Overall Study|Death|0|||
16421279|NCT01088399|40022150|FG000|Overall Study|Lack of Efficacy|298|||
16421280|NCT01088399|40022151|FG001|Overall Study|Lack of Efficacy|7|||
16421281|NCT01088399|40022152|FG002|Overall Study|Lack of Efficacy|5|||
16421282|NCT01088399|40022150|FG000|Overall Study|Lost to Follow-up|1070|||
16421283|NCT01088399|40022151|FG001|Overall Study|Lost to Follow-up|278|||
16421284|NCT01088399|40022152|FG002|Overall Study|Lost to Follow-up|58|||
16421285|NCT01088399|40022150|FG000|Overall Study|Physician Decision|531|||
16421286|NCT01088399|40022151|FG001|Overall Study|Physician Decision|88|||
16421287|NCT01088399|40022152|FG002|Overall Study|Physician Decision|16|||
16421288|NCT01088399|40022150|FG000|Overall Study|Withdrawal by Subject|544|||
16421289|NCT01088399|40022151|FG001|Overall Study|Withdrawal by Subject|195|||
16421290|NCT01088399|40022152|FG002|Overall Study|Withdrawal by Subject|33|||
16421291|NCT01088399|40022150|FG000|Overall Study|Change to or start of somatropin therapy|234|||
16421292|NCT01088399|40022151|FG001|Overall Study|Change to or start of somatropin therapy|17|||
16421293|NCT01088399|40022152|FG002|Overall Study|Change to or start of somatropin therapy|12|||
16421294|NCT01088399|40022150|FG000|Overall Study|Sponsor decision|1573|||
16421295|NCT01088399|40022151|FG001|Overall Study|Sponsor decision|298|||
16421296|NCT01088399|40022152|FG002|Overall Study|Sponsor decision|7|||
16421297|NCT01088399|40022150|FG000|Overall Study|Protocol Violation|10|||
16248895|NCT03465891|39395292|FG001|Overall Study|Disease progression|0|||
16421298|NCT01088399|40022151|FG001|Overall Study|Protocol Violation|1|||
16421299|NCT01088399|40022152|FG002|Overall Study|Protocol Violation|0|||
16421300|NCT01088399|40022150|FG000|Overall Study|Enrollment criteria not met|48|||
16421301|NCT01088399|40022151|FG001|Overall Study|Enrollment criteria not met|119|||
16421302|NCT01088399|40022152|FG002|Overall Study|Enrollment criteria not met|70|||
16421303|NCT01088399|40022150|FG000|Overall Study|Study summary visit not completed|2398|||
16421304|NCT01088399|40022151|FG001|Overall Study|Study summary visit not completed|283|||
16421305|NCT01088399|40022152|FG002|Overall Study|Study summary visit not completed|80|||
16421306|NCT00429169|40022153|FG000|Overall Study|Lost to Follow-up|0|||
16421307|NCT00429169|40022154|FG001|Overall Study|Lost to Follow-up|1|||
16421308|NCT00429169|40022153|FG000|Overall Study|Ineligibility discovered after entry|2|||
16421309|NCT00429169|40022154|FG001|Overall Study|Ineligibility discovered after entry|1|||
16421310|NCT01380834|40022159|FG000|Overall Study|Physician Decision|1|||
16421311|NCT01380834|40022160|FG001|Overall Study|Physician Decision|0|||
16421312|NCT04230213|40022161|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
16421313|NCT04230213|40022162|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
16421314|NCT04230213|40022163|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
16421315|NCT04230213|40022161|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
16421316|NCT04230213|40022162|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
16421317|NCT04230213|40022163|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
16421318|NCT04230213|40022161|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
16421319|NCT04230213|40022162|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
16421320|NCT04230213|40022163|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
16421321|NCT04230213|40022161|FG000|TP2: Week 10 to Week 16|Other|0|||
16421322|NCT04230213|40022162|FG001|TP2: Week 10 to Week 16|Other|2|||
16421323|NCT04230213|40022163|FG002|TP2: Week 10 to Week 16|Other|1|||
16421324|NCT04230213|40022161|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
16421325|NCT04230213|40022162|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
16421326|NCT04230213|40022163|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
16421327|NCT04230213|40022161|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
16421328|NCT04230213|40022162|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
16421329|NCT04230213|40022163|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
16421330|NCT04230213|40022161|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
16421331|NCT04230213|40022162|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
16421332|NCT04230213|40022163|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
16421333|NCT04230213|40022161|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
16421334|NCT04230213|40022162|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
16421335|NCT04230213|40022163|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
16421336|NCT04230213|40022161|FG000|TP3: Week 16 to Week 22|Other|0|||
16421337|NCT04230213|40022162|FG001|TP3: Week 16 to Week 22|Other|1|||
16421338|NCT04230213|40022163|FG002|TP3: Week 16 to Week 22|Other|3|||
16421339|NCT04230213|40022161|FG000|TP4: Week 22 to Week 32|Other|0|||
16421340|NCT04230213|40022162|FG001|TP4: Week 22 to Week 32|Other|5|||
16421341|NCT04230213|40022163|FG002|TP4: Week 22 to Week 32|Other|5|||
16421342|NCT04230213|40022161|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
16421343|NCT04230213|40022162|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
16421344|NCT04230213|40022163|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
16421345|NCT04230213|40022161|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
16421346|NCT04230213|40022162|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
16421347|NCT04230213|40022163|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
16421348|NCT04230213|40022161|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
16421349|NCT04230213|40022162|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
16421350|NCT04230213|40022163|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
16421351|NCT04230213|40022161|FG000|Follow up: Week 32 to Week 36|Other|0|||
16421352|NCT04230213|40022162|FG001|Follow up: Week 32 to Week 36|Other|1|||
16421353|NCT04230213|40022163|FG002|Follow up: Week 32 to Week 36|Other|1|||
16421354|NCT02516592|40022165|FG000|Overall Study|Patient withdrew consent|5|||
16421355|NCT02516592|40022166|FG001|Overall Study|Patient withdrew consent|2|||
16421356|NCT02516592|40022165|FG000|Overall Study|Protocol deviation|4|||
16421357|NCT02516592|40022166|FG001|Overall Study|Protocol deviation|4|||
16421358|NCT02516592|40022165|FG000|Overall Study|Lost to Follow-up|2|||
16421359|NCT02516592|40022166|FG001|Overall Study|Lost to Follow-up|3|||
16421360|NCT02516592|40022165|FG000|Overall Study|Patient/guardian decision|2|||
16421361|NCT02516592|40022166|FG001|Overall Study|Patient/guardian decision|1|||
16421362|NCT02516592|40022165|FG000|Overall Study|Adverse Event|1|||
16421363|NCT02516592|40022166|FG001|Overall Study|Adverse Event|2|||
16421364|NCT02516592|40022165|FG000|Overall Study|Abnormal test procedure result|1|||
16421365|NCT02516592|40022166|FG001|Overall Study|Abnormal test procedure result|0|||
16421366|NCT02516592|40022165|FG000|Overall Study|Death|1|||
16248896|NCT04228302|39395293|FG000|Overall Study|Adverse Event|0|||
16421367|NCT02516592|40022166|FG001|Overall Study|Death|1|||
16421368|NCT00699660|40022167|FG000|Overall Study|Lost to Follow-up|4|||
16421369|NCT00699660|40022168|FG001|Overall Study|Lost to Follow-up|2|||
16421370|NCT00699660|40022167|FG000|Overall Study|missing reports and recording failures|10|||
16421371|NCT00699660|40022168|FG001|Overall Study|missing reports and recording failures|6|||
16421372|NCT03508609|40022169|FG000|Overall Study|Withdrawal by Subject|1|||
16421373|NCT02337634|40022170|FG000|Overall Study|Protocol Violation|3|||
16421374|NCT02337634|40022171|FG001|Overall Study|Protocol Violation|1|||
16421375|NCT02337634|40022170|FG000|Overall Study|Lost to Follow-up|1|||
16421376|NCT02337634|40022171|FG001|Overall Study|Lost to Follow-up|0|||
16421377|NCT04405076|40022172|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
16421378|NCT04405076|40022173|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
16421379|NCT04405076|40022174|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
16421380|NCT04405076|40022175|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
16421381|NCT04405076|40022176|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
16421382|NCT04405076|40022177|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
16421383|NCT04405076|40022178|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
16421384|NCT04405076|40022179|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
16421385|NCT04405076|40022180|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
16421386|NCT04405076|40022172|FG000|Part A (Blinded Phase)|Physician Decision|1|||
16421387|NCT04405076|40022173|FG001|Part A (Blinded Phase)|Physician Decision|2|||
16421388|NCT04405076|40022174|FG002|Part A (Blinded Phase)|Physician Decision|0|||
16421389|NCT04405076|40022175|FG003|Part A (Blinded Phase)|Physician Decision|0|||
16421390|NCT04405076|40022176|FG004|Part A (Blinded Phase)|Physician Decision|0|||
16421391|NCT04405076|40022177|FG005|Part A (Blinded Phase)|Physician Decision|0|||
16421392|NCT04405076|40022178|FG006|Part A (Blinded Phase)|Physician Decision|0|||
16421393|NCT04405076|40022179|FG007|Part A (Blinded Phase)|Physician Decision|0|||
16421394|NCT04405076|40022180|FG008|Part A (Blinded Phase)|Physician Decision|0|||
16421395|NCT04405076|40022172|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
16421396|NCT04405076|40022173|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
16421397|NCT04405076|40022174|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
16421398|NCT04405076|40022175|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
16421399|NCT04405076|40022176|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
16421400|NCT04405076|40022177|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
16421401|NCT04405076|40022178|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
16421402|NCT04405076|40022179|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
16421403|NCT04405076|40022180|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
16421404|NCT04405076|40022172|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
16421405|NCT04405076|40022173|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
16421406|NCT04405076|40022174|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
16421407|NCT04405076|40022175|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
16421408|NCT04405076|40022176|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
16248897|NCT04228302|39395294|FG001|Overall Study|Adverse Event|0|||
16248898|NCT04228302|39395295|FG002|Overall Study|Adverse Event|0|||
16248899|NCT04228302|39395296|FG003|Overall Study|Adverse Event|0|||
16248900|NCT04228302|39395297|FG004|Overall Study|Adverse Event|1|||
16248901|NCT04228302|39395298|FG005|Overall Study|Adverse Event|0|||
16248902|NCT02473510|39395299|FG000|Overall Study|Lost to Follow-up|1|||
16248903|NCT02473510|39395300|FG001|Overall Study|Lost to Follow-up|2|||
16248904|NCT00295854|39395301|FG000|Overall Study|Adverse Event|7|||
16248905|NCT00295854|39395302|FG001|Overall Study|Adverse Event|7|||
16248906|NCT00295854|39395303|FG002|Overall Study|Adverse Event|6|||
16248907|NCT00295854|39395301|FG000|Overall Study|Protocol Violation|1|||
16248908|NCT00295854|39395302|FG001|Overall Study|Protocol Violation|1|||
16248909|NCT00295854|39395303|FG002|Overall Study|Protocol Violation|1|||
16248910|NCT00295854|39395301|FG000|Overall Study|Lost to Follow-up|2|||
16248911|NCT00295854|39395302|FG001|Overall Study|Lost to Follow-up|0|||
16248912|NCT00295854|39395303|FG002|Overall Study|Lost to Follow-up|1|||
16248913|NCT00295854|39395301|FG000|Overall Study|Withdrawal by Subject|3|||
16248914|NCT00295854|39395302|FG001|Overall Study|Withdrawal by Subject|7|||
16248915|NCT00295854|39395303|FG002|Overall Study|Withdrawal by Subject|4|||
16248916|NCT00295854|39395301|FG000|Overall Study|did not continue to meet criteria|1|||
16248917|NCT00295854|39395302|FG001|Overall Study|did not continue to meet criteria|1|||
16248918|NCT00295854|39395303|FG002|Overall Study|did not continue to meet criteria|2|||
16248919|NCT00295854|39395301|FG000|Overall Study|required a prohibited medication|1|||
16248920|NCT00295854|39395302|FG001|Overall Study|required a prohibited medication|0|||
16248921|NCT00295854|39395303|FG002|Overall Study|required a prohibited medication|0|||
16248922|NCT00295854|39395301|FG000|Overall Study|Other|3|||
16248923|NCT00295854|39395302|FG001|Overall Study|Other|5|||
16421409|NCT04405076|40022177|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
16248924|NCT00295854|39395303|FG002|Overall Study|Other|1|||
16248928|NCT00827827|39395306|FG000|Overall Study|Lost to Follow-up|3|||
16421410|NCT04405076|40022178|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
16421411|NCT04405076|40022179|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
16248929|NCT00827827|39395307|FG001|Overall Study|Lost to Follow-up|0|||
16248930|NCT00827827|39395306|FG000|Overall Study|Fall at home- hospitalization|1|||
16248931|NCT00827827|39395307|FG001|Overall Study|Fall at home- hospitalization|0|||
16421412|NCT04405076|40022180|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
16421413|NCT04405076|40022172|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
16421414|NCT04405076|40022173|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
16421415|NCT04405076|40022174|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
16421416|NCT04405076|40022175|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
16421417|NCT04405076|40022176|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
16421418|NCT04405076|40022177|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
16421419|NCT04405076|40022178|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
16421420|NCT04405076|40022179|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
16421421|NCT04405076|40022180|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
16421422|NCT04405076|40022172|FG000|Part A (Blinded Phase)|Other than Specified|0|||
16421423|NCT04405076|40022173|FG001|Part A (Blinded Phase)|Other than Specified|0|||
16421424|NCT04405076|40022174|FG002|Part A (Blinded Phase)|Other than Specified|3|||
16421425|NCT04405076|40022175|FG003|Part A (Blinded Phase)|Other than Specified|0|||
16421426|NCT04405076|40022176|FG004|Part A (Blinded Phase)|Other than Specified|0|||
16421427|NCT04405076|40022177|FG005|Part A (Blinded Phase)|Other than Specified|0|||
16421428|NCT04405076|40022178|FG006|Part A (Blinded Phase)|Other than Specified|0|||
16421429|NCT04405076|40022179|FG007|Part A (Blinded Phase)|Other than Specified|0|||
16421430|NCT04405076|40022180|FG008|Part A (Blinded Phase)|Other than Specified|0|||
16421431|NCT04405076|40022172|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
16421432|NCT04405076|40022173|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
16421433|NCT04405076|40022174|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
16421434|NCT04405076|40022175|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
16421435|NCT04405076|40022176|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
16421436|NCT04405076|40022177|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
16421437|NCT04405076|40022178|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
16421438|NCT04405076|40022179|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
16421439|NCT04405076|40022180|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
16421440|NCT04405076|40022172|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
16421441|NCT04405076|40022173|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
16421442|NCT04405076|40022174|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
16421443|NCT04405076|40022175|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
16421444|NCT04405076|40022176|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
16421445|NCT04405076|40022177|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
16421446|NCT04405076|40022178|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
16421447|NCT04405076|40022179|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
16421448|NCT04405076|40022180|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
16421449|NCT04405076|40022172|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
16421450|NCT04405076|40022173|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
16421451|NCT04405076|40022174|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
16421452|NCT04405076|40022175|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
16421453|NCT04405076|40022176|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
16421454|NCT04405076|40022177|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
16421455|NCT04405076|40022178|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
16421456|NCT04405076|40022179|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
16421457|NCT04405076|40022180|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
16421458|NCT04405076|40022172|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
16421459|NCT04405076|40022173|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
16421460|NCT04405076|40022174|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
16421461|NCT04405076|40022175|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
16421462|NCT04405076|40022176|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
16421463|NCT04405076|40022177|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
16421464|NCT04405076|40022178|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
16421465|NCT04405076|40022179|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
16421466|NCT04405076|40022180|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
16421467|NCT04405076|40022172|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
16421468|NCT04405076|40022173|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
16421469|NCT04405076|40022174|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
16359683|NCT02834975|39804197|FG000|Overall Study|Physician Decision|2|||
16359684|NCT02834975|39804197|FG000|Overall Study|Adverse Event|1|||
16359685|NCT02834975|39804197|FG000|Overall Study|Withdrawal by Subject|1|||
16359686|NCT02834975|39804197|FG000|Overall Study|Lack of Efficacy|1|||
16359687|NCT02513550|39804199|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
16359688|NCT02513550|39804200|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
16359689|NCT02513550|39804201|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
16359690|NCT02513550|39804202|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
16359691|NCT02513550|39804203|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
16359692|NCT02513550|39804204|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
16359693|NCT02513550|39804199|FG000|Double Blind Treatment Period|Adverse Event|5|||
16359694|NCT02513550|39804200|FG001|Double Blind Treatment Period|Adverse Event|13|||
16359695|NCT02513550|39804201|FG002|Double Blind Treatment Period|Adverse Event|17|||
16359696|NCT02513550|39804202|FG003|Double Blind Treatment Period|Adverse Event|0|||
16359697|NCT02513550|39804203|FG004|Double Blind Treatment Period|Adverse Event|1|||
16359698|NCT02513550|39804204|FG005|Double Blind Treatment Period|Adverse Event|0|||
16359699|NCT02513550|39804199|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
16359700|NCT02513550|39804200|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
16359701|NCT02513550|39804201|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
16359702|NCT02513550|39804202|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
16359703|NCT02513550|39804203|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
16359704|NCT02513550|39804204|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
16359705|NCT02513550|39804199|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
16359706|NCT02513550|39804200|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
16359707|NCT02513550|39804201|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
16359708|NCT02513550|39804202|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
16359709|NCT02513550|39804203|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
16359710|NCT02513550|39804204|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
16359711|NCT02513550|39804199|FG000|Double Blind Treatment Period|Protocol Violation|1|||
16359712|NCT02513550|39804200|FG001|Double Blind Treatment Period|Protocol Violation|1|||
16359713|NCT02513550|39804201|FG002|Double Blind Treatment Period|Protocol Violation|4|||
16359714|NCT02513550|39804202|FG003|Double Blind Treatment Period|Protocol Violation|0|||
16359715|NCT02513550|39804203|FG004|Double Blind Treatment Period|Protocol Violation|0|||
16359716|NCT02513550|39804204|FG005|Double Blind Treatment Period|Protocol Violation|0|||
16359717|NCT02513550|39804199|FG000|Double Blind Treatment Period|Physician Decision|2|||
16359718|NCT02513550|39804200|FG001|Double Blind Treatment Period|Physician Decision|0|||
16359719|NCT02513550|39804201|FG002|Double Blind Treatment Period|Physician Decision|4|||
16359720|NCT02513550|39804202|FG003|Double Blind Treatment Period|Physician Decision|0|||
16359721|NCT02513550|39804203|FG004|Double Blind Treatment Period|Physician Decision|0|||
16359722|NCT02513550|39804204|FG005|Double Blind Treatment Period|Physician Decision|0|||
16359723|NCT02513550|39804199|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
16359724|NCT02513550|39804200|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
16359725|NCT02513550|39804201|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
16359726|NCT02513550|39804202|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
16359727|NCT02513550|39804203|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
16359728|NCT02513550|39804204|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
16359729|NCT02513550|39804199|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
16359730|NCT02513550|39804200|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
16359731|NCT02513550|39804201|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
16359732|NCT02513550|39804202|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
16359733|NCT02513550|39804203|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
16359734|NCT02513550|39804204|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
16359735|NCT02513550|39804199|FG000|Double Blind Treatment Period|Due to personal business|2|||
16359736|NCT02513550|39804200|FG001|Double Blind Treatment Period|Due to personal business|0|||
16359737|NCT02513550|39804201|FG002|Double Blind Treatment Period|Due to personal business|1|||
16359738|NCT02513550|39804202|FG003|Double Blind Treatment Period|Due to personal business|0|||
16359739|NCT02513550|39804203|FG004|Double Blind Treatment Period|Due to personal business|0|||
16359740|NCT02513550|39804204|FG005|Double Blind Treatment Period|Due to personal business|0|||
16359741|NCT02513550|39804199|FG000|Double Blind Treatment Period|Death|1|||
16359742|NCT02513550|39804200|FG001|Double Blind Treatment Period|Death|0|||
16359743|NCT02513550|39804201|FG002|Double Blind Treatment Period|Death|2|||
16359744|NCT02513550|39804202|FG003|Double Blind Treatment Period|Death|0|||
16359745|NCT02513550|39804203|FG004|Double Blind Treatment Period|Death|0|||
16359746|NCT02513550|39804204|FG005|Double Blind Treatment Period|Death|0|||
16359747|NCT02513550|39804199|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
16359748|NCT02513550|39804200|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
16359749|NCT02513550|39804201|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
16248932|NCT00827827|39395306|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
16248933|NCT00827827|39395307|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
16248934|NCT00827827|39395306|FG000|Overall Study|Gout|1|||
16248935|NCT00827827|39395307|FG001|Overall Study|Gout|0|||
16248936|NCT00827827|39395306|FG000|Overall Study|Transportation issues|1|||
16248937|NCT00827827|39395307|FG001|Overall Study|Transportation issues|0|||
16248938|NCT00827827|39395306|FG000|Overall Study|Burned with water at home|1|||
16248939|NCT00827827|39395307|FG001|Overall Study|Burned with water at home|0|||
16248940|NCT02585258|39395308|FG000|Overall Study|Adverse Event|28|||
16248941|NCT02585258|39395309|FG001|Overall Study|Adverse Event|29|||
16248942|NCT02585258|39395308|FG000|Overall Study|Death|3|||
16248943|NCT02585258|39395309|FG001|Overall Study|Death|2|||
16248944|NCT02585258|39395308|FG000|Overall Study|Lack of Efficacy|7|||
16248945|NCT02585258|39395309|FG001|Overall Study|Lack of Efficacy|9|||
16248946|NCT02585258|39395308|FG000|Overall Study|includes covid-related access problems|42|||
16248947|NCT02585258|39395309|FG001|Overall Study|includes covid-related access problems|46|||
16248948|NCT02585258|39395308|FG000|Overall Study|Lost to Follow-up|5|||
16248949|NCT02585258|39395309|FG001|Overall Study|Lost to Follow-up|2|||
16248950|NCT01612000|39395310|FG000|Overall Study|Lost to Follow-up|6|||
16248951|NCT01612000|39395311|FG001|Overall Study|Lost to Follow-up|4|||
16248952|NCT01612000|39395312|FG002|Overall Study|Lost to Follow-up|4|||
16248953|NCT01612000|39395313|FG003|Overall Study|Lost to Follow-up|8|||
16248954|NCT01612000|39395310|FG000|Overall Study|Physician Decision|0|||
16248955|NCT01612000|39395311|FG001|Overall Study|Physician Decision|0|||
16248956|NCT01612000|39395312|FG002|Overall Study|Physician Decision|1|||
16248957|NCT01612000|39395313|FG003|Overall Study|Physician Decision|0|||
16248958|NCT01612000|39395310|FG000|Overall Study|Withdrawal by Subject|3|||
16248959|NCT01612000|39395311|FG001|Overall Study|Withdrawal by Subject|1|||
16248960|NCT01612000|39395312|FG002|Overall Study|Withdrawal by Subject|2|||
16248961|NCT01612000|39395313|FG003|Overall Study|Withdrawal by Subject|2|||
16421470|NCT04405076|40022175|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
16421471|NCT04405076|40022176|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
16421472|NCT04405076|40022177|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
16421473|NCT04405076|40022178|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
16421474|NCT04405076|40022179|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
16421475|NCT04405076|40022180|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
16421476|NCT00384332|40022181|FG000|Overall Study|Lost to Follow-up|4|||
16421477|NCT00384332|40022182|FG001|Overall Study|Lost to Follow-up|0|||
16421478|NCT04407234|40022183|FG000|Overall Study|Adverse Event|3|||
16421479|NCT04407234|40022184|FG001|Overall Study|Adverse Event|3|||
16421480|NCT01772576|40022185|FG000|Overall Study|Death|15|||
16421481|NCT01772576|40022185|FG000|Overall Study|Protocol Violation|1|||
16421482|NCT01772576|40022185|FG000|Overall Study|Lost to Follow-up|3|||
16421483|NCT01772576|40022185|FG000|Overall Study|Study device not used|3|||
16421484|NCT01772576|40022185|FG000|Overall Study|Adverse Event|6|||
16421485|NCT01772576|40022185|FG000|Overall Study|Withdrawal by Subject|6|||
16421486|NCT00566254|40022186|FG000|Overall Study|Adverse Event|3|||
16421487|NCT00566254|40022187|FG001|Overall Study|Adverse Event|1|||
16421488|NCT00566254|40022186|FG000|Overall Study|Protocol Violation|1|||
16421489|NCT00566254|40022187|FG001|Overall Study|Protocol Violation|3|||
16248962|NCT01048333|39395314|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
16248963|NCT01048333|39395315|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
16421490|NCT00566254|40022186|FG000|Overall Study|Withdrawal by Subject|1|||
16421491|NCT00566254|40022187|FG001|Overall Study|Withdrawal by Subject|2|||
16421492|NCT00566254|40022186|FG000|Overall Study|Lack of Efficacy|5|||
16421493|NCT00566254|40022187|FG001|Overall Study|Lack of Efficacy|6|||
16421494|NCT00566254|40022186|FG000|Overall Study|Other|0|||
16421495|NCT00566254|40022187|FG001|Overall Study|Other|2|||
16421496|NCT00895453|40022188|FG000|Overall Study|Lost to Follow-up|25|||
16421497|NCT00895453|40022189|FG001|Overall Study|Lost to Follow-up|25|||
16421498|NCT00895453|40022190|FG002|Overall Study|Lost to Follow-up|23|||
16248964|NCT01048333|39395316|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
16248965|NCT01048333|39395317|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
16248966|NCT01048333|39395318|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
16248967|NCT01048333|39395319|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
16248968|NCT00113490|39395320|FG000|Overall Study|Withdrawal by Subject|1|||
16248969|NCT00113490|39395321|FG001|Overall Study|Withdrawal by Subject|3|||
16421499|NCT04541628|40022191|FG000|Overall Study|Study Terminated|1|||
16421500|NCT04541628|40022192|FG001|Overall Study|Study Terminated|1|||
16421501|NCT04541628|40022193|FG002|Overall Study|Study Terminated|1|||
16421502|NCT00626405|40022194|FG000|Overall Study|Deemed Ineligible|1|||
16421503|NCT00626405|40022195|FG001|Overall Study|Deemed Ineligible|0|||
16248970|NCT00113490|39395320|FG000|Overall Study|Lost to Follow-up|1|||
16248971|NCT00113490|39395321|FG001|Overall Study|Lost to Follow-up|0|||
16248972|NCT01565083|39395322|FG000|Overall Study|Withdrawal by Subject|6|||
16421504|NCT00626405|40022194|FG000|Overall Study|Withdrawal by Subject|0|||
16421505|NCT00626405|40022195|FG001|Overall Study|Withdrawal by Subject|1|||
16421506|NCT01496846|40022196|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
16421507|NCT01496846|40022197|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
16421508|NCT01496846|40022198|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
16421509|NCT01496846|40022199|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
16421510|NCT01496846|40022200|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
16421511|NCT01496846|40022201|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
16421512|NCT03405818|40022204|FG000|Overall Study|Withdrawal by Subject|4|||
16421513|NCT03405818|40022204|FG000|Overall Study|Lost to Follow-up|4|||
16421514|NCT00856297|40022205|FG000|Overall Study|Unable to classify|2|||
16421515|NCT00856297|40022206|FG001|Overall Study|Unable to classify|0|||
16421516|NCT00856297|40022207|FG002|Overall Study|Unable to classify|0|||
16421517|NCT00856297|40022208|FG003|Overall Study|Unable to classify|0|||
16421518|NCT00856297|40022209|FG004|Overall Study|Unable to classify|0|||
16421519|NCT01371305|40022210|FG000|Overall Study|Adverse Event|0|||
16421520|NCT01371305|40022211|FG001|Overall Study|Adverse Event|0|||
16421521|NCT01371305|40022212|FG002|Overall Study|Adverse Event|0|||
16421522|NCT01371305|40022213|FG003|Overall Study|Adverse Event|2|||
16421523|NCT01371305|40022214|FG004|Overall Study|Adverse Event|1|||
16421524|NCT01371305|40022215|FG005|Overall Study|Adverse Event|0|||
16421525|NCT01371305|40022210|FG000|Overall Study|Study terminated by sponsor|0|||
16421526|NCT01371305|40022211|FG001|Overall Study|Study terminated by sponsor|0|||
16421527|NCT01371305|40022212|FG002|Overall Study|Study terminated by sponsor|0|||
16421528|NCT01371305|40022213|FG003|Overall Study|Study terminated by sponsor|0|||
16130883|NCT00600886|38967150|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
16421529|NCT01371305|40022214|FG004|Overall Study|Study terminated by sponsor|3|||
16421530|NCT01371305|40022215|FG005|Overall Study|Study terminated by sponsor|1|||
16421531|NCT01371305|40022210|FG000|Overall Study|Subject request|0|||
16421532|NCT01371305|40022211|FG001|Overall Study|Subject request|0|||
16421533|NCT01371305|40022212|FG002|Overall Study|Subject request|0|||
16421534|NCT01371305|40022213|FG003|Overall Study|Subject request|0|||
16421535|NCT01371305|40022214|FG004|Overall Study|Subject request|0|||
16421536|NCT01371305|40022215|FG005|Overall Study|Subject request|1|||
16421537|NCT03304873|40025380|FG000|Overall Study|Lost to Follow-up|1|||
16421538|NCT03304873|40025381|FG001|Overall Study|Lost to Follow-up|8|||
16421539|NCT02123576|40025382|FG000|Overall Study|Adverse Event|1|||
16421540|NCT02123576|40025383|FG001|Overall Study|Adverse Event|0|||
16421541|NCT04736628|40025384|FG000|Overall Study|Not treated|0|||
16421542|NCT04736628|40025385|FG001|Overall Study|Not treated|0|||
16421543|NCT04736628|40025386|FG002|Overall Study|Not treated|0|||
16421544|NCT04736628|40025387|FG003|Overall Study|Not treated|2|||
16421545|NCT04736628|40025384|FG000|Overall Study|Other reason than listed|1|||
16421546|NCT04736628|40025385|FG001|Overall Study|Other reason than listed|2|||
16421547|NCT04736628|40025386|FG002|Overall Study|Other reason than listed|2|||
16421548|NCT04736628|40025387|FG003|Overall Study|Other reason than listed|3|||
16421549|NCT04736628|40025384|FG000|Overall Study|Protocol deviation|0|||
16421550|NCT04736628|40025385|FG001|Overall Study|Protocol deviation|0|||
16421551|NCT04736628|40025386|FG002|Overall Study|Protocol deviation|0|||
16421552|NCT04736628|40025387|FG003|Overall Study|Protocol deviation|1|||
16421553|NCT04736628|40025384|FG000|Overall Study|Burden of study procedures|1|||
16421554|NCT04736628|40025385|FG001|Overall Study|Burden of study procedures|0|||
16421555|NCT04736628|40025386|FG002|Overall Study|Burden of study procedures|0|||
16421556|NCT04736628|40025387|FG003|Overall Study|Burden of study procedures|1|||
16421557|NCT04736628|40025384|FG000|Overall Study|Change of residence|0|||
16421558|NCT04736628|40025385|FG001|Overall Study|Change of residence|1|||
16421559|NCT04736628|40025386|FG002|Overall Study|Change of residence|0|||
16421560|NCT04736628|40025387|FG003|Overall Study|Change of residence|0|||
16421561|NCT04736628|40025384|FG000|Overall Study|Perceived lack of efficacy|1|||
16421562|NCT04736628|40025385|FG001|Overall Study|Perceived lack of efficacy|0|||
16421563|NCT04736628|40025386|FG002|Overall Study|Perceived lack of efficacy|0|||
16421564|NCT04736628|40025387|FG003|Overall Study|Perceived lack of efficacy|1|||
16421565|NCT04736628|40025384|FG000|Overall Study|Adverse Event|3|||
16421566|NCT04736628|40025385|FG001|Overall Study|Adverse Event|2|||
16248973|NCT01565083|39395323|FG001|Overall Study|Withdrawal by Subject|4|||
16421567|NCT04736628|40025386|FG002|Overall Study|Adverse Event|4|||
16421568|NCT04736628|40025387|FG003|Overall Study|Adverse Event|3|||
16421569|NCT04000581|40025392|FG000|Overall Study|Withdrawal by Subject|0|||
16421570|NCT04000581|40025393|FG001|Overall Study|Withdrawal by Subject|1|||
16421571|NCT04223778|40025396|FG000|Overall Study|Ongoing|322|||
16421572|NCT04223778|40025397|FG001|Overall Study|Ongoing|326|||
16421573|NCT04223778|40025396|FG000|Overall Study|Death|0|||
16421574|NCT04223778|40025397|FG001|Overall Study|Death|1|||
16421575|NCT04223778|40025396|FG000|Overall Study|Lost to Follow-up|1|||
16421576|NCT04223778|40025397|FG001|Overall Study|Lost to Follow-up|5|||
16421577|NCT04223778|40025396|FG000|Overall Study|Physician Decision|3|||
16421578|NCT04223778|40025397|FG001|Overall Study|Physician Decision|1|||
16421579|NCT04223778|40025396|FG000|Overall Study|Withdrawal by Subject|10|||
16421580|NCT04223778|40025397|FG001|Overall Study|Withdrawal by Subject|1|||
16421581|NCT04223778|40025396|FG000|Overall Study|Lack of Efficacy|0|||
16421582|NCT04223778|40025397|FG001|Overall Study|Lack of Efficacy|2|||
16421583|NCT04752358|40025399|FG000|Overall Study|Death|2|||
16421584|NCT04752358|40025400|FG001|Overall Study|Death|1|||
16421585|NCT01894243|40025401|FG000|Overall Study|Adverse Event|0|||
16421586|NCT01894243|40025402|FG001|Overall Study|Adverse Event|1|||
16421587|NCT01894243|40025403|FG002|Overall Study|Adverse Event|2|||
16421588|NCT01894243|40025401|FG000|Overall Study|Death|0|||
16421589|NCT01894243|40025402|FG001|Overall Study|Death|0|||
16421590|NCT01894243|40025403|FG002|Overall Study|Death|3|||
16421591|NCT01894243|40025401|FG000|Overall Study|Lack of Efficacy|3|||
16421592|NCT01894243|40025402|FG001|Overall Study|Lack of Efficacy|3|||
16421593|NCT01894243|40025403|FG002|Overall Study|Lack of Efficacy|1|||
16421594|NCT01894243|40025401|FG000|Overall Study|Condition under investigation worsened|8|||
16421595|NCT01894243|40025402|FG001|Overall Study|Condition under investigation worsened|6|||
16421596|NCT01894243|40025403|FG002|Overall Study|Condition under investigation worsened|2|||
16421597|NCT01894243|40025401|FG000|Overall Study|Subject decision|1|||
16421598|NCT01894243|40025402|FG001|Overall Study|Subject decision|0|||
16421599|NCT01894243|40025403|FG002|Overall Study|Subject decision|0|||
16421600|NCT01894243|40025401|FG000|Overall Study|Other|1|||
16421601|NCT01894243|40025402|FG001|Overall Study|Other|0|||
16421602|NCT01894243|40025403|FG002|Overall Study|Other|0|||
16248974|NCT01565083|39395322|FG000|Overall Study|Lost to Follow-up|2|||
16248975|NCT01565083|39395323|FG001|Overall Study|Lost to Follow-up|7|||
16421603|NCT02487030|40025404|FG000|Overall Study|Lack of Efficacy|2|||
16421604|NCT02487030|40025405|FG001|Overall Study|Lack of Efficacy|4|||
16421605|NCT02487030|40025406|FG002|Overall Study|Lack of Efficacy|1|||
16421606|NCT02487030|40025407|FG003|Overall Study|Lack of Efficacy|0|||
16421607|NCT02487030|40025408|FG004|Overall Study|Lack of Efficacy|1|||
16421608|NCT02487030|40025409|FG005|Overall Study|Lack of Efficacy|0|||
16421609|NCT02487030|40025410|FG006|Overall Study|Lack of Efficacy|0|||
16421610|NCT02487030|40025404|FG000|Overall Study|Lost to Follow-up|0|||
16421611|NCT02487030|40025405|FG001|Overall Study|Lost to Follow-up|0|||
16421612|NCT02487030|40025406|FG002|Overall Study|Lost to Follow-up|1|||
16421613|NCT02487030|40025407|FG003|Overall Study|Lost to Follow-up|1|||
16421614|NCT02487030|40025408|FG004|Overall Study|Lost to Follow-up|0|||
16421615|NCT02487030|40025409|FG005|Overall Study|Lost to Follow-up|1|||
16421616|NCT02487030|40025410|FG006|Overall Study|Lost to Follow-up|0|||
16421617|NCT02487030|40025404|FG000|Overall Study|Adverse Event|0|||
16421618|NCT02487030|40025405|FG001|Overall Study|Adverse Event|0|||
16421619|NCT02487030|40025406|FG002|Overall Study|Adverse Event|0|||
16421620|NCT02487030|40025407|FG003|Overall Study|Adverse Event|1|||
16421621|NCT02487030|40025408|FG004|Overall Study|Adverse Event|0|||
16421622|NCT02487030|40025409|FG005|Overall Study|Adverse Event|0|||
16421623|NCT02487030|40025410|FG006|Overall Study|Adverse Event|0|||
16421624|NCT02487030|40025404|FG000|Overall Study|Death|0|||
16421625|NCT02487030|40025405|FG001|Overall Study|Death|0|||
16421626|NCT02487030|40025406|FG002|Overall Study|Death|0|||
16421627|NCT02487030|40025407|FG003|Overall Study|Death|0|||
16421628|NCT02487030|40025408|FG004|Overall Study|Death|1|||
16421629|NCT02487030|40025409|FG005|Overall Study|Death|0|||
16421630|NCT02487030|40025410|FG006|Overall Study|Death|0|||
16248976|NCT01565083|39395322|FG000|Overall Study|Death|22|||
16248977|NCT01565083|39395323|FG001|Overall Study|Death|23|||
16421631|NCT00367835|40025411|FG000|Overall Study|Adverse Event|14|||
16421632|NCT00367835|40025412|FG001|Overall Study|Adverse Event|1|||
16421633|NCT00367835|40025411|FG000|Overall Study|Protocol Violation|1|||
16421634|NCT00367835|40025412|FG001|Overall Study|Protocol Violation|7|||
16421635|NCT00367835|40025411|FG000|Overall Study|Withdrawal by Subject|7|||
16421636|NCT00367835|40025412|FG001|Overall Study|Withdrawal by Subject|6|||
16421637|NCT00367835|40025411|FG000|Overall Study|Lost to Follow-up|1|||
16421638|NCT00367835|40025412|FG001|Overall Study|Lost to Follow-up|4|||
16421639|NCT00367835|40025411|FG000|Overall Study|Lack of Efficacy|3|||
16421640|NCT00367835|40025412|FG001|Overall Study|Lack of Efficacy|12|||
16421641|NCT00367835|40025411|FG000|Overall Study|Subject in juvenile detention center|1|||
16421642|NCT00367835|40025412|FG001|Overall Study|Subject in juvenile detention center|0|||
16421643|NCT00367835|40025411|FG000|Overall Study|refused blood collection|1|||
16421644|NCT00367835|40025412|FG001|Overall Study|refused blood collection|0|||
16421645|NCT00367835|40025411|FG000|Overall Study|Did not respond to calls|1|||
16421646|NCT00367835|40025412|FG001|Overall Study|Did not respond to calls|0|||
16421647|NCT00367835|40025411|FG000|Overall Study|History of lead poisoning|0|||
16421648|NCT00367835|40025412|FG001|Overall Study|History of lead poisoning|1|||
16421649|NCT01846741|40025413|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
16421650|NCT00151476|40025414|FG000|FAP Identified Subjects|Protocol Violation|0|||
16421651|NCT00151476|40025415|FG001|FAP Identified Subjects|Protocol Violation|1|||
16421652|NCT00151476|40025414|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
16421653|NCT00151476|40025415|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
16421654|NCT00151476|40025414|FG000|FAP Analyzed Subjects|Other study participation|0|||
16421655|NCT00151476|40025415|FG001|FAP Analyzed Subjects|Other study participation|1|||
16421656|NCT00410605|40025417|FG000|Overall Study|Adverse Event|12|||
16421657|NCT00410605|40025417|FG000|Overall Study|Physician Decision|3|||
16421658|NCT00410605|40025417|FG000|Overall Study|Withdrawal by Subject|5|||
16421659|NCT00410605|40025417|FG000|Overall Study|Started Non-Protocol Therapy|3|||
16421660|NCT00410605|40025417|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
16421661|NCT00410605|40025417|FG000|Overall Study|Transferred to another Institution|1|||
16421662|NCT01022424|40025418|FG000|Overall Study|Adverse Event|1|||
16421663|NCT01022424|40025418|FG000|Overall Study|Physician Decision|1|||
16130884|NCT00600886|38967149|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
16130885|NCT00600886|38967150|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
16130886|NCT00600886|38967149|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
16130887|NCT00600886|38967150|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
16130888|NCT00600886|38967149|FG000|Extension - After Crossover (CAS)|Death|1|||
16130889|NCT00600886|38967150|FG001|Extension - After Crossover (CAS)|Death|0|||
16130890|NCT01074216|38967151|FG000|Overall Study|Physician Decision|1|||
16130891|NCT01074216|38967151|FG000|Overall Study|Not Treated|12|||
16130892|NCT01323634|38967152|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
16421664|NCT01022424|40025418|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
16421665|NCT00652951|40025421|FG000|Booster Phase|Adverse event, non-fatal|0|||
16421666|NCT00652951|40025422|FG001|Booster Phase|Adverse event, non-fatal|1|||
16421667|NCT00652951|40025423|FG002|Booster Phase|Adverse event, non-fatal|0|||
16421668|NCT00652951|40025421|FG000|Booster Phase|Other|1|||
16421669|NCT00652951|40025422|FG001|Booster Phase|Other|0|||
16421670|NCT00652951|40025423|FG002|Booster Phase|Other|0|||
16421671|NCT04439318|40025424|FG000|Overall Study|Ineligible|1|||
16421672|NCT04439318|40025424|FG000|Overall Study|Never Started Treatment|3|||
16421673|NCT04439318|40025424|FG000|Overall Study|Adverse Event|10|||
16421674|NCT04439318|40025424|FG000|Overall Study|Death|2|||
16421675|NCT04439318|40025424|FG000|Overall Study|Disease Progression|25|||
16421676|NCT04439318|40025424|FG000|Overall Study|Other Complicating Disease|2|||
16421677|NCT04439318|40025424|FG000|Overall Study|Withdrawal by Subject|4|||
16421678|NCT04439318|40025424|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
16421679|NCT04439318|40025424|FG000|Overall Study|Non-Compliance|1|||
16421680|NCT04439318|40025424|FG000|Overall Study|Still on Treatment|1|||
16421681|NCT02476006|40025425|FG000|Overall Study|Death|4|||
16421682|NCT02476006|40025425|FG000|Overall Study|Lack of treatment efficacy|2|||
16421683|NCT02476006|40025425|FG000|Overall Study|Pregnancy|1|||
16421684|NCT02476006|40025425|FG000|Overall Study|Participant did not wish to continue|39|||
16421685|NCT02476006|40025425|FG000|Overall Study|Adverse Event|41|||
16421686|NCT02476006|40025425|FG000|Overall Study|Poor compliance to study protocol|3|||
16421687|NCT02476006|40025425|FG000|Overall Study|Sponsor decision|6|||
16421688|NCT02476006|40025425|FG000|Overall Study|Lost to Follow-up|5|||
16421689|NCT02476006|40025425|FG000|Overall Study|Physician Decision|5|||
16421690|NCT02476006|40025425|FG000|Overall Study|Study ended treatment not available|4|||
16421691|NCT02476006|40025425|FG000|Overall Study|Switched to commercial drug|4|||
16421692|NCT02476006|40025425|FG000|Overall Study|Excluded from study|1|||
16421693|NCT02476006|40025425|FG000|Overall Study|Protocol Violation|1|||
16421694|NCT02476006|40025425|FG000|Overall Study|Enrolled but not treated|4|||
16421695|NCT01393639|40025427|FG000|Overall Study|Protocol Violation|0|||
16421696|NCT01393639|40025428|FG001|Overall Study|Protocol Violation|0|||
16421697|NCT01393639|40025429|FG002|Overall Study|Protocol Violation|0|||
16421698|NCT01393639|40025430|FG003|Overall Study|Protocol Violation|1|||
16421699|NCT01393639|40025431|FG004|Overall Study|Protocol Violation|0|||
16421700|NCT01393639|40025432|FG005|Overall Study|Protocol Violation|0|||
16421701|NCT01393639|40025433|FG006|Overall Study|Protocol Violation|0|||
16421702|NCT01393639|40025427|FG000|Overall Study|Other|0|||
16421703|NCT01393639|40025428|FG001|Overall Study|Other|2|||
16421704|NCT01393639|40025429|FG002|Overall Study|Other|0|||
16421705|NCT01393639|40025430|FG003|Overall Study|Other|2|||
16130893|NCT01323634|38967153|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
16130894|NCT01323634|38967154|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
16130895|NCT01323634|38967152|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
16130896|NCT01323634|38967153|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
16421706|NCT01393639|40025431|FG004|Overall Study|Other|1|||
16421707|NCT01393639|40025432|FG005|Overall Study|Other|0|||
16421708|NCT01393639|40025433|FG006|Overall Study|Other|1|||
16421709|NCT01393639|40025427|FG000|Overall Study|Withdrawal by Subject|1|||
16421710|NCT01393639|40025428|FG001|Overall Study|Withdrawal by Subject|1|||
16421711|NCT01393639|40025429|FG002|Overall Study|Withdrawal by Subject|0|||
16421712|NCT01393639|40025430|FG003|Overall Study|Withdrawal by Subject|0|||
16421713|NCT01393639|40025431|FG004|Overall Study|Withdrawal by Subject|0|||
16421714|NCT01393639|40025432|FG005|Overall Study|Withdrawal by Subject|0|||
16421715|NCT01393639|40025433|FG006|Overall Study|Withdrawal by Subject|1|||
16421716|NCT01393639|40025427|FG000|Overall Study|Medication error without associated AE|0|||
16421717|NCT01393639|40025428|FG001|Overall Study|Medication error without associated AE|0|||
16421718|NCT01393639|40025429|FG002|Overall Study|Medication error without associated AE|0|||
16421719|NCT01393639|40025430|FG003|Overall Study|Medication error without associated AE|0|||
16421720|NCT01393639|40025431|FG004|Overall Study|Medication error without associated AE|0|||
16421721|NCT01393639|40025432|FG005|Overall Study|Medication error without associated AE|0|||
16421722|NCT01393639|40025433|FG006|Overall Study|Medication error without associated AE|1|||
16421723|NCT01393639|40025427|FG000|Overall Study|Lost to Follow-up|0|||
16421724|NCT01393639|40025428|FG001|Overall Study|Lost to Follow-up|1|||
16421725|NCT01393639|40025429|FG002|Overall Study|Lost to Follow-up|0|||
16421726|NCT01393639|40025430|FG003|Overall Study|Lost to Follow-up|0|||
16421727|NCT01393639|40025431|FG004|Overall Study|Lost to Follow-up|0|||
16421728|NCT01393639|40025432|FG005|Overall Study|Lost to Follow-up|0|||
16421729|NCT01393639|40025433|FG006|Overall Study|Lost to Follow-up|1|||
16421730|NCT01393639|40025427|FG000|Overall Study|Lack of Efficacy|0|||
16421731|NCT01393639|40025428|FG001|Overall Study|Lack of Efficacy|0|||
16421732|NCT01393639|40025429|FG002|Overall Study|Lack of Efficacy|0|||
16421733|NCT01393639|40025430|FG003|Overall Study|Lack of Efficacy|0|||
16421734|NCT01393639|40025431|FG004|Overall Study|Lack of Efficacy|0|||
16421735|NCT01393639|40025432|FG005|Overall Study|Lack of Efficacy|0|||
16421736|NCT01393639|40025433|FG006|Overall Study|Lack of Efficacy|1|||
16421737|NCT01393639|40025427|FG000|Overall Study|Adverse Event|2|||
16421738|NCT01393639|40025428|FG001|Overall Study|Adverse Event|3|||
16421739|NCT01393639|40025429|FG002|Overall Study|Adverse Event|1|||
16421740|NCT01393639|40025430|FG003|Overall Study|Adverse Event|2|||
16421741|NCT01393639|40025431|FG004|Overall Study|Adverse Event|0|||
16421742|NCT01393639|40025432|FG005|Overall Study|Adverse Event|2|||
16421743|NCT01393639|40025433|FG006|Overall Study|Adverse Event|3|||
16421744|NCT03078855|40025434|FG000|Overall Study|Lack of Efficacy|62|||
16421745|NCT03078855|40025435|FG001|Overall Study|Lack of Efficacy|31|||
16421746|NCT03078855|40025434|FG000|Overall Study|Death|1|||
16421747|NCT03078855|40025435|FG001|Overall Study|Death|0|||
16421748|NCT03078855|40025434|FG000|Overall Study|Withdrawal by Subject|12|||
16421749|NCT03078855|40025435|FG001|Overall Study|Withdrawal by Subject|6|||
16421750|NCT03078855|40025434|FG000|Overall Study|Physician Decision|3|||
16421751|NCT03078855|40025435|FG001|Overall Study|Physician Decision|2|||
16421752|NCT03078855|40025434|FG000|Overall Study|Second Malignancy|4|||
16421753|NCT03078855|40025435|FG001|Overall Study|Second Malignancy|0|||
16421754|NCT03078855|40025434|FG000|Overall Study|Ineligible|2|||
16421755|NCT03078855|40025435|FG001|Overall Study|Ineligible|0|||
16421756|NCT03078855|40025434|FG000|Overall Study|Withdrew before day 1 treatment|2|||
16421757|NCT03078855|40025435|FG001|Overall Study|Withdrew before day 1 treatment|1|||
16421758|NCT00767819|40025436|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
16421759|NCT00767819|40025437|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
16421760|NCT00767819|40025438|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16421761|NCT00767819|40025436|FG000|Overall Study|Withdrawal by Subject|1|||
16421762|NCT00767819|40025437|FG001|Overall Study|Withdrawal by Subject|1|||
16421763|NCT00767819|40025438|FG002|Overall Study|Withdrawal by Subject|0|||
16421764|NCT00767819|40025436|FG000|Overall Study|Administrative problems|0|||
16421765|NCT00767819|40025437|FG001|Overall Study|Administrative problems|1|||
16421766|NCT00767819|40025438|FG002|Overall Study|Administrative problems|0|||
16421767|NCT00767819|40025436|FG000|Overall Study|Death|2|||
16421768|NCT00767819|40025437|FG001|Overall Study|Death|3|||
16421769|NCT00767819|40025438|FG002|Overall Study|Death|0|||
16421770|NCT00767819|40025436|FG000|Overall Study|Adverse Event|2|||
16421771|NCT00767819|40025437|FG001|Overall Study|Adverse Event|0|||
16421772|NCT00767819|40025438|FG002|Overall Study|Adverse Event|0|||
16421773|NCT00767819|40025436|FG000|Overall Study|Abnormal lab values|1|||
16421774|NCT00767819|40025437|FG001|Overall Study|Abnormal lab values|0|||
16421775|NCT00767819|40025438|FG002|Overall Study|Abnormal lab values|0|||
16421776|NCT00767819|40025436|FG000|Overall Study|Lost to Follow-up|1|||
16421777|NCT00767819|40025437|FG001|Overall Study|Lost to Follow-up|0|||
16421778|NCT00767819|40025438|FG002|Overall Study|Lost to Follow-up|0|||
16421779|NCT00320424|40025447|FG000|Overall Study|Adverse Event|3|||
16421780|NCT00320424|40025447|FG000|Overall Study|Other|3|||
16421781|NCT01546688|40025448|FG000|Overall Study|Adverse Event|0|||
16421782|NCT01546688|40025449|FG001|Overall Study|Adverse Event|4|||
16421783|NCT01546688|40025448|FG000|Overall Study|Withdrawal by Subject|2|||
16421784|NCT01546688|40025449|FG001|Overall Study|Withdrawal by Subject|1|||
16421785|NCT01546688|40025448|FG000|Overall Study|Lack of Efficacy|1|||
16421786|NCT01546688|40025449|FG001|Overall Study|Lack of Efficacy|0|||
16421787|NCT04167137|40025450|FG000|Overall Study|Disease progression|1|||
16421788|NCT04167137|40025451|FG001|Overall Study|Disease progression|1|||
16421789|NCT04167137|40025452|FG002|Overall Study|Disease progression|3|||
16421790|NCT04167137|40025453|FG003|Overall Study|Disease progression|3|||
16421791|NCT04167137|40025454|FG004|Overall Study|Disease progression|2|||
16421792|NCT04167137|40025455|FG005|Overall Study|Disease progression|3|||
16421793|NCT04167137|40025456|FG006|Overall Study|Disease progression|2|||
16421794|NCT04167137|40025457|FG007|Overall Study|Disease progression|2|||
16421795|NCT04167137|40025450|FG000|Overall Study|Withdrawal by Subject|1|||
16421796|NCT04167137|40025451|FG001|Overall Study|Withdrawal by Subject|0|||
16421797|NCT04167137|40025452|FG002|Overall Study|Withdrawal by Subject|0|||
16421798|NCT04167137|40025453|FG003|Overall Study|Withdrawal by Subject|1|||
16421799|NCT04167137|40025454|FG004|Overall Study|Withdrawal by Subject|0|||
16421800|NCT04167137|40025455|FG005|Overall Study|Withdrawal by Subject|2|||
16421801|NCT04167137|40025456|FG006|Overall Study|Withdrawal by Subject|1|||
16421802|NCT04167137|40025457|FG007|Overall Study|Withdrawal by Subject|0|||
16421803|NCT04167137|40025450|FG000|Overall Study|Adverse Event|0|||
16421804|NCT04167137|40025451|FG001|Overall Study|Adverse Event|0|||
16421805|NCT04167137|40025452|FG002|Overall Study|Adverse Event|0|||
16421806|NCT04167137|40025453|FG003|Overall Study|Adverse Event|0|||
16421807|NCT04167137|40025454|FG004|Overall Study|Adverse Event|0|||
16421808|NCT04167137|40025455|FG005|Overall Study|Adverse Event|1|||
16421809|NCT04167137|40025456|FG006|Overall Study|Adverse Event|0|||
16421810|NCT04167137|40025457|FG007|Overall Study|Adverse Event|1|||
16421811|NCT04167137|40025450|FG000|Overall Study|Physician Decision|0|||
16421812|NCT04167137|40025451|FG001|Overall Study|Physician Decision|0|||
16421813|NCT04167137|40025452|FG002|Overall Study|Physician Decision|0|||
16421814|NCT04167137|40025453|FG003|Overall Study|Physician Decision|1|||
16421815|NCT04167137|40025454|FG004|Overall Study|Physician Decision|0|||
16421816|NCT04167137|40025455|FG005|Overall Study|Physician Decision|0|||
16421817|NCT04167137|40025456|FG006|Overall Study|Physician Decision|1|||
16421818|NCT04167137|40025457|FG007|Overall Study|Physician Decision|0|||
16421819|NCT04167137|40025450|FG000|Overall Study|Death|0|||
16421820|NCT04167137|40025451|FG001|Overall Study|Death|1|||
16421821|NCT04167137|40025452|FG002|Overall Study|Death|0|||
16421822|NCT04167137|40025453|FG003|Overall Study|Death|0|||
16421823|NCT04167137|40025454|FG004|Overall Study|Death|0|||
16421824|NCT04167137|40025455|FG005|Overall Study|Death|0|||
16421825|NCT04167137|40025456|FG006|Overall Study|Death|0|||
16421826|NCT04167137|40025457|FG007|Overall Study|Death|0|||
16421827|NCT04167137|40025450|FG000|Overall Study|Study terminated by Sponsor|0|||
16421828|NCT04167137|40025451|FG001|Overall Study|Study terminated by Sponsor|0|||
16421829|NCT04167137|40025452|FG002|Overall Study|Study terminated by Sponsor|0|||
16421830|NCT04167137|40025453|FG003|Overall Study|Study terminated by Sponsor|0|||
16421831|NCT04167137|40025454|FG004|Overall Study|Study terminated by Sponsor|0|||
16421832|NCT04167137|40025455|FG005|Overall Study|Study terminated by Sponsor|0|||
16421833|NCT04167137|40025456|FG006|Overall Study|Study terminated by Sponsor|0|||
16421834|NCT04167137|40025457|FG007|Overall Study|Study terminated by Sponsor|1|||
16421835|NCT01023672|40025458|FG000|Overall Study|Worsening disease|2|||
16421836|NCT01023672|40025458|FG000|Overall Study|Death|1|||
16421837|NCT03761810|40025459|FG000|Overall Study|Adverse Event|12|||
16421838|NCT03761810|40025460|FG001|Overall Study|Adverse Event|0|||
16421839|NCT03761810|40025459|FG000|Overall Study|Lost to Follow-up|15|||
16421840|NCT03761810|40025460|FG001|Overall Study|Lost to Follow-up|7|||
16421841|NCT03761810|40025459|FG000|Overall Study|Pregnancy|1|||
16421842|NCT03761810|40025460|FG001|Overall Study|Pregnancy|0|||
16421843|NCT03761810|40025459|FG000|Overall Study|Withdrawal by Subject|14|||
16421844|NCT03761810|40025460|FG001|Overall Study|Withdrawal by Subject|5|||
16421845|NCT03761810|40025459|FG000|Overall Study|Physician Decision|1|||
16421846|NCT03761810|40025460|FG001|Overall Study|Physician Decision|0|||
16421847|NCT03761810|40025459|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
16421848|NCT03761810|40025460|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16421849|NCT03761810|40025459|FG000|Overall Study|Other Than Specified|1|||
16421850|NCT03761810|40025460|FG001|Overall Study|Other Than Specified|0|||
16421851|NCT01717326|40025462|FG000|Overall Study|Death|0|||
16421852|NCT01717326|40025463|FG001|Overall Study|Death|0|||
16421853|NCT01717326|40025464|FG002|Overall Study|Death|0|||
16421854|NCT01717326|40025465|FG003|Overall Study|Death|0|||
16562309|NCT02018861|40525382|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
16562310|NCT02018861|40525383|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
16562311|NCT02018861|40525384|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
16562312|NCT02018861|40525385|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
16562313|NCT02018861|40525376|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16421855|NCT01717326|40025466|FG004|Overall Study|Death|0|||
16421856|NCT01717326|40025467|FG005|Overall Study|Death|0|||
16421857|NCT01717326|40025468|FG006|Overall Study|Death|0|||
16421858|NCT01717326|40025469|FG007|Overall Study|Death|0|||
16248978|NCT01565083|39395322|FG000|Overall Study|Other|3|||
16421859|NCT01717326|40025470|FG008|Overall Study|Death|0|||
16421860|NCT01717326|40025471|FG009|Overall Study|Death|0|||
16421861|NCT01717326|40025472|FG010|Overall Study|Death|1|||
16421862|NCT01717326|40025473|FG011|Overall Study|Death|0|||
16421863|NCT01717326|40025474|FG012|Overall Study|Death|0|||
16421864|NCT01717326|40025475|FG013|Overall Study|Death|0|||
16421865|NCT01717326|40025476|FG014|Overall Study|Death|0|||
16421866|NCT01717326|40025477|FG015|Overall Study|Death|0|||
16421867|NCT01717326|40025478|FG016|Overall Study|Death|0|||
16421868|NCT01717326|40025479|FG017|Overall Study|Death|0|||
16421869|NCT01717326|40025480|FG018|Overall Study|Death|0|||
16421870|NCT01717326|40025481|FG019|Overall Study|Death|0|||
16421871|NCT01717326|40025462|FG000|Overall Study|Lost to Follow-up|3|||
16421872|NCT01717326|40025463|FG001|Overall Study|Lost to Follow-up|0|||
16421873|NCT01717326|40025464|FG002|Overall Study|Lost to Follow-up|0|||
16421874|NCT01717326|40025465|FG003|Overall Study|Lost to Follow-up|2|||
16421875|NCT01717326|40025466|FG004|Overall Study|Lost to Follow-up|1|||
16421876|NCT01717326|40025467|FG005|Overall Study|Lost to Follow-up|0|||
16421877|NCT01717326|40025468|FG006|Overall Study|Lost to Follow-up|1|||
16421878|NCT01717326|40025469|FG007|Overall Study|Lost to Follow-up|0|||
16421879|NCT01717326|40025470|FG008|Overall Study|Lost to Follow-up|0|||
16421880|NCT01717326|40025471|FG009|Overall Study|Lost to Follow-up|0|||
16421881|NCT01717326|40025472|FG010|Overall Study|Lost to Follow-up|1|||
16421882|NCT01717326|40025473|FG011|Overall Study|Lost to Follow-up|0|||
16421883|NCT01717326|40025474|FG012|Overall Study|Lost to Follow-up|0|||
16421884|NCT01717326|40025475|FG013|Overall Study|Lost to Follow-up|0|||
16421885|NCT01717326|40025476|FG014|Overall Study|Lost to Follow-up|0|||
16421886|NCT01717326|40025477|FG015|Overall Study|Lost to Follow-up|2|||
16421887|NCT01717326|40025478|FG016|Overall Study|Lost to Follow-up|1|||
16421888|NCT01717326|40025479|FG017|Overall Study|Lost to Follow-up|0|||
16421889|NCT01717326|40025480|FG018|Overall Study|Lost to Follow-up|2|||
16421890|NCT01717326|40025481|FG019|Overall Study|Lost to Follow-up|3|||
16421891|NCT01717326|40025462|FG000|Overall Study|Physician Decision|0|||
16421892|NCT01717326|40025463|FG001|Overall Study|Physician Decision|0|||
16421893|NCT01717326|40025464|FG002|Overall Study|Physician Decision|0|||
16421894|NCT01717326|40025465|FG003|Overall Study|Physician Decision|0|||
16421895|NCT01717326|40025466|FG004|Overall Study|Physician Decision|0|||
16421896|NCT01717326|40025467|FG005|Overall Study|Physician Decision|0|||
16421897|NCT01717326|40025468|FG006|Overall Study|Physician Decision|0|||
16421898|NCT01717326|40025469|FG007|Overall Study|Physician Decision|0|||
16421899|NCT01717326|40025470|FG008|Overall Study|Physician Decision|0|||
16421900|NCT01717326|40025471|FG009|Overall Study|Physician Decision|1|||
16421901|NCT01717326|40025472|FG010|Overall Study|Physician Decision|0|||
16421902|NCT01717326|40025473|FG011|Overall Study|Physician Decision|0|||
16421903|NCT01717326|40025474|FG012|Overall Study|Physician Decision|0|||
16421904|NCT01717326|40025475|FG013|Overall Study|Physician Decision|0|||
16421905|NCT01717326|40025476|FG014|Overall Study|Physician Decision|0|||
16421906|NCT01717326|40025477|FG015|Overall Study|Physician Decision|0|||
16421907|NCT01717326|40025478|FG016|Overall Study|Physician Decision|0|||
16421908|NCT01717326|40025479|FG017|Overall Study|Physician Decision|0|||
16421909|NCT01717326|40025480|FG018|Overall Study|Physician Decision|0|||
16421910|NCT01717326|40025481|FG019|Overall Study|Physician Decision|0|||
16421911|NCT01717326|40025462|FG000|Overall Study|Protocol Violation|0|||
16421912|NCT01717326|40025463|FG001|Overall Study|Protocol Violation|0|||
16421913|NCT01717326|40025464|FG002|Overall Study|Protocol Violation|0|||
16421914|NCT01717326|40025465|FG003|Overall Study|Protocol Violation|0|||
16421915|NCT01717326|40025466|FG004|Overall Study|Protocol Violation|1|||
16421916|NCT01717326|40025467|FG005|Overall Study|Protocol Violation|0|||
16421917|NCT01717326|40025468|FG006|Overall Study|Protocol Violation|0|||
16421918|NCT01717326|40025469|FG007|Overall Study|Protocol Violation|0|||
16421919|NCT01717326|40025470|FG008|Overall Study|Protocol Violation|0|||
16421920|NCT01717326|40025471|FG009|Overall Study|Protocol Violation|0|||
16421921|NCT01717326|40025472|FG010|Overall Study|Protocol Violation|0|||
16421922|NCT01717326|40025473|FG011|Overall Study|Protocol Violation|0|||
16421923|NCT01717326|40025474|FG012|Overall Study|Protocol Violation|0|||
16421924|NCT01717326|40025475|FG013|Overall Study|Protocol Violation|0|||
16421925|NCT01717326|40025476|FG014|Overall Study|Protocol Violation|0|||
16421926|NCT01717326|40025477|FG015|Overall Study|Protocol Violation|0|||
16421927|NCT01717326|40025478|FG016|Overall Study|Protocol Violation|0|||
16421928|NCT01717326|40025479|FG017|Overall Study|Protocol Violation|0|||
16421929|NCT01717326|40025480|FG018|Overall Study|Protocol Violation|0|||
16421930|NCT01717326|40025481|FG019|Overall Study|Protocol Violation|0|||
16421931|NCT01717326|40025462|FG000|Overall Study|Withdrawal by Subject|0|||
16421932|NCT01717326|40025463|FG001|Overall Study|Withdrawal by Subject|1|||
16421933|NCT01717326|40025464|FG002|Overall Study|Withdrawal by Subject|0|||
16421934|NCT01717326|40025465|FG003|Overall Study|Withdrawal by Subject|0|||
16421935|NCT01717326|40025466|FG004|Overall Study|Withdrawal by Subject|0|||
16421936|NCT01717326|40025467|FG005|Overall Study|Withdrawal by Subject|0|||
16421937|NCT01717326|40025468|FG006|Overall Study|Withdrawal by Subject|0|||
16421938|NCT01717326|40025469|FG007|Overall Study|Withdrawal by Subject|0|||
16421939|NCT01717326|40025470|FG008|Overall Study|Withdrawal by Subject|0|||
16421940|NCT01717326|40025471|FG009|Overall Study|Withdrawal by Subject|1|||
16421941|NCT01717326|40025472|FG010|Overall Study|Withdrawal by Subject|0|||
16421942|NCT01717326|40025473|FG011|Overall Study|Withdrawal by Subject|0|||
16421943|NCT01717326|40025474|FG012|Overall Study|Withdrawal by Subject|1|||
16421944|NCT01717326|40025475|FG013|Overall Study|Withdrawal by Subject|0|||
16421945|NCT01717326|40025476|FG014|Overall Study|Withdrawal by Subject|0|||
16421946|NCT01717326|40025477|FG015|Overall Study|Withdrawal by Subject|1|||
16421947|NCT01717326|40025478|FG016|Overall Study|Withdrawal by Subject|0|||
16421948|NCT01717326|40025479|FG017|Overall Study|Withdrawal by Subject|0|||
16421949|NCT01717326|40025480|FG018|Overall Study|Withdrawal by Subject|2|||
16421950|NCT01717326|40025481|FG019|Overall Study|Withdrawal by Subject|3|||
16421951|NCT03422536|40025482|FG000|Randomized|Physician Decision|1|||
16421952|NCT03422536|40025483|FG001|Randomized|Physician Decision|1|||
16421953|NCT03422536|40025482|FG000|Allocation - Received Intervention|Disease progression|19|||
16421954|NCT03422536|40025483|FG001|Allocation - Received Intervention|Disease progression|25|||
16421955|NCT03422536|40025482|FG000|Allocation - Received Intervention|Death|1|||
16421956|NCT03422536|40025483|FG001|Allocation - Received Intervention|Death|3|||
16421957|NCT03422536|40025482|FG000|Allocation - Received Intervention|Adverse Event|1|||
16421958|NCT03422536|40025483|FG001|Allocation - Received Intervention|Adverse Event|0|||
16421959|NCT03422536|40025482|FG000|Allocation - Received Intervention|Physician Decision|1|||
16421960|NCT03422536|40025483|FG001|Allocation - Received Intervention|Physician Decision|1|||
16421961|NCT03422536|40025482|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
16421962|NCT03422536|40025483|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
16421963|NCT03422536|40025482|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
16421964|NCT03422536|40025483|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
16421965|NCT01368081|40025484|FG000|Overall Study|Adverse Event|4|||
16421966|NCT01368081|40025485|FG001|Overall Study|Adverse Event|4|||
16421967|NCT01368081|40025486|FG002|Overall Study|Adverse Event|3|||
16421968|NCT01368081|40025487|FG003|Overall Study|Adverse Event|2|||
16421969|NCT01368081|40025488|FG004|Overall Study|Adverse Event|2|||
16421970|NCT01368081|40025489|FG005|Overall Study|Adverse Event|5|||
16421971|NCT01368081|40025490|FG006|Overall Study|Adverse Event|6|||
16421972|NCT01368081|40025491|FG007|Overall Study|Adverse Event|2|||
16421973|NCT01368081|40025492|FG008|Overall Study|Adverse Event|3|||
16421974|NCT01368081|40025493|FG009|Overall Study|Adverse Event|5|||
16421975|NCT01368081|40025494|FG010|Overall Study|Adverse Event|6|||
16421976|NCT01368081|40025495|FG011|Overall Study|Adverse Event|1|||
16421977|NCT01368081|40025496|FG012|Overall Study|Adverse Event|3|||
16421978|NCT01368081|40025484|FG000|Overall Study|Lack of Efficacy|0|||
16421979|NCT01368081|40025485|FG001|Overall Study|Lack of Efficacy|1|||
16421980|NCT01368081|40025486|FG002|Overall Study|Lack of Efficacy|0|||
16421981|NCT01368081|40025487|FG003|Overall Study|Lack of Efficacy|1|||
16421982|NCT01368081|40025488|FG004|Overall Study|Lack of Efficacy|0|||
16421983|NCT01368081|40025489|FG005|Overall Study|Lack of Efficacy|0|||
16421984|NCT01368081|40025490|FG006|Overall Study|Lack of Efficacy|0|||
16421985|NCT01368081|40025491|FG007|Overall Study|Lack of Efficacy|2|||
16421986|NCT01368081|40025492|FG008|Overall Study|Lack of Efficacy|0|||
16421987|NCT01368081|40025493|FG009|Overall Study|Lack of Efficacy|0|||
16421988|NCT01368081|40025494|FG010|Overall Study|Lack of Efficacy|0|||
16421989|NCT01368081|40025495|FG011|Overall Study|Lack of Efficacy|0|||
16421990|NCT01368081|40025496|FG012|Overall Study|Lack of Efficacy|0|||
16421991|NCT01368081|40025484|FG000|Overall Study|Protocol Violation|0|||
16421992|NCT01368081|40025485|FG001|Overall Study|Protocol Violation|0|||
16421993|NCT01368081|40025486|FG002|Overall Study|Protocol Violation|0|||
16421994|NCT01368081|40025487|FG003|Overall Study|Protocol Violation|0|||
16421995|NCT01368081|40025488|FG004|Overall Study|Protocol Violation|0|||
16421996|NCT01368081|40025489|FG005|Overall Study|Protocol Violation|1|||
16421997|NCT01368081|40025490|FG006|Overall Study|Protocol Violation|0|||
16421998|NCT01368081|40025491|FG007|Overall Study|Protocol Violation|1|||
16421999|NCT01368081|40025492|FG008|Overall Study|Protocol Violation|0|||
16422000|NCT01368081|40025493|FG009|Overall Study|Protocol Violation|0|||
16422001|NCT01368081|40025494|FG010|Overall Study|Protocol Violation|0|||
16422002|NCT01368081|40025495|FG011|Overall Study|Protocol Violation|0|||
16422003|NCT01368081|40025496|FG012|Overall Study|Protocol Violation|0|||
16422004|NCT01368081|40025484|FG000|Overall Study|Lost to Follow-up|0|||
16422005|NCT01368081|40025485|FG001|Overall Study|Lost to Follow-up|0|||
16422006|NCT01368081|40025486|FG002|Overall Study|Lost to Follow-up|0|||
16422007|NCT01368081|40025487|FG003|Overall Study|Lost to Follow-up|0|||
16422008|NCT01368081|40025488|FG004|Overall Study|Lost to Follow-up|0|||
16422009|NCT01368081|40025489|FG005|Overall Study|Lost to Follow-up|0|||
16422010|NCT01368081|40025490|FG006|Overall Study|Lost to Follow-up|0|||
16422011|NCT01368081|40025491|FG007|Overall Study|Lost to Follow-up|0|||
16422012|NCT01368081|40025492|FG008|Overall Study|Lost to Follow-up|0|||
16422013|NCT01368081|40025493|FG009|Overall Study|Lost to Follow-up|0|||
16422014|NCT01368081|40025494|FG010|Overall Study|Lost to Follow-up|0|||
16422015|NCT01368081|40025495|FG011|Overall Study|Lost to Follow-up|0|||
16248979|NCT01565083|39395323|FG001|Overall Study|Other|5|||
16422016|NCT01368081|40025496|FG012|Overall Study|Lost to Follow-up|1|||
16422017|NCT01368081|40025484|FG000|Overall Study|Withdrawal by Subject|4|||
16422018|NCT01368081|40025485|FG001|Overall Study|Withdrawal by Subject|4|||
16422019|NCT01368081|40025486|FG002|Overall Study|Withdrawal by Subject|1|||
16422020|NCT01368081|40025487|FG003|Overall Study|Withdrawal by Subject|1|||
16422021|NCT01368081|40025488|FG004|Overall Study|Withdrawal by Subject|0|||
16422022|NCT01368081|40025489|FG005|Overall Study|Withdrawal by Subject|3|||
16422023|NCT01368081|40025490|FG006|Overall Study|Withdrawal by Subject|4|||
16422024|NCT01368081|40025491|FG007|Overall Study|Withdrawal by Subject|2|||
16422025|NCT01368081|40025492|FG008|Overall Study|Withdrawal by Subject|5|||
16422026|NCT01368081|40025493|FG009|Overall Study|Withdrawal by Subject|4|||
16422027|NCT01368081|40025494|FG010|Overall Study|Withdrawal by Subject|3|||
16422028|NCT01368081|40025495|FG011|Overall Study|Withdrawal by Subject|2|||
16422029|NCT01368081|40025496|FG012|Overall Study|Withdrawal by Subject|0|||
16422030|NCT01368081|40025484|FG000|Overall Study|Other reason not defined above|2|||
16422031|NCT01368081|40025485|FG001|Overall Study|Other reason not defined above|0|||
16422032|NCT01368081|40025486|FG002|Overall Study|Other reason not defined above|0|||
16422033|NCT01368081|40025487|FG003|Overall Study|Other reason not defined above|1|||
16422034|NCT01368081|40025488|FG004|Overall Study|Other reason not defined above|0|||
16422035|NCT01368081|40025489|FG005|Overall Study|Other reason not defined above|1|||
16422036|NCT01368081|40025490|FG006|Overall Study|Other reason not defined above|2|||
16422037|NCT01368081|40025491|FG007|Overall Study|Other reason not defined above|0|||
16422038|NCT01368081|40025492|FG008|Overall Study|Other reason not defined above|0|||
16422039|NCT01368081|40025493|FG009|Overall Study|Other reason not defined above|1|||
16130897|NCT01323634|38967154|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
16248980|NCT00112489|39395324|FG000|Overall Study|Refused further treatment|8|||
16248981|NCT00112489|39395324|FG000|Overall Study|Adverse Event|12|||
16248982|NCT00112489|39395324|FG000|Overall Study|Death|2|||
16248983|NCT00112489|39395324|FG000|Overall Study|Other, Not Specified|9|||
16248984|NCT00112489|39395324|FG000|Overall Study|Patient never treated|2|||
16248985|NCT00112489|39395324|FG000|Overall Study|Ineligible|7|||
16248986|NCT02360397|39395328|FG000|Overall Study|Incomplete screening|3|||
16248987|NCT02360397|39395328|FG000|Overall Study|Adverse Event|1|||
16248988|NCT01706198|39395329|FG000|Overall Study|Adverse Event|12|||
16248989|NCT01706198|39395330|FG001|Overall Study|Adverse Event|15|||
16422040|NCT01368081|40025494|FG010|Overall Study|Other reason not defined above|0|||
16422041|NCT01368081|40025495|FG011|Overall Study|Other reason not defined above|0|||
16422042|NCT01368081|40025496|FG012|Overall Study|Other reason not defined above|3|||
16422043|NCT02328027|40025497|FG000|Overall Study|Withdrawal by Subject|0|||
16422044|NCT02328027|40025498|FG001|Overall Study|Withdrawal by Subject|1|||
16422045|NCT02596945|40025499|FG000|Overall Study|No documentation of study drug dosing|3|||
16422046|NCT02596945|40025499|FG000|Overall Study|Other|32|||
16422047|NCT02596945|40025499|FG000|Overall Study|Change to hemodialysis|15|||
16422048|NCT02596945|40025499|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
16422049|NCT02596945|40025499|FG000|Overall Study|Withdrawal by Subject|1|||
16422050|NCT02596945|40025499|FG000|Overall Study|Missing|1|||
16422051|NCT02836249|40025500|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
16422052|NCT02836249|40025501|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
16422053|NCT02836249|40025502|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
16422054|NCT02836249|40025503|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
16422055|NCT02836249|40025500|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
16422056|NCT02836249|40025501|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
16422057|NCT02836249|40025502|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
16422058|NCT02836249|40025503|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
16422059|NCT02836249|40025500|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
16422060|NCT02836249|40025501|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
16422061|NCT02836249|40025502|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
16422062|NCT02836249|40025503|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
16422063|NCT02836249|40025500|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16422064|NCT02836249|40025501|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
16422065|NCT02836249|40025502|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16422066|NCT02836249|40025503|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
16422067|NCT02836249|40025500|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
16422068|NCT02836249|40025501|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
16422069|NCT02836249|40025502|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
16422070|NCT02836249|40025503|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
16248990|NCT01706198|39395329|FG000|Overall Study|Protocol Violation|7|||
16422071|NCT02836249|40025500|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
16422072|NCT02836249|40025501|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
16422073|NCT02836249|40025502|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
16359750|NCT02513550|39804202|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16359751|NCT02513550|39804203|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16359752|NCT02513550|39804204|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
16359753|NCT02513550|39804199|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
16359754|NCT02513550|39804200|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
16359755|NCT02513550|39804201|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
16359756|NCT02513550|39804202|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
16359757|NCT02513550|39804203|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
16359758|NCT02513550|39804204|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
16359759|NCT02513550|39804199|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
16359760|NCT02513550|39804200|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
16359761|NCT02513550|39804201|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
16359762|NCT02513550|39804202|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16359763|NCT02513550|39804203|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16359764|NCT02513550|39804204|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
16359765|NCT02513550|39804199|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
16359766|NCT02513550|39804200|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
16359767|NCT02513550|39804201|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
16359768|NCT02513550|39804202|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
16359769|NCT02513550|39804203|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
16359770|NCT02513550|39804204|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
16359771|NCT02513550|39804199|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
16359772|NCT02513550|39804200|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
16359773|NCT02513550|39804201|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
16359774|NCT02513550|39804202|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
16359775|NCT02513550|39804203|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
16359776|NCT02513550|39804204|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
16359777|NCT02513550|39804199|FG000|Post-Treatment Follow-up Period|Death|0|||
16359778|NCT02513550|39804200|FG001|Post-Treatment Follow-up Period|Death|0|||
16359779|NCT02513550|39804201|FG002|Post-Treatment Follow-up Period|Death|1|||
16359780|NCT02513550|39804202|FG003|Post-Treatment Follow-up Period|Death|0|||
16359781|NCT02513550|39804203|FG004|Post-Treatment Follow-up Period|Death|0|||
16359782|NCT02513550|39804204|FG005|Post-Treatment Follow-up Period|Death|0|||
16359783|NCT02513550|39804199|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
16359784|NCT02513550|39804200|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
16359785|NCT02513550|39804201|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
16359786|NCT02513550|39804202|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
16359787|NCT02513550|39804203|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
16359788|NCT02513550|39804204|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
16359789|NCT02513550|39804199|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
16359790|NCT02513550|39804200|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
16359791|NCT02513550|39804201|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
16359792|NCT02513550|39804202|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
16359793|NCT02513550|39804203|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
16359794|NCT02513550|39804204|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
16359795|NCT02513550|39804199|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
16359796|NCT02513550|39804200|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
16359797|NCT02513550|39804201|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
16359798|NCT02513550|39804202|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
16359799|NCT02513550|39804203|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
16359800|NCT02513550|39804204|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
16359801|NCT04745351|39804205|FG000|Overall Study|Death|51|||
16359802|NCT04745351|39804206|FG001|Overall Study|Death|25|||
16359803|NCT04745351|39804205|FG000|Overall Study|Lost to Follow-up|9|||
16359804|NCT04745351|39804206|FG001|Overall Study|Lost to Follow-up|3|||
16359805|NCT04745351|39804205|FG000|Overall Study|Randomized but Never Treated|3|||
16359806|NCT04745351|39804206|FG001|Overall Study|Randomized but Never Treated|3|||
16359807|NCT04745351|39804205|FG000|Overall Study|Adverse Event|4|||
16359808|NCT04745351|39804206|FG001|Overall Study|Adverse Event|0|||
16359809|NCT04745351|39804205|FG000|Overall Study|Withdrew Consent|1|||
16422074|NCT02836249|40025503|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
16422075|NCT02836249|40025500|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
16422076|NCT02836249|40025501|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
16422077|NCT02836249|40025502|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
16422078|NCT02836249|40025503|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
16422079|NCT02836249|40025500|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
16422080|NCT02836249|40025501|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
16422081|NCT02836249|40025502|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
16422082|NCT02836249|40025503|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
16422083|NCT02836249|40025500|FG000|Open-Label TAF Treatment Phase|Death|0|||
16422084|NCT02836249|40025501|FG001|Open-Label TAF Treatment Phase|Death|0|||
16422085|NCT02836249|40025502|FG002|Open-Label TAF Treatment Phase|Death|1|||
16422086|NCT02836249|40025503|FG003|Open-Label TAF Treatment Phase|Death|0|||
16422087|NCT02836249|40025500|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
16422088|NCT02836249|40025501|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
16422089|NCT02836249|40025502|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
16422090|NCT02836249|40025503|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
16422091|NCT02836249|40025500|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
16422092|NCT02836249|40025501|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
16422093|NCT02836249|40025502|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
16422094|NCT02836249|40025503|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
16422095|NCT03068767|40025504|FG000|Overall Study|Lost to Follow-up|7|||
16422096|NCT03068767|40025505|FG001|Overall Study|Lost to Follow-up|3|||
16422097|NCT03068767|40025504|FG000|Overall Study|Protocol Violation|3|||
16422098|NCT03068767|40025505|FG001|Overall Study|Protocol Violation|0|||
16422099|NCT00547521|40025506|FG000|Short Term Study (4 Months)|Adverse Event|1|||
16422100|NCT00547521|40025507|FG001|Short Term Study (4 Months)|Adverse Event|0|||
16422101|NCT00547521|40025506|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
16422102|NCT00547521|40025507|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
16422103|NCT00547521|40025506|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
16422104|NCT00547521|40025507|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
16422105|NCT00547521|40025506|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
16422106|NCT00547521|40025507|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
16422107|NCT00547521|40025506|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
16422108|NCT00547521|40025507|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
16422109|NCT00547521|40025506|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
16422110|NCT00547521|40025507|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
16562314|NCT02018861|40525377|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16248991|NCT01706198|39395330|FG001|Overall Study|Protocol Violation|5|||
16248992|NCT01706198|39395329|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
16248993|NCT01706198|39395330|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
16248994|NCT01706198|39395329|FG000|Overall Study|Lost to Follow-up|97|||
16248995|NCT01706198|39395330|FG001|Overall Study|Lost to Follow-up|93|||
16248996|NCT01706198|39395329|FG000|Overall Study|Physician Decision|23|||
16248997|NCT01706198|39395330|FG001|Overall Study|Physician Decision|37|||
16248998|NCT01706198|39395329|FG000|Overall Study|Withdrawal by Subject|23|||
16248999|NCT01706198|39395330|FG001|Overall Study|Withdrawal by Subject|31|||
16422111|NCT00547521|40025506|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
16562315|NCT02018861|40525378|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16562316|NCT02018861|40525379|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
16562317|NCT02018861|40525380|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
16562318|NCT02018861|40525381|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16562319|NCT02018861|40525382|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16562320|NCT02018861|40525383|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16562321|NCT02018861|40525384|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16562322|NCT02018861|40525385|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
16562323|NCT02018861|40525376|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
16562324|NCT02018861|40525377|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
16562325|NCT02018861|40525378|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
16562326|NCT02018861|40525379|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
16562327|NCT02018861|40525380|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
16562328|NCT02018861|40525381|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
16562329|NCT02018861|40525382|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
16562330|NCT02018861|40525383|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
16562331|NCT02018861|40525384|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
16562332|NCT02018861|40525385|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
16249000|NCT00788957|39395336|FG000|Part 1|Death|8|||
16249001|NCT00788957|39395337|FG001|Part 1|Death|0|||
16249002|NCT00788957|39395338|FG002|Part 1|Death|0|||
16249003|NCT00788957|39395339|FG003|Part 1|Death|0|||
16422112|NCT00547521|40025507|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
16422113|NCT00547521|40025506|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
16422114|NCT00547521|40025507|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
16422115|NCT00547521|40025506|FG000|Long Term Extension (LTE) Study|Other|0|||
16422116|NCT00547521|40025507|FG001|Long Term Extension (LTE) Study|Other|2|||
16422117|NCT00547521|40025506|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
16422118|NCT00547521|40025507|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
16422119|NCT01743040|40025508|FG000|Overall Study|Death|1|||
16422120|NCT01743040|40025508|FG000|Overall Study|Lost to Follow-up|66|||
16422121|NCT01743040|40025508|FG000|Overall Study|Physician Decision|40|||
16422122|NCT01743040|40025508|FG000|Overall Study|Protocol Violation|1|||
16422123|NCT01743040|40025508|FG000|Overall Study|Withdrawal by Subject|121|||
16422124|NCT01534195|40025513|FG000|Overall Study|Withdrawal by Subject|1|||
16422125|NCT01534195|40025514|FG001|Overall Study|Withdrawal by Subject|1|||
16422126|NCT02160145|40025515|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
16422127|NCT02160145|40025516|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
16422128|NCT02160145|40025517|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
16422129|NCT02160145|40025515|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
16422130|NCT02160145|40025516|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
16422131|NCT02160145|40025517|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
16422132|NCT02160145|40025515|FG000|Randomized Double-blind Period|Subject decision|0|||
16422133|NCT02160145|40025516|FG001|Randomized Double-blind Period|Subject decision|21|||
16422134|NCT02160145|40025517|FG002|Randomized Double-blind Period|Subject decision|20|||
16422135|NCT02160145|40025515|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
16422136|NCT02160145|40025516|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
16422137|NCT02160145|40025517|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
16422138|NCT02160145|40025515|FG000|Randomized Double-blind Period|Physician Decision|0|||
16422139|NCT02160145|40025516|FG001|Randomized Double-blind Period|Physician Decision|7|||
16422140|NCT02160145|40025517|FG002|Randomized Double-blind Period|Physician Decision|5|||
16422141|NCT01867086|40025518|FG000|Overall Study|Disease Progression|1|||
16422142|NCT03245775|40025519|FG000|Overall Study|Lost to Follow-up|25|||
16422143|NCT03245775|40025520|FG001|Overall Study|Lost to Follow-up|26|||
16422144|NCT03245775|40025521|FG002|Overall Study|Lost to Follow-up|16|||
16422145|NCT03245775|40025522|FG003|Overall Study|Lost to Follow-up|16|||
16422146|NCT01611194|40025523|FG000|Overall Study|Lost to Follow-up|0|||
16422147|NCT01611194|40025524|FG001|Overall Study|Lost to Follow-up|1|||
16422148|NCT01611194|40025523|FG000|Overall Study|Withdrawal by Subject|0|||
16422149|NCT01611194|40025524|FG001|Overall Study|Withdrawal by Subject|1|||
16422150|NCT01611194|40025523|FG000|Overall Study|drug use|0|||
16422151|NCT01611194|40025524|FG001|Overall Study|drug use|1|||
16422152|NCT01630889|40025528|FG000|Overall Study|Death|2|||
16422153|NCT01630889|40025528|FG000|Overall Study|Withdrawal by Subject|1|||
16422154|NCT01630889|40025528|FG000|Overall Study|Other than Specified|2|||
16422155|NCT01630889|40025528|FG000|Overall Study|Lost to Follow-up|4|||
16422156|NCT01630889|40025528|FG000|Overall Study|Other|1|||
16422157|NCT01628965|40025530|FG000|Overall Study|Adverse Event|30|||
16422158|NCT01628965|40025530|FG000|Overall Study|Lack of Efficacy|7|||
16422159|NCT01628965|40025530|FG000|Overall Study|Withdrawal by Subject|3|||
16422160|NCT01628965|40025530|FG000|Overall Study|Lost to Follow-up|1|||
16422161|NCT01628965|40025530|FG000|Overall Study|Discontinuation criteria|8|||
16422162|NCT01069705|40025533|FG000|Overall Study|Adverse Event|1|||
16422163|NCT01069705|40025533|FG000|Overall Study|Withdrawal by Subject|2|||
16422164|NCT03459365|40025534|FG000|Overall Study|Withdrawal by Subject|6|||
16422165|NCT03459365|40025534|FG000|Overall Study|Protocol Violation|8|||
16422166|NCT04378114|40025535|FG000|Overall Study|Withdrawal by Subject|5|||
16422167|NCT04039217|40025536|FG000|Overall Study|Lost to Follow-up|1|||
16422168|NCT04078152|40025537|FG000|Overall Study|Other|83|||
16422169|NCT04078152|40025538|FG001|Overall Study|Other|22|||
16422170|NCT04078152|40025539|FG002|Overall Study|Other|25|||
16422171|NCT04078152|40025537|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
16422172|NCT04078152|40025538|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
16422173|NCT04078152|40025539|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
16422174|NCT04078152|40025537|FG000|Overall Study|Withdrawal by Subject|5|||
16422175|NCT04078152|40025538|FG001|Overall Study|Withdrawal by Subject|0|||
16422176|NCT04078152|40025539|FG002|Overall Study|Withdrawal by Subject|1|||
16422177|NCT04078152|40025537|FG000|Overall Study|Death|10|||
16422178|NCT04078152|40025538|FG001|Overall Study|Death|2|||
16249004|NCT00788957|39395340|FG004|Part 1|Death|0|||
16422179|NCT04078152|40025539|FG002|Overall Study|Death|12|||
16249005|NCT00788957|39395341|FG005|Part 1|Death|0|||
16422180|NCT04078152|40025537|FG000|Overall Study|Adverse Event|1|||
16422181|NCT04078152|40025538|FG001|Overall Study|Adverse Event|0|||
16422182|NCT04078152|40025539|FG002|Overall Study|Adverse Event|0|||
16422183|NCT02421588|40025544|FG000|Overall Study|Non-treatment-related AE|8|||
16422184|NCT02421588|40025545|FG001|Overall Study|Non-treatment-related AE|8|||
16422185|NCT02421588|40025544|FG000|Overall Study|Progressive disease|152|||
16422186|NCT02421588|40025545|FG001|Overall Study|Progressive disease|135|||
16422187|NCT02421588|40025544|FG000|Overall Study|Death|11|||
16422188|NCT02421588|40025545|FG001|Overall Study|Death|3|||
16422189|NCT02421588|40025544|FG000|Overall Study|Physician Decision|8|||
16422190|NCT02421588|40025545|FG001|Overall Study|Physician Decision|17|||
16422191|NCT02421588|40025544|FG000|Overall Study|Other reason not specified|3|||
16422192|NCT02421588|40025545|FG001|Overall Study|Other reason not specified|1|||
16422193|NCT02421588|40025544|FG000|Overall Study|Symptomatic deterioration|13|||
16422194|NCT02421588|40025545|FG001|Overall Study|Symptomatic deterioration|19|||
16422195|NCT02421588|40025544|FG000|Overall Study|Treatment-related AE|10|||
16422196|NCT02421588|40025545|FG001|Overall Study|Treatment-related AE|14|||
16422197|NCT02421588|40025544|FG000|Overall Study|Withdrawal by Subject|14|||
16422198|NCT02421588|40025545|FG001|Overall Study|Withdrawal by Subject|16|||
16422199|NCT02421588|40025544|FG000|Overall Study|Not treated|2|||
16422200|NCT02421588|40025545|FG001|Overall Study|Not treated|8|||
16422201|NCT04079114|40025547|FG000|Overall Study|Study prematuely terminated.|166|||
16422202|NCT01052077|40025551|FG000|Phase A|Lost to Follow-up|22|||
16422203|NCT01052077|40025552|FG001|Phase A|Lost to Follow-up|0|||
16422204|NCT01052077|40025553|FG002|Phase A|Lost to Follow-up|0|||
16422205|NCT01052077|40025554|FG003|Phase A|Lost to Follow-up|0|||
16422206|NCT01052077|40025551|FG000|Phase A|Adverse Event|32|||
16422207|NCT01052077|40025552|FG001|Phase A|Adverse Event|0|||
16422208|NCT01052077|40025553|FG002|Phase A|Adverse Event|0|||
16422209|NCT01052077|40025554|FG003|Phase A|Adverse Event|0|||
16422210|NCT01052077|40025551|FG000|Phase A|Met Withdrawal Criteria|26|||
16422211|NCT01052077|40025552|FG001|Phase A|Met Withdrawal Criteria|0|||
16422212|NCT01052077|40025553|FG002|Phase A|Met Withdrawal Criteria|0|||
16422213|NCT01052077|40025554|FG003|Phase A|Met Withdrawal Criteria|0|||
16422214|NCT01052077|40025551|FG000|Phase A|Physician Decision|10|||
16422215|NCT01052077|40025552|FG001|Phase A|Physician Decision|0|||
16422216|NCT01052077|40025553|FG002|Phase A|Physician Decision|0|||
16422217|NCT01052077|40025554|FG003|Phase A|Physician Decision|0|||
16422218|NCT01052077|40025551|FG000|Phase A|Withdrawal by Subject|29|||
16422219|NCT01052077|40025552|FG001|Phase A|Withdrawal by Subject|0|||
16422220|NCT01052077|40025553|FG002|Phase A|Withdrawal by Subject|0|||
16422221|NCT01052077|40025554|FG003|Phase A|Withdrawal by Subject|0|||
16422222|NCT01052077|40025551|FG000|Phase A|Protocol Deviation|27|||
16422223|NCT01052077|40025552|FG001|Phase A|Protocol Deviation|0|||
16422224|NCT01052077|40025553|FG002|Phase A|Protocol Deviation|0|||
16422225|NCT01052077|40025554|FG003|Phase A|Protocol Deviation|0|||
16422226|NCT01052077|40025551|FG000|Phase B|Lost to Follow-up|0|||
16422227|NCT01052077|40025552|FG001|Phase B|Lost to Follow-up|2|||
16422228|NCT01052077|40025553|FG002|Phase B|Lost to Follow-up|3|||
16422229|NCT01052077|40025554|FG003|Phase B|Lost to Follow-up|0|||
16422230|NCT01052077|40025551|FG000|Phase B|Adverse Event|0|||
16422231|NCT01052077|40025552|FG001|Phase B|Adverse Event|9|||
16422232|NCT01052077|40025553|FG002|Phase B|Adverse Event|2|||
16422233|NCT01052077|40025554|FG003|Phase B|Adverse Event|0|||
16422234|NCT01052077|40025551|FG000|Phase B|Met Withdrawal Criteria|0|||
16422235|NCT01052077|40025552|FG001|Phase B|Met Withdrawal Criteria|2|||
16422236|NCT01052077|40025553|FG002|Phase B|Met Withdrawal Criteria|1|||
16422237|NCT01052077|40025554|FG003|Phase B|Met Withdrawal Criteria|0|||
16422238|NCT01052077|40025551|FG000|Phase B|Physician Decision|0|||
16422239|NCT01052077|40025552|FG001|Phase B|Physician Decision|1|||
16422240|NCT01052077|40025553|FG002|Phase B|Physician Decision|1|||
16422241|NCT01052077|40025554|FG003|Phase B|Physician Decision|0|||
16422242|NCT01052077|40025551|FG000|Phase B|Withdrawal by Subject|0|||
16422243|NCT01052077|40025552|FG001|Phase B|Withdrawal by Subject|0|||
16422244|NCT01052077|40025553|FG002|Phase B|Withdrawal by Subject|5|||
16422245|NCT01052077|40025554|FG003|Phase B|Withdrawal by Subject|0|||
16422246|NCT01052077|40025551|FG000|Phase B|Protocol Deviation|0|||
16422247|NCT01052077|40025552|FG001|Phase B|Protocol Deviation|3|||
16422248|NCT01052077|40025553|FG002|Phase B|Protocol Deviation|4|||
16422249|NCT01052077|40025554|FG003|Phase B|Protocol Deviation|0|||
16422250|NCT01052077|40025551|FG000|Phase B|Lack of Efficacy|0|||
16422251|NCT01052077|40025552|FG001|Phase B|Lack of Efficacy|1|||
16422252|NCT01052077|40025553|FG002|Phase B|Lack of Efficacy|0|||
16422253|NCT01052077|40025554|FG003|Phase B|Lack of Efficacy|0|||
16249006|NCT00788957|39395336|FG000|Part 1|Lost to Follow-up|1|||
16422254|NCT01052077|40025551|FG000|Phase A+|Lost to Follow-up|0|||
16422255|NCT01052077|40025552|FG001|Phase A+|Lost to Follow-up|0|||
16422256|NCT01052077|40025553|FG002|Phase A+|Lost to Follow-up|0|||
16422257|NCT01052077|40025554|FG003|Phase A+|Lost to Follow-up|8|||
16422258|NCT01052077|40025551|FG000|Phase A+|Adverse Event|0|||
16422259|NCT01052077|40025552|FG001|Phase A+|Adverse Event|0|||
16422260|NCT01052077|40025553|FG002|Phase A+|Adverse Event|0|||
16422261|NCT01052077|40025554|FG003|Phase A+|Adverse Event|4|||
16422262|NCT01052077|40025551|FG000|Phase A+|Met Withdrawal Criteria|0|||
16422263|NCT01052077|40025552|FG001|Phase A+|Met Withdrawal Criteria|0|||
16422264|NCT01052077|40025553|FG002|Phase A+|Met Withdrawal Criteria|0|||
16422265|NCT01052077|40025554|FG003|Phase A+|Met Withdrawal Criteria|2|||
16422266|NCT01052077|40025551|FG000|Phase A+|Withdrawal by Subject|0|||
16422267|NCT01052077|40025552|FG001|Phase A+|Withdrawal by Subject|0|||
16422268|NCT01052077|40025553|FG002|Phase A+|Withdrawal by Subject|0|||
16422269|NCT01052077|40025554|FG003|Phase A+|Withdrawal by Subject|7|||
16422270|NCT03364309|40025562|FG000|Induction Period|Adverse Event|4|||
16422271|NCT03364309|40025563|FG001|Induction Period|Adverse Event|0|||
16422272|NCT03364309|40025564|FG002|Induction Period|Adverse Event|1|||
16422273|NCT03364309|40025565|FG003|Induction Period|Adverse Event|0|||
16422274|NCT03364309|40025566|FG004|Induction Period|Adverse Event|0|||
16422275|NCT03364309|40025567|FG005|Induction Period|Adverse Event|0|||
16422276|NCT03364309|40025568|FG006|Induction Period|Adverse Event|0|||
16422277|NCT03364309|40025569|FG007|Induction Period|Adverse Event|0|||
16422278|NCT03364309|40025570|FG008|Induction Period|Adverse Event|0|||
16422279|NCT03364309|40025571|FG009|Induction Period|Adverse Event|0|||
16422280|NCT03364309|40025572|FG010|Induction Period|Adverse Event|0|||
16422281|NCT03364309|40025573|FG011|Induction Period|Adverse Event|0|||
16422282|NCT03364309|40025574|FG012|Induction Period|Adverse Event|0|||
16422283|NCT03364309|40025575|FG013|Induction Period|Adverse Event|0|||
16422284|NCT03364309|40025576|FG014|Induction Period|Adverse Event|0|||
16422285|NCT03364309|40025577|FG015|Induction Period|Adverse Event|0|||
16422286|NCT03364309|40025578|FG016|Induction Period|Adverse Event|0|||
16422287|NCT03364309|40025579|FG017|Induction Period|Adverse Event|0|||
16422288|NCT03364309|40025580|FG018|Induction Period|Adverse Event|0|||
16422289|NCT03364309|40025562|FG000|Induction Period|Withdrawal by Subject|1|||
16422290|NCT03364309|40025563|FG001|Induction Period|Withdrawal by Subject|3|||
16422291|NCT03364309|40025564|FG002|Induction Period|Withdrawal by Subject|0|||
16422292|NCT03364309|40025565|FG003|Induction Period|Withdrawal by Subject|0|||
16422293|NCT03364309|40025566|FG004|Induction Period|Withdrawal by Subject|0|||
16422294|NCT03364309|40025567|FG005|Induction Period|Withdrawal by Subject|0|||
16422295|NCT03364309|40025568|FG006|Induction Period|Withdrawal by Subject|0|||
16422296|NCT03364309|40025569|FG007|Induction Period|Withdrawal by Subject|0|||
16422297|NCT03364309|40025570|FG008|Induction Period|Withdrawal by Subject|0|||
16422298|NCT03364309|40025571|FG009|Induction Period|Withdrawal by Subject|0|||
16422299|NCT03364309|40025572|FG010|Induction Period|Withdrawal by Subject|0|||
16422300|NCT03364309|40025573|FG011|Induction Period|Withdrawal by Subject|0|||
16422301|NCT03364309|40025574|FG012|Induction Period|Withdrawal by Subject|0|||
16422302|NCT03364309|40025575|FG013|Induction Period|Withdrawal by Subject|0|||
16422303|NCT03364309|40025576|FG014|Induction Period|Withdrawal by Subject|0|||
16422304|NCT03364309|40025577|FG015|Induction Period|Withdrawal by Subject|0|||
16422305|NCT03364309|40025578|FG016|Induction Period|Withdrawal by Subject|0|||
16422306|NCT03364309|40025579|FG017|Induction Period|Withdrawal by Subject|0|||
16422307|NCT03364309|40025580|FG018|Induction Period|Withdrawal by Subject|0|||
16422308|NCT03364309|40025562|FG000|Induction Period|Lost to Follow-up|1|||
16422309|NCT03364309|40025563|FG001|Induction Period|Lost to Follow-up|0|||
16422310|NCT03364309|40025564|FG002|Induction Period|Lost to Follow-up|0|||
16422311|NCT03364309|40025565|FG003|Induction Period|Lost to Follow-up|0|||
16422312|NCT03364309|40025566|FG004|Induction Period|Lost to Follow-up|0|||
16422313|NCT03364309|40025567|FG005|Induction Period|Lost to Follow-up|0|||
16422314|NCT03364309|40025568|FG006|Induction Period|Lost to Follow-up|0|||
16422315|NCT03364309|40025569|FG007|Induction Period|Lost to Follow-up|0|||
16422316|NCT03364309|40025570|FG008|Induction Period|Lost to Follow-up|0|||
16422317|NCT03364309|40025571|FG009|Induction Period|Lost to Follow-up|0|||
16422318|NCT03364309|40025572|FG010|Induction Period|Lost to Follow-up|0|||
16422319|NCT03364309|40025573|FG011|Induction Period|Lost to Follow-up|0|||
16422320|NCT03364309|40025574|FG012|Induction Period|Lost to Follow-up|0|||
16422321|NCT03364309|40025575|FG013|Induction Period|Lost to Follow-up|0|||
16422322|NCT03364309|40025576|FG014|Induction Period|Lost to Follow-up|0|||
16422323|NCT03364309|40025577|FG015|Induction Period|Lost to Follow-up|0|||
16422324|NCT03364309|40025578|FG016|Induction Period|Lost to Follow-up|0|||
16422325|NCT03364309|40025579|FG017|Induction Period|Lost to Follow-up|0|||
16422326|NCT03364309|40025580|FG018|Induction Period|Lost to Follow-up|0|||
16422327|NCT03364309|40025562|FG000|Induction Period|Physician Decision|0|||
16422328|NCT03364309|40025563|FG001|Induction Period|Physician Decision|1|||
16422329|NCT03364309|40025564|FG002|Induction Period|Physician Decision|0|||
16422330|NCT03364309|40025565|FG003|Induction Period|Physician Decision|0|||
16422331|NCT03364309|40025566|FG004|Induction Period|Physician Decision|0|||
16130898|NCT01323634|38967152|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
16422332|NCT03364309|40025567|FG005|Induction Period|Physician Decision|0|||
16422333|NCT03364309|40025568|FG006|Induction Period|Physician Decision|0|||
16422334|NCT03364309|40025569|FG007|Induction Period|Physician Decision|0|||
16422335|NCT03364309|40025570|FG008|Induction Period|Physician Decision|0|||
16422336|NCT03364309|40025571|FG009|Induction Period|Physician Decision|0|||
16130899|NCT01323634|38967153|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16249007|NCT00788957|39395337|FG001|Part 1|Lost to Follow-up|0|||
16422337|NCT03364309|40025572|FG010|Induction Period|Physician Decision|0|||
16422338|NCT03364309|40025573|FG011|Induction Period|Physician Decision|0|||
16422339|NCT03364309|40025574|FG012|Induction Period|Physician Decision|0|||
16422340|NCT03364309|40025575|FG013|Induction Period|Physician Decision|0|||
16422341|NCT03364309|40025576|FG014|Induction Period|Physician Decision|0|||
16422342|NCT03364309|40025577|FG015|Induction Period|Physician Decision|0|||
16422343|NCT03364309|40025578|FG016|Induction Period|Physician Decision|0|||
16422344|NCT03364309|40025579|FG017|Induction Period|Physician Decision|0|||
16422345|NCT03364309|40025580|FG018|Induction Period|Physician Decision|0|||
16422346|NCT03364309|40025562|FG000|Maintenance Period|Withdrawal by Subject|0|||
16422347|NCT03364309|40025563|FG001|Maintenance Period|Withdrawal by Subject|0|||
16422348|NCT03364309|40025564|FG002|Maintenance Period|Withdrawal by Subject|0|||
16422349|NCT03364309|40025565|FG003|Maintenance Period|Withdrawal by Subject|1|||
16422350|NCT03364309|40025566|FG004|Maintenance Period|Withdrawal by Subject|3|||
16422351|NCT03364309|40025567|FG005|Maintenance Period|Withdrawal by Subject|1|||
16422352|NCT03364309|40025568|FG006|Maintenance Period|Withdrawal by Subject|3|||
16422353|NCT03364309|40025569|FG007|Maintenance Period|Withdrawal by Subject|0|||
16422354|NCT03364309|40025570|FG008|Maintenance Period|Withdrawal by Subject|1|||
16422355|NCT03364309|40025571|FG009|Maintenance Period|Withdrawal by Subject|1|||
16422356|NCT03364309|40025572|FG010|Maintenance Period|Withdrawal by Subject|2|||
16422357|NCT03364309|40025573|FG011|Maintenance Period|Withdrawal by Subject|0|||
16422358|NCT03364309|40025574|FG012|Maintenance Period|Withdrawal by Subject|0|||
16422359|NCT03364309|40025575|FG013|Maintenance Period|Withdrawal by Subject|0|||
16422360|NCT03364309|40025576|FG014|Maintenance Period|Withdrawal by Subject|0|||
16422361|NCT03364309|40025577|FG015|Maintenance Period|Withdrawal by Subject|0|||
16422362|NCT03364309|40025578|FG016|Maintenance Period|Withdrawal by Subject|0|||
16422363|NCT03364309|40025579|FG017|Maintenance Period|Withdrawal by Subject|0|||
16422364|NCT03364309|40025580|FG018|Maintenance Period|Withdrawal by Subject|0|||
16422365|NCT03364309|40025562|FG000|Maintenance Period|Adverse Event|0|||
16422366|NCT03364309|40025563|FG001|Maintenance Period|Adverse Event|0|||
16422367|NCT03364309|40025564|FG002|Maintenance Period|Adverse Event|0|||
16422368|NCT03364309|40025565|FG003|Maintenance Period|Adverse Event|0|||
16422369|NCT03364309|40025566|FG004|Maintenance Period|Adverse Event|2|||
16422370|NCT03364309|40025567|FG005|Maintenance Period|Adverse Event|0|||
16422371|NCT03364309|40025568|FG006|Maintenance Period|Adverse Event|3|||
16422372|NCT03364309|40025569|FG007|Maintenance Period|Adverse Event|0|||
16422373|NCT03364309|40025570|FG008|Maintenance Period|Adverse Event|1|||
16422374|NCT03364309|40025571|FG009|Maintenance Period|Adverse Event|0|||
16422375|NCT03364309|40025572|FG010|Maintenance Period|Adverse Event|2|||
16422376|NCT03364309|40025573|FG011|Maintenance Period|Adverse Event|0|||
16422377|NCT03364309|40025574|FG012|Maintenance Period|Adverse Event|0|||
16422378|NCT03364309|40025575|FG013|Maintenance Period|Adverse Event|0|||
16422379|NCT03364309|40025576|FG014|Maintenance Period|Adverse Event|0|||
16422380|NCT03364309|40025577|FG015|Maintenance Period|Adverse Event|0|||
16422381|NCT03364309|40025578|FG016|Maintenance Period|Adverse Event|0|||
16422382|NCT03364309|40025579|FG017|Maintenance Period|Adverse Event|0|||
16422383|NCT03364309|40025580|FG018|Maintenance Period|Adverse Event|0|||
16422384|NCT03364309|40025562|FG000|Maintenance Period|Relapsed|0|||
16422385|NCT03364309|40025563|FG001|Maintenance Period|Relapsed|0|||
16422386|NCT03364309|40025564|FG002|Maintenance Period|Relapsed|0|||
16422387|NCT03364309|40025565|FG003|Maintenance Period|Relapsed|43|||
16562333|NCT02018861|40525376|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
16562334|NCT02018861|40525377|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16562335|NCT02018861|40525378|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16130900|NCT01323634|38967154|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16249008|NCT00788957|39395338|FG002|Part 1|Lost to Follow-up|0|||
16249009|NCT00788957|39395339|FG003|Part 1|Lost to Follow-up|0|||
16249010|NCT00788957|39395340|FG004|Part 1|Lost to Follow-up|0|||
16422388|NCT03364309|40025566|FG004|Maintenance Period|Relapsed|7|||
16422389|NCT03364309|40025567|FG005|Maintenance Period|Relapsed|45|||
16422390|NCT03364309|40025568|FG006|Maintenance Period|Relapsed|10|||
16422391|NCT03364309|40025569|FG007|Maintenance Period|Relapsed|2|||
16422392|NCT03364309|40025570|FG008|Maintenance Period|Relapsed|0|||
16422393|NCT03364309|40025571|FG009|Maintenance Period|Relapsed|0|||
16422394|NCT03364309|40025572|FG010|Maintenance Period|Relapsed|0|||
16422395|NCT03364309|40025573|FG011|Maintenance Period|Relapsed|0|||
16422396|NCT03364309|40025574|FG012|Maintenance Period|Relapsed|0|||
16422397|NCT03364309|40025575|FG013|Maintenance Period|Relapsed|0|||
16422398|NCT03364309|40025576|FG014|Maintenance Period|Relapsed|0|||
16422399|NCT03364309|40025577|FG015|Maintenance Period|Relapsed|0|||
16422400|NCT03364309|40025578|FG016|Maintenance Period|Relapsed|0|||
16422401|NCT03364309|40025579|FG017|Maintenance Period|Relapsed|0|||
16422402|NCT03364309|40025580|FG018|Maintenance Period|Relapsed|0|||
16422403|NCT03364309|40025562|FG000|Maintenance Period|Lack of Efficacy|0|||
16422404|NCT03364309|40025563|FG001|Maintenance Period|Lack of Efficacy|0|||
16422405|NCT03364309|40025564|FG002|Maintenance Period|Lack of Efficacy|0|||
16422406|NCT03364309|40025565|FG003|Maintenance Period|Lack of Efficacy|0|||
16249011|NCT00788957|39395341|FG005|Part 1|Lost to Follow-up|0|||
16249012|NCT00788957|39395336|FG000|Part 2|Withdrawal by Subject|0|||
16422407|NCT03364309|40025566|FG004|Maintenance Period|Lack of Efficacy|0|||
16422408|NCT03364309|40025567|FG005|Maintenance Period|Lack of Efficacy|0|||
16422409|NCT03364309|40025568|FG006|Maintenance Period|Lack of Efficacy|0|||
16422410|NCT03364309|40025569|FG007|Maintenance Period|Lack of Efficacy|0|||
16422411|NCT03364309|40025570|FG008|Maintenance Period|Lack of Efficacy|1|||
16422412|NCT03364309|40025571|FG009|Maintenance Period|Lack of Efficacy|3|||
16422413|NCT03364309|40025572|FG010|Maintenance Period|Lack of Efficacy|2|||
16422414|NCT03364309|40025573|FG011|Maintenance Period|Lack of Efficacy|0|||
16422415|NCT03364309|40025574|FG012|Maintenance Period|Lack of Efficacy|0|||
16422416|NCT03364309|40025575|FG013|Maintenance Period|Lack of Efficacy|0|||
16422417|NCT03364309|40025576|FG014|Maintenance Period|Lack of Efficacy|0|||
16422418|NCT03364309|40025577|FG015|Maintenance Period|Lack of Efficacy|0|||
16422419|NCT03364309|40025578|FG016|Maintenance Period|Lack of Efficacy|0|||
16422420|NCT03364309|40025579|FG017|Maintenance Period|Lack of Efficacy|0|||
16422421|NCT03364309|40025580|FG018|Maintenance Period|Lack of Efficacy|0|||
16422422|NCT03364309|40025562|FG000|Maintenance Period|Death|0|||
16422423|NCT03364309|40025563|FG001|Maintenance Period|Death|0|||
16422424|NCT03364309|40025564|FG002|Maintenance Period|Death|0|||
16422425|NCT03364309|40025565|FG003|Maintenance Period|Death|0|||
16422426|NCT03364309|40025566|FG004|Maintenance Period|Death|0|||
16422427|NCT03364309|40025567|FG005|Maintenance Period|Death|0|||
16422428|NCT03364309|40025568|FG006|Maintenance Period|Death|0|||
16422429|NCT03364309|40025569|FG007|Maintenance Period|Death|0|||
16422430|NCT03364309|40025570|FG008|Maintenance Period|Death|1|||
16422431|NCT03364309|40025571|FG009|Maintenance Period|Death|0|||
16422432|NCT03364309|40025572|FG010|Maintenance Period|Death|0|||
16422433|NCT03364309|40025573|FG011|Maintenance Period|Death|0|||
16422434|NCT03364309|40025574|FG012|Maintenance Period|Death|0|||
16422435|NCT03364309|40025575|FG013|Maintenance Period|Death|0|||
16422436|NCT03364309|40025576|FG014|Maintenance Period|Death|0|||
16422437|NCT03364309|40025577|FG015|Maintenance Period|Death|0|||
16422438|NCT03364309|40025578|FG016|Maintenance Period|Death|0|||
16422439|NCT03364309|40025579|FG017|Maintenance Period|Death|0|||
16422440|NCT03364309|40025580|FG018|Maintenance Period|Death|0|||
16422441|NCT03364309|40025562|FG000|Maintenance Period|Lost to Follow-up|0|||
16422442|NCT03364309|40025563|FG001|Maintenance Period|Lost to Follow-up|0|||
16422443|NCT03364309|40025564|FG002|Maintenance Period|Lost to Follow-up|0|||
16422444|NCT03364309|40025565|FG003|Maintenance Period|Lost to Follow-up|0|||
16422445|NCT03364309|40025566|FG004|Maintenance Period|Lost to Follow-up|0|||
16422446|NCT03364309|40025567|FG005|Maintenance Period|Lost to Follow-up|0|||
16422447|NCT03364309|40025568|FG006|Maintenance Period|Lost to Follow-up|0|||
16422448|NCT03364309|40025569|FG007|Maintenance Period|Lost to Follow-up|0|||
16422449|NCT03364309|40025570|FG008|Maintenance Period|Lost to Follow-up|1|||
16422450|NCT03364309|40025571|FG009|Maintenance Period|Lost to Follow-up|0|||
16422451|NCT03364309|40025572|FG010|Maintenance Period|Lost to Follow-up|0|||
16422452|NCT03364309|40025573|FG011|Maintenance Period|Lost to Follow-up|0|||
16422453|NCT03364309|40025574|FG012|Maintenance Period|Lost to Follow-up|0|||
16422454|NCT03364309|40025575|FG013|Maintenance Period|Lost to Follow-up|0|||
16422455|NCT03364309|40025576|FG014|Maintenance Period|Lost to Follow-up|0|||
16422456|NCT03364309|40025577|FG015|Maintenance Period|Lost to Follow-up|0|||
16422457|NCT03364309|40025578|FG016|Maintenance Period|Lost to Follow-up|0|||
16422458|NCT03364309|40025579|FG017|Maintenance Period|Lost to Follow-up|0|||
16422459|NCT03364309|40025580|FG018|Maintenance Period|Lost to Follow-up|0|||
16422460|NCT03364309|40025562|FG000|Maintenance Period|Miscellaneous|0|||
16422461|NCT03364309|40025563|FG001|Maintenance Period|Miscellaneous|0|||
16422462|NCT03364309|40025564|FG002|Maintenance Period|Miscellaneous|0|||
16422463|NCT03364309|40025565|FG003|Maintenance Period|Miscellaneous|0|||
16422464|NCT03364309|40025566|FG004|Maintenance Period|Miscellaneous|0|||
16422465|NCT03364309|40025567|FG005|Maintenance Period|Miscellaneous|0|||
16422466|NCT03364309|40025568|FG006|Maintenance Period|Miscellaneous|0|||
16422467|NCT03364309|40025569|FG007|Maintenance Period|Miscellaneous|0|||
16422468|NCT03364309|40025570|FG008|Maintenance Period|Miscellaneous|1|||
16422469|NCT03364309|40025571|FG009|Maintenance Period|Miscellaneous|0|||
16422470|NCT03364309|40025572|FG010|Maintenance Period|Miscellaneous|0|||
16422471|NCT03364309|40025573|FG011|Maintenance Period|Miscellaneous|0|||
16249013|NCT00788957|39395337|FG001|Part 2|Withdrawal by Subject|9|||
16422472|NCT03364309|40025574|FG012|Maintenance Period|Miscellaneous|0|||
16422473|NCT03364309|40025575|FG013|Maintenance Period|Miscellaneous|0|||
16422474|NCT03364309|40025576|FG014|Maintenance Period|Miscellaneous|0|||
16422475|NCT03364309|40025577|FG015|Maintenance Period|Miscellaneous|0|||
16422476|NCT03364309|40025578|FG016|Maintenance Period|Miscellaneous|0|||
16422477|NCT03364309|40025579|FG017|Maintenance Period|Miscellaneous|0|||
16359810|NCT04745351|39804206|FG001|Overall Study|Withdrew Consent|2|||
16422478|NCT03364309|40025580|FG018|Maintenance Period|Miscellaneous|0|||
16359811|NCT04745351|39804205|FG000|Overall Study|Investigator's Discretion|2|||
16359812|NCT04745351|39804206|FG001|Overall Study|Investigator's Discretion|0|||
16359813|NCT04745351|39804205|FG000|Overall Study|Protocol Violation|1|||
16359814|NCT04745351|39804206|FG001|Overall Study|Protocol Violation|0|||
16359815|NCT03473197|39804216|FG000|Overall Study|Adverse Event|4|||
16359816|NCT03473197|39804216|FG000|Overall Study|Lost to Follow-up|1|||
16359817|NCT03473197|39804216|FG000|Overall Study|Withdrawal by Subject|5|||
16359818|NCT03620162|39804218|FG000|Overall Study|Physician Decision|4|||
16422479|NCT03364309|40025562|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422480|NCT03364309|40025563|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422481|NCT03364309|40025564|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422482|NCT03364309|40025565|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422483|NCT03364309|40025566|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422484|NCT03364309|40025567|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422485|NCT03364309|40025568|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422486|NCT03364309|40025569|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422487|NCT03364309|40025570|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422488|NCT03364309|40025571|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422489|NCT03364309|40025572|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422490|NCT03364309|40025573|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422491|NCT03364309|40025574|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422492|NCT03364309|40025575|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
16422493|NCT03364309|40025576|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
16422494|NCT03364309|40025577|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
16422495|NCT03364309|40025578|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422496|NCT03364309|40025579|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422497|NCT03364309|40025580|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
16422498|NCT03364309|40025562|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422499|NCT03364309|40025563|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422500|NCT03364309|40025564|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422501|NCT03364309|40025565|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422502|NCT03364309|40025566|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422503|NCT03364309|40025567|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422504|NCT03364309|40025568|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422505|NCT03364309|40025569|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422506|NCT03364309|40025570|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422507|NCT03364309|40025571|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422508|NCT03364309|40025572|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422509|NCT03364309|40025573|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422510|NCT03364309|40025574|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422511|NCT03364309|40025575|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422512|NCT03364309|40025576|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
16422513|NCT03364309|40025577|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422514|NCT03364309|40025578|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422515|NCT03364309|40025579|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422516|NCT03364309|40025580|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
16422517|NCT03364309|40025562|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
16422518|NCT03364309|40025563|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
16422519|NCT03364309|40025564|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
16422520|NCT03364309|40025565|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
16422521|NCT03364309|40025566|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
16422522|NCT03364309|40025567|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
16422523|NCT03364309|40025568|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
16422524|NCT03364309|40025569|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
16422525|NCT03364309|40025570|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
16422526|NCT03364309|40025571|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
16422527|NCT03364309|40025572|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
16422528|NCT03364309|40025573|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
16422529|NCT03364309|40025574|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
16422530|NCT03364309|40025575|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
16422531|NCT03364309|40025576|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
16422532|NCT03364309|40025577|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
16422533|NCT03364309|40025578|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
16422534|NCT03364309|40025579|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
16422535|NCT03364309|40025580|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
16422536|NCT03364309|40025562|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422537|NCT03364309|40025563|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422538|NCT03364309|40025564|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422539|NCT03364309|40025565|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422540|NCT03364309|40025566|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422541|NCT03364309|40025567|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422542|NCT03364309|40025568|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422543|NCT03364309|40025569|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422544|NCT03364309|40025570|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422545|NCT03364309|40025571|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422546|NCT03364309|40025572|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16249014|NCT00788957|39395338|FG002|Part 2|Withdrawal by Subject|5|||
16422547|NCT03364309|40025573|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422548|NCT03364309|40025574|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422549|NCT03364309|40025575|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422550|NCT03364309|40025576|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422551|NCT03364309|40025577|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
16422552|NCT03364309|40025578|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
16422553|NCT03364309|40025579|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
16422554|NCT03364309|40025580|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
16422555|NCT03364309|40025562|FG000|Post-Treatment Followup Period|Adverse Event|0|||
16422556|NCT03364309|40025563|FG001|Post-Treatment Followup Period|Adverse Event|0|||
16422557|NCT03364309|40025564|FG002|Post-Treatment Followup Period|Adverse Event|0|||
16422558|NCT03364309|40025565|FG003|Post-Treatment Followup Period|Adverse Event|0|||
16422559|NCT03364309|40025566|FG004|Post-Treatment Followup Period|Adverse Event|0|||
16422560|NCT03364309|40025567|FG005|Post-Treatment Followup Period|Adverse Event|0|||
16422561|NCT03364309|40025568|FG006|Post-Treatment Followup Period|Adverse Event|0|||
16422562|NCT03364309|40025569|FG007|Post-Treatment Followup Period|Adverse Event|0|||
16422563|NCT03364309|40025570|FG008|Post-Treatment Followup Period|Adverse Event|0|||
16422564|NCT03364309|40025571|FG009|Post-Treatment Followup Period|Adverse Event|0|||
16422565|NCT03364309|40025572|FG010|Post-Treatment Followup Period|Adverse Event|0|||
16422566|NCT03364309|40025573|FG011|Post-Treatment Followup Period|Adverse Event|0|||
16422567|NCT03364309|40025574|FG012|Post-Treatment Followup Period|Adverse Event|0|||
16422568|NCT03364309|40025575|FG013|Post-Treatment Followup Period|Adverse Event|0|||
16422569|NCT03364309|40025576|FG014|Post-Treatment Followup Period|Adverse Event|0|||
16422570|NCT03364309|40025577|FG015|Post-Treatment Followup Period|Adverse Event|0|||
16422571|NCT03364309|40025578|FG016|Post-Treatment Followup Period|Adverse Event|2|||
16422572|NCT03364309|40025579|FG017|Post-Treatment Followup Period|Adverse Event|6|||
16422573|NCT03364309|40025580|FG018|Post-Treatment Followup Period|Adverse Event|1|||
16422574|NCT03364309|40025562|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422575|NCT03364309|40025563|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422576|NCT03364309|40025564|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422577|NCT03364309|40025565|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422578|NCT03364309|40025566|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422579|NCT03364309|40025567|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422580|NCT03364309|40025568|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422581|NCT03364309|40025569|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422582|NCT03364309|40025570|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422583|NCT03364309|40025571|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422584|NCT03364309|40025572|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422585|NCT03364309|40025573|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422586|NCT03364309|40025574|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422587|NCT03364309|40025575|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422588|NCT03364309|40025576|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422589|NCT03364309|40025577|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422590|NCT03364309|40025578|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422591|NCT03364309|40025579|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
16422592|NCT03364309|40025580|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
16422593|NCT03364309|40025562|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
16422594|NCT03364309|40025563|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
16422595|NCT03364309|40025564|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
16422596|NCT03364309|40025565|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
16422597|NCT03364309|40025566|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
16422598|NCT03364309|40025567|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
16422599|NCT03364309|40025568|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
16422600|NCT03364309|40025569|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
16422601|NCT03364309|40025570|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
16422602|NCT03364309|40025571|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
16422603|NCT03364309|40025572|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
16422604|NCT03364309|40025573|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
16422605|NCT03364309|40025574|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
16422606|NCT03364309|40025575|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
16422607|NCT03364309|40025576|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
16422608|NCT03364309|40025577|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
16422609|NCT03364309|40025578|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
16562336|NCT02018861|40525379|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
16422610|NCT03364309|40025579|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
16422611|NCT03364309|40025580|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
16422612|NCT02006979|40025581|FG000|Overall Study|Withdrawal by Subject|1|||
16422613|NCT02006979|40025582|FG001|Overall Study|Withdrawal by Subject|1|||
16249015|NCT00788957|39395339|FG003|Part 2|Withdrawal by Subject|3|||
16422614|NCT02006979|40025581|FG000|Overall Study|Protocol Violation|0|||
16422615|NCT02006979|40025582|FG001|Overall Study|Protocol Violation|1|||
16422616|NCT01431963|40025583|FG000|Overall Study|Adverse Event|18|||
16422617|NCT01431963|40025583|FG000|Overall Study|Lack of Efficacy|7|||
16422618|NCT01431963|40025583|FG000|Overall Study|Protocol Violation|1|||
16422619|NCT01431963|40025583|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
16422620|NCT01431963|40025583|FG000|Overall Study|Physician Decision|4|||
16422621|NCT01431963|40025583|FG000|Overall Study|Withdrawal by Subject|3|||
16422622|NCT01543776|40025586|FG000|Overall Study|Withdrawal by Subject|2|||
16422623|NCT01543776|40025587|FG001|Overall Study|Withdrawal by Subject|2|||
16422624|NCT00620113|40025588|FG000|Overall Study|Adverse Event|3|||
16422625|NCT00620113|40025589|FG001|Overall Study|Adverse Event|2|||
16422626|NCT00620113|40025590|FG002|Overall Study|Adverse Event|2|||
16422627|NCT00620113|40025591|FG003|Overall Study|Adverse Event|1|||
16422628|NCT00620113|40025588|FG000|Overall Study|Lack of Efficacy|2|||
16422629|NCT00620113|40025589|FG001|Overall Study|Lack of Efficacy|3|||
16422630|NCT00620113|40025590|FG002|Overall Study|Lack of Efficacy|0|||
16422631|NCT00620113|40025591|FG003|Overall Study|Lack of Efficacy|2|||
16422632|NCT00620113|40025588|FG000|Overall Study|Physician Decision|1|||
16422633|NCT00620113|40025589|FG001|Overall Study|Physician Decision|0|||
16422634|NCT00620113|40025590|FG002|Overall Study|Physician Decision|0|||
16422635|NCT00620113|40025591|FG003|Overall Study|Physician Decision|2|||
16422636|NCT00620113|40025588|FG000|Overall Study|Protocol Violation|2|||
16422637|NCT00620113|40025589|FG001|Overall Study|Protocol Violation|1|||
16422638|NCT00620113|40025590|FG002|Overall Study|Protocol Violation|0|||
16422639|NCT00620113|40025591|FG003|Overall Study|Protocol Violation|0|||
16422640|NCT00620113|40025588|FG000|Overall Study|Withdrawal by Subject|5|||
16422641|NCT00620113|40025589|FG001|Overall Study|Withdrawal by Subject|1|||
16422642|NCT00620113|40025590|FG002|Overall Study|Withdrawal by Subject|3|||
16422643|NCT00620113|40025591|FG003|Overall Study|Withdrawal by Subject|5|||
16422644|NCT00172042|40025595|FG000|Overall Study|Adverse Event|27|||
16422645|NCT00172042|40025596|FG001|Overall Study|Adverse Event|13|||
16422646|NCT00172042|40025595|FG000|Overall Study|Abnormal laboratory value(s)|5|||
16422647|NCT00172042|40025596|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16422648|NCT00172042|40025595|FG000|Overall Study|Abnormal test procedure(s)|0|||
16422649|NCT00172042|40025596|FG001|Overall Study|Abnormal test procedure(s)|3|||
16422650|NCT00172042|40025595|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
16422651|NCT00172042|40025596|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
16422652|NCT00172042|40025595|FG000|Overall Study|Patient no longer requires study drug|10|||
16422653|NCT00172042|40025596|FG001|Overall Study|Patient no longer requires study drug|8|||
16422654|NCT00172042|40025595|FG000|Overall Study|Protocol Violation|8|||
16422655|NCT00172042|40025596|FG001|Overall Study|Protocol Violation|7|||
16422656|NCT00172042|40025595|FG000|Overall Study|Withdrawal by Subject|37|||
16422657|NCT00172042|40025596|FG001|Overall Study|Withdrawal by Subject|25|||
16422658|NCT00172042|40025595|FG000|Overall Study|Lost to Follow-up|3|||
16422659|NCT00172042|40025596|FG001|Overall Study|Lost to Follow-up|5|||
16422660|NCT00172042|40025595|FG000|Overall Study|Administrative problems|13|||
16422661|NCT00172042|40025596|FG001|Overall Study|Administrative problems|10|||
16422662|NCT00172042|40025595|FG000|Overall Study|Death|42|||
16422663|NCT00172042|40025596|FG001|Overall Study|Death|42|||
16422664|NCT00264537|40025597|FG000|Overall Study|Death|0|||
16422665|NCT00264537|40025598|FG001|Overall Study|Death|3|||
16422666|NCT00264537|40025599|FG002|Overall Study|Death|3|||
16422667|NCT00264537|40025600|FG003|Overall Study|Death|2|||
16422668|NCT00264537|40025597|FG000|Overall Study|Lost to Follow-up|3|||
16422669|NCT00264537|40025598|FG001|Overall Study|Lost to Follow-up|4|||
16422670|NCT00264537|40025599|FG002|Overall Study|Lost to Follow-up|7|||
16422671|NCT00264537|40025600|FG003|Overall Study|Lost to Follow-up|6|||
16422672|NCT00264537|40025597|FG000|Overall Study|Adverse Event|21|||
16422673|NCT00264537|40025598|FG001|Overall Study|Adverse Event|32|||
16422674|NCT00264537|40025599|FG002|Overall Study|Adverse Event|24|||
16130901|NCT01323634|38967152|FG000|2-week Run-in Period|Physician Decision|5|||
16422675|NCT00264537|40025600|FG003|Overall Study|Adverse Event|34|||
16422676|NCT00264537|40025597|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
16130902|NCT01323634|38967153|FG001|2-week Run-in Period|Physician Decision|0|||
16422677|NCT00264537|40025598|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
16422678|NCT00264537|40025599|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
16422679|NCT00264537|40025600|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
16422680|NCT00264537|40025597|FG000|Overall Study|Other|21|||
16422681|NCT00264537|40025598|FG001|Overall Study|Other|11|||
16422682|NCT00264537|40025599|FG002|Overall Study|Other|10|||
16422683|NCT00264537|40025600|FG003|Overall Study|Other|11|||
16422684|NCT00264537|40025597|FG000|Overall Study|Not treated|0|||
16422685|NCT00264537|40025598|FG001|Overall Study|Not treated|2|||
16422686|NCT00264537|40025599|FG002|Overall Study|Not treated|1|||
16422687|NCT00264537|40025600|FG003|Overall Study|Not treated|0|||
16422688|NCT00825812|40025601|FG000|Overall Study|Never entered follow up|0|||
16422689|NCT00825812|40025602|FG001|Overall Study|Never entered follow up|0|||
16422690|NCT00825812|40025603|FG002|Overall Study|Never entered follow up|0|||
16249016|NCT00788957|39395340|FG004|Part 2|Withdrawal by Subject|0|||
16249017|NCT00788957|39395341|FG005|Part 2|Withdrawal by Subject|0|||
16249018|NCT00788957|39395336|FG000|Part 2|Death|0|||
16249019|NCT00788957|39395337|FG001|Part 2|Death|32|||
16249020|NCT00788957|39395338|FG002|Part 2|Death|35|||
16249021|NCT00788957|39395339|FG003|Part 2|Death|37|||
16249022|NCT00788957|39395340|FG004|Part 2|Death|0|||
16249023|NCT00788957|39395341|FG005|Part 2|Death|0|||
16249024|NCT00788957|39395336|FG000|Part 2|Lost to Follow-up|0|||
16249025|NCT00788957|39395337|FG001|Part 2|Lost to Follow-up|0|||
16249026|NCT00788957|39395338|FG002|Part 2|Lost to Follow-up|3|||
16249027|NCT00788957|39395339|FG003|Part 2|Lost to Follow-up|0|||
16249028|NCT00788957|39395340|FG004|Part 2|Lost to Follow-up|0|||
16249029|NCT00788957|39395341|FG005|Part 2|Lost to Follow-up|0|||
16249030|NCT00788957|39395336|FG000|Part 2|On-study at time of data cut-off|0|||
16249031|NCT00788957|39395337|FG001|Part 2|On-study at time of data cut-off|1|||
16249032|NCT00788957|39395338|FG002|Part 2|On-study at time of data cut-off|1|||
16249033|NCT00788957|39395339|FG003|Part 2|On-study at time of data cut-off|1|||
16249034|NCT00788957|39395340|FG004|Part 2|On-study at time of data cut-off|0|||
16249035|NCT00788957|39395341|FG005|Part 2|On-study at time of data cut-off|0|||
16249036|NCT00788957|39395336|FG000|Part 3|Withdrawal by Subject|0|||
16249037|NCT00788957|39395337|FG001|Part 3|Withdrawal by Subject|0|||
16249038|NCT00788957|39395338|FG002|Part 3|Withdrawal by Subject|0|||
16249039|NCT00788957|39395339|FG003|Part 3|Withdrawal by Subject|0|||
16249040|NCT00788957|39395340|FG004|Part 3|Withdrawal by Subject|0|||
16249041|NCT00788957|39395341|FG005|Part 3|Withdrawal by Subject|2|||
16249042|NCT00788957|39395336|FG000|Part 3|Death|0|||
16249043|NCT00788957|39395337|FG001|Part 3|Death|0|||
16249044|NCT00788957|39395338|FG002|Part 3|Death|0|||
16249045|NCT00788957|39395339|FG003|Part 3|Death|0|||
16249046|NCT00788957|39395340|FG004|Part 3|Death|8|||
16249047|NCT00788957|39395341|FG005|Part 3|Death|8|||
16249048|NCT00788957|39395336|FG000|Part 3|On-study at time of data cut-off|0|||
16249049|NCT00788957|39395337|FG001|Part 3|On-study at time of data cut-off|0|||
16249050|NCT00788957|39395338|FG002|Part 3|On-study at time of data cut-off|0|||
16249051|NCT00788957|39395339|FG003|Part 3|On-study at time of data cut-off|0|||
16249052|NCT00788957|39395340|FG004|Part 3|On-study at time of data cut-off|1|||
16249053|NCT00788957|39395341|FG005|Part 3|On-study at time of data cut-off|0|||
16249054|NCT02985151|39395342|FG000|Original Randomization|Withdrawal by Subject|0|||
16249055|NCT02985151|39395343|FG001|Original Randomization|Withdrawal by Subject|1|||
16249056|NCT00265759|39395344|FG000|Overall Study|Withdrawal by Subject|0|||
16249057|NCT00265759|39395345|FG001|Overall Study|Withdrawal by Subject|1|||
16249058|NCT00265759|39395346|FG002|Overall Study|Withdrawal by Subject|2|||
16249059|NCT00265759|39395347|FG003|Overall Study|Withdrawal by Subject|2|||
16249060|NCT00265759|39395344|FG000|Overall Study|Cancel|0|||
16249061|NCT00265759|39395345|FG001|Overall Study|Cancel|0|||
16249062|NCT00265759|39395346|FG002|Overall Study|Cancel|0|||
16249063|NCT00265759|39395347|FG003|Overall Study|Cancel|3|||
16249064|NCT00265759|39395344|FG000|Overall Study|Ineligible|0|||
16249065|NCT00265759|39395345|FG001|Overall Study|Ineligible|0|||
16249066|NCT00265759|39395346|FG002|Overall Study|Ineligible|0|||
16249067|NCT00265759|39395347|FG003|Overall Study|Ineligible|1|||
16249068|NCT00265759|39395344|FG000|Overall Study|Bilateral disease|0|||
16249069|NCT00265759|39395345|FG001|Overall Study|Bilateral disease|0|||
16249070|NCT00265759|39395346|FG002|Overall Study|Bilateral disease|0|||
16249071|NCT00265759|39395347|FG003|Overall Study|Bilateral disease|2|||
16422691|NCT00825812|40025604|FG003|Overall Study|Never entered follow up|1|||
16422692|NCT00825812|40025601|FG000|Overall Study|Adverse Event|0|||
16422693|NCT00825812|40025602|FG001|Overall Study|Adverse Event|0|||
16422694|NCT00825812|40025603|FG002|Overall Study|Adverse Event|0|||
16422695|NCT00825812|40025604|FG003|Overall Study|Adverse Event|1|||
16422696|NCT00825812|40025601|FG000|Overall Study|Subject withdrew consent|0|||
16422697|NCT00825812|40025602|FG001|Overall Study|Subject withdrew consent|0|||
16422698|NCT00825812|40025603|FG002|Overall Study|Subject withdrew consent|3|||
16422699|NCT00825812|40025604|FG003|Overall Study|Subject withdrew consent|2|||
16422700|NCT00825812|40025601|FG000|Overall Study|Non-compliance with protocol|0|||
16422701|NCT00825812|40025602|FG001|Overall Study|Non-compliance with protocol|0|||
16422702|NCT00825812|40025603|FG002|Overall Study|Non-compliance with protocol|0|||
16422703|NCT00825812|40025604|FG003|Overall Study|Non-compliance with protocol|1|||
16422704|NCT00825812|40025601|FG000|Overall Study|Administrative|0|||
16422705|NCT00825812|40025602|FG001|Overall Study|Administrative|1|||
16422706|NCT00825812|40025603|FG002|Overall Study|Administrative|3|||
16422707|NCT00825812|40025604|FG003|Overall Study|Administrative|5|||
16422708|NCT00250276|40025607|FG000|Overall Study|Serious Adverse Event|0|||
16422709|NCT00250276|40025608|FG001|Overall Study|Serious Adverse Event|0|||
16422710|NCT00250276|40025609|FG002|Overall Study|Serious Adverse Event|1|||
16422711|NCT00250276|40025610|FG003|Overall Study|Serious Adverse Event|0|||
16422712|NCT00250276|40025607|FG000|Overall Study|Non-serious Adverse Event|2|||
16422713|NCT00250276|40025608|FG001|Overall Study|Non-serious Adverse Event|0|||
16422714|NCT00250276|40025609|FG002|Overall Study|Non-serious Adverse Event|0|||
16422715|NCT00250276|40025610|FG003|Overall Study|Non-serious Adverse Event|2|||
16422716|NCT00250276|40025607|FG000|Overall Study|Protocol Violation|0|||
16422717|NCT00250276|40025608|FG001|Overall Study|Protocol Violation|1|||
16422718|NCT00250276|40025609|FG002|Overall Study|Protocol Violation|0|||
16422719|NCT00250276|40025610|FG003|Overall Study|Protocol Violation|0|||
16422720|NCT00250276|40025607|FG000|Overall Study|Withdrawal by Subject|1|||
16422721|NCT00250276|40025608|FG001|Overall Study|Withdrawal by Subject|2|||
16422722|NCT00250276|40025609|FG002|Overall Study|Withdrawal by Subject|3|||
16422723|NCT00250276|40025610|FG003|Overall Study|Withdrawal by Subject|2|||
16422724|NCT00250276|40025607|FG000|Overall Study|Migrated/moved from study area|3|||
16422725|NCT00250276|40025608|FG001|Overall Study|Migrated/moved from study area|0|||
16422726|NCT00250276|40025609|FG002|Overall Study|Migrated/moved from study area|2|||
16422727|NCT00250276|40025610|FG003|Overall Study|Migrated/moved from study area|7|||
16422728|NCT00250276|40025607|FG000|Overall Study|Lost to Follow-up|11|||
16422729|NCT00250276|40025608|FG001|Overall Study|Lost to Follow-up|18|||
16422730|NCT00250276|40025609|FG002|Overall Study|Lost to Follow-up|13|||
16422731|NCT00250276|40025610|FG003|Overall Study|Lost to Follow-up|8|||
16422732|NCT02725866|40025613|FG000|Overall Study|Failure to return|6|||
16422733|NCT02725866|40025613|FG000|Overall Study|Withdrew consent|3|||
16422734|NCT02725866|40025613|FG000|Overall Study|Insufficient virological response|1|||
16422735|NCT02725866|40025613|FG000|Overall Study|Other, not specified|4|||
16422736|NCT00615992|40025614|FG000|Overall Study|Protocol Violation|67|||
16422737|NCT00619307|40025615|FG000|Overall Study|Adverse Event|0|||
16422738|NCT00619307|40025616|FG001|Overall Study|Adverse Event|1|||
16422739|NCT00619307|40025615|FG000|Overall Study|Lost to Follow-up|0|||
16422740|NCT00619307|40025616|FG001|Overall Study|Lost to Follow-up|1|||
16422741|NCT00619307|40025615|FG000|Overall Study|Protocol Violation|3|||
16422742|NCT00619307|40025616|FG001|Overall Study|Protocol Violation|0|||
16422743|NCT00619307|40025615|FG000|Overall Study|Withdrew consent|1|||
16422744|NCT00619307|40025616|FG001|Overall Study|Withdrew consent|0|||
16422745|NCT00619307|40025615|FG000|Overall Study|Severe migraine|0|||
16422746|NCT00619307|40025616|FG001|Overall Study|Severe migraine|1|||
16422747|NCT00619307|40025615|FG000|Overall Study|MS attack plus steroids|0|||
16422748|NCT00619307|40025616|FG001|Overall Study|MS attack plus steroids|1|||
16422749|NCT05513053|40025617|FG000|Overall Study|Lost to Follow-up|9|||
16422750|NCT05513053|40025618|FG001|Overall Study|Lost to Follow-up|11|||
16422751|NCT05513053|40025617|FG000|Overall Study|Withdrawal by parent/guardian|2|||
16422752|NCT05513053|40025618|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16422753|NCT05513053|40025617|FG000|Overall Study|Withdrawal by Subject|2|||
16422754|NCT05513053|40025618|FG001|Overall Study|Withdrawal by Subject|9|||
16422755|NCT05513053|40025617|FG000|Overall Study|Protocol Violation|6|||
16422756|NCT05513053|40025618|FG001|Overall Study|Protocol Violation|3|||
16422757|NCT05513053|40025617|FG000|Overall Study|Adverse Event|0|||
16422758|NCT05513053|40025618|FG001|Overall Study|Adverse Event|2|||
16422759|NCT00999518|40025620|FG000|Overall Study|Adverse Event|1|||
16422760|NCT00999518|40025621|FG001|Overall Study|Adverse Event|6|||
16422761|NCT00999518|40025622|FG002|Overall Study|Adverse Event|3|||
16422762|NCT00999518|40025623|FG003|Overall Study|Adverse Event|1|||
16422763|NCT00999518|40025624|FG004|Overall Study|Adverse Event|2|||
16422764|NCT00999518|40025620|FG000|Overall Study|Lack of Efficacy|2|||
16422765|NCT00999518|40025621|FG001|Overall Study|Lack of Efficacy|0|||
16422766|NCT00999518|40025622|FG002|Overall Study|Lack of Efficacy|0|||
16422767|NCT00999518|40025623|FG003|Overall Study|Lack of Efficacy|2|||
16422768|NCT00999518|40025624|FG004|Overall Study|Lack of Efficacy|2|||
16422769|NCT00999518|40025620|FG000|Overall Study|Lost to Follow-up|0|||
16422770|NCT00999518|40025621|FG001|Overall Study|Lost to Follow-up|0|||
16422771|NCT00999518|40025622|FG002|Overall Study|Lost to Follow-up|0|||
16422772|NCT00999518|40025623|FG003|Overall Study|Lost to Follow-up|4|||
16422773|NCT00999518|40025624|FG004|Overall Study|Lost to Follow-up|1|||
16422774|NCT00999518|40025620|FG000|Overall Study|Did not meet entrance criteria|0|||
16422775|NCT00999518|40025621|FG001|Overall Study|Did not meet entrance criteria|0|||
16422776|NCT00999518|40025622|FG002|Overall Study|Did not meet entrance criteria|0|||
16422777|NCT00999518|40025623|FG003|Overall Study|Did not meet entrance criteria|0|||
16422778|NCT00999518|40025624|FG004|Overall Study|Did not meet entrance criteria|1|||
16422779|NCT00999518|40025620|FG000|Overall Study|Study terminated by sponsor|10|||
16422780|NCT00999518|40025621|FG001|Overall Study|Study terminated by sponsor|6|||
16422781|NCT00999518|40025622|FG002|Overall Study|Study terminated by sponsor|5|||
16422782|NCT00999518|40025623|FG003|Overall Study|Study terminated by sponsor|5|||
16422783|NCT00999518|40025624|FG004|Overall Study|Study terminated by sponsor|9|||
16422784|NCT00999518|40025620|FG000|Overall Study|Pregnancy|0|||
16422785|NCT00999518|40025621|FG001|Overall Study|Pregnancy|0|||
16422786|NCT00999518|40025622|FG002|Overall Study|Pregnancy|1|||
16422787|NCT00999518|40025623|FG003|Overall Study|Pregnancy|0|||
16422788|NCT00999518|40025624|FG004|Overall Study|Pregnancy|0|||
16422789|NCT00999518|40025620|FG000|Overall Study|Protocol Violation|0|||
16422790|NCT00999518|40025621|FG001|Overall Study|Protocol Violation|1|||
16422791|NCT00999518|40025622|FG002|Overall Study|Protocol Violation|0|||
16422792|NCT00999518|40025623|FG003|Overall Study|Protocol Violation|0|||
16422793|NCT00999518|40025624|FG004|Overall Study|Protocol Violation|2|||
16422794|NCT00999518|40025620|FG000|Overall Study|Withdrawal by Subject|5|||
16422795|NCT00999518|40025621|FG001|Overall Study|Withdrawal by Subject|4|||
16422796|NCT00999518|40025622|FG002|Overall Study|Withdrawal by Subject|10|||
16422797|NCT00999518|40025623|FG003|Overall Study|Withdrawal by Subject|6|||
16422798|NCT00999518|40025624|FG004|Overall Study|Withdrawal by Subject|1|||
16422799|NCT00999518|40025620|FG000|Overall Study|Other|5|||
16422800|NCT00999518|40025621|FG001|Overall Study|Other|7|||
16422801|NCT00999518|40025622|FG002|Overall Study|Other|1|||
16422802|NCT00999518|40025623|FG003|Overall Study|Other|4|||
16422803|NCT00999518|40025624|FG004|Overall Study|Other|5|||
16422804|NCT00999518|40025620|FG000|Overall Study|Randomized but not Treated|1|||
16422805|NCT00999518|40025621|FG001|Overall Study|Randomized but not Treated|1|||
16422806|NCT00999518|40025622|FG002|Overall Study|Randomized but not Treated|2|||
16422807|NCT00999518|40025623|FG003|Overall Study|Randomized but not Treated|0|||
16422808|NCT00999518|40025624|FG004|Overall Study|Randomized but not Treated|1|||
16422809|NCT03691571|40025625|FG000|Overall Study|Withdrawal by Subject|9|||
16422810|NCT03691571|40025626|FG001|Overall Study|Withdrawal by Subject|2|||
16422811|NCT00527332|40025629|FG000|Overall Study|Protocol Violation|4|||
16422812|NCT00527332|40025630|FG001|Overall Study|Protocol Violation|8|||
16422813|NCT00527332|40025629|FG000|Overall Study|Withdrew consent|5|||
16422814|NCT00527332|40025630|FG001|Overall Study|Withdrew consent|1|||
16422815|NCT04302545|40025631|FG000|Overall Study|Lost to Follow-up|3|||
16422816|NCT04302545|40025632|FG001|Overall Study|Lost to Follow-up|4|||
16422817|NCT03922620|40025641|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
16422818|NCT03922620|40025642|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
16422819|NCT00392990|40025644|FG000|Treatment on Study|Adverse Event|3|||
16422820|NCT00392990|40025645|FG001|Treatment on Study|Adverse Event|1|||
16422821|NCT00392990|40025644|FG000|Follow up for 2 Years|Death|4|||
16422822|NCT00392990|40025645|FG001|Follow up for 2 Years|Death|0|||
16422823|NCT00622388|40025647|FG000|Overall Study|Disease Progression|47|||
16422824|NCT00622388|40025647|FG000|Overall Study|Adverse Event|6|||
16422825|NCT00622388|40025647|FG000|Overall Study|Protocol Violation|3|||
16422826|NCT00622388|40025647|FG000|Overall Study|Participant Refusal|1|||
16422827|NCT00622388|40025647|FG000|Overall Study|Death|3|||
16422828|NCT00622388|40025647|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
16422829|NCT00622388|40025647|FG000|Overall Study|Took Prohibited Medication|2|||
16422830|NCT00622388|40025647|FG000|Overall Study|Withdrew Consent|1|||
16422831|NCT00622388|40025647|FG000|Overall Study|Insurance Expired|1|||
16422832|NCT01730586|40025648|FG000|Overall Study|Progressive Disease|2|||
16422833|NCT01730586|40025648|FG000|Overall Study|Inadequate Trial|8|||
16422834|NCT01730586|40025648|FG000|Overall Study|Adverse Event|2|||
16422835|NCT01730586|40025648|FG000|Overall Study|Hospice|1|||
16422836|NCT01879072|40025649|FG000|Overall Study|Withdrawal by Subject|121|||
16422837|NCT01879072|40025649|FG000|Overall Study|Not Transplanted|30|||
16422838|NCT00447122|40025650|FG000|Overall Study|worsening medical condition -came off|0|||
16422839|NCT00447122|40025651|FG001|Overall Study|worsening medical condition -came off|1|||
16422840|NCT00447122|40025652|FG002|Overall Study|worsening medical condition -came off|0|||
16422841|NCT00447122|40025653|FG003|Overall Study|worsening medical condition -came off|0|||
16422842|NCT04667104|40025654|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
16422843|NCT04667104|40025655|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
16422844|NCT04667104|40025656|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
16422845|NCT03916081|40025658|FG000|Overall Study|Adverse Event|1|||
16422846|NCT03916081|40025659|FG001|Overall Study|Adverse Event|0|||
16422847|NCT03916081|40025660|FG002|Overall Study|Adverse Event|0|||
16422848|NCT03916081|40025658|FG000|Overall Study|Physician Decision|0|||
16422849|NCT03916081|40025659|FG001|Overall Study|Physician Decision|0|||
16422850|NCT03916081|40025660|FG002|Overall Study|Physician Decision|1|||
16422851|NCT03916081|40025658|FG000|Overall Study|Lost to Follow-up|0|||
16422852|NCT03916081|40025659|FG001|Overall Study|Lost to Follow-up|1|||
16422853|NCT03916081|40025660|FG002|Overall Study|Lost to Follow-up|0|||
16422854|NCT03916081|40025658|FG000|Overall Study|Withdrawal by Subject|3|||
16422855|NCT03916081|40025659|FG001|Overall Study|Withdrawal by Subject|0|||
16422856|NCT03916081|40025660|FG002|Overall Study|Withdrawal by Subject|1|||
16422857|NCT03916081|40025658|FG000|Overall Study|Worsening of AD|0|||
16422858|NCT03916081|40025659|FG001|Overall Study|Worsening of AD|0|||
16422859|NCT03916081|40025660|FG002|Overall Study|Worsening of AD|1|||
16422860|NCT00793325|40025663|FG000|Overall Study|Protocol Violation|18|||
16422861|NCT00793325|40025663|FG000|Overall Study|Lost to Follow-up|1|||
16422862|NCT00847197|40025664|FG000|Overall Study|Adverse Event|21|||
16422863|NCT00847197|40025665|FG001|Overall Study|Adverse Event|3|||
16422864|NCT00847197|40025664|FG000|Overall Study|Protocol Violation|0|||
16422865|NCT00847197|40025665|FG001|Overall Study|Protocol Violation|1|||
16422866|NCT00847197|40025664|FG000|Overall Study|Withdrawal by Subject|3|||
16422867|NCT00847197|40025665|FG001|Overall Study|Withdrawal by Subject|1|||
16422868|NCT00118430|40025666|FG000|Overall Study|Withdrawal by Subject|6|||
16422869|NCT00118430|40025667|FG001|Overall Study|Withdrawal by Subject|2|||
16422870|NCT00118430|40025668|FG002|Overall Study|Withdrawal by Subject|0|||
16422871|NCT00118430|40025666|FG000|Overall Study|Lost to Follow-up|15|||
16422872|NCT00118430|40025667|FG001|Overall Study|Lost to Follow-up|22|||
16422873|NCT00118430|40025668|FG002|Overall Study|Lost to Follow-up|28|||
16422874|NCT00605345|40025669|FG000|Overall Study|Withdrawal by Subject|1|||
16422875|NCT00605345|40025670|FG001|Overall Study|Withdrawal by Subject|0|||
16422876|NCT00605345|40025669|FG000|Overall Study|Adverse Event|0|||
16422877|NCT00605345|40025670|FG001|Overall Study|Adverse Event|1|||
16422878|NCT00605345|40025669|FG000|Overall Study|Protocol Violation|0|||
16422879|NCT00605345|40025670|FG001|Overall Study|Protocol Violation|2|||
16422880|NCT02485704|40025671|FG000|Overall Study|Lost to Follow-up|4|||
16422881|NCT02485704|40025672|FG001|Overall Study|Lost to Follow-up|5|||
16422882|NCT02485704|40025671|FG000|Overall Study|Withdrawal by Subject|0|||
16422883|NCT02485704|40025672|FG001|Overall Study|Withdrawal by Subject|3|||
16422884|NCT02485704|40025671|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
16422885|NCT02485704|40025672|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
16422886|NCT02038075|40025673|FG000|Overall Study|Withdrawal by Subject|3|||
16422887|NCT02038075|40025674|FG001|Overall Study|Withdrawal by Subject|0|||
16422888|NCT01853878|40025675|FG000|Overall Study|Recurrence|2|||
16422889|NCT01853878|40025676|FG001|Overall Study|Recurrence|0|||
16422890|NCT01853878|40025675|FG000|Overall Study|Adverse Event|2|||
16422891|NCT01853878|40025676|FG001|Overall Study|Adverse Event|0|||
16422892|NCT01853878|40025675|FG000|Overall Study|Withdrawal by Subject|3|||
16422893|NCT01853878|40025676|FG001|Overall Study|Withdrawal by Subject|1|||
16422894|NCT01853878|40025675|FG000|Overall Study|Migrated/moved from the study area|1|||
16422895|NCT01853878|40025676|FG001|Overall Study|Migrated/moved from the study area|0|||
16422896|NCT01853878|40025675|FG000|Overall Study|Other|55|||
16422897|NCT01853878|40025676|FG001|Overall Study|Other|43|||
16422898|NCT03052049|40025680|FG000|Overall Study|Withdrawal by Subject|2|||
16422899|NCT03188510|40025681|FG000|Overall Study|Inappropriate behavior with site staff|0|||
16422900|NCT03188510|40025682|FG001|Overall Study|Inappropriate behavior with site staff|1|||
16422901|NCT03188510|40025683|FG002|Overall Study|Inappropriate behavior with site staff|0|||
16422902|NCT03208088|40028044|FG000|Period 2|Withdrawal by Subject|0|||
16422903|NCT03208088|40028045|FG001|Period 2|Withdrawal by Subject|0|||
16422904|NCT03208088|40028046|FG002|Period 2|Withdrawal by Subject|0|||
16249072|NCT00265759|39395344|FG000|Overall Study|Discontinued due to intolerability|0|||
16249073|NCT00265759|39395345|FG001|Overall Study|Discontinued due to intolerability|0|||
16249074|NCT00265759|39395346|FG002|Overall Study|Discontinued due to intolerability|0|||
16249075|NCT00265759|39395347|FG003|Overall Study|Discontinued due to intolerability|1|||
16249076|NCT02178709|39395348|FG000|Overall Study|Adverse Event|5|||
16249077|NCT02178709|39395348|FG000|Overall Study|Death|2|||
16249078|NCT02178709|39395348|FG000|Overall Study|Withdrawal by Subject|2|||
16249079|NCT02178709|39395348|FG000|Overall Study|Physician Decision|2|||
16422905|NCT03208088|40028047|FG003|Period 2|Withdrawal by Subject|0|||
16422906|NCT03208088|40028048|FG004|Period 2|Withdrawal by Subject|0|||
16422907|NCT03208088|40028049|FG005|Period 2|Withdrawal by Subject|0|||
16422908|NCT03208088|40028050|FG006|Period 2|Withdrawal by Subject|0|||
16422909|NCT03208088|40028051|FG007|Period 2|Withdrawal by Subject|0|||
16422910|NCT03208088|40028052|FG008|Period 2|Withdrawal by Subject|1|||
16422911|NCT03208088|40028053|FG009|Period 2|Withdrawal by Subject|0|||
16422912|NCT03208088|40028044|FG000|Period 3|Unsatisfactory Test Article|0|||
16422913|NCT03208088|40028045|FG001|Period 3|Unsatisfactory Test Article|0|||
16422914|NCT03208088|40028046|FG002|Period 3|Unsatisfactory Test Article|0|||
16422915|NCT03208088|40028047|FG003|Period 3|Unsatisfactory Test Article|1|||
16422916|NCT03208088|40028048|FG004|Period 3|Unsatisfactory Test Article|0|||
16422917|NCT03208088|40028049|FG005|Period 3|Unsatisfactory Test Article|0|||
16422918|NCT03208088|40028050|FG006|Period 3|Unsatisfactory Test Article|0|||
16422919|NCT03208088|40028051|FG007|Period 3|Unsatisfactory Test Article|0|||
16422920|NCT03208088|40028052|FG008|Period 3|Unsatisfactory Test Article|0|||
16422921|NCT03208088|40028053|FG009|Period 3|Unsatisfactory Test Article|0|||
16422922|NCT03208088|40028044|FG000|Period 4|Unsatisfactory Test Article|0|||
16422923|NCT03208088|40028045|FG001|Period 4|Unsatisfactory Test Article|0|||
16422924|NCT03208088|40028046|FG002|Period 4|Unsatisfactory Test Article|0|||
16422925|NCT03208088|40028047|FG003|Period 4|Unsatisfactory Test Article|1|||
16422926|NCT03208088|40028048|FG004|Period 4|Unsatisfactory Test Article|0|||
16422927|NCT03208088|40028049|FG005|Period 4|Unsatisfactory Test Article|0|||
16422928|NCT03208088|40028050|FG006|Period 4|Unsatisfactory Test Article|0|||
16422929|NCT03208088|40028051|FG007|Period 4|Unsatisfactory Test Article|0|||
16422930|NCT03208088|40028052|FG008|Period 4|Unsatisfactory Test Article|0|||
16422931|NCT03208088|40028053|FG009|Period 4|Unsatisfactory Test Article|0|||
16422932|NCT03364738|40028054|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
16422933|NCT03364738|40028054|FG000|Overall Study|Withdrawal by Subject|1|||
16422934|NCT03364738|40028054|FG000|Overall Study|Adverse Event|1|||
16422935|NCT04677504|40028055|FG000|Overall Study|Death|51|||
16422936|NCT04677504|40028056|FG001|Overall Study|Death|49|||
16422937|NCT04677504|40028055|FG000|Overall Study|Progressive Disease|1|||
16422938|NCT04677504|40028056|FG001|Overall Study|Progressive Disease|0|||
16422939|NCT04677504|40028055|FG000|Overall Study|Symptomatic Deterioration|1|||
16422940|NCT04677504|40028056|FG001|Overall Study|Symptomatic Deterioration|0|||
16422941|NCT04677504|40028055|FG000|Overall Study|Withdrawal by Subject|2|||
16422942|NCT04677504|40028056|FG001|Overall Study|Withdrawal by Subject|5|||
16422943|NCT04677504|40028055|FG000|Overall Study|Study Terminated By Sponsor|28|||
16422944|NCT04677504|40028056|FG001|Overall Study|Study Terminated By Sponsor|24|||
16422945|NCT04677504|40028055|FG000|Overall Study|Adverse Event|0|||
16422946|NCT04677504|40028056|FG001|Overall Study|Adverse Event|1|||
16422947|NCT02161380|40028059|FG000|Overall Study|Lost to Follow-up|0|||
16422948|NCT02161380|40028060|FG001|Overall Study|Lost to Follow-up|1|||
16422949|NCT02161380|40028061|FG002|Overall Study|Lost to Follow-up|0|||
16422950|NCT02161380|40028062|FG003|Overall Study|Lost to Follow-up|0|||
16422951|NCT02465203|40028063|FG000|Overall Study|Protocol Violation|1|||
16422952|NCT02465203|40028064|FG001|Overall Study|Protocol Violation|1|||
16422953|NCT02465203|40028065|FG002|Overall Study|Protocol Violation|1|||
16422954|NCT02465203|40028063|FG000|Overall Study|Study terminated by sponsor|50|||
16422955|NCT02465203|40028064|FG001|Overall Study|Study terminated by sponsor|34|||
16422956|NCT02465203|40028065|FG002|Overall Study|Study terminated by sponsor|11|||
16422957|NCT02465203|40028063|FG000|Overall Study|New therapy for study indication|4|||
16422958|NCT02465203|40028064|FG001|Overall Study|New therapy for study indication|0|||
16422959|NCT02465203|40028065|FG002|Overall Study|New therapy for study indication|0|||
16422960|NCT02465203|40028063|FG000|Overall Study|Patient/guardian decision|1|||
16422961|NCT02465203|40028064|FG001|Overall Study|Patient/guardian decision|1|||
16422962|NCT02465203|40028065|FG002|Overall Study|Patient/guardian decision|1|||
16249080|NCT02178709|39395348|FG000|Overall Study|Disease Progression|5|||
16422963|NCT00302211|40028066|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
16422964|NCT00302211|40028067|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
16422965|NCT00302211|40028068|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
16422966|NCT00302211|40028069|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
16422967|NCT00302211|40028070|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
16422968|NCT00302211|40028066|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
16422969|NCT00302211|40028067|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
16422970|NCT00302211|40028068|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
16422971|NCT00302211|40028069|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
16422972|NCT00302211|40028070|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
16422973|NCT00302211|40028066|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
16422974|NCT00302211|40028067|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
16422975|NCT00302211|40028068|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
16422976|NCT00302211|40028069|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
16422977|NCT00302211|40028070|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
16422978|NCT00302211|40028066|FG000|Double Blind Period (New Patients)|Disease progression|0|||
16422979|NCT00302211|40028067|FG001|Double Blind Period (New Patients)|Disease progression|1|||
16422980|NCT00302211|40028068|FG002|Double Blind Period (New Patients)|Disease progression|1|||
16422981|NCT00302211|40028069|FG003|Double Blind Period (New Patients)|Disease progression|0|||
16422982|NCT00302211|40028070|FG004|Double Blind Period (New Patients)|Disease progression|0|||
16422983|NCT00302211|40028066|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
16249081|NCT01118728|39395349|FG000|Overall Study|Adverse Event|17|||
16249082|NCT01118728|39395349|FG000|Overall Study|Lack of Efficacy|27|||
16249083|NCT01118728|39395349|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
16249084|NCT01118728|39395349|FG000|Overall Study|Withdrawal by Subject|3|||
16249085|NCT01118728|39395349|FG000|Overall Study|Lost to Follow-up|4|||
16249086|NCT00447603|39395350|FG000|Screening|Withdrawal by Subject|1|||
16249087|NCT00447603|39395351|FG001|Screening|Withdrawal by Subject|0|||
16249088|NCT00447603|39395352|FG002|Screening|Withdrawal by Subject|0|||
16249089|NCT00447603|39395350|FG000|Screening|Protocol Violation|1|||
16249090|NCT00447603|39395351|FG001|Screening|Protocol Violation|0|||
16249091|NCT00447603|39395352|FG002|Screening|Protocol Violation|0|||
16249092|NCT00447603|39395350|FG000|Screening|Screen Failure|4|||
16249093|NCT00447603|39395351|FG001|Screening|Screen Failure|0|||
16249094|NCT00447603|39395352|FG002|Screening|Screen Failure|0|||
16249095|NCT00447603|39395350|FG000|Screening|Study Terminated by Sponsor|15|||
16249096|NCT00447603|39395351|FG001|Screening|Study Terminated by Sponsor|0|||
16249097|NCT00447603|39395352|FG002|Screening|Study Terminated by Sponsor|0|||
16249098|NCT00447603|39395350|FG000|Filter Period|Adverse Event|0|||
16249099|NCT00447603|39395351|FG001|Filter Period|Adverse Event|0|||
16249100|NCT00447603|39395352|FG002|Filter Period|Adverse Event|1|||
16249101|NCT00447603|39395350|FG000|Filter Period|Screen Failure|0|||
16249102|NCT00447603|39395351|FG001|Filter Period|Screen Failure|3|||
16249103|NCT00447603|39395352|FG002|Filter Period|Screen Failure|4|||
16249104|NCT00447603|39395350|FG000|Filter Period|Study terminated by Sponsor|0|||
16249105|NCT00447603|39395351|FG001|Filter Period|Study terminated by Sponsor|1|||
16249106|NCT00447603|39395352|FG002|Filter Period|Study terminated by Sponsor|10|||
16249107|NCT02315898|39395353|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
16249108|NCT02315898|39395354|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
16249109|NCT02315898|39395355|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
16249110|NCT02315898|39395356|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
16249111|NCT00922779|39395357|FG000|Overall Study|Adverse Event|67|||
16249112|NCT00922779|39395357|FG000|Overall Study|Pregnancy|7|||
16249113|NCT00922779|39395357|FG000|Overall Study|Withdrawal by Subject|308|||
16359819|NCT03620162|39804219|FG001|Overall Study|Physician Decision|0|||
16359820|NCT03620162|39804220|FG002|Overall Study|Physician Decision|1|||
16359821|NCT03620162|39804221|FG003|Overall Study|Physician Decision|0|||
16359822|NCT03620162|39804222|FG004|Overall Study|Physician Decision|2|||
16359823|NCT03620162|39804218|FG000|Overall Study|Lost to Follow-up|2|||
16359824|NCT03620162|39804219|FG001|Overall Study|Lost to Follow-up|6|||
16359825|NCT03620162|39804220|FG002|Overall Study|Lost to Follow-up|7|||
16359826|NCT03620162|39804221|FG003|Overall Study|Lost to Follow-up|3|||
16359827|NCT03620162|39804222|FG004|Overall Study|Lost to Follow-up|2|||
16359828|NCT03620162|39804218|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
16359829|NCT03620162|39804219|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
16359830|NCT03620162|39804220|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
16359831|NCT03620162|39804221|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
16422984|NCT00302211|40028067|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
16422985|NCT00302211|40028068|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
16422986|NCT00302211|40028069|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
16422987|NCT00302211|40028070|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
16422988|NCT00302211|40028066|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
16422989|NCT00302211|40028067|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
16422990|NCT00302211|40028068|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
16422991|NCT00302211|40028069|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
16422992|NCT00302211|40028070|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
16422993|NCT00302211|40028066|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
16422994|NCT00302211|40028067|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
16422995|NCT00302211|40028068|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
16422996|NCT00302211|40028069|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
16422997|NCT00302211|40028070|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
16422998|NCT00302211|40028066|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
16249114|NCT00922779|39395357|FG000|Overall Study|Lost to Follow-up|44|||
16249115|NCT00922779|39395357|FG000|Overall Study|Other|27|||
16249116|NCT00922779|39395357|FG000|Overall Study|Missing|1874|||
16249117|NCT01042977|39395361|FG000|Overall Study|Adverse Event|4|||
16249118|NCT01042977|39395362|FG001|Overall Study|Adverse Event|12|||
16249119|NCT01042977|39395361|FG000|Overall Study|Death|2|||
16249120|NCT01042977|39395362|FG001|Overall Study|Death|1|||
16422999|NCT00302211|40028067|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
16423000|NCT00302211|40028068|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
16423001|NCT00302211|40028069|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
16423002|NCT00302211|40028070|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
16423003|NCT00302211|40028066|FG000|Open Label-Patients From Double-Blind|Death|0|||
16423004|NCT00302211|40028067|FG001|Open Label-Patients From Double-Blind|Death|0|||
16423005|NCT00302211|40028068|FG002|Open Label-Patients From Double-Blind|Death|0|||
16423006|NCT00302211|40028069|FG003|Open Label-Patients From Double-Blind|Death|1|||
16423007|NCT00302211|40028070|FG004|Open Label-Patients From Double-Blind|Death|1|||
16423008|NCT00302211|40028066|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
16423009|NCT00302211|40028067|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
16423010|NCT00302211|40028068|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
16249121|NCT01042977|39395361|FG000|Overall Study|Withdrawal by Subject|8|||
16249122|NCT01042977|39395362|FG001|Overall Study|Withdrawal by Subject|16|||
16423011|NCT00302211|40028069|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
16423012|NCT00302211|40028070|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
16423013|NCT00302211|40028066|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
16249123|NCT01042977|39395361|FG000|Overall Study|Lost to Follow-up|0|||
16249124|NCT01042977|39395362|FG001|Overall Study|Lost to Follow-up|2|||
16423014|NCT00302211|40028067|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
16423015|NCT00302211|40028068|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
16423016|NCT00302211|40028069|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
16423017|NCT00302211|40028070|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
16423018|NCT00302211|40028066|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
16423019|NCT00302211|40028067|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
16423020|NCT00302211|40028068|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
16423021|NCT00302211|40028069|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
16423022|NCT00302211|40028070|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
16423023|NCT01140061|40028071|FG000|Part I|Adverse Event|1|||
16423024|NCT01140061|40028072|FG001|Part I|Adverse Event|0|||
16423025|NCT01140061|40028073|FG002|Part I|Adverse Event|0|||
16423026|NCT01140061|40028074|FG003|Part I|Adverse Event|0|||
16423027|NCT01140061|40028075|FG004|Part I|Adverse Event|0|||
16423028|NCT01140061|40028076|FG005|Part I|Adverse Event|0|||
16423029|NCT01140061|40028077|FG006|Part I|Adverse Event|0|||
16423030|NCT01140061|40028078|FG007|Part I|Adverse Event|0|||
16423031|NCT01140061|40028079|FG008|Part I|Adverse Event|0|||
16423032|NCT01140061|40028080|FG009|Part I|Adverse Event|0|||
16423033|NCT01140061|40028071|FG000|Extension|Laboratory Adverse Event|0|||
16423034|NCT01140061|40028072|FG001|Extension|Laboratory Adverse Event|0|||
16423035|NCT01140061|40028073|FG002|Extension|Laboratory Adverse Event|0|||
16423036|NCT01140061|40028074|FG003|Extension|Laboratory Adverse Event|0|||
16423037|NCT01140061|40028075|FG004|Extension|Laboratory Adverse Event|0|||
16423038|NCT01140061|40028076|FG005|Extension|Laboratory Adverse Event|0|||
16423039|NCT01140061|40028077|FG006|Extension|Laboratory Adverse Event|0|||
16423040|NCT01140061|40028078|FG007|Extension|Laboratory Adverse Event|0|||
16423041|NCT01140061|40028079|FG008|Extension|Laboratory Adverse Event|0|||
16423042|NCT01140061|40028080|FG009|Extension|Laboratory Adverse Event|1|||
16423043|NCT00965419|40028081|FG000|Open Label Treatment for Responders|Adverse Event|33|||
16423044|NCT00965419|40028081|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
16423045|NCT00965419|40028081|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
16423046|NCT00965419|40028081|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
16423047|NCT00965419|40028081|FG000|Open Label Treatment for Responders|Physician Decision|6|||
16423048|NCT00965419|40028081|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
16423049|NCT00965419|40028081|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
16423050|NCT00965419|40028081|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
16423051|NCT00965419|40028081|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
16423052|NCT00965419|40028081|FG000|Follow-up Phase|Adverse Event|9|||
16423053|NCT00965419|40028081|FG000|Follow-up Phase|Protocol Violation|4|||
16423054|NCT00965419|40028081|FG000|Follow-up Phase|Withdrawal by Subject|8|||
16423055|NCT00965419|40028081|FG000|Follow-up Phase|Physician Decision|4|||
16423056|NCT00965419|40028081|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
16423057|NCT00965419|40028081|FG000|Follow-up Phase|Lack of Efficacy|28|||
16423058|NCT02978833|40028083|FG000|Overall Study|Study terminated|1|||
16423059|NCT02978833|40028084|FG001|Overall Study|Study terminated|1|||
16423060|NCT00492050|40028093|FG000|Overall Study|Adverse Event|1|||
16423061|NCT00492050|40028093|FG000|Overall Study|Lack of Efficacy|1|||
16249125|NCT01042977|39395361|FG000|Overall Study|Poor/non-compliance|3|||
16249126|NCT01042977|39395362|FG001|Overall Study|Poor/non-compliance|4|||
16249127|NCT01042977|39395361|FG000|Overall Study|Subject no longer meets study criteria|15|||
16249128|NCT01042977|39395362|FG001|Overall Study|Subject no longer meets study criteria|13|||
16249129|NCT01042977|39395361|FG000|Overall Study|Incorrect enrollment|6|||
16249130|NCT01042977|39395362|FG001|Overall Study|Incorrect enrollment|4|||
16249131|NCT01042977|39395361|FG000|Overall Study|Safety|0|||
16249132|NCT01042977|39395362|FG001|Overall Study|Safety|2|||
16249133|NCT01042977|39395361|FG000|Overall Study|Administrative reason by sponsor|0|||
16423062|NCT00492050|40028093|FG000|Overall Study|Withdrawal by Subject|3|||
16423063|NCT00492050|40028093|FG000|Overall Study|Unable to collect SCT|2|||
16423064|NCT00492050|40028093|FG000|Overall Study|Progressive Disease|2|||
16423065|NCT01099397|40028107|FG000|Overall Study|Lost to Follow-up|4|||
16423066|NCT01099397|40028107|FG000|Overall Study|Protocol Violation|4|||
16423067|NCT01099397|40028107|FG000|Overall Study|Withdrawal by Subject|5|||
16423068|NCT00986362|40028110|FG000|Overall Study|Death|2|||
16423069|NCT00986362|40028111|FG001|Overall Study|Death|0|||
16423070|NCT00986362|40028110|FG000|Overall Study|Lost to Follow-up|0|||
16423071|NCT00986362|40028111|FG001|Overall Study|Lost to Follow-up|1|||
16249134|NCT01042977|39395362|FG001|Overall Study|Administrative reason by sponsor|1|||
16249135|NCT01042977|39395361|FG000|Overall Study|Various|3|||
16423072|NCT00659230|40028117|FG000|Overall Study|Lost to Follow-up|2|||
16423073|NCT00659230|40028118|FG001|Overall Study|Lost to Follow-up|5|||
16423074|NCT00659230|40028117|FG000|Overall Study|Lost source documentation|5|||
16249136|NCT01042977|39395362|FG001|Overall Study|Various|0|||
16423075|NCT00659230|40028118|FG001|Overall Study|Lost source documentation|4|||
16423076|NCT00659230|40028117|FG000|Overall Study|Did not return post-randomization|2|||
16423077|NCT00659230|40028118|FG001|Overall Study|Did not return post-randomization|3|||
16423078|NCT02564978|40028119|FG000|Overall Study|Adverse Event|8|||
16423079|NCT02564978|40028119|FG000|Overall Study|Death|1|||
16423080|NCT02564978|40028119|FG000|Overall Study|Lost to Follow-up|1|||
16423081|NCT02564978|40028119|FG000|Overall Study|Withdrawal by Subject|15|||
16423082|NCT02564978|40028119|FG000|Overall Study|Early Study Closure|2|||
16423083|NCT02564978|40028119|FG000|Overall Study|Other Reason|5|||
16423084|NCT03182907|40028126|FG000|Overall Study|Death|3|||
16423085|NCT03182907|40028127|FG001|Overall Study|Death|0|||
16423086|NCT03182907|40028126|FG000|Overall Study|Protocol Violation|4|||
16423087|NCT03182907|40028127|FG001|Overall Study|Protocol Violation|0|||
16423088|NCT03182907|40028126|FG000|Overall Study|Lost to Follow-up|1|||
16423089|NCT03182907|40028127|FG001|Overall Study|Lost to Follow-up|0|||
16423090|NCT03182907|40028126|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16423091|NCT03182907|40028127|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
16423092|NCT00238238|40028130|FG000|Overall Study|Withdrawal by Subject|0|||
16423093|NCT00238238|40028131|FG001|Overall Study|Withdrawal by Subject|3|||
16423094|NCT00238238|40028132|FG002|Overall Study|Withdrawal by Subject|0|||
16423095|NCT04310566|40028133|FG000|Period 1|Study Termination due to COVID-19|15|||
16423096|NCT04310566|40028134|FG001|Period 1|Study Termination due to COVID-19|17|||
16423097|NCT04310566|40028133|FG000|Period 1|Protocol Violation|0|||
16423098|NCT04310566|40028134|FG001|Period 1|Protocol Violation|1|||
16423099|NCT04310566|40028133|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
16423100|NCT04310566|40028134|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
16423101|NCT04310566|40028133|FG000|Period 1|Lost to Follow-up|1|||
16423102|NCT04310566|40028134|FG001|Period 1|Lost to Follow-up|0|||
16423103|NCT04310566|40028133|FG000|Period 1|Withdrawal by Subject|0|||
16423104|NCT04310566|40028134|FG001|Period 1|Withdrawal by Subject|1|||
16423105|NCT04310566|40028133|FG000|Period 2|Study Termination|7|||
16423106|NCT04310566|40028134|FG001|Period 2|Study Termination|5|||
16423107|NCT00850538|40028139|FG000|Overall Study|unable/unwilling to complete MRI|13|||
16423108|NCT00850538|40028139|FG000|Overall Study|specimen missed due to scheduling error|14|||
16423109|NCT00850538|40028139|FG000|Overall Study|specimen unusable|7|||
16423110|NCT00850538|40028139|FG000|Overall Study|Withdrawal by Subject|3|||
16423111|NCT00850538|40028139|FG000|Overall Study|radiology error|2|||
16423112|NCT00850538|40028139|FG000|Overall Study|Protocol Violation|2|||
16423113|NCT05198843|40028142|FG000|Overall Study|Lack of Efficacy|1|||
16423114|NCT03556891|40028146|FG000|Overall Study|Adverse Event|4|||
16423115|NCT03556891|40028146|FG000|Overall Study|MRI Need|3|||
16423116|NCT03556891|40028146|FG000|Overall Study|Device Failure|1|||
16423117|NCT03556891|40028146|FG000|Overall Study|Death|1|||
16423118|NCT03556891|40028146|FG000|Overall Study|Lost to Follow-up|1|||
16423119|NCT03556891|40028146|FG000|Overall Study|Missing at random|1|||
16423120|NCT03556891|40028146|FG000|Overall Study|Missing due to COVID|1|||
16423121|NCT03556891|40028146|FG000|Overall Study|Protocol Violation|1|||
16423122|NCT01068158|40028147|FG000|Overall Study|Withdrawal by Subject|1|||
16423123|NCT01068158|40028148|FG001|Overall Study|Withdrawal by Subject|2|||
16423124|NCT01068158|40028147|FG000|Overall Study|Lost to Follow-up|7|||
16423125|NCT01068158|40028148|FG001|Overall Study|Lost to Follow-up|0|||
16423126|NCT01068158|40028147|FG000|Overall Study|Protocol Violation|0|||
16423127|NCT01068158|40028148|FG001|Overall Study|Protocol Violation|2|||
16423128|NCT00934128|40028149|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
16423129|NCT00934128|40028150|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
16423130|NCT00934128|40028149|FG000|First Intervention (2 Hours)|Adverse Event|4|||
16423131|NCT00934128|40028150|FG001|First Intervention (2 Hours)|Adverse Event|1|||
16423132|NCT00934128|40028149|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
16423133|NCT00934128|40028150|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
16423134|NCT00934128|40028149|FG000|Washout Period (1 Hour)|Patient preference|1|||
16423135|NCT00934128|40028150|FG001|Washout Period (1 Hour)|Patient preference|3|||
16423136|NCT00934128|40028149|FG000|Washout Period (1 Hour)|Pain|1|||
16423137|NCT00934128|40028150|FG001|Washout Period (1 Hour)|Pain|0|||
16423138|NCT00934128|40028149|FG000|Washout Period (1 Hour)|Too tired|1|||
16423139|NCT00934128|40028150|FG001|Washout Period (1 Hour)|Too tired|0|||
16423140|NCT00934128|40028149|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
16423141|NCT00934128|40028150|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
16423142|NCT00934128|40028149|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
16423143|NCT00934128|40028150|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
16423144|NCT03088813|40028153|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
16423145|NCT03088813|40028154|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
16562337|NCT02018861|40525380|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
16562338|NCT02018861|40525381|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16562339|NCT02018861|40525382|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16423146|NCT03088813|40028155|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
16562340|NCT02018861|40525383|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16249137|NCT00712010|39395363|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
16249138|NCT01078090|39395372|FG000|Overall Study|Lost to Follow-up|2363|||
16249139|NCT01078090|39395372|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
16249140|NCT01078090|39395372|FG000|Overall Study|Lack of Efficacy|1193|||
16249141|NCT01078090|39395372|FG000|Overall Study|ADR and lack of efficacy|61|||
16249142|NCT01078090|39395372|FG000|Overall Study|Other|523|||
16249143|NCT05188521|39395375|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
16249144|NCT05188521|39395376|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
16249145|NCT01873859|39395377|FG000|Overall Study|Withdrawal by Subject|0|||
16249146|NCT01873859|39395378|FG001|Overall Study|Withdrawal by Subject|4|||
16249147|NCT02008721|39395379|FG000|Overall Study|Withdrawal by Subject|5|||
16249148|NCT02008721|39395380|FG001|Overall Study|Withdrawal by Subject|1|||
16249149|NCT02008721|39395379|FG000|Overall Study|Death|4|||
16249150|NCT02008721|39395380|FG001|Overall Study|Death|2|||
16249151|NCT02008721|39395379|FG000|Overall Study|Adverse Event|3|||
16249152|NCT02008721|39395380|FG001|Overall Study|Adverse Event|5|||
16249153|NCT02008721|39395379|FG000|Overall Study|Protocol Violation|3|||
16249154|NCT02008721|39395380|FG001|Overall Study|Protocol Violation|2|||
16249155|NCT02497781|39395381|FG000|Overall Study|Withdrawal by Subject|2|||
16249156|NCT02497781|39395382|FG001|Overall Study|Withdrawal by Subject|0|||
16249157|NCT02497781|39395381|FG000|Overall Study|Lack of Efficacy|0|||
16249158|NCT02497781|39395382|FG001|Overall Study|Lack of Efficacy|1|||
16249159|NCT02497781|39395381|FG000|Overall Study|Randomised but not treated|1|||
16249160|NCT02497781|39395382|FG001|Overall Study|Randomised but not treated|1|||
16249161|NCT02497781|39395381|FG000|Overall Study|Lost to Follow-up|1|||
16249162|NCT02497781|39395382|FG001|Overall Study|Lost to Follow-up|1|||
16249163|NCT01326026|39395383|FG000|Overall Study|Adverse Event|4|||
16249164|NCT01326026|39395384|FG001|Overall Study|Adverse Event|3|||
16249165|NCT01326026|39395383|FG000|Overall Study|Withdrawal Criteria|5|||
16249166|NCT01326026|39395384|FG001|Overall Study|Withdrawal Criteria|7|||
16249167|NCT01326026|39395383|FG000|Overall Study|Other|3|||
16249168|NCT01326026|39395384|FG001|Overall Study|Other|3|||
16249169|NCT00124020|39395386|FG000|Overall Study|Death|67|||
16249170|NCT00124020|39395387|FG001|Overall Study|Death|71|||
16249171|NCT00124020|39395386|FG000|Overall Study|Withdrawal by Subject|13|||
16249172|NCT00124020|39395387|FG001|Overall Study|Withdrawal by Subject|11|||
16249173|NCT00124020|39395386|FG000|Overall Study|Lost to Follow-up|5|||
16249174|NCT00124020|39395387|FG001|Overall Study|Lost to Follow-up|8|||
16249175|NCT00124020|39395386|FG000|Overall Study|Other|1|||
16249176|NCT00124020|39395387|FG001|Overall Study|Other|1|||
16249177|NCT00124020|39395386|FG000|Overall Study|Transfer to another hospital|2|||
16249178|NCT00124020|39395387|FG001|Overall Study|Transfer to another hospital|0|||
16249179|NCT00891774|39395388|FG000|Overall Study|Lost to Follow-up|5|||
16249180|NCT00891774|39395388|FG000|Overall Study|Illness (Self/Mother)|3|||
16249181|NCT00891774|39395388|FG000|Overall Study|Withdrawal by Subject|2|||
16249182|NCT00891774|39395388|FG000|Overall Study|Protocol Violation|4|||
16249183|NCT00549198|39395395|FG000|Overall Study|Adverse Event|28|||
16249184|NCT00549198|39395396|FG001|Overall Study|Adverse Event|26|||
16249185|NCT00549198|39395395|FG000|Overall Study|Insufficient Viral Load Response|4|||
16249186|NCT00549198|39395396|FG001|Overall Study|Insufficient Viral Load Response|2|||
16249187|NCT00549198|39395395|FG000|Overall Study|Protocol-defined Virological Failure|7|||
16249188|NCT00549198|39395396|FG001|Overall Study|Protocol-defined Virological Failure|0|||
16249189|NCT00549198|39395395|FG000|Overall Study|Non-compliance|2|||
16249190|NCT00549198|39395396|FG001|Overall Study|Non-compliance|4|||
16249191|NCT00549198|39395395|FG000|Overall Study|Lost to Follow-up|7|||
16249192|NCT00549198|39395396|FG001|Overall Study|Lost to Follow-up|8|||
16249193|NCT00549198|39395395|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
16249194|NCT00549198|39395396|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
16249195|NCT00549198|39395395|FG000|Overall Study|Protocol Violation|7|||
16249196|NCT00549198|39395396|FG001|Overall Study|Protocol Violation|2|||
16249197|NCT00549198|39395395|FG000|Overall Study|Investigator Decision|4|||
16249198|NCT00549198|39395396|FG001|Overall Study|Investigator Decision|3|||
16249199|NCT00549198|39395395|FG000|Overall Study|Withdrawal by Subject|7|||
16249200|NCT00549198|39395396|FG001|Overall Study|Withdrawal by Subject|7|||
16249201|NCT00549198|39395395|FG000|Overall Study|Disease Progression|1|||
16249202|NCT00549198|39395396|FG001|Overall Study|Disease Progression|0|||
16249203|NCT00549198|39395395|FG000|Overall Study|Participant Moved|2|||
16359832|NCT03620162|39804222|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
16249204|NCT00549198|39395396|FG001|Overall Study|Participant Moved|0|||
16249205|NCT00549198|39395395|FG000|Overall Study|Participant not able to perform Week 96|1|||
16249206|NCT00549198|39395396|FG001|Overall Study|Participant not able to perform Week 96|0|||
16249207|NCT00549198|39395395|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
16249208|NCT00549198|39395396|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
16249209|NCT00549198|39395395|FG000|Overall Study|Prohibited Medication|1|||
16423147|NCT03088813|40028156|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
16423148|NCT03088813|40028153|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
16423149|NCT03088813|40028154|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
16423150|NCT03088813|40028155|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
16423151|NCT03088813|40028156|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
16423152|NCT03088813|40028153|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
16423153|NCT03088813|40028154|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
16423154|NCT03088813|40028155|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
16423155|NCT03088813|40028156|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
16423156|NCT03088813|40028153|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
16423157|NCT03088813|40028154|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
16423158|NCT03088813|40028155|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
16423159|NCT03088813|40028156|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
16423160|NCT03088813|40028153|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
16423161|NCT03088813|40028154|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
16423162|NCT03088813|40028155|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
16423163|NCT03088813|40028156|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
16423164|NCT03088813|40028153|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
16423165|NCT03088813|40028154|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
16423166|NCT03088813|40028155|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
16423167|NCT03088813|40028156|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
16423168|NCT03088813|40028153|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
16423169|NCT03088813|40028154|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
16423170|NCT03088813|40028155|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
16423171|NCT03088813|40028156|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
16423172|NCT03170193|40028159|FG000|Overall Study|Withdrawal by Subject|0|||
16423173|NCT03170193|40028160|FG001|Overall Study|Withdrawal by Subject|0|||
16423174|NCT03170193|40028161|FG002|Overall Study|Withdrawal by Subject|0|||
16423175|NCT03170193|40028162|FG003|Overall Study|Withdrawal by Subject|1|||
16423176|NCT03170193|40028163|FG004|Overall Study|Withdrawal by Subject|0|||
16423177|NCT03170193|40028164|FG005|Overall Study|Withdrawal by Subject|0|||
16423178|NCT03170193|40028165|FG006|Overall Study|Withdrawal by Subject|0|||
16423179|NCT03170193|40028159|FG000|Overall Study|Lost to Follow-up|1|||
16423180|NCT03170193|40028160|FG001|Overall Study|Lost to Follow-up|1|||
16423181|NCT03170193|40028161|FG002|Overall Study|Lost to Follow-up|0|||
16423182|NCT03170193|40028162|FG003|Overall Study|Lost to Follow-up|0|||
16423183|NCT03170193|40028163|FG004|Overall Study|Lost to Follow-up|0|||
16423184|NCT03170193|40028164|FG005|Overall Study|Lost to Follow-up|0|||
16423185|NCT03170193|40028165|FG006|Overall Study|Lost to Follow-up|0|||
16423186|NCT00828750|40028166|FG000|Overall Study|Lack of Efficacy|3|||
16423187|NCT00828750|40028166|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
16423188|NCT02451124|40028169|FG000|Overall Study|Withdrawal by Subject|1|||
16423189|NCT00699335|40028177|FG000|Overall Study|Combination of multiple reasons|176|||
16423190|NCT00699335|40028177|FG000|Overall Study|Missing data|52|||
16423191|NCT02709330|40028180|FG000|Overall Study|Death|5|||
16423192|NCT02709330|40028181|FG001|Overall Study|Death|0|||
16423193|NCT02709330|40028180|FG000|Overall Study|Lost to Follow-up|2|||
16423194|NCT02709330|40028181|FG001|Overall Study|Lost to Follow-up|0|||
16423195|NCT02709330|40028180|FG000|Overall Study|Physician Decision|2|||
16423196|NCT02709330|40028181|FG001|Overall Study|Physician Decision|0|||
16423197|NCT02709330|40028180|FG000|Overall Study|Withdrawal by Subject|4|||
16423198|NCT02709330|40028181|FG001|Overall Study|Withdrawal by Subject|0|||
16423199|NCT01345669|40028182|FG000|Overall Study|Primary tumour recurrence|53|||
16423200|NCT01345669|40028183|FG001|Overall Study|Primary tumour recurrence|32|||
16423201|NCT01345669|40028182|FG000|Overall Study|Second primary tumour|4|||
16423202|NCT01345669|40028183|FG001|Overall Study|Second primary tumour|3|||
16423203|NCT01345669|40028182|FG000|Overall Study|Adverse Event|63|||
16423204|NCT01345669|40028183|FG001|Overall Study|Adverse Event|9|||
16423205|NCT01345669|40028182|FG000|Overall Study|Protocol Violation|3|||
16423206|NCT01345669|40028183|FG001|Overall Study|Protocol Violation|1|||
16423207|NCT01345669|40028182|FG000|Overall Study|Lost to Follow-up|1|||
16423208|NCT01345669|40028183|FG001|Overall Study|Lost to Follow-up|1|||
16423209|NCT01345669|40028182|FG000|Overall Study|Withdrawal by Subject|52|||
16423210|NCT01345669|40028183|FG001|Overall Study|Withdrawal by Subject|13|||
16423211|NCT01345669|40028182|FG000|Overall Study|Other Reasons|111|||
16423212|NCT01345669|40028183|FG001|Overall Study|Other Reasons|60|||
16423213|NCT02283788|40028184|FG000|Overall Study|Adverse Event|1|||
16423214|NCT02283788|40028185|FG001|Overall Study|Adverse Event|3|||
16423215|NCT02283788|40028186|FG002|Overall Study|Adverse Event|5|||
16423216|NCT02283788|40028187|FG003|Overall Study|Adverse Event|1|||
16423217|NCT02283788|40028184|FG000|Overall Study|Withdrawal by Subject|0|||
16423218|NCT02283788|40028185|FG001|Overall Study|Withdrawal by Subject|1|||
16423219|NCT02283788|40028186|FG002|Overall Study|Withdrawal by Subject|0|||
16423220|NCT02283788|40028187|FG003|Overall Study|Withdrawal by Subject|1|||
16423221|NCT00947115|40028188|FG000|Overall Study|Missed reporting interval|3|||
16423222|NCT00947115|40028189|FG001|Overall Study|Missed reporting interval|4|||
16423223|NCT00947115|40028190|FG002|Overall Study|Missed reporting interval|2|||
16423224|NCT00947115|40028188|FG000|Overall Study|Physician Decision|0|||
16423225|NCT00947115|40028189|FG001|Overall Study|Physician Decision|2|||
16423226|NCT00947115|40028190|FG002|Overall Study|Physician Decision|0|||
16423227|NCT00947115|40028188|FG000|Overall Study|Death|0|||
16423228|NCT00947115|40028189|FG001|Overall Study|Death|1|||
16423229|NCT00947115|40028190|FG002|Overall Study|Death|1|||
16423230|NCT00947115|40028188|FG000|Overall Study|Migrated from study area|2|||
16423231|NCT00947115|40028189|FG001|Overall Study|Migrated from study area|0|||
16423232|NCT00947115|40028190|FG002|Overall Study|Migrated from study area|0|||
16423233|NCT00947115|40028188|FG000|Overall Study|Withdrawal by Subject|1|||
16423234|NCT00947115|40028189|FG001|Overall Study|Withdrawal by Subject|3|||
16423235|NCT00947115|40028190|FG002|Overall Study|Withdrawal by Subject|4|||
16423236|NCT00947115|40028188|FG000|Overall Study|Lost to Follow-up|11|||
16423237|NCT00947115|40028189|FG001|Overall Study|Lost to Follow-up|12|||
16423238|NCT00947115|40028190|FG002|Overall Study|Lost to Follow-up|8|||
16423239|NCT00555217|40028191|FG000|Overall Study|Withdrawal by Subject|35|||
16423240|NCT00555217|40028192|FG001|Overall Study|Withdrawal by Subject|31|||
16423241|NCT00555217|40028191|FG000|Overall Study|Lost to Follow-up|19|||
16423242|NCT00555217|40028192|FG001|Overall Study|Lost to Follow-up|20|||
16423243|NCT00555217|40028191|FG000|Overall Study|close out sites|21|||
16423244|NCT00555217|40028192|FG001|Overall Study|close out sites|17|||
16423245|NCT02593318|40028197|FG000|Overall Study|Withdrawal by Subject|1|||
16423246|NCT02593318|40028198|FG001|Overall Study|Withdrawal by Subject|1|||
16423247|NCT02578186|40028201|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
16423248|NCT02578186|40028202|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
16423249|NCT02578186|40028201|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
16423250|NCT02578186|40028202|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
16423251|NCT00372697|40028203|FG000|Overall Study|Protocol Violation|1|||
16423252|NCT00372697|40028204|FG001|Overall Study|Protocol Violation|1|||
16423253|NCT02679287|40028205|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
16423254|NCT02679287|40028206|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
16423255|NCT02679287|40028205|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
16423256|NCT02679287|40028206|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
16423257|NCT02679287|40028205|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
16423258|NCT02679287|40028206|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
16423259|NCT02679287|40028205|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
16423260|NCT02679287|40028206|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
16423261|NCT02679287|40028205|FG000|Period 2|Work/Scheduling Conflict|1|||
16423262|NCT02679287|40028206|FG001|Period 2|Work/Scheduling Conflict|0|||
16423263|NCT02679287|40028205|FG000|Period 2|Disliked Mobile System|2|||
16423264|NCT02679287|40028206|FG001|Period 2|Disliked Mobile System|0|||
16423265|NCT02679287|40028205|FG000|Period 3|Work/Scheduling Conflict|0|||
16423266|NCT02679287|40028206|FG001|Period 3|Work/Scheduling Conflict|1|||
16423267|NCT01108523|40028207|FG000|Overall Study|Protocol Violation|4|||
16423268|NCT02969356|40028208|FG000|Overall Study|Adverse Event|7|||
16423269|NCT02969356|40028208|FG000|Overall Study|Consent withdrawn|2|||
16423270|NCT02969356|40028208|FG000|Overall Study|Lost to Follow-up|3|||
16423271|NCT02969356|40028208|FG000|Overall Study|Did not need to be reinjected|6|||
16423272|NCT02969356|40028208|FG000|Overall Study|Personal reasons|5|||
16423273|NCT00662909|40028210|FG000|Overall Study|Adverse Event|17|||
16423274|NCT00662909|40028211|FG001|Overall Study|Adverse Event|18|||
16423275|NCT00662909|40028212|FG002|Overall Study|Adverse Event|19|||
16423276|NCT00662909|40028210|FG000|Overall Study|Lack of Efficacy|9|||
16423277|NCT00662909|40028211|FG001|Overall Study|Lack of Efficacy|1|||
16423278|NCT00662909|40028212|FG002|Overall Study|Lack of Efficacy|5|||
16423279|NCT00662909|40028210|FG000|Overall Study|Withdrawal by Subject|29|||
16423280|NCT00662909|40028211|FG001|Overall Study|Withdrawal by Subject|22|||
16423281|NCT00662909|40028212|FG002|Overall Study|Withdrawal by Subject|16|||
16423282|NCT00662909|40028210|FG000|Overall Study|Lost to Follow-up|2|||
16423283|NCT00662909|40028211|FG001|Overall Study|Lost to Follow-up|9|||
16423284|NCT00662909|40028212|FG002|Overall Study|Lost to Follow-up|3|||
16423285|NCT00662909|40028210|FG000|Overall Study|Protocol Violation|7|||
16423286|NCT00662909|40028211|FG001|Overall Study|Protocol Violation|4|||
16423287|NCT00662909|40028212|FG002|Overall Study|Protocol Violation|5|||
16423288|NCT00662909|40028210|FG000|Overall Study|Randomized- never received study drug|1|||
16423289|NCT00662909|40028211|FG001|Overall Study|Randomized- never received study drug|0|||
16423290|NCT00662909|40028212|FG002|Overall Study|Randomized- never received study drug|0|||
16359833|NCT01697579|39804225|FG000|Base Study-Cycle 1|Adverse Event|1|||
16359834|NCT01697579|39804226|FG001|Base Study-Cycle 1|Adverse Event|0|||
16359835|NCT01697579|39804227|FG002|Base Study-Cycle 1|Adverse Event|0|||
16359836|NCT01697579|39804228|FG003|Base Study-Cycle 1|Adverse Event|0|||
16359837|NCT01697579|39804229|FG004|Base Study-Cycle 1|Adverse Event|0|||
16359838|NCT01697579|39804230|FG005|Base Study-Cycle 1|Adverse Event|0|||
16359839|NCT01697579|39804231|FG006|Base Study-Cycle 1|Adverse Event|0|||
16359840|NCT01697579|39804225|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
16359841|NCT01697579|39804226|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16359842|NCT01697579|39804227|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16359843|NCT01697579|39804228|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16359844|NCT01697579|39804229|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16359845|NCT01697579|39804230|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16359846|NCT01697579|39804231|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
16359847|NCT01697579|39804225|FG000|Base Study-Cycle 1|Protocol Violation|0|||
16359848|NCT01697579|39804226|FG001|Base Study-Cycle 1|Protocol Violation|0|||
16359849|NCT01697579|39804227|FG002|Base Study-Cycle 1|Protocol Violation|0|||
16359850|NCT01697579|39804228|FG003|Base Study-Cycle 1|Protocol Violation|0|||
16359851|NCT01697579|39804229|FG004|Base Study-Cycle 1|Protocol Violation|3|||
16359852|NCT01697579|39804230|FG005|Base Study-Cycle 1|Protocol Violation|0|||
16359853|NCT01697579|39804231|FG006|Base Study-Cycle 1|Protocol Violation|0|||
16359854|NCT01697579|39804225|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16359855|NCT01697579|39804226|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
16359856|NCT01697579|39804227|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16359857|NCT01697579|39804228|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16359858|NCT01697579|39804229|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16359859|NCT01697579|39804230|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16359860|NCT01697579|39804231|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
16359861|NCT01697579|39804225|FG000|Base Study-Cycle 1|Technical Problems|0|||
16359862|NCT01697579|39804226|FG001|Base Study-Cycle 1|Technical Problems|0|||
16359863|NCT01697579|39804227|FG002|Base Study-Cycle 1|Technical Problems|1|||
16359864|NCT01697579|39804228|FG003|Base Study-Cycle 1|Technical Problems|1|||
16359865|NCT01697579|39804229|FG004|Base Study-Cycle 1|Technical Problems|0|||
16359866|NCT01697579|39804230|FG005|Base Study-Cycle 1|Technical Problems|0|||
16359867|NCT01697579|39804231|FG006|Base Study-Cycle 1|Technical Problems|0|||
16359868|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Death|0|||
16359869|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Death|0|||
16359870|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Death|0|||
16359871|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Death|0|||
16359872|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Death|0|||
16359873|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Death|0|||
16359874|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Death|2|||
16359875|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16359876|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16359877|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16359878|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16359879|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
16359880|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
16359881|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
16359882|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
16359883|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
16359884|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
16359885|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
16359886|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
16359887|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
16359888|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
16359889|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16359890|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16359891|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16359892|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16359893|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16359894|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
16359895|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
16359896|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
16359897|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
16359898|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
16359899|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
16359900|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
16359901|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
16359902|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
16359903|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16249210|NCT00549198|39395396|FG001|Overall Study|Prohibited Medication|2|||
16249211|NCT00549198|39395395|FG000|Overall Study|Participant planning pregnancy|1|||
16249212|NCT00549198|39395396|FG001|Overall Study|Participant planning pregnancy|0|||
16249213|NCT00549198|39395395|FG000|Overall Study|Participant overweight, no scan possible|1|||
16249214|NCT00549198|39395396|FG001|Overall Study|Participant overweight, no scan possible|0|||
16249215|NCT00549198|39395395|FG000|Overall Study|No scan facilities|0|||
16249216|NCT00549198|39395396|FG001|Overall Study|No scan facilities|2|||
16249217|NCT00549198|39395395|FG000|Overall Study|Pregnancy|0|||
16249218|NCT00549198|39395396|FG001|Overall Study|Pregnancy|3|||
16249219|NCT00549198|39395395|FG000|Overall Study|Not Exposed to Study Drug|3|||
16249220|NCT00549198|39395396|FG001|Overall Study|Not Exposed to Study Drug|4|||
16249221|NCT01809314|39395397|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
16249222|NCT01809314|39395397|FG000|Overall Study|Adverse Event|6|||
16249223|NCT01809314|39395397|FG000|Overall Study|Insufficient Therapeutic Response|14|||
16249224|NCT01809314|39395397|FG000|Overall Study|Lost to Follow-up|724|||
16249225|NCT00752856|39395402|FG000|Overall Study|randomized but did not do viral kinetics|0|||
16249226|NCT00752856|39395403|FG001|Overall Study|randomized but did not do viral kinetics|1|||
16249227|NCT03907280|39395406|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
16249228|NCT03907280|39395407|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
16249229|NCT03907280|39395408|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
16249230|NCT00576199|39395417|FG000|Overall Study|Adverse Event|12|||
16249231|NCT00576199|39395417|FG000|Overall Study|Insufficient Therapeutic Response|14|||
16249232|NCT00576199|39395417|FG000|Overall Study|Refused Treatment|2|||
16249233|NCT00576199|39395417|FG000|Overall Study|Reason Unspecified|2|||
16249234|NCT03305055|39395418|FG000|Overall Study|Withdrawal by Subject|0|||
16249235|NCT03305055|39395419|FG001|Overall Study|Withdrawal by Subject|1|||
16249236|NCT03305055|39395418|FG000|Overall Study|Adverse Event|1|||
16249237|NCT03305055|39395419|FG001|Overall Study|Adverse Event|1|||
16249238|NCT01199601|39395422|FG000|Overall Study|Lost to Follow-up|47|||
16249239|NCT01199601|39395423|FG001|Overall Study|Lost to Follow-up|66|||
16249240|NCT01199601|39395422|FG000|Overall Study|Withdrawal by Subject|15|||
16249241|NCT01199601|39395423|FG001|Overall Study|Withdrawal by Subject|3|||
16249242|NCT01199601|39395422|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
16249243|NCT01199601|39395423|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
16249244|NCT02232074|39395428|FG000|Overall Study|Withdrawal by Subject|5|||
16249245|NCT02232074|39395429|FG001|Overall Study|Withdrawal by Subject|3|||
16249246|NCT02232074|39395428|FG000|Overall Study|No legal concerns at baseline|36|||
16249247|NCT02232074|39395429|FG001|Overall Study|No legal concerns at baseline|41|||
16249248|NCT02232074|39395428|FG000|Overall Study|deemed ineligible|0|||
16249249|NCT02232074|39395429|FG001|Overall Study|deemed ineligible|1|||
16249250|NCT03922477|39395430|FG000|Overall Study|Death|9|||
16249251|NCT03922477|39395430|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
16249252|NCT03922477|39395430|FG000|Overall Study|Physician Decision|1|||
16249253|NCT03922477|39395430|FG000|Overall Study|Withdrawal by Subject|2|||
16249254|NCT02637557|39395431|FG000|Overall Study|Adverse Event|3|||
16249255|NCT02637557|39395432|FG001|Overall Study|Adverse Event|1|||
16249256|NCT02637557|39395433|FG002|Overall Study|Adverse Event|3|||
16249257|NCT02637557|39395434|FG003|Overall Study|Adverse Event|3|||
16249258|NCT02637557|39395431|FG000|Overall Study|Lost to Follow-up|1|||
16249259|NCT02637557|39395432|FG001|Overall Study|Lost to Follow-up|1|||
16249260|NCT02637557|39395433|FG002|Overall Study|Lost to Follow-up|0|||
16249261|NCT02637557|39395434|FG003|Overall Study|Lost to Follow-up|1|||
16249262|NCT02637557|39395431|FG000|Overall Study|Physician Decision|1|||
16249263|NCT02637557|39395432|FG001|Overall Study|Physician Decision|0|||
16249264|NCT02637557|39395433|FG002|Overall Study|Physician Decision|0|||
16249265|NCT02637557|39395434|FG003|Overall Study|Physician Decision|0|||
16249266|NCT02637557|39395431|FG000|Overall Study|Protocol Violation|2|||
16249267|NCT02637557|39395432|FG001|Overall Study|Protocol Violation|0|||
16249268|NCT02637557|39395433|FG002|Overall Study|Protocol Violation|2|||
16249269|NCT02637557|39395434|FG003|Overall Study|Protocol Violation|1|||
16562341|NCT02018861|40525384|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16562342|NCT02018861|40525385|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
16562343|NCT02018861|40525376|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16562344|NCT02018861|40525377|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16562345|NCT02018861|40525378|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
16562346|NCT02018861|40525379|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
16562347|NCT02018861|40525380|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16249270|NCT02637557|39395431|FG000|Overall Study|Withdrawal by Subject|1|||
16249271|NCT02637557|39395432|FG001|Overall Study|Withdrawal by Subject|3|||
16249272|NCT02637557|39395433|FG002|Overall Study|Withdrawal by Subject|4|||
16249273|NCT02637557|39395434|FG003|Overall Study|Withdrawal by Subject|2|||
16249274|NCT05266456|39395435|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
16249275|NCT05266456|39395436|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
16249276|NCT05266456|39395437|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
16249277|NCT05266456|39395438|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
16249278|NCT05266456|39395435|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
16249279|NCT05266456|39395436|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
16249280|NCT05266456|39395437|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
16249281|NCT05266456|39395438|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
16249282|NCT05266456|39395435|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
16249283|NCT05266456|39395436|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
16249284|NCT05266456|39395437|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
16249285|NCT05266456|39395438|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
16249286|NCT05266456|39395435|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
16249287|NCT05266456|39395436|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
16249288|NCT05266456|39395437|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
16249289|NCT05266456|39395438|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
16249290|NCT05266456|39395435|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
16423291|NCT00662909|40028210|FG000|Overall Study|Non-compliance with study procedures|3|||
16423292|NCT00662909|40028211|FG001|Overall Study|Non-compliance with study procedures|3|||
16423293|NCT00662909|40028212|FG002|Overall Study|Non-compliance with study procedures|2|||
16423294|NCT00662909|40028210|FG000|Overall Study|Physician Decision|1|||
16423295|NCT00662909|40028211|FG001|Overall Study|Physician Decision|1|||
16423296|NCT00662909|40028212|FG002|Overall Study|Physician Decision|2|||
16423297|NCT00662909|40028210|FG000|Overall Study|Eligibility criterion not met|0|||
16423298|NCT00662909|40028211|FG001|Overall Study|Eligibility criterion not met|1|||
16423299|NCT00662909|40028212|FG002|Overall Study|Eligibility criterion not met|1|||
16423300|NCT03043651|40028213|FG000|Overall Study|Death|1|||
16423301|NCT03043651|40028213|FG000|Overall Study|Progressive Disease|2|||
16423302|NCT03043651|40028213|FG000|Overall Study|Adverse Event|2|||
16423303|NCT03043651|40028213|FG000|Overall Study|Withdrawal by Subject|4|||
16423304|NCT03043651|40028213|FG000|Overall Study|Study Terminated by Sponsor|39|||
16423305|NCT00595478|40028214|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
16423306|NCT00595478|40028215|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
16423307|NCT00595478|40028214|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
16423308|NCT00595478|40028215|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
16423309|NCT02397057|40028221|FG000|Overall Study|Withdrawal by Subject|6|||
16423310|NCT02397057|40028222|FG001|Overall Study|Withdrawal by Subject|7|||
16423311|NCT02397057|40028221|FG000|Overall Study|Lost to Follow-up|4|||
16423312|NCT02397057|40028222|FG001|Overall Study|Lost to Follow-up|3|||
16423313|NCT02397057|40028221|FG000|Overall Study|Death|1|||
16423314|NCT02397057|40028222|FG001|Overall Study|Death|0|||
16423315|NCT02397057|40028221|FG000|Overall Study|Adverse Event|0|||
16423316|NCT02397057|40028222|FG001|Overall Study|Adverse Event|1|||
16423317|NCT02397057|40028221|FG000|Overall Study|Physician Decision|0|||
16423318|NCT02397057|40028222|FG001|Overall Study|Physician Decision|1|||
16423319|NCT02397057|40028221|FG000|Overall Study|Subject did not receive study drug|0|||
16423320|NCT02397057|40028222|FG001|Overall Study|Subject did not receive study drug|1|||
16423321|NCT01463306|40028226|FG000|Overall Study|Adverse Event|6|||
16423322|NCT01463306|40028227|FG001|Overall Study|Adverse Event|9|||
16423323|NCT01463306|40028228|FG002|Overall Study|Adverse Event|3|||
16423324|NCT01463306|40028226|FG000|Overall Study|Death|3|||
16423325|NCT01463306|40028227|FG001|Overall Study|Death|3|||
16423326|NCT01463306|40028228|FG002|Overall Study|Death|0|||
16423327|NCT01463306|40028226|FG000|Overall Study|Lack of Efficacy|22|||
16423328|NCT01463306|40028227|FG001|Overall Study|Lack of Efficacy|16|||
16423329|NCT01463306|40028228|FG002|Overall Study|Lack of Efficacy|1|||
16423330|NCT01463306|40028226|FG000|Overall Study|Lost to Follow-up|5|||
16423331|NCT01463306|40028227|FG001|Overall Study|Lost to Follow-up|2|||
16423332|NCT01463306|40028228|FG002|Overall Study|Lost to Follow-up|0|||
16423333|NCT01463306|40028226|FG000|Overall Study|Protocol Violation|4|||
16423334|NCT01463306|40028227|FG001|Overall Study|Protocol Violation|0|||
16423335|NCT01463306|40028228|FG002|Overall Study|Protocol Violation|0|||
16423336|NCT01463306|40028226|FG000|Overall Study|Withdrawal by Subject|19|||
16249291|NCT05266456|39395436|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
16423337|NCT01463306|40028227|FG001|Overall Study|Withdrawal by Subject|9|||
16423338|NCT01463306|40028228|FG002|Overall Study|Withdrawal by Subject|1|||
16423339|NCT01463306|40028226|FG000|Overall Study|Other|26|||
16423340|NCT01463306|40028227|FG001|Overall Study|Other|13|||
16423341|NCT01463306|40028228|FG002|Overall Study|Other|0|||
16423342|NCT01463306|40028226|FG000|Overall Study|Approval expiry at site|1|||
16423343|NCT01463306|40028227|FG001|Overall Study|Approval expiry at site|0|||
16249292|NCT05266456|39395437|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
16249293|NCT05266456|39395438|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
16423344|NCT01463306|40028228|FG002|Overall Study|Approval expiry at site|0|||
16423345|NCT00599755|40028229|FG000|Overall Study|Adverse Event|11|||
16423346|NCT00599755|40028229|FG000|Overall Study|Withdrawal by Subject|2|||
16423347|NCT00599755|40028229|FG000|Overall Study|Progression of Disease|3|||
16423348|NCT00599755|40028229|FG000|Overall Study|Other Reason|2|||
16423349|NCT00599755|40028229|FG000|Overall Study|No data available|1|||
16423350|NCT01320202|40028230|FG000|Overall Study|Adverse Event|5|||
16423351|NCT01320202|40028231|FG001|Overall Study|Adverse Event|5|||
16423352|NCT01320202|40028230|FG000|Overall Study|Death|5|||
16423353|NCT01320202|40028231|FG001|Overall Study|Death|3|||
16423354|NCT01320202|40028230|FG000|Overall Study|Lost to Follow-up|1|||
16423355|NCT01320202|40028231|FG001|Overall Study|Lost to Follow-up|0|||
16423356|NCT01320202|40028230|FG000|Overall Study|Physician Decision|3|||
16423357|NCT01320202|40028231|FG001|Overall Study|Physician Decision|1|||
16423358|NCT01320202|40028230|FG000|Overall Study|Protocol Violation|2|||
16423359|NCT01320202|40028231|FG001|Overall Study|Protocol Violation|1|||
16423360|NCT01320202|40028230|FG000|Overall Study|Withdrawal by Subject|10|||
16423361|NCT01320202|40028231|FG001|Overall Study|Withdrawal by Subject|3|||
16423362|NCT01320202|40028230|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
16423363|NCT01320202|40028231|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
16423364|NCT01320202|40028230|FG000|Overall Study|kidney transplant|1|||
16423365|NCT01320202|40028231|FG001|Overall Study|kidney transplant|2|||
16423366|NCT01320202|40028230|FG000|Overall Study|blood transfusion|1|||
16423367|NCT01320202|40028231|FG001|Overall Study|blood transfusion|7|||
16423368|NCT01320202|40028230|FG000|Overall Study|moved/changed dialysis|5|||
16423369|NCT01320202|40028231|FG001|Overall Study|moved/changed dialysis|2|||
16423370|NCT01320202|40028230|FG000|Overall Study|sponsor request|2|||
16423371|NCT01320202|40028231|FG001|Overall Study|sponsor request|0|||
16423372|NCT01320202|40028230|FG000|Overall Study|ineligible|3|||
16423373|NCT01320202|40028231|FG001|Overall Study|ineligible|0|||
16423374|NCT01320202|40028230|FG000|Overall Study|regained renal function|1|||
16423375|NCT01320202|40028231|FG001|Overall Study|regained renal function|0|||
16423376|NCT04390841|40028232|FG000|Overall Study|Withdrawal by Subject|2|||
16423377|NCT03659136|40028233|FG000|Overall Study|Not treated|2|||
16423378|NCT03659136|40028234|FG001|Overall Study|Not treated|0|||
16423379|NCT03659136|40028233|FG000|Overall Study|Covid-19 related|1|||
16423380|NCT03659136|40028234|FG001|Overall Study|Covid-19 related|1|||
16423381|NCT03659136|40028233|FG000|Overall Study|Withdrawal by Subject|1|||
16423382|NCT03659136|40028234|FG001|Overall Study|Withdrawal by Subject|6|||
16423383|NCT03659136|40028233|FG000|Overall Study|Adverse Event|4|||
16423384|NCT03659136|40028234|FG001|Overall Study|Adverse Event|6|||
16423385|NCT03659136|40028233|FG000|Overall Study|Progressive disease|37|||
16423386|NCT03659136|40028234|FG001|Overall Study|Progressive disease|31|||
16423387|NCT03659136|40028233|FG000|Overall Study|Study closure|2|||
16423388|NCT03659136|40028234|FG001|Overall Study|Study closure|2|||
16423389|NCT03659136|40028233|FG000|Overall Study|Sponsor decision/recommendation|3|||
16423390|NCT03659136|40028234|FG001|Overall Study|Sponsor decision/recommendation|2|||
16423391|NCT03659136|40028233|FG000|Overall Study|Switched to other drug/therapy|2|||
16423392|NCT03659136|40028234|FG001|Overall Study|Switched to other drug/therapy|2|||
16423393|NCT03659136|40028233|FG000|Overall Study|Lack of clinical benefit|0|||
16423394|NCT03659136|40028234|FG001|Overall Study|Lack of clinical benefit|1|||
16423395|NCT00861471|40028235|FG000|Overall Study|Withdrawal by Subject|1|||
16423396|NCT00861471|40028235|FG000|Overall Study|Adverse Event|2|||
16423397|NCT00861471|40028235|FG000|Overall Study|Lack of Efficacy|3|||
16423398|NCT00861471|40028235|FG000|Overall Study|treatment for lumbar laminectomy|1|||
16423399|NCT00861471|40028235|FG000|Overall Study|Physician Decision|2|||
16423400|NCT00549445|40028240|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
16423401|NCT00549445|40028241|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
16423402|NCT00465647|40028246|FG000|Overall Study|Administrative|2|||
16423403|NCT00465647|40028247|FG001|Overall Study|Administrative|2|||
16423404|NCT00465647|40028248|FG002|Overall Study|Administrative|3|||
16423405|NCT00465647|40028249|FG003|Overall Study|Administrative|2|||
16423406|NCT00465647|40028246|FG000|Overall Study|Adverse Event|2|||
16423407|NCT00465647|40028247|FG001|Overall Study|Adverse Event|0|||
16423408|NCT00465647|40028248|FG002|Overall Study|Adverse Event|3|||
16423409|NCT00465647|40028249|FG003|Overall Study|Adverse Event|2|||
16423410|NCT00465647|40028246|FG000|Overall Study|Withdrawal by Subject|1|||
16423411|NCT00465647|40028247|FG001|Overall Study|Withdrawal by Subject|2|||
16423412|NCT00465647|40028248|FG002|Overall Study|Withdrawal by Subject|2|||
16423413|NCT00465647|40028249|FG003|Overall Study|Withdrawal by Subject|7|||
16423414|NCT00465647|40028246|FG000|Overall Study|"The other reasons included loss of IV"|8|||
16423415|NCT00465647|40028247|FG001|Overall Study|"The other reasons included loss of IV"|4|||
16423416|NCT00465647|40028248|FG002|Overall Study|"The other reasons included loss of IV"|3|||
16423417|NCT00465647|40028249|FG003|Overall Study|"The other reasons included loss of IV"|2|||
16423418|NCT00534976|40028250|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
16423419|NCT00534976|40028251|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
16423420|NCT00534976|40028250|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
16562348|NCT02018861|40525381|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16562349|NCT02018861|40525382|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16423421|NCT00534976|40028251|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
16423422|NCT00534976|40028250|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
16423423|NCT00534976|40028251|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
16423424|NCT04371666|40028252|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
16423425|NCT04371666|40028253|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
16423426|NCT04371666|40028252|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
16423427|NCT04371666|40028253|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
16423428|NCT04371666|40028252|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
16423429|NCT04371666|40028253|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
16423430|NCT04371666|40028252|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
16423431|NCT04371666|40028253|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
16423432|NCT04371666|40028252|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
16423433|NCT04371666|40028253|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
16423434|NCT04371666|40028252|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
16423435|NCT04371666|40028253|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
16423436|NCT02332291|40028254|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
16423437|NCT02332291|40028255|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
16423438|NCT02332291|40028254|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
16423439|NCT02332291|40028255|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
16423440|NCT02332291|40028254|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
16423441|NCT02332291|40028255|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
16423442|NCT02332291|40028254|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
16423443|NCT02332291|40028255|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
16423444|NCT02332291|40028254|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
16423445|NCT02332291|40028255|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
16423446|NCT02332291|40028254|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
16423447|NCT02332291|40028255|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
16423448|NCT02834247|40028256|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
16423449|NCT02834247|40028257|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
16423450|NCT02834247|40028258|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
16423451|NCT02834247|40028259|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
16423452|NCT02834247|40028256|FG000|Dose Escalation Phase|Death|5|||
16423453|NCT02834247|40028257|FG001|Dose Escalation Phase|Death|6|||
16423454|NCT02834247|40028258|FG002|Dose Escalation Phase|Death|5|||
16423455|NCT02834247|40028259|FG003|Dose Escalation Phase|Death|0|||
16423456|NCT02834247|40028256|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
16423457|NCT02834247|40028257|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
16423458|NCT02834247|40028258|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
16423459|NCT02834247|40028259|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
16423460|NCT02834247|40028256|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
16423461|NCT02834247|40028257|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
16423462|NCT02834247|40028258|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
16423463|NCT02834247|40028259|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16423464|NCT02834247|40028256|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
16423465|NCT02834247|40028257|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
16423466|NCT02834247|40028258|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
16423467|NCT02834247|40028259|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
16423468|NCT02834247|40028256|FG000|Dose Expansion Phase|Death|0|||
16423469|NCT02834247|40028257|FG001|Dose Expansion Phase|Death|0|||
16423470|NCT02834247|40028258|FG002|Dose Expansion Phase|Death|0|||
16423471|NCT02834247|40028259|FG003|Dose Expansion Phase|Death|8|||
16423472|NCT02834247|40028256|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
16423473|NCT02834247|40028257|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
16423474|NCT02834247|40028258|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
16423475|NCT02834247|40028259|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
16130903|NCT01323634|38967154|FG002|2-week Run-in Period|Physician Decision|0|||
16130904|NCT01323634|38967152|FG000|2-week Run-in Period|Protocol Violation|1|||
16130905|NCT01323634|38967153|FG001|2-week Run-in Period|Protocol Violation|0|||
16130906|NCT01323634|38967154|FG002|2-week Run-in Period|Protocol Violation|0|||
16130907|NCT01323634|38967152|FG000|2-week Run-in Period|Adverse Event|1|||
16130908|NCT01323634|38967153|FG001|2-week Run-in Period|Adverse Event|0|||
16130909|NCT01323634|38967154|FG002|2-week Run-in Period|Adverse Event|0|||
16130910|NCT01323634|38967152|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16130911|NCT01323634|38967153|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
16130912|NCT01323634|38967154|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
16249294|NCT02115256|39395439|FG000|Overall Study|Withdrawal by Subject|0|||
16130913|NCT01323634|38967152|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16249295|NCT02115256|39395440|FG001|Overall Study|Withdrawal by Subject|1|||
16423476|NCT02834247|40028256|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
16423477|NCT02834247|40028257|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
16423478|NCT02834247|40028258|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
16423479|NCT02834247|40028259|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
16423480|NCT03890367|40028260|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16423481|NCT03890367|40028261|FG001|Overall Study|Withdrawal by parent/guardian|3|||
16423482|NCT03890367|40028262|FG002|Overall Study|Withdrawal by parent/guardian|0|||
16423483|NCT03890367|40028260|FG000|Overall Study|Protocol deviation|2|||
16423484|NCT03890367|40028261|FG001|Overall Study|Protocol deviation|2|||
16423485|NCT03890367|40028262|FG002|Overall Study|Protocol deviation|1|||
16423486|NCT03890367|40028260|FG000|Overall Study|Lost to Follow-up|1|||
16423487|NCT03890367|40028261|FG001|Overall Study|Lost to Follow-up|1|||
16423488|NCT03890367|40028262|FG002|Overall Study|Lost to Follow-up|0|||
16423489|NCT01983774|40028264|FG000|Overall Study|Lung Transplant|0|||
16423490|NCT01983774|40028265|FG001|Overall Study|Lung Transplant|1|||
16423491|NCT01983774|40028264|FG000|Overall Study|Lost to Follow-up|1|||
16423492|NCT01983774|40028265|FG001|Overall Study|Lost to Follow-up|0|||
16423493|NCT00900029|40028268|FG000|Overall Study|Lost to Follow-up|0|||
16423494|NCT00900029|40028269|FG001|Overall Study|Lost to Follow-up|2|||
16423495|NCT00900029|40028270|FG002|Overall Study|Lost to Follow-up|1|||
16423496|NCT00900029|40028271|FG003|Overall Study|Lost to Follow-up|4|||
16423497|NCT00900029|40028272|FG004|Overall Study|Lost to Follow-up|4|||
16423498|NCT00900029|40028268|FG000|Overall Study|Withdrawal by Subject|2|||
16423499|NCT00900029|40028269|FG001|Overall Study|Withdrawal by Subject|2|||
16423500|NCT00900029|40028270|FG002|Overall Study|Withdrawal by Subject|1|||
16423501|NCT00900029|40028271|FG003|Overall Study|Withdrawal by Subject|1|||
16423502|NCT00900029|40028272|FG004|Overall Study|Withdrawal by Subject|1|||
16423503|NCT00900029|40028268|FG000|Overall Study|Adverse Event|0|||
16423504|NCT00900029|40028269|FG001|Overall Study|Adverse Event|0|||
16423505|NCT00900029|40028270|FG002|Overall Study|Adverse Event|1|||
16423506|NCT00900029|40028271|FG003|Overall Study|Adverse Event|1|||
16423507|NCT00900029|40028272|FG004|Overall Study|Adverse Event|1|||
16423508|NCT00900029|40028268|FG000|Overall Study|Death|1|||
16423509|NCT00900029|40028269|FG001|Overall Study|Death|0|||
16423510|NCT00900029|40028270|FG002|Overall Study|Death|0|||
16423511|NCT00900029|40028271|FG003|Overall Study|Death|1|||
16423512|NCT00900029|40028272|FG004|Overall Study|Death|0|||
16423513|NCT03915470|40028273|FG000|Overall Study|Death|3|||
16423514|NCT03915470|40028274|FG001|Overall Study|Death|1|||
16423515|NCT03915470|40028273|FG000|Overall Study|Adverse Event|1|||
16423516|NCT03915470|40028274|FG001|Overall Study|Adverse Event|0|||
16130914|NCT01323634|38967153|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16423517|NCT03915470|40028273|FG000|Overall Study|Physician Decision|1|||
16423518|NCT03915470|40028274|FG001|Overall Study|Physician Decision|0|||
16423519|NCT03915470|40028273|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
16423520|NCT03915470|40028274|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
16562350|NCT02018861|40525383|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16562351|NCT02018861|40525384|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16562352|NCT02018861|40525385|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
16562353|NCT02018861|40525376|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16562354|NCT02018861|40525377|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16562355|NCT02018861|40525378|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16562356|NCT02018861|40525379|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16562357|NCT02018861|40525380|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
16562358|NCT02018861|40525381|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16562359|NCT02018861|40525382|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16562360|NCT02018861|40525383|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16562361|NCT02018861|40525384|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16562362|NCT02018861|40525385|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
16562363|NCT02018861|40525376|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16562364|NCT02018861|40525377|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16562365|NCT02018861|40525378|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16423521|NCT02112448|40028275|FG000|Overall Study|lab values precluding use of ketorolac|2|||
16423522|NCT02112448|40028276|FG001|Overall Study|lab values precluding use of ketorolac|2|||
16423523|NCT02112448|40028275|FG000|Overall Study|Protocol Violation|1|||
16423524|NCT02112448|40028276|FG001|Overall Study|Protocol Violation|2|||
16423525|NCT02112448|40028275|FG000|Overall Study|Physician Decision|4|||
16423526|NCT02112448|40028276|FG001|Overall Study|Physician Decision|6|||
16423527|NCT02112448|40028275|FG000|Overall Study|required heparin so could not use ketoro|1|||
16423528|NCT02112448|40028276|FG001|Overall Study|required heparin so could not use ketoro|0|||
16423529|NCT00423449|40028279|FG000|Overall Study|Clinical Adverse Event|1|||
16423530|NCT00423449|40028280|FG001|Overall Study|Clinical Adverse Event|0|||
16423531|NCT00423449|40028281|FG002|Overall Study|Clinical Adverse Event|1|||
16423532|NCT00423449|40028282|FG003|Overall Study|Clinical Adverse Event|8|||
16423533|NCT00423449|40028283|FG004|Overall Study|Clinical Adverse Event|2|||
16423534|NCT00423449|40028279|FG000|Overall Study|Death|1|||
16423535|NCT00423449|40028280|FG001|Overall Study|Death|0|||
16423536|NCT00423449|40028281|FG002|Overall Study|Death|2|||
16423537|NCT00423449|40028282|FG003|Overall Study|Death|1|||
16423538|NCT00423449|40028283|FG004|Overall Study|Death|1|||
16423539|NCT00423449|40028279|FG000|Overall Study|Progressive Disease|1|||
16423540|NCT00423449|40028280|FG001|Overall Study|Progressive Disease|3|||
16423541|NCT00423449|40028281|FG002|Overall Study|Progressive Disease|8|||
16423542|NCT00423449|40028282|FG003|Overall Study|Progressive Disease|11|||
16423543|NCT00423449|40028283|FG004|Overall Study|Progressive Disease|4|||
16423544|NCT00423449|40028279|FG000|Overall Study|Laboratory Adverse Event|0|||
16423545|NCT00423449|40028280|FG001|Overall Study|Laboratory Adverse Event|1|||
16423546|NCT00423449|40028281|FG002|Overall Study|Laboratory Adverse Event|2|||
16423547|NCT00423449|40028282|FG003|Overall Study|Laboratory Adverse Event|0|||
16423548|NCT00423449|40028283|FG004|Overall Study|Laboratory Adverse Event|0|||
16423549|NCT00423449|40028279|FG000|Overall Study|Other|0|||
16423550|NCT00423449|40028280|FG001|Overall Study|Other|0|||
16423551|NCT00423449|40028281|FG002|Overall Study|Other|0|||
16423552|NCT00423449|40028282|FG003|Overall Study|Other|1|||
16423553|NCT00423449|40028283|FG004|Overall Study|Other|0|||
16423554|NCT00423449|40028279|FG000|Overall Study|Protocol Violation|0|||
16423555|NCT00423449|40028280|FG001|Overall Study|Protocol Violation|0|||
16423556|NCT00423449|40028281|FG002|Overall Study|Protocol Violation|2|||
16423557|NCT00423449|40028282|FG003|Overall Study|Protocol Violation|1|||
16423558|NCT00423449|40028283|FG004|Overall Study|Protocol Violation|0|||
16423559|NCT04725500|40028284|FG000|Screening|Screen Failure|26|||
16423560|NCT04725500|40028284|FG000|Screening|Withdrawal by Subject|1|||
16423561|NCT04725500|40028284|FG000|2 Week Take Home|Screen Fail|5|||
16423562|NCT00061633|40028285|FG000|Overall Study|Adverse Event|1|||
16423563|NCT00061633|40028286|FG001|Overall Study|Adverse Event|2|||
16423564|NCT00061633|40028285|FG000|Overall Study|Withdrawal by Subject|2|||
16423565|NCT00061633|40028286|FG001|Overall Study|Withdrawal by Subject|2|||
16423566|NCT00061633|40028285|FG000|Overall Study|Lost to Follow-up|1|||
16423567|NCT00061633|40028286|FG001|Overall Study|Lost to Follow-up|4|||
16423568|NCT00061633|40028285|FG000|Overall Study|Other|1|||
16423569|NCT00061633|40028286|FG001|Overall Study|Other|1|||
16423570|NCT00061633|40028285|FG000|Overall Study|Never received study treatment|0|||
16423571|NCT00061633|40028286|FG001|Overall Study|Never received study treatment|2|||
16423572|NCT02560012|40028290|FG000|Overall Study|Study Terminated|2|||
16423573|NCT03772665|40028292|FG000|Overall Study|Protocol Violation|1|||
16423574|NCT03772665|40028293|FG001|Overall Study|Protocol Violation|0|||
16423575|NCT02927938|40028294|FG000|Overall Study|Death|0|||
16423576|NCT02927938|40028295|FG001|Overall Study|Death|1|||
16423577|NCT02927938|40028296|FG002|Overall Study|Death|0|||
16423578|NCT02927938|40028297|FG003|Overall Study|Death|4|||
16423579|NCT02927938|40028294|FG000|Overall Study|Early Study Termination|1|||
16423580|NCT02927938|40028295|FG001|Overall Study|Early Study Termination|5|||
16423581|NCT02927938|40028296|FG002|Overall Study|Early Study Termination|4|||
16423582|NCT02927938|40028297|FG003|Overall Study|Early Study Termination|3|||
16423583|NCT00511238|40028300|FG000|Overall Study|Adverse Event|13|||
16423584|NCT00511238|40028301|FG001|Overall Study|Adverse Event|33|||
16423585|NCT00511238|40028300|FG000|Overall Study|Withdrawal by Subject|2|||
16423586|NCT00511238|40028301|FG001|Overall Study|Withdrawal by Subject|22|||
16423587|NCT00511238|40028300|FG000|Overall Study|Progressive Disease|23|||
16423588|NCT00511238|40028301|FG001|Overall Study|Progressive Disease|157|||
16423589|NCT00511238|40028300|FG000|Overall Study|various reasons|4|||
16423590|NCT00511238|40028301|FG001|Overall Study|various reasons|14|||
16423591|NCT00588354|40028302|FG000|Baseline to 2 Weeks|Adverse Event|1|||
16423592|NCT00588354|40028303|FG001|Baseline to 2 Weeks|Adverse Event|0|||
16423593|NCT00588354|40028302|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
16423594|NCT00588354|40028303|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
16423595|NCT00588354|40028302|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
16423596|NCT00588354|40028303|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
16423597|NCT00621140|40028304|FG000|Overall Study|Adverse Event|4|||
16423598|NCT00621140|40028305|FG001|Overall Study|Adverse Event|5|||
16423599|NCT00621140|40028304|FG000|Overall Study|Lost to Follow-up|1|||
16423600|NCT00621140|40028305|FG001|Overall Study|Lost to Follow-up|2|||
16423601|NCT00621140|40028304|FG000|Overall Study|Withdrawal by Subject|4|||
16423602|NCT00621140|40028305|FG001|Overall Study|Withdrawal by Subject|6|||
16423603|NCT00621140|40028304|FG000|Overall Study|Other incl. lack of efficacy|6|||
16423604|NCT00621140|40028305|FG001|Overall Study|Other incl. lack of efficacy|5|||
16423605|NCT00319254|40028315|FG000|Overall Study|Withdrawal by Subject|4|||
16423606|NCT00319254|40028315|FG000|Overall Study|Death|46|||
16423607|NCT00319254|40028315|FG000|Overall Study|Lost to Follow-up|2|||
16423608|NCT00319254|40028315|FG000|Overall Study|Enrolled, Not Treated|2|||
16423609|NCT00811174|40028316|FG000|Overall Study|Protocol Violation|2|||
16423610|NCT00811174|40028316|FG000|Overall Study|Sponsors Decision|1|||
16423611|NCT00869518|40028317|FG000|Overall Study|Lost to Follow-up|1|||
16423612|NCT00869518|40028318|FG001|Overall Study|Lost to Follow-up|1|||
16423613|NCT00483938|40028319|FG000|Overall Study|Protocol Violation|0|||
16423614|NCT00483938|40028320|FG001|Overall Study|Protocol Violation|0|||
16423615|NCT00483938|40028321|FG002|Overall Study|Protocol Violation|0|||
16423616|NCT00483938|40028322|FG003|Overall Study|Protocol Violation|0|||
16423617|NCT00483938|40028323|FG004|Overall Study|Protocol Violation|0|||
16423618|NCT00483938|40028324|FG005|Overall Study|Protocol Violation|0|||
16423619|NCT00483938|40028325|FG006|Overall Study|Protocol Violation|3|||
16423620|NCT00483938|40028319|FG000|Overall Study|Withdrawal by Subject|1|||
16423621|NCT00483938|40028320|FG001|Overall Study|Withdrawal by Subject|6|||
16423622|NCT00483938|40028321|FG002|Overall Study|Withdrawal by Subject|0|||
16423623|NCT00483938|40028322|FG003|Overall Study|Withdrawal by Subject|0|||
16423624|NCT00483938|40028323|FG004|Overall Study|Withdrawal by Subject|1|||
16423625|NCT00483938|40028324|FG005|Overall Study|Withdrawal by Subject|3|||
16423626|NCT00483938|40028325|FG006|Overall Study|Withdrawal by Subject|2|||
16423627|NCT00483938|40028319|FG000|Overall Study|Lost to Follow-up|1|||
16423628|NCT00483938|40028320|FG001|Overall Study|Lost to Follow-up|2|||
16423629|NCT00483938|40028321|FG002|Overall Study|Lost to Follow-up|0|||
16423630|NCT00483938|40028322|FG003|Overall Study|Lost to Follow-up|2|||
16423631|NCT00483938|40028323|FG004|Overall Study|Lost to Follow-up|1|||
16423632|NCT00483938|40028324|FG005|Overall Study|Lost to Follow-up|1|||
16423633|NCT00483938|40028325|FG006|Overall Study|Lost to Follow-up|3|||
16423634|NCT00483938|40028319|FG000|Overall Study|Death|0|||
16423635|NCT00483938|40028320|FG001|Overall Study|Death|2|||
16423636|NCT00483938|40028321|FG002|Overall Study|Death|0|||
16423637|NCT00483938|40028322|FG003|Overall Study|Death|0|||
16423638|NCT00483938|40028323|FG004|Overall Study|Death|0|||
16423639|NCT00483938|40028324|FG005|Overall Study|Death|0|||
16423640|NCT00483938|40028325|FG006|Overall Study|Death|0|||
16423641|NCT00483938|40028319|FG000|Overall Study|Other|3|||
16423642|NCT00483938|40028320|FG001|Overall Study|Other|9|||
16423643|NCT00483938|40028321|FG002|Overall Study|Other|0|||
16423644|NCT00483938|40028322|FG003|Overall Study|Other|4|||
16423645|NCT00483938|40028323|FG004|Overall Study|Other|0|||
16423646|NCT00483938|40028324|FG005|Overall Study|Other|4|||
16423647|NCT00483938|40028325|FG006|Overall Study|Other|32|||
16423648|NCT00858637|40028326|FG000|Active Comparison Phase|Adverse Event|14|||
16423649|NCT00858637|40028327|FG001|Active Comparison Phase|Adverse Event|0|||
16423650|NCT00858637|40028328|FG002|Active Comparison Phase|Adverse Event|0|||
16423651|NCT00858637|40028329|FG003|Active Comparison Phase|Adverse Event|9|||
16423652|NCT00858637|40028330|FG004|Active Comparison Phase|Adverse Event|0|||
16423653|NCT00858637|40028331|FG005|Active Comparison Phase|Adverse Event|0|||
16423654|NCT00858637|40028326|FG000|Active Comparison Phase|Death|1|||
16423655|NCT00858637|40028327|FG001|Active Comparison Phase|Death|0|||
16423656|NCT00858637|40028328|FG002|Active Comparison Phase|Death|0|||
16423657|NCT00858637|40028329|FG003|Active Comparison Phase|Death|1|||
16423658|NCT00858637|40028330|FG004|Active Comparison Phase|Death|0|||
16423659|NCT00858637|40028331|FG005|Active Comparison Phase|Death|0|||
16423660|NCT00858637|40028326|FG000|Active Comparison Phase|Physician Decision|1|||
16423661|NCT00858637|40028327|FG001|Active Comparison Phase|Physician Decision|0|||
16423662|NCT00858637|40028328|FG002|Active Comparison Phase|Physician Decision|0|||
16423663|NCT00858637|40028329|FG003|Active Comparison Phase|Physician Decision|1|||
16423664|NCT00858637|40028330|FG004|Active Comparison Phase|Physician Decision|0|||
16423665|NCT00858637|40028331|FG005|Active Comparison Phase|Physician Decision|0|||
16423666|NCT00858637|40028326|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
16423667|NCT00858637|40028327|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
16423668|NCT00858637|40028328|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
16423669|NCT00858637|40028329|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
16423670|NCT00858637|40028330|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
16423671|NCT00858637|40028331|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
16423672|NCT00858637|40028326|FG000|Active Comparison Phase|Other Reasons|1|||
16423673|NCT00858637|40028327|FG001|Active Comparison Phase|Other Reasons|0|||
16423674|NCT00858637|40028328|FG002|Active Comparison Phase|Other Reasons|0|||
16423675|NCT00858637|40028329|FG003|Active Comparison Phase|Other Reasons|1|||
16423676|NCT00858637|40028330|FG004|Active Comparison Phase|Other Reasons|0|||
16423677|NCT00858637|40028331|FG005|Active Comparison Phase|Other Reasons|0|||
16423678|NCT00858637|40028326|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
16423679|NCT00858637|40028327|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
16423680|NCT00858637|40028328|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
16423681|NCT00858637|40028329|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
16359904|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16359905|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16359906|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16359907|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16359908|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
16359909|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
16359910|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
16359911|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
16359912|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
16359913|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
16359914|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
16359915|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
16359916|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
16359917|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
16359918|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
16359919|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
16359920|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
16359921|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
16359922|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
16359923|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
16359924|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16359925|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16359926|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16359927|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16359928|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16359929|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
16359930|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
16359931|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
16359932|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
16359933|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
16359934|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
16359935|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
16359936|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
16359937|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
16359938|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
16359939|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
16359940|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
16359941|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
16359942|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
16359943|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
16359944|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
16359945|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
16359946|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
16359947|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
16359948|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
16359949|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
16359950|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
16359951|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
16359952|NCT01697579|39804225|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16359953|NCT01697579|39804226|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16359954|NCT01697579|39804227|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16359955|NCT01697579|39804228|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16359956|NCT01697579|39804229|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16359957|NCT01697579|39804230|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
16359958|NCT01697579|39804231|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
16359959|NCT00109343|39804234|FG000|Overall Study|Adverse Event|1|||
16359960|NCT00109343|39804235|FG001|Overall Study|Adverse Event|0|||
16359961|NCT00109343|39804236|FG002|Overall Study|Adverse Event|2|||
16359962|NCT00109343|39804234|FG000|Overall Study|Lack of Efficacy|1|||
16423682|NCT00858637|40028330|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
16562366|NCT02018861|40525379|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
16562367|NCT02018861|40525380|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
16562368|NCT02018861|40525381|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
16562369|NCT02018861|40525382|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16562370|NCT02018861|40525383|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16423683|NCT00858637|40028331|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
16423684|NCT00858637|40028326|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
16423685|NCT00858637|40028327|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
16423686|NCT00858637|40028328|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
16423687|NCT00858637|40028329|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
16423688|NCT00858637|40028330|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
16423689|NCT00858637|40028331|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
16423690|NCT00770809|40031425|FG000|Overall Study|Adverse Event|9|||
16423691|NCT00770809|40031426|FG001|Overall Study|Adverse Event|1|||
16423692|NCT00770809|40031427|FG002|Overall Study|Adverse Event|12|||
16423693|NCT00770809|40031425|FG000|Overall Study|Death|1|||
16423694|NCT00770809|40031426|FG001|Overall Study|Death|0|||
16423695|NCT00770809|40031427|FG002|Overall Study|Death|0|||
16423696|NCT00770809|40031425|FG000|Overall Study|Withdrawal by Subject|3|||
16423697|NCT00770809|40031426|FG001|Overall Study|Withdrawal by Subject|3|||
16423698|NCT00770809|40031427|FG002|Overall Study|Withdrawal by Subject|7|||
16423699|NCT00770809|40031425|FG000|Overall Study|Progression|2|||
16423700|NCT00770809|40031426|FG001|Overall Study|Progression|2|||
16423701|NCT00770809|40031427|FG002|Overall Study|Progression|0|||
16423702|NCT00770809|40031425|FG000|Overall Study|Complicating illness|0|||
16423703|NCT00770809|40031426|FG001|Overall Study|Complicating illness|0|||
16423704|NCT00770809|40031427|FG002|Overall Study|Complicating illness|1|||
16423705|NCT00770809|40031425|FG000|Overall Study|Other Medical Reasons|2|||
16423706|NCT00770809|40031426|FG001|Overall Study|Other Medical Reasons|4|||
16423707|NCT00770809|40031427|FG002|Overall Study|Other Medical Reasons|3|||
16423708|NCT00782483|40031428|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
16423709|NCT02003209|40031429|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
16423710|NCT02003209|40031430|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
16423711|NCT00892775|40031431|FG000|Overall Study|Protocol Violation|1|||
16423712|NCT00892775|40031432|FG001|Overall Study|Protocol Violation|0|||
16423713|NCT00892775|40031431|FG000|Overall Study|Subject difficulties with blood drawing|1|||
16423714|NCT00892775|40031432|FG001|Overall Study|Subject difficulties with blood drawing|0|||
16423715|NCT00892775|40031431|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
16423716|NCT00892775|40031432|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
16423717|NCT00892775|40031431|FG000|Overall Study|Migrated/ moved from study area|1|||
16423718|NCT00892775|40031432|FG001|Overall Study|Migrated/ moved from study area|0|||
16130915|NCT01323634|38967154|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
16249296|NCT02468557|39395441|FG000|Overall Study|Adverse Event|1|||
16423719|NCT00892775|40031431|FG000|Overall Study|Withdrawal by Subject|0|||
16423720|NCT00892775|40031432|FG001|Overall Study|Withdrawal by Subject|1|||
16423721|NCT00892775|40031431|FG000|Overall Study|Lost to Follow-up|1|||
16423722|NCT00892775|40031432|FG001|Overall Study|Lost to Follow-up|0|||
16423723|NCT02188849|40031433|FG000|Overall Study|Lost to Follow-up|3|||
16423724|NCT02188849|40031434|FG001|Overall Study|Lost to Follow-up|8|||
16423725|NCT00940498|40031435|FG000|Overall Study|Death|2|||
16423726|NCT00940498|40031436|FG001|Overall Study|Death|0|||
16423727|NCT00940498|40031437|FG002|Overall Study|Death|0|||
16423728|NCT00940498|40031438|FG003|Overall Study|Death|1|||
16423729|NCT00940498|40031439|FG004|Overall Study|Death|5|||
16423730|NCT00940498|40031440|FG005|Overall Study|Death|0|||
16423731|NCT00940498|40031441|FG006|Overall Study|Death|1|||
16423732|NCT00940498|40031442|FG007|Overall Study|Death|0|||
16423733|NCT00940498|40031435|FG000|Overall Study|Lost to Follow-up|1|||
16423734|NCT00940498|40031436|FG001|Overall Study|Lost to Follow-up|1|||
16423735|NCT00940498|40031437|FG002|Overall Study|Lost to Follow-up|2|||
16423736|NCT00940498|40031438|FG003|Overall Study|Lost to Follow-up|0|||
16423737|NCT00940498|40031439|FG004|Overall Study|Lost to Follow-up|1|||
16423738|NCT00940498|40031440|FG005|Overall Study|Lost to Follow-up|0|||
16423739|NCT00940498|40031441|FG006|Overall Study|Lost to Follow-up|0|||
16423740|NCT00940498|40031442|FG007|Overall Study|Lost to Follow-up|1|||
16423741|NCT00940498|40031435|FG000|Overall Study|Disease Progression|0|||
16423742|NCT00940498|40031436|FG001|Overall Study|Disease Progression|0|||
16423743|NCT00940498|40031437|FG002|Overall Study|Disease Progression|1|||
16562371|NCT02018861|40525384|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16562372|NCT02018861|40525385|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
16562373|NCT02018861|40525376|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16562374|NCT02018861|40525377|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16562375|NCT02018861|40525378|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16562376|NCT02018861|40525379|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
16562377|NCT02018861|40525380|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
16562378|NCT02018861|40525381|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16562379|NCT02018861|40525382|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16562380|NCT02018861|40525383|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16562381|NCT02018861|40525384|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16562382|NCT02018861|40525385|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
16562383|NCT02018861|40525376|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16562384|NCT02018861|40525377|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16562385|NCT02018861|40525378|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16562386|NCT02018861|40525379|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16562387|NCT02018861|40525380|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16562388|NCT02018861|40525381|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16562389|NCT02018861|40525382|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
16562390|NCT02018861|40525383|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
16562391|NCT02018861|40525384|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16562392|NCT02018861|40525385|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
16562393|NCT02018861|40525376|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16562394|NCT02018861|40525377|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16562395|NCT02018861|40525378|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16562396|NCT02018861|40525379|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16562397|NCT02018861|40525380|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16562398|NCT02018861|40525381|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16562399|NCT02018861|40525382|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
16562400|NCT02018861|40525383|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
16423744|NCT00940498|40031438|FG003|Overall Study|Disease Progression|1|||
16423745|NCT00940498|40031439|FG004|Overall Study|Disease Progression|0|||
16423746|NCT00940498|40031440|FG005|Overall Study|Disease Progression|1|||
16423747|NCT00940498|40031441|FG006|Overall Study|Disease Progression|0|||
16423748|NCT00940498|40031442|FG007|Overall Study|Disease Progression|0|||
16423749|NCT00940498|40031435|FG000|Overall Study|Physician Decision|0|||
16423750|NCT00940498|40031436|FG001|Overall Study|Physician Decision|0|||
16423751|NCT00940498|40031437|FG002|Overall Study|Physician Decision|0|||
16423752|NCT00940498|40031438|FG003|Overall Study|Physician Decision|0|||
16423753|NCT00940498|40031439|FG004|Overall Study|Physician Decision|2|||
16423754|NCT00940498|40031440|FG005|Overall Study|Physician Decision|0|||
16423755|NCT00940498|40031441|FG006|Overall Study|Physician Decision|0|||
16423756|NCT00940498|40031442|FG007|Overall Study|Physician Decision|0|||
16423757|NCT00940498|40031435|FG000|Overall Study|Not treated due to disease related pain|0|||
16423758|NCT00940498|40031436|FG001|Overall Study|Not treated due to disease related pain|0|||
16423759|NCT00940498|40031437|FG002|Overall Study|Not treated due to disease related pain|0|||
16423760|NCT00940498|40031438|FG003|Overall Study|Not treated due to disease related pain|0|||
16423761|NCT00940498|40031439|FG004|Overall Study|Not treated due to disease related pain|1|||
16423762|NCT00940498|40031440|FG005|Overall Study|Not treated due to disease related pain|0|||
16423763|NCT00940498|40031441|FG006|Overall Study|Not treated due to disease related pain|0|||
16423764|NCT00940498|40031442|FG007|Overall Study|Not treated due to disease related pain|0|||
16423765|NCT03737994|40031443|FG000|Overall Study|Withdrawal by Subject|0|||
16423766|NCT03737994|40031444|FG001|Overall Study|Withdrawal by Subject|0|||
16423767|NCT03737994|40031445|FG002|Overall Study|Withdrawal by Subject|0|||
16423768|NCT03737994|40031446|FG003|Overall Study|Withdrawal by Subject|0|||
16423769|NCT03737994|40031447|FG004|Overall Study|Withdrawal by Subject|0|||
16423770|NCT03737994|40031448|FG005|Overall Study|Withdrawal by Subject|0|||
16423771|NCT03737994|40031449|FG006|Overall Study|Withdrawal by Subject|1|||
16423772|NCT01059318|40031454|FG000|Core Study (26 Week)|Adverse Event|3|||
16423773|NCT01059318|40031454|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
16423774|NCT01059318|40031454|FG000|Extension (36 Week)|Adverse Event|3|||
16423775|NCT02890355|40031455|FG000|Overall Study|Adverse Event|5|||
16423776|NCT02890355|40031456|FG001|Overall Study|Adverse Event|5|||
16423777|NCT02890355|40031455|FG000|Overall Study|Refusal unrelated to adverse event|5|||
16423778|NCT02890355|40031456|FG001|Overall Study|Refusal unrelated to adverse event|10|||
16423779|NCT02890355|40031455|FG000|Overall Study|Progression/relapse|46|||
16423780|NCT02890355|40031456|FG001|Overall Study|Progression/relapse|39|||
16423781|NCT02890355|40031455|FG000|Overall Study|Not protocol specified|3|||
16423782|NCT02890355|40031456|FG001|Overall Study|Not protocol specified|4|||
16423783|NCT02775916|40031458|FG000|Overall Study|Adverse Event|1|||
16423784|NCT02775916|40031459|FG001|Overall Study|Adverse Event|0|||
16423785|NCT02775916|40031458|FG000|Overall Study|Subject/Guardian Decision|2|||
16423786|NCT02775916|40031459|FG001|Overall Study|Subject/Guardian Decision|0|||
16423787|NCT01364389|40031463|FG000|Overall Study|Withdrawal by Subject|0|||
16423788|NCT01364389|40031464|FG001|Overall Study|Withdrawal by Subject|1|||
16423789|NCT01364389|40031465|FG002|Overall Study|Withdrawal by Subject|0|||
16423790|NCT01364389|40031463|FG000|Overall Study|Protocol deviation|0|||
16423791|NCT01364389|40031464|FG001|Overall Study|Protocol deviation|0|||
16423792|NCT01364389|40031465|FG002|Overall Study|Protocol deviation|1|||
16423793|NCT01364389|40031463|FG000|Overall Study|Administrative problems|1|||
16423794|NCT01364389|40031464|FG001|Overall Study|Administrative problems|0|||
16423795|NCT01364389|40031465|FG002|Overall Study|Administrative problems|0|||
16423796|NCT01364389|40031463|FG000|Overall Study|Adverse Event|1|||
16423797|NCT01364389|40031464|FG001|Overall Study|Adverse Event|0|||
16423798|NCT01364389|40031465|FG002|Overall Study|Adverse Event|0|||
16423799|NCT00151372|40031466|FG000|Overall Study|Death|12|||
16423800|NCT00151372|40031467|FG001|Overall Study|Death|11|||
16423801|NCT00151372|40031466|FG000|Overall Study|Lost to Follow-up|5|||
16423802|NCT00151372|40031467|FG001|Overall Study|Lost to Follow-up|5|||
16423803|NCT00151372|40031466|FG000|Overall Study|Too sick medically to continue|5|||
16423804|NCT00151372|40031467|FG001|Overall Study|Too sick medically to continue|6|||
16423805|NCT00151372|40031466|FG000|Overall Study|Withdrawal by Subject|7|||
16423806|NCT00151372|40031467|FG001|Overall Study|Withdrawal by Subject|7|||
16423807|NCT02697435|40031471|FG000|Overall Study|Withdrawal by Subject|1|||
16423808|NCT02697435|40031472|FG001|Overall Study|Withdrawal by Subject|0|||
16423809|NCT02697435|40031471|FG000|Overall Study|Physician Decision|0|||
16423810|NCT02697435|40031472|FG001|Overall Study|Physician Decision|4|||
16423811|NCT00176462|40031473|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
16423812|NCT00176462|40031474|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
16423813|NCT00176462|40031473|FG000|Induction (4 Weeks)|Death|1|||
16423814|NCT00176462|40031474|FG001|Induction (4 Weeks)|Death|2|||
16423815|NCT00176462|40031473|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
16423816|NCT00176462|40031474|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
16423817|NCT00176462|40031473|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
16423818|NCT00176462|40031474|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
16423819|NCT00176462|40031473|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
16423820|NCT00176462|40031474|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
16423821|NCT00176462|40031473|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
16423822|NCT00176462|40031474|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
16423823|NCT00176462|40031473|FG000|Consolidation (12 Weeks)|Not documented|0|||
16423824|NCT00176462|40031474|FG001|Consolidation (12 Weeks)|Not documented|1|||
16423825|NCT00176462|40031473|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
16423826|NCT00176462|40031474|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
16423827|NCT00176462|40031473|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
16423828|NCT00176462|40031474|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
16423829|NCT02799745|40031478|FG000|Overall Study|Participant moved out of state|1|||
16423830|NCT02799745|40031479|FG001|Overall Study|Participant moved out of state|0|||
16423831|NCT02799745|40031478|FG000|Overall Study|Discontinued due to planned surgery|1|||
16423832|NCT02799745|40031479|FG001|Overall Study|Discontinued due to planned surgery|0|||
16423833|NCT02799745|40031478|FG000|Overall Study|Withdrawal by Subject|16|||
16423834|NCT02799745|40031479|FG001|Overall Study|Withdrawal by Subject|25|||
16423835|NCT02799745|40031478|FG000|Overall Study|Protocol Deviation|4|||
16423836|NCT02799745|40031479|FG001|Overall Study|Protocol Deviation|5|||
16423837|NCT02799745|40031478|FG000|Overall Study|Progressive Disease|28|||
16423838|NCT02799745|40031479|FG001|Overall Study|Progressive Disease|38|||
16423839|NCT02799745|40031478|FG000|Overall Study|Lost to Follow-up|3|||
16423840|NCT02799745|40031479|FG001|Overall Study|Lost to Follow-up|2|||
16423841|NCT02799745|40031478|FG000|Overall Study|Death|3|||
16423842|NCT02799745|40031479|FG001|Overall Study|Death|0|||
16423843|NCT02799745|40031478|FG000|Overall Study|Adverse Event|0|||
16423844|NCT02799745|40031479|FG001|Overall Study|Adverse Event|1|||
16423845|NCT00635882|40031488|FG000|Overall Study|Protocol Violation|1|||
16423846|NCT00635882|40031489|FG001|Overall Study|Protocol Violation|0|||
16423847|NCT00635882|40031490|FG002|Overall Study|Protocol Violation|0|||
16423848|NCT00635882|40031491|FG003|Overall Study|Protocol Violation|0|||
16423849|NCT00635882|40031492|FG004|Overall Study|Protocol Violation|0|||
16423850|NCT00635882|40031493|FG005|Overall Study|Protocol Violation|0|||
16423851|NCT02363959|40031494|FG000|Overall Study|Medical instability|1|||
16423852|NCT02363959|40031495|FG001|Overall Study|Medical instability|0|||
16423853|NCT02343406|40031496|FG000|Overall Study|Progressive disease|72|||
16423854|NCT02343406|40031497|FG001|Overall Study|Progressive disease|70|||
16423855|NCT02343406|40031498|FG002|Overall Study|Progressive disease|43|||
16423856|NCT02343406|40031499|FG003|Overall Study|Progressive disease|15|||
16423857|NCT02343406|40031500|FG004|Overall Study|Progressive disease|5|||
16423858|NCT02343406|40031496|FG000|Overall Study|Adverse Event|6|||
16423859|NCT02343406|40031497|FG001|Overall Study|Adverse Event|8|||
16423860|NCT02343406|40031498|FG002|Overall Study|Adverse Event|6|||
16423861|NCT02343406|40031499|FG003|Overall Study|Adverse Event|3|||
16423862|NCT02343406|40031500|FG004|Overall Study|Adverse Event|0|||
16423863|NCT02343406|40031496|FG000|Overall Study|Withdrawal by Subject|6|||
16423864|NCT02343406|40031497|FG001|Overall Study|Withdrawal by Subject|4|||
16423865|NCT02343406|40031498|FG002|Overall Study|Withdrawal by Subject|8|||
16423866|NCT02343406|40031499|FG003|Overall Study|Withdrawal by Subject|3|||
16423867|NCT02343406|40031500|FG004|Overall Study|Withdrawal by Subject|0|||
16423868|NCT02343406|40031496|FG000|Overall Study|Death|2|||
16423869|NCT02343406|40031497|FG001|Overall Study|Death|1|||
16423870|NCT02343406|40031498|FG002|Overall Study|Death|0|||
16423871|NCT02343406|40031499|FG003|Overall Study|Death|0|||
16423872|NCT02343406|40031500|FG004|Overall Study|Death|0|||
16423873|NCT02343406|40031496|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
16423874|NCT02343406|40031497|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
16423875|NCT02343406|40031498|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
16423876|NCT02343406|40031499|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
16423877|NCT02343406|40031500|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
16423878|NCT02343406|40031496|FG000|Overall Study|Other primary malignancy|0|||
16423879|NCT02343406|40031497|FG001|Overall Study|Other primary malignancy|1|||
16423880|NCT02343406|40031498|FG002|Overall Study|Other primary malignancy|0|||
16423881|NCT02343406|40031499|FG003|Overall Study|Other primary malignancy|0|||
16423882|NCT02343406|40031500|FG004|Overall Study|Other primary malignancy|0|||
16249297|NCT02468557|39395441|FG000|Overall Study|Death|1|||
16423883|NCT02343406|40031496|FG000|Overall Study|Other, not specified|2|||
16423884|NCT02343406|40031497|FG001|Overall Study|Other, not specified|1|||
16423885|NCT02343406|40031498|FG002|Overall Study|Other, not specified|1|||
16423886|NCT02343406|40031499|FG003|Overall Study|Other, not specified|4|||
16423887|NCT02343406|40031500|FG004|Overall Study|Other, not specified|0|||
16423888|NCT00235716|40031503|FG000|Overall Study|Death|26|||
16423889|NCT00235716|40031504|FG001|Overall Study|Death|39|||
16423890|NCT00235716|40031505|FG002|Overall Study|Death|32|||
16423891|NCT00235716|40031506|FG003|Overall Study|Death|31|||
16423892|NCT00235716|40031503|FG000|Overall Study|Withdrawal by Subject|23|||
16423893|NCT00235716|40031504|FG001|Overall Study|Withdrawal by Subject|19|||
16423894|NCT00235716|40031505|FG002|Overall Study|Withdrawal by Subject|17|||
16423895|NCT00235716|40031506|FG003|Overall Study|Withdrawal by Subject|18|||
16423896|NCT00235716|40031503|FG000|Overall Study|Lost to Follow-up|12|||
16423897|NCT00235716|40031504|FG001|Overall Study|Lost to Follow-up|7|||
16423898|NCT00235716|40031505|FG002|Overall Study|Lost to Follow-up|14|||
16423899|NCT00235716|40031506|FG003|Overall Study|Lost to Follow-up|10|||
16423900|NCT00235716|40031503|FG000|Overall Study|Adverse Event|1|||
16423901|NCT00235716|40031504|FG001|Overall Study|Adverse Event|1|||
16423902|NCT00235716|40031505|FG002|Overall Study|Adverse Event|1|||
16423903|NCT00235716|40031506|FG003|Overall Study|Adverse Event|0|||
16423904|NCT00235716|40031503|FG000|Overall Study|Physician Decision|0|||
16423905|NCT00235716|40031504|FG001|Overall Study|Physician Decision|1|||
16423906|NCT00235716|40031505|FG002|Overall Study|Physician Decision|1|||
16423907|NCT00235716|40031506|FG003|Overall Study|Physician Decision|3|||
16423908|NCT02218008|40031507|FG000|Stage 1 (S1)|Adverse Event|6|||
16423909|NCT02218008|40031508|FG001|Stage 1 (S1)|Adverse Event|5|||
16423910|NCT02218008|40031509|FG002|Stage 1 (S1)|Adverse Event|11|||
16423911|NCT02218008|40031510|FG003|Stage 1 (S1)|Adverse Event|0|||
16423912|NCT02218008|40031511|FG004|Stage 1 (S1)|Adverse Event|0|||
16423913|NCT02218008|40031512|FG005|Stage 1 (S1)|Adverse Event|0|||
16423914|NCT02218008|40031507|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
16562401|NCT02018861|40525384|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16562402|NCT02018861|40525385|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
16359963|NCT00109343|39804235|FG001|Overall Study|Lack of Efficacy|0|||
16359964|NCT00109343|39804236|FG002|Overall Study|Lack of Efficacy|0|||
16359965|NCT00109343|39804234|FG000|Overall Study|Lost to Follow-up|35|||
16359966|NCT00109343|39804235|FG001|Overall Study|Lost to Follow-up|20|||
16359967|NCT00109343|39804236|FG002|Overall Study|Lost to Follow-up|14|||
16359968|NCT00109343|39804234|FG000|Overall Study|Protocol Violation|1|||
16359969|NCT00109343|39804235|FG001|Overall Study|Protocol Violation|2|||
16359970|NCT00109343|39804236|FG002|Overall Study|Protocol Violation|2|||
16359971|NCT00109343|39804234|FG000|Overall Study|Withdrawal by Subject|15|||
16359972|NCT00109343|39804235|FG001|Overall Study|Withdrawal by Subject|11|||
16359973|NCT00109343|39804236|FG002|Overall Study|Withdrawal by Subject|10|||
16359974|NCT00109343|39804234|FG000|Overall Study|Subject Moved|6|||
16359975|NCT00109343|39804235|FG001|Overall Study|Subject Moved|2|||
16359976|NCT00109343|39804236|FG002|Overall Study|Subject Moved|1|||
16359977|NCT00109343|39804234|FG000|Overall Study|Other|5|||
16359978|NCT00109343|39804235|FG001|Overall Study|Other|2|||
16359979|NCT00109343|39804236|FG002|Overall Study|Other|1|||
16359980|NCT02030600|39804237|FG000|Treatment Period 1|Adverse Event|5|||
16359981|NCT02030600|39804238|FG001|Treatment Period 1|Adverse Event|7|||
16359982|NCT02030600|39804237|FG000|Treatment Period 1|Lack of Efficacy|0|||
16359983|NCT02030600|39804238|FG001|Treatment Period 1|Lack of Efficacy|1|||
16359984|NCT02030600|39804237|FG000|Treatment Period 1|Lost to Follow-up|11|||
16359985|NCT02030600|39804238|FG001|Treatment Period 1|Lost to Follow-up|3|||
16359986|NCT02030600|39804237|FG000|Treatment Period 1|Protocol Violation|22|||
16359987|NCT02030600|39804238|FG001|Treatment Period 1|Protocol Violation|17|||
16359988|NCT02030600|39804237|FG000|Treatment Period 1|Withdrawal by Subject|13|||
16359989|NCT02030600|39804238|FG001|Treatment Period 1|Withdrawal by Subject|17|||
16359990|NCT02030600|39804237|FG000|Treatment Period 1|Casebook Unsigned|1|||
16359991|NCT02030600|39804238|FG001|Treatment Period 1|Casebook Unsigned|0|||
16359992|NCT02030600|39804237|FG000|Treatment Period 1|Unclassified|1|||
16359993|NCT02030600|39804238|FG001|Treatment Period 1|Unclassified|0|||
16359994|NCT02030600|39804237|FG000|Treatment Period 2|Adverse Event|4|||
16359995|NCT02030600|39804238|FG001|Treatment Period 2|Adverse Event|4|||
16359996|NCT02030600|39804237|FG000|Treatment Period 2|Lack of Efficacy|2|||
16359997|NCT02030600|39804238|FG001|Treatment Period 2|Lack of Efficacy|1|||
16359998|NCT02030600|39804237|FG000|Treatment Period 2|Lost to Follow-up|4|||
16359999|NCT02030600|39804238|FG001|Treatment Period 2|Lost to Follow-up|2|||
16360000|NCT02030600|39804237|FG000|Treatment Period 2|Protocol Violation|1|||
16360001|NCT02030600|39804238|FG001|Treatment Period 2|Protocol Violation|2|||
16360002|NCT02030600|39804237|FG000|Treatment Period 2|Withdrawal by Subject|13|||
16360003|NCT02030600|39804238|FG001|Treatment Period 2|Withdrawal by Subject|9|||
16360004|NCT02030600|39804237|FG000|Treatment Period 2|Unclassified|1|||
16360005|NCT02030600|39804238|FG001|Treatment Period 2|Unclassified|0|||
16360006|NCT00862992|39804243|FG000|Overall Study|Adverse Event|2|||
16360007|NCT00862992|39804244|FG001|Overall Study|Adverse Event|1|||
16360008|NCT00862992|39804245|FG002|Overall Study|Adverse Event|1|||
16360009|NCT00862992|39804243|FG000|Overall Study|Physician Decision|1|||
16360010|NCT00862992|39804244|FG001|Overall Study|Physician Decision|0|||
16360011|NCT00862992|39804245|FG002|Overall Study|Physician Decision|0|||
16360012|NCT00862992|39804243|FG000|Overall Study|Withdrawal by Subject|0|||
16360013|NCT00862992|39804244|FG001|Overall Study|Withdrawal by Subject|0|||
16360014|NCT00862992|39804245|FG002|Overall Study|Withdrawal by Subject|2|||
16360015|NCT00157755|39804253|FG000|Overall Study|Death|2|||
16360016|NCT00157755|39804254|FG001|Overall Study|Death|3|||
16360017|NCT00157755|39804255|FG002|Overall Study|Death|3|||
16360018|NCT00157755|39804256|FG003|Overall Study|Death|2|||
16360019|NCT00157755|39804257|FG004|Overall Study|Death|0|||
16360020|NCT00157755|39804258|FG005|Overall Study|Death|0|||
16360021|NCT00157755|39804253|FG000|Overall Study|Lost to Follow-up|0|||
16249298|NCT02468557|39395441|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
16249299|NCT02468557|39395441|FG000|Overall Study|All Enrolled but Never Dosed|4|||
16249300|NCT02918162|39395445|FG000|Overall Study|Withdrawal by Subject|1|||
16249301|NCT02918162|39395445|FG000|Overall Study|Omental Disease|1|||
16249302|NCT00704418|39395446|FG000|Overall Study|Withdrawal by Subject|2|||
16249303|NCT00704418|39395447|FG001|Overall Study|Withdrawal by Subject|0|||
16249304|NCT00704418|39395446|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
16249305|NCT00704418|39395447|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
16249306|NCT03469271|39395448|FG000|Overall Study|Withdrawal by Subject|2|||
16249307|NCT03469271|39395449|FG001|Overall Study|Withdrawal by Subject|0|||
16249308|NCT03469271|39395450|FG002|Overall Study|Withdrawal by Subject|0|||
16249309|NCT03469271|39395451|FG003|Overall Study|Withdrawal by Subject|1|||
16249310|NCT01533428|39395452|FG000|Overall Study|Adverse Event|0|||
16249311|NCT01533428|39395453|FG001|Overall Study|Adverse Event|1|||
16249312|NCT01533428|39395452|FG000|Overall Study|Lost to Follow-up|2|||
16249313|NCT01533428|39395453|FG001|Overall Study|Lost to Follow-up|1|||
16249314|NCT01533428|39395452|FG000|Overall Study|Withdrawal by Subject|7|||
16249315|NCT01533428|39395453|FG001|Overall Study|Withdrawal by Subject|6|||
16249316|NCT01104662|39395454|FG000|Overall Study|Adverse Event|2|||
16249317|NCT01104662|39395455|FG001|Overall Study|Adverse Event|2|||
16249318|NCT01104662|39395456|FG002|Overall Study|Adverse Event|0|||
16249319|NCT01104662|39395457|FG003|Overall Study|Adverse Event|1|||
16249320|NCT01104662|39395458|FG004|Overall Study|Adverse Event|1|||
16249321|NCT01104662|39395459|FG005|Overall Study|Adverse Event|1|||
16249322|NCT01104662|39395460|FG006|Overall Study|Adverse Event|0|||
16249323|NCT01104662|39395461|FG007|Overall Study|Adverse Event|0|||
16249324|NCT01104662|39395454|FG000|Overall Study|Clinical Failure|1|||
16249325|NCT01104662|39395455|FG001|Overall Study|Clinical Failure|0|||
16249326|NCT01104662|39395456|FG002|Overall Study|Clinical Failure|0|||
16249327|NCT01104662|39395457|FG003|Overall Study|Clinical Failure|0|||
16249328|NCT01104662|39395458|FG004|Overall Study|Clinical Failure|0|||
16249329|NCT01104662|39395459|FG005|Overall Study|Clinical Failure|1|||
16249330|NCT01104662|39395460|FG006|Overall Study|Clinical Failure|0|||
16249331|NCT01104662|39395461|FG007|Overall Study|Clinical Failure|0|||
16249332|NCT01104662|39395454|FG000|Overall Study|Participant left investigator's care|1|||
16249333|NCT01104662|39395455|FG001|Overall Study|Participant left investigator's care|1|||
16249334|NCT01104662|39395456|FG002|Overall Study|Participant left investigator's care|0|||
16249335|NCT01104662|39395457|FG003|Overall Study|Participant left investigator's care|0|||
16249336|NCT01104662|39395458|FG004|Overall Study|Participant left investigator's care|0|||
16249337|NCT01104662|39395459|FG005|Overall Study|Participant left investigator's care|0|||
16249338|NCT01104662|39395460|FG006|Overall Study|Participant left investigator's care|0|||
16249339|NCT01104662|39395461|FG007|Overall Study|Participant left investigator's care|0|||
16249340|NCT01104662|39395454|FG000|Overall Study|Reason not specified|3|||
16249341|NCT01104662|39395455|FG001|Overall Study|Reason not specified|3|||
16249342|NCT01104662|39395456|FG002|Overall Study|Reason not specified|0|||
16249343|NCT01104662|39395457|FG003|Overall Study|Reason not specified|0|||
16360022|NCT00157755|39804254|FG001|Overall Study|Lost to Follow-up|0|||
16360023|NCT00157755|39804255|FG002|Overall Study|Lost to Follow-up|1|||
16360024|NCT00157755|39804256|FG003|Overall Study|Lost to Follow-up|0|||
16360025|NCT00157755|39804257|FG004|Overall Study|Lost to Follow-up|0|||
16360026|NCT00157755|39804258|FG005|Overall Study|Lost to Follow-up|0|||
16360027|NCT00157755|39804253|FG000|Overall Study|Withdrawal by Subject|0|||
16360028|NCT00157755|39804254|FG001|Overall Study|Withdrawal by Subject|0|||
16360029|NCT00157755|39804255|FG002|Overall Study|Withdrawal by Subject|1|||
16360030|NCT00157755|39804256|FG003|Overall Study|Withdrawal by Subject|1|||
16360031|NCT00157755|39804257|FG004|Overall Study|Withdrawal by Subject|1|||
16360032|NCT00157755|39804258|FG005|Overall Study|Withdrawal by Subject|2|||
16360033|NCT00157755|39804253|FG000|Overall Study|Explant due to infection|0|||
16360034|NCT00157755|39804254|FG001|Overall Study|Explant due to infection|0|||
16249344|NCT01104662|39395458|FG004|Overall Study|Reason not specified|0|||
16249345|NCT01104662|39395459|FG005|Overall Study|Reason not specified|1|||
16249346|NCT01104662|39395460|FG006|Overall Study|Reason not specified|0|||
16360035|NCT00157755|39804255|FG002|Overall Study|Explant due to infection|1|||
16360036|NCT00157755|39804256|FG003|Overall Study|Explant due to infection|0|||
16360037|NCT00157755|39804257|FG004|Overall Study|Explant due to infection|0|||
16360038|NCT00157755|39804258|FG005|Overall Study|Explant due to infection|0|||
16360039|NCT00157755|39804253|FG000|Overall Study|Medical reason|0|||
16360040|NCT00157755|39804254|FG001|Overall Study|Medical reason|0|||
16360041|NCT00157755|39804255|FG002|Overall Study|Medical reason|1|||
16360042|NCT00157755|39804256|FG003|Overall Study|Medical reason|1|||
16360043|NCT00157755|39804257|FG004|Overall Study|Medical reason|0|||
16360044|NCT00157755|39804258|FG005|Overall Study|Medical reason|0|||
16360045|NCT00157755|39804253|FG000|Overall Study|Study site closure|0|||
16360046|NCT00157755|39804254|FG001|Overall Study|Study site closure|1|||
16360047|NCT00157755|39804255|FG002|Overall Study|Study site closure|0|||
16360048|NCT00157755|39804256|FG003|Overall Study|Study site closure|0|||
16360049|NCT00157755|39804257|FG004|Overall Study|Study site closure|0|||
16360050|NCT00157755|39804258|FG005|Overall Study|Study site closure|0|||
16360051|NCT00157755|39804253|FG000|Overall Study|Subject non-compliance|0|||
16360052|NCT00157755|39804254|FG001|Overall Study|Subject non-compliance|0|||
16360053|NCT00157755|39804255|FG002|Overall Study|Subject non-compliance|0|||
16360054|NCT00157755|39804256|FG003|Overall Study|Subject non-compliance|0|||
16360055|NCT00157755|39804257|FG004|Overall Study|Subject non-compliance|0|||
16360056|NCT00157755|39804258|FG005|Overall Study|Subject non-compliance|1|||
16360057|NCT00157755|39804253|FG000|Overall Study|Study completion|0|||
16360058|NCT00157755|39804254|FG001|Overall Study|Study completion|0|||
16360059|NCT00157755|39804255|FG002|Overall Study|Study completion|0|||
16360060|NCT00157755|39804256|FG003|Overall Study|Study completion|0|||
16360061|NCT00157755|39804257|FG004|Overall Study|Study completion|1|||
16360062|NCT00157755|39804258|FG005|Overall Study|Study completion|2|||
16360063|NCT02873689|39804259|FG000|Overall Study|Lack of Efficacy|1|||
16360064|NCT02873689|39804260|FG001|Overall Study|Lack of Efficacy|0|||
16360065|NCT02873689|39804259|FG000|Overall Study|Withdrawal by Subject|2|||
16360066|NCT02873689|39804260|FG001|Overall Study|Withdrawal by Subject|2|||
16360067|NCT02873689|39804259|FG000|Overall Study|Protocol Violation|1|||
16360068|NCT02873689|39804260|FG001|Overall Study|Protocol Violation|0|||
16360069|NCT02873689|39804259|FG000|Overall Study|Adverse Event|2|||
16360070|NCT02873689|39804260|FG001|Overall Study|Adverse Event|2|||
16360071|NCT02873689|39804259|FG000|Overall Study|Randomized but not Treated|1|||
16360072|NCT02873689|39804260|FG001|Overall Study|Randomized but not Treated|1|||
16360073|NCT00127803|39804261|FG000|Overall Study|Adverse Event|2|||
16360074|NCT00127803|39804262|FG001|Overall Study|Adverse Event|0|||
16360075|NCT00127803|39804263|FG002|Overall Study|Adverse Event|0|||
16360076|NCT00127803|39804264|FG003|Overall Study|Adverse Event|0|||
16360077|NCT00127803|39804261|FG000|Overall Study|Withdrawal by Subject|1|||
16360078|NCT00127803|39804262|FG001|Overall Study|Withdrawal by Subject|0|||
16360079|NCT00127803|39804263|FG002|Overall Study|Withdrawal by Subject|0|||
16360080|NCT00127803|39804264|FG003|Overall Study|Withdrawal by Subject|0|||
16360081|NCT00127803|39804261|FG000|Overall Study|Lost to Follow-up|0|||
16360082|NCT00127803|39804262|FG001|Overall Study|Lost to Follow-up|0|||
16360083|NCT00127803|39804263|FG002|Overall Study|Lost to Follow-up|0|||
16360084|NCT00127803|39804264|FG003|Overall Study|Lost to Follow-up|1|||
16360085|NCT00473083|39804265|FG000|Overall Study|Adverse Event|1|||
16360086|NCT00473083|39804266|FG001|Overall Study|Adverse Event|0|||
16360087|NCT00473083|39804267|FG002|Overall Study|Adverse Event|0|||
16360088|NCT00433836|39804268|FG000|Overall Study|Adverse Event|7|||
16360089|NCT00433836|39804269|FG001|Overall Study|Adverse Event|0|||
16360090|NCT00433836|39804268|FG000|Overall Study|Lost to Follow-up|3|||
16360091|NCT00433836|39804269|FG001|Overall Study|Lost to Follow-up|0|||
16360092|NCT00433836|39804268|FG000|Overall Study|Withdrawal by Subject|2|||
16360093|NCT00433836|39804269|FG001|Overall Study|Withdrawal by Subject|1|||
16360094|NCT00433836|39804268|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16360095|NCT00433836|39804269|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16360096|NCT00433836|39804268|FG000|Overall Study|Protocol Violation|0|||
16360097|NCT00433836|39804269|FG001|Overall Study|Protocol Violation|2|||
16360098|NCT00433836|39804268|FG000|Overall Study|Condition no longer requires study drug|0|||
16360099|NCT00433836|39804269|FG001|Overall Study|Condition no longer requires study drug|1|||
16360100|NCT00433836|39804268|FG000|Overall Study|Abnormal laboratory values|0|||
16360101|NCT00433836|39804269|FG001|Overall Study|Abnormal laboratory values|1|||
16360102|NCT02495389|39804270|FG000|Overall Study|Withdrawal by Subject|40|||
16360103|NCT01192815|39804271|FG000|Overall Study|Withdrawal by Subject|1|||
16360104|NCT01192815|39804271|FG000|Overall Study|Lack of Efficacy|1|||
16360105|NCT02391337|39804275|FG000|6 Months Follow-up|Death|5|||
16360106|NCT02391337|39804276|FG001|6 Months Follow-up|Death|4|||
16360107|NCT02391337|39804275|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
16360108|NCT02391337|39804276|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
16360109|NCT02391337|39804275|FG000|12 Months Follow-up|Death|2|||
16360110|NCT02391337|39804276|FG001|12 Months Follow-up|Death|0|||
16360111|NCT02391337|39804275|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
16360112|NCT02391337|39804276|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
16360113|NCT02391337|39804275|FG000|12 Months Follow-up|Lost to Follow-up|0|||
16360114|NCT02391337|39804276|FG001|12 Months Follow-up|Lost to Follow-up|2|||
16360115|NCT03334175|39804277|FG000|Overall Study|Lost to Follow-up|0|||
16360116|NCT03334175|39804278|FG001|Overall Study|Lost to Follow-up|1|||
16360117|NCT01056536|39804291|FG000|Overall Study|Lost to Follow-up|202|||
16423915|NCT02218008|40031508|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
16423916|NCT02218008|40031509|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
16423917|NCT02218008|40031510|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
16423918|NCT02218008|40031511|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
16423919|NCT02218008|40031512|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
16423920|NCT02218008|40031507|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
16423921|NCT02218008|40031508|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
16423922|NCT02218008|40031509|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
16423923|NCT02218008|40031510|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
16423924|NCT02218008|40031511|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
16423925|NCT02218008|40031512|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
16423926|NCT02218008|40031507|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
16423927|NCT02218008|40031508|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
16423928|NCT02218008|40031509|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
16423929|NCT02218008|40031510|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
16423930|NCT02218008|40031511|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
16423931|NCT02218008|40031512|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
16423932|NCT02218008|40031507|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
16423933|NCT02218008|40031508|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
16423934|NCT02218008|40031509|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
16423935|NCT02218008|40031510|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
16423936|NCT02218008|40031511|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
16423937|NCT02218008|40031512|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
16423938|NCT02218008|40031507|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
16423939|NCT02218008|40031508|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
16423940|NCT02218008|40031509|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
16423941|NCT02218008|40031510|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
16423942|NCT02218008|40031511|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
16423943|NCT02218008|40031512|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
16423944|NCT02218008|40031507|FG000|Stage 1 (S1)|Pregnancy|0|||
16423945|NCT02218008|40031508|FG001|Stage 1 (S1)|Pregnancy|0|||
16423946|NCT02218008|40031509|FG002|Stage 1 (S1)|Pregnancy|1|||
16423947|NCT02218008|40031510|FG003|Stage 1 (S1)|Pregnancy|0|||
16423948|NCT02218008|40031511|FG004|Stage 1 (S1)|Pregnancy|0|||
16423949|NCT02218008|40031512|FG005|Stage 1 (S1)|Pregnancy|0|||
16423950|NCT02218008|40031507|FG000|Stage 1 (S1)|Protocol Violation|0|||
16423951|NCT02218008|40031508|FG001|Stage 1 (S1)|Protocol Violation|0|||
16423952|NCT02218008|40031509|FG002|Stage 1 (S1)|Protocol Violation|1|||
16423953|NCT02218008|40031510|FG003|Stage 1 (S1)|Protocol Violation|0|||
16423954|NCT02218008|40031511|FG004|Stage 1 (S1)|Protocol Violation|0|||
16423955|NCT02218008|40031512|FG005|Stage 1 (S1)|Protocol Violation|0|||
16423956|NCT02218008|40031507|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
16423957|NCT02218008|40031508|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
16423958|NCT02218008|40031509|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
16423959|NCT02218008|40031510|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
16423960|NCT02218008|40031511|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
16423961|NCT02218008|40031512|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
16423962|NCT02218008|40031507|FG000|Stage 2 (S2)|Adverse Event|0|||
16423963|NCT02218008|40031508|FG001|Stage 2 (S2)|Adverse Event|0|||
16423964|NCT02218008|40031509|FG002|Stage 2 (S2)|Adverse Event|0|||
16423965|NCT02218008|40031510|FG003|Stage 2 (S2)|Adverse Event|2|||
16423966|NCT02218008|40031511|FG004|Stage 2 (S2)|Adverse Event|3|||
16423967|NCT02218008|40031512|FG005|Stage 2 (S2)|Adverse Event|3|||
16423968|NCT02218008|40031507|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
16423969|NCT02218008|40031508|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
16423970|NCT02218008|40031509|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
16423971|NCT02218008|40031510|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
16423972|NCT02218008|40031511|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
16423973|NCT02218008|40031512|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
16423974|NCT02218008|40031507|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
16423975|NCT02218008|40031508|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
16423976|NCT02218008|40031509|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
16423977|NCT02218008|40031510|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
16423978|NCT02218008|40031511|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
16423979|NCT02218008|40031512|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
16423980|NCT02218008|40031507|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
16423981|NCT02218008|40031508|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
16423982|NCT02218008|40031509|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
16423983|NCT02218008|40031510|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
16423984|NCT02218008|40031511|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
16423985|NCT02218008|40031512|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
16423986|NCT02218008|40031507|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
16423987|NCT02218008|40031508|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
16423988|NCT02218008|40031509|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
16423989|NCT02218008|40031510|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
16423990|NCT02218008|40031511|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
16423991|NCT02218008|40031512|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
16423992|NCT05090852|40031513|FG000|Overall Study|Physician Decision|5|||
16423993|NCT02587819|40031514|FG000|Overall Study|Adverse Event|1|||
16423994|NCT02587819|40031514|FG000|Overall Study|Lost to Follow-up|1|||
16423995|NCT00434109|40031515|FG000|Overall Study|Physician Decision|9|||
16423996|NCT00434109|40031515|FG000|Overall Study|Adverse Event|5|||
16423997|NCT00434109|40031515|FG000|Overall Study|Protocol Violation|1|||
16423998|NCT00434109|40031515|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
16423999|NCT04072887|40031516|FG000|Overall Study|Withdrawal by Subject|3|||
16424000|NCT04072887|40031517|FG001|Overall Study|Withdrawal by Subject|8|||
16424001|NCT04072887|40031518|FG002|Overall Study|Withdrawal by Subject|1|||
16424002|NCT04072887|40031519|FG003|Overall Study|Withdrawal by Subject|3|||
16424003|NCT04072887|40031520|FG004|Overall Study|Withdrawal by Subject|3|||
16424004|NCT04072887|40031521|FG005|Overall Study|Withdrawal by Subject|13|||
16424005|NCT04072887|40031516|FG000|Overall Study|Adverse Event|2|||
16424006|NCT04072887|40031517|FG001|Overall Study|Adverse Event|4|||
16424007|NCT04072887|40031518|FG002|Overall Study|Adverse Event|1|||
16424008|NCT04072887|40031519|FG003|Overall Study|Adverse Event|4|||
16424009|NCT04072887|40031520|FG004|Overall Study|Adverse Event|0|||
16424010|NCT04072887|40031521|FG005|Overall Study|Adverse Event|1|||
16424011|NCT04072887|40031516|FG000|Overall Study|Physician Decision|2|||
16424012|NCT04072887|40031517|FG001|Overall Study|Physician Decision|0|||
16424013|NCT04072887|40031518|FG002|Overall Study|Physician Decision|0|||
16424014|NCT04072887|40031519|FG003|Overall Study|Physician Decision|0|||
16424015|NCT04072887|40031520|FG004|Overall Study|Physician Decision|0|||
16424016|NCT04072887|40031521|FG005|Overall Study|Physician Decision|1|||
16424017|NCT04072887|40031516|FG000|Overall Study|Lost to Follow-up|1|||
16424018|NCT04072887|40031517|FG001|Overall Study|Lost to Follow-up|3|||
16424019|NCT04072887|40031518|FG002|Overall Study|Lost to Follow-up|0|||
16424020|NCT04072887|40031519|FG003|Overall Study|Lost to Follow-up|0|||
16424021|NCT04072887|40031520|FG004|Overall Study|Lost to Follow-up|0|||
16424022|NCT04072887|40031521|FG005|Overall Study|Lost to Follow-up|0|||
16424023|NCT04072887|40031516|FG000|Overall Study|Death|0|||
16424024|NCT04072887|40031517|FG001|Overall Study|Death|2|||
16424025|NCT04072887|40031518|FG002|Overall Study|Death|0|||
16424026|NCT04072887|40031519|FG003|Overall Study|Death|2|||
16424027|NCT04072887|40031520|FG004|Overall Study|Death|3|||
16424028|NCT04072887|40031521|FG005|Overall Study|Death|0|||
16424029|NCT01564732|40031522|FG000|Overall Study|Early termination by the study sponsor|6|||
16424030|NCT01564732|40031523|FG001|Overall Study|Early termination by the study sponsor|5|||
16424031|NCT00320515|40031527|FG000|Overall Study|Death|33|||
16424032|NCT00320515|40031527|FG000|Overall Study|Lost to Follow-up|6|||
16424033|NCT00320515|40031527|FG000|Overall Study|Physician Decision|2|||
16424034|NCT00320515|40031527|FG000|Overall Study|Withdrawal by Subject|8|||
16424035|NCT03228212|40031528|FG000|Period 1|Adverse Event|1|||
16424036|NCT03228212|40031529|FG001|Period 1|Adverse Event|0|||
16424037|NCT03228212|40031528|FG000|Period 1|no longer meets eligibility criteria|0|||
16424038|NCT03228212|40031529|FG001|Period 1|no longer meets eligibility criteria|1|||
16424039|NCT03228212|40031528|FG000|Period 2|Lost to Follow-up|1|||
16424040|NCT03228212|40031529|FG001|Period 2|Lost to Follow-up|0|||
16424041|NCT00895310|40031534|FG000|Overall Study|Withdrawal by Subject|1|||
16424042|NCT00163020|40031536|FG000|Overall Study|Lost to Follow-up|0|||
16424043|NCT00163020|40031537|FG001|Overall Study|Lost to Follow-up|2|||
16424044|NCT04565951|40031538|FG000|Overall Study|Lost to Follow-up|66|||
16424045|NCT04565951|40031539|FG001|Overall Study|Lost to Follow-up|38|||
16424046|NCT04565951|40031538|FG000|Overall Study|Withdrawal by Subject|14|||
16424047|NCT04565951|40031539|FG001|Overall Study|Withdrawal by Subject|7|||
16424048|NCT04565951|40031538|FG000|Overall Study|Death|0|||
16424049|NCT04565951|40031539|FG001|Overall Study|Death|1|||
16424050|NCT01433172|40031540|FG000|Overall Study|Withdrawal by Subject|0|||
16424051|NCT01433172|40031541|FG001|Overall Study|Withdrawal by Subject|1|||
16424052|NCT01433172|40031542|FG002|Overall Study|Withdrawal by Subject|0|||
16424053|NCT01433172|40031540|FG000|Overall Study|Disease Progression|0|||
16424054|NCT01433172|40031541|FG001|Overall Study|Disease Progression|0|||
16424055|NCT01433172|40031542|FG002|Overall Study|Disease Progression|1|||
16424056|NCT01433172|40031540|FG000|Overall Study|Death|0|||
16424057|NCT01433172|40031541|FG001|Overall Study|Death|2|||
16424058|NCT01433172|40031542|FG002|Overall Study|Death|0|||
16424059|NCT01150097|40031544|FG000|Months 24 to 36 Post-transplantation|Death|2|||
16424060|NCT01150097|40031545|FG001|Months 24 to 36 Post-transplantation|Death|0|||
16424061|NCT01150097|40031546|FG002|Months 24 to 36 Post-transplantation|Death|0|||
16424062|NCT01150097|40031544|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
16424063|NCT01150097|40031545|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
16424064|NCT01150097|40031546|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
16424065|NCT01150097|40031544|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
16424066|NCT01150097|40031545|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
16424067|NCT01150097|40031546|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
16424068|NCT01150097|40031544|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
16424069|NCT01150097|40031545|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
16424070|NCT01150097|40031546|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
16424071|NCT01150097|40031544|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
16424072|NCT01150097|40031545|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
16424073|NCT01150097|40031546|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
16424074|NCT01150097|40031544|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
16424075|NCT01150097|40031545|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
16424076|NCT01150097|40031546|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
16424077|NCT01150097|40031544|FG000|Months 24 to 48 Post-transplantation|Death|2|||
16424078|NCT01150097|40031545|FG001|Months 24 to 48 Post-transplantation|Death|0|||
16424079|NCT01150097|40031546|FG002|Months 24 to 48 Post-transplantation|Death|0|||
16424080|NCT01635855|40031549|FG000|Overall Study|Withdrawal by Subject|4|||
16424081|NCT00794950|40031554|FG000|BCG Induction|Withdrawal by Subject|2|||
16424082|NCT00794950|40031554|FG000|BCG Induction|ineligible|3|||
16424083|NCT00794950|40031554|FG000|BCG Induction|noncompliant w. BCG|1|||
16424084|NCT00794950|40031554|FG000|BCG Induction|Adverse Event|1|||
16424085|NCT00794950|40031554|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
16424086|NCT00794950|40031554|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
16424087|NCT00794950|40031554|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
16424088|NCT00794950|40031554|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
16424089|NCT04178720|40031555|FG000|Overall Study|Withdrawal by Subject|2|||
16424090|NCT04178720|40031556|FG001|Overall Study|Withdrawal by Subject|0|||
16424091|NCT04178720|40031555|FG000|Overall Study|Relocation|0|||
16424092|NCT04178720|40031556|FG001|Overall Study|Relocation|1|||
16424093|NCT00411632|40031560|FG000|Overall Study|Death|1|||
16424094|NCT00445770|40031561|FG000|Overall Study|Adverse Event|9|||
16424095|NCT00445770|40031562|FG001|Overall Study|Adverse Event|15|||
16424096|NCT00445770|40031563|FG002|Overall Study|Adverse Event|19|||
16424097|NCT00445770|40031561|FG000|Overall Study|Lack of Efficacy|38|||
16424098|NCT00445770|40031562|FG001|Overall Study|Lack of Efficacy|13|||
16424099|NCT00445770|40031563|FG002|Overall Study|Lack of Efficacy|6|||
16424100|NCT00445770|40031561|FG000|Overall Study|Lost to Follow-up|0|||
16424101|NCT00445770|40031562|FG001|Overall Study|Lost to Follow-up|2|||
16424102|NCT00445770|40031563|FG002|Overall Study|Lost to Follow-up|0|||
16424103|NCT00445770|40031561|FG000|Overall Study|Other|6|||
16424104|NCT00445770|40031562|FG001|Overall Study|Other|5|||
16424105|NCT00445770|40031563|FG002|Overall Study|Other|6|||
16424106|NCT03932760|40031565|FG000|Overall Study|Became Ineligible|2|||
16424107|NCT03932760|40031566|FG001|Overall Study|Became Ineligible|5|||
16424108|NCT03932760|40031565|FG000|Overall Study|Withdrawal by Subject|6|||
16424109|NCT03932760|40031566|FG001|Overall Study|Withdrawal by Subject|6|||
16424110|NCT01943591|40031569|FG000|Overall Study|Lost to Follow-up|3|||
16424111|NCT01943591|40031570|FG001|Overall Study|Lost to Follow-up|4|||
16424112|NCT01943591|40031569|FG000|Overall Study|Death|2|||
16424113|NCT01943591|40031570|FG001|Overall Study|Death|7|||
16424114|NCT01123395|40031571|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
16424115|NCT01123395|40031572|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
16424116|NCT02360228|40031576|FG000|Overall Study|Withdrawal by Subject|1|||
16424117|NCT02360228|40031577|FG001|Overall Study|Withdrawal by Subject|0|||
16424118|NCT02360228|40031578|FG002|Overall Study|Withdrawal by Subject|0|||
16424119|NCT02360228|40031576|FG000|Overall Study|Self-discontinued medication|0|||
16424120|NCT02360228|40031577|FG001|Overall Study|Self-discontinued medication|1|||
16424121|NCT02360228|40031578|FG002|Overall Study|Self-discontinued medication|0|||
16424122|NCT02360228|40031576|FG000|Overall Study|Unstable symptoms during screening|0|||
16424123|NCT02360228|40031577|FG001|Overall Study|Unstable symptoms during screening|0|||
16424124|NCT02360228|40031578|FG002|Overall Study|Unstable symptoms during screening|1|||
16424125|NCT01169337|40031579|FG000|Overall Study|Lack of Efficacy|5|||
16424126|NCT01169337|40031580|FG001|Overall Study|Lack of Efficacy|7|||
16424127|NCT01169337|40031581|FG002|Overall Study|Lack of Efficacy|0|||
16424128|NCT01169337|40031579|FG000|Overall Study|Adverse Event|12|||
16424129|NCT01169337|40031580|FG001|Overall Study|Adverse Event|18|||
16360118|NCT01056536|39804292|FG001|Overall Study|Lost to Follow-up|116|||
16360119|NCT01056536|39804293|FG002|Overall Study|Lost to Follow-up|248|||
16360120|NCT01496456|39804294|FG000|Overall Study|Protocol Violation|1|||
16360121|NCT01496456|39804294|FG000|Overall Study|Lost to Follow-up|7|||
16360122|NCT02566005|39804295|FG000|Overall Study|vaginal bleeding|0|||
16360123|NCT02566005|39804296|FG001|Overall Study|vaginal bleeding|1|||
16360124|NCT02566005|39804295|FG000|Overall Study|received foley|8|||
16360125|NCT02566005|39804296|FG001|Overall Study|received foley|0|||
16360126|NCT02566005|39804295|FG000|Overall Study|did not receive foley|0|||
16360127|NCT02566005|39804296|FG001|Overall Study|did not receive foley|1|||
16360128|NCT02566005|39804295|FG000|Overall Study|labor after randomization|0|||
16360129|NCT02566005|39804296|FG001|Overall Study|labor after randomization|4|||
16360130|NCT01553851|39804297|FG000|Overall Study|Adverse Event|2|||
16360131|NCT01553851|39804297|FG000|Overall Study|constipation|1|||
16360132|NCT02313155|39804298|FG000|Overall Study|Lost to Follow-up|0|||
16360133|NCT02313155|39804299|FG001|Overall Study|Lost to Follow-up|1|||
16360134|NCT04556760|39804300|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
16360135|NCT04556760|39804301|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
16360136|NCT04556760|39804302|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
16360137|NCT04556760|39804303|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
16360138|NCT04556760|39804304|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
16360139|NCT04556760|39804305|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
16360140|NCT04556760|39804300|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
16360141|NCT04556760|39804301|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
16360142|NCT04556760|39804302|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
16360143|NCT04556760|39804303|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
16360144|NCT04556760|39804304|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
16360145|NCT04556760|39804305|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
16360146|NCT00655889|39804306|FG000|Overall Study|Inadequate cell growth|1|||
16360147|NCT00655889|39804306|FG000|Overall Study|Protocol Violation|1|||
16360148|NCT03034967|39804307|FG000|Overall Study|Withdrawal by Subject|9|||
16360149|NCT03034967|39804308|FG001|Overall Study|Withdrawal by Subject|2|||
16360150|NCT03034967|39804309|FG002|Overall Study|Withdrawal by Subject|6|||
16360151|NCT03034967|39804310|FG003|Overall Study|Withdrawal by Subject|6|||
16360152|NCT03034967|39804311|FG004|Overall Study|Withdrawal by Subject|9|||
16360153|NCT03034967|39804312|FG005|Overall Study|Withdrawal by Subject|2|||
16360154|NCT03034967|39804307|FG000|Overall Study|Physician Decision|1|||
16360155|NCT03034967|39804308|FG001|Overall Study|Physician Decision|0|||
16360156|NCT03034967|39804309|FG002|Overall Study|Physician Decision|1|||
16360157|NCT03034967|39804310|FG003|Overall Study|Physician Decision|1|||
16360158|NCT03034967|39804311|FG004|Overall Study|Physician Decision|1|||
16360159|NCT03034967|39804312|FG005|Overall Study|Physician Decision|0|||
16360160|NCT03034967|39804307|FG000|Overall Study|Lost to Follow-up|0|||
16360161|NCT03034967|39804308|FG001|Overall Study|Lost to Follow-up|0|||
16360162|NCT03034967|39804309|FG002|Overall Study|Lost to Follow-up|0|||
16360163|NCT03034967|39804310|FG003|Overall Study|Lost to Follow-up|1|||
16360164|NCT03034967|39804311|FG004|Overall Study|Lost to Follow-up|0|||
16360165|NCT03034967|39804312|FG005|Overall Study|Lost to Follow-up|2|||
16360166|NCT03034967|39804307|FG000|Overall Study|Liver function test abnormality|0|||
16360167|NCT03034967|39804308|FG001|Overall Study|Liver function test abnormality|0|||
16360168|NCT03034967|39804309|FG002|Overall Study|Liver function test abnormality|1|||
16360169|NCT03034967|39804310|FG003|Overall Study|Liver function test abnormality|0|||
16424130|NCT01169337|40031581|FG002|Overall Study|Adverse Event|0|||
16424131|NCT01169337|40031579|FG000|Overall Study|Death|2|||
16424132|NCT01169337|40031580|FG001|Overall Study|Death|0|||
16424133|NCT01169337|40031581|FG002|Overall Study|Death|0|||
16424134|NCT01169337|40031579|FG000|Overall Study|Withdrawal by Subject|11|||
16424135|NCT01169337|40031580|FG001|Overall Study|Withdrawal by Subject|11|||
16424136|NCT01169337|40031581|FG002|Overall Study|Withdrawal by Subject|6|||
16424137|NCT01169337|40031579|FG000|Overall Study|Noncompliance|2|||
16424138|NCT01169337|40031580|FG001|Overall Study|Noncompliance|0|||
16424139|NCT01169337|40031581|FG002|Overall Study|Noncompliance|0|||
16424140|NCT01169337|40031579|FG000|Overall Study|Other complicating disease|1|||
16424141|NCT01169337|40031580|FG001|Overall Study|Other complicating disease|1|||
16424142|NCT01169337|40031581|FG002|Overall Study|Other complicating disease|0|||
16424143|NCT01169337|40031579|FG000|Overall Study|Physician Decision|1|||
16424144|NCT01169337|40031580|FG001|Overall Study|Physician Decision|5|||
16424145|NCT01169337|40031581|FG002|Overall Study|Physician Decision|0|||
16424146|NCT01169337|40031579|FG000|Overall Study|Alternative therapy|0|||
16424147|NCT01169337|40031580|FG001|Overall Study|Alternative therapy|2|||
16424148|NCT01169337|40031581|FG002|Overall Study|Alternative therapy|0|||
16424149|NCT01169337|40031579|FG000|Overall Study|Changed hospital|0|||
16424150|NCT01169337|40031580|FG001|Overall Study|Changed hospital|1|||
16424151|NCT01169337|40031581|FG002|Overall Study|Changed hospital|0|||
16424152|NCT01169337|40031579|FG000|Overall Study|Never started treatment|0|||
16424153|NCT01169337|40031580|FG001|Overall Study|Never started treatment|2|||
16424154|NCT01169337|40031581|FG002|Overall Study|Never started treatment|0|||
16424155|NCT01169337|40031579|FG000|Overall Study|Reason not reported|1|||
16424156|NCT01169337|40031580|FG001|Overall Study|Reason not reported|0|||
16424157|NCT01169337|40031581|FG002|Overall Study|Reason not reported|0|||
16424158|NCT01169337|40031579|FG000|Overall Study|Continuing lenalidomide|9|||
16424159|NCT01169337|40031580|FG001|Overall Study|Continuing lenalidomide|43|||
16424160|NCT01169337|40031581|FG002|Overall Study|Continuing lenalidomide|0|||
16424161|NCT00874848|40031586|FG000|Overall Study|Adverse Event|13|||
16424162|NCT00874848|40031587|FG001|Overall Study|Adverse Event|2|||
16424163|NCT00874848|40031586|FG000|Overall Study|Progressive neoplastic disease|38|||
16424164|NCT00874848|40031587|FG001|Overall Study|Progressive neoplastic disease|18|||
16424165|NCT00874848|40031586|FG000|Overall Study|Withdrawal by Subject|7|||
16424166|NCT00874848|40031587|FG001|Overall Study|Withdrawal by Subject|4|||
16424167|NCT00874848|40031586|FG000|Overall Study|Noncompliance|1|||
16424168|NCT00874848|40031587|FG001|Overall Study|Noncompliance|1|||
16424169|NCT00874848|40031586|FG000|Overall Study|Failure to comply with protocol|0|||
16424170|NCT00874848|40031587|FG001|Overall Study|Failure to comply with protocol|1|||
16424171|NCT00874848|40031586|FG000|Overall Study|Physician Decision|0|||
16424172|NCT00874848|40031587|FG001|Overall Study|Physician Decision|2|||
16424173|NCT01272037|40031588|FG000|Overall Study|Death|25|||
16424174|NCT01272037|40031589|FG001|Overall Study|Death|28|||
16424175|NCT01272037|40031588|FG000|Overall Study|Adverse Event|12|||
16424176|NCT01272037|40031589|FG001|Overall Study|Adverse Event|7|||
16424177|NCT01272037|40031588|FG000|Overall Study|Withdrawal by Subject|175|||
16424178|NCT01272037|40031589|FG001|Overall Study|Withdrawal by Subject|93|||
16424179|NCT01272037|40031588|FG000|Overall Study|Disease progression|70|||
16424180|NCT01272037|40031589|FG001|Overall Study|Disease progression|111|||
16424181|NCT01272037|40031588|FG000|Overall Study|Other reason|42|||
16424182|NCT01272037|40031589|FG001|Overall Study|Other reason|41|||
16424183|NCT01272037|40031588|FG000|Overall Study|Delinquent data|24|||
16424184|NCT01272037|40031589|FG001|Overall Study|Delinquent data|19|||
16424185|NCT01272037|40031588|FG000|Overall Study|Reason under review|33|||
16424186|NCT01272037|40031589|FG001|Overall Study|Reason under review|29|||
16424187|NCT01272037|40031588|FG000|Overall Study|On treatment|626|||
16424188|NCT01272037|40031589|FG001|Overall Study|On treatment|632|||
16424189|NCT02926638|40031593|FG000|Overall Study|Progression|2|||
16424190|NCT02926638|40031594|FG001|Overall Study|Progression|5|||
16424191|NCT02926638|40031593|FG000|Overall Study|Ineligible|1|||
16424192|NCT02926638|40031594|FG001|Overall Study|Ineligible|0|||
16424193|NCT02926638|40031593|FG000|Overall Study|Not protocol specified|1|||
16424194|NCT02926638|40031594|FG001|Overall Study|Not protocol specified|0|||
16424195|NCT00166439|40031595|FG000|Overall Study|Ineligible|5|||
16424196|NCT03992846|40031596|FG000|Overall Study|Adverse Event|8|||
16424197|NCT03992846|40031597|FG001|Overall Study|Adverse Event|6|||
16424198|NCT03992846|40031598|FG002|Overall Study|Adverse Event|3|||
16424199|NCT03992846|40031596|FG000|Overall Study|Lost to Follow-up|0|||
16424200|NCT03992846|40031597|FG001|Overall Study|Lost to Follow-up|1|||
16424201|NCT03992846|40031598|FG002|Overall Study|Lost to Follow-up|1|||
16424202|NCT03992846|40031596|FG000|Overall Study|Pregnancy|2|||
16424203|NCT03992846|40031597|FG001|Overall Study|Pregnancy|0|||
16424204|NCT03992846|40031598|FG002|Overall Study|Pregnancy|1|||
16424205|NCT03992846|40031596|FG000|Overall Study|Protocol Violation|1|||
16130916|NCT01323634|38967152|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16424206|NCT03992846|40031597|FG001|Overall Study|Protocol Violation|2|||
16424207|NCT03992846|40031598|FG002|Overall Study|Protocol Violation|0|||
16424208|NCT03992846|40031596|FG000|Overall Study|Withdrawal by Subject|8|||
16424209|NCT03992846|40031597|FG001|Overall Study|Withdrawal by Subject|10|||
16424210|NCT03992846|40031598|FG002|Overall Study|Withdrawal by Subject|20|||
16424211|NCT03992846|40031596|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
16424212|NCT03992846|40031597|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
16424213|NCT03992846|40031598|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
16424214|NCT01505374|40031603|FG000|Overall Study|Lost to Follow-up|1|||
16424215|NCT01505374|40031604|FG001|Overall Study|Lost to Follow-up|0|||
16424216|NCT01278797|40031608|FG000|Period 1|Adverse Event|0|||
16424217|NCT01278797|40031609|FG001|Period 1|Adverse Event|1|||
16424218|NCT01278797|40031608|FG000|Period 1|Protocol Violation|1|||
16424219|NCT01278797|40031609|FG001|Period 1|Protocol Violation|0|||
16424220|NCT01279681|40031610|FG000|Overall Study|Disease Progression|9|||
16424221|NCT01279681|40031611|FG001|Overall Study|Disease Progression|6|||
16424222|NCT01279681|40031610|FG000|Overall Study|Withdrawal by Subject|3|||
16424223|NCT01279681|40031611|FG001|Overall Study|Withdrawal by Subject|4|||
16424224|NCT01279681|40031610|FG000|Overall Study|Adverse Event|2|||
16424225|NCT01279681|40031611|FG001|Overall Study|Adverse Event|3|||
16424226|NCT01279681|40031610|FG000|Overall Study|Death|0|||
16424227|NCT01279681|40031611|FG001|Overall Study|Death|1|||
16424228|NCT01279681|40031610|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
16424229|NCT01279681|40031611|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
16424230|NCT01279681|40031610|FG000|Overall Study|Physician Decision|1|||
16424231|NCT01279681|40031611|FG001|Overall Study|Physician Decision|0|||
16424232|NCT01279681|40031610|FG000|Overall Study|Other Reason|0|||
16424233|NCT01279681|40031611|FG001|Overall Study|Other Reason|2|||
16424234|NCT00774800|40031612|FG000|Intervention 4|Withdrawal by Subject|1|||
16424235|NCT00704288|40031613|FG000|Overall Treatment Period|Adverse Event|11|||
16360170|NCT03034967|39804311|FG004|Overall Study|Liver function test abnormality|0|||
16360171|NCT03034967|39804312|FG005|Overall Study|Liver function test abnormality|0|||
16360172|NCT03034967|39804307|FG000|Overall Study|Protocol Violation|1|||
16360173|NCT03034967|39804308|FG001|Overall Study|Protocol Violation|0|||
16360174|NCT03034967|39804309|FG002|Overall Study|Protocol Violation|0|||
16360175|NCT03034967|39804310|FG003|Overall Study|Protocol Violation|0|||
16360176|NCT03034967|39804311|FG004|Overall Study|Protocol Violation|0|||
16360177|NCT03034967|39804312|FG005|Overall Study|Protocol Violation|2|||
16360178|NCT03034967|39804307|FG000|Overall Study|Lack of Efficacy|0|||
16360179|NCT03034967|39804308|FG001|Overall Study|Lack of Efficacy|1|||
16360180|NCT03034967|39804309|FG002|Overall Study|Lack of Efficacy|2|||
16360181|NCT03034967|39804310|FG003|Overall Study|Lack of Efficacy|1|||
16360182|NCT03034967|39804311|FG004|Overall Study|Lack of Efficacy|1|||
16360183|NCT03034967|39804312|FG005|Overall Study|Lack of Efficacy|0|||
16360184|NCT03034967|39804307|FG000|Overall Study|Adverse Event, non-fatal|3|||
16360185|NCT03034967|39804308|FG001|Overall Study|Adverse Event, non-fatal|1|||
16360186|NCT03034967|39804309|FG002|Overall Study|Adverse Event, non-fatal|2|||
16360187|NCT03034967|39804310|FG003|Overall Study|Adverse Event, non-fatal|0|||
16360188|NCT03034967|39804311|FG004|Overall Study|Adverse Event, non-fatal|2|||
16360189|NCT03034967|39804312|FG005|Overall Study|Adverse Event, non-fatal|8|||
16360190|NCT03034967|39804307|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
16360191|NCT03034967|39804308|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
16360192|NCT03034967|39804309|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
16360193|NCT03034967|39804310|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
16360194|NCT03034967|39804311|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
16360195|NCT03034967|39804312|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
16360196|NCT03256578|39804315|FG000|Overall Study|Excluded Post Randomization|66|||
16360197|NCT03256578|39804316|FG001|Overall Study|Excluded Post Randomization|56|||
16360198|NCT00303186|39804317|FG000|Overall Study|Other|52|||
16360199|NCT01648764|39804320|FG000|Overall Study|Progressive Disease|0|||
16360200|NCT01648764|39804321|FG001|Overall Study|Progressive Disease|1|||
16360201|NCT01648764|39804322|FG002|Overall Study|Progressive Disease|0|||
16360202|NCT01648764|39804323|FG003|Overall Study|Progressive Disease|0|||
16360203|NCT01648764|39804324|FG004|Overall Study|Progressive Disease|0|||
16360204|NCT01648764|39804325|FG005|Overall Study|Progressive Disease|1|||
16360205|NCT01648764|39804326|FG006|Overall Study|Progressive Disease|1|||
16360206|NCT01648764|39804327|FG007|Overall Study|Progressive Disease|0|||
16360207|NCT01648764|39804328|FG008|Overall Study|Progressive Disease|0|||
16360208|NCT01648764|39804329|FG009|Overall Study|Progressive Disease|2|||
16360209|NCT01648764|39804330|FG010|Overall Study|Progressive Disease|0|||
16360210|NCT01648764|39804331|FG011|Overall Study|Progressive Disease|1|||
16360211|NCT01648764|39804332|FG012|Overall Study|Progressive Disease|2|||
16360212|NCT01648764|39804333|FG013|Overall Study|Progressive Disease|1|||
16360213|NCT01648764|39804320|FG000|Overall Study|Adverse Event|0|||
16360214|NCT01648764|39804321|FG001|Overall Study|Adverse Event|0|||
16360215|NCT01648764|39804322|FG002|Overall Study|Adverse Event|0|||
16360216|NCT01648764|39804323|FG003|Overall Study|Adverse Event|0|||
16360217|NCT01648764|39804324|FG004|Overall Study|Adverse Event|0|||
16360218|NCT01648764|39804325|FG005|Overall Study|Adverse Event|1|||
16360219|NCT01648764|39804326|FG006|Overall Study|Adverse Event|0|||
16360220|NCT01648764|39804327|FG007|Overall Study|Adverse Event|0|||
16360221|NCT01648764|39804328|FG008|Overall Study|Adverse Event|0|||
16360222|NCT01648764|39804329|FG009|Overall Study|Adverse Event|1|||
16562403|NCT02018861|40525376|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16360223|NCT01648764|39804330|FG010|Overall Study|Adverse Event|0|||
16360224|NCT01648764|39804331|FG011|Overall Study|Adverse Event|3|||
16360225|NCT01648764|39804332|FG012|Overall Study|Adverse Event|1|||
16360226|NCT01648764|39804333|FG013|Overall Study|Adverse Event|1|||
16360227|NCT01648764|39804320|FG000|Overall Study|Death|0|||
16360228|NCT01648764|39804321|FG001|Overall Study|Death|0|||
16360229|NCT01648764|39804322|FG002|Overall Study|Death|0|||
16360230|NCT01648764|39804323|FG003|Overall Study|Death|0|||
16360231|NCT01648764|39804324|FG004|Overall Study|Death|0|||
16360232|NCT01648764|39804325|FG005|Overall Study|Death|0|||
16360233|NCT01648764|39804326|FG006|Overall Study|Death|1|||
16360234|NCT01648764|39804327|FG007|Overall Study|Death|0|||
16360235|NCT01648764|39804328|FG008|Overall Study|Death|0|||
16360236|NCT01648764|39804329|FG009|Overall Study|Death|0|||
16360237|NCT01648764|39804330|FG010|Overall Study|Death|0|||
16360238|NCT01648764|39804331|FG011|Overall Study|Death|0|||
16360239|NCT01648764|39804332|FG012|Overall Study|Death|0|||
16360240|NCT01648764|39804333|FG013|Overall Study|Death|1|||
16360241|NCT01648764|39804320|FG000|Overall Study|Withdrawal by Subject|0|||
16360242|NCT01648764|39804321|FG001|Overall Study|Withdrawal by Subject|0|||
16360243|NCT01648764|39804322|FG002|Overall Study|Withdrawal by Subject|0|||
16360244|NCT01648764|39804323|FG003|Overall Study|Withdrawal by Subject|0|||
16360245|NCT01648764|39804324|FG004|Overall Study|Withdrawal by Subject|0|||
16360246|NCT01648764|39804325|FG005|Overall Study|Withdrawal by Subject|0|||
16360247|NCT01648764|39804326|FG006|Overall Study|Withdrawal by Subject|2|||
16360248|NCT01648764|39804327|FG007|Overall Study|Withdrawal by Subject|0|||
16360249|NCT01648764|39804328|FG008|Overall Study|Withdrawal by Subject|0|||
16360250|NCT01648764|39804329|FG009|Overall Study|Withdrawal by Subject|0|||
16360251|NCT01648764|39804330|FG010|Overall Study|Withdrawal by Subject|0|||
16360252|NCT01648764|39804331|FG011|Overall Study|Withdrawal by Subject|0|||
16360253|NCT01648764|39804332|FG012|Overall Study|Withdrawal by Subject|1|||
16360254|NCT01648764|39804333|FG013|Overall Study|Withdrawal by Subject|0|||
16360255|NCT01648764|39804320|FG000|Overall Study|Investigator Decision|0|||
16360256|NCT01648764|39804321|FG001|Overall Study|Investigator Decision|0|||
16360257|NCT01648764|39804322|FG002|Overall Study|Investigator Decision|0|||
16360258|NCT01648764|39804323|FG003|Overall Study|Investigator Decision|0|||
16360259|NCT01648764|39804324|FG004|Overall Study|Investigator Decision|0|||
16360260|NCT01648764|39804325|FG005|Overall Study|Investigator Decision|0|||
16360261|NCT01648764|39804326|FG006|Overall Study|Investigator Decision|1|||
16360262|NCT01648764|39804327|FG007|Overall Study|Investigator Decision|0|||
16360263|NCT01648764|39804328|FG008|Overall Study|Investigator Decision|0|||
16360264|NCT01648764|39804329|FG009|Overall Study|Investigator Decision|0|||
16360265|NCT01648764|39804330|FG010|Overall Study|Investigator Decision|0|||
16360266|NCT01648764|39804331|FG011|Overall Study|Investigator Decision|1|||
16360267|NCT01648764|39804332|FG012|Overall Study|Investigator Decision|0|||
16360268|NCT01648764|39804333|FG013|Overall Study|Investigator Decision|0|||
16360269|NCT02747927|39804335|FG000|Overall Study|Adverse Event|5|||
16360270|NCT02747927|39804336|FG001|Overall Study|Adverse Event|14|||
16360271|NCT02747927|39804335|FG000|Overall Study|Lost to Follow-up|22|||
16360272|NCT02747927|39804336|FG001|Overall Study|Lost to Follow-up|43|||
16360273|NCT02747927|39804335|FG000|Overall Study|Pregnancy|34|||
16360274|NCT02747927|39804336|FG001|Overall Study|Pregnancy|66|||
16360275|NCT02747927|39804335|FG000|Overall Study|Protocol Violation|2|||
16360276|NCT02747927|39804336|FG001|Overall Study|Protocol Violation|4|||
16360277|NCT02747927|39804335|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
16360278|NCT02747927|39804336|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
16360279|NCT02747927|39804335|FG000|Overall Study|Reason not Specified|11|||
16360280|NCT02747927|39804336|FG001|Overall Study|Reason not Specified|27|||
16360281|NCT01802385|39804344|FG000|Overall Study|Death|106|||
16360282|NCT01802385|39804345|FG001|Overall Study|Death|120|||
16360283|NCT02990000|39804346|FG000|Overall Study|Failed to provide data beyond baseline|36|||
16360284|NCT02990000|39804347|FG001|Overall Study|Failed to provide data beyond baseline|34|||
16360285|NCT00576758|39804349|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
16360286|NCT00576758|39804350|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
16360287|NCT00576758|39804349|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
16360288|NCT00576758|39804350|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
16360289|NCT00576758|39804349|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
16360290|NCT00576758|39804350|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
16360291|NCT00576758|39804349|FG000|Induction Treatment Period|Death|1|||
16360292|NCT00576758|39804350|FG001|Induction Treatment Period|Death|0|||
16360293|NCT00576758|39804349|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
16360294|NCT00576758|39804350|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
16424236|NCT00704288|40031614|FG001|Overall Treatment Period|Adverse Event|8|||
16424237|NCT00704288|40031615|FG002|Overall Treatment Period|Adverse Event|22|||
16424238|NCT00704288|40031613|FG000|Overall Treatment Period|Death|0|||
16424239|NCT00704288|40031614|FG001|Overall Treatment Period|Death|0|||
16424240|NCT00704288|40031615|FG002|Overall Treatment Period|Death|1|||
16424241|NCT00704288|40031613|FG000|Overall Treatment Period|Physician Decision|0|||
16424242|NCT00704288|40031614|FG001|Overall Treatment Period|Physician Decision|2|||
16424243|NCT00704288|40031615|FG002|Overall Treatment Period|Physician Decision|0|||
16424244|NCT00704288|40031613|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
16424245|NCT00704288|40031614|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
16424246|NCT00704288|40031615|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
16424247|NCT00704288|40031613|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
16424248|NCT00704288|40031614|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
16424249|NCT00704288|40031615|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
16424250|NCT00704288|40031613|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
16424251|NCT00704288|40031614|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
16424252|NCT00704288|40031615|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
16424253|NCT00704288|40031613|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
16424254|NCT00704288|40031614|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
16424255|NCT00704288|40031615|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
16424256|NCT00704288|40031613|FG000|Overall Treatment Period|Roll-over to another study|1|||
16424257|NCT00704288|40031614|FG001|Overall Treatment Period|Roll-over to another study|0|||
16424258|NCT00704288|40031615|FG002|Overall Treatment Period|Roll-over to another study|4|||
16424259|NCT00704288|40031613|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
16424260|NCT00704288|40031614|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
16424261|NCT00704288|40031615|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
16562404|NCT02018861|40525377|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16360295|NCT00576758|39804349|FG000|Induction Treatment Period|Withdrew consent|1|||
16360296|NCT00576758|39804350|FG001|Induction Treatment Period|Withdrew consent|0|||
16360297|NCT00576758|39804349|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
16360298|NCT00576758|39804350|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
16360299|NCT00576758|39804349|FG000|Extension Treatment Period|Death|1|||
16360300|NCT00576758|39804350|FG001|Extension Treatment Period|Death|1|||
16360301|NCT00576758|39804349|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
16360302|NCT00576758|39804350|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
16360303|NCT00576758|39804349|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
16360304|NCT00576758|39804350|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
16360305|NCT00576758|39804349|FG000|Extension Treatment Period|Administrative/Other|3|||
16360306|NCT00576758|39804350|FG001|Extension Treatment Period|Administrative/Other|1|||
16360307|NCT00576758|39804349|FG000|Follow-up Period|Administrative/Other|6|||
16360308|NCT00576758|39804350|FG001|Follow-up Period|Administrative/Other|8|||
16360309|NCT00576758|39804349|FG000|Follow-up Period|Death|3|||
16360310|NCT00576758|39804350|FG001|Follow-up Period|Death|3|||
16562405|NCT02018861|40525378|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16562406|NCT02018861|40525379|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16562407|NCT02018861|40525380|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16562408|NCT02018861|40525381|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16562409|NCT02018861|40525382|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16562410|NCT02018861|40525383|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16562411|NCT02018861|40525384|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
16562412|NCT02018861|40525385|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
16562413|NCT02018861|40525376|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16562414|NCT02018861|40525377|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16562415|NCT02018861|40525378|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16562416|NCT02018861|40525379|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16562417|NCT02018861|40525380|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16562418|NCT02018861|40525381|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16562419|NCT02018861|40525382|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16562420|NCT02018861|40525383|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16360311|NCT00576758|39804349|FG000|Follow-up Period|Insufficient therapeutic response|16|||
16360312|NCT00576758|39804350|FG001|Follow-up Period|Insufficient therapeutic response|5|||
16360313|NCT00576758|39804349|FG000|Follow-up Period|Withdrew consent|2|||
16360314|NCT00576758|39804350|FG001|Follow-up Period|Withdrew consent|1|||
16360315|NCT01799941|39804351|FG000|Overall Study|Adverse Event|34|||
16360316|NCT01799941|39804351|FG000|Overall Study|Withdrawal by Subject|21|||
16424262|NCT00704288|40031613|FG000|Extended Post Treatment Follow Up Period|Death|41|||
16424263|NCT00704288|40031614|FG001|Extended Post Treatment Follow Up Period|Death|50|||
16424264|NCT00704288|40031615|FG002|Extended Post Treatment Follow Up Period|Death|93|||
16424265|NCT00704288|40031613|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
16424266|NCT00704288|40031614|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
16424267|NCT00704288|40031615|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
16424268|NCT00704288|40031613|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
16424269|NCT00704288|40031614|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
16424270|NCT00704288|40031615|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
16424271|NCT00704288|40031613|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
16424272|NCT00704288|40031614|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
16424273|NCT00704288|40031615|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
16424274|NCT01138501|40031616|FG000|Overall Study|Protocol Violation|2|||
16424275|NCT01138501|40031616|FG000|Overall Study|Withdrawal by Subject|3|||
16424276|NCT01771250|40031619|FG000|Period 1|Met exclusion criteria|1|||
16424277|NCT01771250|40031620|FG001|Period 1|Met exclusion criteria|0|||
16424278|NCT03172130|40031627|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
16424279|NCT03172130|40031628|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
16424280|NCT04158583|40031629|FG000|Overall Study|Withdrawal by Subject|1|||
16424281|NCT04158583|40031630|FG001|Overall Study|Withdrawal by Subject|1|||
16424282|NCT04158583|40031631|FG002|Overall Study|Withdrawal by Subject|0|||
16424283|NCT04158583|40031632|FG003|Overall Study|Withdrawal by Subject|0|||
16424284|NCT04158583|40031633|FG004|Overall Study|Withdrawal by Subject|1|||
16424285|NCT04158583|40031634|FG005|Overall Study|Withdrawal by Subject|0|||
16424286|NCT04158583|40031635|FG006|Overall Study|Withdrawal by Subject|0|||
16424287|NCT04158583|40031636|FG007|Overall Study|Withdrawal by Subject|0|||
16424288|NCT04158583|40031637|FG008|Overall Study|Withdrawal by Subject|2|||
16424289|NCT04158583|40031638|FG009|Overall Study|Withdrawal by Subject|0|||
16424290|NCT04158583|40031629|FG000|Overall Study|Study Terminated by Sponsor|0|||
16424291|NCT04158583|40031630|FG001|Overall Study|Study Terminated by Sponsor|0|||
16424292|NCT04158583|40031631|FG002|Overall Study|Study Terminated by Sponsor|0|||
16424293|NCT04158583|40031632|FG003|Overall Study|Study Terminated by Sponsor|1|||
16424294|NCT04158583|40031633|FG004|Overall Study|Study Terminated by Sponsor|0|||
16424295|NCT04158583|40031634|FG005|Overall Study|Study Terminated by Sponsor|0|||
16424296|NCT04158583|40031635|FG006|Overall Study|Study Terminated by Sponsor|0|||
16424297|NCT04158583|40031636|FG007|Overall Study|Study Terminated by Sponsor|0|||
16424298|NCT04158583|40031637|FG008|Overall Study|Study Terminated by Sponsor|0|||
16424299|NCT04158583|40031638|FG009|Overall Study|Study Terminated by Sponsor|0|||
16424300|NCT04158583|40031629|FG000|Overall Study|Progressive Disease|1|||
16424301|NCT04158583|40031630|FG001|Overall Study|Progressive Disease|0|||
16424302|NCT04158583|40031631|FG002|Overall Study|Progressive Disease|3|||
16424303|NCT04158583|40031632|FG003|Overall Study|Progressive Disease|5|||
16424304|NCT04158583|40031633|FG004|Overall Study|Progressive Disease|0|||
16424305|NCT04158583|40031634|FG005|Overall Study|Progressive Disease|1|||
16424306|NCT04158583|40031635|FG006|Overall Study|Progressive Disease|6|||
16424307|NCT04158583|40031636|FG007|Overall Study|Progressive Disease|2|||
16424308|NCT04158583|40031637|FG008|Overall Study|Progressive Disease|1|||
16424309|NCT04158583|40031638|FG009|Overall Study|Progressive Disease|2|||
16424310|NCT04158583|40031629|FG000|Overall Study|Lost to Follow-up|0|||
16424311|NCT04158583|40031630|FG001|Overall Study|Lost to Follow-up|0|||
16424312|NCT04158583|40031631|FG002|Overall Study|Lost to Follow-up|1|||
16424313|NCT04158583|40031632|FG003|Overall Study|Lost to Follow-up|1|||
16424314|NCT04158583|40031633|FG004|Overall Study|Lost to Follow-up|1|||
16424315|NCT04158583|40031634|FG005|Overall Study|Lost to Follow-up|0|||
16424316|NCT04158583|40031635|FG006|Overall Study|Lost to Follow-up|0|||
16424317|NCT04158583|40031636|FG007|Overall Study|Lost to Follow-up|0|||
16424318|NCT04158583|40031637|FG008|Overall Study|Lost to Follow-up|0|||
16424319|NCT04158583|40031638|FG009|Overall Study|Lost to Follow-up|0|||
16424320|NCT04158583|40031629|FG000|Overall Study|Due To Patient Status|0|||
16424321|NCT04158583|40031630|FG001|Overall Study|Due To Patient Status|0|||
16424322|NCT04158583|40031631|FG002|Overall Study|Due To Patient Status|0|||
16424323|NCT04158583|40031632|FG003|Overall Study|Due To Patient Status|0|||
16424324|NCT04158583|40031633|FG004|Overall Study|Due To Patient Status|0|||
16424325|NCT04158583|40031634|FG005|Overall Study|Due To Patient Status|0|||
16424326|NCT04158583|40031635|FG006|Overall Study|Due To Patient Status|0|||
16424327|NCT04158583|40031636|FG007|Overall Study|Due To Patient Status|0|||
16424328|NCT04158583|40031637|FG008|Overall Study|Due To Patient Status|1|||
16424329|NCT04158583|40031638|FG009|Overall Study|Due To Patient Status|0|||
16424330|NCT04158583|40031629|FG000|Overall Study|Death|3|||
16424331|NCT04158583|40031630|FG001|Overall Study|Death|4|||
16424332|NCT04158583|40031631|FG002|Overall Study|Death|2|||
16424333|NCT04158583|40031632|FG003|Overall Study|Death|2|||
16424334|NCT04158583|40031633|FG004|Overall Study|Death|4|||
16424335|NCT04158583|40031634|FG005|Overall Study|Death|3|||
16424336|NCT04158583|40031635|FG006|Overall Study|Death|5|||
16424337|NCT04158583|40031636|FG007|Overall Study|Death|2|||
16424338|NCT04158583|40031637|FG008|Overall Study|Death|0|||
16424339|NCT04158583|40031638|FG009|Overall Study|Death|1|||
16424340|NCT04158583|40031629|FG000|Overall Study|Clinical Progression Disease|0|||
16424341|NCT04158583|40031630|FG001|Overall Study|Clinical Progression Disease|0|||
16424342|NCT04158583|40031631|FG002|Overall Study|Clinical Progression Disease|0|||
16424343|NCT04158583|40031632|FG003|Overall Study|Clinical Progression Disease|1|||
16424344|NCT04158583|40031633|FG004|Overall Study|Clinical Progression Disease|0|||
16424345|NCT04158583|40031634|FG005|Overall Study|Clinical Progression Disease|0|||
16424346|NCT04158583|40031635|FG006|Overall Study|Clinical Progression Disease|0|||
16424347|NCT04158583|40031636|FG007|Overall Study|Clinical Progression Disease|0|||
16424348|NCT04158583|40031637|FG008|Overall Study|Clinical Progression Disease|0|||
16424349|NCT04158583|40031638|FG009|Overall Study|Clinical Progression Disease|0|||
16424350|NCT04158583|40031629|FG000|Overall Study|Clinical Progression|0|||
16424351|NCT04158583|40031630|FG001|Overall Study|Clinical Progression|0|||
16424352|NCT04158583|40031631|FG002|Overall Study|Clinical Progression|0|||
16424353|NCT04158583|40031632|FG003|Overall Study|Clinical Progression|0|||
16424354|NCT04158583|40031633|FG004|Overall Study|Clinical Progression|1|||
16424355|NCT04158583|40031634|FG005|Overall Study|Clinical Progression|0|||
16424356|NCT04158583|40031635|FG006|Overall Study|Clinical Progression|2|||
16424357|NCT04158583|40031636|FG007|Overall Study|Clinical Progression|0|||
16424358|NCT04158583|40031637|FG008|Overall Study|Clinical Progression|0|||
16424359|NCT04158583|40031638|FG009|Overall Study|Clinical Progression|0|||
16424360|NCT04158583|40031629|FG000|Overall Study|Clinical Deterioration|0|||
16424361|NCT04158583|40031630|FG001|Overall Study|Clinical Deterioration|0|||
16424362|NCT04158583|40031631|FG002|Overall Study|Clinical Deterioration|0|||
16424363|NCT04158583|40031632|FG003|Overall Study|Clinical Deterioration|1|||
16424364|NCT04158583|40031633|FG004|Overall Study|Clinical Deterioration|0|||
16424365|NCT04158583|40031634|FG005|Overall Study|Clinical Deterioration|0|||
16424366|NCT04158583|40031635|FG006|Overall Study|Clinical Deterioration|0|||
16424367|NCT04158583|40031636|FG007|Overall Study|Clinical Deterioration|0|||
16424368|NCT04158583|40031637|FG008|Overall Study|Clinical Deterioration|0|||
16424369|NCT04158583|40031638|FG009|Overall Study|Clinical Deterioration|1|||
16424370|NCT01240135|40031639|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
16424371|NCT01240135|40031640|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
16424372|NCT01240135|40031639|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
16424373|NCT01240135|40031640|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
16424374|NCT01815840|40031641|FG000|Overall Study|Missing|1|||
16424375|NCT01815840|40031642|FG001|Overall Study|Missing|0|||
16424376|NCT01815840|40031641|FG000|Overall Study|Withdrew Consent|31|||
16424377|NCT01815840|40031642|FG001|Overall Study|Withdrew Consent|30|||
16424378|NCT01815840|40031641|FG000|Overall Study|Administrative/Other|1|||
16424379|NCT01815840|40031642|FG001|Overall Study|Administrative/Other|3|||
16424380|NCT01815840|40031641|FG000|Overall Study|Adverse Event|10|||
16424381|NCT01815840|40031642|FG001|Overall Study|Adverse Event|16|||
16424382|NCT01815840|40031641|FG000|Overall Study|Death|2|||
16424383|NCT01815840|40031642|FG001|Overall Study|Death|2|||
16424384|NCT01815840|40031641|FG000|Overall Study|Disease progression|3|||
16424385|NCT01815840|40031642|FG001|Overall Study|Disease progression|2|||
16424386|NCT01815840|40031641|FG000|Overall Study|Investigators Decision|2|||
16424387|NCT01815840|40031642|FG001|Overall Study|Investigators Decision|3|||
16424388|NCT01815840|40031641|FG000|Overall Study|Lost to Follow-up|3|||
16424389|NCT01815840|40031642|FG001|Overall Study|Lost to Follow-up|6|||
16424390|NCT01815840|40031641|FG000|Overall Study|Refused Treatment|5|||
16424391|NCT01815840|40031642|FG001|Overall Study|Refused Treatment|1|||
16424392|NCT01815840|40031641|FG000|Overall Study|Sponsor Termination Treatment|1|||
16424393|NCT01815840|40031642|FG001|Overall Study|Sponsor Termination Treatment|0|||
16424394|NCT00422383|40031644|FG000|Overall Study|Adverse Event|5|||
16424395|NCT00422383|40031645|FG001|Overall Study|Adverse Event|3|||
16424396|NCT00422383|40031646|FG002|Overall Study|Adverse Event|1|||
16424397|NCT00422383|40031647|FG003|Overall Study|Adverse Event|1|||
16424398|NCT00422383|40031648|FG004|Overall Study|Adverse Event|0|||
16424399|NCT00422383|40031644|FG000|Overall Study|Lack of Efficacy|4|||
16424400|NCT00422383|40031645|FG001|Overall Study|Lack of Efficacy|4|||
16424401|NCT00422383|40031646|FG002|Overall Study|Lack of Efficacy|2|||
16424402|NCT00422383|40031647|FG003|Overall Study|Lack of Efficacy|1|||
16424403|NCT00422383|40031648|FG004|Overall Study|Lack of Efficacy|1|||
16424404|NCT00422383|40031644|FG000|Overall Study|Lost to Follow-up|0|||
16424405|NCT00422383|40031645|FG001|Overall Study|Lost to Follow-up|1|||
16424406|NCT00422383|40031646|FG002|Overall Study|Lost to Follow-up|0|||
16424407|NCT00422383|40031647|FG003|Overall Study|Lost to Follow-up|0|||
16424408|NCT00422383|40031648|FG004|Overall Study|Lost to Follow-up|1|||
16424409|NCT00422383|40031644|FG000|Overall Study|Protocol Violation|1|||
16424410|NCT00422383|40031645|FG001|Overall Study|Protocol Violation|1|||
16424411|NCT00422383|40031646|FG002|Overall Study|Protocol Violation|1|||
16424412|NCT00422383|40031647|FG003|Overall Study|Protocol Violation|0|||
16424413|NCT00422383|40031648|FG004|Overall Study|Protocol Violation|0|||
16424414|NCT00422383|40031644|FG000|Overall Study|Withdrawal by Subject|5|||
16424415|NCT00422383|40031645|FG001|Overall Study|Withdrawal by Subject|5|||
16424416|NCT00422383|40031646|FG002|Overall Study|Withdrawal by Subject|0|||
16424417|NCT00422383|40031647|FG003|Overall Study|Withdrawal by Subject|0|||
16424418|NCT00422383|40031648|FG004|Overall Study|Withdrawal by Subject|1|||
16424419|NCT02092025|40031649|FG000|Overall Study|Case Report Forms Uncollected|44|||
16424420|NCT02092025|40031649|FG000|Overall Study|Protocol Deviation|24|||
16424421|NCT02663622|40031650|FG000|Overall Study|Death|3|||
16424422|NCT02663622|40031651|FG001|Overall Study|Death|1|||
16424423|NCT02663622|40031652|FG002|Overall Study|Death|1|||
16424424|NCT02663622|40031653|FG003|Overall Study|Death|8|||
16424425|NCT02663622|40031650|FG000|Overall Study|Protocol Violation|0|||
16424426|NCT02663622|40031651|FG001|Overall Study|Protocol Violation|0|||
16424427|NCT02663622|40031652|FG002|Overall Study|Protocol Violation|0|||
16424428|NCT02663622|40031653|FG003|Overall Study|Protocol Violation|1|||
16424429|NCT04618744|40031657|FG000|Overall Study|Adverse Event|0|||
16424430|NCT04618744|40031658|FG001|Overall Study|Adverse Event|1|||
16424431|NCT04618744|40031657|FG000|Overall Study|Withdrawal by Subject|0|||
16424432|NCT04618744|40031658|FG001|Overall Study|Withdrawal by Subject|1|||
16424433|NCT01114828|40031659|FG000|Overall Study|Adverse Event|1|||
16424434|NCT01114828|40031660|FG001|Overall Study|Adverse Event|1|||
16424435|NCT01114828|40031659|FG000|Overall Study|Lack of Efficacy|0|||
16424436|NCT01114828|40031660|FG001|Overall Study|Lack of Efficacy|2|||
16424437|NCT01114828|40031659|FG000|Overall Study|Protocol Violation|2|||
16424438|NCT01114828|40031660|FG001|Overall Study|Protocol Violation|0|||
16424439|NCT01114828|40031659|FG000|Overall Study|Withdrawal by Subject|0|||
16424440|NCT01114828|40031660|FG001|Overall Study|Withdrawal by Subject|1|||
16424441|NCT01887353|40031661|FG000|Overall Study|Study stopped early|4|||
16424442|NCT01887353|40031662|FG001|Overall Study|Study stopped early|3|||
16424443|NCT02227199|40031663|FG000|Overall Study|Physician Decision|0|||
16424444|NCT02227199|40031664|FG001|Overall Study|Physician Decision|0|||
16424445|NCT02227199|40031665|FG002|Overall Study|Physician Decision|1|||
16424446|NCT02227199|40031663|FG000|Overall Study|Adverse Event|0|||
16424447|NCT02227199|40031664|FG001|Overall Study|Adverse Event|0|||
16424448|NCT02227199|40031665|FG002|Overall Study|Adverse Event|3|||
16424449|NCT02687581|40031666|FG000|Overall Study|Withdrawal by Subject|1|||
16424450|NCT02687581|40031667|FG001|Overall Study|Withdrawal by Subject|0|||
16424451|NCT02687581|40031668|FG002|Overall Study|Withdrawal by Subject|0|||
16424452|NCT02687581|40031669|FG003|Overall Study|Withdrawal by Subject|1|||
16424453|NCT02687581|40031666|FG000|Overall Study|Lost to Follow-up|2|||
16424454|NCT02687581|40031667|FG001|Overall Study|Lost to Follow-up|2|||
16424455|NCT02687581|40031668|FG002|Overall Study|Lost to Follow-up|0|||
16424456|NCT02687581|40031669|FG003|Overall Study|Lost to Follow-up|0|||
16424457|NCT02687581|40031666|FG000|Overall Study|the device is too small for the patient.|1|||
16424458|NCT02687581|40031667|FG001|Overall Study|the device is too small for the patient.|0|||
16424459|NCT02687581|40031668|FG002|Overall Study|the device is too small for the patient.|0|||
16424460|NCT02687581|40031669|FG003|Overall Study|the device is too small for the patient.|0|||
16424461|NCT00310817|40031670|FG000|Overall Study|AE or Death|3|||
16424462|NCT00310817|40031671|FG001|Overall Study|AE or Death|1|||
16424463|NCT00310817|40031672|FG002|Overall Study|AE or Death|0|||
16424464|NCT00310817|40031673|FG003|Overall Study|AE or Death|0|||
16424465|NCT00310817|40031670|FG000|Overall Study|Withdrawal by Subject|1|||
16424466|NCT00310817|40031671|FG001|Overall Study|Withdrawal by Subject|4|||
16424467|NCT00310817|40031672|FG002|Overall Study|Withdrawal by Subject|6|||
16424468|NCT00310817|40031673|FG003|Overall Study|Withdrawal by Subject|7|||
16424469|NCT00310817|40031670|FG000|Overall Study|Lost to Follow-up|2|||
16424470|NCT00310817|40031671|FG001|Overall Study|Lost to Follow-up|1|||
16424471|NCT00310817|40031672|FG002|Overall Study|Lost to Follow-up|0|||
16424472|NCT00310817|40031673|FG003|Overall Study|Lost to Follow-up|0|||
16424473|NCT00310817|40031670|FG000|Overall Study|Inappropriate Enrollment|1|||
16424474|NCT00310817|40031671|FG001|Overall Study|Inappropriate Enrollment|0|||
16424475|NCT00310817|40031672|FG002|Overall Study|Inappropriate Enrollment|1|||
16424476|NCT00310817|40031673|FG003|Overall Study|Inappropriate Enrollment|0|||
16424477|NCT00310817|40031670|FG000|Overall Study|Protocol Violation|1|||
16424478|NCT00310817|40031671|FG001|Overall Study|Protocol Violation|1|||
16424479|NCT00310817|40031672|FG002|Overall Study|Protocol Violation|1|||
16424480|NCT00310817|40031673|FG003|Overall Study|Protocol Violation|1|||
16424481|NCT00310817|40031670|FG000|Overall Study|Unable to classify|3|||
16424482|NCT00310817|40031671|FG001|Overall Study|Unable to classify|1|||
16424483|NCT00310817|40031672|FG002|Overall Study|Unable to classify|0|||
16424484|NCT00310817|40031673|FG003|Overall Study|Unable to classify|0|||
16424485|NCT00048347|40031674|FG000|Overall Study|Screen failure|2|||
16424486|NCT02152982|40031675|FG000|Overall Study|Ineligible|4|||
16424487|NCT02152982|40031676|FG001|Overall Study|Ineligible|4|||
16562421|NCT02018861|40525384|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
16424488|NCT02152982|40031675|FG000|Overall Study|Did not start treatment|12|||
16424489|NCT02152982|40031676|FG001|Overall Study|Did not start treatment|6|||
16424490|NCT01657292|40031681|FG000|Overall Study|Adverse Event|6|||
16424491|NCT01657292|40031681|FG000|Overall Study|Withdrawal by Subject|2|||
16424492|NCT01657292|40031681|FG000|Overall Study|Violation of eligibility criteria|1|||
16424493|NCT01657292|40031681|FG000|Overall Study|Change of therapy|1|||
16424494|NCT04177212|40031682|FG000|Overall Study|Withdrawal by Subject|9|||
16360317|NCT01799941|39804351|FG000|Overall Study|Death|2|||
16360318|NCT01799941|39804351|FG000|Overall Study|Investigator Decision|4|||
16360319|NCT01799941|39804351|FG000|Overall Study|Lack of Efficacy|3|||
16360320|NCT01799941|39804351|FG000|Overall Study|Lost to Follow-up|17|||
16360321|NCT01799941|39804351|FG000|Overall Study|Other|15|||
16360322|NCT02915835|39804358|FG000|Overall Study|Physician Decision|1|||
16360323|NCT02915835|39804359|FG001|Overall Study|Physician Decision|0|||
16360324|NCT02915835|39804358|FG000|Overall Study|Withdrawal by Subject|0|||
16360325|NCT02915835|39804359|FG001|Overall Study|Withdrawal by Subject|1|||
16360326|NCT02026141|39804369|FG000|Overall Study|Protocol Violation|0|||
16360327|NCT02026141|39804370|FG001|Overall Study|Protocol Violation|1|||
16360328|NCT03188822|39804371|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
16360329|NCT03188822|39804371|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
16360330|NCT04635839|39804375|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
16360331|NCT04635839|39804376|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
16360332|NCT02034006|39804395|FG000|Overall Study|Withdrawal by Subject|7|||
16360333|NCT02034006|39804395|FG000|Overall Study|Lost to Follow-up|5|||
16360334|NCT02034006|39804395|FG000|Overall Study|Death|1|||
16360335|NCT02034006|39804395|FG000|Overall Study|Pregnancy|1|||
16360336|NCT01516216|39804399|FG000|Overall Study|Adverse Event|2|||
16360337|NCT01516216|39804400|FG001|Overall Study|Adverse Event|4|||
16360338|NCT01516216|39804399|FG000|Overall Study|Disease Progression|38|||
16360339|NCT01516216|39804400|FG001|Overall Study|Disease Progression|34|||
16360340|NCT01516216|39804399|FG000|Overall Study|Withdrawal by Subject|9|||
16360341|NCT01516216|39804400|FG001|Overall Study|Withdrawal by Subject|11|||
16360342|NCT01516216|39804399|FG000|Overall Study|Potentially Curative Resection|6|||
16360343|NCT01516216|39804400|FG001|Overall Study|Potentially Curative Resection|12|||
16360344|NCT01516216|39804399|FG000|Overall Study|Nonadherence|2|||
16360345|NCT01516216|39804400|FG001|Overall Study|Nonadherence|3|||
16360346|NCT01516216|39804399|FG000|Overall Study|Physician Decision|6|||
16360347|NCT01516216|39804400|FG001|Overall Study|Physician Decision|3|||
16360348|NCT01516216|39804399|FG000|Overall Study|Prolonged Treatment Delay|5|||
16360349|NCT01516216|39804400|FG001|Overall Study|Prolonged Treatment Delay|1|||
16360350|NCT01516216|39804399|FG000|Overall Study|Intercurrent Illness|1|||
16360351|NCT01516216|39804400|FG001|Overall Study|Intercurrent Illness|0|||
16360352|NCT01516216|39804399|FG000|Overall Study|Death|1|||
16360353|NCT01516216|39804400|FG001|Overall Study|Death|1|||
16360354|NCT00658528|39804401|FG000|Overall Study|Adverse Event|5|||
16360355|NCT00658528|39804402|FG001|Overall Study|Adverse Event|7|||
16360356|NCT00658528|39804401|FG000|Overall Study|Lost to Follow-up|14|||
16360357|NCT00658528|39804402|FG001|Overall Study|Lost to Follow-up|22|||
16360358|NCT00658528|39804401|FG000|Overall Study|Withdrawal by Subject|8|||
16360359|NCT00658528|39804402|FG001|Overall Study|Withdrawal by Subject|6|||
16360360|NCT00658528|39804401|FG000|Overall Study|Withdrawal of consent|5|||
16360361|NCT00658528|39804402|FG001|Overall Study|Withdrawal of consent|6|||
16360362|NCT00658528|39804401|FG000|Overall Study|Other|8|||
16360363|NCT00658528|39804402|FG001|Overall Study|Other|4|||
16360364|NCT03408899|39804412|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
16360365|NCT01937299|39807444|FG000|Overall Study|Adverse Event|13|||
16360366|NCT01937299|39807445|FG001|Overall Study|Adverse Event|0|||
16360367|NCT01937299|39807444|FG000|Overall Study|Lack of Efficacy|0|||
16360368|NCT01937299|39807445|FG001|Overall Study|Lack of Efficacy|4|||
16360369|NCT01937299|39807444|FG000|Overall Study|Withdrawal by Subject|1|||
16360370|NCT01937299|39807445|FG001|Overall Study|Withdrawal by Subject|0|||
16360371|NCT01155141|39807446|FG000|Overall Study|Withdrawal by Subject|1|||
16360372|NCT01155141|39807446|FG000|Overall Study|Screen Failure|1|||
16360373|NCT02202616|39807453|FG000|Overall Study|Screen failed|24|||
16360374|NCT02202616|39807453|FG000|Overall Study|Adverse Event|32|||
16360375|NCT02202616|39807453|FG000|Overall Study|Protocol deviation|18|||
16360376|NCT02202616|39807453|FG000|Overall Study|Patient withdrew consent|12|||
16360377|NCT02202616|39807453|FG000|Overall Study|Lost to Follow-up|6|||
16360378|NCT02202616|39807453|FG000|Overall Study|Administrative problems|6|||
16424495|NCT04177212|40031683|FG001|Overall Study|Withdrawal by Subject|7|||
16424496|NCT04177212|40031682|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
16360379|NCT02202616|39807453|FG000|Overall Study|Abnormal test procedure result|1|||
16360380|NCT02202616|39807453|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16360381|NCT01160614|39807454|FG000|Overall Study|Withdrawal by Subject|0|||
16360382|NCT01160614|39807455|FG001|Overall Study|Withdrawal by Subject|2|||
16360383|NCT00407511|39807460|FG000|Overall Study|Adverse Event|9|||
16360384|NCT00407511|39807460|FG000|Overall Study|Lost to Follow-up|4|||
16360385|NCT00407511|39807460|FG000|Overall Study|Other|5|||
16360386|NCT00407511|39807460|FG000|Overall Study|Withdrawal by Subject|4|||
16360387|NCT00689936|39807465|FG000|Active Treatment Phase|Adverse Event|68|||
16360388|NCT00689936|39807466|FG001|Active Treatment Phase|Adverse Event|71|||
16360389|NCT00689936|39807467|FG002|Active Treatment Phase|Adverse Event|76|||
16360390|NCT00689936|39807465|FG000|Active Treatment Phase|Disease Progression|273|||
16249347|NCT01104662|39395461|FG007|Overall Study|Reason not specified|0|||
16249348|NCT01104662|39395454|FG000|Overall Study|Randomized but not treated|3|||
16249349|NCT01104662|39395455|FG001|Overall Study|Randomized but not treated|4|||
16249350|NCT01104662|39395456|FG002|Overall Study|Randomized but not treated|1|||
16249351|NCT01104662|39395457|FG003|Overall Study|Randomized but not treated|0|||
16249352|NCT01104662|39395458|FG004|Overall Study|Randomized but not treated|0|||
16249353|NCT01104662|39395459|FG005|Overall Study|Randomized but not treated|1|||
16249354|NCT01104662|39395460|FG006|Overall Study|Randomized but not treated|0|||
16249355|NCT01104662|39395461|FG007|Overall Study|Randomized but not treated|0|||
16249356|NCT02180061|39395462|FG000|Overall Study|Adverse Event|4|||
16249357|NCT02180061|39395463|FG001|Overall Study|Adverse Event|2|||
16249358|NCT02180061|39395462|FG000|Overall Study|Clinical Progression|5|||
16249359|NCT02180061|39395463|FG001|Overall Study|Clinical Progression|1|||
16249360|NCT02180061|39395462|FG000|Overall Study|Progressive Disease|15|||
16249361|NCT02180061|39395463|FG001|Overall Study|Progressive Disease|5|||
16249362|NCT02180061|39395462|FG000|Overall Study|Physician Decision|1|||
16249363|NCT02180061|39395463|FG001|Overall Study|Physician Decision|0|||
16249364|NCT01280981|39395464|FG000|Overall Study|Withdrawal by Subject|11|||
16249365|NCT01280981|39395464|FG000|Overall Study|Protocol Violation|2|||
16249366|NCT01280981|39395464|FG000|Overall Study|Lack of Efficacy|13|||
16249367|NCT01280981|39395464|FG000|Overall Study|Lost to Follow-up|3|||
16249368|NCT01280981|39395464|FG000|Overall Study|Adverse Event|6|||
16249369|NCT01280981|39395464|FG000|Overall Study|Irregular or discontinued menses|3|||
16249370|NCT01280981|39395464|FG000|Overall Study|Failed to return|45|||
16249371|NCT01280981|39395464|FG000|Overall Study|Non-compliance with protocol|3|||
16249372|NCT01280981|39395464|FG000|Overall Study|Withdrawal of consent|3|||
16249373|NCT01280981|39395464|FG000|Overall Study|Elective surgery|2|||
16249374|NCT01280981|39395464|FG000|Overall Study|Study site closure|1|||
16249375|NCT02410252|39395465|FG000|Overall Study|Withdrawal by Subject|4|||
16249376|NCT02410252|39395465|FG000|Overall Study|Physician Decision|2|||
16249377|NCT01427920|39395466|FG000|Overall Study|Adverse Event|1|||
16249378|NCT01427920|39395467|FG001|Overall Study|Adverse Event|2|||
16249379|NCT01427920|39395466|FG000|Overall Study|Lack of Efficacy|1|||
16249380|NCT01427920|39395467|FG001|Overall Study|Lack of Efficacy|0|||
16562422|NCT02018861|40525385|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
16562423|NCT02018861|40525376|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16562424|NCT02018861|40525377|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16562425|NCT02018861|40525378|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16562426|NCT02018861|40525379|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16562427|NCT02018861|40525380|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16562428|NCT02018861|40525381|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16562429|NCT02018861|40525382|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16562430|NCT02018861|40525383|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16562431|NCT02018861|40525384|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
16562432|NCT02018861|40525385|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
16562433|NCT01734811|40525393|FG000|Overall Study|Lost to Follow-up|2|||
16562434|NCT01734811|40525394|FG001|Overall Study|Lost to Follow-up|3|||
16562435|NCT01734811|40525393|FG000|Overall Study|Withdrawal by Subject|2|||
16562436|NCT01734811|40525394|FG001|Overall Study|Withdrawal by Subject|0|||
16562437|NCT00445692|40525396|FG000|Overall Study|Adverse Event|11|||
16562438|NCT00445692|40525396|FG000|Overall Study|Lack of Efficacy|5|||
16562439|NCT01021878|40525402|FG000|Overall Study|Lost to Follow-up|4|||
16562440|NCT01021878|40525403|FG001|Overall Study|Lost to Follow-up|3|||
16562441|NCT01021878|40525402|FG000|Overall Study|Death|0|||
16562442|NCT01021878|40525403|FG001|Overall Study|Death|1|||
16562443|NCT01021878|40525402|FG000|Overall Study|Adverse Event|6|||
16562444|NCT01021878|40525403|FG001|Overall Study|Adverse Event|5|||
16562445|NCT01021878|40525402|FG000|Overall Study|Transplantation|6|||
16562446|NCT01021878|40525403|FG001|Overall Study|Transplantation|1|||
16562447|NCT00519779|40525404|FG000|Overall Study|Withdrawal by Subject|0|||
16562448|NCT00519779|40525405|FG001|Overall Study|Withdrawal by Subject|1|||
16562449|NCT02153788|40525406|FG000|Overall Study|Physician Decision|2|||
16562450|NCT02153788|40525407|FG001|Overall Study|Physician Decision|1|||
16562451|NCT03905135|40525408|FG000|Dose Escalation|Adverse Event|1|||
16562452|NCT03905135|40525409|FG001|Dose Escalation|Adverse Event|1|||
16130917|NCT01323634|38967153|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
16249381|NCT01427920|39395466|FG000|Overall Study|Protocol Violation|1|||
16249382|NCT01427920|39395467|FG001|Overall Study|Protocol Violation|3|||
16249383|NCT01427920|39395466|FG000|Overall Study|Withdrawal Criteria|4|||
16249384|NCT01427920|39395467|FG001|Overall Study|Withdrawal Criteria|4|||
16249385|NCT01427920|39395466|FG000|Overall Study|Unclassified|2|||
16424497|NCT04177212|40031683|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
16562453|NCT03905135|40525408|FG000|Dose Escalation|Progressive disease|3|||
16562454|NCT03905135|40525409|FG001|Dose Escalation|Progressive disease|1|||
16249386|NCT01427920|39395467|FG001|Overall Study|Unclassified|8|||
16249387|NCT01752920|39395470|FG000|Overall Study|Adverse Event|1|||
16249388|NCT01752920|39395471|FG001|Overall Study|Adverse Event|0|||
16424498|NCT04177212|40031682|FG000|Overall Study|Physician Decision|1|||
16424499|NCT04177212|40031683|FG001|Overall Study|Physician Decision|0|||
16424500|NCT04177212|40031682|FG000|Overall Study|Lost to Follow-up|0|||
16424501|NCT04177212|40031683|FG001|Overall Study|Lost to Follow-up|3|||
16360391|NCT00689936|39807466|FG001|Active Treatment Phase|Disease Progression|362|||
16360392|NCT00689936|39807467|FG002|Active Treatment Phase|Disease Progression|339|||
16360393|NCT00689936|39807465|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
16360394|NCT00689936|39807466|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
16360395|NCT00689936|39807467|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
16360396|NCT00689936|39807465|FG000|Active Treatment Phase|Death|60|||
16360397|NCT00689936|39807466|FG001|Active Treatment Phase|Death|28|||
16360398|NCT00689936|39807467|FG002|Active Treatment Phase|Death|37|||
16360399|NCT00689936|39807465|FG000|Active Treatment Phase|Lost to Follow-up|0|||
16360400|NCT00689936|39807466|FG001|Active Treatment Phase|Lost to Follow-up|2|||
16360401|NCT00689936|39807467|FG002|Active Treatment Phase|Lost to Follow-up|2|||
16360402|NCT00689936|39807465|FG000|Active Treatment Phase|Protocol Violation|2|||
16360403|NCT00689936|39807466|FG001|Active Treatment Phase|Protocol Violation|2|||
16360404|NCT00689936|39807467|FG002|Active Treatment Phase|Protocol Violation|4|||
16360405|NCT00689936|39807465|FG000|Active Treatment Phase|Study Close Out|64|||
16360406|NCT00689936|39807466|FG001|Active Treatment Phase|Study Close Out|26|||
16360407|NCT00689936|39807467|FG002|Active Treatment Phase|Study Close Out|21|||
16360408|NCT00689936|39807465|FG000|Active Treatment Phase|Miscellaneous|52|||
16360409|NCT00689936|39807466|FG001|Active Treatment Phase|Miscellaneous|34|||
16360410|NCT00689936|39807467|FG002|Active Treatment Phase|Miscellaneous|47|||
16360411|NCT00689936|39807465|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
16360412|NCT00689936|39807466|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
16360413|NCT00689936|39807467|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
16360414|NCT01408641|39807468|FG000|Overall Study|Physician Decision|1|||
16360415|NCT01408641|39807469|FG001|Overall Study|Physician Decision|0|||
16360416|NCT01572792|39807470|FG000|Lead-in Study|Lost to Follow-up|5|||
16360417|NCT01572792|39807471|FG001|Lead-in Study|Lost to Follow-up|9|||
16360418|NCT01572792|39807472|FG002|Lead-in Study|Lost to Follow-up|4|||
16360419|NCT01572792|39807473|FG003|Lead-in Study|Lost to Follow-up|2|||
16360420|NCT01572792|39807474|FG004|Lead-in Study|Lost to Follow-up|4|||
16360421|NCT01572792|39807470|FG000|Lead-in Study|Withdrawal by Subject|22|||
16360422|NCT01572792|39807471|FG001|Lead-in Study|Withdrawal by Subject|11|||
16360423|NCT01572792|39807472|FG002|Lead-in Study|Withdrawal by Subject|12|||
16360424|NCT01572792|39807473|FG003|Lead-in Study|Withdrawal by Subject|24|||
16360425|NCT01572792|39807474|FG004|Lead-in Study|Withdrawal by Subject|11|||
16360426|NCT01572792|39807470|FG000|Lead-in Study|Protocol Violation|19|||
16360427|NCT01572792|39807471|FG001|Lead-in Study|Protocol Violation|10|||
16360428|NCT01572792|39807472|FG002|Lead-in Study|Protocol Violation|12|||
16360429|NCT01572792|39807473|FG003|Lead-in Study|Protocol Violation|13|||
16360430|NCT01572792|39807474|FG004|Lead-in Study|Protocol Violation|21|||
16360431|NCT01572792|39807470|FG000|Lead-in Study|Lack of Efficacy|20|||
16360432|NCT01572792|39807471|FG001|Lead-in Study|Lack of Efficacy|5|||
16360433|NCT01572792|39807472|FG002|Lead-in Study|Lack of Efficacy|4|||
16360434|NCT01572792|39807473|FG003|Lead-in Study|Lack of Efficacy|8|||
16360435|NCT01572792|39807474|FG004|Lead-in Study|Lack of Efficacy|10|||
16360436|NCT01572792|39807470|FG000|Lead-in Study|Adverse Event|21|||
16360437|NCT01572792|39807471|FG001|Lead-in Study|Adverse Event|21|||
16360438|NCT01572792|39807472|FG002|Lead-in Study|Adverse Event|22|||
16360439|NCT01572792|39807473|FG003|Lead-in Study|Adverse Event|16|||
16360440|NCT01572792|39807474|FG004|Lead-in Study|Adverse Event|14|||
16360441|NCT01572792|39807470|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
16360442|NCT01572792|39807471|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
16360443|NCT01572792|39807472|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
16360444|NCT01572792|39807473|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
16360445|NCT01572792|39807474|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
16360446|NCT01572792|39807470|FG000|Extension Study|Lost to Follow-up|6|||
16360447|NCT01572792|39807471|FG001|Extension Study|Lost to Follow-up|2|||
16360448|NCT01572792|39807472|FG002|Extension Study|Lost to Follow-up|0|||
16360449|NCT01572792|39807473|FG003|Extension Study|Lost to Follow-up|3|||
16360450|NCT01572792|39807474|FG004|Extension Study|Lost to Follow-up|3|||
16360451|NCT01572792|39807470|FG000|Extension Study|Withdrawal by Subject|7|||
16360452|NCT01572792|39807471|FG001|Extension Study|Withdrawal by Subject|6|||
16360453|NCT01572792|39807472|FG002|Extension Study|Withdrawal by Subject|11|||
16360454|NCT01572792|39807473|FG003|Extension Study|Withdrawal by Subject|8|||
16360455|NCT01572792|39807474|FG004|Extension Study|Withdrawal by Subject|14|||
16424502|NCT04177212|40031682|FG000|Overall Study|Adverse Event|0|||
16424503|NCT04177212|40031683|FG001|Overall Study|Adverse Event|1|||
16360456|NCT01572792|39807470|FG000|Extension Study|Protocol Violation|0|||
16360457|NCT01572792|39807471|FG001|Extension Study|Protocol Violation|4|||
16360458|NCT01572792|39807472|FG002|Extension Study|Protocol Violation|3|||
16360459|NCT01572792|39807473|FG003|Extension Study|Protocol Violation|4|||
16360460|NCT01572792|39807474|FG004|Extension Study|Protocol Violation|3|||
16424504|NCT04177212|40031682|FG000|Overall Study|Other|1|||
16424505|NCT04177212|40031683|FG001|Overall Study|Other|2|||
16424506|NCT03566082|40031684|FG000|Overall Study|Death|7|||
16424507|NCT03566082|40031684|FG000|Overall Study|Failures (revision required)|2|||
16424508|NCT03566082|40031684|FG000|Overall Study|Lost to Follow-up|8|||
16424509|NCT02058563|40031685|FG000|Overall Study|Lost to Follow-up|26|||
16424510|NCT02058563|40031686|FG001|Overall Study|Lost to Follow-up|22|||
16424511|NCT02058563|40031685|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
16424512|NCT02058563|40031686|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
16424513|NCT02058563|40031685|FG000|Overall Study|Consent Withdrawal|1|||
16424514|NCT02058563|40031686|FG001|Overall Study|Consent Withdrawal|1|||
16249389|NCT01752920|39395472|FG002|Overall Study|Adverse Event|5|||
16249390|NCT01752920|39395473|FG003|Overall Study|Adverse Event|10|||
16249391|NCT01752920|39395470|FG000|Overall Study|Clinical Disease Progression|6|||
16249392|NCT01752920|39395471|FG001|Overall Study|Clinical Disease Progression|4|||
16249393|NCT01752920|39395472|FG002|Overall Study|Clinical Disease Progression|1|||
16249394|NCT01752920|39395473|FG003|Overall Study|Clinical Disease Progression|13|||
16249395|NCT01752920|39395470|FG000|Overall Study|Physician Decision|1|||
16249396|NCT01752920|39395471|FG001|Overall Study|Physician Decision|0|||
16249397|NCT01752920|39395472|FG002|Overall Study|Physician Decision|0|||
16424515|NCT02058563|40031685|FG000|Overall Study|Other (patient incarcerated)|0|||
16424516|NCT02058563|40031686|FG001|Overall Study|Other (patient incarcerated)|1|||
16424517|NCT00379912|40031687|FG000|Overall Study|Lack of Efficacy|1|||
16424518|NCT00379912|40031688|FG001|Overall Study|Lack of Efficacy|0|||
16424519|NCT02413489|40031694|FG000|Overall Study|Death|11|||
16424520|NCT02413489|40031695|FG001|Overall Study|Death|3|||
16424521|NCT02413489|40031696|FG002|Overall Study|Death|4|||
16424522|NCT02413489|40031694|FG000|Overall Study|Withdrawal by Subject|2|||
16424523|NCT02413489|40031695|FG001|Overall Study|Withdrawal by Subject|0|||
16424524|NCT02413489|40031696|FG002|Overall Study|Withdrawal by Subject|0|||
16424525|NCT02413489|40031694|FG000|Overall Study|Study Terminated By Sponsor|2|||
16424526|NCT02413489|40031695|FG001|Overall Study|Study Terminated By Sponsor|13|||
16424527|NCT02413489|40031696|FG002|Overall Study|Study Terminated By Sponsor|1|||
16424528|NCT01408459|40031697|FG000|Overall Study|Withdrawal by Subject|1|||
16424529|NCT01408459|40031698|FG001|Overall Study|Withdrawal by Subject|1|||
16424530|NCT00569127|40031701|FG000|Overall Study|Adverse Event|57|||
16424531|NCT00569127|40031702|FG001|Overall Study|Adverse Event|47|||
16424532|NCT00569127|40031701|FG000|Overall Study|Withdrawal by Subject|13|||
16424533|NCT00569127|40031702|FG001|Overall Study|Withdrawal by Subject|27|||
16424534|NCT00569127|40031701|FG000|Overall Study|Progression|99|||
16424535|NCT00569127|40031702|FG001|Overall Study|Progression|100|||
16424536|NCT00569127|40031701|FG000|Overall Study|Death|4|||
16562455|NCT03905135|40525408|FG000|Dose Escalation|Intercurrent illness|1|||
16249398|NCT01752920|39395473|FG003|Overall Study|Physician Decision|3|||
16249399|NCT01752920|39395470|FG000|Overall Study|Radiographic Disease Progression|20|||
16249400|NCT01752920|39395471|FG001|Overall Study|Radiographic Disease Progression|7|||
16249401|NCT01752920|39395472|FG002|Overall Study|Radiographic Disease Progression|12|||
16360461|NCT01572792|39807470|FG000|Extension Study|Lack of Efficacy|2|||
16360462|NCT01572792|39807471|FG001|Extension Study|Lack of Efficacy|3|||
16360463|NCT01572792|39807472|FG002|Extension Study|Lack of Efficacy|3|||
16360464|NCT01572792|39807473|FG003|Extension Study|Lack of Efficacy|2|||
16360465|NCT01572792|39807474|FG004|Extension Study|Lack of Efficacy|2|||
16360466|NCT01572792|39807470|FG000|Extension Study|Adverse Event|7|||
16360467|NCT01572792|39807471|FG001|Extension Study|Adverse Event|6|||
16360468|NCT01572792|39807472|FG002|Extension Study|Adverse Event|5|||
16360469|NCT01572792|39807473|FG003|Extension Study|Adverse Event|6|||
16360470|NCT01572792|39807474|FG004|Extension Study|Adverse Event|4|||
16360471|NCT01572792|39807470|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
16360472|NCT01572792|39807471|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
16360473|NCT01572792|39807472|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
16360474|NCT01572792|39807473|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
16360475|NCT01572792|39807474|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
16360476|NCT02969018|39807476|FG000|Overall Study|Adverse Event|2|||
16360477|NCT02969018|39807477|FG001|Overall Study|Adverse Event|4|||
16360478|NCT02969018|39807478|FG002|Overall Study|Adverse Event|1|||
16360479|NCT02969018|39807479|FG003|Overall Study|Adverse Event|2|||
16360480|NCT02969018|39807480|FG004|Overall Study|Adverse Event|0|||
16360481|NCT02969018|39807481|FG005|Overall Study|Adverse Event|1|||
16360482|NCT02969018|39807482|FG006|Overall Study|Adverse Event|2|||
16360483|NCT02969018|39807483|FG007|Overall Study|Adverse Event|0|||
16360484|NCT02969018|39807476|FG000|Overall Study|Lack of Efficacy|0|||
16424537|NCT00569127|40031702|FG001|Overall Study|Death|3|||
16424538|NCT00569127|40031701|FG000|Overall Study|Other|20|||
16249402|NCT01752920|39395473|FG003|Overall Study|Radiographic Disease Progression|29|||
16360485|NCT02969018|39807477|FG001|Overall Study|Lack of Efficacy|1|||
16360486|NCT02969018|39807478|FG002|Overall Study|Lack of Efficacy|0|||
16360487|NCT02969018|39807479|FG003|Overall Study|Lack of Efficacy|0|||
16424539|NCT00569127|40031702|FG001|Overall Study|Other|19|||
16249403|NCT01752920|39395470|FG000|Overall Study|Study Terminated by Sponsor|0|||
16249404|NCT01752920|39395471|FG001|Overall Study|Study Terminated by Sponsor|0|||
16249405|NCT01752920|39395472|FG002|Overall Study|Study Terminated by Sponsor|0|||
16249406|NCT01752920|39395473|FG003|Overall Study|Study Terminated by Sponsor|1|||
16249407|NCT01752920|39395470|FG000|Overall Study|Withdrawal by Subject|0|||
16249408|NCT01752920|39395471|FG001|Overall Study|Withdrawal by Subject|1|||
16249409|NCT01752920|39395472|FG002|Overall Study|Withdrawal by Subject|0|||
16249410|NCT01752920|39395473|FG003|Overall Study|Withdrawal by Subject|1|||
16249411|NCT01752920|39395470|FG000|Overall Study|Lack of clinical benefit|1|||
16249412|NCT01752920|39395471|FG001|Overall Study|Lack of clinical benefit|1|||
16249413|NCT01752920|39395472|FG002|Overall Study|Lack of clinical benefit|1|||
16249414|NCT01752920|39395473|FG003|Overall Study|Lack of clinical benefit|1|||
16249415|NCT00385541|39395477|FG000|Overall Study|severe pain, clinician requested unblind|0|||
16249416|NCT00385541|39395478|FG001|Overall Study|severe pain, clinician requested unblind|1|||
16249417|NCT01868009|39395479|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
16249418|NCT01868009|39395480|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
16562456|NCT03905135|40525409|FG001|Dose Escalation|Intercurrent illness|0|||
16562457|NCT04776213|40525410|FG000|Overall Study|Other|1|||
16562458|NCT04776213|40525410|FG000|Overall Study|Withdrawal by Subject|7|||
16562459|NCT04776213|40525410|FG000|Overall Study|Protocol Violation|1|||
16562460|NCT04776213|40525410|FG000|Overall Study|Lost to Follow-up|2|||
16562461|NCT02652130|40525411|FG000|Overall Study|Death|1|||
16562462|NCT00630864|40525412|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
16562463|NCT00630864|40525412|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
16562464|NCT00953160|40525413|FG000|Overall Study|Lost to Follow-up|23|||
16249419|NCT01868009|39395479|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
16249420|NCT01868009|39395480|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
16249421|NCT01868009|39395479|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
16249422|NCT01868009|39395480|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
16249423|NCT00760383|39395481|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
16249424|NCT00760383|39395482|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
16249425|NCT00829413|39395485|FG000|Overall Study|No study drug admimnistered|13|||
16249426|NCT00829413|39395485|FG000|Overall Study|Training Patients|67|||
16249427|NCT00829413|39395485|FG000|Overall Study|No truth standard procedure available|9|||
16249428|NCT00829413|39395485|FG000|Overall Study|Technically inadequate truth standard|2|||
16249429|NCT00829413|39395485|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
16249430|NCT01754259|39395488|FG000|Overall Study|Withdrawal by Subject|2|||
16249431|NCT01754259|39395489|FG001|Overall Study|Withdrawal by Subject|4|||
16249432|NCT01754259|39395488|FG000|Overall Study|Adverse Event|3|||
16249433|NCT01754259|39395489|FG001|Overall Study|Adverse Event|1|||
16249434|NCT01754259|39395488|FG000|Overall Study|Lost to Follow-up|0|||
16249435|NCT01754259|39395489|FG001|Overall Study|Lost to Follow-up|1|||
16249436|NCT03687125|39395490|FG000|Overall Study|Progressive Disease|2|||
16130918|NCT01323634|38967154|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
16249437|NCT03687125|39395491|FG001|Overall Study|Progressive Disease|1|||
16249438|NCT03687125|39395490|FG000|Overall Study|Protocol Violation|1|||
16249439|NCT03687125|39395491|FG001|Overall Study|Protocol Violation|0|||
16249440|NCT01953783|39395492|FG000|Overall Study|Progressive disease|2|||
16249441|NCT04081337|39395493|FG000|Overall Study|Adverse Event|0|||
16249442|NCT04081337|39395494|FG001|Overall Study|Adverse Event|1|||
16562465|NCT00953160|40525413|FG000|Overall Study|Withdrawal by Subject|4|||
16360488|NCT02969018|39807480|FG004|Overall Study|Lack of Efficacy|1|||
16360489|NCT02969018|39807481|FG005|Overall Study|Lack of Efficacy|1|||
16360490|NCT02969018|39807482|FG006|Overall Study|Lack of Efficacy|1|||
16360491|NCT02969018|39807483|FG007|Overall Study|Lack of Efficacy|1|||
16360492|NCT02969018|39807476|FG000|Overall Study|Lost to Follow-up|1|||
16360493|NCT02969018|39807477|FG001|Overall Study|Lost to Follow-up|2|||
16360494|NCT02969018|39807478|FG002|Overall Study|Lost to Follow-up|2|||
16360495|NCT02969018|39807479|FG003|Overall Study|Lost to Follow-up|0|||
16360496|NCT02969018|39807480|FG004|Overall Study|Lost to Follow-up|1|||
16360497|NCT02969018|39807481|FG005|Overall Study|Lost to Follow-up|1|||
16360498|NCT02969018|39807482|FG006|Overall Study|Lost to Follow-up|0|||
16360499|NCT02969018|39807483|FG007|Overall Study|Lost to Follow-up|1|||
16360500|NCT02969018|39807476|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16360501|NCT02969018|39807477|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16360502|NCT02969018|39807478|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
16360503|NCT02969018|39807479|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
16360504|NCT02969018|39807480|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
16360505|NCT02969018|39807481|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
16360506|NCT02969018|39807482|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
16360507|NCT02969018|39807483|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
16360508|NCT02969018|39807476|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16360509|NCT02969018|39807477|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16360510|NCT02969018|39807478|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16360511|NCT02969018|39807479|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16360512|NCT02969018|39807480|FG004|Overall Study|Non-Compliance With Study Drug|0|||
16360513|NCT02969018|39807481|FG005|Overall Study|Non-Compliance With Study Drug|0|||
16360514|NCT02969018|39807482|FG006|Overall Study|Non-Compliance With Study Drug|0|||
16360515|NCT02969018|39807483|FG007|Overall Study|Non-Compliance With Study Drug|0|||
16360516|NCT02969018|39807476|FG000|Overall Study|Other|0|||
16360517|NCT02969018|39807477|FG001|Overall Study|Other|0|||
16360518|NCT02969018|39807478|FG002|Overall Study|Other|0|||
16360519|NCT02969018|39807479|FG003|Overall Study|Other|1|||
16360520|NCT02969018|39807480|FG004|Overall Study|Other|0|||
16360521|NCT02969018|39807481|FG005|Overall Study|Other|0|||
16360522|NCT02969018|39807482|FG006|Overall Study|Other|0|||
16360523|NCT02969018|39807483|FG007|Overall Study|Other|2|||
16360524|NCT02969018|39807476|FG000|Overall Study|Pregnancy|0|||
16360525|NCT02969018|39807477|FG001|Overall Study|Pregnancy|0|||
16360526|NCT02969018|39807478|FG002|Overall Study|Pregnancy|0|||
16360527|NCT02969018|39807479|FG003|Overall Study|Pregnancy|0|||
16360528|NCT02969018|39807480|FG004|Overall Study|Pregnancy|0|||
16360529|NCT02969018|39807481|FG005|Overall Study|Pregnancy|1|||
16360530|NCT02969018|39807482|FG006|Overall Study|Pregnancy|0|||
16360531|NCT02969018|39807483|FG007|Overall Study|Pregnancy|0|||
16360532|NCT02969018|39807476|FG000|Overall Study|Protocol Violation|0|||
16360533|NCT02969018|39807477|FG001|Overall Study|Protocol Violation|0|||
16360534|NCT02969018|39807478|FG002|Overall Study|Protocol Violation|1|||
16360535|NCT02969018|39807479|FG003|Overall Study|Protocol Violation|1|||
16360536|NCT02969018|39807480|FG004|Overall Study|Protocol Violation|0|||
16360537|NCT02969018|39807481|FG005|Overall Study|Protocol Violation|0|||
16360538|NCT02969018|39807482|FG006|Overall Study|Protocol Violation|0|||
16360539|NCT02969018|39807483|FG007|Overall Study|Protocol Violation|0|||
16360540|NCT02969018|39807476|FG000|Overall Study|Withdrawal by Subject|0|||
16360541|NCT02969018|39807477|FG001|Overall Study|Withdrawal by Subject|1|||
16360542|NCT02969018|39807478|FG002|Overall Study|Withdrawal by Subject|2|||
16360543|NCT02969018|39807479|FG003|Overall Study|Withdrawal by Subject|1|||
16360544|NCT02969018|39807480|FG004|Overall Study|Withdrawal by Subject|0|||
16360545|NCT02969018|39807481|FG005|Overall Study|Withdrawal by Subject|4|||
16360546|NCT02969018|39807482|FG006|Overall Study|Withdrawal by Subject|4|||
16360547|NCT02969018|39807483|FG007|Overall Study|Withdrawal by Subject|3|||
16360548|NCT00549055|39807484|FG000|Overall Study|Adverse Event|4|||
16360549|NCT00549055|39807484|FG000|Overall Study|Lack of Efficacy|18|||
16360550|NCT00549055|39807484|FG000|Overall Study|Stabilization|5|||
16360551|NCT00549055|39807484|FG000|Overall Study|Progression to fibrosis|2|||
16360552|NCT00549055|39807484|FG000|Overall Study|Decrease of size|1|||
16360553|NCT00549055|39807484|FG000|Overall Study|Active choroidal neovascula increased|1|||
16360554|NCT00549055|39807484|FG000|Overall Study|Vitreous hemorrhage|1|||
16360555|NCT00549055|39807484|FG000|Overall Study|Growth choroidal neovascularisation|1|||
16360556|NCT00549055|39807484|FG000|Overall Study|Choroidal neovascularization|1|||
16360557|NCT00549055|39807484|FG000|Overall Study|Very low visual acuity (VA)|1|||
16360558|NCT04470427|39807485|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
16360559|NCT04470427|39807486|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
16360560|NCT04470427|39807487|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
16360561|NCT04470427|39807488|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
16424540|NCT00569127|40031701|FG000|Overall Study|Lost to Follow-up|0|||
16424541|NCT00569127|40031702|FG001|Overall Study|Lost to Follow-up|3|||
16424542|NCT00569127|40031701|FG000|Overall Study|Not Eligible|14|||
16424543|NCT00569127|40031702|FG001|Overall Study|Not Eligible|11|||
16424544|NCT00569127|40031701|FG000|Overall Study|Still on Treatment|7|||
16424545|NCT00569127|40031702|FG001|Overall Study|Still on Treatment|3|||
16424546|NCT01007838|40031703|FG000|Overall Study|Withdrawal by Subject|1|||
16424547|NCT01007838|40031704|FG001|Overall Study|Withdrawal by Subject|0|||
16424548|NCT01007838|40031705|FG002|Overall Study|Withdrawal by Subject|0|||
16424549|NCT01007838|40031706|FG003|Overall Study|Withdrawal by Subject|0|||
16424550|NCT01007838|40031703|FG000|Overall Study|Physician Decision|1|||
16424551|NCT01007838|40031704|FG001|Overall Study|Physician Decision|0|||
16424552|NCT01007838|40031705|FG002|Overall Study|Physician Decision|0|||
16424553|NCT01007838|40031706|FG003|Overall Study|Physician Decision|0|||
16424554|NCT01007838|40031703|FG000|Overall Study|Started home haemodialysis|1|||
16424555|NCT01007838|40031704|FG001|Overall Study|Started home haemodialysis|0|||
16424556|NCT01007838|40031705|FG002|Overall Study|Started home haemodialysis|0|||
16424557|NCT01007838|40031706|FG003|Overall Study|Started home haemodialysis|0|||
16424558|NCT00350844|40031707|FG000|Overall Study|Lost to Follow-up|1|||
16424559|NCT00387725|40031708|FG000|Overall Study|Adverse Event|0|||
16424560|NCT00387725|40031709|FG001|Overall Study|Adverse Event|0|||
16424561|NCT00387725|40031710|FG002|Overall Study|Adverse Event|0|||
16424562|NCT00387725|40031711|FG003|Overall Study|Adverse Event|1|||
16424563|NCT00387725|40031708|FG000|Overall Study|Protocol Violation|0|||
16424564|NCT00387725|40031709|FG001|Overall Study|Protocol Violation|1|||
16424565|NCT00387725|40031710|FG002|Overall Study|Protocol Violation|0|||
16424566|NCT00387725|40031711|FG003|Overall Study|Protocol Violation|0|||
16424567|NCT00387725|40031708|FG000|Overall Study|Withdrawal by Subject|1|||
16424568|NCT00387725|40031709|FG001|Overall Study|Withdrawal by Subject|0|||
16424569|NCT00387725|40031710|FG002|Overall Study|Withdrawal by Subject|1|||
16424570|NCT00387725|40031711|FG003|Overall Study|Withdrawal by Subject|0|||
16424571|NCT00387725|40031708|FG000|Overall Study|Parent/legal guardian request|0|||
16424572|NCT00387725|40031709|FG001|Overall Study|Parent/legal guardian request|0|||
16424573|NCT00387725|40031710|FG002|Overall Study|Parent/legal guardian request|1|||
16424574|NCT00387725|40031711|FG003|Overall Study|Parent/legal guardian request|1|||
16424575|NCT04698993|40031721|FG000|Overall Study|PCR results not accessible|2|||
16424576|NCT04698993|40031722|FG001|Overall Study|PCR results not accessible|7|||
16424577|NCT04698993|40031721|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
16424578|NCT04698993|40031722|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
16424579|NCT01807299|40031723|FG000|Overall Study|Protocol Violation|3|||
16424580|NCT01807299|40031724|FG001|Overall Study|Protocol Violation|1|||
16424581|NCT01807299|40031725|FG002|Overall Study|Protocol Violation|0|||
16424582|NCT01807299|40031726|FG003|Overall Study|Protocol Violation|2|||
16424583|NCT04412707|40031730|FG000|Cycle 1|Death|0|||
16424584|NCT04412707|40031731|FG001|Cycle 1|Death|3|||
16424585|NCT04412707|40031730|FG000|Cycle 1|Disease progression|1|||
16424586|NCT04412707|40031731|FG001|Cycle 1|Disease progression|2|||
16424587|NCT04412707|40031730|FG000|Cycle 2|Death|0|||
16424588|NCT04412707|40031731|FG001|Cycle 2|Death|1|||
16424589|NCT04412707|40031730|FG000|Cycle 2|Disease progression|3|||
16424590|NCT04412707|40031731|FG001|Cycle 2|Disease progression|0|||
16424591|NCT04412707|40031730|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
16424592|NCT04412707|40031731|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
16424593|NCT04412707|40031730|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
16424594|NCT04412707|40031731|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
16424595|NCT04412707|40031730|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
16424596|NCT04412707|40031731|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
16424597|NCT04412707|40031730|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
16424598|NCT04412707|40031731|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
16424599|NCT00286429|40031732|FG000|Overall Study|Adverse Event|4|||
16424600|NCT00286429|40031733|FG001|Overall Study|Adverse Event|1|||
16424601|NCT00286429|40031734|FG002|Overall Study|Adverse Event|6|||
16424602|NCT00286429|40031732|FG000|Overall Study|Lack of Efficacy|52|||
16424603|NCT00286429|40031733|FG001|Overall Study|Lack of Efficacy|27|||
16424604|NCT00286429|40031734|FG002|Overall Study|Lack of Efficacy|25|||
16424605|NCT00286429|40031732|FG000|Overall Study|Lost to Follow-up|2|||
16424606|NCT00286429|40031733|FG001|Overall Study|Lost to Follow-up|4|||
16424607|NCT00286429|40031734|FG002|Overall Study|Lost to Follow-up|3|||
16424608|NCT00286429|40031732|FG000|Overall Study|Physician Decision|10|||
16424609|NCT00286429|40031733|FG001|Overall Study|Physician Decision|7|||
16424610|NCT00286429|40031734|FG002|Overall Study|Physician Decision|7|||
16424611|NCT00286429|40031732|FG000|Overall Study|Protocol Violation|3|||
16424612|NCT00286429|40031733|FG001|Overall Study|Protocol Violation|5|||
16424613|NCT00286429|40031734|FG002|Overall Study|Protocol Violation|4|||
16424614|NCT00286429|40031732|FG000|Overall Study|Withdrawal by Subject|3|||
16424615|NCT00286429|40031733|FG001|Overall Study|Withdrawal by Subject|2|||
16424616|NCT00286429|40031734|FG002|Overall Study|Withdrawal by Subject|6|||
16424617|NCT00286429|40031732|FG000|Overall Study|Administrative Error|1|||
16130919|NCT01323634|38967152|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16249443|NCT04081337|39395493|FG000|Overall Study|Withdrawal by Subject|2|||
16249444|NCT04081337|39395494|FG001|Overall Study|Withdrawal by Subject|0|||
16249445|NCT04081337|39395493|FG000|Overall Study|Physician Decision|1|||
16249446|NCT04081337|39395494|FG001|Overall Study|Physician Decision|2|||
16249447|NCT04081337|39395493|FG000|Overall Study|Lost to Follow-up|1|||
16249448|NCT04081337|39395494|FG001|Overall Study|Lost to Follow-up|0|||
16249449|NCT02672553|39395495|FG000|Overall Study|Death|3|||
16249450|NCT02672553|39395496|FG001|Overall Study|Death|5|||
16249451|NCT02672553|39395495|FG000|Overall Study|Valve Explant|1|||
16249452|NCT02672553|39395496|FG001|Overall Study|Valve Explant|0|||
16249453|NCT02672553|39395495|FG000|Overall Study|Conversion to Commercial Valve|3|||
16249454|NCT02672553|39395496|FG001|Overall Study|Conversion to Commercial Valve|0|||
16249455|NCT02672553|39395495|FG000|Overall Study|Withdrawal by Subject|3|||
16249456|NCT02672553|39395496|FG001|Overall Study|Withdrawal by Subject|3|||
16249457|NCT02672553|39395495|FG000|Overall Study|Intraoperative screen failure|2|||
16249458|NCT02672553|39395496|FG001|Overall Study|Intraoperative screen failure|0|||
16249459|NCT01618266|39395497|FG000|Overall Study|Lost to Follow-up|9|||
16249460|NCT01618266|39395497|FG000|Overall Study|Treatment satisfaction|10|||
16249461|NCT01618266|39395497|FG000|Overall Study|Other reasons|11|||
16249462|NCT01618266|39395497|FG000|Overall Study|Lack of Efficacy|23|||
16249463|NCT01618266|39395497|FG000|Overall Study|Protocol Violation|43|||
16249464|NCT02396381|39395498|FG000|Overall Study|Adverse Event|3|||
16249465|NCT02396381|39395499|FG001|Overall Study|Adverse Event|2|||
16249466|NCT02396381|39395498|FG000|Overall Study|Withdrawal by Subject|33|||
16249467|NCT02396381|39395499|FG001|Overall Study|Withdrawal by Subject|24|||
16249468|NCT02396381|39395498|FG000|Overall Study|Lost to Follow-up|49|||
16249469|NCT02396381|39395499|FG001|Overall Study|Lost to Follow-up|31|||
16249470|NCT02396381|39395498|FG000|Overall Study|Protocol Violation|1|||
16249471|NCT02396381|39395499|FG001|Overall Study|Protocol Violation|0|||
16249472|NCT02396381|39395498|FG000|Overall Study|Site terminated by sponsor|7|||
16249473|NCT02396381|39395499|FG001|Overall Study|Site terminated by sponsor|8|||
16249474|NCT02396381|39395498|FG000|Overall Study|Physician Decision|5|||
16249475|NCT02396381|39395499|FG001|Overall Study|Physician Decision|5|||
16249476|NCT02396381|39395498|FG000|Overall Study|Pregnancy|2|||
16249477|NCT02396381|39395499|FG001|Overall Study|Pregnancy|0|||
16249478|NCT02396381|39395498|FG000|Overall Study|Non-compliance with study procedures|1|||
16249479|NCT02396381|39395499|FG001|Overall Study|Non-compliance with study procedures|0|||
16249480|NCT02396381|39395498|FG000|Overall Study|Moved out of town/state|1|||
16249481|NCT02396381|39395499|FG001|Overall Study|Moved out of town/state|3|||
16249482|NCT02396381|39395498|FG000|Overall Study|Could not complete visit|1|||
16249483|NCT02396381|39395499|FG001|Overall Study|Could not complete visit|0|||
16249484|NCT02396381|39395498|FG000|Overall Study|Possible conflict of interest|1|||
16249485|NCT02396381|39395499|FG001|Overall Study|Possible conflict of interest|0|||
16249486|NCT02396381|39395498|FG000|Overall Study|Randomization/Screening Error|3|||
16249487|NCT02396381|39395499|FG001|Overall Study|Randomization/Screening Error|1|||
16249488|NCT02322879|39395508|FG000|First Intervention|Physician Decision|1|||
16249489|NCT02322879|39395509|FG001|First Intervention|Physician Decision|0|||
16249490|NCT00745251|39397825|FG000|Overall Study|Adverse Event|1|||
16249491|NCT00745251|39397826|FG001|Overall Study|Adverse Event|2|||
16249492|NCT00745251|39397825|FG000|Overall Study|Withdrawal by Subject|1|||
16249493|NCT00745251|39397826|FG001|Overall Study|Withdrawal by Subject|1|||
16249494|NCT02093689|39397827|FG000|Overall Study|Physician Decision|4|||
16249495|NCT02093689|39397828|FG001|Overall Study|Physician Decision|0|||
16249496|NCT02093689|39397829|FG002|Overall Study|Physician Decision|0|||
16130920|NCT01323634|38967153|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
16130921|NCT01323634|38967154|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
16249497|NCT04272775|39397832|FG000|Overall Study|Study Terminated by Sponsor|1|||
16360562|NCT04470427|39807489|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
16249498|NCT04272775|39397833|FG001|Overall Study|Study Terminated by Sponsor|0|||
16249499|NCT04272775|39397832|FG000|Overall Study|Protocol Violation|0|||
16249500|NCT04272775|39397833|FG001|Overall Study|Protocol Violation|1|||
16424618|NCT00286429|40031733|FG001|Overall Study|Administrative Error|1|||
16424619|NCT00286429|40031734|FG002|Overall Study|Administrative Error|1|||
16424620|NCT00286429|40031732|FG000|Overall Study|Administrative Decision|0|||
16424621|NCT00286429|40031733|FG001|Overall Study|Administrative Decision|1|||
16424622|NCT00286429|40031734|FG002|Overall Study|Administrative Decision|0|||
16424623|NCT04369950|40031737|FG000|Overall Study|Protocol Violation|2|||
16424624|NCT04369950|40031738|FG001|Overall Study|Protocol Violation|2|||
16424625|NCT02503501|40031741|FG000|Overall Study|Physician Decision|1|||
16424626|NCT02503501|40031742|FG001|Overall Study|Physician Decision|0|||
16424627|NCT02503501|40031741|FG000|Overall Study|Protocol Violation|0|||
16424628|NCT02503501|40031742|FG001|Overall Study|Protocol Violation|1|||
16424629|NCT02503501|40031741|FG000|Overall Study|Withdrawal by Subject|0|||
16424630|NCT02503501|40031742|FG001|Overall Study|Withdrawal by Subject|2|||
16424631|NCT01209078|40031743|FG000|Overall Study|Adverse Event|5|||
16424632|NCT01209078|40031744|FG001|Overall Study|Adverse Event|0|||
16424633|NCT01209078|40031743|FG000|Overall Study|Lost to Follow-up|4|||
16424634|NCT01209078|40031744|FG001|Overall Study|Lost to Follow-up|0|||
16424635|NCT01209078|40031743|FG000|Overall Study|Physician Decision|5|||
16424636|NCT01209078|40031744|FG001|Overall Study|Physician Decision|2|||
16424637|NCT01209078|40031743|FG000|Overall Study|Withdrawal by Subject|2|||
16424638|NCT01209078|40031744|FG001|Overall Study|Withdrawal by Subject|1|||
16424639|NCT03878758|40031745|FG000|Overall Study|Withdrawal by Subject|1|||
16424640|NCT03878758|40031745|FG000|Overall Study|Protocol defined|2|||
16424641|NCT03878758|40031745|FG000|Overall Study|Improper consent documentation|1|||
16424642|NCT00416455|40031746|FG000|Overall Study|PET / CT not done|3|||
16424643|NCT00416455|40031747|FG001|Overall Study|PET / CT not done|5|||
16424644|NCT00416455|40031746|FG000|Overall Study|PET / CT poor quality|2|||
16424645|NCT00416455|40031747|FG001|Overall Study|PET / CT poor quality|1|||
16424646|NCT00416455|40031746|FG000|Overall Study|Inadequate pathology|11|||
16424647|NCT00416455|40031747|FG001|Overall Study|Inadequate pathology|2|||
16424648|NCT01792115|40035612|FG000|Overall Study|Lost to Follow-up|0|||
16424649|NCT01792115|40035613|FG001|Overall Study|Lost to Follow-up|1|||
16424650|NCT01792115|40035614|FG002|Overall Study|Lost to Follow-up|0|||
16424651|NCT00742417|40035615|FG000|Randomized|Withdrawal by legal representative|0|||
16424652|NCT00742417|40035616|FG001|Randomized|Withdrawal by legal representative|1|||
16424653|NCT00742417|40035615|FG000|Randomized|Withdrawal by Subject|1|||
16424654|NCT00742417|40035616|FG001|Randomized|Withdrawal by Subject|0|||
16424655|NCT00742417|40035615|FG000|Randomized|Physician Decision|1|||
16424656|NCT00742417|40035616|FG001|Randomized|Physician Decision|0|||
16424657|NCT00742417|40035615|FG000|Intensive Period|Withdrawal by Subject|1|||
16424658|NCT00742417|40035616|FG001|Intensive Period|Withdrawal by Subject|1|||
16424659|NCT00742417|40035615|FG000|Intensive Period|Adverse Event|2|||
16424660|NCT00742417|40035616|FG001|Intensive Period|Adverse Event|0|||
16424661|NCT01221350|40035617|FG000|Overall Study|Discontinued intervention (GERD)|1|||
16424662|NCT01221350|40035618|FG001|Overall Study|Discontinued intervention (GERD)|0|||
16424663|NCT01221350|40035617|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
16424664|NCT01221350|40035618|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
16424665|NCT01221350|40035617|FG000|Overall Study|Withdrawal by Subject|4|||
16424666|NCT01221350|40035618|FG001|Overall Study|Withdrawal by Subject|2|||
16424667|NCT01990612|40035619|FG000|Overall Study|Lost to Follow-up|2|||
16424668|NCT01990612|40035620|FG001|Overall Study|Lost to Follow-up|1|||
16424669|NCT01990612|40035619|FG000|Overall Study|Withdrawal by Subject|5|||
16424670|NCT01990612|40035620|FG001|Overall Study|Withdrawal by Subject|2|||
16424671|NCT01180296|40035623|FG000|Overall Study|Protocol Violation|1|||
16424672|NCT01180296|40035624|FG001|Overall Study|Protocol Violation|2|||
16424673|NCT00856544|40035632|FG000|Overall Study|Randomized but not treated|3|||
16424674|NCT00856544|40035633|FG001|Overall Study|Randomized but not treated|0|||
16424675|NCT00856544|40035634|FG002|Overall Study|Randomized but not treated|0|||
16424676|NCT00856544|40035635|FG003|Overall Study|Randomized but not treated|0|||
16424677|NCT00856544|40035632|FG000|Overall Study|Death|0|||
16424678|NCT00856544|40035633|FG001|Overall Study|Death|2|||
16424679|NCT00856544|40035634|FG002|Overall Study|Death|0|||
16424680|NCT00856544|40035635|FG003|Overall Study|Death|0|||
16424681|NCT00856544|40035632|FG000|Overall Study|Adverse Event|20|||
16424682|NCT00856544|40035633|FG001|Overall Study|Adverse Event|29|||
16424683|NCT00856544|40035634|FG002|Overall Study|Adverse Event|2|||
16424684|NCT00856544|40035635|FG003|Overall Study|Adverse Event|3|||
16424685|NCT00856544|40035632|FG000|Overall Study|Lack of Efficacy|16|||
16424686|NCT00856544|40035633|FG001|Overall Study|Lack of Efficacy|12|||
16424687|NCT00856544|40035634|FG002|Overall Study|Lack of Efficacy|3|||
16424688|NCT00856544|40035635|FG003|Overall Study|Lack of Efficacy|3|||
16424689|NCT00856544|40035632|FG000|Overall Study|Other|9|||
16424690|NCT00856544|40035633|FG001|Overall Study|Other|16|||
16424691|NCT00856544|40035634|FG002|Overall Study|Other|1|||
16424692|NCT00856544|40035635|FG003|Overall Study|Other|6|||
16424693|NCT00856544|40035632|FG000|Overall Study|Lost to Follow-up|1|||
16424694|NCT00856544|40035633|FG001|Overall Study|Lost to Follow-up|2|||
16424695|NCT00856544|40035634|FG002|Overall Study|Lost to Follow-up|2|||
16424696|NCT00856544|40035635|FG003|Overall Study|Lost to Follow-up|0|||
16424697|NCT00856544|40035632|FG000|Overall Study|Withdrawal by Subject|8|||
16424698|NCT00856544|40035633|FG001|Overall Study|Withdrawal by Subject|5|||
16424699|NCT00856544|40035634|FG002|Overall Study|Withdrawal by Subject|0|||
16424700|NCT00856544|40035635|FG003|Overall Study|Withdrawal by Subject|1|||
16424701|NCT00291486|40035640|FG000|Overall Study|Adverse Event|0|||
16424702|NCT00291486|40035641|FG001|Overall Study|Adverse Event|3|||
16424703|NCT00291486|40035642|FG002|Overall Study|Adverse Event|0|||
16424704|NCT00291486|40035643|FG003|Overall Study|Adverse Event|1|||
16424705|NCT00291486|40035644|FG004|Overall Study|Adverse Event|0|||
16424706|NCT00291486|40035640|FG000|Overall Study|Withdrawal by Subject|0|||
16424707|NCT00291486|40035641|FG001|Overall Study|Withdrawal by Subject|0|||
16424708|NCT00291486|40035642|FG002|Overall Study|Withdrawal by Subject|0|||
16424709|NCT00291486|40035643|FG003|Overall Study|Withdrawal by Subject|0|||
16424710|NCT00291486|40035644|FG004|Overall Study|Withdrawal by Subject|1|||
16424711|NCT00291486|40035640|FG000|Overall Study|Disease progression|1|||
16424712|NCT00291486|40035641|FG001|Overall Study|Disease progression|0|||
16424713|NCT00291486|40035642|FG002|Overall Study|Disease progression|1|||
16424714|NCT00291486|40035643|FG003|Overall Study|Disease progression|0|||
16424715|NCT00291486|40035644|FG004|Overall Study|Disease progression|0|||
16424716|NCT01445080|40035645|FG000|Overall Study|Adverse Event|5|||
16424717|NCT01445080|40035646|FG001|Overall Study|Adverse Event|3|||
16424718|NCT01445080|40035647|FG002|Overall Study|Adverse Event|11|||
16424719|NCT01445080|40035648|FG003|Overall Study|Adverse Event|6|||
16424720|NCT01445080|40035649|FG004|Overall Study|Adverse Event|2|||
16424721|NCT01445080|40035650|FG005|Overall Study|Adverse Event|3|||
16424722|NCT01445080|40035651|FG006|Overall Study|Adverse Event|0|||
16424723|NCT01445080|40035652|FG007|Overall Study|Adverse Event|3|||
16424724|NCT01445080|40035653|FG008|Overall Study|Adverse Event|10|||
16424725|NCT01445080|40035645|FG000|Overall Study|Physician Decision|0|||
16424726|NCT01445080|40035646|FG001|Overall Study|Physician Decision|0|||
16424727|NCT01445080|40035647|FG002|Overall Study|Physician Decision|1|||
16424728|NCT01445080|40035648|FG003|Overall Study|Physician Decision|0|||
16424729|NCT01445080|40035649|FG004|Overall Study|Physician Decision|0|||
16424730|NCT01445080|40035650|FG005|Overall Study|Physician Decision|3|||
16424731|NCT01445080|40035651|FG006|Overall Study|Physician Decision|2|||
16424732|NCT01445080|40035652|FG007|Overall Study|Physician Decision|2|||
16424733|NCT01445080|40035653|FG008|Overall Study|Physician Decision|0|||
16424734|NCT01445080|40035645|FG000|Overall Study|Withdrawal by Subject|1|||
16424735|NCT01445080|40035646|FG001|Overall Study|Withdrawal by Subject|0|||
16424736|NCT01445080|40035647|FG002|Overall Study|Withdrawal by Subject|0|||
16424737|NCT01445080|40035648|FG003|Overall Study|Withdrawal by Subject|1|||
16424738|NCT01445080|40035649|FG004|Overall Study|Withdrawal by Subject|0|||
16424739|NCT01445080|40035650|FG005|Overall Study|Withdrawal by Subject|0|||
16424740|NCT01445080|40035651|FG006|Overall Study|Withdrawal by Subject|0|||
16424741|NCT01445080|40035652|FG007|Overall Study|Withdrawal by Subject|0|||
16424742|NCT01445080|40035653|FG008|Overall Study|Withdrawal by Subject|2|||
16424743|NCT01445080|40035645|FG000|Overall Study|Ineligible/Inevaluable|1|||
16424744|NCT01445080|40035646|FG001|Overall Study|Ineligible/Inevaluable|2|||
16424745|NCT01445080|40035647|FG002|Overall Study|Ineligible/Inevaluable|0|||
16424746|NCT01445080|40035648|FG003|Overall Study|Ineligible/Inevaluable|1|||
16424747|NCT01445080|40035649|FG004|Overall Study|Ineligible/Inevaluable|2|||
16424748|NCT01445080|40035650|FG005|Overall Study|Ineligible/Inevaluable|3|||
16424749|NCT01445080|40035651|FG006|Overall Study|Ineligible/Inevaluable|0|||
16424750|NCT01445080|40035652|FG007|Overall Study|Ineligible/Inevaluable|0|||
16424751|NCT01445080|40035653|FG008|Overall Study|Ineligible/Inevaluable|6|||
16424752|NCT02586727|40035656|FG000|Overall Study|Lost to Follow-up|1|||
16424753|NCT02586727|40035657|FG001|Overall Study|Lost to Follow-up|0|||
16424754|NCT01900652|40035658|FG000|Overall Study|Progressive Disease|1|||
16424755|NCT01900652|40035659|FG001|Overall Study|Progressive Disease|0|||
16424756|NCT01900652|40035658|FG000|Overall Study|Consent withdrawn by subject|1|||
16424757|NCT01900652|40035659|FG001|Overall Study|Consent withdrawn by subject|1|||
16424758|NCT01900652|40035658|FG000|Overall Study|Death|3|||
16424759|NCT01900652|40035659|FG001|Overall Study|Death|0|||
16424760|NCT01900652|40035658|FG000|Overall Study|Adverse Event|2|||
16424761|NCT01900652|40035659|FG001|Overall Study|Adverse Event|1|||
16424762|NCT01900652|40035658|FG000|Overall Study|Physician Decision|1|||
16424763|NCT01900652|40035659|FG001|Overall Study|Physician Decision|1|||
16424764|NCT02863328|40035660|FG000|Overall Study|Lost to Follow-up|4|||
16424765|NCT02863328|40035661|FG001|Overall Study|Lost to Follow-up|10|||
16424766|NCT02863328|40035660|FG000|Overall Study|Withdrawal by Subject|7|||
16424767|NCT02863328|40035661|FG001|Overall Study|Withdrawal by Subject|12|||
16424768|NCT02863328|40035660|FG000|Overall Study|Died|0|||
16424769|NCT02863328|40035661|FG001|Overall Study|Died|1|||
16424770|NCT01363661|40035662|FG000|Overall Study|Adverse Event|9|||
16424771|NCT01363661|40035663|FG001|Overall Study|Adverse Event|2|||
16424772|NCT01363661|40035662|FG000|Overall Study|Withdrawal by Subject|1|||
16424773|NCT01363661|40035663|FG001|Overall Study|Withdrawal by Subject|1|||
16424774|NCT01363661|40035662|FG000|Overall Study|Protocol Violation|1|||
16424775|NCT01363661|40035663|FG001|Overall Study|Protocol Violation|0|||
16424776|NCT01363661|40035662|FG000|Overall Study|Lost to Follow-up|3|||
16424777|NCT01363661|40035663|FG001|Overall Study|Lost to Follow-up|1|||
16424778|NCT00548145|40035667|FG000|Overall Study|Death|0|||
16424779|NCT00548145|40035668|FG001|Overall Study|Death|1|||
16424780|NCT00548145|40035667|FG000|Overall Study|Withdrawal by Subject|0|||
16424781|NCT00548145|40035668|FG001|Overall Study|Withdrawal by Subject|2|||
16424782|NCT00548145|40035667|FG000|Overall Study|Physician Decision|1|||
16424783|NCT00548145|40035668|FG001|Overall Study|Physician Decision|1|||
16424784|NCT01371734|40035669|FG000|Overall Study|Other|2|||
16424785|NCT01371734|40035670|FG001|Overall Study|Other|1|||
16424786|NCT01371734|40035671|FG002|Overall Study|Other|2|||
16424787|NCT01371734|40035669|FG000|Overall Study|Withdrawal by Subject|3|||
16424788|NCT01371734|40035670|FG001|Overall Study|Withdrawal by Subject|4|||
16424789|NCT01371734|40035671|FG002|Overall Study|Withdrawal by Subject|9|||
16424790|NCT01371734|40035669|FG000|Overall Study|Lost to Follow-up|5|||
16424791|NCT01371734|40035670|FG001|Overall Study|Lost to Follow-up|3|||
16424792|NCT01371734|40035671|FG002|Overall Study|Lost to Follow-up|1|||
16424793|NCT01371734|40035669|FG000|Overall Study|Protocol Violation|3|||
16424794|NCT01371734|40035670|FG001|Overall Study|Protocol Violation|1|||
16424795|NCT01371734|40035671|FG002|Overall Study|Protocol Violation|2|||
16424796|NCT01371734|40035669|FG000|Overall Study|Adverse Event|8|||
16424797|NCT01371734|40035670|FG001|Overall Study|Adverse Event|8|||
16424798|NCT01371734|40035671|FG002|Overall Study|Adverse Event|3|||
16424799|NCT01371734|40035669|FG000|Overall Study|Lack of Efficacy|2|||
16424800|NCT01371734|40035670|FG001|Overall Study|Lack of Efficacy|2|||
16424801|NCT01371734|40035671|FG002|Overall Study|Lack of Efficacy|0|||
16424802|NCT01777776|40035675|FG000|Overall Study|Adverse Event|2|||
16424803|NCT01777776|40035676|FG001|Overall Study|Adverse Event|4|||
16424804|NCT01777776|40035677|FG002|Overall Study|Adverse Event|0|||
16424805|NCT01777776|40035678|FG003|Overall Study|Adverse Event|0|||
16424806|NCT01777776|40035675|FG000|Overall Study|Disease Progression|4|||
16424807|NCT01777776|40035676|FG001|Overall Study|Disease Progression|8|||
16424808|NCT01777776|40035677|FG002|Overall Study|Disease Progression|6|||
16424809|NCT01777776|40035678|FG003|Overall Study|Disease Progression|3|||
16424810|NCT01777776|40035675|FG000|Overall Study|Withdrawal by Subject|0|||
16424811|NCT01777776|40035676|FG001|Overall Study|Withdrawal by Subject|0|||
16424812|NCT01777776|40035677|FG002|Overall Study|Withdrawal by Subject|0|||
16424813|NCT01777776|40035678|FG003|Overall Study|Withdrawal by Subject|1|||
16424814|NCT02106403|40035679|FG000|Follow-Up Visit 3|Other Reason|0|||
16424815|NCT02106403|40035680|FG001|Follow-Up Visit 3|Other Reason|0|||
16424816|NCT02106403|40035681|FG002|Follow-Up Visit 3|Other Reason|0|||
16424817|NCT02106403|40035682|FG003|Follow-Up Visit 3|Other Reason|0|||
16424818|NCT02106403|40035683|FG004|Follow-Up Visit 3|Other Reason|0|||
16424819|NCT02106403|40035684|FG005|Follow-Up Visit 3|Other Reason|1|||
16424820|NCT03857542|40035685|FG000|Overall Study|Adverse Event|1|||
16424821|NCT03857542|40035686|FG001|Overall Study|Adverse Event|3|||
16424822|NCT03857542|40035685|FG000|Overall Study|Withdrawal by Subject|2|||
16424823|NCT03857542|40035686|FG001|Overall Study|Withdrawal by Subject|1|||
16424824|NCT03857542|40035685|FG000|Overall Study|Lost to Follow-up|2|||
16424825|NCT03857542|40035686|FG001|Overall Study|Lost to Follow-up|1|||
16424826|NCT03857542|40035685|FG000|Overall Study|Reason not Specified|1|||
16424827|NCT03857542|40035686|FG001|Overall Study|Reason not Specified|0|||
16424828|NCT06359080|40035687|FG000|Overall Study|Withdrawal by Subject|3|||
16424829|NCT02008227|40035688|FG000|Overall Study|Lost to Follow-up|7|||
16424830|NCT02008227|40035689|FG001|Overall Study|Lost to Follow-up|9|||
16424831|NCT02008227|40035688|FG000|Overall Study|Death|494|||
16424832|NCT02008227|40035689|FG001|Overall Study|Death|485|||
16424833|NCT02008227|40035688|FG000|Overall Study|Withdrawal by Subject|67|||
16424834|NCT02008227|40035689|FG001|Overall Study|Withdrawal by Subject|36|||
16424835|NCT02008227|40035688|FG000|Overall Study|Study Terminated By Sponsor|44|||
16424836|NCT02008227|40035689|FG001|Overall Study|Study Terminated By Sponsor|83|||
16424837|NCT00145574|40035690|FG000|Double Blind|Adverse Event|0|||
16424838|NCT00145574|40035691|FG001|Double Blind|Adverse Event|3|||
16424839|NCT00145574|40035692|FG002|Double Blind|Adverse Event|1|||
16424840|NCT00145574|40035690|FG000|Double Blind|Withdrawal by Subject|1|||
16424841|NCT00145574|40035691|FG001|Double Blind|Withdrawal by Subject|1|||
16424842|NCT00145574|40035692|FG002|Double Blind|Withdrawal by Subject|1|||
16424843|NCT00145574|40035690|FG000|Double Blind|required restricted medicine|0|||
16424844|NCT00145574|40035691|FG001|Double Blind|required restricted medicine|1|||
16424845|NCT00145574|40035692|FG002|Double Blind|required restricted medicine|0|||
16424846|NCT00145574|40035690|FG000|Open Label Long-term Extension|Adverse Event|0|||
16424847|NCT00145574|40035691|FG001|Open Label Long-term Extension|Adverse Event|0|||
16424848|NCT00145574|40035692|FG002|Open Label Long-term Extension|Adverse Event|5|||
16424849|NCT00145574|40035690|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
16424850|NCT00145574|40035691|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
16424851|NCT00145574|40035692|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
16424852|NCT00145574|40035690|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
16424853|NCT00145574|40035691|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
16424854|NCT00145574|40035692|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
16424855|NCT00145574|40035690|FG000|Open Label Long-term Extension|required restricted medicine|0|||
16424856|NCT00145574|40035691|FG001|Open Label Long-term Extension|required restricted medicine|0|||
16424857|NCT00145574|40035692|FG002|Open Label Long-term Extension|required restricted medicine|1|||
16424858|NCT01856192|40035693|FG000|Overall Study|Adverse Event|12|||
16424859|NCT01856192|40035694|FG001|Overall Study|Adverse Event|4|||
16424860|NCT01856192|40035693|FG000|Overall Study|Alternative therapy|0|||
16424861|NCT01856192|40035694|FG001|Overall Study|Alternative therapy|3|||
16424862|NCT01856192|40035693|FG000|Overall Study|Death|3|||
16424863|NCT01856192|40035694|FG001|Overall Study|Death|5|||
16424864|NCT01856192|40035693|FG000|Overall Study|Lack of Efficacy|0|||
16424865|NCT01856192|40035694|FG001|Overall Study|Lack of Efficacy|5|||
16424866|NCT01856192|40035693|FG000|Overall Study|Withdrawal by Subject|1|||
16424867|NCT01856192|40035694|FG001|Overall Study|Withdrawal by Subject|1|||
16424868|NCT01856192|40035693|FG000|Overall Study|Other diseases|1|||
16424869|NCT01856192|40035694|FG001|Overall Study|Other diseases|0|||
16424870|NCT01856192|40035693|FG000|Overall Study|Never started treatment|7|||
16424871|NCT01856192|40035694|FG001|Overall Study|Never started treatment|5|||
16424872|NCT01856192|40035693|FG000|Overall Study|Path ineligible|20|||
16424873|NCT01856192|40035694|FG001|Overall Study|Path ineligible|34|||
16424874|NCT01856192|40035693|FG000|Overall Study|Non-path ineligible|2|||
16424875|NCT01856192|40035694|FG001|Overall Study|Non-path ineligible|2|||
16424876|NCT01856192|40035693|FG000|Overall Study|Physician Decision|1|||
16424877|NCT01856192|40035694|FG001|Overall Study|Physician Decision|1|||
16424878|NCT01856192|40035693|FG000|Overall Study|Suspicion of progressive disease|1|||
16424879|NCT01856192|40035694|FG001|Overall Study|Suspicion of progressive disease|0|||
16424880|NCT01856192|40035693|FG000|Overall Study|Non-compliance|1|||
16424881|NCT01856192|40035694|FG001|Overall Study|Non-compliance|0|||
16424882|NCT01142388|40035695|FG000|Overall Study|Lack of Efficacy|21|||
16424883|NCT01142388|40035696|FG001|Overall Study|Lack of Efficacy|31|||
16424884|NCT01142388|40035695|FG000|Overall Study|Adverse Event|9|||
16424885|NCT01142388|40035696|FG001|Overall Study|Adverse Event|5|||
16424886|NCT01142388|40035695|FG000|Overall Study|Death|3|||
16424887|NCT01142388|40035696|FG001|Overall Study|Death|2|||
16424888|NCT01142388|40035695|FG000|Overall Study|Withdrawal by Subject|5|||
16424889|NCT01142388|40035696|FG001|Overall Study|Withdrawal by Subject|3|||
16424890|NCT01142388|40035695|FG000|Overall Study|Alternative therapy|1|||
16424891|NCT01142388|40035696|FG001|Overall Study|Alternative therapy|0|||
16424892|NCT01142388|40035695|FG000|Overall Study|Other complications|0|||
16424893|NCT01142388|40035696|FG001|Overall Study|Other complications|2|||
16424894|NCT01142388|40035695|FG000|Overall Study|Other|1|||
16424895|NCT01142388|40035696|FG001|Overall Study|Other|1|||
16424896|NCT01142388|40035695|FG000|Overall Study|Never started therapy|7|||
16424897|NCT01142388|40035696|FG001|Overall Study|Never started therapy|3|||
16424898|NCT02519595|40035697|FG000|Overall Study|Protocol Violation|8|||
16424899|NCT02519595|40035698|FG001|Overall Study|Protocol Violation|22|||
16424900|NCT02519595|40035699|FG002|Overall Study|Protocol Violation|16|||
16424901|NCT04090242|40035700|FG000|Overall Study|Withdrawal by Subject|1|||
16424902|NCT04090242|40035701|FG001|Overall Study|Withdrawal by Subject|0|||
16424903|NCT02504580|40035703|FG000|Overall Study|Other|1|||
16424904|NCT02504580|40035704|FG001|Overall Study|Other|0|||
16424905|NCT02504580|40035705|FG002|Overall Study|Other|0|||
16424906|NCT02504580|40035706|FG003|Overall Study|Other|2|||
16424907|NCT02504580|40035707|FG004|Overall Study|Other|1|||
16249501|NCT04272775|39397832|FG000|Overall Study|Symptomatic Deterioration|1|||
16249502|NCT04272775|39397833|FG001|Overall Study|Symptomatic Deterioration|1|||
16249503|NCT04272775|39397832|FG000|Overall Study|Withdrawal by Subject|1|||
16249504|NCT04272775|39397833|FG001|Overall Study|Withdrawal by Subject|2|||
16249505|NCT04272775|39397832|FG000|Overall Study|Adverse Event|1|||
16249506|NCT04272775|39397833|FG001|Overall Study|Adverse Event|2|||
16249507|NCT04272775|39397832|FG000|Overall Study|Progressive Disease|3|||
16249508|NCT04272775|39397833|FG001|Overall Study|Progressive Disease|1|||
16424908|NCT02504580|40035708|FG005|Overall Study|Other|1|||
16424909|NCT02504580|40035709|FG006|Overall Study|Other|1|||
16424910|NCT02504580|40035710|FG007|Overall Study|Other|2|||
16424911|NCT02504580|40035711|FG008|Overall Study|Other|0|||
16424912|NCT02504580|40035712|FG009|Overall Study|Other|0|||
16424913|NCT02504580|40035713|FG010|Overall Study|Other|0|||
16424914|NCT02504580|40035714|FG011|Overall Study|Other|2|||
16424915|NCT02504580|40035703|FG000|Overall Study|Subject refusal to continue|0|||
16249509|NCT00582036|39397834|FG000|Overall Study|Withdrawal by Subject|0|||
16249510|NCT00582036|39397835|FG001|Overall Study|Withdrawal by Subject|1|||
16249511|NCT01466686|39397836|FG000|Overall Study|Withdrawal by Subject|1|||
16424916|NCT02504580|40035704|FG001|Overall Study|Subject refusal to continue|1|||
16424917|NCT02504580|40035705|FG002|Overall Study|Subject refusal to continue|0|||
16424918|NCT02504580|40035706|FG003|Overall Study|Subject refusal to continue|0|||
16424919|NCT02504580|40035707|FG004|Overall Study|Subject refusal to continue|0|||
16249512|NCT00553540|39397837|FG000|Overall Study|discharged after first visit|2|||
16249513|NCT00553540|39397838|FG001|Overall Study|discharged after first visit|5|||
16249514|NCT04534283|39397839|FG000|Overall Study|Physician Decision|2|||
16424920|NCT02504580|40035708|FG005|Overall Study|Subject refusal to continue|0|||
16424921|NCT02504580|40035709|FG006|Overall Study|Subject refusal to continue|0|||
16424922|NCT02504580|40035710|FG007|Overall Study|Subject refusal to continue|0|||
16424923|NCT02504580|40035711|FG008|Overall Study|Subject refusal to continue|0|||
16424924|NCT02504580|40035712|FG009|Overall Study|Subject refusal to continue|0|||
16424925|NCT02504580|40035713|FG010|Overall Study|Subject refusal to continue|0|||
16424926|NCT02504580|40035714|FG011|Overall Study|Subject refusal to continue|0|||
16424927|NCT03698019|40035715|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
16424928|NCT03698019|40035716|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
16424929|NCT03698019|40035715|FG000|Step 1: Registration|Withdrawal by Subject|7|||
16424930|NCT03698019|40035716|FG001|Step 1: Registration|Withdrawal by Subject|2|||
16424931|NCT03698019|40035715|FG000|Step 1: Registration|Toxicity|0|||
16424932|NCT03698019|40035716|FG001|Step 1: Registration|Toxicity|1|||
16424933|NCT03698019|40035715|FG000|Step 1: Registration|Disease Progression|0|||
16424934|NCT03698019|40035716|FG001|Step 1: Registration|Disease Progression|12|||
16424935|NCT03698019|40035715|FG000|Step 1: Registration|Co-morbidities|0|||
16424936|NCT03698019|40035716|FG001|Step 1: Registration|Co-morbidities|1|||
16424937|NCT03698019|40035715|FG000|Step 1: Registration|Scheduling Issues|1|||
16424938|NCT03698019|40035716|FG001|Step 1: Registration|Scheduling Issues|0|||
16424939|NCT03698019|40035715|FG000|Step 1: Registration|Participant Refusal|0|||
16424940|NCT03698019|40035716|FG001|Step 1: Registration|Participant Refusal|1|||
16424941|NCT03698019|40035715|FG000|Step 2: Surgery|Participant Refusal|2|||
16424942|NCT03698019|40035716|FG001|Step 2: Surgery|Participant Refusal|1|||
16424943|NCT03698019|40035715|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
16424944|NCT03698019|40035716|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
16424945|NCT03698019|40035715|FG000|Step 2: Surgery|Metastatic Disease|16|||
16424946|NCT03698019|40035716|FG001|Step 2: Surgery|Metastatic Disease|9|||
16424947|NCT03698019|40035715|FG000|Step 2: Surgery|Residual Disease|2|||
16424948|NCT03698019|40035716|FG001|Step 2: Surgery|Residual Disease|1|||
16424949|NCT03698019|40035715|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
16424950|NCT03698019|40035716|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
16424951|NCT03698019|40035715|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
16424952|NCT03698019|40035716|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
16424953|NCT03698019|40035715|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
16424954|NCT03698019|40035716|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
16424955|NCT03698019|40035715|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
16424956|NCT03698019|40035716|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
16424957|NCT03698019|40035715|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
16424958|NCT03698019|40035716|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
16424959|NCT03698019|40035715|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
16424960|NCT03698019|40035716|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
16424961|NCT03698019|40035715|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
16424962|NCT03698019|40035716|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
16424963|NCT03698019|40035715|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
16424964|NCT03698019|40035716|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
16424965|NCT00375518|40035719|FG000|Overall Study|Withdrawal by Subject|2|||
16424966|NCT00375518|40035720|FG001|Overall Study|Withdrawal by Subject|10|||
16424967|NCT00375518|40035719|FG000|Overall Study|Patient Not Treated|6|||
16424968|NCT00375518|40035720|FG001|Overall Study|Patient Not Treated|6|||
16249515|NCT04534283|39397839|FG000|Overall Study|Withdrawal by Subject|1|||
16249516|NCT04534283|39397839|FG000|Overall Study|Disease Progression|12|||
16249517|NCT04534283|39397839|FG000|Overall Study|Adverse Event|1|||
16249518|NCT01799590|39397840|FG000|Overall Study|Adverse Event|13|||
16249519|NCT01799590|39397841|FG001|Overall Study|Adverse Event|7|||
16249520|NCT01799590|39397842|FG002|Overall Study|Adverse Event|5|||
16249521|NCT01799590|39397840|FG000|Overall Study|Pregnancy|2|||
16249522|NCT01799590|39397841|FG001|Overall Study|Pregnancy|0|||
16249523|NCT01799590|39397842|FG002|Overall Study|Pregnancy|0|||
16249524|NCT01799590|39397840|FG000|Overall Study|Lack of Efficacy|3|||
16249525|NCT01799590|39397841|FG001|Overall Study|Lack of Efficacy|1|||
16249526|NCT01799590|39397842|FG002|Overall Study|Lack of Efficacy|3|||
16249527|NCT01799590|39397840|FG000|Overall Study|Participants convenience|4|||
16249528|NCT01799590|39397841|FG001|Overall Study|Participants convenience|4|||
16249529|NCT01799590|39397842|FG002|Overall Study|Participants convenience|2|||
16424969|NCT00375518|40035719|FG000|Overall Study|Death|0|||
16424970|NCT00375518|40035720|FG001|Overall Study|Death|1|||
16424971|NCT02452424|40035722|FG000|Overall Study|Death|2|||
16424972|NCT02452424|40035723|FG001|Overall Study|Death|2|||
16424973|NCT02452424|40035724|FG002|Overall Study|Death|2|||
16424974|NCT02452424|40035725|FG003|Overall Study|Death|6|||
16424975|NCT02452424|40035726|FG004|Overall Study|Death|2|||
16424976|NCT02452424|40035727|FG005|Overall Study|Death|0|||
16424977|NCT02452424|40035728|FG006|Overall Study|Death|5|||
16424978|NCT02452424|40035729|FG007|Overall Study|Death|1|||
16424979|NCT02452424|40035730|FG008|Overall Study|Death|3|||
16424980|NCT02452424|40035731|FG009|Overall Study|Death|1|||
16424981|NCT02452424|40035732|FG010|Overall Study|Death|0|||
16424982|NCT02452424|40035722|FG000|Overall Study|Lost to Follow-up|0|||
16424983|NCT02452424|40035723|FG001|Overall Study|Lost to Follow-up|1|||
16424984|NCT02452424|40035724|FG002|Overall Study|Lost to Follow-up|1|||
16424985|NCT02452424|40035725|FG003|Overall Study|Lost to Follow-up|0|||
16424986|NCT02452424|40035726|FG004|Overall Study|Lost to Follow-up|0|||
16424987|NCT02452424|40035727|FG005|Overall Study|Lost to Follow-up|0|||
16424988|NCT02452424|40035728|FG006|Overall Study|Lost to Follow-up|0|||
16424989|NCT02452424|40035729|FG007|Overall Study|Lost to Follow-up|0|||
16424990|NCT02452424|40035730|FG008|Overall Study|Lost to Follow-up|0|||
16424991|NCT02452424|40035731|FG009|Overall Study|Lost to Follow-up|0|||
16424992|NCT02452424|40035732|FG010|Overall Study|Lost to Follow-up|0|||
16424993|NCT02452424|40035722|FG000|Overall Study|Withdrawal by Subject|0|||
16424994|NCT02452424|40035723|FG001|Overall Study|Withdrawal by Subject|0|||
16424995|NCT02452424|40035724|FG002|Overall Study|Withdrawal by Subject|3|||
16424996|NCT02452424|40035725|FG003|Overall Study|Withdrawal by Subject|2|||
16424997|NCT02452424|40035726|FG004|Overall Study|Withdrawal by Subject|0|||
16424998|NCT02452424|40035727|FG005|Overall Study|Withdrawal by Subject|0|||
16424999|NCT02452424|40035728|FG006|Overall Study|Withdrawal by Subject|1|||
16425000|NCT02452424|40035729|FG007|Overall Study|Withdrawal by Subject|0|||
16425001|NCT02452424|40035730|FG008|Overall Study|Withdrawal by Subject|1|||
16425002|NCT02452424|40035731|FG009|Overall Study|Withdrawal by Subject|1|||
16425003|NCT02452424|40035732|FG010|Overall Study|Withdrawal by Subject|0|||
16425004|NCT02452424|40035722|FG000|Overall Study|Other|0|||
16425005|NCT02452424|40035723|FG001|Overall Study|Other|0|||
16425006|NCT02452424|40035724|FG002|Overall Study|Other|1|||
16425007|NCT02452424|40035725|FG003|Overall Study|Other|0|||
16425008|NCT02452424|40035726|FG004|Overall Study|Other|0|||
16425009|NCT02452424|40035727|FG005|Overall Study|Other|1|||
16425010|NCT02452424|40035728|FG006|Overall Study|Other|4|||
16425011|NCT02452424|40035729|FG007|Overall Study|Other|3|||
16425012|NCT02452424|40035730|FG008|Overall Study|Other|0|||
16425013|NCT02452424|40035731|FG009|Overall Study|Other|0|||
16425014|NCT02452424|40035732|FG010|Overall Study|Other|1|||
16425015|NCT02452424|40035722|FG000|Overall Study|Progressive disease (per RECIST)|0|||
16425016|NCT02452424|40035723|FG001|Overall Study|Progressive disease (per RECIST)|0|||
16425017|NCT02452424|40035724|FG002|Overall Study|Progressive disease (per RECIST)|0|||
16425018|NCT02452424|40035725|FG003|Overall Study|Progressive disease (per RECIST)|0|||
16425019|NCT02452424|40035726|FG004|Overall Study|Progressive disease (per RECIST)|0|||
16425020|NCT02452424|40035727|FG005|Overall Study|Progressive disease (per RECIST)|0|||
16425021|NCT02452424|40035728|FG006|Overall Study|Progressive disease (per RECIST)|0|||
16425022|NCT02452424|40035729|FG007|Overall Study|Progressive disease (per RECIST)|0|||
16425023|NCT02452424|40035730|FG008|Overall Study|Progressive disease (per RECIST)|2|||
16425024|NCT02452424|40035731|FG009|Overall Study|Progressive disease (per RECIST)|0|||
16425025|NCT02452424|40035732|FG010|Overall Study|Progressive disease (per RECIST)|0|||
16425026|NCT02452424|40035722|FG000|Overall Study|Adverse Event|0|||
16425027|NCT02452424|40035723|FG001|Overall Study|Adverse Event|0|||
16425028|NCT02452424|40035724|FG002|Overall Study|Adverse Event|0|||
16425029|NCT02452424|40035725|FG003|Overall Study|Adverse Event|0|||
16425030|NCT02452424|40035726|FG004|Overall Study|Adverse Event|0|||
16425031|NCT02452424|40035727|FG005|Overall Study|Adverse Event|0|||
16425032|NCT02452424|40035728|FG006|Overall Study|Adverse Event|0|||
16425033|NCT02452424|40035729|FG007|Overall Study|Adverse Event|0|||
16425034|NCT02452424|40035730|FG008|Overall Study|Adverse Event|0|||
16425035|NCT02452424|40035731|FG009|Overall Study|Adverse Event|0|||
16425036|NCT02452424|40035732|FG010|Overall Study|Adverse Event|1|||
16425037|NCT02100969|40035733|FG000|Overall Study|Did not pass screening phase|1|||
16425038|NCT01223183|40035746|FG000|Imaging Day 1|Physician Decision|0|||
16425039|NCT01223183|40035747|FG001|Imaging Day 1|Physician Decision|1|||
16425040|NCT01223183|40035746|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
16425041|NCT01223183|40035747|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
16425042|NCT01223183|40035746|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
16425043|NCT01223183|40035747|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
16425044|NCT03790917|40035748|FG000|Overall Study|Death|1|||
16425045|NCT02881762|40035749|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
16425046|NCT02881762|40035750|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
16425047|NCT01769196|40035755|FG000|Overall Study|Adverse Event|24|||
16425048|NCT01769196|40035756|FG001|Overall Study|Adverse Event|20|||
16425049|NCT01769196|40035755|FG000|Overall Study|Death|21|||
16360563|NCT04470427|39807490|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
16360564|NCT04470427|39807485|FG000|Part B :Open-label|Other than specified|0|||
16360565|NCT04470427|39807486|FG001|Part B :Open-label|Other than specified|0|||
16360566|NCT04470427|39807487|FG002|Part B :Open-label|Other than specified|788|||
16360567|NCT04470427|39807488|FG003|Part B :Open-label|Other than specified|0|||
16249530|NCT01799590|39397840|FG000|Overall Study|Aggravation of complications|0|||
16249531|NCT01799590|39397841|FG001|Overall Study|Aggravation of complications|1|||
16249532|NCT01799590|39397842|FG002|Overall Study|Aggravation of complications|1|||
16249533|NCT01799590|39397840|FG000|Overall Study|Using drugs with restricted days of use|0|||
16249534|NCT01799590|39397841|FG001|Overall Study|Using drugs with restricted days of use|3|||
16249535|NCT01799590|39397842|FG002|Overall Study|Using drugs with restricted days of use|2|||
16249536|NCT01799590|39397840|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
16249537|NCT01799590|39397841|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
16249538|NCT01799590|39397842|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
16249539|NCT01799590|39397840|FG000|Overall Study|Other|3|||
16249540|NCT01799590|39397841|FG001|Overall Study|Other|0|||
16249541|NCT01799590|39397842|FG002|Overall Study|Other|1|||
16249542|NCT00601354|39397843|FG000|Overall Study|Lost to Follow-up|4|||
16249543|NCT00601354|39397844|FG001|Overall Study|Lost to Follow-up|5|||
16249544|NCT01847313|39397845|FG000|Overall Study|Death|0|||
16249545|NCT01847313|39397846|FG001|Overall Study|Death|1|||
16249546|NCT01847313|39397845|FG000|Overall Study|Withdrawal by Subject|0|||
16249547|NCT01847313|39397846|FG001|Overall Study|Withdrawal by Subject|1|||
16249548|NCT05073133|39397847|FG000|Overall Study|Death|2|||
16249549|NCT00192296|39397850|FG000|Overall Study|Withdrawal by Subject|0|||
16249550|NCT00192296|39397851|FG001|Overall Study|Withdrawal by Subject|1|||
16249551|NCT00192296|39397852|FG002|Overall Study|Withdrawal by Subject|0|||
16249552|NCT00192296|39397853|FG003|Overall Study|Withdrawal by Subject|0|||
16249553|NCT01162499|39397855|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
16249554|NCT01162499|39397856|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
16249555|NCT02354586|39397859|FG000|Overall Study|Death|230|||
16249556|NCT02354586|39397859|FG000|Overall Study|Withdrawal by Subject|59|||
16249557|NCT02354586|39397859|FG000|Overall Study|Lost to Follow-up|11|||
16249558|NCT02354586|39397859|FG000|Overall Study|Sponsor decision|51|||
16249559|NCT02354586|39397859|FG000|Overall Study|Site closure|2|||
16249560|NCT02354586|39397859|FG000|Overall Study|Intercurrent illness|1|||
16249561|NCT02354586|39397859|FG000|Overall Study|Protocol Violation|3|||
16249562|NCT02354586|39397859|FG000|Overall Study|Physician Decision|13|||
16249563|NCT02354586|39397859|FG000|Overall Study|Lack of Efficacy|86|||
16249564|NCT02354586|39397859|FG000|Overall Study|Adverse Event|7|||
16249565|NCT00886483|39397860|FG000|Overall Study|Lost to Follow-up|0|||
16249566|NCT00886483|39397861|FG001|Overall Study|Lost to Follow-up|1|||
16249567|NCT00886483|39397860|FG000|Overall Study|Pursue medications|1|||
16249568|NCT00886483|39397861|FG001|Overall Study|Pursue medications|2|||
16249569|NCT00886483|39397860|FG000|Overall Study|Distance to center, poor grades|1|||
16249570|NCT00886483|39397861|FG001|Overall Study|Distance to center, poor grades|0|||
16249571|NCT01339910|39397862|FG000|Overall Study|Withdrawal by Subject|1|||
16249572|NCT01339910|39397863|FG001|Overall Study|Withdrawal by Subject|0|||
16249573|NCT01339910|39397862|FG000|Overall Study|Physician Decision|1|||
16249574|NCT01339910|39397863|FG001|Overall Study|Physician Decision|0|||
16249575|NCT01339910|39397862|FG000|Overall Study|Disease relapse|1|||
16249576|NCT01339910|39397863|FG001|Overall Study|Disease relapse|4|||
16249577|NCT01400113|39397866|FG000|Overall Study|Withdrawal by Subject|1|||
16249578|NCT01400113|39397867|FG001|Overall Study|Withdrawal by Subject|1|||
16249579|NCT00661505|39397868|FG000|Overall Study|Adverse Event|3|||
16249580|NCT00661505|39397868|FG000|Overall Study|Protocol Violation|14|||
16249581|NCT00661505|39397868|FG000|Overall Study|Withdrawal by Subject|8|||
16249582|NCT00661505|39397868|FG000|Overall Study|Lost to Follow-up|3|||
16249583|NCT00661505|39397868|FG000|Overall Study|Other|2|||
16249584|NCT01047345|39397872|FG000|Base Study|Adverse Event|3|||
16249585|NCT01047345|39397873|FG001|Base Study|Adverse Event|0|||
16249586|NCT01047345|39397874|FG002|Base Study|Adverse Event|0|||
16249587|NCT01047345|39397872|FG000|Base Study|Lost to Follow-up|4|||
16249588|NCT01047345|39397873|FG001|Base Study|Lost to Follow-up|1|||
16249589|NCT01047345|39397874|FG002|Base Study|Lost to Follow-up|0|||
16249590|NCT01047345|39397872|FG000|Base Study|Protocol Violation|3|||
16249591|NCT01047345|39397873|FG001|Base Study|Protocol Violation|1|||
16249592|NCT01047345|39397874|FG002|Base Study|Protocol Violation|0|||
16360568|NCT04470427|39807489|FG004|Part B :Open-label|Other than specified|523|||
16249593|NCT01047345|39397872|FG000|Base Study|Withdrawal by Subject|12|||
16249594|NCT01047345|39397873|FG001|Base Study|Withdrawal by Subject|4|||
16249595|NCT01047345|39397874|FG002|Base Study|Withdrawal by Subject|0|||
16249596|NCT01047345|39397872|FG000|Extension|Withdrawal by Subject|0|||
16249597|NCT01047345|39397873|FG001|Extension|Withdrawal by Subject|0|||
16249598|NCT01047345|39397874|FG002|Extension|Withdrawal by Subject|1|||
16249599|NCT01047345|39397872|FG000|Extension|Lost to Follow-up|0|||
16249600|NCT01047345|39397873|FG001|Extension|Lost to Follow-up|0|||
16425050|NCT01769196|40035756|FG001|Overall Study|Death|26|||
16425051|NCT01769196|40035755|FG000|Overall Study|Investigator Discretion|7|||
16425052|NCT01769196|40035756|FG001|Overall Study|Investigator Discretion|3|||
16425053|NCT01769196|40035755|FG000|Overall Study|Lack of Efficacy|3|||
16425054|NCT01769196|40035756|FG001|Overall Study|Lack of Efficacy|2|||
16425055|NCT01769196|40035755|FG000|Overall Study|Progressive disease|11|||
16425056|NCT01769196|40035756|FG001|Overall Study|Progressive disease|6|||
16425057|NCT01769196|40035755|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
16425058|NCT01769196|40035756|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
16425059|NCT01769196|40035755|FG000|Overall Study|Protocol Violation|0|||
16425060|NCT01769196|40035756|FG001|Overall Study|Protocol Violation|3|||
16425061|NCT01769196|40035755|FG000|Overall Study|Study terminated by sponsor|160|||
16425062|NCT01769196|40035756|FG001|Overall Study|Study terminated by sponsor|161|||
16425063|NCT01769196|40035755|FG000|Overall Study|Participant never dosed with study drug|1|||
16425064|NCT01769196|40035756|FG001|Overall Study|Participant never dosed with study drug|0|||
16425065|NCT01769196|40035755|FG000|Overall Study|Withdrew consent|36|||
16425066|NCT01769196|40035756|FG001|Overall Study|Withdrew consent|40|||
16425067|NCT00003199|40035757|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
16425068|NCT00003199|40035757|FG000|Overall Study|Lack of insurance clearance|2|||
16425069|NCT00003199|40035757|FG000|Overall Study|Screen fail|15|||
16425070|NCT03302247|40035758|FG000|Overall Study|the study has closed prematurely|2|||
16425071|NCT03302247|40035758|FG000|Overall Study|Death|1|||
16425072|NCT00650845|40035765|FG000|Overall Study|Withdrawal by Subject|5|||
16425073|NCT00650845|40035766|FG001|Overall Study|Withdrawal by Subject|0|||
16425074|NCT00650845|40035765|FG000|Overall Study|Protocol Violation|0|||
16425075|NCT00650845|40035766|FG001|Overall Study|Protocol Violation|13|||
16425076|NCT03160898|40035769|FG000|Overall Study|Adverse Event|4|||
16425077|NCT03160898|40035770|FG001|Overall Study|Adverse Event|8|||
16425078|NCT03160898|40035771|FG002|Overall Study|Adverse Event|7|||
16425079|NCT03160898|40035772|FG003|Overall Study|Adverse Event|10|||
16425080|NCT03160898|40035769|FG000|Overall Study|Death|1|||
16425081|NCT03160898|40035770|FG001|Overall Study|Death|0|||
16425082|NCT03160898|40035771|FG002|Overall Study|Death|0|||
16425083|NCT03160898|40035772|FG003|Overall Study|Death|1|||
16425084|NCT03160898|40035769|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
16425085|NCT03160898|40035770|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
16425086|NCT03160898|40035771|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
16425087|NCT03160898|40035772|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
16425088|NCT03160898|40035769|FG000|Overall Study|Lost to Follow-up|1|||
16425089|NCT03160898|40035770|FG001|Overall Study|Lost to Follow-up|1|||
16425090|NCT03160898|40035771|FG002|Overall Study|Lost to Follow-up|1|||
16425091|NCT03160898|40035772|FG003|Overall Study|Lost to Follow-up|2|||
16425092|NCT03160898|40035769|FG000|Overall Study|Physician Decision|1|||
16425093|NCT03160898|40035770|FG001|Overall Study|Physician Decision|0|||
16425094|NCT03160898|40035771|FG002|Overall Study|Physician Decision|0|||
16425095|NCT03160898|40035772|FG003|Overall Study|Physician Decision|1|||
16425096|NCT03160898|40035769|FG000|Overall Study|Progressive Disease|4|||
16425097|NCT03160898|40035770|FG001|Overall Study|Progressive Disease|1|||
16425098|NCT03160898|40035771|FG002|Overall Study|Progressive Disease|2|||
16425099|NCT03160898|40035772|FG003|Overall Study|Progressive Disease|1|||
16425100|NCT03160898|40035769|FG000|Overall Study|Protocol Violation|1|||
16425101|NCT03160898|40035770|FG001|Overall Study|Protocol Violation|0|||
16425102|NCT03160898|40035771|FG002|Overall Study|Protocol Violation|2|||
16425103|NCT03160898|40035772|FG003|Overall Study|Protocol Violation|0|||
16425104|NCT03160898|40035769|FG000|Overall Study|Sponsor Discretion|2|||
16425105|NCT03160898|40035770|FG001|Overall Study|Sponsor Discretion|0|||
16425106|NCT03160898|40035771|FG002|Overall Study|Sponsor Discretion|0|||
16425107|NCT03160898|40035772|FG003|Overall Study|Sponsor Discretion|0|||
16425108|NCT03160898|40035769|FG000|Overall Study|Withdrawal by Subject|1|||
16425109|NCT03160898|40035770|FG001|Overall Study|Withdrawal by Subject|3|||
16425110|NCT03160898|40035771|FG002|Overall Study|Withdrawal by Subject|2|||
16425111|NCT03160898|40035772|FG003|Overall Study|Withdrawal by Subject|1|||
16425112|NCT03160898|40035769|FG000|Overall Study|Other|2|||
16425113|NCT03160898|40035770|FG001|Overall Study|Other|0|||
16562466|NCT01167023|40525414|FG000|Overall Study|Lost to Follow-up|0|||
16562467|NCT01167023|40525415|FG001|Overall Study|Lost to Follow-up|1|||
16562468|NCT01167023|40525416|FG002|Overall Study|Lost to Follow-up|1|||
16425114|NCT03160898|40035771|FG002|Overall Study|Other|2|||
16425115|NCT03160898|40035772|FG003|Overall Study|Other|2|||
16425116|NCT01098305|40035780|FG000|Overall Study|Lost to Follow-up|31|||
16425117|NCT01098305|40035781|FG001|Overall Study|Lost to Follow-up|33|||
16425118|NCT03517228|40035782|FG000|Overall Study|Withdrawal by Subject|2|||
16425119|NCT03517228|40035782|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
16425120|NCT03517228|40035782|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
16425121|NCT03517228|40035782|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
16425122|NCT03517228|40035782|FG000|Overall Study|Canceled due to device being updated|1|||
16425123|NCT03517228|40035782|FG000|Overall Study|No V Cares in stock|1|||
16562469|NCT01167023|40525414|FG000|Overall Study|Screen Failure|0|||
16425124|NCT03517228|40035782|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
16425125|NCT04522141|40035783|FG000|Overall Study|Withdrawal by Subject|1|||
16425126|NCT04522141|40035784|FG001|Overall Study|Withdrawal by Subject|0|||
16425127|NCT00799591|40035785|FG000|Overall Study|De-escalation of doses|20|||
16425128|NCT00799591|40035785|FG000|Overall Study|Death|14|||
16425129|NCT00799591|40035785|FG000|Overall Study|Technical failure|12|||
16425130|NCT00799591|40035785|FG000|Overall Study|Resistant germ|11|||
16425131|NCT00799591|40035785|FG000|Overall Study|New infection|4|||
16425132|NCT00799591|40035785|FG000|Overall Study|Resistance germ and technical failure|2|||
16425133|NCT00799591|40035785|FG000|Overall Study|Persistance of fever undetermined origin|1|||
16425134|NCT00799591|40035785|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
16425135|NCT00799591|40035785|FG000|Overall Study|Infectious origin not probable|1|||
16425136|NCT01748825|40035786|FG000|Dose Escalation|Refused further treatment|2|||
16425137|NCT01748825|40035787|FG001|Dose Escalation|Refused further treatment|2|||
16425138|NCT01748825|40035788|FG002|Dose Escalation|Refused further treatment|0|||
16425139|NCT01748825|40035789|FG003|Dose Escalation|Refused further treatment|0|||
16425140|NCT01748825|40035790|FG004|Dose Escalation|Refused further treatment|1|||
16425141|NCT01748825|40035791|FG005|Dose Escalation|Refused further treatment|2|||
16425142|NCT01748825|40035792|FG006|Dose Escalation|Refused further treatment|0|||
16425143|NCT01748825|40035793|FG007|Dose Escalation|Refused further treatment|0|||
16425144|NCT01748825|40035794|FG008|Dose Escalation|Refused further treatment|0|||
16425145|NCT01748825|40035795|FG009|Dose Escalation|Refused further treatment|0|||
16425146|NCT01748825|40035786|FG000|Dose Escalation|Switched to alternative treatment|0|||
16425147|NCT01748825|40035787|FG001|Dose Escalation|Switched to alternative treatment|0|||
16425148|NCT01748825|40035788|FG002|Dose Escalation|Switched to alternative treatment|0|||
16425149|NCT01748825|40035789|FG003|Dose Escalation|Switched to alternative treatment|1|||
16425150|NCT01748825|40035790|FG004|Dose Escalation|Switched to alternative treatment|0|||
16425151|NCT01748825|40035791|FG005|Dose Escalation|Switched to alternative treatment|0|||
16425152|NCT01748825|40035792|FG006|Dose Escalation|Switched to alternative treatment|0|||
16425153|NCT01748825|40035793|FG007|Dose Escalation|Switched to alternative treatment|0|||
16425154|NCT01748825|40035794|FG008|Dose Escalation|Switched to alternative treatment|0|||
16425155|NCT01748825|40035795|FG009|Dose Escalation|Switched to alternative treatment|0|||
16425156|NCT01748825|40035786|FG000|Dose Escalation|Adverse Event|0|||
16425157|NCT01748825|40035787|FG001|Dose Escalation|Adverse Event|0|||
16425158|NCT01748825|40035788|FG002|Dose Escalation|Adverse Event|0|||
16425159|NCT01748825|40035789|FG003|Dose Escalation|Adverse Event|0|||
16425160|NCT01748825|40035790|FG004|Dose Escalation|Adverse Event|0|||
16425161|NCT01748825|40035791|FG005|Dose Escalation|Adverse Event|0|||
16425162|NCT01748825|40035792|FG006|Dose Escalation|Adverse Event|1|||
16425163|NCT01748825|40035793|FG007|Dose Escalation|Adverse Event|0|||
16425164|NCT01748825|40035794|FG008|Dose Escalation|Adverse Event|0|||
16425165|NCT01748825|40035795|FG009|Dose Escalation|Adverse Event|0|||
16425166|NCT01748825|40035786|FG000|Dose Expansion|Refused further treatment|0|||
16425167|NCT01748825|40035787|FG001|Dose Expansion|Refused further treatment|0|||
16425168|NCT01748825|40035788|FG002|Dose Expansion|Refused further treatment|0|||
16425169|NCT01748825|40035789|FG003|Dose Expansion|Refused further treatment|0|||
16425170|NCT01748825|40035790|FG004|Dose Expansion|Refused further treatment|0|||
16425171|NCT01748825|40035791|FG005|Dose Expansion|Refused further treatment|0|||
16425172|NCT01748825|40035792|FG006|Dose Expansion|Refused further treatment|0|||
16425173|NCT01748825|40035793|FG007|Dose Expansion|Refused further treatment|0|||
16425174|NCT01748825|40035794|FG008|Dose Expansion|Refused further treatment|1|||
16425175|NCT01748825|40035795|FG009|Dose Expansion|Refused further treatment|1|||
16425176|NCT01748825|40035786|FG000|Dose Expansion|Switched to alternative treatment|0|||
16425177|NCT01748825|40035787|FG001|Dose Expansion|Switched to alternative treatment|0|||
16425178|NCT01748825|40035788|FG002|Dose Expansion|Switched to alternative treatment|0|||
16425179|NCT01748825|40035789|FG003|Dose Expansion|Switched to alternative treatment|0|||
16425180|NCT01748825|40035790|FG004|Dose Expansion|Switched to alternative treatment|0|||
16425181|NCT01748825|40035791|FG005|Dose Expansion|Switched to alternative treatment|0|||
16425182|NCT01748825|40035792|FG006|Dose Expansion|Switched to alternative treatment|0|||
16425183|NCT01748825|40035793|FG007|Dose Expansion|Switched to alternative treatment|0|||
16425184|NCT01748825|40035794|FG008|Dose Expansion|Switched to alternative treatment|0|||
16425185|NCT01748825|40035795|FG009|Dose Expansion|Switched to alternative treatment|1|||
16425186|NCT01748825|40035786|FG000|Dose Expansion|Adverse Event|0|||
16425187|NCT01748825|40035787|FG001|Dose Expansion|Adverse Event|0|||
16425188|NCT01748825|40035788|FG002|Dose Expansion|Adverse Event|0|||
16425189|NCT01748825|40035789|FG003|Dose Expansion|Adverse Event|0|||
16425190|NCT01748825|40035790|FG004|Dose Expansion|Adverse Event|0|||
16425191|NCT01748825|40035791|FG005|Dose Expansion|Adverse Event|0|||
16425192|NCT01748825|40035792|FG006|Dose Expansion|Adverse Event|0|||
16425193|NCT01748825|40035793|FG007|Dose Expansion|Adverse Event|0|||
16130922|NCT01323634|38967152|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
16425194|NCT01748825|40035794|FG008|Dose Expansion|Adverse Event|0|||
16425195|NCT01748825|40035795|FG009|Dose Expansion|Adverse Event|3|||
16425196|NCT01748825|40035786|FG000|Dose Expansion|Physician Decision|0|||
16425197|NCT01748825|40035787|FG001|Dose Expansion|Physician Decision|0|||
16425198|NCT01748825|40035788|FG002|Dose Expansion|Physician Decision|0|||
16425199|NCT01748825|40035789|FG003|Dose Expansion|Physician Decision|0|||
16425200|NCT01748825|40035790|FG004|Dose Expansion|Physician Decision|0|||
16425201|NCT01748825|40035791|FG005|Dose Expansion|Physician Decision|0|||
16425202|NCT01748825|40035792|FG006|Dose Expansion|Physician Decision|0|||
16425203|NCT01748825|40035793|FG007|Dose Expansion|Physician Decision|0|||
16425204|NCT01748825|40035794|FG008|Dose Expansion|Physician Decision|1|||
16425205|NCT01748825|40035795|FG009|Dose Expansion|Physician Decision|0|||
16425206|NCT01371552|40035797|FG000|Part 1, First 3 Days|Inconvenience|0|||
16425207|NCT01371552|40035798|FG001|Part 1, First 3 Days|Inconvenience|0|||
16425208|NCT01371552|40035799|FG002|Part 1, First 3 Days|Inconvenience|1|||
16425209|NCT01371552|40035800|FG003|Part 1, First 3 Days|Inconvenience|0|||
16425210|NCT01371552|40035801|FG004|Part 1, First 3 Days|Inconvenience|0|||
16425211|NCT01371552|40035802|FG005|Part 1, First 3 Days|Inconvenience|0|||
16425212|NCT00601900|40035805|FG000|Overall Study|Withdrawal by Subject|0|||
16425213|NCT00601900|40035806|FG001|Overall Study|Withdrawal by Subject|3|||
16425214|NCT01339897|40035809|FG000|Overall Study|Adverse Event|1|||
16425215|NCT01339897|40035810|FG001|Overall Study|Adverse Event|0|||
16425216|NCT01339897|40035811|FG002|Overall Study|Adverse Event|0|||
16425217|NCT01339897|40035812|FG003|Overall Study|Adverse Event|1|||
16425218|NCT00527904|40035813|FG000|Overall Study|Adverse Event|45|||
16425219|NCT00527904|40035813|FG000|Overall Study|Withdrawal by Subject|21|||
16425220|NCT00527904|40035813|FG000|Overall Study|Lost to Follow-up|8|||
16425221|NCT00527904|40035813|FG000|Overall Study|misc|22|||
16425222|NCT01063153|40035819|FG000|Overall Study|Found Ineligible During Screening|2|||
16425223|NCT01063153|40035820|FG001|Overall Study|Found Ineligible During Screening|0|||
16425224|NCT01063153|40035819|FG000|Overall Study|Lost to Follow-up|0|||
16425225|NCT01063153|40035820|FG001|Overall Study|Lost to Follow-up|7|||
16425226|NCT01063153|40035819|FG000|Overall Study|Withdrawal by Subject|0|||
16425227|NCT01063153|40035820|FG001|Overall Study|Withdrawal by Subject|1|||
16425228|NCT01063153|40035819|FG000|Overall Study|Physician Decision|0|||
16425229|NCT01063153|40035820|FG001|Overall Study|Physician Decision|4|||
16425230|NCT02081599|40035822|FG000|Period 1：Double-blind Period|Adverse Event|3|||
16425231|NCT02081599|40035823|FG001|Period 1：Double-blind Period|Adverse Event|0|||
16425232|NCT02081599|40035822|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
16425233|NCT02081599|40035823|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
16425234|NCT02081599|40035822|FG000|Period 1：Double-blind Period|Physician Decision|1|||
16425235|NCT02081599|40035823|FG001|Period 1：Double-blind Period|Physician Decision|0|||
16425236|NCT02081599|40035822|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
16425237|NCT02081599|40035823|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
16425238|NCT02081599|40035822|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
16425239|NCT02081599|40035823|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
16425240|NCT02081599|40035822|FG000|Period 1：Double-blind Period|stopping criteria|1|||
16425241|NCT02081599|40035823|FG001|Period 1：Double-blind Period|stopping criteria|0|||
16425242|NCT02081599|40035822|FG000|Period 2：Open-label Period|Adverse Event|1|||
16425243|NCT02081599|40035823|FG001|Period 2：Open-label Period|Adverse Event|0|||
16425244|NCT02081599|40035822|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
16425245|NCT02081599|40035823|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
16425246|NCT02081599|40035822|FG000|Period 2：Open-label Period|Physician Decision|1|||
16425247|NCT02081599|40035823|FG001|Period 2：Open-label Period|Physician Decision|0|||
16425248|NCT02081599|40035822|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
16425249|NCT02081599|40035823|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
16425250|NCT00983385|40035829|FG000|Observation Period|Not eligible to be dosed|20|||
16425251|NCT00983385|40035829|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
16425252|NCT02853435|40035830|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
16425253|NCT02853435|40035831|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
16425254|NCT02853435|40035832|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
16425255|NCT02853435|40035833|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
16425256|NCT02853435|40035834|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
16425257|NCT02853435|40035835|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
16425258|NCT01357551|40035836|FG000|Overall Study|Withdrawal by Subject|6|||
16425259|NCT01357551|40035837|FG001|Overall Study|Withdrawal by Subject|4|||
16425260|NCT01357551|40035836|FG000|Overall Study|Death|0|||
16425261|NCT01357551|40035837|FG001|Overall Study|Death|1|||
16425262|NCT01357551|40035836|FG000|Overall Study|Lost to Follow-up|16|||
16425263|NCT01357551|40035837|FG001|Overall Study|Lost to Follow-up|6|||
16425264|NCT00206440|40035845|FG000|Overall Study|Protocol Violation|1|||
16425265|NCT00206440|40035846|FG001|Overall Study|Protocol Violation|2|||
16425266|NCT00206440|40035845|FG000|Overall Study|Adverse Event|4|||
16425267|NCT00206440|40035846|FG001|Overall Study|Adverse Event|2|||
16425268|NCT01240200|40035847|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
16425269|NCT01240200|40035848|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
16562470|NCT01167023|40525415|FG001|Overall Study|Screen Failure|1|||
16425270|NCT02141360|40035851|FG000|Overall Study|Withdrawal by Subject|6|||
16425271|NCT02141360|40035852|FG001|Overall Study|Withdrawal by Subject|0|||
16425272|NCT02141360|40035853|FG002|Overall Study|Withdrawal by Subject|0|||
16425273|NCT02141360|40035851|FG000|Overall Study|Study Terminated before Visit|1|||
16425274|NCT02141360|40035852|FG001|Overall Study|Study Terminated before Visit|0|||
16425275|NCT02141360|40035853|FG002|Overall Study|Study Terminated before Visit|0|||
16425276|NCT00779025|40035854|FG000|Overall Study|Withdrawal by Subject|1|||
16425277|NCT03245398|40035855|FG000|Overall Study|Travelled to another island|1|||
16425278|NCT03245398|40035856|FG001|Overall Study|Travelled to another island|0|||
16425279|NCT04680975|40035857|FG000|Overall Study|Adverse Event|3|||
16425280|NCT04680975|40035857|FG000|Overall Study|Death|1|||
16425281|NCT04680975|40035857|FG000|Overall Study|Progressive Disease|1|||
16425282|NCT04680975|40035857|FG000|Overall Study|Withdrawal by Subject|1|||
16425283|NCT03781778|40035859|FG000|Overall Study|Withdrawal by Subject|2|||
16425284|NCT03781778|40035860|FG001|Overall Study|Withdrawal by Subject|2|||
16425285|NCT01949090|40035861|FG000|Overall Study|Serious Adverse Event|0|||
16425286|NCT01949090|40035862|FG001|Overall Study|Serious Adverse Event|1|||
16425287|NCT01949090|40035863|FG002|Overall Study|Serious Adverse Event|2|||
16425288|NCT01949090|40035864|FG003|Overall Study|Serious Adverse Event|0|||
16425289|NCT01949090|40035865|FG004|Overall Study|Serious Adverse Event|1|||
16425290|NCT01949090|40035861|FG000|Overall Study|Withdrawal by Subject|2|||
16425291|NCT01949090|40035862|FG001|Overall Study|Withdrawal by Subject|0|||
16425292|NCT01949090|40035863|FG002|Overall Study|Withdrawal by Subject|0|||
16425293|NCT01949090|40035864|FG003|Overall Study|Withdrawal by Subject|0|||
16425294|NCT01949090|40035865|FG004|Overall Study|Withdrawal by Subject|1|||
16425295|NCT01949090|40035861|FG000|Overall Study|Protocol non-compliance|0|||
16425296|NCT01949090|40035862|FG001|Overall Study|Protocol non-compliance|0|||
16425297|NCT01949090|40035863|FG002|Overall Study|Protocol non-compliance|0|||
16425298|NCT01949090|40035864|FG003|Overall Study|Protocol non-compliance|0|||
16425299|NCT01949090|40035865|FG004|Overall Study|Protocol non-compliance|1|||
16425300|NCT01949090|40035861|FG000|Overall Study|Lost to Follow-up|2|||
16425301|NCT01949090|40035862|FG001|Overall Study|Lost to Follow-up|1|||
16425302|NCT01949090|40035863|FG002|Overall Study|Lost to Follow-up|0|||
16425303|NCT01949090|40035864|FG003|Overall Study|Lost to Follow-up|1|||
16425304|NCT01949090|40035865|FG004|Overall Study|Lost to Follow-up|1|||
16425305|NCT02241343|40035866|FG000|Overall Study|Adverse Event|1|||
16425306|NCT01504841|40035867|FG000|Overall Study|Withdrawal by Subject|1|||
16425307|NCT01504841|40035868|FG001|Overall Study|Withdrawal by Subject|1|||
16425308|NCT01504841|40035869|FG002|Overall Study|Withdrawal by Subject|0|||
16425309|NCT02152761|40035870|FG000|Epoch: Treatment Epoch|Technical problems|0|||
16425310|NCT02152761|40035871|FG001|Epoch: Treatment Epoch|Technical problems|0|||
16425311|NCT02152761|40035872|FG002|Epoch: Treatment Epoch|Technical problems|0|||
16425312|NCT02152761|40035873|FG003|Epoch: Treatment Epoch|Technical problems|1|||
16425313|NCT02152761|40035870|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
16425314|NCT02152761|40035871|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
16425315|NCT02152761|40035872|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
16425316|NCT02152761|40035873|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
16425317|NCT02152761|40035870|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
16425318|NCT02152761|40035871|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
16425319|NCT02152761|40035872|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
16425320|NCT02152761|40035873|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
16425321|NCT02152761|40035870|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
16425322|NCT02152761|40035871|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
16425323|NCT02152761|40035872|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
16425324|NCT02152761|40035873|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
16425325|NCT02152761|40035870|FG000|Epoch: Treatment Epoch|Death|0|||
16425326|NCT02152761|40035871|FG001|Epoch: Treatment Epoch|Death|3|||
16425327|NCT02152761|40035872|FG002|Epoch: Treatment Epoch|Death|1|||
16425328|NCT02152761|40035873|FG003|Epoch: Treatment Epoch|Death|0|||
16425329|NCT02152761|40035870|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
16425330|NCT02152761|40035871|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
16425331|NCT02152761|40035872|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
16425332|NCT02152761|40035873|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
16425333|NCT02152761|40035870|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
16425334|NCT02152761|40035871|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
16425335|NCT02152761|40035872|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
16425336|NCT02152761|40035873|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
16425337|NCT02152761|40035870|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
16425338|NCT02152761|40035871|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
16425339|NCT02152761|40035872|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
16425340|NCT02152761|40035873|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
16425341|NCT02152761|40035870|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
16425342|NCT02152761|40035871|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
16425343|NCT02152761|40035872|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
16425344|NCT02152761|40035873|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
16425345|NCT02152761|40035870|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
16425346|NCT02152761|40035871|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
16425347|NCT02152761|40035872|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
16425348|NCT02152761|40035873|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
16425349|NCT01266590|40035874|FG000|Overall Study|Adverse Event|3|||
16425350|NCT01266590|40035874|FG000|Overall Study|Lost to Follow-up|1|||
16425351|NCT01266590|40035874|FG000|Overall Study|Withdrawal by Subject|1|||
16425352|NCT01266590|40035874|FG000|Overall Study|Physician Decision|1|||
16425353|NCT00348673|40035875|FG000|Stage 1|Randomized but not Treated|0|||
16425354|NCT00348673|40035876|FG001|Stage 1|Randomized but not Treated|0|||
16425355|NCT00348673|40035877|FG002|Stage 1|Randomized but not Treated|1|||
16425356|NCT00348673|40035878|FG003|Stage 1|Randomized but not Treated|0|||
16425357|NCT00348673|40035879|FG004|Stage 1|Randomized but not Treated|0|||
16425358|NCT00348673|40035880|FG005|Stage 1|Randomized but not Treated|0|||
16425359|NCT00348673|40035881|FG006|Stage 1|Randomized but not Treated|0|||
16425360|NCT00348673|40035882|FG007|Stage 1|Randomized but not Treated|0|||
16425361|NCT00348673|40035883|FG008|Stage 1|Randomized but not Treated|0|||
16425362|NCT01641601|40035884|FG000|Overall Study|Study discontinued.|3|||
16425363|NCT01641601|40035885|FG001|Overall Study|Study discontinued.|5|||
16425364|NCT00324805|40035886|FG000|Overall Study|Adverse Event|62|||
16425365|NCT00324805|40035887|FG001|Overall Study|Adverse Event|203|||
16425366|NCT00324805|40035886|FG000|Overall Study|Progression|7|||
16425367|NCT00324805|40035887|FG001|Overall Study|Progression|35|||
16425368|NCT00324805|40035886|FG000|Overall Study|Withdrawal by Subject|51|||
16425369|NCT00324805|40035887|FG001|Overall Study|Withdrawal by Subject|174|||
16425370|NCT00324805|40035886|FG000|Overall Study|Death|6|||
16425371|NCT00324805|40035887|FG001|Overall Study|Death|9|||
16425372|NCT00324805|40035886|FG000|Overall Study|Alternative therapy|4|||
16425373|NCT00324805|40035887|FG001|Overall Study|Alternative therapy|8|||
16425374|NCT00324805|40035886|FG000|Overall Study|Other complicating disease|1|||
16425375|NCT00324805|40035887|FG001|Overall Study|Other complicating disease|9|||
16425376|NCT00324805|40035886|FG000|Overall Study|Other reasons|7|||
16425377|NCT00324805|40035887|FG001|Overall Study|Other reasons|26|||
16425378|NCT00324805|40035886|FG000|Overall Study|Other|0|||
16425379|NCT00324805|40035887|FG001|Overall Study|Other|2|||
16425380|NCT00324805|40035886|FG000|Overall Study|Did not start therapy|12|||
16425381|NCT00324805|40035887|FG001|Overall Study|Did not start therapy|17|||
16425382|NCT00615030|40035888|FG000|Period I|Administrative problem|0|||
16425383|NCT00615030|40035889|FG001|Period I|Administrative problem|0|||
16425384|NCT00615030|40035890|FG002|Period I|Administrative problem|0|||
16425385|NCT00615030|40035891|FG003|Period I|Administrative problem|0|||
16425386|NCT00615030|40035892|FG004|Period I|Administrative problem|1|||
16425387|NCT00615030|40035893|FG005|Period I|Administrative problem|0|||
16425388|NCT00615030|40035894|FG006|Period I|Administrative problem|0|||
16425389|NCT00615030|40035895|FG007|Period I|Administrative problem|0|||
16425390|NCT00615030|40035896|FG008|Period I|Administrative problem|0|||
16425391|NCT00615030|40035897|FG009|Period I|Administrative problem|0|||
16425392|NCT00615030|40035898|FG010|Period I|Administrative problem|0|||
16425393|NCT00615030|40035899|FG011|Period I|Administrative problem|0|||
16425394|NCT00615030|40035888|FG000|Period I|Protocol deviation|1|||
16425395|NCT00615030|40035889|FG001|Period I|Protocol deviation|0|||
16425396|NCT00615030|40035890|FG002|Period I|Protocol deviation|0|||
16425397|NCT00615030|40035891|FG003|Period I|Protocol deviation|0|||
16425398|NCT00615030|40035892|FG004|Period I|Protocol deviation|0|||
16425399|NCT00615030|40035893|FG005|Period I|Protocol deviation|0|||
16425400|NCT00615030|40035894|FG006|Period I|Protocol deviation|0|||
16425401|NCT00615030|40035895|FG007|Period I|Protocol deviation|0|||
16425402|NCT00615030|40035896|FG008|Period I|Protocol deviation|0|||
16425403|NCT00615030|40035897|FG009|Period I|Protocol deviation|0|||
16425404|NCT00615030|40035898|FG010|Period I|Protocol deviation|0|||
16425405|NCT00615030|40035899|FG011|Period I|Protocol deviation|0|||
16425406|NCT00615030|40035888|FG000|Period I|Subject withdrew consent|0|||
16425407|NCT00615030|40035889|FG001|Period I|Subject withdrew consent|0|||
16425408|NCT00615030|40035890|FG002|Period I|Subject withdrew consent|0|||
16425409|NCT00615030|40035891|FG003|Period I|Subject withdrew consent|0|||
16425410|NCT00615030|40035892|FG004|Period I|Subject withdrew consent|0|||
16425411|NCT00615030|40035893|FG005|Period I|Subject withdrew consent|0|||
16425412|NCT00615030|40035894|FG006|Period I|Subject withdrew consent|0|||
16425413|NCT00615030|40035895|FG007|Period I|Subject withdrew consent|0|||
16425414|NCT00615030|40035896|FG008|Period I|Subject withdrew consent|1|||
16425415|NCT00615030|40035897|FG009|Period I|Subject withdrew consent|0|||
16425416|NCT00615030|40035898|FG010|Period I|Subject withdrew consent|1|||
16425417|NCT00615030|40035899|FG011|Period I|Subject withdrew consent|1|||
16425418|NCT00615030|40035888|FG000|Period I|Abnormal laboratory value(s)|0|||
16425419|NCT00615030|40035889|FG001|Period I|Abnormal laboratory value(s)|0|||
16425420|NCT00615030|40035890|FG002|Period I|Abnormal laboratory value(s)|0|||
16425421|NCT00615030|40035891|FG003|Period I|Abnormal laboratory value(s)|0|||
16425422|NCT00615030|40035892|FG004|Period I|Abnormal laboratory value(s)|0|||
16425423|NCT00615030|40035893|FG005|Period I|Abnormal laboratory value(s)|1|||
16425424|NCT00615030|40035894|FG006|Period I|Abnormal laboratory value(s)|0|||
16425425|NCT00615030|40035895|FG007|Period I|Abnormal laboratory value(s)|0|||
16425426|NCT00615030|40035896|FG008|Period I|Abnormal laboratory value(s)|0|||
16425427|NCT00615030|40035897|FG009|Period I|Abnormal laboratory value(s)|0|||
16425428|NCT00615030|40035898|FG010|Period I|Abnormal laboratory value(s)|0|||
16425429|NCT00615030|40035899|FG011|Period I|Abnormal laboratory value(s)|0|||
16425430|NCT00615030|40035888|FG000|Period II|Adverse Event|0|||
16425431|NCT00615030|40035889|FG001|Period II|Adverse Event|0|||
16425432|NCT00615030|40035890|FG002|Period II|Adverse Event|1|||
16425433|NCT00615030|40035891|FG003|Period II|Adverse Event|0|||
16425434|NCT00615030|40035892|FG004|Period II|Adverse Event|0|||
16425435|NCT00615030|40035893|FG005|Period II|Adverse Event|0|||
16425436|NCT00615030|40035894|FG006|Period II|Adverse Event|0|||
16425437|NCT00615030|40035895|FG007|Period II|Adverse Event|0|||
16425438|NCT00615030|40035896|FG008|Period II|Adverse Event|1|||
16425439|NCT00615030|40035897|FG009|Period II|Adverse Event|0|||
16425440|NCT00615030|40035898|FG010|Period II|Adverse Event|0|||
16425441|NCT00615030|40035899|FG011|Period II|Adverse Event|0|||
16425442|NCT00615030|40035888|FG000|Period II|Subject withdrew consent|0|||
16425443|NCT00615030|40035889|FG001|Period II|Subject withdrew consent|0|||
16425444|NCT00615030|40035890|FG002|Period II|Subject withdrew consent|0|||
16425445|NCT00615030|40035891|FG003|Period II|Subject withdrew consent|1|||
16425446|NCT00615030|40035892|FG004|Period II|Subject withdrew consent|0|||
16425447|NCT00615030|40035893|FG005|Period II|Subject withdrew consent|0|||
16425448|NCT00615030|40035894|FG006|Period II|Subject withdrew consent|1|||
16425449|NCT00615030|40035895|FG007|Period II|Subject withdrew consent|0|||
16425450|NCT00615030|40035896|FG008|Period II|Subject withdrew consent|0|||
16425451|NCT00615030|40035897|FG009|Period II|Subject withdrew consent|0|||
16425452|NCT00615030|40035898|FG010|Period II|Subject withdrew consent|0|||
16425453|NCT00615030|40035899|FG011|Period II|Subject withdrew consent|0|||
16425454|NCT00615030|40035888|FG000|Period III|Administrative problems|1|||
16425455|NCT00615030|40035889|FG001|Period III|Administrative problems|0|||
16425456|NCT00615030|40035890|FG002|Period III|Administrative problems|0|||
16425457|NCT00615030|40035891|FG003|Period III|Administrative problems|1|||
16425458|NCT00615030|40035892|FG004|Period III|Administrative problems|0|||
16425459|NCT00615030|40035893|FG005|Period III|Administrative problems|0|||
16425460|NCT00615030|40035894|FG006|Period III|Administrative problems|0|||
16425461|NCT00615030|40035895|FG007|Period III|Administrative problems|0|||
16425462|NCT00615030|40035896|FG008|Period III|Administrative problems|0|||
16425463|NCT00615030|40035897|FG009|Period III|Administrative problems|0|||
16425464|NCT00615030|40035898|FG010|Period III|Administrative problems|0|||
16425465|NCT00615030|40035899|FG011|Period III|Administrative problems|0|||
16425466|NCT00532298|40035900|FG000|Overall Study|Adverse Event|1|||
16425467|NCT00532298|40035901|FG001|Overall Study|Adverse Event|0|||
16425468|NCT00532298|40035902|FG002|Overall Study|Adverse Event|0|||
16425469|NCT00532298|40035903|FG003|Overall Study|Adverse Event|0|||
16425470|NCT00532298|40035904|FG004|Overall Study|Adverse Event|1|||
16425471|NCT00532298|40035905|FG005|Overall Study|Adverse Event|1|||
16425472|NCT00532298|40035900|FG000|Overall Study|Lost to Follow-up|1|||
16425473|NCT00532298|40035901|FG001|Overall Study|Lost to Follow-up|1|||
16425474|NCT00532298|40035902|FG002|Overall Study|Lost to Follow-up|1|||
16425475|NCT00532298|40035903|FG003|Overall Study|Lost to Follow-up|0|||
16425476|NCT00532298|40035904|FG004|Overall Study|Lost to Follow-up|0|||
16425477|NCT00532298|40035905|FG005|Overall Study|Lost to Follow-up|1|||
16425478|NCT00781859|40035906|FG000|Overall Study|Adverse Event|2|||
16425479|NCT00781859|40035907|FG001|Overall Study|Adverse Event|2|||
16425480|NCT00781859|40035906|FG000|Overall Study|Withdrawal by Subject|8|||
16425481|NCT00781859|40035907|FG001|Overall Study|Withdrawal by Subject|4|||
16425482|NCT00781859|40035906|FG000|Overall Study|Lost to Follow-up|6|||
16425483|NCT00781859|40035907|FG001|Overall Study|Lost to Follow-up|3|||
16425484|NCT00781859|40035906|FG000|Overall Study|Death|3|||
16425485|NCT00781859|40035907|FG001|Overall Study|Death|0|||
16425486|NCT00992459|40035908|FG000|Overall Study|Withdrawal by Subject|0|||
16425487|NCT00992459|40035909|FG001|Overall Study|Withdrawal by Subject|1|||
16425488|NCT00992459|40035908|FG000|Overall Study|Adverse Event|1|||
16562471|NCT01167023|40525416|FG002|Overall Study|Screen Failure|0|||
16425489|NCT00992459|40035909|FG001|Overall Study|Adverse Event|0|||
16425490|NCT04829916|40035910|FG000|Overall Study|Withdrawal by Subject|1|||
16425491|NCT04829916|40035911|FG001|Overall Study|Withdrawal by Subject|0|||
16425492|NCT00950248|40035913|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
16425493|NCT00950248|40035914|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
16425494|NCT00950248|40035915|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
16425495|NCT00950248|40035913|FG000|Year 1: Baseline|worsening of symptoms|2|||
16425496|NCT00950248|40035914|FG001|Year 1: Baseline|worsening of symptoms|0|||
16425497|NCT00950248|40035915|FG002|Year 1: Baseline|worsening of symptoms|0|||
16425498|NCT00950248|40035913|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
16425499|NCT00950248|40035914|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
16425500|NCT00950248|40035915|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
16425501|NCT00950248|40035913|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
16425502|NCT00950248|40035914|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
16425503|NCT00950248|40035915|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
16425504|NCT00950248|40035913|FG000|Year 2&3 Treatment Randomization|Death|0|||
16425505|NCT00950248|40035914|FG001|Year 2&3 Treatment Randomization|Death|0|||
16425506|NCT00950248|40035915|FG002|Year 2&3 Treatment Randomization|Death|1|||
16130923|NCT01323634|38967153|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
16130924|NCT01323634|38967154|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
16425507|NCT00950248|40035913|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
16425508|NCT00950248|40035914|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
16425509|NCT00950248|40035915|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
16425510|NCT03100058|40035923|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
16425511|NCT03100058|40035924|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
16425512|NCT03100058|40035925|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
16425513|NCT03100058|40035926|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
16425514|NCT03100058|40035927|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
16425515|NCT03100058|40035928|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
16425516|NCT03100058|40035929|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
16425517|NCT03100058|40035930|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
16425518|NCT03100058|40035931|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
16425519|NCT03100058|40035932|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
16425520|NCT03100058|40035933|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
16425521|NCT03100058|40035934|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
16425522|NCT03100058|40035935|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
16425523|NCT03100058|40035923|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
16425524|NCT03100058|40035924|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
16425525|NCT03100058|40035925|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
16425526|NCT03100058|40035926|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
16425527|NCT03100058|40035927|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
16425528|NCT03100058|40035928|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
16425529|NCT03100058|40035929|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
16425530|NCT03100058|40035930|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
16425531|NCT03100058|40035931|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
16425532|NCT03100058|40035932|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
16425533|NCT03100058|40035933|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
16425534|NCT03100058|40035934|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
16425535|NCT03100058|40035935|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
16425536|NCT03100058|40035923|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
16425537|NCT03100058|40035924|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
16425538|NCT03100058|40035925|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
16425539|NCT03100058|40035926|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
16425540|NCT03100058|40035927|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
16425541|NCT03100058|40035928|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
16425542|NCT03100058|40035929|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
16425543|NCT03100058|40035930|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
16425544|NCT03100058|40035931|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
16425545|NCT03100058|40035932|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
16425546|NCT03100058|40035933|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
16425547|NCT03100058|40035934|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
16360569|NCT04470427|39807490|FG005|Part B :Open-label|Other than specified|0|||
16360570|NCT04470427|39807485|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
16360571|NCT04470427|39807486|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
16360572|NCT04470427|39807487|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
16360573|NCT04470427|39807488|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
16360574|NCT04470427|39807489|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
16360575|NCT04470427|39807490|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
16360576|NCT04470427|39807485|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
16360577|NCT04470427|39807486|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
16360578|NCT04470427|39807487|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
16360579|NCT04470427|39807488|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
16360580|NCT04470427|39807489|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
16360581|NCT04470427|39807490|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
16360582|NCT02696798|39807491|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
16360583|NCT02696798|39807492|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
16360584|NCT02696798|39807493|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
16360585|NCT02696798|39807491|FG000|Blinded Treatment Dosing Period|Death|0|||
16360586|NCT02696798|39807492|FG001|Blinded Treatment Dosing Period|Death|0|||
16360587|NCT02696798|39807493|FG002|Blinded Treatment Dosing Period|Death|1|||
16360588|NCT02696798|39807491|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
16360589|NCT02696798|39807492|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
16360590|NCT02696798|39807493|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
16360591|NCT02696798|39807491|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
16360592|NCT02696798|39807492|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
16360593|NCT02696798|39807493|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
16360594|NCT02696798|39807491|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
16360595|NCT02696798|39807492|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
16360596|NCT02696798|39807493|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
16360597|NCT02696798|39807491|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
16360598|NCT02696798|39807492|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
16360599|NCT02696798|39807493|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
16360600|NCT02696798|39807491|FG000|Extended Treatment Period|Adverse Event|1|||
16360601|NCT02696798|39807492|FG001|Extended Treatment Period|Adverse Event|4|||
16360602|NCT02696798|39807493|FG002|Extended Treatment Period|Adverse Event|5|||
16360603|NCT02696798|39807491|FG000|Extended Treatment Period|Lack of Efficacy|7|||
16360604|NCT02696798|39807492|FG001|Extended Treatment Period|Lack of Efficacy|2|||
16360605|NCT02696798|39807493|FG002|Extended Treatment Period|Lack of Efficacy|2|||
16360606|NCT02696798|39807491|FG000|Extended Treatment Period|Lost to Follow-up|1|||
16360607|NCT02696798|39807492|FG001|Extended Treatment Period|Lost to Follow-up|0|||
16360608|NCT02696798|39807493|FG002|Extended Treatment Period|Lost to Follow-up|0|||
16360609|NCT02696798|39807491|FG000|Extended Treatment Period|Physician Decision|0|||
16360610|NCT02696798|39807492|FG001|Extended Treatment Period|Physician Decision|1|||
16360611|NCT02696798|39807493|FG002|Extended Treatment Period|Physician Decision|0|||
16360612|NCT02696798|39807491|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
16360613|NCT02696798|39807492|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
16360614|NCT02696798|39807493|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
16360615|NCT02696798|39807491|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
16360616|NCT02696798|39807492|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
16360617|NCT02696798|39807493|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
16360618|NCT02696798|39807491|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
16360619|NCT02696798|39807492|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
16360620|NCT02696798|39807493|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
16360621|NCT02696798|39807491|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
16360622|NCT02696798|39807492|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
16360623|NCT02696798|39807493|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
16360624|NCT02696798|39807491|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
16360625|NCT02696798|39807492|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
16360626|NCT02696798|39807493|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
16360627|NCT02696798|39807491|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
16360628|NCT02696798|39807492|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
16360629|NCT02696798|39807493|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
16360630|NCT02696798|39807491|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
16360631|NCT02696798|39807492|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
16360632|NCT02696798|39807493|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
16360633|NCT01218308|39807495|FG000|Overall Study|Adverse Event|1|||
16360634|NCT01218308|39807496|FG001|Overall Study|Adverse Event|2|||
16360635|NCT01218308|39807495|FG000|Overall Study|Protocol Violation|0|||
16360636|NCT01218308|39807496|FG001|Overall Study|Protocol Violation|2|||
16360637|NCT01218308|39807495|FG000|Overall Study|Withdrawal by Subject|61|||
16562472|NCT01167023|40525414|FG000|Overall Study|Sponsor Decision|0|||
16425548|NCT03100058|40035935|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
16425549|NCT03100058|40035923|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
16425550|NCT03100058|40035924|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
16425551|NCT03100058|40035925|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
16425552|NCT03100058|40035926|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
16425553|NCT03100058|40035927|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
16425554|NCT03100058|40035928|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
16425555|NCT03100058|40035929|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
16425556|NCT03100058|40035930|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
16425557|NCT03100058|40035931|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
16425558|NCT03100058|40035932|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
16425559|NCT03100058|40035933|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
16425560|NCT03100058|40035934|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
16425561|NCT03100058|40035935|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
16425562|NCT03100058|40035923|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425563|NCT03100058|40035924|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425564|NCT03100058|40035925|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425565|NCT03100058|40035926|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
16425566|NCT03100058|40035927|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425567|NCT03100058|40035928|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425568|NCT03100058|40035929|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425569|NCT03100058|40035930|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
16425570|NCT03100058|40035931|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425571|NCT03100058|40035932|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425572|NCT03100058|40035933|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425573|NCT03100058|40035934|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425574|NCT03100058|40035935|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
16425575|NCT03100058|40035923|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425576|NCT03100058|40035924|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425577|NCT03100058|40035925|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425578|NCT03100058|40035926|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
16425579|NCT03100058|40035927|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425580|NCT03100058|40035928|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425581|NCT03100058|40035929|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
16425582|NCT03100058|40035930|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425583|NCT03100058|40035931|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425584|NCT03100058|40035932|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425585|NCT03100058|40035933|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425586|NCT03100058|40035934|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425587|NCT03100058|40035935|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
16425588|NCT03100058|40035923|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425589|NCT03100058|40035924|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
16425590|NCT03100058|40035925|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425591|NCT03100058|40035926|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425592|NCT03100058|40035927|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425593|NCT03100058|40035928|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425594|NCT03100058|40035929|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425595|NCT03100058|40035930|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425596|NCT03100058|40035931|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425597|NCT03100058|40035932|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425598|NCT03100058|40035933|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425599|NCT03100058|40035934|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425600|NCT03100058|40035935|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
16425601|NCT03100058|40035923|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
16425602|NCT03100058|40035924|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425603|NCT03100058|40035925|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425604|NCT03100058|40035926|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425605|NCT03100058|40035927|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425606|NCT03100058|40035928|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425607|NCT03100058|40035929|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425608|NCT03100058|40035930|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425609|NCT03100058|40035931|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425610|NCT03100058|40035932|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425611|NCT03100058|40035933|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425612|NCT03100058|40035934|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425613|NCT03100058|40035935|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
16425614|NCT03100058|40035923|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425615|NCT03100058|40035924|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425616|NCT03100058|40035925|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425617|NCT03100058|40035926|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425618|NCT03100058|40035927|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425619|NCT03100058|40035928|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425620|NCT03100058|40035929|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
16425621|NCT03100058|40035930|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425622|NCT03100058|40035931|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425623|NCT03100058|40035932|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425624|NCT03100058|40035933|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425625|NCT03100058|40035934|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425626|NCT03100058|40035935|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
16425627|NCT03100058|40035923|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
16425628|NCT03100058|40035924|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
16425629|NCT03100058|40035925|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
16425630|NCT03100058|40035926|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
16425631|NCT03100058|40035927|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
16425632|NCT03100058|40035928|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
16425633|NCT03100058|40035929|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
16425634|NCT03100058|40035930|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
16425635|NCT03100058|40035931|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
16425636|NCT03100058|40035932|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
16425637|NCT03100058|40035933|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
16425638|NCT03100058|40035934|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
16425639|NCT03100058|40035935|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
16425640|NCT03100058|40035923|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425641|NCT03100058|40035924|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425642|NCT03100058|40035925|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425643|NCT03100058|40035926|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425644|NCT03100058|40035927|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425645|NCT03100058|40035928|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425646|NCT03100058|40035929|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425647|NCT03100058|40035930|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425648|NCT03100058|40035931|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425649|NCT03100058|40035932|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425650|NCT03100058|40035933|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
16425651|NCT03100058|40035934|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
16425652|NCT03100058|40035935|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
16425653|NCT03100058|40035923|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
16425654|NCT03100058|40035924|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
16425655|NCT03100058|40035925|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
16425656|NCT03100058|40035926|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
16425657|NCT03100058|40035927|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
16425658|NCT03100058|40035928|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
16425659|NCT03100058|40035929|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
16425660|NCT03100058|40035930|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
16425661|NCT03100058|40035931|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
16425662|NCT03100058|40035932|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
16425663|NCT03100058|40035933|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
16425664|NCT03100058|40035934|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
16425665|NCT03100058|40035935|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
16425666|NCT03100058|40035923|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425667|NCT03100058|40035924|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16130925|NCT01323634|38967152|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16130926|NCT01323634|38967153|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
16425668|NCT03100058|40035925|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425669|NCT03100058|40035926|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425670|NCT03100058|40035927|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425671|NCT03100058|40035928|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425672|NCT03100058|40035929|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425673|NCT03100058|40035930|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425674|NCT03100058|40035931|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425675|NCT03100058|40035932|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425676|NCT03100058|40035933|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
16425677|NCT03100058|40035934|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425678|NCT03100058|40035935|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
16425679|NCT03100058|40035923|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425680|NCT03100058|40035924|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425681|NCT03100058|40035925|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425682|NCT03100058|40035926|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425683|NCT03100058|40035927|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425684|NCT03100058|40035928|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425685|NCT03100058|40035929|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425686|NCT03100058|40035930|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425687|NCT03100058|40035931|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425688|NCT03100058|40035932|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425689|NCT03100058|40035933|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425690|NCT03100058|40035934|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
16425691|NCT03100058|40035935|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
16425692|NCT03100058|40035923|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425693|NCT03100058|40035924|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425694|NCT03100058|40035925|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425695|NCT03100058|40035926|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425696|NCT03100058|40035927|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425697|NCT03100058|40035928|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425698|NCT03100058|40035929|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425699|NCT03100058|40035930|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425700|NCT03100058|40035931|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425701|NCT03100058|40035932|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
16425702|NCT03100058|40035933|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425703|NCT03100058|40035934|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425704|NCT03100058|40035935|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
16425705|NCT01068769|40035936|FG000|Overall Study|Ineligible|1|||
16425706|NCT01971008|40035937|FG000|Overall Study|Protocol Violation|2|||
16562473|NCT01167023|40525415|FG001|Overall Study|Sponsor Decision|1|||
16562474|NCT01167023|40525416|FG002|Overall Study|Sponsor Decision|0|||
16562475|NCT01167023|40525414|FG000|Overall Study|Withdrawal by Subject|0|||
16562476|NCT01167023|40525415|FG001|Overall Study|Withdrawal by Subject|0|||
16562477|NCT01167023|40525416|FG002|Overall Study|Withdrawal by Subject|1|||
16562478|NCT00772928|40525418|FG000|Overall Study|Lost to Follow-up|9|||
16562479|NCT00772928|40525419|FG001|Overall Study|Lost to Follow-up|6|||
16562480|NCT00772928|40525418|FG000|Overall Study|Protocol Violation|10|||
16562481|NCT00772928|40525419|FG001|Overall Study|Protocol Violation|12|||
16562482|NCT00772928|40525418|FG000|Overall Study|Withdrawal by Subject|25|||
16562483|NCT00772928|40525419|FG001|Overall Study|Withdrawal by Subject|22|||
16562484|NCT00772928|40525418|FG000|Overall Study|Did not receive vaccine|0|||
16562485|NCT00772928|40525419|FG001|Overall Study|Did not receive vaccine|1|||
16562486|NCT02321540|40525422|FG000|Overall Study|Death|0|||
16562487|NCT02321540|40525423|FG001|Overall Study|Death|1|||
16562488|NCT02321540|40525422|FG000|Overall Study|Progression|3|||
16562489|NCT02321540|40525423|FG001|Overall Study|Progression|9|||
16562490|NCT00329303|40525424|FG000|Overall Study|Lack of Efficacy|1|||
16562491|NCT00329303|40525425|FG001|Overall Study|Lack of Efficacy|0|||
16562492|NCT00329303|40525424|FG000|Overall Study|Decision of the sponsor|0|||
16562493|NCT00329303|40525425|FG001|Overall Study|Decision of the sponsor|1|||
16562494|NCT00329303|40525424|FG000|Overall Study|Patient no longer available|1|||
16562495|NCT00329303|40525425|FG001|Overall Study|Patient no longer available|0|||
16562496|NCT00329303|40525424|FG000|Overall Study|Patient relocated|0|||
16562497|NCT00329303|40525425|FG001|Overall Study|Patient relocated|1|||
16562498|NCT04796935|40525426|FG000|Overall Study|Withdrawal by Subject|0|||
16562499|NCT04796935|40525427|FG001|Overall Study|Withdrawal by Subject|1|||
16562500|NCT04796935|40525426|FG000|Overall Study|Physician Decision|0|||
16562501|NCT04796935|40525427|FG001|Overall Study|Physician Decision|1|||
16562502|NCT04796935|40525426|FG000|Overall Study|Device not available|1|||
16562503|NCT04796935|40525427|FG001|Overall Study|Device not available|0|||
16562504|NCT04796935|40525426|FG000|Overall Study|Trained provider not available|1|||
16562505|NCT04796935|40525427|FG001|Overall Study|Trained provider not available|0|||
16425707|NCT01971008|40035938|FG001|Overall Study|Protocol Violation|1|||
16425708|NCT03887221|40035939|FG000|Overall Study|Protocol Violation|1|||
16425709|NCT03887221|40035940|FG001|Overall Study|Protocol Violation|0|||
16425710|NCT02942485|40035946|FG000|Overall Study|Lost to Follow-up|1|||
16425711|NCT02942485|40035947|FG001|Overall Study|Lost to Follow-up|0|||
16425712|NCT00303485|40035948|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
16425713|NCT00303485|40035949|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
16425714|NCT00303485|40035948|FG000|Overall Study|Failure to return|0|||
16425715|NCT00303485|40035949|FG001|Overall Study|Failure to return|1|||
16425716|NCT00303485|40035948|FG000|Overall Study|Withdrawal by Subject|1|||
16425717|NCT00303485|40035949|FG001|Overall Study|Withdrawal by Subject|0|||
16425718|NCT00381693|40035950|FG000|Overall Study|Death|1|||
16425719|NCT00381693|40035950|FG000|Overall Study|Adverse Event|4|||
16425720|NCT00381693|40035950|FG000|Overall Study|Patient Choice|1|||
16562506|NCT00124982|40525430|FG000|Short-term Period|Death|1|||
16425721|NCT00381693|40035950|FG000|Overall Study|Progression|2|||
16425722|NCT00851786|40035951|FG000|Overall Study|Withdrawal by Subject|0|||
16425723|NCT00851786|40035952|FG001|Overall Study|Withdrawal by Subject|1|||
16425724|NCT00851786|40035951|FG000|Overall Study|Protocol Violation|0|||
16425725|NCT00851786|40035952|FG001|Overall Study|Protocol Violation|1|||
16425726|NCT00851786|40035951|FG000|Overall Study|Lost to Follow-up|1|||
16425727|NCT00851786|40035952|FG001|Overall Study|Lost to Follow-up|0|||
16425728|NCT00851786|40035951|FG000|Overall Study|Incarceration|1|||
16425729|NCT00851786|40035952|FG001|Overall Study|Incarceration|0|||
16425730|NCT00851786|40035951|FG000|Overall Study|Site Closure|1|||
16425731|NCT00851786|40035952|FG001|Overall Study|Site Closure|0|||
16425732|NCT00851786|40035951|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
16425733|NCT00851786|40035952|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
16425734|NCT00543387|40035953|FG000|Panel 1 + Panel 2|Adverse Event|0|||
16425735|NCT00543387|40035954|FG001|Panel 1 + Panel 2|Adverse Event|1|||
16425736|NCT00543387|40035955|FG002|Panel 1 + Panel 2|Adverse Event|0|||
16425737|NCT00543387|40035956|FG003|Panel 1 + Panel 2|Adverse Event|0|||
16425738|NCT00543387|40035957|FG004|Panel 1 + Panel 2|Adverse Event|0|||
16425739|NCT00543387|40035958|FG005|Panel 1 + Panel 2|Adverse Event|0|||
16425740|NCT00543387|40035959|FG006|Panel 1 + Panel 2|Adverse Event|0|||
16425741|NCT00543387|40035960|FG007|Panel 1 + Panel 2|Adverse Event|1|||
16425742|NCT00543387|40035961|FG008|Panel 1 + Panel 2|Adverse Event|1|||
16425743|NCT00543387|40035962|FG009|Panel 1 + Panel 2|Adverse Event|0|||
16425744|NCT00543387|40035963|FG010|Panel 1 + Panel 2|Adverse Event|0|||
16425745|NCT00543387|40035953|FG000|Panel 1 + Panel 2|Physician Decision|0|||
16425746|NCT00543387|40035954|FG001|Panel 1 + Panel 2|Physician Decision|0|||
16425747|NCT00543387|40035955|FG002|Panel 1 + Panel 2|Physician Decision|1|||
16425748|NCT00543387|40035956|FG003|Panel 1 + Panel 2|Physician Decision|0|||
16425749|NCT00543387|40035957|FG004|Panel 1 + Panel 2|Physician Decision|0|||
16425750|NCT00543387|40035958|FG005|Panel 1 + Panel 2|Physician Decision|0|||
16425751|NCT00543387|40035959|FG006|Panel 1 + Panel 2|Physician Decision|0|||
16425752|NCT00543387|40035960|FG007|Panel 1 + Panel 2|Physician Decision|1|||
16425753|NCT00543387|40035961|FG008|Panel 1 + Panel 2|Physician Decision|0|||
16425754|NCT00543387|40035962|FG009|Panel 1 + Panel 2|Physician Decision|0|||
16425755|NCT00543387|40035963|FG010|Panel 1 + Panel 2|Physician Decision|0|||
16425756|NCT00543387|40035953|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
16425757|NCT00543387|40035954|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
16425758|NCT00543387|40035955|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
16425759|NCT00543387|40035956|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
16425760|NCT00543387|40035957|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
16425761|NCT00543387|40035958|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
16425762|NCT00543387|40035959|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
16425763|NCT00543387|40035960|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
16425764|NCT00543387|40035961|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
16425765|NCT00543387|40035962|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
16425766|NCT00543387|40035963|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
16425767|NCT00543387|40035953|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
16425768|NCT00543387|40035954|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
16425769|NCT00543387|40035955|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
16425770|NCT00543387|40035956|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
16425771|NCT00543387|40035957|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
16425772|NCT00543387|40035958|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
16425773|NCT00543387|40035959|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
16425774|NCT00543387|40035960|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
16425775|NCT00543387|40035961|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
16425776|NCT00543387|40035962|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
16425777|NCT00543387|40035963|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
16425778|NCT00543387|40035953|FG000|Crossover Participants|Progressive Disease|0|||
16425779|NCT00543387|40035954|FG001|Crossover Participants|Progressive Disease|0|||
16425780|NCT00543387|40035955|FG002|Crossover Participants|Progressive Disease|0|||
16425781|NCT00543387|40035956|FG003|Crossover Participants|Progressive Disease|0|||
16425782|NCT00543387|40035957|FG004|Crossover Participants|Progressive Disease|0|||
16425783|NCT00543387|40035958|FG005|Crossover Participants|Progressive Disease|0|||
16425784|NCT00543387|40035959|FG006|Crossover Participants|Progressive Disease|0|||
16562507|NCT00124982|40525431|FG001|Short-term Period|Death|1|||
16562508|NCT00124982|40525432|FG002|Short-term Period|Death|0|||
16562509|NCT00124982|40525430|FG000|Short-term Period|Adverse Event|17|||
16562510|NCT00124982|40525431|FG001|Short-term Period|Adverse Event|22|||
16562511|NCT00124982|40525432|FG002|Short-term Period|Adverse Event|0|||
16562512|NCT00124982|40525430|FG000|Short-term Period|Lack of Efficacy|32|||
16425785|NCT00543387|40035960|FG007|Crossover Participants|Progressive Disease|0|||
16425786|NCT00543387|40035961|FG008|Crossover Participants|Progressive Disease|0|||
16425787|NCT00543387|40035962|FG009|Crossover Participants|Progressive Disease|1|||
16425788|NCT00543387|40035963|FG010|Crossover Participants|Progressive Disease|2|||
16425789|NCT00543387|40035953|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
16425790|NCT00543387|40035954|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
16425791|NCT00543387|40035955|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
16425792|NCT00543387|40035956|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
16425793|NCT00543387|40035957|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
16425794|NCT00543387|40035958|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
16249601|NCT01047345|39397874|FG002|Extension|Lost to Follow-up|5|||
16249602|NCT01772368|39397875|FG000|Overall Study|Adverse Event|1|||
16249603|NCT01772368|39397875|FG000|Overall Study|Withdrawal by Subject|3|||
16249604|NCT01772368|39397875|FG000|Overall Study|Protocol Violation|2|||
16249605|NCT01772368|39397875|FG000|Overall Study|Other|1|||
16249606|NCT04467697|39397876|FG000|Overall Study|Adverse Event|2|||
16249607|NCT04467697|39397876|FG000|Overall Study|Lost to Follow-up|6|||
16249608|NCT04467697|39397876|FG000|Overall Study|Withdrawal by Subject|9|||
16249609|NCT04467697|39397876|FG000|Overall Study|Protocol Violation|3|||
16249610|NCT01996033|39397878|FG000|Overall Study|Death|1|||
16249611|NCT01996033|39397878|FG000|Overall Study|Physician Decision|1|||
16249612|NCT01996033|39397878|FG000|Overall Study|Withdrawal by Subject|4|||
16249613|NCT01996033|39397878|FG000|Overall Study|Lost to Follow-up|3|||
16249614|NCT04471935|39397879|FG000|Overall Study|Withdrawal by Subject|1|||
16249615|NCT04471935|39397879|FG000|Overall Study|Deemed ineligible to participate|1|||
16249616|NCT00947856|39397880|FG000|Treatment Period|Progressive Disease|33|||
16249617|NCT00947856|39397881|FG001|Treatment Period|Progressive Disease|12|||
16249618|NCT00947856|39397880|FG000|Treatment Period|Adverse Event|15|||
16249619|NCT00947856|39397881|FG001|Treatment Period|Adverse Event|9|||
16249620|NCT00947856|39397880|FG000|Treatment Period|Physician Decision|14|||
16249621|NCT00947856|39397881|FG001|Treatment Period|Physician Decision|6|||
16249622|NCT00947856|39397880|FG000|Treatment Period|Study Stopped by Sponsor|4|||
16249623|NCT00947856|39397881|FG001|Treatment Period|Study Stopped by Sponsor|4|||
16249624|NCT00947856|39397880|FG000|Treatment Period|Withdrawal by Subject|12|||
16249625|NCT00947856|39397881|FG001|Treatment Period|Withdrawal by Subject|1|||
16249626|NCT00947856|39397880|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
16249627|NCT00947856|39397881|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
16249628|NCT00947856|39397880|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
16249629|NCT00947856|39397881|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
16249630|NCT00947856|39397880|FG000|Follow-up Period|Lost to Follow-up|7|||
16249631|NCT00947856|39397881|FG001|Follow-up Period|Lost to Follow-up|0|||
16249632|NCT00947856|39397880|FG000|Follow-up Period|Patient unavailable for site visits|1|||
16249633|NCT00947856|39397881|FG001|Follow-up Period|Patient unavailable for site visits|0|||
16249634|NCT00947856|39397880|FG000|Follow-up Period|Withdrawal by Subject|1|||
16249635|NCT00947856|39397881|FG001|Follow-up Period|Withdrawal by Subject|0|||
16249636|NCT03828461|39397884|FG000|Overall Study|Lost to Follow-up|1|||
16249637|NCT03828461|39397884|FG000|Overall Study|Withdrawal by Subject|3|||
16249638|NCT01058421|39397885|FG000|1 Month Outcomes|Death|10|||
16249639|NCT01058421|39397886|FG001|1 Month Outcomes|Death|6|||
16249640|NCT01058421|39397885|FG000|1 Month Outcomes|Lost to Follow-up|8|||
16249641|NCT01058421|39397886|FG001|1 Month Outcomes|Lost to Follow-up|7|||
16249642|NCT01058421|39397885|FG000|1 Month Outcomes|Remained in Hospital|5|||
16249643|NCT01058421|39397886|FG001|1 Month Outcomes|Remained in Hospital|12|||
16249644|NCT01058421|39397885|FG000|1 Month Outcomes|Remained in Other Facility|16|||
16249645|NCT01058421|39397886|FG001|1 Month Outcomes|Remained in Other Facility|17|||
16249646|NCT01058421|39397885|FG000|3 Month Outcomes|Death|3|||
16249647|NCT01058421|39397886|FG001|3 Month Outcomes|Death|5|||
16249648|NCT01058421|39397885|FG000|3 Month Outcomes|Lost to Follow-up|12|||
16249649|NCT01058421|39397886|FG001|3 Month Outcomes|Lost to Follow-up|11|||
16249650|NCT01058421|39397885|FG000|3 Month Outcomes|Remained in Hospital|0|||
16249651|NCT01058421|39397886|FG001|3 Month Outcomes|Remained in Hospital|2|||
16249652|NCT01058421|39397885|FG000|3 Month Outcomes|Remained in Other Facility|5|||
16249653|NCT01058421|39397886|FG001|3 Month Outcomes|Remained in Other Facility|8|||
16249654|NCT01058421|39397885|FG000|6 Month Outcomes|Death|2|||
16360638|NCT01218308|39807496|FG001|Overall Study|Withdrawal by Subject|64|||
16360639|NCT01218308|39807495|FG000|Overall Study|Lost to Follow-up|27|||
16360640|NCT01218308|39807496|FG001|Overall Study|Lost to Follow-up|31|||
16360641|NCT01218308|39807495|FG000|Overall Study|Other|14|||
16360642|NCT01218308|39807496|FG001|Overall Study|Other|21|||
16360643|NCT03370302|39807499|FG000|Dose Escalation Phase|Other|0|||
16360644|NCT03370302|39807500|FG001|Dose Escalation Phase|Other|1|||
16360645|NCT03370302|39807501|FG002|Dose Escalation Phase|Other|1|||
16249655|NCT01058421|39397886|FG001|6 Month Outcomes|Death|2|||
16249656|NCT01058421|39397885|FG000|6 Month Outcomes|Lost to Follow-up|16|||
16249657|NCT01058421|39397886|FG001|6 Month Outcomes|Lost to Follow-up|21|||
16249658|NCT01058421|39397885|FG000|6 Month Outcomes|Remained in Other Facility|1|||
16249659|NCT01058421|39397886|FG001|6 Month Outcomes|Remained in Other Facility|3|||
16249660|NCT00506753|39397893|FG000|Overall Study|Lost to Follow-up|21|||
16249661|NCT00506753|39397894|FG001|Overall Study|Lost to Follow-up|15|||
16249662|NCT01628120|39397895|FG000|Overall Study|Withdrawal by Subject|7|||
16360646|NCT03370302|39807502|FG003|Dose Escalation Phase|Other|0|||
16425795|NCT00543387|40035959|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
16425796|NCT00543387|40035960|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
16425797|NCT00543387|40035961|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
16425798|NCT00543387|40035962|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
16425799|NCT00543387|40035963|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
16425800|NCT00761527|40035964|FG000|Overall Study|Adverse Event|3|||
16425801|NCT00761527|40035964|FG000|Overall Study|Poor Compliance|8|||
16425802|NCT00761527|40035964|FG000|Overall Study|Lost to Follow-up|9|||
16425803|NCT00761527|40035964|FG000|Overall Study|Unknown reason|2|||
16425804|NCT00245037|40035965|FG000|Overall Study|Death|17|||
16425805|NCT03654885|40035975|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
16425806|NCT03654885|40035976|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
16425807|NCT03654885|40035975|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
16425808|NCT03654885|40035976|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
16425809|NCT03654885|40035975|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
16425810|NCT03654885|40035976|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
16425811|NCT03654885|40035975|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
16425812|NCT03654885|40035976|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
16425813|NCT03654885|40035975|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
16425814|NCT03654885|40035976|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
16425815|NCT03654885|40035975|FG000|Overall Study|Adverse Event in Study Eye|3|||
16425816|NCT03654885|40035976|FG001|Overall Study|Adverse Event in Study Eye|0|||
16425817|NCT03654885|40035975|FG000|Overall Study|Consent Withdrawn|1|||
16425818|NCT03654885|40035976|FG001|Overall Study|Consent Withdrawn|0|||
16425819|NCT03654885|40035975|FG000|Overall Study|Death|3|||
16425820|NCT03654885|40035976|FG001|Overall Study|Death|1|||
16425821|NCT03654885|40035975|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
16425822|NCT03654885|40035976|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
16425823|NCT03654885|40035975|FG000|Overall Study|Lost to Follow-up|3|||
16425824|NCT03654885|40035976|FG001|Overall Study|Lost to Follow-up|3|||
16425825|NCT01610336|40035977|FG000|Overall Study|Progressive Disease|4|||
16425826|NCT01610336|40035978|FG001|Overall Study|Progressive Disease|6|||
16425827|NCT01610336|40035979|FG002|Overall Study|Progressive Disease|6|||
16425828|NCT01610336|40035980|FG003|Overall Study|Progressive Disease|5|||
16425829|NCT01610336|40035981|FG004|Overall Study|Progressive Disease|3|||
16425830|NCT01610336|40035982|FG005|Overall Study|Progressive Disease|10|||
16425831|NCT01610336|40035983|FG006|Overall Study|Progressive Disease|1|||
16425832|NCT01610336|40035984|FG007|Overall Study|Progressive Disease|6|||
16425833|NCT01610336|40035985|FG008|Overall Study|Progressive Disease|6|||
16425834|NCT01610336|40035986|FG009|Overall Study|Progressive Disease|40|||
16425835|NCT01610336|40035987|FG010|Overall Study|Progressive Disease|36|||
16425836|NCT01610336|40035977|FG000|Overall Study|Adverse Event|0|||
16425837|NCT01610336|40035978|FG001|Overall Study|Adverse Event|0|||
16425838|NCT01610336|40035979|FG002|Overall Study|Adverse Event|0|||
16425839|NCT01610336|40035980|FG003|Overall Study|Adverse Event|1|||
16425840|NCT01610336|40035981|FG004|Overall Study|Adverse Event|1|||
16425841|NCT01610336|40035982|FG005|Overall Study|Adverse Event|1|||
16425842|NCT01610336|40035983|FG006|Overall Study|Adverse Event|0|||
16425843|NCT01610336|40035984|FG007|Overall Study|Adverse Event|0|||
16425844|NCT01610336|40035985|FG008|Overall Study|Adverse Event|2|||
16425845|NCT01610336|40035986|FG009|Overall Study|Adverse Event|8|||
16425846|NCT01610336|40035987|FG010|Overall Study|Adverse Event|6|||
16425847|NCT01610336|40035977|FG000|Overall Study|Subject/Guardian decision|1|||
16425848|NCT01610336|40035978|FG001|Overall Study|Subject/Guardian decision|1|||
16425849|NCT01610336|40035979|FG002|Overall Study|Subject/Guardian decision|0|||
16425850|NCT01610336|40035980|FG003|Overall Study|Subject/Guardian decision|1|||
16425851|NCT01610336|40035981|FG004|Overall Study|Subject/Guardian decision|0|||
16425852|NCT01610336|40035982|FG005|Overall Study|Subject/Guardian decision|0|||
16425853|NCT01610336|40035983|FG006|Overall Study|Subject/Guardian decision|0|||
16425854|NCT01610336|40035984|FG007|Overall Study|Subject/Guardian decision|1|||
16425855|NCT01610336|40035985|FG008|Overall Study|Subject/Guardian decision|0|||
16425856|NCT01610336|40035986|FG009|Overall Study|Subject/Guardian decision|2|||
16425857|NCT01610336|40035987|FG010|Overall Study|Subject/Guardian decision|2|||
16425858|NCT01610336|40035977|FG000|Overall Study|Death|0|||
16425859|NCT01610336|40035978|FG001|Overall Study|Death|0|||
16425860|NCT01610336|40035979|FG002|Overall Study|Death|0|||
16425861|NCT01610336|40035980|FG003|Overall Study|Death|0|||
16425862|NCT01610336|40035981|FG004|Overall Study|Death|0|||
16425863|NCT01610336|40035982|FG005|Overall Study|Death|1|||
16425864|NCT01610336|40035983|FG006|Overall Study|Death|3|||
16425865|NCT01610336|40035984|FG007|Overall Study|Death|0|||
16425866|NCT01610336|40035985|FG008|Overall Study|Death|0|||
16425867|NCT01610336|40035986|FG009|Overall Study|Death|1|||
16425868|NCT01610336|40035987|FG010|Overall Study|Death|2|||
16425869|NCT01610336|40035977|FG000|Overall Study|Non-Compliance with study treatment|0|||
16425870|NCT01610336|40035978|FG001|Overall Study|Non-Compliance with study treatment|0|||
16425871|NCT01610336|40035979|FG002|Overall Study|Non-Compliance with study treatment|0|||
16425872|NCT01610336|40035980|FG003|Overall Study|Non-Compliance with study treatment|0|||
16425873|NCT01610336|40035981|FG004|Overall Study|Non-Compliance with study treatment|0|||
16425874|NCT01610336|40035982|FG005|Overall Study|Non-Compliance with study treatment|0|||
16425875|NCT01610336|40035983|FG006|Overall Study|Non-Compliance with study treatment|0|||
16425876|NCT01610336|40035984|FG007|Overall Study|Non-Compliance with study treatment|0|||
16425877|NCT01610336|40035985|FG008|Overall Study|Non-Compliance with study treatment|0|||
16425878|NCT01610336|40035986|FG009|Overall Study|Non-Compliance with study treatment|1|||
16425879|NCT01610336|40035987|FG010|Overall Study|Non-Compliance with study treatment|0|||
16425880|NCT01610336|40035977|FG000|Overall Study|Physician Decision|0|||
16425881|NCT01610336|40035978|FG001|Overall Study|Physician Decision|0|||
16425882|NCT01610336|40035979|FG002|Overall Study|Physician Decision|0|||
16425883|NCT01610336|40035980|FG003|Overall Study|Physician Decision|0|||
16425884|NCT01610336|40035981|FG004|Overall Study|Physician Decision|0|||
16425885|NCT01610336|40035982|FG005|Overall Study|Physician Decision|0|||
16425886|NCT01610336|40035983|FG006|Overall Study|Physician Decision|1|||
16425887|NCT01610336|40035984|FG007|Overall Study|Physician Decision|0|||
16425888|NCT01610336|40035985|FG008|Overall Study|Physician Decision|0|||
16425889|NCT01610336|40035986|FG009|Overall Study|Physician Decision|0|||
16425890|NCT01610336|40035987|FG010|Overall Study|Physician Decision|0|||
16425891|NCT01610336|40035977|FG000|Overall Study|Protocol Deviation|0|||
16425892|NCT01610336|40035978|FG001|Overall Study|Protocol Deviation|0|||
16425893|NCT01610336|40035979|FG002|Overall Study|Protocol Deviation|0|||
16425894|NCT01610336|40035980|FG003|Overall Study|Protocol Deviation|0|||
16425895|NCT01610336|40035981|FG004|Overall Study|Protocol Deviation|0|||
16425896|NCT01610336|40035982|FG005|Overall Study|Protocol Deviation|0|||
16425897|NCT01610336|40035983|FG006|Overall Study|Protocol Deviation|0|||
16425898|NCT01610336|40035984|FG007|Overall Study|Protocol Deviation|0|||
16425899|NCT01610336|40035985|FG008|Overall Study|Protocol Deviation|0|||
16425900|NCT01610336|40035986|FG009|Overall Study|Protocol Deviation|1|||
16425901|NCT01610336|40035987|FG010|Overall Study|Protocol Deviation|0|||
16425902|NCT01610336|40035977|FG000|Overall Study|Transfer to another trial|0|||
16425903|NCT01610336|40035978|FG001|Overall Study|Transfer to another trial|0|||
16425904|NCT01610336|40035979|FG002|Overall Study|Transfer to another trial|0|||
16425905|NCT01610336|40035980|FG003|Overall Study|Transfer to another trial|0|||
16425906|NCT01610336|40035981|FG004|Overall Study|Transfer to another trial|0|||
16425907|NCT01610336|40035982|FG005|Overall Study|Transfer to another trial|0|||
16425908|NCT01610336|40035983|FG006|Overall Study|Transfer to another trial|0|||
16425909|NCT01610336|40035984|FG007|Overall Study|Transfer to another trial|0|||
16425910|NCT01610336|40035985|FG008|Overall Study|Transfer to another trial|0|||
16425911|NCT01610336|40035986|FG009|Overall Study|Transfer to another trial|0|||
16425912|NCT01610336|40035987|FG010|Overall Study|Transfer to another trial|1|||
16425913|NCT01286077|40035988|FG000|Overall Study|Adverse Event|2|||
16425914|NCT01286077|40035989|FG001|Overall Study|Adverse Event|0|||
16425915|NCT01286077|40035988|FG000|Overall Study|Death|1|||
16425916|NCT01286077|40035989|FG001|Overall Study|Death|0|||
16425917|NCT01286077|40035988|FG000|Overall Study|Protocol Violation|1|||
16425918|NCT01286077|40035989|FG001|Overall Study|Protocol Violation|1|||
16425919|NCT01286077|40035988|FG000|Overall Study|Withdrawal by Subject|0|||
16425920|NCT01286077|40035989|FG001|Overall Study|Withdrawal by Subject|2|||
16425921|NCT01286077|40035988|FG000|Overall Study|Intercurrent illness|1|||
16425922|NCT01286077|40035989|FG001|Overall Study|Intercurrent illness|0|||
16425923|NCT01286077|40035988|FG000|Overall Study|Non-compliance|1|||
16425924|NCT01286077|40035989|FG001|Overall Study|Non-compliance|0|||
16425925|NCT01286077|40035988|FG000|Overall Study|The subject starts with alternative MMY|0|||
16425926|NCT01286077|40035989|FG001|Overall Study|The subject starts with alternative MMY|3|||
16425927|NCT01286077|40035988|FG000|Overall Study|Patient's decision to stop treatment|3|||
16425928|NCT01286077|40035989|FG001|Overall Study|Patient's decision to stop treatment|0|||
16425929|NCT01286077|40035988|FG000|Overall Study|Progression of disease|0|||
16425930|NCT01286077|40035989|FG001|Overall Study|Progression of disease|1|||
16425931|NCT01286077|40035988|FG000|Overall Study|refill medication not received in time|1|||
16425932|NCT01286077|40035989|FG001|Overall Study|refill medication not received in time|0|||
16425933|NCT00714415|40039262|FG000|Overall Study|Lack of Efficacy|1|||
16425934|NCT00714415|40039263|FG001|Overall Study|Lack of Efficacy|0|||
16425935|NCT00714415|40039262|FG000|Overall Study|Death|1|||
16425936|NCT00714415|40039263|FG001|Overall Study|Death|0|||
16425937|NCT02315560|40039264|FG000|Overall Study|noncompliance by subjects|3|||
16425938|NCT02255461|40039265|FG000|Overall Study|Adverse Event|0|||
16425939|NCT02255461|40039266|FG001|Overall Study|Adverse Event|1|||
16425940|NCT02255461|40039267|FG002|Overall Study|Adverse Event|0|||
16425941|NCT02255461|40039268|FG003|Overall Study|Adverse Event|0|||
16425942|NCT02255461|40039269|FG004|Overall Study|Adverse Event|1|||
16425943|NCT02255461|40039265|FG000|Overall Study|Withdrawal by Subject|0|||
16425944|NCT02255461|40039266|FG001|Overall Study|Withdrawal by Subject|0|||
16425945|NCT02255461|40039267|FG002|Overall Study|Withdrawal by Subject|1|||
16425946|NCT02255461|40039268|FG003|Overall Study|Withdrawal by Subject|0|||
16425947|NCT02255461|40039269|FG004|Overall Study|Withdrawal by Subject|1|||
16425948|NCT02255461|40039265|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
16425949|NCT02255461|40039266|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
16425950|NCT02255461|40039267|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
16425951|NCT02255461|40039268|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
16425952|NCT02255461|40039269|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
16425953|NCT01161537|40039270|FG000|Part B|Withdrawal by Subject|2|||
16425954|NCT02069392|40039273|FG000|Overall Study|Withdrawal by Subject|4|||
16425955|NCT02069392|40039274|FG001|Overall Study|Withdrawal by Subject|2|||
16425956|NCT00709618|40039275|FG000|Overall Study|Withdrawal by Subject|4|||
16425957|NCT00709618|40039275|FG000|Overall Study|Lost to Follow-up|1|||
16425958|NCT00709618|40039275|FG000|Overall Study|Study Closed/Terminated|25|||
16425959|NCT03647267|40039279|FG000|Overall Study|Lost to Follow-up|1|||
16425960|NCT03647267|40039280|FG001|Overall Study|Lost to Follow-up|0|||
16425961|NCT02147288|40039286|FG000|Overall Study|post-operative hematoma|1|||
16425962|NCT02147288|40039287|FG001|Overall Study|post-operative hematoma|1|||
16425963|NCT02147288|40039288|FG002|Overall Study|post-operative hematoma|0|||
16425964|NCT02147288|40039289|FG003|Overall Study|post-operative hematoma|0|||
16425965|NCT02147288|40039290|FG004|Overall Study|post-operative hematoma|0|||
16425966|NCT02147288|40039291|FG005|Overall Study|post-operative hematoma|0|||
16425967|NCT02147288|40039292|FG006|Overall Study|post-operative hematoma|0|||
16425968|NCT02147288|40039293|FG007|Overall Study|post-operative hematoma|0|||
16425969|NCT02147288|40039294|FG008|Overall Study|post-operative hematoma|0|||
16425970|NCT02147288|40039295|FG009|Overall Study|post-operative hematoma|0|||
16425971|NCT02147288|40039286|FG000|Overall Study|complications from concurrent hernia rep|0|||
16425972|NCT02147288|40039287|FG001|Overall Study|complications from concurrent hernia rep|1|||
16425973|NCT02147288|40039288|FG002|Overall Study|complications from concurrent hernia rep|0|||
16425974|NCT02147288|40039289|FG003|Overall Study|complications from concurrent hernia rep|0|||
16425975|NCT02147288|40039290|FG004|Overall Study|complications from concurrent hernia rep|0|||
16425976|NCT02147288|40039291|FG005|Overall Study|complications from concurrent hernia rep|0|||
16425977|NCT02147288|40039292|FG006|Overall Study|complications from concurrent hernia rep|0|||
16425978|NCT02147288|40039293|FG007|Overall Study|complications from concurrent hernia rep|0|||
16425979|NCT02147288|40039294|FG008|Overall Study|complications from concurrent hernia rep|0|||
16425980|NCT02147288|40039295|FG009|Overall Study|complications from concurrent hernia rep|0|||
16425981|NCT00930930|40039298|FG000|Overall Study|Death|1|||
16425982|NCT00930930|40039299|FG001|Overall Study|Death|0|||
16425983|NCT00930930|40039298|FG000|Overall Study|Physician Decision|1|||
16425984|NCT00930930|40039299|FG001|Overall Study|Physician Decision|0|||
16425985|NCT00930930|40039298|FG000|Overall Study|Adverse Event|13|||
16425986|NCT00930930|40039299|FG001|Overall Study|Adverse Event|3|||
16130927|NCT01323634|38967154|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
16130928|NCT01323634|38967152|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
16130929|NCT01323634|38967153|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
16130930|NCT01323634|38967154|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
16130931|NCT00687973|38967155|FG000|Overall Study|Adverse Event|18|||
16130932|NCT00687973|38967156|FG001|Overall Study|Adverse Event|28|||
16130933|NCT00687973|38967155|FG000|Overall Study|Lack of Efficacy|2|||
16130934|NCT00687973|38967156|FG001|Overall Study|Lack of Efficacy|3|||
16130935|NCT00687973|38967155|FG000|Overall Study|Protocol Violation|1|||
16130936|NCT00687973|38967156|FG001|Overall Study|Protocol Violation|2|||
16130937|NCT00687973|38967155|FG000|Overall Study|Administrative Reasons|0|||
16130938|NCT00687973|38967156|FG001|Overall Study|Administrative Reasons|2|||
16130939|NCT00687973|38967155|FG000|Overall Study|Withdrawal by Subject|3|||
16130940|NCT00687973|38967156|FG001|Overall Study|Withdrawal by Subject|3|||
16130941|NCT03647488|38967157|FG000|Overall Study|Progressive disease|10|||
16130942|NCT03647488|38967158|FG001|Overall Study|Progressive disease|0|||
16130943|NCT03647488|38967159|FG002|Overall Study|Progressive disease|0|||
16130944|NCT03647488|38967157|FG000|Overall Study|Adverse Event|5|||
16130945|NCT03647488|38967158|FG001|Overall Study|Adverse Event|0|||
16130946|NCT03647488|38967159|FG002|Overall Study|Adverse Event|0|||
16425987|NCT00930930|40039298|FG000|Overall Study|Withdrawal by Subject|3|||
16425988|NCT00930930|40039299|FG001|Overall Study|Withdrawal by Subject|1|||
16425989|NCT00930930|40039298|FG000|Overall Study|Disease progression|2|||
16425990|NCT00930930|40039299|FG001|Overall Study|Disease progression|3|||
16425991|NCT00930930|40039298|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
16425992|NCT00930930|40039299|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
16425993|NCT00930930|40039298|FG000|Overall Study|patients not compliant|1|||
16425994|NCT00930930|40039299|FG001|Overall Study|patients not compliant|1|||
16425995|NCT00767806|40039301|FG000|Overall Study|Adverse Event|30|||
16425996|NCT00767806|40039302|FG001|Overall Study|Adverse Event|11|||
16130947|NCT03647488|38967157|FG000|Overall Study|Clinical progression|2|||
16130948|NCT03647488|38967158|FG001|Overall Study|Clinical progression|0|||
16130949|NCT03647488|38967159|FG002|Overall Study|Clinical progression|0|||
16425997|NCT00767806|40039301|FG000|Overall Study|Withdrawal by Subject|8|||
16425998|NCT00767806|40039302|FG001|Overall Study|Withdrawal by Subject|13|||
16425999|NCT00767806|40039301|FG000|Overall Study|Protocol Violation|6|||
16426000|NCT00767806|40039302|FG001|Overall Study|Protocol Violation|5|||
16426001|NCT00767806|40039301|FG000|Overall Study|Lack of Efficacy|1|||
16426002|NCT00767806|40039302|FG001|Overall Study|Lack of Efficacy|9|||
16426003|NCT00767806|40039301|FG000|Overall Study|Physician Decision|4|||
16426004|NCT00767806|40039302|FG001|Overall Study|Physician Decision|3|||
16426005|NCT00767806|40039301|FG000|Overall Study|Lost to Follow-up|1|||
16426006|NCT00767806|40039302|FG001|Overall Study|Lost to Follow-up|4|||
16426007|NCT00767806|40039301|FG000|Overall Study|Entry Criteria Not Met|1|||
16426008|NCT00767806|40039302|FG001|Overall Study|Entry Criteria Not Met|1|||
16426009|NCT00767806|40039301|FG000|Overall Study|Sponsor Decision|0|||
16426010|NCT00767806|40039302|FG001|Overall Study|Sponsor Decision|1|||
16426011|NCT01128946|40039304|FG000|Period I|Protocol Violation|0|||
16426012|NCT01128946|40039305|FG001|Period I|Protocol Violation|1|||
16426013|NCT01128946|40039306|FG002|Period I|Protocol Violation|0|||
16426014|NCT01128946|40039307|FG003|Period I|Protocol Violation|0|||
16426015|NCT01128946|40039304|FG000|Period I|Withdrawal by Subject|0|||
16426016|NCT01128946|40039305|FG001|Period I|Withdrawal by Subject|0|||
16426017|NCT01128946|40039306|FG002|Period I|Withdrawal by Subject|1|||
16426018|NCT01128946|40039307|FG003|Period I|Withdrawal by Subject|1|||
16426019|NCT01128946|40039304|FG000|Period II|Protocol Violation|0|||
16426020|NCT01128946|40039305|FG001|Period II|Protocol Violation|1|||
16426021|NCT01128946|40039306|FG002|Period II|Protocol Violation|0|||
16426022|NCT01128946|40039307|FG003|Period II|Protocol Violation|0|||
16426023|NCT01128946|40039304|FG000|Period II|Withdrawal by Subject|0|||
16426024|NCT01128946|40039305|FG001|Period II|Withdrawal by Subject|0|||
16426025|NCT01128946|40039306|FG002|Period II|Withdrawal by Subject|0|||
16426026|NCT01128946|40039307|FG003|Period II|Withdrawal by Subject|1|||
16426027|NCT01128946|40039304|FG000|Period III|Protocol Violation|1|||
16426028|NCT01128946|40039305|FG001|Period III|Protocol Violation|0|||
16426029|NCT01128946|40039306|FG002|Period III|Protocol Violation|0|||
16426030|NCT01128946|40039307|FG003|Period III|Protocol Violation|0|||
16426031|NCT00452790|40039308|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
16426032|NCT00452790|40039309|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
16426033|NCT00452790|40039308|FG000|Infant Series|Parent/legal guardian request|8|||
16426034|NCT00452790|40039309|FG001|Infant Series|Parent/legal guardian request|6|||
16426035|NCT00452790|40039308|FG000|Infant Series|Failed to return|4|||
16426036|NCT00452790|40039309|FG001|Infant Series|Failed to return|1|||
16426037|NCT00452790|40039308|FG000|Infant Series|Protocol Violation|1|||
16426038|NCT00452790|40039309|FG001|Infant Series|Protocol Violation|3|||
16426039|NCT00452790|40039308|FG000|Infant Series|Lost to Follow-up|2|||
16426040|NCT00452790|40039309|FG001|Infant Series|Lost to Follow-up|2|||
16426041|NCT00452790|40039308|FG000|Infant Series|Adverse Event|1|||
16426042|NCT00452790|40039309|FG001|Infant Series|Adverse Event|2|||
16426043|NCT00452790|40039308|FG000|Infant Series|Other reasons|1|||
16426044|NCT00452790|40039309|FG001|Infant Series|Other reasons|2|||
16426045|NCT00452790|40039308|FG000|Infant Series|Investigator request|0|||
16426046|NCT00452790|40039309|FG001|Infant Series|Investigator request|1|||
16426047|NCT00452790|40039308|FG000|Infant Series|Death|0|||
16426048|NCT00452790|40039309|FG001|Infant Series|Death|1|||
16426049|NCT00452790|40039308|FG000|After Infant Series|Investigator request|10|||
16426050|NCT00452790|40039309|FG001|After Infant Series|Investigator request|10|||
16426051|NCT00452790|40039308|FG000|After Infant Series|Adverse Event|4|||
16426052|NCT00452790|40039309|FG001|After Infant Series|Adverse Event|1|||
16426053|NCT00452790|40039308|FG000|After Infant Series|Parent/legal guardian request|1|||
16426054|NCT00452790|40039309|FG001|After Infant Series|Parent/legal guardian request|3|||
16426055|NCT00452790|40039308|FG000|After Infant Series|Lost to Follow-up|4|||
16426056|NCT00452790|40039309|FG001|After Infant Series|Lost to Follow-up|0|||
16426057|NCT00452790|40039308|FG000|After Infant Series|Failed to return|1|||
16426058|NCT00452790|40039309|FG001|After Infant Series|Failed to return|0|||
16426059|NCT00452790|40039308|FG000|After Infant Series|Other reasons|1|||
16426060|NCT00452790|40039309|FG001|After Infant Series|Other reasons|0|||
16426061|NCT00452790|40039308|FG000|Toddler Dose|Failed to return|0|||
16426062|NCT00452790|40039309|FG001|Toddler Dose|Failed to return|1|||
16426063|NCT00452790|40039308|FG000|Toddler Dose|Parent/legal guardian request|0|||
16426064|NCT00452790|40039309|FG001|Toddler Dose|Parent/legal guardian request|1|||
16426065|NCT01496469|40039310|FG000|Overall Study|Adverse Event|1|||
16426066|NCT01496469|40039311|FG001|Overall Study|Adverse Event|0|||
16130950|NCT03647488|38967157|FG000|Overall Study|Participant refused to take investigational product|1|||
16426067|NCT01496469|40039310|FG000|Overall Study|Protocol Violation|2|||
16426068|NCT01496469|40039311|FG001|Overall Study|Protocol Violation|0|||
16130951|NCT03647488|38967158|FG001|Overall Study|Participant refused to take investigational product|0|||
16426069|NCT01496469|40039310|FG000|Overall Study|Lost to Follow-up|1|||
16426070|NCT01496469|40039311|FG001|Overall Study|Lost to Follow-up|1|||
16426071|NCT01496469|40039310|FG000|Overall Study|Withdrawal by Subject|4|||
16426072|NCT01496469|40039311|FG001|Overall Study|Withdrawal by Subject|4|||
16426073|NCT01496469|40039310|FG000|Overall Study|BP exceeds protocol limits|1|||
16426074|NCT01496469|40039311|FG001|Overall Study|BP exceeds protocol limits|2|||
16426075|NCT01496469|40039310|FG000|Overall Study|Other|1|||
16426076|NCT01496469|40039311|FG001|Overall Study|Other|1|||
16426077|NCT01456169|40039312|FG000|Overall Study|Adverse Event|1|||
16426078|NCT01456169|40039313|FG001|Overall Study|Adverse Event|2|||
16426079|NCT01456169|40039314|FG002|Overall Study|Adverse Event|7|||
16426080|NCT01456169|40039312|FG000|Overall Study|Major Protocol Deviation|3|||
16426081|NCT01456169|40039313|FG001|Overall Study|Major Protocol Deviation|2|||
16426082|NCT01456169|40039314|FG002|Overall Study|Major Protocol Deviation|3|||
16426083|NCT01456169|40039312|FG000|Overall Study|Voluntary Withdrawal|3|||
16426084|NCT01456169|40039313|FG001|Overall Study|Voluntary Withdrawal|0|||
16426085|NCT01456169|40039314|FG002|Overall Study|Voluntary Withdrawal|2|||
16426086|NCT01456169|40039312|FG000|Overall Study|Lack of Efficacy|2|||
16426087|NCT01456169|40039313|FG001|Overall Study|Lack of Efficacy|0|||
16426088|NCT01456169|40039314|FG002|Overall Study|Lack of Efficacy|0|||
16426089|NCT01456169|40039312|FG000|Overall Study|Other|1|||
16426090|NCT01456169|40039313|FG001|Overall Study|Other|1|||
16426091|NCT01456169|40039314|FG002|Overall Study|Other|0|||
16426092|NCT01206582|40039331|FG000|Overall Study|Withdrew prior to study|1|||
16426093|NCT01206582|40039332|FG001|Overall Study|Withdrew prior to study|0|||
16426094|NCT01206582|40039331|FG000|Overall Study|Discontinued intervention before week 8|1|||
16426095|NCT01206582|40039332|FG001|Overall Study|Discontinued intervention before week 8|2|||
16426096|NCT01835223|40039333|FG000|Overall Study|Adverse Event|1|||
16426097|NCT01835223|40039334|FG001|Overall Study|Adverse Event|0|||
16426098|NCT01835223|40039333|FG000|Overall Study|Withdrawal by Subject|2|||
16426099|NCT01835223|40039334|FG001|Overall Study|Withdrawal by Subject|0|||
16426100|NCT01835223|40039333|FG000|Overall Study|Disease progression|2|||
16426101|NCT01835223|40039334|FG001|Overall Study|Disease progression|1|||
16426102|NCT01835223|40039333|FG000|Overall Study|Became Inelligible|4|||
16426103|NCT01835223|40039334|FG001|Overall Study|Became Inelligible|0|||
16426104|NCT01301833|40039335|FG000|Overall Study|Adverse Event|7|||
16426105|NCT01301833|40039336|FG001|Overall Study|Adverse Event|5|||
16426106|NCT01301833|40039337|FG002|Overall Study|Adverse Event|5|||
16426107|NCT01301833|40039338|FG003|Overall Study|Adverse Event|5|||
16426108|NCT01301833|40039335|FG000|Overall Study|Lack of Efficacy|1|||
16426109|NCT01301833|40039336|FG001|Overall Study|Lack of Efficacy|1|||
16426110|NCT01301833|40039337|FG002|Overall Study|Lack of Efficacy|0|||
16426111|NCT01301833|40039338|FG003|Overall Study|Lack of Efficacy|0|||
16426112|NCT01301833|40039335|FG000|Overall Study|Physician Decision|3|||
16426113|NCT01301833|40039336|FG001|Overall Study|Physician Decision|1|||
16426114|NCT01301833|40039337|FG002|Overall Study|Physician Decision|1|||
16426115|NCT01301833|40039338|FG003|Overall Study|Physician Decision|0|||
16426116|NCT01301833|40039335|FG000|Overall Study|Withdrawal by Subject|3|||
16426117|NCT01301833|40039336|FG001|Overall Study|Withdrawal by Subject|1|||
16426118|NCT01301833|40039337|FG002|Overall Study|Withdrawal by Subject|1|||
16426119|NCT01301833|40039338|FG003|Overall Study|Withdrawal by Subject|2|||
16426120|NCT01301833|40039335|FG000|Overall Study|Personal matter|1|||
16426121|NCT01301833|40039336|FG001|Overall Study|Personal matter|0|||
16426122|NCT01301833|40039337|FG002|Overall Study|Personal matter|0|||
16426123|NCT01301833|40039338|FG003|Overall Study|Personal matter|0|||
16426124|NCT02720692|40039341|FG000|Overall Study|Withdrawal by Subject|3|||
16426125|NCT02720692|40039342|FG001|Overall Study|Withdrawal by Subject|0|||
16426126|NCT02720692|40039341|FG000|Overall Study|Physician Decision|1|||
16426127|NCT02720692|40039342|FG001|Overall Study|Physician Decision|0|||
16426128|NCT02720692|40039341|FG000|Overall Study|Lost to Follow-up|8|||
16426129|NCT02720692|40039342|FG001|Overall Study|Lost to Follow-up|3|||
16426130|NCT02720692|40039341|FG000|Overall Study|Subject unable to return for visit|1|||
16426131|NCT02720692|40039342|FG001|Overall Study|Subject unable to return for visit|0|||
16426132|NCT00660179|40039348|FG000|Overall Study|Death|44|||
16426133|NCT00660179|40039349|FG001|Overall Study|Death|47|||
16426134|NCT00660179|40039350|FG002|Overall Study|Death|34|||
16426135|NCT00660179|40039348|FG000|Overall Study|Withdrawal of consent|4|||
16426136|NCT00660179|40039349|FG001|Overall Study|Withdrawal of consent|6|||
16426137|NCT00660179|40039350|FG002|Overall Study|Withdrawal of consent|4|||
16426138|NCT00660179|40039348|FG000|Overall Study|Lost to Follow-up|7|||
16426139|NCT00660179|40039349|FG001|Overall Study|Lost to Follow-up|5|||
16426140|NCT00660179|40039350|FG002|Overall Study|Lost to Follow-up|2|||
16426141|NCT00660179|40039348|FG000|Overall Study|Administrative reason|0|||
16426142|NCT00660179|40039349|FG001|Overall Study|Administrative reason|0|||
16426143|NCT00660179|40039350|FG002|Overall Study|Administrative reason|1|||
16426144|NCT00660179|40039348|FG000|Overall Study|Incorrect randomization|1|||
16426145|NCT00660179|40039349|FG001|Overall Study|Incorrect randomization|0|||
16426146|NCT00660179|40039350|FG002|Overall Study|Incorrect randomization|0|||
16426147|NCT00377858|40039351|FG000|Overall Study|Withdrawal by Subject|12|||
16426148|NCT00377858|40039352|FG001|Overall Study|Withdrawal by Subject|11|||
16426149|NCT00377858|40039351|FG000|Overall Study|Lost to Follow-up|6|||
16426150|NCT00377858|40039352|FG001|Overall Study|Lost to Follow-up|1|||
16426151|NCT00377858|40039351|FG000|Overall Study|Physician Decision|5|||
16426152|NCT00377858|40039352|FG001|Overall Study|Physician Decision|5|||
16426153|NCT00377858|40039351|FG000|Overall Study|Protocol Violation|3|||
16426154|NCT00377858|40039352|FG001|Overall Study|Protocol Violation|4|||
16426155|NCT00377858|40039351|FG000|Overall Study|Adverse Event|2|||
16426156|NCT00377858|40039352|FG001|Overall Study|Adverse Event|1|||
16426157|NCT00377858|40039351|FG000|Overall Study|Entry Criteria Not Met|2|||
16426158|NCT00377858|40039352|FG001|Overall Study|Entry Criteria Not Met|0|||
16426159|NCT00377858|40039351|FG000|Overall Study|Sponsor Decision|1|||
16426160|NCT00377858|40039352|FG001|Overall Study|Sponsor Decision|2|||
16426161|NCT00377858|40039351|FG000|Overall Study|Death|0|||
16426162|NCT00377858|40039352|FG001|Overall Study|Death|3|||
16426163|NCT00466921|40039353|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
16426164|NCT00466921|40039353|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
16426165|NCT00466921|40039353|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
16426166|NCT00466921|40039353|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
16426167|NCT00466921|40039353|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
16426168|NCT00466921|40039353|FG000|Follow up for a Minimum of 1 Year|Death|6|||
16426169|NCT01865448|40039356|FG000|Overall Study|Adverse Event|1|||
16426170|NCT01865448|40039357|FG001|Overall Study|Adverse Event|1|||
16426171|NCT01865448|40039356|FG000|Overall Study|Pregnancy|0|||
16426172|NCT01865448|40039357|FG001|Overall Study|Pregnancy|1|||
16426173|NCT01865448|40039356|FG000|Overall Study|dropout unrelated to study|1|||
16426174|NCT01865448|40039357|FG001|Overall Study|dropout unrelated to study|1|||
16426175|NCT01386385|40039358|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
16426176|NCT01386385|40039359|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16426177|NCT01386385|40039360|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16426178|NCT01386385|40039361|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16426179|NCT01386385|40039362|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16426180|NCT01386385|40039363|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16426181|NCT01386385|40039364|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16426182|NCT01386385|40039365|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
16426183|NCT01386385|40039358|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
16426184|NCT01386385|40039359|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16426185|NCT01386385|40039360|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16426186|NCT01386385|40039361|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16426187|NCT01386385|40039362|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16426188|NCT01386385|40039363|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16426189|NCT01386385|40039364|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16426190|NCT01386385|40039365|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
16426191|NCT01386385|40039358|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16426192|NCT01386385|40039359|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16426193|NCT01386385|40039360|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
16426194|NCT01386385|40039361|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16426195|NCT01386385|40039362|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16426196|NCT01386385|40039363|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16426197|NCT01386385|40039364|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16426198|NCT01386385|40039365|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
16426199|NCT01386385|40039358|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16426200|NCT01386385|40039359|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16426201|NCT01386385|40039360|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16426202|NCT01386385|40039361|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16426203|NCT01386385|40039362|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
16426204|NCT01386385|40039363|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16426205|NCT01386385|40039364|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16426206|NCT01386385|40039365|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
16426207|NCT01386385|40039358|FG000|Phase II Concurrent CRT|Adverse Event|0|||
16426208|NCT01386385|40039359|FG001|Phase II Concurrent CRT|Adverse Event|0|||
16426209|NCT01386385|40039360|FG002|Phase II Concurrent CRT|Adverse Event|0|||
16426210|NCT01386385|40039361|FG003|Phase II Concurrent CRT|Adverse Event|0|||
16426211|NCT01386385|40039362|FG004|Phase II Concurrent CRT|Adverse Event|0|||
16426212|NCT01386385|40039363|FG005|Phase II Concurrent CRT|Adverse Event|0|||
16562513|NCT00124982|40525431|FG001|Short-term Period|Lack of Efficacy|73|||
16562514|NCT00124982|40525432|FG002|Short-term Period|Lack of Efficacy|0|||
16562515|NCT00124982|40525430|FG000|Short-term Period|Lost to Follow-up|8|||
16426213|NCT01386385|40039364|FG006|Phase II Concurrent CRT|Adverse Event|3|||
16426214|NCT01386385|40039365|FG007|Phase II Concurrent CRT|Adverse Event|3|||
16426215|NCT01386385|40039358|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16426216|NCT01386385|40039359|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16426217|NCT01386385|40039360|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16426218|NCT01386385|40039361|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16426219|NCT01386385|40039362|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16426220|NCT01386385|40039363|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16426221|NCT01386385|40039364|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
16426222|NCT01386385|40039365|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
16426223|NCT01386385|40039358|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
16426224|NCT01386385|40039359|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
16426225|NCT01386385|40039360|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
16426226|NCT01386385|40039361|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
16426227|NCT01386385|40039362|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
16426228|NCT01386385|40039363|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
16426229|NCT01386385|40039364|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
16426230|NCT01386385|40039365|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
16426231|NCT01386385|40039358|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16426232|NCT01386385|40039359|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16426233|NCT01386385|40039360|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16426234|NCT01386385|40039361|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16426235|NCT01386385|40039362|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16426236|NCT01386385|40039363|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16426237|NCT01386385|40039364|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
16426238|NCT01386385|40039365|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
16426239|NCT01386385|40039358|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
16426240|NCT01386385|40039359|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
16426241|NCT01386385|40039360|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
16426242|NCT01386385|40039361|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
16426243|NCT01386385|40039362|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
16426244|NCT01386385|40039363|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
16426245|NCT01386385|40039364|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
16426246|NCT01386385|40039365|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
16426247|NCT00705367|40039366|FG000|Long-term Extension Period|Adverse Event|2|||
16426248|NCT00705367|40039367|FG001|Long-term Extension Period|Adverse Event|0|||
16426249|NCT00705367|40039366|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
16426250|NCT00705367|40039367|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
16426251|NCT00705367|40039366|FG000|Long-term Extension Period|Lack of Efficacy|1|||
16426252|NCT00705367|40039367|FG001|Long-term Extension Period|Lack of Efficacy|0|||
16426253|NCT00705367|40039366|FG000|Long-term Extension Period|No longer met study criteria|1|||
16426254|NCT00705367|40039367|FG001|Long-term Extension Period|No longer met study criteria|0|||
16426255|NCT00705367|40039366|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
16426256|NCT00705367|40039367|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
16426257|NCT03382561|40039368|FG000|Overall Study|Disease progression|47|||
16426258|NCT03382561|40039369|FG001|Overall Study|Disease progression|6|||
16426259|NCT03382561|40039368|FG000|Overall Study|Adverse Event|10|||
16426260|NCT03382561|40039369|FG001|Overall Study|Adverse Event|2|||
16426261|NCT03382561|40039368|FG000|Overall Study|Death|8|||
16426262|NCT03382561|40039369|FG001|Overall Study|Death|3|||
16426263|NCT03382561|40039368|FG000|Overall Study|Withdrawal by Subject|6|||
16426264|NCT03382561|40039369|FG001|Overall Study|Withdrawal by Subject|5|||
16426265|NCT03382561|40039368|FG000|Overall Study|Alternative therapy|2|||
16426266|NCT03382561|40039369|FG001|Overall Study|Alternative therapy|8|||
16426267|NCT03382561|40039368|FG000|Overall Study|Never started treatment|3|||
16426268|NCT03382561|40039369|FG001|Overall Study|Never started treatment|6|||
16426269|NCT03382561|40039368|FG000|Overall Study|Lack of Efficacy|0|||
16426270|NCT03382561|40039369|FG001|Overall Study|Lack of Efficacy|1|||
16426271|NCT03382561|40039368|FG000|Overall Study|Physician Decision|0|||
16426272|NCT03382561|40039369|FG001|Overall Study|Physician Decision|1|||
16426273|NCT03382561|40039368|FG000|Overall Study|Other complicating disease|0|||
16426274|NCT03382561|40039369|FG001|Overall Study|Other complicating disease|1|||
16426275|NCT01103063|40039370|FG000|Overall Study|Adverse Event|3|||
16426276|NCT01103063|40039371|FG001|Overall Study|Adverse Event|1|||
16426277|NCT01103063|40039370|FG000|Overall Study|Lost to Follow-up|68|||
16426278|NCT01103063|40039371|FG001|Overall Study|Lost to Follow-up|51|||
16426279|NCT01103063|40039370|FG000|Overall Study|Withdrawal by Subject|60|||
16426280|NCT01103063|40039371|FG001|Overall Study|Withdrawal by Subject|15|||
16426281|NCT01103063|40039370|FG000|Overall Study|Other|16|||
16426282|NCT01103063|40039371|FG001|Overall Study|Other|11|||
16426283|NCT01103063|40039370|FG000|Overall Study|Protocol Violation|1|||
16426284|NCT01103063|40039371|FG001|Overall Study|Protocol Violation|0|||
16426285|NCT01103063|40039370|FG000|Overall Study|Study terminated by Sponsor|326|||
16426286|NCT01103063|40039371|FG001|Overall Study|Study terminated by Sponsor|342|||
16426287|NCT01103063|40039370|FG000|Overall Study|Death|3|||
16426288|NCT01103063|40039371|FG001|Overall Study|Death|1|||
16426289|NCT01248949|40039372|FG000|Overall Study|Lost to Follow-up|2|||
16426290|NCT01248949|40039373|FG001|Overall Study|Lost to Follow-up|2|||
16426291|NCT01248949|40039374|FG002|Overall Study|Lost to Follow-up|2|||
16426292|NCT01248949|40039375|FG003|Overall Study|Lost to Follow-up|1|||
16426293|NCT01248949|40039376|FG004|Overall Study|Lost to Follow-up|0|||
16426294|NCT01248949|40039372|FG000|Overall Study|Withdrawal by Subject|5|||
16426295|NCT01248949|40039373|FG001|Overall Study|Withdrawal by Subject|3|||
16426296|NCT01248949|40039374|FG002|Overall Study|Withdrawal by Subject|11|||
16426297|NCT01248949|40039375|FG003|Overall Study|Withdrawal by Subject|3|||
16426298|NCT01248949|40039376|FG004|Overall Study|Withdrawal by Subject|1|||
16426299|NCT01248949|40039372|FG000|Overall Study|Death|22|||
16426300|NCT01248949|40039373|FG001|Overall Study|Death|7|||
16426301|NCT01248949|40039374|FG002|Overall Study|Death|21|||
16426302|NCT01248949|40039375|FG003|Overall Study|Death|6|||
16426303|NCT01248949|40039376|FG004|Overall Study|Death|2|||
16426304|NCT01248949|40039372|FG000|Overall Study|Alternative Therapy|1|||
16426305|NCT01248949|40039373|FG001|Overall Study|Alternative Therapy|0|||
16426306|NCT01248949|40039374|FG002|Overall Study|Alternative Therapy|0|||
16426307|NCT01248949|40039375|FG003|Overall Study|Alternative Therapy|0|||
16426308|NCT01248949|40039376|FG004|Overall Study|Alternative Therapy|0|||
16426309|NCT01248949|40039372|FG000|Overall Study|Alternative Therapy.|1|||
16426310|NCT01248949|40039373|FG001|Overall Study|Alternative Therapy.|0|||
16426311|NCT01248949|40039374|FG002|Overall Study|Alternative Therapy.|0|||
16426312|NCT01248949|40039375|FG003|Overall Study|Alternative Therapy.|0|||
16426313|NCT01248949|40039376|FG004|Overall Study|Alternative Therapy.|0|||
16426314|NCT01248949|40039372|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
16249663|NCT01628120|39397895|FG000|Overall Study|Adverse Event|12|||
16249664|NCT01628120|39397895|FG000|Overall Study|Lost to Follow-up|1|||
16426315|NCT01248949|40039373|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
16426316|NCT01248949|40039374|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
16426317|NCT01248949|40039375|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
16426318|NCT01248949|40039376|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
16426319|NCT01248949|40039372|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
16426320|NCT01248949|40039373|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
16426321|NCT01248949|40039374|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
16426322|NCT01248949|40039375|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
16426323|NCT01248949|40039376|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
16426324|NCT01248949|40039372|FG000|Overall Study|Participant Went To Hospice|0|||
16426325|NCT01248949|40039373|FG001|Overall Study|Participant Went To Hospice|0|||
16426326|NCT01248949|40039374|FG002|Overall Study|Participant Went To Hospice|1|||
16426327|NCT01248949|40039375|FG003|Overall Study|Participant Went To Hospice|0|||
16426328|NCT01248949|40039376|FG004|Overall Study|Participant Went To Hospice|0|||
16426329|NCT01248949|40039372|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
16426330|NCT01248949|40039373|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
16426331|NCT01248949|40039374|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
16426332|NCT01248949|40039375|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
16426333|NCT01248949|40039376|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
16426334|NCT01248949|40039372|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
16426335|NCT01248949|40039373|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
16426336|NCT01248949|40039374|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
16426337|NCT01248949|40039375|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
16426338|NCT01248949|40039376|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
16426339|NCT01248949|40039372|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
16426340|NCT01248949|40039373|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
16426341|NCT01248949|40039374|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
16426342|NCT01248949|40039375|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
16426343|NCT01248949|40039376|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
16426344|NCT01248949|40039372|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
16426345|NCT01248949|40039373|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
16426346|NCT01248949|40039374|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
16426347|NCT01248949|40039375|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
16426348|NCT01248949|40039376|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
16426349|NCT00891228|40039378|FG000|Overall Study|Adverse Event|0|||
16426350|NCT00891228|40039379|FG001|Overall Study|Adverse Event|2|||
16426351|NCT00891228|40039380|FG002|Overall Study|Adverse Event|3|||
16426352|NCT00891228|40039378|FG000|Overall Study|Withdrawal by Subject|2|||
16426353|NCT00891228|40039379|FG001|Overall Study|Withdrawal by Subject|4|||
16426354|NCT00891228|40039380|FG002|Overall Study|Withdrawal by Subject|5|||
16426355|NCT00891228|40039378|FG000|Overall Study|Protocol Violation|3|||
16426356|NCT00891228|40039379|FG001|Overall Study|Protocol Violation|1|||
16426357|NCT00891228|40039380|FG002|Overall Study|Protocol Violation|2|||
16426358|NCT00891228|40039378|FG000|Overall Study|Physician Decision|2|||
16426359|NCT00891228|40039379|FG001|Overall Study|Physician Decision|1|||
16426360|NCT00891228|40039380|FG002|Overall Study|Physician Decision|0|||
16426361|NCT00891228|40039378|FG000|Overall Study|Lost to Follow-up|4|||
16426362|NCT00891228|40039379|FG001|Overall Study|Lost to Follow-up|4|||
16426363|NCT00891228|40039380|FG002|Overall Study|Lost to Follow-up|5|||
16426364|NCT00891228|40039378|FG000|Overall Study|Pregnancy|0|||
16426365|NCT00891228|40039379|FG001|Overall Study|Pregnancy|1|||
16426366|NCT00891228|40039380|FG002|Overall Study|Pregnancy|0|||
16426367|NCT01740401|40039381|FG000|Overall Study|Progression of disease|6|||
16426368|NCT01740401|40039381|FG000|Overall Study|Adverse Event|2|||
16426369|NCT01740401|40039381|FG000|Overall Study|Did not reach primary endpoint|2|||
16426370|NCT01856582|40039382|FG000|Overall Study|Died prior to Boost infusion|1|||
16426371|NCT02629822|40039383|FG000|Base Study|Lost to Follow-up|2|||
16426372|NCT02629822|40039383|FG000|Base Study|Non-Compliance With Study Drug|1|||
16426373|NCT02629822|40039383|FG000|Extension Study|Adverse Event|1|||
16426374|NCT02629822|40039383|FG000|Extension Study|Lost to Follow-up|1|||
16426375|NCT03386487|40039390|FG000|Overall Study|Lost to Follow-up|5|||
16426376|NCT03386487|40039391|FG001|Overall Study|Lost to Follow-up|6|||
16426377|NCT03386487|40039390|FG000|Overall Study|Withdrawal by Subject|11|||
16426378|NCT03386487|40039391|FG001|Overall Study|Withdrawal by Subject|7|||
16426379|NCT03386487|40039390|FG000|Overall Study|Physician Decision|11|||
16426380|NCT03386487|40039391|FG001|Overall Study|Physician Decision|8|||
16426381|NCT03301350|40039392|FG000|Overall Study|Withdrawal by Subject|4|||
16426382|NCT03301350|40039392|FG000|Overall Study|Adverse Event|1|||
16426383|NCT03301350|40039392|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
16426384|NCT03301350|40039392|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
16426385|NCT03301350|40039392|FG000|Overall Study|no detail provided|1|||
16426386|NCT00596830|40039394|FG000|Overall Study|Death|258|||
16426387|NCT00596830|40039395|FG001|Overall Study|Death|247|||
16426388|NCT00596830|40039394|FG000|Overall Study|Lost to Follow-up|7|||
16426389|NCT00596830|40039395|FG001|Overall Study|Lost to Follow-up|11|||
16426390|NCT00596830|40039394|FG000|Overall Study|Withdrawal by Subject|22|||
16130952|NCT03647488|38967159|FG002|Overall Study|Participant refused to take investigational product|0|||
16360647|NCT03370302|39807503|FG004|Dose Escalation Phase|Other|0|||
16360648|NCT03370302|39807504|FG005|Dose Escalation Phase|Other|0|||
16360649|NCT03370302|39807499|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
16360650|NCT03370302|39807500|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
16360651|NCT03370302|39807501|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
16360652|NCT03370302|39807502|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16360653|NCT03370302|39807503|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
16360654|NCT03370302|39807504|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
16360655|NCT03370302|39807499|FG000|Dose Escalation Phase|Adverse Event|1|||
16360656|NCT03370302|39807500|FG001|Dose Escalation Phase|Adverse Event|0|||
16360657|NCT03370302|39807501|FG002|Dose Escalation Phase|Adverse Event|2|||
16360658|NCT03370302|39807502|FG003|Dose Escalation Phase|Adverse Event|0|||
16426391|NCT00596830|40039395|FG001|Overall Study|Withdrawal by Subject|12|||
16426392|NCT00596830|40039394|FG000|Overall Study|Study terminated by sponsor|51|||
16426393|NCT00596830|40039395|FG001|Overall Study|Study terminated by sponsor|62|||
16426394|NCT00596830|40039394|FG000|Overall Study|Follow-up was discontinued|1|||
16426395|NCT00596830|40039395|FG001|Overall Study|Follow-up was discontinued|0|||
16426396|NCT00596830|40039394|FG000|Overall Study|Randomized but not treated|3|||
16360659|NCT03370302|39807503|FG004|Dose Escalation Phase|Adverse Event|0|||
16360660|NCT03370302|39807504|FG005|Dose Escalation Phase|Adverse Event|0|||
16360661|NCT03370302|39807499|FG000|Dose Escalation Phase|Progressive Disease|2|||
16360662|NCT03370302|39807500|FG001|Dose Escalation Phase|Progressive Disease|4|||
16360663|NCT03370302|39807501|FG002|Dose Escalation Phase|Progressive Disease|2|||
16360664|NCT03370302|39807502|FG003|Dose Escalation Phase|Progressive Disease|0|||
16360665|NCT03370302|39807503|FG004|Dose Escalation Phase|Progressive Disease|3|||
16360666|NCT03370302|39807504|FG005|Dose Escalation Phase|Progressive Disease|1|||
16130953|NCT02915302|38967168|FG000|Overall Study|Adverse Event|3|||
16130954|NCT02915302|38967169|FG001|Overall Study|Adverse Event|0|||
16130955|NCT02915302|38967168|FG000|Overall Study|Protocol Violation|20|||
16130956|NCT02915302|38967169|FG001|Overall Study|Protocol Violation|27|||
16130957|NCT02915302|38967168|FG000|Overall Study|Lost to Follow-up|19|||
16130958|NCT02915302|38967169|FG001|Overall Study|Lost to Follow-up|22|||
16130959|NCT02915302|38967168|FG000|Overall Study|Withdrawal by Subject|22|||
16130960|NCT02915302|38967169|FG001|Overall Study|Withdrawal by Subject|29|||
16130961|NCT02915302|38967168|FG000|Overall Study|Other|1|||
16130962|NCT02915302|38967169|FG001|Overall Study|Other|0|||
16130963|NCT03695237|38967173|FG000|Overall Study|Withdrawal by Subject|1|||
16130964|NCT03695237|38967174|FG001|Overall Study|Withdrawal by Subject|3|||
16130965|NCT03695237|38967173|FG000|Overall Study|Lost to Follow-up|1|||
16130966|NCT03695237|38967174|FG001|Overall Study|Lost to Follow-up|2|||
16130967|NCT03695237|38967173|FG000|Overall Study|Other, Not Specified|8|||
16130968|NCT03695237|38967174|FG001|Overall Study|Other, Not Specified|2|||
16130969|NCT02041520|38967175|FG000|Overall Study|Adverse Event|2|||
16130970|NCT02041520|38967176|FG001|Overall Study|Adverse Event|1|||
16130971|NCT02041520|38967175|FG000|Overall Study|Withdrawal by Subject|3|||
16130972|NCT02041520|38967176|FG001|Overall Study|Withdrawal by Subject|4|||
16130973|NCT02041520|38967175|FG000|Overall Study|Protocol Violation|1|||
16130974|NCT02041520|38967176|FG001|Overall Study|Protocol Violation|0|||
16130975|NCT02041520|38967175|FG000|Overall Study|Lost to Follow-up|0|||
16130976|NCT02041520|38967176|FG001|Overall Study|Lost to Follow-up|1|||
16130977|NCT02041520|38967175|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
16130978|NCT02041520|38967176|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
16130979|NCT03254485|38967177|FG000|Overall Study|Adverse Event|3|||
16130980|NCT03254485|38967178|FG001|Overall Study|Adverse Event|0|||
16130981|NCT03254485|38967179|FG002|Overall Study|Adverse Event|0|||
16130982|NCT03254485|38967180|FG003|Overall Study|Adverse Event|6|||
16130983|NCT03254485|38967177|FG000|Overall Study|Protocol Violation|6|||
16130984|NCT03254485|38967178|FG001|Overall Study|Protocol Violation|0|||
16130985|NCT03254485|38967179|FG002|Overall Study|Protocol Violation|0|||
16130986|NCT03254485|38967180|FG003|Overall Study|Protocol Violation|2|||
16130987|NCT03254485|38967177|FG000|Overall Study|Withdrawal by Subject|1|||
16130988|NCT03254485|38967178|FG001|Overall Study|Withdrawal by Subject|0|||
16130989|NCT03254485|38967179|FG002|Overall Study|Withdrawal by Subject|0|||
16130990|NCT03254485|38967180|FG003|Overall Study|Withdrawal by Subject|4|||
16130991|NCT03254485|38967177|FG000|Overall Study|Death|0|||
16130992|NCT03254485|38967178|FG001|Overall Study|Death|0|||
16130993|NCT03254485|38967179|FG002|Overall Study|Death|0|||
16130994|NCT03254485|38967180|FG003|Overall Study|Death|1|||
16130995|NCT03254485|38967177|FG000|Overall Study|Lost to Follow-up|1|||
16130996|NCT03254485|38967178|FG001|Overall Study|Lost to Follow-up|0|||
16130997|NCT03254485|38967179|FG002|Overall Study|Lost to Follow-up|0|||
16130998|NCT03254485|38967180|FG003|Overall Study|Lost to Follow-up|0|||
16130999|NCT03254485|38967177|FG000|Overall Study|Other|1|||
16131000|NCT03254485|38967178|FG001|Overall Study|Other|0|||
16131001|NCT03254485|38967179|FG002|Overall Study|Other|0|||
16131002|NCT03254485|38967180|FG003|Overall Study|Other|2|||
16131003|NCT00969709|38967181|FG000|Overall Study|Adverse Event|3|||
16131004|NCT00969709|38967182|FG001|Overall Study|Adverse Event|13|||
16131005|NCT00969709|38967183|FG002|Overall Study|Adverse Event|26|||
16131006|NCT00969709|38967184|FG003|Overall Study|Adverse Event|12|||
16131007|NCT00969709|38967181|FG000|Overall Study|Lack of Efficacy|7|||
16131008|NCT00969709|38967182|FG001|Overall Study|Lack of Efficacy|4|||
16131009|NCT00969709|38967183|FG002|Overall Study|Lack of Efficacy|1|||
16131010|NCT00969709|38967184|FG003|Overall Study|Lack of Efficacy|3|||
16131011|NCT00969709|38967181|FG000|Overall Study|Protocol Violation|9|||
16131012|NCT00969709|38967182|FG001|Overall Study|Protocol Violation|5|||
16131013|NCT00969709|38967183|FG002|Overall Study|Protocol Violation|9|||
16131014|NCT00969709|38967184|FG003|Overall Study|Protocol Violation|10|||
16131015|NCT00969709|38967181|FG000|Overall Study|Withdrawal by Subject|9|||
16360667|NCT03370302|39807499|FG000|Dose Expansion Phase|Progressive Disease|0|||
16131016|NCT00969709|38967182|FG001|Overall Study|Withdrawal by Subject|12|||
16426397|NCT00596830|40039395|FG001|Overall Study|Randomized but not treated|7|||
16426398|NCT00296140|40039396|FG000|Overall Study|Lost to Follow-up|1|||
16426399|NCT00296140|40039397|FG001|Overall Study|Lost to Follow-up|0|||
16426400|NCT00296140|40039396|FG000|Overall Study|Withdrawal by Subject|1|||
16426401|NCT00296140|40039397|FG001|Overall Study|Withdrawal by Subject|0|||
16426402|NCT00296140|40039396|FG000|Overall Study|Discharge to Nursing Home|1|||
16426403|NCT00296140|40039397|FG001|Overall Study|Discharge to Nursing Home|0|||
16426404|NCT00753454|40039400|FG000|Overall Study|Adverse Event|4|||
16426405|NCT00753454|40039400|FG000|Overall Study|Lack of Efficacy|1|||
16426406|NCT00753454|40039400|FG000|Overall Study|Lost to Follow-up|3|||
16426407|NCT00753454|40039400|FG000|Overall Study|Withdrawal by Subject|5|||
16426408|NCT00753454|40039400|FG000|Overall Study|Investigator Decision|1|||
16426409|NCT00924508|40039405|FG000|Overall Study|Withdrawal by Subject|3|||
16426410|NCT03221842|40039406|FG000|Period 1 (Open-label)|Adverse Event|4|||
16426411|NCT03221842|40039407|FG001|Period 1 (Open-label)|Adverse Event|0|||
16426412|NCT03221842|40039406|FG000|Period 1 (Open-label)|Physician Decision|2|||
16426413|NCT03221842|40039407|FG001|Period 1 (Open-label)|Physician Decision|0|||
16426414|NCT03221842|40039406|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
16426415|NCT03221842|40039407|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
16426416|NCT03221842|40039406|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
16426417|NCT03221842|40039407|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
16426418|NCT03221842|40039406|FG000|Period 1 (Open-label)|Other|2|||
16426419|NCT03221842|40039407|FG001|Period 1 (Open-label)|Other|0|||
16426420|NCT03221842|40039406|FG000|Period 2 (Randomized, Blinded)|Death|0|||
16426421|NCT03221842|40039407|FG001|Period 2 (Randomized, Blinded)|Death|1|||
16426422|NCT03221842|40039406|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
16426423|NCT03221842|40039407|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
16426424|NCT00880191|40039408|FG000|Overall Study|Refused further treatment|4|||
16426425|NCT00880191|40039409|FG001|Overall Study|Refused further treatment|1|||
16426426|NCT00880191|40039408|FG000|Overall Study|Adverse Event|8|||
16426427|NCT00880191|40039409|FG001|Overall Study|Adverse Event|6|||
16426428|NCT00880191|40039408|FG000|Overall Study|Hospitalization/efficacy|1|||
16426429|NCT00880191|40039409|FG001|Overall Study|Hospitalization/efficacy|1|||
16426430|NCT01746225|40039410|FG000|Overall Study|Death|1|||
16426431|NCT01746225|40039411|FG001|Overall Study|Death|0|||
16562516|NCT00124982|40525431|FG001|Short-term Period|Lost to Follow-up|5|||
16562517|NCT00124982|40525432|FG002|Short-term Period|Lost to Follow-up|0|||
16562518|NCT00124982|40525430|FG000|Short-term Period|Withdrawal of Consent|7|||
16562519|NCT00124982|40525431|FG001|Short-term Period|Withdrawal of Consent|9|||
16562520|NCT00124982|40525432|FG002|Short-term Period|Withdrawal of Consent|0|||
16562521|NCT00124982|40525430|FG000|Short-term Period|Poor/Non-compliance|3|||
16562522|NCT00124982|40525431|FG001|Short-term Period|Poor/Non-compliance|1|||
16562523|NCT00124982|40525432|FG002|Short-term Period|Poor/Non-compliance|0|||
16562524|NCT00124982|40525430|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
16562525|NCT00124982|40525431|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
16562526|NCT00124982|40525432|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
16562527|NCT00124982|40525430|FG000|Short-term Period|Participant Decision|1|||
16562528|NCT00124982|40525431|FG001|Short-term Period|Participant Decision|0|||
16562529|NCT00124982|40525432|FG002|Short-term Period|Participant Decision|0|||
16562530|NCT00124982|40525430|FG000|Short-term Period|Participant Chose Own Doctor|0|||
16562531|NCT00124982|40525431|FG001|Short-term Period|Participant Chose Own Doctor|1|||
16562532|NCT00124982|40525432|FG002|Short-term Period|Participant Chose Own Doctor|0|||
16562533|NCT00124982|40525430|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
16562534|NCT00124982|40525431|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
16562535|NCT00124982|40525432|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
16562536|NCT00124982|40525430|FG000|Short-term Period|Participant Had Lymphopenia|1|||
16562537|NCT00124982|40525431|FG001|Short-term Period|Participant Had Lymphopenia|0|||
16562538|NCT00124982|40525432|FG002|Short-term Period|Participant Had Lymphopenia|0|||
16562539|NCT00124982|40525430|FG000|Long-term Period|Death|0|||
16562540|NCT00124982|40525431|FG001|Long-term Period|Death|0|||
16562541|NCT00124982|40525432|FG002|Long-term Period|Death|1|||
16562542|NCT00124982|40525430|FG000|Long-term Period|Adverse Event|0|||
16562543|NCT00124982|40525431|FG001|Long-term Period|Adverse Event|0|||
16562544|NCT00124982|40525432|FG002|Long-term Period|Adverse Event|17|||
16562545|NCT00124982|40525430|FG000|Long-term Period|Lack of Efficacy|0|||
16562546|NCT00124982|40525431|FG001|Long-term Period|Lack of Efficacy|0|||
16426432|NCT01746225|40039412|FG002|Overall Study|Death|1|||
16426433|NCT01746225|40039410|FG000|Overall Study|Withdrawal by Subject|5|||
16426434|NCT01746225|40039411|FG001|Overall Study|Withdrawal by Subject|15|||
16426435|NCT01746225|40039412|FG002|Overall Study|Withdrawal by Subject|19|||
16426436|NCT01746225|40039410|FG000|Overall Study|Physician Decision|14|||
16426437|NCT01746225|40039411|FG001|Overall Study|Physician Decision|11|||
16426438|NCT01746225|40039412|FG002|Overall Study|Physician Decision|3|||
16426439|NCT01746225|40039410|FG000|Overall Study|Adverse Event|15|||
16426440|NCT01746225|40039411|FG001|Overall Study|Adverse Event|12|||
16426441|NCT01746225|40039412|FG002|Overall Study|Adverse Event|17|||
16426442|NCT01746225|40039410|FG000|Overall Study|Continuing Treatment|5|||
16426443|NCT01746225|40039411|FG001|Overall Study|Continuing Treatment|8|||
16426444|NCT01746225|40039412|FG002|Overall Study|Continuing Treatment|3|||
16426445|NCT02806960|40039415|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
16426446|NCT02806960|40039416|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
16426447|NCT02806960|40039417|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
16426448|NCT02806960|40039418|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
16426449|NCT00103740|40039419|FG000|Period 1 - Core|Adverse Event|1|||
16426450|NCT00103740|40039420|FG001|Period 1 - Core|Adverse Event|0|||
16426451|NCT00103740|40039419|FG000|Period 1 - Core|Protocol Violation|3|||
16426452|NCT00103740|40039420|FG001|Period 1 - Core|Protocol Violation|2|||
16426453|NCT00103740|40039419|FG000|Period 1 - Core|Patient withdrew consent|3|||
16426454|NCT00103740|40039420|FG001|Period 1 - Core|Patient withdrew consent|2|||
16426455|NCT00103740|40039419|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
16426456|NCT00103740|40039420|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
16426457|NCT00103740|40039419|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
16426458|NCT00103740|40039420|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
16426459|NCT00103740|40039419|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
16426460|NCT00103740|40039420|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
16426461|NCT00103740|40039419|FG000|Period 2 - Extended Observation Period|Death|6|||
16426462|NCT00103740|40039420|FG001|Period 2 - Extended Observation Period|Death|2|||
16426463|NCT00103740|40039419|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
16426464|NCT00103740|40039420|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
16426465|NCT01807598|40039424|FG000|Overall Study|Withdrawal by Subject|4|||
16426466|NCT01807598|40039424|FG000|Overall Study|Adverse Event|1|||
16426467|NCT01807598|40039424|FG000|Overall Study|Other Physician Decision|1|||
16426468|NCT01565694|40039435|FG000|Dose-Titration Period|Adverse Event|4|||
16426469|NCT01565694|40039435|FG000|Dose-Titration Period|Protocol Violation|10|||
16426470|NCT01565694|40039435|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
16426471|NCT03671304|40039436|FG000|Overall Study|study terminated|7|||
16426472|NCT00291018|40039437|FG000|Overall Study|Not Consented or Declined PAS|12|||
16426473|NCT00291018|40039438|FG001|Overall Study|Not Consented or Declined PAS|15|||
16426474|NCT00291018|40039439|FG002|Overall Study|Not Consented or Declined PAS|15|||
16426475|NCT00291018|40039437|FG000|Overall Study|Death|3|||
16426476|NCT00291018|40039438|FG001|Overall Study|Death|3|||
16426477|NCT00291018|40039439|FG002|Overall Study|Death|4|||
16426478|NCT00291018|40039437|FG000|Overall Study|Withdrawal by Subject|2|||
16426479|NCT00291018|40039438|FG001|Overall Study|Withdrawal by Subject|8|||
16426480|NCT00291018|40039439|FG002|Overall Study|Withdrawal by Subject|1|||
16426481|NCT00291018|40039437|FG000|Overall Study|Failures|5|||
16426482|NCT00291018|40039438|FG001|Overall Study|Failures|12|||
16426483|NCT00291018|40039439|FG002|Overall Study|Failures|5|||
16426484|NCT00291018|40039437|FG000|Overall Study|Lost to Follow-up|3|||
16426485|NCT00291018|40039438|FG001|Overall Study|Lost to Follow-up|4|||
16426486|NCT00291018|40039439|FG002|Overall Study|Lost to Follow-up|18|||
16426487|NCT00193180|40039440|FG000|Overall Study|Lack of Efficacy|1|||
16426488|NCT00193180|40039440|FG000|Overall Study|Adverse Event|8|||
16426489|NCT00193180|40039440|FG000|Overall Study|Protocol Violation|1|||
16426490|NCT03472586|40039441|FG000|Overall Study|Physician Decision|6|||
16426491|NCT03472586|40039441|FG000|Overall Study|Death|6|||
16426492|NCT03472586|40039441|FG000|Overall Study|Adverse Event|1|||
16426493|NCT01970306|40039442|FG000|Overall Study|Not eligible|3|||
16426494|NCT01970306|40039442|FG000|Overall Study|Not able to be treated|9|||
16426495|NCT04639219|40039443|FG000|Overall Study|Withdrawal by Subject|8|||
16426496|NCT04639219|40039443|FG000|Overall Study|Lost to Follow-up|6|||
16426497|NCT04639219|40039443|FG000|Overall Study|Death|55|||
16426498|NCT00495625|40039446|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
16426499|NCT03416127|40039447|FG000|Overall Study|Withdrawal by Subject|0|||
16426500|NCT03416127|40039448|FG001|Overall Study|Withdrawal by Subject|1|||
16426501|NCT03416127|40039449|FG002|Overall Study|Withdrawal by Subject|1|||
16426502|NCT01928927|40039450|FG000|Overall Study|Lost to Follow-up|1|||
16426503|NCT01928927|40039451|FG001|Overall Study|Lost to Follow-up|0|||
16426504|NCT01928927|40039450|FG000|Overall Study|Withdrawal by Subject|1|||
16426505|NCT01928927|40039451|FG001|Overall Study|Withdrawal by Subject|1|||
16426506|NCT02489942|40039452|FG000|Overall Study|Request by patient|602|||
16426507|NCT02489942|40039452|FG000|Overall Study|Improvement/remission|157|||
16426508|NCT02489942|40039452|FG000|Overall Study|No change/Progressive disease|263|||
16562547|NCT00124982|40525432|FG002|Long-term Period|Lack of Efficacy|46|||
16426509|NCT02489942|40039452|FG000|Overall Study|Adverse Event|522|||
16426510|NCT02489942|40039452|FG000|Overall Study|Other personal reasons|1218|||
16426511|NCT02489942|40039452|FG000|Overall Study|Lost to Follow-up|456|||
16426512|NCT02489942|40039452|FG000|Overall Study|Not continuously investigated|7|||
16426513|NCT02489942|40039452|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
16426514|NCT02489942|40039452|FG000|Overall Study|Multiple registration|1|||
16426515|NCT02489942|40039452|FG000|Overall Study|No patient visit after entry|100|||
16426516|NCT02489942|40039452|FG000|Overall Study|No treatment with Jardiance|2|||
16426517|NCT02489942|40039452|FG000|Overall Study|Patient received Jardiance before registration|1|||
16426518|NCT02489942|40039452|FG000|Overall Study|No CRF collected|86|||
16426519|NCT03614325|40039457|FG000|Overall Study|Withdrawal by Subject|0|||
16426520|NCT03614325|40039458|FG001|Overall Study|Withdrawal by Subject|2|||
16426521|NCT03614325|40039457|FG000|Overall Study|Surgery Cancelled|2|||
16426522|NCT03614325|40039458|FG001|Overall Study|Surgery Cancelled|1|||
16426523|NCT03614325|40039457|FG000|Overall Study|Lost to Follow-up|2|||
16426524|NCT03614325|40039458|FG001|Overall Study|Lost to Follow-up|1|||
16426525|NCT03614325|40039457|FG000|Overall Study|Surgery never scheduled|1|||
16426526|NCT03614325|40039458|FG001|Overall Study|Surgery never scheduled|0|||
16426527|NCT02219334|40039459|FG000|Overall Study|Withdrawal by Subject|1|||
16426528|NCT02219334|40039460|FG001|Overall Study|Withdrawal by Subject|0|||
16426529|NCT02219334|40039459|FG000|Overall Study|Protocol Violation|7|||
16426530|NCT02219334|40039460|FG001|Overall Study|Protocol Violation|3|||
16426531|NCT00269633|40039461|FG000|Overall Study|Withdrawal by Subject|1|||
16426532|NCT00269633|40039462|FG001|Overall Study|Withdrawal by Subject|0|||
16426533|NCT00859937|40039467|FG000|Overall Study|Protocol Violation|1|||
16426534|NCT00859937|40039468|FG001|Overall Study|Protocol Violation|0|||
16426535|NCT02097030|40039469|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
16426536|NCT02097030|40039470|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
16426537|NCT02097030|40039469|FG000|First Intervention (3 Days)|Visual Acuity|0|||
16426538|NCT02097030|40039470|FG001|First Intervention (3 Days)|Visual Acuity|1|||
16426539|NCT01055314|40039471|FG000|Overall Study|Adverse Event|7|||
16426540|NCT01055314|40039472|FG001|Overall Study|Adverse Event|4|||
16426541|NCT01055314|40039471|FG000|Overall Study|Death|2|||
16426542|NCT01055314|40039472|FG001|Overall Study|Death|1|||
16426543|NCT01055314|40039471|FG000|Overall Study|Lack of Efficacy|11|||
16426544|NCT01055314|40039472|FG001|Overall Study|Lack of Efficacy|19|||
16426545|NCT01055314|40039471|FG000|Overall Study|Physician Decision|10|||
16426546|NCT01055314|40039472|FG001|Overall Study|Physician Decision|5|||
16426547|NCT01055314|40039471|FG000|Overall Study|Withdrawal by Subject|1|||
16426548|NCT01055314|40039472|FG001|Overall Study|Withdrawal by Subject|0|||
16426549|NCT01055314|40039471|FG000|Overall Study|Ineligible|3|||
16426550|NCT01055314|40039472|FG001|Overall Study|Ineligible|5|||
16426551|NCT01055314|40039471|FG000|Overall Study|Refusal of further protocol therapy|10|||
16426552|NCT01055314|40039472|FG001|Overall Study|Refusal of further protocol therapy|4|||
16426553|NCT01055314|40039471|FG000|Overall Study|No treatment|1|||
16426554|NCT01055314|40039472|FG001|Overall Study|No treatment|0|||
16426555|NCT01363908|40039476|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
16426556|NCT01363908|40039477|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
16426557|NCT01363908|40039476|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
16426558|NCT01363908|40039477|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
16426559|NCT01363908|40039476|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
16426560|NCT01363908|40039477|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
16426561|NCT01363908|40039476|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
16426562|NCT01363908|40039477|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
16426563|NCT03539601|40039482|FG000|Overall Study|Withdraw by parent/guardian|1|||
16426564|NCT03539601|40039483|FG001|Overall Study|Withdraw by parent/guardian|0|||
16426565|NCT03539601|40039484|FG002|Overall Study|Withdraw by parent/guardian|1|||
16426566|NCT03539601|40039485|FG003|Overall Study|Withdraw by parent/guardian|0|||
16426567|NCT03539601|40039482|FG000|Overall Study|Adverse Event|0|||
16426568|NCT03539601|40039483|FG001|Overall Study|Adverse Event|2|||
16426569|NCT03539601|40039484|FG002|Overall Study|Adverse Event|0|||
16426570|NCT03539601|40039485|FG003|Overall Study|Adverse Event|0|||
16426571|NCT03539601|40039482|FG000|Overall Study|Lost to Follow-up|2|||
16426572|NCT03539601|40039483|FG001|Overall Study|Lost to Follow-up|4|||
16426573|NCT03539601|40039484|FG002|Overall Study|Lost to Follow-up|5|||
16426574|NCT03539601|40039485|FG003|Overall Study|Lost to Follow-up|0|||
16562548|NCT00124982|40525430|FG000|Long-term Period|Lost to Follow-up|0|||
16562549|NCT00124982|40525431|FG001|Long-term Period|Lost to Follow-up|0|||
16426575|NCT03539601|40039482|FG000|Overall Study|Withdrawal by Subject|2|||
16426576|NCT03539601|40039483|FG001|Overall Study|Withdrawal by Subject|0|||
16426577|NCT03539601|40039484|FG002|Overall Study|Withdrawal by Subject|0|||
16426578|NCT03539601|40039485|FG003|Overall Study|Withdrawal by Subject|1|||
16426579|NCT03539601|40039482|FG000|Overall Study|Randomized but not treated|1|||
16426580|NCT03539601|40039483|FG001|Overall Study|Randomized but not treated|1|||
16426581|NCT03539601|40039484|FG002|Overall Study|Randomized but not treated|0|||
16426582|NCT03539601|40039485|FG003|Overall Study|Randomized but not treated|0|||
16426583|NCT00741013|40039486|FG000|Overall Study|Adverse Event|1|||
16426584|NCT00741013|40039487|FG001|Overall Study|Adverse Event|0|||
16426585|NCT00741013|40039488|FG002|Overall Study|Adverse Event|0|||
16426586|NCT00741013|40039486|FG000|Overall Study|Withdrawal by Subject|0|||
16426587|NCT00741013|40039487|FG001|Overall Study|Withdrawal by Subject|0|||
16426588|NCT00741013|40039488|FG002|Overall Study|Withdrawal by Subject|1|||
16426589|NCT00741013|40039486|FG000|Overall Study|Discovered failed screen after enrolled|0|||
16426590|NCT00741013|40039487|FG001|Overall Study|Discovered failed screen after enrolled|2|||
16426591|NCT00741013|40039488|FG002|Overall Study|Discovered failed screen after enrolled|0|||
16426592|NCT00842543|40039489|FG000|Overall Study|Withdrawal by Subject|2|||
16426593|NCT00842543|40039490|FG001|Overall Study|Withdrawal by Subject|0|||
16426594|NCT00842543|40039491|FG002|Overall Study|Withdrawal by Subject|3|||
16426595|NCT00842543|40039492|FG003|Overall Study|Withdrawal by Subject|4|||
16426596|NCT02718716|40039504|FG000|Overall Study|Lack of Efficacy|1|||
16426597|NCT02718716|40039505|FG001|Overall Study|Lack of Efficacy|0|||
16426598|NCT02718716|40039506|FG002|Overall Study|Lack of Efficacy|0|||
16426599|NCT02718716|40039507|FG003|Overall Study|Lack of Efficacy|0|||
16426600|NCT02718716|40039508|FG004|Overall Study|Lack of Efficacy|0|||
16426601|NCT02652260|40039509|FG000|Overall Study|Pregnancy|0|||
16426602|NCT02652260|40039510|FG001|Overall Study|Pregnancy|1|||
16426603|NCT02652260|40039509|FG000|Overall Study|Withdrawal by Subject|0|||
16426604|NCT02652260|40039510|FG001|Overall Study|Withdrawal by Subject|1|||
16426605|NCT00646399|40039515|FG000|Overall Study|Death|63|||
16426606|NCT00646399|40039516|FG001|Overall Study|Death|53|||
16426607|NCT00646399|40039515|FG000|Overall Study|Withdrawal by Subject|9|||
16426608|NCT00646399|40039516|FG001|Overall Study|Withdrawal by Subject|10|||
16426609|NCT00646399|40039515|FG000|Overall Study|Other Reason|11|||
16426610|NCT00646399|40039516|FG001|Overall Study|Other Reason|11|||
16426611|NCT01440816|40039517|FG000|Overall Study|Disease Progression|0|||
16426612|NCT01440816|40039518|FG001|Overall Study|Disease Progression|9|||
16426613|NCT01440816|40039517|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
16426614|NCT01440816|40039518|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
16426615|NCT01196026|40039519|FG000|Overall Study|Withdrawal by Subject|1|||
16426616|NCT01196026|40039520|FG001|Overall Study|Withdrawal by Subject|4|||
16426617|NCT01196026|40039521|FG002|Overall Study|Withdrawal by Subject|0|||
16426618|NCT01196026|40039522|FG003|Overall Study|Withdrawal by Subject|0|||
16426619|NCT01196026|40039523|FG004|Overall Study|Withdrawal by Subject|0|||
16426620|NCT01196026|40039524|FG005|Overall Study|Withdrawal by Subject|0|||
16426621|NCT01196026|40039519|FG000|Overall Study|Lost to Follow-up|0|||
16426622|NCT01196026|40039520|FG001|Overall Study|Lost to Follow-up|3|||
16426623|NCT01196026|40039521|FG002|Overall Study|Lost to Follow-up|0|||
16426624|NCT01196026|40039522|FG003|Overall Study|Lost to Follow-up|0|||
16426625|NCT01196026|40039523|FG004|Overall Study|Lost to Follow-up|1|||
16426626|NCT01196026|40039524|FG005|Overall Study|Lost to Follow-up|0|||
16426627|NCT01196026|40039519|FG000|Overall Study|Other|0|||
16426628|NCT01196026|40039520|FG001|Overall Study|Other|1|||
16426629|NCT01196026|40039521|FG002|Overall Study|Other|0|||
16426630|NCT01196026|40039522|FG003|Overall Study|Other|0|||
16426631|NCT01196026|40039523|FG004|Overall Study|Other|0|||
16426632|NCT01196026|40039524|FG005|Overall Study|Other|0|||
16426633|NCT03116685|40039528|FG000|Overall Study|Physician Decision|0|||
16426634|NCT03116685|40039529|FG001|Overall Study|Physician Decision|1|||
16426635|NCT01912339|40039531|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
16426636|NCT01912339|40039532|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
16426637|NCT01912339|40039533|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
16426638|NCT01912339|40039531|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
16426639|NCT01912339|40039532|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
16426640|NCT01912339|40039533|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
16426641|NCT01912339|40039531|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
16426642|NCT01912339|40039532|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
16426643|NCT01912339|40039533|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
16426644|NCT01912339|40039531|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
16426645|NCT01912339|40039532|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
16426646|NCT01912339|40039533|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
16426647|NCT01912339|40039531|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
16426648|NCT01912339|40039532|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
16426649|NCT01912339|40039533|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
16426650|NCT01912339|40039531|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
16426651|NCT01912339|40039532|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
16426652|NCT01912339|40039533|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
16426653|NCT01912339|40039531|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
16426654|NCT01912339|40039532|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
16426655|NCT01912339|40039533|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
16426656|NCT01912339|40039531|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
16249665|NCT01628120|39397895|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
16249666|NCT01628120|39397895|FG000|Overall Study|Non-compliant with Study Procedures|1|||
16249667|NCT01628120|39397895|FG000|Overall Study|Not Treated|3|||
16249668|NCT01628120|39397895|FG000|Overall Study|Sponsor Decision|5|||
16249669|NCT01628120|39397895|FG000|Overall Study|Switched Dialysis Method|2|||
16249670|NCT01628120|39397895|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
16249671|NCT01628120|39397895|FG000|Overall Study|Moved or Relocated|5|||
16249672|NCT01628120|39397895|FG000|Overall Study|Kidney Transplant|2|||
16249673|NCT01628120|39397895|FG000|Overall Study|Use of Standard of Care|1|||
16249674|NCT00696709|39397896|FG000|Overall Study|Withdrawal by Subject|1|||
16249675|NCT00696709|39397897|FG001|Overall Study|Withdrawal by Subject|2|||
16249676|NCT00696709|39397898|FG002|Overall Study|Withdrawal by Subject|1|||
16249677|NCT00696709|39397899|FG003|Overall Study|Withdrawal by Subject|4|||
16249678|NCT00696709|39397900|FG004|Overall Study|Withdrawal by Subject|3|||
16249679|NCT00696709|39397896|FG000|Overall Study|Protocol Violation|1|||
16249680|NCT00696709|39397897|FG001|Overall Study|Protocol Violation|0|||
16249681|NCT00696709|39397898|FG002|Overall Study|Protocol Violation|0|||
16249682|NCT00696709|39397899|FG003|Overall Study|Protocol Violation|0|||
16249683|NCT00696709|39397900|FG004|Overall Study|Protocol Violation|0|||
16249684|NCT00696709|39397896|FG000|Overall Study|Lost to Follow-up|1|||
16249685|NCT00696709|39397897|FG001|Overall Study|Lost to Follow-up|1|||
16249686|NCT00696709|39397898|FG002|Overall Study|Lost to Follow-up|0|||
16249687|NCT00696709|39397899|FG003|Overall Study|Lost to Follow-up|0|||
16249688|NCT00696709|39397900|FG004|Overall Study|Lost to Follow-up|0|||
16249689|NCT00696709|39397896|FG000|Overall Study|Adverse Event|0|||
16249690|NCT00696709|39397897|FG001|Overall Study|Adverse Event|0|||
16249691|NCT00696709|39397898|FG002|Overall Study|Adverse Event|0|||
16249692|NCT00696709|39397899|FG003|Overall Study|Adverse Event|1|||
16249693|NCT00696709|39397900|FG004|Overall Study|Adverse Event|0|||
16249694|NCT01003886|39397902|FG000|Overall Study|Lack of Efficacy|5|||
16249695|NCT01003886|39397902|FG000|Overall Study|Lost to Follow-up|169|||
16249696|NCT01003886|39397902|FG000|Overall Study|Withdrawal by Subject|39|||
16249697|NCT01003886|39397902|FG000|Overall Study|Other|14|||
16249698|NCT01003886|39397902|FG000|Overall Study|Adverse Event|3|||
16249699|NCT01901055|39397905|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
16249700|NCT01901055|39397906|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
16249701|NCT01901055|39397905|FG000|Randomization But Not Titrated|Physician Decision|0|||
16249702|NCT01901055|39397906|FG001|Randomization But Not Titrated|Physician Decision|1|||
16249703|NCT01901055|39397905|FG000|Started Protocol to Week 6|Physician Decision|2|||
16249704|NCT01901055|39397906|FG001|Started Protocol to Week 6|Physician Decision|1|||
16249705|NCT01901055|39397905|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
16249706|NCT01901055|39397906|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
16249707|NCT01901055|39397905|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
16249708|NCT01901055|39397906|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
16249709|NCT01901055|39397905|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
16249710|NCT01901055|39397906|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
16249711|NCT01901055|39397905|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
16249712|NCT01901055|39397906|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
16249713|NCT01901055|39397905|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
16249714|NCT01901055|39397906|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
16249715|NCT01901055|39397905|FG000|Week 24|Withdrawal by Subject|13|||
16249716|NCT01901055|39397906|FG001|Week 24|Withdrawal by Subject|19|||
16249717|NCT01901055|39397905|FG000|Week 24|Physician Decision|1|||
16249718|NCT01901055|39397906|FG001|Week 24|Physician Decision|0|||
16249719|NCT01901055|39397905|FG000|Week 36|Withdrawal by Subject|0|||
16249720|NCT01901055|39397906|FG001|Week 36|Withdrawal by Subject|5|||
16249721|NCT00635778|39397909|FG000|Overall Study|Adverse Event|1|||
16249722|NCT00635778|39397910|FG001|Overall Study|Adverse Event|0|||
16249723|NCT00635778|39397911|FG002|Overall Study|Adverse Event|0|||
16249724|NCT00635778|39397912|FG003|Overall Study|Adverse Event|3|||
16249725|NCT00635778|39397913|FG004|Overall Study|Adverse Event|3|||
16249726|NCT00635778|39397914|FG005|Overall Study|Adverse Event|6|||
16249727|NCT00635778|39397915|FG006|Overall Study|Adverse Event|1|||
16249728|NCT00635778|39397909|FG000|Overall Study|Withdrawal by Subject|0|||
16249729|NCT00635778|39397910|FG001|Overall Study|Withdrawal by Subject|0|||
16249730|NCT00635778|39397911|FG002|Overall Study|Withdrawal by Subject|0|||
16562550|NCT00124982|40525432|FG002|Long-term Period|Lost to Follow-up|4|||
16249731|NCT00635778|39397912|FG003|Overall Study|Withdrawal by Subject|1|||
16249732|NCT00635778|39397913|FG004|Overall Study|Withdrawal by Subject|0|||
16249733|NCT00635778|39397914|FG005|Overall Study|Withdrawal by Subject|1|||
16249734|NCT00635778|39397915|FG006|Overall Study|Withdrawal by Subject|1|||
16249735|NCT00635778|39397909|FG000|Overall Study|Progressive disease|0|||
16249736|NCT00635778|39397910|FG001|Overall Study|Progressive disease|3|||
16249737|NCT00635778|39397911|FG002|Overall Study|Progressive disease|3|||
16426657|NCT01912339|40039532|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
16426658|NCT01912339|40039533|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
16426659|NCT01912339|40039531|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
16426660|NCT01912339|40039532|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
16426661|NCT01912339|40039533|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
16426662|NCT01912339|40039531|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
16426663|NCT01912339|40039532|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
16426664|NCT01912339|40039533|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
16426665|NCT01912339|40039531|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
16426666|NCT01912339|40039532|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
16426667|NCT01912339|40039533|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
16426668|NCT01912339|40039531|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
16426669|NCT01912339|40039532|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
16426670|NCT01912339|40039533|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
16426671|NCT01912339|40039531|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
16426672|NCT01912339|40039532|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
16426673|NCT01912339|40039533|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
16426674|NCT01041287|40039534|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
16426675|NCT01041287|40039535|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
16426676|NCT01041287|40039534|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
16426677|NCT01041287|40039535|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
16426678|NCT02649894|40039536|FG000|Overall Study|Adverse Event|1|||
16360668|NCT03370302|39807500|FG001|Dose Expansion Phase|Progressive Disease|0|||
16360669|NCT03370302|39807501|FG002|Dose Expansion Phase|Progressive Disease|0|||
16360670|NCT03370302|39807502|FG003|Dose Expansion Phase|Progressive Disease|6|||
16360671|NCT03370302|39807503|FG004|Dose Expansion Phase|Progressive Disease|0|||
16360672|NCT03370302|39807504|FG005|Dose Expansion Phase|Progressive Disease|0|||
16360673|NCT03261401|39807505|FG000|Overall Study|Withdrawal by Subject|0|||
16360674|NCT03261401|39807506|FG001|Overall Study|Withdrawal by Subject|0|||
16360675|NCT03261401|39807507|FG002|Overall Study|Withdrawal by Subject|0|||
16360676|NCT03261401|39807508|FG003|Overall Study|Withdrawal by Subject|0|||
16360677|NCT03261401|39807509|FG004|Overall Study|Withdrawal by Subject|0|||
16360678|NCT03261401|39807510|FG005|Overall Study|Withdrawal by Subject|1|||
16360679|NCT03261401|39807511|FG006|Overall Study|Withdrawal by Subject|0|||
16360680|NCT03261401|39807512|FG007|Overall Study|Withdrawal by Subject|0|||
16360681|NCT03261401|39807513|FG008|Overall Study|Withdrawal by Subject|0|||
16360682|NCT03261401|39807514|FG009|Overall Study|Withdrawal by Subject|0|||
16360683|NCT03261401|39807515|FG010|Overall Study|Withdrawal by Subject|0|||
16360684|NCT03261401|39807516|FG011|Overall Study|Withdrawal by Subject|0|||
16360685|NCT03261401|39807517|FG012|Overall Study|Withdrawal by Subject|0|||
16360686|NCT03261401|39807505|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
16360687|NCT03261401|39807506|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
16360688|NCT03261401|39807507|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
16360689|NCT03261401|39807508|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
16360690|NCT03261401|39807509|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
16360691|NCT03261401|39807510|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
16360692|NCT03261401|39807511|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
16360693|NCT03261401|39807512|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
16360694|NCT03261401|39807513|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
16360695|NCT03261401|39807514|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
16360696|NCT03261401|39807515|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
16360697|NCT03261401|39807516|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
16360698|NCT03261401|39807517|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
16360699|NCT00671060|39807518|FG000|Overall Study|Protocol Violation|1|||
16360700|NCT00671060|39807519|FG001|Overall Study|Protocol Violation|0|||
16360701|NCT00671060|39807518|FG000|Overall Study|Physician Decision|0|||
16360702|NCT00671060|39807519|FG001|Overall Study|Physician Decision|1|||
16360703|NCT03530293|39807520|FG000|Pre-randomization|Adverse Event|12|||
16360704|NCT03530293|39807521|FG001|Pre-randomization|Adverse Event|0|||
16360705|NCT03530293|39807522|FG002|Pre-randomization|Adverse Event|0|||
16360706|NCT03530293|39807520|FG000|Pre-randomization|Protocol Violation|2|||
16360707|NCT03530293|39807521|FG001|Pre-randomization|Protocol Violation|0|||
16360708|NCT03530293|39807522|FG002|Pre-randomization|Protocol Violation|0|||
16360709|NCT03530293|39807520|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
16426679|NCT02649894|40039537|FG001|Overall Study|Adverse Event|0|||
16426680|NCT02649894|40039536|FG000|Overall Study|Physician Decision|0|||
16426681|NCT02649894|40039537|FG001|Overall Study|Physician Decision|1|||
16426682|NCT02649894|40039536|FG000|Overall Study|Withdrawal by Subject|5|||
16426683|NCT02649894|40039537|FG001|Overall Study|Withdrawal by Subject|2|||
16426684|NCT02649894|40039536|FG000|Overall Study|Lost to Follow-up|2|||
16426685|NCT02649894|40039537|FG001|Overall Study|Lost to Follow-up|1|||
16426686|NCT02649894|40039536|FG000|Overall Study|Death|30|||
16426687|NCT02649894|40039537|FG001|Overall Study|Death|7|||
16426688|NCT02649894|40039536|FG000|Overall Study|Other, not specified|6|||
16426689|NCT02649894|40039537|FG001|Overall Study|Other, not specified|0|||
16426690|NCT02522325|40039540|FG000|Overall Study|Adverse Event|0|||
16426691|NCT02522325|40039541|FG001|Overall Study|Adverse Event|1|||
16426692|NCT02114606|40039542|FG000|Overall Study|Unable to swallow Cytosponge|6|||
16426693|NCT04599465|40039543|FG000|Overall Study|Physician Decision|1|||
16426694|NCT04599465|40039543|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
16426695|NCT01502228|40039548|FG000|Overall Study|Death|1|||
16426696|NCT02728089|40039549|FG000|Overall Study|Physician Decision|2|||
16426697|NCT02728089|40039549|FG000|Overall Study|Withdrawal by Subject|1|||
16426698|NCT01832155|40039551|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
16426699|NCT01832155|40039552|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
16426700|NCT01832155|40039551|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
16426701|NCT01832155|40039552|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
16426702|NCT00568126|40039555|FG000|Overall Study|Adverse Event|3|||
16426703|NCT00568126|40039556|FG001|Overall Study|Adverse Event|0|||
16426704|NCT00568126|40039555|FG000|Overall Study|Withdrawal by Subject|2|||
16426705|NCT00568126|40039556|FG001|Overall Study|Withdrawal by Subject|3|||
16426706|NCT00568126|40039555|FG000|Overall Study|Lost to Follow-up|4|||
16426707|NCT00568126|40039556|FG001|Overall Study|Lost to Follow-up|3|||
16426708|NCT00568126|40039555|FG000|Overall Study|Lack of Efficacy|0|||
16426709|NCT00568126|40039556|FG001|Overall Study|Lack of Efficacy|1|||
16426710|NCT00568126|40039555|FG000|Overall Study|Physician Decision|2|||
16426711|NCT00568126|40039556|FG001|Overall Study|Physician Decision|2|||
16426712|NCT01380769|40039558|FG000|Overall Study|Withdrawal by Subject|7|||
16426713|NCT01380769|40039559|FG001|Overall Study|Withdrawal by Subject|11|||
16426714|NCT01380769|40039558|FG000|Overall Study|Physician Decision|1|||
16426715|NCT01380769|40039559|FG001|Overall Study|Physician Decision|1|||
16426716|NCT01380769|40039558|FG000|Overall Study|Adverse Event|1|||
16426717|NCT01380769|40039559|FG001|Overall Study|Adverse Event|1|||
16426718|NCT01380769|40039558|FG000|Overall Study|Protocol Violation|0|||
16426719|NCT01380769|40039559|FG001|Overall Study|Protocol Violation|1|||
16426720|NCT00358436|40039560|FG000|Overall Study|Adverse Event|29|||
16426721|NCT00358436|40039561|FG001|Overall Study|Adverse Event|13|||
16426722|NCT00358436|40039560|FG000|Overall Study|Lack of Efficacy|34|||
16426723|NCT00358436|40039561|FG001|Overall Study|Lack of Efficacy|36|||
16426724|NCT00358436|40039560|FG000|Overall Study|Lost to Follow-up|11|||
16426725|NCT00358436|40039561|FG001|Overall Study|Lost to Follow-up|6|||
16426726|NCT00358436|40039560|FG000|Overall Study|Protocol Violation|8|||
16426727|NCT00358436|40039561|FG001|Overall Study|Protocol Violation|3|||
16426728|NCT00358436|40039560|FG000|Overall Study|Withdrawal by Subject|40|||
16426729|NCT00358436|40039561|FG001|Overall Study|Withdrawal by Subject|17|||
16426730|NCT00358436|40039560|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
16426731|NCT00358436|40039561|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
16426732|NCT00358436|40039560|FG000|Overall Study|COPD exacerbation|22|||
16426733|NCT00358436|40039561|FG001|Overall Study|COPD exacerbation|10|||
16426734|NCT00358436|40039560|FG000|Overall Study|Other|6|||
16426735|NCT00358436|40039561|FG001|Overall Study|Other|1|||
16426736|NCT00773747|40039573|FG000|Overall Study|Lack of Efficacy|112|||
16426737|NCT00773747|40039574|FG001|Overall Study|Lack of Efficacy|144|||
16426738|NCT00773747|40039573|FG000|Overall Study|Physician Decision|26|||
16426739|NCT00773747|40039574|FG001|Overall Study|Physician Decision|18|||
16426740|NCT00773747|40039573|FG000|Overall Study|Lost to Follow-up|0|||
16426741|NCT00773747|40039574|FG001|Overall Study|Lost to Follow-up|1|||
16426742|NCT00773747|40039573|FG000|Overall Study|Protocol Violation|2|||
16426743|NCT00773747|40039574|FG001|Overall Study|Protocol Violation|2|||
16426744|NCT00773747|40039573|FG000|Overall Study|Withdrawal by Subject|89|||
16426745|NCT00773747|40039574|FG001|Overall Study|Withdrawal by Subject|61|||
16249738|NCT00635778|39397912|FG003|Overall Study|Progressive disease|4|||
16426746|NCT00773747|40039573|FG000|Overall Study|Adverse Event|61|||
16426747|NCT00773747|40039574|FG001|Overall Study|Adverse Event|62|||
16426748|NCT00773747|40039573|FG000|Overall Study|Death|5|||
16426749|NCT00773747|40039574|FG001|Overall Study|Death|8|||
16426750|NCT00773747|40039573|FG000|Overall Study|Not Treated|2|||
16426751|NCT00773747|40039574|FG001|Overall Study|Not Treated|0|||
16426752|NCT02524158|40039575|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
16426753|NCT02524158|40039576|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
16426754|NCT02524158|40039575|FG000|12-weeks Assessment|Lost to Follow-up|18|||
16426755|NCT02524158|40039576|FG001|12-weeks Assessment|Lost to Follow-up|12|||
16426756|NCT02524158|40039575|FG000|6-month Assessment|Withdrawal by Subject|1|||
16426757|NCT02524158|40039576|FG001|6-month Assessment|Withdrawal by Subject|1|||
16426758|NCT02524158|40039575|FG000|6-month Assessment|Lost to Follow-up|21|||
16426759|NCT02524158|40039576|FG001|6-month Assessment|Lost to Follow-up|20|||
16426760|NCT02279095|40042290|FG000|Overall Study|Non-Compliance|1|||
16426761|NCT02279095|40042290|FG000|Overall Study|Withdrawal by Subject|8|||
16426762|NCT02279095|40042290|FG000|Overall Study|Adverse Event|2|||
16426763|NCT02279095|40042290|FG000|Overall Study|Other|7|||
16426764|NCT02279095|40042290|FG000|Overall Study|Lost to Follow-up|1|||
16426765|NCT01618695|40042293|FG000|Core Phase|Adverse Event|4|||
16426766|NCT01618695|40042294|FG001|Core Phase|Adverse Event|5|||
16426767|NCT01618695|40042295|FG002|Core Phase|Adverse Event|15|||
16426768|NCT01618695|40042296|FG003|Core Phase|Adverse Event|20|||
16426769|NCT01618695|40042293|FG000|Core Phase|Lost to Follow-up|0|||
16426770|NCT01618695|40042294|FG001|Core Phase|Lost to Follow-up|0|||
16426771|NCT01618695|40042295|FG002|Core Phase|Lost to Follow-up|1|||
16426772|NCT01618695|40042296|FG003|Core Phase|Lost to Follow-up|0|||
16426773|NCT01618695|40042293|FG000|Core Phase|Withdrawal by Subject|16|||
16426774|NCT01618695|40042294|FG001|Core Phase|Withdrawal by Subject|11|||
16426775|NCT01618695|40042295|FG002|Core Phase|Withdrawal by Subject|9|||
16426776|NCT01618695|40042296|FG003|Core Phase|Withdrawal by Subject|13|||
16426777|NCT01618695|40042293|FG000|Core Phase|Pregnancy|2|||
16426778|NCT01618695|40042294|FG001|Core Phase|Pregnancy|0|||
16426779|NCT01618695|40042295|FG002|Core Phase|Pregnancy|0|||
16426780|NCT01618695|40042296|FG003|Core Phase|Pregnancy|0|||
16426781|NCT01618695|40042293|FG000|Core Phase|Lack of Efficacy|1|||
16426782|NCT01618695|40042294|FG001|Core Phase|Lack of Efficacy|2|||
16426783|NCT01618695|40042295|FG002|Core Phase|Lack of Efficacy|1|||
16426784|NCT01618695|40042296|FG003|Core Phase|Lack of Efficacy|1|||
16426785|NCT01618695|40042293|FG000|Core Phase|Other than specified|1|||
16426786|NCT01618695|40042294|FG001|Core Phase|Other than specified|2|||
16426787|NCT01618695|40042295|FG002|Core Phase|Other than specified|2|||
16426788|NCT01618695|40042296|FG003|Core Phase|Other than specified|2|||
16426789|NCT01618695|40042293|FG000|Core Phase|Not treated|1|||
16426790|NCT01618695|40042294|FG001|Core Phase|Not treated|0|||
16426791|NCT01618695|40042295|FG002|Core Phase|Not treated|2|||
16426792|NCT01618695|40042296|FG003|Core Phase|Not treated|0|||
16426793|NCT01618695|40042293|FG000|Extension Phase|Lack of Efficacy|17|||
16426794|NCT01618695|40042294|FG001|Extension Phase|Lack of Efficacy|33|||
16426795|NCT01618695|40042295|FG002|Extension Phase|Lack of Efficacy|26|||
16426796|NCT01618695|40042296|FG003|Extension Phase|Lack of Efficacy|24|||
16426797|NCT01618695|40042293|FG000|Extension Phase|Pregnancy|2|||
16426798|NCT01618695|40042294|FG001|Extension Phase|Pregnancy|0|||
16426799|NCT01618695|40042295|FG002|Extension Phase|Pregnancy|1|||
16426800|NCT01618695|40042296|FG003|Extension Phase|Pregnancy|1|||
16426801|NCT01618695|40042293|FG000|Extension Phase|Withdrawal by Subject|43|||
16426802|NCT01618695|40042294|FG001|Extension Phase|Withdrawal by Subject|48|||
16426803|NCT01618695|40042295|FG002|Extension Phase|Withdrawal by Subject|42|||
16426804|NCT01618695|40042296|FG003|Extension Phase|Withdrawal by Subject|33|||
16426805|NCT01618695|40042293|FG000|Extension Phase|Adverse Event|18|||
16426806|NCT01618695|40042294|FG001|Extension Phase|Adverse Event|16|||
16426807|NCT01618695|40042295|FG002|Extension Phase|Adverse Event|9|||
16426808|NCT01618695|40042296|FG003|Extension Phase|Adverse Event|20|||
16426809|NCT01618695|40042293|FG000|Extension Phase|Lost to Follow-up|2|||
16426810|NCT01618695|40042294|FG001|Extension Phase|Lost to Follow-up|1|||
16426811|NCT01618695|40042295|FG002|Extension Phase|Lost to Follow-up|1|||
16426812|NCT01618695|40042296|FG003|Extension Phase|Lost to Follow-up|1|||
16426813|NCT01618695|40042293|FG000|Extension Phase|Other than specified|13|||
16426814|NCT01618695|40042294|FG001|Extension Phase|Other than specified|18|||
16426815|NCT01618695|40042295|FG002|Extension Phase|Other than specified|13|||
16426816|NCT01618695|40042296|FG003|Extension Phase|Other than specified|18|||
16249739|NCT00635778|39397913|FG004|Overall Study|Progressive disease|5|||
16426817|NCT01871519|40042298|FG000|Overall Study|Death|26|||
16426818|NCT01871519|40042298|FG000|Overall Study|Lost to Follow-up|15|||
16426819|NCT01871519|40042298|FG000|Overall Study|Withdrawal by Subject|49|||
16426820|NCT01858766|40042299|FG000|Overall Study|Randomized but Never Treated|0|||
16426821|NCT01858766|40042300|FG001|Overall Study|Randomized but Never Treated|0|||
16426822|NCT01858766|40042301|FG002|Overall Study|Randomized but Never Treated|0|||
16426823|NCT01858766|40042302|FG003|Overall Study|Randomized but Never Treated|0|||
16426824|NCT01858766|40042303|FG004|Overall Study|Randomized but Never Treated|0|||
16426825|NCT01858766|40042304|FG005|Overall Study|Randomized but Never Treated|1|||
16426826|NCT01858766|40042305|FG006|Overall Study|Randomized but Never Treated|0|||
16426827|NCT01858766|40042306|FG007|Overall Study|Randomized but Never Treated|0|||
16131017|NCT00969709|38967183|FG002|Overall Study|Withdrawal by Subject|11|||
16249740|NCT00635778|39397914|FG005|Overall Study|Progressive disease|14|||
16249741|NCT00635778|39397915|FG006|Overall Study|Progressive disease|4|||
16249742|NCT01387282|39397922|FG000|Overall Study|Death|47|||
16249743|NCT01387282|39397923|FG001|Overall Study|Death|16|||
16249744|NCT01387282|39397922|FG000|Overall Study|Other|5|||
16249745|NCT01387282|39397923|FG001|Overall Study|Other|1|||
16249746|NCT01387282|39397922|FG000|Overall Study|Unrelated AE|6|||
16249747|NCT01387282|39397923|FG001|Overall Study|Unrelated AE|4|||
16249748|NCT01387282|39397922|FG000|Overall Study|Withdrawal by patient|33|||
16249749|NCT01387282|39397923|FG001|Overall Study|Withdrawal by patient|23|||
16249750|NCT01387282|39397922|FG000|Overall Study|Study drug-related AE|2|||
16249751|NCT01387282|39397923|FG001|Overall Study|Study drug-related AE|2|||
16249752|NCT01387282|39397922|FG000|Overall Study|Lost to Follow-up|4|||
16249753|NCT01387282|39397923|FG001|Overall Study|Lost to Follow-up|1|||
16249754|NCT02006706|39397924|FG000|Overall Study|Lost to Follow-up|1|||
16249755|NCT00619385|39397925|FG000|Overall Study|Adverse Event|0|||
16131018|NCT00969709|38967184|FG003|Overall Study|Withdrawal by Subject|23|||
16249756|NCT00619385|39397926|FG001|Overall Study|Adverse Event|0|||
16426828|NCT01858766|40042307|FG008|Overall Study|Randomized but Never Treated|0|||
16426829|NCT01858766|40042308|FG009|Overall Study|Randomized but Never Treated|0|||
16426830|NCT01858766|40042309|FG010|Overall Study|Randomized but Never Treated|0|||
16426831|NCT01858766|40042310|FG011|Overall Study|Randomized but Never Treated|0|||
16426832|NCT01858766|40042311|FG012|Overall Study|Randomized but Never Treated|0|||
16426833|NCT01858766|40042312|FG013|Overall Study|Randomized but Never Treated|0|||
16426834|NCT01858766|40042313|FG014|Overall Study|Randomized but Never Treated|0|||
16426835|NCT01858766|40042314|FG015|Overall Study|Randomized but Never Treated|0|||
16426836|NCT01858766|40042315|FG016|Overall Study|Randomized but Never Treated|0|||
16426837|NCT01858766|40042316|FG017|Overall Study|Randomized but Never Treated|1|||
16426838|NCT01858766|40042317|FG018|Overall Study|Randomized but Never Treated|0|||
16426839|NCT01858766|40042299|FG000|Overall Study|Death|0|||
16426840|NCT01858766|40042300|FG001|Overall Study|Death|0|||
16426841|NCT01858766|40042301|FG002|Overall Study|Death|1|||
16426842|NCT01858766|40042302|FG003|Overall Study|Death|0|||
16426843|NCT01858766|40042303|FG004|Overall Study|Death|0|||
16426844|NCT01858766|40042304|FG005|Overall Study|Death|0|||
16426845|NCT01858766|40042305|FG006|Overall Study|Death|0|||
16426846|NCT01858766|40042306|FG007|Overall Study|Death|0|||
16426847|NCT01858766|40042307|FG008|Overall Study|Death|0|||
16426848|NCT01858766|40042308|FG009|Overall Study|Death|0|||
16426849|NCT01858766|40042309|FG010|Overall Study|Death|0|||
16426850|NCT01858766|40042310|FG011|Overall Study|Death|0|||
16426851|NCT01858766|40042311|FG012|Overall Study|Death|0|||
16426852|NCT01858766|40042312|FG013|Overall Study|Death|0|||
16426853|NCT01858766|40042313|FG014|Overall Study|Death|0|||
16426854|NCT01858766|40042314|FG015|Overall Study|Death|0|||
16426855|NCT01858766|40042315|FG016|Overall Study|Death|0|||
16426856|NCT01858766|40042316|FG017|Overall Study|Death|0|||
16426857|NCT01858766|40042317|FG018|Overall Study|Death|0|||
16426858|NCT01858766|40042299|FG000|Overall Study|Lack of Efficacy|1|||
16426859|NCT01858766|40042300|FG001|Overall Study|Lack of Efficacy|0|||
16426860|NCT01858766|40042301|FG002|Overall Study|Lack of Efficacy|0|||
16426861|NCT01858766|40042302|FG003|Overall Study|Lack of Efficacy|0|||
16426862|NCT01858766|40042303|FG004|Overall Study|Lack of Efficacy|1|||
16426863|NCT01858766|40042304|FG005|Overall Study|Lack of Efficacy|2|||
16426864|NCT01858766|40042305|FG006|Overall Study|Lack of Efficacy|0|||
16426865|NCT01858766|40042306|FG007|Overall Study|Lack of Efficacy|0|||
16426866|NCT01858766|40042307|FG008|Overall Study|Lack of Efficacy|0|||
16426867|NCT01858766|40042308|FG009|Overall Study|Lack of Efficacy|0|||
16426868|NCT01858766|40042309|FG010|Overall Study|Lack of Efficacy|0|||
16426869|NCT01858766|40042310|FG011|Overall Study|Lack of Efficacy|3|||
16426870|NCT01858766|40042311|FG012|Overall Study|Lack of Efficacy|5|||
16426871|NCT01858766|40042312|FG013|Overall Study|Lack of Efficacy|3|||
16426872|NCT01858766|40042313|FG014|Overall Study|Lack of Efficacy|5|||
16426873|NCT01858766|40042314|FG015|Overall Study|Lack of Efficacy|5|||
16426874|NCT01858766|40042315|FG016|Overall Study|Lack of Efficacy|2|||
16426875|NCT01858766|40042316|FG017|Overall Study|Lack of Efficacy|3|||
16426876|NCT01858766|40042317|FG018|Overall Study|Lack of Efficacy|3|||
16426877|NCT01858766|40042299|FG000|Overall Study|Lost to Follow-up|0|||
16426878|NCT01858766|40042300|FG001|Overall Study|Lost to Follow-up|0|||
16426879|NCT01858766|40042301|FG002|Overall Study|Lost to Follow-up|0|||
16426880|NCT01858766|40042302|FG003|Overall Study|Lost to Follow-up|0|||
16426881|NCT01858766|40042303|FG004|Overall Study|Lost to Follow-up|0|||
16426882|NCT01858766|40042304|FG005|Overall Study|Lost to Follow-up|1|||
16426883|NCT01858766|40042305|FG006|Overall Study|Lost to Follow-up|0|||
16426884|NCT01858766|40042306|FG007|Overall Study|Lost to Follow-up|2|||
16426885|NCT01858766|40042307|FG008|Overall Study|Lost to Follow-up|0|||
16426886|NCT01858766|40042308|FG009|Overall Study|Lost to Follow-up|0|||
16426887|NCT01858766|40042309|FG010|Overall Study|Lost to Follow-up|0|||
16426888|NCT01858766|40042310|FG011|Overall Study|Lost to Follow-up|1|||
16426889|NCT01858766|40042311|FG012|Overall Study|Lost to Follow-up|0|||
16426890|NCT01858766|40042312|FG013|Overall Study|Lost to Follow-up|0|||
16426891|NCT01858766|40042313|FG014|Overall Study|Lost to Follow-up|3|||
16426892|NCT01858766|40042314|FG015|Overall Study|Lost to Follow-up|1|||
16426893|NCT01858766|40042315|FG016|Overall Study|Lost to Follow-up|1|||
16426894|NCT01858766|40042316|FG017|Overall Study|Lost to Follow-up|0|||
16426895|NCT01858766|40042317|FG018|Overall Study|Lost to Follow-up|1|||
16426896|NCT01858766|40042299|FG000|Overall Study|Withdrew Consent|0|||
16426897|NCT01858766|40042300|FG001|Overall Study|Withdrew Consent|0|||
16426898|NCT01858766|40042301|FG002|Overall Study|Withdrew Consent|0|||
16426899|NCT01858766|40042302|FG003|Overall Study|Withdrew Consent|0|||
16426900|NCT01858766|40042303|FG004|Overall Study|Withdrew Consent|0|||
16426901|NCT01858766|40042304|FG005|Overall Study|Withdrew Consent|0|||
16426902|NCT01858766|40042305|FG006|Overall Study|Withdrew Consent|0|||
16426903|NCT01858766|40042306|FG007|Overall Study|Withdrew Consent|0|||
16426904|NCT01858766|40042307|FG008|Overall Study|Withdrew Consent|0|||
16426905|NCT01858766|40042308|FG009|Overall Study|Withdrew Consent|0|||
16426906|NCT01858766|40042309|FG010|Overall Study|Withdrew Consent|0|||
16426907|NCT01858766|40042310|FG011|Overall Study|Withdrew Consent|1|||
16426908|NCT01858766|40042311|FG012|Overall Study|Withdrew Consent|0|||
16426909|NCT01858766|40042312|FG013|Overall Study|Withdrew Consent|0|||
16426910|NCT01858766|40042313|FG014|Overall Study|Withdrew Consent|0|||
16426911|NCT01858766|40042314|FG015|Overall Study|Withdrew Consent|0|||
16426912|NCT01858766|40042315|FG016|Overall Study|Withdrew Consent|0|||
16426913|NCT01858766|40042316|FG017|Overall Study|Withdrew Consent|0|||
16426914|NCT01858766|40042317|FG018|Overall Study|Withdrew Consent|0|||
16426915|NCT00765063|40042318|FG000|Overall Study|Lack of Efficacy|5|||
16426916|NCT00765063|40042318|FG000|Overall Study|Withdrawal by Subject|1|||
16426917|NCT00765063|40042318|FG000|Overall Study|Other|16|||
16426918|NCT00765063|40042318|FG000|Overall Study|Protocol Violation|6|||
16426919|NCT00765063|40042318|FG000|Overall Study|Adverse Event|4|||
16426920|NCT00528801|40042321|FG000|Overall Study|Withdrawal by Subject|1|||
16426921|NCT00528801|40042322|FG001|Overall Study|Withdrawal by Subject|1|||
16426922|NCT00528801|40042321|FG000|Overall Study|Protocol Violation|11|||
16426923|NCT00528801|40042322|FG001|Overall Study|Protocol Violation|5|||
16426924|NCT00528801|40042321|FG000|Overall Study|Lost to Follow-up|15|||
16426925|NCT00528801|40042322|FG001|Overall Study|Lost to Follow-up|4|||
16426926|NCT00528801|40042321|FG000|Overall Study|Administrative Reasons|0|||
16426927|NCT00528801|40042322|FG001|Overall Study|Administrative Reasons|1|||
16426928|NCT00622505|40042323|FG000|Overall Study|Adverse Event|9|||
16426929|NCT00622505|40042324|FG001|Overall Study|Adverse Event|7|||
16426930|NCT00622505|40042323|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
16426931|NCT00622505|40042324|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
16426932|NCT00622505|40042323|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
16426933|NCT00622505|40042324|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
16249757|NCT00619385|39397927|FG002|Overall Study|Adverse Event|3|||
16249758|NCT00619385|39397925|FG000|Overall Study|Other|1|||
16249759|NCT00619385|39397926|FG001|Overall Study|Other|2|||
16249760|NCT00619385|39397927|FG002|Overall Study|Other|1|||
16249761|NCT00182091|39397929|FG000|Overall Study|Withdrawal by Subject|1|||
16249762|NCT00182091|39397930|FG001|Overall Study|Withdrawal by Subject|0|||
16249763|NCT00182091|39397931|FG002|Overall Study|Withdrawal by Subject|0|||
16249764|NCT00182091|39397932|FG003|Overall Study|Withdrawal by Subject|0|||
16249765|NCT01341639|39397939|FG000|Infant Series|Protocol Violation|1|||
16249766|NCT01341639|39397940|FG001|Infant Series|Protocol Violation|0|||
16249767|NCT01341639|39397939|FG000|Infant Series|Not Vaccinated|0|||
16249768|NCT01341639|39397940|FG001|Infant Series|Not Vaccinated|1|||
16249769|NCT01341639|39397939|FG000|Infant Series|Adverse Event|0|||
16249770|NCT01341639|39397940|FG001|Infant Series|Adverse Event|5|||
16249771|NCT01341639|39397939|FG000|Infant Series|Withdrawal by Subject|11|||
16249772|NCT01341639|39397940|FG001|Infant Series|Withdrawal by Subject|8|||
16426934|NCT00622505|40042323|FG000|Overall Study|Withdrawal by Subject|12|||
16426935|NCT00622505|40042324|FG001|Overall Study|Withdrawal by Subject|5|||
16426936|NCT00622505|40042323|FG000|Overall Study|Administrative Problems|2|||
16426937|NCT00622505|40042324|FG001|Overall Study|Administrative Problems|4|||
16426938|NCT00622505|40042323|FG000|Overall Study|Death|2|||
16426939|NCT00622505|40042324|FG001|Overall Study|Death|2|||
16249773|NCT01341639|39397939|FG000|Infant Series|Lost to Follow-up|0|||
16249774|NCT01341639|39397940|FG001|Infant Series|Lost to Follow-up|2|||
16249775|NCT01341639|39397939|FG000|Infant Series|Site 0048 Participants|17|||
16249776|NCT01341639|39397940|FG001|Infant Series|Site 0048 Participants|16|||
16249777|NCT01341639|39397939|FG000|Interim Period|Withdrawal by Subject|6|||
16249778|NCT01341639|39397940|FG001|Interim Period|Withdrawal by Subject|7|||
16249779|NCT01341639|39397939|FG000|Interim Period|Lost to Follow-up|2|||
16249780|NCT01341639|39397940|FG001|Interim Period|Lost to Follow-up|0|||
16249781|NCT01341639|39397939|FG000|Interim Period|Physician Decision|0|||
16249782|NCT01341639|39397940|FG001|Interim Period|Physician Decision|1|||
16249783|NCT01341639|39397939|FG000|Interim Period|Protocol Violation|0|||
16249784|NCT01341639|39397940|FG001|Interim Period|Protocol Violation|1|||
16249785|NCT01341639|39397939|FG000|Post-Treatment|Withdrawal by Subject|0|||
16426940|NCT01450098|40042325|FG000|Period 3|Protocol Violation|0|||
16426941|NCT01450098|40042326|FG001|Period 3|Protocol Violation|1|||
16426942|NCT01450098|40042325|FG000|Period 3|Withdrawal by Subject|0|||
16426943|NCT01450098|40042326|FG001|Period 3|Withdrawal by Subject|2|||
16426944|NCT04034927|40042327|FG000|Overall Study|Adverse Event|4|||
16426945|NCT04034927|40042328|FG001|Overall Study|Adverse Event|9|||
16426946|NCT04034927|40042327|FG000|Overall Study|Death|0|||
16249786|NCT01341639|39397940|FG001|Post-Treatment|Withdrawal by Subject|1|||
16249787|NCT01341639|39397939|FG000|Post-Treatment|Adverse Event|0|||
16249788|NCT01341639|39397940|FG001|Post-Treatment|Adverse Event|2|||
16426947|NCT04034927|40042328|FG001|Overall Study|Death|1|||
16426948|NCT04034927|40042327|FG000|Overall Study|Withdrawal by Subject|0|||
16426949|NCT04034927|40042328|FG001|Overall Study|Withdrawal by Subject|3|||
16426950|NCT04034927|40042327|FG000|Overall Study|Still on Treatment|2|||
16426951|NCT04034927|40042328|FG001|Overall Study|Still on Treatment|1|||
16426952|NCT04034927|40042327|FG000|Overall Study|Other|1|||
16426953|NCT04034927|40042328|FG001|Overall Study|Other|1|||
16426954|NCT00719355|40042329|FG000|Overall Study|Death|0|||
16426955|NCT00719355|40042330|FG001|Overall Study|Death|1|||
16426956|NCT00719355|40042329|FG000|Overall Study|Medical|14|||
16426957|NCT00719355|40042330|FG001|Overall Study|Medical|5|||
16426958|NCT00719355|40042329|FG000|Overall Study|Compliance|4|||
16426959|NCT00719355|40042330|FG001|Overall Study|Compliance|6|||
16426960|NCT00719355|40042329|FG000|Overall Study|Moved|0|||
16426961|NCT00719355|40042330|FG001|Overall Study|Moved|1|||
16426962|NCT01702246|40042333|FG000|Overall Study|Lost to Follow-up|2|||
16426963|NCT01702246|40042333|FG000|Overall Study|Withdrawal by Subject|2|||
16426964|NCT01702246|40042333|FG000|Overall Study|Physician Decision|1|||
16426965|NCT03710642|40042334|FG000|Overall Study|Adverse Event|5|||
16426966|NCT03710642|40042335|FG001|Overall Study|Adverse Event|1|||
16426967|NCT03710642|40042334|FG000|Overall Study|non-site physician recommendation|1|||
16426968|NCT03710642|40042335|FG001|Overall Study|non-site physician recommendation|0|||
16426969|NCT03710642|40042334|FG000|Overall Study|Participant unwilling or unable to participate|1|||
16426970|NCT03710642|40042335|FG001|Overall Study|Participant unwilling or unable to participate|1|||
16426971|NCT03710642|40042334|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
16426972|NCT03710642|40042335|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
16426973|NCT03710642|40042334|FG000|Overall Study|NA-no code provided|1|||
16426974|NCT03710642|40042335|FG001|Overall Study|NA-no code provided|0|||
16426975|NCT03710642|40042334|FG000|Overall Study|Withdrawal by Subject|1|||
16426976|NCT03710642|40042335|FG001|Overall Study|Withdrawal by Subject|0|||
16426977|NCT00720343|40042336|FG000|Overall Study|Lost to Follow-up|1|||
16426978|NCT00720343|40042337|FG001|Overall Study|Lost to Follow-up|0|||
16426979|NCT00720343|40042336|FG000|Overall Study|Protocol Violation|0|||
16426980|NCT00720343|40042337|FG001|Overall Study|Protocol Violation|2|||
16426981|NCT01858740|40042338|FG000|Overall Study|Death|4|||
16426982|NCT01067144|40042339|FG000|Treatment|Did not receive allocated intervention|4|||
16426983|NCT01067144|40042340|FG001|Treatment|Did not receive allocated intervention|7|||
16426984|NCT01067144|40042339|FG000|Follow-up|Lost to Follow-up|22|||
16426985|NCT01067144|40042340|FG001|Follow-up|Lost to Follow-up|12|||
16426986|NCT01067144|40042339|FG000|Follow-up|Censored owing to second surgery|19|||
16426987|NCT01067144|40042340|FG001|Follow-up|Censored owing to second surgery|28|||
16426988|NCT01067144|40042339|FG000|Follow-up|Withdrawal by Subject|18|||
16426989|NCT01067144|40042340|FG001|Follow-up|Withdrawal by Subject|14|||
16426990|NCT01067144|40042339|FG000|Follow-up|Surgery cancelled|0|||
16426991|NCT01067144|40042340|FG001|Follow-up|Surgery cancelled|1|||
16426992|NCT01067144|40042339|FG000|Follow-up|Death|0|||
16426993|NCT01067144|40042340|FG001|Follow-up|Death|1|||
16426994|NCT03543137|40042343|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
16426995|NCT03543137|40042344|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
16426996|NCT03543137|40042343|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
16426997|NCT03543137|40042344|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
16426998|NCT03543137|40042343|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
16426999|NCT03543137|40042344|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
16427000|NCT01843023|40042345|FG000|Overall Study|Death|1|||
16427001|NCT01843023|40042346|FG001|Overall Study|Death|0|||
16427002|NCT01843023|40042345|FG000|Overall Study|Lost to Follow-up|24|||
16427003|NCT01843023|40042346|FG001|Overall Study|Lost to Follow-up|29|||
16427004|NCT01843023|40042345|FG000|Overall Study|Withdrawal by Subject|8|||
16427005|NCT01843023|40042346|FG001|Overall Study|Withdrawal by Subject|6|||
16427006|NCT02717494|40042347|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
16427007|NCT02717494|40042348|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
16427008|NCT02717494|40042349|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
16427009|NCT02717494|40042347|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
16427010|NCT02717494|40042348|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
16427011|NCT02717494|40042349|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
16427012|NCT02717494|40042347|FG000|First Intervention (Step 1)|Death|0|||
16427013|NCT02717494|40042348|FG001|First Intervention (Step 1)|Death|0|||
16427014|NCT02717494|40042349|FG002|First Intervention (Step 1)|Death|1|||
16427015|NCT02717494|40042347|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
16427016|NCT02717494|40042348|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
16427017|NCT02717494|40042349|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
16427018|NCT00086047|40042350|FG000|Overall Study|Lost to Follow-up|7|||
16427019|NCT00086047|40042351|FG001|Overall Study|Lost to Follow-up|6|||
16427020|NCT00086047|40042350|FG000|Overall Study|Physician Decision|0|||
16427021|NCT00086047|40042351|FG001|Overall Study|Physician Decision|1|||
16427022|NCT00887926|40042356|FG000|Overall Study|Withdrawal by Subject|0|||
16427023|NCT00887926|40042357|FG001|Overall Study|Withdrawal by Subject|1|||
16427024|NCT00887926|40042358|FG002|Overall Study|Withdrawal by Subject|0|||
16427025|NCT00887926|40042359|FG003|Overall Study|Withdrawal by Subject|0|||
16427026|NCT01395901|40042364|FG000|Overall Study|Lost to Follow-up|4|||
16427027|NCT01395901|40042365|FG001|Overall Study|Lost to Follow-up|0|||
16427028|NCT01395901|40042364|FG000|Overall Study|Randomized but not received study drug|5|||
16562551|NCT00124982|40525430|FG000|Long-term Period|Withdrawal by Subject|0|||
16427029|NCT01395901|40042365|FG001|Overall Study|Randomized but not received study drug|4|||
16427030|NCT01395901|40042364|FG000|Overall Study|Adverse Event|0|||
16427031|NCT01395901|40042365|FG001|Overall Study|Adverse Event|1|||
16427032|NCT01395901|40042364|FG000|Overall Study|Withdrawal of consent|1|||
16427033|NCT01395901|40042365|FG001|Overall Study|Withdrawal of consent|0|||
16427034|NCT00713544|40042366|FG000|Overall Study|Adverse Event|5|||
16427035|NCT00713544|40042367|FG001|Overall Study|Adverse Event|3|||
16427036|NCT00713544|40042368|FG002|Overall Study|Adverse Event|7|||
16427037|NCT00713544|40042369|FG003|Overall Study|Adverse Event|7|||
16427038|NCT00713544|40042370|FG004|Overall Study|Adverse Event|3|||
16427039|NCT00713544|40042371|FG005|Overall Study|Adverse Event|5|||
16427040|NCT00713544|40042366|FG000|Overall Study|Withdrawal by Subject|2|||
16427041|NCT00713544|40042367|FG001|Overall Study|Withdrawal by Subject|0|||
16427042|NCT00713544|40042368|FG002|Overall Study|Withdrawal by Subject|3|||
16427043|NCT00713544|40042369|FG003|Overall Study|Withdrawal by Subject|2|||
16427044|NCT00713544|40042370|FG004|Overall Study|Withdrawal by Subject|3|||
16427045|NCT00713544|40042371|FG005|Overall Study|Withdrawal by Subject|1|||
16427046|NCT00713544|40042366|FG000|Overall Study|Protocol Violation|0|||
16427047|NCT00713544|40042367|FG001|Overall Study|Protocol Violation|0|||
16427048|NCT00713544|40042368|FG002|Overall Study|Protocol Violation|0|||
16427049|NCT00713544|40042369|FG003|Overall Study|Protocol Violation|0|||
16427050|NCT00713544|40042370|FG004|Overall Study|Protocol Violation|0|||
16427051|NCT00713544|40042371|FG005|Overall Study|Protocol Violation|1|||
16427052|NCT00713544|40042366|FG000|Overall Study|Physician Decision|0|||
16427053|NCT00713544|40042367|FG001|Overall Study|Physician Decision|0|||
16427054|NCT00713544|40042368|FG002|Overall Study|Physician Decision|0|||
16427055|NCT00713544|40042369|FG003|Overall Study|Physician Decision|0|||
16427056|NCT00713544|40042370|FG004|Overall Study|Physician Decision|0|||
16427057|NCT00713544|40042371|FG005|Overall Study|Physician Decision|2|||
16427058|NCT00713544|40042366|FG000|Overall Study|Lack of Efficacy|0|||
16427059|NCT00713544|40042367|FG001|Overall Study|Lack of Efficacy|1|||
16427060|NCT00713544|40042368|FG002|Overall Study|Lack of Efficacy|0|||
16427061|NCT00713544|40042369|FG003|Overall Study|Lack of Efficacy|1|||
16427062|NCT00713544|40042370|FG004|Overall Study|Lack of Efficacy|1|||
16427063|NCT00713544|40042371|FG005|Overall Study|Lack of Efficacy|0|||
16427064|NCT00713544|40042366|FG000|Overall Study|Lost to Follow-up|0|||
16427065|NCT00713544|40042367|FG001|Overall Study|Lost to Follow-up|0|||
16427066|NCT00713544|40042368|FG002|Overall Study|Lost to Follow-up|1|||
16427067|NCT00713544|40042369|FG003|Overall Study|Lost to Follow-up|0|||
16427068|NCT00713544|40042370|FG004|Overall Study|Lost to Follow-up|0|||
16427069|NCT00713544|40042371|FG005|Overall Study|Lost to Follow-up|0|||
16427070|NCT00713544|40042366|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
16427071|NCT00713544|40042367|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
16427072|NCT00713544|40042368|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
16427073|NCT00713544|40042369|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
16427074|NCT00713544|40042370|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
16427075|NCT00713544|40042371|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
16427076|NCT00713544|40042366|FG000|Overall Study|Incorrect enrollment|0|||
16427077|NCT00713544|40042367|FG001|Overall Study|Incorrect enrollment|1|||
16427078|NCT00713544|40042368|FG002|Overall Study|Incorrect enrollment|0|||
16427079|NCT00713544|40042369|FG003|Overall Study|Incorrect enrollment|0|||
16427080|NCT00713544|40042370|FG004|Overall Study|Incorrect enrollment|0|||
16427081|NCT00713544|40042371|FG005|Overall Study|Incorrect enrollment|0|||
16427082|NCT00713544|40042366|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
16427083|NCT00713544|40042367|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
16427084|NCT00713544|40042368|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
16427085|NCT00713544|40042369|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
16427086|NCT00713544|40042370|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
16427087|NCT00713544|40042371|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
16249789|NCT01992107|39397942|FG000|Overall Study|Administrative reasons|2|||
16427088|NCT02598297|40042372|FG000|Overall Study|Study terminated by Sponsor|21|||
16427089|NCT02598297|40042373|FG001|Overall Study|Study terminated by Sponsor|23|||
16427090|NCT02598297|40042372|FG000|Overall Study|Adverse Event|1|||
16427091|NCT02598297|40042373|FG001|Overall Study|Adverse Event|1|||
16427092|NCT02598297|40042372|FG000|Overall Study|Physician Decision|1|||
16427093|NCT02598297|40042373|FG001|Overall Study|Physician Decision|0|||
16427094|NCT02598297|40042372|FG000|Overall Study|Subject/guardian decision|1|||
16427095|NCT02598297|40042373|FG001|Overall Study|Subject/guardian decision|0|||
16249790|NCT01992107|39397943|FG001|Overall Study|Administrative reasons|0|||
16249791|NCT01992107|39397944|FG002|Overall Study|Administrative reasons|0|||
16249792|NCT01992107|39397942|FG000|Overall Study|Adverse Event|0|||
16249793|NCT01992107|39397943|FG001|Overall Study|Adverse Event|1|||
16249794|NCT01992107|39397944|FG002|Overall Study|Adverse Event|0|||
16360710|NCT03530293|39807521|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
16360711|NCT03530293|39807522|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
16360712|NCT03530293|39807520|FG000|Pre-randomization|Withdrawal by Subject|5|||
16360713|NCT03530293|39807521|FG001|Pre-randomization|Withdrawal by Subject|0|||
16360714|NCT03530293|39807522|FG002|Pre-randomization|Withdrawal by Subject|0|||
16360715|NCT03530293|39807520|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
16360716|NCT03530293|39807521|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
16360717|NCT03530293|39807522|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
16360718|NCT03530293|39807520|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
16360719|NCT03530293|39807521|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
16360720|NCT03530293|39807522|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
16360721|NCT03530293|39807520|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
16360722|NCT03530293|39807521|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
16360723|NCT03530293|39807522|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
16360724|NCT03530293|39807520|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
16360725|NCT03530293|39807521|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
16360726|NCT03530293|39807522|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
16360727|NCT03530293|39807520|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
16360728|NCT03530293|39807521|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
16360729|NCT03530293|39807522|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
16360730|NCT00634504|39807526|FG000|Overall Study|Protocol Violation|1|||
16360731|NCT00634504|39807527|FG001|Overall Study|Protocol Violation|0|||
16360732|NCT01925417|39807529|FG000|Overall Study|Withdrawal by Subject|2|||
16360733|NCT01925417|39807529|FG000|Overall Study|Death|1|||
16360734|NCT03415178|39807534|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
16360735|NCT03415178|39807535|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
16360736|NCT03415178|39807534|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
16360737|NCT03415178|39807535|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
16360738|NCT00587457|39807536|FG000|Overall Study|Adverse Event|1|||
16360739|NCT00587457|39807537|FG001|Overall Study|Adverse Event|2|||
16562552|NCT00124982|40525431|FG001|Long-term Period|Withdrawal by Subject|0|||
16562553|NCT00124982|40525432|FG002|Long-term Period|Withdrawal by Subject|16|||
16562554|NCT00124982|40525430|FG000|Long-term Period|Pregnancy|0|||
16562555|NCT00124982|40525431|FG001|Long-term Period|Pregnancy|0|||
16562556|NCT00124982|40525432|FG002|Long-term Period|Pregnancy|1|||
16562557|NCT00124982|40525430|FG000|Long-term Period|Poor/Non-compliance|0|||
16562558|NCT00124982|40525431|FG001|Long-term Period|Poor/Non-compliance|0|||
16562559|NCT00124982|40525432|FG002|Long-term Period|Poor/Non-compliance|2|||
16562560|NCT00124982|40525430|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
16562561|NCT00124982|40525431|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
16562562|NCT00124982|40525432|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
16562563|NCT00124982|40525430|FG000|Long-term Period|Neurologist Recommendation|0|||
16562564|NCT00124982|40525431|FG001|Long-term Period|Neurologist Recommendation|0|||
16562565|NCT00124982|40525432|FG002|Long-term Period|Neurologist Recommendation|1|||
16562566|NCT04697069|40525433|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
16562567|NCT04697069|40525434|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
16562568|NCT04697069|40525433|FG000|Overall Study|Study termination|2|||
16562569|NCT04697069|40525434|FG001|Overall Study|Study termination|1|||
16562570|NCT01101542|40525435|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
16562571|NCT01101542|40525435|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
16562572|NCT01101542|40525435|FG000|Year 4 Surveillance Period|Other|287|||
16562573|NCT01101542|40525435|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
16562574|NCT01101542|40525435|FG000|Year 5 Surveillance Period|Pregnancy|1|||
16562575|NCT01101542|40525435|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
16249795|NCT01992107|39397942|FG000|Overall Study|Lost to Follow-up|46|||
16360740|NCT00587457|39807538|FG002|Overall Study|Adverse Event|1|||
16562576|NCT01101542|40525435|FG000|Year 6 Surveillance Period|Pregnancy|1|||
16562577|NCT01101542|40525435|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
16249796|NCT01992107|39397943|FG001|Overall Study|Lost to Follow-up|22|||
16249797|NCT01992107|39397944|FG002|Overall Study|Lost to Follow-up|26|||
16249798|NCT01992107|39397942|FG000|Overall Study|noncompliance and were unavailable|7|||
16249799|NCT01992107|39397943|FG001|Overall Study|noncompliance and were unavailable|3|||
16249800|NCT01992107|39397944|FG002|Overall Study|noncompliance and were unavailable|2|||
16249801|NCT01992107|39397942|FG000|Overall Study|Withdrawal by Subject|13|||
16249802|NCT01992107|39397943|FG001|Overall Study|Withdrawal by Subject|7|||
16249803|NCT01992107|39397944|FG002|Overall Study|Withdrawal by Subject|8|||
16249804|NCT00429923|39397947|FG000|Overall Study|Adverse Event|0|||
16249805|NCT00429923|39397948|FG001|Overall Study|Adverse Event|2|||
16249806|NCT00429923|39397949|FG002|Overall Study|Adverse Event|3|||
16249807|NCT00429923|39397947|FG000|Overall Study|Lack of Efficacy|4|||
16562578|NCT01838551|40525441|FG000|Overall Study|Adverse Event|16|||
16562579|NCT01838551|40525441|FG000|Overall Study|Death|1|||
16562580|NCT01838551|40525441|FG000|Overall Study|Lack of Efficacy|10|||
16562581|NCT01838551|40525441|FG000|Overall Study|Physician Decision|4|||
16562582|NCT01838551|40525441|FG000|Overall Study|Withdrawal by Subject|10|||
16562583|NCT01838551|40525441|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
16562584|NCT00530777|40525447|FG000|Overall Study|Lost to Follow-up|0|||
16562585|NCT00530777|40525448|FG001|Overall Study|Lost to Follow-up|1|||
16562586|NCT00530777|40525447|FG000|Overall Study|Death|1|||
16562587|NCT00530777|40525448|FG001|Overall Study|Death|2|||
16562588|NCT00530777|40525447|FG000|Overall Study|Physician Decision|1|||
16562589|NCT00530777|40525448|FG001|Overall Study|Physician Decision|0|||
16562590|NCT00530777|40525447|FG000|Overall Study|Withdrawal by Subject|0|||
16562591|NCT00530777|40525448|FG001|Overall Study|Withdrawal by Subject|1|||
16562592|NCT00530777|40525447|FG000|Overall Study|Unable to adhere to visit schedule|5|||
16562593|NCT00530777|40525448|FG001|Overall Study|Unable to adhere to visit schedule|1|||
16562594|NCT01852162|40525458|FG000|Overall Study|Adverse Event|1|||
16562595|NCT01852162|40525459|FG001|Overall Study|Adverse Event|0|||
16562596|NCT01852162|40525458|FG000|Overall Study|Withdrawal by Subject|3|||
16562597|NCT01852162|40525459|FG001|Overall Study|Withdrawal by Subject|1|||
16562598|NCT01474512|40525460|FG000|Induction Period|Adverse Event|6|||
16562599|NCT01474512|40525461|FG001|Induction Period|Adverse Event|10|||
16562600|NCT01474512|40525462|FG002|Induction Period|Adverse Event|10|||
16562601|NCT01474512|40525463|FG003|Induction Period|Adverse Event|0|||
16562602|NCT01474512|40525464|FG004|Induction Period|Adverse Event|0|||
16562603|NCT01474512|40525465|FG005|Induction Period|Adverse Event|0|||
16562604|NCT01474512|40525466|FG006|Induction Period|Adverse Event|0|||
16562605|NCT01474512|40525467|FG007|Induction Period|Adverse Event|0|||
16562606|NCT01474512|40525468|FG008|Induction Period|Adverse Event|0|||
16562607|NCT01474512|40525469|FG009|Induction Period|Adverse Event|0|||
16562608|NCT01474512|40525470|FG010|Induction Period|Adverse Event|0|||
16562609|NCT01474512|40525471|FG011|Induction Period|Adverse Event|0|||
16562610|NCT01474512|40525472|FG012|Induction Period|Adverse Event|0|||
16562611|NCT01474512|40525473|FG013|Induction Period|Adverse Event|0|||
16562612|NCT01474512|40525474|FG014|Induction Period|Adverse Event|0|||
16562613|NCT01474512|40525475|FG015|Induction Period|Adverse Event|0|||
16562614|NCT01474512|40525476|FG016|Induction Period|Adverse Event|0|||
16562615|NCT01474512|40525477|FG017|Induction Period|Adverse Event|0|||
16562616|NCT01474512|40525460|FG000|Induction Period|Lack of Efficacy|7|||
16562617|NCT01474512|40525461|FG001|Induction Period|Lack of Efficacy|1|||
16562618|NCT01474512|40525462|FG002|Induction Period|Lack of Efficacy|0|||
16562619|NCT01474512|40525463|FG003|Induction Period|Lack of Efficacy|0|||
16562620|NCT01474512|40525464|FG004|Induction Period|Lack of Efficacy|0|||
16562621|NCT01474512|40525465|FG005|Induction Period|Lack of Efficacy|0|||
16562622|NCT01474512|40525466|FG006|Induction Period|Lack of Efficacy|0|||
16562623|NCT01474512|40525467|FG007|Induction Period|Lack of Efficacy|0|||
16562624|NCT01474512|40525468|FG008|Induction Period|Lack of Efficacy|0|||
16562625|NCT01474512|40525469|FG009|Induction Period|Lack of Efficacy|0|||
16131019|NCT00969709|38967181|FG000|Overall Study|Lost to Follow-up|10|||
16360741|NCT00587457|39807536|FG000|Overall Study|Disease progression|2|||
16360742|NCT00587457|39807537|FG001|Overall Study|Disease progression|0|||
16360743|NCT00587457|39807538|FG002|Overall Study|Disease progression|2|||
16360744|NCT00587457|39807536|FG000|Overall Study|Initiation of alternative therapy|0|||
16249808|NCT00429923|39397948|FG001|Overall Study|Lack of Efficacy|1|||
16562626|NCT01474512|40525470|FG010|Induction Period|Lack of Efficacy|0|||
16562627|NCT01474512|40525471|FG011|Induction Period|Lack of Efficacy|0|||
16562628|NCT01474512|40525472|FG012|Induction Period|Lack of Efficacy|0|||
16562629|NCT01474512|40525473|FG013|Induction Period|Lack of Efficacy|0|||
16562630|NCT01474512|40525474|FG014|Induction Period|Lack of Efficacy|0|||
16562631|NCT01474512|40525475|FG015|Induction Period|Lack of Efficacy|0|||
16562632|NCT01474512|40525476|FG016|Induction Period|Lack of Efficacy|0|||
16562633|NCT01474512|40525477|FG017|Induction Period|Lack of Efficacy|0|||
16562634|NCT01474512|40525460|FG000|Induction Period|Withdrawal by Subject|6|||
16427096|NCT02598297|40042372|FG000|Overall Study|Followed for survival|1|||
16427097|NCT02598297|40042373|FG001|Overall Study|Followed for survival|0|||
16427098|NCT03792256|40042377|FG000|Overall Study|Death|0|||
16427099|NCT03792256|40042378|FG001|Overall Study|Death|1|||
16427100|NCT03792256|40042377|FG000|Overall Study|Lack of Efficacy|0|||
16427101|NCT03792256|40042378|FG001|Overall Study|Lack of Efficacy|1|||
16427102|NCT03792256|40042377|FG000|Overall Study|Withdrawal by Subject|0|||
16427103|NCT03792256|40042378|FG001|Overall Study|Withdrawal by Subject|1|||
16427104|NCT03712787|40042381|FG000|Overall Study|Adverse Event|2|||
16427105|NCT03712787|40042382|FG001|Overall Study|Adverse Event|3|||
16427106|NCT03712787|40042383|FG002|Overall Study|Adverse Event|0|||
16427107|NCT03712787|40042384|FG003|Overall Study|Adverse Event|4|||
16427108|NCT03712787|40042381|FG000|Overall Study|Withdrawal by Subject|4|||
16427109|NCT03712787|40042382|FG001|Overall Study|Withdrawal by Subject|14|||
16427110|NCT03712787|40042383|FG002|Overall Study|Withdrawal by Subject|12|||
16427111|NCT03712787|40042384|FG003|Overall Study|Withdrawal by Subject|8|||
16427112|NCT03712787|40042381|FG000|Overall Study|Lost to Follow-up|1|||
16427113|NCT03712787|40042382|FG001|Overall Study|Lost to Follow-up|1|||
16427114|NCT03712787|40042383|FG002|Overall Study|Lost to Follow-up|2|||
16427115|NCT03712787|40042384|FG003|Overall Study|Lost to Follow-up|1|||
16427116|NCT03712787|40042381|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
16427117|NCT03712787|40042382|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
16427118|NCT03712787|40042383|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
16427119|NCT03712787|40042384|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
16427120|NCT03712787|40042381|FG000|Overall Study|COVID-19 Infection|0|||
16427121|NCT03712787|40042382|FG001|Overall Study|COVID-19 Infection|1|||
16427122|NCT03712787|40042383|FG002|Overall Study|COVID-19 Infection|0|||
16427123|NCT03712787|40042384|FG003|Overall Study|COVID-19 Infection|0|||
16427124|NCT03712787|40042381|FG000|Overall Study|Other, Not Specified|79|||
16427125|NCT03712787|40042382|FG001|Overall Study|Other, Not Specified|77|||
16427126|NCT03712787|40042383|FG002|Overall Study|Other, Not Specified|74|||
16427127|NCT03712787|40042384|FG003|Overall Study|Other, Not Specified|78|||
16427128|NCT03688074|40042388|FG000|Overall Study|Adverse Event|0|||
16427129|NCT03688074|40042389|FG001|Overall Study|Adverse Event|1|||
16427130|NCT03688074|40042388|FG000|Overall Study|Other|1|||
16427131|NCT03688074|40042389|FG001|Overall Study|Other|0|||
16427132|NCT00958165|40042392|FG000|Overall Study|Lost to Follow-up|5|||
16427133|NCT00958165|40042392|FG000|Overall Study|Not eligible|9|||
16427134|NCT01957202|40042397|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427135|NCT01957202|40042398|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
16427136|NCT01957202|40042399|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427137|NCT01957202|40042400|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427138|NCT01957202|40042401|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427139|NCT01957202|40042402|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427140|NCT01957202|40042403|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427141|NCT01957202|40042404|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427142|NCT01957202|40042405|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427143|NCT01957202|40042406|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427144|NCT01957202|40042407|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427145|NCT01957202|40042408|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427146|NCT01957202|40042409|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427147|NCT01957202|40042410|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427148|NCT01957202|40042411|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427149|NCT01957202|40042412|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427150|NCT01957202|40042413|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
16427151|NCT01957202|40042414|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
16427152|NCT01957202|40042397|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427153|NCT01957202|40042398|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427154|NCT01957202|40042399|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427155|NCT01957202|40042400|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427156|NCT01957202|40042401|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427157|NCT01957202|40042402|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427158|NCT01957202|40042403|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427159|NCT01957202|40042404|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427160|NCT01957202|40042405|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427161|NCT01957202|40042406|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427162|NCT01957202|40042407|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427163|NCT01957202|40042408|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427164|NCT01957202|40042409|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427165|NCT01957202|40042410|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427166|NCT01957202|40042411|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
16131020|NCT00969709|38967182|FG001|Overall Study|Lost to Follow-up|14|||
16131021|NCT00969709|38967183|FG002|Overall Study|Lost to Follow-up|8|||
16249809|NCT00429923|39397949|FG002|Overall Study|Lack of Efficacy|33|||
16249810|NCT00429923|39397947|FG000|Overall Study|Lost to Follow-up|0|||
16249811|NCT00429923|39397948|FG001|Overall Study|Lost to Follow-up|0|||
16249812|NCT00429923|39397949|FG002|Overall Study|Lost to Follow-up|2|||
16249813|NCT00429923|39397947|FG000|Overall Study|Withdrew Consent|1|||
16249814|NCT00429923|39397948|FG001|Overall Study|Withdrew Consent|0|||
16249815|NCT00429923|39397949|FG002|Overall Study|Withdrew Consent|1|||
16249816|NCT00429923|39397947|FG000|Overall Study|Early Termination|0|||
16249817|NCT00429923|39397948|FG001|Overall Study|Early Termination|1|||
16249818|NCT00429923|39397949|FG002|Overall Study|Early Termination|0|||
16249819|NCT02097121|39397951|FG000|Overall Study|Other, not specified|4|||
16249820|NCT02097121|39397952|FG001|Overall Study|Other, not specified|2|||
16249821|NCT02097121|39397953|FG002|Overall Study|Other, not specified|3|||
16249822|NCT02097121|39397951|FG000|Overall Study|Lack of Efficacy|2|||
16249823|NCT02097121|39397952|FG001|Overall Study|Lack of Efficacy|1|||
16249824|NCT02097121|39397953|FG002|Overall Study|Lack of Efficacy|3|||
16249825|NCT02097121|39397951|FG000|Overall Study|Withdrawal by Subject|0|||
16249826|NCT02097121|39397952|FG001|Overall Study|Withdrawal by Subject|1|||
16249827|NCT02097121|39397953|FG002|Overall Study|Withdrawal by Subject|2|||
16249828|NCT02097121|39397951|FG000|Overall Study|Adverse Event|0|||
16249829|NCT02097121|39397952|FG001|Overall Study|Adverse Event|1|||
16249830|NCT02097121|39397953|FG002|Overall Study|Adverse Event|0|||
16249831|NCT02097121|39397951|FG000|Overall Study|Lost to Follow-up|1|||
16249832|NCT02097121|39397952|FG001|Overall Study|Lost to Follow-up|1|||
16249833|NCT02097121|39397953|FG002|Overall Study|Lost to Follow-up|2|||
16249834|NCT03341273|39397954|FG000|Overall Study|Lost to Follow-up|7|||
16249835|NCT03341273|39397955|FG001|Overall Study|Lost to Follow-up|7|||
16249836|NCT03341273|39397954|FG000|Overall Study|Withdrawal by Subject|4|||
16249837|NCT03341273|39397955|FG001|Overall Study|Withdrawal by Subject|2|||
16249838|NCT03341273|39397954|FG000|Overall Study|Physician Decision|1|||
16249839|NCT03341273|39397955|FG001|Overall Study|Physician Decision|0|||
16249840|NCT03341273|39397954|FG000|Overall Study|Protocol Violation|0|||
16249841|NCT03341273|39397955|FG001|Overall Study|Protocol Violation|1|||
16249842|NCT03341273|39397954|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
16249843|NCT03341273|39397955|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
16249844|NCT03341273|39397954|FG000|Overall Study|Became ineligible after enrollment|1|||
16249845|NCT03341273|39397955|FG001|Overall Study|Became ineligible after enrollment|0|||
16249846|NCT03341273|39397954|FG000|Overall Study|Not Eligible at Enrollment|0|||
16249847|NCT03341273|39397955|FG001|Overall Study|Not Eligible at Enrollment|1|||
16249848|NCT03341273|39397954|FG000|Overall Study|Participant incarcerated|1|||
16249849|NCT03341273|39397955|FG001|Overall Study|Participant incarcerated|0|||
16427167|NCT01957202|40042412|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427168|NCT01957202|40042413|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
16427169|NCT01957202|40042414|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
16427170|NCT00742183|40042418|FG000|Overall Study|Adverse Event|2|||
16427171|NCT00742183|40042419|FG001|Overall Study|Adverse Event|2|||
16562635|NCT01474512|40525461|FG001|Induction Period|Withdrawal by Subject|6|||
16562636|NCT01474512|40525462|FG002|Induction Period|Withdrawal by Subject|5|||
16562637|NCT01474512|40525463|FG003|Induction Period|Withdrawal by Subject|0|||
16562638|NCT01474512|40525464|FG004|Induction Period|Withdrawal by Subject|0|||
16562639|NCT01474512|40525465|FG005|Induction Period|Withdrawal by Subject|0|||
16562640|NCT01474512|40525466|FG006|Induction Period|Withdrawal by Subject|0|||
16562641|NCT01474512|40525467|FG007|Induction Period|Withdrawal by Subject|0|||
16562642|NCT01474512|40525468|FG008|Induction Period|Withdrawal by Subject|0|||
16562643|NCT01474512|40525469|FG009|Induction Period|Withdrawal by Subject|0|||
16562644|NCT01474512|40525470|FG010|Induction Period|Withdrawal by Subject|0|||
16562645|NCT01474512|40525471|FG011|Induction Period|Withdrawal by Subject|0|||
16562646|NCT01474512|40525472|FG012|Induction Period|Withdrawal by Subject|0|||
16562647|NCT01474512|40525473|FG013|Induction Period|Withdrawal by Subject|0|||
16562648|NCT01474512|40525474|FG014|Induction Period|Withdrawal by Subject|0|||
16562649|NCT01474512|40525475|FG015|Induction Period|Withdrawal by Subject|0|||
16562650|NCT01474512|40525476|FG016|Induction Period|Withdrawal by Subject|0|||
16562651|NCT01474512|40525477|FG017|Induction Period|Withdrawal by Subject|0|||
16562652|NCT01474512|40525460|FG000|Induction Period|Protocol Violation|3|||
16562653|NCT01474512|40525461|FG001|Induction Period|Protocol Violation|6|||
16562654|NCT01474512|40525462|FG002|Induction Period|Protocol Violation|0|||
16562655|NCT01474512|40525463|FG003|Induction Period|Protocol Violation|0|||
16562656|NCT01474512|40525464|FG004|Induction Period|Protocol Violation|0|||
16249850|NCT00368277|39397959|FG000|Overall Study|Adverse Event|33|||
16249851|NCT00368277|39397960|FG001|Overall Study|Adverse Event|49|||
16249852|NCT00368277|39397959|FG000|Overall Study|Death|2|||
16249853|NCT00368277|39397960|FG001|Overall Study|Death|1|||
16249854|NCT00368277|39397959|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
16427172|NCT00742183|40042418|FG000|Overall Study|Death|1|||
16427173|NCT00742183|40042419|FG001|Overall Study|Death|0|||
16562657|NCT01474512|40525465|FG005|Induction Period|Protocol Violation|0|||
16562658|NCT01474512|40525466|FG006|Induction Period|Protocol Violation|0|||
16427174|NCT00742183|40042418|FG000|Overall Study|Physician Decision|0|||
16427175|NCT00742183|40042419|FG001|Overall Study|Physician Decision|2|||
16427176|NCT00742183|40042418|FG000|Overall Study|Lost to Follow-up|4|||
16427177|NCT00742183|40042419|FG001|Overall Study|Lost to Follow-up|4|||
16427178|NCT00742183|40042418|FG000|Overall Study|Required skin-graft|1|||
16427179|NCT00742183|40042419|FG001|Overall Study|Required skin-graft|1|||
16427180|NCT00742183|40042418|FG000|Overall Study|Withdrawal by Subject|1|||
16427181|NCT00742183|40042419|FG001|Overall Study|Withdrawal by Subject|0|||
16427182|NCT00742183|40042418|FG000|Overall Study|Lack of Efficacy|0|||
16427183|NCT00742183|40042419|FG001|Overall Study|Lack of Efficacy|3|||
16427184|NCT02644343|40042420|FG000|Overall Study|Withdrawal by Subject|1|||
16427185|NCT01919801|40042421|FG000|Overall Study|Withdrawal by Subject|1|||
16427186|NCT01919801|40042422|FG001|Overall Study|Withdrawal by Subject|0|||
16427187|NCT01919801|40042421|FG000|Overall Study|Physician Decision|0|||
16427188|NCT01919801|40042422|FG001|Overall Study|Physician Decision|1|||
16427189|NCT01919801|40042421|FG000|Overall Study|Lost to Follow-up|0|||
16427190|NCT01919801|40042422|FG001|Overall Study|Lost to Follow-up|1|||
16427191|NCT01919801|40042421|FG000|Overall Study|Other|0|||
16427192|NCT01919801|40042422|FG001|Overall Study|Other|1|||
16427193|NCT03068754|40042426|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
16427194|NCT03068754|40042427|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
16427195|NCT03068754|40042428|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
16427196|NCT03068754|40042429|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
16427197|NCT03068754|40042426|FG000|Randomized Treatment Period (RTP)|Death|2|||
16427198|NCT03068754|40042427|FG001|Randomized Treatment Period (RTP)|Death|2|||
16427199|NCT03068754|40042428|FG002|Randomized Treatment Period (RTP)|Death|0|||
16427200|NCT03068754|40042429|FG003|Randomized Treatment Period (RTP)|Death|0|||
16427201|NCT03068754|40042426|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
16427202|NCT03068754|40042427|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
16427203|NCT03068754|40042428|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
16427204|NCT03068754|40042429|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
16427205|NCT03068754|40042426|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
16427206|NCT03068754|40042427|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
16427207|NCT03068754|40042428|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
16427208|NCT03068754|40042429|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
16427209|NCT03068754|40042426|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
16427210|NCT03068754|40042427|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
16427211|NCT03068754|40042428|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
16427212|NCT03068754|40042429|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
16427213|NCT03068754|40042426|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
16427214|NCT03068754|40042427|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
16427215|NCT03068754|40042428|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
16427216|NCT03068754|40042429|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
16427217|NCT03068754|40042426|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
16427218|NCT03068754|40042427|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
16427219|NCT03068754|40042428|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
16427220|NCT03068754|40042429|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
16427221|NCT03068754|40042426|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
16427222|NCT03068754|40042427|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
16427223|NCT03068754|40042428|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
16427224|NCT03068754|40042429|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
16427225|NCT03068754|40042426|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
16427226|NCT03068754|40042427|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
16427227|NCT03068754|40042428|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
16427228|NCT03068754|40042429|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
16427229|NCT03068754|40042426|FG000|Open Label Extension Period (OLE)|Death|0|||
16427230|NCT03068754|40042427|FG001|Open Label Extension Period (OLE)|Death|0|||
16427231|NCT03068754|40042428|FG002|Open Label Extension Period (OLE)|Death|0|||
16427232|NCT03068754|40042429|FG003|Open Label Extension Period (OLE)|Death|1|||
16427233|NCT03068754|40042426|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
16427234|NCT03068754|40042427|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
16427235|NCT03068754|40042428|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
16427236|NCT03068754|40042429|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
16427237|NCT03068754|40042426|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
16427238|NCT03068754|40042427|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
16427239|NCT03068754|40042428|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
16427240|NCT03068754|40042429|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
16427241|NCT03068754|40042426|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
16131022|NCT00969709|38967184|FG003|Overall Study|Lost to Follow-up|15|||
16427242|NCT03068754|40042427|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
16427243|NCT03068754|40042428|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
16427244|NCT03068754|40042429|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
16427245|NCT03068754|40042426|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
16427246|NCT03068754|40042427|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
16427247|NCT03068754|40042428|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
16427248|NCT03068754|40042429|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
16427249|NCT04440813|40042430|FG000|Overall Study|Lost to Follow-up|5|||
16427250|NCT04440813|40042431|FG001|Overall Study|Lost to Follow-up|5|||
16427251|NCT01843062|40042432|FG000|Overall Study|Protocol Violation|1|||
16427252|NCT01843062|40042433|FG001|Overall Study|Protocol Violation|0|||
16427253|NCT01843062|40042432|FG000|Overall Study|New treatment following progression|2|||
16427254|NCT01843062|40042433|FG001|Overall Study|New treatment following progression|0|||
16427255|NCT01843062|40042432|FG000|Overall Study|Pregnancy|1|||
16427256|NCT01843062|40042433|FG001|Overall Study|Pregnancy|0|||
16427257|NCT01843062|40042432|FG000|Overall Study|Adverse Event|2|||
16427258|NCT01843062|40042433|FG001|Overall Study|Adverse Event|0|||
16427259|NCT01843062|40042432|FG000|Overall Study|Incorrect randomisation|1|||
16427260|NCT01843062|40042433|FG001|Overall Study|Incorrect randomisation|0|||
16427261|NCT01843062|40042432|FG000|Overall Study|Withdrawal by Subject|12|||
16427262|NCT01843062|40042433|FG001|Overall Study|Withdrawal by Subject|3|||
16427263|NCT01843062|40042432|FG000|Overall Study|Death|1|||
16427264|NCT01843062|40042433|FG001|Overall Study|Death|2|||
16427265|NCT01843062|40042432|FG000|Overall Study|Lost to Follow-up|2|||
16427266|NCT01843062|40042433|FG001|Overall Study|Lost to Follow-up|4|||
16427267|NCT00787189|40042436|FG000|Overall Study|Lost to Follow-up|2|||
16427268|NCT00787189|40042437|FG001|Overall Study|Lost to Follow-up|2|||
16427269|NCT03495102|40042438|FG000|Overall Study|Adverse Event|5|||
16427270|NCT03495102|40042439|FG001|Overall Study|Adverse Event|7|||
16427271|NCT03495102|40042440|FG002|Overall Study|Adverse Event|10|||
16427272|NCT03495102|40042438|FG000|Overall Study|Death|3|||
16427273|NCT03495102|40042439|FG001|Overall Study|Death|4|||
16427274|NCT03495102|40042440|FG002|Overall Study|Death|4|||
16427275|NCT03495102|40042438|FG000|Overall Study|Lost to Follow-up|15|||
16562659|NCT01474512|40525467|FG007|Induction Period|Protocol Violation|0|||
16249855|NCT00368277|39397960|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
16249856|NCT00368277|39397959|FG000|Overall Study|Protocol deviation|7|||
16249857|NCT00368277|39397960|FG001|Overall Study|Protocol deviation|0|||
16249858|NCT00368277|39397959|FG000|Overall Study|Patient withdrew consent|32|||
16427276|NCT03495102|40042439|FG001|Overall Study|Lost to Follow-up|16|||
16562660|NCT01474512|40525468|FG008|Induction Period|Protocol Violation|0|||
16562661|NCT01474512|40525469|FG009|Induction Period|Protocol Violation|0|||
16562662|NCT01474512|40525470|FG010|Induction Period|Protocol Violation|0|||
16562663|NCT01474512|40525471|FG011|Induction Period|Protocol Violation|0|||
16562664|NCT01474512|40525472|FG012|Induction Period|Protocol Violation|0|||
16562665|NCT01474512|40525473|FG013|Induction Period|Protocol Violation|0|||
16562666|NCT01474512|40525474|FG014|Induction Period|Protocol Violation|0|||
16562667|NCT01474512|40525475|FG015|Induction Period|Protocol Violation|0|||
16562668|NCT01474512|40525476|FG016|Induction Period|Protocol Violation|0|||
16562669|NCT01474512|40525477|FG017|Induction Period|Protocol Violation|0|||
16562670|NCT01474512|40525460|FG000|Induction Period|Sponsor Decision|1|||
16562671|NCT01474512|40525461|FG001|Induction Period|Sponsor Decision|1|||
16562672|NCT01474512|40525462|FG002|Induction Period|Sponsor Decision|1|||
16562673|NCT01474512|40525463|FG003|Induction Period|Sponsor Decision|0|||
16562674|NCT01474512|40525464|FG004|Induction Period|Sponsor Decision|0|||
16562675|NCT01474512|40525465|FG005|Induction Period|Sponsor Decision|0|||
16562676|NCT01474512|40525466|FG006|Induction Period|Sponsor Decision|0|||
16562677|NCT01474512|40525467|FG007|Induction Period|Sponsor Decision|0|||
16562678|NCT01474512|40525468|FG008|Induction Period|Sponsor Decision|0|||
16562679|NCT01474512|40525469|FG009|Induction Period|Sponsor Decision|0|||
16562680|NCT01474512|40525470|FG010|Induction Period|Sponsor Decision|0|||
16562681|NCT01474512|40525471|FG011|Induction Period|Sponsor Decision|0|||
16562682|NCT01474512|40525472|FG012|Induction Period|Sponsor Decision|0|||
16427277|NCT03495102|40042440|FG002|Overall Study|Lost to Follow-up|17|||
16427278|NCT03495102|40042438|FG000|Overall Study|Physician Decision|2|||
16427279|NCT03495102|40042439|FG001|Overall Study|Physician Decision|0|||
16427280|NCT03495102|40042440|FG002|Overall Study|Physician Decision|2|||
16427281|NCT03495102|40042438|FG000|Overall Study|Withdrawal by Subject|25|||
16562683|NCT01474512|40525473|FG013|Induction Period|Sponsor Decision|0|||
16562684|NCT01474512|40525474|FG014|Induction Period|Sponsor Decision|0|||
16562685|NCT01474512|40525475|FG015|Induction Period|Sponsor Decision|0|||
16562686|NCT01474512|40525476|FG016|Induction Period|Sponsor Decision|0|||
16562687|NCT01474512|40525477|FG017|Induction Period|Sponsor Decision|0|||
16131023|NCT00969709|38967181|FG000|Overall Study|Other reasons|0|||
16131024|NCT00969709|38967182|FG001|Overall Study|Other reasons|0|||
16131025|NCT00969709|38967183|FG002|Overall Study|Other reasons|3|||
16131026|NCT00969709|38967184|FG003|Overall Study|Other reasons|0|||
16131027|NCT04447846|38967185|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
16131028|NCT00081497|38967186|FG000|Overall Study|Adverse Event|2|||
16360745|NCT00587457|39807537|FG001|Overall Study|Initiation of alternative therapy|1|||
16360746|NCT00587457|39807538|FG002|Overall Study|Initiation of alternative therapy|0|||
16360747|NCT00587457|39807536|FG000|Overall Study|Undefined|0|||
16360748|NCT00587457|39807537|FG001|Overall Study|Undefined|0|||
16360749|NCT00587457|39807538|FG002|Overall Study|Undefined|1|||
16360750|NCT00587457|39807536|FG000|Overall Study|Development of neutralizing Abs|0|||
16360751|NCT00587457|39807537|FG001|Overall Study|Development of neutralizing Abs|0|||
16360752|NCT00587457|39807538|FG002|Overall Study|Development of neutralizing Abs|1|||
16360753|NCT03451071|39807539|FG000|First Vaccine|Withdrawal by Subject|1|||
16360754|NCT03451071|39807539|FG000|Second Vaccine|Lost to Follow-up|19|||
16360755|NCT03451071|39807539|FG000|Third Vaccine|Lost to Follow-up|22|||
16360756|NCT03451071|39807539|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
16360757|NCT02643693|39807540|FG000|Overall Study|Physician Decision|0|||
16360758|NCT02643693|39807541|FG001|Overall Study|Physician Decision|1|||
16360759|NCT02643693|39807542|FG002|Overall Study|Physician Decision|0|||
16360760|NCT02643693|39807543|FG003|Overall Study|Physician Decision|0|||
16360761|NCT02643693|39807544|FG004|Overall Study|Physician Decision|0|||
16360762|NCT02643693|39807545|FG005|Overall Study|Physician Decision|0|||
16360763|NCT02643693|39807540|FG000|Overall Study|Withdrawal by Subject|0|||
16360764|NCT02643693|39807541|FG001|Overall Study|Withdrawal by Subject|1|||
16360765|NCT02643693|39807542|FG002|Overall Study|Withdrawal by Subject|0|||
16360766|NCT02643693|39807543|FG003|Overall Study|Withdrawal by Subject|0|||
16360767|NCT02643693|39807544|FG004|Overall Study|Withdrawal by Subject|0|||
16360768|NCT02643693|39807545|FG005|Overall Study|Withdrawal by Subject|0|||
16360769|NCT02643693|39807540|FG000|Overall Study|Protocol Adherence Issues|2|||
16360770|NCT02643693|39807541|FG001|Overall Study|Protocol Adherence Issues|0|||
16360771|NCT02643693|39807542|FG002|Overall Study|Protocol Adherence Issues|1|||
16360772|NCT02643693|39807543|FG003|Overall Study|Protocol Adherence Issues|0|||
16360773|NCT02643693|39807544|FG004|Overall Study|Protocol Adherence Issues|0|||
16360774|NCT02643693|39807545|FG005|Overall Study|Protocol Adherence Issues|1|||
16360775|NCT00089648|39807546|FG000|Overall Study|Adverse Event|7|||
16360776|NCT00089648|39807546|FG000|Overall Study|Withdrawal by Subject|1|||
16360777|NCT00089648|39807546|FG000|Overall Study|Lack of Efficacy|33|||
16360778|NCT01259245|39807549|FG000|Overall Study|Withdrawal by Subject|27|||
16360779|NCT01259245|39807550|FG001|Overall Study|Withdrawal by Subject|24|||
16360780|NCT01259245|39807549|FG000|Overall Study|Death|1|||
16360781|NCT01259245|39807550|FG001|Overall Study|Death|2|||
16360782|NCT03479905|39807551|FG000|Overall Study|Other airway method used|4|||
16360783|NCT03479905|39807552|FG001|Overall Study|Other airway method used|5|||
16360784|NCT03479905|39807553|FG002|Overall Study|Other airway method used|5|||
16360785|NCT02832037|39807554|FG000|Overall Study|Administrative reasons|0|||
16360786|NCT02832037|39807555|FG001|Overall Study|Administrative reasons|0|||
16360787|NCT02832037|39807556|FG002|Overall Study|Administrative reasons|1|||
16360788|NCT02832037|39807557|FG003|Overall Study|Administrative reasons|0|||
16360789|NCT02832037|39807558|FG004|Overall Study|Administrative reasons|0|||
16360790|NCT02832037|39807554|FG000|Overall Study|Protocol Violation|3|||
16360791|NCT02832037|39807555|FG001|Overall Study|Protocol Violation|0|||
16360792|NCT02832037|39807556|FG002|Overall Study|Protocol Violation|4|||
16360793|NCT02832037|39807557|FG003|Overall Study|Protocol Violation|1|||
16360794|NCT02832037|39807558|FG004|Overall Study|Protocol Violation|2|||
16360795|NCT02832037|39807554|FG000|Overall Study|Lost to Follow-up|2|||
16360796|NCT02832037|39807555|FG001|Overall Study|Lost to Follow-up|0|||
16360797|NCT02832037|39807556|FG002|Overall Study|Lost to Follow-up|3|||
16360798|NCT02832037|39807557|FG003|Overall Study|Lost to Follow-up|0|||
16360799|NCT02832037|39807558|FG004|Overall Study|Lost to Follow-up|5|||
16360800|NCT02832037|39807554|FG000|Overall Study|Withdrawal by Subject|9|||
16360801|NCT02832037|39807555|FG001|Overall Study|Withdrawal by Subject|8|||
16360802|NCT02832037|39807556|FG002|Overall Study|Withdrawal by Subject|0|||
16360803|NCT02832037|39807557|FG003|Overall Study|Withdrawal by Subject|4|||
16360804|NCT02832037|39807558|FG004|Overall Study|Withdrawal by Subject|8|||
16360805|NCT02832037|39807554|FG000|Overall Study|Adverse Event|5|||
16360806|NCT02832037|39807555|FG001|Overall Study|Adverse Event|4|||
16360807|NCT02832037|39807556|FG002|Overall Study|Adverse Event|0|||
16360808|NCT02832037|39807557|FG003|Overall Study|Adverse Event|2|||
16360809|NCT02832037|39807558|FG004|Overall Study|Adverse Event|4|||
16360810|NCT00423046|39807559|FG000|Overall Study|Other|340|||
16360811|NCT00423046|39807560|FG001|Overall Study|Other|345|||
16360812|NCT01631188|39807561|FG000|Overall Study|Physician Decision|75|||
16360813|NCT01847209|39807564|FG000|Overall Study|Withdrawal by Subject|1|||
16249859|NCT00368277|39397960|FG001|Overall Study|Patient withdrew consent|28|||
16249860|NCT00368277|39397959|FG000|Overall Study|Lost to Follow-up|8|||
16249861|NCT00368277|39397960|FG001|Overall Study|Lost to Follow-up|6|||
16249862|NCT02737306|39397961|FG000|Overall Study|Adverse Event|3|||
16249863|NCT02737306|39397962|FG001|Overall Study|Adverse Event|0|||
16249864|NCT02737306|39397961|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
16249865|NCT02737306|39397962|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
16249866|NCT00698685|39397963|FG000|Overall Study|Sister withdrew as donor|1|||
16249867|NCT00698685|39397963|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
16249868|NCT02224456|39397964|FG000|Overall Study|Lack of Efficacy|1|||
16249869|NCT02224456|39397964|FG000|Overall Study|Lost to Follow-up|15|||
16249870|NCT02224456|39397964|FG000|Overall Study|Withdrawal by Subject|9|||
16249871|NCT02224456|39397964|FG000|Overall Study|Physician Decision|3|||
16249872|NCT02224456|39397964|FG000|Overall Study|Death|2|||
16249873|NCT02224456|39397964|FG000|Overall Study|Pregnancy|4|||
16249874|NCT02224456|39397964|FG000|Overall Study|Protocol Violation|1|||
16249875|NCT02224456|39397964|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
16249876|NCT00419926|39397965|FG000|Overall Study|Withdrawal by Subject|7|||
16249877|NCT00419926|39397966|FG001|Overall Study|Withdrawal by Subject|3|||
16249878|NCT00419926|39397965|FG000|Overall Study|Administrative Problem|4|||
16249879|NCT00419926|39397966|FG001|Overall Study|Administrative Problem|4|||
16249880|NCT00419926|39397965|FG000|Overall Study|Lost to Follow-up|1|||
16249881|NCT00419926|39397966|FG001|Overall Study|Lost to Follow-up|2|||
16249882|NCT00419926|39397965|FG000|Overall Study|Death|2|||
16249883|NCT00419926|39397966|FG001|Overall Study|Death|1|||
16249884|NCT03992196|39397967|FG000|Enrollment|lost to follow-up prior dosing|1|||
16249885|NCT03992196|39397968|FG001|Enrollment|lost to follow-up prior dosing|0|||
16249886|NCT03992196|39397969|FG002|Enrollment|lost to follow-up prior dosing|0|||
16249887|NCT03992196|39397967|FG000|Treatment|Protocol Violation|0|||
16249888|NCT03992196|39397968|FG001|Treatment|Protocol Violation|0|||
16249889|NCT03992196|39397969|FG002|Treatment|Protocol Violation|1|||
16249890|NCT03992196|39397967|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
16249891|NCT03992196|39397968|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
16249892|NCT03992196|39397969|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
16249893|NCT03992196|39397967|FG000|Treatment|Withdrawal due to non-compliance|0|||
16249894|NCT03992196|39397968|FG001|Treatment|Withdrawal due to non-compliance|0|||
16249895|NCT03992196|39397969|FG002|Treatment|Withdrawal due to non-compliance|1|||
16249896|NCT03992196|39397967|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
16249897|NCT03992196|39397968|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
16249898|NCT03992196|39397969|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
16249899|NCT03992196|39397967|FG000|Treatment|Withdrawal by parent/guardian|0|||
16249900|NCT03992196|39397968|FG001|Treatment|Withdrawal by parent/guardian|0|||
16249901|NCT03992196|39397969|FG002|Treatment|Withdrawal by parent/guardian|2|||
16249902|NCT01347710|39397970|FG000|Overall Study|Withdrawal by Subject|2|||
16249903|NCT01347710|39397970|FG000|Overall Study|Adverse Event|4|||
16249904|NCT01347710|39397970|FG000|Overall Study|Angio or SPECT not completed|18|||
16249905|NCT01347710|39397970|FG000|Overall Study|issue with vitals prior to dosing|1|||
16249906|NCT01347710|39397970|FG000|Overall Study|Lost to Follow-up|1|||
16249907|NCT01347710|39397970|FG000|Overall Study|Physician Decision|2|||
16249908|NCT01347710|39397970|FG000|Overall Study|Other|3|||
16249909|NCT01411995|39397971|FG000|Overall Study|Failed IUD insertion|0|||
16360814|NCT01847209|39807564|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
16360815|NCT03617588|39807569|FG000|Overall Study|Withdrawal by Subject|1|||
16360816|NCT03617588|39807570|FG001|Overall Study|Withdrawal by Subject|0|||
16360817|NCT01218802|39807571|FG000|Overall Study|Lost to Follow-up|5|||
16360818|NCT01218802|39807572|FG001|Overall Study|Lost to Follow-up|6|||
16360819|NCT01218802|39807571|FG000|Overall Study|Withdrawal by Subject|3|||
16360820|NCT01218802|39807572|FG001|Overall Study|Withdrawal by Subject|10|||
16360821|NCT01218802|39807571|FG000|Overall Study|Adverse Event|0|||
16360822|NCT01218802|39807572|FG001|Overall Study|Adverse Event|2|||
16360823|NCT01218802|39807571|FG000|Overall Study|Incarcerated|2|||
16360824|NCT01218802|39807572|FG001|Overall Study|Incarcerated|0|||
16360825|NCT03010501|39807573|FG000|Study Week 1|Withdrawal by Subject|2|||
16360826|NCT03010501|39807574|FG001|Study Week 1|Withdrawal by Subject|1|||
16360827|NCT03010501|39807575|FG002|Study Week 1|Withdrawal by Subject|0|||
16360828|NCT03010501|39807576|FG003|Study Week 1|Withdrawal by Subject|2|||
16360829|NCT03010501|39807577|FG004|Study Week 1|Withdrawal by Subject|0|||
16360830|NCT03010501|39807578|FG005|Study Week 1|Withdrawal by Subject|0|||
16249910|NCT01411995|39397972|FG001|Overall Study|Failed IUD insertion|1|||
16249911|NCT01211769|39397973|FG000|Overall Study|Lost to Follow-up|7|||
16249912|NCT01211769|39397974|FG001|Overall Study|Lost to Follow-up|9|||
16249913|NCT01211769|39397975|FG002|Overall Study|Lost to Follow-up|5|||
16249914|NCT01211769|39397976|FG003|Overall Study|Lost to Follow-up|9|||
16249915|NCT01211769|39397973|FG000|Overall Study|Physician Decision|2|||
16249916|NCT01211769|39397974|FG001|Overall Study|Physician Decision|0|||
16249917|NCT01211769|39397975|FG002|Overall Study|Physician Decision|2|||
16249918|NCT01211769|39397976|FG003|Overall Study|Physician Decision|1|||
16249919|NCT01211769|39397973|FG000|Overall Study|Adverse Event|0|||
16249920|NCT01211769|39397974|FG001|Overall Study|Adverse Event|1|||
16249921|NCT01211769|39397975|FG002|Overall Study|Adverse Event|1|||
16249922|NCT01211769|39397976|FG003|Overall Study|Adverse Event|1|||
16249923|NCT00264810|39397977|FG000|Baseline|Withdrawal by Subject|10|||
16249924|NCT00264810|39397978|FG001|Baseline|Withdrawal by Subject|10|||
16249925|NCT00264810|39397977|FG000|Baseline|Physician Decision|7|||
16249926|NCT00264810|39397978|FG001|Baseline|Physician Decision|8|||
16249927|NCT00264810|39397977|FG000|Baseline|Subject Compliance Failure|3|||
16249928|NCT00264810|39397978|FG001|Baseline|Subject Compliance Failure|3|||
16249929|NCT00264810|39397977|FG000|Baseline|Insufficient Seizure Frequency|2|||
16249930|NCT00264810|39397978|FG001|Baseline|Insufficient Seizure Frequency|2|||
16249931|NCT00264810|39397977|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
16249932|NCT00264810|39397978|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
16249933|NCT00264810|39397977|FG000|Baseline|Other|0|||
16249934|NCT00264810|39397978|FG001|Baseline|Other|1|||
16249935|NCT00264810|39397977|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
16249936|NCT00264810|39397978|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
16249937|NCT00264810|39397977|FG000|Stimulation Optimization Period|Death|0|||
16249938|NCT00264810|39397978|FG001|Stimulation Optimization Period|Death|1|||
16249939|NCT00264810|39397977|FG000|Blinded Evaluation Period|Explant due to infection|1|||
16249940|NCT00264810|39397978|FG001|Blinded Evaluation Period|Explant due to infection|1|||
16249941|NCT00264810|39397977|FG000|Open Label Evaluation Period|Explant due to infection|1|||
16249942|NCT00264810|39397978|FG001|Open Label Evaluation Period|Explant due to infection|1|||
16249943|NCT00264810|39397977|FG000|Open Label Evaluation Period|Death|3|||
16249944|NCT00264810|39397978|FG001|Open Label Evaluation Period|Death|2|||
16249945|NCT00264810|39397977|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
16249946|NCT00264810|39397978|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
16249947|NCT01724359|39397979|FG000|Overall Study|Adverse Event|10|||
16249948|NCT01724359|39397979|FG000|Overall Study|Death|1|||
16427282|NCT03495102|40042439|FG001|Overall Study|Withdrawal by Subject|36|||
16562688|NCT01474512|40525460|FG000|Induction Period|Lost to Follow-up|1|||
16562689|NCT01474512|40525461|FG001|Induction Period|Lost to Follow-up|0|||
16562690|NCT01474512|40525462|FG002|Induction Period|Lost to Follow-up|2|||
16562691|NCT01474512|40525463|FG003|Induction Period|Lost to Follow-up|0|||
16562692|NCT01474512|40525464|FG004|Induction Period|Lost to Follow-up|0|||
16562693|NCT01474512|40525465|FG005|Induction Period|Lost to Follow-up|0|||
16562694|NCT01474512|40525466|FG006|Induction Period|Lost to Follow-up|0|||
16562695|NCT01474512|40525467|FG007|Induction Period|Lost to Follow-up|0|||
16562696|NCT01474512|40525468|FG008|Induction Period|Lost to Follow-up|0|||
16562697|NCT01474512|40525469|FG009|Induction Period|Lost to Follow-up|0|||
16562698|NCT01474512|40525470|FG010|Induction Period|Lost to Follow-up|0|||
16562699|NCT01474512|40525471|FG011|Induction Period|Lost to Follow-up|0|||
16562700|NCT01474512|40525472|FG012|Induction Period|Lost to Follow-up|0|||
16562701|NCT01474512|40525473|FG013|Induction Period|Lost to Follow-up|0|||
16562702|NCT01474512|40525474|FG014|Induction Period|Lost to Follow-up|0|||
16562703|NCT01474512|40525475|FG015|Induction Period|Lost to Follow-up|0|||
16562704|NCT01474512|40525476|FG016|Induction Period|Lost to Follow-up|0|||
16562705|NCT01474512|40525477|FG017|Induction Period|Lost to Follow-up|0|||
16562706|NCT01474512|40525460|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562707|NCT01474512|40525461|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562708|NCT01474512|40525462|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562709|NCT01474512|40525463|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
16562710|NCT01474512|40525464|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
16562711|NCT01474512|40525465|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
16562712|NCT01474512|40525466|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
16562713|NCT01474512|40525467|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562714|NCT01474512|40525468|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16427283|NCT03495102|40042440|FG002|Overall Study|Withdrawal by Subject|18|||
16562715|NCT01474512|40525469|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562716|NCT01474512|40525470|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562717|NCT01474512|40525471|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562718|NCT01474512|40525472|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562719|NCT01474512|40525473|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16249949|NCT01724359|39397979|FG000|Overall Study|Other|20|||
16427284|NCT03495102|40042438|FG000|Overall Study|Protocol Violation|1|||
16562720|NCT01474512|40525474|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16249950|NCT02101853|39397982|FG000|Block 1 Induction|Adverse Event|11|||
16249951|NCT02101853|39397983|FG001|Block 1 Induction|Adverse Event|0|||
16249952|NCT02101853|39397984|FG002|Block 1 Induction|Adverse Event|0|||
16249953|NCT02101853|39397985|FG003|Block 1 Induction|Adverse Event|0|||
16249954|NCT02101853|39397986|FG004|Block 1 Induction|Adverse Event|0|||
16249955|NCT02101853|39397987|FG005|Block 1 Induction|Adverse Event|0|||
16249956|NCT02101853|39397982|FG000|Block 1 Induction|Death|20|||
16249957|NCT02101853|39397983|FG001|Block 1 Induction|Death|0|||
16249958|NCT02101853|39397984|FG002|Block 1 Induction|Death|0|||
16249959|NCT02101853|39397985|FG003|Block 1 Induction|Death|0|||
16249960|NCT02101853|39397986|FG004|Block 1 Induction|Death|0|||
16249961|NCT02101853|39397987|FG005|Block 1 Induction|Death|0|||
16249962|NCT02101853|39397982|FG000|Block 1 Induction|Lack of Efficacy|6|||
16249963|NCT02101853|39397983|FG001|Block 1 Induction|Lack of Efficacy|0|||
16249964|NCT02101853|39397984|FG002|Block 1 Induction|Lack of Efficacy|0|||
16249965|NCT02101853|39397985|FG003|Block 1 Induction|Lack of Efficacy|0|||
16249966|NCT02101853|39397986|FG004|Block 1 Induction|Lack of Efficacy|0|||
16249967|NCT02101853|39397987|FG005|Block 1 Induction|Lack of Efficacy|0|||
16249968|NCT02101853|39397982|FG000|Block 1 Induction|Physician Decision|61|||
16249969|NCT02101853|39397983|FG001|Block 1 Induction|Physician Decision|0|||
16249970|NCT02101853|39397984|FG002|Block 1 Induction|Physician Decision|0|||
16249971|NCT02101853|39397985|FG003|Block 1 Induction|Physician Decision|0|||
16249972|NCT02101853|39397986|FG004|Block 1 Induction|Physician Decision|0|||
16249973|NCT02101853|39397987|FG005|Block 1 Induction|Physician Decision|0|||
16249974|NCT02101853|39397982|FG000|Block 1 Induction|Protocol Violation|2|||
16249975|NCT02101853|39397983|FG001|Block 1 Induction|Protocol Violation|0|||
16249976|NCT02101853|39397984|FG002|Block 1 Induction|Protocol Violation|0|||
16249977|NCT02101853|39397985|FG003|Block 1 Induction|Protocol Violation|0|||
16249978|NCT02101853|39397986|FG004|Block 1 Induction|Protocol Violation|0|||
16249979|NCT02101853|39397987|FG005|Block 1 Induction|Protocol Violation|0|||
16249980|NCT02101853|39397982|FG000|Block 1 Induction|Withdrawal by Subject|65|||
16249981|NCT02101853|39397983|FG001|Block 1 Induction|Withdrawal by Subject|0|||
16249982|NCT02101853|39397984|FG002|Block 1 Induction|Withdrawal by Subject|0|||
16249983|NCT02101853|39397985|FG003|Block 1 Induction|Withdrawal by Subject|0|||
16249984|NCT02101853|39397986|FG004|Block 1 Induction|Withdrawal by Subject|0|||
16249985|NCT02101853|39397987|FG005|Block 1 Induction|Withdrawal by Subject|0|||
16249986|NCT02101853|39397982|FG000|Block 1 Induction|Ineligible|8|||
16249987|NCT02101853|39397983|FG001|Block 1 Induction|Ineligible|0|||
16562721|NCT01474512|40525475|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562722|NCT01474512|40525476|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562723|NCT01474512|40525477|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
16562724|NCT01474512|40525460|FG000|Maintenance Period|Adverse Event|0|||
16562725|NCT01474512|40525461|FG001|Maintenance Period|Adverse Event|0|||
16562726|NCT01474512|40525462|FG002|Maintenance Period|Adverse Event|0|||
16562727|NCT01474512|40525463|FG003|Maintenance Period|Adverse Event|4|||
16562728|NCT01474512|40525464|FG004|Maintenance Period|Adverse Event|2|||
16562729|NCT01474512|40525465|FG005|Maintenance Period|Adverse Event|7|||
16562730|NCT01474512|40525466|FG006|Maintenance Period|Adverse Event|0|||
16562731|NCT01474512|40525467|FG007|Maintenance Period|Adverse Event|19|||
16562732|NCT01474512|40525468|FG008|Maintenance Period|Adverse Event|1|||
16562733|NCT01474512|40525469|FG009|Maintenance Period|Adverse Event|3|||
16562734|NCT01474512|40525470|FG010|Maintenance Period|Adverse Event|0|||
16562735|NCT01474512|40525471|FG011|Maintenance Period|Adverse Event|0|||
16562736|NCT01474512|40525472|FG012|Maintenance Period|Adverse Event|0|||
16562737|NCT01474512|40525473|FG013|Maintenance Period|Adverse Event|0|||
16562738|NCT01474512|40525474|FG014|Maintenance Period|Adverse Event|0|||
16562739|NCT01474512|40525475|FG015|Maintenance Period|Adverse Event|0|||
16562740|NCT01474512|40525476|FG016|Maintenance Period|Adverse Event|0|||
16562741|NCT01474512|40525477|FG017|Maintenance Period|Adverse Event|0|||
16562742|NCT01474512|40525460|FG000|Maintenance Period|Withdrawal by Subject|0|||
16562743|NCT01474512|40525461|FG001|Maintenance Period|Withdrawal by Subject|0|||
16562744|NCT01474512|40525462|FG002|Maintenance Period|Withdrawal by Subject|0|||
16562745|NCT01474512|40525463|FG003|Maintenance Period|Withdrawal by Subject|6|||
16562746|NCT01474512|40525464|FG004|Maintenance Period|Withdrawal by Subject|2|||
16562747|NCT01474512|40525465|FG005|Maintenance Period|Withdrawal by Subject|3|||
16562748|NCT01474512|40525466|FG006|Maintenance Period|Withdrawal by Subject|1|||
16562749|NCT01474512|40525467|FG007|Maintenance Period|Withdrawal by Subject|6|||
16562750|NCT01474512|40525468|FG008|Maintenance Period|Withdrawal by Subject|3|||
16562751|NCT01474512|40525469|FG009|Maintenance Period|Withdrawal by Subject|1|||
16562752|NCT01474512|40525470|FG010|Maintenance Period|Withdrawal by Subject|0|||
16562753|NCT01474512|40525471|FG011|Maintenance Period|Withdrawal by Subject|0|||
16562754|NCT01474512|40525472|FG012|Maintenance Period|Withdrawal by Subject|0|||
16562755|NCT01474512|40525473|FG013|Maintenance Period|Withdrawal by Subject|0|||
16562756|NCT01474512|40525474|FG014|Maintenance Period|Withdrawal by Subject|0|||
16562757|NCT01474512|40525475|FG015|Maintenance Period|Withdrawal by Subject|0|||
16249988|NCT02101853|39397984|FG002|Block 1 Induction|Ineligible|0|||
16249989|NCT02101853|39397985|FG003|Block 1 Induction|Ineligible|0|||
16249990|NCT02101853|39397986|FG004|Block 1 Induction|Ineligible|0|||
16427285|NCT03495102|40042439|FG001|Overall Study|Protocol Violation|1|||
16427286|NCT03495102|40042440|FG002|Overall Study|Protocol Violation|0|||
16427287|NCT03495102|40042438|FG000|Overall Study|Site Closure|3|||
16427288|NCT03495102|40042439|FG001|Overall Study|Site Closure|1|||
16427289|NCT03495102|40042440|FG002|Overall Study|Site Closure|2|||
16427290|NCT03495102|40042438|FG000|Overall Study|Non-compliance|1|||
16427291|NCT03495102|40042439|FG001|Overall Study|Non-compliance|0|||
16427292|NCT03495102|40042440|FG002|Overall Study|Non-compliance|0|||
16427293|NCT03495102|40042438|FG000|Overall Study|Participant Duplicated at Another Site|0|||
16427294|NCT03495102|40042439|FG001|Overall Study|Participant Duplicated at Another Site|0|||
16427295|NCT03495102|40042440|FG002|Overall Study|Participant Duplicated at Another Site|1|||
16427296|NCT03495102|40042438|FG000|Overall Study|Primary Care Physician Recommendation|0|||
16427297|NCT03495102|40042439|FG001|Overall Study|Primary Care Physician Recommendation|1|||
16427298|NCT03495102|40042440|FG002|Overall Study|Primary Care Physician Recommendation|0|||
16427299|NCT03495102|40042438|FG000|Overall Study|Relocated to Another Country|0|||
16427300|NCT03495102|40042439|FG001|Overall Study|Relocated to Another Country|1|||
16427301|NCT03495102|40042440|FG002|Overall Study|Relocated to Another Country|0|||
16427302|NCT03495102|40042438|FG000|Overall Study|Participant was in Rehabilitation|1|||
16427303|NCT03495102|40042439|FG001|Overall Study|Participant was in Rehabilitation|0|||
16427304|NCT03495102|40042440|FG002|Overall Study|Participant was in Rehabilitation|0|||
16427305|NCT03679624|40042441|FG000|Overall Study|Adverse Event|1|||
16427306|NCT03679624|40042442|FG001|Overall Study|Adverse Event|0|||
16427307|NCT00080301|40042443|FG000|Overall Study|Randomized but Never Treated|5|||
16427308|NCT00080301|40042444|FG001|Overall Study|Randomized but Never Treated|10|||
16427309|NCT00080301|40042443|FG000|Overall Study|Still on Treatment as of CSR date|0|||
16427310|NCT00080301|40042444|FG001|Overall Study|Still on Treatment as of CSR date|1|||
16427311|NCT00649428|40042447|FG000|Overall Study|Adverse Event|2|||
16427312|NCT00649428|40042448|FG001|Overall Study|Adverse Event|2|||
16427313|NCT00649428|40042447|FG000|Overall Study|Withdrawal by Subject|6|||
16427314|NCT00649428|40042448|FG001|Overall Study|Withdrawal by Subject|6|||
16427315|NCT00649428|40042447|FG000|Overall Study|Lost to Follow-up|1|||
16427316|NCT00649428|40042448|FG001|Overall Study|Lost to Follow-up|3|||
16427317|NCT00649428|40042447|FG000|Overall Study|Insufficient manufacturing yield|5|||
16427318|NCT00649428|40042448|FG001|Overall Study|Insufficient manufacturing yield|1|||
16427319|NCT00649428|40042447|FG000|Overall Study|Protocol Violation|6|||
16427320|NCT00649428|40042448|FG001|Overall Study|Protocol Violation|2|||
16427321|NCT00649428|40042447|FG000|Overall Study|Physician Decision|0|||
16427322|NCT00649428|40042448|FG001|Overall Study|Physician Decision|1|||
16427323|NCT03775512|40042451|FG000|Overall Study|Death|1|||
16427324|NCT03775512|40042452|FG001|Overall Study|Death|1|||
16427325|NCT03775512|40042451|FG000|Overall Study|Withdrawal by Subject|7|||
16427326|NCT03775512|40042452|FG001|Overall Study|Withdrawal by Subject|4|||
16427327|NCT03775512|40042451|FG000|Overall Study|Lost to Follow-up|5|||
16427328|NCT03775512|40042452|FG001|Overall Study|Lost to Follow-up|5|||
16427329|NCT03775512|40042451|FG000|Overall Study|Excluded before Catheter insertion|14|||
16427330|NCT03775512|40042452|FG001|Overall Study|Excluded before Catheter insertion|5|||
16427331|NCT03775512|40042451|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
16427332|NCT03775512|40042452|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
16427333|NCT03775512|40042451|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
16427334|NCT03775512|40042452|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
16427335|NCT02287467|40042460|FG000|Overall Study|Protocol Violation|12|||
16427336|NCT02287467|40042461|FG001|Overall Study|Protocol Violation|9|||
16427337|NCT00279916|40042464|FG000|Overall Study|Withdrawal by Subject|4|||
16427338|NCT00279916|40042465|FG001|Overall Study|Withdrawal by Subject|3|||
16427339|NCT00279916|40042464|FG000|Overall Study|Lost to Follow-up|3|||
16427340|NCT00279916|40042465|FG001|Overall Study|Lost to Follow-up|2|||
16427341|NCT01677858|40042468|FG000|Overall Study|Adverse Event|0|||
16427342|NCT01677858|40042469|FG001|Overall Study|Adverse Event|0|||
16427343|NCT01677858|40042470|FG002|Overall Study|Adverse Event|2|||
16427344|NCT01677858|40042471|FG003|Overall Study|Adverse Event|3|||
16427345|NCT01677858|40042472|FG004|Overall Study|Adverse Event|13|||
16427346|NCT01677858|40042468|FG000|Overall Study|Death|0|||
16427347|NCT01677858|40042469|FG001|Overall Study|Death|0|||
16427348|NCT01677858|40042470|FG002|Overall Study|Death|0|||
16427349|NCT01677858|40042471|FG003|Overall Study|Death|0|||
16427350|NCT01677858|40042472|FG004|Overall Study|Death|1|||
16427351|NCT01677858|40042468|FG000|Overall Study|Physician Decision|1|||
16427352|NCT01677858|40042469|FG001|Overall Study|Physician Decision|0|||
16427353|NCT01677858|40042470|FG002|Overall Study|Physician Decision|2|||
16427354|NCT01677858|40042471|FG003|Overall Study|Physician Decision|0|||
16427355|NCT01677858|40042472|FG004|Overall Study|Physician Decision|12|||
16427356|NCT01677858|40042468|FG000|Overall Study|Progressive Disease|2|||
16427357|NCT01677858|40042469|FG001|Overall Study|Progressive Disease|1|||
16427358|NCT01677858|40042470|FG002|Overall Study|Progressive Disease|9|||
16427359|NCT01677858|40042471|FG003|Overall Study|Progressive Disease|3|||
16427360|NCT01677858|40042472|FG004|Overall Study|Progressive Disease|43|||
16427361|NCT01677858|40042468|FG000|Overall Study|Withdrawal by Subject|0|||
16427362|NCT01677858|40042469|FG001|Overall Study|Withdrawal by Subject|1|||
16427363|NCT01677858|40042470|FG002|Overall Study|Withdrawal by Subject|1|||
16427364|NCT01677858|40042471|FG003|Overall Study|Withdrawal by Subject|0|||
16427365|NCT01677858|40042472|FG004|Overall Study|Withdrawal by Subject|15|||
16427366|NCT01677858|40042468|FG000|Overall Study|Lost to Follow-up|0|||
16427367|NCT01677858|40042469|FG001|Overall Study|Lost to Follow-up|0|||
16427368|NCT01677858|40042470|FG002|Overall Study|Lost to Follow-up|0|||
16427369|NCT01677858|40042471|FG003|Overall Study|Lost to Follow-up|0|||
16427370|NCT01677858|40042472|FG004|Overall Study|Lost to Follow-up|1|||
16427371|NCT00989963|40042473|FG000|Overall Study|Adverse Event|1|||
16427372|NCT00989963|40042474|FG001|Overall Study|Adverse Event|1|||
16427373|NCT00989963|40042475|FG002|Overall Study|Adverse Event|1|||
16427374|NCT00607087|40042478|FG000|Overall Study|Withdrawal by Subject|9|||
16427375|NCT00607087|40042479|FG001|Overall Study|Withdrawal by Subject|4|||
16427376|NCT00607087|40042480|FG002|Overall Study|Withdrawal by Subject|4|||
16427377|NCT00607087|40042478|FG000|Overall Study|Adverse Event|3|||
16427378|NCT00607087|40042479|FG001|Overall Study|Adverse Event|2|||
16427379|NCT00607087|40042480|FG002|Overall Study|Adverse Event|3|||
16427380|NCT00607087|40042478|FG000|Overall Study|Other reason|1|||
16427381|NCT00607087|40042479|FG001|Overall Study|Other reason|5|||
16427382|NCT00607087|40042480|FG002|Overall Study|Other reason|2|||
16427383|NCT00607087|40042478|FG000|Overall Study|Poor compliance to protocol|1|||
16427384|NCT00607087|40042479|FG001|Overall Study|Poor compliance to protocol|0|||
16427385|NCT00607087|40042480|FG002|Overall Study|Poor compliance to protocol|1|||
16427386|NCT00607087|40042478|FG000|Overall Study|Lost to Follow-up|1|||
16427387|NCT00607087|40042479|FG001|Overall Study|Lost to Follow-up|0|||
16427388|NCT00607087|40042480|FG002|Overall Study|Lost to Follow-up|0|||
16427389|NCT00607087|40042478|FG000|Period 1|Withdrawal by Subject|7|||
16427390|NCT00607087|40042479|FG001|Period 1|Withdrawal by Subject|2|||
16427391|NCT00607087|40042480|FG002|Period 1|Withdrawal by Subject|3|||
16427392|NCT00607087|40042478|FG000|Period 1|Adverse Event|3|||
16427393|NCT00607087|40042479|FG001|Period 1|Adverse Event|0|||
16427394|NCT00607087|40042480|FG002|Period 1|Adverse Event|0|||
16427395|NCT00607087|40042478|FG000|Period 1|Poor compliance to protocol|1|||
16427396|NCT00607087|40042479|FG001|Period 1|Poor compliance to protocol|0|||
16427397|NCT00607087|40042480|FG002|Period 1|Poor compliance to protocol|0|||
16427398|NCT00607087|40042478|FG000|Period 1|Lost to Follow-up|1|||
16427399|NCT00607087|40042479|FG001|Period 1|Lost to Follow-up|0|||
16427400|NCT00607087|40042480|FG002|Period 1|Lost to Follow-up|0|||
16427401|NCT00607087|40042478|FG000|Period 1|Other reason|0|||
16427402|NCT00607087|40042479|FG001|Period 1|Other reason|4|||
16427403|NCT00607087|40042480|FG002|Period 1|Other reason|2|||
16427404|NCT00607087|40042478|FG000|Period 2|Withdrawal by Subject|0|||
16427405|NCT00607087|40042479|FG001|Period 2|Withdrawal by Subject|1|||
16427406|NCT00607087|40042480|FG002|Period 2|Withdrawal by Subject|1|||
16427407|NCT00607087|40042478|FG000|Period 2|Other reason|1|||
16427408|NCT00607087|40042479|FG001|Period 2|Other reason|1|||
16427409|NCT00607087|40042480|FG002|Period 2|Other reason|0|||
16427410|NCT00607087|40042478|FG000|Period 2|Adverse Event|0|||
16427411|NCT00607087|40042479|FG001|Period 2|Adverse Event|1|||
16427412|NCT00607087|40042480|FG002|Period 2|Adverse Event|3|||
16427413|NCT00607087|40042478|FG000|Period 2|Poor compliance to protocol|0|||
16427414|NCT00607087|40042479|FG001|Period 2|Poor compliance to protocol|0|||
16427415|NCT00607087|40042480|FG002|Period 2|Poor compliance to protocol|1|||
16427416|NCT00607087|40042478|FG000|Period 3|Withdrawal by Subject|2|||
16427417|NCT00607087|40042479|FG001|Period 3|Withdrawal by Subject|1|||
16427418|NCT00607087|40042480|FG002|Period 3|Withdrawal by Subject|0|||
16427419|NCT00607087|40042478|FG000|Period 3|Adverse Event|0|||
16427420|NCT00607087|40042479|FG001|Period 3|Adverse Event|1|||
16427421|NCT00607087|40042480|FG002|Period 3|Adverse Event|0|||
16131029|NCT00081497|38967187|FG001|Overall Study|Adverse Event|0|||
16427422|NCT00448747|40042481|FG000|Overall Study|collapsed veins|1|||
16427423|NCT00448747|40042482|FG001|Overall Study|collapsed veins|0|||
16427424|NCT01415401|40042483|FG000|Overall Study|Adverse Event|5|||
16427425|NCT01415401|40042483|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
16427426|NCT01415401|40042483|FG000|Overall Study|Terminated by Sponsor|1|||
16427427|NCT02292446|40042484|FG000|Overall Study|Adverse Event|12|||
16427428|NCT02292446|40042484|FG000|Overall Study|Death|1|||
16427429|NCT02292446|40042484|FG000|Overall Study|Disease progression|2|||
16427430|NCT02292446|40042484|FG000|Overall Study|Subject/guardian decision|2|||
16427431|NCT02292446|40042484|FG000|Overall Study|Withdrawal by Subject|3|||
16427432|NCT01959139|40042485|FG000|Phase II|Disease progression|0|||
16427433|NCT01959139|40042486|FG001|Phase II|Disease progression|0|||
16427434|NCT01959139|40042487|FG002|Phase II|Disease progression|26|||
16427435|NCT01959139|40042488|FG003|Phase II|Disease progression|34|||
16427436|NCT01959139|40042485|FG000|Phase II|Adverse Event|0|||
16427437|NCT01959139|40042486|FG001|Phase II|Adverse Event|0|||
16427438|NCT01959139|40042487|FG002|Phase II|Adverse Event|10|||
16427439|NCT01959139|40042488|FG003|Phase II|Adverse Event|11|||
16427440|NCT01959139|40042485|FG000|Phase II|Patient Refusal|0|||
16427441|NCT01959139|40042486|FG001|Phase II|Patient Refusal|0|||
16427442|NCT01959139|40042487|FG002|Phase II|Patient Refusal|5|||
16427443|NCT01959139|40042488|FG003|Phase II|Patient Refusal|4|||
16427444|NCT01959139|40042485|FG000|Phase II|Death|0|||
16427445|NCT01959139|40042486|FG001|Phase II|Death|0|||
16427446|NCT01959139|40042487|FG002|Phase II|Death|3|||
16427447|NCT01959139|40042488|FG003|Phase II|Death|1|||
16427448|NCT01959139|40042485|FG000|Phase II|Other/Unknown|0|||
16427449|NCT01959139|40042486|FG001|Phase II|Other/Unknown|0|||
16427450|NCT01959139|40042487|FG002|Phase II|Other/Unknown|8|||
16427451|NCT01959139|40042488|FG003|Phase II|Other/Unknown|5|||
16427452|NCT01959139|40042485|FG000|Phase II|On treatment|0|||
16427453|NCT01959139|40042486|FG001|Phase II|On treatment|0|||
16427454|NCT01959139|40042487|FG002|Phase II|On treatment|4|||
16427455|NCT01959139|40042488|FG003|Phase II|On treatment|0|||
16427456|NCT01824355|40042490|FG000|Overall Study|Adverse Event|2|||
16249991|NCT02101853|39397987|FG005|Block 1 Induction|Ineligible|0|||
16249992|NCT02101853|39397982|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
16249993|NCT02101853|39397983|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
16249994|NCT02101853|39397984|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
16249995|NCT02101853|39397985|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
16249996|NCT02101853|39397986|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
16249997|NCT02101853|39397987|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
16249998|NCT02101853|39397982|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
16249999|NCT02101853|39397983|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16250000|NCT02101853|39397984|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16250001|NCT02101853|39397985|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16250002|NCT02101853|39397986|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16250003|NCT02101853|39397987|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16250004|NCT02101853|39397982|FG000|Post Induction Randomization|Adverse Event|0|||
16250005|NCT02101853|39397983|FG001|Post Induction Randomization|Adverse Event|3|||
16250006|NCT02101853|39397984|FG002|Post Induction Randomization|Adverse Event|8|||
16250007|NCT02101853|39397985|FG003|Post Induction Randomization|Adverse Event|4|||
16250008|NCT02101853|39397986|FG004|Post Induction Randomization|Adverse Event|4|||
16250009|NCT02101853|39397987|FG005|Post Induction Randomization|Adverse Event|0|||
16250010|NCT02101853|39397982|FG000|Post Induction Randomization|Death|0|||
16250011|NCT02101853|39397983|FG001|Post Induction Randomization|Death|9|||
16250012|NCT02101853|39397984|FG002|Post Induction Randomization|Death|2|||
16250013|NCT02101853|39397985|FG003|Post Induction Randomization|Death|2|||
16250014|NCT02101853|39397986|FG004|Post Induction Randomization|Death|0|||
16250015|NCT02101853|39397987|FG005|Post Induction Randomization|Death|0|||
16250016|NCT02101853|39397982|FG000|Post Induction Randomization|Lack of Efficacy|0|||
16250017|NCT02101853|39397983|FG001|Post Induction Randomization|Lack of Efficacy|14|||
16250018|NCT02101853|39397984|FG002|Post Induction Randomization|Lack of Efficacy|23|||
16250019|NCT02101853|39397985|FG003|Post Induction Randomization|Lack of Efficacy|18|||
16250020|NCT02101853|39397986|FG004|Post Induction Randomization|Lack of Efficacy|21|||
16250021|NCT02101853|39397987|FG005|Post Induction Randomization|Lack of Efficacy|0|||
16250022|NCT02101853|39397982|FG000|Post Induction Randomization|Physician Decision|0|||
16250023|NCT02101853|39397983|FG001|Post Induction Randomization|Physician Decision|43|||
16250024|NCT02101853|39397984|FG002|Post Induction Randomization|Physician Decision|23|||
16427457|NCT01824355|40042490|FG000|Overall Study|unevaluable reference method results per|1|||
16427458|NCT00630344|40042491|FG000|Overall Study|Adverse Event|5|||
16427459|NCT00630344|40042491|FG000|Overall Study|Progressive Disease|19|||
16427460|NCT00630344|40042491|FG000|Overall Study|Physician Decision|9|||
16427461|NCT00630344|40042491|FG000|Overall Study|Withdrawal by Subject|1|||
16427462|NCT00630344|40042491|FG000|Overall Study|Intercurrent Illness|1|||
16427463|NCT00630344|40042491|FG000|Overall Study|Other|1|||
16427464|NCT01529034|40042492|FG000|Overall Study|Discontinued prior to study treatment|14|||
16427465|NCT01529034|40042492|FG000|Overall Study|Site closure|62|||
16427466|NCT01529034|40042492|FG000|Overall Study|Study termination|29|||
16427467|NCT01529034|40042492|FG000|Overall Study|Withdrawal by Subject|25|||
16427468|NCT01529034|40042492|FG000|Overall Study|No treated SCs within protocol window|13|||
16427469|NCT01529034|40042492|FG000|Overall Study|Noncompliance|8|||
16427470|NCT01529034|40042492|FG000|Overall Study|Caregiver no longer available|7|||
16427471|NCT01529034|40042492|FG000|Overall Study|Adverse Event|4|||
16427472|NCT01529034|40042492|FG000|Overall Study|Protocol Violation|4|||
16427473|NCT01529034|40042492|FG000|Overall Study|Lack of Efficacy|4|||
16427474|NCT01529034|40042492|FG000|Overall Study|Investigator no longer available|2|||
16427475|NCT01529034|40042492|FG000|Overall Study|Study drug not available|2|||
16427476|NCT01420926|40042493|FG000|Overall Study|Adverse Event|6|||
16427477|NCT01420926|40042494|FG001|Overall Study|Adverse Event|4|||
16427478|NCT01420926|40042493|FG000|Overall Study|Death|18|||
16427479|NCT01420926|40042494|FG001|Overall Study|Death|17|||
16427480|NCT01420926|40042493|FG000|Overall Study|Withdrawal by Subject|11|||
16427481|NCT01420926|40042494|FG001|Overall Study|Withdrawal by Subject|17|||
16427482|NCT01420926|40042493|FG000|Overall Study|Non-protocol treatment|17|||
16427483|NCT01420926|40042494|FG001|Overall Study|Non-protocol treatment|20|||
16427484|NCT01420926|40042493|FG000|Overall Study|Physician Decision|8|||
16427485|NCT01420926|40042494|FG001|Overall Study|Physician Decision|5|||
16427486|NCT01559675|40042495|FG000|Overall Study|Protocol Violation|1|||
16427487|NCT01559675|40042496|FG001|Overall Study|Protocol Violation|2|||
16427488|NCT01559675|40042495|FG000|Overall Study|2nd operation on same patient excluded|14|||
16427489|NCT01559675|40042496|FG001|Overall Study|2nd operation on same patient excluded|12|||
16427490|NCT01128244|40042498|FG000|Overall Study|Adverse Event|1|||
16427491|NCT01128244|40042498|FG000|Overall Study|Scheduling conflict|2|||
16427492|NCT02844816|40042499|FG000|Overall Study|No protocol treatment received|5|||
16427493|NCT02844816|40042500|FG001|Overall Study|No protocol treatment received|1|||
16427494|NCT02844816|40042499|FG000|Overall Study|Ineligible|22|||
16427495|NCT02844816|40042500|FG001|Overall Study|Ineligible|15|||
16427496|NCT02844816|40042499|FG000|Overall Study|Participant refusal|5|||
16427497|NCT02844816|40042500|FG001|Overall Study|Participant refusal|5|||
16427498|NCT02844816|40042499|FG000|Overall Study|Adverse Event|5|||
16427499|NCT02844816|40042500|FG001|Overall Study|Adverse Event|4|||
16427500|NCT02844816|40042499|FG000|Overall Study|Death|0|||
16427501|NCT02844816|40042500|FG001|Overall Study|Death|1|||
16427502|NCT02844816|40042499|FG000|Overall Study|Disease progression/recurrence|50|||
16427503|NCT02844816|40042500|FG001|Overall Study|Disease progression/recurrence|24|||
16427504|NCT02844816|40042499|FG000|Overall Study|Physician Decision|1|||
16427505|NCT02844816|40042500|FG001|Overall Study|Physician Decision|1|||
16427506|NCT00203424|40042501|FG000|Treatment Period|Withdrawal by Subject|4|||
16427507|NCT00203424|40042501|FG000|Treatment Period|Adverse Event|5|||
16427508|NCT00203424|40042501|FG000|Treatment Period|progressive disease|2|||
16427509|NCT00203424|40042501|FG000|Follow-up Period|Withdrawal by Subject|1|||
16427510|NCT00203424|40042501|FG000|Follow-up Period|progressive disease|4|||
16427511|NCT00203424|40042501|FG000|Follow-up Period|Lost to Follow-up|1|||
16427512|NCT02950480|40042504|FG000|Overall Study|Withdrawal by Subject|1|||
16427513|NCT02950480|40042505|FG001|Overall Study|Withdrawal by Subject|0|||
16427514|NCT03003962|40042521|FG000|Overall Study|Withdrawal by Subject|5|||
16427515|NCT03003962|40042522|FG001|Overall Study|Withdrawal by Subject|17|||
16427516|NCT03003962|40042521|FG000|Overall Study|Death|274|||
16427517|NCT03003962|40042522|FG001|Overall Study|Death|277|||
16427518|NCT03003962|40042521|FG000|Overall Study|Participants ongoing at DCO|55|||
16427519|NCT03003962|40042522|FG001|Overall Study|Participants ongoing at DCO|40|||
16427520|NCT01946152|40042523|FG000|Overall Study|Adverse Event|1|||
16427521|NCT01946152|40042524|FG001|Overall Study|Adverse Event|0|||
16427522|NCT01946152|40042525|FG002|Overall Study|Adverse Event|0|||
16427523|NCT01946152|40042526|FG003|Overall Study|Adverse Event|0|||
16427524|NCT01946152|40042523|FG000|Overall Study|Withdrawal by Subject|0|||
16427525|NCT01946152|40042524|FG001|Overall Study|Withdrawal by Subject|2|||
16427526|NCT01946152|40042525|FG002|Overall Study|Withdrawal by Subject|0|||
16427527|NCT01946152|40042526|FG003|Overall Study|Withdrawal by Subject|0|||
16427528|NCT01946152|40042523|FG000|Overall Study|Progression|0|||
16427529|NCT01946152|40042524|FG001|Overall Study|Progression|1|||
16427530|NCT01946152|40042525|FG002|Overall Study|Progression|4|||
16427531|NCT01946152|40042526|FG003|Overall Study|Progression|7|||
16427532|NCT01946152|40042523|FG000|Overall Study|Physician Decision|0|||
16427533|NCT01946152|40042524|FG001|Overall Study|Physician Decision|0|||
16427534|NCT01946152|40042525|FG002|Overall Study|Physician Decision|1|||
16427535|NCT01946152|40042526|FG003|Overall Study|Physician Decision|0|||
16427536|NCT01946152|40042523|FG000|Overall Study|Second malignancy|0|||
16562758|NCT01474512|40525476|FG016|Maintenance Period|Withdrawal by Subject|0|||
16562759|NCT01474512|40525477|FG017|Maintenance Period|Withdrawal by Subject|0|||
16562760|NCT01474512|40525460|FG000|Maintenance Period|Lost to Follow-up|0|||
16562761|NCT01474512|40525461|FG001|Maintenance Period|Lost to Follow-up|0|||
16427537|NCT01946152|40042524|FG001|Overall Study|Second malignancy|0|||
16427538|NCT01946152|40042525|FG002|Overall Study|Second malignancy|1|||
16427539|NCT01946152|40042526|FG003|Overall Study|Second malignancy|0|||
16427540|NCT01946152|40042523|FG000|Overall Study|Adverse Event|0|||
16427541|NCT01946152|40042524|FG001|Overall Study|Adverse Event|0|||
16427542|NCT01946152|40042525|FG002|Overall Study|Adverse Event|0|||
16427543|NCT01946152|40042526|FG003|Overall Study|Adverse Event|1|||
16427544|NCT01510158|40042529|FG000|Overall Study|Adverse Event|7|||
16427545|NCT01510158|40042530|FG001|Overall Study|Adverse Event|8|||
16427546|NCT01510158|40042531|FG002|Overall Study|Adverse Event|5|||
16427547|NCT01510158|40042529|FG000|Overall Study|Gout flare|1|||
16427548|NCT01510158|40042530|FG001|Overall Study|Gout flare|0|||
16427549|NCT01510158|40042531|FG002|Overall Study|Gout flare|0|||
16427550|NCT01510158|40042529|FG000|Overall Study|Protocol Violation|17|||
16427551|NCT01510158|40042530|FG001|Overall Study|Protocol Violation|16|||
16427552|NCT01510158|40042531|FG002|Overall Study|Protocol Violation|24|||
16427553|NCT01510158|40042529|FG000|Overall Study|Sponsor terminated study.|2|||
16427554|NCT01510158|40042530|FG001|Overall Study|Sponsor terminated study.|0|||
16427555|NCT01510158|40042531|FG002|Overall Study|Sponsor terminated study.|2|||
16427556|NCT01510158|40042529|FG000|Overall Study|Lost to Follow-up|13|||
16427557|NCT01510158|40042530|FG001|Overall Study|Lost to Follow-up|16|||
16427558|NCT01510158|40042531|FG002|Overall Study|Lost to Follow-up|9|||
16427559|NCT01510158|40042529|FG000|Overall Study|Withdrawal by Subject|10|||
16427560|NCT01510158|40042530|FG001|Overall Study|Withdrawal by Subject|13|||
16427561|NCT01510158|40042531|FG002|Overall Study|Withdrawal by Subject|10|||
16250025|NCT02101853|39397985|FG003|Post Induction Randomization|Physician Decision|14|||
16250026|NCT02101853|39397986|FG004|Post Induction Randomization|Physician Decision|14|||
16250027|NCT02101853|39397987|FG005|Post Induction Randomization|Physician Decision|0|||
16250028|NCT02101853|39397982|FG000|Post Induction Randomization|Protocol Violation|0|||
16250029|NCT02101853|39397983|FG001|Post Induction Randomization|Protocol Violation|3|||
16250030|NCT02101853|39397984|FG002|Post Induction Randomization|Protocol Violation|0|||
16250031|NCT02101853|39397985|FG003|Post Induction Randomization|Protocol Violation|0|||
16250032|NCT02101853|39397986|FG004|Post Induction Randomization|Protocol Violation|0|||
16250033|NCT02101853|39397987|FG005|Post Induction Randomization|Protocol Violation|0|||
16250034|NCT02101853|39397982|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
16250035|NCT02101853|39397983|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
16250036|NCT02101853|39397984|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
16250037|NCT02101853|39397985|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
16250038|NCT02101853|39397986|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
16250039|NCT02101853|39397987|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
16250040|NCT02101853|39397982|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16250041|NCT02101853|39397983|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16250042|NCT02101853|39397984|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16427562|NCT01510158|40042529|FG000|Overall Study|Death|1|||
16427563|NCT01510158|40042530|FG001|Overall Study|Death|0|||
16427564|NCT01510158|40042531|FG002|Overall Study|Death|0|||
16427565|NCT00479856|40042532|FG000|Overall Study|Adverse Event|1|||
16427566|NCT00479856|40042532|FG000|Overall Study|Withdrawal by Subject|1|||
16427567|NCT00479856|40042532|FG000|Overall Study|Physician Decision|1|||
16427568|NCT01427933|40042538|FG000|Overall Study|Withdrawal by Subject|5|||
16427569|NCT01427933|40042539|FG001|Overall Study|Withdrawal by Subject|8|||
16562762|NCT01474512|40525462|FG002|Maintenance Period|Lost to Follow-up|0|||
16562763|NCT01474512|40525463|FG003|Maintenance Period|Lost to Follow-up|3|||
16562764|NCT01474512|40525464|FG004|Maintenance Period|Lost to Follow-up|3|||
16562765|NCT01474512|40525465|FG005|Maintenance Period|Lost to Follow-up|0|||
16562766|NCT01474512|40525466|FG006|Maintenance Period|Lost to Follow-up|0|||
16562767|NCT01474512|40525467|FG007|Maintenance Period|Lost to Follow-up|2|||
16562768|NCT01474512|40525468|FG008|Maintenance Period|Lost to Follow-up|1|||
16562769|NCT01474512|40525469|FG009|Maintenance Period|Lost to Follow-up|1|||
16562770|NCT01474512|40525470|FG010|Maintenance Period|Lost to Follow-up|0|||
16562771|NCT01474512|40525471|FG011|Maintenance Period|Lost to Follow-up|0|||
16562772|NCT01474512|40525472|FG012|Maintenance Period|Lost to Follow-up|0|||
16562773|NCT01474512|40525473|FG013|Maintenance Period|Lost to Follow-up|0|||
16562774|NCT01474512|40525474|FG014|Maintenance Period|Lost to Follow-up|0|||
16562775|NCT01474512|40525475|FG015|Maintenance Period|Lost to Follow-up|0|||
16562776|NCT01474512|40525476|FG016|Maintenance Period|Lost to Follow-up|0|||
16562777|NCT01474512|40525477|FG017|Maintenance Period|Lost to Follow-up|0|||
16562778|NCT01474512|40525460|FG000|Maintenance Period|Death|0|||
16562779|NCT01474512|40525461|FG001|Maintenance Period|Death|0|||
16562780|NCT01474512|40525462|FG002|Maintenance Period|Death|0|||
16562781|NCT01474512|40525463|FG003|Maintenance Period|Death|0|||
16562782|NCT01474512|40525464|FG004|Maintenance Period|Death|0|||
16562783|NCT01474512|40525465|FG005|Maintenance Period|Death|2|||
16427570|NCT01427933|40042538|FG000|Overall Study|Lost to Follow-up|1|||
16427571|NCT01427933|40042539|FG001|Overall Study|Lost to Follow-up|5|||
16427572|NCT01427933|40042538|FG000|Overall Study|Other|1|||
16562784|NCT01474512|40525466|FG006|Maintenance Period|Death|0|||
16427573|NCT01427933|40042539|FG001|Overall Study|Other|0|||
16427574|NCT01427933|40042538|FG000|Overall Study|Investigator's Decision|1|||
16562785|NCT01474512|40525467|FG007|Maintenance Period|Death|0|||
16562786|NCT01474512|40525468|FG008|Maintenance Period|Death|0|||
16562787|NCT01474512|40525469|FG009|Maintenance Period|Death|0|||
16562788|NCT01474512|40525470|FG010|Maintenance Period|Death|0|||
16562789|NCT01474512|40525471|FG011|Maintenance Period|Death|0|||
16562790|NCT01474512|40525472|FG012|Maintenance Period|Death|0|||
16562791|NCT01474512|40525473|FG013|Maintenance Period|Death|0|||
16427575|NCT01427933|40042539|FG001|Overall Study|Investigator's Decision|0|||
16427576|NCT01629953|40042544|FG000|Overall Study|Death|3|||
16427577|NCT01629953|40042545|FG001|Overall Study|Death|1|||
16427578|NCT01629953|40042544|FG000|Overall Study|Lost to Follow-up|10|||
16427579|NCT01629953|40042545|FG001|Overall Study|Lost to Follow-up|14|||
16427580|NCT00707954|40042546|FG000|Overall Study|Physician Decision|0|||
16427581|NCT00707954|40042547|FG001|Overall Study|Physician Decision|0|||
16427582|NCT00707954|40042548|FG002|Overall Study|Physician Decision|0|||
16427583|NCT00707954|40042549|FG003|Overall Study|Physician Decision|0|||
16427584|NCT00707954|40042550|FG004|Overall Study|Physician Decision|1|||
16427585|NCT00847886|40042557|FG000|Overall Study|Adverse Event|0|||
16427586|NCT00847886|40042558|FG001|Overall Study|Adverse Event|1|||
16427587|NCT04207749|40042560|FG000|Overall Study|Lost to Follow-up|0|||
16427588|NCT04207749|40042561|FG001|Overall Study|Lost to Follow-up|2|||
16427589|NCT04207749|40042560|FG000|Overall Study|Protocol Violation|0|||
16427590|NCT04207749|40042561|FG001|Overall Study|Protocol Violation|1|||
16427591|NCT04207749|40042560|FG000|Overall Study|Withdrawal by Subject|3|||
16427592|NCT04207749|40042561|FG001|Overall Study|Withdrawal by Subject|0|||
16427593|NCT04207749|40042560|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
16427594|NCT04207749|40042561|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
16427595|NCT01235234|40042562|FG000|Overall Study|Adverse Event|2|||
16427596|NCT01235234|40042563|FG001|Overall Study|Adverse Event|2|||
16427597|NCT01235234|40042564|FG002|Overall Study|Adverse Event|1|||
16427598|NCT02669212|40042566|FG000|Overall Study|Lost to Follow-up|1|||
16427599|NCT02669212|40042567|FG001|Overall Study|Lost to Follow-up|0|||
16427600|NCT02669212|40042566|FG000|Overall Study|Medical Condition|3|||
16427601|NCT02669212|40042567|FG001|Overall Study|Medical Condition|4|||
16427602|NCT02669212|40042566|FG000|Overall Study|Withdrawal by Subject|0|||
16427603|NCT02669212|40042567|FG001|Overall Study|Withdrawal by Subject|2|||
16427604|NCT02669212|40042566|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
16427605|NCT02669212|40042567|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
16427606|NCT02488005|40042570|FG000|Overall Study|Lost to Follow-up|2|||
16427607|NCT01504412|40042571|FG000|Overall Study|Adverse Event|1|||
16427608|NCT01504412|40042572|FG001|Overall Study|Adverse Event|8|||
16427609|NCT01504412|40042573|FG002|Overall Study|Adverse Event|1|||
16427610|NCT01504412|40042574|FG003|Overall Study|Adverse Event|7|||
16427611|NCT01504412|40042575|FG004|Overall Study|Adverse Event|10|||
16427612|NCT01504412|40042571|FG000|Overall Study|Withdrawal by Subject|2|||
16427613|NCT01504412|40042572|FG001|Overall Study|Withdrawal by Subject|1|||
16427614|NCT01504412|40042573|FG002|Overall Study|Withdrawal by Subject|1|||
16427615|NCT01504412|40042574|FG003|Overall Study|Withdrawal by Subject|5|||
16427616|NCT01504412|40042575|FG004|Overall Study|Withdrawal by Subject|1|||
16427617|NCT01504412|40042571|FG000|Overall Study|Other|2|||
16427618|NCT01504412|40042572|FG001|Overall Study|Other|1|||
16427619|NCT01504412|40042573|FG002|Overall Study|Other|1|||
16427620|NCT01504412|40042574|FG003|Overall Study|Other|6|||
16427621|NCT01504412|40042575|FG004|Overall Study|Other|1|||
16427622|NCT01504412|40042571|FG000|Overall Study|Lost to Follow-up|0|||
16427623|NCT01504412|40042572|FG001|Overall Study|Lost to Follow-up|2|||
16427624|NCT01504412|40042573|FG002|Overall Study|Lost to Follow-up|0|||
16427625|NCT01504412|40042574|FG003|Overall Study|Lost to Follow-up|0|||
16427626|NCT01504412|40042575|FG004|Overall Study|Lost to Follow-up|0|||
16427627|NCT01504412|40042571|FG000|Overall Study|Lack of Efficacy|0|||
16427628|NCT01504412|40042572|FG001|Overall Study|Lack of Efficacy|0|||
16427629|NCT01504412|40042573|FG002|Overall Study|Lack of Efficacy|1|||
16427630|NCT01504412|40042574|FG003|Overall Study|Lack of Efficacy|0|||
16427631|NCT01504412|40042575|FG004|Overall Study|Lack of Efficacy|1|||
16427632|NCT01504412|40042571|FG000|Overall Study|Death|0|||
16427633|NCT01504412|40042572|FG001|Overall Study|Death|0|||
16427634|NCT01504412|40042573|FG002|Overall Study|Death|0|||
16427635|NCT01504412|40042574|FG003|Overall Study|Death|1|||
16427636|NCT01504412|40042575|FG004|Overall Study|Death|0|||
16427637|NCT00517361|40042576|FG000|Overall Study|Death|6|||
16427638|NCT00517361|40042576|FG000|Overall Study|The study was terminated|5|||
16427639|NCT02478164|40042577|FG000|Overall Study|Lack of Efficacy|13|||
16427640|NCT02478164|40042577|FG000|Overall Study|Adverse Event|1|||
16427641|NCT02478164|40042577|FG000|Overall Study|Withdrawal by Subject|1|||
16427642|NCT00539305|40042580|FG000|Overall Study|Adverse Event|1|||
16427643|NCT00539305|40042581|FG001|Overall Study|Adverse Event|0|||
16427644|NCT00539305|40042580|FG000|Overall Study|Substance Use|0|||
16562792|NCT01474512|40525474|FG014|Maintenance Period|Death|0|||
16562793|NCT01474512|40525475|FG015|Maintenance Period|Death|0|||
16427645|NCT00539305|40042581|FG001|Overall Study|Substance Use|1|||
16427646|NCT00539305|40042580|FG000|Overall Study|Withdrawal by Subject|0|||
16427647|NCT00539305|40042581|FG001|Overall Study|Withdrawal by Subject|1|||
16427648|NCT04868968|40042582|FG000|Overall Study|Lost to Follow-up|1|||
16427649|NCT01378325|40042583|FG000|Overall Study|Protocol Violation|0|||
16427650|NCT01378325|40042584|FG001|Overall Study|Protocol Violation|1|||
16427651|NCT02828436|40042585|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
16562794|NCT01474512|40525476|FG016|Maintenance Period|Death|0|||
16427652|NCT02828436|40042586|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
16427653|NCT02828436|40042585|FG000|Period 1|Lost to Follow-up|0|||
16427654|NCT02828436|40042586|FG001|Period 1|Lost to Follow-up|1|||
16427655|NCT02828436|40042585|FG000|Period 2|Withdrawal by Subject|4|||
16427656|NCT02828436|40042586|FG001|Period 2|Withdrawal by Subject|0|||
16427657|NCT02828436|40042585|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
16427658|NCT02828436|40042586|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
16427659|NCT02828436|40042585|FG000|Period 2|Lost to Follow-up|1|||
16427660|NCT02828436|40042586|FG001|Period 2|Lost to Follow-up|0|||
16427661|NCT00965575|40042592|FG000|Overall Study|subject unwillingness to swallow study c|1|||
16427662|NCT00965575|40042593|FG001|Overall Study|subject unwillingness to swallow study c|0|||
16427663|NCT00104650|40042599|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
16427664|NCT00104650|40042600|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
16427665|NCT00104650|40042601|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
16427666|NCT00104650|40042599|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
16427667|NCT00104650|40042600|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
16427668|NCT00104650|40042601|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
16427669|NCT00104650|40042599|FG000|Treatment Period (25 Weeks)|Death|7|||
16427670|NCT00104650|40042600|FG001|Treatment Period (25 Weeks)|Death|5|||
16427671|NCT00104650|40042601|FG002|Treatment Period (25 Weeks)|Death|6|||
16427672|NCT00104650|40042599|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
16427673|NCT00104650|40042600|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
16131030|NCT00081497|38967186|FG000|Overall Study|Death|0|||
16427674|NCT00104650|40042601|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
16131031|NCT00081497|38967187|FG001|Overall Study|Death|1|||
16131032|NCT00081497|38967186|FG000|Overall Study|Withdrawal by Subject|1|||
16131033|NCT00081497|38967187|FG001|Overall Study|Withdrawal by Subject|0|||
16131034|NCT00081497|38967186|FG000|Overall Study|Non-compliance|0|||
16427675|NCT00104650|40042599|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
16427676|NCT00104650|40042600|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
16427677|NCT00104650|40042601|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
16427678|NCT00104650|40042599|FG000|Treatment Period (25 Weeks)|Other|1|||
16131035|NCT00081497|38967187|FG001|Overall Study|Non-compliance|1|||
16131036|NCT01201265|38967188|FG000|Overall Study|Death|14|||
16131037|NCT01201265|38967188|FG000|Overall Study|Insufficient Therapeutic Response|3|||
16131038|NCT01201265|38967188|FG000|Overall Study|Lost to Follow-up|10|||
16427679|NCT00104650|40042600|FG001|Treatment Period (25 Weeks)|Other|0|||
16427680|NCT00104650|40042601|FG002|Treatment Period (25 Weeks)|Other|0|||
16131039|NCT01201265|38967188|FG000|Overall Study|Withdrawal by Subject|7|||
16131040|NCT01201265|38967188|FG000|Overall Study|Disease Progression|4|||
16131041|NCT02891408|38967189|FG000|Overall Study|Lost to Follow-up|0|||
16131042|NCT02891408|38967190|FG001|Overall Study|Lost to Follow-up|0|||
16131043|NCT02891408|38967191|FG002|Overall Study|Lost to Follow-up|1|||
16131044|NCT02891408|38967192|FG003|Overall Study|Lost to Follow-up|0|||
16131045|NCT02891408|38967193|FG004|Overall Study|Lost to Follow-up|0|||
16427681|NCT00104650|40042599|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
16131046|NCT02891408|38967194|FG005|Overall Study|Lost to Follow-up|0|||
16131047|NCT02891408|38967195|FG006|Overall Study|Lost to Follow-up|0|||
16131048|NCT01768637|38967196|FG000|Overall Study|Lost to Follow-up|2|||
16131049|NCT01768637|38967197|FG001|Overall Study|Lost to Follow-up|7|||
16131050|NCT01768637|38967196|FG000|Overall Study|Difficult blood draw|1|||
16131051|NCT01768637|38967197|FG001|Overall Study|Difficult blood draw|0|||
16131052|NCT02516332|38967198|FG000|Overall Study|Withdrawal by Subject|2|||
16427682|NCT00104650|40042600|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
16131053|NCT02516332|38967199|FG001|Overall Study|Withdrawal by Subject|1|||
16427683|NCT00104650|40042601|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
16427684|NCT00104650|40042599|FG000|Follow-up Period|Physician Decision|1|||
16427685|NCT00104650|40042600|FG001|Follow-up Period|Physician Decision|1|||
16427686|NCT00104650|40042601|FG002|Follow-up Period|Physician Decision|0|||
16427687|NCT00104650|40042599|FG000|Follow-up Period|Adverse Event|1|||
16427688|NCT00104650|40042600|FG001|Follow-up Period|Adverse Event|0|||
16427689|NCT00104650|40042601|FG002|Follow-up Period|Adverse Event|1|||
16427690|NCT00104650|40042599|FG000|Follow-up Period|Withdrawal by Subject|0|||
16427691|NCT00104650|40042600|FG001|Follow-up Period|Withdrawal by Subject|3|||
16427692|NCT00104650|40042601|FG002|Follow-up Period|Withdrawal by Subject|3|||
16427693|NCT00104650|40042599|FG000|Follow-up Period|Death|6|||
16427694|NCT00104650|40042600|FG001|Follow-up Period|Death|6|||
16427695|NCT00104650|40042601|FG002|Follow-up Period|Death|4|||
16427696|NCT00104650|40042599|FG000|Follow-up Period|Disease progression|3|||
16427697|NCT00104650|40042600|FG001|Follow-up Period|Disease progression|1|||
16427698|NCT00104650|40042601|FG002|Follow-up Period|Disease progression|0|||
16427699|NCT00104650|40042599|FG000|Follow-up Period|Lost to Follow-up|0|||
16427700|NCT00104650|40042600|FG001|Follow-up Period|Lost to Follow-up|1|||
16427701|NCT00104650|40042601|FG002|Follow-up Period|Lost to Follow-up|2|||
16427702|NCT00104650|40042599|FG000|Follow-up Period|Other|0|||
16427703|NCT00104650|40042600|FG001|Follow-up Period|Other|1|||
16427704|NCT00104650|40042601|FG002|Follow-up Period|Other|0|||
16427705|NCT02630472|40042602|FG000|Overall Study|Physician Decision|10|||
16427706|NCT02630472|40042603|FG001|Overall Study|Physician Decision|0|||
16427707|NCT03927144|40042609|FG000|Core Phase|Adverse Event|9|||
16427708|NCT03927144|40042610|FG001|Core Phase|Adverse Event|5|||
16427709|NCT03927144|40042609|FG000|Core Phase|Lost to Follow-up|3|||
16427710|NCT03927144|40042610|FG001|Core Phase|Lost to Follow-up|2|||
16427711|NCT03927144|40042609|FG000|Core Phase|New Therapy for Study Indication|0|||
16427712|NCT03927144|40042610|FG001|Core Phase|New Therapy for Study Indication|1|||
16427713|NCT03927144|40042609|FG000|Core Phase|No Longer Clinically Benefiting|4|||
16427714|NCT03927144|40042610|FG001|Core Phase|No Longer Clinically Benefiting|4|||
16427715|NCT03927144|40042609|FG000|Core Phase|Physician Decision|2|||
16427716|NCT03927144|40042610|FG001|Core Phase|Physician Decision|8|||
16427717|NCT03927144|40042609|FG000|Core Phase|Protocol Violation|2|||
16427718|NCT03927144|40042610|FG001|Core Phase|Protocol Violation|2|||
16427719|NCT03927144|40042609|FG000|Core Phase|Withdrawal by Subject|16|||
16427720|NCT03927144|40042610|FG001|Core Phase|Withdrawal by Subject|40|||
16427721|NCT03927144|40042609|FG000|Extension Phase|Adverse Event|2|||
16427722|NCT03927144|40042610|FG001|Extension Phase|Adverse Event|1|||
16427723|NCT03927144|40042609|FG000|Extension Phase|No longer clinically benefiting|4|||
16427724|NCT03927144|40042610|FG001|Extension Phase|No longer clinically benefiting|5|||
16427725|NCT03927144|40042609|FG000|Extension Phase|Pregnancy|1|||
16427726|NCT03927144|40042610|FG001|Extension Phase|Pregnancy|0|||
16427727|NCT03927144|40042609|FG000|Extension Phase|Protocol Violation|0|||
16427728|NCT03927144|40042610|FG001|Extension Phase|Protocol Violation|1|||
16427729|NCT03927144|40042609|FG000|Extension Phase|Withdrawal by Subject|8|||
16427730|NCT03927144|40042610|FG001|Extension Phase|Withdrawal by Subject|3|||
16427731|NCT03499314|40042611|FG000|Overall Study|Time Commitment|1|||
16427732|NCT03499314|40042612|FG001|Overall Study|Time Commitment|2|||
16427733|NCT03499314|40042611|FG000|Overall Study|Medical issue unrelated to research study|1|||
16427734|NCT03499314|40042612|FG001|Overall Study|Medical issue unrelated to research study|1|||
16427735|NCT01587040|40042619|FG000|Overall Study|Protocol Violation|0|||
16427736|NCT01587040|40042620|FG001|Overall Study|Protocol Violation|0|||
16427737|NCT01587040|40042621|FG002|Overall Study|Protocol Violation|1|||
16427738|NCT01587040|40042622|FG003|Overall Study|Protocol Violation|0|||
16427739|NCT01587040|40042619|FG000|Overall Study|Adverse Event|0|||
16427740|NCT01587040|40042620|FG001|Overall Study|Adverse Event|1|||
16427741|NCT01587040|40042621|FG002|Overall Study|Adverse Event|10|||
16427742|NCT01587040|40042622|FG003|Overall Study|Adverse Event|0|||
16427743|NCT01587040|40042619|FG000|Overall Study|Disease progression|12|||
16427744|NCT01587040|40042620|FG001|Overall Study|Disease progression|1|||
16427745|NCT01587040|40042621|FG002|Overall Study|Disease progression|15|||
16427746|NCT01587040|40042622|FG003|Overall Study|Disease progression|3|||
16427747|NCT01587040|40042619|FG000|Overall Study|Other than specified|5|||
16427748|NCT01587040|40042620|FG001|Overall Study|Other than specified|1|||
16427749|NCT01587040|40042621|FG002|Overall Study|Other than specified|11|||
16427750|NCT01587040|40042622|FG003|Overall Study|Other than specified|1|||
16427751|NCT01754493|40042625|FG000|Overall Study|Adverse Event|1|||
16427752|NCT01754493|40042625|FG000|Overall Study|Lost to Follow-up|3|||
16427753|NCT01754493|40042625|FG000|Overall Study|Withdrawal by Subject|1|||
16427754|NCT01754493|40042625|FG000|Overall Study|Moved out of town|1|||
16427755|NCT01754493|40042625|FG000|Overall Study|Scheduling conflict|1|||
16427756|NCT02333799|40042627|FG000|Treatment Period|Withdrawal by Subject|1|||
16427757|NCT02333799|40042627|FG000|Treatment Period|Death|6|||
16427758|NCT02333799|40042627|FG000|6 Month Follow Up Period|Physician Decision|1|||
16427759|NCT02333799|40042627|FG000|6 Month Follow Up Period|Death|1|||
16427760|NCT02333799|40042627|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
16427761|NCT02333799|40042627|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
16427762|NCT00988091|40042629|FG000|Double-blind Period|Withdrawal by Subject|15|||
16427763|NCT00988091|40042630|FG001|Double-blind Period|Withdrawal by Subject|13|||
16427764|NCT00988091|40042629|FG000|Double-blind Period|Lost to Follow-up|12|||
16427765|NCT00988091|40042630|FG001|Double-blind Period|Lost to Follow-up|14|||
16427766|NCT00988091|40042629|FG000|Double-blind Period|Other|8|||
16427767|NCT00988091|40042630|FG001|Double-blind Period|Other|8|||
16427768|NCT00988091|40042629|FG000|Double-blind Period|Adverse Event|6|||
16427769|NCT00988091|40042630|FG001|Double-blind Period|Adverse Event|9|||
16427770|NCT00988091|40042629|FG000|Double-blind Period|Use of exclusionary medication|2|||
16427771|NCT00988091|40042630|FG001|Double-blind Period|Use of exclusionary medication|3|||
16427772|NCT00988091|40042629|FG000|Open-label Period|Adverse Event|4|||
16427773|NCT00988091|40042630|FG001|Open-label Period|Adverse Event|7|||
16427774|NCT00988091|40042629|FG000|Open-label Period|Use of exclusionary medication|1|||
16427775|NCT00988091|40042630|FG001|Open-label Period|Use of exclusionary medication|1|||
16427776|NCT00988091|40042629|FG000|Open-label Period|Protocol Violation|1|||
16427777|NCT00988091|40042630|FG001|Open-label Period|Protocol Violation|1|||
16427778|NCT00988091|40042629|FG000|Open-label Period|Withdrawal by Subject|10|||
16427779|NCT00988091|40042630|FG001|Open-label Period|Withdrawal by Subject|16|||
16427780|NCT00988091|40042629|FG000|Open-label Period|Lost to Follow-up|3|||
16427781|NCT00988091|40042630|FG001|Open-label Period|Lost to Follow-up|5|||
16427782|NCT00988091|40042629|FG000|Open-label Period|Other|2|||
16427783|NCT00988091|40042630|FG001|Open-label Period|Other|3|||
16427784|NCT03521141|40042633|FG000|Overall Study|Death|1|||
16427785|NCT03521141|40042634|FG001|Overall Study|Death|0|||
16427786|NCT03521141|40042635|FG002|Overall Study|Death|1|||
16427787|NCT01036321|40042636|FG000|Overall Study|Ineligible after randomization|0|||
16427788|NCT01036321|40042637|FG001|Overall Study|Ineligible after randomization|1|||
16427789|NCT01036321|40042636|FG000|Overall Study|Withdrawal by Subject|3|||
16427790|NCT01036321|40042637|FG001|Overall Study|Withdrawal by Subject|2|||
16427791|NCT01036321|40042636|FG000|Overall Study|Adverse Event|2|||
16427792|NCT01036321|40042637|FG001|Overall Study|Adverse Event|1|||
16427793|NCT05258149|40042638|FG000|Period 1|Protocol Deviation|1|||
16427794|NCT05258149|40042639|FG001|Period 1|Protocol Deviation|0|||
16427795|NCT05258149|40042638|FG000|Period 1|Adverse Event|0|||
16427796|NCT05258149|40042639|FG001|Period 1|Adverse Event|1|||
16427797|NCT05258149|40042638|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
16427798|NCT05258149|40042639|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
16427799|NCT05258149|40042638|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
16427800|NCT05258149|40042639|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
16427801|NCT05258149|40042638|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
16427802|NCT05258149|40042639|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
16427803|NCT00837213|40046978|FG000|Overall Study|Lost to Follow-up|3|||
16427804|NCT00837213|40046979|FG001|Overall Study|Lost to Follow-up|2|||
16427805|NCT00837213|40046978|FG000|Overall Study|Withdrawal by Subject|2|||
16427806|NCT00837213|40046979|FG001|Overall Study|Withdrawal by Subject|2|||
16427807|NCT00837213|40046978|FG000|Overall Study|not stated|1|||
16427808|NCT00837213|40046979|FG001|Overall Study|not stated|1|||
16427809|NCT05249569|40046981|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
16427810|NCT01080807|40046982|FG000|Overall Study|Adverse Event|9|||
16427811|NCT01080807|40046983|FG001|Overall Study|Adverse Event|1|||
16427812|NCT01080807|40046982|FG000|Overall Study|Lack of Efficacy|0|||
16427813|NCT01080807|40046983|FG001|Overall Study|Lack of Efficacy|1|||
16427814|NCT01080807|40046982|FG000|Overall Study|Withdrawal by Subject|7|||
16427815|NCT01080807|40046983|FG001|Overall Study|Withdrawal by Subject|2|||
16427816|NCT01080807|40046982|FG000|Overall Study|Protocol Violation|7|||
16427817|NCT01080807|40046983|FG001|Overall Study|Protocol Violation|6|||
16427818|NCT01080807|40046982|FG000|Overall Study|Lost to Follow-up|6|||
16427819|NCT01080807|40046983|FG001|Overall Study|Lost to Follow-up|4|||
16427820|NCT01080807|40046982|FG000|Overall Study|Noncompliance with drug administration|1|||
16427821|NCT01080807|40046983|FG001|Overall Study|Noncompliance with drug administration|1|||
16427822|NCT01080807|40046982|FG000|Overall Study|Noncompliance to study procedures|1|||
16427823|NCT01080807|40046983|FG001|Overall Study|Noncompliance to study procedures|1|||
16427824|NCT01080807|40046982|FG000|Overall Study|Began working day shift|0|||
16427825|NCT01080807|40046983|FG001|Overall Study|Began working day shift|2|||
16427826|NCT01080807|40046982|FG000|Overall Study|Laid off or terminated from job|1|||
16427827|NCT01080807|40046983|FG001|Overall Study|Laid off or terminated from job|2|||
16427828|NCT01080807|40046982|FG000|Overall Study|Stopped working consistent night shifts|0|||
16427829|NCT01080807|40046983|FG001|Overall Study|Stopped working consistent night shifts|1|||
16427830|NCT01080807|40046982|FG000|Overall Study|Work schedule changing|1|||
16427831|NCT01080807|40046983|FG001|Overall Study|Work schedule changing|1|||
16427832|NCT01080807|40046982|FG000|Overall Study|Work schedule and travel|0|||
16427833|NCT01080807|40046983|FG001|Overall Study|Work schedule and travel|1|||
16427834|NCT01080807|40046982|FG000|Overall Study|Switched to first shift|1|||
16427835|NCT01080807|40046983|FG001|Overall Study|Switched to first shift|0|||
16250043|NCT02101853|39397985|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
16250044|NCT02101853|39397986|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16250045|NCT02101853|39397987|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
16250046|NCT02101853|39397982|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
16250047|NCT02101853|39397983|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
16250048|NCT02101853|39397984|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
16250049|NCT02101853|39397985|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
16250050|NCT02101853|39397986|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
16250051|NCT02101853|39397987|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
16250052|NCT02101853|39397982|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
16250053|NCT02101853|39397983|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
16250054|NCT02101853|39397984|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
16250055|NCT02101853|39397985|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
16250056|NCT02101853|39397986|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
16250057|NCT02101853|39397987|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
16250058|NCT02101853|39397982|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
16250059|NCT02101853|39397983|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
16250060|NCT02101853|39397984|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
16250061|NCT02101853|39397985|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
16250062|NCT02101853|39397986|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
16250063|NCT02101853|39397987|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
16250064|NCT02101853|39397982|FG000|Blinatumomab Salvage Therapy|Death|0|||
16250065|NCT02101853|39397983|FG001|Blinatumomab Salvage Therapy|Death|0|||
16250066|NCT02101853|39397984|FG002|Blinatumomab Salvage Therapy|Death|0|||
16250067|NCT02101853|39397985|FG003|Blinatumomab Salvage Therapy|Death|0|||
16250068|NCT02101853|39397986|FG004|Blinatumomab Salvage Therapy|Death|0|||
16250069|NCT02101853|39397987|FG005|Blinatumomab Salvage Therapy|Death|2|||
16250070|NCT02101853|39397982|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
16250071|NCT02101853|39397983|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
16250072|NCT02101853|39397984|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
16250073|NCT02101853|39397985|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
16250074|NCT02101853|39397986|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
16250075|NCT02101853|39397987|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
16250076|NCT02101853|39397982|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
16250077|NCT02101853|39397983|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
16250078|NCT02101853|39397984|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
16250079|NCT02101853|39397985|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
16250080|NCT02101853|39397986|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
16250081|NCT02101853|39397987|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
16250082|NCT02101853|39397982|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
16250083|NCT02101853|39397983|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
16250084|NCT02101853|39397984|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
16250085|NCT02101853|39397985|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
16250086|NCT02101853|39397986|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
16250087|NCT02101853|39397987|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
16250088|NCT02058628|39397988|FG000|Overall Study|Adverse Event|1|||
16250089|NCT02058628|39397989|FG001|Overall Study|Adverse Event|0|||
16250090|NCT02058628|39397988|FG000|Overall Study|Withdrawal by Subject|2|||
16250091|NCT02058628|39397989|FG001|Overall Study|Withdrawal by Subject|2|||
16250092|NCT02058628|39397988|FG000|Overall Study|Lost to Follow-up|2|||
16427836|NCT01080807|40046982|FG000|Overall Study|Moved away without notifying center|1|||
16427837|NCT01080807|40046983|FG001|Overall Study|Moved away without notifying center|0|||
16427838|NCT01732770|40046984|FG000|Overall Study|Lost to Follow-up|2|||
16427839|NCT01732770|40046985|FG001|Overall Study|Lost to Follow-up|3|||
16427840|NCT01732770|40046984|FG000|Overall Study|Withdrawal by Subject|5|||
16427841|NCT01732770|40046985|FG001|Overall Study|Withdrawal by Subject|3|||
16427842|NCT01732770|40046984|FG000|Overall Study|Decision by Sponsor|2|||
16427843|NCT01732770|40046985|FG001|Overall Study|Decision by Sponsor|2|||
16427844|NCT01732770|40046984|FG000|Overall Study|Death|1|||
16427845|NCT01732770|40046985|FG001|Overall Study|Death|0|||
16427846|NCT00994422|40046988|FG000|Overall Study|Lost to Follow-up|7|||
16427847|NCT00994422|40046989|FG001|Overall Study|Lost to Follow-up|1|||
16427848|NCT00731679|40046990|FG000|Overall Study|Adverse Event|7|||
16427849|NCT00731679|40046991|FG001|Overall Study|Adverse Event|8|||
16427850|NCT00731679|40046990|FG000|Overall Study|Withdrawal by Subject|8|||
16427851|NCT00731679|40046991|FG001|Overall Study|Withdrawal by Subject|8|||
16427852|NCT00731679|40046990|FG000|Overall Study|Lost to Follow-up|7|||
16427853|NCT00731679|40046991|FG001|Overall Study|Lost to Follow-up|8|||
16427854|NCT00731679|40046990|FG000|Overall Study|Noncompliance|0|||
16427855|NCT00731679|40046991|FG001|Overall Study|Noncompliance|1|||
16427856|NCT00731679|40046990|FG000|Overall Study|Pregnancy|0|||
16427857|NCT00731679|40046991|FG001|Overall Study|Pregnancy|1|||
16427858|NCT01691794|40046997|FG000|Overall Study|Poor/Non-Compliance|1|||
16427859|NCT01691794|40046998|FG001|Overall Study|Poor/Non-Compliance|4|||
16427860|NCT01691794|40046999|FG002|Overall Study|Poor/Non-Compliance|1|||
16427861|NCT01691794|40046997|FG000|Overall Study|Death|0|||
16427862|NCT01691794|40046998|FG001|Overall Study|Death|0|||
16427863|NCT01691794|40046999|FG002|Overall Study|Death|1|||
16427864|NCT01691794|40046997|FG000|Overall Study|Lack of Efficacy|0|||
16427865|NCT01691794|40046998|FG001|Overall Study|Lack of Efficacy|7|||
16427866|NCT01691794|40046999|FG002|Overall Study|Lack of Efficacy|1|||
16427867|NCT01691794|40046997|FG000|Overall Study|Participant request to discontinue|0|||
16427868|NCT01691794|40046998|FG001|Overall Study|Participant request to discontinue|1|||
16427869|NCT01691794|40046999|FG002|Overall Study|Participant request to discontinue|0|||
16427870|NCT01691794|40046997|FG000|Overall Study|Adverse Event|0|||
16427871|NCT01691794|40046998|FG001|Overall Study|Adverse Event|1|||
16427872|NCT01691794|40046999|FG002|Overall Study|Adverse Event|1|||
16427873|NCT01691794|40046997|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
16427874|NCT01691794|40046998|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
16427875|NCT01691794|40046999|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
16427876|NCT01691794|40046997|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
16427877|NCT01691794|40046998|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
16427878|NCT01691794|40046999|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
16427879|NCT02223715|40047008|FG000|Overall Study|Death|31|||
16427880|NCT02223715|40047008|FG000|Overall Study|Lost to Follow-up|73|||
16427881|NCT02454478|40047009|FG000|Overall Study|Incomplete DLT Evaluation|1|||
16427882|NCT00154297|40047010|FG000|Overall Study|Death|5|||
16427883|NCT00154297|40047011|FG001|Overall Study|Death|2|||
16427884|NCT00154297|40047010|FG000|Overall Study|Withdrawal by Subject|0|||
16427885|NCT00154297|40047011|FG001|Overall Study|Withdrawal by Subject|5|||
16427886|NCT00154297|40047010|FG000|Overall Study|Lost to Follow-up|3|||
16427887|NCT00154297|40047011|FG001|Overall Study|Lost to Follow-up|0|||
16427888|NCT00479713|40047013|FG000|Overall Study|Adverse Event|8|||
16427889|NCT00479713|40047014|FG001|Overall Study|Adverse Event|6|||
16427890|NCT00479713|40047013|FG000|Overall Study|Death|1|||
16427891|NCT00479713|40047014|FG001|Overall Study|Death|0|||
16427892|NCT00479713|40047013|FG000|Overall Study|Lost to Follow-up|0|||
16427893|NCT00479713|40047014|FG001|Overall Study|Lost to Follow-up|1|||
16427894|NCT00479713|40047013|FG000|Overall Study|Protocol Violation|0|||
16427895|NCT00479713|40047014|FG001|Overall Study|Protocol Violation|1|||
16427896|NCT00479713|40047013|FG000|Overall Study|Withdrawal by Subject|4|||
16427897|NCT00479713|40047014|FG001|Overall Study|Withdrawal by Subject|1|||
16427898|NCT01096368|40047020|FG000|Overall Study|Death|0|||
16427899|NCT01096368|40047021|FG001|Overall Study|Death|1|||
16427900|NCT01096368|40047022|FG002|Overall Study|Death|0|||
16427901|NCT01096368|40047023|FG003|Overall Study|Death|0|||
16427902|NCT01096368|40047024|FG004|Overall Study|Death|0|||
16427903|NCT01096368|40047020|FG000|Overall Study|Physician Decision|0|||
16427904|NCT01096368|40047021|FG001|Overall Study|Physician Decision|13|||
16427905|NCT01096368|40047022|FG002|Overall Study|Physician Decision|2|||
16427906|NCT01096368|40047023|FG003|Overall Study|Physician Decision|4|||
16427907|NCT01096368|40047024|FG004|Overall Study|Physician Decision|6|||
16427908|NCT01096368|40047020|FG000|Overall Study|Withdrawal by Subject|0|||
16427909|NCT01096368|40047021|FG001|Overall Study|Withdrawal by Subject|52|||
16427910|NCT01096368|40047022|FG002|Overall Study|Withdrawal by Subject|0|||
16427911|NCT01096368|40047023|FG003|Overall Study|Withdrawal by Subject|10|||
16427912|NCT01096368|40047024|FG004|Overall Study|Withdrawal by Subject|14|||
16427913|NCT01096368|40047020|FG000|Overall Study|Ineligible|0|||
16427914|NCT01096368|40047021|FG001|Overall Study|Ineligible|3|||
16427915|NCT01096368|40047022|FG002|Overall Study|Ineligible|2|||
16427916|NCT01096368|40047023|FG003|Overall Study|Ineligible|0|||
16427917|NCT01096368|40047024|FG004|Overall Study|Ineligible|25|||
16427918|NCT01096368|40047020|FG000|Overall Study|Did not start treatment|0|||
16427919|NCT01096368|40047021|FG001|Overall Study|Did not start treatment|4|||
16427920|NCT01096368|40047022|FG002|Overall Study|Did not start treatment|4|||
16427921|NCT01096368|40047023|FG003|Overall Study|Did not start treatment|0|||
16427922|NCT01096368|40047024|FG004|Overall Study|Did not start treatment|0|||
16427923|NCT01096368|40047020|FG000|Overall Study|Progressive disease|0|||
16427924|NCT01096368|40047021|FG001|Overall Study|Progressive disease|6|||
16427925|NCT01096368|40047022|FG002|Overall Study|Progressive disease|0|||
16427926|NCT01096368|40047023|FG003|Overall Study|Progressive disease|10|||
16427927|NCT01096368|40047024|FG004|Overall Study|Progressive disease|3|||
16427928|NCT01096368|40047020|FG000|Overall Study|Other|0|||
16427929|NCT01096368|40047021|FG001|Overall Study|Other|0|||
16427930|NCT01096368|40047022|FG002|Overall Study|Other|1|||
16427931|NCT01096368|40047023|FG003|Overall Study|Other|0|||
16427932|NCT01096368|40047024|FG004|Overall Study|Other|0|||
16427933|NCT01096368|40047020|FG000|Overall Study|Treated with institutional review|0|||
16427934|NCT01096368|40047021|FG001|Overall Study|Treated with institutional review|0|||
16427935|NCT01096368|40047022|FG002|Overall Study|Treated with institutional review|0|||
16427936|NCT01096368|40047023|FG003|Overall Study|Treated with institutional review|0|||
16427937|NCT01096368|40047024|FG004|Overall Study|Treated with institutional review|1|||
16427938|NCT00991939|40047025|FG000|Overall Study|Lost to Follow-up|0|||
16427939|NCT00991939|40047026|FG001|Overall Study|Lost to Follow-up|1|||
16427940|NCT00991939|40047025|FG000|Overall Study|Withdrawal by Subject|1|||
16427941|NCT00991939|40047026|FG001|Overall Study|Withdrawal by Subject|0|||
16427942|NCT00991939|40047025|FG000|Overall Study|Entire study terminated|4|||
16427943|NCT00991939|40047026|FG001|Overall Study|Entire study terminated|1|||
16427944|NCT02837029|40047032|FG000|Screening|Failed to meet screening requirements.|7|||
16427945|NCT02837029|40047033|FG001|Screening|Failed to meet screening requirements.|3|||
16427946|NCT02837029|40047034|FG002|Screening|Failed to meet screening requirements.|0|||
16427947|NCT02837029|40047032|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
16427948|NCT02837029|40047033|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
16427949|NCT02837029|40047034|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
16427950|NCT02837029|40047032|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
16427951|NCT02837029|40047033|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
16427952|NCT02837029|40047034|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
16427953|NCT02837029|40047032|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
16427954|NCT02837029|40047033|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
16427955|NCT02837029|40047034|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
16427956|NCT02837029|40047032|FG000|Cycle 2 and Beyond|Adverse Event|1|||
16427957|NCT02837029|40047033|FG001|Cycle 2 and Beyond|Adverse Event|0|||
16427958|NCT02837029|40047034|FG002|Cycle 2 and Beyond|Adverse Event|0|||
16427959|NCT02837029|40047032|FG000|2 Year Follow-up|Death|6|||
16427960|NCT02837029|40047033|FG001|2 Year Follow-up|Death|7|||
16427961|NCT02837029|40047034|FG002|2 Year Follow-up|Death|0|||
16427962|NCT02544503|40047037|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
16427963|NCT02544503|40047038|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
16427964|NCT02544503|40047037|FG000|Overall Study|Lost to Follow-up|9|||
16427965|NCT02544503|40047038|FG001|Overall Study|Lost to Follow-up|0|||
16427966|NCT02544503|40047037|FG000|Overall Study|Withdrawal by Subject|1|||
16427967|NCT02544503|40047038|FG001|Overall Study|Withdrawal by Subject|0|||
16427968|NCT02134925|40047043|FG000|Overall Study|Withdrawal by Subject|1|||
16427969|NCT02134925|40047044|FG001|Overall Study|Withdrawal by Subject|0|||
16131054|NCT02516332|38967200|FG002|Overall Study|Withdrawal by Subject|2|||
16427970|NCT02134925|40047043|FG000|Overall Study|Cancel|1|||
16427971|NCT02134925|40047044|FG001|Overall Study|Cancel|6|||
16427972|NCT01450761|40047045|FG000|Randomization|Subject no longer meets study criteria|1|||
16427973|NCT01450761|40047046|FG001|Randomization|Subject no longer meets study criteria|2|||
16427974|NCT01450761|40047045|FG000|Randomization|Withdrawal by Subject|2|||
16427975|NCT01450761|40047046|FG001|Randomization|Withdrawal by Subject|0|||
16427976|NCT01450761|40047045|FG000|Randomization|Disease progression|0|||
16427977|NCT01450761|40047046|FG001|Randomization|Disease progression|2|||
16427978|NCT01450761|40047045|FG000|Randomization|Adverse Event unrelated to study drug|1|||
16562795|NCT01474512|40525477|FG017|Maintenance Period|Death|0|||
16250093|NCT02058628|39397989|FG001|Overall Study|Lost to Follow-up|4|||
16250094|NCT02058628|39397988|FG000|Overall Study|Not in time schedule|0|||
16250095|NCT02058628|39397989|FG001|Overall Study|Not in time schedule|1|||
16250096|NCT02058628|39397988|FG000|Overall Study|The visit date was not in timeline|0|||
16250097|NCT02058628|39397989|FG001|Overall Study|The visit date was not in timeline|1|||
16250098|NCT02058628|39397988|FG000|Overall Study|A lot of time for study for participant|1|||
16131055|NCT02257567|38967203|FG000|Overall Study|Adverse Event|0|||
16131056|NCT02257567|38967204|FG001|Overall Study|Adverse Event|0|||
16250099|NCT02058628|39397989|FG001|Overall Study|A lot of time for study for participant|0|||
16250100|NCT02058628|39397988|FG000|Overall Study|Non compliance|1|||
16250101|NCT02058628|39397989|FG001|Overall Study|Non compliance|0|||
16250102|NCT02545998|39397990|FG000|Overall Study|Lost to Follow-up|12|||
16250103|NCT02545998|39397991|FG001|Overall Study|Lost to Follow-up|3|||
16250104|NCT02545998|39397990|FG000|Overall Study|Withdrawal by Subject|3|||
16250105|NCT02545998|39397991|FG001|Overall Study|Withdrawal by Subject|2|||
16250106|NCT00617461|39397992|FG000|First Treatment Intervention Period|Adverse Event|2|||
16250107|NCT00617461|39397993|FG001|First Treatment Intervention Period|Adverse Event|0|||
16250108|NCT00617461|39397992|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
16250109|NCT00617461|39397993|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
16250110|NCT00617461|39397992|FG000|First Treatment Intervention Period|Protocol Violation|2|||
16250111|NCT00617461|39397993|FG001|First Treatment Intervention Period|Protocol Violation|1|||
16250112|NCT00617461|39397992|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
16250113|NCT00617461|39397993|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
16250114|NCT00617461|39397992|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
16250115|NCT00617461|39397993|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
16250116|NCT00617461|39397992|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
16250117|NCT00617461|39397993|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
16250118|NCT00617461|39397992|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
16250119|NCT00617461|39397993|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
16250120|NCT00617461|39397992|FG000|Second Treatment Intervention Period|Adverse Event|0|||
16250121|NCT00617461|39397993|FG001|Second Treatment Intervention Period|Adverse Event|1|||
16250122|NCT00617461|39397992|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
16250123|NCT00617461|39397993|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
16250124|NCT00617461|39397992|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
16250125|NCT00617461|39397993|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
16250126|NCT00617461|39397992|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
16562796|NCT01474512|40525460|FG000|Maintenance Period|Physician Decision|0|||
16562797|NCT01474512|40525461|FG001|Maintenance Period|Physician Decision|0|||
16131057|NCT02257567|38967205|FG002|Overall Study|Adverse Event|0|||
16131058|NCT02257567|38967206|FG003|Overall Study|Adverse Event|1|||
16131059|NCT02257567|38967207|FG004|Overall Study|Adverse Event|1|||
16131060|NCT02257567|38967208|FG005|Overall Study|Adverse Event|0|||
16131061|NCT02257567|38967209|FG006|Overall Study|Adverse Event|0|||
16131062|NCT02257567|38967210|FG007|Overall Study|Adverse Event|0|||
16131063|NCT02257567|38967211|FG008|Overall Study|Adverse Event|1|||
16131064|NCT02257567|38967212|FG009|Overall Study|Adverse Event|0|||
16131065|NCT02257567|38967213|FG010|Overall Study|Adverse Event|0|||
16131066|NCT02257567|38967203|FG000|Overall Study|Death|2|||
16131067|NCT02257567|38967204|FG001|Overall Study|Death|2|||
16131068|NCT02257567|38967205|FG002|Overall Study|Death|2|||
16131069|NCT02257567|38967206|FG003|Overall Study|Death|4|||
16131070|NCT02257567|38967207|FG004|Overall Study|Death|15|||
16131071|NCT02257567|38967208|FG005|Overall Study|Death|11|||
16131072|NCT02257567|38967209|FG006|Overall Study|Death|26|||
16131073|NCT02257567|38967210|FG007|Overall Study|Death|30|||
16131074|NCT02257567|38967211|FG008|Overall Study|Death|2|||
16131075|NCT02257567|38967212|FG009|Overall Study|Death|18|||
16131076|NCT02257567|38967213|FG010|Overall Study|Death|65|||
16131077|NCT02257567|38967203|FG000|Overall Study|Lost to Follow-up|0|||
16131078|NCT02257567|38967204|FG001|Overall Study|Lost to Follow-up|0|||
16131079|NCT02257567|38967205|FG002|Overall Study|Lost to Follow-up|0|||
16131080|NCT02257567|38967206|FG003|Overall Study|Lost to Follow-up|0|||
16131081|NCT02257567|38967207|FG004|Overall Study|Lost to Follow-up|2|||
16131082|NCT02257567|38967208|FG005|Overall Study|Lost to Follow-up|2|||
16131083|NCT02257567|38967209|FG006|Overall Study|Lost to Follow-up|0|||
16250127|NCT00617461|39397993|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
16250128|NCT02649231|39397997|FG000|Overall Study|Adverse Event|0|||
16360831|NCT03010501|39807573|FG000|Study Week 3|Withdrawal by Subject|0|||
16562798|NCT01474512|40525462|FG002|Maintenance Period|Physician Decision|0|||
16131084|NCT02257567|38967210|FG007|Overall Study|Lost to Follow-up|0|||
16131085|NCT02257567|38967211|FG008|Overall Study|Lost to Follow-up|0|||
16131086|NCT02257567|38967212|FG009|Overall Study|Lost to Follow-up|1|||
16131087|NCT02257567|38967213|FG010|Overall Study|Lost to Follow-up|1|||
16173376|NCT01147809|39111196|FG002|Phase II (168 Days)|Protocol Violation|0|||
16173377|NCT01147809|39111197|FG003|Phase II (168 Days)|Protocol Violation|0|||
16131088|NCT02257567|38967203|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16427979|NCT01450761|40047046|FG001|Randomization|Adverse Event unrelated to study drug|0|||
16427980|NCT01450761|40047045|FG000|Randomization|Other|0|||
16427981|NCT01450761|40047046|FG001|Randomization|Other|1|||
16427982|NCT01450761|40047045|FG000|Lead-in Chemotherapy|Disease progression|33|||
16427983|NCT01450761|40047046|FG001|Lead-in Chemotherapy|Disease progression|32|||
16427984|NCT01450761|40047045|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
16427985|NCT01450761|40047046|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
16427986|NCT01450761|40047045|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
16427987|NCT01450761|40047046|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
16427988|NCT01450761|40047045|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
16427989|NCT01450761|40047046|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
16427990|NCT01450761|40047045|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
16427991|NCT01450761|40047046|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
16427992|NCT01450761|40047045|FG000|Lead-in Chemotherapy|Death|3|||
16427993|NCT01450761|40047046|FG001|Lead-in Chemotherapy|Death|3|||
16427994|NCT01450761|40047045|FG000|Lead-in Chemotherapy|Other|2|||
16427995|NCT01450761|40047046|FG001|Lead-in Chemotherapy|Other|2|||
16427996|NCT01450761|40047045|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
16427997|NCT01450761|40047046|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
16427998|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
16427999|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
16428000|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
16428001|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
16428002|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
16428003|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
16428004|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
16428005|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
16428006|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
16428007|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
16428008|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Death|5|||
16428009|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Death|6|||
16428010|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
16428011|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
16428012|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
16428013|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
16428014|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
16428015|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
16428016|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
16428017|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
16428018|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
16428019|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
16428020|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
16428021|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
16428022|NCT01450761|40047045|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
16428023|NCT01450761|40047046|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
16428024|NCT03384940|40047050|FG000|Overall Study|Progressive disease|36|||
16428025|NCT03384940|40047051|FG001|Overall Study|Progressive disease|11|||
16428026|NCT03384940|40047052|FG002|Overall Study|Progressive disease|13|||
16428027|NCT03384940|40047050|FG000|Overall Study|Clinical progression|4|||
16428028|NCT03384940|40047051|FG001|Overall Study|Clinical progression|0|||
16428029|NCT03384940|40047052|FG002|Overall Study|Clinical progression|3|||
16428030|NCT03384940|40047050|FG000|Overall Study|Adverse Event|7|||
16428031|NCT03384940|40047051|FG001|Overall Study|Adverse Event|1|||
16428032|NCT03384940|40047052|FG002|Overall Study|Adverse Event|1|||
16428033|NCT03384940|40047050|FG000|Overall Study|Withdrawal by Subject|3|||
16428034|NCT03384940|40047051|FG001|Overall Study|Withdrawal by Subject|1|||
16428035|NCT03384940|40047052|FG002|Overall Study|Withdrawal by Subject|0|||
16428036|NCT03384940|40047050|FG000|Overall Study|Physician Decision|1|||
16428037|NCT03384940|40047051|FG001|Overall Study|Physician Decision|1|||
16250129|NCT02649231|39397998|FG001|Overall Study|Adverse Event|0|||
16428038|NCT03384940|40047052|FG002|Overall Study|Physician Decision|0|||
16428039|NCT03384940|40047050|FG000|Overall Study|Death|2|||
16428040|NCT03384940|40047051|FG001|Overall Study|Death|1|||
16428041|NCT03384940|40047052|FG002|Overall Study|Death|0|||
16428042|NCT03384940|40047050|FG000|Overall Study|Other|0|||
16428043|NCT03384940|40047051|FG001|Overall Study|Other|0|||
16428044|NCT03384940|40047052|FG002|Overall Study|Other|1|||
16428045|NCT00511134|40047053|FG000|Overall Study|Withdrawal by Subject|0|||
16428046|NCT00511134|40047054|FG001|Overall Study|Withdrawal by Subject|2|||
16428047|NCT00394706|40047055|FG000|Overall Study|Withdrawal by Subject|2|||
16428048|NCT00394706|40047056|FG001|Overall Study|Withdrawal by Subject|0|||
16428049|NCT00394706|40047057|FG002|Overall Study|Withdrawal by Subject|1|||
16428050|NCT00394706|40047058|FG003|Overall Study|Withdrawal by Subject|0|||
16428051|NCT00394706|40047059|FG004|Overall Study|Withdrawal by Subject|0|||
16428052|NCT00394706|40047060|FG005|Overall Study|Withdrawal by Subject|2|||
16428053|NCT00394706|40047061|FG006|Overall Study|Withdrawal by Subject|1|||
16428054|NCT00394706|40047062|FG007|Overall Study|Withdrawal by Subject|0|||
16428055|NCT00394706|40047055|FG000|Overall Study|Lost to Follow-up|2|||
16428056|NCT00394706|40047056|FG001|Overall Study|Lost to Follow-up|2|||
16428057|NCT00394706|40047057|FG002|Overall Study|Lost to Follow-up|8|||
16428058|NCT00394706|40047058|FG003|Overall Study|Lost to Follow-up|1|||
16428059|NCT00394706|40047059|FG004|Overall Study|Lost to Follow-up|2|||
16428060|NCT00394706|40047060|FG005|Overall Study|Lost to Follow-up|5|||
16428061|NCT00394706|40047061|FG006|Overall Study|Lost to Follow-up|2|||
16428062|NCT00394706|40047062|FG007|Overall Study|Lost to Follow-up|0|||
16428063|NCT03464019|40047063|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
16428064|NCT03464019|40047064|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
16428065|NCT03464019|40047065|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
16428066|NCT03464019|40047063|FG000|NODE-301 Part 1|Ablation|0|||
16428067|NCT03464019|40047064|FG001|NODE-301 Part 1|Ablation|0|||
16428068|NCT03464019|40047065|FG002|NODE-301 Part 1|Ablation|16|||
16428069|NCT03464019|40047063|FG000|NODE-301 Part 1|Test Dose Failure|0|||
16131089|NCT02257567|38967204|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16131090|NCT02257567|38967205|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16131091|NCT02257567|38967206|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16131092|NCT02257567|38967207|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
16131093|NCT02257567|38967208|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16131094|NCT02257567|38967209|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
16131095|NCT02257567|38967210|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16131096|NCT02257567|38967211|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16131097|NCT02257567|38967212|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16131098|NCT02257567|38967213|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
16131099|NCT02257567|38967203|FG000|Overall Study|Physician Decision|0|||
16131100|NCT02257567|38967204|FG001|Overall Study|Physician Decision|0|||
16131101|NCT02257567|38967205|FG002|Overall Study|Physician Decision|0|||
16131102|NCT02257567|38967206|FG003|Overall Study|Physician Decision|0|||
16131103|NCT02257567|38967207|FG004|Overall Study|Physician Decision|0|||
16131104|NCT02257567|38967208|FG005|Overall Study|Physician Decision|0|||
16131105|NCT02257567|38967209|FG006|Overall Study|Physician Decision|0|||
16131106|NCT02257567|38967210|FG007|Overall Study|Physician Decision|2|||
16131107|NCT02257567|38967211|FG008|Overall Study|Physician Decision|0|||
16131108|NCT02257567|38967212|FG009|Overall Study|Physician Decision|1|||
16131109|NCT02257567|38967213|FG010|Overall Study|Physician Decision|0|||
16131110|NCT02257567|38967203|FG000|Overall Study|Withdrawal by Subject|0|||
16428070|NCT03464019|40047064|FG001|NODE-301 Part 1|Test Dose Failure|0|||
16428071|NCT03464019|40047065|FG002|NODE-301 Part 1|Test Dose Failure|8|||
16428072|NCT03464019|40047063|FG000|NODE-301 Part 1|Adverse Event|0|||
16428073|NCT03464019|40047064|FG001|NODE-301 Part 1|Adverse Event|0|||
16428074|NCT03464019|40047065|FG002|NODE-301 Part 1|Adverse Event|5|||
16428075|NCT03464019|40047063|FG000|NODE-301 Part 1|Physician Decision|0|||
16428076|NCT03464019|40047064|FG001|NODE-301 Part 1|Physician Decision|0|||
16428077|NCT03464019|40047065|FG002|NODE-301 Part 1|Physician Decision|4|||
16428078|NCT03464019|40047063|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
16428079|NCT03464019|40047064|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
16428080|NCT03464019|40047065|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
16428081|NCT03464019|40047063|FG000|NODE-301 Part 1|Protocol Violation|0|||
16428082|NCT03464019|40047064|FG001|NODE-301 Part 1|Protocol Violation|0|||
16428083|NCT03464019|40047065|FG002|NODE-301 Part 1|Protocol Violation|2|||
16428084|NCT03464019|40047063|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
16428085|NCT03464019|40047064|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
16428086|NCT03464019|40047065|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
16428087|NCT03464019|40047063|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
16250130|NCT02649231|39397999|FG002|Overall Study|Adverse Event|0|||
16250131|NCT02649231|39398000|FG003|Overall Study|Adverse Event|1|||
16250132|NCT02649231|39397997|FG000|Overall Study|Lost to Follow-up|2|||
16250133|NCT02649231|39397998|FG001|Overall Study|Lost to Follow-up|1|||
16250134|NCT02649231|39397999|FG002|Overall Study|Lost to Follow-up|1|||
16250135|NCT02649231|39398000|FG003|Overall Study|Lost to Follow-up|0|||
16250136|NCT02649231|39397997|FG000|Overall Study|Withdrawal by Subject|0|||
16250137|NCT02649231|39397998|FG001|Overall Study|Withdrawal by Subject|1|||
16250138|NCT02649231|39397999|FG002|Overall Study|Withdrawal by Subject|0|||
16250139|NCT02649231|39398000|FG003|Overall Study|Withdrawal by Subject|1|||
16250140|NCT02649231|39397997|FG000|Overall Study|Protocol Violation|2|||
16250141|NCT02649231|39397998|FG001|Overall Study|Protocol Violation|1|||
16250142|NCT02649231|39397999|FG002|Overall Study|Protocol Violation|1|||
16250143|NCT02649231|39398000|FG003|Overall Study|Protocol Violation|0|||
16250144|NCT03355742|39398001|FG000|Overall Study|Lost to Follow-up|4|||
16250145|NCT03355742|39398001|FG000|Overall Study|Withdrawal by Subject|29|||
16250146|NCT03355742|39398001|FG000|Overall Study|Physician Decision|6|||
16250147|NCT03355742|39398001|FG000|Overall Study|Death|55|||
16250148|NCT03355742|39398001|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
16250149|NCT00814320|39398002|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
16250150|NCT00814320|39398003|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
16250151|NCT00814320|39398002|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
16250152|NCT00814320|39398003|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
16250153|NCT00814320|39398002|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
16250154|NCT00814320|39398003|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
16250155|NCT00814320|39398002|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
16250156|NCT00814320|39398003|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
16250157|NCT00814320|39398002|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
16250158|NCT00814320|39398003|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
16250159|NCT00814320|39398002|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
16250160|NCT00814320|39398003|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
16250161|NCT00814320|39398002|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
16250162|NCT00814320|39398003|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
16250163|NCT00814320|39398002|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
16250164|NCT00814320|39398003|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
16250165|NCT00814320|39398002|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
16250166|NCT00814320|39398003|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
16250167|NCT00814320|39398002|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
16250168|NCT00814320|39398003|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
16250169|NCT01659567|39398004|FG000|Overall Study|Lack of Efficacy|22|||
16250170|NCT01659567|39398004|FG000|Overall Study|Switched to Pegferon|6|||
16250171|NCT01659567|39398004|FG000|Overall Study|Adverse Event|12|||
16250172|NCT01659567|39398004|FG000|Overall Study|Good result at early stage of treatment|5|||
16250173|NCT01659567|39398004|FG000|Overall Study|Withdrawal by Subject|64|||
16250174|NCT01659567|39398004|FG000|Overall Study|Progression of the main disease|1|||
16250175|NCT01659567|39398004|FG000|Overall Study|Other|13|||
16250176|NCT02114931|39398005|FG000|Overall Study|Withdrawal by Subject|15|||
16250177|NCT02114931|39398006|FG001|Overall Study|Withdrawal by Subject|18|||
16250178|NCT02114931|39398005|FG000|Overall Study|Adverse Event|4|||
16250179|NCT02114931|39398006|FG001|Overall Study|Adverse Event|6|||
16250180|NCT02114931|39398005|FG000|Overall Study|Lost to Follow-up|3|||
16250181|NCT02114931|39398006|FG001|Overall Study|Lost to Follow-up|3|||
16250182|NCT02114931|39398005|FG000|Overall Study|Physician Decision|1|||
16250183|NCT02114931|39398006|FG001|Overall Study|Physician Decision|2|||
16250184|NCT02114931|39398005|FG000|Overall Study|Other|2|||
16250185|NCT02114931|39398006|FG001|Overall Study|Other|1|||
16250186|NCT02674334|39398007|FG000|Overall Study|Lost to Follow-up|5|||
16250187|NCT02674334|39398008|FG001|Overall Study|Lost to Follow-up|3|||
16250188|NCT02674334|39398007|FG000|Overall Study|participant difficulty breathing|1|||
16250189|NCT02674334|39398008|FG001|Overall Study|participant difficulty breathing|0|||
16250190|NCT02674334|39398007|FG000|Overall Study|NIRS not recording|1|||
16250191|NCT02674334|39398008|FG001|Overall Study|NIRS not recording|0|||
16250192|NCT02784106|39398009|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
16250193|NCT02784106|39398010|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
16428088|NCT03464019|40047064|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
16250194|NCT02784106|39398011|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
16250195|NCT02784106|39398012|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
16250196|NCT02784106|39398009|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
16250197|NCT02784106|39398010|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
16250198|NCT02784106|39398011|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
16250199|NCT02784106|39398012|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
16250200|NCT02784106|39398009|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
16428089|NCT03464019|40047065|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
16428090|NCT03464019|40047063|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
16428091|NCT03464019|40047064|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
16428092|NCT03464019|40047065|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
16428093|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
16428094|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
16428095|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
16428096|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
16428097|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
16428098|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
16428099|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
16428100|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
16428101|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
16428102|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
16428103|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
16428104|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
16250201|NCT02784106|39398010|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
16428105|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
16428106|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
16428107|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
16428108|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
16428109|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
16428110|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
16428111|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
16428112|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
16428113|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
16428114|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
16428115|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
16428116|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
16428117|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
16428118|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
16428119|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
16428120|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
16428121|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
16428122|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
16428123|NCT03464019|40047063|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
16428124|NCT03464019|40047064|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
16428125|NCT03464019|40047065|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
16428126|NCT00637416|40047068|FG000|Overall Study|Lost to Follow-up|1|||
16428127|NCT00637416|40047069|FG001|Overall Study|Lost to Follow-up|1|||
16428128|NCT00637416|40047068|FG000|Overall Study|Unable to take study drug|0|||
16428129|NCT00637416|40047069|FG001|Overall Study|Unable to take study drug|1|||
16428130|NCT00082407|40047070|FG000|Overall Study|Adverse Event|20|||
16428131|NCT00082407|40047071|FG001|Overall Study|Adverse Event|0|||
16428132|NCT00082407|40047070|FG000|Overall Study|Protocol Violation|14|||
16428133|NCT00082407|40047071|FG001|Overall Study|Protocol Violation|12|||
16428134|NCT00082407|40047070|FG000|Overall Study|Patient Decision|13|||
16428135|NCT00082407|40047071|FG001|Overall Study|Patient Decision|6|||
16428136|NCT00082407|40047070|FG000|Overall Study|Physician Decision|5|||
16428137|NCT00082407|40047071|FG001|Overall Study|Physician Decision|3|||
16428138|NCT00082407|40047070|FG000|Overall Study|Loss of Glucose Control|2|||
16428139|NCT00082407|40047071|FG001|Overall Study|Loss of Glucose Control|2|||
16428140|NCT00082407|40047070|FG000|Overall Study|Death|2|||
16428141|NCT00082407|40047071|FG001|Overall Study|Death|1|||
16428142|NCT00082407|40047070|FG000|Overall Study|Lost to Follow-up|0|||
16428143|NCT00082407|40047071|FG001|Overall Study|Lost to Follow-up|3|||
16428144|NCT02657889|40047072|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
16428145|NCT02657889|40047073|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
16428146|NCT02657889|40047074|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
16428147|NCT02657889|40047075|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
16428148|NCT02657889|40047072|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
16428149|NCT02657889|40047073|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
16428150|NCT02657889|40047074|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
16428151|NCT02657889|40047075|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
16428152|NCT02657889|40047072|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
16428153|NCT02657889|40047073|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
16428154|NCT02657889|40047074|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
16562799|NCT01474512|40525463|FG003|Maintenance Period|Physician Decision|0|||
16428155|NCT02657889|40047075|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
16428156|NCT02657889|40047072|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
16428157|NCT02657889|40047073|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
16428158|NCT02657889|40047074|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
16428159|NCT02657889|40047075|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
16428160|NCT02657889|40047072|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
16428161|NCT02657889|40047073|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
16428162|NCT02657889|40047074|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
16428163|NCT02657889|40047075|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
16428164|NCT02657889|40047072|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
16428165|NCT02657889|40047073|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
16428166|NCT02657889|40047074|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
16428167|NCT02657889|40047075|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
16428168|NCT02657889|40047072|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
16428169|NCT02657889|40047073|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
16428170|NCT02657889|40047074|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
16428171|NCT02657889|40047075|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
16428172|NCT02657889|40047072|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
16428173|NCT02657889|40047073|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
16428174|NCT02657889|40047074|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
16428175|NCT02657889|40047075|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
16428176|NCT02657889|40047072|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
16428177|NCT02657889|40047073|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
16428178|NCT02657889|40047074|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
16428179|NCT02657889|40047075|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
16428180|NCT02657889|40047072|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
16428181|NCT02657889|40047073|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
16428182|NCT02657889|40047074|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
16428183|NCT02657889|40047075|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
16428184|NCT02657889|40047072|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
16428185|NCT02657889|40047073|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
16428186|NCT02657889|40047074|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
16428187|NCT02657889|40047075|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
16428188|NCT02657889|40047072|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
16428189|NCT02657889|40047073|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
16428190|NCT02657889|40047074|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
16428191|NCT02657889|40047075|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
16428192|NCT01687101|40047078|FG000|Overall Study|Lost to Follow-up|7|||
16428193|NCT04566601|40047080|FG000|Overall Study|Other than listed|13|||
16428194|NCT04566601|40047081|FG001|Overall Study|Other than listed|4|||
16428195|NCT04566601|40047082|FG002|Overall Study|Other than listed|2|||
16428196|NCT04566601|40047083|FG003|Overall Study|Other than listed|1|||
16428197|NCT04566601|40047084|FG004|Overall Study|Other than listed|4|||
16428198|NCT04566601|40047080|FG000|Overall Study|Protocol deviation|3|||
16428199|NCT04566601|40047081|FG001|Overall Study|Protocol deviation|0|||
16428200|NCT04566601|40047082|FG002|Overall Study|Protocol deviation|1|||
16428201|NCT04566601|40047083|FG003|Overall Study|Protocol deviation|1|||
16428202|NCT04566601|40047084|FG004|Overall Study|Protocol deviation|1|||
16428203|NCT04566601|40047080|FG000|Overall Study|Technical problems|0|||
16428204|NCT04566601|40047081|FG001|Overall Study|Technical problems|0|||
16428205|NCT04566601|40047082|FG002|Overall Study|Technical problems|1|||
16428206|NCT04566601|40047083|FG003|Overall Study|Technical problems|0|||
16428207|NCT04566601|40047084|FG004|Overall Study|Technical problems|0|||
16428208|NCT04566601|40047080|FG000|Overall Study|No reason available|3|||
16428209|NCT04566601|40047081|FG001|Overall Study|No reason available|2|||
16428210|NCT04566601|40047082|FG002|Overall Study|No reason available|7|||
16428211|NCT04566601|40047083|FG003|Overall Study|No reason available|1|||
16428212|NCT04566601|40047084|FG004|Overall Study|No reason available|5|||
16428213|NCT04566601|40047080|FG000|Overall Study|Burden of study procedures|3|||
16428214|NCT04566601|40047081|FG001|Overall Study|Burden of study procedures|0|||
16428215|NCT04566601|40047082|FG002|Overall Study|Burden of study procedures|0|||
16428216|NCT04566601|40047083|FG003|Overall Study|Burden of study procedures|3|||
16428217|NCT04566601|40047084|FG004|Overall Study|Burden of study procedures|1|||
16428218|NCT04566601|40047080|FG000|Overall Study|Change of residence|2|||
16428219|NCT04566601|40047081|FG001|Overall Study|Change of residence|2|||
16428220|NCT04566601|40047082|FG002|Overall Study|Change of residence|0|||
16428221|NCT04566601|40047083|FG003|Overall Study|Change of residence|1|||
16428222|NCT04566601|40047084|FG004|Overall Study|Change of residence|2|||
16428223|NCT04566601|40047080|FG000|Overall Study|Perceived lack of efficacy|2|||
16428224|NCT04566601|40047081|FG001|Overall Study|Perceived lack of efficacy|0|||
16428225|NCT04566601|40047082|FG002|Overall Study|Perceived lack of efficacy|1|||
16428226|NCT04566601|40047083|FG003|Overall Study|Perceived lack of efficacy|1|||
16428227|NCT04566601|40047084|FG004|Overall Study|Perceived lack of efficacy|2|||
16428228|NCT04566601|40047080|FG000|Overall Study|Adverse Event|7|||
16428229|NCT04566601|40047081|FG001|Overall Study|Adverse Event|4|||
16428230|NCT04566601|40047082|FG002|Overall Study|Adverse Event|6|||
16428231|NCT04566601|40047083|FG003|Overall Study|Adverse Event|5|||
16428232|NCT04566601|40047084|FG004|Overall Study|Adverse Event|12|||
16428233|NCT03201419|40047087|FG000|Overall Study|Adverse Event|3|||
16428234|NCT03201419|40047088|FG001|Overall Study|Adverse Event|1|||
16428235|NCT03201419|40047089|FG002|Overall Study|Adverse Event|0|||
16428236|NCT03201419|40047090|FG003|Overall Study|Adverse Event|0|||
16428237|NCT03201419|40047091|FG004|Overall Study|Adverse Event|1|||
16428238|NCT03201419|40047092|FG005|Overall Study|Adverse Event|1|||
16428239|NCT03201419|40047093|FG006|Overall Study|Adverse Event|5|||
16428240|NCT03201419|40047094|FG007|Overall Study|Adverse Event|0|||
16428241|NCT03201419|40047095|FG008|Overall Study|Adverse Event|0|||
16428242|NCT03201419|40047087|FG000|Overall Study|Lost to Follow-up|1|||
16428243|NCT03201419|40047088|FG001|Overall Study|Lost to Follow-up|0|||
16428244|NCT03201419|40047089|FG002|Overall Study|Lost to Follow-up|0|||
16428245|NCT03201419|40047090|FG003|Overall Study|Lost to Follow-up|0|||
16428246|NCT03201419|40047091|FG004|Overall Study|Lost to Follow-up|0|||
16428247|NCT03201419|40047092|FG005|Overall Study|Lost to Follow-up|0|||
16428248|NCT03201419|40047093|FG006|Overall Study|Lost to Follow-up|0|||
16428249|NCT03201419|40047094|FG007|Overall Study|Lost to Follow-up|0|||
16428250|NCT03201419|40047095|FG008|Overall Study|Lost to Follow-up|0|||
16428251|NCT03201419|40047087|FG000|Overall Study|Protocol Deviation|0|||
16428252|NCT03201419|40047088|FG001|Overall Study|Protocol Deviation|0|||
16428253|NCT03201419|40047089|FG002|Overall Study|Protocol Deviation|0|||
16428254|NCT03201419|40047090|FG003|Overall Study|Protocol Deviation|0|||
16428255|NCT03201419|40047091|FG004|Overall Study|Protocol Deviation|0|||
16428256|NCT03201419|40047092|FG005|Overall Study|Protocol Deviation|0|||
16428257|NCT03201419|40047093|FG006|Overall Study|Protocol Deviation|1|||
16428258|NCT03201419|40047094|FG007|Overall Study|Protocol Deviation|0|||
16428259|NCT03201419|40047095|FG008|Overall Study|Protocol Deviation|0|||
16428260|NCT03201419|40047087|FG000|Overall Study|Withdrawal by Subject|4|||
16428261|NCT03201419|40047088|FG001|Overall Study|Withdrawal by Subject|2|||
16428262|NCT03201419|40047089|FG002|Overall Study|Withdrawal by Subject|1|||
16428263|NCT03201419|40047090|FG003|Overall Study|Withdrawal by Subject|0|||
16428264|NCT03201419|40047091|FG004|Overall Study|Withdrawal by Subject|0|||
16428265|NCT03201419|40047092|FG005|Overall Study|Withdrawal by Subject|0|||
16428266|NCT03201419|40047093|FG006|Overall Study|Withdrawal by Subject|0|||
16428267|NCT03201419|40047094|FG007|Overall Study|Withdrawal by Subject|1|||
16428268|NCT03201419|40047095|FG008|Overall Study|Withdrawal by Subject|2|||
16428269|NCT03201419|40047087|FG000|Overall Study|Other|0|||
16428270|NCT03201419|40047088|FG001|Overall Study|Other|0|||
16428271|NCT03201419|40047089|FG002|Overall Study|Other|1|||
16428272|NCT03201419|40047090|FG003|Overall Study|Other|0|||
16428273|NCT03201419|40047091|FG004|Overall Study|Other|0|||
16428274|NCT03201419|40047092|FG005|Overall Study|Other|0|||
16428275|NCT03201419|40047093|FG006|Overall Study|Other|0|||
16428276|NCT03201419|40047094|FG007|Overall Study|Other|0|||
16428277|NCT03201419|40047095|FG008|Overall Study|Other|0|||
16428278|NCT00191334|40047096|FG000|Overall Study|Adverse Event|4|||
16428279|NCT00191334|40047096|FG000|Overall Study|Disease Progression or Relapse|8|||
16428280|NCT00191334|40047096|FG000|Overall Study|Physician Decision|1|||
16428281|NCT00191334|40047096|FG000|Overall Study|Withdrawal by Subject|4|||
16428282|NCT01544920|40047097|FG000|Overall Study|Adverse Event|0|||
16428283|NCT01544920|40047098|FG001|Overall Study|Adverse Event|3|||
16428284|NCT01544920|40047097|FG000|Overall Study|Death|0|||
16428285|NCT01544920|40047098|FG001|Overall Study|Death|1|||
16428286|NCT01544920|40047097|FG000|Overall Study|Lost to Follow-up|11|||
16428287|NCT01544920|40047098|FG001|Overall Study|Lost to Follow-up|12|||
16428288|NCT01544920|40047097|FG000|Overall Study|Protocol Violation|0|||
16428289|NCT01544920|40047098|FG001|Overall Study|Protocol Violation|2|||
16428290|NCT01544920|40047097|FG000|Overall Study|Physician Decision|4|||
16428291|NCT01544920|40047098|FG001|Overall Study|Physician Decision|1|||
16428292|NCT01544920|40047097|FG000|Overall Study|Withdrawal by Subject|4|||
16428293|NCT01544920|40047098|FG001|Overall Study|Withdrawal by Subject|4|||
16428294|NCT00546000|40047099|FG000|Overall Study|Adverse Event|1|||
16428295|NCT00546000|40047099|FG000|Overall Study|Lost to Follow-up|1|||
16428296|NCT00546000|40047099|FG000|Overall Study|Baseline HPA Axis Supression|2|||
16428297|NCT01698814|40047100|FG000|Overall Study|Adverse Event|0|||
16428298|NCT01698814|40047101|FG001|Overall Study|Adverse Event|2|||
16428299|NCT01698814|40047100|FG000|Overall Study|Lost to Follow-up|0|||
16428300|NCT01698814|40047101|FG001|Overall Study|Lost to Follow-up|1|||
16428301|NCT01698814|40047100|FG000|Overall Study|Pregnancy|1|||
16428302|NCT01698814|40047101|FG001|Overall Study|Pregnancy|0|||
16428303|NCT01698814|40047100|FG000|Overall Study|Randomized in error|1|||
16428304|NCT01698814|40047101|FG001|Overall Study|Randomized in error|0|||
16428305|NCT00413036|40047102|FG000|Overall Study|Adverse Event|44|||
16428306|NCT00413036|40047102|FG000|Overall Study|Lack of Efficacy|129|||
16428307|NCT00413036|40047102|FG000|Overall Study|Withdrawal by Subject|7|||
16428308|NCT00413036|40047102|FG000|Overall Study|Death|9|||
16428309|NCT00413036|40047102|FG000|Overall Study|Other|26|||
16428310|NCT00413036|40047102|FG000|Overall Study|Missing|2|||
16428311|NCT02043938|40047103|FG000|Overall Study|Withdrawal by Subject|7|||
16428312|NCT02043938|40047103|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
16428313|NCT02043938|40047103|FG000|Overall Study|No show by subject|1|||
16428314|NCT02043938|40047103|FG000|Overall Study|Investigator decision|1|||
16428315|NCT02473367|40047104|FG000|Wait 1|Withdrawal by Subject|1|||
16428316|NCT02473367|40047104|FG000|Period 4|Lost to Follow-up|1|||
16428317|NCT01461707|40047105|FG000|Overall Study|Withdrawal by Subject|1|||
16428318|NCT01461707|40047106|FG001|Overall Study|Withdrawal by Subject|0|||
16428319|NCT00650767|40047112|FG000|Overall Study|Adverse Event|0|||
16428320|NCT00650767|40047113|FG001|Overall Study|Adverse Event|3|||
16428321|NCT00650767|40047114|FG002|Overall Study|Adverse Event|10|||
16428322|NCT00650767|40047115|FG003|Overall Study|Adverse Event|8|||
16428323|NCT00650767|40047112|FG000|Overall Study|Death|1|||
16428324|NCT00650767|40047113|FG001|Overall Study|Death|0|||
16428325|NCT00650767|40047114|FG002|Overall Study|Death|0|||
16428326|NCT00650767|40047115|FG003|Overall Study|Death|0|||
16428327|NCT00650767|40047112|FG000|Overall Study|Withdrawal by Subject|2|||
16428328|NCT00650767|40047113|FG001|Overall Study|Withdrawal by Subject|4|||
16428329|NCT00650767|40047114|FG002|Overall Study|Withdrawal by Subject|3|||
16428330|NCT00650767|40047115|FG003|Overall Study|Withdrawal by Subject|3|||
16428331|NCT00650767|40047112|FG000|Overall Study|Lost to Follow-up|1|||
16428332|NCT00650767|40047113|FG001|Overall Study|Lost to Follow-up|1|||
16428333|NCT00650767|40047114|FG002|Overall Study|Lost to Follow-up|1|||
16428334|NCT00650767|40047115|FG003|Overall Study|Lost to Follow-up|0|||
16428335|NCT00650767|40047112|FG000|Overall Study|Other|1|||
16428336|NCT00650767|40047113|FG001|Overall Study|Other|1|||
16428337|NCT00650767|40047114|FG002|Overall Study|Other|0|||
16428338|NCT00650767|40047115|FG003|Overall Study|Other|0|||
16428339|NCT00226811|40047119|FG000|Overall Study|Death|8|||
16428340|NCT00226811|40047119|FG000|Overall Study|Adverse Event|11|||
16428341|NCT00226811|40047119|FG000|Overall Study|Lack of Efficacy|55|||
16428342|NCT00226811|40047119|FG000|Overall Study|Withdrawal by Subject|2|||
16428343|NCT04071158|40047122|FG000|Overall Study|Lost to Follow-up|1|||
16428344|NCT04071158|40047123|FG001|Overall Study|Lost to Follow-up|2|||
16428345|NCT04071158|40047124|FG002|Overall Study|Lost to Follow-up|3|||
16428346|NCT04071158|40047125|FG003|Overall Study|Lost to Follow-up|3|||
16428347|NCT04071158|40047126|FG004|Overall Study|Lost to Follow-up|5|||
16428348|NCT04071158|40047122|FG000|Overall Study|Randomized but not treated|2|||
16428349|NCT04071158|40047123|FG001|Overall Study|Randomized but not treated|2|||
16428350|NCT04071158|40047124|FG002|Overall Study|Randomized but not treated|0|||
16428351|NCT04071158|40047125|FG003|Overall Study|Randomized but not treated|0|||
16428352|NCT04071158|40047126|FG004|Overall Study|Randomized but not treated|0|||
16428353|NCT00344500|40047134|FG000|Overall Study|Adverse Event|6|||
16428354|NCT00344500|40047135|FG001|Overall Study|Adverse Event|2|||
16428355|NCT00344500|40047136|FG002|Overall Study|Adverse Event|0|||
16428356|NCT00344500|40047134|FG000|Overall Study|Lost to Follow-up|5|||
16428357|NCT00344500|40047135|FG001|Overall Study|Lost to Follow-up|13|||
16428358|NCT00344500|40047136|FG002|Overall Study|Lost to Follow-up|1|||
16428359|NCT00344500|40047134|FG000|Overall Study|Withdrawal by Subject|7|||
16428360|NCT00344500|40047135|FG001|Overall Study|Withdrawal by Subject|10|||
16428361|NCT00344500|40047136|FG002|Overall Study|Withdrawal by Subject|0|||
16428362|NCT00344500|40047134|FG000|Overall Study|Protocol Violation|4|||
16428363|NCT00344500|40047135|FG001|Overall Study|Protocol Violation|7|||
16428364|NCT00344500|40047136|FG002|Overall Study|Protocol Violation|1|||
16428365|NCT00344500|40047134|FG000|Overall Study|Not Noted|1|||
16428366|NCT00344500|40047135|FG001|Overall Study|Not Noted|3|||
16428367|NCT00344500|40047136|FG002|Overall Study|Not Noted|0|||
16428368|NCT00711971|40047141|FG000|Overall Study|Lost to Follow-up|3|||
16428369|NCT00711971|40047142|FG001|Overall Study|Lost to Follow-up|4|||
16428370|NCT00711971|40047143|FG002|Overall Study|Lost to Follow-up|1|||
16428371|NCT03729570|40047144|FG000|Overall Study|Lost to Follow-up|16|||
16428372|NCT03729570|40047145|FG001|Overall Study|Lost to Follow-up|20|||
16428373|NCT03729570|40047144|FG000|Overall Study|Seroconversion|5|||
16428374|NCT03729570|40047145|FG001|Overall Study|Seroconversion|0|||
16428375|NCT03729570|40047144|FG000|Overall Study|Moved out of the city|1|||
16428376|NCT03729570|40047145|FG001|Overall Study|Moved out of the city|0|||
16428377|NCT03729570|40047144|FG000|Overall Study|Time Conflict|1|||
16428378|NCT03729570|40047145|FG001|Overall Study|Time Conflict|0|||
16428379|NCT03729570|40047144|FG000|Overall Study|Time Commitment|2|||
16428380|NCT03729570|40047145|FG001|Overall Study|Time Commitment|0|||
16428381|NCT03729570|40047144|FG000|Overall Study|Bad Experience|0|||
16428382|NCT03729570|40047145|FG001|Overall Study|Bad Experience|1|||
16428383|NCT03729570|40047144|FG000|Overall Study|No reason provided|2|||
16428384|NCT03729570|40047145|FG001|Overall Study|No reason provided|1|||
16428385|NCT03729570|40047144|FG000|Overall Study|Family Conflict|0|||
16428386|NCT03729570|40047145|FG001|Overall Study|Family Conflict|1|||
16428387|NCT03729570|40047144|FG000|Overall Study|Did not want to continue taking medications|0|||
16428388|NCT03729570|40047145|FG001|Overall Study|Did not want to continue taking medications|1|||
16428389|NCT03729570|40047144|FG000|Overall Study|Found another PrEP provider|1|||
16428390|NCT03729570|40047145|FG001|Overall Study|Found another PrEP provider|0|||
16428391|NCT03729570|40047144|FG000|Overall Study|Did not enjoy being in the control group|0|||
16428392|NCT03729570|40047145|FG001|Overall Study|Did not enjoy being in the control group|1|||
16428393|NCT01574651|40047148|FG000|Overall Study|Lost to Follow-up|2|||
16428394|NCT01574651|40047149|FG001|Overall Study|Lost to Follow-up|4|||
16428395|NCT01574651|40047148|FG000|Overall Study|Administrative problems|0|||
16428396|NCT01574651|40047149|FG001|Overall Study|Administrative problems|1|||
16428397|NCT01574651|40047148|FG000|Overall Study|Death|3|||
16428398|NCT01574651|40047149|FG001|Overall Study|Death|3|||
16428399|NCT01574651|40047148|FG000|Overall Study|Patient's inability to use the device|0|||
16428400|NCT01574651|40047149|FG001|Overall Study|Patient's inability to use the device|1|||
16428401|NCT01574651|40047148|FG000|Overall Study|Adverse Event|36|||
16428402|NCT01574651|40047149|FG001|Overall Study|Adverse Event|27|||
16428403|NCT01574651|40047148|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16428404|NCT01574651|40047149|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16428405|NCT01574651|40047148|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16428406|NCT01574651|40047149|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16428407|NCT01574651|40047148|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
16428408|NCT01574651|40047149|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16428409|NCT01574651|40047148|FG000|Overall Study|Protocol Violation|3|||
16428410|NCT01574651|40047149|FG001|Overall Study|Protocol Violation|5|||
16428411|NCT01574651|40047148|FG000|Overall Study|Withdrawal by Subject|9|||
16428412|NCT01574651|40047149|FG001|Overall Study|Withdrawal by Subject|10|||
16428413|NCT04124705|40047152|FG000|Titration Period|Adverse Event|9|||
16428414|NCT04124705|40047153|FG001|Titration Period|Adverse Event|5|||
16428415|NCT04124705|40047152|FG000|Titration Period|Withdrawal by Subject|6|||
16428416|NCT04124705|40047153|FG001|Titration Period|Withdrawal by Subject|3|||
16428417|NCT04124705|40047152|FG000|Titration Period|Lost to Follow-up|0|||
16428418|NCT04124705|40047153|FG001|Titration Period|Lost to Follow-up|1|||
16428419|NCT04124705|40047152|FG000|Titration Period|Death|1|||
16428420|NCT04124705|40047153|FG001|Titration Period|Death|1|||
16428421|NCT04124705|40047152|FG000|Titration Period|Lack of Efficacy|2|||
16428422|NCT04124705|40047153|FG001|Titration Period|Lack of Efficacy|0|||
16428423|NCT04124705|40047152|FG000|Titration Period|Physician Decision|2|||
16428424|NCT04124705|40047153|FG001|Titration Period|Physician Decision|0|||
16428425|NCT04124705|40047152|FG000|Titration Period|Non-compliance with Study Drug|2|||
16428426|NCT04124705|40047153|FG001|Titration Period|Non-compliance with Study Drug|0|||
16428427|NCT04124705|40047152|FG000|Titration Period|Other|4|||
16428428|NCT04124705|40047153|FG001|Titration Period|Other|9|||
16428429|NCT04124705|40047152|FG000|Stabilization Period|Adverse Event|4|||
16428430|NCT04124705|40047153|FG001|Stabilization Period|Adverse Event|2|||
16428431|NCT04124705|40047152|FG000|Stabilization Period|Withdrawal by Subject|1|||
16428432|NCT04124705|40047153|FG001|Stabilization Period|Withdrawal by Subject|1|||
16428433|NCT04124705|40047152|FG000|Stabilization Period|Lost to Follow-up|0|||
16428434|NCT04124705|40047153|FG001|Stabilization Period|Lost to Follow-up|1|||
16428435|NCT04124705|40047152|FG000|Stabilization Period|Lack of Efficacy|4|||
16428436|NCT04124705|40047153|FG001|Stabilization Period|Lack of Efficacy|2|||
16428437|NCT04124705|40047152|FG000|Stabilization Period|Protocol Deviation|0|||
16428438|NCT04124705|40047153|FG001|Stabilization Period|Protocol Deviation|2|||
16428439|NCT04124705|40047152|FG000|Stabilization Period|Other|2|||
16428440|NCT04124705|40047153|FG001|Stabilization Period|Other|2|||
16428441|NCT03109184|40047154|FG000|Overall Study|Lost to Follow-up|6|||
16428442|NCT03109184|40047155|FG001|Overall Study|Lost to Follow-up|6|||
16428443|NCT03109184|40047154|FG000|Overall Study|Withdrawal by Subject|1|||
16428444|NCT03109184|40047155|FG001|Overall Study|Withdrawal by Subject|1|||
16428445|NCT02207491|40047158|FG000|Overall Study|Adverse Event|20|||
16428446|NCT02207491|40047159|FG001|Overall Study|Adverse Event|4|||
16428447|NCT02207491|40047158|FG000|Overall Study|Withdrawal by Subject|3|||
16428448|NCT02207491|40047159|FG001|Overall Study|Withdrawal by Subject|2|||
16428449|NCT02207491|40047158|FG000|Overall Study|Non-compliant|0|||
16428450|NCT02207491|40047159|FG001|Overall Study|Non-compliant|1|||
16428451|NCT02207491|40047158|FG000|Overall Study|Lost to Follow-up|0|||
16428452|NCT02207491|40047159|FG001|Overall Study|Lost to Follow-up|1|||
16428453|NCT02207491|40047158|FG000|Overall Study|Lack of Efficacy|3|||
16428454|NCT02207491|40047159|FG001|Overall Study|Lack of Efficacy|0|||
16428455|NCT02207491|40047158|FG000|Overall Study|Physician Decision|2|||
16428456|NCT02207491|40047159|FG001|Overall Study|Physician Decision|0|||
16428457|NCT02207491|40047158|FG000|Overall Study|Protocol Violation|3|||
16428458|NCT02207491|40047159|FG001|Overall Study|Protocol Violation|5|||
16428459|NCT04395690|40047160|FG000|Overall Study|Lost to Follow-up|1|||
16428460|NCT04395690|40047161|FG001|Overall Study|Lost to Follow-up|1|||
16428461|NCT01286740|40047164|FG000|Overall Study|Enrolled but not treated|1|||
16428462|NCT01286740|40047164|FG000|Overall Study|Protocol Violation|1|||
16428463|NCT00666224|40047165|FG000|Double-Blind|Adverse Event|15|||
16428464|NCT00666224|40047166|FG001|Double-Blind|Adverse Event|5|||
16428465|NCT00666224|40047165|FG000|Double-Blind|Lost to Follow-up|2|||
16428466|NCT00666224|40047166|FG001|Double-Blind|Lost to Follow-up|2|||
16428467|NCT00666224|40047165|FG000|Double-Blind|Withdrawal by Subject|18|||
16428468|NCT00666224|40047166|FG001|Double-Blind|Withdrawal by Subject|14|||
16428469|NCT00666224|40047165|FG000|Double-Blind|Physician Decision|0|||
16428470|NCT00666224|40047166|FG001|Double-Blind|Physician Decision|3|||
16428471|NCT00666224|40047165|FG000|Double-Blind|Sponsor decision|1|||
16428472|NCT00666224|40047166|FG001|Double-Blind|Sponsor decision|0|||
16428473|NCT00666224|40047165|FG000|Double-Blind|Pregnancy|3|||
16428474|NCT00666224|40047166|FG001|Double-Blind|Pregnancy|2|||
16428475|NCT00666224|40047165|FG000|Double-Blind|Noncompliance|1|||
16428476|NCT00666224|40047166|FG001|Double-Blind|Noncompliance|0|||
16428477|NCT00666224|40047165|FG000|Double-Blind|Death|1|||
16428478|NCT00666224|40047166|FG001|Double-Blind|Death|0|||
16428479|NCT00666224|40047165|FG000|Double-Blind|Undefined/Unknown|4|||
16428480|NCT00666224|40047166|FG001|Double-Blind|Undefined/Unknown|1|||
16428481|NCT00666224|40047165|FG000|Open-Label|Adverse Event|8|||
16428482|NCT00666224|40047166|FG001|Open-Label|Adverse Event|43|||
16428483|NCT00666224|40047165|FG000|Open-Label|Lost to Follow-up|4|||
16428484|NCT00666224|40047166|FG001|Open-Label|Lost to Follow-up|5|||
16428485|NCT00666224|40047165|FG000|Open-Label|Withdrawal by Subject|12|||
16428486|NCT00666224|40047166|FG001|Open-Label|Withdrawal by Subject|25|||
16428487|NCT00666224|40047165|FG000|Open-Label|Physician Decision|7|||
16428488|NCT00666224|40047166|FG001|Open-Label|Physician Decision|5|||
16428489|NCT00666224|40047165|FG000|Open-Label|Pregnancy|1|||
16428490|NCT00666224|40047166|FG001|Open-Label|Pregnancy|5|||
16428491|NCT00666224|40047165|FG000|Open-Label|Noncompliance|2|||
16428492|NCT00666224|40047166|FG001|Open-Label|Noncompliance|1|||
16428493|NCT00666224|40047165|FG000|Open-Label|Undefined/Unknown|1|||
16428494|NCT00666224|40047166|FG001|Open-Label|Undefined/Unknown|1|||
16428495|NCT03294590|40047167|FG000|Overall Study|Lost to Follow-up|105|||
16428496|NCT03294590|40047168|FG001|Overall Study|Lost to Follow-up|107|||
16428497|NCT00398567|40047169|FG000|Overall Study|Disease Progression|3|||
16428498|NCT00398567|40047170|FG001|Overall Study|Disease Progression|4|||
16428499|NCT00398567|40047171|FG002|Overall Study|Disease Progression|27|||
16428500|NCT00398567|40047169|FG000|Overall Study|Withdrawal by Subject|1|||
16428501|NCT00398567|40047170|FG001|Overall Study|Withdrawal by Subject|0|||
16428502|NCT00398567|40047171|FG002|Overall Study|Withdrawal by Subject|4|||
16428503|NCT00398567|40047169|FG000|Overall Study|Adverse Event|0|||
16428504|NCT00398567|40047170|FG001|Overall Study|Adverse Event|0|||
16428505|NCT00398567|40047171|FG002|Overall Study|Adverse Event|2|||
16428506|NCT00398567|40047169|FG000|Overall Study|Protocol Violation|0|||
16428507|NCT00398567|40047170|FG001|Overall Study|Protocol Violation|0|||
16428508|NCT00398567|40047171|FG002|Overall Study|Protocol Violation|1|||
16428509|NCT02475278|40047172|FG000|Overall Study|Lost to Follow-up|1|||
16428510|NCT02475278|40047172|FG000|Overall Study|Reason Not Specified|1|||
16428511|NCT04538417|40047173|FG000|Overall Study|Withdrawal by Subject|2|||
16428512|NCT01685697|40047174|FG000|Overall Study|Protocol Violation|3|||
16428513|NCT01685697|40047175|FG001|Overall Study|Protocol Violation|3|||
16428514|NCT03187132|40047183|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
16428515|NCT03187132|40047184|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
16428516|NCT03187132|40047183|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
16428517|NCT03187132|40047184|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
16428518|NCT03187132|40047183|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
16428519|NCT03187132|40047184|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
16428520|NCT03187132|40047183|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
16428521|NCT03187132|40047184|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
16428522|NCT03187132|40047183|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
16428523|NCT03187132|40047184|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
16428524|NCT03187132|40047183|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
16562800|NCT01474512|40525464|FG004|Maintenance Period|Physician Decision|0|||
16562801|NCT01474512|40525465|FG005|Maintenance Period|Physician Decision|1|||
16562802|NCT01474512|40525466|FG006|Maintenance Period|Physician Decision|0|||
16562803|NCT01474512|40525467|FG007|Maintenance Period|Physician Decision|2|||
16562804|NCT01474512|40525468|FG008|Maintenance Period|Physician Decision|0|||
16428525|NCT03187132|40047184|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
16428526|NCT03187132|40047183|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
16428527|NCT03187132|40047184|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
16428528|NCT03187132|40047183|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
16428529|NCT03187132|40047184|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
16428530|NCT03187132|40047183|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
16428531|NCT03187132|40047184|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
16428532|NCT03187132|40047183|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
16428533|NCT03187132|40047184|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
16428534|NCT03187132|40047183|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
16428535|NCT03187132|40047184|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
16428536|NCT01136408|40047188|FG000|Overall Study|Adverse Event|4|||
16428537|NCT01136408|40047189|FG001|Overall Study|Adverse Event|8|||
16428538|NCT01136408|40047190|FG002|Overall Study|Adverse Event|4|||
16428539|NCT01136408|40047188|FG000|Overall Study|Protocol Violation|1|||
16428540|NCT01136408|40047189|FG001|Overall Study|Protocol Violation|1|||
16428541|NCT01136408|40047190|FG002|Overall Study|Protocol Violation|1|||
16428542|NCT01514201|40047191|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
16428543|NCT01514201|40047192|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16428544|NCT01514201|40047193|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16428545|NCT01514201|40047194|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16428546|NCT01514201|40047191|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
16428547|NCT01514201|40047192|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
16428548|NCT01514201|40047193|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
16428549|NCT01514201|40047194|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
16428550|NCT01514201|40047191|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
16428551|NCT01514201|40047192|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
16428552|NCT01514201|40047193|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
16428553|NCT01514201|40047194|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
16428554|NCT01514201|40047191|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
16428555|NCT01514201|40047192|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
16428556|NCT01514201|40047193|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
16428557|NCT01514201|40047194|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
16428558|NCT01514201|40047191|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
16428559|NCT01514201|40047192|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
16428560|NCT01514201|40047193|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
16428561|NCT01514201|40047194|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
16428562|NCT01514201|40047191|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
16428563|NCT01514201|40047192|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
16428564|NCT01514201|40047193|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
16428565|NCT01514201|40047194|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
16428566|NCT01514201|40047191|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
16428567|NCT01514201|40047192|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
16428568|NCT01514201|40047193|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
16428569|NCT01514201|40047194|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
16428570|NCT01514201|40047191|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16428571|NCT01514201|40047192|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16428572|NCT01514201|40047193|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
16428573|NCT01514201|40047194|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
16428574|NCT01514201|40047191|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
16428575|NCT01514201|40047192|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
16428576|NCT01514201|40047193|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
16428577|NCT01514201|40047194|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
16428578|NCT01514201|40047191|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
16428579|NCT01514201|40047192|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
16428580|NCT01514201|40047193|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
16428581|NCT01514201|40047194|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
16428582|NCT01514201|40047191|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
16428583|NCT01514201|40047192|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
16428584|NCT01514201|40047193|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
16428585|NCT01514201|40047194|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
16562805|NCT01474512|40525469|FG009|Maintenance Period|Physician Decision|0|||
16562806|NCT01474512|40525470|FG010|Maintenance Period|Physician Decision|0|||
16562807|NCT01474512|40525471|FG011|Maintenance Period|Physician Decision|0|||
16562808|NCT01474512|40525472|FG012|Maintenance Period|Physician Decision|0|||
16562809|NCT01474512|40525473|FG013|Maintenance Period|Physician Decision|0|||
16562810|NCT01474512|40525474|FG014|Maintenance Period|Physician Decision|0|||
16562811|NCT01474512|40525475|FG015|Maintenance Period|Physician Decision|0|||
16562812|NCT01474512|40525476|FG016|Maintenance Period|Physician Decision|0|||
16562813|NCT01474512|40525477|FG017|Maintenance Period|Physician Decision|0|||
16562814|NCT01474512|40525460|FG000|Maintenance Period|Clinical Relapse|0|||
16562815|NCT01474512|40525461|FG001|Maintenance Period|Clinical Relapse|0|||
16562816|NCT01474512|40525462|FG002|Maintenance Period|Clinical Relapse|0|||
16562817|NCT01474512|40525463|FG003|Maintenance Period|Clinical Relapse|1|||
16428586|NCT01514201|40047191|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
16562818|NCT01474512|40525464|FG004|Maintenance Period|Clinical Relapse|0|||
16562819|NCT01474512|40525465|FG005|Maintenance Period|Clinical Relapse|0|||
16428587|NCT01514201|40047192|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
16428588|NCT01514201|40047193|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
16428589|NCT01514201|40047194|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
16428590|NCT00306527|40047195|FG000|Overall Study|Lost to Follow-up|3|||
16428591|NCT00306527|40047196|FG001|Overall Study|Lost to Follow-up|4|||
16428592|NCT00306527|40047197|FG002|Overall Study|Lost to Follow-up|3|||
16428593|NCT00306527|40047198|FG003|Overall Study|Lost to Follow-up|0|||
16428594|NCT00306527|40047195|FG000|Overall Study|Withdrawal by Subject|2|||
16428595|NCT00306527|40047196|FG001|Overall Study|Withdrawal by Subject|3|||
16428596|NCT00306527|40047197|FG002|Overall Study|Withdrawal by Subject|0|||
16428597|NCT00306527|40047198|FG003|Overall Study|Withdrawal by Subject|3|||
16428598|NCT00306527|40047195|FG000|Overall Study|Adverse Event|0|||
16428599|NCT00306527|40047196|FG001|Overall Study|Adverse Event|0|||
16428600|NCT00306527|40047197|FG002|Overall Study|Adverse Event|1|||
16428601|NCT00306527|40047198|FG003|Overall Study|Adverse Event|1|||
16131111|NCT02257567|38967204|FG001|Overall Study|Withdrawal by Subject|0|||
16428602|NCT00306527|40047195|FG000|Overall Study|Death|1|||
16428603|NCT00306527|40047196|FG001|Overall Study|Death|0|||
16428604|NCT00306527|40047197|FG002|Overall Study|Death|1|||
16428605|NCT00306527|40047198|FG003|Overall Study|Death|2|||
16428606|NCT03387020|40047201|FG000|Overall Study|Adverse Event|0|||
16428607|NCT03387020|40047202|FG001|Overall Study|Adverse Event|2|||
16428608|NCT03387020|40047203|FG002|Overall Study|Adverse Event|0|||
16428609|NCT03387020|40047201|FG000|Overall Study|Withdrawal by Subject|2|||
16428610|NCT03387020|40047202|FG001|Overall Study|Withdrawal by Subject|0|||
16428611|NCT03387020|40047203|FG002|Overall Study|Withdrawal by Subject|0|||
16428612|NCT03801174|40047204|FG000|Overall Study|Withdrawal by Subject|14|||
16428613|NCT03801174|40047205|FG001|Overall Study|Withdrawal by Subject|15|||
16428614|NCT03801174|40047204|FG000|Overall Study|Death|1|||
16428615|NCT03801174|40047205|FG001|Overall Study|Death|0|||
16428616|NCT03801174|40047204|FG000|Overall Study|Pregnancy|2|||
16428617|NCT03801174|40047205|FG001|Overall Study|Pregnancy|2|||
16428618|NCT03801174|40047204|FG000|Overall Study|Lost to Follow-up|19|||
16428619|NCT03801174|40047205|FG001|Overall Study|Lost to Follow-up|10|||
16428620|NCT03801174|40047204|FG000|Overall Study|Other|4|||
16428621|NCT03801174|40047205|FG001|Overall Study|Other|3|||
16428622|NCT03801174|40047204|FG000|Overall Study|Lack of Efficacy|4|||
16428623|NCT03801174|40047205|FG001|Overall Study|Lack of Efficacy|0|||
16428624|NCT03801174|40047204|FG000|Overall Study|Unwilling to complete activities|5|||
16250202|NCT02784106|39398011|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
16250203|NCT02784106|39398012|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
16250204|NCT02784106|39398009|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
16250205|NCT02784106|39398010|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
16250206|NCT02784106|39398011|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
16250207|NCT02784106|39398012|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
16250208|NCT02784106|39398009|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
16250209|NCT02784106|39398010|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
16250210|NCT02784106|39398011|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
16250211|NCT02784106|39398012|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
16250212|NCT02784106|39398009|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
16250213|NCT02784106|39398010|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
16250214|NCT02784106|39398011|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
16250215|NCT02784106|39398012|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
16250216|NCT01767597|39398013|FG000|Overall Study|Incomplete intervention|3|||
16250217|NCT01767597|39398014|FG001|Overall Study|Incomplete intervention|1|||
16250218|NCT01767597|39398013|FG000|Overall Study|Withdrawal by Subject|1|||
16250219|NCT01767597|39398014|FG001|Overall Study|Withdrawal by Subject|0|||
16250220|NCT01227668|39398015|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
16250221|NCT01227668|39398016|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
16250222|NCT01227668|39398015|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
16250223|NCT01227668|39398016|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
16250224|NCT01227668|39398015|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
16250225|NCT01227668|39398016|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
16250226|NCT01227668|39398015|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
16250227|NCT01227668|39398016|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
16250228|NCT01227668|39398015|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
16250229|NCT01227668|39398016|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
16250230|NCT01227668|39398015|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
16250231|NCT01227668|39398016|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
16250232|NCT01227668|39398015|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
16250233|NCT01227668|39398016|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
16250234|NCT01227668|39398015|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
16250235|NCT01227668|39398016|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
16250236|NCT01227668|39398015|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
16250237|NCT01227668|39398016|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
16250238|NCT01227668|39398015|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
16250239|NCT01227668|39398016|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
16250240|NCT01227668|39398015|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
16250241|NCT01227668|39398016|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
16250242|NCT01227668|39398015|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
16250243|NCT01227668|39398016|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
16250244|NCT00770991|39398017|FG000|Overall Study|Physician Decision|2|||
16250245|NCT00770991|39398018|FG001|Overall Study|Physician Decision|0|||
16250246|NCT00770991|39398017|FG000|Overall Study|Withdrawal by Subject|1|||
16250247|NCT00770991|39398018|FG001|Overall Study|Withdrawal by Subject|0|||
16250248|NCT00770991|39398017|FG000|Overall Study|Adverse Event|1|||
16250249|NCT00770991|39398018|FG001|Overall Study|Adverse Event|5|||
16250250|NCT00770991|39398017|FG000|Overall Study|Pregnancy|1|||
16250251|NCT00770991|39398018|FG001|Overall Study|Pregnancy|0|||
16250252|NCT00522457|39398019|FG000|Overall Study|Due to disease progression|16|||
16250253|NCT00522457|39398019|FG000|Overall Study|Adverse Event|2|||
16250254|NCT03402893|39398021|FG000|Overall Study|Withdrawal by Subject|1|||
16250255|NCT02736227|39398022|FG000|Overall Study|Withdrawal by Subject|0|||
16250256|NCT02736227|39398023|FG001|Overall Study|Withdrawal by Subject|0|||
16250257|NCT02736227|39398024|FG002|Overall Study|Withdrawal by Subject|1|||
16250258|NCT02736227|39398022|FG000|Overall Study|Physician Decision|0|||
16250259|NCT02736227|39398023|FG001|Overall Study|Physician Decision|0|||
16250260|NCT02736227|39398024|FG002|Overall Study|Physician Decision|5|||
16250261|NCT02736227|39398022|FG000|Overall Study|Non Compliant|0|||
16250262|NCT02736227|39398023|FG001|Overall Study|Non Compliant|0|||
16250263|NCT02736227|39398024|FG002|Overall Study|Non Compliant|2|||
16250264|NCT00467584|39398025|FG000|Overall Study|Withdrawal by Subject|4|||
16250265|NCT00467584|39398026|FG001|Overall Study|Withdrawal by Subject|5|||
16250266|NCT00467584|39398027|FG002|Overall Study|Withdrawal by Subject|1|||
16250267|NCT02843074|39398028|FG000|Overall Study|Withdrawal by Subject|5|||
16428625|NCT03801174|40047205|FG001|Overall Study|Unwilling to complete activities|6|||
16428626|NCT03801174|40047204|FG000|Overall Study|Moved out of area|3|||
16428627|NCT03801174|40047205|FG001|Overall Study|Moved out of area|0|||
16428628|NCT02326597|40047218|FG000|Overall Study|Lost to Follow-up|42|||
16428629|NCT02326597|40047219|FG001|Overall Study|Lost to Follow-up|32|||
16428630|NCT03592368|40047220|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
16428631|NCT03592368|40047221|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
16428632|NCT03592368|40047222|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
16428633|NCT03592368|40047223|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
16428634|NCT03592368|40047220|FG000|Overall Study|Adverse Event|0|||
16428635|NCT03592368|40047221|FG001|Overall Study|Adverse Event|0|||
16428636|NCT03592368|40047222|FG002|Overall Study|Adverse Event|0|||
16428637|NCT03592368|40047223|FG003|Overall Study|Adverse Event|1|||
16428638|NCT03592368|40047220|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
16428639|NCT03592368|40047221|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
16428640|NCT03592368|40047222|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
16428641|NCT03592368|40047223|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
16428642|NCT03350815|40047224|FG000|Period 1|Adverse Event|10|||
16428643|NCT03350815|40047225|FG001|Period 1|Adverse Event|0|||
16428644|NCT03350815|40047226|FG002|Period 1|Adverse Event|0|||
16428645|NCT03350815|40047227|FG003|Period 1|Adverse Event|0|||
16428646|NCT03350815|40047224|FG000|Period 1|Technical problems|1|||
16428647|NCT03350815|40047225|FG001|Period 1|Technical problems|0|||
16428648|NCT03350815|40047226|FG002|Period 1|Technical problems|0|||
16428649|NCT03350815|40047227|FG003|Period 1|Technical problems|0|||
16428650|NCT03350815|40047224|FG000|Period 1|Lost to Follow-up|3|||
16428651|NCT03350815|40047225|FG001|Period 1|Lost to Follow-up|0|||
16428652|NCT03350815|40047226|FG002|Period 1|Lost to Follow-up|0|||
16428653|NCT03350815|40047227|FG003|Period 1|Lost to Follow-up|0|||
16428654|NCT03350815|40047224|FG000|Period 1|Physician Decision|1|||
16428655|NCT03350815|40047225|FG001|Period 1|Physician Decision|0|||
16428656|NCT03350815|40047226|FG002|Period 1|Physician Decision|0|||
16428657|NCT03350815|40047227|FG003|Period 1|Physician Decision|0|||
16428658|NCT03350815|40047224|FG000|Period 1|Withdrawal by Subject|8|||
16428659|NCT03350815|40047225|FG001|Period 1|Withdrawal by Subject|0|||
16428660|NCT03350815|40047226|FG002|Period 1|Withdrawal by Subject|0|||
16428661|NCT03350815|40047227|FG003|Period 1|Withdrawal by Subject|0|||
16428662|NCT03350815|40047224|FG000|Period 1|Lack of Efficacy|15|||
16428663|NCT03350815|40047225|FG001|Period 1|Lack of Efficacy|0|||
16428664|NCT03350815|40047226|FG002|Period 1|Lack of Efficacy|0|||
16428665|NCT03350815|40047227|FG003|Period 1|Lack of Efficacy|0|||
16428666|NCT03350815|40047224|FG000|Period 1|Non-compliance with study treatment|2|||
16428667|NCT03350815|40047225|FG001|Period 1|Non-compliance with study treatment|0|||
16428668|NCT03350815|40047226|FG002|Period 1|Non-compliance with study treatment|0|||
16428669|NCT03350815|40047227|FG003|Period 1|Non-compliance with study treatment|0|||
16428670|NCT03350815|40047224|FG000|Period 1|Protocol Violation|3|||
16428671|NCT03350815|40047225|FG001|Period 1|Protocol Violation|0|||
16428672|NCT03350815|40047226|FG002|Period 1|Protocol Violation|0|||
16428673|NCT03350815|40047227|FG003|Period 1|Protocol Violation|0|||
16428674|NCT03350815|40047224|FG000|Period 2|Adverse Event|0|||
16428675|NCT03350815|40047225|FG001|Period 2|Adverse Event|3|||
16428676|NCT03350815|40047226|FG002|Period 2|Adverse Event|5|||
16428677|NCT03350815|40047227|FG003|Period 2|Adverse Event|0|||
16428678|NCT03350815|40047224|FG000|Period 2|Technical problem|0|||
16428679|NCT03350815|40047225|FG001|Period 2|Technical problem|1|||
16428680|NCT03350815|40047226|FG002|Period 2|Technical problem|0|||
16428681|NCT03350815|40047227|FG003|Period 2|Technical problem|0|||
16428682|NCT03350815|40047224|FG000|Period 2|Lost to Follow-up|0|||
16428683|NCT03350815|40047225|FG001|Period 2|Lost to Follow-up|3|||
16428684|NCT03350815|40047226|FG002|Period 2|Lost to Follow-up|3|||
16428685|NCT03350815|40047227|FG003|Period 2|Lost to Follow-up|0|||
16428686|NCT03350815|40047224|FG000|Period 2|Physician Decision|0|||
16428687|NCT03350815|40047225|FG001|Period 2|Physician Decision|0|||
16428688|NCT03350815|40047226|FG002|Period 2|Physician Decision|1|||
16428689|NCT03350815|40047227|FG003|Period 2|Physician Decision|0|||
16428690|NCT03350815|40047224|FG000|Period 2|Withdrawal by Subject|0|||
16428691|NCT03350815|40047225|FG001|Period 2|Withdrawal by Subject|3|||
16428692|NCT03350815|40047226|FG002|Period 2|Withdrawal by Subject|4|||
16428693|NCT03350815|40047227|FG003|Period 2|Withdrawal by Subject|0|||
16428694|NCT03350815|40047224|FG000|Period 2|Lack of Efficacy|0|||
16428695|NCT03350815|40047225|FG001|Period 2|Lack of Efficacy|6|||
16428696|NCT03350815|40047226|FG002|Period 2|Lack of Efficacy|2|||
16428697|NCT03350815|40047227|FG003|Period 2|Lack of Efficacy|0|||
16428698|NCT03350815|40047224|FG000|Period 2|Protocol Violation|0|||
16428699|NCT03350815|40047225|FG001|Period 2|Protocol Violation|0|||
16562820|NCT01474512|40525466|FG006|Maintenance Period|Clinical Relapse|0|||
16562821|NCT01474512|40525467|FG007|Maintenance Period|Clinical Relapse|0|||
16562822|NCT01474512|40525468|FG008|Maintenance Period|Clinical Relapse|0|||
16428700|NCT03350815|40047226|FG002|Period 2|Protocol Violation|1|||
16428701|NCT03350815|40047227|FG003|Period 2|Protocol Violation|0|||
16360832|NCT03010501|39807574|FG001|Study Week 3|Withdrawal by Subject|0|||
16360833|NCT03010501|39807575|FG002|Study Week 3|Withdrawal by Subject|0|||
16360834|NCT03010501|39807576|FG003|Study Week 3|Withdrawal by Subject|1|||
16360835|NCT03010501|39807577|FG004|Study Week 3|Withdrawal by Subject|0|||
16360836|NCT03010501|39807578|FG005|Study Week 3|Withdrawal by Subject|0|||
16360837|NCT02530385|39807579|FG000|Overall Study|Withdrawal by Subject|0|||
16360838|NCT02530385|39807580|FG001|Overall Study|Withdrawal by Subject|1|||
16360839|NCT03250273|39807581|FG000|Overall Study|Disease Progression|2|||
16360840|NCT03250273|39807582|FG001|Overall Study|Disease Progression|11|||
16360841|NCT03250273|39807581|FG000|Overall Study|Death|0|||
16360842|NCT03250273|39807582|FG001|Overall Study|Death|1|||
16360843|NCT00434252|39807583|FG000|Overall Study|Lack of Efficacy|50|||
16360844|NCT00434252|39807584|FG001|Overall Study|Lack of Efficacy|100|||
16360845|NCT00434252|39807583|FG000|Overall Study|Adverse Event|6|||
16360846|NCT00434252|39807584|FG001|Overall Study|Adverse Event|13|||
16360847|NCT00434252|39807583|FG000|Overall Study|Death|1|||
16360848|NCT00434252|39807584|FG001|Overall Study|Death|2|||
16360849|NCT00434252|39807583|FG000|Overall Study|Lost to Follow-up|0|||
16360850|NCT00434252|39807584|FG001|Overall Study|Lost to Follow-up|1|||
16360851|NCT00434252|39807583|FG000|Overall Study|Physician Decision|4|||
16360852|NCT00434252|39807584|FG001|Overall Study|Physician Decision|8|||
16360853|NCT00434252|39807583|FG000|Overall Study|Withdrawal by Subject|3|||
16360854|NCT00434252|39807584|FG001|Overall Study|Withdrawal by Subject|7|||
16360855|NCT03440320|39807587|FG000|Overall Study|Withdrawal by Subject|0|||
16360856|NCT03440320|39807588|FG001|Overall Study|Withdrawal by Subject|1|||
16360857|NCT05073315|39807590|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
16360858|NCT05073315|39807591|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
16360859|NCT05073315|39807592|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
16360860|NCT05073315|39807590|FG000|Period 1 (Lead-in Period)|Death|1|||
16360861|NCT05073315|39807591|FG001|Period 1 (Lead-in Period)|Death|0|||
16360862|NCT05073315|39807592|FG002|Period 1 (Lead-in Period)|Death|0|||
16360863|NCT05073315|39807590|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
16360864|NCT05073315|39807591|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
16360865|NCT05073315|39807592|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
16360866|NCT05073315|39807590|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
16360867|NCT05073315|39807591|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
16360868|NCT05073315|39807592|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
16360869|NCT05073315|39807590|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
16360870|NCT05073315|39807591|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
16360871|NCT05073315|39807592|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
16360872|NCT05073315|39807590|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
16360873|NCT05073315|39807591|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
16360874|NCT05073315|39807592|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
16360875|NCT05073315|39807590|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
16360876|NCT05073315|39807591|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
16360877|NCT05073315|39807592|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
16360878|NCT05073315|39807590|FG000|Period 2|Adverse Event|0|||
16360879|NCT05073315|39807591|FG001|Period 2|Adverse Event|3|||
16360880|NCT05073315|39807592|FG002|Period 2|Adverse Event|6|||
16360881|NCT05073315|39807590|FG000|Period 2|Lost to Follow-up|0|||
16360882|NCT05073315|39807591|FG001|Period 2|Lost to Follow-up|5|||
16360883|NCT05073315|39807592|FG002|Period 2|Lost to Follow-up|5|||
16360884|NCT05073315|39807590|FG000|Period 2|Withdrawal by Subject|0|||
16360885|NCT05073315|39807591|FG001|Period 2|Withdrawal by Subject|4|||
16360886|NCT05073315|39807592|FG002|Period 2|Withdrawal by Subject|9|||
16360887|NCT05073315|39807590|FG000|Period 2|Protocol Violation|0|||
16360888|NCT05073315|39807591|FG001|Period 2|Protocol Violation|0|||
16360889|NCT05073315|39807592|FG002|Period 2|Protocol Violation|1|||
16360890|NCT01652690|39807593|FG000|Overall Study|Withdrawal by Subject|16|||
16360891|NCT01652690|39807594|FG001|Overall Study|Withdrawal by Subject|4|||
16360892|NCT01652690|39807593|FG000|Overall Study|Other|8|||
16360893|NCT01652690|39807594|FG001|Overall Study|Other|9|||
16360894|NCT01652690|39807593|FG000|Overall Study|Lost to Follow-up|6|||
16360895|NCT01652690|39807594|FG001|Overall Study|Lost to Follow-up|6|||
16360896|NCT01652690|39807593|FG000|Overall Study|Death|5|||
16360897|NCT01652690|39807594|FG001|Overall Study|Death|2|||
16360898|NCT02921789|39807595|FG000|Overall Study|Adverse Event|0|||
16360899|NCT02921789|39807596|FG001|Overall Study|Adverse Event|1|||
16360900|NCT02921789|39807595|FG000|Overall Study|Lost to Follow-up|1|||
16360901|NCT02921789|39807596|FG001|Overall Study|Lost to Follow-up|0|||
16360902|NCT02921789|39807595|FG000|Overall Study|Protocol Deviation|2|||
16360903|NCT02921789|39807596|FG001|Overall Study|Protocol Deviation|0|||
16360904|NCT02921789|39807595|FG000|Overall Study|Withdrawal by Subject|2|||
16360905|NCT02921789|39807596|FG001|Overall Study|Withdrawal by Subject|1|||
16360906|NCT02921789|39807595|FG000|Overall Study|Miscellaneous|3|||
16360907|NCT02921789|39807596|FG001|Overall Study|Miscellaneous|2|||
16428702|NCT03350815|40047224|FG000|Period 2|New therapy for study indication|0|||
16428703|NCT03350815|40047225|FG001|Period 2|New therapy for study indication|0|||
16428704|NCT03350815|40047226|FG002|Period 2|New therapy for study indication|1|||
16428705|NCT03350815|40047227|FG003|Period 2|New therapy for study indication|0|||
16428706|NCT01965704|40047231|FG000|Overall Study|Withdrawal by Subject|2|||
16428707|NCT01965704|40047232|FG001|Overall Study|Withdrawal by Subject|2|||
16428708|NCT01965704|40047233|FG002|Overall Study|Withdrawal by Subject|1|||
16428709|NCT01965704|40047234|FG003|Overall Study|Withdrawal by Subject|1|||
16428710|NCT01965704|40047231|FG000|Overall Study|Delivered at home|1|||
16428711|NCT01965704|40047232|FG001|Overall Study|Delivered at home|1|||
16428712|NCT01965704|40047233|FG002|Overall Study|Delivered at home|0|||
16428713|NCT01965704|40047234|FG003|Overall Study|Delivered at home|0|||
16428714|NCT01965704|40047231|FG000|Overall Study|Experienced complications|0|||
16428715|NCT01965704|40047232|FG001|Overall Study|Experienced complications|0|||
16428716|NCT01965704|40047233|FG002|Overall Study|Experienced complications|2|||
16428717|NCT01965704|40047234|FG003|Overall Study|Experienced complications|2|||
16428718|NCT01965704|40047231|FG000|Overall Study|Adverse Event|0|||
16428719|NCT01965704|40047232|FG001|Overall Study|Adverse Event|0|||
16428720|NCT01965704|40047233|FG002|Overall Study|Adverse Event|1|||
16428721|NCT01965704|40047234|FG003|Overall Study|Adverse Event|1|||
16428722|NCT01965704|40047231|FG000|Overall Study|Did not meet inclusion criteria|0|||
16428723|NCT01965704|40047232|FG001|Overall Study|Did not meet inclusion criteria|0|||
16428724|NCT01965704|40047233|FG002|Overall Study|Did not meet inclusion criteria|1|||
16428725|NCT01965704|40047234|FG003|Overall Study|Did not meet inclusion criteria|1|||
16428726|NCT03282097|40047235|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
16428727|NCT03282097|40047236|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
16428728|NCT03282097|40047235|FG000|Intervention Visit Complete|Patient Death|13|||
16428729|NCT03282097|40047236|FG001|Intervention Visit Complete|Patient Death|15|||
16428730|NCT03282097|40047235|FG000|Intervention Visit Complete|Caregiver Death|0|||
16428731|NCT03282097|40047236|FG001|Intervention Visit Complete|Caregiver Death|3|||
16428732|NCT03282097|40047235|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
16428733|NCT03282097|40047236|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
16428734|NCT03282097|40047235|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
16360908|NCT02152007|39807597|FG000|Overall Study|Withdrawal by Subject|1|||
16360909|NCT03839641|39807601|FG000|Overall Study|Withdrawal by Subject|1|||
16360910|NCT03839641|39807602|FG001|Overall Study|Withdrawal by Subject|1|||
16360911|NCT02145390|39807606|FG000|Overall Study|Withdrawal by Subject|1|||
16360912|NCT03427892|39807612|FG000|Overall Study|Lost to Follow-up|2|||
16360913|NCT01373164|39807619|FG000|Overall Study|Lost to Follow-up|0|||
16360914|NCT01373164|39807620|FG001|Overall Study|Lost to Follow-up|0|||
16360915|NCT01373164|39807621|FG002|Overall Study|Lost to Follow-up|1|||
16360916|NCT01373164|39807622|FG003|Overall Study|Lost to Follow-up|2|||
16360917|NCT01373164|39807623|FG004|Overall Study|Lost to Follow-up|0|||
16360918|NCT01373164|39807619|FG000|Overall Study|Withdrawal by Subject|0|||
16360919|NCT01373164|39807620|FG001|Overall Study|Withdrawal by Subject|1|||
16360920|NCT01373164|39807621|FG002|Overall Study|Withdrawal by Subject|0|||
16360921|NCT01373164|39807622|FG003|Overall Study|Withdrawal by Subject|10|||
16360922|NCT01373164|39807623|FG004|Overall Study|Withdrawal by Subject|2|||
16360923|NCT02357459|39807626|FG000|Overall Study|Adverse Event|0|||
16360924|NCT02357459|39807627|FG001|Overall Study|Adverse Event|1|||
16360925|NCT02357459|39807628|FG002|Overall Study|Adverse Event|1|||
16360926|NCT02357459|39807626|FG000|Overall Study|Withdrawal by Subject|5|||
16360927|NCT02357459|39807627|FG001|Overall Study|Withdrawal by Subject|3|||
16360928|NCT02357459|39807628|FG002|Overall Study|Withdrawal by Subject|3|||
16360929|NCT02357459|39807626|FG000|Overall Study|Physician Decision|0|||
16360930|NCT02357459|39807627|FG001|Overall Study|Physician Decision|2|||
16360931|NCT02357459|39807628|FG002|Overall Study|Physician Decision|0|||
16360932|NCT02357459|39807626|FG000|Overall Study|Protocol Violation|1|||
16360933|NCT02357459|39807627|FG001|Overall Study|Protocol Violation|1|||
16360934|NCT02357459|39807628|FG002|Overall Study|Protocol Violation|0|||
16360935|NCT02357459|39807626|FG000|Overall Study|Lost to Follow-up|1|||
16360936|NCT02357459|39807627|FG001|Overall Study|Lost to Follow-up|3|||
16360937|NCT02357459|39807628|FG002|Overall Study|Lost to Follow-up|0|||
16360938|NCT02357459|39807626|FG000|Overall Study|Lack of Efficacy|7|||
16360939|NCT02357459|39807627|FG001|Overall Study|Lack of Efficacy|4|||
16360940|NCT02357459|39807628|FG002|Overall Study|Lack of Efficacy|4|||
16360941|NCT02357459|39807626|FG000|Overall Study|Patient Relocated|2|||
16360942|NCT02357459|39807627|FG001|Overall Study|Patient Relocated|0|||
16360943|NCT02357459|39807628|FG002|Overall Study|Patient Relocated|0|||
16360944|NCT02357459|39807626|FG000|Overall Study|Instruction from PCP|1|||
16360945|NCT02357459|39807627|FG001|Overall Study|Instruction from PCP|0|||
16360946|NCT02357459|39807628|FG002|Overall Study|Instruction from PCP|0|||
16360947|NCT02357459|39807626|FG000|Overall Study|Incarceration|0|||
16360948|NCT02357459|39807627|FG001|Overall Study|Incarceration|0|||
16360949|NCT02357459|39807628|FG002|Overall Study|Incarceration|1|||
16360950|NCT02357459|39807626|FG000|Overall Study|Pre-planned Knee surgery|0|||
16428735|NCT03282097|40047236|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
16428736|NCT03282097|40047235|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
16428737|NCT03282097|40047236|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
16428738|NCT03282097|40047235|FG000|Primary Outcome Data Collection Complete|Missing|2|||
16428739|NCT03282097|40047236|FG001|Primary Outcome Data Collection Complete|Missing|3|||
16428740|NCT03282097|40047235|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
16428741|NCT03282097|40047236|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
16428742|NCT03282097|40047235|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
16428743|NCT03282097|40047236|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
16428744|NCT03282097|40047235|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
16428745|NCT03282097|40047236|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
16428746|NCT02462720|40047237|FG000|Part 2|Withdrawal by Subject|1|||
16428747|NCT02462720|40047238|FG001|Part 2|Withdrawal by Subject|0|||
16428748|NCT02462720|40047237|FG000|Part 2|Protocol Violation|0|||
16428749|NCT02462720|40047238|FG001|Part 2|Protocol Violation|1|||
16428750|NCT02003534|40047242|FG000|Overall Study|Lost to Follow-up|47|||
16428751|NCT02291419|40047243|FG000|Overall Study|Early study termination|1|||
16428752|NCT02291419|40047244|FG001|Overall Study|Early study termination|5|||
16428753|NCT03078556|40047245|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
16428754|NCT03078556|40047246|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
16428755|NCT03078556|40047247|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
16428756|NCT03078556|40047248|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
16428757|NCT03078556|40047245|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
16428758|NCT03078556|40047246|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
16428759|NCT03078556|40047247|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
16428760|NCT03078556|40047248|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
16428761|NCT03078556|40047245|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
16428762|NCT03078556|40047246|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
16428763|NCT03078556|40047247|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
16428764|NCT03078556|40047248|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
16428765|NCT03078556|40047245|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
16428766|NCT03078556|40047246|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
16428767|NCT03078556|40047247|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
16428768|NCT03078556|40047248|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
16428769|NCT02703324|40047252|FG000|Period Two|Withdrawal by Subject|0|||
16428770|NCT02703324|40047253|FG001|Period Two|Withdrawal by Subject|0|||
16428771|NCT02703324|40047254|FG002|Period Two|Withdrawal by Subject|1|||
16428772|NCT02703324|40047255|FG003|Period Two|Withdrawal by Subject|0|||
16428773|NCT02703324|40047256|FG004|Period Two|Withdrawal by Subject|0|||
16428774|NCT02703324|40047257|FG005|Period Two|Withdrawal by Subject|0|||
16428775|NCT00592904|40047258|FG000|Overall Study|Adverse Event|15|||
16428776|NCT00592904|40047259|FG001|Overall Study|Adverse Event|25|||
16428777|NCT00592904|40047260|FG002|Overall Study|Adverse Event|13|||
16428778|NCT00592904|40047261|FG003|Overall Study|Adverse Event|5|||
16428779|NCT00592904|40047258|FG000|Overall Study|Protocol Violation|1|||
16428780|NCT00592904|40047259|FG001|Overall Study|Protocol Violation|1|||
16428781|NCT00592904|40047260|FG002|Overall Study|Protocol Violation|0|||
16428782|NCT00592904|40047261|FG003|Overall Study|Protocol Violation|1|||
16428783|NCT00592904|40047258|FG000|Overall Study|Withdrawal by Subject|4|||
16428784|NCT00592904|40047259|FG001|Overall Study|Withdrawal by Subject|16|||
16428785|NCT00592904|40047260|FG002|Overall Study|Withdrawal by Subject|1|||
16428786|NCT00592904|40047261|FG003|Overall Study|Withdrawal by Subject|2|||
16428787|NCT00592904|40047258|FG000|Overall Study|Lack of Efficacy|2|||
16428788|NCT00592904|40047259|FG001|Overall Study|Lack of Efficacy|7|||
16428789|NCT00592904|40047260|FG002|Overall Study|Lack of Efficacy|2|||
16428790|NCT00592904|40047261|FG003|Overall Study|Lack of Efficacy|3|||
16428791|NCT00592904|40047258|FG000|Overall Study|Physician Decision|0|||
16428792|NCT00592904|40047259|FG001|Overall Study|Physician Decision|3|||
16428793|NCT00592904|40047260|FG002|Overall Study|Physician Decision|1|||
16428794|NCT00592904|40047261|FG003|Overall Study|Physician Decision|0|||
16428795|NCT00592904|40047258|FG000|Overall Study|Other|3|||
16428796|NCT00592904|40047259|FG001|Overall Study|Other|3|||
16428797|NCT00592904|40047260|FG002|Overall Study|Other|0|||
16428798|NCT00592904|40047261|FG003|Overall Study|Other|0|||
16428799|NCT01818596|40047262|FG000|Overall Study|Enrolled but Not Treated|4|||
16428800|NCT01818596|40047263|FG001|Overall Study|Enrolled but Not Treated|0|||
16428801|NCT01818596|40047262|FG000|Overall Study|Adverse Event|7|||
16428802|NCT01818596|40047263|FG001|Overall Study|Adverse Event|0|||
16428803|NCT01818596|40047262|FG000|Overall Study|Death|3|||
16428804|NCT01818596|40047263|FG001|Overall Study|Death|0|||
16428805|NCT01818596|40047262|FG000|Overall Study|Investigator's Discretion|4|||
16428806|NCT01818596|40047263|FG001|Overall Study|Investigator's Discretion|0|||
16428807|NCT01818596|40047262|FG000|Overall Study|Protocol Violation|1|||
16428808|NCT01818596|40047263|FG001|Overall Study|Protocol Violation|0|||
16428809|NCT01818596|40047262|FG000|Overall Study|Withdrew Consent|5|||
16428810|NCT01818596|40047263|FG001|Overall Study|Withdrew Consent|0|||
16428811|NCT01818596|40047262|FG000|Overall Study|Lost to Follow-up|7|||
16428812|NCT01818596|40047263|FG001|Overall Study|Lost to Follow-up|0|||
16428813|NCT02737475|40047264|FG000|Overall Study|Other reasons|0|||
16428814|NCT02737475|40047265|FG001|Overall Study|Other reasons|0|||
16428815|NCT02737475|40047266|FG002|Overall Study|Other reasons|0|||
16428816|NCT02737475|40047267|FG003|Overall Study|Other reasons|0|||
16428817|NCT02737475|40047268|FG004|Overall Study|Other reasons|1|||
16428818|NCT02737475|40047269|FG005|Overall Study|Other reasons|1|||
16428819|NCT02737475|40047270|FG006|Overall Study|Other reasons|0|||
16428820|NCT02737475|40047271|FG007|Overall Study|Other reasons|0|||
16428821|NCT02737475|40047272|FG008|Overall Study|Other reasons|1|||
16428822|NCT02737475|40047273|FG009|Overall Study|Other reasons|0|||
16428823|NCT02737475|40047274|FG010|Overall Study|Other reasons|1|||
16428824|NCT02737475|40047275|FG011|Overall Study|Other reasons|0|||
16428825|NCT02737475|40047276|FG012|Overall Study|Other reasons|0|||
16428826|NCT02737475|40047277|FG013|Overall Study|Other reasons|0|||
16428827|NCT02737475|40047278|FG014|Overall Study|Other reasons|0|||
16428828|NCT02737475|40047279|FG015|Overall Study|Other reasons|0|||
16428829|NCT02737475|40047280|FG016|Overall Study|Other reasons|0|||
16428830|NCT02737475|40047281|FG017|Overall Study|Other reasons|0|||
16428831|NCT02737475|40047282|FG018|Overall Study|Other reasons|0|||
16428832|NCT02737475|40047283|FG019|Overall Study|Other reasons|0|||
16428833|NCT02737475|40047284|FG020|Overall Study|Other reasons|0|||
16428834|NCT02737475|40047285|FG021|Overall Study|Other reasons|1|||
16428835|NCT02737475|40047286|FG022|Overall Study|Other reasons|0|||
16428836|NCT02737475|40047287|FG023|Overall Study|Other reasons|1|||
16428837|NCT02737475|40047288|FG024|Overall Study|Other reasons|1|||
16428838|NCT02737475|40047289|FG025|Overall Study|Other reasons|1|||
16428839|NCT02737475|40047290|FG026|Overall Study|Other reasons|0|||
16428840|NCT02737475|40047264|FG000|Overall Study|Death|1|||
16428841|NCT02737475|40047265|FG001|Overall Study|Death|0|||
16428842|NCT02737475|40047266|FG002|Overall Study|Death|0|||
16428843|NCT02737475|40047267|FG003|Overall Study|Death|1|||
16428844|NCT02737475|40047268|FG004|Overall Study|Death|0|||
16428845|NCT02737475|40047269|FG005|Overall Study|Death|0|||
16428846|NCT02737475|40047270|FG006|Overall Study|Death|0|||
16428847|NCT02737475|40047271|FG007|Overall Study|Death|2|||
16428848|NCT02737475|40047272|FG008|Overall Study|Death|0|||
16428849|NCT02737475|40047273|FG009|Overall Study|Death|0|||
16428850|NCT02737475|40047274|FG010|Overall Study|Death|0|||
16428851|NCT02737475|40047275|FG011|Overall Study|Death|4|||
16428852|NCT02737475|40047276|FG012|Overall Study|Death|2|||
16428853|NCT02737475|40047277|FG013|Overall Study|Death|2|||
16428854|NCT02737475|40047278|FG014|Overall Study|Death|0|||
16428855|NCT02737475|40047279|FG015|Overall Study|Death|2|||
16428856|NCT02737475|40047280|FG016|Overall Study|Death|2|||
16428857|NCT02737475|40047281|FG017|Overall Study|Death|2|||
16428858|NCT02737475|40047282|FG018|Overall Study|Death|1|||
16428859|NCT02737475|40047283|FG019|Overall Study|Death|0|||
16428860|NCT02737475|40047284|FG020|Overall Study|Death|0|||
16428861|NCT02737475|40047285|FG021|Overall Study|Death|0|||
16428862|NCT02737475|40047286|FG022|Overall Study|Death|0|||
16428863|NCT02737475|40047287|FG023|Overall Study|Death|0|||
16428864|NCT02737475|40047288|FG024|Overall Study|Death|0|||
16428865|NCT02737475|40047289|FG025|Overall Study|Death|0|||
16428866|NCT02737475|40047290|FG026|Overall Study|Death|0|||
16428867|NCT02737475|40047264|FG000|Overall Study|Participant withdrew consent|0|||
16428868|NCT02737475|40047265|FG001|Overall Study|Participant withdrew consent|0|||
16428869|NCT02737475|40047266|FG002|Overall Study|Participant withdrew consent|0|||
16428870|NCT02737475|40047267|FG003|Overall Study|Participant withdrew consent|0|||
16428871|NCT02737475|40047268|FG004|Overall Study|Participant withdrew consent|0|||
16428872|NCT02737475|40047269|FG005|Overall Study|Participant withdrew consent|2|||
16428873|NCT02737475|40047270|FG006|Overall Study|Participant withdrew consent|0|||
16428874|NCT02737475|40047271|FG007|Overall Study|Participant withdrew consent|0|||
16428875|NCT02737475|40047272|FG008|Overall Study|Participant withdrew consent|0|||
16428876|NCT02737475|40047273|FG009|Overall Study|Participant withdrew consent|0|||
16428877|NCT02737475|40047274|FG010|Overall Study|Participant withdrew consent|0|||
16428878|NCT02737475|40047275|FG011|Overall Study|Participant withdrew consent|0|||
16428879|NCT02737475|40047276|FG012|Overall Study|Participant withdrew consent|0|||
16428880|NCT02737475|40047277|FG013|Overall Study|Participant withdrew consent|0|||
16428881|NCT02737475|40047278|FG014|Overall Study|Participant withdrew consent|1|||
16428882|NCT02737475|40047279|FG015|Overall Study|Participant withdrew consent|0|||
16428883|NCT02737475|40047280|FG016|Overall Study|Participant withdrew consent|0|||
16428884|NCT02737475|40047281|FG017|Overall Study|Participant withdrew consent|2|||
16428885|NCT02737475|40047282|FG018|Overall Study|Participant withdrew consent|1|||
16428886|NCT02737475|40047283|FG019|Overall Study|Participant withdrew consent|0|||
16428887|NCT02737475|40047284|FG020|Overall Study|Participant withdrew consent|2|||
16428888|NCT02737475|40047285|FG021|Overall Study|Participant withdrew consent|0|||
16428889|NCT02737475|40047286|FG022|Overall Study|Participant withdrew consent|0|||
16428890|NCT02737475|40047287|FG023|Overall Study|Participant withdrew consent|0|||
16428891|NCT02737475|40047288|FG024|Overall Study|Participant withdrew consent|0|||
16428892|NCT02737475|40047289|FG025|Overall Study|Participant withdrew consent|0|||
16428893|NCT02737475|40047290|FG026|Overall Study|Participant withdrew consent|0|||
16428894|NCT02737475|40047264|FG000|Overall Study|Lost to Follow-up|0|||
16428895|NCT02737475|40047265|FG001|Overall Study|Lost to Follow-up|0|||
16428896|NCT02737475|40047266|FG002|Overall Study|Lost to Follow-up|0|||
16428897|NCT02737475|40047267|FG003|Overall Study|Lost to Follow-up|0|||
16428898|NCT02737475|40047268|FG004|Overall Study|Lost to Follow-up|0|||
16428899|NCT02737475|40047269|FG005|Overall Study|Lost to Follow-up|0|||
16428900|NCT02737475|40047270|FG006|Overall Study|Lost to Follow-up|0|||
16428901|NCT02737475|40047271|FG007|Overall Study|Lost to Follow-up|0|||
16428902|NCT02737475|40047272|FG008|Overall Study|Lost to Follow-up|0|||
16428903|NCT02737475|40047273|FG009|Overall Study|Lost to Follow-up|0|||
16428904|NCT02737475|40047274|FG010|Overall Study|Lost to Follow-up|0|||
16428905|NCT02737475|40047275|FG011|Overall Study|Lost to Follow-up|0|||
16428906|NCT02737475|40047276|FG012|Overall Study|Lost to Follow-up|0|||
16428907|NCT02737475|40047277|FG013|Overall Study|Lost to Follow-up|0|||
16428908|NCT02737475|40047278|FG014|Overall Study|Lost to Follow-up|0|||
16428909|NCT02737475|40047279|FG015|Overall Study|Lost to Follow-up|1|||
16428910|NCT02737475|40047280|FG016|Overall Study|Lost to Follow-up|0|||
16428911|NCT02737475|40047281|FG017|Overall Study|Lost to Follow-up|0|||
16428912|NCT02737475|40047282|FG018|Overall Study|Lost to Follow-up|0|||
16428913|NCT02737475|40047283|FG019|Overall Study|Lost to Follow-up|0|||
16428914|NCT02737475|40047284|FG020|Overall Study|Lost to Follow-up|0|||
16428915|NCT02737475|40047285|FG021|Overall Study|Lost to Follow-up|0|||
16428916|NCT02737475|40047286|FG022|Overall Study|Lost to Follow-up|0|||
16428917|NCT02737475|40047287|FG023|Overall Study|Lost to Follow-up|0|||
16428918|NCT02737475|40047288|FG024|Overall Study|Lost to Follow-up|0|||
16428919|NCT02737475|40047289|FG025|Overall Study|Lost to Follow-up|0|||
16428920|NCT02737475|40047290|FG026|Overall Study|Lost to Follow-up|0|||
16428921|NCT02737475|40047264|FG000|Overall Study|Disease Progression|0|||
16428922|NCT02737475|40047265|FG001|Overall Study|Disease Progression|0|||
16428923|NCT02737475|40047266|FG002|Overall Study|Disease Progression|0|||
16428924|NCT02737475|40047267|FG003|Overall Study|Disease Progression|0|||
16428925|NCT02737475|40047268|FG004|Overall Study|Disease Progression|0|||
16428926|NCT02737475|40047269|FG005|Overall Study|Disease Progression|0|||
16428927|NCT02737475|40047270|FG006|Overall Study|Disease Progression|0|||
16428928|NCT02737475|40047271|FG007|Overall Study|Disease Progression|0|||
16428929|NCT02737475|40047272|FG008|Overall Study|Disease Progression|0|||
16428930|NCT02737475|40047273|FG009|Overall Study|Disease Progression|0|||
16428931|NCT02737475|40047274|FG010|Overall Study|Disease Progression|0|||
16428932|NCT02737475|40047275|FG011|Overall Study|Disease Progression|0|||
16428933|NCT02737475|40047276|FG012|Overall Study|Disease Progression|0|||
16428934|NCT02737475|40047277|FG013|Overall Study|Disease Progression|0|||
16428935|NCT02737475|40047278|FG014|Overall Study|Disease Progression|0|||
16428936|NCT02737475|40047279|FG015|Overall Study|Disease Progression|0|||
16428937|NCT02737475|40047280|FG016|Overall Study|Disease Progression|0|||
16428938|NCT02737475|40047281|FG017|Overall Study|Disease Progression|0|||
16428939|NCT02737475|40047282|FG018|Overall Study|Disease Progression|0|||
16428940|NCT02737475|40047283|FG019|Overall Study|Disease Progression|0|||
16428941|NCT02737475|40047284|FG020|Overall Study|Disease Progression|0|||
16428942|NCT02737475|40047285|FG021|Overall Study|Disease Progression|0|||
16428943|NCT02737475|40047286|FG022|Overall Study|Disease Progression|0|||
16428944|NCT02737475|40047287|FG023|Overall Study|Disease Progression|0|||
16428945|NCT02737475|40047288|FG024|Overall Study|Disease Progression|0|||
16428946|NCT02737475|40047289|FG025|Overall Study|Disease Progression|0|||
16428947|NCT02737475|40047290|FG026|Overall Study|Disease Progression|1|||
16428948|NCT01670721|40047291|FG000|Overall Study|Participant's decision|15|||
16428949|NCT01670721|40047291|FG000|Overall Study|Other than specified above|38|||
16428950|NCT03305770|40047292|FG000|Overall Study|Physician Decision - prior to dispense|0|||
16428951|NCT03305770|40047293|FG001|Overall Study|Physician Decision - prior to dispense|1|||
16428952|NCT03305770|40047292|FG000|Overall Study|Subject moved|1|||
16428953|NCT03305770|40047293|FG001|Overall Study|Subject moved|0|||
16428954|NCT01219985|40047299|FG000|Overall Study|Physician Decision|20|||
16428955|NCT03472326|40047300|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
16428956|NCT03472326|40047301|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
16428957|NCT03472326|40047302|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
16428958|NCT03472326|40047303|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
16428959|NCT03472326|40047300|FG000|Part 2: Combination Therapy|Pregnancy|0|||
16428960|NCT03472326|40047301|FG001|Part 2: Combination Therapy|Pregnancy|0|||
16428961|NCT03472326|40047302|FG002|Part 2: Combination Therapy|Pregnancy|0|||
16428962|NCT03472326|40047303|FG003|Part 2: Combination Therapy|Pregnancy|1|||
16428963|NCT01327599|40047306|FG000|Overall Study|Adverse Event|1|||
16428964|NCT01327599|40047306|FG000|Overall Study|Could Not Attend Visit|1|||
16428965|NCT01327599|40047306|FG000|Overall Study|Withdrawal of Consent|1|||
16428966|NCT03268941|40047309|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
16131112|NCT02257567|38967205|FG002|Overall Study|Withdrawal by Subject|2|||
16131113|NCT02257567|38967206|FG003|Overall Study|Withdrawal by Subject|0|||
16131114|NCT02257567|38967207|FG004|Overall Study|Withdrawal by Subject|0|||
16131115|NCT02257567|38967208|FG005|Overall Study|Withdrawal by Subject|6|||
16131116|NCT02257567|38967209|FG006|Overall Study|Withdrawal by Subject|6|||
16131117|NCT02257567|38967210|FG007|Overall Study|Withdrawal by Subject|6|||
16131118|NCT02257567|38967211|FG008|Overall Study|Withdrawal by Subject|1|||
16131119|NCT02257567|38967212|FG009|Overall Study|Withdrawal by Subject|1|||
16131120|NCT02257567|38967213|FG010|Overall Study|Withdrawal by Subject|10|||
16131121|NCT00712673|38967214|FG000|Overall Study|Adverse Event|3|||
16131122|NCT00712673|38967215|FG001|Overall Study|Adverse Event|3|||
16131123|NCT00712673|38967216|FG002|Overall Study|Adverse Event|21|||
16131124|NCT00712673|38967217|FG003|Overall Study|Adverse Event|26|||
16131125|NCT00712673|38967214|FG000|Overall Study|Lack of Efficacy|2|||
16131126|NCT00712673|38967215|FG001|Overall Study|Lack of Efficacy|8|||
16131127|NCT00712673|38967216|FG002|Overall Study|Lack of Efficacy|8|||
16131128|NCT00712673|38967217|FG003|Overall Study|Lack of Efficacy|6|||
16131129|NCT00712673|38967214|FG000|Overall Study|Poor Compliance to Protocol|3|||
16131130|NCT00712673|38967215|FG001|Overall Study|Poor Compliance to Protocol|3|||
16131131|NCT00712673|38967216|FG002|Overall Study|Poor Compliance to Protocol|4|||
16131132|NCT00712673|38967217|FG003|Overall Study|Poor Compliance to Protocol|16|||
16131133|NCT00712673|38967214|FG000|Overall Study|Lost to Follow-up|1|||
16131134|NCT00712673|38967215|FG001|Overall Study|Lost to Follow-up|0|||
16131135|NCT00712673|38967216|FG002|Overall Study|Lost to Follow-up|2|||
16131136|NCT00712673|38967217|FG003|Overall Study|Lost to Follow-up|0|||
16131137|NCT00712673|38967214|FG000|Overall Study|Withdrawal by Subject|6|||
16131138|NCT00712673|38967215|FG001|Overall Study|Withdrawal by Subject|7|||
16131139|NCT00712673|38967216|FG002|Overall Study|Withdrawal by Subject|15|||
16131140|NCT00712673|38967217|FG003|Overall Study|Withdrawal by Subject|20|||
16131141|NCT00712673|38967214|FG000|Overall Study|Familial and Personal Reasons|5|||
16131142|NCT00712673|38967215|FG001|Overall Study|Familial and Personal Reasons|0|||
16131143|NCT00712673|38967216|FG002|Overall Study|Familial and Personal Reasons|5|||
16131144|NCT00712673|38967217|FG003|Overall Study|Familial and Personal Reasons|2|||
16131145|NCT00712673|38967214|FG000|Overall Study|Investigator's Decision|1|||
16131146|NCT00712673|38967215|FG001|Overall Study|Investigator's Decision|0|||
16131147|NCT00712673|38967216|FG002|Overall Study|Investigator's Decision|0|||
16131148|NCT00712673|38967217|FG003|Overall Study|Investigator's Decision|0|||
16131149|NCT00712673|38967214|FG000|Overall Study|Protocol Violation|0|||
16131150|NCT00712673|38967215|FG001|Overall Study|Protocol Violation|0|||
16131151|NCT00712673|38967216|FG002|Overall Study|Protocol Violation|2|||
16131152|NCT00712673|38967217|FG003|Overall Study|Protocol Violation|0|||
16131153|NCT03733899|38967223|FG000|Period 1|Protocol Violation|0|||
16131154|NCT03733899|38967224|FG001|Period 1|Protocol Violation|0|||
16131155|NCT03733899|38967225|FG002|Period 1|Protocol Violation|0|||
16131156|NCT03733899|38967226|FG003|Period 1|Protocol Violation|0|||
16131157|NCT03733899|38967227|FG004|Period 1|Protocol Violation|0|||
16131158|NCT03733899|38967228|FG005|Period 1|Protocol Violation|1|||
16131159|NCT03733899|38967223|FG000|Period 2|Unscuccessful Treatment|0|||
16131160|NCT03733899|38967224|FG001|Period 2|Unscuccessful Treatment|1|||
16131161|NCT03733899|38967225|FG002|Period 2|Unscuccessful Treatment|0|||
16131162|NCT03733899|38967226|FG003|Period 2|Unscuccessful Treatment|0|||
16131163|NCT03733899|38967227|FG004|Period 2|Unscuccessful Treatment|0|||
16131164|NCT03733899|38967228|FG005|Period 2|Unscuccessful Treatment|0|||
16131165|NCT03733899|38967223|FG000|Period 3|Withdrawal by Subject|1|||
16131166|NCT03733899|38967224|FG001|Period 3|Withdrawal by Subject|0|||
16131167|NCT03733899|38967225|FG002|Period 3|Withdrawal by Subject|0|||
16131168|NCT03733899|38967226|FG003|Period 3|Withdrawal by Subject|0|||
16131169|NCT03733899|38967227|FG004|Period 3|Withdrawal by Subject|0|||
16131170|NCT03733899|38967228|FG005|Period 3|Withdrawal by Subject|0|||
16131171|NCT02121834|38967229|FG000|Overall Study|Protocol Violation|0|||
16131172|NCT02121834|38967230|FG001|Overall Study|Protocol Violation|1|||
16131173|NCT02121834|38967231|FG002|Overall Study|Protocol Violation|0|||
16131174|NCT02121834|38967232|FG003|Overall Study|Protocol Violation|0|||
16131175|NCT02121834|38967233|FG004|Overall Study|Protocol Violation|0|||
16131176|NCT02121834|38967234|FG005|Overall Study|Protocol Violation|0|||
16131177|NCT02121834|38967235|FG006|Overall Study|Protocol Violation|0|||
16428967|NCT03268941|40047310|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
16131178|NCT02121834|38967229|FG000|Overall Study|Withdrawal by Subject|0|||
16131179|NCT02121834|38967230|FG001|Overall Study|Withdrawal by Subject|1|||
16131180|NCT02121834|38967231|FG002|Overall Study|Withdrawal by Subject|1|||
16131181|NCT02121834|38967232|FG003|Overall Study|Withdrawal by Subject|0|||
16131182|NCT02121834|38967233|FG004|Overall Study|Withdrawal by Subject|0|||
16131183|NCT02121834|38967234|FG005|Overall Study|Withdrawal by Subject|0|||
16131184|NCT02121834|38967235|FG006|Overall Study|Withdrawal by Subject|0|||
16131185|NCT02121834|38967229|FG000|Overall Study|Lost to Follow-up|0|||
16131186|NCT02121834|38967230|FG001|Overall Study|Lost to Follow-up|0|||
16131187|NCT02121834|38967231|FG002|Overall Study|Lost to Follow-up|1|||
16428968|NCT03268941|40047311|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
16250268|NCT02843074|39398028|FG000|Overall Study|Progressive disease|1|||
16250269|NCT02843074|39398028|FG000|Overall Study|Physician Decision|1|||
16250270|NCT02843074|39398028|FG000|Overall Study|Lost to Follow-up|1|||
16250271|NCT02843074|39398028|FG000|Overall Study|Death|9|||
16250272|NCT00738673|39398033|FG000|Overall Study|Adverse Event|1|||
16250273|NCT00738673|39398034|FG001|Overall Study|Adverse Event|0|||
16250274|NCT00738673|39398033|FG000|Overall Study|Lack of Efficacy|19|||
16250275|NCT00738673|39398034|FG001|Overall Study|Lack of Efficacy|8|||
16250276|NCT00738673|39398033|FG000|Overall Study|Protocol Violation|1|||
16250277|NCT00738673|39398034|FG001|Overall Study|Protocol Violation|2|||
16250278|NCT00738673|39398033|FG000|Overall Study|Withdrawal by Subject|3|||
16250279|NCT00738673|39398034|FG001|Overall Study|Withdrawal by Subject|1|||
16250280|NCT05487456|39398037|FG000|Overall Study|Withdrawal by Subject|0|||
16250281|NCT05487456|39398038|FG001|Overall Study|Withdrawal by Subject|0|||
16250282|NCT05487456|39398039|FG002|Overall Study|Withdrawal by Subject|1|||
16250283|NCT05487456|39398040|FG003|Overall Study|Withdrawal by Subject|0|||
16250284|NCT01077713|39398046|FG000|Overall Study|Withdrawal by Subject|1|||
16250285|NCT01077713|39398047|FG001|Overall Study|Withdrawal by Subject|2|||
16250286|NCT01077713|39398046|FG000|Overall Study|Progressive Disease (PD)|0|||
16250287|NCT01077713|39398047|FG001|Overall Study|Progressive Disease (PD)|1|||
16250288|NCT01077713|39398046|FG000|Overall Study|Death|28|||
16250289|NCT01077713|39398047|FG001|Overall Study|Death|29|||
16250290|NCT01077713|39398046|FG000|Overall Study|Lost to Follow-up|1|||
16250291|NCT01077713|39398047|FG001|Overall Study|Lost to Follow-up|1|||
16250292|NCT01077713|39398046|FG000|Overall Study|Adverse Event|2|||
16250293|NCT01077713|39398047|FG001|Overall Study|Adverse Event|1|||
16250294|NCT01077713|39398046|FG000|Overall Study|Other|4|||
16250295|NCT01077713|39398047|FG001|Overall Study|Other|2|||
16250296|NCT02034799|39398048|FG000|Overall Study|Withdrawal by Subject|0|||
16250297|NCT02034799|39398049|FG001|Overall Study|Withdrawal by Subject|2|||
16250298|NCT02034799|39398048|FG000|Overall Study|Lost to Follow-up|0|||
16250299|NCT02034799|39398049|FG001|Overall Study|Lost to Follow-up|1|||
16250300|NCT02034799|39398048|FG000|Overall Study|Death|2|||
16428969|NCT03268941|40047312|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
16428970|NCT03268941|40047313|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
16428971|NCT03268941|40047314|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
16428972|NCT03268941|40047315|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
16428973|NCT03268941|40047309|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
16428974|NCT03268941|40047310|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
16428975|NCT03268941|40047311|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
16428976|NCT03268941|40047312|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
16428977|NCT03268941|40047313|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
16428978|NCT03268941|40047314|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
16428979|NCT03268941|40047315|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
16428980|NCT03268941|40047309|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
16428981|NCT03268941|40047310|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
16428982|NCT03268941|40047311|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
16428983|NCT03268941|40047312|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
16428984|NCT03268941|40047313|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
16428985|NCT03268941|40047314|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
16428986|NCT03268941|40047315|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
16428987|NCT03268941|40047309|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
16428988|NCT03268941|40047310|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
16428989|NCT03268941|40047311|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
16428990|NCT03268941|40047312|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
16428991|NCT03268941|40047313|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
16428992|NCT03268941|40047314|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
16428993|NCT03268941|40047315|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
16428994|NCT03268941|40047309|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
16428995|NCT03268941|40047310|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
16428996|NCT03268941|40047311|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
16428997|NCT03268941|40047312|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
16428998|NCT03268941|40047313|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
16428999|NCT03268941|40047314|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
16429000|NCT03268941|40047315|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
16429001|NCT04327024|40047324|FG000|Overall Study|Death|1|||
16429002|NCT04327024|40047325|FG001|Overall Study|Death|2|||
16429003|NCT04327024|40047326|FG002|Overall Study|Death|1|||
16429004|NCT04327024|40047324|FG000|Overall Study|Non-compliance with study drug|0|||
16429005|NCT04327024|40047325|FG001|Overall Study|Non-compliance with study drug|1|||
16429006|NCT04327024|40047326|FG002|Overall Study|Non-compliance with study drug|0|||
16429007|NCT04327024|40047324|FG000|Overall Study|Withdrawal by Subject|1|||
16429008|NCT04327024|40047325|FG001|Overall Study|Withdrawal by Subject|1|||
16429009|NCT04327024|40047326|FG002|Overall Study|Withdrawal by Subject|2|||
16429010|NCT00126776|40047331|FG000|Overall Study|follow up complete on all patients|0|||
16429011|NCT00126776|40047332|FG001|Overall Study|follow up complete on all patients|0|||
16429012|NCT02274792|40047335|FG000|Overall Study|Withdrawal by Subject|13|||
16429013|NCT02274792|40047335|FG000|Overall Study|Lost to Follow-up|8|||
16429014|NCT02274792|40047335|FG000|Overall Study|Protocol Specified Criteria|2|||
16429015|NCT02274792|40047335|FG000|Overall Study|Sponsor Decision|2|||
16429016|NCT01178099|40050400|FG000|Overall Study|Physician Decision|0|||
16429017|NCT01178099|40050401|FG001|Overall Study|Physician Decision|1|||
16429018|NCT01369784|40050402|FG000|Overall Study|Protocol Violation|12|||
16429019|NCT04343755|40050403|FG000|Overall Study|Death|11|||
16429020|NCT04343755|40050403|FG000|Overall Study|Screen Failure|1|||
16429021|NCT03594773|40050404|FG000|Overall Study|Withdrawal by Subject|3|||
16429022|NCT03594773|40050405|FG001|Overall Study|Withdrawal by Subject|2|||
16429023|NCT03594773|40050404|FG000|Overall Study|Lost to Follow-up|3|||
16429024|NCT03594773|40050405|FG001|Overall Study|Lost to Follow-up|4|||
16429025|NCT01331109|40050406|FG000|Overall Study|Adverse Event|6|||
16429026|NCT01331109|40050406|FG000|Overall Study|Lack of Efficacy|2|||
16429027|NCT01331109|40050406|FG000|Overall Study|Protocol Violation|3|||
16562823|NCT01474512|40525469|FG009|Maintenance Period|Clinical Relapse|0|||
16562824|NCT01474512|40525470|FG010|Maintenance Period|Clinical Relapse|0|||
16562825|NCT01474512|40525471|FG011|Maintenance Period|Clinical Relapse|0|||
16562826|NCT01474512|40525472|FG012|Maintenance Period|Clinical Relapse|0|||
16250301|NCT02034799|39398049|FG001|Overall Study|Death|1|||
16429028|NCT01331109|40050406|FG000|Overall Study|Withdrawal by Subject|7|||
16429029|NCT01331109|40050406|FG000|Overall Study|Lost to Follow-up|1|||
16429030|NCT01331109|40050406|FG000|Overall Study|Study Terminated by Sponsor|38|||
16429031|NCT03437577|40050407|FG000|Pre-Randomization|Withdrawal by Subject|0|||
16429032|NCT03437577|40050408|FG001|Pre-Randomization|Withdrawal by Subject|0|||
16429033|NCT03437577|40050409|FG002|Pre-Randomization|Withdrawal by Subject|10|||
16429034|NCT03437577|40050407|FG000|Post-Randomization|Physician Decision|0|||
16429035|NCT03437577|40050408|FG001|Post-Randomization|Physician Decision|2|||
16429036|NCT03437577|40050409|FG002|Post-Randomization|Physician Decision|0|||
16429037|NCT03777059|40050410|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
16429038|NCT03777059|40050411|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
16429039|NCT03777059|40050412|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
16429040|NCT03777059|40050413|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
16429041|NCT03777059|40050410|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
16429042|NCT03777059|40050411|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
16429043|NCT03777059|40050412|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
16429044|NCT03777059|40050413|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
16429045|NCT03777059|40050410|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
16429046|NCT03777059|40050411|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
16429047|NCT03777059|40050412|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
16429048|NCT03777059|40050413|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
16429049|NCT03777059|40050410|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
16429050|NCT03777059|40050411|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
16429051|NCT03777059|40050412|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
16562827|NCT01474512|40525473|FG013|Maintenance Period|Clinical Relapse|0|||
16562828|NCT01474512|40525474|FG014|Maintenance Period|Clinical Relapse|0|||
16562829|NCT01474512|40525475|FG015|Maintenance Period|Clinical Relapse|0|||
16131188|NCT02121834|38967232|FG003|Overall Study|Lost to Follow-up|0|||
16131189|NCT02121834|38967233|FG004|Overall Study|Lost to Follow-up|0|||
16131190|NCT02121834|38967234|FG005|Overall Study|Lost to Follow-up|0|||
16131191|NCT02121834|38967235|FG006|Overall Study|Lost to Follow-up|0|||
16131192|NCT02128542|38967236|FG000|Overall Study|Lost to Follow-up|3|||
16131193|NCT02128542|38967237|FG001|Overall Study|Lost to Follow-up|0|||
16131194|NCT02128542|38967236|FG000|Overall Study|Withdrew Consent|1|||
16131195|NCT02128542|38967237|FG001|Overall Study|Withdrew Consent|0|||
16131196|NCT02706899|38967239|FG000|Overall Study|Withdrawal by Subject|1|||
16131197|NCT02706899|38967240|FG001|Overall Study|Withdrawal by Subject|0|||
16131198|NCT02706899|38967239|FG000|Overall Study|Death|8|||
16131199|NCT02706899|38967240|FG001|Overall Study|Death|0|||
16131200|NCT02706899|38967239|FG000|Overall Study|Study Termination by Sponsor|4|||
16131201|NCT02706899|38967240|FG001|Overall Study|Study Termination by Sponsor|6|||
16131202|NCT00682890|38967241|FG000|Overall Study|Lost to Follow-up|1|||
16131203|NCT00682890|38967242|FG001|Overall Study|Lost to Follow-up|1|||
16562830|NCT01474512|40525476|FG016|Maintenance Period|Clinical Relapse|0|||
16562831|NCT01474512|40525477|FG017|Maintenance Period|Clinical Relapse|0|||
16562832|NCT01474512|40525460|FG000|Maintenance Period|Lack of Efficacy|0|||
16562833|NCT01474512|40525461|FG001|Maintenance Period|Lack of Efficacy|0|||
16562834|NCT01474512|40525462|FG002|Maintenance Period|Lack of Efficacy|0|||
16562835|NCT01474512|40525463|FG003|Maintenance Period|Lack of Efficacy|1|||
16562836|NCT01474512|40525464|FG004|Maintenance Period|Lack of Efficacy|0|||
16562837|NCT01474512|40525465|FG005|Maintenance Period|Lack of Efficacy|0|||
16562838|NCT01474512|40525466|FG006|Maintenance Period|Lack of Efficacy|0|||
16562839|NCT01474512|40525467|FG007|Maintenance Period|Lack of Efficacy|11|||
16562840|NCT01474512|40525468|FG008|Maintenance Period|Lack of Efficacy|11|||
16562841|NCT01474512|40525469|FG009|Maintenance Period|Lack of Efficacy|12|||
16562842|NCT01474512|40525470|FG010|Maintenance Period|Lack of Efficacy|0|||
16562843|NCT01474512|40525471|FG011|Maintenance Period|Lack of Efficacy|0|||
16562844|NCT01474512|40525472|FG012|Maintenance Period|Lack of Efficacy|0|||
16562845|NCT01474512|40525473|FG013|Maintenance Period|Lack of Efficacy|0|||
16562846|NCT01474512|40525474|FG014|Maintenance Period|Lack of Efficacy|0|||
16562847|NCT01474512|40525475|FG015|Maintenance Period|Lack of Efficacy|0|||
16131204|NCT00682890|38967241|FG000|Overall Study|subject moved away|0|||
16429052|NCT03777059|40050413|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
16562848|NCT01474512|40525476|FG016|Maintenance Period|Lack of Efficacy|0|||
16562849|NCT01474512|40525477|FG017|Maintenance Period|Lack of Efficacy|0|||
16429053|NCT03777059|40050410|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
16429054|NCT03777059|40050411|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
16429055|NCT03777059|40050412|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
16429056|NCT03777059|40050413|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
16429057|NCT03777059|40050410|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
16429058|NCT03777059|40050411|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
16429059|NCT03777059|40050412|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
16429060|NCT03777059|40050413|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
16429061|NCT03777059|40050410|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
16429062|NCT03777059|40050411|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
16429063|NCT03777059|40050412|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
16429064|NCT03777059|40050413|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
16429065|NCT03777059|40050410|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
16429066|NCT03777059|40050411|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
16429067|NCT03777059|40050412|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
16429068|NCT03777059|40050413|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
16429069|NCT03777059|40050410|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
16429070|NCT03777059|40050411|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
16429071|NCT03777059|40050412|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
16429072|NCT03777059|40050413|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
16429073|NCT03777059|40050410|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
16429074|NCT03777059|40050411|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
16429075|NCT03777059|40050412|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
16429076|NCT03777059|40050413|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
16429077|NCT03777059|40050410|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
16429078|NCT03777059|40050411|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
16429079|NCT03777059|40050412|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
16429080|NCT03777059|40050413|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
16429081|NCT05274269|40050414|FG000|Overall Study|Adverse Event|0|||
16429082|NCT05274269|40050415|FG001|Overall Study|Adverse Event|3|||
16429083|NCT05274269|40050414|FG000|Overall Study|Death|0|||
16429084|NCT05274269|40050415|FG001|Overall Study|Death|1|||
16429085|NCT05274269|40050414|FG000|Overall Study|Other|0|||
16429086|NCT05274269|40050415|FG001|Overall Study|Other|2|||
16429087|NCT05274269|40050414|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
16429088|NCT05274269|40050415|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
16429089|NCT03077542|40050423|FG000|Overall Study|Death|4|||
16429090|NCT03077542|40050424|FG001|Overall Study|Death|0|||
16429091|NCT03077542|40050423|FG000|Overall Study|Physician Decision|6|||
16429092|NCT03077542|40050424|FG001|Overall Study|Physician Decision|1|||
16429093|NCT03077542|40050423|FG000|Overall Study|Withdrawal by Subject|0|||
16429094|NCT03077542|40050424|FG001|Overall Study|Withdrawal by Subject|1|||
16429095|NCT00931606|40050429|FG000|Overall Study|Death|1|||
16429096|NCT00931606|40050430|FG001|Overall Study|Death|3|||
16429097|NCT00931606|40050431|FG002|Overall Study|Death|2|||
16429098|NCT00931606|40050432|FG003|Overall Study|Death|0|||
16429099|NCT00931606|40050429|FG000|Overall Study|Lost to Follow-up|0|||
16429100|NCT00931606|40050430|FG001|Overall Study|Lost to Follow-up|1|||
16429101|NCT00931606|40050431|FG002|Overall Study|Lost to Follow-up|0|||
16429102|NCT00931606|40050432|FG003|Overall Study|Lost to Follow-up|0|||
16429103|NCT00931606|40050429|FG000|Overall Study|Physician Decision|0|||
16429104|NCT00931606|40050430|FG001|Overall Study|Physician Decision|0|||
16429105|NCT00931606|40050431|FG002|Overall Study|Physician Decision|3|||
16429106|NCT00931606|40050432|FG003|Overall Study|Physician Decision|0|||
16429107|NCT00931606|40050429|FG000|Overall Study|Sponsor Decision|1|||
16429108|NCT00931606|40050430|FG001|Overall Study|Sponsor Decision|4|||
16429109|NCT00931606|40050431|FG002|Overall Study|Sponsor Decision|0|||
16429110|NCT00931606|40050432|FG003|Overall Study|Sponsor Decision|2|||
16429111|NCT00931606|40050429|FG000|Overall Study|Withdrawal by Subject|3|||
16429112|NCT00931606|40050430|FG001|Overall Study|Withdrawal by Subject|1|||
16429113|NCT00931606|40050431|FG002|Overall Study|Withdrawal by Subject|1|||
16429114|NCT00931606|40050432|FG003|Overall Study|Withdrawal by Subject|1|||
16429115|NCT00685165|40050433|FG000|Washout Period of 14 Days|Adverse Event|1|||
16429116|NCT00685165|40050434|FG001|Washout Period of 14 Days|Adverse Event|0|||
16429117|NCT01272635|40050435|FG000|Overall Study|Lost to Follow-up|31|||
16429118|NCT01272635|40050436|FG001|Overall Study|Lost to Follow-up|20|||
16429119|NCT01272635|40050437|FG002|Overall Study|Lost to Follow-up|31|||
16429120|NCT01272635|40050438|FG003|Overall Study|Lost to Follow-up|23|||
16429121|NCT00565851|40050440|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
16429122|NCT00565851|40050441|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
16429123|NCT00565851|40050442|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
16562850|NCT01474512|40525460|FG000|Maintenance Period|Protocol Violation|0|||
16131205|NCT00682890|38967242|FG001|Overall Study|subject moved away|1|||
16562851|NCT01474512|40525461|FG001|Maintenance Period|Protocol Violation|0|||
16429124|NCT00565851|40050443|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
16429125|NCT00565851|40050444|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
16429126|NCT00565851|40050445|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
16429127|NCT00565851|40050446|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
16429128|NCT00565851|40050447|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
16429129|NCT00565851|40050440|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
16429130|NCT00565851|40050441|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
16429131|NCT00565851|40050442|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
16429132|NCT00565851|40050443|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
16429133|NCT00565851|40050444|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
16429134|NCT00565851|40050445|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
16429135|NCT00565851|40050446|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
16429136|NCT00565851|40050447|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
16429137|NCT03056339|40050452|FG000|Overall Study|Failed Requirements|0|||
16429138|NCT03056339|40050453|FG001|Overall Study|Failed Requirements|2|||
16429139|NCT03056339|40050454|FG002|Overall Study|Failed Requirements|7|||
16429140|NCT03056339|40050455|FG003|Overall Study|Failed Requirements|1|||
16429141|NCT02073682|40050456|FG000|Overall Study|Low Creatinine Clearance|1|||
16429142|NCT02073682|40050457|FG001|Overall Study|Low Creatinine Clearance|2|||
16429143|NCT02073682|40050456|FG000|Overall Study|Death|86|||
16429144|NCT02073682|40050457|FG001|Overall Study|Death|100|||
16429145|NCT02073682|40050456|FG000|Overall Study|Cancer Cured|10|||
16429146|NCT02073682|40050457|FG001|Overall Study|Cancer Cured|15|||
16429147|NCT02073682|40050456|FG000|Overall Study|ID: Patient Noncompliance|1|||
16429148|NCT02073682|40050457|FG001|Overall Study|ID: Patient Noncompliance|2|||
16429149|NCT02073682|40050456|FG000|Overall Study|ID: Palliative Treatment Only|10|||
16429150|NCT02073682|40050457|FG001|Overall Study|ID: Palliative Treatment Only|7|||
16429151|NCT02073682|40050456|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
16429152|NCT02073682|40050457|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
16429153|NCT02073682|40050456|FG000|Overall Study|Platelet Count <50,000/mL|1|||
16429154|NCT02073682|40050457|FG001|Overall Study|Platelet Count <50,000/mL|2|||
16429155|NCT02073682|40050456|FG000|Overall Study|Surgery/Medical Procedure|3|||
16429156|NCT02073682|40050457|FG001|Overall Study|Surgery/Medical Procedure|1|||
16429157|NCT02073682|40050456|FG000|Overall Study|Withdrawal by Subject|6|||
16429158|NCT02073682|40050457|FG001|Overall Study|Withdrawal by Subject|8|||
16429159|NCT02073682|40050456|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
16429160|NCT02073682|40050457|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
16429161|NCT02073682|40050456|FG000|Overall Study|Cancer Progression|53|||
16429162|NCT02073682|40050457|FG001|Overall Study|Cancer Progression|33|||
16429163|NCT02073682|40050456|FG000|Overall Study|Protocol Violation|1|||
16429164|NCT02073682|40050457|FG001|Overall Study|Protocol Violation|0|||
16429165|NCT02073682|40050456|FG000|Overall Study|Adverse Event|79|||
16429166|NCT02073682|40050457|FG001|Overall Study|Adverse Event|62|||
16429167|NCT02073682|40050456|FG000|Overall Study|No reason provided|11|||
16429168|NCT02073682|40050457|FG001|Overall Study|No reason provided|9|||
16429169|NCT02073682|40050456|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
16429170|NCT02073682|40050457|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
16429171|NCT02073682|40050456|FG000|Overall Study|Lost to Follow-up|1|||
16429172|NCT02073682|40050457|FG001|Overall Study|Lost to Follow-up|1|||
16429173|NCT02073682|40050456|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
16429174|NCT02073682|40050457|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
16429175|NCT03956550|40050461|FG000|Overall Study|Sponsor decision|65|||
16429176|NCT03956550|40050462|FG001|Overall Study|Sponsor decision|66|||
16429177|NCT03956550|40050463|FG002|Overall Study|Sponsor decision|64|||
16429178|NCT03956550|40050461|FG000|Overall Study|Adverse Event|0|||
16429179|NCT03956550|40050462|FG001|Overall Study|Adverse Event|1|||
16429180|NCT03956550|40050463|FG002|Overall Study|Adverse Event|0|||
16429181|NCT03956550|40050461|FG000|Overall Study|Withdrawal by Subject|5|||
16429182|NCT03956550|40050462|FG001|Overall Study|Withdrawal by Subject|5|||
16429183|NCT03956550|40050463|FG002|Overall Study|Withdrawal by Subject|6|||
16429184|NCT02128724|40050471|FG000|Overall Study|Death|1|||
16429185|NCT02128724|40050472|FG001|Overall Study|Death|0|||
16429186|NCT02128724|40050473|FG002|Overall Study|Death|0|||
16429187|NCT02128724|40050474|FG003|Overall Study|Death|0|||
16429188|NCT02128724|40050471|FG000|Overall Study|Adverse Event|0|||
16429189|NCT02128724|40050472|FG001|Overall Study|Adverse Event|1|||
16429190|NCT02128724|40050473|FG002|Overall Study|Adverse Event|0|||
16429191|NCT02128724|40050474|FG003|Overall Study|Adverse Event|0|||
16429192|NCT02128724|40050471|FG000|Overall Study|Physician Decision|0|||
16429193|NCT02128724|40050472|FG001|Overall Study|Physician Decision|0|||
16429194|NCT02128724|40050473|FG002|Overall Study|Physician Decision|0|||
16429195|NCT02128724|40050474|FG003|Overall Study|Physician Decision|2|||
16429196|NCT02128724|40050471|FG000|Overall Study|Withdrawal by Subject|0|||
16429197|NCT02128724|40050472|FG001|Overall Study|Withdrawal by Subject|0|||
16429198|NCT02128724|40050473|FG002|Overall Study|Withdrawal by Subject|0|||
16429199|NCT02128724|40050474|FG003|Overall Study|Withdrawal by Subject|1|||
16429200|NCT03738618|40050475|FG000|Overall Study|Protocol deviation|23|||
16429201|NCT03738618|40050476|FG001|Overall Study|Protocol deviation|0|||
16429202|NCT03738618|40050475|FG000|Overall Study|Adverse Event|4|||
16429203|NCT03738618|40050476|FG001|Overall Study|Adverse Event|0|||
16429204|NCT03738618|40050475|FG000|Overall Study|Lost to Follow-up|2|||
16429205|NCT03738618|40050476|FG001|Overall Study|Lost to Follow-up|0|||
16429206|NCT03738618|40050475|FG000|Overall Study|Randomization failure|1|||
16429207|NCT03738618|40050476|FG001|Overall Study|Randomization failure|0|||
16429208|NCT03738618|40050475|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
16429209|NCT03738618|40050476|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
16429210|NCT03738618|40050475|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
16429211|NCT03738618|40050476|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
16429212|NCT00824473|40050484|FG000|Overall Study|Adverse Event|4|||
16429213|NCT00824473|40050485|FG001|Overall Study|Adverse Event|5|||
16429214|NCT00824473|40050484|FG000|Overall Study|Lack of Efficacy|2|||
16429215|NCT00824473|40050485|FG001|Overall Study|Lack of Efficacy|2|||
16429216|NCT00824473|40050484|FG000|Overall Study|Protocol Violation|2|||
16429217|NCT00824473|40050485|FG001|Overall Study|Protocol Violation|0|||
16429218|NCT00824473|40050484|FG000|Overall Study|Non-Compliance|4|||
16429219|NCT00824473|40050485|FG001|Overall Study|Non-Compliance|2|||
16429220|NCT00824473|40050484|FG000|Overall Study|Withdrawal by Subject|2|||
16429221|NCT00824473|40050485|FG001|Overall Study|Withdrawal by Subject|3|||
16429222|NCT00824473|40050484|FG000|Overall Study|Other|1|||
16429223|NCT00824473|40050485|FG001|Overall Study|Other|1|||
16429224|NCT02919761|40050486|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
16429225|NCT02919761|40050487|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
16429226|NCT02919761|40050488|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
16360951|NCT02357459|39807627|FG001|Overall Study|Pre-planned Knee surgery|0|||
16360952|NCT02357459|39807628|FG002|Overall Study|Pre-planned Knee surgery|2|||
16360953|NCT02357459|39807626|FG000|Overall Study|Job Commitments|0|||
16360954|NCT02357459|39807627|FG001|Overall Study|Job Commitments|0|||
16360955|NCT02357459|39807628|FG002|Overall Study|Job Commitments|1|||
16360956|NCT02787304|39807631|FG000|Overall Study|Adverse Event|9|||
16360957|NCT02787304|39807632|FG001|Overall Study|Adverse Event|3|||
16360958|NCT02787304|39807633|FG002|Overall Study|Adverse Event|8|||
16360959|NCT02787304|39807634|FG003|Overall Study|Adverse Event|1|||
16360960|NCT02787304|39807631|FG000|Overall Study|Withdrawal by Subject|1|||
16360961|NCT02787304|39807632|FG001|Overall Study|Withdrawal by Subject|4|||
16360962|NCT02787304|39807633|FG002|Overall Study|Withdrawal by Subject|0|||
16360963|NCT02787304|39807634|FG003|Overall Study|Withdrawal by Subject|0|||
16360964|NCT02787304|39807631|FG000|Overall Study|Lost to Follow-up|1|||
16360965|NCT02787304|39807632|FG001|Overall Study|Lost to Follow-up|0|||
16360966|NCT02787304|39807633|FG002|Overall Study|Lost to Follow-up|0|||
16360967|NCT02787304|39807634|FG003|Overall Study|Lost to Follow-up|1|||
16360968|NCT02787304|39807631|FG000|Overall Study|Noncompliance with study drug|0|||
16360969|NCT02787304|39807632|FG001|Overall Study|Noncompliance with study drug|0|||
16360970|NCT02787304|39807633|FG002|Overall Study|Noncompliance with study drug|1|||
16360971|NCT02787304|39807634|FG003|Overall Study|Noncompliance with study drug|0|||
16360972|NCT02787304|39807631|FG000|Overall Study|Physician Decision|0|||
16360973|NCT02787304|39807632|FG001|Overall Study|Physician Decision|0|||
16360974|NCT02787304|39807633|FG002|Overall Study|Physician Decision|1|||
16360975|NCT02787304|39807634|FG003|Overall Study|Physician Decision|0|||
16360976|NCT02787304|39807631|FG000|Overall Study|Study terminated by sponsor|25|||
16360977|NCT02787304|39807632|FG001|Overall Study|Study terminated by sponsor|31|||
16360978|NCT02787304|39807633|FG002|Overall Study|Study terminated by sponsor|31|||
16360979|NCT02787304|39807634|FG003|Overall Study|Study terminated by sponsor|32|||
16360980|NCT02426684|39807635|FG000|Overall Study|Physician Decision|1|||
16360981|NCT04682301|39807636|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
16360982|NCT04682301|39807636|FG000|Overall Study|Death|2|||
16360983|NCT01294514|39807637|FG000|Overall Study|Excluded due to Arrhythmia|1|||
16360984|NCT00572832|39807640|FG000|Overall Study|Lost to Follow-up|0|||
16360985|NCT00572832|39807641|FG001|Overall Study|Lost to Follow-up|11|||
16360986|NCT00572832|39807640|FG000|Overall Study|Pregnancy|0|||
16360987|NCT00572832|39807641|FG001|Overall Study|Pregnancy|1|||
16360988|NCT03937778|39807649|FG000|Overall Study|Withdrawal by Subject|1|||
16360989|NCT03937778|39807649|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
16360990|NCT04040439|39807650|FG000|Overall Study|Invalid registration|11|||
16360991|NCT04040439|39807650|FG000|Overall Study|No IC* on publication of study results|2|||
16360992|NCT02774889|39807651|FG000|Overall Study|Lost to Follow-up|2|||
16360993|NCT02774889|39807652|FG001|Overall Study|Lost to Follow-up|1|||
16360994|NCT00724945|39807653|FG000|Period 1|non-compliance|1|||
16360995|NCT00724945|39807654|FG001|Period 1|non-compliance|0|||
16360996|NCT00724945|39807653|FG000|Period 1|Adverse Event|1|||
16360997|NCT00724945|39807654|FG001|Period 1|Adverse Event|1|||
16360998|NCT00724945|39807653|FG000|Period 1|Lost to Follow-up|1|||
16360999|NCT00724945|39807654|FG001|Period 1|Lost to Follow-up|0|||
16361000|NCT00724945|39807653|FG000|Period 2|lens comfort issue|3|||
16429227|NCT02919761|40050486|FG000|Part 1: Open Label|Adverse Event|1|||
16429228|NCT02919761|40050487|FG001|Part 1: Open Label|Adverse Event|0|||
16429229|NCT02919761|40050488|FG002|Part 1: Open Label|Adverse Event|0|||
16429230|NCT02919761|40050486|FG000|Part 1: Open Label|Lost to Follow-up|1|||
16429231|NCT02919761|40050487|FG001|Part 1: Open Label|Lost to Follow-up|0|||
16429232|NCT02919761|40050488|FG002|Part 1: Open Label|Lost to Follow-up|0|||
16429233|NCT02919761|40050486|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
16429234|NCT02919761|40050487|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
16429235|NCT02919761|40050488|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
16429236|NCT02919761|40050486|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
16429237|NCT02919761|40050487|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
16429238|NCT02919761|40050488|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
16429239|NCT02919761|40050486|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
16429240|NCT02919761|40050487|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
16429241|NCT02919761|40050488|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
16429242|NCT02919761|40050486|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
16429243|NCT02919761|40050487|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
16429244|NCT02919761|40050488|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
16429245|NCT02919761|40050486|FG000|Part 1: Open Label|Termination by Sponsor|1|||
16429246|NCT02919761|40050487|FG001|Part 1: Open Label|Termination by Sponsor|0|||
16429247|NCT02919761|40050488|FG002|Part 1: Open Label|Termination by Sponsor|0|||
16429248|NCT02919761|40050486|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
16429249|NCT02919761|40050487|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
16429250|NCT02919761|40050488|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
16429251|NCT02919761|40050486|FG000|Part 2: Double-blind|Adverse Event|0|||
16429252|NCT02919761|40050487|FG001|Part 2: Double-blind|Adverse Event|1|||
16429253|NCT02919761|40050488|FG002|Part 2: Double-blind|Adverse Event|0|||
16429254|NCT02919761|40050486|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
16429255|NCT02919761|40050487|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
16429256|NCT02919761|40050488|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
16429257|NCT02919761|40050486|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
16429258|NCT02919761|40050487|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
16429259|NCT02919761|40050488|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
16429260|NCT02919761|40050486|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
16429261|NCT02919761|40050487|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
16429262|NCT02919761|40050488|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
16429263|NCT02919761|40050486|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
16429264|NCT02919761|40050487|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
16429265|NCT02919761|40050488|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
16429266|NCT02919761|40050486|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
16429267|NCT02919761|40050487|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
16429268|NCT02919761|40050488|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
16429269|NCT02919761|40050486|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
16429270|NCT02919761|40050487|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
16429271|NCT02919761|40050488|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
16429272|NCT04050618|40050491|FG000|First Intervention|Withdrawal by Subject|2|||
16429273|NCT04050618|40050492|FG001|First Intervention|Withdrawal by Subject|0|||
16429274|NCT04050618|40050491|FG000|Second Intervention|Withdrawal by Subject|1|||
16429275|NCT04050618|40050492|FG001|Second Intervention|Withdrawal by Subject|0|||
16429276|NCT00550407|40050493|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
16429277|NCT00550407|40050494|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
16429278|NCT00550407|40050495|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
16429279|NCT00550407|40050493|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
16429280|NCT00550407|40050494|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
16131206|NCT00682890|38967241|FG000|Overall Study|heavy menstrual bleeding|1|||
16250302|NCT00720798|39398050|FG000|Overall Study|Adverse Event|304|||
16429281|NCT00550407|40050495|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
16429282|NCT00550407|40050493|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
16429283|NCT00550407|40050494|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
16562852|NCT01474512|40525462|FG002|Maintenance Period|Protocol Violation|0|||
16429284|NCT00550407|40050495|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
16562853|NCT01474512|40525463|FG003|Maintenance Period|Protocol Violation|1|||
16562854|NCT01474512|40525464|FG004|Maintenance Period|Protocol Violation|0|||
16562855|NCT01474512|40525465|FG005|Maintenance Period|Protocol Violation|0|||
16562856|NCT01474512|40525466|FG006|Maintenance Period|Protocol Violation|0|||
16562857|NCT01474512|40525467|FG007|Maintenance Period|Protocol Violation|1|||
16562858|NCT01474512|40525468|FG008|Maintenance Period|Protocol Violation|0|||
16562859|NCT01474512|40525469|FG009|Maintenance Period|Protocol Violation|1|||
16562860|NCT01474512|40525470|FG010|Maintenance Period|Protocol Violation|0|||
16429285|NCT00550407|40050493|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
16429286|NCT00550407|40050494|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
16429287|NCT00550407|40050495|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
16429288|NCT00550407|40050493|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
16429289|NCT00550407|40050494|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
16429290|NCT00550407|40050495|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
16429291|NCT00550407|40050493|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
16429292|NCT00550407|40050494|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
16429293|NCT00550407|40050495|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
16429294|NCT00550407|40050493|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
16429295|NCT00550407|40050494|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
16429296|NCT00550407|40050495|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
16429297|NCT00550407|40050493|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
16429298|NCT00550407|40050494|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
16429299|NCT00550407|40050495|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
16429300|NCT00550407|40050493|FG000|26-Week Randomized Phase|Adverse Event|0|||
16429301|NCT00550407|40050494|FG001|26-Week Randomized Phase|Adverse Event|5|||
16429302|NCT00550407|40050495|FG002|26-Week Randomized Phase|Adverse Event|2|||
16429303|NCT00550407|40050493|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
16429304|NCT00550407|40050494|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
16429305|NCT00550407|40050495|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
16131207|NCT00682890|38967242|FG001|Overall Study|heavy menstrual bleeding|0|||
16131208|NCT01774487|38967243|FG000|Overall Study|Did not tolerate taste|4|||
16131209|NCT01774487|38967244|FG001|Overall Study|Did not tolerate taste|4|||
16131210|NCT01815138|38967256|FG000|Overall Study|Withdrawal by Subject|0|||
16131211|NCT01815138|38967257|FG001|Overall Study|Withdrawal by Subject|1|||
16131212|NCT01815138|38967256|FG000|Overall Study|Physician Decision|8|||
16131213|NCT01815138|38967257|FG001|Overall Study|Physician Decision|5|||
16131214|NCT03541174|38967258|FG000|Part 1 Double-Blind|Adverse Event|6|||
16131215|NCT03541174|38967259|FG001|Part 1 Double-Blind|Adverse Event|5|||
16131216|NCT03541174|38967260|FG002|Part 1 Double-Blind|Adverse Event|2|||
16131217|NCT03541174|38967261|FG003|Part 1 Double-Blind|Adverse Event|0|||
16131218|NCT03541174|38967262|FG004|Part 1 Double-Blind|Adverse Event|0|||
16131219|NCT03541174|38967263|FG005|Part 1 Double-Blind|Adverse Event|0|||
16131220|NCT03541174|38967258|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
16131221|NCT03541174|38967259|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
16131222|NCT03541174|38967260|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
16131223|NCT03541174|38967261|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
16131224|NCT03541174|38967262|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
16131225|NCT03541174|38967263|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
16131226|NCT03541174|38967258|FG000|Part 1 Double-Blind|Other reasons|3|||
16131227|NCT03541174|38967259|FG001|Part 1 Double-Blind|Other reasons|2|||
16131228|NCT03541174|38967260|FG002|Part 1 Double-Blind|Other reasons|3|||
16131229|NCT03541174|38967261|FG003|Part 1 Double-Blind|Other reasons|0|||
16131230|NCT03541174|38967262|FG004|Part 1 Double-Blind|Other reasons|0|||
16131231|NCT03541174|38967263|FG005|Part 1 Double-Blind|Other reasons|0|||
16131232|NCT03541174|38967258|FG000|Part 2 Single-Blind|Adverse Event|0|||
16131233|NCT03541174|38967259|FG001|Part 2 Single-Blind|Adverse Event|0|||
16131234|NCT03541174|38967260|FG002|Part 2 Single-Blind|Adverse Event|0|||
16131235|NCT03541174|38967261|FG003|Part 2 Single-Blind|Adverse Event|25|||
16131236|NCT03541174|38967262|FG004|Part 2 Single-Blind|Adverse Event|0|||
16131237|NCT03541174|38967263|FG005|Part 2 Single-Blind|Adverse Event|0|||
16131238|NCT03541174|38967258|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
16131239|NCT03541174|38967259|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
16131240|NCT03541174|38967260|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
16131241|NCT03541174|38967261|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
16131242|NCT03541174|38967262|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
16429306|NCT00550407|40050493|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
16429307|NCT00550407|40050494|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
16429308|NCT00550407|40050495|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
16429309|NCT00550407|40050493|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
16429310|NCT00550407|40050494|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
16429311|NCT00550407|40050495|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
16429312|NCT01442714|40050501|FG000|Overall Study|Death|11|||
16562861|NCT01474512|40525471|FG011|Maintenance Period|Protocol Violation|0|||
16131243|NCT03541174|38967263|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
16131244|NCT03541174|38967258|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
16131245|NCT03541174|38967259|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
16131246|NCT03541174|38967260|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
16131247|NCT03541174|38967261|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
16131248|NCT03541174|38967262|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
16131249|NCT03541174|38967263|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
16429313|NCT01442714|40050501|FG000|Overall Study|Withdrawal by Subject|1|||
16429314|NCT02688985|40050502|FG000|Overall Study|Adverse Event|1|||
16429315|NCT02688985|40050503|FG001|Overall Study|Adverse Event|2|||
16429316|NCT02688985|40050504|FG002|Overall Study|Adverse Event|2|||
16429317|NCT02688985|40050505|FG003|Overall Study|Adverse Event|0|||
16429318|NCT02688985|40050506|FG004|Overall Study|Adverse Event|0|||
16429319|NCT02688985|40050502|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
16429320|NCT02688985|40050503|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
16429321|NCT02688985|40050504|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
16429322|NCT02688985|40050505|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
16429323|NCT02688985|40050506|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
16429324|NCT02688985|40050502|FG000|Overall Study|Death|0|||
16429325|NCT02688985|40050503|FG001|Overall Study|Death|0|||
16429326|NCT02688985|40050504|FG002|Overall Study|Death|0|||
16429327|NCT02688985|40050505|FG003|Overall Study|Death|0|||
16429328|NCT02688985|40050506|FG004|Overall Study|Death|1|||
16429329|NCT02688985|40050502|FG000|Overall Study|Lack of Efficacy|0|||
16429330|NCT02688985|40050503|FG001|Overall Study|Lack of Efficacy|0|||
16429331|NCT02688985|40050504|FG002|Overall Study|Lack of Efficacy|0|||
16429332|NCT02688985|40050505|FG003|Overall Study|Lack of Efficacy|0|||
16429333|NCT02688985|40050506|FG004|Overall Study|Lack of Efficacy|1|||
16429334|NCT02688985|40050502|FG000|Overall Study|Lost to Follow-up|2|||
16429335|NCT02688985|40050503|FG001|Overall Study|Lost to Follow-up|0|||
16429336|NCT02688985|40050504|FG002|Overall Study|Lost to Follow-up|1|||
16429337|NCT02688985|40050505|FG003|Overall Study|Lost to Follow-up|1|||
16429338|NCT02688985|40050506|FG004|Overall Study|Lost to Follow-up|1|||
16429339|NCT02688985|40050502|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16429340|NCT02688985|40050503|FG001|Overall Study|Non-Compliance With Study Drug|3|||
16429341|NCT02688985|40050504|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16429342|NCT02688985|40050505|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16429343|NCT02688985|40050506|FG004|Overall Study|Non-Compliance With Study Drug|1|||
16429344|NCT02688985|40050502|FG000|Overall Study|Other|3|||
16429345|NCT02688985|40050503|FG001|Overall Study|Other|4|||
16429346|NCT02688985|40050504|FG002|Overall Study|Other|1|||
16429347|NCT02688985|40050505|FG003|Overall Study|Other|0|||
16429348|NCT02688985|40050506|FG004|Overall Study|Other|0|||
16429349|NCT02688985|40050502|FG000|Overall Study|Physician Decision|2|||
16429350|NCT02688985|40050503|FG001|Overall Study|Physician Decision|2|||
16429351|NCT02688985|40050504|FG002|Overall Study|Physician Decision|0|||
16429352|NCT02688985|40050505|FG003|Overall Study|Physician Decision|0|||
16429353|NCT02688985|40050506|FG004|Overall Study|Physician Decision|1|||
16429354|NCT02688985|40050502|FG000|Overall Study|Pregnancy|0|||
16429355|NCT02688985|40050503|FG001|Overall Study|Pregnancy|0|||
16429356|NCT02688985|40050504|FG002|Overall Study|Pregnancy|2|||
16429357|NCT02688985|40050505|FG003|Overall Study|Pregnancy|1|||
16429358|NCT02688985|40050506|FG004|Overall Study|Pregnancy|0|||
16429359|NCT02688985|40050502|FG000|Overall Study|Study Terminated By Sponsor|0|||
16429360|NCT02688985|40050503|FG001|Overall Study|Study Terminated By Sponsor|0|||
16429361|NCT02688985|40050504|FG002|Overall Study|Study Terminated By Sponsor|0|||
16429362|NCT02688985|40050505|FG003|Overall Study|Study Terminated By Sponsor|1|||
16429363|NCT02688985|40050506|FG004|Overall Study|Study Terminated By Sponsor|0|||
16429364|NCT02688985|40050502|FG000|Overall Study|Withdrawal by Subject|2|||
16429365|NCT02688985|40050503|FG001|Overall Study|Withdrawal by Subject|8|||
16429366|NCT02688985|40050504|FG002|Overall Study|Withdrawal by Subject|7|||
16429367|NCT02688985|40050505|FG003|Overall Study|Withdrawal by Subject|1|||
16429368|NCT02688985|40050506|FG004|Overall Study|Withdrawal by Subject|4|||
16429369|NCT00853151|40050510|FG000|Overall Study|Adverse Event|1|||
16429370|NCT00853151|40050511|FG001|Overall Study|Adverse Event|4|||
16429371|NCT00853151|40050512|FG002|Overall Study|Adverse Event|2|||
16429372|NCT00853151|40050513|FG003|Overall Study|Adverse Event|0|||
16429373|NCT00853151|40050510|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
16429374|NCT00853151|40050511|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16429375|NCT00853151|40050512|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16429376|NCT00853151|40050513|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16429377|NCT00853151|40050510|FG000|Overall Study|Lost to Follow-up|2|||
16429378|NCT00853151|40050511|FG001|Overall Study|Lost to Follow-up|0|||
16429379|NCT00853151|40050512|FG002|Overall Study|Lost to Follow-up|3|||
16429380|NCT00853151|40050513|FG003|Overall Study|Lost to Follow-up|0|||
16429381|NCT00853151|40050510|FG000|Overall Study|Death|1|||
16429382|NCT00853151|40050511|FG001|Overall Study|Death|0|||
16429383|NCT00853151|40050512|FG002|Overall Study|Death|0|||
16429384|NCT00853151|40050513|FG003|Overall Study|Death|1|||
16429385|NCT00853151|40050510|FG000|Overall Study|Protocol Violation|0|||
16429386|NCT00853151|40050511|FG001|Overall Study|Protocol Violation|0|||
16429387|NCT00853151|40050512|FG002|Overall Study|Protocol Violation|0|||
16429388|NCT00853151|40050513|FG003|Overall Study|Protocol Violation|1|||
16429389|NCT00853151|40050510|FG000|Overall Study|Withdrawal by Subject|5|||
16429390|NCT00853151|40050511|FG001|Overall Study|Withdrawal by Subject|4|||
16429391|NCT00853151|40050512|FG002|Overall Study|Withdrawal by Subject|2|||
16429392|NCT00853151|40050513|FG003|Overall Study|Withdrawal by Subject|1|||
16429393|NCT00853151|40050510|FG000|Overall Study|Physician Decision|0|||
16429394|NCT00853151|40050511|FG001|Overall Study|Physician Decision|2|||
16131250|NCT03541174|38967258|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
16131251|NCT03541174|38967259|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
16131252|NCT03541174|38967260|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
16131253|NCT03541174|38967261|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
16131254|NCT03541174|38967262|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
16131255|NCT03541174|38967263|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
16131256|NCT03541174|38967258|FG000|Part 2 Single-Blind|Death|0|||
16131257|NCT03541174|38967259|FG001|Part 2 Single-Blind|Death|0|||
16429395|NCT00853151|40050512|FG002|Overall Study|Physician Decision|1|||
16429396|NCT00853151|40050513|FG003|Overall Study|Physician Decision|0|||
16429397|NCT00853151|40050510|FG000|Overall Study|Sponsor Decision|0|||
16429398|NCT00853151|40050511|FG001|Overall Study|Sponsor Decision|3|||
16131258|NCT03541174|38967260|FG002|Part 2 Single-Blind|Death|0|||
16562862|NCT01474512|40525472|FG012|Maintenance Period|Protocol Violation|0|||
16562863|NCT01474512|40525473|FG013|Maintenance Period|Protocol Violation|0|||
16562864|NCT01474512|40525474|FG014|Maintenance Period|Protocol Violation|0|||
16562865|NCT01474512|40525475|FG015|Maintenance Period|Protocol Violation|0|||
16562866|NCT01474512|40525476|FG016|Maintenance Period|Protocol Violation|0|||
16562867|NCT01474512|40525477|FG017|Maintenance Period|Protocol Violation|0|||
16562868|NCT01474512|40525460|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
16562869|NCT01474512|40525461|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
16562870|NCT01474512|40525462|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
16562871|NCT01474512|40525463|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
16562872|NCT01474512|40525464|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
16562873|NCT01474512|40525465|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
16562874|NCT01474512|40525466|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
16562875|NCT01474512|40525467|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
16562876|NCT01474512|40525468|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
16562877|NCT01474512|40525469|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
16562878|NCT01474512|40525470|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
16562879|NCT01474512|40525471|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
16562880|NCT01474512|40525472|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
16562881|NCT01474512|40525473|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
16562882|NCT01474512|40525474|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
16562883|NCT01474512|40525475|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
16562884|NCT01474512|40525476|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
16562885|NCT01474512|40525477|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
16562886|NCT01474512|40525460|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
16562887|NCT01474512|40525461|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
16562888|NCT01474512|40525462|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
16562889|NCT01474512|40525463|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
16562890|NCT01474512|40525464|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
16562891|NCT01474512|40525465|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
16562892|NCT01474512|40525466|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
16562893|NCT01474512|40525467|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
16562894|NCT01474512|40525468|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
16562895|NCT01474512|40525469|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
16562896|NCT01474512|40525470|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
16562897|NCT01474512|40525471|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
16131259|NCT03541174|38967261|FG003|Part 2 Single-Blind|Death|5|||
16429399|NCT00853151|40050512|FG002|Overall Study|Sponsor Decision|0|||
16429400|NCT00853151|40050513|FG003|Overall Study|Sponsor Decision|0|||
16429401|NCT02532465|40050514|FG000|Overall Study|Protocol Violation|1|||
16562898|NCT01474512|40525472|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
16562899|NCT01474512|40525473|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
16562900|NCT01474512|40525474|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
16131260|NCT03541174|38967262|FG004|Part 2 Single-Blind|Death|0|||
16429402|NCT02532465|40050515|FG001|Overall Study|Protocol Violation|0|||
16429403|NCT02532465|40050514|FG000|Overall Study|Lack of Efficacy|0|||
16429404|NCT02532465|40050515|FG001|Overall Study|Lack of Efficacy|1|||
16429405|NCT01687296|40050522|FG000|Overall Study|Lack of Efficacy|1|||
16429406|NCT01687296|40050523|FG001|Overall Study|Lack of Efficacy|1|||
16429407|NCT01687296|40050522|FG000|Overall Study|Protocol Violation|0|||
16429408|NCT01687296|40050523|FG001|Overall Study|Protocol Violation|1|||
16429409|NCT01687296|40050522|FG000|Overall Study|Withdrawal by Subject|6|||
16429410|NCT01687296|40050523|FG001|Overall Study|Withdrawal by Subject|3|||
16429411|NCT00699608|40050526|FG000|First Intervention|Withdrawal by Subject|0|||
16429412|NCT00699608|40050527|FG001|First Intervention|Withdrawal by Subject|0|||
16429413|NCT00699608|40050528|FG002|First Intervention|Withdrawal by Subject|1|||
16429414|NCT00699608|40050529|FG003|First Intervention|Withdrawal by Subject|0|||
16429415|NCT00699608|40050530|FG004|First Intervention|Withdrawal by Subject|0|||
16429416|NCT00699608|40050531|FG005|First Intervention|Withdrawal by Subject|0|||
16429417|NCT00699608|40050526|FG000|First Intervention|Protocol Violation|0|||
16429418|NCT00699608|40050527|FG001|First Intervention|Protocol Violation|0|||
16429419|NCT00699608|40050528|FG002|First Intervention|Protocol Violation|0|||
16429420|NCT00699608|40050529|FG003|First Intervention|Protocol Violation|0|||
16429421|NCT00699608|40050530|FG004|First Intervention|Protocol Violation|1|||
16429422|NCT00699608|40050531|FG005|First Intervention|Protocol Violation|0|||
16429423|NCT00699608|40050526|FG000|Second Intervention|Adverse Event|0|||
16429424|NCT00699608|40050527|FG001|Second Intervention|Adverse Event|0|||
16429425|NCT00699608|40050528|FG002|Second Intervention|Adverse Event|1|||
16429426|NCT00699608|40050529|FG003|Second Intervention|Adverse Event|0|||
16429427|NCT00699608|40050530|FG004|Second Intervention|Adverse Event|0|||
16429428|NCT00699608|40050531|FG005|Second Intervention|Adverse Event|0|||
16429429|NCT00699608|40050526|FG000|Second Intervention|Withdrawal by Subject|0|||
16429430|NCT00699608|40050527|FG001|Second Intervention|Withdrawal by Subject|0|||
16429431|NCT00699608|40050528|FG002|Second Intervention|Withdrawal by Subject|0|||
16429432|NCT00699608|40050529|FG003|Second Intervention|Withdrawal by Subject|1|||
16429433|NCT00699608|40050530|FG004|Second Intervention|Withdrawal by Subject|0|||
16429434|NCT00699608|40050531|FG005|Second Intervention|Withdrawal by Subject|0|||
16429435|NCT01359904|40050532|FG000|Overall Study|Withdrawal by Subject|1|||
16429436|NCT01359904|40050533|FG001|Overall Study|Withdrawal by Subject|0|||
16429437|NCT00930553|40050543|FG000|Overall Study|Adverse Event|1|||
16429438|NCT00930553|40050543|FG000|Overall Study|Lack of Efficacy|7|||
16429439|NCT00930553|40050543|FG000|Overall Study|Physician Decision|39|||
16429440|NCT00930553|40050543|FG000|Overall Study|Protocol Violation|1|||
16429441|NCT00930553|40050543|FG000|Overall Study|Pregnancy|1|||
16429442|NCT00930553|40050543|FG000|Overall Study|Withdrawal by Subject|88|||
16429443|NCT00930553|40050543|FG000|Overall Study|Lost to Follow-up|25|||
16429444|NCT00930553|40050543|FG000|Overall Study|Death|9|||
16429445|NCT00930553|40050543|FG000|Overall Study|Study terminated by sponsor|24|||
16429446|NCT00930553|40050543|FG000|Overall Study|Other than specified above|28|||
16429447|NCT00571038|40050544|FG000|Overall Study|Lost to Follow-up|1|||
16429448|NCT00571038|40050545|FG001|Overall Study|Lost to Follow-up|4|||
16429449|NCT00571038|40050544|FG000|Overall Study|Death|7|||
16429450|NCT00571038|40050545|FG001|Overall Study|Death|5|||
16429451|NCT00571038|40050544|FG000|Overall Study|Withdrawal by Subject|1|||
16429452|NCT00571038|40050545|FG001|Overall Study|Withdrawal by Subject|3|||
16429453|NCT00571038|40050544|FG000|Overall Study|Moved out of state|2|||
16429454|NCT00571038|40050545|FG001|Overall Study|Moved out of state|2|||
16429455|NCT02352753|40050546|FG000|6-Month Dosing Period|Decision by sponsor|2|||
16429456|NCT02352753|40050546|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
16429457|NCT02352753|40050546|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
16429458|NCT02352753|40050546|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
16429459|NCT02352753|40050546|FG000|3-Month Dosing Period|Decision by sponsor|14|||
16429460|NCT02352753|40050546|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
16429461|NCT04303572|40050550|FG000|Overall Study|Study closed due to poor enrollment|1|||
16429462|NCT04170543|40050551|FG000|Overall Study|Death|1|||
16429463|NCT04170543|40050552|FG001|Overall Study|Death|1|||
16429464|NCT04170543|40050553|FG002|Overall Study|Death|1|||
16429465|NCT04170543|40050554|FG003|Overall Study|Death|1|||
16429466|NCT04170543|40050555|FG004|Overall Study|Death|1|||
16562901|NCT01474512|40525475|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
16429467|NCT04170543|40050551|FG000|Overall Study|Lost to Follow-up|3|||
16429468|NCT04170543|40050552|FG001|Overall Study|Lost to Follow-up|3|||
16429469|NCT04170543|40050553|FG002|Overall Study|Lost to Follow-up|0|||
16429470|NCT04170543|40050554|FG003|Overall Study|Lost to Follow-up|3|||
16429471|NCT04170543|40050555|FG004|Overall Study|Lost to Follow-up|1|||
16429472|NCT04170543|40050551|FG000|Overall Study|Withdrawal by Subject|13|||
16429473|NCT04170543|40050552|FG001|Overall Study|Withdrawal by Subject|6|||
16429474|NCT04170543|40050553|FG002|Overall Study|Withdrawal by Subject|5|||
16429475|NCT04170543|40050554|FG003|Overall Study|Withdrawal by Subject|4|||
16429476|NCT04170543|40050555|FG004|Overall Study|Withdrawal by Subject|9|||
16429477|NCT04170543|40050551|FG000|Overall Study|Not able to transition to phase 2b|8|||
16429478|NCT04170543|40050552|FG001|Overall Study|Not able to transition to phase 2b|0|||
16429479|NCT04170543|40050553|FG002|Overall Study|Not able to transition to phase 2b|10|||
16429480|NCT04170543|40050554|FG003|Overall Study|Not able to transition to phase 2b|0|||
16429481|NCT04170543|40050555|FG004|Overall Study|Not able to transition to phase 2b|6|||
16250303|NCT00720798|39398050|FG000|Overall Study|Death|39|||
16250304|NCT00720798|39398050|FG000|Overall Study|Insufficient Therapeutic Response|129|||
16250305|NCT00720798|39398050|FG000|Overall Study|Protocol Violation|4|||
16250306|NCT00720798|39398050|FG000|Overall Study|Refused Treatment|151|||
16250307|NCT00720798|39398050|FG000|Overall Study|Failure to Return|46|||
16250308|NCT00720798|39398050|FG000|Overall Study|Reason not Specified|83|||
16250309|NCT00891293|39400426|FG000|Overall Study|Adverse Event|2|||
16250310|NCT00891293|39400426|FG000|Overall Study|Protocol Violation|2|||
16250311|NCT00891293|39400426|FG000|Overall Study|Laboratory abnormality|4|||
16250312|NCT00891293|39400426|FG000|Overall Study|Lost to Follow-up|7|||
16250313|NCT00891293|39400426|FG000|Overall Study|Subject withdrew consent|7|||
16250314|NCT00891293|39400426|FG000|Overall Study|Sponsor termination|62|||
16250315|NCT01025037|39400427|FG000|Overall Study|Adverse Event|3|||
16250316|NCT01025037|39400427|FG000|Overall Study|Lost to Follow-up|7|||
16250317|NCT01025037|39400427|FG000|Overall Study|Withdrawal by Subject|1|||
16250318|NCT01185288|39400428|FG000|Overall Study|Adverse Event|7|||
16250319|NCT01185288|39400429|FG001|Overall Study|Adverse Event|6|||
16250320|NCT01185288|39400428|FG000|Overall Study|Withdrawal by Subject|6|||
16250321|NCT01185288|39400429|FG001|Overall Study|Withdrawal by Subject|4|||
16250322|NCT01185288|39400428|FG000|Overall Study|Lost to Follow-up|2|||
16250323|NCT01185288|39400429|FG001|Overall Study|Lost to Follow-up|5|||
16250324|NCT01185288|39400428|FG000|Overall Study|Lack of Efficacy|2|||
16250325|NCT01185288|39400429|FG001|Overall Study|Lack of Efficacy|0|||
16250326|NCT01185288|39400428|FG000|Overall Study|Investigator discretion|1|||
16250327|NCT01185288|39400429|FG001|Overall Study|Investigator discretion|0|||
16250328|NCT01185288|39400428|FG000|Overall Study|Did not meet inclusion criteria|1|||
16250329|NCT01185288|39400429|FG001|Overall Study|Did not meet inclusion criteria|0|||
16250330|NCT01185288|39400428|FG000|Overall Study|Noncompliance|0|||
16250331|NCT01185288|39400429|FG001|Overall Study|Noncompliance|1|||
16250332|NCT03347695|39400430|FG000|Overall Study|Death|0|||
16250333|NCT03347695|39400431|FG001|Overall Study|Death|4|||
16250334|NCT03347695|39400430|FG000|Overall Study|Lost to Follow-up|0|||
16250335|NCT03347695|39400431|FG001|Overall Study|Lost to Follow-up|1|||
16250336|NCT03141177|39400448|FG000|Overall Study|Death|62|||
16250337|NCT03141177|39400449|FG001|Overall Study|Death|13|||
16250338|NCT03141177|39400450|FG002|Overall Study|Death|84|||
16250339|NCT03141177|39400448|FG000|Overall Study|Participant withdrew consent|9|||
16250340|NCT03141177|39400449|FG001|Overall Study|Participant withdrew consent|2|||
16562902|NCT01474512|40525476|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
16562903|NCT01474512|40525477|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
16562904|NCT01474512|40525460|FG000|Long-Term Extension Period|Adverse Event|0|||
16562905|NCT01474512|40525461|FG001|Long-Term Extension Period|Adverse Event|0|||
16562906|NCT01474512|40525462|FG002|Long-Term Extension Period|Adverse Event|0|||
16562907|NCT01474512|40525463|FG003|Long-Term Extension Period|Adverse Event|0|||
16562908|NCT01474512|40525464|FG004|Long-Term Extension Period|Adverse Event|0|||
16562909|NCT01474512|40525465|FG005|Long-Term Extension Period|Adverse Event|0|||
16562910|NCT01474512|40525466|FG006|Long-Term Extension Period|Adverse Event|0|||
16562911|NCT01474512|40525467|FG007|Long-Term Extension Period|Adverse Event|0|||
16562912|NCT01474512|40525468|FG008|Long-Term Extension Period|Adverse Event|0|||
16562913|NCT01474512|40525469|FG009|Long-Term Extension Period|Adverse Event|0|||
16562914|NCT01474512|40525470|FG010|Long-Term Extension Period|Adverse Event|0|||
16562915|NCT01474512|40525471|FG011|Long-Term Extension Period|Adverse Event|1|||
16250341|NCT03141177|39400450|FG002|Overall Study|Participant withdrew consent|13|||
16250342|NCT03141177|39400448|FG000|Overall Study|Not reported|1|||
16250343|NCT03141177|39400449|FG001|Overall Study|Not reported|0|||
16562916|NCT01474512|40525472|FG012|Long-Term Extension Period|Adverse Event|57|||
16562917|NCT01474512|40525473|FG013|Long-Term Extension Period|Adverse Event|58|||
16562918|NCT01474512|40525474|FG014|Long-Term Extension Period|Adverse Event|0|||
16562919|NCT01474512|40525475|FG015|Long-Term Extension Period|Adverse Event|0|||
16429482|NCT04170543|40050551|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
16429483|NCT04170543|40050552|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
16429484|NCT04170543|40050553|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
16429485|NCT04170543|40050554|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
16429486|NCT04170543|40050555|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
16429487|NCT04170543|40050551|FG000|Overall Study|Not Treated|0|||
16429488|NCT04170543|40050552|FG001|Overall Study|Not Treated|0|||
16429489|NCT04170543|40050553|FG002|Overall Study|Not Treated|0|||
16429490|NCT04170543|40050554|FG003|Overall Study|Not Treated|0|||
16429491|NCT04170543|40050555|FG004|Overall Study|Not Treated|2|||
16429492|NCT04170543|40050551|FG000|Overall Study|(CRF)|16|||
16429493|NCT04170543|40050552|FG001|Overall Study|(CRF)|15|||
16429494|NCT04170543|40050553|FG002|Overall Study|(CRF)|12|||
16429495|NCT04170543|40050554|FG003|Overall Study|(CRF)|17|||
16429496|NCT04170543|40050555|FG004|Overall Study|(CRF)|17|||
16429497|NCT04170543|40050551|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
16429498|NCT04170543|40050552|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
16429499|NCT04170543|40050553|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
16429500|NCT04170543|40050554|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
16429501|NCT04170543|40050555|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
16429502|NCT01973998|40050556|FG000|Overall Study|Death|2|||
16429503|NCT01973998|40050557|FG001|Overall Study|Death|2|||
16429504|NCT01279616|40050558|FG000|Overall Study|donor could not be located|5|||
16429505|NCT01279616|40050558|FG000|Overall Study|no signs of sickle cell disease|2|||
16429506|NCT01835158|40050559|FG000|Overall Study|Withdrawal by Subject|1|||
16429507|NCT01835158|40050560|FG001|Overall Study|Withdrawal by Subject|6|||
16429508|NCT02855268|40050561|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
16429509|NCT02855268|40050562|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
16429510|NCT02855268|40050561|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
16429511|NCT02855268|40050562|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
16429512|NCT02855268|40050561|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
16429513|NCT02855268|40050562|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
16429514|NCT02855268|40050561|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
16429515|NCT02855268|40050562|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
16429516|NCT02855268|40050561|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
16429517|NCT02855268|40050562|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
16429518|NCT02855268|40050561|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
16429519|NCT02855268|40050562|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
16429520|NCT03755882|40050563|FG000|Period 1|Protocol Violation|1|||
16429521|NCT03755882|40050564|FG001|Period 1|Protocol Violation|0|||
16429522|NCT03755882|40050563|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
16429523|NCT03755882|40050564|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
16429524|NCT02366312|40050565|FG000|Overall Study|Lost to Follow-up|0|||
16429525|NCT02366312|40050566|FG001|Overall Study|Lost to Follow-up|1|||
16429526|NCT01359943|40050570|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
16429527|NCT01359943|40050571|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
16429528|NCT01359943|40050572|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
16429529|NCT01359943|40050570|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
16429530|NCT01359943|40050571|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
16429531|NCT01359943|40050572|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
16429532|NCT01359943|40050570|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
16429533|NCT01359943|40050571|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
16429534|NCT01359943|40050572|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
16429535|NCT01359943|40050570|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
16429536|NCT01359943|40050571|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
16429537|NCT01359943|40050572|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
16429538|NCT01359943|40050570|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
16429539|NCT01359943|40050571|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
16429540|NCT01359943|40050572|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
16429541|NCT01359943|40050570|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
16429542|NCT01359943|40050571|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
16429543|NCT01359943|40050572|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
16429544|NCT01359943|40050570|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
16429545|NCT01359943|40050571|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
16429546|NCT01359943|40050572|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
16429547|NCT01359943|40050570|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
16429548|NCT01359943|40050571|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
16429549|NCT01359943|40050572|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
16429550|NCT01359943|40050570|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
16429551|NCT01359943|40050571|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
16429552|NCT01359943|40050572|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
16429553|NCT01359943|40050570|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
16429554|NCT01359943|40050571|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
16429555|NCT01359943|40050572|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
16429556|NCT01359943|40050570|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
16429557|NCT01359943|40050571|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
16429558|NCT01359943|40050572|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
16429559|NCT01359943|40050570|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
16429560|NCT01359943|40050571|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
16429561|NCT01359943|40050572|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
16429562|NCT01359943|40050570|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
16429563|NCT01359943|40050571|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
16429564|NCT01359943|40050572|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
16429565|NCT01359943|40050570|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
16429566|NCT01359943|40050571|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
16429567|NCT01359943|40050572|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
16429568|NCT01359943|40050570|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
16429569|NCT01359943|40050571|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
16429570|NCT01359943|40050572|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
16429571|NCT01726582|40050579|FG000|Overall Study|Physician Decision|99|||
16429572|NCT01726582|40050579|FG000|Overall Study|Death|85|||
16429573|NCT01217463|40050580|FG000|Overall Study|Adverse Event|8|||
16429574|NCT01217463|40050581|FG001|Overall Study|Adverse Event|5|||
16429575|NCT01217463|40050580|FG000|Overall Study|Physician Decision|0|||
16429576|NCT01217463|40050581|FG001|Overall Study|Physician Decision|1|||
16429577|NCT01217463|40050580|FG000|Overall Study|Withdrawal by Subject|3|||
16429578|NCT01217463|40050581|FG001|Overall Study|Withdrawal by Subject|0|||
16429579|NCT01217463|40050580|FG000|Overall Study|Surgery on the Target Limb|0|||
16429580|NCT01217463|40050581|FG001|Overall Study|Surgery on the Target Limb|1|||
16429581|NCT01217463|40050580|FG000|Overall Study|Patient Non-compliant|1|||
16429582|NCT01217463|40050581|FG001|Overall Study|Patient Non-compliant|0|||
16429583|NCT01217463|40050580|FG000|Overall Study|Other|1|||
16429584|NCT01217463|40050581|FG001|Overall Study|Other|1|||
16429585|NCT04089761|40050588|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
16429586|NCT04089761|40050588|FG000|"Run In Phase"|Lost to Follow-up|1|||
16429587|NCT04089761|40050588|FG000|"Treatment Phase"|No evaluable data|5|||
16429588|NCT04089761|40050588|FG000|"Treatment Phase"|Lost to Follow-up|1|||
16429589|NCT02517541|40050590|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
16131261|NCT03541174|38967263|FG005|Part 2 Single-Blind|Death|0|||
16429590|NCT02517541|40050590|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
16429591|NCT02517541|40050590|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
16429592|NCT02517541|40050590|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
16429593|NCT02517541|40050590|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
16429594|NCT02517541|40050590|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
16429595|NCT02442349|40050591|FG000|Overall Study|Death|14|||
16429596|NCT02442349|40050591|FG000|Overall Study|Withdrawal by Subject|8|||
16429597|NCT02442349|40050591|FG000|Overall Study|On-going Study at Data Cut-off|149|||
16429598|NCT01388907|40050592|FG000|Overall Study|Adverse Event|2|||
16429599|NCT01388907|40050593|FG001|Overall Study|Adverse Event|0|||
16429600|NCT04492722|40050600|FG000|Overall Study|Adverse Event|7|||
16429601|NCT04492722|40050601|FG001|Overall Study|Adverse Event|2|||
16429602|NCT04492722|40050602|FG002|Overall Study|Adverse Event|3|||
16429603|NCT04492722|40050603|FG003|Overall Study|Adverse Event|0|||
16429604|NCT04492722|40050600|FG000|Overall Study|Death|0|||
16429605|NCT04492722|40050601|FG001|Overall Study|Death|0|||
16429606|NCT04492722|40050602|FG002|Overall Study|Death|0|||
16429607|NCT04492722|40050603|FG003|Overall Study|Death|1|||
16429608|NCT04492722|40050600|FG000|Overall Study|Lost to Follow-up|0|||
16429609|NCT04492722|40050601|FG001|Overall Study|Lost to Follow-up|1|||
16429610|NCT04492722|40050602|FG002|Overall Study|Lost to Follow-up|0|||
16429611|NCT04492722|40050603|FG003|Overall Study|Lost to Follow-up|1|||
16429612|NCT04492722|40050600|FG000|Overall Study|Physician Decision|0|||
16131262|NCT03541174|38967258|FG000|Part 2 Single-Blind|Pregnancy|0|||
16429613|NCT04492722|40050601|FG001|Overall Study|Physician Decision|3|||
16429614|NCT04492722|40050602|FG002|Overall Study|Physician Decision|1|||
16429615|NCT04492722|40050603|FG003|Overall Study|Physician Decision|1|||
16429616|NCT04492722|40050600|FG000|Overall Study|Withdrawal by Subject|6|||
16429617|NCT04492722|40050601|FG001|Overall Study|Withdrawal by Subject|6|||
16429618|NCT04492722|40050602|FG002|Overall Study|Withdrawal by Subject|0|||
16429619|NCT04492722|40050603|FG003|Overall Study|Withdrawal by Subject|3|||
16429620|NCT04492722|40050600|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
16429621|NCT04492722|40050601|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
16429622|NCT04492722|40050602|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
16429623|NCT04492722|40050603|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
16429624|NCT04492722|40050600|FG000|Overall Study|Due to Covid-19 pandemic|7|||
16429625|NCT04492722|40050601|FG001|Overall Study|Due to Covid-19 pandemic|3|||
16429626|NCT04492722|40050602|FG002|Overall Study|Due to Covid-19 pandemic|7|||
16429627|NCT04492722|40050603|FG003|Overall Study|Due to Covid-19 pandemic|6|||
16429628|NCT04492722|40050600|FG000|Overall Study|Failure to meet randomisation criteria|2|||
16429629|NCT04492722|40050601|FG001|Overall Study|Failure to meet randomisation criteria|3|||
16429630|NCT04492722|40050602|FG002|Overall Study|Failure to meet randomisation criteria|4|||
16429631|NCT04492722|40050603|FG003|Overall Study|Failure to meet randomisation criteria|2|||
16429632|NCT04492722|40050600|FG000|Overall Study|Early termination from the study|54|||
16429633|NCT04492722|40050601|FG001|Overall Study|Early termination from the study|51|||
16429634|NCT04492722|40050602|FG002|Overall Study|Early termination from the study|50|||
16429635|NCT04492722|40050603|FG003|Overall Study|Early termination from the study|50|||
16429636|NCT04492722|40050600|FG000|Overall Study|Missing|3|||
16429637|NCT04492722|40050601|FG001|Overall Study|Missing|0|||
16429638|NCT04492722|40050602|FG002|Overall Study|Missing|0|||
16429639|NCT04492722|40050603|FG003|Overall Study|Missing|5|||
16429640|NCT04492722|40050600|FG000|Overall Study|Participants who did not receive treatment|0|||
16429641|NCT04492722|40050601|FG001|Overall Study|Participants who did not receive treatment|1|||
16429642|NCT04492722|40050602|FG002|Overall Study|Participants who did not receive treatment|4|||
16429643|NCT04492722|40050603|FG003|Overall Study|Participants who did not receive treatment|0|||
16429644|NCT00770601|40050604|FG000|Overall Study|Withdrawal by Subject|1|||
16429645|NCT01288989|40050608|FG000|Overall Study|Death|0|||
16429646|NCT01288989|40050609|FG001|Overall Study|Death|0|||
16429647|NCT01288989|40050610|FG002|Overall Study|Death|0|||
16429648|NCT01288989|40050611|FG003|Overall Study|Death|1|||
16429649|NCT01288989|40050612|FG004|Overall Study|Death|0|||
16429650|NCT01288989|40050608|FG000|Overall Study|Dose limiting toxicity|1|||
16429651|NCT01288989|40050609|FG001|Overall Study|Dose limiting toxicity|0|||
16429652|NCT01288989|40050610|FG002|Overall Study|Dose limiting toxicity|0|||
16429653|NCT01288989|40050611|FG003|Overall Study|Dose limiting toxicity|0|||
16429654|NCT01288989|40050612|FG004|Overall Study|Dose limiting toxicity|0|||
16429655|NCT01288989|40050608|FG000|Overall Study|Adverse Event|0|||
16429656|NCT01288989|40050609|FG001|Overall Study|Adverse Event|0|||
16429657|NCT01288989|40050610|FG002|Overall Study|Adverse Event|0|||
16429658|NCT01288989|40050611|FG003|Overall Study|Adverse Event|0|||
16429659|NCT01288989|40050612|FG004|Overall Study|Adverse Event|2|||
16429660|NCT01288989|40050608|FG000|Overall Study|Physician Decision|0|||
16429661|NCT01288989|40050609|FG001|Overall Study|Physician Decision|0|||
16429662|NCT01288989|40050610|FG002|Overall Study|Physician Decision|0|||
16429663|NCT01288989|40050611|FG003|Overall Study|Physician Decision|0|||
16429664|NCT01288989|40050612|FG004|Overall Study|Physician Decision|1|||
16429665|NCT01288989|40050608|FG000|Overall Study|Withdrawal by Subject|0|||
16429666|NCT01288989|40050609|FG001|Overall Study|Withdrawal by Subject|0|||
16429667|NCT01288989|40050610|FG002|Overall Study|Withdrawal by Subject|0|||
16429668|NCT01288989|40050611|FG003|Overall Study|Withdrawal by Subject|0|||
16429669|NCT01288989|40050612|FG004|Overall Study|Withdrawal by Subject|3|||
16429670|NCT01797263|40050613|FG000|Overall Study|Withdrawal by Subject|21|||
16429671|NCT01797263|40050614|FG001|Overall Study|Withdrawal by Subject|25|||
16429672|NCT01797263|40050613|FG000|Overall Study|Death|1|||
16429673|NCT01797263|40050614|FG001|Overall Study|Death|0|||
16429674|NCT01797263|40050613|FG000|Overall Study|Lost to Follow-up|15|||
16429675|NCT01797263|40050614|FG001|Overall Study|Lost to Follow-up|15|||
16429676|NCT00832416|40050615|FG000|Overall Study|Lack of Efficacy|17|||
16429677|NCT00832416|40050616|FG001|Overall Study|Lack of Efficacy|15|||
16429678|NCT00832416|40050617|FG002|Overall Study|Lack of Efficacy|13|||
16429679|NCT00832416|40050618|FG003|Overall Study|Lack of Efficacy|52|||
16429680|NCT00832416|40050615|FG000|Overall Study|Withdrawal by Subject|5|||
16429681|NCT00832416|40050616|FG001|Overall Study|Withdrawal by Subject|7|||
16429682|NCT00832416|40050617|FG002|Overall Study|Withdrawal by Subject|2|||
16429683|NCT00832416|40050618|FG003|Overall Study|Withdrawal by Subject|10|||
16429684|NCT00832416|40050615|FG000|Overall Study|Physician Decision|2|||
16562920|NCT01474512|40525476|FG016|Long-Term Extension Period|Adverse Event|0|||
16562921|NCT01474512|40525477|FG017|Long-Term Extension Period|Adverse Event|0|||
16429685|NCT00832416|40050616|FG001|Overall Study|Physician Decision|12|||
16429686|NCT00832416|40050617|FG002|Overall Study|Physician Decision|5|||
16429687|NCT00832416|40050618|FG003|Overall Study|Physician Decision|10|||
16429688|NCT00832416|40050615|FG000|Overall Study|Administrative|0|||
16429689|NCT00832416|40050616|FG001|Overall Study|Administrative|0|||
16429690|NCT00832416|40050617|FG002|Overall Study|Administrative|0|||
16429691|NCT00832416|40050618|FG003|Overall Study|Administrative|1|||
16429692|NCT00832416|40050615|FG000|Overall Study|Adverse Event|21|||
16429693|NCT00832416|40050616|FG001|Overall Study|Adverse Event|19|||
16429694|NCT00832416|40050617|FG002|Overall Study|Adverse Event|41|||
16429695|NCT00832416|40050618|FG003|Overall Study|Adverse Event|10|||
16429696|NCT00832416|40050615|FG000|Overall Study|Death|1|||
16429697|NCT00832416|40050616|FG001|Overall Study|Death|0|||
16429698|NCT00832416|40050617|FG002|Overall Study|Death|0|||
16429699|NCT00832416|40050618|FG003|Overall Study|Death|0|||
16131263|NCT03541174|38967259|FG001|Part 2 Single-Blind|Pregnancy|0|||
16250344|NCT03141177|39400450|FG002|Overall Study|Not reported|1|||
16250345|NCT03141177|39400448|FG000|Overall Study|Lost to Follow-up|2|||
16250346|NCT03141177|39400449|FG001|Overall Study|Lost to Follow-up|1|||
16250347|NCT03141177|39400450|FG002|Overall Study|Lost to Follow-up|1|||
16250348|NCT03141177|39400448|FG000|Overall Study|Other reasons|4|||
16250349|NCT03141177|39400449|FG001|Overall Study|Other reasons|0|||
16250350|NCT03141177|39400450|FG002|Overall Study|Other reasons|11|||
16250351|NCT03141177|39400448|FG000|Overall Study|Participants did not start treatment period|3|||
16250352|NCT03141177|39400449|FG001|Overall Study|Participants did not start treatment period|0|||
16250353|NCT03141177|39400450|FG002|Overall Study|Participants did not start treatment period|8|||
16250354|NCT01793610|39400452|FG000|Overall Study|Withdrawal by Subject|1|||
16250355|NCT01793610|39400453|FG001|Overall Study|Withdrawal by Subject|0|||
16250356|NCT01793610|39400454|FG002|Overall Study|Withdrawal by Subject|1|||
16250357|NCT00678392|39400455|FG000|Overall Study|Adverse Event|0|||
16250358|NCT00678392|39400456|FG001|Overall Study|Adverse Event|6|||
16250359|NCT00678392|39400455|FG000|Overall Study|Death|280|||
16250360|NCT00678392|39400456|FG001|Overall Study|Death|269|||
16250361|NCT00678392|39400455|FG000|Overall Study|Lost to Follow-up|15|||
16250362|NCT00678392|39400456|FG001|Overall Study|Lost to Follow-up|13|||
16250363|NCT00678392|39400455|FG000|Overall Study|Objective Progression or Relapse|3|||
16250364|NCT00678392|39400456|FG001|Overall Study|Objective Progression or Relapse|8|||
16250365|NCT00678392|39400455|FG000|Overall Study|Sponsor's Decision|1|||
16250366|NCT00678392|39400456|FG001|Overall Study|Sponsor's Decision|2|||
16250367|NCT00678392|39400455|FG000|Overall Study|Withdrawal by Subject|4|||
16250368|NCT00678392|39400456|FG001|Overall Study|Withdrawal by Subject|4|||
16250369|NCT00678392|39400455|FG000|Overall Study|Randomized But Not Treated|2|||
16250370|NCT00678392|39400456|FG001|Overall Study|Randomized But Not Treated|7|||
16250371|NCT00678392|39400455|FG000|Overall Study|Other|56|||
16250372|NCT00678392|39400456|FG001|Overall Study|Other|53|||
16250373|NCT00278200|39400463|FG000|Overall Study|Death|1|||
16250374|NCT00278200|39400464|FG001|Overall Study|Death|3|||
16250375|NCT00278200|39400463|FG000|Overall Study|Physician Decision|0|||
16250376|NCT00278200|39400464|FG001|Overall Study|Physician Decision|1|||
16250377|NCT03850509|39400465|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
16250378|NCT03850509|39400466|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
16250379|NCT01405820|39400471|FG000|Randomized Treatment Period|Adverse Event|3|||
16250380|NCT01405820|39400472|FG001|Randomized Treatment Period|Adverse Event|3|||
16250381|NCT01405820|39400473|FG002|Randomized Treatment Period|Adverse Event|3|||
16250382|NCT01405820|39400474|FG003|Randomized Treatment Period|Adverse Event|0|||
16250383|NCT01405820|39400475|FG004|Randomized Treatment Period|Adverse Event|2|||
16250384|NCT01405820|39400476|FG005|Randomized Treatment Period|Adverse Event|1|||
16250385|NCT01405820|39400471|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
16250386|NCT01405820|39400472|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
16250387|NCT01405820|39400473|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
16250388|NCT01405820|39400474|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
16250389|NCT01405820|39400475|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
16250390|NCT01405820|39400476|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
16250391|NCT01405820|39400471|FG000|Randomized Treatment Period|Other|2|||
16250392|NCT01405820|39400472|FG001|Randomized Treatment Period|Other|2|||
16250393|NCT01405820|39400473|FG002|Randomized Treatment Period|Other|1|||
16250394|NCT01405820|39400474|FG003|Randomized Treatment Period|Other|1|||
16250395|NCT01405820|39400475|FG004|Randomized Treatment Period|Other|0|||
16250396|NCT01405820|39400476|FG005|Randomized Treatment Period|Other|0|||
16250397|NCT01405820|39400471|FG000|Randomized Treatment Period|Physician Decision|0|||
16250398|NCT01405820|39400472|FG001|Randomized Treatment Period|Physician Decision|2|||
16250399|NCT01405820|39400473|FG002|Randomized Treatment Period|Physician Decision|1|||
16250400|NCT01405820|39400474|FG003|Randomized Treatment Period|Physician Decision|0|||
16250401|NCT01405820|39400475|FG004|Randomized Treatment Period|Physician Decision|0|||
16250402|NCT01405820|39400476|FG005|Randomized Treatment Period|Physician Decision|0|||
16250403|NCT01405820|39400471|FG000|Randomized Treatment Period|Rescue|0|||
16250404|NCT01405820|39400472|FG001|Randomized Treatment Period|Rescue|1|||
16250405|NCT01405820|39400473|FG002|Randomized Treatment Period|Rescue|13|||
16250406|NCT01405820|39400474|FG003|Randomized Treatment Period|Rescue|10|||
16250407|NCT01405820|39400475|FG004|Randomized Treatment Period|Rescue|8|||
16250408|NCT01405820|39400476|FG005|Randomized Treatment Period|Rescue|8|||
16250409|NCT01405820|39400471|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
16250410|NCT01405820|39400472|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
16250411|NCT01405820|39400473|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
16250412|NCT01405820|39400474|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
16250413|NCT01405820|39400475|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
16250414|NCT01405820|39400476|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
16250415|NCT01405820|39400471|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
16250416|NCT01405820|39400472|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
16250417|NCT01405820|39400473|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
16429700|NCT01362608|40050619|FG000|Overall Study|Protocol Violation|0|||
16429701|NCT01362608|40050620|FG001|Overall Study|Protocol Violation|1|||
16429702|NCT01362608|40050619|FG000|Overall Study|Lost to Follow-up|3|||
16429703|NCT01362608|40050620|FG001|Overall Study|Lost to Follow-up|1|||
16429704|NCT01362608|40050619|FG000|Overall Study|Withdrawal by Subject|1|||
16429705|NCT01362608|40050620|FG001|Overall Study|Withdrawal by Subject|2|||
16429706|NCT01362608|40050619|FG000|Overall Study|Lack of Efficacy|0|||
16429707|NCT01362608|40050620|FG001|Overall Study|Lack of Efficacy|2|||
16429708|NCT01362608|40050619|FG000|Overall Study|Adverse Event|0|||
16429709|NCT01362608|40050620|FG001|Overall Study|Adverse Event|2|||
16429710|NCT00462306|40050622|FG000|Overall Study|insufficient data|0|||
16429711|NCT00462306|40050623|FG001|Overall Study|insufficient data|13|||
16429712|NCT03461146|40050624|FG000|Overall Study|Adverse Event|2|||
16429713|NCT03461146|40050624|FG000|Overall Study|Physician Decision|1|||
16429714|NCT02640547|40050625|FG000|Overall Study|Failure to Return|1|||
16429715|NCT02640547|40050625|FG000|Overall Study|Withdrawal by Subject|1|||
16429716|NCT02640547|40050625|FG000|Overall Study|Death|6|||
16429717|NCT02640547|40050625|FG000|Overall Study|Miscellaneous|3|||
16429718|NCT02045095|40050628|FG000|Overall Study|Other|0|||
16429719|NCT02045095|40050629|FG001|Overall Study|Other|0|||
16429720|NCT02045095|40050630|FG002|Overall Study|Other|1|||
16429721|NCT02045095|40050631|FG003|Overall Study|Other|0|||
16429722|NCT02045095|40050632|FG004|Overall Study|Other|0|||
16429723|NCT02045095|40050633|FG005|Overall Study|Other|2|||
16429724|NCT02045095|40050634|FG006|Overall Study|Other|0|||
16429725|NCT02045095|40050628|FG000|Overall Study|Progressive Disease|3|||
16429726|NCT02045095|40050629|FG001|Overall Study|Progressive Disease|3|||
16429727|NCT02045095|40050630|FG002|Overall Study|Progressive Disease|2|||
16429728|NCT02045095|40050631|FG003|Overall Study|Progressive Disease|4|||
16429729|NCT02045095|40050632|FG004|Overall Study|Progressive Disease|2|||
16429730|NCT02045095|40050633|FG005|Overall Study|Progressive Disease|4|||
16429731|NCT02045095|40050634|FG006|Overall Study|Progressive Disease|1|||
16429732|NCT02045095|40050628|FG000|Overall Study|Withdrawal by Subject|0|||
16429733|NCT02045095|40050629|FG001|Overall Study|Withdrawal by Subject|0|||
16429734|NCT02045095|40050630|FG002|Overall Study|Withdrawal by Subject|0|||
16429735|NCT02045095|40050631|FG003|Overall Study|Withdrawal by Subject|0|||
16429736|NCT02045095|40050632|FG004|Overall Study|Withdrawal by Subject|3|||
16429737|NCT02045095|40050633|FG005|Overall Study|Withdrawal by Subject|0|||
16429738|NCT02045095|40050634|FG006|Overall Study|Withdrawal by Subject|0|||
16429739|NCT02045095|40050628|FG000|Overall Study|Adverse Event|0|||
16429740|NCT02045095|40050629|FG001|Overall Study|Adverse Event|1|||
16429741|NCT02045095|40050630|FG002|Overall Study|Adverse Event|1|||
16429742|NCT02045095|40050631|FG003|Overall Study|Adverse Event|0|||
16429743|NCT02045095|40050632|FG004|Overall Study|Adverse Event|0|||
16429744|NCT02045095|40050633|FG005|Overall Study|Adverse Event|2|||
16429745|NCT02045095|40050634|FG006|Overall Study|Adverse Event|0|||
16429746|NCT01156714|40050635|FG000|Overall Study|Withdrawal by Subject|9|||
16429747|NCT01156714|40050636|FG001|Overall Study|Withdrawal by Subject|4|||
16429748|NCT01156714|40050637|FG002|Overall Study|Withdrawal by Subject|3|||
16429749|NCT00584415|40050638|FG000|Overall Study|Adverse Event|7|||
16429750|NCT01220167|40050639|FG000|Period 3|Urine positive for substance abuse|0|||
16429751|NCT01220167|40050640|FG001|Period 3|Urine positive for substance abuse|1|||
16429752|NCT01220167|40050641|FG002|Period 3|Urine positive for substance abuse|0|||
16429753|NCT01391663|40050642|FG000|Overall Study|Withdrawal by Subject|0|||
16429754|NCT01391663|40050643|FG001|Overall Study|Withdrawal by Subject|0|||
16429755|NCT01391663|40050644|FG002|Overall Study|Withdrawal by Subject|1|||
16429756|NCT01391663|40050645|FG003|Overall Study|Withdrawal by Subject|0|||
16429757|NCT00391027|40050646|FG000|Overall Study|Adverse Event|8|||
16429758|NCT00391027|40050647|FG001|Overall Study|Adverse Event|8|||
16429759|NCT00391027|40050646|FG000|Overall Study|Lack of Efficacy|3|||
16429760|NCT00391027|40050647|FG001|Overall Study|Lack of Efficacy|0|||
16429761|NCT00391027|40050646|FG000|Overall Study|Withdrawal by Subject|10|||
16429762|NCT00391027|40050647|FG001|Overall Study|Withdrawal by Subject|1|||
16429763|NCT00391027|40050646|FG000|Overall Study|Other|4|||
16429764|NCT00391027|40050647|FG001|Overall Study|Other|3|||
16429765|NCT01919229|40050648|FG000|Overall Study|Subject/guardian decision|0|||
16429766|NCT01919229|40050649|FG001|Overall Study|Subject/guardian decision|0|||
16429767|NCT01919229|40050650|FG002|Overall Study|Subject/guardian decision|1|||
16429768|NCT02100475|40050651|FG000|Overall Study|Unclassified|1|||
16429769|NCT02100475|40050652|FG001|Overall Study|Unclassified|2|||
16429770|NCT02100475|40050651|FG000|Overall Study|Withdrawal criteria|1|||
16429771|NCT02100475|40050652|FG001|Overall Study|Withdrawal criteria|0|||
16429772|NCT05011513|40050653|FG000|Overall Study|Death|0|||
16429773|NCT05011513|40050654|FG001|Overall Study|Death|1|||
16429774|NCT05011513|40050653|FG000|Overall Study|Lost to Follow-up|4|||
16429775|NCT05011513|40050654|FG001|Overall Study|Lost to Follow-up|0|||
16429776|NCT05011513|40050653|FG000|Overall Study|Withdrawal by Subject|18|||
16429777|NCT05011513|40050654|FG001|Overall Study|Withdrawal by Subject|17|||
16429778|NCT05011513|40050653|FG000|Overall Study|Other|4|||
16429779|NCT05011513|40050654|FG001|Overall Study|Other|2|||
16429780|NCT00855816|40050655|FG000|Overall Study|Withdrawal by Subject|22|||
16429781|NCT00855816|40050656|FG001|Overall Study|Withdrawal by Subject|15|||
16429782|NCT00855816|40050655|FG000|Overall Study|Lost to Follow-up|3|||
16429783|NCT00855816|40050656|FG001|Overall Study|Lost to Follow-up|5|||
16429784|NCT00855816|40050655|FG000|Overall Study|Death|1|||
16429785|NCT00855816|40050656|FG001|Overall Study|Death|0|||
16429786|NCT00855816|40050655|FG000|Overall Study|Became ineligible|0|||
16429787|NCT00855816|40050656|FG001|Overall Study|Became ineligible|1|||
16429788|NCT01636986|40050659|FG000|Overall Study|Withdrawal by Subject|0|||
16429789|NCT01636986|40050660|FG001|Overall Study|Withdrawal by Subject|1|||
16429790|NCT01636986|40050659|FG000|Overall Study|Corneal Staining|0|||
16429791|NCT01636986|40050660|FG001|Overall Study|Corneal Staining|1|||
16429792|NCT00981461|40050661|FG000|Overall Study|Lost to Follow-up|5|||
16429793|NCT00981461|40050662|FG001|Overall Study|Lost to Follow-up|2|||
16429794|NCT03785964|40050663|FG000|Overall Study|Adverse Event|14|||
16429795|NCT03785964|40050664|FG001|Overall Study|Adverse Event|1|||
16429796|NCT03785964|40050663|FG000|Overall Study|Unqualified Clinical Progression|1|||
16429797|NCT03785964|40050664|FG001|Overall Study|Unqualified Clinical Progression|1|||
16429798|NCT03785964|40050663|FG000|Overall Study|Participant non-compliance|1|||
16429799|NCT03785964|40050664|FG001|Overall Study|Participant non-compliance|1|||
16429800|NCT03785964|40050663|FG000|Overall Study|Not treated|1|||
16429801|NCT03785964|40050664|FG001|Overall Study|Not treated|0|||
16429802|NCT03785964|40050663|FG000|Overall Study|Other reason|5|||
16429803|NCT03785964|40050664|FG001|Overall Study|Other reason|11|||
16429804|NCT03785964|40050663|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
16429805|NCT03785964|40050664|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
16429806|NCT01684202|40050665|FG000|Dose-escalation Period|Adverse Event|0|||
16429807|NCT01684202|40050666|FG001|Dose-escalation Period|Adverse Event|1|||
16429808|NCT01684202|40050667|FG002|Dose-escalation Period|Adverse Event|0|||
16429809|NCT01684202|40050668|FG003|Dose-escalation Period|Adverse Event|0|||
16429810|NCT01684202|40050665|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
16429811|NCT01684202|40050666|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
16429812|NCT01684202|40050667|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
16429813|NCT01684202|40050668|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
16429814|NCT01684202|40050665|FG000|Maintenance Period|Adverse Event|1|||
16429815|NCT01684202|40050666|FG001|Maintenance Period|Adverse Event|1|||
16429816|NCT01684202|40050667|FG002|Maintenance Period|Adverse Event|1|||
16429817|NCT01684202|40050668|FG003|Maintenance Period|Adverse Event|1|||
16429818|NCT01684202|40050665|FG000|Maintenance Period|Physician Decision|0|||
16429819|NCT01684202|40050666|FG001|Maintenance Period|Physician Decision|1|||
16429820|NCT01684202|40050667|FG002|Maintenance Period|Physician Decision|0|||
16429821|NCT01684202|40050668|FG003|Maintenance Period|Physician Decision|0|||
16429822|NCT01684202|40050665|FG000|Maintenance Period|Withdrawal by Subject|0|||
16429823|NCT01684202|40050666|FG001|Maintenance Period|Withdrawal by Subject|1|||
16429824|NCT01684202|40050667|FG002|Maintenance Period|Withdrawal by Subject|0|||
16429825|NCT01684202|40050668|FG003|Maintenance Period|Withdrawal by Subject|0|||
16429826|NCT04531241|40050669|FG000|Period 1|Withdrawal by Subject|2|||
16429827|NCT04531241|40050670|FG001|Period 1|Withdrawal by Subject|0|||
16429828|NCT04531241|40050669|FG000|Period 1|Dispesed incorrect lens power|1|||
16429829|NCT04531241|40050670|FG001|Period 1|Dispesed incorrect lens power|0|||
16429830|NCT04531241|40050669|FG000|Period 1|Protocol Violation|1|||
16429831|NCT04531241|40050670|FG001|Period 1|Protocol Violation|0|||
16429832|NCT04531241|40050669|FG000|Period 1|No longer eligible|0|||
16429833|NCT04531241|40050670|FG001|Period 1|No longer eligible|1|||
16429834|NCT04531241|40050669|FG000|Period 1|Lens Discomfort|0|||
16429835|NCT04531241|40050670|FG001|Period 1|Lens Discomfort|1|||
16429836|NCT04531241|40050669|FG000|Period 2|Covid-19 Related|1|||
16429837|NCT04531241|40050670|FG001|Period 2|Covid-19 Related|1|||
16429838|NCT01550757|40050671|FG000|Overall Study|Lost to Follow-up|21|||
16429839|NCT01550757|40050672|FG001|Overall Study|Lost to Follow-up|14|||
16429840|NCT01550757|40050673|FG002|Overall Study|Lost to Follow-up|42|||
16429841|NCT01550757|40050674|FG003|Overall Study|Lost to Follow-up|53|||
16429842|NCT01550757|40050671|FG000|Overall Study|Withdrawal by Subject|2|||
16562922|NCT01474512|40525460|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
16562923|NCT01474512|40525461|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
16429843|NCT01550757|40050672|FG001|Overall Study|Withdrawal by Subject|0|||
16429844|NCT01550757|40050673|FG002|Overall Study|Withdrawal by Subject|3|||
16429845|NCT01550757|40050674|FG003|Overall Study|Withdrawal by Subject|1|||
16429846|NCT03089580|40050675|FG000|Overall Study|Lost to Follow-up|2|||
16429847|NCT00826618|40050678|FG000|Overall Study|Withdrawal by Subject|1|||
16250418|NCT01405820|39400474|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
16429848|NCT00566852|40050679|FG000|Overall Study|Protocol Violation|22|||
16429849|NCT00566852|40050680|FG001|Overall Study|Protocol Violation|24|||
16429850|NCT00566852|40050679|FG000|Overall Study|Death|95|||
16429851|NCT00566852|40050680|FG001|Overall Study|Death|78|||
16429852|NCT00566852|40050679|FG000|Overall Study|Withdrawal by Subject|30|||
16429853|NCT00566852|40050680|FG001|Overall Study|Withdrawal by Subject|25|||
16562924|NCT01474512|40525462|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
16562925|NCT01474512|40525463|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
16562926|NCT01474512|40525464|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
16562927|NCT01474512|40525465|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
16562928|NCT01474512|40525466|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
16131264|NCT03541174|38967260|FG002|Part 2 Single-Blind|Pregnancy|0|||
16131265|NCT03541174|38967261|FG003|Part 2 Single-Blind|Pregnancy|1|||
16131266|NCT03541174|38967262|FG004|Part 2 Single-Blind|Pregnancy|0|||
16131267|NCT03541174|38967263|FG005|Part 2 Single-Blind|Pregnancy|0|||
16131268|NCT03541174|38967258|FG000|Part 2 Single-Blind|Other reasons|0|||
16131269|NCT03541174|38967259|FG001|Part 2 Single-Blind|Other reasons|0|||
16131270|NCT03541174|38967260|FG002|Part 2 Single-Blind|Other reasons|0|||
16562929|NCT01474512|40525467|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
16562930|NCT01474512|40525468|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
16562931|NCT01474512|40525469|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
16131271|NCT03541174|38967261|FG003|Part 2 Single-Blind|Other reasons|32|||
16361001|NCT00724945|39807654|FG001|Period 2|lens comfort issue|0|||
16562932|NCT01474512|40525470|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
16562933|NCT01474512|40525471|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
16562934|NCT01474512|40525472|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
16361002|NCT00724945|39807653|FG000|Period 2|lens physiology issue|1|||
16361003|NCT00724945|39807654|FG001|Period 2|lens physiology issue|0|||
16562935|NCT01474512|40525473|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
16562936|NCT01474512|40525474|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
16562937|NCT01474512|40525475|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
16562938|NCT01474512|40525476|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
16562939|NCT01474512|40525477|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
16562940|NCT01474512|40525460|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
16562941|NCT01474512|40525461|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
16562942|NCT01474512|40525462|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
16562943|NCT01474512|40525463|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
16562944|NCT01474512|40525464|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
16562945|NCT01474512|40525465|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
16562946|NCT01474512|40525466|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
16562947|NCT01474512|40525467|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
16562948|NCT01474512|40525468|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
16562949|NCT01474512|40525469|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
16562950|NCT01474512|40525470|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
16562951|NCT01474512|40525471|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
16562952|NCT01474512|40525472|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
16562953|NCT01474512|40525473|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
16562954|NCT01474512|40525474|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
16562955|NCT01474512|40525475|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
16562956|NCT01474512|40525476|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
16562957|NCT01474512|40525477|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
16562958|NCT01474512|40525460|FG000|Long-Term Extension Period|Physician Decision|0|||
16562959|NCT01474512|40525461|FG001|Long-Term Extension Period|Physician Decision|0|||
16562960|NCT01474512|40525462|FG002|Long-Term Extension Period|Physician Decision|0|||
16562961|NCT01474512|40525463|FG003|Long-Term Extension Period|Physician Decision|0|||
16562962|NCT01474512|40525464|FG004|Long-Term Extension Period|Physician Decision|0|||
16562963|NCT01474512|40525465|FG005|Long-Term Extension Period|Physician Decision|0|||
16562964|NCT01474512|40525466|FG006|Long-Term Extension Period|Physician Decision|0|||
16562965|NCT01474512|40525467|FG007|Long-Term Extension Period|Physician Decision|0|||
16562966|NCT01474512|40525468|FG008|Long-Term Extension Period|Physician Decision|0|||
16562967|NCT01474512|40525469|FG009|Long-Term Extension Period|Physician Decision|0|||
16562968|NCT01474512|40525470|FG010|Long-Term Extension Period|Physician Decision|0|||
16562969|NCT01474512|40525471|FG011|Long-Term Extension Period|Physician Decision|0|||
16562970|NCT01474512|40525472|FG012|Long-Term Extension Period|Physician Decision|21|||
16562971|NCT01474512|40525473|FG013|Long-Term Extension Period|Physician Decision|21|||
16562972|NCT01474512|40525474|FG014|Long-Term Extension Period|Physician Decision|0|||
16562973|NCT01474512|40525475|FG015|Long-Term Extension Period|Physician Decision|0|||
16562974|NCT01474512|40525476|FG016|Long-Term Extension Period|Physician Decision|0|||
16562975|NCT01474512|40525477|FG017|Long-Term Extension Period|Physician Decision|0|||
16562976|NCT01474512|40525460|FG000|Long-Term Extension Period|Clinical Relapse|0|||
16562977|NCT01474512|40525461|FG001|Long-Term Extension Period|Clinical Relapse|0|||
16562978|NCT01474512|40525462|FG002|Long-Term Extension Period|Clinical Relapse|0|||
16562979|NCT01474512|40525463|FG003|Long-Term Extension Period|Clinical Relapse|0|||
16562980|NCT01474512|40525464|FG004|Long-Term Extension Period|Clinical Relapse|0|||
16562981|NCT01474512|40525465|FG005|Long-Term Extension Period|Clinical Relapse|0|||
16562982|NCT01474512|40525466|FG006|Long-Term Extension Period|Clinical Relapse|0|||
16562983|NCT01474512|40525467|FG007|Long-Term Extension Period|Clinical Relapse|0|||
16562984|NCT01474512|40525468|FG008|Long-Term Extension Period|Clinical Relapse|0|||
16562985|NCT01474512|40525469|FG009|Long-Term Extension Period|Clinical Relapse|0|||
16562986|NCT01474512|40525470|FG010|Long-Term Extension Period|Clinical Relapse|0|||
16562987|NCT01474512|40525471|FG011|Long-Term Extension Period|Clinical Relapse|0|||
16562988|NCT01474512|40525472|FG012|Long-Term Extension Period|Clinical Relapse|9|||
16131272|NCT03541174|38967262|FG004|Part 2 Single-Blind|Other reasons|0|||
16131273|NCT03541174|38967263|FG005|Part 2 Single-Blind|Other reasons|0|||
16131274|NCT03541174|38967258|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
16131275|NCT03541174|38967259|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
16131276|NCT03541174|38967260|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
16131277|NCT03541174|38967261|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
16131278|NCT03541174|38967262|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
16131279|NCT03541174|38967263|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
16131280|NCT03541174|38967258|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
16131281|NCT03541174|38967259|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
16131282|NCT03541174|38967260|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
16361004|NCT00922636|39807657|FG000|Overall Study|Adverse Event|3|||
16131283|NCT03541174|38967261|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
16361005|NCT00922636|39807658|FG001|Overall Study|Adverse Event|3|||
16361006|NCT00922636|39807659|FG002|Overall Study|Adverse Event|2|||
16361007|NCT00922636|39807660|FG003|Overall Study|Adverse Event|3|||
16361008|NCT00922636|39807661|FG004|Overall Study|Adverse Event|2|||
16361009|NCT00922636|39807657|FG000|Overall Study|Lack of Efficacy|1|||
16250419|NCT01405820|39400475|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
16250420|NCT01405820|39400476|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
16250421|NCT01405820|39400471|FG000|Randomized Treatment Period|Death|0|||
16250422|NCT01405820|39400472|FG001|Randomized Treatment Period|Death|0|||
16250423|NCT01405820|39400473|FG002|Randomized Treatment Period|Death|0|||
16250424|NCT01405820|39400474|FG003|Randomized Treatment Period|Death|1|||
16250425|NCT01405820|39400475|FG004|Randomized Treatment Period|Death|0|||
16250426|NCT01405820|39400476|FG005|Randomized Treatment Period|Death|0|||
16250427|NCT01405820|39400471|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
16250428|NCT01405820|39400472|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
16361010|NCT00922636|39807658|FG001|Overall Study|Lack of Efficacy|7|||
16361011|NCT00922636|39807659|FG002|Overall Study|Lack of Efficacy|3|||
16361012|NCT00922636|39807660|FG003|Overall Study|Lack of Efficacy|2|||
16429854|NCT00566852|40050679|FG000|Overall Study|Patient refusal|37|||
16429855|NCT00566852|40050680|FG001|Overall Study|Patient refusal|37|||
16429856|NCT00566852|40050679|FG000|Overall Study|Not tested due to disability|6|||
16429857|NCT00566852|40050680|FG001|Overall Study|Not tested due to disability|12|||
16429858|NCT00566852|40050679|FG000|Overall Study|Missing reason not specified|1|||
16429859|NCT00566852|40050680|FG001|Overall Study|Missing reason not specified|2|||
16429860|NCT00566852|40050679|FG000|Overall Study|Missing reason not reported|16|||
16429861|NCT00566852|40050680|FG001|Overall Study|Missing reason not reported|20|||
16429862|NCT00555672|40050681|FG000|Overall Study|Death|0|||
16429863|NCT00555672|40050682|FG001|Overall Study|Death|2|||
16429864|NCT00555672|40050681|FG000|Overall Study|Adverse Event|8|||
16429865|NCT00555672|40050682|FG001|Overall Study|Adverse Event|2|||
16429866|NCT00555672|40050681|FG000|Overall Study|Objective progression or relapse|11|||
16429867|NCT00555672|40050682|FG001|Overall Study|Objective progression or relapse|5|||
16429868|NCT00555672|40050681|FG000|Overall Study|Other|3|||
16429869|NCT00555672|40050682|FG001|Overall Study|Other|1|||
16429870|NCT00555672|40050681|FG000|Overall Study|Participant refused|2|||
16429871|NCT00555672|40050682|FG001|Overall Study|Participant refused|0|||
16429872|NCT00321464|40050683|FG000|Overall Study|Death|169|||
16429873|NCT00321464|40050684|FG001|Overall Study|Death|174|||
16429874|NCT00321464|40050683|FG000|Overall Study|Disease progression|124|||
16429875|NCT00321464|40050684|FG001|Overall Study|Disease progression|124|||
16429876|NCT00321464|40050683|FG000|Overall Study|Withdrawal by Subject|117|||
16429877|NCT00321464|40050684|FG001|Overall Study|Withdrawal by Subject|118|||
16429878|NCT00321464|40050683|FG000|Overall Study|Participant request|57|||
16429879|NCT00321464|40050684|FG001|Overall Study|Participant request|61|||
16429880|NCT00321464|40050683|FG000|Overall Study|Adverse Event|43|||
16429881|NCT00321464|40050684|FG001|Overall Study|Adverse Event|28|||
16429882|NCT00321464|40050683|FG000|Overall Study|Physician Decision|15|||
16429883|NCT00321464|40050684|FG001|Overall Study|Physician Decision|14|||
16429884|NCT00321464|40050683|FG000|Overall Study|Noncompliance|4|||
16429885|NCT00321464|40050684|FG001|Overall Study|Noncompliance|10|||
16429886|NCT00321464|40050683|FG000|Overall Study|Lost to Follow-up|7|||
16429887|NCT00321464|40050684|FG001|Overall Study|Lost to Follow-up|8|||
16429888|NCT00321464|40050683|FG000|Overall Study|Protocol deviation|0|||
16429889|NCT00321464|40050684|FG001|Overall Study|Protocol deviation|2|||
16429890|NCT00321464|40050683|FG000|Overall Study|Ineligibility determined|2|||
16429891|NCT00321464|40050684|FG001|Overall Study|Ineligibility determined|1|||
16429892|NCT00321464|40050683|FG000|Overall Study|Other|21|||
16429893|NCT00321464|40050684|FG001|Overall Study|Other|18|||
16429894|NCT01979952|40050687|FG000|Overall Study|Adverse Event|4|||
16429895|NCT01979952|40050688|FG001|Overall Study|Adverse Event|5|||
16429896|NCT01979952|40050687|FG000|Overall Study|Protocol Violation|1|||
16429897|NCT01979952|40050688|FG001|Overall Study|Protocol Violation|0|||
16429898|NCT01979952|40050687|FG000|Overall Study|Withdrawal by Subject|2|||
16429899|NCT01979952|40050688|FG001|Overall Study|Withdrawal by Subject|1|||
16429900|NCT01979952|40050687|FG000|Overall Study|Other than specified above|1|||
16429901|NCT01979952|40050688|FG001|Overall Study|Other than specified above|0|||
16429902|NCT02370420|40050689|FG000|Overall Study|Physician Decision|3|||
16429903|NCT02370420|40050690|FG001|Overall Study|Physician Decision|3|||
16429904|NCT02370420|40050689|FG000|Overall Study|Lost to Follow-up|11|||
16429905|NCT02370420|40050690|FG001|Overall Study|Lost to Follow-up|9|||
16429906|NCT00936702|40050691|FG000|Overall Study|Disease progression|34|||
16429907|NCT00936702|40050691|FG000|Overall Study|Adverse Event|8|||
16429908|NCT00936702|40050691|FG000|Overall Study|Withdrawal by Subject|2|||
16429909|NCT00936702|40050691|FG000|Overall Study|Alternative Treatment|1|||
16429910|NCT00936702|40050691|FG000|Overall Study|Other|1|||
16429911|NCT02698826|40050694|FG000|Overall Study|Death|13|||
16429912|NCT02698826|40050694|FG000|Overall Study|Adverse Event|1|||
16429913|NCT01625000|40050695|FG000|Overall Study|Physician Decision|15|||
16429914|NCT01625000|40050696|FG001|Overall Study|Physician Decision|7|||
16429915|NCT01625000|40050697|FG002|Overall Study|Physician Decision|7|||
16429916|NCT01625000|40050698|FG003|Overall Study|Physician Decision|2|||
16429917|NCT01625000|40050699|FG004|Overall Study|Physician Decision|15|||
16429918|NCT01625000|40050695|FG000|Overall Study|Protocol Violation|3|||
16429919|NCT01625000|40050696|FG001|Overall Study|Protocol Violation|10|||
16429920|NCT01625000|40050697|FG002|Overall Study|Protocol Violation|4|||
16429921|NCT01625000|40050698|FG003|Overall Study|Protocol Violation|1|||
16429922|NCT01625000|40050699|FG004|Overall Study|Protocol Violation|2|||
16429923|NCT01625000|40050695|FG000|Overall Study|Withdrawal by Subject|19|||
16429924|NCT01625000|40050696|FG001|Overall Study|Withdrawal by Subject|16|||
16429925|NCT01625000|40050697|FG002|Overall Study|Withdrawal by Subject|11|||
16429926|NCT01625000|40050698|FG003|Overall Study|Withdrawal by Subject|9|||
16429927|NCT01625000|40050699|FG004|Overall Study|Withdrawal by Subject|17|||
16429928|NCT01625000|40050695|FG000|Overall Study|Adverse Event (including Death)|15|||
16429929|NCT01625000|40050696|FG001|Overall Study|Adverse Event (including Death)|19|||
16429930|NCT01625000|40050697|FG002|Overall Study|Adverse Event (including Death)|11|||
16429931|NCT01625000|40050698|FG003|Overall Study|Adverse Event (including Death)|7|||
16429932|NCT01625000|40050699|FG004|Overall Study|Adverse Event (including Death)|21|||
16429933|NCT00726232|40053865|FG000|Initial Phase (Dose-finding)|Death|0|||
16429934|NCT00726232|40053866|FG001|Initial Phase (Dose-finding)|Death|0|||
16429935|NCT00726232|40053867|FG002|Initial Phase (Dose-finding)|Death|0|||
16429936|NCT00726232|40053868|FG003|Initial Phase (Dose-finding)|Death|0|||
16429937|NCT00726232|40053869|FG004|Initial Phase (Dose-finding)|Death|1|||
16429938|NCT00726232|40053870|FG005|Initial Phase (Dose-finding)|Death|0|||
16429939|NCT00726232|40053871|FG006|Initial Phase (Dose-finding)|Death|0|||
16429940|NCT00726232|40053872|FG007|Initial Phase (Dose-finding)|Death|0|||
16429941|NCT00726232|40053865|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
16429942|NCT00726232|40053866|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
16429943|NCT00726232|40053867|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
16429944|NCT00726232|40053868|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
16429945|NCT00726232|40053869|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
16429946|NCT00726232|40053870|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
16429947|NCT00726232|40053871|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
16429948|NCT00726232|40053872|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
16429949|NCT00726232|40053865|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
16429950|NCT00726232|40053866|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
16429951|NCT00726232|40053867|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
16429952|NCT00726232|40053868|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
16429953|NCT00726232|40053869|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
16429954|NCT00726232|40053870|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
16429955|NCT00726232|40053871|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
16429956|NCT00726232|40053872|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
16429957|NCT00726232|40053865|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
16429958|NCT00726232|40053866|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
16429959|NCT00726232|40053867|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
16429960|NCT00726232|40053868|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
16429961|NCT00726232|40053869|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
16429962|NCT00726232|40053870|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
16429963|NCT00726232|40053871|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
16429964|NCT00726232|40053872|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
16429965|NCT00726232|40053865|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
16429966|NCT00726232|40053866|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
16429967|NCT00726232|40053867|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
16429968|NCT00726232|40053868|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
16429969|NCT00726232|40053869|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
16429970|NCT00726232|40053870|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
16429971|NCT00726232|40053871|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
16429972|NCT00726232|40053872|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
16429973|NCT00726232|40053865|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
16429974|NCT00726232|40053866|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
16429975|NCT00726232|40053867|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
16429976|NCT00726232|40053868|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
16429977|NCT00726232|40053869|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
16429978|NCT00726232|40053870|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
16429979|NCT00726232|40053871|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
16429980|NCT00726232|40053872|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
16429981|NCT00726232|40053865|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
16429982|NCT00726232|40053866|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
16429983|NCT00726232|40053867|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
16429984|NCT00726232|40053868|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
16429985|NCT00726232|40053869|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
16429986|NCT00726232|40053870|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
16429987|NCT00726232|40053871|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
16429988|NCT00726232|40053872|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
16429989|NCT00726232|40053865|FG000|Expansion Phase|Death|0|||
16429990|NCT00726232|40053866|FG001|Expansion Phase|Death|0|||
16429991|NCT00726232|40053867|FG002|Expansion Phase|Death|0|||
16429992|NCT00726232|40053868|FG003|Expansion Phase|Death|0|||
16429993|NCT00726232|40053869|FG004|Expansion Phase|Death|0|||
16429994|NCT00726232|40053870|FG005|Expansion Phase|Death|0|||
16429995|NCT00726232|40053871|FG006|Expansion Phase|Death|0|||
16429996|NCT00726232|40053872|FG007|Expansion Phase|Death|1|||
16429997|NCT00726232|40053865|FG000|Expansion Phase|Adverse Event|0|||
16429998|NCT00726232|40053866|FG001|Expansion Phase|Adverse Event|0|||
16429999|NCT00726232|40053867|FG002|Expansion Phase|Adverse Event|0|||
16430000|NCT00726232|40053868|FG003|Expansion Phase|Adverse Event|0|||
16430001|NCT00726232|40053869|FG004|Expansion Phase|Adverse Event|0|||
16430002|NCT00726232|40053870|FG005|Expansion Phase|Adverse Event|0|||
16430003|NCT00726232|40053871|FG006|Expansion Phase|Adverse Event|6|||
16430004|NCT00726232|40053872|FG007|Expansion Phase|Adverse Event|11|||
16430005|NCT00726232|40053865|FG000|Expansion Phase|Withdrawal by Subject|0|||
16430006|NCT00726232|40053866|FG001|Expansion Phase|Withdrawal by Subject|0|||
16430007|NCT00726232|40053867|FG002|Expansion Phase|Withdrawal by Subject|0|||
16131284|NCT03541174|38967262|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
16131285|NCT03541174|38967263|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
16131286|NCT03541174|38967258|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
16131287|NCT03541174|38967259|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
16131288|NCT03541174|38967260|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
16131289|NCT03541174|38967261|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
16131290|NCT03541174|38967262|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
16131291|NCT03541174|38967263|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
16131292|NCT03541174|38967258|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
16131293|NCT03541174|38967259|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
16131294|NCT03541174|38967260|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
16131295|NCT03541174|38967261|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
16131296|NCT03541174|38967262|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
16131297|NCT03541174|38967263|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
16131298|NCT03541174|38967258|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
16430008|NCT00726232|40053868|FG003|Expansion Phase|Withdrawal by Subject|0|||
16430009|NCT00726232|40053869|FG004|Expansion Phase|Withdrawal by Subject|0|||
16430010|NCT00726232|40053870|FG005|Expansion Phase|Withdrawal by Subject|0|||
16430011|NCT00726232|40053871|FG006|Expansion Phase|Withdrawal by Subject|2|||
16430012|NCT00726232|40053872|FG007|Expansion Phase|Withdrawal by Subject|3|||
16562989|NCT01474512|40525473|FG013|Long-Term Extension Period|Clinical Relapse|9|||
16562990|NCT01474512|40525474|FG014|Long-Term Extension Period|Clinical Relapse|0|||
16562991|NCT01474512|40525475|FG015|Long-Term Extension Period|Clinical Relapse|0|||
16562992|NCT01474512|40525476|FG016|Long-Term Extension Period|Clinical Relapse|0|||
16562993|NCT01474512|40525477|FG017|Long-Term Extension Period|Clinical Relapse|0|||
16562994|NCT01474512|40525460|FG000|Long-Term Extension Period|Death|0|||
16562995|NCT01474512|40525461|FG001|Long-Term Extension Period|Death|0|||
16562996|NCT01474512|40525462|FG002|Long-Term Extension Period|Death|0|||
16562997|NCT01474512|40525463|FG003|Long-Term Extension Period|Death|0|||
16562998|NCT01474512|40525464|FG004|Long-Term Extension Period|Death|0|||
16562999|NCT01474512|40525465|FG005|Long-Term Extension Period|Death|0|||
16563000|NCT01474512|40525466|FG006|Long-Term Extension Period|Death|0|||
16563001|NCT01474512|40525467|FG007|Long-Term Extension Period|Death|0|||
16131299|NCT03541174|38967259|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
16361013|NCT00922636|39807661|FG004|Overall Study|Lack of Efficacy|4|||
16361014|NCT00922636|39807657|FG000|Overall Study|Sponsor Decision|0|||
16361015|NCT00922636|39807658|FG001|Overall Study|Sponsor Decision|0|||
16361016|NCT00922636|39807659|FG002|Overall Study|Sponsor Decision|2|||
16361017|NCT00922636|39807660|FG003|Overall Study|Sponsor Decision|0|||
16361018|NCT00922636|39807661|FG004|Overall Study|Sponsor Decision|0|||
16361019|NCT00922636|39807657|FG000|Overall Study|Withdrawal by Subject|0|||
16361020|NCT00922636|39807658|FG001|Overall Study|Withdrawal by Subject|0|||
16361021|NCT00922636|39807659|FG002|Overall Study|Withdrawal by Subject|5|||
16361022|NCT00922636|39807660|FG003|Overall Study|Withdrawal by Subject|2|||
16361023|NCT00922636|39807661|FG004|Overall Study|Withdrawal by Subject|4|||
16361024|NCT00922636|39807657|FG000|Overall Study|Protocol Violation|0|||
16361025|NCT00922636|39807658|FG001|Overall Study|Protocol Violation|0|||
16361026|NCT00922636|39807659|FG002|Overall Study|Protocol Violation|2|||
16361027|NCT00922636|39807660|FG003|Overall Study|Protocol Violation|2|||
16361028|NCT00922636|39807661|FG004|Overall Study|Protocol Violation|0|||
16361029|NCT00922636|39807657|FG000|Overall Study|Entry Criteria Not Met|0|||
16361030|NCT00922636|39807658|FG001|Overall Study|Entry Criteria Not Met|0|||
16361031|NCT00922636|39807659|FG002|Overall Study|Entry Criteria Not Met|1|||
16361032|NCT00922636|39807660|FG003|Overall Study|Entry Criteria Not Met|1|||
16361033|NCT00922636|39807661|FG004|Overall Study|Entry Criteria Not Met|0|||
16361034|NCT00922636|39807657|FG000|Overall Study|Parent/Caregiver Decision|2|||
16361035|NCT00922636|39807658|FG001|Overall Study|Parent/Caregiver Decision|4|||
16361036|NCT00922636|39807659|FG002|Overall Study|Parent/Caregiver Decision|3|||
16361037|NCT00922636|39807660|FG003|Overall Study|Parent/Caregiver Decision|5|||
16361038|NCT00922636|39807661|FG004|Overall Study|Parent/Caregiver Decision|2|||
16361039|NCT00922636|39807657|FG000|Overall Study|Lost to Follow-up|1|||
16361040|NCT00922636|39807658|FG001|Overall Study|Lost to Follow-up|2|||
16361041|NCT00922636|39807659|FG002|Overall Study|Lost to Follow-up|2|||
16430013|NCT00726232|40053865|FG000|Expansion Phase|Disease progression|0|||
16430014|NCT00726232|40053866|FG001|Expansion Phase|Disease progression|0|||
16430015|NCT00726232|40053867|FG002|Expansion Phase|Disease progression|0|||
16563002|NCT01474512|40525468|FG008|Long-Term Extension Period|Death|0|||
16250429|NCT01405820|39400473|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
16250430|NCT01405820|39400474|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
16250431|NCT01405820|39400475|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
16250432|NCT01405820|39400476|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
16250433|NCT01405820|39400471|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
16250434|NCT01405820|39400472|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
16250435|NCT01405820|39400473|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
16250436|NCT01405820|39400474|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
16250437|NCT01405820|39400475|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
16250438|NCT01405820|39400476|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
16250439|NCT01405820|39400471|FG000|Open-Label Treatment Period|Other|1|||
16250440|NCT01405820|39400472|FG001|Open-Label Treatment Period|Other|1|||
16250441|NCT01405820|39400473|FG002|Open-Label Treatment Period|Other|1|||
16250442|NCT01405820|39400474|FG003|Open-Label Treatment Period|Other|1|||
16250443|NCT01405820|39400475|FG004|Open-Label Treatment Period|Other|1|||
16250444|NCT01405820|39400476|FG005|Open-Label Treatment Period|Other|1|||
16250445|NCT01405820|39400471|FG000|Open-Label Treatment Period|Physician Decision|0|||
16250446|NCT01405820|39400472|FG001|Open-Label Treatment Period|Physician Decision|0|||
16250447|NCT01405820|39400473|FG002|Open-Label Treatment Period|Physician Decision|1|||
16250448|NCT01405820|39400474|FG003|Open-Label Treatment Period|Physician Decision|2|||
16250449|NCT01405820|39400475|FG004|Open-Label Treatment Period|Physician Decision|1|||
16250450|NCT01405820|39400476|FG005|Open-Label Treatment Period|Physician Decision|0|||
16250451|NCT01405820|39400471|FG000|Open-Label Treatment Period|Adverse Event|0|||
16250452|NCT01405820|39400472|FG001|Open-Label Treatment Period|Adverse Event|0|||
16250453|NCT01405820|39400473|FG002|Open-Label Treatment Period|Adverse Event|0|||
16250454|NCT01405820|39400474|FG003|Open-Label Treatment Period|Adverse Event|1|||
16250455|NCT01405820|39400475|FG004|Open-Label Treatment Period|Adverse Event|0|||
16250456|NCT01405820|39400476|FG005|Open-Label Treatment Period|Adverse Event|0|||
16250457|NCT02192905|39400478|FG000|Overall Study|Lost to Follow-up|1|||
16250458|NCT03066999|39400479|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
16250459|NCT03066999|39400480|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
16250460|NCT02637076|39400488|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
16250461|NCT02637076|39400489|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
16250462|NCT02637076|39400488|FG000|Overall Study|Withdrawal by Subject|0|||
16250463|NCT02637076|39400489|FG001|Overall Study|Withdrawal by Subject|4|||
16250464|NCT01432171|39400490|FG000|Overall Study|Death|1|||
16250465|NCT01432171|39400491|FG001|Overall Study|Death|2|||
16250466|NCT01432171|39400490|FG000|Overall Study|Lost to Follow-up|6|||
16250467|NCT01432171|39400491|FG001|Overall Study|Lost to Follow-up|5|||
16250468|NCT01432171|39400490|FG000|Overall Study|Withdrawal by Subject|3|||
16250469|NCT01432171|39400491|FG001|Overall Study|Withdrawal by Subject|1|||
16361042|NCT00922636|39807660|FG003|Overall Study|Lost to Follow-up|2|||
16361043|NCT00922636|39807661|FG004|Overall Study|Lost to Follow-up|4|||
16361044|NCT05166876|39807666|FG000|Overall Study|Withdrawal by Subject|1|||
16361045|NCT05166876|39807667|FG001|Overall Study|Withdrawal by Subject|0|||
16361046|NCT05166876|39807668|FG002|Overall Study|Withdrawal by Subject|0|||
16361047|NCT00855218|39807669|FG000|Overall Study|Adverse Event|43|||
16361048|NCT00855218|39807670|FG001|Overall Study|Adverse Event|27|||
16361049|NCT00855218|39807669|FG000|Overall Study|Withdrawal by Subject|10|||
16361050|NCT00855218|39807670|FG001|Overall Study|Withdrawal by Subject|6|||
16361051|NCT00855218|39807669|FG000|Overall Study|Physician Decision|18|||
16361052|NCT00855218|39807670|FG001|Overall Study|Physician Decision|11|||
16361053|NCT00855218|39807669|FG000|Overall Study|Lost to Follow-up|0|||
16361054|NCT00855218|39807670|FG001|Overall Study|Lost to Follow-up|1|||
16361055|NCT00855218|39807669|FG000|Overall Study|Protocol Violation|5|||
16361056|NCT00855218|39807670|FG001|Overall Study|Protocol Violation|9|||
16361057|NCT00855218|39807669|FG000|Overall Study|non-compliant with study drug|3|||
16361058|NCT00855218|39807670|FG001|Overall Study|non-compliant with study drug|1|||
16361059|NCT00855218|39807669|FG000|Overall Study|patient convenience|2|||
16361060|NCT00855218|39807670|FG001|Overall Study|patient convenience|0|||
16361061|NCT00855218|39807669|FG000|Overall Study|technical problems|2|||
16361062|NCT00855218|39807670|FG001|Overall Study|technical problems|1|||
16361063|NCT00855218|39807669|FG000|Overall Study|Still treated with study medication|0|||
16361064|NCT00855218|39807670|FG001|Overall Study|Still treated with study medication|1|||
16361065|NCT00855218|39807669|FG000|Overall Study|Untreatable disease progression|54|||
16361066|NCT00855218|39807670|FG001|Overall Study|Untreatable disease progression|67|||
16361067|NCT00855218|39807669|FG000|Overall Study|Second malignancy|0|||
16361068|NCT00855218|39807670|FG001|Overall Study|Second malignancy|1|||
16361069|NCT00855218|39807669|FG000|Overall Study|Progression measurement proven|7|||
16361070|NCT00855218|39807670|FG001|Overall Study|Progression measurement proven|15|||
16361071|NCT00855218|39807669|FG000|Overall Study|Clinical endpoint reached|10|||
16361072|NCT00855218|39807670|FG001|Overall Study|Clinical endpoint reached|13|||
16430016|NCT00726232|40053868|FG003|Expansion Phase|Disease progression|0|||
16430017|NCT00726232|40053869|FG004|Expansion Phase|Disease progression|0|||
16430018|NCT00726232|40053870|FG005|Expansion Phase|Disease progression|0|||
16430019|NCT00726232|40053871|FG006|Expansion Phase|Disease progression|4|||
16430020|NCT00726232|40053872|FG007|Expansion Phase|Disease progression|0|||
16430021|NCT00726232|40053865|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
16430022|NCT00726232|40053866|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
16430023|NCT00726232|40053867|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
16430024|NCT00726232|40053868|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
16430025|NCT00726232|40053869|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
16430026|NCT00726232|40053870|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
16430027|NCT00726232|40053871|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
16430028|NCT00726232|40053872|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
16430029|NCT00726232|40053865|FG000|Expansion Phase|Per Investigator: lack of response|0|||
16430030|NCT00726232|40053866|FG001|Expansion Phase|Per Investigator: lack of response|0|||
16430031|NCT00726232|40053867|FG002|Expansion Phase|Per Investigator: lack of response|0|||
16430032|NCT00726232|40053868|FG003|Expansion Phase|Per Investigator: lack of response|0|||
16430033|NCT00726232|40053869|FG004|Expansion Phase|Per Investigator: lack of response|0|||
16430034|NCT00726232|40053870|FG005|Expansion Phase|Per Investigator: lack of response|0|||
16430035|NCT00726232|40053871|FG006|Expansion Phase|Per Investigator: lack of response|1|||
16430036|NCT00726232|40053872|FG007|Expansion Phase|Per Investigator: lack of response|7|||
16430037|NCT00726232|40053865|FG000|Expansion Phase|Unspecified reason|0|||
16430038|NCT00726232|40053866|FG001|Expansion Phase|Unspecified reason|0|||
16430039|NCT00726232|40053867|FG002|Expansion Phase|Unspecified reason|0|||
16430040|NCT00726232|40053868|FG003|Expansion Phase|Unspecified reason|0|||
16430041|NCT00726232|40053869|FG004|Expansion Phase|Unspecified reason|0|||
16430042|NCT00726232|40053870|FG005|Expansion Phase|Unspecified reason|0|||
16430043|NCT00726232|40053871|FG006|Expansion Phase|Unspecified reason|1|||
16430044|NCT00726232|40053872|FG007|Expansion Phase|Unspecified reason|0|||
16430045|NCT04862065|40053873|FG000|Screening|Protocol Violation|54|||
16430046|NCT04862065|40053874|FG001|Screening|Protocol Violation|0|||
16430047|NCT04862065|40053875|FG002|Screening|Protocol Violation|0|||
16430048|NCT04862065|40053873|FG000|Screening|Insufficient Sample|1|||
16430049|NCT04862065|40053874|FG001|Screening|Insufficient Sample|0|||
16430050|NCT04862065|40053875|FG002|Screening|Insufficient Sample|0|||
16430051|NCT04862065|40053873|FG000|Follow-Up|Lost to Follow-up|3|||
16430052|NCT04862065|40053874|FG001|Follow-Up|Lost to Follow-up|0|||
16430053|NCT04862065|40053875|FG002|Follow-Up|Lost to Follow-up|0|||
16430054|NCT00785980|40053876|FG000|7 Day Washout Period|Protocol Violation|3|||
16430055|NCT00858208|40053877|FG000|Overall Study|Adverse Event|3|||
16430056|NCT00858208|40053877|FG000|Overall Study|Lost to Follow-up|26|||
16430057|NCT00858208|40053877|FG000|Overall Study|Participant refused|40|||
16430058|NCT00858208|40053877|FG000|Overall Study|Other|10|||
16430059|NCT01518374|40053878|FG000|Overall Study|Withdrawal by Subject|2|||
16430060|NCT01518374|40053878|FG000|Overall Study|Protocol Violation|3|||
16430061|NCT01518374|40053878|FG000|Overall Study|Lost to Follow-up|2|||
16430062|NCT00256724|40053879|FG000|Overall Study|Physician Decision|2|||
16430063|NCT00256724|40053880|FG001|Overall Study|Physician Decision|5|||
16430064|NCT00256724|40053879|FG000|Overall Study|Protocol Violation|3|||
16430065|NCT00256724|40053880|FG001|Overall Study|Protocol Violation|3|||
16430066|NCT00475709|40053881|FG000|Overall Study|Did not meet eligibility criteria|8|||
16430067|NCT00475709|40053881|FG000|Overall Study|Death|41|||
16430068|NCT00475709|40053881|FG000|Overall Study|Device Explant|6|||
16430069|NCT00475709|40053881|FG000|Overall Study|Lost to Follow-up|21|||
16430070|NCT03386721|40053882|FG000|Overall Study|Death|12|||
16430071|NCT03386721|40053883|FG001|Overall Study|Death|21|||
16430072|NCT03386721|40053884|FG002|Overall Study|Death|2|||
16430073|NCT03386721|40053885|FG003|Overall Study|Death|5|||
16430074|NCT03386721|40053886|FG004|Overall Study|Death|1|||
16430075|NCT03386721|40053887|FG005|Overall Study|Death|12|||
16430076|NCT03386721|40053888|FG006|Overall Study|Death|1|||
16430077|NCT03386721|40053889|FG007|Overall Study|Death|1|||
16430078|NCT03386721|40053890|FG008|Overall Study|Death|12|||
16430079|NCT03386721|40053891|FG009|Overall Study|Death|20|||
16430080|NCT03386721|40053892|FG010|Overall Study|Death|21|||
16430081|NCT03386721|40053893|FG011|Overall Study|Death|21|||
16430082|NCT03386721|40053894|FG012|Overall Study|Death|14|||
16430083|NCT03386721|40053895|FG013|Overall Study|Death|2|||
16430084|NCT03386721|40053896|FG014|Overall Study|Death|1|||
16430085|NCT03386721|40053882|FG000|Overall Study|Lost to Follow-up|1|||
16430086|NCT03386721|40053883|FG001|Overall Study|Lost to Follow-up|3|||
16430087|NCT03386721|40053884|FG002|Overall Study|Lost to Follow-up|0|||
16430088|NCT03386721|40053885|FG003|Overall Study|Lost to Follow-up|0|||
16430089|NCT03386721|40053886|FG004|Overall Study|Lost to Follow-up|0|||
16430090|NCT03386721|40053887|FG005|Overall Study|Lost to Follow-up|2|||
16430091|NCT03386721|40053888|FG006|Overall Study|Lost to Follow-up|1|||
16430092|NCT03386721|40053889|FG007|Overall Study|Lost to Follow-up|0|||
16430093|NCT03386721|40053890|FG008|Overall Study|Lost to Follow-up|1|||
16430094|NCT03386721|40053891|FG009|Overall Study|Lost to Follow-up|2|||
16430095|NCT03386721|40053892|FG010|Overall Study|Lost to Follow-up|1|||
16430096|NCT03386721|40053893|FG011|Overall Study|Lost to Follow-up|0|||
16430097|NCT03386721|40053894|FG012|Overall Study|Lost to Follow-up|0|||
16430098|NCT03386721|40053895|FG013|Overall Study|Lost to Follow-up|0|||
16430099|NCT03386721|40053896|FG014|Overall Study|Lost to Follow-up|0|||
16430100|NCT03386721|40053882|FG000|Overall Study|Reason not specified|3|||
16430101|NCT03386721|40053883|FG001|Overall Study|Reason not specified|0|||
16430102|NCT03386721|40053884|FG002|Overall Study|Reason not specified|0|||
16430103|NCT03386721|40053885|FG003|Overall Study|Reason not specified|0|||
16430104|NCT03386721|40053886|FG004|Overall Study|Reason not specified|0|||
16430105|NCT03386721|40053887|FG005|Overall Study|Reason not specified|3|||
16430106|NCT03386721|40053888|FG006|Overall Study|Reason not specified|1|||
16430107|NCT03386721|40053889|FG007|Overall Study|Reason not specified|0|||
16430108|NCT03386721|40053890|FG008|Overall Study|Reason not specified|0|||
16430109|NCT03386721|40053891|FG009|Overall Study|Reason not specified|1|||
16430110|NCT03386721|40053892|FG010|Overall Study|Reason not specified|2|||
16430111|NCT03386721|40053893|FG011|Overall Study|Reason not specified|6|||
16430112|NCT03386721|40053894|FG012|Overall Study|Reason not specified|1|||
16430113|NCT03386721|40053895|FG013|Overall Study|Reason not specified|0|||
16430114|NCT03386721|40053896|FG014|Overall Study|Reason not specified|0|||
16430115|NCT03386721|40053882|FG000|Overall Study|Progressive Disease|0|||
16430116|NCT03386721|40053883|FG001|Overall Study|Progressive Disease|0|||
16430117|NCT03386721|40053884|FG002|Overall Study|Progressive Disease|1|||
16430118|NCT03386721|40053885|FG003|Overall Study|Progressive Disease|0|||
16430119|NCT03386721|40053886|FG004|Overall Study|Progressive Disease|0|||
16430120|NCT03386721|40053887|FG005|Overall Study|Progressive Disease|1|||
16430121|NCT03386721|40053888|FG006|Overall Study|Progressive Disease|0|||
16430122|NCT03386721|40053889|FG007|Overall Study|Progressive Disease|0|||
16430123|NCT03386721|40053890|FG008|Overall Study|Progressive Disease|2|||
16430124|NCT03386721|40053891|FG009|Overall Study|Progressive Disease|1|||
16430125|NCT03386721|40053892|FG010|Overall Study|Progressive Disease|1|||
16430126|NCT03386721|40053893|FG011|Overall Study|Progressive Disease|0|||
16430127|NCT03386721|40053894|FG012|Overall Study|Progressive Disease|1|||
16430128|NCT03386721|40053895|FG013|Overall Study|Progressive Disease|0|||
16430129|NCT03386721|40053896|FG014|Overall Study|Progressive Disease|0|||
16430130|NCT03386721|40053882|FG000|Overall Study|Site Terminated by Sponsor|5|||
16430131|NCT03386721|40053883|FG001|Overall Study|Site Terminated by Sponsor|5|||
16430132|NCT03386721|40053884|FG002|Overall Study|Site Terminated by Sponsor|0|||
16430133|NCT03386721|40053885|FG003|Overall Study|Site Terminated by Sponsor|0|||
16430134|NCT03386721|40053886|FG004|Overall Study|Site Terminated by Sponsor|1|||
16430135|NCT03386721|40053887|FG005|Overall Study|Site Terminated by Sponsor|3|||
16430136|NCT03386721|40053888|FG006|Overall Study|Site Terminated by Sponsor|0|||
16430137|NCT03386721|40053889|FG007|Overall Study|Site Terminated by Sponsor|1|||
16430138|NCT03386721|40053890|FG008|Overall Study|Site Terminated by Sponsor|4|||
16430139|NCT03386721|40053891|FG009|Overall Study|Site Terminated by Sponsor|5|||
16430140|NCT03386721|40053892|FG010|Overall Study|Site Terminated by Sponsor|3|||
16430141|NCT03386721|40053893|FG011|Overall Study|Site Terminated by Sponsor|11|||
16430142|NCT03386721|40053894|FG012|Overall Study|Site Terminated by Sponsor|6|||
16430143|NCT03386721|40053895|FG013|Overall Study|Site Terminated by Sponsor|0|||
16430144|NCT03386721|40053896|FG014|Overall Study|Site Terminated by Sponsor|0|||
16430145|NCT03386721|40053882|FG000|Overall Study|Symptomatic Deterioration|0|||
16430146|NCT03386721|40053883|FG001|Overall Study|Symptomatic Deterioration|0|||
16430147|NCT03386721|40053884|FG002|Overall Study|Symptomatic Deterioration|0|||
16430148|NCT03386721|40053885|FG003|Overall Study|Symptomatic Deterioration|0|||
16430149|NCT03386721|40053886|FG004|Overall Study|Symptomatic Deterioration|0|||
16430150|NCT03386721|40053887|FG005|Overall Study|Symptomatic Deterioration|0|||
16430151|NCT03386721|40053888|FG006|Overall Study|Symptomatic Deterioration|0|||
16430152|NCT03386721|40053889|FG007|Overall Study|Symptomatic Deterioration|0|||
16430153|NCT03386721|40053890|FG008|Overall Study|Symptomatic Deterioration|1|||
16430154|NCT03386721|40053891|FG009|Overall Study|Symptomatic Deterioration|0|||
16430155|NCT03386721|40053892|FG010|Overall Study|Symptomatic Deterioration|0|||
16430156|NCT03386721|40053893|FG011|Overall Study|Symptomatic Deterioration|1|||
16430157|NCT03386721|40053894|FG012|Overall Study|Symptomatic Deterioration|0|||
16430158|NCT03386721|40053895|FG013|Overall Study|Symptomatic Deterioration|0|||
16430159|NCT03386721|40053896|FG014|Overall Study|Symptomatic Deterioration|0|||
16430160|NCT03386721|40053882|FG000|Overall Study|Withdrawal by Subject|1|||
16430161|NCT03386721|40053883|FG001|Overall Study|Withdrawal by Subject|2|||
16430162|NCT03386721|40053884|FG002|Overall Study|Withdrawal by Subject|0|||
16430163|NCT03386721|40053885|FG003|Overall Study|Withdrawal by Subject|0|||
16430164|NCT03386721|40053886|FG004|Overall Study|Withdrawal by Subject|0|||
16430165|NCT03386721|40053887|FG005|Overall Study|Withdrawal by Subject|0|||
16430166|NCT03386721|40053888|FG006|Overall Study|Withdrawal by Subject|0|||
16430167|NCT03386721|40053889|FG007|Overall Study|Withdrawal by Subject|0|||
16430168|NCT03386721|40053890|FG008|Overall Study|Withdrawal by Subject|2|||
16430169|NCT03386721|40053891|FG009|Overall Study|Withdrawal by Subject|1|||
16430170|NCT03386721|40053892|FG010|Overall Study|Withdrawal by Subject|3|||
16430171|NCT03386721|40053893|FG011|Overall Study|Withdrawal by Subject|2|||
16430172|NCT03386721|40053894|FG012|Overall Study|Withdrawal by Subject|3|||
16430173|NCT03386721|40053895|FG013|Overall Study|Withdrawal by Subject|0|||
16430174|NCT03386721|40053896|FG014|Overall Study|Withdrawal by Subject|0|||
16430175|NCT01525615|40053898|FG000|Overall Study|Adverse Event|11|||
16430176|NCT01525615|40053899|FG001|Overall Study|Adverse Event|7|||
16430177|NCT01525615|40053900|FG002|Overall Study|Adverse Event|5|||
16430178|NCT01525615|40053898|FG000|Overall Study|Lost to Follow-up|1|||
16430179|NCT01525615|40053899|FG001|Overall Study|Lost to Follow-up|0|||
16430180|NCT01525615|40053900|FG002|Overall Study|Lost to Follow-up|0|||
16430181|NCT01525615|40053898|FG000|Overall Study|Withdrawal by Subject|1|||
16430182|NCT01525615|40053899|FG001|Overall Study|Withdrawal by Subject|0|||
16430183|NCT01525615|40053900|FG002|Overall Study|Withdrawal by Subject|0|||
16430184|NCT01525615|40053898|FG000|Overall Study|Other reason not described above|1|||
16430185|NCT01525615|40053899|FG001|Overall Study|Other reason not described above|0|||
16430186|NCT01525615|40053900|FG002|Overall Study|Other reason not described above|1|||
16430187|NCT00619515|40053901|FG000|Overall Study|Study Termination by IRB|73|||
16430188|NCT01774799|40053902|FG000|Overall Study|Lost to Follow-up|1|||
16430189|NCT01774799|40053903|FG001|Overall Study|Lost to Follow-up|1|||
16430190|NCT01774799|40053904|FG002|Overall Study|Lost to Follow-up|0|||
16430191|NCT01774799|40053905|FG003|Overall Study|Lost to Follow-up|0|||
16430192|NCT01008943|40053906|FG000|Overall Study|Withdrawal by Subject|1|||
16430193|NCT00894361|40053907|FG000|Overall Study|deaths and less than 2 years followup|24|||
16430194|NCT00894361|40053908|FG001|Overall Study|deaths and less than 2 years followup|64|||
16430195|NCT03018691|40053911|FG000|Overall Study|Adverse Event|1|||
16430196|NCT03018691|40053912|FG001|Overall Study|Adverse Event|1|||
16430197|NCT03018691|40053913|FG002|Overall Study|Adverse Event|4|||
16430198|NCT03018691|40053911|FG000|Overall Study|Lack of Efficacy|0|||
16430199|NCT03018691|40053912|FG001|Overall Study|Lack of Efficacy|0|||
16430200|NCT03018691|40053913|FG002|Overall Study|Lack of Efficacy|1|||
16430201|NCT03018691|40053911|FG000|Overall Study|Withdrawal by Subject|0|||
16430202|NCT03018691|40053912|FG001|Overall Study|Withdrawal by Subject|0|||
16430203|NCT03018691|40053913|FG002|Overall Study|Withdrawal by Subject|1|||
16430204|NCT03018691|40053911|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16430205|NCT03018691|40053912|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16430206|NCT03018691|40053913|FG002|Overall Study|Withdrawal by parent/guardian|1|||
16430207|NCT00567359|40053918|FG000|Overall Study|Withdrawal by Subject|1|||
16430208|NCT00577824|40053925|FG000|Overall Study|Adverse Event|6|||
16430209|NCT00577824|40053926|FG001|Overall Study|Adverse Event|18|||
16430210|NCT00577824|40053927|FG002|Overall Study|Adverse Event|1|||
16430211|NCT00577824|40053925|FG000|Overall Study|Patient decision|0|||
16430212|NCT00577824|40053926|FG001|Overall Study|Patient decision|1|||
16563003|NCT01474512|40525469|FG009|Long-Term Extension Period|Death|0|||
16563004|NCT01474512|40525470|FG010|Long-Term Extension Period|Death|0|||
16563005|NCT01474512|40525471|FG011|Long-Term Extension Period|Death|0|||
16563006|NCT01474512|40525472|FG012|Long-Term Extension Period|Death|9|||
16563007|NCT01474512|40525473|FG013|Long-Term Extension Period|Death|9|||
16563008|NCT01474512|40525474|FG014|Long-Term Extension Period|Death|0|||
16563009|NCT01474512|40525475|FG015|Long-Term Extension Period|Death|0|||
16563010|NCT01474512|40525476|FG016|Long-Term Extension Period|Death|0|||
16563011|NCT01474512|40525477|FG017|Long-Term Extension Period|Death|0|||
16563012|NCT01474512|40525460|FG000|Long-Term Extension Period|Sponsor Decision|0|||
16563013|NCT01474512|40525461|FG001|Long-Term Extension Period|Sponsor Decision|0|||
16563014|NCT01474512|40525462|FG002|Long-Term Extension Period|Sponsor Decision|0|||
16563015|NCT01474512|40525463|FG003|Long-Term Extension Period|Sponsor Decision|0|||
16563016|NCT01474512|40525464|FG004|Long-Term Extension Period|Sponsor Decision|0|||
16563017|NCT01474512|40525465|FG005|Long-Term Extension Period|Sponsor Decision|0|||
16563018|NCT01474512|40525466|FG006|Long-Term Extension Period|Sponsor Decision|0|||
16563019|NCT01474512|40525467|FG007|Long-Term Extension Period|Sponsor Decision|0|||
16563020|NCT01474512|40525468|FG008|Long-Term Extension Period|Sponsor Decision|0|||
16563021|NCT01474512|40525469|FG009|Long-Term Extension Period|Sponsor Decision|0|||
16563022|NCT01474512|40525470|FG010|Long-Term Extension Period|Sponsor Decision|0|||
16563023|NCT01474512|40525471|FG011|Long-Term Extension Period|Sponsor Decision|0|||
16563024|NCT01474512|40525472|FG012|Long-Term Extension Period|Sponsor Decision|6|||
16563025|NCT01474512|40525473|FG013|Long-Term Extension Period|Sponsor Decision|6|||
16430213|NCT00577824|40053927|FG002|Overall Study|Patient decision|1|||
16430214|NCT00577824|40053925|FG000|Overall Study|Protocol Violation|1|||
16430215|NCT00577824|40053926|FG001|Overall Study|Protocol Violation|1|||
16430216|NCT00577824|40053927|FG002|Overall Study|Protocol Violation|0|||
16430217|NCT01132313|40053928|FG000|Overall Study|Lack of Efficacy|1|||
16430218|NCT01132313|40053929|FG001|Overall Study|Lack of Efficacy|0|||
16430219|NCT01132313|40053930|FG002|Overall Study|Lack of Efficacy|0|||
16430220|NCT01132313|40053931|FG003|Overall Study|Lack of Efficacy|0|||
16563026|NCT01474512|40525474|FG014|Long-Term Extension Period|Sponsor Decision|0|||
16563027|NCT01474512|40525475|FG015|Long-Term Extension Period|Sponsor Decision|0|||
16430221|NCT01132313|40053932|FG004|Overall Study|Lack of Efficacy|0|||
16430222|NCT01132313|40053933|FG005|Overall Study|Lack of Efficacy|0|||
16430223|NCT01132313|40053934|FG006|Overall Study|Lack of Efficacy|0|||
16430224|NCT01132313|40053935|FG007|Overall Study|Lack of Efficacy|3|||
16430225|NCT01132313|40053936|FG008|Overall Study|Lack of Efficacy|14|||
16430226|NCT01132313|40053937|FG009|Overall Study|Lack of Efficacy|16|||
16430227|NCT01132313|40053938|FG010|Overall Study|Lack of Efficacy|0|||
16430228|NCT01132313|40053939|FG011|Overall Study|Lack of Efficacy|0|||
16430229|NCT01132313|40053928|FG000|Overall Study|Not treated|2|||
16430230|NCT01132313|40053929|FG001|Overall Study|Not treated|0|||
16430231|NCT01132313|40053930|FG002|Overall Study|Not treated|0|||
16430232|NCT01132313|40053931|FG003|Overall Study|Not treated|0|||
16430233|NCT01132313|40053932|FG004|Overall Study|Not treated|2|||
16430234|NCT01132313|40053933|FG005|Overall Study|Not treated|1|||
16430235|NCT01132313|40053934|FG006|Overall Study|Not treated|3|||
16430236|NCT01132313|40053935|FG007|Overall Study|Not treated|0|||
16430237|NCT01132313|40053936|FG008|Overall Study|Not treated|0|||
16430238|NCT01132313|40053937|FG009|Overall Study|Not treated|0|||
16430239|NCT01132313|40053938|FG010|Overall Study|Not treated|0|||
16430240|NCT01132313|40053939|FG011|Overall Study|Not treated|0|||
16430241|NCT01132313|40053928|FG000|Overall Study|Adverse Event|0|||
16430242|NCT01132313|40053929|FG001|Overall Study|Adverse Event|0|||
16430243|NCT01132313|40053930|FG002|Overall Study|Adverse Event|4|||
16563028|NCT01474512|40525476|FG016|Long-Term Extension Period|Sponsor Decision|0|||
16563029|NCT01474512|40525477|FG017|Long-Term Extension Period|Sponsor Decision|0|||
16563030|NCT01474512|40525460|FG000|Long-Term Extension Period|Protocol Violation|0|||
16563031|NCT01474512|40525461|FG001|Long-Term Extension Period|Protocol Violation|0|||
16563032|NCT01474512|40525462|FG002|Long-Term Extension Period|Protocol Violation|0|||
16563033|NCT01474512|40525463|FG003|Long-Term Extension Period|Protocol Violation|0|||
16563034|NCT01474512|40525464|FG004|Long-Term Extension Period|Protocol Violation|0|||
16563035|NCT01474512|40525465|FG005|Long-Term Extension Period|Protocol Violation|0|||
16563036|NCT01474512|40525466|FG006|Long-Term Extension Period|Protocol Violation|0|||
16563037|NCT01474512|40525467|FG007|Long-Term Extension Period|Protocol Violation|0|||
16563038|NCT01474512|40525468|FG008|Long-Term Extension Period|Protocol Violation|0|||
16563039|NCT01474512|40525469|FG009|Long-Term Extension Period|Protocol Violation|0|||
16563040|NCT01474512|40525470|FG010|Long-Term Extension Period|Protocol Violation|0|||
16563041|NCT01474512|40525471|FG011|Long-Term Extension Period|Protocol Violation|0|||
16563042|NCT01474512|40525472|FG012|Long-Term Extension Period|Protocol Violation|5|||
16563043|NCT01474512|40525473|FG013|Long-Term Extension Period|Protocol Violation|5|||
16563044|NCT01474512|40525474|FG014|Long-Term Extension Period|Protocol Violation|0|||
16563045|NCT01474512|40525475|FG015|Long-Term Extension Period|Protocol Violation|0|||
16563046|NCT01474512|40525476|FG016|Long-Term Extension Period|Protocol Violation|0|||
16563047|NCT01474512|40525477|FG017|Long-Term Extension Period|Protocol Violation|0|||
16563048|NCT01474512|40525460|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563049|NCT01474512|40525461|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563050|NCT01474512|40525462|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563051|NCT01474512|40525463|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563052|NCT01474512|40525464|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563053|NCT01474512|40525465|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563054|NCT01474512|40525466|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563055|NCT01474512|40525467|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563056|NCT01474512|40525468|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563057|NCT01474512|40525469|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563058|NCT01474512|40525470|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563059|NCT01474512|40525471|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563060|NCT01474512|40525472|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
16563061|NCT01474512|40525473|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
16563062|NCT01474512|40525474|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563063|NCT01474512|40525475|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563064|NCT01474512|40525476|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16563065|NCT01474512|40525477|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
16131300|NCT03541174|38967260|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
16131301|NCT03541174|38967261|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
16131302|NCT03541174|38967262|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
16250470|NCT01432171|39400490|FG000|Overall Study|Noncompliance|2|||
16250471|NCT01432171|39400491|FG001|Overall Study|Noncompliance|3|||
16250472|NCT01432171|39400490|FG000|Overall Study|Insurance denial trial coverage|1|||
16430244|NCT01132313|40053931|FG003|Overall Study|Adverse Event|10|||
16430245|NCT01132313|40053932|FG004|Overall Study|Adverse Event|19|||
16430246|NCT01132313|40053933|FG005|Overall Study|Adverse Event|6|||
16430247|NCT01132313|40053934|FG006|Overall Study|Adverse Event|5|||
16430248|NCT01132313|40053935|FG007|Overall Study|Adverse Event|3|||
16430249|NCT01132313|40053936|FG008|Overall Study|Adverse Event|7|||
16131303|NCT03541174|38967263|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
16430250|NCT01132313|40053937|FG009|Overall Study|Adverse Event|2|||
16563066|NCT01474512|40525460|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563067|NCT01474512|40525461|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563068|NCT01474512|40525462|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563069|NCT01474512|40525463|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563070|NCT01474512|40525464|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563071|NCT01474512|40525465|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563072|NCT01474512|40525466|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563073|NCT01474512|40525467|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563074|NCT01474512|40525468|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563075|NCT01474512|40525469|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563076|NCT01474512|40525470|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563077|NCT01474512|40525471|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
16563078|NCT01474512|40525472|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563079|NCT01474512|40525473|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563080|NCT01474512|40525474|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563081|NCT01474512|40525475|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563082|NCT01474512|40525476|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563083|NCT01474512|40525477|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
16563084|NCT01474512|40525460|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
16563085|NCT01474512|40525461|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
16563086|NCT01474512|40525462|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
16563087|NCT01474512|40525463|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
16563088|NCT01474512|40525464|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
16563089|NCT01474512|40525465|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
16563090|NCT01474512|40525466|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
16563091|NCT01474512|40525467|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
16563092|NCT01474512|40525468|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
16563093|NCT01474512|40525469|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
16563094|NCT01474512|40525470|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
16563095|NCT01474512|40525471|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
16563096|NCT01474512|40525472|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
16563097|NCT01474512|40525473|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
16563098|NCT01474512|40525474|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
16563099|NCT01474512|40525475|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
16563100|NCT01474512|40525476|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
16563101|NCT01474512|40525477|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
16563102|NCT01474512|40525460|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563103|NCT01474512|40525461|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563104|NCT01474512|40525462|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563105|NCT01474512|40525463|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563106|NCT01474512|40525464|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563107|NCT01474512|40525465|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563108|NCT01474512|40525466|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563109|NCT01474512|40525467|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563110|NCT01474512|40525468|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563111|NCT01474512|40525469|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563112|NCT01474512|40525470|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563113|NCT01474512|40525471|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563114|NCT01474512|40525472|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563115|NCT01474512|40525473|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
16563116|NCT01474512|40525474|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
16563117|NCT01474512|40525475|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
16563118|NCT01474512|40525476|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
16563119|NCT01474512|40525477|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
16563120|NCT01474512|40525460|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563121|NCT01474512|40525461|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563122|NCT01474512|40525462|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563123|NCT01474512|40525463|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16430251|NCT01132313|40053938|FG010|Overall Study|Adverse Event|0|||
16430252|NCT01132313|40053939|FG011|Overall Study|Adverse Event|0|||
16430253|NCT01132313|40053928|FG000|Overall Study|Protocol Violation|0|||
16430254|NCT01132313|40053929|FG001|Overall Study|Protocol Violation|0|||
16430255|NCT01132313|40053930|FG002|Overall Study|Protocol Violation|0|||
16430256|NCT01132313|40053931|FG003|Overall Study|Protocol Violation|1|||
16430257|NCT01132313|40053932|FG004|Overall Study|Protocol Violation|0|||
16131304|NCT02224690|38967264|FG000|Overall Study|Adverse Event|8|||
16131305|NCT02224690|38967265|FG001|Overall Study|Adverse Event|1|||
16430258|NCT01132313|40053933|FG005|Overall Study|Protocol Violation|0|||
16430259|NCT01132313|40053934|FG006|Overall Study|Protocol Violation|0|||
16430260|NCT01132313|40053935|FG007|Overall Study|Protocol Violation|0|||
16563124|NCT01474512|40525464|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563125|NCT01474512|40525465|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563126|NCT01474512|40525466|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563127|NCT01474512|40525467|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563128|NCT01474512|40525468|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563129|NCT01474512|40525469|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563130|NCT01474512|40525470|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563131|NCT01474512|40525471|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563132|NCT01474512|40525472|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563133|NCT01474512|40525473|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
16563134|NCT01474512|40525474|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
16563135|NCT01474512|40525475|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
16563136|NCT01474512|40525476|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
16563137|NCT01474512|40525477|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
16563138|NCT01474512|40525460|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563139|NCT01474512|40525461|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563140|NCT01474512|40525462|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563141|NCT01474512|40525463|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563142|NCT01474512|40525464|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563143|NCT01474512|40525465|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563144|NCT01474512|40525466|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563145|NCT01474512|40525467|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563146|NCT01474512|40525468|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563147|NCT01474512|40525469|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563148|NCT01474512|40525470|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563149|NCT01474512|40525471|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563150|NCT01474512|40525472|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563151|NCT01474512|40525473|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16361073|NCT03738215|39807675|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
16361074|NCT03738215|39807676|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
16361075|NCT03738215|39807677|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
16361076|NCT03738215|39807675|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
16361077|NCT03738215|39807676|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
16361078|NCT03738215|39807677|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
16361079|NCT03738215|39807675|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
16430261|NCT01132313|40053936|FG008|Overall Study|Protocol Violation|0|||
16430262|NCT01132313|40053937|FG009|Overall Study|Protocol Violation|0|||
16430263|NCT01132313|40053938|FG010|Overall Study|Protocol Violation|0|||
16430264|NCT01132313|40053939|FG011|Overall Study|Protocol Violation|0|||
16430265|NCT01132313|40053928|FG000|Overall Study|Lost to Follow-up|0|||
16430266|NCT01132313|40053929|FG001|Overall Study|Lost to Follow-up|0|||
16430267|NCT01132313|40053930|FG002|Overall Study|Lost to Follow-up|1|||
16430268|NCT01132313|40053931|FG003|Overall Study|Lost to Follow-up|0|||
16430269|NCT01132313|40053932|FG004|Overall Study|Lost to Follow-up|0|||
16430270|NCT01132313|40053933|FG005|Overall Study|Lost to Follow-up|0|||
16430271|NCT01132313|40053934|FG006|Overall Study|Lost to Follow-up|0|||
16430272|NCT01132313|40053935|FG007|Overall Study|Lost to Follow-up|1|||
16430273|NCT01132313|40053936|FG008|Overall Study|Lost to Follow-up|0|||
16430274|NCT01132313|40053937|FG009|Overall Study|Lost to Follow-up|0|||
16430275|NCT01132313|40053938|FG010|Overall Study|Lost to Follow-up|0|||
16430276|NCT01132313|40053939|FG011|Overall Study|Lost to Follow-up|0|||
16430277|NCT01132313|40053928|FG000|Overall Study|Withdrawal by Subject|0|||
16430278|NCT01132313|40053929|FG001|Overall Study|Withdrawal by Subject|0|||
16430279|NCT01132313|40053930|FG002|Overall Study|Withdrawal by Subject|3|||
16430280|NCT01132313|40053931|FG003|Overall Study|Withdrawal by Subject|3|||
16430281|NCT01132313|40053932|FG004|Overall Study|Withdrawal by Subject|6|||
16430282|NCT01132313|40053933|FG005|Overall Study|Withdrawal by Subject|0|||
16430283|NCT01132313|40053934|FG006|Overall Study|Withdrawal by Subject|1|||
16430284|NCT01132313|40053935|FG007|Overall Study|Withdrawal by Subject|0|||
16563152|NCT01474512|40525474|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563153|NCT01474512|40525475|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
16563154|NCT01474512|40525476|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
16361080|NCT03738215|39807676|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
16361081|NCT03738215|39807677|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
16361082|NCT03738215|39807675|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
16361083|NCT03738215|39807676|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
16361084|NCT03738215|39807677|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
16361085|NCT03738215|39807675|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
16361086|NCT03738215|39807676|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
16430285|NCT01132313|40053936|FG008|Overall Study|Withdrawal by Subject|0|||
16430286|NCT01132313|40053937|FG009|Overall Study|Withdrawal by Subject|2|||
16430287|NCT01132313|40053938|FG010|Overall Study|Withdrawal by Subject|0|||
16563155|NCT01474512|40525477|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
16563156|NCT01474512|40525460|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
16563157|NCT01474512|40525461|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
16563158|NCT01474512|40525462|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
16563159|NCT01474512|40525463|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
16563160|NCT01474512|40525464|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
16563161|NCT01474512|40525465|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
16563162|NCT01474512|40525466|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
16563163|NCT01474512|40525467|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
16563164|NCT01474512|40525468|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
16563165|NCT01474512|40525469|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
16563166|NCT01474512|40525470|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
16563167|NCT01474512|40525471|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
16563168|NCT01474512|40525472|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
16563169|NCT01474512|40525473|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
16563170|NCT01474512|40525474|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
16563171|NCT01474512|40525475|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
16563172|NCT01474512|40525476|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
16563173|NCT01474512|40525477|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
16563174|NCT01474512|40525460|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563175|NCT01474512|40525461|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563176|NCT01474512|40525462|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563177|NCT01474512|40525463|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563178|NCT01474512|40525464|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563179|NCT01474512|40525465|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563180|NCT01474512|40525466|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563181|NCT01474512|40525467|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563182|NCT01474512|40525468|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563183|NCT01474512|40525469|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563184|NCT01474512|40525470|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563185|NCT01474512|40525471|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563186|NCT01474512|40525472|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563187|NCT01474512|40525473|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563188|NCT01474512|40525474|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563189|NCT01474512|40525475|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
16563190|NCT01474512|40525476|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
16563191|NCT01474512|40525477|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
16563192|NCT01474512|40525460|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
16563193|NCT01474512|40525461|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
16563194|NCT01474512|40525462|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
16563195|NCT01474512|40525463|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
16563196|NCT01474512|40525464|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
16563197|NCT01474512|40525465|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
16563198|NCT01474512|40525466|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
16563199|NCT01474512|40525467|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
16563200|NCT01474512|40525468|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
16563201|NCT01474512|40525469|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
16563202|NCT01474512|40525470|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
16563203|NCT01474512|40525471|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
16563204|NCT01474512|40525472|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
16563205|NCT01474512|40525473|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
16563206|NCT01474512|40525474|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
16563207|NCT01474512|40525475|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
16563208|NCT01474512|40525476|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
16563209|NCT01474512|40525477|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
16563210|NCT01474512|40525460|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563211|NCT01474512|40525461|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563212|NCT01474512|40525462|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563213|NCT01474512|40525463|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563214|NCT01474512|40525464|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563215|NCT01474512|40525465|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563216|NCT01474512|40525466|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563217|NCT01474512|40525467|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563218|NCT01474512|40525468|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563219|NCT01474512|40525469|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563220|NCT01474512|40525470|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563221|NCT01474512|40525471|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563222|NCT01474512|40525472|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563223|NCT01474512|40525473|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563224|NCT01474512|40525474|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
16563225|NCT01474512|40525475|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563226|NCT01474512|40525476|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
16563227|NCT01474512|40525477|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
16563228|NCT01474512|40525460|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563229|NCT01474512|40525461|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563230|NCT01474512|40525462|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563231|NCT01474512|40525463|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563232|NCT01474512|40525464|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563233|NCT01474512|40525465|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563234|NCT01474512|40525466|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563235|NCT01474512|40525467|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563236|NCT01474512|40525468|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563237|NCT01474512|40525469|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563238|NCT01474512|40525470|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563239|NCT01474512|40525471|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563240|NCT01474512|40525472|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16361087|NCT03738215|39807677|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
16361088|NCT03738215|39807675|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
16361089|NCT03738215|39807676|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
16361090|NCT03738215|39807677|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
16361091|NCT03738215|39807675|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
16361092|NCT03738215|39807676|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
16361093|NCT03738215|39807677|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
16361094|NCT03738215|39807675|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
16361095|NCT03738215|39807676|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
16361096|NCT03738215|39807677|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
16361097|NCT03738215|39807675|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
16361098|NCT03738215|39807676|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
16361099|NCT03738215|39807677|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
16361100|NCT03738215|39807675|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
16361101|NCT03738215|39807676|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
16361102|NCT03738215|39807677|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
16361103|NCT00116142|39807681|FG000|Overall Study|Adverse Event|8|||
16361104|NCT00116142|39807682|FG001|Overall Study|Adverse Event|7|||
16361105|NCT00116142|39807681|FG000|Overall Study|Protocol Violation|2|||
16361106|NCT00116142|39807682|FG001|Overall Study|Protocol Violation|1|||
16361107|NCT00116142|39807681|FG000|Overall Study|Withdrawal by Subject|5|||
16361108|NCT00116142|39807682|FG001|Overall Study|Withdrawal by Subject|5|||
16361109|NCT00116142|39807681|FG000|Overall Study|Physician Decision|3|||
16361110|NCT00116142|39807682|FG001|Overall Study|Physician Decision|1|||
16361111|NCT00116142|39807681|FG000|Overall Study|Delayed Radiation Therapy|1|||
16361112|NCT00116142|39807682|FG001|Overall Study|Delayed Radiation Therapy|0|||
16361113|NCT00116142|39807681|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
16361114|NCT00116142|39807682|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
16361115|NCT00116142|39807681|FG000|Overall Study|Patient stopped due to depression|0|||
16361116|NCT00116142|39807682|FG001|Overall Study|Patient stopped due to depression|1|||
16361117|NCT00116142|39807681|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
16563241|NCT01474512|40525473|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563242|NCT01474512|40525474|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
16563243|NCT01474512|40525475|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563244|NCT01474512|40525476|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
16563245|NCT01474512|40525477|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
16563246|NCT01474512|40525460|FG000|Post-Treatment Follow-Up|Death|0|||
16563247|NCT01474512|40525461|FG001|Post-Treatment Follow-Up|Death|0|||
16563248|NCT01474512|40525462|FG002|Post-Treatment Follow-Up|Death|0|||
16563249|NCT01474512|40525463|FG003|Post-Treatment Follow-Up|Death|0|||
16563250|NCT01474512|40525464|FG004|Post-Treatment Follow-Up|Death|0|||
16563251|NCT01474512|40525465|FG005|Post-Treatment Follow-Up|Death|0|||
16563252|NCT01474512|40525466|FG006|Post-Treatment Follow-Up|Death|0|||
16563253|NCT01474512|40525467|FG007|Post-Treatment Follow-Up|Death|0|||
16563254|NCT01474512|40525468|FG008|Post-Treatment Follow-Up|Death|0|||
16563255|NCT01474512|40525469|FG009|Post-Treatment Follow-Up|Death|0|||
16563256|NCT01474512|40525470|FG010|Post-Treatment Follow-Up|Death|0|||
16563257|NCT01474512|40525471|FG011|Post-Treatment Follow-Up|Death|0|||
16563258|NCT01474512|40525472|FG012|Post-Treatment Follow-Up|Death|0|||
16563259|NCT01474512|40525473|FG013|Post-Treatment Follow-Up|Death|0|||
16563260|NCT01474512|40525474|FG014|Post-Treatment Follow-Up|Death|0|||
16563261|NCT01474512|40525475|FG015|Post-Treatment Follow-Up|Death|0|||
16563262|NCT01474512|40525476|FG016|Post-Treatment Follow-Up|Death|1|||
16563263|NCT01474512|40525477|FG017|Post-Treatment Follow-Up|Death|0|||
16563264|NCT04226495|40525480|FG000|Overall Study|Withdrawal by Subject|3|||
16563265|NCT04226495|40525481|FG001|Overall Study|Withdrawal by Subject|3|||
16563266|NCT04226495|40525480|FG000|Overall Study|PI discretion|2|||
16563267|NCT04226495|40525481|FG001|Overall Study|PI discretion|4|||
16563268|NCT00562965|40525482|FG000|Overall Study|Withdrawal by Subject|0|||
16563269|NCT00562965|40525483|FG001|Overall Study|Withdrawal by Subject|1|||
16563270|NCT00562965|40525482|FG000|Overall Study|Death|2|||
16563271|NCT00562965|40525483|FG001|Overall Study|Death|4|||
16563272|NCT00562965|40525482|FG000|Overall Study|Lost to Follow-up|1|||
16563273|NCT00562965|40525483|FG001|Overall Study|Lost to Follow-up|0|||
16563274|NCT00562965|40525482|FG000|Overall Study|Other|0|||
16563275|NCT00562965|40525483|FG001|Overall Study|Other|1|||
16563276|NCT02320721|40525484|FG000|Overall Study|Adverse Event|6|||
16430288|NCT01132313|40053939|FG011|Overall Study|Withdrawal by Subject|0|||
16430289|NCT01132313|40053928|FG000|Overall Study|Lack of antiviral response|0|||
16430290|NCT01132313|40053929|FG001|Overall Study|Lack of antiviral response|0|||
16563277|NCT02320721|40525485|FG001|Overall Study|Adverse Event|6|||
16563278|NCT02320721|40525484|FG000|Overall Study|Lack of Efficacy|2|||
16563279|NCT02320721|40525485|FG001|Overall Study|Lack of Efficacy|0|||
16563280|NCT02320721|40525484|FG000|Overall Study|Poor compliance to protocol|3|||
16563281|NCT02320721|40525485|FG001|Overall Study|Poor compliance to protocol|7|||
16563282|NCT02320721|40525484|FG000|Overall Study|Randomized but not treated|0|||
16563283|NCT02320721|40525485|FG001|Overall Study|Randomized but not treated|1|||
16563284|NCT02320721|40525484|FG000|Overall Study|Hypoglycemia|1|||
16563285|NCT02320721|40525485|FG001|Overall Study|Hypoglycemia|0|||
16563286|NCT02320721|40525484|FG000|Overall Study|Other than specified above|15|||
16563287|NCT02320721|40525485|FG001|Overall Study|Other than specified above|20|||
16563288|NCT02906683|40527238|FG000|Overall Study|Adverse Event|0|||
16563289|NCT02906683|40527239|FG001|Overall Study|Adverse Event|1|||
16563290|NCT02906683|40527240|FG002|Overall Study|Adverse Event|0|||
16563291|NCT02906683|40527238|FG000|Overall Study|Physician Decision|0|||
16563292|NCT02906683|40527239|FG001|Overall Study|Physician Decision|1|||
16563293|NCT02906683|40527240|FG002|Overall Study|Physician Decision|1|||
16563294|NCT02906683|40527238|FG000|Overall Study|Withdrawal by Subject|0|||
16563295|NCT02906683|40527239|FG001|Overall Study|Withdrawal by Subject|2|||
16563296|NCT02906683|40527240|FG002|Overall Study|Withdrawal by Subject|1|||
16563297|NCT02906683|40527238|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
16563298|NCT02906683|40527239|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
16563299|NCT02906683|40527240|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
16563300|NCT02906683|40527238|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
16563301|NCT02906683|40527239|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
16563302|NCT02906683|40527240|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
16563303|NCT01274338|40527241|FG000|Overall Study|Lack of Efficacy|72|||
16563304|NCT01274338|40527242|FG001|Overall Study|Lack of Efficacy|108|||
16563305|NCT01274338|40527243|FG002|Overall Study|Lack of Efficacy|116|||
16563306|NCT01274338|40527244|FG003|Overall Study|Lack of Efficacy|0|||
16563307|NCT01274338|40527245|FG004|Overall Study|Lack of Efficacy|0|||
16563308|NCT01274338|40527246|FG005|Overall Study|Lack of Efficacy|0|||
16563309|NCT01274338|40527241|FG000|Overall Study|Adverse Event|272|||
16563310|NCT01274338|40527242|FG001|Overall Study|Adverse Event|105|||
16563311|NCT01274338|40527243|FG002|Overall Study|Adverse Event|180|||
16563312|NCT01274338|40527244|FG003|Overall Study|Adverse Event|1|||
16563313|NCT01274338|40527245|FG004|Overall Study|Adverse Event|0|||
16250473|NCT01432171|39400491|FG001|Overall Study|Insurance denial trial coverage|0|||
16250474|NCT01432171|39400490|FG000|Overall Study|Patient moved to palliative care|1|||
16250475|NCT01432171|39400491|FG001|Overall Study|Patient moved to palliative care|0|||
16250476|NCT02896361|39400492|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
16563314|NCT01274338|40527246|FG005|Overall Study|Adverse Event|0|||
16563315|NCT01274338|40527241|FG000|Overall Study|Death|8|||
16563316|NCT01274338|40527242|FG001|Overall Study|Death|1|||
16563317|NCT01274338|40527243|FG002|Overall Study|Death|0|||
16563318|NCT01274338|40527244|FG003|Overall Study|Death|0|||
16563319|NCT01274338|40527245|FG004|Overall Study|Death|0|||
16563320|NCT01274338|40527246|FG005|Overall Study|Death|0|||
16563321|NCT01274338|40527241|FG000|Overall Study|Withdrawal by Subject|27|||
16563322|NCT01274338|40527242|FG001|Overall Study|Withdrawal by Subject|99|||
16563323|NCT01274338|40527243|FG002|Overall Study|Withdrawal by Subject|17|||
16563324|NCT01274338|40527244|FG003|Overall Study|Withdrawal by Subject|0|||
16563325|NCT01274338|40527245|FG004|Overall Study|Withdrawal by Subject|0|||
16563326|NCT01274338|40527246|FG005|Overall Study|Withdrawal by Subject|0|||
16563327|NCT01274338|40527241|FG000|Overall Study|Did not start treatment|8|||
16563328|NCT01274338|40527242|FG001|Overall Study|Did not start treatment|116|||
16563329|NCT01274338|40527243|FG002|Overall Study|Did not start treatment|7|||
16563330|NCT01274338|40527244|FG003|Overall Study|Did not start treatment|0|||
16563331|NCT01274338|40527245|FG004|Overall Study|Did not start treatment|0|||
16563332|NCT01274338|40527246|FG005|Overall Study|Did not start treatment|0|||
16563333|NCT01274338|40527241|FG000|Overall Study|Alternative therapy|0|||
16563334|NCT01274338|40527242|FG001|Overall Study|Alternative therapy|1|||
16563335|NCT01274338|40527243|FG002|Overall Study|Alternative therapy|0|||
16563336|NCT01274338|40527244|FG003|Overall Study|Alternative therapy|0|||
16563337|NCT01274338|40527245|FG004|Overall Study|Alternative therapy|0|||
16563338|NCT01274338|40527246|FG005|Overall Study|Alternative therapy|0|||
16563339|NCT01274338|40527241|FG000|Overall Study|Other complicating diseases|0|||
16563340|NCT01274338|40527242|FG001|Overall Study|Other complicating diseases|3|||
16563341|NCT01274338|40527243|FG002|Overall Study|Other complicating diseases|1|||
16563342|NCT01274338|40527244|FG003|Overall Study|Other complicating diseases|0|||
16563343|NCT01274338|40527245|FG004|Overall Study|Other complicating diseases|0|||
16563344|NCT01274338|40527246|FG005|Overall Study|Other complicating diseases|0|||
16563345|NCT01274338|40527241|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
16563346|NCT01274338|40527242|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
16563347|NCT01274338|40527243|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
16563348|NCT01274338|40527244|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
16563349|NCT01274338|40527245|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
16563350|NCT01274338|40527246|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
16563351|NCT01274338|40527241|FG000|Overall Study|Pregnancy|0|||
16563352|NCT01274338|40527242|FG001|Overall Study|Pregnancy|0|||
16563353|NCT01274338|40527243|FG002|Overall Study|Pregnancy|1|||
16563354|NCT01274338|40527244|FG003|Overall Study|Pregnancy|0|||
16563355|NCT01274338|40527245|FG004|Overall Study|Pregnancy|0|||
16563356|NCT01274338|40527246|FG005|Overall Study|Pregnancy|0|||
16563357|NCT01274338|40527241|FG000|Overall Study|Reason not reported|12|||
16250477|NCT02896361|39400493|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
16563358|NCT01274338|40527242|FG001|Overall Study|Reason not reported|21|||
16563359|NCT01274338|40527243|FG002|Overall Study|Reason not reported|3|||
16563360|NCT01274338|40527244|FG003|Overall Study|Reason not reported|0|||
16563361|NCT01274338|40527245|FG004|Overall Study|Reason not reported|1|||
16563362|NCT01274338|40527246|FG005|Overall Study|Reason not reported|0|||
16563363|NCT04672460|40527247|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
16563364|NCT04672460|40527248|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
16563365|NCT04672460|40527247|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
16563366|NCT04672460|40527248|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
16563367|NCT04672460|40527247|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
16563368|NCT04672460|40527248|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
16563369|NCT04672460|40527247|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
16563370|NCT04672460|40527248|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
16563371|NCT04672460|40527247|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
16563372|NCT04672460|40527248|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
16563373|NCT04672460|40527247|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
16563374|NCT04672460|40527248|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
16563375|NCT04672460|40527247|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
16563376|NCT04672460|40527248|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
16563377|NCT04672460|40527247|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
16563378|NCT04672460|40527248|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
16563379|NCT04672460|40527247|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
16563380|NCT04672460|40527248|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
16563381|NCT04672460|40527247|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
16563382|NCT04672460|40527248|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
16563383|NCT04672460|40527247|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
16563384|NCT04672460|40527248|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
16563385|NCT04672460|40527247|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
16563386|NCT04672460|40527248|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
16563387|NCT04672460|40527247|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
16563388|NCT04672460|40527248|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
16563389|NCT04672460|40527247|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
16563390|NCT04672460|40527248|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
16563391|NCT04672460|40527247|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
16563392|NCT04672460|40527248|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
16563393|NCT04672460|40527247|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
16563394|NCT04672460|40527248|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
16563395|NCT04672460|40527247|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
16563396|NCT04672460|40527248|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
16563397|NCT02775851|40527249|FG000|Overall Study|Adverse Event|1|||
16563398|NCT02775851|40527250|FG001|Overall Study|Adverse Event|10|||
16563399|NCT02775851|40527249|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
16563400|NCT02775851|40527250|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
16131306|NCT02224690|38967264|FG000|Overall Study|Met Withdrawal Criteria|4|||
16131307|NCT02224690|38967265|FG001|Overall Study|Met Withdrawal Criteria|0|||
16131308|NCT02224690|38967264|FG000|Overall Study|Use of G-tube|1|||
16131309|NCT02224690|38967265|FG001|Overall Study|Use of G-tube|0|||
16131310|NCT02224690|38967264|FG000|Overall Study|Did not meet eligibility criteria|1|||
16131311|NCT02224690|38967265|FG001|Overall Study|Did not meet eligibility criteria|0|||
16131312|NCT01183260|38967266|FG000|Overall Study|Intraop screen failure|2|||
16563401|NCT02775851|40527249|FG000|Overall Study|Progression/Relapse|0|||
16563402|NCT02775851|40527250|FG001|Overall Study|Progression/Relapse|4|||
16563403|NCT02775851|40527249|FG000|Overall Study|Other - Not Protocol Specified|0|||
16563404|NCT02775851|40527250|FG001|Overall Study|Other - Not Protocol Specified|7|||
16563405|NCT02775851|40527249|FG000|Overall Study|Withdrawal by Subject|1|||
16563406|NCT02775851|40527250|FG001|Overall Study|Withdrawal by Subject|0|||
16563407|NCT04213846|40527251|FG000|Overall Study|Withdrawal by Subject|7|||
16563408|NCT04213846|40527252|FG001|Overall Study|Withdrawal by Subject|6|||
16563409|NCT04213846|40527251|FG000|Overall Study|Lost to Follow-up|15|||
16563410|NCT04213846|40527252|FG001|Overall Study|Lost to Follow-up|21|||
16563411|NCT03201757|40527259|FG000|Overall Study|Withdrawal by Subject|133|||
16563412|NCT03201757|40527259|FG000|Overall Study|Adverse Event|44|||
16131313|NCT01183260|38967267|FG001|Overall Study|Intraop screen failure|0|||
16131314|NCT01183260|38967266|FG000|Overall Study|Withdrawal by Subject|1|||
16131315|NCT01183260|38967267|FG001|Overall Study|Withdrawal by Subject|1|||
16131316|NCT01183260|38967266|FG000|Overall Study|Revised within 30 days|0|||
16361118|NCT00116142|39807682|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
16361119|NCT00116142|39807681|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
16563413|NCT03201757|40527259|FG000|Overall Study|Lost to Follow-up|37|||
16563414|NCT03201757|40527259|FG000|Overall Study|Pregnancy|2|||
16563415|NCT03201757|40527259|FG000|Overall Study|Lack of Efficacy|1|||
16563416|NCT03201757|40527259|FG000|Overall Study|Protocol Violation|20|||
16563417|NCT03201757|40527259|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
16563418|NCT03201757|40527259|FG000|Overall Study|Not Yet Determined|5|||
16563419|NCT03201757|40527259|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
16563420|NCT03201757|40527259|FG000|Overall Study|Other|20|||
16563421|NCT03092674|40527260|FG000|Overall Study|Adverse Event or Side Effects|1|||
16563422|NCT03092674|40527261|FG001|Overall Study|Adverse Event or Side Effects|4|||
16563423|NCT03092674|40527262|FG002|Overall Study|Adverse Event or Side Effects|4|||
16563424|NCT03092674|40527260|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
16563425|NCT03092674|40527261|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
16563426|NCT03092674|40527262|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
16563427|NCT03092674|40527260|FG000|Overall Study|Progression/Relapse|5|||
16563428|NCT03092674|40527261|FG001|Overall Study|Progression/Relapse|4|||
16563429|NCT03092674|40527262|FG002|Overall Study|Progression/Relapse|8|||
16563430|NCT03092674|40527260|FG000|Overall Study|Death|4|||
16563431|NCT03092674|40527261|FG001|Overall Study|Death|8|||
16563432|NCT03092674|40527262|FG002|Overall Study|Death|2|||
16563433|NCT03092674|40527260|FG000|Overall Study|Other - Not Protocol Specified|11|||
16563434|NCT03092674|40527261|FG001|Overall Study|Other - Not Protocol Specified|8|||
16563435|NCT03092674|40527262|FG002|Overall Study|Other - Not Protocol Specified|8|||
16563436|NCT00433511|40527263|FG000|Step 1|Adverse Event|50|||
16563437|NCT00433511|40527264|FG001|Step 1|Adverse Event|157|||
16563438|NCT00433511|40527265|FG002|Step 1|Adverse Event|153|||
16563439|NCT00433511|40527263|FG000|Step 1|Withdrawal by Subject|45|||
16563440|NCT00433511|40527264|FG001|Step 1|Withdrawal by Subject|143|||
16563441|NCT00433511|40527265|FG002|Step 1|Withdrawal by Subject|154|||
16563442|NCT00433511|40527263|FG000|Step 1|Death|3|||
16563443|NCT00433511|40527264|FG001|Step 1|Death|1|||
16563444|NCT00433511|40527265|FG002|Step 1|Death|1|||
16563445|NCT00433511|40527263|FG000|Step 1|Physician Decision|1|||
16563446|NCT00433511|40527264|FG001|Step 1|Physician Decision|4|||
16563447|NCT00433511|40527265|FG002|Step 1|Physician Decision|3|||
16563448|NCT00433511|40527263|FG000|Step 1|Never started protocol therapy|28|||
16563449|NCT00433511|40527264|FG001|Step 1|Never started protocol therapy|64|||
16563450|NCT00433511|40527265|FG002|Step 1|Never started protocol therapy|66|||
16563451|NCT00433511|40527263|FG000|Step 1|Alternative therapy|2|||
16563452|NCT00433511|40527264|FG001|Step 1|Alternative therapy|1|||
16563453|NCT00433511|40527265|FG002|Step 1|Alternative therapy|3|||
16563454|NCT00433511|40527263|FG000|Step 1|Disease progression, relapse|5|||
16563455|NCT00433511|40527264|FG001|Step 1|Disease progression, relapse|3|||
16563456|NCT00433511|40527265|FG002|Step 1|Disease progression, relapse|3|||
16563457|NCT00433511|40527263|FG000|Step 1|Other complicating disease|2|||
16563458|NCT00433511|40527264|FG001|Step 1|Other complicating disease|6|||
16563459|NCT00433511|40527265|FG002|Step 1|Other complicating disease|3|||
16563460|NCT00433511|40527263|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
16563461|NCT00433511|40527264|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
16563462|NCT00433511|40527265|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
16563463|NCT00433511|40527263|FG000|Step 1|Suspected recurrence|0|||
16563464|NCT00433511|40527264|FG001|Step 1|Suspected recurrence|1|||
16563465|NCT00433511|40527265|FG002|Step 1|Suspected recurrence|0|||
16563466|NCT00433511|40527263|FG000|Step 1|Insurance/drug distribution issues|0|||
16563467|NCT00433511|40527264|FG001|Step 1|Insurance/drug distribution issues|1|||
16563468|NCT00433511|40527265|FG002|Step 1|Insurance/drug distribution issues|2|||
16563469|NCT00433511|40527263|FG000|Step 1|Patient moved|0|||
16563470|NCT00433511|40527264|FG001|Step 1|Patient moved|0|||
16563471|NCT00433511|40527265|FG002|Step 1|Patient moved|1|||
16563472|NCT00433511|40527263|FG000|Step 2 (Arm D)|Adverse Event|0|||
16563473|NCT00433511|40527264|FG001|Step 2 (Arm D)|Adverse Event|0|||
16563474|NCT00433511|40527265|FG002|Step 2 (Arm D)|Adverse Event|135|||
16563475|NCT00433511|40527263|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
16563476|NCT00433511|40527264|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
16563477|NCT00433511|40527265|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
16563478|NCT00433511|40527263|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
16563479|NCT00433511|40527264|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
16563480|NCT00433511|40527265|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
16563481|NCT00433511|40527263|FG000|Step 2 (Arm D)|Physician Decision|0|||
16563482|NCT00433511|40527264|FG001|Step 2 (Arm D)|Physician Decision|0|||
16563483|NCT00433511|40527265|FG002|Step 2 (Arm D)|Physician Decision|9|||
16563484|NCT00433511|40527263|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
16563485|NCT00433511|40527264|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
16563486|NCT00433511|40527265|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
16563487|NCT00433511|40527263|FG000|Step 2 (Arm D)|Other complicating disease|0|||
16563488|NCT00433511|40527264|FG001|Step 2 (Arm D)|Other complicating disease|0|||
16563489|NCT00433511|40527265|FG002|Step 2 (Arm D)|Other complicating disease|3|||
16563490|NCT00433511|40527263|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
16563491|NCT00433511|40527264|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
16563492|NCT00433511|40527265|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
16563493|NCT00433511|40527263|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
16563494|NCT00433511|40527264|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
16563495|NCT00433511|40527265|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
16563496|NCT00433511|40527263|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
16563497|NCT00433511|40527264|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
16563498|NCT00433511|40527265|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
16563499|NCT00433511|40527263|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
16563500|NCT00433511|40527264|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
16563501|NCT00433511|40527265|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
16563502|NCT00602641|40527266|FG000|Overall Study|Never started protocol therapy|6|||
16563503|NCT00602641|40527267|FG001|Overall Study|Never started protocol therapy|2|||
16563504|NCT00602641|40527266|FG000|Overall Study|Still on treatment at time of analysis|8|||
16563505|NCT00602641|40527267|FG001|Overall Study|Still on treatment at time of analysis|15|||
16563506|NCT00602641|40527266|FG000|Overall Study|Adverse Event|62|||
16563507|NCT00602641|40527267|FG001|Overall Study|Adverse Event|53|||
16563508|NCT00602641|40527266|FG000|Overall Study|Disease progression|38|||
16563509|NCT00602641|40527267|FG001|Overall Study|Disease progression|55|||
16563510|NCT00602641|40527266|FG000|Overall Study|Death|6|||
16563511|NCT00602641|40527267|FG001|Overall Study|Death|5|||
16563512|NCT00602641|40527266|FG000|Overall Study|Withdrawal by Subject|15|||
16563513|NCT00602641|40527267|FG001|Overall Study|Withdrawal by Subject|12|||
16563514|NCT00602641|40527266|FG000|Overall Study|Alternative therapy|5|||
16563515|NCT00602641|40527267|FG001|Overall Study|Alternative therapy|2|||
16563516|NCT00602641|40527266|FG000|Overall Study|Other Complicating Disease|5|||
16563517|NCT00602641|40527267|FG001|Overall Study|Other Complicating Disease|2|||
16563518|NCT00602641|40527266|FG000|Overall Study|Physician Decision|5|||
16563519|NCT00602641|40527267|FG001|Overall Study|Physician Decision|4|||
16563520|NCT00602641|40527266|FG000|Overall Study|Administrative Closure|1|||
16563521|NCT00602641|40527267|FG001|Overall Study|Administrative Closure|1|||
16563522|NCT00602641|40527266|FG000|Overall Study|Other|3|||
16563523|NCT00602641|40527267|FG001|Overall Study|Other|1|||
16563524|NCT03523585|40527268|FG000|Overall Study|Progressive Disease|174|||
16563525|NCT03523585|40527269|FG001|Overall Study|Progressive Disease|64|||
16563526|NCT03523585|40527270|FG002|Overall Study|Progressive Disease|77|||
16563527|NCT03523585|40527268|FG000|Overall Study|Adverse Event|74|||
16563528|NCT03523585|40527269|FG001|Overall Study|Adverse Event|5|||
16563529|NCT03523585|40527270|FG002|Overall Study|Adverse Event|9|||
16563530|NCT03523585|40527268|FG000|Overall Study|Withdrawal by Subject|30|||
16563531|NCT03523585|40527269|FG001|Overall Study|Withdrawal by Subject|11|||
16563532|NCT03523585|40527270|FG002|Overall Study|Withdrawal by Subject|6|||
16563533|NCT03523585|40527268|FG000|Overall Study|Clinical Progression|23|||
16563534|NCT03523585|40527269|FG001|Overall Study|Clinical Progression|5|||
16563535|NCT03523585|40527270|FG002|Overall Study|Clinical Progression|10|||
16563536|NCT03523585|40527268|FG000|Overall Study|Death|4|||
16563537|NCT03523585|40527269|FG001|Overall Study|Death|0|||
16563538|NCT03523585|40527270|FG002|Overall Study|Death|1|||
16563539|NCT03523585|40527268|FG000|Overall Study|Physician Decision|2|||
16563540|NCT03523585|40527269|FG001|Overall Study|Physician Decision|1|||
16563541|NCT03523585|40527270|FG002|Overall Study|Physician Decision|0|||
16563542|NCT03523585|40527268|FG000|Overall Study|Lost to Follow-up|1|||
16563543|NCT03523585|40527269|FG001|Overall Study|Lost to Follow-up|0|||
16563544|NCT03523585|40527270|FG002|Overall Study|Lost to Follow-up|0|||
16563545|NCT03523585|40527268|FG000|Overall Study|Miscellaneous|1|||
16563546|NCT03523585|40527269|FG001|Overall Study|Miscellaneous|0|||
16563547|NCT03523585|40527270|FG002|Overall Study|Miscellaneous|0|||
16563548|NCT03523585|40527268|FG000|Overall Study|Protocol Deviation|1|||
16563549|NCT03523585|40527269|FG001|Overall Study|Protocol Deviation|0|||
16563550|NCT03523585|40527270|FG002|Overall Study|Protocol Deviation|1|||
16563551|NCT03523585|40527268|FG000|Overall Study|Randomized But Not Treated|2|||
16563552|NCT03523585|40527269|FG001|Overall Study|Randomized But Not Treated|4|||
16563553|NCT03523585|40527270|FG002|Overall Study|Randomized But Not Treated|3|||
16563554|NCT05349084|40527275|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
16563555|NCT00070499|40527276|FG000|Overall Study|Adverse Event|6|||
16563556|NCT00070499|40527277|FG001|Overall Study|Adverse Event|6|||
16563557|NCT00070499|40527278|FG002|Overall Study|Adverse Event|19|||
16563558|NCT00070499|40527279|FG003|Overall Study|Adverse Event|15|||
16563559|NCT00070499|40527276|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
16563560|NCT00070499|40527277|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
16563561|NCT00070499|40527278|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
16563562|NCT00070499|40527279|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
16563563|NCT00070499|40527276|FG000|Overall Study|Progression/relapse|4|||
16563564|NCT00070499|40527277|FG001|Overall Study|Progression/relapse|2|||
16563565|NCT00070499|40527278|FG002|Overall Study|Progression/relapse|1|||
16563566|NCT00070499|40527279|FG003|Overall Study|Progression/relapse|4|||
16563567|NCT00070499|40527276|FG000|Overall Study|Death|1|||
16563568|NCT00070499|40527277|FG001|Overall Study|Death|1|||
16563569|NCT00070499|40527278|FG002|Overall Study|Death|1|||
16563570|NCT00070499|40527279|FG003|Overall Study|Death|2|||
16563571|NCT00070499|40527276|FG000|Overall Study|Other - not protocol specified|7|||
16563572|NCT00070499|40527277|FG001|Overall Study|Other - not protocol specified|3|||
16563573|NCT00070499|40527278|FG002|Overall Study|Other - not protocol specified|12|||
16563574|NCT00070499|40527279|FG003|Overall Study|Other - not protocol specified|20|||
16563575|NCT00070499|40527276|FG000|Overall Study|Still on protocol treatment|10|||
16563576|NCT00070499|40527277|FG001|Overall Study|Still on protocol treatment|4|||
16563577|NCT00070499|40527278|FG002|Overall Study|Still on protocol treatment|79|||
16563578|NCT00070499|40527279|FG003|Overall Study|Still on protocol treatment|57|||
16563579|NCT00070499|40527276|FG000|Overall Study|Did not start treatment|1|||
16563580|NCT00070499|40527277|FG001|Overall Study|Did not start treatment|0|||
16563581|NCT00070499|40527278|FG002|Overall Study|Did not start treatment|0|||
16563582|NCT00070499|40527279|FG003|Overall Study|Did not start treatment|2|||
16563583|NCT00070499|40527276|FG000|Overall Study|Not eligible|2|||
16563584|NCT00070499|40527277|FG001|Overall Study|Not eligible|5|||
16563585|NCT00070499|40527278|FG002|Overall Study|Not eligible|3|||
16563586|NCT00070499|40527279|FG003|Overall Study|Not eligible|2|||
16563587|NCT05177848|40527282|FG000|Overall Study|Lost to Follow-up|1|||
16563588|NCT05177848|40527283|FG001|Overall Study|Lost to Follow-up|4|||
16563589|NCT05177848|40527282|FG000|Overall Study|Discontinued|2|||
16563590|NCT05177848|40527283|FG001|Overall Study|Discontinued|1|||
16563591|NCT02498613|40527284|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
16563592|NCT02498613|40527285|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
16563593|NCT02498613|40527286|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
16563594|NCT02498613|40527287|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
16563595|NCT02498613|40527284|FG000|Overall Study|Withdrawal by Subject|3|||
16563596|NCT02498613|40527285|FG001|Overall Study|Withdrawal by Subject|1|||
16563597|NCT02498613|40527286|FG002|Overall Study|Withdrawal by Subject|0|||
16563598|NCT02498613|40527287|FG003|Overall Study|Withdrawal by Subject|0|||
16563599|NCT01708941|40527288|FG000|Overall Study|Adverse Event|4|||
16563600|NCT01708941|40527289|FG001|Overall Study|Adverse Event|6|||
16563601|NCT01708941|40527290|FG002|Overall Study|Adverse Event|1|||
16563602|NCT01708941|40527291|FG003|Overall Study|Adverse Event|0|||
16563603|NCT01708941|40527288|FG000|Overall Study|Death|1|||
16563604|NCT01708941|40527289|FG001|Overall Study|Death|1|||
16563605|NCT01708941|40527290|FG002|Overall Study|Death|2|||
16563606|NCT01708941|40527291|FG003|Overall Study|Death|14|||
16563607|NCT01708941|40527288|FG000|Overall Study|Withdrawal by Subject|1|||
16563608|NCT01708941|40527289|FG001|Overall Study|Withdrawal by Subject|0|||
16563609|NCT01708941|40527290|FG002|Overall Study|Withdrawal by Subject|3|||
16563610|NCT01708941|40527291|FG003|Overall Study|Withdrawal by Subject|4|||
16563611|NCT01708941|40527288|FG000|Overall Study|Disease progression|9|||
16563612|NCT01708941|40527289|FG001|Overall Study|Disease progression|10|||
16563613|NCT01708941|40527290|FG002|Overall Study|Disease progression|8|||
16563614|NCT01708941|40527291|FG003|Overall Study|Disease progression|0|||
16563615|NCT01708941|40527288|FG000|Overall Study|Alternative therapy|0|||
16563616|NCT01708941|40527289|FG001|Overall Study|Alternative therapy|0|||
16563617|NCT01708941|40527290|FG002|Overall Study|Alternative therapy|2|||
16563618|NCT01708941|40527291|FG003|Overall Study|Alternative therapy|0|||
16563619|NCT01708941|40527288|FG000|Overall Study|Ineligible and never started treatment|1|||
16563620|NCT01708941|40527289|FG001|Overall Study|Ineligible and never started treatment|0|||
16563621|NCT01708941|40527290|FG002|Overall Study|Ineligible and never started treatment|1|||
16563622|NCT01708941|40527291|FG003|Overall Study|Ineligible and never started treatment|0|||
16563623|NCT01708941|40527288|FG000|Overall Study|Never started treatment|2|||
16563624|NCT01708941|40527289|FG001|Overall Study|Never started treatment|1|||
16563625|NCT01708941|40527290|FG002|Overall Study|Never started treatment|0|||
16563626|NCT01708941|40527291|FG003|Overall Study|Never started treatment|0|||
16563627|NCT01708941|40527288|FG000|Overall Study|Ineligible|0|||
16563628|NCT01708941|40527289|FG001|Overall Study|Ineligible|0|||
16563629|NCT01708941|40527290|FG002|Overall Study|Ineligible|2|||
16563630|NCT01708941|40527291|FG003|Overall Study|Ineligible|0|||
16563631|NCT02048813|40527292|FG000|Overall Study|Still on treatment|279|||
16563632|NCT02048813|40527293|FG001|Overall Study|Still on treatment|0|||
16563633|NCT02048813|40527292|FG000|Overall Study|Adverse Event|40|||
16563634|NCT02048813|40527293|FG001|Overall Study|Adverse Event|38|||
16563635|NCT02048813|40527292|FG000|Overall Study|Disease progression|13|||
16563636|NCT02048813|40527293|FG001|Overall Study|Disease progression|3|||
16563637|NCT02048813|40527292|FG000|Overall Study|Withdrawal by Subject|7|||
16563638|NCT02048813|40527293|FG001|Overall Study|Withdrawal by Subject|8|||
16563639|NCT02048813|40527292|FG000|Overall Study|Death|2|||
16563640|NCT02048813|40527293|FG001|Overall Study|Death|1|||
16563641|NCT02048813|40527292|FG000|Overall Study|Complication|2|||
16563642|NCT02048813|40527293|FG001|Overall Study|Complication|2|||
16563643|NCT02048813|40527292|FG000|Overall Study|Non-protocol therapy|0|||
16563644|NCT02048813|40527293|FG001|Overall Study|Non-protocol therapy|1|||
16563645|NCT02048813|40527292|FG000|Overall Study|Second primary cancer|2|||
16563646|NCT02048813|40527293|FG001|Overall Study|Second primary cancer|0|||
16563647|NCT02048813|40527292|FG000|Overall Study|Insurance|2|||
16563648|NCT02048813|40527293|FG001|Overall Study|Insurance|0|||
16563649|NCT02048813|40527292|FG000|Overall Study|Wound infection/healing|2|||
16563650|NCT02048813|40527293|FG001|Overall Study|Wound infection/healing|0|||
16563651|NCT02048813|40527292|FG000|Overall Study|Missed appointment|3|||
16563652|NCT02048813|40527293|FG001|Overall Study|Missed appointment|0|||
16563653|NCT02048813|40527292|FG000|Overall Study|Never started treatment|2|||
16563654|NCT02048813|40527293|FG001|Overall Study|Never started treatment|17|||
16563655|NCT03909165|40527294|FG000|Overall Study|Physician Decision|0|||
16563656|NCT03909165|40527295|FG001|Overall Study|Physician Decision|1|||
16563657|NCT03909165|40527296|FG002|Overall Study|Physician Decision|0|||
16563658|NCT03909165|40527297|FG003|Overall Study|Physician Decision|0|||
16563659|NCT03909165|40527298|FG004|Overall Study|Physician Decision|0|||
16563660|NCT03909165|40527294|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16563661|NCT03909165|40527295|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16563662|NCT03909165|40527296|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16563663|NCT03909165|40527297|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16563664|NCT03909165|40527298|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
16563665|NCT03909165|40527294|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
16563666|NCT03909165|40527295|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
16563667|NCT03909165|40527296|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
16563668|NCT03909165|40527297|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
16563669|NCT03909165|40527298|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
16563670|NCT03909165|40527294|FG000|Overall Study|Previous Drug Exposure|0|||
16563671|NCT03909165|40527295|FG001|Overall Study|Previous Drug Exposure|0|||
16563672|NCT03909165|40527296|FG002|Overall Study|Previous Drug Exposure|1|||
16563673|NCT03909165|40527297|FG003|Overall Study|Previous Drug Exposure|0|||
16563674|NCT03909165|40527298|FG004|Overall Study|Previous Drug Exposure|0|||
16563675|NCT03909165|40527294|FG000|Overall Study|Early Discharge|1|||
16563676|NCT03909165|40527295|FG001|Overall Study|Early Discharge|0|||
16563677|NCT03909165|40527296|FG002|Overall Study|Early Discharge|0|||
16563678|NCT03909165|40527297|FG003|Overall Study|Early Discharge|0|||
16563679|NCT03909165|40527298|FG004|Overall Study|Early Discharge|0|||
16563680|NCT02993146|40527299|FG000|Overall Study|Withdrawal by Subject|0|||
16563681|NCT02993146|40527300|FG001|Overall Study|Withdrawal by Subject|0|||
16563682|NCT02993146|40527301|FG002|Overall Study|Withdrawal by Subject|1|||
16563683|NCT02993146|40527302|FG003|Overall Study|Withdrawal by Subject|1|||
16563684|NCT04088409|40527303|FG000|Part A|Withdrawal by Subject|2|||
16563685|NCT04088409|40527304|FG001|Part A|Withdrawal by Subject|1|||
16563686|NCT04088409|40527303|FG000|Part A|Did Not Meet Randomization Criteria|2|||
16563687|NCT04088409|40527304|FG001|Part A|Did Not Meet Randomization Criteria|0|||
16563688|NCT04088409|40527303|FG000|Part A|Lack of Efficacy|9|||
16563689|NCT04088409|40527304|FG001|Part A|Lack of Efficacy|0|||
16563690|NCT04088409|40527303|FG000|Part A|Lost to Follow-up|1|||
16563691|NCT04088409|40527304|FG001|Part A|Lost to Follow-up|0|||
16563692|NCT04088409|40527303|FG000|Part A|Adverse Event|1|||
16563693|NCT04088409|40527304|FG001|Part A|Adverse Event|0|||
16563694|NCT04088409|40527303|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
16563695|NCT04088409|40527304|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
16563696|NCT04088409|40527303|FG000|Part B|Ongoing Treatment|10|||
16563697|NCT04088409|40527304|FG001|Part B|Ongoing Treatment|0|||
16563698|NCT03033576|40527305|FG000|Overall Study|Ineligible|1|||
16563699|NCT03033576|40527306|FG001|Overall Study|Ineligible|1|||
16563700|NCT03033576|40527305|FG000|Overall Study|Adverse Event|4|||
16563701|NCT03033576|40527306|FG001|Overall Study|Adverse Event|20|||
16563702|NCT03033576|40527305|FG000|Overall Study|Progression/relapse|9|||
16563703|NCT03033576|40527306|FG001|Overall Study|Progression/relapse|36|||
16563704|NCT03033576|40527305|FG000|Overall Study|Death|1|||
16563705|NCT03033576|40527306|FG001|Overall Study|Death|1|||
16131317|NCT01183260|38967267|FG001|Overall Study|Revised within 30 days|1|||
16563706|NCT03033576|40527305|FG000|Overall Study|Patient refusal|1|||
16563707|NCT03033576|40527306|FG001|Overall Study|Patient refusal|6|||
16563708|NCT03033576|40527305|FG000|Overall Study|Other, unspecified reasons|0|||
16563709|NCT03033576|40527306|FG001|Overall Study|Other, unspecified reasons|4|||
16563710|NCT03033576|40527305|FG000|Overall Study|Currently on protocol therapy|0|||
16563711|NCT03033576|40527306|FG001|Overall Study|Currently on protocol therapy|2|||
16563712|NCT05420961|40527312|FG000|Overall Study|Withdrawal by Subject|2|||
16563713|NCT05420961|40527313|FG001|Overall Study|Withdrawal by Subject|1|||
16563714|NCT05420961|40527314|FG002|Overall Study|Withdrawal by Subject|1|||
16563715|NCT05420961|40527315|FG003|Overall Study|Withdrawal by Subject|0|||
16563716|NCT05420961|40527316|FG004|Overall Study|Withdrawal by Subject|0|||
16563717|NCT05420961|40527312|FG000|Overall Study|Lost to Follow-up|0|||
16563718|NCT05420961|40527313|FG001|Overall Study|Lost to Follow-up|0|||
16563719|NCT05420961|40527314|FG002|Overall Study|Lost to Follow-up|1|||
16563720|NCT05420961|40527315|FG003|Overall Study|Lost to Follow-up|0|||
16563721|NCT05420961|40527316|FG004|Overall Study|Lost to Follow-up|0|||
16563722|NCT05420961|40527312|FG000|Overall Study|Randomized by mistake without study treatment|0|||
16563723|NCT05420961|40527313|FG001|Overall Study|Randomized by mistake without study treatment|0|||
16563724|NCT05420961|40527314|FG002|Overall Study|Randomized by mistake without study treatment|1|||
16563725|NCT05420961|40527315|FG003|Overall Study|Randomized by mistake without study treatment|0|||
16563726|NCT05420961|40527316|FG004|Overall Study|Randomized by mistake without study treatment|1|||
16563727|NCT01886872|40527319|FG000|Overall Study|Ineligible|7|||
16563728|NCT01886872|40527320|FG001|Overall Study|Ineligible|4|||
16563729|NCT01886872|40527321|FG002|Overall Study|Ineligible|12|||
16563730|NCT02939183|40527326|FG000|Overall Study|Death|0|||
16563731|NCT02939183|40527327|FG001|Overall Study|Death|0|||
16563732|NCT02939183|40527328|FG002|Overall Study|Death|1|||
16563733|NCT02939183|40527329|FG003|Overall Study|Death|0|||
16563734|NCT02939183|40527330|FG004|Overall Study|Death|0|||
16563735|NCT02939183|40527331|FG005|Overall Study|Death|2|||
16563736|NCT02939183|40527332|FG006|Overall Study|Death|1|||
16563737|NCT02939183|40527333|FG007|Overall Study|Death|0|||
16563738|NCT02939183|40527334|FG008|Overall Study|Death|0|||
16563739|NCT02939183|40527326|FG000|Overall Study|Sponsor decision|0|||
16563740|NCT02939183|40527327|FG001|Overall Study|Sponsor decision|1|||
16563741|NCT02939183|40527328|FG002|Overall Study|Sponsor decision|0|||
16563742|NCT02939183|40527329|FG003|Overall Study|Sponsor decision|1|||
16563743|NCT02939183|40527330|FG004|Overall Study|Sponsor decision|2|||
16563744|NCT02939183|40527331|FG005|Overall Study|Sponsor decision|0|||
16430291|NCT01132313|40053930|FG002|Overall Study|Lack of antiviral response|12|||
16430292|NCT01132313|40053931|FG003|Overall Study|Lack of antiviral response|18|||
16430293|NCT01132313|40053932|FG004|Overall Study|Lack of antiviral response|18|||
16430294|NCT01132313|40053933|FG005|Overall Study|Lack of antiviral response|18|||
16430295|NCT01132313|40053934|FG006|Overall Study|Lack of antiviral response|21|||
16430296|NCT01132313|40053935|FG007|Overall Study|Lack of antiviral response|0|||
16430297|NCT01132313|40053936|FG008|Overall Study|Lack of antiviral response|0|||
16430298|NCT01132313|40053937|FG009|Overall Study|Lack of antiviral response|0|||
16430299|NCT01132313|40053938|FG010|Overall Study|Lack of antiviral response|1|||
16430300|NCT01132313|40053939|FG011|Overall Study|Lack of antiviral response|0|||
16430301|NCT01132313|40053928|FG000|Overall Study|Other reason not defined above|0|||
16430302|NCT01132313|40053929|FG001|Overall Study|Other reason not defined above|0|||
16430303|NCT01132313|40053930|FG002|Overall Study|Other reason not defined above|0|||
16430304|NCT01132313|40053931|FG003|Overall Study|Other reason not defined above|0|||
16430305|NCT01132313|40053932|FG004|Overall Study|Other reason not defined above|0|||
16563745|NCT02939183|40527332|FG006|Overall Study|Sponsor decision|3|||
16563746|NCT02939183|40527333|FG007|Overall Study|Sponsor decision|1|||
16563747|NCT02939183|40527334|FG008|Overall Study|Sponsor decision|4|||
16563748|NCT02939183|40527326|FG000|Overall Study|Withdrawal by Subject|0|||
16563749|NCT02939183|40527327|FG001|Overall Study|Withdrawal by Subject|2|||
16563750|NCT02939183|40527328|FG002|Overall Study|Withdrawal by Subject|0|||
16563751|NCT02939183|40527329|FG003|Overall Study|Withdrawal by Subject|1|||
16563752|NCT02939183|40527330|FG004|Overall Study|Withdrawal by Subject|0|||
16563753|NCT02939183|40527331|FG005|Overall Study|Withdrawal by Subject|0|||
16563754|NCT02939183|40527332|FG006|Overall Study|Withdrawal by Subject|2|||
16563755|NCT02939183|40527333|FG007|Overall Study|Withdrawal by Subject|2|||
16563756|NCT02939183|40527334|FG008|Overall Study|Withdrawal by Subject|2|||
16563757|NCT02939183|40527326|FG000|Overall Study|Not treated due to adverse event|0|||
16563758|NCT02939183|40527327|FG001|Overall Study|Not treated due to adverse event|0|||
16563759|NCT02939183|40527328|FG002|Overall Study|Not treated due to adverse event|0|||
16563760|NCT02939183|40527329|FG003|Overall Study|Not treated due to adverse event|1|||
16563761|NCT02939183|40527330|FG004|Overall Study|Not treated due to adverse event|0|||
16563762|NCT02939183|40527331|FG005|Overall Study|Not treated due to adverse event|0|||
16563763|NCT02939183|40527332|FG006|Overall Study|Not treated due to adverse event|1|||
16563764|NCT02939183|40527333|FG007|Overall Study|Not treated due to adverse event|0|||
16563765|NCT02939183|40527334|FG008|Overall Study|Not treated due to adverse event|0|||
16563766|NCT03176134|40527335|FG000|Overall Study|Lost to Follow-up|0|||
16563767|NCT03176134|40527336|FG001|Overall Study|Lost to Follow-up|2|||
16563768|NCT03176134|40527337|FG002|Overall Study|Lost to Follow-up|0|||
16563769|NCT03176134|40527338|FG003|Overall Study|Lost to Follow-up|0|||
16563770|NCT03176134|40527339|FG004|Overall Study|Lost to Follow-up|0|||
16131318|NCT01183260|38967266|FG000|Overall Study|Death|1|||
16563771|NCT03176134|40527340|FG005|Overall Study|Lost to Follow-up|0|||
16563772|NCT03176134|40527341|FG006|Overall Study|Lost to Follow-up|0|||
16563773|NCT03176134|40527342|FG007|Overall Study|Lost to Follow-up|0|||
16563774|NCT03176134|40527335|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
16563775|NCT03176134|40527336|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16563776|NCT03176134|40527337|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
16563777|NCT03176134|40527338|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
16563778|NCT03176134|40527339|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
16563779|NCT03176134|40527340|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
16563780|NCT03176134|40527341|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
16563781|NCT03176134|40527342|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
16563782|NCT04939428|40527343|FG000|Overall Study|Death|0|||
16563783|NCT04939428|40527344|FG001|Overall Study|Death|1|||
16563784|NCT04939428|40527345|FG002|Overall Study|Death|0|||
16563785|NCT04939428|40527343|FG000|Overall Study|Lost to Follow-up|0|||
16563786|NCT04939428|40527344|FG001|Overall Study|Lost to Follow-up|5|||
16563787|NCT04939428|40527345|FG002|Overall Study|Lost to Follow-up|0|||
16563788|NCT04939428|40527343|FG000|Overall Study|Physician Decision|1|||
16563789|NCT04939428|40527344|FG001|Overall Study|Physician Decision|0|||
16563790|NCT04939428|40527345|FG002|Overall Study|Physician Decision|0|||
16563791|NCT04939428|40527343|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
16563792|NCT04939428|40527344|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16563793|NCT04939428|40527345|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16563794|NCT04939428|40527343|FG000|Overall Study|Withdrawal by Subject|10|||
16563795|NCT04939428|40527344|FG001|Overall Study|Withdrawal by Subject|11|||
16563796|NCT04939428|40527345|FG002|Overall Study|Withdrawal by Subject|0|||
16563797|NCT04939428|40527343|FG000|Overall Study|Unkown|6|||
16563798|NCT04939428|40527344|FG001|Overall Study|Unkown|3|||
16563799|NCT04939428|40527345|FG002|Overall Study|Unkown|0|||
16563800|NCT04939428|40527343|FG000|Overall Study|Discotinued per protocol|0|||
16563801|NCT04939428|40527344|FG001|Overall Study|Discotinued per protocol|0|||
16563802|NCT04939428|40527345|FG002|Overall Study|Discotinued per protocol|902|||
16563803|NCT00588770|40527347|FG000|Overall Study|Disease progression|85|||
16563804|NCT00588770|40527348|FG001|Overall Study|Disease progression|68|||
16563805|NCT00588770|40527347|FG000|Overall Study|Adverse Event|29|||
16563806|NCT00588770|40527348|FG001|Overall Study|Adverse Event|58|||
16563807|NCT00588770|40527347|FG000|Overall Study|Death|13|||
16563808|NCT00588770|40527348|FG001|Overall Study|Death|22|||
16563809|NCT00588770|40527347|FG000|Overall Study|Withdrawal by Subject|15|||
16563810|NCT00588770|40527348|FG001|Overall Study|Withdrawal by Subject|25|||
16563811|NCT00588770|40527347|FG000|Overall Study|Alternative therapy|2|||
16563812|NCT00588770|40527348|FG001|Overall Study|Alternative therapy|4|||
16563813|NCT00588770|40527347|FG000|Overall Study|Other complicating disease|3|||
16563814|NCT00588770|40527348|FG001|Overall Study|Other complicating disease|2|||
16563815|NCT00588770|40527347|FG000|Overall Study|Not start protocol therapy|0|||
16563816|NCT00588770|40527348|FG001|Overall Study|Not start protocol therapy|9|||
16563817|NCT00588770|40527347|FG000|Overall Study|Lack of Efficacy|8|||
16563818|NCT00588770|40527348|FG001|Overall Study|Lack of Efficacy|10|||
16563819|NCT00588770|40527347|FG000|Overall Study|Physician discretion|2|||
16563820|NCT00588770|40527348|FG001|Overall Study|Physician discretion|0|||
16563821|NCT00588770|40527347|FG000|Overall Study|Patient non-compliance|2|||
16563822|NCT00588770|40527348|FG001|Overall Study|Patient non-compliance|2|||
16563823|NCT02099539|40527351|FG000|Overall Study|Progressive Disease|3|||
16563824|NCT02099539|40527352|FG001|Overall Study|Progressive Disease|2|||
16563825|NCT02099539|40527353|FG002|Overall Study|Progressive Disease|2|||
16563826|NCT02099539|40527354|FG003|Overall Study|Progressive Disease|1|||
16563827|NCT02099539|40527355|FG004|Overall Study|Progressive Disease|4|||
16563828|NCT02099539|40527356|FG005|Overall Study|Progressive Disease|2|||
16563829|NCT02099539|40527357|FG006|Overall Study|Progressive Disease|0|||
16563830|NCT02099539|40527351|FG000|Overall Study|Adverse Event|0|||
16563831|NCT02099539|40527352|FG001|Overall Study|Adverse Event|0|||
16131319|NCT01183260|38967267|FG001|Overall Study|Death|0|||
16563832|NCT02099539|40527353|FG002|Overall Study|Adverse Event|1|||
16563833|NCT02099539|40527354|FG003|Overall Study|Adverse Event|1|||
16563834|NCT02099539|40527355|FG004|Overall Study|Adverse Event|0|||
16563835|NCT02099539|40527356|FG005|Overall Study|Adverse Event|0|||
16563836|NCT02099539|40527357|FG006|Overall Study|Adverse Event|0|||
16563837|NCT02099539|40527351|FG000|Overall Study|Physician Decision|0|||
16563838|NCT02099539|40527352|FG001|Overall Study|Physician Decision|0|||
16563839|NCT02099539|40527353|FG002|Overall Study|Physician Decision|0|||
16563840|NCT02099539|40527354|FG003|Overall Study|Physician Decision|0|||
16563841|NCT02099539|40527355|FG004|Overall Study|Physician Decision|0|||
16563842|NCT02099539|40527356|FG005|Overall Study|Physician Decision|1|||
16563843|NCT02099539|40527357|FG006|Overall Study|Physician Decision|0|||
16563844|NCT00843882|40527359|FG000|Step 1|Lack of Efficacy|14|||
16563845|NCT00843882|40527360|FG001|Step 1|Lack of Efficacy|10|||
16563846|NCT00843882|40527361|FG002|Step 1|Lack of Efficacy|21|||
16563847|NCT00843882|40527359|FG000|Step 1|Adverse Event|8|||
16563848|NCT00843882|40527360|FG001|Step 1|Adverse Event|17|||
16563849|NCT00843882|40527361|FG002|Step 1|Adverse Event|20|||
16563850|NCT00843882|40527359|FG000|Step 1|Death|1|||
16563851|NCT00843882|40527360|FG001|Step 1|Death|2|||
16563852|NCT00843882|40527361|FG002|Step 1|Death|4|||
16563853|NCT00843882|40527359|FG000|Step 1|Withdrawal by Subject|6|||
16563854|NCT00843882|40527360|FG001|Step 1|Withdrawal by Subject|12|||
16563855|NCT00843882|40527361|FG002|Step 1|Withdrawal by Subject|9|||
16563856|NCT00843882|40527359|FG000|Step 1|Physician Decision|0|||
16563857|NCT00843882|40527360|FG001|Step 1|Physician Decision|5|||
16563858|NCT00843882|40527361|FG002|Step 1|Physician Decision|1|||
16563859|NCT00843882|40527359|FG000|Step 1|Patient and physician's decision|0|||
16563860|NCT00843882|40527360|FG001|Step 1|Patient and physician's decision|0|||
16563861|NCT00843882|40527361|FG002|Step 1|Patient and physician's decision|1|||
16563862|NCT00843882|40527359|FG000|Step 1|Other complicating disease|1|||
16563863|NCT00843882|40527360|FG001|Step 1|Other complicating disease|3|||
16563864|NCT00843882|40527361|FG002|Step 1|Other complicating disease|4|||
16563865|NCT00843882|40527359|FG000|Step 1|Alternative therapy|0|||
16563866|NCT00843882|40527360|FG001|Step 1|Alternative therapy|1|||
16563867|NCT00843882|40527361|FG002|Step 1|Alternative therapy|1|||
16563868|NCT00843882|40527359|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
16563869|NCT00843882|40527360|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
16563870|NCT00843882|40527361|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
16563871|NCT00843882|40527359|FG000|Step 1|Off treatment reason unknown|0|||
16563872|NCT00843882|40527360|FG001|Step 1|Off treatment reason unknown|1|||
16563873|NCT00843882|40527361|FG002|Step 1|Off treatment reason unknown|4|||
16563874|NCT00843882|40527359|FG000|Step 1|Never started treatment|2|||
16563875|NCT00843882|40527360|FG001|Step 1|Never started treatment|0|||
16563876|NCT00843882|40527361|FG002|Step 1|Never started treatment|0|||
16563877|NCT00843882|40527359|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
16563878|NCT00843882|40527360|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
16563879|NCT00843882|40527361|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
16563880|NCT00843882|40527359|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
16563881|NCT00843882|40527360|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
16563882|NCT00843882|40527361|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
16563883|NCT00843882|40527359|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
16563884|NCT00843882|40527360|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
16563885|NCT00843882|40527361|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
16563886|NCT00843882|40527359|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
16563887|NCT00843882|40527360|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
16563888|NCT00843882|40527361|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
16563889|NCT00843882|40527359|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
16563890|NCT00843882|40527360|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
16563891|NCT00843882|40527361|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
16563892|NCT00843882|40527359|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
16563893|NCT00843882|40527360|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
16563894|NCT00843882|40527361|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
16563895|NCT00843882|40527359|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
16563896|NCT00843882|40527360|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
16563897|NCT00843882|40527361|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
16563898|NCT02115282|40527362|FG000|Overall Study|Disease progression during treatment|216|||
16563899|NCT02115282|40527363|FG001|Overall Study|Disease progression during treatment|229|||
16563900|NCT02115282|40527362|FG000|Overall Study|Adverse Event|49|||
16563901|NCT02115282|40527363|FG001|Overall Study|Adverse Event|23|||
16563902|NCT02115282|40527362|FG000|Overall Study|Death|1|||
16563903|NCT02115282|40527363|FG001|Overall Study|Death|3|||
16563904|NCT02115282|40527362|FG000|Overall Study|Alternative therapy|1|||
16563905|NCT02115282|40527363|FG001|Overall Study|Alternative therapy|1|||
16563906|NCT02115282|40527362|FG000|Overall Study|Complicating disease|0|||
16563907|NCT02115282|40527363|FG001|Overall Study|Complicating disease|3|||
16563908|NCT02115282|40527362|FG000|Overall Study|Withdrawal by Subject|12|||
16563909|NCT02115282|40527363|FG001|Overall Study|Withdrawal by Subject|10|||
16563910|NCT02115282|40527362|FG000|Overall Study|Symptomatic progression/deterioration|7|||
16563911|NCT02115282|40527363|FG001|Overall Study|Symptomatic progression/deterioration|18|||
16563912|NCT02115282|40527362|FG000|Overall Study|Non-compliance|5|||
16563913|NCT02115282|40527363|FG001|Overall Study|Non-compliance|1|||
16563914|NCT02115282|40527362|FG000|Overall Study|Protocol Violation|2|||
16563915|NCT02115282|40527363|FG001|Overall Study|Protocol Violation|2|||
16563916|NCT02115282|40527362|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
16563917|NCT02115282|40527363|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
16563918|NCT02115282|40527362|FG000|Overall Study|Not start protocol therapy|9|||
16563919|NCT02115282|40527363|FG001|Overall Study|Not start protocol therapy|10|||
16563920|NCT03976375|40527364|FG000|Overall Study|Death|147|||
16563921|NCT03976375|40527365|FG001|Overall Study|Death|150|||
16563922|NCT03976375|40527366|FG002|Overall Study|Death|38|||
16563923|NCT03976375|40527364|FG000|Overall Study|Lost to Follow-up|1|||
16563924|NCT03976375|40527365|FG001|Overall Study|Lost to Follow-up|1|||
16563925|NCT03976375|40527366|FG002|Overall Study|Lost to Follow-up|1|||
16563926|NCT03976375|40527364|FG000|Overall Study|Withdrawal by Subject|4|||
16563927|NCT03976375|40527365|FG001|Overall Study|Withdrawal by Subject|9|||
16563928|NCT03976375|40527366|FG002|Overall Study|Withdrawal by Subject|4|||
16563929|NCT03976375|40527364|FG000|Overall Study|Ongoing|33|||
16563930|NCT03976375|40527365|FG001|Overall Study|Ongoing|29|||
16563931|NCT03976375|40527366|FG002|Overall Study|Ongoing|5|||
16563932|NCT01275677|40527367|FG000|Overall Study|Not at risk for recurrence.|1|||
16563933|NCT01275677|40527368|FG001|Overall Study|Not at risk for recurrence.|1|||
16563934|NCT01275677|40527367|FG000|Overall Study|No follow-up|26|||
16563935|NCT01275677|40527368|FG001|Overall Study|No follow-up|37|||
16563936|NCT01275677|40527367|FG000|Overall Study|No clinical follow up.|1|||
16563937|NCT01275677|40527368|FG001|Overall Study|No clinical follow up.|4|||
16563938|NCT02446600|40527373|FG000|Overall Study|Never treated|20|||
16563939|NCT02446600|40527374|FG001|Overall Study|Never treated|2|||
16563940|NCT02446600|40527375|FG002|Overall Study|Never treated|6|||
16563941|NCT02446600|40527376|FG003|Overall Study|Never treated|0|||
16563942|NCT02446600|40527373|FG000|Overall Study|Withdrawal by Subject|19|||
16563943|NCT02446600|40527374|FG001|Overall Study|Withdrawal by Subject|5|||
16563944|NCT02446600|40527375|FG002|Overall Study|Withdrawal by Subject|17|||
16563945|NCT02446600|40527376|FG003|Overall Study|Withdrawal by Subject|0|||
16563946|NCT02446600|40527373|FG000|Overall Study|Ineligible|1|||
16563947|NCT02446600|40527374|FG001|Overall Study|Ineligible|4|||
16563948|NCT02446600|40527375|FG002|Overall Study|Ineligible|4|||
16563949|NCT02446600|40527376|FG003|Overall Study|Ineligible|1|||
16563950|NCT02446600|40527373|FG000|Overall Study|Duplicate Enrollment|0|||
16563951|NCT02446600|40527374|FG001|Overall Study|Duplicate Enrollment|1|||
16563952|NCT02446600|40527375|FG002|Overall Study|Duplicate Enrollment|0|||
16563953|NCT02446600|40527376|FG003|Overall Study|Duplicate Enrollment|0|||
16563954|NCT03251378|40527377|FG000|Overall Study|Death|3|||
16563955|NCT03251378|40527378|FG001|Overall Study|Death|2|||
16563956|NCT03251378|40527379|FG002|Overall Study|Death|3|||
16563957|NCT03251378|40527380|FG003|Overall Study|Death|30|||
16563958|NCT03251378|40527381|FG004|Overall Study|Death|24|||
16563959|NCT03251378|40527382|FG005|Overall Study|Death|12|||
16563960|NCT03251378|40527383|FG006|Overall Study|Death|12|||
16563961|NCT03251378|40527377|FG000|Overall Study|Lost to Follow-up|0|||
16563962|NCT03251378|40527378|FG001|Overall Study|Lost to Follow-up|0|||
16563963|NCT03251378|40527379|FG002|Overall Study|Lost to Follow-up|1|||
16563964|NCT03251378|40527380|FG003|Overall Study|Lost to Follow-up|3|||
16563965|NCT03251378|40527381|FG004|Overall Study|Lost to Follow-up|0|||
16563966|NCT03251378|40527382|FG005|Overall Study|Lost to Follow-up|0|||
16563967|NCT03251378|40527383|FG006|Overall Study|Lost to Follow-up|0|||
16563968|NCT03251378|40527377|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
16563969|NCT03251378|40527378|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
16563970|NCT03251378|40527379|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
16563971|NCT03251378|40527380|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
16563972|NCT03251378|40527381|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
16563973|NCT03251378|40527382|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
16563974|NCT03251378|40527383|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
16563975|NCT03251378|40527377|FG000|Overall Study|Progressive disease|2|||
16563976|NCT03251378|40527378|FG001|Overall Study|Progressive disease|0|||
16563977|NCT03251378|40527379|FG002|Overall Study|Progressive disease|0|||
16563978|NCT03251378|40527380|FG003|Overall Study|Progressive disease|1|||
16563979|NCT03251378|40527381|FG004|Overall Study|Progressive disease|0|||
16563980|NCT03251378|40527382|FG005|Overall Study|Progressive disease|0|||
16563981|NCT03251378|40527383|FG006|Overall Study|Progressive disease|0|||
16563982|NCT03251378|40527377|FG000|Overall Study|Physician Decision|0|||
16563983|NCT03251378|40527378|FG001|Overall Study|Physician Decision|2|||
16563984|NCT03251378|40527379|FG002|Overall Study|Physician Decision|0|||
16563985|NCT03251378|40527380|FG003|Overall Study|Physician Decision|0|||
16563986|NCT03251378|40527381|FG004|Overall Study|Physician Decision|0|||
16563987|NCT03251378|40527382|FG005|Overall Study|Physician Decision|0|||
16563988|NCT03251378|40527383|FG006|Overall Study|Physician Decision|0|||
16563989|NCT03251378|40527377|FG000|Overall Study|Other|2|||
16563990|NCT03251378|40527378|FG001|Overall Study|Other|3|||
16563991|NCT03251378|40527379|FG002|Overall Study|Other|2|||
16563992|NCT03251378|40527380|FG003|Overall Study|Other|0|||
16563993|NCT03251378|40527381|FG004|Overall Study|Other|1|||
16563994|NCT03251378|40527382|FG005|Overall Study|Other|1|||
16563995|NCT03251378|40527383|FG006|Overall Study|Other|1|||
16563996|NCT03251378|40527377|FG000|Overall Study|Other|0|||
16563997|NCT03251378|40527378|FG001|Overall Study|Other|0|||
16563998|NCT03251378|40527379|FG002|Overall Study|Other|0|||
16563999|NCT03251378|40527380|FG003|Overall Study|Other|4|||
16564000|NCT03251378|40527381|FG004|Overall Study|Other|13|||
16564001|NCT03251378|40527382|FG005|Overall Study|Other|0|||
16564002|NCT03251378|40527383|FG006|Overall Study|Other|0|||
16564003|NCT05576662|40527386|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
16564004|NCT05576662|40527387|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
16564005|NCT05576662|40527386|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
16564006|NCT05576662|40527387|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
16564007|NCT05576662|40527386|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
16564008|NCT05576662|40527387|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
16564009|NCT05576662|40527386|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
16564010|NCT05576662|40527387|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
16564011|NCT05824351|40527388|FG000|Overall Study|Adverse Event|6|||
16564012|NCT05550337|40527389|FG000|Overall Study|Lack of Efficacy|0|||
16564013|NCT05550337|40527390|FG001|Overall Study|Lack of Efficacy|0|||
16564014|NCT05550337|40527391|FG002|Overall Study|Lack of Efficacy|1|||
16564015|NCT05550337|40527389|FG000|Overall Study|Adverse Event|1|||
16564016|NCT05550337|40527390|FG001|Overall Study|Adverse Event|5|||
16564017|NCT05550337|40527391|FG002|Overall Study|Adverse Event|0|||
16564018|NCT05550337|40527389|FG000|Overall Study|Withdrawal by Subject|8|||
16564019|NCT05550337|40527390|FG001|Overall Study|Withdrawal by Subject|14|||
16564020|NCT05550337|40527391|FG002|Overall Study|Withdrawal by Subject|10|||
16564021|NCT05550337|40527389|FG000|Overall Study|Pregnancy|0|||
16564022|NCT05550337|40527390|FG001|Overall Study|Pregnancy|0|||
16564023|NCT05550337|40527391|FG002|Overall Study|Pregnancy|1|||
16564024|NCT05550337|40527389|FG000|Overall Study|Protocol Violation|1|||
16564025|NCT05550337|40527390|FG001|Overall Study|Protocol Violation|3|||
16564026|NCT05550337|40527391|FG002|Overall Study|Protocol Violation|4|||
16564027|NCT05550337|40527389|FG000|Overall Study|Physician Decision|2|||
16564028|NCT05550337|40527390|FG001|Overall Study|Physician Decision|1|||
16564029|NCT05550337|40527391|FG002|Overall Study|Physician Decision|1|||
16564030|NCT05550337|40527389|FG000|Overall Study|Lost to Follow-up|16|||
16564031|NCT05550337|40527390|FG001|Overall Study|Lost to Follow-up|11|||
16564032|NCT05550337|40527391|FG002|Overall Study|Lost to Follow-up|11|||
16564033|NCT03115346|40527392|FG000|Overall Study|Did not have AAA surgery|28|||
16564034|NCT03115346|40527393|FG001|Overall Study|Did not have AAA surgery|15|||
16564035|NCT03115346|40527392|FG000|Overall Study|Death|3|||
16564036|NCT03115346|40527393|FG001|Overall Study|Death|1|||
16564037|NCT03115346|40527392|FG000|Overall Study|Withdrawal by Subject|0|||
16564038|NCT03115346|40527393|FG001|Overall Study|Withdrawal by Subject|3|||
16564039|NCT03115346|40527392|FG000|Overall Study|Lost to Follow-up|0|||
16564040|NCT03115346|40527393|FG001|Overall Study|Lost to Follow-up|3|||
16564041|NCT03698994|40527397|FG000|Overall Study|Adverse Event|2|||
16564042|NCT03698994|40527397|FG000|Overall Study|Death|1|||
16564043|NCT03698994|40527397|FG000|Overall Study|Physician Decision|1|||
16564044|NCT03698994|40527397|FG000|Overall Study|Withdrawal by Subject|3|||
16564045|NCT03698994|40527397|FG000|Overall Study|Progressive Disease|12|||
16564046|NCT04236986|40527398|FG000|Overall Study|Withdrawal by Subject|3|||
16564047|NCT04236986|40527399|FG001|Overall Study|Withdrawal by Subject|1|||
16564048|NCT05355805|40527400|FG000|Overall Study|Lost to Follow-up|6|||
16564049|NCT05355805|40527401|FG001|Overall Study|Lost to Follow-up|5|||
16564050|NCT05355805|40527402|FG002|Overall Study|Lost to Follow-up|6|||
16564051|NCT05355805|40527403|FG003|Overall Study|Lost to Follow-up|2|||
16564052|NCT05355805|40527400|FG000|Overall Study|Decision by Sponsor|0|||
16564053|NCT05355805|40527401|FG001|Overall Study|Decision by Sponsor|0|||
16564054|NCT05355805|40527402|FG002|Overall Study|Decision by Sponsor|0|||
16564055|NCT05355805|40527403|FG003|Overall Study|Decision by Sponsor|1|||
16564056|NCT05355805|40527400|FG000|Overall Study|Withdrawal by Subject|7|||
16564057|NCT05355805|40527401|FG001|Overall Study|Withdrawal by Subject|10|||
16564058|NCT05355805|40527402|FG002|Overall Study|Withdrawal by Subject|9|||
16564059|NCT05355805|40527403|FG003|Overall Study|Withdrawal by Subject|2|||
16564060|NCT05355805|40527400|FG000|Overall Study|Missing|0|||
16564061|NCT05355805|40527401|FG001|Overall Study|Missing|0|||
16564062|NCT05355805|40527402|FG002|Overall Study|Missing|1|||
16564063|NCT05355805|40527403|FG003|Overall Study|Missing|0|||
16564064|NCT05355805|40527400|FG000|Overall Study|Ongoing|0|||
16564065|NCT05355805|40527401|FG001|Overall Study|Ongoing|41|||
16564066|NCT05355805|40527402|FG002|Overall Study|Ongoing|38|||
16564067|NCT05355805|40527403|FG003|Overall Study|Ongoing|48|||
16564068|NCT04155424|40527404|FG000|Overall Study|Other than specified|3|||
16564069|NCT04155424|40527404|FG000|Overall Study|Withdrawal by Subject|1|||
16564070|NCT04155424|40527404|FG000|Overall Study|Adverse Event|1|||
16564071|NCT04159506|40527405|FG000|Overall Study|Lost to Follow-up|2|||
16564072|NCT04159506|40527406|FG001|Overall Study|Lost to Follow-up|5|||
16564073|NCT04133363|40527411|FG000|Overall Study|Lost to Follow-up|2|||
16564074|NCT04133363|40527412|FG001|Overall Study|Lost to Follow-up|1|||
16564075|NCT04133363|40527413|FG002|Overall Study|Lost to Follow-up|4|||
16564076|NCT01251861|40527418|FG000|Overall Study|Disease progression|6|||
16564077|NCT01251861|40527419|FG001|Overall Study|Disease progression|6|||
16564078|NCT01251861|40527418|FG000|Overall Study|Adverse Event|2|||
16564079|NCT01251861|40527419|FG001|Overall Study|Adverse Event|17|||
16564080|NCT01251861|40527418|FG000|Overall Study|Withdrawal by Subject|2|||
16564081|NCT01251861|40527419|FG001|Overall Study|Withdrawal by Subject|2|||
16564082|NCT01251861|40527418|FG000|Overall Study|Alternative therapy|1|||
16564083|NCT01251861|40527419|FG001|Overall Study|Alternative therapy|0|||
16564084|NCT01251861|40527418|FG000|Overall Study|Other complicating disease|0|||
16564085|NCT01251861|40527419|FG001|Overall Study|Other complicating disease|1|||
16564086|NCT01251861|40527418|FG000|Overall Study|Physician Decision|1|||
16564087|NCT01251861|40527419|FG001|Overall Study|Physician Decision|0|||
16564088|NCT01251861|40527418|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
16564089|NCT01251861|40527419|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
16564090|NCT01251861|40527418|FG000|Overall Study|Other|1|||
16564091|NCT01251861|40527419|FG001|Overall Study|Other|0|||
16564092|NCT01251861|40527418|FG000|Overall Study|Never started therapy|4|||
16564093|NCT01251861|40527419|FG001|Overall Study|Never started therapy|1|||
16564094|NCT01251861|40527418|FG000|Overall Study|Potential interaction of drugs|0|||
16564095|NCT01251861|40527419|FG001|Overall Study|Potential interaction of drugs|1|||
16361120|NCT00116142|39807682|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
16430306|NCT01132313|40053933|FG005|Overall Study|Other reason not defined above|0|||
16250478|NCT02896361|39400494|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
16430307|NCT01132313|40053934|FG006|Overall Study|Other reason not defined above|0|||
16430308|NCT01132313|40053935|FG007|Overall Study|Other reason not defined above|1|||
16430309|NCT01132313|40053936|FG008|Overall Study|Other reason not defined above|0|||
16430310|NCT01132313|40053937|FG009|Overall Study|Other reason not defined above|0|||
16430311|NCT01132313|40053938|FG010|Overall Study|Other reason not defined above|0|||
16430312|NCT01132313|40053939|FG011|Overall Study|Other reason not defined above|0|||
16430313|NCT01147055|40053944|FG000|First Intervention Period|Lost to Follow-up|1|||
16430314|NCT01147055|40053945|FG001|First Intervention Period|Lost to Follow-up|0|||
16430315|NCT03831100|40053946|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
16430316|NCT03831100|40053947|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
16430317|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
16430318|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
16430319|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
16430320|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
16131320|NCT01315353|38967268|FG000|Overall Study|Death|2|||
16250479|NCT02896361|39400492|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
16250480|NCT02896361|39400493|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
16250481|NCT02896361|39400494|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
16250482|NCT00672620|39400501|FG000|Overall Study|Adverse Event|7|||
16250483|NCT00672620|39400502|FG001|Overall Study|Adverse Event|7|||
16250484|NCT00672620|39400503|FG002|Overall Study|Adverse Event|12|||
16250485|NCT00672620|39400504|FG003|Overall Study|Adverse Event|17|||
16250486|NCT00672620|39400501|FG000|Overall Study|Lack of Efficacy|1|||
16250487|NCT00672620|39400502|FG001|Overall Study|Lack of Efficacy|2|||
16250488|NCT00672620|39400503|FG002|Overall Study|Lack of Efficacy|2|||
16250489|NCT00672620|39400504|FG003|Overall Study|Lack of Efficacy|0|||
16250490|NCT00672620|39400501|FG000|Overall Study|Noncompliance with Study Drug|3|||
16250491|NCT00672620|39400502|FG001|Overall Study|Noncompliance with Study Drug|4|||
16250492|NCT00672620|39400503|FG002|Overall Study|Noncompliance with Study Drug|0|||
16250493|NCT00672620|39400504|FG003|Overall Study|Noncompliance with Study Drug|2|||
16250494|NCT00672620|39400501|FG000|Overall Study|Protocol Deviations|5|||
16250495|NCT00672620|39400502|FG001|Overall Study|Protocol Deviations|7|||
16250496|NCT00672620|39400503|FG002|Overall Study|Protocol Deviations|2|||
16250497|NCT00672620|39400504|FG003|Overall Study|Protocol Deviations|5|||
16250498|NCT00672620|39400501|FG000|Overall Study|Withdrawal of Consent|6|||
16250499|NCT00672620|39400502|FG001|Overall Study|Withdrawal of Consent|12|||
16250500|NCT00672620|39400503|FG002|Overall Study|Withdrawal of Consent|5|||
16250501|NCT00672620|39400504|FG003|Overall Study|Withdrawal of Consent|6|||
16250502|NCT00672620|39400501|FG000|Overall Study|Lost to Follow-up|8|||
16250503|NCT00672620|39400502|FG001|Overall Study|Lost to Follow-up|19|||
16250504|NCT00672620|39400503|FG002|Overall Study|Lost to Follow-up|8|||
16250505|NCT00672620|39400504|FG003|Overall Study|Lost to Follow-up|11|||
16250506|NCT00672620|39400501|FG000|Overall Study|Reason not Specified|3|||
16250507|NCT00672620|39400502|FG001|Overall Study|Reason not Specified|3|||
16250508|NCT00672620|39400503|FG002|Overall Study|Reason not Specified|2|||
16250509|NCT00672620|39400504|FG003|Overall Study|Reason not Specified|1|||
16250510|NCT02607800|39400505|FG000|Overall Study|Lost to Follow-up|7|||
16250511|NCT02607800|39400506|FG001|Overall Study|Lost to Follow-up|10|||
16250512|NCT02607800|39400505|FG000|Overall Study|Withdrew Consent|2|||
16250513|NCT02607800|39400506|FG001|Overall Study|Withdrew Consent|0|||
16250514|NCT02607800|39400505|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
16250515|NCT02607800|39400506|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
16250516|NCT04480463|39400507|FG000|Overall Study|Death|0|||
16250517|NCT04480463|39400508|FG001|Overall Study|Death|1|||
16250518|NCT04480463|39400507|FG000|Overall Study|Adverse Event|6|||
16250519|NCT04480463|39400508|FG001|Overall Study|Adverse Event|8|||
16250520|NCT04480463|39400507|FG000|Overall Study|Lost to Follow-up|3|||
16250521|NCT04480463|39400508|FG001|Overall Study|Lost to Follow-up|2|||
16250522|NCT04480463|39400507|FG000|Overall Study|Physician Decision|2|||
16250523|NCT04480463|39400508|FG001|Overall Study|Physician Decision|5|||
16250524|NCT04480463|39400507|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
16250525|NCT04480463|39400508|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
16250526|NCT04480463|39400507|FG000|Overall Study|Protocol Violation|2|||
16250527|NCT04480463|39400508|FG001|Overall Study|Protocol Violation|1|||
16250528|NCT04480463|39400507|FG000|Overall Study|Withdrawal by Subject|6|||
16250529|NCT04480463|39400508|FG001|Overall Study|Withdrawal by Subject|7|||
16250530|NCT04480463|39400507|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
16131321|NCT01315353|38967269|FG001|Overall Study|Death|1|||
16131322|NCT01315353|38967270|FG002|Overall Study|Death|0|||
16131323|NCT01315353|38967268|FG000|Overall Study|Withdrawal by Subject|2|||
16250531|NCT04480463|39400508|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
16250532|NCT04480463|39400507|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
16250533|NCT04480463|39400508|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
16250534|NCT04480463|39400507|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
16250535|NCT04480463|39400508|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
16250536|NCT04480463|39400507|FG000|Overall Study|Other|6|||
16250537|NCT04480463|39400508|FG001|Overall Study|Other|4|||
16250538|NCT00376220|39400510|FG000|Overall Study|Lost to Follow-up|7|||
16250539|NCT00376220|39400511|FG001|Overall Study|Lost to Follow-up|10|||
16250540|NCT00376220|39400510|FG000|Overall Study|Withdrawal by Subject|3|||
16250541|NCT00376220|39400511|FG001|Overall Study|Withdrawal by Subject|2|||
16250542|NCT00299156|39400513|FG000|Period 2 (Randomized)|Screen Failure|0|||
16250543|NCT00299156|39400514|FG001|Period 2 (Randomized)|Screen Failure|1|||
16250544|NCT00299156|39400515|FG002|Period 2 (Randomized)|Screen Failure|0|||
16250545|NCT00434161|39400516|FG000|Overall Study|Adverse Event|5|||
16250546|NCT00434161|39400517|FG001|Overall Study|Adverse Event|1|||
16250547|NCT00434161|39400518|FG002|Overall Study|Adverse Event|4|||
16250548|NCT00434161|39400516|FG000|Overall Study|Lost to Follow-up|0|||
16250549|NCT00434161|39400517|FG001|Overall Study|Lost to Follow-up|1|||
16250550|NCT00434161|39400518|FG002|Overall Study|Lost to Follow-up|0|||
16250551|NCT00434161|39400516|FG000|Overall Study|Death|1|||
16250552|NCT00434161|39400517|FG001|Overall Study|Death|0|||
16250553|NCT00434161|39400518|FG002|Overall Study|Death|1|||
16250554|NCT00434161|39400516|FG000|Overall Study|Non-Compliance|1|||
16250555|NCT00434161|39400517|FG001|Overall Study|Non-Compliance|1|||
16250556|NCT00434161|39400518|FG002|Overall Study|Non-Compliance|0|||
16250557|NCT00434161|39400516|FG000|Overall Study|Withdrawal by Subject|2|||
16250558|NCT00434161|39400517|FG001|Overall Study|Withdrawal by Subject|0|||
16250559|NCT00434161|39400518|FG002|Overall Study|Withdrawal by Subject|3|||
16250560|NCT00434161|39400516|FG000|Overall Study|Logistical error study assessments|1|||
16250561|NCT00434161|39400517|FG001|Overall Study|Logistical error study assessments|0|||
16250562|NCT00434161|39400518|FG002|Overall Study|Logistical error study assessments|3|||
16250563|NCT02961920|39400522|FG000|Overall Study|did not achive stydy protocol schedule|1|||
16250564|NCT02961920|39400523|FG001|Overall Study|did not achive stydy protocol schedule|1|||
16250565|NCT02658084|39400524|FG000|Overall Study|Withdrawal by Subject|1|||
16250566|NCT02658084|39400525|FG001|Overall Study|Withdrawal by Subject|0|||
16250567|NCT02658084|39400524|FG000|Overall Study|Study Termination|1|||
16250568|NCT02658084|39400525|FG001|Overall Study|Study Termination|0|||
16250569|NCT05431153|39400526|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
16250570|NCT05431153|39400527|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
16250571|NCT05431153|39400528|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
16250572|NCT05431153|39400529|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
16250573|NCT05431153|39400530|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
16250574|NCT05431153|39400531|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
16250575|NCT03342898|39400534|FG000|Overall Study|Adverse Event|3|||
16250576|NCT03342898|39400535|FG001|Overall Study|Adverse Event|1|||
16250577|NCT03342898|39400536|FG002|Overall Study|Adverse Event|0|||
16250578|NCT03342898|39400534|FG000|Overall Study|Lost to Follow-up|44|||
16250579|NCT03342898|39400535|FG001|Overall Study|Lost to Follow-up|40|||
16250580|NCT03342898|39400536|FG002|Overall Study|Lost to Follow-up|42|||
16250581|NCT03342898|39400534|FG000|Overall Study|Withdrawal of Consent|5|||
16250582|NCT03342898|39400535|FG001|Overall Study|Withdrawal of Consent|9|||
16250583|NCT03342898|39400536|FG002|Overall Study|Withdrawal of Consent|11|||
16250584|NCT03342898|39400534|FG000|Overall Study|Death|0|||
16250585|NCT03342898|39400535|FG001|Overall Study|Death|1|||
16250586|NCT03342898|39400536|FG002|Overall Study|Death|1|||
16250587|NCT03342898|39400534|FG000|Overall Study|Reason not Specified|2|||
16250588|NCT03342898|39400535|FG001|Overall Study|Reason not Specified|2|||
16250589|NCT03342898|39400536|FG002|Overall Study|Reason not Specified|0|||
16250590|NCT02043366|39400537|FG000|Overall Study|Lost to Follow-up|2|||
16250591|NCT02043366|39400538|FG001|Overall Study|Lost to Follow-up|2|||
16250592|NCT02043366|39400539|FG002|Overall Study|Lost to Follow-up|2|||
16250593|NCT02043366|39400540|FG003|Overall Study|Lost to Follow-up|2|||
16250594|NCT02043366|39400541|FG004|Overall Study|Lost to Follow-up|2|||
16250595|NCT02043366|39400542|FG005|Overall Study|Lost to Follow-up|2|||
16250596|NCT03093454|39400543|FG000|Overall Study|Withdrawal by Subject|1|||
16250597|NCT03093454|39400544|FG001|Overall Study|Withdrawal by Subject|1|||
16250598|NCT03093454|39400543|FG000|Overall Study|Scheduling conflict|3|||
16250599|NCT03093454|39400544|FG001|Overall Study|Scheduling conflict|1|||
16250600|NCT03093454|39400543|FG000|Overall Study|Physician Decision|2|||
16250601|NCT03093454|39400544|FG001|Overall Study|Physician Decision|1|||
16250602|NCT01315249|39400545|FG000|Overall Study|Adverse Event|22|||
16250603|NCT01315249|39400546|FG001|Overall Study|Adverse Event|26|||
16250604|NCT01315249|39400545|FG000|Overall Study|Withdrawal by Subject|11|||
16250605|NCT01315249|39400546|FG001|Overall Study|Withdrawal by Subject|10|||
16250606|NCT01315249|39400545|FG000|Overall Study|Protocol Violation|8|||
16250607|NCT01315249|39400546|FG001|Overall Study|Protocol Violation|5|||
16250608|NCT01315249|39400545|FG000|Overall Study|Abnormal test results|1|||
16131324|NCT01315353|38967269|FG001|Overall Study|Withdrawal by Subject|6|||
16430321|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
16430322|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
16250609|NCT01315249|39400546|FG001|Overall Study|Abnormal test results|2|||
16250610|NCT01315249|39400545|FG000|Overall Study|Administrative problems|1|||
16250611|NCT01315249|39400546|FG001|Overall Study|Administrative problems|0|||
16250612|NCT01315249|39400545|FG000|Overall Study|inability to use device|1|||
16250613|NCT01315249|39400546|FG001|Overall Study|inability to use device|0|||
16250614|NCT01315249|39400545|FG000|Overall Study|Lack of Efficacy|0|||
16250615|NCT01315249|39400546|FG001|Overall Study|Lack of Efficacy|1|||
16250616|NCT01315249|39400545|FG000|Overall Study|Lost to Follow-up|0|||
16250617|NCT01315249|39400546|FG001|Overall Study|Lost to Follow-up|2|||
16250618|NCT01315249|39400545|FG000|Overall Study|Death|0|||
16250619|NCT01315249|39400546|FG001|Overall Study|Death|1|||
16250620|NCT03522948|39400547|FG000|Overall Study|Lost to Follow-up|1|||
16250621|NCT01939197|39400554|FG000|Overall Study|Withdrawal by Subject|1|||
16250622|NCT01939197|39400555|FG001|Overall Study|Withdrawal by Subject|0|||
16250623|NCT01939197|39400556|FG002|Overall Study|Withdrawal by Subject|0|||
16250624|NCT01939197|39400557|FG003|Overall Study|Withdrawal by Subject|0|||
16250625|NCT01939197|39400558|FG004|Overall Study|Withdrawal by Subject|1|||
16250626|NCT01939197|39400559|FG005|Overall Study|Withdrawal by Subject|0|||
16250627|NCT01939197|39400560|FG006|Overall Study|Withdrawal by Subject|0|||
16250628|NCT01939197|39400554|FG000|Overall Study|Lost to Follow-up|0|||
16250629|NCT01939197|39400555|FG001|Overall Study|Lost to Follow-up|1|||
16250630|NCT01939197|39400556|FG002|Overall Study|Lost to Follow-up|0|||
16250631|NCT01939197|39400557|FG003|Overall Study|Lost to Follow-up|1|||
16250632|NCT01939197|39400558|FG004|Overall Study|Lost to Follow-up|3|||
16250633|NCT01939197|39400559|FG005|Overall Study|Lost to Follow-up|1|||
16250634|NCT01939197|39400560|FG006|Overall Study|Lost to Follow-up|2|||
16250635|NCT02322047|39400567|FG000|Overall Study|Physician Decision|1|||
16250636|NCT02322047|39400568|FG001|Overall Study|Physician Decision|0|||
16250637|NCT02322047|39400569|FG002|Overall Study|Physician Decision|0|||
16361121|NCT00116142|39807681|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
16361122|NCT00116142|39807682|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
16361123|NCT00753519|39807683|FG000|Overall Study|Withdrawal by Subject|0|||
16361124|NCT00753519|39807684|FG001|Overall Study|Withdrawal by Subject|2|||
16361125|NCT04124965|39807686|FG000|Overall Study|Adverse event, non-fatal|3|||
16361126|NCT04124965|39807687|FG001|Overall Study|Adverse event, non-fatal|1|||
16361127|NCT04124965|39807686|FG000|Overall Study|Withdrawal by Subject|1|||
16361128|NCT04124965|39807687|FG001|Overall Study|Withdrawal by Subject|1|||
16361129|NCT04124965|39807686|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
16361130|NCT04124965|39807687|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
16361131|NCT04124965|39807686|FG000|Overall Study|Pregnancy|1|||
16361132|NCT04124965|39807687|FG001|Overall Study|Pregnancy|0|||
16361133|NCT04124965|39807686|FG000|Overall Study|Sponsor and participant decision|0|||
16361134|NCT04124965|39807687|FG001|Overall Study|Sponsor and participant decision|1|||
16361135|NCT04124965|39807686|FG000|Overall Study|Personal surgery|0|||
16361136|NCT04124965|39807687|FG001|Overall Study|Personal surgery|1|||
16361137|NCT04124965|39807686|FG000|Overall Study|Physician Decision|0|||
16361138|NCT04124965|39807687|FG001|Overall Study|Physician Decision|1|||
16361139|NCT00924898|39807688|FG000|Overall Study|Withdrawal by Subject|2|||
16361140|NCT02059239|39807689|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
16361141|NCT02059239|39807690|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
16361142|NCT02059239|39807689|FG000|Overall Study|Physician Decision|1|||
16250638|NCT02322047|39400570|FG003|Overall Study|Physician Decision|0|||
16361143|NCT02059239|39807690|FG001|Overall Study|Physician Decision|0|||
16250639|NCT02322047|39400567|FG000|Overall Study|Withdrawal by Subject|1|||
16250640|NCT02322047|39400568|FG001|Overall Study|Withdrawal by Subject|0|||
16430323|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
16430324|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
16430325|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
16361144|NCT01723072|39807695|FG000|Overall Study|Withdrawal by Subject|7|||
16361145|NCT01723072|39807696|FG001|Overall Study|Withdrawal by Subject|13|||
16430326|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
16430327|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
16430328|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
16430329|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
16430330|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
16430331|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
16430332|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
16430333|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
16430334|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
16430335|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
16430336|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
16430337|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
16430338|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
16430339|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
16430340|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
16430341|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
16430342|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
16430343|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
16430344|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
16430345|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
16430346|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
16430347|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
16430348|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
16430349|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
16430350|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
16430351|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
16430352|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
16430353|NCT02586623|40053950|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
16430354|NCT02586623|40053951|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
16430355|NCT02586623|40053952|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
16430356|NCT02586623|40053950|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
16430357|NCT02586623|40053951|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
16430358|NCT02586623|40053952|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
16430359|NCT02586623|40053950|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
16430360|NCT02586623|40053951|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
16430361|NCT02586623|40053952|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
16430362|NCT02586623|40053950|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
16430363|NCT02586623|40053951|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
16430364|NCT02586623|40053952|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
16430365|NCT02586623|40053950|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
16430366|NCT02586623|40053951|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
16430367|NCT02586623|40053952|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
16430368|NCT02586623|40053950|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
16430369|NCT02586623|40053951|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
16430370|NCT02586623|40053952|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
16430371|NCT02586623|40053950|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
16430372|NCT02586623|40053951|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
16430373|NCT02586623|40053952|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
16430374|NCT02586623|40053950|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
16430375|NCT02586623|40053951|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
16430376|NCT02586623|40053952|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
16430377|NCT02586623|40053950|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
16430378|NCT02586623|40053951|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
16131325|NCT01315353|38967270|FG002|Overall Study|Withdrawal by Subject|1|||
16131326|NCT01315353|38967268|FG000|Overall Study|Lost to Follow-up|13|||
16250641|NCT02322047|39400569|FG002|Overall Study|Withdrawal by Subject|0|||
16430379|NCT02586623|40053952|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
16430380|NCT01216683|40053956|FG000|Induction|Never started treatment|0|||
16430381|NCT01216683|40053957|FG001|Induction|Never started treatment|6|||
16430382|NCT01216683|40053958|FG002|Induction|Never started treatment|3|||
16430383|NCT01216683|40053956|FG000|Induction|Lack of Efficacy|4|||
16430384|NCT01216683|40053957|FG001|Induction|Lack of Efficacy|3|||
16430385|NCT01216683|40053958|FG002|Induction|Lack of Efficacy|7|||
16430386|NCT01216683|40053956|FG000|Induction|Adverse Event|0|||
16430387|NCT01216683|40053957|FG001|Induction|Adverse Event|5|||
16430388|NCT01216683|40053958|FG002|Induction|Adverse Event|5|||
16430389|NCT01216683|40053956|FG000|Induction|Death|0|||
16430390|NCT01216683|40053957|FG001|Induction|Death|0|||
16430391|NCT01216683|40053958|FG002|Induction|Death|2|||
16430392|NCT01216683|40053956|FG000|Induction|Withdrawal by Subject|0|||
16430393|NCT01216683|40053957|FG001|Induction|Withdrawal by Subject|4|||
16430394|NCT01216683|40053958|FG002|Induction|Withdrawal by Subject|2|||
16430395|NCT01216683|40053956|FG000|Induction|Other disease|0|||
16430396|NCT01216683|40053957|FG001|Induction|Other disease|1|||
16430397|NCT01216683|40053958|FG002|Induction|Other disease|2|||
16430398|NCT01216683|40053956|FG000|Continuation|Lack of Efficacy|3|||
16430399|NCT01216683|40053957|FG001|Continuation|Lack of Efficacy|2|||
16430400|NCT01216683|40053958|FG002|Continuation|Lack of Efficacy|7|||
16430401|NCT01216683|40053956|FG000|Continuation|Adverse Event|5|||
16430402|NCT01216683|40053957|FG001|Continuation|Adverse Event|3|||
16430403|NCT01216683|40053958|FG002|Continuation|Adverse Event|16|||
16430404|NCT01216683|40053956|FG000|Continuation|Death|1|||
16430405|NCT01216683|40053957|FG001|Continuation|Death|0|||
16430406|NCT01216683|40053958|FG002|Continuation|Death|2|||
16430407|NCT01216683|40053956|FG000|Continuation|Withdrawal by Subject|4|||
16430408|NCT01216683|40053957|FG001|Continuation|Withdrawal by Subject|5|||
16430409|NCT01216683|40053958|FG002|Continuation|Withdrawal by Subject|9|||
16430410|NCT01216683|40053956|FG000|Continuation|Other diseases|0|||
16430411|NCT01216683|40053957|FG001|Continuation|Other diseases|2|||
16430412|NCT01216683|40053958|FG002|Continuation|Other diseases|1|||
16430413|NCT01216683|40053956|FG000|Continuation|Physician Decision|1|||
16430414|NCT01216683|40053957|FG001|Continuation|Physician Decision|0|||
16430415|NCT01216683|40053958|FG002|Continuation|Physician Decision|1|||
16430416|NCT01216683|40053956|FG000|Continuation|Non-compliance|1|||
16430417|NCT01216683|40053957|FG001|Continuation|Non-compliance|0|||
16430418|NCT01216683|40053958|FG002|Continuation|Non-compliance|1|||
16430419|NCT01216683|40053956|FG000|Continuation|Insurance change|0|||
16430420|NCT01216683|40053957|FG001|Continuation|Insurance change|1|||
16430421|NCT01216683|40053958|FG002|Continuation|Insurance change|0|||
16430422|NCT01216683|40053956|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
16430423|NCT01216683|40053957|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
16430424|NCT01216683|40053958|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
16430425|NCT01216683|40053956|FG000|Continuation|Not reported|0|||
16430426|NCT01216683|40053957|FG001|Continuation|Not reported|0|||
16430427|NCT01216683|40053958|FG002|Continuation|Not reported|1|||
16430428|NCT01216683|40053956|FG000|Continuation|Never started treatment|0|||
16430429|NCT01216683|40053957|FG001|Continuation|Never started treatment|1|||
16430430|NCT01216683|40053958|FG002|Continuation|Never started treatment|5|||
16430431|NCT02206035|40053961|FG000|Overall Study|Physician Decision|10|||
16430432|NCT02206035|40053962|FG001|Overall Study|Physician Decision|0|||
16430433|NCT02206035|40053963|FG002|Overall Study|Physician Decision|175|||
16430434|NCT02420093|40053964|FG000|Overall Study|Withdrawal by Subject|1|||
16430435|NCT02420093|40053965|FG001|Overall Study|Withdrawal by Subject|1|||
16430436|NCT00719680|40053966|FG000|Overall Study|Adverse Event|1|||
16430437|NCT00719680|40053966|FG000|Overall Study|Lost to Follow-up|1|||
16430438|NCT00719680|40053966|FG000|Overall Study|Withdrawal by Subject|3|||
16430439|NCT04034004|40053967|FG000|Overall Study|Withdrawal by Subject|1|||
16430440|NCT04034004|40053968|FG001|Overall Study|Withdrawal by Subject|2|||
16430441|NCT04034004|40053969|FG002|Overall Study|Withdrawal by Subject|2|||
16430442|NCT04034004|40053970|FG003|Overall Study|Withdrawal by Subject|3|||
16430443|NCT04034004|40053967|FG000|Overall Study|could not find vein to administer IV|2|||
16430444|NCT04034004|40053968|FG001|Overall Study|could not find vein to administer IV|1|||
16430445|NCT04034004|40053969|FG002|Overall Study|could not find vein to administer IV|0|||
16430446|NCT04034004|40053970|FG003|Overall Study|could not find vein to administer IV|0|||
16430447|NCT04034004|40053967|FG000|Overall Study|nurse accidentally unblinded subject|0|||
16430448|NCT04034004|40053968|FG001|Overall Study|nurse accidentally unblinded subject|0|||
16430449|NCT04034004|40053969|FG002|Overall Study|nurse accidentally unblinded subject|0|||
16430450|NCT04034004|40053970|FG003|Overall Study|nurse accidentally unblinded subject|1|||
16430451|NCT03191630|40053971|FG000|Overall Study|Lost to Follow-up|7|||
16430452|NCT03191630|40053972|FG001|Overall Study|Lost to Follow-up|7|||
16430453|NCT02034877|40053973|FG000|Overall Study|Lost to Follow-up|0|||
16430454|NCT02034877|40053974|FG001|Overall Study|Lost to Follow-up|3|||
16430455|NCT02034877|40053973|FG000|Overall Study|No Longer Willing to Participate|0|||
16430456|NCT02034877|40053974|FG001|Overall Study|No Longer Willing to Participate|3|||
16430457|NCT04816214|40053975|FG000|Overall Study|Progressive Disease|4|||
16430458|NCT04816214|40053976|FG001|Overall Study|Progressive Disease|0|||
16430459|NCT04816214|40053977|FG002|Overall Study|Progressive Disease|0|||
16430460|NCT04816214|40053975|FG000|Overall Study|Death|1|||
16430461|NCT04816214|40053976|FG001|Overall Study|Death|0|||
16430462|NCT04816214|40053977|FG002|Overall Study|Death|0|||
16430463|NCT04816214|40053975|FG000|Overall Study|Study Terminated by Sponsor|1|||
16430464|NCT04816214|40053976|FG001|Overall Study|Study Terminated by Sponsor|0|||
16430465|NCT04816214|40053977|FG002|Overall Study|Study Terminated by Sponsor|0|||
16430466|NCT01487265|40053978|FG000|Overall Study|Adverse Event|8|||
16430467|NCT01487265|40053978|FG000|Overall Study|Withdrawal by Subject|5|||
16430468|NCT01487265|40053978|FG000|Overall Study|Disease Progression|21|||
16430469|NCT01487265|40053978|FG000|Overall Study|Death|2|||
16430470|NCT01487265|40053978|FG000|Overall Study|Still on Treatment|1|||
16430471|NCT03948334|40053979|FG000|Overall Study|Adverse Event|1|||
16430472|NCT03948334|40053980|FG001|Overall Study|Adverse Event|4|||
16430473|NCT03948334|40053979|FG000|Overall Study|Lack of Efficacy|2|||
16430474|NCT03948334|40053980|FG001|Overall Study|Lack of Efficacy|0|||
16430475|NCT03948334|40053979|FG000|Overall Study|Lost to Follow-up|1|||
16430476|NCT03948334|40053980|FG001|Overall Study|Lost to Follow-up|0|||
16430477|NCT03948334|40053979|FG000|Overall Study|Physician Decision|1|||
16430478|NCT03948334|40053980|FG001|Overall Study|Physician Decision|0|||
16430479|NCT03948334|40053979|FG000|Overall Study|Pregnancy|0|||
16430480|NCT03948334|40053980|FG001|Overall Study|Pregnancy|1|||
16430481|NCT03948334|40053979|FG000|Overall Study|Protocol Deviation|1|||
16430482|NCT03948334|40053980|FG001|Overall Study|Protocol Deviation|0|||
16430483|NCT03948334|40053979|FG000|Overall Study|Study terminated by Sponsor|50|||
16430484|NCT03948334|40053980|FG001|Overall Study|Study terminated by Sponsor|51|||
16430485|NCT03948334|40053979|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
16430486|NCT03948334|40053980|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
16430487|NCT00871338|40053981|FG000|Prior to Booster|Withdrawal by Subject|1|||
16430488|NCT00871338|40053982|FG001|Prior to Booster|Withdrawal by Subject|3|||
16430489|NCT00871338|40053981|FG000|Prior to Booster|Lost to Follow-up|1|||
16430490|NCT00871338|40053982|FG001|Prior to Booster|Lost to Follow-up|0|||
16430491|NCT02596230|40053987|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
16430492|NCT02596230|40053988|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
16430493|NCT02596230|40053989|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
16430494|NCT02596230|40053990|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
16430495|NCT02596230|40053991|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
16430496|NCT02596230|40053987|FG000|Objective 2, One Year|Lost to Follow-up|0|||
16430497|NCT02596230|40053988|FG001|Objective 2, One Year|Lost to Follow-up|41|||
16430498|NCT02596230|40053989|FG002|Objective 2, One Year|Lost to Follow-up|41|||
16430499|NCT02596230|40053990|FG003|Objective 2, One Year|Lost to Follow-up|32|||
16430500|NCT02596230|40053991|FG004|Objective 2, One Year|Lost to Follow-up|46|||
16430501|NCT02596230|40053987|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
16430502|NCT02596230|40053988|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
16430503|NCT02596230|40053989|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
16430504|NCT02596230|40053990|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
16430505|NCT02596230|40053991|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
16430506|NCT02596230|40053987|FG000|Objective 2, One Year|Adverse drug reaction|0|||
16430507|NCT02596230|40053988|FG001|Objective 2, One Year|Adverse drug reaction|1|||
16430508|NCT02596230|40053989|FG002|Objective 2, One Year|Adverse drug reaction|0|||
16430509|NCT02596230|40053990|FG003|Objective 2, One Year|Adverse drug reaction|0|||
16430510|NCT02596230|40053991|FG004|Objective 2, One Year|Adverse drug reaction|0|||
16430511|NCT02596230|40053987|FG000|Objective 2, One Year|Death|0|||
16430512|NCT02596230|40053988|FG001|Objective 2, One Year|Death|12|||
16430513|NCT02596230|40053989|FG002|Objective 2, One Year|Death|41|||
16430514|NCT02596230|40053990|FG003|Objective 2, One Year|Death|21|||
16430515|NCT02596230|40053991|FG004|Objective 2, One Year|Death|30|||
16430516|NCT02596230|40053987|FG000|Objective 2, One Year|Other|0|||
16430517|NCT02596230|40053988|FG001|Objective 2, One Year|Other|3|||
16430518|NCT02596230|40053989|FG002|Objective 2, One Year|Other|2|||
16430519|NCT02596230|40053990|FG003|Objective 2, One Year|Other|0|||
16430520|NCT02596230|40053991|FG004|Objective 2, One Year|Other|0|||
16430521|NCT02995980|40053992|FG000|Overall Study|Lost to Follow-up|14|||
16430522|NCT00354679|40053993|FG000|Overall Study|Patient Not Treated|1|||
16430523|NCT00132808|40054000|FG000|Stratum I|Adverse Event|2|||
16430524|NCT00132808|40054001|FG001|Stratum I|Adverse Event|1|||
16361146|NCT01723072|39807695|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
16361147|NCT01723072|39807696|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
16361148|NCT01723072|39807695|FG000|Overall Study|Other|4|||
16361149|NCT01723072|39807696|FG001|Overall Study|Other|3|||
16361150|NCT01416571|39807697|FG000|Overall Study|Lost to Follow-up|2|||
16361151|NCT00959751|39807698|FG000|Overall Study|Lost to Follow-up|2|||
16361152|NCT00959751|39807699|FG001|Overall Study|Lost to Follow-up|3|||
16361153|NCT00959751|39807698|FG000|Overall Study|Consent Withdrawn|0|||
16361154|NCT00959751|39807699|FG001|Overall Study|Consent Withdrawn|1|||
16361155|NCT00959751|39807698|FG000|Overall Study|Non-compliance to Study Procedures|0|||
16361156|NCT00959751|39807699|FG001|Overall Study|Non-compliance to Study Procedures|1|||
16361157|NCT00959751|39807698|FG000|Overall Study|No migraine headache without aura|7|||
16361158|NCT00959751|39807699|FG001|Overall Study|No migraine headache without aura|7|||
16361159|NCT01500187|39807700|FG000|Overall Study|Lost to Follow-up|6|||
16361160|NCT01500187|39807701|FG001|Overall Study|Lost to Follow-up|0|||
16361161|NCT02133508|39807706|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
16361162|NCT02133508|39807706|FG000|Overall Study|Death|12|||
16361163|NCT02133508|39807706|FG000|Overall Study|Lost to Follow-up|2|||
16361164|NCT01294046|39807707|FG000|Overall Study|Infection and surgical explant|1|||
16430525|NCT00132808|40054002|FG002|Stratum I|Adverse Event|0|||
16430526|NCT00132808|40054000|FG000|Stratum I|Lost to Follow-up|3|||
16430527|NCT00132808|40054001|FG001|Stratum I|Lost to Follow-up|4|||
16430528|NCT00132808|40054002|FG002|Stratum I|Lost to Follow-up|1|||
16430529|NCT00132808|40054000|FG000|Stratum I|Withdrawal by Subject|4|||
16430530|NCT00132808|40054001|FG001|Stratum I|Withdrawal by Subject|7|||
16430531|NCT00132808|40054002|FG002|Stratum I|Withdrawal by Subject|3|||
16430532|NCT00132808|40054000|FG000|Stratum I|Abnormal test procedure result (s)|0|||
16430533|NCT00132808|40054001|FG001|Stratum I|Abnormal test procedure result (s)|0|||
16430534|NCT00132808|40054002|FG002|Stratum I|Abnormal test procedure result (s)|1|||
16430535|NCT00132808|40054000|FG000|Stratum II|Adverse Event|1|||
16430536|NCT00132808|40054001|FG001|Stratum II|Adverse Event|2|||
16430537|NCT00132808|40054002|FG002|Stratum II|Adverse Event|1|||
16430538|NCT00132808|40054000|FG000|Stratum II|Death|1|||
16430539|NCT00132808|40054001|FG001|Stratum II|Death|0|||
16430540|NCT00132808|40054002|FG002|Stratum II|Death|0|||
16430541|NCT00132808|40054000|FG000|Stratum II|Lost to Follow-up|2|||
16430542|NCT00132808|40054001|FG001|Stratum II|Lost to Follow-up|2|||
16430543|NCT00132808|40054002|FG002|Stratum II|Lost to Follow-up|1|||
16430544|NCT00132808|40054000|FG000|Stratum II|Protocol Violation|0|||
16430545|NCT00132808|40054001|FG001|Stratum II|Protocol Violation|2|||
16430546|NCT00132808|40054002|FG002|Stratum II|Protocol Violation|1|||
16430547|NCT00132808|40054000|FG000|Stratum II|Withdrawal by Subject|4|||
16430548|NCT00132808|40054001|FG001|Stratum II|Withdrawal by Subject|9|||
16430549|NCT00132808|40054002|FG002|Stratum II|Withdrawal by Subject|6|||
16430550|NCT03980730|40054010|FG000|Overall Study|Study Terminated by Sponsor|0|||
16430551|NCT03980730|40054011|FG001|Overall Study|Study Terminated by Sponsor|3|||
16430552|NCT03980730|40054010|FG000|Overall Study|Adverse Event|2|||
16430553|NCT03980730|40054011|FG001|Overall Study|Adverse Event|0|||
16430554|NCT03980730|40054010|FG000|Overall Study|Sponsor Request|0|||
16430555|NCT03980730|40054011|FG001|Overall Study|Sponsor Request|1|||
16430556|NCT03549104|40054012|FG000|Overall Study|Withdrawal by Subject|5|||
16430557|NCT03549104|40054013|FG001|Overall Study|Withdrawal by Subject|2|||
16430558|NCT03549104|40054012|FG000|Overall Study|Covid shelter in place|1|||
16430559|NCT03549104|40054013|FG001|Overall Study|Covid shelter in place|2|||
16430560|NCT01449006|40054017|FG000|Overall Study|Lost to Follow-up|1|||
16430561|NCT01449006|40054018|FG001|Overall Study|Lost to Follow-up|0|||
16430562|NCT01449006|40054017|FG000|Overall Study|Withdrawal by Subject|1|||
16430563|NCT01449006|40054018|FG001|Overall Study|Withdrawal by Subject|0|||
16430564|NCT01449006|40054017|FG000|Overall Study|Protocol Violation|1|||
16430565|NCT01449006|40054018|FG001|Overall Study|Protocol Violation|0|||
16430566|NCT03635996|40054019|FG000|Overall Study|Study terminated by Sponsor|94|||
16430567|NCT03635996|40054019|FG000|Overall Study|Withdrawal by Subject|20|||
16430568|NCT03635996|40054019|FG000|Overall Study|Ablation|26|||
16430569|NCT03635996|40054019|FG000|Overall Study|Adverse Event|7|||
16430570|NCT03635996|40054019|FG000|Overall Study|Physician Decision|3|||
16430571|NCT03635996|40054019|FG000|Overall Study|Prohibited medication|5|||
16430572|NCT03635996|40054019|FG000|Overall Study|Did not meet eligibility criteria|5|||
16430573|NCT03635996|40054019|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
16430574|NCT03635996|40054019|FG000|Overall Study|Protocol Violation|1|||
16430575|NCT03635996|40054019|FG000|Overall Study|Lost to Follow-up|1|||
16430576|NCT00191308|40054020|FG000|Overall Study|Adverse Event|1|||
16430577|NCT03087513|40054023|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
16430578|NCT01964963|40054026|FG000|Overall Study|Case Report Forms Uncollected|888|||
16430579|NCT01964963|40054026|FG000|Overall Study|Protocol Deviation|50|||
16430580|NCT01964963|40054026|FG000|Overall Study|Data Reliability was not Assured|5|||
16430581|NCT02478463|40054029|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
16430582|NCT02478463|40054029|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
16430583|NCT02478463|40054029|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
16430584|NCT03600740|40054031|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
16430585|NCT00786799|40054032|FG000|Overall Study|Lost to Follow-up|1|||
16430586|NCT00786799|40054033|FG001|Overall Study|Lost to Follow-up|1|||
16430587|NCT01010971|40054035|FG000|Overall Study|Adverse Event|2|||
16430588|NCT01010971|40054036|FG001|Overall Study|Adverse Event|4|||
16430589|NCT01010971|40054037|FG002|Overall Study|Adverse Event|3|||
16430590|NCT01010971|40054035|FG000|Overall Study|Withdrawal by Subject|0|||
16430591|NCT01010971|40054036|FG001|Overall Study|Withdrawal by Subject|2|||
16430592|NCT01010971|40054037|FG002|Overall Study|Withdrawal by Subject|5|||
16430593|NCT01010971|40054035|FG000|Overall Study|Lost to Follow-up|0|||
16430594|NCT01010971|40054036|FG001|Overall Study|Lost to Follow-up|2|||
16430595|NCT01010971|40054037|FG002|Overall Study|Lost to Follow-up|3|||
16430596|NCT01010971|40054035|FG000|Overall Study|Other|1|||
16430597|NCT01010971|40054036|FG001|Overall Study|Other|0|||
16430598|NCT01010971|40054037|FG002|Overall Study|Other|2|||
16430599|NCT00988884|40054038|FG000|Overall Study|Adverse Event|0|||
16430600|NCT00988884|40054039|FG001|Overall Study|Adverse Event|1|||
16430601|NCT00988884|40054038|FG000|Overall Study|Lost to Follow-up|20|||
16430602|NCT00988884|40054039|FG001|Overall Study|Lost to Follow-up|16|||
16430603|NCT00988884|40054038|FG000|Overall Study|Protocol Violation|0|||
16430604|NCT00988884|40054039|FG001|Overall Study|Protocol Violation|1|||
16430605|NCT00988884|40054038|FG000|Overall Study|Withdrawal by Subject|15|||
16430606|NCT00988884|40054039|FG001|Overall Study|Withdrawal by Subject|18|||
16430607|NCT00920855|40054040|FG000|Overall Study|Adverse Event|1|||
16430608|NCT00920855|40054041|FG001|Overall Study|Adverse Event|1|||
16430609|NCT00920855|40054042|FG002|Overall Study|Adverse Event|4|||
16430610|NCT00920855|40054040|FG000|Overall Study|Withdrawal by Subject|2|||
16430611|NCT00920855|40054041|FG001|Overall Study|Withdrawal by Subject|1|||
16430612|NCT00920855|40054042|FG002|Overall Study|Withdrawal by Subject|6|||
16430613|NCT00920855|40054040|FG000|Overall Study|Disease progression|2|||
16430614|NCT00920855|40054041|FG001|Overall Study|Disease progression|1|||
16430615|NCT00920855|40054042|FG002|Overall Study|Disease progression|10|||
16430616|NCT00920855|40054040|FG000|Overall Study|Noncompliance to study medication|0|||
16430617|NCT00920855|40054041|FG001|Overall Study|Noncompliance to study medication|0|||
16430618|NCT00920855|40054042|FG002|Overall Study|Noncompliance to study medication|1|||
16430619|NCT00920855|40054040|FG000|Overall Study|Response plateau; started maintenance|0|||
16430620|NCT00920855|40054041|FG001|Overall Study|Response plateau; started maintenance|0|||
16430621|NCT00920855|40054042|FG002|Overall Study|Response plateau; started maintenance|1|||
16430622|NCT03539458|40054043|FG000|Overall Study|Death|1|||
16430623|NCT03920254|40054055|FG000|Overall Study|Adverse Event|1|||
16430624|NCT03920254|40054056|FG001|Overall Study|Adverse Event|0|||
16430625|NCT03920254|40054057|FG002|Overall Study|Adverse Event|0|||
16430626|NCT03920254|40054055|FG000|Overall Study|Physician Decision|0|||
16430627|NCT03920254|40054056|FG001|Overall Study|Physician Decision|1|||
16430628|NCT03920254|40054057|FG002|Overall Study|Physician Decision|2|||
16430629|NCT03920254|40054055|FG000|Overall Study|Study Terminated By Sponsor|12|||
16430630|NCT03920254|40054056|FG001|Overall Study|Study Terminated By Sponsor|17|||
16430631|NCT03920254|40054057|FG002|Overall Study|Study Terminated By Sponsor|12|||
16430632|NCT03920254|40054055|FG000|Overall Study|Withdrawal by Subject|0|||
16430633|NCT03920254|40054056|FG001|Overall Study|Withdrawal by Subject|0|||
16430634|NCT03920254|40054057|FG002|Overall Study|Withdrawal by Subject|1|||
16430635|NCT04972786|40054060|FG000|First Intervention (1 Day)|Adverse Event|1|||
16430636|NCT04972786|40054061|FG001|First Intervention (1 Day)|Adverse Event|0|||
16430637|NCT01959841|40054062|FG000|Overall Study|Adverse Event|1|||
16430638|NCT01959841|40054063|FG001|Overall Study|Adverse Event|3|||
16430639|NCT01959841|40054064|FG002|Overall Study|Adverse Event|2|||
16430640|NCT01959841|40054062|FG000|Overall Study|Lack of Efficacy|5|||
16430641|NCT01959841|40054063|FG001|Overall Study|Lack of Efficacy|0|||
16430642|NCT01959841|40054064|FG002|Overall Study|Lack of Efficacy|0|||
16430643|NCT01959841|40054062|FG000|Overall Study|Lost to Follow-up|1|||
16430644|NCT01959841|40054063|FG001|Overall Study|Lost to Follow-up|1|||
16430645|NCT01959841|40054064|FG002|Overall Study|Lost to Follow-up|0|||
16430646|NCT01959841|40054062|FG000|Overall Study|Physician Decision|0|||
16430647|NCT01959841|40054063|FG001|Overall Study|Physician Decision|2|||
16430648|NCT01959841|40054064|FG002|Overall Study|Physician Decision|3|||
16430649|NCT01959841|40054062|FG000|Overall Study|Protocol Violation|16|||
16430650|NCT01959841|40054063|FG001|Overall Study|Protocol Violation|23|||
16430651|NCT01959841|40054064|FG002|Overall Study|Protocol Violation|16|||
16430652|NCT01959841|40054062|FG000|Overall Study|Withdrawal by Subject|7|||
16430653|NCT01959841|40054063|FG001|Overall Study|Withdrawal by Subject|7|||
16430654|NCT01959841|40054064|FG002|Overall Study|Withdrawal by Subject|5|||
16430655|NCT01959841|40054062|FG000|Overall Study|Clinical laboratory value|2|||
16430656|NCT01959841|40054063|FG001|Overall Study|Clinical laboratory value|6|||
16430657|NCT01959841|40054064|FG002|Overall Study|Clinical laboratory value|6|||
16430658|NCT01959841|40054062|FG000|Overall Study|Platelet count below on day1 or 4|11|||
16430659|NCT01959841|40054063|FG001|Overall Study|Platelet count below on day1 or 4|15|||
16430660|NCT01959841|40054064|FG002|Overall Study|Platelet count below on day1 or 4|11|||
16430661|NCT04137731|40054067|FG000|Overall Study|Surgery Cancellation|1|||
16430662|NCT04137731|40054068|FG001|Overall Study|Surgery Cancellation|2|||
16430663|NCT04137731|40054067|FG000|Overall Study|Withdrawal by Subject|2|||
16430664|NCT04137731|40054068|FG001|Overall Study|Withdrawal by Subject|0|||
16430665|NCT04137731|40054067|FG000|Overall Study|Protocol Violation|0|||
16430666|NCT04137731|40054068|FG001|Overall Study|Protocol Violation|1|||
16430667|NCT01787461|40054069|FG000|Overall Study|Adverse Event|4|||
16430668|NCT01787461|40054070|FG001|Overall Study|Adverse Event|3|||
16430669|NCT01787461|40054069|FG000|Overall Study|Lost to Follow-up|3|||
16430670|NCT01787461|40054070|FG001|Overall Study|Lost to Follow-up|2|||
16430671|NCT01787461|40054069|FG000|Overall Study|No longer met eligibility criteria|1|||
16430672|NCT01787461|40054070|FG001|Overall Study|No longer met eligibility criteria|0|||
16430673|NCT01787461|40054069|FG000|Overall Study|Withdrawal by Subject|3|||
16430674|NCT01787461|40054070|FG001|Overall Study|Withdrawal by Subject|4|||
16430675|NCT01787461|40054069|FG000|Overall Study|Protocol Violation|3|||
16430676|NCT01787461|40054070|FG001|Overall Study|Protocol Violation|0|||
16430677|NCT04303559|40054071|FG000|Overall Study|Study closed due to poor enrollment.|1|||
16430678|NCT01962441|40054072|FG000|Randomized Period|Randomized but Never Treated|4|||
16430679|NCT01962441|40054073|FG001|Randomized Period|Randomized but Never Treated|2|||
16430680|NCT01962441|40054074|FG002|Randomized Period|Randomized but Never Treated|3|||
16430681|NCT01962441|40054072|FG000|Randomized Period|Lost to Follow-up|2|||
16430682|NCT01962441|40054073|FG001|Randomized Period|Lost to Follow-up|4|||
16430683|NCT01962441|40054074|FG002|Randomized Period|Lost to Follow-up|4|||
16430684|NCT01962441|40054072|FG000|Randomized Period|Withdrew Consent|3|||
16430685|NCT01962441|40054073|FG001|Randomized Period|Withdrew Consent|3|||
16430686|NCT01962441|40054074|FG002|Randomized Period|Withdrew Consent|2|||
16430687|NCT01962441|40054072|FG000|Randomized Period|Adverse Event|1|||
16430688|NCT01962441|40054073|FG001|Randomized Period|Adverse Event|1|||
16430689|NCT01962441|40054074|FG002|Randomized Period|Adverse Event|0|||
16430690|NCT01962441|40054072|FG000|Randomized Period|Death|0|||
16430691|NCT01962441|40054073|FG001|Randomized Period|Death|0|||
16430692|NCT01962441|40054074|FG002|Randomized Period|Death|2|||
16430693|NCT01962441|40054072|FG000|Randomized Period|Protocol Violation|0|||
16430694|NCT01962441|40054073|FG001|Randomized Period|Protocol Violation|1|||
16430695|NCT01962441|40054074|FG002|Randomized Period|Protocol Violation|0|||
16430696|NCT01962441|40054072|FG000|Retreatment Substudy|Lack of Efficacy|1|||
16430697|NCT01962441|40054073|FG001|Retreatment Substudy|Lack of Efficacy|0|||
16430698|NCT01962441|40054074|FG002|Retreatment Substudy|Lack of Efficacy|0|||
16430699|NCT01962441|40054072|FG000|Retreatment Substudy|Lost to Follow-up|1|||
16430700|NCT01962441|40054073|FG001|Retreatment Substudy|Lost to Follow-up|0|||
16430701|NCT01962441|40054074|FG002|Retreatment Substudy|Lost to Follow-up|0|||
16430702|NCT03081884|40054075|FG000|Overall Study|deferred prostate cancer treatment|1|||
16430703|NCT03081884|40054075|FG000|Overall Study|metastasis managed with systemic therapy|3|||
16430704|NCT00887549|40054076|FG000|Induction Therapy|Adverse Event|8|||
16430705|NCT00887549|40054076|FG000|Induction Therapy|Physician Decision|1|||
16430706|NCT00887549|40054076|FG000|Induction Therapy|Progressive Disease|13|||
16430707|NCT00887549|40054076|FG000|Induction Therapy|Death due to Study Disease|4|||
16430708|NCT00887549|40054076|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
16430709|NCT00887549|40054076|FG000|Maintenance Therapy|Adverse Event|16|||
16430710|NCT00887549|40054076|FG000|Maintenance Therapy|Physician Decision|1|||
16430711|NCT00887549|40054076|FG000|Maintenance Therapy|Progressive Disease|25|||
16430712|NCT00887549|40054076|FG000|Maintenance Therapy|Death due to adverse event|1|||
16430713|NCT03361293|40054077|FG000|Overall Study|Lost to Follow-up|0|||
16430714|NCT03361293|40054078|FG001|Overall Study|Lost to Follow-up|2|||
16430715|NCT03361293|40054077|FG000|Overall Study|Withdrawal by Subject|1|||
16430716|NCT03361293|40054078|FG001|Overall Study|Withdrawal by Subject|3|||
16430717|NCT01934010|40054082|FG000|Overall Study|Adverse Event|1|||
16430718|NCT01934010|40054083|FG001|Overall Study|Adverse Event|1|||
16430719|NCT01934010|40054084|FG002|Overall Study|Adverse Event|0|||
16430720|NCT01934010|40054082|FG000|Overall Study|Withdrawal by Subject|15|||
16430721|NCT01934010|40054083|FG001|Overall Study|Withdrawal by Subject|6|||
16430722|NCT01934010|40054084|FG002|Overall Study|Withdrawal by Subject|2|||
16430723|NCT01934010|40054082|FG000|Overall Study|Lost to Follow-up|7|||
16430724|NCT01934010|40054083|FG001|Overall Study|Lost to Follow-up|4|||
16430725|NCT01934010|40054084|FG002|Overall Study|Lost to Follow-up|0|||
16430726|NCT02652156|40054085|FG000|Overall Study|Physician Decision|1|||
16430727|NCT02652156|40054086|FG001|Overall Study|Physician Decision|0|||
16430728|NCT02652156|40054087|FG002|Overall Study|Physician Decision|0|||
16430729|NCT02702180|40054088|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
16430730|NCT02702180|40054089|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
16430731|NCT02702180|40054090|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16430732|NCT02702180|40054088|FG000|Double-blind Treatment Period|Adverse Event|0|||
16430733|NCT02702180|40054089|FG001|Double-blind Treatment Period|Adverse Event|0|||
16430734|NCT02702180|40054090|FG002|Double-blind Treatment Period|Adverse Event|1|||
16430735|NCT02702180|40054088|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
16430736|NCT02702180|40054089|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
16430737|NCT02702180|40054090|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
16430738|NCT02702180|40054088|FG000|Double-blind Treatment Period|Protocol Violation|0|||
16430739|NCT02702180|40054089|FG001|Double-blind Treatment Period|Protocol Violation|0|||
16430740|NCT02702180|40054090|FG002|Double-blind Treatment Period|Protocol Violation|2|||
16430741|NCT02702180|40054088|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
16430742|NCT02702180|40054089|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
16430743|NCT02702180|40054090|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
16430744|NCT02702180|40054088|FG000|Open-label Treatment Period|Withdrawn in error|0|||
16430745|NCT02702180|40054089|FG001|Open-label Treatment Period|Withdrawn in error|0|||
16430746|NCT02702180|40054090|FG002|Open-label Treatment Period|Withdrawn in error|1|||
16430747|NCT00434642|40054091|FG000|Blinded Treatment Phase|Adverse Event|12|||
16430748|NCT00434642|40054092|FG001|Blinded Treatment Phase|Adverse Event|58|||
16430749|NCT00434642|40054091|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
16430750|NCT00434642|40054092|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
16361165|NCT01294046|39807707|FG000|Overall Study|Eligibility criteria expanded|1|||
16361166|NCT01294046|39807707|FG000|Overall Study|Stimulation response inadqequate|1|||
16361167|NCT00817063|39807710|FG000|Overall Study|Adverse Event|32|||
16361168|NCT00817063|39807711|FG001|Overall Study|Adverse Event|13|||
16361169|NCT00817063|39807710|FG000|Overall Study|Death|1|||
16361170|NCT00817063|39807711|FG001|Overall Study|Death|1|||
16361171|NCT00817063|39807710|FG000|Overall Study|Lack of Efficacy|33|||
16361172|NCT00817063|39807711|FG001|Overall Study|Lack of Efficacy|86|||
16361173|NCT00817063|39807710|FG000|Overall Study|Failure to Return|13|||
16361174|NCT00817063|39807711|FG001|Overall Study|Failure to Return|12|||
16361175|NCT00817063|39807710|FG000|Overall Study|Violation of Selection at Entry|7|||
16361176|NCT00817063|39807711|FG001|Overall Study|Violation of Selection at Entry|4|||
16361177|NCT00817063|39807710|FG000|Overall Study|Protocol Violation|3|||
16361178|NCT00817063|39807711|FG001|Overall Study|Protocol Violation|8|||
16361179|NCT00817063|39807710|FG000|Overall Study|Withdrawal by Subject|17|||
16361180|NCT00817063|39807711|FG001|Overall Study|Withdrawal by Subject|37|||
16361181|NCT00817063|39807710|FG000|Overall Study|Early Improvement|19|||
16361182|NCT00817063|39807711|FG001|Overall Study|Early Improvement|4|||
16361183|NCT00817063|39807710|FG000|Overall Study|Administrative|10|||
16361184|NCT00817063|39807711|FG001|Overall Study|Administrative|4|||
16361185|NCT00817063|39807710|FG000|Overall Study|Abnormality of Laboratory Test|2|||
16361186|NCT00817063|39807711|FG001|Overall Study|Abnormality of Laboratory Test|1|||
16361187|NCT00750269|39807712|FG000|Overall Study|Protocol Violation|0|||
16361188|NCT00750269|39807713|FG001|Overall Study|Protocol Violation|1|||
16361189|NCT00750269|39807714|FG002|Overall Study|Protocol Violation|1|||
16361190|NCT00750269|39807715|FG003|Overall Study|Protocol Violation|2|||
16361191|NCT00750269|39807716|FG004|Overall Study|Protocol Violation|4|||
16361192|NCT00750269|39807712|FG000|Overall Study|Withdrawal by Subject|0|||
16361193|NCT00750269|39807713|FG001|Overall Study|Withdrawal by Subject|0|||
16361194|NCT00750269|39807714|FG002|Overall Study|Withdrawal by Subject|2|||
16361195|NCT00750269|39807715|FG003|Overall Study|Withdrawal by Subject|2|||
16361196|NCT00750269|39807716|FG004|Overall Study|Withdrawal by Subject|2|||
16361197|NCT00750269|39807712|FG000|Overall Study|Physician Decision|0|||
16361198|NCT00750269|39807713|FG001|Overall Study|Physician Decision|0|||
16361199|NCT00750269|39807714|FG002|Overall Study|Physician Decision|0|||
16361200|NCT00750269|39807715|FG003|Overall Study|Physician Decision|0|||
16361201|NCT00750269|39807716|FG004|Overall Study|Physician Decision|2|||
16361202|NCT00750269|39807712|FG000|Overall Study|Patient too large for positioning|0|||
16361203|NCT00750269|39807713|FG001|Overall Study|Patient too large for positioning|0|||
16361204|NCT00750269|39807714|FG002|Overall Study|Patient too large for positioning|1|||
16361205|NCT00750269|39807715|FG003|Overall Study|Patient too large for positioning|0|||
16361206|NCT00750269|39807716|FG004|Overall Study|Patient too large for positioning|0|||
16361207|NCT00750269|39807712|FG000|Overall Study|Site error|0|||
16131327|NCT01315353|38967269|FG001|Overall Study|Lost to Follow-up|6|||
16361208|NCT00750269|39807713|FG001|Overall Study|Site error|0|||
16361209|NCT00750269|39807714|FG002|Overall Study|Site error|0|||
16430751|NCT00434642|40054091|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
16430752|NCT00434642|40054092|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
16430753|NCT00434642|40054091|FG000|Blinded Treatment Phase|Physician Decision|19|||
16430754|NCT00434642|40054092|FG001|Blinded Treatment Phase|Physician Decision|27|||
16430755|NCT00434642|40054091|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
16430756|NCT00434642|40054092|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
16430757|NCT00434642|40054091|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
16430758|NCT00434642|40054092|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
16430759|NCT00434642|40054091|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
16430760|NCT00434642|40054092|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
16430761|NCT00434642|40054091|FG000|Open-label Treatment Phase|Adverse Event|0|||
16430762|NCT00434642|40054092|FG001|Open-label Treatment Phase|Adverse Event|5|||
16430763|NCT00434642|40054091|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
16430764|NCT00434642|40054092|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
16430765|NCT00799903|40054096|FG000|Overall Study|Investigator Site Closed|25|||
16430766|NCT00799903|40054097|FG001|Overall Study|Investigator Site Closed|23|||
16430767|NCT00799903|40054096|FG000|Overall Study|Withdrawal by Subject|179|||
16430768|NCT00799903|40054097|FG001|Overall Study|Withdrawal by Subject|175|||
16430769|NCT00799903|40054096|FG000|Overall Study|Lost to Follow-up|69|||
16430770|NCT00799903|40054097|FG001|Overall Study|Lost to Follow-up|80|||
16430771|NCT01053988|40054098|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
16430772|NCT01053988|40054099|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16430773|NCT01053988|40054100|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16430774|NCT01053988|40054101|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16430775|NCT01053988|40054102|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16430776|NCT01053988|40054103|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16430777|NCT01053988|40054098|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
16430778|NCT01053988|40054099|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16430779|NCT01053988|40054100|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16430780|NCT01053988|40054101|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16430781|NCT01053988|40054102|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16430782|NCT01053988|40054103|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16430783|NCT01053988|40054098|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
16430784|NCT01053988|40054099|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16430785|NCT01053988|40054100|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16430786|NCT01053988|40054101|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16430787|NCT01053988|40054102|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16430788|NCT01053988|40054103|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16430789|NCT01053988|40054098|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
16430790|NCT01053988|40054099|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
16430791|NCT01053988|40054100|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
16430792|NCT01053988|40054101|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
16430793|NCT01053988|40054102|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
16430794|NCT01053988|40054103|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
16430795|NCT01053988|40054098|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
16430796|NCT01053988|40054099|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
16430797|NCT01053988|40054100|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
16430798|NCT01053988|40054101|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
16430799|NCT01053988|40054102|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
16430800|NCT01053988|40054103|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
16430801|NCT01053988|40054098|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
16430802|NCT01053988|40054099|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16430803|NCT01053988|40054100|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16430804|NCT01053988|40054101|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16430805|NCT01053988|40054102|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16361210|NCT00750269|39807715|FG003|Overall Study|Site error|1|||
16361211|NCT00750269|39807716|FG004|Overall Study|Site error|0|||
16361212|NCT00750269|39807712|FG000|Overall Study|SBRT plan could not be drawn|0|||
16361213|NCT00750269|39807713|FG001|Overall Study|SBRT plan could not be drawn|0|||
16361214|NCT00750269|39807714|FG002|Overall Study|SBRT plan could not be drawn|0|||
16361215|NCT00750269|39807715|FG003|Overall Study|SBRT plan could not be drawn|0|||
16361216|NCT00750269|39807716|FG004|Overall Study|SBRT plan could not be drawn|1|||
16361217|NCT00750269|39807712|FG000|Overall Study|Fiducials could not be placed|0|||
16361218|NCT00750269|39807713|FG001|Overall Study|Fiducials could not be placed|0|||
16361219|NCT00750269|39807714|FG002|Overall Study|Fiducials could not be placed|0|||
16361220|NCT00750269|39807715|FG003|Overall Study|Fiducials could not be placed|0|||
16430806|NCT01053988|40054103|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16430807|NCT01053988|40054098|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
16430808|NCT01053988|40054099|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
16430809|NCT01053988|40054100|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
16430810|NCT01053988|40054101|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
16430811|NCT01053988|40054102|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
16430812|NCT01053988|40054103|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
16430813|NCT01053988|40054098|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16430814|NCT01053988|40054099|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
16430815|NCT01053988|40054100|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
16430816|NCT01053988|40054101|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
16430817|NCT01053988|40054102|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
16430818|NCT01053988|40054103|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16430819|NCT01053988|40054098|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
16430820|NCT01053988|40054099|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
16430821|NCT01053988|40054100|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
16430822|NCT01053988|40054101|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
16430823|NCT01053988|40054102|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
16430824|NCT01053988|40054103|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
16430825|NCT01053988|40054098|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
16430826|NCT01053988|40054099|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
16430827|NCT01053988|40054100|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
16430828|NCT01053988|40054101|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
16131328|NCT01315353|38967270|FG002|Overall Study|Lost to Follow-up|6|||
16430829|NCT01053988|40054102|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
16430830|NCT01053988|40054103|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
16430831|NCT01053988|40054098|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
16430832|NCT01053988|40054099|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
16430833|NCT01053988|40054100|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
16430834|NCT01053988|40054101|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
16430835|NCT01053988|40054102|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
16430836|NCT01053988|40054103|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
16430837|NCT01053988|40054098|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16430838|NCT01053988|40054099|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
16361221|NCT00750269|39807716|FG004|Overall Study|Fiducials could not be placed|1|||
16361222|NCT00423605|39807717|FG000|Overall Study|Adverse Event|129|||
16361223|NCT00423605|39807717|FG000|Overall Study|Withdrawal by Subject|36|||
16361224|NCT00423605|39807717|FG000|Overall Study|Lost to Follow-up|15|||
16361225|NCT00423605|39807717|FG000|Overall Study|Lack of Efficacy|38|||
16361226|NCT00423605|39807717|FG000|Overall Study|Sponsor Decision|3|||
16361227|NCT00423605|39807717|FG000|Overall Study|Physician Decision|8|||
16361228|NCT00423605|39807717|FG000|Overall Study|Protocol Violation|7|||
16361229|NCT00423605|39807717|FG000|Overall Study|Not one of the pre-specified options|5|||
16361230|NCT01799889|39807718|FG000|Overall Study|Adverse Event|4|||
16361231|NCT01799889|39807719|FG001|Overall Study|Adverse Event|4|||
16361232|NCT01799889|39807720|FG002|Overall Study|Adverse Event|5|||
16131329|NCT01315353|38967268|FG000|Overall Study|Unwilling to adhere to requirements|5|||
16131330|NCT01315353|38967269|FG001|Overall Study|Unwilling to adhere to requirements|5|||
16131331|NCT01315353|38967270|FG002|Overall Study|Unwilling to adhere to requirements|4|||
16131332|NCT01315353|38967268|FG000|Overall Study|Site closing|7|||
16131333|NCT01315353|38967269|FG001|Overall Study|Site closing|4|||
16361233|NCT01799889|39807721|FG003|Overall Study|Adverse Event|1|||
16361234|NCT01799889|39807722|FG004|Overall Study|Adverse Event|11|||
16361235|NCT01799889|39807723|FG005|Overall Study|Adverse Event|1|||
16361236|NCT01799889|39807724|FG006|Overall Study|Adverse Event|5|||
16361237|NCT01799889|39807725|FG007|Overall Study|Adverse Event|2|||
16361238|NCT01799889|39807726|FG008|Overall Study|Adverse Event|3|||
16361239|NCT01799889|39807727|FG009|Overall Study|Adverse Event|1|||
16361240|NCT01799889|39807728|FG010|Overall Study|Adverse Event|1|||
16361241|NCT01799889|39807729|FG011|Overall Study|Adverse Event|0|||
16361242|NCT01799889|39807718|FG000|Overall Study|Death|1|||
16361243|NCT01799889|39807719|FG001|Overall Study|Death|0|||
16361244|NCT01799889|39807720|FG002|Overall Study|Death|5|||
16361245|NCT01799889|39807721|FG003|Overall Study|Death|3|||
16361246|NCT01799889|39807722|FG004|Overall Study|Death|1|||
16361247|NCT01799889|39807723|FG005|Overall Study|Death|0|||
16361248|NCT01799889|39807724|FG006|Overall Study|Death|0|||
16361249|NCT01799889|39807725|FG007|Overall Study|Death|0|||
16361250|NCT01799889|39807726|FG008|Overall Study|Death|1|||
16361251|NCT01799889|39807727|FG009|Overall Study|Death|0|||
16430839|NCT01053988|40054100|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16430840|NCT01053988|40054101|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
16430841|NCT01053988|40054102|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
16430842|NCT01053988|40054103|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
16430843|NCT01053988|40054098|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
16430844|NCT01053988|40054099|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
16430845|NCT01053988|40054100|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
16430846|NCT01053988|40054101|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
16430847|NCT01053988|40054102|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
16430848|NCT01053988|40054103|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
16430849|NCT01053988|40054098|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16430850|NCT01053988|40054099|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
16430851|NCT01053988|40054100|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
16430852|NCT01053988|40054101|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
16430853|NCT01053988|40054102|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
16430854|NCT01053988|40054103|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
16430855|NCT02735343|40054104|FG000|Overall Study|screen fail|0|||
16430856|NCT02735343|40054105|FG001|Overall Study|screen fail|2|||
16430857|NCT00740584|40054111|FG000|Overall Study|Withdrawal by Subject|1|||
16430858|NCT00183625|40054117|FG000|Overall Study|Withdrawal by Subject|18|||
16430859|NCT00183625|40054118|FG001|Overall Study|Withdrawal by Subject|18|||
16430860|NCT00183625|40054119|FG002|Overall Study|Withdrawal by Subject|19|||
16430861|NCT00183625|40054120|FG003|Overall Study|Withdrawal by Subject|14|||
16430862|NCT01012258|40054122|FG000|Overall Study|Death|14|||
16430863|NCT01012258|40054122|FG000|Overall Study|Lost to Follow-up|1|||
16430864|NCT01012258|40054122|FG000|Overall Study|Adverse Event|1|||
16430865|NCT01012258|40054122|FG000|Overall Study|Progressive Disease (PD)|18|||
16430866|NCT01012258|40054122|FG000|Overall Study|Symptomatic Deterioration|1|||
16430867|NCT01012258|40054122|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
16430868|NCT01012258|40054122|FG000|Overall Study|Another Tumor Discovered|1|||
16430869|NCT01012258|40054122|FG000|Overall Study|Ongoing|29|||
16430870|NCT01858363|40054123|FG000|Overall Study|Death|35|||
16430871|NCT01858363|40054124|FG001|Overall Study|Death|9|||
16430872|NCT01858363|40054123|FG000|Overall Study|Withdrawal by Subject|28|||
16430873|NCT01858363|40054124|FG001|Overall Study|Withdrawal by Subject|14|||
16430874|NCT01858363|40054123|FG000|Overall Study|Lost to Follow-up|13|||
16430875|NCT01858363|40054124|FG001|Overall Study|Lost to Follow-up|3|||
16430876|NCT00556894|40054125|FG000|Overall Study|Adverse Event|2|||
16430877|NCT00556894|40054126|FG001|Overall Study|Adverse Event|3|||
16430878|NCT00556894|40054127|FG002|Overall Study|Adverse Event|3|||
16430879|NCT00556894|40054125|FG000|Overall Study|Death|1|||
16430880|NCT00556894|40054126|FG001|Overall Study|Death|0|||
16430881|NCT00556894|40054127|FG002|Overall Study|Death|0|||
16430882|NCT00556894|40054125|FG000|Overall Study|regulatory decision in Bulgaria|10|||
16430883|NCT00556894|40054126|FG001|Overall Study|regulatory decision in Bulgaria|14|||
16430884|NCT00556894|40054127|FG002|Overall Study|regulatory decision in Bulgaria|13|||
16430885|NCT00556894|40054125|FG000|Overall Study|Change in therapy|2|||
16430886|NCT00556894|40054126|FG001|Overall Study|Change in therapy|1|||
16430887|NCT00556894|40054127|FG002|Overall Study|Change in therapy|2|||
16430888|NCT00556894|40054125|FG000|Overall Study|Withdrawal by Subject|1|||
16430889|NCT00556894|40054126|FG001|Overall Study|Withdrawal by Subject|1|||
16430890|NCT00556894|40054127|FG002|Overall Study|Withdrawal by Subject|1|||
16430891|NCT00782717|40054129|FG000|Overall Study|Adverse Event|2|||
16430892|NCT00782717|40054130|FG001|Overall Study|Adverse Event|5|||
16430893|NCT00782717|40054129|FG000|Overall Study|Patient decision unrelated to AE|6|||
16430894|NCT00782717|40054130|FG001|Overall Study|Patient decision unrelated to AE|3|||
16430895|NCT00782717|40054129|FG000|Overall Study|Noncompliance|2|||
16430896|NCT00782717|40054130|FG001|Overall Study|Noncompliance|1|||
16430897|NCT00782717|40054129|FG000|Overall Study|Treatment failure|3|||
16430898|NCT00782717|40054130|FG001|Overall Study|Treatment failure|14|||
16430899|NCT00782717|40054129|FG000|Overall Study|Enrollment close prior to surgery|1|||
16430900|NCT00782717|40054130|FG001|Overall Study|Enrollment close prior to surgery|0|||
16430901|NCT00782717|40054129|FG000|Overall Study|Did not meet entrance criteria|1|||
16430902|NCT00782717|40054130|FG001|Overall Study|Did not meet entrance criteria|3|||
16430903|NCT00782717|40054129|FG000|Overall Study|Exited in error|0|||
16430904|NCT00782717|40054130|FG001|Overall Study|Exited in error|2|||
16430905|NCT01168349|40054131|FG000|Overall Study|Death|157|||
16430906|NCT01168349|40054131|FG000|Overall Study|Lost to Follow-up|34|||
16430907|NCT01168349|40054131|FG000|Overall Study|Withdrawal by Subject|9|||
16430908|NCT01168349|40054131|FG000|Overall Study|Kidney transplantation|3|||
16430909|NCT01168349|40054131|FG000|Overall Study|Other|22|||
16430910|NCT01168349|40054131|FG000|Overall Study|Protocol Violation|76|||
16430911|NCT02756338|40054133|FG000|Overall Study|Withdrawn by Investigator|1|||
16430912|NCT02756338|40054133|FG000|Overall Study|Device Replaced with Pacemaker|4|||
16430913|NCT03010527|40054134|FG000|Overall Study|Death|0|||
16430914|NCT03010527|40054135|FG001|Overall Study|Death|0|||
16430915|NCT03010527|40054136|FG002|Overall Study|Death|1|||
16430916|NCT03010527|40054134|FG000|Overall Study|Adverse Event|0|||
16430917|NCT03010527|40054135|FG001|Overall Study|Adverse Event|4|||
16430918|NCT03010527|40054136|FG002|Overall Study|Adverse Event|2|||
16430919|NCT03010527|40054134|FG000|Overall Study|Protocol Violation|0|||
16430920|NCT03010527|40054135|FG001|Overall Study|Protocol Violation|1|||
16430921|NCT03010527|40054136|FG002|Overall Study|Protocol Violation|0|||
16430922|NCT03010527|40054134|FG000|Overall Study|Lost to Follow-up|0|||
16430923|NCT03010527|40054135|FG001|Overall Study|Lost to Follow-up|2|||
16430924|NCT03010527|40054136|FG002|Overall Study|Lost to Follow-up|1|||
16430925|NCT03010527|40054134|FG000|Overall Study|Withdrawal by Subject|0|||
16430926|NCT03010527|40054135|FG001|Overall Study|Withdrawal by Subject|3|||
16430927|NCT03010527|40054136|FG002|Overall Study|Withdrawal by Subject|4|||
16430928|NCT03010527|40054134|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
16430929|NCT03010527|40054135|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
16430930|NCT03010527|40054136|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
16430931|NCT03010527|40054134|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
16430932|NCT03010527|40054135|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
16430933|NCT03010527|40054136|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
16430934|NCT03010527|40054134|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
16430935|NCT03010527|40054135|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
16430936|NCT03010527|40054136|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
16430937|NCT04469465|40054140|FG000|Overall Study|Adverse Event|2|||
16430938|NCT04469465|40054141|FG001|Overall Study|Adverse Event|1|||
16430939|NCT04469465|40054140|FG000|Overall Study|Ongoing treatment|7|||
16430940|NCT04469465|40054141|FG001|Overall Study|Ongoing treatment|4|||
16430941|NCT04469465|40054140|FG000|Overall Study|Withdrawal by Subject|0|||
16430942|NCT04469465|40054141|FG001|Overall Study|Withdrawal by Subject|1|||
16430943|NCT02294058|40054142|FG000|Overall Study|Adverse Event|16|||
16430944|NCT02294058|40054143|FG001|Overall Study|Adverse Event|7|||
16430945|NCT02294058|40054144|FG002|Overall Study|Adverse Event|13|||
16430946|NCT02294058|40054142|FG000|Overall Study|Lack of Efficacy|3|||
16430947|NCT02294058|40054143|FG001|Overall Study|Lack of Efficacy|3|||
16430948|NCT02294058|40054144|FG002|Overall Study|Lack of Efficacy|0|||
16430949|NCT02294058|40054142|FG000|Overall Study|Lost to Follow-up|1|||
16430950|NCT02294058|40054143|FG001|Overall Study|Lost to Follow-up|0|||
16430951|NCT02294058|40054144|FG002|Overall Study|Lost to Follow-up|2|||
16430952|NCT02294058|40054142|FG000|Overall Study|Withdrawal by Subject|10|||
16430953|NCT02294058|40054143|FG001|Overall Study|Withdrawal by Subject|14|||
16430954|NCT02294058|40054144|FG002|Overall Study|Withdrawal by Subject|13|||
16430955|NCT02294058|40054142|FG000|Overall Study|Physician Decision|2|||
16430956|NCT02294058|40054143|FG001|Overall Study|Physician Decision|1|||
16430957|NCT02294058|40054144|FG002|Overall Study|Physician Decision|0|||
16430958|NCT02294058|40054142|FG000|Overall Study|Miscellaneous|4|||
16430959|NCT02294058|40054143|FG001|Overall Study|Miscellaneous|1|||
16430960|NCT02294058|40054144|FG002|Overall Study|Miscellaneous|1|||
16430961|NCT00536471|40054147|FG000|Overall Study|Lost to Follow-up|48|||
16430962|NCT00536471|40054148|FG001|Overall Study|Lost to Follow-up|23|||
16430963|NCT00536471|40054149|FG002|Overall Study|Lost to Follow-up|48|||
16430964|NCT00536471|40054150|FG003|Overall Study|Lost to Follow-up|22|||
16430965|NCT00536471|40054147|FG000|Overall Study|Adverse Event|32|||
16430966|NCT00536471|40054148|FG001|Overall Study|Adverse Event|16|||
16430967|NCT00536471|40054149|FG002|Overall Study|Adverse Event|28|||
16430968|NCT00536471|40054150|FG003|Overall Study|Adverse Event|13|||
16430969|NCT00536471|40054147|FG000|Overall Study|Withdrawal by Subject|40|||
16430970|NCT00536471|40054148|FG001|Overall Study|Withdrawal by Subject|24|||
16430971|NCT00536471|40054149|FG002|Overall Study|Withdrawal by Subject|43|||
16430972|NCT00536471|40054150|FG003|Overall Study|Withdrawal by Subject|21|||
16430973|NCT00536471|40054147|FG000|Overall Study|Lack of Efficacy|17|||
16430974|NCT00536471|40054148|FG001|Overall Study|Lack of Efficacy|18|||
16430975|NCT00536471|40054149|FG002|Overall Study|Lack of Efficacy|11|||
16430976|NCT00536471|40054150|FG003|Overall Study|Lack of Efficacy|9|||
16430977|NCT00536471|40054147|FG000|Overall Study|Protocol Violation|8|||
16430978|NCT00536471|40054148|FG001|Overall Study|Protocol Violation|1|||
16430979|NCT00536471|40054149|FG002|Overall Study|Protocol Violation|2|||
16430980|NCT00536471|40054150|FG003|Overall Study|Protocol Violation|3|||
16430981|NCT00536471|40054147|FG000|Overall Study|Physician Decision|11|||
16430982|NCT00536471|40054148|FG001|Overall Study|Physician Decision|1|||
16430983|NCT00536471|40054149|FG002|Overall Study|Physician Decision|3|||
16430984|NCT00536471|40054150|FG003|Overall Study|Physician Decision|2|||
16430985|NCT00536471|40054147|FG000|Overall Study|Death|0|||
16430986|NCT00536471|40054148|FG001|Overall Study|Death|0|||
16430987|NCT00536471|40054149|FG002|Overall Study|Death|1|||
16430988|NCT00536471|40054150|FG003|Overall Study|Death|2|||
16430989|NCT00536471|40054147|FG000|Overall Study|Sponsor Decision|0|||
16430990|NCT00536471|40054148|FG001|Overall Study|Sponsor Decision|1|||
16430991|NCT00536471|40054149|FG002|Overall Study|Sponsor Decision|3|||
16430992|NCT00536471|40054150|FG003|Overall Study|Sponsor Decision|2|||
16430993|NCT03155724|40054156|FG000|Overall Study|Death|3|||
16430994|NCT03155724|40054156|FG000|Overall Study|Physician Decision|1|||
16430995|NCT03155724|40054156|FG000|Overall Study|Study closure|7|||
16430996|NCT03649074|40054161|FG000|Overall Study|Lost to Follow-up|2|||
16430997|NCT03649074|40054162|FG001|Overall Study|Lost to Follow-up|1|||
16430998|NCT03649074|40054161|FG000|Overall Study|Adverse Event|1|||
16430999|NCT03649074|40054162|FG001|Overall Study|Adverse Event|0|||
16431000|NCT03649074|40054161|FG000|Overall Study|Physician Decision|1|||
16431001|NCT03649074|40054162|FG001|Overall Study|Physician Decision|0|||
16431002|NCT03649074|40054161|FG000|Overall Study|Withdrawal by Subject|0|||
16431003|NCT03649074|40054162|FG001|Overall Study|Withdrawal by Subject|2|||
16431004|NCT03649074|40054161|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
16431005|NCT03649074|40054162|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
16431006|NCT03649074|40054161|FG000|Overall Study|Other|1|||
16431007|NCT03649074|40054162|FG001|Overall Study|Other|0|||
16431008|NCT02915263|40054163|FG000|Overall Study|Covid|3|||
16131334|NCT01315353|38967270|FG002|Overall Study|Site closing|0|||
16431009|NCT02915263|40054164|FG001|Overall Study|Covid|2|||
16431010|NCT05066165|40054165|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
16431011|NCT05066165|40054166|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
16431012|NCT05066165|40054165|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
16431013|NCT05066165|40054166|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
16431014|NCT03852719|40054169|FG000|Overall Study|Still on study after Week 144|49|||
16431015|NCT03852719|40054170|FG001|Overall Study|Still on study after Week 144|44|||
16431016|NCT03852719|40054171|FG002|Overall Study|Still on study after Week 144|44|||
16431017|NCT03852719|40054169|FG000|Overall Study|Withdrawal of consent|0|||
16431018|NCT03852719|40054170|FG001|Overall Study|Withdrawal of consent|4|||
16431019|NCT03852719|40054171|FG002|Overall Study|Withdrawal of consent|5|||
16431020|NCT03852719|40054169|FG000|Overall Study|Physician Decision|0|||
16431021|NCT03852719|40054170|FG001|Overall Study|Physician Decision|0|||
16131335|NCT01315353|38967268|FG000|Overall Study|Taken off study by site in error|0|||
16131336|NCT01315353|38967269|FG001|Overall Study|Taken off study by site in error|1|||
16431022|NCT03852719|40054171|FG002|Overall Study|Physician Decision|1|||
16431023|NCT03852719|40054169|FG000|Overall Study|Pregnancy|1|||
16431024|NCT03852719|40054170|FG001|Overall Study|Pregnancy|1|||
16131337|NCT01315353|38967270|FG002|Overall Study|Taken off study by site in error|0|||
16131338|NCT01315353|38967268|FG000|Overall Study|Inadvertent randomization/assignment|0|||
16131339|NCT01315353|38967269|FG001|Overall Study|Inadvertent randomization/assignment|0|||
16131340|NCT01315353|38967270|FG002|Overall Study|Inadvertent randomization/assignment|2|||
16131341|NCT02831387|38967282|FG000|Overall Study|Withdrawal by Subject|1|||
16131342|NCT02831387|38967283|FG001|Overall Study|Withdrawal by Subject|1|||
16131343|NCT02831387|38967282|FG000|Overall Study|Discontinued due to stock recovery|0|||
16431025|NCT03852719|40054171|FG002|Overall Study|Pregnancy|0|||
16431026|NCT03852719|40054169|FG000|Overall Study|Death|1|||
16431027|NCT03852719|40054170|FG001|Overall Study|Death|0|||
16131344|NCT02831387|38967283|FG001|Overall Study|Discontinued due to stock recovery|1|||
16431028|NCT03852719|40054171|FG002|Overall Study|Death|0|||
16431029|NCT03010319|40054174|FG000|Overall Study|Adverse Event|15|||
16431030|NCT03010319|40054175|FG001|Overall Study|Adverse Event|9|||
16431031|NCT03010319|40054174|FG000|Overall Study|Withdrawal by Subject|1|||
16431032|NCT03010319|40054175|FG001|Overall Study|Withdrawal by Subject|6|||
16431033|NCT03010319|40054174|FG000|Overall Study|Physician Decision|2|||
16431034|NCT03010319|40054175|FG001|Overall Study|Physician Decision|4|||
16431035|NCT03010319|40054174|FG000|Overall Study|Sponsor requested withdrawal|2|||
16431036|NCT03010319|40054175|FG001|Overall Study|Sponsor requested withdrawal|2|||
16431037|NCT03010319|40054174|FG000|Overall Study|Death|1|||
16431038|NCT03010319|40054175|FG001|Overall Study|Death|0|||
16431039|NCT03010319|40054174|FG000|Overall Study|Lost to Follow-up|0|||
16431040|NCT03010319|40054175|FG001|Overall Study|Lost to Follow-up|1|||
16431041|NCT03010319|40054174|FG000|Overall Study|Other Reason|5|||
16431042|NCT03010319|40054175|FG001|Overall Study|Other Reason|7|||
16431043|NCT04393493|40057680|FG000|First 4 Days of Intervention|Early improvement|5|||
16431044|NCT04393493|40057681|FG001|First 4 Days of Intervention|Early improvement|7|||
16431045|NCT01397461|40057693|FG000|Overall Study|Withdrawal by Subject|2|||
16431046|NCT01397461|40057694|FG001|Overall Study|Withdrawal by Subject|1|||
16431047|NCT01397461|40057695|FG002|Overall Study|Withdrawal by Subject|0|||
16431048|NCT01397461|40057693|FG000|Overall Study|Lost to Follow-up|0|||
16431049|NCT01397461|40057694|FG001|Overall Study|Lost to Follow-up|2|||
16431050|NCT01397461|40057695|FG002|Overall Study|Lost to Follow-up|1|||
16431051|NCT01397461|40057693|FG000|Overall Study|Lack of Efficacy|0|||
16431052|NCT01397461|40057694|FG001|Overall Study|Lack of Efficacy|3|||
16431053|NCT01397461|40057695|FG002|Overall Study|Lack of Efficacy|0|||
16431054|NCT01397461|40057693|FG000|Overall Study|Not treated|0|||
16431055|NCT01397461|40057694|FG001|Overall Study|Not treated|0|||
16431056|NCT01397461|40057695|FG002|Overall Study|Not treated|1|||
16431057|NCT01632020|40057696|FG000|Overall Study|Withdrawal by Subject|1|||
16431058|NCT01632020|40057697|FG001|Overall Study|Withdrawal by Subject|0|||
16431059|NCT01632020|40057696|FG000|Overall Study|Adverse Event|1|||
16431060|NCT01632020|40057697|FG001|Overall Study|Adverse Event|0|||
16431061|NCT03040674|40057698|FG000|Overall Study|Lost to Follow-up|225|||
16431062|NCT03040674|40057698|FG000|Overall Study|Death|23|||
16431063|NCT04701333|40057701|FG000|Overall Study|Lost to Follow-up|3|||
16431064|NCT04701333|40057702|FG001|Overall Study|Lost to Follow-up|7|||
16431065|NCT04701333|40057701|FG000|Overall Study|Withdrawal by Subject|0|||
16431066|NCT04701333|40057702|FG001|Overall Study|Withdrawal by Subject|1|||
16431067|NCT00806988|40057703|FG000|Overall Study|Death|15|||
16431068|NCT00806988|40057704|FG001|Overall Study|Death|16|||
16431069|NCT00806988|40057703|FG000|Overall Study|Withdrawal by Subject|8|||
16431070|NCT00806988|40057704|FG001|Overall Study|Withdrawal by Subject|8|||
16431071|NCT00806988|40057703|FG000|Overall Study|Lost to Follow-up|4|||
16431072|NCT00806988|40057704|FG001|Overall Study|Lost to Follow-up|19|||
16431073|NCT02396212|40057705|FG000|Overall Study|Adverse Event|1|||
16431074|NCT02396212|40057705|FG000|Overall Study|Lack of Efficacy|2|||
16431075|NCT03250182|40057708|FG000|Overall Study|Withdrawal by Subject|1|||
16431076|NCT01879683|40057713|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
16431077|NCT03058692|40057717|FG000|Overall Study|Lost to Follow-up|2|||
16431078|NCT03058692|40057718|FG001|Overall Study|Lost to Follow-up|1|||
16431079|NCT03058692|40057717|FG000|Overall Study|Withdrawal by Subject|1|||
16431080|NCT03058692|40057718|FG001|Overall Study|Withdrawal by Subject|1|||
16431081|NCT04079816|40057721|FG000|Overall Study|Request of Subject|2|||
16431082|NCT04079816|40057721|FG000|Overall Study|Unable to draw samples|1|||
16431083|NCT05051579|40057722|FG000|Overall Study|Withdrawal by Subject|3|||
16431084|NCT05051579|40057723|FG001|Overall Study|Withdrawal by Subject|5|||
16431085|NCT05051579|40057724|FG002|Overall Study|Withdrawal by Subject|2|||
16431086|NCT05051579|40057725|FG003|Overall Study|Withdrawal by Subject|1|||
16431087|NCT05051579|40057726|FG004|Overall Study|Withdrawal by Subject|4|||
16431088|NCT05051579|40057727|FG005|Overall Study|Withdrawal by Subject|0|||
16431089|NCT05051579|40057728|FG006|Overall Study|Withdrawal by Subject|4|||
16431090|NCT05051579|40057722|FG000|Overall Study|Lost to Follow-up|1|||
16431091|NCT05051579|40057723|FG001|Overall Study|Lost to Follow-up|0|||
16431092|NCT05051579|40057724|FG002|Overall Study|Lost to Follow-up|0|||
16431093|NCT05051579|40057725|FG003|Overall Study|Lost to Follow-up|0|||
16431094|NCT05051579|40057726|FG004|Overall Study|Lost to Follow-up|1|||
16431095|NCT05051579|40057727|FG005|Overall Study|Lost to Follow-up|0|||
16431096|NCT05051579|40057728|FG006|Overall Study|Lost to Follow-up|1|||
16431097|NCT05051579|40057722|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
16431098|NCT05051579|40057723|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
16431099|NCT05051579|40057724|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
16431100|NCT05051579|40057725|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
16361252|NCT01799889|39807728|FG010|Overall Study|Death|1|||
16131345|NCT01011387|38967286|FG000|Overall Study|Withdrawal by Subject|3|||
16131346|NCT01011387|38967286|FG000|Overall Study|Adverse Event|2|||
16131347|NCT01011387|38967286|FG000|Overall Study|Protocol Violation|1|||
16131348|NCT01383499|38967287|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
16131349|NCT01383499|38967288|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16431101|NCT05051579|40057726|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
16431102|NCT05051579|40057727|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
16431103|NCT05051579|40057728|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
16431104|NCT05051579|40057722|FG000|Overall Study|Adverse Event|2|||
16431105|NCT05051579|40057723|FG001|Overall Study|Adverse Event|1|||
16431106|NCT05051579|40057724|FG002|Overall Study|Adverse Event|0|||
16431107|NCT05051579|40057725|FG003|Overall Study|Adverse Event|4|||
16431108|NCT05051579|40057726|FG004|Overall Study|Adverse Event|1|||
16131350|NCT01383499|38967289|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16131351|NCT01383499|38967290|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
16431109|NCT05051579|40057727|FG005|Overall Study|Adverse Event|2|||
16431110|NCT05051579|40057728|FG006|Overall Study|Adverse Event|0|||
16431111|NCT05051579|40057722|FG000|Overall Study|Inadvertent Enrollment|0|||
16431112|NCT05051579|40057723|FG001|Overall Study|Inadvertent Enrollment|0|||
16431113|NCT05051579|40057724|FG002|Overall Study|Inadvertent Enrollment|0|||
16431114|NCT05051579|40057725|FG003|Overall Study|Inadvertent Enrollment|0|||
16431115|NCT05051579|40057726|FG004|Overall Study|Inadvertent Enrollment|0|||
16431116|NCT05051579|40057727|FG005|Overall Study|Inadvertent Enrollment|0|||
16431117|NCT05051579|40057728|FG006|Overall Study|Inadvertent Enrollment|1|||
16431118|NCT05051579|40057722|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
16431119|NCT05051579|40057723|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
16431120|NCT05051579|40057724|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
16431121|NCT05051579|40057725|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
16431122|NCT05051579|40057726|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
16431123|NCT05051579|40057727|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
16431124|NCT05051579|40057728|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
16431125|NCT05051579|40057722|FG000|Overall Study|Sponsor Decision|0|||
16431126|NCT05051579|40057723|FG001|Overall Study|Sponsor Decision|0|||
16431127|NCT05051579|40057724|FG002|Overall Study|Sponsor Decision|0|||
16431128|NCT05051579|40057725|FG003|Overall Study|Sponsor Decision|0|||
16431129|NCT05051579|40057726|FG004|Overall Study|Sponsor Decision|1|||
16431130|NCT05051579|40057727|FG005|Overall Study|Sponsor Decision|0|||
16431131|NCT05051579|40057728|FG006|Overall Study|Sponsor Decision|0|||
16431132|NCT05051579|40057722|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
16431133|NCT05051579|40057723|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
16431134|NCT05051579|40057724|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
16431135|NCT05051579|40057725|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
16431136|NCT05051579|40057726|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
16431137|NCT05051579|40057727|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
16431138|NCT05051579|40057728|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
16431139|NCT03275740|40057729|FG000|Overall Study|Adverse Event|0|||
16431140|NCT03275740|40057730|FG001|Overall Study|Adverse Event|0|||
16431141|NCT03275740|40057731|FG002|Overall Study|Adverse Event|0|||
16431142|NCT03275740|40057732|FG003|Overall Study|Adverse Event|0|||
16431143|NCT03275740|40057733|FG004|Overall Study|Adverse Event|1|||
16431144|NCT03275740|40057734|FG005|Overall Study|Adverse Event|0|||
16431145|NCT03275740|40057735|FG006|Overall Study|Adverse Event|0|||
16431146|NCT03275740|40057736|FG007|Overall Study|Adverse Event|0|||
16431147|NCT03275740|40057737|FG008|Overall Study|Adverse Event|0|||
16431148|NCT03275740|40057738|FG009|Overall Study|Adverse Event|0|||
16431149|NCT03275740|40057739|FG010|Overall Study|Adverse Event|0|||
16431150|NCT03275740|40057740|FG011|Overall Study|Adverse Event|0|||
16431151|NCT03275740|40057729|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431152|NCT03275740|40057730|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431153|NCT03275740|40057731|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431154|NCT03275740|40057732|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431155|NCT03275740|40057733|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431156|NCT03275740|40057734|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
16431157|NCT03275740|40057735|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431158|NCT03275740|40057736|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431159|NCT03275740|40057737|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431160|NCT03275740|40057738|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431161|NCT03275740|40057739|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431162|NCT03275740|40057740|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
16431163|NCT03275740|40057729|FG000|Overall Study|Withdrawal by Subject|0|||
16431164|NCT03275740|40057730|FG001|Overall Study|Withdrawal by Subject|0|||
16431165|NCT03275740|40057731|FG002|Overall Study|Withdrawal by Subject|0|||
16431166|NCT03275740|40057732|FG003|Overall Study|Withdrawal by Subject|0|||
16431167|NCT03275740|40057733|FG004|Overall Study|Withdrawal by Subject|0|||
16431168|NCT03275740|40057734|FG005|Overall Study|Withdrawal by Subject|0|||
16431169|NCT03275740|40057735|FG006|Overall Study|Withdrawal by Subject|0|||
16431170|NCT03275740|40057736|FG007|Overall Study|Withdrawal by Subject|0|||
16431171|NCT03275740|40057737|FG008|Overall Study|Withdrawal by Subject|1|||
16431172|NCT03275740|40057738|FG009|Overall Study|Withdrawal by Subject|1|||
16431173|NCT03275740|40057739|FG010|Overall Study|Withdrawal by Subject|0|||
16131352|NCT02433340|38967291|FG000|Overall Study|Adverse Event|0|||
16431174|NCT03275740|40057740|FG011|Overall Study|Withdrawal by Subject|0|||
16431175|NCT01702558|40057745|FG000|Overall Study|Withdrawal by Subject|0|||
16431176|NCT01702558|40057746|FG001|Overall Study|Withdrawal by Subject|0|||
16431177|NCT01702558|40057747|FG002|Overall Study|Withdrawal by Subject|0|||
16431178|NCT01702558|40057748|FG003|Overall Study|Withdrawal by Subject|12|||
16431179|NCT01702558|40057749|FG004|Overall Study|Withdrawal by Subject|4|||
16431180|NCT01702558|40057745|FG000|Overall Study|Lost to Follow-up|0|||
16431181|NCT01702558|40057746|FG001|Overall Study|Lost to Follow-up|0|||
16431182|NCT01702558|40057747|FG002|Overall Study|Lost to Follow-up|0|||
16431183|NCT01702558|40057748|FG003|Overall Study|Lost to Follow-up|3|||
16431184|NCT01702558|40057749|FG004|Overall Study|Lost to Follow-up|0|||
16431185|NCT01702558|40057745|FG000|Overall Study|Death|4|||
16431186|NCT01702558|40057746|FG001|Overall Study|Death|3|||
16431187|NCT01702558|40057747|FG002|Overall Study|Death|3|||
16431188|NCT01702558|40057748|FG003|Overall Study|Death|16|||
16431189|NCT01702558|40057749|FG004|Overall Study|Death|20|||
16431190|NCT01702558|40057745|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
16431191|NCT01702558|40057746|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
16431192|NCT01702558|40057747|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
16431193|NCT01702558|40057748|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
16431194|NCT01702558|40057749|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
16431195|NCT01702558|40057745|FG000|Overall Study|Study Terminated by Sponsor|0|||
16431196|NCT01702558|40057746|FG001|Overall Study|Study Terminated by Sponsor|1|||
16431197|NCT01702558|40057747|FG002|Overall Study|Study Terminated by Sponsor|0|||
16431198|NCT01702558|40057748|FG003|Overall Study|Study Terminated by Sponsor|0|||
16431199|NCT01702558|40057749|FG004|Overall Study|Study Terminated by Sponsor|1|||
16431200|NCT01702558|40057745|FG000|Overall Study|Other|0|||
16431201|NCT01702558|40057746|FG001|Overall Study|Other|0|||
16431202|NCT01702558|40057747|FG002|Overall Study|Other|0|||
16431203|NCT01702558|40057748|FG003|Overall Study|Other|16|||
16431204|NCT01702558|40057749|FG004|Overall Study|Other|17|||
16431205|NCT04628780|40057752|FG000|Overall Study|Death|0|||
16431206|NCT04628780|40057753|FG001|Overall Study|Death|1|||
16431207|NCT04628780|40057754|FG002|Overall Study|Death|0|||
16431208|NCT04628780|40057755|FG003|Overall Study|Death|0|||
16431209|NCT04628780|40057756|FG004|Overall Study|Death|1|||
16431210|NCT04628780|40057757|FG005|Overall Study|Death|0|||
16431211|NCT04628780|40057752|FG000|Overall Study|Physician Decision|2|||
16431212|NCT04628780|40057753|FG001|Overall Study|Physician Decision|0|||
16431213|NCT04628780|40057754|FG002|Overall Study|Physician Decision|0|||
16431214|NCT04628780|40057755|FG003|Overall Study|Physician Decision|0|||
16431215|NCT04628780|40057756|FG004|Overall Study|Physician Decision|2|||
16431216|NCT04628780|40057757|FG005|Overall Study|Physician Decision|0|||
16131353|NCT02433340|38967292|FG001|Overall Study|Adverse Event|0|||
16431217|NCT04628780|40057752|FG000|Overall Study|Progressive disease|2|||
16431218|NCT04628780|40057753|FG001|Overall Study|Progressive disease|2|||
16431219|NCT04628780|40057754|FG002|Overall Study|Progressive disease|2|||
16431220|NCT04628780|40057755|FG003|Overall Study|Progressive disease|3|||
16431221|NCT04628780|40057756|FG004|Overall Study|Progressive disease|9|||
16431222|NCT04628780|40057757|FG005|Overall Study|Progressive disease|4|||
16431223|NCT04628780|40057752|FG000|Overall Study|Withdrawal by Subject|0|||
16431224|NCT04628780|40057753|FG001|Overall Study|Withdrawal by Subject|1|||
16431225|NCT04628780|40057754|FG002|Overall Study|Withdrawal by Subject|2|||
16431226|NCT04628780|40057755|FG003|Overall Study|Withdrawal by Subject|0|||
16431227|NCT04628780|40057756|FG004|Overall Study|Withdrawal by Subject|3|||
16431228|NCT04628780|40057757|FG005|Overall Study|Withdrawal by Subject|1|||
16431229|NCT04628780|40057752|FG000|Overall Study|Global deterioration of health status|0|||
16431230|NCT04628780|40057753|FG001|Overall Study|Global deterioration of health status|0|||
16431231|NCT04628780|40057754|FG002|Overall Study|Global deterioration of health status|0|||
16431232|NCT04628780|40057755|FG003|Overall Study|Global deterioration of health status|0|||
16431233|NCT04628780|40057756|FG004|Overall Study|Global deterioration of health status|1|||
16431234|NCT04628780|40057757|FG005|Overall Study|Global deterioration of health status|1|||
16431235|NCT01400698|40057765|FG000|Overall Study|Lost to Follow-up|2|||
16431236|NCT01400698|40057766|FG001|Overall Study|Lost to Follow-up|5|||
16431237|NCT01400698|40057767|FG002|Overall Study|Lost to Follow-up|2|||
16431238|NCT01400698|40057768|FG003|Overall Study|Lost to Follow-up|1|||
16131354|NCT02433340|38967293|FG002|Overall Study|Adverse Event|1|||
16131355|NCT02433340|38967294|FG003|Overall Study|Adverse Event|0|||
16131356|NCT02433340|38967291|FG000|Overall Study|Withdrawal by Subject|1|||
16131357|NCT02433340|38967292|FG001|Overall Study|Withdrawal by Subject|0|||
16131358|NCT02433340|38967293|FG002|Overall Study|Withdrawal by Subject|1|||
16431239|NCT01400698|40057769|FG004|Overall Study|Lost to Follow-up|4|||
16131359|NCT02433340|38967294|FG003|Overall Study|Withdrawal by Subject|2|||
16131360|NCT02433340|38967291|FG000|Overall Study|Lost to Follow-up|0|||
16131361|NCT02433340|38967292|FG001|Overall Study|Lost to Follow-up|1|||
16131362|NCT02433340|38967293|FG002|Overall Study|Lost to Follow-up|0|||
16131363|NCT02433340|38967294|FG003|Overall Study|Lost to Follow-up|0|||
16131364|NCT02433340|38967291|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
16431240|NCT01400698|40057770|FG005|Overall Study|Lost to Follow-up|3|||
16431241|NCT01400698|40057765|FG000|Overall Study|Withdrawal by Subject|8|||
16431242|NCT01400698|40057766|FG001|Overall Study|Withdrawal by Subject|2|||
16431243|NCT01400698|40057767|FG002|Overall Study|Withdrawal by Subject|0|||
16431244|NCT01400698|40057768|FG003|Overall Study|Withdrawal by Subject|4|||
16431245|NCT01400698|40057769|FG004|Overall Study|Withdrawal by Subject|1|||
16431246|NCT01400698|40057770|FG005|Overall Study|Withdrawal by Subject|3|||
16431247|NCT01400698|40057765|FG000|Overall Study|Protocol Violation|0|||
16431248|NCT01400698|40057766|FG001|Overall Study|Protocol Violation|1|||
16431249|NCT01400698|40057767|FG002|Overall Study|Protocol Violation|0|||
16431250|NCT01400698|40057768|FG003|Overall Study|Protocol Violation|0|||
16361253|NCT01799889|39807729|FG011|Overall Study|Death|0|||
16361254|NCT01799889|39807718|FG000|Overall Study|Lack of Efficacy|1|||
16361255|NCT01799889|39807719|FG001|Overall Study|Lack of Efficacy|1|||
16361256|NCT01799889|39807720|FG002|Overall Study|Lack of Efficacy|0|||
16361257|NCT01799889|39807721|FG003|Overall Study|Lack of Efficacy|1|||
16361258|NCT01799889|39807722|FG004|Overall Study|Lack of Efficacy|2|||
16361259|NCT01799889|39807723|FG005|Overall Study|Lack of Efficacy|2|||
16361260|NCT01799889|39807724|FG006|Overall Study|Lack of Efficacy|0|||
16361261|NCT01799889|39807725|FG007|Overall Study|Lack of Efficacy|0|||
16361262|NCT01799889|39807726|FG008|Overall Study|Lack of Efficacy|2|||
16131365|NCT02433340|38967292|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
16131366|NCT02433340|38967293|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
16131367|NCT02433340|38967294|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
16131368|NCT02433340|38967291|FG000|Overall Study|Other|0|||
16361263|NCT01799889|39807727|FG009|Overall Study|Lack of Efficacy|0|||
16131369|NCT02433340|38967292|FG001|Overall Study|Other|1|||
16131370|NCT02433340|38967293|FG002|Overall Study|Other|0|||
16131371|NCT02433340|38967294|FG003|Overall Study|Other|0|||
16131372|NCT00717067|38967297|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
16131373|NCT00717067|38967298|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
16131374|NCT00717067|38967299|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
16431251|NCT01400698|40057769|FG004|Overall Study|Protocol Violation|1|||
16131375|NCT00717067|38967300|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
16131376|NCT00717067|38967301|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
16431252|NCT01400698|40057770|FG005|Overall Study|Protocol Violation|0|||
16431253|NCT01400698|40057765|FG000|Overall Study|Non-compliance|0|||
16431254|NCT01400698|40057766|FG001|Overall Study|Non-compliance|1|||
16431255|NCT01400698|40057767|FG002|Overall Study|Non-compliance|0|||
16431256|NCT01400698|40057768|FG003|Overall Study|Non-compliance|1|||
16431257|NCT01400698|40057769|FG004|Overall Study|Non-compliance|0|||
16431258|NCT01400698|40057770|FG005|Overall Study|Non-compliance|0|||
16431259|NCT01400698|40057765|FG000|Overall Study|Adverse Event|1|||
16431260|NCT01400698|40057766|FG001|Overall Study|Adverse Event|0|||
16431261|NCT01400698|40057767|FG002|Overall Study|Adverse Event|0|||
16431262|NCT01400698|40057768|FG003|Overall Study|Adverse Event|0|||
16431263|NCT01400698|40057769|FG004|Overall Study|Adverse Event|0|||
16431264|NCT01400698|40057770|FG005|Overall Study|Adverse Event|0|||
16431265|NCT01400698|40057765|FG000|Overall Study|Other|4|||
16431266|NCT01400698|40057766|FG001|Overall Study|Other|2|||
16431267|NCT01400698|40057767|FG002|Overall Study|Other|0|||
16431268|NCT01400698|40057768|FG003|Overall Study|Other|2|||
16431269|NCT01400698|40057769|FG004|Overall Study|Other|1|||
16431270|NCT01400698|40057770|FG005|Overall Study|Other|0|||
16431271|NCT03137992|40057771|FG000|Washout Period 1|Adverse Event|1|||
16431272|NCT03137992|40057772|FG001|Washout Period 1|Adverse Event|1|||
16431273|NCT03137992|40057773|FG002|Washout Period 1|Adverse Event|0|||
16431274|NCT03137992|40057774|FG003|Washout Period 1|Adverse Event|0|||
16431275|NCT03137992|40057775|FG004|Washout Period 1|Adverse Event|0|||
16431276|NCT03137992|40057776|FG005|Washout Period 1|Adverse Event|1|||
16431277|NCT03137992|40057771|FG000|Washout Period 1|Withdrawal by Subject|0|||
16431278|NCT03137992|40057772|FG001|Washout Period 1|Withdrawal by Subject|1|||
16431279|NCT03137992|40057773|FG002|Washout Period 1|Withdrawal by Subject|1|||
16431280|NCT03137992|40057774|FG003|Washout Period 1|Withdrawal by Subject|0|||
16431281|NCT03137992|40057775|FG004|Washout Period 1|Withdrawal by Subject|0|||
16431282|NCT03137992|40057776|FG005|Washout Period 1|Withdrawal by Subject|0|||
16431283|NCT03137992|40057771|FG000|Washout Period 1|Principal Investigator Discretion|0|||
16431284|NCT03137992|40057772|FG001|Washout Period 1|Principal Investigator Discretion|1|||
16431285|NCT03137992|40057773|FG002|Washout Period 1|Principal Investigator Discretion|0|||
16431286|NCT03137992|40057774|FG003|Washout Period 1|Principal Investigator Discretion|0|||
16431287|NCT03137992|40057775|FG004|Washout Period 1|Principal Investigator Discretion|0|||
16431288|NCT03137992|40057776|FG005|Washout Period 1|Principal Investigator Discretion|0|||
16431289|NCT03137992|40057771|FG000|Washout Period 1|COPD Exacerbation|1|||
16431290|NCT03137992|40057772|FG001|Washout Period 1|COPD Exacerbation|1|||
16431291|NCT03137992|40057773|FG002|Washout Period 1|COPD Exacerbation|1|||
16431292|NCT03137992|40057774|FG003|Washout Period 1|COPD Exacerbation|0|||
16431293|NCT03137992|40057775|FG004|Washout Period 1|COPD Exacerbation|1|||
16431294|NCT03137992|40057776|FG005|Washout Period 1|COPD Exacerbation|1|||
16431295|NCT03137992|40057771|FG000|Washout Period 1|Subject Noncompliance|1|||
16431296|NCT03137992|40057772|FG001|Washout Period 1|Subject Noncompliance|0|||
16431297|NCT03137992|40057773|FG002|Washout Period 1|Subject Noncompliance|0|||
16431298|NCT03137992|40057774|FG003|Washout Period 1|Subject Noncompliance|0|||
16431299|NCT03137992|40057775|FG004|Washout Period 1|Subject Noncompliance|1|||
16431300|NCT03137992|40057776|FG005|Washout Period 1|Subject Noncompliance|0|||
16431301|NCT03137992|40057771|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
16431302|NCT03137992|40057772|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
16431303|NCT03137992|40057773|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
16431304|NCT03137992|40057774|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
16431305|NCT03137992|40057775|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
16431306|NCT03137992|40057776|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
16431307|NCT03137992|40057771|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
16431308|NCT03137992|40057772|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
16431309|NCT03137992|40057773|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
16431310|NCT03137992|40057774|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
16431311|NCT03137992|40057775|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
16431312|NCT03137992|40057776|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
16431313|NCT03137992|40057771|FG000|Period 2 (Visit 3)|Adverse Event|0|||
16431314|NCT03137992|40057772|FG001|Period 2 (Visit 3)|Adverse Event|1|||
16431315|NCT03137992|40057773|FG002|Period 2 (Visit 3)|Adverse Event|0|||
16431316|NCT03137992|40057774|FG003|Period 2 (Visit 3)|Adverse Event|0|||
16431317|NCT03137992|40057775|FG004|Period 2 (Visit 3)|Adverse Event|0|||
16431318|NCT03137992|40057776|FG005|Period 2 (Visit 3)|Adverse Event|0|||
16431319|NCT03137992|40057771|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
16431320|NCT03137992|40057772|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
16431321|NCT03137992|40057773|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
16431322|NCT03137992|40057774|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
16431323|NCT03137992|40057775|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
16431324|NCT03137992|40057776|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
16431325|NCT03137992|40057771|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
16431326|NCT03137992|40057772|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
16431327|NCT03137992|40057773|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
16431328|NCT03137992|40057774|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
16431329|NCT03137992|40057775|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
16431330|NCT03137992|40057776|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
16431331|NCT03137992|40057771|FG000|Washout Period 2|COPD Exacerbation|1|||
16431332|NCT03137992|40057772|FG001|Washout Period 2|COPD Exacerbation|1|||
16431333|NCT03137992|40057773|FG002|Washout Period 2|COPD Exacerbation|0|||
16431334|NCT03137992|40057774|FG003|Washout Period 2|COPD Exacerbation|0|||
16431335|NCT03137992|40057775|FG004|Washout Period 2|COPD Exacerbation|1|||
16431336|NCT03137992|40057776|FG005|Washout Period 2|COPD Exacerbation|0|||
16431337|NCT03137992|40057771|FG000|Washout Period 2|Subject Non-compliance|0|||
16431338|NCT03137992|40057772|FG001|Washout Period 2|Subject Non-compliance|1|||
16431339|NCT03137992|40057773|FG002|Washout Period 2|Subject Non-compliance|0|||
16431340|NCT03137992|40057774|FG003|Washout Period 2|Subject Non-compliance|0|||
16431341|NCT03137992|40057775|FG004|Washout Period 2|Subject Non-compliance|0|||
16431342|NCT03137992|40057776|FG005|Washout Period 2|Subject Non-compliance|0|||
16431343|NCT03137992|40057771|FG000|Washout Period 2|Adverse Event|0|||
16431344|NCT03137992|40057772|FG001|Washout Period 2|Adverse Event|0|||
16431345|NCT03137992|40057773|FG002|Washout Period 2|Adverse Event|0|||
16431346|NCT03137992|40057774|FG003|Washout Period 2|Adverse Event|1|||
16431347|NCT03137992|40057775|FG004|Washout Period 2|Adverse Event|1|||
16431348|NCT03137992|40057776|FG005|Washout Period 2|Adverse Event|0|||
16431349|NCT03137992|40057771|FG000|Washout Period 2|Withdrawal by Subject|1|||
16431350|NCT03137992|40057772|FG001|Washout Period 2|Withdrawal by Subject|0|||
16431351|NCT03137992|40057773|FG002|Washout Period 2|Withdrawal by Subject|0|||
16431352|NCT03137992|40057774|FG003|Washout Period 2|Withdrawal by Subject|0|||
16431353|NCT03137992|40057775|FG004|Washout Period 2|Withdrawal by Subject|1|||
16431354|NCT03137992|40057776|FG005|Washout Period 2|Withdrawal by Subject|0|||
16431355|NCT03137992|40057771|FG000|Washout Period 2|Sponsor Decision|0|||
16431356|NCT03137992|40057772|FG001|Washout Period 2|Sponsor Decision|0|||
16431357|NCT03137992|40057773|FG002|Washout Period 2|Sponsor Decision|0|||
16431358|NCT03137992|40057774|FG003|Washout Period 2|Sponsor Decision|0|||
16431359|NCT03137992|40057775|FG004|Washout Period 2|Sponsor Decision|0|||
16431360|NCT03137992|40057776|FG005|Washout Period 2|Sponsor Decision|1|||
16431361|NCT03137992|40057771|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
16431362|NCT03137992|40057772|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
16431363|NCT03137992|40057773|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
16431364|NCT03137992|40057774|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
16431365|NCT03137992|40057775|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
16431366|NCT03137992|40057776|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
16431367|NCT03137992|40057771|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
16431368|NCT03137992|40057772|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
16431369|NCT03137992|40057773|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
16431370|NCT03137992|40057774|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
16431371|NCT03137992|40057775|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
16431372|NCT03137992|40057776|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
16431373|NCT03137992|40057771|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
16431374|NCT03137992|40057772|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
16431375|NCT03137992|40057773|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
16131377|NCT00551460|38967302|FG000|Overall Study|Adverse Event|1|||
16361264|NCT01799889|39807728|FG010|Overall Study|Lack of Efficacy|1|||
16361265|NCT01799889|39807729|FG011|Overall Study|Lack of Efficacy|0|||
16361266|NCT01799889|39807718|FG000|Overall Study|Lost to Follow-up|0|||
16361267|NCT01799889|39807719|FG001|Overall Study|Lost to Follow-up|1|||
16361268|NCT01799889|39807720|FG002|Overall Study|Lost to Follow-up|0|||
16361269|NCT01799889|39807721|FG003|Overall Study|Lost to Follow-up|0|||
16361270|NCT01799889|39807722|FG004|Overall Study|Lost to Follow-up|0|||
16361271|NCT01799889|39807723|FG005|Overall Study|Lost to Follow-up|0|||
16361272|NCT01799889|39807724|FG006|Overall Study|Lost to Follow-up|0|||
16361273|NCT01799889|39807725|FG007|Overall Study|Lost to Follow-up|0|||
16361274|NCT01799889|39807726|FG008|Overall Study|Lost to Follow-up|0|||
16361275|NCT01799889|39807727|FG009|Overall Study|Lost to Follow-up|0|||
16361276|NCT01799889|39807728|FG010|Overall Study|Lost to Follow-up|0|||
16361277|NCT01799889|39807729|FG011|Overall Study|Lost to Follow-up|0|||
16361278|NCT01799889|39807718|FG000|Overall Study|Physician Decision|3|||
16361279|NCT01799889|39807719|FG001|Overall Study|Physician Decision|2|||
16361280|NCT01799889|39807720|FG002|Overall Study|Physician Decision|4|||
16361281|NCT01799889|39807721|FG003|Overall Study|Physician Decision|4|||
16361282|NCT01799889|39807722|FG004|Overall Study|Physician Decision|5|||
16361283|NCT01799889|39807723|FG005|Overall Study|Physician Decision|5|||
16361284|NCT01799889|39807724|FG006|Overall Study|Physician Decision|5|||
16361285|NCT01799889|39807725|FG007|Overall Study|Physician Decision|2|||
16361286|NCT01799889|39807726|FG008|Overall Study|Physician Decision|6|||
16361287|NCT01799889|39807727|FG009|Overall Study|Physician Decision|0|||
16361288|NCT01799889|39807728|FG010|Overall Study|Physician Decision|0|||
16361289|NCT01799889|39807729|FG011|Overall Study|Physician Decision|1|||
16361290|NCT01799889|39807718|FG000|Overall Study|Progressive Disease|30|||
16361291|NCT01799889|39807719|FG001|Overall Study|Progressive Disease|26|||
16361292|NCT01799889|39807720|FG002|Overall Study|Progressive Disease|25|||
16361293|NCT01799889|39807721|FG003|Overall Study|Progressive Disease|30|||
16361294|NCT01799889|39807722|FG004|Overall Study|Progressive Disease|23|||
16361295|NCT01799889|39807723|FG005|Overall Study|Progressive Disease|9|||
16361296|NCT01799889|39807724|FG006|Overall Study|Progressive Disease|8|||
16361297|NCT01799889|39807725|FG007|Overall Study|Progressive Disease|13|||
16361298|NCT01799889|39807726|FG008|Overall Study|Progressive Disease|18|||
16361299|NCT01799889|39807727|FG009|Overall Study|Progressive Disease|5|||
16361300|NCT01799889|39807728|FG010|Overall Study|Progressive Disease|3|||
16431376|NCT03137992|40057774|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
16431377|NCT03137992|40057775|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
16431378|NCT03137992|40057776|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
16431379|NCT03137992|40057771|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
16431380|NCT03137992|40057772|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
16431381|NCT03137992|40057773|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
16431382|NCT03137992|40057774|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
16431383|NCT03137992|40057775|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
16431384|NCT03137992|40057776|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
16431385|NCT03137992|40057771|FG000|Part 2 (Open-label Extension)|Per study team|1|||
16431386|NCT03137992|40057772|FG001|Part 2 (Open-label Extension)|Per study team|0|||
16431387|NCT03137992|40057773|FG002|Part 2 (Open-label Extension)|Per study team|0|||
16361301|NCT01799889|39807729|FG011|Overall Study|Progressive Disease|1|||
16361302|NCT01799889|39807718|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
16361303|NCT01799889|39807719|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
16361304|NCT01799889|39807720|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
16131378|NCT00551460|38967302|FG000|Overall Study|Withdrawal by Subject|1|||
16131379|NCT00551460|38967302|FG000|Overall Study|Physician Decision|1|||
16131380|NCT00551460|38967302|FG000|Overall Study|Death|7|||
16131381|NCT00551460|38967302|FG000|Overall Study|Ineligible|4|||
16131382|NCT00551460|38967302|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
16431388|NCT03137992|40057774|FG003|Part 2 (Open-label Extension)|Per study team|0|||
16431389|NCT03137992|40057775|FG004|Part 2 (Open-label Extension)|Per study team|0|||
16431390|NCT03137992|40057776|FG005|Part 2 (Open-label Extension)|Per study team|0|||
16431391|NCT03137992|40057771|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
16431392|NCT03137992|40057772|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
16431393|NCT03137992|40057773|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
16131383|NCT00574873|38967307|FG000|Overall Study|Withdrawal by Subject|18|||
16131384|NCT00574873|38967308|FG001|Overall Study|Withdrawal by Subject|19|||
16131385|NCT00574873|38967307|FG000|Overall Study|Investigator request|18|||
16131386|NCT00574873|38967308|FG001|Overall Study|Investigator request|8|||
16131387|NCT00574873|38967307|FG000|Overall Study|Death|15|||
16131388|NCT00574873|38967308|FG001|Overall Study|Death|14|||
16131389|NCT00574873|38967307|FG000|Overall Study|Lost to Follow-up|14|||
16131390|NCT00574873|38967308|FG001|Overall Study|Lost to Follow-up|5|||
16131391|NCT00574873|38967307|FG000|Overall Study|Other|40|||
16131392|NCT00574873|38967308|FG001|Overall Study|Other|4|||
16131393|NCT00574873|38967307|FG000|Overall Study|Discontinuation of study by sponsor|5|||
16131394|NCT00574873|38967308|FG001|Overall Study|Discontinuation of study by sponsor|199|||
16131395|NCT00574873|38967307|FG000|Overall Study|Blank, site closed per local regulations|2|||
16131396|NCT00574873|38967308|FG001|Overall Study|Blank, site closed per local regulations|2|||
16131397|NCT00574873|38967307|FG000|Overall Study|Extension Study|126|||
16131398|NCT00574873|38967308|FG001|Overall Study|Extension Study|0|||
16131399|NCT01941719|38967312|FG000|Overall Study|Lost to Follow-up|20|||
16431394|NCT03137992|40057774|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
16131400|NCT01941719|38967313|FG001|Overall Study|Lost to Follow-up|19|||
16131401|NCT00605215|38967318|FG000|Overall Study|Death|0|||
16131402|NCT00605215|38967319|FG001|Overall Study|Death|0|||
16131403|NCT00605215|38967320|FG002|Overall Study|Death|1|||
16431395|NCT03137992|40057775|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
16431396|NCT03137992|40057776|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
16431397|NCT02025179|40057777|FG000|Overall Study|Lost to Follow-up|0|||
16431398|NCT02025179|40057778|FG001|Overall Study|Lost to Follow-up|0|||
16431399|NCT02025179|40057779|FG002|Overall Study|Lost to Follow-up|1|||
16431400|NCT02905266|40057780|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
16431401|NCT02905266|40057781|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
16431402|NCT02905266|40057780|FG000|Treatment Phase Part 1|Disease Progression|6|||
16431403|NCT02905266|40057781|FG001|Treatment Phase Part 1|Disease Progression|7|||
16431404|NCT02905266|40057780|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
16431405|NCT02905266|40057781|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
16431406|NCT02905266|40057780|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
16431407|NCT02905266|40057781|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
16431408|NCT02905266|40057780|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
16431409|NCT02905266|40057781|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
16431410|NCT02905266|40057780|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
16431411|NCT02905266|40057781|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
16431412|NCT02905266|40057780|FG000|Transition From Part 1 to Part 2|Death|0|||
16431413|NCT02905266|40057781|FG001|Transition From Part 1 to Part 2|Death|1|||
16431414|NCT02905266|40057780|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
16431415|NCT02905266|40057781|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
16431416|NCT02905266|40057780|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
16431417|NCT02905266|40057781|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
16431418|NCT02905266|40057780|FG000|Maintenance Phase Part 2|Disease Progression|9|||
16431419|NCT02905266|40057781|FG001|Maintenance Phase Part 2|Disease Progression|2|||
16431420|NCT02905266|40057780|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
16431421|NCT02905266|40057781|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
16431422|NCT02905266|40057780|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
16431423|NCT02905266|40057781|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
16431424|NCT00950846|40057783|FG000|Overall Study|Death|6|||
16431425|NCT00950846|40057783|FG000|Overall Study|Lost to Follow-up|3|||
16431426|NCT00950846|40057783|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
16431427|NCT02391363|40057786|FG000|Overall Study|Lost to Follow-up|5|||
16431428|NCT02391363|40057787|FG001|Overall Study|Lost to Follow-up|5|||
16431429|NCT02391363|40057786|FG000|Overall Study|Withdrawal by Subject|6|||
16431430|NCT02391363|40057787|FG001|Overall Study|Withdrawal by Subject|3|||
16431431|NCT03500640|40057788|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
16431432|NCT03500640|40057789|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
16431433|NCT03500640|40057790|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
16431434|NCT03500640|40057788|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
16431435|NCT03500640|40057789|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
16431436|NCT03500640|40057790|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
16431437|NCT03500640|40057788|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
16431438|NCT03500640|40057789|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
16431439|NCT03500640|40057790|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
16431440|NCT03500640|40057788|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
16431441|NCT03500640|40057789|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
16431442|NCT03500640|40057790|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
16431443|NCT03500640|40057788|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
16431444|NCT03500640|40057789|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
16431445|NCT03500640|40057790|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
16431446|NCT03500640|40057788|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
16431447|NCT03500640|40057789|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
16431448|NCT03500640|40057790|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
16431449|NCT03500640|40057788|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
16431450|NCT03500640|40057789|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
16431451|NCT03500640|40057790|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
16431452|NCT03500640|40057788|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
16431453|NCT03500640|40057789|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
16431454|NCT03500640|40057790|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
16431455|NCT03500640|40057788|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
16431456|NCT03500640|40057789|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
16431457|NCT03500640|40057790|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
16431458|NCT03500640|40057788|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
16431459|NCT03500640|40057789|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
16431460|NCT03500640|40057790|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
16431461|NCT01054456|40057796|FG000|Overall Study|Other|1|||
16431462|NCT03672292|40057797|FG000|Overall Study|Adverse Event|3|||
16431463|NCT03672292|40057798|FG001|Overall Study|Adverse Event|1|||
16431464|NCT03672292|40057797|FG000|Overall Study|Physician Decision|0|||
16431465|NCT03672292|40057798|FG001|Overall Study|Physician Decision|1|||
16431466|NCT03672292|40057797|FG000|Overall Study|Withdrawal by Subject|1|||
16431467|NCT03672292|40057798|FG001|Overall Study|Withdrawal by Subject|2|||
16431468|NCT01125800|40057802|FG000|Phase I|Protocol Violation|0|||
16431469|NCT01125800|40057803|FG001|Phase I|Protocol Violation|3|||
16131404|NCT00605215|38967318|FG000|Overall Study|Adverse Event|19|||
16431470|NCT01125800|40057804|FG002|Phase I|Protocol Violation|1|||
16431471|NCT01125800|40057805|FG003|Phase I|Protocol Violation|1|||
16431472|NCT01125800|40057806|FG004|Phase I|Protocol Violation|0|||
16431473|NCT01125800|40057802|FG000|Phase I|Adverse Event|2|||
16431474|NCT01125800|40057803|FG001|Phase I|Adverse Event|2|||
16431475|NCT01125800|40057804|FG002|Phase I|Adverse Event|1|||
16431476|NCT01125800|40057805|FG003|Phase I|Adverse Event|7|||
16431477|NCT01125800|40057806|FG004|Phase I|Adverse Event|0|||
16431478|NCT01125800|40057802|FG000|Phase I|Administrative problems|1|||
16431479|NCT01125800|40057803|FG001|Phase I|Administrative problems|0|||
16431480|NCT01125800|40057804|FG002|Phase I|Administrative problems|0|||
16431481|NCT01125800|40057805|FG003|Phase I|Administrative problems|0|||
16431482|NCT01125800|40057806|FG004|Phase I|Administrative problems|0|||
16431483|NCT01125800|40057802|FG000|Phase I|Withdrawal by Subject|0|||
16131405|NCT00605215|38967319|FG001|Overall Study|Adverse Event|21|||
16431484|NCT01125800|40057803|FG001|Phase I|Withdrawal by Subject|0|||
16431485|NCT01125800|40057804|FG002|Phase I|Withdrawal by Subject|1|||
16431486|NCT01125800|40057805|FG003|Phase I|Withdrawal by Subject|0|||
16431487|NCT01125800|40057806|FG004|Phase I|Withdrawal by Subject|0|||
16431488|NCT01125800|40057802|FG000|Phase I|Disease progression|5|||
16431489|NCT01125800|40057803|FG001|Phase I|Disease progression|4|||
16361305|NCT01799889|39807721|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
16361306|NCT01799889|39807722|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
16361307|NCT01799889|39807723|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
16361308|NCT01799889|39807724|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
16361309|NCT01799889|39807725|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
16361310|NCT01799889|39807726|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
16361311|NCT01799889|39807727|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
16361312|NCT01799889|39807728|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
16361313|NCT01799889|39807729|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
16431490|NCT01125800|40057804|FG002|Phase I|Disease progression|1|||
16431491|NCT01125800|40057805|FG003|Phase I|Disease progression|3|||
16431492|NCT01125800|40057806|FG004|Phase I|Disease progression|0|||
16431493|NCT01125800|40057802|FG000|Phase II|Protocol Violation|0|||
16431494|NCT01125800|40057803|FG001|Phase II|Protocol Violation|0|||
16431495|NCT01125800|40057804|FG002|Phase II|Protocol Violation|0|||
16431496|NCT01125800|40057805|FG003|Phase II|Protocol Violation|0|||
16431497|NCT01125800|40057806|FG004|Phase II|Protocol Violation|1|||
16431498|NCT01125800|40057802|FG000|Phase II|Adverse Event|0|||
16431499|NCT01125800|40057803|FG001|Phase II|Adverse Event|0|||
16431500|NCT01125800|40057804|FG002|Phase II|Adverse Event|0|||
16431501|NCT01125800|40057805|FG003|Phase II|Adverse Event|0|||
16431502|NCT01125800|40057806|FG004|Phase II|Adverse Event|2|||
16431503|NCT01125800|40057802|FG000|Phase II|Disease progression|0|||
16431504|NCT01125800|40057803|FG001|Phase II|Disease progression|0|||
16431505|NCT01125800|40057804|FG002|Phase II|Disease progression|0|||
16431506|NCT01125800|40057805|FG003|Phase II|Disease progression|1|||
16431507|NCT01125800|40057806|FG004|Phase II|Disease progression|8|||
16431508|NCT00687804|40057807|FG000|Core Study|Adverse Event|5|||
16431509|NCT00687804|40057808|FG001|Core Study|Adverse Event|3|||
16431510|NCT00687804|40057809|FG002|Core Study|Adverse Event|3|||
16431511|NCT00687804|40057807|FG000|Core Study|Abnormal laboratory value(s)|1|||
16431512|NCT00687804|40057808|FG001|Core Study|Abnormal laboratory value(s)|0|||
16431513|NCT00687804|40057809|FG002|Core Study|Abnormal laboratory value(s)|0|||
16431514|NCT00687804|40057807|FG000|Core Study|Lack of Efficacy|1|||
16431515|NCT00687804|40057808|FG001|Core Study|Lack of Efficacy|1|||
16431516|NCT00687804|40057809|FG002|Core Study|Lack of Efficacy|1|||
16431517|NCT00687804|40057807|FG000|Core Study|Withdrawal by Subject|4|||
16431518|NCT00687804|40057808|FG001|Core Study|Withdrawal by Subject|7|||
16431519|NCT00687804|40057809|FG002|Core Study|Withdrawal by Subject|7|||
16431520|NCT00687804|40057807|FG000|Core Study|Lost to Follow-up|0|||
16431521|NCT00687804|40057808|FG001|Core Study|Lost to Follow-up|1|||
16431522|NCT00687804|40057809|FG002|Core Study|Lost to Follow-up|0|||
16431523|NCT00687804|40057807|FG000|Core Study|Death|2|||
16431524|NCT00687804|40057808|FG001|Core Study|Death|2|||
16431525|NCT00687804|40057809|FG002|Core Study|Death|2|||
16431526|NCT00687804|40057807|FG000|Core Study|Protocol Violation|1|||
16431527|NCT00687804|40057808|FG001|Core Study|Protocol Violation|1|||
16431528|NCT00687804|40057809|FG002|Core Study|Protocol Violation|0|||
16431529|NCT00687804|40057807|FG000|Open-Label Extension Study|Adverse Event|2|||
16431530|NCT00687804|40057808|FG001|Open-Label Extension Study|Adverse Event|2|||
16431531|NCT00687804|40057809|FG002|Open-Label Extension Study|Adverse Event|2|||
16131406|NCT00605215|38967320|FG002|Overall Study|Adverse Event|26|||
16431532|NCT00687804|40057807|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
16431533|NCT00687804|40057808|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
16431534|NCT00687804|40057809|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
16431535|NCT00687804|40057807|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
16431536|NCT00687804|40057808|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
16431537|NCT00687804|40057809|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
16361314|NCT01799889|39807718|FG000|Overall Study|Study Terminated By Sponsor|1|||
16431538|NCT00687804|40057807|FG000|Open-Label Extension Study|Administrative problems|1|||
16431539|NCT00687804|40057808|FG001|Open-Label Extension Study|Administrative problems|1|||
16361315|NCT01799889|39807719|FG001|Overall Study|Study Terminated By Sponsor|0|||
16361316|NCT01799889|39807720|FG002|Overall Study|Study Terminated By Sponsor|0|||
16361317|NCT01799889|39807721|FG003|Overall Study|Study Terminated By Sponsor|0|||
16361318|NCT01799889|39807722|FG004|Overall Study|Study Terminated By Sponsor|2|||
16361319|NCT01799889|39807723|FG005|Overall Study|Study Terminated By Sponsor|1|||
16361320|NCT01799889|39807724|FG006|Overall Study|Study Terminated By Sponsor|0|||
16361321|NCT01799889|39807725|FG007|Overall Study|Study Terminated By Sponsor|2|||
16361322|NCT01799889|39807726|FG008|Overall Study|Study Terminated By Sponsor|1|||
16361323|NCT01799889|39807727|FG009|Overall Study|Study Terminated By Sponsor|1|||
16361324|NCT01799889|39807728|FG010|Overall Study|Study Terminated By Sponsor|0|||
16361325|NCT01799889|39807729|FG011|Overall Study|Study Terminated By Sponsor|0|||
16361326|NCT01799889|39807718|FG000|Overall Study|Withdrawal by Subject|1|||
16361327|NCT01799889|39807719|FG001|Overall Study|Withdrawal by Subject|6|||
16361328|NCT01799889|39807720|FG002|Overall Study|Withdrawal by Subject|4|||
16361329|NCT01799889|39807721|FG003|Overall Study|Withdrawal by Subject|0|||
16361330|NCT01799889|39807722|FG004|Overall Study|Withdrawal by Subject|5|||
16361331|NCT01799889|39807723|FG005|Overall Study|Withdrawal by Subject|1|||
16361332|NCT01799889|39807724|FG006|Overall Study|Withdrawal by Subject|3|||
16361333|NCT01799889|39807725|FG007|Overall Study|Withdrawal by Subject|1|||
16361334|NCT01799889|39807726|FG008|Overall Study|Withdrawal by Subject|2|||
16361335|NCT01799889|39807727|FG009|Overall Study|Withdrawal by Subject|1|||
16431540|NCT00687804|40057809|FG002|Open-Label Extension Study|Administrative problems|0|||
16431541|NCT00687804|40057807|FG000|Open-Label Extension Study|Death|2|||
16431542|NCT00687804|40057808|FG001|Open-Label Extension Study|Death|3|||
16431543|NCT00687804|40057809|FG002|Open-Label Extension Study|Death|3|||
16431544|NCT00483405|40057810|FG000|Overall Study|Adverse Event|8|||
16431545|NCT00483405|40057810|FG000|Overall Study|Lack of Efficacy|14|||
16431546|NCT00483405|40057810|FG000|Overall Study|Death|3|||
16431547|NCT00483405|40057810|FG000|Overall Study|Withdrawal by Subject|2|||
16431548|NCT00483405|40057810|FG000|Overall Study|Other complicating disease|1|||
16431549|NCT00584012|40057811|FG000|Overall Study|Withdrawal by Subject|1|||
16431550|NCT02292719|40057812|FG000|Overall Study|Withdrawal by Subject|0|||
16431551|NCT02292719|40057813|FG001|Overall Study|Withdrawal by Subject|0|||
16431552|NCT02292719|40057814|FG002|Overall Study|Withdrawal by Subject|0|||
16431553|NCT02292719|40057815|FG003|Overall Study|Withdrawal by Subject|1|||
16431554|NCT02292719|40057816|FG004|Overall Study|Withdrawal by Subject|1|||
16431555|NCT02292719|40057817|FG005|Overall Study|Withdrawal by Subject|0|||
16431556|NCT02292719|40057812|FG000|Overall Study|Subject enrolled in new study.|0|||
16431557|NCT02292719|40057813|FG001|Overall Study|Subject enrolled in new study.|0|||
16431558|NCT02292719|40057814|FG002|Overall Study|Subject enrolled in new study.|1|||
16431559|NCT02292719|40057815|FG003|Overall Study|Subject enrolled in new study.|0|||
16431560|NCT02292719|40057816|FG004|Overall Study|Subject enrolled in new study.|0|||
16431561|NCT02292719|40057817|FG005|Overall Study|Subject enrolled in new study.|0|||
16431562|NCT00836186|40057818|FG000|Overall Study|Blood could not be drawn|1|||
16431563|NCT01633541|40057819|FG000|Overall Study|Death|1|||
16431564|NCT01633541|40057820|FG001|Overall Study|Death|0|||
16431565|NCT00671034|40057821|FG000|Overall Study|Adverse Event|5|||
16431566|NCT00671034|40057822|FG001|Overall Study|Adverse Event|7|||
16431567|NCT00671034|40057823|FG002|Overall Study|Adverse Event|1|||
16431568|NCT00671034|40057821|FG000|Overall Study|Death|3|||
16431569|NCT00671034|40057822|FG001|Overall Study|Death|2|||
16431570|NCT00671034|40057823|FG002|Overall Study|Death|1|||
16431571|NCT00671034|40057821|FG000|Overall Study|Physician Decision|12|||
16431572|NCT00671034|40057822|FG001|Overall Study|Physician Decision|4|||
16431573|NCT00671034|40057823|FG002|Overall Study|Physician Decision|5|||
16431574|NCT00671034|40057821|FG000|Overall Study|VHR ALL feature|8|||
16431575|NCT00671034|40057822|FG001|Overall Study|VHR ALL feature|3|||
16431576|NCT00671034|40057823|FG002|Overall Study|VHR ALL feature|5|||
16431577|NCT00671034|40057821|FG000|Overall Study|Refusal|5|||
16431578|NCT00671034|40057822|FG001|Overall Study|Refusal|3|||
16131407|NCT00605215|38967318|FG000|Overall Study|Refusal to sign the re-consent form|8|||
16361336|NCT01799889|39807728|FG010|Overall Study|Withdrawal by Subject|1|||
16361337|NCT01799889|39807729|FG011|Overall Study|Withdrawal by Subject|1|||
16361338|NCT01799889|39807718|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16431579|NCT00671034|40057823|FG002|Overall Study|Refusal|5|||
16431580|NCT00671034|40057821|FG000|Overall Study|includes Alternative therapy, etc.|6|||
16431581|NCT00671034|40057822|FG001|Overall Study|includes Alternative therapy, etc.|1|||
16431582|NCT00671034|40057823|FG002|Overall Study|includes Alternative therapy, etc.|7|||
16431583|NCT02045862|40057828|FG000|Overall Study|Death|0|||
16431584|NCT02045862|40057829|FG001|Overall Study|Death|0|||
16361339|NCT01799889|39807719|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16361340|NCT01799889|39807720|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16431585|NCT02045862|40057830|FG002|Overall Study|Death|1|||
16431586|NCT02045862|40057828|FG000|Overall Study|Miscellaneous|5|||
16250642|NCT02322047|39400570|FG003|Overall Study|Withdrawal by Subject|1|||
16250643|NCT02322047|39400567|FG000|Overall Study|Adverse Event|0|||
16431587|NCT02045862|40057829|FG001|Overall Study|Miscellaneous|0|||
16431588|NCT02045862|40057830|FG002|Overall Study|Miscellaneous|8|||
16431589|NCT02045862|40057828|FG000|Overall Study|Withdrawal by Patient|18|||
16431590|NCT02045862|40057829|FG001|Overall Study|Withdrawal by Patient|27|||
16431591|NCT02045862|40057830|FG002|Overall Study|Withdrawal by Patient|57|||
16431592|NCT02045862|40057828|FG000|Overall Study|Protocol Violation|0|||
16431593|NCT02045862|40057829|FG001|Overall Study|Protocol Violation|0|||
16431594|NCT02045862|40057830|FG002|Overall Study|Protocol Violation|6|||
16431595|NCT02045862|40057828|FG000|Overall Study|Lack of Efficacy|8|||
16431596|NCT02045862|40057829|FG001|Overall Study|Lack of Efficacy|4|||
16431597|NCT02045862|40057830|FG002|Overall Study|Lack of Efficacy|13|||
16431598|NCT02045862|40057828|FG000|Overall Study|Randomized but not Received Study Drug|0|||
16431599|NCT02045862|40057829|FG001|Overall Study|Randomized but not Received Study Drug|2|||
16431600|NCT02045862|40057830|FG002|Overall Study|Randomized but not Received Study Drug|8|||
16431601|NCT02045862|40057828|FG000|Overall Study|Adverse Event|7|||
16431602|NCT02045862|40057829|FG001|Overall Study|Adverse Event|5|||
16431603|NCT02045862|40057830|FG002|Overall Study|Adverse Event|27|||
16431604|NCT02045862|40057828|FG000|Overall Study|Lost to Follow-up|1|||
16431605|NCT02045862|40057829|FG001|Overall Study|Lost to Follow-up|2|||
16431606|NCT02045862|40057830|FG002|Overall Study|Lost to Follow-up|6|||
16431607|NCT01200368|40057831|FG000|Infant Series|Adverse Event|2|||
16431608|NCT01200368|40057832|FG001|Infant Series|Adverse Event|2|||
16431609|NCT01200368|40057833|FG002|Infant Series|Adverse Event|3|||
16431610|NCT01200368|40057831|FG000|Infant Series|Withdrawal by Subject|0|||
16431611|NCT01200368|40057832|FG001|Infant Series|Withdrawal by Subject|2|||
16431612|NCT01200368|40057833|FG002|Infant Series|Withdrawal by Subject|2|||
16431613|NCT01200368|40057831|FG000|Infant Series|Did not meet entrance criteria|0|||
16431614|NCT01200368|40057832|FG001|Infant Series|Did not meet entrance criteria|1|||
16431615|NCT01200368|40057833|FG002|Infant Series|Did not meet entrance criteria|0|||
16431616|NCT01200368|40057831|FG000|Infant Series|Randomized, not vaccinated|0|||
16431617|NCT01200368|40057832|FG001|Infant Series|Randomized, not vaccinated|1|||
16431618|NCT01200368|40057833|FG002|Infant Series|Randomized, not vaccinated|1|||
16431619|NCT01200368|40057831|FG000|Infant Series|Other|1|||
16431620|NCT01200368|40057832|FG001|Infant Series|Other|0|||
16431621|NCT01200368|40057833|FG002|Infant Series|Other|0|||
16431622|NCT01200368|40057831|FG000|After Infant Series|Adverse Event|6|||
16431623|NCT01200368|40057832|FG001|After Infant Series|Adverse Event|6|||
16431624|NCT01200368|40057833|FG002|After Infant Series|Adverse Event|3|||
16431625|NCT01200368|40057831|FG000|After Infant Series|Withdrawal by Subject|10|||
16431626|NCT01200368|40057832|FG001|After Infant Series|Withdrawal by Subject|8|||
16431627|NCT01200368|40057833|FG002|After Infant Series|Withdrawal by Subject|4|||
16431628|NCT01200368|40057831|FG000|After Infant Series|Lost to Follow-up|1|||
16431629|NCT01200368|40057832|FG001|After Infant Series|Lost to Follow-up|0|||
16431630|NCT01200368|40057833|FG002|After Infant Series|Lost to Follow-up|0|||
16431631|NCT01200368|40057831|FG000|After Infant Series|Other|1|||
16431632|NCT01200368|40057832|FG001|After Infant Series|Other|2|||
16431633|NCT01200368|40057833|FG002|After Infant Series|Other|2|||
16431634|NCT01200368|40057831|FG000|Toddler Dose|Adverse Event|0|||
16431635|NCT01200368|40057832|FG001|Toddler Dose|Adverse Event|3|||
16431636|NCT01200368|40057833|FG002|Toddler Dose|Adverse Event|1|||
16431637|NCT03579940|40057834|FG000|Period 2|Withdrawal by Subject|0|||
16431638|NCT03579940|40057835|FG001|Period 2|Withdrawal by Subject|0|||
16431639|NCT03579940|40057836|FG002|Period 2|Withdrawal by Subject|1|||
16431640|NCT03579940|40057837|FG003|Period 2|Withdrawal by Subject|0|||
16431641|NCT03579940|40057838|FG004|Period 2|Withdrawal by Subject|0|||
16431642|NCT03579940|40057839|FG005|Period 2|Withdrawal by Subject|0|||
16431643|NCT03579940|40057840|FG006|Period 2|Withdrawal by Subject|0|||
16431644|NCT03579940|40057841|FG007|Period 2|Withdrawal by Subject|0|||
16431645|NCT03579940|40057842|FG008|Period 2|Withdrawal by Subject|0|||
16431646|NCT03579940|40057843|FG009|Period 2|Withdrawal by Subject|0|||
16431647|NCT03579940|40057844|FG010|Period 2|Withdrawal by Subject|0|||
16431648|NCT02910466|40057845|FG000|Overall Study|Adverse Event|1|||
16431649|NCT02910466|40057845|FG000|Overall Study|Withdrawal by Subject|3|||
16431650|NCT02910466|40057845|FG000|Overall Study|Lost to Follow-up|5|||
16431651|NCT02910466|40057845|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
16431652|NCT02910466|40057845|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
16431653|NCT00795704|40057847|FG000|Overall Study|Withdrawal by Subject|3|||
16431654|NCT00795704|40057848|FG001|Overall Study|Withdrawal by Subject|2|||
16431655|NCT00795704|40057847|FG000|Overall Study|Adverse Event|1|||
16431656|NCT00795704|40057848|FG001|Overall Study|Adverse Event|1|||
16431657|NCT04024891|40057850|FG000|Overall Study|Pregnancy|0|||
16431658|NCT04024891|40057851|FG001|Overall Study|Pregnancy|1|||
16431659|NCT00402168|40057852|FG000|Randomized|Lost to Follow-up|1|||
16431660|NCT00402168|40057853|FG001|Randomized|Lost to Follow-up|0|||
16431661|NCT00402168|40057852|FG000|Randomized|Withdrawal by Subject|0|||
16431662|NCT00402168|40057853|FG001|Randomized|Withdrawal by Subject|1|||
16431663|NCT00402168|40057852|FG000|Treatment (up to 12 Months)|Death|0|||
16431664|NCT00402168|40057853|FG001|Treatment (up to 12 Months)|Death|1|||
16431665|NCT00402168|40057852|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
16431666|NCT00402168|40057853|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
16431667|NCT00402168|40057852|FG000|Treatment (up to 12 Months)|non-specified|0|||
16431668|NCT00402168|40057853|FG001|Treatment (up to 12 Months)|non-specified|1|||
16431669|NCT00402168|40057852|FG000|Long Term (LT)|Adverse Event|1|||
16431670|NCT00402168|40057853|FG001|Long Term (LT)|Adverse Event|5|||
16361341|NCT01799889|39807721|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16361342|NCT01799889|39807722|FG004|Overall Study|Non-Compliance With Study Drug|0|||
16361343|NCT01799889|39807723|FG005|Overall Study|Non-Compliance With Study Drug|1|||
16361344|NCT01799889|39807724|FG006|Overall Study|Non-Compliance With Study Drug|0|||
16361345|NCT01799889|39807725|FG007|Overall Study|Non-Compliance With Study Drug|0|||
16361346|NCT01799889|39807726|FG008|Overall Study|Non-Compliance With Study Drug|0|||
16361347|NCT01799889|39807727|FG009|Overall Study|Non-Compliance With Study Drug|0|||
16361348|NCT01799889|39807728|FG010|Overall Study|Non-Compliance With Study Drug|0|||
16361349|NCT01799889|39807729|FG011|Overall Study|Non-Compliance With Study Drug|0|||
16361350|NCT03098979|39807730|FG000|Overall Study|Adverse Event|1|||
16361351|NCT03098979|39807731|FG001|Overall Study|Adverse Event|0|||
16361352|NCT03098979|39807732|FG002|Overall Study|Adverse Event|1|||
16361353|NCT03098979|39807733|FG003|Overall Study|Adverse Event|4|||
16361354|NCT03098979|39807734|FG004|Overall Study|Adverse Event|6|||
16361355|NCT03098979|39807735|FG005|Overall Study|Adverse Event|1|||
16361356|NCT03098979|39807730|FG000|Overall Study|Withdrawal by Subject|2|||
16361357|NCT03098979|39807731|FG001|Overall Study|Withdrawal by Subject|1|||
16361358|NCT03098979|39807732|FG002|Overall Study|Withdrawal by Subject|1|||
16250644|NCT02322047|39400568|FG001|Overall Study|Adverse Event|1|||
16361359|NCT03098979|39807733|FG003|Overall Study|Withdrawal by Subject|1|||
16431671|NCT00402168|40057852|FG000|Long Term (LT)|Withdrawal by Subject|4|||
16431672|NCT00402168|40057853|FG001|Long Term (LT)|Withdrawal by Subject|7|||
16431673|NCT00402168|40057852|FG000|Long Term (LT)|Pregnancy|0|||
16431674|NCT00402168|40057853|FG001|Long Term (LT)|Pregnancy|1|||
16431675|NCT00402168|40057852|FG000|Long Term (LT)|Lost to Follow-up|1|||
16431676|NCT00402168|40057853|FG001|Long Term (LT)|Lost to Follow-up|0|||
16431677|NCT00402168|40057852|FG000|Long Term (LT)|Death|4|||
16431678|NCT00402168|40057853|FG001|Long Term (LT)|Death|0|||
16431679|NCT00402168|40057852|FG000|Long Term (LT)|Lack of Efficacy|0|||
16431680|NCT00402168|40057853|FG001|Long Term (LT)|Lack of Efficacy|2|||
16431681|NCT00402168|40057852|FG000|Long Term (LT)|non-specified|1|||
16431682|NCT00402168|40057853|FG001|Long Term (LT)|non-specified|2|||
16431683|NCT00402168|40057852|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
16431684|NCT00402168|40057853|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
16431685|NCT00402168|40057852|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
16431686|NCT00402168|40057853|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
16431687|NCT01176058|40057854|FG000|Overall Study|Adverse Event|1|||
16431688|NCT01176058|40057855|FG001|Overall Study|Adverse Event|0|||
16431689|NCT01176058|40057854|FG000|Overall Study|Insufficient clinical response|2|||
16431690|NCT01176058|40057855|FG001|Overall Study|Insufficient clinical response|2|||
16431691|NCT01176058|40057854|FG000|Overall Study|Insufficient mycological response|0|||
16431692|NCT01176058|40057855|FG001|Overall Study|Insufficient mycological response|1|||
16431693|NCT01176058|40057854|FG000|Overall Study|Withdrawal by Subject|1|||
16431694|NCT01176058|40057855|FG001|Overall Study|Withdrawal by Subject|0|||
16431695|NCT03369418|40057856|FG000|Overall Study|Withdrawal by Subject|3|||
16431696|NCT03369418|40057857|FG001|Overall Study|Withdrawal by Subject|3|||
16431697|NCT01910402|40057862|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
16431698|NCT01910402|40057863|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
16431699|NCT01910402|40057864|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
16431700|NCT01910402|40057862|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
16431701|NCT01910402|40057863|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
16431702|NCT01910402|40057864|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
16431703|NCT01910402|40057862|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
16431704|NCT01910402|40057863|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
16431705|NCT01910402|40057864|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
16431706|NCT01910402|40057862|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
16431707|NCT01910402|40057863|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
16431708|NCT01910402|40057864|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
16431709|NCT01910402|40057862|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
16431710|NCT01910402|40057863|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
16431711|NCT01910402|40057864|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
16431712|NCT01910402|40057862|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
16431713|NCT01910402|40057863|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
16431714|NCT01910402|40057864|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
16431715|NCT01910402|40057862|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
16431716|NCT01910402|40057863|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
16431717|NCT01910402|40057864|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
16431718|NCT01910402|40057862|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
16431719|NCT01910402|40057863|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
16431720|NCT01910402|40057864|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
16431721|NCT01910402|40057862|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
16431722|NCT01910402|40057863|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
16431723|NCT01910402|40057864|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
16431724|NCT01910402|40057862|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
16431725|NCT01910402|40057863|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
16431726|NCT01910402|40057864|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
16431727|NCT01910402|40057862|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
16431728|NCT01910402|40057863|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
16431729|NCT01910402|40057864|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
16431730|NCT01910402|40057862|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
16431731|NCT01910402|40057863|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
16431732|NCT01910402|40057864|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
16431733|NCT01910402|40057862|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
16431734|NCT01910402|40057863|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
16431735|NCT01910402|40057864|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
16431736|NCT00890825|40057870|FG000|Overall Study|Withdrawal by Subject|1|||
16431737|NCT00890825|40057871|FG001|Overall Study|Withdrawal by Subject|0|||
16431738|NCT00890825|40057870|FG000|Overall Study|Alive at data cut off (DCO)|13|||
16431739|NCT00890825|40057871|FG001|Overall Study|Alive at data cut off (DCO)|14|||
16431740|NCT02525588|40057874|FG000|Overall Study|Death|3|||
16431741|NCT02525588|40057875|FG001|Overall Study|Death|1|||
16431742|NCT02525588|40057874|FG000|Overall Study|Lost to Follow-up|2|||
16431743|NCT02525588|40057875|FG001|Overall Study|Lost to Follow-up|0|||
16431744|NCT02525588|40057874|FG000|Overall Study|Withdrawal by Subject|1|||
16431745|NCT02525588|40057875|FG001|Overall Study|Withdrawal by Subject|1|||
16431746|NCT02525588|40057874|FG000|Overall Study|Adverse Event|0|||
16431747|NCT02525588|40057875|FG001|Overall Study|Adverse Event|1|||
16431748|NCT04303780|40057876|FG000|Overall Study|Death|104|||
16431749|NCT04303780|40057877|FG001|Overall Study|Death|85|||
16431750|NCT04303780|40057876|FG000|Overall Study|Lost to Follow-up|5|||
16431751|NCT04303780|40057877|FG001|Overall Study|Lost to Follow-up|2|||
16431752|NCT04303780|40057876|FG000|Overall Study|Withdrawal by Subject|12|||
16431753|NCT04303780|40057877|FG001|Overall Study|Withdrawal by Subject|39|||
16431754|NCT04303780|40057876|FG000|Overall Study|Ongoing in study|50|||
16431755|NCT04303780|40057877|FG001|Overall Study|Ongoing in study|45|||
16431756|NCT02741596|40057878|FG000|Overall Study|Adverse Event|1|||
16431757|NCT02741596|40057879|FG001|Overall Study|Adverse Event|5|||
16431758|NCT02741596|40057878|FG000|Overall Study|Lost to Follow-up|1|||
16431759|NCT02741596|40057879|FG001|Overall Study|Lost to Follow-up|1|||
16431760|NCT02741596|40057878|FG000|Overall Study|Physician Decision|2|||
16431761|NCT02741596|40057879|FG001|Overall Study|Physician Decision|1|||
16431762|NCT02741596|40057878|FG000|Overall Study|Pregnancy|3|||
16431763|NCT02741596|40057879|FG001|Overall Study|Pregnancy|1|||
16431764|NCT02741596|40057878|FG000|Overall Study|Other (Unspecified)|0|||
16431765|NCT02741596|40057879|FG001|Overall Study|Other (Unspecified)|3|||
16431766|NCT02741596|40057878|FG000|Overall Study|Subject withdrawn-Other|17|||
16431767|NCT02741596|40057879|FG001|Overall Study|Subject withdrawn-Other|4|||
16431768|NCT02741596|40057878|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
16431769|NCT02741596|40057879|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
16431770|NCT00730158|40057880|FG000|Overall Study|Withdrawal by Subject|1|||
16431771|NCT00730158|40057881|FG001|Overall Study|Withdrawal by Subject|1|||
16431772|NCT02342223|40057882|FG000|Overall Study|Lost to Follow-up|1|||
16431773|NCT01031979|40057883|FG000|Overall Study|Lost to Follow-up|5|||
16431774|NCT01031979|40057884|FG001|Overall Study|Lost to Follow-up|4|||
16431775|NCT01061359|40057888|FG000|Overall Study|Death|32|||
16431776|NCT01061359|40057888|FG000|Overall Study|Lost to Follow-up|1072|||
16431777|NCT01061359|40057888|FG000|Overall Study|Relapse|187|||
16431778|NCT01061359|40057888|FG000|Overall Study|Secondary neoplasm|11|||
16431779|NCT00108862|40057889|FG000|Overall Study|Death|31|||
16431780|NCT00108862|40057890|FG001|Overall Study|Death|37|||
16431781|NCT00108862|40057889|FG000|Overall Study|Withdrawal by Subject|10|||
16431782|NCT00108862|40057890|FG001|Overall Study|Withdrawal by Subject|6|||
16431783|NCT00108862|40057889|FG000|Overall Study|Lost to Follow-up|27|||
16431784|NCT00108862|40057890|FG001|Overall Study|Lost to Follow-up|19|||
16431785|NCT00773513|40057892|FG000|Overall Study|Renal Transplant|254|||
16431786|NCT00773513|40057893|FG001|Overall Study|Renal Transplant|263|||
16431787|NCT00773513|40057892|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
16431788|NCT00773513|40057893|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
16431789|NCT00773513|40057892|FG000|Overall Study|Withdrew Consent|68|||
16431790|NCT00773513|40057893|FG001|Overall Study|Withdrew Consent|69|||
16431791|NCT00773513|40057892|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
16431792|NCT00773513|40057893|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
16431793|NCT00773513|40057892|FG000|Overall Study|Failure to Return|22|||
16431794|NCT00773513|40057893|FG001|Overall Study|Failure to Return|8|||
16431795|NCT00773513|40057892|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16431796|NCT00773513|40057893|FG001|Overall Study|Insufficient Therapeutic Response|18|||
16431797|NCT00773513|40057892|FG000|Overall Study|Reason Not Specified|159|||
16431798|NCT00773513|40057893|FG001|Overall Study|Reason Not Specified|126|||
16431799|NCT00773513|40057892|FG000|Overall Study|Death|531|||
16431800|NCT00773513|40057893|FG001|Overall Study|Death|545|||
16431801|NCT03515824|40057894|FG000|Overall Study|Death|3|||
16431802|NCT03515824|40057895|FG001|Overall Study|Death|2|||
16431803|NCT03515824|40057896|FG002|Overall Study|Death|6|||
16431804|NCT03515824|40057897|FG003|Overall Study|Death|0|||
16431805|NCT03515824|40057894|FG000|Overall Study|Lost to Follow-up|0|||
16431806|NCT03515824|40057895|FG001|Overall Study|Lost to Follow-up|1|||
16431807|NCT03515824|40057896|FG002|Overall Study|Lost to Follow-up|1|||
16431808|NCT03515824|40057897|FG003|Overall Study|Lost to Follow-up|0|||
16431809|NCT03515824|40057894|FG000|Overall Study|Study terminated by sponsor|0|||
16431810|NCT03515824|40057895|FG001|Overall Study|Study terminated by sponsor|1|||
16431811|NCT03515824|40057896|FG002|Overall Study|Study terminated by sponsor|6|||
16431812|NCT03515824|40057897|FG003|Overall Study|Study terminated by sponsor|0|||
16431813|NCT03515824|40057894|FG000|Overall Study|Status not recorded|0|||
16431814|NCT03515824|40057895|FG001|Overall Study|Status not recorded|0|||
16431815|NCT03515824|40057896|FG002|Overall Study|Status not recorded|2|||
16431816|NCT03515824|40057897|FG003|Overall Study|Status not recorded|0|||
16431817|NCT00239928|40057898|FG000|Overall Study|Lack of Efficacy|1|||
16431818|NCT00239928|40057898|FG000|Overall Study|Adverse Event|4|||
16431819|NCT00239928|40057898|FG000|Overall Study|Not need to continue study|3|||
16431820|NCT00239928|40057898|FG000|Overall Study|Withdrawal by Subject|2|||
16431821|NCT03088917|40057900|FG000|Overall Study|In care/cured elsewhere|15|||
16431822|NCT03088917|40057900|FG000|Overall Study|Refuse re-evaluation|13|||
16431823|NCT03088917|40057900|FG000|Overall Study|Contact not established|13|||
16431824|NCT03088917|40057900|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
16431825|NCT03088917|40057900|FG000|Overall Study|Moved outside study region|50|||
16431826|NCT01253291|40057905|FG000|Overall Study|Withdrawal by Subject|1|||
16431827|NCT01253291|40057906|FG001|Overall Study|Withdrawal by Subject|1|||
16431828|NCT01253291|40057907|FG002|Overall Study|Withdrawal by Subject|0|||
16431829|NCT01253291|40057908|FG003|Overall Study|Withdrawal by Subject|0|||
16431830|NCT01253291|40057909|FG004|Overall Study|Withdrawal by Subject|0|||
16431831|NCT01253291|40057905|FG000|Overall Study|Adverse Event|0|||
16431832|NCT01253291|40057906|FG001|Overall Study|Adverse Event|1|||
16431833|NCT01253291|40057907|FG002|Overall Study|Adverse Event|0|||
16431834|NCT01253291|40057908|FG003|Overall Study|Adverse Event|0|||
16431835|NCT01253291|40057909|FG004|Overall Study|Adverse Event|0|||
16431836|NCT01253291|40057905|FG000|Overall Study|Lack of Efficacy|1|||
16431837|NCT01253291|40057906|FG001|Overall Study|Lack of Efficacy|0|||
16431838|NCT01253291|40057907|FG002|Overall Study|Lack of Efficacy|0|||
16431839|NCT01253291|40057908|FG003|Overall Study|Lack of Efficacy|0|||
16431840|NCT01253291|40057909|FG004|Overall Study|Lack of Efficacy|0|||
16431841|NCT01253291|40057905|FG000|Overall Study|Physician Decision|2|||
16431842|NCT01253291|40057906|FG001|Overall Study|Physician Decision|0|||
16250645|NCT02322047|39400569|FG002|Overall Study|Adverse Event|0|||
16431843|NCT01253291|40057907|FG002|Overall Study|Physician Decision|0|||
16431844|NCT01253291|40057908|FG003|Overall Study|Physician Decision|0|||
16431845|NCT01253291|40057909|FG004|Overall Study|Physician Decision|2|||
16431846|NCT00369577|40057918|FG000|Overall Study|Withdrawal by Subject|0|||
16431847|NCT00369577|40057919|FG001|Overall Study|Withdrawal by Subject|0|||
16431848|NCT00369577|40057920|FG002|Overall Study|Withdrawal by Subject|1|||
16431849|NCT03571204|40057921|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
16431850|NCT03571204|40057922|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
16361360|NCT03098979|39807734|FG004|Overall Study|Withdrawal by Subject|2|||
16361361|NCT03098979|39807735|FG005|Overall Study|Withdrawal by Subject|1|||
16361362|NCT03098979|39807730|FG000|Overall Study|Death|1|||
16361363|NCT03098979|39807731|FG001|Overall Study|Death|0|||
16361364|NCT03098979|39807732|FG002|Overall Study|Death|2|||
16361365|NCT03098979|39807733|FG003|Overall Study|Death|0|||
16361366|NCT03098979|39807734|FG004|Overall Study|Death|1|||
16361367|NCT03098979|39807735|FG005|Overall Study|Death|0|||
16361368|NCT03098979|39807730|FG000|Overall Study|Physician Decision|2|||
16361369|NCT03098979|39807731|FG001|Overall Study|Physician Decision|1|||
16361370|NCT03098979|39807732|FG002|Overall Study|Physician Decision|0|||
16361371|NCT03098979|39807733|FG003|Overall Study|Physician Decision|0|||
16361372|NCT03098979|39807734|FG004|Overall Study|Physician Decision|0|||
16361373|NCT03098979|39807735|FG005|Overall Study|Physician Decision|0|||
16361374|NCT03098979|39807730|FG000|Overall Study|Non-compliance|0|||
16361375|NCT03098979|39807731|FG001|Overall Study|Non-compliance|0|||
16361376|NCT03098979|39807732|FG002|Overall Study|Non-compliance|0|||
16361377|NCT03098979|39807733|FG003|Overall Study|Non-compliance|0|||
16361378|NCT03098979|39807734|FG004|Overall Study|Non-compliance|0|||
16431851|NCT03571204|40057923|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
16431852|NCT03571204|40057921|FG000|Overall Study|Physician Decision|0|||
16431853|NCT03571204|40057922|FG001|Overall Study|Physician Decision|1|||
16431854|NCT03571204|40057923|FG002|Overall Study|Physician Decision|0|||
16431855|NCT01987102|40057924|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
16431856|NCT01987102|40057925|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
16431857|NCT01987102|40057924|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
16431858|NCT01987102|40057925|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
16431859|NCT01987102|40057924|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
16361379|NCT03098979|39807735|FG005|Overall Study|Non-compliance|1|||
16361380|NCT03098979|39807730|FG000|Overall Study|Protocol Violation|0|||
16361381|NCT03098979|39807731|FG001|Overall Study|Protocol Violation|0|||
16361382|NCT03098979|39807732|FG002|Overall Study|Protocol Violation|0|||
16361383|NCT03098979|39807733|FG003|Overall Study|Protocol Violation|0|||
16361384|NCT03098979|39807734|FG004|Overall Study|Protocol Violation|0|||
16361385|NCT03098979|39807735|FG005|Overall Study|Protocol Violation|1|||
16361386|NCT02802228|39807737|FG000|Overall Study|Withdrawal by Subject|2|||
16361387|NCT02802228|39807738|FG001|Overall Study|Withdrawal by Subject|0|||
16361388|NCT02802228|39807737|FG000|Overall Study|Lost to Follow-up|1|||
16361389|NCT02802228|39807738|FG001|Overall Study|Lost to Follow-up|0|||
16361390|NCT02802228|39807737|FG000|Overall Study|Adverse Event|1|||
16361391|NCT02802228|39807738|FG001|Overall Study|Adverse Event|0|||
16361392|NCT02802228|39807737|FG000|Overall Study|Physician Decision|1|||
16361393|NCT02802228|39807738|FG001|Overall Study|Physician Decision|0|||
16361394|NCT01548599|39811656|FG000|Overall Study|Lost to Follow-up|0|||
16361395|NCT01548599|39811657|FG001|Overall Study|Lost to Follow-up|1|||
16361396|NCT01548599|39811656|FG000|Overall Study|Withdrawal by Subject|4|||
16361397|NCT01548599|39811657|FG001|Overall Study|Withdrawal by Subject|0|||
16361398|NCT01548599|39811656|FG000|Overall Study|Death|2|||
16361399|NCT01548599|39811657|FG001|Overall Study|Death|1|||
16361400|NCT01431976|39811658|FG000|Overall Study|Adverse Event|6|||
16361401|NCT01431976|39811658|FG000|Overall Study|Lack of Efficacy|2|||
16361402|NCT01431976|39811658|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
16361403|NCT01431976|39811658|FG000|Overall Study|Physician Decision|1|||
16361404|NCT01431976|39811658|FG000|Overall Study|Withdrawal by Subject|1|||
16361405|NCT00858988|39811663|FG000|Analysis|Lactulose unable to be detected in urine|2|||
16361406|NCT00858988|39811664|FG001|Analysis|Lactulose unable to be detected in urine|1|||
16361407|NCT01715298|39811665|FG000|Overall Study|Lost to Follow-up|0|||
16361408|NCT01715298|39811666|FG001|Overall Study|Lost to Follow-up|2|||
16361409|NCT01715298|39811665|FG000|Overall Study|Patient/guardian decision|7|||
16361410|NCT01715298|39811666|FG001|Overall Study|Patient/guardian decision|9|||
16361411|NCT01069939|39811667|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
16361412|NCT01069939|39811668|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
16361413|NCT01069939|39811667|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
16361414|NCT01069939|39811668|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
16361415|NCT01069939|39811667|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
16361416|NCT01069939|39811668|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
16361417|NCT01069939|39811667|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
16361418|NCT01069939|39811668|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
16361419|NCT01069939|39811667|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
16361420|NCT01069939|39811668|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
16361421|NCT01069939|39811667|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
16361422|NCT01069939|39811668|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
16361423|NCT01069939|39811667|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
16361424|NCT01069939|39811668|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
16361425|NCT01069939|39811667|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
16361426|NCT01069939|39811668|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
16361427|NCT01069939|39811667|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
16361428|NCT01069939|39811668|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
16361429|NCT01069939|39811667|FG000|Randomised and Included in the Analyses|Removal|1|||
16361430|NCT01069939|39811668|FG001|Randomised and Included in the Analyses|Removal|0|||
16431860|NCT01987102|40057925|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
16431861|NCT01987102|40057924|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
16431862|NCT01987102|40057925|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
16431863|NCT01987102|40057924|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
16431864|NCT01987102|40057925|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
16431865|NCT01987102|40057924|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
16431866|NCT01987102|40057925|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
16431867|NCT04524858|40057926|FG000|Overall Study|Adverse Event|1|||
16431868|NCT03760081|40057927|FG000|Overall Study|Miscellaneous|0|||
16431869|NCT03760081|40057928|FG001|Overall Study|Miscellaneous|1|||
16431870|NCT03760081|40057927|FG000|Overall Study|Progressive Disease|5|||
16431871|NCT03760081|40057928|FG001|Overall Study|Progressive Disease|10|||
16431872|NCT03760081|40057927|FG000|Overall Study|Death|1|||
16431873|NCT03760081|40057928|FG001|Overall Study|Death|1|||
16431874|NCT03359174|40057932|FG000|Overall Study|Adverse Event|1|||
16431875|NCT00867165|40057934|FG000|Overall Study|Adverse Event|3|||
16431876|NCT00867165|40057935|FG001|Overall Study|Adverse Event|0|||
16431877|NCT00867165|40057934|FG000|Overall Study|Withdrawal by Subject|1|||
16431878|NCT00867165|40057935|FG001|Overall Study|Withdrawal by Subject|0|||
16431879|NCT00286442|40057938|FG000|Overall Study|Hyperglycemic Rescue|19|||
16431880|NCT00286442|40057939|FG001|Overall Study|Hyperglycemic Rescue|17|||
16431881|NCT00286442|40057940|FG002|Overall Study|Hyperglycemic Rescue|25|||
16431882|NCT00286442|40057938|FG000|Overall Study|Adverse Event|7|||
16431883|NCT00286442|40057939|FG001|Overall Study|Adverse Event|6|||
16431884|NCT00286442|40057940|FG002|Overall Study|Adverse Event|1|||
16431885|NCT00286442|40057938|FG000|Overall Study|Protocol Violation|2|||
16431886|NCT00286442|40057939|FG001|Overall Study|Protocol Violation|4|||
16431887|NCT00286442|40057940|FG002|Overall Study|Protocol Violation|2|||
16431888|NCT00286442|40057938|FG000|Overall Study|Lost to Follow-up|5|||
16431889|NCT00286442|40057939|FG001|Overall Study|Lost to Follow-up|2|||
16431890|NCT00286442|40057940|FG002|Overall Study|Lost to Follow-up|1|||
16431891|NCT00286442|40057938|FG000|Overall Study|Physician Decision|1|||
16431892|NCT00286442|40057939|FG001|Overall Study|Physician Decision|1|||
16431893|NCT00286442|40057940|FG002|Overall Study|Physician Decision|1|||
16431894|NCT00286442|40057938|FG000|Overall Study|Administrative Error|1|||
16431895|NCT00286442|40057939|FG001|Overall Study|Administrative Error|1|||
16431896|NCT00286442|40057940|FG002|Overall Study|Administrative Error|0|||
16431897|NCT00286442|40057938|FG000|Overall Study|Withdrawal by Subject|2|||
16431898|NCT00286442|40057939|FG001|Overall Study|Withdrawal by Subject|14|||
16431899|NCT00286442|40057940|FG002|Overall Study|Withdrawal by Subject|2|||
16431900|NCT00602420|40057942|FG000|Overall Study|Death|1|||
16431901|NCT00602420|40057943|FG001|Overall Study|Death|4|||
16431902|NCT00602420|40057942|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
16361431|NCT02225587|39811672|FG000|Overall Study|Adverse Event|5|||
16361432|NCT02225587|39811673|FG001|Overall Study|Adverse Event|5|||
16361433|NCT02225587|39811672|FG000|Overall Study|Lost to Follow-up|5|||
16361434|NCT02225587|39811673|FG001|Overall Study|Lost to Follow-up|5|||
16361435|NCT02225587|39811672|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16361436|NCT02225587|39811673|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16361437|NCT02225587|39811672|FG000|Overall Study|Physician Decision|2|||
16361438|NCT02225587|39811673|FG001|Overall Study|Physician Decision|0|||
16361439|NCT02225587|39811672|FG000|Overall Study|Protocol Violation|1|||
16361440|NCT02225587|39811673|FG001|Overall Study|Protocol Violation|0|||
16361441|NCT02225587|39811672|FG000|Overall Study|Participant Moved|1|||
16361442|NCT02225587|39811673|FG001|Overall Study|Participant Moved|0|||
16361443|NCT02225587|39811672|FG000|Overall Study|Withdrawal by Subject|13|||
16361444|NCT02225587|39811673|FG001|Overall Study|Withdrawal by Subject|28|||
16361445|NCT00607893|39811674|FG000|Overall Study|Lost to Follow-up|4|||
16361446|NCT00607893|39811675|FG001|Overall Study|Lost to Follow-up|0|||
16361447|NCT00607893|39811674|FG000|Overall Study|withdrew due to loss of interest|0|||
16361448|NCT00607893|39811675|FG001|Overall Study|withdrew due to loss of interest|1|||
16361449|NCT00607893|39811674|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
16361450|NCT00607893|39811675|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
16361451|NCT00607893|39811674|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
16361452|NCT00607893|39811675|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
16361453|NCT00607893|39811674|FG000|Overall Study|Declined to be treated|1|||
16361454|NCT00607893|39811675|FG001|Overall Study|Declined to be treated|0|||
16361455|NCT00607893|39811674|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
16361456|NCT00607893|39811675|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
16361457|NCT00851591|39811676|FG000|Overall Study|Withdrawal by Subject|2|||
16361458|NCT00851591|39811677|FG001|Overall Study|Withdrawal by Subject|0|||
16361459|NCT03482024|39811680|FG000|Overall Study|Physician Decision|1|||
16361460|NCT03482024|39811681|FG001|Overall Study|Physician Decision|0|||
16361461|NCT03482024|39811682|FG002|Overall Study|Physician Decision|0|||
16361462|NCT03482024|39811683|FG003|Overall Study|Physician Decision|0|||
16361463|NCT03482024|39811684|FG004|Overall Study|Physician Decision|0|||
16361464|NCT00141817|39811685|FG000|Overall Study|Protocol Violation|0|||
16361465|NCT00141817|39811686|FG001|Overall Study|Protocol Violation|0|||
16361466|NCT00141817|39811687|FG002|Overall Study|Protocol Violation|1|||
16361467|NCT00141817|39811688|FG003|Overall Study|Protocol Violation|0|||
16361468|NCT00141817|39811685|FG000|Overall Study|Parent request|1|||
16361469|NCT00141817|39811686|FG001|Overall Study|Parent request|0|||
16431903|NCT00602420|40057943|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
16361470|NCT00141817|39811687|FG002|Overall Study|Parent request|0|||
16361471|NCT00141817|39811688|FG003|Overall Study|Parent request|0|||
16361472|NCT03846479|39811689|FG000|Overall Study|Death|8|||
16361473|NCT03846479|39811689|FG000|Overall Study|Lost to Follow-up|1|||
16361474|NCT00900562|39811690|FG000|Overall Study|Progressive disease|9|||
16361475|NCT00900562|39811691|FG001|Overall Study|Progressive disease|5|||
16431904|NCT00602420|40057942|FG000|Overall Study|Withdrawal by Subject|18|||
16431905|NCT00602420|40057943|FG001|Overall Study|Withdrawal by Subject|17|||
16431906|NCT00602420|40057942|FG000|Overall Study|Adverse Event|1|||
16431907|NCT00602420|40057943|FG001|Overall Study|Adverse Event|0|||
16431908|NCT01483183|40057945|FG000|Overall Study|Physician Decision|0|||
16431909|NCT01483183|40057946|FG001|Overall Study|Physician Decision|0|||
16431910|NCT01483183|40057947|FG002|Overall Study|Physician Decision|0|||
16431911|NCT01483183|40057948|FG003|Overall Study|Physician Decision|0|||
16431912|NCT01483183|40057949|FG004|Overall Study|Physician Decision|0|||
16431913|NCT01483183|40057950|FG005|Overall Study|Physician Decision|0|||
16431914|NCT01483183|40057951|FG006|Overall Study|Physician Decision|2|||
16431915|NCT01483183|40057952|FG007|Overall Study|Physician Decision|0|||
16431916|NCT01483183|40057953|FG008|Overall Study|Physician Decision|0|||
16431917|NCT01483183|40057954|FG009|Overall Study|Physician Decision|0|||
16431918|NCT01483183|40057945|FG000|Overall Study|Withdrawal by Subject|0|||
16431919|NCT01483183|40057946|FG001|Overall Study|Withdrawal by Subject|0|||
16431920|NCT01483183|40057947|FG002|Overall Study|Withdrawal by Subject|0|||
16431921|NCT01483183|40057948|FG003|Overall Study|Withdrawal by Subject|0|||
16431922|NCT01483183|40057949|FG004|Overall Study|Withdrawal by Subject|0|||
16431923|NCT01483183|40057950|FG005|Overall Study|Withdrawal by Subject|0|||
16431924|NCT01483183|40057951|FG006|Overall Study|Withdrawal by Subject|0|||
16431925|NCT01483183|40057952|FG007|Overall Study|Withdrawal by Subject|0|||
16431926|NCT01483183|40057953|FG008|Overall Study|Withdrawal by Subject|0|||
16431927|NCT01483183|40057954|FG009|Overall Study|Withdrawal by Subject|1|||
16431928|NCT02680665|40057956|FG000|Overall Study|No visit after the first prescription|5|||
16431929|NCT02678351|40057959|FG000|Overall Study|Withdrawal by Subject|1|||
16431930|NCT01292187|40057960|FG000|Overall Study|Adverse Event|10|||
16431931|NCT01292187|40057961|FG001|Overall Study|Adverse Event|5|||
16431932|NCT01292187|40057960|FG000|Overall Study|Withdrawal by Subject|6|||
16431933|NCT01292187|40057961|FG001|Overall Study|Withdrawal by Subject|5|||
16431934|NCT01292187|40057960|FG000|Overall Study|All other reasons|1|||
16431935|NCT01292187|40057961|FG001|Overall Study|All other reasons|3|||
16431936|NCT00410761|40057962|FG000|Overall Study|Adverse Event|29|||
16431937|NCT00410761|40057963|FG001|Overall Study|Adverse Event|3|||
16431938|NCT00410761|40057962|FG000|Overall Study|objective disease progression|71|||
16431939|NCT00410761|40057963|FG001|Overall Study|objective disease progression|55|||
16431940|NCT00410761|40057962|FG000|Overall Study|Withdrawal by Subject|8|||
16431941|NCT00410761|40057963|FG001|Overall Study|Withdrawal by Subject|4|||
16431942|NCT00410761|40057962|FG000|Overall Study|Other|12|||
16431943|NCT00410761|40057963|FG001|Overall Study|Other|9|||
16431944|NCT00410761|40057962|FG000|Overall Study|Never received randomised treatment|0|||
16431945|NCT00410761|40057963|FG001|Overall Study|Never received randomised treatment|1|||
16431946|NCT02038153|40057964|FG000|Overall Study|Withdrawal by Subject|1|||
16431947|NCT01050634|40057965|FG000|Overall Study|Enrolled, but Not Treated|56|||
16431948|NCT01050634|40057965|FG000|Overall Study|Death|2|||
16431949|NCT01050634|40057965|FG000|Overall Study|Adverse Event|42|||
16431950|NCT01050634|40057965|FG000|Overall Study|Lost to Follow-up|2|||
16431951|NCT01050634|40057965|FG000|Overall Study|Other|21|||
16431952|NCT01050634|40057965|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
16431953|NCT00269919|40061217|FG000|Overall Study|Other|26|||
16431954|NCT00269919|40061217|FG000|Overall Study|Started but not treated|1|||
16431955|NCT03210961|40061218|FG000|Overall Study|Adverse Event|0|||
16431956|NCT03210961|40061219|FG001|Overall Study|Adverse Event|0|||
16431957|NCT03210961|40061220|FG002|Overall Study|Adverse Event|0|||
16431958|NCT03210961|40061221|FG003|Overall Study|Adverse Event|0|||
16431959|NCT03210961|40061222|FG004|Overall Study|Adverse Event|0|||
16431960|NCT03210961|40061223|FG005|Overall Study|Adverse Event|0|||
16431961|NCT03210961|40061224|FG006|Overall Study|Adverse Event|0|||
16431962|NCT03210961|40061225|FG007|Overall Study|Adverse Event|0|||
16431963|NCT03210961|40061226|FG008|Overall Study|Adverse Event|0|||
16431964|NCT03210961|40061227|FG009|Overall Study|Adverse Event|0|||
16431965|NCT03210961|40061228|FG010|Overall Study|Adverse Event|0|||
16431966|NCT03210961|40061229|FG011|Overall Study|Adverse Event|0|||
16431967|NCT03210961|40061230|FG012|Overall Study|Adverse Event|0|||
16431968|NCT03210961|40061231|FG013|Overall Study|Adverse Event|1|||
16431969|NCT03210961|40061232|FG014|Overall Study|Adverse Event|0|||
16431970|NCT03210961|40061218|FG000|Overall Study|Lost to Follow-up|0|||
16431971|NCT03210961|40061219|FG001|Overall Study|Lost to Follow-up|0|||
16431972|NCT03210961|40061220|FG002|Overall Study|Lost to Follow-up|0|||
16431973|NCT03210961|40061221|FG003|Overall Study|Lost to Follow-up|0|||
16431974|NCT03210961|40061222|FG004|Overall Study|Lost to Follow-up|0|||
16431975|NCT03210961|40061223|FG005|Overall Study|Lost to Follow-up|0|||
16431976|NCT03210961|40061224|FG006|Overall Study|Lost to Follow-up|0|||
16431977|NCT03210961|40061225|FG007|Overall Study|Lost to Follow-up|0|||
16431978|NCT03210961|40061226|FG008|Overall Study|Lost to Follow-up|0|||
16431979|NCT03210961|40061227|FG009|Overall Study|Lost to Follow-up|0|||
16431980|NCT03210961|40061228|FG010|Overall Study|Lost to Follow-up|0|||
16431981|NCT03210961|40061229|FG011|Overall Study|Lost to Follow-up|0|||
16431982|NCT03210961|40061230|FG012|Overall Study|Lost to Follow-up|0|||
16431983|NCT03210961|40061231|FG013|Overall Study|Lost to Follow-up|0|||
16431984|NCT03210961|40061232|FG014|Overall Study|Lost to Follow-up|1|||
16431985|NCT03210961|40061218|FG000|Overall Study|Withdrawal by Subject|0|||
16431986|NCT03210961|40061219|FG001|Overall Study|Withdrawal by Subject|0|||
16431987|NCT03210961|40061220|FG002|Overall Study|Withdrawal by Subject|0|||
16431988|NCT03210961|40061221|FG003|Overall Study|Withdrawal by Subject|0|||
16431989|NCT03210961|40061222|FG004|Overall Study|Withdrawal by Subject|0|||
16431990|NCT03210961|40061223|FG005|Overall Study|Withdrawal by Subject|0|||
16431991|NCT03210961|40061224|FG006|Overall Study|Withdrawal by Subject|0|||
16431992|NCT03210961|40061225|FG007|Overall Study|Withdrawal by Subject|0|||
16431993|NCT03210961|40061226|FG008|Overall Study|Withdrawal by Subject|0|||
16431994|NCT03210961|40061227|FG009|Overall Study|Withdrawal by Subject|0|||
16431995|NCT03210961|40061228|FG010|Overall Study|Withdrawal by Subject|0|||
16250646|NCT02322047|39400570|FG003|Overall Study|Adverse Event|0|||
16250647|NCT02322047|39400567|FG000|Overall Study|Lost to Follow-up|0|||
16250648|NCT02322047|39400568|FG001|Overall Study|Lost to Follow-up|0|||
16250649|NCT02322047|39400569|FG002|Overall Study|Lost to Follow-up|1|||
16250650|NCT02322047|39400570|FG003|Overall Study|Lost to Follow-up|1|||
16361476|NCT00900562|39811690|FG000|Overall Study|Toxicity|1|||
16361477|NCT00900562|39811691|FG001|Overall Study|Toxicity|0|||
16361478|NCT00900562|39811690|FG000|Overall Study|Death|1|||
16361479|NCT00900562|39811691|FG001|Overall Study|Death|1|||
16361480|NCT00900562|39811690|FG000|Overall Study|Withdrawal by Subject|0|||
16361481|NCT00900562|39811691|FG001|Overall Study|Withdrawal by Subject|1|||
16431996|NCT03210961|40061229|FG011|Overall Study|Withdrawal by Subject|0|||
16250651|NCT03702621|39400583|FG000|Overall Study|Physician Decision|6|||
16250652|NCT03702621|39400584|FG001|Overall Study|Physician Decision|6|||
16431997|NCT03210961|40061230|FG012|Overall Study|Withdrawal by Subject|0|||
16431998|NCT03210961|40061231|FG013|Overall Study|Withdrawal by Subject|0|||
16361482|NCT00900562|39811690|FG000|Overall Study|Unrelated adverse event|1|||
16361483|NCT00900562|39811691|FG001|Overall Study|Unrelated adverse event|0|||
16250653|NCT01937364|39400587|FG000|Overall Study|Adverse Event|2|||
16361484|NCT01163617|39811692|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16361485|NCT01163617|39811693|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
16361486|NCT01163617|39811694|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16361487|NCT01163617|39811695|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16361488|NCT01163617|39811696|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16361489|NCT01163617|39811697|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16361490|NCT01163617|39811698|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16361491|NCT01163617|39811699|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
16361492|NCT01163617|39811692|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16361493|NCT01163617|39811693|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
16361494|NCT01163617|39811694|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16131408|NCT00605215|38967319|FG001|Overall Study|Refusal to sign the re-consent form|3|||
16131409|NCT00605215|38967320|FG002|Overall Study|Refusal to sign the re-consent form|3|||
16131410|NCT00605215|38967318|FG000|Overall Study|Withdrawal by Subject|39|||
16131411|NCT00605215|38967319|FG001|Overall Study|Withdrawal by Subject|37|||
16131412|NCT00605215|38967320|FG002|Overall Study|Withdrawal by Subject|27|||
16131413|NCT00605215|38967318|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
16131414|NCT00605215|38967319|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
16131415|NCT00605215|38967320|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
16131416|NCT00605215|38967318|FG000|Overall Study|Protocol Violation|3|||
16131417|NCT00605215|38967319|FG001|Overall Study|Protocol Violation|4|||
16131418|NCT00605215|38967320|FG002|Overall Study|Protocol Violation|1|||
16131419|NCT00605215|38967318|FG000|Overall Study|Pregnancy|8|||
16131420|NCT00605215|38967319|FG001|Overall Study|Pregnancy|5|||
16131421|NCT00605215|38967320|FG002|Overall Study|Pregnancy|4|||
16131422|NCT00605215|38967318|FG000|Overall Study|Lost to Follow-up|8|||
16131423|NCT00605215|38967319|FG001|Overall Study|Lost to Follow-up|5|||
16131424|NCT00605215|38967320|FG002|Overall Study|Lost to Follow-up|2|||
16131425|NCT00605215|38967318|FG000|Overall Study|Other than specified|0|||
16131426|NCT00605215|38967319|FG001|Overall Study|Other than specified|2|||
16131427|NCT00605215|38967320|FG002|Overall Study|Other than specified|1|||
16131428|NCT03536754|38967321|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
16361495|NCT01163617|39811695|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16361496|NCT01163617|39811696|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16361497|NCT01163617|39811697|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16361498|NCT01163617|39811698|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16361499|NCT01163617|39811699|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
16361500|NCT01163617|39811692|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16361501|NCT01163617|39811693|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16361502|NCT01163617|39811694|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
16361503|NCT01163617|39811695|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16361504|NCT01163617|39811696|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16361505|NCT01163617|39811697|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16361506|NCT01163617|39811698|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16361507|NCT01163617|39811699|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
16361508|NCT00481676|39811703|FG000|Overall Study|Adverse Event|0|||
16361509|NCT00481676|39811704|FG001|Overall Study|Adverse Event|1|||
16361510|NCT00481676|39811703|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16361511|NCT00481676|39811704|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
16361512|NCT00481676|39811703|FG000|Overall Study|Administrative problem|1|||
16361513|NCT00481676|39811704|FG001|Overall Study|Administrative problem|0|||
16361514|NCT01458587|39811705|FG000|Overall Study|Withdrawal by Subject|1|||
16361515|NCT01458587|39811706|FG001|Overall Study|Withdrawal by Subject|0|||
16361516|NCT02349412|39811707|FG000|Overall Study|Withdrawal by Subject|7|||
16361517|NCT02349412|39811708|FG001|Overall Study|Withdrawal by Subject|7|||
16361518|NCT02107898|39811709|FG000|Overall Study|Adverse Event|4|||
16361519|NCT02107898|39811710|FG001|Overall Study|Adverse Event|7|||
16361520|NCT02107898|39811709|FG000|Overall Study|Poor compliance to protocol|0|||
16361521|NCT02107898|39811710|FG001|Overall Study|Poor compliance to protocol|1|||
16361522|NCT02107898|39811709|FG000|Overall Study|Participant moved|0|||
16361523|NCT02107898|39811710|FG001|Overall Study|Participant moved|2|||
16361524|NCT02107898|39811709|FG000|Overall Study|Consent withdrawn by participant|2|||
16361525|NCT02107898|39811710|FG001|Overall Study|Consent withdrawn by participant|1|||
16361526|NCT02107898|39811709|FG000|Overall Study|Randomized but not treated|0|||
16361527|NCT02107898|39811710|FG001|Overall Study|Randomized but not treated|1|||
16361528|NCT00294658|39811711|FG000|Overall Study|Death|0|||
16361529|NCT00294658|39811712|FG001|Overall Study|Death|1|||
16361530|NCT00294658|39811711|FG000|Overall Study|Lost to Follow-up|4|||
16361531|NCT00294658|39811712|FG001|Overall Study|Lost to Follow-up|0|||
16361532|NCT00294658|39811711|FG000|Overall Study|Physician Decision|1|||
16361533|NCT00294658|39811712|FG001|Overall Study|Physician Decision|2|||
16361534|NCT00294658|39811711|FG000|Overall Study|Pregnancy|0|||
16361535|NCT00294658|39811712|FG001|Overall Study|Pregnancy|1|||
16361536|NCT00294658|39811711|FG000|Overall Study|Withdrawal by Subject|0|||
16361537|NCT00294658|39811712|FG001|Overall Study|Withdrawal by Subject|4|||
16361538|NCT00294658|39811711|FG000|Overall Study|Found to have invasive thymoma|1|||
16250654|NCT01937364|39400588|FG001|Overall Study|Adverse Event|1|||
16250655|NCT02040766|39400589|FG000|Overall Study|Adverse Event|1|||
16250656|NCT02040766|39400590|FG001|Overall Study|Adverse Event|1|||
16250657|NCT02040766|39400591|FG002|Overall Study|Adverse Event|1|||
16250658|NCT02040766|39400592|FG003|Overall Study|Adverse Event|0|||
16250659|NCT02040766|39400593|FG004|Overall Study|Adverse Event|2|||
16250660|NCT02040766|39400589|FG000|Overall Study|Withdrawal by Subject|4|||
16250661|NCT02040766|39400590|FG001|Overall Study|Withdrawal by Subject|3|||
16250662|NCT02040766|39400591|FG002|Overall Study|Withdrawal by Subject|2|||
16250663|NCT02040766|39400592|FG003|Overall Study|Withdrawal by Subject|3|||
16250664|NCT02040766|39400593|FG004|Overall Study|Withdrawal by Subject|2|||
16250665|NCT02040766|39400589|FG000|Overall Study|Non-compliance|0|||
16250666|NCT02040766|39400590|FG001|Overall Study|Non-compliance|1|||
16250667|NCT02040766|39400591|FG002|Overall Study|Non-compliance|0|||
16250668|NCT02040766|39400592|FG003|Overall Study|Non-compliance|0|||
16250669|NCT02040766|39400593|FG004|Overall Study|Non-compliance|0|||
16250670|NCT02040766|39400589|FG000|Overall Study|Protocol Violation|2|||
16250671|NCT02040766|39400590|FG001|Overall Study|Protocol Violation|1|||
16250672|NCT02040766|39400591|FG002|Overall Study|Protocol Violation|2|||
16250673|NCT02040766|39400592|FG003|Overall Study|Protocol Violation|3|||
16250674|NCT02040766|39400593|FG004|Overall Study|Protocol Violation|0|||
16250675|NCT02040766|39400589|FG000|Overall Study|Lost to Follow-up|4|||
16250676|NCT02040766|39400590|FG001|Overall Study|Lost to Follow-up|1|||
16250677|NCT02040766|39400591|FG002|Overall Study|Lost to Follow-up|3|||
16250678|NCT02040766|39400592|FG003|Overall Study|Lost to Follow-up|1|||
16250679|NCT02040766|39400593|FG004|Overall Study|Lost to Follow-up|4|||
16250680|NCT02040766|39400589|FG000|Overall Study|Not reported|1|||
16250681|NCT02040766|39400590|FG001|Overall Study|Not reported|0|||
16250682|NCT02040766|39400591|FG002|Overall Study|Not reported|0|||
16250683|NCT02040766|39400592|FG003|Overall Study|Not reported|0|||
16250684|NCT02040766|39400593|FG004|Overall Study|Not reported|0|||
16250685|NCT02040766|39400589|FG000|Overall Study|Lack of Efficacy|6|||
16250686|NCT02040766|39400590|FG001|Overall Study|Lack of Efficacy|3|||
16250687|NCT02040766|39400591|FG002|Overall Study|Lack of Efficacy|4|||
16250688|NCT02040766|39400592|FG003|Overall Study|Lack of Efficacy|6|||
16250689|NCT02040766|39400593|FG004|Overall Study|Lack of Efficacy|5|||
16250690|NCT05085964|39400594|FG000|Overall Study|Premature termination of study|21|||
16250691|NCT05085964|39400595|FG001|Overall Study|Premature termination of study|0|||
16250692|NCT03175120|39400597|FG000|Overall Study|Adverse Event|2|||
16250693|NCT03175120|39400598|FG001|Overall Study|Adverse Event|2|||
16250694|NCT03175120|39400597|FG000|Overall Study|Protocol Violation|5|||
16250695|NCT03175120|39400598|FG001|Overall Study|Protocol Violation|2|||
16250696|NCT03175120|39400597|FG000|Overall Study|Lost to Follow-up|1|||
16250697|NCT03175120|39400598|FG001|Overall Study|Lost to Follow-up|0|||
16250698|NCT03175120|39400597|FG000|Overall Study|Withdrawal by Subject|2|||
16250699|NCT03175120|39400598|FG001|Overall Study|Withdrawal by Subject|5|||
16250700|NCT03175120|39400597|FG000|Overall Study|Other|2|||
16250701|NCT03175120|39400598|FG001|Overall Study|Other|3|||
16250702|NCT00745095|39400607|FG000|Overall Study|Declined to participate|1|||
16250703|NCT00745095|39400608|FG001|Overall Study|Declined to participate|0|||
16250704|NCT00745095|39400609|FG002|Overall Study|Declined to participate|0|||
16250705|NCT00745095|39400610|FG003|Overall Study|Declined to participate|0|||
16250706|NCT00745095|39400611|FG004|Overall Study|Declined to participate|92|||
16250707|NCT00745095|39400612|FG005|Overall Study|Declined to participate|95|||
16250708|NCT00745095|39400607|FG000|Overall Study|Ineligible due to GFR criteria|0|||
16250709|NCT00745095|39400608|FG001|Overall Study|Ineligible due to GFR criteria|2|||
16250710|NCT00745095|39400609|FG002|Overall Study|Ineligible due to GFR criteria|3|||
16250711|NCT00745095|39400610|FG003|Overall Study|Ineligible due to GFR criteria|3|||
16250712|NCT00745095|39400611|FG004|Overall Study|Ineligible due to GFR criteria|30|||
16250713|NCT00745095|39400612|FG005|Overall Study|Ineligible due to GFR criteria|28|||
16250714|NCT01894984|39400614|FG000|Overall Study|Other|314|||
16250715|NCT01894984|39400615|FG001|Overall Study|Other|175|||
16250716|NCT01952574|39400617|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
16250717|NCT01952574|39400618|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
16250718|NCT01952574|39400619|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
16250719|NCT01952574|39400620|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
16250720|NCT01952574|39400621|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16250721|NCT01952574|39400622|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16250722|NCT01952574|39400623|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16250723|NCT01952574|39400617|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
16250724|NCT01952574|39400618|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
16250725|NCT01952574|39400619|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
16250726|NCT01952574|39400620|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
16250727|NCT01952574|39400621|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
16250728|NCT01952574|39400622|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
16361539|NCT00294658|39811712|FG001|Overall Study|Found to have invasive thymoma|0|||
16250729|NCT01952574|39400623|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
16431999|NCT03210961|40061232|FG014|Overall Study|Withdrawal by Subject|1|||
16361540|NCT00294658|39811711|FG000|Overall Study|Patient and family were not satisfied|0|||
16361541|NCT00294658|39811712|FG001|Overall Study|Patient and family were not satisfied|1|||
16361542|NCT01248455|39811713|FG000|Overall Study|switched to alternate treatment|1|||
16131429|NCT03536754|38967322|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
16131430|NCT03536754|38967323|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
16131431|NCT03536754|38967324|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
16131432|NCT03536754|38967325|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
16131433|NCT03536754|38967321|FG000|Open Label Extension|Other|0|||
16131434|NCT03536754|38967322|FG001|Open Label Extension|Other|0|||
16131435|NCT03536754|38967323|FG002|Open Label Extension|Other|0|||
16131436|NCT03536754|38967324|FG003|Open Label Extension|Other|0|||
16131437|NCT03536754|38967325|FG004|Open Label Extension|Other|1|||
16131438|NCT01257425|38967326|FG000|Overall Study|Lack of Efficacy|3|||
16131439|NCT01257425|38967327|FG001|Overall Study|Lack of Efficacy|3|||
16131440|NCT01257425|38967326|FG000|Overall Study|Adverse Event|1|||
16131441|NCT01257425|38967327|FG001|Overall Study|Adverse Event|1|||
16131442|NCT01257425|38967326|FG000|Overall Study|Protocol Violation|1|||
16131443|NCT01257425|38967327|FG001|Overall Study|Protocol Violation|1|||
16131444|NCT01257425|38967326|FG000|Overall Study|Withdrawal by Subject|0|||
16131445|NCT01257425|38967327|FG001|Overall Study|Withdrawal by Subject|1|||
16131446|NCT01257425|38967326|FG000|Overall Study|Death|1|||
16131447|NCT01257425|38967327|FG001|Overall Study|Death|0|||
16131448|NCT03737474|38967328|FG000|Overall Study|Adverse Event|18|||
16131449|NCT03737474|38967329|FG001|Overall Study|Adverse Event|48|||
16131450|NCT03737474|38967328|FG000|Overall Study|Lack of Efficacy|1|||
16131451|NCT03737474|38967329|FG001|Overall Study|Lack of Efficacy|3|||
16131452|NCT03737474|38967328|FG000|Overall Study|Protocol Violation|0|||
16131453|NCT03737474|38967329|FG001|Overall Study|Protocol Violation|8|||
16131454|NCT03737474|38967328|FG000|Overall Study|Withdrawal by Subject|5|||
16131455|NCT03737474|38967329|FG001|Overall Study|Withdrawal by Subject|20|||
16131456|NCT03737474|38967328|FG000|Overall Study|Non-compliance With Study Drug|0|||
16131457|NCT03737474|38967329|FG001|Overall Study|Non-compliance With Study Drug|1|||
16131458|NCT03737474|38967328|FG000|Overall Study|Physician Decision|1|||
16131459|NCT03737474|38967329|FG001|Overall Study|Physician Decision|4|||
16131460|NCT01076192|38967330|FG000|Overall Study|Other|197|||
16131461|NCT02476279|38969532|FG000|Overall Study|Lost to Follow-up|1|||
16131462|NCT02476279|38969533|FG001|Overall Study|Lost to Follow-up|1|||
16131463|NCT00640133|38969534|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
16131464|NCT00640133|38969535|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
16131465|NCT00640133|38969534|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
16131466|NCT00640133|38969535|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
16131467|NCT00640133|38969534|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
16131468|NCT00640133|38969535|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
16131469|NCT01920854|38969536|FG000|Overall Study|Withdrawal by Subject|1|||
16131470|NCT01920854|38969537|FG001|Overall Study|Withdrawal by Subject|0|||
16131471|NCT01920854|38969538|FG002|Overall Study|Withdrawal by Subject|0|||
16131472|NCT01920854|38969539|FG003|Overall Study|Withdrawal by Subject|0|||
16131473|NCT01920854|38969540|FG004|Overall Study|Withdrawal by Subject|1|||
16131474|NCT01920854|38969541|FG005|Overall Study|Withdrawal by Subject|0|||
16131475|NCT01920854|38969542|FG006|Overall Study|Withdrawal by Subject|1|||
16131476|NCT00055601|38969543|FG000|Overall Study|Protocol Violation|1|||
16131477|NCT00055601|38969544|FG001|Overall Study|Protocol Violation|1|||
16131478|NCT00055601|38969543|FG000|Overall Study|No protocol treatment received|1|||
16131479|NCT00055601|38969544|FG001|Overall Study|No protocol treatment received|1|||
16131480|NCT01948908|38969545|FG000|Overall Study|Protocol Violation|1|||
16131481|NCT01948908|38969546|FG001|Overall Study|Protocol Violation|0|||
16131482|NCT01948908|38969547|FG002|Overall Study|Protocol Violation|2|||
16131483|NCT01877837|38969548|FG000|Overall Study|Lost to Follow-up|1|||
16131484|NCT01877837|38969548|FG000|Overall Study|Ineligible|4|||
16131485|NCT01296347|38969549|FG000|Allocation|Withdrawal by Subject|1|||
16131486|NCT01296347|38969550|FG001|Allocation|Withdrawal by Subject|2|||
16131487|NCT01296347|38969549|FG000|Allocation|Lack of Efficacy|1|||
16250730|NCT01952574|39400617|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
16250731|NCT01952574|39400618|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
16250732|NCT01952574|39400619|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
16250733|NCT01952574|39400620|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
16250734|NCT01952574|39400621|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
16250735|NCT01952574|39400622|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
16250736|NCT01952574|39400623|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
16250737|NCT01952574|39400617|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
16250738|NCT01952574|39400618|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
16250739|NCT01952574|39400619|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
16361543|NCT01603602|39811714|FG000|Overall Study|Adverse Event|1|||
16361544|NCT01603602|39811715|FG001|Overall Study|Adverse Event|0|||
16131488|NCT01296347|38969550|FG001|Allocation|Lack of Efficacy|2|||
16361545|NCT01603602|39811716|FG002|Overall Study|Adverse Event|0|||
16361546|NCT01603602|39811714|FG000|Overall Study|Personal Reasons|1|||
16361547|NCT01603602|39811715|FG001|Overall Study|Personal Reasons|0|||
16361548|NCT01603602|39811716|FG002|Overall Study|Personal Reasons|1|||
16361549|NCT00883181|39811721|FG000|Overall Study|Hematological Adverse Event|26|||
16361550|NCT00883181|39811721|FG000|Overall Study|Non-hematological Adverse Event|55|||
16361551|NCT00883181|39811721|FG000|Overall Study|Disease Progression|94|||
16361552|NCT00883181|39811721|FG000|Overall Study|Administrative Reason|24|||
16361553|NCT00883181|39811721|FG000|Overall Study|Withdrawal by Subject|4|||
16361554|NCT00883181|39811721|FG000|Overall Study|Death|31|||
16361555|NCT00883181|39811721|FG000|Overall Study|Other|38|||
16361556|NCT00883181|39811721|FG000|Overall Study|Protocol Deviation|3|||
16361557|NCT00883181|39811721|FG000|Overall Study|Noncompliance|3|||
16361558|NCT02058095|39811722|FG000|Overall Study|Adverse Event|1|||
16361559|NCT02058095|39811723|FG001|Overall Study|Adverse Event|0|||
16361560|NCT00726453|39811726|FG000|Primary Enrollment Group|Death|18|||
16361561|NCT00726453|39811727|FG001|Primary Enrollment Group|Death|0|||
16361562|NCT00726453|39811726|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
16361563|NCT00726453|39811727|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
16361564|NCT00726453|39811726|FG000|38 mm Length Group|Death|0|||
16361565|NCT00726453|39811727|FG001|38 mm Length Group|Death|3|||
16361566|NCT01654276|39811728|FG000|Overall Study|Lack of Efficacy|1|||
16361567|NCT01654276|39811728|FG000|Overall Study|Lost to Follow-up|4|||
16361568|NCT01654276|39811728|FG000|Overall Study|Withdrawal by Subject|1|||
16361569|NCT03736967|39811730|FG000|Overall Study|Withdrawal by Subject|26|||
16361570|NCT03736967|39811731|FG001|Overall Study|Withdrawal by Subject|25|||
16361571|NCT03736967|39811732|FG002|Overall Study|Withdrawal by Subject|23|||
16361572|NCT03736967|39811733|FG003|Overall Study|Withdrawal by Subject|26|||
16361573|NCT03736967|39811730|FG000|Overall Study|Lost to Follow-up|3|||
16361574|NCT03736967|39811731|FG001|Overall Study|Lost to Follow-up|2|||
16361575|NCT03736967|39811732|FG002|Overall Study|Lost to Follow-up|1|||
16361576|NCT03736967|39811733|FG003|Overall Study|Lost to Follow-up|1|||
16361577|NCT03736967|39811730|FG000|Overall Study|Physician Decision|1|||
16361578|NCT03736967|39811731|FG001|Overall Study|Physician Decision|0|||
16361579|NCT03736967|39811732|FG002|Overall Study|Physician Decision|0|||
16361580|NCT03736967|39811733|FG003|Overall Study|Physician Decision|1|||
16361581|NCT03736967|39811730|FG000|Overall Study|Adverse Event|0|||
16361582|NCT03736967|39811731|FG001|Overall Study|Adverse Event|1|||
16361583|NCT03736967|39811732|FG002|Overall Study|Adverse Event|0|||
16361584|NCT03736967|39811733|FG003|Overall Study|Adverse Event|1|||
16432000|NCT03210961|40061218|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432001|NCT03210961|40061219|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432002|NCT03210961|40061220|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432003|NCT03210961|40061221|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432004|NCT03210961|40061222|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432005|NCT03210961|40061223|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432006|NCT03210961|40061224|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432007|NCT03210961|40061225|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432008|NCT03210961|40061226|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
16361585|NCT03736967|39811730|FG000|Overall Study|Death|0|||
16361586|NCT03736967|39811731|FG001|Overall Study|Death|0|||
16361587|NCT03736967|39811732|FG002|Overall Study|Death|0|||
16361588|NCT03736967|39811733|FG003|Overall Study|Death|1|||
16361589|NCT03736967|39811730|FG000|Overall Study|Randomized but never treated|1|||
16361590|NCT03736967|39811731|FG001|Overall Study|Randomized but never treated|0|||
16131489|NCT01296347|38969549|FG000|Allocation|not received infusion|1|||
16131490|NCT01296347|38969550|FG001|Allocation|not received infusion|0|||
16131491|NCT01296347|38969549|FG000|6 Week Follow up|Death|0|||
16361591|NCT03736967|39811732|FG002|Overall Study|Randomized but never treated|0|||
16361592|NCT03736967|39811733|FG003|Overall Study|Randomized but never treated|0|||
16361593|NCT03636256|39811739|FG000|Overall Study|Lost to Follow-up|3|||
16361594|NCT03636256|39811740|FG001|Overall Study|Lost to Follow-up|0|||
16361595|NCT03636256|39811741|FG002|Overall Study|Lost to Follow-up|2|||
16361596|NCT03636256|39811742|FG003|Overall Study|Lost to Follow-up|1|||
16361597|NCT03636256|39811743|FG004|Overall Study|Lost to Follow-up|0|||
16361598|NCT03636256|39811744|FG005|Overall Study|Lost to Follow-up|4|||
16361599|NCT03636256|39811745|FG006|Overall Study|Lost to Follow-up|2|||
16361600|NCT03636256|39811746|FG007|Overall Study|Lost to Follow-up|0|||
16361601|NCT03636256|39811747|FG008|Overall Study|Lost to Follow-up|4|||
16361602|NCT03636256|39811739|FG000|Overall Study|Withdrawal by Subject|0|||
16361603|NCT03636256|39811740|FG001|Overall Study|Withdrawal by Subject|0|||
16361604|NCT03636256|39811741|FG002|Overall Study|Withdrawal by Subject|0|||
16361605|NCT03636256|39811742|FG003|Overall Study|Withdrawal by Subject|0|||
16361606|NCT03636256|39811743|FG004|Overall Study|Withdrawal by Subject|0|||
16432009|NCT03210961|40061227|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
16361607|NCT03636256|39811744|FG005|Overall Study|Withdrawal by Subject|0|||
16131492|NCT01296347|38969550|FG001|6 Week Follow up|Death|1|||
16361608|NCT03636256|39811745|FG006|Overall Study|Withdrawal by Subject|0|||
16432010|NCT03210961|40061228|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432011|NCT03210961|40061229|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432012|NCT03210961|40061230|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432013|NCT03210961|40061231|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
16432014|NCT03210961|40061232|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
16432015|NCT03210961|40061218|FG000|Overall Study|Other|0|||
16432016|NCT03210961|40061219|FG001|Overall Study|Other|0|||
16432017|NCT03210961|40061220|FG002|Overall Study|Other|0|||
16432018|NCT03210961|40061221|FG003|Overall Study|Other|1|||
16432019|NCT03210961|40061222|FG004|Overall Study|Other|0|||
16432020|NCT03210961|40061223|FG005|Overall Study|Other|0|||
16432021|NCT03210961|40061224|FG006|Overall Study|Other|1|||
16432022|NCT03210961|40061225|FG007|Overall Study|Other|0|||
16432023|NCT03210961|40061226|FG008|Overall Study|Other|0|||
16432024|NCT03210961|40061227|FG009|Overall Study|Other|0|||
16432025|NCT03210961|40061228|FG010|Overall Study|Other|1|||
16432026|NCT03210961|40061229|FG011|Overall Study|Other|0|||
16432027|NCT03210961|40061230|FG012|Overall Study|Other|2|||
16432028|NCT03210961|40061231|FG013|Overall Study|Other|2|||
16432029|NCT03210961|40061232|FG014|Overall Study|Other|0|||
16432030|NCT04950465|40061237|FG000|Overall Study|Lost to Follow-up|1|||
16432031|NCT04950465|40061238|FG001|Overall Study|Lost to Follow-up|0|||
16432032|NCT04950465|40061239|FG002|Overall Study|Lost to Follow-up|0|||
16432033|NCT00687739|40061241|FG000|Overall Study|Lost to Follow-up|2|||
16432034|NCT00687739|40061242|FG001|Overall Study|Lost to Follow-up|2|||
16432035|NCT00687739|40061243|FG002|Overall Study|Lost to Follow-up|1|||
16432036|NCT00687739|40061244|FG003|Overall Study|Lost to Follow-up|2|||
16432037|NCT00687739|40061241|FG000|Overall Study|Adverse Event|0|||
16432038|NCT00687739|40061242|FG001|Overall Study|Adverse Event|1|||
16432039|NCT00687739|40061243|FG002|Overall Study|Adverse Event|1|||
16432040|NCT00687739|40061244|FG003|Overall Study|Adverse Event|0|||
16432041|NCT02675231|40061248|FG000|Overall Study|Withdrawal by Subject|1|||
16432042|NCT02675231|40061249|FG001|Overall Study|Withdrawal by Subject|3|||
16432043|NCT02675231|40061250|FG002|Overall Study|Withdrawal by Subject|1|||
16432044|NCT02675231|40061248|FG000|Overall Study|Lost to Follow-up|2|||
16432045|NCT02675231|40061249|FG001|Overall Study|Lost to Follow-up|2|||
16432046|NCT02675231|40061250|FG002|Overall Study|Lost to Follow-up|2|||
16432047|NCT02675231|40061248|FG000|Overall Study|On study treatment/follow up|23|||
16432048|NCT02675231|40061249|FG001|Overall Study|On study treatment/follow up|31|||
16432049|NCT02675231|40061250|FG002|Overall Study|On study treatment/follow up|23|||
16432050|NCT01247324|40061251|FG000|Overall Study|Death|6|||
16432051|NCT01247324|40061252|FG001|Overall Study|Death|10|||
16432052|NCT01247324|40061251|FG000|Overall Study|Physician Decision|2|||
16432053|NCT01247324|40061252|FG001|Overall Study|Physician Decision|3|||
16432054|NCT01247324|40061251|FG000|Overall Study|Non-compliance with study drug|3|||
16432055|NCT01247324|40061252|FG001|Overall Study|Non-compliance with study drug|0|||
16432056|NCT01247324|40061251|FG000|Overall Study|Lack of Efficacy|24|||
16432057|NCT01247324|40061252|FG001|Overall Study|Lack of Efficacy|14|||
16432058|NCT01247324|40061251|FG000|Overall Study|Non-compliance|3|||
16432059|NCT01247324|40061252|FG001|Overall Study|Non-compliance|2|||
16432060|NCT01247324|40061251|FG000|Overall Study|Pregnancy|5|||
16432061|NCT01247324|40061252|FG001|Overall Study|Pregnancy|10|||
16432062|NCT01247324|40061251|FG000|Overall Study|Protocol Violation|1|||
16432063|NCT01247324|40061252|FG001|Overall Study|Protocol Violation|1|||
16432064|NCT01247324|40061251|FG000|Overall Study|Reason not specified|42|||
16432065|NCT01247324|40061252|FG001|Overall Study|Reason not specified|32|||
16432066|NCT01247324|40061251|FG000|Overall Study|Consent withdrawn by participant|41|||
16432067|NCT01247324|40061252|FG001|Overall Study|Consent withdrawn by participant|56|||
16361609|NCT03636256|39811746|FG007|Overall Study|Withdrawal by Subject|0|||
16361610|NCT03636256|39811747|FG008|Overall Study|Withdrawal by Subject|1|||
16361611|NCT02369653|39811751|FG000|Overall Study|Lost to Follow-up|0|||
16361612|NCT02369653|39811752|FG001|Overall Study|Lost to Follow-up|1|||
16361613|NCT02369653|39811751|FG000|Overall Study|Administrative reason by sponsor|0|||
16361614|NCT02369653|39811752|FG001|Overall Study|Administrative reason by sponsor|1|||
16361615|NCT02369653|39811751|FG000|Overall Study|Death|1|||
16361616|NCT02369653|39811752|FG001|Overall Study|Death|2|||
16361617|NCT02369653|39811751|FG000|Overall Study|Participant withdrew consent|13|||
16361618|NCT02369653|39811752|FG001|Overall Study|Participant withdrew consent|3|||
16361619|NCT01732783|39811753|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
16361620|NCT01732783|39811754|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
16432068|NCT01247324|40061251|FG000|Overall Study|Adverse Event|49|||
16432069|NCT01247324|40061252|FG001|Overall Study|Adverse Event|35|||
16432070|NCT01247324|40061251|FG000|Overall Study|Lost to Follow-up|3|||
16432071|NCT01247324|40061252|FG001|Overall Study|Lost to Follow-up|6|||
16432072|NCT01247324|40061251|FG000|Overall Study|Study Terminated by Sponsor|4|||
16432073|NCT01247324|40061252|FG001|Overall Study|Study Terminated by Sponsor|1|||
16432074|NCT01247324|40061251|FG000|Overall Study|Missing|2|||
16432075|NCT01247324|40061252|FG001|Overall Study|Missing|1|||
16432076|NCT01486966|40061255|FG000|Overall Study|Adverse Event|0|||
16432077|NCT01486966|40061256|FG001|Overall Study|Adverse Event|1|||
16432078|NCT01486966|40061255|FG000|Overall Study|Withdrawal by Subject|0|||
16432079|NCT01486966|40061256|FG001|Overall Study|Withdrawal by Subject|1|||
16432080|NCT02792231|40061257|FG000|Overall Study|Patient/guardian decision|32|||
16432081|NCT02792231|40061258|FG001|Overall Study|Patient/guardian decision|42|||
16432082|NCT02792231|40061257|FG000|Overall Study|Adverse Event|15|||
16432083|NCT02792231|40061258|FG001|Overall Study|Adverse Event|11|||
16432084|NCT02792231|40061257|FG000|Overall Study|Physician Decision|14|||
16432085|NCT02792231|40061258|FG001|Overall Study|Physician Decision|12|||
16432086|NCT02792231|40061257|FG000|Overall Study|Lack of Efficacy|7|||
16432087|NCT02792231|40061258|FG001|Overall Study|Lack of Efficacy|9|||
16432088|NCT02792231|40061257|FG000|Overall Study|Lost to Follow-up|9|||
16432089|NCT02792231|40061258|FG001|Overall Study|Lost to Follow-up|5|||
16432090|NCT02792231|40061257|FG000|Overall Study|Pregnancy|1|||
16432091|NCT02792231|40061258|FG001|Overall Study|Pregnancy|3|||
16432092|NCT02792231|40061257|FG000|Overall Study|Non-compliance with study treatment|2|||
16432093|NCT02792231|40061258|FG001|Overall Study|Non-compliance with study treatment|1|||
16432094|NCT02792231|40061257|FG000|Overall Study|Protocol deviation|2|||
16432095|NCT02792231|40061258|FG001|Overall Study|Protocol deviation|0|||
16432096|NCT02792231|40061257|FG000|Overall Study|Technical problems|0|||
16432097|NCT02792231|40061258|FG001|Overall Study|Technical problems|1|||
16432098|NCT01076036|40061259|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
16432099|NCT00428948|40061260|FG000|Overall Study|Lost to Follow-up|15|||
16432100|NCT00428948|40061261|FG001|Overall Study|Lost to Follow-up|8|||
16432101|NCT00428948|40061260|FG000|Overall Study|Adverse Event|148|||
16432102|NCT00428948|40061261|FG001|Overall Study|Adverse Event|24|||
16432103|NCT00428948|40061260|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
16432104|NCT00428948|40061261|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
16432105|NCT00428948|40061260|FG000|Overall Study|Investigator Withdrew Subject|3|||
16432106|NCT00428948|40061261|FG001|Overall Study|Investigator Withdrew Subject|4|||
16432107|NCT00428948|40061260|FG000|Overall Study|Subject Withdrew Consent|50|||
16432108|NCT00428948|40061261|FG001|Overall Study|Subject Withdrew Consent|30|||
16432109|NCT00428948|40061260|FG000|Overall Study|Protocol Deviation|1|||
16432110|NCT00428948|40061261|FG001|Overall Study|Protocol Deviation|1|||
16432111|NCT02362724|40061268|FG000|Overall Study|Withdrawal by Subject|3|||
16432112|NCT02362724|40061269|FG001|Overall Study|Withdrawal by Subject|1|||
16432113|NCT02362724|40061268|FG000|Overall Study|Adverse Event|3|||
16432114|NCT02362724|40061269|FG001|Overall Study|Adverse Event|0|||
16432115|NCT00780416|40061272|FG000|Overall Study|Physician Decision|3|||
16432116|NCT00780416|40061273|FG001|Overall Study|Physician Decision|3|||
16432117|NCT00780416|40061272|FG000|Overall Study|Protocol Violation|1|||
16432118|NCT00780416|40061273|FG001|Overall Study|Protocol Violation|0|||
16432119|NCT00780416|40061272|FG000|Overall Study|Withdrawal by Subject|8|||
16432120|NCT00780416|40061273|FG001|Overall Study|Withdrawal by Subject|6|||
16432121|NCT02532517|40061274|FG000|Overall Study|Did not complete 24-Month visit|4|||
16432122|NCT02532517|40061274|FG000|Overall Study|Failed Angiographic eligibility|1|||
16432123|NCT02532517|40061274|FG000|Overall Study|Lost to Follow-up|4|||
16432124|NCT02532517|40061274|FG000|Overall Study|Withdrawal by Subject|4|||
16432125|NCT02532517|40061274|FG000|Overall Study|Death|4|||
16432126|NCT00556075|40061283|FG000|Overall Study|Lost to Follow-up|3|||
16432127|NCT00556075|40061284|FG001|Overall Study|Lost to Follow-up|0|||
16432128|NCT00556075|40061285|FG002|Overall Study|Lost to Follow-up|3|||
16432129|NCT00556075|40061283|FG000|Overall Study|Withdrawal by Subject|3|||
16432130|NCT00556075|40061284|FG001|Overall Study|Withdrawal by Subject|3|||
16432131|NCT00556075|40061285|FG002|Overall Study|Withdrawal by Subject|0|||
16432132|NCT00556075|40061283|FG000|Overall Study|Protocol Violation|1|||
16432133|NCT00556075|40061284|FG001|Overall Study|Protocol Violation|1|||
16432134|NCT00556075|40061285|FG002|Overall Study|Protocol Violation|3|||
16432135|NCT00556075|40061283|FG000|Overall Study|Not eligible|1|||
16432136|NCT00556075|40061284|FG001|Overall Study|Not eligible|1|||
16432137|NCT00556075|40061285|FG002|Overall Study|Not eligible|2|||
16432138|NCT00556075|40061283|FG000|Overall Study|Adverse Event|1|||
16432139|NCT00556075|40061284|FG001|Overall Study|Adverse Event|2|||
16432140|NCT00556075|40061285|FG002|Overall Study|Adverse Event|0|||
16432141|NCT00556075|40061283|FG000|Overall Study|Personal issues|4|||
16432142|NCT00556075|40061284|FG001|Overall Study|Personal issues|1|||
16432143|NCT00556075|40061285|FG002|Overall Study|Personal issues|0|||
16432144|NCT00556075|40061283|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
16432145|NCT00556075|40061284|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
16432146|NCT00556075|40061285|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
16432147|NCT02741245|40061286|FG000|Overall Study|Adverse Event|0|||
16432148|NCT02741245|40061287|FG001|Overall Study|Adverse Event|0|||
16432149|NCT02741245|40061288|FG002|Overall Study|Adverse Event|0|||
16432150|NCT02741245|40061289|FG003|Overall Study|Adverse Event|2|||
16432151|NCT02741245|40061290|FG004|Overall Study|Adverse Event|2|||
16432152|NCT02741245|40061286|FG000|Overall Study|Protocol Violation|0|||
16432153|NCT02741245|40061287|FG001|Overall Study|Protocol Violation|1|||
16432154|NCT02741245|40061288|FG002|Overall Study|Protocol Violation|0|||
16432155|NCT02741245|40061289|FG003|Overall Study|Protocol Violation|1|||
16432156|NCT02741245|40061290|FG004|Overall Study|Protocol Violation|0|||
16432157|NCT02741245|40061286|FG000|Overall Study|Withdrawal by Subject|0|||
16432158|NCT02741245|40061287|FG001|Overall Study|Withdrawal by Subject|0|||
16432159|NCT02741245|40061288|FG002|Overall Study|Withdrawal by Subject|0|||
16432160|NCT02741245|40061289|FG003|Overall Study|Withdrawal by Subject|1|||
16432161|NCT02741245|40061290|FG004|Overall Study|Withdrawal by Subject|0|||
16432162|NCT01033240|40061291|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
16432163|NCT01033240|40061292|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
16432164|NCT01033240|40061293|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
16432165|NCT01033240|40061291|FG000|Overall Study|Death|2|||
16432166|NCT01033240|40061292|FG001|Overall Study|Death|0|||
16432167|NCT01033240|40061293|FG002|Overall Study|Death|0|||
16432168|NCT01033240|40061291|FG000|Overall Study|Withdrew Consent|2|||
16432169|NCT01033240|40061292|FG001|Overall Study|Withdrew Consent|9|||
16432170|NCT01033240|40061293|FG002|Overall Study|Withdrew Consent|2|||
16432171|NCT01033240|40061291|FG000|Overall Study|Disease Progression|35|||
16432172|NCT01033240|40061292|FG001|Overall Study|Disease Progression|32|||
16432173|NCT01033240|40061293|FG002|Overall Study|Disease Progression|41|||
16432174|NCT01033240|40061291|FG000|Overall Study|Investigator Discretion|0|||
16432175|NCT01033240|40061292|FG001|Overall Study|Investigator Discretion|0|||
16432176|NCT01033240|40061293|FG002|Overall Study|Investigator Discretion|2|||
16432177|NCT01033240|40061291|FG000|Overall Study|Other|0|||
16432178|NCT01033240|40061292|FG001|Overall Study|Other|1|||
16432179|NCT01033240|40061293|FG002|Overall Study|Other|2|||
16432180|NCT00655629|40061294|FG000|Overall Study|Adverse Event|4|||
16432181|NCT00655629|40061295|FG001|Overall Study|Adverse Event|1|||
16432182|NCT00655629|40061294|FG000|Overall Study|Lack of Efficacy|2|||
16432183|NCT00655629|40061295|FG001|Overall Study|Lack of Efficacy|12|||
16432184|NCT00655629|40061294|FG000|Overall Study|Lost to Follow-up|4|||
16432185|NCT00655629|40061295|FG001|Overall Study|Lost to Follow-up|3|||
16432186|NCT00655629|40061294|FG000|Overall Study|Protocol Violation|5|||
16432187|NCT00655629|40061295|FG001|Overall Study|Protocol Violation|3|||
16432188|NCT00655629|40061294|FG000|Overall Study|consent withdrawn|6|||
16432189|NCT00655629|40061295|FG001|Overall Study|consent withdrawn|4|||
16432190|NCT02869633|40061296|FG000|Overall Study|Death|2|||
16432191|NCT02869633|40061297|FG001|Overall Study|Death|1|||
16432192|NCT02869633|40061296|FG000|Overall Study|Patient refused follow-up|1|||
16432193|NCT02869633|40061297|FG001|Overall Study|Patient refused follow-up|0|||
16432194|NCT02869633|40061296|FG000|Overall Study|Provider discretion|1|||
16432195|NCT02869633|40061297|FG001|Overall Study|Provider discretion|0|||
16432196|NCT02869633|40061296|FG000|Overall Study|Investigator decision|1|||
16432197|NCT02869633|40061297|FG001|Overall Study|Investigator decision|0|||
16432198|NCT02869633|40061296|FG000|Overall Study|Lost to Follow-up|0|||
16432199|NCT02869633|40061297|FG001|Overall Study|Lost to Follow-up|1|||
16432200|NCT02869633|40061296|FG000|Overall Study|Not eligible|6|||
16432201|NCT02869633|40061297|FG001|Overall Study|Not eligible|1|||
16432202|NCT02869633|40061296|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
16432203|NCT02869633|40061297|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
16432204|NCT02869633|40061296|FG000|Overall Study|Withdrawal by Subject|0|||
16432205|NCT02869633|40061297|FG001|Overall Study|Withdrawal by Subject|1|||
16432206|NCT03229109|40061298|FG000|Overall Study|Withdrawal by Subject|0|||
16432207|NCT03229109|40061299|FG001|Overall Study|Withdrawal by Subject|0|||
16432208|NCT03229109|40061300|FG002|Overall Study|Withdrawal by Subject|0|||
16432209|NCT03229109|40061301|FG003|Overall Study|Withdrawal by Subject|1|||
16432210|NCT02487095|40061302|FG000|Dose Expansion|Unable to scan/restage participant|0|||
16432211|NCT02487095|40061303|FG001|Dose Expansion|Unable to scan/restage participant|0|||
16432212|NCT02487095|40061304|FG002|Dose Expansion|Unable to scan/restage participant|0|||
16432213|NCT02487095|40061305|FG003|Dose Expansion|Unable to scan/restage participant|0|||
16432214|NCT02487095|40061306|FG004|Dose Expansion|Unable to scan/restage participant|1|||
16432215|NCT01358825|40061307|FG000|Overall Study|Blood sample not drawn|0|||
16432216|NCT01358825|40061308|FG001|Overall Study|Blood sample not drawn|1|||
16432217|NCT03642873|40061309|FG000|Third Intervention (1 Day)|Screen failure|0|||
16432218|NCT03642873|40061310|FG001|Third Intervention (1 Day)|Screen failure|0|||
16432219|NCT03642873|40061311|FG002|Third Intervention (1 Day)|Screen failure|0|||
16432220|NCT03642873|40061312|FG003|Third Intervention (1 Day)|Screen failure|0|||
16432221|NCT03642873|40061313|FG004|Third Intervention (1 Day)|Screen failure|1|||
16432222|NCT03642873|40061314|FG005|Third Intervention (1 Day)|Screen failure|0|||
16432223|NCT02542865|40061315|FG000|Overall Study|Identified as screen failure|1|||
16432224|NCT02542865|40061316|FG001|Overall Study|Identified as screen failure|0|||
16432225|NCT02542865|40061315|FG000|Overall Study|Withdrawal by Subject|16|||
16432226|NCT02542865|40061316|FG001|Overall Study|Withdrawal by Subject|0|||
16432227|NCT02380287|40061317|FG000|Overall Study|Adverse Event|0|||
16432228|NCT02380287|40061318|FG001|Overall Study|Adverse Event|0|||
16432229|NCT02380287|40061319|FG002|Overall Study|Adverse Event|1|||
16432230|NCT02380287|40061320|FG003|Overall Study|Adverse Event|0|||
16432231|NCT02380287|40061321|FG004|Overall Study|Adverse Event|0|||
16432232|NCT02380287|40061322|FG005|Overall Study|Adverse Event|0|||
16432233|NCT02380287|40061323|FG006|Overall Study|Adverse Event|0|||
16432234|NCT02380287|40061324|FG007|Overall Study|Adverse Event|0|||
16432235|NCT05274958|40061326|FG000|Overall Study|Only completed 1 set of PROMs|22|||
16432236|NCT05274958|40061327|FG001|Overall Study|Only completed 1 set of PROMs|35|||
16432237|NCT01290757|40061328|FG000|Overall Study|Adverse Event|1|||
16432238|NCT01290757|40061329|FG001|Overall Study|Adverse Event|0|||
16432239|NCT01290757|40061328|FG000|Overall Study|Protocol Violation|1|||
16432240|NCT01290757|40061329|FG001|Overall Study|Protocol Violation|1|||
16432241|NCT01290757|40061328|FG000|Overall Study|Other|0|||
16432242|NCT01290757|40061329|FG001|Overall Study|Other|1|||
16432243|NCT01693029|40061332|FG000|Overall Study|Withdrawal by Subject|15|||
16432244|NCT01693029|40061333|FG001|Overall Study|Withdrawal by Subject|22|||
16432245|NCT01693029|40061332|FG000|Overall Study|Kidney transplantation|7|||
16432246|NCT01693029|40061333|FG001|Overall Study|Kidney transplantation|7|||
16432247|NCT01693029|40061332|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
16432248|NCT01693029|40061333|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
16432249|NCT01693029|40061332|FG000|Overall Study|Protocol Violation|6|||
16432250|NCT01693029|40061333|FG001|Overall Study|Protocol Violation|7|||
16432251|NCT01693029|40061332|FG000|Overall Study|Change in dialysis modality|2|||
16432252|NCT01693029|40061333|FG001|Overall Study|Change in dialysis modality|1|||
16432253|NCT01693029|40061332|FG000|Overall Study|Physician Decision|0|||
16432254|NCT01693029|40061333|FG001|Overall Study|Physician Decision|2|||
16432255|NCT01693029|40061332|FG000|Overall Study|Lost to Follow-up|0|||
16432256|NCT01693029|40061333|FG001|Overall Study|Lost to Follow-up|1|||
16432257|NCT01693029|40061332|FG000|Overall Study|Adverse Event|1|||
16432258|NCT01693029|40061333|FG001|Overall Study|Adverse Event|6|||
16432259|NCT01693029|40061332|FG000|Overall Study|Death|5|||
16432260|NCT01693029|40061333|FG001|Overall Study|Death|8|||
16432261|NCT01693029|40061332|FG000|Overall Study|Non-compliance|2|||
16432262|NCT01693029|40061333|FG001|Overall Study|Non-compliance|1|||
16432263|NCT03535974|40061334|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
16432264|NCT03535974|40061335|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
16432265|NCT03535974|40061336|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
16432266|NCT03535974|40061334|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
16432267|NCT03535974|40061335|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
16432268|NCT03535974|40061336|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
16432269|NCT02055898|40061337|FG000|First Intervention (5 Days)|Physician Decision|2|||
16432270|NCT02055898|40061338|FG001|First Intervention (5 Days)|Physician Decision|0|||
16432271|NCT02055898|40061337|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
16432272|NCT02055898|40061338|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
16432273|NCT01384734|40061339|FG000|Overall Study|Adverse Event|0|||
16432274|NCT01384734|40061340|FG001|Overall Study|Adverse Event|3|||
16432275|NCT01384734|40061341|FG002|Overall Study|Adverse Event|0|||
16432276|NCT01384734|40061342|FG003|Overall Study|Adverse Event|2|||
16432277|NCT01384734|40061343|FG004|Overall Study|Adverse Event|7|||
16432278|NCT01384734|40061339|FG000|Overall Study|Death|1|||
16432279|NCT01384734|40061340|FG001|Overall Study|Death|0|||
16432280|NCT01384734|40061341|FG002|Overall Study|Death|1|||
16432281|NCT01384734|40061342|FG003|Overall Study|Death|0|||
16432282|NCT01384734|40061343|FG004|Overall Study|Death|0|||
16432283|NCT01384734|40061339|FG000|Overall Study|Continuation criteria not met|0|||
16432284|NCT01384734|40061340|FG001|Overall Study|Continuation criteria not met|0|||
16432285|NCT01384734|40061341|FG002|Overall Study|Continuation criteria not met|1|||
16432286|NCT01384734|40061342|FG003|Overall Study|Continuation criteria not met|1|||
16432287|NCT01384734|40061343|FG004|Overall Study|Continuation criteria not met|0|||
16432288|NCT01384734|40061339|FG000|Overall Study|Lack of Efficacy|3|||
16432289|NCT01384734|40061340|FG001|Overall Study|Lack of Efficacy|7|||
16432290|NCT01384734|40061341|FG002|Overall Study|Lack of Efficacy|4|||
16432291|NCT01384734|40061342|FG003|Overall Study|Lack of Efficacy|4|||
16432292|NCT01384734|40061343|FG004|Overall Study|Lack of Efficacy|2|||
16432293|NCT01384734|40061339|FG000|Overall Study|Lost to Follow-up|5|||
16432294|NCT01384734|40061340|FG001|Overall Study|Lost to Follow-up|3|||
16432295|NCT01384734|40061341|FG002|Overall Study|Lost to Follow-up|3|||
16432296|NCT01384734|40061342|FG003|Overall Study|Lost to Follow-up|8|||
16432297|NCT01384734|40061343|FG004|Overall Study|Lost to Follow-up|5|||
16432298|NCT01384734|40061339|FG000|Overall Study|Non-compliance with study drug|1|||
16432299|NCT01384734|40061340|FG001|Overall Study|Non-compliance with study drug|2|||
16432300|NCT01384734|40061341|FG002|Overall Study|Non-compliance with study drug|6|||
16432301|NCT01384734|40061342|FG003|Overall Study|Non-compliance with study drug|0|||
16432302|NCT01384734|40061343|FG004|Overall Study|Non-compliance with study drug|2|||
16432303|NCT01384734|40061339|FG000|Overall Study|Pregnancy|0|||
16432304|NCT01384734|40061340|FG001|Overall Study|Pregnancy|1|||
16432305|NCT01384734|40061341|FG002|Overall Study|Pregnancy|0|||
16432306|NCT01384734|40061342|FG003|Overall Study|Pregnancy|0|||
16432307|NCT01384734|40061343|FG004|Overall Study|Pregnancy|1|||
16432308|NCT01384734|40061339|FG000|Overall Study|Sponsor terminated|0|||
16432309|NCT01384734|40061340|FG001|Overall Study|Sponsor terminated|0|||
16432310|NCT01384734|40061341|FG002|Overall Study|Sponsor terminated|0|||
16432311|NCT01384734|40061342|FG003|Overall Study|Sponsor terminated|0|||
16432312|NCT01384734|40061343|FG004|Overall Study|Sponsor terminated|1|||
16432313|NCT01384734|40061339|FG000|Overall Study|Withdrawal by Subject|5|||
16432314|NCT01384734|40061340|FG001|Overall Study|Withdrawal by Subject|5|||
16432315|NCT01384734|40061341|FG002|Overall Study|Withdrawal by Subject|6|||
16432316|NCT01384734|40061342|FG003|Overall Study|Withdrawal by Subject|7|||
16432317|NCT01384734|40061343|FG004|Overall Study|Withdrawal by Subject|9|||
16432318|NCT01384734|40061339|FG000|Overall Study|Investigator relocating|0|||
16432319|NCT01384734|40061340|FG001|Overall Study|Investigator relocating|2|||
16432320|NCT01384734|40061341|FG002|Overall Study|Investigator relocating|0|||
16432321|NCT01384734|40061342|FG003|Overall Study|Investigator relocating|3|||
16432322|NCT01384734|40061343|FG004|Overall Study|Investigator relocating|1|||
16432323|NCT01384734|40061339|FG000|Overall Study|Unable to come back for visit|1|||
16432324|NCT01384734|40061340|FG001|Overall Study|Unable to come back for visit|0|||
16432325|NCT01384734|40061341|FG002|Overall Study|Unable to come back for visit|1|||
16432326|NCT01384734|40061342|FG003|Overall Study|Unable to come back for visit|1|||
16432327|NCT01384734|40061343|FG004|Overall Study|Unable to come back for visit|0|||
16131493|NCT01296347|38969549|FG000|3 Month Follow up|Death|1|||
16432328|NCT01384734|40061339|FG000|Overall Study|Prison|0|||
16432329|NCT01384734|40061340|FG001|Overall Study|Prison|0|||
16432330|NCT01384734|40061341|FG002|Overall Study|Prison|1|||
16432331|NCT01384734|40061342|FG003|Overall Study|Prison|0|||
16432332|NCT01384734|40061343|FG004|Overall Study|Prison|0|||
16432333|NCT01384734|40061339|FG000|Overall Study|As per Exclusion criteria|0|||
16432334|NCT01384734|40061340|FG001|Overall Study|As per Exclusion criteria|1|||
16432335|NCT01384734|40061341|FG002|Overall Study|As per Exclusion criteria|0|||
16432336|NCT01384734|40061342|FG003|Overall Study|As per Exclusion criteria|0|||
16432337|NCT01384734|40061343|FG004|Overall Study|As per Exclusion criteria|0|||
16432338|NCT01384734|40061339|FG000|Overall Study|Missed End of treatment visit|0|||
16432339|NCT01384734|40061340|FG001|Overall Study|Missed End of treatment visit|0|||
16432340|NCT01384734|40061341|FG002|Overall Study|Missed End of treatment visit|0|||
16432341|NCT01384734|40061342|FG003|Overall Study|Missed End of treatment visit|1|||
16432342|NCT01384734|40061343|FG004|Overall Study|Missed End of treatment visit|0|||
16432343|NCT01384734|40061339|FG000|Overall Study|Adhesion problem|0|||
16432344|NCT01384734|40061340|FG001|Overall Study|Adhesion problem|0|||
16432345|NCT01384734|40061341|FG002|Overall Study|Adhesion problem|0|||
16432346|NCT01384734|40061342|FG003|Overall Study|Adhesion problem|1|||
16432347|NCT01384734|40061343|FG004|Overall Study|Adhesion problem|0|||
16432348|NCT01384734|40061339|FG000|Overall Study|Early termination|0|||
16432349|NCT01384734|40061340|FG001|Overall Study|Early termination|0|||
16432350|NCT01384734|40061341|FG002|Overall Study|Early termination|0|||
16432351|NCT01384734|40061342|FG003|Overall Study|Early termination|0|||
16432352|NCT01384734|40061343|FG004|Overall Study|Early termination|1|||
16361621|NCT01732783|39811755|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
16361622|NCT01732783|39811753|FG000|Overall Study|Death|13|||
16361623|NCT01732783|39811754|FG001|Overall Study|Death|4|||
16361624|NCT01732783|39811755|FG002|Overall Study|Death|1|||
16361625|NCT01732783|39811753|FG000|Overall Study|Lost to Follow-up|7|||
16361626|NCT01732783|39811754|FG001|Overall Study|Lost to Follow-up|1|||
16361627|NCT01732783|39811755|FG002|Overall Study|Lost to Follow-up|1|||
16361628|NCT01732783|39811753|FG000|Overall Study|Administrative Decision|8|||
16361629|NCT01732783|39811754|FG001|Overall Study|Administrative Decision|2|||
16361630|NCT01732783|39811755|FG002|Overall Study|Administrative Decision|1|||
16361631|NCT01732783|39811753|FG000|Overall Study|Withdrawal by Subject|1|||
16361632|NCT01732783|39811754|FG001|Overall Study|Withdrawal by Subject|0|||
16361633|NCT01732783|39811755|FG002|Overall Study|Withdrawal by Subject|0|||
16361634|NCT01245751|39811756|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
16361635|NCT01245751|39811757|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
16361636|NCT01245751|39811758|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
16361637|NCT01245751|39811759|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
16361638|NCT01245751|39811756|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
16361639|NCT01245751|39811757|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
16361640|NCT01245751|39811758|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
16361641|NCT01245751|39811759|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
16361642|NCT01245751|39811756|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
16361643|NCT01245751|39811757|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
16361644|NCT01245751|39811758|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
16361645|NCT01245751|39811759|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
16361646|NCT00226655|39811764|FG000|Overall Study|Death|13|||
16361647|NCT00226655|39811764|FG000|Overall Study|Withdrawal by Subject|15|||
16361648|NCT00226655|39811764|FG000|Overall Study|Adverse Event|35|||
16361649|NCT00226655|39811764|FG000|Overall Study|Physician Decision|6|||
16361650|NCT00226655|39811764|FG000|Overall Study|Clinical deterioration|10|||
16361651|NCT00362232|39811765|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
16361652|NCT00362232|39811766|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
16361653|NCT00362232|39811765|FG000|Treatment (12 +/- 2 Days)|Death|1|||
16361654|NCT00362232|39811766|FG001|Treatment (12 +/- 2 Days)|Death|3|||
16361655|NCT00362232|39811765|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
16361656|NCT00362232|39811766|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
16361657|NCT00362232|39811765|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
16361658|NCT00362232|39811766|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
16361659|NCT00362232|39811765|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
16361660|NCT00362232|39811766|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
16361661|NCT00362232|39811765|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
16361662|NCT00362232|39811766|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
16361663|NCT00362232|39811765|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
16361664|NCT00362232|39811766|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
16361665|NCT00362232|39811765|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
16361666|NCT00362232|39811766|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
16361667|NCT00362232|39811765|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
16361668|NCT00362232|39811766|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
16361669|NCT00362232|39811765|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
16361670|NCT00362232|39811766|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
16361671|NCT00362232|39811765|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
16432353|NCT01384734|40061339|FG000|Overall Study|Physician Decision|1|||
16432354|NCT01384734|40061340|FG001|Overall Study|Physician Decision|0|||
16432355|NCT01384734|40061341|FG002|Overall Study|Physician Decision|0|||
16432356|NCT01384734|40061342|FG003|Overall Study|Physician Decision|0|||
16432357|NCT01384734|40061343|FG004|Overall Study|Physician Decision|0|||
16432358|NCT01300728|40061344|FG000|Overall Study|Withdrawal by Subject|1|||
16432359|NCT01300728|40061345|FG001|Overall Study|Withdrawal by Subject|1|||
16432360|NCT01300728|40061344|FG000|Overall Study|Physician Decision|1|||
16432361|NCT01300728|40061345|FG001|Overall Study|Physician Decision|0|||
16432362|NCT01011673|40061346|FG000|Randomized|Secondary headache|2|||
16432363|NCT01011673|40061347|FG001|Randomized|Secondary headache|1|||
16432364|NCT01011673|40061346|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
16131494|NCT01296347|38969550|FG001|3 Month Follow up|Death|0|||
16131495|NCT01296347|38969549|FG000|3 Month Follow up|Lost to Follow-up|0|||
16131496|NCT01296347|38969550|FG001|3 Month Follow up|Lost to Follow-up|1|||
16131497|NCT01296347|38969549|FG000|6 Month Follow up|Death|2|||
16131498|NCT01296347|38969550|FG001|6 Month Follow up|Death|1|||
16361672|NCT00362232|39811766|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
16361673|NCT00362232|39811765|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
16361674|NCT00362232|39811766|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
16361675|NCT00362232|39811765|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
16361676|NCT00362232|39811766|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
16361677|NCT00676143|39811768|FG000|Overall Study|Adverse Event|34|||
16361678|NCT00676143|39811769|FG001|Overall Study|Adverse Event|60|||
16361679|NCT00676143|39811768|FG000|Overall Study|Death|4|||
16361680|NCT00676143|39811769|FG001|Overall Study|Death|4|||
16361681|NCT00676143|39811768|FG000|Overall Study|Lack of Efficacy|0|||
16361682|NCT00676143|39811769|FG001|Overall Study|Lack of Efficacy|6|||
16361683|NCT00676143|39811768|FG000|Overall Study|Lost to Follow-up|0|||
16361684|NCT00676143|39811769|FG001|Overall Study|Lost to Follow-up|13|||
16361685|NCT00676143|39811768|FG000|Overall Study|Physician Decision|5|||
16361686|NCT00676143|39811769|FG001|Overall Study|Physician Decision|8|||
16361687|NCT00676143|39811768|FG000|Overall Study|Protocol Violation|4|||
16361688|NCT00676143|39811769|FG001|Overall Study|Protocol Violation|8|||
16361689|NCT00676143|39811768|FG000|Overall Study|Withdrawal by Subject|24|||
16361690|NCT00676143|39811769|FG001|Overall Study|Withdrawal by Subject|42|||
16361691|NCT00676143|39811768|FG000|Overall Study|Discontinuation of study by sponsor|65|||
16361692|NCT00676143|39811769|FG001|Overall Study|Discontinuation of study by sponsor|88|||
16361693|NCT00676143|39811768|FG000|Overall Study|Failed to return|2|||
16361694|NCT00676143|39811769|FG001|Overall Study|Failed to return|1|||
16361695|NCT00676143|39811768|FG000|Overall Study|Loss of caregiver|5|||
16361696|NCT00676143|39811769|FG001|Overall Study|Loss of caregiver|3|||
16361697|NCT00676143|39811768|FG000|Overall Study|Other|11|||
16361698|NCT00676143|39811769|FG001|Overall Study|Other|20|||
16361699|NCT00676143|39811768|FG000|Overall Study|Participant participation unknown|1|||
16361700|NCT00676143|39811769|FG001|Overall Study|Participant participation unknown|4|||
16361701|NCT00676143|39811768|FG000|Overall Study|Vasogenic edema recurrence|1|||
16361702|NCT00676143|39811769|FG001|Overall Study|Vasogenic edema recurrence|3|||
16361703|NCT00392223|39811770|FG000|Overall Study|Adverse Event|5|||
16361704|NCT00392223|39811771|FG001|Overall Study|Adverse Event|4|||
16361705|NCT00392223|39811770|FG000|Overall Study|Lost to Follow-up|1|||
16361706|NCT00392223|39811771|FG001|Overall Study|Lost to Follow-up|4|||
16361707|NCT00392223|39811770|FG000|Overall Study|Protocol Violation|0|||
16361708|NCT00392223|39811771|FG001|Overall Study|Protocol Violation|3|||
16361709|NCT00392223|39811770|FG000|Overall Study|Withdrawal by Subject|3|||
16361710|NCT00392223|39811771|FG001|Overall Study|Withdrawal by Subject|2|||
16361711|NCT00712920|39811778|FG000|Overall Study|Adverse Event|3|||
16361712|NCT00712920|39811779|FG001|Overall Study|Adverse Event|4|||
16361713|NCT00712920|39811780|FG002|Overall Study|Adverse Event|7|||
16361714|NCT00712920|39811778|FG000|Overall Study|Withdrawal by Subject|4|||
16361715|NCT00712920|39811779|FG001|Overall Study|Withdrawal by Subject|2|||
16361716|NCT00712920|39811780|FG002|Overall Study|Withdrawal by Subject|1|||
16361717|NCT00712920|39811778|FG000|Overall Study|Lost to Follow-up|1|||
16361718|NCT00712920|39811779|FG001|Overall Study|Lost to Follow-up|4|||
16361719|NCT00712920|39811780|FG002|Overall Study|Lost to Follow-up|0|||
16432365|NCT01011673|40061347|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
16131499|NCT01296347|38969549|FG000|6 Month Follow up|Lost to Follow-up|0|||
16131500|NCT01296347|38969550|FG001|6 Month Follow up|Lost to Follow-up|1|||
16131501|NCT01296347|38969549|FG000|12 Month Follow up|Lost to Follow-up|3|||
16361720|NCT00712920|39811778|FG000|Overall Study|Lack of Efficacy|1|||
16361721|NCT00712920|39811779|FG001|Overall Study|Lack of Efficacy|0|||
16361722|NCT00712920|39811780|FG002|Overall Study|Lack of Efficacy|1|||
16361723|NCT00712920|39811778|FG000|Overall Study|Other|5|||
16361724|NCT00712920|39811779|FG001|Overall Study|Other|7|||
16361725|NCT00712920|39811780|FG002|Overall Study|Other|3|||
16361726|NCT00712920|39811778|FG000|Overall Study|Non-compliance|3|||
16361727|NCT00712920|39811779|FG001|Overall Study|Non-compliance|0|||
16361728|NCT00712920|39811780|FG002|Overall Study|Non-compliance|0|||
16361729|NCT02572167|39811781|FG000|Overall Study|Withdrawal by Subject|0|||
16432366|NCT01594931|40061348|FG000|Overall Study|Adverse Event|3|||
16432367|NCT01594931|40061349|FG001|Overall Study|Adverse Event|1|||
16432368|NCT01594931|40061350|FG002|Overall Study|Adverse Event|1|||
16432369|NCT01594931|40061348|FG000|Overall Study|Withdrawal by Subject|2|||
16432370|NCT01594931|40061349|FG001|Overall Study|Withdrawal by Subject|1|||
16432371|NCT01594931|40061350|FG002|Overall Study|Withdrawal by Subject|1|||
16432372|NCT01594931|40061348|FG000|Overall Study|Lack of Efficacy|7|||
16432373|NCT01594931|40061349|FG001|Overall Study|Lack of Efficacy|2|||
16432374|NCT01594931|40061350|FG002|Overall Study|Lack of Efficacy|2|||
16432375|NCT01594931|40061348|FG000|Overall Study|Lost to Follow-up|4|||
16432376|NCT01594931|40061349|FG001|Overall Study|Lost to Follow-up|3|||
16432377|NCT01594931|40061350|FG002|Overall Study|Lost to Follow-up|3|||
16432378|NCT01594931|40061348|FG000|Overall Study|Protocol Violation|2|||
16432379|NCT01594931|40061349|FG001|Overall Study|Protocol Violation|1|||
16131502|NCT01296347|38969550|FG001|12 Month Follow up|Lost to Follow-up|1|||
16131503|NCT01296347|38969549|FG000|12 Month Follow up|Death|1|||
16131504|NCT01296347|38969550|FG001|12 Month Follow up|Death|1|||
16361730|NCT02572167|39811782|FG001|Overall Study|Withdrawal by Subject|3|||
16361731|NCT02572167|39811783|FG002|Overall Study|Withdrawal by Subject|0|||
16361732|NCT02572167|39811781|FG000|Overall Study|Lost to Follow-up|2|||
16361733|NCT02572167|39811782|FG001|Overall Study|Lost to Follow-up|5|||
16361734|NCT02572167|39811783|FG002|Overall Study|Lost to Follow-up|3|||
16361735|NCT02572167|39811781|FG000|Overall Study|Death|0|||
16361736|NCT02572167|39811782|FG001|Overall Study|Death|8|||
16361737|NCT02572167|39811783|FG002|Overall Study|Death|3|||
16361738|NCT02572167|39811781|FG000|Overall Study|Did not meet inclusion criteria|0|||
16361739|NCT02572167|39811782|FG001|Overall Study|Did not meet inclusion criteria|0|||
16361740|NCT02572167|39811783|FG002|Overall Study|Did not meet inclusion criteria|1|||
16361741|NCT02572167|39811781|FG000|Overall Study|Study closure by Sponsor|4|||
16361742|NCT02572167|39811782|FG001|Overall Study|Study closure by Sponsor|40|||
16361743|NCT02572167|39811783|FG002|Overall Study|Study closure by Sponsor|24|||
16361744|NCT01143324|39811784|FG000|Overall Study|Lost to Follow-up|11|||
16361745|NCT01143324|39811784|FG000|Overall Study|Withdrawal by Subject|4|||
16361746|NCT01143324|39811784|FG000|Overall Study|Explant of the device|4|||
16361747|NCT04333498|39811785|FG000|Overall Study|Lost to Follow-up|1|||
16131505|NCT01296347|38969549|FG000|12 Month Follow up|Withdrawal by Subject|0|||
16131506|NCT01296347|38969550|FG001|12 Month Follow up|Withdrawal by Subject|1|||
16361748|NCT04333498|39811786|FG001|Overall Study|Lost to Follow-up|0|||
16361749|NCT04333498|39811785|FG000|Overall Study|Lost to Follow-up|0|||
16361750|NCT04333498|39811786|FG001|Overall Study|Lost to Follow-up|1|||
16432380|NCT01594931|40061350|FG002|Overall Study|Protocol Violation|0|||
16432381|NCT01594931|40061348|FG000|Overall Study|No defiined|11|||
16432382|NCT01594931|40061349|FG001|Overall Study|No defiined|4|||
16432383|NCT01594931|40061350|FG002|Overall Study|No defiined|7|||
16432384|NCT00985465|40061351|FG000|Overall Study|Withdrawal by Subject|1|||
16432385|NCT00985465|40061352|FG001|Overall Study|Withdrawal by Subject|2|||
16432386|NCT00985465|40061351|FG000|Overall Study|Considered to be part of the other group|0|||
16432387|NCT00985465|40061352|FG001|Overall Study|Considered to be part of the other group|1|||
16432388|NCT01623115|40061353|FG000|Overall Study|Randomized but not treated|0|||
16432389|NCT01623115|40061354|FG001|Overall Study|Randomized but not treated|1|||
16432390|NCT01623115|40061353|FG000|Overall Study|Physician Decision|1|||
16432391|NCT01623115|40061354|FG001|Overall Study|Physician Decision|0|||
16432392|NCT01623115|40061353|FG000|Overall Study|Participants moved|1|||
16432393|NCT01623115|40061354|FG001|Overall Study|Participants moved|5|||
16432394|NCT01623115|40061353|FG000|Overall Study|Adverse Event|10|||
16432395|NCT01623115|40061354|FG001|Overall Study|Adverse Event|13|||
16432396|NCT01623115|40061353|FG000|Overall Study|Poor compliance to protocol|4|||
16432397|NCT01623115|40061354|FG001|Overall Study|Poor compliance to protocol|10|||
16432398|NCT01623115|40061353|FG000|Overall Study|Consent withdrawn by participant|2|||
16432399|NCT01623115|40061354|FG001|Overall Study|Consent withdrawn by participant|6|||
16432400|NCT01623115|40061353|FG000|Overall Study|Related to study drug administration|0|||
16432401|NCT01623115|40061354|FG001|Overall Study|Related to study drug administration|2|||
16432402|NCT01623115|40061353|FG000|Overall Study|Last visit outside protocol visit window|14|||
16432403|NCT01623115|40061354|FG001|Overall Study|Last visit outside protocol visit window|26|||
16432404|NCT01623115|40061353|FG000|Overall Study|Site closure|1|||
16432405|NCT01623115|40061354|FG001|Overall Study|Site closure|7|||
16432406|NCT01623115|40061353|FG000|Overall Study|Death|0|||
16432407|NCT01623115|40061354|FG001|Overall Study|Death|4|||
16432408|NCT01623115|40061353|FG000|Overall Study|Other than specified above|0|||
16432409|NCT01623115|40061354|FG001|Overall Study|Other than specified above|3|||
16432410|NCT04317040|40061355|FG000|Overall Study|Lost to Follow-up|2|||
16432411|NCT04317040|40061356|FG001|Overall Study|Lost to Follow-up|0|||
16432412|NCT04317040|40061355|FG000|Overall Study|Death|16|||
16432413|NCT04317040|40061356|FG001|Overall Study|Death|18|||
16432414|NCT04317040|40061355|FG000|Overall Study|Withdrawal by Subject|0|||
16432415|NCT04317040|40061356|FG001|Overall Study|Withdrawal by Subject|1|||
16432416|NCT04317040|40061355|FG000|Overall Study|Incomplete assessments|0|||
16432417|NCT04317040|40061356|FG001|Overall Study|Incomplete assessments|1|||
16432418|NCT01101035|40061366|FG000|Overall Study|Adverse Event|191|||
16432419|NCT01101035|40061367|FG001|Overall Study|Adverse Event|172|||
16432420|NCT01101035|40061366|FG000|Overall Study|Major Protocol Deviation|52|||
16432421|NCT01101035|40061367|FG001|Overall Study|Major Protocol Deviation|46|||
16432422|NCT01101035|40061366|FG000|Overall Study|Lost to Follow-up|226|||
16432423|NCT01101035|40061367|FG001|Overall Study|Lost to Follow-up|223|||
16432424|NCT01101035|40061366|FG000|Overall Study|Voluntary Withdrawal|595|||
16432425|NCT01101035|40061367|FG001|Overall Study|Voluntary Withdrawal|587|||
16432426|NCT01101035|40061366|FG000|Overall Study|Reason not Specified|333|||
16432427|NCT01101035|40061367|FG001|Overall Study|Reason not Specified|363|||
16432428|NCT00570310|40061373|FG000|Overall Study|Adverse Event|1|||
16432429|NCT00570310|40061374|FG001|Overall Study|Adverse Event|2|||
16432430|NCT00570310|40061373|FG000|Overall Study|Lack of Efficacy|1|||
16432431|NCT00570310|40061374|FG001|Overall Study|Lack of Efficacy|4|||
16432432|NCT02611479|40061375|FG000|Baseline Enrollment|Exited study|13|||
16432433|NCT02611479|40061375|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
16432434|NCT02611479|40061375|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
16432435|NCT02611479|40061375|FG000|Data Cleaning|No baseline function or pain metrics|2|||
16432436|NCT02021643|40061377|FG000|Overall Study|Enrolled but Never Treated|1|||
16432437|NCT02021643|40061378|FG001|Overall Study|Enrolled but Never Treated|0|||
16432438|NCT02021643|40061379|FG002|Overall Study|Enrolled but Never Treated|0|||
16432439|NCT02021643|40061380|FG003|Overall Study|Enrolled but Never Treated|0|||
16432440|NCT02021643|40061377|FG000|Overall Study|Adverse Event|0|||
16432441|NCT02021643|40061378|FG001|Overall Study|Adverse Event|1|||
16432442|NCT02021643|40061379|FG002|Overall Study|Adverse Event|0|||
16432443|NCT02021643|40061380|FG003|Overall Study|Adverse Event|0|||
16432444|NCT02021643|40061377|FG000|Overall Study|Death|0|||
16432445|NCT02021643|40061378|FG001|Overall Study|Death|1|||
16432446|NCT02021643|40061379|FG002|Overall Study|Death|0|||
16432447|NCT02021643|40061380|FG003|Overall Study|Death|0|||
16432448|NCT02021643|40061377|FG000|Overall Study|Investigator's Discretion|1|||
16432449|NCT02021643|40061378|FG001|Overall Study|Investigator's Discretion|0|||
16432450|NCT02021643|40061379|FG002|Overall Study|Investigator's Discretion|0|||
16432451|NCT02021643|40061380|FG003|Overall Study|Investigator's Discretion|0|||
16361751|NCT02911116|39811789|FG000|Overall Study|Insufficient Therapeutic Response|1|||
16361752|NCT02911116|39811790|FG001|Overall Study|Insufficient Therapeutic Response|0|||
16361753|NCT02911116|39811789|FG000|Overall Study|Lost to Follow-up|0|||
16361754|NCT02911116|39811790|FG001|Overall Study|Lost to Follow-up|1|||
16361755|NCT01240694|39811791|FG000|Overall Study|Adverse Event|9|||
16361756|NCT01240694|39811791|FG000|Overall Study|Lack of Efficacy|6|||
16432452|NCT02021643|40061377|FG000|Overall Study|Lack of Efficacy|7|||
16361757|NCT01240694|39811791|FG000|Overall Study|Withdrawal by Subject|6|||
16361758|NCT01240694|39811791|FG000|Overall Study|Protocol Violation|2|||
16361759|NCT01240694|39811791|FG000|Overall Study|Lost to Follow-up|2|||
16432453|NCT02021643|40061378|FG001|Overall Study|Lack of Efficacy|6|||
16432454|NCT02021643|40061379|FG002|Overall Study|Lack of Efficacy|0|||
16432455|NCT02021643|40061380|FG003|Overall Study|Lack of Efficacy|12|||
16432456|NCT02021643|40061377|FG000|Overall Study|Lost to Follow-up|0|||
16432457|NCT02021643|40061378|FG001|Overall Study|Lost to Follow-up|1|||
16432458|NCT02021643|40061379|FG002|Overall Study|Lost to Follow-up|0|||
16432459|NCT02021643|40061380|FG003|Overall Study|Lost to Follow-up|0|||
16432460|NCT02021643|40061377|FG000|Overall Study|Withdrew Consent|0|||
16432461|NCT02021643|40061378|FG001|Overall Study|Withdrew Consent|1|||
16432462|NCT02021643|40061379|FG002|Overall Study|Withdrew Consent|0|||
16432463|NCT02021643|40061380|FG003|Overall Study|Withdrew Consent|0|||
16432464|NCT02260934|40061381|FG000|Overall Study|Lost to Follow-up|2|||
16432465|NCT02260934|40061382|FG001|Overall Study|Lost to Follow-up|1|||
16432466|NCT02260934|40061381|FG000|Overall Study|Withdrawal by Subject|0|||
16432467|NCT02260934|40061382|FG001|Overall Study|Withdrawal by Subject|2|||
16432468|NCT02260934|40061381|FG000|Overall Study|Participant Relocated|1|||
16432469|NCT02260934|40061382|FG001|Overall Study|Participant Relocated|0|||
16432470|NCT02260934|40061381|FG000|Overall Study|Site error|0|||
16432471|NCT02260934|40061382|FG001|Overall Study|Site error|1|||
16432472|NCT02518971|40061387|FG000|Overall Study|Lost to Follow-up|0|||
16432473|NCT02518971|40061388|FG001|Overall Study|Lost to Follow-up|1|||
16432474|NCT02518971|40061387|FG000|Overall Study|Physician Decision|6|||
16432475|NCT02518971|40061388|FG001|Overall Study|Physician Decision|6|||
16432476|NCT02518971|40061387|FG000|Overall Study|Protocol Violation|6|||
16432477|NCT02518971|40061388|FG001|Overall Study|Protocol Violation|4|||
16432478|NCT02518971|40061387|FG000|Overall Study|Withdrawal by Subject|4|||
16432479|NCT02518971|40061388|FG001|Overall Study|Withdrawal by Subject|5|||
16432480|NCT02518971|40061387|FG000|Overall Study|Side effects|1|||
16432481|NCT02518971|40061388|FG001|Overall Study|Side effects|0|||
16432482|NCT02518971|40061387|FG000|Overall Study|medication lost in mail|0|||
16432483|NCT02518971|40061388|FG001|Overall Study|medication lost in mail|1|||
16432484|NCT02518971|40061387|FG000|Overall Study|eligibility criteria no longer met|6|||
16432485|NCT02518971|40061388|FG001|Overall Study|eligibility criteria no longer met|3|||
16432486|NCT01546857|40061389|FG000|Overall Study|Withdrawal by Subject|2|||
16432487|NCT01546857|40061390|FG001|Overall Study|Withdrawal by Subject|3|||
16432488|NCT04794270|40061395|FG000|Period 1|Non Compliance|1|||
16432489|NCT04794270|40061396|FG001|Period 1|Non Compliance|0|||
16432490|NCT04794270|40061395|FG000|Period 1|Adverse Event|1|||
16432491|NCT04794270|40061396|FG001|Period 1|Adverse Event|0|||
16432492|NCT04794270|40061395|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
16432493|NCT04794270|40061396|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
16432494|NCT01922271|40061399|FG000|WASHOUT Period|Withdrawal by Subject|1|||
16432495|NCT01922271|40061400|FG001|WASHOUT Period|Withdrawal by Subject|0|||
16432496|NCT02446717|40061401|FG000|Overall Study|Adverse Event|0|||
16432497|NCT02446717|40061402|FG001|Overall Study|Adverse Event|0|||
16432498|NCT02446717|40061403|FG002|Overall Study|Adverse Event|1|||
16432499|NCT02446717|40061404|FG003|Overall Study|Adverse Event|0|||
16432500|NCT02446717|40061405|FG004|Overall Study|Adverse Event|0|||
16432501|NCT02446717|40061401|FG000|Overall Study|Lost to Follow-up|0|||
16432502|NCT02446717|40061402|FG001|Overall Study|Lost to Follow-up|1|||
16432503|NCT02446717|40061403|FG002|Overall Study|Lost to Follow-up|1|||
16432504|NCT02446717|40061404|FG003|Overall Study|Lost to Follow-up|0|||
16432505|NCT02446717|40061405|FG004|Overall Study|Lost to Follow-up|1|||
16131507|NCT00983931|38969551|FG000|14 Day Washout Period|Physician Decision|1|||
16131508|NCT03929757|38969552|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
16361760|NCT01240694|39811791|FG000|Overall Study|Other than specified|3|||
16361761|NCT01240694|39811791|FG000|Overall Study|Withdrawn due to early study termination|107|||
16361762|NCT05172570|39811792|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
16361763|NCT05172570|39811793|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
16361764|NCT05172570|39811794|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
16361765|NCT05172570|39811792|FG000|Overall Study|PI Decision due to equipment shortages|0|||
16361766|NCT05172570|39811793|FG001|Overall Study|PI Decision due to equipment shortages|0|||
16361767|NCT05172570|39811794|FG002|Overall Study|PI Decision due to equipment shortages|1|||
16361768|NCT02724644|39811795|FG000|Overall Study|Adverse Event|7|||
16361769|NCT02724644|39811796|FG001|Overall Study|Adverse Event|1|||
16361770|NCT02724644|39811795|FG000|Overall Study|Lost to Follow-up|6|||
16361771|NCT02724644|39811796|FG001|Overall Study|Lost to Follow-up|2|||
16361772|NCT02724644|39811795|FG000|Overall Study|Withdrawal by Subject|7|||
16361773|NCT02724644|39811796|FG001|Overall Study|Withdrawal by Subject|1|||
16361774|NCT02724644|39811795|FG000|Overall Study|Administrative|1|||
16361775|NCT02724644|39811796|FG001|Overall Study|Administrative|0|||
16361776|NCT05630196|39811802|FG000|Overall Study|Adverse Event|2|||
16361777|NCT05630196|39811803|FG001|Overall Study|Adverse Event|1|||
16361778|NCT05630196|39811802|FG000|Overall Study|Lost to Follow-up|1|||
16361779|NCT05630196|39811803|FG001|Overall Study|Lost to Follow-up|1|||
16361780|NCT05630196|39811802|FG000|Overall Study|Protocol Violation|2|||
16361781|NCT05630196|39811803|FG001|Overall Study|Protocol Violation|3|||
16361782|NCT05630196|39811802|FG000|Overall Study|Physician Decision|1|||
16361783|NCT05630196|39811803|FG001|Overall Study|Physician Decision|0|||
16361784|NCT05630196|39811802|FG000|Overall Study|Withdrawal by Subject|3|||
16361785|NCT05630196|39811803|FG001|Overall Study|Withdrawal by Subject|4|||
16361786|NCT02577029|39811808|FG000|Overall Study|Adverse Event|1|||
16361787|NCT02577029|39811809|FG001|Overall Study|Adverse Event|0|||
16432506|NCT02446717|40061401|FG000|Overall Study|Withdrew consent|0|||
16432507|NCT02446717|40061402|FG001|Overall Study|Withdrew consent|0|||
16432508|NCT02446717|40061403|FG002|Overall Study|Withdrew consent|0|||
16432509|NCT02446717|40061404|FG003|Overall Study|Withdrew consent|1|||
16432510|NCT02446717|40061405|FG004|Overall Study|Withdrew consent|0|||
16432511|NCT00717249|40061406|FG000|Overall Study|Lens Discomfort|4|||
16432512|NCT00717249|40061407|FG001|Overall Study|Lens Discomfort|1|||
16361788|NCT02577029|39811810|FG002|Overall Study|Adverse Event|2|||
16361789|NCT02577029|39811811|FG003|Overall Study|Adverse Event|0|||
16361790|NCT02577029|39811812|FG004|Overall Study|Adverse Event|1|||
16361791|NCT02577029|39811813|FG005|Overall Study|Adverse Event|0|||
16361792|NCT02577029|39811814|FG006|Overall Study|Adverse Event|0|||
16361793|NCT02577029|39811815|FG007|Overall Study|Adverse Event|0|||
16361794|NCT02577029|39811808|FG000|Overall Study|Withdrawal by Subject|0|||
16361795|NCT02577029|39811809|FG001|Overall Study|Withdrawal by Subject|0|||
16361796|NCT02577029|39811810|FG002|Overall Study|Withdrawal by Subject|0|||
16131509|NCT03929757|38969553|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
16361797|NCT02577029|39811811|FG003|Overall Study|Withdrawal by Subject|0|||
16361798|NCT02577029|39811812|FG004|Overall Study|Withdrawal by Subject|0|||
16361799|NCT02577029|39811813|FG005|Overall Study|Withdrawal by Subject|1|||
16361800|NCT02577029|39811814|FG006|Overall Study|Withdrawal by Subject|0|||
16361801|NCT02577029|39811815|FG007|Overall Study|Withdrawal by Subject|0|||
16361802|NCT02577029|39811808|FG000|Overall Study|Sponsor Termination of the Study|9|||
16131510|NCT03929757|38969554|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
16131511|NCT03929757|38969552|FG000|Main Study: Up to Day 365|Other|1|||
16131512|NCT03929757|38969553|FG001|Main Study: Up to Day 365|Other|0|||
16131513|NCT03929757|38969554|FG002|Main Study: Up to Day 365|Other|0|||
16131514|NCT03929757|38969552|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
16131515|NCT03929757|38969553|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
16131516|NCT03929757|38969554|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
16131517|NCT02667587|38969555|FG000|Pre-Treatment|Not reported|1|||
16131518|NCT02667587|38969556|FG001|Pre-Treatment|Not reported|0|||
16131519|NCT02667587|38969555|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
16131520|NCT02667587|38969556|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
16131521|NCT02667587|38969555|FG000|Pre-Treatment|Participant withdrew consent|0|||
16131522|NCT02667587|38969556|FG001|Pre-Treatment|Participant withdrew consent|1|||
16131523|NCT02667587|38969555|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
16131524|NCT02667587|38969556|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
16131525|NCT02667587|38969555|FG000|End of Treatment|Other reasons|11|||
16131526|NCT02667587|38969556|FG001|End of Treatment|Other reasons|8|||
16131527|NCT02667587|38969555|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
16131528|NCT02667587|38969556|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
16131529|NCT02667587|38969555|FG000|End of Treatment|Poor/Non-Compliance|0|||
16131530|NCT02667587|38969556|FG001|End of Treatment|Poor/Non-Compliance|1|||
16131531|NCT02667587|38969555|FG000|End of Treatment|Maximum Clinical Benefit|3|||
16131532|NCT02667587|38969556|FG001|End of Treatment|Maximum Clinical Benefit|3|||
16131533|NCT02667587|38969555|FG000|End of Treatment|Participant Withdrew Consent|5|||
16131534|NCT02667587|38969556|FG001|End of Treatment|Participant Withdrew Consent|6|||
16131535|NCT02667587|38969555|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
16131536|NCT02667587|38969556|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
16131537|NCT02667587|38969555|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
16250740|NCT01952574|39400620|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
16131538|NCT02667587|38969556|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
16131539|NCT02667587|38969555|FG000|End of Treatment|Death|2|||
16131540|NCT02667587|38969556|FG001|End of Treatment|Death|1|||
16131541|NCT02667587|38969555|FG000|End of Treatment|Study Drug Toxicity|74|||
16432513|NCT00717249|40061406|FG000|Overall Study|Unsatisfactory visual Response|0|||
16432514|NCT00717249|40061407|FG001|Overall Study|Unsatisfactory visual Response|2|||
16432515|NCT00717249|40061406|FG000|Overall Study|Adverse Event|4|||
16432516|NCT00717249|40061407|FG001|Overall Study|Adverse Event|2|||
16432517|NCT00717249|40061406|FG000|Overall Study|Lost to Follow-up|2|||
16432518|NCT00717249|40061407|FG001|Overall Study|Lost to Follow-up|0|||
16432519|NCT00717249|40061406|FG000|Overall Study|Withdrawal by Subject|1|||
16432520|NCT00717249|40061407|FG001|Overall Study|Withdrawal by Subject|2|||
16432521|NCT00717249|40061406|FG000|Overall Study|Pregnancy|6|||
16432522|NCT00717249|40061407|FG001|Overall Study|Pregnancy|3|||
16432523|NCT00717249|40061406|FG000|Overall Study|Protocol Violation|0|||
16432524|NCT00717249|40061407|FG001|Overall Study|Protocol Violation|2|||
16432525|NCT00717249|40061406|FG000|Overall Study|Subject became Ineligible|1|||
16432526|NCT00717249|40061407|FG001|Overall Study|Subject became Ineligible|1|||
16432527|NCT00717249|40061406|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
16432528|NCT00717249|40061407|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
16432529|NCT00717249|40061406|FG000|Overall Study|Gastric Surgery|0|||
16432530|NCT00717249|40061407|FG001|Overall Study|Gastric Surgery|1|||
16432531|NCT00717249|40061406|FG000|Overall Study|Diagnosed with Diabetes|1|||
16432532|NCT00717249|40061407|FG001|Overall Study|Diagnosed with Diabetes|0|||
16432533|NCT00717249|40061406|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
16432534|NCT00717249|40061407|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
16432535|NCT00717249|40061406|FG000|Overall Study|Subject relocated|1|||
16432536|NCT00717249|40061407|FG001|Overall Study|Subject relocated|0|||
16432537|NCT00717249|40061406|FG000|Overall Study|Headaches|1|||
16432538|NCT00717249|40061407|FG001|Overall Study|Headaches|0|||
16432539|NCT01633788|40061409|FG000|Overall Study|Adverse Event|1|||
16432540|NCT01633788|40061410|FG001|Overall Study|Adverse Event|3|||
16432541|NCT01633788|40061411|FG002|Overall Study|Adverse Event|3|||
16432542|NCT01633788|40061412|FG003|Overall Study|Adverse Event|3|||
16432543|NCT01633788|40061409|FG000|Overall Study|Lost to Follow-up|2|||
16432544|NCT01633788|40061410|FG001|Overall Study|Lost to Follow-up|2|||
16432545|NCT01633788|40061411|FG002|Overall Study|Lost to Follow-up|2|||
16432546|NCT01633788|40061412|FG003|Overall Study|Lost to Follow-up|0|||
16432547|NCT01633788|40061409|FG000|Overall Study|Personal Reasons|3|||
16432548|NCT01633788|40061410|FG001|Overall Study|Personal Reasons|1|||
16432549|NCT01633788|40061411|FG002|Overall Study|Personal Reasons|1|||
16432550|NCT01633788|40061412|FG003|Overall Study|Personal Reasons|3|||
16131542|NCT02667587|38969556|FG001|End of Treatment|Study Drug Toxicity|18|||
16432551|NCT01633788|40061409|FG000|Overall Study|Protocol Violation|1|||
16432552|NCT01633788|40061410|FG001|Overall Study|Protocol Violation|0|||
16432553|NCT01633788|40061411|FG002|Overall Study|Protocol Violation|1|||
16432554|NCT01633788|40061412|FG003|Overall Study|Protocol Violation|0|||
16432555|NCT01633788|40061409|FG000|Overall Study|Other Reasons|0|||
16432556|NCT01633788|40061410|FG001|Overall Study|Other Reasons|2|||
16432557|NCT01633788|40061411|FG002|Overall Study|Other Reasons|3|||
16432558|NCT01633788|40061412|FG003|Overall Study|Other Reasons|7|||
16432559|NCT04014062|40061421|FG000|Period I: Dosing|Medical Grounds|4|||
16432560|NCT04014062|40061422|FG001|Period I: Dosing|Medical Grounds|5|||
16432561|NCT04014062|40061421|FG000|Period I: Dosing|Withdrawal by Subject|3|||
16432562|NCT04014062|40061422|FG001|Period I: Dosing|Withdrawal by Subject|1|||
16432563|NCT03329846|40061427|FG000|Overall Study|Disease progression|4|||
16432564|NCT03329846|40061428|FG001|Overall Study|Disease progression|6|||
16432565|NCT03329846|40061427|FG000|Overall Study|Study drug toxicity|1|||
16432566|NCT03329846|40061428|FG001|Overall Study|Study drug toxicity|0|||
16432567|NCT03329846|40061427|FG000|Overall Study|Participant request to discontinue treatment|0|||
16432568|NCT03329846|40061428|FG001|Overall Study|Participant request to discontinue treatment|1|||
16432569|NCT03329846|40061427|FG000|Overall Study|Participant withdrew consent|1|||
16432570|NCT03329846|40061428|FG001|Overall Study|Participant withdrew consent|0|||
16432571|NCT03329846|40061427|FG000|Overall Study|Other reasons|2|||
16432572|NCT03329846|40061428|FG001|Overall Study|Other reasons|2|||
16432573|NCT00265317|40061430|FG000|Lead-In|Objective progression or relapse|6|||
16432574|NCT00265317|40061431|FG001|Lead-In|Objective progression or relapse|11|||
16432575|NCT00265317|40061432|FG002|Lead-In|Objective progression or relapse|0|||
16432576|NCT00265317|40061433|FG003|Lead-In|Objective progression or relapse|0|||
16432577|NCT00265317|40061430|FG000|Lead-In|Adverse Event|2|||
16432578|NCT00265317|40061431|FG001|Lead-In|Adverse Event|1|||
16432579|NCT00265317|40061432|FG002|Lead-In|Adverse Event|0|||
16432580|NCT00265317|40061433|FG003|Lead-In|Adverse Event|0|||
16432581|NCT00265317|40061430|FG000|Lead-In|Death|3|||
16432582|NCT00265317|40061431|FG001|Lead-In|Death|5|||
16432583|NCT00265317|40061432|FG002|Lead-In|Death|0|||
16432584|NCT00265317|40061433|FG003|Lead-In|Death|0|||
16432585|NCT00265317|40061430|FG000|Lead-In|Withdrawal/other than adverse event|1|||
16432586|NCT00265317|40061431|FG001|Lead-In|Withdrawal/other than adverse event|0|||
16432587|NCT00265317|40061432|FG002|Lead-In|Withdrawal/other than adverse event|0|||
16432588|NCT00265317|40061433|FG003|Lead-In|Withdrawal/other than adverse event|0|||
16432589|NCT00265317|40061430|FG000|Phase 2|Objective progression or relapse|0|||
16432590|NCT00265317|40061431|FG001|Phase 2|Objective progression or relapse|0|||
16432591|NCT00265317|40061432|FG002|Phase 2|Objective progression or relapse|37|||
16432592|NCT00265317|40061433|FG003|Phase 2|Objective progression or relapse|38|||
16432593|NCT00265317|40061430|FG000|Phase 2|Global deterioration of health status|0|||
16432594|NCT00265317|40061431|FG001|Phase 2|Global deterioration of health status|0|||
16432595|NCT00265317|40061432|FG002|Phase 2|Global deterioration of health status|3|||
16432596|NCT00265317|40061433|FG003|Phase 2|Global deterioration of health status|0|||
16432597|NCT00265317|40061430|FG000|Phase 2|Adverse Event|0|||
16432598|NCT00265317|40061431|FG001|Phase 2|Adverse Event|0|||
16432599|NCT00265317|40061432|FG002|Phase 2|Adverse Event|7|||
16432600|NCT00265317|40061433|FG003|Phase 2|Adverse Event|5|||
16432601|NCT00265317|40061430|FG000|Phase 2|Death|0|||
16432602|NCT00265317|40061431|FG001|Phase 2|Death|0|||
16432603|NCT00265317|40061432|FG002|Phase 2|Death|12|||
16432604|NCT00265317|40061433|FG003|Phase 2|Death|15|||
16432605|NCT00265317|40061430|FG000|Phase 2|Protocol Violation|0|||
16432606|NCT00265317|40061431|FG001|Phase 2|Protocol Violation|0|||
16432607|NCT00265317|40061432|FG002|Phase 2|Protocol Violation|1|||
16432608|NCT00265317|40061433|FG003|Phase 2|Protocol Violation|4|||
16131543|NCT02667587|38969555|FG000|End of Treatment|Disease progression|177|||
16131544|NCT02667587|38969556|FG001|End of Treatment|Disease progression|222|||
16131545|NCT02667587|38969555|FG000|End of Treatment|Lost to Follow-up|1|||
16131546|NCT02667587|38969556|FG001|End of Treatment|Lost to Follow-up|3|||
16131547|NCT04882995|38969557|FG000|Overall Study|Withdrawal by Subject|1|||
16131548|NCT04882995|38969558|FG001|Overall Study|Withdrawal by Subject|2|||
16131549|NCT04882995|38969557|FG000|Overall Study|Protocol Violation|4|||
16131550|NCT04882995|38969558|FG001|Overall Study|Protocol Violation|4|||
16131551|NCT04882995|38969557|FG000|Overall Study|Surgery postponed due to COVID|1|||
16131552|NCT04882995|38969558|FG001|Overall Study|Surgery postponed due to COVID|1|||
16131553|NCT03866473|38969559|FG000|Phase 1|Death|1|||
16131554|NCT03866473|38969560|FG001|Phase 1|Death|0|||
16131555|NCT03866473|38969559|FG000|Phase 2|Death|0|||
16131556|NCT03866473|38969560|FG001|Phase 2|Death|2|||
16131557|NCT03866473|38969559|FG000|Phase 2|Dropped|1|||
16131558|NCT03866473|38969560|FG001|Phase 2|Dropped|1|||
16131559|NCT03866473|38969559|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
16131560|NCT03866473|38969560|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
16131561|NCT03343301|38969573|FG000|Overall Study|Withdrawal by Subject|1|||
16131562|NCT03343301|38969574|FG001|Overall Study|Withdrawal by Subject|1|||
16131563|NCT03343301|38969573|FG000|Overall Study|Death|0|||
16432609|NCT00265317|40061430|FG000|Phase 2|Lost to Follow-up|0|||
16432610|NCT00265317|40061431|FG001|Phase 2|Lost to Follow-up|0|||
16432611|NCT00265317|40061432|FG002|Phase 2|Lost to Follow-up|0|||
16432612|NCT00265317|40061433|FG003|Phase 2|Lost to Follow-up|1|||
16432613|NCT00265317|40061430|FG000|Phase 2|Withdrawal/other than adverse event|0|||
16432614|NCT00265317|40061431|FG001|Phase 2|Withdrawal/other than adverse event|0|||
16432615|NCT00265317|40061432|FG002|Phase 2|Withdrawal/other than adverse event|2|||
16131564|NCT03343301|38969574|FG001|Overall Study|Death|2|||
16131565|NCT03343301|38969573|FG000|Overall Study|Other|0|||
16131566|NCT03343301|38969574|FG001|Overall Study|Other|6|||
16432616|NCT00265317|40061433|FG003|Phase 2|Withdrawal/other than adverse event|1|||
16432617|NCT00265317|40061430|FG000|Phase 2|Study terminated by sponsor|0|||
16131567|NCT03343301|38969573|FG000|Overall Study|Missing|2|||
16131568|NCT03343301|38969574|FG001|Overall Study|Missing|0|||
16131569|NCT00744523|38969575|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
16131570|NCT00744523|38969576|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
16131571|NCT04097301|38969581|FG000|Overall Study|Death|1|||
16131572|NCT04097301|38969581|FG000|Overall Study|Withdrawal by Subject|1|||
16131573|NCT04097301|38969581|FG000|Overall Study|Screening Failure|5|||
16131574|NCT00986674|38969585|FG000|Overall Study|Lack of Efficacy|28|||
16432618|NCT00265317|40061431|FG001|Phase 2|Study terminated by sponsor|0|||
16432619|NCT00265317|40061432|FG002|Phase 2|Study terminated by sponsor|1|||
16432620|NCT00265317|40061433|FG003|Phase 2|Study terminated by sponsor|0|||
16432621|NCT00265317|40061430|FG000|Phase 2|Other|0|||
16432622|NCT00265317|40061431|FG001|Phase 2|Other|0|||
16432623|NCT00265317|40061432|FG002|Phase 2|Other|1|||
16432624|NCT00265317|40061433|FG003|Phase 2|Other|1|||
16432625|NCT02634333|40061434|FG000|Overall Study|Completed out of Window|3|||
16432626|NCT02634333|40061435|FG001|Overall Study|Completed out of Window|2|||
16432627|NCT02634333|40061434|FG000|Overall Study|Missed Visit|5|||
16432628|NCT02634333|40061435|FG001|Overall Study|Missed Visit|2|||
16432629|NCT02634333|40061434|FG000|Overall Study|Lost to Follow-up|12|||
16432630|NCT02634333|40061435|FG001|Overall Study|Lost to Follow-up|7|||
16432631|NCT02634333|40061434|FG000|Overall Study|Withdrawal by Subject|9|||
16432632|NCT02634333|40061435|FG001|Overall Study|Withdrawal by Subject|13|||
16432633|NCT02634333|40061434|FG000|Overall Study|Death|11|||
16432634|NCT02634333|40061435|FG001|Overall Study|Death|8|||
16432635|NCT03259087|40061436|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
16432636|NCT03259087|40061437|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
16432637|NCT03259087|40061438|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
16432638|NCT03259087|40061439|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
16432639|NCT03259087|40061440|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
16432640|NCT03259087|40061436|FG000|Period 2 of Part 2|Adverse Event|0|||
16432641|NCT03259087|40061437|FG001|Period 2 of Part 2|Adverse Event|0|||
16432642|NCT03259087|40061438|FG002|Period 2 of Part 2|Adverse Event|0|||
16432643|NCT03259087|40061439|FG003|Period 2 of Part 2|Adverse Event|0|||
16432644|NCT03259087|40061440|FG004|Period 2 of Part 2|Adverse Event|1|||
16432645|NCT02222558|40061442|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
16432646|NCT02222558|40061443|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
16432647|NCT02222558|40061444|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
16432648|NCT02222558|40061445|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
16432649|NCT02222558|40061446|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
16432650|NCT02222558|40061447|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
16432651|NCT02222558|40061442|FG000|Period 3|Withdrawal by Subject|0|||
16432652|NCT02222558|40061443|FG001|Period 3|Withdrawal by Subject|0|||
16432653|NCT02222558|40061444|FG002|Period 3|Withdrawal by Subject|0|||
16432654|NCT02222558|40061445|FG003|Period 3|Withdrawal by Subject|0|||
16432655|NCT02222558|40061446|FG004|Period 3|Withdrawal by Subject|0|||
16432656|NCT02222558|40061447|FG005|Period 3|Withdrawal by Subject|1|||
16432657|NCT02611817|40061450|FG000|Open-label Induction Phase|Reason not Specified|9|||
16432658|NCT02611817|40061451|FG001|Open-label Induction Phase|Reason not Specified|0|||
16432659|NCT02611817|40061452|FG002|Open-label Induction Phase|Reason not Specified|0|||
16432660|NCT02611817|40061450|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
16432661|NCT02611817|40061451|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
16432662|NCT02611817|40061452|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
16432663|NCT02611817|40061450|FG000|Open-label Induction Phase|Pregnancy|1|||
16131575|NCT00986674|38969586|FG001|Overall Study|Lack of Efficacy|25|||
16131576|NCT00986674|38969587|FG002|Overall Study|Lack of Efficacy|23|||
16131577|NCT00986674|38969585|FG000|Overall Study|Adverse Event|4|||
16131578|NCT00986674|38969586|FG001|Overall Study|Adverse Event|8|||
16131579|NCT00986674|38969587|FG002|Overall Study|Adverse Event|9|||
16131580|NCT00986674|38969585|FG000|Overall Study|Death|5|||
16131581|NCT00986674|38969586|FG001|Overall Study|Death|0|||
16131582|NCT00986674|38969587|FG002|Overall Study|Death|4|||
16131583|NCT00986674|38969585|FG000|Overall Study|Withdrawal by Subject|6|||
16131584|NCT00986674|38969586|FG001|Overall Study|Withdrawal by Subject|2|||
16432664|NCT02611817|40061451|FG001|Open-label Induction Phase|Pregnancy|0|||
16432665|NCT02611817|40061452|FG002|Open-label Induction Phase|Pregnancy|0|||
16432666|NCT02611817|40061450|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
16432667|NCT02611817|40061451|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
16432668|NCT02611817|40061452|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
16432669|NCT02611817|40061450|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
16432670|NCT02611817|40061451|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
16432671|NCT02611817|40061452|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
16131585|NCT00986674|38969587|FG002|Overall Study|Withdrawal by Subject|1|||
16131586|NCT00986674|38969585|FG000|Overall Study|alternative therapy|0|||
16131587|NCT00986674|38969586|FG001|Overall Study|alternative therapy|0|||
16131588|NCT00986674|38969587|FG002|Overall Study|alternative therapy|1|||
16131589|NCT00986674|38969585|FG000|Overall Study|not start protocol therapy|4|||
16131590|NCT00986674|38969586|FG001|Overall Study|not start protocol therapy|3|||
16131591|NCT00986674|38969587|FG002|Overall Study|not start protocol therapy|1|||
16131592|NCT00986674|38969585|FG000|Overall Study|unknown/not specify|0|||
16131593|NCT00986674|38969586|FG001|Overall Study|unknown/not specify|7|||
16131594|NCT00986674|38969587|FG002|Overall Study|unknown/not specify|9|||
16131595|NCT03730480|38969588|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
16131596|NCT01028027|38969589|FG000|Overall Study|Lost to Follow-up|4|||
16131597|NCT01028027|38969590|FG001|Overall Study|Lost to Follow-up|1|||
16131598|NCT01028027|38969589|FG000|Overall Study|Withdrawal by Subject|5|||
16131599|NCT01028027|38969590|FG001|Overall Study|Withdrawal by Subject|3|||
16131600|NCT01028027|38969589|FG000|Overall Study|Adverse Event|4|||
16131601|NCT01028027|38969590|FG001|Overall Study|Adverse Event|7|||
16131602|NCT01028027|38969589|FG000|Overall Study|Protocol Violation|3|||
16131603|NCT01028027|38969590|FG001|Overall Study|Protocol Violation|1|||
16131604|NCT01028027|38969589|FG000|Overall Study|Lack of Efficacy|0|||
16432672|NCT02611817|40061450|FG000|Open-label Induction Phase|Protocol Violation|5|||
16432673|NCT02611817|40061451|FG001|Open-label Induction Phase|Protocol Violation|0|||
16432674|NCT02611817|40061452|FG002|Open-label Induction Phase|Protocol Violation|0|||
16432675|NCT02611817|40061450|FG000|Open-label Induction Phase|Adverse Event|16|||
16432676|NCT02611817|40061451|FG001|Open-label Induction Phase|Adverse Event|0|||
16432677|NCT02611817|40061452|FG002|Open-label Induction Phase|Adverse Event|0|||
16432678|NCT02611817|40061450|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
16432679|NCT02611817|40061451|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
16131605|NCT01028027|38969590|FG001|Overall Study|Lack of Efficacy|1|||
16432680|NCT02611817|40061452|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
16131606|NCT04375761|38969591|FG000|Overall Study|Death|1|||
16131607|NCT04375761|38969592|FG001|Overall Study|Death|2|||
16131608|NCT04375761|38969591|FG000|Overall Study|Lost to Follow-up|203|||
16432681|NCT02611817|40061450|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
16432682|NCT02611817|40061451|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
16432683|NCT02611817|40061452|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
16432684|NCT02611817|40061450|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
16432685|NCT02611817|40061451|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
16432686|NCT02611817|40061452|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
16432687|NCT02611817|40061450|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
16432688|NCT02611817|40061451|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
16432689|NCT02611817|40061452|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
16432690|NCT02611817|40061450|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
16432691|NCT02611817|40061451|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
16432692|NCT02611817|40061452|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
16432693|NCT02611817|40061450|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
16432694|NCT02611817|40061451|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
16432695|NCT02611817|40061452|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
16432696|NCT02611817|40061450|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
16432697|NCT02611817|40061451|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
16432698|NCT02611817|40061452|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
16432699|NCT03066193|40061453|FG000|Overall Study|Withdrawal by Subject|1|||
16432700|NCT01855412|40061455|FG000|Overall Study|Death|77|||
16432701|NCT01855412|40061456|FG001|Overall Study|Death|123|||
16432702|NCT01855412|40061457|FG002|Overall Study|Death|30|||
16432703|NCT01855412|40061455|FG000|Overall Study|Lost to Follow-up|28|||
16432704|NCT01855412|40061456|FG001|Overall Study|Lost to Follow-up|46|||
16432705|NCT01855412|40061457|FG002|Overall Study|Lost to Follow-up|15|||
16432706|NCT01855412|40061455|FG000|Overall Study|Withdrawal by Subject|77|||
16432707|NCT01855412|40061456|FG001|Overall Study|Withdrawal by Subject|123|||
16432708|NCT01855412|40061457|FG002|Overall Study|Withdrawal by Subject|24|||
16432709|NCT01855412|40061455|FG000|Overall Study|Physician Decision|25|||
16432710|NCT01855412|40061456|FG001|Overall Study|Physician Decision|31|||
16432711|NCT01855412|40061457|FG002|Overall Study|Physician Decision|3|||
16432712|NCT01855412|40061455|FG000|Overall Study|Site Closure|4|||
16432713|NCT01855412|40061456|FG001|Overall Study|Site Closure|18|||
16432714|NCT01855412|40061457|FG002|Overall Study|Site Closure|1|||
16432715|NCT01855412|40061455|FG000|Overall Study|Reason not Specified|1|||
16432716|NCT01855412|40061456|FG001|Overall Study|Reason not Specified|2|||
16432717|NCT01855412|40061457|FG002|Overall Study|Reason not Specified|3|||
16432718|NCT01016600|40061463|FG000|Overall Study|Did not start treatment|1|||
16432719|NCT01016600|40061464|FG001|Overall Study|Did not start treatment|0|||
16432720|NCT01016600|40061465|FG002|Overall Study|Did not start treatment|0|||
16432721|NCT01016600|40061466|FG003|Overall Study|Did not start treatment|0|||
16432722|NCT00193206|40061467|FG000|Preoperative Therapy|Lack of Efficacy|2|||
16432723|NCT00193206|40061467|FG000|Preoperative Therapy|Adverse Event|2|||
16432724|NCT00193206|40061467|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
16432725|NCT00193206|40061467|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
16432726|NCT00193206|40061467|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
16432727|NCT00193206|40061467|FG000|Postoperative Therapy|Physician Decision|3|||
16432728|NCT00193206|40061467|FG000|Postoperative Therapy|Intercurrent Illness|2|||
16432729|NCT00193206|40061467|FG000|Postoperative Therapy|Lack of Efficacy|1|||
16432730|NCT00193206|40061467|FG000|Postoperative Therapy|Protocol Violation|1|||
16432731|NCT02730728|40061471|FG000|Overall Study|Withdrawal by Subject|0|||
16432732|NCT02730728|40061472|FG001|Overall Study|Withdrawal by Subject|1|||
16432733|NCT02730728|40061473|FG002|Overall Study|Withdrawal by Subject|0|||
16432734|NCT02730728|40061471|FG000|Overall Study|Lack of Efficacy|0|||
16432735|NCT02730728|40061472|FG001|Overall Study|Lack of Efficacy|1|||
16432736|NCT02730728|40061473|FG002|Overall Study|Lack of Efficacy|1|||
16432737|NCT00844376|40061474|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
16432738|NCT00844376|40061475|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
16432739|NCT00948064|40061477|FG000|Phase I|No treatment received|1|||
16432740|NCT00948064|40061478|FG001|Phase I|No treatment received|0|||
16432741|NCT00948064|40061479|FG002|Phase I|No treatment received|0|||
16432742|NCT00948064|40061477|FG000|Phase II|Physician Decision|0|||
16432743|NCT00948064|40061478|FG001|Phase II|Physician Decision|0|||
16432744|NCT00948064|40061479|FG002|Phase II|Physician Decision|1|||
16432745|NCT00948064|40061477|FG000|Phase II|Withdrawal by Subject|0|||
16432746|NCT00948064|40061478|FG001|Phase II|Withdrawal by Subject|1|||
16432747|NCT00948064|40061479|FG002|Phase II|Withdrawal by Subject|0|||
16432748|NCT01794000|40061480|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
16432749|NCT01794000|40061481|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
16432750|NCT01794000|40061480|FG000|Double-Blind Phase (DBP)|Death|1|||
16432751|NCT01794000|40061481|FG001|Double-Blind Phase (DBP)|Death|2|||
16432752|NCT01794000|40061480|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
16432753|NCT01794000|40061481|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
16432754|NCT01794000|40061480|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
16432755|NCT01794000|40061481|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
16432756|NCT01794000|40061480|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
16432757|NCT01794000|40061481|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
16432758|NCT01794000|40061480|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
16432759|NCT01794000|40061481|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
16432760|NCT01794000|40061480|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
16361803|NCT02577029|39811809|FG001|Overall Study|Sponsor Termination of the Study|2|||
16361804|NCT02577029|39811810|FG002|Overall Study|Sponsor Termination of the Study|5|||
16361805|NCT02577029|39811811|FG003|Overall Study|Sponsor Termination of the Study|12|||
16361806|NCT02577029|39811812|FG004|Overall Study|Sponsor Termination of the Study|10|||
16361807|NCT02577029|39811813|FG005|Overall Study|Sponsor Termination of the Study|12|||
16361808|NCT02577029|39811814|FG006|Overall Study|Sponsor Termination of the Study|12|||
16361809|NCT02577029|39811815|FG007|Overall Study|Sponsor Termination of the Study|12|||
16361810|NCT00695019|39811816|FG000|Overall Study|Withdrawal by Subject|8|||
16361811|NCT00695019|39811817|FG001|Overall Study|Withdrawal by Subject|6|||
16361812|NCT00695019|39811818|FG002|Overall Study|Withdrawal by Subject|4|||
16432761|NCT01794000|40061481|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
16432762|NCT01794000|40061480|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
16432763|NCT01794000|40061481|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
16432764|NCT01271725|40061482|FG000|Part A|Progressive disease according to RECIST|8|||
16432765|NCT01271725|40061483|FG001|Part A|Progressive disease according to RECIST|0|||
16432766|NCT01271725|40061482|FG000|Part A|Clinical signs/symptoms of progression|2|||
16432767|NCT01271725|40061483|FG001|Part A|Clinical signs/symptoms of progression|0|||
16432768|NCT01271725|40061482|FG000|Part A|Other Adverse Event|8|||
16432769|NCT01271725|40061483|FG001|Part A|Other Adverse Event|0|||
16432770|NCT01271725|40061482|FG000|Part A|Lost to Follow-up|1|||
16432771|NCT01271725|40061483|FG001|Part A|Lost to Follow-up|0|||
16432772|NCT01271725|40061482|FG000|Part A|Withdrawal by Subject|12|||
16432773|NCT01271725|40061483|FG001|Part A|Withdrawal by Subject|0|||
16432774|NCT01271725|40061482|FG000|Part A|Other than specified|3|||
16432775|NCT01271725|40061483|FG001|Part A|Other than specified|0|||
16432776|NCT01271725|40061482|FG000|Part A|Protocol Violation|1|||
16432777|NCT01271725|40061483|FG001|Part A|Protocol Violation|0|||
16432778|NCT01271725|40061482|FG000|Part B|Other than specified|0|||
16432779|NCT01271725|40061483|FG001|Part B|Other than specified|2|||
16432780|NCT01271725|40061482|FG000|Part B|Clinical signs/symptoms of progression|0|||
16432781|NCT01271725|40061483|FG001|Part B|Clinical signs/symptoms of progression|2|||
16432782|NCT01271725|40061482|FG000|Part B|Other Adverse Event|0|||
16432783|NCT01271725|40061483|FG001|Part B|Other Adverse Event|1|||
16432784|NCT01271725|40061482|FG000|Part B|Protocol Violation|0|||
16432785|NCT01271725|40061483|FG001|Part B|Protocol Violation|1|||
16432786|NCT01271725|40061482|FG000|Part B|Withdrawal by Subject|0|||
16432787|NCT01271725|40061483|FG001|Part B|Withdrawal by Subject|6|||
16432788|NCT00732875|40061484|FG000|Overall Study|Adverse Event|16|||
16432789|NCT00732875|40061484|FG000|Overall Study|Withdrawal by Subject|6|||
16432790|NCT00732875|40061484|FG000|Overall Study|Lack of Efficacy|13|||
16432791|NCT03354273|40061485|FG000|Overall Study|Adverse Event|5|||
16432792|NCT03354273|40061485|FG000|Overall Study|Screen Failure|21|||
16432793|NCT03354273|40061485|FG000|Overall Study|Withdrawal by Subject|34|||
16432794|NCT03354273|40061485|FG000|Overall Study|Technical Problems|30|||
16432795|NCT03354273|40061485|FG000|Overall Study|Lost to Follow-up|4|||
16432796|NCT03354273|40061485|FG000|Overall Study|Investigator Decision|3|||
16432797|NCT03354273|40061485|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
16432798|NCT03354273|40061485|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
16432799|NCT03354273|40061485|FG000|Overall Study|COVID-19 Restrictions|9|||
16432800|NCT03354273|40061485|FG000|Overall Study|Other|5|||
16432801|NCT00796666|40061486|FG000|Overall Study|Death|2|||
16432802|NCT00796666|40061487|FG001|Overall Study|Death|4|||
16432803|NCT00796666|40061486|FG000|Overall Study|Withdrawal by Subject|2|||
16432804|NCT00796666|40061487|FG001|Overall Study|Withdrawal by Subject|0|||
16432805|NCT00796666|40061486|FG000|Overall Study|Adverse Event|7|||
16432806|NCT00796666|40061487|FG001|Overall Study|Adverse Event|5|||
16432807|NCT00796666|40061486|FG000|Overall Study|Protocol Violation|1|||
16432808|NCT00796666|40061487|FG001|Overall Study|Protocol Violation|0|||
16432809|NCT00796666|40061486|FG000|Overall Study|Other|1|||
16432810|NCT00796666|40061487|FG001|Overall Study|Other|0|||
16432811|NCT00796666|40061486|FG000|Overall Study|Terminated by sponsor|53|||
16432812|NCT00796666|40061487|FG001|Overall Study|Terminated by sponsor|55|||
16432813|NCT00796666|40061486|FG000|Overall Study|Randomized and not treated|1|||
16131609|NCT04375761|38969592|FG001|Overall Study|Lost to Follow-up|380|||
16432814|NCT00796666|40061487|FG001|Overall Study|Randomized and not treated|0|||
16432815|NCT00330759|40061490|FG000|Overall Study|Death|316|||
16432816|NCT00330759|40061491|FG001|Overall Study|Death|310|||
16432817|NCT00330759|40061490|FG000|Overall Study|Disease progression|104|||
16432818|NCT00330759|40061491|FG001|Overall Study|Disease progression|126|||
16432819|NCT00330759|40061490|FG000|Overall Study|Withdrawal by Subject|143|||
16432820|NCT00330759|40061491|FG001|Overall Study|Withdrawal by Subject|124|||
16432821|NCT00330759|40061490|FG000|Overall Study|Adverse Event|48|||
16432822|NCT00330759|40061491|FG001|Overall Study|Adverse Event|36|||
16432823|NCT00330759|40061490|FG000|Overall Study|Participant request|31|||
16432824|NCT00330759|40061491|FG001|Overall Study|Participant request|22|||
16432825|NCT00330759|40061490|FG000|Overall Study|Lost to Follow-up|16|||
16432826|NCT00330759|40061491|FG001|Overall Study|Lost to Follow-up|22|||
16131610|NCT04375761|38969591|FG000|Overall Study|Withdrawal by Subject|47|||
16131611|NCT04375761|38969592|FG001|Overall Study|Withdrawal by Subject|98|||
16131612|NCT04375761|38969591|FG000|Overall Study|Noncompliance with study procedure|121|||
16131613|NCT04375761|38969592|FG001|Overall Study|Noncompliance with study procedure|251|||
16131614|NCT04375761|38969591|FG000|Overall Study|Reimbursement not enough|1|||
16361813|NCT00695019|39811816|FG000|Overall Study|Protocol Violation|1|||
16361814|NCT00695019|39811817|FG001|Overall Study|Protocol Violation|3|||
16361815|NCT00695019|39811818|FG002|Overall Study|Protocol Violation|1|||
16361816|NCT00695019|39811816|FG000|Overall Study|Lack of Efficacy|0|||
16361817|NCT00695019|39811817|FG001|Overall Study|Lack of Efficacy|0|||
16361818|NCT00695019|39811818|FG002|Overall Study|Lack of Efficacy|1|||
16361819|NCT00695019|39811816|FG000|Overall Study|Various|4|||
16361820|NCT00695019|39811817|FG001|Overall Study|Various|5|||
16361821|NCT00695019|39811818|FG002|Overall Study|Various|4|||
16361822|NCT01113749|39811828|FG000|Overall Study|Lost to Follow-up|1|||
16361823|NCT01113749|39811829|FG001|Overall Study|Lost to Follow-up|2|||
16361824|NCT04113694|39811831|FG000|Overall Study|Adverse Event|2|||
16361825|NCT04113694|39811831|FG000|Overall Study|Lost to Follow-up|2|||
16361826|NCT04113694|39811831|FG000|Overall Study|Withdrawal by Subject|6|||
16361827|NCT04113694|39811831|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
16361828|NCT04181788|39811832|FG000|TREATMENT|Adverse Event|0|||
16361829|NCT04181788|39811833|FG001|TREATMENT|Adverse Event|2|||
16361830|NCT04181788|39811834|FG002|TREATMENT|Adverse Event|1|||
16361831|NCT04181788|39811835|FG003|TREATMENT|Adverse Event|0|||
16361832|NCT04181788|39811836|FG004|TREATMENT|Adverse Event|1|||
16361833|NCT04181788|39811837|FG005|TREATMENT|Adverse Event|3|||
16361834|NCT04181788|39811832|FG000|TREATMENT|Death|0|||
16361835|NCT04181788|39811833|FG001|TREATMENT|Death|0|||
16361836|NCT04181788|39811834|FG002|TREATMENT|Death|0|||
16131615|NCT04375761|38969592|FG001|Overall Study|Reimbursement not enough|2|||
16131616|NCT04375761|38969591|FG000|Overall Study|Unforeseen family circumstances|1|||
16131617|NCT04375761|38969592|FG001|Overall Study|Unforeseen family circumstances|3|||
16131618|NCT04375761|38969591|FG000|Overall Study|Test too painful|1|||
16131619|NCT04375761|38969592|FG001|Overall Study|Test too painful|1|||
16131620|NCT04375761|38969591|FG000|Overall Study|Moved|0|||
16131621|NCT04375761|38969592|FG001|Overall Study|Moved|2|||
16131622|NCT04375761|38969591|FG000|Overall Study|Nonresponsive|0|||
16131623|NCT04375761|38969592|FG001|Overall Study|Nonresponsive|5|||
16131624|NCT03562247|38969593|FG000|Overall Study|Lost to Follow-up|3|||
16131625|NCT03562247|38969594|FG001|Overall Study|Lost to Follow-up|1|||
16131626|NCT03562247|38969595|FG002|Overall Study|Lost to Follow-up|1|||
16131627|NCT01290315|38969596|FG000|Overall Study|Adverse Event|0|||
16131628|NCT01290315|38969597|FG001|Overall Study|Adverse Event|0|||
16131629|NCT01290315|38969598|FG002|Overall Study|Adverse Event|0|||
16131630|NCT01290315|38969599|FG003|Overall Study|Adverse Event|3|||
16131631|NCT01290315|38969596|FG000|Overall Study|Selection criteria/compliance|2|||
16131632|NCT01290315|38969597|FG001|Overall Study|Selection criteria/compliance|1|||
16432827|NCT00330759|40061490|FG000|Overall Study|Noncompliance|15|||
16432828|NCT00330759|40061491|FG001|Overall Study|Noncompliance|17|||
16131633|NCT01290315|38969598|FG002|Overall Study|Selection criteria/compliance|0|||
16131634|NCT01290315|38969599|FG003|Overall Study|Selection criteria/compliance|2|||
16131635|NCT01290315|38969596|FG000|Overall Study|Lost to Follow-up|0|||
16131636|NCT01290315|38969597|FG001|Overall Study|Lost to Follow-up|1|||
16131637|NCT01290315|38969598|FG002|Overall Study|Lost to Follow-up|0|||
16131638|NCT01290315|38969599|FG003|Overall Study|Lost to Follow-up|0|||
16131639|NCT01290315|38969596|FG000|Overall Study|Withdrawal by Subject|1|||
16131640|NCT01290315|38969597|FG001|Overall Study|Withdrawal by Subject|1|||
16131641|NCT01290315|38969598|FG002|Overall Study|Withdrawal by Subject|0|||
16131642|NCT01290315|38969599|FG003|Overall Study|Withdrawal by Subject|0|||
16131643|NCT00421707|38969600|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
16131644|NCT00421707|38969601|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
16131645|NCT00421707|38969600|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
16131646|NCT00421707|38969601|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
16131647|NCT00421707|38969600|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
16131648|NCT00421707|38969601|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
16131649|NCT00421707|38969600|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
16131650|NCT00421707|38969601|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
16131651|NCT00421707|38969600|FG000|Period 2: Washout|Adverse Event|1|||
16131652|NCT00421707|38969601|FG001|Period 2: Washout|Adverse Event|1|||
16131653|NCT00421707|38969600|FG000|Period 2: Washout|Withdrawal by Subject|0|||
16361837|NCT04181788|39811835|FG003|TREATMENT|Death|0|||
16432829|NCT00330759|40061490|FG000|Overall Study|Physician Decision|1|||
16432830|NCT00330759|40061491|FG001|Overall Study|Physician Decision|2|||
16432831|NCT00330759|40061490|FG000|Overall Study|Protocol deviation|0|||
16432832|NCT00330759|40061491|FG001|Overall Study|Protocol deviation|2|||
16432833|NCT00330759|40061490|FG000|Overall Study|Ineligibility determined|2|||
16432834|NCT00330759|40061491|FG001|Overall Study|Ineligibility determined|1|||
16432835|NCT00330759|40061490|FG000|Overall Study|Other|36|||
16432836|NCT00330759|40061491|FG001|Overall Study|Other|44|||
16432837|NCT00872599|40061502|FG000|Second Washout Period|Adverse Event|1|||
16432838|NCT00872599|40061503|FG001|Second Washout Period|Adverse Event|1|||
16432839|NCT03007966|40061504|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
16432840|NCT03007966|40061505|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
16432841|NCT00703924|40061507|FG000|Overall Study|Withdrawal by Subject|1|||
16432842|NCT00703924|40061508|FG001|Overall Study|Withdrawal by Subject|1|||
16432843|NCT02587520|40061510|FG000|Overall Study|Protocol Violation|2|||
16432844|NCT02587520|40061511|FG001|Overall Study|Protocol Violation|0|||
16432845|NCT02587520|40061512|FG002|Overall Study|Protocol Violation|0|||
16432846|NCT02587520|40061513|FG003|Overall Study|Protocol Violation|2|||
16432847|NCT02587520|40061514|FG004|Overall Study|Protocol Violation|0|||
16432848|NCT02587520|40061515|FG005|Overall Study|Protocol Violation|1|||
16432849|NCT02587520|40061516|FG006|Overall Study|Protocol Violation|1|||
16432850|NCT02587520|40061517|FG007|Overall Study|Protocol Violation|1|||
16432851|NCT02587520|40061518|FG008|Overall Study|Protocol Violation|3|||
16432852|NCT02587520|40061519|FG009|Overall Study|Protocol Violation|3|||
16432853|NCT02587520|40061520|FG010|Overall Study|Protocol Violation|1|||
16432854|NCT02587520|40061521|FG011|Overall Study|Protocol Violation|2|||
16432855|NCT02587520|40061522|FG012|Overall Study|Protocol Violation|0|||
16432856|NCT02587520|40061523|FG013|Overall Study|Protocol Violation|0|||
16432857|NCT02587520|40061524|FG014|Overall Study|Protocol Violation|0|||
16432858|NCT02587520|40061525|FG015|Overall Study|Protocol Violation|0|||
16432859|NCT02587520|40061526|FG016|Overall Study|Protocol Violation|0|||
16432860|NCT02587520|40061527|FG017|Overall Study|Protocol Violation|0|||
16432861|NCT02587520|40061510|FG000|Overall Study|Adverse Event|0|||
16432862|NCT02587520|40061511|FG001|Overall Study|Adverse Event|0|||
16432863|NCT02587520|40061512|FG002|Overall Study|Adverse Event|0|||
16432864|NCT02587520|40061513|FG003|Overall Study|Adverse Event|0|||
16432865|NCT02587520|40061514|FG004|Overall Study|Adverse Event|0|||
16432866|NCT02587520|40061515|FG005|Overall Study|Adverse Event|0|||
16432867|NCT02587520|40061516|FG006|Overall Study|Adverse Event|0|||
16432868|NCT02587520|40061517|FG007|Overall Study|Adverse Event|0|||
16432869|NCT02587520|40061518|FG008|Overall Study|Adverse Event|0|||
16432870|NCT02587520|40061519|FG009|Overall Study|Adverse Event|0|||
16432871|NCT02587520|40061520|FG010|Overall Study|Adverse Event|0|||
16432872|NCT02587520|40061521|FG011|Overall Study|Adverse Event|1|||
16432873|NCT02587520|40061522|FG012|Overall Study|Adverse Event|0|||
16432874|NCT02587520|40061523|FG013|Overall Study|Adverse Event|0|||
16432875|NCT02587520|40061524|FG014|Overall Study|Adverse Event|0|||
16432876|NCT02587520|40061525|FG015|Overall Study|Adverse Event|0|||
16432877|NCT02587520|40061526|FG016|Overall Study|Adverse Event|0|||
16432878|NCT02587520|40061527|FG017|Overall Study|Adverse Event|0|||
16432879|NCT02587520|40061510|FG000|Overall Study|Withdrawal by Subject|0|||
16432880|NCT02587520|40061511|FG001|Overall Study|Withdrawal by Subject|0|||
16432881|NCT02587520|40061512|FG002|Overall Study|Withdrawal by Subject|1|||
16432882|NCT02587520|40061513|FG003|Overall Study|Withdrawal by Subject|1|||
16432883|NCT02587520|40061514|FG004|Overall Study|Withdrawal by Subject|0|||
16432884|NCT02587520|40061515|FG005|Overall Study|Withdrawal by Subject|1|||
16432885|NCT02587520|40061516|FG006|Overall Study|Withdrawal by Subject|1|||
16432886|NCT02587520|40061517|FG007|Overall Study|Withdrawal by Subject|0|||
16432887|NCT02587520|40061518|FG008|Overall Study|Withdrawal by Subject|0|||
16432888|NCT02587520|40061519|FG009|Overall Study|Withdrawal by Subject|0|||
16432889|NCT02587520|40061520|FG010|Overall Study|Withdrawal by Subject|0|||
16432890|NCT02587520|40061521|FG011|Overall Study|Withdrawal by Subject|0|||
16432891|NCT02587520|40061522|FG012|Overall Study|Withdrawal by Subject|0|||
16432892|NCT02587520|40061523|FG013|Overall Study|Withdrawal by Subject|1|||
16432893|NCT02587520|40061524|FG014|Overall Study|Withdrawal by Subject|0|||
16432894|NCT02587520|40061525|FG015|Overall Study|Withdrawal by Subject|0|||
16432895|NCT02587520|40061526|FG016|Overall Study|Withdrawal by Subject|0|||
16432896|NCT02587520|40061527|FG017|Overall Study|Withdrawal by Subject|0|||
16432897|NCT02587520|40061510|FG000|Overall Study|Lost to Follow-up|0|||
16432898|NCT02587520|40061511|FG001|Overall Study|Lost to Follow-up|2|||
16432899|NCT02587520|40061512|FG002|Overall Study|Lost to Follow-up|0|||
16432900|NCT02587520|40061513|FG003|Overall Study|Lost to Follow-up|2|||
16432901|NCT02587520|40061514|FG004|Overall Study|Lost to Follow-up|0|||
16432902|NCT02587520|40061515|FG005|Overall Study|Lost to Follow-up|1|||
16432903|NCT02587520|40061516|FG006|Overall Study|Lost to Follow-up|1|||
16432904|NCT02587520|40061517|FG007|Overall Study|Lost to Follow-up|1|||
16432905|NCT02587520|40061518|FG008|Overall Study|Lost to Follow-up|0|||
16432906|NCT02587520|40061519|FG009|Overall Study|Lost to Follow-up|2|||
16432907|NCT02587520|40061520|FG010|Overall Study|Lost to Follow-up|2|||
16432908|NCT02587520|40061521|FG011|Overall Study|Lost to Follow-up|1|||
16432909|NCT02587520|40061522|FG012|Overall Study|Lost to Follow-up|0|||
16432910|NCT02587520|40061523|FG013|Overall Study|Lost to Follow-up|0|||
16432911|NCT02587520|40061524|FG014|Overall Study|Lost to Follow-up|0|||
16432912|NCT02587520|40061525|FG015|Overall Study|Lost to Follow-up|0|||
16432913|NCT02587520|40061526|FG016|Overall Study|Lost to Follow-up|0|||
16432914|NCT02587520|40061527|FG017|Overall Study|Lost to Follow-up|0|||
16432915|NCT02631551|40061528|FG000|Overall Study|Adverse Event|1|||
16432916|NCT02631551|40061529|FG001|Overall Study|Adverse Event|2|||
16432917|NCT02631551|40061530|FG002|Overall Study|Adverse Event|4|||
16432918|NCT02631551|40061531|FG003|Overall Study|Adverse Event|0|||
16432919|NCT02631551|40061528|FG000|Overall Study|Lack of Efficacy|0|||
16432920|NCT02631551|40061529|FG001|Overall Study|Lack of Efficacy|0|||
16432921|NCT02631551|40061530|FG002|Overall Study|Lack of Efficacy|1|||
16432922|NCT02631551|40061531|FG003|Overall Study|Lack of Efficacy|0|||
16432923|NCT02631551|40061528|FG000|Overall Study|Lost to Follow-up|1|||
16432924|NCT02631551|40061529|FG001|Overall Study|Lost to Follow-up|2|||
16432925|NCT02631551|40061530|FG002|Overall Study|Lost to Follow-up|0|||
16432926|NCT02631551|40061531|FG003|Overall Study|Lost to Follow-up|3|||
16432927|NCT02631551|40061528|FG000|Overall Study|Withdrawal by Subject|2|||
16432928|NCT02631551|40061529|FG001|Overall Study|Withdrawal by Subject|2|||
16432929|NCT02631551|40061530|FG002|Overall Study|Withdrawal by Subject|0|||
16432930|NCT02631551|40061531|FG003|Overall Study|Withdrawal by Subject|5|||
16432931|NCT02631551|40061528|FG000|Overall Study|Protocol deviation|3|||
16432932|NCT02631551|40061529|FG001|Overall Study|Protocol deviation|6|||
16432933|NCT02631551|40061530|FG002|Overall Study|Protocol deviation|3|||
16432934|NCT02631551|40061531|FG003|Overall Study|Protocol deviation|0|||
16432935|NCT02631551|40061528|FG000|Overall Study|Non-compliance with study procedures|0|||
16432936|NCT02631551|40061529|FG001|Overall Study|Non-compliance with study procedures|0|||
16432937|NCT02631551|40061530|FG002|Overall Study|Non-compliance with study procedures|1|||
16432938|NCT02631551|40061531|FG003|Overall Study|Non-compliance with study procedures|1|||
16432939|NCT02631551|40061528|FG000|Overall Study|Non-compliance with study drug|1|||
16432940|NCT02631551|40061529|FG001|Overall Study|Non-compliance with study drug|0|||
16432941|NCT02631551|40061530|FG002|Overall Study|Non-compliance with study drug|0|||
16432942|NCT02631551|40061531|FG003|Overall Study|Non-compliance with study drug|0|||
16432943|NCT02631551|40061528|FG000|Overall Study|Other, specific reasons not collected|5|||
16432944|NCT02631551|40061529|FG001|Overall Study|Other, specific reasons not collected|7|||
16432945|NCT02631551|40061530|FG002|Overall Study|Other, specific reasons not collected|2|||
16432946|NCT02631551|40061531|FG003|Overall Study|Other, specific reasons not collected|2|||
16432947|NCT01426958|40061532|FG000|Overall Study|Adverse Event|2|||
16432948|NCT02936635|40061535|FG000|Overall Study|Adverse Event|43|||
16432949|NCT02936635|40061536|FG001|Overall Study|Adverse Event|25|||
16432950|NCT02936635|40061535|FG000|Overall Study|Progressive Disease|10|||
16432951|NCT02936635|40061536|FG001|Overall Study|Progressive Disease|18|||
16432952|NCT02936635|40061535|FG000|Overall Study|Sponsor Discretion|10|||
16432953|NCT02936635|40061536|FG001|Overall Study|Sponsor Discretion|16|||
16432954|NCT02936635|40061535|FG000|Overall Study|Death|9|||
16432955|NCT02936635|40061536|FG001|Overall Study|Death|15|||
16432956|NCT02936635|40061535|FG000|Overall Study|Withdrawal by Subject|8|||
16432957|NCT02936635|40061536|FG001|Overall Study|Withdrawal by Subject|15|||
16432958|NCT02936635|40061535|FG000|Overall Study|Physician Decision|2|||
16361838|NCT04181788|39811836|FG004|TREATMENT|Death|8|||
16361839|NCT04181788|39811837|FG005|TREATMENT|Death|8|||
16361840|NCT04181788|39811832|FG000|TREATMENT|Physician Decision|0|||
16361841|NCT04181788|39811833|FG001|TREATMENT|Physician Decision|0|||
16361842|NCT04181788|39811834|FG002|TREATMENT|Physician Decision|0|||
16361843|NCT04181788|39811835|FG003|TREATMENT|Physician Decision|0|||
16361844|NCT04181788|39811836|FG004|TREATMENT|Physician Decision|0|||
16361845|NCT04181788|39811837|FG005|TREATMENT|Physician Decision|1|||
16361846|NCT04181788|39811832|FG000|TREATMENT|Progressive disease|3|||
16361847|NCT04181788|39811833|FG001|TREATMENT|Progressive disease|3|||
16361848|NCT04181788|39811834|FG002|TREATMENT|Progressive disease|5|||
16361849|NCT04181788|39811835|FG003|TREATMENT|Progressive disease|7|||
16361850|NCT04181788|39811836|FG004|TREATMENT|Progressive disease|20|||
16361851|NCT04181788|39811837|FG005|TREATMENT|Progressive disease|38|||
16361852|NCT04181788|39811832|FG000|TREATMENT|Global deterioration of health status|0|||
16361853|NCT04181788|39811833|FG001|TREATMENT|Global deterioration of health status|2|||
16361854|NCT04181788|39811834|FG002|TREATMENT|Global deterioration of health status|0|||
16361855|NCT04181788|39811835|FG003|TREATMENT|Global deterioration of health status|0|||
16361856|NCT04181788|39811836|FG004|TREATMENT|Global deterioration of health status|2|||
16361857|NCT04181788|39811837|FG005|TREATMENT|Global deterioration of health status|8|||
16361858|NCT04181788|39811832|FG000|TREATMENT|Withdrawal by Subject|1|||
16361859|NCT04181788|39811833|FG001|TREATMENT|Withdrawal by Subject|2|||
16361860|NCT04181788|39811834|FG002|TREATMENT|Withdrawal by Subject|0|||
16361861|NCT04181788|39811835|FG003|TREATMENT|Withdrawal by Subject|0|||
16361862|NCT04181788|39811836|FG004|TREATMENT|Withdrawal by Subject|3|||
16361863|NCT04181788|39811837|FG005|TREATMENT|Withdrawal by Subject|5|||
16361864|NCT04181788|39811832|FG000|TREATMENT|Other unspecified|0|||
16361865|NCT04181788|39811833|FG001|TREATMENT|Other unspecified|0|||
16361866|NCT04181788|39811834|FG002|TREATMENT|Other unspecified|0|||
16361867|NCT04181788|39811835|FG003|TREATMENT|Other unspecified|0|||
16361868|NCT04181788|39811836|FG004|TREATMENT|Other unspecified|0|||
16131654|NCT00421707|38969601|FG001|Period 2: Washout|Withdrawal by Subject|1|||
16131655|NCT00421707|38969600|FG000|Period 2: Washout|Lost to Follow-up|0|||
16131656|NCT00421707|38969601|FG001|Period 2: Washout|Lost to Follow-up|1|||
16131657|NCT00421707|38969600|FG000|Period 2: Washout|Other: Pregnancy|0|||
16131658|NCT00421707|38969601|FG001|Period 2: Washout|Other: Pregnancy|1|||
16131659|NCT00421707|38969600|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
16131660|NCT00421707|38969601|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
16131661|NCT00421707|38969600|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
16131662|NCT00421707|38969601|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
16131663|NCT00421707|38969600|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
16131664|NCT00421707|38969601|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
16131665|NCT05718466|38969602|FG000|Overall Study|Withdrawal by Subject|1|||
16131666|NCT05718466|38969603|FG001|Overall Study|Withdrawal by Subject|2|||
16131667|NCT05718466|38969602|FG000|Overall Study|Death|0|||
16131668|NCT05718466|38969603|FG001|Overall Study|Death|1|||
16131669|NCT03384654|38969604|FG000|Overall Study|Withdrawal by Subject|0|||
16131670|NCT03384654|38969605|FG001|Overall Study|Withdrawal by Subject|0|||
16131671|NCT03384654|38969606|FG002|Overall Study|Withdrawal by Subject|1|||
16131672|NCT03384654|38969607|FG003|Overall Study|Withdrawal by Subject|0|||
16131673|NCT02090959|38969608|FG000|Overall Study|Withdrawal by Subject|10|||
16131674|NCT02090959|38969608|FG000|Overall Study|Adverse Event|1|||
16131675|NCT02090959|38969608|FG000|Overall Study|Investigator decision|2|||
16131676|NCT02090959|38969608|FG000|Overall Study|Study termination|6|||
16131677|NCT02090959|38969608|FG000|Overall Study|Enrolled but not treated|1|||
16131678|NCT02090959|38969608|FG000|Overall Study|Transfer for compassionate use medicine|4|||
16131679|NCT02090959|38969608|FG000|Overall Study|Move to medical need program|3|||
16131680|NCT02090959|38969608|FG000|Overall Study|Entered in to other study|34|||
16131681|NCT02090959|38969608|FG000|Overall Study|Switched to commercial supply|88|||
16131682|NCT02090959|38969608|FG000|Overall Study|Other than specified|2|||
16131683|NCT00591721|38969609|FG000|Overall Study|Withdrawal by Subject|10|||
16131684|NCT00591721|38969610|FG001|Overall Study|Withdrawal by Subject|10|||
16131685|NCT00591721|38969609|FG000|Overall Study|Lost to Follow-up|1|||
16131686|NCT00591721|38969610|FG001|Overall Study|Lost to Follow-up|4|||
16131687|NCT00591721|38969609|FG000|Overall Study|Intervention not received|10|||
16131688|NCT00591721|38969610|FG001|Overall Study|Intervention not received|8|||
16131689|NCT00122460|38969611|FG000|Overall Study|investigational study phase ongoing|7|||
16131690|NCT00122460|38969612|FG001|Overall Study|investigational study phase ongoing|1|||
16131691|NCT01145898|38969615|FG000|3-year Treatment|medication change by treating physician|3|||
16131692|NCT01145898|38969616|FG001|3-year Treatment|medication change by treating physician|16|||
16131693|NCT01575028|38969617|FG000|Overall Study|Physician Decision|0|||
16131694|NCT01575028|38969618|FG001|Overall Study|Physician Decision|1|||
16432959|NCT02936635|40061536|FG001|Overall Study|Physician Decision|9|||
16432960|NCT02936635|40061535|FG000|Overall Study|Lost to Follow-up|1|||
16432961|NCT02936635|40061536|FG001|Overall Study|Lost to Follow-up|2|||
16432962|NCT02936635|40061535|FG000|Overall Study|Protocol Violation|1|||
16432963|NCT02936635|40061536|FG001|Overall Study|Protocol Violation|0|||
16432964|NCT02936635|40061535|FG000|Overall Study|Lack of effect/Entry into other study|31|||
16432965|NCT02936635|40061536|FG001|Overall Study|Lack of effect/Entry into other study|65|||
16432966|NCT00496080|40061539|FG000|Overall Study|Lost to Follow-up|9|||
16432967|NCT00496080|40061539|FG000|Overall Study|Surgical re-intervention|7|||
16432968|NCT00496080|40061539|FG000|Overall Study|Withdrawal by Subject|5|||
16432969|NCT00496080|40061539|FG000|Overall Study|Physician Decision|6|||
16432970|NCT04590014|40061548|FG000|Overall Study|Withdrawal by Subject|1|||
16432971|NCT04590014|40061549|FG001|Overall Study|Withdrawal by Subject|0|||
16432972|NCT01458639|40064255|FG000|Overall Study|Physician Decision|4|||
16432973|NCT01458639|40064255|FG000|Overall Study|Equipment issue|1|||
16432974|NCT01458639|40064255|FG000|Overall Study|Inability to obtain subject blood sample|1|||
16432975|NCT00922623|40064262|FG000|Overall Study|Other|4|||
16432976|NCT00922623|40064262|FG000|Overall Study|Lost to Follow-up|1|||
16432977|NCT01479868|40064263|FG000|Overall Study|Adverse Event|1|||
16432978|NCT01479868|40064263|FG000|Overall Study|Lost to Follow-up|4|||
16432979|NCT01479868|40064263|FG000|Overall Study|Protocol Violation|1|||
16432980|NCT01479868|40064263|FG000|Overall Study|Withdrawal by Subject|1|||
16432981|NCT01479868|40064263|FG000|Overall Study|Sponsor's Decision|1|||
16432982|NCT01479868|40064263|FG000|Overall Study|Initiation of new HCV Therapy|1|||
16432983|NCT04390243|40064264|FG000|Overall Study|Death|1|||
16432984|NCT04390243|40064264|FG000|Overall Study|Disease Progression|4|||
16432985|NCT04390243|40064264|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
16432986|NCT01569841|40064265|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
16432987|NCT01569841|40064266|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
16432988|NCT00466440|40064268|FG000|Overall Study|Adverse Event|0|||
16432989|NCT00466440|40064269|FG001|Overall Study|Adverse Event|3|||
16432990|NCT00466440|40064270|FG002|Overall Study|Adverse Event|1|||
16432991|NCT00466440|40064268|FG000|Overall Study|Death|1|||
16432992|NCT00466440|40064269|FG001|Overall Study|Death|1|||
16432993|NCT00466440|40064270|FG002|Overall Study|Death|0|||
16432994|NCT00466440|40064268|FG000|Overall Study|Progressive disease|13|||
16432995|NCT00466440|40064269|FG001|Overall Study|Progressive disease|5|||
16432996|NCT00466440|40064270|FG002|Overall Study|Progressive disease|4|||
16131695|NCT02009761|38969619|FG000|Overall Study|Adverse Event|4|||
16131696|NCT00153062|38969622|FG000|Overall Study|Death|360|||
16432997|NCT00466440|40064268|FG000|Overall Study|Lost to Follow-up|0|||
16432998|NCT00466440|40064269|FG001|Overall Study|Lost to Follow-up|1|||
16432999|NCT00466440|40064270|FG002|Overall Study|Lost to Follow-up|0|||
16361869|NCT04181788|39811837|FG005|TREATMENT|Other unspecified|2|||
16361870|NCT04181788|39811832|FG000|TREATMENT|Ongoing|0|||
16131697|NCT00153062|38969623|FG001|Overall Study|Death|352|||
16433000|NCT00466440|40064268|FG000|Overall Study|Physician Decision|0|||
16433001|NCT00466440|40064269|FG001|Overall Study|Physician Decision|1|||
16433002|NCT00466440|40064270|FG002|Overall Study|Physician Decision|2|||
16433003|NCT00466440|40064268|FG000|Overall Study|Protocol entry criteria not met|0|||
16433004|NCT00466440|40064269|FG001|Overall Study|Protocol entry criteria not met|0|||
16433005|NCT00466440|40064270|FG002|Overall Study|Protocol entry criteria not met|4|||
16433006|NCT00466440|40064268|FG000|Overall Study|Withdrawal by Subject|0|||
16433007|NCT00466440|40064269|FG001|Overall Study|Withdrawal by Subject|1|||
16433008|NCT00466440|40064270|FG002|Overall Study|Withdrawal by Subject|0|||
16433009|NCT00466440|40064268|FG000|Overall Study|Sponsor decision|0|||
16433010|NCT00466440|40064269|FG001|Overall Study|Sponsor decision|0|||
16433011|NCT00466440|40064270|FG002|Overall Study|Sponsor decision|1|||
16433012|NCT00801229|40064271|FG000|Signed Consent|Withdrawal by Subject|2|||
16433013|NCT00801229|40064272|FG001|Signed Consent|Withdrawal by Subject|2|||
16433014|NCT00801229|40064271|FG000|Signed Consent|Found Ineligible|1|||
16433015|NCT00801229|40064272|FG001|Signed Consent|Found Ineligible|1|||
16433016|NCT00801229|40064271|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
16433017|NCT00801229|40064272|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
16433018|NCT00801229|40064271|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
16433019|NCT00801229|40064272|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
16433020|NCT00801229|40064271|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
16433021|NCT00801229|40064272|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
16433022|NCT00801229|40064271|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
16433023|NCT00801229|40064272|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
16433024|NCT00801229|40064271|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
16433025|NCT00801229|40064272|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
16433026|NCT00801229|40064271|FG000|Received Study Drug/Placebo|Adverse Event|1|||
16433027|NCT00801229|40064272|FG001|Received Study Drug/Placebo|Adverse Event|1|||
16433028|NCT04378270|40064280|FG000|Overall Study|Lack of Efficacy|1|||
16433029|NCT04378270|40064280|FG000|Overall Study|Withdrawal by Subject|1|||
16433030|NCT04378270|40064280|FG000|Overall Study|Screen Failure|1|||
16433031|NCT04378270|40064280|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
16433032|NCT00880620|40064286|FG000|Overall Study|Adverse Event|4|||
16433033|NCT00880620|40064287|FG001|Overall Study|Adverse Event|5|||
16433034|NCT00880620|40064288|FG002|Overall Study|Adverse Event|15|||
16361871|NCT04181788|39811833|FG001|TREATMENT|Ongoing|3|||
16361872|NCT04181788|39811834|FG002|TREATMENT|Ongoing|0|||
16361873|NCT04181788|39811835|FG003|TREATMENT|Ongoing|5|||
16361874|NCT04181788|39811836|FG004|TREATMENT|Ongoing|7|||
16361875|NCT04181788|39811837|FG005|TREATMENT|Ongoing|15|||
16361876|NCT04181788|39811832|FG000|FOLLOW-UP|Death|0|||
16361877|NCT04181788|39811833|FG001|FOLLOW-UP|Death|0|||
16361878|NCT04181788|39811834|FG002|FOLLOW-UP|Death|1|||
16361879|NCT04181788|39811835|FG003|FOLLOW-UP|Death|2|||
16361880|NCT04181788|39811836|FG004|FOLLOW-UP|Death|8|||
16361881|NCT04181788|39811837|FG005|FOLLOW-UP|Death|20|||
16433035|NCT00880620|40064289|FG003|Overall Study|Adverse Event|15|||
16433036|NCT00880620|40064286|FG000|Overall Study|Death|0|||
16361882|NCT04181788|39811832|FG000|FOLLOW-UP|Lost to Follow-up|0|||
16361883|NCT04181788|39811833|FG001|FOLLOW-UP|Lost to Follow-up|0|||
16361884|NCT04181788|39811834|FG002|FOLLOW-UP|Lost to Follow-up|0|||
16131698|NCT00153062|38969624|FG002|Overall Study|Death|369|||
16361885|NCT04181788|39811835|FG003|FOLLOW-UP|Lost to Follow-up|0|||
16433037|NCT00880620|40064287|FG001|Overall Study|Death|0|||
16433038|NCT00880620|40064288|FG002|Overall Study|Death|1|||
16433039|NCT00880620|40064289|FG003|Overall Study|Death|0|||
16433040|NCT00880620|40064286|FG000|Overall Study|Lack of Efficacy|12|||
16433041|NCT00880620|40064287|FG001|Overall Study|Lack of Efficacy|4|||
16433042|NCT00880620|40064288|FG002|Overall Study|Lack of Efficacy|0|||
16433043|NCT00880620|40064289|FG003|Overall Study|Lack of Efficacy|1|||
16433044|NCT00880620|40064286|FG000|Overall Study|Lost to Follow-up|0|||
16433045|NCT00880620|40064287|FG001|Overall Study|Lost to Follow-up|1|||
16433046|NCT00880620|40064288|FG002|Overall Study|Lost to Follow-up|1|||
16433047|NCT00880620|40064289|FG003|Overall Study|Lost to Follow-up|0|||
16433048|NCT00880620|40064286|FG000|Overall Study|Protocol Violation|0|||
16433049|NCT00880620|40064287|FG001|Overall Study|Protocol Violation|1|||
16433050|NCT00880620|40064288|FG002|Overall Study|Protocol Violation|0|||
16433051|NCT00880620|40064289|FG003|Overall Study|Protocol Violation|2|||
16433052|NCT00880620|40064286|FG000|Overall Study|Withdrawal by Subject|4|||
16433053|NCT00880620|40064287|FG001|Overall Study|Withdrawal by Subject|3|||
16433054|NCT00880620|40064288|FG002|Overall Study|Withdrawal by Subject|1|||
16433055|NCT00880620|40064289|FG003|Overall Study|Withdrawal by Subject|3|||
16433056|NCT00880620|40064286|FG000|Overall Study|Noncompliance|0|||
16433057|NCT00880620|40064287|FG001|Overall Study|Noncompliance|0|||
16433058|NCT00880620|40064288|FG002|Overall Study|Noncompliance|1|||
16433059|NCT00880620|40064289|FG003|Overall Study|Noncompliance|1|||
16433060|NCT00880620|40064286|FG000|Overall Study|Other|1|||
16433061|NCT00880620|40064287|FG001|Overall Study|Other|1|||
16433062|NCT00880620|40064288|FG002|Overall Study|Other|2|||
16433063|NCT00880620|40064289|FG003|Overall Study|Other|2|||
16433064|NCT00181766|40064296|FG000|Overall Study|Lost to Follow-up|6|||
16433065|NCT00181766|40064296|FG000|Overall Study|Adverse Event|4|||
16433066|NCT00181766|40064296|FG000|Overall Study|non-compliance|2|||
16433067|NCT04528641|40064297|FG000|Overall Study|Withdrawal by Subject|0|||
16433068|NCT04528641|40064298|FG001|Overall Study|Withdrawal by Subject|0|||
16433069|NCT04528641|40064299|FG002|Overall Study|Withdrawal by Subject|0|||
16433070|NCT04528641|40064300|FG003|Overall Study|Withdrawal by Subject|1|||
16131699|NCT00153062|38969625|FG003|Overall Study|Death|365|||
16433071|NCT04528641|40064301|FG004|Overall Study|Withdrawal by Subject|0|||
16433072|NCT04528641|40064302|FG005|Overall Study|Withdrawal by Subject|1|||
16433073|NCT00496015|40064303|FG000|Overall Study|Other|1|||
16433074|NCT00496015|40064304|FG001|Overall Study|Other|0|||
16433075|NCT00496015|40064305|FG002|Overall Study|Other|0|||
16433076|NCT00496015|40064306|FG003|Overall Study|Other|1|||
16433077|NCT00496015|40064307|FG004|Overall Study|Other|0|||
16433078|NCT00626275|40064308|FG000|Part A - Treatment Period 1|Adverse Event|1|||
16433079|NCT00626275|40064309|FG001|Part A - Treatment Period 1|Adverse Event|0|||
16433080|NCT00626275|40064310|FG002|Part A - Treatment Period 1|Adverse Event|0|||
16433081|NCT00626275|40064311|FG003|Part A - Treatment Period 1|Adverse Event|0|||
16433082|NCT00626275|40064312|FG004|Part A - Treatment Period 1|Adverse Event|0|||
16433083|NCT00626275|40064313|FG005|Part A - Treatment Period 1|Adverse Event|0|||
16433084|NCT00626275|40064314|FG006|Part A - Treatment Period 1|Adverse Event|0|||
16433085|NCT00626275|40064315|FG007|Part A - Treatment Period 1|Adverse Event|0|||
16433086|NCT00626275|40064308|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
16433087|NCT00626275|40064309|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
16433088|NCT00626275|40064310|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
16433089|NCT00626275|40064311|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
16433090|NCT00626275|40064312|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
16433091|NCT00626275|40064313|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
16433092|NCT00626275|40064314|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
16433093|NCT00626275|40064315|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
16433094|NCT00626275|40064308|FG000|Part B|Lost to Follow-up|0|||
16433095|NCT00626275|40064309|FG001|Part B|Lost to Follow-up|0|||
16433096|NCT00626275|40064310|FG002|Part B|Lost to Follow-up|0|||
16433097|NCT00626275|40064311|FG003|Part B|Lost to Follow-up|0|||
16433098|NCT00626275|40064312|FG004|Part B|Lost to Follow-up|0|||
16433099|NCT00626275|40064313|FG005|Part B|Lost to Follow-up|0|||
16433100|NCT00626275|40064314|FG006|Part B|Lost to Follow-up|1|||
16433101|NCT00626275|40064315|FG007|Part B|Lost to Follow-up|0|||
16433102|NCT00626275|40064308|FG000|Part B|Withdrawal by Subject|0|||
16433103|NCT00626275|40064309|FG001|Part B|Withdrawal by Subject|0|||
16433104|NCT00626275|40064310|FG002|Part B|Withdrawal by Subject|0|||
16433105|NCT00626275|40064311|FG003|Part B|Withdrawal by Subject|0|||
16433106|NCT00626275|40064312|FG004|Part B|Withdrawal by Subject|0|||
16433107|NCT00626275|40064313|FG005|Part B|Withdrawal by Subject|0|||
16433108|NCT00626275|40064314|FG006|Part B|Withdrawal by Subject|0|||
16433109|NCT00626275|40064315|FG007|Part B|Withdrawal by Subject|1|||
16433110|NCT01177007|40064316|FG000|Overall Study|Lost to Follow-up|2|||
16433111|NCT01177007|40064316|FG000|Overall Study|Death|4|||
16433112|NCT01177007|40064316|FG000|Overall Study|Entered hospice care|5|||
16433113|NCT01177007|40064316|FG000|Overall Study|Required additional Y90 treatment|6|||
16433114|NCT01177007|40064316|FG000|Overall Study|Change in treatment modality|21|||
16433115|NCT03077919|40064317|FG000|Overall Study|Lost to Follow-up|4|||
16433116|NCT03077919|40064318|FG001|Overall Study|Lost to Follow-up|1|||
16433117|NCT00549640|40064324|FG000|Overall Study|Withdrawal by Subject|6|||
16433118|NCT00549640|40064325|FG001|Overall Study|Withdrawal by Subject|12|||
16433119|NCT00549640|40064324|FG000|Overall Study|Adverse Event|5|||
16433120|NCT00549640|40064325|FG001|Overall Study|Adverse Event|0|||
16433121|NCT00549640|40064324|FG000|Overall Study|Lost to Follow-up|7|||
16433122|NCT00549640|40064325|FG001|Overall Study|Lost to Follow-up|4|||
16433123|NCT03038126|40064326|FG000|Overall Study|Death|1|||
16433124|NCT03038126|40064327|FG001|Overall Study|Death|1|||
16433125|NCT03038126|40064326|FG000|Overall Study|Withdrawal by Subject|5|||
16433126|NCT03038126|40064327|FG001|Overall Study|Withdrawal by Subject|0|||
16433127|NCT03038126|40064326|FG000|Overall Study|Lost to Follow-up|0|||
16433128|NCT03038126|40064327|FG001|Overall Study|Lost to Follow-up|1|||
16433129|NCT03038126|40064326|FG000|Overall Study|Long Term Hospitalization|2|||
16433130|NCT03038126|40064327|FG001|Overall Study|Long Term Hospitalization|0|||
16131700|NCT00153062|38969622|FG000|Overall Study|Withdrawal by Subject|14|||
16131701|NCT00153062|38969623|FG001|Overall Study|Withdrawal by Subject|30|||
16131702|NCT00153062|38969624|FG002|Overall Study|Withdrawal by Subject|27|||
16131703|NCT00153062|38969625|FG003|Overall Study|Withdrawal by Subject|28|||
16433131|NCT03038126|40064326|FG000|Overall Study|Too Ill to Participate|1|||
16433132|NCT03038126|40064327|FG001|Overall Study|Too Ill to Participate|2|||
16433133|NCT02407223|40064331|FG000|Overall Study|Adverse Event|1|||
16433134|NCT02407223|40064332|FG001|Overall Study|Adverse Event|0|||
16433135|NCT02407223|40064333|FG002|Overall Study|Adverse Event|1|||
16433136|NCT02407223|40064331|FG000|Overall Study|Lack of Efficacy|6|||
16433137|NCT02407223|40064332|FG001|Overall Study|Lack of Efficacy|6|||
16433138|NCT02407223|40064333|FG002|Overall Study|Lack of Efficacy|4|||
16433139|NCT02407223|40064331|FG000|Overall Study|Lost to Follow-up|1|||
16433140|NCT02407223|40064332|FG001|Overall Study|Lost to Follow-up|0|||
16433141|NCT02407223|40064333|FG002|Overall Study|Lost to Follow-up|2|||
16433142|NCT02407223|40064331|FG000|Overall Study|Withdrawal by Subject|2|||
16433143|NCT02407223|40064332|FG001|Overall Study|Withdrawal by Subject|4|||
16433144|NCT02407223|40064333|FG002|Overall Study|Withdrawal by Subject|4|||
16433145|NCT02407223|40064331|FG000|Overall Study|Study Terminated by Sponsor|77|||
16433146|NCT02407223|40064332|FG001|Overall Study|Study Terminated by Sponsor|80|||
16433147|NCT02407223|40064333|FG002|Overall Study|Study Terminated by Sponsor|86|||
16433148|NCT02407223|40064331|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
16433149|NCT02407223|40064332|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
16433150|NCT02407223|40064333|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
16433151|NCT02407223|40064331|FG000|Overall Study|Other|29|||
16433152|NCT02407223|40064332|FG001|Overall Study|Other|27|||
16433153|NCT02407223|40064333|FG002|Overall Study|Other|25|||
16433154|NCT03400852|40064334|FG000|Blinded Treatment Period|Physician Decision|0|||
16433155|NCT03400852|40064335|FG001|Blinded Treatment Period|Physician Decision|1|||
16433156|NCT03400852|40064336|FG002|Blinded Treatment Period|Physician Decision|0|||
16433157|NCT03400852|40064334|FG000|Blinded Treatment Period|Adverse Event|1|||
16433158|NCT03400852|40064335|FG001|Blinded Treatment Period|Adverse Event|1|||
16131704|NCT00153062|38969622|FG000|Overall Study|Lost to Follow-up|12|||
16131705|NCT00153062|38969623|FG001|Overall Study|Lost to Follow-up|20|||
16131706|NCT00153062|38969624|FG002|Overall Study|Lost to Follow-up|15|||
16131707|NCT00153062|38969625|FG003|Overall Study|Lost to Follow-up|16|||
16131708|NCT00153062|38969622|FG000|Overall Study|Adverse Event|0|||
16131709|NCT00153062|38969623|FG001|Overall Study|Adverse Event|1|||
16131710|NCT00153062|38969624|FG002|Overall Study|Adverse Event|1|||
16131711|NCT00153062|38969625|FG003|Overall Study|Adverse Event|0|||
16131712|NCT00153062|38969622|FG000|Overall Study|Protocol Violation|0|||
16131713|NCT00153062|38969623|FG001|Overall Study|Protocol Violation|2|||
16131714|NCT00153062|38969624|FG002|Overall Study|Protocol Violation|1|||
16131715|NCT00153062|38969625|FG003|Overall Study|Protocol Violation|1|||
16131716|NCT00153062|38969622|FG000|Overall Study|No disposition data available|1|||
16433159|NCT03400852|40064336|FG002|Blinded Treatment Period|Adverse Event|0|||
16433160|NCT03400852|40064334|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
16433161|NCT03400852|40064335|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
16131717|NCT00153062|38969623|FG001|Overall Study|No disposition data available|1|||
16433162|NCT03400852|40064336|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
16433163|NCT03400852|40064334|FG000|Open Label Period|Physician Decision|0|||
16131718|NCT00153062|38969624|FG002|Overall Study|No disposition data available|1|||
16131719|NCT00153062|38969625|FG003|Overall Study|No disposition data available|1|||
16131720|NCT00153062|38969622|FG000|Overall Study|Other|0|||
16131721|NCT00153062|38969623|FG001|Overall Study|Other|0|||
16433164|NCT03400852|40064335|FG001|Open Label Period|Physician Decision|0|||
16131722|NCT00153062|38969624|FG002|Overall Study|Other|1|||
16131723|NCT00153062|38969625|FG003|Overall Study|Other|0|||
16131724|NCT01828073|38969627|FG000|Overall Study|Lost to Follow-up|1|||
16131725|NCT01828073|38969628|FG001|Overall Study|Lost to Follow-up|2|||
16131726|NCT02595073|38969629|FG000|Overall Study|Progressive Disease|0|||
16131727|NCT02595073|38969630|FG001|Overall Study|Progressive Disease|1|||
16131728|NCT02595073|38969629|FG000|Overall Study|Protocol Violation|2|||
16131729|NCT02595073|38969630|FG001|Overall Study|Protocol Violation|0|||
16131730|NCT01015560|38969631|FG000|Overall Study|Adverse Event|1|||
16131731|NCT01015560|38969631|FG000|Overall Study|Not protocol specified|1|||
16131732|NCT01015560|38969631|FG000|Overall Study|Withdrawal by Subject|1|||
16131733|NCT01178385|38969632|FG000|Overall Study|Withdrawal by Subject|2|||
16131734|NCT01178385|38969633|FG001|Overall Study|Withdrawal by Subject|0|||
16131735|NCT01079663|38969634|FG000|Overall Study|Adverse Event|0|||
16131736|NCT01079663|38969635|FG001|Overall Study|Adverse Event|2|||
16131737|NCT01079663|38969634|FG000|Overall Study|Protocol Violation|0|||
16131738|NCT01079663|38969635|FG001|Overall Study|Protocol Violation|2|||
16131739|NCT00932113|38969636|FG000|Overall Study|Lost to Follow-up|1|||
16131740|NCT00932113|38969637|FG001|Overall Study|Lost to Follow-up|0|||
16131741|NCT00156819|38969646|FG000|Overall Study|Lost to Follow-up|1|||
16131742|NCT00156819|38969647|FG001|Overall Study|Lost to Follow-up|1|||
16131743|NCT00156819|38969648|FG002|Overall Study|Lost to Follow-up|3|||
16131744|NCT01222507|38969650|FG000|Overall Study|Physician Decision|1|||
16131745|NCT01222507|38969650|FG000|Overall Study|Withdrawal by Subject|1|||
16131746|NCT00320541|38969651|FG000|Overall Study|Adverse Event|21|||
16131747|NCT00320541|38969652|FG001|Overall Study|Adverse Event|19|||
16131748|NCT00320541|38969651|FG000|Overall Study|Protocol Violation|0|||
16131749|NCT00320541|38969652|FG001|Overall Study|Protocol Violation|1|||
16131750|NCT00320541|38969651|FG000|Overall Study|Withdrawal by Subject|12|||
16131751|NCT00320541|38969652|FG001|Overall Study|Withdrawal by Subject|16|||
16131752|NCT00320541|38969651|FG000|Overall Study|Physician Decision|9|||
16131753|NCT00320541|38969652|FG001|Overall Study|Physician Decision|13|||
16131754|NCT00320541|38969651|FG000|Overall Study|Other|3|||
16131755|NCT00320541|38969652|FG001|Overall Study|Other|4|||
16131756|NCT00320541|38969651|FG000|Overall Study|Sponsor Decision|2|||
16131757|NCT00320541|38969652|FG001|Overall Study|Sponsor Decision|1|||
16131758|NCT00320541|38969651|FG000|Overall Study|Death due to Study Disease|1|||
16131759|NCT00320541|38969652|FG001|Overall Study|Death due to Study Disease|3|||
16131760|NCT00320541|38969651|FG000|Overall Study|Death due to Adverse Event(s)|1|||
16131761|NCT00320541|38969652|FG001|Overall Study|Death due to Adverse Event(s)|0|||
16131762|NCT00320541|38969651|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
16131763|NCT00320541|38969652|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
16131764|NCT02649946|38969655|FG000|Overall Study|Withdrawal by Subject|1|||
16131765|NCT02649946|38969656|FG001|Overall Study|Withdrawal by Subject|1|||
16131766|NCT02649946|38969655|FG000|Overall Study|Death|7|||
16131767|NCT02649946|38969656|FG001|Overall Study|Death|9|||
16131768|NCT02649946|38969655|FG000|Overall Study|Physician Decision|1|||
16131769|NCT02649946|38969656|FG001|Overall Study|Physician Decision|0|||
16131770|NCT02649946|38969655|FG000|Overall Study|Lost to Follow-up|2|||
16433165|NCT03400852|40064336|FG002|Open Label Period|Physician Decision|1|||
16131771|NCT02649946|38969656|FG001|Overall Study|Lost to Follow-up|1|||
16131772|NCT02649946|38969655|FG000|Overall Study|Erroneously enrolled|1|||
16131773|NCT02649946|38969656|FG001|Overall Study|Erroneously enrolled|0|||
16131774|NCT02649946|38969655|FG000|Overall Study|Missed 6-month follow-up visit|0|||
16131775|NCT02649946|38969656|FG001|Overall Study|Missed 6-month follow-up visit|4|||
16131776|NCT02962960|38969659|FG000|Overall Study|Withdrawal by Subject|1|||
16131777|NCT02962960|38969660|FG001|Overall Study|Withdrawal by Subject|1|||
16131778|NCT02962960|38969661|FG002|Overall Study|Withdrawal by Subject|0|||
16131779|NCT02962960|38969659|FG000|Overall Study|Adverse Event|1|||
16131780|NCT02962960|38969660|FG001|Overall Study|Adverse Event|1|||
16131781|NCT02962960|38969661|FG002|Overall Study|Adverse Event|0|||
16131782|NCT02962960|38969659|FG000|Overall Study|Protocol Violation|1|||
16131783|NCT02962960|38969660|FG001|Overall Study|Protocol Violation|0|||
16131784|NCT02962960|38969661|FG002|Overall Study|Protocol Violation|0|||
16131785|NCT02924064|38969663|FG000|Overall Study|Adverse Event|2|||
16131786|NCT02924064|38969664|FG001|Overall Study|Adverse Event|2|||
16131787|NCT02924064|38969663|FG000|Overall Study|Lost to Follow-up|0|||
16131788|NCT02924064|38969664|FG001|Overall Study|Lost to Follow-up|2|||
16131789|NCT02924064|38969663|FG000|Overall Study|Physician Decision|0|||
16131790|NCT02924064|38969664|FG001|Overall Study|Physician Decision|2|||
16131791|NCT02924064|38969663|FG000|Overall Study|Protocol Violation|1|||
16131792|NCT02924064|38969664|FG001|Overall Study|Protocol Violation|3|||
16131793|NCT02924064|38969663|FG000|Overall Study|Withdrawal by Subject|4|||
16131794|NCT02924064|38969664|FG001|Overall Study|Withdrawal by Subject|5|||
16131795|NCT02924064|38969663|FG000|Overall Study|Other|17|||
16131796|NCT02924064|38969664|FG001|Overall Study|Other|29|||
16131797|NCT03278106|38969665|FG000|Overall Study|No protocol treatment|1|||
16131798|NCT02054741|38969666|FG000|Overall Study|Protocol Violation|13|||
16131799|NCT02054741|38969667|FG001|Overall Study|Protocol Violation|2|||
16131800|NCT02054741|38969666|FG000|Overall Study|Withdrawal by Subject|10|||
16131801|NCT02054741|38969667|FG001|Overall Study|Withdrawal by Subject|5|||
16131802|NCT02054741|38969666|FG000|Overall Study|Death|94|||
16131803|NCT02054741|38969667|FG001|Overall Study|Death|90|||
16131804|NCT02054741|38969666|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
16131805|NCT02054741|38969667|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
16131806|NCT03170349|38969668|FG000|At 30 Days Follow-up|Death|1|||
16131807|NCT03170349|38969668|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
16131808|NCT03170349|38969668|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
16131809|NCT03170349|38969668|FG000|At 6 Months Follow-up|Death|3|||
16131810|NCT03170349|38969668|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
16131811|NCT03170349|38969668|FG000|At 1 Year Follow-up|Death|6|||
16131812|NCT03170349|38969668|FG000|At 2 Year Follow-up|Missed Visit|4|||
16131813|NCT03170349|38969668|FG000|At 2 Year Follow-up|Death|13|||
16131814|NCT03170349|38969668|FG000|At 2 Year Follow-up|Withdrawal by Subject|1|||
16131815|NCT04822597|38969671|FG000|Overall Study|Withdrawal by Subject|0|||
16131816|NCT04822597|38969672|FG001|Overall Study|Withdrawal by Subject|1|||
16131817|NCT04822597|38969673|FG002|Overall Study|Withdrawal by Subject|1|||
16131818|NCT04822597|38969674|FG003|Overall Study|Withdrawal by Subject|0|||
16131819|NCT04822597|38969671|FG000|Overall Study|Physician Decision|0|||
16131820|NCT04822597|38969672|FG001|Overall Study|Physician Decision|0|||
16131821|NCT04822597|38969673|FG002|Overall Study|Physician Decision|1|||
16131822|NCT04822597|38969674|FG003|Overall Study|Physician Decision|1|||
16131823|NCT04822597|38969671|FG000|Overall Study|Subject withdrawn after enrollment|0|||
16131824|NCT04822597|38969672|FG001|Overall Study|Subject withdrawn after enrollment|1|||
16131825|NCT04822597|38969673|FG002|Overall Study|Subject withdrawn after enrollment|0|||
16131826|NCT04822597|38969674|FG003|Overall Study|Subject withdrawn after enrollment|1|||
16131827|NCT04822597|38969671|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
16361886|NCT04181788|39811836|FG004|FOLLOW-UP|Lost to Follow-up|0|||
16361887|NCT04181788|39811837|FG005|FOLLOW-UP|Lost to Follow-up|2|||
16361888|NCT04181788|39811832|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
16361889|NCT04181788|39811833|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
16361890|NCT04181788|39811834|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
16361891|NCT04181788|39811835|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
16361892|NCT04181788|39811836|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
16361893|NCT04181788|39811837|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
16361894|NCT04181788|39811832|FG000|FOLLOW-UP|Other unspecified|0|||
16361895|NCT04181788|39811833|FG001|FOLLOW-UP|Other unspecified|1|||
16361896|NCT04181788|39811834|FG002|FOLLOW-UP|Other unspecified|0|||
16361897|NCT04181788|39811835|FG003|FOLLOW-UP|Other unspecified|0|||
16361898|NCT04181788|39811836|FG004|FOLLOW-UP|Other unspecified|0|||
16361899|NCT04181788|39811837|FG005|FOLLOW-UP|Other unspecified|3|||
16361900|NCT04181788|39811832|FG000|FOLLOW-UP|Ongoing|0|||
16361901|NCT04181788|39811833|FG001|FOLLOW-UP|Ongoing|0|||
16361902|NCT04181788|39811834|FG002|FOLLOW-UP|Ongoing|1|||
16361903|NCT04181788|39811835|FG003|FOLLOW-UP|Ongoing|3|||
16361904|NCT04181788|39811836|FG004|FOLLOW-UP|Ongoing|2|||
16361905|NCT04181788|39811837|FG005|FOLLOW-UP|Ongoing|2|||
16361906|NCT02515227|39811838|FG000|Overall Study|Adverse Event|0|||
16361907|NCT02515227|39811839|FG001|Overall Study|Adverse Event|2|||
16361908|NCT02515227|39811838|FG000|Overall Study|Progressive disease|2|||
16361909|NCT02515227|39811839|FG001|Overall Study|Progressive disease|9|||
16361910|NCT00972738|39811840|FG000|Overall Study|Adverse Event|7|||
16361911|NCT00972738|39811841|FG001|Overall Study|Adverse Event|1|||
16361912|NCT00972738|39811842|FG002|Overall Study|Adverse Event|8|||
16361913|NCT00972738|39811840|FG000|Overall Study|Protocol Violation|2|||
16361914|NCT00972738|39811841|FG001|Overall Study|Protocol Violation|1|||
16361915|NCT00972738|39811842|FG002|Overall Study|Protocol Violation|3|||
16361916|NCT00972738|39811840|FG000|Overall Study|Lost to Follow-up|1|||
16361917|NCT00972738|39811841|FG001|Overall Study|Lost to Follow-up|0|||
16361918|NCT00972738|39811842|FG002|Overall Study|Lost to Follow-up|1|||
16361919|NCT00972738|39811840|FG000|Overall Study|Lack of Efficacy|5|||
16361920|NCT00972738|39811841|FG001|Overall Study|Lack of Efficacy|1|||
16361921|NCT00972738|39811842|FG002|Overall Study|Lack of Efficacy|11|||
16361922|NCT00972738|39811840|FG000|Overall Study|Withdrawal by Subject|5|||
16361923|NCT00972738|39811841|FG001|Overall Study|Withdrawal by Subject|1|||
16361924|NCT00972738|39811842|FG002|Overall Study|Withdrawal by Subject|4|||
16361925|NCT00972738|39811840|FG000|Overall Study|Moved|0|||
16361926|NCT00972738|39811841|FG001|Overall Study|Moved|0|||
16361927|NCT00972738|39811842|FG002|Overall Study|Moved|1|||
16361928|NCT00972738|39811840|FG000|Overall Study|Other|1|||
16361929|NCT00972738|39811841|FG001|Overall Study|Other|2|||
16361930|NCT00972738|39811842|FG002|Overall Study|Other|1|||
16361931|NCT02593864|39811843|FG000|Overall Study|Withdrawal by Subject|3|||
16361932|NCT02593864|39811843|FG000|Overall Study|Lost to Follow-up|3|||
16361933|NCT02101294|39811844|FG000|Overall Study|Withdrawal by Subject|5|||
16361934|NCT02101294|39811844|FG000|Overall Study|Lost to Follow-up|6|||
16361935|NCT01963611|39811847|FG000|Overall Study|Adverse Event|1|||
16433166|NCT03400852|40064334|FG000|Open Label Period|Study terminated by sponsor|0|||
16131828|NCT04822597|38969672|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
16131829|NCT04822597|38969673|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
16433167|NCT03400852|40064335|FG001|Open Label Period|Study terminated by sponsor|0|||
16131830|NCT04822597|38969674|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
16131831|NCT00645801|38969675|FG000|Overall Study|unclear if patient took all the medication.|1|||
16131832|NCT00645801|38969676|FG001|Overall Study|unclear if patient took all the medication.|0|||
16131833|NCT00645801|38969675|FG000|Overall Study|Lost to Follow-up|19|||
16131834|NCT00645801|38969676|FG001|Overall Study|Lost to Follow-up|15|||
16131835|NCT01227577|38969677|FG000|Overall Study|Protocol deviation|3|||
16131836|NCT01227577|38969677|FG000|Overall Study|Death|3|||
16131837|NCT01227577|38969677|FG000|Overall Study|Administrative problems|2|||
16131838|NCT01227577|38969677|FG000|Overall Study|Lost to Follow-up|1|||
16131839|NCT01227577|38969677|FG000|Overall Study|Withdrawal by Subject|4|||
16131840|NCT01227577|38969677|FG000|Overall Study|Lack of Efficacy|5|||
16131841|NCT01227577|38969677|FG000|Overall Study|Adverse Event|17|||
16131842|NCT00141219|38969678|FG000|Overall Study|Protocol violations|5|||
16131843|NCT00141219|38969679|FG001|Overall Study|Protocol violations|4|||
16131844|NCT00141219|38969678|FG000|Overall Study|Adverse Event|8|||
16131845|NCT00141219|38969679|FG001|Overall Study|Adverse Event|6|||
16131846|NCT00141219|38969678|FG000|Overall Study|Lack of Efficacy|5|||
16131847|NCT00141219|38969679|FG001|Overall Study|Lack of Efficacy|4|||
16131848|NCT00141219|38969678|FG000|Overall Study|Withdrawal by Subject|6|||
16131849|NCT00141219|38969679|FG001|Overall Study|Withdrawal by Subject|2|||
16131850|NCT02678247|38969680|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
16131851|NCT02678247|38969681|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
16131852|NCT02678247|38969680|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
16131853|NCT02678247|38969681|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
16131854|NCT02678247|38969680|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
16131855|NCT02678247|38969681|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
16131856|NCT02678247|38969680|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
16131857|NCT02678247|38969681|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
16131858|NCT02678247|38969680|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
16131859|NCT02678247|38969681|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
16131860|NCT02678247|38969680|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
16131861|NCT02678247|38969681|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
16131862|NCT01119105|38969683|FG000|Overall Study|Withdrawal by Subject|1|||
16131863|NCT01119105|38969684|FG001|Overall Study|Withdrawal by Subject|1|||
16131864|NCT01119105|38969685|FG002|Overall Study|Withdrawal by Subject|1|||
16131865|NCT01119105|38969683|FG000|Overall Study|Lost to Follow-up|0|||
16131866|NCT01119105|38969684|FG001|Overall Study|Lost to Follow-up|2|||
16131867|NCT01119105|38969685|FG002|Overall Study|Lost to Follow-up|5|||
16131868|NCT01119105|38969683|FG000|Overall Study|Adverse Event|1|||
16361936|NCT01963611|39811848|FG001|Overall Study|Adverse Event|1|||
16361937|NCT01963611|39811849|FG002|Overall Study|Adverse Event|3|||
16361938|NCT01963611|39811850|FG003|Overall Study|Adverse Event|4|||
16361939|NCT01963611|39811851|FG004|Overall Study|Adverse Event|3|||
16361940|NCT01963611|39811847|FG000|Overall Study|Protocol Violation|0|||
16361941|NCT01963611|39811848|FG001|Overall Study|Protocol Violation|0|||
16361942|NCT01963611|39811849|FG002|Overall Study|Protocol Violation|0|||
16361943|NCT01963611|39811850|FG003|Overall Study|Protocol Violation|1|||
16361944|NCT01963611|39811851|FG004|Overall Study|Protocol Violation|0|||
16361945|NCT01963611|39811847|FG000|Overall Study|Lack of Efficacy|0|||
16361946|NCT01963611|39811848|FG001|Overall Study|Lack of Efficacy|0|||
16433168|NCT03400852|40064336|FG002|Open Label Period|Study terminated by sponsor|21|||
16131869|NCT01119105|38969684|FG001|Overall Study|Adverse Event|0|||
16361947|NCT01963611|39811849|FG002|Overall Study|Lack of Efficacy|0|||
16433169|NCT03683173|40064337|FG000|Completed Follow-up|Unavailable|235|||
16131870|NCT01119105|38969685|FG002|Overall Study|Adverse Event|1|||
16131871|NCT01119105|38969683|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
16131872|NCT01119105|38969684|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
16361948|NCT01963611|39811850|FG003|Overall Study|Lack of Efficacy|1|||
16361949|NCT01963611|39811851|FG004|Overall Study|Lack of Efficacy|0|||
16250741|NCT01952574|39400621|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
16250742|NCT01952574|39400622|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
16250743|NCT01952574|39400623|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
16250744|NCT01952574|39400617|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
16433170|NCT03683173|40064338|FG001|Completed Follow-up|Unavailable|217|||
16433171|NCT03683173|40064337|FG000|Completed Follow-up|Refused|69|||
16433172|NCT03683173|40064338|FG001|Completed Follow-up|Refused|59|||
16433173|NCT03683173|40064337|FG000|Completed Follow-up|Disconnected phone|65|||
16433174|NCT03683173|40064338|FG001|Completed Follow-up|Disconnected phone|95|||
16433175|NCT03683173|40064337|FG000|Completed Follow-up|Health issue/deceased|10|||
16433176|NCT03683173|40064338|FG001|Completed Follow-up|Health issue/deceased|4|||
16433177|NCT03683173|40064337|FG000|Completed Follow-up|Moved away|8|||
16433178|NCT03683173|40064338|FG001|Completed Follow-up|Moved away|1|||
16433179|NCT02871635|40064339|FG000|Overall Study|Primary lack of efficacy|4|||
16433180|NCT02871635|40064340|FG001|Overall Study|Primary lack of efficacy|4|||
16433181|NCT02871635|40064339|FG000|Overall Study|Protocol Violation|3|||
16433182|NCT02871635|40064340|FG001|Overall Study|Protocol Violation|1|||
16433183|NCT02871635|40064339|FG000|Overall Study|Lost to Follow-up|1|||
16433184|NCT02871635|40064340|FG001|Overall Study|Lost to Follow-up|2|||
16433185|NCT02871635|40064339|FG000|Overall Study|Pregnancy|0|||
16433186|NCT02871635|40064340|FG001|Overall Study|Pregnancy|2|||
16433187|NCT02871635|40064339|FG000|Overall Study|Physician Decision|1|||
16433188|NCT02871635|40064340|FG001|Overall Study|Physician Decision|1|||
16433189|NCT02871635|40064339|FG000|Overall Study|Withdrawal by Subject|3|||
16433190|NCT02871635|40064340|FG001|Overall Study|Withdrawal by Subject|4|||
16433191|NCT02871635|40064339|FG000|Overall Study|Adverse Event|4|||
16433192|NCT02871635|40064340|FG001|Overall Study|Adverse Event|4|||
16433193|NCT02871635|40064339|FG000|Overall Study|Secondary lack of efficacy|2|||
16433194|NCT02871635|40064340|FG001|Overall Study|Secondary lack of efficacy|1|||
16131873|NCT01119105|38969685|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
16131874|NCT01119105|38969683|FG000|Overall Study|Other|1|||
16131875|NCT01119105|38969684|FG001|Overall Study|Other|1|||
16131876|NCT01119105|38969685|FG002|Overall Study|Other|0|||
16131877|NCT01942785|38969695|FG000|Overall Study|Adverse Event|2|||
16131878|NCT01942785|38969695|FG000|Overall Study|Withdrawal by Subject|1|||
16250745|NCT01952574|39400618|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
16250746|NCT01952574|39400619|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
16250747|NCT01952574|39400620|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
16250748|NCT01952574|39400621|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
16250749|NCT01952574|39400622|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
16250750|NCT01952574|39400623|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
16250751|NCT01952574|39400617|FG000|Open-label Treatment Phase|Missing|0|||
16131879|NCT01942785|38969695|FG000|Overall Study|Protocol Violation|1|||
16131880|NCT04002401|38969696|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
16131881|NCT04002401|38969696|FG000|Overall Study|Death|10|||
16131882|NCT04002401|38969696|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
16131883|NCT04002401|38969696|FG000|Overall Study|Enrolled but Never Treated|1|||
16131884|NCT04002401|38969696|FG000|Overall Study|Lost to Follow-up|1|||
16131885|NCT03038438|38969697|FG000|Overall Study|Death|3|||
16131886|NCT03038438|38969697|FG000|Overall Study|Lost to Follow-up|8|||
16250752|NCT01952574|39400618|FG001|Open-label Treatment Phase|Missing|0|||
16131887|NCT03038438|38969697|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
16131888|NCT03038438|38969697|FG000|Overall Study|Withdrawal by Subject|5|||
16131889|NCT03038438|38969697|FG000|Overall Study|No 36-Month Follow-Up|18|||
16131890|NCT01886378|38969698|FG000|Overall Study|Adverse Event|1|||
16131891|NCT01886378|38969698|FG000|Overall Study|Withdrawal by Subject|4|||
16131892|NCT01585987|38969701|FG000|Randomized|Withdrawal by Subject|0|||
16131893|NCT01585987|38969702|FG001|Randomized|Withdrawal by Subject|4|||
16131894|NCT01585987|38969701|FG000|Randomized|No longer met criteria|0|||
16131895|NCT01585987|38969702|FG001|Randomized|No longer met criteria|2|||
16131896|NCT01585987|38969701|FG000|Treated|Disease Progression|39|||
16131897|NCT01585987|38969702|FG001|Treated|Disease Progression|36|||
16131898|NCT01585987|38969701|FG000|Treated|Study Drug Toxicity|9|||
16131899|NCT01585987|38969702|FG001|Treated|Study Drug Toxicity|5|||
16131900|NCT01585987|38969701|FG000|Treated|Adverse Event|3|||
16131901|NCT01585987|38969702|FG001|Treated|Adverse Event|0|||
16131902|NCT01585987|38969701|FG000|Treated|Withdrawal by Subject|1|||
16433195|NCT01469221|40064341|FG000|Double Blind Phase|Protocol Violation|1|||
16433196|NCT01469221|40064342|FG001|Double Blind Phase|Protocol Violation|0|||
16433197|NCT01469221|40064343|FG002|Double Blind Phase|Protocol Violation|0|||
16433198|NCT01469221|40064341|FG000|Double Blind Phase|Physician Decision|1|||
16433199|NCT01469221|40064342|FG001|Double Blind Phase|Physician Decision|1|||
16433200|NCT01469221|40064343|FG002|Double Blind Phase|Physician Decision|0|||
16433201|NCT01469221|40064341|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
16433202|NCT01469221|40064342|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
16433203|NCT01469221|40064343|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
16433204|NCT03551626|40064346|FG000|Overall Study|Adverse Event|88|||
16433205|NCT03551626|40064346|FG000|Overall Study|Disease relapse|18|||
16433206|NCT03551626|40064346|FG000|Overall Study|Withdrawal of informed consent|6|||
16433207|NCT03551626|40064346|FG000|Overall Study|Patient decision|5|||
16433208|NCT03551626|40064346|FG000|Overall Study|Physician Decision|4|||
16433209|NCT03551626|40064346|FG000|Overall Study|Lost to Follow-up|3|||
16433210|NCT03551626|40064346|FG000|Overall Study|Pregnancy|1|||
16433211|NCT03551626|40064346|FG000|Overall Study|Protocol deviation|1|||
16433212|NCT03551626|40064346|FG000|Overall Study|Technical problems|1|||
16131903|NCT01585987|38969702|FG001|Treated|Withdrawal by Subject|2|||
16433213|NCT01702025|40064347|FG000|Overall Study|Equipment failure|1|||
16433214|NCT01702025|40064348|FG001|Overall Study|Equipment failure|0|||
16433215|NCT01702025|40064349|FG002|Overall Study|Equipment failure|0|||
16433216|NCT01702025|40064350|FG003|Overall Study|Equipment failure|0|||
16433217|NCT01702025|40064347|FG000|Overall Study|Adverse Event|1|||
16433218|NCT01702025|40064348|FG001|Overall Study|Adverse Event|1|||
16433219|NCT01702025|40064349|FG002|Overall Study|Adverse Event|1|||
16433220|NCT01702025|40064350|FG003|Overall Study|Adverse Event|0|||
16433221|NCT04486235|40064357|FG000|Overall Study|Pregnancy|1|||
16433222|NCT04486235|40064358|FG001|Overall Study|Pregnancy|0|||
16433223|NCT04486235|40064357|FG000|Overall Study|Lost to Follow-up|1|||
16433224|NCT04486235|40064358|FG001|Overall Study|Lost to Follow-up|0|||
16433225|NCT00700713|40064359|FG000|Overall Study|Protocol Violation|1|||
16433226|NCT00700713|40064360|FG001|Overall Study|Protocol Violation|0|||
16433227|NCT00700713|40064361|FG002|Overall Study|Protocol Violation|1|||
16433228|NCT00700713|40064359|FG000|Overall Study|Withdrawal by Subject|0|||
16433229|NCT00700713|40064360|FG001|Overall Study|Withdrawal by Subject|0|||
16433230|NCT00700713|40064361|FG002|Overall Study|Withdrawal by Subject|1|||
16433231|NCT00423657|40064362|FG000|Overall Study|Withdrew consent|10|||
16433232|NCT00423657|40064363|FG001|Overall Study|Withdrew consent|8|||
16433233|NCT00423657|40064362|FG000|Overall Study|Non-compliance|0|||
16433234|NCT00423657|40064363|FG001|Overall Study|Non-compliance|1|||
16433235|NCT00423657|40064362|FG000|Overall Study|Other|15|||
16433236|NCT00423657|40064363|FG001|Overall Study|Other|16|||
16433237|NCT00423657|40064362|FG000|Overall Study|Request of sponsor/investigator|1|||
16433238|NCT00423657|40064363|FG001|Overall Study|Request of sponsor/investigator|0|||
16433239|NCT00799266|40064373|FG000|Overall Study|Adverse Event|0|||
16433240|NCT00799266|40064374|FG001|Overall Study|Adverse Event|1|||
16433241|NCT00799266|40064373|FG000|Overall Study|Subject withdrew consent|3|||
16433242|NCT00799266|40064374|FG001|Overall Study|Subject withdrew consent|0|||
16433243|NCT01508169|40064378|FG000|Overall Study|Adverse Event|1|||
16433244|NCT01508169|40064379|FG001|Overall Study|Adverse Event|0|||
16433245|NCT01508169|40064378|FG000|Overall Study|Withdrawal by Subject|1|||
16433246|NCT01508169|40064379|FG001|Overall Study|Withdrawal by Subject|0|||
16433247|NCT01508169|40064378|FG000|Overall Study|Lost to Follow-up|1|||
16433248|NCT01508169|40064379|FG001|Overall Study|Lost to Follow-up|2|||
16433249|NCT00688259|40064380|FG000|Overall Study|Lost to Follow-up|2|||
16433250|NCT00688259|40064381|FG001|Overall Study|Lost to Follow-up|4|||
16433251|NCT00688259|40064380|FG000|Overall Study|Physician Decision|1|||
16433252|NCT00688259|40064381|FG001|Overall Study|Physician Decision|0|||
16433253|NCT00688259|40064380|FG000|Overall Study|Withdrawal by Subject|2|||
16433254|NCT00688259|40064381|FG001|Overall Study|Withdrawal by Subject|0|||
16433255|NCT00688259|40064380|FG000|Overall Study|Declined Interview|2|||
16433256|NCT00688259|40064381|FG001|Overall Study|Declined Interview|3|||
16433257|NCT00688259|40064380|FG000|Overall Study|Hospitalized at Follow-up|0|||
16433258|NCT00688259|40064381|FG001|Overall Study|Hospitalized at Follow-up|1|||
16433259|NCT02354235|40064384|FG000|Overall Study|Adverse Event|2|||
16433260|NCT02354235|40064385|FG001|Overall Study|Adverse Event|2|||
16433261|NCT02354235|40064384|FG000|Overall Study|Physician Decision|0|||
16433262|NCT02354235|40064385|FG001|Overall Study|Physician Decision|1|||
16433263|NCT02354235|40064384|FG000|Overall Study|Withdrawal by Subject|1|||
16433264|NCT02354235|40064385|FG001|Overall Study|Withdrawal by Subject|3|||
16433265|NCT02354235|40064384|FG000|Overall Study|Conflict with the stopping criteria|0|||
16433266|NCT02354235|40064385|FG001|Overall Study|Conflict with the stopping criteria|1|||
16433267|NCT00596752|40064392|FG000|Overall Study|Other Reason|44|||
16433268|NCT00596752|40064393|FG001|Overall Study|Other Reason|49|||
16433269|NCT00596752|40064392|FG000|Overall Study|Adverse Event|34|||
16433270|NCT00596752|40064393|FG001|Overall Study|Adverse Event|34|||
16433271|NCT00596752|40064392|FG000|Overall Study|Lost to Follow-up|22|||
16433272|NCT00596752|40064393|FG001|Overall Study|Lost to Follow-up|38|||
16433273|NCT00596752|40064392|FG000|Overall Study|Withdrawal by Subject|12|||
16433274|NCT00596752|40064393|FG001|Overall Study|Withdrawal by Subject|9|||
16433275|NCT00596752|40064392|FG000|Overall Study|Unsatisfactory Compliance|9|||
16433276|NCT00596752|40064393|FG001|Overall Study|Unsatisfactory Compliance|6|||
16433277|NCT00596752|40064392|FG000|Overall Study|Lack of Efficacy|4|||
16433278|NCT00596752|40064393|FG001|Overall Study|Lack of Efficacy|7|||
16433279|NCT00596752|40064392|FG000|Overall Study|Protocol Violation|1|||
16433280|NCT00596752|40064393|FG001|Overall Study|Protocol Violation|0|||
16433281|NCT03244917|40064396|FG000|Overall Study|Lost to Follow-up|2|||
16433282|NCT03244917|40064397|FG001|Overall Study|Lost to Follow-up|2|||
16433283|NCT01631435|40064398|FG000|Overall Study|Adverse Event|2|||
16433284|NCT01631435|40064398|FG000|Overall Study|Withdrawal by Subject|2|||
16433285|NCT01631435|40064398|FG000|Overall Study|incomplete study procedure|5|||
16433286|NCT01176032|40064400|FG000|Overall Study|Adverse Event|1|||
16433287|NCT01176032|40064401|FG001|Overall Study|Adverse Event|0|||
16433288|NCT01176032|40064400|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16433289|NCT01176032|40064401|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16433290|NCT01176032|40064400|FG000|Overall Study|Protocol Violation|1|||
16433291|NCT01176032|40064401|FG001|Overall Study|Protocol Violation|0|||
16433292|NCT01176032|40064400|FG000|Overall Study|Informed consent withdrawn|3|||
16433293|NCT01176032|40064401|FG001|Overall Study|Informed consent withdrawn|0|||
16433294|NCT01176032|40064400|FG000|Overall Study|Other|1|||
16433295|NCT01176032|40064401|FG001|Overall Study|Other|0|||
16433296|NCT04864639|40064402|FG000|Overall Study|Death|1|||
16433297|NCT04864639|40064402|FG000|Overall Study|Lost to Follow-up|1|||
16433298|NCT02252146|40064403|FG000|Overall Study|Lack of Efficacy|4|||
16433299|NCT02252146|40064403|FG000|Overall Study|Entered hospice care|1|||
16433300|NCT02252146|40064403|FG000|Overall Study|Inability to travel to study site|1|||
16433301|NCT04023526|40064404|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
16433302|NCT04023526|40064405|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
16433303|NCT04023526|40064404|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
16433304|NCT04023526|40064405|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
16433305|NCT00502671|40064410|FG000|Overall Study|Disease Progression|13|||
16433306|NCT00502671|40064410|FG000|Overall Study|Personal Reasons|22|||
16433307|NCT00502671|40064410|FG000|Overall Study|Lost to Follow-up|7|||
16433308|NCT00502671|40064410|FG000|Overall Study|Protocol Violation|16|||
16433309|NCT00502671|40064410|FG000|Overall Study|Adverse Event|19|||
16433310|NCT03553758|40064411|FG000|Overall Study|Lost to Follow-up|1|||
16433311|NCT03827655|40064412|FG000|Overall Study|Death|0|||
16433312|NCT03827655|40064413|FG001|Overall Study|Death|0|||
16433313|NCT03827655|40064414|FG002|Overall Study|Death|0|||
16433314|NCT03827655|40064415|FG003|Overall Study|Death|0|||
16433315|NCT03827655|40064416|FG004|Overall Study|Death|1|||
16433316|NCT03827655|40064412|FG000|Overall Study|Protocol Deviation|1|||
16433317|NCT03827655|40064413|FG001|Overall Study|Protocol Deviation|0|||
16433318|NCT03827655|40064414|FG002|Overall Study|Protocol Deviation|1|||
16433319|NCT03827655|40064415|FG003|Overall Study|Protocol Deviation|1|||
16433320|NCT03827655|40064416|FG004|Overall Study|Protocol Deviation|0|||
16433321|NCT03827655|40064412|FG000|Overall Study|Withdrawal by Subject|3|||
16433322|NCT03827655|40064413|FG001|Overall Study|Withdrawal by Subject|2|||
16433323|NCT03827655|40064414|FG002|Overall Study|Withdrawal by Subject|2|||
16433324|NCT03827655|40064415|FG003|Overall Study|Withdrawal by Subject|0|||
16433325|NCT03827655|40064416|FG004|Overall Study|Withdrawal by Subject|1|||
16433326|NCT03827655|40064412|FG000|Overall Study|Reason not Specified|3|||
16433327|NCT03827655|40064413|FG001|Overall Study|Reason not Specified|1|||
16433328|NCT03827655|40064414|FG002|Overall Study|Reason not Specified|1|||
16433329|NCT03827655|40064415|FG003|Overall Study|Reason not Specified|1|||
16433330|NCT03827655|40064416|FG004|Overall Study|Reason not Specified|1|||
16433331|NCT02913482|40064423|FG000|Overall Study|Death|0|||
16433332|NCT02913482|40064424|FG001|Overall Study|Death|2|||
16433333|NCT02913482|40064425|FG002|Overall Study|Death|2|||
16433334|NCT02913482|40064423|FG000|Overall Study|Progressive Disease|1|||
16433335|NCT02913482|40064424|FG001|Overall Study|Progressive Disease|1|||
16433336|NCT02913482|40064425|FG002|Overall Study|Progressive Disease|1|||
16433337|NCT02913482|40064423|FG000|Overall Study|Reason not specified|0|||
16433338|NCT02913482|40064424|FG001|Overall Study|Reason not specified|0|||
16433339|NCT02913482|40064425|FG002|Overall Study|Reason not specified|1|||
16131904|NCT01585987|38969701|FG000|Treated|Death|1|||
16131905|NCT01585987|38969702|FG001|Treated|Death|0|||
16131906|NCT01585987|38969701|FG000|Treated|Lost to Follow-up|0|||
16131907|NCT01585987|38969702|FG001|Treated|Lost to Follow-up|1|||
16131908|NCT01585987|38969701|FG000|Treated|Maximum Clinical Benefit|0|||
16250753|NCT01952574|39400619|FG002|Open-label Treatment Phase|Missing|0|||
16433340|NCT02913482|40064423|FG000|Overall Study|Withdrawal by Subject|0|||
16433341|NCT02913482|40064424|FG001|Overall Study|Withdrawal by Subject|1|||
16433342|NCT02913482|40064425|FG002|Overall Study|Withdrawal by Subject|1|||
16433343|NCT04073186|40064428|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
16433344|NCT04073186|40064428|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
16433345|NCT04073186|40064428|FG000|First Wearing Cycle|Protocol Violation|1|||
16433346|NCT04073186|40064428|FG000|First Wearing Cycle|Lens Discomfort|2|||
16433347|NCT04073186|40064428|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
16433348|NCT04073186|40064428|FG000|Second Wearing Cycle|Adverse Event|1|||
16433349|NCT02738008|40064432|FG000|Overall Study|Study Terminated by Sponsor|1|||
16433350|NCT02738008|40064433|FG001|Overall Study|Study Terminated by Sponsor|5|||
16433351|NCT02738008|40064434|FG002|Overall Study|Study Terminated by Sponsor|3|||
16433352|NCT02738008|40064432|FG000|Overall Study|Adverse Event|0|||
16361950|NCT01963611|39811847|FG000|Overall Study|Withdrawal by Subject|3|||
16361951|NCT01963611|39811848|FG001|Overall Study|Withdrawal by Subject|2|||
16361952|NCT01963611|39811849|FG002|Overall Study|Withdrawal by Subject|1|||
16361953|NCT01963611|39811850|FG003|Overall Study|Withdrawal by Subject|1|||
16361954|NCT01963611|39811851|FG004|Overall Study|Withdrawal by Subject|3|||
16433353|NCT02738008|40064433|FG001|Overall Study|Adverse Event|1|||
16131909|NCT01585987|38969702|FG001|Treated|Maximum Clinical Benefit|1|||
16131910|NCT01585987|38969701|FG000|Treated|Non-Specified|1|||
16131911|NCT01585987|38969702|FG001|Treated|Non-Specified|2|||
16131912|NCT01585987|38969701|FG000|Treated|Subject Request|0|||
16131913|NCT01585987|38969702|FG001|Treated|Subject Request|1|||
16361955|NCT01963611|39811847|FG000|Overall Study|Other|47|||
16131914|NCT01585987|38969701|FG000|Treated|Poor/Non-Compliance|0|||
16131915|NCT01585987|38969702|FG001|Treated|Poor/Non-Compliance|1|||
16131916|NCT01439360|38969703|FG000|Overall Study|Adverse Event|4|||
16131917|NCT01439360|38969704|FG001|Overall Study|Adverse Event|16|||
16131918|NCT01439360|38969703|FG000|Overall Study|Lost to Follow-up|43|||
16131919|NCT01439360|38969704|FG001|Overall Study|Lost to Follow-up|58|||
16131920|NCT01439360|38969703|FG000|Overall Study|Others|10|||
16131921|NCT01439360|38969704|FG001|Overall Study|Others|5|||
16131922|NCT01439360|38969703|FG000|Overall Study|Protocol Violation|1|||
16361956|NCT01963611|39811848|FG001|Overall Study|Other|46|||
16433354|NCT02738008|40064434|FG002|Overall Study|Adverse Event|2|||
16433355|NCT03863509|40064435|FG000|Overall Study|COVID-19 shutdown period|0|||
16433356|NCT03863509|40064436|FG001|Overall Study|COVID-19 shutdown period|4|||
16433357|NCT03863509|40064437|FG002|Overall Study|COVID-19 shutdown period|0|||
16433358|NCT03863509|40064435|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
16433359|NCT03863509|40064436|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
16433360|NCT03863509|40064437|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
16433361|NCT03863509|40064435|FG000|Overall Study|Lost to Follow-up|8|||
16433362|NCT03863509|40064436|FG001|Overall Study|Lost to Follow-up|0|||
16433363|NCT03863509|40064437|FG002|Overall Study|Lost to Follow-up|2|||
16433364|NCT03863509|40064435|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
16433365|NCT03863509|40064436|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
16433366|NCT03863509|40064437|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
16433367|NCT03863509|40064435|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
16433368|NCT03863509|40064436|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
16433369|NCT03863509|40064437|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
16433370|NCT01363700|40064438|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
16433371|NCT01363700|40064439|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
16433372|NCT01363700|40064440|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
16433373|NCT01363700|40064441|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
16433374|NCT01363700|40064442|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
16433375|NCT01745367|40064443|FG000|Overall Study|Death|1|||
16433376|NCT01745367|40064444|FG001|Overall Study|Death|0|||
16433377|NCT01745367|40064443|FG000|Overall Study|Withdrawal by Subject|1|||
16433378|NCT01745367|40064444|FG001|Overall Study|Withdrawal by Subject|2|||
16433379|NCT01745367|40064443|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
16433380|NCT01745367|40064444|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
16433381|NCT01745367|40064443|FG000|Overall Study|Other Reasons Unspecified|0|||
16433382|NCT01745367|40064444|FG001|Overall Study|Other Reasons Unspecified|2|||
16433383|NCT00474955|40064447|FG000|Overall Study|Adverse Event|2|||
16433384|NCT00474955|40064447|FG000|Overall Study|Drug unavailability|1|||
16433385|NCT00474955|40064447|FG000|Overall Study|Personal reasons|5|||
16433386|NCT01597635|40064448|FG000|Part A|Adverse Event|3|||
16433387|NCT01597635|40064449|FG001|Part A|Adverse Event|0|||
16433388|NCT01597635|40064450|FG002|Part A|Adverse Event|0|||
16433389|NCT01597635|40064448|FG000|Part B|Adverse Event|0|||
16433390|NCT01597635|40064449|FG001|Part B|Adverse Event|0|||
16433391|NCT01597635|40064450|FG002|Part B|Adverse Event|1|||
16433392|NCT01597635|40064448|FG000|Part B|Protocol Violation|0|||
16433393|NCT01597635|40064449|FG001|Part B|Protocol Violation|1|||
16433394|NCT01597635|40064450|FG002|Part B|Protocol Violation|0|||
16433395|NCT01597635|40064448|FG000|Part B|Protocol-defined stopping criteria|0|||
16433396|NCT01597635|40064449|FG001|Part B|Protocol-defined stopping criteria|4|||
16433397|NCT01597635|40064450|FG002|Part B|Protocol-defined stopping criteria|3|||
16433398|NCT01597635|40064448|FG000|Part B|Withdrawal by Subject|0|||
16433399|NCT01597635|40064449|FG001|Part B|Withdrawal by Subject|1|||
16433400|NCT01597635|40064450|FG002|Part B|Withdrawal by Subject|0|||
16433401|NCT01485094|40064452|FG000|Overall Study|Adverse Event|1|||
16433402|NCT01485094|40064453|FG001|Overall Study|Adverse Event|1|||
16433403|NCT01485094|40064454|FG002|Overall Study|Adverse Event|1|||
16433404|NCT01485094|40064452|FG000|Overall Study|Lost to Follow-up|1|||
16433405|NCT01485094|40064453|FG001|Overall Study|Lost to Follow-up|0|||
16433406|NCT01485094|40064454|FG002|Overall Study|Lost to Follow-up|0|||
16433407|NCT01485094|40064452|FG000|Overall Study|Withdrawal by Subject|1|||
16433408|NCT01485094|40064453|FG001|Overall Study|Withdrawal by Subject|1|||
16433409|NCT01485094|40064454|FG002|Overall Study|Withdrawal by Subject|0|||
16433410|NCT03016312|40064456|FG000|Overall Study|discontinued before the treatment started|0|||
16433411|NCT03016312|40064457|FG001|Overall Study|discontinued before the treatment started|1|||
16433412|NCT03016312|40064456|FG000|Overall Study|Withdrawal by Subject|37|||
16433413|NCT03016312|40064457|FG001|Overall Study|Withdrawal by Subject|44|||
16433414|NCT03016312|40064456|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
16433415|NCT03016312|40064457|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
16131923|NCT01439360|38969704|FG001|Overall Study|Protocol Violation|0|||
16131924|NCT01439360|38969703|FG000|Overall Study|Withdrawal by Subject|140|||
16131925|NCT01439360|38969704|FG001|Overall Study|Withdrawal by Subject|129|||
16131926|NCT03291587|38969705|FG000|Overall Study|Lost to Follow-up|62|||
16361957|NCT01963611|39811849|FG002|Overall Study|Other|48|||
16361958|NCT01963611|39811850|FG003|Overall Study|Other|45|||
16361959|NCT01963611|39811851|FG004|Overall Study|Other|45|||
16361960|NCT01047319|39811852|FG000|Overall Study|Teva requested participant withdrawal|3|||
16361961|NCT01047319|39811853|FG001|Overall Study|Teva requested participant withdrawal|0|||
16361962|NCT01047319|39811854|FG002|Overall Study|Teva requested participant withdrawal|1|||
16361963|NCT01047319|39811852|FG000|Overall Study|Protocol Violation|3|||
16361964|NCT01047319|39811853|FG001|Overall Study|Protocol Violation|2|||
16361965|NCT01047319|39811854|FG002|Overall Study|Protocol Violation|4|||
16361966|NCT01047319|39811852|FG000|Overall Study|Lack of Efficacy|4|||
16361967|NCT01047319|39811853|FG001|Overall Study|Lack of Efficacy|3|||
16361968|NCT01047319|39811854|FG002|Overall Study|Lack of Efficacy|3|||
16361969|NCT01047319|39811852|FG000|Overall Study|Death|5|||
16361970|NCT01047319|39811853|FG001|Overall Study|Death|1|||
16361971|NCT01047319|39811854|FG002|Overall Study|Death|5|||
16361972|NCT01047319|39811852|FG000|Overall Study|Pregnancy|13|||
16361973|NCT01047319|39811853|FG001|Overall Study|Pregnancy|8|||
16361974|NCT01047319|39811854|FG002|Overall Study|Pregnancy|8|||
16361975|NCT01047319|39811852|FG000|Overall Study|Physician Decision|12|||
16361976|NCT01047319|39811853|FG001|Overall Study|Physician Decision|9|||
16361977|NCT01047319|39811854|FG002|Overall Study|Physician Decision|10|||
16361978|NCT01047319|39811852|FG000|Overall Study|Lost to Follow-up|14|||
16361979|NCT01047319|39811853|FG001|Overall Study|Lost to Follow-up|10|||
16361980|NCT01047319|39811854|FG002|Overall Study|Lost to Follow-up|10|||
16361981|NCT01047319|39811852|FG000|Overall Study|Adverse Event|16|||
16361982|NCT01047319|39811853|FG001|Overall Study|Adverse Event|27|||
16361983|NCT01047319|39811854|FG002|Overall Study|Adverse Event|21|||
16361984|NCT01047319|39811852|FG000|Overall Study|Withdrawal by Subject|77|||
16361985|NCT01047319|39811853|FG001|Overall Study|Withdrawal by Subject|75|||
16361986|NCT01047319|39811854|FG002|Overall Study|Withdrawal by Subject|87|||
16361987|NCT01047319|39811852|FG000|Overall Study|Study terminated by Sponsor|198|||
16361988|NCT01047319|39811853|FG001|Overall Study|Study terminated by Sponsor|215|||
16361989|NCT01047319|39811854|FG002|Overall Study|Study terminated by Sponsor|203|||
16361990|NCT00118287|39811855|FG000|Overall Study|Intracranial haemorrhage|1|||
16361991|NCT00118287|39811855|FG000|Overall Study|Muscle pain|1|||
16361992|NCT03587636|39811856|FG000|Overall Study|Lost to Follow-up|2|||
16361993|NCT03587636|39811857|FG001|Overall Study|Lost to Follow-up|5|||
16361994|NCT00903201|39811858|FG000|Overall Study|Adverse Event|1|||
16361995|NCT00903201|39811859|FG001|Overall Study|Adverse Event|4|||
16361996|NCT00903201|39811860|FG002|Overall Study|Adverse Event|0|||
16361997|NCT00903201|39811858|FG000|Overall Study|Protocol Violation|2|||
16361998|NCT00903201|39811859|FG001|Overall Study|Protocol Violation|1|||
16361999|NCT00903201|39811860|FG002|Overall Study|Protocol Violation|0|||
16362000|NCT00903201|39811858|FG000|Overall Study|Lost to Follow-up|0|||
16362001|NCT00903201|39811859|FG001|Overall Study|Lost to Follow-up|1|||
16362002|NCT00903201|39811860|FG002|Overall Study|Lost to Follow-up|0|||
16362003|NCT00903201|39811858|FG000|Overall Study|Physician Decision|1|||
16362004|NCT00903201|39811859|FG001|Overall Study|Physician Decision|0|||
16362005|NCT00903201|39811860|FG002|Overall Study|Physician Decision|1|||
16362006|NCT00903201|39811858|FG000|Overall Study|Withdrawal by Subject|1|||
16362007|NCT00903201|39811859|FG001|Overall Study|Withdrawal by Subject|0|||
16362008|NCT00903201|39811860|FG002|Overall Study|Withdrawal by Subject|1|||
16362009|NCT00484159|39811868|FG000|Overall Study|Lost to Follow-up|1|||
16362010|NCT00484159|39811869|FG001|Overall Study|Lost to Follow-up|1|||
16362011|NCT00484159|39811870|FG002|Overall Study|Lost to Follow-up|0|||
16362012|NCT00662259|39811871|FG000|Overall Study|Adverse Event|2|||
16362013|NCT00662259|39811872|FG001|Overall Study|Adverse Event|0|||
16362014|NCT00548327|39811873|FG000|Overall Study|Adverse Event|0|||
16362015|NCT00548327|39811874|FG001|Overall Study|Adverse Event|1|||
16362016|NCT00849056|39811882|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
16362017|NCT00849056|39811883|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
16362018|NCT00849056|39811882|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
16362019|NCT00849056|39811883|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
16362020|NCT00849056|39811882|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
16362021|NCT00849056|39811883|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
16362022|NCT00849056|39811882|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
16362023|NCT00849056|39811883|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
16362024|NCT00849056|39811882|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
16362025|NCT00849056|39811883|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
16362026|NCT00849056|39811882|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
16362027|NCT00849056|39811883|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
16362028|NCT00849056|39811882|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
16362029|NCT00849056|39811883|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
16362030|NCT00849056|39811882|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
16362031|NCT00849056|39811883|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
16362032|NCT00849056|39811882|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
16362033|NCT00849056|39811883|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
16362034|NCT00849056|39811882|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
16362035|NCT00849056|39811883|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
16362036|NCT00849056|39811882|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
16362037|NCT00849056|39811883|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
16362038|NCT00849056|39811882|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
16362039|NCT00849056|39811883|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
16362040|NCT00849056|39811882|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
16362041|NCT00849056|39811883|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
16131927|NCT03291587|38969706|FG001|Overall Study|Lost to Follow-up|43|||
16131928|NCT03291587|38969705|FG000|Overall Study|Refused to Answer|5|||
16131929|NCT03291587|38969706|FG001|Overall Study|Refused to Answer|2|||
16131930|NCT03291587|38969705|FG000|Overall Study|Death|2|||
16131931|NCT03291587|38969706|FG001|Overall Study|Death|4|||
16131932|NCT03291587|38969705|FG000|Overall Study|Not interested in participating|8|||
16131933|NCT03291587|38969706|FG001|Overall Study|Not interested in participating|6|||
16131934|NCT03291587|38969705|FG000|Overall Study|Too busy to participate|4|||
16131935|NCT03291587|38969706|FG001|Overall Study|Too busy to participate|2|||
16131936|NCT00901186|38969707|FG000|Overall Study|Lack of Efficacy|0|||
16131937|NCT00901186|38969708|FG001|Overall Study|Lack of Efficacy|1|||
16131938|NCT00901186|38969707|FG000|Overall Study|Abnormal laboratory values|0|||
16131939|NCT00901186|38969708|FG001|Overall Study|Abnormal laboratory values|1|||
16131940|NCT00901186|38969707|FG000|Overall Study|Lost to Follow-up|2|||
16131941|NCT00901186|38969708|FG001|Overall Study|Lost to Follow-up|0|||
16131942|NCT00901186|38969707|FG000|Overall Study|Adverse Event|2|||
16131943|NCT00901186|38969708|FG001|Overall Study|Adverse Event|4|||
16131944|NCT00901186|38969707|FG000|Overall Study|Administration problems|0|||
16131945|NCT00901186|38969708|FG001|Overall Study|Administration problems|1|||
16131946|NCT00901186|38969707|FG000|Overall Study|Protocol deviations|5|||
16362042|NCT00849056|39811882|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
16362043|NCT00849056|39811883|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
16362044|NCT00849056|39811882|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
16131947|NCT00901186|38969708|FG001|Overall Study|Protocol deviations|4|||
16131948|NCT02578862|38969709|FG000|Overall Study|Withdrawal by Subject|0|||
16131949|NCT02578862|38969710|FG001|Overall Study|Withdrawal by Subject|1|||
16131950|NCT02578862|38969709|FG000|Overall Study|Unplanned unilateral procedure|0|||
16131951|NCT02578862|38969710|FG001|Overall Study|Unplanned unilateral procedure|1|||
16131952|NCT02029846|38969713|FG000|Overall Study|n=1 each arm|1|||
16131953|NCT02029846|38969714|FG001|Overall Study|n=1 each arm|1|||
16131954|NCT01009580|38969720|FG000|Overall Study|Adverse Event|4|||
16131955|NCT01009580|38969721|FG001|Overall Study|Adverse Event|4|||
16131956|NCT01009580|38969720|FG000|Overall Study|Lack of Efficacy|0|||
16131957|NCT01009580|38969721|FG001|Overall Study|Lack of Efficacy|1|||
16131958|NCT01009580|38969720|FG000|Overall Study|Protocol Violation|2|||
16131959|NCT01009580|38969721|FG001|Overall Study|Protocol Violation|3|||
16131960|NCT01009580|38969720|FG000|Overall Study|Withdrawal Criteria|4|||
16131961|NCT01009580|38969721|FG001|Overall Study|Withdrawal Criteria|6|||
16131962|NCT01009580|38969720|FG000|Overall Study|Unclassified|17|||
16131963|NCT01009580|38969721|FG001|Overall Study|Unclassified|21|||
16131964|NCT01411215|38969724|FG000|Overall Study|Adverse Event|1|||
16131965|NCT01411215|38969725|FG001|Overall Study|Adverse Event|2|||
16131966|NCT01411215|38969724|FG000|Overall Study|Lack of Efficacy|2|||
16131967|NCT01411215|38969725|FG001|Overall Study|Lack of Efficacy|4|||
16131968|NCT01411215|38969724|FG000|Overall Study|Lost to Follow-up|12|||
16131969|NCT01411215|38969725|FG001|Overall Study|Lost to Follow-up|18|||
16131970|NCT01411215|38969724|FG000|Overall Study|Did not meet entrance criteria|0|||
16433416|NCT03016312|40064456|FG000|Overall Study|Physician Decision|1|||
16433417|NCT03016312|40064457|FG001|Overall Study|Physician Decision|3|||
16433418|NCT03016312|40064456|FG000|Overall Study|Lost to Follow-up|12|||
16433419|NCT03016312|40064457|FG001|Overall Study|Lost to Follow-up|12|||
16433420|NCT03016312|40064456|FG000|Overall Study|Death|210|||
16433421|NCT03016312|40064457|FG001|Overall Study|Death|184|||
16433422|NCT03016312|40064456|FG000|Overall Study|loss to contact|1|||
16433423|NCT03016312|40064457|FG001|Overall Study|loss to contact|0|||
16433424|NCT03016312|40064456|FG000|Overall Study|started a new cancer therapy|1|||
16433425|NCT03016312|40064457|FG001|Overall Study|started a new cancer therapy|0|||
16433426|NCT03347123|40064458|FG000|Overall Study|Death|1|||
16433427|NCT03347123|40064459|FG001|Overall Study|Death|2|||
16131971|NCT01411215|38969725|FG001|Overall Study|Did not meet entrance criteria|1|||
16131972|NCT01411215|38969724|FG000|Overall Study|Study terminated by sponsor|2|||
16131973|NCT01411215|38969725|FG001|Overall Study|Study terminated by sponsor|15|||
16131974|NCT01411215|38969724|FG000|Overall Study|Protocol Violation|3|||
16131975|NCT01411215|38969725|FG001|Overall Study|Protocol Violation|5|||
16131976|NCT01411215|38969724|FG000|Overall Study|Withdrawal by Subject|34|||
16131977|NCT01411215|38969725|FG001|Overall Study|Withdrawal by Subject|21|||
16131978|NCT01411215|38969724|FG000|Overall Study|Other|12|||
16131979|NCT01411215|38969725|FG001|Overall Study|Other|17|||
16131980|NCT01411215|38969724|FG000|Overall Study|Screen failure|0|||
16131981|NCT01411215|38969725|FG001|Overall Study|Screen failure|1|||
16131982|NCT04675151|38969728|FG000|Overall Study|Protocol Violation|1|||
16131983|NCT04675151|38969729|FG001|Overall Study|Protocol Violation|0|||
16131984|NCT04675151|38969730|FG002|Overall Study|Protocol Violation|0|||
16131985|NCT04675151|38969731|FG003|Overall Study|Protocol Violation|1|||
16131986|NCT01744392|38969733|FG000|Overall Study|Physician Decision|1|||
16131987|NCT02354508|38969740|FG000|Period 1: Core Phase|Adverse Event|1|||
16131988|NCT02354508|38969741|FG001|Period 1: Core Phase|Adverse Event|1|||
16131989|NCT02354508|38969742|FG002|Period 1: Core Phase|Adverse Event|2|||
16131990|NCT02354508|38969740|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
16131991|NCT02354508|38969741|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
16131992|NCT02354508|38969742|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
16131993|NCT02354508|38969740|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
16131994|NCT02354508|38969741|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
16131995|NCT02354508|38969742|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
16250754|NCT01952574|39400620|FG003|Open-label Treatment Phase|Missing|0|||
16250755|NCT01952574|39400621|FG004|Open-label Treatment Phase|Missing|4|||
16250756|NCT01952574|39400622|FG005|Open-label Treatment Phase|Missing|0|||
16250757|NCT01952574|39400623|FG006|Open-label Treatment Phase|Missing|0|||
16250758|NCT01952574|39400617|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
16131996|NCT02354508|38969740|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
16131997|NCT02354508|38969741|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
16131998|NCT02354508|38969742|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
16250759|NCT01952574|39400618|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
16250760|NCT01952574|39400619|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
16250761|NCT01952574|39400620|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
16250762|NCT01952574|39400621|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
16250763|NCT01952574|39400622|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
16250764|NCT01952574|39400623|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
16250765|NCT01952574|39400617|FG000|Open-label Treatment Phase|Death|0|||
16250766|NCT01952574|39400618|FG001|Open-label Treatment Phase|Death|0|||
16250767|NCT01952574|39400619|FG002|Open-label Treatment Phase|Death|0|||
16250768|NCT01952574|39400620|FG003|Open-label Treatment Phase|Death|0|||
16250769|NCT01952574|39400621|FG004|Open-label Treatment Phase|Death|1|||
16250770|NCT01952574|39400622|FG005|Open-label Treatment Phase|Death|0|||
16250771|NCT01952574|39400623|FG006|Open-label Treatment Phase|Death|0|||
16250772|NCT01952574|39400617|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
16250773|NCT01952574|39400618|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
16250774|NCT01952574|39400619|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
16250775|NCT01952574|39400620|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
16131999|NCT02354508|38969740|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
16250776|NCT01952574|39400621|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
16250777|NCT01952574|39400622|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
16250778|NCT01952574|39400623|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
16433428|NCT03347123|40064460|FG002|Overall Study|Death|0|||
16132000|NCT02354508|38969741|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
16132001|NCT02354508|38969742|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
16132002|NCT02354508|38969740|FG000|Period 2: Extension Phase|Physician Decision|5|||
16132003|NCT02354508|38969741|FG001|Period 2: Extension Phase|Physician Decision|0|||
16132004|NCT02354508|38969742|FG002|Period 2: Extension Phase|Physician Decision|1|||
16132005|NCT02354508|38969740|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
16132006|NCT02354508|38969741|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
16132007|NCT02354508|38969742|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
16132008|NCT02354508|38969740|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
16132009|NCT02354508|38969741|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
16132010|NCT02354508|38969742|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
16132011|NCT02354508|38969740|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
16132012|NCT02354508|38969741|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
16132013|NCT02354508|38969742|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
16132014|NCT01226095|38969743|FG000|Overall Study|Poor compliance|1|||
16132015|NCT02175004|38969748|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
16132016|NCT02175004|38969749|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
16132017|NCT02175004|38969748|FG000|Overall Study|Investigator Judgment|1|||
16132018|NCT02175004|38969749|FG001|Overall Study|Investigator Judgment|4|||
16132019|NCT02175004|38969748|FG000|Overall Study|Voluntary Withdrawal|6|||
16132020|NCT02175004|38969749|FG001|Overall Study|Voluntary Withdrawal|19|||
16132021|NCT02175004|38969748|FG000|Overall Study|Liver Transplant|1|||
16132022|NCT02175004|38969749|FG001|Overall Study|Liver Transplant|0|||
16132023|NCT02175004|38969748|FG000|Overall Study|Disease Progression|1|||
16132024|NCT02175004|38969749|FG001|Overall Study|Disease Progression|0|||
16132025|NCT02175004|38969748|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
16132026|NCT02175004|38969749|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
16132027|NCT00591370|38969750|FG000|Overall Study|Not Treated|2|||
16132028|NCT01209143|38972825|FG000|Overall Study|Adverse Event|2|||
16132029|NCT01209143|38972826|FG001|Overall Study|Adverse Event|1|||
16132030|NCT01209143|38972825|FG000|Overall Study|Death|0|||
16132031|NCT01209143|38972826|FG001|Overall Study|Death|1|||
16132032|NCT01209143|38972825|FG000|Overall Study|Physician Decision|3|||
16132033|NCT01209143|38972826|FG001|Overall Study|Physician Decision|1|||
16132034|NCT01209143|38972825|FG000|Overall Study|Lost to Follow-up|1|||
16132035|NCT01209143|38972826|FG001|Overall Study|Lost to Follow-up|0|||
16132036|NCT01209143|38972825|FG000|Overall Study|Withdrawal by Subject|2|||
16132037|NCT01209143|38972826|FG001|Overall Study|Withdrawal by Subject|1|||
16132038|NCT01209143|38972825|FG000|Overall Study|Disease progression|11|||
16132039|NCT01209143|38972826|FG001|Overall Study|Disease progression|16|||
16132040|NCT03587974|38972827|FG000|Overall Study|caregiver demented, care recipient died|3|||
16132041|NCT03587974|38972828|FG001|Overall Study|caregiver demented, care recipient died|3|||
16433429|NCT03347123|40064461|FG003|Overall Study|Death|0|||
16433430|NCT03347123|40064462|FG004|Overall Study|Death|0|||
16433431|NCT03347123|40064463|FG005|Overall Study|Death|0|||
16433432|NCT03347123|40064464|FG006|Overall Study|Death|0|||
16433433|NCT03347123|40064458|FG000|Overall Study|Withdrawal by Subject|1|||
16433434|NCT03347123|40064459|FG001|Overall Study|Withdrawal by Subject|0|||
16433435|NCT03347123|40064460|FG002|Overall Study|Withdrawal by Subject|0|||
16433436|NCT03347123|40064461|FG003|Overall Study|Withdrawal by Subject|0|||
16433437|NCT03347123|40064462|FG004|Overall Study|Withdrawal by Subject|0|||
16433438|NCT03347123|40064463|FG005|Overall Study|Withdrawal by Subject|0|||
16433439|NCT03347123|40064464|FG006|Overall Study|Withdrawal by Subject|0|||
16433440|NCT03347123|40064458|FG000|Overall Study|Reason not Specified|3|||
16433441|NCT03347123|40064459|FG001|Overall Study|Reason not Specified|4|||
16433442|NCT03347123|40064460|FG002|Overall Study|Reason not Specified|0|||
16433443|NCT03347123|40064461|FG003|Overall Study|Reason not Specified|0|||
16433444|NCT03347123|40064462|FG004|Overall Study|Reason not Specified|0|||
16433445|NCT03347123|40064463|FG005|Overall Study|Reason not Specified|0|||
16433446|NCT03347123|40064464|FG006|Overall Study|Reason not Specified|0|||
16433447|NCT03826186|40064470|FG000|Overall Study|Protocol Violation|2|||
16433448|NCT03826186|40064471|FG001|Overall Study|Protocol Violation|0|||
16433449|NCT03826186|40064470|FG000|Overall Study|Withdrawal by Subject|1|||
16433450|NCT03826186|40064471|FG001|Overall Study|Withdrawal by Subject|0|||
16433451|NCT03828617|40064474|FG000|Overall Study|Lost to Follow-up|22|||
16433452|NCT03828617|40064475|FG001|Overall Study|Lost to Follow-up|12|||
16433453|NCT03828617|40064476|FG002|Overall Study|Lost to Follow-up|23|||
16433454|NCT03828617|40064477|FG003|Overall Study|Lost to Follow-up|7|||
16433455|NCT03828617|40064474|FG000|Overall Study|No longer met eligibility criteria|0|||
16433456|NCT03828617|40064475|FG001|Overall Study|No longer met eligibility criteria|1|||
16433457|NCT03828617|40064476|FG002|Overall Study|No longer met eligibility criteria|1|||
16433458|NCT03828617|40064477|FG003|Overall Study|No longer met eligibility criteria|3|||
16433459|NCT03828617|40064474|FG000|Overall Study|Protocol Violation|0|||
16433460|NCT03828617|40064475|FG001|Overall Study|Protocol Violation|2|||
16433461|NCT03828617|40064476|FG002|Overall Study|Protocol Violation|0|||
16433462|NCT03828617|40064477|FG003|Overall Study|Protocol Violation|0|||
16433463|NCT03828617|40064474|FG000|Overall Study|Withdrawal by Subject|2|||
16433464|NCT03828617|40064475|FG001|Overall Study|Withdrawal by Subject|0|||
16433465|NCT03828617|40064476|FG002|Overall Study|Withdrawal by Subject|2|||
16433466|NCT03828617|40064477|FG003|Overall Study|Withdrawal by Subject|0|||
16433467|NCT00684996|40064480|FG000|Overall Study|Adverse Event|1|||
16433468|NCT00684996|40064480|FG000|Overall Study|Refusal unrelated to adverse event|1|||
16433469|NCT00684996|40064480|FG000|Overall Study|Progression/relapse|2|||
16433470|NCT00684996|40064480|FG000|Overall Study|Other reasons not protocol specified|1|||
16433471|NCT00165672|40064481|FG000|Overall Study|Adverse Event|0|||
16433472|NCT00165672|40064482|FG001|Overall Study|Adverse Event|1|||
16433473|NCT02330055|40064483|FG000|Overall Study|technical issues|2|||
16433474|NCT02330055|40064484|FG001|Overall Study|technical issues|0|||
16433475|NCT02330055|40064483|FG000|Overall Study|participant forgot to wear device|5|||
16433476|NCT02330055|40064484|FG001|Overall Study|participant forgot to wear device|5|||
16433477|NCT02330055|40064483|FG000|Overall Study|data for less than 60 minutes|3|||
16433478|NCT02330055|40064484|FG001|Overall Study|data for less than 60 minutes|3|||
16433479|NCT02330055|40064483|FG000|Overall Study|participant did not sleep|0|||
16433480|NCT02330055|40064484|FG001|Overall Study|participant did not sleep|1|||
16433481|NCT02814175|40064489|FG000|Part 1|Adverse Event|2|||
16433482|NCT02814175|40064490|FG001|Part 1|Adverse Event|3|||
16433483|NCT02814175|40064491|FG002|Part 1|Adverse Event|0|||
16433484|NCT02814175|40064492|FG003|Part 1|Adverse Event|0|||
16433485|NCT02814175|40064493|FG004|Part 1|Adverse Event|0|||
16433486|NCT02814175|40064494|FG005|Part 1|Adverse Event|0|||
16132042|NCT03587974|38972827|FG000|Overall Study|Withdrawal by Subject|2|||
16132043|NCT03587974|38972828|FG001|Overall Study|Withdrawal by Subject|1|||
16132044|NCT01210118|38972829|FG000|Overall Study|Lost to Follow-up|1|||
16433487|NCT02814175|40064489|FG000|Part 1|Withdrawal Consent|8|||
16433488|NCT02814175|40064490|FG001|Part 1|Withdrawal Consent|1|||
16433489|NCT02814175|40064491|FG002|Part 1|Withdrawal Consent|0|||
16433490|NCT02814175|40064492|FG003|Part 1|Withdrawal Consent|0|||
16433491|NCT02814175|40064493|FG004|Part 1|Withdrawal Consent|0|||
16433492|NCT02814175|40064494|FG005|Part 1|Withdrawal Consent|0|||
16433493|NCT02814175|40064489|FG000|Part 1|Lost to Follow-up|1|||
16433494|NCT02814175|40064490|FG001|Part 1|Lost to Follow-up|0|||
16433495|NCT02814175|40064491|FG002|Part 1|Lost to Follow-up|0|||
16433496|NCT02814175|40064492|FG003|Part 1|Lost to Follow-up|0|||
16433497|NCT02814175|40064493|FG004|Part 1|Lost to Follow-up|0|||
16433498|NCT02814175|40064494|FG005|Part 1|Lost to Follow-up|0|||
16433499|NCT02814175|40064489|FG000|Part 1|Lack of Efficacy|1|||
16433500|NCT02814175|40064490|FG001|Part 1|Lack of Efficacy|2|||
16433501|NCT02814175|40064491|FG002|Part 1|Lack of Efficacy|0|||
16433502|NCT02814175|40064492|FG003|Part 1|Lack of Efficacy|0|||
16433503|NCT02814175|40064493|FG004|Part 1|Lack of Efficacy|0|||
16433504|NCT02814175|40064494|FG005|Part 1|Lack of Efficacy|0|||
16433505|NCT02814175|40064489|FG000|Part 2|Adverse Event|0|||
16433506|NCT02814175|40064490|FG001|Part 2|Adverse Event|0|||
16433507|NCT02814175|40064491|FG002|Part 2|Adverse Event|0|||
16433508|NCT02814175|40064492|FG003|Part 2|Adverse Event|1|||
16433509|NCT02814175|40064493|FG004|Part 2|Adverse Event|1|||
16433510|NCT02814175|40064494|FG005|Part 2|Adverse Event|2|||
16433511|NCT02814175|40064489|FG000|Part 2|Withdrawal Consent|0|||
16433512|NCT02814175|40064490|FG001|Part 2|Withdrawal Consent|0|||
16433513|NCT02814175|40064491|FG002|Part 2|Withdrawal Consent|0|||
16433514|NCT02814175|40064492|FG003|Part 2|Withdrawal Consent|2|||
16433515|NCT02814175|40064493|FG004|Part 2|Withdrawal Consent|1|||
16433516|NCT02814175|40064494|FG005|Part 2|Withdrawal Consent|1|||
16433517|NCT02814175|40064489|FG000|Part 2|Lost to Follow-up|0|||
16433518|NCT02814175|40064490|FG001|Part 2|Lost to Follow-up|0|||
16433519|NCT02814175|40064491|FG002|Part 2|Lost to Follow-up|0|||
16132045|NCT01210118|38972830|FG001|Overall Study|Lost to Follow-up|1|||
16132046|NCT01210118|38972829|FG000|Overall Study|Protocol Violation|1|||
16132047|NCT01210118|38972830|FG001|Overall Study|Protocol Violation|1|||
16433520|NCT02814175|40064492|FG003|Part 2|Lost to Follow-up|1|||
16433521|NCT02814175|40064493|FG004|Part 2|Lost to Follow-up|0|||
16433522|NCT02814175|40064494|FG005|Part 2|Lost to Follow-up|0|||
16433523|NCT02814175|40064489|FG000|Part 2|Lack of Efficacy|0|||
16433524|NCT02814175|40064490|FG001|Part 2|Lack of Efficacy|0|||
16433525|NCT02814175|40064491|FG002|Part 2|Lack of Efficacy|0|||
16132048|NCT01210118|38972829|FG000|Overall Study|Spontaneous abortion|1|||
16132049|NCT01210118|38972830|FG001|Overall Study|Spontaneous abortion|3|||
16433526|NCT02814175|40064492|FG003|Part 2|Lack of Efficacy|0|||
16433527|NCT02814175|40064493|FG004|Part 2|Lack of Efficacy|0|||
16433528|NCT02814175|40064494|FG005|Part 2|Lack of Efficacy|3|||
16433529|NCT01473732|40064495|FG000|Overall Study|Adverse Event|1|||
16433530|NCT01473732|40064496|FG001|Overall Study|Adverse Event|0|||
16433531|NCT01473732|40064495|FG000|Overall Study|Death|1|||
16433532|NCT01473732|40064496|FG001|Overall Study|Death|0|||
16433533|NCT04716426|40064497|FG000|Overall Study|Vaccination|1|||
16433534|NCT04716426|40064498|FG001|Overall Study|Vaccination|1|||
16433535|NCT04716426|40064497|FG000|Overall Study|Contamination|1|||
16433536|NCT04716426|40064498|FG001|Overall Study|Contamination|0|||
16433537|NCT04549545|40064499|FG000|Initial Period|Withdrawal by Subject|4|||
16433538|NCT04549545|40064500|FG001|Initial Period|Withdrawal by Subject|0|||
16433539|NCT04549545|40064499|FG000|Initial Period|Additional ENT Procedure|3|||
16433540|NCT04549545|40064500|FG001|Initial Period|Additional ENT Procedure|0|||
16433541|NCT04549545|40064499|FG000|Initial Period|Lost to Follow-up|3|||
16433542|NCT04549545|40064500|FG001|Initial Period|Lost to Follow-up|1|||
16433543|NCT04549545|40064499|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
16433544|NCT04549545|40064500|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
16433545|NCT04549545|40064499|FG000|Crossover Period|Additional ENT Procedure|0|||
16433546|NCT04549545|40064500|FG001|Crossover Period|Additional ENT Procedure|6|||
16433547|NCT04549545|40064499|FG000|Crossover Period|Lost to Follow-up|0|||
16433548|NCT04549545|40064500|FG001|Crossover Period|Lost to Follow-up|1|||
16433549|NCT04549545|40064499|FG000|Crossover Period|Withdrawal by Subject|0|||
16433550|NCT04549545|40064500|FG001|Crossover Period|Withdrawal by Subject|4|||
16433551|NCT04098809|40067168|FG000|Overall Study|Withdrawal by Subject|1|||
16433552|NCT04098809|40067169|FG001|Overall Study|Withdrawal by Subject|3|||
16433553|NCT04098809|40067168|FG000|Overall Study|Physician Decision|2|||
16433554|NCT04098809|40067169|FG001|Overall Study|Physician Decision|1|||
16433555|NCT00743249|40067171|FG000|Overall Study|Adverse Event|0|||
16433556|NCT00743249|40067172|FG001|Overall Study|Adverse Event|4|||
16433557|NCT00743249|40067171|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
16433558|NCT00743249|40067172|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
16433559|NCT00743249|40067171|FG000|Overall Study|Unsuccessful insertion of stent|2|||
16433560|NCT00743249|40067172|FG001|Overall Study|Unsuccessful insertion of stent|1|||
16433561|NCT02519439|40067173|FG000|Overall Study|Study Termination|19|||
16433562|NCT02519439|40067173|FG000|Overall Study|Withdrawal by Subject|1|||
16433563|NCT02519439|40067173|FG000|Overall Study|Adverse Event|1|||
16433564|NCT00527735|40067175|FG000|Overall Study|Disease progression|47|||
16433565|NCT00527735|40067176|FG001|Overall Study|Disease progression|61|||
16433566|NCT00527735|40067177|FG002|Overall Study|Disease progression|53|||
16433567|NCT00527735|40067175|FG000|Overall Study|Death|23|||
16433568|NCT00527735|40067176|FG001|Overall Study|Death|13|||
16433569|NCT00527735|40067177|FG002|Overall Study|Death|15|||
16433570|NCT00527735|40067175|FG000|Overall Study|Completed treatment in treatment phase|14|||
16433571|NCT00527735|40067176|FG001|Overall Study|Completed treatment in treatment phase|13|||
16433572|NCT00527735|40067177|FG002|Overall Study|Completed treatment in treatment phase|18|||
16433573|NCT00527735|40067175|FG000|Overall Study|Adverse Event|10|||
16433574|NCT00527735|40067176|FG001|Overall Study|Adverse Event|6|||
16433575|NCT00527735|40067177|FG002|Overall Study|Adverse Event|7|||
16433576|NCT00527735|40067175|FG000|Overall Study|Not identified|5|||
16433577|NCT00527735|40067176|FG001|Overall Study|Not identified|5|||
16433578|NCT00527735|40067177|FG002|Overall Study|Not identified|5|||
16433579|NCT00527735|40067175|FG000|Overall Study|Withdrawal by Subject|5|||
16433580|NCT00527735|40067176|FG001|Overall Study|Withdrawal by Subject|4|||
16433581|NCT00527735|40067177|FG002|Overall Study|Withdrawal by Subject|3|||
16433582|NCT00527735|40067175|FG000|Overall Study|No longer met study criteria|2|||
16433583|NCT00527735|40067176|FG001|Overall Study|No longer met study criteria|2|||
16433584|NCT00527735|40067177|FG002|Overall Study|No longer met study criteria|1|||
16433585|NCT00527735|40067175|FG000|Overall Study|Lost to Follow-up|0|||
16433586|NCT00527735|40067176|FG001|Overall Study|Lost to Follow-up|0|||
16433587|NCT00527735|40067177|FG002|Overall Study|Lost to Follow-up|3|||
16433588|NCT00527735|40067175|FG000|Overall Study|Poor compliance or noncompliance|0|||
16433589|NCT00527735|40067176|FG001|Overall Study|Poor compliance or noncompliance|1|||
16433590|NCT00527735|40067177|FG002|Overall Study|Poor compliance or noncompliance|1|||
16433591|NCT00527735|40067175|FG000|Overall Study|Completed treatment during maintenance|2|||
16433592|NCT00527735|40067176|FG001|Overall Study|Completed treatment during maintenance|2|||
16433593|NCT00527735|40067177|FG002|Overall Study|Completed treatment during maintenance|1|||
16433594|NCT02524171|40067178|FG000|6-month Follow-up|Lost to Follow-up|53|||
16433595|NCT02524171|40067179|FG001|6-month Follow-up|Lost to Follow-up|45|||
16433596|NCT02524171|40067178|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
16433597|NCT02524171|40067179|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
16433598|NCT01859923|40067180|FG000|Overall Study|Adverse Event|0|||
16433599|NCT01859923|40067181|FG001|Overall Study|Adverse Event|0|||
16433600|NCT01859923|40067182|FG002|Overall Study|Adverse Event|1|||
16433601|NCT01859923|40067183|FG003|Overall Study|Adverse Event|1|||
16433602|NCT01290523|40067193|FG000|Overall Study|Death|3|||
16433603|NCT01362348|40067196|FG000|Overall Study|Protocol-defined stopping criteria|9|||
16433604|NCT01362348|40067196|FG000|Overall Study|Study closed/terminated|5|||
16433605|NCT02469623|40067197|FG000|Overall Study|Not consented for long-term follow-up|4|||
16433606|NCT02469623|40067197|FG000|Overall Study|Lost to Follow-up|4|||
16433607|NCT02469623|40067197|FG000|Overall Study|Withdrawal by Subject|2|||
16433608|NCT02469623|40067197|FG000|Overall Study|Death|3|||
16433609|NCT03206216|40067198|FG000|Overall Study|Withdrawal by Subject|0|||
16433610|NCT03206216|40067199|FG001|Overall Study|Withdrawal by Subject|1|||
16433611|NCT01402817|40067202|FG000|Overall Study|Withdrawal by Subject|3|||
16433612|NCT01402817|40067202|FG000|Overall Study|Study Suspended by FDA|8|||
16433613|NCT01424501|40067204|FG000|Overall Study|Withdrawal by Subject|1|||
16433614|NCT01424501|40067205|FG001|Overall Study|Withdrawal by Subject|0|||
16433615|NCT01424501|40067206|FG002|Overall Study|Withdrawal by Subject|1|||
16433616|NCT01424501|40067207|FG003|Overall Study|Withdrawal by Subject|0|||
16433617|NCT01424501|40067208|FG004|Overall Study|Withdrawal by Subject|0|||
16433618|NCT01424501|40067209|FG005|Overall Study|Withdrawal by Subject|0|||
16433619|NCT01424501|40067204|FG000|Overall Study|Lost to Follow-up|0|||
16433620|NCT01424501|40067205|FG001|Overall Study|Lost to Follow-up|1|||
16433621|NCT01424501|40067206|FG002|Overall Study|Lost to Follow-up|1|||
16433622|NCT01424501|40067207|FG003|Overall Study|Lost to Follow-up|0|||
16433623|NCT01424501|40067208|FG004|Overall Study|Lost to Follow-up|0|||
16433624|NCT01424501|40067209|FG005|Overall Study|Lost to Follow-up|0|||
16433625|NCT00961181|40067218|FG000|Overall Study|Death|2|||
16433626|NCT00961181|40067218|FG000|Overall Study|Withdrawal by Subject|2|||
16433627|NCT00961181|40067218|FG000|Overall Study|Lost to Follow-up|1|||
16433628|NCT02920892|40067219|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
16433629|NCT02920892|40067220|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
16433630|NCT02920892|40067221|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
16433631|NCT02920892|40067219|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
16433632|NCT02920892|40067220|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
16433633|NCT02920892|40067221|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
16433634|NCT02920892|40067219|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
16433635|NCT02920892|40067220|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
16433636|NCT02920892|40067221|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
16433637|NCT02920892|40067219|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
16433638|NCT02920892|40067220|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
16433639|NCT02920892|40067221|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
16433640|NCT02920892|40067219|FG000|Placebo-Controlled Period|Physician Decision|0|||
16433641|NCT02920892|40067220|FG001|Placebo-Controlled Period|Physician Decision|0|||
16433642|NCT02920892|40067221|FG002|Placebo-Controlled Period|Physician Decision|1|||
16433643|NCT02920892|40067219|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
16433644|NCT02920892|40067220|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
16433645|NCT02920892|40067221|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
16433646|NCT02920892|40067219|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
16433647|NCT02920892|40067220|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
16433648|NCT02920892|40067221|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
16433649|NCT02920892|40067219|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
16433650|NCT02920892|40067220|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
16433651|NCT02920892|40067221|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
16433652|NCT01946139|40067222|FG000|Overall Study|Withdrawal by Subject|8|||
16433653|NCT01946139|40067222|FG000|Overall Study|ineligible|8|||
16433654|NCT01946139|40067222|FG000|Overall Study|Specimens not available|4|||
16433655|NCT01453140|40067223|FG000|Overall Study|Adverse Event|3|||
16433656|NCT02210000|40067224|FG000|Overall Study|Study Terminated|11|||
16433657|NCT02210000|40067225|FG001|Overall Study|Study Terminated|12|||
16433658|NCT02210000|40067224|FG000|Overall Study|Withdrawal by Subject|7|||
16433659|NCT02210000|40067225|FG001|Overall Study|Withdrawal by Subject|1|||
16433660|NCT02210000|40067224|FG000|Overall Study|Adverse Event|1|||
16433661|NCT02210000|40067225|FG001|Overall Study|Adverse Event|5|||
16433662|NCT02210000|40067224|FG000|Overall Study|Lost to Follow-up|0|||
16433663|NCT02210000|40067225|FG001|Overall Study|Lost to Follow-up|2|||
16433664|NCT02210000|40067224|FG000|Overall Study|Physician Decision|0|||
16433665|NCT02210000|40067225|FG001|Overall Study|Physician Decision|1|||
16433666|NCT01421017|40067231|FG000|Overall Study|Withdrawal by Subject|2|||
16433667|NCT01421017|40067232|FG001|Overall Study|Withdrawal by Subject|0|||
16433668|NCT01421017|40067233|FG002|Overall Study|Withdrawal by Subject|0|||
16433669|NCT01421017|40067231|FG000|Overall Study|POD|0|||
16433670|NCT01421017|40067232|FG001|Overall Study|POD|6|||
16433671|NCT01421017|40067233|FG002|Overall Study|POD|3|||
16433672|NCT00672555|40067234|FG000|Overall Study|Lost to Follow-up|4|||
16433673|NCT00672555|40067234|FG000|Overall Study|Did not want to answer questionnaire|2|||
16433674|NCT04292535|40067235|FG000|Overall Study|Withdrawal by Subject|0|||
16362045|NCT00849056|39811883|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
16362046|NCT00849056|39811882|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
16362047|NCT00849056|39811883|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
16362048|NCT00350545|39811884|FG000|Overall Study|Withdrawal by Subject|2|||
16362049|NCT02324153|39811887|FG000|Overall Study|Withdrawal by Subject|4|||
16362050|NCT02324153|39811888|FG001|Overall Study|Withdrawal by Subject|1|||
16362051|NCT02324153|39811887|FG000|Overall Study|Surgery postponed after randomization|3|||
16362052|NCT02324153|39811888|FG001|Overall Study|Surgery postponed after randomization|0|||
16362053|NCT02324153|39811887|FG000|Overall Study|Developed delirium preoperatively|1|||
16433675|NCT04292535|40067236|FG001|Overall Study|Withdrawal by Subject|0|||
16433676|NCT04292535|40067237|FG002|Overall Study|Withdrawal by Subject|0|||
16433677|NCT04292535|40067238|FG003|Overall Study|Withdrawal by Subject|0|||
16433678|NCT04292535|40067239|FG004|Overall Study|Withdrawal by Subject|0|||
16132050|NCT01577745|38972833|FG000|Overall Study|Withdrawal by Subject|0|||
16132051|NCT01577745|38972834|FG001|Overall Study|Withdrawal by Subject|1|||
16132052|NCT01577745|38972835|FG002|Overall Study|Withdrawal by Subject|0|||
16132053|NCT01577745|38972836|FG003|Overall Study|Withdrawal by Subject|3|||
16132054|NCT01577745|38972837|FG004|Overall Study|Withdrawal by Subject|2|||
16132055|NCT01577745|38972838|FG005|Overall Study|Withdrawal by Subject|0|||
16132056|NCT01577745|38972833|FG000|Overall Study|Death|3|||
16132057|NCT01577745|38972834|FG001|Overall Study|Death|2|||
16132058|NCT01577745|38972835|FG002|Overall Study|Death|2|||
16132059|NCT01577745|38972836|FG003|Overall Study|Death|1|||
16132060|NCT01577745|38972837|FG004|Overall Study|Death|1|||
16132061|NCT01577745|38972838|FG005|Overall Study|Death|3|||
16132062|NCT01577745|38972833|FG000|Overall Study|Physician Decision|0|||
16132063|NCT01577745|38972834|FG001|Overall Study|Physician Decision|0|||
16132064|NCT01577745|38972835|FG002|Overall Study|Physician Decision|0|||
16132065|NCT01577745|38972836|FG003|Overall Study|Physician Decision|1|||
16132066|NCT01577745|38972837|FG004|Overall Study|Physician Decision|1|||
16132067|NCT01577745|38972838|FG005|Overall Study|Physician Decision|0|||
16132068|NCT01577745|38972833|FG000|Overall Study|Lost to Follow-up|0|||
16132069|NCT01577745|38972834|FG001|Overall Study|Lost to Follow-up|0|||
16433679|NCT04292535|40067240|FG005|Overall Study|Withdrawal by Subject|0|||
16433680|NCT04292535|40067241|FG006|Overall Study|Withdrawal by Subject|0|||
16433681|NCT04292535|40067242|FG007|Overall Study|Withdrawal by Subject|1|||
16433682|NCT04292535|40067243|FG008|Overall Study|Withdrawal by Subject|0|||
16433683|NCT04292535|40067244|FG009|Overall Study|Withdrawal by Subject|0|||
16433684|NCT04292535|40067245|FG010|Overall Study|Withdrawal by Subject|0|||
16433685|NCT04292535|40067246|FG011|Overall Study|Withdrawal by Subject|0|||
16433686|NCT04292535|40067247|FG012|Overall Study|Withdrawal by Subject|0|||
16433687|NCT04292535|40067248|FG013|Overall Study|Withdrawal by Subject|0|||
16433688|NCT04292535|40067235|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16433689|NCT04292535|40067236|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16433690|NCT04292535|40067237|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16433691|NCT04292535|40067238|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16433692|NCT04292535|40067239|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16132070|NCT01577745|38972835|FG002|Overall Study|Lost to Follow-up|0|||
16362054|NCT02324153|39811888|FG001|Overall Study|Developed delirium preoperatively|0|||
16362055|NCT02783911|39811889|FG000|Overall Study|Lost to Follow-up|3|||
16362056|NCT02783911|39811890|FG001|Overall Study|Lost to Follow-up|32|||
16362057|NCT03880565|39811891|FG000|Overall Study|Withdrawal by Subject|1|||
16362058|NCT03880565|39811892|FG001|Overall Study|Withdrawal by Subject|0|||
16433693|NCT04292535|40067240|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16433694|NCT04292535|40067241|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16433695|NCT04292535|40067242|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
16433696|NCT04292535|40067243|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16433697|NCT04292535|40067244|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16433698|NCT04292535|40067245|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16433699|NCT04292535|40067246|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
16433700|NCT04292535|40067247|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
16433701|NCT04292535|40067248|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
16433702|NCT04292535|40067235|FG000|Overall Study|Report of Dizziness|0|||
16433703|NCT04292535|40067236|FG001|Overall Study|Report of Dizziness|0|||
16433704|NCT04292535|40067237|FG002|Overall Study|Report of Dizziness|0|||
16433705|NCT04292535|40067238|FG003|Overall Study|Report of Dizziness|0|||
16433706|NCT04292535|40067239|FG004|Overall Study|Report of Dizziness|0|||
16433707|NCT04292535|40067240|FG005|Overall Study|Report of Dizziness|0|||
16433708|NCT04292535|40067241|FG006|Overall Study|Report of Dizziness|0|||
16433709|NCT04292535|40067242|FG007|Overall Study|Report of Dizziness|0|||
16433710|NCT04292535|40067243|FG008|Overall Study|Report of Dizziness|0|||
16132071|NCT01577745|38972836|FG003|Overall Study|Lost to Follow-up|0|||
16433711|NCT04292535|40067244|FG009|Overall Study|Report of Dizziness|0|||
16132072|NCT01577745|38972837|FG004|Overall Study|Lost to Follow-up|0|||
16132073|NCT01577745|38972838|FG005|Overall Study|Lost to Follow-up|1|||
16132074|NCT01577745|38972833|FG000|Overall Study|Alternative Therapy|0|||
16132075|NCT01577745|38972834|FG001|Overall Study|Alternative Therapy|0|||
16132076|NCT01577745|38972835|FG002|Overall Study|Alternative Therapy|0|||
16132077|NCT01577745|38972836|FG003|Overall Study|Alternative Therapy|1|||
16132078|NCT01577745|38972837|FG004|Overall Study|Alternative Therapy|1|||
16132079|NCT01577745|38972838|FG005|Overall Study|Alternative Therapy|0|||
16132080|NCT01650246|38972841|FG000|Overall Study|Adverse Event|23|||
16132081|NCT01650246|38972841|FG000|Overall Study|Protocol Violation|5|||
16132082|NCT01650246|38972841|FG000|Overall Study|Sponsor terminated study|53|||
16132083|NCT01650246|38972841|FG000|Overall Study|Lost to Follow-up|5|||
16132084|NCT01650246|38972841|FG000|Overall Study|Withdrawal by Subject|26|||
16132085|NCT01650246|38972841|FG000|Overall Study|Death|1|||
16132086|NCT01650246|38972841|FG000|Overall Study|Lack of Efficacy|30|||
16132087|NCT00252577|38972842|FG000|Overall Study|Lost to Follow-up|20|||
16132088|NCT01990560|38972843|FG000|Overall Study|Withdrawal by Subject|1|||
16132089|NCT00757783|38972844|FG000|Overall Study|Adverse Event|0|||
16433712|NCT04292535|40067245|FG010|Overall Study|Report of Dizziness|0|||
16433713|NCT04292535|40067246|FG011|Overall Study|Report of Dizziness|0|||
16433714|NCT04292535|40067247|FG012|Overall Study|Report of Dizziness|0|||
16433715|NCT04292535|40067248|FG013|Overall Study|Report of Dizziness|1|||
16433716|NCT04292535|40067235|FG000|Overall Study|Equipment Failure|0|||
16433717|NCT04292535|40067236|FG001|Overall Study|Equipment Failure|0|||
16433718|NCT04292535|40067237|FG002|Overall Study|Equipment Failure|0|||
16433719|NCT04292535|40067238|FG003|Overall Study|Equipment Failure|0|||
16433720|NCT04292535|40067239|FG004|Overall Study|Equipment Failure|0|||
16433721|NCT04292535|40067240|FG005|Overall Study|Equipment Failure|0|||
16433722|NCT04292535|40067241|FG006|Overall Study|Equipment Failure|0|||
16433723|NCT04292535|40067242|FG007|Overall Study|Equipment Failure|0|||
16433724|NCT04292535|40067243|FG008|Overall Study|Equipment Failure|0|||
16433725|NCT04292535|40067244|FG009|Overall Study|Equipment Failure|0|||
16433726|NCT04292535|40067245|FG010|Overall Study|Equipment Failure|0|||
16433727|NCT04292535|40067246|FG011|Overall Study|Equipment Failure|1|||
16433728|NCT04292535|40067247|FG012|Overall Study|Equipment Failure|0|||
16433729|NCT04292535|40067248|FG013|Overall Study|Equipment Failure|0|||
16433730|NCT01392547|40067249|FG000|Overall Study|Adverse Event|2|||
16433731|NCT01392547|40067249|FG000|Overall Study|Non-compliance|2|||
16433732|NCT01392547|40067249|FG000|Overall Study|Withdrawal criteria|3|||
16433733|NCT01392547|40067249|FG000|Overall Study|Unclassified|1|||
16433734|NCT00871871|40067250|FG000|Part I|Adverse Event|0|||
16433735|NCT00871871|40067251|FG001|Part I|Adverse Event|2|||
16433736|NCT00871871|40067252|FG002|Part I|Adverse Event|0|||
16433737|NCT00871871|40067253|FG003|Part I|Adverse Event|0|||
16433738|NCT00871871|40067250|FG000|Part I|Withdrawal by Subject|3|||
16433739|NCT00871871|40067251|FG001|Part I|Withdrawal by Subject|0|||
16433740|NCT00871871|40067252|FG002|Part I|Withdrawal by Subject|0|||
16433741|NCT00871871|40067253|FG003|Part I|Withdrawal by Subject|0|||
16433742|NCT00871871|40067250|FG000|Part I|Laboratory abnormality|0|||
16433743|NCT00871871|40067251|FG001|Part I|Laboratory abnormality|1|||
16433744|NCT00871871|40067252|FG002|Part I|Laboratory abnormality|0|||
16433745|NCT00871871|40067253|FG003|Part I|Laboratory abnormality|0|||
16433746|NCT00871871|40067250|FG000|Part II|Lack of Efficacy|0|||
16433747|NCT00871871|40067251|FG001|Part II|Lack of Efficacy|0|||
16433748|NCT00871871|40067252|FG002|Part II|Lack of Efficacy|1|||
16433749|NCT00871871|40067253|FG003|Part II|Lack of Efficacy|0|||
16433750|NCT00871871|40067250|FG000|Part II|Withdrawal by Subject|0|||
16433751|NCT00871871|40067251|FG001|Part II|Withdrawal by Subject|0|||
16433752|NCT00871871|40067252|FG002|Part II|Withdrawal by Subject|2|||
16433753|NCT00871871|40067253|FG003|Part II|Withdrawal by Subject|1|||
16433754|NCT00871871|40067250|FG000|Part II|Adverse Event|0|||
16433755|NCT00871871|40067251|FG001|Part II|Adverse Event|0|||
16433756|NCT00871871|40067252|FG002|Part II|Adverse Event|1|||
16433757|NCT00871871|40067253|FG003|Part II|Adverse Event|2|||
16433758|NCT00871871|40067250|FG000|Part II|Protocol Violation|0|||
16433759|NCT00871871|40067251|FG001|Part II|Protocol Violation|0|||
16433760|NCT00871871|40067252|FG002|Part II|Protocol Violation|0|||
16433761|NCT00871871|40067253|FG003|Part II|Protocol Violation|1|||
16433762|NCT01620060|40067254|FG000|Overall Study|Adverse Event|9|||
16433763|NCT01620060|40067254|FG000|Overall Study|Protocol Violation|1|||
16433764|NCT01620060|40067254|FG000|Overall Study|Withdrawal by Subject|1|||
16433765|NCT01620060|40067254|FG000|Overall Study|Did not comply with Study Produre|1|||
16433766|NCT01620060|40067254|FG000|Overall Study|Family emergency|1|||
16433767|NCT01620060|40067254|FG000|Overall Study|Per Sponsor Decision|2|||
16433768|NCT00628030|40067255|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
16433769|NCT00628030|40067256|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
16433770|NCT00628030|40067255|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
16433771|NCT00628030|40067256|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
16433772|NCT00628030|40067255|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
16433773|NCT00628030|40067256|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
16433774|NCT02679755|40067257|FG000|Overall Study|Death|0|||
16433775|NCT02679755|40067258|FG001|Overall Study|Death|3|||
16433776|NCT02679755|40067257|FG000|Overall Study|Global deterioration of health status|1|||
16433777|NCT02679755|40067258|FG001|Overall Study|Global deterioration of health status|8|||
16433778|NCT02679755|40067257|FG000|Overall Study|Lost to Follow-up|1|||
16433779|NCT02679755|40067258|FG001|Overall Study|Lost to Follow-up|0|||
16433780|NCT02679755|40067257|FG000|Overall Study|Objective progression or relapse|24|||
16433781|NCT02679755|40067258|FG001|Overall Study|Objective progression or relapse|83|||
16433782|NCT02679755|40067257|FG000|Overall Study|Not defined|0|||
16433783|NCT02679755|40067258|FG001|Overall Study|Not defined|2|||
16433784|NCT02679755|40067257|FG000|Overall Study|Withdrawal by participant|6|||
16433785|NCT02679755|40067258|FG001|Overall Study|Withdrawal by participant|3|||
16433786|NCT02679755|40067257|FG000|Overall Study|Adverse Event|1|||
16433787|NCT02679755|40067258|FG001|Overall Study|Adverse Event|4|||
16433788|NCT02679755|40067257|FG000|Overall Study|Adverse events not related to study drug|1|||
16433789|NCT02679755|40067258|FG001|Overall Study|Adverse events not related to study drug|2|||
16433790|NCT04854551|40067263|FG000|Overall Study|Withdrawal by Subject|1|||
16433791|NCT04854551|40067264|FG001|Overall Study|Withdrawal by Subject|1|||
16433792|NCT00601835|40067266|FG000|Overall Study|Withdrawal by Subject|9|||
16433793|NCT00601835|40067267|FG001|Overall Study|Withdrawal by Subject|6|||
16433794|NCT00601835|40067266|FG000|Overall Study|Physician Decision|1|||
16433795|NCT00601835|40067267|FG001|Overall Study|Physician Decision|0|||
16433796|NCT00601835|40067266|FG000|Overall Study|Lost to Follow-up|37|||
16433797|NCT00601835|40067267|FG001|Overall Study|Lost to Follow-up|5|||
16433798|NCT00601835|40067266|FG000|Overall Study|Adverse Event|1|||
16433799|NCT00601835|40067267|FG001|Overall Study|Adverse Event|1|||
16433800|NCT00601835|40067266|FG000|Overall Study|Relocate|12|||
16433801|NCT00601835|40067267|FG001|Overall Study|Relocate|2|||
16433802|NCT00763386|40067277|FG000|Overall Study|Adverse Event|43|||
16433803|NCT00763386|40067278|FG001|Overall Study|Adverse Event|33|||
16433804|NCT00763386|40067277|FG000|Overall Study|Death|1|||
16433805|NCT00763386|40067278|FG001|Overall Study|Death|2|||
16433806|NCT00763386|40067277|FG000|Overall Study|Lost to Follow-up|3|||
16433807|NCT00763386|40067278|FG001|Overall Study|Lost to Follow-up|3|||
16433808|NCT00763386|40067277|FG000|Overall Study|Withdrawal by Subject|0|||
16433809|NCT00763386|40067278|FG001|Overall Study|Withdrawal by Subject|1|||
16433810|NCT00763386|40067277|FG000|Overall Study|CRF missing|0|||
16433811|NCT00763386|40067278|FG001|Overall Study|CRF missing|1|||
16433812|NCT00763386|40067277|FG000|Overall Study|Study Prosthesis Removed|1|||
16433813|NCT00763386|40067278|FG001|Overall Study|Study Prosthesis Removed|0|||
16433814|NCT00657540|40067279|FG000|Overall Study|Lost to Follow-up|1|||
16433815|NCT00657540|40067280|FG001|Overall Study|Lost to Follow-up|4|||
16433816|NCT01488045|40067281|FG000|Overall Study|Withdrawal by Subject|6|||
16433817|NCT01488045|40067282|FG001|Overall Study|Withdrawal by Subject|11|||
16433818|NCT01488045|40067281|FG000|Overall Study|Failure to present for colonoscopy|3|||
16433819|NCT01488045|40067282|FG001|Overall Study|Failure to present for colonoscopy|6|||
16433820|NCT01488045|40067281|FG000|Overall Study|Failure to report exclusion criteria|0|||
16433821|NCT01488045|40067282|FG001|Overall Study|Failure to report exclusion criteria|1|||
16433822|NCT05135871|40067283|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
16433823|NCT05135871|40067284|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
16433824|NCT05135871|40067285|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
16433825|NCT05135871|40067286|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
16433826|NCT01535807|40067287|FG000|Overall Study|Withdrawal by Subject|1|||
16433827|NCT01535807|40067288|FG001|Overall Study|Withdrawal by Subject|1|||
16433828|NCT01535807|40067287|FG000|Overall Study|Data collection error|1|||
16433829|NCT01535807|40067288|FG001|Overall Study|Data collection error|1|||
16433830|NCT00411671|40067289|FG000|Overall Study|Adverse Event|15|||
16433831|NCT00411671|40067289|FG000|Overall Study|Death|2|||
16433832|NCT00411671|40067289|FG000|Overall Study|Lost to Follow-up|3|||
16433833|NCT03550378|40067292|FG000|Overall Study|Death|0|||
16433834|NCT03550378|40067293|FG001|Overall Study|Death|1|||
16433835|NCT01092728|40067296|FG000|Overall Study|Withdrawal by Subject|2|||
16433836|NCT01092728|40067297|FG001|Overall Study|Withdrawal by Subject|0|||
16433837|NCT01092728|40067296|FG000|Overall Study|Adverse Event|0|||
16433838|NCT01092728|40067297|FG001|Overall Study|Adverse Event|1|||
16433839|NCT01092728|40067296|FG000|Overall Study|Disease Progression|1|||
16433840|NCT01092728|40067297|FG001|Overall Study|Disease Progression|13|||
16433841|NCT01092728|40067296|FG000|Overall Study|Prohibited Concomitant Medications|1|||
16433842|NCT01092728|40067297|FG001|Overall Study|Prohibited Concomitant Medications|0|||
16433843|NCT00795535|40067298|FG000|Overall Study|incomplete data and technical problems|20|||
16433844|NCT00551759|40067299|FG000|Overall Study|Adverse Event|7|||
16433845|NCT00551759|40067299|FG000|Overall Study|Death|5|||
16132090|NCT00757783|38972845|FG001|Overall Study|Adverse Event|2|||
16433846|NCT00551759|40067299|FG000|Overall Study|Ineligible|1|||
16132091|NCT00757783|38972844|FG000|Overall Study|Lost to Follow-up|1|||
16433847|NCT03343626|40067300|FG000|Overall Study|Lost to Follow-up|4|||
16132092|NCT00757783|38972845|FG001|Overall Study|Lost to Follow-up|1|||
16132093|NCT00757783|38972844|FG000|Overall Study|Protocol Violation|1|||
16433848|NCT03343626|40067301|FG001|Overall Study|Lost to Follow-up|3|||
16433849|NCT03343626|40067302|FG002|Overall Study|Lost to Follow-up|2|||
16433850|NCT03343626|40067303|FG003|Overall Study|Lost to Follow-up|5|||
16433851|NCT03343626|40067304|FG004|Overall Study|Lost to Follow-up|4|||
16433852|NCT03343626|40067305|FG005|Overall Study|Lost to Follow-up|4|||
16433853|NCT03343626|40067306|FG006|Overall Study|Lost to Follow-up|4|||
16433854|NCT03343626|40067307|FG007|Overall Study|Lost to Follow-up|7|||
16433855|NCT03343626|40067300|FG000|Overall Study|Withdrawal of Consent|2|||
16433856|NCT03343626|40067301|FG001|Overall Study|Withdrawal of Consent|1|||
16433857|NCT03343626|40067302|FG002|Overall Study|Withdrawal of Consent|0|||
16433858|NCT03343626|40067303|FG003|Overall Study|Withdrawal of Consent|3|||
16433859|NCT03343626|40067304|FG004|Overall Study|Withdrawal of Consent|3|||
16433860|NCT03343626|40067305|FG005|Overall Study|Withdrawal of Consent|1|||
16433861|NCT03343626|40067306|FG006|Overall Study|Withdrawal of Consent|1|||
16433862|NCT03343626|40067307|FG007|Overall Study|Withdrawal of Consent|2|||
16433863|NCT03343626|40067300|FG000|Overall Study|Reason not Specified|0|||
16362059|NCT01405911|39811893|FG000|Overall Study|Pre-treatment lab AE|0|||
16362060|NCT01405911|39811894|FG001|Overall Study|Pre-treatment lab AE|1|||
16362061|NCT01405911|39811895|FG002|Overall Study|Pre-treatment lab AE|0|||
16362062|NCT01405911|39811893|FG000|Overall Study|Lost to Follow-up|0|||
16362063|NCT01405911|39811894|FG001|Overall Study|Lost to Follow-up|1|||
16362064|NCT01405911|39811895|FG002|Overall Study|Lost to Follow-up|0|||
16362065|NCT01405911|39811893|FG000|Overall Study|Protocol Violation|1|||
16362066|NCT01405911|39811894|FG001|Overall Study|Protocol Violation|0|||
16433864|NCT03343626|40067301|FG001|Overall Study|Reason not Specified|1|||
16433865|NCT03343626|40067302|FG002|Overall Study|Reason not Specified|0|||
16433866|NCT03343626|40067303|FG003|Overall Study|Reason not Specified|0|||
16362067|NCT01405911|39811895|FG002|Overall Study|Protocol Violation|0|||
16433867|NCT03343626|40067304|FG004|Overall Study|Reason not Specified|0|||
16433868|NCT03343626|40067305|FG005|Overall Study|Reason not Specified|0|||
16362068|NCT01405911|39811893|FG000|Overall Study|Withdrawal by Subject|3|||
16433869|NCT03343626|40067306|FG006|Overall Study|Reason not Specified|0|||
16433870|NCT03343626|40067307|FG007|Overall Study|Reason not Specified|1|||
16433871|NCT03343626|40067300|FG000|Overall Study|Data Entry Error|0|||
16433872|NCT03343626|40067301|FG001|Overall Study|Data Entry Error|0|||
16433873|NCT03343626|40067302|FG002|Overall Study|Data Entry Error|0|||
16433874|NCT03343626|40067303|FG003|Overall Study|Data Entry Error|0|||
16433875|NCT03343626|40067304|FG004|Overall Study|Data Entry Error|0|||
16433876|NCT03343626|40067305|FG005|Overall Study|Data Entry Error|0|||
16433877|NCT03343626|40067306|FG006|Overall Study|Data Entry Error|0|||
16433878|NCT03343626|40067307|FG007|Overall Study|Data Entry Error|1|||
16433879|NCT04332107|40067309|FG000|Day 3|Lost to Follow-up|23|||
16433880|NCT04332107|40067310|FG001|Day 3|Lost to Follow-up|14|||
16433881|NCT04332107|40067309|FG000|Day 3|Missing outcome data|3|||
16433882|NCT04332107|40067310|FG001|Day 3|Missing outcome data|6|||
16433883|NCT04332107|40067309|FG000|Day 14|Lost to Follow-up|13|||
16433884|NCT04332107|40067310|FG001|Day 14|Lost to Follow-up|4|||
16433885|NCT04332107|40067309|FG000|Day 14|Missing outcome data|4|||
16433886|NCT04332107|40067310|FG001|Day 14|Missing outcome data|4|||
16433887|NCT04332107|40067309|FG000|Day 21|Lost to Follow-up|10|||
16433888|NCT04332107|40067310|FG001|Day 21|Lost to Follow-up|2|||
16433889|NCT01618669|40067321|FG000|Overall Study|Lost to Follow-up|1|||
16433890|NCT01618669|40067322|FG001|Overall Study|Lost to Follow-up|1|||
16433891|NCT01618669|40067321|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
16433892|NCT01618669|40067322|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
16433893|NCT01618669|40067321|FG000|Overall Study|Adverse Event|16|||
16433894|NCT01618669|40067322|FG001|Overall Study|Adverse Event|7|||
16433895|NCT01618669|40067321|FG000|Overall Study|Protocol Violation|5|||
16433896|NCT01618669|40067322|FG001|Overall Study|Protocol Violation|3|||
16433897|NCT01618669|40067321|FG000|Overall Study|Withdrawal by Subject|9|||
16433898|NCT01618669|40067322|FG001|Overall Study|Withdrawal by Subject|9|||
16433899|NCT01618669|40067321|FG000|Overall Study|Miscellaneous Reason|0|||
16433900|NCT01618669|40067322|FG001|Overall Study|Miscellaneous Reason|1|||
16433901|NCT00300755|40067324|FG000|Overall Study|Adverse Event|1|||
16433902|NCT00300755|40067325|FG001|Overall Study|Adverse Event|2|||
16433903|NCT00300755|40067326|FG002|Overall Study|Adverse Event|1|||
16433904|NCT00300755|40067324|FG000|Overall Study|Withdrawal by Subject|0|||
16433905|NCT00300755|40067325|FG001|Overall Study|Withdrawal by Subject|2|||
16433906|NCT00300755|40067326|FG002|Overall Study|Withdrawal by Subject|0|||
16433907|NCT00300755|40067324|FG000|Overall Study|Protocol Violation|0|||
16433908|NCT00300755|40067325|FG001|Overall Study|Protocol Violation|0|||
16433909|NCT00300755|40067326|FG002|Overall Study|Protocol Violation|1|||
16433910|NCT00681629|40067327|FG000|Overall Study|Study termination|4|||
16433911|NCT00681629|40067328|FG001|Overall Study|Study termination|2|||
16433912|NCT00681629|40067327|FG000|Overall Study|Adverse Event|1|||
16433913|NCT00681629|40067328|FG001|Overall Study|Adverse Event|0|||
16433914|NCT00667888|40067331|FG000|Overall Study|Death|1|||
16433915|NCT00667888|40067332|FG001|Overall Study|Death|1|||
16433916|NCT00667888|40067331|FG000|Overall Study|Withdrawal by Subject|6|||
16433917|NCT00667888|40067332|FG001|Overall Study|Withdrawal by Subject|3|||
16433918|NCT00667888|40067331|FG000|Overall Study|Proceed with other treatment|3|||
16433919|NCT00667888|40067332|FG001|Overall Study|Proceed with other treatment|3|||
16433920|NCT00667888|40067331|FG000|Overall Study|Ineligible after SIM|0|||
16433921|NCT00667888|40067332|FG001|Overall Study|Ineligible after SIM|2|||
16433922|NCT01156480|40067336|FG000|Overall Study|change in diagnosis|0|||
16433923|NCT01156480|40067337|FG001|Overall Study|change in diagnosis|1|||
16433924|NCT02221674|40067338|FG000|Overall Study|Lost to Follow-up|1|||
16433925|NCT02221674|40067339|FG001|Overall Study|Lost to Follow-up|0|||
16433926|NCT02221674|40067340|FG002|Overall Study|Lost to Follow-up|0|||
16433927|NCT01370265|40067341|FG000|First Intervention|Adverse Event|1|||
16433928|NCT01370265|40067342|FG001|First Intervention|Adverse Event|1|||
16433929|NCT02336230|40067343|FG000|Overall Study|Adverse Event|1|||
16433930|NCT02336230|40067343|FG000|Overall Study|Withdrawal of consent|1|||
16433931|NCT02336230|40067343|FG000|Overall Study|Death|9|||
16433932|NCT02336230|40067343|FG000|Overall Study|Dose not received due to shipping delay|1|||
16433933|NCT02336230|40067343|FG000|Overall Study|Discontinuation of MSC infusion|1|||
16433934|NCT00764361|40067346|FG000|Overall Study|Withdrawal by Subject|2|||
16433935|NCT00764361|40067347|FG001|Overall Study|Withdrawal by Subject|3|||
16433936|NCT00764361|40067346|FG000|Overall Study|Adverse Event|0|||
16433937|NCT00764361|40067347|FG001|Overall Study|Adverse Event|1|||
16433938|NCT02420379|40067348|FG000|Overall Study|Withdrawal by Subject|0|||
16433939|NCT02420379|40067349|FG001|Overall Study|Withdrawal by Subject|3|||
16433940|NCT02420379|40067348|FG000|Overall Study|Unable to complete due to schooling|0|||
16433941|NCT02420379|40067349|FG001|Overall Study|Unable to complete due to schooling|1|||
16362069|NCT01405911|39811894|FG001|Overall Study|Withdrawal by Subject|1|||
16362070|NCT01405911|39811895|FG002|Overall Study|Withdrawal by Subject|1|||
16362071|NCT03530696|39811896|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
16362072|NCT03530696|39811897|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
16362073|NCT01682031|39811898|FG000|Overall Study|Withdrawal by Subject|0|||
16362074|NCT01682031|39811899|FG001|Overall Study|Withdrawal by Subject|1|||
16362075|NCT01682031|39811898|FG000|Overall Study|Adverse Event|0|||
16362076|NCT01682031|39811899|FG001|Overall Study|Adverse Event|2|||
16362077|NCT01682031|39811898|FG000|Overall Study|MRI results indicate increased nodul|0|||
16362078|NCT01682031|39811899|FG001|Overall Study|MRI results indicate increased nodul|1|||
16362079|NCT01682031|39811898|FG000|Overall Study|Patient could not swallow tablets|1|||
16362080|NCT01682031|39811899|FG001|Overall Study|Patient could not swallow tablets|0|||
16362081|NCT01682031|39811898|FG000|Overall Study|Patient stopped selenium on his own|0|||
16362082|NCT01682031|39811899|FG001|Overall Study|Patient stopped selenium on his own|1|||
16362083|NCT00916578|39811900|FG000|Overall Study|Physician Decision|2|||
16362084|NCT00916578|39811900|FG000|Overall Study|Withdrawal by Subject|3|||
16362085|NCT00916578|39811900|FG000|Overall Study|Insurance Denial|2|||
16362086|NCT01240746|39811901|FG000|Overall Study|Adverse Event|2|||
16362087|NCT01240746|39811902|FG001|Overall Study|Adverse Event|0|||
16362088|NCT01240746|39811903|FG002|Overall Study|Adverse Event|10|||
16362089|NCT01240746|39811901|FG000|Overall Study|Lost to Follow-up|23|||
16362090|NCT01240746|39811902|FG001|Overall Study|Lost to Follow-up|20|||
16362091|NCT01240746|39811903|FG002|Overall Study|Lost to Follow-up|102|||
16362092|NCT01240746|39811901|FG000|Overall Study|Protocol Violation|24|||
16362093|NCT01240746|39811902|FG001|Overall Study|Protocol Violation|15|||
16362094|NCT01240746|39811903|FG002|Overall Study|Protocol Violation|72|||
16362095|NCT01240746|39811901|FG000|Overall Study|Withdrawal by Subject|10|||
16362096|NCT01240746|39811902|FG001|Overall Study|Withdrawal by Subject|13|||
16362097|NCT01240746|39811903|FG002|Overall Study|Withdrawal by Subject|59|||
16132094|NCT00757783|38972845|FG001|Overall Study|Protocol Violation|0|||
16132095|NCT00757783|38972844|FG000|Overall Study|Withdrawal by Subject|2|||
16132096|NCT00757783|38972845|FG001|Overall Study|Withdrawal by Subject|1|||
16132097|NCT00757783|38972844|FG000|Overall Study|Other|1|||
16132098|NCT00757783|38972845|FG001|Overall Study|Other|2|||
16132099|NCT00577473|38972855|FG000|Overall Study|Protocol Violation|1|||
16132100|NCT00577473|38972856|FG001|Overall Study|Protocol Violation|4|||
16250779|NCT01952574|39400617|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
16132101|NCT00577473|38972855|FG000|Overall Study|Adverse Event|8|||
16132102|NCT00577473|38972856|FG001|Overall Study|Adverse Event|5|||
16132103|NCT00577473|38972855|FG000|Overall Study|Withdrawal by Subject|2|||
16132104|NCT00577473|38972856|FG001|Overall Study|Withdrawal by Subject|6|||
16132105|NCT00577473|38972855|FG000|Overall Study|Physician Decision|2|||
16132106|NCT00577473|38972856|FG001|Overall Study|Physician Decision|2|||
16132107|NCT00577473|38972855|FG000|Overall Study|Lack of Efficacy|8|||
16132108|NCT00577473|38972856|FG001|Overall Study|Lack of Efficacy|7|||
16132109|NCT00262951|38972857|FG000|Overall Study|Progressive disease/relapse|3|||
16132110|NCT00262951|38972857|FG000|Overall Study|Adverse Event|7|||
16132111|NCT00262951|38972857|FG000|Overall Study|Death|1|||
16132112|NCT00262951|38972857|FG000|Overall Study|Withdrawal by Subject|1|||
16132113|NCT00262951|38972857|FG000|Overall Study|Alternative treatment|3|||
16132114|NCT00262951|38972857|FG000|Overall Study|Off treatment for other disease|1|||
16132115|NCT02571049|38972858|FG000|Screening|Did not meet entry criteria|2|||
16132116|NCT02571049|38972859|FG001|Screening|Did not meet entry criteria|2|||
16132117|NCT02571049|38972858|FG000|Randomization|No migraine attack|0|||
16132118|NCT02571049|38972859|FG001|Randomization|No migraine attack|1|||
16132119|NCT02571049|38972858|FG000|Randomization|Adverse Event|0|||
16132120|NCT02571049|38972859|FG001|Randomization|Adverse Event|1|||
16132121|NCT02730598|38972861|FG000|Overall Study|Withdrawal by Subject|3|||
16132122|NCT02730598|38972862|FG001|Overall Study|Withdrawal by Subject|3|||
16132123|NCT02730598|38972861|FG000|Overall Study|Protocol Violation|0|||
16132124|NCT02730598|38972862|FG001|Overall Study|Protocol Violation|1|||
16132125|NCT02730598|38972861|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
16132126|NCT02730598|38972862|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
16132127|NCT00784693|38972869|FG000|Overall Study|Lost to Follow-up|0|||
16132128|NCT00784693|38972870|FG001|Overall Study|Lost to Follow-up|1|||
16132129|NCT00784693|38972869|FG000|Overall Study|Lack of Efficacy|1|||
16132130|NCT00784693|38972870|FG001|Overall Study|Lack of Efficacy|1|||
16132131|NCT00784693|38972869|FG000|Overall Study|Withdrawal by Subject|0|||
16132132|NCT00784693|38972870|FG001|Overall Study|Withdrawal by Subject|4|||
16132133|NCT00784693|38972869|FG000|Overall Study|Randomized but not Treated|1|||
16132134|NCT00784693|38972870|FG001|Overall Study|Randomized but not Treated|0|||
16132135|NCT00784693|38972869|FG000|Overall Study|Other|1|||
16132136|NCT00784693|38972870|FG001|Overall Study|Other|0|||
16132137|NCT01696942|38972874|FG000|Overall Study|Withdrawal by Subject|1|||
16132138|NCT01696942|38972875|FG001|Overall Study|Withdrawal by Subject|0|||
16132139|NCT01696942|38972874|FG000|Overall Study|Protocol Violation|1|||
16132140|NCT01696942|38972875|FG001|Overall Study|Protocol Violation|2|||
16132141|NCT01696942|38972874|FG000|Overall Study|screen failure|0|||
16132142|NCT01696942|38972875|FG001|Overall Study|screen failure|1|||
16132143|NCT04975438|38972876|FG000|Overall Study|Lost to Follow-up|1|||
16250780|NCT01952574|39400618|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
16250781|NCT01952574|39400619|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
16250782|NCT01952574|39400620|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
16250783|NCT01952574|39400621|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
16250784|NCT01952574|39400622|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
16250785|NCT01952574|39400623|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
16250786|NCT01748890|39400626|FG000|Overall Study|Insufficient recruitment for analysis|4|||
16250787|NCT00524459|39400631|FG000|Overall Study|Withdrawal by Subject|1|||
16250788|NCT00524459|39400631|FG000|Overall Study|Other|1|||
16250789|NCT00622908|39400634|FG000|Overall Study|Protocol Violation|1|||
16250790|NCT00622908|39400635|FG001|Overall Study|Protocol Violation|0|||
16250791|NCT00622908|39400634|FG000|Overall Study|Adverse Event|0|||
16250792|NCT00622908|39400635|FG001|Overall Study|Adverse Event|1|||
16250793|NCT00622908|39400634|FG000|Overall Study|Lack of Efficacy|1|||
16250794|NCT00622908|39400635|FG001|Overall Study|Lack of Efficacy|7|||
16250795|NCT00622908|39400634|FG000|Overall Study|Lost to Follow-up|1|||
16250796|NCT00622908|39400635|FG001|Overall Study|Lost to Follow-up|0|||
16250797|NCT00622908|39400634|FG000|Overall Study|Refusal|0|||
16250798|NCT00622908|39400635|FG001|Overall Study|Refusal|1|||
16250799|NCT00622908|39400634|FG000|Overall Study|Termination by study sponser|0|||
16250800|NCT00622908|39400635|FG001|Overall Study|Termination by study sponser|1|||
16250801|NCT00146770|39400637|FG000|Overall Study|Adverse Event|2|||
16250802|NCT00146770|39400638|FG001|Overall Study|Adverse Event|0|||
16250803|NCT00146770|39400637|FG000|Overall Study|Pregnancy|1|||
16250804|NCT00146770|39400638|FG001|Overall Study|Pregnancy|0|||
16250805|NCT00146770|39400637|FG000|Overall Study|Withdrawal by Subject|2|||
16250806|NCT00146770|39400638|FG001|Overall Study|Withdrawal by Subject|0|||
16250807|NCT01567306|39400643|FG000|Overall Study|Protocol Violation|2|||
16250808|NCT01567306|39400644|FG001|Overall Study|Protocol Violation|2|||
16250809|NCT01567306|39400645|FG002|Overall Study|Protocol Violation|0|||
16250810|NCT01567306|39400646|FG003|Overall Study|Protocol Violation|3|||
16250811|NCT01567306|39400647|FG004|Overall Study|Protocol Violation|1|||
16250812|NCT01567306|39400648|FG005|Overall Study|Protocol Violation|1|||
16250813|NCT01567306|39400643|FG000|Overall Study|Change site living|1|||
16132144|NCT04975438|38972877|FG001|Overall Study|Lost to Follow-up|0|||
16132145|NCT04975438|38972878|FG002|Overall Study|Lost to Follow-up|1|||
16132146|NCT04975438|38972879|FG003|Overall Study|Lost to Follow-up|0|||
16132147|NCT04975438|38972876|FG000|Overall Study|Withdrawal by Subject|1|||
16132148|NCT04975438|38972877|FG001|Overall Study|Withdrawal by Subject|0|||
16132149|NCT04975438|38972878|FG002|Overall Study|Withdrawal by Subject|0|||
16132150|NCT04975438|38972879|FG003|Overall Study|Withdrawal by Subject|0|||
16132151|NCT02164383|38972880|FG000|Overall Study|Lost to Follow-up|1|||
16132152|NCT02164383|38972881|FG001|Overall Study|Lost to Follow-up|0|||
16132153|NCT01236339|38972884|FG000|Overall Study|Termination of study by sponsor|11|||
16132154|NCT01236339|38972885|FG001|Overall Study|Termination of study by sponsor|13|||
16132155|NCT00368992|38972886|FG000|Overall Study|Ineligible|5|||
16132156|NCT00368992|38972886|FG000|Overall Study|Refused treatment|3|||
16132157|NCT00368992|38972886|FG000|Overall Study|Lack of Efficacy|63|||
16132158|NCT00368992|38972886|FG000|Overall Study|Adverse Event|26|||
16132159|NCT00368992|38972886|FG000|Overall Study|Death|4|||
16132160|NCT00368992|38972886|FG000|Overall Study|Other|9|||
16132161|NCT00790751|38972889|FG000|Overall Study|Protocol non-compliance|16|||
16132162|NCT00790751|38972890|FG001|Overall Study|Protocol non-compliance|16|||
16132163|NCT00790751|38972891|FG002|Overall Study|Protocol non-compliance|10|||
16132164|NCT00790751|38972892|FG003|Overall Study|Protocol non-compliance|11|||
16132165|NCT00790751|38972889|FG000|Overall Study|Lost to Follow-up|4|||
16132166|NCT00790751|38972890|FG001|Overall Study|Lost to Follow-up|9|||
16132167|NCT00790751|38972891|FG002|Overall Study|Lost to Follow-up|4|||
16132168|NCT00790751|38972892|FG003|Overall Study|Lost to Follow-up|5|||
16132169|NCT00790751|38972889|FG000|Overall Study|Adverse Event|5|||
16132170|NCT00790751|38972890|FG001|Overall Study|Adverse Event|3|||
16132171|NCT00790751|38972891|FG002|Overall Study|Adverse Event|5|||
16132172|NCT00790751|38972892|FG003|Overall Study|Adverse Event|4|||
16132173|NCT00790751|38972889|FG000|Overall Study|Requirement for restricted medication|0|||
16132174|NCT00790751|38972890|FG001|Overall Study|Requirement for restricted medication|2|||
16132175|NCT00790751|38972891|FG002|Overall Study|Requirement for restricted medication|0|||
16132176|NCT00790751|38972892|FG003|Overall Study|Requirement for restricted medication|0|||
16132177|NCT00790751|38972889|FG000|Overall Study|Death|0|||
16132178|NCT00790751|38972890|FG001|Overall Study|Death|0|||
16132179|NCT00790751|38972891|FG002|Overall Study|Death|1|||
16132180|NCT00790751|38972892|FG003|Overall Study|Death|0|||
16132181|NCT00790751|38972889|FG000|Overall Study|Physician Decision|0|||
16132182|NCT00790751|38972890|FG001|Overall Study|Physician Decision|0|||
16132183|NCT00790751|38972891|FG002|Overall Study|Physician Decision|0|||
16132184|NCT00790751|38972892|FG003|Overall Study|Physician Decision|1|||
16132185|NCT00799513|38972893|FG000|Overall Study|Physician Decision|1|||
16132186|NCT00799513|38972893|FG000|Overall Study|Adverse Event|1|||
16132187|NCT02630693|38972896|FG000|Overall Study|No receive treatment|0|||
16132188|NCT02630693|38972897|FG001|Overall Study|No receive treatment|1|||
16132189|NCT00413972|38972898|FG000|Overall Study|Adverse Event|2|||
16132190|NCT00413972|38972899|FG001|Overall Study|Adverse Event|1|||
16132191|NCT00413972|38972900|FG002|Overall Study|Adverse Event|0|||
16132192|NCT00413972|38972901|FG003|Overall Study|Adverse Event|0|||
16132193|NCT00413972|38972898|FG000|Overall Study|Lost to Follow-up|1|||
16132194|NCT00413972|38972899|FG001|Overall Study|Lost to Follow-up|2|||
16132195|NCT00413972|38972900|FG002|Overall Study|Lost to Follow-up|1|||
16132196|NCT00413972|38972901|FG003|Overall Study|Lost to Follow-up|0|||
16132197|NCT00413972|38972898|FG000|Overall Study|Withdrawal by Subject|4|||
16132198|NCT00413972|38972899|FG001|Overall Study|Withdrawal by Subject|5|||
16132199|NCT00413972|38972900|FG002|Overall Study|Withdrawal by Subject|7|||
16132200|NCT00413972|38972901|FG003|Overall Study|Withdrawal by Subject|2|||
16132201|NCT00413972|38972898|FG000|Overall Study|Protocol Violation|0|||
16132202|NCT00413972|38972899|FG001|Overall Study|Protocol Violation|0|||
16132203|NCT00413972|38972900|FG002|Overall Study|Protocol Violation|2|||
16132204|NCT00413972|38972901|FG003|Overall Study|Protocol Violation|0|||
16132205|NCT00413972|38972898|FG000|Overall Study|Other|0|||
16132206|NCT00413972|38972899|FG001|Overall Study|Other|0|||
16132207|NCT00413972|38972900|FG002|Overall Study|Other|0|||
16132208|NCT00413972|38972901|FG003|Overall Study|Other|1|||
16132209|NCT02383056|38972902|FG000|Overall Study|Adverse Event|1|||
16132210|NCT02383056|38972903|FG001|Overall Study|Adverse Event|0|||
16433942|NCT02420379|40067348|FG000|Overall Study|Transitioned to commercial drug|1|||
16433943|NCT02420379|40067349|FG001|Overall Study|Transitioned to commercial drug|0|||
16433944|NCT00113841|40067350|FG000|Overall Study|Disease progression|0|||
16433945|NCT00113841|40067351|FG001|Overall Study|Disease progression|2|||
16433946|NCT00113841|40067350|FG000|Overall Study|Non-compliant|1|||
16433947|NCT00113841|40067351|FG001|Overall Study|Non-compliant|0|||
16433948|NCT00836589|40067352|FG000|Overall Study|Lost to Follow-up|246|||
16433949|NCT00836589|40067352|FG000|Overall Study|Death|429|||
16433950|NCT00836589|40067352|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
16433951|NCT00718510|40067353|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
16433952|NCT00718510|40067354|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16433953|NCT00718510|40067353|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
16433954|NCT00718510|40067354|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
16433955|NCT00539994|40067355|FG000|Overall Study|Lost to Follow-up|2|||
16433956|NCT00539994|40067356|FG001|Overall Study|Lost to Follow-up|1|||
16433957|NCT00539994|40067357|FG002|Overall Study|Lost to Follow-up|0|||
16433958|NCT00539994|40067355|FG000|Overall Study|Withdrawal by Subject|1|||
16433959|NCT00539994|40067356|FG001|Overall Study|Withdrawal by Subject|0|||
16433960|NCT00539994|40067357|FG002|Overall Study|Withdrawal by Subject|1|||
16433961|NCT00539994|40067355|FG000|Overall Study|Physician Decision|0|||
16433962|NCT00539994|40067356|FG001|Overall Study|Physician Decision|0|||
16433963|NCT00539994|40067357|FG002|Overall Study|Physician Decision|1|||
16433964|NCT01272232|40067358|FG000|Weeks 0-56|Adverse Event|39|||
16433965|NCT01272232|40067359|FG001|Weeks 0-56|Adverse Event|18|||
16433966|NCT01272232|40067360|FG002|Weeks 0-56|Adverse Event|7|||
16433967|NCT01272232|40067358|FG000|Weeks 0-56|Lack of Efficacy|0|||
16433968|NCT01272232|40067359|FG001|Weeks 0-56|Lack of Efficacy|0|||
16433969|NCT01272232|40067360|FG002|Weeks 0-56|Lack of Efficacy|3|||
16433970|NCT01272232|40067358|FG000|Weeks 0-56|Protocol Violation|12|||
16433971|NCT01272232|40067359|FG001|Weeks 0-56|Protocol Violation|8|||
16433972|NCT01272232|40067360|FG002|Weeks 0-56|Protocol Violation|13|||
16433973|NCT01272232|40067358|FG000|Weeks 0-56|Withdrawal criteria|32|||
16433974|NCT01272232|40067359|FG001|Weeks 0-56|Withdrawal criteria|14|||
16433975|NCT01272232|40067360|FG002|Weeks 0-56|Withdrawal criteria|37|||
16433976|NCT01272232|40067358|FG000|Weeks 0-56|Unclassified|16|||
16433977|NCT01272232|40067359|FG001|Weeks 0-56|Unclassified|7|||
16132211|NCT02383056|38972902|FG000|Overall Study|Lost to Follow-up|0|||
16433978|NCT01272232|40067360|FG002|Weeks 0-56|Unclassified|12|||
16433979|NCT01272232|40067358|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
16433980|NCT01272232|40067359|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
16433981|NCT01272232|40067360|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
16433982|NCT01272232|40067358|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
16132212|NCT02383056|38972903|FG001|Overall Study|Lost to Follow-up|2|||
16132213|NCT01047293|38972906|FG000|Overall Study|DLT criteria not fulfilled|1|||
16362098|NCT00975923|39811906|FG000|Overall Study|Withdrawal by Subject|0|||
16362099|NCT00975923|39811907|FG001|Overall Study|Withdrawal by Subject|1|||
16362100|NCT01006629|39811910|FG000|Overall Study|Adverse Event|1|||
16362101|NCT01006629|39811910|FG000|Overall Study|Parent refused to continue participation|1|||
16362102|NCT01006629|39811910|FG000|Overall Study|Parent unable to perform site visit|4|||
16362103|NCT03416179|39811911|FG000|Overall Study|Death|90|||
16362104|NCT03416179|39811912|FG001|Overall Study|Death|87|||
16362105|NCT03416179|39811913|FG002|Overall Study|Death|117|||
16362106|NCT03416179|39811914|FG003|Overall Study|Death|113|||
16362107|NCT03416179|39811911|FG000|Overall Study|Withdrawal by Subject|15|||
16362108|NCT03416179|39811912|FG001|Overall Study|Withdrawal by Subject|20|||
16362109|NCT03416179|39811913|FG002|Overall Study|Withdrawal by Subject|6|||
16362110|NCT03416179|39811914|FG003|Overall Study|Withdrawal by Subject|9|||
16362111|NCT03416179|39811911|FG000|Overall Study|Lost to Follow-up|1|||
16362112|NCT03416179|39811912|FG001|Overall Study|Lost to Follow-up|1|||
16362113|NCT03416179|39811913|FG002|Overall Study|Lost to Follow-up|0|||
16362114|NCT03416179|39811914|FG003|Overall Study|Lost to Follow-up|3|||
16132214|NCT01047293|38972907|FG001|Overall Study|DLT criteria not fulfilled|1|||
16132215|NCT01047293|38972908|FG002|Overall Study|DLT criteria not fulfilled|0|||
16132216|NCT01047293|38972909|FG003|Overall Study|DLT criteria not fulfilled|0|||
16132217|NCT02634346|38972910|FG000|Overall Study|Withdrawal by Subject|8|||
16132218|NCT02634346|38972911|FG001|Overall Study|Withdrawal by Subject|9|||
16132219|NCT02634346|38972912|FG002|Overall Study|Withdrawal by Subject|8|||
16132220|NCT02634346|38972910|FG000|Overall Study|Adverse Event|2|||
16132221|NCT02634346|38972911|FG001|Overall Study|Adverse Event|2|||
16132222|NCT02634346|38972912|FG002|Overall Study|Adverse Event|7|||
16132223|NCT02634346|38972910|FG000|Overall Study|Lack of Efficacy|1|||
16132224|NCT02634346|38972911|FG001|Overall Study|Lack of Efficacy|2|||
16132225|NCT02634346|38972912|FG002|Overall Study|Lack of Efficacy|8|||
16132226|NCT02634346|38972910|FG000|Overall Study|Lost to Follow-up|1|||
16132227|NCT02634346|38972911|FG001|Overall Study|Lost to Follow-up|0|||
16132228|NCT02634346|38972912|FG002|Overall Study|Lost to Follow-up|0|||
16132229|NCT02634346|38972910|FG000|Overall Study|Protocol Violation|0|||
16132230|NCT02634346|38972911|FG001|Overall Study|Protocol Violation|1|||
16132231|NCT02634346|38972912|FG002|Overall Study|Protocol Violation|0|||
16132232|NCT03169101|38972913|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
16132233|NCT03169101|38972914|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
16132234|NCT03169101|38972915|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
16132235|NCT03169101|38972916|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
16132236|NCT04161495|38972917|FG000|Overall Study|Withdrawal by Subject|3|||
16132237|NCT04161495|38972918|FG001|Overall Study|Withdrawal by Subject|0|||
16132238|NCT04161495|38972917|FG000|Overall Study|Protocol Violation|1|||
16132239|NCT04161495|38972918|FG001|Overall Study|Protocol Violation|0|||
16132240|NCT04161495|38972917|FG000|Overall Study|Prohibited concomitant medication|3|||
16132241|NCT04161495|38972918|FG001|Overall Study|Prohibited concomitant medication|0|||
16132242|NCT04161495|38972917|FG000|Overall Study|Adverse Event|1|||
16132243|NCT04161495|38972918|FG001|Overall Study|Adverse Event|0|||
16132244|NCT04161495|38972917|FG000|Overall Study|Other - Unspecified|1|||
16132245|NCT04161495|38972918|FG001|Overall Study|Other - Unspecified|0|||
16132246|NCT04161495|38972917|FG000|Overall Study|Death|0|||
16132247|NCT04161495|38972918|FG001|Overall Study|Death|1|||
16132248|NCT00511901|38972923|FG000|Overall Study|Withdrawal by Subject|1|||
16132249|NCT00511901|38972924|FG001|Overall Study|Withdrawal by Subject|3|||
16132250|NCT01635920|38972926|FG000|Overall Study|Adverse Event|1|||
16132251|NCT01635920|38972927|FG001|Overall Study|Adverse Event|0|||
16132252|NCT01635920|38972926|FG000|Overall Study|Lost to Follow-up|0|||
16132253|NCT01635920|38972927|FG001|Overall Study|Lost to Follow-up|1|||
16132254|NCT01635920|38972926|FG000|Overall Study|Subject decision|2|||
16132255|NCT01635920|38972927|FG001|Overall Study|Subject decision|0|||
16132256|NCT00896051|38972932|FG000|Overall Study|Adverse Event|2|||
16132257|NCT00896051|38972933|FG001|Overall Study|Adverse Event|1|||
16132258|NCT00896051|38972932|FG000|Overall Study|Lost to Follow-up|3|||
16132259|NCT00896051|38972933|FG001|Overall Study|Lost to Follow-up|2|||
16132260|NCT00896051|38972932|FG000|Overall Study|Withdrawal by Subject|3|||
16132261|NCT00896051|38972933|FG001|Overall Study|Withdrawal by Subject|2|||
16132262|NCT00896051|38972932|FG000|Overall Study|Subject noncompliant|1|||
16132263|NCT00896051|38972933|FG001|Overall Study|Subject noncompliant|3|||
16132264|NCT00896051|38972932|FG000|Overall Study|Other|1|||
16132265|NCT00896051|38972933|FG001|Overall Study|Other|1|||
16132266|NCT03401229|38972934|FG000|Overall Study|Lost to Follow-up|2|||
16132267|NCT03401229|38972935|FG001|Overall Study|Lost to Follow-up|1|||
16132268|NCT03401229|38972934|FG000|Overall Study|Other|1|||
16132269|NCT03401229|38972935|FG001|Overall Study|Other|3|||
16132270|NCT03401229|38972934|FG000|Overall Study|Adverse Event|8|||
16132271|NCT03401229|38972935|FG001|Overall Study|Adverse Event|6|||
16132272|NCT03401229|38972934|FG000|Overall Study|Withdrawal by Subject|29|||
16132273|NCT03401229|38972935|FG001|Overall Study|Withdrawal by Subject|26|||
16132274|NCT03401229|38972934|FG000|Overall Study|COVID-19|0|||
16132275|NCT03401229|38972935|FG001|Overall Study|COVID-19|1|||
16132276|NCT02668185|38972936|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
16132277|NCT02668185|38972937|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
16132278|NCT02668185|38972936|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
16132279|NCT02668185|38972937|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
16132280|NCT02668185|38972936|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
16132281|NCT02668185|38972937|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
16132282|NCT02668185|38972936|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
16132283|NCT02668185|38972937|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
16132284|NCT01853137|38972938|FG000|Overall Study|Lost to Follow-up|4|||
16132285|NCT01853137|38972939|FG001|Overall Study|Lost to Follow-up|1|||
16132286|NCT02208999|38972942|FG000|Overall Study|Lost to Follow-up|1|||
16132287|NCT00522873|38972947|FG000|Overall Study|Adverse Event|41|||
16132288|NCT00522873|38972948|FG001|Overall Study|Adverse Event|26|||
16132289|NCT00522873|38972947|FG000|Overall Study|Withdrawal by Subject|20|||
16132290|NCT00522873|38972948|FG001|Overall Study|Withdrawal by Subject|9|||
16132291|NCT00522873|38972947|FG000|Overall Study|Protocol Violation|14|||
16132292|NCT00522873|38972948|FG001|Overall Study|Protocol Violation|4|||
16132293|NCT00522873|38972947|FG000|Overall Study|Lost to Follow-up|11|||
16132294|NCT00522873|38972948|FG001|Overall Study|Lost to Follow-up|3|||
16132295|NCT00522873|38972947|FG000|Overall Study|Personal Reasons|8|||
16132296|NCT00522873|38972948|FG001|Overall Study|Personal Reasons|1|||
16132297|NCT00522873|38972947|FG000|Overall Study|Medication Errors|1|||
16132298|NCT00522873|38972948|FG001|Overall Study|Medication Errors|1|||
16132299|NCT00522873|38972947|FG000|Overall Study|Never Received Medication|1|||
16132300|NCT00522873|38972948|FG001|Overall Study|Never Received Medication|0|||
16132301|NCT03426267|38972949|FG000|Overall Study|Physician Decision|1|||
16132302|NCT03426267|38972950|FG001|Overall Study|Physician Decision|4|||
16132303|NCT03426267|38972949|FG000|Overall Study|Lost to Follow-up|1|||
16132304|NCT03426267|38972950|FG001|Overall Study|Lost to Follow-up|0|||
16132305|NCT03426267|38972949|FG000|Overall Study|Withdrawal by Subject|4|||
16132306|NCT03426267|38972950|FG001|Overall Study|Withdrawal by Subject|10|||
16132307|NCT03426267|38972949|FG000|Overall Study|Protocol Violation|1|||
16132308|NCT03426267|38972950|FG001|Overall Study|Protocol Violation|3|||
16132309|NCT03426267|38972949|FG000|Overall Study|Adverse Event|9|||
16362115|NCT03416179|39811911|FG000|Overall Study|Study participation terminated by Sponsor|93|||
16132310|NCT03426267|38972950|FG001|Overall Study|Adverse Event|27|||
16132311|NCT03426267|38972949|FG000|Overall Study|Prohibited Treatment Intake|2|||
16132312|NCT03426267|38972950|FG001|Overall Study|Prohibited Treatment Intake|3|||
16132313|NCT03426267|38972949|FG000|Overall Study|Lack of Efficacy|0|||
16132314|NCT03426267|38972950|FG001|Overall Study|Lack of Efficacy|25|||
16132315|NCT03426267|38972949|FG000|Overall Study|other|3|||
16132316|NCT03426267|38972950|FG001|Overall Study|other|0|||
16132317|NCT01777269|38972951|FG000|Overall Study|Adverse Event|24|||
16132318|NCT01777269|38972952|FG001|Overall Study|Adverse Event|33|||
16132319|NCT01777269|38972951|FG000|Overall Study|Lack of Efficacy|8|||
16132320|NCT01777269|38972952|FG001|Overall Study|Lack of Efficacy|10|||
16132321|NCT01777269|38972951|FG000|Overall Study|Protocol Violation|4|||
16132322|NCT01777269|38972952|FG001|Overall Study|Protocol Violation|4|||
16132323|NCT01777269|38972951|FG000|Overall Study|Participants reached stopping criteria|1|||
16132324|NCT01777269|38972952|FG001|Overall Study|Participants reached stopping criteria|1|||
16132325|NCT01777269|38972951|FG000|Overall Study|Lost to Follow-up|4|||
16132326|NCT01777269|38972952|FG001|Overall Study|Lost to Follow-up|0|||
16132327|NCT01777269|38972951|FG000|Overall Study|Physician Decision|5|||
16132328|NCT01777269|38972952|FG001|Overall Study|Physician Decision|2|||
16132329|NCT01777269|38972951|FG000|Overall Study|Withdrawal by Subject|9|||
16132330|NCT01777269|38972952|FG001|Overall Study|Withdrawal by Subject|9|||
16433983|NCT01272232|40067359|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
16433984|NCT01272232|40067360|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
16433985|NCT01272232|40067358|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
16433986|NCT01272232|40067359|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
16433987|NCT01272232|40067360|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
16433988|NCT01272232|40067358|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
16433989|NCT01272232|40067359|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
16433990|NCT01272232|40067360|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
16433991|NCT01272232|40067358|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
16433992|NCT01272232|40067359|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
16433993|NCT01272232|40067360|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
16433994|NCT02201524|40067361|FG000|Overall Study|Adverse Event|0|||
16433995|NCT02201524|40067362|FG001|Overall Study|Adverse Event|2|||
16433996|NCT02201524|40067363|FG002|Overall Study|Adverse Event|1|||
16433997|NCT02201524|40067364|FG003|Overall Study|Adverse Event|0|||
16433998|NCT02201524|40067361|FG000|Overall Study|Insufficient clinical response|1|||
16433999|NCT02201524|40067362|FG001|Overall Study|Insufficient clinical response|0|||
16434000|NCT02201524|40067363|FG002|Overall Study|Insufficient clinical response|0|||
16132331|NCT00959647|38972953|FG000|Overall Study|Adverse Event|2|||
16132332|NCT00959647|38972953|FG000|Overall Study|Progressive disease|6|||
16132333|NCT00959647|38972953|FG000|Overall Study|Study terminated by sponsor|4|||
16132334|NCT00959647|38972953|FG000|Overall Study|Withdrawal by Subject|7|||
16132335|NCT01209780|38972956|FG000|Overall Study|Adverse Event|0|||
16132336|NCT01209780|38972957|FG001|Overall Study|Adverse Event|1|||
16132337|NCT01209780|38972958|FG002|Overall Study|Adverse Event|0|||
16132338|NCT01209780|38972959|FG003|Overall Study|Adverse Event|0|||
16132339|NCT01209780|38972960|FG004|Overall Study|Adverse Event|0|||
16132340|NCT01209780|38972956|FG000|Overall Study|Withdrawal by Subject|9|||
16132341|NCT01209780|38972957|FG001|Overall Study|Withdrawal by Subject|2|||
16132342|NCT01209780|38972958|FG002|Overall Study|Withdrawal by Subject|1|||
16132343|NCT01209780|38972959|FG003|Overall Study|Withdrawal by Subject|1|||
16132344|NCT01209780|38972960|FG004|Overall Study|Withdrawal by Subject|0|||
16132345|NCT01209780|38972956|FG000|Overall Study|Lost to Follow-up|17|||
16132346|NCT01209780|38972957|FG001|Overall Study|Lost to Follow-up|12|||
16132347|NCT01209780|38972958|FG002|Overall Study|Lost to Follow-up|3|||
16132348|NCT01209780|38972959|FG003|Overall Study|Lost to Follow-up|9|||
16132349|NCT01209780|38972960|FG004|Overall Study|Lost to Follow-up|4|||
16132350|NCT01209780|38972956|FG000|Overall Study|Protocol Violation|0|||
16132351|NCT01209780|38972957|FG001|Overall Study|Protocol Violation|1|||
16132352|NCT01209780|38972958|FG002|Overall Study|Protocol Violation|0|||
16132353|NCT01209780|38972959|FG003|Overall Study|Protocol Violation|0|||
16132354|NCT01209780|38972960|FG004|Overall Study|Protocol Violation|0|||
16132355|NCT01209780|38972956|FG000|Overall Study|Inappropriate enrollment|0|||
16132356|NCT01209780|38972957|FG001|Overall Study|Inappropriate enrollment|2|||
16132357|NCT01209780|38972958|FG002|Overall Study|Inappropriate enrollment|0|||
16132358|NCT01209780|38972959|FG003|Overall Study|Inappropriate enrollment|0|||
16132359|NCT01209780|38972960|FG004|Overall Study|Inappropriate enrollment|1|||
16132360|NCT00899548|38972967|FG000|Overall Study|Physician Decision|3|||
16132361|NCT00423930|38972968|FG000|Overall Study|Withdrawal by Subject|2|||
16132362|NCT01340651|38972972|FG000|Overall Study|Adverse Event|3|||
16132363|NCT01340651|38972972|FG000|Overall Study|Consent Withdrawn|2|||
16132364|NCT01340651|38972972|FG000|Overall Study|Commercial Supply per Sponsor|12|||
16132365|NCT01078454|38972975|FG000|Overall Study|Adverse Event|1|||
16132366|NCT01078454|38972976|FG001|Overall Study|Adverse Event|1|||
16132367|NCT01078454|38972975|FG000|Overall Study|Death|0|||
16132368|NCT01078454|38972976|FG001|Overall Study|Death|1|||
16132369|NCT02884908|38972977|FG000|Overall Study|Lost to Follow-up|13|||
16132370|NCT02884908|38972978|FG001|Overall Study|Lost to Follow-up|18|||
16132371|NCT03037931|38972984|FG000|Overall Study|Death|354|||
16132372|NCT03037931|38972985|FG001|Overall Study|Death|367|||
16132373|NCT03037931|38972984|FG000|Overall Study|Lost to Follow-up|7|||
16132374|NCT03037931|38972985|FG001|Overall Study|Lost to Follow-up|4|||
16132375|NCT03037931|38972984|FG000|Overall Study|Withdrawal by Subject|48|||
16132376|NCT03037931|38972985|FG001|Overall Study|Withdrawal by Subject|41|||
16132377|NCT01079130|38972986|FG000|Overall Study|Adverse Event|1|||
16132378|NCT01079130|38972987|FG001|Overall Study|Adverse Event|1|||
16362116|NCT03416179|39811912|FG001|Overall Study|Study participation terminated by Sponsor|91|||
16362117|NCT03416179|39811913|FG002|Overall Study|Study participation terminated by Sponsor|26|||
16362118|NCT03416179|39811914|FG003|Overall Study|Study participation terminated by Sponsor|31|||
16362119|NCT03416179|39811911|FG000|Overall Study|Other|2|||
16362120|NCT03416179|39811912|FG001|Overall Study|Other|3|||
16362121|NCT03416179|39811913|FG002|Overall Study|Other|1|||
16434001|NCT02201524|40067364|FG003|Overall Study|Insufficient clinical response|0|||
16434002|NCT02201524|40067361|FG000|Overall Study|Lost to Follow-up|0|||
16434003|NCT02201524|40067362|FG001|Overall Study|Lost to Follow-up|0|||
16434004|NCT02201524|40067363|FG002|Overall Study|Lost to Follow-up|2|||
16434005|NCT02201524|40067364|FG003|Overall Study|Lost to Follow-up|0|||
16434006|NCT02201524|40067361|FG000|Overall Study|No longer meets eligibility criteria|0|||
16434007|NCT02201524|40067362|FG001|Overall Study|No longer meets eligibility criteria|0|||
16434008|NCT02201524|40067363|FG002|Overall Study|No longer meets eligibility criteria|0|||
16132379|NCT01079130|38972988|FG002|Overall Study|Adverse Event|0|||
16132380|NCT01079130|38972989|FG003|Overall Study|Adverse Event|1|||
16132381|NCT01079130|38972990|FG004|Overall Study|Adverse Event|5|||
16132382|NCT01079130|38972991|FG005|Overall Study|Adverse Event|1|||
16132383|NCT01079130|38972986|FG000|Overall Study|Administrative problems|1|||
16362122|NCT03416179|39811914|FG003|Overall Study|Other|0|||
16362123|NCT04400318|39811917|FG000|Overall Study|Adverse Event|1|||
16434009|NCT02201524|40067364|FG003|Overall Study|No longer meets eligibility criteria|2|||
16434010|NCT02201524|40067361|FG000|Overall Study|Protocol Violation|0|||
16434011|NCT02201524|40067362|FG001|Overall Study|Protocol Violation|0|||
16132384|NCT01079130|38972987|FG001|Overall Study|Administrative problems|3|||
16132385|NCT01079130|38972988|FG002|Overall Study|Administrative problems|0|||
16434012|NCT02201524|40067363|FG002|Overall Study|Protocol Violation|0|||
16434013|NCT02201524|40067364|FG003|Overall Study|Protocol Violation|1|||
16434014|NCT02201524|40067361|FG000|Overall Study|Withdrawal by Subject|0|||
16434015|NCT02201524|40067362|FG001|Overall Study|Withdrawal by Subject|0|||
16434016|NCT02201524|40067363|FG002|Overall Study|Withdrawal by Subject|1|||
16434017|NCT02201524|40067364|FG003|Overall Study|Withdrawal by Subject|1|||
16434018|NCT02201524|40067361|FG000|Overall Study|Other|1|||
16434019|NCT02201524|40067362|FG001|Overall Study|Other|1|||
16434020|NCT02201524|40067363|FG002|Overall Study|Other|0|||
16434021|NCT02201524|40067364|FG003|Overall Study|Other|0|||
16434022|NCT01339689|40067368|FG000|Overall Study|Adverse Event|1|||
16434023|NCT01339689|40067369|FG001|Overall Study|Adverse Event|2|||
16434024|NCT01339689|40067368|FG000|Overall Study|Lost to Follow-up|9|||
16434025|NCT01339689|40067369|FG001|Overall Study|Lost to Follow-up|3|||
16434026|NCT01339689|40067368|FG000|Overall Study|Withdrawal by Subject|3|||
16434027|NCT01339689|40067369|FG001|Overall Study|Withdrawal by Subject|0|||
16434028|NCT01339689|40067368|FG000|Overall Study|Noncompliance|1|||
16434029|NCT01339689|40067369|FG001|Overall Study|Noncompliance|0|||
16434030|NCT01339689|40067368|FG000|Overall Study|Relocated out of area|0|||
16434031|NCT01339689|40067369|FG001|Overall Study|Relocated out of area|1|||
16434032|NCT01339689|40067368|FG000|Overall Study|Other|2|||
16434033|NCT01339689|40067369|FG001|Overall Study|Other|2|||
16434034|NCT01339689|40067368|FG000|Overall Study|multiple reasons|1|||
16434035|NCT01339689|40067369|FG001|Overall Study|multiple reasons|1|||
16434036|NCT04999839|40067376|FG000|Overall Study|Adverse Event|1|||
16434037|NCT04999839|40067377|FG001|Overall Study|Adverse Event|1|||
16434038|NCT04999839|40067378|FG002|Overall Study|Adverse Event|1|||
16434039|NCT04999839|40067379|FG003|Overall Study|Adverse Event|1|||
16434040|NCT04999839|40067380|FG004|Overall Study|Adverse Event|1|||
16434041|NCT04999839|40067376|FG000|Overall Study|Lost to Follow-up|2|||
16434042|NCT04999839|40067377|FG001|Overall Study|Lost to Follow-up|0|||
16434043|NCT04999839|40067378|FG002|Overall Study|Lost to Follow-up|2|||
16434044|NCT04999839|40067379|FG003|Overall Study|Lost to Follow-up|4|||
16434045|NCT04999839|40067380|FG004|Overall Study|Lost to Follow-up|1|||
16434046|NCT04999839|40067376|FG000|Overall Study|Withdrawal by Subject|6|||
16434047|NCT04999839|40067377|FG001|Overall Study|Withdrawal by Subject|5|||
16434048|NCT04999839|40067378|FG002|Overall Study|Withdrawal by Subject|3|||
16434049|NCT04999839|40067379|FG003|Overall Study|Withdrawal by Subject|2|||
16434050|NCT04999839|40067380|FG004|Overall Study|Withdrawal by Subject|2|||
16434051|NCT04999839|40067376|FG000|Overall Study|Lack of Efficacy|0|||
16434052|NCT04999839|40067377|FG001|Overall Study|Lack of Efficacy|1|||
16434053|NCT04999839|40067378|FG002|Overall Study|Lack of Efficacy|0|||
16434054|NCT04999839|40067379|FG003|Overall Study|Lack of Efficacy|0|||
16434055|NCT04999839|40067380|FG004|Overall Study|Lack of Efficacy|0|||
16434056|NCT04999839|40067376|FG000|Overall Study|Physician Decision|0|||
16362124|NCT04400318|39811918|FG001|Overall Study|Adverse Event|0|||
16362125|NCT04400318|39811917|FG000|Overall Study|Withdrawal by Subject|1|||
16362126|NCT04400318|39811918|FG001|Overall Study|Withdrawal by Subject|1|||
16362127|NCT04400318|39811917|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
16362128|NCT04400318|39811918|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
16362129|NCT01655901|39811919|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
16362130|NCT01655901|39811920|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
16362131|NCT01655901|39811921|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
16362132|NCT01655901|39811922|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
16250814|NCT01567306|39400644|FG001|Overall Study|Change site living|0|||
16434057|NCT04999839|40067377|FG001|Overall Study|Physician Decision|0|||
16434058|NCT04999839|40067378|FG002|Overall Study|Physician Decision|0|||
16434059|NCT04999839|40067379|FG003|Overall Study|Physician Decision|0|||
16434060|NCT04999839|40067380|FG004|Overall Study|Physician Decision|1|||
16434061|NCT04999839|40067376|FG000|Overall Study|Sponsor request|0|||
16434062|NCT04999839|40067377|FG001|Overall Study|Sponsor request|1|||
16434063|NCT04999839|40067378|FG002|Overall Study|Sponsor request|0|||
16434064|NCT04999839|40067379|FG003|Overall Study|Sponsor request|0|||
16434065|NCT04999839|40067380|FG004|Overall Study|Sponsor request|0|||
16434066|NCT04999839|40067376|FG000|Overall Study|Other|0|||
16434067|NCT04999839|40067377|FG001|Overall Study|Other|0|||
16434068|NCT04999839|40067378|FG002|Overall Study|Other|1|||
16434069|NCT04999839|40067379|FG003|Overall Study|Other|0|||
16434070|NCT04999839|40067380|FG004|Overall Study|Other|0|||
16434071|NCT02451917|40067382|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
16434072|NCT02451917|40067383|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
16434073|NCT02451917|40067382|FG000|First Intervention (24 Weeks)|Death|0|||
16132386|NCT01079130|38972989|FG003|Overall Study|Administrative problems|0|||
16132387|NCT01079130|38972990|FG004|Overall Study|Administrative problems|0|||
16132388|NCT01079130|38972991|FG005|Overall Study|Administrative problems|1|||
16132389|NCT01079130|38972986|FG000|Overall Study|Withdrawal by Subject|0|||
16132390|NCT01079130|38972987|FG001|Overall Study|Withdrawal by Subject|1|||
16132391|NCT01079130|38972988|FG002|Overall Study|Withdrawal by Subject|0|||
16132392|NCT01079130|38972989|FG003|Overall Study|Withdrawal by Subject|0|||
16434074|NCT02451917|40067383|FG001|First Intervention (24 Weeks)|Death|1|||
16434075|NCT02451917|40067382|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
16132393|NCT01079130|38972990|FG004|Overall Study|Withdrawal by Subject|1|||
16132394|NCT01079130|38972991|FG005|Overall Study|Withdrawal by Subject|3|||
16132395|NCT01079130|38972986|FG000|Overall Study|Protocol deviation|0|||
16132396|NCT01079130|38972987|FG001|Overall Study|Protocol deviation|2|||
16132397|NCT01079130|38972988|FG002|Overall Study|Protocol deviation|1|||
16132398|NCT01079130|38972989|FG003|Overall Study|Protocol deviation|2|||
16132399|NCT01079130|38972990|FG004|Overall Study|Protocol deviation|0|||
16132400|NCT01079130|38972991|FG005|Overall Study|Protocol deviation|0|||
16132401|NCT01079130|38972986|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16132402|NCT01079130|38972987|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16132403|NCT01079130|38972988|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16132404|NCT01079130|38972989|FG003|Overall Study|Abnormal test procedure result(s)|0|||
16132405|NCT01079130|38972990|FG004|Overall Study|Abnormal test procedure result(s)|1|||
16132406|NCT01079130|38972991|FG005|Overall Study|Abnormal test procedure result(s)|0|||
16132407|NCT01079130|38972986|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16132408|NCT01079130|38972987|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16132409|NCT01079130|38972988|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16132410|NCT01079130|38972989|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
16132411|NCT01079130|38972990|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
16132412|NCT01079130|38972991|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
16132413|NCT01079130|38972986|FG000|Overall Study|Lost to Follow-up|0|||
16132414|NCT01079130|38972987|FG001|Overall Study|Lost to Follow-up|0|||
16132415|NCT01079130|38972988|FG002|Overall Study|Lost to Follow-up|0|||
16132416|NCT01079130|38972989|FG003|Overall Study|Lost to Follow-up|0|||
16132417|NCT01079130|38972990|FG004|Overall Study|Lost to Follow-up|1|||
16132418|NCT01079130|38972991|FG005|Overall Study|Lost to Follow-up|0|||
16132419|NCT00946101|38972992|FG000|Overall Study|Lost to Follow-up|2|||
16132420|NCT00946101|38972993|FG001|Overall Study|Lost to Follow-up|1|||
16132421|NCT00946101|38972992|FG000|Overall Study|Withdrawal of consent|2|||
16132422|NCT00946101|38972993|FG001|Overall Study|Withdrawal of consent|0|||
16132423|NCT00946101|38972992|FG000|Overall Study|Physician Decision|0|||
16132424|NCT00946101|38972993|FG001|Overall Study|Physician Decision|1|||
16132425|NCT01248780|38972994|FG000|Overall Study|Lack of Efficacy|2|||
16132426|NCT01248780|38972995|FG001|Overall Study|Lack of Efficacy|0|||
16132427|NCT01248780|38972994|FG000|Overall Study|Lost to Follow-up|0|||
16132428|NCT01248780|38972995|FG001|Overall Study|Lost to Follow-up|1|||
16132429|NCT01248780|38972994|FG000|Overall Study|Death|0|||
16132430|NCT01248780|38972995|FG001|Overall Study|Death|1|||
16132431|NCT01248780|38972994|FG000|Overall Study|Adverse Event|2|||
16132432|NCT01248780|38972995|FG001|Overall Study|Adverse Event|7|||
16132433|NCT01248780|38972994|FG000|Overall Study|Protocol Violation|1|||
16132434|NCT01248780|38972995|FG001|Overall Study|Protocol Violation|1|||
16132435|NCT01248780|38972994|FG000|Overall Study|Withdrawal by Subject|4|||
16362133|NCT01655901|39811923|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
16362134|NCT01655901|39811924|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
16362135|NCT04748718|39811925|FG000|Overall Study|Lost to Follow-up|50|||
16362136|NCT03069989|39811931|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
16362137|NCT03069989|39811932|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
16362138|NCT04739709|39811933|FG000|Overall Study|Physician Decision|1|||
16362139|NCT04739709|39811934|FG001|Overall Study|Physician Decision|0|||
16362140|NCT04079790|39811937|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
16362141|NCT04079790|39811938|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
16362142|NCT04079790|39811939|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
16362143|NCT04079790|39811940|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
16362144|NCT04079790|39811937|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
16362145|NCT04079790|39811938|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
16362146|NCT04079790|39811939|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
16362147|NCT04079790|39811940|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
16362148|NCT04079790|39811937|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
16362149|NCT04079790|39811938|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
16362150|NCT04079790|39811939|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
16362151|NCT04079790|39811940|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
16362152|NCT01452347|39811941|FG000|Overall Study|Adverse Event|2|||
16362153|NCT01452347|39811942|FG001|Overall Study|Adverse Event|1|||
16362154|NCT01452347|39811941|FG000|Overall Study|Non compliance protocol|2|||
16362155|NCT01452347|39811942|FG001|Overall Study|Non compliance protocol|0|||
16362156|NCT01452347|39811941|FG000|Overall Study|Lost to Follow-up|2|||
16362157|NCT01452347|39811942|FG001|Overall Study|Lost to Follow-up|0|||
16362158|NCT01452347|39811941|FG000|Overall Study|Withdrawal by Subject|3|||
16362159|NCT01452347|39811942|FG001|Overall Study|Withdrawal by Subject|3|||
16362160|NCT01452347|39811941|FG000|Overall Study|Not treated|6|||
16362161|NCT01452347|39811942|FG001|Overall Study|Not treated|3|||
16362162|NCT01452347|39811941|FG000|Overall Study|Other reason not defined above|2|||
16362163|NCT01452347|39811942|FG001|Overall Study|Other reason not defined above|0|||
16362164|NCT01838876|39811945|FG000|Overall Study|Adverse Event|49|||
16362165|NCT01838876|39811945|FG000|Overall Study|Insufficient Therapeutic Response|10|||
16362166|NCT01838876|39811945|FG000|Overall Study|Protocol Violation|34|||
16132436|NCT01248780|38972995|FG001|Overall Study|Withdrawal by Subject|4|||
16132437|NCT01248780|38972994|FG000|Overall Study|Not treated|0|||
16132438|NCT01248780|38972995|FG001|Overall Study|Not treated|1|||
16132439|NCT01201317|38972996|FG000|Overall Study|Withdrawal by Subject|5|||
16132440|NCT01201317|38972997|FG001|Overall Study|Withdrawal by Subject|0|||
16132441|NCT01201317|38972998|FG002|Overall Study|Withdrawal by Subject|3|||
16132442|NCT01201317|38972996|FG000|Overall Study|Adverse Event|2|||
16132443|NCT01201317|38972997|FG001|Overall Study|Adverse Event|2|||
16132444|NCT01201317|38972998|FG002|Overall Study|Adverse Event|2|||
16132445|NCT01201317|38972996|FG000|Overall Study|Screen failure|1|||
16132446|NCT01201317|38972997|FG001|Overall Study|Screen failure|1|||
16132447|NCT01201317|38972998|FG002|Overall Study|Screen failure|0|||
16132448|NCT01201317|38972996|FG000|Overall Study|Protocol Violation|0|||
16132449|NCT01201317|38972997|FG001|Overall Study|Protocol Violation|1|||
16132450|NCT01201317|38972998|FG002|Overall Study|Protocol Violation|1|||
16132451|NCT01201317|38972996|FG000|Overall Study|Death|0|||
16132452|NCT01201317|38972997|FG001|Overall Study|Death|1|||
16132453|NCT01201317|38972998|FG002|Overall Study|Death|0|||
16132454|NCT01201317|38972996|FG000|Overall Study|Study-specific withdrawal criteria|0|||
16132455|NCT01201317|38972997|FG001|Overall Study|Study-specific withdrawal criteria|0|||
16132456|NCT01201317|38972998|FG002|Overall Study|Study-specific withdrawal criteria|1|||
16132457|NCT01201317|38972996|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
16132458|NCT01201317|38972997|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
16132459|NCT01201317|38972998|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
16132460|NCT01201317|38972996|FG000|Overall Study|Decrease in renal function|0|||
16132461|NCT01201317|38972997|FG001|Overall Study|Decrease in renal function|1|||
16132462|NCT01201317|38972998|FG002|Overall Study|Decrease in renal function|0|||
16132463|NCT01201317|38972996|FG000|Overall Study|Lack of Efficacy|1|||
16132464|NCT01201317|38972997|FG001|Overall Study|Lack of Efficacy|0|||
16132465|NCT01201317|38972998|FG002|Overall Study|Lack of Efficacy|0|||
16132466|NCT01201317|38972996|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
16132467|NCT01201317|38972997|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
16132468|NCT01201317|38972998|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
16132469|NCT01506609|38972999|FG000|Overall Study|Adverse Event Related to Progression|0|||
16132470|NCT01506609|38973000|FG001|Overall Study|Adverse Event Related to Progression|0|||
16132471|NCT01506609|38973001|FG002|Overall Study|Adverse Event Related to Progression|0|||
16250815|NCT01567306|39400645|FG002|Overall Study|Change site living|0|||
16132472|NCT01506609|38973002|FG003|Overall Study|Adverse Event Related to Progression|3|||
16132473|NCT01506609|38973003|FG004|Overall Study|Adverse Event Related to Progression|7|||
16132474|NCT01506609|38973004|FG005|Overall Study|Adverse Event Related to Progression|3|||
16132475|NCT01506609|38972999|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
16132476|NCT01506609|38973000|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
16132477|NCT01506609|38973001|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
16132478|NCT01506609|38973002|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
16132479|NCT01506609|38973003|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
16132480|NCT01506609|38973004|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
16132481|NCT01506609|38972999|FG000|Overall Study|Withdrawal by Subject|0|||
16132482|NCT01506609|38973000|FG001|Overall Study|Withdrawal by Subject|0|||
16132483|NCT01506609|38973001|FG002|Overall Study|Withdrawal by Subject|0|||
16132484|NCT01506609|38973002|FG003|Overall Study|Withdrawal by Subject|9|||
16132485|NCT01506609|38973003|FG004|Overall Study|Withdrawal by Subject|7|||
16132486|NCT01506609|38973004|FG005|Overall Study|Withdrawal by Subject|7|||
16132487|NCT01506609|38972999|FG000|Overall Study|Lost to Follow-up|0|||
16132488|NCT01506609|38973000|FG001|Overall Study|Lost to Follow-up|0|||
16132489|NCT01506609|38973001|FG002|Overall Study|Lost to Follow-up|0|||
16132490|NCT01506609|38973002|FG003|Overall Study|Lost to Follow-up|1|||
16132491|NCT01506609|38973003|FG004|Overall Study|Lost to Follow-up|2|||
16132492|NCT01506609|38973004|FG005|Overall Study|Lost to Follow-up|0|||
16132493|NCT01506609|38972999|FG000|Overall Study|Sponsor Discontinued Study|0|||
16250816|NCT01567306|39400646|FG003|Overall Study|Change site living|0|||
16250817|NCT01567306|39400647|FG004|Overall Study|Change site living|0|||
16250818|NCT01567306|39400648|FG005|Overall Study|Change site living|0|||
16250819|NCT01567306|39400643|FG000|Overall Study|Adverse Event|0|||
16250820|NCT01567306|39400644|FG001|Overall Study|Adverse Event|0|||
16250821|NCT01567306|39400645|FG002|Overall Study|Adverse Event|0|||
16132494|NCT01506609|38973000|FG001|Overall Study|Sponsor Discontinued Study|0|||
16132495|NCT01506609|38973001|FG002|Overall Study|Sponsor Discontinued Study|0|||
16132496|NCT01506609|38973002|FG003|Overall Study|Sponsor Discontinued Study|2|||
16132497|NCT01506609|38973003|FG004|Overall Study|Sponsor Discontinued Study|2|||
16132498|NCT01506609|38973004|FG005|Overall Study|Sponsor Discontinued Study|0|||
16132499|NCT01506609|38972999|FG000|Overall Study|Progressive Disease per Protocol|1|||
16132500|NCT01506609|38973000|FG001|Overall Study|Progressive Disease per Protocol|0|||
16132501|NCT01506609|38973001|FG002|Overall Study|Progressive Disease per Protocol|0|||
16132502|NCT01506609|38973002|FG003|Overall Study|Progressive Disease per Protocol|64|||
16132503|NCT01506609|38973003|FG004|Overall Study|Progressive Disease per Protocol|57|||
16132504|NCT01506609|38973004|FG005|Overall Study|Progressive Disease per Protocol|74|||
16132505|NCT01506609|38972999|FG000|Overall Study|Other, Not Specified|0|||
16132506|NCT01506609|38973000|FG001|Overall Study|Other, Not Specified|0|||
16132507|NCT01506609|38973001|FG002|Overall Study|Other, Not Specified|0|||
16132508|NCT01506609|38973002|FG003|Overall Study|Other, Not Specified|10|||
16132509|NCT01506609|38973003|FG004|Overall Study|Other, Not Specified|7|||
16132510|NCT01506609|38973004|FG005|Overall Study|Other, Not Specified|3|||
16132511|NCT01506609|38972999|FG000|Overall Study|Missing / Unknown Reason|1|||
16132512|NCT01506609|38973000|FG001|Overall Study|Missing / Unknown Reason|0|||
16132513|NCT01506609|38973001|FG002|Overall Study|Missing / Unknown Reason|1|||
16132514|NCT01506609|38973002|FG003|Overall Study|Missing / Unknown Reason|4|||
16132515|NCT01506609|38973003|FG004|Overall Study|Missing / Unknown Reason|4|||
16132516|NCT01506609|38973004|FG005|Overall Study|Missing / Unknown Reason|2|||
16132517|NCT03527173|38973005|FG000|Overall Study|Lost to Follow-up|4|||
16132518|NCT03527173|38973006|FG001|Overall Study|Lost to Follow-up|2|||
16132519|NCT03527173|38973005|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
16132520|NCT03527173|38973006|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
16132521|NCT03527173|38973005|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
16132522|NCT03527173|38973006|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
16132523|NCT03527173|38973005|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
16132524|NCT03527173|38973006|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
16132525|NCT02483585|38973007|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
16132526|NCT02483585|38973008|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
16132527|NCT02483585|38973007|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
16132528|NCT02483585|38973008|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
16132529|NCT02483585|38973007|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
16132530|NCT02483585|38973008|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
16132531|NCT02483585|38973007|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
16132532|NCT02483585|38973008|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
16132533|NCT02483585|38973007|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
16132534|NCT02483585|38973008|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
16132535|NCT02483585|38973007|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
16132536|NCT02483585|38973008|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
16132537|NCT02483585|38973007|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
16132538|NCT02483585|38973008|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
16132539|NCT00394082|38973009|FG000|Overall Study|Unacceptable toxicity|15|||
16132540|NCT00394082|38973009|FG000|Overall Study|Adverse Event|4|||
16132541|NCT00394082|38973009|FG000|Overall Study|Physician Decision|4|||
16132542|NCT00394082|38973009|FG000|Overall Study|Withdrawal by Subject|2|||
16132543|NCT00394082|38973009|FG000|Overall Study|Other|1|||
16132544|NCT00031551|38973010|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
16362167|NCT01838876|39811945|FG000|Overall Study|Withdrawal of Consent|33|||
16362168|NCT01838876|39811945|FG000|Overall Study|Lost to Follow-up|21|||
16132545|NCT00031551|38973011|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
16132546|NCT02656329|38973012|FG000|Overall Study|Lost to Follow-up|2|||
16132547|NCT02656329|38973013|FG001|Overall Study|Lost to Follow-up|3|||
16132548|NCT02656329|38973012|FG000|Overall Study|Withdrawal by Subject|7|||
16132549|NCT02656329|38973013|FG001|Overall Study|Withdrawal by Subject|6|||
16132550|NCT02656329|38973012|FG000|Overall Study|Study termination by Sponsor|150|||
16132551|NCT02656329|38973013|FG001|Overall Study|Study termination by Sponsor|142|||
16132552|NCT02656329|38973012|FG000|Overall Study|Other than specified above|5|||
16132553|NCT02656329|38973013|FG001|Overall Study|Other than specified above|6|||
16132554|NCT00596427|38973014|FG000|Overall Study|Withdrawal by Subject|2|||
16132555|NCT00596427|38973015|FG001|Overall Study|Withdrawal by Subject|2|||
16132556|NCT00596427|38973014|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
16132557|NCT00596427|38973015|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
16132558|NCT00596427|38973014|FG000|Overall Study|Protocol Violation|1|||
16434076|NCT02451917|40067383|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
16434077|NCT01236521|40067384|FG000|Overall Study|Withdrawal by Subject|12|||
16434078|NCT01236521|40067385|FG001|Overall Study|Withdrawal by Subject|17|||
16434079|NCT01236521|40067384|FG000|Overall Study|Death|2|||
16434080|NCT01236521|40067385|FG001|Overall Study|Death|1|||
16434081|NCT01236521|40067384|FG000|Overall Study|Lost to Follow-up|9|||
16434082|NCT01236521|40067385|FG001|Overall Study|Lost to Follow-up|7|||
16434083|NCT01799226|40067386|FG000|Overall Study|Withdrawal by Subject|1|||
16434084|NCT01799226|40067387|FG001|Overall Study|Withdrawal by Subject|0|||
16434085|NCT01799226|40067386|FG000|Overall Study|Disqualified at Day 14|1|||
16434086|NCT01799226|40067387|FG001|Overall Study|Disqualified at Day 14|0|||
16434087|NCT00999544|40067388|FG000|Overall Study|Withdrawal by Subject|1|||
16434088|NCT02753946|40067389|FG000|Overall Study|Adverse Event|7|||
16132559|NCT00596427|38973015|FG001|Overall Study|Protocol Violation|0|||
16132560|NCT02372136|38973016|FG000|Overall Study|Death|3|||
16132561|NCT02372136|38973017|FG001|Overall Study|Death|1|||
16434089|NCT02753946|40067390|FG001|Overall Study|Adverse Event|6|||
16132562|NCT01813929|38973019|FG000|Overall Study|Withdrawal by Subject|0|||
16132563|NCT01813929|38973020|FG001|Overall Study|Withdrawal by Subject|1|||
16132564|NCT01116882|38973023|FG000|30-day|Lost to Follow-up|50|||
16132565|NCT01116882|38973024|FG001|30-day|Lost to Follow-up|21|||
16132566|NCT01116882|38973023|FG000|30-day|Withdrawal by Subject|2|||
16132567|NCT01116882|38973024|FG001|30-day|Withdrawal by Subject|4|||
16132568|NCT01116882|38973023|FG000|30-day|Other Reasons|16|||
16132569|NCT01116882|38973024|FG001|30-day|Other Reasons|6|||
16132570|NCT01116882|38973023|FG000|12-month|Lost to Follow-up|111|||
16132571|NCT01116882|38973024|FG001|12-month|Lost to Follow-up|42|||
16132572|NCT01116882|38973023|FG000|12-month|Other Reasons|151|||
16132573|NCT01116882|38973024|FG001|12-month|Other Reasons|49|||
16132574|NCT01116882|38973023|FG000|12-month|Withdrawal by Subject|5|||
16132575|NCT01116882|38973024|FG001|12-month|Withdrawal by Subject|8|||
16132576|NCT02768870|38973025|FG000|Overall Study|Death|1|||
16132577|NCT02768870|38973025|FG000|Overall Study|Reoperation|6|||
16132578|NCT02768870|38973025|FG000|Overall Study|Lost to Follow-up|1|||
16132579|NCT02768870|38973025|FG000|Overall Study|Exit|4|||
16132580|NCT00618982|38973026|FG000|Overall Study|Adverse Event|23|||
16132581|NCT00618982|38973026|FG000|Overall Study|Withdrawal by Subject|1|||
16132582|NCT00618982|38973026|FG000|Overall Study|Protocol Violation|1|||
16132583|NCT00618982|38973026|FG000|Overall Study|ongoing, still treated with study med.|25|||
16132584|NCT01012739|38973030|FG000|Treatment Period 1|Adverse Event|0|||
16132585|NCT01012739|38973031|FG001|Treatment Period 1|Adverse Event|0|||
16132586|NCT01012739|38973032|FG002|Treatment Period 1|Adverse Event|0|||
16132587|NCT01012739|38973033|FG003|Treatment Period 1|Adverse Event|1|||
16132588|NCT01012739|38973030|FG000|Treatment Period 2|Abnormal test procedure results|0|||
16132589|NCT01012739|38973031|FG001|Treatment Period 2|Abnormal test procedure results|0|||
16132590|NCT01012739|38973032|FG002|Treatment Period 2|Abnormal test procedure results|0|||
16434090|NCT02753946|40067389|FG000|Overall Study|Withdrawal by Subject|6|||
16434091|NCT02753946|40067390|FG001|Overall Study|Withdrawal by Subject|1|||
16434092|NCT02753946|40067389|FG000|Overall Study|Lack of Efficacy|1|||
16434093|NCT02753946|40067390|FG001|Overall Study|Lack of Efficacy|0|||
16434094|NCT02753946|40067389|FG000|Overall Study|Physician Decision|0|||
16434095|NCT02753946|40067390|FG001|Overall Study|Physician Decision|2|||
16434096|NCT00479336|40067394|FG000|Overall Study|Adverse Event|1|||
16434097|NCT00479336|40067395|FG001|Overall Study|Adverse Event|1|||
16434098|NCT00479336|40067396|FG002|Overall Study|Adverse Event|1|||
16434099|NCT00479336|40067397|FG003|Overall Study|Adverse Event|3|||
16434100|NCT00479336|40067394|FG000|Overall Study|Lack of Efficacy|1|||
16434101|NCT00479336|40067395|FG001|Overall Study|Lack of Efficacy|0|||
16434102|NCT00479336|40067396|FG002|Overall Study|Lack of Efficacy|0|||
16434103|NCT00479336|40067397|FG003|Overall Study|Lack of Efficacy|0|||
16434104|NCT00479336|40067394|FG000|Overall Study|Protocol Violation|0|||
16434105|NCT00479336|40067395|FG001|Overall Study|Protocol Violation|1|||
16434106|NCT00479336|40067396|FG002|Overall Study|Protocol Violation|0|||
16434107|NCT00479336|40067397|FG003|Overall Study|Protocol Violation|0|||
16434108|NCT00479336|40067394|FG000|Overall Study|Withdrawal by Subject|1|||
16434109|NCT00479336|40067395|FG001|Overall Study|Withdrawal by Subject|2|||
16132591|NCT01012739|38973033|FG003|Treatment Period 2|Abnormal test procedure results|1|||
16132592|NCT04788511|38973034|FG000|Overall Study|Withdrawal by Subject|2|||
16132593|NCT04788511|38973035|FG001|Overall Study|Withdrawal by Subject|1|||
16132594|NCT04788511|38973034|FG000|Overall Study|Lost to Follow-up|2|||
16362169|NCT01838876|39811945|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
16362170|NCT01838876|39811945|FG000|Overall Study|Reason not Specified|7|||
16362171|NCT01838876|39811945|FG000|Overall Study|Did not meet eligibility criteria|78|||
16362172|NCT01117870|39811948|FG000|Overall Study|Inability to place needle|1|||
16362173|NCT01117870|39811949|FG001|Overall Study|Inability to place needle|0|||
16362174|NCT02555878|39811952|FG000|Overall Study|Lost to Follow-up|2|||
16362175|NCT02555878|39811953|FG001|Overall Study|Lost to Follow-up|3|||
16362176|NCT02555878|39811952|FG000|Overall Study|Withdrawal by Subject|48|||
16362177|NCT02555878|39811953|FG001|Overall Study|Withdrawal by Subject|48|||
16362178|NCT02555878|39811952|FG000|Overall Study|Adverse Event|12|||
16362179|NCT02555878|39811953|FG001|Overall Study|Adverse Event|8|||
16362180|NCT02555878|39811952|FG000|Overall Study|Death|74|||
16362181|NCT02555878|39811953|FG001|Overall Study|Death|59|||
16362182|NCT02555878|39811952|FG000|Overall Study|Protocol Violation|1|||
16362183|NCT02555878|39811953|FG001|Overall Study|Protocol Violation|2|||
16434110|NCT00479336|40067396|FG002|Overall Study|Withdrawal by Subject|0|||
16132595|NCT04788511|38973035|FG001|Overall Study|Lost to Follow-up|7|||
16132596|NCT04788511|38973034|FG000|Overall Study|Death|3|||
16132597|NCT04788511|38973035|FG001|Overall Study|Death|4|||
16132598|NCT03725085|38973038|FG000|Overall Study|Lost to Follow-up|2|||
16362184|NCT02555878|39811952|FG000|Overall Study|Physician Decision|12|||
16434111|NCT00479336|40067397|FG003|Overall Study|Withdrawal by Subject|0|||
16434112|NCT00479336|40067394|FG000|Overall Study|Physician Decision|0|||
16434113|NCT00479336|40067395|FG001|Overall Study|Physician Decision|1|||
16434114|NCT00479336|40067396|FG002|Overall Study|Physician Decision|0|||
16434115|NCT00479336|40067397|FG003|Overall Study|Physician Decision|2|||
16434116|NCT00479336|40067394|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
16434117|NCT00479336|40067395|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
16434118|NCT00479336|40067396|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
16434119|NCT00479336|40067397|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
16434120|NCT01454596|40067398|FG000|Overall Study|Death|0|||
16132599|NCT00705679|38973039|FG000|Overall Study|Adverse Event|1|||
16132600|NCT00705679|38973040|FG001|Overall Study|Adverse Event|1|||
16132601|NCT00705679|38973041|FG002|Overall Study|Adverse Event|0|||
16132602|NCT00705679|38973042|FG003|Overall Study|Adverse Event|0|||
16132603|NCT00705679|38973043|FG004|Overall Study|Adverse Event|0|||
16132604|NCT00705679|38973039|FG000|Overall Study|Death|0|||
16132605|NCT00705679|38973040|FG001|Overall Study|Death|0|||
16132606|NCT00705679|38973041|FG002|Overall Study|Death|3|||
16132607|NCT00705679|38973042|FG003|Overall Study|Death|2|||
16132608|NCT00705679|38973043|FG004|Overall Study|Death|1|||
16132609|NCT00705679|38973039|FG000|Overall Study|Lost to Follow-up|32|||
16132610|NCT00705679|38973040|FG001|Overall Study|Lost to Follow-up|60|||
16132611|NCT00705679|38973041|FG002|Overall Study|Lost to Follow-up|44|||
16132612|NCT00705679|38973042|FG003|Overall Study|Lost to Follow-up|30|||
16132613|NCT00705679|38973043|FG004|Overall Study|Lost to Follow-up|35|||
16132614|NCT00705679|38973039|FG000|Overall Study|Physician Decision|0|||
16132615|NCT00705679|38973040|FG001|Overall Study|Physician Decision|1|||
16132616|NCT00705679|38973041|FG002|Overall Study|Physician Decision|0|||
16132617|NCT00705679|38973042|FG003|Overall Study|Physician Decision|1|||
16132618|NCT00705679|38973043|FG004|Overall Study|Physician Decision|0|||
16132619|NCT00705679|38973039|FG000|Overall Study|Withdrawal by Subject|32|||
16132620|NCT00705679|38973040|FG001|Overall Study|Withdrawal by Subject|77|||
16132621|NCT00705679|38973041|FG002|Overall Study|Withdrawal by Subject|68|||
16132622|NCT00705679|38973042|FG003|Overall Study|Withdrawal by Subject|47|||
16132623|NCT00705679|38973043|FG004|Overall Study|Withdrawal by Subject|33|||
16132624|NCT03945825|38973044|FG000|Overall Study|Enrolled but treatment not administered|0|||
16132625|NCT03945825|38973045|FG001|Overall Study|Enrolled but treatment not administered|0|||
16132626|NCT03945825|38973046|FG002|Overall Study|Enrolled but treatment not administered|0|||
16132627|NCT03945825|38973047|FG003|Overall Study|Enrolled but treatment not administered|0|||
16132628|NCT03945825|38973048|FG004|Overall Study|Enrolled but treatment not administered|1|||
16132629|NCT03945825|38973049|FG005|Overall Study|Enrolled but treatment not administered|0|||
16132630|NCT03945825|38973044|FG000|Overall Study|Lost to Follow-up|1|||
16132631|NCT03945825|38973045|FG001|Overall Study|Lost to Follow-up|5|||
16132632|NCT03945825|38973046|FG002|Overall Study|Lost to Follow-up|0|||
16132633|NCT03945825|38973047|FG003|Overall Study|Lost to Follow-up|1|||
16132634|NCT03945825|38973048|FG004|Overall Study|Lost to Follow-up|2|||
16132635|NCT03945825|38973049|FG005|Overall Study|Lost to Follow-up|2|||
16132636|NCT03945825|38973044|FG000|Overall Study|Withdrawal by Subject|1|||
16132637|NCT03945825|38973045|FG001|Overall Study|Withdrawal by Subject|0|||
16132638|NCT03945825|38973046|FG002|Overall Study|Withdrawal by Subject|1|||
16132639|NCT03945825|38973047|FG003|Overall Study|Withdrawal by Subject|1|||
16132640|NCT03945825|38973048|FG004|Overall Study|Withdrawal by Subject|0|||
16132641|NCT03945825|38973049|FG005|Overall Study|Withdrawal by Subject|1|||
16132642|NCT00081770|38973050|FG000|Overall Study|Adverse Event|130|||
16132643|NCT00081770|38973051|FG001|Overall Study|Adverse Event|98|||
16132644|NCT00081770|38973052|FG002|Overall Study|Adverse Event|136|||
16132645|NCT00081770|38973050|FG000|Overall Study|Lack of Efficacy|262|||
16132646|NCT00081770|38973051|FG001|Overall Study|Lack of Efficacy|357|||
16132647|NCT00081770|38973052|FG002|Overall Study|Lack of Efficacy|211|||
16132648|NCT00081770|38973050|FG000|Overall Study|Lost to Follow-up|45|||
16132649|NCT00081770|38973051|FG001|Overall Study|Lost to Follow-up|34|||
16132650|NCT00081770|38973052|FG002|Overall Study|Lost to Follow-up|45|||
16132651|NCT00081770|38973050|FG000|Overall Study|Protocol Violation|15|||
16132652|NCT00081770|38973051|FG001|Overall Study|Protocol Violation|10|||
16132653|NCT00081770|38973052|FG002|Overall Study|Protocol Violation|10|||
16132654|NCT00081770|38973050|FG000|Overall Study|Withdrawal by Subject|45|||
16132655|NCT00081770|38973051|FG001|Overall Study|Withdrawal by Subject|40|||
16132656|NCT00081770|38973052|FG002|Overall Study|Withdrawal by Subject|42|||
16132657|NCT00081770|38973050|FG000|Overall Study|Did not meet protocol eligibility|2|||
16132658|NCT00081770|38973051|FG001|Overall Study|Did not meet protocol eligibility|0|||
16132659|NCT00081770|38973052|FG002|Overall Study|Did not meet protocol eligibility|3|||
16132660|NCT00081770|38973050|FG000|Overall Study|Administrative|1|||
16132661|NCT00081770|38973051|FG001|Overall Study|Administrative|0|||
16132662|NCT00081770|38973052|FG002|Overall Study|Administrative|1|||
16132663|NCT00081770|38973050|FG000|Overall Study|Other|2|||
16132664|NCT00081770|38973051|FG001|Overall Study|Other|7|||
16132665|NCT00081770|38973052|FG002|Overall Study|Other|8|||
16132666|NCT01013597|38973053|FG000|Overall Study|Withdrawal by Subject|1|||
16132667|NCT01122862|38973057|FG000|Period 1|Protocol Violation|0|||
16132668|NCT01122862|38973058|FG001|Period 1|Protocol Violation|1|||
16132669|NCT01122862|38973059|FG002|Period 1|Protocol Violation|0|||
16132670|NCT01122862|38973057|FG000|Period 2|Adverse Event|0|||
16132671|NCT01122862|38973058|FG001|Period 2|Adverse Event|0|||
16132672|NCT01122862|38973059|FG002|Period 2|Adverse Event|1|||
16132673|NCT00448279|38973060|FG000|Overall Study|Lost to Follow-up|2|||
16132674|NCT00448279|38973061|FG001|Overall Study|Lost to Follow-up|2|||
16132675|NCT00448279|38973060|FG000|Overall Study|Adverse Event|1|||
16132676|NCT00448279|38973061|FG001|Overall Study|Adverse Event|1|||
16132677|NCT00448279|38973060|FG000|Overall Study|Disease progression|16|||
16132678|NCT00448279|38973061|FG001|Overall Study|Disease progression|18|||
16132679|NCT00448279|38973060|FG000|Overall Study|Withdrawal by Subject|4|||
16132680|NCT00448279|38973061|FG001|Overall Study|Withdrawal by Subject|3|||
16132681|NCT00448279|38973060|FG000|Overall Study|Other|6|||
16132682|NCT00448279|38973061|FG001|Overall Study|Other|4|||
16132683|NCT00448279|38973060|FG000|Overall Study|Protocol Violation|0|||
16132684|NCT00448279|38973061|FG001|Overall Study|Protocol Violation|1|||
16132685|NCT02683876|38973062|FG000|Overall Study|samples damaged during shipping|2|||
16132686|NCT02683876|38973063|FG001|Overall Study|samples damaged during shipping|0|||
16132687|NCT02134977|38973066|FG000|Overall Study|Protocol Deviation|102|||
16132688|NCT01411839|38973067|FG000|Overall Study|Lost to Follow-up|4|||
16132689|NCT01411839|38973068|FG001|Overall Study|Lost to Follow-up|3|||
16132690|NCT01878214|38973071|FG000|Overall Study|Withdrawal by Subject|18|||
16132691|NCT01878214|38973072|FG001|Overall Study|Withdrawal by Subject|7|||
16132692|NCT01878214|38973071|FG000|Overall Study|Death|0|||
16132693|NCT01878214|38973072|FG001|Overall Study|Death|1|||
16132694|NCT01878214|38973071|FG000|Overall Study|Lost to Follow-up|35|||
16132695|NCT01878214|38973072|FG001|Overall Study|Lost to Follow-up|36|||
16132696|NCT01912456|38973073|FG000|Period 1|Physician Decision|0|||
16132697|NCT01912456|38973074|FG001|Period 1|Physician Decision|0|||
16132698|NCT01912456|38973075|FG002|Period 1|Physician Decision|1|||
16132699|NCT01912456|38973076|FG003|Period 1|Physician Decision|0|||
16132700|NCT01912456|38973073|FG000|Period 1|non-compliance|1|||
16132701|NCT01912456|38973074|FG001|Period 1|non-compliance|0|||
16132702|NCT01912456|38973075|FG002|Period 1|non-compliance|0|||
16132703|NCT01912456|38973076|FG003|Period 1|non-compliance|1|||
16132704|NCT01912456|38973073|FG000|Period 1|Adverse Event|1|||
16132705|NCT01912456|38973074|FG001|Period 1|Adverse Event|0|||
16132706|NCT01912456|38973075|FG002|Period 1|Adverse Event|0|||
16132707|NCT01912456|38973076|FG003|Period 1|Adverse Event|1|||
16132708|NCT01912456|38973073|FG000|Period 1|Withdrawal by Subject|0|||
16132709|NCT01912456|38973074|FG001|Period 1|Withdrawal by Subject|1|||
16132710|NCT01912456|38973075|FG002|Period 1|Withdrawal by Subject|1|||
16132711|NCT01912456|38973076|FG003|Period 1|Withdrawal by Subject|1|||
16132712|NCT01912456|38973073|FG000|Period 2|Lack of Efficacy|0|||
16132713|NCT01912456|38973074|FG001|Period 2|Lack of Efficacy|2|||
16132714|NCT01912456|38973075|FG002|Period 2|Lack of Efficacy|0|||
16132715|NCT01912456|38973076|FG003|Period 2|Lack of Efficacy|0|||
16132716|NCT01912456|38973073|FG000|Period 2|Adverse Event|0|||
16132717|NCT01912456|38973074|FG001|Period 2|Adverse Event|0|||
16132718|NCT01912456|38973075|FG002|Period 2|Adverse Event|0|||
16132719|NCT01912456|38973076|FG003|Period 2|Adverse Event|1|||
16132720|NCT00560066|38973081|FG000|Overall Study|Death|2|||
16132721|NCT00560066|38973082|FG001|Overall Study|Death|1|||
16132722|NCT00560066|38973081|FG000|Overall Study|Withdrawal by Subject|0|||
16132723|NCT00560066|38973082|FG001|Overall Study|Withdrawal by Subject|3|||
16132724|NCT00560066|38973081|FG000|Overall Study|Lost to Follow-up|4|||
16132725|NCT00560066|38973082|FG001|Overall Study|Lost to Follow-up|10|||
16132726|NCT00560066|38973081|FG000|Overall Study|Protocol Violation|0|||
16132727|NCT00560066|38973082|FG001|Overall Study|Protocol Violation|1|||
16132728|NCT00560066|38973081|FG000|Overall Study|Administrative reason|0|||
16132729|NCT00560066|38973082|FG001|Overall Study|Administrative reason|5|||
16132730|NCT00560066|38973081|FG000|Overall Study|Missing primary reason|0|||
16132731|NCT00560066|38973082|FG001|Overall Study|Missing primary reason|2|||
16132732|NCT01773291|38973083|FG000|Overall Study|Protocol Violation|1|||
16132733|NCT01773291|38973084|FG001|Overall Study|Protocol Violation|0|||
16132734|NCT01773291|38973085|FG002|Overall Study|Protocol Violation|0|||
16132735|NCT01773291|38973083|FG000|Overall Study|Withdrawal by Subject|0|||
16132736|NCT01773291|38973084|FG001|Overall Study|Withdrawal by Subject|0|||
16132737|NCT01773291|38973085|FG002|Overall Study|Withdrawal by Subject|1|||
16132738|NCT03607422|38973086|FG000|Overall Study|Adverse Event|7|||
16132739|NCT03607422|38973087|FG001|Overall Study|Adverse Event|3|||
16132740|NCT03607422|38973088|FG002|Overall Study|Adverse Event|2|||
16132741|NCT03607422|38973089|FG003|Overall Study|Adverse Event|0|||
16132742|NCT03607422|38973090|FG004|Overall Study|Adverse Event|2|||
16132743|NCT03607422|38973091|FG005|Overall Study|Adverse Event|0|||
16132744|NCT03607422|38973086|FG000|Overall Study|Withdrawal by Subject|11|||
16362185|NCT02555878|39811953|FG001|Overall Study|Physician Decision|13|||
16362186|NCT02555878|39811952|FG000|Overall Study|Other|17|||
16132745|NCT03607422|38973087|FG001|Overall Study|Withdrawal by Subject|3|||
16362187|NCT02555878|39811953|FG001|Overall Study|Other|17|||
16132746|NCT03607422|38973088|FG002|Overall Study|Withdrawal by Subject|6|||
16132747|NCT03607422|38973089|FG003|Overall Study|Withdrawal by Subject|2|||
16132748|NCT03607422|38973090|FG004|Overall Study|Withdrawal by Subject|0|||
16132749|NCT03607422|38973091|FG005|Overall Study|Withdrawal by Subject|0|||
16132750|NCT03607422|38973086|FG000|Overall Study|Lost to Follow-up|0|||
16132751|NCT03607422|38973087|FG001|Overall Study|Lost to Follow-up|0|||
16132752|NCT03607422|38973088|FG002|Overall Study|Lost to Follow-up|1|||
16132753|NCT03607422|38973089|FG003|Overall Study|Lost to Follow-up|0|||
16132754|NCT03607422|38973090|FG004|Overall Study|Lost to Follow-up|0|||
16132755|NCT03607422|38973091|FG005|Overall Study|Lost to Follow-up|0|||
16434121|NCT01454596|40067399|FG001|Overall Study|Death|0|||
16434122|NCT01454596|40067400|FG002|Overall Study|Death|0|||
16434123|NCT01454596|40067401|FG003|Overall Study|Death|0|||
16434124|NCT01454596|40067402|FG004|Overall Study|Death|0|||
16434125|NCT01454596|40067403|FG005|Overall Study|Death|0|||
16434126|NCT01454596|40067404|FG006|Overall Study|Death|0|||
16434127|NCT01454596|40067405|FG007|Overall Study|Death|0|||
16434128|NCT01454596|40067406|FG008|Overall Study|Death|0|||
16434129|NCT01454596|40067407|FG009|Overall Study|Death|1|||
16434130|NCT01454596|40067408|FG010|Overall Study|Death|1|||
16434131|NCT01454596|40067409|FG011|Overall Study|Death|0|||
16434132|NCT01410890|40067410|FG000|Overall Study|Withdrawal by Subject|0|||
16434133|NCT01410890|40067411|FG001|Overall Study|Withdrawal by Subject|1|||
16434134|NCT00337207|40067416|FG000|Overall Study|Withdrawal by Subject|3|||
16434135|NCT04112303|40067420|FG000|Overall Study|Death|1|||
16434136|NCT02485691|40067422|FG000|Overall Study|Adverse Event|25|||
16434137|NCT02485691|40067423|FG001|Overall Study|Adverse Event|11|||
16434138|NCT02485691|40067422|FG000|Overall Study|Poor compliance to protocol|0|||
16434139|NCT02485691|40067423|FG001|Overall Study|Poor compliance to protocol|1|||
16434140|NCT02485691|40067422|FG000|Overall Study|Disease progression|57|||
16434141|NCT02485691|40067423|FG001|Overall Study|Disease progression|92|||
16434142|NCT02485691|40067422|FG000|Overall Study|Investigator's decision|23|||
16434143|NCT02485691|40067423|FG001|Overall Study|Investigator's decision|5|||
16434144|NCT02485691|40067422|FG000|Overall Study|Participant's request|13|||
16434145|NCT02485691|40067423|FG001|Overall Study|Participant's request|6|||
16434146|NCT02485691|40067422|FG000|Overall Study|Other reason|8|||
16132756|NCT03607422|38973086|FG000|Overall Study|Other|12|||
16132757|NCT03607422|38973087|FG001|Overall Study|Other|4|||
16132758|NCT03607422|38973088|FG002|Overall Study|Other|1|||
16132759|NCT03607422|38973089|FG003|Overall Study|Other|2|||
16132760|NCT03607422|38973090|FG004|Overall Study|Other|0|||
16132761|NCT03607422|38973091|FG005|Overall Study|Other|2|||
16132762|NCT03607422|38973086|FG000|Overall Study|Ongoing at Time of Analysis|8|||
16132763|NCT03607422|38973087|FG001|Overall Study|Ongoing at Time of Analysis|0|||
16132764|NCT03607422|38973088|FG002|Overall Study|Ongoing at Time of Analysis|2|||
16132765|NCT03607422|38973089|FG003|Overall Study|Ongoing at Time of Analysis|1|||
16132766|NCT03607422|38973090|FG004|Overall Study|Ongoing at Time of Analysis|1|||
16132767|NCT03607422|38973091|FG005|Overall Study|Ongoing at Time of Analysis|1|||
16132768|NCT00777946|38973092|FG000|Overall Study|Adverse Event|11|||
16132769|NCT00777946|38973093|FG001|Overall Study|Adverse Event|1|||
16132770|NCT00777946|38973094|FG002|Overall Study|Adverse Event|3|||
16132771|NCT00777946|38973092|FG000|Overall Study|Lack of Efficacy|0|||
16132772|NCT00777946|38973093|FG001|Overall Study|Lack of Efficacy|0|||
16132773|NCT00777946|38973094|FG002|Overall Study|Lack of Efficacy|9|||
16132774|NCT00777946|38973092|FG000|Overall Study|Condition no longer required study drug|1|||
16132775|NCT00777946|38973093|FG001|Overall Study|Condition no longer required study drug|0|||
16132776|NCT00777946|38973094|FG002|Overall Study|Condition no longer required study drug|0|||
16132777|NCT00777946|38973092|FG000|Overall Study|Patient withdrew consent|3|||
16132778|NCT00777946|38973093|FG001|Overall Study|Patient withdrew consent|2|||
16132779|NCT00777946|38973094|FG002|Overall Study|Patient withdrew consent|3|||
16132780|NCT00777946|38973092|FG000|Overall Study|Lost to Follow-up|3|||
16132781|NCT00777946|38973093|FG001|Overall Study|Lost to Follow-up|1|||
16132782|NCT00777946|38973094|FG002|Overall Study|Lost to Follow-up|0|||
16132783|NCT00777946|38973092|FG000|Overall Study|Protocol deviation|2|||
16132784|NCT00777946|38973093|FG001|Overall Study|Protocol deviation|1|||
16132785|NCT00777946|38973094|FG002|Overall Study|Protocol deviation|1|||
16132786|NCT00777946|38973092|FG000|Overall Study|Randomized in error|1|||
16132787|NCT00777946|38973093|FG001|Overall Study|Randomized in error|1|||
16132788|NCT00777946|38973094|FG002|Overall Study|Randomized in error|0|||
16132789|NCT00427895|38973099|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
16132790|NCT00427895|38973100|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
16132791|NCT00427895|38973101|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
16132792|NCT00427895|38973102|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
16434147|NCT02485691|40067423|FG001|Overall Study|Other reason|9|||
16434148|NCT02485691|40067422|FG000|Overall Study|Randomized and not treated|3|||
16434149|NCT02485691|40067423|FG001|Overall Study|Randomized and not treated|2|||
16132793|NCT00427895|38973103|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
16132794|NCT00427895|38973104|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
16132795|NCT00427895|38973105|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
16132796|NCT00427895|38973106|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
16132797|NCT00427895|38973099|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
16132798|NCT00427895|38973100|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
16132799|NCT00427895|38973101|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
16132800|NCT00427895|38973102|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
16132801|NCT00427895|38973103|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
16132802|NCT00427895|38973104|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
16132803|NCT00427895|38973105|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
16132804|NCT00427895|38973106|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
16434150|NCT00404651|40067424|FG000|Overall Study|Serious Adverse Event|0|||
16132805|NCT00427895|38973099|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
16132806|NCT00427895|38973100|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
16132807|NCT00427895|38973101|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
16132808|NCT00427895|38973102|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
16132809|NCT00427895|38973103|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
16132810|NCT00427895|38973104|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
16132811|NCT00427895|38973105|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
16132812|NCT00427895|38973106|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
16132813|NCT00427895|38973099|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
16132814|NCT00427895|38973100|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
16132815|NCT00427895|38973101|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
16132816|NCT00427895|38973102|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
16132817|NCT00427895|38973103|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
16132818|NCT00427895|38973104|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
16132819|NCT00427895|38973105|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
16132820|NCT00427895|38973106|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
16132821|NCT00427895|38973099|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
16132822|NCT00427895|38973100|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
16132823|NCT00427895|38973101|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
16132824|NCT00427895|38973102|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
16132825|NCT00427895|38973103|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
16132826|NCT00427895|38973104|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
16132827|NCT00427895|38973105|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
16132828|NCT00427895|38973106|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
16132829|NCT00427895|38973099|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
16132830|NCT00427895|38973100|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
16132831|NCT00427895|38973101|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
16132832|NCT00427895|38973102|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
16132833|NCT00427895|38973103|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
16132834|NCT00427895|38973104|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
16132835|NCT00427895|38973105|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
16132836|NCT00427895|38973106|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
16132837|NCT00427895|38973099|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
16132838|NCT00427895|38973100|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
16132839|NCT00427895|38973101|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
16132840|NCT00427895|38973102|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
16132841|NCT00427895|38973103|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
16132842|NCT00427895|38973104|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
16132843|NCT00427895|38973105|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
16132844|NCT00427895|38973106|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
16132845|NCT00427895|38973099|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
16132846|NCT00427895|38973100|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
16132847|NCT00427895|38973101|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
16132848|NCT00427895|38973102|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
16132849|NCT00427895|38973103|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
16132850|NCT00427895|38973104|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
16132851|NCT00427895|38973105|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
16132852|NCT00427895|38973106|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
16434151|NCT00404651|40067425|FG001|Overall Study|Serious Adverse Event|0|||
16434152|NCT00404651|40067426|FG002|Overall Study|Serious Adverse Event|2|||
16434153|NCT00404651|40067427|FG003|Overall Study|Serious Adverse Event|0|||
16434154|NCT00404651|40067424|FG000|Overall Study|Protocol Violation|10|||
16434155|NCT00404651|40067425|FG001|Overall Study|Protocol Violation|5|||
16434156|NCT00404651|40067426|FG002|Overall Study|Protocol Violation|14|||
16434157|NCT00404651|40067427|FG003|Overall Study|Protocol Violation|5|||
16434158|NCT00404651|40067424|FG000|Overall Study|Lost to Follow-up|15|||
16434159|NCT00404651|40067425|FG001|Overall Study|Lost to Follow-up|11|||
16434160|NCT00404651|40067426|FG002|Overall Study|Lost to Follow-up|13|||
16434161|NCT00404651|40067427|FG003|Overall Study|Lost to Follow-up|10|||
16434162|NCT00404651|40067424|FG000|Overall Study|Withdrawal by Subject|14|||
16434163|NCT00404651|40067425|FG001|Overall Study|Withdrawal by Subject|12|||
16434164|NCT00404651|40067426|FG002|Overall Study|Withdrawal by Subject|16|||
16434165|NCT00404651|40067427|FG003|Overall Study|Withdrawal by Subject|6|||
16434166|NCT00580723|40067428|FG000|Overall Study|Did not want to participate in extension|3|||
16132853|NCT00427895|38973099|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
16132854|NCT00427895|38973100|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
16132855|NCT00427895|38973101|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
16434167|NCT00580723|40067428|FG000|Overall Study|Lost to Follow-up|5|||
16434168|NCT02314052|40067429|FG000|Cycle One|Adverse Event|0|||
16434169|NCT02314052|40067430|FG001|Cycle One|Adverse Event|0|||
16434170|NCT02314052|40067431|FG002|Cycle One|Adverse Event|0|||
16434171|NCT02314052|40067432|FG003|Cycle One|Adverse Event|1|||
16434172|NCT02314052|40067433|FG004|Cycle One|Adverse Event|0|||
16434173|NCT02314052|40067434|FG005|Cycle One|Adverse Event|0|||
16434174|NCT01643668|40067437|FG000|Overall Study|Death|1|||
16132856|NCT00427895|38973102|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
16132857|NCT00427895|38973103|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
16132858|NCT00427895|38973104|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
16250822|NCT01567306|39400646|FG003|Overall Study|Adverse Event|2|||
16362188|NCT00390689|39811954|FG000|Overall Study|Adverse Event|2|||
16250823|NCT01567306|39400647|FG004|Overall Study|Adverse Event|4|||
16362189|NCT00390689|39811955|FG001|Overall Study|Adverse Event|5|||
16362190|NCT00390689|39811956|FG002|Overall Study|Adverse Event|2|||
16362191|NCT00390689|39811954|FG000|Overall Study|Lack of Efficacy|0|||
16362192|NCT00390689|39811955|FG001|Overall Study|Lack of Efficacy|0|||
16362193|NCT00390689|39811956|FG002|Overall Study|Lack of Efficacy|1|||
16362194|NCT00390689|39811954|FG000|Overall Study|Protocol Violation|1|||
16362195|NCT00390689|39811955|FG001|Overall Study|Protocol Violation|0|||
16362196|NCT00390689|39811956|FG002|Overall Study|Protocol Violation|0|||
16362197|NCT00390689|39811954|FG000|Overall Study|Investigator's judgement|2|||
16362198|NCT00390689|39811955|FG001|Overall Study|Investigator's judgement|0|||
16362199|NCT00390689|39811956|FG002|Overall Study|Investigator's judgement|0|||
16362200|NCT02332707|39811957|FG000|Overall Study|Adverse Event|0|||
16362201|NCT02332707|39811958|FG001|Overall Study|Adverse Event|0|||
16362202|NCT02332707|39811959|FG002|Overall Study|Adverse Event|0|||
16362203|NCT02332707|39811960|FG003|Overall Study|Adverse Event|0|||
16362204|NCT02332707|39811961|FG004|Overall Study|Adverse Event|0|||
16362205|NCT02332707|39811962|FG005|Overall Study|Adverse Event|0|||
16362206|NCT02332707|39811963|FG006|Overall Study|Adverse Event|0|||
16362207|NCT02332707|39811964|FG007|Overall Study|Adverse Event|0|||
16362208|NCT02332707|39811965|FG008|Overall Study|Adverse Event|0|||
16132859|NCT00427895|38973105|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
16132860|NCT00427895|38973106|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
16132861|NCT00427895|38973099|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
16132862|NCT00427895|38973100|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
16132863|NCT00427895|38973101|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
16132864|NCT00427895|38973102|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
16132865|NCT00427895|38973103|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
16132866|NCT00427895|38973104|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
16132867|NCT00427895|38973105|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
16132868|NCT00427895|38973106|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
16132869|NCT00427895|38973099|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
16132870|NCT00427895|38973100|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
16132871|NCT00427895|38973101|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
16132872|NCT00427895|38973102|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
16132873|NCT00427895|38973103|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
16132874|NCT00427895|38973104|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
16132875|NCT00427895|38973105|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
16132876|NCT00427895|38973106|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
16132877|NCT00427895|38973099|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
16132878|NCT00427895|38973100|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
16132879|NCT00427895|38973101|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
16132880|NCT00427895|38973102|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
16132881|NCT00427895|38973103|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
16132882|NCT00427895|38973104|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
16132883|NCT00427895|38973105|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
16132884|NCT00427895|38973106|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
16132885|NCT00427895|38973099|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
16132886|NCT00427895|38973100|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
16132887|NCT00427895|38973101|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
16132888|NCT00427895|38973102|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
16362209|NCT02332707|39811966|FG009|Overall Study|Adverse Event|0|||
16132889|NCT00427895|38973103|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
16132890|NCT00427895|38973104|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
16132891|NCT00427895|38973105|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
16132892|NCT00427895|38973106|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
16132893|NCT00427895|38973099|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
16132894|NCT00427895|38973100|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
16132895|NCT00427895|38973101|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
16132896|NCT00427895|38973102|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
16132897|NCT00427895|38973103|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
16132898|NCT00427895|38973104|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
16132899|NCT00427895|38973105|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
16132900|NCT00427895|38973106|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
16132901|NCT00427895|38973099|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
16132902|NCT00427895|38973100|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
16132903|NCT00427895|38973101|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
16132904|NCT00427895|38973102|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
16132905|NCT00427895|38973103|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
16132906|NCT00427895|38973104|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
16132907|NCT00427895|38973105|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
16132908|NCT00427895|38973106|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
16132909|NCT00427895|38973099|FG000|Vax 1/Year 1 Follow-up|Death|1|||
16132910|NCT00427895|38973100|FG001|Vax 1/Year 1 Follow-up|Death|0|||
16132911|NCT00427895|38973101|FG002|Vax 1/Year 1 Follow-up|Death|0|||
16132912|NCT00427895|38973102|FG003|Vax 1/Year 1 Follow-up|Death|0|||
16132913|NCT00427895|38973103|FG004|Vax 1/Year 1 Follow-up|Death|0|||
16362210|NCT02332707|39811967|FG010|Overall Study|Adverse Event|0|||
16362211|NCT02332707|39811968|FG011|Overall Study|Adverse Event|0|||
16362212|NCT02332707|39811969|FG012|Overall Study|Adverse Event|1|||
16362213|NCT02332707|39811970|FG013|Overall Study|Adverse Event|0|||
16362214|NCT02332707|39811971|FG014|Overall Study|Adverse Event|0|||
16362215|NCT02332707|39811972|FG015|Overall Study|Adverse Event|0|||
16362216|NCT02332707|39811973|FG016|Overall Study|Adverse Event|0|||
16362217|NCT02332707|39811974|FG017|Overall Study|Adverse Event|0|||
16362218|NCT02332707|39811957|FG000|Overall Study|Lost to Follow-up|0|||
16362219|NCT02332707|39811958|FG001|Overall Study|Lost to Follow-up|0|||
16362220|NCT02332707|39811959|FG002|Overall Study|Lost to Follow-up|0|||
16362221|NCT02332707|39811960|FG003|Overall Study|Lost to Follow-up|0|||
16362222|NCT02332707|39811961|FG004|Overall Study|Lost to Follow-up|0|||
16434175|NCT01135134|40067438|FG000|Overall Study|Adverse Event|1|||
16434176|NCT01135134|40067439|FG001|Overall Study|Adverse Event|1|||
16434177|NCT01135134|40067438|FG000|Overall Study|Did not meet protocol eligibility|1|||
16434178|NCT01135134|40067439|FG001|Overall Study|Did not meet protocol eligibility|0|||
16434179|NCT02741635|40067440|FG000|Overall Study|Withdrawal by Subject|1|||
16434180|NCT01751984|40067441|FG000|Overall Study|Adverse Event|5|||
16434181|NCT01751984|40067442|FG001|Overall Study|Adverse Event|3|||
16434182|NCT01751984|40067441|FG000|Overall Study|Withdrawal by Subject|0|||
16434183|NCT01751984|40067442|FG001|Overall Study|Withdrawal by Subject|1|||
16434184|NCT01751984|40067441|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
16434185|NCT01751984|40067442|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
16434186|NCT01521507|40067447|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
16132914|NCT00427895|38973104|FG005|Vax 1/Year 1 Follow-up|Death|0|||
16132915|NCT00427895|38973105|FG006|Vax 1/Year 1 Follow-up|Death|0|||
16132916|NCT00427895|38973106|FG007|Vax 1/Year 1 Follow-up|Death|0|||
16132917|NCT00427895|38973099|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
16132918|NCT00427895|38973100|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
16132919|NCT00427895|38973101|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
16132920|NCT00427895|38973102|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
16132921|NCT00427895|38973103|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
16132922|NCT00427895|38973104|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
16132923|NCT00427895|38973105|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
16132924|NCT00427895|38973106|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
16132925|NCT00427895|38973099|FG000|Vax 1/Year 1 Follow-up|Other|0|||
16132926|NCT00427895|38973100|FG001|Vax 1/Year 1 Follow-up|Other|0|||
16132927|NCT00427895|38973101|FG002|Vax 1/Year 1 Follow-up|Other|0|||
16362223|NCT02332707|39811962|FG005|Overall Study|Lost to Follow-up|1|||
16362224|NCT02332707|39811963|FG006|Overall Study|Lost to Follow-up|0|||
16362225|NCT02332707|39811964|FG007|Overall Study|Lost to Follow-up|0|||
16362226|NCT02332707|39811965|FG008|Overall Study|Lost to Follow-up|0|||
16434187|NCT01521507|40067448|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
16434188|NCT01521507|40067447|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
16434189|NCT01521507|40067448|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
16434190|NCT01521507|40067447|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
16132928|NCT00427895|38973102|FG003|Vax 1/Year 1 Follow-up|Other|2|||
16132929|NCT00427895|38973103|FG004|Vax 1/Year 1 Follow-up|Other|0|||
16132930|NCT00427895|38973104|FG005|Vax 1/Year 1 Follow-up|Other|0|||
16132931|NCT00427895|38973105|FG006|Vax 1/Year 1 Follow-up|Other|0|||
16132932|NCT00427895|38973106|FG007|Vax 1/Year 1 Follow-up|Other|0|||
16132933|NCT00427895|38973099|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
16132934|NCT00427895|38973100|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
16362227|NCT02332707|39811966|FG009|Overall Study|Lost to Follow-up|0|||
16132935|NCT00427895|38973101|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
16132936|NCT00427895|38973102|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
16132937|NCT00427895|38973103|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
16132938|NCT00427895|38973104|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
16132939|NCT00427895|38973105|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
16132940|NCT00427895|38973106|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
16132941|NCT03268954|38973107|FG000|Overall Study|Ongoing|23|||
16132942|NCT03268954|38973108|FG001|Overall Study|Ongoing|31|||
16132943|NCT03268954|38973107|FG000|Overall Study|Adverse Event|53|||
16132944|NCT03268954|38973108|FG001|Overall Study|Adverse Event|62|||
16132945|NCT03268954|38973107|FG000|Overall Study|Withdrawal by Subject|25|||
16132946|NCT03268954|38973108|FG001|Overall Study|Withdrawal by Subject|16|||
16132947|NCT03268954|38973107|FG000|Overall Study|Progressive Disease|61|||
16132948|NCT03268954|38973108|FG001|Overall Study|Progressive Disease|48|||
16132949|NCT03268954|38973107|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
16132950|NCT03268954|38973108|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
16132951|NCT03268954|38973107|FG000|Overall Study|Reason not Specified|40|||
16132952|NCT03268954|38973108|FG001|Overall Study|Reason not Specified|40|||
16132953|NCT02533570|38973109|FG000|Overall Study|Adverse Event|0|||
16132954|NCT02533570|38973110|FG001|Overall Study|Adverse Event|1|||
16132955|NCT02533570|38973111|FG002|Overall Study|Adverse Event|1|||
16132956|NCT00323856|38973112|FG000|Overall Study|Withdrawal by Subject|1|||
16132957|NCT00323856|38973112|FG000|Overall Study|Was uncooperative and noncompliant|1|||
16132958|NCT00323856|38973112|FG000|Overall Study|Reason not specified|1|||
16132959|NCT00323856|38973112|FG000|Overall Study|Missing|2|||
16132960|NCT01491672|38973115|FG000|Overall Study|Lost to Follow-up|0|||
16132961|NCT01491672|38973116|FG001|Overall Study|Lost to Follow-up|4|||
16132962|NCT01491672|38973117|FG002|Overall Study|Lost to Follow-up|1|||
16132963|NCT01491672|38973115|FG000|Overall Study|Withdrawal by Subject|6|||
16132964|NCT01491672|38973116|FG001|Overall Study|Withdrawal by Subject|7|||
16132965|NCT01491672|38973117|FG002|Overall Study|Withdrawal by Subject|0|||
16132966|NCT01491672|38973115|FG000|Overall Study|Adverse Event|8|||
16132967|NCT01491672|38973116|FG001|Overall Study|Adverse Event|10|||
16132968|NCT01491672|38973117|FG002|Overall Study|Adverse Event|4|||
16132969|NCT01491672|38973115|FG000|Overall Study|Disease progression|42|||
16132970|NCT01491672|38973116|FG001|Overall Study|Disease progression|34|||
16132971|NCT01491672|38973117|FG002|Overall Study|Disease progression|6|||
16132972|NCT01491672|38973115|FG000|Overall Study|Protocol deviation|0|||
16132973|NCT01491672|38973116|FG001|Overall Study|Protocol deviation|1|||
16132974|NCT01491672|38973117|FG002|Overall Study|Protocol deviation|0|||
16132975|NCT01491672|38973115|FG000|Overall Study|Death|0|||
16132976|NCT01491672|38973116|FG001|Overall Study|Death|4|||
16132977|NCT01491672|38973117|FG002|Overall Study|Death|0|||
16132978|NCT03057977|38973118|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
16132979|NCT03057977|38973119|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
16132980|NCT03057977|38973118|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
16132981|NCT03057977|38973119|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
16132982|NCT03057977|38973118|FG000|Discontinuation From Treatment|Protocol Violation|6|||
16132983|NCT03057977|38973119|FG001|Discontinuation From Treatment|Protocol Violation|5|||
16132984|NCT03057977|38973118|FG000|Discontinuation From Treatment|Not treated|4|||
16132985|NCT03057977|38973119|FG001|Discontinuation From Treatment|Not treated|0|||
16132986|NCT03057977|38973118|FG000|Discontinuation From Treatment|Adverse Event|343|||
16132987|NCT03057977|38973119|FG001|Discontinuation From Treatment|Adverse Event|337|||
16132988|NCT03057977|38973118|FG000|Discontinuation From Treatment|Reason Unknown|0|||
16132989|NCT03057977|38973119|FG001|Discontinuation From Treatment|Reason Unknown|1|||
16132990|NCT03057977|38973118|FG000|Discontinuation From Treatment|Personal Reasons|1|||
16132991|NCT03057977|38973119|FG001|Discontinuation From Treatment|Personal Reasons|1|||
16132992|NCT03057977|38973118|FG000|Discontinuation From Treatment|Unblinded medication|1|||
16132993|NCT03057977|38973119|FG001|Discontinuation From Treatment|Unblinded medication|0|||
16132994|NCT03057977|38973118|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
16132995|NCT03057977|38973119|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
16132996|NCT03057977|38973118|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
16132997|NCT03057977|38973119|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
16132998|NCT03057977|38973118|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
16132999|NCT03057977|38973119|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
16133000|NCT03057977|38973118|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
16133001|NCT03057977|38973119|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
16133002|NCT03057977|38973118|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
16133003|NCT03057977|38973119|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
16133004|NCT03057977|38973118|FG000|Discontinuation From Treatment|Not attending study visit|3|||
16133005|NCT03057977|38973119|FG001|Discontinuation From Treatment|Not attending study visit|10|||
16133006|NCT03057977|38973118|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
16133007|NCT03057977|38973119|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
16133008|NCT03057977|38973118|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
16133009|NCT03057977|38973119|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
16133010|NCT03057977|38973118|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
16133011|NCT03057977|38973119|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
16133012|NCT03057977|38973118|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
16133013|NCT03057977|38973119|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
16133014|NCT03057977|38973118|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
16133015|NCT03057977|38973119|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
16133016|NCT04615247|38976718|FG000|Overall Study|Adverse Event|0|||
16133017|NCT04615247|38976719|FG001|Overall Study|Adverse Event|2|||
16133018|NCT04615247|38976718|FG000|Overall Study|Withdrawal by Subject|1|||
16133019|NCT04615247|38976719|FG001|Overall Study|Withdrawal by Subject|1|||
16133020|NCT02647320|38976720|FG000|Overall Study|Adverse Event|0|||
16133021|NCT02647320|38976721|FG001|Overall Study|Adverse Event|1|||
16133022|NCT02647320|38976722|FG002|Overall Study|Adverse Event|3|||
16133023|NCT02647320|38976723|FG003|Overall Study|Adverse Event|2|||
16133024|NCT02647320|38976724|FG004|Overall Study|Adverse Event|1|||
16133025|NCT02647320|38976720|FG000|Overall Study|Protocol Violation|0|||
16133026|NCT02647320|38976721|FG001|Overall Study|Protocol Violation|0|||
16133027|NCT02647320|38976722|FG002|Overall Study|Protocol Violation|3|||
16133028|NCT02647320|38976723|FG003|Overall Study|Protocol Violation|0|||
16133029|NCT02647320|38976724|FG004|Overall Study|Protocol Violation|0|||
16133030|NCT02647320|38976720|FG000|Overall Study|Withdrawal by Subject|7|||
16133031|NCT02647320|38976721|FG001|Overall Study|Withdrawal by Subject|4|||
16133032|NCT02647320|38976722|FG002|Overall Study|Withdrawal by Subject|2|||
16133033|NCT02647320|38976723|FG003|Overall Study|Withdrawal by Subject|2|||
16133034|NCT02647320|38976724|FG004|Overall Study|Withdrawal by Subject|7|||
16133035|NCT02647320|38976720|FG000|Overall Study|Persistent hyperglycemia|0|||
16133036|NCT02647320|38976721|FG001|Overall Study|Persistent hyperglycemia|1|||
16133037|NCT02647320|38976722|FG002|Overall Study|Persistent hyperglycemia|1|||
16133038|NCT02647320|38976723|FG003|Overall Study|Persistent hyperglycemia|1|||
16133039|NCT02647320|38976724|FG004|Overall Study|Persistent hyperglycemia|1|||
16133040|NCT02647320|38976720|FG000|Overall Study|Study terminated by sponsor|1|||
16133041|NCT02647320|38976721|FG001|Overall Study|Study terminated by sponsor|1|||
16133042|NCT02647320|38976722|FG002|Overall Study|Study terminated by sponsor|1|||
16133043|NCT02647320|38976723|FG003|Overall Study|Study terminated by sponsor|1|||
16133044|NCT02647320|38976724|FG004|Overall Study|Study terminated by sponsor|2|||
16133045|NCT02647320|38976720|FG000|Overall Study|Reason not provided|0|||
16133046|NCT02647320|38976721|FG001|Overall Study|Reason not provided|0|||
16133047|NCT02647320|38976722|FG002|Overall Study|Reason not provided|1|||
16133048|NCT02647320|38976723|FG003|Overall Study|Reason not provided|0|||
16133049|NCT02647320|38976724|FG004|Overall Study|Reason not provided|2|||
16133050|NCT02647320|38976720|FG000|Overall Study|Lost to Follow-up|1|||
16133051|NCT02647320|38976721|FG001|Overall Study|Lost to Follow-up|1|||
16133052|NCT02647320|38976722|FG002|Overall Study|Lost to Follow-up|0|||
16133053|NCT02647320|38976723|FG003|Overall Study|Lost to Follow-up|0|||
16133054|NCT02647320|38976724|FG004|Overall Study|Lost to Follow-up|0|||
16133055|NCT02647320|38976720|FG000|Overall Study|Develop anemia|1|||
16133056|NCT02647320|38976721|FG001|Overall Study|Develop anemia|0|||
16133057|NCT02647320|38976722|FG002|Overall Study|Develop anemia|0|||
16133058|NCT02647320|38976723|FG003|Overall Study|Develop anemia|0|||
16133059|NCT02647320|38976724|FG004|Overall Study|Develop anemia|0|||
16133060|NCT02647320|38976720|FG000|Overall Study|Lack of Efficacy|0|||
16133061|NCT02647320|38976721|FG001|Overall Study|Lack of Efficacy|0|||
16133062|NCT02647320|38976722|FG002|Overall Study|Lack of Efficacy|0|||
16133063|NCT02647320|38976723|FG003|Overall Study|Lack of Efficacy|1|||
16362228|NCT02332707|39811967|FG010|Overall Study|Lost to Follow-up|2|||
16133064|NCT02647320|38976724|FG004|Overall Study|Lack of Efficacy|0|||
16133065|NCT02647320|38976720|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
16133066|NCT02647320|38976721|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
16133067|NCT02647320|38976722|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
16133068|NCT02647320|38976723|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
16133069|NCT02647320|38976724|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
16133070|NCT02054520|38976725|FG000|Overall Study|Adverse Event|1|||
16133071|NCT02054520|38976726|FG001|Overall Study|Adverse Event|4|||
16362229|NCT02332707|39811968|FG011|Overall Study|Lost to Follow-up|0|||
16362230|NCT02332707|39811969|FG012|Overall Study|Lost to Follow-up|3|||
16362231|NCT02332707|39811970|FG013|Overall Study|Lost to Follow-up|0|||
16362232|NCT02332707|39811971|FG014|Overall Study|Lost to Follow-up|0|||
16362233|NCT02332707|39811972|FG015|Overall Study|Lost to Follow-up|0|||
16362234|NCT02332707|39811973|FG016|Overall Study|Lost to Follow-up|0|||
16362235|NCT02332707|39811974|FG017|Overall Study|Lost to Follow-up|0|||
16362236|NCT02332707|39811957|FG000|Overall Study|Physician Decision|0|||
16362237|NCT02332707|39811958|FG001|Overall Study|Physician Decision|0|||
16362238|NCT02332707|39811959|FG002|Overall Study|Physician Decision|0|||
16362239|NCT02332707|39811960|FG003|Overall Study|Physician Decision|1|||
16133072|NCT02054520|38976727|FG002|Overall Study|Adverse Event|2|||
16362240|NCT02332707|39811961|FG004|Overall Study|Physician Decision|0|||
16133073|NCT02054520|38976728|FG003|Overall Study|Adverse Event|1|||
16133074|NCT02054520|38976729|FG004|Overall Study|Adverse Event|1|||
16133075|NCT02054520|38976730|FG005|Overall Study|Adverse Event|0|||
16133076|NCT02054520|38976725|FG000|Overall Study|Lack of Efficacy|7|||
16133077|NCT02054520|38976726|FG001|Overall Study|Lack of Efficacy|0|||
16133078|NCT02054520|38976727|FG002|Overall Study|Lack of Efficacy|2|||
16133079|NCT02054520|38976728|FG003|Overall Study|Lack of Efficacy|1|||
16133080|NCT02054520|38976729|FG004|Overall Study|Lack of Efficacy|3|||
16133081|NCT02054520|38976730|FG005|Overall Study|Lack of Efficacy|2|||
16133082|NCT02054520|38976725|FG000|Overall Study|Withdrawal by Subject|1|||
16133083|NCT02054520|38976726|FG001|Overall Study|Withdrawal by Subject|0|||
16133084|NCT02054520|38976727|FG002|Overall Study|Withdrawal by Subject|0|||
16133085|NCT02054520|38976728|FG003|Overall Study|Withdrawal by Subject|2|||
16133086|NCT02054520|38976729|FG004|Overall Study|Withdrawal by Subject|1|||
16133087|NCT02054520|38976730|FG005|Overall Study|Withdrawal by Subject|0|||
16133088|NCT02054520|38976725|FG000|Overall Study|Physician Decision|0|||
16133089|NCT02054520|38976726|FG001|Overall Study|Physician Decision|1|||
16133090|NCT02054520|38976727|FG002|Overall Study|Physician Decision|0|||
16133091|NCT02054520|38976728|FG003|Overall Study|Physician Decision|1|||
16133092|NCT02054520|38976729|FG004|Overall Study|Physician Decision|0|||
16133093|NCT02054520|38976730|FG005|Overall Study|Physician Decision|1|||
16133094|NCT02054520|38976725|FG000|Overall Study|Study terminated by Sponsor|0|||
16133095|NCT02054520|38976726|FG001|Overall Study|Study terminated by Sponsor|0|||
16133096|NCT02054520|38976727|FG002|Overall Study|Study terminated by Sponsor|2|||
16133097|NCT02054520|38976728|FG003|Overall Study|Study terminated by Sponsor|1|||
16133098|NCT02054520|38976729|FG004|Overall Study|Study terminated by Sponsor|0|||
16133099|NCT02054520|38976730|FG005|Overall Study|Study terminated by Sponsor|0|||
16133100|NCT01839487|38976731|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
16133101|NCT01839487|38976732|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
16133102|NCT01839487|38976733|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
16133103|NCT01839487|38976734|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
16133104|NCT01839487|38976735|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
16133105|NCT01839487|38976736|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
16133106|NCT01839487|38976731|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
16133107|NCT01839487|38976732|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
16133108|NCT01839487|38976733|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
16133109|NCT01839487|38976734|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
16133110|NCT01839487|38976735|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
16133111|NCT01839487|38976736|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
16133112|NCT01839487|38976731|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
16133113|NCT01839487|38976732|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
16133114|NCT01839487|38976733|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
16133115|NCT01839487|38976734|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
16133116|NCT01839487|38976735|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
16133117|NCT01839487|38976736|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
16133118|NCT01839487|38976731|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
16133119|NCT01839487|38976732|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
16434191|NCT01521507|40067448|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
16133120|NCT01839487|38976733|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
16133121|NCT01839487|38976734|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
16133122|NCT01839487|38976735|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
16133123|NCT01839487|38976736|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
16133124|NCT01839487|38976731|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
16133125|NCT01839487|38976732|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
16434192|NCT01521507|40067447|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
16133126|NCT01839487|38976733|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
16133127|NCT01839487|38976734|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
16133128|NCT01839487|38976735|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
16133129|NCT01839487|38976736|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
16133130|NCT01839487|38976731|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
16133131|NCT01839487|38976732|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
16133132|NCT01839487|38976733|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
16133133|NCT01839487|38976734|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
16133134|NCT01839487|38976735|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
16133135|NCT01839487|38976736|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
16133136|NCT01839487|38976731|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
16133137|NCT01839487|38976732|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
16133138|NCT01839487|38976733|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
16133139|NCT01839487|38976734|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
16133140|NCT01839487|38976735|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
16133141|NCT01839487|38976736|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
16133142|NCT01839487|38976731|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
16133143|NCT01839487|38976732|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
16133144|NCT01839487|38976733|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
16133145|NCT01839487|38976734|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
16362241|NCT02332707|39811962|FG005|Overall Study|Physician Decision|0|||
16133146|NCT01839487|38976735|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
16133147|NCT01839487|38976736|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
16133148|NCT01839487|38976731|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
16133149|NCT01839487|38976732|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
16133150|NCT01839487|38976733|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
16133151|NCT01839487|38976734|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
16133152|NCT01839487|38976735|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
16133153|NCT01839487|38976736|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
16133154|NCT00731120|38976738|FG000|Overall Study|Adverse Event|7|||
16133155|NCT00731120|38976739|FG001|Overall Study|Adverse Event|6|||
16133156|NCT00731120|38976740|FG002|Overall Study|Adverse Event|8|||
16133157|NCT00731120|38976738|FG000|Overall Study|Lack of Efficacy|4|||
16133158|NCT00731120|38976739|FG001|Overall Study|Lack of Efficacy|5|||
16133159|NCT00731120|38976740|FG002|Overall Study|Lack of Efficacy|4|||
16133160|NCT00731120|38976738|FG000|Overall Study|Noncompliance with Study Drug|3|||
16133161|NCT00731120|38976739|FG001|Overall Study|Noncompliance with Study Drug|3|||
16133162|NCT00731120|38976740|FG002|Overall Study|Noncompliance with Study Drug|1|||
16133163|NCT00731120|38976738|FG000|Overall Study|Protocol Deviations|1|||
16133164|NCT00731120|38976739|FG001|Overall Study|Protocol Deviations|6|||
16133165|NCT00731120|38976740|FG002|Overall Study|Protocol Deviations|1|||
16133166|NCT00731120|38976738|FG000|Overall Study|Withdrawal of Consent|13|||
16133167|NCT00731120|38976739|FG001|Overall Study|Withdrawal of Consent|8|||
16133168|NCT00731120|38976740|FG002|Overall Study|Withdrawal of Consent|4|||
16133169|NCT00731120|38976738|FG000|Overall Study|Lost to Follow-up|10|||
16133170|NCT00731120|38976739|FG001|Overall Study|Lost to Follow-up|15|||
16133171|NCT00731120|38976740|FG002|Overall Study|Lost to Follow-up|17|||
16133172|NCT00731120|38976738|FG000|Overall Study|Other|4|||
16133173|NCT00731120|38976739|FG001|Overall Study|Other|0|||
16133174|NCT00731120|38976740|FG002|Overall Study|Other|1|||
16133175|NCT02680002|38976741|FG000|Overall Study|Lost to Follow-up|5|||
16133176|NCT02680002|38976742|FG001|Overall Study|Lost to Follow-up|1|||
16133177|NCT02680002|38976743|FG002|Overall Study|Lost to Follow-up|4|||
16133178|NCT02680002|38976744|FG003|Overall Study|Lost to Follow-up|2|||
16133179|NCT02680002|38976745|FG004|Overall Study|Lost to Follow-up|0|||
16133180|NCT02680002|38976746|FG005|Overall Study|Lost to Follow-up|2|||
16133181|NCT02680002|38976741|FG000|Overall Study|Physician Decision|5|||
16133182|NCT02680002|38976742|FG001|Overall Study|Physician Decision|1|||
16133183|NCT02680002|38976743|FG002|Overall Study|Physician Decision|1|||
16133184|NCT02680002|38976744|FG003|Overall Study|Physician Decision|1|||
16133185|NCT02680002|38976745|FG004|Overall Study|Physician Decision|1|||
16133186|NCT02680002|38976746|FG005|Overall Study|Physician Decision|1|||
16133187|NCT02680002|38976741|FG000|Overall Study|Protocol Violation|1|||
16133188|NCT02680002|38976742|FG001|Overall Study|Protocol Violation|0|||
16133189|NCT02680002|38976743|FG002|Overall Study|Protocol Violation|1|||
16133190|NCT02680002|38976744|FG003|Overall Study|Protocol Violation|0|||
16133191|NCT02680002|38976745|FG004|Overall Study|Protocol Violation|1|||
16133192|NCT02680002|38976746|FG005|Overall Study|Protocol Violation|2|||
16133193|NCT02680002|38976741|FG000|Overall Study|Withdrawal by Subject|0|||
16133194|NCT02680002|38976742|FG001|Overall Study|Withdrawal by Subject|0|||
16133195|NCT02680002|38976743|FG002|Overall Study|Withdrawal by Subject|1|||
16133196|NCT02680002|38976744|FG003|Overall Study|Withdrawal by Subject|0|||
16133197|NCT02680002|38976745|FG004|Overall Study|Withdrawal by Subject|2|||
16133198|NCT02680002|38976746|FG005|Overall Study|Withdrawal by Subject|2|||
16133199|NCT02680002|38976741|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
16133200|NCT02680002|38976742|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
16133201|NCT02680002|38976743|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
16133202|NCT02680002|38976744|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
16133203|NCT02680002|38976745|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
16133204|NCT02680002|38976746|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
16133205|NCT02680002|38976741|FG000|Overall Study|Other|0|||
16133206|NCT02680002|38976742|FG001|Overall Study|Other|1|||
16133207|NCT02680002|38976743|FG002|Overall Study|Other|0|||
16133208|NCT02680002|38976744|FG003|Overall Study|Other|0|||
16133209|NCT02680002|38976745|FG004|Overall Study|Other|1|||
16434193|NCT01521507|40067448|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
16434194|NCT01521507|40067447|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
16434195|NCT01521507|40067448|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
16434196|NCT01521507|40067447|FG000|Stage 2: Observational Design|Physician Decision|1|||
16434197|NCT01521507|40067448|FG001|Stage 2: Observational Design|Physician Decision|0|||
16434198|NCT00721396|40070337|FG000|Overall Study|Adverse Event|4|||
16434199|NCT00721396|40070338|FG001|Overall Study|Adverse Event|7|||
16434200|NCT00721396|40070339|FG002|Overall Study|Adverse Event|2|||
16434201|NCT00721396|40070340|FG003|Overall Study|Adverse Event|0|||
16434202|NCT00721396|40070337|FG000|Overall Study|Withdrawal by Subject|12|||
16434203|NCT00721396|40070338|FG001|Overall Study|Withdrawal by Subject|15|||
16434204|NCT00721396|40070339|FG002|Overall Study|Withdrawal by Subject|3|||
16434205|NCT00721396|40070340|FG003|Overall Study|Withdrawal by Subject|7|||
16434206|NCT00721396|40070337|FG000|Overall Study|Lost to Follow-up|7|||
16434207|NCT00721396|40070338|FG001|Overall Study|Lost to Follow-up|9|||
16434208|NCT00721396|40070339|FG002|Overall Study|Lost to Follow-up|3|||
16434209|NCT00721396|40070340|FG003|Overall Study|Lost to Follow-up|3|||
16434210|NCT00721396|40070337|FG000|Overall Study|Protocol Violation|4|||
16434211|NCT00721396|40070338|FG001|Overall Study|Protocol Violation|3|||
16434212|NCT00721396|40070339|FG002|Overall Study|Protocol Violation|1|||
16434213|NCT00721396|40070340|FG003|Overall Study|Protocol Violation|0|||
16434214|NCT00721396|40070337|FG000|Overall Study|Inappropriate enrollment|0|||
16434215|NCT00721396|40070338|FG001|Overall Study|Inappropriate enrollment|2|||
16434216|NCT00721396|40070339|FG002|Overall Study|Inappropriate enrollment|0|||
16434217|NCT00721396|40070340|FG003|Overall Study|Inappropriate enrollment|0|||
16434218|NCT00721396|40070337|FG000|Overall Study|Administrative reason|3|||
16434219|NCT00721396|40070338|FG001|Overall Study|Administrative reason|0|||
16434220|NCT00721396|40070339|FG002|Overall Study|Administrative reason|1|||
16434221|NCT00721396|40070340|FG003|Overall Study|Administrative reason|0|||
16434222|NCT00849940|40070347|FG000|Overall Study|Physician Decision|4|||
16434223|NCT03880019|40070348|FG000|Overall Study|Competing disease|1|||
16434224|NCT01350999|40070349|FG000|Overall Study|Adverse Event|4|||
16434225|NCT01350999|40070350|FG001|Overall Study|Adverse Event|9|||
16434226|NCT01350999|40070351|FG002|Overall Study|Adverse Event|10|||
16434227|NCT01350999|40070349|FG000|Overall Study|Voluntary withdrawal|3|||
16434228|NCT01350999|40070350|FG001|Overall Study|Voluntary withdrawal|4|||
16434229|NCT01350999|40070351|FG002|Overall Study|Voluntary withdrawal|6|||
16434230|NCT01350999|40070349|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
16434231|NCT01350999|40070350|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
16434232|NCT01350999|40070351|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
16434233|NCT02610777|40070352|FG000|Overall Study|Lost to Follow-up|1|||
16434234|NCT02610777|40070353|FG001|Overall Study|Lost to Follow-up|0|||
16434235|NCT02610777|40070352|FG000|Overall Study|Site Terminated by Sponsor|9|||
16434236|NCT02610777|40070353|FG001|Overall Study|Site Terminated by Sponsor|8|||
16434237|NCT02610777|40070352|FG000|Overall Study|Withdrawal by Subject|2|||
16434238|NCT02610777|40070353|FG001|Overall Study|Withdrawal by Subject|2|||
16434239|NCT02610777|40070352|FG000|Overall Study|Reason not Specified|0|||
16434240|NCT02610777|40070353|FG001|Overall Study|Reason not Specified|1|||
16434241|NCT02610777|40070352|FG000|Overall Study|Death|50|||
16434242|NCT02610777|40070353|FG001|Overall Study|Death|47|||
16434243|NCT03310723|40070355|FG000|Overall Study|Withdrawal by Subject|0|||
16434244|NCT03310723|40070356|FG001|Overall Study|Withdrawal by Subject|1|||
16434245|NCT03310723|40070355|FG000|Overall Study|Protocol Violation|0|||
16434246|NCT03310723|40070356|FG001|Overall Study|Protocol Violation|2|||
16434247|NCT01724866|40070357|FG000|Overall Study|Adverse Event|0|||
16434248|NCT01724866|40070358|FG001|Overall Study|Adverse Event|0|||
16434249|NCT01724866|40070359|FG002|Overall Study|Adverse Event|1|||
16434250|NCT01724866|40070360|FG003|Overall Study|Adverse Event|1|||
16133210|NCT02680002|38976746|FG005|Overall Study|Other|0|||
16133211|NCT02680002|38976741|FG000|Overall Study|Adverse Event|0|||
16133212|NCT02680002|38976742|FG001|Overall Study|Adverse Event|0|||
16133213|NCT02680002|38976743|FG002|Overall Study|Adverse Event|0|||
16133214|NCT02680002|38976744|FG003|Overall Study|Adverse Event|0|||
16133215|NCT02680002|38976745|FG004|Overall Study|Adverse Event|1|||
16434251|NCT01724866|40070357|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
16434252|NCT01724866|40070358|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
16434253|NCT01724866|40070359|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
16434254|NCT01724866|40070360|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
16133216|NCT02680002|38976746|FG005|Overall Study|Adverse Event|2|||
16133217|NCT01853982|38976752|FG000|Overall Study|Withdrawal by Subject|1|||
16133218|NCT01853982|38976753|FG001|Overall Study|Withdrawal by Subject|0|||
16434255|NCT01724866|40070357|FG000|Overall Study|Investigator's Discretion|0|||
16434256|NCT01724866|40070358|FG001|Overall Study|Investigator's Discretion|1|||
16434257|NCT01724866|40070359|FG002|Overall Study|Investigator's Discretion|1|||
16133219|NCT01853982|38976752|FG000|Overall Study|Death|1|||
16434258|NCT01724866|40070360|FG003|Overall Study|Investigator's Discretion|0|||
16434259|NCT01724866|40070357|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
16434260|NCT01724866|40070358|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
16434261|NCT01724866|40070359|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
16434262|NCT01724866|40070360|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
16434263|NCT01724866|40070357|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
16434264|NCT01724866|40070358|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
16434265|NCT01724866|40070359|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
16434266|NCT01724866|40070360|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
16434267|NCT00377520|40070369|FG000|Overall Study|Ineligible (Prior radiation)|1|||
16434268|NCT00614380|40070370|FG000|Overall Study|Adverse Event|14|||
16434269|NCT00614380|40070371|FG001|Overall Study|Adverse Event|4|||
16434270|NCT00614380|40070372|FG002|Overall Study|Adverse Event|0|||
16434271|NCT00614380|40070373|FG003|Overall Study|Adverse Event|0|||
16434272|NCT00614380|40070370|FG000|Overall Study|Lost to Follow-up|6|||
16434273|NCT00614380|40070371|FG001|Overall Study|Lost to Follow-up|1|||
16434274|NCT00614380|40070372|FG002|Overall Study|Lost to Follow-up|0|||
16434275|NCT00614380|40070373|FG003|Overall Study|Lost to Follow-up|0|||
16434276|NCT00614380|40070370|FG000|Overall Study|Non compliant with the protocol|12|||
16434277|NCT00614380|40070371|FG001|Overall Study|Non compliant with the protocol|2|||
16434278|NCT00614380|40070372|FG002|Overall Study|Non compliant with the protocol|1|||
16434279|NCT00614380|40070373|FG003|Overall Study|Non compliant with the protocol|2|||
16434280|NCT00614380|40070370|FG000|Overall Study|Consent withdrawn|3|||
16434281|NCT00614380|40070371|FG001|Overall Study|Consent withdrawn|1|||
16133220|NCT01853982|38976753|FG001|Overall Study|Death|0|||
16133221|NCT01853982|38976752|FG000|Overall Study|Lost to Follow-up|0|||
16434282|NCT00614380|40070372|FG002|Overall Study|Consent withdrawn|0|||
16434283|NCT00614380|40070373|FG003|Overall Study|Consent withdrawn|0|||
16434284|NCT02807623|40070378|FG000|Overall Study|Lost to Follow-up|23|||
16434285|NCT02807623|40070379|FG001|Overall Study|Lost to Follow-up|18|||
16434286|NCT02807623|40070380|FG002|Overall Study|Lost to Follow-up|22|||
16434287|NCT02807623|40070378|FG000|Overall Study|Drug intolerance|0|||
16434288|NCT02807623|40070379|FG001|Overall Study|Drug intolerance|1|||
16434289|NCT02807623|40070380|FG002|Overall Study|Drug intolerance|0|||
16434290|NCT02807623|40070378|FG000|Overall Study|incomplete blood draw|0|||
16434291|NCT02807623|40070379|FG001|Overall Study|incomplete blood draw|2|||
16434292|NCT02807623|40070380|FG002|Overall Study|incomplete blood draw|1|||
16434293|NCT00556998|40070381|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
16434294|NCT00556998|40070381|FG000|Voriconazole Intravenous (IV)|Other|4|||
16434295|NCT00556998|40070381|FG000|Voriconazole Oral|Adverse Event|1|||
16434296|NCT00556998|40070381|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
16133222|NCT01853982|38976753|FG001|Overall Study|Lost to Follow-up|1|||
16434297|NCT01929226|40070382|FG000|Overall Study|Lost to Follow-up|4|||
16434298|NCT01929226|40070383|FG001|Overall Study|Lost to Follow-up|0|||
16434299|NCT01929226|40070382|FG000|Overall Study|Withdrawal by Subject|1|||
16434300|NCT01929226|40070383|FG001|Overall Study|Withdrawal by Subject|1|||
16434301|NCT01695135|40070393|FG000|Double-blind Treatment Phase|Progressive disease|50|||
16434302|NCT01695135|40070394|FG001|Double-blind Treatment Phase|Progressive disease|110|||
16434303|NCT01695135|40070395|FG002|Double-blind Treatment Phase|Progressive disease|0|||
16434304|NCT01695135|40070396|FG003|Double-blind Treatment Phase|Progressive disease|0|||
16434305|NCT01695135|40070393|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
16434306|NCT01695135|40070394|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
16434307|NCT01695135|40070395|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16434308|NCT01695135|40070396|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16434309|NCT01695135|40070393|FG000|Double-blind Treatment Phase|Adverse Event|7|||
16434310|NCT01695135|40070394|FG001|Double-blind Treatment Phase|Adverse Event|7|||
16434311|NCT01695135|40070395|FG002|Double-blind Treatment Phase|Adverse Event|0|||
16434312|NCT01695135|40070396|FG003|Double-blind Treatment Phase|Adverse Event|0|||
16434313|NCT01695135|40070393|FG000|Double-blind Treatment Phase|Other|1|||
16434314|NCT01695135|40070394|FG001|Double-blind Treatment Phase|Other|3|||
16434315|NCT01695135|40070395|FG002|Double-blind Treatment Phase|Other|0|||
16434316|NCT01695135|40070396|FG003|Double-blind Treatment Phase|Other|0|||
16434317|NCT01695135|40070393|FG000|Double-blind Treatment Phase|Physician Decision|6|||
16434318|NCT01695135|40070394|FG001|Double-blind Treatment Phase|Physician Decision|3|||
16434319|NCT01695135|40070395|FG002|Double-blind Treatment Phase|Physician Decision|0|||
16434320|NCT01695135|40070396|FG003|Double-blind Treatment Phase|Physician Decision|0|||
16133223|NCT02684357|38976754|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
16434321|NCT01695135|40070393|FG000|Double-blind Treatment Phase|Death|1|||
16434322|NCT01695135|40070394|FG001|Double-blind Treatment Phase|Death|1|||
16434323|NCT01695135|40070395|FG002|Double-blind Treatment Phase|Death|0|||
16434324|NCT01695135|40070396|FG003|Double-blind Treatment Phase|Death|0|||
16434325|NCT01695135|40070393|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
16434326|NCT01695135|40070394|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
16434327|NCT01695135|40070395|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
16133224|NCT02684357|38976755|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
16133225|NCT02684357|38976756|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
16133226|NCT02684357|38976757|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
16133227|NCT02684357|38976758|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
16133228|NCT02684357|38976759|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
16133229|NCT02684357|38976754|FG000|Part A|Lost to Follow-up|0|||
16133230|NCT02684357|38976755|FG001|Part A|Lost to Follow-up|2|||
16133231|NCT02684357|38976756|FG002|Part A|Lost to Follow-up|2|||
16133232|NCT02684357|38976757|FG003|Part A|Lost to Follow-up|0|||
16133233|NCT02684357|38976758|FG004|Part A|Lost to Follow-up|0|||
16133234|NCT02684357|38976759|FG005|Part A|Lost to Follow-up|0|||
16133235|NCT02684357|38976754|FG000|Part A|Withdrawal by Subject|3|||
16133236|NCT02684357|38976755|FG001|Part A|Withdrawal by Subject|0|||
16133237|NCT02684357|38976756|FG002|Part A|Withdrawal by Subject|0|||
16133238|NCT02684357|38976757|FG003|Part A|Withdrawal by Subject|0|||
16133239|NCT02684357|38976758|FG004|Part A|Withdrawal by Subject|0|||
16133240|NCT02684357|38976759|FG005|Part A|Withdrawal by Subject|0|||
16133241|NCT02684357|38976754|FG000|Part A|Other|0|||
16133242|NCT02684357|38976755|FG001|Part A|Other|1|||
16133243|NCT02684357|38976756|FG002|Part A|Other|0|||
16434328|NCT01695135|40070396|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
16434329|NCT01695135|40070393|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
16434330|NCT01695135|40070394|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
16434331|NCT01695135|40070395|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
16434332|NCT01695135|40070396|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
16434333|NCT01695135|40070393|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
16434334|NCT01695135|40070394|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
16434335|NCT01695135|40070395|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
16434336|NCT01695135|40070396|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
16434337|NCT01695135|40070393|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
16434338|NCT01695135|40070394|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
16434339|NCT01695135|40070395|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
16434340|NCT01695135|40070396|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
16133244|NCT02684357|38976757|FG003|Part A|Other|0|||
16133245|NCT02684357|38976758|FG004|Part A|Other|0|||
16133246|NCT02684357|38976759|FG005|Part A|Other|0|||
16133247|NCT02684357|38976754|FG000|Part B|Adverse Event (Other)|0|||
16133248|NCT02684357|38976755|FG001|Part B|Adverse Event (Other)|0|||
16434341|NCT01695135|40070393|FG000|Open Label Extension Treatment Phase|Other|0|||
16434342|NCT01695135|40070394|FG001|Open Label Extension Treatment Phase|Other|0|||
16434343|NCT01695135|40070395|FG002|Open Label Extension Treatment Phase|Other|4|||
16434344|NCT01695135|40070396|FG003|Open Label Extension Treatment Phase|Other|7|||
16434345|NCT01695135|40070393|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
16434346|NCT01695135|40070394|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
16434347|NCT01695135|40070395|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
16434348|NCT01695135|40070396|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
16434349|NCT01695135|40070393|FG000|Open Label Extension Treatment Phase|Death|0|||
16434350|NCT01695135|40070394|FG001|Open Label Extension Treatment Phase|Death|0|||
16434351|NCT01695135|40070395|FG002|Open Label Extension Treatment Phase|Death|2|||
16434352|NCT01695135|40070396|FG003|Open Label Extension Treatment Phase|Death|7|||
16434353|NCT01695135|40070393|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
16434354|NCT01695135|40070394|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
16434355|NCT01695135|40070395|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
16434356|NCT01695135|40070396|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
16434357|NCT01338818|40070399|FG000|Overall Study|Adverse Event|8|||
16434358|NCT01338818|40070399|FG000|Overall Study|Lack of Efficacy|5|||
16133249|NCT02684357|38976756|FG002|Part B|Adverse Event (Other)|0|||
16133250|NCT02684357|38976757|FG003|Part B|Adverse Event (Other)|1|||
16133251|NCT02684357|38976758|FG004|Part B|Adverse Event (Other)|1|||
16133252|NCT02684357|38976759|FG005|Part B|Adverse Event (Other)|1|||
16133253|NCT02684357|38976754|FG000|Part B|Lost to Follow-up|0|||
16133254|NCT02684357|38976755|FG001|Part B|Lost to Follow-up|0|||
16434359|NCT01338818|40070399|FG000|Overall Study|no longer require study drug|1|||
16434360|NCT01338818|40070399|FG000|Overall Study|Withdrawal by Subject|11|||
16434361|NCT01338818|40070399|FG000|Overall Study|Lost to Follow-up|4|||
16133255|NCT02684357|38976756|FG002|Part B|Lost to Follow-up|0|||
16133256|NCT02684357|38976757|FG003|Part B|Lost to Follow-up|1|||
16133257|NCT02684357|38976758|FG004|Part B|Lost to Follow-up|1|||
16133258|NCT02684357|38976759|FG005|Part B|Lost to Follow-up|7|||
16133259|NCT02684357|38976754|FG000|Part B|Withdrawal by Subject|0|||
16133260|NCT02684357|38976755|FG001|Part B|Withdrawal by Subject|0|||
16133261|NCT02684357|38976756|FG002|Part B|Withdrawal by Subject|0|||
16133262|NCT02684357|38976757|FG003|Part B|Withdrawal by Subject|0|||
16133263|NCT02684357|38976758|FG004|Part B|Withdrawal by Subject|2|||
16133264|NCT02684357|38976759|FG005|Part B|Withdrawal by Subject|4|||
16133265|NCT02684357|38976754|FG000|Part B|Other|0|||
16133266|NCT02684357|38976755|FG001|Part B|Other|0|||
16133267|NCT02684357|38976756|FG002|Part B|Other|0|||
16133268|NCT02684357|38976757|FG003|Part B|Other|1|||
16133269|NCT02684357|38976758|FG004|Part B|Other|0|||
16133270|NCT02684357|38976759|FG005|Part B|Other|1|||
16133271|NCT00390910|38976760|FG000|Overall Study|Adverse Event|1|||
16133272|NCT00390910|38976761|FG001|Overall Study|Adverse Event|0|||
16133273|NCT00390910|38976762|FG002|Overall Study|Adverse Event|0|||
16133274|NCT00390910|38976760|FG000|Overall Study|Lost to Follow-up|0|||
16133275|NCT00390910|38976761|FG001|Overall Study|Lost to Follow-up|1|||
16133276|NCT00390910|38976762|FG002|Overall Study|Lost to Follow-up|5|||
16133277|NCT00390910|38976760|FG000|Overall Study|Withdrawal by Subject|1|||
16133278|NCT00390910|38976761|FG001|Overall Study|Withdrawal by Subject|3|||
16133279|NCT00390910|38976762|FG002|Overall Study|Withdrawal by Subject|2|||
16133280|NCT00390910|38976760|FG000|Overall Study|Migrated/moved from study area|0|||
16133281|NCT00390910|38976761|FG001|Overall Study|Migrated/moved from study area|0|||
16133282|NCT00390910|38976762|FG002|Overall Study|Migrated/moved from study area|3|||
16133283|NCT01759407|38976765|FG000|Overall Study|Protocol Violation|0|||
16133284|NCT01759407|38976766|FG001|Overall Study|Protocol Violation|2|||
16133285|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
16133286|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
16133287|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
16133288|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
16133289|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
16133290|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
16133291|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
16133292|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
16133293|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
16133294|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
16434362|NCT01338818|40070399|FG000|Overall Study|Administrative problems|3|||
16434363|NCT01338818|40070399|FG000|Overall Study|Protocol Deviation|4|||
16133295|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
16133296|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
16133297|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Death|1|||
16133298|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Death|2|||
16434364|NCT01814527|40070400|FG000|Overall Study|RTP greater than 30 days|6|||
16133299|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Death|2|||
16133300|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Death|0|||
16133301|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Death|0|||
16133302|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Death|0|||
16133303|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
16133304|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
16133305|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
16133306|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
16133307|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
16133308|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
16133309|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
16133310|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
16133311|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
16133312|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
16133313|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
16133314|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
16133315|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
16133316|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
16133317|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
16133318|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
16133319|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
16133320|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
16133321|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
16133322|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
16133323|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
16133324|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
16133325|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
16133326|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
16133327|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
16133328|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
16133329|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
16133330|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
16133331|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
16133332|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
16133333|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
16133334|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
16133335|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
16133336|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
16133337|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
16133338|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
16133339|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
16133340|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
16133341|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
16133342|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
16133343|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
16133344|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
16133345|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Site closure|0|||
16133346|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Site closure|0|||
16133347|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Site closure|1|||
16133348|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Site closure|0|||
16133349|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Site closure|0|||
16133350|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Site closure|0|||
16133351|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
16133352|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
16133353|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
16133354|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
16133355|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
16133356|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
16133357|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
16133358|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
16250824|NCT01567306|39400648|FG005|Overall Study|Adverse Event|1|||
16133359|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
16133360|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
16133361|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
16133362|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
16133363|NCT03439254|38976768|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
16133364|NCT03439254|38976769|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
16133365|NCT03439254|38976770|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
16133366|NCT03439254|38976771|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
16133367|NCT03439254|38976772|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
16133368|NCT03439254|38976773|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
16133369|NCT03439254|38976768|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
16133370|NCT03439254|38976769|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
16133371|NCT03439254|38976770|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
16133372|NCT03439254|38976771|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
16133373|NCT03439254|38976772|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
16133374|NCT03439254|38976773|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
16133375|NCT03439254|38976768|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
16133376|NCT03439254|38976769|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
16133377|NCT03439254|38976770|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
16133378|NCT03439254|38976771|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
16133379|NCT03439254|38976772|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
16133380|NCT03439254|38976773|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
16133381|NCT03439254|38976768|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
16133382|NCT03439254|38976769|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
16133383|NCT03439254|38976770|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
16133384|NCT03439254|38976771|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
16133385|NCT03439254|38976772|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
16133386|NCT03439254|38976773|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
16133387|NCT03439254|38976768|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
16133388|NCT03439254|38976769|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
16133389|NCT03439254|38976770|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
16133390|NCT03439254|38976771|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
16133391|NCT03439254|38976772|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
16133392|NCT03439254|38976773|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
16133393|NCT03439254|38976768|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
16133394|NCT03439254|38976769|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
16133395|NCT03439254|38976770|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
16133396|NCT03439254|38976771|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
16133397|NCT03439254|38976772|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
16133398|NCT03439254|38976773|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
16133399|NCT03439254|38976768|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
16133400|NCT03439254|38976769|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
16133401|NCT03439254|38976770|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
16133402|NCT03439254|38976771|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
16133403|NCT03439254|38976772|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
16133404|NCT03439254|38976773|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
16133405|NCT03439254|38976768|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
16133406|NCT03439254|38976769|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
16133407|NCT03439254|38976770|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
16133408|NCT03439254|38976771|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
16133409|NCT03439254|38976772|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
16133410|NCT03439254|38976773|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
16133411|NCT03439254|38976768|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
16133412|NCT03439254|38976769|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
16133413|NCT03439254|38976770|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
16133414|NCT03439254|38976771|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
16133415|NCT03439254|38976772|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
16133416|NCT03439254|38976773|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
16133417|NCT03439254|38976768|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
16133418|NCT03439254|38976769|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
16133419|NCT03439254|38976770|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
16133420|NCT03439254|38976771|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
16133421|NCT03439254|38976772|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
16133422|NCT03439254|38976773|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
16133423|NCT03536143|38976774|FG000|Overall Study|Early termination, Sponsor decision|1|||
16133424|NCT03603028|38976778|FG000|Overall Study|Withdrawal by Subject|1|||
16133425|NCT01898923|38976780|FG000|Overall Study|Lack of Efficacy|5|||
16133426|NCT01898923|38976781|FG001|Overall Study|Lack of Efficacy|6|||
16133427|NCT01898923|38976780|FG000|Overall Study|Adverse Event|3|||
16133428|NCT01898923|38976781|FG001|Overall Study|Adverse Event|1|||
16133429|NCT01898923|38976780|FG000|Overall Study|Lost to Follow-up|0|||
16133430|NCT01898923|38976781|FG001|Overall Study|Lost to Follow-up|1|||
16133431|NCT01898923|38976780|FG000|Overall Study|Withdrawal by Subject|4|||
16133432|NCT01898923|38976781|FG001|Overall Study|Withdrawal by Subject|7|||
16133433|NCT01898923|38976780|FG000|Overall Study|Physician Decision|3|||
16133434|NCT01898923|38976781|FG001|Overall Study|Physician Decision|4|||
16133435|NCT01898923|38976780|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
16133436|NCT01898923|38976781|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
16133437|NCT02401867|38976782|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
16133438|NCT02401867|38976782|FG000|Analysis|Cervical assay could not be conducted|9|||
16133439|NCT04214600|38976783|FG000|Overall Study|Lost to Follow-up|9|||
16133440|NCT04214600|38976784|FG001|Overall Study|Lost to Follow-up|14|||
16133441|NCT04025580|38976785|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
16133442|NCT04025580|38976786|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
16133443|NCT04025580|38976787|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
16133444|NCT01688830|38976791|FG000|Overall Study|Lost to Follow-up|0|||
16133445|NCT01688830|38976792|FG001|Overall Study|Lost to Follow-up|0|||
16133446|NCT01688830|38976793|FG002|Overall Study|Lost to Follow-up|0|||
16133447|NCT01688830|38976794|FG003|Overall Study|Lost to Follow-up|0|||
16133448|NCT01688830|38976795|FG004|Overall Study|Lost to Follow-up|0|||
16133449|NCT01688830|38976796|FG005|Overall Study|Lost to Follow-up|0|||
16133450|NCT01688830|38976797|FG006|Overall Study|Lost to Follow-up|0|||
16133451|NCT01688830|38976798|FG007|Overall Study|Lost to Follow-up|0|||
16133452|NCT01688830|38976799|FG008|Overall Study|Lost to Follow-up|0|||
16133453|NCT01688830|38976800|FG009|Overall Study|Lost to Follow-up|0|||
16133454|NCT01688830|38976801|FG010|Overall Study|Lost to Follow-up|1|||
16133455|NCT01688830|38976802|FG011|Overall Study|Lost to Follow-up|0|||
16133456|NCT01688830|38976803|FG012|Overall Study|Lost to Follow-up|0|||
16133457|NCT01688830|38976804|FG013|Overall Study|Lost to Follow-up|0|||
16133458|NCT01688830|38976805|FG014|Overall Study|Lost to Follow-up|0|||
16133459|NCT01688830|38976806|FG015|Overall Study|Lost to Follow-up|0|||
16133460|NCT01688830|38976807|FG016|Overall Study|Lost to Follow-up|0|||
16133461|NCT01688830|38976808|FG017|Overall Study|Lost to Follow-up|0|||
16133462|NCT01688830|38976809|FG018|Overall Study|Lost to Follow-up|0|||
16133463|NCT01688830|38976810|FG019|Overall Study|Lost to Follow-up|0|||
16133464|NCT01688830|38976811|FG020|Overall Study|Lost to Follow-up|0|||
16133465|NCT00759915|38976814|FG000|Overall Study|Withdrawal by Subject|1|||
16133466|NCT00759915|38976815|FG001|Overall Study|Withdrawal by Subject|0|||
16133467|NCT00759915|38976814|FG000|Overall Study|Adverse Event|0|||
16133468|NCT00759915|38976815|FG001|Overall Study|Adverse Event|1|||
16133469|NCT00824161|38976818|FG000|Overall Study|Withdrawal by Subject|1|||
16133470|NCT00824161|38976818|FG000|Overall Study|Screen Failure|1|||
16133471|NCT01874431|38976821|FG000|Overall Study|Physician Decision|0|||
16133472|NCT01874431|38976822|FG001|Overall Study|Physician Decision|0|||
16133473|NCT01874431|38976823|FG002|Overall Study|Physician Decision|1|||
16133474|NCT01874431|38976824|FG003|Overall Study|Physician Decision|0|||
16133475|NCT01874431|38976825|FG004|Overall Study|Physician Decision|0|||
16133476|NCT01874431|38976826|FG005|Overall Study|Physician Decision|0|||
16133477|NCT01874431|38976827|FG006|Overall Study|Physician Decision|0|||
16133478|NCT01874431|38976828|FG007|Overall Study|Physician Decision|0|||
16133479|NCT01874431|38976821|FG000|Overall Study|Adverse Event|5|||
16133480|NCT01874431|38976822|FG001|Overall Study|Adverse Event|4|||
16133481|NCT01874431|38976823|FG002|Overall Study|Adverse Event|6|||
16133482|NCT01874431|38976824|FG003|Overall Study|Adverse Event|5|||
16133483|NCT01874431|38976825|FG004|Overall Study|Adverse Event|2|||
16133484|NCT01874431|38976826|FG005|Overall Study|Adverse Event|8|||
16133485|NCT01874431|38976827|FG006|Overall Study|Adverse Event|2|||
16133486|NCT01874431|38976828|FG007|Overall Study|Adverse Event|3|||
16133487|NCT01874431|38976821|FG000|Overall Study|Protocol Violation|1|||
16133488|NCT01874431|38976822|FG001|Overall Study|Protocol Violation|1|||
16133489|NCT01874431|38976823|FG002|Overall Study|Protocol Violation|1|||
16133490|NCT01874431|38976824|FG003|Overall Study|Protocol Violation|0|||
16133491|NCT01874431|38976825|FG004|Overall Study|Protocol Violation|3|||
16133492|NCT01874431|38976826|FG005|Overall Study|Protocol Violation|2|||
16133493|NCT01874431|38976827|FG006|Overall Study|Protocol Violation|1|||
16133494|NCT01874431|38976828|FG007|Overall Study|Protocol Violation|1|||
16133495|NCT01874431|38976821|FG000|Overall Study|Non-compliance|0|||
16133496|NCT01874431|38976822|FG001|Overall Study|Non-compliance|0|||
16133497|NCT01874431|38976823|FG002|Overall Study|Non-compliance|0|||
16133498|NCT01874431|38976824|FG003|Overall Study|Non-compliance|0|||
16133499|NCT01874431|38976825|FG004|Overall Study|Non-compliance|1|||
16250825|NCT01567306|39400643|FG000|Overall Study|Lost to Follow-up|0|||
16250826|NCT01567306|39400644|FG001|Overall Study|Lost to Follow-up|0|||
16250827|NCT01567306|39400645|FG002|Overall Study|Lost to Follow-up|0|||
16250828|NCT01567306|39400646|FG003|Overall Study|Lost to Follow-up|0|||
16250829|NCT01567306|39400647|FG004|Overall Study|Lost to Follow-up|2|||
16250830|NCT01567306|39400648|FG005|Overall Study|Lost to Follow-up|0|||
16250831|NCT01567306|39400643|FG000|Overall Study|Withdrawal by Subject|0|||
16250832|NCT01567306|39400644|FG001|Overall Study|Withdrawal by Subject|0|||
16250833|NCT01567306|39400645|FG002|Overall Study|Withdrawal by Subject|0|||
16250834|NCT01567306|39400646|FG003|Overall Study|Withdrawal by Subject|0|||
16250835|NCT01567306|39400647|FG004|Overall Study|Withdrawal by Subject|0|||
16250836|NCT01567306|39400648|FG005|Overall Study|Withdrawal by Subject|1|||
16250837|NCT00282256|39400654|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
16250838|NCT00282256|39400654|FG000|Extension Treatment Period|Adverse Event|2|||
16250839|NCT01909466|39400655|FG000|Overall Study|Lost to Follow-up|5|||
16250840|NCT01909466|39400656|FG001|Overall Study|Lost to Follow-up|7|||
16250841|NCT01909466|39400655|FG000|Overall Study|Adverse Event|3|||
16250842|NCT01909466|39400656|FG001|Overall Study|Adverse Event|4|||
16250843|NCT01909466|39400655|FG000|Overall Study|Met Withdrawal Criteria|0|||
16250844|NCT01909466|39400656|FG001|Overall Study|Met Withdrawal Criteria|3|||
16250845|NCT01909466|39400655|FG000|Overall Study|Physician Decision|2|||
16250846|NCT01909466|39400656|FG001|Overall Study|Physician Decision|0|||
16250847|NCT01909466|39400655|FG000|Overall Study|Withdrawal by Subject|11|||
16250848|NCT01909466|39400656|FG001|Overall Study|Withdrawal by Subject|9|||
16250849|NCT01909466|39400655|FG000|Overall Study|Lack of Efficacy|1|||
16250850|NCT01909466|39400656|FG001|Overall Study|Lack of Efficacy|0|||
16250851|NCT01656889|39400657|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
16250852|NCT01656889|39400658|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
16250853|NCT01656889|39400657|FG000|Treatment Period, 12 Weeks|Death|0|||
16250854|NCT01656889|39400658|FG001|Treatment Period, 12 Weeks|Death|1|||
16250855|NCT01656889|39400657|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
16250856|NCT01656889|39400658|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
16250857|NCT01656889|39400657|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
16250858|NCT01656889|39400658|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
16250859|NCT01656889|39400657|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
16250860|NCT01656889|39400658|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
16250861|NCT01656889|39400657|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
16250862|NCT01656889|39400658|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
16133500|NCT01874431|38976826|FG005|Overall Study|Non-compliance|0|||
16133501|NCT01874431|38976827|FG006|Overall Study|Non-compliance|1|||
16133502|NCT01874431|38976828|FG007|Overall Study|Non-compliance|0|||
16133503|NCT01874431|38976821|FG000|Overall Study|Logistical difficulties|0|||
16133504|NCT01874431|38976822|FG001|Overall Study|Logistical difficulties|0|||
16133505|NCT01874431|38976823|FG002|Overall Study|Logistical difficulties|0|||
16133506|NCT01874431|38976824|FG003|Overall Study|Logistical difficulties|0|||
16133507|NCT01874431|38976825|FG004|Overall Study|Logistical difficulties|0|||
16133508|NCT01874431|38976826|FG005|Overall Study|Logistical difficulties|0|||
16133509|NCT01874431|38976827|FG006|Overall Study|Logistical difficulties|1|||
16133510|NCT01874431|38976828|FG007|Overall Study|Logistical difficulties|0|||
16133511|NCT01874431|38976821|FG000|Overall Study|Withdrawal by Subject|0|||
16133512|NCT01874431|38976822|FG001|Overall Study|Withdrawal by Subject|0|||
16133513|NCT01874431|38976823|FG002|Overall Study|Withdrawal by Subject|1|||
16133514|NCT01874431|38976824|FG003|Overall Study|Withdrawal by Subject|2|||
16133515|NCT01874431|38976825|FG004|Overall Study|Withdrawal by Subject|1|||
16133516|NCT01874431|38976826|FG005|Overall Study|Withdrawal by Subject|1|||
16133517|NCT01874431|38976827|FG006|Overall Study|Withdrawal by Subject|3|||
16133518|NCT01874431|38976828|FG007|Overall Study|Withdrawal by Subject|0|||
16133519|NCT01874431|38976821|FG000|Overall Study|Sponsor decision|0|||
16133520|NCT01874431|38976822|FG001|Overall Study|Sponsor decision|0|||
16133521|NCT01874431|38976823|FG002|Overall Study|Sponsor decision|0|||
16133522|NCT01874431|38976824|FG003|Overall Study|Sponsor decision|0|||
16133523|NCT01874431|38976825|FG004|Overall Study|Sponsor decision|1|||
16133524|NCT01874431|38976826|FG005|Overall Study|Sponsor decision|0|||
16133525|NCT01874431|38976827|FG006|Overall Study|Sponsor decision|0|||
16133526|NCT01874431|38976828|FG007|Overall Study|Sponsor decision|0|||
16250863|NCT01656889|39400657|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
16250864|NCT01656889|39400658|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
16250865|NCT01656889|39400657|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
16250866|NCT01656889|39400658|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
16250867|NCT01656889|39400657|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
16434365|NCT01814527|40070401|FG001|Overall Study|RTP greater than 30 days|1|||
16133527|NCT01874431|38976821|FG000|Overall Study|Lost to Follow-up|0|||
16133528|NCT01874431|38976822|FG001|Overall Study|Lost to Follow-up|0|||
16133529|NCT01874431|38976823|FG002|Overall Study|Lost to Follow-up|1|||
16133530|NCT01874431|38976824|FG003|Overall Study|Lost to Follow-up|0|||
16250868|NCT01656889|39400658|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
16133531|NCT01874431|38976825|FG004|Overall Study|Lost to Follow-up|0|||
16133532|NCT01874431|38976826|FG005|Overall Study|Lost to Follow-up|0|||
16133533|NCT01874431|38976827|FG006|Overall Study|Lost to Follow-up|0|||
16133534|NCT01874431|38976828|FG007|Overall Study|Lost to Follow-up|0|||
16133535|NCT00796120|38976829|FG000|Overall Study|Death|3|||
16133536|NCT00796120|38976830|FG001|Overall Study|Death|0|||
16133537|NCT00796120|38976829|FG000|Overall Study|Adverse Event|11|||
16133538|NCT00796120|38976830|FG001|Overall Study|Adverse Event|6|||
16133539|NCT00796120|38976829|FG000|Overall Study|Progressive disease|22|||
16133540|NCT00796120|38976830|FG001|Overall Study|Progressive disease|13|||
16133541|NCT00796120|38976829|FG000|Overall Study|Participant refusal|3|||
16133542|NCT00796120|38976830|FG001|Overall Study|Participant refusal|4|||
16133543|NCT00796120|38976829|FG000|Overall Study|Other|6|||
16133544|NCT00796120|38976830|FG001|Overall Study|Other|17|||
16133545|NCT00796120|38976829|FG000|Overall Study|Physician Decision|16|||
16133546|NCT00796120|38976830|FG001|Overall Study|Physician Decision|17|||
16133547|NCT00796120|38976829|FG000|Overall Study|Randomized but not treated|0|||
16133548|NCT00796120|38976830|FG001|Overall Study|Randomized but not treated|3|||
16133549|NCT01037244|38976845|FG000|Overall Study|Adverse Event|3|||
16133550|NCT01037244|38976846|FG001|Overall Study|Adverse Event|2|||
16133551|NCT01037244|38976847|FG002|Overall Study|Adverse Event|6|||
16133552|NCT01037244|38976848|FG003|Overall Study|Adverse Event|3|||
16133553|NCT01037244|38976845|FG000|Overall Study|Lack of Efficacy|1|||
16133554|NCT01037244|38976846|FG001|Overall Study|Lack of Efficacy|1|||
16250869|NCT01656889|39400657|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
16250870|NCT01656889|39400658|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
16250871|NCT02199509|39400659|FG000|Overall Study|Suicidal Ideation|0|||
16250872|NCT02199509|39400660|FG001|Overall Study|Suicidal Ideation|1|||
16250873|NCT02199509|39400659|FG000|Overall Study|Misunderstood titration schedule|1|||
16250874|NCT02199509|39400660|FG001|Overall Study|Misunderstood titration schedule|0|||
16133555|NCT01037244|38976847|FG002|Overall Study|Lack of Efficacy|0|||
16133556|NCT01037244|38976848|FG003|Overall Study|Lack of Efficacy|1|||
16133557|NCT01037244|38976845|FG000|Overall Study|Lost to Follow-up|3|||
16133558|NCT01037244|38976846|FG001|Overall Study|Lost to Follow-up|3|||
16133559|NCT01037244|38976847|FG002|Overall Study|Lost to Follow-up|4|||
16133560|NCT01037244|38976848|FG003|Overall Study|Lost to Follow-up|4|||
16133561|NCT01037244|38976845|FG000|Overall Study|Withdrawal by Subject|1|||
16133562|NCT01037244|38976846|FG001|Overall Study|Withdrawal by Subject|5|||
16133563|NCT01037244|38976847|FG002|Overall Study|Withdrawal by Subject|3|||
16133564|NCT01037244|38976848|FG003|Overall Study|Withdrawal by Subject|5|||
16133565|NCT01037244|38976845|FG000|Overall Study|Partner Withdrew Consent|2|||
16250875|NCT02305758|39400661|FG000|Overall Study|Death|27|||
16250876|NCT02305758|39400662|FG001|Overall Study|Death|27|||
16250877|NCT02305758|39400661|FG000|Overall Study|Withdrew consent|9|||
16250878|NCT02305758|39400662|FG001|Overall Study|Withdrew consent|2|||
16250879|NCT02305758|39400661|FG000|Overall Study|Lost to Follow-up|6|||
16250880|NCT02305758|39400662|FG001|Overall Study|Lost to Follow-up|1|||
16250881|NCT02305758|39400661|FG000|Overall Study|Study Terminated by Sponsor|21|||
16250882|NCT02305758|39400662|FG001|Overall Study|Study Terminated by Sponsor|34|||
16250883|NCT02305758|39400661|FG000|Overall Study|Other, not specified|2|||
16250884|NCT02305758|39400662|FG001|Overall Study|Other, not specified|1|||
16133566|NCT01037244|38976846|FG001|Overall Study|Partner Withdrew Consent|1|||
16133567|NCT01037244|38976847|FG002|Overall Study|Partner Withdrew Consent|0|||
16133568|NCT01037244|38976848|FG003|Overall Study|Partner Withdrew Consent|0|||
16133569|NCT01037244|38976845|FG000|Overall Study|Various|3|||
16133570|NCT01037244|38976846|FG001|Overall Study|Various|2|||
16133571|NCT01037244|38976847|FG002|Overall Study|Various|1|||
16250885|NCT03532009|39400663|FG000|Overall Study|Other|1|||
16250886|NCT03532009|39400664|FG001|Overall Study|Other|1|||
16250887|NCT03532009|39400663|FG000|Overall Study|Death|1|||
16250888|NCT03532009|39400664|FG001|Overall Study|Death|1|||
16133572|NCT01037244|38976848|FG003|Overall Study|Various|1|||
16133573|NCT01745848|38976849|FG000|Overall Study|Adverse Event|6|||
16133574|NCT00495586|38976850|FG000|Overall Study|Withdrawal by Subject|4|||
16133575|NCT00495586|38976851|FG001|Overall Study|Withdrawal by Subject|4|||
16133576|NCT01139021|38976852|FG000|Overall Study|Adverse Event|0|||
16133577|NCT01139021|38976853|FG001|Overall Study|Adverse Event|0|||
16133578|NCT01139021|38976854|FG002|Overall Study|Adverse Event|0|||
16133579|NCT01139021|38976855|FG003|Overall Study|Adverse Event|0|||
16133580|NCT01139021|38976856|FG004|Overall Study|Adverse Event|1|||
16250889|NCT03532009|39400663|FG000|Overall Study|Withdrawal by Patient|0|||
16250890|NCT03532009|39400664|FG001|Overall Study|Withdrawal by Patient|2|||
16133581|NCT01139021|38976857|FG005|Overall Study|Adverse Event|0|||
16133582|NCT01139021|38976852|FG000|Overall Study|Lost to Follow-up|0|||
16250891|NCT02540356|39400665|FG000|Overall Study|Terminated due to disease progression|1|||
16250892|NCT02540356|39400666|FG001|Overall Study|Terminated due to disease progression|0|||
16133583|NCT01139021|38976853|FG001|Overall Study|Lost to Follow-up|0|||
16133584|NCT01139021|38976854|FG002|Overall Study|Lost to Follow-up|0|||
16133585|NCT01139021|38976855|FG003|Overall Study|Lost to Follow-up|0|||
16250893|NCT01842958|39400667|FG000|Overall Study|Lost to Follow-up|1|||
16250894|NCT01842958|39400668|FG001|Overall Study|Lost to Follow-up|1|||
16250895|NCT03495869|39400669|FG000|Overall Study|Lost to Follow-up|4|||
16250896|NCT03495869|39400670|FG001|Overall Study|Lost to Follow-up|17|||
16250897|NCT03495869|39400671|FG002|Overall Study|Lost to Follow-up|8|||
16250898|NCT03495869|39400672|FG003|Overall Study|Lost to Follow-up|14|||
16250899|NCT03495869|39400669|FG000|Overall Study|Withdrawal by Subject|0|||
16250900|NCT03495869|39400670|FG001|Overall Study|Withdrawal by Subject|3|||
16250901|NCT03495869|39400671|FG002|Overall Study|Withdrawal by Subject|0|||
16250902|NCT03495869|39400672|FG003|Overall Study|Withdrawal by Subject|3|||
16250903|NCT03495869|39400669|FG000|Overall Study|Dropped from study|0|||
16250904|NCT03495869|39400670|FG001|Overall Study|Dropped from study|7|||
16250905|NCT03495869|39400671|FG002|Overall Study|Dropped from study|2|||
16250906|NCT03495869|39400672|FG003|Overall Study|Dropped from study|4|||
16250907|NCT00708422|39400673|FG000|Overall Study|Adverse Event|3|||
16250908|NCT00708422|39400674|FG001|Overall Study|Adverse Event|1|||
16250909|NCT00708422|39400673|FG000|Overall Study|Withdrawal by Subject|1|||
16250910|NCT00708422|39400674|FG001|Overall Study|Withdrawal by Subject|0|||
16250911|NCT01247922|39400676|FG000|Overall Study|Disease progression|4|||
16250912|NCT00322556|39400677|FG000|Overall Study|Adverse Event|1|||
16250913|NCT00322556|39400677|FG000|Overall Study|Withdrawal by Subject|1|||
16250914|NCT00322556|39400677|FG000|Overall Study|Lost to Follow-up|3|||
16250915|NCT00322556|39400677|FG000|Overall Study|Other Reason|7|||
16250916|NCT00449072|39400678|FG000|Overall Study|Adverse Event|3|||
16250917|NCT00449072|39400679|FG001|Overall Study|Adverse Event|1|||
16250918|NCT00449072|39400678|FG000|Overall Study|Protocol Violation|14|||
16250919|NCT00449072|39400679|FG001|Overall Study|Protocol Violation|12|||
16250920|NCT00449072|39400678|FG000|Overall Study|Lost to Follow-up|5|||
16250921|NCT00449072|39400679|FG001|Overall Study|Lost to Follow-up|7|||
16250922|NCT00449072|39400678|FG000|Overall Study|Withdrawal by Subject|11|||
16250923|NCT00449072|39400679|FG001|Overall Study|Withdrawal by Subject|8|||
16250924|NCT00449072|39400678|FG000|Overall Study|Lack of Efficacy|1|||
16250925|NCT00449072|39400679|FG001|Overall Study|Lack of Efficacy|1|||
16250926|NCT00449072|39400678|FG000|Overall Study|Physician Decision|1|||
16250927|NCT00449072|39400679|FG001|Overall Study|Physician Decision|0|||
16250928|NCT00449072|39400678|FG000|Overall Study|Not treated|0|||
16250929|NCT00449072|39400679|FG001|Overall Study|Not treated|1|||
16250930|NCT00449072|39400678|FG000|Overall Study|Excluded medication|0|||
16250931|NCT00449072|39400679|FG001|Overall Study|Excluded medication|2|||
16250932|NCT00449072|39400678|FG000|Overall Study|Non-compliance|2|||
16250933|NCT00449072|39400679|FG001|Overall Study|Non-compliance|5|||
16250934|NCT00449072|39400678|FG000|Overall Study|Sponsor decision|1|||
16250935|NCT00449072|39400679|FG001|Overall Study|Sponsor decision|3|||
16250936|NCT00449072|39400678|FG000|Overall Study|Relocation|3|||
16250937|NCT00449072|39400679|FG001|Overall Study|Relocation|2|||
16250938|NCT02220907|39400682|FG000|Overall Study|Adverse Event|7|||
16250939|NCT02220907|39400682|FG000|Overall Study|Physician Decision|1|||
16250940|NCT02220907|39400682|FG000|Overall Study|Withdrawal by Subject|2|||
16250941|NCT02220907|39400682|FG000|Overall Study|Conflict with the stopping criteria|1|||
16250942|NCT00819247|39400685|FG000|Overall Study|Adverse Event|0|||
16250943|NCT00819247|39400686|FG001|Overall Study|Adverse Event|5|||
16250944|NCT00819247|39400687|FG002|Overall Study|Adverse Event|3|||
16250945|NCT00819247|39400685|FG000|Overall Study|Insufficient testosterone response|5|||
16250946|NCT00819247|39400686|FG001|Overall Study|Insufficient testosterone response|8|||
16250947|NCT00819247|39400687|FG002|Overall Study|Insufficient testosterone response|10|||
16250948|NCT00819247|39400685|FG000|Overall Study|Withdrawal by Subject|1|||
16250949|NCT00819247|39400686|FG001|Overall Study|Withdrawal by Subject|0|||
16250950|NCT00819247|39400687|FG002|Overall Study|Withdrawal by Subject|0|||
16250951|NCT00819247|39400685|FG000|Overall Study|Protocol Violation|1|||
16250952|NCT00819247|39400686|FG001|Overall Study|Protocol Violation|0|||
16250953|NCT00819247|39400687|FG002|Overall Study|Protocol Violation|1|||
16250954|NCT00819247|39400685|FG000|Overall Study|Mistakenly withdrawn|0|||
16250955|NCT00819247|39400686|FG001|Overall Study|Mistakenly withdrawn|1|||
16250956|NCT00819247|39400687|FG002|Overall Study|Mistakenly withdrawn|0|||
16250957|NCT00819247|39400685|FG000|Overall Study|Bad prostate-specific antigen response|3|||
16250958|NCT00819247|39400686|FG001|Overall Study|Bad prostate-specific antigen response|2|||
16250959|NCT00819247|39400687|FG002|Overall Study|Bad prostate-specific antigen response|0|||
16250960|NCT00819247|39400685|FG000|Overall Study|Other|1|||
16250961|NCT00819247|39400686|FG001|Overall Study|Other|0|||
16250962|NCT00819247|39400687|FG002|Overall Study|Other|0|||
16250963|NCT01844583|39400688|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
16250964|NCT01844583|39400689|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
16250965|NCT01400425|39400690|FG000|Overall Study|Withdrawal by Subject|10|||
16250966|NCT01090765|39400696|FG000|Overall Study|Patient withdrew consent|0|||
16250967|NCT01090765|39400697|FG001|Overall Study|Patient withdrew consent|0|||
16250968|NCT01090765|39400698|FG002|Overall Study|Patient withdrew consent|0|||
16250969|NCT01090765|39400699|FG003|Overall Study|Patient withdrew consent|0|||
16250970|NCT01090765|39400700|FG004|Overall Study|Patient withdrew consent|1|||
16250971|NCT01090765|39400701|FG005|Overall Study|Patient withdrew consent|1|||
16250972|NCT01090765|39400696|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
16250973|NCT01090765|39400697|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
16250974|NCT01090765|39400698|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
16250975|NCT01090765|39400699|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
16250976|NCT01090765|39400700|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
16250977|NCT01090765|39400701|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
16250978|NCT01090765|39400696|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
16250979|NCT01090765|39400697|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
16250980|NCT01090765|39400698|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
16133586|NCT01139021|38976856|FG004|Overall Study|Lost to Follow-up|2|||
16362242|NCT02332707|39811963|FG006|Overall Study|Physician Decision|0|||
16362243|NCT02332707|39811964|FG007|Overall Study|Physician Decision|0|||
16362244|NCT02332707|39811965|FG008|Overall Study|Physician Decision|0|||
16362245|NCT02332707|39811966|FG009|Overall Study|Physician Decision|0|||
16362246|NCT02332707|39811967|FG010|Overall Study|Physician Decision|0|||
16362247|NCT02332707|39811968|FG011|Overall Study|Physician Decision|0|||
16362248|NCT02332707|39811969|FG012|Overall Study|Physician Decision|1|||
16362249|NCT02332707|39811970|FG013|Overall Study|Physician Decision|0|||
16362250|NCT02332707|39811971|FG014|Overall Study|Physician Decision|0|||
16434366|NCT02562716|40070402|FG000|Overall Study|Adverse Event|7|||
16434367|NCT02562716|40070403|FG001|Overall Study|Adverse Event|14|||
16434368|NCT02562716|40070402|FG000|Overall Study|Withdrawal unrelated to AE|7|||
16434369|NCT02562716|40070403|FG001|Overall Study|Withdrawal unrelated to AE|1|||
16434370|NCT02562716|40070402|FG000|Overall Study|Progression|8|||
16434371|NCT02562716|40070403|FG001|Overall Study|Progression|10|||
16434372|NCT02562716|40070402|FG000|Overall Study|Death|2|||
16434373|NCT02562716|40070403|FG001|Overall Study|Death|1|||
16434374|NCT02562716|40070402|FG000|Overall Study|Not protocol specified|4|||
16434375|NCT02562716|40070403|FG001|Overall Study|Not protocol specified|2|||
16434376|NCT02614729|40070404|FG000|Overall Study|Withdrawal by Subject|1|||
16434377|NCT02614729|40070405|FG001|Overall Study|Withdrawal by Subject|0|||
16434378|NCT01908426|40070414|FG000|Overall Study|Adverse Event|98|||
16434379|NCT01908426|40070415|FG001|Overall Study|Adverse Event|11|||
16434380|NCT01908426|40070414|FG000|Overall Study|Clinical Deterioration|72|||
16434381|NCT01908426|40070415|FG001|Overall Study|Clinical Deterioration|38|||
16434382|NCT01908426|40070414|FG000|Overall Study|Lack of Efficacy|3|||
16434383|NCT01908426|40070415|FG001|Overall Study|Lack of Efficacy|0|||
16434384|NCT01908426|40070414|FG000|Overall Study|Lost to Follow-up|0|||
16434385|NCT01908426|40070415|FG001|Overall Study|Lost to Follow-up|1|||
16434386|NCT01908426|40070414|FG000|Overall Study|Physician Decision|3|||
16434387|NCT01908426|40070415|FG001|Overall Study|Physician Decision|3|||
16434388|NCT01908426|40070414|FG000|Overall Study|Withdrawal by Subject|11|||
16434389|NCT01908426|40070415|FG001|Overall Study|Withdrawal by Subject|6|||
16434390|NCT01908426|40070414|FG000|Overall Study|Progressive Disease|206|||
16434391|NCT01908426|40070415|FG001|Overall Study|Progressive Disease|152|||
16434392|NCT01908426|40070414|FG000|Overall Study|Protocol Violation|1|||
16434393|NCT01908426|40070415|FG001|Overall Study|Protocol Violation|0|||
16434394|NCT01908426|40070414|FG000|Overall Study|No Study Treatment Given|3|||
16434395|NCT01908426|40070415|FG001|Overall Study|No Study Treatment Given|0|||
16250981|NCT01090765|39400699|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
16250982|NCT01090765|39400700|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
16250983|NCT01090765|39400701|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
16250984|NCT03870997|39400702|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
16250985|NCT03870997|39400703|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
16250986|NCT03870997|39400704|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
16250987|NCT03870997|39400705|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
16250988|NCT03870997|39400706|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
16250989|NCT03870997|39400707|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
16250990|NCT02456909|39400712|FG000|Overall Study|Did not receive allocated intervention|24|||
16250991|NCT02456909|39400713|FG001|Overall Study|Did not receive allocated intervention|26|||
16250992|NCT02456909|39400712|FG000|Overall Study|Did not complete the primary outcome|0|||
16250993|NCT02456909|39400713|FG001|Overall Study|Did not complete the primary outcome|1|||
16250994|NCT01153984|39400714|FG000|Overall Study|Withdrawal by Subject|1|||
16250995|NCT01153984|39400714|FG000|Overall Study|Adverse Event|1|||
16250996|NCT01802879|39400717|FG000|Overall Study|Administrative problems|2|||
16250997|NCT01802879|39400717|FG000|Overall Study|Disease progression|6|||
16250998|NCT00859469|39400718|FG000|Overall Study|Adverse Event|2|||
16250999|NCT00859469|39400718|FG000|Overall Study|Lack of Efficacy|9|||
16251000|NCT00859469|39400718|FG000|Overall Study|Withdrawal by Subject|1|||
16251001|NCT00859469|39400718|FG000|Overall Study|Death|16|||
16251002|NCT01787825|39404251|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
16251003|NCT01787825|39404252|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
16251004|NCT01787825|39404251|FG000|Overall Study|Data Not Analyzable|5|||
16434396|NCT02098746|40070418|FG000|Overall Study|Changes of Investigator|2|||
16434397|NCT02098746|40070418|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16434398|NCT02098746|40070418|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
16434399|NCT02098746|40070418|FG000|Overall Study|Data Not Available After Treatment|1|||
16434400|NCT01329263|40070421|FG000|Overall Study|Lost to Follow-up|4|||
16434401|NCT01329263|40070422|FG001|Overall Study|Lost to Follow-up|21|||
16434402|NCT01329263|40070421|FG000|Overall Study|Withdrawal by Subject|1|||
16434403|NCT01329263|40070422|FG001|Overall Study|Withdrawal by Subject|2|||
16434404|NCT01451723|40070428|FG000|Overall Study|study halted|6|||
16434405|NCT01451723|40070429|FG001|Overall Study|study halted|5|||
16434406|NCT03546621|40070433|FG000|Overall Study|Withdrawal by Subject|0|||
16434407|NCT03546621|40070434|FG001|Overall Study|Withdrawal by Subject|1|||
16434408|NCT03546621|40070435|FG002|Overall Study|Withdrawal by Subject|2|||
16251005|NCT01787825|39404252|FG001|Overall Study|Data Not Analyzable|1|||
16251006|NCT03206203|39404255|FG000|Treatment|Death|38|||
16251007|NCT03206203|39404256|FG001|Treatment|Death|26|||
16251008|NCT03206203|39404257|FG002|Treatment|Death|0|||
16251009|NCT03206203|39404255|FG000|Treatment|Withdrawal by Subject|1|||
16434409|NCT03546621|40070436|FG003|Overall Study|Withdrawal by Subject|1|||
16434410|NCT03546621|40070433|FG000|Overall Study|Lost to Follow-up|0|||
16434411|NCT03546621|40070434|FG001|Overall Study|Lost to Follow-up|1|||
16434412|NCT03546621|40070435|FG002|Overall Study|Lost to Follow-up|0|||
16434413|NCT03546621|40070436|FG003|Overall Study|Lost to Follow-up|0|||
16434414|NCT03546621|40070433|FG000|Overall Study|Adverse Event|0|||
16434415|NCT03546621|40070434|FG001|Overall Study|Adverse Event|1|||
16434416|NCT03546621|40070435|FG002|Overall Study|Adverse Event|0|||
16133587|NCT01139021|38976857|FG005|Overall Study|Lost to Follow-up|0|||
16133588|NCT01139021|38976852|FG000|Overall Study|Protocol Violation|1|||
16133589|NCT01139021|38976853|FG001|Overall Study|Protocol Violation|0|||
16133590|NCT01139021|38976854|FG002|Overall Study|Protocol Violation|0|||
16133591|NCT01139021|38976855|FG003|Overall Study|Protocol Violation|0|||
16133592|NCT01139021|38976856|FG004|Overall Study|Protocol Violation|2|||
16133593|NCT01139021|38976857|FG005|Overall Study|Protocol Violation|0|||
16133594|NCT01139021|38976852|FG000|Overall Study|Withdrawal by Subject|0|||
16133595|NCT01139021|38976853|FG001|Overall Study|Withdrawal by Subject|0|||
16434417|NCT03546621|40070436|FG003|Overall Study|Adverse Event|1|||
16133596|NCT01139021|38976854|FG002|Overall Study|Withdrawal by Subject|0|||
16133597|NCT01139021|38976855|FG003|Overall Study|Withdrawal by Subject|1|||
16133598|NCT01139021|38976856|FG004|Overall Study|Withdrawal by Subject|4|||
16133599|NCT01139021|38976857|FG005|Overall Study|Withdrawal by Subject|0|||
16133600|NCT01313117|38976858|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
16133601|NCT01313117|38976858|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
16133602|NCT01502631|38976863|FG000|Overall Study|Adverse Event|5|||
16133603|NCT01502631|38976864|FG001|Overall Study|Adverse Event|8|||
16133604|NCT01502631|38976863|FG000|Overall Study|Lost to Follow-up|2|||
16133605|NCT01502631|38976864|FG001|Overall Study|Lost to Follow-up|2|||
16251010|NCT03206203|39404256|FG001|Treatment|Withdrawal by Subject|0|||
16434418|NCT03546621|40070433|FG000|Overall Study|Progressive disease|0|||
16434419|NCT03546621|40070434|FG001|Overall Study|Progressive disease|0|||
16434420|NCT03546621|40070435|FG002|Overall Study|Progressive disease|0|||
16251011|NCT03206203|39404257|FG002|Treatment|Withdrawal by Subject|0|||
16251012|NCT03206203|39404255|FG000|Treatment|Lost to Follow-up|4|||
16251013|NCT03206203|39404256|FG001|Treatment|Lost to Follow-up|0|||
16251014|NCT03206203|39404257|FG002|Treatment|Lost to Follow-up|0|||
16251015|NCT03206203|39404255|FG000|Treatment|N/A in Follow-Up|8|||
16251016|NCT03206203|39404256|FG001|Treatment|N/A in Follow-Up|1|||
16251017|NCT03206203|39404257|FG002|Treatment|N/A in Follow-Up|0|||
16251018|NCT03206203|39404255|FG000|Treatment|Disease progression|0|||
16251019|NCT03206203|39404256|FG001|Treatment|Disease progression|1|||
16251020|NCT03206203|39404257|FG002|Treatment|Disease progression|0|||
16251021|NCT03206203|39404255|FG000|Treatment|Refused follow-up|0|||
16251022|NCT03206203|39404256|FG001|Treatment|Refused follow-up|1|||
16251023|NCT03206203|39404257|FG002|Treatment|Refused follow-up|0|||
16251024|NCT03206203|39404255|FG000|Treatment|Cross over to Arm 1|0|||
16434421|NCT03546621|40070436|FG003|Overall Study|Progressive disease|1|||
16434422|NCT00360412|40070450|FG000|Overall Study|Adverse Event|37|||
16434423|NCT00360412|40070451|FG001|Overall Study|Adverse Event|65|||
16434424|NCT00360412|40070450|FG000|Overall Study|Protocol Violation|2|||
16434425|NCT00360412|40070451|FG001|Overall Study|Protocol Violation|5|||
16434426|NCT00360412|40070450|FG000|Overall Study|Patient withdrew consent|27|||
16434427|NCT00360412|40070451|FG001|Overall Study|Patient withdrew consent|52|||
16434428|NCT00360412|40070450|FG000|Overall Study|Lack of therapeutic efficacy|46|||
16434429|NCT00360412|40070451|FG001|Overall Study|Lack of therapeutic efficacy|61|||
16434430|NCT00360412|40070450|FG000|Overall Study|Physician Decision|2|||
16434431|NCT00360412|40070451|FG001|Overall Study|Physician Decision|4|||
16434432|NCT00360412|40070450|FG000|Overall Study|Other|5|||
16434433|NCT00360412|40070451|FG001|Overall Study|Other|6|||
16434434|NCT00360412|40070450|FG000|Overall Study|Study termination by Sponsor|214|||
16434435|NCT00360412|40070451|FG001|Overall Study|Study termination by Sponsor|469|||
16133606|NCT01502631|38976863|FG000|Overall Study|Participant withdrew consent|2|||
16251025|NCT03206203|39404256|FG001|Treatment|Cross over to Arm 1|19|||
16251026|NCT03206203|39404257|FG002|Treatment|Cross over to Arm 1|0|||
16251027|NCT03206203|39404255|FG000|Optional Cross-Over|Death|0|||
16251028|NCT03206203|39404256|FG001|Optional Cross-Over|Death|0|||
16251029|NCT03206203|39404257|FG002|Optional Cross-Over|Death|14|||
16251030|NCT03206203|39404255|FG000|Optional Cross-Over|Refused follow-up|0|||
16251031|NCT03206203|39404256|FG001|Optional Cross-Over|Refused follow-up|0|||
16251032|NCT03206203|39404257|FG002|Optional Cross-Over|Refused follow-up|2|||
16251033|NCT00818883|39404258|FG000|Overall Study|Adverse Event|28|||
16251034|NCT00818883|39404259|FG001|Overall Study|Adverse Event|19|||
16251035|NCT00818883|39404258|FG000|Overall Study|Protocol Violation|2|||
16133607|NCT01502631|38976864|FG001|Overall Study|Participant withdrew consent|4|||
16251036|NCT00818883|39404259|FG001|Overall Study|Protocol Violation|2|||
16133608|NCT01502631|38976863|FG000|Overall Study|Participant non-compliant|1|||
16133609|NCT01502631|38976864|FG001|Overall Study|Participant non-compliant|0|||
16133610|NCT01502631|38976863|FG000|Overall Study|Investigator's decision|0|||
16251037|NCT00818883|39404258|FG000|Overall Study|Lost to Follow-up|3|||
16434436|NCT00074711|40070452|FG000|Overall Study|Withdrawal by Subject|1|||
16434437|NCT00074711|40070453|FG001|Overall Study|Withdrawal by Subject|1|||
16434438|NCT00074711|40070452|FG000|Overall Study|Lost to Follow-up|10|||
16434439|NCT00074711|40070453|FG001|Overall Study|Lost to Follow-up|8|||
16133611|NCT01502631|38976864|FG001|Overall Study|Investigator's decision|1|||
16133612|NCT01502631|38976863|FG000|Overall Study|Other|10|||
16133613|NCT01502631|38976864|FG001|Overall Study|Other|5|||
16133614|NCT00950950|38976865|FG000|Overall Study|Adverse Event|1|||
16133615|NCT00950950|38976866|FG001|Overall Study|Adverse Event|0|||
16133616|NCT00950950|38976865|FG000|Overall Study|Withdrawal by Subject|0|||
16133617|NCT00950950|38976866|FG001|Overall Study|Withdrawal by Subject|1|||
16133618|NCT03213457|38976867|FG000|Overall Study|Not Treated|1|||
16133619|NCT03213457|38976868|FG001|Overall Study|Not Treated|1|||
16133620|NCT03213457|38976869|FG002|Overall Study|Not Treated|0|||
16133621|NCT03213457|38976867|FG000|Overall Study|Adverse Event|16|||
16133622|NCT03213457|38976868|FG001|Overall Study|Adverse Event|9|||
16133623|NCT03213457|38976869|FG002|Overall Study|Adverse Event|41|||
16133624|NCT03213457|38976867|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16133625|NCT03213457|38976868|FG001|Overall Study|Non-Compliance With Study Drug|2|||
16133626|NCT03213457|38976869|FG002|Overall Study|Non-Compliance With Study Drug|7|||
16133627|NCT03213457|38976867|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
16434440|NCT00074711|40070452|FG000|Overall Study|Participant stopped study drug|4|||
16434441|NCT00074711|40070453|FG001|Overall Study|Participant stopped study drug|6|||
16434442|NCT01096316|40070457|FG000|Overall Study|Lost to Follow-up|15|||
16434443|NCT01096316|40070458|FG001|Overall Study|Lost to Follow-up|9|||
16434444|NCT02831764|40070459|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
16434445|NCT02831764|40070460|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
16434446|NCT02831764|40070461|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
16434447|NCT02831764|40070462|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
16434448|NCT02831764|40070463|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
16434449|NCT02831764|40070459|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
16133628|NCT03213457|38976868|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
16133629|NCT03213457|38976869|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
16133630|NCT03213457|38976867|FG000|Overall Study|Withdrawal by Subject|18|||
16133631|NCT03213457|38976868|FG001|Overall Study|Withdrawal by Subject|7|||
16133632|NCT03213457|38976869|FG002|Overall Study|Withdrawal by Subject|35|||
16133633|NCT03213457|38976867|FG000|Overall Study|Lost to Follow-up|12|||
16133634|NCT03213457|38976868|FG001|Overall Study|Lost to Follow-up|12|||
16133635|NCT03213457|38976869|FG002|Overall Study|Lost to Follow-up|33|||
16133636|NCT03213457|38976867|FG000|Overall Study|Pregnancy|11|||
16133637|NCT03213457|38976868|FG001|Overall Study|Pregnancy|0|||
16133638|NCT03213457|38976869|FG002|Overall Study|Pregnancy|7|||
16133639|NCT03213457|38976867|FG000|Overall Study|Protocol Violation|1|||
16133640|NCT03213457|38976868|FG001|Overall Study|Protocol Violation|1|||
16133641|NCT03213457|38976869|FG002|Overall Study|Protocol Violation|6|||
16133642|NCT03213457|38976867|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
16133643|NCT03213457|38976868|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
16133644|NCT03213457|38976869|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
16133645|NCT03213457|38976867|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
16133646|NCT03213457|38976868|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
16133647|NCT03213457|38976869|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
16133648|NCT03213457|38976867|FG000|Overall Study|Lack of Efficacy|12|||
16133649|NCT03213457|38976868|FG001|Overall Study|Lack of Efficacy|2|||
16133650|NCT03213457|38976869|FG002|Overall Study|Lack of Efficacy|9|||
16133651|NCT03213457|38976867|FG000|Overall Study|Other, Not Specified|11|||
16133652|NCT03213457|38976868|FG001|Overall Study|Other, Not Specified|3|||
16133653|NCT03213457|38976869|FG002|Overall Study|Other, Not Specified|26|||
16133654|NCT01636960|38976874|FG000|Induction Phase|Adverse Event|2|||
16133655|NCT01636960|38976874|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
16133656|NCT01636960|38976874|FG000|Maintenance Phase|Adverse Event|3|||
16133657|NCT01636960|38976874|FG000|Maintenance Phase|Progressive disease|1|||
16133658|NCT01590017|38976875|FG000|Overall Study|Adverse Event|1|||
16434450|NCT02831764|40070460|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
16133659|NCT01590017|38976875|FG000|Overall Study|Withdrawal by Subject|1|||
16133660|NCT01590017|38976875|FG000|Overall Study|Lack of Efficacy|1|||
16133661|NCT01590017|38976875|FG000|Overall Study|Physician Decision|1|||
16133662|NCT00903630|38976876|FG000|Phase 2|Adverse Event|0|||
16133663|NCT00903630|38976877|FG001|Phase 2|Adverse Event|0|||
16133664|NCT00903630|38976878|FG002|Phase 2|Adverse Event|1|||
16133665|NCT00690820|38976879|FG000|Period 1|Withdrawal by Subject|0|||
16133666|NCT00690820|38976880|FG001|Period 1|Withdrawal by Subject|1|||
16133667|NCT01639495|38976881|FG000|Overall Study|Lost to Follow-up|6|||
16133668|NCT01639495|38976881|FG000|Overall Study|Consented but didn't have study catheter|4|||
16133669|NCT01639495|38976881|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
16133670|NCT01639495|38976881|FG000|Overall Study|No radiofrequency energy applied|2|||
16434451|NCT02831764|40070461|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
16434452|NCT02831764|40070462|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
16434453|NCT02831764|40070463|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
16434454|NCT02831764|40070459|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
16434455|NCT02831764|40070460|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
16434456|NCT02831764|40070461|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
16434457|NCT02831764|40070462|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
16434458|NCT02831764|40070463|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
16434459|NCT02831764|40070459|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
16434460|NCT02831764|40070460|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
16434461|NCT02831764|40070461|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
16434462|NCT02831764|40070462|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
16434463|NCT02831764|40070463|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
16434464|NCT02831764|40070459|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
16434465|NCT02831764|40070460|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
16434466|NCT02831764|40070461|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
16434467|NCT02831764|40070462|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
16434468|NCT02831764|40070463|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
16434469|NCT02831764|40070459|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
16434470|NCT02831764|40070460|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
16251038|NCT00818883|39404259|FG001|Overall Study|Lost to Follow-up|2|||
16434471|NCT02831764|40070461|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
16434472|NCT02831764|40070462|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
16434473|NCT02831764|40070463|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
16434474|NCT02831764|40070459|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
16434475|NCT02831764|40070460|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
16434476|NCT02831764|40070461|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
16434477|NCT02831764|40070462|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
16434478|NCT02831764|40070463|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
16434479|NCT02831764|40070459|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
16434480|NCT02831764|40070460|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
16434481|NCT02831764|40070461|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
16434482|NCT02831764|40070462|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
16434483|NCT02831764|40070463|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
16434484|NCT02831764|40070459|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
16434485|NCT02831764|40070460|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
16434486|NCT02831764|40070461|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
16434487|NCT02831764|40070462|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
16434488|NCT02831764|40070463|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
16434489|NCT02831764|40070459|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
16434490|NCT02831764|40070460|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
16434491|NCT02831764|40070461|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
16434492|NCT02831764|40070462|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
16434493|NCT02831764|40070463|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
16251039|NCT00818883|39404258|FG000|Overall Study|Withdrawal by Subject|16|||
16251040|NCT00818883|39404259|FG001|Overall Study|Withdrawal by Subject|14|||
16251041|NCT00818883|39404258|FG000|Overall Study|Lack of Efficacy|0|||
16251042|NCT00818883|39404259|FG001|Overall Study|Lack of Efficacy|2|||
16251043|NCT00818883|39404258|FG000|Overall Study|Other|2|||
16251044|NCT00818883|39404259|FG001|Overall Study|Other|7|||
16251045|NCT02688608|39404268|FG000|Overall Study|Lost to Follow-up|1|||
16251046|NCT01808209|39404271|FG000|Overall Study|Lost to Follow-up|0|||
16251047|NCT01808209|39404272|FG001|Overall Study|Lost to Follow-up|1|||
16251048|NCT01309919|39404273|FG000|Overall Study|Did not receive a postpartum IUD|17|||
16251049|NCT01309919|39404274|FG001|Overall Study|Did not receive a postpartum IUD|48|||
16251050|NCT02518113|39404278|FG000|Overall Study|Adverse Event|1|||
16251051|NCT02518113|39404279|FG001|Overall Study|Adverse Event|0|||
16251052|NCT02518113|39404280|FG002|Overall Study|Adverse Event|1|||
16251053|NCT02518113|39404281|FG003|Overall Study|Adverse Event|0|||
16434494|NCT02831764|40070459|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
16434495|NCT02831764|40070460|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
16434496|NCT02831764|40070461|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
16434497|NCT02831764|40070462|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
16251054|NCT02518113|39404278|FG000|Overall Study|Death|1|||
16251055|NCT02518113|39404279|FG001|Overall Study|Death|2|||
16251056|NCT02518113|39404280|FG002|Overall Study|Death|0|||
16251057|NCT02518113|39404281|FG003|Overall Study|Death|0|||
16251058|NCT02518113|39404278|FG000|Overall Study|Physician Decision|0|||
16133671|NCT00609765|38976882|FG000|Overall Study|Study ended prior to 12 months|1|||
16133672|NCT00723021|38976883|FG000|Intervention Period 4|Adverse Event|0|||
16133673|NCT00723021|38976884|FG001|Intervention Period 4|Adverse Event|0|||
16133674|NCT00723021|38976885|FG002|Intervention Period 4|Adverse Event|0|||
16133675|NCT00723021|38976886|FG003|Intervention Period 4|Adverse Event|0|||
16133676|NCT00723021|38976887|FG004|Intervention Period 4|Adverse Event|1|||
16133677|NCT01136811|38976888|FG000|Overall Study|Physician Decision|11|||
16133678|NCT00738582|38976889|FG000|Combination Therapy|Completed Combination Therapy|1|||
16133679|NCT00738582|38976890|FG001|Combination Therapy|Completed Combination Therapy|0|||
16133680|NCT00738582|38976889|FG000|Combination Therapy|Physician Decision|1|||
16133681|NCT00738582|38976890|FG001|Combination Therapy|Physician Decision|0|||
16133682|NCT00738582|38976889|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
16133683|NCT00738582|38976890|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
16133684|NCT00738582|38976889|FG000|Combination Therapy|Other|5|||
16133685|NCT00738582|38976890|FG001|Combination Therapy|Other|0|||
16133686|NCT00738582|38976889|FG000|Combination Therapy|Adverse Event|16|||
16133687|NCT00738582|38976890|FG001|Combination Therapy|Adverse Event|0|||
16133688|NCT00738582|38976889|FG000|Combination Therapy|Progressive Disease|9|||
16133689|NCT00738582|38976890|FG001|Combination Therapy|Progressive Disease|0|||
16133690|NCT00738582|38976889|FG000|Maintenance Therapy|Other|0|||
16133691|NCT00738582|38976890|FG001|Maintenance Therapy|Other|2|||
16133692|NCT00738582|38976889|FG000|Maintenance Therapy|Adverse Event|0|||
16133693|NCT00738582|38976890|FG001|Maintenance Therapy|Adverse Event|6|||
16434498|NCT02831764|40070463|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
16434499|NCT02831764|40070459|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
16434500|NCT02831764|40070460|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
16434501|NCT02831764|40070461|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
16473171|NCT01147172|40210746|FG000|Overall Study|Withdrawal by Subject|2|||
16133694|NCT00738582|38976889|FG000|Maintenance Therapy|Progressive Disease|0|||
16133695|NCT00738582|38976890|FG001|Maintenance Therapy|Progressive Disease|47|||
16133696|NCT00738582|38976889|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
16133697|NCT00738582|38976890|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
16133698|NCT00848926|38976891|FG000|Treatment Period|Progressive disease|45|||
16133699|NCT00848926|38976891|FG000|Treatment Period|Adverse Event|20|||
16133700|NCT00848926|38976891|FG000|Treatment Period|Physician Decision|12|||
16133701|NCT00848926|38976891|FG000|Treatment Period|Withdrawal by Subject|7|||
16133702|NCT00848926|38976891|FG000|Follow-up Period|Lost to Follow-up|7|||
16133703|NCT00848926|38976891|FG000|Follow-up Period|Withdrawal by Subject|3|||
16133704|NCT00848926|38976891|FG000|Follow-up Period|Other|2|||
16133705|NCT00423943|38976892|FG000|Overall Study|Withdrawal by Subject|3|||
16133706|NCT00423943|38976893|FG001|Overall Study|Withdrawal by Subject|1|||
16133707|NCT03801915|38976894|FG000|Overall Study|Screen failure|0|||
16133708|NCT03801915|38976895|FG001|Overall Study|Screen failure|0|||
16133709|NCT03801915|38976896|FG002|Overall Study|Screen failure|1|||
16133710|NCT03801915|38976894|FG000|Overall Study|Ineligible|1|||
16133711|NCT03801915|38976895|FG001|Overall Study|Ineligible|0|||
16133712|NCT03801915|38976896|FG002|Overall Study|Ineligible|0|||
16434502|NCT02831764|40070462|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
16434503|NCT02831764|40070463|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
16434504|NCT02831764|40070459|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
16434505|NCT02831764|40070460|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
16434506|NCT02831764|40070461|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
16434507|NCT02831764|40070462|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
16434508|NCT02831764|40070463|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
16434509|NCT02831764|40070459|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
16434510|NCT02831764|40070460|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
16434511|NCT02831764|40070461|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
16434512|NCT02831764|40070462|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
16434513|NCT02831764|40070463|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
16434514|NCT02831764|40070459|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
16434515|NCT02831764|40070460|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
16434516|NCT02831764|40070461|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
16434517|NCT02831764|40070462|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
16434518|NCT02831764|40070463|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
16434519|NCT02831764|40070459|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
16434520|NCT02831764|40070460|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
16434521|NCT02831764|40070461|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
16434522|NCT02831764|40070462|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
16434523|NCT02831764|40070463|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
16434524|NCT02831764|40070459|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
16434525|NCT02831764|40070460|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
16434526|NCT02831764|40070461|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
16434527|NCT02831764|40070462|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
16434528|NCT02831764|40070463|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
16434529|NCT02831764|40070459|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
16434530|NCT02831764|40070460|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
16434531|NCT02831764|40070461|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
16434532|NCT02831764|40070462|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
16434533|NCT02831764|40070463|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
16434534|NCT02831764|40070459|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
16434535|NCT02831764|40070460|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
16434536|NCT02831764|40070461|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
16434537|NCT02831764|40070462|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
16133713|NCT03801915|38976894|FG000|Overall Study|Physician Decision|2|||
16133714|NCT03801915|38976895|FG001|Overall Study|Physician Decision|1|||
16133715|NCT03801915|38976896|FG002|Overall Study|Physician Decision|0|||
16133716|NCT03265938|38976897|FG000|Overall Study|Withdrawal by Subject|1|||
16434538|NCT02831764|40070463|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
16434539|NCT03309878|40070468|FG000|Overall Study|Adverse Event|1|||
16434540|NCT03309878|40070469|FG001|Overall Study|Adverse Event|0|||
16434541|NCT03309878|40070470|FG002|Overall Study|Adverse Event|0|||
16434542|NCT03309878|40070471|FG003|Overall Study|Adverse Event|0|||
16434543|NCT03309878|40070468|FG000|Overall Study|Did not maintain eligibility|2|||
16133717|NCT03265938|38976897|FG000|Overall Study|Physician Decision|1|||
16133718|NCT03265938|38976897|FG000|Overall Study|friable mass|6|||
16133719|NCT03305731|38976900|FG000|Overall Study|Protocol Violation|1|||
16133720|NCT01324440|38976901|FG000|Overall Study|Subject moved|0|||
16133721|NCT01324440|38976902|FG001|Overall Study|Subject moved|1|||
16133722|NCT02699983|38976903|FG000|Overall Study|Withdrawal by Subject|1|||
16133723|NCT02699983|38976904|FG001|Overall Study|Withdrawal by Subject|0|||
16133724|NCT02679508|38976905|FG000|Healing Phase|Protocol Violation|1|||
16133725|NCT02679508|38976906|FG001|Healing Phase|Protocol Violation|1|||
16133726|NCT02679508|38976905|FG000|Healing Phase|Lost to Follow-up|1|||
16133727|NCT02679508|38976906|FG001|Healing Phase|Lost to Follow-up|0|||
16133728|NCT02679508|38976905|FG000|Maintenance Phase|Adverse Event|12|||
16133729|NCT02679508|38976906|FG001|Maintenance Phase|Adverse Event|2|||
16133730|NCT02679508|38976905|FG000|Maintenance Phase|Lost to Follow-up|0|||
16434544|NCT03309878|40070469|FG001|Overall Study|Did not maintain eligibility|1|||
16434545|NCT03309878|40070470|FG002|Overall Study|Did not maintain eligibility|0|||
16133731|NCT02679508|38976906|FG001|Maintenance Phase|Lost to Follow-up|1|||
16133732|NCT02679508|38976905|FG000|Maintenance Phase|Withdrawal by Subject|15|||
16133733|NCT02679508|38976906|FG001|Maintenance Phase|Withdrawal by Subject|8|||
16133734|NCT02679508|38976905|FG000|Maintenance Phase|Other|5|||
16133735|NCT02679508|38976906|FG001|Maintenance Phase|Other|4|||
16133736|NCT03809429|38976907|FG000|Overall Study|Withdrawal by Subject|7|||
16133737|NCT03809429|38976908|FG001|Overall Study|Withdrawal by Subject|3|||
16133738|NCT03809429|38976907|FG000|Overall Study|Adverse Event|6|||
16133739|NCT03809429|38976908|FG001|Overall Study|Adverse Event|9|||
16133740|NCT03809429|38976907|FG000|Overall Study|COVID-19|3|||
16133741|NCT03809429|38976908|FG001|Overall Study|COVID-19|1|||
16133742|NCT03809429|38976907|FG000|Overall Study|Participant was discontinued by investigator|12|||
16133743|NCT03809429|38976908|FG001|Overall Study|Participant was discontinued by investigator|7|||
16133744|NCT02027623|38976909|FG000|Overall Study|Lost to Follow-up|3|||
16133745|NCT02027623|38976910|FG001|Overall Study|Lost to Follow-up|3|||
16133746|NCT02027623|38976909|FG000|Overall Study|Withdrawal by Subject|6|||
16133747|NCT02027623|38976910|FG001|Overall Study|Withdrawal by Subject|9|||
16133748|NCT02893930|38976911|FG000|Overall Study|Adverse Event|3|||
16133749|NCT02893930|38976911|FG000|Overall Study|Death|1|||
16133750|NCT02893930|38976911|FG000|Overall Study|Disease progression|5|||
16133751|NCT02893930|38976911|FG000|Overall Study|Withdrawal by Subject|2|||
16133752|NCT02893930|38976911|FG000|Overall Study|Physician Decision|1|||
16434546|NCT03309878|40070471|FG003|Overall Study|Did not maintain eligibility|0|||
16434547|NCT03309878|40070468|FG000|Overall Study|Withdrawal by Subject|0|||
16434548|NCT03309878|40070469|FG001|Overall Study|Withdrawal by Subject|1|||
16434549|NCT03309878|40070470|FG002|Overall Study|Withdrawal by Subject|0|||
16434550|NCT03309878|40070471|FG003|Overall Study|Withdrawal by Subject|0|||
16434551|NCT02300259|40070472|FG000|Period 1|Adverse Event|0|||
16434552|NCT02300259|40070473|FG001|Period 1|Adverse Event|0|||
16434553|NCT02300259|40070474|FG002|Period 1|Adverse Event|1|||
16434554|NCT02300259|40070472|FG000|Period 1|Withdrawal by Subject|0|||
16434555|NCT02300259|40070473|FG001|Period 1|Withdrawal by Subject|0|||
16434556|NCT02300259|40070474|FG002|Period 1|Withdrawal by Subject|1|||
16434557|NCT02300259|40070472|FG000|Period 2|Adverse Event|1|||
16434558|NCT02300259|40070473|FG001|Period 2|Adverse Event|0|||
16434559|NCT02300259|40070474|FG002|Period 2|Adverse Event|0|||
16434560|NCT02300259|40070472|FG000|Period 2|Withdrawal by Subject|0|||
16133753|NCT02893930|38976911|FG000|Overall Study|Ineligible|1|||
16133754|NCT00825916|38976914|FG000|Overall Study|Lost to Follow-up|4|||
16133755|NCT00825916|38976915|FG001|Overall Study|Lost to Follow-up|2|||
16133756|NCT00825916|38976916|FG002|Overall Study|Lost to Follow-up|1|||
16133757|NCT01778023|38976920|FG000|Overall Study|Withdrawal by Subject|0|||
16133758|NCT01778023|38976921|FG001|Overall Study|Withdrawal by Subject|3|||
16133759|NCT00063154|38976922|FG000|Overall Study|Disease progression|27|||
16133760|NCT00063154|38976922|FG000|Overall Study|Adverse Event|2|||
16133761|NCT00063154|38976922|FG000|Overall Study|Physician Decision|10|||
16133762|NCT00063154|38976922|FG000|Overall Study|Death|3|||
16133763|NCT00063154|38976922|FG000|Overall Study|Reason unspecified|1|||
16434561|NCT02300259|40070473|FG001|Period 2|Withdrawal by Subject|0|||
16133764|NCT00063154|38976922|FG000|Overall Study|Did not receive treatment|8|||
16133765|NCT01270971|38976926|FG000|Overall Study|Withdrawal by Subject|24|||
16133766|NCT01270971|38976927|FG001|Overall Study|Withdrawal by Subject|11|||
16133767|NCT01270971|38976926|FG000|Overall Study|Lost to Follow-up|18|||
16133768|NCT01270971|38976927|FG001|Overall Study|Lost to Follow-up|5|||
16133769|NCT01270971|38976926|FG000|Overall Study|Adverse Event|1|||
16133770|NCT01270971|38976927|FG001|Overall Study|Adverse Event|2|||
16133771|NCT01270971|38976926|FG000|Overall Study|Non compliance|2|||
16133772|NCT01270971|38976927|FG001|Overall Study|Non compliance|2|||
16133773|NCT01270971|38976926|FG000|Overall Study|Non-specific|7|||
16133774|NCT01270971|38976927|FG001|Overall Study|Non-specific|3|||
16133775|NCT01945060|38976928|FG000|Overall Study|Lost to follow up|1|||
16133776|NCT01945060|38976929|FG001|Overall Study|Lost to follow up|0|||
16133777|NCT01945060|38976928|FG000|Overall Study|Distress related to IV access|0|||
16133778|NCT01945060|38976929|FG001|Overall Study|Distress related to IV access|1|||
16133779|NCT02875977|38976939|FG000|Overall Study|Lost to Follow-up|42|||
16133780|NCT02875977|38976940|FG001|Overall Study|Lost to Follow-up|29|||
16133781|NCT01003990|38976941|FG000|Overall Study|Adverse Event|8|||
16133782|NCT01003990|38976942|FG001|Overall Study|Adverse Event|5|||
16133783|NCT01003990|38976943|FG002|Overall Study|Adverse Event|11|||
16133784|NCT01003990|38976941|FG000|Overall Study|Death|0|||
16133785|NCT01003990|38976942|FG001|Overall Study|Death|8|||
16133786|NCT01003990|38976943|FG002|Overall Study|Death|1|||
16133787|NCT01003990|38976941|FG000|Overall Study|Lack of Efficacy|10|||
16133788|NCT01003990|38976942|FG001|Overall Study|Lack of Efficacy|2|||
16133789|NCT01003990|38976943|FG002|Overall Study|Lack of Efficacy|3|||
16133790|NCT01003990|38976941|FG000|Overall Study|Lost to Follow-up|30|||
16133791|NCT01003990|38976942|FG001|Overall Study|Lost to Follow-up|12|||
16133792|NCT01003990|38976943|FG002|Overall Study|Lost to Follow-up|7|||
16133793|NCT01003990|38976941|FG000|Overall Study|Reasons Not Identified|14|||
16133794|NCT01003990|38976942|FG001|Overall Study|Reasons Not Identified|13|||
16133795|NCT01003990|38976943|FG002|Overall Study|Reasons Not Identified|8|||
16133796|NCT01003990|38976941|FG000|Overall Study|Poor/Non-compliance|4|||
16133797|NCT01003990|38976942|FG001|Overall Study|Poor/Non-compliance|3|||
16133798|NCT01003990|38976943|FG002|Overall Study|Poor/Non-compliance|2|||
16133799|NCT01003990|38976941|FG000|Overall Study|Pregnancy|10|||
16133800|NCT01003990|38976942|FG001|Overall Study|Pregnancy|2|||
16133801|NCT01003990|38976943|FG002|Overall Study|Pregnancy|4|||
16133802|NCT01003990|38976941|FG000|Overall Study|No Longer Met Study Criteria|4|||
16133803|NCT01003990|38976942|FG001|Overall Study|No Longer Met Study Criteria|1|||
16133804|NCT01003990|38976943|FG002|Overall Study|No Longer Met Study Criteria|0|||
16133805|NCT01003990|38976941|FG000|Overall Study|Subject Withdrew Consent|12|||
16133806|NCT01003990|38976942|FG001|Overall Study|Subject Withdrew Consent|5|||
16133807|NCT01003990|38976943|FG002|Overall Study|Subject Withdrew Consent|7|||
16133808|NCT02937454|38976946|FG000|Overall Study|Adverse Event|0|||
16133809|NCT02937454|38976947|FG001|Overall Study|Adverse Event|1|||
16133810|NCT02937454|38976946|FG000|Overall Study|Death|98|||
16133811|NCT02937454|38976947|FG001|Overall Study|Death|95|||
16133812|NCT02937454|38976946|FG000|Overall Study|Lost to Follow-up|1|||
16133813|NCT02937454|38976947|FG001|Overall Study|Lost to Follow-up|1|||
16133814|NCT02937454|38976946|FG000|Overall Study|Physician Decision|0|||
16133815|NCT02937454|38976947|FG001|Overall Study|Physician Decision|1|||
16133816|NCT02937454|38976946|FG000|Overall Study|Protocol Violation|6|||
16133817|NCT02937454|38976947|FG001|Overall Study|Protocol Violation|10|||
16133818|NCT02937454|38976946|FG000|Overall Study|Withdrawal by Subject|27|||
16133819|NCT02937454|38976947|FG001|Overall Study|Withdrawal by Subject|15|||
16133820|NCT02937454|38976946|FG000|Overall Study|Other|8|||
16133821|NCT02937454|38976947|FG001|Overall Study|Other|5|||
16133822|NCT00319839|38976948|FG000|Overall Study|Adverse Event|5|||
16133823|NCT00319839|38976948|FG000|Overall Study|Withdrawal by Subject|1|||
16133824|NCT01145755|38976952|FG000|Overall Study|Adverse Event|2|||
16133825|NCT01145755|38976953|FG001|Overall Study|Adverse Event|4|||
16133826|NCT01145755|38976954|FG002|Overall Study|Adverse Event|2|||
16133827|NCT01145755|38976952|FG000|Overall Study|Withdrawal by Subject|2|||
16133828|NCT01145755|38976953|FG001|Overall Study|Withdrawal by Subject|2|||
16251059|NCT02518113|39404279|FG001|Overall Study|Physician Decision|1|||
16251060|NCT02518113|39404280|FG002|Overall Study|Physician Decision|0|||
16133829|NCT01145755|38976954|FG002|Overall Study|Withdrawal by Subject|2|||
16133830|NCT01145755|38976952|FG000|Overall Study|Lost to Follow-up|2|||
16133831|NCT01145755|38976953|FG001|Overall Study|Lost to Follow-up|3|||
16133832|NCT01145755|38976954|FG002|Overall Study|Lost to Follow-up|1|||
16133833|NCT01145755|38976952|FG000|Overall Study|Protocol Violation|0|||
16251061|NCT02518113|39404281|FG003|Overall Study|Physician Decision|0|||
16251062|NCT02518113|39404278|FG000|Overall Study|Progressive Disease|1|||
16251063|NCT02518113|39404279|FG001|Overall Study|Progressive Disease|2|||
16434562|NCT02300259|40070474|FG002|Period 2|Withdrawal by Subject|1|||
16434563|NCT03259555|40070475|FG000|Overall Study|Adverse Event|6|||
16251064|NCT02518113|39404280|FG002|Overall Study|Progressive Disease|3|||
16251065|NCT02518113|39404281|FG003|Overall Study|Progressive Disease|0|||
16251066|NCT00635154|39404282|FG000|Overall Study|Alternative Treatment|8|||
16251067|NCT00635154|39404282|FG000|Overall Study|Other|4|||
16251068|NCT00635154|39404282|FG000|Overall Study|Still on treatment|21|||
16251069|NCT01974895|39404283|FG000|Overall Study|Protocol Violation|1|||
16251070|NCT01974895|39404284|FG001|Overall Study|Protocol Violation|0|||
16251071|NCT01974895|39404283|FG000|Overall Study|Lost to Follow-up|4|||
16251072|NCT01974895|39404284|FG001|Overall Study|Lost to Follow-up|6|||
16251073|NCT01974895|39404283|FG000|Overall Study|Withdrawal by Subject|0|||
16251074|NCT01974895|39404284|FG001|Overall Study|Withdrawal by Subject|1|||
16251075|NCT01974895|39404283|FG000|Overall Study|Other (Missed Visit)|1|||
16251076|NCT01974895|39404284|FG001|Overall Study|Other (Missed Visit)|0|||
16251077|NCT01974895|39404283|FG000|Overall Study|Other (Reason unknown)|9|||
16251078|NCT01974895|39404284|FG001|Overall Study|Other (Reason unknown)|8|||
16251079|NCT00944697|39404285|FG000|Overall Study|Withdrawal by Subject|1|||
16251080|NCT00944697|39404286|FG001|Overall Study|Withdrawal by Subject|1|||
16251081|NCT00944697|39404285|FG000|Overall Study|Adverse Event|0|||
16251082|NCT00944697|39404286|FG001|Overall Study|Adverse Event|3|||
16251083|NCT00944697|39404285|FG000|Overall Study|Administrative|1|||
16251084|NCT00944697|39404286|FG001|Overall Study|Administrative|1|||
16251085|NCT02795104|39404287|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
16251086|NCT02795104|39404288|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
16251087|NCT02795104|39404289|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
16251088|NCT02795104|39404287|FG000|Overall Study|Withdrawal by Subject|0|||
16251089|NCT02795104|39404288|FG001|Overall Study|Withdrawal by Subject|2|||
16251090|NCT02795104|39404289|FG002|Overall Study|Withdrawal by Subject|0|||
16251091|NCT02795104|39404287|FG000|Overall Study|Lost to Follow-up|0|||
16251092|NCT02795104|39404288|FG001|Overall Study|Lost to Follow-up|0|||
16251093|NCT02795104|39404289|FG002|Overall Study|Lost to Follow-up|1|||
16251094|NCT00475020|39404290|FG000|Overall Study|Physician Decision|3|||
16251095|NCT00475020|39404290|FG000|Overall Study|Insurance Denial|1|||
16251096|NCT00475020|39404290|FG000|Overall Study|Donor not able to donate the last minute|1|||
16251097|NCT03131999|39404293|FG000|Overall Study|Withdrawal by Subject|0|||
16251098|NCT03131999|39404294|FG001|Overall Study|Withdrawal by Subject|1|||
16251099|NCT01107535|39404295|FG000|Overall Study|Death|5|||
16251100|NCT00358826|39404296|FG000|Core Study|Adverse Event|1|||
16251101|NCT00358826|39404297|FG001|Core Study|Adverse Event|3|||
16251102|NCT00358826|39404298|FG002|Core Study|Adverse Event|1|||
16251103|NCT00358826|39404299|FG003|Core Study|Adverse Event|1|||
16251104|NCT00358826|39404300|FG004|Core Study|Adverse Event|0|||
16251105|NCT00358826|39404301|FG005|Core Study|Adverse Event|0|||
16251106|NCT00358826|39404302|FG006|Core Study|Adverse Event|0|||
16251107|NCT00358826|39404303|FG007|Core Study|Adverse Event|0|||
16251108|NCT00358826|39404296|FG000|Core Study|Withdrawal by Subject|2|||
16251109|NCT00358826|39404297|FG001|Core Study|Withdrawal by Subject|2|||
16251110|NCT00358826|39404298|FG002|Core Study|Withdrawal by Subject|0|||
16251111|NCT00358826|39404299|FG003|Core Study|Withdrawal by Subject|0|||
16251112|NCT00358826|39404300|FG004|Core Study|Withdrawal by Subject|0|||
16251113|NCT00358826|39404301|FG005|Core Study|Withdrawal by Subject|0|||
16251114|NCT00358826|39404302|FG006|Core Study|Withdrawal by Subject|0|||
16251115|NCT00358826|39404303|FG007|Core Study|Withdrawal by Subject|0|||
16133834|NCT01145755|38976953|FG001|Overall Study|Protocol Violation|3|||
16251116|NCT00358826|39404296|FG000|Core Study|Lost to Follow-up|0|||
16251117|NCT00358826|39404297|FG001|Core Study|Lost to Follow-up|0|||
16133835|NCT01145755|38976954|FG002|Overall Study|Protocol Violation|1|||
16133836|NCT01145755|38976952|FG000|Overall Study|Study Closure|14|||
16133837|NCT01145755|38976953|FG001|Overall Study|Study Closure|14|||
16251118|NCT00358826|39404298|FG002|Core Study|Lost to Follow-up|0|||
16251119|NCT00358826|39404299|FG003|Core Study|Lost to Follow-up|1|||
16251120|NCT00358826|39404300|FG004|Core Study|Lost to Follow-up|0|||
16251121|NCT00358826|39404301|FG005|Core Study|Lost to Follow-up|0|||
16251122|NCT00358826|39404302|FG006|Core Study|Lost to Follow-up|0|||
16251123|NCT00358826|39404303|FG007|Core Study|Lost to Follow-up|0|||
16251124|NCT00358826|39404296|FG000|Core Study|Physician Decision|0|||
16251125|NCT00358826|39404297|FG001|Core Study|Physician Decision|0|||
16251126|NCT00358826|39404298|FG002|Core Study|Physician Decision|1|||
16251127|NCT00358826|39404299|FG003|Core Study|Physician Decision|0|||
16251128|NCT00358826|39404300|FG004|Core Study|Physician Decision|0|||
16251129|NCT00358826|39404301|FG005|Core Study|Physician Decision|0|||
16251130|NCT00358826|39404302|FG006|Core Study|Physician Decision|0|||
16251131|NCT00358826|39404303|FG007|Core Study|Physician Decision|0|||
16251132|NCT00358826|39404296|FG000|MDCT Substudy|Adverse Event|0|||
16251133|NCT00358826|39404297|FG001|MDCT Substudy|Adverse Event|0|||
16251134|NCT00358826|39404298|FG002|MDCT Substudy|Adverse Event|0|||
16251135|NCT00358826|39404299|FG003|MDCT Substudy|Adverse Event|0|||
16251136|NCT00358826|39404300|FG004|MDCT Substudy|Adverse Event|1|||
16251137|NCT00358826|39404301|FG005|MDCT Substudy|Adverse Event|0|||
16251138|NCT00358826|39404302|FG006|MDCT Substudy|Adverse Event|0|||
16251139|NCT00358826|39404303|FG007|MDCT Substudy|Adverse Event|0|||
16251140|NCT00358826|39404296|FG000|MDCT Substudy|Lost to Follow-up|0|||
16251141|NCT00358826|39404297|FG001|MDCT Substudy|Lost to Follow-up|0|||
16251142|NCT00358826|39404298|FG002|MDCT Substudy|Lost to Follow-up|0|||
16251143|NCT00358826|39404299|FG003|MDCT Substudy|Lost to Follow-up|0|||
16251144|NCT00358826|39404300|FG004|MDCT Substudy|Lost to Follow-up|0|||
16434564|NCT03259555|40070476|FG001|Overall Study|Adverse Event|4|||
16434565|NCT03259555|40070475|FG000|Overall Study|Lack of Efficacy|6|||
16133838|NCT01145755|38976954|FG002|Overall Study|Study Closure|17|||
16133839|NCT01145755|38976952|FG000|Overall Study|Lack of Efficacy|0|||
16133840|NCT01145755|38976953|FG001|Overall Study|Lack of Efficacy|1|||
16133841|NCT01145755|38976954|FG002|Overall Study|Lack of Efficacy|0|||
16133842|NCT01145755|38976952|FG000|Overall Study|Patient could not swollow medication|0|||
16251145|NCT00358826|39404301|FG005|MDCT Substudy|Lost to Follow-up|1|||
16251146|NCT00358826|39404302|FG006|MDCT Substudy|Lost to Follow-up|0|||
16251147|NCT00358826|39404303|FG007|MDCT Substudy|Lost to Follow-up|0|||
16251148|NCT00358826|39404296|FG000|MDCT Substudy|Withdrawal by Subject|0|||
16251149|NCT00358826|39404297|FG001|MDCT Substudy|Withdrawal by Subject|0|||
16251150|NCT00358826|39404298|FG002|MDCT Substudy|Withdrawal by Subject|0|||
16251151|NCT00358826|39404299|FG003|MDCT Substudy|Withdrawal by Subject|0|||
16251152|NCT00358826|39404300|FG004|MDCT Substudy|Withdrawal by Subject|0|||
16251153|NCT00358826|39404301|FG005|MDCT Substudy|Withdrawal by Subject|1|||
16251154|NCT00358826|39404302|FG006|MDCT Substudy|Withdrawal by Subject|0|||
16251155|NCT00358826|39404303|FG007|MDCT Substudy|Withdrawal by Subject|0|||
16251156|NCT00743197|39404307|FG000|Overall Study|Study terminated due to departure of PI.|1|||
16251157|NCT00743197|39404308|FG001|Overall Study|Study terminated due to departure of PI.|2|||
16251158|NCT03036579|39404311|FG000|2 Years|Lost to Follow-up|1|||
16251159|NCT03036579|39404312|FG001|2 Years|Lost to Follow-up|0|||
16251160|NCT03036579|39404311|FG000|3 Years|Lost to Follow-up|0|||
16251161|NCT03036579|39404312|FG001|3 Years|Lost to Follow-up|1|||
16251162|NCT04053764|39404314|FG000|Overall Study|Withdrawal by Subject|6|||
16251163|NCT04053764|39404315|FG001|Overall Study|Withdrawal by Subject|2|||
16251164|NCT04053764|39404314|FG000|Overall Study|Physician Decision|2|||
16251165|NCT04053764|39404315|FG001|Overall Study|Physician Decision|1|||
16251166|NCT04053764|39404314|FG000|Overall Study|Adverse Event|1|||
16251167|NCT04053764|39404315|FG001|Overall Study|Adverse Event|0|||
16251168|NCT04053764|39404314|FG000|Overall Study|Pregnancy|1|||
16251169|NCT04053764|39404315|FG001|Overall Study|Pregnancy|0|||
16251170|NCT02153736|39404318|FG000|Overall Study|Lost to Follow-up|1|||
16251171|NCT02153736|39404319|FG001|Overall Study|Lost to Follow-up|0|||
16251172|NCT02153736|39404318|FG000|Overall Study|Medical status change made ineligible|1|||
16251173|NCT02153736|39404319|FG001|Overall Study|Medical status change made ineligible|0|||
16251174|NCT02153736|39404318|FG000|Overall Study|Death|0|||
16251175|NCT02153736|39404319|FG001|Overall Study|Death|1|||
16251176|NCT02153736|39404318|FG000|Overall Study|Withdrawal by Subject|0|||
16251177|NCT02153736|39404319|FG001|Overall Study|Withdrawal by Subject|1|||
16251178|NCT00806156|39404322|FG000|Overall Study|Death|35|||
16251179|NCT00806156|39404323|FG001|Overall Study|Death|95|||
16251180|NCT00806156|39404322|FG000|Overall Study|Did not meet eligibility criteria|1|||
16251181|NCT00806156|39404323|FG001|Overall Study|Did not meet eligibility criteria|0|||
16251182|NCT00806156|39404322|FG000|Overall Study|Study terminated by Sponsor|2|||
16251183|NCT00806156|39404323|FG001|Overall Study|Study terminated by Sponsor|40|||
16251184|NCT00806156|39404322|FG000|Overall Study|Consent withdrawn by subject|1|||
16251185|NCT00806156|39404323|FG001|Overall Study|Consent withdrawn by subject|3|||
16251186|NCT00806156|39404322|FG000|Overall Study|Lost to Follow-up|0|||
16251187|NCT00806156|39404323|FG001|Overall Study|Lost to Follow-up|1|||
16251188|NCT02070744|39404325|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
16251189|NCT02070744|39404326|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
16434566|NCT03259555|40070476|FG001|Overall Study|Lack of Efficacy|4|||
16133843|NCT01145755|38976953|FG001|Overall Study|Patient could not swollow medication|0|||
16251190|NCT02070744|39404327|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
16251191|NCT02070744|39404328|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
16251192|NCT02070744|39404329|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
16434567|NCT03259555|40070475|FG000|Overall Study|Lost to Follow-up|0|||
16133844|NCT01145755|38976954|FG002|Overall Study|Patient could not swollow medication|1|||
16434568|NCT03259555|40070476|FG001|Overall Study|Lost to Follow-up|2|||
16133845|NCT01145755|38976952|FG000|Overall Study|Withdrawal by Subject|0|||
16133846|NCT01145755|38976953|FG001|Overall Study|Withdrawal by Subject|0|||
16133847|NCT01145755|38976954|FG002|Overall Study|Withdrawal by Subject|1|||
16133848|NCT01145755|38976952|FG000|Overall Study|Positive urine ethanol|0|||
16133849|NCT01145755|38976953|FG001|Overall Study|Positive urine ethanol|1|||
16133850|NCT01145755|38976954|FG002|Overall Study|Positive urine ethanol|0|||
16133851|NCT03240874|38976955|FG000|Overall Study|Lost to Follow-up|0|||
16133852|NCT03240874|38976956|FG001|Overall Study|Lost to Follow-up|2|||
16133853|NCT03240874|38976957|FG002|Overall Study|Lost to Follow-up|4|||
16133854|NCT03240874|38976958|FG003|Overall Study|Lost to Follow-up|1|||
16133855|NCT03513588|38976959|FG000|Overall Study|Lost to Follow-up|0|||
16133856|NCT03513588|38976960|FG001|Overall Study|Lost to Follow-up|1|||
16133857|NCT03513588|38976961|FG002|Overall Study|Lost to Follow-up|1|||
16133858|NCT03513588|38976959|FG000|Overall Study|Study dosing paused by sponsor|1|||
16133859|NCT03513588|38976960|FG001|Overall Study|Study dosing paused by sponsor|1|||
16133860|NCT03513588|38976961|FG002|Overall Study|Study dosing paused by sponsor|0|||
16133861|NCT03513588|38976959|FG000|Overall Study|Death|0|||
16133862|NCT03513588|38976960|FG001|Overall Study|Death|0|||
16133863|NCT03513588|38976961|FG002|Overall Study|Death|1|||
16133864|NCT02935452|38976962|FG000|Overall Study|work and life commintment|3|||
16133865|NCT02935452|38976963|FG001|Overall Study|work and life commintment|1|||
16133866|NCT02043678|38976966|FG000|Overall Study|Never treated|11|||
16133867|NCT02043678|38976967|FG001|Overall Study|Never treated|9|||
16133868|NCT02043678|38976966|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
16133869|NCT02043678|38976967|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
16133870|NCT02043678|38976966|FG000|Overall Study|AE without clinical PD|51|||
16133871|NCT02043678|38976967|FG001|Overall Study|AE without clinical PD|34|||
16133872|NCT02043678|38976966|FG000|Overall Study|Lost to Follow-up|1|||
16133873|NCT02043678|38976967|FG001|Overall Study|Lost to Follow-up|1|||
16133874|NCT02043678|38976966|FG000|Overall Study|Other|19|||
16133875|NCT02043678|38976967|FG001|Overall Study|Other|16|||
16133876|NCT02043678|38976966|FG000|Overall Study|Clinical PD|108|||
16133877|NCT02043678|38976967|FG001|Overall Study|Clinical PD|138|||
16133878|NCT02043678|38976966|FG000|Overall Study|Radiological PD|91|||
16133879|NCT02043678|38976967|FG001|Overall Study|Radiological PD|80|||
16133880|NCT02043678|38976966|FG000|Overall Study|Protocol-driven decision point|56|||
16133881|NCT02043678|38976967|FG001|Overall Study|Protocol-driven decision point|56|||
16133882|NCT02043678|38976966|FG000|Overall Study|Withdrawal by Subject|12|||
16133883|NCT02043678|38976967|FG001|Overall Study|Withdrawal by Subject|15|||
16133884|NCT02043678|38976966|FG000|Overall Study|Ongoing with treatment|34|||
16133885|NCT02043678|38976967|FG001|Overall Study|Ongoing with treatment|38|||
16133886|NCT00810394|38976968|FG000|Overall Study|Withdrawal by Subject|3|||
16133887|NCT01201343|38976969|FG000|Overall Study|Adverse Event|6|||
16133888|NCT01201343|38976969|FG000|Overall Study|Withdrawal by Subject|5|||
16133889|NCT01201343|38976969|FG000|Overall Study|Lost to Follow-up|2|||
16133890|NCT01201343|38976969|FG000|Overall Study|Lack of Efficacy|2|||
16133891|NCT01201343|38976969|FG000|Overall Study|Participant wrongly included in trial|1|||
16133892|NCT01201343|38976969|FG000|Overall Study|Randomized, not treated|3|||
16133893|NCT01271803|38976970|FG000|Overall Study|Progressive disease|0|||
16133894|NCT01271803|38976971|FG001|Overall Study|Progressive disease|0|||
16133895|NCT01271803|38976972|FG002|Overall Study|Progressive disease|2|||
16133896|NCT01271803|38976970|FG000|Overall Study|Death|53|||
16133897|NCT01271803|38976971|FG001|Overall Study|Death|34|||
16133898|NCT01271803|38976972|FG002|Overall Study|Death|0|||
16133899|NCT01271803|38976970|FG000|Overall Study|Withdrawal by Subject|1|||
16133900|NCT01271803|38976971|FG001|Overall Study|Withdrawal by Subject|5|||
16133901|NCT01271803|38976972|FG002|Overall Study|Withdrawal by Subject|0|||
16133902|NCT01271803|38976970|FG000|Overall Study|Lost to Follow-up|1|||
16133903|NCT01271803|38976971|FG001|Overall Study|Lost to Follow-up|0|||
16133904|NCT01271803|38976972|FG002|Overall Study|Lost to Follow-up|0|||
16133905|NCT00409773|38976973|FG000|Overall Study|Adverse Event|3|||
16133906|NCT00409773|38976974|FG001|Overall Study|Adverse Event|4|||
16133907|NCT00409773|38976975|FG002|Overall Study|Adverse Event|4|||
16133908|NCT00409773|38976976|FG003|Overall Study|Adverse Event|2|||
16133909|NCT00409773|38976977|FG004|Overall Study|Adverse Event|6|||
16133910|NCT00409773|38976973|FG000|Overall Study|Lost to Follow-up|6|||
16133911|NCT00409773|38976974|FG001|Overall Study|Lost to Follow-up|1|||
16133912|NCT00409773|38976975|FG002|Overall Study|Lost to Follow-up|2|||
16133913|NCT00409773|38976976|FG003|Overall Study|Lost to Follow-up|3|||
16133914|NCT00409773|38976977|FG004|Overall Study|Lost to Follow-up|1|||
16133915|NCT00409773|38976973|FG000|Overall Study|Physician Decision|0|||
16133916|NCT00409773|38976974|FG001|Overall Study|Physician Decision|0|||
16133917|NCT00409773|38976975|FG002|Overall Study|Physician Decision|0|||
16133918|NCT00409773|38976976|FG003|Overall Study|Physician Decision|2|||
16133919|NCT00409773|38976977|FG004|Overall Study|Physician Decision|0|||
16133920|NCT00409773|38976973|FG000|Overall Study|Protocol Violation|0|||
16133921|NCT00409773|38976974|FG001|Overall Study|Protocol Violation|2|||
16133922|NCT00409773|38976975|FG002|Overall Study|Protocol Violation|3|||
16133923|NCT00409773|38976976|FG003|Overall Study|Protocol Violation|3|||
16133924|NCT00409773|38976977|FG004|Overall Study|Protocol Violation|1|||
16133925|NCT00409773|38976973|FG000|Overall Study|Withdrawal by Subject|0|||
16133926|NCT00409773|38976974|FG001|Overall Study|Withdrawal by Subject|0|||
16133927|NCT00409773|38976975|FG002|Overall Study|Withdrawal by Subject|0|||
16133928|NCT00409773|38976976|FG003|Overall Study|Withdrawal by Subject|2|||
16133929|NCT00409773|38976977|FG004|Overall Study|Withdrawal by Subject|1|||
16133930|NCT00409773|38976973|FG000|Overall Study|Lack of Eligibility|0|||
16133931|NCT00409773|38976974|FG001|Overall Study|Lack of Eligibility|0|||
16133932|NCT00409773|38976975|FG002|Overall Study|Lack of Eligibility|0|||
16133933|NCT00409773|38976976|FG003|Overall Study|Lack of Eligibility|0|||
16133934|NCT00409773|38976977|FG004|Overall Study|Lack of Eligibility|1|||
16133935|NCT03241225|38976979|FG000|Overall Study|Lost to Follow-up|2|||
16133936|NCT03241225|38976980|FG001|Overall Study|Lost to Follow-up|1|||
16133937|NCT03241225|38976979|FG000|Overall Study|Protocol Violation|4|||
16133938|NCT03241225|38976980|FG001|Overall Study|Protocol Violation|1|||
16133939|NCT03241225|38976979|FG000|Overall Study|Withdrawal by Subject|1|||
16133940|NCT03241225|38976980|FG001|Overall Study|Withdrawal by Subject|0|||
16133941|NCT01174160|38976984|FG000|Overall Study|Adverse Event|1|||
16133942|NCT01174160|38976985|FG001|Overall Study|Adverse Event|0|||
16133943|NCT01174160|38976984|FG000|Overall Study|Lost to Follow-up|1|||
16133944|NCT01174160|38976985|FG001|Overall Study|Lost to Follow-up|0|||
16133945|NCT01174160|38976984|FG000|Overall Study|Physician Decision|1|||
16133946|NCT01174160|38976985|FG001|Overall Study|Physician Decision|0|||
16133947|NCT01174160|38976984|FG000|Overall Study|Protocol Violation|4|||
16133948|NCT01174160|38976985|FG001|Overall Study|Protocol Violation|6|||
16434569|NCT03259555|40070475|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16434570|NCT03259555|40070476|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16434571|NCT03259555|40070475|FG000|Overall Study|Progressive Disease|0|||
16434572|NCT03259555|40070476|FG001|Overall Study|Progressive Disease|2|||
16434573|NCT03259555|40070475|FG000|Overall Study|Withdrawal by Subject|19|||
16434574|NCT03259555|40070476|FG001|Overall Study|Withdrawal by Subject|16|||
16434575|NCT03259555|40070475|FG000|Overall Study|Physician Decision|1|||
16251193|NCT02070744|39404325|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
16251194|NCT02070744|39404326|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
16251195|NCT02070744|39404327|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
16434576|NCT03259555|40070476|FG001|Overall Study|Physician Decision|2|||
16434577|NCT03259555|40070475|FG000|Overall Study|Other|1|||
16434578|NCT03259555|40070476|FG001|Overall Study|Other|0|||
16434579|NCT04516746|40070477|FG000|Overall Study|Randomized but not Treated|51|||
16434580|NCT04516746|40070478|FG001|Overall Study|Randomized but not Treated|19|||
16133949|NCT01174160|38976984|FG000|Overall Study|Withdrawal by Subject|1|||
16133950|NCT01174160|38976985|FG001|Overall Study|Withdrawal by Subject|0|||
16133951|NCT01588496|38976986|FG000|Overall Study|Withdrawal by Subject|0|||
16133952|NCT01588496|38976987|FG001|Overall Study|Withdrawal by Subject|1|||
16133953|NCT01588496|38976988|FG002|Overall Study|Withdrawal by Subject|0|||
16133954|NCT01272804|38976989|FG000|Overall Study|Adverse Event|1|||
16133955|NCT01272804|38976990|FG001|Overall Study|Adverse Event|0|||
16434581|NCT04516746|40070477|FG000|Overall Study|Adverse Event|0|||
16434582|NCT04516746|40070478|FG001|Overall Study|Adverse Event|1|||
16434583|NCT04516746|40070477|FG000|Overall Study|Death|62|||
16434584|NCT04516746|40070478|FG001|Overall Study|Death|32|||
16434585|NCT04516746|40070477|FG000|Overall Study|Lost to Follow-up|3431|||
16434586|NCT04516746|40070478|FG001|Overall Study|Lost to Follow-up|1831|||
16434587|NCT04516746|40070477|FG000|Overall Study|Withdrawal by Subject|1946|||
16434588|NCT04516746|40070478|FG001|Overall Study|Withdrawal by Subject|1696|||
16133956|NCT01272804|38976991|FG002|Overall Study|Adverse Event|0|||
16133957|NCT01272804|38976992|FG003|Overall Study|Adverse Event|0|||
16133958|NCT01272804|38976993|FG004|Overall Study|Adverse Event|2|||
16133959|NCT01272804|38976994|FG005|Overall Study|Adverse Event|1|||
16251196|NCT02070744|39404328|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
16434589|NCT04516746|40070477|FG000|Overall Study|Physician Decision|10|||
16434590|NCT04516746|40070478|FG001|Overall Study|Physician Decision|8|||
16434591|NCT04516746|40070477|FG000|Overall Study|Other|35|||
16434592|NCT04516746|40070478|FG001|Overall Study|Other|16|||
16434593|NCT02576639|40070480|FG000|Overall Study|Withdrawal by Subject|1|||
16434594|NCT02576639|40070481|FG001|Overall Study|Withdrawal by Subject|2|||
16434595|NCT02576639|40070482|FG002|Overall Study|Withdrawal by Subject|1|||
16434596|NCT02576639|40070483|FG003|Overall Study|Withdrawal by Subject|0|||
16434597|NCT02576639|40070484|FG004|Overall Study|Withdrawal by Subject|1|||
16434598|NCT02576639|40070480|FG000|Overall Study|Adverse Event|1|||
16133960|NCT02075541|38976995|FG000|Overall Study|Serious Adverse Event|1|||
16133961|NCT02075541|38976996|FG001|Overall Study|Serious Adverse Event|4|||
16133962|NCT02075541|38976995|FG000|Overall Study|Protocol Violation|1|||
16133963|NCT02075541|38976996|FG001|Overall Study|Protocol Violation|0|||
16133964|NCT02075541|38976995|FG000|Overall Study|Withdrawal by Subject|1|||
16133965|NCT02075541|38976996|FG001|Overall Study|Withdrawal by Subject|3|||
16133966|NCT02075541|38976995|FG000|Overall Study|Sponsor study termination|0|||
16133967|NCT02075541|38976996|FG001|Overall Study|Sponsor study termination|1|||
16434599|NCT02576639|40070481|FG001|Overall Study|Adverse Event|0|||
16434600|NCT02576639|40070482|FG002|Overall Study|Adverse Event|1|||
16434601|NCT02576639|40070483|FG003|Overall Study|Adverse Event|1|||
16434602|NCT02576639|40070484|FG004|Overall Study|Adverse Event|2|||
16434603|NCT02576639|40070480|FG000|Overall Study|Physician Decision|0|||
16434604|NCT02576639|40070481|FG001|Overall Study|Physician Decision|0|||
16434605|NCT02576639|40070482|FG002|Overall Study|Physician Decision|0|||
16434606|NCT02576639|40070483|FG003|Overall Study|Physician Decision|0|||
16434607|NCT02576639|40070484|FG004|Overall Study|Physician Decision|1|||
16434608|NCT01300234|40070494|FG000|Overall Study|Adverse Event|1|||
16434609|NCT01300234|40070495|FG001|Overall Study|Adverse Event|1|||
16434610|NCT01300234|40070494|FG000|Overall Study|Protocol Violation|2|||
16434611|NCT01300234|40070495|FG001|Overall Study|Protocol Violation|3|||
16434612|NCT01300234|40070494|FG000|Overall Study|Withdrawal by Subject|5|||
16434613|NCT01300234|40070495|FG001|Overall Study|Withdrawal by Subject|9|||
16434614|NCT01300234|40070494|FG000|Overall Study|Lost to Follow-up|14|||
16434615|NCT01300234|40070495|FG001|Overall Study|Lost to Follow-up|12|||
16434616|NCT01300234|40070494|FG000|Overall Study|Pregnancy|2|||
16434617|NCT01300234|40070495|FG001|Overall Study|Pregnancy|1|||
16434618|NCT01300234|40070494|FG000|Overall Study|Participant reached stopping critera|2|||
16434619|NCT01300234|40070495|FG001|Overall Study|Participant reached stopping critera|0|||
16434620|NCT01300234|40070494|FG000|Overall Study|Participant stopped medication|1|||
16434621|NCT01300234|40070495|FG001|Overall Study|Participant stopped medication|1|||
16434622|NCT01300234|40070494|FG000|Overall Study|Participant refused return to hospital|1|||
16434623|NCT01300234|40070495|FG001|Overall Study|Participant refused return to hospital|0|||
16434624|NCT00227721|40070499|FG000|Overall Study|On study, but never treated.|1|||
16434625|NCT00088530|40070500|FG000|Overall Study|Progressive/Relapsed Disease|28|||
16434626|NCT00088530|40070501|FG001|Overall Study|Progressive/Relapsed Disease|39|||
16434627|NCT00088530|40070500|FG000|Overall Study|Adverse Event|15|||
16434628|NCT00088530|40070501|FG001|Overall Study|Adverse Event|9|||
16434629|NCT00088530|40070500|FG000|Overall Study|Withdrawal by Subject|2|||
16434630|NCT00088530|40070501|FG001|Overall Study|Withdrawal by Subject|5|||
16434631|NCT00088530|40070500|FG000|Overall Study|Lost to Follow-up|2|||
16434632|NCT00088530|40070501|FG001|Overall Study|Lost to Follow-up|0|||
16434633|NCT00088530|40070500|FG000|Overall Study|Physician Decision|2|||
16434634|NCT00088530|40070501|FG001|Overall Study|Physician Decision|0|||
16434635|NCT00088530|40070500|FG000|Overall Study|Sponsor decision|0|||
16434636|NCT00088530|40070501|FG001|Overall Study|Sponsor decision|1|||
16434637|NCT00088530|40070500|FG000|Overall Study|Patient never treated|1|||
16434638|NCT00088530|40070501|FG001|Overall Study|Patient never treated|0|||
16434639|NCT00833040|40070505|FG000|Overall Study|Adverse Event|0|||
16434640|NCT00833040|40070506|FG001|Overall Study|Adverse Event|0|||
16434641|NCT00833040|40070507|FG002|Overall Study|Adverse Event|0|||
16434642|NCT00833040|40070508|FG003|Overall Study|Adverse Event|0|||
16434643|NCT00833040|40070509|FG004|Overall Study|Adverse Event|0|||
16434644|NCT00833040|40070510|FG005|Overall Study|Adverse Event|1|||
16434645|NCT00057863|40070511|FG000|Overall Study|Death|1|||
16434646|NCT00057863|40070511|FG000|Overall Study|Withdrawal by Subject|2|||
16434647|NCT02090426|40070512|FG000|Overall Study|Lost to Follow-up|12|||
16434648|NCT02090426|40070513|FG001|Overall Study|Lost to Follow-up|6|||
16434649|NCT00757237|40070514|FG000|Overall Study|Lost to Follow-up|0|||
16434650|NCT00757237|40070515|FG001|Overall Study|Lost to Follow-up|1|||
16434651|NCT00757237|40070514|FG000|Overall Study|Protocol Violation|0|||
16434652|NCT00757237|40070515|FG001|Overall Study|Protocol Violation|2|||
16434653|NCT00757237|40070514|FG000|Overall Study|Physician Decision|2|||
16434654|NCT00757237|40070515|FG001|Overall Study|Physician Decision|3|||
16434655|NCT00757237|40070514|FG000|Overall Study|Withdrawal by Subject|8|||
16434656|NCT00757237|40070515|FG001|Overall Study|Withdrawal by Subject|12|||
16362251|NCT02332707|39811972|FG015|Overall Study|Physician Decision|0|||
16362252|NCT02332707|39811973|FG016|Overall Study|Physician Decision|0|||
16362253|NCT02332707|39811974|FG017|Overall Study|Physician Decision|0|||
16362254|NCT02332707|39811957|FG000|Overall Study|Withdrawal by Subject|0|||
16133968|NCT02075541|38976995|FG000|Overall Study|Other- unable to perform study procedure|1|||
16133969|NCT02075541|38976996|FG001|Overall Study|Other- unable to perform study procedure|0|||
16133970|NCT01139658|38976997|FG000|Overall Study|Adverse Event|10|||
16133971|NCT01139658|38976998|FG001|Overall Study|Adverse Event|27|||
16133972|NCT01139658|38976997|FG000|Overall Study|Lack of Efficacy|15|||
16133973|NCT01139658|38976998|FG001|Overall Study|Lack of Efficacy|7|||
16133974|NCT01139658|38976997|FG000|Overall Study|Withdrawal by Subject|2|||
16133975|NCT01139658|38976998|FG001|Overall Study|Withdrawal by Subject|4|||
16133976|NCT01139658|38976997|FG000|Overall Study|No documentation of treatment|1|||
16133977|NCT01139658|38976998|FG001|Overall Study|No documentation of treatment|0|||
16133978|NCT01139658|38976997|FG000|Overall Study|Other|28|||
16133979|NCT01139658|38976998|FG001|Overall Study|Other|75|||
16133980|NCT00511472|38977003|FG000|Overall Study|Clinical Adverse Event|1|||
16133981|NCT00511472|38977004|FG001|Overall Study|Clinical Adverse Event|2|||
16133982|NCT00511472|38977003|FG000|Overall Study|Laboratory Adverse Event|0|||
16133983|NCT00511472|38977004|FG001|Overall Study|Laboratory Adverse Event|2|||
16133984|NCT00511472|38977003|FG000|Overall Study|Not reported|2|||
16133985|NCT00511472|38977004|FG001|Overall Study|Not reported|2|||
16133986|NCT01580969|38977005|FG000|Overall Study|Physician Decision|3|||
16133987|NCT01580969|38977006|FG001|Overall Study|Physician Decision|0|||
16133988|NCT01580969|38977007|FG002|Overall Study|Physician Decision|0|||
16133989|NCT01275131|38977008|FG000|Period 1|Withdrawal by Subject|1|||
16133990|NCT01275131|38977009|FG001|Period 1|Withdrawal by Subject|0|||
16133991|NCT01275131|38977010|FG002|Period 1|Withdrawal by Subject|3|||
16133992|NCT01275131|38977011|FG003|Period 1|Withdrawal by Subject|2|||
16133993|NCT01275131|38977008|FG000|Period 1|Physician Decision|1|||
16133994|NCT01275131|38977009|FG001|Period 1|Physician Decision|0|||
16133995|NCT01275131|38977010|FG002|Period 1|Physician Decision|0|||
16133996|NCT01275131|38977011|FG003|Period 1|Physician Decision|0|||
16362255|NCT02332707|39811958|FG001|Overall Study|Withdrawal by Subject|0|||
16362256|NCT02332707|39811959|FG002|Overall Study|Withdrawal by Subject|1|||
16362257|NCT02332707|39811960|FG003|Overall Study|Withdrawal by Subject|0|||
16362258|NCT02332707|39811961|FG004|Overall Study|Withdrawal by Subject|0|||
16362259|NCT02332707|39811962|FG005|Overall Study|Withdrawal by Subject|0|||
16133997|NCT01275131|38977008|FG000|Period 2 (Crossover)|Adverse Event|0|||
16133998|NCT01275131|38977009|FG001|Period 2 (Crossover)|Adverse Event|1|||
16133999|NCT01275131|38977010|FG002|Period 2 (Crossover)|Adverse Event|0|||
16134000|NCT01275131|38977011|FG003|Period 2 (Crossover)|Adverse Event|0|||
16134001|NCT01275131|38977008|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
16134002|NCT01275131|38977009|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
16134003|NCT01275131|38977010|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
16134004|NCT01275131|38977011|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
16134005|NCT00585195|38977018|FG000|Overall Study|Adverse Event|0|||
16251197|NCT02070744|39404329|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
16251198|NCT02070744|39404325|FG000|OLE Phase (48 Weeks)|Other|0|||
16251199|NCT02070744|39404326|FG001|OLE Phase (48 Weeks)|Other|0|||
16251200|NCT02070744|39404327|FG002|OLE Phase (48 Weeks)|Other|0|||
16251201|NCT02070744|39404328|FG003|OLE Phase (48 Weeks)|Other|0|||
16251202|NCT02070744|39404329|FG004|OLE Phase (48 Weeks)|Other|1|||
16251203|NCT05034731|39404333|FG000|Overall Study|Screen fail|1|||
16251204|NCT05034731|39404334|FG001|Overall Study|Screen fail|1|||
16251205|NCT01884025|39404335|FG000|Overall Study|Lost to Follow-up|3|||
16251206|NCT01884025|39404336|FG001|Overall Study|Lost to Follow-up|4|||
16251207|NCT03144687|39404337|FG000|Overall Study|Death|0|||
16251208|NCT03144687|39404338|FG001|Overall Study|Death|2|||
16251209|NCT03144687|39404337|FG000|Overall Study|Lost to Follow-up|0|||
16251210|NCT03144687|39404338|FG001|Overall Study|Lost to Follow-up|1|||
16251211|NCT03144687|39404337|FG000|Overall Study|Physician Decision|0|||
16251212|NCT03144687|39404338|FG001|Overall Study|Physician Decision|1|||
16251213|NCT03144687|39404337|FG000|Overall Study|Withdrawal by Subject|1|||
16251214|NCT03144687|39404338|FG001|Overall Study|Withdrawal by Subject|3|||
16251215|NCT03144687|39404337|FG000|Overall Study|Not Reported|2|||
16251216|NCT03144687|39404338|FG001|Overall Study|Not Reported|0|||
16251217|NCT02768298|39404339|FG000|Overall Study|Adverse Event|1|||
16251218|NCT02768298|39404340|FG001|Overall Study|Adverse Event|4|||
16251219|NCT02768298|39404339|FG000|Overall Study|Death|2|||
16251220|NCT02768298|39404340|FG001|Overall Study|Death|1|||
16251221|NCT02768298|39404339|FG000|Overall Study|Non-compliance with study treatment|0|||
16251222|NCT02768298|39404340|FG001|Overall Study|Non-compliance with study treatment|1|||
16251223|NCT02768298|39404339|FG000|Overall Study|Subject/guardian decision|1|||
16251224|NCT02768298|39404340|FG001|Overall Study|Subject/guardian decision|0|||
16251225|NCT02768298|39404339|FG000|Overall Study|Withdrawal of informed consent|0|||
16251226|NCT02768298|39404340|FG001|Overall Study|Withdrawal of informed consent|1|||
16251227|NCT00198029|39404341|FG000|Overall Study|Withdrawal by Subject|4|||
16251228|NCT03882047|39404342|FG000|Overall Study|Adverse Event|0|||
16251229|NCT03882047|39404343|FG001|Overall Study|Adverse Event|2|||
16251230|NCT03882047|39404344|FG002|Overall Study|Adverse Event|2|||
16251231|NCT03882047|39404342|FG000|Overall Study|Treatment Failure|3|||
16251232|NCT03882047|39404343|FG001|Overall Study|Treatment Failure|3|||
16251233|NCT03882047|39404344|FG002|Overall Study|Treatment Failure|12|||
16251234|NCT03882047|39404342|FG000|Overall Study|Lost to Follow-up|0|||
16251235|NCT03882047|39404343|FG001|Overall Study|Lost to Follow-up|1|||
16251236|NCT03882047|39404344|FG002|Overall Study|Lost to Follow-up|0|||
16251237|NCT03882047|39404342|FG000|Overall Study|Did Not Wish to Continue|1|||
16251238|NCT03882047|39404343|FG001|Overall Study|Did Not Wish to Continue|4|||
16251239|NCT03882047|39404344|FG002|Overall Study|Did Not Wish to Continue|1|||
16251240|NCT03882047|39404342|FG000|Overall Study|Noncompliance With Protocol|2|||
16251241|NCT03882047|39404343|FG001|Overall Study|Noncompliance With Protocol|0|||
16251242|NCT03882047|39404344|FG002|Overall Study|Noncompliance With Protocol|0|||
16251243|NCT03882047|39404342|FG000|Overall Study|Did Not Meet Eligibility|0|||
16251244|NCT03882047|39404343|FG001|Overall Study|Did Not Meet Eligibility|0|||
16251245|NCT03882047|39404344|FG002|Overall Study|Did Not Meet Eligibility|1|||
16362260|NCT02332707|39811963|FG006|Overall Study|Withdrawal by Subject|0|||
16362261|NCT02332707|39811964|FG007|Overall Study|Withdrawal by Subject|0|||
16362262|NCT02332707|39811965|FG008|Overall Study|Withdrawal by Subject|0|||
16362263|NCT02332707|39811966|FG009|Overall Study|Withdrawal by Subject|3|||
16362264|NCT02332707|39811967|FG010|Overall Study|Withdrawal by Subject|0|||
16362265|NCT02332707|39811968|FG011|Overall Study|Withdrawal by Subject|0|||
16362266|NCT02332707|39811969|FG012|Overall Study|Withdrawal by Subject|0|||
16362267|NCT02332707|39811970|FG013|Overall Study|Withdrawal by Subject|0|||
16362268|NCT02332707|39811971|FG014|Overall Study|Withdrawal by Subject|0|||
16362269|NCT02332707|39811972|FG015|Overall Study|Withdrawal by Subject|0|||
16362270|NCT02332707|39811973|FG016|Overall Study|Withdrawal by Subject|0|||
16434657|NCT00757237|40070514|FG000|Overall Study|Safety or Tolerability|3|||
16134006|NCT00585195|38977019|FG001|Overall Study|Adverse Event|0|||
16134007|NCT00585195|38977020|FG002|Overall Study|Adverse Event|0|||
16134008|NCT00585195|38977021|FG003|Overall Study|Adverse Event|0|||
16134009|NCT00585195|38977022|FG004|Overall Study|Adverse Event|2|||
16134010|NCT00585195|38977023|FG005|Overall Study|Adverse Event|1|||
16134011|NCT00585195|38977024|FG006|Overall Study|Adverse Event|0|||
16134012|NCT00585195|38977025|FG007|Overall Study|Adverse Event|1|||
16251246|NCT00903383|39404345|FG000|Overall Study|Adverse Event|1|||
16251247|NCT00903383|39404346|FG001|Overall Study|Adverse Event|2|||
16251248|NCT00903383|39404347|FG002|Overall Study|Adverse Event|3|||
16251249|NCT00903383|39404348|FG003|Overall Study|Adverse Event|1|||
16251250|NCT00903383|39404345|FG000|Overall Study|Physician Decision|1|||
16251251|NCT00903383|39404346|FG001|Overall Study|Physician Decision|2|||
16251252|NCT00903383|39404347|FG002|Overall Study|Physician Decision|0|||
16251253|NCT00903383|39404348|FG003|Overall Study|Physician Decision|0|||
16251254|NCT00903383|39404345|FG000|Overall Study|Lost to Follow-up|0|||
16251255|NCT00903383|39404346|FG001|Overall Study|Lost to Follow-up|0|||
16251256|NCT00903383|39404347|FG002|Overall Study|Lost to Follow-up|0|||
16251257|NCT00903383|39404348|FG003|Overall Study|Lost to Follow-up|1|||
16251258|NCT00903383|39404345|FG000|Overall Study|Decision of Sponsor|1|||
16251259|NCT00903383|39404346|FG001|Overall Study|Decision of Sponsor|0|||
16251260|NCT00903383|39404347|FG002|Overall Study|Decision of Sponsor|0|||
16251261|NCT00903383|39404348|FG003|Overall Study|Decision of Sponsor|0|||
16251262|NCT00903383|39404345|FG000|Overall Study|Withdrawal by Subject|4|||
16251263|NCT00903383|39404346|FG001|Overall Study|Withdrawal by Subject|1|||
16251264|NCT00903383|39404347|FG002|Overall Study|Withdrawal by Subject|0|||
16251265|NCT00903383|39404348|FG003|Overall Study|Withdrawal by Subject|2|||
16251266|NCT00903383|39404345|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
16251267|NCT00903383|39404346|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
16251268|NCT00903383|39404347|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
16251269|NCT00903383|39404348|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
16251270|NCT00903383|39404345|FG000|Overall Study|Patient Decision|0|||
16251271|NCT00903383|39404346|FG001|Overall Study|Patient Decision|0|||
16251272|NCT00903383|39404347|FG002|Overall Study|Patient Decision|0|||
16251273|NCT00903383|39404348|FG003|Overall Study|Patient Decision|1|||
16251274|NCT01298323|39404349|FG000|Overall Study|Adverse Event|2|||
16251275|NCT01298323|39404350|FG001|Overall Study|Adverse Event|4|||
16251276|NCT01298323|39404349|FG000|Overall Study|Death|11|||
16251277|NCT01298323|39404350|FG001|Overall Study|Death|16|||
16251278|NCT01298323|39404349|FG000|Overall Study|Lost to Follow-up|1|||
16251279|NCT01298323|39404350|FG001|Overall Study|Lost to Follow-up|0|||
16251280|NCT01298323|39404349|FG000|Overall Study|Withdrawal by Subject|6|||
16251281|NCT01298323|39404350|FG001|Overall Study|Withdrawal by Subject|3|||
16251282|NCT01298323|39404349|FG000|Overall Study|Protocol Violation|1|||
16251283|NCT01298323|39404350|FG001|Overall Study|Protocol Violation|0|||
16251284|NCT01298323|39404349|FG000|Overall Study|Other|10|||
16251285|NCT01298323|39404350|FG001|Overall Study|Other|9|||
16251286|NCT01298323|39404349|FG000|Overall Study|Ongoing|55|||
16362271|NCT02332707|39811974|FG017|Overall Study|Withdrawal by Subject|0|||
16362272|NCT00596635|39811975|FG000|Overall Study|Lost to Follow-up|0|||
16362273|NCT00596635|39811976|FG001|Overall Study|Lost to Follow-up|2|||
16362274|NCT00596635|39811977|FG002|Overall Study|Lost to Follow-up|0|||
16362275|NCT00596635|39811975|FG000|Overall Study|Treatment for symptomatic UTI|4|||
16362276|NCT00596635|39811976|FG001|Overall Study|Treatment for symptomatic UTI|6|||
16362277|NCT00596635|39811977|FG002|Overall Study|Treatment for symptomatic UTI|3|||
16362278|NCT00596635|39811975|FG000|Overall Study|Hip fracture|2|||
16362279|NCT00596635|39811976|FG001|Overall Study|Hip fracture|3|||
16362280|NCT00596635|39811977|FG002|Overall Study|Hip fracture|3|||
16362281|NCT00596635|39811975|FG000|Overall Study|Could not provide urine specimen|1|||
16362282|NCT00596635|39811976|FG001|Overall Study|Could not provide urine specimen|2|||
16362283|NCT00596635|39811977|FG002|Overall Study|Could not provide urine specimen|2|||
16362284|NCT00112957|39811981|FG000|Overall Study|Progressive disease|18|||
16134013|NCT00585195|38977026|FG008|Overall Study|Adverse Event|0|||
16134014|NCT00585195|38977027|FG009|Overall Study|Adverse Event|0|||
16134015|NCT00585195|38977028|FG010|Overall Study|Adverse Event|3|||
16134016|NCT00585195|38977029|FG011|Overall Study|Adverse Event|0|||
16251287|NCT01298323|39404350|FG001|Overall Study|Ongoing|55|||
16362285|NCT00112957|39811981|FG000|Overall Study|Physician Decision|1|||
16362286|NCT00324155|39811982|FG000|Enrolled and Randomized|No longer met study criteria|3|||
16434658|NCT00757237|40070515|FG001|Overall Study|Safety or Tolerability|5|||
16434659|NCT00757237|40070514|FG000|Overall Study|Other|0|||
16134017|NCT00585195|38977030|FG012|Overall Study|Adverse Event|8|||
16251288|NCT01298323|39404349|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16251289|NCT01298323|39404350|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16251290|NCT00125359|39404351|FG000|Overall Study|Death|4|||
16251291|NCT00125359|39404351|FG000|Overall Study|Adverse Event|5|||
16251292|NCT00125359|39404351|FG000|Overall Study|Physician Decision|14|||
16251293|NCT02352337|39404352|FG000|Overall Study|Patients never treated|4|||
16251294|NCT02352337|39404353|FG001|Overall Study|Patients never treated|1|||
16362287|NCT00324155|39811983|FG001|Enrolled and Randomized|No longer met study criteria|0|||
16362288|NCT00324155|39811982|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
16362289|NCT00324155|39811983|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
16362290|NCT00324155|39811982|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
16362291|NCT00324155|39811983|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
16362292|NCT00324155|39811982|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
16362293|NCT00324155|39811983|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
16362294|NCT00324155|39811982|FG000|Received Treatment in Induction Phase|Death|8|||
16362295|NCT00324155|39811983|FG001|Received Treatment in Induction Phase|Death|15|||
16362296|NCT00324155|39811982|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
16362297|NCT00324155|39811983|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
16362298|NCT00324155|39811982|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
16362299|NCT00324155|39811983|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
16362300|NCT00324155|39811982|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
16362301|NCT00324155|39811983|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
16362302|NCT00324155|39811982|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
16362303|NCT00324155|39811983|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
16362304|NCT00324155|39811982|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
16362305|NCT00324155|39811983|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
16362306|NCT00324155|39811982|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
16362307|NCT00324155|39811983|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
16362308|NCT00324155|39811982|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
16362309|NCT00324155|39811983|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
16362310|NCT00324155|39811982|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
16362311|NCT00324155|39811983|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
16362312|NCT00324155|39811982|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
16362313|NCT00324155|39811983|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
16362314|NCT00324155|39811982|FG000|Follow-up Phase|On-going participants still on drug|11|||
16362315|NCT00324155|39811983|FG001|Follow-up Phase|On-going participants still on drug|6|||
16362316|NCT01033942|39811988|FG000|Overall Study|Withdrawal by Subject|1|||
16362317|NCT01033942|39811989|FG001|Overall Study|Withdrawal by Subject|1|||
16134018|NCT00585195|38977031|FG013|Overall Study|Adverse Event|6|||
16134019|NCT00585195|38977032|FG014|Overall Study|Adverse Event|4|||
16134020|NCT00585195|38977033|FG015|Overall Study|Adverse Event|1|||
16134021|NCT00585195|38977034|FG016|Overall Study|Adverse Event|14|||
16134022|NCT00585195|38977035|FG017|Overall Study|Adverse Event|9|||
16134023|NCT00585195|38977036|FG018|Overall Study|Adverse Event|2|||
16362318|NCT01033942|39811990|FG002|Overall Study|Withdrawal by Subject|1|||
16362319|NCT01033942|39811988|FG000|Overall Study|Lost to Follow-up|1|||
16362320|NCT01033942|39811989|FG001|Overall Study|Lost to Follow-up|0|||
16362321|NCT01033942|39811990|FG002|Overall Study|Lost to Follow-up|0|||
16362322|NCT01033942|39811988|FG000|Overall Study|Enrolled in Extension Study|0|||
16362323|NCT01033942|39811989|FG001|Overall Study|Enrolled in Extension Study|3|||
16362324|NCT01033942|39811990|FG002|Overall Study|Enrolled in Extension Study|0|||
16362325|NCT02362451|39811991|FG000|Overall Study|Withdrawal by Subject|0|||
16362326|NCT02362451|39811992|FG001|Overall Study|Withdrawal by Subject|1|||
16362327|NCT02362451|39811991|FG000|Overall Study|Lack of Efficacy|2|||
16362328|NCT02362451|39811992|FG001|Overall Study|Lack of Efficacy|0|||
16362329|NCT02362451|39811991|FG000|Overall Study|Progression|1|||
16362330|NCT02362451|39811992|FG001|Overall Study|Progression|0|||
16362331|NCT02362451|39811991|FG000|Overall Study|Participant chose other therapy.|1|||
16362332|NCT02362451|39811992|FG001|Overall Study|Participant chose other therapy.|0|||
16362333|NCT00352118|39811993|FG000|Overall Study|Physician Decision|4|||
16362334|NCT00998946|39814881|FG000|Overall Study|Lost to Follow-up|1|||
16362335|NCT00998946|39814881|FG000|Overall Study|Withdrawal by Subject|1|||
16362336|NCT00998946|39814881|FG000|Overall Study|Death|2|||
16362337|NCT00998946|39814881|FG000|Overall Study|Reason Unspecified|3|||
16134024|NCT00585195|38977037|FG019|Overall Study|Adverse Event|3|||
16362338|NCT00998946|39814881|FG000|Overall Study|Enrolled but not Dosed|2|||
16362339|NCT01279200|39814882|FG000|Overall Study|Withdrawal by Subject|1|||
16362340|NCT01279200|39814883|FG001|Overall Study|Withdrawal by Subject|3|||
16362341|NCT01279200|39814882|FG000|Overall Study|Patient withdrawal due to high cost|0|||
16362342|NCT01279200|39814883|FG001|Overall Study|Patient withdrawal due to high cost|1|||
16362343|NCT01279200|39814882|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
16362344|NCT01279200|39814883|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
16362345|NCT01279200|39814882|FG000|Overall Study|ultrasound screening failure|0|||
16362346|NCT01279200|39814883|FG001|Overall Study|ultrasound screening failure|1|||
16362347|NCT01279200|39814882|FG000|Overall Study|Lost to Follow-up|0|||
16362348|NCT01279200|39814883|FG001|Overall Study|Lost to Follow-up|1|||
16134025|NCT00585195|38977038|FG020|Overall Study|Adverse Event|1|||
16134026|NCT00585195|38977018|FG000|Overall Study|Progressive Disease|2|||
16134027|NCT00585195|38977019|FG001|Overall Study|Progressive Disease|2|||
16134028|NCT00585195|38977020|FG002|Overall Study|Progressive Disease|5|||
16134029|NCT00585195|38977021|FG003|Overall Study|Progressive Disease|4|||
16134030|NCT00585195|38977022|FG004|Overall Study|Progressive Disease|6|||
16134031|NCT00585195|38977023|FG005|Overall Study|Progressive Disease|4|||
16134032|NCT00585195|38977024|FG006|Overall Study|Progressive Disease|6|||
16134033|NCT00585195|38977025|FG007|Overall Study|Progressive Disease|3|||
16134034|NCT00585195|38977026|FG008|Overall Study|Progressive Disease|0|||
16134035|NCT00585195|38977027|FG009|Overall Study|Progressive Disease|5|||
16134036|NCT00585195|38977028|FG010|Overall Study|Progressive Disease|2|||
16134037|NCT00585195|38977029|FG011|Overall Study|Progressive Disease|25|||
16134038|NCT00585195|38977030|FG012|Overall Study|Progressive Disease|29|||
16134039|NCT00585195|38977031|FG013|Overall Study|Progressive Disease|26|||
16134040|NCT00585195|38977032|FG014|Overall Study|Progressive Disease|21|||
16134041|NCT00585195|38977033|FG015|Overall Study|Progressive Disease|12|||
16134042|NCT00585195|38977034|FG016|Overall Study|Progressive Disease|94|||
16134043|NCT00585195|38977035|FG017|Overall Study|Progressive Disease|42|||
16134044|NCT00585195|38977036|FG018|Overall Study|Progressive Disease|4|||
16134045|NCT00585195|38977037|FG019|Overall Study|Progressive Disease|9|||
16134046|NCT00585195|38977038|FG020|Overall Study|Progressive Disease|8|||
16134047|NCT00585195|38977018|FG000|Overall Study|Withdrawal by Subject|1|||
16134048|NCT00585195|38977019|FG001|Overall Study|Withdrawal by Subject|1|||
16134049|NCT00585195|38977020|FG002|Overall Study|Withdrawal by Subject|2|||
16134050|NCT00585195|38977021|FG003|Overall Study|Withdrawal by Subject|2|||
16134051|NCT00585195|38977022|FG004|Overall Study|Withdrawal by Subject|0|||
16134052|NCT00585195|38977023|FG005|Overall Study|Withdrawal by Subject|0|||
16134053|NCT00585195|38977024|FG006|Overall Study|Withdrawal by Subject|0|||
16134054|NCT00585195|38977025|FG007|Overall Study|Withdrawal by Subject|1|||
16134055|NCT00585195|38977026|FG008|Overall Study|Withdrawal by Subject|0|||
16134056|NCT00585195|38977027|FG009|Overall Study|Withdrawal by Subject|0|||
16134057|NCT00585195|38977028|FG010|Overall Study|Withdrawal by Subject|3|||
16134058|NCT00585195|38977029|FG011|Overall Study|Withdrawal by Subject|8|||
16134059|NCT00585195|38977030|FG012|Overall Study|Withdrawal by Subject|15|||
16134060|NCT00585195|38977031|FG013|Overall Study|Withdrawal by Subject|0|||
16134061|NCT00585195|38977032|FG014|Overall Study|Withdrawal by Subject|3|||
16134062|NCT00585195|38977033|FG015|Overall Study|Withdrawal by Subject|0|||
16134063|NCT00585195|38977034|FG016|Overall Study|Withdrawal by Subject|7|||
16134064|NCT00585195|38977035|FG017|Overall Study|Withdrawal by Subject|1|||
16134065|NCT00585195|38977036|FG018|Overall Study|Withdrawal by Subject|2|||
16134066|NCT00585195|38977037|FG019|Overall Study|Withdrawal by Subject|2|||
16134067|NCT00585195|38977038|FG020|Overall Study|Withdrawal by Subject|0|||
16134068|NCT00585195|38977018|FG000|Overall Study|Other|0|||
16134069|NCT00585195|38977019|FG001|Overall Study|Other|1|||
16134070|NCT00585195|38977020|FG002|Overall Study|Other|1|||
16134071|NCT00585195|38977021|FG003|Overall Study|Other|1|||
16134072|NCT00585195|38977022|FG004|Overall Study|Other|0|||
16134073|NCT00585195|38977023|FG005|Overall Study|Other|1|||
16134074|NCT00585195|38977024|FG006|Overall Study|Other|0|||
16134075|NCT00585195|38977025|FG007|Overall Study|Other|0|||
16134076|NCT00585195|38977026|FG008|Overall Study|Other|2|||
16134077|NCT00585195|38977027|FG009|Overall Study|Other|1|||
16134078|NCT00585195|38977028|FG010|Overall Study|Other|0|||
16134079|NCT00585195|38977029|FG011|Overall Study|Other|19|||
16134080|NCT00585195|38977030|FG012|Overall Study|Other|24|||
16134081|NCT00585195|38977031|FG013|Overall Study|Other|7|||
16134082|NCT00585195|38977032|FG014|Overall Study|Other|11|||
16134083|NCT00585195|38977033|FG015|Overall Study|Other|3|||
16134084|NCT00585195|38977034|FG016|Overall Study|Other|28|||
16134085|NCT00585195|38977035|FG017|Overall Study|Other|12|||
16134086|NCT00585195|38977036|FG018|Overall Study|Other|10|||
16134087|NCT00585195|38977037|FG019|Overall Study|Other|4|||
16134088|NCT00585195|38977038|FG020|Overall Study|Other|2|||
16134089|NCT00585195|38977018|FG000|Overall Study|Randomized not treated|0|||
16134090|NCT00585195|38977019|FG001|Overall Study|Randomized not treated|0|||
16134091|NCT00585195|38977020|FG002|Overall Study|Randomized not treated|1|||
16134092|NCT00585195|38977021|FG003|Overall Study|Randomized not treated|0|||
16134093|NCT00585195|38977022|FG004|Overall Study|Randomized not treated|1|||
16134094|NCT00585195|38977023|FG005|Overall Study|Randomized not treated|0|||
16134095|NCT00585195|38977024|FG006|Overall Study|Randomized not treated|1|||
16134096|NCT00585195|38977025|FG007|Overall Study|Randomized not treated|0|||
16134097|NCT00585195|38977026|FG008|Overall Study|Randomized not treated|0|||
16134098|NCT00585195|38977027|FG009|Overall Study|Randomized not treated|0|||
16134099|NCT00585195|38977028|FG010|Overall Study|Randomized not treated|2|||
16134100|NCT00585195|38977029|FG011|Overall Study|Randomized not treated|0|||
16134101|NCT00585195|38977030|FG012|Overall Study|Randomized not treated|0|||
16134102|NCT00585195|38977031|FG013|Overall Study|Randomized not treated|0|||
16134103|NCT00585195|38977032|FG014|Overall Study|Randomized not treated|0|||
16134104|NCT00585195|38977033|FG015|Overall Study|Randomized not treated|1|||
16134105|NCT00585195|38977034|FG016|Overall Study|Randomized not treated|0|||
16134106|NCT00585195|38977035|FG017|Overall Study|Randomized not treated|1|||
16134107|NCT00585195|38977036|FG018|Overall Study|Randomized not treated|3|||
16134108|NCT00585195|38977037|FG019|Overall Study|Randomized not treated|0|||
16134109|NCT00585195|38977038|FG020|Overall Study|Randomized not treated|2|||
16134110|NCT00585195|38977018|FG000|Overall Study|Death|0|||
16134111|NCT00585195|38977019|FG001|Overall Study|Death|0|||
16134112|NCT00585195|38977020|FG002|Overall Study|Death|0|||
16134113|NCT00585195|38977021|FG003|Overall Study|Death|0|||
16134114|NCT00585195|38977022|FG004|Overall Study|Death|0|||
16134115|NCT00585195|38977023|FG005|Overall Study|Death|0|||
16134116|NCT00585195|38977024|FG006|Overall Study|Death|0|||
16134117|NCT00585195|38977025|FG007|Overall Study|Death|0|||
16134118|NCT00585195|38977026|FG008|Overall Study|Death|1|||
16134119|NCT00585195|38977027|FG009|Overall Study|Death|0|||
16134120|NCT00585195|38977028|FG010|Overall Study|Death|1|||
16134121|NCT00585195|38977029|FG011|Overall Study|Death|1|||
16134122|NCT00585195|38977030|FG012|Overall Study|Death|7|||
16134123|NCT00585195|38977031|FG013|Overall Study|Death|2|||
16134124|NCT00585195|38977032|FG014|Overall Study|Death|8|||
16134125|NCT00585195|38977033|FG015|Overall Study|Death|2|||
16134126|NCT00585195|38977034|FG016|Overall Study|Death|11|||
16134127|NCT00585195|38977035|FG017|Overall Study|Death|0|||
16134128|NCT00585195|38977036|FG018|Overall Study|Death|0|||
16134129|NCT00585195|38977037|FG019|Overall Study|Death|0|||
16134130|NCT00585195|38977038|FG020|Overall Study|Death|1|||
16134131|NCT00585195|38977018|FG000|Overall Study|Lost to Follow-up|0|||
16134132|NCT00585195|38977019|FG001|Overall Study|Lost to Follow-up|0|||
16134133|NCT00585195|38977020|FG002|Overall Study|Lost to Follow-up|0|||
16134134|NCT00585195|38977021|FG003|Overall Study|Lost to Follow-up|0|||
16134135|NCT00585195|38977022|FG004|Overall Study|Lost to Follow-up|0|||
16134136|NCT00585195|38977023|FG005|Overall Study|Lost to Follow-up|0|||
16134137|NCT00585195|38977024|FG006|Overall Study|Lost to Follow-up|0|||
16134138|NCT00585195|38977025|FG007|Overall Study|Lost to Follow-up|0|||
16134139|NCT00585195|38977026|FG008|Overall Study|Lost to Follow-up|0|||
16134140|NCT00585195|38977027|FG009|Overall Study|Lost to Follow-up|0|||
16134141|NCT00585195|38977028|FG010|Overall Study|Lost to Follow-up|0|||
16134142|NCT00585195|38977029|FG011|Overall Study|Lost to Follow-up|0|||
16134143|NCT00585195|38977030|FG012|Overall Study|Lost to Follow-up|1|||
16134144|NCT00585195|38977031|FG013|Overall Study|Lost to Follow-up|0|||
16134145|NCT00585195|38977032|FG014|Overall Study|Lost to Follow-up|0|||
16134146|NCT00585195|38977033|FG015|Overall Study|Lost to Follow-up|0|||
16134147|NCT00585195|38977034|FG016|Overall Study|Lost to Follow-up|0|||
16134148|NCT00585195|38977035|FG017|Overall Study|Lost to Follow-up|2|||
16134149|NCT00585195|38977036|FG018|Overall Study|Lost to Follow-up|0|||
16134150|NCT00585195|38977037|FG019|Overall Study|Lost to Follow-up|0|||
16134151|NCT00585195|38977038|FG020|Overall Study|Lost to Follow-up|0|||
16134152|NCT00585195|38977018|FG000|Overall Study|Site Terminated by Sponsor|0|||
16134153|NCT00585195|38977019|FG001|Overall Study|Site Terminated by Sponsor|0|||
16134154|NCT00585195|38977020|FG002|Overall Study|Site Terminated by Sponsor|0|||
16134155|NCT00585195|38977021|FG003|Overall Study|Site Terminated by Sponsor|0|||
16134156|NCT00585195|38977022|FG004|Overall Study|Site Terminated by Sponsor|0|||
16134157|NCT00585195|38977023|FG005|Overall Study|Site Terminated by Sponsor|0|||
16134158|NCT00585195|38977024|FG006|Overall Study|Site Terminated by Sponsor|0|||
16134159|NCT00585195|38977025|FG007|Overall Study|Site Terminated by Sponsor|0|||
16134160|NCT00585195|38977026|FG008|Overall Study|Site Terminated by Sponsor|0|||
16134161|NCT00585195|38977027|FG009|Overall Study|Site Terminated by Sponsor|0|||
16134162|NCT00585195|38977028|FG010|Overall Study|Site Terminated by Sponsor|0|||
16134163|NCT00585195|38977029|FG011|Overall Study|Site Terminated by Sponsor|0|||
16134164|NCT00585195|38977030|FG012|Overall Study|Site Terminated by Sponsor|1|||
16134165|NCT00585195|38977031|FG013|Overall Study|Site Terminated by Sponsor|0|||
16134166|NCT00585195|38977032|FG014|Overall Study|Site Terminated by Sponsor|0|||
16134167|NCT00585195|38977033|FG015|Overall Study|Site Terminated by Sponsor|0|||
16134168|NCT00585195|38977034|FG016|Overall Study|Site Terminated by Sponsor|0|||
16134169|NCT00585195|38977035|FG017|Overall Study|Site Terminated by Sponsor|0|||
16134170|NCT00585195|38977036|FG018|Overall Study|Site Terminated by Sponsor|0|||
16134171|NCT00585195|38977037|FG019|Overall Study|Site Terminated by Sponsor|0|||
16134172|NCT00585195|38977038|FG020|Overall Study|Site Terminated by Sponsor|0|||
16134173|NCT00585195|38977018|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
16134174|NCT00585195|38977019|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
16134175|NCT00585195|38977020|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
16134176|NCT00585195|38977021|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
16134177|NCT00585195|38977022|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
16134178|NCT00585195|38977023|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
16134179|NCT00585195|38977024|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
16134180|NCT00585195|38977025|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
16134181|NCT00585195|38977026|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
16134182|NCT00585195|38977027|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
16134183|NCT00585195|38977028|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
16134184|NCT00585195|38977029|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
16134185|NCT00585195|38977030|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
16134186|NCT00585195|38977031|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
16134187|NCT00585195|38977032|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
16134188|NCT00585195|38977033|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
16134189|NCT00585195|38977034|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
16134190|NCT00585195|38977035|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
16134191|NCT00585195|38977036|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
16134192|NCT00585195|38977037|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
16134193|NCT00585195|38977038|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
16134194|NCT01801735|38977039|FG000|Overall Study|Adverse Event|79|||
16134195|NCT01801735|38977039|FG000|Overall Study|Lack of Efficacy|28|||
16134196|NCT01801735|38977039|FG000|Overall Study|Withdrawal by Subject|27|||
16134197|NCT01801735|38977039|FG000|Overall Study|Protocol Violation|25|||
16134198|NCT01801735|38977039|FG000|Overall Study|Lost to Follow-up|15|||
16134199|NCT01801735|38977039|FG000|Overall Study|Non-compliance with Trial Drug|13|||
16134200|NCT01801735|38977039|FG000|Overall Study|Physician Decision|3|||
16134201|NCT01801735|38977039|FG000|Overall Study|Death|1|||
16134202|NCT01801735|38977039|FG000|Overall Study|Other, including site closure|19|||
16134203|NCT00346268|38977040|FG000|Overall Study|Adverse Event|1|||
16134204|NCT00346268|38977041|FG001|Overall Study|Adverse Event|0|||
16134205|NCT00346268|38977040|FG000|Overall Study|Protocol Violation|1|||
16134206|NCT00346268|38977041|FG001|Overall Study|Protocol Violation|0|||
16134207|NCT00346268|38977040|FG000|Overall Study|Participant refused|0|||
16134208|NCT00346268|38977041|FG001|Overall Study|Participant refused|3|||
16134209|NCT03658668|38977042|FG000|Overall Study|Time Commitment|1|||
16134210|NCT03658668|38977043|FG001|Overall Study|Time Commitment|1|||
16134211|NCT00701779|38977044|FG000|Overall Study|Adverse Event|6|||
16134212|NCT00701779|38977044|FG000|Overall Study|Lost to Follow-up|1|||
16134213|NCT00701779|38977044|FG000|Overall Study|Withdrawal by Subject|2|||
16134214|NCT02186223|38980276|FG000|Overall Study|Not eligible for device placement|6|||
16134215|NCT02186223|38980276|FG000|Overall Study|Unable to obtain femoral access|3|||
16134216|NCT02186223|38980276|FG000|Overall Study|Death|3|||
16134217|NCT02186223|38980276|FG000|Overall Study|Device in place less than 48 hours|9|||
16134218|NCT04754477|38980277|FG000|Overall Study|Withdrawal by Subject|1|||
16134219|NCT02520284|38980278|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
16134220|NCT02520284|38980279|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
16134221|NCT02520284|38980280|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
16134222|NCT02520284|38980278|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
16134223|NCT02520284|38980279|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
16134224|NCT02520284|38980280|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
16134225|NCT02520284|38980278|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
16134226|NCT02520284|38980279|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
16134227|NCT02520284|38980280|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
16134228|NCT02520284|38980278|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
16134229|NCT02520284|38980279|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
16134230|NCT02520284|38980280|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
16134231|NCT02520284|38980278|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
16134232|NCT02520284|38980279|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
16134233|NCT02520284|38980280|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
16134234|NCT02520284|38980278|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
16134235|NCT02520284|38980279|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
16134236|NCT02520284|38980280|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
16134237|NCT02520284|38980278|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
16134238|NCT02520284|38980279|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
16134239|NCT02520284|38980280|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
16134240|NCT02520284|38980278|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
16134241|NCT02520284|38980279|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
16134242|NCT02520284|38980280|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
16134243|NCT02520284|38980278|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
16134244|NCT02520284|38980279|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
16134245|NCT02520284|38980280|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
16134246|NCT02520284|38980278|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
16134247|NCT02520284|38980279|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
16134248|NCT02520284|38980280|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
16134249|NCT02520284|38980278|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
16134250|NCT02520284|38980279|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
16134251|NCT02520284|38980280|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
16134252|NCT01435616|38980281|FG000|Overall Study|Adverse Event|39|||
16251295|NCT02352337|39404354|FG002|Overall Study|Patients never treated|2|||
16362349|NCT01279200|39814882|FG000|Overall Study|Adverse Event|1|||
16362350|NCT01279200|39814883|FG001|Overall Study|Adverse Event|0|||
16362351|NCT00479232|39814884|FG000|Overall Study|Adverse Event|0|||
16362352|NCT00479232|39814885|FG001|Overall Study|Adverse Event|0|||
16362353|NCT00479232|39814886|FG002|Overall Study|Adverse Event|5|||
16362354|NCT00479232|39814887|FG003|Overall Study|Adverse Event|0|||
16362355|NCT00479232|39814888|FG004|Overall Study|Adverse Event|0|||
16362356|NCT00479232|39814889|FG005|Overall Study|Adverse Event|10|||
16362357|NCT00479232|39814884|FG000|Overall Study|Deviation from Protocol|0|||
16362358|NCT00479232|39814885|FG001|Overall Study|Deviation from Protocol|0|||
16362359|NCT00479232|39814886|FG002|Overall Study|Deviation from Protocol|1|||
16434660|NCT00757237|40070515|FG001|Overall Study|Other|2|||
16434661|NCT03071263|40070516|FG000|Overall Study|Adverse Event|1|||
16434662|NCT03071263|40070517|FG001|Overall Study|Adverse Event|3|||
16434663|NCT03071263|40070516|FG000|Overall Study|Withdrawal by Subject|1|||
16362360|NCT00479232|39814887|FG003|Overall Study|Deviation from Protocol|0|||
16362361|NCT00479232|39814888|FG004|Overall Study|Deviation from Protocol|0|||
16434664|NCT03071263|40070517|FG001|Overall Study|Withdrawal by Subject|3|||
16434665|NCT03071263|40070516|FG000|Overall Study|Physician Decision|1|||
16362362|NCT00479232|39814889|FG005|Overall Study|Deviation from Protocol|0|||
16362363|NCT00479232|39814884|FG000|Overall Study|Lack of Efficacy|0|||
16434666|NCT03071263|40070517|FG001|Overall Study|Physician Decision|0|||
16134253|NCT01435616|38980282|FG001|Overall Study|Adverse Event|21|||
16251296|NCT04025879|39404355|FG000|Randomization|Participant withdrew consent|0|||
16251297|NCT04025879|39404356|FG001|Randomization|Participant withdrew consent|1|||
16251298|NCT04025879|39404355|FG000|Randomization|Participant no longer met study criteria|1|||
16251299|NCT04025879|39404356|FG001|Randomization|Participant no longer met study criteria|1|||
16251300|NCT04025879|39404355|FG000|Treatment|Ongoing treatment|10|||
16251301|NCT04025879|39404356|FG001|Treatment|Ongoing treatment|8|||
16251302|NCT04025879|39404355|FG000|Treatment|Disease progression/recurrence|36|||
16251303|NCT04025879|39404356|FG001|Treatment|Disease progression/recurrence|72|||
16251304|NCT04025879|39404355|FG000|Treatment|Study drug toxicity|36|||
16251305|NCT04025879|39404356|FG001|Treatment|Study drug toxicity|13|||
16251306|NCT04025879|39404355|FG000|Treatment|Death|2|||
16251307|NCT04025879|39404356|FG001|Treatment|Death|0|||
16251308|NCT04025879|39404355|FG000|Treatment|Adverse event unrelated to study drug|21|||
16251309|NCT04025879|39404356|FG001|Treatment|Adverse event unrelated to study drug|14|||
16251310|NCT04025879|39404355|FG000|Treatment|Participant request to discontinue study treatment|16|||
16134254|NCT01435616|38980281|FG000|Overall Study|Death|7|||
16134255|NCT01435616|38980282|FG001|Overall Study|Death|2|||
16251311|NCT04025879|39404356|FG001|Treatment|Participant request to discontinue study treatment|8|||
16251312|NCT04025879|39404355|FG000|Treatment|Participant withdrew consent|1|||
16251313|NCT04025879|39404356|FG001|Treatment|Participant withdrew consent|3|||
16251314|NCT04025879|39404355|FG000|Treatment|Participant no longer meets study criteria|3|||
16251315|NCT04025879|39404356|FG001|Treatment|Participant no longer meets study criteria|2|||
16251316|NCT04025879|39404355|FG000|Treatment|Lost to Follow-up|1|||
16251317|NCT04025879|39404356|FG001|Treatment|Lost to Follow-up|0|||
16362364|NCT00479232|39814885|FG001|Overall Study|Lack of Efficacy|0|||
16134256|NCT01435616|38980281|FG000|Overall Study|Lost to Follow-up|22|||
16134257|NCT01435616|38980282|FG001|Overall Study|Lost to Follow-up|13|||
16134258|NCT01435616|38980281|FG000|Overall Study|Protocol Violation|16|||
16134259|NCT01435616|38980282|FG001|Overall Study|Protocol Violation|13|||
16134260|NCT01435616|38980281|FG000|Overall Study|Withdrawal by Subject|66|||
16134261|NCT01435616|38980282|FG001|Overall Study|Withdrawal by Subject|24|||
16134262|NCT01435616|38980281|FG000|Overall Study|Physician Decision|20|||
16134263|NCT01435616|38980282|FG001|Overall Study|Physician Decision|7|||
16134264|NCT01435616|38980281|FG000|Overall Study|Sponsor Decision|1|||
16134265|NCT01435616|38980282|FG001|Overall Study|Sponsor Decision|0|||
16134266|NCT00985946|38980283|FG000|Overall Study|Lost to Follow-up|6|||
16134267|NCT00985946|38980283|FG000|Overall Study|Withdrawal by Subject|1|||
16134268|NCT02709096|38980290|FG000|Overall Study|non-compliance|1|||
16134269|NCT02709096|38980291|FG001|Overall Study|non-compliance|1|||
16134270|NCT00547365|38980292|FG000|Overall Study|Physician Decision|1|||
16134271|NCT00547365|38980292|FG000|Overall Study|Lost to Follow-up|1|||
16134272|NCT00547365|38980292|FG000|Overall Study|Protocol Violation|2|||
16134273|NCT00547365|38980292|FG000|Overall Study|death (not related to study)|4|||
16251318|NCT04025879|39404355|FG000|Treatment|Other reasons|15|||
16251319|NCT04025879|39404356|FG001|Treatment|Other reasons|17|||
16251320|NCT04025879|39404355|FG000|Treatment|Administrative reason by sponsor|0|||
16251321|NCT04025879|39404356|FG001|Treatment|Administrative reason by sponsor|1|||
16251322|NCT04025879|39404355|FG000|Treatment|Not reported|2|||
16251323|NCT04025879|39404356|FG001|Treatment|Not reported|0|||
16251324|NCT03519256|39404367|FG000|Overall Study|Disease recurrence|4|||
16251325|NCT03519256|39404368|FG001|Overall Study|Disease recurrence|4|||
16362365|NCT00479232|39814886|FG002|Overall Study|Lack of Efficacy|2|||
16434667|NCT03071263|40070516|FG000|Overall Study|Participant moved to another city|0|||
16434668|NCT03071263|40070517|FG001|Overall Study|Participant moved to another city|1|||
16434669|NCT00399516|40070518|FG000|Overall Study|Lost to Follow-up|2|||
16134274|NCT01259284|38980293|FG000|Overall Study|Study Termination|2|||
16134275|NCT01259284|38980294|FG001|Overall Study|Study Termination|0|||
16134276|NCT01259284|38980295|FG002|Overall Study|Study Termination|0|||
16134277|NCT00370331|38980296|FG000|Overall Study|Adverse Event|4|||
16134278|NCT00370331|38980297|FG001|Overall Study|Adverse Event|13|||
16134279|NCT00370331|38980296|FG000|Overall Study|Withdrawal by Subject|2|||
16134280|NCT00370331|38980297|FG001|Overall Study|Withdrawal by Subject|4|||
16134281|NCT00370331|38980296|FG000|Overall Study|Lost to Follow-up|0|||
16134282|NCT00370331|38980297|FG001|Overall Study|Lost to Follow-up|3|||
16134283|NCT00370331|38980296|FG000|Overall Study|Lack of Efficacy|0|||
16134284|NCT00370331|38980297|FG001|Overall Study|Lack of Efficacy|1|||
16134285|NCT00370331|38980296|FG000|Overall Study|Non-compliance|0|||
16134286|NCT00370331|38980297|FG001|Overall Study|Non-compliance|1|||
16134287|NCT00370331|38980296|FG000|Overall Study|Protocol Violation|1|||
16134288|NCT00370331|38980297|FG001|Overall Study|Protocol Violation|1|||
16134289|NCT00561951|38980298|FG000|Overall Study|Adverse Event|11|||
16134290|NCT00561951|38980299|FG001|Overall Study|Adverse Event|14|||
16134291|NCT00561951|38980300|FG002|Overall Study|Adverse Event|14|||
16134292|NCT00561951|38980298|FG000|Overall Study|Lack of Efficacy|5|||
16134293|NCT00561951|38980299|FG001|Overall Study|Lack of Efficacy|3|||
16134294|NCT00561951|38980300|FG002|Overall Study|Lack of Efficacy|2|||
16134295|NCT00561951|38980298|FG000|Overall Study|Lost to Follow-up|1|||
16134296|NCT00561951|38980299|FG001|Overall Study|Lost to Follow-up|1|||
16134297|NCT00561951|38980300|FG002|Overall Study|Lost to Follow-up|0|||
16134298|NCT00561951|38980298|FG000|Overall Study|Withdrawal by Subject|10|||
16134299|NCT00561951|38980299|FG001|Overall Study|Withdrawal by Subject|9|||
16134300|NCT00561951|38980300|FG002|Overall Study|Withdrawal by Subject|10|||
16134301|NCT00561951|38980298|FG000|Overall Study|Protocol Violation|4|||
16134302|NCT00561951|38980299|FG001|Overall Study|Protocol Violation|3|||
16134303|NCT00561951|38980300|FG002|Overall Study|Protocol Violation|4|||
16134304|NCT00561951|38980298|FG000|Overall Study|Physician Decision|1|||
16134305|NCT00561951|38980299|FG001|Overall Study|Physician Decision|0|||
16134306|NCT00561951|38980300|FG002|Overall Study|Physician Decision|0|||
16134307|NCT00561951|38980298|FG000|Overall Study|Pregnancy|0|||
16134308|NCT00561951|38980299|FG001|Overall Study|Pregnancy|1|||
16134309|NCT00561951|38980300|FG002|Overall Study|Pregnancy|0|||
16134310|NCT00561951|38980298|FG000|Overall Study|Meet Withdrawal Criterion|0|||
16134311|NCT00561951|38980299|FG001|Overall Study|Meet Withdrawal Criterion|1|||
16134312|NCT00561951|38980300|FG002|Overall Study|Meet Withdrawal Criterion|1|||
16134313|NCT00561951|38980298|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
16134314|NCT00561951|38980299|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
16134315|NCT00561951|38980300|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
16134316|NCT00679627|38980301|FG000|Overall Study|Death|41|||
16134317|NCT00679627|38980302|FG001|Overall Study|Death|29|||
16134318|NCT00679627|38980301|FG000|Overall Study|Adverse Event|43|||
16134319|NCT00679627|38980302|FG001|Overall Study|Adverse Event|53|||
16134320|NCT00679627|38980301|FG000|Overall Study|Withdrawal by Subject|168|||
16134321|NCT00679627|38980302|FG001|Overall Study|Withdrawal by Subject|172|||
16134322|NCT00679627|38980301|FG000|Overall Study|Lost to Follow-up|22|||
16134323|NCT00679627|38980302|FG001|Overall Study|Lost to Follow-up|26|||
16134324|NCT00679627|38980301|FG000|Overall Study|Early Study Closure|425|||
16134325|NCT00679627|38980302|FG001|Overall Study|Early Study Closure|405|||
16134326|NCT04526197|38980303|FG000|Period 1|Adverse Event|0|||
16134327|NCT04526197|38980304|FG001|Period 1|Adverse Event|1|||
16134328|NCT04526197|38980303|FG000|Period 1|Withdrawal by Subject|1|||
16134329|NCT04526197|38980304|FG001|Period 1|Withdrawal by Subject|0|||
16134330|NCT04526197|38980303|FG000|Period 2|Adverse Event|0|||
16134331|NCT04526197|38980304|FG001|Period 2|Adverse Event|1|||
16134332|NCT04526197|38980303|FG000|Period 2|Withdrawal by Subject|0|||
16134333|NCT04526197|38980304|FG001|Period 2|Withdrawal by Subject|1|||
16134334|NCT00953407|38980305|FG000|Overall Study|Failed inclusion criteria|1|||
16134335|NCT00953407|38980306|FG001|Overall Study|Failed inclusion criteria|1|||
16251326|NCT03519256|39404369|FG002|Overall Study|Disease recurrence|5|||
16251327|NCT03519256|39404370|FG003|Overall Study|Disease recurrence|2|||
16251328|NCT03519256|39404367|FG000|Overall Study|Study drug toxicity|0|||
16251329|NCT03519256|39404368|FG001|Overall Study|Study drug toxicity|2|||
16251330|NCT03519256|39404369|FG002|Overall Study|Study drug toxicity|5|||
16251331|NCT03519256|39404370|FG003|Overall Study|Study drug toxicity|2|||
16251332|NCT03519256|39404367|FG000|Overall Study|Adverse event unrelated to study drug|0|||
16362366|NCT00479232|39814887|FG003|Overall Study|Lack of Efficacy|0|||
16134336|NCT00953407|38980307|FG002|Overall Study|Failed inclusion criteria|1|||
16134337|NCT00953407|38980308|FG003|Overall Study|Failed inclusion criteria|1|||
16134338|NCT00953407|38980309|FG004|Overall Study|Failed inclusion criteria|1|||
16134339|NCT00953407|38980305|FG000|Overall Study|Lost to Follow-up|0|||
16134340|NCT00953407|38980306|FG001|Overall Study|Lost to Follow-up|0|||
16134341|NCT00953407|38980307|FG002|Overall Study|Lost to Follow-up|0|||
16134342|NCT00953407|38980308|FG003|Overall Study|Lost to Follow-up|1|||
16134343|NCT00953407|38980309|FG004|Overall Study|Lost to Follow-up|0|||
16134344|NCT01217957|38980310|FG000|Phase 1|Withdrawal by Patient|1|||
16134345|NCT01217957|38980311|FG001|Phase 1|Withdrawal by Patient|0|||
16134346|NCT01217957|38980312|FG002|Phase 1|Withdrawal by Patient|1|||
16134347|NCT01217957|38980313|FG003|Phase 1|Withdrawal by Patient|1|||
16134348|NCT01217957|38980314|FG004|Phase 1|Withdrawal by Patient|0|||
16134349|NCT01217957|38980310|FG000|Phase 2|Withdrawal by Patient|0|||
16134350|NCT01217957|38980311|FG001|Phase 2|Withdrawal by Patient|0|||
16134351|NCT01217957|38980312|FG002|Phase 2|Withdrawal by Patient|0|||
16134352|NCT01217957|38980313|FG003|Phase 2|Withdrawal by Patient|0|||
16134353|NCT01217957|38980314|FG004|Phase 2|Withdrawal by Patient|1|||
16134354|NCT00601419|38980315|FG000|Overall Study|Lost to Follow-up|3|||
16134355|NCT00601419|38980315|FG000|Overall Study|Missed Visits|1|||
16134356|NCT01190514|38980316|FG000|First Intervention (Period 1)|Adverse Event|1|||
16134357|NCT01190514|38980317|FG001|First Intervention (Period 1)|Adverse Event|0|||
16134358|NCT01190514|38980318|FG002|First Intervention (Period 1)|Adverse Event|0|||
16134359|NCT01190514|38980319|FG003|First Intervention (Period 1)|Adverse Event|0|||
16134360|NCT01190514|38980316|FG000|Third Intervention (Period 3)|Adverse Event|1|||
16134361|NCT01190514|38980317|FG001|Third Intervention (Period 3)|Adverse Event|0|||
16134362|NCT01190514|38980318|FG002|Third Intervention (Period 3)|Adverse Event|0|||
16134363|NCT01190514|38980319|FG003|Third Intervention (Period 3)|Adverse Event|0|||
16134364|NCT02217332|38980323|FG000|Overall Study|Adverse Event|3|||
16134365|NCT02217332|38980323|FG000|Overall Study|Dose interruption >1 month|1|||
16134366|NCT02217332|38980323|FG000|Overall Study|Protocol Violation (eligibility)|1|||
16134367|NCT02217332|38980323|FG000|Overall Study|Withdrawal by Subject|1|||
16134368|NCT02217332|38980323|FG000|Overall Study|Lost to Follow-up|1|||
16134369|NCT02325557|38980328|FG000|Overall Study|Progressive disease|1|||
16134370|NCT02325557|38980329|FG001|Overall Study|Progressive disease|0|||
16134371|NCT02325557|38980330|FG002|Overall Study|Progressive disease|0|||
16134372|NCT02325557|38980331|FG003|Overall Study|Progressive disease|0|||
16134373|NCT02325557|38980328|FG000|Overall Study|Withdrawal by Subject|4|||
16251333|NCT03519256|39404368|FG001|Overall Study|Adverse event unrelated to study drug|1|||
16251334|NCT03519256|39404369|FG002|Overall Study|Adverse event unrelated to study drug|1|||
16134374|NCT02325557|38980329|FG001|Overall Study|Withdrawal by Subject|0|||
16134375|NCT02325557|38980330|FG002|Overall Study|Withdrawal by Subject|0|||
16134376|NCT02325557|38980331|FG003|Overall Study|Withdrawal by Subject|15|||
16134377|NCT02325557|38980328|FG000|Overall Study|Death|5|||
16134378|NCT02325557|38980329|FG001|Overall Study|Death|1|||
16134379|NCT02325557|38980330|FG002|Overall Study|Death|1|||
16134380|NCT02325557|38980331|FG003|Overall Study|Death|16|||
16134381|NCT02325557|38980328|FG000|Overall Study|Lost to Follow-up|0|||
16134382|NCT02325557|38980329|FG001|Overall Study|Lost to Follow-up|0|||
16134383|NCT02325557|38980330|FG002|Overall Study|Lost to Follow-up|1|||
16134384|NCT02325557|38980331|FG003|Overall Study|Lost to Follow-up|1|||
16251335|NCT03519256|39404370|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16251336|NCT03519256|39404367|FG000|Overall Study|Participant request to discontinue study treatment|0|||
16251337|NCT03519256|39404368|FG001|Overall Study|Participant request to discontinue study treatment|0|||
16251338|NCT03519256|39404369|FG002|Overall Study|Participant request to discontinue study treatment|0|||
16251339|NCT03519256|39404370|FG003|Overall Study|Participant request to discontinue study treatment|2|||
16251340|NCT03519256|39404367|FG000|Overall Study|Other reasons|0|||
16251341|NCT03519256|39404368|FG001|Overall Study|Other reasons|0|||
16251342|NCT03519256|39404369|FG002|Overall Study|Other reasons|2|||
16251343|NCT03519256|39404370|FG003|Overall Study|Other reasons|0|||
16251344|NCT03519256|39404367|FG000|Overall Study|Disease progression|6|||
16251345|NCT03519256|39404368|FG001|Overall Study|Disease progression|3|||
16251346|NCT03519256|39404369|FG002|Overall Study|Disease progression|2|||
16251347|NCT03519256|39404370|FG003|Overall Study|Disease progression|1|||
16251348|NCT03519256|39404367|FG000|Overall Study|Lost to Follow-up|0|||
16251349|NCT03519256|39404368|FG001|Overall Study|Lost to Follow-up|1|||
16251350|NCT03519256|39404369|FG002|Overall Study|Lost to Follow-up|0|||
16251351|NCT03519256|39404370|FG003|Overall Study|Lost to Follow-up|0|||
16251352|NCT02419313|39404371|FG000|First Intervention|Lost to Follow-up|2|||
16251353|NCT02419313|39404372|FG001|First Intervention|Lost to Follow-up|0|||
16251354|NCT02419313|39404371|FG000|Second Intervention|Lost to Follow-up|1|||
16251355|NCT02419313|39404372|FG001|Second Intervention|Lost to Follow-up|0|||
16251356|NCT04323436|39404375|FG000|Overall Study|Adverse Event|7|||
16251357|NCT04323436|39404376|FG001|Overall Study|Adverse Event|0|||
16251358|NCT04323436|39404377|FG002|Overall Study|Adverse Event|0|||
16251359|NCT04323436|39404375|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
16251360|NCT04323436|39404376|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
16434670|NCT00687401|40070519|FG000|Overall Study|Protocol Violation|7|||
16251361|NCT04323436|39404377|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
16251362|NCT04323436|39404375|FG000|Overall Study|Death|1|||
16251363|NCT04323436|39404376|FG001|Overall Study|Death|0|||
16251364|NCT04323436|39404377|FG002|Overall Study|Death|0|||
16251365|NCT04323436|39404375|FG000|Overall Study|Physician Decision|2|||
16251366|NCT04323436|39404376|FG001|Overall Study|Physician Decision|0|||
16251367|NCT04323436|39404377|FG002|Overall Study|Physician Decision|0|||
16251368|NCT04323436|39404375|FG000|Overall Study|Progressive disease|10|||
16251369|NCT04323436|39404376|FG001|Overall Study|Progressive disease|0|||
16251370|NCT04323436|39404377|FG002|Overall Study|Progressive disease|0|||
16251371|NCT04323436|39404375|FG000|Overall Study|Subject decision|3|||
16251372|NCT04323436|39404376|FG001|Overall Study|Subject decision|0|||
16251373|NCT04323436|39404377|FG002|Overall Study|Subject decision|0|||
16251374|NCT01606306|39404379|FG000|Overall Study|Lack of Efficacy|2|||
16251375|NCT01606306|39404380|FG001|Overall Study|Lack of Efficacy|1|||
16251376|NCT01606306|39404381|FG002|Overall Study|Lack of Efficacy|4|||
16251377|NCT01606306|39404382|FG003|Overall Study|Lack of Efficacy|4|||
16251378|NCT01606306|39404383|FG004|Overall Study|Lack of Efficacy|1|||
16251379|NCT01606306|39404384|FG005|Overall Study|Lack of Efficacy|2|||
16434671|NCT00687401|40070519|FG000|Overall Study|Adverse Event|6|||
16434672|NCT00687401|40070519|FG000|Overall Study|Lack of Efficacy|6|||
16434673|NCT00687401|40070519|FG000|Overall Study|Withdrawal by Subject|4|||
16434674|NCT00687401|40070519|FG000|Overall Study|Did not return for visit|3|||
16434675|NCT00687401|40070519|FG000|Overall Study|For reasons different from those above|4|||
16434676|NCT00859547|40070520|FG000|Overall Study|Lost to Follow-up|1|||
16434677|NCT00859547|40070520|FG000|Overall Study|Parent withdrew consent|1|||
16434678|NCT02552966|40070521|FG000|Overall Study|Lost to Follow-up|2|||
16434679|NCT02552966|40070521|FG000|Overall Study|Withdrawal by Subject|3|||
16434680|NCT02763644|40070528|FG000|Overall Study|Patient/guardian decision|1|||
16434681|NCT02763644|40070529|FG001|Overall Study|Patient/guardian decision|0|||
16434682|NCT02763644|40070528|FG000|Overall Study|Death|1|||
16434683|NCT02763644|40070529|FG001|Overall Study|Death|1|||
16434684|NCT02763644|40070528|FG000|Overall Study|Adverse Event|1|||
16434685|NCT02763644|40070529|FG001|Overall Study|Adverse Event|1|||
16434686|NCT01100320|40070530|FG000|Period 1|Withdrawal by Subject|2|||
16434687|NCT01100320|40070531|FG001|Period 1|Withdrawal by Subject|4|||
16434688|NCT01100320|40070530|FG000|Period 1|Positive Drug Screen|1|||
16434689|NCT01100320|40070531|FG001|Period 1|Positive Drug Screen|1|||
16434690|NCT01100320|40070530|FG000|Period 1|Adverse Event|2|||
16434691|NCT01100320|40070531|FG001|Period 1|Adverse Event|2|||
16434692|NCT01100320|40070530|FG000|Period 2|Withdrawal by Subject|1|||
16434693|NCT01100320|40070531|FG001|Period 2|Withdrawal by Subject|1|||
16434694|NCT02888106|40070534|FG000|Overall Study|Withdrawal by Subject|1|||
16434695|NCT02888106|40070535|FG001|Overall Study|Withdrawal by Subject|2|||
16434696|NCT02888106|40070536|FG002|Overall Study|Withdrawal by Subject|0|||
16251380|NCT01606306|39404379|FG000|Overall Study|Adverse Event|1|||
16251381|NCT01606306|39404380|FG001|Overall Study|Adverse Event|0|||
16251382|NCT01606306|39404381|FG002|Overall Study|Adverse Event|1|||
16251383|NCT01606306|39404382|FG003|Overall Study|Adverse Event|1|||
16434697|NCT02888106|40070537|FG003|Overall Study|Withdrawal by Subject|1|||
16434698|NCT02888106|40070538|FG004|Overall Study|Withdrawal by Subject|0|||
16434699|NCT02888106|40070539|FG005|Overall Study|Withdrawal by Subject|0|||
16434700|NCT02888106|40070534|FG000|Overall Study|Lost to Follow-up|1|||
16434701|NCT02888106|40070535|FG001|Overall Study|Lost to Follow-up|0|||
16434702|NCT02888106|40070536|FG002|Overall Study|Lost to Follow-up|0|||
16434703|NCT02888106|40070537|FG003|Overall Study|Lost to Follow-up|1|||
16434704|NCT02888106|40070538|FG004|Overall Study|Lost to Follow-up|0|||
16434705|NCT02888106|40070539|FG005|Overall Study|Lost to Follow-up|1|||
16434706|NCT02888106|40070534|FG000|Overall Study|Adverse Event|2|||
16434707|NCT02888106|40070535|FG001|Overall Study|Adverse Event|0|||
16434708|NCT02888106|40070536|FG002|Overall Study|Adverse Event|0|||
16434709|NCT02888106|40070537|FG003|Overall Study|Adverse Event|0|||
16434710|NCT02888106|40070538|FG004|Overall Study|Adverse Event|0|||
16434711|NCT02888106|40070539|FG005|Overall Study|Adverse Event|0|||
16434712|NCT02888106|40070534|FG000|Overall Study|Withdrawal of consent|0|||
16434713|NCT02888106|40070535|FG001|Overall Study|Withdrawal of consent|0|||
16434714|NCT02888106|40070536|FG002|Overall Study|Withdrawal of consent|0|||
16434715|NCT02888106|40070537|FG003|Overall Study|Withdrawal of consent|0|||
16434716|NCT02888106|40070538|FG004|Overall Study|Withdrawal of consent|1|||
16434717|NCT02888106|40070539|FG005|Overall Study|Withdrawal of consent|0|||
16434718|NCT02888106|40070534|FG000|Overall Study|Pregnancy|1|||
16434719|NCT02888106|40070535|FG001|Overall Study|Pregnancy|0|||
16434720|NCT02888106|40070536|FG002|Overall Study|Pregnancy|0|||
16434721|NCT02888106|40070537|FG003|Overall Study|Pregnancy|0|||
16434722|NCT02888106|40070538|FG004|Overall Study|Pregnancy|0|||
16434723|NCT02888106|40070539|FG005|Overall Study|Pregnancy|0|||
16434724|NCT00255190|40070548|FG000|Overall Study|Adverse Event|17|||
16434725|NCT00255190|40070549|FG001|Overall Study|Adverse Event|36|||
16434726|NCT00255190|40070548|FG000|Overall Study|Protocol Violation|2|||
16434727|NCT00255190|40070549|FG001|Overall Study|Protocol Violation|2|||
16362367|NCT00479232|39814888|FG004|Overall Study|Lack of Efficacy|0|||
16362368|NCT00479232|39814889|FG005|Overall Study|Lack of Efficacy|4|||
16362369|NCT00479232|39814884|FG000|Overall Study|Physician Decision|0|||
16362370|NCT00479232|39814885|FG001|Overall Study|Physician Decision|0|||
16362371|NCT00479232|39814886|FG002|Overall Study|Physician Decision|2|||
16362372|NCT00479232|39814887|FG003|Overall Study|Physician Decision|0|||
16362373|NCT00479232|39814888|FG004|Overall Study|Physician Decision|0|||
16362374|NCT00479232|39814889|FG005|Overall Study|Physician Decision|1|||
16362375|NCT00479232|39814884|FG000|Overall Study|Progressive Disease|3|||
16362376|NCT00479232|39814885|FG001|Overall Study|Progressive Disease|1|||
16362377|NCT00479232|39814886|FG002|Overall Study|Progressive Disease|12|||
16362378|NCT00479232|39814887|FG003|Overall Study|Progressive Disease|3|||
16362379|NCT00479232|39814888|FG004|Overall Study|Progressive Disease|3|||
16362380|NCT00479232|39814889|FG005|Overall Study|Progressive Disease|12|||
16362381|NCT00479232|39814884|FG000|Overall Study|Withdrew Consent|0|||
16362382|NCT00479232|39814885|FG001|Overall Study|Withdrew Consent|2|||
16362383|NCT00479232|39814886|FG002|Overall Study|Withdrew Consent|6|||
16434728|NCT00255190|40070548|FG000|Overall Study|Lost to Follow-up|10|||
16434729|NCT00255190|40070549|FG001|Overall Study|Lost to Follow-up|27|||
16434730|NCT00255190|40070548|FG000|Overall Study|Withdrew Consent|17|||
16434731|NCT00255190|40070549|FG001|Overall Study|Withdrew Consent|48|||
16434732|NCT00255190|40070548|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
16434733|NCT00255190|40070549|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
16434734|NCT00255190|40070548|FG000|Overall Study|Erosive esophagitis not healed|0|||
16434735|NCT00255190|40070549|FG001|Overall Study|Erosive esophagitis not healed|20|||
16434736|NCT00255190|40070548|FG000|Overall Study|Various|4|||
16434737|NCT00255190|40070549|FG001|Overall Study|Various|23|||
16434738|NCT04664153|40070551|FG000|Overall Study|Lack of Efficacy|0|||
16434739|NCT04664153|40070552|FG001|Overall Study|Lack of Efficacy|0|||
16434740|NCT04664153|40070553|FG002|Overall Study|Lack of Efficacy|1|||
16434741|NCT04664153|40070554|FG003|Overall Study|Lack of Efficacy|0|||
16434742|NCT04664153|40070551|FG000|Overall Study|Physician Decision|0|||
16434743|NCT04664153|40070552|FG001|Overall Study|Physician Decision|0|||
16434744|NCT04664153|40070553|FG002|Overall Study|Physician Decision|1|||
16434745|NCT04664153|40070554|FG003|Overall Study|Physician Decision|0|||
16434746|NCT04664153|40070551|FG000|Overall Study|Withdrawal by Subject|3|||
16434747|NCT04664153|40070552|FG001|Overall Study|Withdrawal by Subject|2|||
16434748|NCT04664153|40070553|FG002|Overall Study|Withdrawal by Subject|1|||
16434749|NCT04664153|40070554|FG003|Overall Study|Withdrawal by Subject|2|||
16434750|NCT04664153|40070551|FG000|Overall Study|Other|0|||
16434751|NCT04664153|40070552|FG001|Overall Study|Other|1|||
16434752|NCT04664153|40070553|FG002|Overall Study|Other|0|||
16134385|NCT02325557|38980328|FG000|Overall Study|Other|0|||
16434753|NCT04664153|40070554|FG003|Overall Study|Other|0|||
16434754|NCT04664153|40070551|FG000|Overall Study|Adverse Event|4|||
16434755|NCT04664153|40070552|FG001|Overall Study|Adverse Event|0|||
16434756|NCT04664153|40070553|FG002|Overall Study|Adverse Event|1|||
16362384|NCT00479232|39814887|FG003|Overall Study|Withdrew Consent|0|||
16362385|NCT00479232|39814888|FG004|Overall Study|Withdrew Consent|1|||
16434757|NCT04664153|40070554|FG003|Overall Study|Adverse Event|0|||
16434758|NCT04842747|40070555|FG000|Overall Study|Withdrawal by Subject|6|||
16251384|NCT01606306|39404383|FG004|Overall Study|Adverse Event|2|||
16251385|NCT01606306|39404384|FG005|Overall Study|Adverse Event|0|||
16251386|NCT01606306|39404379|FG000|Overall Study|Lost to Follow-up|7|||
16251387|NCT01606306|39404380|FG001|Overall Study|Lost to Follow-up|4|||
16251388|NCT01606306|39404381|FG002|Overall Study|Lost to Follow-up|5|||
16251389|NCT01606306|39404382|FG003|Overall Study|Lost to Follow-up|4|||
16251390|NCT01606306|39404383|FG004|Overall Study|Lost to Follow-up|3|||
16251391|NCT01606306|39404384|FG005|Overall Study|Lost to Follow-up|5|||
16251392|NCT01606306|39404379|FG000|Overall Study|Withdrawal by Subject|4|||
16251393|NCT01606306|39404380|FG001|Overall Study|Withdrawal by Subject|3|||
16251394|NCT01606306|39404381|FG002|Overall Study|Withdrawal by Subject|4|||
16251395|NCT01606306|39404382|FG003|Overall Study|Withdrawal by Subject|4|||
16251396|NCT01606306|39404383|FG004|Overall Study|Withdrawal by Subject|5|||
16251397|NCT01606306|39404384|FG005|Overall Study|Withdrawal by Subject|4|||
16251398|NCT01606306|39404379|FG000|Overall Study|Physician Decision|1|||
16251399|NCT01606306|39404380|FG001|Overall Study|Physician Decision|2|||
16251400|NCT01606306|39404381|FG002|Overall Study|Physician Decision|0|||
16251401|NCT01606306|39404382|FG003|Overall Study|Physician Decision|0|||
16251402|NCT01606306|39404383|FG004|Overall Study|Physician Decision|0|||
16251403|NCT01606306|39404384|FG005|Overall Study|Physician Decision|0|||
16251404|NCT03335371|39404387|FG000|Overall Study|Lost to Follow-up|0|||
16251405|NCT03335371|39404388|FG001|Overall Study|Lost to Follow-up|0|||
16251406|NCT03335371|39404389|FG002|Overall Study|Lost to Follow-up|0|||
16251407|NCT03335371|39404390|FG003|Overall Study|Lost to Follow-up|0|||
16251408|NCT03335371|39404391|FG004|Overall Study|Lost to Follow-up|1|||
16251409|NCT03335371|39404387|FG000|Overall Study|Withdrawal by Subject|0|||
16251410|NCT03335371|39404388|FG001|Overall Study|Withdrawal by Subject|0|||
16251411|NCT03335371|39404389|FG002|Overall Study|Withdrawal by Subject|0|||
16251412|NCT03335371|39404390|FG003|Overall Study|Withdrawal by Subject|0|||
16251413|NCT03335371|39404391|FG004|Overall Study|Withdrawal by Subject|1|||
16251414|NCT03335371|39404387|FG000|Overall Study|Randomization Error|0|||
16251415|NCT03335371|39404388|FG001|Overall Study|Randomization Error|0|||
16251416|NCT03335371|39404389|FG002|Overall Study|Randomization Error|1|||
16251417|NCT03335371|39404390|FG003|Overall Study|Randomization Error|0|||
16251418|NCT03335371|39404391|FG004|Overall Study|Randomization Error|0|||
16251419|NCT00970281|39404392|FG000|Overall Study|Lack of Efficacy|1|||
16251420|NCT00970281|39404393|FG001|Overall Study|Lack of Efficacy|14|||
16251421|NCT00970281|39404392|FG000|Overall Study|Withdrawal by Subject|0|||
16251422|NCT00970281|39404393|FG001|Overall Study|Withdrawal by Subject|1|||
16251423|NCT00970281|39404392|FG000|Overall Study|Physician Decision|1|||
16251424|NCT00970281|39404393|FG001|Overall Study|Physician Decision|1|||
16251425|NCT00993616|39404398|FG000|Overall Study|No tumor at entry|1|||
16251426|NCT00993616|39404398|FG000|Overall Study|Never treated|1|||
16251427|NCT00982410|39404399|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
16251428|NCT00982410|39404400|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
16251429|NCT00982410|39404399|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
16251430|NCT00982410|39404400|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
16251431|NCT00982410|39404399|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
16251432|NCT00982410|39404400|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
16251433|NCT00982410|39404399|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
16251434|NCT00982410|39404400|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
16251435|NCT00982410|39404399|FG000|6-month Follow-up Assessment|participant no transportation|1|||
16251436|NCT00982410|39404400|FG001|6-month Follow-up Assessment|participant no transportation|0|||
16251437|NCT00982410|39404399|FG000|6-month Follow-up Assessment|incarceration|0|||
16251438|NCT00982410|39404400|FG001|6-month Follow-up Assessment|incarceration|2|||
16251439|NCT00982410|39404399|FG000|6-month Follow-up Assessment|patent surgery|0|||
16251440|NCT00982410|39404400|FG001|6-month Follow-up Assessment|patent surgery|1|||
16251441|NCT00982410|39404399|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
16251442|NCT00982410|39404400|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
16251443|NCT00982410|39404399|FG000|12-month Follow-up Assessment|Death|0|||
16251444|NCT00982410|39404400|FG001|12-month Follow-up Assessment|Death|2|||
16251445|NCT00982410|39404399|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
16251446|NCT00982410|39404400|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
16251447|NCT00982410|39404399|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
16251448|NCT00982410|39404400|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
16251449|NCT00982410|39404399|FG000|12-month Follow-up Assessment|incarceration|2|||
16251450|NCT00982410|39404400|FG001|12-month Follow-up Assessment|incarceration|1|||
16134386|NCT02325557|38980329|FG001|Overall Study|Other|0|||
16251451|NCT00982410|39404399|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
16251452|NCT00982410|39404400|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
16251453|NCT02570165|39404401|FG000|Overall Study|Adverse Event|1|||
16251454|NCT02570165|39404402|FG001|Overall Study|Adverse Event|0|||
16362386|NCT00479232|39814889|FG005|Overall Study|Withdrew Consent|3|||
16251455|NCT02570165|39404403|FG002|Overall Study|Adverse Event|2|||
16251456|NCT02570165|39404404|FG003|Overall Study|Adverse Event|0|||
16434759|NCT04842747|40070556|FG001|Overall Study|Withdrawal by Subject|2|||
16434760|NCT04842747|40070555|FG000|Overall Study|Lost to Follow-up|1|||
16434761|NCT04842747|40070556|FG001|Overall Study|Lost to Follow-up|2|||
16434762|NCT04842747|40070555|FG000|Overall Study|Physician Decision|1|||
16434763|NCT04842747|40070556|FG001|Overall Study|Physician Decision|0|||
16434764|NCT04842747|40070555|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
16434765|NCT04842747|40070556|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
16434766|NCT01620086|40070557|FG000|Overall Study|Withdrawal by Subject|3|||
16434767|NCT01620086|40070558|FG001|Overall Study|Withdrawal by Subject|3|||
16434768|NCT01620086|40070559|FG002|Overall Study|Withdrawal by Subject|0|||
16434769|NCT01620086|40070557|FG000|Overall Study|failed study criteria|1|||
16434770|NCT01620086|40070558|FG001|Overall Study|failed study criteria|4|||
16434771|NCT01620086|40070559|FG002|Overall Study|failed study criteria|0|||
16434772|NCT01620086|40070557|FG000|Overall Study|Physician Decision|1|||
16251457|NCT02570165|39404405|FG004|Overall Study|Adverse Event|0|||
16251458|NCT02570165|39404406|FG005|Overall Study|Adverse Event|0|||
16251459|NCT02570165|39404407|FG006|Overall Study|Adverse Event|0|||
16251460|NCT02570165|39404401|FG000|Overall Study|Lack of Efficacy|0|||
16251461|NCT02570165|39404402|FG001|Overall Study|Lack of Efficacy|1|||
16251462|NCT02570165|39404403|FG002|Overall Study|Lack of Efficacy|0|||
16251463|NCT02570165|39404404|FG003|Overall Study|Lack of Efficacy|0|||
16251464|NCT02570165|39404405|FG004|Overall Study|Lack of Efficacy|4|||
16251465|NCT02570165|39404406|FG005|Overall Study|Lack of Efficacy|0|||
16251466|NCT02570165|39404407|FG006|Overall Study|Lack of Efficacy|0|||
16251467|NCT02570165|39404401|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
16251468|NCT02570165|39404402|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
16251469|NCT02570165|39404403|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
16251470|NCT02570165|39404404|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
16251471|NCT02570165|39404405|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
16251472|NCT02570165|39404406|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
16251473|NCT02570165|39404407|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
16251474|NCT02570165|39404401|FG000|Overall Study|Lost to Follow-up|0|||
16251475|NCT02570165|39404402|FG001|Overall Study|Lost to Follow-up|0|||
16251476|NCT02570165|39404403|FG002|Overall Study|Lost to Follow-up|1|||
16251477|NCT02570165|39404404|FG003|Overall Study|Lost to Follow-up|1|||
16251478|NCT02570165|39404405|FG004|Overall Study|Lost to Follow-up|0|||
16251479|NCT02570165|39404406|FG005|Overall Study|Lost to Follow-up|0|||
16251480|NCT02570165|39404407|FG006|Overall Study|Lost to Follow-up|0|||
16251481|NCT02570165|39404401|FG000|Overall Study|Physician Decision|0|||
16251482|NCT02570165|39404402|FG001|Overall Study|Physician Decision|1|||
16434773|NCT01620086|40070558|FG001|Overall Study|Physician Decision|0|||
16434774|NCT01620086|40070559|FG002|Overall Study|Physician Decision|0|||
16434775|NCT01332994|40070560|FG000|Overall Study|Adverse Event|34|||
16434776|NCT01332994|40070560|FG000|Overall Study|Death|1|||
16434777|NCT01332994|40070560|FG000|Overall Study|Lack of Efficacy|1|||
16251483|NCT02570165|39404403|FG002|Overall Study|Physician Decision|0|||
16251484|NCT02570165|39404404|FG003|Overall Study|Physician Decision|0|||
16251485|NCT02570165|39404405|FG004|Overall Study|Physician Decision|0|||
16251486|NCT02570165|39404406|FG005|Overall Study|Physician Decision|0|||
16251487|NCT02570165|39404407|FG006|Overall Study|Physician Decision|0|||
16251488|NCT02570165|39404401|FG000|Overall Study|Withdrawal by Subject|0|||
16251489|NCT02570165|39404402|FG001|Overall Study|Withdrawal by Subject|0|||
16251490|NCT02570165|39404403|FG002|Overall Study|Withdrawal by Subject|0|||
16251491|NCT02570165|39404404|FG003|Overall Study|Withdrawal by Subject|2|||
16251492|NCT02570165|39404405|FG004|Overall Study|Withdrawal by Subject|1|||
16251493|NCT02570165|39404406|FG005|Overall Study|Withdrawal by Subject|0|||
16251494|NCT02570165|39404407|FG006|Overall Study|Withdrawal by Subject|0|||
16251495|NCT02570165|39404401|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
16251496|NCT02570165|39404402|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
16251497|NCT02570165|39404403|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
16251498|NCT02570165|39404404|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
16251499|NCT02570165|39404405|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
16251500|NCT02570165|39404406|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
16251501|NCT02570165|39404407|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
16251502|NCT02570165|39404401|FG000|Overall Study|Withdrawal Request by GSK|0|||
16251503|NCT02570165|39404402|FG001|Overall Study|Withdrawal Request by GSK|0|||
16251504|NCT02570165|39404403|FG002|Overall Study|Withdrawal Request by GSK|2|||
16251505|NCT02570165|39404404|FG003|Overall Study|Withdrawal Request by GSK|0|||
16251506|NCT02570165|39404405|FG004|Overall Study|Withdrawal Request by GSK|0|||
16251507|NCT02570165|39404406|FG005|Overall Study|Withdrawal Request by GSK|0|||
16251508|NCT02570165|39404407|FG006|Overall Study|Withdrawal Request by GSK|0|||
16251509|NCT02275364|39404412|FG000|Period 1|Withdrawal by Subject|1|||
16251510|NCT02275364|39404413|FG001|Period 1|Withdrawal by Subject|0|||
16251511|NCT02275364|39404412|FG000|Period 1|Other reason|1|||
16251512|NCT02275364|39404413|FG001|Period 1|Other reason|0|||
16251513|NCT00992407|39404414|FG000|Overall Study|Protocol Violation|2|||
16251514|NCT00992407|39404415|FG001|Overall Study|Protocol Violation|1|||
16251515|NCT00992407|39404414|FG000|Overall Study|Lost to Follow-up|3|||
16251516|NCT00992407|39404415|FG001|Overall Study|Lost to Follow-up|3|||
16251517|NCT00992407|39404414|FG000|Overall Study|Adverse Event|3|||
16251518|NCT00992407|39404415|FG001|Overall Study|Adverse Event|2|||
16251519|NCT00992407|39404414|FG000|Overall Study|protocol Violation & Adverse events|2|||
16251520|NCT00992407|39404415|FG001|Overall Study|protocol Violation & Adverse events|4|||
16251521|NCT00992407|39404414|FG000|Overall Study|Other|2|||
16251522|NCT00992407|39404415|FG001|Overall Study|Other|0|||
16251523|NCT00992407|39404414|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
16251524|NCT00992407|39404415|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
16251525|NCT00992407|39404414|FG000|Overall Study|Study medication not administered|17|||
16251526|NCT00992407|39404415|FG001|Overall Study|Study medication not administered|13|||
16251527|NCT02710071|39404416|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
16251528|NCT02710071|39404417|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
16251529|NCT02710071|39404416|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
16251530|NCT02710071|39404417|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
16251531|NCT02158936|39404418|FG000|Overall Study|Study closed/ terminated|57|||
16251532|NCT02158936|39404419|FG001|Overall Study|Study closed/ terminated|77|||
16251533|NCT02158936|39404418|FG000|Overall Study|Azacitidine tx discontinued|53|||
16251534|NCT02158936|39404419|FG001|Overall Study|Azacitidine tx discontinued|46|||
16251535|NCT02158936|39404418|FG000|Overall Study|Adverse Event|39|||
16251536|NCT02158936|39404419|FG001|Overall Study|Adverse Event|24|||
16251537|NCT02158936|39404418|FG000|Overall Study|Withdrawal by Subject|15|||
16251538|NCT02158936|39404419|FG001|Overall Study|Withdrawal by Subject|16|||
16251539|NCT02158936|39404418|FG000|Overall Study|Physician Decision|15|||
16251540|NCT02158936|39404419|FG001|Overall Study|Physician Decision|13|||
16251541|NCT02158936|39404418|FG000|Overall Study|Lost to Follow-up|0|||
16362387|NCT01126424|39814894|FG000|Overall Study|Adverse Event|0|||
16362388|NCT01126424|39814895|FG001|Overall Study|Adverse Event|0|||
16362389|NCT01126424|39814896|FG002|Overall Study|Adverse Event|0|||
16362390|NCT01126424|39814897|FG003|Overall Study|Adverse Event|0|||
16362391|NCT01126424|39814898|FG004|Overall Study|Adverse Event|1|||
16362392|NCT01126424|39814899|FG005|Overall Study|Adverse Event|0|||
16362393|NCT01126424|39814894|FG000|Overall Study|Withdrawal by Subject|0|||
16362394|NCT01126424|39814895|FG001|Overall Study|Withdrawal by Subject|0|||
16362395|NCT01126424|39814896|FG002|Overall Study|Withdrawal by Subject|1|||
16362396|NCT01126424|39814897|FG003|Overall Study|Withdrawal by Subject|3|||
16362397|NCT01126424|39814898|FG004|Overall Study|Withdrawal by Subject|1|||
16362398|NCT01126424|39814899|FG005|Overall Study|Withdrawal by Subject|0|||
16134387|NCT02325557|38980330|FG002|Overall Study|Other|0|||
16251542|NCT02158936|39404419|FG001|Overall Study|Lost to Follow-up|1|||
16251543|NCT02398188|39404420|FG000|Overall Study|Adverse Event|2|||
16434778|NCT01332994|40070560|FG000|Overall Study|Lost to Follow-up|4|||
16434779|NCT01332994|40070560|FG000|Overall Study|Protocol Violation|6|||
16434780|NCT01332994|40070560|FG000|Overall Study|Withdrawal by Subject|15|||
16434781|NCT01332994|40070560|FG000|Overall Study|Administrative Problem|2|||
16434782|NCT01332994|40070560|FG000|Overall Study|Other|8|||
16434783|NCT02738801|40070563|FG000|Overall Study|Adverse Event|1|||
16434784|NCT02738801|40070564|FG001|Overall Study|Adverse Event|1|||
16434785|NCT02738801|40070563|FG000|Overall Study|Withdrawal by Subject|0|||
16434786|NCT02738801|40070564|FG001|Overall Study|Withdrawal by Subject|1|||
16434787|NCT01005251|40070566|FG000|Overall Study|Withdrawal by Subject|2|||
16434788|NCT01005251|40070567|FG001|Overall Study|Withdrawal by Subject|5|||
16434789|NCT01005251|40070568|FG002|Overall Study|Withdrawal by Subject|3|||
16434790|NCT01005251|40070569|FG003|Overall Study|Withdrawal by Subject|4|||
16434791|NCT01005251|40070570|FG004|Overall Study|Withdrawal by Subject|9|||
16434792|NCT01005251|40070566|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
16434793|NCT01005251|40070567|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16434794|NCT01005251|40070568|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
16434795|NCT01005251|40070569|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
16434796|NCT01005251|40070570|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
16434797|NCT01005251|40070566|FG000|Overall Study|Adverse Event|2|||
16434798|NCT01005251|40070567|FG001|Overall Study|Adverse Event|6|||
16434799|NCT01005251|40070568|FG002|Overall Study|Adverse Event|8|||
16434800|NCT01005251|40070569|FG003|Overall Study|Adverse Event|5|||
16434801|NCT01005251|40070570|FG004|Overall Study|Adverse Event|4|||
16434802|NCT01005251|40070566|FG000|Overall Study|Protocol Violation|1|||
16434803|NCT01005251|40070567|FG001|Overall Study|Protocol Violation|0|||
16434804|NCT01005251|40070568|FG002|Overall Study|Protocol Violation|0|||
16434805|NCT01005251|40070569|FG003|Overall Study|Protocol Violation|0|||
16434806|NCT01005251|40070570|FG004|Overall Study|Protocol Violation|2|||
16434807|NCT01005251|40070566|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
16434808|NCT01005251|40070567|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
16251544|NCT02398188|39404421|FG001|Overall Study|Adverse Event|3|||
16251545|NCT02398188|39404420|FG000|Overall Study|Lost to Follow-up|5|||
16434809|NCT01005251|40070568|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
16434810|NCT01005251|40070569|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
16434811|NCT01005251|40070570|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
16434812|NCT01005251|40070566|FG000|Overall Study|Lost to Follow-up|1|||
16434813|NCT01005251|40070567|FG001|Overall Study|Lost to Follow-up|4|||
16434814|NCT01005251|40070568|FG002|Overall Study|Lost to Follow-up|2|||
16251546|NCT02398188|39404421|FG001|Overall Study|Lost to Follow-up|0|||
16251547|NCT02398188|39404420|FG000|Overall Study|Non-compliance|4|||
16251548|NCT02398188|39404421|FG001|Overall Study|Non-compliance|4|||
16251549|NCT02398188|39404420|FG000|Overall Study|Protocol Violation|6|||
16251550|NCT02398188|39404421|FG001|Overall Study|Protocol Violation|10|||
16251551|NCT02398188|39404420|FG000|Overall Study|Sponsor Decision|2|||
16251552|NCT02398188|39404421|FG001|Overall Study|Sponsor Decision|1|||
16251553|NCT02398188|39404420|FG000|Overall Study|Pregnancy|1|||
16251554|NCT02398188|39404421|FG001|Overall Study|Pregnancy|0|||
16251555|NCT02398188|39404420|FG000|Overall Study|Withdrawal by Subject|7|||
16251556|NCT02398188|39404421|FG001|Overall Study|Withdrawal by Subject|16|||
16434815|NCT01005251|40070569|FG003|Overall Study|Lost to Follow-up|0|||
16434816|NCT01005251|40070570|FG004|Overall Study|Lost to Follow-up|0|||
16434817|NCT01005251|40070566|FG000|Overall Study|Physician Decision|0|||
16434818|NCT01005251|40070567|FG001|Overall Study|Physician Decision|0|||
16434819|NCT01005251|40070568|FG002|Overall Study|Physician Decision|0|||
16251557|NCT01399723|39404422|FG000|Overall Study|Lost to Follow-up|0|||
16434820|NCT01005251|40070569|FG003|Overall Study|Physician Decision|0|||
16434821|NCT01005251|40070570|FG004|Overall Study|Physician Decision|2|||
16434822|NCT01005251|40070566|FG000|Overall Study|Patient moved|1|||
16251558|NCT01399723|39404423|FG001|Overall Study|Lost to Follow-up|1|||
16434823|NCT01005251|40070567|FG001|Overall Study|Patient moved|0|||
16434824|NCT01005251|40070568|FG002|Overall Study|Patient moved|0|||
16434825|NCT01005251|40070569|FG003|Overall Study|Patient moved|0|||
16251559|NCT03381248|39404426|FG000|0-6 Months|Withdrawal by Subject|4|||
16134388|NCT02325557|38980331|FG003|Overall Study|Other|5|||
16434826|NCT01005251|40070570|FG004|Overall Study|Patient moved|0|||
16434827|NCT01005251|40070566|FG000|Overall Study|Wrong drug dispensed|0|||
16434828|NCT01005251|40070567|FG001|Overall Study|Wrong drug dispensed|1|||
16434829|NCT01005251|40070568|FG002|Overall Study|Wrong drug dispensed|0|||
16434830|NCT01005251|40070569|FG003|Overall Study|Wrong drug dispensed|0|||
16434831|NCT01005251|40070570|FG004|Overall Study|Wrong drug dispensed|0|||
16434832|NCT01005251|40070566|FG000|Overall Study|Randomized in error|0|||
16434833|NCT01005251|40070567|FG001|Overall Study|Randomized in error|0|||
16434834|NCT01005251|40070568|FG002|Overall Study|Randomized in error|1|||
16434835|NCT01005251|40070569|FG003|Overall Study|Randomized in error|1|||
16434836|NCT01005251|40070570|FG004|Overall Study|Randomized in error|0|||
16434837|NCT01005251|40070566|FG000|Overall Study|Lack of Efficacy|0|||
16434838|NCT01005251|40070567|FG001|Overall Study|Lack of Efficacy|0|||
16434839|NCT01005251|40070568|FG002|Overall Study|Lack of Efficacy|1|||
16434840|NCT01005251|40070569|FG003|Overall Study|Lack of Efficacy|1|||
16434841|NCT01005251|40070570|FG004|Overall Study|Lack of Efficacy|0|||
16434842|NCT03623243|40070571|FG000|Overall Study|Adverse Event|15|||
16434843|NCT03623243|40070571|FG000|Overall Study|Guardian Decision|1|||
16434844|NCT03623243|40070571|FG000|Overall Study|New Therapy for Study Indication|1|||
16434845|NCT03623243|40070571|FG000|Overall Study|Protocol Deviation|3|||
16434846|NCT03623243|40070571|FG000|Overall Study|Physician Decision|4|||
16434847|NCT03623243|40070571|FG000|Overall Study|Patient Decision|15|||
16434848|NCT02422498|40070572|FG000|Overall Study|Inevaluable|4|||
16434849|NCT02079038|40070575|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
16434850|NCT02079038|40070576|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
16434851|NCT02079038|40070575|FG000|Modified Intent to Treat Population|Death|1|||
16434852|NCT02079038|40070576|FG001|Modified Intent to Treat Population|Death|0|||
16434853|NCT02079038|40070575|FG000|Completed 6 Months|Lost to Follow-up|2|||
16434854|NCT02079038|40070576|FG001|Completed 6 Months|Lost to Follow-up|1|||
16434855|NCT02748863|40070577|FG000|Treatment Period 1|Adverse Event|0|||
16434856|NCT02748863|40070578|FG001|Treatment Period 1|Adverse Event|1|||
16434857|NCT02748863|40070579|FG002|Treatment Period 1|Adverse Event|0|||
16434858|NCT02748863|40070580|FG003|Treatment Period 1|Adverse Event|0|||
16434859|NCT02748863|40070581|FG004|Treatment Period 1|Adverse Event|0|||
16434860|NCT02748863|40070577|FG000|Treatment Period 1|Lack of Efficacy|0|||
16434861|NCT02748863|40070578|FG001|Treatment Period 1|Lack of Efficacy|0|||
16434862|NCT02748863|40070579|FG002|Treatment Period 1|Lack of Efficacy|1|||
16434863|NCT02748863|40070580|FG003|Treatment Period 1|Lack of Efficacy|0|||
16434864|NCT02748863|40070581|FG004|Treatment Period 1|Lack of Efficacy|0|||
16434865|NCT02748863|40070577|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16434866|NCT02748863|40070578|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16434867|NCT02748863|40070579|FG002|Treatment Period 1|Withdrawal by Subject|1|||
16434868|NCT02748863|40070580|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16434869|NCT02748863|40070581|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16434870|NCT02748863|40070577|FG000|Treatment Period 2|Lost to Follow-up|2|||
16434871|NCT02748863|40070578|FG001|Treatment Period 2|Lost to Follow-up|0|||
16434872|NCT02748863|40070579|FG002|Treatment Period 2|Lost to Follow-up|0|||
16434873|NCT02748863|40070580|FG003|Treatment Period 2|Lost to Follow-up|0|||
16134389|NCT00960531|38980332|FG000|Overall Study|Lack of Efficacy|1|||
16134390|NCT00960531|38980333|FG001|Overall Study|Lack of Efficacy|0|||
16134391|NCT00960531|38980334|FG002|Overall Study|Lack of Efficacy|0|||
16134392|NCT00960531|38980335|FG003|Overall Study|Lack of Efficacy|0|||
16134393|NCT00960531|38980336|FG004|Overall Study|Lack of Efficacy|0|||
16134394|NCT00960531|38980337|FG005|Overall Study|Lack of Efficacy|0|||
16134395|NCT00960531|38980338|FG006|Overall Study|Lack of Efficacy|0|||
16134396|NCT00960531|38980339|FG007|Overall Study|Lack of Efficacy|0|||
16134397|NCT00960531|38980340|FG008|Overall Study|Lack of Efficacy|0|||
16134398|NCT00960531|38980341|FG009|Overall Study|Lack of Efficacy|0|||
16134399|NCT00960531|38980332|FG000|Overall Study|Withdrawal by Subject|1|||
16134400|NCT00960531|38980333|FG001|Overall Study|Withdrawal by Subject|0|||
16134401|NCT00960531|38980334|FG002|Overall Study|Withdrawal by Subject|5|||
16134402|NCT00960531|38980335|FG003|Overall Study|Withdrawal by Subject|2|||
16134403|NCT00960531|38980336|FG004|Overall Study|Withdrawal by Subject|0|||
16134404|NCT00960531|38980337|FG005|Overall Study|Withdrawal by Subject|0|||
16134405|NCT00960531|38980338|FG006|Overall Study|Withdrawal by Subject|2|||
16134406|NCT00960531|38980339|FG007|Overall Study|Withdrawal by Subject|0|||
16134407|NCT00960531|38980340|FG008|Overall Study|Withdrawal by Subject|1|||
16134408|NCT00960531|38980341|FG009|Overall Study|Withdrawal by Subject|0|||
16134409|NCT00960531|38980332|FG000|Overall Study|Caregiver Request|2|||
16134410|NCT00960531|38980333|FG001|Overall Study|Caregiver Request|0|||
16134411|NCT00960531|38980334|FG002|Overall Study|Caregiver Request|6|||
16134412|NCT00960531|38980335|FG003|Overall Study|Caregiver Request|5|||
16134413|NCT00960531|38980336|FG004|Overall Study|Caregiver Request|0|||
16134414|NCT00960531|38980337|FG005|Overall Study|Caregiver Request|2|||
16134415|NCT00960531|38980338|FG006|Overall Study|Caregiver Request|3|||
16134416|NCT00960531|38980339|FG007|Overall Study|Caregiver Request|1|||
16134417|NCT00960531|38980340|FG008|Overall Study|Caregiver Request|3|||
16134418|NCT00960531|38980341|FG009|Overall Study|Caregiver Request|0|||
16134419|NCT00960531|38980332|FG000|Overall Study|Investigator Request|0|||
16134420|NCT00960531|38980333|FG001|Overall Study|Investigator Request|0|||
16134421|NCT00960531|38980334|FG002|Overall Study|Investigator Request|1|||
16134422|NCT00960531|38980335|FG003|Overall Study|Investigator Request|0|||
16134423|NCT00960531|38980336|FG004|Overall Study|Investigator Request|0|||
16134424|NCT00960531|38980337|FG005|Overall Study|Investigator Request|0|||
16134425|NCT00960531|38980338|FG006|Overall Study|Investigator Request|0|||
16134426|NCT00960531|38980339|FG007|Overall Study|Investigator Request|0|||
16134427|NCT00960531|38980340|FG008|Overall Study|Investigator Request|0|||
16134428|NCT00960531|38980341|FG009|Overall Study|Investigator Request|0|||
16134429|NCT00960531|38980332|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
16134430|NCT00960531|38980333|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
16134431|NCT00960531|38980334|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
16134432|NCT00960531|38980335|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
16134433|NCT00960531|38980336|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
16134434|NCT00960531|38980337|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
16134435|NCT00960531|38980338|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
16134436|NCT00960531|38980339|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
16134437|NCT00960531|38980340|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
16134438|NCT00960531|38980341|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
16134439|NCT00960531|38980332|FG000|Overall Study|Lost to Follow-up|0|||
16134440|NCT00960531|38980333|FG001|Overall Study|Lost to Follow-up|0|||
16134441|NCT00960531|38980334|FG002|Overall Study|Lost to Follow-up|1|||
16134442|NCT00960531|38980335|FG003|Overall Study|Lost to Follow-up|0|||
16134443|NCT00960531|38980336|FG004|Overall Study|Lost to Follow-up|0|||
16134444|NCT00960531|38980337|FG005|Overall Study|Lost to Follow-up|0|||
16134445|NCT00960531|38980338|FG006|Overall Study|Lost to Follow-up|1|||
16134446|NCT00960531|38980339|FG007|Overall Study|Lost to Follow-up|0|||
16134447|NCT00960531|38980340|FG008|Overall Study|Lost to Follow-up|0|||
16134448|NCT00960531|38980341|FG009|Overall Study|Lost to Follow-up|0|||
16134449|NCT00960531|38980332|FG000|Overall Study|Failed to Return|2|||
16134450|NCT00960531|38980333|FG001|Overall Study|Failed to Return|0|||
16134451|NCT00960531|38980334|FG002|Overall Study|Failed to Return|0|||
16134452|NCT00960531|38980335|FG003|Overall Study|Failed to Return|0|||
16134453|NCT00960531|38980336|FG004|Overall Study|Failed to Return|0|||
16134454|NCT00960531|38980337|FG005|Overall Study|Failed to Return|0|||
16134455|NCT00960531|38980338|FG006|Overall Study|Failed to Return|0|||
16134456|NCT00960531|38980339|FG007|Overall Study|Failed to Return|2|||
16134457|NCT00960531|38980340|FG008|Overall Study|Failed to Return|0|||
16134458|NCT00960531|38980341|FG009|Overall Study|Failed to Return|0|||
16134459|NCT00960531|38980332|FG000|Overall Study|Adverse Event (AE)|2|||
16134460|NCT00960531|38980333|FG001|Overall Study|Adverse Event (AE)|0|||
16134461|NCT00960531|38980334|FG002|Overall Study|Adverse Event (AE)|0|||
16134462|NCT00960531|38980335|FG003|Overall Study|Adverse Event (AE)|0|||
16134463|NCT00960531|38980336|FG004|Overall Study|Adverse Event (AE)|0|||
16134464|NCT00960531|38980337|FG005|Overall Study|Adverse Event (AE)|1|||
16134465|NCT00960531|38980338|FG006|Overall Study|Adverse Event (AE)|2|||
16134466|NCT00960531|38980339|FG007|Overall Study|Adverse Event (AE)|0|||
16134467|NCT00960531|38980340|FG008|Overall Study|Adverse Event (AE)|2|||
16134468|NCT00960531|38980341|FG009|Overall Study|Adverse Event (AE)|0|||
16134469|NCT00960531|38980332|FG000|Overall Study|Reason not Specified|2|||
16134470|NCT00960531|38980333|FG001|Overall Study|Reason not Specified|1|||
16134471|NCT00960531|38980334|FG002|Overall Study|Reason not Specified|13|||
16134472|NCT00960531|38980335|FG003|Overall Study|Reason not Specified|1|||
16134473|NCT00960531|38980336|FG004|Overall Study|Reason not Specified|2|||
16134474|NCT00960531|38980337|FG005|Overall Study|Reason not Specified|0|||
16134475|NCT00960531|38980338|FG006|Overall Study|Reason not Specified|16|||
16134476|NCT00960531|38980339|FG007|Overall Study|Reason not Specified|0|||
16134477|NCT00960531|38980340|FG008|Overall Study|Reason not Specified|8|||
16134478|NCT00960531|38980341|FG009|Overall Study|Reason not Specified|1|||
16134479|NCT02480153|38980345|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
16134480|NCT02480153|38980346|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
16134481|NCT02480153|38980347|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
16134482|NCT02480153|38980345|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
16134483|NCT02480153|38980346|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
16134484|NCT02480153|38980347|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
16134485|NCT02480153|38980345|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
16134486|NCT02480153|38980346|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
16134487|NCT02480153|38980347|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
16134488|NCT02480153|38980345|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
16134489|NCT02480153|38980346|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
16134490|NCT02480153|38980347|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
16134491|NCT02480153|38980345|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
16134492|NCT02480153|38980346|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
16134493|NCT02480153|38980347|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
16134494|NCT02480153|38980345|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
16134495|NCT02480153|38980346|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
16134496|NCT02480153|38980347|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
16134497|NCT02480153|38980345|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
16134498|NCT02480153|38980346|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
16134499|NCT02480153|38980347|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
16134500|NCT02480153|38980345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
16134501|NCT02480153|38980346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
16134502|NCT02480153|38980347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
16134503|NCT02480153|38980345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
16134504|NCT02480153|38980346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
16134505|NCT02480153|38980347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
16134506|NCT02480153|38980345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
16134507|NCT02480153|38980346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
16134508|NCT02480153|38980347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
16134509|NCT02480153|38980345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
16134510|NCT02480153|38980346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
16134511|NCT02480153|38980347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
16134512|NCT02480153|38980345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
16134513|NCT02480153|38980346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
16134514|NCT02480153|38980347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
16134515|NCT02480153|38980345|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
16134516|NCT02480153|38980346|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
16134517|NCT02480153|38980347|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
16134518|NCT02480153|38980345|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
16134519|NCT02480153|38980346|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
16134520|NCT02480153|38980347|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
16134521|NCT02480153|38980345|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
16134522|NCT02480153|38980346|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
16134523|NCT02480153|38980347|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
16434874|NCT02748863|40070581|FG004|Treatment Period 2|Lost to Follow-up|0|||
16134524|NCT02480153|38980345|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
16134525|NCT02480153|38980346|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
16251560|NCT03381248|39404427|FG001|0-6 Months|Withdrawal by Subject|1|||
16251561|NCT03381248|39404426|FG000|0-6 Months|Lost to Follow-up|3|||
16251562|NCT03381248|39404427|FG001|0-6 Months|Lost to Follow-up|2|||
16434875|NCT02748863|40070577|FG000|Treatment Period 2|Adverse Event|3|||
16251563|NCT03381248|39404426|FG000|0-6 Months|Lack of Efficacy|1|||
16251564|NCT03381248|39404427|FG001|0-6 Months|Lack of Efficacy|0|||
16251565|NCT03381248|39404426|FG000|0-6 Months|Adverse Event|1|||
16251566|NCT03381248|39404427|FG001|0-6 Months|Adverse Event|0|||
16251567|NCT03381248|39404426|FG000|0-6 Months|Protocol Violation|2|||
16251568|NCT03381248|39404427|FG001|0-6 Months|Protocol Violation|1|||
16251569|NCT03381248|39404426|FG000|0-6 Months|Physician Decision|1|||
16251570|NCT03381248|39404427|FG001|0-6 Months|Physician Decision|0|||
16251571|NCT03381248|39404426|FG000|0-6 Months|Planning another procedure|1|||
16251572|NCT03381248|39404427|FG001|0-6 Months|Planning another procedure|2|||
16251573|NCT03381248|39404426|FG000|6-12 Months|Withdrawal by Subject|1|||
16251574|NCT03381248|39404427|FG001|6-12 Months|Withdrawal by Subject|3|||
16251575|NCT03381248|39404426|FG000|6-12 Months|Lost to Follow-up|0|||
16362399|NCT01913353|39814900|FG000|Overall Study|Adverse Event|2|||
16362400|NCT01913353|39814901|FG001|Overall Study|Adverse Event|0|||
16434876|NCT02748863|40070578|FG001|Treatment Period 2|Adverse Event|2|||
16434877|NCT02748863|40070579|FG002|Treatment Period 2|Adverse Event|0|||
16434878|NCT02748863|40070580|FG003|Treatment Period 2|Adverse Event|2|||
16434879|NCT02748863|40070581|FG004|Treatment Period 2|Adverse Event|0|||
16434880|NCT02748863|40070577|FG000|Treatment Period 2|Lack of Efficacy|0|||
16434881|NCT02748863|40070578|FG001|Treatment Period 2|Lack of Efficacy|1|||
16434882|NCT02748863|40070579|FG002|Treatment Period 2|Lack of Efficacy|0|||
16434883|NCT02748863|40070580|FG003|Treatment Period 2|Lack of Efficacy|0|||
16434884|NCT02748863|40070581|FG004|Treatment Period 2|Lack of Efficacy|0|||
16434885|NCT02748863|40070577|FG000|Treatment Period 2|Pregnancy|0|||
16434886|NCT02748863|40070578|FG001|Treatment Period 2|Pregnancy|0|||
16434887|NCT02748863|40070579|FG002|Treatment Period 2|Pregnancy|0|||
16434888|NCT02748863|40070580|FG003|Treatment Period 2|Pregnancy|0|||
16434889|NCT02748863|40070581|FG004|Treatment Period 2|Pregnancy|1|||
16251576|NCT03381248|39404427|FG001|6-12 Months|Lost to Follow-up|2|||
16362401|NCT01913353|39814900|FG000|Overall Study|Physician Decision|0|||
16362402|NCT01913353|39814901|FG001|Overall Study|Physician Decision|2|||
16362403|NCT01913353|39814900|FG000|Overall Study|Withdrawal by Subject|20|||
16362404|NCT01913353|39814901|FG001|Overall Study|Withdrawal by Subject|6|||
16362405|NCT01913353|39814900|FG000|Overall Study|multiple reasons|10|||
16362406|NCT01913353|39814901|FG001|Overall Study|multiple reasons|7|||
16362407|NCT00831844|39814902|FG000|Overall Study|Adverse Event|2|||
16362408|NCT00831844|39814903|FG001|Overall Study|Adverse Event|0|||
16362409|NCT00831844|39814904|FG002|Overall Study|Adverse Event|0|||
16362410|NCT00831844|39814905|FG003|Overall Study|Adverse Event|0|||
16362411|NCT00831844|39814906|FG004|Overall Study|Adverse Event|1|||
16134526|NCT02480153|38980347|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
16134527|NCT02480153|38980345|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
16134528|NCT02480153|38980346|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
16134529|NCT02480153|38980347|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
16134530|NCT02480153|38980345|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
16134531|NCT02480153|38980346|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
16134532|NCT02480153|38980347|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
16134533|NCT02318797|38980348|FG000|Overall Study|Death|3|||
16134534|NCT02318797|38980349|FG001|Overall Study|Death|6|||
16134535|NCT02318797|38980348|FG000|Overall Study|Lost to Follow-up|85|||
16134536|NCT02318797|38980349|FG001|Overall Study|Lost to Follow-up|96|||
16134537|NCT00838929|38980352|FG000|Overall Study|Protocol Violation|0|||
16134538|NCT00838929|38980353|FG001|Overall Study|Protocol Violation|1|||
16134539|NCT00838929|38980354|FG002|Overall Study|Protocol Violation|0|||
16134540|NCT00838929|38980352|FG000|Overall Study|Disease progression|0|||
16134541|NCT00838929|38980353|FG001|Overall Study|Disease progression|2|||
16134542|NCT00838929|38980354|FG002|Overall Study|Disease progression|1|||
16134543|NCT02409368|38980356|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
16251577|NCT03381248|39404426|FG000|6-12 Months|Protocol Violation|3|||
16251578|NCT03381248|39404427|FG001|6-12 Months|Protocol Violation|2|||
16251579|NCT03381248|39404426|FG000|6-12 Months|Planning another procedure|6|||
16251580|NCT03381248|39404427|FG001|6-12 Months|Planning another procedure|2|||
16251581|NCT03381248|39404426|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
16134544|NCT02409368|38980357|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
16134545|NCT02409368|38980358|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
16362412|NCT00831844|39814907|FG005|Overall Study|Adverse Event|1|||
16362413|NCT00831844|39814908|FG006|Overall Study|Adverse Event|2|||
16362414|NCT00831844|39814909|FG007|Overall Study|Adverse Event|0|||
16362415|NCT00831844|39814910|FG008|Overall Study|Adverse Event|0|||
16362416|NCT00831844|39814911|FG009|Overall Study|Adverse Event|0|||
16362417|NCT00831844|39814902|FG000|Overall Study|Death|0|||
16362418|NCT00831844|39814903|FG001|Overall Study|Death|0|||
16362419|NCT00831844|39814904|FG002|Overall Study|Death|0|||
16362420|NCT00831844|39814905|FG003|Overall Study|Death|1|||
16362421|NCT00831844|39814906|FG004|Overall Study|Death|0|||
16362422|NCT00831844|39814907|FG005|Overall Study|Death|0|||
16362423|NCT00831844|39814908|FG006|Overall Study|Death|0|||
16134546|NCT02409368|38980359|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
16134547|NCT02409368|38980356|FG000|ECOG Reclassification|Death|1|||
16134548|NCT02409368|38980357|FG001|ECOG Reclassification|Death|5|||
16134549|NCT02409368|38980358|FG002|ECOG Reclassification|Death|0|||
16434890|NCT01255423|40070582|FG000|Overall Study|Abnormal Laboratory value|3|||
16434891|NCT01255423|40070583|FG001|Overall Study|Abnormal Laboratory value|2|||
16434892|NCT01255423|40070582|FG000|Overall Study|Use of prohibited medications|0|||
16434893|NCT01255423|40070583|FG001|Overall Study|Use of prohibited medications|1|||
16434894|NCT04612725|40070588|FG000|Overall Study|Adverse Event|1|||
16434895|NCT04612725|40070589|FG001|Overall Study|Adverse Event|3|||
16434896|NCT04612725|40070590|FG002|Overall Study|Adverse Event|1|||
16434897|NCT04612725|40070591|FG003|Overall Study|Adverse Event|0|||
16434898|NCT04612725|40070592|FG004|Overall Study|Adverse Event|1|||
16434899|NCT04612725|40070588|FG000|Overall Study|Lost to Follow-up|0|||
16434900|NCT04612725|40070589|FG001|Overall Study|Lost to Follow-up|1|||
16434901|NCT04612725|40070590|FG002|Overall Study|Lost to Follow-up|0|||
16434902|NCT04612725|40070591|FG003|Overall Study|Lost to Follow-up|0|||
16434903|NCT04612725|40070592|FG004|Overall Study|Lost to Follow-up|0|||
16434904|NCT04612725|40070588|FG000|Overall Study|Physician Decision|2|||
16134550|NCT02409368|38980359|FG003|ECOG Reclassification|Death|0|||
16134551|NCT02409368|38980356|FG000|ECOG Reclassification|Disease Progression|113|||
16134552|NCT02409368|38980357|FG001|ECOG Reclassification|Disease Progression|382|||
16134553|NCT02409368|38980358|FG002|ECOG Reclassification|Disease Progression|70|||
16434905|NCT04612725|40070589|FG001|Overall Study|Physician Decision|0|||
16434906|NCT04612725|40070590|FG002|Overall Study|Physician Decision|0|||
16434907|NCT04612725|40070591|FG003|Overall Study|Physician Decision|0|||
16134554|NCT02409368|38980359|FG003|ECOG Reclassification|Disease Progression|1|||
16134555|NCT02409368|38980356|FG000|ECOG Reclassification|Lost to Follow-up|1|||
16134556|NCT02409368|38980357|FG001|ECOG Reclassification|Lost to Follow-up|5|||
16434908|NCT04612725|40070592|FG004|Overall Study|Physician Decision|0|||
16434909|NCT04612725|40070588|FG000|Overall Study|Study terminated by sponsor|3|||
16251582|NCT03381248|39404427|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
16251583|NCT03381248|39404426|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
16251584|NCT03381248|39404427|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
16251585|NCT03381248|39404426|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
16251586|NCT03381248|39404427|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
16251587|NCT01497938|39404432|FG000|Overall Study|Adverse Event|0|||
16251588|NCT01497938|39404433|FG001|Overall Study|Adverse Event|1|||
16251589|NCT01497938|39404432|FG000|Overall Study|Physician Decision|0|||
16251590|NCT01497938|39404433|FG001|Overall Study|Physician Decision|1|||
16134557|NCT02409368|38980358|FG002|ECOG Reclassification|Lost to Follow-up|0|||
16134558|NCT02409368|38980359|FG003|ECOG Reclassification|Lost to Follow-up|0|||
16134559|NCT02409368|38980356|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
16134560|NCT02409368|38980357|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
16134561|NCT02409368|38980358|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
16134562|NCT02409368|38980359|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
16134563|NCT02409368|38980356|FG000|ECOG Reclassification|Poor/non-compliance|0|||
16134564|NCT02409368|38980357|FG001|ECOG Reclassification|Poor/non-compliance|3|||
16134565|NCT02409368|38980358|FG002|ECOG Reclassification|Poor/non-compliance|2|||
16134566|NCT02409368|38980359|FG003|ECOG Reclassification|Poor/non-compliance|0|||
16134567|NCT02409368|38980356|FG000|ECOG Reclassification|Study drug toxicity|17|||
16134568|NCT02409368|38980357|FG001|ECOG Reclassification|Study drug toxicity|42|||
16134569|NCT02409368|38980358|FG002|ECOG Reclassification|Study drug toxicity|7|||
16134570|NCT02409368|38980359|FG003|ECOG Reclassification|Study drug toxicity|0|||
16134571|NCT02409368|38980356|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
16134572|NCT02409368|38980357|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
16134573|NCT02409368|38980358|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
16134574|NCT02409368|38980359|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
16134575|NCT02409368|38980356|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
16134576|NCT02409368|38980357|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
16251591|NCT01497938|39404432|FG000|Overall Study|Withdrawal by Subject|4|||
16134577|NCT02409368|38980358|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
16134578|NCT02409368|38980359|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
16251592|NCT01497938|39404433|FG001|Overall Study|Withdrawal by Subject|0|||
16434910|NCT04612725|40070589|FG001|Overall Study|Study terminated by sponsor|1|||
16434911|NCT04612725|40070590|FG002|Overall Study|Study terminated by sponsor|2|||
16134579|NCT02409368|38980356|FG000|ECOG Reclassification|Participant withdrew consent|2|||
16434912|NCT04612725|40070591|FG003|Overall Study|Study terminated by sponsor|4|||
16434913|NCT04612725|40070592|FG004|Overall Study|Study terminated by sponsor|5|||
16434914|NCT04612725|40070588|FG000|Overall Study|Withdrawal by Subject|8|||
16434915|NCT04612725|40070589|FG001|Overall Study|Withdrawal by Subject|3|||
16434916|NCT04612725|40070590|FG002|Overall Study|Withdrawal by Subject|5|||
16434917|NCT04612725|40070591|FG003|Overall Study|Withdrawal by Subject|1|||
16434918|NCT04612725|40070592|FG004|Overall Study|Withdrawal by Subject|9|||
16434919|NCT04612725|40070588|FG000|Overall Study|Other|0|||
16434920|NCT04612725|40070589|FG001|Overall Study|Other|0|||
16434921|NCT04612725|40070590|FG002|Overall Study|Other|0|||
16434922|NCT04612725|40070591|FG003|Overall Study|Other|0|||
16434923|NCT04612725|40070592|FG004|Overall Study|Other|1|||
16434924|NCT02960217|40070593|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
16434925|NCT02960217|40070594|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
16434926|NCT02960217|40070593|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
16434927|NCT02960217|40070594|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
16434928|NCT02960217|40070593|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
16434929|NCT02960217|40070594|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
16434930|NCT02960217|40070593|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
16434931|NCT02960217|40070594|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
16434932|NCT02960217|40070593|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
16473172|NCT01147172|40210746|FG000|Overall Study|Lost to Follow-up|2|||
16473173|NCT00678080|40210747|FG000|Overall Study|Physician Decision|2|||
16473174|NCT00678080|40210748|FG001|Overall Study|Physician Decision|0|||
16473175|NCT00678080|40210747|FG000|Overall Study|Lost to Follow-up|1|||
16473176|NCT00678080|40210748|FG001|Overall Study|Lost to Follow-up|0|||
16473177|NCT00678080|40210747|FG000|Overall Study|Withdrawal by Subject|0|||
16473178|NCT00678080|40210748|FG001|Overall Study|Withdrawal by Subject|1|||
16251593|NCT01497938|39404432|FG000|Overall Study|Device Violation|1|||
16251594|NCT01497938|39404433|FG001|Overall Study|Device Violation|0|||
16434933|NCT02960217|40070594|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
16434934|NCT02960217|40070593|FG000|Open-Label Extension Phase|Adverse Event|1|||
16434935|NCT02960217|40070594|FG001|Open-Label Extension Phase|Adverse Event|0|||
16434936|NCT02960217|40070593|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
16434937|NCT02960217|40070594|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
16434938|NCT02960217|40070593|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
16251595|NCT01730937|39404434|FG000|Overall Study|Protocol Violation|5|||
16434939|NCT02960217|40070594|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
16434940|NCT02960217|40070593|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
16434941|NCT02960217|40070594|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
16434942|NCT03649217|40070597|FG000|Overall Study|subject had severe ataxia not initially found|1|||
16434943|NCT03649217|40070597|FG000|Overall Study|subject had cognitive issues not initially found|1|||
16434944|NCT01216202|40070604|FG000|Overall Study|Withdrawal by Subject|8|||
16434945|NCT01216202|40070605|FG001|Overall Study|Withdrawal by Subject|0|||
16434946|NCT01216202|40070604|FG000|Overall Study|Death|0|||
16434947|NCT01216202|40070605|FG001|Overall Study|Death|2|||
16434948|NCT01216202|40070604|FG000|Overall Study|Lost to Follow-up|14|||
16434949|NCT01216202|40070605|FG001|Overall Study|Lost to Follow-up|0|||
16434950|NCT00857285|40070609|FG000|Overall Study|Adverse Event|4|||
16434951|NCT00857285|40070610|FG001|Overall Study|Adverse Event|2|||
16434952|NCT00857285|40070609|FG000|Overall Study|Lack of Efficacy|0|||
16434953|NCT00857285|40070610|FG001|Overall Study|Lack of Efficacy|2|||
16434954|NCT00857285|40070609|FG000|Overall Study|Protocol Violation|3|||
16251596|NCT01730937|39404435|FG001|Overall Study|Protocol Violation|11|||
16251597|NCT00721409|39404436|FG000|Overall Study|Global deterioration of health status|2|||
16251598|NCT00721409|39404437|FG001|Overall Study|Global deterioration of health status|6|||
16251599|NCT00721409|39404438|FG002|Overall Study|Global deterioration of health status|3|||
16251600|NCT00721409|39404436|FG000|Overall Study|Death|0|||
16362424|NCT00831844|39814909|FG007|Overall Study|Death|0|||
16362425|NCT00831844|39814910|FG008|Overall Study|Death|0|||
16362426|NCT00831844|39814911|FG009|Overall Study|Death|0|||
16362427|NCT00831844|39814902|FG000|Overall Study|Lack of Efficacy|8|||
16362428|NCT00831844|39814903|FG001|Overall Study|Lack of Efficacy|10|||
16362429|NCT00831844|39814904|FG002|Overall Study|Lack of Efficacy|15|||
16362430|NCT00831844|39814905|FG003|Overall Study|Lack of Efficacy|8|||
16362431|NCT00831844|39814906|FG004|Overall Study|Lack of Efficacy|11|||
16362432|NCT00831844|39814907|FG005|Overall Study|Lack of Efficacy|17|||
16362433|NCT00831844|39814908|FG006|Overall Study|Lack of Efficacy|8|||
16251601|NCT00721409|39404437|FG001|Overall Study|Death|1|||
16251602|NCT00721409|39404438|FG002|Overall Study|Death|0|||
16251603|NCT00721409|39404436|FG000|Overall Study|Randomized not Treated|0|||
16434955|NCT00857285|40070610|FG001|Overall Study|Protocol Violation|1|||
16434956|NCT00857285|40070609|FG000|Overall Study|Withdrawal by Subject|4|||
16434957|NCT00857285|40070610|FG001|Overall Study|Withdrawal by Subject|0|||
16434958|NCT00857285|40070609|FG000|Overall Study|Randomization criteria not met|1|||
16434959|NCT00857285|40070610|FG001|Overall Study|Randomization criteria not met|1|||
16434960|NCT03951077|40070614|FG000|Overall Study|Adverse Event|1|||
16434961|NCT03951077|40070615|FG001|Overall Study|Adverse Event|0|||
16251604|NCT00721409|39404437|FG001|Overall Study|Randomized not Treated|1|||
16434962|NCT03951077|40070616|FG002|Overall Study|Adverse Event|0|||
16434963|NCT03951077|40070617|FG003|Overall Study|Adverse Event|0|||
16434964|NCT03951077|40070618|FG004|Overall Study|Adverse Event|0|||
16434965|NCT03951077|40070619|FG005|Overall Study|Adverse Event|0|||
16434966|NCT03951077|40070614|FG000|Overall Study|Withdrawal by Subject|3|||
16434967|NCT03951077|40070615|FG001|Overall Study|Withdrawal by Subject|3|||
16434968|NCT03951077|40070616|FG002|Overall Study|Withdrawal by Subject|0|||
16434969|NCT03951077|40070617|FG003|Overall Study|Withdrawal by Subject|3|||
16434970|NCT03951077|40070618|FG004|Overall Study|Withdrawal by Subject|3|||
16434971|NCT03951077|40070619|FG005|Overall Study|Withdrawal by Subject|2|||
16434972|NCT03951077|40070614|FG000|Overall Study|Lost to Follow-up|1|||
16434973|NCT03951077|40070615|FG001|Overall Study|Lost to Follow-up|1|||
16434974|NCT03951077|40070616|FG002|Overall Study|Lost to Follow-up|2|||
16434975|NCT03951077|40070617|FG003|Overall Study|Lost to Follow-up|3|||
16434976|NCT03951077|40070618|FG004|Overall Study|Lost to Follow-up|2|||
16434977|NCT03951077|40070619|FG005|Overall Study|Lost to Follow-up|3|||
16434978|NCT03951077|40070614|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
16434979|NCT03951077|40070615|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
16434980|NCT03951077|40070616|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
16434981|NCT03951077|40070617|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
16434982|NCT03951077|40070618|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
16434983|NCT03951077|40070619|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
16434984|NCT03951077|40070614|FG000|Overall Study|Other, Not Specified|12|||
16434985|NCT03951077|40070615|FG001|Overall Study|Other, Not Specified|10|||
16434986|NCT03951077|40070616|FG002|Overall Study|Other, Not Specified|10|||
16434987|NCT03951077|40070617|FG003|Overall Study|Other, Not Specified|5|||
16434988|NCT03951077|40070618|FG004|Overall Study|Other, Not Specified|9|||
16434989|NCT03951077|40070619|FG005|Overall Study|Other, Not Specified|6|||
16434990|NCT03951077|40070614|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
16434991|NCT03951077|40070615|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
16434992|NCT03951077|40070616|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
16434993|NCT03951077|40070617|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
16434994|NCT03951077|40070618|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
16434995|NCT03951077|40070619|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
16434996|NCT02922725|40070620|FG000|Overall Study|Withdrawal by Subject|1|||
16434997|NCT02922725|40070621|FG001|Overall Study|Withdrawal by Subject|0|||
16434998|NCT02922725|40070622|FG002|Overall Study|Withdrawal by Subject|0|||
16434999|NCT00965081|40070624|FG000|Overall Study|Adverse Event|14|||
16435000|NCT00965081|40070625|FG001|Overall Study|Adverse Event|9|||
16435001|NCT00965081|40070624|FG000|Overall Study|Lack of Efficacy|2|||
16435002|NCT00965081|40070625|FG001|Overall Study|Lack of Efficacy|5|||
16435003|NCT00965081|40070624|FG000|Overall Study|Lost to Follow-up|4|||
16435004|NCT00965081|40070625|FG001|Overall Study|Lost to Follow-up|5|||
16435005|NCT00965081|40070624|FG000|Overall Study|Physician Decision|2|||
16435006|NCT00965081|40070625|FG001|Overall Study|Physician Decision|0|||
16435007|NCT00965081|40070624|FG000|Overall Study|Protocol Violation|2|||
16435008|NCT00965081|40070625|FG001|Overall Study|Protocol Violation|5|||
16435009|NCT00965081|40070624|FG000|Overall Study|Sponsor Decision|1|||
16435010|NCT00965081|40070625|FG001|Overall Study|Sponsor Decision|0|||
16435011|NCT00965081|40070624|FG000|Overall Study|Withdrawal by Subject|4|||
16435012|NCT00965081|40070625|FG001|Overall Study|Withdrawal by Subject|7|||
16435013|NCT00965081|40070624|FG000|Overall Study|Switched to Rescue Arm|5|||
16435014|NCT00965081|40070625|FG001|Overall Study|Switched to Rescue Arm|12|||
16435015|NCT01650558|40070627|FG000|Overall Study|Migration out of study area|61|||
16435016|NCT01650558|40070628|FG001|Overall Study|Migration out of study area|71|||
16435017|NCT01650558|40070629|FG002|Overall Study|Migration out of study area|56|||
16435018|NCT01650558|40070627|FG000|Overall Study|Lost to Follow-up|10|||
16435019|NCT01650558|40070628|FG001|Overall Study|Lost to Follow-up|13|||
16435020|NCT01650558|40070629|FG002|Overall Study|Lost to Follow-up|6|||
16435021|NCT01650558|40070627|FG000|Overall Study|Death|10|||
16435022|NCT01650558|40070628|FG001|Overall Study|Death|6|||
16435023|NCT01650558|40070629|FG002|Overall Study|Death|8|||
16435024|NCT01650558|40070627|FG000|Overall Study|Withdrawal by Subject|1|||
16435025|NCT01650558|40070628|FG001|Overall Study|Withdrawal by Subject|1|||
16435026|NCT01650558|40070629|FG002|Overall Study|Withdrawal by Subject|3|||
16435027|NCT01650558|40070627|FG000|Overall Study|Non-compliant participant|1|||
16435028|NCT01650558|40070628|FG001|Overall Study|Non-compliant participant|0|||
16435029|NCT01650558|40070629|FG002|Overall Study|Non-compliant participant|2|||
16435030|NCT01650558|40070627|FG000|Overall Study|Physician Decision|0|||
16435031|NCT01650558|40070628|FG001|Overall Study|Physician Decision|1|||
16435032|NCT01650558|40070629|FG002|Overall Study|Physician Decision|0|||
16435033|NCT00308139|40070630|FG000|Overall Study|Adverse Event|20|||
16435034|NCT00308139|40070631|FG001|Overall Study|Adverse Event|14|||
16435035|NCT00308139|40070630|FG000|Overall Study|Lost to Follow-up|13|||
16435036|NCT00308139|40070631|FG001|Overall Study|Lost to Follow-up|8|||
16435037|NCT00308139|40070630|FG000|Overall Study|Protocol Violation|3|||
16435038|NCT00308139|40070631|FG001|Overall Study|Protocol Violation|2|||
16435039|NCT00308139|40070630|FG000|Overall Study|Withdrawal of Consent|40|||
16435040|NCT00308139|40070631|FG001|Overall Study|Withdrawal of Consent|42|||
16251605|NCT00721409|39404438|FG002|Overall Study|Randomized not Treated|4|||
16251606|NCT00721409|39404436|FG000|Overall Study|Reason not specified|1|||
16251607|NCT00721409|39404437|FG001|Overall Study|Reason not specified|0|||
16251608|NCT00721409|39404438|FG002|Overall Study|Reason not specified|2|||
16251609|NCT00721409|39404436|FG000|Overall Study|Adverse Event|0|||
16251610|NCT00721409|39404437|FG001|Overall Study|Adverse Event|13|||
16251611|NCT00721409|39404438|FG002|Overall Study|Adverse Event|2|||
16251612|NCT00721409|39404436|FG000|Overall Study|Lost to Follow-up|0|||
16251613|NCT00721409|39404437|FG001|Overall Study|Lost to Follow-up|0|||
16251614|NCT00721409|39404438|FG002|Overall Study|Lost to Follow-up|1|||
16251615|NCT00721409|39404436|FG000|Overall Study|Withdrawal by Subject|1|||
16251616|NCT00721409|39404437|FG001|Overall Study|Withdrawal by Subject|6|||
16251617|NCT00721409|39404438|FG002|Overall Study|Withdrawal by Subject|5|||
16251618|NCT00721409|39404436|FG000|Overall Study|Objective progression or relapse|8|||
16251619|NCT00721409|39404437|FG001|Overall Study|Objective progression or relapse|55|||
16251620|NCT00721409|39404438|FG002|Overall Study|Objective progression or relapse|62|||
16251621|NCT02841709|39404439|FG000|5th Intervention|Adverse Event|2|||
16362434|NCT00831844|39814909|FG007|Overall Study|Lack of Efficacy|9|||
16362435|NCT00831844|39814910|FG008|Overall Study|Lack of Efficacy|7|||
16362436|NCT00831844|39814911|FG009|Overall Study|Lack of Efficacy|0|||
16362437|NCT00831844|39814902|FG000|Overall Study|Physician Decision|0|||
16362438|NCT00831844|39814903|FG001|Overall Study|Physician Decision|1|||
16362439|NCT00831844|39814904|FG002|Overall Study|Physician Decision|3|||
16362440|NCT00831844|39814905|FG003|Overall Study|Physician Decision|1|||
16362441|NCT00831844|39814906|FG004|Overall Study|Physician Decision|1|||
16362442|NCT00831844|39814907|FG005|Overall Study|Physician Decision|1|||
16362443|NCT00831844|39814908|FG006|Overall Study|Physician Decision|0|||
16362444|NCT00831844|39814909|FG007|Overall Study|Physician Decision|0|||
16362445|NCT00831844|39814910|FG008|Overall Study|Physician Decision|1|||
16362446|NCT00831844|39814911|FG009|Overall Study|Physician Decision|0|||
16362447|NCT00831844|39814902|FG000|Overall Study|Withdrawal by Subject|0|||
16362448|NCT00831844|39814903|FG001|Overall Study|Withdrawal by Subject|0|||
16362449|NCT00831844|39814904|FG002|Overall Study|Withdrawal by Subject|1|||
16362450|NCT00831844|39814905|FG003|Overall Study|Withdrawal by Subject|0|||
16362451|NCT00831844|39814906|FG004|Overall Study|Withdrawal by Subject|0|||
16362452|NCT00831844|39814907|FG005|Overall Study|Withdrawal by Subject|0|||
16362453|NCT00831844|39814908|FG006|Overall Study|Withdrawal by Subject|0|||
16362454|NCT00831844|39814909|FG007|Overall Study|Withdrawal by Subject|1|||
16362455|NCT00831844|39814910|FG008|Overall Study|Withdrawal by Subject|1|||
16362456|NCT00831844|39814911|FG009|Overall Study|Withdrawal by Subject|0|||
16362457|NCT00831844|39814902|FG000|Overall Study|Ineligible|0|||
16362458|NCT00831844|39814903|FG001|Overall Study|Ineligible|1|||
16362459|NCT00831844|39814904|FG002|Overall Study|Ineligible|1|||
16362460|NCT00831844|39814905|FG003|Overall Study|Ineligible|0|||
16362461|NCT00831844|39814906|FG004|Overall Study|Ineligible|1|||
16362462|NCT00831844|39814907|FG005|Overall Study|Ineligible|0|||
16362463|NCT00831844|39814908|FG006|Overall Study|Ineligible|0|||
16362464|NCT00831844|39814909|FG007|Overall Study|Ineligible|0|||
16362465|NCT00831844|39814910|FG008|Overall Study|Ineligible|0|||
16362466|NCT00831844|39814911|FG009|Overall Study|Ineligible|0|||
16362467|NCT02323880|39814912|FG000|Overall Study|Adverse Event|2|||
16362468|NCT02323880|39814913|FG001|Overall Study|Adverse Event|0|||
16362469|NCT02323880|39814914|FG002|Overall Study|Adverse Event|1|||
16362470|NCT02323880|39814915|FG003|Overall Study|Adverse Event|1|||
16362471|NCT02323880|39814916|FG004|Overall Study|Adverse Event|1|||
16362472|NCT02323880|39814917|FG005|Overall Study|Adverse Event|0|||
16362473|NCT02323880|39814918|FG006|Overall Study|Adverse Event|1|||
16362474|NCT02323880|39814919|FG007|Overall Study|Adverse Event|0|||
16362475|NCT02323880|39814912|FG000|Overall Study|Death|0|||
16435041|NCT00308139|40070630|FG000|Overall Study|Investigator Decision|11|||
16362476|NCT02323880|39814913|FG001|Overall Study|Death|0|||
16251622|NCT02841709|39404440|FG001|5th Intervention|Adverse Event|0|||
16251623|NCT02841709|39404441|FG002|5th Intervention|Adverse Event|0|||
16251624|NCT02841709|39404442|FG003|5th Intervention|Adverse Event|0|||
16251625|NCT02841709|39404443|FG004|5th Intervention|Adverse Event|2|||
16251626|NCT00729859|39404444|FG000|Overall Study|Adverse Event|0|||
16362477|NCT02323880|39814914|FG002|Overall Study|Death|0|||
16362478|NCT02323880|39814915|FG003|Overall Study|Death|0|||
16251627|NCT00729859|39404445|FG001|Overall Study|Adverse Event|1|||
16251628|NCT00729859|39404446|FG002|Overall Study|Adverse Event|0|||
16251629|NCT00729859|39404444|FG000|Overall Study|Withdrawal by Subject|0|||
16251630|NCT00729859|39404445|FG001|Overall Study|Withdrawal by Subject|1|||
16251631|NCT00729859|39404446|FG002|Overall Study|Withdrawal by Subject|0|||
16251632|NCT00680121|39404447|FG000|Overall Study|Lost to Follow-up|27|||
16251633|NCT00680121|39404448|FG001|Overall Study|Lost to Follow-up|23|||
16251634|NCT04161144|39404451|FG000|Overall Study|Withdrawal by Subject|0|||
16251635|NCT04161144|39404452|FG001|Overall Study|Withdrawal by Subject|1|||
16251636|NCT04161144|39404451|FG000|Overall Study|Protocol Violation|1|||
16251637|NCT04161144|39404452|FG001|Overall Study|Protocol Violation|0|||
16251638|NCT03387098|39404455|FG000|Overall Study|progressive disease|1|||
16251639|NCT03387098|39404455|FG000|Overall Study|Withdrawal by Subject|2|||
16251640|NCT03387098|39404455|FG000|Overall Study|study terminated by sponsor|1|||
16251641|NCT03500484|39404466|FG000|Overall Study|Adverse Event|2|||
16251642|NCT03500484|39404467|FG001|Overall Study|Adverse Event|0|||
16251643|NCT03500484|39404466|FG000|Overall Study|Physician Decision|1|||
16251644|NCT03500484|39404467|FG001|Overall Study|Physician Decision|0|||
16251645|NCT03500484|39404466|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
16251646|NCT03500484|39404467|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
16251647|NCT00249821|39404468|FG000|Overall Study|Technical problem|0|||
16251648|NCT00249821|39404469|FG001|Overall Study|Technical problem|1|||
16251649|NCT03980483|39404470|FG000|Overall Study|Adverse Event|13|||
16251650|NCT03980483|39404471|FG001|Overall Study|Adverse Event|29|||
16251651|NCT03980483|39404472|FG002|Overall Study|Adverse Event|11|||
16251652|NCT03980483|39404473|FG003|Overall Study|Adverse Event|2|||
16251653|NCT03980483|39404474|FG004|Overall Study|Adverse Event|2|||
16251654|NCT03980483|39404475|FG005|Overall Study|Adverse Event|2|||
16251655|NCT03980483|39404470|FG000|Overall Study|Lack of Efficacy|7|||
16251656|NCT03980483|39404471|FG001|Overall Study|Lack of Efficacy|6|||
16251657|NCT03980483|39404472|FG002|Overall Study|Lack of Efficacy|0|||
16251658|NCT03980483|39404473|FG003|Overall Study|Lack of Efficacy|3|||
16251659|NCT03980483|39404474|FG004|Overall Study|Lack of Efficacy|1|||
16251660|NCT03980483|39404475|FG005|Overall Study|Lack of Efficacy|1|||
16251661|NCT03980483|39404470|FG000|Overall Study|Lost to Follow-up|2|||
16251662|NCT03980483|39404471|FG001|Overall Study|Lost to Follow-up|4|||
16251663|NCT03980483|39404472|FG002|Overall Study|Lost to Follow-up|2|||
16251664|NCT03980483|39404473|FG003|Overall Study|Lost to Follow-up|1|||
16251665|NCT03980483|39404474|FG004|Overall Study|Lost to Follow-up|2|||
16251666|NCT03980483|39404475|FG005|Overall Study|Lost to Follow-up|0|||
16251667|NCT03980483|39404470|FG000|Overall Study|Protocol Violation|4|||
16251668|NCT03980483|39404471|FG001|Overall Study|Protocol Violation|2|||
16251669|NCT03980483|39404472|FG002|Overall Study|Protocol Violation|1|||
16251670|NCT03980483|39404473|FG003|Overall Study|Protocol Violation|1|||
16251671|NCT03980483|39404474|FG004|Overall Study|Protocol Violation|0|||
16251672|NCT03980483|39404475|FG005|Overall Study|Protocol Violation|0|||
16251673|NCT03980483|39404470|FG000|Overall Study|Physician Decision|14|||
16251674|NCT03980483|39404471|FG001|Overall Study|Physician Decision|10|||
16251675|NCT03980483|39404472|FG002|Overall Study|Physician Decision|7|||
16251676|NCT03980483|39404473|FG003|Overall Study|Physician Decision|4|||
16251677|NCT03980483|39404474|FG004|Overall Study|Physician Decision|4|||
16251678|NCT03980483|39404475|FG005|Overall Study|Physician Decision|2|||
16251679|NCT03980483|39404470|FG000|Overall Study|Withdrawal by Subject|38|||
16251680|NCT03980483|39404471|FG001|Overall Study|Withdrawal by Subject|21|||
16251681|NCT03980483|39404472|FG002|Overall Study|Withdrawal by Subject|15|||
16251682|NCT03980483|39404473|FG003|Overall Study|Withdrawal by Subject|5|||
16251683|NCT03980483|39404474|FG004|Overall Study|Withdrawal by Subject|3|||
16251684|NCT03980483|39404475|FG005|Overall Study|Withdrawal by Subject|4|||
16362479|NCT02323880|39814916|FG004|Overall Study|Death|0|||
16362480|NCT02323880|39814917|FG005|Overall Study|Death|1|||
16362481|NCT02323880|39814918|FG006|Overall Study|Death|0|||
16362482|NCT02323880|39814919|FG007|Overall Study|Death|0|||
16134580|NCT02409368|38980357|FG001|ECOG Reclassification|Participant withdrew consent|3|||
16362483|NCT02323880|39814912|FG000|Overall Study|Lack of Efficacy|4|||
16134581|NCT02409368|38980358|FG002|ECOG Reclassification|Participant withdrew consent|4|||
16251685|NCT03980483|39404470|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
16251686|NCT03980483|39404471|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
16251687|NCT03980483|39404472|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
16251688|NCT03980483|39404473|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
16251689|NCT03980483|39404474|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
16362484|NCT02323880|39814913|FG001|Overall Study|Lack of Efficacy|11|||
16134582|NCT02409368|38980359|FG003|ECOG Reclassification|Participant withdrew consent|0|||
16134583|NCT02409368|38980356|FG000|ECOG Reclassification|Other Reasons|5|||
16134584|NCT02409368|38980357|FG001|ECOG Reclassification|Other Reasons|26|||
16134585|NCT02409368|38980358|FG002|ECOG Reclassification|Other Reasons|2|||
16251690|NCT03980483|39404475|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
16251691|NCT03980483|39404470|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
16251692|NCT03980483|39404471|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
16251693|NCT03980483|39404472|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
16251694|NCT03980483|39404473|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
16251695|NCT03980483|39404474|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
16251696|NCT03980483|39404475|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
16251697|NCT03980483|39404470|FG000|Overall Study|Other|0|||
16251698|NCT03980483|39404471|FG001|Overall Study|Other|1|||
16362485|NCT02323880|39814914|FG002|Overall Study|Lack of Efficacy|5|||
16362486|NCT02323880|39814915|FG003|Overall Study|Lack of Efficacy|5|||
16362487|NCT02323880|39814916|FG004|Overall Study|Lack of Efficacy|4|||
16362488|NCT02323880|39814917|FG005|Overall Study|Lack of Efficacy|8|||
16362489|NCT02323880|39814918|FG006|Overall Study|Lack of Efficacy|4|||
16362490|NCT02323880|39814919|FG007|Overall Study|Lack of Efficacy|6|||
16134586|NCT02409368|38980359|FG003|ECOG Reclassification|Other Reasons|0|||
16251699|NCT03980483|39404472|FG002|Overall Study|Other|0|||
16251700|NCT03980483|39404473|FG003|Overall Study|Other|0|||
16362491|NCT02323880|39814912|FG000|Overall Study|Physician Decision|0|||
16362492|NCT02323880|39814913|FG001|Overall Study|Physician Decision|0|||
16362493|NCT02323880|39814914|FG002|Overall Study|Physician Decision|0|||
16362494|NCT02323880|39814915|FG003|Overall Study|Physician Decision|0|||
16362495|NCT02323880|39814916|FG004|Overall Study|Physician Decision|1|||
16362496|NCT02323880|39814917|FG005|Overall Study|Physician Decision|1|||
16362497|NCT02323880|39814918|FG006|Overall Study|Physician Decision|1|||
16362498|NCT02323880|39814919|FG007|Overall Study|Physician Decision|0|||
16362499|NCT02323880|39814912|FG000|Overall Study|Withdrawal by Subject|0|||
16362500|NCT02323880|39814913|FG001|Overall Study|Withdrawal by Subject|2|||
16362501|NCT02323880|39814914|FG002|Overall Study|Withdrawal by Subject|0|||
16435042|NCT00308139|40070631|FG001|Overall Study|Investigator Decision|10|||
16435043|NCT00308139|40070630|FG000|Overall Study|Loss of Glucose Control|5|||
16435044|NCT00308139|40070631|FG001|Overall Study|Loss of Glucose Control|7|||
16435045|NCT00308139|40070630|FG000|Overall Study|Administrative|1|||
16435046|NCT00308139|40070631|FG001|Overall Study|Administrative|4|||
16435047|NCT00308139|40070630|FG000|Overall Study|Other|1|||
16435048|NCT00308139|40070631|FG001|Overall Study|Other|0|||
16435049|NCT00412893|40070632|FG000|Overall Study|Adverse Event|31|||
16435050|NCT00412893|40070633|FG001|Overall Study|Adverse Event|53|||
16435051|NCT00412893|40070632|FG000|Overall Study|Death|17|||
16435052|NCT00412893|40070633|FG001|Overall Study|Death|21|||
16435053|NCT00412893|40070632|FG000|Overall Study|Insufficient Therapeutic Response|39|||
16435054|NCT00412893|40070633|FG001|Overall Study|Insufficient Therapeutic Response|23|||
16435055|NCT00412893|40070632|FG000|Overall Study|Lost to Follow-up|2|||
16435056|NCT00412893|40070633|FG001|Overall Study|Lost to Follow-up|1|||
16435057|NCT00412893|40070632|FG000|Overall Study|Violation of Selection at Entry|17|||
16435058|NCT00412893|40070633|FG001|Overall Study|Violation of Selection at Entry|10|||
16435059|NCT00412893|40070632|FG000|Overall Study|Other Protocol Violation|10|||
16435060|NCT00412893|40070633|FG001|Overall Study|Other Protocol Violation|6|||
16435061|NCT00412893|40070632|FG000|Overall Study|Did Not Cooperate|12|||
16435062|NCT00412893|40070633|FG001|Overall Study|Did Not Cooperate|9|||
16435063|NCT00412893|40070632|FG000|Overall Study|Administrative Reason|12|||
16435064|NCT00412893|40070633|FG001|Overall Study|Administrative Reason|15|||
16435065|NCT00412893|40070632|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
16435066|NCT00412893|40070633|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
16435067|NCT00686777|40070634|FG000|Overall Study|Adverse Event|2|||
16435068|NCT00686777|40070634|FG000|Overall Study|Pregnancy|1|||
16435069|NCT00686777|40070634|FG000|Overall Study|Withdrawal by Subject|2|||
16435070|NCT00686777|40070634|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
16435071|NCT00686777|40070634|FG000|Overall Study|No Visit|1|||
16435072|NCT00604565|40070635|FG000|Overall Study|Study terminated|0|||
16435073|NCT00604565|40070636|FG001|Overall Study|Study terminated|3|||
16435074|NCT00844844|40070637|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
16435075|NCT00844844|40070637|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
16435076|NCT00844844|40070637|FG000|Extension Treatment Period|Adverse Event|2|||
16435077|NCT00844844|40070637|FG000|Post Treatment Period|Withdrawal by Subject|1|||
16435078|NCT01367834|40070638|FG000|Overall Study|Withdrawal by Subject|2|||
16435079|NCT01367834|40070639|FG001|Overall Study|Withdrawal by Subject|2|||
16435080|NCT01367834|40070638|FG000|Overall Study|Study was ended.|0|||
16435081|NCT01367834|40070639|FG001|Overall Study|Study was ended.|1|||
16435082|NCT00880698|40070640|FG000|Overall Study|Death|0|||
16435083|NCT00880698|40070641|FG001|Overall Study|Death|0|||
16435084|NCT00880698|40070642|FG002|Overall Study|Death|1|||
16435085|NCT00880698|40070643|FG003|Overall Study|Death|2|||
16435086|NCT00880698|40070640|FG000|Overall Study|Lost to Follow-up|1|||
16435087|NCT00880698|40070641|FG001|Overall Study|Lost to Follow-up|3|||
16435088|NCT00880698|40070642|FG002|Overall Study|Lost to Follow-up|0|||
16435089|NCT00880698|40070643|FG003|Overall Study|Lost to Follow-up|1|||
16251701|NCT03980483|39404474|FG004|Overall Study|Other|0|||
16435090|NCT00148759|40070645|FG000|Overall Study|Withdrawal by Subject|1|||
16435091|NCT00148759|40070646|FG001|Overall Study|Withdrawal by Subject|1|||
16435092|NCT00148759|40070645|FG000|Overall Study|Lost to Follow-up|1|||
16435093|NCT00148759|40070646|FG001|Overall Study|Lost to Follow-up|0|||
16435094|NCT01046565|40070650|FG000|Overall Study|Adverse Event|2|||
16435095|NCT01046565|40070650|FG000|Overall Study|Withdrawal by Subject|7|||
16435096|NCT01076959|40070651|FG000|Overall Study|Adverse Event|767|||
16435097|NCT01076959|40070651|FG000|Overall Study|Lack of Efficacy|849|||
16435098|NCT01076959|40070651|FG000|Overall Study|Non-compliance|274|||
16435099|NCT01076959|40070651|FG000|Overall Study|Lost to Follow-up|241|||
16435100|NCT01076959|40070651|FG000|Overall Study|Other|119|||
16435101|NCT03836625|40070652|FG000|Overall Study|Lost to Follow-up|9|||
16435102|NCT03836625|40070653|FG001|Overall Study|Lost to Follow-up|9|||
16435103|NCT03836625|40070652|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
16435104|NCT03836625|40070653|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
16435105|NCT03836625|40070652|FG000|Overall Study|Death|0|||
16435106|NCT03836625|40070653|FG001|Overall Study|Death|1|||
16435107|NCT03836625|40070652|FG000|Overall Study|Refused follow-up|0|||
16435108|NCT03836625|40070653|FG001|Overall Study|Refused follow-up|1|||
16435109|NCT02313766|40070654|FG000|Overall Study|surgery cancelled|1|||
16435110|NCT02313766|40070655|FG001|Overall Study|surgery cancelled|0|||
16435111|NCT02313766|40070656|FG002|Overall Study|surgery cancelled|0|||
16435112|NCT02313766|40070654|FG000|Overall Study|Lost to Follow-up|0|||
16435113|NCT02313766|40070655|FG001|Overall Study|Lost to Follow-up|2|||
16435114|NCT02313766|40070656|FG002|Overall Study|Lost to Follow-up|0|||
16435115|NCT02313766|40070654|FG000|Overall Study|Adverse Event|0|||
16435116|NCT02313766|40070655|FG001|Overall Study|Adverse Event|1|||
16435117|NCT02313766|40070656|FG002|Overall Study|Adverse Event|0|||
16435118|NCT01602224|40074021|FG000|Overall Study|Adverse Event|0|||
16435119|NCT01602224|40074022|FG001|Overall Study|Adverse Event|1|||
16435120|NCT01602224|40074023|FG002|Overall Study|Adverse Event|0|||
16435121|NCT01602224|40074021|FG000|Overall Study|Investigator Decison|1|||
16435122|NCT01602224|40074022|FG001|Overall Study|Investigator Decison|0|||
16435123|NCT01602224|40074023|FG002|Overall Study|Investigator Decison|0|||
16435124|NCT01602224|40074021|FG000|Overall Study|Lost to Follow-up|0|||
16435125|NCT01602224|40074022|FG001|Overall Study|Lost to Follow-up|0|||
16435126|NCT01602224|40074023|FG002|Overall Study|Lost to Follow-up|1|||
16435127|NCT01602224|40074021|FG000|Overall Study|Protocol Violation|0|||
16435128|NCT01602224|40074022|FG001|Overall Study|Protocol Violation|1|||
16435129|NCT01602224|40074023|FG002|Overall Study|Protocol Violation|0|||
16435130|NCT01602224|40074021|FG000|Overall Study|Sponsor Decision|2|||
16435131|NCT01602224|40074022|FG001|Overall Study|Sponsor Decision|3|||
16435132|NCT01602224|40074023|FG002|Overall Study|Sponsor Decision|2|||
16435133|NCT01602224|40074021|FG000|Overall Study|Withdrawal by Subject|5|||
16435134|NCT01602224|40074022|FG001|Overall Study|Withdrawal by Subject|3|||
16435135|NCT01602224|40074023|FG002|Overall Study|Withdrawal by Subject|3|||
16435136|NCT00395746|40074024|FG000|Overall Study|Adverse Event|5|||
16435137|NCT00395746|40074025|FG001|Overall Study|Adverse Event|2|||
16435138|NCT00395746|40074026|FG002|Overall Study|Adverse Event|2|||
16435139|NCT00395746|40074024|FG000|Overall Study|Protocol Violation|0|||
16435140|NCT00395746|40074025|FG001|Overall Study|Protocol Violation|1|||
16435141|NCT00395746|40074026|FG002|Overall Study|Protocol Violation|0|||
16435142|NCT00395746|40074024|FG000|Overall Study|Lack of Efficacy|2|||
16435143|NCT00395746|40074025|FG001|Overall Study|Lack of Efficacy|0|||
16435144|NCT00395746|40074026|FG002|Overall Study|Lack of Efficacy|17|||
16435145|NCT00395746|40074024|FG000|Overall Study|Hypoglycaemia|2|||
16435146|NCT00395746|40074025|FG001|Overall Study|Hypoglycaemia|1|||
16435147|NCT00395746|40074026|FG002|Overall Study|Hypoglycaemia|0|||
16435148|NCT00395746|40074024|FG000|Overall Study|Subject decision|0|||
16435149|NCT00395746|40074025|FG001|Overall Study|Subject decision|0|||
16435150|NCT00395746|40074026|FG002|Overall Study|Subject decision|1|||
16435151|NCT00395746|40074024|FG000|Overall Study|Withdrawal of consent|0|||
16435152|NCT00395746|40074025|FG001|Overall Study|Withdrawal of consent|0|||
16435153|NCT00395746|40074026|FG002|Overall Study|Withdrawal of consent|1|||
16435154|NCT00395746|40074024|FG000|Overall Study|Difficultulty in use of device|0|||
16435155|NCT00395746|40074025|FG001|Overall Study|Difficultulty in use of device|0|||
16435156|NCT00395746|40074026|FG002|Overall Study|Difficultulty in use of device|1|||
16435157|NCT00395746|40074024|FG000|Overall Study|Unable to visit site on schedule|1|||
16435158|NCT00395746|40074025|FG001|Overall Study|Unable to visit site on schedule|0|||
16435159|NCT00395746|40074026|FG002|Overall Study|Unable to visit site on schedule|0|||
16435160|NCT04737278|40074027|FG000|Overall Study|Lost to Follow-up|1|||
16435161|NCT04737278|40074028|FG001|Overall Study|Lost to Follow-up|1|||
16435162|NCT04737278|40074027|FG000|Overall Study|Withdrawal by Subject|1|||
16435163|NCT04737278|40074028|FG001|Overall Study|Withdrawal by Subject|0|||
16435164|NCT04737278|40074027|FG000|Overall Study|Protocol Violation|1|||
16435165|NCT04737278|40074028|FG001|Overall Study|Protocol Violation|1|||
16435166|NCT04737278|40074027|FG000|Overall Study|failure to complete questionnaire|1|||
16134587|NCT02409368|38980356|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
16134588|NCT02409368|38980357|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
16134589|NCT02409368|38980358|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
16134590|NCT02409368|38980359|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
16362502|NCT02323880|39814915|FG003|Overall Study|Withdrawal by Subject|0|||
16362503|NCT02323880|39814916|FG004|Overall Study|Withdrawal by Subject|0|||
16362504|NCT02323880|39814917|FG005|Overall Study|Withdrawal by Subject|0|||
16362505|NCT02323880|39814918|FG006|Overall Study|Withdrawal by Subject|0|||
16362506|NCT02323880|39814919|FG007|Overall Study|Withdrawal by Subject|0|||
16362507|NCT03595748|39814922|FG000|Overall Study|Death|11|||
16362508|NCT03595748|39814923|FG001|Overall Study|Death|12|||
16362509|NCT03595748|39814922|FG000|Overall Study|Withdrawal by Subject|28|||
16362510|NCT03595748|39814923|FG001|Overall Study|Withdrawal by Subject|29|||
16362511|NCT03595748|39814922|FG000|Overall Study|Protocol Violation|0|||
16362512|NCT03595748|39814923|FG001|Overall Study|Protocol Violation|1|||
16362513|NCT00303953|39814924|FG000|Overall Study|Ineligible|1|||
16362514|NCT00303953|39814924|FG000|Overall Study|Death|1|||
16134591|NCT01127139|38980364|FG000|Overall Study|Adverse Event|40|||
16134592|NCT01127139|38980364|FG000|Overall Study|Incompliance|12|||
16134593|NCT01127139|38980364|FG000|Overall Study|Lack of Efficacy|4|||
16134594|NCT01127139|38980364|FG000|Overall Study|Reason not specified|1|||
16134595|NCT02084056|38980367|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
16134596|NCT02084056|38980368|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16134597|NCT02084056|38980369|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16134598|NCT02084056|38980370|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
16134599|NCT02084056|38980367|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
16134600|NCT02084056|38980368|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16134601|NCT02084056|38980369|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16134602|NCT02084056|38980370|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
16134603|NCT00846391|38980376|FG000|Overall Study|Physician Decision|0|||
16134604|NCT00846391|38980377|FG001|Overall Study|Physician Decision|0|||
16134605|NCT00846391|38980378|FG002|Overall Study|Physician Decision|1|||
16134606|NCT00846391|38980376|FG000|Overall Study|Study Terminated by Sponsor|1|||
16134607|NCT00846391|38980377|FG001|Overall Study|Study Terminated by Sponsor|2|||
16134608|NCT00846391|38980378|FG002|Overall Study|Study Terminated by Sponsor|2|||
16134609|NCT00424385|38980391|FG000|Cohort 0|Withdrawal by Subject|5|||
16134610|NCT00424385|38980391|FG000|Cohort 0|Physician Decision|1|||
16134611|NCT00424385|38980391|FG000|Cohort 1|Withdrawal by Subject|1|||
16134612|NCT03486457|38980396|FG000|Up to Month 3|Adverse Event|2|||
16134613|NCT03486457|38980397|FG001|Up to Month 3|Adverse Event|5|||
16134614|NCT03486457|38980396|FG000|Up to Month 3|Lack of Efficacy|1|||
16134615|NCT03486457|38980397|FG001|Up to Month 3|Lack of Efficacy|0|||
16134616|NCT03486457|38980396|FG000|Up to Month 3|Withdrawal by Subject|1|||
16134617|NCT03486457|38980397|FG001|Up to Month 3|Withdrawal by Subject|0|||
16134618|NCT03486457|38980396|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
16134619|NCT03486457|38980397|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
16134620|NCT03486457|38980396|FG000|Up to Month 3|Other|1|||
16134621|NCT03486457|38980397|FG001|Up to Month 3|Other|0|||
16134622|NCT03486457|38980396|FG000|Month 3 to Month 6|Adverse Event|2|||
16134623|NCT03486457|38980397|FG001|Month 3 to Month 6|Adverse Event|0|||
16134624|NCT03486457|38980396|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
16134625|NCT03486457|38980397|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
16134626|NCT03486457|38980396|FG000|Month 3 to Month 6|Pregnancy|0|||
16134627|NCT03486457|38980397|FG001|Month 3 to Month 6|Pregnancy|1|||
16134628|NCT03486457|38980396|FG000|Month 3 to Month 6|Other|1|||
16134629|NCT03486457|38980397|FG001|Month 3 to Month 6|Other|0|||
16362515|NCT00303953|39814924|FG000|Overall Study|Adverse Event|4|||
16362516|NCT00303953|39814924|FG000|Overall Study|Lack of Efficacy|12|||
16435167|NCT04737278|40074028|FG001|Overall Study|failure to complete questionnaire|1|||
16435168|NCT03935126|40074032|FG000|Overall Study|Study termination by sponsor|3|||
16362517|NCT00303953|39814924|FG000|Overall Study|Physician Decision|1|||
16362518|NCT02188160|39814928|FG000|Overall Study|Adverse Event|1|||
16362519|NCT02188160|39814929|FG001|Overall Study|Adverse Event|0|||
16134630|NCT01211522|38980398|FG000|Overall Study|Withdrawal by Subject|3|||
16134631|NCT01211522|38980399|FG001|Overall Study|Withdrawal by Subject|7|||
16134632|NCT01211522|38980400|FG002|Overall Study|Withdrawal by Subject|5|||
16134633|NCT00966277|38980401|FG000|Overall Study|Withdrawal by Subject|3|||
16134634|NCT00966277|38980402|FG001|Overall Study|Withdrawal by Subject|0|||
16134635|NCT00966277|38980401|FG000|Overall Study|Ineligible|1|||
16134636|NCT00966277|38980402|FG001|Overall Study|Ineligible|3|||
16134637|NCT00966277|38980401|FG000|Overall Study|Treatment Plan Changed|0|||
16134638|NCT00966277|38980402|FG001|Overall Study|Treatment Plan Changed|1|||
16134639|NCT00512317|38980403|FG000|Overall Study|Insufficient clinical response|36|||
16134640|NCT00512317|38980403|FG000|Overall Study|Withdrawal by Subject|23|||
16134641|NCT00512317|38980403|FG000|Overall Study|Sponsor closure of study|21|||
16134642|NCT00512317|38980403|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
16134643|NCT00512317|38980403|FG000|Overall Study|Adverse Event|13|||
16134644|NCT00512317|38980403|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
16134645|NCT00512317|38980403|FG000|Overall Study|Lost to Follow-up|2|||
16134646|NCT00512317|38980403|FG000|Overall Study|Other|2|||
16134647|NCT00642772|38980404|FG000|Overall Study|Lost to Follow-up|3|||
16134648|NCT00642772|38980404|FG000|Overall Study|Withdrawal by Subject|7|||
16134649|NCT04281004|38980407|FG000|Overall Study|Physician Decision|1|||
16362520|NCT02188160|39814928|FG000|Overall Study|Use of an excluded medication|0|||
16362521|NCT02188160|39814929|FG001|Overall Study|Use of an excluded medication|1|||
16362522|NCT00408005|39814937|FG000|Induction|Adverse Event|19|||
16362523|NCT00408005|39814938|FG001|Induction|Adverse Event|3|||
16362524|NCT00408005|39814939|FG002|Induction|Adverse Event|0|||
16362525|NCT00408005|39814940|FG003|Induction|Adverse Event|0|||
16362526|NCT00408005|39814941|FG004|Induction|Adverse Event|0|||
16362527|NCT00408005|39814942|FG005|Induction|Adverse Event|0|||
16134650|NCT04281004|38980408|FG001|Overall Study|Physician Decision|0|||
16134651|NCT01768117|38980409|FG000|Overall Study|Lost to Follow-up|1|||
16134652|NCT01768117|38980409|FG000|Overall Study|Withdrawal by Subject|2|||
16134653|NCT01768117|38980409|FG000|Overall Study|Protocol Violation|3|||
16134654|NCT02795429|38980411|FG000|Overall Study|Adverse Event|1|||
16134655|NCT02795429|38980412|FG001|Overall Study|Adverse Event|2|||
16134656|NCT02795429|38980413|FG002|Overall Study|Adverse Event|1|||
16134657|NCT02795429|38980414|FG003|Overall Study|Adverse Event|2|||
16134658|NCT02795429|38980415|FG004|Overall Study|Adverse Event|1|||
16134659|NCT02795429|38980411|FG000|Overall Study|Death|1|||
16134660|NCT02795429|38980412|FG001|Overall Study|Death|0|||
16134661|NCT02795429|38980413|FG002|Overall Study|Death|1|||
16134662|NCT02795429|38980414|FG003|Overall Study|Death|2|||
16134663|NCT02795429|38980415|FG004|Overall Study|Death|1|||
16134664|NCT02795429|38980411|FG000|Overall Study|Physician Decision|0|||
16134665|NCT02795429|38980412|FG001|Overall Study|Physician Decision|0|||
16134666|NCT02795429|38980413|FG002|Overall Study|Physician Decision|2|||
16134667|NCT02795429|38980414|FG003|Overall Study|Physician Decision|1|||
16362528|NCT00408005|39814943|FG006|Induction|Adverse Event|0|||
16362529|NCT00408005|39814944|FG007|Induction|Adverse Event|0|||
16362530|NCT00408005|39814937|FG000|Induction|Death|6|||
16362531|NCT00408005|39814938|FG001|Induction|Death|0|||
16362532|NCT00408005|39814939|FG002|Induction|Death|0|||
16362533|NCT00408005|39814940|FG003|Induction|Death|0|||
16362534|NCT00408005|39814941|FG004|Induction|Death|0|||
16362535|NCT00408005|39814942|FG005|Induction|Death|0|||
16134668|NCT02795429|38980415|FG004|Overall Study|Physician Decision|5|||
16134669|NCT02795429|38980411|FG000|Overall Study|Progressive disease|3|||
16134670|NCT02795429|38980412|FG001|Overall Study|Progressive disease|7|||
16134671|NCT02795429|38980413|FG002|Overall Study|Progressive disease|6|||
16134672|NCT02795429|38980414|FG003|Overall Study|Progressive disease|26|||
16134673|NCT02795429|38980415|FG004|Overall Study|Progressive disease|20|||
16134674|NCT02795429|38980411|FG000|Overall Study|Subject/guardian decision|1|||
16134675|NCT02795429|38980412|FG001|Overall Study|Subject/guardian decision|1|||
16134676|NCT02795429|38980413|FG002|Overall Study|Subject/guardian decision|1|||
16362536|NCT00408005|39814943|FG006|Induction|Death|0|||
16251702|NCT03980483|39404475|FG005|Overall Study|Other|0|||
16251703|NCT02524379|39404476|FG000|Overall Study|Death|1|||
16251704|NCT01029353|39404477|FG000|Overall Study|Lost to Follow-up|4|||
16251705|NCT01029353|39404478|FG001|Overall Study|Lost to Follow-up|5|||
16251706|NCT01029353|39404479|FG002|Overall Study|Lost to Follow-up|5|||
16251707|NCT01029353|39404480|FG003|Overall Study|Lost to Follow-up|4|||
16251708|NCT01029353|39404477|FG000|Overall Study|Consent Withdrawn|2|||
16251709|NCT01029353|39404478|FG001|Overall Study|Consent Withdrawn|0|||
16251710|NCT01029353|39404479|FG002|Overall Study|Consent Withdrawn|0|||
16251711|NCT01029353|39404480|FG003|Overall Study|Consent Withdrawn|0|||
16251712|NCT01029353|39404477|FG000|Overall Study|Primary Outcome Indeterminate|1|||
16251713|NCT01029353|39404478|FG001|Overall Study|Primary Outcome Indeterminate|3|||
16251714|NCT01029353|39404479|FG002|Overall Study|Primary Outcome Indeterminate|2|||
16251715|NCT01029353|39404480|FG003|Overall Study|Primary Outcome Indeterminate|0|||
16251716|NCT00287118|39404481|FG000|Overall Study|Adverse Event|30|||
16251717|NCT00287118|39404481|FG000|Overall Study|Death|1|||
16251718|NCT00287118|39404481|FG000|Overall Study|Lack of Efficacy|11|||
16251719|NCT00287118|39404481|FG000|Overall Study|Lost to Follow-up|1|||
16251720|NCT00287118|39404481|FG000|Overall Study|Protocol Violation|2|||
16251721|NCT00287118|39404481|FG000|Overall Study|Other|7|||
16251722|NCT00387712|39404482|FG000|Overall Study|Physician Decision|6|||
16251723|NCT00387712|39404483|FG001|Overall Study|Physician Decision|4|||
16435169|NCT02719171|40074033|FG000|Overall Study|Adverse Event|1|||
16134677|NCT02795429|38980414|FG003|Overall Study|Subject/guardian decision|1|||
16251724|NCT00387712|39404482|FG000|Overall Study|Lost to Follow-up|17|||
16251725|NCT00387712|39404483|FG001|Overall Study|Lost to Follow-up|20|||
16251726|NCT00387712|39404482|FG000|Overall Study|Withdrawal by Subject|6|||
16251727|NCT00387712|39404483|FG001|Overall Study|Withdrawal by Subject|12|||
16251728|NCT02153398|39404485|FG000|Overall Study|Withdrawal by Subject|1|||
16251729|NCT02153398|39404486|FG001|Overall Study|Withdrawal by Subject|0|||
16251730|NCT02153398|39404487|FG002|Overall Study|Withdrawal by Subject|0|||
16251731|NCT02153398|39404488|FG003|Overall Study|Withdrawal by Subject|0|||
16251732|NCT02153398|39404489|FG004|Overall Study|Withdrawal by Subject|0|||
16251733|NCT02153398|39404485|FG000|Overall Study|Adverse Event|0|||
16251734|NCT02153398|39404486|FG001|Overall Study|Adverse Event|0|||
16251735|NCT02153398|39404487|FG002|Overall Study|Adverse Event|1|||
16251736|NCT02153398|39404488|FG003|Overall Study|Adverse Event|1|||
16251737|NCT02153398|39404489|FG004|Overall Study|Adverse Event|0|||
16251738|NCT04604184|39404490|FG000|Overall Study|Adverse Event|5|||
16251739|NCT04604184|39404491|FG001|Overall Study|Adverse Event|5|||
16251740|NCT04604184|39404490|FG000|Overall Study|Death|2|||
16251741|NCT04604184|39404491|FG001|Overall Study|Death|1|||
16251742|NCT04604184|39404490|FG000|Overall Study|Withdrawal by Subject|1|||
16251743|NCT04604184|39404491|FG001|Overall Study|Withdrawal by Subject|3|||
16251744|NCT04604184|39404490|FG000|Overall Study|Not treated|2|||
16251745|NCT04604184|39404491|FG001|Overall Study|Not treated|2|||
16251746|NCT04604184|39404490|FG000|Overall Study|Due to sponsor decision|9|||
16251747|NCT04604184|39404491|FG001|Overall Study|Due to sponsor decision|7|||
16251748|NCT04604184|39404490|FG000|Overall Study|Physician Decision|0|||
16251749|NCT04604184|39404491|FG001|Overall Study|Physician Decision|1|||
16251750|NCT04604184|39404490|FG000|Overall Study|Transfer to healthcare|1|||
16251751|NCT04604184|39404491|FG001|Overall Study|Transfer to healthcare|0|||
16251752|NCT01290263|39404495|FG000|Overall Study|Adverse Event|0|||
16251753|NCT01290263|39404496|FG001|Overall Study|Adverse Event|0|||
16251754|NCT01290263|39404497|FG002|Overall Study|Adverse Event|0|||
16251755|NCT01290263|39404498|FG003|Overall Study|Adverse Event|1|||
16251756|NCT01290263|39404499|FG004|Overall Study|Adverse Event|1|||
16251757|NCT01290263|39404495|FG000|Overall Study|Lack of Efficacy|8|||
16251758|NCT01290263|39404496|FG001|Overall Study|Lack of Efficacy|2|||
16251759|NCT01290263|39404497|FG002|Overall Study|Lack of Efficacy|7|||
16251760|NCT01290263|39404498|FG003|Overall Study|Lack of Efficacy|24|||
16251761|NCT01290263|39404499|FG004|Overall Study|Lack of Efficacy|33|||
16251762|NCT01290263|39404495|FG000|Overall Study|Withdrawal by Subject|3|||
16251763|NCT01290263|39404496|FG001|Overall Study|Withdrawal by Subject|1|||
16251764|NCT01290263|39404497|FG002|Overall Study|Withdrawal by Subject|0|||
16251765|NCT01290263|39404498|FG003|Overall Study|Withdrawal by Subject|1|||
16251766|NCT01290263|39404499|FG004|Overall Study|Withdrawal by Subject|2|||
16251767|NCT01290263|39404495|FG000|Overall Study|Participant Non-Compliance|0|||
16251768|NCT01290263|39404496|FG001|Overall Study|Participant Non-Compliance|0|||
16251769|NCT01290263|39404497|FG002|Overall Study|Participant Non-Compliance|0|||
16251770|NCT01290263|39404498|FG003|Overall Study|Participant Non-Compliance|1|||
16251771|NCT01290263|39404499|FG004|Overall Study|Participant Non-Compliance|1|||
16251772|NCT01691859|39404500|FG000|Overall Study|Adverse Event|19|||
16251773|NCT01691859|39404500|FG000|Overall Study|Lack of Efficacy|11|||
16251774|NCT01691859|39404500|FG000|Overall Study|Protocol Violation|4|||
16251775|NCT01691859|39404500|FG000|Overall Study|Product commercially available|221|||
16362537|NCT00408005|39814944|FG007|Induction|Death|0|||
16362538|NCT00408005|39814937|FG000|Induction|Physician Decision|83|||
16362539|NCT00408005|39814938|FG001|Induction|Physician Decision|9|||
16362540|NCT00408005|39814939|FG002|Induction|Physician Decision|0|||
16362541|NCT00408005|39814940|FG003|Induction|Physician Decision|0|||
16362542|NCT00408005|39814941|FG004|Induction|Physician Decision|0|||
16362543|NCT00408005|39814942|FG005|Induction|Physician Decision|0|||
16362544|NCT00408005|39814943|FG006|Induction|Physician Decision|0|||
16362545|NCT00408005|39814944|FG007|Induction|Physician Decision|0|||
16362546|NCT00408005|39814937|FG000|Induction|Withdrawal by Subject|2|||
16362547|NCT00408005|39814938|FG001|Induction|Withdrawal by Subject|4|||
16362548|NCT00408005|39814939|FG002|Induction|Withdrawal by Subject|0|||
16362549|NCT00408005|39814940|FG003|Induction|Withdrawal by Subject|0|||
16362550|NCT00408005|39814941|FG004|Induction|Withdrawal by Subject|0|||
16362551|NCT00408005|39814942|FG005|Induction|Withdrawal by Subject|0|||
16362552|NCT00408005|39814943|FG006|Induction|Withdrawal by Subject|0|||
16362553|NCT00408005|39814944|FG007|Induction|Withdrawal by Subject|0|||
16362554|NCT00408005|39814937|FG000|Induction|Ineligible|33|||
16362555|NCT00408005|39814938|FG001|Induction|Ineligible|14|||
16362556|NCT00408005|39814939|FG002|Induction|Ineligible|0|||
16362557|NCT00408005|39814940|FG003|Induction|Ineligible|0|||
16362558|NCT00408005|39814941|FG004|Induction|Ineligible|0|||
16362559|NCT00408005|39814942|FG005|Induction|Ineligible|0|||
16251776|NCT01691859|39404500|FG000|Overall Study|Study closed/terminated|50|||
16251777|NCT01691859|39404500|FG000|Overall Study|Lost to Follow-up|5|||
16362560|NCT00408005|39814943|FG006|Induction|Ineligible|0|||
16251778|NCT01691859|39404500|FG000|Overall Study|Physician Decision|6|||
16251779|NCT01691859|39404500|FG000|Overall Study|Withdrawal by Subject|31|||
16251780|NCT01725451|39404503|FG000|Period 1|Withdrawal by Subject|1|||
16251781|NCT01725451|39404504|FG001|Period 1|Withdrawal by Subject|0|||
16251782|NCT01725451|39404505|FG002|Period 1|Withdrawal by Subject|0|||
16251783|NCT01725451|39404506|FG003|Period 1|Withdrawal by Subject|0|||
16251784|NCT01725451|39404503|FG000|Washout From Period 3|Protocol Violation|0|||
16251785|NCT01725451|39404504|FG001|Washout From Period 3|Protocol Violation|0|||
16251786|NCT01725451|39404505|FG002|Washout From Period 3|Protocol Violation|1|||
16251787|NCT01725451|39404506|FG003|Washout From Period 3|Protocol Violation|0|||
16251788|NCT01725451|39404503|FG000|Washout From Period 3|Adverse Event|0|||
16251789|NCT01725451|39404504|FG001|Washout From Period 3|Adverse Event|1|||
16251790|NCT01725451|39404505|FG002|Washout From Period 3|Adverse Event|0|||
16251791|NCT01725451|39404506|FG003|Washout From Period 3|Adverse Event|0|||
16251792|NCT01725451|39404503|FG000|Period 4|Adverse Event|0|||
16251793|NCT01725451|39404504|FG001|Period 4|Adverse Event|0|||
16251794|NCT01725451|39404505|FG002|Period 4|Adverse Event|1|||
16251795|NCT01725451|39404506|FG003|Period 4|Adverse Event|0|||
16251796|NCT03361423|39404507|FG000|Overall Study|Withdrawal by Subject|4|||
16251797|NCT03361423|39404508|FG001|Overall Study|Withdrawal by Subject|3|||
16251798|NCT03361423|39404507|FG000|Overall Study|Did not treat|19|||
16251799|NCT03361423|39404508|FG001|Overall Study|Did not treat|18|||
16251800|NCT03361423|39404507|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
16251801|NCT03361423|39404508|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
16251802|NCT03361423|39404507|FG000|Overall Study|Missing data|4|||
16251803|NCT03361423|39404508|FG001|Overall Study|Missing data|1|||
16251804|NCT00958256|39404509|FG000|Overall Study|Adverse Event|3|||
16251805|NCT05200858|39404512|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
16251806|NCT05200858|39404513|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
16251807|NCT05200858|39404514|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
16251808|NCT05200858|39404515|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
16251809|NCT02374918|39404517|FG000|Overall Study|Protocol Violation|2|||
16251810|NCT02374918|39404518|FG001|Overall Study|Protocol Violation|0|||
16251811|NCT02374918|39404519|FG002|Overall Study|Protocol Violation|2|||
16251812|NCT02374918|39404520|FG003|Overall Study|Protocol Violation|1|||
16251813|NCT02374918|39404517|FG000|Overall Study|Withdrawal by Subject|1|||
16251814|NCT02374918|39404518|FG001|Overall Study|Withdrawal by Subject|1|||
16251815|NCT02374918|39404519|FG002|Overall Study|Withdrawal by Subject|1|||
16251816|NCT02374918|39404520|FG003|Overall Study|Withdrawal by Subject|0|||
16251817|NCT02374918|39404517|FG000|Overall Study|Lack of Efficacy|0|||
16251818|NCT02374918|39404518|FG001|Overall Study|Lack of Efficacy|0|||
16251819|NCT02374918|39404519|FG002|Overall Study|Lack of Efficacy|1|||
16251820|NCT02374918|39404520|FG003|Overall Study|Lack of Efficacy|1|||
16362561|NCT00408005|39814944|FG007|Induction|Ineligible|0|||
16362562|NCT00408005|39814937|FG000|Induction|Refusal of Further Protocol Therapy|225|||
16251821|NCT01927757|39404521|FG000|Overall Study|Withdrawal by Subject|14|||
16251822|NCT01927757|39404521|FG000|Overall Study|Lost to Follow-up|2|||
16251823|NCT01927757|39404521|FG000|Overall Study|Decision by Sponsor|2|||
16251824|NCT01927757|39404521|FG000|Overall Study|Other|1|||
16251825|NCT01927757|39404521|FG000|Overall Study|Ethical Reasons|4|||
16251826|NCT04583579|39404523|FG000|Overall Study|Lost to Follow-up|4|||
16251827|NCT00681863|39404524|FG000|Overall Study|Adverse Event|1|||
16251828|NCT00681863|39404524|FG000|Overall Study|Lost to Follow-up|2|||
16251829|NCT00681863|39404524|FG000|Overall Study|Lack of Efficacy|2|||
16251830|NCT00681863|39404524|FG000|Overall Study|Other|18|||
16251831|NCT02236130|39404531|FG000|Overall Study|Lost to Follow-up|7|||
16251832|NCT02236130|39404532|FG001|Overall Study|Lost to Follow-up|12|||
16251833|NCT00278512|39404533|FG000|Overall Study|Death|1|||
16251834|NCT00278512|39404534|FG001|Overall Study|Death|0|||
16251835|NCT00319111|39404535|FG000|Overall Study|Adverse Event|20|||
16251836|NCT00319111|39404535|FG000|Overall Study|Withdrawal of consent|11|||
16251837|NCT00319111|39404535|FG000|Overall Study|Death|9|||
16251838|NCT00319111|39404535|FG000|Overall Study|Lack of clinical improvement|4|||
16251839|NCT00319111|39404535|FG000|Overall Study|Administrative|2|||
16251840|NCT00319111|39404535|FG000|Overall Study|Treatment failure|1|||
16251841|NCT02863575|39404536|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
16251842|NCT02863575|39404537|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
16251843|NCT02863575|39404538|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
16251844|NCT02863575|39404536|FG000|Overall Study|Withdrawal by Subject|0|||
16251845|NCT02863575|39404537|FG001|Overall Study|Withdrawal by Subject|1|||
16251846|NCT02863575|39404538|FG002|Overall Study|Withdrawal by Subject|1|||
16251847|NCT02863575|39404536|FG000|Overall Study|Adverse Event|0|||
16251848|NCT02863575|39404537|FG001|Overall Study|Adverse Event|1|||
16251849|NCT02863575|39404538|FG002|Overall Study|Adverse Event|0|||
16251850|NCT01621490|39404539|FG000|Overall Study|Subject no longer meets study criteria|0|||
16251851|NCT01621490|39404540|FG001|Overall Study|Subject no longer meets study criteria|0|||
16251852|NCT01621490|39404541|FG002|Overall Study|Subject no longer meets study criteria|0|||
16251853|NCT01621490|39404542|FG003|Overall Study|Subject no longer meets study criteria|0|||
16251854|NCT01621490|39404543|FG004|Overall Study|Subject no longer meets study criteria|1|||
16251855|NCT01621490|39404544|FG005|Overall Study|Subject no longer meets study criteria|0|||
16251856|NCT01621490|39404545|FG006|Overall Study|Subject no longer meets study criteria|0|||
16251857|NCT01621490|39404546|FG007|Overall Study|Subject no longer meets study criteria|0|||
16251858|NCT01621490|39404547|FG008|Overall Study|Subject no longer meets study criteria|0|||
16251859|NCT01621490|39404548|FG009|Overall Study|Subject no longer meets study criteria|0|||
16251860|NCT01621490|39404549|FG010|Overall Study|Subject no longer meets study criteria|0|||
16251861|NCT01621490|39404539|FG000|Overall Study|Maximum clinical benefit|3|||
16251862|NCT01621490|39404540|FG001|Overall Study|Maximum clinical benefit|2|||
16251863|NCT01621490|39404541|FG002|Overall Study|Maximum clinical benefit|0|||
16251864|NCT01621490|39404542|FG003|Overall Study|Maximum clinical benefit|0|||
16251865|NCT01621490|39404543|FG004|Overall Study|Maximum clinical benefit|0|||
16251866|NCT01621490|39404544|FG005|Overall Study|Maximum clinical benefit|0|||
16251867|NCT01621490|39404545|FG006|Overall Study|Maximum clinical benefit|1|||
16251868|NCT01621490|39404546|FG007|Overall Study|Maximum clinical benefit|2|||
16251869|NCT01621490|39404547|FG008|Overall Study|Maximum clinical benefit|2|||
16251870|NCT01621490|39404548|FG009|Overall Study|Maximum clinical benefit|0|||
16251871|NCT01621490|39404549|FG010|Overall Study|Maximum clinical benefit|0|||
16251872|NCT01621490|39404539|FG000|Overall Study|Withdrawal by Subject|1|||
16251873|NCT01621490|39404540|FG001|Overall Study|Withdrawal by Subject|0|||
16251874|NCT01621490|39404541|FG002|Overall Study|Withdrawal by Subject|0|||
16251875|NCT01621490|39404542|FG003|Overall Study|Withdrawal by Subject|0|||
16251876|NCT01621490|39404543|FG004|Overall Study|Withdrawal by Subject|0|||
16251877|NCT01621490|39404544|FG005|Overall Study|Withdrawal by Subject|1|||
16251878|NCT01621490|39404545|FG006|Overall Study|Withdrawal by Subject|0|||
16251879|NCT01621490|39404546|FG007|Overall Study|Withdrawal by Subject|0|||
16251880|NCT01621490|39404547|FG008|Overall Study|Withdrawal by Subject|0|||
16251881|NCT01621490|39404548|FG009|Overall Study|Withdrawal by Subject|0|||
16251882|NCT01621490|39404549|FG010|Overall Study|Withdrawal by Subject|0|||
16251883|NCT01621490|39404539|FG000|Overall Study|Subject request to discontinue study|1|||
16251884|NCT01621490|39404540|FG001|Overall Study|Subject request to discontinue study|3|||
16251885|NCT01621490|39404541|FG002|Overall Study|Subject request to discontinue study|1|||
16251886|NCT01621490|39404542|FG003|Overall Study|Subject request to discontinue study|1|||
16251887|NCT01621490|39404543|FG004|Overall Study|Subject request to discontinue study|0|||
16251888|NCT01621490|39404544|FG005|Overall Study|Subject request to discontinue study|2|||
16251889|NCT01621490|39404545|FG006|Overall Study|Subject request to discontinue study|1|||
16251890|NCT01621490|39404546|FG007|Overall Study|Subject request to discontinue study|0|||
16251891|NCT01621490|39404547|FG008|Overall Study|Subject request to discontinue study|1|||
16251892|NCT01621490|39404548|FG009|Overall Study|Subject request to discontinue study|0|||
16251893|NCT01621490|39404549|FG010|Overall Study|Subject request to discontinue study|0|||
16251894|NCT01621490|39404539|FG000|Overall Study|Adverse event unrelated to study drug|1|||
16251895|NCT01621490|39404540|FG001|Overall Study|Adverse event unrelated to study drug|1|||
16251896|NCT01621490|39404541|FG002|Overall Study|Adverse event unrelated to study drug|0|||
16251897|NCT01621490|39404542|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16251898|NCT01621490|39404543|FG004|Overall Study|Adverse event unrelated to study drug|0|||
16251899|NCT01621490|39404544|FG005|Overall Study|Adverse event unrelated to study drug|0|||
16435170|NCT02719171|40074034|FG001|Overall Study|Adverse Event|2|||
16435171|NCT02719171|40074035|FG002|Overall Study|Adverse Event|0|||
16435172|NCT02719171|40074036|FG003|Overall Study|Adverse Event|0|||
16251900|NCT01621490|39404545|FG006|Overall Study|Adverse event unrelated to study drug|0|||
16435173|NCT02719171|40074037|FG004|Overall Study|Adverse Event|2|||
16435174|NCT02719171|40074033|FG000|Overall Study|Lost to Follow-up|0|||
16435175|NCT02719171|40074034|FG001|Overall Study|Lost to Follow-up|0|||
16435176|NCT02719171|40074035|FG002|Overall Study|Lost to Follow-up|1|||
16435177|NCT02719171|40074036|FG003|Overall Study|Lost to Follow-up|0|||
16435178|NCT02719171|40074037|FG004|Overall Study|Lost to Follow-up|0|||
16435179|NCT02719171|40074033|FG000|Overall Study|Subject Withdrawal|0|||
16435180|NCT02719171|40074034|FG001|Overall Study|Subject Withdrawal|2|||
16435181|NCT02719171|40074035|FG002|Overall Study|Subject Withdrawal|2|||
16435182|NCT02719171|40074036|FG003|Overall Study|Subject Withdrawal|1|||
16435183|NCT02719171|40074037|FG004|Overall Study|Subject Withdrawal|0|||
16435184|NCT02719171|40074033|FG000|Overall Study|Other|0|||
16435185|NCT02719171|40074034|FG001|Overall Study|Other|0|||
16435186|NCT02719171|40074035|FG002|Overall Study|Other|0|||
16435187|NCT02719171|40074036|FG003|Overall Study|Other|1|||
16435188|NCT02719171|40074037|FG004|Overall Study|Other|0|||
16435189|NCT03253393|40074038|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
16435190|NCT03253393|40074039|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
16435191|NCT03253393|40074040|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
16435192|NCT02653326|40074041|FG000|Overall Study|Lost to Follow-up|10|||
16435193|NCT02653326|40074042|FG001|Overall Study|Lost to Follow-up|7|||
16435194|NCT00615017|40074045|FG000|Overall Study|Adverse Event|0|||
16435195|NCT00615017|40074046|FG001|Overall Study|Adverse Event|1|||
16435196|NCT00615017|40074047|FG002|Overall Study|Adverse Event|2|||
16435197|NCT00615017|40074048|FG003|Overall Study|Adverse Event|0|||
16435198|NCT00615017|40074049|FG004|Overall Study|Adverse Event|0|||
16435199|NCT00615017|40074050|FG005|Overall Study|Adverse Event|1|||
16435200|NCT00615017|40074045|FG000|Overall Study|Death|0|||
16435201|NCT00615017|40074046|FG001|Overall Study|Death|0|||
16435202|NCT00615017|40074047|FG002|Overall Study|Death|2|||
16435203|NCT00615017|40074048|FG003|Overall Study|Death|0|||
16435204|NCT00615017|40074049|FG004|Overall Study|Death|1|||
16435205|NCT00615017|40074050|FG005|Overall Study|Death|1|||
16435206|NCT00615017|40074045|FG000|Overall Study|Sepsis resolved|0|||
16435207|NCT00615017|40074046|FG001|Overall Study|Sepsis resolved|0|||
16435208|NCT00615017|40074047|FG002|Overall Study|Sepsis resolved|1|||
16435209|NCT00615017|40074048|FG003|Overall Study|Sepsis resolved|0|||
16435210|NCT00615017|40074049|FG004|Overall Study|Sepsis resolved|0|||
16435211|NCT00615017|40074050|FG005|Overall Study|Sepsis resolved|0|||
16435212|NCT00615017|40074045|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
16134678|NCT02795429|38980415|FG004|Overall Study|Subject/guardian decision|3|||
16134679|NCT00372229|38980418|FG000|Study Phase|Graft loss|0|||
16134680|NCT00372229|38980419|FG001|Study Phase|Graft loss|3|||
16134681|NCT00372229|38980418|FG000|Study Phase|Protocol Violation|3|||
16134682|NCT00372229|38980419|FG001|Study Phase|Protocol Violation|4|||
16134683|NCT00372229|38980418|FG000|Study Phase|Consent withdrawn|16|||
16134684|NCT00372229|38980419|FG001|Study Phase|Consent withdrawn|14|||
16134685|NCT00372229|38980418|FG000|Study Phase|Refused treatment/did not cooperate|3|||
16134686|NCT00372229|38980419|FG001|Study Phase|Refused treatment/did not cooperate|1|||
16134687|NCT00372229|38980418|FG000|Study Phase|Death|3|||
16134688|NCT00372229|38980419|FG001|Study Phase|Death|2|||
16134689|NCT00372229|38980418|FG000|Study Phase|Reason not specified|3|||
16134690|NCT00372229|38980419|FG001|Study Phase|Reason not specified|2|||
16134691|NCT00372229|38980418|FG000|Study Phase|Lost to Follow-up|3|||
16134692|NCT00372229|38980419|FG001|Study Phase|Lost to Follow-up|3|||
16251901|NCT01621490|39404546|FG007|Overall Study|Adverse event unrelated to study drug|2|||
16251902|NCT01621490|39404547|FG008|Overall Study|Adverse event unrelated to study drug|0|||
16251903|NCT01621490|39404548|FG009|Overall Study|Adverse event unrelated to study drug|0|||
16251904|NCT01621490|39404549|FG010|Overall Study|Adverse event unrelated to study drug|0|||
16251905|NCT01621490|39404539|FG000|Overall Study|Disease progression|27|||
16251906|NCT01621490|39404540|FG001|Overall Study|Disease progression|28|||
16251907|NCT01621490|39404541|FG002|Overall Study|Disease progression|1|||
16251908|NCT01621490|39404542|FG003|Overall Study|Disease progression|5|||
16251909|NCT01621490|39404543|FG004|Overall Study|Disease progression|3|||
16251910|NCT01621490|39404544|FG005|Overall Study|Disease progression|8|||
16251911|NCT01621490|39404545|FG006|Overall Study|Disease progression|7|||
16435213|NCT00615017|40074046|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
16435214|NCT00615017|40074047|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
16435215|NCT00615017|40074048|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
16435216|NCT00615017|40074049|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
16435217|NCT00615017|40074050|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
16435218|NCT00615017|40074045|FG000|Overall Study|Physician discontinued drug|0|||
16435219|NCT00615017|40074046|FG001|Overall Study|Physician discontinued drug|0|||
16134693|NCT00372229|38980418|FG000|Follow-Up Phase|Graft loss|8|||
16134694|NCT00372229|38980419|FG001|Follow-Up Phase|Graft loss|7|||
16134695|NCT00372229|38980418|FG000|Follow-Up Phase|Consent withdrawn|13|||
16251912|NCT01621490|39404546|FG007|Overall Study|Disease progression|1|||
16251913|NCT01621490|39404547|FG008|Overall Study|Disease progression|4|||
16251914|NCT01621490|39404548|FG009|Overall Study|Disease progression|1|||
16251915|NCT01621490|39404549|FG010|Overall Study|Disease progression|1|||
16251916|NCT01621490|39404539|FG000|Overall Study|Study drug toxicity|1|||
16251917|NCT01621490|39404540|FG001|Overall Study|Study drug toxicity|4|||
16251918|NCT01621490|39404541|FG002|Overall Study|Study drug toxicity|5|||
16251919|NCT01621490|39404542|FG003|Overall Study|Study drug toxicity|3|||
16251920|NCT01621490|39404543|FG004|Overall Study|Study drug toxicity|1|||
16251921|NCT01621490|39404544|FG005|Overall Study|Study drug toxicity|10|||
16251922|NCT01621490|39404545|FG006|Overall Study|Study drug toxicity|1|||
16251923|NCT01621490|39404546|FG007|Overall Study|Study drug toxicity|4|||
16251924|NCT01621490|39404547|FG008|Overall Study|Study drug toxicity|1|||
16251925|NCT01621490|39404548|FG009|Overall Study|Study drug toxicity|0|||
16251926|NCT01621490|39404549|FG010|Overall Study|Study drug toxicity|0|||
16251927|NCT01621490|39404539|FG000|Overall Study|Death|0|||
16251928|NCT01621490|39404540|FG001|Overall Study|Death|0|||
16251929|NCT01621490|39404541|FG002|Overall Study|Death|0|||
16251930|NCT01621490|39404542|FG003|Overall Study|Death|0|||
16251931|NCT01621490|39404543|FG004|Overall Study|Death|0|||
16251932|NCT01621490|39404544|FG005|Overall Study|Death|0|||
16251933|NCT01621490|39404545|FG006|Overall Study|Death|0|||
16251934|NCT01621490|39404546|FG007|Overall Study|Death|0|||
16251935|NCT01621490|39404547|FG008|Overall Study|Death|1|||
16251936|NCT01621490|39404548|FG009|Overall Study|Death|0|||
16251937|NCT01621490|39404549|FG010|Overall Study|Death|0|||
16251938|NCT01621490|39404539|FG000|Overall Study|Other reasons|7|||
16251939|NCT01621490|39404540|FG001|Overall Study|Other reasons|6|||
16251940|NCT01621490|39404541|FG002|Overall Study|Other reasons|4|||
16251941|NCT01621490|39404542|FG003|Overall Study|Other reasons|1|||
16251942|NCT01621490|39404543|FG004|Overall Study|Other reasons|1|||
16251943|NCT01621490|39404544|FG005|Overall Study|Other reasons|3|||
16251944|NCT01621490|39404545|FG006|Overall Study|Other reasons|1|||
16251945|NCT01621490|39404546|FG007|Overall Study|Other reasons|1|||
16251946|NCT01621490|39404547|FG008|Overall Study|Other reasons|1|||
16251947|NCT01621490|39404548|FG009|Overall Study|Other reasons|0|||
16362563|NCT00408005|39814938|FG001|Induction|Refusal of Further Protocol Therapy|44|||
16362564|NCT00408005|39814939|FG002|Induction|Refusal of Further Protocol Therapy|0|||
16362565|NCT00408005|39814940|FG003|Induction|Refusal of Further Protocol Therapy|0|||
16362566|NCT00408005|39814941|FG004|Induction|Refusal of Further Protocol Therapy|0|||
16362567|NCT00408005|39814942|FG005|Induction|Refusal of Further Protocol Therapy|0|||
16362568|NCT00408005|39814943|FG006|Induction|Refusal of Further Protocol Therapy|0|||
16362569|NCT00408005|39814944|FG007|Induction|Refusal of Further Protocol Therapy|0|||
16362570|NCT00408005|39814937|FG000|Induction|Entered another COG therapeutic protocol|4|||
16362571|NCT00408005|39814938|FG001|Induction|Entered another COG therapeutic protocol|0|||
16362572|NCT00408005|39814939|FG002|Induction|Entered another COG therapeutic protocol|0|||
16362573|NCT00408005|39814940|FG003|Induction|Entered another COG therapeutic protocol|0|||
16362574|NCT00408005|39814941|FG004|Induction|Entered another COG therapeutic protocol|0|||
16362575|NCT00408005|39814942|FG005|Induction|Entered another COG therapeutic protocol|0|||
16362576|NCT00408005|39814943|FG006|Induction|Entered another COG therapeutic protocol|0|||
16362577|NCT00408005|39814944|FG007|Induction|Entered another COG therapeutic protocol|0|||
16362578|NCT00408005|39814937|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
16362579|NCT00408005|39814938|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
16362580|NCT00408005|39814939|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
16362581|NCT00408005|39814940|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
16362582|NCT00408005|39814941|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
16362583|NCT00408005|39814942|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
16362584|NCT00408005|39814943|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
16362585|NCT00408005|39814944|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
16362586|NCT00408005|39814937|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
16362587|NCT00408005|39814938|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
16362588|NCT00408005|39814939|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
16362589|NCT00408005|39814940|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
16362590|NCT00408005|39814941|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
16251948|NCT01621490|39404549|FG010|Overall Study|Other reasons|0|||
16251949|NCT01922349|39404550|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
16251950|NCT01922349|39404551|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
16251951|NCT01922349|39404552|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
16251952|NCT01922349|39404553|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
16251953|NCT04041570|39404555|FG000|Overall Study|Moved from Area|0|||
16362591|NCT00408005|39814942|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
16362592|NCT00408005|39814943|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
16251954|NCT04041570|39404556|FG001|Overall Study|Moved from Area|2|||
16251955|NCT02848599|39404559|FG000|Overall Study|Protocol Violation|7|||
16251956|NCT02848599|39404560|FG001|Overall Study|Protocol Violation|9|||
16251957|NCT04099888|39404566|FG000|Overall Study|Study terminated by sponsor|9|||
16251958|NCT04099888|39404567|FG001|Overall Study|Study terminated by sponsor|11|||
16251959|NCT04099888|39404566|FG000|Overall Study|Lost to Follow-up|1|||
16251960|NCT04099888|39404567|FG001|Overall Study|Lost to Follow-up|1|||
16251961|NCT04099888|39404566|FG000|Overall Study|Withdrawal by Subject|5|||
16251962|NCT04099888|39404567|FG001|Overall Study|Withdrawal by Subject|6|||
16251963|NCT04099888|39404566|FG000|Overall Study|Death|5|||
16251964|NCT04099888|39404567|FG001|Overall Study|Death|2|||
16251965|NCT04099888|39404566|FG000|Overall Study|Other|1|||
16251966|NCT04099888|39404567|FG001|Overall Study|Other|0|||
16251967|NCT03267264|39404568|FG000|Overall Study|Withdrawal by Subject|1|||
16251968|NCT03267264|39404569|FG001|Overall Study|Withdrawal by Subject|0|||
16251969|NCT03267264|39404570|FG002|Overall Study|Withdrawal by Subject|2|||
16251970|NCT03267264|39404571|FG003|Overall Study|Withdrawal by Subject|4|||
16251971|NCT02448771|39404574|FG000|Overall Study|Disease Progression|30|||
16251972|NCT02448771|39404574|FG000|Overall Study|Unacceptable Toxicity|1|||
16251973|NCT02448771|39404574|FG000|Overall Study|Physician Decision|3|||
16251974|NCT02448771|39404574|FG000|Overall Study|Started new therapy|2|||
16251975|NCT03276975|39404575|FG000|Overall Study|Withdrawal by Subject|1|||
16251976|NCT03276975|39404576|FG001|Overall Study|Withdrawal by Subject|0|||
16251977|NCT03341507|39404577|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
16251978|NCT02668302|39408499|FG000|Overall Study|Withdrawal by Subject|1|||
16251979|NCT02668302|39408500|FG001|Overall Study|Withdrawal by Subject|0|||
16251980|NCT01054599|39408501|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
16251981|NCT01054599|39408502|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
16251982|NCT01054599|39408501|FG000|Overall Study|Protocol Violation|1|||
16251983|NCT01054599|39408502|FG001|Overall Study|Protocol Violation|0|||
16251984|NCT01054599|39408501|FG000|Overall Study|Spells/seizure-like episodes|1|||
16251985|NCT01054599|39408502|FG001|Overall Study|Spells/seizure-like episodes|1|||
16251986|NCT01054599|39408501|FG000|Overall Study|Timing/scheduling difficulties|1|||
16251987|NCT01054599|39408502|FG001|Overall Study|Timing/scheduling difficulties|1|||
16251988|NCT01054599|39408501|FG000|Overall Study|Visual impairment, WTAR <80|0|||
16251989|NCT01054599|39408502|FG001|Overall Study|Visual impairment, WTAR <80|1|||
16251990|NCT01054599|39408501|FG000|Overall Study|Lost to Follow-up|0|||
16251991|NCT01054599|39408502|FG001|Overall Study|Lost to Follow-up|2|||
16251992|NCT01054599|39408501|FG000|Overall Study|Adverse Event|0|||
16251993|NCT01054599|39408502|FG001|Overall Study|Adverse Event|1|||
16251994|NCT01054599|39408501|FG000|Overall Study|Withdrawal by Subject|0|||
16251995|NCT01054599|39408502|FG001|Overall Study|Withdrawal by Subject|1|||
16251996|NCT01006707|39408503|FG000|Study Session 1|Lost to Follow-up|2|||
16251997|NCT01006707|39408504|FG001|Study Session 1|Lost to Follow-up|0|||
16251998|NCT01006707|39408505|FG002|Study Session 1|Lost to Follow-up|0|||
16251999|NCT01006707|39408503|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
16252000|NCT01006707|39408504|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
16252001|NCT01006707|39408505|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
16252002|NCT04588259|39408518|FG000|Run-in Period|Run-in failure|0|||
16252003|NCT04588259|39408519|FG001|Run-in Period|Run-in failure|23|||
16435220|NCT00615017|40074047|FG002|Overall Study|Physician discontinued drug|0|||
16252004|NCT04588259|39408518|FG000|Run-in Period|Withdrawn before randomisation|0|||
16252005|NCT04588259|39408519|FG001|Run-in Period|Withdrawn before randomisation|8|||
16252006|NCT04588259|39408518|FG000|Treatment Period|Withdrawal by Subject|6|||
16252007|NCT04588259|39408519|FG001|Treatment Period|Withdrawal by Subject|6|||
16252008|NCT03529955|39408521|FG000|Overall Study|Adverse Event|1|||
16252009|NCT03529955|39408521|FG000|Overall Study|Lack of Efficacy|1|||
16252010|NCT01031537|39408525|FG000|Overall Study|medical reasons not related to study|3|||
16435221|NCT00615017|40074048|FG003|Overall Study|Physician discontinued drug|0|||
16252011|NCT01031537|39408525|FG000|Overall Study|Lack of Efficacy|1|||
16252012|NCT01031537|39408525|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
16252013|NCT01031537|39408525|FG000|Overall Study|moved, met exclusion criteria|10|||
16252014|NCT01031537|39408525|FG000|Overall Study|Withdrawal by Subject|5|||
16252015|NCT01031537|39408525|FG000|Overall Study|PI removal, no longer met eligibility|12|||
16252016|NCT02866175|39408526|FG000|Overall Study|Adverse Event|56|||
16252017|NCT02866175|39408527|FG001|Overall Study|Adverse Event|54|||
16252018|NCT02866175|39408526|FG000|Overall Study|Withdrawal by Subject|31|||
16252019|NCT02866175|39408527|FG001|Overall Study|Withdrawal by Subject|52|||
16134696|NCT00372229|38980419|FG001|Follow-Up Phase|Consent withdrawn|19|||
16252020|NCT02866175|39408526|FG000|Overall Study|Death|30|||
16252021|NCT02866175|39408527|FG001|Overall Study|Death|23|||
16252022|NCT02866175|39408526|FG000|Overall Study|Other|7|||
16252023|NCT02866175|39408527|FG001|Overall Study|Other|14|||
16252024|NCT02866175|39408526|FG000|Overall Study|Progressive disease|1|||
16252025|NCT02866175|39408527|FG001|Overall Study|Progressive disease|1|||
16252026|NCT02866175|39408526|FG000|Overall Study|Lost to Follow-up|2|||
16252027|NCT02866175|39408527|FG001|Overall Study|Lost to Follow-up|0|||
16252028|NCT02866175|39408526|FG000|Overall Study|Lack of Efficacy|0|||
16252029|NCT02866175|39408527|FG001|Overall Study|Lack of Efficacy|1|||
16252030|NCT02866175|39408526|FG000|Overall Study|Physician Decision|3|||
16252031|NCT02866175|39408527|FG001|Overall Study|Physician Decision|15|||
16252032|NCT02866175|39408526|FG000|Overall Study|Did not receive treatment|5|||
16252033|NCT02866175|39408527|FG001|Overall Study|Did not receive treatment|15|||
16252034|NCT01325207|39408530|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
16252035|NCT01325207|39408531|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
16252036|NCT01325207|39408532|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
16252037|NCT01325207|39408533|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
16252038|NCT01325207|39408534|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
16252039|NCT01325207|39408535|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
16252040|NCT01325207|39408530|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
16252041|NCT01325207|39408531|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
16134697|NCT00372229|38980418|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
16134698|NCT00372229|38980419|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
16252042|NCT01325207|39408532|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
16252043|NCT01325207|39408533|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
16252044|NCT01325207|39408534|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
16252045|NCT01325207|39408535|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
16252046|NCT01325207|39408530|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
16252047|NCT01325207|39408531|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
16252048|NCT01325207|39408532|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
16252049|NCT01325207|39408533|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
16252050|NCT01325207|39408534|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
16252051|NCT01325207|39408535|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
16252052|NCT01325207|39408530|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
16252053|NCT01325207|39408531|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
16252054|NCT01325207|39408532|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
16252055|NCT01325207|39408533|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
16252056|NCT01325207|39408534|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
16252057|NCT01325207|39408535|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
16252058|NCT01325207|39408530|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
16252059|NCT01325207|39408531|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
16252060|NCT01325207|39408532|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
16252061|NCT01325207|39408533|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
16252062|NCT01325207|39408534|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
16134699|NCT00372229|38980418|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
16252063|NCT01325207|39408535|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
16252064|NCT01325207|39408530|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
16252065|NCT01325207|39408531|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
16252066|NCT01325207|39408532|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
16252067|NCT01325207|39408533|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
16252068|NCT01325207|39408534|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
16252069|NCT01325207|39408535|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
16252070|NCT01325207|39408530|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
16252071|NCT01325207|39408531|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
16252072|NCT01325207|39408532|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
16252073|NCT01325207|39408533|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
16252074|NCT01325207|39408534|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
16252075|NCT01325207|39408535|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
16252076|NCT03222141|39408540|FG000|Overall Study|Death|15|||
16252077|NCT03222141|39408540|FG000|Overall Study|Lost to Follow-up|3|||
16252078|NCT02806232|39408541|FG000|Overall Study|Lost to Follow-up|1|||
16252079|NCT02806232|39408542|FG001|Overall Study|Lost to Follow-up|2|||
16252080|NCT02806232|39408543|FG002|Overall Study|Lost to Follow-up|1|||
16252081|NCT02806232|39408544|FG003|Overall Study|Lost to Follow-up|0|||
16252082|NCT02806232|39408545|FG004|Overall Study|Lost to Follow-up|0|||
16252083|NCT02806232|39408546|FG005|Overall Study|Lost to Follow-up|1|||
16252084|NCT02806232|39408547|FG006|Overall Study|Lost to Follow-up|0|||
16252085|NCT02806232|39408548|FG007|Overall Study|Lost to Follow-up|0|||
16252086|NCT02806232|39408549|FG008|Overall Study|Lost to Follow-up|0|||
16252087|NCT02806232|39408541|FG000|Overall Study|Withdrawal by Subject|0|||
16252088|NCT02806232|39408542|FG001|Overall Study|Withdrawal by Subject|2|||
16252089|NCT02806232|39408543|FG002|Overall Study|Withdrawal by Subject|0|||
16252090|NCT02806232|39408544|FG003|Overall Study|Withdrawal by Subject|0|||
16252091|NCT02806232|39408545|FG004|Overall Study|Withdrawal by Subject|2|||
16252092|NCT02806232|39408546|FG005|Overall Study|Withdrawal by Subject|1|||
16252093|NCT02806232|39408547|FG006|Overall Study|Withdrawal by Subject|0|||
16252094|NCT02806232|39408548|FG007|Overall Study|Withdrawal by Subject|0|||
16252095|NCT02806232|39408549|FG008|Overall Study|Withdrawal by Subject|0|||
16252096|NCT01666730|39408553|FG000|Overall Study|Adverse Event|16|||
16252097|NCT01666730|39408553|FG000|Overall Study|Death|2|||
16252098|NCT01666730|39408553|FG000|Overall Study|Physician Decision|5|||
16252099|NCT01666730|39408553|FG000|Overall Study|Withdrawal by Subject|9|||
16252100|NCT01666730|39408553|FG000|Overall Study|Disease progression/relapse|18|||
16252101|NCT00424489|39408554|FG000|Overall Study|Death|3|||
16252102|NCT00379340|39408555|FG000|Overall Study|Death|0|||
16252103|NCT00379340|39408556|FG001|Overall Study|Death|0|||
16252104|NCT00379340|39408557|FG002|Overall Study|Death|0|||
16252105|NCT00379340|39408558|FG003|Overall Study|Death|2|||
16252106|NCT00379340|39408559|FG004|Overall Study|Death|0|||
16252107|NCT00379340|39408555|FG000|Overall Study|Lack of Efficacy|6|||
16252108|NCT00379340|39408556|FG001|Overall Study|Lack of Efficacy|1|||
16252109|NCT00379340|39408557|FG002|Overall Study|Lack of Efficacy|0|||
16252110|NCT00379340|39408558|FG003|Overall Study|Lack of Efficacy|4|||
16252111|NCT00379340|39408559|FG004|Overall Study|Lack of Efficacy|3|||
16252112|NCT00379340|39408555|FG000|Overall Study|Physician Decision|6|||
16252113|NCT00379340|39408556|FG001|Overall Study|Physician Decision|2|||
16252114|NCT00379340|39408557|FG002|Overall Study|Physician Decision|1|||
16252115|NCT00379340|39408558|FG003|Overall Study|Physician Decision|2|||
16252116|NCT00379340|39408559|FG004|Overall Study|Physician Decision|3|||
16252117|NCT00379340|39408555|FG000|Overall Study|Withdrawal by Subject|0|||
16252118|NCT00379340|39408556|FG001|Overall Study|Withdrawal by Subject|0|||
16252119|NCT00379340|39408557|FG002|Overall Study|Withdrawal by Subject|0|||
16252120|NCT00379340|39408558|FG003|Overall Study|Withdrawal by Subject|1|||
16252121|NCT00379340|39408559|FG004|Overall Study|Withdrawal by Subject|0|||
16252122|NCT00379340|39408555|FG000|Overall Study|Refusal of further protocol therapy|1|||
16252123|NCT00379340|39408556|FG001|Overall Study|Refusal of further protocol therapy|0|||
16252124|NCT00379340|39408557|FG002|Overall Study|Refusal of further protocol therapy|1|||
16252125|NCT00379340|39408558|FG003|Overall Study|Refusal of further protocol therapy|1|||
16252126|NCT00379340|39408559|FG004|Overall Study|Refusal of further protocol therapy|7|||
16252127|NCT00379340|39408555|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
16252128|NCT00379340|39408556|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
16252129|NCT00379340|39408557|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
16252130|NCT00379340|39408558|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
16252131|NCT00379340|39408559|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
16252132|NCT00379340|39408555|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
16252133|NCT00379340|39408556|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
16252134|NCT00379340|39408557|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
16252135|NCT00379340|39408558|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
16252136|NCT00379340|39408559|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
16252137|NCT01513551|39408560|FG000|Overall Study|Death|0|||
16252138|NCT01513551|39408561|FG001|Overall Study|Death|1|||
16252139|NCT01513551|39408562|FG002|Overall Study|Death|0|||
16252140|NCT01513551|39408560|FG000|Overall Study|Lost to Follow-up|3|||
16252141|NCT01513551|39408561|FG001|Overall Study|Lost to Follow-up|5|||
16252142|NCT01513551|39408562|FG002|Overall Study|Lost to Follow-up|2|||
16252143|NCT01513551|39408560|FG000|Overall Study|Withdrawal by Subject|1|||
16252144|NCT01513551|39408561|FG001|Overall Study|Withdrawal by Subject|0|||
16252145|NCT01513551|39408562|FG002|Overall Study|Withdrawal by Subject|2|||
16252146|NCT01513551|39408560|FG000|Overall Study|Randomized but not vaccinated|0|||
16252147|NCT01513551|39408561|FG001|Overall Study|Randomized but not vaccinated|0|||
16252148|NCT01513551|39408562|FG002|Overall Study|Randomized but not vaccinated|1|||
16252149|NCT00818623|39408564|FG000|Overall Study|Adverse Event|1|||
16252150|NCT00818623|39408565|FG001|Overall Study|Adverse Event|0|||
16252151|NCT00818623|39408566|FG002|Overall Study|Adverse Event|1|||
16252152|NCT00818623|39408567|FG003|Overall Study|Adverse Event|0|||
16252153|NCT00818623|39408568|FG004|Overall Study|Adverse Event|0|||
16252154|NCT00818623|39408569|FG005|Overall Study|Adverse Event|1|||
16252155|NCT00818623|39408570|FG006|Overall Study|Adverse Event|0|||
16252156|NCT00818623|39408571|FG007|Overall Study|Adverse Event|0|||
16252157|NCT00818623|39408564|FG000|Overall Study|Bad prostate specific antigen response|0|||
16252158|NCT00818623|39408565|FG001|Overall Study|Bad prostate specific antigen response|3|||
16252159|NCT00818623|39408566|FG002|Overall Study|Bad prostate specific antigen response|2|||
16252160|NCT00818623|39408567|FG003|Overall Study|Bad prostate specific antigen response|5|||
16252161|NCT00818623|39408568|FG004|Overall Study|Bad prostate specific antigen response|0|||
16252162|NCT00818623|39408569|FG005|Overall Study|Bad prostate specific antigen response|1|||
16252163|NCT00818623|39408570|FG006|Overall Study|Bad prostate specific antigen response|0|||
16252164|NCT00818623|39408571|FG007|Overall Study|Bad prostate specific antigen response|0|||
16252165|NCT00818623|39408564|FG000|Overall Study|Withdrawal by Subject|0|||
16252166|NCT00818623|39408565|FG001|Overall Study|Withdrawal by Subject|1|||
16252167|NCT00818623|39408566|FG002|Overall Study|Withdrawal by Subject|1|||
16252168|NCT00818623|39408567|FG003|Overall Study|Withdrawal by Subject|0|||
16252169|NCT00818623|39408568|FG004|Overall Study|Withdrawal by Subject|0|||
16435222|NCT00615017|40074049|FG004|Overall Study|Physician discontinued drug|0|||
16252170|NCT00818623|39408569|FG005|Overall Study|Withdrawal by Subject|1|||
16252171|NCT00818623|39408570|FG006|Overall Study|Withdrawal by Subject|1|||
16252172|NCT00818623|39408571|FG007|Overall Study|Withdrawal by Subject|1|||
16252173|NCT00818623|39408564|FG000|Overall Study|Protocol Violation|1|||
16252174|NCT00818623|39408565|FG001|Overall Study|Protocol Violation|0|||
16252175|NCT00818623|39408566|FG002|Overall Study|Protocol Violation|0|||
16252176|NCT00818623|39408567|FG003|Overall Study|Protocol Violation|0|||
16252177|NCT00818623|39408568|FG004|Overall Study|Protocol Violation|1|||
16252178|NCT00818623|39408569|FG005|Overall Study|Protocol Violation|0|||
16252179|NCT00818623|39408570|FG006|Overall Study|Protocol Violation|1|||
16252180|NCT00818623|39408571|FG007|Overall Study|Protocol Violation|0|||
16252181|NCT00818623|39408564|FG000|Overall Study|Need of additional treatment|0|||
16252182|NCT00818623|39408565|FG001|Overall Study|Need of additional treatment|0|||
16252183|NCT00818623|39408566|FG002|Overall Study|Need of additional treatment|0|||
16252184|NCT00818623|39408567|FG003|Overall Study|Need of additional treatment|0|||
16252185|NCT00818623|39408568|FG004|Overall Study|Need of additional treatment|1|||
16252186|NCT00818623|39408569|FG005|Overall Study|Need of additional treatment|0|||
16252187|NCT00818623|39408570|FG006|Overall Study|Need of additional treatment|0|||
16252188|NCT00818623|39408571|FG007|Overall Study|Need of additional treatment|0|||
16252189|NCT00818623|39408564|FG000|Overall Study|Lack of trial drug at site|0|||
16252190|NCT00818623|39408565|FG001|Overall Study|Lack of trial drug at site|0|||
16252191|NCT00818623|39408566|FG002|Overall Study|Lack of trial drug at site|0|||
16252192|NCT00818623|39408567|FG003|Overall Study|Lack of trial drug at site|0|||
16252193|NCT00818623|39408568|FG004|Overall Study|Lack of trial drug at site|2|||
16252194|NCT00818623|39408569|FG005|Overall Study|Lack of trial drug at site|0|||
16252195|NCT00818623|39408570|FG006|Overall Study|Lack of trial drug at site|1|||
16252196|NCT00818623|39408571|FG007|Overall Study|Lack of trial drug at site|0|||
16252197|NCT00818623|39408564|FG000|Overall Study|Disease progression|0|||
16252198|NCT00818623|39408565|FG001|Overall Study|Disease progression|0|||
16252199|NCT00818623|39408566|FG002|Overall Study|Disease progression|0|||
16252200|NCT00818623|39408567|FG003|Overall Study|Disease progression|0|||
16252201|NCT00818623|39408568|FG004|Overall Study|Disease progression|0|||
16252202|NCT00818623|39408569|FG005|Overall Study|Disease progression|0|||
16252203|NCT00818623|39408570|FG006|Overall Study|Disease progression|1|||
16252204|NCT00818623|39408571|FG007|Overall Study|Disease progression|0|||
16252205|NCT02132247|39408578|FG000|Overall Study|Protocol Violation|1|||
16252206|NCT02132247|39408579|FG001|Overall Study|Protocol Violation|0|||
16252207|NCT01893138|39408580|FG000|Double-Blind Period|Withdrawal by Subject|1|||
16252208|NCT01893138|39408581|FG001|Double-Blind Period|Withdrawal by Subject|1|||
16252209|NCT01893138|39408580|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
16252210|NCT01893138|39408581|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
16252211|NCT01893138|39408580|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
16252212|NCT01893138|39408581|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
16252213|NCT01893138|39408580|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
16252214|NCT01893138|39408581|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
16252215|NCT01893138|39408580|FG000|Open Label - Unblinded Period|Adverse Event|1|||
16252216|NCT01893138|39408581|FG001|Open Label - Unblinded Period|Adverse Event|0|||
16252217|NCT02001558|39408582|FG000|Overall Study|Lost to Follow-up|8|||
16252218|NCT02001558|39408583|FG001|Overall Study|Lost to Follow-up|14|||
16252219|NCT04700449|39408584|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
16252220|NCT04700449|39408585|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
16252221|NCT04700449|39408586|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
16134700|NCT00372229|38980419|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
16134701|NCT00372229|38980418|FG000|Follow-Up Phase|Death|9|||
16134702|NCT00372229|38980419|FG001|Follow-Up Phase|Death|12|||
16134703|NCT00372229|38980418|FG000|Follow-Up Phase|Administrative|1|||
16134704|NCT00372229|38980419|FG001|Follow-Up Phase|Administrative|0|||
16134705|NCT00372229|38980418|FG000|Follow-Up Phase|Reason not specified|2|||
16134706|NCT00372229|38980419|FG001|Follow-Up Phase|Reason not specified|3|||
16134707|NCT00372229|38980418|FG000|Follow-Up Phase|Lost to Follow-up|12|||
16134708|NCT00372229|38980419|FG001|Follow-Up Phase|Lost to Follow-up|10|||
16134709|NCT02958267|38980423|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
16134710|NCT02958267|38980424|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
16134711|NCT02958267|38980423|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
16134712|NCT02958267|38980424|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
16134713|NCT02958267|38980423|FG000|Follow-up Visits|Additional treatment pursued|2|||
16134714|NCT02958267|38980424|FG001|Follow-up Visits|Additional treatment pursued|1|||
16134715|NCT01285609|38980433|FG000|Randomized|Progressive Disease|41|||
16134716|NCT01285609|38980434|FG001|Randomized|Progressive Disease|61|||
16134717|NCT01285609|38980433|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
16134718|NCT01285609|38980434|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
16134719|NCT01285609|38980433|FG000|Randomized|Study Drug Toxicity|13|||
16134720|NCT01285609|38980434|FG001|Randomized|Study Drug Toxicity|14|||
16134721|NCT01285609|38980433|FG000|Randomized|Death|5|||
16134722|NCT01285609|38980434|FG001|Randomized|Death|7|||
16134723|NCT01285609|38980433|FG000|Randomized|Withdrawal by Subject|8|||
16134724|NCT01285609|38980434|FG001|Randomized|Withdrawal by Subject|11|||
16134725|NCT01285609|38980433|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
16134726|NCT01285609|38980434|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
16134727|NCT01285609|38980433|FG000|Randomized|Undisclosed Reasons|1|||
16134728|NCT01285609|38980434|FG001|Randomized|Undisclosed Reasons|0|||
16134729|NCT01285609|38980433|FG000|Randomized|Randomized but not Treated|4|||
16134730|NCT01285609|38980434|FG001|Randomized|Randomized but not Treated|4|||
16134731|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
16134732|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
16134733|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
16134734|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
16134735|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
16134736|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
16134737|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
16134738|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
16134739|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Death|11|||
16134740|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Death|3|||
16134741|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
16134742|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
16134743|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Not Reported|0|||
16134744|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Not Reported|2|||
16134745|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
16134746|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
16134747|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
16134748|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
16134749|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
16134750|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
16134751|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
16134752|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
16134753|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
16134754|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
16435223|NCT00615017|40074050|FG005|Overall Study|Physician discontinued drug|1|||
16134755|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
16134756|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
16134757|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
16134758|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
16134759|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
16134760|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
16134761|NCT01285609|38980433|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
16134762|NCT01285609|38980434|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
16134763|NCT01285609|38980433|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
16134764|NCT01285609|38980434|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
16134765|NCT00381303|38980437|FG000|Overall Study|Lost to Follow-up|25|||
16134766|NCT00381303|38980438|FG001|Overall Study|Lost to Follow-up|9|||
16134767|NCT00381303|38980437|FG000|Overall Study|AE/HIV-related event|22|||
16134768|NCT00381303|38980438|FG001|Overall Study|AE/HIV-related event|6|||
16134769|NCT00381303|38980437|FG000|Overall Study|Non-Adherence|13|||
16134770|NCT00381303|38980438|FG001|Overall Study|Non-Adherence|6|||
16134771|NCT00381303|38980437|FG000|Overall Study|Withdrawal by Subject|13|||
16134772|NCT00381303|38980438|FG001|Overall Study|Withdrawal by Subject|6|||
16134773|NCT00381303|38980437|FG000|Overall Study|Virologic failure|6|||
16134774|NCT00381303|38980438|FG001|Overall Study|Virologic failure|4|||
16134775|NCT00381303|38980437|FG000|Overall Study|Ineligible to continue the trial|2|||
16134776|NCT00381303|38980438|FG001|Overall Study|Ineligible to continue the trial|1|||
16134777|NCT00381303|38980437|FG000|Overall Study|Pregnancy|2|||
16134778|NCT00381303|38980438|FG001|Overall Study|Pregnancy|0|||
16134779|NCT00381303|38980437|FG000|Overall Study|Physician Decision|1|||
16134780|NCT00381303|38980438|FG001|Overall Study|Physician Decision|0|||
16134781|NCT00381303|38980437|FG000|Overall Study|Physician's decision to close the site|3|||
16134782|NCT00381303|38980438|FG001|Overall Study|Physician's decision to close the site|1|||
16134783|NCT00381303|38980437|FG000|Overall Study|Subject moved out of state|2|||
16134784|NCT00381303|38980438|FG001|Overall Study|Subject moved out of state|0|||
16134785|NCT00381303|38980437|FG000|Overall Study|Subject taking too many different meds|1|||
16134786|NCT00381303|38980438|FG001|Overall Study|Subject taking too many different meds|0|||
16134787|NCT00381303|38980437|FG000|Overall Study|No virologic response by week 12|1|||
16134788|NCT00381303|38980438|FG001|Overall Study|No virologic response by week 12|0|||
16134789|NCT00381303|38980437|FG000|Overall Study|Subject was too busy for appointments|1|||
16134790|NCT00381303|38980438|FG001|Overall Study|Subject was too busy for appointments|0|||
16134791|NCT00381303|38980437|FG000|Overall Study|Subject did not continue visits|1|||
16134792|NCT00381303|38980438|FG001|Overall Study|Subject did not continue visits|0|||
16134793|NCT00381303|38980437|FG000|Overall Study|Subject primary physician's decision|1|||
16134794|NCT00381303|38980438|FG001|Overall Study|Subject primary physician's decision|0|||
16134795|NCT02796560|38980439|FG000|Overall Study|Adverse Event|2|||
16134796|NCT02796560|38980440|FG001|Overall Study|Adverse Event|0|||
16134797|NCT02796560|38980439|FG000|Overall Study|Withdrawal by Subject|2|||
16134798|NCT02796560|38980440|FG001|Overall Study|Withdrawal by Subject|2|||
16134799|NCT01442779|38980447|FG000|Overall Study|Withdrawal by Subject|3|||
16134800|NCT01442779|38980447|FG000|Overall Study|Death|3|||
16134801|NCT01442779|38980447|FG000|Overall Study|Non-compliance|1|||
16134802|NCT00343252|38980448|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
16134803|NCT00343252|38980449|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
16134804|NCT00343252|38980448|FG000|6 Months (All Treated Participants)|Death|0|||
16134805|NCT00343252|38980449|FG001|6 Months (All Treated Participants)|Death|2|||
16134806|NCT00343252|38980448|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
16134807|NCT00343252|38980449|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
16134808|NCT00343252|38980448|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
16134809|NCT00343252|38980449|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
16134810|NCT00343252|38980448|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
16134811|NCT00343252|38980449|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
16134812|NCT00343252|38980448|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
16134813|NCT00343252|38980449|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
16134814|NCT00343252|38980448|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
16134815|NCT00343252|38980449|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
16435224|NCT01147666|40074061|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
16435225|NCT01147666|40074062|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
16435226|NCT01147666|40074063|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
16435227|NCT01147666|40074064|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16435228|NCT01147666|40074065|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16435229|NCT01147666|40074066|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16435230|NCT01147666|40074067|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16435231|NCT01147666|40074068|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16435232|NCT01147666|40074069|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16134816|NCT00343252|38980448|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
16134817|NCT00343252|38980449|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
16435233|NCT01147666|40074070|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16435234|NCT01147666|40074071|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16134818|NCT00343252|38980448|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
16134819|NCT00343252|38980449|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
16134820|NCT00343252|38980448|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
16134821|NCT00343252|38980449|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
16134822|NCT00343252|38980448|FG000|12 Months (All Treated Participants)|Death|3|||
16134823|NCT00343252|38980449|FG001|12 Months (All Treated Participants)|Death|3|||
16134824|NCT00343252|38980448|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
16134825|NCT00343252|38980449|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
16134826|NCT00343252|38980448|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
16134827|NCT00343252|38980449|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
16134828|NCT00343252|38980448|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
16134829|NCT00343252|38980449|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
16134830|NCT00343252|38980448|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
16134831|NCT00343252|38980449|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
16134832|NCT00343252|38980448|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
16134833|NCT00343252|38980449|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
16134834|NCT00343252|38980448|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
16134835|NCT00343252|38980449|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
16134836|NCT00343252|38980448|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
16134837|NCT00343252|38980449|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
16134838|NCT00343252|38980448|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
16134839|NCT00343252|38980449|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
16134840|NCT00343252|38980448|FG000|18 Months (All Treated Participants)|Death|4|||
16134841|NCT00343252|38980449|FG001|18 Months (All Treated Participants)|Death|5|||
16134842|NCT00343252|38980448|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
16134843|NCT00343252|38980449|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
16435235|NCT01147666|40074072|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16134844|NCT00343252|38980448|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
16134845|NCT00343252|38980449|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
16134846|NCT00343252|38980448|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
16134847|NCT00343252|38980449|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
16134848|NCT00343252|38980448|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
16134849|NCT00343252|38980449|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
16134850|NCT00343252|38980448|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
16134851|NCT00343252|38980449|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
16134852|NCT00343252|38980448|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
16134853|NCT00343252|38980449|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
16134854|NCT00343252|38980448|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
16134855|NCT00343252|38980449|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
16134856|NCT01347762|38980454|FG000|Overall Study|Lost to Follow-up|0|||
16134857|NCT01347762|38980455|FG001|Overall Study|Lost to Follow-up|1|||
16134858|NCT01347762|38980456|FG002|Overall Study|Lost to Follow-up|6|||
16134859|NCT01347762|38980457|FG003|Overall Study|Lost to Follow-up|5|||
16134860|NCT01347762|38980454|FG000|Overall Study|Withdrawal by Subject|4|||
16134861|NCT01347762|38980455|FG001|Overall Study|Withdrawal by Subject|1|||
16134862|NCT01347762|38980456|FG002|Overall Study|Withdrawal by Subject|3|||
16134863|NCT01347762|38980457|FG003|Overall Study|Withdrawal by Subject|3|||
16134864|NCT01340196|38980458|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
16134865|NCT02966301|38980463|FG000|Overall Study|Death|2|||
16134866|NCT02966301|38980463|FG000|Overall Study|Withdrawal by Subject|1|||
16134867|NCT00593957|38980464|FG000|Overall Study|Physician Decision|0|||
16134868|NCT00593957|38980465|FG001|Overall Study|Physician Decision|1|||
16134869|NCT00593957|38980466|FG002|Overall Study|Physician Decision|2|||
16134870|NCT01403610|38980467|FG000|Overall Study|Withdrawal by Subject|2|||
16134871|NCT01403610|38980468|FG001|Overall Study|Withdrawal by Subject|0|||
16134872|NCT01403610|38980469|FG002|Overall Study|Withdrawal by Subject|0|||
16134873|NCT01403610|38980470|FG003|Overall Study|Withdrawal by Subject|0|||
16134874|NCT01403610|38980467|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
16134875|NCT01403610|38980468|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
16134876|NCT01403610|38980469|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
16134877|NCT01403610|38980470|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
16134878|NCT00711529|38980471|FG000|Overall Study|Protocol Violation|2|||
16134879|NCT00711529|38980472|FG001|Overall Study|Protocol Violation|0|||
16134880|NCT00711529|38980471|FG000|Overall Study|Withdrawal by Subject|2|||
16134881|NCT00711529|38980472|FG001|Overall Study|Withdrawal by Subject|6|||
16435236|NCT01147666|40074073|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
16435237|NCT01147666|40074074|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16435238|NCT01147666|40074075|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
16435239|NCT01147666|40074061|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
16134882|NCT02513745|38980473|FG000|Overall Study|Criteria at time of surgery not met.|3|||
16134883|NCT02513745|38980474|FG001|Overall Study|Criteria at time of surgery not met.|3|||
16134884|NCT00940108|38980477|FG000|Overall Study|Adverse Event|2|||
16134885|NCT00940108|38980478|FG001|Overall Study|Adverse Event|4|||
16134886|NCT00940108|38980479|FG002|Overall Study|Adverse Event|0|||
16134887|NCT00940108|38980480|FG003|Overall Study|Adverse Event|2|||
16134888|NCT00940108|38980477|FG000|Overall Study|Withdrew Consent|2|||
16134889|NCT00940108|38980478|FG001|Overall Study|Withdrew Consent|1|||
16134890|NCT00940108|38980479|FG002|Overall Study|Withdrew Consent|0|||
16134891|NCT00940108|38980480|FG003|Overall Study|Withdrew Consent|1|||
16134892|NCT00940108|38980477|FG000|Overall Study|Dose 2 contraindicated|1|||
16134893|NCT00940108|38980478|FG001|Overall Study|Dose 2 contraindicated|1|||
16134894|NCT00940108|38980479|FG002|Overall Study|Dose 2 contraindicated|0|||
16134895|NCT00940108|38980480|FG003|Overall Study|Dose 2 contraindicated|1|||
16134896|NCT00940108|38980477|FG000|Overall Study|Declined further vaccination|0|||
16134897|NCT00940108|38980478|FG001|Overall Study|Declined further vaccination|1|||
16134898|NCT00940108|38980479|FG002|Overall Study|Declined further vaccination|3|||
16134899|NCT00940108|38980480|FG003|Overall Study|Declined further vaccination|0|||
16134900|NCT00940108|38980477|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
16134901|NCT00940108|38980478|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
16134902|NCT00940108|38980479|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
16134903|NCT00940108|38980480|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
16134904|NCT00940108|38980477|FG000|Overall Study|Viral illness after Dose 1|0|||
16134905|NCT00940108|38980478|FG001|Overall Study|Viral illness after Dose 1|1|||
16134906|NCT00940108|38980479|FG002|Overall Study|Viral illness after Dose 1|0|||
16134907|NCT00940108|38980480|FG003|Overall Study|Viral illness after Dose 1|0|||
16134908|NCT00940108|38980477|FG000|Overall Study|Diagnosed with H1N1|0|||
16435240|NCT01147666|40074062|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
16435241|NCT01147666|40074063|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
16435242|NCT01147666|40074064|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
16435243|NCT01147666|40074065|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
16134909|NCT00940108|38980478|FG001|Overall Study|Diagnosed with H1N1|0|||
16134910|NCT00940108|38980479|FG002|Overall Study|Diagnosed with H1N1|0|||
16134911|NCT00940108|38980480|FG003|Overall Study|Diagnosed with H1N1|1|||
16134912|NCT00400985|38980481|FG000|Overall Study|Withdrawal by Subject|5|||
16134913|NCT00400985|38980481|FG000|Overall Study|system modification|8|||
16134914|NCT00400985|38980481|FG000|Overall Study|Death|30|||
16134915|NCT00400985|38980481|FG000|Overall Study|Lost to Follow-up|9|||
16134916|NCT01919814|38980482|FG000|Overall Study|Adverse Event|1|||
16435244|NCT01147666|40074066|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
16435245|NCT01147666|40074067|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
16435246|NCT01147666|40074068|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
16435247|NCT01147666|40074069|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
16134917|NCT01919814|38980483|FG001|Overall Study|Adverse Event|0|||
16134918|NCT01919814|38980482|FG000|Overall Study|Protocol Violation|1|||
16134919|NCT01919814|38980483|FG001|Overall Study|Protocol Violation|0|||
16134920|NCT01919814|38980482|FG000|Overall Study|Withdrawal by Subject|1|||
16134921|NCT01919814|38980483|FG001|Overall Study|Withdrawal by Subject|0|||
16134922|NCT00232141|38980487|FG000|Overall Study|Adverse Event|9|||
16134923|NCT00232141|38980488|FG001|Overall Study|Adverse Event|4|||
16134924|NCT00232141|38980487|FG000|Overall Study|Lack of Efficacy|0|||
16134925|NCT00232141|38980488|FG001|Overall Study|Lack of Efficacy|3|||
16134926|NCT00232141|38980487|FG000|Overall Study|Lost to Follow-up|9|||
16134927|NCT00232141|38980488|FG001|Overall Study|Lost to Follow-up|6|||
16134928|NCT00232141|38980487|FG000|Overall Study|Other|8|||
16134929|NCT00232141|38980488|FG001|Overall Study|Other|10|||
16134930|NCT00232141|38980487|FG000|Overall Study|Withdrawal by Subject|5|||
16134931|NCT00232141|38980488|FG001|Overall Study|Withdrawal by Subject|3|||
16134932|NCT01098097|38980489|FG000|Overall Study|Adverse Event|17|||
16134933|NCT01098097|38980489|FG000|Overall Study|Lost to Follow-up|18|||
16134934|NCT01098097|38980489|FG000|Overall Study|Status unknown|16|||
16134935|NCT01098097|38980489|FG000|Overall Study|No reason reported|31|||
16134936|NCT00221195|38980493|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
16134937|NCT00221195|38980494|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
16134938|NCT00221195|38980493|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
16134939|NCT00221195|38980494|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
16134940|NCT00221195|38980493|FG000|Washout Period (Months 7-9)|Death|0|||
16134941|NCT00221195|38980494|FG001|Washout Period (Months 7-9)|Death|1|||
16134942|NCT00221195|38980493|FG000|Therapy 2 (Months 10-15)|Death|1|||
16134943|NCT00221195|38980494|FG001|Therapy 2 (Months 10-15)|Death|0|||
16134944|NCT00221195|38980493|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
16134945|NCT00221195|38980494|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
16134946|NCT00250679|38980495|FG000|Overall Study|Adverse Event|12|||
16134947|NCT00250679|38980496|FG001|Overall Study|Adverse Event|15|||
16134948|NCT00250679|38980497|FG002|Overall Study|Adverse Event|16|||
16134949|NCT00250679|38980495|FG000|Overall Study|Protocol Violation|2|||
16134950|NCT00250679|38980496|FG001|Overall Study|Protocol Violation|4|||
16134951|NCT00250679|38980497|FG002|Overall Study|Protocol Violation|3|||
16134952|NCT00250679|38980495|FG000|Overall Study|Withdrawal by Subject|15|||
16134953|NCT00250679|38980496|FG001|Overall Study|Withdrawal by Subject|18|||
16134954|NCT00250679|38980497|FG002|Overall Study|Withdrawal by Subject|15|||
16134955|NCT00250679|38980495|FG000|Overall Study|Lost to Follow-up|3|||
16134956|NCT00250679|38980496|FG001|Overall Study|Lost to Follow-up|4|||
16134957|NCT00250679|38980497|FG002|Overall Study|Lost to Follow-up|2|||
16134958|NCT00250679|38980495|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
16134959|NCT00250679|38980496|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
16134960|NCT00250679|38980497|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
16134961|NCT00250679|38980495|FG000|Overall Study|Lack of Efficacy|0|||
16134962|NCT00250679|38980496|FG001|Overall Study|Lack of Efficacy|1|||
16134963|NCT00250679|38980497|FG002|Overall Study|Lack of Efficacy|3|||
16134964|NCT00250679|38980495|FG000|Overall Study|Technical Holter issues|1|||
16134965|NCT00250679|38980496|FG001|Overall Study|Technical Holter issues|0|||
16134966|NCT00250679|38980497|FG002|Overall Study|Technical Holter issues|2|||
16134967|NCT00250679|38980495|FG000|Overall Study|Moved|1|||
16134968|NCT00250679|38980496|FG001|Overall Study|Moved|1|||
16134969|NCT00250679|38980497|FG002|Overall Study|Moved|0|||
16134970|NCT00250679|38980495|FG000|Overall Study|Non-compliance|1|||
16134971|NCT00250679|38980496|FG001|Overall Study|Non-compliance|1|||
16134972|NCT00250679|38980497|FG002|Overall Study|Non-compliance|0|||
16134973|NCT00250679|38980495|FG000|Overall Study|various single events: hip surgery,diary|3|||
16134974|NCT00250679|38980496|FG001|Overall Study|various single events: hip surgery,diary|1|||
16134975|NCT00250679|38980497|FG002|Overall Study|various single events: hip surgery,diary|1|||
16134976|NCT02245672|38980498|FG000|Overall Study|Adverse Event|4|||
16134977|NCT02245672|38980499|FG001|Overall Study|Adverse Event|4|||
16134978|NCT02245672|38980500|FG002|Overall Study|Adverse Event|4|||
16134979|NCT02245672|38980498|FG000|Overall Study|Lost to Follow-up|3|||
16134980|NCT02245672|38980499|FG001|Overall Study|Lost to Follow-up|5|||
16134981|NCT02245672|38980500|FG002|Overall Study|Lost to Follow-up|1|||
16134982|NCT02245672|38980498|FG000|Overall Study|Withdrawal by Subject|6|||
16134983|NCT02245672|38980499|FG001|Overall Study|Withdrawal by Subject|3|||
16134984|NCT02245672|38980500|FG002|Overall Study|Withdrawal by Subject|0|||
16134985|NCT02245672|38980498|FG000|Overall Study|Randomized in error (not treated)|0|||
16134986|NCT02245672|38980499|FG001|Overall Study|Randomized in error (not treated)|1|||
16134987|NCT02245672|38980500|FG002|Overall Study|Randomized in error (not treated)|0|||
16134988|NCT03435497|38980507|FG000|Overall Study|Lost to Follow-up|1|||
16134989|NCT03435497|38980508|FG001|Overall Study|Lost to Follow-up|0|||
16134990|NCT03435497|38980507|FG000|Overall Study|Death|1|||
16134991|NCT03435497|38980508|FG001|Overall Study|Death|0|||
16134992|NCT03435497|38980507|FG000|Overall Study|Withdrawal by Subject|0|||
16134993|NCT03435497|38980508|FG001|Overall Study|Withdrawal by Subject|4|||
16134994|NCT03435497|38980507|FG000|Overall Study|Wrong survey administered|0|||
16134995|NCT03435497|38980508|FG001|Overall Study|Wrong survey administered|2|||
16134996|NCT01000636|38980509|FG000|Overall Study|Withdrawal by Subject|1|||
16134997|NCT01000636|38980509|FG000|Overall Study|Adverse Event|1|||
16134998|NCT00505284|38980510|FG000|Overall Study|Adverse Event|3|||
16134999|NCT00505284|38980511|FG001|Overall Study|Adverse Event|7|||
16135000|NCT00505284|38980512|FG002|Overall Study|Adverse Event|9|||
16135001|NCT00505284|38980513|FG003|Overall Study|Adverse Event|14|||
16135002|NCT00505284|38980514|FG004|Overall Study|Adverse Event|22|||
16135003|NCT00505284|38980510|FG000|Overall Study|Protocol Violation|0|||
16135004|NCT00505284|38980511|FG001|Overall Study|Protocol Violation|1|||
16135005|NCT00505284|38980512|FG002|Overall Study|Protocol Violation|1|||
16135006|NCT00505284|38980513|FG003|Overall Study|Protocol Violation|0|||
16135007|NCT00505284|38980514|FG004|Overall Study|Protocol Violation|0|||
16135008|NCT00505284|38980510|FG000|Overall Study|Withdrawal by Subject|2|||
16135009|NCT00505284|38980511|FG001|Overall Study|Withdrawal by Subject|6|||
16135010|NCT00505284|38980512|FG002|Overall Study|Withdrawal by Subject|1|||
16135011|NCT00505284|38980513|FG003|Overall Study|Withdrawal by Subject|0|||
16135012|NCT00505284|38980514|FG004|Overall Study|Withdrawal by Subject|6|||
16135013|NCT00505284|38980510|FG000|Overall Study|Lack of Efficacy|0|||
16135014|NCT00505284|38980511|FG001|Overall Study|Lack of Efficacy|1|||
16135015|NCT00505284|38980512|FG002|Overall Study|Lack of Efficacy|1|||
16135016|NCT00505284|38980513|FG003|Overall Study|Lack of Efficacy|1|||
16135017|NCT00505284|38980514|FG004|Overall Study|Lack of Efficacy|1|||
16135018|NCT00505284|38980510|FG000|Overall Study|Physician Decision|0|||
16135019|NCT00505284|38980511|FG001|Overall Study|Physician Decision|1|||
16135020|NCT00505284|38980512|FG002|Overall Study|Physician Decision|0|||
16135021|NCT00505284|38980513|FG003|Overall Study|Physician Decision|0|||
16135022|NCT00505284|38980514|FG004|Overall Study|Physician Decision|0|||
16135023|NCT00505284|38980510|FG000|Overall Study|Other|5|||
16135024|NCT00505284|38980511|FG001|Overall Study|Other|0|||
16135025|NCT00505284|38980512|FG002|Overall Study|Other|0|||
16135026|NCT00505284|38980513|FG003|Overall Study|Other|4|||
16135027|NCT00505284|38980514|FG004|Overall Study|Other|4|||
16135028|NCT01249274|38980517|FG000|Overall Study|Lost to Follow-up|3|||
16135029|NCT01249274|38980518|FG001|Overall Study|Lost to Follow-up|4|||
16135030|NCT01249274|38980517|FG000|Overall Study|Received inpatient substance treatment|1|||
16135031|NCT01249274|38980518|FG001|Overall Study|Received inpatient substance treatment|2|||
16135032|NCT01211288|38980519|FG000|Overall Study|Lost to Follow-up|1|||
16135033|NCT01211288|38980520|FG001|Overall Study|Lost to Follow-up|1|||
16135034|NCT00887432|38980523|FG000|Overall Study|Start Excluded Therapy|3|||
16135035|NCT00887432|38980524|FG001|Overall Study|Start Excluded Therapy|0|||
16135036|NCT00887432|38980523|FG000|Overall Study|Did not complete treatment|6|||
16135037|NCT00887432|38980524|FG001|Overall Study|Did not complete treatment|8|||
16135038|NCT00887432|38980523|FG000|Overall Study|Protocol Violation|2|||
16135039|NCT00887432|38980524|FG001|Overall Study|Protocol Violation|3|||
16135040|NCT00887432|38980523|FG000|Overall Study|Withdrawal by Subject|3|||
16135041|NCT00887432|38980524|FG001|Overall Study|Withdrawal by Subject|2|||
16135042|NCT00887432|38980523|FG000|Overall Study|Lost to Follow-up|1|||
16135043|NCT00887432|38980524|FG001|Overall Study|Lost to Follow-up|0|||
16135044|NCT00887432|38980523|FG000|Overall Study|No reason provided|0|||
16135045|NCT00887432|38980524|FG001|Overall Study|No reason provided|1|||
16135046|NCT01596621|38980527|FG000|Overall Study|Death|4|||
16135047|NCT01596621|38980527|FG000|Overall Study|Withdrawal by Subject|9|||
16135048|NCT01596621|38980527|FG000|Overall Study|Disease Progression|49|||
16135049|NCT01596621|38980527|FG000|Overall Study|Lost to Follow-up|3|||
16135050|NCT01596621|38980527|FG000|Overall Study|Other than specified|13|||
16135051|NCT02752074|38980532|FG000|Overall Study|Lost to Follow-up|1|||
16135052|NCT02752074|38980533|FG001|Overall Study|Lost to Follow-up|4|||
16135053|NCT02752074|38980532|FG000|Overall Study|Death|146|||
16135054|NCT02752074|38980533|FG001|Overall Study|Death|129|||
16135055|NCT02752074|38980532|FG000|Overall Study|Withdrawal by Subject|9|||
16135056|NCT02752074|38980533|FG001|Overall Study|Withdrawal by Subject|10|||
16135057|NCT01036763|38980536|FG000|Overall Study|Adverse Event|25|||
16135058|NCT01036763|38980536|FG000|Overall Study|Lost to Follow-up|28|||
16135059|NCT01036763|38980536|FG000|Overall Study|Other reason (not specified)|40|||
16135060|NCT01054846|38980537|FG000|Overall Study|Lost to Follow-up|76|||
16135061|NCT01054846|38980538|FG001|Overall Study|Lost to Follow-up|17|||
16135062|NCT00881608|38980539|FG000|Overall Study|Study prematurely terminated|11|||
16135063|NCT00753272|38980540|FG000|Overall Study|Adverse Event|878|||
16135064|NCT00753272|38980541|FG001|Overall Study|Adverse Event|869|||
16135065|NCT00753272|38980540|FG000|Overall Study|Protocol Violation|28|||
16135066|NCT00753272|38980541|FG001|Overall Study|Protocol Violation|46|||
16135067|NCT00753272|38980540|FG000|Overall Study|Withdrawal by Subject|2481|||
16135068|NCT00753272|38980541|FG001|Overall Study|Withdrawal by Subject|2407|||
16135069|NCT00753272|38980540|FG000|Overall Study|Lost to Follow-up|491|||
16252222|NCT04700449|39408587|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
16252223|NCT04700449|39408584|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
16252224|NCT04700449|39408585|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
16252225|NCT04700449|39408586|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
16252226|NCT04700449|39408587|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
16252227|NCT04700449|39408584|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
16252228|NCT04700449|39408585|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
16252229|NCT04700449|39408586|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
16252230|NCT04700449|39408587|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
16252231|NCT04700449|39408584|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
16252232|NCT04700449|39408585|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
16252233|NCT04700449|39408586|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
16252234|NCT04700449|39408587|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
16135070|NCT00753272|38980541|FG001|Overall Study|Lost to Follow-up|497|||
16135071|NCT00753272|38980540|FG000|Overall Study|Other|1104|||
16135072|NCT00753272|38980541|FG001|Overall Study|Other|1088|||
16135073|NCT00203476|38980542|FG000|Overall Study|Lost to Follow-up|1|||
16435248|NCT01147666|40074070|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
16135074|NCT00203476|38980543|FG001|Overall Study|Lost to Follow-up|0|||
16135075|NCT00203476|38980544|FG002|Overall Study|Lost to Follow-up|0|||
16135076|NCT00203476|38980542|FG000|Overall Study|Withdrawal by Subject|0|||
16135077|NCT00203476|38980543|FG001|Overall Study|Withdrawal by Subject|1|||
16135078|NCT00203476|38980544|FG002|Overall Study|Withdrawal by Subject|0|||
16135079|NCT00406653|38980545|FG000|Induction Period|Adverse Event|1|||
16135080|NCT00406653|38980546|FG001|Induction Period|Adverse Event|10|||
16135081|NCT00406653|38980547|FG002|Induction Period|Adverse Event|4|||
16135082|NCT00406653|38980548|FG003|Induction Period|Adverse Event|11|||
16135083|NCT00406653|38980549|FG004|Induction Period|Adverse Event|0|||
16135084|NCT00406653|38980550|FG005|Induction Period|Adverse Event|0|||
16135085|NCT00406653|38980551|FG006|Induction Period|Adverse Event|0|||
16135086|NCT00406653|38980545|FG000|Induction Period|Lack of Efficacy|11|||
16252235|NCT04700449|39408584|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
16252236|NCT04700449|39408585|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
16252237|NCT04700449|39408586|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
16252238|NCT04700449|39408587|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
16252239|NCT04700449|39408584|FG000|Stage 1: Double-Blind Period|Other|0|||
16252240|NCT04700449|39408585|FG001|Stage 1: Double-Blind Period|Other|0|||
16252241|NCT04700449|39408586|FG002|Stage 1: Double-Blind Period|Other|1|||
16252242|NCT04700449|39408587|FG003|Stage 1: Double-Blind Period|Other|0|||
16252243|NCT04700449|39408584|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
16135087|NCT00406653|38980546|FG001|Induction Period|Lack of Efficacy|14|||
16135088|NCT00406653|38980547|FG002|Induction Period|Lack of Efficacy|8|||
16135089|NCT00406653|38980548|FG003|Induction Period|Lack of Efficacy|10|||
16135090|NCT00406653|38980549|FG004|Induction Period|Lack of Efficacy|0|||
16435249|NCT01147666|40074071|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
16435250|NCT01147666|40074072|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
16435251|NCT01147666|40074073|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
16435252|NCT01147666|40074074|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
16435253|NCT01147666|40074075|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
16435254|NCT01147666|40074061|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
16435255|NCT01147666|40074062|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
16435256|NCT01147666|40074063|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
16435257|NCT01147666|40074064|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
16435258|NCT01147666|40074065|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
16435259|NCT01147666|40074066|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
16435260|NCT01147666|40074067|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
16135091|NCT00406653|38980550|FG005|Induction Period|Lack of Efficacy|0|||
16135092|NCT00406653|38980551|FG006|Induction Period|Lack of Efficacy|0|||
16135093|NCT00406653|38980545|FG000|Induction Period|Lost to Follow-up|0|||
16135094|NCT00406653|38980546|FG001|Induction Period|Lost to Follow-up|2|||
16135095|NCT00406653|38980547|FG002|Induction Period|Lost to Follow-up|0|||
16135096|NCT00406653|38980548|FG003|Induction Period|Lost to Follow-up|0|||
16135097|NCT00406653|38980549|FG004|Induction Period|Lost to Follow-up|0|||
16135098|NCT00406653|38980550|FG005|Induction Period|Lost to Follow-up|0|||
16135099|NCT00406653|38980551|FG006|Induction Period|Lost to Follow-up|0|||
16135100|NCT00406653|38980545|FG000|Induction Period|Withdrawal of Consent|2|||
16135101|NCT00406653|38980546|FG001|Induction Period|Withdrawal of Consent|5|||
16135102|NCT00406653|38980547|FG002|Induction Period|Withdrawal of Consent|1|||
16135103|NCT00406653|38980548|FG003|Induction Period|Withdrawal of Consent|2|||
16135104|NCT00406653|38980549|FG004|Induction Period|Withdrawal of Consent|0|||
16252244|NCT04700449|39408585|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
16252245|NCT04700449|39408586|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
16252246|NCT04700449|39408587|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
16435261|NCT01147666|40074068|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
16135105|NCT00406653|38980550|FG005|Induction Period|Withdrawal of Consent|0|||
16135106|NCT00406653|38980551|FG006|Induction Period|Withdrawal of Consent|0|||
16135107|NCT00406653|38980545|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
16252247|NCT04700449|39408584|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
16252248|NCT04700449|39408585|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
16252249|NCT04700449|39408586|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
16252250|NCT04700449|39408587|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
16252251|NCT04700449|39408584|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
16252252|NCT04700449|39408585|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
16252253|NCT04700449|39408586|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
16252254|NCT04700449|39408587|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
16252255|NCT04700449|39408584|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
16252256|NCT04700449|39408585|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
16252257|NCT04700449|39408586|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
16252258|NCT04700449|39408587|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
16252259|NCT04700449|39408584|FG000|Stage 2 Sub-study 1|Other|1|||
16252260|NCT04700449|39408585|FG001|Stage 2 Sub-study 1|Other|2|||
16252261|NCT04700449|39408586|FG002|Stage 2 Sub-study 1|Other|0|||
16252262|NCT04700449|39408587|FG003|Stage 2 Sub-study 1|Other|0|||
16252263|NCT04700449|39408584|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
16252264|NCT04700449|39408585|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
16252265|NCT04700449|39408586|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
16252266|NCT04700449|39408587|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
16252267|NCT04700449|39408584|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
16252268|NCT04700449|39408585|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
16252269|NCT04700449|39408586|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
16252270|NCT04700449|39408587|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
16252271|NCT04700449|39408584|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
16252272|NCT04700449|39408585|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
16252273|NCT04700449|39408586|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
16252274|NCT04700449|39408587|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
16252275|NCT04700449|39408584|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
16252276|NCT04700449|39408585|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
16252277|NCT04700449|39408586|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
16252278|NCT04700449|39408587|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
16252279|NCT04700449|39408584|FG000|Stage 2 Sub-study 2|Other|0|||
16252280|NCT04700449|39408585|FG001|Stage 2 Sub-study 2|Other|0|||
16252281|NCT04700449|39408586|FG002|Stage 2 Sub-study 2|Other|0|||
16252282|NCT04700449|39408587|FG003|Stage 2 Sub-study 2|Other|5|||
16252283|NCT02003183|39408589|FG000|Overall Study|Lost to Follow-up|0|||
16252284|NCT02003183|39408590|FG001|Overall Study|Lost to Follow-up|2|||
16252285|NCT03209570|39408593|FG000|Overall Study|Death|1|||
16252286|NCT03209570|39408594|FG001|Overall Study|Death|0|||
16252287|NCT03209570|39408593|FG000|Overall Study|Incomplete Data|8|||
16252288|NCT03209570|39408594|FG001|Overall Study|Incomplete Data|10|||
16252289|NCT03209570|39408593|FG000|Overall Study|Protocol Violation|1|||
16252290|NCT03209570|39408594|FG001|Overall Study|Protocol Violation|0|||
16252291|NCT03209570|39408593|FG000|Overall Study|Withdrawal by Subject|0|||
16252292|NCT03209570|39408594|FG001|Overall Study|Withdrawal by Subject|3|||
16252293|NCT02563522|39408598|FG000|Overall Study|Adverse Event|2|||
16252294|NCT02563522|39408599|FG001|Overall Study|Adverse Event|3|||
16252295|NCT02563522|39408598|FG000|Overall Study|Lost to Follow-up|1|||
16252296|NCT02563522|39408599|FG001|Overall Study|Lost to Follow-up|0|||
16252297|NCT02563522|39408598|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
16252298|NCT02563522|39408599|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
16252299|NCT02532764|39408601|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16252300|NCT02532764|39408602|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16252301|NCT02532764|39408603|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16252302|NCT02532764|39408604|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16252303|NCT02532764|39408605|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16252304|NCT02532764|39408606|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16252305|NCT02532764|39408607|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
16252306|NCT02532764|39408608|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
16252307|NCT02532764|39408609|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
16252308|NCT02532764|39408610|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
16252309|NCT00449150|39408613|FG000|Overall Study|Adverse Event|11|||
16252310|NCT00449150|39408614|FG001|Overall Study|Adverse Event|18|||
16252311|NCT00449150|39408615|FG002|Overall Study|Adverse Event|9|||
16252312|NCT00449150|39408613|FG000|Overall Study|Lack of Efficacy|1|||
16252313|NCT00449150|39408614|FG001|Overall Study|Lack of Efficacy|2|||
16252314|NCT00449150|39408615|FG002|Overall Study|Lack of Efficacy|2|||
16252315|NCT00449150|39408613|FG000|Overall Study|Other|16|||
16252316|NCT00449150|39408614|FG001|Overall Study|Other|13|||
16252317|NCT00449150|39408615|FG002|Overall Study|Other|14|||
16252318|NCT00449150|39408613|FG000|Overall Study|Withdrawal by Subject|17|||
16252319|NCT00449150|39408614|FG001|Overall Study|Withdrawal by Subject|18|||
16252320|NCT00449150|39408615|FG002|Overall Study|Withdrawal by Subject|21|||
16252321|NCT00449150|39408613|FG000|Overall Study|Protocol Violation|1|||
16252322|NCT00449150|39408614|FG001|Overall Study|Protocol Violation|2|||
16252323|NCT00449150|39408615|FG002|Overall Study|Protocol Violation|1|||
16435262|NCT01147666|40074069|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
16435263|NCT01147666|40074070|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
16435264|NCT01147666|40074071|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
16435265|NCT01147666|40074072|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
16435266|NCT01147666|40074073|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
16435267|NCT01147666|40074074|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
16435268|NCT01147666|40074075|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
16435269|NCT01147666|40074061|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
16435270|NCT01147666|40074062|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16435271|NCT01147666|40074063|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16435272|NCT01147666|40074064|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
16435273|NCT01147666|40074065|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16135108|NCT00406653|38980546|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
16135109|NCT00406653|38980547|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
16435274|NCT01147666|40074066|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16435275|NCT01147666|40074067|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16435276|NCT01147666|40074068|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16435277|NCT01147666|40074069|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16435278|NCT01147666|40074070|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16435279|NCT01147666|40074071|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
16435280|NCT01147666|40074072|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16435281|NCT01147666|40074073|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16435282|NCT01147666|40074074|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16135110|NCT00406653|38980548|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
16135111|NCT00406653|38980549|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
16135112|NCT00406653|38980550|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
16135113|NCT00406653|38980551|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
16135114|NCT00406653|38980545|FG000|Induction Period|Pregnancy|1|||
16135115|NCT00406653|38980546|FG001|Induction Period|Pregnancy|0|||
16135116|NCT00406653|38980547|FG002|Induction Period|Pregnancy|0|||
16135117|NCT00406653|38980548|FG003|Induction Period|Pregnancy|0|||
16135118|NCT00406653|38980549|FG004|Induction Period|Pregnancy|0|||
16135119|NCT00406653|38980550|FG005|Induction Period|Pregnancy|0|||
16135120|NCT00406653|38980551|FG006|Induction Period|Pregnancy|0|||
16135121|NCT00406653|38980545|FG000|Induction Period|Declined participation but followup done|0|||
16135122|NCT00406653|38980546|FG001|Induction Period|Declined participation but followup done|2|||
16135123|NCT00406653|38980547|FG002|Induction Period|Declined participation but followup done|1|||
16135124|NCT00406653|38980548|FG003|Induction Period|Declined participation but followup done|1|||
16135125|NCT00406653|38980549|FG004|Induction Period|Declined participation but followup done|0|||
16135126|NCT00406653|38980550|FG005|Induction Period|Declined participation but followup done|0|||
16135127|NCT00406653|38980551|FG006|Induction Period|Declined participation but followup done|0|||
16135128|NCT00406653|38980545|FG000|Induction Period|Given prohibited drug|0|||
16135129|NCT00406653|38980546|FG001|Induction Period|Given prohibited drug|1|||
16135130|NCT00406653|38980547|FG002|Induction Period|Given prohibited drug|2|||
16135131|NCT00406653|38980548|FG003|Induction Period|Given prohibited drug|0|||
16135132|NCT00406653|38980549|FG004|Induction Period|Given prohibited drug|0|||
16135133|NCT00406653|38980550|FG005|Induction Period|Given prohibited drug|0|||
16135134|NCT00406653|38980551|FG006|Induction Period|Given prohibited drug|0|||
16135135|NCT00406653|38980545|FG000|Induction Period|Incarcerated|0|||
16135136|NCT00406653|38980546|FG001|Induction Period|Incarcerated|0|||
16135137|NCT00406653|38980547|FG002|Induction Period|Incarcerated|1|||
16135138|NCT00406653|38980548|FG003|Induction Period|Incarcerated|0|||
16135139|NCT00406653|38980549|FG004|Induction Period|Incarcerated|0|||
16135140|NCT00406653|38980550|FG005|Induction Period|Incarcerated|0|||
16135141|NCT00406653|38980551|FG006|Induction Period|Incarcerated|0|||
16135142|NCT00406653|38980545|FG000|Induction Period|Patient relocated|0|||
16135143|NCT00406653|38980546|FG001|Induction Period|Patient relocated|0|||
16135144|NCT00406653|38980547|FG002|Induction Period|Patient relocated|1|||
16135145|NCT00406653|38980548|FG003|Induction Period|Patient relocated|0|||
16135146|NCT00406653|38980549|FG004|Induction Period|Patient relocated|0|||
16135147|NCT00406653|38980550|FG005|Induction Period|Patient relocated|0|||
16135148|NCT00406653|38980551|FG006|Induction Period|Patient relocated|0|||
16135149|NCT00406653|38980545|FG000|Maintenance Period|Adverse Event|0|||
16135150|NCT00406653|38980546|FG001|Maintenance Period|Adverse Event|0|||
16135151|NCT00406653|38980547|FG002|Maintenance Period|Adverse Event|0|||
16135152|NCT00406653|38980548|FG003|Maintenance Period|Adverse Event|0|||
16135153|NCT00406653|38980549|FG004|Maintenance Period|Adverse Event|1|||
16135154|NCT00406653|38980550|FG005|Maintenance Period|Adverse Event|1|||
16135155|NCT00406653|38980551|FG006|Maintenance Period|Adverse Event|0|||
16135156|NCT00406653|38980545|FG000|Maintenance Period|Lack of Efficacy|0|||
16135157|NCT00406653|38980546|FG001|Maintenance Period|Lack of Efficacy|0|||
16135158|NCT00406653|38980547|FG002|Maintenance Period|Lack of Efficacy|0|||
16135159|NCT00406653|38980548|FG003|Maintenance Period|Lack of Efficacy|0|||
16135160|NCT00406653|38980549|FG004|Maintenance Period|Lack of Efficacy|20|||
16135161|NCT00406653|38980550|FG005|Maintenance Period|Lack of Efficacy|26|||
16135162|NCT00406653|38980551|FG006|Maintenance Period|Lack of Efficacy|0|||
16135163|NCT00406653|38980545|FG000|Maintenance Period|Lost to Follow-up|0|||
16135164|NCT00406653|38980546|FG001|Maintenance Period|Lost to Follow-up|0|||
16135165|NCT00406653|38980547|FG002|Maintenance Period|Lost to Follow-up|0|||
16135166|NCT00406653|38980548|FG003|Maintenance Period|Lost to Follow-up|0|||
16135167|NCT00406653|38980549|FG004|Maintenance Period|Lost to Follow-up|2|||
16135168|NCT00406653|38980550|FG005|Maintenance Period|Lost to Follow-up|1|||
16135169|NCT00406653|38980551|FG006|Maintenance Period|Lost to Follow-up|0|||
16135170|NCT00406653|38980545|FG000|Maintenance Period|Withdrawal of Consent|0|||
16135171|NCT00406653|38980546|FG001|Maintenance Period|Withdrawal of Consent|0|||
16135172|NCT00406653|38980547|FG002|Maintenance Period|Withdrawal of Consent|0|||
16135173|NCT00406653|38980548|FG003|Maintenance Period|Withdrawal of Consent|0|||
16135174|NCT00406653|38980549|FG004|Maintenance Period|Withdrawal of Consent|2|||
16135175|NCT00406653|38980550|FG005|Maintenance Period|Withdrawal of Consent|0|||
16135176|NCT00406653|38980551|FG006|Maintenance Period|Withdrawal of Consent|0|||
16135177|NCT00406653|38980545|FG000|Maintenance Period|Pregnancy|0|||
16135178|NCT00406653|38980546|FG001|Maintenance Period|Pregnancy|0|||
16135179|NCT00406653|38980547|FG002|Maintenance Period|Pregnancy|0|||
16135180|NCT00406653|38980548|FG003|Maintenance Period|Pregnancy|0|||
16135181|NCT00406653|38980549|FG004|Maintenance Period|Pregnancy|0|||
16135182|NCT00406653|38980550|FG005|Maintenance Period|Pregnancy|1|||
16135183|NCT00406653|38980551|FG006|Maintenance Period|Pregnancy|0|||
16135184|NCT00406653|38980545|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
16135185|NCT00406653|38980546|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
16135186|NCT00406653|38980547|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
16135187|NCT00406653|38980548|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
16135188|NCT00406653|38980549|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
16135189|NCT00406653|38980550|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
16135190|NCT00406653|38980551|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
16135191|NCT00406653|38980545|FG000|Maintenance Period|Error in disease score evaluation|0|||
16135192|NCT00406653|38980546|FG001|Maintenance Period|Error in disease score evaluation|0|||
16135193|NCT00406653|38980547|FG002|Maintenance Period|Error in disease score evaluation|0|||
16135194|NCT00406653|38980548|FG003|Maintenance Period|Error in disease score evaluation|0|||
16135195|NCT00406653|38980549|FG004|Maintenance Period|Error in disease score evaluation|1|||
16135196|NCT00406653|38980550|FG005|Maintenance Period|Error in disease score evaluation|0|||
16135197|NCT00406653|38980551|FG006|Maintenance Period|Error in disease score evaluation|0|||
16135198|NCT00406653|38980545|FG000|Open-Label Period|Death|0|||
16135199|NCT00406653|38980546|FG001|Open-Label Period|Death|0|||
16135200|NCT00406653|38980547|FG002|Open-Label Period|Death|0|||
16135201|NCT00406653|38980548|FG003|Open-Label Period|Death|0|||
16135202|NCT00406653|38980549|FG004|Open-Label Period|Death|0|||
16135203|NCT00406653|38980550|FG005|Open-Label Period|Death|0|||
16252324|NCT03247556|39408623|FG000|Overall Study|Adverse Event|1|||
16252325|NCT03247556|39408624|FG001|Overall Study|Adverse Event|4|||
16252326|NCT03247556|39408625|FG002|Overall Study|Adverse Event|5|||
16252327|NCT03247556|39408623|FG000|Overall Study|Lost to Follow-up|5|||
16435283|NCT01147666|40074075|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
16435284|NCT01147666|40074061|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
16435285|NCT01147666|40074062|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
16435286|NCT01147666|40074063|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
16435287|NCT01147666|40074064|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
16252328|NCT03247556|39408624|FG001|Overall Study|Lost to Follow-up|5|||
16362593|NCT00408005|39814944|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
16362594|NCT00408005|39814937|FG000|Induction|Progressive Disease|0|||
16252329|NCT03247556|39408625|FG002|Overall Study|Lost to Follow-up|4|||
16252330|NCT03247556|39408623|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
16252331|NCT03247556|39408624|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
16252332|NCT03247556|39408625|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
16252333|NCT03247556|39408623|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
16252334|NCT03247556|39408624|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
16252335|NCT03247556|39408625|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
16252336|NCT03247556|39408623|FG000|Overall Study|Protocol Violation|2|||
16252337|NCT03247556|39408624|FG001|Overall Study|Protocol Violation|0|||
16252338|NCT03247556|39408625|FG002|Overall Study|Protocol Violation|1|||
16252339|NCT03247556|39408623|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
16252340|NCT03247556|39408624|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
16252341|NCT03247556|39408625|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
16252342|NCT00531206|39408632|FG000|Overall Study|Adverse Event related|5|||
16252343|NCT00531206|39408632|FG000|Overall Study|Lack of Efficacy|2|||
16252344|NCT00531206|39408632|FG000|Overall Study|Lost to Follow-up|5|||
16252345|NCT00531206|39408632|FG000|Overall Study|including non-related adverse events|8|||
16252346|NCT02309099|39408633|FG000|Overall Study|Adverse Event|2|||
16252347|NCT02309099|39408634|FG001|Overall Study|Adverse Event|0|||
16252348|NCT01215942|39408635|FG000|Treatment Period|Adverse Event|15|||
16252349|NCT01215942|39408636|FG001|Treatment Period|Adverse Event|26|||
16252350|NCT01215942|39408635|FG000|Treatment Period|Death|2|||
16252351|NCT01215942|39408636|FG001|Treatment Period|Death|4|||
16252352|NCT01215942|39408635|FG000|Treatment Period|Lack of Efficacy|23|||
16252353|NCT01215942|39408636|FG001|Treatment Period|Lack of Efficacy|62|||
16252354|NCT01215942|39408635|FG000|Treatment Period|Lost to Follow-up|3|||
16252355|NCT01215942|39408636|FG001|Treatment Period|Lost to Follow-up|4|||
16252356|NCT01215942|39408635|FG000|Treatment Period|Withdrawal by Subject|17|||
16362595|NCT00408005|39814938|FG001|Induction|Progressive Disease|1|||
16362596|NCT00408005|39814939|FG002|Induction|Progressive Disease|0|||
16362597|NCT00408005|39814940|FG003|Induction|Progressive Disease|0|||
16362598|NCT00408005|39814941|FG004|Induction|Progressive Disease|0|||
16362599|NCT00408005|39814942|FG005|Induction|Progressive Disease|0|||
16362600|NCT00408005|39814943|FG006|Induction|Progressive Disease|0|||
16135204|NCT00406653|38980551|FG006|Open-Label Period|Death|1|||
16252357|NCT01215942|39408636|FG001|Treatment Period|Withdrawal by Subject|40|||
16252358|NCT01215942|39408635|FG000|Treatment Period|Physician Decision|5|||
16252359|NCT01215942|39408636|FG001|Treatment Period|Physician Decision|5|||
16252360|NCT01215942|39408635|FG000|Treatment Period|Protocol Violation|0|||
16252361|NCT01215942|39408636|FG001|Treatment Period|Protocol Violation|1|||
16362601|NCT00408005|39814944|FG007|Induction|Progressive Disease|0|||
16135205|NCT00406653|38980545|FG000|Open-Label Period|Adverse Event|0|||
16135206|NCT00406653|38980546|FG001|Open-Label Period|Adverse Event|0|||
16135207|NCT00406653|38980547|FG002|Open-Label Period|Adverse Event|0|||
16135208|NCT00406653|38980548|FG003|Open-Label Period|Adverse Event|0|||
16135209|NCT00406653|38980549|FG004|Open-Label Period|Adverse Event|0|||
16135210|NCT00406653|38980550|FG005|Open-Label Period|Adverse Event|0|||
16135211|NCT00406653|38980551|FG006|Open-Label Period|Adverse Event|18|||
16135212|NCT00406653|38980545|FG000|Open-Label Period|Lack of Efficacy|0|||
16135213|NCT00406653|38980546|FG001|Open-Label Period|Lack of Efficacy|0|||
16135214|NCT00406653|38980547|FG002|Open-Label Period|Lack of Efficacy|0|||
16135215|NCT00406653|38980548|FG003|Open-Label Period|Lack of Efficacy|0|||
16135216|NCT00406653|38980549|FG004|Open-Label Period|Lack of Efficacy|0|||
16135217|NCT00406653|38980550|FG005|Open-Label Period|Lack of Efficacy|0|||
16135218|NCT00406653|38980551|FG006|Open-Label Period|Lack of Efficacy|160|||
16135219|NCT00406653|38980545|FG000|Open-Label Period|Lost to Follow-up|0|||
16135220|NCT00406653|38980546|FG001|Open-Label Period|Lost to Follow-up|0|||
16135221|NCT00406653|38980547|FG002|Open-Label Period|Lost to Follow-up|0|||
16135222|NCT00406653|38980548|FG003|Open-Label Period|Lost to Follow-up|0|||
16135223|NCT00406653|38980549|FG004|Open-Label Period|Lost to Follow-up|0|||
16135224|NCT00406653|38980550|FG005|Open-Label Period|Lost to Follow-up|0|||
16135225|NCT00406653|38980551|FG006|Open-Label Period|Lost to Follow-up|6|||
16135226|NCT00406653|38980545|FG000|Open-Label Period|Withdrawal of Consent|0|||
16135227|NCT00406653|38980546|FG001|Open-Label Period|Withdrawal of Consent|0|||
16135228|NCT00406653|38980547|FG002|Open-Label Period|Withdrawal of Consent|0|||
16135229|NCT00406653|38980548|FG003|Open-Label Period|Withdrawal of Consent|0|||
16135230|NCT00406653|38980549|FG004|Open-Label Period|Withdrawal of Consent|0|||
16135231|NCT00406653|38980550|FG005|Open-Label Period|Withdrawal of Consent|0|||
16135232|NCT00406653|38980551|FG006|Open-Label Period|Withdrawal of Consent|11|||
16135233|NCT00406653|38980545|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
16252362|NCT01215942|39408635|FG000|Treatment Period|Sponsor Decision|349|||
16252363|NCT01215942|39408636|FG001|Treatment Period|Sponsor Decision|530|||
16252364|NCT01215942|39408635|FG000|Post-Treatment Follow-Up Period|Death|0|||
16252365|NCT01215942|39408636|FG001|Post-Treatment Follow-Up Period|Death|1|||
16252366|NCT01215942|39408635|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
16252367|NCT01215942|39408636|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
16252368|NCT01215942|39408635|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
16252369|NCT01215942|39408636|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
16252370|NCT01215942|39408635|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
16252371|NCT01215942|39408636|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
16252372|NCT01215942|39408635|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
16252373|NCT01215942|39408636|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
16252374|NCT00337077|39408640|FG000|Overall Study|Progressive disease|25|||
16252375|NCT00337077|39408641|FG001|Overall Study|Progressive disease|37|||
16252376|NCT00337077|39408642|FG002|Overall Study|Progressive disease|19|||
16252377|NCT00337077|39408640|FG000|Overall Study|Adverse Event|7|||
16252378|NCT00337077|39408641|FG001|Overall Study|Adverse Event|7|||
16252379|NCT00337077|39408642|FG002|Overall Study|Adverse Event|1|||
16252380|NCT00337077|39408640|FG000|Overall Study|Death|0|||
16252381|NCT00337077|39408641|FG001|Overall Study|Death|1|||
16252382|NCT00337077|39408642|FG002|Overall Study|Death|0|||
16252383|NCT00337077|39408640|FG000|Overall Study|Withdrawal by Subject|7|||
16252384|NCT00337077|39408641|FG001|Overall Study|Withdrawal by Subject|2|||
16252385|NCT00337077|39408642|FG002|Overall Study|Withdrawal by Subject|2|||
16252386|NCT00337077|39408640|FG000|Overall Study|Alternative therapy|1|||
16252387|NCT00337077|39408641|FG001|Overall Study|Alternative therapy|0|||
16252388|NCT00337077|39408642|FG002|Overall Study|Alternative therapy|0|||
16252389|NCT00337077|39408640|FG000|Overall Study|Physician Decision|1|||
16252390|NCT00337077|39408641|FG001|Overall Study|Physician Decision|4|||
16252391|NCT00337077|39408642|FG002|Overall Study|Physician Decision|2|||
16252392|NCT00337077|39408640|FG000|Overall Study|Never started treatment|1|||
16252393|NCT00337077|39408641|FG001|Overall Study|Never started treatment|1|||
16252394|NCT00337077|39408642|FG002|Overall Study|Never started treatment|0|||
16252395|NCT00337077|39408640|FG000|Overall Study|Ineligible|1|||
16252396|NCT00337077|39408641|FG001|Overall Study|Ineligible|1|||
16252397|NCT00337077|39408642|FG002|Overall Study|Ineligible|1|||
16252398|NCT03775681|39408644|FG000|Overall Study|Physician Decision|3|||
16252399|NCT04149964|39408645|FG000|Overall Study|Lost to Follow-up|19|||
16252400|NCT04149964|39408646|FG001|Overall Study|Lost to Follow-up|18|||
16252401|NCT00135707|39408647|FG000|Overall Study|Lost to Follow-up|94|||
16252402|NCT00135707|39408648|FG001|Overall Study|Lost to Follow-up|89|||
16252403|NCT00135707|39408647|FG000|Overall Study|Withdrawal by Subject|0|||
16252404|NCT00135707|39408648|FG001|Overall Study|Withdrawal by Subject|1|||
16252405|NCT00135707|39408647|FG000|Overall Study|Institutional review board request|1|||
16252406|NCT00135707|39408648|FG001|Overall Study|Institutional review board request|0|||
16252407|NCT03594123|39408649|FG000|Overall Study|Lost to Follow-up|0|||
16252408|NCT03594123|39408650|FG001|Overall Study|Lost to Follow-up|1|||
16252409|NCT03594123|39408649|FG000|Overall Study|Adverse Event|8|||
16252410|NCT03594123|39408650|FG001|Overall Study|Adverse Event|5|||
16252411|NCT03594123|39408649|FG000|Overall Study|Site Terminated by Sponsor|4|||
16252412|NCT03594123|39408650|FG001|Overall Study|Site Terminated by Sponsor|1|||
16252413|NCT03594123|39408649|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
16252414|NCT03594123|39408650|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
16252415|NCT03594123|39408649|FG000|Overall Study|Lack of Efficacy|1|||
16252416|NCT03594123|39408650|FG001|Overall Study|Lack of Efficacy|0|||
16252417|NCT03594123|39408649|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
16252418|NCT03594123|39408650|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
16252419|NCT02324465|39408651|FG000|Overall Study|device failure|0|||
16252420|NCT02324465|39408652|FG001|Overall Study|device failure|1|||
16252421|NCT02130466|39408655|FG000|Overall Study|Death|4|||
16252422|NCT02130466|39408656|FG001|Overall Study|Death|1|||
16252423|NCT02130466|39408657|FG002|Overall Study|Death|1|||
16252424|NCT02130466|39408658|FG003|Overall Study|Death|3|||
16252425|NCT02130466|39408659|FG004|Overall Study|Death|2|||
16252426|NCT02130466|39408660|FG005|Overall Study|Death|30|||
16135234|NCT00406653|38980546|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
16252427|NCT02130466|39408661|FG006|Overall Study|Death|45|||
16252428|NCT02130466|39408662|FG007|Overall Study|Death|2|||
16362602|NCT00408005|39814937|FG000|Induction|Inevaluable|18|||
16135235|NCT00406653|38980547|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
16252429|NCT02130466|39408663|FG008|Overall Study|Death|3|||
16252430|NCT02130466|39408664|FG009|Overall Study|Death|4|||
16252431|NCT02130466|39408665|FG010|Overall Study|Death|5|||
16252432|NCT02130466|39408666|FG011|Overall Study|Death|3|||
16252433|NCT02130466|39408667|FG012|Overall Study|Death|11|||
16252434|NCT02130466|39408668|FG013|Overall Study|Death|7|||
16252435|NCT02130466|39408655|FG000|Overall Study|Lost to Follow-up|1|||
16252436|NCT02130466|39408656|FG001|Overall Study|Lost to Follow-up|0|||
16362603|NCT00408005|39814938|FG001|Induction|Inevaluable|14|||
16252437|NCT02130466|39408657|FG002|Overall Study|Lost to Follow-up|0|||
16252438|NCT02130466|39408658|FG003|Overall Study|Lost to Follow-up|0|||
16252439|NCT02130466|39408659|FG004|Overall Study|Lost to Follow-up|0|||
16252440|NCT02130466|39408660|FG005|Overall Study|Lost to Follow-up|1|||
16252441|NCT02130466|39408661|FG006|Overall Study|Lost to Follow-up|0|||
16252442|NCT02130466|39408662|FG007|Overall Study|Lost to Follow-up|0|||
16252443|NCT02130466|39408663|FG008|Overall Study|Lost to Follow-up|0|||
16252444|NCT02130466|39408664|FG009|Overall Study|Lost to Follow-up|0|||
16252445|NCT02130466|39408665|FG010|Overall Study|Lost to Follow-up|0|||
16252446|NCT02130466|39408666|FG011|Overall Study|Lost to Follow-up|0|||
16252447|NCT02130466|39408667|FG012|Overall Study|Lost to Follow-up|1|||
16252448|NCT02130466|39408668|FG013|Overall Study|Lost to Follow-up|0|||
16252449|NCT02130466|39408655|FG000|Overall Study|Physician Decision|0|||
16252450|NCT02130466|39408656|FG001|Overall Study|Physician Decision|0|||
16252451|NCT02130466|39408657|FG002|Overall Study|Physician Decision|0|||
16252452|NCT02130466|39408658|FG003|Overall Study|Physician Decision|0|||
16252453|NCT02130466|39408659|FG004|Overall Study|Physician Decision|0|||
16252454|NCT02130466|39408660|FG005|Overall Study|Physician Decision|1|||
16252455|NCT02130466|39408661|FG006|Overall Study|Physician Decision|1|||
16252456|NCT02130466|39408662|FG007|Overall Study|Physician Decision|0|||
16252457|NCT02130466|39408663|FG008|Overall Study|Physician Decision|0|||
16252458|NCT02130466|39408664|FG009|Overall Study|Physician Decision|0|||
16252459|NCT02130466|39408665|FG010|Overall Study|Physician Decision|0|||
16252460|NCT02130466|39408666|FG011|Overall Study|Physician Decision|0|||
16252461|NCT02130466|39408667|FG012|Overall Study|Physician Decision|0|||
16252462|NCT02130466|39408668|FG013|Overall Study|Physician Decision|0|||
16252463|NCT02130466|39408655|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
16252464|NCT02130466|39408656|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
16252465|NCT02130466|39408657|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
16252466|NCT02130466|39408658|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
16252467|NCT02130466|39408659|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
16252468|NCT02130466|39408660|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
16252469|NCT02130466|39408661|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
16252470|NCT02130466|39408662|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
16252471|NCT02130466|39408663|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
16252472|NCT02130466|39408664|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
16252473|NCT02130466|39408665|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
16252474|NCT02130466|39408666|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
16252475|NCT02130466|39408667|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
16252476|NCT02130466|39408668|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
16252477|NCT02130466|39408655|FG000|Overall Study|Withdrawal by Subject|1|||
16252478|NCT02130466|39408656|FG001|Overall Study|Withdrawal by Subject|0|||
16252479|NCT02130466|39408657|FG002|Overall Study|Withdrawal by Subject|0|||
16252480|NCT02130466|39408658|FG003|Overall Study|Withdrawal by Subject|0|||
16252481|NCT02130466|39408659|FG004|Overall Study|Withdrawal by Subject|0|||
16252482|NCT02130466|39408660|FG005|Overall Study|Withdrawal by Subject|1|||
16252483|NCT02130466|39408661|FG006|Overall Study|Withdrawal by Subject|0|||
16252484|NCT02130466|39408662|FG007|Overall Study|Withdrawal by Subject|0|||
16252485|NCT02130466|39408663|FG008|Overall Study|Withdrawal by Subject|1|||
16252486|NCT02130466|39408664|FG009|Overall Study|Withdrawal by Subject|0|||
16252487|NCT02130466|39408665|FG010|Overall Study|Withdrawal by Subject|0|||
16252488|NCT02130466|39408666|FG011|Overall Study|Withdrawal by Subject|0|||
16252489|NCT02130466|39408667|FG012|Overall Study|Withdrawal by Subject|0|||
16252490|NCT02130466|39408668|FG013|Overall Study|Withdrawal by Subject|0|||
16252491|NCT00832377|39408669|FG000|Overall Study|Protocol Violation|1|||
16252492|NCT04543136|39408670|FG000|Overall Study|Withdrawal by Subject|0|||
16252493|NCT04543136|39408671|FG001|Overall Study|Withdrawal by Subject|1|||
16362604|NCT00408005|39814939|FG002|Induction|Inevaluable|0|||
16362605|NCT00408005|39814940|FG003|Induction|Inevaluable|0|||
16362606|NCT00408005|39814941|FG004|Induction|Inevaluable|0|||
16362607|NCT00408005|39814942|FG005|Induction|Inevaluable|0|||
16362608|NCT00408005|39814943|FG006|Induction|Inevaluable|0|||
16252494|NCT04543136|39408672|FG002|Overall Study|Withdrawal by Subject|0|||
16252495|NCT04543136|39408673|FG003|Overall Study|Withdrawal by Subject|1|||
16252496|NCT04543136|39408674|FG004|Overall Study|Withdrawal by Subject|0|||
16252497|NCT04543136|39408675|FG005|Overall Study|Withdrawal by Subject|0|||
16252498|NCT01595009|39408676|FG000|Core|Patients completed per protocol|85|||
16252499|NCT01595009|39408677|FG001|Core|Patients completed per protocol|44|||
16252500|NCT01595009|39408678|FG002|Core|Patients completed per protocol|0|||
16252501|NCT01595009|39408679|FG003|Core|Patients completed per protocol|0|||
16252502|NCT01595009|39408676|FG000|Core|Adverse Event|19|||
16252503|NCT01595009|39408677|FG001|Core|Adverse Event|23|||
16252504|NCT01595009|39408678|FG002|Core|Adverse Event|0|||
16252505|NCT01595009|39408679|FG003|Core|Adverse Event|0|||
16362609|NCT00408005|39814944|FG007|Induction|Inevaluable|0|||
16435288|NCT01147666|40074065|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
16135236|NCT00406653|38980548|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
16135237|NCT00406653|38980549|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
16135238|NCT00406653|38980550|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
16135239|NCT00406653|38980551|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
16135240|NCT00406653|38980545|FG000|Open-Label Period|Pregnancy|0|||
16135241|NCT00406653|38980546|FG001|Open-Label Period|Pregnancy|0|||
16135242|NCT00406653|38980547|FG002|Open-Label Period|Pregnancy|0|||
16135243|NCT00406653|38980548|FG003|Open-Label Period|Pregnancy|0|||
16135244|NCT00406653|38980549|FG004|Open-Label Period|Pregnancy|0|||
16135245|NCT00406653|38980550|FG005|Open-Label Period|Pregnancy|0|||
16135246|NCT00406653|38980551|FG006|Open-Label Period|Pregnancy|2|||
16135247|NCT00406653|38980545|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
16135248|NCT00406653|38980546|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
16135249|NCT00406653|38980547|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
16135250|NCT00406653|38980548|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
16135251|NCT00406653|38980549|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
16135252|NCT00406653|38980550|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
16135253|NCT00406653|38980551|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
16135254|NCT00406653|38980545|FG000|Open-Label Period|Declined participation but followup done|0|||
16135255|NCT00406653|38980546|FG001|Open-Label Period|Declined participation but followup done|0|||
16135256|NCT00406653|38980547|FG002|Open-Label Period|Declined participation but followup done|0|||
16135257|NCT00406653|38980548|FG003|Open-Label Period|Declined participation but followup done|0|||
16135258|NCT00406653|38980549|FG004|Open-Label Period|Declined participation but followup done|0|||
16135259|NCT00406653|38980550|FG005|Open-Label Period|Declined participation but followup done|0|||
16135260|NCT00406653|38980551|FG006|Open-Label Period|Declined participation but followup done|8|||
16135261|NCT00406653|38980545|FG000|Open-Label Period|Discontinued by Sponsor|0|||
16135262|NCT00406653|38980546|FG001|Open-Label Period|Discontinued by Sponsor|0|||
16135263|NCT00406653|38980547|FG002|Open-Label Period|Discontinued by Sponsor|0|||
16135264|NCT00406653|38980548|FG003|Open-Label Period|Discontinued by Sponsor|0|||
16135265|NCT00406653|38980549|FG004|Open-Label Period|Discontinued by Sponsor|0|||
16135266|NCT00406653|38980550|FG005|Open-Label Period|Discontinued by Sponsor|0|||
16135267|NCT00406653|38980551|FG006|Open-Label Period|Discontinued by Sponsor|1|||
16135268|NCT00406653|38980545|FG000|Open-Label Period|Refused followup|0|||
16135269|NCT00406653|38980546|FG001|Open-Label Period|Refused followup|0|||
16135270|NCT00406653|38980547|FG002|Open-Label Period|Refused followup|0|||
16135271|NCT00406653|38980548|FG003|Open-Label Period|Refused followup|0|||
16135272|NCT00406653|38980549|FG004|Open-Label Period|Refused followup|0|||
16135273|NCT00406653|38980550|FG005|Open-Label Period|Refused followup|0|||
16135274|NCT00406653|38980551|FG006|Open-Label Period|Refused followup|1|||
16135275|NCT00770341|38980552|FG000|Overall Study|Did not meet eligibility criteria|1|||
16435289|NCT01147666|40074066|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
16435290|NCT01147666|40074067|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
16135276|NCT00770341|38980553|FG001|Overall Study|Did not meet eligibility criteria|0|||
16135277|NCT00770341|38980554|FG002|Overall Study|Did not meet eligibility criteria|0|||
16135278|NCT00770341|38980552|FG000|Overall Study|Withdrawal by Subject|0|||
16135279|NCT00770341|38980553|FG001|Overall Study|Withdrawal by Subject|1|||
16135280|NCT00770341|38980554|FG002|Overall Study|Withdrawal by Subject|0|||
16135281|NCT00770341|38980552|FG000|Overall Study|Clinical Adverse Event|3|||
16135282|NCT00770341|38980553|FG001|Overall Study|Clinical Adverse Event|1|||
16135283|NCT00770341|38980554|FG002|Overall Study|Clinical Adverse Event|2|||
16135284|NCT00770341|38980552|FG000|Overall Study|Laboratory adverse event|3|||
16135285|NCT00770341|38980553|FG001|Overall Study|Laboratory adverse event|3|||
16135286|NCT00770341|38980554|FG002|Overall Study|Laboratory adverse event|0|||
16135287|NCT00770341|38980552|FG000|Overall Study|Lack of Efficacy|3|||
16135288|NCT00770341|38980553|FG001|Overall Study|Lack of Efficacy|0|||
16135289|NCT00770341|38980554|FG002|Overall Study|Lack of Efficacy|1|||
16135290|NCT00770341|38980552|FG000|Overall Study|Other|1|||
16135291|NCT00770341|38980553|FG001|Overall Study|Other|0|||
16135292|NCT00770341|38980554|FG002|Overall Study|Other|0|||
16135293|NCT00770341|38980552|FG000|Overall Study|Not treated|1|||
16135294|NCT00770341|38980553|FG001|Overall Study|Not treated|0|||
16135295|NCT00770341|38980554|FG002|Overall Study|Not treated|0|||
16135296|NCT00743275|38980555|FG000|Overall Study|Protocol Violation|0|||
16135297|NCT00743275|38980556|FG001|Overall Study|Protocol Violation|1|||
16135298|NCT02027701|38980557|FG000|Overall Study|Adverse Event|3|||
16135299|NCT02027701|38980557|FG000|Overall Study|Lack of Efficacy|8|||
16135300|NCT02027701|38980557|FG000|Overall Study|Physician Decision|2|||
16135301|NCT02027701|38980557|FG000|Overall Study|Withdrawal by Subject|3|||
16135302|NCT01444456|38980558|FG000|Overall Study|Withdrawal by Subject|21|||
16135303|NCT01444456|38980558|FG000|Overall Study|Physician Decision|9|||
16135304|NCT01444456|38980558|FG000|Overall Study|Lost to Follow-up|37|||
16135305|NCT01444456|38980558|FG000|Overall Study|Death|73|||
16135306|NCT01444456|38980558|FG000|Overall Study|Ineligibility determined|23|||
16135307|NCT01444456|38980558|FG000|Overall Study|Other|18|||
16135308|NCT01444456|38980558|FG000|Overall Study|Not treated|104|||
16135309|NCT01146054|38980560|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
16135310|NCT01146054|38980560|FG000|Overall Study|Rapid tumor progression|2|||
16135311|NCT01146054|38980560|FG000|Overall Study|Other illness precluded treatment|2|||
16135312|NCT01146054|38980560|FG000|Overall Study|Lost to Follow-up|1|||
16135313|NCT00866723|38980561|FG000|Overall Study|Withdrawal by Subject|1|||
16135314|NCT00866723|38980561|FG000|Overall Study|Disease Progression|4|||
16135315|NCT01177787|38980562|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
16135316|NCT01177787|38980562|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
16135317|NCT01177787|38980562|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
16135318|NCT02499770|38980565|FG000|Overall Study|Death|17|||
16135319|NCT02499770|38980566|FG001|Overall Study|Death|56|||
16135320|NCT02499770|38980565|FG000|Overall Study|Study completion|1|||
16135321|NCT02499770|38980566|FG001|Overall Study|Study completion|10|||
16135322|NCT02499770|38980565|FG000|Overall Study|Withdrawal by Subject|0|||
16135323|NCT02499770|38980566|FG001|Overall Study|Withdrawal by Subject|7|||
16135324|NCT02499770|38980565|FG000|Overall Study|Lost to Follow-up|0|||
16362610|NCT00408005|39814937|FG000|Induction|Failed to Complete Randomization|3|||
16362611|NCT00408005|39814938|FG001|Induction|Failed to Complete Randomization|2|||
16362612|NCT00408005|39814939|FG002|Induction|Failed to Complete Randomization|0|||
16362613|NCT00408005|39814940|FG003|Induction|Failed to Complete Randomization|0|||
16362614|NCT00408005|39814941|FG004|Induction|Failed to Complete Randomization|0|||
16362615|NCT00408005|39814942|FG005|Induction|Failed to Complete Randomization|0|||
16362616|NCT00408005|39814943|FG006|Induction|Failed to Complete Randomization|0|||
16362617|NCT00408005|39814944|FG007|Induction|Failed to Complete Randomization|0|||
16362618|NCT00408005|39814937|FG000|Induction|Protocol Deviation|3|||
16362619|NCT00408005|39814938|FG001|Induction|Protocol Deviation|1|||
16362620|NCT00408005|39814939|FG002|Induction|Protocol Deviation|0|||
16362621|NCT00408005|39814940|FG003|Induction|Protocol Deviation|0|||
16362622|NCT00408005|39814941|FG004|Induction|Protocol Deviation|0|||
16362623|NCT00408005|39814942|FG005|Induction|Protocol Deviation|0|||
16435291|NCT01147666|40074068|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
16435292|NCT01147666|40074069|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
16435293|NCT01147666|40074070|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
16435294|NCT01147666|40074071|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
16435295|NCT01147666|40074072|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
16435296|NCT01147666|40074073|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
16435297|NCT01147666|40074074|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
16135325|NCT02499770|38980566|FG001|Overall Study|Lost to Follow-up|2|||
16135326|NCT02499770|38980565|FG000|Overall Study|Subject declined further treatment|1|||
16135327|NCT02499770|38980566|FG001|Overall Study|Subject declined further treatment|0|||
16135328|NCT02499770|38980565|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
16135329|NCT02499770|38980566|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
16435298|NCT01147666|40074075|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
16135330|NCT02499770|38980565|FG000|Overall Study|Randomized but not enrolled|0|||
16135331|NCT02499770|38980566|FG001|Overall Study|Randomized but not enrolled|1|||
16435299|NCT01147666|40074061|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435300|NCT01147666|40074062|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435301|NCT01147666|40074063|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435302|NCT01147666|40074064|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
16435303|NCT01147666|40074065|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435304|NCT01147666|40074066|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435305|NCT01147666|40074067|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435306|NCT01147666|40074068|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435307|NCT01147666|40074069|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435308|NCT01147666|40074070|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435309|NCT01147666|40074071|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
16435310|NCT01147666|40074072|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435311|NCT01147666|40074073|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435312|NCT01147666|40074074|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435313|NCT01147666|40074075|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
16435314|NCT01147666|40074061|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435315|NCT01147666|40074062|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435316|NCT01147666|40074063|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435317|NCT01147666|40074064|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435318|NCT01147666|40074065|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435319|NCT01147666|40074066|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435320|NCT01147666|40074067|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435321|NCT01147666|40074068|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435322|NCT01147666|40074069|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16135332|NCT04751656|38980568|FG000|Overall Study|Lost to Follow-up|1|||
16135333|NCT00757588|38980569|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
16135334|NCT00757588|38980570|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
16135335|NCT00757588|38980569|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
16135336|NCT00757588|38980570|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
16135337|NCT00757588|38980569|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
16435323|NCT01147666|40074070|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435324|NCT01147666|40074071|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435325|NCT01147666|40074072|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
16435326|NCT01147666|40074073|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
16435327|NCT01147666|40074074|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
16435328|NCT01147666|40074075|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
16435329|NCT01147666|40074061|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
16435330|NCT01147666|40074062|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
16435331|NCT01147666|40074063|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
16435332|NCT01147666|40074064|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
16435333|NCT01147666|40074065|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
16435334|NCT01147666|40074066|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
16435335|NCT01147666|40074067|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
16435336|NCT01147666|40074068|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
16435337|NCT01147666|40074069|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
16435338|NCT01147666|40074070|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
16435339|NCT01147666|40074071|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
16435340|NCT01147666|40074072|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
16435341|NCT01147666|40074073|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
16435342|NCT01147666|40074074|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
16435343|NCT01147666|40074075|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
16435344|NCT01147666|40074061|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
16435345|NCT01147666|40074062|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
16435346|NCT01147666|40074063|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
16135338|NCT00757588|38980570|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
16135339|NCT00757588|38980569|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
16135340|NCT00757588|38980570|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
16135341|NCT00757588|38980569|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
16135342|NCT00757588|38980570|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
16135343|NCT00757588|38980569|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
16135344|NCT00757588|38980570|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
16135345|NCT00757588|38980569|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
16135346|NCT00757588|38980570|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
16135347|NCT00757588|38980569|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
16135348|NCT00757588|38980570|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
16135349|NCT00757588|38980569|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
16435347|NCT01147666|40074064|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
16435348|NCT01147666|40074065|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
16435349|NCT01147666|40074066|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
16435350|NCT01147666|40074067|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
16435351|NCT01147666|40074068|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
16435352|NCT01147666|40074069|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
16435353|NCT01147666|40074070|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
16435354|NCT01147666|40074071|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
16435355|NCT01147666|40074072|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
16435356|NCT01147666|40074073|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
16435357|NCT01147666|40074074|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
16435358|NCT01147666|40074075|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
16435359|NCT01147666|40074061|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435360|NCT01147666|40074062|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435361|NCT01147666|40074063|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435362|NCT01147666|40074064|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
16435363|NCT01147666|40074065|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435364|NCT01147666|40074066|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16135350|NCT00757588|38980570|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
16135351|NCT00757588|38980569|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
16135352|NCT00757588|38980570|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
16135353|NCT00757588|38980569|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
16135354|NCT00757588|38980570|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
16135355|NCT00757588|38980569|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
16135356|NCT00757588|38980570|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
16135357|NCT00757588|38980569|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
16135358|NCT00757588|38980570|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
16135359|NCT00757588|38980569|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
16135360|NCT00757588|38980570|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
16135361|NCT00757588|38980569|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
16135362|NCT00757588|38980570|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
16135363|NCT00757588|38980569|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
16135364|NCT00757588|38980570|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
16135365|NCT00871780|38980572|FG000|Overall Study|Enrolled But Not Treated|6|||
16362624|NCT00408005|39814943|FG006|Induction|Protocol Deviation|0|||
16362625|NCT00408005|39814944|FG007|Induction|Protocol Deviation|0|||
16362626|NCT00408005|39814937|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
16362627|NCT00408005|39814938|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
16435365|NCT01147666|40074067|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435366|NCT01147666|40074068|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435367|NCT01147666|40074069|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435368|NCT01147666|40074070|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435369|NCT01147666|40074071|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435370|NCT01147666|40074072|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435371|NCT01147666|40074073|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435372|NCT01147666|40074074|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435373|NCT01147666|40074075|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
16435374|NCT01147666|40074061|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
16435375|NCT01147666|40074062|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
16435376|NCT01147666|40074063|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
16435377|NCT01147666|40074064|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
16435378|NCT01147666|40074065|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
16362628|NCT00408005|39814939|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
16362629|NCT00408005|39814940|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
16362630|NCT00408005|39814941|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
16362631|NCT00408005|39814942|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
16362632|NCT00408005|39814943|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
16135366|NCT00871780|38980572|FG000|Overall Study|Withdrawal by Subject|9|||
16135367|NCT00871780|38980572|FG000|Overall Study|Adverse Event|6|||
16135368|NCT00871780|38980572|FG000|Overall Study|Voluntary Discontinuation|4|||
16135369|NCT00871780|38980572|FG000|Overall Study|Death|1|||
16135370|NCT00871780|38980572|FG000|Overall Study|Physician Decision|1|||
16135371|NCT00971243|38983890|FG000|Double Blind Period|Adverse Event|2|||
16135372|NCT00971243|38983891|FG001|Double Blind Period|Adverse Event|3|||
16135373|NCT00971243|38983892|FG002|Double Blind Period|Adverse Event|2|||
16135374|NCT00971243|38983893|FG003|Double Blind Period|Adverse Event|2|||
16135375|NCT00971243|38983894|FG004|Double Blind Period|Adverse Event|3|||
16135376|NCT00971243|38983890|FG000|Double Blind Period|Lost to Follow-up|0|||
16135377|NCT00971243|38983891|FG001|Double Blind Period|Lost to Follow-up|1|||
16135378|NCT00971243|38983892|FG002|Double Blind Period|Lost to Follow-up|1|||
16135379|NCT00971243|38983893|FG003|Double Blind Period|Lost to Follow-up|0|||
16135380|NCT00971243|38983894|FG004|Double Blind Period|Lost to Follow-up|1|||
16135381|NCT00971243|38983890|FG000|Double Blind Period|Physician Decision|10|||
16135382|NCT00971243|38983891|FG001|Double Blind Period|Physician Decision|6|||
16135383|NCT00971243|38983892|FG002|Double Blind Period|Physician Decision|7|||
16135384|NCT00971243|38983893|FG003|Double Blind Period|Physician Decision|6|||
16135385|NCT00971243|38983894|FG004|Double Blind Period|Physician Decision|7|||
16135386|NCT00971243|38983890|FG000|Double Blind Period|Protocol Violation|2|||
16135387|NCT00971243|38983891|FG001|Double Blind Period|Protocol Violation|0|||
16135388|NCT00971243|38983892|FG002|Double Blind Period|Protocol Violation|3|||
16135389|NCT00971243|38983893|FG003|Double Blind Period|Protocol Violation|2|||
16135390|NCT00971243|38983894|FG004|Double Blind Period|Protocol Violation|2|||
16135391|NCT00971243|38983890|FG000|Double Blind Period|Withdrawal by Subject|4|||
16135392|NCT00971243|38983891|FG001|Double Blind Period|Withdrawal by Subject|1|||
16135393|NCT00971243|38983892|FG002|Double Blind Period|Withdrawal by Subject|4|||
16135394|NCT00971243|38983893|FG003|Double Blind Period|Withdrawal by Subject|4|||
16135395|NCT00971243|38983894|FG004|Double Blind Period|Withdrawal by Subject|4|||
16135396|NCT00971243|38983890|FG000|Double Blind Period|Other reasons|1|||
16135397|NCT00971243|38983891|FG001|Double Blind Period|Other reasons|0|||
16135398|NCT00971243|38983892|FG002|Double Blind Period|Other reasons|2|||
16135399|NCT00971243|38983893|FG003|Double Blind Period|Other reasons|0|||
16135400|NCT00971243|38983894|FG004|Double Blind Period|Other reasons|1|||
16135401|NCT00971243|38983890|FG000|Open-label Period|Adverse Event|1|||
16135402|NCT00971243|38983891|FG001|Open-label Period|Adverse Event|0|||
16135403|NCT00971243|38983892|FG002|Open-label Period|Adverse Event|1|||
16135404|NCT00971243|38983893|FG003|Open-label Period|Adverse Event|1|||
16135405|NCT00971243|38983894|FG004|Open-label Period|Adverse Event|0|||
16135406|NCT00971243|38983890|FG000|Open-label Period|Physician Decision|5|||
16135407|NCT00971243|38983891|FG001|Open-label Period|Physician Decision|9|||
16135408|NCT00971243|38983892|FG002|Open-label Period|Physician Decision|3|||
16135409|NCT00971243|38983893|FG003|Open-label Period|Physician Decision|7|||
16135410|NCT00971243|38983894|FG004|Open-label Period|Physician Decision|2|||
16135411|NCT00971243|38983890|FG000|Open-label Period|Protocol Violation|1|||
16135412|NCT00971243|38983891|FG001|Open-label Period|Protocol Violation|1|||
16135413|NCT00971243|38983892|FG002|Open-label Period|Protocol Violation|1|||
16135414|NCT00971243|38983893|FG003|Open-label Period|Protocol Violation|0|||
16135415|NCT00971243|38983894|FG004|Open-label Period|Protocol Violation|1|||
16135416|NCT00971243|38983890|FG000|Open-label Period|Withdrawal by Subject|1|||
16135417|NCT00971243|38983891|FG001|Open-label Period|Withdrawal by Subject|0|||
16135418|NCT00971243|38983892|FG002|Open-label Period|Withdrawal by Subject|0|||
16135419|NCT00971243|38983893|FG003|Open-label Period|Withdrawal by Subject|2|||
16135420|NCT00971243|38983894|FG004|Open-label Period|Withdrawal by Subject|1|||
16135421|NCT00971243|38983890|FG000|Open-label Period|Other reason|0|||
16135422|NCT00971243|38983891|FG001|Open-label Period|Other reason|0|||
16135423|NCT00971243|38983892|FG002|Open-label Period|Other reason|0|||
16135424|NCT00971243|38983893|FG003|Open-label Period|Other reason|0|||
16135425|NCT00971243|38983894|FG004|Open-label Period|Other reason|2|||
16135426|NCT00107120|38983895|FG000|Overall Study|Adverse Event|4|||
16135427|NCT00107120|38983896|FG001|Overall Study|Adverse Event|1|||
16135428|NCT00107120|38983895|FG000|Overall Study|Lack of Efficacy|5|||
16135429|NCT00107120|38983896|FG001|Overall Study|Lack of Efficacy|5|||
16135430|NCT00107120|38983895|FG000|Overall Study|Protocol Violation|3|||
16135431|NCT00107120|38983896|FG001|Overall Study|Protocol Violation|0|||
16135432|NCT00107120|38983895|FG000|Overall Study|Withdrawal by Subject|8|||
16135433|NCT00107120|38983896|FG001|Overall Study|Withdrawal by Subject|9|||
16135434|NCT00107120|38983895|FG000|Overall Study|Lost to Follow-up|8|||
16135435|NCT00107120|38983896|FG001|Overall Study|Lost to Follow-up|6|||
16135436|NCT00107120|38983895|FG000|Overall Study|Pregnancy|0|||
16135437|NCT00107120|38983896|FG001|Overall Study|Pregnancy|1|||
16135438|NCT00107120|38983895|FG000|Overall Study|moving away from site|1|||
16135439|NCT00107120|38983896|FG001|Overall Study|moving away from site|1|||
16135440|NCT00107120|38983895|FG000|Overall Study|death of parent|0|||
16135441|NCT00107120|38983896|FG001|Overall Study|death of parent|1|||
16135442|NCT02434939|38983901|FG000|Overall Study|Lack of Efficacy|34|||
16135443|NCT02434939|38983902|FG001|Overall Study|Lack of Efficacy|48|||
16135444|NCT02434939|38983901|FG000|Overall Study|Withdrawal by Subject|3|||
16135445|NCT02434939|38983902|FG001|Overall Study|Withdrawal by Subject|0|||
16135446|NCT02434939|38983901|FG000|Overall Study|Adverse Event|0|||
16135447|NCT02434939|38983902|FG001|Overall Study|Adverse Event|1|||
16135448|NCT00494481|38983903|FG000|Overall Study|Condition under investigation worsened|11|||
16135449|NCT00494481|38983904|FG001|Overall Study|Condition under investigation worsened|13|||
16135450|NCT00494481|38983903|FG000|Overall Study|Adverse Event|15|||
16135451|NCT00494481|38983904|FG001|Overall Study|Adverse Event|11|||
16135452|NCT00494481|38983903|FG000|Overall Study|Other|1|||
16135453|NCT00494481|38983904|FG001|Overall Study|Other|0|||
16135454|NCT00494481|38983903|FG000|Overall Study|Never received IP|2|||
16135455|NCT00494481|38983904|FG001|Overall Study|Never received IP|0|||
16135456|NCT02057523|38983905|FG000|Overall Study|Withdrawal by Subject|1|||
16135457|NCT02057523|38983905|FG000|Overall Study|Lack of Efficacy|1|||
16135458|NCT02070588|38983906|FG000|Overall Study|Withdrawal by Subject|29|||
16135459|NCT02070588|38983907|FG001|Overall Study|Withdrawal by Subject|1|||
16135460|NCT02070588|38983908|FG002|Overall Study|Withdrawal by Subject|0|||
16135461|NCT02070588|38983906|FG000|Overall Study|Writhdrawal due to early termination|9|||
16135462|NCT02070588|38983907|FG001|Overall Study|Writhdrawal due to early termination|0|||
16135463|NCT02070588|38983908|FG002|Overall Study|Writhdrawal due to early termination|0|||
16135464|NCT02070588|38983906|FG000|Overall Study|Adverse Event|1|||
16135465|NCT02070588|38983907|FG001|Overall Study|Adverse Event|0|||
16135466|NCT02070588|38983908|FG002|Overall Study|Adverse Event|0|||
16135467|NCT01774110|38983909|FG000|Overall Study|Lost to Follow-up|7|||
16135468|NCT04058366|38983922|FG000|Overall Study|Adverse Event|14|||
16135469|NCT04058366|38983922|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
16135470|NCT04058366|38983922|FG000|Overall Study|Commercial drug is available for participants|6|||
16135471|NCT04058366|38983922|FG000|Overall Study|Death|1|||
16135472|NCT04058366|38983922|FG000|Overall Study|Other non-compliance|2|||
16135473|NCT04058366|38983922|FG000|Overall Study|Other|6|||
16135474|NCT00820027|38983923|FG000|Overall Study|Adverse Event|15|||
16135475|NCT00820027|38983924|FG001|Overall Study|Adverse Event|8|||
16252506|NCT01595009|39408676|FG000|Core|Disease progression|14|||
16135476|NCT00820027|38983925|FG002|Overall Study|Adverse Event|10|||
16135477|NCT00820027|38983926|FG003|Overall Study|Adverse Event|5|||
16135478|NCT00820027|38983923|FG000|Overall Study|Lack of Efficacy|2|||
16135479|NCT00820027|38983924|FG001|Overall Study|Lack of Efficacy|1|||
16135480|NCT00820027|38983925|FG002|Overall Study|Lack of Efficacy|2|||
16135481|NCT00820027|38983926|FG003|Overall Study|Lack of Efficacy|2|||
16135482|NCT00820027|38983923|FG000|Overall Study|Physician Decision|0|||
16135483|NCT00820027|38983924|FG001|Overall Study|Physician Decision|1|||
16135484|NCT00820027|38983925|FG002|Overall Study|Physician Decision|1|||
16252507|NCT01595009|39408677|FG001|Core|Disease progression|26|||
16135485|NCT00820027|38983926|FG003|Overall Study|Physician Decision|0|||
16135486|NCT00820027|38983923|FG000|Overall Study|Protocol Violation|3|||
16135487|NCT00820027|38983924|FG001|Overall Study|Protocol Violation|0|||
16252508|NCT01595009|39408678|FG002|Core|Disease progression|0|||
16135488|NCT00820027|38983925|FG002|Overall Study|Protocol Violation|4|||
16135489|NCT00820027|38983926|FG003|Overall Study|Protocol Violation|0|||
16135490|NCT00820027|38983923|FG000|Overall Study|Withdrawal by Subject|6|||
16135491|NCT00820027|38983924|FG001|Overall Study|Withdrawal by Subject|4|||
16135492|NCT00820027|38983925|FG002|Overall Study|Withdrawal by Subject|4|||
16135493|NCT00820027|38983926|FG003|Overall Study|Withdrawal by Subject|6|||
16135494|NCT02308020|38983927|FG000|Overall Study|Lost to Follow-up|1|||
16135495|NCT02308020|38983928|FG001|Overall Study|Lost to Follow-up|7|||
16135496|NCT02308020|38983929|FG002|Overall Study|Lost to Follow-up|0|||
16135497|NCT02308020|38983930|FG003|Overall Study|Lost to Follow-up|0|||
16135498|NCT02308020|38983931|FG004|Overall Study|Lost to Follow-up|1|||
16135499|NCT02308020|38983932|FG005|Overall Study|Lost to Follow-up|2|||
16135500|NCT02308020|38983927|FG000|Overall Study|Sponsor Decision|0|||
16135501|NCT02308020|38983928|FG001|Overall Study|Sponsor Decision|8|||
16135502|NCT02308020|38983929|FG002|Overall Study|Sponsor Decision|0|||
16252509|NCT01595009|39408679|FG003|Core|Disease progression|0|||
16252510|NCT01595009|39408676|FG000|Core|Withdrawal by Subject|4|||
16252511|NCT01595009|39408677|FG001|Core|Withdrawal by Subject|17|||
16252512|NCT01595009|39408678|FG002|Core|Withdrawal by Subject|0|||
16252513|NCT01595009|39408679|FG003|Core|Withdrawal by Subject|0|||
16252514|NCT01595009|39408676|FG000|Core|Death|3|||
16252515|NCT01595009|39408677|FG001|Core|Death|6|||
16252516|NCT01595009|39408678|FG002|Core|Death|0|||
16252517|NCT01595009|39408679|FG003|Core|Death|0|||
16252518|NCT01595009|39408676|FG000|Core|Lost to Follow-up|1|||
16252519|NCT01595009|39408677|FG001|Core|Lost to Follow-up|2|||
16252520|NCT01595009|39408678|FG002|Core|Lost to Follow-up|0|||
16252521|NCT01595009|39408679|FG003|Core|Lost to Follow-up|0|||
16252522|NCT01595009|39408676|FG000|Core|Protocol deviation|0|||
16252523|NCT01595009|39408677|FG001|Core|Protocol deviation|1|||
16252524|NCT01595009|39408678|FG002|Core|Protocol deviation|0|||
16252525|NCT01595009|39408679|FG003|Core|Protocol deviation|0|||
16252526|NCT01595009|39408676|FG000|Core|Administrative problems|0|||
16252527|NCT01595009|39408677|FG001|Core|Administrative problems|1|||
16252528|NCT01595009|39408678|FG002|Core|Administrative problems|0|||
16252529|NCT01595009|39408679|FG003|Core|Administrative problems|0|||
16252530|NCT01595009|39408676|FG000|Extension|Administrative problems|0|||
16252531|NCT01595009|39408677|FG001|Extension|Administrative problems|0|||
16252532|NCT01595009|39408678|FG002|Extension|Administrative problems|0|||
16252533|NCT01595009|39408679|FG003|Extension|Administrative problems|1|||
16252534|NCT01595009|39408676|FG000|Extension|Patients completed per protocol|0|||
16252535|NCT01595009|39408677|FG001|Extension|Patients completed per protocol|0|||
16252536|NCT01595009|39408678|FG002|Extension|Patients completed per protocol|0|||
16252537|NCT01595009|39408679|FG003|Extension|Patients completed per protocol|2|||
16135503|NCT02308020|38983930|FG003|Overall Study|Sponsor Decision|2|||
16135504|NCT02308020|38983931|FG004|Overall Study|Sponsor Decision|2|||
16135505|NCT02308020|38983932|FG005|Overall Study|Sponsor Decision|1|||
16252538|NCT01595009|39408676|FG000|Extension|Disease progression|0|||
16252539|NCT01595009|39408677|FG001|Extension|Disease progression|0|||
16252540|NCT01595009|39408678|FG002|Extension|Disease progression|4|||
16135506|NCT02308020|38983927|FG000|Overall Study|Withdrawal by Subject|3|||
16135507|NCT02308020|38983928|FG001|Overall Study|Withdrawal by Subject|5|||
16135508|NCT02308020|38983929|FG002|Overall Study|Withdrawal by Subject|3|||
16135509|NCT02308020|38983930|FG003|Overall Study|Withdrawal by Subject|2|||
16135510|NCT02308020|38983931|FG004|Overall Study|Withdrawal by Subject|1|||
16135511|NCT02308020|38983932|FG005|Overall Study|Withdrawal by Subject|2|||
16135512|NCT00158860|38983933|FG000|Overall Study|Adverse Event|3|||
16135513|NCT00158860|38983934|FG001|Overall Study|Adverse Event|6|||
16135514|NCT00158860|38983933|FG000|Overall Study|Lost to Follow-up|11|||
16135515|NCT00158860|38983934|FG001|Overall Study|Lost to Follow-up|17|||
16135516|NCT00158860|38983933|FG000|Overall Study|Protocol Violation|8|||
16135517|NCT00158860|38983934|FG001|Overall Study|Protocol Violation|23|||
16135518|NCT00158860|38983933|FG000|Overall Study|Withdrawal by Subject|7|||
16135519|NCT00158860|38983934|FG001|Overall Study|Withdrawal by Subject|17|||
16135520|NCT00158860|38983933|FG000|Overall Study|MOVING OUT OF STATE|1|||
16135521|NCT00158860|38983934|FG001|Overall Study|MOVING OUT OF STATE|0|||
16135522|NCT00158860|38983933|FG000|Overall Study|Pregnancy|3|||
16135523|NCT00158860|38983934|FG001|Overall Study|Pregnancy|3|||
16135524|NCT00158860|38983933|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
16135525|NCT00158860|38983934|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
16135526|NCT00158860|38983933|FG000|Overall Study|SPONSOR REQUEST|0|||
16135527|NCT00158860|38983934|FG001|Overall Study|SPONSOR REQUEST|1|||
16135528|NCT00158860|38983933|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
16135529|NCT00158860|38983934|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
16135530|NCT00158860|38983933|FG000|Overall Study|Closed per sponsor|0|||
16135531|NCT00158860|38983934|FG001|Overall Study|Closed per sponsor|1|||
16135532|NCT00995020|38983935|FG000|Overall Study|margin analysis not performed|2|||
16135533|NCT00995020|38983936|FG001|Overall Study|margin analysis not performed|5|||
16135534|NCT00995020|38983935|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
16135535|NCT00995020|38983936|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
16135536|NCT00138671|38983940|FG000|Overall Study|Death|0|||
16135537|NCT00138671|38983941|FG001|Overall Study|Death|3|||
16135538|NCT00138671|38983940|FG000|Overall Study|Adverse Event|6|||
16135539|NCT00138671|38983941|FG001|Overall Study|Adverse Event|3|||
16135540|NCT00138671|38983940|FG000|Overall Study|Lost to Follow-up|1|||
16135541|NCT00138671|38983941|FG001|Overall Study|Lost to Follow-up|2|||
16135542|NCT00138671|38983940|FG000|Overall Study|Withdrawal by Subject|3|||
16135543|NCT00138671|38983941|FG001|Overall Study|Withdrawal by Subject|5|||
16135544|NCT00138671|38983940|FG000|Overall Study|Other|3|||
16135545|NCT00138671|38983941|FG001|Overall Study|Other|3|||
16135546|NCT00332189|38983942|FG000|Overall Study|Adverse Event|3|||
16135547|NCT00332189|38983942|FG000|Overall Study|Uncooperative/Noncompliant|3|||
16135548|NCT00332189|38983942|FG000|Overall Study|Withdrawal by Subject|9|||
16135549|NCT00332189|38983942|FG000|Overall Study|Lack of Efficacy|4|||
16435379|NCT01147666|40074066|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
16435380|NCT01147666|40074067|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
16435381|NCT01147666|40074068|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
16435382|NCT01147666|40074069|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
16435383|NCT01147666|40074070|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
16435384|NCT01147666|40074071|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
16435385|NCT01147666|40074072|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
16435386|NCT01147666|40074073|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
16435387|NCT01147666|40074074|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
16435388|NCT01147666|40074075|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
16435389|NCT01147666|40074061|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435390|NCT01147666|40074062|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435391|NCT01147666|40074063|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435392|NCT01147666|40074064|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
16435393|NCT01147666|40074065|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435394|NCT01147666|40074066|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435395|NCT01147666|40074067|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435396|NCT01147666|40074068|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435397|NCT01147666|40074069|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435398|NCT01147666|40074070|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435399|NCT01147666|40074071|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
16435400|NCT01147666|40074072|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435401|NCT01147666|40074073|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435402|NCT01147666|40074074|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435403|NCT01147666|40074075|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
16435404|NCT01147666|40074061|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435405|NCT01147666|40074062|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435406|NCT01147666|40074063|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435407|NCT01147666|40074064|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435408|NCT01147666|40074065|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435409|NCT01147666|40074066|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435410|NCT01147666|40074067|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435411|NCT01147666|40074068|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435412|NCT01147666|40074069|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16135550|NCT00332189|38983942|FG000|Overall Study|Moved out of country|2|||
16135551|NCT00372385|38983943|FG000|Overall Study|Adverse Event|6|||
16135552|NCT00372385|38983944|FG001|Overall Study|Adverse Event|11|||
16135553|NCT00372385|38983945|FG002|Overall Study|Adverse Event|9|||
16135554|NCT00372385|38983946|FG003|Overall Study|Adverse Event|7|||
16135555|NCT00372385|38983943|FG000|Overall Study|Noncompliance|0|||
16135556|NCT00372385|38983944|FG001|Overall Study|Noncompliance|1|||
16435413|NCT01147666|40074070|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16135557|NCT00372385|38983945|FG002|Overall Study|Noncompliance|1|||
16135558|NCT00372385|38983946|FG003|Overall Study|Noncompliance|1|||
16135559|NCT00372385|38983943|FG000|Overall Study|Physician Decision|1|||
16135560|NCT00372385|38983944|FG001|Overall Study|Physician Decision|0|||
16135561|NCT00372385|38983945|FG002|Overall Study|Physician Decision|0|||
16135562|NCT00372385|38983946|FG003|Overall Study|Physician Decision|0|||
16135563|NCT00372385|38983943|FG000|Overall Study|Lost to Follow-up|2|||
16135564|NCT00372385|38983944|FG001|Overall Study|Lost to Follow-up|0|||
16135565|NCT00372385|38983945|FG002|Overall Study|Lost to Follow-up|0|||
16135566|NCT00372385|38983946|FG003|Overall Study|Lost to Follow-up|0|||
16135567|NCT00372385|38983943|FG000|Overall Study|Withdrawal by Subject|2|||
16135568|NCT00372385|38983944|FG001|Overall Study|Withdrawal by Subject|1|||
16135569|NCT00372385|38983945|FG002|Overall Study|Withdrawal by Subject|0|||
16135570|NCT00372385|38983946|FG003|Overall Study|Withdrawal by Subject|0|||
16135571|NCT00372385|38983943|FG000|Overall Study|Refusal of Treatment|3|||
16135572|NCT00372385|38983944|FG001|Overall Study|Refusal of Treatment|6|||
16135573|NCT00372385|38983945|FG002|Overall Study|Refusal of Treatment|0|||
16135574|NCT00372385|38983946|FG003|Overall Study|Refusal of Treatment|0|||
16135575|NCT00372385|38983943|FG000|Overall Study|No Response|1|||
16135576|NCT00372385|38983944|FG001|Overall Study|No Response|1|||
16135577|NCT00372385|38983945|FG002|Overall Study|No Response|0|||
16135578|NCT00372385|38983946|FG003|Overall Study|No Response|0|||
16135579|NCT00372385|38983943|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
16135580|NCT00372385|38983944|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
16135581|NCT00372385|38983945|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
16135582|NCT00372385|38983946|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
16135583|NCT00372385|38983943|FG000|Overall Study|Virologic Stopping Rule|17|||
16135584|NCT00372385|38983944|FG001|Overall Study|Virologic Stopping Rule|0|||
16135585|NCT00372385|38983945|FG002|Overall Study|Virologic Stopping Rule|0|||
16135586|NCT00372385|38983946|FG003|Overall Study|Virologic Stopping Rule|0|||
16135587|NCT02359877|38983947|FG000|Overall Study|Withdrawal by Subject|1|||
16135588|NCT02359877|38983948|FG001|Overall Study|Withdrawal by Subject|0|||
16135589|NCT02359877|38983949|FG002|Overall Study|Withdrawal by Subject|0|||
16135590|NCT02359877|38983950|FG003|Overall Study|Withdrawal by Subject|2|||
16135591|NCT02359877|38983947|FG000|Overall Study|Adverse Event|0|||
16135592|NCT02359877|38983948|FG001|Overall Study|Adverse Event|0|||
16135593|NCT02359877|38983949|FG002|Overall Study|Adverse Event|0|||
16135594|NCT02359877|38983950|FG003|Overall Study|Adverse Event|1|||
16135595|NCT00093808|38983951|FG000|Overall Study|Cancel participation before receiving tx|1|||
16135596|NCT00093808|38983951|FG000|Overall Study|Protocol Violation|1|||
16135597|NCT00252733|38983952|FG000|Overall Study|Withdrawal by Subject|73|||
16135598|NCT00252733|38983953|FG001|Overall Study|Withdrawal by Subject|67|||
16135599|NCT00252733|38983952|FG000|Overall Study|Death|7|||
16135600|NCT00252733|38983953|FG001|Overall Study|Death|5|||
16135601|NCT00252733|38983952|FG000|Overall Study|Lost to Follow-up|12|||
16135602|NCT00252733|38983953|FG001|Overall Study|Lost to Follow-up|6|||
16135603|NCT00252733|38983952|FG000|Overall Study|Multiple Reasons|14|||
16135604|NCT00252733|38983953|FG001|Overall Study|Multiple Reasons|14|||
16135605|NCT01589237|38983954|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
16135606|NCT01589237|38983955|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
16135607|NCT01589237|38983956|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
16135608|NCT01589237|38983957|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
16135609|NCT01589237|38983954|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
16135610|NCT01589237|38983955|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
16135611|NCT01589237|38983956|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
16135612|NCT01589237|38983957|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
16135613|NCT01589237|38983954|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
16135614|NCT01589237|38983955|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
16135615|NCT01589237|38983956|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
16135616|NCT01589237|38983957|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
16135617|NCT01589237|38983954|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
16135618|NCT01589237|38983955|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
16135619|NCT01589237|38983956|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
16135620|NCT01589237|38983957|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
16135621|NCT03575143|38983960|FG000|Overall Study|Lost to Follow-up|0|||
16135622|NCT03575143|38983961|FG001|Overall Study|Lost to Follow-up|0|||
16135623|NCT03575143|38983962|FG002|Overall Study|Lost to Follow-up|4|||
16135624|NCT03575143|38983960|FG000|Overall Study|Withdrawal by Subject|0|||
16135625|NCT03575143|38983961|FG001|Overall Study|Withdrawal by Subject|0|||
16135626|NCT03575143|38983962|FG002|Overall Study|Withdrawal by Subject|5|||
16135627|NCT03575143|38983960|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
16135628|NCT03575143|38983961|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
16135629|NCT03575143|38983962|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
16135630|NCT01614197|38983963|FG000|Overall Study|Withdrawal by Subject|0|||
16135631|NCT01614197|38983964|FG001|Overall Study|Withdrawal by Subject|1|||
16135632|NCT01614197|38983965|FG002|Overall Study|Withdrawal by Subject|0|||
16135633|NCT01614197|38983966|FG003|Overall Study|Withdrawal by Subject|0|||
16135634|NCT00706433|38983967|FG000|Overall Study|Lost to Follow-up|3|||
16135635|NCT00706433|38983968|FG001|Overall Study|Lost to Follow-up|1|||
16135636|NCT00706433|38983969|FG002|Overall Study|Lost to Follow-up|6|||
16135637|NCT00706433|38983970|FG003|Overall Study|Lost to Follow-up|0|||
16135638|NCT00706433|38983967|FG000|Overall Study|Withdrawal by Subject|1|||
16135639|NCT00706433|38983968|FG001|Overall Study|Withdrawal by Subject|2|||
16135640|NCT00706433|38983969|FG002|Overall Study|Withdrawal by Subject|3|||
16135641|NCT00706433|38983970|FG003|Overall Study|Withdrawal by Subject|1|||
16135642|NCT00706433|38983967|FG000|Overall Study|Adverse Event|0|||
16135643|NCT00706433|38983968|FG001|Overall Study|Adverse Event|0|||
16135644|NCT00706433|38983969|FG002|Overall Study|Adverse Event|1|||
16135645|NCT00706433|38983970|FG003|Overall Study|Adverse Event|0|||
16135646|NCT00706433|38983967|FG000|Overall Study|Protocol Violation|1|||
16135647|NCT00706433|38983968|FG001|Overall Study|Protocol Violation|0|||
16135648|NCT00706433|38983969|FG002|Overall Study|Protocol Violation|0|||
16135649|NCT00706433|38983970|FG003|Overall Study|Protocol Violation|0|||
16135650|NCT00706433|38983967|FG000|Overall Study|new job|0|||
16135651|NCT00706433|38983968|FG001|Overall Study|new job|0|||
16135652|NCT00706433|38983969|FG002|Overall Study|new job|0|||
16135653|NCT00706433|38983970|FG003|Overall Study|new job|1|||
16135654|NCT03226275|38983971|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
16135655|NCT03226275|38983972|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
16135656|NCT03226275|38983973|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
16135657|NCT03226275|38983974|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
16135658|NCT03226275|38983971|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
16135659|NCT03226275|38983972|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
16135660|NCT03226275|38983973|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
16135661|NCT03226275|38983974|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
16135662|NCT02092220|38983975|FG000|Period 1|Unrelated Illness|0|||
16135663|NCT02092220|38983976|FG001|Period 1|Unrelated Illness|2|||
16135664|NCT02092220|38983975|FG000|Period 2|Severe Hypoglycaemia|1|||
16135665|NCT02092220|38983976|FG001|Period 2|Severe Hypoglycaemia|0|||
16135666|NCT02092220|38983975|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
16135667|NCT02092220|38983976|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
16135668|NCT01689337|38983980|FG000|Overall Study|Study Discontinuation|1|||
16135669|NCT04875676|38983981|FG000|Overall Study|Lost to Follow-up|1|||
16135670|NCT04875676|38983982|FG001|Overall Study|Lost to Follow-up|0|||
16135671|NCT04875676|38983983|FG002|Overall Study|Lost to Follow-up|0|||
16135672|NCT00852540|38983984|FG000|Overall Study|Adverse Event|10|||
16135673|NCT00852540|38983985|FG001|Overall Study|Adverse Event|3|||
16135674|NCT00852540|38983984|FG000|Overall Study|Lack of Efficacy|15|||
16135675|NCT00852540|38983985|FG001|Overall Study|Lack of Efficacy|3|||
16135676|NCT00852540|38983984|FG000|Overall Study|Protocol Violation|1|||
16135677|NCT00852540|38983985|FG001|Overall Study|Protocol Violation|2|||
16135678|NCT00852540|38983984|FG000|Overall Study|Lost to Follow-up|2|||
16135679|NCT00852540|38983985|FG001|Overall Study|Lost to Follow-up|3|||
16135680|NCT00852540|38983984|FG000|Overall Study|Investigator Discretion|2|||
16135681|NCT00852540|38983985|FG001|Overall Study|Investigator Discretion|3|||
16135682|NCT00852540|38983984|FG000|Overall Study|Withdrawal by Subject|3|||
16135683|NCT00852540|38983985|FG001|Overall Study|Withdrawal by Subject|1|||
16135684|NCT00852540|38983984|FG000|Overall Study|Did Not Receive Study Drug|3|||
16135685|NCT00852540|38983985|FG001|Overall Study|Did Not Receive Study Drug|3|||
16135686|NCT04634825|38983986|FG000|Overall Study|Death|10|||
16135687|NCT04634825|38983987|FG001|Overall Study|Death|3|||
16135688|NCT04634825|38983986|FG000|Overall Study|Lost to Follow-up|1|||
16135689|NCT04634825|38983987|FG001|Overall Study|Lost to Follow-up|0|||
16135690|NCT04634825|38983986|FG000|Overall Study|Study terminated by sponsor|35|||
16135691|NCT04634825|38983987|FG001|Overall Study|Study terminated by sponsor|11|||
16135692|NCT04634825|38983986|FG000|Overall Study|Withdrawal by Subject|2|||
16135693|NCT04634825|38983987|FG001|Overall Study|Withdrawal by Subject|0|||
16135694|NCT01350336|38983988|FG000|Overall Study|Lost to Follow-up|31|||
16135695|NCT01350336|38983988|FG000|Overall Study|Withdrawal by Subject|14|||
16135696|NCT01350336|38983988|FG000|Overall Study|Physician Decision|8|||
16135697|NCT01350336|38983988|FG000|Overall Study|Death|4|||
16135698|NCT01272947|38983992|FG000|Overall Study|Abnormal Laboratory Value|2|||
16135699|NCT01272947|38983993|FG001|Overall Study|Abnormal Laboratory Value|2|||
16435414|NCT01147666|40074071|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435415|NCT01147666|40074072|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435416|NCT01147666|40074073|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
16435417|NCT01147666|40074074|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435418|NCT01147666|40074075|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
16435419|NCT01147666|40074061|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435420|NCT01147666|40074062|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435421|NCT01147666|40074063|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435422|NCT01147666|40074064|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435423|NCT01147666|40074065|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435424|NCT01147666|40074066|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435425|NCT01147666|40074067|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435426|NCT01147666|40074068|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435427|NCT01147666|40074069|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435428|NCT01147666|40074070|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435429|NCT01147666|40074071|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435430|NCT01147666|40074072|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435431|NCT01147666|40074073|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
16435432|NCT01147666|40074074|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
16435433|NCT01147666|40074075|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
16435434|NCT03489863|40074077|FG000|Overall Study|Withdrawal by Subject|0|||
16435435|NCT03489863|40074078|FG001|Overall Study|Withdrawal by Subject|1|||
16435436|NCT00614575|40074082|FG000|Overall Study|Adverse Event|106|||
16435437|NCT00614575|40074082|FG000|Overall Study|Lost to Follow-up|55|||
16435438|NCT00614575|40074082|FG000|Overall Study|Lack of Efficacy|14|||
16252541|NCT01595009|39408679|FG003|Extension|Disease progression|7|||
16135700|NCT02720536|38983994|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
16135701|NCT02720536|38983994|FG000|Overall Study|PR - pregnancy|2|||
16135702|NCT02720536|38983994|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
16135703|NCT02720536|38983994|FG000|Overall Study|PR - death|1|||
16135704|NCT02720536|38983994|FG000|Overall Study|PR - adverse event|1|||
16135705|NCT02720536|38983994|FG000|Overall Study|PR - abnormal lab value(s)|1|||
16135706|NCT02720536|38983994|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
16135707|NCT03406260|38983997|FG000|Period 1|Adverse Event|0|||
16135708|NCT03406260|38983998|FG001|Period 1|Adverse Event|0|||
16135709|NCT03406260|38983999|FG002|Period 1|Adverse Event|0|||
16135710|NCT03406260|38984000|FG003|Period 1|Adverse Event|0|||
16135711|NCT03406260|38984001|FG004|Period 1|Adverse Event|1|||
16135712|NCT03406260|38984002|FG005|Period 1|Adverse Event|0|||
16135713|NCT02640157|38984003|FG000|Overall Study|Adverse Event|2|||
16435439|NCT00614575|40074082|FG000|Overall Study|Withdrawal by Subject|6|||
16435440|NCT00614575|40074082|FG000|Overall Study|Death|3|||
16435441|NCT00614575|40074082|FG000|Overall Study|Physician Decision|2|||
16435442|NCT00614575|40074082|FG000|Overall Study|No data were collected.|18|||
16435443|NCT00614575|40074082|FG000|Overall Study|Irregularly enrolled patients|23|||
16435444|NCT00614575|40074082|FG000|Overall Study|No treatment|1|||
16435445|NCT01467505|40074085|FG000|Overall Study|Adverse Event|1|||
16435446|NCT01467505|40074086|FG001|Overall Study|Adverse Event|0|||
16435447|NCT01467505|40074085|FG000|Overall Study|Withdrawal by Subject|4|||
16435448|NCT01467505|40074086|FG001|Overall Study|Withdrawal by Subject|0|||
16435449|NCT01467505|40074085|FG000|Overall Study|Study Terminated by Sponsor|28|||
16435450|NCT01467505|40074086|FG001|Overall Study|Study Terminated by Sponsor|3|||
16135714|NCT02640157|38984004|FG001|Overall Study|Adverse Event|2|||
16252542|NCT01595009|39408676|FG000|Extension|Adverse Event|0|||
16252543|NCT01595009|39408677|FG001|Extension|Adverse Event|0|||
16252544|NCT01595009|39408678|FG002|Extension|Adverse Event|0|||
16252545|NCT01595009|39408679|FG003|Extension|Adverse Event|1|||
16252546|NCT01046253|39408681|FG000|Second Intervention|Adverse Event|0|||
16135715|NCT02640157|38984005|FG002|Overall Study|Adverse Event|1|||
16135716|NCT02640157|38984003|FG000|Overall Study|Withdrew consent|2|||
16135717|NCT02640157|38984004|FG001|Overall Study|Withdrew consent|0|||
16252547|NCT01046253|39408682|FG001|Second Intervention|Adverse Event|1|||
16135718|NCT02640157|38984005|FG002|Overall Study|Withdrew consent|2|||
16135719|NCT02640157|38984003|FG000|Overall Study|Lost to Follow-up|9|||
16135720|NCT02640157|38984004|FG001|Overall Study|Lost to Follow-up|2|||
16135721|NCT02640157|38984005|FG002|Overall Study|Lost to Follow-up|7|||
16135722|NCT02640157|38984003|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
16135723|NCT02640157|38984004|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
16135724|NCT02640157|38984005|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
16135725|NCT05105789|38984006|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
16135726|NCT01664598|38984007|FG000|Overall Study|Sponsor Decision|1|||
16135727|NCT01664598|38984007|FG000|Overall Study|Withdrawal of Informed Consent|4|||
16135728|NCT01664598|38984007|FG000|Overall Study|Adverse Event|1|||
16135729|NCT03451162|38984008|FG000|Overall Study|Lost to Follow-up|1|||
16135730|NCT03451162|38984009|FG001|Overall Study|Lost to Follow-up|0|||
16135731|NCT03451162|38984010|FG002|Overall Study|Lost to Follow-up|0|||
16135732|NCT03451162|38984011|FG003|Overall Study|Lost to Follow-up|0|||
16135733|NCT03451162|38984012|FG004|Overall Study|Lost to Follow-up|0|||
16135734|NCT03451162|38984008|FG000|Overall Study|Physician Decision|0|||
16135735|NCT03451162|38984009|FG001|Overall Study|Physician Decision|1|||
16135736|NCT03451162|38984010|FG002|Overall Study|Physician Decision|0|||
16135737|NCT03451162|38984011|FG003|Overall Study|Physician Decision|0|||
16135738|NCT03451162|38984012|FG004|Overall Study|Physician Decision|0|||
16135739|NCT03451162|38984008|FG000|Overall Study|Withdrawal by Subject|1|||
16135740|NCT03451162|38984009|FG001|Overall Study|Withdrawal by Subject|1|||
16135741|NCT03451162|38984010|FG002|Overall Study|Withdrawal by Subject|0|||
16135742|NCT03451162|38984011|FG003|Overall Study|Withdrawal by Subject|0|||
16135743|NCT03451162|38984012|FG004|Overall Study|Withdrawal by Subject|0|||
16135744|NCT00876928|38984014|FG000|Overall Study|Lost to Follow-up|2|||
16135745|NCT00876928|38984015|FG001|Overall Study|Lost to Follow-up|5|||
16135746|NCT00876928|38984014|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
16135747|NCT00876928|38984015|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
16135748|NCT03628898|38984025|FG000|Overall Study|Device deficiency|1|||
16135749|NCT05208866|38984028|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
16135750|NCT01026454|38984036|FG000|Second Intervention|Pregnancy|1|||
16135751|NCT01026454|38984037|FG001|Second Intervention|Pregnancy|1|||
16135752|NCT02502097|38984039|FG000|Period 1|Adverse Event|0|||
16135753|NCT02502097|38984040|FG001|Period 1|Adverse Event|0|||
16135754|NCT02502097|38984041|FG002|Period 1|Adverse Event|1|||
16135755|NCT02502097|38984042|FG003|Period 1|Adverse Event|0|||
16135756|NCT02502097|38984039|FG000|Wash Out Period|Adverse Event|0|||
16135757|NCT02502097|38984040|FG001|Wash Out Period|Adverse Event|1|||
16135758|NCT02502097|38984041|FG002|Wash Out Period|Adverse Event|1|||
16135759|NCT02502097|38984042|FG003|Wash Out Period|Adverse Event|1|||
16135760|NCT02502097|38984039|FG000|Period 2|Adverse Event|0|||
16135761|NCT02502097|38984040|FG001|Period 2|Adverse Event|0|||
16135762|NCT02502097|38984041|FG002|Period 2|Adverse Event|1|||
16135763|NCT02502097|38984042|FG003|Period 2|Adverse Event|0|||
16135764|NCT00640016|38984045|FG000|Overall Study|Withdrawal by Subject|0|||
16135765|NCT00640016|38984046|FG001|Overall Study|Withdrawal by Subject|1|||
16135766|NCT00640016|38984047|FG002|Overall Study|Withdrawal by Subject|0|||
16135767|NCT00640016|38984048|FG003|Overall Study|Withdrawal by Subject|0|||
16135768|NCT00640016|38984045|FG000|Overall Study|Study termination|2|||
16135769|NCT00640016|38984046|FG001|Overall Study|Study termination|1|||
16135770|NCT00640016|38984047|FG002|Overall Study|Study termination|3|||
16135771|NCT00640016|38984048|FG003|Overall Study|Study termination|2|||
16135772|NCT00640016|38984045|FG000|Overall Study|Adverse Event|0|||
16135773|NCT00640016|38984046|FG001|Overall Study|Adverse Event|0|||
16135774|NCT00640016|38984047|FG002|Overall Study|Adverse Event|0|||
16135775|NCT00640016|38984048|FG003|Overall Study|Adverse Event|1|||
16135776|NCT02038543|38984051|FG000|Overall Study|Screen Failure|0|||
16135777|NCT02038543|38984052|FG001|Overall Study|Screen Failure|0|||
16135778|NCT02038543|38984053|FG002|Overall Study|Screen Failure|0|||
16135779|NCT02038543|38984054|FG003|Overall Study|Screen Failure|1|||
16135780|NCT02038543|38984051|FG000|Overall Study|Withdrawal by Subject|0|||
16362633|NCT00408005|39814944|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
16362634|NCT00408005|39814937|FG000|Induction|Recurrent leukemia|1|||
16135781|NCT02038543|38984052|FG001|Overall Study|Withdrawal by Subject|0|||
16135782|NCT02038543|38984053|FG002|Overall Study|Withdrawal by Subject|0|||
16135783|NCT02038543|38984054|FG003|Overall Study|Withdrawal by Subject|1|||
16135784|NCT00504881|38984055|FG000|Overall Study|Lack of Efficacy|1|||
16135785|NCT00504881|38984056|FG001|Overall Study|Lack of Efficacy|5|||
16135786|NCT00504881|38984055|FG000|Overall Study|Lost to Follow-up|0|||
16135787|NCT00504881|38984056|FG001|Overall Study|Lost to Follow-up|2|||
16135788|NCT00504881|38984055|FG000|Overall Study|Withdrawal by Subject|1|||
16135789|NCT00504881|38984056|FG001|Overall Study|Withdrawal by Subject|4|||
16135790|NCT00504881|38984055|FG000|Overall Study|Non-Compliance|1|||
16135791|NCT00504881|38984056|FG001|Overall Study|Non-Compliance|0|||
16135792|NCT00504881|38984055|FG000|Overall Study|No Birth Control|0|||
16135793|NCT00504881|38984056|FG001|Overall Study|No Birth Control|1|||
16135794|NCT00504881|38984055|FG000|Overall Study|Safety Visit not performed|0|||
16135795|NCT00504881|38984056|FG001|Overall Study|Safety Visit not performed|1|||
16135796|NCT00504881|38984055|FG000|Overall Study|AE, serious fatal|0|||
16135797|NCT00504881|38984056|FG001|Overall Study|AE, serious fatal|1|||
16135798|NCT00504881|38984055|FG000|Overall Study|SAE, non-fatal|2|||
16135799|NCT00504881|38984056|FG001|Overall Study|SAE, non-fatal|6|||
16135800|NCT00504881|38984055|FG000|Overall Study|AE, non-serious non-fatal|4|||
16135801|NCT00504881|38984056|FG001|Overall Study|AE, non-serious non-fatal|14|||
16135802|NCT00504881|38984055|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
16135803|NCT00504881|38984056|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
16135804|NCT00504881|38984055|FG000|Overall Study|AE of unknown type|1|||
16135805|NCT00504881|38984056|FG001|Overall Study|AE of unknown type|0|||
16135806|NCT01215175|38984059|FG000|Overall Study|Lost to Follow-up|0|||
16135807|NCT01215175|38984060|FG001|Overall Study|Lost to Follow-up|1|||
16135808|NCT01215175|38984061|FG002|Overall Study|Lost to Follow-up|0|||
16135809|NCT01215175|38984062|FG003|Overall Study|Lost to Follow-up|1|||
16135810|NCT01215175|38984063|FG004|Overall Study|Lost to Follow-up|0|||
16135811|NCT01100034|38984064|FG000|Overall Study|Lost to Follow-up|11|||
16135812|NCT01100034|38984064|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
16135813|NCT01100034|38984064|FG000|Overall Study|Withdrawal by Subject|4|||
16135814|NCT01100034|38984064|FG000|Overall Study|Sponsor decision|21|||
16135815|NCT01100034|38984064|FG000|Overall Study|Participated in another clinical trial|1|||
16135816|NCT01100034|38984064|FG000|Overall Study|Participants moved to another hospital|4|||
16135817|NCT01100034|38984064|FG000|Overall Study|Site closed due to non-responsiveness|1|||
16135818|NCT00394953|38984065|FG000|First Treatment Period|Adverse Event|1|||
16135819|NCT00394953|38984066|FG001|First Treatment Period|Adverse Event|2|||
16135820|NCT00394953|38984065|FG000|First Treatment Period|Death|6|||
16135821|NCT00394953|38984066|FG001|First Treatment Period|Death|7|||
16135822|NCT00394953|38984065|FG000|First Treatment Period|Lack of Efficacy|1|||
16135823|NCT00394953|38984066|FG001|First Treatment Period|Lack of Efficacy|1|||
16135824|NCT00394953|38984065|FG000|First Treatment Period|Withdrawal by Subject|6|||
16135825|NCT00394953|38984066|FG001|First Treatment Period|Withdrawal by Subject|3|||
16135826|NCT00394953|38984065|FG000|First Treatment Period|Lost to Follow-up|0|||
16135827|NCT00394953|38984066|FG001|First Treatment Period|Lost to Follow-up|1|||
16135828|NCT00394953|38984065|FG000|First Treatment Period|Renal transplant|11|||
16135829|NCT00394953|38984066|FG001|First Treatment Period|Renal transplant|7|||
16435451|NCT00141102|40074089|FG000|Overall Study|Adverse Event|233|||
16135830|NCT00394953|38984065|FG000|First Treatment Period|Not defined|4|||
16135831|NCT00394953|38984066|FG001|First Treatment Period|Not defined|1|||
16135832|NCT00394953|38984065|FG000|Second Treatment Period|Adverse Event|2|||
16135833|NCT00394953|38984066|FG001|Second Treatment Period|Adverse Event|5|||
16135834|NCT00394953|38984065|FG000|Second Treatment Period|Death|8|||
16135835|NCT00394953|38984066|FG001|Second Treatment Period|Death|4|||
16135836|NCT00394953|38984065|FG000|Second Treatment Period|Lack of Efficacy|9|||
16135837|NCT00394953|38984066|FG001|Second Treatment Period|Lack of Efficacy|47|||
16135838|NCT00394953|38984065|FG000|Second Treatment Period|Withdrawal by Subject|3|||
16135839|NCT00394953|38984066|FG001|Second Treatment Period|Withdrawal by Subject|3|||
16135840|NCT00394953|38984065|FG000|Second Treatment Period|Lost to Follow-up|0|||
16135841|NCT00394953|38984066|FG001|Second Treatment Period|Lost to Follow-up|1|||
16135842|NCT00394953|38984065|FG000|Second Treatment Period|Renal transplant|4|||
16135843|NCT00394953|38984066|FG001|Second Treatment Period|Renal transplant|6|||
16135844|NCT00394953|38984065|FG000|Second Treatment Period|Not defined|3|||
16135845|NCT00394953|38984066|FG001|Second Treatment Period|Not defined|8|||
16135846|NCT02973048|38984069|FG000|Overall Study|Epidural catheter insertion failure|1|||
16135847|NCT02973048|38984070|FG001|Overall Study|Epidural catheter insertion failure|0|||
16135848|NCT02973048|38984069|FG000|Overall Study|Withdrawal by Subject|0|||
16135849|NCT02973048|38984070|FG001|Overall Study|Withdrawal by Subject|3|||
16135850|NCT00971932|38984071|FG000|Overall Study|Withdrawal by Subject|1|||
16135851|NCT00971932|38984071|FG000|Overall Study|Investigator's decision|2|||
16135852|NCT00971932|38984071|FG000|Overall Study|Ongoing|4|||
16135853|NCT02074553|38984073|FG000|Intervention Period 1|Family Emergency|0|||
16135854|NCT02074553|38984074|FG001|Intervention Period 1|Family Emergency|0|||
16135855|NCT02074553|38984075|FG002|Intervention Period 1|Family Emergency|0|||
16135856|NCT02074553|38984076|FG003|Intervention Period 1|Family Emergency|1|||
16135857|NCT02074553|38984077|FG004|Intervention Period 1|Family Emergency|0|||
16135858|NCT02074553|38984078|FG005|Intervention Period 1|Family Emergency|0|||
16135859|NCT02074553|38984079|FG006|Intervention Period 1|Family Emergency|0|||
16135860|NCT02074553|38984080|FG007|Intervention Period 1|Family Emergency|0|||
16135861|NCT02074553|38984073|FG000|Washout Period 1|Adverse Event|1|||
16135862|NCT02074553|38984074|FG001|Washout Period 1|Adverse Event|0|||
16435452|NCT00141102|40074090|FG001|Overall Study|Adverse Event|305|||
16435453|NCT00141102|40074089|FG000|Overall Study|Laboratory Abnormality|9|||
16135863|NCT02074553|38984075|FG002|Washout Period 1|Adverse Event|0|||
16135864|NCT02074553|38984076|FG003|Washout Period 1|Adverse Event|0|||
16135865|NCT02074553|38984077|FG004|Washout Period 1|Adverse Event|0|||
16135866|NCT02074553|38984078|FG005|Washout Period 1|Adverse Event|0|||
16135867|NCT02074553|38984079|FG006|Washout Period 1|Adverse Event|0|||
16135868|NCT02074553|38984080|FG007|Washout Period 1|Adverse Event|0|||
16135869|NCT02074553|38984073|FG000|Washout Period 1|Physician Decision|0|||
16135870|NCT02074553|38984074|FG001|Washout Period 1|Physician Decision|0|||
16135871|NCT02074553|38984075|FG002|Washout Period 1|Physician Decision|0|||
16135872|NCT02074553|38984076|FG003|Washout Period 1|Physician Decision|1|||
16135873|NCT02074553|38984077|FG004|Washout Period 1|Physician Decision|0|||
16135874|NCT02074553|38984078|FG005|Washout Period 1|Physician Decision|0|||
16135875|NCT02074553|38984079|FG006|Washout Period 1|Physician Decision|0|||
16135876|NCT02074553|38984080|FG007|Washout Period 1|Physician Decision|0|||
16135877|NCT02074553|38984073|FG000|Washout Period 1|Other|0|||
16135878|NCT02074553|38984074|FG001|Washout Period 1|Other|0|||
16135879|NCT02074553|38984075|FG002|Washout Period 1|Other|0|||
16135880|NCT02074553|38984076|FG003|Washout Period 1|Other|0|||
16135881|NCT02074553|38984077|FG004|Washout Period 1|Other|0|||
16135882|NCT02074553|38984078|FG005|Washout Period 1|Other|1|||
16435454|NCT00141102|40074090|FG001|Overall Study|Laboratory Abnormality|33|||
16435455|NCT00141102|40074089|FG000|Overall Study|Lack of Efficacy|21|||
16135883|NCT02074553|38984079|FG006|Washout Period 1|Other|0|||
16135884|NCT02074553|38984080|FG007|Washout Period 1|Other|0|||
16135885|NCT02074553|38984073|FG000|Washout Period 2|Adverse Event|0|||
16135886|NCT02074553|38984074|FG001|Washout Period 2|Adverse Event|0|||
16135887|NCT02074553|38984075|FG002|Washout Period 2|Adverse Event|0|||
16135888|NCT02074553|38984076|FG003|Washout Period 2|Adverse Event|0|||
16135889|NCT02074553|38984077|FG004|Washout Period 2|Adverse Event|0|||
16435456|NCT00141102|40074090|FG001|Overall Study|Lack of Efficacy|26|||
16435457|NCT00141102|40074089|FG000|Overall Study|Lost to Follow-up|29|||
16435458|NCT00141102|40074090|FG001|Overall Study|Lost to Follow-up|32|||
16435459|NCT00141102|40074089|FG000|Overall Study|Other|87|||
16435460|NCT00141102|40074090|FG001|Overall Study|Other|76|||
16435461|NCT00141102|40074089|FG000|Overall Study|Withdrawal by Subject|112|||
16435462|NCT00141102|40074090|FG001|Overall Study|Withdrawal by Subject|142|||
16435463|NCT00141102|40074089|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
16435464|NCT00141102|40074090|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
16435465|NCT00141102|40074089|FG000|Overall Study|Death|2|||
16435466|NCT00141102|40074090|FG001|Overall Study|Death|2|||
16435467|NCT01173601|40074091|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
16435468|NCT01173601|40074092|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16435469|NCT01173601|40074093|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16435470|NCT01173601|40074094|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16435471|NCT01173601|40074095|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
16435472|NCT01173601|40074091|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
16435473|NCT01173601|40074092|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16435474|NCT01173601|40074093|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16435475|NCT01173601|40074094|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16435476|NCT01173601|40074095|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
16435477|NCT01173601|40074091|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
16135890|NCT02074553|38984078|FG005|Washout Period 2|Adverse Event|0|||
16135891|NCT02074553|38984079|FG006|Washout Period 2|Adverse Event|1|||
16135892|NCT02074553|38984080|FG007|Washout Period 2|Adverse Event|0|||
16135893|NCT02074553|38984073|FG000|Washout Period 2|Physician Decision|0|||
16135894|NCT02074553|38984074|FG001|Washout Period 2|Physician Decision|0|||
16135895|NCT02074553|38984075|FG002|Washout Period 2|Physician Decision|0|||
16135896|NCT02074553|38984076|FG003|Washout Period 2|Physician Decision|0|||
16435478|NCT01173601|40074092|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16435479|NCT01173601|40074093|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16435480|NCT01173601|40074094|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16435481|NCT01173601|40074095|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
16135897|NCT02074553|38984077|FG004|Washout Period 2|Physician Decision|0|||
16435482|NCT01173601|40074091|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
16135898|NCT02074553|38984078|FG005|Washout Period 2|Physician Decision|1|||
16135899|NCT02074553|38984079|FG006|Washout Period 2|Physician Decision|0|||
16135900|NCT02074553|38984080|FG007|Washout Period 2|Physician Decision|0|||
16135901|NCT02074553|38984073|FG000|Washout Period 2|Lost to Follow-up|0|||
16135902|NCT02074553|38984074|FG001|Washout Period 2|Lost to Follow-up|0|||
16135903|NCT02074553|38984075|FG002|Washout Period 2|Lost to Follow-up|1|||
16135904|NCT02074553|38984076|FG003|Washout Period 2|Lost to Follow-up|0|||
16135905|NCT02074553|38984077|FG004|Washout Period 2|Lost to Follow-up|0|||
16135906|NCT02074553|38984078|FG005|Washout Period 2|Lost to Follow-up|0|||
16135907|NCT02074553|38984079|FG006|Washout Period 2|Lost to Follow-up|0|||
16135908|NCT02074553|38984080|FG007|Washout Period 2|Lost to Follow-up|0|||
16135909|NCT02074553|38984073|FG000|Washout Period 3|Physician Decision|0|||
16135910|NCT02074553|38984074|FG001|Washout Period 3|Physician Decision|0|||
16135911|NCT02074553|38984075|FG002|Washout Period 3|Physician Decision|0|||
16135912|NCT02074553|38984076|FG003|Washout Period 3|Physician Decision|0|||
16135913|NCT02074553|38984077|FG004|Washout Period 3|Physician Decision|0|||
16135914|NCT02074553|38984078|FG005|Washout Period 3|Physician Decision|0|||
16135915|NCT02074553|38984079|FG006|Washout Period 3|Physician Decision|0|||
16135916|NCT02074553|38984080|FG007|Washout Period 3|Physician Decision|1|||
16135917|NCT02019927|38984083|FG000|Overall Study|Lost to Follow-up|2|||
16135918|NCT02019927|38984084|FG001|Overall Study|Lost to Follow-up|4|||
16135919|NCT02019927|38984085|FG002|Overall Study|Lost to Follow-up|1|||
16135920|NCT02019927|38984086|FG003|Overall Study|Lost to Follow-up|2|||
16135921|NCT02019927|38984087|FG004|Overall Study|Lost to Follow-up|3|||
16135922|NCT02019927|38984088|FG005|Overall Study|Lost to Follow-up|1|||
16135923|NCT01193920|38984089|FG000|Overall Study|Withdrawal by Subject|1|||
16135924|NCT01193920|38984090|FG001|Overall Study|Withdrawal by Subject|0|||
16135925|NCT01193920|38984091|FG002|Overall Study|Withdrawal by Subject|5|||
16135926|NCT01193920|38984092|FG003|Overall Study|Withdrawal by Subject|1|||
16135927|NCT01193920|38984093|FG004|Overall Study|Withdrawal by Subject|3|||
16135928|NCT01193920|38984094|FG005|Overall Study|Withdrawal by Subject|1|||
16135929|NCT01193920|38984095|FG006|Overall Study|Withdrawal by Subject|3|||
16135930|NCT01193920|38984096|FG007|Overall Study|Withdrawal by Subject|0|||
16135931|NCT01193920|38984097|FG008|Overall Study|Withdrawal by Subject|1|||
16135932|NCT01193920|38984098|FG009|Overall Study|Withdrawal by Subject|0|||
16135933|NCT01193920|38984089|FG000|Overall Study|Lost to Follow-up|1|||
16135934|NCT01193920|38984090|FG001|Overall Study|Lost to Follow-up|0|||
16135935|NCT01193920|38984091|FG002|Overall Study|Lost to Follow-up|1|||
16135936|NCT01193920|38984092|FG003|Overall Study|Lost to Follow-up|1|||
16135937|NCT01193920|38984093|FG004|Overall Study|Lost to Follow-up|3|||
16135938|NCT01193920|38984094|FG005|Overall Study|Lost to Follow-up|3|||
16135939|NCT01193920|38984095|FG006|Overall Study|Lost to Follow-up|1|||
16135940|NCT01193920|38984096|FG007|Overall Study|Lost to Follow-up|0|||
16135941|NCT01193920|38984097|FG008|Overall Study|Lost to Follow-up|2|||
16135942|NCT01193920|38984098|FG009|Overall Study|Lost to Follow-up|3|||
16135943|NCT01193920|38984089|FG000|Overall Study|Protocol Violation|1|||
16135944|NCT01193920|38984090|FG001|Overall Study|Protocol Violation|0|||
16135945|NCT01193920|38984091|FG002|Overall Study|Protocol Violation|0|||
16135946|NCT01193920|38984092|FG003|Overall Study|Protocol Violation|0|||
16135947|NCT01193920|38984093|FG004|Overall Study|Protocol Violation|0|||
16135948|NCT01193920|38984094|FG005|Overall Study|Protocol Violation|0|||
16135949|NCT01193920|38984095|FG006|Overall Study|Protocol Violation|0|||
16135950|NCT01193920|38984096|FG007|Overall Study|Protocol Violation|0|||
16135951|NCT01193920|38984097|FG008|Overall Study|Protocol Violation|0|||
16135952|NCT01193920|38984098|FG009|Overall Study|Protocol Violation|0|||
16135953|NCT01193920|38984089|FG000|Overall Study|Death|0|||
16135954|NCT01193920|38984090|FG001|Overall Study|Death|0|||
16135955|NCT01193920|38984091|FG002|Overall Study|Death|0|||
16135956|NCT01193920|38984092|FG003|Overall Study|Death|1|||
16135957|NCT01193920|38984093|FG004|Overall Study|Death|0|||
16135958|NCT01193920|38984094|FG005|Overall Study|Death|0|||
16135959|NCT01193920|38984095|FG006|Overall Study|Death|2|||
16135960|NCT01193920|38984096|FG007|Overall Study|Death|3|||
16135961|NCT01193920|38984097|FG008|Overall Study|Death|2|||
16135962|NCT01193920|38984098|FG009|Overall Study|Death|4|||
16135963|NCT01193920|38984089|FG000|Overall Study|Unable to classify|0|||
16135964|NCT01193920|38984090|FG001|Overall Study|Unable to classify|0|||
16135965|NCT01193920|38984091|FG002|Overall Study|Unable to classify|0|||
16135966|NCT01193920|38984092|FG003|Overall Study|Unable to classify|1|||
16135967|NCT01193920|38984093|FG004|Overall Study|Unable to classify|0|||
16135968|NCT01193920|38984094|FG005|Overall Study|Unable to classify|0|||
16135969|NCT01193920|38984095|FG006|Overall Study|Unable to classify|0|||
16135970|NCT01193920|38984096|FG007|Overall Study|Unable to classify|1|||
16135971|NCT01193920|38984097|FG008|Overall Study|Unable to classify|0|||
16252548|NCT01046253|39408681|FG000|Second Intervention|Protocol Violation|0|||
16252549|NCT01046253|39408682|FG001|Second Intervention|Protocol Violation|1|||
16252550|NCT03583333|39408686|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
16252551|NCT03583333|39408687|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
16252552|NCT03583333|39408686|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
16435483|NCT01173601|40074092|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16435484|NCT01173601|40074093|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16435485|NCT01173601|40074094|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16435486|NCT01173601|40074095|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
16435487|NCT01173601|40074091|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
16435488|NCT01173601|40074092|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16435489|NCT01173601|40074093|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16435490|NCT01173601|40074094|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16435491|NCT01173601|40074095|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
16252553|NCT03583333|39408687|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
16252554|NCT03583333|39408686|FG000|Overall Study|Withdrawal by Subject|9|||
16252555|NCT03583333|39408687|FG001|Overall Study|Withdrawal by Subject|5|||
16252556|NCT03583333|39408686|FG000|Overall Study|Physician Decision|3|||
16252557|NCT03583333|39408687|FG001|Overall Study|Physician Decision|2|||
16252558|NCT03583333|39408686|FG000|Overall Study|Death|12|||
16252559|NCT03583333|39408687|FG001|Overall Study|Death|7|||
16252560|NCT00084084|39408692|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
16252561|NCT00084084|39408692|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
16252562|NCT01492361|39408696|FG000|Overall Study|Withdrawal by Subject|281|||
16435492|NCT01173601|40074091|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
16435493|NCT01173601|40074092|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16435494|NCT01173601|40074093|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16135972|NCT01193920|38984098|FG009|Overall Study|Unable to classify|0|||
16135973|NCT01602562|38984099|FG000|Overall Study|Adverse Event|3|||
16135974|NCT01602562|38984100|FG001|Overall Study|Adverse Event|1|||
16135975|NCT01602562|38984099|FG000|Overall Study|Physician Decision|1|||
16135976|NCT01602562|38984100|FG001|Overall Study|Physician Decision|1|||
16135977|NCT01602562|38984099|FG000|Overall Study|Withdrawal by Subject|1|||
16135978|NCT01602562|38984100|FG001|Overall Study|Withdrawal by Subject|1|||
16135979|NCT03713632|38984101|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
16135980|NCT03713632|38984102|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
16135981|NCT03713632|38984103|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
16435495|NCT01173601|40074094|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16435496|NCT01173601|40074095|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
16435497|NCT01173601|40074091|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
16435498|NCT01173601|40074092|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16435499|NCT01173601|40074093|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16135982|NCT03713632|38984104|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
16135983|NCT03713632|38984105|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
16135984|NCT03713632|38984101|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
16135985|NCT03713632|38984102|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
16135986|NCT03713632|38984103|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
16135987|NCT03713632|38984104|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
16135988|NCT03713632|38984105|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
16135989|NCT03713632|38984101|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
16135990|NCT03713632|38984102|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
16252563|NCT01492361|39408697|FG001|Overall Study|Withdrawal by Subject|297|||
16252564|NCT01492361|39408696|FG000|Overall Study|Physician Decision|12|||
16252565|NCT01492361|39408697|FG001|Overall Study|Physician Decision|12|||
16435500|NCT01173601|40074094|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16435501|NCT01173601|40074095|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
16435502|NCT01173601|40074091|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
16435503|NCT01173601|40074092|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
16435504|NCT01173601|40074093|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
16435505|NCT01173601|40074094|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
16435506|NCT01173601|40074095|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
16435507|NCT01173601|40074091|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
16435508|NCT01173601|40074092|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
16435509|NCT01173601|40074093|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
16435510|NCT01173601|40074094|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
16252566|NCT01492361|39408696|FG000|Overall Study|Lost to Follow-up|6|||
16435511|NCT01173601|40074095|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
16435512|NCT01173601|40074091|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
16435513|NCT01173601|40074092|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
16435514|NCT01173601|40074093|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
16435515|NCT01173601|40074094|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
16435516|NCT01173601|40074095|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
16435517|NCT01173601|40074091|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16435518|NCT01173601|40074092|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
16435519|NCT01173601|40074093|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
16435520|NCT01173601|40074094|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
16135991|NCT03713632|38984103|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
16135992|NCT03713632|38984104|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
16135993|NCT03713632|38984105|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
16135994|NCT03713632|38984101|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
16135995|NCT03713632|38984102|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
16135996|NCT03713632|38984103|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
16135997|NCT03713632|38984104|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
16135998|NCT03713632|38984105|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
16135999|NCT03713632|38984101|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
16136000|NCT03713632|38984102|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
16136001|NCT03713632|38984103|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
16136002|NCT03713632|38984104|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
16136003|NCT03713632|38984105|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
16136004|NCT03713632|38984101|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
16136005|NCT03713632|38984102|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
16136006|NCT03713632|38984103|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
16136007|NCT03713632|38984104|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
16136008|NCT03713632|38984105|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
16136009|NCT03713632|38984101|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
16136010|NCT03713632|38984102|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
16136011|NCT03713632|38984103|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
16136012|NCT03713632|38984104|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
16136013|NCT03713632|38984105|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
16136014|NCT03713632|38984101|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
16136015|NCT03713632|38984102|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
16136016|NCT03713632|38984103|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
16136017|NCT03713632|38984104|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
16136018|NCT03713632|38984105|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
16136019|NCT03713632|38984101|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
16136020|NCT03713632|38984102|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
16136021|NCT03713632|38984103|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
16136022|NCT03713632|38984104|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
16136023|NCT03713632|38984105|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
16136024|NCT03713632|38984101|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
16136025|NCT03713632|38984102|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
16136026|NCT03713632|38984103|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
16136027|NCT03713632|38984104|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
16136028|NCT03713632|38984105|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
16136029|NCT03713632|38984101|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
16136030|NCT03713632|38984102|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
16136031|NCT03713632|38984103|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
16136032|NCT03713632|38984104|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
16136033|NCT03713632|38984105|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
16136034|NCT03713632|38984101|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
16136035|NCT03713632|38984102|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
16136036|NCT03713632|38984103|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
16136037|NCT03713632|38984104|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
16136038|NCT03713632|38984105|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
16252567|NCT01492361|39408697|FG001|Overall Study|Lost to Follow-up|13|||
16252568|NCT01492361|39408696|FG000|Overall Study|Other than specified above|106|||
16252569|NCT01492361|39408697|FG001|Overall Study|Other than specified above|138|||
16252570|NCT04634409|39408698|FG000|Overall Study|Death|0|||
16252571|NCT04634409|39408699|FG001|Overall Study|Death|0|||
16252572|NCT04634409|39408700|FG002|Overall Study|Death|0|||
16252573|NCT04634409|39408701|FG003|Overall Study|Death|0|||
16252574|NCT04634409|39408702|FG004|Overall Study|Death|0|||
16362635|NCT00408005|39814938|FG001|Induction|Recurrent leukemia|0|||
16435521|NCT01173601|40074095|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
16435522|NCT01173601|40074091|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
16435523|NCT01173601|40074092|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
16435524|NCT01173601|40074093|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
16362636|NCT00408005|39814939|FG002|Induction|Recurrent leukemia|0|||
16362637|NCT00408005|39814940|FG003|Induction|Recurrent leukemia|0|||
16362638|NCT00408005|39814941|FG004|Induction|Recurrent leukemia|0|||
16362639|NCT00408005|39814942|FG005|Induction|Recurrent leukemia|0|||
16362640|NCT00408005|39814943|FG006|Induction|Recurrent leukemia|0|||
16362641|NCT00408005|39814944|FG007|Induction|Recurrent leukemia|0|||
16362642|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
16362643|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
16435525|NCT01173601|40074094|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
16435526|NCT01173601|40074095|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
16435527|NCT01173601|40074091|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
16435528|NCT01173601|40074092|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
16435529|NCT01173601|40074093|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
16435530|NCT01173601|40074094|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
16136039|NCT03713632|38984101|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
16136040|NCT03713632|38984102|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
16136041|NCT03713632|38984103|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
16136042|NCT03713632|38984104|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
16136043|NCT03713632|38984105|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
16136044|NCT03713632|38984101|FG000|Treatment Period 2 (After Week 16)|Death|0|||
16136045|NCT03713632|38984102|FG001|Treatment Period 2 (After Week 16)|Death|1|||
16136046|NCT03713632|38984103|FG002|Treatment Period 2 (After Week 16)|Death|0|||
16136047|NCT03713632|38984104|FG003|Treatment Period 2 (After Week 16)|Death|0|||
16136048|NCT03713632|38984105|FG004|Treatment Period 2 (After Week 16)|Death|0|||
16136049|NCT03713632|38984101|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
16136050|NCT03713632|38984102|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
16136051|NCT03713632|38984103|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
16136052|NCT03713632|38984104|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
16136053|NCT03713632|38984105|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
16136054|NCT01485354|38984109|FG000|Overall Study|Withdrawal by Subject|5|||
16136055|NCT04187989|38984110|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
16136056|NCT04187989|38984111|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
16136057|NCT04187989|38984110|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
16136058|NCT04187989|38984111|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
16136059|NCT04508023|38984112|FG000|Overall Study|Withdrawal by Subject|1|||
16136060|NCT04508023|38984113|FG001|Overall Study|Withdrawal by Subject|2|||
16136061|NCT03588728|38984114|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
16136062|NCT03588728|38984115|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
16136063|NCT03588728|38984116|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
16136064|NCT03588728|38984117|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
16136065|NCT03588728|38984114|FG000|Overall Study|Lab shut down due to COVID-19|0|||
16136066|NCT03588728|38984115|FG001|Overall Study|Lab shut down due to COVID-19|0|||
16136067|NCT03588728|38984116|FG002|Overall Study|Lab shut down due to COVID-19|0|||
16136068|NCT03588728|38984117|FG003|Overall Study|Lab shut down due to COVID-19|1|||
16136069|NCT03588728|38984114|FG000|Overall Study|multiple technical issues|1|||
16136070|NCT03588728|38984115|FG001|Overall Study|multiple technical issues|0|||
16136071|NCT03588728|38984116|FG002|Overall Study|multiple technical issues|0|||
16136072|NCT03588728|38984117|FG003|Overall Study|multiple technical issues|0|||
16136073|NCT03588728|38984114|FG000|Overall Study|Hospitalized for COVID|1|||
16136074|NCT03588728|38984115|FG001|Overall Study|Hospitalized for COVID|0|||
16136075|NCT03588728|38984116|FG002|Overall Study|Hospitalized for COVID|0|||
16136076|NCT03588728|38984117|FG003|Overall Study|Hospitalized for COVID|0|||
16136077|NCT03588728|38984114|FG000|Overall Study|Schedule change unable to attend sessions|1|||
16136078|NCT03588728|38984115|FG001|Overall Study|Schedule change unable to attend sessions|0|||
16136079|NCT03588728|38984116|FG002|Overall Study|Schedule change unable to attend sessions|0|||
16136080|NCT03588728|38984117|FG003|Overall Study|Schedule change unable to attend sessions|0|||
16136081|NCT01072877|38984118|FG000|Overall Study|Lost to Follow-up|1|||
16136082|NCT01072877|38984119|FG001|Overall Study|Lost to Follow-up|1|||
16136083|NCT01072877|38984120|FG002|Overall Study|Lost to Follow-up|0|||
16136084|NCT01072877|38984121|FG003|Overall Study|Lost to Follow-up|2|||
16136085|NCT01072877|38984122|FG004|Overall Study|Lost to Follow-up|0|||
16136086|NCT01551212|38984124|FG000|Overall Study|Graft loss/Retransplantation|0|||
16136087|NCT01551212|38984125|FG001|Overall Study|Graft loss/Retransplantation|1|||
16136088|NCT01551212|38984124|FG000|Overall Study|Administrative problems|1|||
16136089|NCT01551212|38984125|FG001|Overall Study|Administrative problems|2|||
16136090|NCT01551212|38984124|FG000|Overall Study|Lost to Follow-up|0|||
16136091|NCT01551212|38984125|FG001|Overall Study|Lost to Follow-up|1|||
16136092|NCT01551212|38984124|FG000|Overall Study|Protocol Violation|0|||
16136093|NCT01551212|38984125|FG001|Overall Study|Protocol Violation|1|||
16136094|NCT01551212|38984124|FG000|Overall Study|Withdrawal by Subject|0|||
16136095|NCT01551212|38984125|FG001|Overall Study|Withdrawal by Subject|7|||
16136096|NCT01551212|38984124|FG000|Overall Study|Death|2|||
16136097|NCT01551212|38984125|FG001|Overall Study|Death|4|||
16136098|NCT01551212|38984124|FG000|Overall Study|Never Received Study Treatment|2|||
16136099|NCT01551212|38984125|FG001|Overall Study|Never Received Study Treatment|4|||
16136100|NCT02344004|38984126|FG000|Overall Study|Adverse Event|11|||
16136101|NCT02344004|38984127|FG001|Overall Study|Adverse Event|1|||
16136102|NCT02344004|38984126|FG000|Overall Study|Death|9|||
16136103|NCT02344004|38984127|FG001|Overall Study|Death|7|||
16136104|NCT02344004|38984126|FG000|Overall Study|Physician Decision|4|||
16136105|NCT02344004|38984127|FG001|Overall Study|Physician Decision|1|||
16136106|NCT02344004|38984126|FG000|Overall Study|Withdrawal by Subject|22|||
16136107|NCT02344004|38984127|FG001|Overall Study|Withdrawal by Subject|5|||
16136108|NCT02344004|38984126|FG000|Overall Study|Rescue Medication|2|||
16136109|NCT02344004|38984127|FG001|Overall Study|Rescue Medication|0|||
16136110|NCT02344004|38984126|FG000|Overall Study|Other Not Specified|12|||
16136111|NCT02344004|38984127|FG001|Overall Study|Other Not Specified|0|||
16136112|NCT02344004|38984126|FG000|Overall Study|Protocol Violation|1|||
16136113|NCT02344004|38984127|FG001|Overall Study|Protocol Violation|0|||
16136114|NCT02243605|38984134|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
16136115|NCT02243605|38984135|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
16136116|NCT02243605|38984134|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
16136117|NCT02243605|38984135|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
16136118|NCT02243605|38984134|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
16136119|NCT02243605|38984135|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
16136120|NCT02243605|38984134|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
16136121|NCT02243605|38984135|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
16136122|NCT02243605|38984134|FG000|Stage 2 - Final Analysis Population|Progression|0|||
16136123|NCT02243605|38984135|FG001|Stage 2 - Final Analysis Population|Progression|1|||
16136124|NCT01369511|38984136|FG000|Overall Study|Adverse Event|1|||
16136125|NCT01369511|38984137|FG001|Overall Study|Adverse Event|1|||
16136126|NCT01369511|38984138|FG002|Overall Study|Adverse Event|5|||
16136127|NCT01369511|38984139|FG003|Overall Study|Adverse Event|0|||
16136128|NCT01369511|38984136|FG000|Overall Study|Entry criteria not met|2|||
16136129|NCT01369511|38984137|FG001|Overall Study|Entry criteria not met|0|||
16136130|NCT01369511|38984138|FG002|Overall Study|Entry criteria not met|0|||
16136131|NCT01369511|38984139|FG003|Overall Study|Entry criteria not met|1|||
16136132|NCT01369511|38984136|FG000|Overall Study|Lost to Follow-up|0|||
16136133|NCT01369511|38984137|FG001|Overall Study|Lost to Follow-up|1|||
16136134|NCT01369511|38984138|FG002|Overall Study|Lost to Follow-up|1|||
16136135|NCT01369511|38984139|FG003|Overall Study|Lost to Follow-up|2|||
16136136|NCT01369511|38984136|FG000|Overall Study|Protocol Violation|0|||
16136137|NCT01369511|38984137|FG001|Overall Study|Protocol Violation|1|||
16136138|NCT01369511|38984138|FG002|Overall Study|Protocol Violation|0|||
16136139|NCT01369511|38984139|FG003|Overall Study|Protocol Violation|2|||
16136140|NCT01369511|38984136|FG000|Overall Study|Physician Decision|3|||
16136141|NCT01369511|38984137|FG001|Overall Study|Physician Decision|4|||
16136142|NCT01369511|38984138|FG002|Overall Study|Physician Decision|0|||
16136143|NCT01369511|38984139|FG003|Overall Study|Physician Decision|0|||
16136144|NCT01369511|38984136|FG000|Overall Study|Sponsor decision|2|||
16136145|NCT01369511|38984137|FG001|Overall Study|Sponsor decision|0|||
16136146|NCT01369511|38984138|FG002|Overall Study|Sponsor decision|1|||
16136147|NCT01369511|38984139|FG003|Overall Study|Sponsor decision|0|||
16136148|NCT01369511|38984136|FG000|Overall Study|Withdrawal by Subject|5|||
16136149|NCT01369511|38984137|FG001|Overall Study|Withdrawal by Subject|6|||
16136150|NCT01369511|38984138|FG002|Overall Study|Withdrawal by Subject|4|||
16136151|NCT01369511|38984139|FG003|Overall Study|Withdrawal by Subject|6|||
16136152|NCT01718353|38984140|FG000|Overall Study|Lost to Follow-up|0|||
16136153|NCT01718353|38984141|FG001|Overall Study|Lost to Follow-up|1|||
16136154|NCT01718353|38984140|FG000|Overall Study|Principal Investigator's Decision|10|||
16136155|NCT01718353|38984141|FG001|Overall Study|Principal Investigator's Decision|4|||
16136156|NCT01718353|38984140|FG000|Overall Study|Randomized but not treated|2|||
16136157|NCT01718353|38984141|FG001|Overall Study|Randomized but not treated|0|||
16136158|NCT03907410|38984142|FG000|Overall Study|Lost to Follow-up|4|||
16136159|NCT03907410|38984143|FG001|Overall Study|Lost to Follow-up|1|||
16136160|NCT03907410|38984144|FG002|Overall Study|Lost to Follow-up|1|||
16136161|NCT03907410|38984142|FG000|Overall Study|Lost to follow-up and research burden|0|||
16136162|NCT03907410|38984143|FG001|Overall Study|Lost to follow-up and research burden|0|||
16136163|NCT03907410|38984144|FG002|Overall Study|Lost to follow-up and research burden|1|||
16136164|NCT00928447|38984148|FG000|Overall Study|Withdrawal by Subject|1|||
16136165|NCT00928447|38984148|FG000|Overall Study|Investigator's decision|1|||
16136166|NCT01214187|38984149|FG000|Overall Study|Adverse Event|6|||
16136167|NCT01214187|38984150|FG001|Overall Study|Adverse Event|2|||
16136168|NCT01214187|38984149|FG000|Overall Study|Death|1|||
16136169|NCT01214187|38984150|FG001|Overall Study|Death|1|||
16136170|NCT01214187|38984149|FG000|Overall Study|Withdrawal by Subject|0|||
16136171|NCT01214187|38984150|FG001|Overall Study|Withdrawal by Subject|3|||
16136172|NCT01230788|38984155|FG000|Overall Study|Prescribed exclusion drug|1|||
16136173|NCT01658150|38984156|FG000|Overall Study|Withdrawal by Subject|1|||
16136174|NCT01001832|38984157|FG000|Short-term Period|Adverse Event|2|||
16136175|NCT01001832|38984158|FG001|Short-term Period|Adverse Event|3|||
16136176|NCT01001832|38984157|FG000|Long-term Period|Adverse Event|2|||
16136177|NCT01001832|38984158|FG001|Long-term Period|Adverse Event|1|||
16136178|NCT01001832|38984157|FG000|Long-term Period|Withdrawal by Subject|1|||
16136179|NCT01001832|38984158|FG001|Long-term Period|Withdrawal by Subject|0|||
16136180|NCT01001832|38984157|FG000|Long-term Period|Lack of Efficacy|0|||
16136181|NCT01001832|38984158|FG001|Long-term Period|Lack of Efficacy|2|||
16136182|NCT01001832|38984157|FG000|Long-term Period|Other|1|||
16136183|NCT01001832|38984158|FG001|Long-term Period|Other|2|||
16136184|NCT01001832|38984157|FG000|Follow-up Period|Withdrawal by Subject|1|||
16136185|NCT01001832|38984158|FG001|Follow-up Period|Withdrawal by Subject|0|||
16136186|NCT01001832|38984157|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
16136187|NCT01001832|38984158|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
16136188|NCT01001832|38984157|FG000|Follow-up Period|Other|2|||
16136189|NCT01001832|38984158|FG001|Follow-up Period|Other|1|||
16136190|NCT01699789|38984161|FG000|Overall Study|Withdrawal by Subject|18|||
16136191|NCT01699789|38984162|FG001|Overall Study|Withdrawal by Subject|23|||
16136192|NCT01699789|38984161|FG000|Overall Study|Death|1|||
16136193|NCT01699789|38984162|FG001|Overall Study|Death|2|||
16136194|NCT01699789|38984161|FG000|Overall Study|Lost to Follow-up|83|||
16136195|NCT01699789|38984162|FG001|Overall Study|Lost to Follow-up|101|||
16136196|NCT01952054|38984163|FG000|Overall Study|Physician Decision|1|||
16136197|NCT01658826|38984164|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
16136198|NCT01658826|38984165|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
16136199|NCT01658826|38984164|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
16136200|NCT01658826|38984165|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
16136201|NCT01658826|38984164|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
16136202|NCT01658826|38984165|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
16136203|NCT01658826|38984164|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
16136204|NCT01658826|38984165|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
16136205|NCT01658826|38984164|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
16136206|NCT01658826|38984165|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
16136207|NCT01658826|38984164|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
16136208|NCT01658826|38984165|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
16136209|NCT01658826|38984164|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
16136210|NCT01658826|38984165|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
16136211|NCT01658826|38984164|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
16136212|NCT01658826|38984165|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
16136213|NCT01658826|38984164|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
16136214|NCT01658826|38984165|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
16136215|NCT03604523|38984166|FG000|Overall Study|Physician Decision|1|||
16136216|NCT03604523|38984167|FG001|Overall Study|Physician Decision|0|||
16136217|NCT03235284|38984168|FG000|Overall Study|Adverse Event|1|||
16136218|NCT03235284|38984169|FG001|Overall Study|Adverse Event|2|||
16136219|NCT03235284|38984170|FG002|Overall Study|Adverse Event|1|||
16136220|NCT01142596|38984173|FG000|Overall Study|Withdrawal by Subject|9|||
16136221|NCT01142596|38984174|FG001|Overall Study|Withdrawal by Subject|35|||
16136222|NCT01142596|38984173|FG000|Overall Study|Adverse Event|8|||
16136223|NCT01142596|38984174|FG001|Overall Study|Adverse Event|35|||
16136224|NCT01142596|38984173|FG000|Overall Study|Lack of Efficacy|5|||
16136225|NCT01142596|38984174|FG001|Overall Study|Lack of Efficacy|9|||
16136226|NCT01142596|38984173|FG000|Overall Study|Lost to Follow-up|2|||
16136227|NCT01142596|38984174|FG001|Overall Study|Lost to Follow-up|3|||
16136228|NCT01142596|38984173|FG000|Overall Study|Other reason (not specified)|5|||
16136229|NCT01142596|38984174|FG001|Overall Study|Other reason (not specified)|4|||
16136230|NCT02216357|38984175|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
16136231|NCT02216357|38984176|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
16136232|NCT02076178|38984177|FG000|Oral Phase|Adverse Event|0|||
16136233|NCT02076178|38984178|FG001|Oral Phase|Adverse Event|7|||
16136234|NCT02076178|38984177|FG000|Oral Phase|Withdrawal by Subject|0|||
16136235|NCT02076178|38984178|FG001|Oral Phase|Withdrawal by Subject|4|||
16136236|NCT02076178|38984177|FG000|Oral Phase|Physician Decision|0|||
16136237|NCT02076178|38984178|FG001|Oral Phase|Physician Decision|1|||
16136238|NCT02076178|38984177|FG000|Injection Phase|Protocol defined stopping criteria|1|||
16136239|NCT02076178|38984178|FG001|Injection Phase|Protocol defined stopping criteria|0|||
16136240|NCT02076178|38984177|FG000|Injection Phase|Withdrawal by Subject|0|||
16252575|NCT04634409|39408703|FG005|Overall Study|Death|0|||
16435531|NCT01173601|40074095|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
16435532|NCT01173601|40074091|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16435533|NCT01173601|40074092|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16435534|NCT01173601|40074093|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
16435535|NCT01173601|40074094|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
16435536|NCT01173601|40074095|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
16435537|NCT01894607|40074096|FG000|Overall Study|Ineligible|1|||
16435538|NCT02471014|40074097|FG000|Overall Study|Lost to Follow-up|2|||
16435539|NCT02471014|40074098|FG001|Overall Study|Lost to Follow-up|2|||
16435540|NCT02520726|40074099|FG000|Overall Study|Lost to Follow-up|3|||
16435541|NCT02520726|40074100|FG001|Overall Study|Lost to Follow-up|2|||
16435542|NCT00467740|40074111|FG000|Overall Study|Adverse Event|0|||
16435543|NCT00467740|40074112|FG001|Overall Study|Adverse Event|0|||
16435544|NCT00467740|40074113|FG002|Overall Study|Adverse Event|1|||
16435545|NCT00467740|40074114|FG003|Overall Study|Adverse Event|0|||
16435546|NCT00467740|40074115|FG004|Overall Study|Adverse Event|0|||
16435547|NCT00467740|40074111|FG000|Overall Study|Protocol Violation|0|||
16435548|NCT00467740|40074112|FG001|Overall Study|Protocol Violation|0|||
16435549|NCT00467740|40074113|FG002|Overall Study|Protocol Violation|1|||
16435550|NCT00467740|40074114|FG003|Overall Study|Protocol Violation|0|||
16435551|NCT00467740|40074115|FG004|Overall Study|Protocol Violation|0|||
16435552|NCT00467740|40074111|FG000|Overall Study|Lost to Follow-up|0|||
16435553|NCT00467740|40074112|FG001|Overall Study|Lost to Follow-up|1|||
16435554|NCT00467740|40074113|FG002|Overall Study|Lost to Follow-up|0|||
16435555|NCT00467740|40074114|FG003|Overall Study|Lost to Follow-up|0|||
16252576|NCT04634409|39408704|FG006|Overall Study|Death|0|||
16252577|NCT04634409|39408705|FG007|Overall Study|Death|0|||
16252578|NCT04634409|39408706|FG008|Overall Study|Death|0|||
16252579|NCT04634409|39408707|FG009|Overall Study|Death|0|||
16252580|NCT04634409|39408708|FG010|Overall Study|Death|1|||
16252581|NCT04634409|39408709|FG011|Overall Study|Death|0|||
16252582|NCT04634409|39408710|FG012|Overall Study|Death|1|||
16252583|NCT04634409|39408711|FG013|Overall Study|Death|0|||
16252584|NCT04634409|39408712|FG014|Overall Study|Death|0|||
16252585|NCT04634409|39408713|FG015|Overall Study|Death|0|||
16252586|NCT04634409|39408714|FG016|Overall Study|Death|0|||
16362644|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
16362645|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
16362646|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
16362647|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
16362648|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
16362649|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
16362650|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
16362651|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
16362652|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
16362653|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
16362654|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
16362655|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
16362656|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
16362657|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
16362658|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
16362659|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
16362660|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
16362661|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
16362662|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
16362663|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
16362664|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
16362665|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
16362666|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
16362667|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
16362668|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
16362669|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
16362670|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
16362671|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
16362672|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
16362673|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
16362674|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
16362675|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
16362676|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
16362677|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
16362678|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
16362679|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
16362680|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
16362681|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
16362682|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
16362683|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
16362684|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
16362685|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
16362686|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
16362687|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
16362688|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
16362689|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
16362690|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
16362691|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
16362692|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
16362693|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
16362694|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
16435556|NCT00467740|40074115|FG004|Overall Study|Lost to Follow-up|0|||
16252587|NCT04634409|39408715|FG017|Overall Study|Death|0|||
16252588|NCT04634409|39408716|FG018|Overall Study|Death|0|||
16252589|NCT04634409|39408717|FG019|Overall Study|Death|0|||
16435557|NCT00467740|40074111|FG000|Overall Study|Withdrawal by Subject|1|||
16435558|NCT00467740|40074112|FG001|Overall Study|Withdrawal by Subject|1|||
16435559|NCT00467740|40074113|FG002|Overall Study|Withdrawal by Subject|0|||
16435560|NCT00467740|40074114|FG003|Overall Study|Withdrawal by Subject|1|||
16435561|NCT00467740|40074115|FG004|Overall Study|Withdrawal by Subject|0|||
16435562|NCT00467740|40074111|FG000|Overall Study|Lack of Efficacy|0|||
16435563|NCT00467740|40074112|FG001|Overall Study|Lack of Efficacy|1|||
16435564|NCT00467740|40074113|FG002|Overall Study|Lack of Efficacy|0|||
16435565|NCT00467740|40074114|FG003|Overall Study|Lack of Efficacy|0|||
16435566|NCT00467740|40074115|FG004|Overall Study|Lack of Efficacy|0|||
16435567|NCT00101686|40074119|FG000|Overall Study|Progressive Disease|37|||
16435568|NCT00101686|40074120|FG001|Overall Study|Progressive Disease|28|||
16435569|NCT00101686|40074121|FG002|Overall Study|Progressive Disease|37|||
16435570|NCT00101686|40074122|FG003|Overall Study|Progressive Disease|38|||
16435571|NCT00101686|40074123|FG004|Overall Study|Progressive Disease|28|||
16435572|NCT00101686|40074124|FG005|Overall Study|Progressive Disease|25|||
16435573|NCT00101686|40074125|FG006|Overall Study|Progressive Disease|5|||
16435574|NCT00101686|40074126|FG007|Overall Study|Progressive Disease|7|||
16435575|NCT00101686|40074127|FG008|Overall Study|Progressive Disease|10|||
16136241|NCT02076178|38984178|FG001|Injection Phase|Withdrawal by Subject|3|||
16136242|NCT02076178|38984177|FG000|Injection Phase|Physician Decision|0|||
16136243|NCT02076178|38984178|FG001|Injection Phase|Physician Decision|3|||
16136244|NCT02076178|38984177|FG000|Injection Phase|Lost to Follow-up|0|||
16136245|NCT02076178|38984178|FG001|Injection Phase|Lost to Follow-up|1|||
16136246|NCT03143166|38984181|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
16136247|NCT00705523|38984182|FG000|Overall Study|Lost to Follow-up|2|||
16136248|NCT00705523|38984183|FG001|Overall Study|Lost to Follow-up|3|||
16136249|NCT01966471|38984186|FG000|Overall Study|Death|44|||
16435576|NCT00101686|40074128|FG009|Overall Study|Progressive Disease|8|||
16435577|NCT00101686|40074119|FG000|Overall Study|initiation other anti-cancer treatment|4|||
16435578|NCT00101686|40074120|FG001|Overall Study|initiation other anti-cancer treatment|3|||
16136250|NCT01966471|38984187|FG001|Overall Study|Death|56|||
16136251|NCT01966471|38984186|FG000|Overall Study|Lost to Follow-up|46|||
16136252|NCT01966471|38984187|FG001|Overall Study|Lost to Follow-up|39|||
16136253|NCT01966471|38984186|FG000|Overall Study|Various reasons|4|||
16136254|NCT01966471|38984187|FG001|Overall Study|Various reasons|4|||
16136255|NCT01966471|38984186|FG000|Overall Study|Physician Decision|7|||
16136256|NCT01966471|38984187|FG001|Overall Study|Physician Decision|5|||
16136257|NCT01966471|38984186|FG000|Overall Study|Study Terminated By Sponsor|758|||
16136258|NCT01966471|38984187|FG001|Overall Study|Study Terminated By Sponsor|773|||
16136259|NCT01966471|38984186|FG000|Overall Study|Withdrawal by Subject|59|||
16136260|NCT01966471|38984187|FG001|Overall Study|Withdrawal by Subject|51|||
16136261|NCT00448123|38984188|FG000|Overall Study|Lost to Follow-up|9|||
16136262|NCT00448123|38984189|FG001|Overall Study|Lost to Follow-up|6|||
16136263|NCT00448123|38984188|FG000|Overall Study|Physician Decision|6|||
16136264|NCT00448123|38984189|FG001|Overall Study|Physician Decision|6|||
16136265|NCT04335812|38984190|FG000|Overall Study|Withdrawal by Subject|1|||
16136266|NCT04335812|38984191|FG001|Overall Study|Withdrawal by Subject|3|||
16136267|NCT04335812|38984190|FG000|Overall Study|Lost to Follow-up|12|||
16136268|NCT04335812|38984191|FG001|Overall Study|Lost to Follow-up|12|||
16136269|NCT04335812|38984190|FG000|Overall Study|Did not engage in the intervention|22|||
16136270|NCT04335812|38984191|FG001|Overall Study|Did not engage in the intervention|18|||
16136271|NCT04507126|38984192|FG000|Overall Study|Withdrawal by Subject|1|||
16136272|NCT04507126|38984192|FG000|Overall Study|Protocol Violation|2|||
16136273|NCT04507126|38984192|FG000|Overall Study|Physician Decision|1|||
16136274|NCT03215810|38986532|FG000|Overall Study|Still responding to nivolumab|1|||
16136275|NCT03215810|38986532|FG000|Overall Study|Insufficient TIL growth|1|||
16136276|NCT03215810|38986532|FG000|Overall Study|Decline in performance status|1|||
16136277|NCT03215810|38986532|FG000|Overall Study|Withdrawal by Subject|1|||
16136278|NCT00171704|38986537|FG000|Overall Study|Adverse Event|24|||
16136279|NCT00171704|38986538|FG001|Overall Study|Adverse Event|33|||
16136280|NCT00171704|38986537|FG000|Overall Study|Disease Progression|14|||
16136281|NCT00171704|38986538|FG001|Overall Study|Disease Progression|9|||
16136282|NCT00171704|38986537|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
16136283|NCT00171704|38986538|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
16136284|NCT00171704|38986537|FG000|Overall Study|Administrative Problems|2|||
16136285|NCT00171704|38986538|FG001|Overall Study|Administrative Problems|1|||
16136286|NCT00171704|38986537|FG000|Overall Study|Death|2|||
16136287|NCT00171704|38986538|FG001|Overall Study|Death|2|||
16435579|NCT00101686|40074121|FG002|Overall Study|initiation other anti-cancer treatment|4|||
16136288|NCT00171704|38986537|FG000|Overall Study|Withdrawal by Subject|1|||
16136289|NCT00171704|38986538|FG001|Overall Study|Withdrawal by Subject|3|||
16136290|NCT00171704|38986537|FG000|Overall Study|Protocol Violation|0|||
16136291|NCT00171704|38986538|FG001|Overall Study|Protocol Violation|1|||
16252590|NCT04634409|39408718|FG020|Overall Study|Death|0|||
16362695|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
16362696|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
16136292|NCT03646656|38986541|FG000|Overall Study|Lost to Follow-up|1|||
16252591|NCT04634409|39408719|FG021|Overall Study|Death|0|||
16362697|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
16362698|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
16362699|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
16362700|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
16362701|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
16362702|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
16435580|NCT00101686|40074122|FG003|Overall Study|initiation other anti-cancer treatment|3|||
16435581|NCT00101686|40074123|FG004|Overall Study|initiation other anti-cancer treatment|1|||
16435582|NCT00101686|40074124|FG005|Overall Study|initiation other anti-cancer treatment|1|||
16435583|NCT00101686|40074125|FG006|Overall Study|initiation other anti-cancer treatment|2|||
16435584|NCT00101686|40074126|FG007|Overall Study|initiation other anti-cancer treatment|2|||
16435585|NCT00101686|40074127|FG008|Overall Study|initiation other anti-cancer treatment|3|||
16435586|NCT00101686|40074128|FG009|Overall Study|initiation other anti-cancer treatment|3|||
16252592|NCT04634409|39408720|FG022|Overall Study|Death|0|||
16252593|NCT04634409|39408721|FG023|Overall Study|Death|0|||
16252594|NCT04634409|39408722|FG024|Overall Study|Death|0|||
16252595|NCT04634409|39408723|FG025|Overall Study|Death|0|||
16252596|NCT04634409|39408724|FG026|Overall Study|Death|0|||
16252597|NCT04634409|39408698|FG000|Overall Study|Adverse Event|0|||
16252598|NCT04634409|39408699|FG001|Overall Study|Adverse Event|0|||
16252599|NCT04634409|39408700|FG002|Overall Study|Adverse Event|1|||
16252600|NCT04634409|39408701|FG003|Overall Study|Adverse Event|0|||
16252601|NCT04634409|39408702|FG004|Overall Study|Adverse Event|0|||
16252602|NCT04634409|39408703|FG005|Overall Study|Adverse Event|1|||
16252603|NCT04634409|39408704|FG006|Overall Study|Adverse Event|0|||
16252604|NCT04634409|39408705|FG007|Overall Study|Adverse Event|0|||
16252605|NCT04634409|39408706|FG008|Overall Study|Adverse Event|0|||
16252606|NCT04634409|39408707|FG009|Overall Study|Adverse Event|0|||
16252607|NCT04634409|39408708|FG010|Overall Study|Adverse Event|0|||
16252608|NCT04634409|39408709|FG011|Overall Study|Adverse Event|0|||
16252609|NCT04634409|39408710|FG012|Overall Study|Adverse Event|0|||
16252610|NCT04634409|39408711|FG013|Overall Study|Adverse Event|0|||
16252611|NCT04634409|39408712|FG014|Overall Study|Adverse Event|0|||
16252612|NCT04634409|39408713|FG015|Overall Study|Adverse Event|0|||
16252613|NCT04634409|39408714|FG016|Overall Study|Adverse Event|0|||
16252614|NCT04634409|39408715|FG017|Overall Study|Adverse Event|0|||
16252615|NCT04634409|39408716|FG018|Overall Study|Adverse Event|0|||
16252616|NCT04634409|39408717|FG019|Overall Study|Adverse Event|0|||
16252617|NCT04634409|39408718|FG020|Overall Study|Adverse Event|0|||
16252618|NCT04634409|39408719|FG021|Overall Study|Adverse Event|0|||
16252619|NCT04634409|39408720|FG022|Overall Study|Adverse Event|0|||
16252620|NCT04634409|39408721|FG023|Overall Study|Adverse Event|0|||
16435587|NCT00101686|40074119|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
16435588|NCT00101686|40074120|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
16435589|NCT00101686|40074121|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
16435590|NCT00101686|40074122|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
16435591|NCT00101686|40074123|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
16435592|NCT00101686|40074124|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
16435593|NCT00101686|40074125|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
16435594|NCT00101686|40074126|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
16435595|NCT00101686|40074127|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
16435596|NCT00101686|40074128|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
16252621|NCT04634409|39408722|FG024|Overall Study|Adverse Event|0|||
16252622|NCT04634409|39408723|FG025|Overall Study|Adverse Event|0|||
16252623|NCT04634409|39408724|FG026|Overall Study|Adverse Event|0|||
16252624|NCT04634409|39408698|FG000|Overall Study|Lost to Follow-up|3|||
16252625|NCT04634409|39408699|FG001|Overall Study|Lost to Follow-up|1|||
16252626|NCT04634409|39408700|FG002|Overall Study|Lost to Follow-up|1|||
16252627|NCT04634409|39408701|FG003|Overall Study|Lost to Follow-up|3|||
16252628|NCT04634409|39408702|FG004|Overall Study|Lost to Follow-up|1|||
16252629|NCT04634409|39408703|FG005|Overall Study|Lost to Follow-up|1|||
16252630|NCT04634409|39408704|FG006|Overall Study|Lost to Follow-up|1|||
16252631|NCT04634409|39408705|FG007|Overall Study|Lost to Follow-up|3|||
16252632|NCT04634409|39408706|FG008|Overall Study|Lost to Follow-up|3|||
16252633|NCT04634409|39408707|FG009|Overall Study|Lost to Follow-up|11|||
16252634|NCT04634409|39408708|FG010|Overall Study|Lost to Follow-up|8|||
16252635|NCT04634409|39408709|FG011|Overall Study|Lost to Follow-up|15|||
16252636|NCT04634409|39408710|FG012|Overall Study|Lost to Follow-up|3|||
16252637|NCT04634409|39408711|FG013|Overall Study|Lost to Follow-up|2|||
16252638|NCT04634409|39408712|FG014|Overall Study|Lost to Follow-up|7|||
16252639|NCT04634409|39408713|FG015|Overall Study|Lost to Follow-up|0|||
16252640|NCT04634409|39408714|FG016|Overall Study|Lost to Follow-up|0|||
16252641|NCT04634409|39408715|FG017|Overall Study|Lost to Follow-up|0|||
16252642|NCT04634409|39408716|FG018|Overall Study|Lost to Follow-up|0|||
16252643|NCT04634409|39408717|FG019|Overall Study|Lost to Follow-up|0|||
16252644|NCT04634409|39408718|FG020|Overall Study|Lost to Follow-up|0|||
16252645|NCT04634409|39408719|FG021|Overall Study|Lost to Follow-up|0|||
16362703|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
16362704|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
16362705|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
16362706|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
16362707|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
16435597|NCT00101686|40074119|FG000|Overall Study|unacceptable toxicity|3|||
16435598|NCT00101686|40074120|FG001|Overall Study|unacceptable toxicity|9|||
16435599|NCT00101686|40074121|FG002|Overall Study|unacceptable toxicity|10|||
16435600|NCT00101686|40074122|FG003|Overall Study|unacceptable toxicity|6|||
16435601|NCT00101686|40074123|FG004|Overall Study|unacceptable toxicity|16|||
16435602|NCT00101686|40074124|FG005|Overall Study|unacceptable toxicity|10|||
16435603|NCT00101686|40074125|FG006|Overall Study|unacceptable toxicity|4|||
16252646|NCT04634409|39408720|FG022|Overall Study|Lost to Follow-up|0|||
16252647|NCT04634409|39408721|FG023|Overall Study|Lost to Follow-up|0|||
16252648|NCT04634409|39408722|FG024|Overall Study|Lost to Follow-up|0|||
16252649|NCT04634409|39408723|FG025|Overall Study|Lost to Follow-up|0|||
16252650|NCT04634409|39408724|FG026|Overall Study|Lost to Follow-up|0|||
16252651|NCT04634409|39408698|FG000|Overall Study|Withdrawal by Subject|3|||
16362708|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
16362709|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
16362710|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
16362711|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
16362712|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
16362713|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
16362714|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
16362715|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
16362716|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
16362717|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
16362718|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
16362719|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
16362720|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
16362721|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
16362722|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
16362723|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
16362724|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
16362725|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
16362726|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
16362727|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
16362728|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
16362729|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
16362730|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
16362731|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
16362732|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
16362733|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
16362734|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
16362735|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
16362736|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
16362737|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
16362738|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
16362739|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
16252652|NCT04634409|39408699|FG001|Overall Study|Withdrawal by Subject|1|||
16252653|NCT04634409|39408700|FG002|Overall Study|Withdrawal by Subject|6|||
16252654|NCT04634409|39408701|FG003|Overall Study|Withdrawal by Subject|4|||
16252655|NCT04634409|39408702|FG004|Overall Study|Withdrawal by Subject|2|||
16252656|NCT04634409|39408703|FG005|Overall Study|Withdrawal by Subject|0|||
16252657|NCT04634409|39408704|FG006|Overall Study|Withdrawal by Subject|0|||
16252658|NCT04634409|39408705|FG007|Overall Study|Withdrawal by Subject|2|||
16252659|NCT04634409|39408706|FG008|Overall Study|Withdrawal by Subject|3|||
16252660|NCT04634409|39408707|FG009|Overall Study|Withdrawal by Subject|2|||
16252661|NCT04634409|39408708|FG010|Overall Study|Withdrawal by Subject|3|||
16252662|NCT04634409|39408709|FG011|Overall Study|Withdrawal by Subject|2|||
16252663|NCT04634409|39408710|FG012|Overall Study|Withdrawal by Subject|2|||
16252664|NCT04634409|39408711|FG013|Overall Study|Withdrawal by Subject|1|||
16252665|NCT04634409|39408712|FG014|Overall Study|Withdrawal by Subject|5|||
16252666|NCT04634409|39408713|FG015|Overall Study|Withdrawal by Subject|0|||
16252667|NCT04634409|39408714|FG016|Overall Study|Withdrawal by Subject|0|||
16252668|NCT04634409|39408715|FG017|Overall Study|Withdrawal by Subject|1|||
16252669|NCT04634409|39408716|FG018|Overall Study|Withdrawal by Subject|0|||
16252670|NCT04634409|39408717|FG019|Overall Study|Withdrawal by Subject|0|||
16252671|NCT04634409|39408718|FG020|Overall Study|Withdrawal by Subject|0|||
16252672|NCT04634409|39408719|FG021|Overall Study|Withdrawal by Subject|0|||
16252673|NCT04634409|39408720|FG022|Overall Study|Withdrawal by Subject|0|||
16252674|NCT04634409|39408721|FG023|Overall Study|Withdrawal by Subject|1|||
16252675|NCT04634409|39408722|FG024|Overall Study|Withdrawal by Subject|0|||
16252676|NCT04634409|39408723|FG025|Overall Study|Withdrawal by Subject|0|||
16252677|NCT04634409|39408724|FG026|Overall Study|Withdrawal by Subject|0|||
16252678|NCT04634409|39408698|FG000|Overall Study|Other - As reported by Investigator|1|||
16252679|NCT04634409|39408699|FG001|Overall Study|Other - As reported by Investigator|0|||
16252680|NCT04634409|39408700|FG002|Overall Study|Other - As reported by Investigator|0|||
16252681|NCT04634409|39408701|FG003|Overall Study|Other - As reported by Investigator|0|||
16252682|NCT04634409|39408702|FG004|Overall Study|Other - As reported by Investigator|0|||
16252683|NCT04634409|39408703|FG005|Overall Study|Other - As reported by Investigator|0|||
16252684|NCT04634409|39408704|FG006|Overall Study|Other - As reported by Investigator|0|||
16252685|NCT04634409|39408705|FG007|Overall Study|Other - As reported by Investigator|6|||
16252686|NCT04634409|39408706|FG008|Overall Study|Other - As reported by Investigator|4|||
16252687|NCT04634409|39408707|FG009|Overall Study|Other - As reported by Investigator|0|||
16252688|NCT04634409|39408708|FG010|Overall Study|Other - As reported by Investigator|1|||
16252689|NCT04634409|39408709|FG011|Overall Study|Other - As reported by Investigator|2|||
16252690|NCT04634409|39408710|FG012|Overall Study|Other - As reported by Investigator|2|||
16252691|NCT04634409|39408711|FG013|Overall Study|Other - As reported by Investigator|1|||
16252692|NCT04634409|39408712|FG014|Overall Study|Other - As reported by Investigator|0|||
16252693|NCT04634409|39408713|FG015|Overall Study|Other - As reported by Investigator|0|||
16252694|NCT04634409|39408714|FG016|Overall Study|Other - As reported by Investigator|0|||
16252695|NCT04634409|39408715|FG017|Overall Study|Other - As reported by Investigator|0|||
16252696|NCT04634409|39408716|FG018|Overall Study|Other - As reported by Investigator|0|||
16252697|NCT04634409|39408717|FG019|Overall Study|Other - As reported by Investigator|0|||
16252698|NCT04634409|39408718|FG020|Overall Study|Other - As reported by Investigator|0|||
16252699|NCT04634409|39408719|FG021|Overall Study|Other - As reported by Investigator|0|||
16252700|NCT04634409|39408720|FG022|Overall Study|Other - As reported by Investigator|0|||
16252701|NCT04634409|39408721|FG023|Overall Study|Other - As reported by Investigator|0|||
16252702|NCT04634409|39408722|FG024|Overall Study|Other - As reported by Investigator|0|||
16252703|NCT04634409|39408723|FG025|Overall Study|Other - As reported by Investigator|0|||
16252704|NCT04634409|39408724|FG026|Overall Study|Other - As reported by Investigator|0|||
16252705|NCT00810368|39408725|FG000|Overall Study|Lost to Follow-up|4|||
16362740|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
16252706|NCT00810368|39408726|FG001|Overall Study|Lost to Follow-up|2|||
16252707|NCT00810368|39408725|FG000|Overall Study|Lack of Efficacy|2|||
16362741|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
16362742|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
16362743|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
16362744|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
16362745|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
16362746|NCT00408005|39814937|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
16362747|NCT00408005|39814938|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
16362748|NCT00408005|39814939|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
16362749|NCT00408005|39814940|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
16362750|NCT00408005|39814941|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
16362751|NCT00408005|39814942|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
16252708|NCT00810368|39408726|FG001|Overall Study|Lack of Efficacy|0|||
16252709|NCT02022007|39408727|FG000|Overall Study|Withdrawal by Subject|1|||
16252710|NCT02022007|39408728|FG001|Overall Study|Withdrawal by Subject|1|||
16252711|NCT02022007|39408729|FG002|Overall Study|Withdrawal by Subject|1|||
16252712|NCT02022007|39408727|FG000|Overall Study|Noncompliant|0|||
16252713|NCT02022007|39408728|FG001|Overall Study|Noncompliant|0|||
16252714|NCT02022007|39408729|FG002|Overall Study|Noncompliant|1|||
16252715|NCT02636907|39408730|FG000|Autoinjector Assessment Period|Adverse Event|2|||
16252716|NCT02636907|39408730|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
16252717|NCT02636907|39408730|FG000|Extension Phase|Adverse Event|2|||
16252718|NCT02636907|39408730|FG000|Extension Phase|Withdrawal by Subject|4|||
16252719|NCT02636907|39408730|FG000|Extension Phase|Physician Decision|1|||
16252720|NCT02636907|39408730|FG000|Extension Phase|Lost to Follow-up|2|||
16252721|NCT02636907|39408730|FG000|Extension Phase|Lack of Efficacy|1|||
16252722|NCT00543309|39408740|FG000|Overall Study|Physician Decision|0|||
16252723|NCT00543309|39408741|FG001|Overall Study|Physician Decision|1|||
16252724|NCT00543309|39408742|FG002|Overall Study|Physician Decision|0|||
16252725|NCT02114697|39408744|FG000|Overall Study|Study terminated|5|||
16252726|NCT02114697|39408745|FG001|Overall Study|Study terminated|4|||
16252727|NCT01673009|39408746|FG000|Overall Study|Physician Decision|5|||
16252728|NCT01673009|39408746|FG000|Overall Study|Withdrawal by Subject|8|||
16252729|NCT01202747|39408747|FG000|Overall Study|Withdrawal by Subject|1|||
16252730|NCT02564263|39408748|FG000|Overall Study|Adverse Event|31|||
16252731|NCT02564263|39408749|FG001|Overall Study|Adverse Event|29|||
16252732|NCT02564263|39408748|FG000|Overall Study|Death|270|||
16252733|NCT02564263|39408749|FG001|Overall Study|Death|262|||
16252734|NCT02564263|39408748|FG000|Overall Study|Withdrawal by Subject|4|||
16252735|NCT02564263|39408749|FG001|Overall Study|Withdrawal by Subject|19|||
16252736|NCT02564263|39408748|FG000|Overall Study|Sponsor's decision|9|||
16252737|NCT02564263|39408749|FG001|Overall Study|Sponsor's decision|4|||
16252738|NCT00472290|39408750|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
16252739|NCT00472290|39408750|FG000|Overall Study|Protocol Specified Criteria|7|||
16252740|NCT00472290|39408750|FG000|Overall Study|Administrative Decision|37|||
16252741|NCT00472290|39408750|FG000|Overall Study|Death|3|||
16252742|NCT00472290|39408750|FG000|Overall Study|Lost to Follow-up|1|||
16252743|NCT00472290|39408750|FG000|Overall Study|Lack of Efficacy|1|||
16252744|NCT00472290|39408750|FG000|Overall Study|Disease Progression|4|||
16252745|NCT00472290|39408750|FG000|Overall Study|Withdrawal by Subject|5|||
16252746|NCT00472290|39408750|FG000|Overall Study|Adverse Event|6|||
16252747|NCT00472290|39408750|FG000|Overall Study|Requirement for alternative therapy|7|||
16252748|NCT01265784|39408760|FG000|Overall Study|Lost to Follow-up|5|||
16252749|NCT01265784|39408761|FG001|Overall Study|Lost to Follow-up|3|||
16252750|NCT01265784|39408762|FG002|Overall Study|Lost to Follow-up|2|||
16252751|NCT01265784|39408760|FG000|Overall Study|Withdrawal by Subject|0|||
16252752|NCT01265784|39408761|FG001|Overall Study|Withdrawal by Subject|5|||
16252753|NCT01265784|39408762|FG002|Overall Study|Withdrawal by Subject|0|||
16252754|NCT01265784|39408760|FG000|Overall Study|Physician Decision|1|||
16252755|NCT01265784|39408761|FG001|Overall Study|Physician Decision|0|||
16252756|NCT01265784|39408762|FG002|Overall Study|Physician Decision|1|||
16252757|NCT01265784|39408760|FG000|Overall Study|Adverse Event|1|||
16252758|NCT01265784|39408761|FG001|Overall Study|Adverse Event|0|||
16252759|NCT01265784|39408762|FG002|Overall Study|Adverse Event|0|||
16252760|NCT01265784|39408760|FG000|Overall Study|Death|3|||
16252761|NCT01265784|39408761|FG001|Overall Study|Death|0|||
16252762|NCT01265784|39408762|FG002|Overall Study|Death|0|||
16252763|NCT01265784|39408760|FG000|Overall Study|Protocol Violation|2|||
16252764|NCT01265784|39408761|FG001|Overall Study|Protocol Violation|0|||
16252765|NCT01265784|39408762|FG002|Overall Study|Protocol Violation|0|||
16252766|NCT01265784|39408760|FG000|Overall Study|Incorrectly Randomized|0|||
16252767|NCT01265784|39408761|FG001|Overall Study|Incorrectly Randomized|0|||
16252768|NCT01265784|39408762|FG002|Overall Study|Incorrectly Randomized|1|||
16252769|NCT04538170|39408763|FG000|Overall Study|Withdrawal by Subject|104|||
16252770|NCT04538170|39408764|FG001|Overall Study|Withdrawal by Subject|210|||
16252771|NCT01631864|39408765|FG000|Overall Study|Withdrawal by Subject|0|||
16252772|NCT01631864|39408766|FG001|Overall Study|Withdrawal by Subject|1|||
16252773|NCT01631864|39408765|FG000|Overall Study|Adverse Event|2|||
16362752|NCT00408005|39814943|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
16362753|NCT00408005|39814944|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
16252774|NCT01631864|39408766|FG001|Overall Study|Adverse Event|3|||
16252775|NCT02292238|39408767|FG000|Overall Study|Protocol Violation|1|||
16252776|NCT02292238|39408768|FG001|Overall Study|Protocol Violation|2|||
16252777|NCT02292238|39408767|FG000|Overall Study|Withdrawal by Subject|2|||
16252778|NCT02292238|39408768|FG001|Overall Study|Withdrawal by Subject|1|||
16252779|NCT02292238|39408767|FG000|Overall Study|Lost to Follow-up|1|||
16252780|NCT02292238|39408768|FG001|Overall Study|Lost to Follow-up|0|||
16252781|NCT02292238|39408767|FG000|Overall Study|Physician Decision|0|||
16252782|NCT02292238|39408768|FG001|Overall Study|Physician Decision|1|||
16362754|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
16435604|NCT00101686|40074126|FG007|Overall Study|unacceptable toxicity|2|||
16435605|NCT00101686|40074127|FG008|Overall Study|unacceptable toxicity|1|||
16435606|NCT00101686|40074128|FG009|Overall Study|unacceptable toxicity|4|||
16435607|NCT00101686|40074119|FG000|Overall Study|Randomized but did not receive treament|1|||
16435608|NCT00101686|40074120|FG001|Overall Study|Randomized but did not receive treament|6|||
16435609|NCT00101686|40074121|FG002|Overall Study|Randomized but did not receive treament|2|||
16435610|NCT00101686|40074122|FG003|Overall Study|Randomized but did not receive treament|2|||
16435611|NCT00101686|40074123|FG004|Overall Study|Randomized but did not receive treament|2|||
16435612|NCT00101686|40074124|FG005|Overall Study|Randomized but did not receive treament|2|||
16136293|NCT03646656|38986542|FG001|Overall Study|Lost to Follow-up|0|||
16136294|NCT03646656|38986541|FG000|Overall Study|Withdrawal by Subject|2|||
16136295|NCT03646656|38986542|FG001|Overall Study|Withdrawal by Subject|0|||
16136296|NCT01298518|38986543|FG000|Overall Study|Withdrawal by Subject|0|||
16136297|NCT01298518|38986544|FG001|Overall Study|Withdrawal by Subject|0|||
16136298|NCT01298518|38986545|FG002|Overall Study|Withdrawal by Subject|1|||
16136299|NCT01831856|38986546|FG000|Overall Study|Adverse Event|5|||
16136300|NCT01831856|38986547|FG001|Overall Study|Adverse Event|8|||
16136301|NCT01831856|38986546|FG000|Overall Study|Lack of Efficacy|13|||
16136302|NCT01831856|38986547|FG001|Overall Study|Lack of Efficacy|11|||
16136303|NCT01831856|38986546|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
16136304|NCT01831856|38986547|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
16136305|NCT00275262|38986550|FG000|Overall Study|Adverse Event|2|||
16136306|NCT00275262|38986551|FG001|Overall Study|Adverse Event|0|||
16136307|NCT00275262|38986550|FG000|Overall Study|Disease progression|2|||
16136308|NCT00275262|38986551|FG001|Overall Study|Disease progression|5|||
16136309|NCT00275262|38986550|FG000|Overall Study|Lost to Follow-up|0|||
16136310|NCT00275262|38986551|FG001|Overall Study|Lost to Follow-up|2|||
16136311|NCT00275262|38986550|FG000|Overall Study|Protocol Violation|0|||
16136312|NCT00275262|38986551|FG001|Overall Study|Protocol Violation|2|||
16136313|NCT00275262|38986550|FG000|Overall Study|Death|1|||
16136314|NCT00275262|38986551|FG001|Overall Study|Death|0|||
16136315|NCT00275262|38986550|FG000|Overall Study|Started Chemotherapy|1|||
16136316|NCT00275262|38986551|FG001|Overall Study|Started Chemotherapy|0|||
16136317|NCT01136772|38986552|FG000|Overall Study|Adverse Event|15|||
16136318|NCT01136772|38986553|FG001|Overall Study|Adverse Event|14|||
16136319|NCT01136772|38986552|FG000|Overall Study|Lack of Efficacy|42|||
16136320|NCT01136772|38986553|FG001|Overall Study|Lack of Efficacy|39|||
16435613|NCT00101686|40074125|FG006|Overall Study|Randomized but did not receive treament|0|||
16435614|NCT00101686|40074126|FG007|Overall Study|Randomized but did not receive treament|1|||
16435615|NCT00101686|40074127|FG008|Overall Study|Randomized but did not receive treament|0|||
16435616|NCT00101686|40074128|FG009|Overall Study|Randomized but did not receive treament|1|||
16435617|NCT00101686|40074119|FG000|Overall Study|intercurrent non-cancer related illness|0|||
16435618|NCT00101686|40074120|FG001|Overall Study|intercurrent non-cancer related illness|0|||
16435619|NCT00101686|40074121|FG002|Overall Study|intercurrent non-cancer related illness|2|||
16435620|NCT00101686|40074122|FG003|Overall Study|intercurrent non-cancer related illness|0|||
16435621|NCT00101686|40074123|FG004|Overall Study|intercurrent non-cancer related illness|1|||
16435622|NCT00101686|40074124|FG005|Overall Study|intercurrent non-cancer related illness|3|||
16435623|NCT00101686|40074125|FG006|Overall Study|intercurrent non-cancer related illness|1|||
16435624|NCT00101686|40074126|FG007|Overall Study|intercurrent non-cancer related illness|0|||
16435625|NCT00101686|40074127|FG008|Overall Study|intercurrent non-cancer related illness|1|||
16435626|NCT00101686|40074128|FG009|Overall Study|intercurrent non-cancer related illness|1|||
16435627|NCT00101686|40074119|FG000|Overall Study|Physician Decision|10|||
16435628|NCT00101686|40074120|FG001|Overall Study|Physician Decision|13|||
16435629|NCT00101686|40074121|FG002|Overall Study|Physician Decision|6|||
16435630|NCT00101686|40074122|FG003|Overall Study|Physician Decision|7|||
16435631|NCT00101686|40074123|FG004|Overall Study|Physician Decision|8|||
16435632|NCT00101686|40074124|FG005|Overall Study|Physician Decision|9|||
16435633|NCT00101686|40074125|FG006|Overall Study|Physician Decision|5|||
16435634|NCT00101686|40074126|FG007|Overall Study|Physician Decision|5|||
16136321|NCT01136772|38986552|FG000|Overall Study|Administrative|14|||
16136322|NCT01136772|38986553|FG001|Overall Study|Administrative|12|||
16136323|NCT01136772|38986552|FG000|Overall Study|Withdrawal by Subject|33|||
16136324|NCT01136772|38986553|FG001|Overall Study|Withdrawal by Subject|36|||
16136325|NCT01136772|38986552|FG000|Overall Study|Did not receive injection|10|||
16136326|NCT01136772|38986553|FG001|Overall Study|Did not receive injection|7|||
16136327|NCT01136772|38986552|FG000|Overall Study|Did not follow up after first injection|2|||
16136328|NCT01136772|38986553|FG001|Overall Study|Did not follow up after first injection|2|||
16136329|NCT01672723|38986556|FG000|First Intervention|Adverse Event|3|||
16136330|NCT01672723|38986557|FG001|First Intervention|Adverse Event|0|||
16136331|NCT02739360|38986558|FG000|Overall Study|Adverse Event|1|||
16435635|NCT00101686|40074127|FG008|Overall Study|Physician Decision|1|||
16435636|NCT00101686|40074128|FG009|Overall Study|Physician Decision|1|||
16435637|NCT00101686|40074119|FG000|Overall Study|Other|1|||
16435638|NCT00101686|40074120|FG001|Overall Study|Other|4|||
16435639|NCT00101686|40074121|FG002|Overall Study|Other|1|||
16435640|NCT00101686|40074122|FG003|Overall Study|Other|6|||
16435641|NCT00101686|40074123|FG004|Overall Study|Other|2|||
16435642|NCT00101686|40074124|FG005|Overall Study|Other|12|||
16435643|NCT00101686|40074125|FG006|Overall Study|Other|1|||
16435644|NCT00101686|40074126|FG007|Overall Study|Other|5|||
16435645|NCT00101686|40074127|FG008|Overall Study|Other|3|||
16435646|NCT00101686|40074128|FG009|Overall Study|Other|3|||
16435647|NCT00101686|40074119|FG000|Overall Study|Withdrawal by Subject|9|||
16435648|NCT00101686|40074120|FG001|Overall Study|Withdrawal by Subject|8|||
16435649|NCT00101686|40074121|FG002|Overall Study|Withdrawal by Subject|6|||
16435650|NCT00101686|40074122|FG003|Overall Study|Withdrawal by Subject|8|||
16435651|NCT00101686|40074123|FG004|Overall Study|Withdrawal by Subject|8|||
16435652|NCT00101686|40074124|FG005|Overall Study|Withdrawal by Subject|7|||
16136332|NCT02739360|38986558|FG000|Overall Study|Study terminated by Sponsor|2|||
16136333|NCT03181451|38986559|FG000|Overall Study|Adverse Event|0|||
16435653|NCT00101686|40074125|FG006|Overall Study|Withdrawal by Subject|7|||
16435654|NCT00101686|40074126|FG007|Overall Study|Withdrawal by Subject|7|||
16435655|NCT00101686|40074127|FG008|Overall Study|Withdrawal by Subject|8|||
16435656|NCT00101686|40074128|FG009|Overall Study|Withdrawal by Subject|9|||
16435657|NCT02734693|40074131|FG000|Overall Study|Adverse Event|1|||
16435658|NCT02734693|40074132|FG001|Overall Study|Adverse Event|3|||
16435659|NCT02734693|40074133|FG002|Overall Study|Adverse Event|3|||
16435660|NCT02734693|40074131|FG000|Overall Study|Lack of Efficacy|1|||
16435661|NCT02734693|40074132|FG001|Overall Study|Lack of Efficacy|0|||
16435662|NCT02734693|40074133|FG002|Overall Study|Lack of Efficacy|0|||
16435663|NCT02734693|40074131|FG000|Overall Study|Lost to Follow-up|2|||
16435664|NCT02734693|40074132|FG001|Overall Study|Lost to Follow-up|0|||
16435665|NCT02734693|40074133|FG002|Overall Study|Lost to Follow-up|0|||
16435666|NCT02734693|40074131|FG000|Overall Study|Protocol Violation|1|||
16435667|NCT02734693|40074132|FG001|Overall Study|Protocol Violation|0|||
16435668|NCT02734693|40074133|FG002|Overall Study|Protocol Violation|0|||
16435669|NCT02734693|40074131|FG000|Overall Study|Withdrawal by Subject|1|||
16435670|NCT02734693|40074132|FG001|Overall Study|Withdrawal by Subject|0|||
16435671|NCT02734693|40074133|FG002|Overall Study|Withdrawal by Subject|0|||
16435672|NCT02269124|40074136|FG000|Overall Study|Lost to Follow-up|1|||
16435673|NCT02269124|40074137|FG001|Overall Study|Lost to Follow-up|0|||
16435674|NCT02269124|40074136|FG000|Overall Study|Withdrawal by Subject|0|||
16435675|NCT02269124|40074137|FG001|Overall Study|Withdrawal by Subject|2|||
16435676|NCT00668148|40074140|FG000|Overall Study|Adverse Event|5|||
16435677|NCT00668148|40074140|FG000|Overall Study|Subject Non-compliance|1|||
16435678|NCT00668148|40074140|FG000|Overall Study|Progressive Disease Before Treatment|2|||
16435679|NCT00668148|40074140|FG000|Overall Study|Withdrawal of Consent|2|||
16435680|NCT00659061|40074144|FG000|Overall Study|Migration due to political unrest|21|||
16435681|NCT00659061|40074145|FG001|Overall Study|Migration due to political unrest|15|||
16435682|NCT02721875|40074146|FG000|Overall Study|Progressive disease/relapse|1|||
16435683|NCT02721875|40074147|FG001|Overall Study|Progressive disease/relapse|0|||
16435684|NCT00644358|40074148|FG000|Overall Study|Adverse Event|124|||
16435685|NCT00644358|40074148|FG000|Overall Study|Lost to Follow-up|105|||
16435686|NCT00644358|40074148|FG000|Overall Study|Consent Withdrawal|64|||
16435687|NCT00644358|40074148|FG000|Overall Study|Lack of Effectiveness|39|||
16435688|NCT00644358|40074148|FG000|Overall Study|Protocol Violation|5|||
16435689|NCT00644358|40074148|FG000|Overall Study|Noncompliance|14|||
16435690|NCT00644358|40074148|FG000|Overall Study|Other Unspecified|11|||
16435691|NCT02336607|40074157|FG000|Overall Study|Physician Decision|1|||
16435692|NCT02336607|40074158|FG001|Overall Study|Physician Decision|4|||
16435693|NCT02336607|40074159|FG002|Overall Study|Physician Decision|3|||
16435694|NCT02336607|40074160|FG003|Overall Study|Physician Decision|15|||
16435695|NCT02336607|40074157|FG000|Overall Study|Lack of Efficacy|1|||
16435696|NCT02336607|40074158|FG001|Overall Study|Lack of Efficacy|0|||
16435697|NCT02336607|40074159|FG002|Overall Study|Lack of Efficacy|0|||
16435698|NCT02336607|40074160|FG003|Overall Study|Lack of Efficacy|2|||
16435699|NCT02336607|40074157|FG000|Overall Study|Lost to Follow-up|2|||
16435700|NCT02336607|40074158|FG001|Overall Study|Lost to Follow-up|1|||
16435701|NCT02336607|40074159|FG002|Overall Study|Lost to Follow-up|0|||
16435702|NCT02336607|40074160|FG003|Overall Study|Lost to Follow-up|21|||
16435703|NCT02336607|40074157|FG000|Overall Study|Protocol Violation|0|||
16435704|NCT02336607|40074158|FG001|Overall Study|Protocol Violation|1|||
16435705|NCT02336607|40074159|FG002|Overall Study|Protocol Violation|1|||
16435706|NCT02336607|40074160|FG003|Overall Study|Protocol Violation|3|||
16435707|NCT02336607|40074157|FG000|Overall Study|Adverse Event|0|||
16435708|NCT02336607|40074158|FG001|Overall Study|Adverse Event|2|||
16435709|NCT02336607|40074159|FG002|Overall Study|Adverse Event|2|||
16435710|NCT02336607|40074160|FG003|Overall Study|Adverse Event|26|||
16435711|NCT02336607|40074157|FG000|Overall Study|Withdrawal by Subject|0|||
16435712|NCT02336607|40074158|FG001|Overall Study|Withdrawal by Subject|2|||
16435713|NCT02336607|40074159|FG002|Overall Study|Withdrawal by Subject|0|||
16435714|NCT02336607|40074160|FG003|Overall Study|Withdrawal by Subject|20|||
16136334|NCT03181451|38986560|FG001|Overall Study|Adverse Event|1|||
16136335|NCT03181451|38986561|FG002|Overall Study|Adverse Event|0|||
16435715|NCT00962208|40074161|FG000|Overall Study|Could not achieve good vision|9|||
16435716|NCT00962208|40074162|FG001|Overall Study|Could not achieve good vision|0|||
16435717|NCT00962208|40074161|FG000|Overall Study|Contraindicated to continue study|5|||
16252783|NCT03331042|39408769|FG000|Overall Study|Protocol Violation|1|||
16435718|NCT00962208|40074162|FG001|Overall Study|Contraindicated to continue study|1|||
16435719|NCT00962208|40074161|FG000|Overall Study|Lost to Follow-up|0|||
16435720|NCT00962208|40074162|FG001|Overall Study|Lost to Follow-up|9|||
16435721|NCT01980095|40074163|FG000|Overall Study|Lost to Follow-up|6|||
16435722|NCT01980095|40074164|FG001|Overall Study|Lost to Follow-up|7|||
16435723|NCT01980095|40074163|FG000|Overall Study|Withdrawal by Subject|2|||
16435724|NCT01980095|40074164|FG001|Overall Study|Withdrawal by Subject|3|||
16435725|NCT01980095|40074163|FG000|Overall Study|Poor compliance|5|||
16435726|NCT01980095|40074164|FG001|Overall Study|Poor compliance|0|||
16435727|NCT01980095|40074163|FG000|Overall Study|Safety issue|0|||
16252784|NCT03331042|39408770|FG001|Overall Study|Protocol Violation|0|||
16435728|NCT01980095|40074164|FG001|Overall Study|Safety issue|1|||
16435729|NCT01980095|40074163|FG000|Overall Study|Study drug discontinued|1|||
16435730|NCT01980095|40074164|FG001|Overall Study|Study drug discontinued|0|||
16435731|NCT01980095|40074163|FG000|Overall Study|Randomized by mistake|1|||
16136336|NCT03181451|38986559|FG000|Overall Study|Withdrawal by Subject|0|||
16136337|NCT03181451|38986560|FG001|Overall Study|Withdrawal by Subject|1|||
16136338|NCT03181451|38986561|FG002|Overall Study|Withdrawal by Subject|0|||
16136339|NCT00835120|38986562|FG000|Overall Study|Lack of Efficacy|1|||
16136340|NCT00835120|38986562|FG000|Overall Study|Lost to Follow-up|3|||
16136341|NCT00835120|38986562|FG000|Overall Study|Adverse Event|2|||
16136342|NCT00835120|38986562|FG000|Overall Study|Withdrawal by Subject|2|||
16136343|NCT02349360|38986563|FG000|Overall Study|Withdrawal by Subject|0|||
16136344|NCT02349360|38986564|FG001|Overall Study|Withdrawal by Subject|1|||
16136345|NCT02960854|38986565|FG000|Overall Study|Not Disclosed|2|||
16136346|NCT02960854|38986566|FG001|Overall Study|Not Disclosed|2|||
16136347|NCT02960854|38986565|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
16136348|NCT02960854|38986566|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
16136349|NCT02960854|38986565|FG000|Overall Study|Subject Withdrew Consent|0|||
16136350|NCT02960854|38986566|FG001|Overall Study|Subject Withdrew Consent|1|||
16136351|NCT02960854|38986565|FG000|Overall Study|Death|4|||
16136352|NCT02960854|38986566|FG001|Overall Study|Death|6|||
16136353|NCT02446886|38986570|FG000|Overall Study|Adverse Event|1|||
16136354|NCT02446886|38986571|FG001|Overall Study|Adverse Event|3|||
16136355|NCT02446886|38986570|FG000|Overall Study|Withdrawal by Subject|1|||
16136356|NCT02446886|38986571|FG001|Overall Study|Withdrawal by Subject|1|||
16136357|NCT00823901|38986572|FG000|Overall Study|Adverse Event|1|||
16136358|NCT00823901|38986573|FG001|Overall Study|Adverse Event|1|||
16136359|NCT00823901|38986572|FG000|Overall Study|Lack of Efficacy|1|||
16136360|NCT00823901|38986573|FG001|Overall Study|Lack of Efficacy|0|||
16136361|NCT00823901|38986572|FG000|Overall Study|Lost to Follow-up|2|||
16136362|NCT00823901|38986573|FG001|Overall Study|Lost to Follow-up|1|||
16136363|NCT01155375|38986574|FG000|Overall Study|Adverse Event|1|||
16136364|NCT01155375|38986575|FG001|Overall Study|Adverse Event|0|||
16136365|NCT00475033|38986576|FG000|Infant Series|Failed to return|3|||
16136366|NCT00475033|38986577|FG001|Infant Series|Failed to return|4|||
16136367|NCT00475033|38986576|FG000|Infant Series|Parent or legal guardian request|1|||
16136368|NCT00475033|38986577|FG001|Infant Series|Parent or legal guardian request|5|||
16136369|NCT00475033|38986576|FG000|Infant Series|Protocol Violation|1|||
16136370|NCT00475033|38986577|FG001|Infant Series|Protocol Violation|2|||
16136371|NCT00475033|38986576|FG000|Infant Series|Lost to Follow-up|2|||
16136372|NCT00475033|38986577|FG001|Infant Series|Lost to Follow-up|0|||
16136373|NCT00475033|38986576|FG000|Infant Series|Adverse Event|0|||
16136374|NCT00475033|38986577|FG001|Infant Series|Adverse Event|2|||
16136375|NCT00475033|38986576|FG000|After the Infant Series|Adverse Event|0|||
16136376|NCT00475033|38986577|FG001|After the Infant Series|Adverse Event|4|||
16136377|NCT00475033|38986576|FG000|After the Infant Series|Parent or legal guardian request|2|||
16136378|NCT00475033|38986577|FG001|After the Infant Series|Parent or legal guardian request|2|||
16136379|NCT00475033|38986576|FG000|After the Infant Series|Failed to return|2|||
16136380|NCT00475033|38986577|FG001|After the Infant Series|Failed to return|1|||
16136381|NCT00475033|38986576|FG000|After the Infant Series|Protocol Violation|1|||
16136382|NCT00475033|38986577|FG001|After the Infant Series|Protocol Violation|0|||
16136383|NCT00475033|38986576|FG000|After the Infant Series|Lost to Follow-up|1|||
16136384|NCT00475033|38986577|FG001|After the Infant Series|Lost to Follow-up|0|||
16136385|NCT00475033|38986576|FG000|After the Infant Series|Other|0|||
16136386|NCT00475033|38986577|FG001|After the Infant Series|Other|1|||
16136387|NCT00475033|38986576|FG000|Toddler Dose|Parent or legal guardian request|2|||
16136388|NCT00475033|38986577|FG001|Toddler Dose|Parent or legal guardian request|0|||
16136389|NCT00475033|38986576|FG000|Toddler Dose|Failed to return|1|||
16136390|NCT00475033|38986577|FG001|Toddler Dose|Failed to return|0|||
16435732|NCT01980095|40074164|FG001|Overall Study|Randomized by mistake|0|||
16435733|NCT01721161|40074165|FG000|Overall Study|Adverse Event|2|||
16435734|NCT01721161|40074166|FG001|Overall Study|Adverse Event|3|||
16136391|NCT00475033|38986576|FG000|Toddler Dose|Lost to Follow-up|1|||
16435735|NCT01721161|40074165|FG000|Overall Study|Lost to Follow-up|1|||
16252785|NCT03331042|39408771|FG002|Overall Study|Protocol Violation|0|||
16252786|NCT03331042|39408772|FG003|Overall Study|Protocol Violation|0|||
16435736|NCT01721161|40074166|FG001|Overall Study|Lost to Follow-up|2|||
16136392|NCT00475033|38986577|FG001|Toddler Dose|Lost to Follow-up|0|||
16136393|NCT00836095|38986578|FG000|Overall Study|Physician Decision|0|||
16136394|NCT00836095|38986579|FG001|Overall Study|Physician Decision|3|||
16136395|NCT00001962|38986580|FG000|Overall Study|Lack of Efficacy|18|||
16136396|NCT00001962|38986580|FG000|Overall Study|Lack of Accrual|6|||
16136397|NCT00001962|38986580|FG000|Overall Study|Death|1|||
16136398|NCT00001962|38986580|FG000|Overall Study|Lost to Follow-up|2|||
16252787|NCT03331042|39408769|FG000|Overall Study|Physician Decision|0|||
16136399|NCT00001962|38986580|FG000|Overall Study|Adverse Event|1|||
16136400|NCT05220254|38986581|FG000|Overall Study|Withdrawal by Subject|4|||
16362755|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
16136401|NCT05220254|38986581|FG000|Overall Study|Removed due to ineligibility|1|||
16136402|NCT05220254|38986581|FG000|Overall Study|Lost to Follow-up|7|||
16136403|NCT00756470|38986582|FG000|Overall Study|Withdrawal by Subject|1|||
16252788|NCT03331042|39408770|FG001|Overall Study|Physician Decision|0|||
16252789|NCT03331042|39408771|FG002|Overall Study|Physician Decision|1|||
16252790|NCT03331042|39408772|FG003|Overall Study|Physician Decision|0|||
16252791|NCT03331042|39408769|FG000|Overall Study|Lost to Follow-up|0|||
16252792|NCT03331042|39408770|FG001|Overall Study|Lost to Follow-up|0|||
16252793|NCT03331042|39408771|FG002|Overall Study|Lost to Follow-up|0|||
16252794|NCT03331042|39408772|FG003|Overall Study|Lost to Follow-up|1|||
16252795|NCT02204371|39408773|FG000|Overall Study|Adverse Event|1|||
16252796|NCT01977092|39408780|FG000|Overall Study|Death|3|||
16252797|NCT01977092|39408781|FG001|Overall Study|Death|4|||
16252798|NCT01977092|39408780|FG000|Overall Study|Lost to Follow-up|23|||
16252799|NCT01977092|39408781|FG001|Overall Study|Lost to Follow-up|14|||
16252800|NCT01977092|39408780|FG000|Overall Study|Withdrawal by Subject|2|||
16252801|NCT01977092|39408781|FG001|Overall Study|Withdrawal by Subject|1|||
16252802|NCT01977092|39408780|FG000|Overall Study|In prison|3|||
16252803|NCT01977092|39408781|FG001|Overall Study|In prison|11|||
16252804|NCT04471207|39408784|FG000|Overall Study|Lost to Follow-up|4|||
16252805|NCT04471207|39408785|FG001|Overall Study|Lost to Follow-up|1|||
16252806|NCT04471207|39408784|FG000|Overall Study|Medication Contraindication|0|||
16252807|NCT04471207|39408785|FG001|Overall Study|Medication Contraindication|1|||
16252808|NCT04471207|39408784|FG000|Overall Study|Loss of Interest|2|||
16252809|NCT04471207|39408785|FG001|Overall Study|Loss of Interest|1|||
16252810|NCT04471207|39408784|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
16252811|NCT04471207|39408785|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
16252812|NCT04471207|39408784|FG000|Overall Study|Scheduling Conflicts|3|||
16252813|NCT04471207|39408785|FG001|Overall Study|Scheduling Conflicts|1|||
16252814|NCT04471207|39408784|FG000|Overall Study|Physician Decision|1|||
16252815|NCT04471207|39408785|FG001|Overall Study|Physician Decision|0|||
16252816|NCT04471207|39408784|FG000|Overall Study|Unwilling to Use System|0|||
16252817|NCT04471207|39408785|FG001|Overall Study|Unwilling to Use System|1|||
16252818|NCT00193609|39408788|FG000|Overall Study|Lack of Efficacy|2|||
16435737|NCT01721161|40074165|FG000|Overall Study|Withdrawal by Subject|1|||
16252819|NCT00193609|39408788|FG000|Overall Study|Adverse Event|2|||
16252820|NCT00545233|39408789|FG000|Overall Study|Adverse Event|10|||
16252821|NCT00545233|39408790|FG001|Overall Study|Adverse Event|5|||
16252822|NCT00545233|39408789|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
16252823|NCT00545233|39408790|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
16252824|NCT00545233|39408789|FG000|Overall Study|Protocol Violation|2|||
16252825|NCT00545233|39408790|FG001|Overall Study|Protocol Violation|0|||
16252826|NCT00545233|39408789|FG000|Overall Study|Refused Treatment|9|||
16252827|NCT00545233|39408790|FG001|Overall Study|Refused Treatment|7|||
16252828|NCT00545233|39408789|FG000|Overall Study|Failure to Return|4|||
16252829|NCT00545233|39408790|FG001|Overall Study|Failure to Return|6|||
16435738|NCT01721161|40074166|FG001|Overall Study|Withdrawal by Subject|1|||
16435739|NCT01721161|40074165|FG000|Overall Study|Other|0|||
16435740|NCT01721161|40074166|FG001|Overall Study|Other|1|||
16435741|NCT00419393|40074173|FG000|Overall Study|Adverse Event|5|||
16435742|NCT00419393|40074173|FG000|Overall Study|Protocol Violation|5|||
16435743|NCT00419393|40074173|FG000|Overall Study|Withdrawal by Subject|7|||
16435744|NCT00419393|40074173|FG000|Overall Study|Other: Sponsor request|3|||
16435745|NCT00419393|40074173|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
16435746|NCT00419393|40074173|FG000|Overall Study|Other: Site closure|1|||
16435747|NCT00419393|40074173|FG000|Overall Study|Other: Other health problems|1|||
16252830|NCT00545233|39408789|FG000|Overall Study|Insufficient response|14|||
16252831|NCT00545233|39408790|FG001|Overall Study|Insufficient response|15|||
16252832|NCT00545233|39408789|FG000|Overall Study|Physician Decision|2|||
16252833|NCT00545233|39408790|FG001|Overall Study|Physician Decision|1|||
16252834|NCT01475474|39408791|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
16252835|NCT01475474|39408791|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
16252836|NCT01060670|39408794|FG000|Run In|screen failure|0|||
16252837|NCT01060670|39408795|FG001|Run In|screen failure|238|||
16252838|NCT00576381|39408796|FG000|Overall Study|Reoperation|3|||
16435748|NCT00419393|40074173|FG000|Overall Study|Other: Investigator decision|1|||
16435749|NCT02903160|40074176|FG000|Overall Study|Adverse Event|2|||
16252839|NCT00576381|39408796|FG000|Overall Study|Adverse Event|4|||
16252840|NCT02669264|39408797|FG000|Overall Study|Death|5|||
16252841|NCT02669264|39408798|FG001|Overall Study|Death|5|||
16435750|NCT02903160|40074176|FG000|Overall Study|Death|1|||
16435751|NCT02903160|40074176|FG000|Overall Study|Lost to Follow-up|2|||
16435752|NCT02903160|40074176|FG000|Overall Study|Withdrawal by Subject|1|||
16435753|NCT02903160|40074176|FG000|Overall Study|Medical Insurance Barriers|1|||
16435754|NCT00960063|40074179|FG000|Overall Study|Adverse Event|1|||
16435755|NCT00960063|40074180|FG001|Overall Study|Adverse Event|0|||
16435756|NCT00960063|40074181|FG002|Overall Study|Adverse Event|0|||
16435757|NCT00960063|40074179|FG000|Overall Study|Progression of Disease|0|||
16435758|NCT00960063|40074180|FG001|Overall Study|Progression of Disease|0|||
16435759|NCT00960063|40074181|FG002|Overall Study|Progression of Disease|3|||
16435760|NCT03883581|40074186|FG000|Overall Study|Withdrawal by Subject|4|||
16435761|NCT00473434|40074187|FG000|Overall Study|Physician Decision|3|||
16435762|NCT00473434|40074187|FG000|Overall Study|Withdrawal by Subject|9|||
16435763|NCT00473434|40074187|FG000|Overall Study|Compliance|3|||
16435764|NCT00473434|40074187|FG000|Overall Study|Lack of Efficacy|3|||
16252842|NCT02669264|39408799|FG002|Overall Study|Death|3|||
16252843|NCT02669264|39408800|FG003|Overall Study|Death|3|||
16252844|NCT02669264|39408801|FG004|Overall Study|Death|3|||
16252845|NCT02669264|39408802|FG005|Overall Study|Death|6|||
16252846|NCT02669264|39408803|FG006|Overall Study|Death|3|||
16252847|NCT02669264|39408797|FG000|Overall Study|Withdrawal by Subject|0|||
16252848|NCT02669264|39408798|FG001|Overall Study|Withdrawal by Subject|1|||
16252849|NCT02669264|39408799|FG002|Overall Study|Withdrawal by Subject|0|||
16252850|NCT02669264|39408800|FG003|Overall Study|Withdrawal by Subject|0|||
16252851|NCT02669264|39408801|FG004|Overall Study|Withdrawal by Subject|1|||
16252852|NCT02669264|39408802|FG005|Overall Study|Withdrawal by Subject|0|||
16252853|NCT02669264|39408803|FG006|Overall Study|Withdrawal by Subject|0|||
16252854|NCT02669264|39408797|FG000|Overall Study|Lost to Follow-up|0|||
16252855|NCT02669264|39408798|FG001|Overall Study|Lost to Follow-up|0|||
16252856|NCT02669264|39408799|FG002|Overall Study|Lost to Follow-up|0|||
16252857|NCT02669264|39408800|FG003|Overall Study|Lost to Follow-up|0|||
16252858|NCT02669264|39408801|FG004|Overall Study|Lost to Follow-up|1|||
16252859|NCT02669264|39408802|FG005|Overall Study|Lost to Follow-up|0|||
16252860|NCT02669264|39408803|FG006|Overall Study|Lost to Follow-up|0|||
16252861|NCT02669264|39408797|FG000|Overall Study|Miscellaneous|0|||
16252862|NCT02669264|39408798|FG001|Overall Study|Miscellaneous|0|||
16252863|NCT02669264|39408799|FG002|Overall Study|Miscellaneous|0|||
16252864|NCT02669264|39408800|FG003|Overall Study|Miscellaneous|0|||
16252865|NCT02669264|39408801|FG004|Overall Study|Miscellaneous|0|||
16252866|NCT02669264|39408802|FG005|Overall Study|Miscellaneous|0|||
16252867|NCT02669264|39408803|FG006|Overall Study|Miscellaneous|2|||
16252868|NCT01521559|39408805|FG000|Overall Study|Adverse Event|0|||
16252869|NCT01521559|39408806|FG001|Overall Study|Adverse Event|4|||
16252870|NCT01521559|39408805|FG000|Overall Study|Death|1|||
16252871|NCT01521559|39408806|FG001|Overall Study|Death|0|||
16252872|NCT01521559|39408805|FG000|Overall Study|Withdrawal by Subject|9|||
16252873|NCT01521559|39408806|FG001|Overall Study|Withdrawal by Subject|11|||
16252874|NCT01521559|39408805|FG000|Overall Study|Lost to Follow-up|3|||
16252875|NCT01521559|39408806|FG001|Overall Study|Lost to Follow-up|1|||
16252876|NCT01521559|39408805|FG000|Overall Study|Protocol Violation|1|||
16252877|NCT01521559|39408806|FG001|Overall Study|Protocol Violation|0|||
16252878|NCT01521559|39408805|FG000|Overall Study|Other|1|||
16252879|NCT01521559|39408806|FG001|Overall Study|Other|2|||
16252880|NCT00865709|39408807|FG000|Treatment|Adverse Event|9|||
16252881|NCT00865709|39408808|FG001|Treatment|Adverse Event|6|||
16252882|NCT00865709|39408807|FG000|Treatment|Withdrawal by Subject|10|||
16252883|NCT00865709|39408808|FG001|Treatment|Withdrawal by Subject|7|||
16252884|NCT00865709|39408807|FG000|Treatment|Physician Decision|3|||
16252885|NCT00865709|39408808|FG001|Treatment|Physician Decision|2|||
16252886|NCT00865709|39408807|FG000|Treatment|Surgery|8|||
16252887|NCT00865709|39408808|FG001|Treatment|Surgery|3|||
16252888|NCT01958281|39408809|FG000|Overall Study|Lack of Efficacy|5|||
16252889|NCT01958281|39408810|FG001|Overall Study|Lack of Efficacy|2|||
16252890|NCT01958281|39408811|FG002|Overall Study|Lack of Efficacy|0|||
16252891|NCT01958281|39408809|FG000|Overall Study|Adverse Event|0|||
16252892|NCT01958281|39408810|FG001|Overall Study|Adverse Event|2|||
16252893|NCT01958281|39408811|FG002|Overall Study|Adverse Event|0|||
16252894|NCT01958281|39408809|FG000|Overall Study|Withdrew Consent|1|||
16136404|NCT00756470|38986582|FG000|Overall Study|Adverse Event|4|||
16435765|NCT00473434|40074187|FG000|Overall Study|Adverse Event|3|||
16252895|NCT01958281|39408810|FG001|Overall Study|Withdrew Consent|0|||
16252896|NCT01958281|39408811|FG002|Overall Study|Withdrew Consent|0|||
16252897|NCT01193608|39408812|FG000|Overall Study|Other|0|||
16435766|NCT00473434|40074187|FG000|Overall Study|Patient was selling medication to others|1|||
16252898|NCT01193608|39408813|FG001|Overall Study|Other|1|||
16252899|NCT01193608|39408814|FG002|Overall Study|Other|0|||
16252900|NCT01193608|39408815|FG003|Overall Study|Other|0|||
16252901|NCT01193608|39408816|FG004|Overall Study|Other|0|||
16252902|NCT01193608|39408817|FG005|Overall Study|Other|0|||
16435767|NCT00473434|40074187|FG000|Overall Study|Safety evaluation|1|||
16435768|NCT00473434|40074187|FG000|Overall Study|Reason not specified|6|||
16252903|NCT01193608|39408812|FG000|Overall Study|Withdrawal by Subject|0|||
16252904|NCT01193608|39408813|FG001|Overall Study|Withdrawal by Subject|1|||
16252905|NCT01193608|39408814|FG002|Overall Study|Withdrawal by Subject|2|||
16252906|NCT01193608|39408815|FG003|Overall Study|Withdrawal by Subject|3|||
16252907|NCT01193608|39408816|FG004|Overall Study|Withdrawal by Subject|3|||
16252908|NCT01193608|39408817|FG005|Overall Study|Withdrawal by Subject|0|||
16252909|NCT01193608|39408812|FG000|Overall Study|Lost to Follow-up|0|||
16252910|NCT01193608|39408813|FG001|Overall Study|Lost to Follow-up|0|||
16252911|NCT01193608|39408814|FG002|Overall Study|Lost to Follow-up|0|||
16252912|NCT01193608|39408815|FG003|Overall Study|Lost to Follow-up|0|||
16252913|NCT01193608|39408816|FG004|Overall Study|Lost to Follow-up|1|||
16252914|NCT01193608|39408817|FG005|Overall Study|Lost to Follow-up|2|||
16252915|NCT01193608|39408812|FG000|Overall Study|Adverse Event|0|||
16252916|NCT01193608|39408813|FG001|Overall Study|Adverse Event|0|||
16252917|NCT01193608|39408814|FG002|Overall Study|Adverse Event|0|||
16252918|NCT01193608|39408815|FG003|Overall Study|Adverse Event|0|||
16435769|NCT00473434|40074187|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
16435770|NCT00473434|40074187|FG000|Overall Study|Switching to trial medication|1|||
16435771|NCT00473434|40074187|FG000|Overall Study|No longer required|1|||
16435772|NCT02836652|40074188|FG000|Overall Study|Death|3|||
16435773|NCT02836652|40074189|FG001|Overall Study|Death|3|||
16435774|NCT02836652|40074188|FG000|Overall Study|Transplant/Explant|3|||
16435775|NCT02836652|40074189|FG001|Overall Study|Transplant/Explant|4|||
16435776|NCT02836652|40074188|FG000|Overall Study|Withdrawn|9|||
16435777|NCT02836652|40074189|FG001|Overall Study|Withdrawn|9|||
16435778|NCT02836652|40074188|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
16252919|NCT01193608|39408816|FG004|Overall Study|Adverse Event|1|||
16252920|NCT01193608|39408817|FG005|Overall Study|Adverse Event|0|||
16252921|NCT02492958|39408818|FG000|Overall Study|Withdrawal by Subject|0|||
16252922|NCT02492958|39408819|FG001|Overall Study|Withdrawal by Subject|0|||
16252923|NCT02492958|39408820|FG002|Overall Study|Withdrawal by Subject|1|||
16252924|NCT02492958|39408821|FG003|Overall Study|Withdrawal by Subject|0|||
16252925|NCT02492958|39408818|FG000|Overall Study|Adverse Event|1|||
16252926|NCT02492958|39408819|FG001|Overall Study|Adverse Event|0|||
16252927|NCT02492958|39408820|FG002|Overall Study|Adverse Event|1|||
16252928|NCT02492958|39408821|FG003|Overall Study|Adverse Event|0|||
16252929|NCT01694485|39408827|FG000|Overall Study|Withdrawal by Subject|20|||
16252930|NCT01694485|39408828|FG001|Overall Study|Withdrawal by Subject|6|||
16252931|NCT01694485|39408829|FG002|Overall Study|Withdrawal by Subject|7|||
16252932|NCT01694485|39408830|FG003|Overall Study|Withdrawal by Subject|25|||
16252933|NCT01694485|39408831|FG004|Overall Study|Withdrawal by Subject|18|||
16252934|NCT01694485|39408827|FG000|Overall Study|Sponsor Decision|3|||
16252935|NCT01694485|39408828|FG001|Overall Study|Sponsor Decision|0|||
16252936|NCT01694485|39408829|FG002|Overall Study|Sponsor Decision|0|||
16252937|NCT01694485|39408830|FG003|Overall Study|Sponsor Decision|2|||
16252938|NCT01694485|39408831|FG004|Overall Study|Sponsor Decision|0|||
16252939|NCT01694485|39408827|FG000|Overall Study|Lost to Follow-up|9|||
16252940|NCT01694485|39408828|FG001|Overall Study|Lost to Follow-up|1|||
16252941|NCT01694485|39408829|FG002|Overall Study|Lost to Follow-up|6|||
16252942|NCT01694485|39408830|FG003|Overall Study|Lost to Follow-up|10|||
16252943|NCT01694485|39408831|FG004|Overall Study|Lost to Follow-up|7|||
16252944|NCT01694485|39408827|FG000|Overall Study|Death|1|||
16252945|NCT01694485|39408828|FG001|Overall Study|Death|0|||
16252946|NCT01694485|39408829|FG002|Overall Study|Death|0|||
16252947|NCT01694485|39408830|FG003|Overall Study|Death|1|||
16252948|NCT01694485|39408831|FG004|Overall Study|Death|0|||
16252949|NCT04582266|39408832|FG000|Overall Study|Lost to Follow-up|7|||
16252950|NCT04582266|39408833|FG001|Overall Study|Lost to Follow-up|5|||
16252951|NCT04582266|39408832|FG000|Overall Study|Withdrawal by Subject|1|||
16252952|NCT04582266|39408833|FG001|Overall Study|Withdrawal by Subject|0|||
16252953|NCT04582266|39408832|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
16252954|NCT04582266|39408833|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
16252955|NCT02330081|39408834|FG000|Overall Study|Adverse Event|1|||
16252956|NCT02330081|39408834|FG000|Overall Study|Donation did not meet criteria|1|||
16252957|NCT02330081|39408834|FG000|Overall Study|Protocol Violation|6|||
16252958|NCT01133821|39408837|FG000|Overall Study|Lost to Follow-up|8|||
16252959|NCT01133821|39408838|FG001|Overall Study|Lost to Follow-up|11|||
16252960|NCT01133821|39408837|FG000|Overall Study|Withdrawal by Subject|8|||
16252961|NCT01133821|39408838|FG001|Overall Study|Withdrawal by Subject|3|||
16252962|NCT01133821|39408837|FG000|Overall Study|preferred other treatment|1|||
16252963|NCT01133821|39408838|FG001|Overall Study|preferred other treatment|1|||
16252964|NCT01133821|39408837|FG000|Overall Study|Protocol Violation|0|||
16252965|NCT01133821|39408838|FG001|Overall Study|Protocol Violation|1|||
16435779|NCT02836652|40074189|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
16435780|NCT05579977|40074202|FG000|Treatment Phase|Other|0|||
16435781|NCT05579977|40074203|FG001|Treatment Phase|Other|0|||
16252966|NCT01133821|39408837|FG000|Overall Study|Refused participation|1|||
16252967|NCT01133821|39408838|FG001|Overall Study|Refused participation|3|||
16252968|NCT02507375|39408839|FG000|Overall Study|Progressive Disease|4|||
16252969|NCT02507375|39408840|FG001|Overall Study|Progressive Disease|5|||
16252970|NCT02507375|39408839|FG000|Overall Study|Death|0|||
16252971|NCT02507375|39408840|FG001|Overall Study|Death|1|||
16252972|NCT02507375|39408839|FG000|Overall Study|Refused treatment|0|||
16252973|NCT02507375|39408840|FG001|Overall Study|Refused treatment|1|||
16252974|NCT02507375|39408839|FG000|Overall Study|Adverse Event|0|||
16252975|NCT02507375|39408840|FG001|Overall Study|Adverse Event|1|||
16252976|NCT00585351|39408841|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
16252977|NCT00585351|39408842|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
16252978|NCT00585351|39408843|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
16252979|NCT00585351|39408844|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
16252980|NCT00585351|39408845|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
16252981|NCT00585351|39408846|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
16252982|NCT00585351|39408847|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
16252983|NCT00585351|39408848|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
16252984|NCT00585351|39408841|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
16252985|NCT00585351|39408842|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
16252986|NCT00585351|39408843|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
16252987|NCT00585351|39408844|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
16252988|NCT00585351|39408845|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
16252989|NCT00585351|39408846|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
16252990|NCT00585351|39408847|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
16252991|NCT00585351|39408848|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
16252992|NCT00585351|39408841|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
16252993|NCT00585351|39408842|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
16252994|NCT00585351|39408843|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
16252995|NCT00585351|39408844|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
16252996|NCT00585351|39408845|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
16252997|NCT00585351|39408846|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
16252998|NCT00585351|39408847|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
16252999|NCT00585351|39408848|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
16253000|NCT00585351|39408841|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
16253001|NCT00585351|39408842|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
16253002|NCT00585351|39408843|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
16253003|NCT00585351|39408844|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
16253004|NCT00585351|39408845|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
16362756|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
16253005|NCT00585351|39408846|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
16253006|NCT00585351|39408847|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
16253007|NCT00585351|39408848|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
16136405|NCT01740323|38986584|FG000|Overall Study|Adverse Event|1|||
16136406|NCT01740323|38986585|FG001|Overall Study|Adverse Event|0|||
16136407|NCT01740323|38986584|FG000|Overall Study|Randomized but did not take study drug|1|||
16136408|NCT01740323|38986585|FG001|Overall Study|Randomized but did not take study drug|0|||
16136409|NCT04433585|38986588|FG000|Overall Study|Withdrawal by Subject|15|||
16136410|NCT04433585|38986589|FG001|Overall Study|Withdrawal by Subject|3|||
16435782|NCT05579977|40074204|FG002|Treatment Phase|Other|0|||
16136411|NCT04433585|38986590|FG002|Overall Study|Withdrawal by Subject|15|||
16136412|NCT04433585|38986591|FG003|Overall Study|Withdrawal by Subject|6|||
16136413|NCT04433585|38986588|FG000|Overall Study|Adverse Event|10|||
16136414|NCT04433585|38986589|FG001|Overall Study|Adverse Event|4|||
16136415|NCT04433585|38986590|FG002|Overall Study|Adverse Event|1|||
16435783|NCT05579977|40074205|FG003|Treatment Phase|Other|2|||
16435784|NCT05579977|40074206|FG004|Treatment Phase|Other|1|||
16435785|NCT05579977|40074207|FG005|Treatment Phase|Other|2|||
16435786|NCT05579977|40074208|FG006|Treatment Phase|Other|1|||
16435787|NCT05579977|40074209|FG007|Treatment Phase|Other|2|||
16435788|NCT05579977|40074210|FG008|Treatment Phase|Other|2|||
16435789|NCT05579977|40074211|FG009|Treatment Phase|Other|1|||
16435790|NCT05579977|40074212|FG010|Treatment Phase|Other|0|||
16435791|NCT05579977|40074213|FG011|Treatment Phase|Other|0|||
16435792|NCT05579977|40074214|FG012|Treatment Phase|Other|3|||
16435793|NCT05579977|40074202|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
16435794|NCT05579977|40074203|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
16435795|NCT05579977|40074204|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
16435796|NCT05579977|40074205|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
16435797|NCT05579977|40074206|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
16435798|NCT05579977|40074207|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
16435799|NCT05579977|40074208|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
16435800|NCT05579977|40074209|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
16435801|NCT05579977|40074210|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
16435802|NCT05579977|40074211|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
16435803|NCT05579977|40074212|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
16435804|NCT05579977|40074213|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
16435805|NCT05579977|40074214|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
16435806|NCT05579977|40074202|FG000|Treatment Phase|Withdrawal by Subject|2|||
16435807|NCT05579977|40074203|FG001|Treatment Phase|Withdrawal by Subject|0|||
16435808|NCT05579977|40074204|FG002|Treatment Phase|Withdrawal by Subject|0|||
16435809|NCT05579977|40074205|FG003|Treatment Phase|Withdrawal by Subject|1|||
16435810|NCT05579977|40074206|FG004|Treatment Phase|Withdrawal by Subject|2|||
16435811|NCT05579977|40074207|FG005|Treatment Phase|Withdrawal by Subject|0|||
16435812|NCT05579977|40074208|FG006|Treatment Phase|Withdrawal by Subject|1|||
16435813|NCT05579977|40074209|FG007|Treatment Phase|Withdrawal by Subject|8|||
16435814|NCT05579977|40074210|FG008|Treatment Phase|Withdrawal by Subject|3|||
16435815|NCT05579977|40074211|FG009|Treatment Phase|Withdrawal by Subject|3|||
16435816|NCT05579977|40074212|FG010|Treatment Phase|Withdrawal by Subject|5|||
16435817|NCT05579977|40074213|FG011|Treatment Phase|Withdrawal by Subject|1|||
16435818|NCT05579977|40074214|FG012|Treatment Phase|Withdrawal by Subject|3|||
16435819|NCT05579977|40074202|FG000|Treatment Phase|Study terminated by sponsor|70|||
16435820|NCT05579977|40074203|FG001|Treatment Phase|Study terminated by sponsor|70|||
16435821|NCT05579977|40074204|FG002|Treatment Phase|Study terminated by sponsor|61|||
16435822|NCT05579977|40074205|FG003|Treatment Phase|Study terminated by sponsor|59|||
16435823|NCT05579977|40074206|FG004|Treatment Phase|Study terminated by sponsor|63|||
16435824|NCT05579977|40074207|FG005|Treatment Phase|Study terminated by sponsor|53|||
16435825|NCT05579977|40074208|FG006|Treatment Phase|Study terminated by sponsor|66|||
16435826|NCT05579977|40074209|FG007|Treatment Phase|Study terminated by sponsor|48|||
16435827|NCT05579977|40074210|FG008|Treatment Phase|Study terminated by sponsor|47|||
16435828|NCT05579977|40074211|FG009|Treatment Phase|Study terminated by sponsor|37|||
16136416|NCT04433585|38986591|FG003|Overall Study|Adverse Event|0|||
16435829|NCT05579977|40074212|FG010|Treatment Phase|Study terminated by sponsor|44|||
16435830|NCT05579977|40074213|FG011|Treatment Phase|Study terminated by sponsor|36|||
16435831|NCT05579977|40074214|FG012|Treatment Phase|Study terminated by sponsor|32|||
16435832|NCT05579977|40074202|FG000|Treatment Phase|Pregnancy|0|||
16435833|NCT05579977|40074203|FG001|Treatment Phase|Pregnancy|0|||
16435834|NCT05579977|40074204|FG002|Treatment Phase|Pregnancy|0|||
16435835|NCT05579977|40074205|FG003|Treatment Phase|Pregnancy|0|||
16435836|NCT05579977|40074206|FG004|Treatment Phase|Pregnancy|0|||
16136417|NCT04433585|38986588|FG000|Overall Study|Due to the conflict in Ukraine|2|||
16136418|NCT04433585|38986589|FG001|Overall Study|Due to the conflict in Ukraine|1|||
16136419|NCT04433585|38986590|FG002|Overall Study|Due to the conflict in Ukraine|1|||
16136420|NCT04433585|38986591|FG003|Overall Study|Due to the conflict in Ukraine|2|||
16136421|NCT04433585|38986588|FG000|Overall Study|Physician Decision|1|||
16136422|NCT04433585|38986589|FG001|Overall Study|Physician Decision|2|||
16136423|NCT04433585|38986590|FG002|Overall Study|Physician Decision|0|||
16136424|NCT04433585|38986591|FG003|Overall Study|Physician Decision|0|||
16136425|NCT04433585|38986588|FG000|Overall Study|Lost to Follow-up|1|||
16136426|NCT04433585|38986589|FG001|Overall Study|Lost to Follow-up|1|||
16136427|NCT04433585|38986590|FG002|Overall Study|Lost to Follow-up|1|||
16136428|NCT04433585|38986591|FG003|Overall Study|Lost to Follow-up|0|||
16435837|NCT05579977|40074207|FG005|Treatment Phase|Pregnancy|0|||
16435838|NCT05579977|40074208|FG006|Treatment Phase|Pregnancy|0|||
16435839|NCT05579977|40074209|FG007|Treatment Phase|Pregnancy|0|||
16435840|NCT05579977|40074210|FG008|Treatment Phase|Pregnancy|0|||
16435841|NCT05579977|40074211|FG009|Treatment Phase|Pregnancy|1|||
16435842|NCT05579977|40074212|FG010|Treatment Phase|Pregnancy|0|||
16435843|NCT05579977|40074213|FG011|Treatment Phase|Pregnancy|0|||
16435844|NCT05579977|40074214|FG012|Treatment Phase|Pregnancy|0|||
16435845|NCT05579977|40074202|FG000|Treatment Phase|Physician Decision|0|||
16435846|NCT05579977|40074203|FG001|Treatment Phase|Physician Decision|0|||
16435847|NCT05579977|40074204|FG002|Treatment Phase|Physician Decision|0|||
16435848|NCT05579977|40074205|FG003|Treatment Phase|Physician Decision|0|||
16435849|NCT05579977|40074206|FG004|Treatment Phase|Physician Decision|0|||
16435850|NCT05579977|40074207|FG005|Treatment Phase|Physician Decision|0|||
16435851|NCT05579977|40074208|FG006|Treatment Phase|Physician Decision|0|||
16435852|NCT05579977|40074209|FG007|Treatment Phase|Physician Decision|0|||
16435853|NCT05579977|40074210|FG008|Treatment Phase|Physician Decision|0|||
16136429|NCT04433585|38986588|FG000|Overall Study|Lack of Efficacy|0|||
16136430|NCT04433585|38986589|FG001|Overall Study|Lack of Efficacy|1|||
16136431|NCT04433585|38986590|FG002|Overall Study|Lack of Efficacy|1|||
16136432|NCT04433585|38986591|FG003|Overall Study|Lack of Efficacy|1|||
16136433|NCT04433585|38986588|FG000|Overall Study|Death|0|||
16136434|NCT04433585|38986589|FG001|Overall Study|Death|1|||
16136435|NCT04433585|38986590|FG002|Overall Study|Death|0|||
16136436|NCT04433585|38986591|FG003|Overall Study|Death|0|||
16136437|NCT00141726|38986592|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
16136438|NCT03097133|38986595|FG000|Overall Study|Lost to Follow-up|3|||
16136439|NCT03097133|38986596|FG001|Overall Study|Lost to Follow-up|2|||
16136440|NCT03097133|38986595|FG000|Overall Study|Withdrawal by Subject|2|||
16136441|NCT03097133|38986596|FG001|Overall Study|Withdrawal by Subject|5|||
16136442|NCT03097133|38986595|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
16136443|NCT03097133|38986596|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
16136444|NCT03097133|38986595|FG000|Overall Study|Other|3|||
16136445|NCT03097133|38986596|FG001|Overall Study|Other|2|||
16136446|NCT03097133|38986595|FG000|Overall Study|Adverse Event|1|||
16136447|NCT03097133|38986596|FG001|Overall Study|Adverse Event|0|||
16136448|NCT01940354|38986597|FG000|Overall Study|Withdrawal by Subject|4|||
16136449|NCT01940354|38986598|FG001|Overall Study|Withdrawal by Subject|2|||
16136450|NCT01716117|38986602|FG000|Overall Study|Death|5|||
16136451|NCT01716117|38986603|FG001|Overall Study|Death|2|||
16136452|NCT01716117|38986602|FG000|Overall Study|Withdrawal by Subject|2|||
16136453|NCT01716117|38986603|FG001|Overall Study|Withdrawal by Subject|0|||
16136454|NCT03442985|38986606|FG000|Overall Study|Sponsor Request|55|||
16136455|NCT03442985|38986607|FG001|Overall Study|Sponsor Request|60|||
16136456|NCT03442985|38986608|FG002|Overall Study|Sponsor Request|54|||
16136457|NCT03442985|38986606|FG000|Overall Study|Lost to Follow-up|5|||
16136458|NCT03442985|38986607|FG001|Overall Study|Lost to Follow-up|2|||
16136459|NCT03442985|38986608|FG002|Overall Study|Lost to Follow-up|7|||
16136460|NCT03442985|38986606|FG000|Overall Study|Withdrawal by Subject|2|||
16136461|NCT03442985|38986607|FG001|Overall Study|Withdrawal by Subject|3|||
16136462|NCT03442985|38986608|FG002|Overall Study|Withdrawal by Subject|4|||
16136463|NCT03442985|38986606|FG000|Overall Study|Adverse Event|0|||
16136464|NCT03442985|38986607|FG001|Overall Study|Adverse Event|1|||
16136465|NCT03442985|38986608|FG002|Overall Study|Adverse Event|0|||
16136466|NCT02569957|38986609|FG000|Overall Study|Withdrawal by Subject|0|||
16136467|NCT02569957|38986610|FG001|Overall Study|Withdrawal by Subject|1|||
16136468|NCT00728481|38986611|FG000|Overall Study|Withdrawal by Subject|0|||
16136469|NCT00728481|38986612|FG001|Overall Study|Withdrawal by Subject|1|||
16136470|NCT00728481|38986611|FG000|Overall Study|Adverse Event|0|||
16136471|NCT00728481|38986612|FG001|Overall Study|Adverse Event|1|||
16136472|NCT00728481|38986611|FG000|Overall Study|Study medication non-compliance|0|||
16136473|NCT00728481|38986612|FG001|Overall Study|Study medication non-compliance|2|||
16136474|NCT00728481|38986611|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
16435854|NCT05579977|40074211|FG009|Treatment Phase|Physician Decision|0|||
16435855|NCT05579977|40074212|FG010|Treatment Phase|Physician Decision|0|||
16435856|NCT05579977|40074213|FG011|Treatment Phase|Physician Decision|1|||
16435857|NCT05579977|40074214|FG012|Treatment Phase|Physician Decision|0|||
16435858|NCT05579977|40074202|FG000|Treatment Phase|Lost to Follow-up|0|||
16435859|NCT05579977|40074203|FG001|Treatment Phase|Lost to Follow-up|0|||
16435860|NCT05579977|40074204|FG002|Treatment Phase|Lost to Follow-up|0|||
16435861|NCT05579977|40074205|FG003|Treatment Phase|Lost to Follow-up|1|||
16435862|NCT05579977|40074206|FG004|Treatment Phase|Lost to Follow-up|1|||
16435863|NCT05579977|40074207|FG005|Treatment Phase|Lost to Follow-up|1|||
16435864|NCT05579977|40074208|FG006|Treatment Phase|Lost to Follow-up|0|||
16435865|NCT05579977|40074209|FG007|Treatment Phase|Lost to Follow-up|1|||
16435866|NCT05579977|40074210|FG008|Treatment Phase|Lost to Follow-up|2|||
16435867|NCT05579977|40074211|FG009|Treatment Phase|Lost to Follow-up|2|||
16435868|NCT05579977|40074212|FG010|Treatment Phase|Lost to Follow-up|1|||
16435869|NCT05579977|40074213|FG011|Treatment Phase|Lost to Follow-up|4|||
16435870|NCT05579977|40074214|FG012|Treatment Phase|Lost to Follow-up|3|||
16435871|NCT05579977|40074202|FG000|Treatment Phase|Death|1|||
16435872|NCT05579977|40074203|FG001|Treatment Phase|Death|0|||
16435873|NCT05579977|40074204|FG002|Treatment Phase|Death|0|||
16435874|NCT05579977|40074205|FG003|Treatment Phase|Death|0|||
16435875|NCT05579977|40074206|FG004|Treatment Phase|Death|0|||
16435876|NCT05579977|40074207|FG005|Treatment Phase|Death|0|||
16435877|NCT05579977|40074208|FG006|Treatment Phase|Death|0|||
16435878|NCT05579977|40074209|FG007|Treatment Phase|Death|0|||
16435879|NCT05579977|40074210|FG008|Treatment Phase|Death|0|||
16435880|NCT05579977|40074211|FG009|Treatment Phase|Death|0|||
16435881|NCT05579977|40074212|FG010|Treatment Phase|Death|0|||
16435882|NCT05579977|40074213|FG011|Treatment Phase|Death|0|||
16435883|NCT05579977|40074214|FG012|Treatment Phase|Death|0|||
16435884|NCT05579977|40074202|FG000|Treatment Phase|Adverse Event|0|||
16435885|NCT05579977|40074203|FG001|Treatment Phase|Adverse Event|3|||
16435886|NCT05579977|40074204|FG002|Treatment Phase|Adverse Event|11|||
16435887|NCT05579977|40074205|FG003|Treatment Phase|Adverse Event|10|||
16435888|NCT05579977|40074206|FG004|Treatment Phase|Adverse Event|5|||
16435889|NCT05579977|40074207|FG005|Treatment Phase|Adverse Event|17|||
16435890|NCT05579977|40074208|FG006|Treatment Phase|Adverse Event|5|||
16435891|NCT05579977|40074209|FG007|Treatment Phase|Adverse Event|5|||
16435892|NCT05579977|40074210|FG008|Treatment Phase|Adverse Event|12|||
16435893|NCT05579977|40074211|FG009|Treatment Phase|Adverse Event|20|||
16435894|NCT05579977|40074212|FG010|Treatment Phase|Adverse Event|15|||
16435895|NCT05579977|40074213|FG011|Treatment Phase|Adverse Event|24|||
16435896|NCT05579977|40074214|FG012|Treatment Phase|Adverse Event|23|||
16435897|NCT05579977|40074202|FG000|Treatment Phase|Randomized not treated|0|||
16435898|NCT05579977|40074203|FG001|Treatment Phase|Randomized not treated|0|||
16435899|NCT05579977|40074204|FG002|Treatment Phase|Randomized not treated|0|||
16435900|NCT05579977|40074205|FG003|Treatment Phase|Randomized not treated|0|||
16435901|NCT05579977|40074206|FG004|Treatment Phase|Randomized not treated|1|||
16435902|NCT05579977|40074207|FG005|Treatment Phase|Randomized not treated|0|||
16435903|NCT05579977|40074208|FG006|Treatment Phase|Randomized not treated|0|||
16435904|NCT05579977|40074209|FG007|Treatment Phase|Randomized not treated|0|||
16435905|NCT05579977|40074210|FG008|Treatment Phase|Randomized not treated|0|||
16435906|NCT05579977|40074211|FG009|Treatment Phase|Randomized not treated|0|||
16435907|NCT05579977|40074212|FG010|Treatment Phase|Randomized not treated|0|||
16435908|NCT05579977|40074213|FG011|Treatment Phase|Randomized not treated|0|||
16435909|NCT05579977|40074214|FG012|Treatment Phase|Randomized not treated|0|||
16435910|NCT05579977|40074202|FG000|Follow up|Death|1|||
16435911|NCT05579977|40074203|FG001|Follow up|Death|0|||
16435912|NCT05579977|40074204|FG002|Follow up|Death|0|||
16435913|NCT05579977|40074205|FG003|Follow up|Death|0|||
16435914|NCT05579977|40074206|FG004|Follow up|Death|0|||
16435915|NCT05579977|40074207|FG005|Follow up|Death|0|||
16435916|NCT05579977|40074208|FG006|Follow up|Death|0|||
16435917|NCT05579977|40074209|FG007|Follow up|Death|0|||
16435918|NCT05579977|40074210|FG008|Follow up|Death|0|||
16435919|NCT05579977|40074211|FG009|Follow up|Death|0|||
16435920|NCT05579977|40074212|FG010|Follow up|Death|0|||
16435921|NCT05579977|40074213|FG011|Follow up|Death|0|||
16435922|NCT05579977|40074214|FG012|Follow up|Death|0|||
16435923|NCT05579977|40074202|FG000|Follow up|Lost to Follow-up|0|||
16435924|NCT05579977|40074203|FG001|Follow up|Lost to Follow-up|0|||
16435925|NCT05579977|40074204|FG002|Follow up|Lost to Follow-up|0|||
16435926|NCT05579977|40074205|FG003|Follow up|Lost to Follow-up|1|||
16435927|NCT05579977|40074206|FG004|Follow up|Lost to Follow-up|1|||
16435928|NCT05579977|40074207|FG005|Follow up|Lost to Follow-up|2|||
16435929|NCT05579977|40074208|FG006|Follow up|Lost to Follow-up|1|||
16435930|NCT05579977|40074209|FG007|Follow up|Lost to Follow-up|1|||
16435931|NCT05579977|40074210|FG008|Follow up|Lost to Follow-up|3|||
16435932|NCT05579977|40074211|FG009|Follow up|Lost to Follow-up|2|||
16435933|NCT05579977|40074212|FG010|Follow up|Lost to Follow-up|2|||
16435934|NCT05579977|40074213|FG011|Follow up|Lost to Follow-up|4|||
16435935|NCT05579977|40074214|FG012|Follow up|Lost to Follow-up|4|||
16435936|NCT05579977|40074202|FG000|Follow up|Withdrawal by Subject|2|||
16435937|NCT05579977|40074203|FG001|Follow up|Withdrawal by Subject|0|||
16435938|NCT05579977|40074204|FG002|Follow up|Withdrawal by Subject|0|||
16435939|NCT05579977|40074205|FG003|Follow up|Withdrawal by Subject|0|||
16253008|NCT00585351|39408841|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
16136475|NCT00728481|38986612|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
16136476|NCT01488487|38986613|FG000|Overall Study|Adverse Event|6|||
16136477|NCT01488487|38986613|FG000|Overall Study|Death|1|||
16136478|NCT01488487|38986613|FG000|Overall Study|Withdrawal by Subject|2|||
16136479|NCT02342743|38986614|FG000|Baseline Period|Withdrawal by Subject|3|||
16136480|NCT02342743|38986614|FG000|Baseline Period|Lost to Follow-up|2|||
16136481|NCT02342743|38986614|FG000|Baseline Period|Change in prophylactic medication|3|||
16136482|NCT02342743|38986614|FG000|Baseline Period|Screening failure regarding baseline|7|||
16136483|NCT02342743|38986614|FG000|Treatment Period|Withdrawal by Subject|2|||
16136484|NCT02342743|38986614|FG000|Treatment Period|Lost to Follow-up|8|||
16136485|NCT02342743|38986614|FG000|Treatment Period|Change in prophylactic medication|1|||
16136486|NCT01603082|38986620|FG000|Overall Study|Adverse Event|0|||
16136487|NCT01603082|38986621|FG001|Overall Study|Adverse Event|1|||
16136488|NCT01603082|38986620|FG000|Overall Study|Withdrawal by Subject|1|||
16136489|NCT01603082|38986621|FG001|Overall Study|Withdrawal by Subject|0|||
16253009|NCT00585351|39408842|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
16435940|NCT05579977|40074206|FG004|Follow up|Withdrawal by Subject|1|||
16136490|NCT01603082|38986620|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
16435941|NCT05579977|40074207|FG005|Follow up|Withdrawal by Subject|0|||
16435942|NCT05579977|40074208|FG006|Follow up|Withdrawal by Subject|1|||
16136491|NCT01603082|38986621|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
16136492|NCT00760669|38986623|FG000|Overall Study|Not assessed for overall improvement|18|||
16435943|NCT05579977|40074209|FG007|Follow up|Withdrawal by Subject|4|||
16435944|NCT05579977|40074210|FG008|Follow up|Withdrawal by Subject|2|||
16435945|NCT05579977|40074211|FG009|Follow up|Withdrawal by Subject|3|||
16136493|NCT00760669|38986623|FG000|Overall Study|Participants missing efficacy assessment|6|||
16136494|NCT00760669|38986623|FG000|Overall Study|Participants with overlapping cases|1|||
16136495|NCT00760669|38986623|FG000|Overall Study|Took drug before entering in contract|5|||
16136496|NCT01079741|38986624|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
16136497|NCT01079741|38986625|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
16136498|NCT01079741|38986626|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
16136499|NCT01079741|38986627|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
16136500|NCT01079741|38986628|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
16136501|NCT01079741|38986624|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
16136502|NCT01079741|38986625|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
16136503|NCT01079741|38986626|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
16136504|NCT01079741|38986627|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
16136505|NCT01079741|38986628|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
16136506|NCT00634010|38986632|FG000|Overall Study|Adverse Event|2|||
16136507|NCT00634010|38986633|FG001|Overall Study|Adverse Event|5|||
16136508|NCT00634010|38986632|FG000|Overall Study|Withdrawal by Subject|5|||
16136509|NCT00634010|38986633|FG001|Overall Study|Withdrawal by Subject|6|||
16136510|NCT00634010|38986632|FG000|Overall Study|Physician Decision|1|||
16136511|NCT00634010|38986633|FG001|Overall Study|Physician Decision|1|||
16136512|NCT00634010|38986632|FG000|Overall Study|Disease Progression|1|||
16136513|NCT00634010|38986633|FG001|Overall Study|Disease Progression|1|||
16136514|NCT00634010|38986632|FG000|Overall Study|Non-Compliant|1|||
16136515|NCT00634010|38986633|FG001|Overall Study|Non-Compliant|1|||
16136516|NCT02527343|38986637|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
16136517|NCT02527343|38986638|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
16136518|NCT02527343|38986639|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
16136519|NCT02527343|38986640|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
16136520|NCT02527343|38986641|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
16136521|NCT02527343|38986642|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
16136522|NCT02527343|38986637|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
16136523|NCT02527343|38986638|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
16136524|NCT02527343|38986639|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
16136525|NCT02527343|38986640|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
16136526|NCT02527343|38986641|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
16136527|NCT02527343|38986642|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
16136528|NCT02527343|38986637|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16136529|NCT02527343|38986638|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
16136530|NCT02527343|38986639|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16136531|NCT02527343|38986640|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16136532|NCT02527343|38986641|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16136533|NCT02527343|38986642|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16136534|NCT02527343|38986637|FG000|RT Period: Weeks 1 to 52|Other|4|||
16136535|NCT02527343|38986638|FG001|RT Period: Weeks 1 to 52|Other|3|||
16136536|NCT02527343|38986639|FG002|RT Period: Weeks 1 to 52|Other|0|||
16136537|NCT02527343|38986640|FG003|RT Period: Weeks 1 to 52|Other|0|||
16136538|NCT02527343|38986641|FG004|RT Period: Weeks 1 to 52|Other|0|||
16136539|NCT02527343|38986642|FG005|RT Period: Weeks 1 to 52|Other|0|||
16136540|NCT02527343|38986637|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
16136541|NCT02527343|38986638|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
16136542|NCT02527343|38986639|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
16136543|NCT02527343|38986640|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
16136544|NCT02527343|38986641|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
16136545|NCT02527343|38986642|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
16136546|NCT02527343|38986637|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
16136547|NCT02527343|38986638|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
16136548|NCT02527343|38986639|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
16136549|NCT02527343|38986640|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
16136550|NCT02527343|38986641|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
16136551|NCT02527343|38986642|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
16136552|NCT02527343|38986637|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
16253010|NCT00585351|39408843|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
16253011|NCT00585351|39408844|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
16253012|NCT00585351|39408845|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
16253013|NCT00585351|39408846|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
16136553|NCT02527343|38986638|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
16136554|NCT02527343|38986639|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
16136555|NCT02527343|38986640|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
16136556|NCT02527343|38986641|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
16253014|NCT00585351|39408847|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
16253015|NCT00585351|39408848|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
16253016|NCT00585351|39408841|FG000|Enrollment Period (Intervention)|Death|0|||
16253017|NCT00585351|39408842|FG001|Enrollment Period (Intervention)|Death|0|||
16253018|NCT00585351|39408843|FG002|Enrollment Period (Intervention)|Death|0|||
16253019|NCT00585351|39408844|FG003|Enrollment Period (Intervention)|Death|0|||
16253020|NCT00585351|39408845|FG004|Enrollment Period (Intervention)|Death|1|||
16253021|NCT00585351|39408846|FG005|Enrollment Period (Intervention)|Death|0|||
16253022|NCT00585351|39408847|FG006|Enrollment Period (Intervention)|Death|1|||
16253023|NCT00585351|39408848|FG007|Enrollment Period (Intervention)|Death|0|||
16253024|NCT00585351|39408841|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
16253025|NCT00585351|39408842|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
16253026|NCT00585351|39408843|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
16253027|NCT00585351|39408844|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
16253028|NCT00585351|39408845|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
16253029|NCT00585351|39408846|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
16253030|NCT00585351|39408847|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
16253031|NCT00585351|39408848|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
16253032|NCT03443869|39408849|FG000|Overall Study|Death|3|||
16253033|NCT03443869|39408850|FG001|Overall Study|Death|3|||
16253034|NCT03443869|39408849|FG000|Overall Study|Withdrawal by Subject|34|||
16253035|NCT03443869|39408850|FG001|Overall Study|Withdrawal by Subject|22|||
16253036|NCT03443869|39408849|FG000|Overall Study|Lost to Follow-up|1|||
16253037|NCT03443869|39408850|FG001|Overall Study|Lost to Follow-up|2|||
16253038|NCT03443869|39408849|FG000|Overall Study|Physician Decision|3|||
16253039|NCT03443869|39408850|FG001|Overall Study|Physician Decision|3|||
16253040|NCT03443869|39408849|FG000|Overall Study|Other|4|||
16253041|NCT03443869|39408850|FG001|Overall Study|Other|4|||
16253042|NCT02568384|39408851|FG000|Overall Study|Mobile devices incompatible with App|2|||
16253043|NCT00718159|39408858|FG000|Overall Study|Progressive Disease|3|||
16253044|NCT00718159|39408859|FG001|Overall Study|Progressive Disease|3|||
16253045|NCT00718159|39408860|FG002|Overall Study|Progressive Disease|2|||
16253046|NCT00718159|39408861|FG003|Overall Study|Progressive Disease|0|||
16253047|NCT00718159|39408862|FG004|Overall Study|Progressive Disease|6|||
16253048|NCT00718159|39408863|FG005|Overall Study|Progressive Disease|0|||
16253049|NCT00718159|39408864|FG006|Overall Study|Progressive Disease|0|||
16253050|NCT00718159|39408858|FG000|Overall Study|Death due to Adverse Event|0|||
16253051|NCT00718159|39408859|FG001|Overall Study|Death due to Adverse Event|0|||
16253052|NCT00718159|39408860|FG002|Overall Study|Death due to Adverse Event|0|||
16253053|NCT00718159|39408861|FG003|Overall Study|Death due to Adverse Event|2|||
16253054|NCT00718159|39408862|FG004|Overall Study|Death due to Adverse Event|2|||
16253055|NCT00718159|39408863|FG005|Overall Study|Death due to Adverse Event|0|||
16253056|NCT00718159|39408864|FG006|Overall Study|Death due to Adverse Event|0|||
16253057|NCT00718159|39408858|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
16253058|NCT00718159|39408859|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
16253059|NCT00718159|39408860|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
16253060|NCT00718159|39408861|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
16253061|NCT00718159|39408862|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
16253062|NCT00718159|39408863|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
16253063|NCT00718159|39408864|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
16253064|NCT00718159|39408858|FG000|Overall Study|Investigator Decision|0|||
16253065|NCT00718159|39408859|FG001|Overall Study|Investigator Decision|0|||
16253066|NCT00718159|39408860|FG002|Overall Study|Investigator Decision|0|||
16253067|NCT00718159|39408861|FG003|Overall Study|Investigator Decision|0|||
16253068|NCT00718159|39408862|FG004|Overall Study|Investigator Decision|0|||
16253069|NCT00718159|39408863|FG005|Overall Study|Investigator Decision|1|||
16253070|NCT00718159|39408864|FG006|Overall Study|Investigator Decision|1|||
16253071|NCT00929708|39408865|FG000|Overall Study|Protocol Violation|2|||
16435946|NCT05579977|40074212|FG010|Follow up|Withdrawal by Subject|3|||
16253072|NCT00929708|39408866|FG001|Overall Study|Protocol Violation|1|||
16253073|NCT00929708|39408867|FG002|Overall Study|Protocol Violation|1|||
16253074|NCT00929708|39408868|FG003|Overall Study|Protocol Violation|1|||
16253075|NCT00929708|39408869|FG004|Overall Study|Protocol Violation|1|||
16253076|NCT00929708|39408865|FG000|Overall Study|Withdrawal by Subject|2|||
16253077|NCT00929708|39408866|FG001|Overall Study|Withdrawal by Subject|0|||
16253078|NCT00929708|39408867|FG002|Overall Study|Withdrawal by Subject|0|||
16253079|NCT00929708|39408868|FG003|Overall Study|Withdrawal by Subject|2|||
16253080|NCT00929708|39408869|FG004|Overall Study|Withdrawal by Subject|1|||
16253081|NCT00929708|39408865|FG000|Overall Study|Adverse Event|0|||
16253082|NCT00929708|39408866|FG001|Overall Study|Adverse Event|0|||
16253083|NCT00929708|39408867|FG002|Overall Study|Adverse Event|0|||
16253084|NCT00929708|39408868|FG003|Overall Study|Adverse Event|0|||
16253085|NCT00929708|39408869|FG004|Overall Study|Adverse Event|3|||
16253086|NCT00929708|39408865|FG000|Overall Study|Physician Decision|0|||
16253087|NCT00929708|39408866|FG001|Overall Study|Physician Decision|2|||
16253088|NCT00929708|39408867|FG002|Overall Study|Physician Decision|2|||
16253089|NCT00929708|39408868|FG003|Overall Study|Physician Decision|2|||
16253090|NCT00929708|39408869|FG004|Overall Study|Physician Decision|1|||
16253091|NCT00929708|39408865|FG000|Overall Study|Lost to Follow-up|0|||
16253092|NCT00929708|39408866|FG001|Overall Study|Lost to Follow-up|0|||
16253093|NCT00929708|39408867|FG002|Overall Study|Lost to Follow-up|0|||
16253094|NCT00929708|39408868|FG003|Overall Study|Lost to Follow-up|1|||
16253095|NCT00929708|39408869|FG004|Overall Study|Lost to Follow-up|0|||
16253096|NCT02192099|39408878|FG000|Overall Study|Adverse Event|1|||
16253097|NCT02192099|39408878|FG000|Overall Study|Lost to Follow-up|2|||
16253098|NCT02192099|39408878|FG000|Overall Study|Physician Decision|1|||
16253099|NCT02192099|39408878|FG000|Overall Study|Pregnancy|1|||
16253100|NCT02192099|39408878|FG000|Overall Study|Protocol Violation|8|||
16253101|NCT02192099|39408878|FG000|Overall Study|Study Terminated by Sponsor|32|||
16253102|NCT02192099|39408878|FG000|Overall Study|Withdrawal by Subject|11|||
16253103|NCT02192099|39408878|FG000|Overall Study|Miscellaneous Reasons|5|||
16253104|NCT00536575|39408879|FG000|Overall Study|Withdrawal by Subject|1|||
16253105|NCT00536575|39408879|FG000|Overall Study|Death|1|||
16253106|NCT00996736|39408885|FG000|Overall Study|Death|1|||
16253107|NCT00996736|39408886|FG001|Overall Study|Death|1|||
16253108|NCT00996736|39408885|FG000|Overall Study|Lost to Follow-up|15|||
16253109|NCT00996736|39408886|FG001|Overall Study|Lost to Follow-up|14|||
16253110|NCT00996736|39408885|FG000|Overall Study|Visit not within 3-month window|5|||
16253111|NCT00996736|39408886|FG001|Overall Study|Visit not within 3-month window|3|||
16253112|NCT02346201|39408887|FG000|Overall Study|Adverse Event|3|||
16253113|NCT02346201|39408888|FG001|Overall Study|Adverse Event|2|||
16253114|NCT02346201|39408887|FG000|Overall Study|Lost to Follow-up|1|||
16253115|NCT02346201|39408888|FG001|Overall Study|Lost to Follow-up|0|||
16253116|NCT02346201|39408887|FG000|Overall Study|Withdrawal by Subject|6|||
16253117|NCT02346201|39408888|FG001|Overall Study|Withdrawal by Subject|3|||
16253118|NCT02346201|39408887|FG000|Overall Study|Unavailable for future follow-up|0|||
16253119|NCT02346201|39408888|FG001|Overall Study|Unavailable for future follow-up|1|||
16253120|NCT02346201|39408887|FG000|Overall Study|Physician Decision|0|||
16253121|NCT02346201|39408888|FG001|Overall Study|Physician Decision|1|||
16253122|NCT02346201|39408887|FG000|Overall Study|Missed final visit|0|||
16253123|NCT02346201|39408888|FG001|Overall Study|Missed final visit|2|||
16253124|NCT04128007|39408889|FG000|Overall Study|Withdrawal by Subject|9|||
16253125|NCT04128007|39408890|FG001|Overall Study|Withdrawal by Subject|6|||
16253126|NCT04128007|39408889|FG000|Overall Study|Protocol Violation|1|||
16253127|NCT04128007|39408890|FG001|Overall Study|Protocol Violation|0|||
16253128|NCT04128007|39408889|FG000|Overall Study|Lost to Follow-up|8|||
16253129|NCT04128007|39408890|FG001|Overall Study|Lost to Follow-up|7|||
16253130|NCT04128007|39408889|FG000|Overall Study|Adverse Event|5|||
16253131|NCT04128007|39408890|FG001|Overall Study|Adverse Event|2|||
16253132|NCT04128007|39408889|FG000|Overall Study|Not reported|0|||
16253133|NCT04128007|39408890|FG001|Overall Study|Not reported|2|||
16253134|NCT00294723|39408897|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
16253135|NCT00294723|39408898|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
16253136|NCT00294723|39408899|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
16253137|NCT00294723|39408897|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
16253138|NCT00294723|39408898|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
16253139|NCT00294723|39408899|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
16253140|NCT00294723|39408897|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
16253141|NCT00294723|39408898|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
16253142|NCT00294723|39408899|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
16253143|NCT00294723|39408897|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
16253144|NCT00294723|39408898|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
16253145|NCT00294723|39408899|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
16253146|NCT00294723|39408897|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
16253147|NCT00294723|39408898|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
16253148|NCT00294723|39408899|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
16253149|NCT00294723|39408897|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
16253150|NCT00294723|39408898|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
16253151|NCT00294723|39408899|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
16253152|NCT00294723|39408897|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
16253153|NCT00294723|39408898|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
16253154|NCT00294723|39408899|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
16253155|NCT00294723|39408897|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
16253156|NCT00294723|39408898|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
16253157|NCT00294723|39408899|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
16253158|NCT00294723|39408897|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
16253159|NCT00294723|39408898|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
16253160|NCT00294723|39408899|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
16253161|NCT00294723|39408897|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
16253162|NCT00294723|39408898|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
16253163|NCT00294723|39408899|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
16253164|NCT00294723|39408897|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
16253165|NCT00294723|39408898|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
16253166|NCT00294723|39408899|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
16253167|NCT00294723|39408897|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
16253168|NCT00294723|39408898|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
16253169|NCT00294723|39408899|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
16253170|NCT01957488|39408900|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
16253171|NCT01957488|39408901|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
16253172|NCT01957488|39408902|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
16253173|NCT01957488|39408903|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
16253174|NCT01957488|39408904|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
16253175|NCT01957488|39408905|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
16253176|NCT01957488|39408900|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
16253177|NCT01957488|39408901|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
16253178|NCT01957488|39408902|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
16253179|NCT01957488|39408903|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
16253180|NCT01957488|39408904|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
16253181|NCT01957488|39408905|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
16253182|NCT01957488|39408900|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
16253183|NCT01957488|39408901|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
16253184|NCT01957488|39408902|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
16253185|NCT01957488|39408903|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
16253186|NCT01957488|39408904|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
16253187|NCT01957488|39408905|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
16253188|NCT01957488|39408900|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16253189|NCT01957488|39408901|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16253190|NCT01957488|39408902|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16253191|NCT01957488|39408903|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
16253192|NCT01957488|39408904|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
16253193|NCT01957488|39408905|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
16253194|NCT01957488|39408900|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
16253195|NCT01957488|39408901|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
16253196|NCT01957488|39408902|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
16253197|NCT01957488|39408903|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
16253198|NCT01957488|39408904|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
16253199|NCT01957488|39408905|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
16253200|NCT01957488|39408900|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
16253201|NCT01957488|39408901|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
16253202|NCT01957488|39408902|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
16253203|NCT01957488|39408903|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
16253204|NCT01957488|39408904|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
16253205|NCT01957488|39408905|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
16253206|NCT01957488|39408900|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
16253207|NCT01957488|39408901|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
16253208|NCT01957488|39408902|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
16253209|NCT01957488|39408903|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
16253210|NCT01957488|39408904|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
16253211|NCT01957488|39408905|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
16253212|NCT01957488|39408900|FG000|Test Period 2 (2 Weeks)|Other|1|||
16253213|NCT01957488|39408901|FG001|Test Period 2 (2 Weeks)|Other|0|||
16253214|NCT01957488|39408902|FG002|Test Period 2 (2 Weeks)|Other|0|||
16253215|NCT01957488|39408903|FG003|Test Period 2 (2 Weeks)|Other|0|||
16253216|NCT01957488|39408904|FG004|Test Period 2 (2 Weeks)|Other|0|||
16253217|NCT01957488|39408905|FG005|Test Period 2 (2 Weeks)|Other|0|||
16253218|NCT01957488|39408900|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
16253219|NCT01957488|39408901|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
16253220|NCT01957488|39408902|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
16253221|NCT01957488|39408903|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
16253222|NCT01957488|39408904|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
16253223|NCT01957488|39408905|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
16253224|NCT01957488|39408900|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
16253225|NCT01957488|39408901|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
16253226|NCT01957488|39408902|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
16253227|NCT01957488|39408903|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
16253228|NCT01957488|39408904|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
16253229|NCT01957488|39408905|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
16253230|NCT01957488|39408900|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
16253231|NCT01957488|39408901|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
16253232|NCT01957488|39408902|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
16253233|NCT01957488|39408903|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
16253234|NCT01957488|39408904|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
16253235|NCT01957488|39408905|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
16253236|NCT01957488|39408900|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
16253237|NCT01957488|39408901|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
16253238|NCT01957488|39408902|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
16253239|NCT01957488|39408903|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
16253240|NCT01957488|39408904|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
16253241|NCT01957488|39408905|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
16253242|NCT01957488|39408900|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
16253243|NCT01957488|39408901|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
16253244|NCT01957488|39408902|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
16253245|NCT01957488|39408903|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
16253246|NCT01957488|39408904|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
16253247|NCT01957488|39408905|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
16253248|NCT00566709|39408910|FG000|Overall Study|Protocol Violation|5|||
16253249|NCT00566709|39408911|FG001|Overall Study|Protocol Violation|0|||
16253250|NCT01703741|39412874|FG000|Overall Study|Withdrawal by Subject|6|||
16253251|NCT01703741|39412874|FG000|Overall Study|Adverse Event|2|||
16253252|NCT01703741|39412874|FG000|Overall Study|Physician Decision|2|||
16253253|NCT01703741|39412874|FG000|Overall Study|Protocol Violation|1|||
16253254|NCT01703741|39412874|FG000|Overall Study|Lost to Follow-up|3|||
16253255|NCT01703741|39412874|FG000|Overall Study|Subject did not want to continue|2|||
16253256|NCT01703741|39412874|FG000|Overall Study|Subject cannot comply with study visits|1|||
16253257|NCT01703741|39412874|FG000|Overall Study|Subject started testosterone injections|1|||
16253258|NCT00502775|39412875|FG000|Overall Study|Adverse Event|1|||
16253259|NCT00502775|39412876|FG001|Overall Study|Adverse Event|2|||
16253260|NCT00502775|39412877|FG002|Overall Study|Adverse Event|1|||
16253261|NCT00502775|39412875|FG000|Overall Study|Protocol Violation|1|||
16253262|NCT00502775|39412876|FG001|Overall Study|Protocol Violation|5|||
16253263|NCT00502775|39412877|FG002|Overall Study|Protocol Violation|2|||
16253264|NCT00502775|39412875|FG000|Overall Study|Withdrawal by Subject|1|||
16253265|NCT00502775|39412876|FG001|Overall Study|Withdrawal by Subject|1|||
16253266|NCT00502775|39412877|FG002|Overall Study|Withdrawal by Subject|2|||
16253267|NCT00502775|39412875|FG000|Overall Study|Sponsor Terminated Study|1|||
16253268|NCT00502775|39412876|FG001|Overall Study|Sponsor Terminated Study|0|||
16253269|NCT00502775|39412877|FG002|Overall Study|Sponsor Terminated Study|1|||
16253270|NCT00502775|39412875|FG000|Overall Study|Non-compliance with eDiary|4|||
16253271|NCT00502775|39412876|FG001|Overall Study|Non-compliance with eDiary|1|||
16253272|NCT00502775|39412877|FG002|Overall Study|Non-compliance with eDiary|1|||
16253273|NCT00502775|39412875|FG000|Overall Study|Subject unable to swallow capsule|1|||
16253274|NCT00502775|39412876|FG001|Overall Study|Subject unable to swallow capsule|0|||
16253275|NCT00502775|39412877|FG002|Overall Study|Subject unable to swallow capsule|1|||
16253276|NCT00502775|39412875|FG000|Overall Study|Logpad compliance <80%|1|||
16253277|NCT00502775|39412876|FG001|Overall Study|Logpad compliance <80%|0|||
16253278|NCT00502775|39412877|FG002|Overall Study|Logpad compliance <80%|0|||
16253279|NCT00502775|39412875|FG000|Overall Study|Randomized in error|0|||
16253280|NCT00502775|39412876|FG001|Overall Study|Randomized in error|1|||
16253281|NCT00502775|39412877|FG002|Overall Study|Randomized in error|1|||
16253282|NCT00502775|39412875|FG000|Overall Study|Non-compliance|0|||
16253283|NCT00502775|39412876|FG001|Overall Study|Non-compliance|2|||
16253284|NCT00502775|39412877|FG002|Overall Study|Non-compliance|2|||
16253285|NCT00502775|39412875|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
16253286|NCT00502775|39412876|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
16253287|NCT00502775|39412877|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
16253288|NCT00502775|39412875|FG000|Overall Study|Declining pollen counts|0|||
16253289|NCT00502775|39412876|FG001|Overall Study|Declining pollen counts|1|||
16253290|NCT00502775|39412877|FG002|Overall Study|Declining pollen counts|1|||
16253291|NCT00502775|39412875|FG000|Overall Study|Subject in jail|0|||
16253292|NCT00502775|39412876|FG001|Overall Study|Subject in jail|1|||
16253293|NCT00502775|39412877|FG002|Overall Study|Subject in jail|0|||
16253294|NCT00502775|39412875|FG000|Overall Study|Subject took disallowed drug|0|||
16253295|NCT00502775|39412876|FG001|Overall Study|Subject took disallowed drug|0|||
16253296|NCT00502775|39412877|FG002|Overall Study|Subject took disallowed drug|1|||
16253297|NCT01691248|39412878|FG000|Overall Study|Protocol Violation|43|||
16253298|NCT01691248|39412879|FG001|Overall Study|Protocol Violation|27|||
16253299|NCT01691248|39412878|FG000|Overall Study|Adverse Event|24|||
16253300|NCT01691248|39412879|FG001|Overall Study|Adverse Event|22|||
16253301|NCT01691248|39412878|FG000|Overall Study|Withdrawal by Subject|20|||
16253302|NCT01691248|39412879|FG001|Overall Study|Withdrawal by Subject|18|||
16253303|NCT01691248|39412878|FG000|Overall Study|Confirmed CDAD|14|||
16253304|NCT01691248|39412879|FG001|Overall Study|Confirmed CDAD|31|||
16253305|NCT01691248|39412878|FG000|Overall Study|Lost to Follow-up|2|||
16253306|NCT01691248|39412879|FG001|Overall Study|Lost to Follow-up|5|||
16253307|NCT01691248|39412878|FG000|Overall Study|Reason not provided|4|||
16253308|NCT01691248|39412879|FG001|Overall Study|Reason not provided|4|||
16253309|NCT01691248|39412878|FG000|Overall Study|Not Treated|4|||
16253310|NCT01691248|39412879|FG001|Overall Study|Not Treated|7|||
16253311|NCT01574248|39412880|FG000|Overall Study|Withdrawal by Subject|2|||
16253312|NCT01574248|39412881|FG001|Overall Study|Withdrawal by Subject|0|||
16253313|NCT01574248|39412880|FG000|Overall Study|Missing primary endpoint data|1|||
16253314|NCT01574248|39412881|FG001|Overall Study|Missing primary endpoint data|0|||
16253315|NCT01296932|39412882|FG000|Overall Study|Dose limiting toxicity|0|||
16253316|NCT01296932|39412883|FG001|Overall Study|Dose limiting toxicity|0|||
16253317|NCT01296932|39412884|FG002|Overall Study|Dose limiting toxicity|0|||
16253318|NCT01296932|39412885|FG003|Overall Study|Dose limiting toxicity|0|||
16253319|NCT01296932|39412886|FG004|Overall Study|Dose limiting toxicity|0|||
16253320|NCT01296932|39412887|FG005|Overall Study|Dose limiting toxicity|0|||
16253321|NCT01296932|39412888|FG006|Overall Study|Dose limiting toxicity|1|||
16253322|NCT01296932|39412889|FG007|Overall Study|Dose limiting toxicity|0|||
16253323|NCT01296932|39412890|FG008|Overall Study|Dose limiting toxicity|1|||
16253324|NCT01296932|39412882|FG000|Overall Study|Progressive disease|2|||
16253325|NCT01296932|39412883|FG001|Overall Study|Progressive disease|0|||
16253326|NCT01296932|39412884|FG002|Overall Study|Progressive disease|1|||
16253327|NCT01296932|39412885|FG003|Overall Study|Progressive disease|1|||
16253328|NCT01296932|39412886|FG004|Overall Study|Progressive disease|2|||
16253329|NCT01296932|39412887|FG005|Overall Study|Progressive disease|3|||
16253330|NCT01296932|39412888|FG006|Overall Study|Progressive disease|1|||
16253331|NCT01296932|39412889|FG007|Overall Study|Progressive disease|0|||
16253332|NCT01296932|39412890|FG008|Overall Study|Progressive disease|0|||
16253333|NCT01296932|39412882|FG000|Overall Study|Withdrawal by Subject|0|||
16362757|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
16253334|NCT01296932|39412883|FG001|Overall Study|Withdrawal by Subject|0|||
16253335|NCT01296932|39412884|FG002|Overall Study|Withdrawal by Subject|1|||
16253336|NCT01296932|39412885|FG003|Overall Study|Withdrawal by Subject|1|||
16253337|NCT01296932|39412886|FG004|Overall Study|Withdrawal by Subject|0|||
16253338|NCT01296932|39412887|FG005|Overall Study|Withdrawal by Subject|0|||
16253339|NCT01296932|39412888|FG006|Overall Study|Withdrawal by Subject|3|||
16253340|NCT01296932|39412889|FG007|Overall Study|Withdrawal by Subject|0|||
16253341|NCT01296932|39412890|FG008|Overall Study|Withdrawal by Subject|0|||
16253342|NCT01296932|39412882|FG000|Overall Study|Adverse Event|1|||
16253343|NCT01296932|39412883|FG001|Overall Study|Adverse Event|1|||
16253344|NCT01296932|39412884|FG002|Overall Study|Adverse Event|1|||
16253345|NCT01296932|39412885|FG003|Overall Study|Adverse Event|2|||
16253346|NCT01296932|39412886|FG004|Overall Study|Adverse Event|1|||
16253347|NCT01296932|39412887|FG005|Overall Study|Adverse Event|0|||
16253348|NCT01296932|39412888|FG006|Overall Study|Adverse Event|0|||
16253349|NCT01296932|39412889|FG007|Overall Study|Adverse Event|0|||
16253350|NCT01296932|39412890|FG008|Overall Study|Adverse Event|1|||
16253351|NCT01296932|39412882|FG000|Overall Study|Investigator decision|0|||
16253352|NCT01296932|39412883|FG001|Overall Study|Investigator decision|1|||
16253353|NCT01296932|39412884|FG002|Overall Study|Investigator decision|0|||
16253354|NCT01296932|39412885|FG003|Overall Study|Investigator decision|1|||
16253355|NCT01296932|39412886|FG004|Overall Study|Investigator decision|0|||
16253356|NCT01296932|39412887|FG005|Overall Study|Investigator decision|0|||
16253357|NCT01296932|39412888|FG006|Overall Study|Investigator decision|1|||
16253358|NCT01296932|39412889|FG007|Overall Study|Investigator decision|0|||
16435947|NCT05579977|40074213|FG011|Follow up|Withdrawal by Subject|1|||
16435948|NCT05579977|40074214|FG012|Follow up|Withdrawal by Subject|3|||
16435949|NCT01664910|40074215|FG000|Overall Study|Adverse Event|0|||
16435950|NCT01664910|40074216|FG001|Overall Study|Adverse Event|0|||
16435951|NCT01664910|40074217|FG002|Overall Study|Adverse Event|1|||
16435952|NCT04564846|40074218|FG000|Overall Study|Withdrawal by Subject|2|||
16435953|NCT04564846|40074219|FG001|Overall Study|Withdrawal by Subject|1|||
16435954|NCT04564846|40074218|FG000|Overall Study|Physician Decision|0|||
16253359|NCT01296932|39412890|FG008|Overall Study|Investigator decision|1|||
16253360|NCT01296932|39412882|FG000|Overall Study|No clinical benefit anymore|0|||
16253361|NCT01296932|39412883|FG001|Overall Study|No clinical benefit anymore|1|||
16253362|NCT01296932|39412884|FG002|Overall Study|No clinical benefit anymore|0|||
16253363|NCT01296932|39412885|FG003|Overall Study|No clinical benefit anymore|0|||
16253364|NCT01296932|39412886|FG004|Overall Study|No clinical benefit anymore|0|||
16253365|NCT01296932|39412887|FG005|Overall Study|No clinical benefit anymore|0|||
16253366|NCT01296932|39412888|FG006|Overall Study|No clinical benefit anymore|0|||
16253367|NCT01296932|39412889|FG007|Overall Study|No clinical benefit anymore|0|||
16253368|NCT01296932|39412890|FG008|Overall Study|No clinical benefit anymore|0|||
16253369|NCT01296932|39412882|FG000|Overall Study|Physician Decision|0|||
16253370|NCT01296932|39412883|FG001|Overall Study|Physician Decision|0|||
16253371|NCT01296932|39412884|FG002|Overall Study|Physician Decision|1|||
16253372|NCT01296932|39412885|FG003|Overall Study|Physician Decision|0|||
16253373|NCT01296932|39412886|FG004|Overall Study|Physician Decision|0|||
16253374|NCT01296932|39412887|FG005|Overall Study|Physician Decision|0|||
16253375|NCT01296932|39412888|FG006|Overall Study|Physician Decision|0|||
16435955|NCT04564846|40074219|FG001|Overall Study|Physician Decision|1|||
16253376|NCT01296932|39412889|FG007|Overall Study|Physician Decision|0|||
16435956|NCT04564846|40074218|FG000|Overall Study|Lost to Follow-up|0|||
16435957|NCT04564846|40074219|FG001|Overall Study|Lost to Follow-up|1|||
16435958|NCT04564846|40074218|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
16253377|NCT01296932|39412890|FG008|Overall Study|Physician Decision|0|||
16253378|NCT01296932|39412882|FG000|Overall Study|IV problems, administration not possible|0|||
16253379|NCT01296932|39412883|FG001|Overall Study|IV problems, administration not possible|0|||
16253380|NCT01296932|39412884|FG002|Overall Study|IV problems, administration not possible|1|||
16253381|NCT01296932|39412885|FG003|Overall Study|IV problems, administration not possible|0|||
16253382|NCT01296932|39412886|FG004|Overall Study|IV problems, administration not possible|0|||
16253383|NCT01296932|39412887|FG005|Overall Study|IV problems, administration not possible|0|||
16253384|NCT01296932|39412888|FG006|Overall Study|IV problems, administration not possible|0|||
16253385|NCT01296932|39412889|FG007|Overall Study|IV problems, administration not possible|0|||
16253386|NCT01296932|39412890|FG008|Overall Study|IV problems, administration not possible|0|||
16435959|NCT04564846|40074219|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
16435960|NCT04564846|40074218|FG000|Overall Study|Subject non-compliance|1|||
16435961|NCT04564846|40074219|FG001|Overall Study|Subject non-compliance|0|||
16435962|NCT00660192|40074220|FG000|Overall Study|Lost to Follow-up|2|||
16435963|NCT00660192|40074221|FG001|Overall Study|Lost to Follow-up|3|||
16435964|NCT01759420|40074222|FG000|Overall Study|Screen failure|5|||
16435965|NCT01759420|40074222|FG000|Overall Study|Inaccurate EKG machine readings|1|||
16435966|NCT01574274|40074223|FG000|Overall Study|Ineligible|0|||
16435967|NCT01574274|40074224|FG001|Overall Study|Ineligible|1|||
16435968|NCT01574274|40074223|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
16136557|NCT02527343|38986642|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
16136558|NCT02527343|38986637|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
16136559|NCT02527343|38986638|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
16136560|NCT02527343|38986639|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
16136561|NCT02527343|38986640|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
16136562|NCT02527343|38986641|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
16136563|NCT02527343|38986642|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
16136564|NCT02527343|38986637|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
16136565|NCT02527343|38986638|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
16136566|NCT02527343|38986639|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
16136567|NCT02527343|38986640|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
16136568|NCT02527343|38986641|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
16136569|NCT02527343|38986642|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
16136570|NCT02527343|38986637|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
16136571|NCT02527343|38986638|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
16136572|NCT02527343|38986639|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
16136573|NCT02527343|38986640|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
16136574|NCT02527343|38986641|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
16136575|NCT02527343|38986642|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
16136576|NCT02527343|38986637|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
16136577|NCT02527343|38986638|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
16136578|NCT02527343|38986639|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
16136579|NCT02527343|38986640|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
16136580|NCT02527343|38986641|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
16136581|NCT02527343|38986642|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
16136582|NCT02527343|38986637|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
16136583|NCT02527343|38986638|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
16136584|NCT02527343|38986639|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
16136585|NCT02527343|38986640|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
16136586|NCT02527343|38986641|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
16136587|NCT02527343|38986642|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
16136588|NCT02527343|38986637|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
16136589|NCT02527343|38986638|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
16136590|NCT02527343|38986639|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
16136591|NCT02527343|38986640|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
16136592|NCT02527343|38986641|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
16136593|NCT02527343|38986642|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
16136594|NCT00769860|38986643|FG000|Overall Study|Withdrawal by Subject|2|||
16136595|NCT00769860|38986644|FG001|Overall Study|Withdrawal by Subject|0|||
16136596|NCT00402597|38986645|FG000|Overall Study|Death|15|||
16136597|NCT00402597|38986646|FG001|Overall Study|Death|7|||
16136598|NCT00402597|38986647|FG002|Overall Study|Death|6|||
16136599|NCT00402597|38986648|FG003|Overall Study|Death|4|||
16435969|NCT01574274|40074224|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
16435970|NCT01574274|40074223|FG000|Overall Study|Ph+ B-ALL|3|||
16435971|NCT01574274|40074224|FG001|Overall Study|Ph+ B-ALL|4|||
16435972|NCT01574274|40074223|FG000|Overall Study|Induction Death|2|||
16435973|NCT01574274|40074224|FG001|Overall Study|Induction Death|0|||
16435974|NCT01574274|40074223|FG000|Overall Study|Induction Failure|4|||
16435975|NCT01574274|40074224|FG001|Overall Study|Induction Failure|1|||
16435976|NCT01574274|40074223|FG000|Overall Study|Adverse Event|16|||
16435977|NCT01574274|40074224|FG001|Overall Study|Adverse Event|13|||
16435978|NCT01574274|40074223|FG000|Overall Study|Remission Death|1|||
16435979|NCT01574274|40074224|FG001|Overall Study|Remission Death|0|||
16435980|NCT01574274|40074223|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
16435981|NCT01574274|40074224|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
16435982|NCT01574274|40074223|FG000|Overall Study|Other, unknown|3|||
16435983|NCT01574274|40074224|FG001|Overall Study|Other, unknown|2|||
16435984|NCT00117637|40074227|FG000|First Intervention (Period 1)|Adverse Event|11|||
16435985|NCT00117637|40074228|FG001|First Intervention (Period 1)|Adverse Event|16|||
16435986|NCT00117637|40074227|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
16435987|NCT00117637|40074228|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
16435988|NCT00117637|40074227|FG000|First Intervention (Period 1)|Protocol Violation|1|||
16435989|NCT00117637|40074228|FG001|First Intervention (Period 1)|Protocol Violation|0|||
16435990|NCT00117637|40074227|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
16435991|NCT00117637|40074228|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
16435992|NCT00117637|40074227|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
16435993|NCT00117637|40074228|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
16136600|NCT00402597|38986649|FG004|Overall Study|Death|6|||
16136601|NCT00402597|38986645|FG000|Overall Study|Adverse Event|81|||
16136602|NCT00402597|38986646|FG001|Overall Study|Adverse Event|18|||
16136603|NCT00402597|38986647|FG002|Overall Study|Adverse Event|106|||
16136604|NCT00402597|38986648|FG003|Overall Study|Adverse Event|39|||
16136605|NCT00402597|38986649|FG004|Overall Study|Adverse Event|71|||
16136606|NCT00402597|38986645|FG000|Overall Study|Lost to Follow-up|8|||
16136607|NCT00402597|38986646|FG001|Overall Study|Lost to Follow-up|1|||
16136608|NCT00402597|38986647|FG002|Overall Study|Lost to Follow-up|8|||
16136609|NCT00402597|38986648|FG003|Overall Study|Lost to Follow-up|2|||
16136610|NCT00402597|38986649|FG004|Overall Study|Lost to Follow-up|3|||
16136611|NCT00402597|38986645|FG000|Overall Study|Withdrawal by Subject|57|||
16136612|NCT00402597|38986646|FG001|Overall Study|Withdrawal by Subject|16|||
16136613|NCT00402597|38986647|FG002|Overall Study|Withdrawal by Subject|65|||
16136614|NCT00402597|38986648|FG003|Overall Study|Withdrawal by Subject|15|||
16136615|NCT00402597|38986649|FG004|Overall Study|Withdrawal by Subject|24|||
16136616|NCT00402597|38986645|FG000|Overall Study|reason not specified|30|||
16136617|NCT00402597|38986646|FG001|Overall Study|reason not specified|4|||
16136618|NCT00402597|38986647|FG002|Overall Study|reason not specified|27|||
16136619|NCT00402597|38986648|FG003|Overall Study|reason not specified|14|||
16136620|NCT00402597|38986649|FG004|Overall Study|reason not specified|20|||
16136621|NCT03021954|38986650|FG000|Overall Study|Lost to Follow-up|10|||
16136622|NCT03021954|38986651|FG001|Overall Study|Lost to Follow-up|43|||
16136623|NCT03021954|38986650|FG000|Overall Study|Subjects had avulsion trauma|4|||
16136624|NCT03021954|38986651|FG001|Overall Study|Subjects had avulsion trauma|1|||
16136625|NCT00066742|38986654|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
16136626|NCT00066742|38986654|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
16136627|NCT00066742|38986654|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
16136628|NCT00066742|38986654|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
16136629|NCT00066742|38986654|FG000|Induction Chemoradiotherapy|Ineligible|3|||
16136630|NCT00066742|38986654|FG000|Consolidation Chemotherapy|not protocol specified|1|||
16136631|NCT00066742|38986654|FG000|Consolidation Chemotherapy|Ineligible|2|||
16136632|NCT00323297|38986660|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
16136633|NCT00323297|38986661|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
16136634|NCT00323297|38986660|FG000|Part A (Double Blind Randomized)|Death|0|||
16136635|NCT00323297|38986661|FG001|Part A (Double Blind Randomized)|Death|1|||
16136636|NCT00323297|38986660|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
16136637|NCT00323297|38986661|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
16136638|NCT00323297|38986660|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
16136639|NCT00323297|38986661|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
16136640|NCT00323297|38986660|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
16136641|NCT00323297|38986661|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
16136642|NCT00323297|38986660|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
16136643|NCT00323297|38986661|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
16136644|NCT00323297|38986660|FG000|Part B (Open-label)|Death|0|||
16136645|NCT00323297|38986661|FG001|Part B (Open-label)|Death|1|||
16136646|NCT00323297|38986660|FG000|Part B (Open-label)|Reason unspecified|0|||
16136647|NCT00323297|38986661|FG001|Part B (Open-label)|Reason unspecified|1|||
16136648|NCT00323297|38986660|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
16136649|NCT00323297|38986661|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
16253387|NCT01296932|39412882|FG000|Overall Study|per protocol|0|||
16253388|NCT01296932|39412883|FG001|Overall Study|per protocol|0|||
16253389|NCT01296932|39412884|FG002|Overall Study|per protocol|1|||
16253390|NCT01296932|39412885|FG003|Overall Study|per protocol|1|||
16136650|NCT00323297|38986660|FG000|Part B (Open-label)|Lack of Efficacy|3|||
16136651|NCT00323297|38986661|FG001|Part B (Open-label)|Lack of Efficacy|1|||
16136652|NCT00323297|38986660|FG000|Part B (Open-label)|Adverse Event|5|||
16136653|NCT00323297|38986661|FG001|Part B (Open-label)|Adverse Event|5|||
16136654|NCT00323297|38986660|FG000|Part B (Open-label)|Protocol Violation|0|||
16136655|NCT00323297|38986661|FG001|Part B (Open-label)|Protocol Violation|1|||
16136656|NCT00686725|38986662|FG000|Overall Study|Adverse Event|1|||
16136657|NCT00686725|38986663|FG001|Overall Study|Adverse Event|1|||
16136658|NCT00686725|38986662|FG000|Overall Study|Progressive Disease|17|||
16136659|NCT00686725|38986663|FG001|Overall Study|Progressive Disease|23|||
16136660|NCT00686725|38986662|FG000|Overall Study|Lost to Follow-up|7|||
16136661|NCT00686725|38986663|FG001|Overall Study|Lost to Follow-up|5|||
16136662|NCT00686725|38986662|FG000|Overall Study|Death|6|||
16136663|NCT00686725|38986663|FG001|Overall Study|Death|3|||
16136664|NCT00686725|38986662|FG000|Overall Study|Withdrawal by Subject|13|||
16136665|NCT00686725|38986663|FG001|Overall Study|Withdrawal by Subject|4|||
16136666|NCT00686725|38986662|FG000|Overall Study|Protocol Violation|1|||
16136667|NCT00686725|38986663|FG001|Overall Study|Protocol Violation|3|||
16136668|NCT00686725|38986662|FG000|Overall Study|Other|1|||
16136669|NCT00686725|38986663|FG001|Overall Study|Other|3|||
16136670|NCT01640054|38986667|FG000|Overall Study|Study-specific disc criteria|1|||
16136671|NCT01640054|38986667|FG000|Overall Study|Lack of Efficacy|3|||
16136672|NCT01640054|38986667|FG000|Overall Study|Adverse Event|2|||
16136673|NCT01013285|38986668|FG000|Overall Study|Death|48|||
16136674|NCT01013285|38986669|FG001|Overall Study|Death|89|||
16136675|NCT01440374|38986672|FG000|Part 1: Open-label Phase|Adverse Event|5|||
16136676|NCT01440374|38986673|FG001|Part 1: Open-label Phase|Adverse Event|0|||
16136677|NCT01440374|38986674|FG002|Part 1: Open-label Phase|Adverse Event|0|||
16136678|NCT01440374|38986675|FG003|Part 1: Open-label Phase|Adverse Event|0|||
16136679|NCT01440374|38986672|FG000|Part 1: Open-label Phase|Physician Decision|1|||
16136680|NCT01440374|38986673|FG001|Part 1: Open-label Phase|Physician Decision|0|||
16136681|NCT01440374|38986674|FG002|Part 1: Open-label Phase|Physician Decision|0|||
16136682|NCT01440374|38986675|FG003|Part 1: Open-label Phase|Physician Decision|0|||
16136683|NCT01440374|38986672|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
16136684|NCT01440374|38986673|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
16136685|NCT01440374|38986674|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
16136686|NCT01440374|38986675|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
16136687|NCT01440374|38986672|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
16136688|NCT01440374|38986673|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
16136689|NCT01440374|38986674|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
16136690|NCT01440374|38986675|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
16136691|NCT01440374|38986672|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
16136692|NCT01440374|38986673|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
16136693|NCT01440374|38986674|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
16136694|NCT01440374|38986675|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
16136695|NCT01440374|38986672|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
16136696|NCT01440374|38986673|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
16136697|NCT01440374|38986674|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
16136698|NCT01440374|38986675|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
16136699|NCT01440374|38986672|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
16136700|NCT01440374|38986673|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
16136701|NCT01440374|38986674|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
16136702|NCT01440374|38986675|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
16136703|NCT01440374|38986672|FG000|Part 2; Double-blind Phase|Not treated|0|||
16136704|NCT01440374|38986673|FG001|Part 2; Double-blind Phase|Not treated|0|||
16136705|NCT01440374|38986674|FG002|Part 2; Double-blind Phase|Not treated|1|||
16136706|NCT01440374|38986675|FG003|Part 2; Double-blind Phase|Not treated|0|||
16136707|NCT01440374|38986672|FG000|Part 3: Extension|Withdrawal by Subject|0|||
16136708|NCT01440374|38986673|FG001|Part 3: Extension|Withdrawal by Subject|0|||
16136709|NCT01440374|38986674|FG002|Part 3: Extension|Withdrawal by Subject|0|||
16136710|NCT01440374|38986675|FG003|Part 3: Extension|Withdrawal by Subject|5|||
16136711|NCT01440374|38986672|FG000|Part 3: Extension|Adverse Event|0|||
16136712|NCT01440374|38986673|FG001|Part 3: Extension|Adverse Event|0|||
16136713|NCT01440374|38986674|FG002|Part 3: Extension|Adverse Event|0|||
16136714|NCT01440374|38986675|FG003|Part 3: Extension|Adverse Event|13|||
16136715|NCT01440374|38986672|FG000|Part 3: Extension|Physician Decision|0|||
16136716|NCT01440374|38986673|FG001|Part 3: Extension|Physician Decision|0|||
16136717|NCT01440374|38986674|FG002|Part 3: Extension|Physician Decision|0|||
16136718|NCT01440374|38986675|FG003|Part 3: Extension|Physician Decision|14|||
16136719|NCT02471833|38986676|FG000|Overall Study|Lost to Follow-up|1|||
16136720|NCT02471833|38986677|FG001|Overall Study|Lost to Follow-up|0|||
16136721|NCT02471833|38986678|FG002|Overall Study|Lost to Follow-up|0|||
16136722|NCT02471833|38986676|FG000|Overall Study|Withdrawal by Subject|2|||
16136723|NCT02471833|38986677|FG001|Overall Study|Withdrawal by Subject|1|||
16136724|NCT02471833|38986678|FG002|Overall Study|Withdrawal by Subject|5|||
16136725|NCT02101034|38986679|FG000|Overall Study|Enrolled but did not start treatment|0|||
16136726|NCT02101034|38986680|FG001|Overall Study|Enrolled but did not start treatment|0|||
16136727|NCT02101034|38986681|FG002|Overall Study|Enrolled but did not start treatment|1|||
16136728|NCT02101034|38986682|FG003|Overall Study|Enrolled but did not start treatment|0|||
16136729|NCT02101034|38986683|FG004|Overall Study|Enrolled but did not start treatment|0|||
16136730|NCT03118674|38986684|FG000|Overall Study|Lost to Follow-up|2|||
16136731|NCT03118674|38986684|FG000|Overall Study|Screen Faliure|8|||
16136732|NCT03118674|38986684|FG000|Overall Study|Withdrawal by Subject|5|||
16136733|NCT01480284|38986688|FG000|Overall Study|Withdrawal by Subject|2|||
16136734|NCT01480284|38986689|FG001|Overall Study|Withdrawal by Subject|0|||
16136735|NCT01480284|38986688|FG000|Overall Study|Adverse Event|1|||
16136736|NCT01480284|38986689|FG001|Overall Study|Adverse Event|0|||
16136737|NCT01480284|38986688|FG000|Overall Study|Study closed/terminated|3|||
16136738|NCT01480284|38986689|FG001|Overall Study|Study closed/terminated|0|||
16136739|NCT01480284|38986688|FG000|Overall Study|Lost to Follow-up|1|||
16136740|NCT01480284|38986689|FG001|Overall Study|Lost to Follow-up|0|||
16136741|NCT01480284|38986688|FG000|Overall Study|Physician Decision|1|||
16136742|NCT01480284|38986689|FG001|Overall Study|Physician Decision|0|||
16136743|NCT05266586|38986691|FG000|Overall Study|Adverse Event|2|||
16136744|NCT05266586|38986692|FG001|Overall Study|Adverse Event|2|||
16136745|NCT05266586|38986693|FG002|Overall Study|Adverse Event|1|||
16136746|NCT05266586|38986691|FG000|Overall Study|Withdrawal by Subject|1|||
16136747|NCT05266586|38986692|FG001|Overall Study|Withdrawal by Subject|0|||
16136748|NCT05266586|38986693|FG002|Overall Study|Withdrawal by Subject|1|||
16136749|NCT05266586|38986691|FG000|Overall Study|Non-compliance with study drug|0|||
16136750|NCT05266586|38986692|FG001|Overall Study|Non-compliance with study drug|1|||
16136751|NCT05266586|38986693|FG002|Overall Study|Non-compliance with study drug|0|||
16136752|NCT05266586|38986691|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
16136753|NCT05266586|38986692|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
16136754|NCT05266586|38986693|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
16136755|NCT03019185|38986702|FG000|Overall Study|Lost to Follow-up|3|||
16136756|NCT03019185|38986703|FG001|Overall Study|Lost to Follow-up|0|||
16136757|NCT03019185|38986704|FG002|Overall Study|Lost to Follow-up|2|||
16136758|NCT03019185|38986702|FG000|Overall Study|Withdrawal by Subject|1|||
16136759|NCT03019185|38986703|FG001|Overall Study|Withdrawal by Subject|1|||
16136760|NCT03019185|38986704|FG002|Overall Study|Withdrawal by Subject|0|||
16136761|NCT03019185|38986702|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
16136762|NCT03019185|38986703|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
16136763|NCT03019185|38986704|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
16136764|NCT03019185|38986702|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
16136765|NCT03019185|38986703|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
16136766|NCT03019185|38986704|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
16136767|NCT01890148|38986708|FG000|Overall Study|Adverse Event|1|||
16136768|NCT02196714|38986709|FG000|Overall Study|Protocol Violation|0|||
16136769|NCT02196714|38986710|FG001|Overall Study|Protocol Violation|0|||
16136770|NCT02196714|38986711|FG002|Overall Study|Protocol Violation|1|||
16136771|NCT02196714|38986712|FG003|Overall Study|Protocol Violation|0|||
16136772|NCT01607554|38986713|FG000|Overall Study|Disease progression|2|||
16136773|NCT02808143|38986715|FG000|Maintenance Phase|Disease recurrence|1|||
16136774|NCT02808143|38986716|FG001|Maintenance Phase|Disease recurrence|3|||
16136775|NCT02808143|38986715|FG000|Maintenance Phase|Disease progression|1|||
16136776|NCT02808143|38986716|FG001|Maintenance Phase|Disease progression|2|||
16136777|NCT02808143|38986715|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
16136778|NCT02808143|38986716|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
16136779|NCT02808143|38986715|FG000|Survival Follow-Up|Disease recurrence|0|||
16136780|NCT02808143|38986716|FG001|Survival Follow-Up|Disease recurrence|2|||
16136781|NCT02808143|38986715|FG000|Survival Follow-Up|Adverse Event|0|||
16136782|NCT02808143|38986716|FG001|Survival Follow-Up|Adverse Event|1|||
16136783|NCT02808143|38986715|FG000|Survival Follow-Up|Death|1|||
16136784|NCT02808143|38986716|FG001|Survival Follow-Up|Death|0|||
16136785|NCT03353350|38986723|FG000|30-week Core Treatment Period|Protocol Violation|1|||
16136786|NCT03353350|38986724|FG001|30-week Core Treatment Period|Protocol Violation|1|||
16136787|NCT03353350|38986725|FG002|30-week Core Treatment Period|Protocol Violation|1|||
16136788|NCT03353350|38986726|FG003|30-week Core Treatment Period|Protocol Violation|0|||
16136789|NCT03353350|38986723|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
16136790|NCT03353350|38986724|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
16136791|NCT03353350|38986725|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
16136792|NCT03353350|38986726|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
16136793|NCT03353350|38986723|FG000|30-week Core Treatment Period|Adverse Event|0|||
16136794|NCT03353350|38986724|FG001|30-week Core Treatment Period|Adverse Event|4|||
16136795|NCT03353350|38986725|FG002|30-week Core Treatment Period|Adverse Event|2|||
16136796|NCT03353350|38986726|FG003|30-week Core Treatment Period|Adverse Event|3|||
16136797|NCT03353350|38986723|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
16136798|NCT03353350|38986724|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
16136799|NCT03353350|38986725|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
16136800|NCT03353350|38986726|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
16136801|NCT03353350|38986723|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
16136802|NCT03353350|38986724|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
16136803|NCT03353350|38986725|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
16136804|NCT03353350|38986726|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
16136805|NCT03353350|38986723|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
16136806|NCT03353350|38986724|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
16136807|NCT03353350|38986725|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
16136808|NCT03353350|38986726|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
16136809|NCT03353350|38986723|FG000|26-week Treatment Extension Period|Adverse Event|1|||
16136810|NCT03353350|38986724|FG001|26-week Treatment Extension Period|Adverse Event|0|||
16136811|NCT03353350|38986725|FG002|26-week Treatment Extension Period|Adverse Event|0|||
16136812|NCT03353350|38986726|FG003|26-week Treatment Extension Period|Adverse Event|1|||
16136813|NCT03353350|38986723|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
16136814|NCT03353350|38986724|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
16136815|NCT03353350|38986725|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
16136816|NCT03353350|38986726|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
16136817|NCT02319525|38986727|FG000|Overall Study|Withdrawal by Subject|2|||
16136818|NCT02319525|38986728|FG001|Overall Study|Withdrawal by Subject|1|||
16136819|NCT03718533|38986729|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
16136820|NCT03718533|38986729|FG000|Overall Study|Protocol deviation|1|||
16136821|NCT03718533|38986729|FG000|Overall Study|Disease progression|1|||
16136822|NCT03718533|38986729|FG000|Overall Study|Relapse|1|||
16136823|NCT03718533|38986729|FG000|Overall Study|Physician Decision|2|||
16136824|NCT03718533|38986729|FG000|Overall Study|Physician Decision and Adverse Event|1|||
16136825|NCT01794923|38986730|FG000|Overall Study|Adverse Event|0|||
16136826|NCT01794923|38986731|FG001|Overall Study|Adverse Event|0|||
16136827|NCT01794923|38986732|FG002|Overall Study|Adverse Event|1|||
16136828|NCT01802567|38986733|FG000|Overall Study|Withdrawal by Subject|2|||
16136829|NCT01802567|38986733|FG000|Overall Study|Physician Decision|1|||
16136830|NCT01802567|38986733|FG000|Overall Study|Lack of Efficacy|7|||
16136831|NCT01802567|38986733|FG000|Overall Study|Consented but did not start therapy|7|||
16136832|NCT01802567|38986733|FG000|Overall Study|Protocol Violation|1|||
16136833|NCT00007345|38986734|FG000|Overall Study|Refused further treatment|0|||
16136834|NCT00007345|38986735|FG001|Overall Study|Refused further treatment|7|||
16136835|NCT00007345|38986734|FG000|Overall Study|Switched to alternative treatment|0|||
16136836|NCT00007345|38986735|FG001|Overall Study|Switched to alternative treatment|3|||
16136837|NCT00007345|38986734|FG000|Overall Study|Intercurrent illness|1|||
16136838|NCT00007345|38986735|FG001|Overall Study|Intercurrent illness|0|||
16136839|NCT00007345|38986734|FG000|Overall Study|Death on study|1|||
16136840|NCT00007345|38986735|FG001|Overall Study|Death on study|1|||
16136841|NCT03740997|38986736|FG000|Overall Study|Withdrawal by Subject|1|||
16136842|NCT03740997|38986737|FG001|Overall Study|Withdrawal by Subject|0|||
16136843|NCT03740997|38986736|FG000|Overall Study|Participant was unable to complete study procedures|1|||
16136844|NCT03740997|38986737|FG001|Overall Study|Participant was unable to complete study procedures|0|||
16136845|NCT01163916|38986739|FG000|Overall Study|Withdrawal by Subject|2|||
16136846|NCT01163916|38986740|FG001|Overall Study|Withdrawal by Subject|0|||
16136847|NCT01163916|38986741|FG002|Overall Study|Withdrawal by Subject|2|||
16136848|NCT01163916|38986739|FG000|Overall Study|Adverse Event|2|||
16136849|NCT01163916|38986740|FG001|Overall Study|Adverse Event|0|||
16136850|NCT01163916|38986741|FG002|Overall Study|Adverse Event|1|||
16136851|NCT01163916|38986739|FG000|Overall Study|Lack of Efficacy|2|||
16136852|NCT01163916|38986740|FG001|Overall Study|Lack of Efficacy|0|||
16136853|NCT01163916|38986741|FG002|Overall Study|Lack of Efficacy|1|||
16136854|NCT01163916|38986739|FG000|Overall Study|Other|24|||
16136855|NCT01163916|38986740|FG001|Overall Study|Other|4|||
16136856|NCT01163916|38986741|FG002|Overall Study|Other|16|||
16136857|NCT00985166|38986742|FG000|Overall Study|Lost to Follow-up|3|||
16136858|NCT00985166|38986743|FG001|Overall Study|Lost to Follow-up|2|||
16136859|NCT00985166|38986744|FG002|Overall Study|Lost to Follow-up|2|||
16136860|NCT00985166|38986742|FG000|Overall Study|Withdrawal by Subject|3|||
16136861|NCT00985166|38986743|FG001|Overall Study|Withdrawal by Subject|2|||
16136862|NCT00985166|38986744|FG002|Overall Study|Withdrawal by Subject|0|||
16136863|NCT00985166|38986742|FG000|Overall Study|Test not done|2|||
16136864|NCT00985166|38986743|FG001|Overall Study|Test not done|0|||
16136865|NCT00985166|38986744|FG002|Overall Study|Test not done|4|||
16136866|NCT00985166|38986742|FG000|Overall Study|Other|1|||
16136867|NCT00985166|38986743|FG001|Overall Study|Other|0|||
16136868|NCT00985166|38986744|FG002|Overall Study|Other|1|||
16136869|NCT02079610|38986745|FG000|Overall Study|Withdrawal by Subject|1|||
16136870|NCT02079610|38986746|FG001|Overall Study|Withdrawal by Subject|1|||
16253391|NCT01296932|39412886|FG004|Overall Study|per protocol|0|||
16136871|NCT00537485|38986752|FG000|Overall Study|Adverse Event|10|||
16136872|NCT00537485|38986753|FG001|Overall Study|Adverse Event|5|||
16136873|NCT00537485|38986752|FG000|Overall Study|Withdrawal by Subject|3|||
16136874|NCT00537485|38986753|FG001|Overall Study|Withdrawal by Subject|2|||
16136875|NCT00537485|38986752|FG000|Overall Study|Withdrawal by Subject|1|||
16136876|NCT00537485|38986753|FG001|Overall Study|Withdrawal by Subject|3|||
16136877|NCT00537485|38986752|FG000|Overall Study|Physician Decision|1|||
16136878|NCT00537485|38986753|FG001|Overall Study|Physician Decision|0|||
16136879|NCT00701220|38986760|FG000|Overall Study|Withdrawal by Subject|0|||
16136880|NCT00701220|38986761|FG001|Overall Study|Withdrawal by Subject|2|||
16136881|NCT00701220|38986760|FG000|Overall Study|Protocol Violation|2|||
16136882|NCT00701220|38986761|FG001|Overall Study|Protocol Violation|0|||
16136883|NCT03170154|38986764|FG000|Overall Study|Lost to Follow-up|4|||
16253392|NCT01296932|39412887|FG005|Overall Study|per protocol|0|||
16136884|NCT03170154|38986764|FG000|Overall Study|Death|2|||
16136885|NCT03170154|38986764|FG000|Overall Study|Withdrawal by Subject|2|||
16435994|NCT00117637|40074227|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
16435995|NCT00117637|40074228|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
16435996|NCT00117637|40074227|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
16435997|NCT00117637|40074228|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
16435998|NCT00117637|40074227|FG000|First Intervention (Period 1)|reason not reported|0|||
16435999|NCT00117637|40074228|FG001|First Intervention (Period 1)|reason not reported|1|||
16436000|NCT00117637|40074227|FG000|Second Intervention (Period 2)|Adverse Event|0|||
16436001|NCT00117637|40074228|FG001|Second Intervention (Period 2)|Adverse Event|9|||
16436002|NCT00117637|40074227|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
16436003|NCT00117637|40074228|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
16436004|NCT00117637|40074227|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
16436005|NCT00117637|40074228|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
16436006|NCT00117637|40074227|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
16436007|NCT00117637|40074228|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
16436008|NCT00117637|40074227|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
16436009|NCT00117637|40074228|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
16436010|NCT00117637|40074227|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
16436011|NCT00117637|40074228|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
16436012|NCT00117637|40074227|FG000|Second Intervention (Period 2)|reason not reported|1|||
16436013|NCT00117637|40074228|FG001|Second Intervention (Period 2)|reason not reported|0|||
16436014|NCT01927497|40074248|FG000|Overall Study|Death|0|||
16436015|NCT01927497|40074249|FG001|Overall Study|Death|1|||
16436016|NCT01927497|40074248|FG000|Overall Study|Protocol Violation|2|||
16436017|NCT01927497|40074249|FG001|Overall Study|Protocol Violation|0|||
16436018|NCT02399215|40074250|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
16436019|NCT02399215|40074250|FG000|Overall Study|Withdrawal by Subject|1|||
16436020|NCT00550953|40074254|FG000|Overall Study|Adverse Event|4|||
16436021|NCT00550953|40074255|FG001|Overall Study|Adverse Event|3|||
16436022|NCT00550953|40074254|FG000|Overall Study|Not able to visit the site|2|||
16436023|NCT00550953|40074255|FG001|Overall Study|Not able to visit the site|3|||
16436024|NCT00317473|40074256|FG000|Overall Study|Withdrawal by Subject|2|||
16436025|NCT00317473|40074257|FG001|Overall Study|Withdrawal by Subject|1|||
16436026|NCT00317473|40074258|FG002|Overall Study|Withdrawal by Subject|2|||
16436027|NCT00317473|40074259|FG003|Overall Study|Withdrawal by Subject|1|||
16436028|NCT00317473|40074260|FG004|Overall Study|Withdrawal by Subject|3|||
16436029|NCT00317473|40074261|FG005|Overall Study|Withdrawal by Subject|1|||
16436030|NCT00317473|40074256|FG000|Overall Study|Relocation|1|||
16436031|NCT00317473|40074257|FG001|Overall Study|Relocation|0|||
16436032|NCT00317473|40074258|FG002|Overall Study|Relocation|1|||
16436033|NCT00317473|40074259|FG003|Overall Study|Relocation|1|||
16436034|NCT00317473|40074260|FG004|Overall Study|Relocation|5|||
16436035|NCT00317473|40074261|FG005|Overall Study|Relocation|2|||
16436036|NCT00317473|40074256|FG000|Overall Study|Death|1|||
16436037|NCT00317473|40074257|FG001|Overall Study|Death|0|||
16436038|NCT00317473|40074258|FG002|Overall Study|Death|0|||
16436039|NCT00317473|40074259|FG003|Overall Study|Death|0|||
16436040|NCT00317473|40074260|FG004|Overall Study|Death|0|||
16253393|NCT01296932|39412888|FG006|Overall Study|per protocol|0|||
16253394|NCT01296932|39412889|FG007|Overall Study|per protocol|0|||
16436041|NCT00317473|40074261|FG005|Overall Study|Death|0|||
16436042|NCT00317473|40074256|FG000|Overall Study|Other|0|||
16436043|NCT00317473|40074257|FG001|Overall Study|Other|2|||
16436044|NCT00317473|40074258|FG002|Overall Study|Other|0|||
16436045|NCT00317473|40074259|FG003|Overall Study|Other|0|||
16436046|NCT00317473|40074260|FG004|Overall Study|Other|0|||
16436047|NCT00317473|40074261|FG005|Overall Study|Other|0|||
16436048|NCT00097500|40074263|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
16436049|NCT00097500|40074264|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
16436050|NCT00097500|40074263|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
16436051|NCT00097500|40074264|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
16436052|NCT00097500|40074263|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
16436053|NCT00097500|40074264|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
16436054|NCT00097500|40074263|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
16436055|NCT00097500|40074264|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
16436056|NCT00097500|40074263|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
16436057|NCT00097500|40074264|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
16436058|NCT00097500|40074263|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
16436059|NCT00097500|40074264|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
16436060|NCT00097500|40074263|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
16436061|NCT00097500|40074264|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
16436062|NCT01141712|40074266|FG000|Overall Study|Disease progression|3|||
16436063|NCT01791244|40074271|FG000|Overall Study|Adverse Event|5|||
16436064|NCT01791244|40074272|FG001|Overall Study|Adverse Event|7|||
16436065|NCT01791244|40074271|FG000|Overall Study|Insufficient clinical response|10|||
16436066|NCT01791244|40074272|FG001|Overall Study|Insufficient clinical response|10|||
16436067|NCT01791244|40074271|FG000|Overall Study|Laboratory Abnormality|0|||
16436068|NCT01791244|40074272|FG001|Overall Study|Laboratory Abnormality|1|||
16436069|NCT01425801|40074273|FG000|Period 1|Withdrawal by Subject|0|||
16436070|NCT01425801|40074274|FG001|Period 1|Withdrawal by Subject|0|||
16136886|NCT01376349|38986768|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
16136887|NCT01376349|38986769|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
16136888|NCT01376349|38986770|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
16136889|NCT01376349|38986768|FG000|Raondomized Treatment|Adverse Event|13|||
16136890|NCT01376349|38986769|FG001|Raondomized Treatment|Adverse Event|17|||
16136891|NCT01376349|38986770|FG002|Raondomized Treatment|Adverse Event|14|||
16436071|NCT01425801|40074275|FG002|Period 1|Withdrawal by Subject|0|||
16436072|NCT01425801|40074276|FG003|Period 1|Withdrawal by Subject|0|||
16436073|NCT01425801|40074277|FG004|Period 1|Withdrawal by Subject|1|||
16436074|NCT01425801|40074278|FG005|Period 1|Withdrawal by Subject|0|||
16436075|NCT01425801|40074273|FG000|Period 2|Withdrawal by Subject|0|||
16436076|NCT01425801|40074274|FG001|Period 2|Withdrawal by Subject|0|||
16436077|NCT01425801|40074275|FG002|Period 2|Withdrawal by Subject|0|||
16436078|NCT01425801|40074276|FG003|Period 2|Withdrawal by Subject|0|||
16436079|NCT01425801|40074277|FG004|Period 2|Withdrawal by Subject|1|||
16436080|NCT01425801|40074278|FG005|Period 2|Withdrawal by Subject|0|||
16436081|NCT01425801|40074273|FG000|Period 3|Stability criteria not fullfilled|0|||
16436082|NCT01425801|40074274|FG001|Period 3|Stability criteria not fullfilled|0|||
16436083|NCT01425801|40074275|FG002|Period 3|Stability criteria not fullfilled|1|||
16436084|NCT01425801|40074276|FG003|Period 3|Stability criteria not fullfilled|0|||
16436085|NCT01425801|40074277|FG004|Period 3|Stability criteria not fullfilled|0|||
16436086|NCT01425801|40074278|FG005|Period 3|Stability criteria not fullfilled|0|||
16436087|NCT01425801|40074273|FG000|Period 4|Not able to maintain visit schedule|0|||
16136892|NCT01376349|38986768|FG000|Raondomized Treatment|Unkown|1|||
16136893|NCT01376349|38986769|FG001|Raondomized Treatment|Unkown|2|||
16136894|NCT01376349|38986770|FG002|Raondomized Treatment|Unkown|1|||
16136895|NCT01376349|38986768|FG000|Raondomized Treatment|Alternative Treatment|0|||
16136896|NCT01376349|38986769|FG001|Raondomized Treatment|Alternative Treatment|0|||
16136897|NCT01376349|38986770|FG002|Raondomized Treatment|Alternative Treatment|1|||
16136898|NCT01929980|38989646|FG000|Overall Study|Physician Decision|1|||
16362758|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
16362759|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
16362760|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
16362761|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
16362762|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
16362763|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
16362764|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
16362765|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
16362766|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
16362767|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
16362768|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
16362769|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
16362770|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
16362771|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
16362772|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
16362773|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
16362774|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
16362775|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
16362776|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
16362777|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
16362778|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
16362779|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
16362780|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
16362781|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
16362782|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
16362783|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
16436088|NCT01425801|40074274|FG001|Period 4|Not able to maintain visit schedule|0|||
16436089|NCT01425801|40074275|FG002|Period 4|Not able to maintain visit schedule|1|||
16436090|NCT01425801|40074276|FG003|Period 4|Not able to maintain visit schedule|0|||
16436091|NCT01425801|40074277|FG004|Period 4|Not able to maintain visit schedule|0|||
16436092|NCT01425801|40074278|FG005|Period 4|Not able to maintain visit schedule|0|||
16436093|NCT03914417|40074279|FG000|Overall Study|Withdrawal by Subject|2|||
16436094|NCT00499681|40074286|FG000|Overall Study|toxicity|0|||
16436095|NCT00499681|40074287|FG001|Overall Study|toxicity|1|||
16436096|NCT00499681|40074286|FG000|Overall Study|disease progression|0|||
16436097|NCT00499681|40074287|FG001|Overall Study|disease progression|1|||
16436098|NCT02539797|40074288|FG000|Overall Study|Lost to Follow-up|0|||
16436099|NCT02539797|40074289|FG001|Overall Study|Lost to Follow-up|1|||
16436100|NCT02539797|40074290|FG002|Overall Study|Lost to Follow-up|0|||
16136899|NCT01959516|38989647|FG000|Epoch 1|Adverse Event|4|||
16136900|NCT01959516|38989648|FG001|Epoch 1|Adverse Event|1|||
16136901|NCT01959516|38989647|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
16136902|NCT01959516|38989648|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
16136903|NCT01959516|38989647|FG000|Epoch 1|Subject withdrew consent|3|||
16136904|NCT01959516|38989648|FG001|Epoch 1|Subject withdrew consent|2|||
16136905|NCT01959516|38989647|FG000|Epoch 1|Administrative problems|1|||
16136906|NCT01959516|38989648|FG001|Epoch 1|Administrative problems|0|||
16136907|NCT01959516|38989647|FG000|Epoch 1|Use of prohibited treatment|1|||
16136908|NCT01959516|38989648|FG001|Epoch 1|Use of prohibited treatment|0|||
16136909|NCT01959516|38989647|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
16136910|NCT01959516|38989648|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
16136911|NCT01959516|38989647|FG000|Epoch 1|Protocol deviation|0|||
16136912|NCT01959516|38989648|FG001|Epoch 1|Protocol deviation|1|||
16136913|NCT01959516|38989647|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
16136914|NCT01959516|38989648|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
16136915|NCT01959516|38989647|FG000|Epoch 2|Subject withdrew consent|1|||
16136916|NCT01959516|38989648|FG001|Epoch 2|Subject withdrew consent|0|||
16136917|NCT01959516|38989647|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
16136918|NCT01959516|38989648|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
16136919|NCT00975507|38989651|FG000|Overall Study|Adverse Event|1|||
16136920|NCT00975507|38989652|FG001|Overall Study|Adverse Event|0|||
16136921|NCT00975507|38989651|FG000|Overall Study|Lost to Follow-up|7|||
16136922|NCT00975507|38989652|FG001|Overall Study|Lost to Follow-up|1|||
16136923|NCT00975507|38989651|FG000|Overall Study|Protocol Violation|2|||
16136924|NCT00975507|38989652|FG001|Overall Study|Protocol Violation|0|||
16136925|NCT00975507|38989651|FG000|Overall Study|Withdrawal by Subject|10|||
16362784|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
16362785|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
16362786|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
16362787|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
16362788|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
16362789|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
16362790|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
16362791|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
16362792|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
16362793|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
16362794|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
16362795|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
16362796|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
16362797|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
16136926|NCT00975507|38989652|FG001|Overall Study|Withdrawal by Subject|3|||
16136927|NCT00395460|38989660|FG000|Overall Study|Withdrawal by Subject|1|||
16136928|NCT00395460|38989661|FG001|Overall Study|Withdrawal by Subject|0|||
16253395|NCT01296932|39412890|FG008|Overall Study|per protocol|0|||
16436101|NCT01960140|40074291|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
16436102|NCT00960375|40074292|FG000|Overall Study|Lost to Follow-up|20|||
16436103|NCT00960375|40074293|FG001|Overall Study|Lost to Follow-up|22|||
16436104|NCT01232868|40074296|FG000|Overall Study|Lost to Follow-up|2|||
16136929|NCT04964414|38989662|FG000|Overall Study|Lost to Follow-up|10|||
16136930|NCT04964414|38989663|FG001|Overall Study|Lost to Follow-up|8|||
16136931|NCT04964414|38989662|FG000|Overall Study|Withdrawal by Subject|1|||
16136932|NCT04964414|38989663|FG001|Overall Study|Withdrawal by Subject|1|||
16136933|NCT03214094|38989664|FG000|Overall Study|Case Report Forms Uncollected|14|||
16436105|NCT01232868|40074297|FG001|Overall Study|Lost to Follow-up|4|||
16436106|NCT02510001|40074299|FG000|Overall Study|Early disease progression|0|||
16436107|NCT02510001|40074300|FG001|Overall Study|Early disease progression|0|||
16436108|NCT02510001|40074301|FG002|Overall Study|Early disease progression|0|||
16436109|NCT02510001|40074302|FG003|Overall Study|Early disease progression|1|||
16436110|NCT02510001|40074303|FG004|Overall Study|Early disease progression|1|||
16436111|NCT02510001|40074304|FG005|Overall Study|Early disease progression|1|||
16436112|NCT02510001|40074305|FG006|Overall Study|Early disease progression|0|||
16436113|NCT02510001|40074306|FG007|Overall Study|Early disease progression|0|||
16436114|NCT02510001|40074299|FG000|Overall Study|Adverse Event|0|||
16436115|NCT02510001|40074300|FG001|Overall Study|Adverse Event|0|||
16436116|NCT02510001|40074301|FG002|Overall Study|Adverse Event|0|||
16436117|NCT02510001|40074302|FG003|Overall Study|Adverse Event|1|||
16436118|NCT02510001|40074303|FG004|Overall Study|Adverse Event|2|||
16436119|NCT02510001|40074304|FG005|Overall Study|Adverse Event|1|||
16436120|NCT02510001|40074305|FG006|Overall Study|Adverse Event|2|||
16436121|NCT02510001|40074306|FG007|Overall Study|Adverse Event|5|||
16436122|NCT02510001|40074299|FG000|Overall Study|Physician Decision|0|||
16436123|NCT02510001|40074300|FG001|Overall Study|Physician Decision|0|||
16436124|NCT02510001|40074301|FG002|Overall Study|Physician Decision|0|||
16436125|NCT02510001|40074302|FG003|Overall Study|Physician Decision|0|||
16436126|NCT02510001|40074303|FG004|Overall Study|Physician Decision|1|||
16436127|NCT02510001|40074304|FG005|Overall Study|Physician Decision|0|||
16436128|NCT02510001|40074305|FG006|Overall Study|Physician Decision|0|||
16436129|NCT02510001|40074306|FG007|Overall Study|Physician Decision|0|||
16436130|NCT02510001|40074299|FG000|Overall Study|Withdrawal by Subject|0|||
16436131|NCT02510001|40074300|FG001|Overall Study|Withdrawal by Subject|0|||
16436132|NCT02510001|40074301|FG002|Overall Study|Withdrawal by Subject|0|||
16436133|NCT02510001|40074302|FG003|Overall Study|Withdrawal by Subject|0|||
16436134|NCT02510001|40074303|FG004|Overall Study|Withdrawal by Subject|0|||
16436135|NCT02510001|40074304|FG005|Overall Study|Withdrawal by Subject|0|||
16436136|NCT02510001|40074305|FG006|Overall Study|Withdrawal by Subject|0|||
16436137|NCT02510001|40074306|FG007|Overall Study|Withdrawal by Subject|2|||
16436138|NCT02178995|40074307|FG000|Double Blind|Adverse Event|0|||
16436139|NCT02178995|40074308|FG001|Double Blind|Adverse Event|0|||
16436140|NCT02178995|40074309|FG002|Double Blind|Adverse Event|0|||
16436141|NCT02178995|40074310|FG003|Double Blind|Adverse Event|0|||
16436142|NCT02178995|40074311|FG004|Double Blind|Adverse Event|0|||
16436143|NCT02178995|40074312|FG005|Double Blind|Adverse Event|1|||
16136934|NCT03214094|38989664|FG000|Overall Study|Protocol Deviation|46|||
16136935|NCT01313650|38989669|FG000|Overall Study|Adverse Event|9|||
16136936|NCT01313650|38989670|FG001|Overall Study|Adverse Event|34|||
16436144|NCT02178995|40074313|FG006|Double Blind|Adverse Event|0|||
16436145|NCT02178995|40074314|FG007|Double Blind|Adverse Event|1|||
16436146|NCT02178995|40074315|FG008|Double Blind|Adverse Event|1|||
16436147|NCT02178995|40074307|FG000|Double Blind|Lost to Follow-up|0|||
16436148|NCT02178995|40074308|FG001|Double Blind|Lost to Follow-up|1|||
16436149|NCT02178995|40074309|FG002|Double Blind|Lost to Follow-up|0|||
16136937|NCT01313650|38989671|FG002|Overall Study|Adverse Event|24|||
16136938|NCT01313650|38989672|FG003|Overall Study|Adverse Event|23|||
16136939|NCT01313650|38989669|FG000|Overall Study|Lack of Efficacy|37|||
16136940|NCT01313650|38989670|FG001|Overall Study|Lack of Efficacy|20|||
16136941|NCT01313650|38989671|FG002|Overall Study|Lack of Efficacy|32|||
16436150|NCT02178995|40074310|FG003|Double Blind|Lost to Follow-up|0|||
16436151|NCT02178995|40074311|FG004|Double Blind|Lost to Follow-up|0|||
16436152|NCT02178995|40074312|FG005|Double Blind|Lost to Follow-up|0|||
16436153|NCT02178995|40074313|FG006|Double Blind|Lost to Follow-up|0|||
16436154|NCT02178995|40074314|FG007|Double Blind|Lost to Follow-up|1|||
16436155|NCT02178995|40074315|FG008|Double Blind|Lost to Follow-up|0|||
16436156|NCT02178995|40074307|FG000|Open Label|Adverse Event|2|||
16436157|NCT02178995|40074308|FG001|Open Label|Adverse Event|0|||
16436158|NCT02178995|40074309|FG002|Open Label|Adverse Event|0|||
16436159|NCT02178995|40074310|FG003|Open Label|Adverse Event|0|||
16436160|NCT02178995|40074311|FG004|Open Label|Adverse Event|0|||
16436161|NCT02178995|40074312|FG005|Open Label|Adverse Event|0|||
16436162|NCT02178995|40074313|FG006|Open Label|Adverse Event|0|||
16436163|NCT02178995|40074314|FG007|Open Label|Adverse Event|0|||
16436164|NCT02178995|40074315|FG008|Open Label|Adverse Event|0|||
16436165|NCT00671658|40074316|FG000|Overall Study|Physician Decision|5|||
16136942|NCT01313650|38989672|FG003|Overall Study|Lack of Efficacy|20|||
16136943|NCT01313650|38989669|FG000|Overall Study|Lost to Follow-up|1|||
16136944|NCT01313650|38989670|FG001|Overall Study|Lost to Follow-up|0|||
16136945|NCT01313650|38989671|FG002|Overall Study|Lost to Follow-up|3|||
16136946|NCT01313650|38989672|FG003|Overall Study|Lost to Follow-up|2|||
16136947|NCT01313650|38989669|FG000|Overall Study|Withdrawal by Subject|16|||
16136948|NCT01313650|38989670|FG001|Overall Study|Withdrawal by Subject|20|||
16136949|NCT01313650|38989671|FG002|Overall Study|Withdrawal by Subject|15|||
16253396|NCT01296932|39412882|FG000|Overall Study|Low benefit and too many side effects|0|||
16253397|NCT01296932|39412883|FG001|Overall Study|Low benefit and too many side effects|0|||
16253398|NCT01296932|39412884|FG002|Overall Study|Low benefit and too many side effects|0|||
16253399|NCT01296932|39412885|FG003|Overall Study|Low benefit and too many side effects|0|||
16136950|NCT01313650|38989672|FG003|Overall Study|Withdrawal by Subject|15|||
16136951|NCT01313650|38989669|FG000|Overall Study|Protocol Violation|4|||
16253400|NCT01296932|39412886|FG004|Overall Study|Low benefit and too many side effects|0|||
16253401|NCT01296932|39412887|FG005|Overall Study|Low benefit and too many side effects|0|||
16253402|NCT01296932|39412888|FG006|Overall Study|Low benefit and too many side effects|0|||
16253403|NCT01296932|39412889|FG007|Overall Study|Low benefit and too many side effects|1|||
16253404|NCT01296932|39412890|FG008|Overall Study|Low benefit and too many side effects|0|||
16253405|NCT01296932|39412882|FG000|Overall Study|No adequate treatment response|0|||
16253406|NCT01296932|39412883|FG001|Overall Study|No adequate treatment response|0|||
16253407|NCT01296932|39412884|FG002|Overall Study|No adequate treatment response|0|||
16253408|NCT01296932|39412885|FG003|Overall Study|No adequate treatment response|0|||
16253409|NCT01296932|39412886|FG004|Overall Study|No adequate treatment response|0|||
16253410|NCT01296932|39412887|FG005|Overall Study|No adequate treatment response|0|||
16253411|NCT01296932|39412888|FG006|Overall Study|No adequate treatment response|0|||
16253412|NCT01296932|39412889|FG007|Overall Study|No adequate treatment response|1|||
16253413|NCT01296932|39412890|FG008|Overall Study|No adequate treatment response|0|||
16253414|NCT01296932|39412882|FG000|Overall Study|Dosage already reduced, AE still present|0|||
16253415|NCT01296932|39412883|FG001|Overall Study|Dosage already reduced, AE still present|0|||
16253416|NCT01296932|39412884|FG002|Overall Study|Dosage already reduced, AE still present|0|||
16253417|NCT01296932|39412885|FG003|Overall Study|Dosage already reduced, AE still present|0|||
16253418|NCT01296932|39412886|FG004|Overall Study|Dosage already reduced, AE still present|0|||
16253419|NCT01296932|39412887|FG005|Overall Study|Dosage already reduced, AE still present|0|||
16253420|NCT01296932|39412888|FG006|Overall Study|Dosage already reduced, AE still present|0|||
16253421|NCT01296932|39412889|FG007|Overall Study|Dosage already reduced, AE still present|0|||
16253422|NCT01296932|39412890|FG008|Overall Study|Dosage already reduced, AE still present|1|||
16136952|NCT01313650|38989670|FG001|Overall Study|Protocol Violation|7|||
16136953|NCT01313650|38989671|FG002|Overall Study|Protocol Violation|5|||
16136954|NCT01313650|38989672|FG003|Overall Study|Protocol Violation|6|||
16253423|NCT00368966|39412895|FG000|Infant Series|Withdrawal by Subject|11|||
16253424|NCT00368966|39412896|FG001|Infant Series|Withdrawal by Subject|6|||
16253425|NCT00368966|39412895|FG000|Infant Series|Protocol Violation|2|||
16436166|NCT03924622|40074323|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
16253426|NCT00368966|39412896|FG001|Infant Series|Protocol Violation|1|||
16436167|NCT03924622|40074324|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
16436168|NCT03924622|40074325|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
16436169|NCT03924622|40074326|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
16436170|NCT03924622|40074327|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
16436171|NCT03924622|40074328|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
16436172|NCT00740220|40077660|FG000|Overall Study|screen failures (non-COPD patients)|9|||
16436173|NCT02675907|40077661|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
16436174|NCT02675907|40077662|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
16436175|NCT02675907|40077661|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
16436176|NCT02675907|40077662|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
16436177|NCT02675907|40077661|FG000|Study Overall|Lack of Efficacy|1|||
16436178|NCT02675907|40077662|FG001|Study Overall|Lack of Efficacy|0|||
16436179|NCT02675907|40077661|FG000|Study Overall|Withdrawal by Subject|2|||
16436180|NCT02675907|40077662|FG001|Study Overall|Withdrawal by Subject|2|||
16253427|NCT00368966|39412895|FG000|Infant Series|Lost to Follow-up|2|||
16253428|NCT00368966|39412896|FG001|Infant Series|Lost to Follow-up|0|||
16253429|NCT00368966|39412895|FG000|Infant Series|Randomization error|0|||
16253430|NCT00368966|39412896|FG001|Infant Series|Randomization error|1|||
16253431|NCT00368966|39412895|FG000|Infant Series|Failed to meet eligibility criteria|0|||
16253432|NCT00368966|39412896|FG001|Infant Series|Failed to meet eligibility criteria|1|||
16253433|NCT00368966|39412895|FG000|Infant Series|Adverse Event|0|||
16253434|NCT00368966|39412896|FG001|Infant Series|Adverse Event|1|||
16253435|NCT00368966|39412895|FG000|Infant Series|Failed to return|1|||
16253436|NCT00368966|39412896|FG001|Infant Series|Failed to return|0|||
16253437|NCT00368966|39412895|FG000|After Infant|Failed to return|3|||
16253438|NCT00368966|39412896|FG001|After Infant|Failed to return|1|||
16253439|NCT00368966|39412895|FG000|After Infant|Adverse Event|1|||
16253440|NCT00368966|39412896|FG001|After Infant|Adverse Event|2|||
16253441|NCT00368966|39412895|FG000|After Infant|Withdrawal by Subject|1|||
16253442|NCT00368966|39412896|FG001|After Infant|Withdrawal by Subject|1|||
16253443|NCT00368966|39412895|FG000|After Infant|Death|1|||
16253444|NCT00368966|39412896|FG001|After Infant|Death|0|||
16253445|NCT00368966|39412895|FG000|After Infant|Lost to Follow-up|0|||
16253446|NCT00368966|39412896|FG001|After Infant|Lost to Follow-up|1|||
16253447|NCT00368966|39412895|FG000|Toddler Dose|Withdrawal by Subject|1|||
16253448|NCT00368966|39412896|FG001|Toddler Dose|Withdrawal by Subject|1|||
16253449|NCT00368966|39412895|FG000|Toddler Dose|Lost to Follow-up|0|||
16253450|NCT00368966|39412896|FG001|Toddler Dose|Lost to Follow-up|2|||
16253451|NCT00262223|39412907|FG000|Treatment Phase|Withdrawal by Subject|3|||
16253452|NCT00262223|39412908|FG001|Treatment Phase|Withdrawal by Subject|6|||
16253453|NCT00262223|39412907|FG000|Treatment Phase|Adverse Event|1|||
16253454|NCT00262223|39412908|FG001|Treatment Phase|Adverse Event|2|||
16253455|NCT00262223|39412907|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
16253456|NCT00262223|39412908|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
16136955|NCT01313650|38989669|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
16136956|NCT01313650|38989670|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
16136957|NCT01313650|38989671|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
16136958|NCT01313650|38989672|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
16136959|NCT01030198|38989676|FG000|Overall Study|Could not measure efficacy accurately|0|||
16136960|NCT01030198|38989677|FG001|Overall Study|Could not measure efficacy accurately|7|||
16136961|NCT03333837|38989678|FG000|Overall Study|Adverse Event|2|||
16136962|NCT03333837|38989679|FG001|Overall Study|Adverse Event|1|||
16136963|NCT03333837|38989680|FG002|Overall Study|Adverse Event|1|||
16136964|NCT03333837|38989681|FG003|Overall Study|Adverse Event|1|||
16136965|NCT03333837|38989682|FG004|Overall Study|Adverse Event|0|||
16136966|NCT03333837|38989678|FG000|Overall Study|Caregiver withdrew|0|||
16136967|NCT03333837|38989679|FG001|Overall Study|Caregiver withdrew|2|||
16136968|NCT03333837|38989680|FG002|Overall Study|Caregiver withdrew|1|||
16362798|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
16362799|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
16362800|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
16362801|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
16362802|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
16362803|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
16362804|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
16436181|NCT02675907|40077661|FG000|Study Overall|Lost to Follow-up|0|||
16436182|NCT02675907|40077662|FG001|Study Overall|Lost to Follow-up|2|||
16436183|NCT01884077|40077668|FG000|Overall Study|screen fail|0|||
16436184|NCT01884077|40077669|FG001|Overall Study|screen fail|2|||
16436185|NCT01884077|40077668|FG000|Overall Study|canceled surgery|2|||
16436186|NCT01884077|40077669|FG001|Overall Study|canceled surgery|0|||
16436187|NCT01884077|40077668|FG000|Overall Study|Lost to Follow-up|0|||
16436188|NCT01884077|40077669|FG001|Overall Study|Lost to Follow-up|4|||
16436189|NCT01884077|40077668|FG000|Overall Study|study closed|6|||
16436190|NCT01884077|40077669|FG001|Overall Study|study closed|4|||
16436191|NCT00296816|40077670|FG000|Overall Study|Disease Progression|37|||
16436192|NCT00296816|40077670|FG000|Overall Study|Adverse Event|18|||
16436193|NCT00296816|40077670|FG000|Overall Study|Investigator/Participant request|5|||
16436194|NCT00296816|40077670|FG000|Overall Study|Non-compliance|1|||
16436195|NCT00296816|40077670|FG000|Overall Study|Missing for end of treatment|4|||
16436196|NCT00296816|40077670|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
16436197|NCT00296816|40077670|FG000|Overall Study|Poor performance status|1|||
16436198|NCT00296816|40077670|FG000|Overall Study|Relocation to Florida|1|||
16436199|NCT00296816|40077670|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
16436200|NCT00296816|40077670|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
16436201|NCT00296816|40077670|FG000|Overall Study|Neuropathy/patient preference|1|||
16436202|NCT00296816|40077670|FG000|Overall Study|Proteinuria|1|||
16436203|NCT00296816|40077670|FG000|Overall Study|ineligibility due to radiation treatment|1|||
16436204|NCT02800863|40077674|FG000|Overall Study|Adverse Event|14|||
16436205|NCT02800863|40077674|FG000|Overall Study|Another Device Implanted|1|||
16436206|NCT02800863|40077674|FG000|Overall Study|Device Explanted|1|||
16436207|NCT02800863|40077674|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
16436208|NCT02800863|40077674|FG000|Overall Study|Health Issues|1|||
16436209|NCT02800863|40077674|FG000|Overall Study|Insurance Denial|8|||
16436210|NCT02800863|40077674|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
16436211|NCT02800863|40077674|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
16436212|NCT02800863|40077674|FG000|Overall Study|Screen Failure|1|||
16436213|NCT02800863|40077674|FG000|Overall Study|Sponsor Request|6|||
16436214|NCT02800863|40077674|FG000|Overall Study|Death|3|||
16436215|NCT02800863|40077674|FG000|Overall Study|Subject Implant at Another Facility|1|||
16436216|NCT02800863|40077674|FG000|Overall Study|Lost to Follow-up|26|||
16436217|NCT02800863|40077674|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
16436218|NCT02800863|40077674|FG000|Overall Study|Subject and/or Family Request|64|||
16436219|NCT02800863|40077674|FG000|Overall Study|Trial Failure|81|||
16436220|NCT02800863|40077674|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
16436221|NCT01831596|40077675|FG000|Overall Study|Other|8|||
16136969|NCT03333837|38989681|FG003|Overall Study|Caregiver withdrew|0|||
16136970|NCT03333837|38989682|FG004|Overall Study|Caregiver withdrew|0|||
16362805|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
16436222|NCT03812380|40077678|FG000|Overall Study|Protocol Violation|3|||
16436223|NCT03812380|40077679|FG001|Overall Study|Protocol Violation|3|||
16436224|NCT03812380|40077678|FG000|Overall Study|Withdrawal by Subject|5|||
16436225|NCT03812380|40077679|FG001|Overall Study|Withdrawal by Subject|4|||
16436226|NCT03812380|40077678|FG000|Overall Study|Early termination of study|14|||
16436227|NCT03812380|40077679|FG001|Overall Study|Early termination of study|14|||
16436228|NCT01352117|40077680|FG000|Overall Study|Death|15|||
16436229|NCT01352117|40077681|FG001|Overall Study|Death|16|||
16436230|NCT01352117|40077680|FG000|Overall Study|Withdrawal by Subject|1|||
16136971|NCT03333837|38989678|FG000|Overall Study|Withdrawal by Subject|0|||
16136972|NCT03333837|38989679|FG001|Overall Study|Withdrawal by Subject|0|||
16136973|NCT03333837|38989680|FG002|Overall Study|Withdrawal by Subject|1|||
16136974|NCT03333837|38989681|FG003|Overall Study|Withdrawal by Subject|1|||
16136975|NCT03333837|38989682|FG004|Overall Study|Withdrawal by Subject|3|||
16136976|NCT03333837|38989678|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
16136977|NCT03333837|38989679|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
16136978|NCT03333837|38989680|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
16136979|NCT03333837|38989681|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
16136980|NCT03333837|38989682|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
16136981|NCT01592864|38989683|FG000|Overall Study|Withdrawal by Subject|0|||
16136982|NCT01592864|38989684|FG001|Overall Study|Withdrawal by Subject|1|||
16136983|NCT01324323|38989687|FG000|Overall Study|Withdrawal by Subject|1|||
16136984|NCT00300781|38989688|FG000|Overall Study|Disease Progression|55|||
16136985|NCT00300781|38989689|FG001|Overall Study|Disease Progression|52|||
16136986|NCT00300781|38989688|FG000|Overall Study|Adverse Event|5|||
16136987|NCT00300781|38989689|FG001|Overall Study|Adverse Event|6|||
16136988|NCT00300781|38989688|FG000|Overall Study|Withdrawal by Subject|1|||
16136989|NCT00300781|38989689|FG001|Overall Study|Withdrawal by Subject|2|||
16136990|NCT00300781|38989688|FG000|Overall Study|Physician Decision|1|||
16136991|NCT00300781|38989689|FG001|Overall Study|Physician Decision|0|||
16136992|NCT00300781|38989688|FG000|Overall Study|Not Recorded|0|||
16136993|NCT00300781|38989689|FG001|Overall Study|Not Recorded|1|||
16136994|NCT00300781|38989688|FG000|Overall Study|Symptomatic Deterioration|1|||
16136995|NCT00300781|38989689|FG001|Overall Study|Symptomatic Deterioration|0|||
16136996|NCT00300781|38989688|FG000|Overall Study|Lost to Follow-up|0|||
16136997|NCT00300781|38989689|FG001|Overall Study|Lost to Follow-up|1|||
16136998|NCT01498653|38989696|FG000|Overall Study|Adverse Event|2|||
16136999|NCT01498653|38989697|FG001|Overall Study|Adverse Event|2|||
16137000|NCT01498653|38989696|FG000|Overall Study|Lack of Efficacy|12|||
16137001|NCT01498653|38989697|FG001|Overall Study|Lack of Efficacy|26|||
16137002|NCT01498653|38989696|FG000|Overall Study|Protocol Violation|0|||
16137003|NCT01498653|38989697|FG001|Overall Study|Protocol Violation|4|||
16137004|NCT01498653|38989696|FG000|Overall Study|Lost to Follow-up|1|||
16137005|NCT01498653|38989697|FG001|Overall Study|Lost to Follow-up|0|||
16137006|NCT01498653|38989696|FG000|Overall Study|Physician Decision|2|||
16137007|NCT01498653|38989697|FG001|Overall Study|Physician Decision|0|||
16137008|NCT01498653|38989696|FG000|Overall Study|Withdrawal by Subject|2|||
16137009|NCT01498653|38989697|FG001|Overall Study|Withdrawal by Subject|3|||
16137010|NCT00402363|38989698|FG000|Overall Study|Adverse Event|9|||
16137011|NCT00402363|38989699|FG001|Overall Study|Adverse Event|14|||
16137012|NCT00402363|38989700|FG002|Overall Study|Adverse Event|2|||
16137013|NCT00402363|38989701|FG003|Overall Study|Adverse Event|2|||
16137014|NCT00402363|38989698|FG000|Overall Study|Withdrew Consent|10|||
16137015|NCT00402363|38989699|FG001|Overall Study|Withdrew Consent|5|||
16137016|NCT00402363|38989700|FG002|Overall Study|Withdrew Consent|2|||
16137017|NCT00402363|38989701|FG003|Overall Study|Withdrew Consent|1|||
16137018|NCT00402363|38989698|FG000|Overall Study|Protocol Violation|3|||
16137019|NCT00402363|38989699|FG001|Overall Study|Protocol Violation|5|||
16137020|NCT00402363|38989700|FG002|Overall Study|Protocol Violation|0|||
16137021|NCT00402363|38989701|FG003|Overall Study|Protocol Violation|3|||
16137022|NCT00402363|38989698|FG000|Overall Study|Lost to Follow-up|5|||
16137023|NCT00402363|38989699|FG001|Overall Study|Lost to Follow-up|4|||
16137024|NCT00402363|38989700|FG002|Overall Study|Lost to Follow-up|0|||
16137025|NCT00402363|38989701|FG003|Overall Study|Lost to Follow-up|2|||
16137026|NCT00402363|38989698|FG000|Overall Study|"Captured as Other"|6|||
16137027|NCT00402363|38989699|FG001|Overall Study|"Captured as Other"|2|||
16137028|NCT00402363|38989700|FG002|Overall Study|"Captured as Other"|2|||
16137029|NCT00402363|38989701|FG003|Overall Study|"Captured as Other"|2|||
16137030|NCT05211739|38989704|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
16137031|NCT05211739|38989705|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
16137032|NCT05211739|38989704|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
16137033|NCT05211739|38989705|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
16137034|NCT05211739|38989704|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
16137035|NCT05211739|38989705|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
16137036|NCT05211739|38989704|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
16137037|NCT05211739|38989705|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
16137038|NCT01422850|38989706|FG000|Overall Study|Physician Decision|3|||
16137039|NCT03371381|38989709|FG000|Overall Study|Death|5|||
16137040|NCT03371381|38989709|FG000|Overall Study|Study terminated by sponsor|3|||
16137041|NCT03371381|38989709|FG000|Overall Study|Other|4|||
16137042|NCT03707925|38989710|FG000|Overall Study|Inevaluable|1|||
16137043|NCT01259726|38989711|FG000|Overall Study|Death|1|||
16137044|NCT01259726|38989712|FG001|Overall Study|Death|0|||
16137045|NCT01259726|38989713|FG002|Overall Study|Death|0|||
16137046|NCT01259726|38989714|FG003|Overall Study|Death|0|||
16137047|NCT01259726|38989711|FG000|Overall Study|Physician Decision|2|||
16137048|NCT01259726|38989712|FG001|Overall Study|Physician Decision|0|||
16137049|NCT01259726|38989713|FG002|Overall Study|Physician Decision|1|||
16137050|NCT01259726|38989714|FG003|Overall Study|Physician Decision|1|||
16137051|NCT01259726|38989711|FG000|Overall Study|Withdrawal by Subject|1|||
16137052|NCT01259726|38989712|FG001|Overall Study|Withdrawal by Subject|3|||
16137053|NCT01259726|38989713|FG002|Overall Study|Withdrawal by Subject|2|||
16137054|NCT01259726|38989714|FG003|Overall Study|Withdrawal by Subject|1|||
16137055|NCT01259726|38989711|FG000|Overall Study|Lost to Follow-up|1|||
16137056|NCT01259726|38989712|FG001|Overall Study|Lost to Follow-up|1|||
16137057|NCT01259726|38989713|FG002|Overall Study|Lost to Follow-up|1|||
16137058|NCT01259726|38989714|FG003|Overall Study|Lost to Follow-up|3|||
16137059|NCT03645057|38989716|FG000|Randomization to Baseline|Lost to Follow-up|1|||
16137060|NCT03645057|38989717|FG001|Randomization to Baseline|Lost to Follow-up|0|||
16137061|NCT03645057|38989718|FG002|Randomization to Baseline|Lost to Follow-up|1|||
16137062|NCT03645057|38989719|FG003|Randomization to Baseline|Lost to Follow-up|0|||
16137063|NCT03645057|38989716|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
16137064|NCT03645057|38989717|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
16137065|NCT03645057|38989718|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
16137066|NCT03645057|38989719|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
16137067|NCT03645057|38989716|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
16137068|NCT03645057|38989717|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
16137069|NCT03645057|38989718|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
16137070|NCT03645057|38989719|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
16137071|NCT03645057|38989716|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
16137072|NCT03645057|38989717|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
16137073|NCT03645057|38989718|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
16137074|NCT03645057|38989719|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
16137075|NCT04178967|38989721|FG000|Induction Period|Adverse Event|4|||
16137076|NCT04178967|38989722|FG001|Induction Period|Adverse Event|6|||
16137077|NCT04178967|38989723|FG002|Induction Period|Adverse Event|0|||
16137078|NCT04178967|38989724|FG003|Induction Period|Adverse Event|0|||
16137079|NCT04178967|38989725|FG004|Induction Period|Adverse Event|0|||
16137080|NCT04178967|38989726|FG005|Induction Period|Adverse Event|0|||
16137081|NCT04178967|38989727|FG006|Induction Period|Adverse Event|0|||
16137082|NCT04178967|38989728|FG007|Induction Period|Adverse Event|0|||
16137083|NCT04178967|38989729|FG008|Induction Period|Adverse Event|0|||
16137084|NCT04178967|38989730|FG009|Induction Period|Adverse Event|0|||
16137085|NCT04178967|38989731|FG010|Induction Period|Adverse Event|0|||
16137086|NCT04178967|38989721|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
16137087|NCT04178967|38989722|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
16137088|NCT04178967|38989723|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
16137089|NCT04178967|38989724|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
16137090|NCT04178967|38989725|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
16137091|NCT04178967|38989726|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
16137092|NCT04178967|38989727|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
16137093|NCT04178967|38989728|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
16137094|NCT04178967|38989729|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
16137095|NCT04178967|38989730|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
16137096|NCT04178967|38989731|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
16137097|NCT04178967|38989721|FG000|Induction Period|Lack of Efficacy|4|||
16137098|NCT04178967|38989722|FG001|Induction Period|Lack of Efficacy|1|||
16137099|NCT04178967|38989723|FG002|Induction Period|Lack of Efficacy|0|||
16137100|NCT04178967|38989724|FG003|Induction Period|Lack of Efficacy|0|||
16137101|NCT04178967|38989725|FG004|Induction Period|Lack of Efficacy|0|||
16137102|NCT04178967|38989726|FG005|Induction Period|Lack of Efficacy|0|||
16137103|NCT04178967|38989727|FG006|Induction Period|Lack of Efficacy|0|||
16137104|NCT04178967|38989728|FG007|Induction Period|Lack of Efficacy|0|||
16137105|NCT04178967|38989729|FG008|Induction Period|Lack of Efficacy|0|||
16137106|NCT04178967|38989730|FG009|Induction Period|Lack of Efficacy|0|||
16137107|NCT04178967|38989731|FG010|Induction Period|Lack of Efficacy|0|||
16137108|NCT04178967|38989721|FG000|Induction Period|Protocol Violation|0|||
16137109|NCT04178967|38989722|FG001|Induction Period|Protocol Violation|6|||
16137110|NCT04178967|38989723|FG002|Induction Period|Protocol Violation|0|||
16137111|NCT04178967|38989724|FG003|Induction Period|Protocol Violation|0|||
16137112|NCT04178967|38989725|FG004|Induction Period|Protocol Violation|0|||
16137113|NCT04178967|38989726|FG005|Induction Period|Protocol Violation|0|||
16137114|NCT04178967|38989727|FG006|Induction Period|Protocol Violation|0|||
16137115|NCT04178967|38989728|FG007|Induction Period|Protocol Violation|0|||
16137116|NCT04178967|38989729|FG008|Induction Period|Protocol Violation|0|||
16137117|NCT04178967|38989730|FG009|Induction Period|Protocol Violation|0|||
16137118|NCT04178967|38989731|FG010|Induction Period|Protocol Violation|0|||
16137119|NCT04178967|38989721|FG000|Induction Period|Withdrawal by Subject|6|||
16137120|NCT04178967|38989722|FG001|Induction Period|Withdrawal by Subject|4|||
16137121|NCT04178967|38989723|FG002|Induction Period|Withdrawal by Subject|0|||
16137122|NCT04178967|38989724|FG003|Induction Period|Withdrawal by Subject|0|||
16137123|NCT04178967|38989725|FG004|Induction Period|Withdrawal by Subject|0|||
16362806|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
16362807|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
16362808|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
16362809|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
16137124|NCT04178967|38989726|FG005|Induction Period|Withdrawal by Subject|0|||
16362810|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
16362811|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
16362812|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
16362813|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
16436231|NCT01352117|40077681|FG001|Overall Study|Withdrawal by Subject|0|||
16436232|NCT01352117|40077680|FG000|Overall Study|Lost to Follow-up|2|||
16436233|NCT01352117|40077681|FG001|Overall Study|Lost to Follow-up|7|||
16436234|NCT01352117|40077680|FG000|Overall Study|Non-adherent to study requirements|1|||
16436235|NCT01352117|40077681|FG001|Overall Study|Non-adherent to study requirements|1|||
16436236|NCT01352117|40077680|FG000|Overall Study|Did not initiate study treatment|1|||
16436237|NCT01352117|40077681|FG001|Overall Study|Did not initiate study treatment|0|||
16137125|NCT04178967|38989727|FG006|Induction Period|Withdrawal by Subject|0|||
16137126|NCT04178967|38989728|FG007|Induction Period|Withdrawal by Subject|0|||
16137127|NCT04178967|38989729|FG008|Induction Period|Withdrawal by Subject|0|||
16137128|NCT04178967|38989730|FG009|Induction Period|Withdrawal by Subject|0|||
16137129|NCT04178967|38989731|FG010|Induction Period|Withdrawal by Subject|0|||
16137130|NCT04178967|38989721|FG000|Induction Period|Lost to Follow-up|2|||
16137131|NCT04178967|38989722|FG001|Induction Period|Lost to Follow-up|0|||
16137132|NCT04178967|38989723|FG002|Induction Period|Lost to Follow-up|0|||
16137133|NCT04178967|38989724|FG003|Induction Period|Lost to Follow-up|0|||
16137134|NCT04178967|38989725|FG004|Induction Period|Lost to Follow-up|0|||
16137135|NCT04178967|38989726|FG005|Induction Period|Lost to Follow-up|0|||
16137136|NCT04178967|38989727|FG006|Induction Period|Lost to Follow-up|0|||
16137137|NCT04178967|38989728|FG007|Induction Period|Lost to Follow-up|0|||
16137138|NCT04178967|38989729|FG008|Induction Period|Lost to Follow-up|0|||
16137139|NCT04178967|38989730|FG009|Induction Period|Lost to Follow-up|0|||
16137140|NCT04178967|38989731|FG010|Induction Period|Lost to Follow-up|0|||
16137141|NCT04178967|38989721|FG000|Induction Period|Participant Missed Study Visits|0|||
16137142|NCT04178967|38989722|FG001|Induction Period|Participant Missed Study Visits|1|||
16137143|NCT04178967|38989723|FG002|Induction Period|Participant Missed Study Visits|0|||
16137144|NCT04178967|38989724|FG003|Induction Period|Participant Missed Study Visits|0|||
16137145|NCT04178967|38989725|FG004|Induction Period|Participant Missed Study Visits|0|||
16137146|NCT04178967|38989726|FG005|Induction Period|Participant Missed Study Visits|0|||
16137147|NCT04178967|38989727|FG006|Induction Period|Participant Missed Study Visits|0|||
16137148|NCT04178967|38989728|FG007|Induction Period|Participant Missed Study Visits|0|||
16137149|NCT04178967|38989729|FG008|Induction Period|Participant Missed Study Visits|0|||
16137150|NCT04178967|38989730|FG009|Induction Period|Participant Missed Study Visits|0|||
16137151|NCT04178967|38989731|FG010|Induction Period|Participant Missed Study Visits|0|||
16137152|NCT04178967|38989721|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
16137153|NCT04178967|38989722|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
16137154|NCT04178967|38989723|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
16137155|NCT04178967|38989724|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
16137156|NCT04178967|38989725|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
16137157|NCT04178967|38989726|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
16137158|NCT04178967|38989727|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
16137159|NCT04178967|38989728|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
16137160|NCT04178967|38989729|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
16137161|NCT04178967|38989730|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
16137162|NCT04178967|38989731|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
16137163|NCT04178967|38989721|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16137164|NCT04178967|38989722|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16436238|NCT01352117|40077680|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
16137165|NCT04178967|38989723|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16436239|NCT01352117|40077681|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
16436240|NCT02978417|40077685|FG000|Overall Study|Lost to Follow-up|2|||
16362814|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
16362815|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
16137166|NCT04178967|38989724|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16137167|NCT04178967|38989725|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16137168|NCT04178967|38989726|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
16137169|NCT04178967|38989727|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16137170|NCT04178967|38989728|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16436241|NCT02978417|40077686|FG001|Overall Study|Lost to Follow-up|2|||
16436242|NCT00248495|40077687|FG000|Overall Study|Withdrawal by Subject|1|||
16137171|NCT04178967|38989729|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16137172|NCT04178967|38989730|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16137173|NCT04178967|38989731|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
16137174|NCT04178967|38989721|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16137175|NCT04178967|38989722|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16137176|NCT04178967|38989723|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16137177|NCT04178967|38989724|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
16137178|NCT04178967|38989725|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16137179|NCT04178967|38989726|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16137180|NCT04178967|38989727|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16137181|NCT04178967|38989728|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16137182|NCT04178967|38989729|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16137183|NCT04178967|38989730|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16137184|NCT04178967|38989731|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
16137185|NCT04178967|38989721|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
16137186|NCT04178967|38989722|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
16137187|NCT04178967|38989723|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
16137188|NCT04178967|38989724|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
16137189|NCT04178967|38989725|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
16137190|NCT04178967|38989726|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
16362816|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
16362817|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
16362818|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
16362819|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
16362820|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
16436243|NCT04630158|40077688|FG000|Overall Study|Adverse Event|1|||
16436244|NCT04630158|40077689|FG001|Overall Study|Adverse Event|1|||
16436245|NCT04630158|40077690|FG002|Overall Study|Adverse Event|1|||
16137191|NCT04178967|38989727|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
16137192|NCT04178967|38989728|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
16137193|NCT04178967|38989729|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
16137194|NCT04178967|38989730|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
16137195|NCT04178967|38989731|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
16137196|NCT04178967|38989721|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16436246|NCT04630158|40077688|FG000|Overall Study|Physician Decision|0|||
16436247|NCT04630158|40077689|FG001|Overall Study|Physician Decision|2|||
16137197|NCT04178967|38989722|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16137198|NCT04178967|38989723|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16137199|NCT04178967|38989724|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16137200|NCT04178967|38989725|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
16137201|NCT04178967|38989726|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
16137202|NCT04178967|38989727|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16137203|NCT04178967|38989728|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
16137204|NCT04178967|38989729|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16137205|NCT04178967|38989730|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16137206|NCT04178967|38989731|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
16137207|NCT04178967|38989721|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
16436248|NCT04630158|40077690|FG002|Overall Study|Physician Decision|0|||
16436249|NCT04630158|40077688|FG000|Overall Study|Protocol Violation|1|||
16137208|NCT04178967|38989722|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
16137209|NCT04178967|38989723|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
16137210|NCT04178967|38989724|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
16137211|NCT04178967|38989725|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
16137212|NCT04178967|38989726|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
16137213|NCT04178967|38989727|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
16137214|NCT04178967|38989728|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
16137215|NCT04178967|38989729|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
16137216|NCT04178967|38989730|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
16137217|NCT04178967|38989731|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
16137218|NCT04178967|38989721|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16137219|NCT04178967|38989722|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16137220|NCT04178967|38989723|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16137221|NCT04178967|38989724|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
16137222|NCT04178967|38989725|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16137223|NCT04178967|38989726|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
16137224|NCT04178967|38989727|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
16137225|NCT04178967|38989728|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
16137226|NCT04178967|38989729|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16137227|NCT04178967|38989730|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16137228|NCT04178967|38989731|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
16137229|NCT04178967|38989721|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
16137230|NCT04178967|38989722|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
16137231|NCT04178967|38989723|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
16137232|NCT04178967|38989724|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
16137233|NCT04178967|38989725|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
16137234|NCT04178967|38989726|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
16137235|NCT04178967|38989727|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
16137236|NCT04178967|38989728|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
16137237|NCT04178967|38989729|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
16137238|NCT04178967|38989730|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
16137239|NCT04178967|38989731|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
16137240|NCT04178967|38989721|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16137241|NCT04178967|38989722|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16137242|NCT04178967|38989723|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16137243|NCT04178967|38989724|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16137244|NCT04178967|38989725|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16137245|NCT04178967|38989726|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16253457|NCT00262223|39412907|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
16253458|NCT00262223|39412908|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
16253459|NCT00262223|39412907|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
16253460|NCT00262223|39412908|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
16253461|NCT02761980|39412911|FG000|Overall Study|Adverse Event|4|||
16253462|NCT02761980|39412912|FG001|Overall Study|Adverse Event|6|||
16253463|NCT02761980|39412913|FG002|Overall Study|Adverse Event|5|||
16253464|NCT02761980|39412914|FG003|Overall Study|Adverse Event|6|||
16253465|NCT02761980|39412911|FG000|Overall Study|Withdrawal by Subject|0|||
16253466|NCT02761980|39412912|FG001|Overall Study|Withdrawal by Subject|1|||
16362821|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
16137246|NCT04178967|38989727|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16137247|NCT04178967|38989728|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
16137248|NCT04178967|38989729|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
16137249|NCT04178967|38989730|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
16137250|NCT04178967|38989731|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
16362822|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
16362823|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
16362824|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
16362825|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
16362826|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
16362827|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
16253467|NCT02761980|39412913|FG002|Overall Study|Withdrawal by Subject|0|||
16253468|NCT02761980|39412914|FG003|Overall Study|Withdrawal by Subject|0|||
16253469|NCT02761980|39412911|FG000|Overall Study|Other|0|||
16253470|NCT02761980|39412912|FG001|Overall Study|Other|0|||
16253471|NCT02761980|39412913|FG002|Overall Study|Other|1|||
16253472|NCT02761980|39412914|FG003|Overall Study|Other|0|||
16253473|NCT01946165|39412915|FG000|Overall Study|Physician Decision|2|||
16253474|NCT01946165|39412916|FG001|Overall Study|Physician Decision|0|||
16253475|NCT01946165|39412915|FG000|Overall Study|Withdrawal by Subject|0|||
16253476|NCT01946165|39412916|FG001|Overall Study|Withdrawal by Subject|2|||
16253477|NCT02201251|39412922|FG000|Overall Study|Adverse Event|1|||
16253478|NCT02201251|39412923|FG001|Overall Study|Adverse Event|1|||
16253479|NCT02201251|39412922|FG000|Overall Study|Protocol Violation|1|||
16253480|NCT02201251|39412923|FG001|Overall Study|Protocol Violation|0|||
16253481|NCT02201251|39412922|FG000|Overall Study|Noncompliance with Study Drug|0|||
16253482|NCT02201251|39412923|FG001|Overall Study|Noncompliance with Study Drug|1|||
16253483|NCT02201251|39412922|FG000|Overall Study|Withdrawal by Subject|2|||
16253484|NCT02201251|39412923|FG001|Overall Study|Withdrawal by Subject|1|||
16253485|NCT00659607|39412925|FG000|Overall Study|No blood pressure recorded|147|||
16253486|NCT00659607|39412925|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
16253487|NCT00659607|39412925|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
16253488|NCT00659607|39412925|FG000|Overall Study|No recorded efficacy data|15|||
16253489|NCT00659607|39412925|FG000|Overall Study|Inconsistent BP measuring date|2|||
16253490|NCT01617668|39412926|FG000|Overall Study|Adverse Event|7|||
16253491|NCT01617668|39412927|FG001|Overall Study|Adverse Event|0|||
16253492|NCT01617668|39412928|FG002|Overall Study|Adverse Event|12|||
16253493|NCT01617668|39412929|FG003|Overall Study|Adverse Event|5|||
16253494|NCT01617668|39412926|FG000|Overall Study|Physician Decision|1|||
16253495|NCT01617668|39412927|FG001|Overall Study|Physician Decision|2|||
16253496|NCT01617668|39412928|FG002|Overall Study|Physician Decision|3|||
16253497|NCT01617668|39412929|FG003|Overall Study|Physician Decision|0|||
16253498|NCT01617668|39412926|FG000|Overall Study|Progressive Disease|4|||
16253499|NCT01617668|39412927|FG001|Overall Study|Progressive Disease|4|||
16253500|NCT01617668|39412928|FG002|Overall Study|Progressive Disease|6|||
16253501|NCT01617668|39412929|FG003|Overall Study|Progressive Disease|9|||
16253502|NCT01617668|39412926|FG000|Overall Study|Subject/guardian decision|1|||
16253503|NCT01617668|39412927|FG001|Overall Study|Subject/guardian decision|3|||
16362828|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
16362829|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
16362830|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
16362831|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
16362832|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
16362833|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
16362834|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
16362835|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
16362836|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
16362837|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
16362838|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
16362839|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
16362840|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
16362841|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
16362842|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
16362843|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
16362844|NCT00090103|39814945|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
16362845|NCT00090103|39814946|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
16362846|NCT00090103|39814947|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
16362847|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
16362848|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
16362849|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
16362850|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
16362851|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
16362852|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
16362853|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
16253504|NCT01617668|39412928|FG002|Overall Study|Subject/guardian decision|2|||
16253505|NCT01617668|39412929|FG003|Overall Study|Subject/guardian decision|1|||
16253506|NCT02514174|39412930|FG000|Overall Study|Patient refused to continue medication|1|||
16253507|NCT02514174|39412930|FG000|Overall Study|Adverse Event|2|||
16253508|NCT02514174|39412930|FG000|Overall Study|Study closed by sponsor|9|||
16253509|NCT02514174|39412930|FG000|Overall Study|Progressive disease|11|||
16253510|NCT02514174|39412930|FG000|Overall Study|Treatment change|1|||
16253511|NCT02514174|39412930|FG000|Overall Study|Treated off study with Afatinib.|1|||
16253512|NCT00048048|39412931|FG000|Core Treatment|Withdrawal by Subject|0|||
16253513|NCT00048048|39412932|FG001|Core Treatment|Withdrawal by Subject|0|||
16253514|NCT00048048|39412933|FG002|Core Treatment|Withdrawal by Subject|1|||
16253515|NCT00048048|39412934|FG003|Core Treatment|Withdrawal by Subject|0|||
16253516|NCT00048048|39412935|FG004|Core Treatment|Withdrawal by Subject|0|||
16253517|NCT00048048|39412936|FG005|Core Treatment|Withdrawal by Subject|0|||
16253518|NCT00048048|39412937|FG006|Core Treatment|Withdrawal by Subject|0|||
16253519|NCT00048048|39412938|FG007|Core Treatment|Withdrawal by Subject|0|||
16253520|NCT00048048|39412939|FG008|Core Treatment|Withdrawal by Subject|0|||
16253521|NCT00048048|39412940|FG009|Core Treatment|Withdrawal by Subject|0|||
16253522|NCT00048048|39412941|FG010|Core Treatment|Withdrawal by Subject|0|||
16253523|NCT00048048|39412942|FG011|Core Treatment|Withdrawal by Subject|0|||
16253524|NCT00048048|39412931|FG000|Core Treatment|Adverse Event|0|||
16436250|NCT04630158|40077689|FG001|Overall Study|Protocol Violation|0|||
16436251|NCT04630158|40077690|FG002|Overall Study|Protocol Violation|1|||
16436252|NCT04630158|40077688|FG000|Overall Study|Withdrawal by Subject|2|||
16436253|NCT04630158|40077689|FG001|Overall Study|Withdrawal by Subject|1|||
16436254|NCT04630158|40077690|FG002|Overall Study|Withdrawal by Subject|2|||
16253525|NCT00048048|39412932|FG001|Core Treatment|Adverse Event|0|||
16253526|NCT00048048|39412933|FG002|Core Treatment|Adverse Event|0|||
16253527|NCT00048048|39412934|FG003|Core Treatment|Adverse Event|0|||
16253528|NCT00048048|39412935|FG004|Core Treatment|Adverse Event|0|||
16253529|NCT00048048|39412936|FG005|Core Treatment|Adverse Event|0|||
16253530|NCT00048048|39412937|FG006|Core Treatment|Adverse Event|0|||
16253531|NCT00048048|39412938|FG007|Core Treatment|Adverse Event|1|||
16253532|NCT00048048|39412939|FG008|Core Treatment|Adverse Event|0|||
16253533|NCT00048048|39412940|FG009|Core Treatment|Adverse Event|0|||
16253534|NCT00048048|39412941|FG010|Core Treatment|Adverse Event|0|||
16253535|NCT00048048|39412942|FG011|Core Treatment|Adverse Event|0|||
16253536|NCT00048048|39412931|FG000|Extension Year 1|Early withdrawals|0|||
16253537|NCT00048048|39412932|FG001|Extension Year 1|Early withdrawals|0|||
16253538|NCT00048048|39412933|FG002|Extension Year 1|Early withdrawals|0|||
16253539|NCT00048048|39412934|FG003|Extension Year 1|Early withdrawals|0|||
16253540|NCT00048048|39412935|FG004|Extension Year 1|Early withdrawals|0|||
16253541|NCT00048048|39412936|FG005|Extension Year 1|Early withdrawals|0|||
16253542|NCT00048048|39412937|FG006|Extension Year 1|Early withdrawals|0|||
16253543|NCT00048048|39412938|FG007|Extension Year 1|Early withdrawals|0|||
16253544|NCT00048048|39412939|FG008|Extension Year 1|Early withdrawals|0|||
16253545|NCT00048048|39412940|FG009|Extension Year 1|Early withdrawals|2|||
16253546|NCT00048048|39412941|FG010|Extension Year 1|Early withdrawals|2|||
16253547|NCT00048048|39412942|FG011|Extension Year 1|Early withdrawals|4|||
16253548|NCT00048048|39412931|FG000|Extension Year 2|Early withdrawals|0|||
16253549|NCT00048048|39412932|FG001|Extension Year 2|Early withdrawals|0|||
16253550|NCT00048048|39412933|FG002|Extension Year 2|Early withdrawals|0|||
16253551|NCT00048048|39412934|FG003|Extension Year 2|Early withdrawals|0|||
16253552|NCT00048048|39412935|FG004|Extension Year 2|Early withdrawals|0|||
16253553|NCT00048048|39412936|FG005|Extension Year 2|Early withdrawals|0|||
16253554|NCT00048048|39412937|FG006|Extension Year 2|Early withdrawals|0|||
16253555|NCT00048048|39412938|FG007|Extension Year 2|Early withdrawals|0|||
16253556|NCT00048048|39412939|FG008|Extension Year 2|Early withdrawals|0|||
16253557|NCT00048048|39412940|FG009|Extension Year 2|Early withdrawals|0|||
16253558|NCT00048048|39412941|FG010|Extension Year 2|Early withdrawals|4|||
16253559|NCT00048048|39412942|FG011|Extension Year 2|Early withdrawals|2|||
16253560|NCT01004172|39412943|FG000|Overall Study|Progressive Disease in CNS Only|16|||
16253561|NCT01004172|39412943|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
16253562|NCT01004172|39412943|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
16253563|NCT01004172|39412943|FG000|Overall Study|Adverse Event|1|||
16253564|NCT01004172|39412943|FG000|Overall Study|Physician Decision|1|||
16436255|NCT00525512|40077692|FG000|Double-Blind Phase|Adverse Event|48|||
16253565|NCT01004172|39412943|FG000|Overall Study|Symptomatic Deterioration|2|||
16253566|NCT01241461|39412944|FG000|Overall Study|Progressive Disease|3|||
16253567|NCT01241461|39412945|FG001|Overall Study|Progressive Disease|6|||
16253568|NCT01364870|39412950|FG000|Overall Study|Withdrawal by Subject|13|||
16253569|NCT01364870|39412951|FG001|Overall Study|Withdrawal by Subject|24|||
16253570|NCT01364870|39412952|FG002|Overall Study|Withdrawal by Subject|10|||
16253571|NCT01364870|39412950|FG000|Overall Study|Adverse Event|8|||
16253572|NCT01364870|39412951|FG001|Overall Study|Adverse Event|6|||
16253573|NCT01364870|39412952|FG002|Overall Study|Adverse Event|4|||
16253574|NCT01364870|39412950|FG000|Overall Study|Protocol Violation|1|||
16253575|NCT01364870|39412951|FG001|Overall Study|Protocol Violation|0|||
16253576|NCT01364870|39412952|FG002|Overall Study|Protocol Violation|0|||
16253577|NCT02906709|39412957|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
16253578|NCT02906709|39412958|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
16253579|NCT02906709|39412957|FG000|Phase A (Week 0 to Week 16)|Death|0|||
16253580|NCT02906709|39412958|FG001|Phase A (Week 0 to Week 16)|Death|1|||
16253581|NCT02906709|39412957|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
16253582|NCT02906709|39412958|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
16253583|NCT02906709|39412957|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
16253584|NCT02906709|39412958|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
16253585|NCT00824265|39412959|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
16253586|NCT00824265|39412960|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
16253587|NCT00824265|39412959|FG000|Treatment Phase|Protocol Violation|1|||
16253588|NCT00824265|39412960|FG001|Treatment Phase|Protocol Violation|0|||
16436256|NCT00525512|40077693|FG001|Double-Blind Phase|Adverse Event|28|||
16436257|NCT00525512|40077694|FG002|Double-Blind Phase|Adverse Event|0|||
16436258|NCT00525512|40077695|FG003|Double-Blind Phase|Adverse Event|0|||
16436259|NCT00525512|40077692|FG000|Double-Blind Phase|Protocol Violation|3|||
16436260|NCT00525512|40077693|FG001|Double-Blind Phase|Protocol Violation|1|||
16436261|NCT00525512|40077694|FG002|Double-Blind Phase|Protocol Violation|0|||
16436262|NCT00525512|40077695|FG003|Double-Blind Phase|Protocol Violation|0|||
16436263|NCT00525512|40077692|FG000|Double-Blind Phase|Lost to Follow-up|3|||
16436264|NCT00525512|40077693|FG001|Double-Blind Phase|Lost to Follow-up|7|||
16436265|NCT00525512|40077694|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16436266|NCT00525512|40077695|FG003|Double-Blind Phase|Lost to Follow-up|0|||
16436267|NCT00525512|40077692|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
16436268|NCT00525512|40077693|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
16436269|NCT00525512|40077694|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
16436270|NCT00525512|40077695|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
16436271|NCT00525512|40077692|FG000|Double-Blind Phase|Lack of Efficacy|13|||
16436272|NCT00525512|40077693|FG001|Double-Blind Phase|Lack of Efficacy|5|||
16436273|NCT00525512|40077694|FG002|Double-Blind Phase|Lack of Efficacy|0|||
16436274|NCT00525512|40077695|FG003|Double-Blind Phase|Lack of Efficacy|0|||
16436275|NCT00525512|40077692|FG000|Double-Blind Phase|Other reason (not specified)|12|||
16436276|NCT00525512|40077693|FG001|Double-Blind Phase|Other reason (not specified)|13|||
16436277|NCT00525512|40077694|FG002|Double-Blind Phase|Other reason (not specified)|0|||
16436278|NCT00525512|40077695|FG003|Double-Blind Phase|Other reason (not specified)|0|||
16436279|NCT00525512|40077692|FG000|Open-Label Phase|Adverse Event|0|||
16436280|NCT00525512|40077693|FG001|Open-Label Phase|Adverse Event|0|||
16436281|NCT00525512|40077694|FG002|Open-Label Phase|Adverse Event|1|||
16436282|NCT00525512|40077695|FG003|Open-Label Phase|Adverse Event|0|||
16253589|NCT00824265|39412959|FG000|Treatment Phase|Lost to Follow-up|1|||
16253590|NCT00824265|39412960|FG001|Treatment Phase|Lost to Follow-up|1|||
16436283|NCT00525512|40077692|FG000|Open-Label Phase|Lost to Follow-up|0|||
16436284|NCT00525512|40077693|FG001|Open-Label Phase|Lost to Follow-up|0|||
16436285|NCT00525512|40077694|FG002|Open-Label Phase|Lost to Follow-up|1|||
16436286|NCT00525512|40077695|FG003|Open-Label Phase|Lost to Follow-up|0|||
16436287|NCT00525512|40077692|FG000|Open-Label Phase|Other reason (not specified)|0|||
16436288|NCT00525512|40077693|FG001|Open-Label Phase|Other reason (not specified)|0|||
16436289|NCT00525512|40077694|FG002|Open-Label Phase|Other reason (not specified)|4|||
16436290|NCT00525512|40077695|FG003|Open-Label Phase|Other reason (not specified)|5|||
16436291|NCT00468299|40077696|FG000|Overall Study|Withdrawal by Subject|0|||
16436292|NCT00468299|40077697|FG001|Overall Study|Withdrawal by Subject|1|||
16137251|NCT04178967|38989721|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16137252|NCT04178967|38989722|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16137253|NCT04178967|38989723|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16137254|NCT04178967|38989724|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16137255|NCT04178967|38989725|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16137256|NCT04178967|38989726|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16137257|NCT04178967|38989727|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16137258|NCT04178967|38989728|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16253591|NCT00824265|39412959|FG000|Treatment Phase|Physician Decision|6|||
16253592|NCT00824265|39412960|FG001|Treatment Phase|Physician Decision|12|||
16253593|NCT00824265|39412959|FG000|Treatment Phase|Withdrawal by Subject|6|||
16253594|NCT00824265|39412960|FG001|Treatment Phase|Withdrawal by Subject|15|||
16253595|NCT00824265|39412959|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
16137259|NCT04178967|38989729|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16137260|NCT04178967|38989730|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
16137261|NCT04178967|38989731|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
16137262|NCT04178967|38989721|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16253596|NCT00824265|39412960|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
16253597|NCT00824265|39412959|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
16253598|NCT00824265|39412960|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
16253599|NCT02483975|39412964|FG000|Overall Study|Adverse Event|0|||
16253600|NCT02483975|39412965|FG001|Overall Study|Adverse Event|1|||
16253601|NCT02483975|39412964|FG000|Overall Study|Lost to Follow-up|0|||
16253602|NCT02483975|39412965|FG001|Overall Study|Lost to Follow-up|1|||
16253603|NCT02483975|39412964|FG000|Overall Study|Physician Decision|2|||
16253604|NCT02483975|39412965|FG001|Overall Study|Physician Decision|0|||
16253605|NCT03038113|39412969|FG000|Overall Study|Withdrawal by Subject|0|||
16253606|NCT03038113|39412970|FG001|Overall Study|Withdrawal by Subject|0|||
16253607|NCT03038113|39412971|FG002|Overall Study|Withdrawal by Subject|1|||
16253608|NCT03038113|39412972|FG003|Overall Study|Withdrawal by Subject|0|||
16253609|NCT03038113|39412973|FG004|Overall Study|Withdrawal by Subject|0|||
16253610|NCT03038113|39412974|FG005|Overall Study|Withdrawal by Subject|0|||
16253611|NCT03038113|39412975|FG006|Overall Study|Withdrawal by Subject|0|||
16253612|NCT03038113|39412976|FG007|Overall Study|Withdrawal by Subject|0|||
16253613|NCT03038113|39412977|FG008|Overall Study|Withdrawal by Subject|0|||
16253614|NCT03038113|39412978|FG009|Overall Study|Withdrawal by Subject|0|||
16253615|NCT03038113|39412979|FG010|Overall Study|Withdrawal by Subject|0|||
16253616|NCT03038113|39412980|FG011|Overall Study|Withdrawal by Subject|0|||
16253617|NCT03038113|39412981|FG012|Overall Study|Withdrawal by Subject|0|||
16253618|NCT03038113|39412982|FG013|Overall Study|Withdrawal by Subject|1|||
16253619|NCT03038113|39412969|FG000|Overall Study|Lost to Follow-up|0|||
16253620|NCT03038113|39412970|FG001|Overall Study|Lost to Follow-up|0|||
16253621|NCT03038113|39412971|FG002|Overall Study|Lost to Follow-up|0|||
16137263|NCT04178967|38989722|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16137264|NCT04178967|38989723|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16137265|NCT04178967|38989724|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16137266|NCT04178967|38989725|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16137267|NCT04178967|38989726|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16137268|NCT04178967|38989727|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16137269|NCT04178967|38989728|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
16137270|NCT04178967|38989729|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
16137271|NCT04178967|38989730|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
16137272|NCT04178967|38989731|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
16137273|NCT04178967|38989721|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
16253622|NCT03038113|39412972|FG003|Overall Study|Lost to Follow-up|0|||
16253623|NCT03038113|39412973|FG004|Overall Study|Lost to Follow-up|0|||
16253624|NCT03038113|39412974|FG005|Overall Study|Lost to Follow-up|0|||
16253625|NCT03038113|39412975|FG006|Overall Study|Lost to Follow-up|1|||
16253626|NCT03038113|39412976|FG007|Overall Study|Lost to Follow-up|0|||
16253627|NCT03038113|39412977|FG008|Overall Study|Lost to Follow-up|0|||
16253628|NCT03038113|39412978|FG009|Overall Study|Lost to Follow-up|0|||
16253629|NCT03038113|39412979|FG010|Overall Study|Lost to Follow-up|0|||
16253630|NCT03038113|39412980|FG011|Overall Study|Lost to Follow-up|0|||
16253631|NCT03038113|39412981|FG012|Overall Study|Lost to Follow-up|0|||
16253632|NCT03038113|39412982|FG013|Overall Study|Lost to Follow-up|0|||
16253633|NCT04956666|39412983|FG000|Overall Study|Adverse Event|18|||
16253634|NCT04956666|39412983|FG000|Overall Study|Physician Decision|5|||
16253635|NCT02162758|39412985|FG000|Overall Study|Study termination|0|||
16137274|NCT04178967|38989722|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
16137275|NCT04178967|38989723|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
16253636|NCT02162758|39412986|FG001|Overall Study|Study termination|1|||
16253637|NCT01821625|39412987|FG000|Overall Study|Withdrawal by Subject|2|||
16253638|NCT01821625|39412987|FG000|Overall Study|Lack of Efficacy|2|||
16253639|NCT01821625|39412987|FG000|Overall Study|Adverse Event|1|||
16253640|NCT01821625|39412987|FG000|Overall Study|Medical contraindication|1|||
16253641|NCT01611090|39412991|FG000|Randomized Period|Lost to Follow-up|8|||
16253642|NCT01611090|39412992|FG001|Randomized Period|Lost to Follow-up|3|||
16253643|NCT01611090|39412993|FG002|Randomized Period|Lost to Follow-up|0|||
16253644|NCT01611090|39412991|FG000|Randomized Period|Withdrawal by Subject|22|||
16253645|NCT01611090|39412992|FG001|Randomized Period|Withdrawal by Subject|26|||
16253646|NCT01611090|39412993|FG002|Randomized Period|Withdrawal by Subject|0|||
16253647|NCT01611090|39412991|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
16253648|NCT01611090|39412992|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
16253649|NCT01611090|39412993|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
16253650|NCT01611090|39412991|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
16253651|NCT01611090|39412992|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
16253652|NCT01611090|39412993|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
16253653|NCT00268346|39412996|FG000|Overall Study|Adverse Event|0|||
16253654|NCT00268346|39412997|FG001|Overall Study|Adverse Event|1|||
16253655|NCT00268346|39412996|FG000|Overall Study|Death|0|||
16253656|NCT00268346|39412997|FG001|Overall Study|Death|1|||
16253657|NCT00268346|39412996|FG000|Overall Study|Withdrawal by Subject|0|||
16253658|NCT00268346|39412997|FG001|Overall Study|Withdrawal by Subject|1|||
16253659|NCT02187042|39412998|FG000|Overall Study|Death|1|||
16253660|NCT02187042|39412999|FG001|Overall Study|Death|1|||
16253661|NCT02187042|39412998|FG000|Overall Study|Toxicity|6|||
16253662|NCT02187042|39412999|FG001|Overall Study|Toxicity|5|||
16253663|NCT02187042|39412998|FG000|Overall Study|Participant choice|1|||
16253664|NCT02187042|39412999|FG001|Overall Study|Participant choice|0|||
16253665|NCT02187042|39412998|FG000|Overall Study|Doctor choice|1|||
16253666|NCT02187042|39412999|FG001|Overall Study|Doctor choice|0|||
16253667|NCT02187042|39412998|FG000|Overall Study|Progressive disease|4|||
16253668|NCT02187042|39412999|FG001|Overall Study|Progressive disease|8|||
16253669|NCT00973700|39413000|FG000|Overall Study|Withdrawal by Subject|2|||
16253670|NCT00973700|39413001|FG001|Overall Study|Withdrawal by Subject|2|||
16253671|NCT00973700|39413002|FG002|Overall Study|Withdrawal by Subject|8|||
16253672|NCT00973700|39413003|FG003|Overall Study|Withdrawal by Subject|4|||
16253673|NCT00973700|39413004|FG004|Overall Study|Withdrawal by Subject|4|||
16253674|NCT00973700|39413000|FG000|Overall Study|Lost to Follow-up|5|||
16253675|NCT00973700|39413001|FG001|Overall Study|Lost to Follow-up|0|||
16253676|NCT00973700|39413002|FG002|Overall Study|Lost to Follow-up|1|||
16253677|NCT00973700|39413003|FG003|Overall Study|Lost to Follow-up|8|||
16253678|NCT00973700|39413004|FG004|Overall Study|Lost to Follow-up|5|||
16253679|NCT00973700|39413000|FG000|Overall Study|Inappropriate enrolment|0|||
16253680|NCT00973700|39413001|FG001|Overall Study|Inappropriate enrolment|0|||
16253681|NCT00973700|39413002|FG002|Overall Study|Inappropriate enrolment|0|||
16253682|NCT00973700|39413003|FG003|Overall Study|Inappropriate enrolment|4|||
16253683|NCT00973700|39413004|FG004|Overall Study|Inappropriate enrolment|0|||
16253684|NCT00973700|39413000|FG000|Overall Study|Unable to Classify|0|||
16253685|NCT00973700|39413001|FG001|Overall Study|Unable to Classify|0|||
16253686|NCT00973700|39413002|FG002|Overall Study|Unable to Classify|1|||
16137276|NCT04178967|38989724|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
16137277|NCT04178967|38989725|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
16137278|NCT04178967|38989726|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
16137279|NCT04178967|38989727|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
16137280|NCT04178967|38989728|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
16137281|NCT04178967|38989729|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
16137282|NCT04178967|38989730|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
16137283|NCT04178967|38989731|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
16137284|NCT04178967|38989721|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
16137285|NCT04178967|38989722|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
16137286|NCT04178967|38989723|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
16253687|NCT00973700|39413003|FG003|Overall Study|Unable to Classify|2|||
16137287|NCT04178967|38989724|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
16253688|NCT00973700|39413004|FG004|Overall Study|Unable to Classify|1|||
16137288|NCT04178967|38989725|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
16137289|NCT04178967|38989726|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
16253689|NCT02486796|39413007|FG000|Overall Study|Withdrawal by Subject|1|||
16137290|NCT04178967|38989727|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
16253690|NCT02486796|39413008|FG001|Overall Study|Withdrawal by Subject|1|||
16253691|NCT02486796|39413007|FG000|Overall Study|Physician Decision|1|||
16253692|NCT02486796|39413008|FG001|Overall Study|Physician Decision|0|||
16253693|NCT00720096|39413011|FG000|Overall Study|Withdrawal by Subject|0|||
16253694|NCT00720096|39413012|FG001|Overall Study|Withdrawal by Subject|2|||
16253695|NCT01144663|39413016|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
16253696|NCT01144663|39413017|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
16253697|NCT01144663|39413018|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
16253698|NCT01144663|39413019|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
16253699|NCT01144663|39413016|FG000|Primary Vaccination Phase|Adverse Event|1|||
16253700|NCT01144663|39413017|FG001|Primary Vaccination Phase|Adverse Event|0|||
16253701|NCT01144663|39413018|FG002|Primary Vaccination Phase|Adverse Event|0|||
16253702|NCT01144663|39413019|FG003|Primary Vaccination Phase|Adverse Event|1|||
16137291|NCT04178967|38989728|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
16253703|NCT01144663|39413016|FG000|Primary Vaccination Phase|Protocol Violation|2|||
16137292|NCT04178967|38989729|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
16137293|NCT04178967|38989730|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
16137294|NCT04178967|38989731|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
16137295|NCT03357952|38989733|FG000|Overall Study|Withdrawal by Subject|0|||
16137296|NCT03357952|38989734|FG001|Overall Study|Withdrawal by Subject|1|||
16137297|NCT03357952|38989733|FG000|Overall Study|Sponsor Decision|9|||
16137298|NCT03357952|38989734|FG001|Overall Study|Sponsor Decision|0|||
16137299|NCT02647866|38989735|FG000|Overall Study|Adverse Event|0|||
16137300|NCT02647866|38989736|FG001|Overall Study|Adverse Event|0|||
16137301|NCT02647866|38989737|FG002|Overall Study|Adverse Event|2|||
16137302|NCT02647866|38989738|FG003|Overall Study|Adverse Event|2|||
16137303|NCT02647866|38989739|FG004|Overall Study|Adverse Event|1|||
16137304|NCT02647866|38989735|FG000|Overall Study|Disease Worsening|3|||
16137305|NCT02647866|38989736|FG001|Overall Study|Disease Worsening|1|||
16137306|NCT02647866|38989737|FG002|Overall Study|Disease Worsening|0|||
16137307|NCT02647866|38989738|FG003|Overall Study|Disease Worsening|0|||
16137308|NCT02647866|38989739|FG004|Overall Study|Disease Worsening|1|||
16137309|NCT02647866|38989735|FG000|Overall Study|Withdrawal by Subject|1|||
16137310|NCT02647866|38989736|FG001|Overall Study|Withdrawal by Subject|1|||
16137311|NCT02647866|38989737|FG002|Overall Study|Withdrawal by Subject|2|||
16137312|NCT02647866|38989738|FG003|Overall Study|Withdrawal by Subject|4|||
16137313|NCT02647866|38989739|FG004|Overall Study|Withdrawal by Subject|4|||
16137314|NCT02647866|38989735|FG000|Overall Study|Physician Decision|0|||
16137315|NCT02647866|38989736|FG001|Overall Study|Physician Decision|1|||
16137316|NCT02647866|38989737|FG002|Overall Study|Physician Decision|1|||
16137317|NCT02647866|38989738|FG003|Overall Study|Physician Decision|0|||
16137318|NCT02647866|38989739|FG004|Overall Study|Physician Decision|2|||
16137319|NCT02647866|38989735|FG000|Overall Study|Death|0|||
16137320|NCT02647866|38989736|FG001|Overall Study|Death|1|||
16137321|NCT02647866|38989737|FG002|Overall Study|Death|0|||
16137322|NCT02647866|38989738|FG003|Overall Study|Death|0|||
16137323|NCT02647866|38989739|FG004|Overall Study|Death|0|||
16137324|NCT02647866|38989735|FG000|Overall Study|Subject moved to different country|1|||
16137325|NCT02647866|38989736|FG001|Overall Study|Subject moved to different country|0|||
16137326|NCT02647866|38989737|FG002|Overall Study|Subject moved to different country|0|||
16137327|NCT02647866|38989738|FG003|Overall Study|Subject moved to different country|0|||
16436293|NCT03740048|40077698|FG000|Overall Study|Withdrawal by Subject|1|||
16137328|NCT02647866|38989739|FG004|Overall Study|Subject moved to different country|0|||
16137329|NCT02141074|38989744|FG000|Pre-prophylaxis|Adverse Event|3|||
16137330|NCT02141074|38989745|FG001|Pre-prophylaxis|Adverse Event|0|||
16137331|NCT02141074|38989744|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
16137332|NCT02141074|38989745|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
16137333|NCT02141074|38989744|FG000|Prophylaxis|Adverse Event|0|||
16137334|NCT02141074|38989745|FG001|Prophylaxis|Adverse Event|4|||
16137335|NCT02141074|38989744|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
16436294|NCT03740048|40077699|FG001|Overall Study|Withdrawal by Subject|1|||
16137336|NCT02141074|38989745|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
16137337|NCT02141074|38989744|FG000|Prophylaxis|Withdrawal by Subject|0|||
16137338|NCT02141074|38989745|FG001|Prophylaxis|Withdrawal by Subject|1|||
16137339|NCT01920594|38989748|FG000|Overall Study|Adverse Event|4|||
16137340|NCT01920594|38989749|FG001|Overall Study|Adverse Event|2|||
16137341|NCT01920594|38989748|FG000|Overall Study|Lost to Follow-up|1|||
16137342|NCT01920594|38989749|FG001|Overall Study|Lost to Follow-up|0|||
16137343|NCT01920594|38989748|FG000|Overall Study|Recovery|2|||
16137344|NCT01920594|38989749|FG001|Overall Study|Recovery|0|||
16137345|NCT01920594|38989748|FG000|Overall Study|Investigator discretion|0|||
16137346|NCT01920594|38989749|FG001|Overall Study|Investigator discretion|1|||
16137347|NCT03421431|38989750|FG000|Overall Study|Adverse Event|2|||
16137348|NCT03421431|38989751|FG001|Overall Study|Adverse Event|1|||
16137349|NCT03421431|38989752|FG002|Overall Study|Adverse Event|12|||
16137350|NCT03421431|38989750|FG000|Overall Study|Lost to Follow-up|1|||
16137351|NCT03421431|38989751|FG001|Overall Study|Lost to Follow-up|1|||
16137352|NCT03421431|38989752|FG002|Overall Study|Lost to Follow-up|1|||
16137353|NCT03421431|38989750|FG000|Overall Study|Withdrawal by Subject|3|||
16137354|NCT03421431|38989751|FG001|Overall Study|Withdrawal by Subject|2|||
16137355|NCT03421431|38989752|FG002|Overall Study|Withdrawal by Subject|1|||
16137356|NCT03421431|38989750|FG000|Overall Study|Protocol Violation|0|||
16137357|NCT03421431|38989751|FG001|Overall Study|Protocol Violation|1|||
16137358|NCT03421431|38989752|FG002|Overall Study|Protocol Violation|0|||
16137359|NCT03421431|38989750|FG000|Overall Study|Participant met Stopping Rules|0|||
16137360|NCT03421431|38989751|FG001|Overall Study|Participant met Stopping Rules|1|||
16137361|NCT03421431|38989752|FG002|Overall Study|Participant met Stopping Rules|0|||
16137362|NCT01786174|38989753|FG000|Overall Study|Discontinued Study Drug|2|||
16137363|NCT01786174|38989754|FG001|Overall Study|Discontinued Study Drug|0|||
16137364|NCT01028222|38989755|FG000|Overall Study|Protocol deviation|1|||
16137365|NCT01028222|38989756|FG001|Overall Study|Protocol deviation|0|||
16137366|NCT01028222|38989755|FG000|Overall Study|Disease progression|33|||
16137367|NCT01028222|38989756|FG001|Overall Study|Disease progression|9|||
16137368|NCT01028222|38989755|FG000|Overall Study|Administrative problems|1|||
16137369|NCT01028222|38989756|FG001|Overall Study|Administrative problems|1|||
16137370|NCT01028222|38989755|FG000|Overall Study|Lost to Follow-up|0|||
16137371|NCT01028222|38989756|FG001|Overall Study|Lost to Follow-up|1|||
16137372|NCT01028222|38989755|FG000|Overall Study|Withdrawal by Subject|1|||
16137373|NCT01028222|38989756|FG001|Overall Study|Withdrawal by Subject|0|||
16137374|NCT01028222|38989755|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
16137375|NCT01028222|38989756|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
16137376|NCT01028222|38989755|FG000|Overall Study|Adverse Event|2|||
16137377|NCT01028222|38989756|FG001|Overall Study|Adverse Event|0|||
16137378|NCT03610165|38989758|FG000|Overall Study|Device didn't work|0|||
16137379|NCT03610165|38989759|FG001|Overall Study|Device didn't work|1|||
16137380|NCT01287065|38989766|FG000|Treatment Period 1|Adverse Event|0|||
16137381|NCT01287065|38989767|FG001|Treatment Period 1|Adverse Event|0|||
16137382|NCT01287065|38989768|FG002|Treatment Period 1|Adverse Event|0|||
16137383|NCT01287065|38989769|FG003|Treatment Period 1|Adverse Event|0|||
16137384|NCT01287065|38989770|FG004|Treatment Period 1|Adverse Event|1|||
16137385|NCT01287065|38989771|FG005|Treatment Period 1|Adverse Event|0|||
16137386|NCT01287065|38989766|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16137387|NCT01287065|38989767|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16137388|NCT01287065|38989768|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16137389|NCT01287065|38989769|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16137390|NCT01287065|38989770|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16137391|NCT01287065|38989771|FG005|Treatment Period 1|Withdrawal by Subject|1|||
16137392|NCT00523718|38989772|FG000|Overall Study|Withdrawal by Subject|1|||
16137393|NCT00523718|38989773|FG001|Overall Study|Withdrawal by Subject|0|||
16137394|NCT00523718|38989772|FG000|Overall Study|Protocol Violation|2|||
16137395|NCT00523718|38989773|FG001|Overall Study|Protocol Violation|0|||
16137396|NCT00666679|38989781|FG000|First Intervention|Lost to Follow-up|1|||
16137397|NCT00666679|38989782|FG001|First Intervention|Lost to Follow-up|0|||
16137398|NCT00666679|38989781|FG000|First Intervention|Protocol Violation|1|||
16137399|NCT00666679|38989782|FG001|First Intervention|Protocol Violation|0|||
16137400|NCT00666679|38989781|FG000|First Intervention|Withdrawal by Subject|1|||
16137401|NCT00666679|38989782|FG001|First Intervention|Withdrawal by Subject|0|||
16137402|NCT00666679|38989781|FG000|First Intervention|Randomized did not start treatment|1|||
16137403|NCT00666679|38989782|FG001|First Intervention|Randomized did not start treatment|1|||
16137404|NCT00666679|38989781|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
16137405|NCT00666679|38989782|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
16137406|NCT00666679|38989781|FG000|Washout Period of 1 Week|Protocol Violation|0|||
16137407|NCT00666679|38989782|FG001|Washout Period of 1 Week|Protocol Violation|1|||
16137408|NCT00666679|38989781|FG000|Second Intervention|Adverse Event|1|||
16137409|NCT00666679|38989782|FG001|Second Intervention|Adverse Event|0|||
16137410|NCT00666679|38989781|FG000|Second Intervention|Death|0|||
16137411|NCT00666679|38989782|FG001|Second Intervention|Death|1|||
16137412|NCT01111474|38989784|FG000|Overall Study|Lost to Follow-up|12|||
16137413|NCT00607022|38989794|FG000|Overall Study|Withdrawal by Subject|1|||
16137414|NCT00607022|38989795|FG001|Overall Study|Withdrawal by Subject|0|||
16137415|NCT00607022|38989796|FG002|Overall Study|Withdrawal by Subject|0|||
16137416|NCT00536809|38989801|FG000|Phase II|Adverse Event|1|||
16137417|NCT00536809|38989801|FG000|Phase II|Referred for surgical resection|1|||
16137418|NCT01557283|38989802|FG000|Overall Study|Lost to Follow-up|7|||
16137419|NCT01557283|38989802|FG000|Overall Study|Non-responder|19|||
16137420|NCT01557283|38989802|FG000|Overall Study|Adverse Event|7|||
16137421|NCT01557283|38989802|FG000|Overall Study|Lack of Efficacy|1|||
16137422|NCT01557283|38989802|FG000|Overall Study|Non-compliance|1|||
16137423|NCT01557283|38989802|FG000|Overall Study|Withdrawal by Subject|1|||
16137424|NCT01557283|38989802|FG000|Overall Study|Participant's weight too high for dose|1|||
16137425|NCT01557283|38989802|FG000|Overall Study|Worsening of psoriasis|1|||
16137426|NCT01557283|38989802|FG000|Overall Study|Other|6|||
16137427|NCT01067326|38989803|FG000|Overall Study|Adverse Event|0|||
16137428|NCT01067326|38989804|FG001|Overall Study|Adverse Event|2|||
16137429|NCT01067326|38989803|FG000|Overall Study|Withdrawal by Subject|1|||
16137430|NCT01067326|38989804|FG001|Overall Study|Withdrawal by Subject|0|||
16137431|NCT01067326|38989803|FG000|Overall Study|Early Study Termination|1|||
16137432|NCT01067326|38989804|FG001|Overall Study|Early Study Termination|1|||
16137433|NCT04051827|38989807|FG000|Overall Study|Death|1|||
16137434|NCT04051827|38989807|FG000|Overall Study|Withdrawal by Subject|4|||
16137435|NCT04051827|38989807|FG000|Overall Study|Progressive disease|16|||
16137436|NCT04051827|38989807|FG000|Overall Study|Physician Decision|1|||
16137437|NCT04051827|38989807|FG000|Overall Study|Other|4|||
16137438|NCT01933113|38989808|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
16137439|NCT01978262|38989809|FG000|Overall Study|Withdrawal by Subject|9|||
16137440|NCT01978262|38989809|FG000|Overall Study|Lost to Follow-up|2|||
16137441|NCT01118325|38989813|FG000|Overall Study|Adverse Event|1|||
16137442|NCT01118325|38989814|FG001|Overall Study|Adverse Event|0|||
16137443|NCT01118325|38989815|FG002|Overall Study|Adverse Event|1|||
16137444|NCT04936841|38989816|FG000|Overall Study|Death|1|||
16137445|NCT01906346|38989817|FG000|Overall Study|AEs|1|||
16137446|NCT00412971|38989822|FG000|Overall Study|Lost to Follow-up|17|||
16137447|NCT00412971|38989823|FG001|Overall Study|Lost to Follow-up|9|||
16137448|NCT00412971|38989822|FG000|Overall Study|Protocol Violation|13|||
16137449|NCT00412971|38989823|FG001|Overall Study|Protocol Violation|1|||
16137450|NCT00455325|38989824|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
16137451|NCT00455325|38989825|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
16137452|NCT00455325|38989826|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
16137453|NCT00455325|38989827|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
16137454|NCT00455325|38989824|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
16137455|NCT00455325|38989825|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
16137456|NCT00455325|38989826|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
16436295|NCT03740048|40077698|FG000|Overall Study|Death|1|||
16436296|NCT03740048|40077699|FG001|Overall Study|Death|6|||
16436297|NCT03740048|40077698|FG000|Overall Study|Switched to thrice-weekly HD|2|||
16436298|NCT03740048|40077699|FG001|Overall Study|Switched to thrice-weekly HD|0|||
16436299|NCT03740048|40077698|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
16137457|NCT00455325|38989827|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
16137458|NCT00455325|38989824|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
16436300|NCT03740048|40077699|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
16137459|NCT00455325|38989825|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
16137460|NCT00455325|38989826|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
16137461|NCT00455325|38989827|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
16137462|NCT00455325|38989824|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
16137463|NCT00455325|38989825|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
16436301|NCT03740048|40077698|FG000|Overall Study|Lost to Follow-up|0|||
16436302|NCT03740048|40077699|FG001|Overall Study|Lost to Follow-up|1|||
16253704|NCT01144663|39413017|FG001|Primary Vaccination Phase|Protocol Violation|0|||
16436303|NCT03740048|40077698|FG000|Overall Study|Non-compliance with HD|0|||
16436304|NCT03740048|40077699|FG001|Overall Study|Non-compliance with HD|1|||
16436305|NCT04002960|40077705|FG000|Overall Study|Withdrawn prior to Completion|2|||
16436306|NCT02138890|40077706|FG000|Overall Study|Adverse Event|1|||
16436307|NCT02138890|40077707|FG001|Overall Study|Adverse Event|0|||
16436308|NCT02366195|40077708|FG000|Overall Study|Protocol-specified criteria|3|||
16436309|NCT02366195|40077708|FG000|Overall Study|Withdrawal by Subject|9|||
16436310|NCT02366195|40077708|FG000|Overall Study|Lost to Follow-up|1|||
16436311|NCT02366195|40077708|FG000|Overall Study|Death|41|||
16436312|NCT02294396|40077709|FG000|Overall Study|Adverse Event|26|||
16436313|NCT02294396|40077710|FG001|Overall Study|Adverse Event|25|||
16436314|NCT02294396|40077711|FG002|Overall Study|Adverse Event|21|||
16436315|NCT02294396|40077712|FG003|Overall Study|Adverse Event|24|||
16436316|NCT02294396|40077709|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
16436317|NCT02294396|40077710|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
16436318|NCT02294396|40077711|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
16436319|NCT02294396|40077712|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
16436320|NCT02294396|40077709|FG000|Overall Study|Withdrawal by Subject|8|||
16436321|NCT02294396|40077710|FG001|Overall Study|Withdrawal by Subject|6|||
16436322|NCT02294396|40077711|FG002|Overall Study|Withdrawal by Subject|6|||
16436323|NCT02294396|40077712|FG003|Overall Study|Withdrawal by Subject|8|||
16436324|NCT02294396|40077709|FG000|Overall Study|Lost to Follow-up|0|||
16436325|NCT02294396|40077710|FG001|Overall Study|Lost to Follow-up|0|||
16436326|NCT02294396|40077711|FG002|Overall Study|Lost to Follow-up|1|||
16436327|NCT02294396|40077712|FG003|Overall Study|Lost to Follow-up|1|||
16436328|NCT02294396|40077709|FG000|Overall Study|Protocol Deviation|3|||
16436329|NCT02294396|40077710|FG001|Overall Study|Protocol Deviation|2|||
16137464|NCT00455325|38989826|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
16137465|NCT00455325|38989827|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
16137466|NCT00455325|38989824|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
16137467|NCT00455325|38989825|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
16137468|NCT00455325|38989826|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
16137469|NCT00455325|38989827|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
16137470|NCT00455325|38989824|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
16137471|NCT00455325|38989825|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
16137472|NCT00455325|38989826|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
16137473|NCT00455325|38989827|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
16137474|NCT00455325|38989824|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
16137475|NCT00455325|38989825|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
16137476|NCT00455325|38989826|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
16137477|NCT00455325|38989827|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
16137478|NCT02313233|38989828|FG000|Overall Study|Withdrawal by Subject|1|||
16137479|NCT02313233|38989829|FG001|Overall Study|Withdrawal by Subject|2|||
16137480|NCT02313233|38989828|FG000|Overall Study|Administrative reason|1|||
16137481|NCT02313233|38989829|FG001|Overall Study|Administrative reason|1|||
16137482|NCT00908232|38989830|FG000|Cycle 1 to 4|Death|5|||
16137483|NCT00908232|38989831|FG001|Cycle 1 to 4|Death|0|||
16137484|NCT00908232|38989832|FG002|Cycle 1 to 4|Death|0|||
16137485|NCT00908232|38989833|FG003|Cycle 1 to 4|Death|0|||
16137486|NCT00908232|38989830|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
16137487|NCT00908232|38989831|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
16137488|NCT00908232|38989832|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
16137489|NCT00908232|38989833|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
16137490|NCT00908232|38989830|FG000|Cycle 1 to 4|Progressive Disease|6|||
16137491|NCT00908232|38989831|FG001|Cycle 1 to 4|Progressive Disease|0|||
16137492|NCT00908232|38989832|FG002|Cycle 1 to 4|Progressive Disease|0|||
16137493|NCT00908232|38989833|FG003|Cycle 1 to 4|Progressive Disease|0|||
16137494|NCT00908232|38989830|FG000|Cycle 1 to 4|Adverse Event|12|||
16137495|NCT00908232|38989831|FG001|Cycle 1 to 4|Adverse Event|0|||
16137496|NCT00908232|38989832|FG002|Cycle 1 to 4|Adverse Event|0|||
16137497|NCT00908232|38989833|FG003|Cycle 1 to 4|Adverse Event|0|||
16436330|NCT02294396|40077711|FG002|Overall Study|Protocol Deviation|2|||
16436331|NCT02294396|40077712|FG003|Overall Study|Protocol Deviation|1|||
16436332|NCT02294396|40077709|FG000|Overall Study|Miscellaneous|2|||
16137498|NCT00908232|38989830|FG000|Cycle 1 to 4|Other|1|||
16137499|NCT00908232|38989831|FG001|Cycle 1 to 4|Other|0|||
16137500|NCT00908232|38989832|FG002|Cycle 1 to 4|Other|0|||
16137501|NCT00908232|38989833|FG003|Cycle 1 to 4|Other|0|||
16137502|NCT00908232|38989830|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
16137503|NCT00908232|38989831|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
16137504|NCT00908232|38989832|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
16253705|NCT01144663|39413018|FG002|Primary Vaccination Phase|Protocol Violation|1|||
16436333|NCT02294396|40077710|FG001|Overall Study|Miscellaneous|0|||
16137505|NCT00908232|38989833|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
16436334|NCT02294396|40077711|FG002|Overall Study|Miscellaneous|5|||
16436335|NCT02294396|40077712|FG003|Overall Study|Miscellaneous|2|||
16137506|NCT00908232|38989830|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
16137507|NCT00908232|38989831|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
16137508|NCT00908232|38989832|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
16137509|NCT00908232|38989833|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
16436336|NCT00979901|40077713|FG000|Overall Study|Adverse Event|1|||
16137510|NCT00908232|38989830|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
16436337|NCT00979901|40077714|FG001|Overall Study|Adverse Event|3|||
16436338|NCT00979901|40077715|FG002|Overall Study|Adverse Event|9|||
16436339|NCT00979901|40077716|FG003|Overall Study|Adverse Event|2|||
16436340|NCT00979901|40077713|FG000|Overall Study|Lack of Efficacy|8|||
16362854|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
16436341|NCT00979901|40077714|FG001|Overall Study|Lack of Efficacy|4|||
16137511|NCT00908232|38989831|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
16137512|NCT00908232|38989832|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
16137513|NCT00908232|38989833|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
16137514|NCT00908232|38989830|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
16137515|NCT00908232|38989831|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
16137516|NCT00908232|38989832|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
16137517|NCT00908232|38989833|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
16137518|NCT00908232|38989830|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
16137519|NCT00908232|38989831|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
16137520|NCT00908232|38989832|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
16137521|NCT00908232|38989833|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
16137522|NCT00908232|38989830|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
16137523|NCT00908232|38989831|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
16137524|NCT00908232|38989832|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
16137525|NCT00908232|38989833|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
16137526|NCT00908232|38989830|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
16137527|NCT00908232|38989831|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
16137528|NCT00908232|38989832|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
16137529|NCT00908232|38989833|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
16137530|NCT00908232|38989830|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
16137531|NCT00908232|38989831|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
16137532|NCT00908232|38989832|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
16137533|NCT00908232|38989833|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
16137534|NCT02941926|38989838|FG000|Core Phase|Progressive disease|1109|||
16137535|NCT02941926|38989838|FG000|Core Phase|Adverse Event|504|||
16137536|NCT02941926|38989838|FG000|Core Phase|Subject/guardian decision|127|||
16137537|NCT02941926|38989838|FG000|Core Phase|Physician Decision|112|||
16137538|NCT02941926|38989838|FG000|Core Phase|Death|46|||
16137539|NCT02941926|38989838|FG000|Core Phase|Protocol deviation|34|||
16137540|NCT02941926|38989838|FG000|Core Phase|Lost to Follow-up|8|||
16137541|NCT02941926|38989838|FG000|Core Phase|Technical problems|5|||
16137542|NCT02941926|38989838|FG000|Extension Phase|Physician Decision|155|||
16137543|NCT02941926|38989838|FG000|Extension Phase|Progressive disease|115|||
16137544|NCT02941926|38989838|FG000|Extension Phase|Adverse Event|13|||
16137545|NCT02941926|38989838|FG000|Extension Phase|Subject/Guardian decision|12|||
16137546|NCT02941926|38989838|FG000|Extension Phase|Death|6|||
16137547|NCT00564018|38989842|FG000|Overall Study|Withdrawal by Subject|2|||
16137548|NCT00564018|38989843|FG001|Overall Study|Withdrawal by Subject|3|||
16137549|NCT00564018|38989844|FG002|Overall Study|Withdrawal by Subject|1|||
16137550|NCT02187809|38989848|FG000|Overall Study|The study was terminated|3|||
16137551|NCT01388790|38989849|FG000|Overall Study|Ongoing at data cut-off date|8|||
16137552|NCT03153137|38989854|FG000|Overall Study|Lost to Follow-up|1|||
16137553|NCT03153137|38989855|FG001|Overall Study|Lost to Follow-up|0|||
16137554|NCT03153137|38989854|FG000|Overall Study|Withdrawal by Subject|2|||
16137555|NCT03153137|38989855|FG001|Overall Study|Withdrawal by Subject|1|||
16137556|NCT03153137|38989854|FG000|Overall Study|Physician Decision|0|||
16137557|NCT03153137|38989855|FG001|Overall Study|Physician Decision|3|||
16137558|NCT00762970|38989857|FG000|Overall Study|Withdrawal by Subject|7|||
16137559|NCT00762970|38989858|FG001|Overall Study|Withdrawal by Subject|4|||
16137560|NCT00762970|38989859|FG002|Overall Study|Withdrawal by Subject|0|||
16137561|NCT00762970|38989857|FG000|Overall Study|Protocol Violation|3|||
16137562|NCT00762970|38989858|FG001|Overall Study|Protocol Violation|1|||
16137563|NCT00762970|38989859|FG002|Overall Study|Protocol Violation|1|||
16137564|NCT00762970|38989857|FG000|Overall Study|Lost to Follow-up|1|||
16137565|NCT00762970|38989858|FG001|Overall Study|Lost to Follow-up|2|||
16137566|NCT00762970|38989859|FG002|Overall Study|Lost to Follow-up|0|||
16137567|NCT00762970|38989857|FG000|Overall Study|Difficulty of handling lens|1|||
16137568|NCT00762970|38989858|FG001|Overall Study|Difficulty of handling lens|2|||
16137569|NCT00762970|38989859|FG002|Overall Study|Difficulty of handling lens|0|||
16137570|NCT02411578|38989860|FG000|Crossover Trial Phase|Pregnancy|0|||
16137571|NCT02411578|38989861|FG001|Crossover Trial Phase|Pregnancy|1|||
16137572|NCT02604433|38989862|FG000|Overall Study|Withdrawal by Subject|37|||
16137573|NCT02604433|38989863|FG001|Overall Study|Withdrawal by Subject|16|||
16137574|NCT02604433|38989862|FG000|Overall Study|Adverse Event|4|||
16137575|NCT02604433|38989863|FG001|Overall Study|Adverse Event|0|||
16137576|NCT02604433|38989862|FG000|Overall Study|Other reasons|3|||
16137577|NCT02604433|38989863|FG001|Overall Study|Other reasons|5|||
16137578|NCT02604433|38989862|FG000|Overall Study|Death|4|||
16137579|NCT02604433|38989863|FG001|Overall Study|Death|1|||
16137580|NCT02604433|38989862|FG000|Overall Study|Transition to Rollover Protocol|169|||
16137581|NCT02604433|38989863|FG001|Overall Study|Transition to Rollover Protocol|82|||
16137582|NCT02604433|38989862|FG000|Overall Study|Physician Decision|1|||
16137583|NCT02604433|38989863|FG001|Overall Study|Physician Decision|1|||
16137584|NCT02604433|38989862|FG000|Overall Study|Lack of Efficacy|0|||
16137585|NCT02604433|38989863|FG001|Overall Study|Lack of Efficacy|1|||
16137586|NCT03739437|38989864|FG000|Overall Study|Lost to Follow-up|2|||
16137587|NCT03739437|38989865|FG001|Overall Study|Lost to Follow-up|5|||
16137588|NCT01295034|38989866|FG000|Overall Study|Lost to Follow-up|5|||
16137589|NCT01295034|38989867|FG001|Overall Study|Lost to Follow-up|5|||
16137590|NCT00639223|38989868|FG000|Overall Study|Lost to Follow-up|0|||
16137591|NCT00639223|38989869|FG001|Overall Study|Lost to Follow-up|2|||
16137592|NCT03294109|38989878|FG000|Overall Study|Withdrawal by Subject|6|||
16137593|NCT03294109|38989879|FG001|Overall Study|Withdrawal by Subject|5|||
16137594|NCT00926211|38989880|FG000|Overall Study|Lost to Follow-up|1|||
16137595|NCT01029652|38989881|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
16137596|NCT01029652|38989882|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
16137597|NCT01029652|38989881|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
16137598|NCT01029652|38989882|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
16137599|NCT01029652|38989881|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
16137600|NCT01029652|38989882|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
16137601|NCT01029652|38989881|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
16137602|NCT01029652|38989882|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
16137603|NCT01029652|38989881|FG000|Core Study (0-12 Weeks)|Death|0|||
16137604|NCT01029652|38989882|FG001|Core Study (0-12 Weeks)|Death|1|||
16137605|NCT01029652|38989881|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
16137606|NCT01029652|38989882|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
16137607|NCT01029652|38989881|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
16137608|NCT01029652|38989882|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
16137609|NCT01029652|38989881|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
16137610|NCT01029652|38989882|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
16137611|NCT01029652|38989881|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
16137612|NCT01029652|38989882|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
16137613|NCT01029652|38989881|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
16137614|NCT01029652|38989882|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
16137615|NCT01029652|38989881|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
16436342|NCT00979901|40077715|FG002|Overall Study|Lack of Efficacy|9|||
16436343|NCT00979901|40077716|FG003|Overall Study|Lack of Efficacy|0|||
16436344|NCT00979901|40077713|FG000|Overall Study|Lost to Follow-up|1|||
16436345|NCT00979901|40077714|FG001|Overall Study|Lost to Follow-up|1|||
16436346|NCT00979901|40077715|FG002|Overall Study|Lost to Follow-up|2|||
16436347|NCT00979901|40077716|FG003|Overall Study|Lost to Follow-up|0|||
16436348|NCT00979901|40077713|FG000|Overall Study|Protocol Violation|2|||
16436349|NCT00979901|40077714|FG001|Overall Study|Protocol Violation|2|||
16436350|NCT00979901|40077715|FG002|Overall Study|Protocol Violation|7|||
16436351|NCT00979901|40077716|FG003|Overall Study|Protocol Violation|1|||
16436352|NCT00979901|40077713|FG000|Overall Study|Withdrawal by Subject|2|||
16436353|NCT00979901|40077714|FG001|Overall Study|Withdrawal by Subject|1|||
16436354|NCT00979901|40077715|FG002|Overall Study|Withdrawal by Subject|1|||
16436355|NCT00979901|40077716|FG003|Overall Study|Withdrawal by Subject|1|||
16436356|NCT00979901|40077713|FG000|Overall Study|Noncompliance|1|||
16436357|NCT00979901|40077714|FG001|Overall Study|Noncompliance|0|||
16436358|NCT00979901|40077715|FG002|Overall Study|Noncompliance|0|||
16436359|NCT00979901|40077716|FG003|Overall Study|Noncompliance|0|||
16436360|NCT00979901|40077713|FG000|Overall Study|out-of-state|1|||
16253706|NCT01144663|39413019|FG003|Primary Vaccination Phase|Protocol Violation|0|||
16253707|NCT01144663|39413016|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
16436361|NCT00979901|40077714|FG001|Overall Study|out-of-state|0|||
16436362|NCT00979901|40077715|FG002|Overall Study|out-of-state|0|||
16436363|NCT00979901|40077716|FG003|Overall Study|out-of-state|0|||
16436364|NCT00979901|40077713|FG000|Overall Study|vacation|1|||
16436365|NCT00979901|40077714|FG001|Overall Study|vacation|0|||
16436366|NCT00979901|40077715|FG002|Overall Study|vacation|0|||
16436367|NCT00979901|40077716|FG003|Overall Study|vacation|0|||
16436368|NCT00979901|40077713|FG000|Overall Study|elevated lab values pre-randomization|1|||
16436369|NCT00979901|40077714|FG001|Overall Study|elevated lab values pre-randomization|0|||
16436370|NCT00979901|40077715|FG002|Overall Study|elevated lab values pre-randomization|0|||
16436371|NCT00979901|40077716|FG003|Overall Study|elevated lab values pre-randomization|0|||
16436372|NCT00979901|40077713|FG000|Overall Study|Discontinued in Error|0|||
16436373|NCT00979901|40077714|FG001|Overall Study|Discontinued in Error|1|||
16137616|NCT01029652|38989882|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
16137617|NCT01029652|38989881|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
16137618|NCT01029652|38989882|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
16137619|NCT00821431|38989885|FG000|Overall Study|Adverse Event|6|||
16137620|NCT00821431|38989886|FG001|Overall Study|Adverse Event|3|||
16436374|NCT00979901|40077715|FG002|Overall Study|Discontinued in Error|0|||
16436375|NCT00979901|40077716|FG003|Overall Study|Discontinued in Error|0|||
16436376|NCT00979901|40077713|FG000|Overall Study|Left Country|0|||
16436377|NCT00979901|40077714|FG001|Overall Study|Left Country|0|||
16436378|NCT00979901|40077715|FG002|Overall Study|Left Country|1|||
16436379|NCT00979901|40077716|FG003|Overall Study|Left Country|0|||
16436380|NCT00979901|40077713|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
16436381|NCT00979901|40077714|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
16436382|NCT00979901|40077715|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
16436383|NCT00979901|40077716|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
16436384|NCT00768989|40077717|FG000|Prior to Week 24|Withdrawal by Subject|1|||
16436385|NCT00768989|40077718|FG001|Prior to Week 24|Withdrawal by Subject|0|||
16436386|NCT00768989|40077717|FG000|Prior to Week 24|Adverse Event|3|||
16436387|NCT00768989|40077718|FG001|Prior to Week 24|Adverse Event|0|||
16436388|NCT00768989|40077717|FG000|Prior to Week 24|Lost to Follow-up|0|||
16436389|NCT00768989|40077718|FG001|Prior to Week 24|Lost to Follow-up|1|||
16436390|NCT00768989|40077717|FG000|Prior to Week 24|Protocol Violation|0|||
16436391|NCT00768989|40077718|FG001|Prior to Week 24|Protocol Violation|2|||
16436392|NCT00768989|40077717|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
16436393|NCT00768989|40077718|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
16436394|NCT00768989|40077717|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
16436395|NCT00768989|40077718|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
16436396|NCT00768989|40077717|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
16436397|NCT00768989|40077718|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
16436398|NCT00768989|40077717|FG000|On or After Week 36|Lack of Efficacy|1|||
16436399|NCT00768989|40077718|FG001|On or After Week 36|Lack of Efficacy|0|||
16436400|NCT00768989|40077717|FG000|On or After Week 36|Adverse Event|0|||
16436401|NCT00768989|40077718|FG001|On or After Week 36|Adverse Event|1|||
16436402|NCT00768989|40077717|FG000|On or After Week 36|Lost to Follow-up|1|||
16436403|NCT00768989|40077718|FG001|On or After Week 36|Lost to Follow-up|0|||
16436404|NCT00768989|40077717|FG000|On or After Week 36|Poor Compliance|1|||
16436405|NCT00768989|40077718|FG001|On or After Week 36|Poor Compliance|0|||
16253708|NCT01144663|39413017|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
16362855|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
16362856|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
16362857|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
16362858|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
16362859|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
16362860|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
16362861|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
16362862|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
16362863|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
16362864|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
16362865|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
16362866|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
16362867|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
16362868|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
16362869|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
16362870|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
16362871|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
16362872|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
16362873|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
16362874|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
16362875|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
16362876|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
16362877|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
16253709|NCT01144663|39413018|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
16137621|NCT00821431|38989885|FG000|Overall Study|Withdrawal by Subject|5|||
16137622|NCT00821431|38989886|FG001|Overall Study|Withdrawal by Subject|0|||
16137623|NCT00821431|38989885|FG000|Overall Study|Lost to Follow-up|1|||
16137624|NCT00821431|38989886|FG001|Overall Study|Lost to Follow-up|0|||
16137625|NCT00821431|38989885|FG000|Overall Study|Protocol Violation|3|||
16137626|NCT00821431|38989886|FG001|Overall Study|Protocol Violation|1|||
16137627|NCT00821431|38989885|FG000|Overall Study|Physician Decision|0|||
16436406|NCT00768989|40077717|FG000|On or After Week 36|Protocol Violation|1|||
16436407|NCT00768989|40077718|FG001|On or After Week 36|Protocol Violation|0|||
16436408|NCT00768989|40077717|FG000|On or After Week 36|Did not attend termination visit|2|||
16436409|NCT00768989|40077718|FG001|On or After Week 36|Did not attend termination visit|0|||
16436410|NCT00768989|40077717|FG000|On or After Week 36|Sponsor Termination|45|||
16436411|NCT00768989|40077718|FG001|On or After Week 36|Sponsor Termination|26|||
16137628|NCT00821431|38989886|FG001|Overall Study|Physician Decision|1|||
16436412|NCT01702844|40077719|FG000|Overall Study|Adverse Event|9|||
16436413|NCT01702844|40077719|FG000|Overall Study|Death|1|||
16436414|NCT01702844|40077719|FG000|Overall Study|Withdrawal by Subject|3|||
16436415|NCT01702844|40077719|FG000|Overall Study|Physician Decision|6|||
16436416|NCT01903460|40077721|FG000|Overall Study|Adverse Event|0|||
16436417|NCT01903460|40077722|FG001|Overall Study|Adverse Event|0|||
16436418|NCT01903460|40077723|FG002|Overall Study|Adverse Event|0|||
16436419|NCT01903460|40077724|FG003|Overall Study|Adverse Event|1|||
16436420|NCT00866177|40077725|FG000|Overall Study|Withdrawal by Subject|1|||
16436421|NCT00866177|40077725|FG000|Overall Study|Not Treated|151|||
16436422|NCT00100789|40077726|FG000|Overall Study|Adverse Event|10|||
16436423|NCT00100789|40077726|FG000|Overall Study|Withdrawal by Subject|1|||
16436424|NCT00100789|40077726|FG000|Overall Study|Progression/relapse|42|||
16436425|NCT00100789|40077726|FG000|Overall Study|Death|2|||
16436426|NCT00100789|40077726|FG000|Overall Study|Not protocol specified|5|||
16436427|NCT00100789|40077726|FG000|Overall Study|Ineligible|3|||
16436428|NCT00100789|40077726|FG000|Overall Study|Never received treatment|1|||
16436429|NCT00591006|40077727|FG000|Overall Study|Withdrawal by Subject|0|||
16436430|NCT00591006|40077728|FG001|Overall Study|Withdrawal by Subject|0|||
16137629|NCT01019317|38989887|FG000|Overall Study|Not Eligible|4|||
16436431|NCT00591006|40077729|FG002|Overall Study|Withdrawal by Subject|0|||
16436432|NCT00591006|40077730|FG003|Overall Study|Withdrawal by Subject|0|||
16436433|NCT00591006|40077731|FG004|Overall Study|Withdrawal by Subject|0|||
16436434|NCT00591006|40077732|FG005|Overall Study|Withdrawal by Subject|0|||
16436435|NCT00591006|40077733|FG006|Overall Study|Withdrawal by Subject|0|||
16436436|NCT00591006|40077734|FG007|Overall Study|Withdrawal by Subject|0|||
16436437|NCT00591006|40077735|FG008|Overall Study|Withdrawal by Subject|0|||
16436438|NCT00591006|40077736|FG009|Overall Study|Withdrawal by Subject|0|||
16436439|NCT00591006|40077737|FG010|Overall Study|Withdrawal by Subject|0|||
16436440|NCT00591006|40077738|FG011|Overall Study|Withdrawal by Subject|0|||
16137630|NCT00807235|38989888|FG000|Overall Study|Adverse Event|1|||
16137631|NCT00807235|38989889|FG001|Overall Study|Adverse Event|0|||
16137632|NCT02401412|38989890|FG000|Overall Study|Lost to Follow-up|1|||
16137633|NCT02401412|38989891|FG001|Overall Study|Lost to Follow-up|0|||
16137634|NCT02401412|38989890|FG000|Overall Study|Discontinued Intervention|15|||
16137635|NCT02401412|38989891|FG001|Overall Study|Discontinued Intervention|21|||
16137636|NCT02401412|38989890|FG000|Overall Study|Withdrawal by Subject|4|||
16137637|NCT02401412|38989891|FG001|Overall Study|Withdrawal by Subject|4|||
16137638|NCT02401412|38989890|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
16137639|NCT02401412|38989891|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
16137640|NCT02401412|38989890|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
16137641|NCT02401412|38989891|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
16436441|NCT00591006|40077739|FG012|Overall Study|Withdrawal by Subject|0|||
16436442|NCT00591006|40077740|FG013|Overall Study|Withdrawal by Subject|0|||
16137642|NCT02095951|38989892|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
16137643|NCT02095951|38989893|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
16137644|NCT01765192|38989894|FG000|Treatment Period 1|Adverse Event|0|||
16137645|NCT01765192|38989895|FG001|Treatment Period 1|Adverse Event|1|||
16137646|NCT01765192|38989894|FG000|Washout Period|Voluntary Withdrawal|1|||
16137647|NCT01765192|38989895|FG001|Washout Period|Voluntary Withdrawal|1|||
16137648|NCT01765192|38989894|FG000|Washout Period|Reason not specified|1|||
16137649|NCT01765192|38989895|FG001|Washout Period|Reason not specified|0|||
16137650|NCT01765192|38989894|FG000|Treatment Period 2|Reason not specified|0|||
16137651|NCT01765192|38989895|FG001|Treatment Period 2|Reason not specified|2|||
16137652|NCT01765192|38989894|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
16137653|NCT01765192|38989895|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
16137654|NCT03040622|38989896|FG000|Overall Study|unable to implant device|3|||
16137655|NCT02054325|38989897|FG000|Overall Study|Lost to Follow-up|8|||
16253710|NCT01144663|39413019|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
16253711|NCT01144663|39413016|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
16253712|NCT01144663|39413017|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
16253713|NCT01144663|39413018|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
16253714|NCT01144663|39413019|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
16253715|NCT01144663|39413016|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
16253716|NCT01144663|39413017|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
16253717|NCT01144663|39413018|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
16253718|NCT01144663|39413019|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
16253719|NCT01144663|39413016|FG000|Primary Vaccination Phase|Other|0|||
16253720|NCT01144663|39413017|FG001|Primary Vaccination Phase|Other|1|||
16253721|NCT01144663|39413018|FG002|Primary Vaccination Phase|Other|0|||
16253722|NCT01144663|39413019|FG003|Primary Vaccination Phase|Other|2|||
16362878|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
16362879|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
16362880|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
16362881|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
16362882|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
16362883|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
16362884|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
16362885|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
16362886|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
16362887|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
16362888|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
16436443|NCT00591006|40077741|FG014|Overall Study|Withdrawal by Subject|0|||
16436444|NCT00591006|40077742|FG015|Overall Study|Withdrawal by Subject|1|||
16436445|NCT00591006|40077743|FG016|Overall Study|Withdrawal by Subject|0|||
16436446|NCT00591006|40077744|FG017|Overall Study|Withdrawal by Subject|0|||
16436447|NCT00591006|40077745|FG018|Overall Study|Withdrawal by Subject|0|||
16436448|NCT00591006|40077746|FG019|Overall Study|Withdrawal by Subject|0|||
16436449|NCT00591006|40077747|FG020|Overall Study|Withdrawal by Subject|0|||
16436450|NCT00591006|40077748|FG021|Overall Study|Withdrawal by Subject|0|||
16137656|NCT02054325|38989898|FG001|Overall Study|Lost to Follow-up|5|||
16137657|NCT01641809|38989899|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
16137658|NCT01641809|38989900|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
16253723|NCT01144663|39413016|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
16362889|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
16362890|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
16253724|NCT01144663|39413017|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
16253725|NCT01144663|39413018|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
16253726|NCT01144663|39413019|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
16253727|NCT01144663|39413016|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
16253728|NCT01144663|39413017|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
16253729|NCT01144663|39413018|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
16253730|NCT01144663|39413019|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
16253731|NCT01144663|39413016|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
16253732|NCT01144663|39413017|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
16253733|NCT01144663|39413018|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
16253734|NCT01144663|39413019|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
16253735|NCT01144663|39413016|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
16253736|NCT01144663|39413017|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
16253737|NCT01144663|39413018|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
16253738|NCT01144663|39413019|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
16253739|NCT01144663|39413016|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
16253740|NCT01144663|39413017|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
16253741|NCT01144663|39413018|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
16253742|NCT01144663|39413019|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
16362891|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
16362892|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
16253743|NCT01144663|39413016|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
16253744|NCT01144663|39413017|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
16253745|NCT01144663|39413018|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
16253746|NCT01144663|39413019|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
16253747|NCT00878995|39413020|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
16253748|NCT00878995|39413021|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
16253749|NCT01670500|39413024|FG000|Overall Study|Withdrawal by Subject|1|||
16253750|NCT01670500|39413025|FG001|Overall Study|Withdrawal by Subject|0|||
16253751|NCT01644890|39413028|FG000|Overall Study|Adverse Event|7|||
16253752|NCT01644890|39413029|FG001|Overall Study|Adverse Event|20|||
16253753|NCT01644890|39413028|FG000|Overall Study|Death|1|||
16253754|NCT01644890|39413029|FG001|Overall Study|Death|3|||
16253755|NCT01644890|39413028|FG000|Overall Study|Physician Decision|3|||
16253756|NCT01644890|39413029|FG001|Overall Study|Physician Decision|9|||
16253757|NCT01644890|39413028|FG000|Overall Study|Protocol Violation|6|||
16253758|NCT01644890|39413029|FG001|Overall Study|Protocol Violation|7|||
16253759|NCT01644890|39413028|FG000|Overall Study|Withdrawal by Subject|19|||
16253760|NCT01644890|39413029|FG001|Overall Study|Withdrawal by Subject|27|||
16253761|NCT01644890|39413028|FG000|Overall Study|Progression Disease|160|||
16253762|NCT01644890|39413029|FG001|Overall Study|Progression Disease|131|||
16253763|NCT01644890|39413028|FG000|Overall Study|Clinical Progression|6|||
16253764|NCT01644890|39413029|FG001|Overall Study|Clinical Progression|6|||
16253765|NCT01644890|39413028|FG000|Overall Study|> 28 days since last dose of study drug|6|||
16253766|NCT01644890|39413029|FG001|Overall Study|> 28 days since last dose of study drug|3|||
16253767|NCT01644890|39413028|FG000|Overall Study|Other|8|||
16253768|NCT01644890|39413029|FG001|Overall Study|Other|9|||
16253769|NCT01890915|39413030|FG000|Overall Study|Adverse Event|1|||
16253770|NCT01890915|39413031|FG001|Overall Study|Adverse Event|0|||
16253771|NCT01890915|39413030|FG000|Overall Study|Protocol Violation|2|||
16253772|NCT01890915|39413031|FG001|Overall Study|Protocol Violation|0|||
16253773|NCT01890915|39413030|FG000|Overall Study|Equipment Malfunction|0|||
16253774|NCT01890915|39413031|FG001|Overall Study|Equipment Malfunction|1|||
16253775|NCT03504852|39413032|FG000|Overall Study|Withdrawal of informed consent|2|||
16253776|NCT03504852|39413033|FG001|Overall Study|Withdrawal of informed consent|1|||
16253777|NCT03504852|39413034|FG002|Overall Study|Withdrawal of informed consent|0|||
16253778|NCT03504852|39413032|FG000|Overall Study|Withdrawal by Subject|5|||
16253779|NCT03504852|39413033|FG001|Overall Study|Withdrawal by Subject|5|||
16253780|NCT03504852|39413034|FG002|Overall Study|Withdrawal by Subject|1|||
16253781|NCT03504852|39413032|FG000|Overall Study|Lost to Follow-up|4|||
16253782|NCT03504852|39413033|FG001|Overall Study|Lost to Follow-up|1|||
16253783|NCT03504852|39413034|FG002|Overall Study|Lost to Follow-up|0|||
16253784|NCT03504852|39413032|FG000|Overall Study|New therapy for study indication|1|||
16362893|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
16436451|NCT00591006|40077749|FG022|Overall Study|Withdrawal by Subject|0|||
16253785|NCT03504852|39413033|FG001|Overall Study|New therapy for study indication|0|||
16253786|NCT03504852|39413034|FG002|Overall Study|New therapy for study indication|0|||
16253787|NCT03504852|39413032|FG000|Overall Study|Lack of Efficacy|1|||
16253788|NCT03504852|39413033|FG001|Overall Study|Lack of Efficacy|2|||
16253789|NCT03504852|39413034|FG002|Overall Study|Lack of Efficacy|0|||
16253790|NCT03504852|39413032|FG000|Overall Study|Death|0|||
16253791|NCT03504852|39413033|FG001|Overall Study|Death|1|||
16253792|NCT03504852|39413034|FG002|Overall Study|Death|0|||
16253793|NCT03504852|39413032|FG000|Overall Study|Adverse Event|4|||
16253794|NCT03504852|39413033|FG001|Overall Study|Adverse Event|8|||
16253795|NCT03504852|39413034|FG002|Overall Study|Adverse Event|2|||
16137659|NCT01641809|38989901|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
16137660|NCT01641809|38989902|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
16137661|NCT01641809|38989899|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
16137662|NCT01641809|38989900|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
16137663|NCT01641809|38989901|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
16137664|NCT01641809|38989902|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
16137665|NCT01641809|38989899|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
16137666|NCT01641809|38989900|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
16137667|NCT01641809|38989901|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
16137668|NCT01641809|38989902|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
16137669|NCT01641809|38989899|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
16137670|NCT01641809|38989900|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
16137671|NCT01641809|38989901|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
16137672|NCT01641809|38989902|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
16137673|NCT01641809|38989899|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
16362894|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
16362895|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Death|1|||
16362896|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Death|0|||
16362897|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Death|1|||
16362898|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
16362899|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
16362900|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
16362901|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
16137674|NCT01641809|38989900|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
16137675|NCT01641809|38989901|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
16137676|NCT01641809|38989902|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
16137677|NCT01641809|38989899|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
16137678|NCT01641809|38989900|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
16137679|NCT01641809|38989901|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
16137680|NCT01641809|38989902|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
16137681|NCT01641809|38989899|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
16137682|NCT01641809|38989900|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
16137683|NCT01641809|38989901|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
16137684|NCT01641809|38989902|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
16362902|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
16362903|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
16137685|NCT01641809|38989899|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
16137686|NCT01641809|38989900|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
16137687|NCT01641809|38989901|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
16137688|NCT01641809|38989902|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
16137689|NCT01641809|38989899|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
16137690|NCT01641809|38989900|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
16137691|NCT01641809|38989901|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
16137692|NCT01641809|38989902|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
16137693|NCT01641809|38989899|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
16137694|NCT01641809|38989900|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
16137695|NCT01641809|38989901|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
16137696|NCT01641809|38989902|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
16253796|NCT04849988|39413035|FG000|Overall Study|Lack of Efficacy|3|||
16253797|NCT04849988|39413036|FG001|Overall Study|Lack of Efficacy|4|||
16253798|NCT04849988|39413037|FG002|Overall Study|Lack of Efficacy|1|||
16253799|NCT04849988|39413038|FG003|Overall Study|Lack of Efficacy|4|||
16253800|NCT04849988|39413035|FG000|Overall Study|Other reasons|1|||
16253801|NCT04849988|39413036|FG001|Overall Study|Other reasons|2|||
16253802|NCT04849988|39413037|FG002|Overall Study|Other reasons|2|||
16253803|NCT04849988|39413038|FG003|Overall Study|Other reasons|1|||
16253804|NCT02849652|39413039|FG000|Overall Study|Lost to Follow-up|104|||
16253805|NCT02849652|39413040|FG001|Overall Study|Lost to Follow-up|35|||
16253806|NCT02849652|39413041|FG002|Overall Study|Lost to Follow-up|116|||
16253807|NCT02849652|39413042|FG003|Overall Study|Lost to Follow-up|22|||
16253808|NCT02849652|39413039|FG000|Overall Study|Withdrawal by Subject|10|||
16253809|NCT02849652|39413040|FG001|Overall Study|Withdrawal by Subject|2|||
16253810|NCT02849652|39413041|FG002|Overall Study|Withdrawal by Subject|8|||
16253811|NCT02849652|39413042|FG003|Overall Study|Withdrawal by Subject|4|||
16253812|NCT02994056|39413050|FG000|Overall Study|Death|8|||
16253813|NCT02994056|39413050|FG000|Overall Study|Withdrew Consent|1|||
16253814|NCT01644500|39413052|FG000|Overall Study|Adverse Event|6|||
16253815|NCT01644500|39413053|FG001|Overall Study|Adverse Event|1|||
16253816|NCT01644500|39413054|FG002|Overall Study|Adverse Event|2|||
16253817|NCT01644500|39413052|FG000|Overall Study|Death|0|||
16253818|NCT01644500|39413053|FG001|Overall Study|Death|1|||
16253819|NCT01644500|39413054|FG002|Overall Study|Death|0|||
16253820|NCT01644500|39413052|FG000|Overall Study|Lost to Follow-up|3|||
16253821|NCT01644500|39413053|FG001|Overall Study|Lost to Follow-up|8|||
16253822|NCT01644500|39413054|FG002|Overall Study|Lost to Follow-up|0|||
16253823|NCT01644500|39413052|FG000|Overall Study|Protocol Violation|1|||
16253824|NCT01644500|39413053|FG001|Overall Study|Protocol Violation|1|||
16253825|NCT01644500|39413054|FG002|Overall Study|Protocol Violation|0|||
16253826|NCT01644500|39413052|FG000|Overall Study|Withdrawal by Subject|11|||
16253827|NCT01644500|39413053|FG001|Overall Study|Withdrawal by Subject|12|||
16253828|NCT01644500|39413054|FG002|Overall Study|Withdrawal by Subject|12|||
16253829|NCT01644500|39413052|FG000|Overall Study|Physician Decision|1|||
16436452|NCT00591006|40077750|FG023|Overall Study|Withdrawal by Subject|1|||
16436453|NCT00591006|40077727|FG000|Overall Study|Adverse Event|0|||
16253830|NCT01644500|39413053|FG001|Overall Study|Physician Decision|1|||
16253831|NCT01644500|39413054|FG002|Overall Study|Physician Decision|1|||
16253832|NCT01506947|39413056|FG000|Overall Study|Lost to Follow-up|7|||
16253833|NCT01506947|39413056|FG000|Overall Study|Adverse Event|5|||
16253834|NCT01506947|39413056|FG000|Overall Study|Death|1|||
16253835|NCT01506947|39413056|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
16253836|NCT00442936|39413059|FG000|Overall Study|Protocol Violation|1|||
16253837|NCT00442936|39413060|FG001|Overall Study|Protocol Violation|0|||
16253838|NCT00442936|39413061|FG002|Overall Study|Protocol Violation|1|||
16137697|NCT01641809|38989899|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
16137698|NCT01641809|38989900|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
16137699|NCT01641809|38989901|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
16137700|NCT01641809|38989902|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
16137701|NCT01641809|38989899|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
16137702|NCT01641809|38989900|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
16137703|NCT01641809|38989901|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
16137704|NCT01641809|38989902|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
16137705|NCT01641809|38989899|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
16137706|NCT01641809|38989900|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
16137707|NCT01641809|38989901|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
16137708|NCT01641809|38989902|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
16137709|NCT01641809|38989899|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
16137710|NCT01641809|38989900|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
16137711|NCT01641809|38989901|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
16137712|NCT01641809|38989902|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
16137713|NCT01641809|38989899|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
16137714|NCT01641809|38989900|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
16137715|NCT01641809|38989901|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
16137716|NCT01641809|38989902|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
16137717|NCT01641809|38989899|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
16137718|NCT01641809|38989900|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
16137719|NCT01641809|38989901|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
16137720|NCT01641809|38989902|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
16137721|NCT01641809|38989899|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
16436454|NCT00591006|40077728|FG001|Overall Study|Adverse Event|0|||
16436455|NCT00591006|40077729|FG002|Overall Study|Adverse Event|0|||
16436456|NCT00591006|40077730|FG003|Overall Study|Adverse Event|0|||
16436457|NCT00591006|40077731|FG004|Overall Study|Adverse Event|0|||
16436458|NCT00591006|40077732|FG005|Overall Study|Adverse Event|0|||
16436459|NCT00591006|40077733|FG006|Overall Study|Adverse Event|0|||
16436460|NCT00591006|40077734|FG007|Overall Study|Adverse Event|0|||
16436461|NCT00591006|40077735|FG008|Overall Study|Adverse Event|0|||
16436462|NCT00591006|40077736|FG009|Overall Study|Adverse Event|0|||
16436463|NCT00591006|40077737|FG010|Overall Study|Adverse Event|0|||
16137722|NCT01641809|38989900|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
16137723|NCT01641809|38989901|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
16137724|NCT01641809|38989902|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
16137725|NCT01641809|38989899|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
16137726|NCT01641809|38989900|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
16137727|NCT01641809|38989901|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
16137728|NCT01641809|38989902|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
16137729|NCT01723774|38989903|FG000|Neoadjuvant|Ki67 > 10%|4|||
16137730|NCT01723774|38989904|FG001|Neoadjuvant|Ki67 > 10%|0|||
16137731|NCT01723774|38989905|FG002|Neoadjuvant|Ki67 > 10%|10|||
16137732|NCT01723774|38989906|FG003|Neoadjuvant|Ki67 > 10%|0|||
16137733|NCT01723774|38989903|FG000|Neoadjuvant|Withdrawal by Subject|3|||
16137734|NCT01723774|38989904|FG001|Neoadjuvant|Withdrawal by Subject|1|||
16137735|NCT01723774|38989905|FG002|Neoadjuvant|Withdrawal by Subject|0|||
16137736|NCT01723774|38989906|FG003|Neoadjuvant|Withdrawal by Subject|0|||
16137737|NCT01723774|38989903|FG000|Neoadjuvant|Disease progression|0|||
16137738|NCT01723774|38989904|FG001|Neoadjuvant|Disease progression|1|||
16137739|NCT01723774|38989905|FG002|Neoadjuvant|Disease progression|1|||
16137740|NCT01723774|38989906|FG003|Neoadjuvant|Disease progression|0|||
16137741|NCT01723774|38989903|FG000|Neoadjuvant|Adverse Event|0|||
16137742|NCT01723774|38989904|FG001|Neoadjuvant|Adverse Event|1|||
16137743|NCT01723774|38989905|FG002|Neoadjuvant|Adverse Event|2|||
16436464|NCT00591006|40077738|FG011|Overall Study|Adverse Event|0|||
16137744|NCT01723774|38989906|FG003|Neoadjuvant|Adverse Event|0|||
16137745|NCT01723774|38989903|FG000|Neoadjuvant|High estradiol|0|||
16137746|NCT01723774|38989904|FG001|Neoadjuvant|High estradiol|1|||
16137747|NCT01723774|38989905|FG002|Neoadjuvant|High estradiol|0|||
16137748|NCT01723774|38989906|FG003|Neoadjuvant|High estradiol|0|||
16137749|NCT01211197|38989907|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16137750|NCT01211197|38989908|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16137751|NCT01211197|38989909|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
16137752|NCT01211197|38989910|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16137753|NCT01211197|38989911|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16137754|NCT01211197|38989912|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
16137755|NCT01211197|38989907|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
16137756|NCT01211197|38989908|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
16436465|NCT00591006|40077739|FG012|Overall Study|Adverse Event|0|||
16436466|NCT00591006|40077740|FG013|Overall Study|Adverse Event|0|||
16137757|NCT01211197|38989909|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
16137758|NCT01211197|38989910|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
16137759|NCT01211197|38989911|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
16137760|NCT01211197|38989912|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
16137761|NCT00795951|38989913|FG000|Overall Study|Lost to Follow-up|1|||
16137762|NCT00795951|38989913|FG000|Overall Study|Withdrawal by Subject|1|||
16137763|NCT01206777|38989916|FG000|Overall Study|Death|1|||
16137764|NCT01206777|38989916|FG000|Overall Study|Adverse Event|1|||
16137765|NCT03334409|38989917|FG000|Overall Study|Did not meet inclusion criteria|1|||
16137766|NCT03334409|38989918|FG001|Overall Study|Did not meet inclusion criteria|0|||
16137767|NCT01175356|38989919|FG000|Overall Study|Death|1|||
16137768|NCT01175356|38989919|FG000|Overall Study|Lack of Efficacy|12|||
16137769|NCT01175356|38989919|FG000|Overall Study|Lost to Follow-up|1|||
16137770|NCT01175356|38989919|FG000|Overall Study|Physician Decision|23|||
16137771|NCT01175356|38989919|FG000|Overall Study|Ineligible|1|||
16137772|NCT01175356|38989919|FG000|Overall Study|Treatment Slot Not Available|18|||
16137773|NCT01175356|38989919|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
16137774|NCT01175356|38989919|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
16137775|NCT01175356|38989919|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
16137776|NCT01175356|38989919|FG000|Overall Study|Inadequate stem cell for transplant|1|||
16137777|NCT01175356|38989919|FG000|Overall Study|Initiation other tx prior to completion|9|||
16137778|NCT02435966|38989920|FG000|Overall Study|Withdrawal by Subject|0|||
16137779|NCT02435966|38989921|FG001|Overall Study|Withdrawal by Subject|1|||
16137780|NCT02435966|38989922|FG002|Overall Study|Withdrawal by Subject|0|||
16137781|NCT04484831|38989923|FG000|Overall Study|Withdrawal by Subject|1|||
16137782|NCT04484831|38989924|FG001|Overall Study|Withdrawal by Subject|0|||
16137783|NCT02370043|38989925|FG000|Overall Study|Withdrawal by Subject|0|||
16137784|NCT02370043|38989926|FG001|Overall Study|Withdrawal by Subject|0|||
16137785|NCT02370043|38989927|FG002|Overall Study|Withdrawal by Subject|0|||
16137786|NCT02370043|38989928|FG003|Overall Study|Withdrawal by Subject|0|||
16137787|NCT02370043|38989929|FG004|Overall Study|Withdrawal by Subject|1|||
16137788|NCT02370043|38989930|FG005|Overall Study|Withdrawal by Subject|1|||
16137789|NCT01026142|38993133|FG000|Overall Study|Death|136|||
16137790|NCT01026142|38993134|FG001|Overall Study|Death|134|||
16137791|NCT01026142|38993133|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
16137792|NCT01026142|38993134|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
16137793|NCT01309230|38993135|FG000|Overall Study|Withdrawal by Subject|0|||
16137794|NCT01309230|38993136|FG001|Overall Study|Withdrawal by Subject|2|||
16137795|NCT01309230|38993135|FG000|Overall Study|Observation arm closed|0|||
16137796|NCT01309230|38993136|FG001|Overall Study|Observation arm closed|2|||
16137797|NCT04620811|38993137|FG000|Overall Study|Withdrawal by Subject|18|||
16436467|NCT00591006|40077741|FG014|Overall Study|Adverse Event|0|||
16436468|NCT00591006|40077742|FG015|Overall Study|Adverse Event|0|||
16436469|NCT00591006|40077743|FG016|Overall Study|Adverse Event|0|||
16436470|NCT00591006|40077744|FG017|Overall Study|Adverse Event|0|||
16436471|NCT00591006|40077745|FG018|Overall Study|Adverse Event|0|||
16436472|NCT00591006|40077746|FG019|Overall Study|Adverse Event|0|||
16137798|NCT04620811|38993138|FG001|Overall Study|Withdrawal by Subject|15|||
16137799|NCT04620811|38993137|FG000|Overall Study|Adverse Event|6|||
16137800|NCT04620811|38993138|FG001|Overall Study|Adverse Event|11|||
16137801|NCT04620811|38993137|FG000|Overall Study|Lost to Follow-up|4|||
16137802|NCT04620811|38993138|FG001|Overall Study|Lost to Follow-up|8|||
16137803|NCT04620811|38993137|FG000|Overall Study|Physician Decision|1|||
16137804|NCT04620811|38993138|FG001|Overall Study|Physician Decision|4|||
16436473|NCT00591006|40077747|FG020|Overall Study|Adverse Event|0|||
16137805|NCT04620811|38993137|FG000|Overall Study|Sponsor Decision|0|||
16137806|NCT04620811|38993138|FG001|Overall Study|Sponsor Decision|1|||
16137807|NCT04620811|38993137|FG000|Overall Study|Elevation of ALT or AST|1|||
16137808|NCT04620811|38993138|FG001|Overall Study|Elevation of ALT or AST|0|||
16137809|NCT04620811|38993137|FG000|Overall Study|Other|3|||
16137810|NCT04620811|38993138|FG001|Overall Study|Other|5|||
16137811|NCT01020448|38993139|FG000|Pre-assignment|Adverse Event|6|||
16137812|NCT01020448|38993139|FG000|Pre-assignment|Withdrawal by Subject|5|||
16137813|NCT01020448|38993139|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
16137814|NCT01020448|38993139|FG000|Treatment|Adverse Event|11|||
16137815|NCT01020448|38993139|FG000|Treatment|Consent Withdrawn|3|||
16137816|NCT01020448|38993139|FG000|Treatment|Disease Progression|2|||
16137817|NCT01020448|38993139|FG000|Treatment|Lack of Efficacy|8|||
16137818|NCT01020448|38993139|FG000|Treatment|Lost to Follow-up|2|||
16137819|NCT00528866|38993140|FG000|Overall Study|Protocol Violation|6|||
16137820|NCT02982187|38993141|FG000|Overall Study|Withdrawal by Subject|0|||
16137821|NCT02982187|38993142|FG001|Overall Study|Withdrawal by Subject|0|||
16137822|NCT02982187|38993143|FG002|Overall Study|Withdrawal by Subject|0|||
16137823|NCT02982187|38993144|FG003|Overall Study|Withdrawal by Subject|0|||
16137824|NCT02982187|38993145|FG004|Overall Study|Withdrawal by Subject|0|||
16137825|NCT02982187|38993146|FG005|Overall Study|Withdrawal by Subject|0|||
16137826|NCT02982187|38993147|FG006|Overall Study|Withdrawal by Subject|1|||
16137827|NCT02982187|38993148|FG007|Overall Study|Withdrawal by Subject|0|||
16137828|NCT00938860|38993149|FG000|Overall Study|Adverse Event|2|||
16137829|NCT00938860|38993150|FG001|Overall Study|Adverse Event|1|||
16137830|NCT00938860|38993149|FG000|Overall Study|Abnormal laboratory values|2|||
16137831|NCT00938860|38993150|FG001|Overall Study|Abnormal laboratory values|2|||
16137832|NCT00938860|38993149|FG000|Overall Study|Withdrawal by Subject|11|||
16137833|NCT00938860|38993150|FG001|Overall Study|Withdrawal by Subject|8|||
16137834|NCT00938860|38993149|FG000|Overall Study|Lost to Follow-up|4|||
16137835|NCT00938860|38993150|FG001|Overall Study|Lost to Follow-up|4|||
16137836|NCT00938860|38993149|FG000|Overall Study|Administration problems|2|||
16137837|NCT00938860|38993150|FG001|Overall Study|Administration problems|0|||
16137838|NCT00938860|38993149|FG000|Overall Study|Death|1|||
16137839|NCT00938860|38993150|FG001|Overall Study|Death|1|||
16137840|NCT00938860|38993149|FG000|Overall Study|Protocol Violation|3|||
16137841|NCT00938860|38993150|FG001|Overall Study|Protocol Violation|1|||
16137842|NCT03044886|38993153|FG000|Overall Study|Lost to Follow-up|15|||
16137843|NCT03044886|38993154|FG001|Overall Study|Lost to Follow-up|10|||
16137844|NCT03044886|38993155|FG002|Overall Study|Lost to Follow-up|12|||
16137845|NCT01390181|38993156|FG000|Overall Study|Lost to Follow-up|1|||
16137846|NCT01390181|38993156|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
16137847|NCT00352885|38993158|FG000|Overall Study|Withdrawal by Subject|0|||
16137848|NCT00352885|38993159|FG001|Overall Study|Withdrawal by Subject|3|||
16137849|NCT00352885|38993158|FG000|Overall Study|Development of major depression|0|||
16137850|NCT00352885|38993159|FG001|Overall Study|Development of major depression|1|||
16137851|NCT00352885|38993158|FG000|Overall Study|Progression of metastatic melanoma|5|||
16137852|NCT00352885|38993159|FG001|Overall Study|Progression of metastatic melanoma|3|||
16137853|NCT00352885|38993158|FG000|Overall Study|Side effects of IL-2 administration|1|||
16137854|NCT00352885|38993159|FG001|Overall Study|Side effects of IL-2 administration|0|||
16137855|NCT02273726|38993164|FG000|Overall Study|Death|70|||
16137856|NCT02273726|38993165|FG001|Overall Study|Death|62|||
16137857|NCT02273726|38993164|FG000|Overall Study|Withdrawal by Subject|41|||
16137858|NCT02273726|38993165|FG001|Overall Study|Withdrawal by Subject|29|||
16137859|NCT02273726|38993164|FG000|Overall Study|Kidney transplant|31|||
16137860|NCT02273726|38993165|FG001|Overall Study|Kidney transplant|39|||
16137861|NCT02273726|38993164|FG000|Overall Study|Physician Decision|30|||
16137862|NCT02273726|38993165|FG001|Overall Study|Physician Decision|15|||
16137863|NCT02273726|38993164|FG000|Overall Study|Adverse Event|27|||
16137864|NCT02273726|38993165|FG001|Overall Study|Adverse Event|9|||
16137865|NCT02273726|38993164|FG000|Overall Study|Lost to Follow-up|6|||
16436474|NCT00591006|40077748|FG021|Overall Study|Adverse Event|0|||
16137866|NCT02273726|38993165|FG001|Overall Study|Lost to Follow-up|3|||
16137867|NCT02273726|38993164|FG000|Overall Study|Lack of Efficacy|6|||
16137868|NCT02273726|38993165|FG001|Overall Study|Lack of Efficacy|1|||
16137869|NCT02273726|38993164|FG000|Overall Study|Protocol Violation|4|||
16137870|NCT02273726|38993165|FG001|Overall Study|Protocol Violation|0|||
16137871|NCT02273726|38993164|FG000|Overall Study|Other than specified|28|||
16137872|NCT02273726|38993165|FG001|Overall Study|Other than specified|30|||
16137873|NCT01862640|38993169|FG000|Overall Study|Adverse Event|4|||
16137874|NCT01862640|38993170|FG001|Overall Study|Adverse Event|10|||
16137875|NCT01862640|38993171|FG002|Overall Study|Adverse Event|6|||
16137876|NCT01862640|38993172|FG003|Overall Study|Adverse Event|8|||
16137877|NCT01862640|38993169|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
16137878|NCT01862640|38993170|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
16137879|NCT01862640|38993171|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
16137880|NCT01862640|38993172|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
16137881|NCT01862640|38993169|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
16137882|NCT01862640|38993170|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
16137883|NCT01862640|38993171|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
16137884|NCT01862640|38993172|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
16137885|NCT01862640|38993169|FG000|Overall Study|Withdrawal by Subject|2|||
16137886|NCT01862640|38993170|FG001|Overall Study|Withdrawal by Subject|4|||
16137887|NCT01862640|38993171|FG002|Overall Study|Withdrawal by Subject|8|||
16137888|NCT01862640|38993172|FG003|Overall Study|Withdrawal by Subject|5|||
16137889|NCT01862640|38993169|FG000|Overall Study|Protocol Deviation|0|||
16137890|NCT01862640|38993170|FG001|Overall Study|Protocol Deviation|0|||
16137891|NCT01862640|38993171|FG002|Overall Study|Protocol Deviation|1|||
16137892|NCT01862640|38993172|FG003|Overall Study|Protocol Deviation|0|||
16137893|NCT03872453|38993176|FG000|Overall Study|Adverse Event|1|||
16137894|NCT03872453|38993177|FG001|Overall Study|Adverse Event|1|||
16137895|NCT03872453|38993178|FG002|Overall Study|Adverse Event|0|||
16137896|NCT03872453|38993179|FG003|Overall Study|Adverse Event|0|||
16137897|NCT03872453|38993176|FG000|Overall Study|Lost to Follow-up|8|||
16137898|NCT03872453|38993177|FG001|Overall Study|Lost to Follow-up|7|||
16137899|NCT03872453|38993178|FG002|Overall Study|Lost to Follow-up|4|||
16137900|NCT03872453|38993179|FG003|Overall Study|Lost to Follow-up|4|||
16137901|NCT03872453|38993176|FG000|Overall Study|Never Treated Migraine|19|||
16137902|NCT03872453|38993177|FG001|Overall Study|Never Treated Migraine|17|||
16362904|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
16137903|NCT03872453|38993178|FG002|Overall Study|Never Treated Migraine|13|||
16137904|NCT03872453|38993179|FG003|Overall Study|Never Treated Migraine|12|||
16137905|NCT03872453|38993176|FG000|Overall Study|Pregnancy|1|||
16137906|NCT03872453|38993177|FG001|Overall Study|Pregnancy|0|||
16137907|NCT03872453|38993178|FG002|Overall Study|Pregnancy|0|||
16137908|NCT03872453|38993179|FG003|Overall Study|Pregnancy|0|||
16362905|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
16137909|NCT03872453|38993176|FG000|Overall Study|Protocol Deviation|2|||
16137910|NCT03872453|38993177|FG001|Overall Study|Protocol Deviation|0|||
16137911|NCT03872453|38993178|FG002|Overall Study|Protocol Deviation|0|||
16137912|NCT03872453|38993179|FG003|Overall Study|Protocol Deviation|2|||
16137913|NCT03872453|38993176|FG000|Overall Study|Withdrawal by Subject|0|||
16137914|NCT03872453|38993177|FG001|Overall Study|Withdrawal by Subject|1|||
16137915|NCT03872453|38993178|FG002|Overall Study|Withdrawal by Subject|2|||
16137916|NCT03872453|38993179|FG003|Overall Study|Withdrawal by Subject|0|||
16137917|NCT03872453|38993176|FG000|Overall Study|Other Than Specified|1|||
16137918|NCT03872453|38993177|FG001|Overall Study|Other Than Specified|0|||
16137919|NCT03872453|38993178|FG002|Overall Study|Other Than Specified|0|||
16137920|NCT03872453|38993179|FG003|Overall Study|Other Than Specified|0|||
16137921|NCT02141984|38993180|FG000|Overall Study|Lack of Efficacy|2|||
16436475|NCT00591006|40077749|FG022|Overall Study|Adverse Event|1|||
16137922|NCT01233869|38993181|FG000|Initial Treatment Period (24 Months)|Death|1|||
16137923|NCT01233869|38993182|FG001|Initial Treatment Period (24 Months)|Death|0|||
16137924|NCT01233869|38993183|FG002|Initial Treatment Period (24 Months)|Death|0|||
16137925|NCT01233869|38993184|FG003|Initial Treatment Period (24 Months)|Death|0|||
16137926|NCT01233869|38993181|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
16137927|NCT01233869|38993182|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
16137928|NCT01233869|38993183|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
16137929|NCT01233869|38993184|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
16137930|NCT01233869|38993181|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
16137931|NCT01233869|38993182|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
16137932|NCT01233869|38993183|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
16137933|NCT01233869|38993184|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
16137934|NCT01233869|38993181|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
16253839|NCT00442936|39413062|FG003|Overall Study|Protocol Violation|1|||
16436476|NCT00591006|40077750|FG023|Overall Study|Adverse Event|0|||
16436477|NCT01945021|40077755|FG000|Overall Study|Adverse Event|1|||
16436478|NCT01945021|40077755|FG000|Overall Study|Withdrawal of consent|12|||
16436479|NCT01945021|40077755|FG000|Overall Study|Lost to Follow-up|5|||
16436480|NCT01945021|40077755|FG000|Overall Study|Death|65|||
16436481|NCT00001959|40077756|FG000|Overall Study|newly diagnosed colon cancer|1|||
16436482|NCT00001959|40077756|FG000|Overall Study|disabling sedation|1|||
16436483|NCT00001959|40077756|FG000|Overall Study|non-compliance|1|||
16436484|NCT01788566|40077760|FG000|Overall Study|Death|4|||
16436485|NCT01788566|40077760|FG000|Overall Study|Adverse Event|1|||
16436486|NCT01788566|40077760|FG000|Overall Study|Clinical Progressive Disease|3|||
16436487|NCT03605667|40077761|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
16436488|NCT03605667|40077762|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
16436489|NCT03605667|40077761|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
16436490|NCT03605667|40077762|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
16436491|NCT03605667|40077761|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
16436492|NCT03605667|40077762|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
16253840|NCT03019965|39413064|FG000|Overall Study|Withdrawal by Subject|1|||
16253841|NCT03019965|39413065|FG001|Overall Study|Withdrawal by Subject|0|||
16436493|NCT03605667|40077761|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
16436494|NCT03605667|40077762|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
16436495|NCT03605667|40077761|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
16436496|NCT03605667|40077762|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
16436497|NCT03605667|40077761|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
16436498|NCT03605667|40077762|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
16436499|NCT03605667|40077761|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
16137935|NCT01233869|38993182|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
16137936|NCT01233869|38993183|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
16137937|NCT01233869|38993184|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
16253842|NCT03019965|39413064|FG000|Overall Study|Protocol Violation|1|||
16253843|NCT03019965|39413065|FG001|Overall Study|Protocol Violation|3|||
16253844|NCT03019965|39413064|FG000|Overall Study|viral or fungal infection|3|||
16253845|NCT03019965|39413065|FG001|Overall Study|viral or fungal infection|4|||
16253846|NCT03019965|39413064|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
16253847|NCT03019965|39413065|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
16253848|NCT03019965|39413064|FG000|Overall Study|Physician Decision|1|||
16253849|NCT03019965|39413065|FG001|Overall Study|Physician Decision|1|||
16253850|NCT01267266|39413066|FG000|Enrollment Phase|Withdrawal by Subject|2|||
16253851|NCT01267266|39413067|FG001|Enrollment Phase|Withdrawal by Subject|0|||
16253852|NCT01267266|39413066|FG000|Lead-in Phase|Lack of Efficacy|20|||
16137938|NCT01233869|38993181|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
16137939|NCT01233869|38993182|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
16137940|NCT01233869|38993183|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
16137941|NCT01233869|38993184|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
16137942|NCT01233869|38993181|FG000|Extended Treatment Period (46 Months)|Other|3|||
16137943|NCT01233869|38993182|FG001|Extended Treatment Period (46 Months)|Other|0|||
16137944|NCT01233869|38993183|FG002|Extended Treatment Period (46 Months)|Other|0|||
16137945|NCT01233869|38993184|FG003|Extended Treatment Period (46 Months)|Other|3|||
16137946|NCT01233869|38993181|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
16137947|NCT01233869|38993182|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
16137948|NCT01233869|38993183|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
16137949|NCT01233869|38993184|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
16137950|NCT00975715|38993185|FG000|Titration Period|Adverse Event|6|||
16137951|NCT00975715|38993186|FG001|Titration Period|Adverse Event|0|||
16137952|NCT00975715|38993185|FG000|Titration Period|Protocol Violation|1|||
16137953|NCT00975715|38993186|FG001|Titration Period|Protocol Violation|0|||
16137954|NCT00975715|38993185|FG000|Maintenance Period|Adverse Event|2|||
16137955|NCT00975715|38993186|FG001|Maintenance Period|Adverse Event|1|||
16137956|NCT01477333|38993187|FG000|Overall Study|Adverse Event|1|||
16137957|NCT01477333|38993187|FG000|Overall Study|Withdrawal by Subject|1|||
16137958|NCT01477333|38993187|FG000|Overall Study|Clinical Deterioration|1|||
16137959|NCT03103763|38993196|FG000|Overall Study|Death|15|||
16137960|NCT03103763|38993197|FG001|Overall Study|Death|5|||
16137961|NCT03103763|38993198|FG002|Overall Study|Death|5|||
16137962|NCT03103763|38993196|FG000|Overall Study|Withdrawal by Subject|0|||
16137963|NCT03103763|38993197|FG001|Overall Study|Withdrawal by Subject|3|||
16137964|NCT03103763|38993198|FG002|Overall Study|Withdrawal by Subject|2|||
16137965|NCT00887250|38993201|FG000|Overall Study|Adverse Event|3|||
16137966|NCT00887250|38993202|FG001|Overall Study|Adverse Event|0|||
16137967|NCT00887250|38993203|FG002|Overall Study|Adverse Event|7|||
16137968|NCT00887250|38993201|FG000|Overall Study|Lack of Efficacy|9|||
16137969|NCT00887250|38993202|FG001|Overall Study|Lack of Efficacy|6|||
16137970|NCT00887250|38993203|FG002|Overall Study|Lack of Efficacy|1|||
16137971|NCT00887250|38993201|FG000|Overall Study|Lost to Follow-up|2|||
16137972|NCT00887250|38993202|FG001|Overall Study|Lost to Follow-up|3|||
16137973|NCT00887250|38993203|FG002|Overall Study|Lost to Follow-up|1|||
16137974|NCT00887250|38993201|FG000|Overall Study|Protocol Violation|2|||
16137975|NCT00887250|38993202|FG001|Overall Study|Protocol Violation|2|||
16137976|NCT00887250|38993203|FG002|Overall Study|Protocol Violation|1|||
16137977|NCT00887250|38993201|FG000|Overall Study|Withdrawal by Subject|2|||
16137978|NCT00887250|38993202|FG001|Overall Study|Withdrawal by Subject|1|||
16137979|NCT00887250|38993203|FG002|Overall Study|Withdrawal by Subject|2|||
16137980|NCT00887250|38993201|FG000|Overall Study|Patient uncooperative|0|||
16137981|NCT00887250|38993202|FG001|Overall Study|Patient uncooperative|0|||
16137982|NCT00887250|38993203|FG002|Overall Study|Patient uncooperative|1|||
16137983|NCT02921269|38993204|FG000|Overall Study|Did not complete DLT period|1|||
16137984|NCT04427501|38993205|FG000|Overall Study|Death|0|||
16137985|NCT04427501|38993206|FG001|Overall Study|Death|0|||
16137986|NCT04427501|38993207|FG002|Overall Study|Death|0|||
16137987|NCT04427501|38993208|FG003|Overall Study|Death|0|||
16137988|NCT04427501|38993209|FG004|Overall Study|Death|0|||
16137989|NCT04427501|38993210|FG005|Overall Study|Death|15|||
16137990|NCT04427501|38993211|FG006|Overall Study|Death|0|||
16137991|NCT04427501|38993212|FG007|Overall Study|Death|0|||
16137992|NCT04427501|38993213|FG008|Overall Study|Death|0|||
16137993|NCT04427501|38993214|FG009|Overall Study|Death|0|||
16137994|NCT04427501|38993215|FG010|Overall Study|Death|0|||
16137995|NCT04427501|38993216|FG011|Overall Study|Death|0|||
16137996|NCT04427501|38993205|FG000|Overall Study|Lost to Follow-up|5|||
16137997|NCT04427501|38993206|FG001|Overall Study|Lost to Follow-up|1|||
16137998|NCT04427501|38993207|FG002|Overall Study|Lost to Follow-up|2|||
16137999|NCT04427501|38993208|FG003|Overall Study|Lost to Follow-up|0|||
16138000|NCT04427501|38993209|FG004|Overall Study|Lost to Follow-up|2|||
16138001|NCT04427501|38993210|FG005|Overall Study|Lost to Follow-up|11|||
16138002|NCT04427501|38993211|FG006|Overall Study|Lost to Follow-up|10|||
16138003|NCT04427501|38993212|FG007|Overall Study|Lost to Follow-up|10|||
16138004|NCT04427501|38993213|FG008|Overall Study|Lost to Follow-up|2|||
16138005|NCT04427501|38993214|FG009|Overall Study|Lost to Follow-up|5|||
16138006|NCT04427501|38993215|FG010|Overall Study|Lost to Follow-up|2|||
16138007|NCT04427501|38993216|FG011|Overall Study|Lost to Follow-up|0|||
16138008|NCT04427501|38993205|FG000|Overall Study|Physician Decision|0|||
16138009|NCT04427501|38993206|FG001|Overall Study|Physician Decision|3|||
16138010|NCT04427501|38993207|FG002|Overall Study|Physician Decision|0|||
16138011|NCT04427501|38993208|FG003|Overall Study|Physician Decision|0|||
16138012|NCT04427501|38993209|FG004|Overall Study|Physician Decision|0|||
16138013|NCT04427501|38993210|FG005|Overall Study|Physician Decision|0|||
16138014|NCT04427501|38993211|FG006|Overall Study|Physician Decision|2|||
16138015|NCT04427501|38993212|FG007|Overall Study|Physician Decision|0|||
16138016|NCT04427501|38993213|FG008|Overall Study|Physician Decision|0|||
16138017|NCT04427501|38993214|FG009|Overall Study|Physician Decision|0|||
16138018|NCT04427501|38993215|FG010|Overall Study|Physician Decision|0|||
16138019|NCT04427501|38993216|FG011|Overall Study|Physician Decision|0|||
16138020|NCT04427501|38993205|FG000|Overall Study|Withdrawal by Subject|9|||
16436500|NCT03605667|40077762|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
16436501|NCT03605667|40077761|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
16436502|NCT03605667|40077762|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
16436503|NCT03605667|40077761|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
16436504|NCT03605667|40077762|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
16436505|NCT03605667|40077761|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
16436506|NCT03605667|40077762|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
16436507|NCT03605667|40077761|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
16436508|NCT03605667|40077762|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
16436509|NCT03605667|40077761|FG000|OLE Phase (48 Weeks)|Other|6|||
16436510|NCT03605667|40077762|FG001|OLE Phase (48 Weeks)|Other|8|||
16436511|NCT03605667|40077761|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
16436512|NCT03605667|40077762|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
16436513|NCT03605667|40077761|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
16436514|NCT03605667|40077762|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
16436515|NCT03605667|40077761|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
16436516|NCT03605667|40077762|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
16436517|NCT03605667|40077761|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
16436518|NCT03605667|40077762|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
16436519|NCT03605667|40077761|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
16436520|NCT03605667|40077762|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
16436521|NCT03605667|40077761|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
16436522|NCT03605667|40077762|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
16436523|NCT03605667|40077761|FG000|OLE Phase (48 Weeks)|Death|0|||
16436524|NCT03605667|40077762|FG001|OLE Phase (48 Weeks)|Death|2|||
16436525|NCT03605667|40077761|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
16436526|NCT03605667|40077762|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
16436527|NCT04033367|40077763|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
16436528|NCT04033367|40077764|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
16436529|NCT04033367|40077763|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
16436530|NCT04033367|40077764|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
16436531|NCT04033367|40077763|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
16436532|NCT04033367|40077764|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
16436533|NCT04033367|40077763|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
16436534|NCT04033367|40077764|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
16436535|NCT03557970|40077767|FG000|Overall Study|Study closure|1|||
16436536|NCT03557970|40077768|FG001|Overall Study|Study closure|0|||
16436537|NCT03557970|40077767|FG000|Overall Study|Physician Decision|0|||
16436538|NCT03557970|40077768|FG001|Overall Study|Physician Decision|1|||
16436539|NCT03557970|40077767|FG000|Overall Study|Death|0|||
16436540|NCT03557970|40077768|FG001|Overall Study|Death|1|||
16436541|NCT02914639|40077769|FG000|Overall Study|Withdrawal by Subject|0|||
16436542|NCT02914639|40077770|FG001|Overall Study|Withdrawal by Subject|2|||
16436543|NCT00322881|40077771|FG000|Overall Study|Death|2|||
16436544|NCT00322881|40077771|FG000|Overall Study|Adverse Event|1|||
16436545|NCT00322881|40077771|FG000|Overall Study|Disease Progression|2|||
16436546|NCT00510835|40077772|FG000|Overall Study|Withdrawal by Subject|6|||
16436547|NCT00510835|40077773|FG001|Overall Study|Withdrawal by Subject|2|||
16436548|NCT00510835|40077774|FG002|Overall Study|Withdrawal by Subject|2|||
16436549|NCT02123134|40077777|FG000|Overall Study|Withdrawal of consent|3|||
16436550|NCT02123134|40077778|FG001|Overall Study|Withdrawal of consent|2|||
16436551|NCT02123134|40077777|FG000|Overall Study|Administrative decision|0|||
16436552|NCT02123134|40077778|FG001|Overall Study|Administrative decision|1|||
16436553|NCT02193776|40077779|FG000|Overall Study|Consent withdrawn|1|||
16436554|NCT02193776|40077780|FG001|Overall Study|Consent withdrawn|0|||
16436555|NCT02193776|40077781|FG002|Overall Study|Consent withdrawn|0|||
16436556|NCT02193776|40077782|FG003|Overall Study|Consent withdrawn|0|||
16138021|NCT04427501|38993206|FG001|Overall Study|Withdrawal by Subject|2|||
16138022|NCT04427501|38993207|FG002|Overall Study|Withdrawal by Subject|2|||
16138023|NCT04427501|38993208|FG003|Overall Study|Withdrawal by Subject|3|||
16436557|NCT02193776|40077779|FG000|Overall Study|Failure to comply with protocol|0|||
16436558|NCT02193776|40077780|FG001|Overall Study|Failure to comply with protocol|1|||
16436559|NCT02193776|40077781|FG002|Overall Study|Failure to comply with protocol|0|||
16138024|NCT04427501|38993209|FG004|Overall Study|Withdrawal by Subject|7|||
16138025|NCT04427501|38993210|FG005|Overall Study|Withdrawal by Subject|25|||
16138026|NCT04427501|38993211|FG006|Overall Study|Withdrawal by Subject|15|||
16138027|NCT04427501|38993212|FG007|Overall Study|Withdrawal by Subject|7|||
16138028|NCT04427501|38993213|FG008|Overall Study|Withdrawal by Subject|4|||
16138029|NCT04427501|38993214|FG009|Overall Study|Withdrawal by Subject|1|||
16138030|NCT04427501|38993215|FG010|Overall Study|Withdrawal by Subject|4|||
16138031|NCT04427501|38993216|FG011|Overall Study|Withdrawal by Subject|0|||
16138032|NCT04427501|38993205|FG000|Overall Study|Other - as reported by the investigator|1|||
16138033|NCT04427501|38993206|FG001|Overall Study|Other - as reported by the investigator|0|||
16138034|NCT04427501|38993207|FG002|Overall Study|Other - as reported by the investigator|0|||
16138035|NCT04427501|38993208|FG003|Overall Study|Other - as reported by the investigator|0|||
16138036|NCT04427501|38993209|FG004|Overall Study|Other - as reported by the investigator|0|||
16138037|NCT04427501|38993210|FG005|Overall Study|Other - as reported by the investigator|6|||
16138038|NCT04427501|38993211|FG006|Overall Study|Other - as reported by the investigator|6|||
16138039|NCT04427501|38993212|FG007|Overall Study|Other - as reported by the investigator|0|||
16138040|NCT04427501|38993213|FG008|Overall Study|Other - as reported by the investigator|0|||
16138041|NCT04427501|38993214|FG009|Overall Study|Other - as reported by the investigator|0|||
16138042|NCT04427501|38993215|FG010|Overall Study|Other - as reported by the investigator|0|||
16138043|NCT04427501|38993216|FG011|Overall Study|Other - as reported by the investigator|0|||
16138044|NCT04427501|38993205|FG000|Overall Study|Other|0|||
16138045|NCT04427501|38993206|FG001|Overall Study|Other|0|||
16138046|NCT04427501|38993207|FG002|Overall Study|Other|0|||
16138047|NCT04427501|38993208|FG003|Overall Study|Other|0|||
16138048|NCT04427501|38993209|FG004|Overall Study|Other|0|||
16138049|NCT04427501|38993210|FG005|Overall Study|Other|0|||
16138050|NCT04427501|38993211|FG006|Overall Study|Other|0|||
16138051|NCT04427501|38993212|FG007|Overall Study|Other|0|||
16138052|NCT04427501|38993213|FG008|Overall Study|Other|0|||
16138053|NCT04427501|38993214|FG009|Overall Study|Other|0|||
16138054|NCT04427501|38993215|FG010|Overall Study|Other|0|||
16138055|NCT04427501|38993216|FG011|Overall Study|Other|1|||
16138056|NCT04079803|38993220|FG000|Overall Study|Withdrawal by Subject|0|||
16138057|NCT04079803|38993221|FG001|Overall Study|Withdrawal by Subject|0|||
16138058|NCT04079803|38993222|FG002|Overall Study|Withdrawal by Subject|1|||
16138059|NCT00628251|38993223|FG000|Randomised Part|Withdrawal by Subject|0|||
16138060|NCT00628251|38993224|FG001|Randomised Part|Withdrawal by Subject|0|||
16138061|NCT00628251|38993225|FG002|Randomised Part|Withdrawal by Subject|1|||
16138062|NCT00628251|38993223|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
16138063|NCT00628251|38993224|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
16138064|NCT00628251|38993225|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
16138065|NCT00628251|38993223|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
16138066|NCT00628251|38993224|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
16138067|NCT00628251|38993225|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
16138068|NCT00628251|38993223|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
16138069|NCT00628251|38993224|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
16138070|NCT00628251|38993225|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
16138071|NCT00628251|38993223|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
16138072|NCT00628251|38993224|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
16138073|NCT00628251|38993225|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
16436560|NCT02193776|40077782|FG003|Overall Study|Failure to comply with protocol|0|||
16436561|NCT02193776|40077779|FG000|Overall Study|Investigator/Sponsor decision|1|||
16436562|NCT02193776|40077780|FG001|Overall Study|Investigator/Sponsor decision|1|||
16436563|NCT02193776|40077781|FG002|Overall Study|Investigator/Sponsor decision|0|||
16436564|NCT02193776|40077782|FG003|Overall Study|Investigator/Sponsor decision|0|||
16436565|NCT02193776|40077779|FG000|Overall Study|Death|1|||
16436566|NCT02193776|40077780|FG001|Overall Study|Death|0|||
16436567|NCT02193776|40077781|FG002|Overall Study|Death|0|||
16138074|NCT00628251|38993223|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
16138075|NCT00628251|38993224|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
16138076|NCT00628251|38993225|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
16138077|NCT03678103|38993226|FG000|Overall Study|Withdrawn prior to completion|4|||
16138078|NCT01178671|38993234|FG000|Overall Study|Adverse Event|4|||
16138079|NCT01178671|38993235|FG001|Overall Study|Adverse Event|6|||
16138080|NCT01178671|38993234|FG000|Overall Study|Protocol Violation|1|||
16138081|NCT01178671|38993235|FG001|Overall Study|Protocol Violation|1|||
16436568|NCT02193776|40077782|FG003|Overall Study|Death|0|||
16138082|NCT01178671|38993234|FG000|Overall Study|Lack of Efficacy|0|||
16138083|NCT01178671|38993235|FG001|Overall Study|Lack of Efficacy|1|||
16138084|NCT01178671|38993234|FG000|Overall Study|Lost to Follow-up|3|||
16138085|NCT01178671|38993235|FG001|Overall Study|Lost to Follow-up|1|||
16436569|NCT02193776|40077779|FG000|Overall Study|Adverse event/Specific toxicity|5|||
16436570|NCT02193776|40077780|FG001|Overall Study|Adverse event/Specific toxicity|5|||
16436571|NCT02193776|40077781|FG002|Overall Study|Adverse event/Specific toxicity|2|||
16436572|NCT02193776|40077782|FG003|Overall Study|Adverse event/Specific toxicity|2|||
16436573|NCT02349633|40077785|FG000|Overall Study|Death|0|||
16436574|NCT02349633|40077786|FG001|Overall Study|Death|1|||
16436575|NCT02349633|40077787|FG002|Overall Study|Death|0|||
16436576|NCT02349633|40077788|FG003|Overall Study|Death|0|||
16436577|NCT02349633|40077789|FG004|Overall Study|Death|0|||
16436578|NCT02349633|40077790|FG005|Overall Study|Death|1|||
16436579|NCT02349633|40077791|FG006|Overall Study|Death|1|||
16436580|NCT02349633|40077792|FG007|Overall Study|Death|1|||
16436581|NCT02349633|40077793|FG008|Overall Study|Death|0|||
16436582|NCT02349633|40077794|FG009|Overall Study|Death|1|||
16436583|NCT02349633|40077795|FG010|Overall Study|Death|0|||
16436584|NCT02349633|40077796|FG011|Overall Study|Death|0|||
16436585|NCT02349633|40077797|FG012|Overall Study|Death|0|||
16436586|NCT02349633|40077798|FG013|Overall Study|Death|0|||
16436587|NCT02349633|40077785|FG000|Overall Study|Withdrawal by Subject|0|||
16436588|NCT02349633|40077786|FG001|Overall Study|Withdrawal by Subject|0|||
16436589|NCT02349633|40077787|FG002|Overall Study|Withdrawal by Subject|0|||
16436590|NCT02349633|40077788|FG003|Overall Study|Withdrawal by Subject|1|||
16436591|NCT02349633|40077789|FG004|Overall Study|Withdrawal by Subject|0|||
16436592|NCT02349633|40077790|FG005|Overall Study|Withdrawal by Subject|0|||
16436593|NCT02349633|40077791|FG006|Overall Study|Withdrawal by Subject|0|||
16436594|NCT02349633|40077792|FG007|Overall Study|Withdrawal by Subject|2|||
16436595|NCT02349633|40077793|FG008|Overall Study|Withdrawal by Subject|2|||
16436596|NCT02349633|40077794|FG009|Overall Study|Withdrawal by Subject|1|||
16436597|NCT02349633|40077795|FG010|Overall Study|Withdrawal by Subject|0|||
16436598|NCT02349633|40077796|FG011|Overall Study|Withdrawal by Subject|0|||
16436599|NCT02349633|40077797|FG012|Overall Study|Withdrawal by Subject|0|||
16436600|NCT02349633|40077798|FG013|Overall Study|Withdrawal by Subject|0|||
16436601|NCT02349633|40077785|FG000|Overall Study|Withdrawal of informed consent|0|||
16436602|NCT02349633|40077786|FG001|Overall Study|Withdrawal of informed consent|0|||
16436603|NCT02349633|40077787|FG002|Overall Study|Withdrawal of informed consent|0|||
16436604|NCT02349633|40077788|FG003|Overall Study|Withdrawal of informed consent|1|||
16436605|NCT02349633|40077789|FG004|Overall Study|Withdrawal of informed consent|1|||
16436606|NCT02349633|40077790|FG005|Overall Study|Withdrawal of informed consent|0|||
16436607|NCT02349633|40077791|FG006|Overall Study|Withdrawal of informed consent|0|||
16436608|NCT02349633|40077792|FG007|Overall Study|Withdrawal of informed consent|3|||
16436609|NCT02349633|40077793|FG008|Overall Study|Withdrawal of informed consent|0|||
16436610|NCT02349633|40077794|FG009|Overall Study|Withdrawal of informed consent|0|||
16436611|NCT02349633|40077795|FG010|Overall Study|Withdrawal of informed consent|0|||
16436612|NCT02349633|40077796|FG011|Overall Study|Withdrawal of informed consent|0|||
16436613|NCT02349633|40077797|FG012|Overall Study|Withdrawal of informed consent|0|||
16436614|NCT02349633|40077798|FG013|Overall Study|Withdrawal of informed consent|0|||
16436615|NCT02349633|40077785|FG000|Overall Study|Transition to compassionate use|0|||
16436616|NCT02349633|40077786|FG001|Overall Study|Transition to compassionate use|0|||
16436617|NCT02349633|40077787|FG002|Overall Study|Transition to compassionate use|0|||
16436618|NCT02349633|40077788|FG003|Overall Study|Transition to compassionate use|0|||
16436619|NCT02349633|40077789|FG004|Overall Study|Transition to compassionate use|1|||
16436620|NCT02349633|40077790|FG005|Overall Study|Transition to compassionate use|0|||
16436621|NCT02349633|40077791|FG006|Overall Study|Transition to compassionate use|0|||
16436622|NCT02349633|40077792|FG007|Overall Study|Transition to compassionate use|3|||
16436623|NCT02349633|40077793|FG008|Overall Study|Transition to compassionate use|0|||
16436624|NCT02349633|40077794|FG009|Overall Study|Transition to compassionate use|1|||
16436625|NCT02349633|40077795|FG010|Overall Study|Transition to compassionate use|0|||
16436626|NCT02349633|40077796|FG011|Overall Study|Transition to compassionate use|0|||
16436627|NCT02349633|40077797|FG012|Overall Study|Transition to compassionate use|0|||
16436628|NCT02349633|40077798|FG013|Overall Study|Transition to compassionate use|0|||
16436629|NCT02349633|40077785|FG000|Overall Study|Early termination of survival follow-up|0|||
16436630|NCT02349633|40077786|FG001|Overall Study|Early termination of survival follow-up|0|||
16436631|NCT02349633|40077787|FG002|Overall Study|Early termination of survival follow-up|0|||
16138086|NCT01178671|38993234|FG000|Overall Study|Physician Decision|4|||
16436632|NCT02349633|40077788|FG003|Overall Study|Early termination of survival follow-up|0|||
16436633|NCT02349633|40077789|FG004|Overall Study|Early termination of survival follow-up|0|||
16436634|NCT02349633|40077790|FG005|Overall Study|Early termination of survival follow-up|0|||
16436635|NCT02349633|40077791|FG006|Overall Study|Early termination of survival follow-up|0|||
16436636|NCT02349633|40077792|FG007|Overall Study|Early termination of survival follow-up|4|||
16436637|NCT02349633|40077793|FG008|Overall Study|Early termination of survival follow-up|0|||
16138087|NCT01178671|38993235|FG001|Overall Study|Physician Decision|6|||
16138088|NCT00973362|38993239|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
16138089|NCT00973362|38993240|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
16138090|NCT00973362|38993239|FG000|Baseline Evaluation|No colposcopy visit|62|||
16138091|NCT00973362|38993240|FG001|Baseline Evaluation|No colposcopy visit|0|||
16138092|NCT00973362|38993239|FG000|Baseline Evaluation|Inevaluable|686|||
16138093|NCT00973362|38993240|FG001|Baseline Evaluation|Inevaluable|223|||
16138094|NCT00973362|38993239|FG000|3-Year Follow-up|Lost to Follow-up|17|||
16138095|NCT00973362|38993240|FG001|3-Year Follow-up|Lost to Follow-up|0|||
16138096|NCT03566810|38993241|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
16138097|NCT03566810|38993242|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
16138098|NCT03566810|38993243|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
16138099|NCT03566810|38993244|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
16138100|NCT01351623|38993245|FG000|Overall Study|Protocol Violation|2|||
16138101|NCT01351623|38993245|FG000|Overall Study|Adverse Event|4|||
16138102|NCT01351623|38993245|FG000|Overall Study|Withdrawal by Subject|1|||
16138103|NCT01351623|38993245|FG000|Overall Study|Death|2|||
16138104|NCT01180998|38993247|FG000|Overall Study|Poor Vision|0|||
16138105|NCT01180998|38993248|FG001|Overall Study|Poor Vision|2|||
16138106|NCT01180998|38993249|FG002|Overall Study|Poor Vision|2|||
16138107|NCT01180998|38993247|FG000|Overall Study|Lost to Follow-up|0|||
16138108|NCT01180998|38993248|FG001|Overall Study|Lost to Follow-up|0|||
16138109|NCT01180998|38993249|FG002|Overall Study|Lost to Follow-up|1|||
16138110|NCT01180998|38993247|FG000|Overall Study|Protocol Violation|1|||
16138111|NCT01180998|38993248|FG001|Overall Study|Protocol Violation|2|||
16138112|NCT01180998|38993249|FG002|Overall Study|Protocol Violation|0|||
16138113|NCT01180998|38993247|FG000|Overall Study|Withdrawal by Subject|0|||
16138114|NCT01180998|38993248|FG001|Overall Study|Withdrawal by Subject|0|||
16138115|NCT01180998|38993249|FG002|Overall Study|Withdrawal by Subject|1|||
16138116|NCT01180998|38993247|FG000|Overall Study|Poor comfort|3|||
16138117|NCT01180998|38993248|FG001|Overall Study|Poor comfort|0|||
16138118|NCT01180998|38993249|FG002|Overall Study|Poor comfort|4|||
16138119|NCT01180998|38993247|FG000|Overall Study|Poor lens handling|0|||
16138120|NCT01180998|38993248|FG001|Overall Study|Poor lens handling|0|||
16138121|NCT01180998|38993249|FG002|Overall Study|Poor lens handling|2|||
16138122|NCT02170389|38993250|FG000|Overall Study|Study terminated prior to start of treat|1|||
16138123|NCT01313637|38993251|FG000|Overall Study|Adverse Event|17|||
16138124|NCT01313637|38993252|FG001|Overall Study|Adverse Event|24|||
16138125|NCT01313637|38993253|FG002|Overall Study|Adverse Event|25|||
16138126|NCT01313637|38993254|FG003|Overall Study|Adverse Event|18|||
16138127|NCT01313637|38993251|FG000|Overall Study|Lack of Efficacy|44|||
16138128|NCT01313637|38993252|FG001|Overall Study|Lack of Efficacy|38|||
16138129|NCT01313637|38993253|FG002|Overall Study|Lack of Efficacy|37|||
16138130|NCT01313637|38993254|FG003|Overall Study|Lack of Efficacy|24|||
16138131|NCT01313637|38993251|FG000|Overall Study|Protocol Violation|4|||
16138132|NCT01313637|38993252|FG001|Overall Study|Protocol Violation|3|||
16138133|NCT01313637|38993253|FG002|Overall Study|Protocol Violation|11|||
16138134|NCT01313637|38993254|FG003|Overall Study|Protocol Violation|5|||
16138135|NCT01313637|38993251|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
16436638|NCT02349633|40077794|FG009|Overall Study|Early termination of survival follow-up|0|||
16138136|NCT01313637|38993252|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
16436639|NCT02349633|40077795|FG010|Overall Study|Early termination of survival follow-up|0|||
16138137|NCT01313637|38993253|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
16253853|NCT01267266|39413067|FG001|Lead-in Phase|Lack of Efficacy|0|||
16436640|NCT02349633|40077796|FG011|Overall Study|Early termination of survival follow-up|0|||
16436641|NCT02349633|40077797|FG012|Overall Study|Early termination of survival follow-up|0|||
16436642|NCT02349633|40077798|FG013|Overall Study|Early termination of survival follow-up|0|||
16436643|NCT02349633|40077785|FG000|Overall Study|Termination by sponsor|0|||
16436644|NCT02349633|40077786|FG001|Overall Study|Termination by sponsor|0|||
16436645|NCT02349633|40077787|FG002|Overall Study|Termination by sponsor|0|||
16436646|NCT02349633|40077788|FG003|Overall Study|Termination by sponsor|0|||
16436647|NCT02349633|40077789|FG004|Overall Study|Termination by sponsor|0|||
16436648|NCT02349633|40077790|FG005|Overall Study|Termination by sponsor|0|||
16436649|NCT02349633|40077791|FG006|Overall Study|Termination by sponsor|0|||
16436650|NCT02349633|40077792|FG007|Overall Study|Termination by sponsor|1|||
16436651|NCT02349633|40077793|FG008|Overall Study|Termination by sponsor|0|||
16436652|NCT02349633|40077794|FG009|Overall Study|Termination by sponsor|2|||
16436653|NCT02349633|40077795|FG010|Overall Study|Termination by sponsor|0|||
16436654|NCT02349633|40077796|FG011|Overall Study|Termination by sponsor|0|||
16138138|NCT01313637|38993254|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
16138139|NCT01313637|38993251|FG000|Overall Study|Lost to Follow-up|0|||
16138140|NCT01313637|38993252|FG001|Overall Study|Lost to Follow-up|2|||
16138141|NCT01313637|38993253|FG002|Overall Study|Lost to Follow-up|1|||
16138142|NCT01313637|38993254|FG003|Overall Study|Lost to Follow-up|3|||
16138143|NCT01313637|38993251|FG000|Overall Study|Withdrawal by Subject|11|||
16138144|NCT01313637|38993252|FG001|Overall Study|Withdrawal by Subject|13|||
16138145|NCT01313637|38993253|FG002|Overall Study|Withdrawal by Subject|18|||
16138146|NCT01313637|38993254|FG003|Overall Study|Withdrawal by Subject|15|||
16138147|NCT01480674|38993255|FG000|Overall Study|Death|23|||
16138148|NCT01480674|38993255|FG000|Overall Study|Lost to Follow-up|2|||
16138149|NCT01480674|38993255|FG000|Overall Study|visit not done|10|||
16138150|NCT01143038|38993256|FG000|Overall Study|Withdrawal by Subject|4|||
16138151|NCT01143038|38993256|FG000|Overall Study|Requirement for alternative therapy|5|||
16138152|NCT01143038|38993256|FG000|Overall Study|Adverse Event|3|||
16138153|NCT01143038|38993256|FG000|Overall Study|Lost to Follow-up|2|||
16138154|NCT01143038|38993256|FG000|Overall Study|Protocol Deviation|1|||
16138155|NCT01143038|38993256|FG000|Overall Study|Death|1|||
16138156|NCT00235326|38993258|FG000|Overall Study|Lost to Follow-up|746|||
16138157|NCT00235326|38993259|FG001|Overall Study|Lost to Follow-up|1400|||
16138158|NCT00822172|38993262|FG000|Overall Study|Adverse Event|10|||
16138159|NCT00822172|38993263|FG001|Overall Study|Adverse Event|12|||
16138160|NCT00822172|38993262|FG000|Overall Study|Death|1|||
16138161|NCT00822172|38993263|FG001|Overall Study|Death|0|||
16138162|NCT00822172|38993262|FG000|Overall Study|Lost to Follow-up|3|||
16138163|NCT00822172|38993263|FG001|Overall Study|Lost to Follow-up|1|||
16138164|NCT00822172|38993262|FG000|Overall Study|Withdrawal by Subject|1|||
16138165|NCT00822172|38993263|FG001|Overall Study|Withdrawal by Subject|4|||
16138166|NCT00822172|38993262|FG000|Overall Study|site closed|0|||
16138167|NCT00822172|38993263|FG001|Overall Study|site closed|1|||
16138168|NCT00822172|38993262|FG000|Overall Study|Other|0|||
16138169|NCT00822172|38993263|FG001|Overall Study|Other|1|||
16138170|NCT04217590|38993268|FG000|Overall Study|Other|1|||
16138171|NCT04217590|38993269|FG001|Overall Study|Other|1|||
16138172|NCT04217590|38993268|FG000|Overall Study|Withdrawal by Subject|3|||
16138173|NCT04217590|38993269|FG001|Overall Study|Withdrawal by Subject|1|||
16138174|NCT04217590|38993268|FG000|Overall Study|Death|0|||
16138175|NCT04217590|38993269|FG001|Overall Study|Death|1|||
16138176|NCT00528567|38993270|FG000|Overall Study|Death|4|||
16138177|NCT00528567|38993271|FG001|Overall Study|Death|5|||
16138178|NCT00528567|38993270|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
16138179|NCT00528567|38993271|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
16138180|NCT00528567|38993270|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
16138181|NCT00528567|38993271|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
16138182|NCT00528567|38993270|FG000|Overall Study|Violation Criteria at Entry|3|||
16138183|NCT00528567|38993271|FG001|Overall Study|Violation Criteria at Entry|17|||
16138184|NCT00528567|38993270|FG000|Overall Study|Withdrew Consent|59|||
16138185|NCT00528567|38993271|FG001|Overall Study|Withdrew Consent|55|||
16138186|NCT00528567|38993270|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
16138187|NCT00528567|38993271|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
16138188|NCT00528567|38993270|FG000|Overall Study|Failure to Return|1|||
16138189|NCT00528567|38993271|FG001|Overall Study|Failure to Return|4|||
16138190|NCT00528567|38993270|FG000|Overall Study|Other Protocol Violation|5|||
16138191|NCT00528567|38993271|FG001|Overall Study|Other Protocol Violation|21|||
16138192|NCT00528567|38993270|FG000|Overall Study|Administrative/Other|22|||
16138193|NCT00528567|38993271|FG001|Overall Study|Administrative/Other|75|||
16362906|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
16362907|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
16362908|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
16362909|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
16362910|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
16362911|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
16362912|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
16362913|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
16362914|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
16362915|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
16362916|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
16362917|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
16362918|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
16253854|NCT01267266|39413066|FG000|Lead-in Phase|Adverse Event|2|||
16253855|NCT01267266|39413067|FG001|Lead-in Phase|Adverse Event|0|||
16253856|NCT01267266|39413066|FG000|Lead-in Phase|Withdrawal by Subject|1|||
16253857|NCT01267266|39413067|FG001|Lead-in Phase|Withdrawal by Subject|0|||
16253858|NCT00662129|39413070|FG000|Overall Study|Protocol Violation|1|||
16253859|NCT00662129|39413070|FG000|Overall Study|Cancel prior to beginning treatment|1|||
16253860|NCT00662129|39413070|FG000|Overall Study|Ineligible|1|||
16253861|NCT01829464|39413072|FG000|Overall Study|Adverse Event|1|||
16253862|NCT01829464|39413073|FG001|Overall Study|Adverse Event|0|||
16253863|NCT01829464|39413074|FG002|Overall Study|Adverse Event|0|||
16253864|NCT01829464|39413072|FG000|Overall Study|Lost to Follow-up|0|||
16253865|NCT01829464|39413073|FG001|Overall Study|Lost to Follow-up|0|||
16253866|NCT01829464|39413074|FG002|Overall Study|Lost to Follow-up|1|||
16253867|NCT01829464|39413072|FG000|Overall Study|Withdrawal by Subject|2|||
16253868|NCT01829464|39413073|FG001|Overall Study|Withdrawal by Subject|0|||
16253869|NCT01829464|39413074|FG002|Overall Study|Withdrawal by Subject|0|||
16253870|NCT01829464|39413072|FG000|Overall Study|Study terminated by sponsor|25|||
16253871|NCT01829464|39413073|FG001|Overall Study|Study terminated by sponsor|28|||
16253872|NCT01829464|39413074|FG002|Overall Study|Study terminated by sponsor|25|||
16253873|NCT01829464|39413072|FG000|Overall Study|Lack of Efficacy|0|||
16253874|NCT01829464|39413073|FG001|Overall Study|Lack of Efficacy|1|||
16253875|NCT01829464|39413074|FG002|Overall Study|Lack of Efficacy|0|||
16253876|NCT00989261|39413080|FG000|Overall Study|Still in follow up|12|||
16253877|NCT00989261|39413081|FG001|Overall Study|Still in follow up|21|||
16253878|NCT00989261|39413080|FG000|Overall Study|Withdrawal by Subject|0|||
16253879|NCT00989261|39413081|FG001|Overall Study|Withdrawal by Subject|1|||
16253880|NCT00989261|39413080|FG000|Overall Study|Lost to Follow-up|3|||
16253881|NCT00989261|39413081|FG001|Overall Study|Lost to Follow-up|0|||
16253882|NCT00925769|39413091|FG000|Overall Study|Major toxicity|1|||
16253883|NCT00925769|39413092|FG001|Overall Study|Major toxicity|0|||
16253884|NCT00925769|39413093|FG002|Overall Study|Major toxicity|1|||
16253885|NCT00925769|39413094|FG003|Overall Study|Major toxicity|1|||
16253886|NCT00925769|39413095|FG004|Overall Study|Major toxicity|0|||
16253887|NCT00925769|39413096|FG005|Overall Study|Major toxicity|0|||
16253888|NCT00925769|39413091|FG000|Overall Study|Disease progression|4|||
16362919|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Depression|0|||
16362920|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Depression|1|||
16362921|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Depression|0|||
16362922|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
16253889|NCT00925769|39413092|FG001|Overall Study|Disease progression|5|||
16253890|NCT00925769|39413093|FG002|Overall Study|Disease progression|3|||
16362923|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
16362924|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
16436655|NCT02349633|40077797|FG012|Overall Study|Termination by sponsor|0|||
16253891|NCT00925769|39413094|FG003|Overall Study|Disease progression|4|||
16138194|NCT00708175|38993272|FG000|Overall Study|Adverse Event|4|||
16362925|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Jailed|0|||
16362926|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Jailed|1|||
16138195|NCT00708175|38993273|FG001|Overall Study|Adverse Event|5|||
16138196|NCT00708175|38993272|FG000|Overall Study|Protocol Violation|2|||
16138197|NCT00708175|38993273|FG001|Overall Study|Protocol Violation|3|||
16138198|NCT00708175|38993272|FG000|Overall Study|Lost to Follow-up|5|||
16138199|NCT00708175|38993273|FG001|Overall Study|Lost to Follow-up|3|||
16138200|NCT00708175|38993272|FG000|Overall Study|Withdrawal by Subject|5|||
16138201|NCT00708175|38993273|FG001|Overall Study|Withdrawal by Subject|7|||
16138202|NCT00708175|38993272|FG000|Overall Study|BMD loss >7%|2|||
16138203|NCT00708175|38993273|FG001|Overall Study|BMD loss >7%|3|||
16138204|NCT00162032|38993274|FG000|Overall Study|Lost to Follow-up|4|||
16138205|NCT00162032|38993275|FG001|Overall Study|Lost to Follow-up|2|||
16138206|NCT00162032|38993274|FG000|Overall Study|Reason not specified|1|||
16253892|NCT00925769|39413095|FG004|Overall Study|Disease progression|2|||
16253893|NCT00925769|39413096|FG005|Overall Study|Disease progression|3|||
16253894|NCT00925769|39413091|FG000|Overall Study|Death|0|||
16253895|NCT00925769|39413092|FG001|Overall Study|Death|0|||
16253896|NCT00925769|39413093|FG002|Overall Study|Death|1|||
16253897|NCT00925769|39413094|FG003|Overall Study|Death|0|||
16253898|NCT00925769|39413095|FG004|Overall Study|Death|0|||
16253899|NCT00925769|39413096|FG005|Overall Study|Death|0|||
16253900|NCT00925769|39413091|FG000|Overall Study|Physician Decision|1|||
16253901|NCT00925769|39413092|FG001|Overall Study|Physician Decision|0|||
16253902|NCT00925769|39413093|FG002|Overall Study|Physician Decision|0|||
16253903|NCT00925769|39413094|FG003|Overall Study|Physician Decision|0|||
16253904|NCT00925769|39413095|FG004|Overall Study|Physician Decision|0|||
16253905|NCT00925769|39413096|FG005|Overall Study|Physician Decision|0|||
16253906|NCT00925769|39413091|FG000|Overall Study|Missing documentation|0|||
16253907|NCT00925769|39413092|FG001|Overall Study|Missing documentation|1|||
16253908|NCT00925769|39413093|FG002|Overall Study|Missing documentation|0|||
16253909|NCT00925769|39413094|FG003|Overall Study|Missing documentation|0|||
16253910|NCT00925769|39413095|FG004|Overall Study|Missing documentation|0|||
16253911|NCT00925769|39413096|FG005|Overall Study|Missing documentation|0|||
16253912|NCT00925769|39413091|FG000|Overall Study|End of study visit not done|0|||
16253913|NCT00925769|39413092|FG001|Overall Study|End of study visit not done|0|||
16253914|NCT00925769|39413093|FG002|Overall Study|End of study visit not done|1|||
16253915|NCT00925769|39413094|FG003|Overall Study|End of study visit not done|0|||
16253916|NCT00925769|39413095|FG004|Overall Study|End of study visit not done|0|||
16253917|NCT00925769|39413096|FG005|Overall Study|End of study visit not done|0|||
16253918|NCT00925769|39413091|FG000|Overall Study|Participant is unable to swallow drug|0|||
16253919|NCT00925769|39413092|FG001|Overall Study|Participant is unable to swallow drug|0|||
16253920|NCT00925769|39413093|FG002|Overall Study|Participant is unable to swallow drug|0|||
16362927|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Jailed|0|||
16362928|NCT00090103|39814945|FG000|16-Week Safety Follow-up Period|Other|0|||
16362929|NCT00090103|39814946|FG001|16-Week Safety Follow-up Period|Other|1|||
16362930|NCT00090103|39814947|FG002|16-Week Safety Follow-up Period|Other|0|||
16362931|NCT00844519|39814950|FG000|Overall Study|Withdrawal by Subject|1|||
16362932|NCT00844519|39814951|FG001|Overall Study|Withdrawal by Subject|1|||
16362933|NCT00844519|39814950|FG000|Overall Study|Adverse Event|1|||
16362934|NCT00844519|39814951|FG001|Overall Study|Adverse Event|0|||
16362935|NCT00620542|39814952|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
16362936|NCT00620542|39814953|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
16362937|NCT00620542|39814954|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
16362938|NCT00620542|39814955|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
16362939|NCT00620542|39814952|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
16362940|NCT00620542|39814953|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
16362941|NCT00620542|39814954|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
16362942|NCT00620542|39814955|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
16362943|NCT00620542|39814952|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
16138207|NCT00162032|38993275|FG001|Overall Study|Reason not specified|0|||
16138208|NCT00888433|38993276|FG000|Overall Study|Withdrawal by Subject|1|||
16138209|NCT00888433|38993277|FG001|Overall Study|Withdrawal by Subject|2|||
16138210|NCT00888433|38993276|FG000|Overall Study|Missed Visit|2|||
16138211|NCT00888433|38993277|FG001|Overall Study|Missed Visit|1|||
16138212|NCT00803270|38993283|FG000|Overall Study|Lost to Follow-up|1|||
16138213|NCT00803270|38993284|FG001|Overall Study|Lost to Follow-up|2|||
16138214|NCT03602066|38993287|FG000|Overall Study|Withdrawal by Subject|2|||
16138215|NCT03602066|38993288|FG001|Overall Study|Withdrawal by Subject|0|||
16138216|NCT03602066|38993287|FG000|Overall Study|Physician Decision|1|||
16138217|NCT03602066|38993288|FG001|Overall Study|Physician Decision|0|||
16138218|NCT01971203|38993289|FG000|Overall Study|Protocol Violation|3|||
16138219|NCT01971203|38993290|FG001|Overall Study|Protocol Violation|2|||
16138220|NCT01971203|38993289|FG000|Overall Study|Withdrawal by Subject|5|||
16138221|NCT01971203|38993290|FG001|Overall Study|Withdrawal by Subject|6|||
16138222|NCT01971203|38993289|FG000|Overall Study|Adverse Event|1|||
16138223|NCT01971203|38993290|FG001|Overall Study|Adverse Event|0|||
16138224|NCT04201821|38993293|FG000|Overall Study|Withdrawal by Subject|2|||
16138225|NCT03285178|38993294|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
16138226|NCT03285178|38993295|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
16138227|NCT03285178|38993296|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
16253921|NCT00925769|39413094|FG003|Overall Study|Participant is unable to swallow drug|1|||
16436656|NCT02349633|40077798|FG013|Overall Study|Termination by sponsor|0|||
16436657|NCT02349633|40077785|FG000|Overall Study|Other|0|||
16436658|NCT02349633|40077786|FG001|Overall Study|Other|0|||
16436659|NCT02349633|40077787|FG002|Overall Study|Other|0|||
16436660|NCT02349633|40077788|FG003|Overall Study|Other|0|||
16436661|NCT02349633|40077789|FG004|Overall Study|Other|0|||
16436662|NCT02349633|40077790|FG005|Overall Study|Other|0|||
16436663|NCT02349633|40077791|FG006|Overall Study|Other|0|||
16436664|NCT02349633|40077792|FG007|Overall Study|Other|2|||
16436665|NCT02349633|40077793|FG008|Overall Study|Other|0|||
16436666|NCT02349633|40077794|FG009|Overall Study|Other|0|||
16436667|NCT02349633|40077795|FG010|Overall Study|Other|0|||
16436668|NCT02349633|40077796|FG011|Overall Study|Other|0|||
16436669|NCT02349633|40077797|FG012|Overall Study|Other|0|||
16436670|NCT02349633|40077798|FG013|Overall Study|Other|0|||
16436671|NCT03186209|40077799|FG000|Overall Study|Withdrawal by Subject|11|||
16436672|NCT03186209|40077800|FG001|Overall Study|Withdrawal by Subject|22|||
16436673|NCT03186209|40077799|FG000|Overall Study|Pregnancy|1|||
16436674|NCT03186209|40077800|FG001|Overall Study|Pregnancy|0|||
16436675|NCT03186209|40077799|FG000|Overall Study|Adverse Event|4|||
16436676|NCT03186209|40077800|FG001|Overall Study|Adverse Event|0|||
16253922|NCT00925769|39413095|FG004|Overall Study|Participant is unable to swallow drug|0|||
16253923|NCT00925769|39413096|FG005|Overall Study|Participant is unable to swallow drug|0|||
16436677|NCT03186209|40077799|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
16436678|NCT03186209|40077800|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
16436679|NCT03186209|40077799|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
16436680|NCT03186209|40077800|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
16436681|NCT03186209|40077799|FG000|Overall Study|Fail to meet randomization criteria|0|||
16436682|NCT03186209|40077800|FG001|Overall Study|Fail to meet randomization criteria|1|||
16436683|NCT03186209|40077799|FG000|Overall Study|Lost to Follow-up|0|||
16436684|NCT03186209|40077800|FG001|Overall Study|Lost to Follow-up|1|||
16436685|NCT04481243|40077802|FG000|Overall Study|Withdrawal by Subject|4|||
16436686|NCT02868554|40077804|FG000|Overall Study|Lost to Follow-up|3|||
16253924|NCT00925769|39413091|FG000|Overall Study|Adverse Event|0|||
16253925|NCT00925769|39413092|FG001|Overall Study|Adverse Event|0|||
16253926|NCT00925769|39413093|FG002|Overall Study|Adverse Event|0|||
16253927|NCT00925769|39413094|FG003|Overall Study|Adverse Event|0|||
16253928|NCT00925769|39413095|FG004|Overall Study|Adverse Event|1|||
16253929|NCT00925769|39413096|FG005|Overall Study|Adverse Event|0|||
16253930|NCT01338636|39413098|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
16253931|NCT00525590|39413107|FG000|Overall Study|Adverse Event|3|||
16253932|NCT00525590|39413107|FG000|Overall Study|Physician Decision|3|||
16253933|NCT00525590|39413107|FG000|Overall Study|Withdrawal by Subject|16|||
16253934|NCT00525590|39413107|FG000|Overall Study|Lost to Follow-up|1|||
16253935|NCT00525590|39413107|FG000|Overall Study|Death|9|||
16253936|NCT00525590|39413107|FG000|Overall Study|Other|13|||
16253937|NCT01919190|39413108|FG000|Overall Study|Intra-op findings, etc.|3|||
16253938|NCT01919190|39413109|FG001|Overall Study|Intra-op findings, etc.|0|||
16253939|NCT03322462|39413110|FG000|Overall Study|Technical difficulties|2|||
16436687|NCT02868554|40077805|FG001|Overall Study|Lost to Follow-up|0|||
16436688|NCT02868554|40077806|FG002|Overall Study|Lost to Follow-up|1|||
16436689|NCT00447226|40077807|FG000|12-Week Open-label Phase|Adverse Event|0|||
16436690|NCT00447226|40077808|FG001|12-Week Open-label Phase|Adverse Event|3|||
16436691|NCT00447226|40077807|FG000|12-Week Open-label Phase|Protocol Violation|0|||
16138228|NCT03285178|38993297|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
16138229|NCT03285178|38993298|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
16138230|NCT03285178|38993299|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
16138231|NCT03285178|38993300|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
16138232|NCT03285178|38993294|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
16138233|NCT03285178|38993295|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
16138234|NCT03285178|38993296|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
16138235|NCT03285178|38993297|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
16138236|NCT03285178|38993298|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
16138237|NCT03285178|38993299|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
16138238|NCT03285178|38993300|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
16138239|NCT03285178|38993294|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
16138240|NCT03285178|38993295|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
16138241|NCT03285178|38993296|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
16138242|NCT03285178|38993297|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
16138243|NCT03285178|38993298|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
16138244|NCT03285178|38993299|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
16138245|NCT03285178|38993300|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
16138246|NCT03285178|38993294|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
16138247|NCT03285178|38993295|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
16138248|NCT03285178|38993296|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
16138249|NCT03285178|38993297|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
16138250|NCT03285178|38993298|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
16138251|NCT03285178|38993299|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
16138252|NCT03285178|38993300|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
16138253|NCT03285178|38993294|FG000|Single-Blind Run-In Period|Physician Decision|2|||
16138254|NCT03285178|38993295|FG001|Single-Blind Run-In Period|Physician Decision|0|||
16138255|NCT03285178|38993296|FG002|Single-Blind Run-In Period|Physician Decision|0|||
16138256|NCT03285178|38993297|FG003|Single-Blind Run-In Period|Physician Decision|0|||
16138257|NCT03285178|38993298|FG004|Single-Blind Run-In Period|Physician Decision|0|||
16138258|NCT03285178|38993299|FG005|Single-Blind Run-In Period|Physician Decision|0|||
16138259|NCT03285178|38993300|FG006|Single-Blind Run-In Period|Physician Decision|0|||
16138260|NCT03285178|38993294|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
16138261|NCT03285178|38993295|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
16138262|NCT03285178|38993296|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
16138263|NCT03285178|38993297|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
16138264|NCT03285178|38993298|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
16138265|NCT03285178|38993299|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
16138266|NCT03285178|38993300|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
16138267|NCT03285178|38993294|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16138268|NCT03285178|38993295|FG001|Double-Blind Treatment Period|Adverse Event|0|||
16138269|NCT03285178|38993296|FG002|Double-Blind Treatment Period|Adverse Event|0|||
16138270|NCT03285178|38993297|FG003|Double-Blind Treatment Period|Adverse Event|0|||
16138271|NCT03285178|38993298|FG004|Double-Blind Treatment Period|Adverse Event|0|||
16138272|NCT03285178|38993299|FG005|Double-Blind Treatment Period|Adverse Event|0|||
16138273|NCT03285178|38993300|FG006|Double-Blind Treatment Period|Adverse Event|2|||
16138274|NCT03285178|38993294|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16138275|NCT03285178|38993295|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
16138276|NCT03285178|38993296|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
16138277|NCT03285178|38993297|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
16138278|NCT03285178|38993298|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
16138279|NCT03285178|38993299|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
16138280|NCT03285178|38993300|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
16138281|NCT03285178|38993294|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16138282|NCT03285178|38993295|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16138283|NCT03285178|38993296|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16138284|NCT03285178|38993297|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16138285|NCT03285178|38993298|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16138286|NCT03285178|38993299|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
16138287|NCT03285178|38993300|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16436692|NCT00447226|40077808|FG001|12-Week Open-label Phase|Protocol Violation|1|||
16436693|NCT00447226|40077807|FG000|12-Week Open-label Phase|Disease Progression|0|||
16253940|NCT03322462|39413110|FG000|Overall Study|Other|1|||
16253941|NCT00922974|39413111|FG000|Phase II Component|Protocol Violation|2|||
16253942|NCT00922974|39413112|FG001|Phase II Component|Protocol Violation|0|||
16253943|NCT00922974|39413111|FG000|Phase II Component|Not evaluable for treatment review|5|||
16253944|NCT00922974|39413112|FG001|Phase II Component|Not evaluable for treatment review|0|||
16253945|NCT00922974|39413111|FG000|Phase III Component|Protocol Violation|8|||
16253946|NCT00922974|39413112|FG001|Phase III Component|Protocol Violation|6|||
16253947|NCT02336737|39413114|FG000|Overall Study|Withdrawal by Subject|5|||
16253948|NCT02336737|39413114|FG000|Overall Study|Physician Decision|8|||
16253949|NCT01439165|39413115|FG000|Overall Study|Protocol Violation|3|||
16253950|NCT01439165|39413116|FG001|Overall Study|Protocol Violation|0|||
16253951|NCT01439165|39413115|FG000|Overall Study|Lost to Follow-up|11|||
16253952|NCT01439165|39413116|FG001|Overall Study|Lost to Follow-up|1|||
16253953|NCT01439165|39413115|FG000|Overall Study|Withdrawal by Subject|7|||
16253954|NCT01439165|39413116|FG001|Overall Study|Withdrawal by Subject|1|||
16253955|NCT03687736|39413125|FG000|Overall Study|Lost to Follow-up|7|||
16253956|NCT03687736|39413125|FG000|Overall Study|Withdrawal by Subject|3|||
16253957|NCT00586521|39413126|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
16253958|NCT01374919|39413127|FG000|Overall Study|Withdrawal by Subject|2|||
16253959|NCT01485536|39413128|FG000|Overall Study|Withdrawal by Subject|3|||
16253960|NCT01485536|39413128|FG000|Overall Study|Adverse Event|1|||
16253961|NCT01249664|39413129|FG000|Overall Study|Withdrawal by Subject|5|||
16253962|NCT01249664|39413130|FG001|Overall Study|Withdrawal by Subject|0|||
16253963|NCT01249664|39413129|FG000|Overall Study|Adverse Event|1|||
16253964|NCT01249664|39413130|FG001|Overall Study|Adverse Event|0|||
16253965|NCT00497796|39413131|FG000|Overall Study|Adverse event (not related)|9|||
16253966|NCT00497796|39413132|FG001|Overall Study|Adverse event (not related)|9|||
16253967|NCT00497796|39413131|FG000|Overall Study|Adverse event (related)|5|||
16253968|NCT00497796|39413132|FG001|Overall Study|Adverse event (related)|4|||
16253969|NCT00497796|39413131|FG000|Overall Study|CMV infection or disease treatment|30|||
16138288|NCT03285178|38993294|FG000|Double-Blind Treatment Period|COVID-19|0|||
16138289|NCT03285178|38993295|FG001|Double-Blind Treatment Period|COVID-19|0|||
16138290|NCT03285178|38993296|FG002|Double-Blind Treatment Period|COVID-19|1|||
16138291|NCT03285178|38993297|FG003|Double-Blind Treatment Period|COVID-19|0|||
16138292|NCT03285178|38993298|FG004|Double-Blind Treatment Period|COVID-19|0|||
16138293|NCT03285178|38993299|FG005|Double-Blind Treatment Period|COVID-19|0|||
16138294|NCT03285178|38993300|FG006|Double-Blind Treatment Period|COVID-19|0|||
16138295|NCT03231943|38993301|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138296|NCT03231943|38993302|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
16138297|NCT03231943|38993303|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
16138298|NCT03231943|38993304|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138299|NCT03231943|38993305|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138300|NCT03231943|38993306|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138301|NCT03231943|38993307|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138302|NCT03231943|38993308|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138303|NCT03231943|38993309|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138304|NCT03231943|38993310|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138305|NCT03231943|38993311|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138306|NCT03231943|38993312|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138307|NCT03231943|38993313|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
16138308|NCT03231943|38993301|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138309|NCT03231943|38993302|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
16138310|NCT03231943|38993303|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138311|NCT03231943|38993304|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138312|NCT03231943|38993305|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138313|NCT03231943|38993306|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138314|NCT03231943|38993307|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138315|NCT03231943|38993308|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138316|NCT03231943|38993309|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138317|NCT03231943|38993310|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138318|NCT03231943|38993311|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138319|NCT03231943|38993312|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138320|NCT03231943|38993313|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
16138321|NCT03231943|38993301|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
16138322|NCT03231943|38993302|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138323|NCT03231943|38993303|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138324|NCT03231943|38993304|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138325|NCT03231943|38993305|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138326|NCT03231943|38993306|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138327|NCT03231943|38993307|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138328|NCT03231943|38993308|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138329|NCT03231943|38993309|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16436694|NCT00447226|40077808|FG001|12-Week Open-label Phase|Disease Progression|20|||
16436695|NCT00447226|40077807|FG000|12-Week Open-label Phase|Physician Decision|0|||
16436696|NCT00447226|40077808|FG001|12-Week Open-label Phase|Physician Decision|1|||
16436697|NCT00447226|40077807|FG000|Double-blind Phase|Disease Progression|4|||
16436698|NCT00447226|40077808|FG001|Double-blind Phase|Disease Progression|3|||
16138330|NCT03231943|38993310|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138331|NCT03231943|38993311|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138332|NCT03231943|38993312|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138333|NCT03231943|38993313|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
16138334|NCT03231943|38993301|FG000|Part 2|Adverse Event|0|||
16138335|NCT03231943|38993302|FG001|Part 2|Adverse Event|0|||
16138336|NCT03231943|38993303|FG002|Part 2|Adverse Event|0|||
16138337|NCT03231943|38993304|FG003|Part 2|Adverse Event|0|||
16138338|NCT03231943|38993305|FG004|Part 2|Adverse Event|0|||
16138339|NCT03231943|38993306|FG005|Part 2|Adverse Event|0|||
16138340|NCT03231943|38993307|FG006|Part 2|Adverse Event|0|||
16138341|NCT03231943|38993308|FG007|Part 2|Adverse Event|0|||
16138342|NCT03231943|38993309|FG008|Part 2|Adverse Event|0|||
16138343|NCT03231943|38993310|FG009|Part 2|Adverse Event|0|||
16138344|NCT03231943|38993311|FG010|Part 2|Adverse Event|1|||
16138345|NCT03231943|38993312|FG011|Part 2|Adverse Event|0|||
16138346|NCT03231943|38993313|FG012|Part 2|Adverse Event|0|||
16138347|NCT03231943|38993301|FG000|Part 2|Withdrawal by Subject|0|||
16138348|NCT03231943|38993302|FG001|Part 2|Withdrawal by Subject|0|||
16138349|NCT03231943|38993303|FG002|Part 2|Withdrawal by Subject|0|||
16138350|NCT03231943|38993304|FG003|Part 2|Withdrawal by Subject|0|||
16138351|NCT03231943|38993305|FG004|Part 2|Withdrawal by Subject|0|||
16138352|NCT03231943|38993306|FG005|Part 2|Withdrawal by Subject|0|||
16253970|NCT00497796|39413132|FG001|Overall Study|CMV infection or disease treatment|4|||
16138353|NCT03231943|38993307|FG006|Part 2|Withdrawal by Subject|0|||
16253971|NCT00497796|39413131|FG000|Overall Study|Consent withdrawn|10|||
16436699|NCT00079040|40077812|FG000|Overall Study|Withdrew before treatment|1|||
16253972|NCT00497796|39413132|FG001|Overall Study|Consent withdrawn|3|||
16253973|NCT00497796|39413131|FG000|Overall Study|Investigator/sponsor discretion|31|||
16253974|NCT00497796|39413132|FG001|Overall Study|Investigator/sponsor discretion|34|||
16253975|NCT00497796|39413131|FG000|Overall Study|Lost to Follow-up|0|||
16253976|NCT00497796|39413132|FG001|Overall Study|Lost to Follow-up|1|||
16253977|NCT00497796|39413131|FG000|Overall Study|Not applicable (randomized not treated)|0|||
16253978|NCT00497796|39413132|FG001|Overall Study|Not applicable (randomized not treated)|4|||
16253979|NCT02339909|39413134|FG000|Overall Study|Became ineligible after randomisation|89|||
16253980|NCT02339909|39413135|FG001|Overall Study|Became ineligible after randomisation|63|||
16253981|NCT02339909|39413136|FG002|Overall Study|Became ineligible after randomisation|71|||
16253982|NCT02623829|39413137|FG000|Overall Study|Lost to Follow-up|1|||
16253983|NCT02623829|39413138|FG001|Overall Study|Lost to Follow-up|1|||
16253984|NCT02247479|39413139|FG000|Overall Study|Adverse Event|8|||
16253985|NCT02247479|39413140|FG001|Overall Study|Adverse Event|9|||
16253986|NCT02247479|39413141|FG002|Overall Study|Adverse Event|8|||
16253987|NCT02247479|39413139|FG000|Overall Study|Death|5|||
16253988|NCT02247479|39413140|FG001|Overall Study|Death|4|||
16253989|NCT02247479|39413141|FG002|Overall Study|Death|6|||
16253990|NCT02247479|39413139|FG000|Overall Study|Lost to Follow-up|3|||
16253991|NCT02247479|39413140|FG001|Overall Study|Lost to Follow-up|3|||
16253992|NCT02247479|39413141|FG002|Overall Study|Lost to Follow-up|1|||
16253993|NCT02247479|39413139|FG000|Overall Study|Non-compliance|0|||
16253994|NCT02247479|39413140|FG001|Overall Study|Non-compliance|0|||
16253995|NCT02247479|39413141|FG002|Overall Study|Non-compliance|1|||
16253996|NCT02247479|39413139|FG000|Overall Study|Withdrawal by Subject|25|||
16253997|NCT02247479|39413140|FG001|Overall Study|Withdrawal by Subject|29|||
16253998|NCT02247479|39413141|FG002|Overall Study|Withdrawal by Subject|24|||
16253999|NCT02247479|39413139|FG000|Overall Study|Study Terminated by Sponsor|98|||
16254000|NCT02247479|39413140|FG001|Overall Study|Study Terminated by Sponsor|88|||
16254001|NCT02247479|39413141|FG002|Overall Study|Study Terminated by Sponsor|94|||
16254002|NCT02247479|39413139|FG000|Overall Study|Physician Decision|1|||
16254003|NCT02247479|39413140|FG001|Overall Study|Physician Decision|0|||
16254004|NCT02247479|39413141|FG002|Overall Study|Physician Decision|2|||
16254005|NCT02247479|39413139|FG000|Overall Study|Unspecified Reason|2|||
16254006|NCT02247479|39413140|FG001|Overall Study|Unspecified Reason|5|||
16362944|NCT00620542|39814953|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
16362945|NCT00620542|39814954|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
16362946|NCT00620542|39814955|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
16362947|NCT00620542|39814952|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
16362948|NCT00620542|39814953|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
16362949|NCT00620542|39814954|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
16362950|NCT00620542|39814955|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
16362951|NCT00620542|39814952|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
16362952|NCT00620542|39814953|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
16362953|NCT00620542|39814954|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
16362954|NCT00620542|39814955|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
16436700|NCT00079040|40077812|FG000|Overall Study|Ineligible|1|||
16436701|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
16436702|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
16436703|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
16436704|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
16436705|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
16436706|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
16436707|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
16436708|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
16254007|NCT02247479|39413141|FG002|Overall Study|Unspecified Reason|2|||
16254008|NCT03294538|39413144|FG000|Overall Study|Adverse Event|0|||
16254009|NCT03294538|39413145|FG001|Overall Study|Adverse Event|1|||
16254010|NCT03294538|39413146|FG002|Overall Study|Adverse Event|1|||
16254011|NCT03294538|39413144|FG000|Overall Study|Lost to Follow-up|1|||
16254012|NCT03294538|39413145|FG001|Overall Study|Lost to Follow-up|0|||
16254013|NCT03294538|39413146|FG002|Overall Study|Lost to Follow-up|0|||
16254014|NCT03294538|39413144|FG000|Overall Study|Outside of Visit Window|4|||
16254015|NCT03294538|39413145|FG001|Overall Study|Outside of Visit Window|4|||
16362955|NCT00620542|39814952|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
16254016|NCT03294538|39413146|FG002|Overall Study|Outside of Visit Window|1|||
16254017|NCT00582309|39413148|FG000|Overall Study|Protocol Violation|0|||
16254018|NCT00582309|39413149|FG001|Overall Study|Protocol Violation|0|||
16254019|NCT00582309|39413150|FG002|Overall Study|Protocol Violation|2|||
16254020|NCT00948675|39413156|FG000|Overall Study|Lost to Follow-up|1|||
16254021|NCT00948675|39413157|FG001|Overall Study|Lost to Follow-up|0|||
16254022|NCT00421174|39413158|FG000|Overall Study|Withdrawal by Subject|0|||
16254023|NCT00421174|39413159|FG001|Overall Study|Withdrawal by Subject|1|||
16254024|NCT00421174|39413158|FG000|Overall Study|Ineligible due to infection|2|||
16254025|NCT00421174|39413159|FG001|Overall Study|Ineligible due to infection|0|||
16254026|NCT03267277|39413167|FG000|Overall Study|Withdrawal by Subject|1|||
16254027|NCT00356200|39413168|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
16254028|NCT00356200|39413169|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
16254029|NCT00356200|39413168|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
16254030|NCT00356200|39413169|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
16254031|NCT01941095|39413170|FG000|Overall Study|Insufficient therapeutic response|13|||
16254032|NCT01941095|39413170|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
16254033|NCT01941095|39413170|FG000|Overall Study|Adverse Event|11|||
16254034|NCT01941095|39413170|FG000|Overall Study|Physician Decision|3|||
16254035|NCT01941095|39413170|FG000|Overall Study|Withdrawal by Subject|17|||
16254036|NCT01941095|39413170|FG000|Overall Study|Lost to Follow-up|10|||
16254037|NCT00423800|39413171|FG000|Overall Study|Protocol Violation|0|||
16254038|NCT00423800|39413172|FG001|Overall Study|Protocol Violation|1|||
16254039|NCT00658320|39413175|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
16254040|NCT00658320|39413176|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
16254041|NCT00658320|39413175|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
16254042|NCT00658320|39413176|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
16254043|NCT00658320|39413175|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
16254044|NCT00658320|39413176|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
16254045|NCT00658320|39413175|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
16254046|NCT00658320|39413176|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
16254047|NCT03481309|39413183|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
16254048|NCT03481309|39413184|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
16254049|NCT03481309|39413185|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
16254050|NCT03481309|39413186|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
16254051|NCT03481309|39413187|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
16254052|NCT03481309|39413188|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
16254053|NCT02603952|39413191|FG000|Overall Study|Withdrawal by Subject|1|||
16254054|NCT02603952|39413192|FG001|Overall Study|Withdrawal by Subject|0|||
16254055|NCT02603952|39413193|FG002|Overall Study|Withdrawal by Subject|0|||
16254056|NCT02603952|39413194|FG003|Overall Study|Withdrawal by Subject|0|||
16254057|NCT02603952|39413191|FG000|Overall Study|Received oseltamivir by error|0|||
16254058|NCT02603952|39413192|FG001|Overall Study|Received oseltamivir by error|0|||
16254059|NCT02603952|39413193|FG002|Overall Study|Received oseltamivir by error|0|||
16254060|NCT02603952|39413194|FG003|Overall Study|Received oseltamivir by error|1|||
16254061|NCT02427607|39413199|FG000|Overall Study|Withdrawal by Subject|1|||
16254062|NCT04625114|39413200|FG000|Overall Study|Adverse Event|3|||
16254063|NCT04625114|39413201|FG001|Overall Study|Adverse Event|1|||
16254064|NCT04625114|39413200|FG000|Overall Study|Withdrawal by Subject|2|||
16254065|NCT04625114|39413201|FG001|Overall Study|Withdrawal by Subject|0|||
16254066|NCT02343120|39413202|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
16254067|NCT02343120|39413203|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
16254068|NCT02343120|39413204|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
16254069|NCT02343120|39413205|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
16254070|NCT02343120|39413206|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
16254071|NCT02343120|39413202|FG000|Part 1: Dose Escalation|Death|1|||
16254072|NCT02343120|39413203|FG001|Part 1: Dose Escalation|Death|2|||
16254073|NCT02343120|39413204|FG002|Part 1: Dose Escalation|Death|2|||
16362956|NCT00620542|39814953|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
16254074|NCT02343120|39413205|FG003|Part 1: Dose Escalation|Death|2|||
16254075|NCT02343120|39413206|FG004|Part 1: Dose Escalation|Death|1|||
16362957|NCT00620542|39814954|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
16254076|NCT02343120|39413202|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
16254077|NCT02343120|39413203|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
16254078|NCT02343120|39413204|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
16254079|NCT02343120|39413205|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
16254080|NCT02343120|39413206|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
16254081|NCT02343120|39413202|FG000|Part 2: Expansion|Sponsor decision|0|||
16254082|NCT02343120|39413203|FG001|Part 2: Expansion|Sponsor decision|0|||
16254083|NCT02343120|39413204|FG002|Part 2: Expansion|Sponsor decision|0|||
16254084|NCT02343120|39413205|FG003|Part 2: Expansion|Sponsor decision|165|||
16254085|NCT02343120|39413206|FG004|Part 2: Expansion|Sponsor decision|67|||
16254086|NCT02343120|39413202|FG000|Part 2: Expansion|Death|0|||
16254087|NCT02343120|39413203|FG001|Part 2: Expansion|Death|0|||
16254088|NCT02343120|39413204|FG002|Part 2: Expansion|Death|0|||
16254089|NCT02343120|39413205|FG003|Part 2: Expansion|Death|74|||
16138354|NCT03231943|38993308|FG007|Part 2|Withdrawal by Subject|0|||
16138355|NCT03231943|38993309|FG008|Part 2|Withdrawal by Subject|0|||
16138356|NCT03231943|38993310|FG009|Part 2|Withdrawal by Subject|0|||
16138357|NCT03231943|38993311|FG010|Part 2|Withdrawal by Subject|0|||
16138358|NCT03231943|38993312|FG011|Part 2|Withdrawal by Subject|1|||
16138359|NCT03231943|38993313|FG012|Part 2|Withdrawal by Subject|0|||
16138360|NCT02742766|38993314|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138361|NCT02742766|38993315|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138362|NCT02742766|38993316|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138363|NCT02742766|38993317|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138364|NCT02742766|38993318|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138365|NCT02742766|38993319|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138366|NCT02742766|38993320|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138367|NCT02742766|38993321|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138368|NCT02742766|38993322|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138369|NCT02742766|38993323|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138370|NCT02742766|38993324|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138371|NCT02742766|38993325|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138372|NCT02742766|38993326|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138373|NCT02742766|38993327|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
16138374|NCT02742766|38993328|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138375|NCT02742766|38993329|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138376|NCT02742766|38993330|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138377|NCT02742766|38993331|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138378|NCT02742766|38993332|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
16138379|NCT02742766|38993314|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138380|NCT02742766|38993315|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138381|NCT02742766|38993316|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138382|NCT02742766|38993317|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138383|NCT02742766|38993318|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138384|NCT02742766|38993319|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138385|NCT02742766|38993320|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138386|NCT02742766|38993321|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138387|NCT02742766|38993322|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138388|NCT02742766|38993323|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138389|NCT02742766|38993324|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138390|NCT02742766|38993325|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138391|NCT02742766|38993326|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
16138392|NCT02742766|38993327|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
16138393|NCT02742766|38993328|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138394|NCT02742766|38993329|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
16138395|NCT02742766|38993330|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138396|NCT02742766|38993331|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138397|NCT02742766|38993332|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
16138398|NCT01016964|38993333|FG000|Overall Study|Lost to Follow-up|3|||
16138399|NCT01016964|38993334|FG001|Overall Study|Lost to Follow-up|3|||
16138400|NCT00041067|38993335|FG000|Overall Study|Adverse Event|20|||
16254090|NCT02343120|39413206|FG004|Part 2: Expansion|Death|17|||
16254091|NCT02343120|39413202|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
16254092|NCT02343120|39413203|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
16254093|NCT02343120|39413204|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
16254094|NCT02343120|39413205|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
16254095|NCT02343120|39413206|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
16254096|NCT02343120|39413202|FG000|Part 2: Expansion|Lost to Follow-up|0|||
16254097|NCT02343120|39413203|FG001|Part 2: Expansion|Lost to Follow-up|0|||
16254098|NCT02343120|39413204|FG002|Part 2: Expansion|Lost to Follow-up|0|||
16254099|NCT02343120|39413205|FG003|Part 2: Expansion|Lost to Follow-up|5|||
16254100|NCT02343120|39413206|FG004|Part 2: Expansion|Lost to Follow-up|2|||
16254101|NCT02343120|39413202|FG000|Part 2: Expansion|Other|0|||
16254102|NCT02343120|39413203|FG001|Part 2: Expansion|Other|0|||
16254103|NCT02343120|39413204|FG002|Part 2: Expansion|Other|0|||
16254104|NCT02343120|39413205|FG003|Part 2: Expansion|Other|1|||
16254105|NCT02343120|39413206|FG004|Part 2: Expansion|Other|5|||
16254106|NCT02343120|39413202|FG000|Part 2: Expansion|Adverse Event|0|||
16254107|NCT02343120|39413203|FG001|Part 2: Expansion|Adverse Event|0|||
16254108|NCT02343120|39413204|FG002|Part 2: Expansion|Adverse Event|0|||
16254109|NCT02343120|39413205|FG003|Part 2: Expansion|Adverse Event|1|||
16254110|NCT02343120|39413206|FG004|Part 2: Expansion|Adverse Event|1|||
16254111|NCT02277769|39413207|FG000|Overall Study|Protocol Violation|3|||
16254112|NCT02277769|39413208|FG001|Overall Study|Protocol Violation|3|||
16254113|NCT02277769|39413209|FG002|Overall Study|Protocol Violation|5|||
16254114|NCT02277769|39413207|FG000|Overall Study|Lack of Efficacy|17|||
16254115|NCT02277769|39413208|FG001|Overall Study|Lack of Efficacy|0|||
16254116|NCT02277769|39413209|FG002|Overall Study|Lack of Efficacy|4|||
16254117|NCT02277769|39413207|FG000|Overall Study|Adverse Event|14|||
16254118|NCT02277769|39413208|FG001|Overall Study|Adverse Event|2|||
16254119|NCT02277769|39413209|FG002|Overall Study|Adverse Event|4|||
16254120|NCT02277769|39413207|FG000|Overall Study|Other than specified above|12|||
16254121|NCT02277769|39413208|FG001|Overall Study|Other than specified above|8|||
16254122|NCT02277769|39413209|FG002|Overall Study|Other than specified above|5|||
16254123|NCT02270736|39413210|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
16254124|NCT02270736|39413211|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
16254125|NCT02270736|39413212|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
16254126|NCT02270736|39413213|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
16254127|NCT02270736|39413214|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
16254128|NCT02270736|39413210|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
16254129|NCT02270736|39413211|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
16254130|NCT02270736|39413212|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
16254131|NCT02270736|39413213|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
16254132|NCT02270736|39413214|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
16254133|NCT02270736|39413210|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
16254134|NCT02270736|39413211|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
16254135|NCT02270736|39413212|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
16254136|NCT02270736|39413213|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
16254137|NCT02270736|39413214|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
16254138|NCT02270736|39413210|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
16254139|NCT02270736|39413211|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
16254140|NCT02270736|39413212|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
16254141|NCT02270736|39413213|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
16254142|NCT02270736|39413214|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
16254143|NCT02270736|39413210|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
16254144|NCT02270736|39413211|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
16254145|NCT02270736|39413212|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
16254146|NCT02270736|39413213|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
16254147|NCT02270736|39413214|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
16254148|NCT02270736|39413210|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
16254149|NCT02270736|39413211|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
16254150|NCT02270736|39413212|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
16254151|NCT02270736|39413213|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
16254152|NCT02270736|39413214|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
16254153|NCT02270736|39413210|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
16254154|NCT02270736|39413211|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
16254155|NCT02270736|39413212|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
16254156|NCT02270736|39413213|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
16254157|NCT02270736|39413214|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
16254158|NCT02270736|39413210|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
16254159|NCT02270736|39413211|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
16254160|NCT02270736|39413212|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
16254161|NCT02270736|39413213|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
16254162|NCT02270736|39413214|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
16254163|NCT02270736|39413210|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
16254164|NCT02270736|39413211|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
16254165|NCT02270736|39413212|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
16254166|NCT02270736|39413213|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
16254167|NCT02270736|39413214|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
16254168|NCT00777829|39413215|FG000|Overall Study|Withdrawal by Subject|0|||
16254169|NCT00777829|39413216|FG001|Overall Study|Withdrawal by Subject|2|||
16254170|NCT00782509|39413217|FG000|Overall Study|Adverse Event|20|||
16254171|NCT00782509|39413218|FG001|Overall Study|Adverse Event|10|||
16254172|NCT00782509|39413219|FG002|Overall Study|Adverse Event|20|||
16254173|NCT00782509|39413217|FG000|Overall Study|Lost to Follow-up|1|||
16254174|NCT00782509|39413218|FG001|Overall Study|Lost to Follow-up|2|||
16254175|NCT00782509|39413219|FG002|Overall Study|Lost to Follow-up|3|||
16254176|NCT00782509|39413217|FG000|Overall Study|Withdrawal by Subject|3|||
16254177|NCT00782509|39413218|FG001|Overall Study|Withdrawal by Subject|5|||
16254178|NCT00782509|39413219|FG002|Overall Study|Withdrawal by Subject|8|||
16254179|NCT00782509|39413217|FG000|Overall Study|Non compliance with protocol|2|||
16254180|NCT00782509|39413218|FG001|Overall Study|Non compliance with protocol|0|||
16254181|NCT00782509|39413219|FG002|Overall Study|Non compliance with protocol|0|||
16254182|NCT00782509|39413217|FG000|Overall Study|Other reasons not stated above|5|||
16254183|NCT00782509|39413218|FG001|Overall Study|Other reasons not stated above|2|||
16254184|NCT00782509|39413219|FG002|Overall Study|Other reasons not stated above|3|||
16254185|NCT00782509|39413217|FG000|Overall Study|Lack of Efficacy|10|||
16254186|NCT00782509|39413218|FG001|Overall Study|Lack of Efficacy|5|||
16436709|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
16436710|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
16436711|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
16436712|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
16436713|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
16436714|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
16436715|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
16436716|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
16436717|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
16436718|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
16436719|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
16138401|NCT00041067|38993335|FG000|Overall Study|Progression|19|||
16138402|NCT00041067|38993335|FG000|Overall Study|Patient refusal|12|||
16138403|NCT00041067|38993335|FG000|Overall Study|Other reasons|23|||
16138404|NCT00041067|38993335|FG000|Overall Study|Ineligible|2|||
16138405|NCT02594163|38993336|FG000|Treatment Period|Progressive disease|2|||
16138406|NCT02594163|38993337|FG001|Treatment Period|Progressive disease|3|||
16138407|NCT02594163|38993336|FG000|Treatment Period|Adverse Event|1|||
16138408|NCT02594163|38993337|FG001|Treatment Period|Adverse Event|5|||
16138409|NCT02594163|38993336|FG000|Treatment Period|Physician Decision|1|||
16138410|NCT02594163|38993337|FG001|Treatment Period|Physician Decision|3|||
16138411|NCT02594163|38993336|FG000|Treatment Period|Study termination by sponsor|2|||
16138412|NCT02594163|38993337|FG001|Treatment Period|Study termination by sponsor|1|||
16138413|NCT02594163|38993336|FG000|Treatment Period|Other, Non-AE|1|||
16138414|NCT02594163|38993337|FG001|Treatment Period|Other, Non-AE|0|||
16138415|NCT02594163|38993336|FG000|Follow-up Period|Withdrawal by Subject|0|||
16138416|NCT02594163|38993337|FG001|Follow-up Period|Withdrawal by Subject|1|||
16138417|NCT02594163|38993336|FG000|Follow-up Period|Study Termination by Sponsor|6|||
16138418|NCT02594163|38993337|FG001|Follow-up Period|Study Termination by Sponsor|4|||
16138419|NCT02594163|38993336|FG000|Follow-up Period|Lost to Follow-up|1|||
16138420|NCT02594163|38993337|FG001|Follow-up Period|Lost to Follow-up|0|||
16138421|NCT02594163|38993336|FG000|Follow-up Period|Death|2|||
16138422|NCT02594163|38993337|FG001|Follow-up Period|Death|5|||
16138423|NCT02594163|38993336|FG000|Follow-up Period|Adverse Event|0|||
16138424|NCT02594163|38993337|FG001|Follow-up Period|Adverse Event|1|||
16138425|NCT02594163|38993336|FG000|Follow-up Period|Progressive Disease|2|||
16138426|NCT02594163|38993337|FG001|Follow-up Period|Progressive Disease|0|||
16138427|NCT02594163|38993336|FG000|Follow-up Period|Physician Decision|0|||
16138428|NCT02594163|38993337|FG001|Follow-up Period|Physician Decision|1|||
16138429|NCT00084266|38993340|FG000|Overall Study|Death|42|||
16138430|NCT00084266|38993341|FG001|Overall Study|Death|39|||
16138431|NCT00084266|38993340|FG000|Overall Study|Adverse Event|8|||
16138432|NCT00084266|38993341|FG001|Overall Study|Adverse Event|5|||
16138433|NCT00084266|38993340|FG000|Overall Study|Lack of Efficacy|2|||
16138434|NCT00084266|38993341|FG001|Overall Study|Lack of Efficacy|4|||
16138435|NCT00084266|38993340|FG000|Overall Study|Lost to Follow-up|5|||
16138436|NCT00084266|38993341|FG001|Overall Study|Lost to Follow-up|3|||
16138437|NCT00084266|38993340|FG000|Overall Study|Participant not willing to participate|3|||
16138438|NCT00084266|38993341|FG001|Overall Study|Participant not willing to participate|8|||
16138439|NCT00084266|38993340|FG000|Overall Study|Other|360|||
16138440|NCT00084266|38993341|FG001|Overall Study|Other|344|||
16138441|NCT00084266|38993340|FG000|Overall Study|Randomized not treated|21|||
16138442|NCT00084266|38993341|FG001|Overall Study|Randomized not treated|20|||
16138443|NCT01498289|38993342|FG000|Overall Study|Adverse Event|16|||
16138444|NCT01498289|38993343|FG001|Overall Study|Adverse Event|18|||
16138445|NCT01498289|38993342|FG000|Overall Study|Death|6|||
16138446|NCT01498289|38993343|FG001|Overall Study|Death|8|||
16138447|NCT01498289|38993342|FG000|Overall Study|Withdrawal unrelated to AE|16|||
16138448|NCT01498289|38993343|FG001|Overall Study|Withdrawal unrelated to AE|16|||
16138449|NCT01498289|38993342|FG000|Overall Study|Progression/relapse|53|||
16138450|NCT01498289|38993343|FG001|Overall Study|Progression/relapse|59|||
16138451|NCT01498289|38993342|FG000|Overall Study|Not protocol specified|7|||
16138452|NCT01498289|38993343|FG001|Overall Study|Not protocol specified|2|||
16138453|NCT01498289|38993342|FG000|Overall Study|Reason under review|0|||
16138454|NCT01498289|38993343|FG001|Overall Study|Reason under review|1|||
16138455|NCT04880447|38993344|FG000|Overall Study|No vaccination information|1|||
16138456|NCT04880447|38993344|FG000|Overall Study|No adverse event information (missing information)|1|||
16138457|NCT04880447|38993344|FG000|Overall Study|Disease not covered in this study|35|||
16138458|NCT00567268|38993346|FG000|Overall Study|Protocol Violation|7|||
16138459|NCT00567268|38993346|FG000|Overall Study|Lost to Follow-up|36|||
16138460|NCT00567268|38993346|FG000|Overall Study|No Visit After First Day of Treatment|2|||
16138461|NCT00567268|38993346|FG000|Overall Study|No Drug Administration|4|||
16138462|NCT00567268|38993346|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
16138463|NCT02881957|38993347|FG000|Overall Study|Comfort care|0|||
16138464|NCT02881957|38993348|FG001|Overall Study|Comfort care|1|||
16138465|NCT02881957|38993347|FG000|Overall Study|Concurrent trial enrollment|0|||
16138466|NCT02881957|38993348|FG001|Overall Study|Concurrent trial enrollment|1|||
16138467|NCT02881957|38993347|FG000|Overall Study|Discharged within 48 hours|0|||
16138468|NCT02881957|38993348|FG001|Overall Study|Discharged within 48 hours|1|||
16138469|NCT02881957|38993347|FG000|Overall Study|Withdrawal by Subject|2|||
16138470|NCT02881957|38993348|FG001|Overall Study|Withdrawal by Subject|1|||
16254187|NCT00782509|39413219|FG002|Overall Study|Lack of Efficacy|2|||
16436720|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
16436721|NCT03573323|40077813|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
16436722|NCT03573323|40077814|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
16436723|NCT03573323|40077813|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
16436724|NCT03573323|40077814|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
16436725|NCT03573323|40077813|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
16436726|NCT03573323|40077814|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
16436727|NCT03573323|40077813|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
16436728|NCT03573323|40077814|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
16436729|NCT03573323|40077813|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
16436730|NCT03573323|40077814|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
16436731|NCT03573323|40077813|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
16436732|NCT03573323|40077814|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
16436733|NCT03573323|40077813|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
16138471|NCT02881957|38993347|FG000|Overall Study|Protocol Violation|1|||
16254188|NCT02729896|39413223|FG000|Overall Study|Death|0|||
16254189|NCT02729896|39413224|FG001|Overall Study|Death|2|||
16254190|NCT02729896|39413225|FG002|Overall Study|Death|13|||
16254191|NCT02729896|39413223|FG000|Overall Study|Lost to Follow-up|0|||
16254192|NCT02729896|39413224|FG001|Overall Study|Lost to Follow-up|2|||
16254193|NCT02729896|39413225|FG002|Overall Study|Lost to Follow-up|3|||
16254194|NCT02729896|39413223|FG000|Overall Study|Other|0|||
16254195|NCT02729896|39413224|FG001|Overall Study|Other|2|||
16254196|NCT02729896|39413225|FG002|Overall Study|Other|0|||
16362958|NCT00620542|39814955|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
16362959|NCT00620542|39814952|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
16362960|NCT00620542|39814953|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
16362961|NCT00620542|39814954|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
16362962|NCT00620542|39814955|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
16362963|NCT00620542|39814952|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
16362964|NCT00620542|39814953|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
16362965|NCT00620542|39814954|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
16362966|NCT00620542|39814955|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
16362967|NCT00620542|39814952|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
16362968|NCT00620542|39814953|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
16362969|NCT00620542|39814954|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
16362970|NCT00620542|39814955|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
16362971|NCT00620542|39814952|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
16362972|NCT00620542|39814953|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
16362973|NCT00620542|39814954|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
16362974|NCT00620542|39814955|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
16362975|NCT00620542|39814952|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
16362976|NCT00620542|39814953|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
16362977|NCT00620542|39814954|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
16362978|NCT00620542|39814955|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
16362979|NCT00620542|39814952|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
16362980|NCT00620542|39814953|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
16362981|NCT00620542|39814954|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
16362982|NCT00620542|39814955|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
16362983|NCT00620542|39814952|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
16362984|NCT00620542|39814953|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
16362985|NCT00620542|39814954|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
16362986|NCT00620542|39814955|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
16362987|NCT00620542|39814952|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
16362988|NCT00620542|39814953|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
16362989|NCT00620542|39814954|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
16362990|NCT00620542|39814955|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
16362991|NCT00620542|39814952|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
16254197|NCT02729896|39413223|FG000|Overall Study|Physician Decision|1|||
16436734|NCT03573323|40077814|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
16436735|NCT03573323|40077813|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
16436736|NCT03573323|40077814|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
16436737|NCT03573323|40077813|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
16436738|NCT03573323|40077814|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
16436739|NCT01731912|40077817|FG000|Overall Study|noncompliance|2|||
16436740|NCT00982735|40077823|FG000|Overall Study|Lost to Follow-up|6|||
16436741|NCT00982735|40077823|FG000|Overall Study|Patient ineligible for trial|224|||
16436742|NCT01129622|40077828|FG000|Overall Study|Withdrawal by Subject|2|||
16436743|NCT00531284|40077829|FG000|Overall Study|Progressive Disease|1|||
16436744|NCT00531284|40077830|FG001|Overall Study|Progressive Disease|3|||
16436745|NCT00531284|40077831|FG002|Overall Study|Progressive Disease|5|||
16436746|NCT00531284|40077832|FG003|Overall Study|Progressive Disease|42|||
16436747|NCT00531284|40077833|FG004|Overall Study|Progressive Disease|4|||
16436748|NCT00531284|40077834|FG005|Overall Study|Progressive Disease|4|||
16436749|NCT00531284|40077835|FG006|Overall Study|Progressive Disease|3|||
16436750|NCT00531284|40077836|FG007|Overall Study|Progressive Disease|8|||
16436751|NCT00531284|40077837|FG008|Overall Study|Progressive Disease|6|||
16436752|NCT00531284|40077838|FG009|Overall Study|Progressive Disease|3|||
16436753|NCT00531284|40077839|FG010|Overall Study|Progressive Disease|3|||
16436754|NCT00531284|40077840|FG011|Overall Study|Progressive Disease|14|||
16436755|NCT00531284|40077841|FG012|Overall Study|Progressive Disease|2|||
16436756|NCT00531284|40077842|FG013|Overall Study|Progressive Disease|1|||
16436757|NCT00531284|40077843|FG014|Overall Study|Progressive Disease|2|||
16436758|NCT00531284|40077844|FG015|Overall Study|Progressive Disease|11|||
16436759|NCT00531284|40077845|FG016|Overall Study|Progressive Disease|5|||
16436760|NCT00531284|40077829|FG000|Overall Study|Adverse Event|0|||
16362992|NCT00620542|39814953|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
16362993|NCT00620542|39814954|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
16362994|NCT00620542|39814955|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
16362995|NCT02364557|39814956|FG000|Overall Study|Protocol Violation|3|||
16362996|NCT02364557|39814957|FG001|Overall Study|Protocol Violation|1|||
16362997|NCT01991795|39814958|FG000|Overall Study|Lost to Follow-up|6|||
16362998|NCT01991795|39814959|FG001|Overall Study|Lost to Follow-up|4|||
16362999|NCT01991795|39814958|FG000|Overall Study|Withdrawal by Subject|117|||
16363000|NCT01991795|39814959|FG001|Overall Study|Withdrawal by Subject|94|||
16363001|NCT01991795|39814958|FG000|Overall Study|Site prematurely closed by sponsor|26|||
16436761|NCT00531284|40077830|FG001|Overall Study|Adverse Event|1|||
16436762|NCT00531284|40077831|FG002|Overall Study|Adverse Event|1|||
16436763|NCT00531284|40077832|FG003|Overall Study|Adverse Event|7|||
16436764|NCT00531284|40077833|FG004|Overall Study|Adverse Event|0|||
16436765|NCT00531284|40077834|FG005|Overall Study|Adverse Event|2|||
16436766|NCT00531284|40077835|FG006|Overall Study|Adverse Event|3|||
16436767|NCT00531284|40077836|FG007|Overall Study|Adverse Event|2|||
16436768|NCT00531284|40077837|FG008|Overall Study|Adverse Event|3|||
16436769|NCT00531284|40077838|FG009|Overall Study|Adverse Event|0|||
16436770|NCT00531284|40077839|FG010|Overall Study|Adverse Event|0|||
16436771|NCT00531284|40077840|FG011|Overall Study|Adverse Event|5|||
16436772|NCT00531284|40077841|FG012|Overall Study|Adverse Event|0|||
16436773|NCT00531284|40077842|FG013|Overall Study|Adverse Event|1|||
16436774|NCT00531284|40077843|FG014|Overall Study|Adverse Event|1|||
16436775|NCT00531284|40077844|FG015|Overall Study|Adverse Event|0|||
16436776|NCT00531284|40077845|FG016|Overall Study|Adverse Event|2|||
16436777|NCT00531284|40077829|FG000|Overall Study|Withdrawal by Subject|1|||
16436778|NCT00531284|40077830|FG001|Overall Study|Withdrawal by Subject|0|||
16436779|NCT00531284|40077831|FG002|Overall Study|Withdrawal by Subject|0|||
16436780|NCT00531284|40077832|FG003|Overall Study|Withdrawal by Subject|4|||
16436781|NCT00531284|40077833|FG004|Overall Study|Withdrawal by Subject|0|||
16436782|NCT00531284|40077834|FG005|Overall Study|Withdrawal by Subject|0|||
16436783|NCT00531284|40077835|FG006|Overall Study|Withdrawal by Subject|0|||
16436784|NCT00531284|40077836|FG007|Overall Study|Withdrawal by Subject|0|||
16436785|NCT00531284|40077837|FG008|Overall Study|Withdrawal by Subject|0|||
16436786|NCT00531284|40077838|FG009|Overall Study|Withdrawal by Subject|0|||
16436787|NCT00531284|40077839|FG010|Overall Study|Withdrawal by Subject|0|||
16436788|NCT00531284|40077840|FG011|Overall Study|Withdrawal by Subject|3|||
16436789|NCT00531284|40077841|FG012|Overall Study|Withdrawal by Subject|0|||
16363002|NCT01991795|39814959|FG001|Overall Study|Site prematurely closed by sponsor|25|||
16363003|NCT02326883|39814960|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
16363004|NCT02326883|39814961|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
16436790|NCT00531284|40077842|FG013|Overall Study|Withdrawal by Subject|1|||
16436791|NCT00531284|40077843|FG014|Overall Study|Withdrawal by Subject|0|||
16436792|NCT00531284|40077844|FG015|Overall Study|Withdrawal by Subject|1|||
16436793|NCT00531284|40077845|FG016|Overall Study|Withdrawal by Subject|1|||
16436794|NCT00531284|40077829|FG000|Overall Study|Other|1|||
16436795|NCT00531284|40077830|FG001|Overall Study|Other|0|||
16436796|NCT00531284|40077831|FG002|Overall Study|Other|0|||
16436797|NCT00531284|40077832|FG003|Overall Study|Other|10|||
16436798|NCT00531284|40077833|FG004|Overall Study|Other|2|||
16436799|NCT00531284|40077834|FG005|Overall Study|Other|1|||
16436800|NCT00531284|40077835|FG006|Overall Study|Other|0|||
16436801|NCT00531284|40077836|FG007|Overall Study|Other|0|||
16436802|NCT00531284|40077837|FG008|Overall Study|Other|2|||
16436803|NCT00531284|40077838|FG009|Overall Study|Other|1|||
16436804|NCT00531284|40077839|FG010|Overall Study|Other|0|||
16436805|NCT00531284|40077840|FG011|Overall Study|Other|2|||
16436806|NCT00531284|40077841|FG012|Overall Study|Other|0|||
16436807|NCT00531284|40077842|FG013|Overall Study|Other|0|||
16363005|NCT02326883|39814962|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
16363006|NCT01137812|39814963|FG000|Overall Study|Adverse Event|21|||
16436808|NCT00531284|40077843|FG014|Overall Study|Other|1|||
16436809|NCT00531284|40077844|FG015|Overall Study|Other|0|||
16436810|NCT00531284|40077845|FG016|Overall Study|Other|0|||
16436811|NCT00702702|40077846|FG000|Overall Study|Study prematurely terminated|56|||
16436812|NCT01420861|40077847|FG000|Overall Study|Adverse Event|2|||
16436813|NCT01420861|40077847|FG000|Overall Study|Study terminated by Sponsor|7|||
16436814|NCT01420861|40077847|FG000|Overall Study|Screen failure|7|||
16436815|NCT01420861|40077847|FG000|Overall Study|Randomized not Treated|2|||
16436816|NCT00189540|40077850|FG000|Overall Study|Withdrawal by Subject|3|||
16436817|NCT00189540|40077851|FG001|Overall Study|Withdrawal by Subject|0|||
16436818|NCT00189540|40077850|FG000|Overall Study|Death|4|||
16436819|NCT00189540|40077851|FG001|Overall Study|Death|1|||
16436820|NCT01917747|40077857|FG000|Overall Study|Withdrawal by Subject|1|||
16436821|NCT01917747|40077858|FG001|Overall Study|Withdrawal by Subject|2|||
16436822|NCT01917747|40077857|FG000|Overall Study|Lost to Follow-up|18|||
16436823|NCT01917747|40077858|FG001|Overall Study|Lost to Follow-up|9|||
16436824|NCT03449758|40077860|FG000|Overall Study|Major protocol deviation|1|||
16436825|NCT03449758|40077860|FG000|Overall Study|Treatment inefficacy|5|||
16436826|NCT03449758|40077860|FG000|Overall Study|Adverse Event|9|||
16436827|NCT03449758|40077860|FG000|Overall Study|Consent withdrawal|1|||
16363007|NCT01137812|39814964|FG001|Overall Study|Adverse Event|14|||
16363008|NCT01137812|39814963|FG000|Overall Study|Lost to Follow-up|6|||
16363009|NCT01137812|39814964|FG001|Overall Study|Lost to Follow-up|8|||
16363010|NCT01137812|39814963|FG000|Overall Study|Physician Decision|25|||
16363011|NCT01137812|39814964|FG001|Overall Study|Physician Decision|17|||
16363012|NCT01137812|39814963|FG000|Overall Study|Protocol Violation|5|||
16363013|NCT01137812|39814964|FG001|Overall Study|Protocol Violation|4|||
16363014|NCT01137812|39814963|FG000|Overall Study|Withdrawal by Subject|5|||
16363015|NCT01137812|39814964|FG001|Overall Study|Withdrawal by Subject|13|||
16436828|NCT03449758|40077860|FG000|Overall Study|Other unspecified reason|3|||
16436829|NCT01307319|40077865|FG000|Overall Study|Adverse Event|2|||
16436830|NCT01307319|40077866|FG001|Overall Study|Adverse Event|2|||
16436831|NCT01307319|40077867|FG002|Overall Study|Adverse Event|1|||
16436832|NCT01307319|40077865|FG000|Overall Study|Lost to Follow-up|1|||
16436833|NCT01307319|40077866|FG001|Overall Study|Lost to Follow-up|0|||
16436834|NCT01307319|40077867|FG002|Overall Study|Lost to Follow-up|1|||
16436835|NCT01307319|40077865|FG000|Overall Study|Protocol Violation|1|||
16436836|NCT01307319|40077866|FG001|Overall Study|Protocol Violation|1|||
16436837|NCT01307319|40077867|FG002|Overall Study|Protocol Violation|0|||
16436838|NCT01307319|40077865|FG000|Overall Study|Withdrawal by Subject|0|||
16436839|NCT01307319|40077866|FG001|Overall Study|Withdrawal by Subject|1|||
16436840|NCT01307319|40077867|FG002|Overall Study|Withdrawal by Subject|2|||
16436841|NCT01307319|40077865|FG000|Overall Study|Other|0|||
16436842|NCT01307319|40077866|FG001|Overall Study|Other|4|||
16436843|NCT01307319|40077867|FG002|Overall Study|Other|3|||
16436844|NCT03149055|40077868|FG000|Overall Study|Not treated|4|||
16436845|NCT00587158|40077870|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
16436846|NCT00587158|40077871|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
16436847|NCT00587158|40077870|FG000|Overall Study|Physician Decision|0|||
16436848|NCT00587158|40077871|FG001|Overall Study|Physician Decision|1|||
16363016|NCT01137812|39814963|FG000|Overall Study|Death|2|||
16363017|NCT01137812|39814964|FG001|Overall Study|Death|0|||
16363018|NCT01137812|39814963|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
16363019|NCT01137812|39814964|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
16436849|NCT00587158|40077870|FG000|Overall Study|Lost to Follow-up|1|||
16436850|NCT00587158|40077871|FG001|Overall Study|Lost to Follow-up|2|||
16436851|NCT00587158|40077870|FG000|Overall Study|Death|0|||
16436852|NCT00587158|40077871|FG001|Overall Study|Death|1|||
16436853|NCT00587158|40077870|FG000|Overall Study|Subject did not want to take study med|0|||
16436854|NCT00587158|40077871|FG001|Overall Study|Subject did not want to take study med|1|||
16436855|NCT03582215|40077879|FG000|Overall Study|Adverse Event|1|||
16436856|NCT03582215|40077880|FG001|Overall Study|Adverse Event|0|||
16436857|NCT03582215|40077881|FG002|Overall Study|Adverse Event|0|||
16436858|NCT03582215|40077882|FG003|Overall Study|Adverse Event|0|||
16436859|NCT03582215|40077883|FG004|Overall Study|Adverse Event|0|||
16436860|NCT03582215|40077884|FG005|Overall Study|Adverse Event|0|||
16436861|NCT03582215|40077885|FG006|Overall Study|Adverse Event|2|||
16436862|NCT03582215|40077886|FG007|Overall Study|Adverse Event|2|||
16436863|NCT00539981|40077888|FG000|Overall Study|Adverse events (AE)|3|||
16436864|NCT00539981|40077889|FG001|Overall Study|Adverse events (AE)|3|||
16436865|NCT00539981|40077888|FG000|Overall Study|Lost to Follow-up|260|||
16436866|NCT00539981|40077889|FG001|Overall Study|Lost to Follow-up|251|||
16436867|NCT00539981|40077888|FG000|Overall Study|Withdrew consent|22|||
16436868|NCT00539981|40077889|FG001|Overall Study|Withdrew consent|14|||
16436869|NCT00539981|40077888|FG000|Overall Study|Death|1|||
16436870|NCT00539981|40077889|FG001|Overall Study|Death|1|||
16436871|NCT00539981|40077888|FG000|Overall Study|Other reason-unspecified|9|||
16436872|NCT00539981|40077889|FG001|Overall Study|Other reason-unspecified|13|||
16436873|NCT00647296|40077894|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
16436874|NCT00647296|40077895|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
16436875|NCT00647296|40077896|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
16436876|NCT00647296|40077897|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
16436877|NCT00647296|40077894|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
16436878|NCT00647296|40077895|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
16436879|NCT00647296|40077896|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
16436880|NCT00647296|40077897|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
16436881|NCT00647296|40077894|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
16436882|NCT00647296|40077895|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
16436883|NCT00647296|40077896|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
16436884|NCT00647296|40077897|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
16436885|NCT00647296|40077894|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
16436886|NCT00647296|40077895|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
16436887|NCT00647296|40077896|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
16436888|NCT00647296|40077897|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
16436889|NCT00647296|40077894|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
16436890|NCT00647296|40077895|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
16436891|NCT00647296|40077896|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
16436892|NCT00647296|40077897|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
16436893|NCT00647296|40077894|FG000|Part 2: 4-week Placebo Washout|Death|3|||
16436894|NCT00647296|40077895|FG001|Part 2: 4-week Placebo Washout|Death|0|||
16436895|NCT00647296|40077896|FG002|Part 2: 4-week Placebo Washout|Death|0|||
16436896|NCT00647296|40077897|FG003|Part 2: 4-week Placebo Washout|Death|0|||
16436897|NCT00647296|40077894|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
16436898|NCT00647296|40077895|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
16436899|NCT00647296|40077896|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
16436900|NCT00647296|40077897|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
16436901|NCT00647296|40077894|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
16436902|NCT00647296|40077895|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
16436903|NCT00647296|40077896|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
16436904|NCT00647296|40077897|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
16436905|NCT00647296|40077894|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
16436906|NCT00647296|40077895|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
16436907|NCT00647296|40077896|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
16436908|NCT00647296|40077897|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
16436909|NCT00647296|40077894|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
16436910|NCT00647296|40077895|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
16436911|NCT00647296|40077896|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
16436912|NCT00647296|40077897|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
16436913|NCT00647296|40077894|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
16436914|NCT00647296|40077895|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
16436915|NCT00647296|40077896|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
16436916|NCT00647296|40077897|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
16436917|NCT00333775|40077898|FG000|Overall Study|Death|144|||
16436918|NCT00333775|40077899|FG001|Overall Study|Death|149|||
16436919|NCT00333775|40077900|FG002|Overall Study|Death|143|||
16436920|NCT00333775|40077898|FG000|Overall Study|In Follow-up When Study Stopped|87|||
16436921|NCT00333775|40077899|FG001|Overall Study|In Follow-up When Study Stopped|92|||
16436922|NCT00333775|40077900|FG002|Overall Study|In Follow-up When Study Stopped|96|||
16436923|NCT00333775|40077898|FG000|Overall Study|Lost to Follow-up|10|||
16436924|NCT00333775|40077899|FG001|Overall Study|Lost to Follow-up|7|||
16436925|NCT00333775|40077900|FG002|Overall Study|Lost to Follow-up|8|||
16436926|NCT03261336|40077901|FG000|Overall Study|Adverse Event|1|||
16436927|NCT00217425|40077902|FG000|Overall Study|Never started treatment|2|||
16436928|NCT00217425|40077902|FG000|Overall Study|Patient ineligible|5|||
16436929|NCT00217425|40077902|FG000|Overall Study|Lack of Efficacy|13|||
16436930|NCT00217425|40077902|FG000|Overall Study|Adverse Event|8|||
16436931|NCT00217425|40077902|FG000|Overall Study|Withdrawal by Subject|4|||
16436932|NCT00217425|40077902|FG000|Overall Study|Other complicating disease|1|||
16436933|NCT00217425|40077902|FG000|Overall Study|Other|4|||
16436934|NCT00083889|40077908|FG000|Overall Study|Adverse Event|76|||
16436935|NCT00083889|40077909|FG001|Overall Study|Adverse Event|86|||
16436936|NCT00083889|40077908|FG000|Overall Study|Protocol Violation|2|||
16436937|NCT00083889|40077909|FG001|Overall Study|Protocol Violation|2|||
16436938|NCT00083889|40077908|FG000|Overall Study|Withdrawal by Subject|22|||
16436939|NCT00083889|40077909|FG001|Overall Study|Withdrawal by Subject|24|||
16436940|NCT00083889|40077908|FG000|Overall Study|Lack of Efficacy|240|||
16436941|NCT00083889|40077909|FG001|Overall Study|Lack of Efficacy|219|||
16436942|NCT00083889|40077908|FG000|Overall Study|Decision of sponsor|32|||
16436943|NCT00083889|40077909|FG001|Overall Study|Decision of sponsor|4|||
16436944|NCT00083889|40077908|FG000|Overall Study|Randomized: did not take study drug|0|||
16436945|NCT00083889|40077909|FG001|Overall Study|Randomized: did not take study drug|15|||
16436946|NCT00083889|40077908|FG000|Overall Study|Completed on marketed sunitinub|3|||
16436947|NCT00083889|40077909|FG001|Overall Study|Completed on marketed sunitinub|0|||
16436948|NCT00083889|40077908|FG000|Overall Study|Crossover to SU011248|0|||
16436949|NCT00083889|40077909|FG001|Overall Study|Crossover to SU011248|25|||
16436950|NCT00506350|40077910|FG000|Overall Study|Serious Adverse Event|1|||
16436951|NCT00506350|40077911|FG001|Overall Study|Serious Adverse Event|0|||
16436952|NCT00506350|40077912|FG002|Overall Study|Serious Adverse Event|0|||
16436953|NCT00506350|40077913|FG003|Overall Study|Serious Adverse Event|0|||
16436954|NCT00506350|40077914|FG004|Overall Study|Serious Adverse Event|0|||
16436955|NCT00506350|40077915|FG005|Overall Study|Serious Adverse Event|0|||
16436956|NCT00506350|40077916|FG006|Overall Study|Serious Adverse Event|0|||
16436957|NCT00506350|40077917|FG007|Overall Study|Serious Adverse Event|0|||
16436958|NCT00506350|40077918|FG008|Overall Study|Serious Adverse Event|0|||
16436959|NCT00506350|40077910|FG000|Overall Study|Adverse Event|0|||
16436960|NCT00506350|40077911|FG001|Overall Study|Adverse Event|0|||
16436961|NCT00506350|40077912|FG002|Overall Study|Adverse Event|0|||
16436962|NCT00506350|40077913|FG003|Overall Study|Adverse Event|0|||
16436963|NCT00506350|40077914|FG004|Overall Study|Adverse Event|0|||
16436964|NCT00506350|40077915|FG005|Overall Study|Adverse Event|0|||
16436965|NCT00506350|40077916|FG006|Overall Study|Adverse Event|0|||
16436966|NCT00506350|40077917|FG007|Overall Study|Adverse Event|1|||
16436967|NCT00506350|40077918|FG008|Overall Study|Adverse Event|1|||
16436968|NCT00506350|40077910|FG000|Overall Study|Protocol Violation|0|||
16436969|NCT00506350|40077911|FG001|Overall Study|Protocol Violation|0|||
16436970|NCT00506350|40077912|FG002|Overall Study|Protocol Violation|1|||
16436971|NCT00506350|40077913|FG003|Overall Study|Protocol Violation|0|||
16436972|NCT00506350|40077914|FG004|Overall Study|Protocol Violation|0|||
16254198|NCT02729896|39413224|FG001|Overall Study|Physician Decision|2|||
16436973|NCT00506350|40077915|FG005|Overall Study|Protocol Violation|0|||
16436974|NCT00506350|40077916|FG006|Overall Study|Protocol Violation|1|||
16436975|NCT00506350|40077917|FG007|Overall Study|Protocol Violation|0|||
16436976|NCT00506350|40077918|FG008|Overall Study|Protocol Violation|0|||
16436977|NCT00506350|40077910|FG000|Overall Study|Withdrawal by Subject|0|||
16436978|NCT00506350|40077911|FG001|Overall Study|Withdrawal by Subject|1|||
16436979|NCT00506350|40077912|FG002|Overall Study|Withdrawal by Subject|1|||
16436980|NCT00506350|40077913|FG003|Overall Study|Withdrawal by Subject|1|||
16436981|NCT00506350|40077914|FG004|Overall Study|Withdrawal by Subject|4|||
16436982|NCT00506350|40077915|FG005|Overall Study|Withdrawal by Subject|1|||
16436983|NCT00506350|40077916|FG006|Overall Study|Withdrawal by Subject|1|||
16436984|NCT00506350|40077917|FG007|Overall Study|Withdrawal by Subject|2|||
16436985|NCT00506350|40077918|FG008|Overall Study|Withdrawal by Subject|0|||
16138472|NCT02881957|38993348|FG001|Overall Study|Protocol Violation|0|||
16138473|NCT00876694|38993349|FG000|Overall Study|Adverse Event|10|||
16138474|NCT00876694|38993350|FG001|Overall Study|Adverse Event|7|||
16138475|NCT00876694|38993349|FG000|Overall Study|Subject withdrew consent|6|||
16138476|NCT00876694|38993350|FG001|Overall Study|Subject withdrew consent|4|||
16254199|NCT02729896|39413225|FG002|Overall Study|Physician Decision|3|||
16138477|NCT00876694|38993349|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16138478|NCT00876694|38993350|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16138479|NCT00876694|38993349|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16138480|NCT00876694|38993350|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16138481|NCT00876694|38993349|FG000|Overall Study|Administrative problems|1|||
16138482|NCT00876694|38993350|FG001|Overall Study|Administrative problems|1|||
16138483|NCT00876694|38993349|FG000|Overall Study|Death|1|||
16138484|NCT00876694|38993350|FG001|Overall Study|Death|0|||
16363020|NCT01137812|39814963|FG000|Overall Study|Other|19|||
16363021|NCT01137812|39814964|FG001|Overall Study|Other|27|||
16138485|NCT02824263|38993351|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
16138486|NCT02824263|38993352|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
16138487|NCT02824263|38993351|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
16138488|NCT02824263|38993352|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
16138489|NCT01019980|38993353|FG000|Overall Study|Drug not available.|2|||
16138490|NCT01019980|38993354|FG001|Overall Study|Drug not available.|0|||
16138491|NCT00887679|38993355|FG000|Overall Study|Withdrawal by Subject|1|||
16138492|NCT00887679|38993355|FG000|Overall Study|Lost to Follow-up|4|||
16138493|NCT00887679|38993355|FG000|Overall Study|Physician Decision|5|||
16138494|NCT01128894|38993359|FG000|Overall Study|Adverse Event|31|||
16138495|NCT01128894|38993360|FG001|Overall Study|Adverse Event|41|||
16138496|NCT01128894|38993359|FG000|Overall Study|Protocol Violation|2|||
16138497|NCT01128894|38993360|FG001|Overall Study|Protocol Violation|1|||
16138498|NCT01128894|38993359|FG000|Overall Study|Noncompliance|4|||
16138499|NCT01128894|38993360|FG001|Overall Study|Noncompliance|5|||
16138500|NCT01128894|38993359|FG000|Overall Study|Lost to Follow-up|8|||
16138501|NCT01128894|38993360|FG001|Overall Study|Lost to Follow-up|8|||
16138502|NCT01128894|38993359|FG000|Overall Study|Withdrawal by Subject|10|||
16138503|NCT01128894|38993360|FG001|Overall Study|Withdrawal by Subject|12|||
16138504|NCT01128894|38993359|FG000|Overall Study|Physician Decision|2|||
16138505|NCT01128894|38993360|FG001|Overall Study|Physician Decision|1|||
16138506|NCT01128894|38993359|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
16138507|NCT01128894|38993360|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
16138508|NCT02349451|38993361|FG000|Overall Study|Withdrawal by Subject|0|||
16138509|NCT02349451|38993362|FG001|Overall Study|Withdrawal by Subject|1|||
16138510|NCT02349451|38993363|FG002|Overall Study|Withdrawal by Subject|2|||
16138511|NCT02349451|38993364|FG003|Overall Study|Withdrawal by Subject|1|||
16138512|NCT01294683|38993365|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
16138513|NCT01294683|38993366|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
16138514|NCT01294683|38993365|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
16138515|NCT01294683|38993366|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
16138516|NCT01294683|38993365|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
16138517|NCT01294683|38993366|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
16138518|NCT01294683|38993365|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
16138519|NCT01294683|38993366|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
16138520|NCT01294683|38993365|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
16138521|NCT01294683|38993366|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
16138522|NCT01294683|38993365|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
16138523|NCT01294683|38993366|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
16138524|NCT01294683|38993365|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
16138525|NCT01294683|38993366|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
16138526|NCT01294683|38993365|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
16138527|NCT01294683|38993366|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
16138528|NCT01294683|38993365|FG000|Post Crossover (Period III)|Adverse Event|6|||
16138529|NCT01294683|38993366|FG001|Post Crossover (Period III)|Adverse Event|6|||
16138530|NCT01294683|38993365|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
16138531|NCT01294683|38993366|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
16138532|NCT01294683|38993365|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
16138533|NCT01294683|38993366|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
16138534|NCT01294683|38993365|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
16138535|NCT01294683|38993366|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
16138536|NCT04448756|38993367|FG000|Overall Study|Adverse Event|0|||
16138537|NCT04448756|38993368|FG001|Overall Study|Adverse Event|1|||
16138538|NCT04448756|38993369|FG002|Overall Study|Adverse Event|0|||
16138539|NCT04448756|38993367|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
16138540|NCT04448756|38993368|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
16138541|NCT04448756|38993369|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
16138542|NCT04448756|38993367|FG000|Overall Study|Withdrawal by Subject|0|||
16138543|NCT04448756|38993368|FG001|Overall Study|Withdrawal by Subject|3|||
16138544|NCT04448756|38993369|FG002|Overall Study|Withdrawal by Subject|1|||
16138545|NCT04448756|38993367|FG000|Overall Study|Death|2|||
16138546|NCT04448756|38993368|FG001|Overall Study|Death|1|||
16138547|NCT04448756|38993369|FG002|Overall Study|Death|0|||
16138548|NCT00440700|38993370|FG000|Overall Study|Withdrawal by Subject|8|||
16138549|NCT00440700|38993371|FG001|Overall Study|Withdrawal by Subject|8|||
16138550|NCT00440700|38993372|FG002|Overall Study|Withdrawal by Subject|4|||
16138551|NCT00909792|38993373|FG000|Period 1|Did not meet inclusion criteria|0|||
16138552|NCT00909792|38993374|FG001|Period 1|Did not meet inclusion criteria|1|||
16138553|NCT00909792|38993373|FG000|Period 2|Biomicroscopy|1|||
16138554|NCT00909792|38993374|FG001|Period 2|Biomicroscopy|0|||
16138555|NCT00909792|38993373|FG000|Period 2|Lost to Follow-up|0|||
16138556|NCT00909792|38993374|FG001|Period 2|Lost to Follow-up|1|||
16138557|NCT01791803|38993375|FG000|Overall Study|Withdrawal by Subject|0|||
16138558|NCT01791803|38993376|FG001|Overall Study|Withdrawal by Subject|0|||
16138559|NCT01791803|38993377|FG002|Overall Study|Withdrawal by Subject|0|||
16138560|NCT01791803|38993378|FG003|Overall Study|Withdrawal by Subject|2|||
16138561|NCT01791803|38993375|FG000|Overall Study|Physician Decision|0|||
16138562|NCT01791803|38993376|FG001|Overall Study|Physician Decision|2|||
16138563|NCT01791803|38993377|FG002|Overall Study|Physician Decision|0|||
16138564|NCT01791803|38993378|FG003|Overall Study|Physician Decision|1|||
16138565|NCT01791803|38993375|FG000|Overall Study|Death|0|||
16138566|NCT01791803|38993376|FG001|Overall Study|Death|0|||
16138567|NCT01791803|38993377|FG002|Overall Study|Death|2|||
16138568|NCT01791803|38993378|FG003|Overall Study|Death|2|||
16138569|NCT01016977|38993380|FG000|Overall Study|Lost to Follow-up|1|||
16254200|NCT02729896|39413223|FG000|Overall Study|Progressive Disease|0|||
16254201|NCT02729896|39413224|FG001|Overall Study|Progressive Disease|1|||
16254202|NCT02729896|39413225|FG002|Overall Study|Progressive Disease|0|||
16254203|NCT02729896|39413223|FG000|Overall Study|Withdrawal by Subject|1|||
16254204|NCT02729896|39413224|FG001|Overall Study|Withdrawal by Subject|0|||
16254205|NCT02729896|39413225|FG002|Overall Study|Withdrawal by Subject|3|||
16254206|NCT00667095|39413226|FG000|Overall Study|Withdrawal by Subject|0|||
16254207|NCT00667095|39413227|FG001|Overall Study|Withdrawal by Subject|1|||
16254208|NCT01626859|39413228|FG000|Overall Study|Adverse Event|1|||
16254209|NCT01626859|39413229|FG001|Overall Study|Adverse Event|3|||
16254210|NCT01626859|39413230|FG002|Overall Study|Adverse Event|2|||
16254211|NCT01626859|39413228|FG000|Overall Study|Physician Decision|0|||
16363022|NCT04424901|39814965|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
16363023|NCT04424901|39814966|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
16363024|NCT02807259|39814967|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
16363025|NCT02807259|39814968|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
16363026|NCT02807259|39814967|FG000|Midline (3 Months)|migration, refusal, not available|30|||
16363027|NCT02807259|39814968|FG001|Midline (3 Months)|migration, refusal, not available|34|||
16363028|NCT02807259|39814967|FG000|Endline (3 Months)|migration, refusal, not available|35|||
16363029|NCT02807259|39814968|FG001|Endline (3 Months)|migration, refusal, not available|87|||
16363030|NCT05399771|39814977|FG000|Overall Study|Physician Decision|3|||
16363031|NCT05399771|39814977|FG000|Overall Study|Adverse Event|1|||
16363032|NCT01685437|39814978|FG000|Overall Study|Withdrawal by Subject|22|||
16363033|NCT01685437|39814978|FG000|Overall Study|Lost to Follow-up|3|||
16363034|NCT01685437|39814978|FG000|Overall Study|Adverse Event|1|||
16363035|NCT01685437|39814978|FG000|Overall Study|Protocol Violation|4|||
16363036|NCT01685437|39814978|FG000|Overall Study|Unable to make visits due to work|1|||
16363037|NCT02394275|39814979|FG000|Overall Study|Adverse Event|22|||
16363038|NCT02394275|39814979|FG000|Overall Study|Lost to Follow-up|7|||
16363039|NCT02318940|39814980|FG000|Overall Study|lost the record|1|||
16363040|NCT02318940|39814981|FG001|Overall Study|lost the record|0|||
16363041|NCT02115386|39814986|FG000|Overall Study|Protocol Violation|1|||
16363042|NCT02115386|39814986|FG000|Overall Study|Administrative - trial was terminated|6|||
16363043|NCT01454284|39814987|FG000|Overall Study|Adverse Event|20|||
16363044|NCT01454284|39814988|FG001|Overall Study|Adverse Event|7|||
16363045|NCT01454284|39814987|FG000|Overall Study|Death|0|||
16363046|NCT01454284|39814988|FG001|Overall Study|Death|3|||
16363047|NCT01454284|39814987|FG000|Overall Study|Lost to Follow-up|13|||
16363048|NCT01454284|39814988|FG001|Overall Study|Lost to Follow-up|8|||
16363049|NCT01454284|39814987|FG000|Overall Study|Protocol Violation|9|||
16363050|NCT01454284|39814988|FG001|Overall Study|Protocol Violation|6|||
16363051|NCT01454284|39814987|FG000|Overall Study|Withdrawal by Subject|58|||
16363052|NCT01454284|39814988|FG001|Overall Study|Withdrawal by Subject|36|||
16363053|NCT01454284|39814987|FG000|Overall Study|Physician Decision|16|||
16363054|NCT01454284|39814988|FG001|Overall Study|Physician Decision|11|||
16363055|NCT01454284|39814987|FG000|Overall Study|Sponsor Decision|0|||
16363056|NCT01454284|39814988|FG001|Overall Study|Sponsor Decision|2|||
16363057|NCT03704688|39814989|FG000|Overall Study|Adverse Event|0|||
16363058|NCT03704688|39814990|FG001|Overall Study|Adverse Event|0|||
16363059|NCT03704688|39814991|FG002|Overall Study|Adverse Event|0|||
16363060|NCT03704688|39814992|FG003|Overall Study|Adverse Event|4|||
16138570|NCT01016977|38993381|FG001|Overall Study|Lost to Follow-up|0|||
16138571|NCT01016977|38993380|FG000|Overall Study|Withdrawal by Subject|2|||
16138572|NCT01016977|38993381|FG001|Overall Study|Withdrawal by Subject|2|||
16138573|NCT01176773|38993386|FG000|Overall Study|Screen Failure|2|||
16363061|NCT03704688|39814993|FG004|Overall Study|Adverse Event|1|||
16363062|NCT03704688|39814994|FG005|Overall Study|Adverse Event|0|||
16363063|NCT03704688|39814989|FG000|Overall Study|Disease Progression|0|||
16138574|NCT01176773|38993386|FG000|Overall Study|Withdrew consent|1|||
16138575|NCT03881553|38993387|FG000|Overall Study|Discharged prior to participation|1|||
16138576|NCT03881553|38993388|FG001|Overall Study|Discharged prior to participation|1|||
16138577|NCT03881553|38993389|FG002|Overall Study|Discharged prior to participation|0|||
16138578|NCT03881553|38993387|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
16138579|NCT03881553|38993388|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
16138580|NCT03881553|38993389|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
16138581|NCT02244996|38993390|FG000|Overall Study|Lack of Efficacy|2|||
16138582|NCT02244996|38993391|FG001|Overall Study|Lack of Efficacy|6|||
16436986|NCT00506350|40077910|FG000|Overall Study|Lost to Follow-up|1|||
16436987|NCT00506350|40077911|FG001|Overall Study|Lost to Follow-up|1|||
16436988|NCT00506350|40077912|FG002|Overall Study|Lost to Follow-up|1|||
16436989|NCT00506350|40077913|FG003|Overall Study|Lost to Follow-up|1|||
16436990|NCT00506350|40077914|FG004|Overall Study|Lost to Follow-up|2|||
16436991|NCT00506350|40077915|FG005|Overall Study|Lost to Follow-up|1|||
16436992|NCT00506350|40077916|FG006|Overall Study|Lost to Follow-up|0|||
16436993|NCT00506350|40077917|FG007|Overall Study|Lost to Follow-up|0|||
16436994|NCT00506350|40077918|FG008|Overall Study|Lost to Follow-up|2|||
16436995|NCT00506350|40077910|FG000|Overall Study|Medical Reason|0|||
16138583|NCT01106027|38993392|FG000|Overall Study|Lost graft early, discontinued|1|||
16138584|NCT01176968|38993397|FG000|Overall Study|Adverse Event|10|||
16138585|NCT01176968|38993398|FG001|Overall Study|Adverse Event|11|||
16138586|NCT01176968|38993397|FG000|Overall Study|Death|2|||
16138587|NCT01176968|38993398|FG001|Overall Study|Death|3|||
16138588|NCT01176968|38993397|FG000|Overall Study|Lack of Efficacy|0|||
16138589|NCT01176968|38993398|FG001|Overall Study|Lack of Efficacy|1|||
16138590|NCT01176968|38993397|FG000|Overall Study|Lost to Follow-up|16|||
16138591|NCT01176968|38993398|FG001|Overall Study|Lost to Follow-up|14|||
16138592|NCT01176968|38993397|FG000|Overall Study|Withdrawal by Subject|48|||
16138593|NCT01176968|38993398|FG001|Overall Study|Withdrawal by Subject|48|||
16254212|NCT01626859|39413229|FG001|Overall Study|Physician Decision|1|||
16436996|NCT00506350|40077911|FG001|Overall Study|Medical Reason|0|||
16436997|NCT00506350|40077912|FG002|Overall Study|Medical Reason|0|||
16436998|NCT00506350|40077913|FG003|Overall Study|Medical Reason|0|||
16436999|NCT00506350|40077914|FG004|Overall Study|Medical Reason|1|||
16437000|NCT00506350|40077915|FG005|Overall Study|Medical Reason|0|||
16437001|NCT00506350|40077916|FG006|Overall Study|Medical Reason|0|||
16437002|NCT00506350|40077917|FG007|Overall Study|Medical Reason|0|||
16437003|NCT00506350|40077918|FG008|Overall Study|Medical Reason|0|||
16437004|NCT00506350|40077910|FG000|Overall Study|Other|1|||
16437005|NCT00506350|40077911|FG001|Overall Study|Other|1|||
16437006|NCT00506350|40077912|FG002|Overall Study|Other|3|||
16437007|NCT00506350|40077913|FG003|Overall Study|Other|0|||
16437008|NCT00506350|40077914|FG004|Overall Study|Other|3|||
16437009|NCT00506350|40077915|FG005|Overall Study|Other|0|||
16437010|NCT00506350|40077916|FG006|Overall Study|Other|0|||
16437011|NCT00506350|40077917|FG007|Overall Study|Other|2|||
16437012|NCT00506350|40077918|FG008|Overall Study|Other|2|||
16437013|NCT01276639|40077919|FG000|Week 0 to 16|Death|1|||
16437014|NCT01276639|40077920|FG001|Week 0 to 16|Death|0|||
16437015|NCT01276639|40077921|FG002|Week 0 to 16|Death|0|||
16437016|NCT01276639|40077922|FG003|Week 0 to 16|Death|0|||
16437017|NCT01276639|40077923|FG004|Week 0 to 16|Death|0|||
16437018|NCT01276639|40077919|FG000|Week 0 to 16|Adverse Event|11|||
16437019|NCT01276639|40077920|FG001|Week 0 to 16|Adverse Event|8|||
16437020|NCT01276639|40077921|FG002|Week 0 to 16|Adverse Event|11|||
16437021|NCT01276639|40077922|FG003|Week 0 to 16|Adverse Event|0|||
16437022|NCT01276639|40077923|FG004|Week 0 to 16|Adverse Event|0|||
16437023|NCT01276639|40077919|FG000|Week 0 to 16|Lack of Efficacy|20|||
16437024|NCT01276639|40077920|FG001|Week 0 to 16|Lack of Efficacy|15|||
16437025|NCT01276639|40077921|FG002|Week 0 to 16|Lack of Efficacy|25|||
16138594|NCT01176968|38993397|FG000|Overall Study|Protocol Violation|2|||
16138595|NCT01176968|38993398|FG001|Overall Study|Protocol Violation|1|||
16254213|NCT01626859|39413230|FG002|Overall Study|Physician Decision|0|||
16437026|NCT01276639|40077922|FG003|Week 0 to 16|Lack of Efficacy|0|||
16437027|NCT01276639|40077923|FG004|Week 0 to 16|Lack of Efficacy|0|||
16437028|NCT01276639|40077919|FG000|Week 0 to 16|Lost to Follow-up|3|||
16138596|NCT01176968|38993397|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
16138597|NCT01176968|38993398|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
16138598|NCT01176968|38993397|FG000|Overall Study|Study terminated by sponsor|0|||
16138599|NCT01176968|38993398|FG001|Overall Study|Study terminated by sponsor|1|||
16138600|NCT01176968|38993397|FG000|Overall Study|Reason not defined|5|||
16138601|NCT01176968|38993398|FG001|Overall Study|Reason not defined|3|||
16363064|NCT03704688|39814990|FG001|Overall Study|Disease Progression|0|||
16138602|NCT01979835|38993401|FG000|Primary Outcome SA Measurment|failed insertion|18|||
16138603|NCT01979835|38993401|FG000|Follow-up|Lost to Follow-up|32|||
16138604|NCT03431857|38993404|FG000|Overall Study|Death|6|||
16138605|NCT03431857|38993404|FG000|Overall Study|Lost to Follow-up|41|||
16138606|NCT03431857|38993404|FG000|Overall Study|Adverse Event|6|||
16138607|NCT03431857|38993404|FG000|Overall Study|Withdrawal by Subject|1|||
16138608|NCT02901041|38993405|FG000|Overall Study|Withdrawal by PI|4|||
16138609|NCT02901041|38993406|FG001|Overall Study|Withdrawal by PI|8|||
16138610|NCT02901041|38993405|FG000|Overall Study|Withdrawal by Subject|7|||
16138611|NCT02901041|38993406|FG001|Overall Study|Withdrawal by Subject|3|||
16138612|NCT00655486|38993407|FG000|Overall Study|Adverse Event|10|||
16138613|NCT00655486|38993407|FG000|Overall Study|Lack of Efficacy|8|||
16138614|NCT00655486|38993407|FG000|Overall Study|Withdrawal by Subject|4|||
16138615|NCT00655486|38993407|FG000|Overall Study|Protocol Violation|1|||
16138616|NCT00655486|38993407|FG000|Overall Study|Unsatisfactory compliance|2|||
16138617|NCT00655486|38993407|FG000|Overall Study|Other: Pregnancy|1|||
16138618|NCT00655486|38993407|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
16138619|NCT00655486|38993407|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
16138620|NCT00718640|38993410|FG000|Overall Study|Adverse Event|4|||
16138621|NCT00718640|38993410|FG000|Overall Study|Death|1|||
16138622|NCT00718640|38993410|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
16138623|NCT02080221|38993412|FG000|Overall Study|Withdrawal by Subject|1|||
16138624|NCT02080221|38993412|FG000|Overall Study|Clinical Progression of Disease|1|||
16138625|NCT01448213|38993413|FG000|Overall Study|Lost to Follow-up|12|||
16138626|NCT01448213|38993414|FG001|Overall Study|Lost to Follow-up|10|||
16138627|NCT01448213|38993413|FG000|Overall Study|Adverse Event|4|||
16138628|NCT01448213|38993414|FG001|Overall Study|Adverse Event|10|||
16138629|NCT01448213|38993413|FG000|Overall Study|Protocol Violation|1|||
16138630|NCT01448213|38993414|FG001|Overall Study|Protocol Violation|2|||
16138631|NCT03756350|38993415|FG000|Overall Study|Lost to Follow-up|1|||
16138632|NCT03618823|38993418|FG000|Overall Study|Lost to Follow-up|63|||
16138633|NCT03618823|38993419|FG001|Overall Study|Lost to Follow-up|61|||
16138634|NCT00307125|38993428|FG000|Screening Phase|Adverse Event|1|||
16138635|NCT00307125|38993429|FG001|Screening Phase|Adverse Event|0|||
16138636|NCT00307125|38993430|FG002|Screening Phase|Adverse Event|0|||
16138637|NCT00307125|38993428|FG000|Screening Phase|Protocol Violation|27|||
16138638|NCT00307125|38993429|FG001|Screening Phase|Protocol Violation|0|||
16138639|NCT00307125|38993430|FG002|Screening Phase|Protocol Violation|0|||
16138640|NCT00307125|38993428|FG000|Screening Phase|Lost to Follow-up|87|||
16138641|NCT00307125|38993429|FG001|Screening Phase|Lost to Follow-up|0|||
16363065|NCT03704688|39814991|FG002|Overall Study|Disease Progression|0|||
16363066|NCT03704688|39814992|FG003|Overall Study|Disease Progression|3|||
16363067|NCT03704688|39814993|FG004|Overall Study|Disease Progression|1|||
16363068|NCT03704688|39814994|FG005|Overall Study|Disease Progression|0|||
16363069|NCT03704688|39814989|FG000|Overall Study|Death|0|||
16363070|NCT03704688|39814990|FG001|Overall Study|Death|0|||
16363071|NCT03704688|39814991|FG002|Overall Study|Death|0|||
16363072|NCT03704688|39814992|FG003|Overall Study|Death|0|||
16363073|NCT03704688|39814993|FG004|Overall Study|Death|3|||
16363074|NCT03704688|39814994|FG005|Overall Study|Death|0|||
16363075|NCT02472405|39814995|FG000|Overall Study|Lost to Follow-up|9|||
16363076|NCT02472405|39814995|FG000|Overall Study|Adverse Event|1|||
16363077|NCT04666298|39814998|FG000|Overall Study|Subject decision|1|||
16363078|NCT04666298|39814999|FG001|Overall Study|Subject decision|0|||
16363079|NCT04666298|39815000|FG002|Overall Study|Subject decision|0|||
16363080|NCT04666298|39815001|FG003|Overall Study|Subject decision|2|||
16363081|NCT04666298|39814998|FG000|Overall Study|Death|1|||
16363082|NCT04666298|39814999|FG001|Overall Study|Death|0|||
16363083|NCT04666298|39815000|FG002|Overall Study|Death|0|||
16363084|NCT04666298|39815001|FG003|Overall Study|Death|0|||
16363085|NCT04666298|39814998|FG000|Overall Study|Lost to Follow-up|0|||
16363086|NCT04666298|39814999|FG001|Overall Study|Lost to Follow-up|0|||
16363087|NCT04666298|39815000|FG002|Overall Study|Lost to Follow-up|0|||
16138642|NCT00307125|38993430|FG002|Screening Phase|Lost to Follow-up|0|||
16138643|NCT00307125|38993428|FG000|Screening Phase|Death|10|||
16363088|NCT04666298|39815001|FG003|Overall Study|Lost to Follow-up|1|||
16363089|NCT04666298|39814998|FG000|Overall Study|Physician Decision|0|||
16363090|NCT04666298|39814999|FG001|Overall Study|Physician Decision|0|||
16363091|NCT04666298|39815000|FG002|Overall Study|Physician Decision|0|||
16363092|NCT04666298|39815001|FG003|Overall Study|Physician Decision|1|||
16363093|NCT04666298|39814998|FG000|Overall Study|Protocol deviation|0|||
16138644|NCT00307125|38993429|FG001|Screening Phase|Death|0|||
16138645|NCT00307125|38993430|FG002|Screening Phase|Death|0|||
16138646|NCT00307125|38993428|FG000|Screening Phase|Withdrawal by Subject|77|||
16138647|NCT00307125|38993429|FG001|Screening Phase|Withdrawal by Subject|0|||
16138648|NCT00307125|38993430|FG002|Screening Phase|Withdrawal by Subject|0|||
16138649|NCT00307125|38993428|FG000|Screening Phase|Physician Decision|26|||
16138650|NCT00307125|38993429|FG001|Screening Phase|Physician Decision|0|||
16363094|NCT04666298|39814999|FG001|Overall Study|Protocol deviation|0|||
16363095|NCT04666298|39815000|FG002|Overall Study|Protocol deviation|1|||
16138651|NCT00307125|38993430|FG002|Screening Phase|Physician Decision|0|||
16138652|NCT00307125|38993428|FG000|Screening Phase|Sponsor Decision|4|||
16138653|NCT00307125|38993429|FG001|Screening Phase|Sponsor Decision|0|||
16138654|NCT00307125|38993430|FG002|Screening Phase|Sponsor Decision|0|||
16138655|NCT00307125|38993428|FG000|Screening Phase|Study Terminated|17|||
16138656|NCT00307125|38993429|FG001|Screening Phase|Study Terminated|0|||
16138657|NCT00307125|38993430|FG002|Screening Phase|Study Terminated|0|||
16138658|NCT00307125|38993428|FG000|Screening Phase|Graft Loss|3|||
16138659|NCT00307125|38993429|FG001|Screening Phase|Graft Loss|0|||
16138660|NCT00307125|38993430|FG002|Screening Phase|Graft Loss|0|||
16138661|NCT00307125|38993428|FG000|Screening Phase|Graft Failure|8|||
16138662|NCT00307125|38993429|FG001|Screening Phase|Graft Failure|0|||
16138663|NCT00307125|38993430|FG002|Screening Phase|Graft Failure|0|||
16138664|NCT00307125|38993428|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
16138665|NCT00307125|38993429|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
16138666|NCT00307125|38993430|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
16138667|NCT00307125|38993428|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
16138668|NCT00307125|38993429|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
16138669|NCT00307125|38993430|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
16138670|NCT00307125|38993428|FG000|Screening Phase|Moved or transferred facilities|34|||
16138671|NCT00307125|38993429|FG001|Screening Phase|Moved or transferred facilities|0|||
16138672|NCT00307125|38993430|FG002|Screening Phase|Moved or transferred facilities|0|||
16138673|NCT00307125|38993428|FG000|Screening Phase|Received Pancreas Transplant|8|||
16138674|NCT00307125|38993429|FG001|Screening Phase|Received Pancreas Transplant|0|||
16138675|NCT00307125|38993430|FG002|Screening Phase|Received Pancreas Transplant|0|||
16138676|NCT00307125|38993428|FG000|Screening Phase|Ineligible for pilot|4|||
16138677|NCT00307125|38993429|FG001|Screening Phase|Ineligible for pilot|0|||
16138678|NCT00307125|38993430|FG002|Screening Phase|Ineligible for pilot|0|||
16138679|NCT00307125|38993428|FG000|Screening Phase|Try to get pregnant|1|||
16138680|NCT00307125|38993429|FG001|Screening Phase|Try to get pregnant|0|||
16138681|NCT00307125|38993430|FG002|Screening Phase|Try to get pregnant|0|||
16138682|NCT00307125|38993428|FG000|Screening Phase|Developed acute leukemia|1|||
16254214|NCT01626859|39413228|FG000|Overall Study|Withdrawal by Subject|1|||
16138683|NCT00307125|38993429|FG001|Screening Phase|Developed acute leukemia|0|||
16138684|NCT00307125|38993430|FG002|Screening Phase|Developed acute leukemia|0|||
16138685|NCT00307125|38993428|FG000|Screening Phase|Metastatic colon cancer|1|||
16138686|NCT00307125|38993429|FG001|Screening Phase|Metastatic colon cancer|0|||
16138687|NCT00307125|38993430|FG002|Screening Phase|Metastatic colon cancer|0|||
16138688|NCT00307125|38993428|FG000|Screening Phase|Malignancy|1|||
16138689|NCT00307125|38993429|FG001|Screening Phase|Malignancy|0|||
16138690|NCT00307125|38993430|FG002|Screening Phase|Malignancy|0|||
16138691|NCT00307125|38993428|FG000|Screening Phase|PAK|1|||
16138692|NCT00307125|38993429|FG001|Screening Phase|PAK|0|||
16138693|NCT00307125|38993430|FG002|Screening Phase|PAK|0|||
16138694|NCT00307125|38993428|FG000|Screening Phase|Ineligible|1|||
16138695|NCT00307125|38993429|FG001|Screening Phase|Ineligible|0|||
16138696|NCT00307125|38993430|FG002|Screening Phase|Ineligible|0|||
16138697|NCT00307125|38993428|FG000|Screening Phase|Screen Error|1|||
16138698|NCT00307125|38993429|FG001|Screening Phase|Screen Error|0|||
16138699|NCT00307125|38993430|FG002|Screening Phase|Screen Error|0|||
16138700|NCT00307125|38993428|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
16138701|NCT00307125|38993429|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
16138702|NCT00307125|38993430|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
16138703|NCT00307125|38993428|FG000|Screening Phase|AMR and treated with rituximab|1|||
16138704|NCT00307125|38993429|FG001|Screening Phase|AMR and treated with rituximab|0|||
16138705|NCT00307125|38993430|FG002|Screening Phase|AMR and treated with rituximab|0|||
16138706|NCT00307125|38993428|FG000|Screening Phase|Coronary artery bypass|1|||
16138707|NCT00307125|38993429|FG001|Screening Phase|Coronary artery bypass|0|||
16138708|NCT00307125|38993430|FG002|Screening Phase|Coronary artery bypass|0|||
16138709|NCT00307125|38993428|FG000|Pilot Phase|Lost to Follow-up|0|||
16138710|NCT00307125|38993429|FG001|Pilot Phase|Lost to Follow-up|1|||
16138711|NCT00307125|38993430|FG002|Pilot Phase|Lost to Follow-up|0|||
16138712|NCT00307125|38993428|FG000|Pilot Phase|Withdrawal by Subject|0|||
16138713|NCT00307125|38993429|FG001|Pilot Phase|Withdrawal by Subject|1|||
16138714|NCT00307125|38993430|FG002|Pilot Phase|Withdrawal by Subject|1|||
16138715|NCT00195507|38993433|FG000|Overall Study|Adverse Event|24|||
16138716|NCT00195507|38993434|FG001|Overall Study|Adverse Event|13|||
16138717|NCT00195507|38993433|FG000|Overall Study|Death|0|||
16138718|NCT00195507|38993434|FG001|Overall Study|Death|1|||
16138719|NCT00195507|38993433|FG000|Overall Study|Failed to Return|4|||
16138720|NCT00195507|38993434|FG001|Overall Study|Failed to Return|3|||
16138721|NCT00195507|38993433|FG000|Overall Study|Physician Decision|1|||
16138722|NCT00195507|38993434|FG001|Overall Study|Physician Decision|2|||
16138723|NCT00195507|38993433|FG000|Overall Study|Lost to Follow-up|3|||
16138724|NCT00195507|38993434|FG001|Overall Study|Lost to Follow-up|2|||
16138725|NCT00195507|38993433|FG000|Overall Study|Protocol Violation|5|||
16138726|NCT00195507|38993434|FG001|Overall Study|Protocol Violation|4|||
16138727|NCT00195507|38993433|FG000|Overall Study|Lack of Efficacy|40|||
16138728|NCT00195507|38993434|FG001|Overall Study|Lack of Efficacy|67|||
16138729|NCT00195507|38993433|FG000|Overall Study|Withdrawal by Subject|16|||
16254215|NCT01626859|39413229|FG001|Overall Study|Withdrawal by Subject|4|||
16254216|NCT01626859|39413230|FG002|Overall Study|Withdrawal by Subject|2|||
16254217|NCT00625807|39413231|FG000|Overall Study|schedule conflict|2|||
16254218|NCT00625807|39413232|FG001|Overall Study|schedule conflict|8|||
16254219|NCT02974153|39416605|FG000|Overall Study|Adverse Event|6|||
16254220|NCT02974153|39416606|FG001|Overall Study|Adverse Event|0|||
16254221|NCT02974153|39416607|FG002|Overall Study|Adverse Event|1|||
16254222|NCT02974153|39416605|FG000|Overall Study|Lack of Efficacy|6|||
16254223|NCT02974153|39416606|FG001|Overall Study|Lack of Efficacy|5|||
16138730|NCT00195507|38993434|FG001|Overall Study|Withdrawal by Subject|23|||
16138731|NCT00195507|38993433|FG000|Overall Study|Protocol Deviation|6|||
16138732|NCT00195507|38993434|FG001|Overall Study|Protocol Deviation|3|||
16138733|NCT01620255|38993435|FG000|Overall Study|Withdrawal by Subject|4|||
16138734|NCT01620255|38993436|FG001|Overall Study|Withdrawal by Subject|1|||
16138735|NCT01620255|38993437|FG002|Overall Study|Withdrawal by Subject|1|||
16254224|NCT02974153|39416607|FG002|Overall Study|Lack of Efficacy|10|||
16254225|NCT02974153|39416605|FG000|Overall Study|Lost to Follow-up|9|||
16254226|NCT02974153|39416606|FG001|Overall Study|Lost to Follow-up|10|||
16254227|NCT02974153|39416607|FG002|Overall Study|Lost to Follow-up|17|||
16254228|NCT02974153|39416605|FG000|Overall Study|Physician Decision|0|||
16138736|NCT01620255|38993438|FG003|Overall Study|Withdrawal by Subject|2|||
16138737|NCT01620255|38993439|FG004|Overall Study|Withdrawal by Subject|4|||
16138738|NCT01620255|38993435|FG000|Overall Study|Participant underwent fecal transplant|0|||
16138739|NCT01620255|38993436|FG001|Overall Study|Participant underwent fecal transplant|0|||
16138740|NCT01620255|38993437|FG002|Overall Study|Participant underwent fecal transplant|1|||
16138741|NCT01620255|38993438|FG003|Overall Study|Participant underwent fecal transplant|0|||
16138742|NCT01620255|38993439|FG004|Overall Study|Participant underwent fecal transplant|0|||
16138743|NCT01620255|38993435|FG000|Overall Study|Non-compliance|0|||
16138744|NCT01620255|38993436|FG001|Overall Study|Non-compliance|1|||
16138745|NCT01620255|38993437|FG002|Overall Study|Non-compliance|0|||
16138746|NCT01620255|38993438|FG003|Overall Study|Non-compliance|0|||
16138747|NCT01620255|38993439|FG004|Overall Study|Non-compliance|0|||
16138748|NCT01620255|38993435|FG000|Overall Study|Adverse Event|0|||
16138749|NCT01620255|38993436|FG001|Overall Study|Adverse Event|4|||
16138750|NCT01620255|38993437|FG002|Overall Study|Adverse Event|0|||
16138751|NCT01620255|38993438|FG003|Overall Study|Adverse Event|1|||
16138752|NCT01620255|38993439|FG004|Overall Study|Adverse Event|1|||
16138753|NCT01620255|38993435|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
16138754|NCT01620255|38993436|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
16138755|NCT01620255|38993437|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
16138756|NCT01620255|38993438|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
16138757|NCT01620255|38993439|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
16138758|NCT00764751|38993442|FG000|Overall Study|Adverse Event|1|||
16138759|NCT00764751|38993443|FG001|Overall Study|Adverse Event|1|||
16138760|NCT00764751|38993442|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
16138761|NCT00764751|38993443|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
16138762|NCT02260882|38993444|FG000|Overall Study|Protocol Violation|0|||
16138763|NCT02260882|38993445|FG001|Overall Study|Protocol Violation|1|||
16138764|NCT00092495|38996325|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
16138765|NCT00092495|38996326|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
16138766|NCT00092495|38996327|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
16138767|NCT00092495|38996328|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
16138768|NCT00092495|38996329|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
16138769|NCT00092495|38996325|FG000|Base Study Vaccination Period|Extended|0|||
16138770|NCT00092495|38996326|FG001|Base Study Vaccination Period|Extended|0|||
16138771|NCT00092495|38996327|FG002|Base Study Vaccination Period|Extended|0|||
16138772|NCT00092495|38996328|FG003|Base Study Vaccination Period|Extended|1|||
16138773|NCT00092495|38996329|FG004|Base Study Vaccination Period|Extended|0|||
16138774|NCT00092495|38996325|FG000|Base Study Vaccination Period|*Clinical AE|1|||
16138775|NCT00092495|38996326|FG001|Base Study Vaccination Period|*Clinical AE|0|||
16138776|NCT00092495|38996327|FG002|Base Study Vaccination Period|*Clinical AE|1|||
16138777|NCT00092495|38996328|FG003|Base Study Vaccination Period|*Clinical AE|2|||
16138778|NCT00092495|38996329|FG004|Base Study Vaccination Period|*Clinical AE|0|||
16138779|NCT00092495|38996325|FG000|Base Study Vaccination Period|*Other reasons|1|||
16138780|NCT00092495|38996326|FG001|Base Study Vaccination Period|*Other reasons|0|||
16138781|NCT00092495|38996327|FG002|Base Study Vaccination Period|*Other reasons|0|||
16138782|NCT00092495|38996328|FG003|Base Study Vaccination Period|*Other reasons|1|||
16138783|NCT00092495|38996329|FG004|Base Study Vaccination Period|*Other reasons|0|||
16138784|NCT00092495|38996325|FG000|Base Study Vaccination Period|*Pregnancy|0|||
16138785|NCT00092495|38996326|FG001|Base Study Vaccination Period|*Pregnancy|2|||
16138786|NCT00092495|38996327|FG002|Base Study Vaccination Period|*Pregnancy|5|||
16138787|NCT00092495|38996328|FG003|Base Study Vaccination Period|*Pregnancy|7|||
16138788|NCT00092495|38996329|FG004|Base Study Vaccination Period|*Pregnancy|0|||
16138789|NCT00092495|38996325|FG000|Base Study Vaccination Period|Adverse Event|1|||
16138790|NCT00092495|38996326|FG001|Base Study Vaccination Period|Adverse Event|0|||
16138791|NCT00092495|38996327|FG002|Base Study Vaccination Period|Adverse Event|0|||
16138792|NCT00092495|38996328|FG003|Base Study Vaccination Period|Adverse Event|3|||
16138793|NCT00092495|38996329|FG004|Base Study Vaccination Period|Adverse Event|0|||
16138794|NCT00092495|38996325|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
16138795|NCT00092495|38996326|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
16138796|NCT00092495|38996327|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
16138797|NCT00092495|38996328|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
16254229|NCT02974153|39416606|FG001|Overall Study|Physician Decision|2|||
16254230|NCT02974153|39416607|FG002|Overall Study|Physician Decision|1|||
16138798|NCT00092495|38996329|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
16138799|NCT00092495|38996325|FG000|Base Study Vaccination Period|Moved|3|||
16138800|NCT00092495|38996326|FG001|Base Study Vaccination Period|Moved|1|||
16138801|NCT00092495|38996327|FG002|Base Study Vaccination Period|Moved|2|||
16254231|NCT02974153|39416605|FG000|Overall Study|Withdrawal by Subject|9|||
16138802|NCT00092495|38996328|FG003|Base Study Vaccination Period|Moved|2|||
16138803|NCT00092495|38996329|FG004|Base Study Vaccination Period|Moved|0|||
16138804|NCT00092495|38996325|FG000|Base Study Vaccination Period|Other|1|||
16138805|NCT00092495|38996326|FG001|Base Study Vaccination Period|Other|1|||
16138806|NCT00092495|38996327|FG002|Base Study Vaccination Period|Other|0|||
16138807|NCT00092495|38996328|FG003|Base Study Vaccination Period|Other|2|||
16138808|NCT00092495|38996329|FG004|Base Study Vaccination Period|Other|0|||
16138809|NCT00092495|38996325|FG000|Base Study Vaccination Period|Pregnancy|2|||
16138810|NCT00092495|38996326|FG001|Base Study Vaccination Period|Pregnancy|0|||
16138811|NCT00092495|38996327|FG002|Base Study Vaccination Period|Pregnancy|0|||
16138812|NCT00092495|38996328|FG003|Base Study Vaccination Period|Pregnancy|0|||
16138813|NCT00092495|38996329|FG004|Base Study Vaccination Period|Pregnancy|0|||
16138814|NCT00092495|38996325|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
16138815|NCT00092495|38996326|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
16138816|NCT00092495|38996327|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
16138817|NCT00092495|38996328|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
16138818|NCT00092495|38996329|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
16138819|NCT00092495|38996325|FG000|Base Study Vaccination Period|Protocol Violation|1|||
16138820|NCT00092495|38996326|FG001|Base Study Vaccination Period|Protocol Violation|0|||
16138821|NCT00092495|38996327|FG002|Base Study Vaccination Period|Protocol Violation|0|||
16138822|NCT00092495|38996328|FG003|Base Study Vaccination Period|Protocol Violation|0|||
16138823|NCT00092495|38996329|FG004|Base Study Vaccination Period|Protocol Violation|0|||
16138824|NCT00092495|38996325|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
16138825|NCT00092495|38996326|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
16138826|NCT00092495|38996327|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
16138827|NCT00092495|38996328|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
16138828|NCT00092495|38996329|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
16138829|NCT00092495|38996325|FG000|Base Study Follow-up Period|Extended|0|||
16138830|NCT00092495|38996326|FG001|Base Study Follow-up Period|Extended|0|||
16138831|NCT00092495|38996327|FG002|Base Study Follow-up Period|Extended|1|||
16138832|NCT00092495|38996328|FG003|Base Study Follow-up Period|Extended|2|||
16138833|NCT00092495|38996329|FG004|Base Study Follow-up Period|Extended|0|||
16437029|NCT01276639|40077920|FG001|Week 0 to 16|Lost to Follow-up|5|||
16437030|NCT01276639|40077921|FG002|Week 0 to 16|Lost to Follow-up|3|||
16437031|NCT01276639|40077922|FG003|Week 0 to 16|Lost to Follow-up|0|||
16437032|NCT01276639|40077923|FG004|Week 0 to 16|Lost to Follow-up|0|||
16437033|NCT01276639|40077919|FG000|Week 0 to 16|Withdrawal by Subject|8|||
16437034|NCT01276639|40077920|FG001|Week 0 to 16|Withdrawal by Subject|5|||
16437035|NCT01276639|40077921|FG002|Week 0 to 16|Withdrawal by Subject|4|||
16437036|NCT01276639|40077922|FG003|Week 0 to 16|Withdrawal by Subject|0|||
16437037|NCT01276639|40077923|FG004|Week 0 to 16|Withdrawal by Subject|0|||
16437038|NCT01276639|40077919|FG000|Week 0 to 16|Other|7|||
16437039|NCT01276639|40077920|FG001|Week 0 to 16|Other|7|||
16437040|NCT01276639|40077921|FG002|Week 0 to 16|Other|2|||
16437041|NCT01276639|40077922|FG003|Week 0 to 16|Other|0|||
16437042|NCT01276639|40077923|FG004|Week 0 to 16|Other|0|||
16437043|NCT01276639|40077919|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
16437044|NCT01276639|40077920|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
16437045|NCT01276639|40077921|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
16437046|NCT01276639|40077922|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
16437047|NCT01276639|40077923|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
16437048|NCT01276639|40077919|FG000|Week 16 to 52|Death|1|||
16437049|NCT01276639|40077920|FG001|Week 16 to 52|Death|0|||
16437050|NCT01276639|40077921|FG002|Week 16 to 52|Death|0|||
16437051|NCT01276639|40077922|FG003|Week 16 to 52|Death|0|||
16437052|NCT01276639|40077923|FG004|Week 16 to 52|Death|0|||
16437053|NCT01276639|40077919|FG000|Week 16 to 52|Adverse Event|10|||
16437054|NCT01276639|40077920|FG001|Week 16 to 52|Adverse Event|13|||
16437055|NCT01276639|40077921|FG002|Week 16 to 52|Adverse Event|0|||
16437056|NCT01276639|40077922|FG003|Week 16 to 52|Adverse Event|1|||
16138834|NCT00092495|38996325|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
16138835|NCT00092495|38996326|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
16437057|NCT01276639|40077923|FG004|Week 16 to 52|Adverse Event|3|||
16437058|NCT01276639|40077919|FG000|Week 16 to 52|Lack of Efficacy|99|||
16437059|NCT01276639|40077920|FG001|Week 16 to 52|Lack of Efficacy|71|||
16437060|NCT01276639|40077921|FG002|Week 16 to 52|Lack of Efficacy|0|||
16437061|NCT01276639|40077922|FG003|Week 16 to 52|Lack of Efficacy|14|||
16437062|NCT01276639|40077923|FG004|Week 16 to 52|Lack of Efficacy|13|||
16437063|NCT01276639|40077919|FG000|Week 16 to 52|Lost to Follow-up|3|||
16437064|NCT01276639|40077920|FG001|Week 16 to 52|Lost to Follow-up|1|||
16138836|NCT00092495|38996327|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
16138837|NCT00092495|38996328|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
16138838|NCT00092495|38996329|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
16138839|NCT00092495|38996325|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
16138840|NCT00092495|38996326|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
16138841|NCT00092495|38996327|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
16138842|NCT00092495|38996328|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
16138843|NCT00092495|38996329|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
16254232|NCT02974153|39416606|FG001|Overall Study|Withdrawal by Subject|16|||
16254233|NCT02974153|39416607|FG002|Overall Study|Withdrawal by Subject|11|||
16254234|NCT02974153|39416605|FG000|Overall Study|Study Burden|8|||
16254235|NCT02974153|39416606|FG001|Overall Study|Study Burden|7|||
16254236|NCT02974153|39416607|FG002|Overall Study|Study Burden|3|||
16254237|NCT02974153|39416605|FG000|Overall Study|Other|14|||
16254238|NCT02974153|39416606|FG001|Overall Study|Other|8|||
16254239|NCT02974153|39416607|FG002|Overall Study|Other|7|||
16254240|NCT01545076|39416612|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
16254241|NCT01545076|39416613|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
16254242|NCT01545076|39416614|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
16254243|NCT01545076|39416615|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
16254244|NCT01545076|39416616|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
16254245|NCT01545076|39416612|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
16254246|NCT01545076|39416613|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
16254247|NCT01545076|39416614|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
16254248|NCT01545076|39416615|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
16254249|NCT01545076|39416616|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
16254250|NCT01545076|39416612|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
16254251|NCT01545076|39416613|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
16254252|NCT01545076|39416614|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
16254253|NCT01545076|39416615|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
16254254|NCT01545076|39416616|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
16254255|NCT01545076|39416612|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
16254256|NCT01545076|39416613|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
16254257|NCT01545076|39416614|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
16254258|NCT01545076|39416615|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
16254259|NCT01545076|39416616|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
16254260|NCT01545076|39416612|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
16254261|NCT01545076|39416613|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
16254262|NCT01545076|39416614|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
16254263|NCT01545076|39416615|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
16254264|NCT01545076|39416616|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
16254265|NCT01545076|39416612|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
16254266|NCT01545076|39416613|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
16254267|NCT01545076|39416614|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
16254268|NCT01545076|39416615|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
16254269|NCT01545076|39416616|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
16254270|NCT01545076|39416612|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
16254271|NCT01545076|39416613|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
16254272|NCT01545076|39416614|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
16254273|NCT01545076|39416615|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
16254274|NCT01545076|39416616|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
16254275|NCT01545076|39416612|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
16254276|NCT01545076|39416613|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
16254277|NCT01545076|39416614|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
16363096|NCT04666298|39815001|FG003|Overall Study|Protocol deviation|0|||
16363097|NCT00706797|39815006|FG000|Overall Study|Lack of Efficacy|3|||
16363098|NCT00706797|39815007|FG001|Overall Study|Lack of Efficacy|0|||
16363099|NCT00706797|39815006|FG000|Overall Study|Adverse Event|0|||
16254278|NCT01545076|39416615|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
16254279|NCT01545076|39416616|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
16254280|NCT01545076|39416612|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
16254281|NCT01545076|39416613|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
16254282|NCT01545076|39416614|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
16254283|NCT01545076|39416615|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
16254284|NCT01545076|39416616|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
16254285|NCT03977584|39416619|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
16254286|NCT03977584|39416620|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
16254287|NCT03977584|39416621|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
16254288|NCT01620177|39416626|FG000|Overall Study|Failure at Screening Visit|43|||
16254289|NCT01620177|39416626|FG000|Overall Study|Withdrawal by Subject|26|||
16254290|NCT01620177|39416626|FG000|Overall Study|Lost to Follow-up|7|||
16254291|NCT01620177|39416626|FG000|Overall Study|Physician Decision|2|||
16254292|NCT01620177|39416626|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
16254293|NCT03194464|39416627|FG000|Overall Study|data not usable|2|||
16254294|NCT03717064|39416628|FG000|Period 2|Adverse Event|1|||
16254295|NCT01654380|39416631|FG000|Part B, Period 1|Physician Decision|0|||
16254296|NCT01654380|39416632|FG001|Part B, Period 1|Physician Decision|0|||
16254297|NCT01654380|39416633|FG002|Part B, Period 1|Physician Decision|1|||
16254298|NCT01654380|39416634|FG003|Part B, Period 1|Physician Decision|0|||
16254299|NCT00365300|39416635|FG000|Open-label Phase|Adverse Event|4|||
16254300|NCT00365300|39416636|FG001|Open-label Phase|Adverse Event|0|||
16254301|NCT00365300|39416635|FG000|Open-label Phase|Failed to Return|1|||
16254302|NCT00365300|39416636|FG001|Open-label Phase|Failed to Return|0|||
16254303|NCT00365300|39416635|FG000|Open-label Phase|Physician Decision|1|||
16254304|NCT00365300|39416636|FG001|Open-label Phase|Physician Decision|0|||
16254305|NCT00365300|39416635|FG000|Open-label Phase|Noncompliance|9|||
16254306|NCT00365300|39416636|FG001|Open-label Phase|Noncompliance|0|||
16254307|NCT00365300|39416635|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
16254308|NCT00365300|39416636|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
16254309|NCT00365300|39416635|FG000|Open-label Phase|Protocol Violation|1|||
16254310|NCT00365300|39416636|FG001|Open-label Phase|Protocol Violation|0|||
16254311|NCT00365300|39416635|FG000|Open-label Phase|Lack of Efficacy|1|||
16254312|NCT00365300|39416636|FG001|Open-label Phase|Lack of Efficacy|0|||
16254313|NCT00365300|39416635|FG000|Open-label Phase|Patient skipped open label phase|1|||
16254314|NCT00365300|39416636|FG001|Open-label Phase|Patient skipped open label phase|0|||
16254315|NCT00365300|39416635|FG000|Double-blind Phase|Failed to return|1|||
16254316|NCT00365300|39416636|FG001|Double-blind Phase|Failed to return|0|||
16254317|NCT00365300|39416635|FG000|Double-blind Phase|Noncompliance|1|||
16254318|NCT00365300|39416636|FG001|Double-blind Phase|Noncompliance|1|||
16254319|NCT00365300|39416635|FG000|Double-blind Phase|Withdrawal by Subject|0|||
16254320|NCT00365300|39416636|FG001|Double-blind Phase|Withdrawal by Subject|1|||
16254321|NCT00365300|39416635|FG000|Double-blind Phase|Protocol Violation|3|||
16254322|NCT00365300|39416636|FG001|Double-blind Phase|Protocol Violation|1|||
16254323|NCT00365300|39416635|FG000|Double-blind Phase|Lack of Efficacy|6|||
16254324|NCT00365300|39416636|FG001|Double-blind Phase|Lack of Efficacy|6|||
16254325|NCT01030965|39416637|FG000|Overall Study|Lack of Efficacy|3|||
16254326|NCT01030965|39416638|FG001|Overall Study|Lack of Efficacy|2|||
16254327|NCT01030965|39416639|FG002|Overall Study|Lack of Efficacy|0|||
16254328|NCT01030965|39416640|FG003|Overall Study|Lack of Efficacy|3|||
16254329|NCT01030965|39416637|FG000|Overall Study|Protocol Violation|1|||
16254330|NCT01030965|39416638|FG001|Overall Study|Protocol Violation|1|||
16254331|NCT01030965|39416639|FG002|Overall Study|Protocol Violation|1|||
16254332|NCT01030965|39416640|FG003|Overall Study|Protocol Violation|1|||
16254333|NCT01030965|39416637|FG000|Overall Study|Adverse Event|0|||
16254334|NCT01030965|39416638|FG001|Overall Study|Adverse Event|1|||
16254335|NCT01030965|39416639|FG002|Overall Study|Adverse Event|2|||
16254336|NCT01030965|39416640|FG003|Overall Study|Adverse Event|1|||
16254337|NCT01030965|39416637|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
16254338|NCT01030965|39416638|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
16254339|NCT01030965|39416639|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
16254340|NCT01030965|39416640|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
16254341|NCT01030965|39416637|FG000|Overall Study|Withdrawal by Subject|0|||
16254342|NCT01030965|39416638|FG001|Overall Study|Withdrawal by Subject|1|||
16254343|NCT01030965|39416639|FG002|Overall Study|Withdrawal by Subject|0|||
16254344|NCT01030965|39416640|FG003|Overall Study|Withdrawal by Subject|2|||
16254345|NCT00510510|39416644|FG000|Overall Study|Adverse Event|4|||
16254346|NCT00510510|39416645|FG001|Overall Study|Adverse Event|3|||
16254347|NCT00510510|39416646|FG002|Overall Study|Adverse Event|6|||
16254348|NCT00510510|39416644|FG000|Overall Study|Lack of Efficacy|0|||
16254349|NCT00510510|39416645|FG001|Overall Study|Lack of Efficacy|1|||
16254350|NCT00510510|39416646|FG002|Overall Study|Lack of Efficacy|1|||
16363100|NCT00706797|39815007|FG001|Overall Study|Adverse Event|3|||
16138844|NCT02178553|38996332|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
16138845|NCT02178553|38996333|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
16254351|NCT00510510|39416644|FG000|Overall Study|Subjects no longer requires study drug|0|||
16254352|NCT00510510|39416645|FG001|Overall Study|Subjects no longer requires study drug|0|||
16254353|NCT00510510|39416646|FG002|Overall Study|Subjects no longer requires study drug|2|||
16254354|NCT00510510|39416644|FG000|Overall Study|Withdrawal by Subject|1|||
16254355|NCT00510510|39416645|FG001|Overall Study|Withdrawal by Subject|2|||
16254356|NCT00510510|39416646|FG002|Overall Study|Withdrawal by Subject|3|||
16254357|NCT00510510|39416644|FG000|Overall Study|Lost to Follow-up|0|||
16254358|NCT00510510|39416645|FG001|Overall Study|Lost to Follow-up|0|||
16254359|NCT00510510|39416646|FG002|Overall Study|Lost to Follow-up|1|||
16254360|NCT00510510|39416644|FG000|Overall Study|Protocol Violation|0|||
16254361|NCT00510510|39416645|FG001|Overall Study|Protocol Violation|3|||
16254362|NCT00510510|39416646|FG002|Overall Study|Protocol Violation|4|||
16254363|NCT01367275|39416649|FG000|Overall Study|Ineligible|1|||
16254364|NCT01367275|39416649|FG000|Overall Study|Disease Progression|2|||
16254365|NCT00436007|39416651|FG000|Overall Study|Withdrawal by Subject|5|||
16254366|NCT00436007|39416652|FG001|Overall Study|Withdrawal by Subject|3|||
16254367|NCT00436007|39416653|FG002|Overall Study|Withdrawal by Subject|4|||
16254368|NCT00436007|39416651|FG000|Overall Study|Lost to Follow-up|14|||
16254369|NCT00436007|39416652|FG001|Overall Study|Lost to Follow-up|10|||
16437065|NCT01276639|40077921|FG002|Week 16 to 52|Lost to Follow-up|0|||
16437066|NCT01276639|40077922|FG003|Week 16 to 52|Lost to Follow-up|0|||
16437067|NCT01276639|40077923|FG004|Week 16 to 52|Lost to Follow-up|1|||
16437068|NCT01276639|40077919|FG000|Week 16 to 52|Withdrawal by Subject|4|||
16437069|NCT01276639|40077920|FG001|Week 16 to 52|Withdrawal by Subject|4|||
16437070|NCT01276639|40077921|FG002|Week 16 to 52|Withdrawal by Subject|0|||
16254370|NCT00436007|39416653|FG002|Overall Study|Lost to Follow-up|13|||
16254371|NCT00436007|39416651|FG000|Overall Study|Physician Decision|0|||
16254372|NCT00436007|39416652|FG001|Overall Study|Physician Decision|0|||
16254373|NCT00436007|39416653|FG002|Overall Study|Physician Decision|2|||
16254374|NCT00436007|39416651|FG000|Overall Study|Death|0|||
16254375|NCT00436007|39416652|FG001|Overall Study|Death|1|||
16254376|NCT00436007|39416653|FG002|Overall Study|Death|3|||
16254377|NCT00436007|39416651|FG000|Overall Study|Other|0|||
16254378|NCT00436007|39416652|FG001|Overall Study|Other|0|||
16254379|NCT00436007|39416653|FG002|Overall Study|Other|1|||
16254380|NCT04109222|39416660|FG000|Overall Study|Adverse Event|1|||
16254381|NCT04109222|39416661|FG001|Overall Study|Adverse Event|0|||
16254382|NCT04109222|39416662|FG002|Overall Study|Adverse Event|0|||
16254383|NCT02372409|39416663|FG000|Overall Study|Lost to Follow-up|1|||
16254384|NCT02372409|39416664|FG001|Overall Study|Lost to Follow-up|0|||
16254385|NCT02372409|39416663|FG000|Overall Study|Disease progression|1|||
16254386|NCT02372409|39416664|FG001|Overall Study|Disease progression|1|||
16437071|NCT01276639|40077922|FG003|Week 16 to 52|Withdrawal by Subject|0|||
16437072|NCT01276639|40077923|FG004|Week 16 to 52|Withdrawal by Subject|1|||
16254387|NCT00662025|39416665|FG000|Overall Study|Objective progression or relapse|51|||
16254388|NCT00662025|39416665|FG000|Overall Study|Adverse Event|7|||
16254389|NCT00662025|39416665|FG000|Overall Study|Withdrawal by Subject|1|||
16254390|NCT00662025|39416665|FG000|Overall Study|Results of other clinical study|2|||
16437073|NCT01276639|40077919|FG000|Week 16 to 52|Other|10|||
16437074|NCT01276639|40077920|FG001|Week 16 to 52|Other|12|||
16437075|NCT01276639|40077921|FG002|Week 16 to 52|Other|0|||
16437076|NCT01276639|40077922|FG003|Week 16 to 52|Other|1|||
16437077|NCT01276639|40077923|FG004|Week 16 to 52|Other|3|||
16437078|NCT01091675|40077925|FG000|Overall Study|Adverse Event|7|||
16437079|NCT01091675|40077925|FG000|Overall Study|Lack of Efficacy|27|||
16437080|NCT01405768|40077926|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
16437081|NCT01405768|40077927|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
16437082|NCT02796677|40077935|FG000|Overall Study|Adverse Event|11|||
16437083|NCT02796677|40077936|FG001|Overall Study|Adverse Event|22|||
16437084|NCT02796677|40077937|FG002|Overall Study|Adverse Event|14|||
16437085|NCT02796677|40077938|FG003|Overall Study|Adverse Event|14|||
16437086|NCT02796677|40077935|FG000|Overall Study|Protocol Violation|7|||
16437087|NCT02796677|40077936|FG001|Overall Study|Protocol Violation|5|||
16437088|NCT02796677|40077937|FG002|Overall Study|Protocol Violation|4|||
16437089|NCT02796677|40077938|FG003|Overall Study|Protocol Violation|8|||
16437090|NCT02796677|40077935|FG000|Overall Study|Lost to Follow-up|1|||
16437091|NCT02796677|40077936|FG001|Overall Study|Lost to Follow-up|5|||
16437092|NCT02796677|40077937|FG002|Overall Study|Lost to Follow-up|2|||
16437093|NCT02796677|40077938|FG003|Overall Study|Lost to Follow-up|2|||
16437094|NCT02796677|40077935|FG000|Overall Study|Lack of Efficacy|7|||
16437095|NCT02796677|40077936|FG001|Overall Study|Lack of Efficacy|9|||
16437096|NCT02796677|40077937|FG002|Overall Study|Lack of Efficacy|14|||
16437097|NCT02796677|40077938|FG003|Overall Study|Lack of Efficacy|20|||
16437098|NCT02796677|40077935|FG000|Overall Study|Withdrawal by Subject|4|||
16437099|NCT02796677|40077936|FG001|Overall Study|Withdrawal by Subject|14|||
16437100|NCT02796677|40077937|FG002|Overall Study|Withdrawal by Subject|6|||
16437101|NCT02796677|40077938|FG003|Overall Study|Withdrawal by Subject|7|||
16437102|NCT02796677|40077935|FG000|Overall Study|Progressive disease|6|||
16437103|NCT02796677|40077936|FG001|Overall Study|Progressive disease|15|||
16437104|NCT02796677|40077937|FG002|Overall Study|Progressive disease|13|||
16437105|NCT02796677|40077938|FG003|Overall Study|Progressive disease|18|||
16437106|NCT02796677|40077935|FG000|Overall Study|Reason not mentioned|2|||
16437107|NCT02796677|40077936|FG001|Overall Study|Reason not mentioned|3|||
16437108|NCT02796677|40077937|FG002|Overall Study|Reason not mentioned|0|||
16437109|NCT02796677|40077938|FG003|Overall Study|Reason not mentioned|5|||
16437110|NCT00286494|40077939|FG000|Overall Study|Hyperglycemic rescue|12|||
16437111|NCT00286494|40077940|FG001|Overall Study|Hyperglycemic rescue|19|||
16437112|NCT00286494|40077941|FG002|Overall Study|Hyperglycemic rescue|18|||
16437113|NCT00286494|40077939|FG000|Overall Study|Withdrawal by Subject|2|||
16437114|NCT00286494|40077940|FG001|Overall Study|Withdrawal by Subject|10|||
16437115|NCT00286494|40077941|FG002|Overall Study|Withdrawal by Subject|9|||
16437116|NCT00286494|40077939|FG000|Overall Study|Adverse Event|3|||
16437117|NCT00286494|40077940|FG001|Overall Study|Adverse Event|8|||
16437118|NCT00286494|40077941|FG002|Overall Study|Adverse Event|6|||
16437119|NCT00286494|40077939|FG000|Overall Study|Physician Decision|5|||
16437120|NCT00286494|40077940|FG001|Overall Study|Physician Decision|5|||
16437121|NCT00286494|40077941|FG002|Overall Study|Physician Decision|1|||
16437122|NCT00286494|40077939|FG000|Overall Study|Lost to Follow-up|3|||
16437123|NCT00286494|40077940|FG001|Overall Study|Lost to Follow-up|1|||
16437124|NCT00286494|40077941|FG002|Overall Study|Lost to Follow-up|3|||
16437125|NCT00286494|40077939|FG000|Overall Study|Protocol Violation|1|||
16437126|NCT00286494|40077940|FG001|Overall Study|Protocol Violation|1|||
16437127|NCT00286494|40077941|FG002|Overall Study|Protocol Violation|2|||
16437128|NCT01018030|40077942|FG000|Overall Study|Adverse Event|10|||
16437129|NCT01018030|40077943|FG001|Overall Study|Adverse Event|5|||
16437130|NCT01018030|40077944|FG002|Overall Study|Adverse Event|5|||
16437131|NCT01018030|40077942|FG000|Overall Study|Withdrawal by Subject|2|||
16437132|NCT01018030|40077943|FG001|Overall Study|Withdrawal by Subject|2|||
16437133|NCT01018030|40077944|FG002|Overall Study|Withdrawal by Subject|4|||
16437134|NCT01018030|40077942|FG000|Overall Study|Lost to Follow-up|2|||
16138846|NCT02178553|38996332|FG000|Overall Study|Physician Decision|0|||
16254391|NCT00662025|39416665|FG000|Overall Study|Target lesion cannot be evaluated|1|||
16254392|NCT00662025|39416665|FG000|Overall Study|Domestic circumstances|1|||
16254393|NCT01345019|39416666|FG000|Blinded Treatment Phase|Death|147|||
16254394|NCT01345019|39416667|FG001|Blinded Treatment Phase|Death|137|||
16254395|NCT01345019|39416666|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
16254396|NCT01345019|39416667|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
16254397|NCT01345019|39416666|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
16254398|NCT01345019|39416667|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
16254399|NCT01345019|39416666|FG000|Blinded Treatment Phase|Disease Progression|12|||
16254400|NCT01345019|39416667|FG001|Blinded Treatment Phase|Disease Progression|10|||
16254401|NCT01345019|39416666|FG000|Blinded Treatment Phase|Adverse Event|6|||
16254402|NCT01345019|39416667|FG001|Blinded Treatment Phase|Adverse Event|13|||
16254403|NCT01345019|39416666|FG000|Blinded Treatment Phase|Administrative Decision|10|||
16254404|NCT01345019|39416667|FG001|Blinded Treatment Phase|Administrative Decision|8|||
16254405|NCT01345019|39416666|FG000|Blinded Treatment Phase|Noncompliance|5|||
16254406|NCT01345019|39416667|FG001|Blinded Treatment Phase|Noncompliance|3|||
16254407|NCT01345019|39416666|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
16254408|NCT01345019|39416667|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
16254409|NCT01345019|39416666|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
16254410|NCT01345019|39416667|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
16254411|NCT01345019|39416666|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
16254412|NCT01345019|39416667|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
16254413|NCT01345019|39416666|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
16254414|NCT01345019|39416667|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
16254415|NCT01345019|39416666|FG000|Open Label Treatment Phase|Death|49|||
16254416|NCT01345019|39416667|FG001|Open Label Treatment Phase|Death|48|||
16254417|NCT01345019|39416666|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
16254418|NCT01345019|39416667|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
16254419|NCT01345019|39416666|FG000|Open Label Treatment Phase|Adverse Event|30|||
16254420|NCT01345019|39416667|FG001|Open Label Treatment Phase|Adverse Event|51|||
16254421|NCT01345019|39416666|FG000|Open Label Treatment Phase|Administrative Decision|30|||
16254422|NCT01345019|39416667|FG001|Open Label Treatment Phase|Administrative Decision|15|||
16254423|NCT01345019|39416666|FG000|Open Label Treatment Phase|Disease Progression|17|||
16254424|NCT01345019|39416667|FG001|Open Label Treatment Phase|Disease Progression|18|||
16254425|NCT01345019|39416666|FG000|Open Label Treatment Phase|Noncompliance|5|||
16254426|NCT01345019|39416667|FG001|Open Label Treatment Phase|Noncompliance|4|||
16254427|NCT01345019|39416666|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
16254428|NCT01345019|39416667|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
16254429|NCT01345019|39416666|FG000|Open Label Treatment Phase|Pregnancy|1|||
16254430|NCT01345019|39416667|FG001|Open Label Treatment Phase|Pregnancy|0|||
16363101|NCT00706797|39815006|FG000|Overall Study|Withdrawal by Subject|8|||
16363102|NCT00706797|39815007|FG001|Overall Study|Withdrawal by Subject|1|||
16363103|NCT00706797|39815006|FG000|Overall Study|Death|1|||
16363104|NCT00706797|39815007|FG001|Overall Study|Death|0|||
16363105|NCT00706797|39815006|FG000|Overall Study|Discontinuation of study by sponsor|52|||
16363106|NCT00706797|39815007|FG001|Overall Study|Discontinuation of study by sponsor|63|||
16363107|NCT00706797|39815006|FG000|Overall Study|Protocol Violation|3|||
16363108|NCT00706797|39815007|FG001|Overall Study|Protocol Violation|2|||
16363109|NCT00706797|39815006|FG000|Overall Study|Lost to Follow-up|1|||
16363110|NCT00706797|39815007|FG001|Overall Study|Lost to Follow-up|2|||
16363111|NCT00706797|39815006|FG000|Overall Study|Other|1|||
16363112|NCT00706797|39815007|FG001|Overall Study|Other|0|||
16363113|NCT04711005|39815009|FG000|Overall Study|Withdrawal by Subject|0|||
16363114|NCT04711005|39815010|FG001|Overall Study|Withdrawal by Subject|0|||
16363115|NCT04711005|39815011|FG002|Overall Study|Withdrawal by Subject|0|||
16363116|NCT04711005|39815012|FG003|Overall Study|Withdrawal by Subject|0|||
16363117|NCT04711005|39815013|FG004|Overall Study|Withdrawal by Subject|0|||
16363118|NCT04711005|39815014|FG005|Overall Study|Withdrawal by Subject|0|||
16363119|NCT04711005|39815015|FG006|Overall Study|Withdrawal by Subject|0|||
16363120|NCT04711005|39815016|FG007|Overall Study|Withdrawal by Subject|1|||
16363121|NCT04711005|39815017|FG008|Overall Study|Withdrawal by Subject|0|||
16363122|NCT04711005|39815018|FG009|Overall Study|Withdrawal by Subject|0|||
16363123|NCT04711005|39815009|FG000|Overall Study|Physician Decision|0|||
16363124|NCT04711005|39815010|FG001|Overall Study|Physician Decision|0|||
16363125|NCT04711005|39815011|FG002|Overall Study|Physician Decision|0|||
16363126|NCT04711005|39815012|FG003|Overall Study|Physician Decision|0|||
16363127|NCT04711005|39815013|FG004|Overall Study|Physician Decision|0|||
16363128|NCT04711005|39815014|FG005|Overall Study|Physician Decision|0|||
16363129|NCT04711005|39815015|FG006|Overall Study|Physician Decision|0|||
16363130|NCT04711005|39815016|FG007|Overall Study|Physician Decision|2|||
16363131|NCT04711005|39815017|FG008|Overall Study|Physician Decision|1|||
16363132|NCT04711005|39815018|FG009|Overall Study|Physician Decision|0|||
16363133|NCT03255187|39815023|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
16363134|NCT03255187|39815024|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
16437135|NCT01018030|40077943|FG001|Overall Study|Lost to Follow-up|0|||
16437136|NCT01018030|40077944|FG002|Overall Study|Lost to Follow-up|3|||
16437137|NCT01018030|40077942|FG000|Overall Study|Protocol Violation|2|||
16437138|NCT01018030|40077943|FG001|Overall Study|Protocol Violation|1|||
16437139|NCT01018030|40077944|FG002|Overall Study|Protocol Violation|0|||
16437140|NCT01018030|40077942|FG000|Overall Study|Physician Decision|1|||
16437141|NCT01018030|40077943|FG001|Overall Study|Physician Decision|0|||
16437142|NCT01018030|40077944|FG002|Overall Study|Physician Decision|1|||
16437143|NCT01018030|40077942|FG000|Overall Study|Lack of Efficacy|1|||
16437144|NCT01018030|40077943|FG001|Overall Study|Lack of Efficacy|0|||
16437145|NCT01018030|40077944|FG002|Overall Study|Lack of Efficacy|0|||
16437146|NCT01018030|40077942|FG000|Overall Study|Did Not Receive Study Drug|1|||
16437147|NCT01018030|40077943|FG001|Overall Study|Did Not Receive Study Drug|3|||
16437148|NCT01018030|40077944|FG002|Overall Study|Did Not Receive Study Drug|0|||
16437149|NCT01121146|40077945|FG000|Overall Study|Death|17|||
16437150|NCT01121146|40077946|FG001|Overall Study|Death|15|||
16437151|NCT01121146|40077945|FG000|Overall Study|Adverse Event|2|||
16437152|NCT01121146|40077946|FG001|Overall Study|Adverse Event|11|||
16437153|NCT01121146|40077945|FG000|Overall Study|Lost to Follow-up|7|||
16437154|NCT01121146|40077946|FG001|Overall Study|Lost to Follow-up|16|||
16437155|NCT01389882|40077956|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
16437156|NCT01389882|40077957|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
16437157|NCT01389882|40077956|FG000|Overall Study|Withdrawal by Subject|0|||
16437158|NCT01389882|40077957|FG001|Overall Study|Withdrawal by Subject|1|||
16437159|NCT00863330|40077959|FG000|Overall Study|study terminated early due to administra|6|||
16437160|NCT04050553|40077960|FG000|Period 1|Physician Decision|2|||
16437161|NCT04050553|40077961|FG001|Period 1|Physician Decision|2|||
16437162|NCT04050553|40077960|FG000|Period 1|Adverse Event|1|||
16437163|NCT04050553|40077961|FG001|Period 1|Adverse Event|1|||
16437164|NCT04050553|40077960|FG000|Period 1|Withdrawal by Subject|0|||
16437165|NCT04050553|40077961|FG001|Period 1|Withdrawal by Subject|1|||
16437166|NCT04050553|40077960|FG000|Wash-out|Adverse Event|0|||
16437167|NCT04050553|40077961|FG001|Wash-out|Adverse Event|1|||
16437168|NCT04050553|40077960|FG000|Wash-out|Withdrawal by Subject|0|||
16437169|NCT04050553|40077961|FG001|Wash-out|Withdrawal by Subject|1|||
16437170|NCT02994108|40077964|FG000|Intervention Messages|Withdrawal by Subject|2|||
16437171|NCT02994108|40077965|FG001|Intervention Messages|Withdrawal by Subject|0|||
16437172|NCT02994108|40077964|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
16437173|NCT02994108|40077965|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
16437174|NCT02994108|40077964|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
16437175|NCT02994108|40077965|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
16437176|NCT02994108|40077964|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
16437177|NCT02994108|40077965|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
16437178|NCT02544321|40077966|FG000|Overall Study|Withdrawal by Subject|1|||
16437179|NCT02544321|40077967|FG001|Overall Study|Withdrawal by Subject|2|||
16437180|NCT02544321|40077966|FG000|Overall Study|Adverse Event|1|||
16437181|NCT02544321|40077967|FG001|Overall Study|Adverse Event|1|||
16437182|NCT02544321|40077966|FG000|Overall Study|Protocol Violation|0|||
16437183|NCT02544321|40077967|FG001|Overall Study|Protocol Violation|1|||
16437184|NCT03431441|40077968|FG000|Overall Study|Withdrawal by Subject|2|||
16437185|NCT03431441|40077968|FG000|Overall Study|Adverse Event|2|||
16437186|NCT03431441|40077968|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
16437187|NCT00265564|40077972|FG000|Overall Study|Lost to Follow-up|5|||
16437188|NCT00265564|40077973|FG001|Overall Study|Lost to Follow-up|7|||
16437189|NCT00265564|40077972|FG000|Overall Study|met exclusion criteria|5|||
16437190|NCT00265564|40077973|FG001|Overall Study|met exclusion criteria|2|||
16437191|NCT00475670|40081934|FG000|Overall Study|Death|0|||
16437192|NCT00475670|40081935|FG001|Overall Study|Death|1|||
16437193|NCT00475670|40081934|FG000|Overall Study|Lack of Efficacy|3|||
16437194|NCT00475670|40081935|FG001|Overall Study|Lack of Efficacy|34|||
16437195|NCT00475670|40081934|FG000|Overall Study|Refused treatment|0|||
16437196|NCT00475670|40081935|FG001|Overall Study|Refused treatment|2|||
16437197|NCT00475670|40081934|FG000|Overall Study|Failure to Return|0|||
16437198|NCT00475670|40081935|FG001|Overall Study|Failure to Return|1|||
16437199|NCT00475670|40081934|FG000|Overall Study|Other|0|||
16437200|NCT00475670|40081935|FG001|Overall Study|Other|3|||
16437201|NCT02365649|40081936|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
16437202|NCT02365649|40081937|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
16437203|NCT02365649|40081938|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
16437204|NCT02365649|40081939|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
16437205|NCT02365649|40081940|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
16437206|NCT02365649|40081941|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
16437207|NCT02365649|40081942|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
16437208|NCT02365649|40081943|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
16437209|NCT02365649|40081944|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
16437210|NCT02365649|40081945|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
16437211|NCT02365649|40081936|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
16437212|NCT02365649|40081937|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
16437213|NCT02365649|40081938|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
16437214|NCT02365649|40081939|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
16437215|NCT02365649|40081940|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
16363135|NCT03255187|39815023|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
16363136|NCT03255187|39815024|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
16363137|NCT01245062|39815034|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
16363138|NCT01245062|39815035|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
16363139|NCT01245062|39815036|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
16363140|NCT01245062|39815034|FG000|Randomization and Crossover Phase|Physician Decision|2|||
16363141|NCT01245062|39815035|FG001|Randomization and Crossover Phase|Physician Decision|4|||
16363142|NCT01245062|39815036|FG002|Randomization and Crossover Phase|Physician Decision|0|||
16363143|NCT01245062|39815034|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
16363144|NCT01245062|39815035|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
16363145|NCT01245062|39815036|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
16363146|NCT01245062|39815034|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
16363147|NCT01245062|39815035|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
16363148|NCT01245062|39815036|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
16363149|NCT01245062|39815034|FG000|Cross-over Phase|Lost to Follow-up|0|||
16363150|NCT01245062|39815035|FG001|Cross-over Phase|Lost to Follow-up|0|||
16363151|NCT01245062|39815036|FG002|Cross-over Phase|Lost to Follow-up|1|||
16363152|NCT01245062|39815034|FG000|Cross-over Phase|Physician Decision|0|||
16363153|NCT01245062|39815035|FG001|Cross-over Phase|Physician Decision|0|||
16363154|NCT01245062|39815036|FG002|Cross-over Phase|Physician Decision|1|||
16363155|NCT01245062|39815034|FG000|Cross-over Phase|Withdrew Consent|0|||
16363156|NCT01245062|39815035|FG001|Cross-over Phase|Withdrew Consent|0|||
16363157|NCT01245062|39815036|FG002|Cross-over Phase|Withdrew Consent|4|||
16363158|NCT01245062|39815034|FG000|Cross-over Phase|Study closed/ terminated|0|||
16363159|NCT01245062|39815035|FG001|Cross-over Phase|Study closed/ terminated|0|||
16363160|NCT01245062|39815036|FG002|Cross-over Phase|Study closed/ terminated|11|||
16363161|NCT00961415|39815037|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
16363162|NCT00961415|39815038|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
16363163|NCT00961415|39815039|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
16363164|NCT00961415|39815037|FG000|Induction Treatment Phase|Death|77|||
16363165|NCT00961415|39815038|FG001|Induction Treatment Phase|Death|0|||
16363166|NCT00961415|39815039|FG002|Induction Treatment Phase|Death|0|||
16363167|NCT00961415|39815037|FG000|Induction Treatment Phase|Protocol Violation|1|||
16437216|NCT02365649|40081941|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
16437217|NCT02365649|40081942|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
16437218|NCT02365649|40081943|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
16437219|NCT02365649|40081944|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
16437220|NCT02365649|40081945|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
16363168|NCT00961415|39815038|FG001|Induction Treatment Phase|Protocol Violation|0|||
16363169|NCT00961415|39815039|FG002|Induction Treatment Phase|Protocol Violation|0|||
16363170|NCT00961415|39815037|FG000|Induction Treatment Phase|Physician Decision|2|||
16363171|NCT00961415|39815038|FG001|Induction Treatment Phase|Physician Decision|0|||
16363172|NCT00961415|39815039|FG002|Induction Treatment Phase|Physician Decision|0|||
16363173|NCT00961415|39815037|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
16363174|NCT00961415|39815038|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
16437221|NCT02365649|40081936|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
16437222|NCT02365649|40081937|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
16437223|NCT02365649|40081938|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
16437224|NCT02365649|40081939|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
16437225|NCT02365649|40081940|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
16437226|NCT02365649|40081941|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
16138847|NCT02178553|38996333|FG001|Overall Study|Physician Decision|4|||
16138848|NCT02178553|38996332|FG000|Overall Study|Technical problem with injection|1|||
16138849|NCT02178553|38996333|FG001|Overall Study|Technical problem with injection|3|||
16138850|NCT02308007|38996337|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
16138851|NCT02308007|38996338|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
16138852|NCT02308007|38996339|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
16138853|NCT02308007|38996337|FG000|Overall Study|Positive for STD at Baseline|7|||
16138854|NCT02308007|38996338|FG001|Overall Study|Positive for STD at Baseline|11|||
16138855|NCT02308007|38996339|FG002|Overall Study|Positive for STD at Baseline|7|||
16138856|NCT02308007|38996337|FG000|Overall Study|Lost to Follow-up|3|||
16138857|NCT02308007|38996338|FG001|Overall Study|Lost to Follow-up|0|||
16138858|NCT02308007|38996339|FG002|Overall Study|Lost to Follow-up|1|||
16138859|NCT01295281|38996340|FG000|First Intervention (7 Days)|Death|0|||
16437227|NCT02365649|40081942|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
16437228|NCT02365649|40081943|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
16138860|NCT01295281|38996341|FG001|First Intervention (7 Days)|Death|1|||
16138861|NCT02279862|38996342|FG000|Overall Study|Study drug toxicity|3|||
16138862|NCT02279862|38996343|FG001|Overall Study|Study drug toxicity|6|||
16138863|NCT02279862|38996342|FG000|Overall Study|No longer meets criteria|0|||
16138864|NCT02279862|38996343|FG001|Overall Study|No longer meets criteria|1|||
16138865|NCT02279862|38996342|FG000|Overall Study|Administrative reason by sponsor|0|||
16138866|NCT02279862|38996343|FG001|Overall Study|Administrative reason by sponsor|1|||
16138867|NCT02279862|38996342|FG000|Overall Study|Disease progression|5|||
16138868|NCT02279862|38996343|FG001|Overall Study|Disease progression|2|||
16138869|NCT02279862|38996342|FG000|Overall Study|Study closed by sponsor|16|||
16138870|NCT02279862|38996343|FG001|Overall Study|Study closed by sponsor|13|||
16138871|NCT02279862|38996342|FG000|Overall Study|Other|1|||
16138872|NCT02279862|38996343|FG001|Overall Study|Other|2|||
16138873|NCT02279862|38996342|FG000|Overall Study|Withdrawal by Subject|1|||
16138874|NCT02279862|38996343|FG001|Overall Study|Withdrawal by Subject|0|||
16138875|NCT01829425|38996344|FG000|Overall Study|Withdrawal by Subject|4|||
16138876|NCT01829425|38996345|FG001|Overall Study|Withdrawal by Subject|3|||
16138877|NCT01829425|38996344|FG000|Overall Study|Lost to Follow-up|2|||
16138878|NCT01829425|38996345|FG001|Overall Study|Lost to Follow-up|1|||
16138879|NCT01881750|38996348|FG000|Overall Study|Changes in concomitant therapies|2|||
16138880|NCT01881750|38996349|FG001|Overall Study|Changes in concomitant therapies|3|||
16138881|NCT01881750|38996348|FG000|Overall Study|Lost to Follow-up|0|||
16138882|NCT01881750|38996349|FG001|Overall Study|Lost to Follow-up|1|||
16138883|NCT00293722|38996357|FG000|Overall Study|Other|427|||
16138884|NCT01106404|38996358|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
16138885|NCT01106404|38996359|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
16138886|NCT01106404|38996358|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
16138887|NCT01106404|38996359|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
16138888|NCT01106404|38996358|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
16138889|NCT01106404|38996359|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
16138890|NCT01106404|38996358|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
16138891|NCT01106404|38996359|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
16138892|NCT01357577|38996361|FG000|Overall Study|Lost to Follow-up|20|||
16363175|NCT00961415|39815039|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
16363176|NCT00961415|39815037|FG000|Induction Treatment Phase|Other Reason|5|||
16363177|NCT00961415|39815038|FG001|Induction Treatment Phase|Other Reason|0|||
16363178|NCT00961415|39815039|FG002|Induction Treatment Phase|Other Reason|0|||
16363179|NCT00961415|39815037|FG000|Maintenance Treatment Phase|Death|0|||
16363180|NCT00961415|39815038|FG001|Maintenance Treatment Phase|Death|42|||
16363181|NCT00961415|39815039|FG002|Maintenance Treatment Phase|Death|34|||
16138893|NCT01357577|38996362|FG001|Overall Study|Lost to Follow-up|16|||
16138894|NCT01357577|38996361|FG000|Overall Study|Withdrawal by Subject|16|||
16138895|NCT01357577|38996362|FG001|Overall Study|Withdrawal by Subject|8|||
16138896|NCT01357577|38996361|FG000|Overall Study|look at data in database?|1|||
16138897|NCT01357577|38996362|FG001|Overall Study|look at data in database?|2|||
16138898|NCT03681951|38996363|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
16138899|NCT03681951|38996364|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
16138900|NCT03681951|38996365|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
16138901|NCT03681951|38996366|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
16138902|NCT03681951|38996367|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
16138903|NCT03681951|38996368|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
16138904|NCT03681951|38996369|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
16138905|NCT03681951|38996370|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
16138906|NCT03681951|38996363|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
16138907|NCT03681951|38996364|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
16138908|NCT03681951|38996365|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
16138909|NCT03681951|38996366|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
16138910|NCT03681951|38996367|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
16138911|NCT03681951|38996368|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
16138912|NCT03681951|38996369|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
16138913|NCT03681951|38996370|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
16138914|NCT03681951|38996363|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
16138915|NCT03681951|38996364|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
16138916|NCT03681951|38996365|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
16138917|NCT03681951|38996366|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
16138918|NCT03681951|38996367|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
16138919|NCT03681951|38996368|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
16138920|NCT03681951|38996369|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
16138921|NCT03681951|38996370|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
16138922|NCT00730171|38996376|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
16138923|NCT00730171|38996376|FG000|Overall Study|Adverse Event|193|||
16138924|NCT00730171|38996376|FG000|Overall Study|Protocol Violation|48|||
16138925|NCT00730171|38996376|FG000|Overall Study|Withdrawal by Subject|202|||
16138926|NCT00730171|38996376|FG000|Overall Study|Lost to Follow-up|121|||
16138927|NCT00730171|38996376|FG000|Overall Study|Insufficient Therapeutic Response|141|||
16138928|NCT00730171|38996376|FG000|Overall Study|Other|61|||
16138929|NCT01117857|38996377|FG000|Overall Study|Lost to Follow-up|4|||
16138930|NCT01117857|38996377|FG000|Overall Study|Withdrawal by Subject|4|||
16138931|NCT01117857|38996377|FG000|Overall Study|Physician Decision|1|||
16138932|NCT00928746|38996384|FG000|Overall Study|Adverse Event|2|||
16138933|NCT00928746|38996384|FG000|Overall Study|Protocol Violation|1|||
16138934|NCT00928746|38996384|FG000|Overall Study|Withdrawal by Subject|1|||
16138935|NCT00928746|38996384|FG000|Overall Study|Other|2|||
16138936|NCT05085665|38996387|FG000|Overall Study|Physician Decision|2|||
16138937|NCT01009554|38996388|FG000|Overall Study|Adverse Event|1|||
16138938|NCT01009554|38996389|FG001|Overall Study|Adverse Event|1|||
16138939|NCT01009554|38996388|FG000|Overall Study|Withdrawal by Subject|1|||
16138940|NCT01009554|38996389|FG001|Overall Study|Withdrawal by Subject|3|||
16138941|NCT01009554|38996388|FG000|Overall Study|Noncompliant with Study Product|0|||
16138942|NCT01009554|38996389|FG001|Overall Study|Noncompliant with Study Product|3|||
16138943|NCT01230554|38996390|FG000|Overall Study|Lost to Follow-up|2|||
16138944|NCT01230554|38996390|FG000|Overall Study|Inability to maintain visit schedule|1|||
16138945|NCT02020863|38996392|FG000|Overall Study|Discovery of Metastatic disease|4|||
16138946|NCT02020863|38996392|FG000|Overall Study|Team chose not to place an a line|1|||
16138947|NCT01326533|38996394|FG000|Overall Study|Lost to Follow-up|2|||
16138948|NCT01326533|38996395|FG001|Overall Study|Lost to Follow-up|0|||
16138949|NCT01326533|38996394|FG000|Overall Study|Withdrawal by Subject|1|||
16138950|NCT01326533|38996395|FG001|Overall Study|Withdrawal by Subject|0|||
16138951|NCT01326533|38996394|FG000|Overall Study|Adverse Event|1|||
16138952|NCT01326533|38996395|FG001|Overall Study|Adverse Event|0|||
16138953|NCT03986866|38996397|FG000|Overall Study|Withdrawal by Subject|0|||
16138954|NCT03986866|38996398|FG001|Overall Study|Withdrawal by Subject|3|||
16437229|NCT02365649|40081944|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
16437230|NCT02365649|40081945|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
16437231|NCT02365649|40081936|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
16437232|NCT02365649|40081937|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
16437233|NCT02365649|40081938|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
16437234|NCT02365649|40081939|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
16437235|NCT02365649|40081940|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
16437236|NCT02365649|40081941|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
16437237|NCT02365649|40081942|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
16437238|NCT02365649|40081943|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
16437239|NCT02365649|40081944|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
16437240|NCT02365649|40081945|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
16138955|NCT03986866|38996397|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
16138956|NCT03986866|38996398|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
16138957|NCT00778622|38996399|FG000|Overall Study|Adverse Event|5|||
16138958|NCT00778622|38996400|FG001|Overall Study|Adverse Event|4|||
16138959|NCT00778622|38996401|FG002|Overall Study|Adverse Event|7|||
16138960|NCT00778622|38996399|FG000|Overall Study|Withdrawal by Subject|4|||
16138961|NCT00778622|38996400|FG001|Overall Study|Withdrawal by Subject|5|||
16138962|NCT00778622|38996401|FG002|Overall Study|Withdrawal by Subject|5|||
16138963|NCT00778622|38996399|FG000|Overall Study|Lost to Follow-up|3|||
16138964|NCT00778622|38996400|FG001|Overall Study|Lost to Follow-up|3|||
16138965|NCT00778622|38996401|FG002|Overall Study|Lost to Follow-up|2|||
16138966|NCT00778622|38996399|FG000|Overall Study|Protocol Violation|0|||
16138967|NCT00778622|38996400|FG001|Overall Study|Protocol Violation|3|||
16138968|NCT00778622|38996401|FG002|Overall Study|Protocol Violation|0|||
16138969|NCT00778622|38996399|FG000|Overall Study|Lack of Efficacy|2|||
16138970|NCT00778622|38996400|FG001|Overall Study|Lack of Efficacy|0|||
16138971|NCT00778622|38996401|FG002|Overall Study|Lack of Efficacy|0|||
16138972|NCT00778622|38996399|FG000|Overall Study|immigration|1|||
16138973|NCT00778622|38996400|FG001|Overall Study|immigration|0|||
16138974|NCT00778622|38996401|FG002|Overall Study|immigration|0|||
16138975|NCT00778622|38996399|FG000|Overall Study|Other|1|||
16138976|NCT00778622|38996400|FG001|Overall Study|Other|0|||
16138977|NCT00778622|38996401|FG002|Overall Study|Other|1|||
16138978|NCT01128738|38996404|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
16138979|NCT01128738|38996405|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
16138980|NCT01128738|38996404|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
16138981|NCT01128738|38996405|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
16138982|NCT01128738|38996404|FG000|Second TP|Lost to Follow-up|0|||
16138983|NCT01128738|38996405|FG001|Second TP|Lost to Follow-up|1|||
16138984|NCT01128738|38996404|FG000|Second TP|Withdrawal by Subject|0|||
16138985|NCT01128738|38996405|FG001|Second TP|Withdrawal by Subject|2|||
16138986|NCT00993915|38996408|FG000|Overall Study|Insufficient clinical response|3|||
16138987|NCT00993915|38996408|FG000|Overall Study|Withdrawal by Subject|2|||
16138988|NCT00993915|38996408|FG000|Overall Study|Other|1|||
16138989|NCT00993915|38996408|FG000|Overall Study|Ongoing|3|||
16437241|NCT02365649|40081936|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
16437242|NCT02365649|40081937|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
16138990|NCT00671554|38996409|FG000|Overall Study|Disease progression|3|||
16138991|NCT02225353|38996410|FG000|Overall Study|Lost to Follow-up|0|||
16138992|NCT02225353|38996411|FG001|Overall Study|Lost to Follow-up|1|||
16138993|NCT02225353|38996412|FG002|Overall Study|Lost to Follow-up|3|||
16363182|NCT00961415|39815037|FG000|Maintenance Treatment Phase|Investigators decision|0|||
16363183|NCT00961415|39815038|FG001|Maintenance Treatment Phase|Investigators decision|2|||
16363184|NCT00961415|39815039|FG002|Maintenance Treatment Phase|Investigators decision|0|||
16363185|NCT00961415|39815037|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
16363186|NCT00961415|39815038|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
16363187|NCT00961415|39815039|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
16363188|NCT00961415|39815037|FG000|Maintenance Treatment Phase|Other reason|0|||
16363189|NCT00961415|39815038|FG001|Maintenance Treatment Phase|Other reason|1|||
16363190|NCT00961415|39815039|FG002|Maintenance Treatment Phase|Other reason|3|||
16363191|NCT04591015|39815040|FG000|Overall Study|Death|6|||
16363192|NCT04591015|39815041|FG001|Overall Study|Death|4|||
16363193|NCT04591015|39815040|FG000|Overall Study|Withdrawal by Subject|6|||
16363194|NCT04591015|39815041|FG001|Overall Study|Withdrawal by Subject|3|||
16363195|NCT04591015|39815040|FG000|Overall Study|Lost to Follow-up|16|||
16363196|NCT04591015|39815041|FG001|Overall Study|Lost to Follow-up|11|||
16363197|NCT01499511|39815042|FG000|Overall Study|Death|1|||
16138994|NCT02225353|38996410|FG000|Overall Study|Protocol Violation|4|||
16138995|NCT02225353|38996411|FG001|Overall Study|Protocol Violation|5|||
16138996|NCT02225353|38996412|FG002|Overall Study|Protocol Violation|12|||
16138997|NCT02003014|38996419|FG000|Overall Study|Case report forms uncollected|9|||
16138998|NCT02003014|38996419|FG000|Overall Study|Treatment started after contract period|1|||
16138999|NCT02003014|38996419|FG000|Overall Study|Patient did not visit the study site|5|||
16437243|NCT02365649|40081938|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
16437244|NCT02365649|40081939|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
16437245|NCT02365649|40081940|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
16437246|NCT02365649|40081941|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
16437247|NCT02365649|40081942|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
16437248|NCT02365649|40081943|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
16437249|NCT02365649|40081944|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
16437250|NCT02365649|40081945|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
16437251|NCT02365649|40081936|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
16437252|NCT02365649|40081937|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
16437253|NCT02365649|40081938|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
16437254|NCT02365649|40081939|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
16437255|NCT02365649|40081940|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
16437256|NCT02365649|40081941|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
16437257|NCT02365649|40081942|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
16437258|NCT02365649|40081943|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
16437259|NCT02365649|40081944|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
16437260|NCT02365649|40081945|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
16437261|NCT02365649|40081936|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
16437262|NCT02365649|40081937|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
16437263|NCT02365649|40081938|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
16437264|NCT02365649|40081939|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
16139000|NCT02003014|38996419|FG000|Overall Study|Investigator's transfer|4|||
16437265|NCT02365649|40081940|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
16437266|NCT02365649|40081941|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
16437267|NCT02365649|40081942|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
16437268|NCT02365649|40081943|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
16437269|NCT02365649|40081944|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
16437270|NCT02365649|40081945|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
16437271|NCT02365649|40081936|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
16437272|NCT02365649|40081937|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
16437273|NCT02365649|40081938|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
16437274|NCT02365649|40081939|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
16437275|NCT02365649|40081940|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
16437276|NCT02365649|40081941|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
16437277|NCT02365649|40081942|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
16139001|NCT01605253|38996422|FG000|Overall Study|Physician Decision|3|||
16139002|NCT01605253|38996423|FG001|Overall Study|Physician Decision|2|||
16139003|NCT01605253|38996422|FG000|Overall Study|Lost to Follow-up|3|||
16139004|NCT01605253|38996423|FG001|Overall Study|Lost to Follow-up|1|||
16139005|NCT03873493|38996428|FG000|Overall Study|Withdrawal by Subject|1|||
16139006|NCT03873493|38996428|FG000|Overall Study|Death|9|||
16139007|NCT03873493|38996428|FG000|Overall Study|Lost to Follow-up|1|||
16139008|NCT03873493|38996428|FG000|Overall Study|Study Terminated by Sponsor|1|||
16139009|NCT03873493|38996428|FG000|Overall Study|Other|2|||
16139010|NCT00705432|38996429|FG000|Treatment Period|Adverse Event|45|||
16139011|NCT00705432|38996430|FG001|Treatment Period|Adverse Event|37|||
16139012|NCT00705432|38996431|FG002|Treatment Period|Adverse Event|51|||
16139013|NCT00705432|38996432|FG003|Treatment Period|Adverse Event|12|||
16139014|NCT00705432|38996433|FG004|Treatment Period|Adverse Event|8|||
16139015|NCT00705432|38996434|FG005|Treatment Period|Adverse Event|9|||
16139016|NCT00705432|38996429|FG000|Treatment Period|Treatment failure|92|||
16139017|NCT00705432|38996430|FG001|Treatment Period|Treatment failure|42|||
16139018|NCT00705432|38996431|FG002|Treatment Period|Treatment failure|33|||
16139019|NCT00705432|38996432|FG003|Treatment Period|Treatment failure|25|||
16139020|NCT00705432|38996433|FG004|Treatment Period|Treatment failure|13|||
16139021|NCT00705432|38996434|FG005|Treatment Period|Treatment failure|14|||
16139022|NCT00705432|38996429|FG000|Treatment Period|Non medical reason|26|||
16139023|NCT00705432|38996430|FG001|Treatment Period|Non medical reason|32|||
16139024|NCT00705432|38996431|FG002|Treatment Period|Non medical reason|37|||
16139025|NCT00705432|38996432|FG003|Treatment Period|Non medical reason|4|||
16139026|NCT00705432|38996433|FG004|Treatment Period|Non medical reason|7|||
16139027|NCT00705432|38996434|FG005|Treatment Period|Non medical reason|7|||
16139028|NCT00705432|38996429|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
16139029|NCT00705432|38996430|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
16139030|NCT00705432|38996431|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
16139031|NCT00705432|38996432|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
16254431|NCT01345019|39416666|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
16254432|NCT01345019|39416667|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
16254433|NCT01345019|39416666|FG000|Open Label Treatment Phase|Protocol Violation|0|||
16254434|NCT01345019|39416667|FG001|Open Label Treatment Phase|Protocol Violation|1|||
16254435|NCT01893905|39416668|FG000|Overall Study|Withdrawal by Subject|1|||
16254436|NCT01893905|39416669|FG001|Overall Study|Withdrawal by Subject|0|||
16254437|NCT01893905|39416668|FG000|Overall Study|Adverse Event|9|||
16254438|NCT01893905|39416669|FG001|Overall Study|Adverse Event|3|||
16254439|NCT01893905|39416668|FG000|Overall Study|Lack of Efficacy|5|||
16254440|NCT01893905|39416669|FG001|Overall Study|Lack of Efficacy|7|||
16254441|NCT01893905|39416668|FG000|Overall Study|Lost to Follow-up|1|||
16363198|NCT01499511|39815043|FG001|Overall Study|Death|0|||
16363199|NCT01288430|39815044|FG000|Part 1|Progressive disease|2|||
16363200|NCT01288430|39815045|FG001|Part 1|Progressive disease|1|||
16363201|NCT01288430|39815046|FG002|Part 1|Progressive disease|1|||
16363202|NCT01288430|39815047|FG003|Part 1|Progressive disease|6|||
16363203|NCT01288430|39815048|FG004|Part 1|Progressive disease|2|||
16363204|NCT01288430|39815049|FG005|Part 1|Progressive disease|4|||
16363205|NCT01288430|39815050|FG006|Part 1|Progressive disease|2|||
16363206|NCT01288430|39815051|FG007|Part 1|Progressive disease|0|||
16363207|NCT01288430|39815052|FG008|Part 1|Progressive disease|0|||
16363208|NCT01288430|39815053|FG009|Part 1|Progressive disease|0|||
16363209|NCT01288430|39815044|FG000|Part 1|Clinical disease progression|0|||
16363210|NCT01288430|39815045|FG001|Part 1|Clinical disease progression|0|||
16363211|NCT01288430|39815046|FG002|Part 1|Clinical disease progression|1|||
16139032|NCT00705432|38996433|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
16139033|NCT00705432|38996434|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
16139034|NCT00705432|38996429|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
16139035|NCT00705432|38996430|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
16139036|NCT00705432|38996431|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
16139037|NCT00705432|38996432|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
16139038|NCT00705432|38996433|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
16139039|NCT00705432|38996434|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
16139040|NCT00688181|38996436|FG000|Overall Study|Lost to Follow-up|17|||
16139041|NCT00688181|38996436|FG000|Overall Study|Unknown Reason|4|||
16139042|NCT00688181|38996436|FG000|Overall Study|Non-clinical Reason|2|||
16139043|NCT00655863|38996438|FG000|Overall Study|Lost to Follow-up|0|||
16139044|NCT00655863|38996439|FG001|Overall Study|Lost to Follow-up|0|||
16139045|NCT00655863|38996440|FG002|Overall Study|Lost to Follow-up|1|||
16139046|NCT00833911|38996442|FG000|Titration|Adverse Event|18|||
16139047|NCT00833911|38996442|FG000|Titration|Withdrawal by Subject|3|||
16139048|NCT00833911|38996442|FG000|Maintenance Phase I|Adverse Event|73|||
16139049|NCT00833911|38996442|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
16139050|NCT00833911|38996442|FG000|Maintenance Phase I|Physician Decision|10|||
16363212|NCT01288430|39815047|FG003|Part 1|Clinical disease progression|0|||
16363213|NCT01288430|39815048|FG004|Part 1|Clinical disease progression|0|||
16363214|NCT01288430|39815049|FG005|Part 1|Clinical disease progression|2|||
16363215|NCT01288430|39815050|FG006|Part 1|Clinical disease progression|2|||
16139051|NCT00833911|38996442|FG000|Maintenance Phase I|Lack of Efficacy|4|||
16139052|NCT00833911|38996442|FG000|Maintenance Phase II|Adverse Event|6|||
16363216|NCT01288430|39815051|FG007|Part 1|Clinical disease progression|0|||
16363217|NCT01288430|39815052|FG008|Part 1|Clinical disease progression|0|||
16437278|NCT02365649|40081943|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
16437279|NCT02365649|40081944|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
16437280|NCT02365649|40081945|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
16437281|NCT02365649|40081936|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
16254442|NCT01893905|39416669|FG001|Overall Study|Lost to Follow-up|0|||
16254443|NCT01893905|39416668|FG000|Overall Study|Protocol Violation|6|||
16254444|NCT01893905|39416669|FG001|Overall Study|Protocol Violation|1|||
16254445|NCT01893905|39416668|FG000|Overall Study|Lack of adherence to treatment|2|||
16437282|NCT02365649|40081937|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
16437283|NCT02365649|40081938|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
16437284|NCT02365649|40081939|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
16437285|NCT02365649|40081940|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
16437286|NCT02365649|40081941|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
16437287|NCT02365649|40081942|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
16437288|NCT02365649|40081943|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
16437289|NCT02365649|40081944|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
16437290|NCT02365649|40081945|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
16437291|NCT02365649|40081936|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
16437292|NCT02365649|40081937|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
16437293|NCT02365649|40081938|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
16437294|NCT02365649|40081939|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
16437295|NCT02365649|40081940|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
16437296|NCT02365649|40081941|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
16437297|NCT02365649|40081942|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
16437298|NCT02365649|40081943|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
16437299|NCT02365649|40081944|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
16437300|NCT02365649|40081945|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
16437301|NCT02365649|40081936|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
16437302|NCT02365649|40081937|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
16437303|NCT02365649|40081938|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
16437304|NCT02365649|40081939|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
16437305|NCT02365649|40081940|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
16437306|NCT02365649|40081941|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
16437307|NCT02365649|40081942|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
16437308|NCT02365649|40081943|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
16437309|NCT02365649|40081944|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
16437310|NCT02365649|40081945|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
16437311|NCT02365649|40081936|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
16437312|NCT02365649|40081937|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
16437313|NCT02365649|40081938|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
16437314|NCT02365649|40081939|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
16437315|NCT02365649|40081940|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
16437316|NCT02365649|40081941|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
16437317|NCT02365649|40081942|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
16437318|NCT02365649|40081943|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
16437319|NCT02365649|40081944|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
16437320|NCT02365649|40081945|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
16437321|NCT05362487|40081946|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
16437322|NCT03798717|40081947|FG000|Overall Study|Failed Screening|0|||
16437323|NCT03798717|40081948|FG001|Overall Study|Failed Screening|0|||
16437324|NCT03798717|40081949|FG002|Overall Study|Failed Screening|0|||
16437325|NCT03798717|40081950|FG003|Overall Study|Failed Screening|0|||
16437326|NCT03798717|40081951|FG004|Overall Study|Failed Screening|0|||
16437327|NCT03798717|40081952|FG005|Overall Study|Failed Screening|1|||
16437328|NCT03798717|40081947|FG000|Overall Study|Physician Decision|1|||
16437329|NCT03798717|40081948|FG001|Overall Study|Physician Decision|0|||
16437330|NCT03798717|40081949|FG002|Overall Study|Physician Decision|1|||
16437331|NCT03798717|40081950|FG003|Overall Study|Physician Decision|0|||
16437332|NCT03798717|40081951|FG004|Overall Study|Physician Decision|0|||
16437333|NCT03798717|40081952|FG005|Overall Study|Physician Decision|0|||
16437334|NCT03798717|40081947|FG000|Overall Study|Withdrawal by Subject|0|||
16437335|NCT03798717|40081948|FG001|Overall Study|Withdrawal by Subject|0|||
16437336|NCT03798717|40081949|FG002|Overall Study|Withdrawal by Subject|0|||
16437337|NCT03798717|40081950|FG003|Overall Study|Withdrawal by Subject|1|||
16139053|NCT00833911|38996442|FG000|Maintenance Phase II|Physician Decision|2|||
16139054|NCT00833911|38996442|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
16139055|NCT00833911|38996442|FG000|Maintenance Phase II|Lack of Efficacy|1|||
16139056|NCT01395316|38996445|FG000|Overall Study|Lost to Follow-up|2|||
16139057|NCT01395316|38996445|FG000|Overall Study|poor MRI quality|1|||
16139058|NCT00069238|38996446|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
16139059|NCT00069238|38996447|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
16139060|NCT00069238|38996448|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
16139061|NCT00069238|38996446|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
16139062|NCT00069238|38996447|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
16139063|NCT00069238|38996448|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
16139064|NCT00069238|38996446|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
16139065|NCT00069238|38996447|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
16437338|NCT03798717|40081951|FG004|Overall Study|Withdrawal by Subject|0|||
16437339|NCT03798717|40081952|FG005|Overall Study|Withdrawal by Subject|0|||
16139066|NCT00069238|38996448|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
16139067|NCT03690141|38996458|FG000|Overall Study|Adverse Event|5|||
16139068|NCT03690141|38996458|FG000|Overall Study|Withdrawal by Subject|3|||
16139069|NCT03690141|38996458|FG000|Overall Study|Physician Decision|4|||
16139070|NCT03690141|38996458|FG000|Overall Study|Disease progression|4|||
16437340|NCT03798717|40081947|FG000|Overall Study|Lost to Follow-up|1|||
16437341|NCT03798717|40081948|FG001|Overall Study|Lost to Follow-up|0|||
16437342|NCT03798717|40081949|FG002|Overall Study|Lost to Follow-up|0|||
16437343|NCT03798717|40081950|FG003|Overall Study|Lost to Follow-up|1|||
16437344|NCT03798717|40081951|FG004|Overall Study|Lost to Follow-up|0|||
16437345|NCT03798717|40081952|FG005|Overall Study|Lost to Follow-up|0|||
16437346|NCT03798717|40081947|FG000|Overall Study|Adverse Event|0|||
16437347|NCT03798717|40081948|FG001|Overall Study|Adverse Event|1|||
16437348|NCT03798717|40081949|FG002|Overall Study|Adverse Event|0|||
16437349|NCT03798717|40081950|FG003|Overall Study|Adverse Event|0|||
16437350|NCT03798717|40081951|FG004|Overall Study|Adverse Event|0|||
16437351|NCT03798717|40081952|FG005|Overall Study|Adverse Event|0|||
16437352|NCT03798717|40081947|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
16437353|NCT03798717|40081948|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
16437354|NCT03798717|40081949|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
16139071|NCT00972777|38996459|FG000|Overall Study|Adverse Event|3|||
16139072|NCT00972777|38996460|FG001|Overall Study|Adverse Event|2|||
16139073|NCT00972777|38996459|FG000|Overall Study|Lost to Follow-up|0|||
16139074|NCT00972777|38996460|FG001|Overall Study|Lost to Follow-up|4|||
16139075|NCT00972777|38996459|FG000|Overall Study|Withdrawal by Subject|4|||
16139076|NCT00972777|38996460|FG001|Overall Study|Withdrawal by Subject|5|||
16139077|NCT00972777|38996459|FG000|Overall Study|Physician Decision|4|||
16139078|NCT00972777|38996460|FG001|Overall Study|Physician Decision|0|||
16139079|NCT00972777|38996459|FG000|Overall Study|Protocol Violation|0|||
16139080|NCT00972777|38996460|FG001|Overall Study|Protocol Violation|2|||
16139081|NCT00972777|38996459|FG000|Overall Study|Screening Failure|2|||
16139082|NCT00972777|38996460|FG001|Overall Study|Screening Failure|1|||
16139083|NCT00972777|38996459|FG000|Overall Study|Missed visit|1|||
16254446|NCT01893905|39416669|FG001|Overall Study|Lack of adherence to treatment|0|||
16254447|NCT01893905|39416668|FG000|Overall Study|Other reason|1|||
16254448|NCT01893905|39416669|FG001|Overall Study|Other reason|3|||
16254449|NCT00812253|39416670|FG000|Overall Study|Withdrawal by Subject|3|||
16254450|NCT00812253|39416671|FG001|Overall Study|Withdrawal by Subject|2|||
16254451|NCT00812253|39416670|FG000|Overall Study|Protocol Violation|1|||
16254452|NCT00812253|39416671|FG001|Overall Study|Protocol Violation|1|||
16254453|NCT00812253|39416670|FG000|Overall Study|Lost to Follow-up|2|||
16437355|NCT03798717|40081950|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
16139084|NCT00972777|38996460|FG001|Overall Study|Missed visit|0|||
16139085|NCT00261846|38996461|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
16437356|NCT03798717|40081951|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
16139086|NCT00261846|38996462|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
16254454|NCT00812253|39416671|FG001|Overall Study|Lost to Follow-up|0|||
16254455|NCT00683293|39416672|FG000|Overall Study|Withdrawal by Subject|2|||
16437357|NCT03798717|40081952|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
16437358|NCT00997035|40081954|FG000|3-week Followup Visit|Lost to Follow-up|9|||
16437359|NCT00997035|40081955|FG001|3-week Followup Visit|Lost to Follow-up|6|||
16437360|NCT00997035|40081954|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
16437361|NCT00997035|40081955|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
16254456|NCT00683293|39416673|FG001|Overall Study|Withdrawal by Subject|3|||
16254457|NCT03295721|39416674|FG000|Overall Study|Adverse Event|1|||
16254458|NCT03295721|39416675|FG001|Overall Study|Adverse Event|0|||
16254459|NCT03295721|39416676|FG002|Overall Study|Adverse Event|0|||
16254460|NCT03295721|39416674|FG000|Overall Study|Lost to Follow-up|1|||
16254461|NCT03295721|39416675|FG001|Overall Study|Lost to Follow-up|1|||
16254462|NCT03295721|39416676|FG002|Overall Study|Lost to Follow-up|1|||
16254463|NCT03295721|39416674|FG000|Overall Study|Withdrawal by Subject|1|||
16254464|NCT03295721|39416675|FG001|Overall Study|Withdrawal by Subject|0|||
16254465|NCT03295721|39416676|FG002|Overall Study|Withdrawal by Subject|1|||
16254466|NCT03295721|39416674|FG000|Overall Study|Death|0|||
16254467|NCT03295721|39416675|FG001|Overall Study|Death|0|||
16254468|NCT03295721|39416676|FG002|Overall Study|Death|1|||
16254469|NCT00203307|39416678|FG000|First Intervention|Adverse Event|2|||
16254470|NCT00203307|39416679|FG001|First Intervention|Adverse Event|0|||
16254471|NCT01379781|39416683|FG000|Overall Study|Lost to Follow-up|11|||
16254472|NCT01379781|39416684|FG001|Overall Study|Lost to Follow-up|8|||
16254473|NCT02207231|39416685|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
16254474|NCT02207231|39416686|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
16254475|NCT02207231|39416687|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
16254476|NCT02207231|39416688|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
16254477|NCT02207231|39416685|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
16254478|NCT02207231|39416686|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
16254479|NCT02207231|39416687|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
16254480|NCT02207231|39416688|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
16254481|NCT02207231|39416685|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
16254482|NCT02207231|39416686|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
16254483|NCT02207231|39416687|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
16254484|NCT02207231|39416688|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
16254485|NCT02207231|39416685|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
16254486|NCT02207231|39416686|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
16254487|NCT02207231|39416687|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
16254488|NCT02207231|39416688|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
16254489|NCT02207231|39416685|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
16254490|NCT02207231|39416686|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
16254491|NCT02207231|39416687|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
16254492|NCT02207231|39416688|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
16254493|NCT02207231|39416685|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
16254494|NCT02207231|39416686|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
16254495|NCT02207231|39416687|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
16254496|NCT02207231|39416688|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
16254497|NCT02207231|39416685|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
16254498|NCT02207231|39416686|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
16254499|NCT02207231|39416687|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
16254500|NCT02207231|39416688|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
16254501|NCT02207231|39416685|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
16254502|NCT02207231|39416686|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
16254503|NCT02207231|39416687|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
16254504|NCT02207231|39416688|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
16254505|NCT02207231|39416685|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
16254506|NCT02207231|39416686|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
16254507|NCT02207231|39416687|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
16254508|NCT02207231|39416688|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
16254509|NCT02207231|39416685|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
16254510|NCT02207231|39416686|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
16254511|NCT02207231|39416687|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
16437362|NCT03480152|40081959|FG000|Phase I|Signed consent. Died before treatment.|1|||
16437363|NCT03480152|40081960|FG001|Phase I|Signed consent. Died before treatment.|0|||
16139087|NCT00261846|38996463|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
16139088|NCT00261846|38996464|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16139089|NCT00261846|38996465|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16139090|NCT00261846|38996466|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16139091|NCT00261846|38996467|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16139092|NCT00261846|38996468|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16139093|NCT00261846|38996469|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16437364|NCT03480152|40081961|FG002|Phase I|Signed consent. Died before treatment.|0|||
16437365|NCT00758771|40081962|FG000|Overall Study|Withdrawal by Subject|1|||
16437366|NCT00758771|40081963|FG001|Overall Study|Withdrawal by Subject|1|||
16437367|NCT00758771|40081962|FG000|Overall Study|Did not meet eligibility criteria|2|||
16437368|NCT00758771|40081963|FG001|Overall Study|Did not meet eligibility criteria|4|||
16437369|NCT03289208|40081964|FG000|Overall Study|Adverse Event|1|||
16437370|NCT03289208|40081965|FG001|Overall Study|Adverse Event|0|||
16437371|NCT03289208|40081966|FG002|Overall Study|Adverse Event|0|||
16437372|NCT02782676|40081967|FG000|Overall Study|Lost to Follow-up|0|||
16437373|NCT02782676|40081968|FG001|Overall Study|Lost to Follow-up|1|||
16437374|NCT01751061|40081969|FG000|Overall Study|Death|1|||
16437375|NCT01751061|40081970|FG001|Overall Study|Death|0|||
16437376|NCT01751061|40081969|FG000|Overall Study|patient death|5|||
16437377|NCT01751061|40081970|FG001|Overall Study|patient death|0|||
16437378|NCT01751061|40081969|FG000|Overall Study|Lost to Follow-up|40|||
16437379|NCT01751061|40081970|FG001|Overall Study|Lost to Follow-up|25|||
16437380|NCT01751061|40081969|FG000|Overall Study|patient regained decisional capacity|4|||
16437381|NCT01751061|40081970|FG001|Overall Study|patient regained decisional capacity|8|||
16437382|NCT01751061|40081969|FG000|Overall Study|Withdrawal by Subject|4|||
16437383|NCT01751061|40081970|FG001|Overall Study|Withdrawal by Subject|1|||
16437384|NCT01751061|40081969|FG000|Overall Study|Physician Decision|2|||
16437385|NCT01751061|40081970|FG001|Overall Study|Physician Decision|0|||
16437386|NCT03466658|40081971|FG000|Overall Study|Withdrawal by Subject|3|||
16437387|NCT00918385|40081974|FG000|Monotherapy|Adverse Event|1|||
16437388|NCT00918385|40081975|FG001|Monotherapy|Adverse Event|6|||
16437389|NCT00918385|40081974|FG000|Monotherapy|Complicating illness|1|||
16437390|NCT00918385|40081975|FG001|Monotherapy|Complicating illness|0|||
16437391|NCT00918385|40081974|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
16437392|NCT00918385|40081975|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
16437393|NCT00918385|40081974|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
16437394|NCT00918385|40081975|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
16437395|NCT00918385|40081974|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
16437396|NCT00918385|40081975|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
16437397|NCT00918385|40081974|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
16437398|NCT00918385|40081975|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
16437399|NCT03367858|40081976|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
16437400|NCT03367858|40081977|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
16437401|NCT03367858|40081976|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
16437402|NCT03367858|40081977|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
16437403|NCT03367858|40081976|FG000|3 Month Follow Up|Lost to Follow-up|8|||
16437404|NCT03367858|40081977|FG001|3 Month Follow Up|Lost to Follow-up|3|||
16437405|NCT03367858|40081976|FG000|3 Month Follow Up|Moved out of study area|2|||
16437406|NCT03367858|40081977|FG001|3 Month Follow Up|Moved out of study area|6|||
16437407|NCT03367858|40081976|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
16437408|NCT03367858|40081977|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
16437409|NCT03367858|40081976|FG000|3 Month Follow Up|MRI contraindication|2|||
16437410|NCT03367858|40081977|FG001|3 Month Follow Up|MRI contraindication|1|||
16437411|NCT03367858|40081976|FG000|3 Month Follow Up|Incarcerated|0|||
16437412|NCT03367858|40081977|FG001|3 Month Follow Up|Incarcerated|1|||
16437413|NCT03367858|40081976|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
16437414|NCT03367858|40081977|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
16437415|NCT03367858|40081976|FG000|6 Month Follow Up|Lost to Follow-up|5|||
16437416|NCT03367858|40081977|FG001|6 Month Follow Up|Lost to Follow-up|2|||
16437417|NCT03367858|40081976|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
16437418|NCT03367858|40081977|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
16437419|NCT03367858|40081976|FG000|12 Month Follow Up|Lost to Follow-up|3|||
16437420|NCT03367858|40081977|FG001|12 Month Follow Up|Lost to Follow-up|3|||
16437421|NCT03367858|40081976|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
16437422|NCT03367858|40081977|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
16437423|NCT01132807|40081980|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
16437424|NCT01132807|40081981|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
16437425|NCT01132807|40081982|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
16437426|NCT01132807|40081980|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
16437427|NCT01132807|40081981|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
16437428|NCT01132807|40081982|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
16437429|NCT03050801|40081983|FG000|Experiment 1|Lost to Follow-up|0|||
16437430|NCT03050801|40081984|FG001|Experiment 1|Lost to Follow-up|1|||
16437431|NCT03050801|40081985|FG002|Experiment 1|Lost to Follow-up|0|||
16437432|NCT03050801|40081986|FG003|Experiment 1|Lost to Follow-up|0|||
16437433|NCT03050801|40081987|FG004|Experiment 1|Lost to Follow-up|0|||
16437434|NCT03050801|40081988|FG005|Experiment 1|Lost to Follow-up|0|||
16437435|NCT03050801|40081983|FG000|Experiment 1|Physician Decision|0|||
16437436|NCT03050801|40081984|FG001|Experiment 1|Physician Decision|3|||
16437437|NCT03050801|40081985|FG002|Experiment 1|Physician Decision|0|||
16254512|NCT02207231|39416688|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
16254513|NCT02207231|39416685|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
16437438|NCT03050801|40081986|FG003|Experiment 1|Physician Decision|0|||
16437439|NCT03050801|40081987|FG004|Experiment 1|Physician Decision|0|||
16437440|NCT03050801|40081988|FG005|Experiment 1|Physician Decision|0|||
16437441|NCT03050801|40081983|FG000|Experiment 1|Change of experimental design|0|||
16437442|NCT03050801|40081984|FG001|Experiment 1|Change of experimental design|3|||
16437443|NCT03050801|40081985|FG002|Experiment 1|Change of experimental design|0|||
16437444|NCT03050801|40081986|FG003|Experiment 1|Change of experimental design|0|||
16437445|NCT03050801|40081987|FG004|Experiment 1|Change of experimental design|0|||
16437446|NCT03050801|40081988|FG005|Experiment 1|Change of experimental design|0|||
16437447|NCT03050801|40081983|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
16437448|NCT03050801|40081984|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
16437449|NCT03050801|40081985|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
16437450|NCT03050801|40081986|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
16437451|NCT03050801|40081987|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
16437452|NCT03050801|40081988|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
16437453|NCT03050801|40081983|FG000|Experiment 2|Lost to Follow-up|0|||
16437454|NCT03050801|40081984|FG001|Experiment 2|Lost to Follow-up|0|||
16437455|NCT03050801|40081985|FG002|Experiment 2|Lost to Follow-up|0|||
16437456|NCT03050801|40081986|FG003|Experiment 2|Lost to Follow-up|1|||
16139094|NCT00261846|38996470|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16139095|NCT00261846|38996471|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16139096|NCT00261846|38996472|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
16363218|NCT01288430|39815053|FG009|Part 1|Clinical disease progression|0|||
16363219|NCT01288430|39815044|FG000|Part 1|Death due to disease progression|0|||
16363220|NCT01288430|39815045|FG001|Part 1|Death due to disease progression|0|||
16363221|NCT01288430|39815046|FG002|Part 1|Death due to disease progression|0|||
16363222|NCT01288430|39815047|FG003|Part 1|Death due to disease progression|0|||
16363223|NCT01288430|39815048|FG004|Part 1|Death due to disease progression|1|||
16363224|NCT01288430|39815049|FG005|Part 1|Death due to disease progression|0|||
16363225|NCT01288430|39815050|FG006|Part 1|Death due to disease progression|0|||
16363226|NCT01288430|39815051|FG007|Part 1|Death due to disease progression|0|||
16363227|NCT01288430|39815052|FG008|Part 1|Death due to disease progression|0|||
16363228|NCT01288430|39815053|FG009|Part 1|Death due to disease progression|0|||
16363229|NCT01288430|39815044|FG000|Part 1|Adverse Event|0|||
16363230|NCT01288430|39815045|FG001|Part 1|Adverse Event|0|||
16363231|NCT01288430|39815046|FG002|Part 1|Adverse Event|3|||
16363232|NCT01288430|39815047|FG003|Part 1|Adverse Event|1|||
16363233|NCT01288430|39815048|FG004|Part 1|Adverse Event|0|||
16363234|NCT01288430|39815049|FG005|Part 1|Adverse Event|0|||
16363235|NCT01288430|39815050|FG006|Part 1|Adverse Event|2|||
16363236|NCT01288430|39815051|FG007|Part 1|Adverse Event|0|||
16363237|NCT01288430|39815052|FG008|Part 1|Adverse Event|0|||
16363238|NCT01288430|39815053|FG009|Part 1|Adverse Event|0|||
16363239|NCT01288430|39815044|FG000|Part 1|Other|0|||
16363240|NCT01288430|39815045|FG001|Part 1|Other|2|||
16363241|NCT01288430|39815046|FG002|Part 1|Other|0|||
16363242|NCT01288430|39815047|FG003|Part 1|Other|0|||
16363243|NCT01288430|39815048|FG004|Part 1|Other|0|||
16363244|NCT01288430|39815049|FG005|Part 1|Other|0|||
16139097|NCT00261846|38996461|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16139098|NCT00261846|38996462|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16139099|NCT00261846|38996463|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16139100|NCT00261846|38996464|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
16139101|NCT00261846|38996465|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16139102|NCT00261846|38996466|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16139103|NCT00261846|38996467|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16139104|NCT00261846|38996468|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16139105|NCT00261846|38996469|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
16139106|NCT00261846|38996470|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16139107|NCT00261846|38996471|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16139108|NCT00261846|38996472|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
16139109|NCT00261846|38996461|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
16139110|NCT00261846|38996462|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
16139111|NCT00261846|38996463|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
16139112|NCT00261846|38996464|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
16139113|NCT00261846|38996465|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
16254514|NCT02207231|39416686|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
16254515|NCT02207231|39416687|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
16254516|NCT02207231|39416688|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
16254517|NCT02207231|39416685|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
16254518|NCT02207231|39416686|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
16254519|NCT02207231|39416687|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
16254520|NCT02207231|39416688|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
16437457|NCT03050801|40081987|FG004|Experiment 2|Lost to Follow-up|1|||
16437458|NCT03050801|40081988|FG005|Experiment 2|Lost to Follow-up|0|||
16139114|NCT00261846|38996466|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
16254521|NCT02207231|39416685|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
16254522|NCT02207231|39416686|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
16254523|NCT02207231|39416687|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
16254524|NCT02207231|39416688|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
16254525|NCT02207231|39416685|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
16254526|NCT02207231|39416686|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
16254527|NCT02207231|39416687|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
16254528|NCT02207231|39416688|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
16254529|NCT02207231|39416685|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
16254530|NCT02207231|39416686|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
16254531|NCT02207231|39416687|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
16254532|NCT02207231|39416688|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
16254533|NCT02207231|39416685|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
16254534|NCT02207231|39416686|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
16254535|NCT02207231|39416687|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
16254536|NCT02207231|39416688|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
16254537|NCT02207231|39416685|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
16254538|NCT02207231|39416686|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
16254539|NCT02207231|39416687|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
16254540|NCT02207231|39416688|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
16363245|NCT01288430|39815050|FG006|Part 1|Other|1|||
16363246|NCT01288430|39815051|FG007|Part 1|Other|0|||
16363247|NCT01288430|39815052|FG008|Part 1|Other|0|||
16363248|NCT01288430|39815053|FG009|Part 1|Other|0|||
16363249|NCT01288430|39815044|FG000|Part 2|Progressive disease|0|||
16363250|NCT01288430|39815045|FG001|Part 2|Progressive disease|0|||
16363251|NCT01288430|39815046|FG002|Part 2|Progressive disease|0|||
16363252|NCT01288430|39815047|FG003|Part 2|Progressive disease|0|||
16363253|NCT01288430|39815048|FG004|Part 2|Progressive disease|0|||
16363254|NCT01288430|39815049|FG005|Part 2|Progressive disease|0|||
16363255|NCT01288430|39815050|FG006|Part 2|Progressive disease|0|||
16363256|NCT01288430|39815051|FG007|Part 2|Progressive disease|8|||
16363257|NCT01288430|39815052|FG008|Part 2|Progressive disease|7|||
16363258|NCT01288430|39815053|FG009|Part 2|Progressive disease|2|||
16363259|NCT01288430|39815044|FG000|Part 2|Clinical disease progression|0|||
16363260|NCT01288430|39815045|FG001|Part 2|Clinical disease progression|0|||
16363261|NCT01288430|39815046|FG002|Part 2|Clinical disease progression|0|||
16363262|NCT01288430|39815047|FG003|Part 2|Clinical disease progression|0|||
16363263|NCT01288430|39815048|FG004|Part 2|Clinical disease progression|0|||
16363264|NCT01288430|39815049|FG005|Part 2|Clinical disease progression|0|||
16363265|NCT01288430|39815050|FG006|Part 2|Clinical disease progression|0|||
16363266|NCT01288430|39815051|FG007|Part 2|Clinical disease progression|2|||
16437459|NCT03050801|40081983|FG000|Experiment 2|Physician Decision|0|||
16437460|NCT03050801|40081984|FG001|Experiment 2|Physician Decision|0|||
16437461|NCT03050801|40081985|FG002|Experiment 2|Physician Decision|0|||
16437462|NCT03050801|40081986|FG003|Experiment 2|Physician Decision|0|||
16437463|NCT03050801|40081987|FG004|Experiment 2|Physician Decision|1|||
16437464|NCT03050801|40081988|FG005|Experiment 2|Physician Decision|0|||
16437465|NCT03050801|40081983|FG000|Experiment 2|Pregnancy|0|||
16437466|NCT03050801|40081984|FG001|Experiment 2|Pregnancy|0|||
16437467|NCT03050801|40081985|FG002|Experiment 2|Pregnancy|0|||
16437468|NCT03050801|40081986|FG003|Experiment 2|Pregnancy|0|||
16437469|NCT03050801|40081987|FG004|Experiment 2|Pregnancy|1|||
16437470|NCT03050801|40081988|FG005|Experiment 2|Pregnancy|0|||
16437471|NCT03050801|40081983|FG000|Experiment 2|Withdrawal by Subject|0|||
16437472|NCT03050801|40081984|FG001|Experiment 2|Withdrawal by Subject|0|||
16437473|NCT03050801|40081985|FG002|Experiment 2|Withdrawal by Subject|0|||
16437474|NCT03050801|40081986|FG003|Experiment 2|Withdrawal by Subject|1|||
16437475|NCT03050801|40081987|FG004|Experiment 2|Withdrawal by Subject|0|||
16437476|NCT03050801|40081988|FG005|Experiment 2|Withdrawal by Subject|0|||
16437477|NCT03050801|40081983|FG000|Experiment 2|Poor data quality|0|||
16437478|NCT03050801|40081984|FG001|Experiment 2|Poor data quality|0|||
16437479|NCT03050801|40081985|FG002|Experiment 2|Poor data quality|0|||
16437480|NCT03050801|40081986|FG003|Experiment 2|Poor data quality|4|||
16139115|NCT00261846|38996467|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
16139116|NCT00261846|38996468|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
16139117|NCT00261846|38996469|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
16139118|NCT00261846|38996470|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
16139119|NCT00261846|38996471|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
16139120|NCT00261846|38996472|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
16139121|NCT00261846|38996461|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
16139122|NCT00261846|38996462|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
16139123|NCT00261846|38996463|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
16139124|NCT00261846|38996464|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
16139125|NCT00261846|38996465|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
16139126|NCT00261846|38996466|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
16139127|NCT00261846|38996467|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
16139128|NCT00261846|38996468|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
16139129|NCT00261846|38996469|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
16139130|NCT00261846|38996470|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
16139131|NCT00261846|38996471|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
16139132|NCT00261846|38996472|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
16139133|NCT00261846|38996461|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
16139134|NCT00261846|38996462|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
16139135|NCT00261846|38996463|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
16139136|NCT00261846|38996464|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
16139137|NCT00261846|38996465|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
16139138|NCT00261846|38996466|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
16139139|NCT00261846|38996467|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
16139140|NCT00261846|38996468|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
16139141|NCT00261846|38996469|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
16139142|NCT00261846|38996470|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
16139143|NCT00261846|38996471|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
16139144|NCT00261846|38996472|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
16139145|NCT00261846|38996461|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
16139146|NCT00261846|38996462|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
16139147|NCT00261846|38996463|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
16139148|NCT00261846|38996464|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
16139149|NCT00261846|38996465|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
16139150|NCT00261846|38996466|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
16139151|NCT00261846|38996467|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
16139152|NCT00261846|38996468|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
16139153|NCT00261846|38996469|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
16139154|NCT00261846|38996470|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
16139155|NCT00261846|38996471|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
16139156|NCT00261846|38996472|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
16139157|NCT00261846|38996461|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
16139158|NCT00261846|38996462|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
16139159|NCT00261846|38996463|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
16139160|NCT00261846|38996464|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
16139161|NCT00261846|38996465|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
16139162|NCT00261846|38996466|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
16139163|NCT00261846|38996467|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
16139164|NCT00261846|38996468|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
16139165|NCT00261846|38996469|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
16139166|NCT00261846|38996470|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
16139167|NCT00261846|38996471|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
16139168|NCT00261846|38996472|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
16139169|NCT00026208|38996475|FG000|Overall Study|Complications of auto accident|1|||
16139170|NCT00026208|38996476|FG001|Overall Study|Complications of auto accident|0|||
16139171|NCT03346057|38996479|FG000|Overall Study|Death|1|||
16139172|NCT03346057|38996480|FG001|Overall Study|Death|2|||
16139173|NCT03346057|38996481|FG002|Overall Study|Death|0|||
16139174|NCT03346057|38996482|FG003|Overall Study|Death|0|||
16139175|NCT03346057|38996479|FG000|Overall Study|Lost to Follow-up|0|||
16139176|NCT03346057|38996480|FG001|Overall Study|Lost to Follow-up|2|||
16139177|NCT03346057|38996481|FG002|Overall Study|Lost to Follow-up|1|||
16139178|NCT03346057|38996482|FG003|Overall Study|Lost to Follow-up|0|||
16139179|NCT03346057|38996479|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
16139180|NCT03346057|38996480|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
16139181|NCT03346057|38996481|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
16139182|NCT03346057|38996482|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
16139183|NCT03346057|38996479|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
16139184|NCT03346057|38996480|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
16139185|NCT03346057|38996481|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
16139186|NCT03346057|38996482|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
16139187|NCT03346057|38996479|FG000|Overall Study|Physician Decision|3|||
16139188|NCT03346057|38996480|FG001|Overall Study|Physician Decision|2|||
16139189|NCT03346057|38996481|FG002|Overall Study|Physician Decision|0|||
16139190|NCT03346057|38996482|FG003|Overall Study|Physician Decision|2|||
16139191|NCT03346057|38996479|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
16139192|NCT03346057|38996480|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
16139193|NCT03346057|38996481|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
16139194|NCT03346057|38996482|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
16139195|NCT03346057|38996479|FG000|Overall Study|Withdrawal by Subject|1|||
16139196|NCT03346057|38996480|FG001|Overall Study|Withdrawal by Subject|0|||
16139197|NCT03346057|38996481|FG002|Overall Study|Withdrawal by Subject|0|||
16139198|NCT03346057|38996482|FG003|Overall Study|Withdrawal by Subject|0|||
16139199|NCT05116046|38996483|FG000|Overall Study|Withdrawal by parent/guardian|2|||
16139200|NCT05116046|38996484|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16139201|NCT05116046|38996485|FG002|Overall Study|Withdrawal by parent/guardian|1|||
16139202|NCT05116046|38996483|FG000|Overall Study|Study terminated by sponsor|14|||
16139203|NCT05116046|38996484|FG001|Overall Study|Study terminated by sponsor|16|||
16139204|NCT05116046|38996485|FG002|Overall Study|Study terminated by sponsor|1|||
16139205|NCT01078675|38996486|FG000|Overall Study|Withdrawal by Subject|7|||
16139206|NCT01078675|38996487|FG001|Overall Study|Withdrawal by Subject|3|||
16139207|NCT01078675|38996486|FG000|Overall Study|Protocol Violation|56|||
16139208|NCT01078675|38996487|FG001|Overall Study|Protocol Violation|0|||
16139209|NCT01078675|38996486|FG000|Overall Study|Provided in CRF for specific reasons|2|||
16139210|NCT01078675|38996487|FG001|Overall Study|Provided in CRF for specific reasons|3|||
16139211|NCT01078675|38996486|FG000|Overall Study|Adverse Event|3|||
16139212|NCT01078675|38996487|FG001|Overall Study|Adverse Event|0|||
16139213|NCT01032382|38996488|FG000|Overall Study|Disease dissemination|1|||
16139214|NCT01032382|38996489|FG001|Overall Study|Disease dissemination|1|||
16139215|NCT01032382|38996488|FG000|Overall Study|Treatment failure|3|||
16139216|NCT01032382|38996489|FG001|Overall Study|Treatment failure|1|||
16139217|NCT01032382|38996488|FG000|Overall Study|Index lesion relapse|1|||
16139218|NCT01032382|38996489|FG001|Overall Study|Index lesion relapse|3|||
16139219|NCT01572922|38996494|FG000|Overall Study|Adverse Event|1|||
16139220|NCT01572922|38996494|FG000|Overall Study|Protocol Violation|1|||
16139221|NCT01572922|38996494|FG000|Overall Study|Death|1|||
16139222|NCT03359590|38996495|FG000|First Intervention|Withdrawal by Subject|1|||
16139223|NCT03359590|38996496|FG001|First Intervention|Withdrawal by Subject|1|||
16139224|NCT03359590|38996495|FG000|First Intervention|Protocol Violation|0|||
16139225|NCT03359590|38996496|FG001|First Intervention|Protocol Violation|1|||
16139226|NCT01177722|38996498|FG000|Overall Study|Serious Adverse Event|0|||
16139227|NCT01177722|38996499|FG001|Overall Study|Serious Adverse Event|0|||
16139228|NCT01177722|38996500|FG002|Overall Study|Serious Adverse Event|1|||
16139229|NCT01177722|38996501|FG003|Overall Study|Serious Adverse Event|0|||
16139230|NCT01177722|38996498|FG000|Overall Study|Protocol Violation|0|||
16139231|NCT01177722|38996499|FG001|Overall Study|Protocol Violation|0|||
16139232|NCT01177722|38996500|FG002|Overall Study|Protocol Violation|1|||
16139233|NCT01177722|38996501|FG003|Overall Study|Protocol Violation|0|||
16139234|NCT01177722|38996498|FG000|Overall Study|Lost to Follow-up|3|||
16139235|NCT01177722|38996499|FG001|Overall Study|Lost to Follow-up|4|||
16139236|NCT01177722|38996500|FG002|Overall Study|Lost to Follow-up|3|||
16139237|NCT01177722|38996501|FG003|Overall Study|Lost to Follow-up|1|||
16139238|NCT01177722|38996498|FG000|Overall Study|Withdrawal by Subject|10|||
16139239|NCT01177722|38996499|FG001|Overall Study|Withdrawal by Subject|6|||
16139240|NCT01177722|38996500|FG002|Overall Study|Withdrawal by Subject|4|||
16139241|NCT01177722|38996501|FG003|Overall Study|Withdrawal by Subject|6|||
16139242|NCT04014361|38996502|FG000|Period 2|Physician Decision|0|||
16139243|NCT04014361|38996503|FG001|Period 2|Physician Decision|0|||
16139244|NCT04014361|38996504|FG002|Period 2|Physician Decision|0|||
16139245|NCT04014361|38996505|FG003|Period 2|Physician Decision|1|||
16139246|NCT04014361|38996506|FG004|Period 2|Physician Decision|0|||
16139247|NCT04014361|38996507|FG005|Period 2|Physician Decision|0|||
16139248|NCT04014361|38996508|FG006|Period 2|Physician Decision|0|||
16139249|NCT04014361|38996509|FG007|Period 2|Physician Decision|0|||
16139250|NCT04824521|38996510|FG000|Overall Study|Lost to Follow-up|1|||
16139251|NCT02336178|38996511|FG000|Overall Study|Lost to Follow-up|1|||
16139252|NCT02336178|38996511|FG000|Overall Study|Protocol Violation|1|||
16139253|NCT02336178|38996511|FG000|Overall Study|Withdrawal by Subject|1|||
16139254|NCT02336178|38996511|FG000|Overall Study|Other|1|||
16139255|NCT01231516|38996513|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
16139256|NCT01231516|38996514|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
16139257|NCT01231516|38996513|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
16139258|NCT01231516|38996514|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
16139259|NCT01231516|38996513|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
16139260|NCT01231516|38996514|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
16139261|NCT01231516|38996513|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
16139262|NCT01231516|38996514|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
16139263|NCT01231516|38996513|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
16139264|NCT01231516|38996514|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
16139265|NCT01231516|38996513|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
16139266|NCT01231516|38996514|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
16139267|NCT01231516|38996513|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
16139268|NCT01231516|38996514|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
16139269|NCT01231516|38996513|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
16139270|NCT01231516|38996514|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
16139271|NCT01231516|38996513|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
16139272|NCT01231516|38996514|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
16139273|NCT01231516|38996513|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
16139274|NCT01231516|38996514|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
16139275|NCT01231516|38996513|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
16139276|NCT01231516|38996514|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
16139277|NCT01231516|38996513|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
16139278|NCT01231516|38996514|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
16139279|NCT01231516|38996513|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
16139280|NCT01231516|38996514|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
16363267|NCT01288430|39815052|FG008|Part 2|Clinical disease progression|0|||
16363268|NCT01288430|39815053|FG009|Part 2|Clinical disease progression|0|||
16363269|NCT01288430|39815044|FG000|Part 2|Withdrawal by Subject|0|||
16363270|NCT01288430|39815045|FG001|Part 2|Withdrawal by Subject|0|||
16363271|NCT01288430|39815046|FG002|Part 2|Withdrawal by Subject|0|||
16363272|NCT01288430|39815047|FG003|Part 2|Withdrawal by Subject|0|||
16363273|NCT01288430|39815048|FG004|Part 2|Withdrawal by Subject|0|||
16363274|NCT01288430|39815049|FG005|Part 2|Withdrawal by Subject|0|||
16363275|NCT01288430|39815050|FG006|Part 2|Withdrawal by Subject|0|||
16363276|NCT01288430|39815051|FG007|Part 2|Withdrawal by Subject|1|||
16139281|NCT01231516|38996513|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
16254541|NCT02207231|39416685|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
16254542|NCT02207231|39416686|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
16254543|NCT02207231|39416687|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
16254544|NCT02207231|39416688|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
16254545|NCT02207231|39416685|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
16254546|NCT02207231|39416686|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
16139282|NCT01231516|38996514|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
16139283|NCT01231516|38996513|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
16139284|NCT01231516|38996514|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
16139285|NCT01231516|38996513|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
16139286|NCT01231516|38996514|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
16139287|NCT04399122|38996515|FG000|Overall Study|Lost to Follow-up|2|||
16139288|NCT04399122|38996516|FG001|Overall Study|Lost to Follow-up|0|||
16139289|NCT04399122|38996515|FG000|Overall Study|Withdrawal by Subject|1|||
16139290|NCT04399122|38996516|FG001|Overall Study|Withdrawal by Subject|0|||
16363277|NCT01288430|39815052|FG008|Part 2|Withdrawal by Subject|4|||
16363278|NCT01288430|39815053|FG009|Part 2|Withdrawal by Subject|0|||
16139291|NCT02168842|38996520|FG000|Overall Study|Withdrawal by Subject|5|||
16139292|NCT02168842|38996521|FG001|Overall Study|Withdrawal by Subject|3|||
16139293|NCT02168842|38996520|FG000|Overall Study|Lost to Follow-up|0|||
16139294|NCT02168842|38996521|FG001|Overall Study|Lost to Follow-up|2|||
16139295|NCT02168842|38996520|FG000|Overall Study|Death|2|||
16139296|NCT02168842|38996521|FG001|Overall Study|Death|1|||
16139297|NCT02168842|38996520|FG000|Overall Study|Physician Decision|1|||
16139298|NCT02168842|38996521|FG001|Overall Study|Physician Decision|2|||
16139299|NCT03249714|38996523|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
16139300|NCT03249714|38996524|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
16139301|NCT03249714|38996523|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
16139302|NCT03249714|38996524|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
16139303|NCT03249714|38996523|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
16139304|NCT03249714|38996524|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
16139305|NCT03249714|38996523|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
16139306|NCT03249714|38996524|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
16139307|NCT01383161|38996525|FG000|Overall Study|Adverse Event|5|||
16139308|NCT01383161|38996526|FG001|Overall Study|Adverse Event|1|||
16139309|NCT01383161|38996525|FG000|Overall Study|Withdrawal by Subject|0|||
16139310|NCT01383161|38996526|FG001|Overall Study|Withdrawal by Subject|2|||
16139311|NCT01383161|38996525|FG000|Overall Study|Lack of Efficacy|0|||
16139312|NCT01383161|38996526|FG001|Overall Study|Lack of Efficacy|1|||
16139313|NCT01326728|38996531|FG000|Overall Study|Death|13|||
16139314|NCT01326728|38996532|FG001|Overall Study|Death|0|||
16139315|NCT01326728|38996531|FG000|Overall Study|Early closure of study|34|||
16139316|NCT01326728|38996532|FG001|Overall Study|Early closure of study|9|||
16139317|NCT02147353|38996533|FG000|Overall Study|Lost to Follow-up|2|||
16139318|NCT02147353|38996534|FG001|Overall Study|Lost to Follow-up|0|||
16139319|NCT02147353|38996533|FG000|Overall Study|unable to make visits|4|||
16139320|NCT02147353|38996534|FG001|Overall Study|unable to make visits|0|||
16139321|NCT02147353|38996533|FG000|Overall Study|medication noncompliance|3|||
16363279|NCT01288430|39815044|FG000|Part 2|Adverse Event|0|||
16363280|NCT01288430|39815045|FG001|Part 2|Adverse Event|0|||
16363281|NCT01288430|39815046|FG002|Part 2|Adverse Event|0|||
16363282|NCT01288430|39815047|FG003|Part 2|Adverse Event|0|||
16363283|NCT01288430|39815048|FG004|Part 2|Adverse Event|0|||
16363284|NCT01288430|39815049|FG005|Part 2|Adverse Event|0|||
16363285|NCT01288430|39815050|FG006|Part 2|Adverse Event|0|||
16363286|NCT01288430|39815051|FG007|Part 2|Adverse Event|1|||
16363287|NCT01288430|39815052|FG008|Part 2|Adverse Event|1|||
16363288|NCT01288430|39815053|FG009|Part 2|Adverse Event|0|||
16363289|NCT01288430|39815044|FG000|Part 2|Other|0|||
16363290|NCT01288430|39815045|FG001|Part 2|Other|0|||
16363291|NCT01288430|39815046|FG002|Part 2|Other|0|||
16363292|NCT01288430|39815047|FG003|Part 2|Other|0|||
16363293|NCT01288430|39815048|FG004|Part 2|Other|0|||
16363294|NCT01288430|39815049|FG005|Part 2|Other|0|||
16363295|NCT01288430|39815050|FG006|Part 2|Other|0|||
16363296|NCT01288430|39815051|FG007|Part 2|Other|0|||
16363297|NCT01288430|39815052|FG008|Part 2|Other|0|||
16363298|NCT01288430|39815053|FG009|Part 2|Other|1|||
16363299|NCT01513590|39815055|FG000|Overall Study|Adverse Event|2|||
16363300|NCT01513590|39815056|FG001|Overall Study|Adverse Event|3|||
16363301|NCT01513590|39815055|FG000|Overall Study|Withdrawal Criteria|3|||
16363302|NCT01513590|39815056|FG001|Overall Study|Withdrawal Criteria|0|||
16254547|NCT02207231|39416687|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
16254548|NCT02207231|39416688|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
16254549|NCT02207231|39416685|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
16254550|NCT02207231|39416686|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
16254551|NCT02207231|39416687|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
16254552|NCT02207231|39416688|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
16254553|NCT02207231|39416685|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
16254554|NCT02207231|39416686|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
16254555|NCT02207231|39416687|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
16254556|NCT02207231|39416688|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
16254557|NCT00663871|39416689|FG000|Overall Study|Lost to Follow-up|5|||
16254558|NCT00663871|39416690|FG001|Overall Study|Lost to Follow-up|5|||
16254559|NCT00663871|39416689|FG000|Overall Study|Withdrawal by Subject|5|||
16254560|NCT00663871|39416690|FG001|Overall Study|Withdrawal by Subject|2|||
16254561|NCT01816477|39416693|FG000|Overall Study|Withdrawal by Subject|13|||
16254562|NCT01816477|39416694|FG001|Overall Study|Withdrawal by Subject|1|||
16254563|NCT01816477|39416693|FG000|Overall Study|Unable to tolerate catheter placement|3|||
16254564|NCT01816477|39416694|FG001|Overall Study|Unable to tolerate catheter placement|0|||
16254565|NCT00602030|39416698|FG000|Lead-in Phase|Disease Progression|2|||
16254566|NCT00602030|39416699|FG001|Lead-in Phase|Disease Progression|3|||
16254567|NCT00602030|39416700|FG002|Lead-in Phase|Disease Progression|0|||
16254568|NCT00602030|39416701|FG003|Lead-in Phase|Disease Progression|0|||
16254569|NCT00602030|39416702|FG004|Lead-in Phase|Disease Progression|0|||
16254570|NCT00602030|39416698|FG000|Lead-in Phase|Adverse Event|0|||
16254571|NCT00602030|39416699|FG001|Lead-in Phase|Adverse Event|2|||
16254572|NCT00602030|39416700|FG002|Lead-in Phase|Adverse Event|0|||
16254573|NCT00602030|39416701|FG003|Lead-in Phase|Adverse Event|0|||
16254574|NCT00602030|39416702|FG004|Lead-in Phase|Adverse Event|0|||
16254575|NCT00602030|39416698|FG000|Double-blind Phase|Disease progression|0|||
16254576|NCT00602030|39416699|FG001|Double-blind Phase|Disease progression|0|||
16254577|NCT00602030|39416700|FG002|Double-blind Phase|Disease progression|33|||
16254578|NCT00602030|39416701|FG003|Double-blind Phase|Disease progression|30|||
16254579|NCT00602030|39416702|FG004|Double-blind Phase|Disease progression|0|||
16254580|NCT00602030|39416698|FG000|Double-blind Phase|Adverse Event|0|||
16254581|NCT00602030|39416699|FG001|Double-blind Phase|Adverse Event|0|||
16254582|NCT00602030|39416700|FG002|Double-blind Phase|Adverse Event|9|||
16254583|NCT00602030|39416701|FG003|Double-blind Phase|Adverse Event|18|||
16254584|NCT00602030|39416702|FG004|Double-blind Phase|Adverse Event|0|||
16254585|NCT00602030|39416698|FG000|Double-blind Phase|Consent withdrawal|0|||
16254586|NCT00602030|39416699|FG001|Double-blind Phase|Consent withdrawal|0|||
16254587|NCT00602030|39416700|FG002|Double-blind Phase|Consent withdrawal|4|||
16254588|NCT00602030|39416701|FG003|Double-blind Phase|Consent withdrawal|3|||
16254589|NCT00602030|39416702|FG004|Double-blind Phase|Consent withdrawal|0|||
16254590|NCT00602030|39416698|FG000|Double-blind Phase|Death|0|||
16254591|NCT00602030|39416699|FG001|Double-blind Phase|Death|0|||
16254592|NCT00602030|39416700|FG002|Double-blind Phase|Death|3|||
16254593|NCT00602030|39416701|FG003|Double-blind Phase|Death|3|||
16254594|NCT00602030|39416702|FG004|Double-blind Phase|Death|0|||
16254595|NCT00602030|39416698|FG000|Double-blind Phase|Administrative decision|0|||
16254596|NCT00602030|39416699|FG001|Double-blind Phase|Administrative decision|0|||
16254597|NCT00602030|39416700|FG002|Double-blind Phase|Administrative decision|0|||
16254598|NCT00602030|39416701|FG003|Double-blind Phase|Administrative decision|2|||
16254599|NCT00602030|39416702|FG004|Double-blind Phase|Administrative decision|0|||
16254600|NCT00602030|39416698|FG000|Double-blind Phase|Ineligibility|0|||
16254601|NCT00602030|39416699|FG001|Double-blind Phase|Ineligibility|0|||
16254602|NCT00602030|39416700|FG002|Double-blind Phase|Ineligibility|0|||
16254603|NCT00602030|39416701|FG003|Double-blind Phase|Ineligibility|1|||
16254604|NCT00602030|39416702|FG004|Double-blind Phase|Ineligibility|0|||
16254605|NCT00602030|39416698|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
16254606|NCT00602030|39416699|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
16254607|NCT00602030|39416700|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
16254608|NCT00602030|39416701|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
16254609|NCT00602030|39416702|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
16254610|NCT00602030|39416698|FG000|Double-blind Phase|Reason not specified|0|||
16254611|NCT00602030|39416699|FG001|Double-blind Phase|Reason not specified|0|||
16254612|NCT00602030|39416700|FG002|Double-blind Phase|Reason not specified|4|||
16254613|NCT00602030|39416701|FG003|Double-blind Phase|Reason not specified|2|||
16254614|NCT00602030|39416702|FG004|Double-blind Phase|Reason not specified|0|||
16254615|NCT00602030|39416698|FG000|Crossover Phase|Disease Progression|0|||
16254616|NCT00602030|39416699|FG001|Crossover Phase|Disease Progression|0|||
16254617|NCT00602030|39416700|FG002|Crossover Phase|Disease Progression|0|||
16254618|NCT00602030|39416701|FG003|Crossover Phase|Disease Progression|0|||
16254619|NCT00602030|39416702|FG004|Crossover Phase|Disease Progression|11|||
16254620|NCT00602030|39416698|FG000|Crossover Phase|Adverse Event|0|||
16254621|NCT00602030|39416699|FG001|Crossover Phase|Adverse Event|0|||
16254622|NCT00602030|39416700|FG002|Crossover Phase|Adverse Event|0|||
16254623|NCT00602030|39416701|FG003|Crossover Phase|Adverse Event|0|||
16254624|NCT00602030|39416702|FG004|Crossover Phase|Adverse Event|3|||
16254625|NCT00602030|39416698|FG000|Crossover Phase|Consent withdrawal|0|||
16254626|NCT00602030|39416699|FG001|Crossover Phase|Consent withdrawal|0|||
16254627|NCT00602030|39416700|FG002|Crossover Phase|Consent withdrawal|0|||
16254628|NCT00602030|39416701|FG003|Crossover Phase|Consent withdrawal|0|||
16254629|NCT00602030|39416702|FG004|Crossover Phase|Consent withdrawal|2|||
16254630|NCT00560235|39416703|FG000|Phase 1|Discontinued|8|||
16254631|NCT00560235|39416704|FG001|Phase 1|Discontinued|0|||
16254632|NCT00560235|39416705|FG002|Phase 1|Discontinued|0|||
16254633|NCT00560235|39416703|FG000|Phase 1B|Discontinued|0|||
16254634|NCT00560235|39416704|FG001|Phase 1B|Discontinued|19|||
16254635|NCT00560235|39416705|FG002|Phase 1B|Discontinued|0|||
16254636|NCT00560235|39416703|FG000|Phase 2|Discontinued|0|||
16254637|NCT00560235|39416704|FG001|Phase 2|Discontinued|0|||
16437481|NCT03050801|40081987|FG004|Experiment 2|Poor data quality|1|||
16254638|NCT00560235|39416705|FG002|Phase 2|Discontinued|96|||
16254639|NCT00560235|39416703|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
16254640|NCT00560235|39416704|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
16254641|NCT00560235|39416705|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
16254642|NCT00984295|39416706|FG000|Overall Study|Lost to Follow-up|31|||
16254643|NCT00984295|39416707|FG001|Overall Study|Lost to Follow-up|12|||
16254644|NCT00984295|39416708|FG002|Overall Study|Lost to Follow-up|13|||
16254645|NCT00984295|39416706|FG000|Overall Study|Protocol Violation|2|||
16254646|NCT00984295|39416707|FG001|Overall Study|Protocol Violation|1|||
16254647|NCT00984295|39416708|FG002|Overall Study|Protocol Violation|4|||
16254648|NCT00984295|39416706|FG000|Overall Study|Withdrawal by Subject|18|||
16254649|NCT00984295|39416707|FG001|Overall Study|Withdrawal by Subject|9|||
16254650|NCT00984295|39416708|FG002|Overall Study|Withdrawal by Subject|12|||
16254651|NCT00984295|39416706|FG000|Overall Study|CAE - discontinued test vaccine|0|||
16254652|NCT00984295|39416707|FG001|Overall Study|CAE - discontinued test vaccine|1|||
16254653|NCT00984295|39416708|FG002|Overall Study|CAE - discontinued test vaccine|3|||
16437482|NCT03050801|40081988|FG005|Experiment 2|Poor data quality|0|||
16437483|NCT03050801|40081983|FG000|Experiment 2|Discomfort during stimulation|0|||
16437484|NCT03050801|40081984|FG001|Experiment 2|Discomfort during stimulation|0|||
16437485|NCT03050801|40081985|FG002|Experiment 2|Discomfort during stimulation|0|||
16437486|NCT03050801|40081986|FG003|Experiment 2|Discomfort during stimulation|0|||
16437487|NCT03050801|40081987|FG004|Experiment 2|Discomfort during stimulation|0|||
16437488|NCT03050801|40081988|FG005|Experiment 2|Discomfort during stimulation|2|||
16437489|NCT03773978|40081990|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
16437490|NCT03773978|40081991|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
16437491|NCT03773978|40081990|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
16437492|NCT03773978|40081991|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
16437493|NCT03773978|40081990|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
16437494|NCT03773978|40081991|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
16437495|NCT03773978|40081990|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
16437496|NCT03773978|40081991|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
16437497|NCT03773978|40081990|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
16437498|NCT03773978|40081991|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
16437499|NCT03773978|40081990|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
16437500|NCT03773978|40081991|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
16437501|NCT03773978|40081990|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
16437502|NCT03773978|40081991|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
16437503|NCT03773978|40081990|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
16437504|NCT03773978|40081991|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
16437505|NCT03773978|40081990|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
16437506|NCT03773978|40081991|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
16437507|NCT03773978|40081990|FG000|DBW Period|Adverse Event|2|||
16437508|NCT03773978|40081991|FG001|DBW Period|Adverse Event|2|||
16437509|NCT03773978|40081990|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
16437510|NCT03773978|40081991|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
16437511|NCT03773978|40081990|FG000|DBW Period|Withdrawal by Subject|2|||
16437512|NCT03773978|40081991|FG001|DBW Period|Withdrawal by Subject|1|||
16437513|NCT03773978|40081990|FG000|DBW Period|Due to epidemic or pandemic|5|||
16437514|NCT03773978|40081991|FG001|DBW Period|Due to epidemic or pandemic|6|||
16139322|NCT02147353|38996534|FG001|Overall Study|medication noncompliance|0|||
16139323|NCT00601250|38996535|FG000|Overall Study|Adverse Event|3|||
16139324|NCT00601250|38996536|FG001|Overall Study|Adverse Event|9|||
16139325|NCT00601250|38996535|FG000|Overall Study|Protocol Violation|3|||
16139326|NCT00601250|38996536|FG001|Overall Study|Protocol Violation|2|||
16139327|NCT00601250|38996535|FG000|Overall Study|Lost to Follow-up|2|||
16139328|NCT00601250|38996536|FG001|Overall Study|Lost to Follow-up|6|||
16139329|NCT00601250|38996535|FG000|Overall Study|Withdrawal by Subject|4|||
16139330|NCT00601250|38996536|FG001|Overall Study|Withdrawal by Subject|13|||
16139331|NCT00601250|38996535|FG000|Overall Study|Other incl. lack of efficacy|2|||
16139332|NCT00601250|38996536|FG001|Overall Study|Other incl. lack of efficacy|9|||
16139333|NCT02973425|38996537|FG000|Overall Study|Lost to Follow-up|49|||
16139334|NCT02973425|38996538|FG001|Overall Study|Lost to Follow-up|53|||
16139335|NCT03093350|38996541|FG000|Overall Study|Death|1|||
16139336|NCT03093350|38996541|FG000|Overall Study|Signed consent, never began treartment|1|||
16139337|NCT04464265|38996543|FG000|Overall Study|Physician Decision|2|||
16139338|NCT00091169|38996562|FG000|Overall Study|Disease progression|3|||
16139339|NCT00091169|38996563|FG001|Overall Study|Disease progression|1|||
16139340|NCT00091169|38996562|FG000|Overall Study|Adverse Event|11|||
16139341|NCT00091169|38996563|FG001|Overall Study|Adverse Event|17|||
16139342|NCT00091169|38996562|FG000|Overall Study|Death|4|||
16139343|NCT00091169|38996563|FG001|Overall Study|Death|1|||
16139344|NCT00091169|38996562|FG000|Overall Study|Withdrawal by Subject|10|||
16139345|NCT00091169|38996563|FG001|Overall Study|Withdrawal by Subject|13|||
16139346|NCT00091169|38996562|FG000|Overall Study|Other|3|||
16139347|NCT00091169|38996563|FG001|Overall Study|Other|4|||
16139348|NCT00091169|38996562|FG000|Overall Study|Not start protocol therapy|26|||
16139349|NCT00091169|38996563|FG001|Overall Study|Not start protocol therapy|17|||
16254654|NCT00984295|39416706|FG000|Overall Study|Missed one or more blood samplings|3|||
16254655|NCT00984295|39416707|FG001|Overall Study|Missed one or more blood samplings|7|||
16254656|NCT00984295|39416708|FG002|Overall Study|Missed one or more blood samplings|2|||
16254657|NCT00984295|39416706|FG000|Overall Study|Incomplete safety follow-up|11|||
16254658|NCT00984295|39416707|FG001|Overall Study|Incomplete safety follow-up|2|||
16254659|NCT00984295|39416708|FG002|Overall Study|Incomplete safety follow-up|3|||
16254660|NCT02928848|39416709|FG000|Arm 2|Withdrawal by Subject|1|||
16254661|NCT02928848|39416710|FG001|Arm 2|Withdrawal by Subject|0|||
16254662|NCT02785913|39416711|FG000|Overall Study|Adverse Event|5|||
16254663|NCT02785913|39416711|FG000|Overall Study|Death|2|||
16254664|NCT02785913|39416711|FG000|Overall Study|Progression|18|||
16254665|NCT02785913|39416711|FG000|Overall Study|Not protocol specified|1|||
16254666|NCT01203878|39416712|FG000|Overall Study|Withdrawal by Subject|0|||
16254667|NCT01203878|39416713|FG001|Overall Study|Withdrawal by Subject|0|||
16254668|NCT01203878|39416714|FG002|Overall Study|Withdrawal by Subject|1|||
16254669|NCT01203878|39416712|FG000|Overall Study|Adverse Event|0|||
16254670|NCT01203878|39416713|FG001|Overall Study|Adverse Event|0|||
16254671|NCT01203878|39416714|FG002|Overall Study|Adverse Event|2|||
16254672|NCT03211156|39416717|FG000|Overall Study|Withdrawal by Subject|0|||
16254673|NCT03211156|39416718|FG001|Overall Study|Withdrawal by Subject|2|||
16254674|NCT03211156|39416717|FG000|Overall Study|Lost to Follow-up|1|||
16254675|NCT03211156|39416718|FG001|Overall Study|Lost to Follow-up|1|||
16254676|NCT03211156|39416717|FG000|Overall Study|Adverse Event|1|||
16254677|NCT03211156|39416718|FG001|Overall Study|Adverse Event|0|||
16254678|NCT02888171|39416719|FG000|Overall Study|Lost to Follow-up|2|||
16254679|NCT02888171|39416720|FG001|Overall Study|Lost to Follow-up|1|||
16254680|NCT02888171|39416719|FG000|Overall Study|Withdrawal by Subject|3|||
16254681|NCT02888171|39416720|FG001|Overall Study|Withdrawal by Subject|2|||
16254682|NCT02888171|39416719|FG000|Overall Study|Adverse Event|0|||
16254683|NCT02888171|39416720|FG001|Overall Study|Adverse Event|1|||
16254684|NCT03655106|39416724|FG000|Overall Study|Withdrawal by Subject|3|||
16139350|NCT00775450|38996564|FG000|Overall Study|Serious Adverse Event|2|||
16139351|NCT00775450|38996565|FG001|Overall Study|Serious Adverse Event|0|||
16254685|NCT03655106|39416725|FG001|Overall Study|Withdrawal by Subject|2|||
16254686|NCT03655106|39416724|FG000|Overall Study|Lost to Follow-up|2|||
16254687|NCT03655106|39416725|FG001|Overall Study|Lost to Follow-up|1|||
16254688|NCT03655106|39416724|FG000|Overall Study|Duplicate Enrollment|1|||
16254689|NCT03655106|39416725|FG001|Overall Study|Duplicate Enrollment|1|||
16254690|NCT03655106|39416724|FG000|Overall Study|Protocol Violation|3|||
16139352|NCT00775450|38996566|FG002|Overall Study|Serious Adverse Event|0|||
16254691|NCT03655106|39416725|FG001|Overall Study|Protocol Violation|0|||
16254692|NCT00266409|39416726|FG000|Overall Study|Lack of Efficacy|2|||
16139353|NCT00775450|38996567|FG003|Overall Study|Serious Adverse Event|0|||
16139354|NCT00775450|38996568|FG004|Overall Study|Serious Adverse Event|0|||
16437515|NCT03773978|40081990|FG000|DBW Period|Study team decision|1|||
16437516|NCT03773978|40081991|FG001|DBW Period|Study team decision|0|||
16437517|NCT01451606|40081992|FG000|Overall Study|Withdrawal by Subject|4|||
16139355|NCT00775450|38996564|FG000|Overall Study|Protocol Violation|0|||
16139356|NCT00775450|38996565|FG001|Overall Study|Protocol Violation|0|||
16139357|NCT00775450|38996566|FG002|Overall Study|Protocol Violation|0|||
16139358|NCT00775450|38996567|FG003|Overall Study|Protocol Violation|0|||
16139359|NCT00775450|38996568|FG004|Overall Study|Protocol Violation|1|||
16139360|NCT00775450|38996564|FG000|Overall Study|Withdrawal by Subject|1|||
16139361|NCT00775450|38996565|FG001|Overall Study|Withdrawal by Subject|0|||
16139362|NCT00775450|38996566|FG002|Overall Study|Withdrawal by Subject|0|||
16139363|NCT00775450|38996567|FG003|Overall Study|Withdrawal by Subject|0|||
16139364|NCT00775450|38996568|FG004|Overall Study|Withdrawal by Subject|1|||
16139365|NCT01810016|38996569|FG000|Overall Study|Progressive disease|1|||
16139366|NCT01810016|38996570|FG001|Overall Study|Progressive disease|1|||
16139367|NCT01810016|38996571|FG002|Overall Study|Progressive disease|0|||
16139368|NCT01810016|38996569|FG000|Overall Study|Death|0|||
16139369|NCT01810016|38996570|FG001|Overall Study|Death|0|||
16139370|NCT01810016|38996571|FG002|Overall Study|Death|1|||
16139371|NCT01386788|38996572|FG000|Overall Study|Lost to Follow-up|2|||
16139372|NCT01009034|38996574|FG000|Overall Study|Lost to Follow-up|2|||
16139373|NCT01009034|38996574|FG000|Overall Study|Withdrawal by Subject|2|||
16139374|NCT00938470|38996577|FG000|Overall Study|Disease Progression|3|||
16139375|NCT00938470|38996578|FG001|Overall Study|Disease Progression|0|||
16139376|NCT00938470|38996577|FG000|Overall Study|Alternate Treatment|1|||
16139377|NCT00938470|38996578|FG001|Overall Study|Alternate Treatment|0|||
16139378|NCT00938470|38996577|FG000|Overall Study|Death|3|||
16139379|NCT00938470|38996578|FG001|Overall Study|Death|2|||
16139380|NCT00938470|38996577|FG000|Overall Study|Other Reason|0|||
16139381|NCT00938470|38996578|FG001|Overall Study|Other Reason|1|||
16139382|NCT00117845|38996579|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
16139383|NCT00458341|38996581|FG000|Cycle 1|Adverse Event|1|||
16139384|NCT00458341|38996582|FG001|Cycle 1|Adverse Event|0|||
16139385|NCT04875533|38996583|FG000|Overall Study|Adverse Event|6|||
16139386|NCT04875533|38996584|FG001|Overall Study|Adverse Event|4|||
16139387|NCT04875533|38996583|FG000|Overall Study|Protocol Violation|4|||
16139388|NCT04875533|38996584|FG001|Overall Study|Protocol Violation|0|||
16139389|NCT04875533|38996583|FG000|Overall Study|Withdrawal by Subject|8|||
16139390|NCT04875533|38996584|FG001|Overall Study|Withdrawal by Subject|5|||
16139391|NCT04875533|38996583|FG000|Overall Study|No longer meets eligibility criteria|1|||
16139392|NCT04875533|38996584|FG001|Overall Study|No longer meets eligibility criteria|0|||
16139393|NCT04875533|38996583|FG000|Overall Study|Other|0|||
16139394|NCT04875533|38996584|FG001|Overall Study|Other|2|||
16139395|NCT00388154|38996586|FG000|Overall Study|Withdrawal by Subject|1|||
16139396|NCT00898443|38996588|FG000|Overall Study|Withdrawal by Subject|1|||
16139397|NCT00898443|38996589|FG001|Overall Study|Withdrawal by Subject|0|||
16139398|NCT03064035|38996590|FG000|Overall Study|Did not receive allocated intervention|4|||
16437518|NCT01451606|40081993|FG001|Overall Study|Withdrawal by Subject|3|||
16139399|NCT03064035|38996591|FG001|Overall Study|Did not receive allocated intervention|2|||
16139400|NCT03064035|38996590|FG000|Overall Study|Lost to Follow-up|1|||
16139401|NCT03064035|38996591|FG001|Overall Study|Lost to Follow-up|1|||
16139402|NCT04223830|38996595|FG000|Overall Study|Lost to Follow-up|9|||
16139403|NCT04223830|38996595|FG000|Overall Study|Adverse Event|1|||
16139404|NCT02653300|38996596|FG000|Overall Study|Withdrawal by Subject|2|||
16139405|NCT00583024|38996597|FG000|Overall Study|Lost to Follow-up|4|||
16139406|NCT00568321|38999591|FG000|Overall Study|Adverse Event|1|||
16139407|NCT00568321|38999592|FG001|Overall Study|Adverse Event|0|||
16139408|NCT00568321|38999593|FG002|Overall Study|Adverse Event|0|||
16139409|NCT00568321|38999591|FG000|Overall Study|Lack of Efficacy|8|||
16139410|NCT00568321|38999592|FG001|Overall Study|Lack of Efficacy|5|||
16139411|NCT00568321|38999593|FG002|Overall Study|Lack of Efficacy|6|||
16139412|NCT00568321|38999591|FG000|Overall Study|Lost to Follow-up|0|||
16139413|NCT00568321|38999592|FG001|Overall Study|Lost to Follow-up|0|||
16139414|NCT00568321|38999593|FG002|Overall Study|Lost to Follow-up|1|||
16139415|NCT00568321|38999591|FG000|Overall Study|Withdrawal by Subject|2|||
16139416|NCT00568321|38999592|FG001|Overall Study|Withdrawal by Subject|0|||
16139417|NCT00568321|38999593|FG002|Overall Study|Withdrawal by Subject|0|||
16139418|NCT00568321|38999591|FG000|Overall Study|Protocol Violation|0|||
16139419|NCT00568321|38999592|FG001|Overall Study|Protocol Violation|0|||
16139420|NCT00568321|38999593|FG002|Overall Study|Protocol Violation|1|||
16139421|NCT00568321|38999591|FG000|Overall Study|Randomized, not treated|2|||
16139422|NCT00568321|38999592|FG001|Overall Study|Randomized, not treated|0|||
16139423|NCT00568321|38999593|FG002|Overall Study|Randomized, not treated|1|||
16139424|NCT02301936|38999598|FG000|Overall Study|Lost to Follow-up|1|||
16139425|NCT02301936|38999599|FG001|Overall Study|Lost to Follow-up|0|||
16139426|NCT00051363|38999600|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
16437519|NCT00528957|40081994|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
16437520|NCT00528957|40081995|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
16437521|NCT00528957|40081994|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
16437522|NCT00528957|40081995|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
16437523|NCT00528957|40081994|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
16437524|NCT00528957|40081995|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
16437525|NCT00528957|40081994|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
16437526|NCT00528957|40081995|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
16437527|NCT00528957|40081994|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
16437528|NCT00528957|40081995|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
16437529|NCT00528957|40081994|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
16437530|NCT00528957|40081995|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
16437531|NCT00528957|40081994|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
16437532|NCT00528957|40081995|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
16437533|NCT00528957|40081994|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
16437534|NCT00528957|40081995|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
16437535|NCT00528957|40081994|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
16437536|NCT00528957|40081995|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
16437537|NCT00528957|40081994|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
16437538|NCT00528957|40081995|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
16437539|NCT00528957|40081994|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
16437540|NCT00528957|40081995|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
16437541|NCT00528957|40081994|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
16437542|NCT00528957|40081995|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
16437543|NCT00528957|40081994|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
16437544|NCT00528957|40081995|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
16437545|NCT00528957|40081994|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
16437546|NCT00528957|40081995|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
16437547|NCT00528957|40081994|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
16437548|NCT00528957|40081995|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
16437549|NCT00528957|40081994|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
16437550|NCT00528957|40081995|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
16437551|NCT02636699|40081996|FG000|Overall Study|Adverse Event|4|||
16437552|NCT02636699|40081997|FG001|Overall Study|Adverse Event|0|||
16437553|NCT02636699|40081996|FG000|Overall Study|Lost to Follow-up|3|||
16139427|NCT00051363|38999601|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
16139428|NCT00051363|38999600|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
16139429|NCT00051363|38999601|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
16139430|NCT00051363|38999600|FG000|Overall Study|Death|2|||
16139431|NCT00051363|38999601|FG001|Overall Study|Death|2|||
16139432|NCT00051363|38999600|FG000|Overall Study|Excluded Pre-Randomization|2|||
16139433|NCT00051363|38999601|FG001|Overall Study|Excluded Pre-Randomization|5|||
16139434|NCT03503513|38999602|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
16139435|NCT03503513|38999602|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
16139436|NCT03503513|38999602|FG000|Overall Study|Physician Decision|3|||
16139437|NCT03503513|38999602|FG000|Overall Study|Withdrawal by Subject|2|||
16139438|NCT03503513|38999602|FG000|Overall Study|Lost to Follow-up|1|||
16139439|NCT01774084|38999603|FG000|Overall Study|Personal reasons|1|||
16437554|NCT02636699|40081997|FG001|Overall Study|Lost to Follow-up|3|||
16437555|NCT02636699|40081996|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
16437556|NCT02636699|40081997|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
16437557|NCT02636699|40081996|FG000|Overall Study|Physician Decision|0|||
16437558|NCT02636699|40081997|FG001|Overall Study|Physician Decision|1|||
16437559|NCT02636699|40081996|FG000|Overall Study|Withdrawal by Subject|13|||
16437560|NCT02636699|40081997|FG001|Overall Study|Withdrawal by Subject|6|||
16437561|NCT02636699|40081996|FG000|Overall Study|Other|3|||
16139440|NCT01774084|38999604|FG001|Overall Study|Personal reasons|0|||
16139441|NCT04166383|38999606|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
16139442|NCT04166383|38999606|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
16139443|NCT04166383|38999606|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
16139444|NCT02743819|38999609|FG000|Overall Study|Lack of Efficacy|5|||
16139445|NCT02743819|38999609|FG000|Overall Study|Death|2|||
16139446|NCT02743819|38999609|FG000|Overall Study|Adverse Event|1|||
16139447|NCT02804178|38999612|FG000|Overall Study|Adverse Event|1|||
16139448|NCT02460497|38999613|FG000|Overall Study|Participant Requested Withdrawal|4|||
16139449|NCT02460497|38999613|FG000|Overall Study|Non-Compliance|1|||
16139450|NCT02460497|38999613|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
16139451|NCT02460497|38999613|FG000|Overall Study|Lost to Follow-up|2|||
16139452|NCT02460497|38999613|FG000|Overall Study|Investigator Decision|1|||
16139453|NCT00147823|38999614|FG000|Overall Study|Lost to Follow-up|6|||
16139454|NCT00147823|38999615|FG001|Overall Study|Lost to Follow-up|12|||
16139455|NCT00147823|38999614|FG000|Overall Study|Physician Decision|1|||
16139456|NCT00147823|38999615|FG001|Overall Study|Physician Decision|0|||
16139457|NCT00147823|38999614|FG000|Overall Study|Withdrawal by Subject|0|||
16139458|NCT00147823|38999615|FG001|Overall Study|Withdrawal by Subject|1|||
16139459|NCT00147823|38999614|FG000|Overall Study|Did not receive vitoss due to infection|6|||
16139460|NCT00147823|38999615|FG001|Overall Study|Did not receive vitoss due to infection|2|||
16139461|NCT03267940|38999621|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
16139462|NCT03267940|38999622|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
16139463|NCT03267940|38999623|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
16139464|NCT03267940|38999624|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
16139465|NCT03267940|38999625|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
16139466|NCT03267940|38999626|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
16139467|NCT03267940|38999621|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
16139468|NCT03267940|38999622|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
16139469|NCT03267940|38999623|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
16139470|NCT03267940|38999624|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
16139471|NCT03267940|38999625|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
16139472|NCT03267940|38999626|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
16139473|NCT03267940|38999621|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
16139474|NCT03267940|38999622|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
16139475|NCT03267940|38999623|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
16139476|NCT03267940|38999624|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
16139477|NCT03267940|38999625|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
16139478|NCT03267940|38999626|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
16139479|NCT03267940|38999621|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
16437562|NCT02636699|40081997|FG001|Overall Study|Other|1|||
16437563|NCT00517296|40082002|FG000|Overall Study|Withdrawal by Subject|1|||
16437564|NCT00517296|40082003|FG001|Overall Study|Withdrawal by Subject|0|||
16437565|NCT03084796|40082004|FG000|Overall Study|Adverse Event|4|||
16139480|NCT03267940|38999622|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
16139481|NCT03267940|38999623|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
16139482|NCT03267940|38999624|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
16139483|NCT03267940|38999625|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
16139484|NCT03267940|38999626|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
16139485|NCT03267940|38999621|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
16139486|NCT03267940|38999622|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
16437566|NCT03084796|40082005|FG001|Overall Study|Adverse Event|5|||
16437567|NCT03084796|40082006|FG002|Overall Study|Adverse Event|6|||
16363303|NCT01513590|39815055|FG000|Overall Study|Unclassified|5|||
16437568|NCT03084796|40082007|FG003|Overall Study|Adverse Event|2|||
16437569|NCT03084796|40082008|FG004|Overall Study|Adverse Event|3|||
16437570|NCT03084796|40082009|FG005|Overall Study|Adverse Event|5|||
16437571|NCT03084796|40082004|FG000|Overall Study|Withdrawal by Subject|3|||
16437572|NCT03084796|40082005|FG001|Overall Study|Withdrawal by Subject|5|||
16437573|NCT03084796|40082006|FG002|Overall Study|Withdrawal by Subject|2|||
16437574|NCT03084796|40082007|FG003|Overall Study|Withdrawal by Subject|1|||
16437575|NCT03084796|40082008|FG004|Overall Study|Withdrawal by Subject|3|||
16437576|NCT03084796|40082009|FG005|Overall Study|Withdrawal by Subject|0|||
16437577|NCT03084796|40082004|FG000|Overall Study|Protocol Violation|0|||
16437578|NCT03084796|40082005|FG001|Overall Study|Protocol Violation|0|||
16437579|NCT03084796|40082006|FG002|Overall Study|Protocol Violation|1|||
16437580|NCT03084796|40082007|FG003|Overall Study|Protocol Violation|0|||
16437581|NCT03084796|40082008|FG004|Overall Study|Protocol Violation|1|||
16437582|NCT03084796|40082009|FG005|Overall Study|Protocol Violation|1|||
16437583|NCT03084796|40082004|FG000|Overall Study|Lack of Efficacy|0|||
16437584|NCT03084796|40082005|FG001|Overall Study|Lack of Efficacy|0|||
16437585|NCT03084796|40082006|FG002|Overall Study|Lack of Efficacy|1|||
16437586|NCT03084796|40082007|FG003|Overall Study|Lack of Efficacy|0|||
16437587|NCT03084796|40082008|FG004|Overall Study|Lack of Efficacy|1|||
16437588|NCT03084796|40082009|FG005|Overall Study|Lack of Efficacy|0|||
16437589|NCT03084796|40082004|FG000|Overall Study|Lost to Follow-up|0|||
16437590|NCT03084796|40082005|FG001|Overall Study|Lost to Follow-up|0|||
16363304|NCT01513590|39815056|FG001|Overall Study|Unclassified|10|||
16363305|NCT02934178|39815061|FG000|Received Vaccination 2|Death|0|||
16363306|NCT02934178|39815062|FG001|Received Vaccination 2|Death|1|||
16363307|NCT02934178|39815061|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
16363308|NCT02934178|39815062|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
16363309|NCT03861039|39815063|FG000|Overall Study|Adverse Event|2|||
16363310|NCT03861039|39815064|FG001|Overall Study|Adverse Event|5|||
16363311|NCT03861039|39815065|FG002|Overall Study|Adverse Event|11|||
16363312|NCT03861039|39815063|FG000|Overall Study|Withdrawal by Subject|1|||
16363313|NCT03861039|39815064|FG001|Overall Study|Withdrawal by Subject|3|||
16363314|NCT03861039|39815065|FG002|Overall Study|Withdrawal by Subject|4|||
16363315|NCT00754741|39815068|FG000|Overall Study|Died or disenrolled|57|||
16363316|NCT00754741|39815069|FG001|Overall Study|Died or disenrolled|69|||
16363317|NCT00754741|39815070|FG002|Overall Study|Died or disenrolled|54|||
16363318|NCT02471183|39815073|FG000|Main Treatment Period|Adverse Event|1|||
16363319|NCT02471183|39815073|FG000|Main Treatment Period|Withdrawal by Subject|1|||
16363320|NCT02471183|39815073|FG000|Extended Treatment Period|Lack of Efficacy|1|||
16363321|NCT00329108|39815076|FG000|Overall Study|Adverse Event|2|||
16437591|NCT03084796|40082006|FG002|Overall Study|Lost to Follow-up|1|||
16139487|NCT03267940|38999623|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
16139488|NCT03267940|38999624|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
16139489|NCT03267940|38999625|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
16139490|NCT03267940|38999626|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
16139491|NCT03267940|38999621|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
16139492|NCT03267940|38999622|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
16139493|NCT03267940|38999623|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
16139494|NCT03267940|38999624|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
16139495|NCT03267940|38999625|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
16139496|NCT03267940|38999626|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
16139497|NCT03267940|38999621|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
16139498|NCT03267940|38999622|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
16139499|NCT03267940|38999623|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
16139500|NCT03267940|38999624|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
16139501|NCT03267940|38999625|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
16437592|NCT03084796|40082007|FG003|Overall Study|Lost to Follow-up|1|||
16437593|NCT03084796|40082008|FG004|Overall Study|Lost to Follow-up|3|||
16437594|NCT03084796|40082009|FG005|Overall Study|Lost to Follow-up|1|||
16437595|NCT03084796|40082004|FG000|Overall Study|Randomization error|0|||
16437596|NCT03084796|40082005|FG001|Overall Study|Randomization error|0|||
16139502|NCT03267940|38999626|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
16139503|NCT03267940|38999621|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
16139504|NCT03267940|38999622|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
16139505|NCT03267940|38999623|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
16139506|NCT03267940|38999624|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
16139507|NCT03267940|38999625|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
16139508|NCT03267940|38999626|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
16139509|NCT03267940|38999621|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
16139510|NCT03267940|38999622|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
16139511|NCT03267940|38999623|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
16139512|NCT03267940|38999624|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
16139513|NCT03267940|38999625|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
16139514|NCT03267940|38999626|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
16139515|NCT02038920|38999627|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
16139516|NCT02038920|38999628|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
16139517|NCT02038920|38999629|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
16139518|NCT02038920|38999630|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
16139519|NCT02038920|38999631|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
16139520|NCT02038920|38999632|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
16139521|NCT02038920|38999627|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
16139522|NCT02038920|38999628|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
16139523|NCT02038920|38999629|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
16139524|NCT02038920|38999630|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
16139525|NCT02038920|38999631|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
16139526|NCT02038920|38999632|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
16139527|NCT02038920|38999627|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
16139528|NCT02038920|38999628|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
16139529|NCT02038920|38999629|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
16139530|NCT02038920|38999630|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
16139531|NCT02038920|38999631|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
16139532|NCT02038920|38999632|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
16437597|NCT03084796|40082006|FG002|Overall Study|Randomization error|1|||
16437598|NCT03084796|40082007|FG003|Overall Study|Randomization error|0|||
16139533|NCT02038920|38999627|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
16139534|NCT02038920|38999628|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
16139535|NCT02038920|38999629|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
16139536|NCT02038920|38999630|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
16139537|NCT02038920|38999631|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
16139538|NCT02038920|38999632|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
16139539|NCT02038920|38999627|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
16139540|NCT02038920|38999628|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
16139541|NCT02038920|38999629|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
16139542|NCT02038920|38999630|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
16139543|NCT02038920|38999631|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
16139544|NCT02038920|38999632|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
16139545|NCT02038920|38999627|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
16139546|NCT02038920|38999628|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
16139547|NCT02038920|38999629|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
16139548|NCT02038920|38999630|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
16139549|NCT02038920|38999631|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
16139550|NCT02038920|38999632|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
16437599|NCT03084796|40082008|FG004|Overall Study|Randomization error|0|||
16437600|NCT03084796|40082009|FG005|Overall Study|Randomization error|0|||
16437601|NCT03057496|40082010|FG000|Overall Study|Withdrawal by Subject|8|||
16437602|NCT03057496|40082010|FG000|Overall Study|Lost to Follow-up|5|||
16139551|NCT02038920|38999627|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
16437603|NCT03057496|40082010|FG000|Overall Study|Did not use device during home trial|3|||
16139552|NCT02038920|38999628|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
16139553|NCT02038920|38999629|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
16139554|NCT02038920|38999630|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
16139555|NCT02038920|38999631|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
16139556|NCT02038920|38999632|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
16139557|NCT02038920|38999627|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
16139558|NCT02038920|38999628|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
16139559|NCT02038920|38999629|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
16139560|NCT02038920|38999630|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
16139561|NCT02038920|38999631|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
16139562|NCT02038920|38999632|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
16139563|NCT02038920|38999627|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
16139564|NCT02038920|38999628|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
16139565|NCT02038920|38999629|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
16139566|NCT02038920|38999630|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
16139567|NCT02038920|38999631|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
16139568|NCT02038920|38999632|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
16139569|NCT02038920|38999627|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
16139570|NCT02038920|38999628|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
16139571|NCT02038920|38999629|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
16139572|NCT02038920|38999630|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
16139573|NCT02038920|38999631|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
16139574|NCT02038920|38999632|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
16139575|NCT02038920|38999627|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
16139576|NCT02038920|38999628|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
16139577|NCT02038920|38999629|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
16139578|NCT02038920|38999630|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
16139579|NCT02038920|38999631|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
16139580|NCT02038920|38999632|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
16139581|NCT02038920|38999627|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
16139582|NCT02038920|38999628|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
16139583|NCT02038920|38999629|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
16139584|NCT02038920|38999630|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
16139585|NCT02038920|38999631|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
16139586|NCT02038920|38999632|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
16139587|NCT01256658|38999633|FG000|Period 1|Lost to Follow-up|837|||
16139588|NCT01256658|38999634|FG001|Period 1|Lost to Follow-up|661|||
16139589|NCT01256658|38999633|FG000|Period 1|Withdrawal by Subject|35|||
16139590|NCT01256658|38999634|FG001|Period 1|Withdrawal by Subject|43|||
16139591|NCT01256658|38999633|FG000|Period 1|Death|48|||
16139592|NCT01256658|38999634|FG001|Period 1|Death|44|||
16139593|NCT02374021|38999635|FG000|Overall Study|Adverse Event|1|||
16139594|NCT02374021|38999636|FG001|Overall Study|Adverse Event|0|||
16139595|NCT02374021|38999635|FG000|Overall Study|Lost to Follow-up|3|||
16139596|NCT02374021|38999636|FG001|Overall Study|Lost to Follow-up|2|||
16139597|NCT02374021|38999635|FG000|Overall Study|Physician Decision|0|||
16139598|NCT02374021|38999636|FG001|Overall Study|Physician Decision|3|||
16139599|NCT02374021|38999635|FG000|Overall Study|Withdrawal by Subject|6|||
16139600|NCT02374021|38999636|FG001|Overall Study|Withdrawal by Subject|5|||
16139601|NCT02374021|38999635|FG000|Overall Study|Poor Adherence|0|||
16139602|NCT02374021|38999636|FG001|Overall Study|Poor Adherence|1|||
16139603|NCT02374021|38999635|FG000|Overall Study|Scan protocol not followed|0|||
16139604|NCT02374021|38999636|FG001|Overall Study|Scan protocol not followed|1|||
16139605|NCT02374021|38999635|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
16139606|NCT02374021|38999636|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
16139607|NCT00892723|38999637|FG000|Overall Study|Lost to Follow-up|1|||
16139608|NCT00892723|38999638|FG001|Overall Study|Lost to Follow-up|3|||
16139609|NCT00892723|38999639|FG002|Overall Study|Lost to Follow-up|1|||
16139610|NCT00892723|38999637|FG000|Overall Study|Withdrawal by Subject|1|||
16139611|NCT00892723|38999638|FG001|Overall Study|Withdrawal by Subject|1|||
16139612|NCT00892723|38999639|FG002|Overall Study|Withdrawal by Subject|1|||
16139613|NCT00294554|38999649|FG000|Overall Study|Lack of Efficacy|0|||
16139614|NCT00294554|38999650|FG001|Overall Study|Lack of Efficacy|1|||
16139615|NCT00294554|38999649|FG000|Overall Study|Physician Decision|0|||
16139616|NCT00294554|38999650|FG001|Overall Study|Physician Decision|1|||
16139617|NCT01873495|38999651|FG000|Overall Study|Withdrawal by Subject|1|||
16139618|NCT01873495|38999651|FG000|Overall Study|Physician Decision|3|||
16139619|NCT01873495|38999651|FG000|Overall Study|Adverse Event|1|||
16139620|NCT01873495|38999651|FG000|Overall Study|Removed for Transplantation|1|||
16139621|NCT01873495|38999651|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
16139622|NCT01678209|38999652|FG000|Overall Study|could not scan twice|1|||
16139623|NCT01678209|38999653|FG001|Overall Study|could not scan twice|1|||
16139624|NCT01678209|38999654|FG002|Overall Study|could not scan twice|1|||
16139625|NCT01678209|38999652|FG000|Overall Study|scheduling conflicts|0|||
16139626|NCT01678209|38999653|FG001|Overall Study|scheduling conflicts|0|||
16139627|NCT01678209|38999654|FG002|Overall Study|scheduling conflicts|1|||
16139628|NCT01678209|38999652|FG000|Overall Study|screen fail|16|||
16437604|NCT03057496|40082010|FG000|Overall Study|Device failure|2|||
16437605|NCT00430716|40082011|FG000|Double Blind Phase|Death|1|||
16437606|NCT00430716|40082012|FG001|Double Blind Phase|Death|0|||
16437607|NCT00430716|40082013|FG002|Double Blind Phase|Death|0|||
16437608|NCT00430716|40082011|FG000|Double Blind Phase|No longer willing to participate|2|||
16437609|NCT00430716|40082012|FG001|Double Blind Phase|No longer willing to participate|1|||
16437610|NCT00430716|40082013|FG002|Double Blind Phase|No longer willing to participate|1|||
16437611|NCT00430716|40082011|FG000|Double Blind Phase|Other|0|||
16437612|NCT00430716|40082012|FG001|Double Blind Phase|Other|2|||
16437613|NCT00430716|40082013|FG002|Double Blind Phase|Other|0|||
16437614|NCT00430716|40082011|FG000|Double Blind Phase|Study terminated by sponsor|1|||
16437615|NCT00430716|40082012|FG001|Double Blind Phase|Study terminated by sponsor|1|||
16437616|NCT00430716|40082013|FG002|Double Blind Phase|Study terminated by sponsor|2|||
16437617|NCT00430716|40082011|FG000|Double Blind Phase|Adverse Event|1|||
16437618|NCT00430716|40082012|FG001|Double Blind Phase|Adverse Event|1|||
16437619|NCT00430716|40082013|FG002|Double Blind Phase|Adverse Event|3|||
16437620|NCT00430716|40082011|FG000|Double Blind Phase|Not treated|1|||
16437621|NCT00430716|40082012|FG001|Double Blind Phase|Not treated|0|||
16437622|NCT00430716|40082013|FG002|Double Blind Phase|Not treated|0|||
16437623|NCT00430716|40082011|FG000|Open Label Phase|Lost to Follow-up|1|||
16139629|NCT01678209|38999653|FG001|Overall Study|screen fail|17|||
16139630|NCT01678209|38999654|FG002|Overall Study|screen fail|16|||
16139631|NCT01790126|38999668|FG000|Overall Study|PSA Progression|12|||
16139632|NCT01790126|38999669|FG001|Overall Study|PSA Progression|16|||
16139633|NCT01790126|38999670|FG002|Overall Study|PSA Progression|16|||
16139634|NCT01790126|38999668|FG000|Overall Study|Other|5|||
16139635|NCT01790126|38999669|FG001|Overall Study|Other|4|||
16139636|NCT01790126|38999670|FG002|Overall Study|Other|8|||
16254693|NCT00266409|39416727|FG001|Overall Study|Lack of Efficacy|6|||
16437624|NCT00430716|40082012|FG001|Open Label Phase|Lost to Follow-up|0|||
16437625|NCT00430716|40082013|FG002|Open Label Phase|Lost to Follow-up|1|||
16437626|NCT00430716|40082011|FG000|Open Label Phase|No longer willing to participate|0|||
16139637|NCT01790126|38999668|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
16139638|NCT01790126|38999669|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
16139639|NCT01790126|38999670|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
16139640|NCT01790126|38999668|FG000|Overall Study|Withdrawal by Physician|1|||
16139641|NCT01790126|38999669|FG001|Overall Study|Withdrawal by Physician|1|||
16139642|NCT01790126|38999670|FG002|Overall Study|Withdrawal by Physician|2|||
16139643|NCT01790126|38999668|FG000|Overall Study|Withdrawal by Subject|3|||
16139644|NCT01790126|38999669|FG001|Overall Study|Withdrawal by Subject|1|||
16139645|NCT01790126|38999670|FG002|Overall Study|Withdrawal by Subject|2|||
16139646|NCT01790126|38999668|FG000|Overall Study|Lost to Follow-up|1|||
16139647|NCT01790126|38999669|FG001|Overall Study|Lost to Follow-up|0|||
16139648|NCT01790126|38999670|FG002|Overall Study|Lost to Follow-up|1|||
16139649|NCT01790126|38999668|FG000|Overall Study|Adverse Event|0|||
16139650|NCT01790126|38999669|FG001|Overall Study|Adverse Event|2|||
16139651|NCT01790126|38999670|FG002|Overall Study|Adverse Event|0|||
16139652|NCT01790126|38999668|FG000|Overall Study|Death|2|||
16139653|NCT01790126|38999669|FG001|Overall Study|Death|0|||
16139654|NCT01790126|38999670|FG002|Overall Study|Death|0|||
16139655|NCT01790126|38999668|FG000|Overall Study|Radiographic Progression|3|||
16139656|NCT01790126|38999669|FG001|Overall Study|Radiographic Progression|1|||
16139657|NCT01790126|38999670|FG002|Overall Study|Radiographic Progression|0|||
16139658|NCT04744285|38999671|FG000|Overall Study|Withdrawal by Subject|1|||
16139659|NCT04744285|38999672|FG001|Overall Study|Withdrawal by Subject|1|||
16139660|NCT04744285|38999673|FG002|Overall Study|Withdrawal by Subject|2|||
16139661|NCT04744285|38999674|FG003|Overall Study|Withdrawal by Subject|1|||
16139662|NCT01423253|38999677|FG000|Overall Study|Adverse Event|2|||
16139663|NCT01423253|38999677|FG000|Overall Study|Lack of Efficacy|2|||
16139664|NCT01423253|38999677|FG000|Overall Study|Lost to Follow-up|1|||
16139665|NCT01423253|38999677|FG000|Overall Study|Protocol Violation|2|||
16139666|NCT01423253|38999677|FG000|Overall Study|Withdrawal by Subject|2|||
16139667|NCT00631189|38999689|FG000|Initial Phase|Protocol Violation|347|||
16139668|NCT00631189|38999690|FG001|Initial Phase|Protocol Violation|0|||
16139669|NCT00631189|38999691|FG002|Initial Phase|Protocol Violation|0|||
16139670|NCT00631189|38999692|FG003|Initial Phase|Protocol Violation|0|||
16139671|NCT00631189|38999689|FG000|Initial Phase|Withdrawal by Subject|4|||
16139672|NCT00631189|38999690|FG001|Initial Phase|Withdrawal by Subject|0|||
16139673|NCT00631189|38999691|FG002|Initial Phase|Withdrawal by Subject|0|||
16139674|NCT00631189|38999692|FG003|Initial Phase|Withdrawal by Subject|0|||
16139675|NCT00631189|38999689|FG000|Treatment Phase|Withdrawal by Subject|0|||
16139676|NCT00631189|38999690|FG001|Treatment Phase|Withdrawal by Subject|2|||
16139677|NCT00631189|38999691|FG002|Treatment Phase|Withdrawal by Subject|1|||
16139678|NCT00631189|38999692|FG003|Treatment Phase|Withdrawal by Subject|1|||
16139679|NCT00631189|38999689|FG000|Treatment Phase|Protocol Violation|0|||
16437627|NCT00430716|40082012|FG001|Open Label Phase|No longer willing to participate|1|||
16437628|NCT00430716|40082013|FG002|Open Label Phase|No longer willing to participate|1|||
16139680|NCT00631189|38999690|FG001|Treatment Phase|Protocol Violation|1|||
16139681|NCT00631189|38999691|FG002|Treatment Phase|Protocol Violation|6|||
16139682|NCT00631189|38999692|FG003|Treatment Phase|Protocol Violation|2|||
16139683|NCT00631189|38999689|FG000|Treatment Phase|Adverse Event|0|||
16139684|NCT00631189|38999690|FG001|Treatment Phase|Adverse Event|3|||
16139685|NCT00631189|38999691|FG002|Treatment Phase|Adverse Event|2|||
16254694|NCT00266409|39416728|FG002|Overall Study|Lack of Efficacy|1|||
16254695|NCT00266409|39416729|FG003|Overall Study|Lack of Efficacy|2|||
16254696|NCT00266409|39416726|FG000|Overall Study|Adverse Event|7|||
16254697|NCT00266409|39416727|FG001|Overall Study|Adverse Event|2|||
16254698|NCT00266409|39416728|FG002|Overall Study|Adverse Event|1|||
16254699|NCT00266409|39416729|FG003|Overall Study|Adverse Event|1|||
16254700|NCT00266409|39416726|FG000|Overall Study|Lost to Follow-up|18|||
16254701|NCT00266409|39416727|FG001|Overall Study|Lost to Follow-up|21|||
16254702|NCT00266409|39416728|FG002|Overall Study|Lost to Follow-up|6|||
16254703|NCT00266409|39416729|FG003|Overall Study|Lost to Follow-up|8|||
16254704|NCT00266409|39416726|FG000|Overall Study|Withdrawal by Subject|6|||
16254705|NCT00266409|39416727|FG001|Overall Study|Withdrawal by Subject|10|||
16254706|NCT00266409|39416728|FG002|Overall Study|Withdrawal by Subject|3|||
16254707|NCT00266409|39416729|FG003|Overall Study|Withdrawal by Subject|9|||
16254708|NCT00266409|39416726|FG000|Overall Study|Protocol Violation|5|||
16254709|NCT00266409|39416727|FG001|Overall Study|Protocol Violation|3|||
16254710|NCT00266409|39416728|FG002|Overall Study|Protocol Violation|4|||
16254711|NCT00266409|39416729|FG003|Overall Study|Protocol Violation|2|||
16254712|NCT00266409|39416726|FG000|Overall Study|Other|7|||
16254713|NCT00266409|39416727|FG001|Overall Study|Other|4|||
16254714|NCT00266409|39416728|FG002|Overall Study|Other|2|||
16254715|NCT00266409|39416729|FG003|Overall Study|Other|0|||
16254716|NCT01370408|39416730|FG000|Overall Study|treatment failure|9|||
16254717|NCT03283709|39416731|FG000|Overall Study|trial terminated|0|||
16254718|NCT03283709|39416732|FG001|Overall Study|trial terminated|1|||
16254719|NCT03823300|39416733|FG000|Overall Study|Withdrawal by Subject|16|||
16254720|NCT03823300|39416734|FG001|Overall Study|Withdrawal by Subject|22|||
16254721|NCT03823300|39416733|FG000|Overall Study|Death|10|||
16254722|NCT03823300|39416734|FG001|Overall Study|Death|14|||
16254723|NCT03823300|39416733|FG000|Overall Study|Adverse Event|3|||
16254724|NCT03823300|39416734|FG001|Overall Study|Adverse Event|5|||
16254725|NCT03823300|39416733|FG000|Overall Study|Physician Decision|1|||
16254726|NCT03823300|39416734|FG001|Overall Study|Physician Decision|7|||
16254727|NCT03823300|39416733|FG000|Overall Study|Lost to Follow-up|1|||
16139686|NCT00631189|38999692|FG003|Treatment Phase|Adverse Event|4|||
16254728|NCT03823300|39416734|FG001|Overall Study|Lost to Follow-up|3|||
16254729|NCT03823300|39416733|FG000|Overall Study|Protocol Violation|1|||
16254730|NCT03823300|39416734|FG001|Overall Study|Protocol Violation|1|||
16254731|NCT03823300|39416733|FG000|Overall Study|Lack of Efficacy|1|||
16139687|NCT00631189|38999689|FG000|Treatment Phase|Lost to Follow-up|0|||
16254732|NCT03823300|39416734|FG001|Overall Study|Lack of Efficacy|1|||
16254733|NCT03823300|39416733|FG000|Overall Study|Not Eligible|0|||
16254734|NCT03823300|39416734|FG001|Overall Study|Not Eligible|1|||
16254735|NCT03823300|39416733|FG000|Overall Study|Other|1|||
16254736|NCT03823300|39416734|FG001|Overall Study|Other|0|||
16254737|NCT03444038|39416737|FG000|Overall Study|Adverse Event|12|||
16254738|NCT03444038|39416737|FG000|Overall Study|Withdrawal by Subject|7|||
16254739|NCT03444038|39416737|FG000|Overall Study|Lost to Follow-up|1|||
16254740|NCT03444038|39416737|FG000|Overall Study|Physician Decision|2|||
16254741|NCT03444038|39416737|FG000|Overall Study|Lack of Efficacy|7|||
16254742|NCT04117607|39416738|FG000|Overall Study|Early Termination|0|||
16254743|NCT04117607|39416739|FG001|Overall Study|Early Termination|1|||
16254744|NCT04117607|39416740|FG002|Overall Study|Early Termination|0|||
16254745|NCT04117607|39416741|FG003|Overall Study|Early Termination|0|||
16254746|NCT04117607|39416742|FG004|Overall Study|Early Termination|0|||
16254747|NCT04117607|39416743|FG005|Overall Study|Early Termination|0|||
16254748|NCT04117607|39416744|FG006|Overall Study|Early Termination|1|||
16254749|NCT04117607|39416745|FG007|Overall Study|Early Termination|0|||
16254750|NCT04117607|39416746|FG008|Overall Study|Early Termination|0|||
16254751|NCT04117607|39416747|FG009|Overall Study|Early Termination|0|||
16254752|NCT04117607|39416748|FG010|Overall Study|Early Termination|0|||
16254753|NCT04117607|39416749|FG011|Overall Study|Early Termination|0|||
16254754|NCT04117607|39416750|FG012|Overall Study|Early Termination|0|||
16254755|NCT04117607|39416751|FG013|Overall Study|Early Termination|0|||
16254756|NCT02534493|39416752|FG000|Overall Study|Lost to Follow-up|1|||
16254757|NCT02534493|39416752|FG000|Overall Study|Withdrawal by Subject|1|||
16254758|NCT03679741|39416753|FG000|Period 1|No longer meet eligibility criteria|1|||
16254759|NCT03679741|39416754|FG001|Period 1|No longer meet eligibility criteria|0|||
16254760|NCT03679741|39416753|FG000|Period 1|Lost to Follow-up|0|||
16254761|NCT03679741|39416754|FG001|Period 1|Lost to Follow-up|1|||
16254762|NCT03679741|39416753|FG000|Period 1|Adverse Event|1|||
16254763|NCT03679741|39416754|FG001|Period 1|Adverse Event|1|||
16254764|NCT03679741|39416753|FG000|Period 1|Withdrawal by Subject|0|||
16254765|NCT03679741|39416754|FG001|Period 1|Withdrawal by Subject|1|||
16254766|NCT03679741|39416753|FG000|Period 2|Adverse Event|2|||
16254767|NCT03679741|39416754|FG001|Period 2|Adverse Event|1|||
16254768|NCT03679741|39416753|FG000|Period 2|Withdrawal by Subject|1|||
16254769|NCT03679741|39416754|FG001|Period 2|Withdrawal by Subject|1|||
16254770|NCT01278862|39416758|FG000|Overall Study|Lost to Follow-up|1|||
16254771|NCT01278862|39416759|FG001|Overall Study|Lost to Follow-up|1|||
16254772|NCT03465904|39416760|FG000|Overall Study|Withdrawal by Subject|9|||
16254773|NCT03465904|39416761|FG001|Overall Study|Withdrawal by Subject|5|||
16254774|NCT03465904|39416760|FG000|Overall Study|Lost to Follow-up|10|||
16254775|NCT03465904|39416761|FG001|Overall Study|Lost to Follow-up|9|||
16254776|NCT03465904|39416760|FG000|Overall Study|Protocol Violation|8|||
16254777|NCT03465904|39416761|FG001|Overall Study|Protocol Violation|5|||
16254778|NCT03465904|39416760|FG000|Overall Study|Ineligible for mITT analysis|62|||
16254779|NCT03465904|39416761|FG001|Overall Study|Ineligible for mITT analysis|47|||
16254780|NCT01513148|39416770|FG000|Overall Study|Protocol Violation|2|||
16254781|NCT01513148|39416771|FG001|Overall Study|Protocol Violation|2|||
16254782|NCT02655237|39416772|FG000|Overall Study|Adverse Event|10|||
16254783|NCT02655237|39416773|FG001|Overall Study|Adverse Event|7|||
16254784|NCT02655237|39416772|FG000|Overall Study|Protocol Deviation|2|||
16254785|NCT02655237|39416773|FG001|Overall Study|Protocol Deviation|0|||
16254786|NCT02655237|39416772|FG000|Overall Study|Withdrawal by Participant|1|||
16254787|NCT02655237|39416773|FG001|Overall Study|Withdrawal by Participant|2|||
16254788|NCT02655237|39416772|FG000|Overall Study|Lack of Efficacy|0|||
16254789|NCT02655237|39416773|FG001|Overall Study|Lack of Efficacy|1|||
16254790|NCT02655237|39416772|FG000|Overall Study|Recovery Leading to Surgery|2|||
16254791|NCT02655237|39416773|FG001|Overall Study|Recovery Leading to Surgery|1|||
16254792|NCT02655237|39416772|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
16254793|NCT02655237|39416773|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
16254794|NCT02655237|39416772|FG000|Overall Study|Randomized but Not Treated|1|||
16254795|NCT02655237|39416773|FG001|Overall Study|Randomized but Not Treated|0|||
16254796|NCT02388763|39416774|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
16254797|NCT02388763|39416775|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
16254798|NCT02388763|39416774|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
16254799|NCT02388763|39416775|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
16254800|NCT04000009|39416776|FG000|Overall Study|Adverse Event|13|||
16254801|NCT04000009|39416776|FG000|Overall Study|Lack of Efficacy|7|||
16254802|NCT04000009|39416776|FG000|Overall Study|Lost to Follow-up|8|||
16254803|NCT04000009|39416776|FG000|Overall Study|Noncompliance with study drug|4|||
16254804|NCT04000009|39416776|FG000|Overall Study|Physician Decision|1|||
16363322|NCT00329108|39815077|FG001|Overall Study|Adverse Event|2|||
16363323|NCT00329108|39815076|FG000|Overall Study|Lack of Efficacy|3|||
16363324|NCT00329108|39815077|FG001|Overall Study|Lack of Efficacy|3|||
16363325|NCT00329108|39815076|FG000|Overall Study|Withdrawal by Subject|0|||
16363326|NCT00329108|39815077|FG001|Overall Study|Withdrawal by Subject|2|||
16363327|NCT00329108|39815076|FG000|Overall Study|symptomatic deterioration|1|||
16363328|NCT00329108|39815077|FG001|Overall Study|symptomatic deterioration|1|||
16363329|NCT00329108|39815076|FG000|Overall Study|Subject no longer willing to participate|2|||
16363330|NCT00329108|39815077|FG001|Overall Study|Subject no longer willing to participate|2|||
16363331|NCT00329108|39815076|FG000|Overall Study|study terminated by sponsor|1|||
16363332|NCT00329108|39815077|FG001|Overall Study|study terminated by sponsor|0|||
16254805|NCT04000009|39416776|FG000|Overall Study|Use of prohibited medication|3|||
16254806|NCT04000009|39416776|FG000|Overall Study|Pregnancy|1|||
16254807|NCT04000009|39416776|FG000|Overall Study|Withdrawal by Subject|22|||
16254808|NCT04000009|39416776|FG000|Overall Study|Study terminated by sponsor|98|||
16254809|NCT04000009|39416776|FG000|Overall Study|Not further specified|8|||
16254810|NCT01915732|39416777|FG000|Overall Study|Withdrawal by Subject|18|||
16254811|NCT01915732|39416778|FG001|Overall Study|Withdrawal by Subject|18|||
16363333|NCT00329108|39815076|FG000|Overall Study|withdrew patient after SAE resolved|1|||
16139688|NCT00631189|38999690|FG001|Treatment Phase|Lost to Follow-up|1|||
16139689|NCT00631189|38999691|FG002|Treatment Phase|Lost to Follow-up|0|||
16139690|NCT00631189|38999692|FG003|Treatment Phase|Lost to Follow-up|0|||
16139691|NCT00631189|38999689|FG000|Treatment Phase|Pregnancy|0|||
16437629|NCT00430716|40082011|FG000|Open Label Phase|Other|3|||
16139692|NCT00631189|38999690|FG001|Treatment Phase|Pregnancy|0|||
16139693|NCT00631189|38999691|FG002|Treatment Phase|Pregnancy|1|||
16254812|NCT01915732|39416777|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
16139694|NCT00631189|38999692|FG003|Treatment Phase|Pregnancy|0|||
16139695|NCT00631189|38999689|FG000|Treatment Phase|patient did not take pravastatin|0|||
16139696|NCT00631189|38999690|FG001|Treatment Phase|patient did not take pravastatin|0|||
16139697|NCT00631189|38999691|FG002|Treatment Phase|patient did not take pravastatin|1|||
16139698|NCT00631189|38999692|FG003|Treatment Phase|patient did not take pravastatin|0|||
16139699|NCT01637623|38999693|FG000|Overall Study|Lost to Follow-up|0|||
16139700|NCT01637623|38999694|FG001|Overall Study|Lost to Follow-up|0|||
16139701|NCT01637623|38999695|FG002|Overall Study|Lost to Follow-up|2|||
16139702|NCT01637623|38999693|FG000|Overall Study|Physician Decision|1|||
16139703|NCT01637623|38999694|FG001|Overall Study|Physician Decision|0|||
16139704|NCT01637623|38999695|FG002|Overall Study|Physician Decision|1|||
16139705|NCT00800683|38999696|FG000|Overall Study|Adverse Event|11|||
16139706|NCT00800683|38999697|FG001|Overall Study|Adverse Event|8|||
16139707|NCT00800683|38999696|FG000|Overall Study|Lost to Follow-up|3|||
16139708|NCT00800683|38999697|FG001|Overall Study|Lost to Follow-up|1|||
16139709|NCT00800683|38999696|FG000|Overall Study|Withdrawal by Subject|1|||
16139710|NCT00800683|38999697|FG001|Overall Study|Withdrawal by Subject|7|||
16139711|NCT00800683|38999696|FG000|Overall Study|Lack of Efficacy|1|||
16139712|NCT00800683|38999697|FG001|Overall Study|Lack of Efficacy|1|||
16139713|NCT00800683|38999696|FG000|Overall Study|Other|1|||
16437630|NCT00430716|40082012|FG001|Open Label Phase|Other|1|||
16139714|NCT00800683|38999697|FG001|Overall Study|Other|2|||
16139715|NCT04226833|38999698|FG000|Overall Study|Death|0|||
16139716|NCT04226833|38999699|FG001|Overall Study|Death|0|||
16139717|NCT04226833|38999700|FG002|Overall Study|Death|1|||
16139718|NCT04226833|38999701|FG003|Overall Study|Death|0|||
16139719|NCT02593786|38999704|FG000|Overall Study|Disease progression|12|||
16139720|NCT02593786|38999705|FG001|Overall Study|Disease progression|16|||
16139721|NCT02593786|38999706|FG002|Overall Study|Disease progression|10|||
16139722|NCT02593786|38999707|FG003|Overall Study|Disease progression|7|||
16139723|NCT02593786|38999704|FG000|Overall Study|Study drug toxicity|1|||
16139724|NCT02593786|38999705|FG001|Overall Study|Study drug toxicity|0|||
16139725|NCT02593786|38999706|FG002|Overall Study|Study drug toxicity|0|||
16139726|NCT02593786|38999707|FG003|Overall Study|Study drug toxicity|0|||
16139727|NCT02593786|38999704|FG000|Overall Study|Adverse event unrelated to study drug|1|||
16139728|NCT02593786|38999705|FG001|Overall Study|Adverse event unrelated to study drug|1|||
16139729|NCT02593786|38999706|FG002|Overall Study|Adverse event unrelated to study drug|1|||
16139730|NCT02593786|38999707|FG003|Overall Study|Adverse event unrelated to study drug|0|||
16139731|NCT02593786|38999704|FG000|Overall Study|Participant request to discontinue study therapy|0|||
16139732|NCT02593786|38999705|FG001|Overall Study|Participant request to discontinue study therapy|2|||
16139733|NCT02593786|38999706|FG002|Overall Study|Participant request to discontinue study therapy|0|||
16139734|NCT02593786|38999707|FG003|Overall Study|Participant request to discontinue study therapy|0|||
16139735|NCT02593786|38999704|FG000|Overall Study|Other reasons|1|||
16139736|NCT02593786|38999705|FG001|Overall Study|Other reasons|1|||
16139737|NCT02593786|38999706|FG002|Overall Study|Other reasons|0|||
16437631|NCT00430716|40082013|FG002|Open Label Phase|Other|1|||
16139738|NCT02593786|38999707|FG003|Overall Study|Other reasons|5|||
16139739|NCT01119001|38999708|FG000|Overall Study|Withdrawal by Subject|2|||
16139740|NCT03434353|38999712|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
16139741|NCT03434353|38999713|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
16139742|NCT03434353|38999714|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
16139743|NCT03434353|38999715|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
16363334|NCT00329108|39815077|FG001|Overall Study|withdrew patient after SAE resolved|0|||
16363335|NCT00329108|39815076|FG000|Overall Study|Protocol Violation|0|||
16363336|NCT00329108|39815077|FG001|Overall Study|Protocol Violation|2|||
16363337|NCT01134042|39815078|FG000|Overall Study|Adverse Event|3|||
16363338|NCT01134042|39815079|FG001|Overall Study|Adverse Event|7|||
16437632|NCT00430716|40082011|FG000|Open Label Phase|Protocol Violation|1|||
16437633|NCT00430716|40082012|FG001|Open Label Phase|Protocol Violation|0|||
16437634|NCT00430716|40082013|FG002|Open Label Phase|Protocol Violation|0|||
16437635|NCT00430716|40082011|FG000|Open Label Phase|Study terminated by sponsor|4|||
16363339|NCT01134042|39815080|FG002|Overall Study|Adverse Event|2|||
16363340|NCT01134042|39815078|FG000|Overall Study|Lack of Efficacy|21|||
16363341|NCT01134042|39815079|FG001|Overall Study|Lack of Efficacy|6|||
16363342|NCT01134042|39815080|FG002|Overall Study|Lack of Efficacy|18|||
16363343|NCT01134042|39815078|FG000|Overall Study|Protocol Violation|5|||
16363344|NCT01134042|39815079|FG001|Overall Study|Protocol Violation|3|||
16363345|NCT01134042|39815080|FG002|Overall Study|Protocol Violation|5|||
16363346|NCT01134042|39815078|FG000|Overall Study|Lost to Follow-up|2|||
16363347|NCT01134042|39815079|FG001|Overall Study|Lost to Follow-up|0|||
16437636|NCT00430716|40082012|FG001|Open Label Phase|Study terminated by sponsor|5|||
16139744|NCT03434353|38999716|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
16139745|NCT03434353|38999712|FG000|Overall Study|Withdrew consent|1|||
16139746|NCT03434353|38999713|FG001|Overall Study|Withdrew consent|0|||
16139747|NCT03434353|38999714|FG002|Overall Study|Withdrew consent|3|||
16139748|NCT03434353|38999715|FG003|Overall Study|Withdrew consent|0|||
16363348|NCT01134042|39815080|FG002|Overall Study|Lost to Follow-up|1|||
16437637|NCT00430716|40082013|FG002|Open Label Phase|Study terminated by sponsor|4|||
16437638|NCT00524485|40082017|FG000|Overall Study|Withdrawal by Subject|5|||
16437639|NCT04725188|40082020|FG000|Overall Study|Death|44|||
16437640|NCT04725188|40082021|FG001|Overall Study|Death|46|||
16437641|NCT04725188|40082022|FG002|Overall Study|Death|48|||
16437642|NCT04725188|40082020|FG000|Overall Study|Lost to Follow-up|0|||
16437643|NCT04725188|40082021|FG001|Overall Study|Lost to Follow-up|0|||
16437644|NCT04725188|40082022|FG002|Overall Study|Lost to Follow-up|1|||
16437645|NCT04725188|40082020|FG000|Overall Study|Withdrawal by Subject|2|||
16437646|NCT04725188|40082021|FG001|Overall Study|Withdrawal by Subject|2|||
16437647|NCT04725188|40082022|FG002|Overall Study|Withdrawal by Subject|1|||
16437648|NCT04725188|40082020|FG000|Overall Study|Participants ongoing in the study|41|||
16437649|NCT04725188|40082021|FG001|Overall Study|Participants ongoing in the study|35|||
16437650|NCT04725188|40082022|FG002|Overall Study|Participants ongoing in the study|35|||
16437651|NCT04906499|40082027|FG000|Overall Study|Lack of time|1|||
16437652|NCT00883779|40082029|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
16437653|NCT00883779|40082030|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
16437654|NCT00883779|40082029|FG000|Primary Study Treatment Phase|Disease progression|75|||
16437655|NCT00883779|40082030|FG001|Primary Study Treatment Phase|Disease progression|59|||
16437656|NCT00883779|40082029|FG000|Primary Study Treatment Phase|Adverse Event|16|||
16437657|NCT00883779|40082030|FG001|Primary Study Treatment Phase|Adverse Event|16|||
16437658|NCT00883779|40082029|FG000|Primary Study Treatment Phase|Death|2|||
16437659|NCT00883779|40082030|FG001|Primary Study Treatment Phase|Death|3|||
16437660|NCT00883779|40082029|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
16437661|NCT00883779|40082030|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
16437662|NCT00883779|40082029|FG000|Primary Study Treatment Phase|Other|3|||
16437663|NCT00883779|40082030|FG001|Primary Study Treatment Phase|Other|0|||
16437664|NCT00883779|40082029|FG000|Post-Study Treatment Phase|Adverse Event|2|||
16437665|NCT00883779|40082030|FG001|Post-Study Treatment Phase|Adverse Event|3|||
16437666|NCT00883779|40082029|FG000|Post-Study Treatment Phase|Death|1|||
16437667|NCT00883779|40082030|FG001|Post-Study Treatment Phase|Death|3|||
16437668|NCT00883779|40082029|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
16437669|NCT00883779|40082030|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
16139749|NCT03434353|38999716|FG004|Overall Study|Withdrew consent|0|||
16139750|NCT03434353|38999712|FG000|Overall Study|Adverse Event|1|||
16139751|NCT03434353|38999713|FG001|Overall Study|Adverse Event|0|||
16139752|NCT03434353|38999714|FG002|Overall Study|Adverse Event|0|||
16139753|NCT03434353|38999715|FG003|Overall Study|Adverse Event|0|||
16139754|NCT03434353|38999716|FG004|Overall Study|Adverse Event|1|||
16139755|NCT03434353|38999712|FG000|Overall Study|Lost to Follow-up|2|||
16139756|NCT03434353|38999713|FG001|Overall Study|Lost to Follow-up|0|||
16139757|NCT03434353|38999714|FG002|Overall Study|Lost to Follow-up|0|||
16139758|NCT03434353|38999715|FG003|Overall Study|Lost to Follow-up|0|||
16139759|NCT03434353|38999716|FG004|Overall Study|Lost to Follow-up|0|||
16139760|NCT04540133|38999717|FG000|Overall Study|Lost to Follow-up|1|||
16139761|NCT04540133|38999718|FG001|Overall Study|Lost to Follow-up|0|||
16139762|NCT00387764|38999720|FG000|Overall Study|Adverse Event|12|||
16139763|NCT00387764|38999720|FG000|Overall Study|Withdrawal by Subject|8|||
16139764|NCT00387764|38999720|FG000|Overall Study|Sponsor Terminated Study|1|||
16139765|NCT00387764|38999720|FG000|Overall Study|Physician Decision|1|||
16139766|NCT00387764|38999720|FG000|Overall Study|Other|2|||
16139767|NCT00387764|38999720|FG000|Overall Study|Death|7|||
16139768|NCT03952806|38999721|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
16139769|NCT03952806|38999722|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
16139770|NCT03952806|38999721|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
16139771|NCT03952806|38999722|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
16139772|NCT03952806|38999721|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
16139773|NCT03952806|38999722|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
16139774|NCT03952806|38999721|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
16139775|NCT03952806|38999722|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
16139776|NCT03952806|38999721|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
16139777|NCT03952806|38999722|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
16139778|NCT03952806|38999721|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
16139779|NCT03952806|38999722|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
16139780|NCT03952806|38999721|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
16139781|NCT03952806|38999722|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
16139782|NCT03952806|38999721|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
16139783|NCT03952806|38999722|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
16139784|NCT03952806|38999721|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
16139785|NCT03952806|38999722|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
16139786|NCT03952806|38999721|FG000|OLE Phase (48 Weeks)|Other|16|||
16139787|NCT03952806|38999722|FG001|OLE Phase (48 Weeks)|Other|13|||
16139788|NCT00509067|38999723|FG000|Overall Study|Lost to Follow-up|1|||
16139789|NCT00509067|38999724|FG001|Overall Study|Lost to Follow-up|1|||
16139790|NCT00509067|38999723|FG000|Overall Study|Adverse Event|3|||
16139791|NCT00509067|38999724|FG001|Overall Study|Adverse Event|1|||
16139792|NCT00509067|38999723|FG000|Overall Study|Protocol Violation|0|||
16139793|NCT00509067|38999724|FG001|Overall Study|Protocol Violation|3|||
16139794|NCT01241552|38999725|FG000|Overall Study|Lack of Efficacy|1|||
16139795|NCT01241552|38999726|FG001|Overall Study|Lack of Efficacy|0|||
16139796|NCT01241552|38999727|FG002|Overall Study|Lack of Efficacy|0|||
16139797|NCT01241552|38999728|FG003|Overall Study|Lack of Efficacy|0|||
16139798|NCT01241552|38999725|FG000|Overall Study|Death|26|||
16139799|NCT01241552|38999726|FG001|Overall Study|Death|30|||
16139800|NCT01241552|38999727|FG002|Overall Study|Death|20|||
16139801|NCT01241552|38999728|FG003|Overall Study|Death|25|||
16139802|NCT01241552|38999725|FG000|Overall Study|Adverse Event|1|||
16254813|NCT01915732|39416778|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
16254814|NCT01915732|39416777|FG000|Overall Study|Adverse Event|12|||
16254815|NCT01915732|39416778|FG001|Overall Study|Adverse Event|4|||
16254816|NCT01915732|39416777|FG000|Overall Study|Protocol Violation|5|||
16254817|NCT01915732|39416778|FG001|Overall Study|Protocol Violation|5|||
16254818|NCT01915732|39416777|FG000|Overall Study|Lack of Efficacy|6|||
16254819|NCT01915732|39416778|FG001|Overall Study|Lack of Efficacy|11|||
16254820|NCT01915732|39416777|FG000|Overall Study|Lost to Follow-up|22|||
16254821|NCT01915732|39416778|FG001|Overall Study|Lost to Follow-up|26|||
16254822|NCT01915732|39416777|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
16254823|NCT01915732|39416778|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
16254824|NCT01915732|39416777|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
16254825|NCT01915732|39416778|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
16254826|NCT01915732|39416777|FG000|Overall Study|Drug Release Error|1|||
16254827|NCT01915732|39416778|FG001|Overall Study|Drug Release Error|0|||
16254828|NCT01915732|39416777|FG000|Overall Study|Recovered|1|||
16139803|NCT01241552|38999726|FG001|Overall Study|Adverse Event|1|||
16139804|NCT01241552|38999727|FG002|Overall Study|Adverse Event|0|||
16139805|NCT01241552|38999728|FG003|Overall Study|Adverse Event|0|||
16139806|NCT01241552|38999725|FG000|Overall Study|Technical Problems|2|||
16139807|NCT01241552|38999726|FG001|Overall Study|Technical Problems|0|||
16139808|NCT01241552|38999727|FG002|Overall Study|Technical Problems|2|||
16139809|NCT01241552|38999728|FG003|Overall Study|Technical Problems|2|||
16139810|NCT01241552|38999725|FG000|Overall Study|Progressive Disease|0|||
16139811|NCT01241552|38999726|FG001|Overall Study|Progressive Disease|0|||
16139812|NCT01241552|38999727|FG002|Overall Study|Progressive Disease|1|||
16139813|NCT01241552|38999728|FG003|Overall Study|Progressive Disease|2|||
16139814|NCT01241552|38999725|FG000|Overall Study|Protocol Violation|0|||
16139815|NCT01241552|38999726|FG001|Overall Study|Protocol Violation|2|||
16139816|NCT01241552|38999727|FG002|Overall Study|Protocol Violation|6|||
16139817|NCT01241552|38999728|FG003|Overall Study|Protocol Violation|1|||
16139818|NCT01241552|38999725|FG000|Overall Study|Withdrawal by Subject|7|||
16139819|NCT01241552|38999726|FG001|Overall Study|Withdrawal by Subject|15|||
16139820|NCT01241552|38999727|FG002|Overall Study|Withdrawal by Subject|14|||
16139821|NCT01241552|38999728|FG003|Overall Study|Withdrawal by Subject|15|||
16139822|NCT01241552|38999725|FG000|Overall Study|Physician Decision|2|||
16139823|NCT01241552|38999726|FG001|Overall Study|Physician Decision|4|||
16139824|NCT01241552|38999727|FG002|Overall Study|Physician Decision|2|||
16139825|NCT01241552|38999728|FG003|Overall Study|Physician Decision|3|||
16139826|NCT01241552|38999725|FG000|Overall Study|Lost to Follow-up|2|||
16437670|NCT00883779|40082029|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
16437671|NCT00883779|40082030|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
16139827|NCT01241552|38999726|FG001|Overall Study|Lost to Follow-up|11|||
16139828|NCT01241552|38999727|FG002|Overall Study|Lost to Follow-up|15|||
16139829|NCT01241552|38999728|FG003|Overall Study|Lost to Follow-up|16|||
16139830|NCT00056862|38999729|FG000|Overall Study|Protocol Violation|1|||
16139831|NCT00056862|38999730|FG001|Overall Study|Protocol Violation|0|||
16254829|NCT01915732|39416778|FG001|Overall Study|Recovered|0|||
16254830|NCT01915732|39416777|FG000|Overall Study|Pregnancy|1|||
16254831|NCT01915732|39416778|FG001|Overall Study|Pregnancy|0|||
16254832|NCT01915732|39416777|FG000|Overall Study|Poor Perceived Efficacy|1|||
16254833|NCT01915732|39416778|FG001|Overall Study|Poor Perceived Efficacy|0|||
16254834|NCT01915732|39416777|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
16254835|NCT01915732|39416778|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
16254836|NCT01915732|39416777|FG000|Overall Study|Got Well|0|||
16254837|NCT01915732|39416778|FG001|Overall Study|Got Well|1|||
16254838|NCT01915732|39416777|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
16254839|NCT01915732|39416778|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
16254840|NCT01915732|39416777|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
16254841|NCT01915732|39416778|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
16254842|NCT01915732|39416777|FG000|Overall Study|Job Transfer|0|||
16254843|NCT01915732|39416778|FG001|Overall Study|Job Transfer|1|||
16254844|NCT01915732|39416777|FG000|Overall Study|Improper Facial Procedure|0|||
16254845|NCT01915732|39416778|FG001|Overall Study|Improper Facial Procedure|1|||
16254846|NCT01915732|39416777|FG000|Overall Study|Poor Conscious Effect|0|||
16254847|NCT01915732|39416778|FG001|Overall Study|Poor Conscious Effect|1|||
16254848|NCT01335477|39416782|FG000|Overall Study|Adverse Event|30|||
16254849|NCT01335477|39416783|FG001|Overall Study|Adverse Event|42|||
16363349|NCT01134042|39815078|FG000|Overall Study|Physician Decision|4|||
16363350|NCT01134042|39815079|FG001|Overall Study|Physician Decision|8|||
16363351|NCT01134042|39815080|FG002|Overall Study|Physician Decision|1|||
16363352|NCT01134042|39815078|FG000|Overall Study|Withdrawal by Subject|13|||
16363353|NCT01134042|39815079|FG001|Overall Study|Withdrawal by Subject|4|||
16363354|NCT01134042|39815080|FG002|Overall Study|Withdrawal by Subject|7|||
16363355|NCT01253161|39815083|FG000|Overall Study|Adverse Event|1|||
16363356|NCT01118299|39815086|FG000|Overall Study|Death|7|||
16363357|NCT01118299|39815087|FG001|Overall Study|Death|5|||
16363358|NCT01118299|39815086|FG000|Overall Study|Withdrawal by Subject|8|||
16363359|NCT01118299|39815087|FG001|Overall Study|Withdrawal by Subject|8|||
16363360|NCT01118299|39815086|FG000|Overall Study|Lost to Follow-up|2|||
16363361|NCT01118299|39815087|FG001|Overall Study|Lost to Follow-up|1|||
16363362|NCT01118299|39815086|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
16363363|NCT01118299|39815087|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
16363364|NCT01056276|39815090|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
16363365|NCT01056276|39815091|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
16363366|NCT01056276|39815090|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
16363367|NCT01056276|39815091|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
16139832|NCT01296035|38999731|FG000|Overall Study|Withdrawal by Subject|1|||
16363368|NCT01056276|39815090|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
16363369|NCT01056276|39815091|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
16363370|NCT01056276|39815090|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
16139833|NCT01555151|38999732|FG000|Overall Study|Withdrawal by Subject|6|||
16254850|NCT01335477|39416782|FG000|Overall Study|Non compliant with protocol|0|||
16437672|NCT00883779|40082029|FG000|Post-Study Treatment Phase|Disease progression|103|||
16437673|NCT00883779|40082030|FG001|Post-Study Treatment Phase|Disease progression|122|||
16437674|NCT00883779|40082029|FG000|Post-Study Treatment Phase|Other|3|||
16437675|NCT00883779|40082030|FG001|Post-Study Treatment Phase|Other|0|||
16437676|NCT00883779|40082029|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
16437677|NCT00883779|40082030|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
16437678|NCT00883779|40082029|FG000|Off-study Phase|Death|185|||
16437679|NCT00883779|40082030|FG001|Off-study Phase|Death|174|||
16437680|NCT00883779|40082029|FG000|Off-study Phase|Refused treatment|1|||
16437681|NCT00883779|40082030|FG001|Off-study Phase|Refused treatment|1|||
16437682|NCT00883779|40082029|FG000|Off-study Phase|Failure to return|5|||
16437683|NCT00883779|40082030|FG001|Off-study Phase|Failure to return|6|||
16437684|NCT00883779|40082029|FG000|Off-study Phase|Other|18|||
16437685|NCT00883779|40082030|FG001|Off-study Phase|Other|21|||
16437686|NCT00990106|40082031|FG000|Overall Study|"too busy to continue"|1|||
16437687|NCT00990106|40082032|FG001|Overall Study|"too busy to continue"|2|||
16437688|NCT00990106|40082031|FG000|Overall Study|Lost to Follow-up|1|||
16437689|NCT00990106|40082032|FG001|Overall Study|Lost to Follow-up|3|||
16437690|NCT00990106|40082031|FG000|Overall Study|Withdrawal by Subject|2|||
16437691|NCT00990106|40082032|FG001|Overall Study|Withdrawal by Subject|1|||
16437692|NCT00990106|40082031|FG000|Overall Study|opted for open label prazosin|1|||
16437693|NCT00990106|40082032|FG001|Overall Study|opted for open label prazosin|1|||
16437694|NCT00990106|40082031|FG000|Overall Study|relocation/deployment|4|||
16437695|NCT00990106|40082032|FG001|Overall Study|relocation/deployment|1|||
16437696|NCT00990106|40082031|FG000|Overall Study|started exclusionary medication|0|||
16437697|NCT00990106|40082032|FG001|Overall Study|started exclusionary medication|1|||
16437698|NCT00990106|40082031|FG000|Overall Study|planned major surgery|0|||
16437699|NCT00990106|40082032|FG001|Overall Study|planned major surgery|1|||
16437700|NCT00990106|40082031|FG000|Overall Study|scheduling conflicts|0|||
16437701|NCT00990106|40082032|FG001|Overall Study|scheduling conflicts|2|||
16437702|NCT01921205|40082033|FG000|Overall Study|Adverse Event|12|||
16437703|NCT01921205|40082034|FG001|Overall Study|Adverse Event|7|||
16437704|NCT01921205|40082033|FG000|Overall Study|Lack of Efficacy|1|||
16437705|NCT01921205|40082034|FG001|Overall Study|Lack of Efficacy|0|||
16437706|NCT01921205|40082033|FG000|Overall Study|Protocol Violation|1|||
16437707|NCT01921205|40082034|FG001|Overall Study|Protocol Violation|3|||
16437708|NCT01921205|40082033|FG000|Overall Study|Lost to Follow-up|1|||
16437709|NCT01921205|40082034|FG001|Overall Study|Lost to Follow-up|1|||
16437710|NCT01921205|40082033|FG000|Overall Study|Withdrawal by Subject|6|||
16437711|NCT01921205|40082034|FG001|Overall Study|Withdrawal by Subject|5|||
16437712|NCT01921205|40082033|FG000|Overall Study|Use Of Prohibited Medication|0|||
16437713|NCT01921205|40082034|FG001|Overall Study|Use Of Prohibited Medication|1|||
16437714|NCT01921205|40082033|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
16437715|NCT01921205|40082034|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
16437716|NCT01921205|40082033|FG000|Overall Study|Non Compliance Of The Parent|0|||
16437717|NCT01921205|40082034|FG001|Overall Study|Non Compliance Of The Parent|1|||
16437718|NCT01921205|40082033|FG000|Overall Study|Non Compliance Of Child|0|||
16437719|NCT01921205|40082034|FG001|Overall Study|Non Compliance Of Child|1|||
16437720|NCT05470387|40082035|FG000|Overall Study|Protocol Violation|0|||
16437721|NCT05470387|40082036|FG001|Overall Study|Protocol Violation|3|||
16437722|NCT00651924|40082037|FG000|Overall Study|Withdrawal by PI|0|||
16363371|NCT01056276|39815091|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
16363372|NCT01056276|39815090|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
16363373|NCT01056276|39815091|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
16363374|NCT01056276|39815090|FG000|Treatment Period-Cycles 1-8|Death|3|||
16363375|NCT01056276|39815091|FG001|Treatment Period-Cycles 1-8|Death|1|||
16363376|NCT01056276|39815090|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
16363377|NCT01056276|39815091|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
16363378|NCT01056276|39815090|FG000|Maintenance Therapy|Toxicity|0|||
16363379|NCT01056276|39815091|FG001|Maintenance Therapy|Toxicity|2|||
16363380|NCT01056276|39815090|FG000|Maintenance Therapy|Progressive Disease|0|||
16437723|NCT00651924|40082038|FG001|Overall Study|Withdrawal by PI|2|||
16437724|NCT00651924|40082037|FG000|Overall Study|Withdrawal by Subject|0|||
16437725|NCT00651924|40082038|FG001|Overall Study|Withdrawal by Subject|5|||
16437726|NCT04258423|40082039|FG000|Overall Study|Study Closure|2|||
16437727|NCT04258423|40082040|FG001|Overall Study|Study Closure|2|||
16437728|NCT01428258|40082047|FG000|Intervention 1|Withdrawal by Subject|2|||
16437729|NCT01428258|40082048|FG001|Intervention 1|Withdrawal by Subject|0|||
16437730|NCT03905096|40082049|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
16437731|NCT03905096|40082050|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
16437732|NCT01755234|40082051|FG000|Overall Study|Lost to Follow-up|11|||
16437733|NCT01755234|40082052|FG001|Overall Study|Lost to Follow-up|6|||
16437734|NCT01755234|40082051|FG000|Overall Study|Change in surgical case|2|||
16437735|NCT01755234|40082052|FG001|Overall Study|Change in surgical case|1|||
16437736|NCT01755234|40082051|FG000|Overall Study|case cancelled|1|||
16437737|NCT01755234|40082052|FG001|Overall Study|case cancelled|0|||
16437738|NCT01755234|40082051|FG000|Overall Study|Withdrawal by Subject|0|||
16437739|NCT01755234|40082052|FG001|Overall Study|Withdrawal by Subject|1|||
16437740|NCT01755234|40082051|FG000|Overall Study|unblinded|1|||
16437741|NCT01755234|40082052|FG001|Overall Study|unblinded|0|||
16437742|NCT00625131|40082053|FG000|Overall Study|Lost to Follow-up|3|||
16437743|NCT00625131|40082054|FG001|Overall Study|Lost to Follow-up|2|||
16437744|NCT00625131|40082055|FG002|Overall Study|Lost to Follow-up|0|||
16437745|NCT00625131|40082053|FG000|Overall Study|Withdrawal by Subject|1|||
16437746|NCT00625131|40082054|FG001|Overall Study|Withdrawal by Subject|0|||
16437747|NCT00625131|40082055|FG002|Overall Study|Withdrawal by Subject|5|||
16139834|NCT01555151|38999733|FG001|Overall Study|Withdrawal by Subject|2|||
16139835|NCT01555151|38999734|FG002|Overall Study|Withdrawal by Subject|0|||
16139836|NCT01555151|38999735|FG003|Overall Study|Withdrawal by Subject|2|||
16139837|NCT01555151|38999732|FG000|Overall Study|Administrative|3|||
16139838|NCT01555151|38999733|FG001|Overall Study|Administrative|1|||
16139839|NCT01555151|38999734|FG002|Overall Study|Administrative|2|||
16139840|NCT01555151|38999735|FG003|Overall Study|Administrative|0|||
16139841|NCT01555151|38999732|FG000|Overall Study|Protocol Violation|3|||
16139842|NCT01555151|38999733|FG001|Overall Study|Protocol Violation|3|||
16139843|NCT01555151|38999734|FG002|Overall Study|Protocol Violation|3|||
16139844|NCT01555151|38999735|FG003|Overall Study|Protocol Violation|5|||
16139845|NCT01555151|38999732|FG000|Overall Study|Adverse Event|1|||
16254851|NCT01335477|39416783|FG001|Overall Study|Non compliant with protocol|2|||
16363381|NCT01056276|39815091|FG001|Maintenance Therapy|Progressive Disease|9|||
16363382|NCT01056276|39815090|FG000|Maintenance Therapy|Physician Decision|0|||
16363383|NCT01056276|39815091|FG001|Maintenance Therapy|Physician Decision|1|||
16363384|NCT01056276|39815090|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
16363385|NCT01056276|39815091|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
16363386|NCT01056276|39815090|FG000|Maintenance Therapy|Intercurrent Illness|0|||
16363387|NCT01056276|39815091|FG001|Maintenance Therapy|Intercurrent Illness|1|||
16363388|NCT01056276|39815090|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
16363389|NCT01056276|39815091|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
16363390|NCT00088153|39815094|FG000|Overall Study|Physician Decision|3|||
16363391|NCT00088153|39815095|FG001|Overall Study|Physician Decision|3|||
16363392|NCT00088153|39815094|FG000|Overall Study|Withdrawal by Subject|10|||
16363393|NCT00088153|39815095|FG001|Overall Study|Withdrawal by Subject|10|||
16363394|NCT00088153|39815094|FG000|Overall Study|Lost to Follow-up|11|||
16363395|NCT00088153|39815095|FG001|Overall Study|Lost to Follow-up|12|||
16363396|NCT03915067|39815096|FG000|Overall Study|Adverse Event|0|||
16363397|NCT03915067|39815097|FG001|Overall Study|Adverse Event|0|||
16363398|NCT03915067|39815098|FG002|Overall Study|Adverse Event|1|||
16363399|NCT03915067|39815096|FG000|Overall Study|Withdrawal by Subject|4|||
16363400|NCT03915067|39815097|FG001|Overall Study|Withdrawal by Subject|3|||
16363401|NCT03915067|39815098|FG002|Overall Study|Withdrawal by Subject|0|||
16363402|NCT03915067|39815096|FG000|Overall Study|Lost to Follow-up|3|||
16363403|NCT03915067|39815097|FG001|Overall Study|Lost to Follow-up|2|||
16363404|NCT03915067|39815098|FG002|Overall Study|Lost to Follow-up|0|||
16363405|NCT03915067|39815096|FG000|Overall Study|Protocol Deviation|0|||
16363406|NCT03915067|39815097|FG001|Overall Study|Protocol Deviation|0|||
16363407|NCT03915067|39815098|FG002|Overall Study|Protocol Deviation|1|||
16363408|NCT03915067|39815096|FG000|Overall Study|Covid-19 Related Issues|2|||
16363409|NCT03915067|39815097|FG001|Overall Study|Covid-19 Related Issues|4|||
16363410|NCT03915067|39815098|FG002|Overall Study|Covid-19 Related Issues|4|||
16363411|NCT03915067|39815096|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
16363412|NCT03915067|39815097|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
16363413|NCT03915067|39815098|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
16363414|NCT00426270|39815101|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
16363415|NCT00426270|39815101|FG000|Overall Study|Adverse Event|5|||
16363416|NCT05417113|39815104|FG000|Overall Study|Lost to Follow-up|2|||
16363417|NCT05417113|39815105|FG001|Overall Study|Lost to Follow-up|2|||
16363418|NCT00933933|39815106|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
16363419|NCT00933933|39815107|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
16363420|NCT00933933|39815108|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
16363421|NCT00933933|39815106|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
16363422|NCT00933933|39815107|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
16363423|NCT00933933|39815108|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
16363424|NCT00134719|39815111|FG000|Primary Vaccination Phase|Adverse Event|4|||
16363425|NCT00134719|39815112|FG001|Primary Vaccination Phase|Adverse Event|0|||
16363426|NCT00134719|39815113|FG002|Primary Vaccination Phase|Adverse Event|0|||
16437748|NCT01584232|40082056|FG000|Overall Study|Adverse Event|3|||
16437749|NCT01584232|40082057|FG001|Overall Study|Adverse Event|1|||
16437750|NCT01584232|40082056|FG000|Overall Study|Withdrawal by Subject|2|||
16437751|NCT01584232|40082057|FG001|Overall Study|Withdrawal by Subject|1|||
16437752|NCT01584232|40082056|FG000|Overall Study|Physician Decision|2|||
16437753|NCT01584232|40082057|FG001|Overall Study|Physician Decision|1|||
16437754|NCT01584232|40082056|FG000|Overall Study|Lost to Follow-up|1|||
16363427|NCT00134719|39815111|FG000|Primary Vaccination Phase|Protocol Violation|1|||
16363428|NCT00134719|39815112|FG001|Primary Vaccination Phase|Protocol Violation|0|||
16363429|NCT00134719|39815113|FG002|Primary Vaccination Phase|Protocol Violation|0|||
16363430|NCT00134719|39815111|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
16363431|NCT00134719|39815112|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
16363432|NCT00134719|39815113|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
16363433|NCT00134719|39815111|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
16363434|NCT00134719|39815112|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
16363435|NCT00134719|39815113|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
16363436|NCT00134719|39815111|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
16363437|NCT00134719|39815112|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
16363438|NCT00134719|39815113|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
16363439|NCT00134719|39815111|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
16363440|NCT00134719|39815112|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
16363441|NCT00134719|39815113|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
16363442|NCT01389232|39815115|FG000|Overall Study|Had scaffold removed|15|||
16363443|NCT01389232|39815115|FG000|Overall Study|Personal reasons|2|||
16363444|NCT01389232|39815115|FG000|Overall Study|Adverse Event|1|||
16363445|NCT01389232|39815115|FG000|Overall Study|Death|1|||
16363446|NCT01525589|39815118|FG000|Overall Study|Non-treatment-related AE|1|||
16363447|NCT01525589|39815119|FG001|Overall Study|Non-treatment-related AE|0|||
16437755|NCT01584232|40082057|FG001|Overall Study|Lost to Follow-up|0|||
16437756|NCT03452540|40082059|FG000|Overall Study|Adverse Event|1|||
16437757|NCT03452540|40082059|FG000|Overall Study|Withdrawal by Subject|1|||
16437758|NCT03452540|40082059|FG000|Overall Study|Other SAE and AE|2|||
16437759|NCT02159066|40082060|FG000|Part I|Adverse Event|7|||
16437760|NCT02159066|40082061|FG001|Part I|Adverse Event|5|||
16437761|NCT02159066|40082062|FG002|Part I|Adverse Event|0|||
16139846|NCT01555151|38999733|FG001|Overall Study|Adverse Event|2|||
16363448|NCT01525589|39815120|FG002|Overall Study|Non-treatment-related AE|0|||
16363449|NCT01525589|39815118|FG000|Overall Study|Progressive disease|48|||
16363450|NCT01525589|39815119|FG001|Overall Study|Progressive disease|15|||
16363451|NCT01525589|39815120|FG002|Overall Study|Progressive disease|29|||
16363452|NCT01525589|39815118|FG000|Overall Study|Never treated|2|||
16363453|NCT01525589|39815119|FG001|Overall Study|Never treated|0|||
16363454|NCT01525589|39815120|FG002|Overall Study|Never treated|0|||
16363455|NCT01525589|39815118|FG000|Overall Study|Physician Decision|4|||
16363456|NCT01525589|39815119|FG001|Overall Study|Physician Decision|2|||
16363457|NCT01525589|39815120|FG002|Overall Study|Physician Decision|2|||
16363458|NCT01525589|39815118|FG000|Overall Study|Death|0|||
16363459|NCT01525589|39815119|FG001|Overall Study|Death|0|||
16363460|NCT01525589|39815120|FG002|Overall Study|Death|2|||
16363461|NCT01525589|39815118|FG000|Overall Study|Treatment-related AE|1|||
16363462|NCT01525589|39815119|FG001|Overall Study|Treatment-related AE|1|||
16363463|NCT01525589|39815120|FG002|Overall Study|Treatment-related AE|2|||
16363464|NCT01525589|39815118|FG000|Overall Study|Other reasons|0|||
16363465|NCT01525589|39815119|FG001|Overall Study|Other reasons|1|||
16363466|NCT01525589|39815120|FG002|Overall Study|Other reasons|0|||
16363467|NCT01525589|39815118|FG000|Overall Study|Withdrawal by Subject|0|||
16363468|NCT01525589|39815119|FG001|Overall Study|Withdrawal by Subject|1|||
16363469|NCT01525589|39815120|FG002|Overall Study|Withdrawal by Subject|0|||
16363470|NCT03188705|39815121|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
16363471|NCT03188705|39815121|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
16139847|NCT01555151|38999734|FG002|Overall Study|Adverse Event|1|||
16139848|NCT01555151|38999735|FG003|Overall Study|Adverse Event|2|||
16139849|NCT01555151|38999732|FG000|Overall Study|Lost to Follow-up|0|||
16139850|NCT01555151|38999733|FG001|Overall Study|Lost to Follow-up|0|||
16139851|NCT01555151|38999734|FG002|Overall Study|Lost to Follow-up|0|||
16139852|NCT01555151|38999735|FG003|Overall Study|Lost to Follow-up|1|||
16139853|NCT01130051|38999741|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
16139854|NCT01130051|38999742|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
16139855|NCT01130051|38999741|FG000|Washout Period of 14 Days|Protocol Violation|1|||
16363472|NCT00769561|39815122|FG000|Overall Study|Withdrawal by Subject|2|||
16437762|NCT02159066|40082063|FG003|Part I|Adverse Event|0|||
16437763|NCT02159066|40082064|FG004|Part I|Adverse Event|0|||
16139856|NCT01130051|38999742|FG001|Washout Period of 14 Days|Protocol Violation|1|||
16363473|NCT00769561|39815123|FG001|Overall Study|Withdrawal by Subject|2|||
16363474|NCT00769561|39815122|FG000|Overall Study|Lost to Follow-up|1|||
16363475|NCT00769561|39815123|FG001|Overall Study|Lost to Follow-up|3|||
16437764|NCT02159066|40082065|FG005|Part I|Adverse Event|0|||
16437765|NCT02159066|40082060|FG000|Part I|Death|11|||
16139857|NCT01159912|38999743|FG000|Overall Study|Adverse Event|2|||
16254852|NCT01335477|39416782|FG000|Overall Study|Lost to Follow-up|1|||
16254853|NCT01335477|39416783|FG001|Overall Study|Lost to Follow-up|2|||
16254854|NCT01335477|39416782|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
16254855|NCT01335477|39416783|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
16254856|NCT01335477|39416782|FG000|Overall Study|Not treated|1|||
16254857|NCT01335477|39416783|FG001|Overall Study|Not treated|2|||
16254858|NCT01335477|39416782|FG000|Overall Study|Reason other than those stated above|2|||
16254859|NCT01335477|39416783|FG001|Overall Study|Reason other than those stated above|2|||
16254860|NCT04060680|39416784|FG000|Overall Study|Unsuccessful implant|17|||
16254861|NCT04060680|39416784|FG000|Overall Study|Adverse Event|3|||
16254862|NCT04060680|39416784|FG000|Overall Study|Death|2|||
16254863|NCT04060680|39416784|FG000|Overall Study|Study product no longer in use|1|||
16254864|NCT04060680|39416784|FG000|Overall Study|Withdrawal by Subject|1|||
16254865|NCT03997448|39416786|FG000|Study Treatment|Disease Progression|1|||
16254866|NCT03997448|39416786|FG000|Study Treatment|Symptomatic Deterioration|1|||
16254867|NCT03997448|39416786|FG000|Follow up|Death|2|||
16254868|NCT03997448|39416786|FG000|Follow up|study terminated|1|||
16254869|NCT00275002|39416789|FG000|Overall Study|Death|1|||
16254870|NCT00275002|39416790|FG001|Overall Study|Death|0|||
16254871|NCT00275002|39416789|FG000|Overall Study|Disease progression|21|||
16254872|NCT00275002|39416790|FG001|Overall Study|Disease progression|15|||
16254873|NCT00275002|39416789|FG000|Overall Study|Adverse Event|0|||
16254874|NCT00275002|39416790|FG001|Overall Study|Adverse Event|1|||
16254875|NCT03311646|39416793|FG000|Overall Study|Physician Decision|1|||
16254876|NCT03311646|39416793|FG000|Overall Study|Withdrawal by Subject|5|||
16254877|NCT03311646|39416793|FG000|Overall Study|Lost to Follow-up|5|||
16254878|NCT03311646|39416793|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
16254879|NCT01238848|39416795|FG000|Overall Study|Physician Decision|13|||
16254880|NCT01238848|39416796|FG001|Overall Study|Physician Decision|5|||
16254881|NCT01440283|39416797|FG000|Overall Study|Death|3|||
16254882|NCT01440283|39416797|FG000|Overall Study|Withdrawal by Subject|4|||
16254883|NCT01440283|39416797|FG000|Overall Study|Physician Decision|3|||
16254884|NCT01475838|39416798|FG000|Randomized Phase|Randomized but Not Treated|0|||
16254885|NCT01475838|39416799|FG001|Randomized Phase|Randomized but Not Treated|5|||
16254886|NCT01475838|39416798|FG000|Randomized Phase|Adverse Event|6|||
16254887|NCT01475838|39416799|FG001|Randomized Phase|Adverse Event|1|||
16254888|NCT01475838|39416798|FG000|Randomized Phase|Pregnancy|0|||
16254889|NCT01475838|39416799|FG001|Randomized Phase|Pregnancy|1|||
16254890|NCT01475838|39416798|FG000|Randomized Phase|Investigators Discretion|1|||
16254891|NCT01475838|39416799|FG001|Randomized Phase|Investigators Discretion|2|||
16254892|NCT01475838|39416798|FG000|Randomized Phase|Withdrew Consent|10|||
16254893|NCT01475838|39416799|FG001|Randomized Phase|Withdrew Consent|14|||
16254894|NCT01475838|39416798|FG000|Randomized Phase|Lost to Follow-up|3|||
16254895|NCT01475838|39416799|FG001|Randomized Phase|Lost to Follow-up|4|||
16254896|NCT01475838|39416798|FG000|Randomized Phase|Participant Noncompliance|1|||
16254897|NCT01475838|39416799|FG001|Randomized Phase|Participant Noncompliance|5|||
16254898|NCT01475838|39416798|FG000|Randomized Phase|Protocol Violation|9|||
16254899|NCT01475838|39416799|FG001|Randomized Phase|Protocol Violation|4|||
16254900|NCT01475838|39416798|FG000|Extension Phase|Participant Noncompliance|1|||
16254901|NCT01475838|39416799|FG001|Extension Phase|Participant Noncompliance|0|||
16254902|NCT00860028|39416800|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
16254903|NCT00860028|39416801|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
16254904|NCT01575054|39416802|FG000|Overall Study|Other Reasons|5|||
16254905|NCT01575054|39416803|FG001|Overall Study|Other Reasons|3|||
16254906|NCT01575054|39416802|FG000|Overall Study|Protocol Violation|2|||
16254907|NCT01575054|39416803|FG001|Overall Study|Protocol Violation|1|||
16254908|NCT01575054|39416802|FG000|Overall Study|Personal Reasons|10|||
16254909|NCT01575054|39416803|FG001|Overall Study|Personal Reasons|11|||
16254910|NCT01575054|39416802|FG000|Overall Study|Lost to Follow-up|3|||
16254911|NCT01575054|39416803|FG001|Overall Study|Lost to Follow-up|3|||
16254912|NCT01575054|39416802|FG000|Overall Study|Adverse Event|9|||
16254913|NCT01575054|39416803|FG001|Overall Study|Adverse Event|8|||
16254914|NCT01179919|39416804|FG000|Overall Study|Protocol Violation|1|||
16254915|NCT01179919|39416804|FG000|Overall Study|Adverse Event|1|||
16254916|NCT01739790|39416805|FG000|Overall Study|Early Trial Termination|2|||
16254917|NCT01739790|39416806|FG001|Overall Study|Early Trial Termination|4|||
16254918|NCT02428699|39416809|FG000|Washout Period 1|Screen Failure|1|||
16254919|NCT02428699|39416810|FG001|Washout Period 1|Screen Failure|2|||
16254920|NCT00686959|39416811|FG000|Overall Study|Participants censored (no death events)|124|||
16254921|NCT00686959|39416812|FG001|Overall Study|Participants censored (no death events)|117|||
16254922|NCT01658943|39416813|FG000|Overall Study|Adverse Event|6|||
16254923|NCT01658943|39416814|FG001|Overall Study|Adverse Event|13|||
16254924|NCT01658943|39416813|FG000|Overall Study|Withdrawal by Subject|9|||
16254925|NCT01658943|39416814|FG001|Overall Study|Withdrawal by Subject|2|||
16254926|NCT01658943|39416813|FG000|Overall Study|Progression/Relapse|39|||
16254927|NCT01658943|39416814|FG001|Overall Study|Progression/Relapse|40|||
16254928|NCT01658943|39416813|FG000|Overall Study|Death|4|||
16254929|NCT01658943|39416814|FG001|Overall Study|Death|2|||
16254930|NCT01658943|39416813|FG000|Overall Study|not protocol specified|4|||
16254931|NCT01658943|39416814|FG001|Overall Study|not protocol specified|1|||
16254932|NCT01658943|39416813|FG000|Overall Study|Not eligible|7|||
16254933|NCT01658943|39416814|FG001|Overall Study|Not eligible|9|||
16254934|NCT01658943|39416813|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
16254935|NCT01658943|39416814|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
16254936|NCT02430870|39416819|FG000|Part 2|Voluntary Withdrawal|0|||
16254937|NCT02430870|39416820|FG001|Part 2|Voluntary Withdrawal|0|||
16254938|NCT02430870|39416821|FG002|Part 2|Voluntary Withdrawal|0|||
16363476|NCT00833755|39815135|FG000|Overall Study|Physician Decision|4|||
16363477|NCT00833755|39815136|FG001|Overall Study|Physician Decision|4|||
16254939|NCT02430870|39416822|FG003|Part 2|Voluntary Withdrawal|0|||
16254940|NCT02430870|39416823|FG004|Part 2|Voluntary Withdrawal|0|||
16363478|NCT00833755|39815137|FG002|Overall Study|Physician Decision|2|||
16363479|NCT00833755|39815138|FG003|Overall Study|Physician Decision|6|||
16254941|NCT02430870|39416824|FG005|Part 2|Voluntary Withdrawal|0|||
16254942|NCT02430870|39416825|FG006|Part 2|Voluntary Withdrawal|1|||
16254943|NCT02430870|39416826|FG007|Part 2|Voluntary Withdrawal|0|||
16254944|NCT02430870|39416819|FG000|Part 2|Other Reason Not Specified|0|||
16254945|NCT02430870|39416820|FG001|Part 2|Other Reason Not Specified|0|||
16254946|NCT02430870|39416821|FG002|Part 2|Other Reason Not Specified|0|||
16254947|NCT02430870|39416822|FG003|Part 2|Other Reason Not Specified|0|||
16254948|NCT02430870|39416823|FG004|Part 2|Other Reason Not Specified|0|||
16254949|NCT02430870|39416824|FG005|Part 2|Other Reason Not Specified|0|||
16254950|NCT02430870|39416825|FG006|Part 2|Other Reason Not Specified|0|||
16254951|NCT02430870|39416826|FG007|Part 2|Other Reason Not Specified|1|||
16254952|NCT00620763|39416828|FG000|Period: First Intervention|Withdrawal by Subject|0|||
16254953|NCT00620763|39416829|FG001|Period: First Intervention|Withdrawal by Subject|2|||
16254954|NCT00620763|39416828|FG000|Period: First Intervention|Protocol Violation|0|||
16254955|NCT00620763|39416829|FG001|Period: First Intervention|Protocol Violation|3|||
16254956|NCT00620763|39416828|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
16254957|NCT00620763|39416829|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
16254958|NCT01469546|39416830|FG000|Received 5 mg Dose|Adverse Event|13|||
16254959|NCT01469546|39416830|FG000|Received 5 mg Dose|Death|2|||
16254960|NCT01469546|39416830|FG000|Received 5 mg Dose|Protocol Violation|2|||
16254961|NCT01469546|39416830|FG000|Received 5 mg Dose|Progressive Disease|3|||
16254962|NCT01469546|39416830|FG000|Received 5 mg Dose|Physician Decision|3|||
16254963|NCT01835145|39416831|FG000|Overall Study|Ineligible prior to treatment|1|||
16254964|NCT01835145|39416832|FG001|Overall Study|Ineligible prior to treatment|0|||
16254965|NCT00870870|39416833|FG000|Overall Study|Withdrawal by Subject|0|||
16254966|NCT00870870|39416834|FG001|Overall Study|Withdrawal by Subject|1|||
16254967|NCT00870870|39416835|FG002|Overall Study|Withdrawal by Subject|1|||
16254968|NCT00870870|39416836|FG003|Overall Study|Withdrawal by Subject|3|||
16254969|NCT00870870|39416833|FG000|Overall Study|Adverse Event|0|||
16254970|NCT00870870|39416834|FG001|Overall Study|Adverse Event|0|||
16254971|NCT00870870|39416835|FG002|Overall Study|Adverse Event|2|||
16254972|NCT00870870|39416836|FG003|Overall Study|Adverse Event|2|||
16254973|NCT03738332|39416837|FG000|Overall Study|Withdrawal by Subject|1|||
16254974|NCT03810495|39416838|FG000|Overall Study|Lost to Follow-up|2|||
16254975|NCT03810495|39416838|FG000|Overall Study|Withdrawal by Subject|1|||
16254976|NCT03103100|39416839|FG000|Overall Study|Adverse Event|1|||
16254977|NCT03103100|39416840|FG001|Overall Study|Adverse Event|0|||
16254978|NCT03103100|39416841|FG002|Overall Study|Adverse Event|0|||
16254979|NCT03103100|39416839|FG000|Overall Study|Physician Decision|1|||
16254980|NCT03103100|39416840|FG001|Overall Study|Physician Decision|0|||
16254981|NCT03103100|39416841|FG002|Overall Study|Physician Decision|2|||
16254982|NCT03552757|39416842|FG000|Overall Study|Withdrawal by Subject|10|||
16254983|NCT03552757|39416843|FG001|Overall Study|Withdrawal by Subject|5|||
16254984|NCT03552757|39416844|FG002|Overall Study|Withdrawal by Subject|12|||
16254985|NCT03552757|39416842|FG000|Overall Study|Lost to Follow-up|2|||
16254986|NCT03552757|39416843|FG001|Overall Study|Lost to Follow-up|7|||
16254987|NCT03552757|39416844|FG002|Overall Study|Lost to Follow-up|7|||
16254988|NCT03552757|39416842|FG000|Overall Study|Death|1|||
16254989|NCT03552757|39416843|FG001|Overall Study|Death|1|||
16254990|NCT03552757|39416844|FG002|Overall Study|Death|1|||
16254991|NCT00723554|39416846|FG000|Overall Study|Adverse Event|12|||
16254992|NCT00723554|39416846|FG000|Overall Study|Investigator's judgement|5|||
16254993|NCT00723554|39416846|FG000|Overall Study|Inhaled medication other than iloprost|4|||
16254994|NCT00723554|39416846|FG000|Overall Study|Withdrawal of consent|3|||
16254995|NCT00723554|39416846|FG000|Overall Study|Other|3|||
16254996|NCT00723554|39416846|FG000|Overall Study|Lost to Follow-up|1|||
16254997|NCT00723554|39416846|FG000|Overall Study|Non-compliance|1|||
16254998|NCT01569152|39416847|FG000|Phase IIa, Period 1|Early Escape|5|||
16254999|NCT01569152|39416848|FG001|Phase IIa, Period 1|Early Escape|22|||
16255000|NCT01569152|39416849|FG002|Phase IIa, Period 1|Early Escape|0|||
16255001|NCT01569152|39416847|FG000|Phase IIa, Period 1|Adverse Event|4|||
16255002|NCT01569152|39416848|FG001|Phase IIa, Period 1|Adverse Event|0|||
16255003|NCT01569152|39416849|FG002|Phase IIa, Period 1|Adverse Event|0|||
16255004|NCT01569152|39416847|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
16255005|NCT01569152|39416848|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
16255006|NCT01569152|39416849|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
16255007|NCT01569152|39416847|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
16255008|NCT01569152|39416848|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
16255009|NCT01569152|39416849|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
16255010|NCT01569152|39416847|FG000|Phase IIa, Period 1|Protocol Violation|0|||
16255011|NCT01569152|39416848|FG001|Phase IIa, Period 1|Protocol Violation|1|||
16255012|NCT01569152|39416849|FG002|Phase IIa, Period 1|Protocol Violation|0|||
16255013|NCT01569152|39416847|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
16255014|NCT01569152|39416848|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
16255015|NCT01569152|39416849|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
16255016|NCT01569152|39416847|FG000|Safety Extension, Period 3|Adverse Event|0|||
16255017|NCT01569152|39416848|FG001|Safety Extension, Period 3|Adverse Event|0|||
16255018|NCT01569152|39416849|FG002|Safety Extension, Period 3|Adverse Event|4|||
16255019|NCT01569152|39416847|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
16255020|NCT01569152|39416848|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
16255021|NCT01569152|39416849|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
16255022|NCT01569152|39416847|FG000|Safety Extension, Period 3|Physician Decision|0|||
16255023|NCT01569152|39416848|FG001|Safety Extension, Period 3|Physician Decision|0|||
16255024|NCT01569152|39416849|FG002|Safety Extension, Period 3|Physician Decision|2|||
16255025|NCT01569152|39416847|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
16255026|NCT01569152|39416848|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
16255027|NCT01569152|39416849|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
16255028|NCT01789320|39416852|FG000|Overall Study|Re-enrolled into study|1|||
16255029|NCT01789320|39416852|FG000|Overall Study|Lost to Follow-up|1|||
16255030|NCT01478620|39416853|FG000|Overall Study|Lost to Follow-up|6|||
16255031|NCT01180244|39416854|FG000|Overall Study|Lack of Efficacy|0|||
16255032|NCT01180244|39416855|FG001|Overall Study|Lack of Efficacy|7|||
16255033|NCT01180244|39416854|FG000|Overall Study|Physician Decision|3|||
16255034|NCT01180244|39416855|FG001|Overall Study|Physician Decision|0|||
16255035|NCT01180244|39416854|FG000|Overall Study|Adverse Event|1|||
16255036|NCT01180244|39416855|FG001|Overall Study|Adverse Event|0|||
16255037|NCT01180244|39416854|FG000|Overall Study|Withdrawal by Subject|0|||
16255038|NCT01180244|39416855|FG001|Overall Study|Withdrawal by Subject|1|||
16255039|NCT01180244|39416854|FG000|Overall Study|Protocol Violation|1|||
16255040|NCT01180244|39416855|FG001|Overall Study|Protocol Violation|0|||
16255041|NCT01180244|39416854|FG000|Overall Study|Lost to Follow-up|1|||
16255042|NCT01180244|39416855|FG001|Overall Study|Lost to Follow-up|0|||
16255043|NCT03309956|39416863|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
16255044|NCT04529109|39416864|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
16255045|NCT04529109|39416865|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
16255046|NCT01755858|39416875|FG000|Overall Study|Adverse Event|1|||
16255047|NCT01755858|39416876|FG001|Overall Study|Adverse Event|1|||
16255048|NCT02460159|39416877|FG000|Overall Study|Adverse Event|4|||
16255049|NCT02460159|39416878|FG001|Overall Study|Adverse Event|1|||
16255050|NCT02460159|39416877|FG000|Overall Study|Withdrawal by Subject|2|||
16255051|NCT02460159|39416878|FG001|Overall Study|Withdrawal by Subject|0|||
16255052|NCT00669864|39416880|FG000|Overall Study|Lost to Follow-up|2|||
16255053|NCT00669864|39416880|FG000|Overall Study|Protocol Violation|2|||
16255054|NCT00669864|39416880|FG000|Overall Study|Withdrawal by Subject|3|||
16255055|NCT00669864|39416880|FG000|Overall Study|Other|2|||
16255056|NCT02623959|39416881|FG000|Overall Study|Progression|0|||
16255057|NCT02623959|39416882|FG001|Overall Study|Progression|1|||
16255058|NCT05894577|39416883|FG000|Overall Study|No receipt of study drug|14|||
16255059|NCT05894577|39416884|FG001|Overall Study|No receipt of study drug|13|||
16255060|NCT05894577|39416883|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
16255061|NCT05894577|39416884|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
16255062|NCT05894577|39416883|FG000|Overall Study|Screen Fail|2|||
16255063|NCT05894577|39416884|FG001|Overall Study|Screen Fail|0|||
16255064|NCT05894577|39416883|FG000|Overall Study|Study drug recall|86|||
16255065|NCT05894577|39416884|FG001|Overall Study|Study drug recall|63|||
16255066|NCT01225146|39416887|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
16255067|NCT01225146|39416888|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
16255068|NCT02579096|39416889|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
16255069|NCT02579096|39416890|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
16255070|NCT02579096|39416889|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
16363480|NCT00833755|39815135|FG000|Overall Study|Subject had scheduling issues|0|||
16255071|NCT02579096|39416890|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
16255072|NCT02579096|39416889|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
16255073|NCT02579096|39416890|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
16255074|NCT02579096|39416889|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
16255075|NCT02579096|39416890|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
16255076|NCT02579096|39416889|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
16255077|NCT02579096|39416890|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
16255078|NCT02579096|39416889|FG000|Phase 2, Weeks 25 - 48|Death|2|||
16363481|NCT00833755|39815136|FG001|Overall Study|Subject had scheduling issues|1|||
16363482|NCT00833755|39815137|FG002|Overall Study|Subject had scheduling issues|0|||
16363483|NCT00833755|39815138|FG003|Overall Study|Subject had scheduling issues|0|||
16363484|NCT01047501|39815139|FG000|Overall Study|Adverse Event|7|||
16363485|NCT01047501|39815140|FG001|Overall Study|Adverse Event|8|||
16363486|NCT01047501|39815141|FG002|Overall Study|Adverse Event|5|||
16255079|NCT02579096|39416890|FG001|Phase 2, Weeks 25 - 48|Death|4|||
16255080|NCT02579096|39416889|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
16255081|NCT02579096|39416890|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
16255082|NCT02579096|39416889|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
16255083|NCT02579096|39416890|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
16255084|NCT02579096|39416889|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
16255085|NCT02579096|39416890|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
16255086|NCT02579096|39416889|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
16255087|NCT02579096|39416890|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
16255088|NCT02579096|39416889|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
16363487|NCT01047501|39815139|FG000|Overall Study|Withdrew Consent|6|||
16139858|NCT01159912|38999744|FG001|Overall Study|Adverse Event|2|||
16139859|NCT01159912|38999745|FG002|Overall Study|Adverse Event|3|||
16139860|NCT01159912|38999743|FG000|Overall Study|Lack of Efficacy|23|||
16139861|NCT01159912|38999744|FG001|Overall Study|Lack of Efficacy|15|||
16363488|NCT01047501|39815140|FG001|Overall Study|Withdrew Consent|2|||
16363489|NCT01047501|39815141|FG002|Overall Study|Withdrew Consent|4|||
16363490|NCT01047501|39815139|FG000|Overall Study|Lost to Follow-up|0|||
16363491|NCT01047501|39815140|FG001|Overall Study|Lost to Follow-up|1|||
16363492|NCT01047501|39815141|FG002|Overall Study|Lost to Follow-up|1|||
16363493|NCT01047501|39815139|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
16363494|NCT01047501|39815140|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
16139862|NCT01159912|38999745|FG002|Overall Study|Lack of Efficacy|14|||
16139863|NCT01159912|38999743|FG000|Overall Study|Protocol Violation|1|||
16139864|NCT01159912|38999744|FG001|Overall Study|Protocol Violation|2|||
16139865|NCT01159912|38999745|FG002|Overall Study|Protocol Violation|3|||
16139866|NCT01159912|38999743|FG000|Overall Study|Lost to Follow-up|4|||
16139867|NCT01159912|38999744|FG001|Overall Study|Lost to Follow-up|0|||
16139868|NCT01159912|38999745|FG002|Overall Study|Lost to Follow-up|0|||
16139869|NCT01159912|38999743|FG000|Overall Study|Physician Decision|0|||
16139870|NCT01159912|38999744|FG001|Overall Study|Physician Decision|0|||
16139871|NCT01159912|38999745|FG002|Overall Study|Physician Decision|3|||
16139872|NCT01159912|38999743|FG000|Overall Study|Withdrawal by Subject|10|||
16139873|NCT01159912|38999744|FG001|Overall Study|Withdrawal by Subject|3|||
16139874|NCT01159912|38999745|FG002|Overall Study|Withdrawal by Subject|3|||
16139875|NCT02592018|38999755|FG000|Overall Study|Adverse Event|1|||
16139876|NCT02592018|38999755|FG000|Overall Study|Lost to Follow-up|1|||
16139877|NCT01251120|38999756|FG000|Overall Study|Lack of Efficacy|0|||
16139878|NCT01251120|38999757|FG001|Overall Study|Lack of Efficacy|1|||
16139879|NCT00892177|38999758|FG000|Phase II|Ineligible|0|||
16139880|NCT00892177|38999759|FG001|Phase II|Ineligible|0|||
16139881|NCT00892177|38999760|FG002|Phase II|Ineligible|0|||
16139882|NCT00892177|38999761|FG003|Phase II|Ineligible|0|||
16139883|NCT00892177|38999762|FG004|Phase II|Ineligible|1|||
16139884|NCT00892177|38999763|FG005|Phase II|Ineligible|1|||
16139885|NCT00892177|38999758|FG000|Phase II|Withdrawal by Subject|0|||
16139886|NCT00892177|38999759|FG001|Phase II|Withdrawal by Subject|0|||
16139887|NCT00892177|38999760|FG002|Phase II|Withdrawal by Subject|0|||
16139888|NCT00892177|38999761|FG003|Phase II|Withdrawal by Subject|0|||
16139889|NCT00892177|38999762|FG004|Phase II|Withdrawal by Subject|4|||
16139890|NCT00892177|38999763|FG005|Phase II|Withdrawal by Subject|1|||
16139891|NCT01284062|38999764|FG000|Overall Study|Adverse Event|4|||
16139892|NCT01284062|38999765|FG001|Overall Study|Adverse Event|5|||
16139893|NCT01284062|38999766|FG002|Overall Study|Adverse Event|0|||
16139894|NCT01284062|38999767|FG003|Overall Study|Adverse Event|5|||
16139895|NCT01284062|38999764|FG000|Overall Study|Lack of Efficacy|3|||
16139896|NCT01284062|38999765|FG001|Overall Study|Lack of Efficacy|2|||
16139897|NCT01284062|38999766|FG002|Overall Study|Lack of Efficacy|2|||
16139898|NCT01284062|38999767|FG003|Overall Study|Lack of Efficacy|1|||
16139899|NCT01284062|38999764|FG000|Overall Study|Medication error without adverse event|0|||
16139900|NCT01284062|38999765|FG001|Overall Study|Medication error without adverse event|0|||
16139901|NCT01284062|38999766|FG002|Overall Study|Medication error without adverse event|1|||
16139902|NCT01284062|38999767|FG003|Overall Study|Medication error without adverse event|0|||
16139903|NCT01284062|38999764|FG000|Overall Study|Protocol Violation|1|||
16139904|NCT01284062|38999765|FG001|Overall Study|Protocol Violation|0|||
16363495|NCT01047501|39815141|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
16363496|NCT01047501|39815139|FG000|Overall Study|Death|1|||
16139905|NCT01284062|38999766|FG002|Overall Study|Protocol Violation|0|||
16139906|NCT01284062|38999767|FG003|Overall Study|Protocol Violation|2|||
16255089|NCT02579096|39416890|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
16255090|NCT02579096|39416889|FG000|Phase 3, Weeks 49 - 72|Death|3|||
16255091|NCT02579096|39416890|FG001|Phase 3, Weeks 49 - 72|Death|2|||
16255092|NCT02579096|39416889|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
16255093|NCT02579096|39416890|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
16255094|NCT02579096|39416889|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
16255095|NCT02579096|39416890|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
16255096|NCT02579096|39416889|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
16255097|NCT02579096|39416890|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
16255098|NCT02579096|39416889|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
16255099|NCT02579096|39416890|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
16255100|NCT02579096|39416889|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
16255101|NCT02579096|39416890|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
16255102|NCT02579096|39416889|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
16255103|NCT02579096|39416890|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
16255104|NCT00243932|39416892|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
16255105|NCT00243932|39416893|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
16255106|NCT00243932|39416894|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
16255107|NCT00841100|39416898|FG000|Phase 1 (28 Days)|Adverse Event|1|||
16255108|NCT00841100|39416898|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
16255109|NCT01984242|39419774|FG000|Overall Study|Death|52|||
16255110|NCT01984242|39419775|FG001|Overall Study|Death|50|||
16255111|NCT01984242|39419776|FG002|Overall Study|Death|52|||
16255112|NCT01984242|39419774|FG000|Overall Study|Withdrawal by Subject|5|||
16255113|NCT01984242|39419775|FG001|Overall Study|Withdrawal by Subject|3|||
16255114|NCT01984242|39419776|FG002|Overall Study|Withdrawal by Subject|10|||
16255115|NCT01984242|39419774|FG000|Overall Study|Physician Decision|0|||
16255116|NCT01984242|39419775|FG001|Overall Study|Physician Decision|0|||
16255117|NCT01984242|39419776|FG002|Overall Study|Physician Decision|1|||
16255118|NCT01984242|39419774|FG000|Overall Study|Lost to Follow-up|4|||
16255119|NCT01984242|39419775|FG001|Overall Study|Lost to Follow-up|0|||
16255120|NCT01984242|39419776|FG002|Overall Study|Lost to Follow-up|3|||
16255121|NCT01984242|39419774|FG000|Overall Study|Sponsor Decision|1|||
16255122|NCT01984242|39419775|FG001|Overall Study|Sponsor Decision|0|||
16255123|NCT01984242|39419776|FG002|Overall Study|Sponsor Decision|0|||
16255124|NCT01984242|39419774|FG000|Overall Study|Non-Compliance|1|||
16363497|NCT01047501|39815140|FG001|Overall Study|Death|0|||
16363498|NCT01047501|39815141|FG002|Overall Study|Death|0|||
16363499|NCT01047501|39815139|FG000|Overall Study|Other discontinuation|1|||
16363500|NCT01047501|39815140|FG001|Overall Study|Other discontinuation|0|||
16363501|NCT01047501|39815141|FG002|Overall Study|Other discontinuation|1|||
16363502|NCT01047501|39815139|FG000|Overall Study|Investigator judgement|0|||
16363503|NCT01047501|39815140|FG001|Overall Study|Investigator judgement|0|||
16363504|NCT01047501|39815141|FG002|Overall Study|Investigator judgement|1|||
16363505|NCT00250588|39815143|FG000|Overall Study|Withdrawal by Subject|3|||
16363506|NCT00250588|39815144|FG001|Overall Study|Withdrawal by Subject|6|||
16363507|NCT00250588|39815145|FG002|Overall Study|Withdrawal by Subject|0|||
16363508|NCT00250588|39815143|FG000|Overall Study|Lost to Follow-up|6|||
16363509|NCT00250588|39815144|FG001|Overall Study|Lost to Follow-up|13|||
16363510|NCT00250588|39815145|FG002|Overall Study|Lost to Follow-up|13|||
16363511|NCT02184156|39815146|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
16363512|NCT02184156|39815147|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
16363513|NCT02184156|39815146|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
16363514|NCT02184156|39815147|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
16363515|NCT01407367|39815148|FG000|Overall Study|Death|24|||
16363516|NCT01407367|39815149|FG001|Overall Study|Death|32|||
16255125|NCT01984242|39419775|FG001|Overall Study|Non-Compliance|0|||
16139907|NCT01284062|38999764|FG000|Overall Study|Withdrawal by Subject|3|||
16139908|NCT01284062|38999765|FG001|Overall Study|Withdrawal by Subject|1|||
16139909|NCT01284062|38999766|FG002|Overall Study|Withdrawal by Subject|2|||
16139910|NCT01284062|38999767|FG003|Overall Study|Withdrawal by Subject|5|||
16139911|NCT01284062|38999764|FG000|Overall Study|Other|0|||
16139912|NCT01284062|38999765|FG001|Overall Study|Other|0|||
16139913|NCT01284062|38999766|FG002|Overall Study|Other|0|||
16139914|NCT01284062|38999767|FG003|Overall Study|Other|1|||
16139915|NCT01284062|38999764|FG000|Overall Study|Site Closed|0|||
16139916|NCT01284062|38999765|FG001|Overall Study|Site Closed|0|||
16139917|NCT01284062|38999766|FG002|Overall Study|Site Closed|1|||
16139918|NCT01284062|38999767|FG003|Overall Study|Site Closed|0|||
16139919|NCT00288509|38999770|FG000|Treatment Cycle 1|Adverse Event|1|||
16139920|NCT00288509|38999770|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
16139921|NCT00288509|38999770|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
16139922|NCT00288509|38999770|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
16139923|NCT00288509|38999770|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
16139924|NCT00288509|38999770|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
16139925|NCT00288509|38999770|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
16139926|NCT00288509|38999770|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
16437766|NCT02159066|40082061|FG001|Part I|Death|9|||
16437767|NCT02159066|40082062|FG002|Part I|Death|0|||
16437768|NCT02159066|40082063|FG003|Part I|Death|0|||
16437769|NCT02159066|40082064|FG004|Part I|Death|0|||
16437770|NCT02159066|40082065|FG005|Part I|Death|0|||
16437771|NCT02159066|40082060|FG000|Part I|Progressive Disease|37|||
16437772|NCT02159066|40082061|FG001|Part I|Progressive Disease|46|||
16437773|NCT02159066|40082062|FG002|Part I|Progressive Disease|0|||
16437774|NCT02159066|40082063|FG003|Part I|Progressive Disease|0|||
16363517|NCT01407367|39815148|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
16363518|NCT01407367|39815149|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
16363519|NCT01407367|39815148|FG000|Overall Study|Withdrawal by Subject|4|||
16363520|NCT01407367|39815149|FG001|Overall Study|Withdrawal by Subject|15|||
16363521|NCT01407367|39815148|FG000|Overall Study|Lost to Follow-up|0|||
16363522|NCT01407367|39815149|FG001|Overall Study|Lost to Follow-up|2|||
16363523|NCT04796415|39815150|FG000|Overall Study|not interested|12|||
16363524|NCT04796415|39815150|FG000|Overall Study|health issue|8|||
16363525|NCT04796415|39815150|FG000|Overall Study|Other|4|||
16363526|NCT04796415|39815150|FG000|Overall Study|discharged from home health service|3|||
16363527|NCT04796415|39815150|FG000|Overall Study|re-hospitalization|2|||
16363528|NCT04796415|39815150|FG000|Overall Study|moving to nursing home|1|||
16363529|NCT04796415|39815150|FG000|Overall Study|lost contact|1|||
16363530|NCT00970944|39815151|FG000|Overall Study|Death|1|||
16363531|NCT00970944|39815152|FG001|Overall Study|Death|0|||
16363532|NCT00970944|39815151|FG000|Overall Study|Physician Decision|0|||
16363533|NCT00970944|39815152|FG001|Overall Study|Physician Decision|2|||
16139927|NCT00288509|38999770|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
16139928|NCT00288509|38999770|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
16139929|NCT00288509|38999770|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
16139930|NCT00288509|38999770|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
16139931|NCT00288509|38999770|FG000|Treatment Cycle 4|Physician Decision|4|||
16139932|NCT00288509|38999770|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
16139933|NCT00954174|38999771|FG000|Overall Study|Adverse Event|28|||
16139934|NCT00954174|38999772|FG001|Overall Study|Adverse Event|23|||
16139935|NCT00954174|38999773|FG002|Overall Study|Adverse Event|4|||
16139936|NCT00954174|38999774|FG003|Overall Study|Adverse Event|9|||
16139937|NCT00954174|38999771|FG000|Overall Study|Death|4|||
16363534|NCT01018979|39815155|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
16139938|NCT00954174|38999772|FG001|Overall Study|Death|2|||
16139939|NCT00954174|38999773|FG002|Overall Study|Death|0|||
16363535|NCT01018979|39815156|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
16363536|NCT01018979|39815155|FG000|Overall Study|Not received at least one dose|0|||
16363537|NCT01018979|39815156|FG001|Overall Study|Not received at least one dose|1|||
16437775|NCT02159066|40082064|FG004|Part I|Progressive Disease|0|||
16139940|NCT00954174|38999774|FG003|Overall Study|Death|0|||
16139941|NCT00954174|38999771|FG000|Overall Study|Lack of Efficacy|32|||
16437776|NCT02159066|40082065|FG005|Part I|Progressive Disease|0|||
16437777|NCT02159066|40082060|FG000|Part I|New Therapy for Study Indication|5|||
16363538|NCT01164475|39815157|FG000|Overall Study|Lack of Efficacy|1|||
16363539|NCT01164475|39815158|FG001|Overall Study|Lack of Efficacy|0|||
16363540|NCT01164475|39815157|FG000|Overall Study|Other|0|||
16363541|NCT01164475|39815158|FG001|Overall Study|Other|1|||
16363542|NCT01164475|39815157|FG000|Overall Study|Progressive disease|0|||
16363543|NCT01164475|39815158|FG001|Overall Study|Progressive disease|1|||
16363544|NCT01164475|39815157|FG000|Overall Study|Protocol Violation|1|||
16363545|NCT01164475|39815158|FG001|Overall Study|Protocol Violation|0|||
16363546|NCT01147458|39815160|FG000|First Intervention|Study terminated by sponsor|8|||
16363547|NCT01147458|39815161|FG001|First Intervention|Study terminated by sponsor|8|||
16363548|NCT01147458|39815162|FG002|First Intervention|Study terminated by sponsor|7|||
16363549|NCT01147458|39815163|FG003|First Intervention|Study terminated by sponsor|8|||
16363550|NCT01147458|39815160|FG000|First Intervention|Protocol Violation|2|||
16363551|NCT01147458|39815161|FG001|First Intervention|Protocol Violation|3|||
16363552|NCT01147458|39815162|FG002|First Intervention|Protocol Violation|2|||
16363553|NCT01147458|39815163|FG003|First Intervention|Protocol Violation|3|||
16437778|NCT02159066|40082061|FG001|Part I|New Therapy for Study Indication|4|||
16437779|NCT02159066|40082062|FG002|Part I|New Therapy for Study Indication|0|||
16437780|NCT02159066|40082063|FG003|Part I|New Therapy for Study Indication|0|||
16437781|NCT02159066|40082064|FG004|Part I|New Therapy for Study Indication|0|||
16437782|NCT02159066|40082065|FG005|Part I|New Therapy for Study Indication|0|||
16437783|NCT02159066|40082060|FG000|Part I|Termination of participants from the study|3|||
16437784|NCT02159066|40082061|FG001|Part I|Termination of participants from the study|3|||
16437785|NCT02159066|40082062|FG002|Part I|Termination of participants from the study|0|||
16437786|NCT02159066|40082063|FG003|Part I|Termination of participants from the study|0|||
16437787|NCT02159066|40082064|FG004|Part I|Termination of participants from the study|0|||
16363554|NCT01147458|39815160|FG000|First Intervention|Withdrawal by Subject|3|||
16363555|NCT01147458|39815161|FG001|First Intervention|Withdrawal by Subject|0|||
16363556|NCT01147458|39815162|FG002|First Intervention|Withdrawal by Subject|1|||
16363557|NCT01147458|39815163|FG003|First Intervention|Withdrawal by Subject|0|||
16437788|NCT02159066|40082065|FG005|Part I|Termination of participants from the study|0|||
16437789|NCT02159066|40082060|FG000|Part I|Physician Decision|2|||
16437790|NCT02159066|40082061|FG001|Part I|Physician Decision|9|||
16437791|NCT02159066|40082062|FG002|Part I|Physician Decision|0|||
16437792|NCT02159066|40082063|FG003|Part I|Physician Decision|0|||
16437793|NCT02159066|40082064|FG004|Part I|Physician Decision|0|||
16139942|NCT00954174|38999772|FG001|Overall Study|Lack of Efficacy|22|||
16139943|NCT00954174|38999773|FG002|Overall Study|Lack of Efficacy|8|||
16139944|NCT00954174|38999774|FG003|Overall Study|Lack of Efficacy|6|||
16363558|NCT01147458|39815160|FG000|First Intervention|Adverse Event|0|||
16363559|NCT01147458|39815161|FG001|First Intervention|Adverse Event|3|||
16363560|NCT01147458|39815162|FG002|First Intervention|Adverse Event|2|||
16363561|NCT01147458|39815163|FG003|First Intervention|Adverse Event|3|||
16363562|NCT01147458|39815160|FG000|First Intervention|Other|1|||
16437794|NCT02159066|40082065|FG005|Part I|Physician Decision|0|||
16437795|NCT02159066|40082060|FG000|Part I|Participant/Guardian Decision|9|||
16139945|NCT00954174|38999771|FG000|Overall Study|Withdrawal by Subject|14|||
16139946|NCT00954174|38999772|FG001|Overall Study|Withdrawal by Subject|10|||
16139947|NCT00954174|38999773|FG002|Overall Study|Withdrawal by Subject|4|||
16139948|NCT00954174|38999774|FG003|Overall Study|Withdrawal by Subject|3|||
16139949|NCT00954174|38999771|FG000|Overall Study|Medical Reason|4|||
16363563|NCT01147458|39815161|FG001|First Intervention|Other|2|||
16363564|NCT01147458|39815162|FG002|First Intervention|Other|0|||
16363565|NCT01147458|39815163|FG003|First Intervention|Other|0|||
16363566|NCT01147458|39815160|FG000|Second Intervention|Study terminated by sponsor|7|||
16437796|NCT02159066|40082061|FG001|Part I|Participant/Guardian Decision|3|||
16437797|NCT02159066|40082062|FG002|Part I|Participant/Guardian Decision|0|||
16363567|NCT01147458|39815161|FG001|Second Intervention|Study terminated by sponsor|5|||
16363568|NCT01147458|39815162|FG002|Second Intervention|Study terminated by sponsor|5|||
16363569|NCT01147458|39815163|FG003|Second Intervention|Study terminated by sponsor|3|||
16363570|NCT01147458|39815160|FG000|Second Intervention|Protocol Violation|0|||
16363571|NCT01147458|39815161|FG001|Second Intervention|Protocol Violation|1|||
16363572|NCT01147458|39815162|FG002|Second Intervention|Protocol Violation|1|||
16363573|NCT01147458|39815163|FG003|Second Intervention|Protocol Violation|0|||
16363574|NCT01147458|39815160|FG000|Second Intervention|Withdrawal by Subject|0|||
16363575|NCT01147458|39815161|FG001|Second Intervention|Withdrawal by Subject|1|||
16363576|NCT01147458|39815162|FG002|Second Intervention|Withdrawal by Subject|0|||
16363577|NCT01147458|39815163|FG003|Second Intervention|Withdrawal by Subject|0|||
16363578|NCT01147458|39815160|FG000|Second Intervention|Adverse Event|2|||
16363579|NCT01147458|39815161|FG001|Second Intervention|Adverse Event|0|||
16363580|NCT01147458|39815162|FG002|Second Intervention|Adverse Event|1|||
16363581|NCT01147458|39815163|FG003|Second Intervention|Adverse Event|1|||
16363582|NCT01147458|39815160|FG000|Second Intervention|Other|0|||
16363583|NCT01147458|39815161|FG001|Second Intervention|Other|0|||
16363584|NCT01147458|39815162|FG002|Second Intervention|Other|1|||
16363585|NCT01147458|39815163|FG003|Second Intervention|Other|0|||
16363586|NCT01137786|39815166|FG000|Overall Study|Lost to Follow-up|0|||
16363587|NCT01137786|39815167|FG001|Overall Study|Lost to Follow-up|2|||
16363588|NCT01137786|39815166|FG000|Overall Study|Withdrawal by Subject|1|||
16363589|NCT01137786|39815167|FG001|Overall Study|Withdrawal by Subject|1|||
16363590|NCT02780388|39815168|FG000|Overall Study|Lost to Follow-up|0|||
16363591|NCT02780388|39815169|FG001|Overall Study|Lost to Follow-up|1|||
16363592|NCT02780388|39815170|FG002|Overall Study|Lost to Follow-up|0|||
16363593|NCT02780388|39815171|FG003|Overall Study|Lost to Follow-up|0|||
16363594|NCT02780388|39815172|FG004|Overall Study|Lost to Follow-up|0|||
16363595|NCT02780388|39815168|FG000|Overall Study|Withdrawal by Subject|1|||
16363596|NCT02780388|39815169|FG001|Overall Study|Withdrawal by Subject|1|||
16363597|NCT02780388|39815170|FG002|Overall Study|Withdrawal by Subject|0|||
16363598|NCT02780388|39815171|FG003|Overall Study|Withdrawal by Subject|0|||
16363599|NCT02780388|39815172|FG004|Overall Study|Withdrawal by Subject|0|||
16363600|NCT02394756|39815174|FG000|Period 1|Lens Discomfort|0|||
16363601|NCT02394756|39815175|FG001|Period 1|Lens Discomfort|0|||
16363602|NCT02394756|39815176|FG002|Period 1|Lens Discomfort|0|||
16363603|NCT02394756|39815177|FG003|Period 1|Lens Discomfort|0|||
16437798|NCT02159066|40082063|FG003|Part I|Participant/Guardian Decision|0|||
16437799|NCT02159066|40082064|FG004|Part I|Participant/Guardian Decision|0|||
16437800|NCT02159066|40082065|FG005|Part I|Participant/Guardian Decision|0|||
16437801|NCT02159066|40082060|FG000|Part I|Missing Data|1|||
16437802|NCT02159066|40082061|FG001|Part I|Missing Data|0|||
16437803|NCT02159066|40082062|FG002|Part I|Missing Data|0|||
16437804|NCT02159066|40082063|FG003|Part I|Missing Data|0|||
16437805|NCT02159066|40082064|FG004|Part I|Missing Data|0|||
16437806|NCT02159066|40082065|FG005|Part I|Missing Data|0|||
16437807|NCT02159066|40082060|FG000|Part II|Adverse Event|0|||
16437808|NCT02159066|40082061|FG001|Part II|Adverse Event|0|||
16437809|NCT02159066|40082062|FG002|Part II|Adverse Event|1|||
16437810|NCT02159066|40082063|FG003|Part II|Adverse Event|0|||
16437811|NCT02159066|40082064|FG004|Part II|Adverse Event|1|||
16437812|NCT02159066|40082065|FG005|Part II|Adverse Event|1|||
16437813|NCT02159066|40082060|FG000|Part II|Death|0|||
16437814|NCT02159066|40082061|FG001|Part II|Death|0|||
16437815|NCT02159066|40082062|FG002|Part II|Death|1|||
16437816|NCT02159066|40082063|FG003|Part II|Death|0|||
16437817|NCT02159066|40082064|FG004|Part II|Death|2|||
16437818|NCT02159066|40082065|FG005|Part II|Death|1|||
16437819|NCT02159066|40082060|FG000|Part II|Progressive Disease|0|||
16437820|NCT02159066|40082061|FG001|Part II|Progressive Disease|0|||
16437821|NCT02159066|40082062|FG002|Part II|Progressive Disease|35|||
16437822|NCT02159066|40082063|FG003|Part II|Progressive Disease|1|||
16437823|NCT02159066|40082064|FG004|Part II|Progressive Disease|7|||
16437824|NCT02159066|40082065|FG005|Part II|Progressive Disease|4|||
16363604|NCT02394756|39815178|FG004|Period 1|Lens Discomfort|0|||
16363605|NCT02394756|39815179|FG005|Period 1|Lens Discomfort|1|||
16363606|NCT02394756|39815174|FG000|Period 1|Withdrawal by Subject|0|||
16363607|NCT02394756|39815175|FG001|Period 1|Withdrawal by Subject|1|||
16363608|NCT02394756|39815176|FG002|Period 1|Withdrawal by Subject|1|||
16363609|NCT02394756|39815177|FG003|Period 1|Withdrawal by Subject|1|||
16363610|NCT02394756|39815178|FG004|Period 1|Withdrawal by Subject|0|||
16437825|NCT02159066|40082060|FG000|Part II|New Therapy for Study Indication|0|||
16363611|NCT02394756|39815179|FG005|Period 1|Withdrawal by Subject|0|||
16437826|NCT02159066|40082061|FG001|Part II|New Therapy for Study Indication|0|||
16437827|NCT02159066|40082062|FG002|Part II|New Therapy for Study Indication|0|||
16437828|NCT02159066|40082063|FG003|Part II|New Therapy for Study Indication|0|||
16437829|NCT02159066|40082064|FG004|Part II|New Therapy for Study Indication|1|||
16437830|NCT02159066|40082065|FG005|Part II|New Therapy for Study Indication|0|||
16437831|NCT02159066|40082060|FG000|Part II|Physician Decision|0|||
16437832|NCT02159066|40082061|FG001|Part II|Physician Decision|0|||
16139950|NCT00954174|38999772|FG001|Overall Study|Medical Reason|2|||
16139951|NCT00954174|38999773|FG002|Overall Study|Medical Reason|1|||
16139952|NCT00954174|38999774|FG003|Overall Study|Medical Reason|0|||
16139953|NCT00954174|38999771|FG000|Overall Study|Ineligible|40|||
16139954|NCT00954174|38999772|FG001|Overall Study|Ineligible|47|||
16139955|NCT00954174|38999773|FG002|Overall Study|Ineligible|7|||
16139956|NCT00954174|38999774|FG003|Overall Study|Ineligible|4|||
16139957|NCT00954174|38999771|FG000|Overall Study|Never Treated|4|||
16139958|NCT00954174|38999772|FG001|Overall Study|Never Treated|17|||
16139959|NCT00954174|38999773|FG002|Overall Study|Never Treated|0|||
16139960|NCT00954174|38999774|FG003|Overall Study|Never Treated|3|||
16139961|NCT00596934|38999775|FG000|Overall Study|Protocol Violation|1|||
16139962|NCT00596934|38999775|FG000|Overall Study|Withdrawal by Subject|1|||
16139963|NCT03049735|38999776|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
16139964|NCT03049735|38999777|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
16139965|NCT03049735|38999778|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
16139966|NCT03049735|38999776|FG000|Overall Study|Other|5|||
16139967|NCT03049735|38999777|FG001|Overall Study|Other|3|||
16139968|NCT03049735|38999778|FG002|Overall Study|Other|1|||
16139969|NCT03049735|38999776|FG000|Overall Study|Lack of Efficacy|4|||
16139970|NCT03049735|38999777|FG001|Overall Study|Lack of Efficacy|0|||
16139971|NCT03049735|38999778|FG002|Overall Study|Lack of Efficacy|3|||
16139972|NCT03049735|38999776|FG000|Overall Study|Protocol deviation|1|||
16139973|NCT03049735|38999777|FG001|Overall Study|Protocol deviation|0|||
16139974|NCT03049735|38999778|FG002|Overall Study|Protocol deviation|0|||
16139975|NCT03049735|38999776|FG000|Overall Study|Pregnancy|0|||
16139976|NCT03049735|38999777|FG001|Overall Study|Pregnancy|0|||
16139977|NCT03049735|38999778|FG002|Overall Study|Pregnancy|1|||
16139978|NCT03049735|38999776|FG000|Overall Study|Adverse Event|7|||
16139979|NCT03049735|38999777|FG001|Overall Study|Adverse Event|18|||
16139980|NCT03049735|38999778|FG002|Overall Study|Adverse Event|5|||
16139981|NCT03049735|38999776|FG000|Overall Study|Withdrawal by Subject|10|||
16139982|NCT03049735|38999777|FG001|Overall Study|Withdrawal by Subject|3|||
16139983|NCT03049735|38999778|FG002|Overall Study|Withdrawal by Subject|7|||
16139984|NCT03049735|38999776|FG000|Overall Study|Lost to Follow-up|1|||
16139985|NCT03049735|38999777|FG001|Overall Study|Lost to Follow-up|5|||
16139986|NCT03049735|38999778|FG002|Overall Study|Lost to Follow-up|5|||
16139987|NCT01975428|38999779|FG000|Overall Study|Lost to Follow-up|17|||
16139988|NCT01975428|38999780|FG001|Overall Study|Lost to Follow-up|4|||
16139989|NCT01975428|38999779|FG000|Overall Study|Withdrawal by Subject|3|||
16139990|NCT01975428|38999780|FG001|Overall Study|Withdrawal by Subject|10|||
16139991|NCT02683941|38999781|FG000|Double-blind Phase|Adverse Event|0|||
16139992|NCT02683941|38999782|FG001|Double-blind Phase|Adverse Event|1|||
16139993|NCT02683941|38999781|FG000|Double-blind Phase|Withdrawal by Subject|4|||
16139994|NCT02683941|38999782|FG001|Double-blind Phase|Withdrawal by Subject|2|||
16139995|NCT02683941|38999781|FG000|Double-blind Phase|Lost to Follow-up|1|||
16139996|NCT02683941|38999782|FG001|Double-blind Phase|Lost to Follow-up|0|||
16139997|NCT02683941|38999781|FG000|Double-blind Phase|Disease Progression|5|||
16139998|NCT02683941|38999782|FG001|Double-blind Phase|Disease Progression|2|||
16139999|NCT02683941|38999781|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
16140000|NCT02683941|38999782|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
16140001|NCT02683941|38999781|FG000|Open-label Treatment Phase|Disease Progression|1|||
16140002|NCT02683941|38999782|FG001|Open-label Treatment Phase|Disease Progression|2|||
16140003|NCT02683941|38999781|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
16140004|NCT02683941|38999782|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
16140005|NCT02683941|38999781|FG000|Open-label Treatment Phase|Other|1|||
16140006|NCT02683941|38999782|FG001|Open-label Treatment Phase|Other|0|||
16140007|NCT02683941|38999781|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
16140008|NCT02683941|38999782|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
16140009|NCT02683941|38999781|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
16140010|NCT02683941|38999782|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
16140011|NCT02683941|38999781|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
16255126|NCT01984242|39419776|FG002|Overall Study|Non-Compliance|0|||
16255127|NCT01984242|39419774|FG000|Overall Study|Study terminated by Sponsor|38|||
16437833|NCT02159066|40082062|FG002|Part II|Physician Decision|1|||
16255128|NCT01984242|39419775|FG001|Overall Study|Study terminated by Sponsor|50|||
16437834|NCT02159066|40082063|FG003|Part II|Physician Decision|0|||
16140012|NCT02683941|38999782|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
16140013|NCT02683941|38999781|FG000|Open-label Follow-up Phase|Other|8|||
16140014|NCT02683941|38999782|FG001|Open-label Follow-up Phase|Other|1|||
16140015|NCT00912964|38999783|FG000|Overall Study|Eligibility criterion not met|1|||
16140016|NCT00912964|38999784|FG001|Overall Study|Eligibility criterion not met|1|||
16140017|NCT00912964|38999785|FG002|Overall Study|Eligibility criterion not met|0|||
16140018|NCT00912964|38999783|FG000|Overall Study|Adverse Event|15|||
16437835|NCT02159066|40082064|FG004|Part II|Physician Decision|0|||
16437836|NCT02159066|40082065|FG005|Part II|Physician Decision|0|||
16437837|NCT02159066|40082060|FG000|Part II|Participant/Guardian Decision|0|||
16437838|NCT02159066|40082061|FG001|Part II|Participant/Guardian Decision|0|||
16437839|NCT02159066|40082062|FG002|Part II|Participant/Guardian Decision|0|||
16437840|NCT02159066|40082063|FG003|Part II|Participant/Guardian Decision|0|||
16140019|NCT00912964|38999784|FG001|Overall Study|Adverse Event|18|||
16140020|NCT00912964|38999785|FG002|Overall Study|Adverse Event|12|||
16140021|NCT00912964|38999783|FG000|Overall Study|Lack of Efficacy|11|||
16255129|NCT01984242|39419776|FG002|Overall Study|Study terminated by Sponsor|34|||
16140022|NCT00912964|38999784|FG001|Overall Study|Lack of Efficacy|4|||
16140023|NCT00912964|38999785|FG002|Overall Study|Lack of Efficacy|3|||
16140024|NCT00912964|38999783|FG000|Overall Study|Withdrawal by Subject|20|||
16140025|NCT00912964|38999784|FG001|Overall Study|Withdrawal by Subject|12|||
16140026|NCT00912964|38999785|FG002|Overall Study|Withdrawal by Subject|18|||
16140027|NCT00912964|38999783|FG000|Overall Study|Lost to Follow-up|4|||
16140028|NCT00912964|38999784|FG001|Overall Study|Lost to Follow-up|3|||
16140029|NCT00912964|38999785|FG002|Overall Study|Lost to Follow-up|3|||
16140030|NCT00912964|38999783|FG000|Overall Study|Protocol Violation|5|||
16140031|NCT00912964|38999784|FG001|Overall Study|Protocol Violation|3|||
16140032|NCT00912964|38999785|FG002|Overall Study|Protocol Violation|8|||
16140033|NCT00912964|38999783|FG000|Overall Study|Taking exclusionary medications|7|||
16140034|NCT00912964|38999784|FG001|Overall Study|Taking exclusionary medications|4|||
16140035|NCT00912964|38999785|FG002|Overall Study|Taking exclusionary medications|8|||
16140036|NCT00912964|38999783|FG000|Overall Study|Medical History|1|||
16140037|NCT00912964|38999784|FG001|Overall Study|Medical History|0|||
16140038|NCT00912964|38999785|FG002|Overall Study|Medical History|0|||
16140039|NCT00912964|38999783|FG000|Overall Study|Non-compliance with study procedures|2|||
16140040|NCT00912964|38999784|FG001|Overall Study|Non-compliance with study procedures|0|||
16140041|NCT00912964|38999785|FG002|Overall Study|Non-compliance with study procedures|0|||
16140042|NCT00912964|38999783|FG000|Overall Study|Violation of exclusion criterion|0|||
16140043|NCT00912964|38999784|FG001|Overall Study|Violation of exclusion criterion|0|||
16140044|NCT00912964|38999785|FG002|Overall Study|Violation of exclusion criterion|2|||
16140045|NCT00912964|38999783|FG000|Overall Study|Randomized but never received study drug|0|||
16140046|NCT00912964|38999784|FG001|Overall Study|Randomized but never received study drug|1|||
16140047|NCT00912964|38999785|FG002|Overall Study|Randomized but never received study drug|0|||
16140048|NCT02249767|38999786|FG000|Overall Study|Did not use medication|8|||
16140049|NCT02249767|38999787|FG001|Overall Study|Did not use medication|9|||
16140050|NCT02249767|38999788|FG002|Overall Study|Did not use medication|8|||
16255130|NCT01984242|39419774|FG000|Overall Study|Disease Progression|0|||
16255131|NCT01984242|39419775|FG001|Overall Study|Disease Progression|0|||
16255132|NCT01984242|39419776|FG002|Overall Study|Disease Progression|1|||
16255133|NCT01074554|39419777|FG000|Overall Study|Adverse Event|3|||
16255134|NCT01074554|39419778|FG001|Overall Study|Adverse Event|3|||
16255135|NCT01074554|39419777|FG000|Overall Study|Lost to Follow-up|0|||
16255136|NCT01074554|39419778|FG001|Overall Study|Lost to Follow-up|1|||
16255137|NCT00094302|39419781|FG000|Overall Study|Lost to Follow-up|43|||
16255138|NCT00094302|39419782|FG001|Overall Study|Lost to Follow-up|41|||
16255139|NCT00094302|39419781|FG000|Overall Study|Physician Decision|5|||
16255140|NCT00094302|39419782|FG001|Overall Study|Physician Decision|8|||
16437841|NCT02159066|40082064|FG004|Part II|Participant/Guardian Decision|2|||
16437842|NCT02159066|40082065|FG005|Part II|Participant/Guardian Decision|0|||
16437843|NCT00633477|40082066|FG000|Overall Study|Death|1|||
16140051|NCT02120625|38999789|FG000|Overall Study|Physician Decision|2|||
16255141|NCT00094302|39419781|FG000|Overall Study|Withdrawal by Subject|103|||
16437844|NCT00633477|40082067|FG001|Overall Study|Death|0|||
16363612|NCT02394756|39815174|FG000|Period 2|Unsatisfactory Visual Response|0|||
16363613|NCT02394756|39815175|FG001|Period 2|Unsatisfactory Visual Response|0|||
16363614|NCT02394756|39815176|FG002|Period 2|Unsatisfactory Visual Response|0|||
16363615|NCT02394756|39815177|FG003|Period 2|Unsatisfactory Visual Response|0|||
16363616|NCT02394756|39815178|FG004|Period 2|Unsatisfactory Visual Response|1|||
16363617|NCT02394756|39815179|FG005|Period 2|Unsatisfactory Visual Response|0|||
16363618|NCT00720759|39815180|FG000|Overall Study|Lost to Follow-up|0|||
16363619|NCT00720759|39815181|FG001|Overall Study|Lost to Follow-up|1|||
16363620|NCT00720759|39815182|FG002|Overall Study|Lost to Follow-up|1|||
16363621|NCT00720759|39815183|FG003|Overall Study|Lost to Follow-up|0|||
16363622|NCT00071981|39815184|FG000|Overall Study|Lack of Efficacy|37|||
16363623|NCT00071981|39815185|FG001|Overall Study|Lack of Efficacy|29|||
16363624|NCT00071981|39815186|FG002|Overall Study|Lack of Efficacy|30|||
16363625|NCT00071981|39815187|FG003|Overall Study|Lack of Efficacy|43|||
16363626|NCT00071981|39815184|FG000|Overall Study|Adverse Event|4|||
16363627|NCT00071981|39815185|FG001|Overall Study|Adverse Event|4|||
16363628|NCT00071981|39815186|FG002|Overall Study|Adverse Event|3|||
16363629|NCT00071981|39815187|FG003|Overall Study|Adverse Event|1|||
16363630|NCT00071981|39815184|FG000|Overall Study|Death|0|||
16363631|NCT00071981|39815185|FG001|Overall Study|Death|0|||
16363632|NCT00071981|39815186|FG002|Overall Study|Death|1|||
16437845|NCT00633477|40082066|FG000|Overall Study|Randomized but not treated|1|||
16437846|NCT00633477|40082067|FG001|Overall Study|Randomized but not treated|0|||
16437847|NCT00321789|40082068|FG000|Overall Study|Lost to Follow-up|4|||
16437848|NCT00321789|40082069|FG001|Overall Study|Lost to Follow-up|7|||
16437849|NCT00321789|40082068|FG000|Overall Study|Withdrawal by Subject|6|||
16437850|NCT00321789|40082069|FG001|Overall Study|Withdrawal by Subject|6|||
16437851|NCT00321789|40082068|FG000|Overall Study|Protocol Violation|5|||
16437852|NCT00321789|40082069|FG001|Overall Study|Protocol Violation|3|||
16437853|NCT00791388|40082071|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
16437854|NCT00791388|40082072|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
16437855|NCT00791388|40082073|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
16437856|NCT00791388|40082074|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
16437857|NCT00791388|40082075|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
16437858|NCT00791388|40082071|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
16437859|NCT00791388|40082072|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
16437860|NCT00791388|40082073|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
16437861|NCT00791388|40082074|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
16437862|NCT00791388|40082075|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
16437863|NCT00791388|40082071|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
16437864|NCT00791388|40082072|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
16437865|NCT00791388|40082073|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
16437866|NCT00791388|40082074|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
16437867|NCT00791388|40082075|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
16437868|NCT01706458|40082078|FG000|Overall Study|Physician Decision|3|||
16437869|NCT01706458|40082079|FG001|Overall Study|Physician Decision|4|||
16437870|NCT02694744|40082080|FG000|Overall Study|Adverse Event|2|||
16437871|NCT02694744|40082081|FG001|Overall Study|Adverse Event|1|||
16437872|NCT02694744|40082080|FG000|Overall Study|Withdrawal by Subject|2|||
16437873|NCT02694744|40082081|FG001|Overall Study|Withdrawal by Subject|1|||
16437874|NCT02694744|40082080|FG000|Overall Study|Physician Decision|1|||
16437875|NCT02694744|40082081|FG001|Overall Study|Physician Decision|2|||
16437876|NCT02694744|40082080|FG000|Overall Study|Lost to Follow-up|1|||
16437877|NCT02694744|40082081|FG001|Overall Study|Lost to Follow-up|0|||
16437878|NCT02694744|40082080|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
16437879|NCT02694744|40082081|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
16437880|NCT01078441|40082082|FG000|Overall Study|Withdrawal by Subject|1|||
16437881|NCT02718898|40082085|FG000|Blinded Treatment Period|Adverse Event|5|||
16437882|NCT02718898|40082086|FG001|Blinded Treatment Period|Adverse Event|1|||
16437883|NCT02718898|40082087|FG002|Blinded Treatment Period|Adverse Event|0|||
16437884|NCT02718898|40082088|FG003|Blinded Treatment Period|Adverse Event|0|||
16437885|NCT02718898|40082089|FG004|Blinded Treatment Period|Adverse Event|0|||
16437886|NCT02718898|40082090|FG005|Blinded Treatment Period|Adverse Event|0|||
16437887|NCT02718898|40082091|FG006|Blinded Treatment Period|Adverse Event|0|||
16437888|NCT02718898|40082085|FG000|Blinded Treatment Period|Physician Decision|1|||
16437889|NCT02718898|40082086|FG001|Blinded Treatment Period|Physician Decision|0|||
16437890|NCT02718898|40082087|FG002|Blinded Treatment Period|Physician Decision|0|||
16437891|NCT02718898|40082088|FG003|Blinded Treatment Period|Physician Decision|0|||
16437892|NCT02718898|40082089|FG004|Blinded Treatment Period|Physician Decision|0|||
16437893|NCT02718898|40082090|FG005|Blinded Treatment Period|Physician Decision|0|||
16437894|NCT02718898|40082091|FG006|Blinded Treatment Period|Physician Decision|0|||
16437895|NCT02718898|40082085|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
16437896|NCT02718898|40082086|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
16437897|NCT02718898|40082087|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
16437898|NCT02718898|40082088|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
16437899|NCT02718898|40082089|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
16437900|NCT02718898|40082090|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
16437901|NCT02718898|40082091|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
16437902|NCT02718898|40082085|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
16437903|NCT02718898|40082086|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
16437904|NCT02718898|40082087|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
16437905|NCT02718898|40082088|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
16437906|NCT02718898|40082089|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
16437907|NCT02718898|40082090|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
16363633|NCT00071981|39815187|FG003|Overall Study|Death|1|||
16363634|NCT00071981|39815184|FG000|Overall Study|Withdrawal by Subject|3|||
16363635|NCT00071981|39815185|FG001|Overall Study|Withdrawal by Subject|1|||
16363636|NCT00071981|39815186|FG002|Overall Study|Withdrawal by Subject|0|||
16363637|NCT00071981|39815187|FG003|Overall Study|Withdrawal by Subject|0|||
16363638|NCT00071981|39815184|FG000|Overall Study|No protocol therapy|2|||
16363639|NCT00071981|39815185|FG001|Overall Study|No protocol therapy|5|||
16363640|NCT00071981|39815186|FG002|Overall Study|No protocol therapy|1|||
16363641|NCT00071981|39815187|FG003|Overall Study|No protocol therapy|0|||
16363642|NCT00071981|39815184|FG000|Overall Study|others (not specified in the study)|0|||
16363643|NCT00071981|39815185|FG001|Overall Study|others (not specified in the study)|2|||
16363644|NCT00071981|39815186|FG002|Overall Study|others (not specified in the study)|2|||
16363645|NCT00071981|39815187|FG003|Overall Study|others (not specified in the study)|0|||
16363646|NCT02337764|39815188|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
16363647|NCT02337764|39815188|FG000|Overall Study|Voluntary Withdrawal|12|||
16363648|NCT02337764|39815188|FG000|Overall Study|Lack of Efficacy|2|||
16363649|NCT01551173|39815191|FG000|Overall Study|Withdrawal by Subject|11|||
16363650|NCT01551173|39815192|FG001|Overall Study|Withdrawal by Subject|16|||
16363651|NCT01551173|39815191|FG000|Overall Study|Adverse Event|7|||
16363652|NCT01551173|39815192|FG001|Overall Study|Adverse Event|6|||
16363653|NCT01551173|39815191|FG000|Overall Study|Lost to Follow-up|5|||
16363654|NCT01551173|39815192|FG001|Overall Study|Lost to Follow-up|7|||
16363655|NCT01551173|39815191|FG000|Overall Study|Other|5|||
16363656|NCT01551173|39815192|FG001|Overall Study|Other|3|||
16363657|NCT02693418|39815195|FG000|Overall Study|Lost to Follow-up|1|||
16363658|NCT02693418|39815196|FG001|Overall Study|Lost to Follow-up|2|||
16363659|NCT02693418|39815197|FG002|Overall Study|Lost to Follow-up|0|||
16363660|NCT02693418|39815198|FG003|Overall Study|Lost to Follow-up|0|||
16363661|NCT02693418|39815199|FG004|Overall Study|Lost to Follow-up|0|||
16363662|NCT02693418|39815195|FG000|Overall Study|Menses during study period|0|||
16363663|NCT02693418|39815196|FG001|Overall Study|Menses during study period|0|||
16363664|NCT02693418|39815197|FG002|Overall Study|Menses during study period|2|||
16363665|NCT02693418|39815198|FG003|Overall Study|Menses during study period|0|||
16363666|NCT02693418|39815199|FG004|Overall Study|Menses during study period|0|||
16363667|NCT01260948|39815200|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
16363668|NCT01260948|39815201|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
16363669|NCT01260948|39815200|FG000|Second Intervention|Emesis|0|||
16363670|NCT01260948|39815201|FG001|Second Intervention|Emesis|1|||
16363671|NCT02965833|39815202|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
16363672|NCT02965833|39815203|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
16363673|NCT02965833|39815202|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
16363674|NCT02965833|39815203|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
16363675|NCT02965833|39815202|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
16363676|NCT02965833|39815203|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
16363677|NCT02965833|39815202|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
16363678|NCT02965833|39815203|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
16363679|NCT02965833|39815202|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
16363680|NCT02965833|39815203|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
16437908|NCT02718898|40082091|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
16437909|NCT02718898|40082085|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
16437910|NCT02718898|40082086|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
16363681|NCT05001620|39818025|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
16363682|NCT05001620|39818026|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
16363683|NCT00005047|39818028|FG000|Overall Study|Withdrawal by Subject|12|||
16363684|NCT00005047|39818029|FG001|Overall Study|Withdrawal by Subject|0|||
16363685|NCT00005047|39818030|FG002|Overall Study|Withdrawal by Subject|0|||
16363686|NCT00005047|39818031|FG003|Overall Study|Withdrawal by Subject|0|||
16363687|NCT00005047|39818028|FG000|Overall Study|Adverse Event|5|||
16363688|NCT00005047|39818029|FG001|Overall Study|Adverse Event|0|||
16363689|NCT00005047|39818030|FG002|Overall Study|Adverse Event|0|||
16140052|NCT00719563|38999790|FG000|Overall Study|Adverse Event|16|||
16140053|NCT00719563|38999791|FG001|Overall Study|Adverse Event|13|||
16140054|NCT00719563|38999790|FG000|Overall Study|Medical condition changed|3|||
16140055|NCT00719563|38999791|FG001|Overall Study|Medical condition changed|5|||
16140056|NCT00719563|38999790|FG000|Overall Study|Lack of Efficacy|3|||
16140057|NCT00719563|38999791|FG001|Overall Study|Lack of Efficacy|7|||
16140058|NCT00719563|38999790|FG000|Overall Study|Personal reasons|6|||
16140059|NCT00719563|38999791|FG001|Overall Study|Personal reasons|7|||
16363690|NCT00005047|39818031|FG003|Overall Study|Adverse Event|0|||
16363691|NCT00005047|39818028|FG000|Overall Study|Lost to Follow-up|1|||
16363692|NCT00005047|39818029|FG001|Overall Study|Lost to Follow-up|0|||
16363693|NCT00005047|39818030|FG002|Overall Study|Lost to Follow-up|0|||
16363694|NCT00005047|39818031|FG003|Overall Study|Lost to Follow-up|0|||
16363695|NCT00005047|39818028|FG000|Overall Study|Lack of Efficacy|1|||
16363696|NCT00005047|39818029|FG001|Overall Study|Lack of Efficacy|0|||
16363697|NCT00005047|39818030|FG002|Overall Study|Lack of Efficacy|0|||
16363698|NCT00005047|39818031|FG003|Overall Study|Lack of Efficacy|0|||
16363699|NCT01695746|39818034|FG000|Overall Study|Adverse Event|1|||
16363700|NCT01695746|39818034|FG000|Overall Study|Non-compliance by the participant|3|||
16363701|NCT01695746|39818034|FG000|Overall Study|Protocol Violation|5|||
16363702|NCT01695746|39818034|FG000|Overall Study|Participant not willing to participate|3|||
16363703|NCT01983930|39818035|FG000|Overall Study|Withdrawal by Subject|9|||
16363704|NCT01983930|39818036|FG001|Overall Study|Withdrawal by Subject|8|||
16363705|NCT01983930|39818035|FG000|Overall Study|Adverse Event|0|||
16363706|NCT01983930|39818036|FG001|Overall Study|Adverse Event|1|||
16363707|NCT04459338|39818037|FG000|Overall Study|Loss of IV during study|1|||
16363708|NCT04459338|39818038|FG001|Overall Study|Loss of IV during study|0|||
16363709|NCT02711137|39818041|FG000|Overall Study|Death|1|||
16363710|NCT02711137|39818042|FG001|Overall Study|Death|4|||
16363711|NCT02711137|39818043|FG002|Overall Study|Death|5|||
16140060|NCT00719563|38999790|FG000|Overall Study|Unknown reasons|4|||
16363712|NCT02711137|39818044|FG003|Overall Study|Death|5|||
16363713|NCT02711137|39818045|FG004|Overall Study|Death|3|||
16363714|NCT02711137|39818046|FG005|Overall Study|Death|1|||
16363715|NCT02711137|39818047|FG006|Overall Study|Death|61|||
16363716|NCT02711137|39818048|FG007|Overall Study|Death|3|||
16363717|NCT02711137|39818049|FG008|Overall Study|Death|0|||
16363718|NCT02711137|39818050|FG009|Overall Study|Death|1|||
16363719|NCT02711137|39818051|FG010|Overall Study|Death|1|||
16363720|NCT02711137|39818052|FG011|Overall Study|Death|1|||
16363721|NCT02711137|39818053|FG012|Overall Study|Death|0|||
16363722|NCT02711137|39818054|FG013|Overall Study|Death|0|||
16363723|NCT02711137|39818055|FG014|Overall Study|Death|0|||
16363724|NCT02711137|39818041|FG000|Overall Study|Study Terminated by Sponsor|0|||
16363725|NCT02711137|39818042|FG001|Overall Study|Study Terminated by Sponsor|0|||
16363726|NCT02711137|39818043|FG002|Overall Study|Study Terminated by Sponsor|1|||
16140061|NCT00719563|38999791|FG001|Overall Study|Unknown reasons|6|||
16140062|NCT00719563|38999790|FG000|Overall Study|Noncompliant|1|||
16140063|NCT00719563|38999791|FG001|Overall Study|Noncompliant|1|||
16140064|NCT00719563|38999790|FG000|Overall Study|Lost to Follow-up|5|||
16140065|NCT00719563|38999791|FG001|Overall Study|Lost to Follow-up|3|||
16140066|NCT01170039|38999797|FG000|Overall Study|Withdrawal by Subject|5|||
16140067|NCT01170039|38999798|FG001|Overall Study|Withdrawal by Subject|3|||
16140068|NCT01170039|38999797|FG000|Overall Study|Lack of funding, drug not available|3|||
16140069|NCT01170039|38999798|FG001|Overall Study|Lack of funding, drug not available|3|||
16140070|NCT01479829|38999799|FG000|Overall Study|Withdrawal by Subject|8|||
16140071|NCT01479829|38999800|FG001|Overall Study|Withdrawal by Subject|10|||
16140072|NCT01478360|38999804|FG000|Overall Study|Lost to Follow-up|1|||
16363727|NCT02711137|39818044|FG003|Overall Study|Study Terminated by Sponsor|0|||
16363728|NCT02711137|39818045|FG004|Overall Study|Study Terminated by Sponsor|0|||
16363729|NCT02711137|39818046|FG005|Overall Study|Study Terminated by Sponsor|0|||
16363730|NCT02711137|39818047|FG006|Overall Study|Study Terminated by Sponsor|1|||
16363731|NCT02711137|39818048|FG007|Overall Study|Study Terminated by Sponsor|0|||
16363732|NCT02711137|39818049|FG008|Overall Study|Study Terminated by Sponsor|0|||
16140073|NCT01478360|38999805|FG001|Overall Study|Lost to Follow-up|0|||
16140074|NCT01478360|38999804|FG000|Overall Study|Adverse Event|0|||
16363733|NCT02711137|39818050|FG009|Overall Study|Study Terminated by Sponsor|0|||
16363734|NCT02711137|39818051|FG010|Overall Study|Study Terminated by Sponsor|0|||
16140075|NCT01478360|38999805|FG001|Overall Study|Adverse Event|1|||
16140076|NCT01478360|38999804|FG000|Overall Study|Administrative problems|1|||
16363735|NCT02711137|39818052|FG011|Overall Study|Study Terminated by Sponsor|0|||
16363736|NCT02711137|39818053|FG012|Overall Study|Study Terminated by Sponsor|0|||
16363737|NCT02711137|39818054|FG013|Overall Study|Study Terminated by Sponsor|0|||
16363738|NCT02711137|39818055|FG014|Overall Study|Study Terminated by Sponsor|0|||
16363739|NCT02711137|39818041|FG000|Overall Study|Physician Decision|1|||
16363740|NCT02711137|39818042|FG001|Overall Study|Physician Decision|0|||
16363741|NCT02711137|39818043|FG002|Overall Study|Physician Decision|2|||
16363742|NCT02711137|39818044|FG003|Overall Study|Physician Decision|1|||
16363743|NCT02711137|39818045|FG004|Overall Study|Physician Decision|1|||
16363744|NCT02711137|39818046|FG005|Overall Study|Physician Decision|0|||
16363745|NCT02711137|39818047|FG006|Overall Study|Physician Decision|12|||
16363746|NCT02711137|39818048|FG007|Overall Study|Physician Decision|2|||
16363747|NCT02711137|39818049|FG008|Overall Study|Physician Decision|1|||
16363748|NCT02711137|39818050|FG009|Overall Study|Physician Decision|1|||
16363749|NCT02711137|39818051|FG010|Overall Study|Physician Decision|3|||
16363750|NCT02711137|39818052|FG011|Overall Study|Physician Decision|2|||
16363751|NCT02711137|39818053|FG012|Overall Study|Physician Decision|1|||
16363752|NCT02711137|39818054|FG013|Overall Study|Physician Decision|1|||
16363753|NCT02711137|39818055|FG014|Overall Study|Physician Decision|2|||
16363754|NCT02711137|39818041|FG000|Overall Study|Other|0|||
16363755|NCT02711137|39818042|FG001|Overall Study|Other|1|||
16363756|NCT02711137|39818043|FG002|Overall Study|Other|0|||
16437911|NCT02718898|40082087|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
16437912|NCT02718898|40082088|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
16437913|NCT02718898|40082089|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
16437914|NCT02718898|40082090|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
16437915|NCT02718898|40082091|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
16437916|NCT02718898|40082085|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
16437917|NCT02718898|40082086|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
16437918|NCT02718898|40082087|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
16363757|NCT02711137|39818044|FG003|Overall Study|Other|0|||
16437919|NCT02718898|40082088|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
16437920|NCT02718898|40082089|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
16437921|NCT02718898|40082090|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
16437922|NCT02718898|40082091|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
16437923|NCT02718898|40082085|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16437924|NCT02718898|40082086|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16437925|NCT02718898|40082087|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
16437926|NCT02718898|40082088|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
16140077|NCT01478360|38999805|FG001|Overall Study|Administrative problems|2|||
16140078|NCT03437278|38999806|FG000|Overall Study|Adverse Event|0|||
16140079|NCT03437278|38999807|FG001|Overall Study|Adverse Event|0|||
16140080|NCT03437278|38999808|FG002|Overall Study|Adverse Event|1|||
16140081|NCT03437278|38999806|FG000|Overall Study|Progressive disease|1|||
16140082|NCT03437278|38999807|FG001|Overall Study|Progressive disease|0|||
16140083|NCT03437278|38999808|FG002|Overall Study|Progressive disease|0|||
16140084|NCT03437278|38999806|FG000|Overall Study|Physician Decision|1|||
16140085|NCT03437278|38999807|FG001|Overall Study|Physician Decision|0|||
16140086|NCT03437278|38999808|FG002|Overall Study|Physician Decision|1|||
16140087|NCT02974088|38999823|FG000|Overall Study|Lost to Follow-up|0|||
16140088|NCT02974088|38999824|FG001|Overall Study|Lost to Follow-up|2|||
16140089|NCT02974088|38999823|FG000|Overall Study|Adverse Event|0|||
16140090|NCT02974088|38999824|FG001|Overall Study|Adverse Event|1|||
16140091|NCT00757003|38999826|FG000|Overall Study|Death|33|||
16140092|NCT00757003|38999826|FG000|Overall Study|Lost to Follow-up|9|||
16140093|NCT00757003|38999826|FG000|Overall Study|Withdrawal by Subject|4|||
16140094|NCT00757003|38999826|FG000|Overall Study|Surgically explanted|2|||
16140095|NCT00757003|38999826|FG000|Overall Study|Not implanted|1|||
16140096|NCT00120406|38999827|FG000|Overall Study|Death|9|||
16140097|NCT00120406|38999828|FG001|Overall Study|Death|4|||
16140098|NCT00120406|38999827|FG000|Overall Study|Withdrawal by Subject|5|||
16140099|NCT00120406|38999828|FG001|Overall Study|Withdrawal by Subject|7|||
16140100|NCT00120406|38999827|FG000|Overall Study|Lost to Follow-up|5|||
16140101|NCT00120406|38999828|FG001|Overall Study|Lost to Follow-up|2|||
16363758|NCT02711137|39818045|FG004|Overall Study|Other|0|||
16363759|NCT02711137|39818046|FG005|Overall Study|Other|0|||
16437927|NCT02718898|40082089|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16140102|NCT00120406|38999827|FG000|Overall Study|received non-study stent|0|||
16140103|NCT00120406|38999828|FG001|Overall Study|received non-study stent|2|||
16140104|NCT00120406|38999827|FG000|Overall Study|patient moved but has not withdrawn|0|||
16140105|NCT00120406|38999828|FG001|Overall Study|patient moved but has not withdrawn|1|||
16140106|NCT01526551|38999829|FG000|Overall Study|Lack of returned parental consent form|424|||
16363760|NCT02711137|39818047|FG006|Overall Study|Other|3|||
16140107|NCT03189862|38999830|FG000|Overall Study|Withdrawal by Subject|1|||
16140108|NCT03189862|38999831|FG001|Overall Study|Withdrawal by Subject|0|||
16363761|NCT02711137|39818048|FG007|Overall Study|Other|0|||
16363762|NCT02711137|39818049|FG008|Overall Study|Other|0|||
16140109|NCT03189862|38999830|FG000|Overall Study|Lost to Follow-up|54|||
16140110|NCT03189862|38999831|FG001|Overall Study|Lost to Follow-up|62|||
16140111|NCT00866697|38999832|FG000|Overall Study|Study closed/terminated|156|||
16140112|NCT00866697|38999833|FG001|Overall Study|Study closed/terminated|138|||
16140113|NCT00866697|38999832|FG000|Overall Study|Lost to Follow-up|22|||
16140114|NCT00866697|38999833|FG001|Overall Study|Lost to Follow-up|28|||
16140115|NCT00866697|38999832|FG000|Overall Study|Physician Decision|3|||
16140116|NCT00866697|38999833|FG001|Overall Study|Physician Decision|5|||
16140117|NCT00866697|38999832|FG000|Overall Study|Withdrawal by Subject|33|||
16140118|NCT00866697|38999833|FG001|Overall Study|Withdrawal by Subject|57|||
16140119|NCT00792805|38999837|FG000|Overall Study|Adverse Event|12|||
16140120|NCT00792805|38999838|FG001|Overall Study|Adverse Event|10|||
16140121|NCT00792805|38999839|FG002|Overall Study|Adverse Event|10|||
16140122|NCT00792805|38999837|FG000|Overall Study|Subject withdrew consent|5|||
16140123|NCT00792805|38999838|FG001|Overall Study|Subject withdrew consent|6|||
16255142|NCT00094302|39419782|FG001|Overall Study|Withdrawal by Subject|111|||
16255143|NCT00094302|39419781|FG000|Overall Study|Death|266|||
16140124|NCT00792805|38999839|FG002|Overall Study|Subject withdrew consent|5|||
16140125|NCT00792805|38999837|FG000|Overall Study|Administrative problems|2|||
16140126|NCT00792805|38999838|FG001|Overall Study|Administrative problems|0|||
16140127|NCT00792805|38999839|FG002|Overall Study|Administrative problems|4|||
16140128|NCT00792805|38999837|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16140129|NCT00792805|38999838|FG001|Overall Study|Abnormal test procedure result(s)|2|||
16140130|NCT00792805|38999839|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16140131|NCT00792805|38999837|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16140132|NCT00792805|38999838|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
16140133|NCT00792805|38999839|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
16140134|NCT00792805|38999837|FG000|Overall Study|Lost to Follow-up|1|||
16140135|NCT00792805|38999838|FG001|Overall Study|Lost to Follow-up|1|||
16140136|NCT00792805|38999839|FG002|Overall Study|Lost to Follow-up|6|||
16140137|NCT00792805|38999837|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16140138|NCT00792805|38999838|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16140139|NCT00792805|38999839|FG002|Overall Study|Abnormal laboratory value(s)|1|||
16140140|NCT00792805|38999837|FG000|Overall Study|Protocol deviation|0|||
16140141|NCT00792805|38999838|FG001|Overall Study|Protocol deviation|1|||
16140142|NCT00792805|38999839|FG002|Overall Study|Protocol deviation|1|||
16140143|NCT01674712|38999840|FG000|Overall Study|Adverse Event|5|||
16140144|NCT01674712|38999841|FG001|Overall Study|Adverse Event|6|||
16140145|NCT01674712|38999842|FG002|Overall Study|Adverse Event|3|||
16140146|NCT01674712|38999843|FG003|Overall Study|Adverse Event|4|||
16140147|NCT01674712|38999844|FG004|Overall Study|Adverse Event|6|||
16140148|NCT01674712|38999840|FG000|Overall Study|Lost to Follow-up|1|||
16140149|NCT01674712|38999841|FG001|Overall Study|Lost to Follow-up|0|||
16140150|NCT01674712|38999842|FG002|Overall Study|Lost to Follow-up|0|||
16140151|NCT01674712|38999843|FG003|Overall Study|Lost to Follow-up|0|||
16140152|NCT01674712|38999844|FG004|Overall Study|Lost to Follow-up|0|||
16140153|NCT01674712|38999840|FG000|Overall Study|Protocol Violation|2|||
16140154|NCT01674712|38999841|FG001|Overall Study|Protocol Violation|0|||
16140155|NCT01674712|38999842|FG002|Overall Study|Protocol Violation|0|||
16363763|NCT02711137|39818050|FG009|Overall Study|Other|0|||
16363764|NCT02711137|39818051|FG010|Overall Study|Other|0|||
16255144|NCT00094302|39419782|FG001|Overall Study|Death|246|||
16255145|NCT01929109|39419784|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
16255146|NCT01929109|39419785|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
16255147|NCT01929109|39419786|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
16255148|NCT01929109|39419787|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
16255149|NCT01929109|39419788|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
16255150|NCT00313703|39419789|FG000|Overall Study|Lost to Follow-up|11|||
16255151|NCT00313703|39419790|FG001|Overall Study|Lost to Follow-up|2|||
16255152|NCT00313703|39419791|FG002|Overall Study|Lost to Follow-up|5|||
16255153|NCT00313703|39419792|FG003|Overall Study|Lost to Follow-up|12|||
16255154|NCT00418184|39419795|FG000|Double-blind Phase|Withdrawal by Subject|22|||
16255155|NCT00418184|39419796|FG001|Double-blind Phase|Withdrawal by Subject|9|||
16255156|NCT00418184|39419795|FG000|Double-blind Phase|Adverse Event|2|||
16255157|NCT00418184|39419796|FG001|Double-blind Phase|Adverse Event|1|||
16255158|NCT00418184|39419795|FG000|Double-blind Phase|Poor compliance|3|||
16255159|NCT00418184|39419796|FG001|Double-blind Phase|Poor compliance|1|||
16255160|NCT02015793|39419797|FG000|Overall Study|Adverse Event|3|||
16255161|NCT02015793|39419798|FG001|Overall Study|Adverse Event|3|||
16255162|NCT02015793|39419797|FG000|Overall Study|Withdrawal by Subject|1|||
16255163|NCT02015793|39419798|FG001|Overall Study|Withdrawal by Subject|1|||
16255164|NCT00661999|39419799|FG000|Overall Study|Adverse Event|11|||
16255165|NCT00661999|39419800|FG001|Overall Study|Adverse Event|5|||
16255166|NCT00661999|39419801|FG002|Overall Study|Adverse Event|8|||
16255167|NCT00661999|39419799|FG000|Overall Study|Death|8|||
16255168|NCT00661999|39419800|FG001|Overall Study|Death|6|||
16255169|NCT00661999|39419801|FG002|Overall Study|Death|3|||
16255170|NCT00661999|39419799|FG000|Overall Study|Other Reasons|5|||
16255171|NCT00661999|39419800|FG001|Overall Study|Other Reasons|12|||
16255172|NCT00661999|39419801|FG002|Overall Study|Other Reasons|23|||
16255173|NCT00661999|39419799|FG000|Overall Study|Withdrawal by Subject|30|||
16255174|NCT00661999|39419800|FG001|Overall Study|Withdrawal by Subject|23|||
16255175|NCT00661999|39419801|FG002|Overall Study|Withdrawal by Subject|14|||
16255176|NCT00661999|39419799|FG000|Overall Study|Alternative Treatment|1|||
16437928|NCT02718898|40082090|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16437929|NCT02718898|40082091|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16437930|NCT02718898|40082085|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
16437931|NCT02718898|40082086|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
16437932|NCT02718898|40082087|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
16437933|NCT02718898|40082088|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
16437934|NCT02718898|40082089|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
16437935|NCT02718898|40082090|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
16255177|NCT00661999|39419800|FG001|Overall Study|Alternative Treatment|0|||
16255178|NCT00661999|39419801|FG002|Overall Study|Alternative Treatment|0|||
16255179|NCT00661999|39419799|FG000|Overall Study|Other Medical Problems|4|||
16255180|NCT00661999|39419800|FG001|Overall Study|Other Medical Problems|4|||
16255181|NCT00661999|39419801|FG002|Overall Study|Other Medical Problems|9|||
16255182|NCT00883090|39419802|FG000|Overall Study|Sponsor's decision|1|||
16255183|NCT00883090|39419802|FG000|Overall Study|Withdrawal by Subject|1|||
16255184|NCT00881621|39419805|FG000|Overall Study|Physician Decision|34|||
16255185|NCT00623103|39419806|FG000|Overall Study|Adverse Event|70|||
16255186|NCT00623103|39419807|FG001|Overall Study|Adverse Event|60|||
16255187|NCT00623103|39419806|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16255188|NCT00623103|39419807|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
16255189|NCT00623103|39419806|FG000|Overall Study|Withdrawal by Subject|18|||
16255190|NCT00623103|39419807|FG001|Overall Study|Withdrawal by Subject|24|||
16255191|NCT00623103|39419806|FG000|Overall Study|Lost to Follow-up|4|||
16255192|NCT00623103|39419807|FG001|Overall Study|Lost to Follow-up|1|||
16255193|NCT00623103|39419806|FG000|Overall Study|Administrative problems|2|||
16255194|NCT00623103|39419807|FG001|Overall Study|Administrative problems|4|||
16255195|NCT00623103|39419806|FG000|Overall Study|Death|11|||
16255196|NCT00623103|39419807|FG001|Overall Study|Death|11|||
16255197|NCT00623103|39419806|FG000|Overall Study|Protocol deviation|2|||
16255198|NCT00623103|39419807|FG001|Overall Study|Protocol deviation|1|||
16255199|NCT00634907|39419808|FG000|Overall Study|Withdrawal by Subject|3|||
16255200|NCT00634907|39419809|FG001|Overall Study|Withdrawal by Subject|0|||
16255201|NCT00634907|39419808|FG000|Overall Study|Physician Decision|3|||
16255202|NCT00634907|39419809|FG001|Overall Study|Physician Decision|9|||
16255203|NCT00634907|39419808|FG000|Overall Study|Withdrawal by Subject|11|||
16255204|NCT00634907|39419809|FG001|Overall Study|Withdrawal by Subject|8|||
16255205|NCT00337571|39419812|FG000|Overall Study|Lack of Efficacy|3|||
16255206|NCT00337571|39419813|FG001|Overall Study|Lack of Efficacy|0|||
16437936|NCT02718898|40082091|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
16255207|NCT00337571|39419814|FG002|Overall Study|Lack of Efficacy|0|||
16255208|NCT00337571|39419815|FG003|Overall Study|Lack of Efficacy|0|||
16255209|NCT00337571|39419812|FG000|Overall Study|Adverse Event|4|||
16255210|NCT00337571|39419813|FG001|Overall Study|Adverse Event|5|||
16255211|NCT00337571|39419814|FG002|Overall Study|Adverse Event|8|||
16255212|NCT00337571|39419815|FG003|Overall Study|Adverse Event|4|||
16255213|NCT00337571|39419812|FG000|Overall Study|Withdrawal by Subject|2|||
16255214|NCT00337571|39419813|FG001|Overall Study|Withdrawal by Subject|2|||
16255215|NCT00337571|39419814|FG002|Overall Study|Withdrawal by Subject|1|||
16255216|NCT00337571|39419815|FG003|Overall Study|Withdrawal by Subject|0|||
16255217|NCT00337571|39419812|FG000|Overall Study|Lost to Follow-up|3|||
16255218|NCT00337571|39419813|FG001|Overall Study|Lost to Follow-up|1|||
16255219|NCT00337571|39419814|FG002|Overall Study|Lost to Follow-up|0|||
16437937|NCT02718898|40082085|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
16437938|NCT02718898|40082086|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
16437939|NCT02718898|40082087|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
16437940|NCT02718898|40082088|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
16437941|NCT02718898|40082089|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
16437942|NCT02718898|40082090|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
16437943|NCT02718898|40082091|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
16437944|NCT02718898|40082085|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
16437945|NCT02718898|40082086|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
16437946|NCT02718898|40082087|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
16437947|NCT02718898|40082088|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
16437948|NCT02718898|40082089|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
16437949|NCT02718898|40082090|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
16437950|NCT02718898|40082091|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
16437951|NCT02718898|40082085|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
16437952|NCT02718898|40082086|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
16437953|NCT02718898|40082087|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
16437954|NCT02718898|40082088|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
16437955|NCT02718898|40082089|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
16437956|NCT02718898|40082090|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
16437957|NCT02718898|40082091|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
16437958|NCT02718898|40082085|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
16437959|NCT02718898|40082086|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
16437960|NCT02718898|40082087|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
16437961|NCT02718898|40082088|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
16437962|NCT02718898|40082089|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
16437963|NCT02718898|40082090|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
16437964|NCT02718898|40082091|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
16437965|NCT02718898|40082085|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16437966|NCT02718898|40082086|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16437967|NCT02718898|40082087|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16437968|NCT02718898|40082088|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16437969|NCT02718898|40082089|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
16437970|NCT02718898|40082090|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
16437971|NCT02718898|40082091|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
16437972|NCT03409796|40082092|FG000|Overall Study|Adverse Event|2|||
16437973|NCT03409796|40082093|FG001|Overall Study|Adverse Event|0|||
16437974|NCT03409796|40082092|FG000|Overall Study|Other|0|||
16437975|NCT03409796|40082093|FG001|Overall Study|Other|1|||
16255220|NCT00337571|39419815|FG003|Overall Study|Lost to Follow-up|1|||
16255221|NCT00337571|39419812|FG000|Overall Study|Poor/noncompliance|1|||
16255222|NCT00337571|39419813|FG001|Overall Study|Poor/noncompliance|1|||
16255223|NCT00337571|39419814|FG002|Overall Study|Poor/noncompliance|1|||
16255224|NCT00337571|39419815|FG003|Overall Study|Poor/noncompliance|1|||
16255225|NCT00337571|39419812|FG000|Overall Study|No longer met study criteria|1|||
16255226|NCT00337571|39419813|FG001|Overall Study|No longer met study criteria|0|||
16255227|NCT00337571|39419814|FG002|Overall Study|No longer met study criteria|0|||
16255228|NCT00337571|39419815|FG003|Overall Study|No longer met study criteria|0|||
16255229|NCT00337571|39419812|FG000|Overall Study|High Potassium level|0|||
16255230|NCT00337571|39419813|FG001|Overall Study|High Potassium level|0|||
16255231|NCT00337571|39419814|FG002|Overall Study|High Potassium level|0|||
16255232|NCT00337571|39419815|FG003|Overall Study|High Potassium level|1|||
16255233|NCT01867242|39419818|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
16255234|NCT01867242|39419819|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
16255235|NCT01867242|39419820|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
16255236|NCT01170364|39419821|FG000|Overall Study|Protocol Violation|4|||
16255237|NCT01170364|39419822|FG001|Overall Study|Protocol Violation|1|||
16255238|NCT01087970|39419825|FG000|Overall Study|Protocol Violation|2|||
16255239|NCT00108732|39419826|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
16255240|NCT00108732|39419826|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
16255241|NCT00108732|39419826|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
16255242|NCT00108732|39419826|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
16255243|NCT00108732|39419826|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
16255244|NCT00108732|39419826|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
16255245|NCT00108732|39419826|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
16255246|NCT03401112|39419827|FG000|Overall Study|Adverse Event|1|||
16255247|NCT03401112|39419828|FG001|Overall Study|Adverse Event|2|||
16437976|NCT03001557|40082094|FG000|Core Phase|Randomized but not treated|0|||
16437977|NCT03001557|40082095|FG001|Core Phase|Randomized but not treated|0|||
16437978|NCT03001557|40082096|FG002|Core Phase|Randomized but not treated|1|||
16437979|NCT03001557|40082097|FG003|Core Phase|Randomized but not treated|0|||
16437980|NCT03001557|40082098|FG004|Core Phase|Randomized but not treated|0|||
16437981|NCT03001557|40082099|FG005|Core Phase|Randomized but not treated|0|||
16437982|NCT03001557|40082100|FG006|Core Phase|Randomized but not treated|0|||
16437983|NCT03001557|40082101|FG007|Core Phase|Randomized but not treated|0|||
16437984|NCT03001557|40082094|FG000|Extension Phase|Adverse Event|0|||
16437985|NCT03001557|40082095|FG001|Extension Phase|Adverse Event|0|||
16437986|NCT03001557|40082096|FG002|Extension Phase|Adverse Event|0|||
16255248|NCT03401112|39419829|FG002|Overall Study|Adverse Event|3|||
16255249|NCT03401112|39419830|FG003|Overall Study|Adverse Event|2|||
16255250|NCT03401112|39419831|FG004|Overall Study|Adverse Event|0|||
16255251|NCT03401112|39419827|FG000|Overall Study|Lost to Follow-up|1|||
16255252|NCT03401112|39419828|FG001|Overall Study|Lost to Follow-up|0|||
16255253|NCT03401112|39419829|FG002|Overall Study|Lost to Follow-up|0|||
16255254|NCT03401112|39419830|FG003|Overall Study|Lost to Follow-up|0|||
16255255|NCT03401112|39419831|FG004|Overall Study|Lost to Follow-up|0|||
16255256|NCT03401112|39419827|FG000|Overall Study|Noncompliance|1|||
16437987|NCT03001557|40082097|FG003|Extension Phase|Adverse Event|0|||
16437988|NCT03001557|40082098|FG004|Extension Phase|Adverse Event|0|||
16437989|NCT03001557|40082099|FG005|Extension Phase|Adverse Event|2|||
16140156|NCT01674712|38999843|FG003|Overall Study|Protocol Violation|0|||
16140157|NCT01674712|38999844|FG004|Overall Study|Protocol Violation|0|||
16140158|NCT01674712|38999840|FG000|Overall Study|Withdrawal by Subject|2|||
16140159|NCT01674712|38999841|FG001|Overall Study|Withdrawal by Subject|2|||
16140160|NCT01674712|38999842|FG002|Overall Study|Withdrawal by Subject|5|||
16140161|NCT01674712|38999843|FG003|Overall Study|Withdrawal by Subject|4|||
16140162|NCT01674712|38999844|FG004|Overall Study|Withdrawal by Subject|3|||
16140163|NCT01674712|38999840|FG000|Overall Study|Administrative|0|||
16140164|NCT01674712|38999841|FG001|Overall Study|Administrative|1|||
16140165|NCT01674712|38999842|FG002|Overall Study|Administrative|0|||
16437990|NCT03001557|40082100|FG006|Extension Phase|Adverse Event|0|||
16437991|NCT03001557|40082101|FG007|Extension Phase|Adverse Event|0|||
16437992|NCT03001557|40082094|FG000|Extension Phase|Withdrawal by Subject|0|||
16437993|NCT03001557|40082095|FG001|Extension Phase|Withdrawal by Subject|0|||
16437994|NCT03001557|40082096|FG002|Extension Phase|Withdrawal by Subject|0|||
16437995|NCT03001557|40082097|FG003|Extension Phase|Withdrawal by Subject|0|||
16437996|NCT03001557|40082098|FG004|Extension Phase|Withdrawal by Subject|0|||
16437997|NCT03001557|40082099|FG005|Extension Phase|Withdrawal by Subject|1|||
16437998|NCT03001557|40082100|FG006|Extension Phase|Withdrawal by Subject|5|||
16437999|NCT03001557|40082101|FG007|Extension Phase|Withdrawal by Subject|2|||
16438000|NCT03001557|40082094|FG000|Extension Phase|Lost to Follow-up|0|||
16438001|NCT03001557|40082095|FG001|Extension Phase|Lost to Follow-up|0|||
16438002|NCT03001557|40082096|FG002|Extension Phase|Lost to Follow-up|0|||
16438003|NCT03001557|40082097|FG003|Extension Phase|Lost to Follow-up|0|||
16438004|NCT03001557|40082098|FG004|Extension Phase|Lost to Follow-up|0|||
16438005|NCT03001557|40082099|FG005|Extension Phase|Lost to Follow-up|0|||
16438006|NCT03001557|40082100|FG006|Extension Phase|Lost to Follow-up|2|||
16438007|NCT03001557|40082101|FG007|Extension Phase|Lost to Follow-up|1|||
16438008|NCT03001557|40082094|FG000|Extension Phase|Administrative Reason|0|||
16438009|NCT03001557|40082095|FG001|Extension Phase|Administrative Reason|0|||
16438010|NCT03001557|40082096|FG002|Extension Phase|Administrative Reason|0|||
16438011|NCT03001557|40082097|FG003|Extension Phase|Administrative Reason|0|||
16438012|NCT03001557|40082098|FG004|Extension Phase|Administrative Reason|0|||
16438013|NCT03001557|40082099|FG005|Extension Phase|Administrative Reason|1|||
16438014|NCT03001557|40082100|FG006|Extension Phase|Administrative Reason|3|||
16438015|NCT03001557|40082101|FG007|Extension Phase|Administrative Reason|3|||
16438016|NCT03001557|40082094|FG000|Extension Phase|Loss of caregiver|0|||
16438017|NCT03001557|40082095|FG001|Extension Phase|Loss of caregiver|0|||
16438018|NCT03001557|40082096|FG002|Extension Phase|Loss of caregiver|0|||
16255257|NCT03401112|39419828|FG001|Overall Study|Noncompliance|2|||
16255258|NCT03401112|39419829|FG002|Overall Study|Noncompliance|3|||
16255259|NCT03401112|39419830|FG003|Overall Study|Noncompliance|0|||
16438019|NCT03001557|40082097|FG003|Extension Phase|Loss of caregiver|0|||
16438020|NCT03001557|40082098|FG004|Extension Phase|Loss of caregiver|0|||
16438021|NCT03001557|40082099|FG005|Extension Phase|Loss of caregiver|0|||
16438022|NCT03001557|40082100|FG006|Extension Phase|Loss of caregiver|1|||
16438023|NCT03001557|40082101|FG007|Extension Phase|Loss of caregiver|0|||
16140166|NCT01674712|38999843|FG003|Overall Study|Administrative|0|||
16140167|NCT01674712|38999844|FG004|Overall Study|Administrative|1|||
16140168|NCT01674712|38999840|FG000|Overall Study|Lack of Efficacy|0|||
16140169|NCT01674712|38999841|FG001|Overall Study|Lack of Efficacy|0|||
16140170|NCT01674712|38999842|FG002|Overall Study|Lack of Efficacy|1|||
16140171|NCT01674712|38999843|FG003|Overall Study|Lack of Efficacy|0|||
16140172|NCT01674712|38999844|FG004|Overall Study|Lack of Efficacy|1|||
16140173|NCT01101477|38999845|FG000|Overall Study|Protocol Violation|5|||
16140174|NCT01101477|38999846|FG001|Overall Study|Protocol Violation|3|||
16140175|NCT01101477|38999847|FG002|Overall Study|Protocol Violation|1|||
16140176|NCT04439071|38999849|FG000|Overall Study|Lost to Follow-up|0|||
16140177|NCT04439071|38999850|FG001|Overall Study|Lost to Follow-up|3|||
16140178|NCT04439071|38999849|FG000|Overall Study|Withdrawal by Subject|3|||
16140179|NCT04439071|38999850|FG001|Overall Study|Withdrawal by Subject|8|||
16140180|NCT04439071|38999849|FG000|Overall Study|Death|6|||
16255260|NCT03401112|39419831|FG004|Overall Study|Noncompliance|0|||
16363765|NCT02711137|39818052|FG011|Overall Study|Other|0|||
16363766|NCT02711137|39818053|FG012|Overall Study|Other|0|||
16438024|NCT03001557|40082094|FG000|Extension Phase|Others|0|||
16438025|NCT03001557|40082095|FG001|Extension Phase|Others|0|||
16438026|NCT03001557|40082096|FG002|Extension Phase|Others|0|||
16438027|NCT03001557|40082097|FG003|Extension Phase|Others|0|||
16438028|NCT03001557|40082098|FG004|Extension Phase|Others|0|||
16438029|NCT03001557|40082099|FG005|Extension Phase|Others|1|||
16438030|NCT03001557|40082100|FG006|Extension Phase|Others|3|||
16438031|NCT03001557|40082101|FG007|Extension Phase|Others|0|||
16438032|NCT00528112|40082105|FG000|Treatment up to 3 Years|Adverse Event|313|||
16438033|NCT00528112|40082106|FG001|Treatment up to 3 Years|Adverse Event|278|||
16438034|NCT00528112|40082105|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
16438035|NCT00528112|40082106|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
16438036|NCT00528112|40082105|FG000|Treatment up to 3 Years|Protocol Violation|16|||
16438037|NCT00528112|40082106|FG001|Treatment up to 3 Years|Protocol Violation|16|||
16438038|NCT00528112|40082105|FG000|Treatment up to 3 Years|Death|0|||
16438039|NCT00528112|40082106|FG001|Treatment up to 3 Years|Death|1|||
16438040|NCT00528112|40082105|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
16438041|NCT00528112|40082106|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
16438042|NCT00528112|40082105|FG000|Treatment up to 3 Years|Pregnancy|9|||
16438043|NCT00528112|40082106|FG001|Treatment up to 3 Years|Pregnancy|10|||
16438044|NCT00528112|40082105|FG000|Treatment up to 3 Years|Other reasons|186|||
16438045|NCT00528112|40082106|FG001|Treatment up to 3 Years|Other reasons|186|||
16438046|NCT00528112|40082105|FG000|Extension Phase|Withdrawal by Subject|0|||
16438047|NCT00528112|40082106|FG001|Extension Phase|Withdrawal by Subject|3|||
16438048|NCT00528112|40082105|FG000|Extension Phase|Other reasons|0|||
16438049|NCT00528112|40082106|FG001|Extension Phase|Other reasons|100|||
16363767|NCT02711137|39818054|FG013|Overall Study|Other|0|||
16363768|NCT02711137|39818055|FG014|Overall Study|Other|1|||
16363769|NCT02711137|39818041|FG000|Overall Study|Withdrawal by Subject|1|||
16363770|NCT02711137|39818042|FG001|Overall Study|Withdrawal by Subject|0|||
16363771|NCT02711137|39818043|FG002|Overall Study|Withdrawal by Subject|0|||
16363772|NCT02711137|39818044|FG003|Overall Study|Withdrawal by Subject|1|||
16363773|NCT02711137|39818045|FG004|Overall Study|Withdrawal by Subject|1|||
16363774|NCT02711137|39818046|FG005|Overall Study|Withdrawal by Subject|0|||
16363775|NCT02711137|39818047|FG006|Overall Study|Withdrawal by Subject|7|||
16363776|NCT02711137|39818048|FG007|Overall Study|Withdrawal by Subject|0|||
16363777|NCT02711137|39818049|FG008|Overall Study|Withdrawal by Subject|0|||
16363778|NCT02711137|39818050|FG009|Overall Study|Withdrawal by Subject|0|||
16363779|NCT02711137|39818051|FG010|Overall Study|Withdrawal by Subject|0|||
16363780|NCT02711137|39818052|FG011|Overall Study|Withdrawal by Subject|0|||
16438050|NCT00528112|40082105|FG000|Extension Phase|Pregnancy|0|||
16363781|NCT02711137|39818053|FG012|Overall Study|Withdrawal by Subject|0|||
16363782|NCT02711137|39818054|FG013|Overall Study|Withdrawal by Subject|1|||
16363783|NCT02711137|39818055|FG014|Overall Study|Withdrawal by Subject|0|||
16363784|NCT02711137|39818041|FG000|Overall Study|Lost to Follow-up|1|||
16363785|NCT02711137|39818042|FG001|Overall Study|Lost to Follow-up|0|||
16363786|NCT02711137|39818043|FG002|Overall Study|Lost to Follow-up|0|||
16363787|NCT02711137|39818044|FG003|Overall Study|Lost to Follow-up|0|||
16363788|NCT02711137|39818045|FG004|Overall Study|Lost to Follow-up|0|||
16363789|NCT02711137|39818046|FG005|Overall Study|Lost to Follow-up|0|||
16363790|NCT02711137|39818047|FG006|Overall Study|Lost to Follow-up|2|||
16363791|NCT02711137|39818048|FG007|Overall Study|Lost to Follow-up|0|||
16363792|NCT02711137|39818049|FG008|Overall Study|Lost to Follow-up|0|||
16438051|NCT00528112|40082106|FG001|Extension Phase|Pregnancy|3|||
16438052|NCT00528112|40082105|FG000|Extension Phase|Lost to Follow-up|0|||
16438053|NCT00528112|40082106|FG001|Extension Phase|Lost to Follow-up|12|||
16438054|NCT00528112|40082105|FG000|Extension Phase|Death|0|||
16438055|NCT00528112|40082106|FG001|Extension Phase|Death|1|||
16140181|NCT04439071|38999850|FG001|Overall Study|Death|4|||
16140182|NCT04439071|38999849|FG000|Overall Study|Other than specified|3|||
16140183|NCT04439071|38999850|FG001|Overall Study|Other than specified|3|||
16140184|NCT04439071|38999849|FG000|Overall Study|Randomized but not treated|2|||
16363793|NCT02711137|39818050|FG009|Overall Study|Lost to Follow-up|0|||
16363794|NCT02711137|39818051|FG010|Overall Study|Lost to Follow-up|0|||
16363795|NCT02711137|39818052|FG011|Overall Study|Lost to Follow-up|0|||
16363796|NCT02711137|39818053|FG012|Overall Study|Lost to Follow-up|0|||
16363797|NCT02711137|39818054|FG013|Overall Study|Lost to Follow-up|0|||
16363798|NCT02711137|39818055|FG014|Overall Study|Lost to Follow-up|0|||
16363799|NCT01125748|39818056|FG000|Overall Study|Adverse Event|0|||
16363800|NCT01125748|39818057|FG001|Overall Study|Adverse Event|2|||
16363801|NCT01125748|39818056|FG000|Overall Study|Lost to Follow-up|0|||
16363802|NCT01125748|39818057|FG001|Overall Study|Lost to Follow-up|1|||
16363803|NCT01125748|39818056|FG000|Overall Study|Physician Decision|8|||
16363804|NCT01125748|39818057|FG001|Overall Study|Physician Decision|7|||
16363805|NCT01125748|39818056|FG000|Overall Study|Patient Decision to Withdraw|2|||
16363806|NCT01125748|39818057|FG001|Overall Study|Patient Decision to Withdraw|4|||
16363807|NCT01078545|39818062|FG000|Overall Study|Lost to Follow-up|13|||
16363808|NCT01078545|39818062|FG000|Overall Study|Physician Decision|6|||
16363809|NCT01078545|39818062|FG000|Overall Study|Withdrawal by Subject|3|||
16363810|NCT01078545|39818062|FG000|Overall Study|Death|3|||
16363811|NCT01078545|39818062|FG000|Overall Study|Participant moved to another physician|1|||
16363812|NCT01500083|39818063|FG000|Overall Study|Adverse Event|4|||
16363813|NCT01500083|39818064|FG001|Overall Study|Adverse Event|17|||
16363814|NCT01500083|39818063|FG000|Overall Study|Death|0|||
16438056|NCT00528112|40082105|FG000|Extension Phase|Adverse Event|0|||
16438057|NCT00528112|40082106|FG001|Extension Phase|Adverse Event|36|||
16438058|NCT00528112|40082105|FG000|Extension Phase|Protocol Violation|0|||
16438059|NCT00528112|40082106|FG001|Extension Phase|Protocol Violation|2|||
16438060|NCT01476722|40082107|FG000|Overall Study|Adverse Event|1|||
16438061|NCT04583280|40082110|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
16438062|NCT04583280|40082111|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
16438063|NCT00152503|40082113|FG000|Overall Study|Adverse Event|4|||
16438064|NCT00346216|40082114|FG000|Overall Study|Other|181|||
16438065|NCT00346216|40082115|FG001|Overall Study|Other|231|||
16438066|NCT00346216|40082116|FG002|Overall Study|Other|205|||
16438067|NCT00346216|40082114|FG000|Overall Study|No longer willing to participate|600|||
16438068|NCT00346216|40082115|FG001|Overall Study|No longer willing to participate|606|||
16438069|NCT00346216|40082116|FG002|Overall Study|No longer willing to participate|585|||
16438070|NCT00346216|40082114|FG000|Overall Study|Withdrawal by Subject|661|||
16438071|NCT00346216|40082115|FG001|Overall Study|Withdrawal by Subject|692|||
16438072|NCT00346216|40082116|FG002|Overall Study|Withdrawal by Subject|651|||
16438073|NCT00346216|40082114|FG000|Overall Study|Lost to Follow-up|611|||
16438074|NCT00346216|40082115|FG001|Overall Study|Lost to Follow-up|588|||
16438075|NCT00346216|40082116|FG002|Overall Study|Lost to Follow-up|542|||
16438076|NCT00346216|40082114|FG000|Overall Study|Physician Decision|80|||
16438077|NCT00346216|40082115|FG001|Overall Study|Physician Decision|76|||
16438078|NCT00346216|40082116|FG002|Overall Study|Physician Decision|59|||
16438079|NCT00346216|40082114|FG000|Overall Study|Does not meet entrance criteria|13|||
16438080|NCT00346216|40082115|FG001|Overall Study|Does not meet entrance criteria|10|||
16438081|NCT00346216|40082116|FG002|Overall Study|Does not meet entrance criteria|8|||
16438082|NCT00346216|40082114|FG000|Overall Study|Death|189|||
16438083|NCT00346216|40082115|FG001|Overall Study|Death|192|||
16438084|NCT00346216|40082116|FG002|Overall Study|Death|228|||
16438085|NCT00346216|40082114|FG000|Overall Study|Study terminated by sponsor|11|||
16438086|NCT00346216|40082115|FG001|Overall Study|Study terminated by sponsor|4|||
16438087|NCT00346216|40082116|FG002|Overall Study|Study terminated by sponsor|8|||
16363815|NCT01500083|39818064|FG001|Overall Study|Death|2|||
16363816|NCT01500083|39818063|FG000|Overall Study|Lost to Follow-up|1|||
16363817|NCT01500083|39818064|FG001|Overall Study|Lost to Follow-up|0|||
16363818|NCT01500083|39818063|FG000|Overall Study|Withdrawal of Consent|0|||
16363819|NCT01500083|39818064|FG001|Overall Study|Withdrawal of Consent|1|||
16438088|NCT00346216|40082114|FG000|Overall Study|Missing Subject Summary Status|62|||
16438089|NCT00346216|40082115|FG001|Overall Study|Missing Subject Summary Status|61|||
16363820|NCT01500083|39818063|FG000|Overall Study|Disease Progression|2|||
16438090|NCT00346216|40082116|FG002|Overall Study|Missing Subject Summary Status|62|||
16438091|NCT00772538|40082119|FG000|Overall Study|Adverse Event|6|||
16438092|NCT00772538|40082120|FG001|Overall Study|Adverse Event|6|||
16363821|NCT01500083|39818064|FG001|Overall Study|Disease Progression|10|||
16438093|NCT00772538|40082119|FG000|Overall Study|Protocol Violation|3|||
16438094|NCT00772538|40082120|FG001|Overall Study|Protocol Violation|3|||
16438095|NCT00772538|40082119|FG000|Overall Study|Lost to Follow-up|1|||
16438096|NCT00772538|40082120|FG001|Overall Study|Lost to Follow-up|1|||
16438097|NCT00772538|40082119|FG000|Overall Study|Withdrawal by Subject|3|||
16438098|NCT00772538|40082120|FG001|Overall Study|Withdrawal by Subject|8|||
16438099|NCT00772538|40082119|FG000|Overall Study|Lack of Efficacy|0|||
16438100|NCT00772538|40082120|FG001|Overall Study|Lack of Efficacy|1|||
16438101|NCT00772538|40082119|FG000|Overall Study|Other|7|||
16438102|NCT00772538|40082120|FG001|Overall Study|Other|7|||
16438103|NCT01020786|40082121|FG000|Induction Period|Entry Criteria Not Met|2|||
16140185|NCT04439071|38999850|FG001|Overall Study|Randomized but not treated|0|||
16438104|NCT01020786|40082121|FG000|Induction Period|Adverse Event|10|||
16438105|NCT01020786|40082121|FG000|Induction Period|Progressive Disease|31|||
16438106|NCT01020786|40082121|FG000|Induction Period|Investigator Decision|3|||
16438107|NCT01020786|40082121|FG000|Induction Period|Withdrawal by Subject|3|||
16438108|NCT01020786|40082121|FG000|Maintenance Period|Adverse Event|8|||
16438109|NCT01020786|40082121|FG000|Maintenance Period|Progressive Disease|43|||
16438110|NCT01020786|40082121|FG000|Maintenance Period|Withdrawal by Subject|8|||
16438111|NCT01020786|40082121|FG000|Maintenance Period|Sponsor Decision|1|||
16140186|NCT01310803|38999856|FG000|Overall Study|Subject terminated by Sponsor|1|||
16140187|NCT01310803|38999857|FG001|Overall Study|Subject terminated by Sponsor|0|||
16140188|NCT01601847|38999858|FG000|Overall Study|Death|1|||
16140189|NCT01601847|38999859|FG001|Overall Study|Death|0|||
16140190|NCT01601847|38999858|FG000|Overall Study|Withdrawal by Subject|11|||
16140191|NCT01601847|38999859|FG001|Overall Study|Withdrawal by Subject|7|||
16140192|NCT01601847|38999858|FG000|Overall Study|Lost to Follow-up|1|||
16140193|NCT01601847|38999859|FG001|Overall Study|Lost to Follow-up|3|||
16140194|NCT00047320|38999860|FG000|Overall Study|Lack of Efficacy|8|||
16140195|NCT00047320|38999860|FG000|Overall Study|Lost to Follow-up|1|||
16140196|NCT00047320|38999860|FG000|Overall Study|Physician Decision|8|||
16140197|NCT00047320|38999860|FG000|Overall Study|Withdrawal by Subject|9|||
16140198|NCT00047320|38999860|FG000|Overall Study|Ineligible|2|||
16140199|NCT00325039|38999861|FG000|Overall Study|Lost to Follow-up|18|||
16140200|NCT00325039|38999862|FG001|Overall Study|Lost to Follow-up|14|||
16140201|NCT01290601|38999863|FG000|Overall Study|Adverse Event|0|||
16140202|NCT01290601|38999864|FG001|Overall Study|Adverse Event|2|||
16438112|NCT01329978|40082122|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
16438113|NCT01329978|40082123|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
16438114|NCT01329978|40082124|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
16438115|NCT01329978|40082125|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
16140203|NCT01290601|38999865|FG002|Overall Study|Adverse Event|0|||
16140204|NCT01290601|38999866|FG003|Overall Study|Adverse Event|0|||
16140205|NCT01290601|38999863|FG000|Overall Study|Lack of Efficacy|2|||
16140206|NCT01290601|38999864|FG001|Overall Study|Lack of Efficacy|1|||
16140207|NCT01290601|38999865|FG002|Overall Study|Lack of Efficacy|0|||
16140208|NCT01290601|38999866|FG003|Overall Study|Lack of Efficacy|0|||
16140209|NCT01290601|38999863|FG000|Overall Study|Lost to Follow-up|7|||
16140210|NCT01290601|38999864|FG001|Overall Study|Lost to Follow-up|2|||
16140211|NCT01290601|38999865|FG002|Overall Study|Lost to Follow-up|0|||
16140212|NCT01290601|38999866|FG003|Overall Study|Lost to Follow-up|0|||
16140213|NCT01290601|38999863|FG000|Overall Study|Other|1|||
16140214|NCT01290601|38999864|FG001|Overall Study|Other|0|||
16140215|NCT01290601|38999865|FG002|Overall Study|Other|0|||
16140216|NCT01290601|38999866|FG003|Overall Study|Other|0|||
16140217|NCT01290601|38999863|FG000|Overall Study|Protocol Violation|1|||
16140218|NCT01290601|38999864|FG001|Overall Study|Protocol Violation|0|||
16140219|NCT01290601|38999865|FG002|Overall Study|Protocol Violation|0|||
16140220|NCT01290601|38999866|FG003|Overall Study|Protocol Violation|0|||
16140221|NCT02547233|38999867|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
16140222|NCT02547233|38999868|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
16140223|NCT02547233|38999867|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
16140224|NCT02547233|38999868|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
16140225|NCT02547233|38999867|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
16140226|NCT02547233|38999868|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
16140227|NCT02547233|38999867|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
16140228|NCT02547233|38999868|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
16140229|NCT02547233|38999867|FG000|12-month Follow-up|Withdrawal by Subject|10|||
16140230|NCT02547233|38999868|FG001|12-month Follow-up|Withdrawal by Subject|10|||
16140231|NCT02547233|38999867|FG000|12-month Follow-up|Lost to Follow-up|3|||
16140232|NCT02547233|38999868|FG001|12-month Follow-up|Lost to Follow-up|3|||
16140233|NCT02547233|38999867|FG000|12-month Follow-up|Lack of Efficacy|1|||
16140234|NCT02547233|38999868|FG001|12-month Follow-up|Lack of Efficacy|2|||
16140235|NCT02547233|38999867|FG000|12-month Follow-up|Protocol Violation|0|||
16140236|NCT02547233|38999868|FG001|12-month Follow-up|Protocol Violation|1|||
16140237|NCT02547233|38999867|FG000|12-month Follow-up|Other|0|||
16140238|NCT02547233|38999868|FG001|12-month Follow-up|Other|1|||
16140239|NCT00504153|38999869|FG000|Overall Study|Withdrawal by Subject|1|||
16140240|NCT00504153|38999869|FG000|Overall Study|Adverse Event|4|||
16140241|NCT00504153|38999869|FG000|Overall Study|Death|1|||
16140242|NCT02864381|38999870|FG000|Overall Study|Death|58|||
16140243|NCT02864381|38999871|FG001|Overall Study|Death|61|||
16140244|NCT02864381|38999870|FG000|Overall Study|Withdrew Consent|5|||
16140245|NCT02864381|38999871|FG001|Overall Study|Withdrew Consent|6|||
16140246|NCT02864381|38999870|FG000|Overall Study|Reason Unknown|7|||
16140247|NCT02864381|38999871|FG001|Overall Study|Reason Unknown|3|||
16140248|NCT02864381|38999870|FG000|Overall Study|Lost to Follow-up|1|||
16140249|NCT02864381|38999871|FG001|Overall Study|Lost to Follow-up|1|||
16140250|NCT02864381|38999870|FG000|Overall Study|Investigator's Discretion|1|||
16140251|NCT02864381|38999871|FG001|Overall Study|Investigator's Discretion|0|||
16140252|NCT02864381|38999870|FG000|Overall Study|Protocol Violation|0|||
16140253|NCT02864381|38999871|FG001|Overall Study|Protocol Violation|1|||
16140254|NCT00104676|38999873|FG000|Overall Study|Death|3|||
16140255|NCT00104676|38999874|FG001|Overall Study|Death|2|||
16140256|NCT00104676|38999873|FG000|Overall Study|Withdrawal by Subject|0|||
16140257|NCT00104676|38999874|FG001|Overall Study|Withdrawal by Subject|2|||
16140258|NCT00104676|38999873|FG000|Overall Study|treatment interruption|4|||
16140259|NCT00104676|38999874|FG001|Overall Study|treatment interruption|10|||
16140260|NCT00174265|38999875|FG000|Overall Study|Adverse Event|7|||
16140261|NCT00174265|38999876|FG001|Overall Study|Adverse Event|4|||
16140262|NCT00174265|38999875|FG000|Overall Study|Lack of Efficacy|2|||
16140263|NCT00174265|38999876|FG001|Overall Study|Lack of Efficacy|2|||
16140264|NCT00174265|38999875|FG000|Overall Study|Withdrawal by Subject|3|||
16140265|NCT00174265|38999876|FG001|Overall Study|Withdrawal by Subject|5|||
16140266|NCT00174265|38999875|FG000|Overall Study|Lost to Follow-up|1|||
16140267|NCT00174265|38999876|FG001|Overall Study|Lost to Follow-up|0|||
16140268|NCT00174265|38999875|FG000|Overall Study|Other (Not specified)|16|||
16140269|NCT00174265|38999876|FG001|Overall Study|Other (Not specified)|10|||
16140270|NCT01096342|38999877|FG000|Overall Study|Protocol Violation|1|||
16140271|NCT02202551|38999880|FG000|Overall Study|Adverse Event|8|||
16140272|NCT02202551|38999881|FG001|Overall Study|Adverse Event|19|||
16140273|NCT02202551|38999882|FG002|Overall Study|Adverse Event|5|||
16140274|NCT02202551|38999883|FG003|Overall Study|Adverse Event|9|||
16140275|NCT02202551|38999880|FG000|Overall Study|Death|3|||
16140276|NCT02202551|38999881|FG001|Overall Study|Death|2|||
16140277|NCT02202551|38999882|FG002|Overall Study|Death|1|||
16140278|NCT02202551|38999883|FG003|Overall Study|Death|1|||
16140279|NCT02202551|38999880|FG000|Overall Study|Lost to Follow-up|0|||
16140280|NCT02202551|38999881|FG001|Overall Study|Lost to Follow-up|1|||
16140281|NCT02202551|38999882|FG002|Overall Study|Lost to Follow-up|0|||
16140282|NCT02202551|38999883|FG003|Overall Study|Lost to Follow-up|1|||
16140283|NCT02202551|38999880|FG000|Overall Study|Needed to take excluded medication|0|||
16140284|NCT02202551|38999881|FG001|Overall Study|Needed to take excluded medication|2|||
16140285|NCT02202551|38999882|FG002|Overall Study|Needed to take excluded medication|0|||
16140286|NCT02202551|38999883|FG003|Overall Study|Needed to take excluded medication|1|||
16140287|NCT02202551|38999880|FG000|Overall Study|Subject moved away|0|||
16363822|NCT01500083|39818063|FG000|Overall Study|Investigator Discretion|3|||
16140288|NCT02202551|38999881|FG001|Overall Study|Subject moved away|1|||
16140289|NCT02202551|38999882|FG002|Overall Study|Subject moved away|0|||
16363823|NCT01500083|39818064|FG001|Overall Study|Investigator Discretion|8|||
16363824|NCT01500083|39818063|FG000|Overall Study|Other Reasons|2|||
16363825|NCT01500083|39818064|FG001|Overall Study|Other Reasons|5|||
16363826|NCT03122106|39818070|FG000|Overall Study|Not enough tissue|1|||
16363827|NCT03122106|39818070|FG000|Overall Study|Disease progression during screening|2|||
16363828|NCT03122106|39818070|FG000|Overall Study|Poor RNA quality for vaccine|1|||
16363829|NCT00954538|39818071|FG000|Part III|Withdrawal by Subject|0|||
16363830|NCT00954538|39818072|FG001|Part III|Withdrawal by Subject|0|||
16363831|NCT00954538|39818073|FG002|Part III|Withdrawal by Subject|0|||
16140290|NCT02202551|38999883|FG003|Overall Study|Subject moved away|0|||
16140291|NCT02202551|38999880|FG000|Overall Study|DBS surgery|3|||
16140292|NCT02202551|38999881|FG001|Overall Study|DBS surgery|0|||
16140293|NCT02202551|38999882|FG002|Overall Study|DBS surgery|0|||
16140294|NCT02202551|38999883|FG003|Overall Study|DBS surgery|0|||
16140295|NCT02202551|38999880|FG000|Overall Study|Dyskinesia upon taper|1|||
16140296|NCT02202551|38999881|FG001|Overall Study|Dyskinesia upon taper|0|||
16140297|NCT02202551|38999882|FG002|Overall Study|Dyskinesia upon taper|0|||
16140298|NCT02202551|38999883|FG003|Overall Study|Dyskinesia upon taper|0|||
16140299|NCT02202551|38999880|FG000|Overall Study|Lack of Efficacy|0|||
16140300|NCT02202551|38999881|FG001|Overall Study|Lack of Efficacy|1|||
16140301|NCT02202551|38999882|FG002|Overall Study|Lack of Efficacy|0|||
16140302|NCT02202551|38999883|FG003|Overall Study|Lack of Efficacy|0|||
16140303|NCT02202551|38999880|FG000|Overall Study|Physician Decision|1|||
16140304|NCT02202551|38999881|FG001|Overall Study|Physician Decision|0|||
16140305|NCT02202551|38999882|FG002|Overall Study|Physician Decision|0|||
16140306|NCT02202551|38999883|FG003|Overall Study|Physician Decision|0|||
16140307|NCT02202551|38999880|FG000|Overall Study|Site closure|3|||
16140308|NCT02202551|38999881|FG001|Overall Study|Site closure|0|||
16140309|NCT02202551|38999882|FG002|Overall Study|Site closure|0|||
16140310|NCT02202551|38999883|FG003|Overall Study|Site closure|1|||
16140311|NCT02202551|38999880|FG000|Overall Study|Unable to complete visits per protocol|1|||
16140312|NCT02202551|38999881|FG001|Overall Study|Unable to complete visits per protocol|0|||
16140313|NCT02202551|38999882|FG002|Overall Study|Unable to complete visits per protocol|0|||
16140314|NCT02202551|38999883|FG003|Overall Study|Unable to complete visits per protocol|0|||
16140315|NCT02202551|38999880|FG000|Overall Study|Worsening Dyskinesia|0|||
16140316|NCT02202551|38999881|FG001|Overall Study|Worsening Dyskinesia|0|||
16140317|NCT02202551|38999882|FG002|Overall Study|Worsening Dyskinesia|0|||
16140318|NCT02202551|38999883|FG003|Overall Study|Worsening Dyskinesia|1|||
16140319|NCT02202551|38999880|FG000|Overall Study|Protocol Violation|0|||
16140320|NCT02202551|38999881|FG001|Overall Study|Protocol Violation|1|||
16255261|NCT03401112|39419827|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
16255262|NCT03401112|39419828|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
16255263|NCT03401112|39419829|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
16140321|NCT02202551|38999882|FG002|Overall Study|Protocol Violation|0|||
16140322|NCT02202551|38999883|FG003|Overall Study|Protocol Violation|0|||
16255264|NCT03401112|39419830|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
16255265|NCT03401112|39419831|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
16255266|NCT03401112|39419827|FG000|Overall Study|Withdrawal by Subject|0|||
16363832|NCT00954538|39818074|FG003|Part III|Withdrawal by Subject|0|||
16363833|NCT00954538|39818075|FG004|Part III|Withdrawal by Subject|1|||
16140323|NCT02202551|38999880|FG000|Overall Study|Sponsor's decision|2|||
16140324|NCT02202551|38999881|FG001|Overall Study|Sponsor's decision|0|||
16140325|NCT02202551|38999882|FG002|Overall Study|Sponsor's decision|0|||
16140326|NCT02202551|38999883|FG003|Overall Study|Sponsor's decision|0|||
16255267|NCT03401112|39419828|FG001|Overall Study|Withdrawal by Subject|3|||
16255268|NCT03401112|39419829|FG002|Overall Study|Withdrawal by Subject|2|||
16255269|NCT03401112|39419830|FG003|Overall Study|Withdrawal by Subject|1|||
16255270|NCT03401112|39419831|FG004|Overall Study|Withdrawal by Subject|0|||
16255271|NCT03401112|39419827|FG000|Overall Study|Physician Decision|0|||
16255272|NCT03401112|39419828|FG001|Overall Study|Physician Decision|0|||
16255273|NCT03401112|39419829|FG002|Overall Study|Physician Decision|0|||
16255274|NCT03401112|39419830|FG003|Overall Study|Physician Decision|2|||
16255275|NCT03401112|39419831|FG004|Overall Study|Physician Decision|0|||
16255276|NCT03401112|39419827|FG000|Overall Study|Study was Terminated by Sponsor|0|||
16438116|NCT01329978|40082126|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
16140327|NCT02202551|38999880|FG000|Overall Study|Subject unwilling to proceed|1|||
16140328|NCT02202551|38999881|FG001|Overall Study|Subject unwilling to proceed|5|||
16140329|NCT02202551|38999882|FG002|Overall Study|Subject unwilling to proceed|3|||
16140330|NCT02202551|38999883|FG003|Overall Study|Subject unwilling to proceed|5|||
16140331|NCT02202551|38999880|FG000|Overall Study|Subject consent withdrawn|0|||
16140332|NCT02202551|38999881|FG001|Overall Study|Subject consent withdrawn|3|||
16140333|NCT02202551|38999882|FG002|Overall Study|Subject consent withdrawn|1|||
16140334|NCT02202551|38999883|FG003|Overall Study|Subject consent withdrawn|2|||
16140335|NCT02202551|38999880|FG000|Overall Study|eGFR<50mL/min/m2|2|||
16140336|NCT02202551|38999881|FG001|Overall Study|eGFR<50mL/min/m2|2|||
16255277|NCT03401112|39419828|FG001|Overall Study|Study was Terminated by Sponsor|0|||
16255278|NCT03401112|39419829|FG002|Overall Study|Study was Terminated by Sponsor|0|||
16438117|NCT01329978|40082122|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
16438118|NCT01329978|40082123|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
16438119|NCT01329978|40082124|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
16438120|NCT01329978|40082125|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
16438121|NCT01329978|40082126|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
16438122|NCT01329978|40082122|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
16438123|NCT01329978|40082123|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
16438124|NCT01329978|40082124|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
16438125|NCT01329978|40082125|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
16438126|NCT01329978|40082126|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
16438127|NCT01329978|40082122|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
16438128|NCT01329978|40082123|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
16438129|NCT01329978|40082124|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
16255279|NCT03401112|39419830|FG003|Overall Study|Study was Terminated by Sponsor|1|||
16140337|NCT02202551|38999882|FG002|Overall Study|eGFR<50mL/min/m2|0|||
16140338|NCT02202551|38999883|FG003|Overall Study|eGFR<50mL/min/m2|1|||
16140339|NCT01330914|38999884|FG000|Overall Study|Withdrawal by Subject|4|||
16140340|NCT01330914|38999884|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
16140341|NCT00364156|39003736|FG000|Overall Study|Withdrawal by Subject|73|||
16140342|NCT00364156|39003737|FG001|Overall Study|Withdrawal by Subject|80|||
16140343|NCT00364156|39003736|FG000|Overall Study|Protocol Violation|6|||
16140344|NCT00364156|39003737|FG001|Overall Study|Protocol Violation|1|||
16140345|NCT00732251|39003738|FG000|Overall Study|Lost to Follow-up|3|||
16140346|NCT00732251|39003738|FG000|Overall Study|Withdrawal by Subject|3|||
16140347|NCT00732251|39003738|FG000|Overall Study|Early Term due to Site Closure|1|||
16140348|NCT03942406|39003740|FG000|Overall Study|Lost to Follow-up|4|||
16140349|NCT03942406|39003741|FG001|Overall Study|Lost to Follow-up|5|||
16140350|NCT03942406|39003742|FG002|Overall Study|Lost to Follow-up|3|||
16140351|NCT03942406|39003743|FG003|Overall Study|Lost to Follow-up|7|||
16140352|NCT03942406|39003744|FG004|Overall Study|Lost to Follow-up|1|||
16140353|NCT03942406|39003745|FG005|Overall Study|Lost to Follow-up|0|||
16438130|NCT01329978|40082125|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
16438131|NCT01329978|40082126|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
16255280|NCT03401112|39419831|FG004|Overall Study|Study was Terminated by Sponsor|0|||
16255281|NCT03401112|39419827|FG000|Overall Study|Day 1 Assessment not Done|1|||
16255282|NCT03401112|39419828|FG001|Overall Study|Day 1 Assessment not Done|0|||
16438132|NCT01329978|40082122|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
16438133|NCT01329978|40082123|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
16438134|NCT01329978|40082124|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
16438135|NCT01329978|40082125|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
16438136|NCT01329978|40082126|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
16140354|NCT03942406|39003746|FG006|Overall Study|Lost to Follow-up|0|||
16140355|NCT03942406|39003740|FG000|Overall Study|Withdrawal by Subject|3|||
16140356|NCT03942406|39003741|FG001|Overall Study|Withdrawal by Subject|1|||
16140357|NCT03942406|39003742|FG002|Overall Study|Withdrawal by Subject|1|||
16140358|NCT03942406|39003743|FG003|Overall Study|Withdrawal by Subject|3|||
16140359|NCT03942406|39003744|FG004|Overall Study|Withdrawal by Subject|0|||
16140360|NCT03942406|39003745|FG005|Overall Study|Withdrawal by Subject|0|||
16140361|NCT03942406|39003746|FG006|Overall Study|Withdrawal by Subject|0|||
16140362|NCT03942406|39003740|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
16140363|NCT03942406|39003741|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
16140364|NCT03942406|39003742|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
16140365|NCT03942406|39003743|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
16140366|NCT03942406|39003744|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
16140367|NCT03942406|39003745|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
16140368|NCT03942406|39003746|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
16140369|NCT00702845|39003749|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
16140370|NCT00702845|39003750|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
16140371|NCT00702845|39003749|FG000|Overall Study|Too high ovarian response|5|||
16140372|NCT00702845|39003750|FG001|Overall Study|Too high ovarian response|1|||
16438137|NCT01329978|40082122|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
16140373|NCT00702845|39003749|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
16140374|NCT00702845|39003750|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
16140375|NCT00702845|39003749|FG000|Overall Study|Insufficient ovarian response|1|||
16140376|NCT00702845|39003750|FG001|Overall Study|Insufficient ovarian response|0|||
16140377|NCT00702845|39003749|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
16140378|NCT00702845|39003750|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
16140379|NCT00702845|39003749|FG000|Overall Study|No or abnormal fertilization|4|||
16140380|NCT00702845|39003750|FG001|Overall Study|No or abnormal fertilization|2|||
16140381|NCT00702845|39003749|FG000|Overall Study|Patient's decision|2|||
16140382|NCT00702845|39003750|FG001|Overall Study|Patient's decision|1|||
16140383|NCT00702845|39003749|FG000|Overall Study|Not randomized|0|||
16255283|NCT03401112|39419829|FG002|Overall Study|Day 1 Assessment not Done|0|||
16140384|NCT00702845|39003750|FG001|Overall Study|Not randomized|1|||
16140385|NCT04004429|39003751|FG000|Overall Study|Protocol Violation|1|||
16140386|NCT04004429|39003752|FG001|Overall Study|Protocol Violation|0|||
16255284|NCT03401112|39419830|FG003|Overall Study|Day 1 Assessment not Done|0|||
16140387|NCT04004429|39003753|FG002|Overall Study|Protocol Violation|0|||
16140388|NCT04004429|39003751|FG000|Overall Study|Physician Decision|0|||
16140389|NCT04004429|39003752|FG001|Overall Study|Physician Decision|1|||
16140390|NCT04004429|39003753|FG002|Overall Study|Physician Decision|1|||
16140391|NCT04004429|39003751|FG000|Overall Study|Withdrawal by Subject|1|||
16140392|NCT04004429|39003752|FG001|Overall Study|Withdrawal by Subject|1|||
16140393|NCT04004429|39003753|FG002|Overall Study|Withdrawal by Subject|1|||
16140394|NCT01704287|39003754|FG000|Initial Treatment Period|Death|139|||
16140395|NCT01704287|39003755|FG001|Initial Treatment Period|Death|129|||
16140396|NCT01704287|39003756|FG002|Initial Treatment Period|Death|71|||
16140397|NCT01704287|39003757|FG003|Initial Treatment Period|Death|0|||
16140398|NCT01704287|39003758|FG004|Initial Treatment Period|Death|0|||
16140399|NCT01704287|39003754|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
16140400|NCT01704287|39003755|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
16140401|NCT01704287|39003756|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
16140402|NCT01704287|39003757|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
16140403|NCT01704287|39003758|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
16140404|NCT01704287|39003754|FG000|Initial Treatment Period|Lost to Follow-up|5|||
16140405|NCT01704287|39003755|FG001|Initial Treatment Period|Lost to Follow-up|3|||
16140406|NCT01704287|39003756|FG002|Initial Treatment Period|Lost to Follow-up|0|||
16140407|NCT01704287|39003757|FG003|Initial Treatment Period|Lost to Follow-up|0|||
16140408|NCT01704287|39003758|FG004|Initial Treatment Period|Lost to Follow-up|0|||
16140409|NCT01704287|39003754|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
16140410|NCT01704287|39003755|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
16140411|NCT01704287|39003756|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
16255285|NCT03401112|39419831|FG004|Overall Study|Day 1 Assessment not Done|0|||
16255286|NCT03401112|39419827|FG000|Overall Study|Not Dosed|0|||
16140412|NCT01704287|39003757|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
16255287|NCT03401112|39419828|FG001|Overall Study|Not Dosed|0|||
16255288|NCT03401112|39419829|FG002|Overall Study|Not Dosed|1|||
16255289|NCT03401112|39419830|FG003|Overall Study|Not Dosed|0|||
16255290|NCT03401112|39419831|FG004|Overall Study|Not Dosed|0|||
16255291|NCT03401112|39419827|FG000|Overall Study|Missed Clinical Visit|0|||
16255292|NCT03401112|39419828|FG001|Overall Study|Missed Clinical Visit|0|||
16255293|NCT03401112|39419829|FG002|Overall Study|Missed Clinical Visit|1|||
16255294|NCT03401112|39419830|FG003|Overall Study|Missed Clinical Visit|0|||
16255295|NCT03401112|39419831|FG004|Overall Study|Missed Clinical Visit|0|||
16255296|NCT03401112|39419827|FG000|Overall Study|Missed Doses|0|||
16140413|NCT01704287|39003758|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
16255297|NCT03401112|39419828|FG001|Overall Study|Missed Doses|0|||
16255298|NCT03401112|39419829|FG002|Overall Study|Missed Doses|1|||
16255299|NCT03401112|39419830|FG003|Overall Study|Missed Doses|0|||
16140414|NCT01704287|39003754|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
16255300|NCT03401112|39419831|FG004|Overall Study|Missed Doses|0|||
16255301|NCT01126736|39419834|FG000|Overall Study|Death|2|||
16140415|NCT01704287|39003755|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
16140416|NCT01704287|39003756|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
16438138|NCT01329978|40082123|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
16140417|NCT01704287|39003757|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
16140418|NCT01704287|39003758|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
16140419|NCT01704287|39003754|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
16140420|NCT01704287|39003755|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
16140421|NCT01704287|39003756|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
16140422|NCT01704287|39003757|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
16140423|NCT01704287|39003758|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
16140424|NCT01704287|39003754|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
16140425|NCT01704287|39003755|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
16140426|NCT01704287|39003756|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
16140427|NCT01704287|39003757|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
16140428|NCT01704287|39003758|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
16140429|NCT00146328|39003762|FG000|Overall Study|Adverse Event|39|||
16140430|NCT00146328|39003763|FG001|Overall Study|Adverse Event|48|||
16140431|NCT00146328|39003764|FG002|Overall Study|Adverse Event|79|||
16140432|NCT00146328|39003762|FG000|Overall Study|Protocol Violation|11|||
16140433|NCT00146328|39003763|FG001|Overall Study|Protocol Violation|6|||
16140434|NCT00146328|39003764|FG002|Overall Study|Protocol Violation|12|||
16140435|NCT00146328|39003762|FG000|Overall Study|Lost to Follow-up|7|||
16140436|NCT00146328|39003763|FG001|Overall Study|Lost to Follow-up|4|||
16140437|NCT00146328|39003764|FG002|Overall Study|Lost to Follow-up|7|||
16140438|NCT00146328|39003762|FG000|Overall Study|Withdrawal by Subject|16|||
16140439|NCT00146328|39003763|FG001|Overall Study|Withdrawal by Subject|16|||
16140440|NCT00146328|39003764|FG002|Overall Study|Withdrawal by Subject|22|||
16140441|NCT00146328|39003762|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
16140442|NCT00146328|39003763|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
16140443|NCT00146328|39003764|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
16140444|NCT00146328|39003762|FG000|Overall Study|Trial ended/site closed|8|||
16140445|NCT00146328|39003763|FG001|Overall Study|Trial ended/site closed|2|||
16140446|NCT00146328|39003764|FG002|Overall Study|Trial ended/site closed|19|||
16140447|NCT00146328|39003762|FG000|Overall Study|Patient decision to end|0|||
16140448|NCT00146328|39003763|FG001|Overall Study|Patient decision to end|1|||
16140449|NCT00146328|39003764|FG002|Overall Study|Patient decision to end|6|||
16140450|NCT00146328|39003762|FG000|Overall Study|Enroll into other trial|2|||
16140451|NCT00146328|39003763|FG001|Overall Study|Enroll into other trial|4|||
16140452|NCT00146328|39003764|FG002|Overall Study|Enroll into other trial|2|||
16140453|NCT00146328|39003762|FG000|Overall Study|Death|0|||
16140454|NCT00146328|39003763|FG001|Overall Study|Death|1|||
16140455|NCT00146328|39003764|FG002|Overall Study|Death|1|||
16140456|NCT00146328|39003762|FG000|Overall Study|Moved|2|||
16140457|NCT00146328|39003763|FG001|Overall Study|Moved|0|||
16140458|NCT00146328|39003764|FG002|Overall Study|Moved|0|||
16140459|NCT00146328|39003762|FG000|Overall Study|Interaction with other medication|2|||
16140460|NCT00146328|39003763|FG001|Overall Study|Interaction with other medication|0|||
16140461|NCT00146328|39003764|FG002|Overall Study|Interaction with other medication|1|||
16140462|NCT00108069|39003765|FG000|Overall Study|Never rec'd study drug|0|||
16438139|NCT01329978|40082124|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
16140463|NCT00108069|39003766|FG001|Overall Study|Never rec'd study drug|1|||
16140464|NCT00108069|39003765|FG000|Overall Study|Adverse Event|1|||
16438140|NCT01329978|40082125|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
16438141|NCT01329978|40082126|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
16438142|NCT01329978|40082122|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
16438143|NCT01329978|40082123|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
16438144|NCT01329978|40082124|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
16438145|NCT01329978|40082125|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
16438146|NCT01329978|40082126|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
16438147|NCT02173769|40082127|FG000|Overall Study|Protocol Violation|4|||
16438148|NCT00216671|40082131|FG000|Overall Study|Adverse Event|4|||
16438149|NCT00216671|40082132|FG001|Overall Study|Adverse Event|9|||
16438150|NCT00216671|40082131|FG000|Overall Study|Pregnancy|0|||
16438151|NCT00216671|40082132|FG001|Overall Study|Pregnancy|1|||
16438152|NCT00216671|40082131|FG000|Overall Study|Withdrawal by Subject|4|||
16438153|NCT00216671|40082132|FG001|Overall Study|Withdrawal by Subject|2|||
16438154|NCT00216671|40082131|FG000|Overall Study|Refused Injections|3|||
16438155|NCT00216671|40082132|FG001|Overall Study|Refused Injections|13|||
16438156|NCT00216671|40082131|FG000|Overall Study|No Need to Continue Medication|1|||
16438157|NCT00216671|40082132|FG001|Overall Study|No Need to Continue Medication|1|||
16438158|NCT00216671|40082131|FG000|Overall Study|Insufficient Response|9|||
16438159|NCT00216671|40082132|FG001|Overall Study|Insufficient Response|4|||
16438160|NCT00216671|40082131|FG000|Overall Study|Lost to Follow-up|3|||
16438161|NCT00216671|40082132|FG001|Overall Study|Lost to Follow-up|5|||
16438162|NCT00216671|40082131|FG000|Overall Study|Non compliant|2|||
16438163|NCT00216671|40082132|FG001|Overall Study|Non compliant|2|||
16438164|NCT00216671|40082131|FG000|Overall Study|Ineligible|0|||
16438165|NCT00216671|40082132|FG001|Overall Study|Ineligible|2|||
16438166|NCT00216671|40082131|FG000|Overall Study|Physician Decision|1|||
16438167|NCT00216671|40082132|FG001|Overall Study|Physician Decision|1|||
16438168|NCT00216671|40082131|FG000|Overall Study|Protocol Violation|3|||
16438169|NCT00216671|40082132|FG001|Overall Study|Protocol Violation|5|||
16438170|NCT00216671|40082131|FG000|Overall Study|Relapse|1|||
16438171|NCT00216671|40082132|FG001|Overall Study|Relapse|0|||
16438172|NCT00216671|40082131|FG000|Overall Study|Investigator Illness|0|||
16438173|NCT00216671|40082132|FG001|Overall Study|Investigator Illness|1|||
16438174|NCT00216671|40082131|FG000|Overall Study|Patient Moved|0|||
16438175|NCT00216671|40082132|FG001|Overall Study|Patient Moved|1|||
16255302|NCT01126736|39419835|FG001|Overall Study|Death|2|||
16255303|NCT01126736|39419836|FG002|Overall Study|Death|1|||
16255304|NCT01126736|39419837|FG003|Overall Study|Death|19|||
16255305|NCT01126736|39419838|FG004|Overall Study|Death|19|||
16255306|NCT01126736|39419834|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
16255307|NCT01126736|39419835|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
16255308|NCT01126736|39419836|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
16255309|NCT01126736|39419837|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
16255310|NCT01126736|39419838|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
16255311|NCT01126736|39419834|FG000|Overall Study|Lost to Follow-up|0|||
16255312|NCT01126736|39419835|FG001|Overall Study|Lost to Follow-up|0|||
16255313|NCT01126736|39419836|FG002|Overall Study|Lost to Follow-up|0|||
16255314|NCT01126736|39419837|FG003|Overall Study|Lost to Follow-up|1|||
16255315|NCT01126736|39419838|FG004|Overall Study|Lost to Follow-up|1|||
16255316|NCT01126736|39419834|FG000|Overall Study|Administrative reasons|0|||
16255317|NCT01126736|39419835|FG001|Overall Study|Administrative reasons|0|||
16255318|NCT01126736|39419836|FG002|Overall Study|Administrative reasons|0|||
16255319|NCT01126736|39419837|FG003|Overall Study|Administrative reasons|0|||
16255320|NCT01126736|39419838|FG004|Overall Study|Administrative reasons|1|||
16255321|NCT01126736|39419834|FG000|Overall Study|Progressive disease|0|||
16255322|NCT01126736|39419835|FG001|Overall Study|Progressive disease|0|||
16255323|NCT01126736|39419836|FG002|Overall Study|Progressive disease|0|||
16255324|NCT01126736|39419837|FG003|Overall Study|Progressive disease|2|||
16255325|NCT01126736|39419838|FG004|Overall Study|Progressive disease|1|||
16255326|NCT01126736|39419834|FG000|Overall Study|Withdrawal by Subject|0|||
16255327|NCT01126736|39419835|FG001|Overall Study|Withdrawal by Subject|0|||
16255328|NCT01126736|39419836|FG002|Overall Study|Withdrawal by Subject|0|||
16255329|NCT01126736|39419837|FG003|Overall Study|Withdrawal by Subject|1|||
16255330|NCT01126736|39419838|FG004|Overall Study|Withdrawal by Subject|1|||
16255331|NCT01126736|39419834|FG000|Overall Study|Other|2|||
16255332|NCT01126736|39419835|FG001|Overall Study|Other|4|||
16255333|NCT01126736|39419836|FG002|Overall Study|Other|4|||
16255334|NCT01126736|39419837|FG003|Overall Study|Other|16|||
16438176|NCT00216671|40082131|FG000|Overall Study|Ineligible, no efficacy data|2|||
16438177|NCT00216671|40082132|FG001|Overall Study|Ineligible, no efficacy data|2|||
16140465|NCT00108069|39003766|FG001|Overall Study|Adverse Event|1|||
16255335|NCT01126736|39419838|FG004|Overall Study|Other|15|||
16255336|NCT00304083|39419849|FG000|Overall Study|Withdrawal by Subject|4|||
16255337|NCT00304083|39419850|FG001|Overall Study|Withdrawal by Subject|2|||
16438178|NCT00216671|40082131|FG000|Overall Study|Insufficient Response Adverse Event|2|||
16438179|NCT00216671|40082132|FG001|Overall Study|Insufficient Response Adverse Event|1|||
16438180|NCT00416624|40082140|FG000|Overall Study|Withdrawal by Subject|1|||
16438181|NCT00416624|40082141|FG001|Overall Study|Withdrawal by Subject|6|||
16438182|NCT00416624|40082142|FG002|Overall Study|Withdrawal by Subject|4|||
16438183|NCT00416624|40082143|FG003|Overall Study|Withdrawal by Subject|9|||
16438184|NCT00416624|40082140|FG000|Overall Study|Death|4|||
16438185|NCT00416624|40082141|FG001|Overall Study|Death|7|||
16438186|NCT00416624|40082142|FG002|Overall Study|Death|7|||
16438187|NCT00416624|40082143|FG003|Overall Study|Death|1|||
16438188|NCT00416624|40082140|FG000|Overall Study|Adverse Event|8|||
16438189|NCT00416624|40082141|FG001|Overall Study|Adverse Event|3|||
16438190|NCT00416624|40082142|FG002|Overall Study|Adverse Event|2|||
16438191|NCT00416624|40082143|FG003|Overall Study|Adverse Event|2|||
16438192|NCT00416624|40082140|FG000|Overall Study|Other|8|||
16438193|NCT00416624|40082141|FG001|Overall Study|Other|11|||
16438194|NCT00416624|40082142|FG002|Overall Study|Other|5|||
16438195|NCT00416624|40082143|FG003|Overall Study|Other|5|||
16363834|NCT00954538|39818076|FG005|Part III|Withdrawal by Subject|0|||
16363835|NCT05177094|39818081|FG000|Overall Study|Adverse Event|5|||
16363836|NCT05177094|39818082|FG001|Overall Study|Adverse Event|5|||
16363837|NCT05177094|39818081|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
16363838|NCT05177094|39818082|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
16363839|NCT05177094|39818081|FG000|Overall Study|Protocol Deviation|3|||
16363840|NCT05177094|39818082|FG001|Overall Study|Protocol Deviation|0|||
16363841|NCT05177094|39818081|FG000|Overall Study|Withdrawal by Subject|6|||
16363842|NCT05177094|39818082|FG001|Overall Study|Withdrawal by Subject|3|||
16363843|NCT05177094|39818081|FG000|Overall Study|Participant could not tolerate long study visits|1|||
16363844|NCT05177094|39818082|FG001|Overall Study|Participant could not tolerate long study visits|0|||
16363845|NCT00768053|39818083|FG000|Overall Study|Adverse Event|10|||
16363846|NCT00768053|39818083|FG000|Overall Study|Lost to Follow-up|1|||
16363847|NCT02008370|39818086|FG000|Overall Study|Lost to Follow-up|7|||
16363848|NCT03572218|39818087|FG000|Overall Study|Lost to Follow-up|3|||
16363849|NCT03572218|39818088|FG001|Overall Study|Lost to Follow-up|2|||
16363850|NCT03572218|39818087|FG000|Overall Study|No longer available for study visits|2|||
16363851|NCT03572218|39818088|FG001|Overall Study|No longer available for study visits|1|||
16363852|NCT03572218|39818087|FG000|Overall Study|No longer interested|1|||
16363853|NCT03572218|39818088|FG001|Overall Study|No longer interested|2|||
16363854|NCT00937950|39818089|FG000|Overall Study|Withdrawal by Subject|23|||
16363855|NCT00937950|39818089|FG000|Overall Study|Migrated/moved from study area|27|||
16363856|NCT00937950|39818089|FG000|Overall Study|Lost to Follow-up|144|||
16363857|NCT00937950|39818089|FG000|Overall Study|Missing confirmed|4|||
16363858|NCT00937950|39818089|FG000|Overall Study|Other|18|||
16363859|NCT01901185|39818090|FG000|Overall Study|Withdrawal by Subject|2|||
16438196|NCT00416624|40082140|FG000|Overall Study|Cancel|1|||
16438197|NCT00416624|40082141|FG001|Overall Study|Cancel|0|||
16438198|NCT00416624|40082142|FG002|Overall Study|Cancel|0|||
16438199|NCT00416624|40082143|FG003|Overall Study|Cancel|0|||
16438200|NCT01277744|40082146|FG000|Overall Study|Physician Decision|2|||
16438201|NCT01601535|40082147|FG000|Phase 1|Adverse Event|1|||
16438202|NCT01601535|40082148|FG001|Phase 1|Adverse Event|0|||
16438203|NCT01601535|40082149|FG002|Phase 1|Adverse Event|2|||
16438204|NCT01601535|40082150|FG003|Phase 1|Adverse Event|1|||
16438205|NCT01601535|40082151|FG004|Phase 1|Adverse Event|0|||
16438206|NCT01601535|40082152|FG005|Phase 1|Adverse Event|0|||
16438207|NCT01601535|40082147|FG000|Phase 1|Withdrawal by Subject|2|||
16438208|NCT01601535|40082148|FG001|Phase 1|Withdrawal by Subject|1|||
16438209|NCT01601535|40082149|FG002|Phase 1|Withdrawal by Subject|1|||
16438210|NCT01601535|40082150|FG003|Phase 1|Withdrawal by Subject|2|||
16438211|NCT01601535|40082151|FG004|Phase 1|Withdrawal by Subject|0|||
16438212|NCT01601535|40082152|FG005|Phase 1|Withdrawal by Subject|0|||
16438213|NCT01601535|40082147|FG000|Phase 1|Progressive Disease|2|||
16438214|NCT01601535|40082148|FG001|Phase 1|Progressive Disease|3|||
16438215|NCT01601535|40082149|FG002|Phase 1|Progressive Disease|2|||
16438216|NCT01601535|40082150|FG003|Phase 1|Progressive Disease|1|||
16438217|NCT01601535|40082151|FG004|Phase 1|Progressive Disease|0|||
16438218|NCT01601535|40082152|FG005|Phase 1|Progressive Disease|0|||
16438219|NCT01601535|40082147|FG000|Phase 1|Started Another Treatment|1|||
16438220|NCT01601535|40082148|FG001|Phase 1|Started Another Treatment|2|||
16438221|NCT01601535|40082149|FG002|Phase 1|Started Another Treatment|0|||
16140466|NCT00108069|39003765|FG000|Overall Study|Withdrawal by Subject|1|||
16140467|NCT00108069|39003766|FG001|Overall Study|Withdrawal by Subject|0|||
16140468|NCT00108069|39003765|FG000|Overall Study|Death|1|||
16140469|NCT00108069|39003766|FG001|Overall Study|Death|0|||
16140470|NCT00108069|39003765|FG000|Overall Study|Progessive disease|27|||
16140471|NCT00108069|39003766|FG001|Overall Study|Progessive disease|11|||
16140472|NCT00448435|39003767|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
16140473|NCT00448435|39003768|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
16140474|NCT01776424|39003771|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
16140475|NCT01776424|39003772|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
16140476|NCT01776424|39003773|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
16140477|NCT01776424|39003771|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
16140478|NCT01776424|39003772|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
16140479|NCT01776424|39003773|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
16140480|NCT01776424|39003771|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
16140481|NCT01776424|39003772|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
16140482|NCT01776424|39003773|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
16140483|NCT01776424|39003771|FG000|LTOLE Part (Open Label)|Refused|5|||
16140484|NCT01776424|39003772|FG001|LTOLE Part (Open Label)|Refused|2|||
16140485|NCT01776424|39003773|FG002|LTOLE Part (Open Label)|Refused|11|||
16140486|NCT01776424|39003771|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
16140487|NCT01776424|39003772|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
16140488|NCT01776424|39003773|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
16140489|NCT02234323|39003774|FG000|All Enrolled|Not Treated: Completed study in database|2|||
16140490|NCT02234323|39003774|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
16140491|NCT02234323|39003774|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
16140492|NCT02234323|39003774|FG000|All Treated|Death|1|||
16140493|NCT02234323|39003774|FG000|All Treated|Physician Decision|5|||
16140494|NCT02234323|39003774|FG000|All Treated|Lack of Efficacy|3|||
16140495|NCT02234323|39003774|FG000|All Treated|Exceeded lab value limit|2|||
16140496|NCT02234323|39003774|FG000|All Treated|Other|7|||
16140497|NCT01505010|39003775|FG000|Overall Study|Protocol Violation|0|||
16140498|NCT01505010|39003776|FG001|Overall Study|Protocol Violation|1|||
16140499|NCT01505010|39003775|FG000|Overall Study|Lost to Follow-up|0|||
16140500|NCT01505010|39003776|FG001|Overall Study|Lost to Follow-up|1|||
16363860|NCT04790201|39818091|FG000|Overall Study|Lost to Follow-up|0|||
16363861|NCT04790201|39818092|FG001|Overall Study|Lost to Follow-up|0|||
16363862|NCT04790201|39818093|FG002|Overall Study|Lost to Follow-up|2|||
16363863|NCT04790201|39818091|FG000|Overall Study|Death|0|||
16363864|NCT04790201|39818092|FG001|Overall Study|Death|1|||
16363865|NCT04790201|39818093|FG002|Overall Study|Death|0|||
16363866|NCT04790201|39818091|FG000|Overall Study|Protocol Violation|1|||
16363867|NCT04790201|39818092|FG001|Overall Study|Protocol Violation|0|||
16363868|NCT04790201|39818093|FG002|Overall Study|Protocol Violation|1|||
16363869|NCT00770367|39818094|FG000|First Intervention|Withdrawal by Subject|0|||
16363870|NCT00770367|39818095|FG001|First Intervention|Withdrawal by Subject|2|||
16363871|NCT00770367|39818094|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
16363872|NCT00770367|39818095|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
16363873|NCT00770367|39818094|FG000|Second Intervention|Lost to Follow-up|2|||
16363874|NCT00770367|39818095|FG001|Second Intervention|Lost to Follow-up|0|||
16363875|NCT01901562|39818096|FG000|Overall Study|Protocol Violation|5|||
16363876|NCT01901562|39818096|FG000|Overall Study|Excluded intraoperatively|4|||
16363877|NCT00557466|39818097|FG000|Overall Study|Adverse Event|3|||
16363878|NCT00557466|39818098|FG001|Overall Study|Adverse Event|1|||
16363879|NCT00557466|39818099|FG002|Overall Study|Adverse Event|4|||
16363880|NCT00557466|39818100|FG003|Overall Study|Adverse Event|1|||
16363881|NCT00557466|39818101|FG004|Overall Study|Adverse Event|2|||
16363882|NCT00557466|39818102|FG005|Overall Study|Adverse Event|4|||
16363883|NCT00557466|39818097|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16363884|NCT00557466|39818098|FG001|Overall Study|Abnormal laboratory value(s)|2|||
16363885|NCT00557466|39818099|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16363886|NCT00557466|39818100|FG003|Overall Study|Abnormal laboratory value(s)|0|||
16363887|NCT00557466|39818101|FG004|Overall Study|Abnormal laboratory value(s)|0|||
16363888|NCT00557466|39818102|FG005|Overall Study|Abnormal laboratory value(s)|0|||
16363889|NCT00557466|39818097|FG000|Overall Study|Protocol deviation|0|||
16363890|NCT00557466|39818098|FG001|Overall Study|Protocol deviation|1|||
16140501|NCT01717768|39003779|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16140502|NCT01717768|39003780|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
16140503|NCT01717768|39003781|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16140504|NCT01717768|39003782|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16363891|NCT00557466|39818099|FG002|Overall Study|Protocol deviation|0|||
16363892|NCT00557466|39818100|FG003|Overall Study|Protocol deviation|2|||
16363893|NCT00557466|39818101|FG004|Overall Study|Protocol deviation|0|||
16363894|NCT00557466|39818102|FG005|Overall Study|Protocol deviation|0|||
16140505|NCT01717768|39003783|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16363895|NCT00557466|39818097|FG000|Overall Study|Subject withdrew consent|0|||
16438222|NCT01601535|40082150|FG003|Phase 1|Started Another Treatment|0|||
16438223|NCT01601535|40082151|FG004|Phase 1|Started Another Treatment|0|||
16438224|NCT01601535|40082152|FG005|Phase 1|Started Another Treatment|0|||
16438225|NCT01601535|40082147|FG000|Phase 2|Adverse Event|0|||
16438226|NCT01601535|40082148|FG001|Phase 2|Adverse Event|0|||
16438227|NCT01601535|40082149|FG002|Phase 2|Adverse Event|0|||
16438228|NCT01601535|40082150|FG003|Phase 2|Adverse Event|0|||
16363896|NCT00557466|39818098|FG001|Overall Study|Subject withdrew consent|0|||
16363897|NCT00557466|39818099|FG002|Overall Study|Subject withdrew consent|0|||
16363898|NCT00557466|39818100|FG003|Overall Study|Subject withdrew consent|0|||
16363899|NCT00557466|39818101|FG004|Overall Study|Subject withdrew consent|1|||
16140506|NCT01717768|39003784|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16140507|NCT01717768|39003785|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16140508|NCT01717768|39003786|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16140509|NCT01717768|39003787|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16140510|NCT01717768|39003788|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16140511|NCT01717768|39003789|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16140512|NCT01717768|39003790|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
16140513|NCT01717768|39003779|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16140514|NCT01717768|39003780|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16140515|NCT01717768|39003781|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16140516|NCT01717768|39003782|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16140517|NCT01717768|39003783|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16140518|NCT01717768|39003784|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16255338|NCT00304083|39419849|FG000|Overall Study|Physician Decision|8|||
16255339|NCT00304083|39419850|FG001|Overall Study|Physician Decision|3|||
16255340|NCT00304083|39419849|FG000|Overall Study|Disease Progression|5|||
16363900|NCT00557466|39818102|FG005|Overall Study|Subject withdrew consent|2|||
16255341|NCT00304083|39419850|FG001|Overall Study|Disease Progression|1|||
16255342|NCT00304083|39419849|FG000|Overall Study|Other|5|||
16255343|NCT00304083|39419850|FG001|Overall Study|Other|2|||
16255344|NCT01166568|39419851|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
16255345|NCT01166568|39419852|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
16255346|NCT01166568|39419853|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
16255347|NCT01166568|39419851|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
16255348|NCT01166568|39419852|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
16255349|NCT01166568|39419853|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
16255350|NCT01166568|39419851|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
16255351|NCT01166568|39419852|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
16255352|NCT01166568|39419853|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
16255353|NCT01361126|39419854|FG000|Overall Study|Sponsor decision|0|||
16255354|NCT01361126|39419855|FG001|Overall Study|Sponsor decision|2|||
16255355|NCT01075763|39419868|FG000|Overall Study|Lost to Follow-up|2|||
16255356|NCT01075763|39419869|FG001|Overall Study|Lost to Follow-up|1|||
16255357|NCT01075763|39419868|FG000|Overall Study|Lack of Efficacy|0|||
16255358|NCT01075763|39419869|FG001|Overall Study|Lack of Efficacy|1|||
16255359|NCT01075763|39419868|FG000|Overall Study|Withdrawal by Subject|2|||
16255360|NCT01075763|39419869|FG001|Overall Study|Withdrawal by Subject|2|||
16255361|NCT01717976|39419870|FG000|Overall Study|Protocol Violation|0|||
16255362|NCT01717976|39419871|FG001|Overall Study|Protocol Violation|1|||
16255363|NCT01254409|39419872|FG000|Overall Study|Adverse Event|0|||
16255364|NCT01254409|39419873|FG001|Overall Study|Adverse Event|1|||
16255365|NCT01254409|39419874|FG002|Overall Study|Adverse Event|0|||
16255366|NCT01254409|39419875|FG003|Overall Study|Adverse Event|0|||
16255367|NCT03952039|39419876|FG000|Overall Study|Adverse Event|22|||
16255368|NCT03952039|39419877|FG001|Overall Study|Adverse Event|8|||
16255369|NCT03952039|39419876|FG000|Overall Study|Withdrawal by Participant|17|||
16255370|NCT03952039|39419877|FG001|Overall Study|Withdrawal by Participant|12|||
16255371|NCT03952039|39419876|FG000|Overall Study|Death|13|||
16255372|NCT03952039|39419877|FG001|Overall Study|Death|6|||
16255373|NCT03952039|39419876|FG000|Overall Study|Lack of Efficacy|12|||
16255374|NCT03952039|39419877|FG001|Overall Study|Lack of Efficacy|2|||
16255375|NCT03952039|39419876|FG000|Overall Study|Physician Decision|9|||
16255376|NCT03952039|39419877|FG001|Overall Study|Physician Decision|3|||
16255377|NCT03952039|39419876|FG000|Overall Study|Progressive Disease|6|||
16255378|NCT03952039|39419877|FG001|Overall Study|Progressive Disease|4|||
16255379|NCT03952039|39419876|FG000|Overall Study|Other Reasons|12|||
16363901|NCT00557466|39818097|FG000|Overall Study|Administrative problems|0|||
16363902|NCT00557466|39818098|FG001|Overall Study|Administrative problems|1|||
16363903|NCT00557466|39818099|FG002|Overall Study|Administrative problems|1|||
16438229|NCT01601535|40082151|FG004|Phase 2|Adverse Event|5|||
16438230|NCT01601535|40082152|FG005|Phase 2|Adverse Event|1|||
16363904|NCT00557466|39818100|FG003|Overall Study|Administrative problems|0|||
16438231|NCT01601535|40082147|FG000|Phase 2|Withdrawal by Subject|0|||
16438232|NCT01601535|40082148|FG001|Phase 2|Withdrawal by Subject|0|||
16363905|NCT00557466|39818101|FG004|Overall Study|Administrative problems|0|||
16363906|NCT00557466|39818102|FG005|Overall Study|Administrative problems|0|||
16363907|NCT00557466|39818097|FG000|Overall Study|Abnormal test procedure results|0|||
16363908|NCT00557466|39818098|FG001|Overall Study|Abnormal test procedure results|0|||
16363909|NCT00557466|39818099|FG002|Overall Study|Abnormal test procedure results|1|||
16363910|NCT00557466|39818100|FG003|Overall Study|Abnormal test procedure results|0|||
16363911|NCT00557466|39818101|FG004|Overall Study|Abnormal test procedure results|0|||
16363912|NCT00557466|39818102|FG005|Overall Study|Abnormal test procedure results|0|||
16363913|NCT00557466|39818097|FG000|Overall Study|Lost to Follow-up|0|||
16363914|NCT00557466|39818098|FG001|Overall Study|Lost to Follow-up|0|||
16363915|NCT00557466|39818099|FG002|Overall Study|Lost to Follow-up|0|||
16363916|NCT00557466|39818100|FG003|Overall Study|Lost to Follow-up|1|||
16363917|NCT00557466|39818101|FG004|Overall Study|Lost to Follow-up|0|||
16255380|NCT03952039|39419877|FG001|Overall Study|Other Reasons|4|||
16363918|NCT00557466|39818102|FG005|Overall Study|Lost to Follow-up|0|||
16438233|NCT01601535|40082149|FG002|Phase 2|Withdrawal by Subject|0|||
16438234|NCT01601535|40082150|FG003|Phase 2|Withdrawal by Subject|0|||
16255381|NCT02576509|39419878|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
16255382|NCT02576509|39419879|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
16255383|NCT02576509|39419878|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
16255384|NCT02576509|39419879|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
16255385|NCT02576509|39419878|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
16255386|NCT02576509|39419879|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
16255387|NCT02576509|39419878|FG000|Treatment Period|Disease progression|245|||
16255388|NCT02576509|39419879|FG001|Treatment Period|Disease progression|240|||
16255389|NCT02576509|39419878|FG000|Treatment Period|Study drug toxicity|32|||
16255390|NCT02576509|39419879|FG001|Treatment Period|Study drug toxicity|41|||
16255391|NCT02576509|39419878|FG000|Treatment Period|Death|1|||
16255392|NCT02576509|39419879|FG001|Treatment Period|Death|1|||
16255393|NCT02576509|39419878|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
16255394|NCT02576509|39419879|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
16255395|NCT02576509|39419878|FG000|Treatment Period|Participant request to stop treatment|8|||
16363919|NCT02239328|39818103|FG000|Overall Study|Benign disease noted at time of surgery|6|||
16363920|NCT02239328|39818103|FG000|Overall Study|Equipment or website malfunction|2|||
16438235|NCT01601535|40082151|FG004|Phase 2|Withdrawal by Subject|8|||
16363921|NCT01202591|39818106|FG000|Overall Study|Adverse Event|2|||
16363922|NCT01202591|39818107|FG001|Overall Study|Adverse Event|1|||
16363923|NCT01202591|39818108|FG002|Overall Study|Adverse Event|4|||
16363924|NCT01202591|39818109|FG003|Overall Study|Adverse Event|4|||
16363925|NCT01202591|39818110|FG004|Overall Study|Adverse Event|0|||
16363926|NCT01202591|39818111|FG005|Overall Study|Adverse Event|0|||
16363927|NCT01202591|39818106|FG000|Overall Study|Other reason as per investigator|3|||
16363928|NCT01202591|39818107|FG001|Overall Study|Other reason as per investigator|4|||
16363929|NCT01202591|39818108|FG002|Overall Study|Other reason as per investigator|7|||
16363930|NCT01202591|39818109|FG003|Overall Study|Other reason as per investigator|3|||
16363931|NCT01202591|39818110|FG004|Overall Study|Other reason as per investigator|1|||
16363932|NCT01202591|39818111|FG005|Overall Study|Other reason as per investigator|3|||
16363933|NCT01202591|39818106|FG000|Overall Study|Withdrawal by Subject|0|||
16438236|NCT01601535|40082152|FG005|Phase 2|Withdrawal by Subject|2|||
16438237|NCT01601535|40082147|FG000|Phase 2|Progressive Disease|0|||
16438238|NCT01601535|40082148|FG001|Phase 2|Progressive Disease|0|||
16438239|NCT01601535|40082149|FG002|Phase 2|Progressive Disease|0|||
16438240|NCT01601535|40082150|FG003|Phase 2|Progressive Disease|0|||
16438241|NCT01601535|40082151|FG004|Phase 2|Progressive Disease|5|||
16438242|NCT01601535|40082152|FG005|Phase 2|Progressive Disease|7|||
16438243|NCT01601535|40082147|FG000|Phase 2|Started Another Treatment|0|||
16438244|NCT01601535|40082148|FG001|Phase 2|Started Another Treatment|0|||
16438245|NCT01601535|40082149|FG002|Phase 2|Started Another Treatment|0|||
16438246|NCT01601535|40082150|FG003|Phase 2|Started Another Treatment|0|||
16438247|NCT01601535|40082151|FG004|Phase 2|Started Another Treatment|1|||
16438248|NCT01601535|40082152|FG005|Phase 2|Started Another Treatment|2|||
16438249|NCT00855959|40082153|FG000|Overall Study|Adverse Event|2|||
16438250|NCT00855959|40082153|FG000|Overall Study|Lost to Follow-up|2|||
16438251|NCT00855959|40082153|FG000|Overall Study|Withdrawal by Subject|3|||
16438252|NCT00855959|40082153|FG000|Overall Study|Pregnancy|1|||
16438253|NCT00855959|40082153|FG000|Overall Study|Incorrect enrolment|1|||
16438254|NCT01600885|40082154|FG000|First Period|Adverse Event|1|||
16438255|NCT01600885|40082155|FG001|First Period|Adverse Event|1|||
16438256|NCT01600885|40082154|FG000|First Period|moved out of area|1|||
16438257|NCT01600885|40082155|FG001|First Period|moved out of area|0|||
16438258|NCT03212326|40082156|FG000|Overall Study|Physician Decision|4|||
16438259|NCT00953667|40082157|FG000|Overall Study|Lost to Follow-up|11|||
16438260|NCT00953667|40082157|FG000|Overall Study|Physician Decision|35|||
16438261|NCT00953667|40082157|FG000|Overall Study|Withdrawal by Subject|63|||
16438262|NCT00953667|40082157|FG000|Overall Study|Adverse Event|10|||
16438263|NCT00953667|40082157|FG000|Overall Study|poor venous access,unable to draw blood|4|||
16438264|NCT00981149|40082161|FG000|Overall Study|Lost to Follow-up|1|||
16438265|NCT00981149|40082162|FG001|Overall Study|Lost to Follow-up|2|||
16438266|NCT00981149|40082161|FG000|Overall Study|Withdrawal by Subject|1|||
16438267|NCT00981149|40082162|FG001|Overall Study|Withdrawal by Subject|1|||
16438268|NCT00443040|40082163|FG000|Overall Study|Withdrawal by Subject|1|||
16438269|NCT00443040|40082164|FG001|Overall Study|Withdrawal by Subject|0|||
16438270|NCT00443040|40082165|FG002|Overall Study|Withdrawal by Subject|0|||
16438271|NCT00443040|40082163|FG000|Overall Study|Converted to an open laparotomy|3|||
16438272|NCT00443040|40082164|FG001|Overall Study|Converted to an open laparotomy|0|||
16438273|NCT00443040|40082165|FG002|Overall Study|Converted to an open laparotomy|1|||
16438274|NCT00231777|40082166|FG000|Overall Study|Lost to Follow-up|3|||
16438275|NCT00231777|40082167|FG001|Overall Study|Lost to Follow-up|0|||
16438276|NCT00231777|40082166|FG000|Overall Study|Other|3|||
16438277|NCT00231777|40082167|FG001|Overall Study|Other|2|||
16438278|NCT01611792|40082168|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
16438279|NCT01611792|40082169|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
16438280|NCT01611792|40082168|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
16438281|NCT01611792|40082169|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
16438282|NCT00112736|40082174|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
16438283|NCT00112736|40082175|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
16363934|NCT01202591|39818107|FG001|Overall Study|Withdrawal by Subject|0|||
16438284|NCT01069484|40082176|FG000|Overall Study|Death-in-near-family|1|||
16438285|NCT01069484|40082177|FG001|Overall Study|Death-in-near-family|0|||
16438286|NCT01069484|40082176|FG000|Overall Study|No specific reason|8|||
16438287|NCT01069484|40082177|FG001|Overall Study|No specific reason|2|||
16438288|NCT01069484|40082176|FG000|Overall Study|Illness mother or child|3|||
16438289|NCT01069484|40082177|FG001|Overall Study|Illness mother or child|1|||
16438290|NCT01172535|40082178|FG000|Overall Study|Death|3|||
16438291|NCT01172535|40082178|FG000|Overall Study|Withdrawal by Subject|2|||
16438292|NCT01172535|40082178|FG000|Overall Study|Lost to Follow-up|1|||
16438293|NCT01172535|40082178|FG000|Overall Study|Ineligible at study entry|1|||
16438294|NCT01172535|40082178|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
16363935|NCT01202591|39818108|FG002|Overall Study|Withdrawal by Subject|0|||
16438295|NCT04191616|40082184|FG000|Overall Study|Death|26|||
16438296|NCT04191616|40082184|FG000|Overall Study|Withdrawal by Subject|1|||
16438297|NCT04191616|40082184|FG000|Overall Study|Sponsor decision|2|||
16438298|NCT04191616|40082184|FG000|Overall Study|Continuing study|25|||
16438299|NCT00770653|40082185|FG000|Overall Study|Adverse Event|13|||
16438300|NCT00770653|40082186|FG001|Overall Study|Adverse Event|5|||
16438301|NCT00770653|40082185|FG000|Overall Study|Protocol Violation|8|||
16438302|NCT00770653|40082186|FG001|Overall Study|Protocol Violation|6|||
16438303|NCT00770653|40082185|FG000|Overall Study|Withdrawal by Subject|4|||
16438304|NCT00770653|40082186|FG001|Overall Study|Withdrawal by Subject|7|||
16438305|NCT00770653|40082185|FG000|Overall Study|Lack of Compliance|1|||
16438306|NCT00770653|40082186|FG001|Overall Study|Lack of Compliance|4|||
16438307|NCT00770653|40082185|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
16438308|NCT00770653|40082186|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
16438309|NCT00770653|40082185|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
16438310|NCT00770653|40082186|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
16438311|NCT00770653|40082185|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
16438312|NCT00770653|40082186|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
16438313|NCT00770653|40082185|FG000|Overall Study|Lost to Follow-up|1|||
16438314|NCT00770653|40082186|FG001|Overall Study|Lost to Follow-up|2|||
16438315|NCT00770653|40082185|FG000|Overall Study|Physician Decision|1|||
16438316|NCT00770653|40082186|FG001|Overall Study|Physician Decision|0|||
16438317|NCT03600909|40082187|FG000|Overall Study|Not treated|0|||
16438318|NCT03600909|40082188|FG001|Overall Study|Not treated|3|||
16438319|NCT03600909|40082189|FG002|Overall Study|Not treated|0|||
16438320|NCT04366349|40082192|FG000|Overall Study|Withdrawal by Subject|1|||
16438321|NCT04366349|40082193|FG001|Overall Study|Withdrawal by Subject|0|||
16438322|NCT04366349|40082194|FG002|Overall Study|Withdrawal by Subject|0|||
16438323|NCT04366349|40082195|FG003|Overall Study|Withdrawal by Subject|0|||
16438324|NCT04366349|40082196|FG004|Overall Study|Withdrawal by Subject|0|||
16438325|NCT04366349|40082197|FG005|Overall Study|Withdrawal by Subject|0|||
16438326|NCT01045460|40082199|FG000|Overall Study|Physician Decision|3|||
16438327|NCT01045460|40082200|FG001|Overall Study|Physician Decision|2|||
16438328|NCT01045460|40082199|FG000|Overall Study|Lost to Follow-up|0|||
16438329|NCT01045460|40082200|FG001|Overall Study|Lost to Follow-up|1|||
16438330|NCT01045460|40082199|FG000|Overall Study|Lack of Efficacy|3|||
16438331|NCT01045460|40082200|FG001|Overall Study|Lack of Efficacy|0|||
16438332|NCT01089504|40082201|FG000|Overall Study|Lost to Follow-up|1|||
16438333|NCT01089504|40082202|FG001|Overall Study|Lost to Follow-up|1|||
16438334|NCT01089504|40082201|FG000|Overall Study|Withdrawal by Subject|2|||
16438335|NCT01089504|40082202|FG001|Overall Study|Withdrawal by Subject|0|||
16438336|NCT00388349|40082206|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
16438337|NCT00388349|40082207|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
16438338|NCT01419769|40082209|FG000|Overall Study|Did not receive the AXIOS stent|3|||
16438339|NCT01419769|40082209|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
16438340|NCT03790111|40082213|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
16438341|NCT00292942|40082214|FG000|Overall Study|Withdrawal by Subject|0|||
16438342|NCT00292942|40082215|FG001|Overall Study|Withdrawal by Subject|0|||
16438343|NCT00292942|40082216|FG002|Overall Study|Withdrawal by Subject|1|||
16438344|NCT00292942|40082217|FG003|Overall Study|Withdrawal by Subject|0|||
16438345|NCT00292942|40082214|FG000|Overall Study|Adverse Event|0|||
16438346|NCT00292942|40082215|FG001|Overall Study|Adverse Event|0|||
16438347|NCT00292942|40082216|FG002|Overall Study|Adverse Event|0|||
16438348|NCT00292942|40082217|FG003|Overall Study|Adverse Event|1|||
16438349|NCT02559622|40082218|FG000|Overall Study|Progressive disease|0|||
16438350|NCT02559622|40082219|FG001|Overall Study|Progressive disease|1|||
16438351|NCT02559622|40082220|FG002|Overall Study|Progressive disease|0|||
16438352|NCT02559622|40082221|FG003|Overall Study|Progressive disease|0|||
16438353|NCT02559622|40082218|FG000|Overall Study|Adverse Event|0|||
16438354|NCT02559622|40082219|FG001|Overall Study|Adverse Event|2|||
16438355|NCT02559622|40082220|FG002|Overall Study|Adverse Event|2|||
16438356|NCT02559622|40082221|FG003|Overall Study|Adverse Event|2|||
16438357|NCT02559622|40082218|FG000|Overall Study|Patient/guardian decision|1|||
16438358|NCT02559622|40082219|FG001|Overall Study|Patient/guardian decision|2|||
16438359|NCT02559622|40082220|FG002|Overall Study|Patient/guardian decision|0|||
16438360|NCT02559622|40082221|FG003|Overall Study|Patient/guardian decision|1|||
16438361|NCT00988598|40082229|FG000|Overall Study|Withdrawal by Subject|2|||
16438362|NCT00988598|40082230|FG001|Overall Study|Withdrawal by Subject|0|||
16438363|NCT02813889|40082231|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
16438364|NCT02813889|40082232|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
16438365|NCT01582061|40082233|FG000|Overall Study|Lack of Efficacy|3|||
16438366|NCT01582061|40082234|FG001|Overall Study|Lack of Efficacy|23|||
16438367|NCT01582061|40082233|FG000|Overall Study|Adverse Event|12|||
16438368|NCT01582061|40082234|FG001|Overall Study|Adverse Event|8|||
16438369|NCT01582061|40082233|FG000|Overall Study|Withdrawal by Subject|10|||
16438370|NCT01582061|40082234|FG001|Overall Study|Withdrawal by Subject|4|||
16438371|NCT01582061|40082233|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16438372|NCT01582061|40082234|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16438373|NCT01582061|40082233|FG000|Overall Study|Death|0|||
16438374|NCT01582061|40082234|FG001|Overall Study|Death|1|||
16438375|NCT01582061|40082233|FG000|Overall Study|condition no longer requires study drug|1|||
16438376|NCT01582061|40082234|FG001|Overall Study|condition no longer requires study drug|0|||
16438377|NCT01582061|40082233|FG000|Overall Study|Lost to Follow-up|1|||
16438378|NCT01582061|40082234|FG001|Overall Study|Lost to Follow-up|0|||
16438379|NCT00168844|40082235|FG000|Overall Study|Adverse Event|31|||
16438380|NCT00168844|40082236|FG001|Overall Study|Adverse Event|32|||
16438381|NCT00168844|40082237|FG002|Overall Study|Adverse Event|48|||
16438382|NCT00168844|40082235|FG000|Overall Study|Lost to Follow-up|4|||
16438383|NCT00168844|40082236|FG001|Overall Study|Lost to Follow-up|5|||
16438384|NCT00168844|40082237|FG002|Overall Study|Lost to Follow-up|11|||
16438385|NCT00168844|40082235|FG000|Overall Study|Withdrawal by Subject|12|||
16438386|NCT00168844|40082236|FG001|Overall Study|Withdrawal by Subject|9|||
16438387|NCT00168844|40082237|FG002|Overall Study|Withdrawal by Subject|19|||
16438388|NCT00168844|40082235|FG000|Overall Study|Protocol Violation|2|||
16438389|NCT00168844|40082236|FG001|Overall Study|Protocol Violation|2|||
16438390|NCT00168844|40082237|FG002|Overall Study|Protocol Violation|4|||
16140519|NCT01717768|39003785|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16140520|NCT01717768|39003786|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16140521|NCT01717768|39003787|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16140522|NCT01717768|39003788|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16140523|NCT01717768|39003789|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
16140524|NCT01717768|39003790|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
16140525|NCT01717768|39003779|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16140526|NCT01717768|39003780|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16140527|NCT01717768|39003781|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16140528|NCT01717768|39003782|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16140529|NCT01717768|39003783|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16140530|NCT01717768|39003784|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16140531|NCT01717768|39003785|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16140532|NCT01717768|39003786|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
16140533|NCT01717768|39003787|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16140534|NCT01717768|39003788|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16438391|NCT00168844|40082235|FG000|Overall Study|Other|6|||
16438392|NCT00168844|40082236|FG001|Overall Study|Other|7|||
16140535|NCT01717768|39003789|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16140536|NCT01717768|39003790|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
16140537|NCT01717768|39003779|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16140538|NCT01717768|39003780|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16140539|NCT01717768|39003781|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16363936|NCT01202591|39818109|FG003|Overall Study|Withdrawal by Subject|0|||
16363937|NCT01202591|39818110|FG004|Overall Study|Withdrawal by Subject|2|||
16363938|NCT01202591|39818111|FG005|Overall Study|Withdrawal by Subject|1|||
16363939|NCT01202591|39818106|FG000|Overall Study|Objective Disease Progression|0|||
16363940|NCT01202591|39818107|FG001|Overall Study|Objective Disease Progression|0|||
16363941|NCT01202591|39818108|FG002|Overall Study|Objective Disease Progression|0|||
16363942|NCT01202591|39818109|FG003|Overall Study|Objective Disease Progression|0|||
16363943|NCT01202591|39818110|FG004|Overall Study|Objective Disease Progression|2|||
16363944|NCT01202591|39818111|FG005|Overall Study|Objective Disease Progression|0|||
16363945|NCT01898078|39818112|FG000|Overall Study|Progressive Disease|1|||
16140540|NCT01717768|39003782|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16140541|NCT01717768|39003783|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16140542|NCT01717768|39003784|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16140543|NCT01717768|39003785|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16140544|NCT01717768|39003786|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16140545|NCT01717768|39003787|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16140546|NCT01717768|39003788|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
16140547|NCT01717768|39003789|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16140548|NCT01717768|39003790|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
16140549|NCT01103245|39003791|FG000|Overall Study|Withdrawal by Subject|1|||
16140550|NCT01103245|39003792|FG001|Overall Study|Withdrawal by Subject|0|||
16140551|NCT01103245|39003793|FG002|Overall Study|Withdrawal by Subject|3|||
16140552|NCT01103245|39003794|FG003|Overall Study|Withdrawal by Subject|0|||
16140553|NCT01103245|39003791|FG000|Overall Study|Inadequate IV access|1|||
16140554|NCT01103245|39003792|FG001|Overall Study|Inadequate IV access|0|||
16363946|NCT01898078|39818113|FG001|Overall Study|Progressive Disease|5|||
16363947|NCT01898078|39818112|FG000|Overall Study|Adverse Event|2|||
16363948|NCT01898078|39818113|FG001|Overall Study|Adverse Event|1|||
16363949|NCT01898078|39818112|FG000|Overall Study|Withdrawal by Subject|1|||
16363950|NCT01898078|39818113|FG001|Overall Study|Withdrawal by Subject|1|||
16363951|NCT01898078|39818112|FG000|Overall Study|Symptomatic Deterioration|2|||
16363952|NCT01898078|39818113|FG001|Overall Study|Symptomatic Deterioration|0|||
16438393|NCT00168844|40082237|FG002|Overall Study|Other|9|||
16438394|NCT02872116|40082238|FG000|Pre-Treatment|Disease Progression|0|||
16438395|NCT02872116|40082239|FG001|Pre-Treatment|Disease Progression|1|||
16438396|NCT02872116|40082240|FG002|Pre-Treatment|Disease Progression|0|||
16363953|NCT01898078|39818112|FG000|Overall Study|Reason not Specified|0|||
16363954|NCT01898078|39818113|FG001|Overall Study|Reason not Specified|1|||
16438397|NCT02872116|40082238|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
16438398|NCT02872116|40082239|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
16438399|NCT02872116|40082240|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
16438400|NCT02872116|40082238|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
16438401|NCT02872116|40082239|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
16363955|NCT02347787|39818117|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
16363956|NCT02347787|39818118|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
16363957|NCT02347787|39818117|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
16363958|NCT02347787|39818118|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
16363959|NCT02347787|39818117|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
16363960|NCT02347787|39818118|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
16363961|NCT02347787|39818117|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
16363962|NCT02347787|39818118|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
16363963|NCT02378181|39818121|FG000|Overall Study|Lost to Follow-up|2|||
16363964|NCT02378181|39818122|FG001|Overall Study|Lost to Follow-up|5|||
16363965|NCT02378181|39818121|FG000|Overall Study|Withdrawal by Subject|1|||
16363966|NCT02378181|39818122|FG001|Overall Study|Withdrawal by Subject|1|||
16363967|NCT02378181|39818121|FG000|Overall Study|Incarcerated|0|||
16363968|NCT02378181|39818122|FG001|Overall Study|Incarcerated|1|||
16363969|NCT00593814|39818123|FG000|Overall Study|Death|7|||
16363970|NCT00593814|39818124|FG001|Overall Study|Death|0|||
16363971|NCT00593814|39818123|FG000|Overall Study|Withdrawal by Subject|7|||
16140555|NCT01103245|39003793|FG002|Overall Study|Inadequate IV access|0|||
16255396|NCT02576509|39419879|FG001|Treatment Period|Participant request to stop treatment|17|||
16438402|NCT02872116|40082240|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
16438403|NCT02872116|40082238|FG000|Pre-Treatment|Participant withdrew consent|2|||
16438404|NCT02872116|40082239|FG001|Pre-Treatment|Participant withdrew consent|20|||
16438405|NCT02872116|40082240|FG002|Pre-Treatment|Participant withdrew consent|3|||
16438406|NCT02872116|40082238|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
16438407|NCT02872116|40082239|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
16438408|NCT02872116|40082240|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
16438409|NCT02872116|40082238|FG000|Pre-Treatment|Other reasons|1|||
16438410|NCT02872116|40082239|FG001|Pre-Treatment|Other reasons|2|||
16438411|NCT02872116|40082240|FG002|Pre-Treatment|Other reasons|2|||
16438412|NCT02872116|40082238|FG000|Treatment|Death|122|||
16438413|NCT02872116|40082239|FG001|Treatment|Death|94|||
16438414|NCT02872116|40082240|FG002|Treatment|Death|68|||
16438415|NCT02872116|40082238|FG000|Treatment|Lost to Follow-up|5|||
16438416|NCT02872116|40082239|FG001|Treatment|Lost to Follow-up|7|||
16438417|NCT02872116|40082240|FG002|Treatment|Lost to Follow-up|3|||
16438418|NCT02872116|40082238|FG000|Treatment|Participant withdrew consent|20|||
16438419|NCT02872116|40082239|FG001|Treatment|Participant withdrew consent|40|||
16438420|NCT02872116|40082240|FG002|Treatment|Participant withdrew consent|8|||
16438421|NCT02872116|40082238|FG000|Treatment|Other reasons|12|||
16140556|NCT01103245|39003794|FG003|Overall Study|Inadequate IV access|0|||
16438422|NCT02872116|40082239|FG001|Treatment|Other reasons|12|||
16438423|NCT02872116|40082240|FG002|Treatment|Other reasons|5|||
16438424|NCT01539759|40082243|FG000|Overall Study|Lost to Follow-up|6|||
16438425|NCT01539759|40082244|FG001|Overall Study|Lost to Follow-up|8|||
16438426|NCT00383786|40082252|FG000|Overall Study|Protocol Violation|2|||
16438427|NCT00383786|40082253|FG001|Overall Study|Protocol Violation|6|||
16438428|NCT00383786|40082252|FG000|Overall Study|Withdrawal by Subject|2|||
16438429|NCT00383786|40082253|FG001|Overall Study|Withdrawal by Subject|5|||
16438430|NCT00383786|40082252|FG000|Overall Study|Physician Decision|0|||
16438431|NCT00383786|40082253|FG001|Overall Study|Physician Decision|1|||
16438432|NCT01169103|40085231|FG000|Overall Study|Lost to Follow-up|3|||
16438433|NCT01169103|40085232|FG001|Overall Study|Lost to Follow-up|3|||
16438434|NCT01169103|40085231|FG000|Overall Study|Withdrawal by Subject|3|||
16438435|NCT01169103|40085232|FG001|Overall Study|Withdrawal by Subject|1|||
16438436|NCT00918281|40085233|FG000|Overall Study|Physician Decision|29|||
16438437|NCT01045967|40085234|FG000|Second Intervention|Protocol Violation|0|||
16438438|NCT01045967|40085235|FG001|Second Intervention|Protocol Violation|1|||
16438439|NCT00837434|40085237|FG000|Overall Study|Physician Decision|3|||
16438440|NCT00837434|40085238|FG001|Overall Study|Physician Decision|0|||
16438441|NCT00837434|40085237|FG000|Overall Study|Lost to Follow-up|1|||
16438442|NCT00837434|40085238|FG001|Overall Study|Lost to Follow-up|1|||
16438443|NCT00837434|40085237|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
16438444|NCT00837434|40085238|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
16438445|NCT00837434|40085237|FG000|Overall Study|Noncompliant|2|||
16438446|NCT00837434|40085238|FG001|Overall Study|Noncompliant|0|||
16438447|NCT00837434|40085237|FG000|Overall Study|Baseline assessments not done in time|1|||
16438448|NCT00837434|40085238|FG001|Overall Study|Baseline assessments not done in time|0|||
16438449|NCT00837434|40085237|FG000|Overall Study|Unable to obtain study drug|1|||
16438450|NCT00837434|40085238|FG001|Overall Study|Unable to obtain study drug|0|||
16438451|NCT02051764|40085239|FG000|Overall Study|Study terminated by sponsor|0|||
16438452|NCT02051764|40085240|FG001|Overall Study|Study terminated by sponsor|7|||
16438453|NCT01517750|40085246|FG000|Overall Study|Lost to Follow-up|1|||
16438454|NCT01517750|40085247|FG001|Overall Study|Lost to Follow-up|2|||
16438455|NCT01517750|40085248|FG002|Overall Study|Lost to Follow-up|4|||
16438456|NCT01517750|40085249|FG003|Overall Study|Lost to Follow-up|1|||
16438457|NCT02656017|40085250|FG000|Overall Study|Study burden|3|||
16438458|NCT02656017|40085251|FG001|Overall Study|Study burden|3|||
16438459|NCT02656017|40085250|FG000|Overall Study|Adverse Event|2|||
16438460|NCT02656017|40085251|FG001|Overall Study|Adverse Event|1|||
16438461|NCT02656017|40085250|FG000|Overall Study|Unable/unwilling to take study medication|2|||
16438462|NCT02656017|40085251|FG001|Overall Study|Unable/unwilling to take study medication|1|||
16438463|NCT02656017|40085250|FG000|Overall Study|Began Tolvaptan|1|||
16438464|NCT02656017|40085251|FG001|Overall Study|Began Tolvaptan|1|||
16438465|NCT02656017|40085250|FG000|Overall Study|Withdrawal by Subject|1|||
16438466|NCT02656017|40085251|FG001|Overall Study|Withdrawal by Subject|0|||
16438467|NCT03253679|40085252|FG000|Overall Study|Screen Failure|1|||
16438468|NCT04233801|40085253|FG000|Overall Study|Other than listed|0|||
16438469|NCT04233801|40085254|FG001|Overall Study|Other than listed|0|||
16438470|NCT04233801|40085255|FG002|Overall Study|Other than listed|1|||
16438471|NCT04233801|40085253|FG000|Overall Study|Withdrawal by Subject|0|||
16438472|NCT04233801|40085254|FG001|Overall Study|Withdrawal by Subject|2|||
16438473|NCT04233801|40085255|FG002|Overall Study|Withdrawal by Subject|3|||
16438474|NCT00771914|40085256|FG000|Overall Study|Physician Decision|0|||
16438475|NCT00771914|40085257|FG001|Overall Study|Physician Decision|0|||
16438476|NCT00771914|40085258|FG002|Overall Study|Physician Decision|0|||
16438477|NCT00771914|40085259|FG003|Overall Study|Physician Decision|1|||
16438478|NCT00771914|40085256|FG000|Overall Study|Lost to Follow-up|0|||
16438479|NCT00771914|40085257|FG001|Overall Study|Lost to Follow-up|0|||
16438480|NCT00771914|40085258|FG002|Overall Study|Lost to Follow-up|0|||
16438481|NCT00771914|40085259|FG003|Overall Study|Lost to Follow-up|1|||
16438482|NCT00374140|40085260|FG000|Overall Study|Lost to Follow-up|1|||
16438483|NCT00374140|40085260|FG000|Overall Study|Protocol Violation|1|||
16438484|NCT00894803|40085269|FG000|Overall Study|Death|20|||
16438485|NCT00894803|40085270|FG001|Overall Study|Death|4|||
16438486|NCT00894803|40085269|FG000|Overall Study|Lost to Follow-up|0|||
16438487|NCT00894803|40085270|FG001|Overall Study|Lost to Follow-up|1|||
16438488|NCT03363841|40085272|FG000|Overall Study|Adverse Event|1|||
16438489|NCT03363841|40085272|FG000|Overall Study|Withdrawal by Subject|1|||
16438490|NCT03363841|40085272|FG000|Overall Study|Death|7|||
16438491|NCT03363841|40085272|FG000|Overall Study|Physician Decision|1|||
16438492|NCT00870740|40085284|FG000|Overall Study|Adverse Event|2|||
16438493|NCT00870740|40085285|FG001|Overall Study|Adverse Event|1|||
16438494|NCT00870740|40085286|FG002|Overall Study|Adverse Event|3|||
16438495|NCT00870740|40085287|FG003|Overall Study|Adverse Event|2|||
16438496|NCT00870740|40085288|FG004|Overall Study|Adverse Event|1|||
16438497|NCT00870740|40085289|FG005|Overall Study|Adverse Event|6|||
16438498|NCT00870740|40085284|FG000|Overall Study|Consent Withdrawn|6|||
16438499|NCT00870740|40085285|FG001|Overall Study|Consent Withdrawn|3|||
16438500|NCT00870740|40085286|FG002|Overall Study|Consent Withdrawn|4|||
16438501|NCT00870740|40085287|FG003|Overall Study|Consent Withdrawn|6|||
16438502|NCT00870740|40085288|FG004|Overall Study|Consent Withdrawn|6|||
16438503|NCT00870740|40085289|FG005|Overall Study|Consent Withdrawn|5|||
16438504|NCT00870740|40085284|FG000|Overall Study|Investigator Decision|2|||
16438505|NCT00870740|40085285|FG001|Overall Study|Investigator Decision|0|||
16438506|NCT00870740|40085286|FG002|Overall Study|Investigator Decision|1|||
16438507|NCT00870740|40085287|FG003|Overall Study|Investigator Decision|0|||
16438508|NCT00870740|40085288|FG004|Overall Study|Investigator Decision|0|||
16438509|NCT00870740|40085289|FG005|Overall Study|Investigator Decision|0|||
16438510|NCT00870740|40085284|FG000|Overall Study|Subject Non-compliance|0|||
16438511|NCT00870740|40085285|FG001|Overall Study|Subject Non-compliance|0|||
16438512|NCT00870740|40085286|FG002|Overall Study|Subject Non-compliance|0|||
16438513|NCT00870740|40085287|FG003|Overall Study|Subject Non-compliance|0|||
16438514|NCT00870740|40085288|FG004|Overall Study|Subject Non-compliance|0|||
16438515|NCT00870740|40085289|FG005|Overall Study|Subject Non-compliance|1|||
16438516|NCT00870740|40085284|FG000|Overall Study|Death|0|||
16438517|NCT00870740|40085285|FG001|Overall Study|Death|0|||
16438518|NCT00870740|40085286|FG002|Overall Study|Death|0|||
16438519|NCT00870740|40085287|FG003|Overall Study|Death|0|||
16438520|NCT00870740|40085288|FG004|Overall Study|Death|1|||
16438521|NCT00870740|40085289|FG005|Overall Study|Death|0|||
16438522|NCT00870740|40085284|FG000|Overall Study|Other|2|||
16363972|NCT00593814|39818124|FG001|Overall Study|Withdrawal by Subject|0|||
16363973|NCT00593814|39818123|FG000|Overall Study|Lost to Follow-up|7|||
16363974|NCT00593814|39818124|FG001|Overall Study|Lost to Follow-up|0|||
16363975|NCT00593814|39818123|FG000|Overall Study|Physician Decision|3|||
16363976|NCT00593814|39818124|FG001|Overall Study|Physician Decision|0|||
16363977|NCT01500096|39818125|FG000|Overall Study|Lost to Follow-up|1|||
16363978|NCT01500096|39818126|FG001|Overall Study|Lost to Follow-up|0|||
16363979|NCT01500096|39818127|FG002|Overall Study|Lost to Follow-up|0|||
16363980|NCT01500096|39818128|FG003|Overall Study|Lost to Follow-up|2|||
16363981|NCT01301092|39818130|FG000|Overall Study|Lost to Follow-up|0|||
16363982|NCT01301092|39818131|FG001|Overall Study|Lost to Follow-up|0|||
16363983|NCT01301092|39818132|FG002|Overall Study|Lost to Follow-up|1|||
16363984|NCT02714153|39818133|FG000|Overall Study|Death|1|||
16363985|NCT01348269|39818134|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
16363986|NCT01348269|39818135|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
16363987|NCT01348269|39818134|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
16363988|NCT01348269|39818135|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
16363989|NCT01348269|39818134|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
16363990|NCT01348269|39818135|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
16363991|NCT01177410|39818136|FG000|Overall Study|Adverse Event|0|||
16363992|NCT01177410|39818137|FG001|Overall Study|Adverse Event|2|||
16363993|NCT01177410|39818138|FG002|Overall Study|Adverse Event|2|||
16363994|NCT01177410|39818136|FG000|Overall Study|Withdrawal by Subject|1|||
16363995|NCT01177410|39818137|FG001|Overall Study|Withdrawal by Subject|4|||
16363996|NCT01177410|39818138|FG002|Overall Study|Withdrawal by Subject|3|||
16363997|NCT01177410|39818136|FG000|Overall Study|Lost to Follow-up|0|||
16363998|NCT01177410|39818137|FG001|Overall Study|Lost to Follow-up|1|||
16363999|NCT01177410|39818138|FG002|Overall Study|Lost to Follow-up|0|||
16364000|NCT02469857|39818141|FG000|Overall Study|Death|24|||
16364001|NCT02469857|39818142|FG001|Overall Study|Death|29|||
16364002|NCT02469857|39818141|FG000|Overall Study|Discontinuation|1|||
16364003|NCT02469857|39818142|FG001|Overall Study|Discontinuation|3|||
16364004|NCT00002874|39818154|FG000|Overall Study|Withdrawal by Subject|1|||
16364005|NCT00002874|39818155|FG001|Overall Study|Withdrawal by Subject|1|||
16364006|NCT00002874|39818154|FG000|Overall Study|Protocol Violation|44|||
16364007|NCT00002874|39818155|FG001|Overall Study|Protocol Violation|34|||
16364008|NCT02737618|39818160|FG000|Overall Study|Withdrawal by Subject|9|||
16438523|NCT00870740|40085285|FG001|Overall Study|Other|5|||
16438524|NCT00870740|40085286|FG002|Overall Study|Other|2|||
16438525|NCT00870740|40085287|FG003|Overall Study|Other|4|||
16438526|NCT00870740|40085288|FG004|Overall Study|Other|3|||
16438527|NCT00870740|40085289|FG005|Overall Study|Other|5|||
16438528|NCT01690052|40085290|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
16438529|NCT01690052|40085291|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
16438530|NCT01690143|40085292|FG000|Overall Study|Withdrawal by Subject|1|||
16438531|NCT01393158|40085293|FG000|Overall Study|Adverse Event|1|||
16438532|NCT01393158|40085294|FG001|Overall Study|Adverse Event|0|||
16438533|NCT03624881|40085305|FG000|Overall Study|Screen Failure|14|||
16438534|NCT03624881|40085306|FG001|Overall Study|Screen Failure|0|||
16438535|NCT03624881|40085305|FG000|Overall Study|No Catheter Inserted|6|||
16438536|NCT03624881|40085306|FG001|Overall Study|No Catheter Inserted|1|||
16364009|NCT01022580|39818161|FG000|Overall Study|Death|18|||
16364010|NCT01022580|39818162|FG001|Overall Study|Death|22|||
16364011|NCT00845182|39818163|FG000|Overall Study|Lost to Follow-up|3|||
16364012|NCT00845182|39818164|FG001|Overall Study|Lost to Follow-up|3|||
16364013|NCT00845182|39818165|FG002|Overall Study|Lost to Follow-up|4|||
16364014|NCT00845182|39818163|FG000|Overall Study|Adverse Event|0|||
16140557|NCT01103245|39003791|FG000|Overall Study|Adverse Event|0|||
16140558|NCT01103245|39003792|FG001|Overall Study|Adverse Event|2|||
16140559|NCT01103245|39003793|FG002|Overall Study|Adverse Event|1|||
16140560|NCT01103245|39003794|FG003|Overall Study|Adverse Event|0|||
16140561|NCT01103245|39003791|FG000|Overall Study|Physician Decision|1|||
16140562|NCT01103245|39003792|FG001|Overall Study|Physician Decision|0|||
16140563|NCT01103245|39003793|FG002|Overall Study|Physician Decision|0|||
16140564|NCT01103245|39003794|FG003|Overall Study|Physician Decision|0|||
16140565|NCT02540538|39003795|FG000|Overall Study|Pregnancy|0|||
16140566|NCT02540538|39003796|FG001|Overall Study|Pregnancy|1|||
16140567|NCT02540538|39003797|FG002|Overall Study|Pregnancy|0|||
16140568|NCT04042740|39003798|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
16140569|NCT04042740|39003798|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
16140570|NCT01770912|39003803|FG000|Overall Study|Lost to Follow-up|2|||
16140571|NCT01770912|39003804|FG001|Overall Study|Lost to Follow-up|0|||
16140572|NCT01130974|39003805|FG000|Overall Study|Protocol Violation|10|||
16140573|NCT01130974|39003806|FG001|Overall Study|Protocol Violation|10|||
16140574|NCT01130974|39003805|FG000|Overall Study|Withdrawal by Subject|0|||
16140575|NCT01130974|39003806|FG001|Overall Study|Withdrawal by Subject|1|||
16140576|NCT01130974|39003805|FG000|Overall Study|Ineligibility criteria|5|||
16140577|NCT01130974|39003806|FG001|Overall Study|Ineligibility criteria|2|||
16140578|NCT02678416|39003811|FG000|Part 1|Withdrawal by Subject|1|||
16140579|NCT02678416|39003811|FG000|Part 2|Adverse Event|2|||
16140580|NCT02678416|39003811|FG000|Part 2|Withdrawal by Subject|1|||
16140581|NCT02710136|39003812|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
16140582|NCT02710136|39003813|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
16364015|NCT00845182|39818164|FG001|Overall Study|Adverse Event|1|||
16364016|NCT00845182|39818165|FG002|Overall Study|Adverse Event|1|||
16364017|NCT00845182|39818163|FG000|Overall Study|Physician Decision|0|||
16364018|NCT00845182|39818164|FG001|Overall Study|Physician Decision|0|||
16364019|NCT00845182|39818165|FG002|Overall Study|Physician Decision|1|||
16364020|NCT04327271|39818166|FG000|Overall Study|Death|1|||
16364021|NCT04327271|39818167|FG001|Overall Study|Death|0|||
16364022|NCT04327271|39818166|FG000|Overall Study|Withdrawal by Subject|1|||
16364023|NCT04327271|39818167|FG001|Overall Study|Withdrawal by Subject|0|||
16364024|NCT04327271|39818166|FG000|Overall Study|randomization error (data capture)|4|||
16364025|NCT04327271|39818167|FG001|Overall Study|randomization error (data capture)|3|||
16364026|NCT01881425|39818169|FG000|Overall Study|Death|5|||
16364027|NCT01881425|39818170|FG001|Overall Study|Death|1|||
16364028|NCT01881425|39818169|FG000|Overall Study|Withdrawal by Subject|8|||
16364029|NCT01881425|39818170|FG001|Overall Study|Withdrawal by Subject|3|||
16364030|NCT01881425|39818169|FG000|Overall Study|Physician Decision|2|||
16364031|NCT01881425|39818170|FG001|Overall Study|Physician Decision|1|||
16364032|NCT01881425|39818169|FG000|Overall Study|Adverse Event|3|||
16364033|NCT01881425|39818170|FG001|Overall Study|Adverse Event|0|||
16364034|NCT01881425|39818169|FG000|Overall Study|General Anesthesia panic attack|0|||
16364035|NCT01881425|39818170|FG001|Overall Study|General Anesthesia panic attack|1|||
16364036|NCT01881425|39818169|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
16364037|NCT01881425|39818170|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
16364038|NCT01881425|39818169|FG000|Overall Study|Lost to Follow-up|7|||
16364039|NCT01881425|39818170|FG001|Overall Study|Lost to Follow-up|2|||
16364040|NCT01348698|39818175|FG000|Overall Study|Does not meet lesion size criteria|1|||
16364041|NCT01348698|39818175|FG000|Overall Study|Death|3|||
16364042|NCT01348698|39818175|FG000|Overall Study|PI decision to close study|68|||
16438537|NCT03624881|40085305|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
16438538|NCT03624881|40085306|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
16140583|NCT03876171|39003814|FG000|Overall Study|Withdrawal by Subject|3|||
16140584|NCT03876171|39003815|FG001|Overall Study|Withdrawal by Subject|3|||
16140585|NCT03876171|39003814|FG000|Overall Study|Re-arrest|0|||
16140586|NCT03876171|39003815|FG001|Overall Study|Re-arrest|4|||
16438539|NCT03624881|40085305|FG000|Overall Study|Death|2|||
16438540|NCT03624881|40085306|FG001|Overall Study|Death|0|||
16438541|NCT03624881|40085305|FG000|Overall Study|Lost to Follow-up|10|||
16438542|NCT03624881|40085306|FG001|Overall Study|Lost to Follow-up|4|||
16438543|NCT03624881|40085305|FG000|Overall Study|Withdrawal by Subject|12|||
16438544|NCT03624881|40085306|FG001|Overall Study|Withdrawal by Subject|1|||
16438545|NCT00865345|40085320|FG000|Overall Study|Withdrawal by Subject|2|||
16438546|NCT03811340|40085326|FG000|Overall Study|subjects did not complete the survey.|90|||
16438547|NCT02234843|40085347|FG000|Overall Study|Death|1|||
16438548|NCT02234843|40085348|FG001|Overall Study|Death|0|||
16438549|NCT02234843|40085349|FG002|Overall Study|Death|0|||
16438550|NCT02234843|40085350|FG003|Overall Study|Death|0|||
16438551|NCT02234843|40085351|FG004|Overall Study|Death|0|||
16438552|NCT02234843|40085352|FG005|Overall Study|Death|0|||
16438553|NCT02234843|40085353|FG006|Overall Study|Death|0|||
16438554|NCT02234843|40085354|FG007|Overall Study|Death|0|||
16438555|NCT02234843|40085355|FG008|Overall Study|Death|0|||
16438556|NCT02234843|40085356|FG009|Overall Study|Death|0|||
16438557|NCT02234843|40085347|FG000|Overall Study|Protocol Violation|1|||
16438558|NCT02234843|40085348|FG001|Overall Study|Protocol Violation|0|||
16438559|NCT02234843|40085349|FG002|Overall Study|Protocol Violation|1|||
16438560|NCT02234843|40085350|FG003|Overall Study|Protocol Violation|0|||
16438561|NCT02234843|40085351|FG004|Overall Study|Protocol Violation|0|||
16438562|NCT02234843|40085352|FG005|Overall Study|Protocol Violation|0|||
16438563|NCT02234843|40085353|FG006|Overall Study|Protocol Violation|0|||
16438564|NCT02234843|40085354|FG007|Overall Study|Protocol Violation|0|||
16438565|NCT02234843|40085355|FG008|Overall Study|Protocol Violation|0|||
16438566|NCT02234843|40085356|FG009|Overall Study|Protocol Violation|0|||
16438567|NCT02234843|40085347|FG000|Overall Study|Efficacy outcome reached|2|||
16438568|NCT02234843|40085348|FG001|Overall Study|Efficacy outcome reached|0|||
16438569|NCT02234843|40085349|FG002|Overall Study|Efficacy outcome reached|0|||
16438570|NCT02234843|40085350|FG003|Overall Study|Efficacy outcome reached|0|||
16438571|NCT02234843|40085351|FG004|Overall Study|Efficacy outcome reached|0|||
16438572|NCT02234843|40085352|FG005|Overall Study|Efficacy outcome reached|2|||
16438573|NCT02234843|40085353|FG006|Overall Study|Efficacy outcome reached|0|||
16438574|NCT02234843|40085354|FG007|Overall Study|Efficacy outcome reached|0|||
16438575|NCT02234843|40085355|FG008|Overall Study|Efficacy outcome reached|0|||
16438576|NCT02234843|40085356|FG009|Overall Study|Efficacy outcome reached|0|||
16438577|NCT02234843|40085347|FG000|Overall Study|Patient convenience|2|||
16438578|NCT02234843|40085348|FG001|Overall Study|Patient convenience|0|||
16438579|NCT02234843|40085349|FG002|Overall Study|Patient convenience|0|||
16438580|NCT02234843|40085350|FG003|Overall Study|Patient convenience|0|||
16438581|NCT02234843|40085351|FG004|Overall Study|Patient convenience|0|||
16438582|NCT02234843|40085352|FG005|Overall Study|Patient convenience|1|||
16438583|NCT02234843|40085353|FG006|Overall Study|Patient convenience|0|||
16438584|NCT02234843|40085354|FG007|Overall Study|Patient convenience|0|||
16438585|NCT02234843|40085355|FG008|Overall Study|Patient convenience|0|||
16438586|NCT02234843|40085356|FG009|Overall Study|Patient convenience|0|||
16438587|NCT02234843|40085347|FG000|Overall Study|Withdrawal by Subject|5|||
16438588|NCT02234843|40085348|FG001|Overall Study|Withdrawal by Subject|1|||
16438589|NCT02234843|40085349|FG002|Overall Study|Withdrawal by Subject|1|||
16438590|NCT02234843|40085350|FG003|Overall Study|Withdrawal by Subject|0|||
16438591|NCT02234843|40085351|FG004|Overall Study|Withdrawal by Subject|0|||
16438592|NCT02234843|40085352|FG005|Overall Study|Withdrawal by Subject|7|||
16438593|NCT02234843|40085353|FG006|Overall Study|Withdrawal by Subject|0|||
16438594|NCT02234843|40085354|FG007|Overall Study|Withdrawal by Subject|0|||
16438595|NCT02234843|40085355|FG008|Overall Study|Withdrawal by Subject|0|||
16438596|NCT02234843|40085356|FG009|Overall Study|Withdrawal by Subject|0|||
16438597|NCT02234843|40085347|FG000|Overall Study|Recovery|1|||
16438598|NCT02234843|40085348|FG001|Overall Study|Recovery|0|||
16438599|NCT02234843|40085349|FG002|Overall Study|Recovery|0|||
16438600|NCT02234843|40085350|FG003|Overall Study|Recovery|0|||
16438601|NCT02234843|40085351|FG004|Overall Study|Recovery|0|||
16438602|NCT02234843|40085352|FG005|Overall Study|Recovery|0|||
16438603|NCT02234843|40085353|FG006|Overall Study|Recovery|0|||
16438604|NCT02234843|40085354|FG007|Overall Study|Recovery|0|||
16438605|NCT02234843|40085355|FG008|Overall Study|Recovery|0|||
16438606|NCT02234843|40085356|FG009|Overall Study|Recovery|0|||
16438607|NCT02234843|40085347|FG000|Overall Study|Other|0|||
16438608|NCT02234843|40085348|FG001|Overall Study|Other|2|||
16438609|NCT02234843|40085349|FG002|Overall Study|Other|0|||
16438610|NCT02234843|40085350|FG003|Overall Study|Other|1|||
16438611|NCT02234843|40085351|FG004|Overall Study|Other|0|||
16438612|NCT02234843|40085352|FG005|Overall Study|Other|1|||
16438613|NCT02234843|40085353|FG006|Overall Study|Other|0|||
16438614|NCT02234843|40085354|FG007|Overall Study|Other|1|||
16438615|NCT02234843|40085355|FG008|Overall Study|Other|0|||
16438616|NCT02234843|40085356|FG009|Overall Study|Other|0|||
16438617|NCT02234843|40085347|FG000|Overall Study|Physician Decision|4|||
16438618|NCT02234843|40085348|FG001|Overall Study|Physician Decision|1|||
16438619|NCT02234843|40085349|FG002|Overall Study|Physician Decision|0|||
16438620|NCT02234843|40085350|FG003|Overall Study|Physician Decision|1|||
16438621|NCT02234843|40085351|FG004|Overall Study|Physician Decision|0|||
16438622|NCT02234843|40085352|FG005|Overall Study|Physician Decision|0|||
16438623|NCT02234843|40085353|FG006|Overall Study|Physician Decision|0|||
16438624|NCT02234843|40085354|FG007|Overall Study|Physician Decision|1|||
16438625|NCT02234843|40085355|FG008|Overall Study|Physician Decision|0|||
16438626|NCT02234843|40085356|FG009|Overall Study|Physician Decision|0|||
16438627|NCT02234843|40085347|FG000|Overall Study|Adverse Event|5|||
16438628|NCT02234843|40085348|FG001|Overall Study|Adverse Event|1|||
16438629|NCT02234843|40085349|FG002|Overall Study|Adverse Event|1|||
16438630|NCT02234843|40085350|FG003|Overall Study|Adverse Event|3|||
16438631|NCT02234843|40085351|FG004|Overall Study|Adverse Event|2|||
16438632|NCT02234843|40085352|FG005|Overall Study|Adverse Event|1|||
16438633|NCT02234843|40085353|FG006|Overall Study|Adverse Event|0|||
16438634|NCT02234843|40085354|FG007|Overall Study|Adverse Event|0|||
16438635|NCT02234843|40085355|FG008|Overall Study|Adverse Event|1|||
16438636|NCT02234843|40085356|FG009|Overall Study|Adverse Event|0|||
16438637|NCT02234843|40085347|FG000|Overall Study|Non-compliance with study drug|1|||
16438638|NCT02234843|40085348|FG001|Overall Study|Non-compliance with study drug|0|||
16438639|NCT02234843|40085349|FG002|Overall Study|Non-compliance with study drug|0|||
16438640|NCT02234843|40085350|FG003|Overall Study|Non-compliance with study drug|0|||
16140587|NCT03037619|39003817|FG000|Overall Study|Lost to Follow-up|0|||
16140588|NCT03037619|39003818|FG001|Overall Study|Lost to Follow-up|1|||
16140589|NCT00059839|39003819|FG000|Overall Study|Death|1|||
16140590|NCT00059839|39003820|FG001|Overall Study|Death|1|||
16140591|NCT00059839|39003819|FG000|Overall Study|Lack of Efficacy|6|||
16140592|NCT00059839|39003820|FG001|Overall Study|Lack of Efficacy|5|||
16140593|NCT00059839|39003819|FG000|Overall Study|Lost to Follow-up|2|||
16140594|NCT00059839|39003820|FG001|Overall Study|Lost to Follow-up|0|||
16140595|NCT00059839|39003819|FG000|Overall Study|Physician Decision|1|||
16140596|NCT00059839|39003820|FG001|Overall Study|Physician Decision|2|||
16140597|NCT00059839|39003819|FG000|Overall Study|Withdrawal by Subject|1|||
16140598|NCT00059839|39003820|FG001|Overall Study|Withdrawal by Subject|6|||
16140599|NCT00059839|39003819|FG000|Overall Study|Ineligible|1|||
16140600|NCT00059839|39003820|FG001|Overall Study|Ineligible|3|||
16140601|NCT01436071|39003821|FG000|Overall Study|Adverse Event|1|||
16140602|NCT01436071|39003822|FG001|Overall Study|Adverse Event|0|||
16140603|NCT01436071|39003821|FG000|Overall Study|Lack of Efficacy|16|||
16140604|NCT01436071|39003822|FG001|Overall Study|Lack of Efficacy|7|||
16438641|NCT02234843|40085351|FG004|Overall Study|Non-compliance with study drug|0|||
16438642|NCT02234843|40085352|FG005|Overall Study|Non-compliance with study drug|1|||
16438643|NCT02234843|40085353|FG006|Overall Study|Non-compliance with study drug|1|||
16140605|NCT01436071|39003821|FG000|Overall Study|Protocol Violation|0|||
16438644|NCT02234843|40085354|FG007|Overall Study|Non-compliance with study drug|0|||
16438645|NCT02234843|40085355|FG008|Overall Study|Non-compliance with study drug|0|||
16438646|NCT02234843|40085356|FG009|Overall Study|Non-compliance with study drug|0|||
16438647|NCT02234843|40085347|FG000|Overall Study|Lost to Follow-up|0|||
16438648|NCT02234843|40085348|FG001|Overall Study|Lost to Follow-up|1|||
16438649|NCT02234843|40085349|FG002|Overall Study|Lost to Follow-up|0|||
16438650|NCT02234843|40085350|FG003|Overall Study|Lost to Follow-up|0|||
16438651|NCT02234843|40085351|FG004|Overall Study|Lost to Follow-up|0|||
16140606|NCT01436071|39003822|FG001|Overall Study|Protocol Violation|1|||
16438652|NCT02234843|40085352|FG005|Overall Study|Lost to Follow-up|0|||
16438653|NCT02234843|40085353|FG006|Overall Study|Lost to Follow-up|1|||
16140607|NCT01436071|39003821|FG000|Overall Study|Lost to Follow-up|3|||
16140608|NCT01436071|39003822|FG001|Overall Study|Lost to Follow-up|1|||
16140609|NCT01436071|39003821|FG000|Overall Study|Physician Decision|1|||
16140610|NCT01436071|39003822|FG001|Overall Study|Physician Decision|0|||
16140611|NCT01436071|39003821|FG000|Overall Study|Withdrawal by Subject|2|||
16140612|NCT01436071|39003822|FG001|Overall Study|Withdrawal by Subject|2|||
16140613|NCT01436071|39003821|FG000|Overall Study|Did Not Receive Trial Medication|3|||
16140614|NCT01436071|39003822|FG001|Overall Study|Did Not Receive Trial Medication|3|||
16140615|NCT02129205|39003823|FG000|Overall Study|Withdrawal by Subject|0|||
16140616|NCT02129205|39003824|FG001|Overall Study|Withdrawal by Subject|0|||
16140617|NCT02129205|39003825|FG002|Overall Study|Withdrawal by Subject|0|||
16140618|NCT02129205|39003826|FG003|Overall Study|Withdrawal by Subject|0|||
16140619|NCT02129205|39003827|FG004|Overall Study|Withdrawal by Subject|1|||
16140620|NCT02129205|39003828|FG005|Overall Study|Withdrawal by Subject|1|||
16140621|NCT02129205|39003829|FG006|Overall Study|Withdrawal by Subject|1|||
16140622|NCT02129205|39003830|FG007|Overall Study|Withdrawal by Subject|0|||
16140623|NCT02129205|39003831|FG008|Overall Study|Withdrawal by Subject|1|||
16140624|NCT02129205|39003832|FG009|Overall Study|Withdrawal by Subject|0|||
16140625|NCT02129205|39003823|FG000|Overall Study|Other|1|||
16140626|NCT02129205|39003824|FG001|Overall Study|Other|0|||
16140627|NCT02129205|39003825|FG002|Overall Study|Other|0|||
16140628|NCT02129205|39003826|FG003|Overall Study|Other|0|||
16140629|NCT02129205|39003827|FG004|Overall Study|Other|2|||
16140630|NCT02129205|39003828|FG005|Overall Study|Other|3|||
16140631|NCT02129205|39003829|FG006|Overall Study|Other|3|||
16140632|NCT02129205|39003830|FG007|Overall Study|Other|2|||
16140633|NCT02129205|39003831|FG008|Overall Study|Other|1|||
16140634|NCT02129205|39003832|FG009|Overall Study|Other|0|||
16140635|NCT02060383|39003833|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
16140636|NCT02060383|39003834|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
16140637|NCT02060383|39003835|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
16140638|NCT02060383|39003836|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
16140639|NCT02060383|39003837|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
16140640|NCT02060383|39003833|FG000|Core Phase|Adverse Event|2|||
16140641|NCT02060383|39003834|FG001|Core Phase|Adverse Event|0|||
16140642|NCT02060383|39003835|FG002|Core Phase|Adverse Event|0|||
16140643|NCT02060383|39003836|FG003|Core Phase|Adverse Event|2|||
16140644|NCT02060383|39003837|FG004|Core Phase|Adverse Event|6|||
16140645|NCT02060383|39003833|FG000|Core Phase|Administrative problems|0|||
16140646|NCT02060383|39003834|FG001|Core Phase|Administrative problems|1|||
16140647|NCT02060383|39003835|FG002|Core Phase|Administrative problems|0|||
16140648|NCT02060383|39003836|FG003|Core Phase|Administrative problems|0|||
16140649|NCT02060383|39003837|FG004|Core Phase|Administrative problems|0|||
16140650|NCT02060383|39003833|FG000|Core Phase|Protocol Violation|0|||
16140651|NCT02060383|39003834|FG001|Core Phase|Protocol Violation|0|||
16140652|NCT02060383|39003835|FG002|Core Phase|Protocol Violation|0|||
16140653|NCT02060383|39003836|FG003|Core Phase|Protocol Violation|1|||
16140654|NCT02060383|39003837|FG004|Core Phase|Protocol Violation|0|||
16140655|NCT02060383|39003833|FG000|Core Phase|Withdrawal by Subject|0|||
16140656|NCT02060383|39003834|FG001|Core Phase|Withdrawal by Subject|0|||
16140657|NCT02060383|39003835|FG002|Core Phase|Withdrawal by Subject|0|||
16140658|NCT02060383|39003836|FG003|Core Phase|Withdrawal by Subject|4|||
16140659|NCT02060383|39003837|FG004|Core Phase|Withdrawal by Subject|2|||
16140660|NCT02060383|39003833|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
16140661|NCT02060383|39003834|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
16140662|NCT02060383|39003835|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
16140663|NCT02060383|39003836|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
16140664|NCT02060383|39003837|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
16140665|NCT02060383|39003833|FG000|Extension Phase|Adverse Event|1|||
16140666|NCT02060383|39003834|FG001|Extension Phase|Adverse Event|1|||
16140667|NCT02060383|39003835|FG002|Extension Phase|Adverse Event|2|||
16140668|NCT02060383|39003836|FG003|Extension Phase|Adverse Event|0|||
16140669|NCT02060383|39003837|FG004|Extension Phase|Adverse Event|1|||
16140670|NCT02060383|39003833|FG000|Extension Phase|Withdrawal by Subject|0|||
16438654|NCT02234843|40085354|FG007|Overall Study|Lost to Follow-up|0|||
16140671|NCT02060383|39003834|FG001|Extension Phase|Withdrawal by Subject|1|||
16140672|NCT02060383|39003835|FG002|Extension Phase|Withdrawal by Subject|0|||
16140673|NCT02060383|39003836|FG003|Extension Phase|Withdrawal by Subject|0|||
16140674|NCT02060383|39003837|FG004|Extension Phase|Withdrawal by Subject|2|||
16140675|NCT02060383|39003833|FG000|Extension Phase|Administrative problems|1|||
16140676|NCT02060383|39003834|FG001|Extension Phase|Administrative problems|0|||
16140677|NCT02060383|39003835|FG002|Extension Phase|Administrative problems|0|||
16140678|NCT02060383|39003836|FG003|Extension Phase|Administrative problems|0|||
16140679|NCT02060383|39003837|FG004|Extension Phase|Administrative problems|0|||
16140680|NCT02060383|39003833|FG000|Extension Phase|Death|0|||
16140681|NCT02060383|39003834|FG001|Extension Phase|Death|0|||
16438655|NCT02234843|40085355|FG008|Overall Study|Lost to Follow-up|0|||
16140682|NCT02060383|39003835|FG002|Extension Phase|Death|1|||
16140683|NCT02060383|39003836|FG003|Extension Phase|Death|0|||
16140684|NCT02060383|39003837|FG004|Extension Phase|Death|1|||
16140685|NCT02060383|39003833|FG000|Extension Phase|Protocol Violation|0|||
16140686|NCT02060383|39003834|FG001|Extension Phase|Protocol Violation|0|||
16140687|NCT02060383|39003835|FG002|Extension Phase|Protocol Violation|0|||
16140688|NCT02060383|39003836|FG003|Extension Phase|Protocol Violation|0|||
16140689|NCT02060383|39003837|FG004|Extension Phase|Protocol Violation|1|||
16140690|NCT02366728|39003841|FG000|Overall Study|Death|0|||
16140691|NCT02366728|39003842|FG001|Overall Study|Death|0|||
16140692|NCT02366728|39003843|FG002|Overall Study|Death|1|||
16140693|NCT02366728|39003841|FG000|Overall Study|Adverse Event|1|||
16140694|NCT02366728|39003842|FG001|Overall Study|Adverse Event|0|||
16140695|NCT02366728|39003843|FG002|Overall Study|Adverse Event|0|||
16140696|NCT02366728|39003841|FG000|Overall Study|Screen Failure|2|||
16140697|NCT02366728|39003842|FG001|Overall Study|Screen Failure|1|||
16140698|NCT02366728|39003843|FG002|Overall Study|Screen Failure|0|||
16140699|NCT02366728|39003841|FG000|Overall Study|Only yielded 2 vaccines|1|||
16140700|NCT02366728|39003842|FG001|Overall Study|Only yielded 2 vaccines|0|||
16140701|NCT02366728|39003843|FG002|Overall Study|Only yielded 2 vaccines|0|||
16140702|NCT01009203|39003847|FG000|Overall Study|Withdrawal by Subject|1|||
16140703|NCT01009203|39003847|FG000|Overall Study|Adverse Event|5|||
16140704|NCT01009203|39003847|FG000|Overall Study|Treatment-unrelated death|1|||
16140705|NCT03236246|39003851|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
16140706|NCT03236246|39003852|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
16140707|NCT03236246|39003851|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
16140708|NCT03236246|39003852|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
16140709|NCT03236246|39003851|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
16140710|NCT03236246|39003852|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
16140711|NCT03236246|39003851|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
16140712|NCT03236246|39003852|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
16140713|NCT03236246|39003851|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
16140714|NCT03236246|39003852|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
16140715|NCT03236246|39003851|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
16140716|NCT03236246|39003852|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
16140717|NCT03236246|39003851|FG000|24-Week Dose Titration Period|Death|3|||
16140718|NCT03236246|39003852|FG001|24-Week Dose Titration Period|Death|1|||
16140719|NCT03236246|39003851|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
16140720|NCT03236246|39003852|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
16140721|NCT03236246|39003851|FG000|24-Week Dose Titration Period|Adverse Event|7|||
16140722|NCT03236246|39003852|FG001|24-Week Dose Titration Period|Adverse Event|8|||
16140723|NCT03236246|39003851|FG000|24-Week Dose Titration Period|Captured as Other|1|||
16140724|NCT03236246|39003852|FG001|24-Week Dose Titration Period|Captured as Other|2|||
16140725|NCT03236246|39003851|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
16140726|NCT03236246|39003852|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
16140727|NCT03236246|39003851|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
16140728|NCT03236246|39003852|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
16140729|NCT03236246|39003851|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
16140730|NCT03236246|39003852|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
16140731|NCT03236246|39003851|FG000|24-Week Dose Maintenance Period|Death|0|||
16140732|NCT03236246|39003852|FG001|24-Week Dose Maintenance Period|Death|1|||
16140733|NCT03236246|39003851|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
16140734|NCT03236246|39003852|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
16140735|NCT00974090|39003853|FG000|Period 1: Double Blind Period|Adverse Event|2|||
16140736|NCT00974090|39003854|FG001|Period 1: Double Blind Period|Adverse Event|1|||
16140737|NCT00974090|39003853|FG000|Period 1: Double Blind Period|Physician Decision|1|||
16140738|NCT00974090|39003854|FG001|Period 1: Double Blind Period|Physician Decision|0|||
16140739|NCT00974090|39003853|FG000|Period 2: Open-label Period|Adverse Event|4|||
16140740|NCT00974090|39003854|FG001|Period 2: Open-label Period|Adverse Event|6|||
16140741|NCT00974090|39003853|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
16140742|NCT00974090|39003854|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
16364043|NCT00724893|39818176|FG000|Overall Study|Adverse Event|76|||
16140743|NCT00974090|39003853|FG000|Period 2: Open-label Period|Physician Decision|0|||
16140744|NCT00974090|39003854|FG001|Period 2: Open-label Period|Physician Decision|3|||
16140745|NCT00974090|39003853|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
16140746|NCT00974090|39003854|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
16140747|NCT01280812|39003855|FG000|Overall Study|Withdrawal by Subject|2|||
16140748|NCT01280812|39003856|FG001|Overall Study|Withdrawal by Subject|1|||
16140749|NCT01280812|39003857|FG002|Overall Study|Withdrawal by Subject|0|||
16140750|NCT01280812|39003855|FG000|Overall Study|Lost to Follow-up|1|||
16140751|NCT01280812|39003856|FG001|Overall Study|Lost to Follow-up|1|||
16140752|NCT01280812|39003857|FG002|Overall Study|Lost to Follow-up|1|||
16140753|NCT02545322|39003858|FG000|Overall Study|Withdrawal by Subject|3|||
16140754|NCT00999713|39003859|FG000|Overall Study|Physician Decision|2|||
16140755|NCT00999713|39003860|FG001|Overall Study|Physician Decision|0|||
16140756|NCT04209621|39003861|FG000|Overall Study|Death|1|||
16140757|NCT04209621|39003861|FG000|Overall Study|Study Terminated Early|2|||
16140758|NCT04142450|39003862|FG000|Overall Study|Screen Failure|1|||
16140759|NCT04142450|39003862|FG000|Overall Study|Lost to Follow-up|1|||
16140760|NCT00597753|39003863|FG000|Overall Study|Adverse Event|6|||
16140761|NCT00597753|39003864|FG001|Overall Study|Adverse Event|2|||
16140762|NCT00597753|39003863|FG000|Overall Study|Death|55|||
16140763|NCT00597753|39003864|FG001|Overall Study|Death|29|||
16140764|NCT00597753|39003863|FG000|Overall Study|Lack of Efficacy|2|||
16140765|NCT00597753|39003864|FG001|Overall Study|Lack of Efficacy|0|||
16140766|NCT00597753|39003863|FG000|Overall Study|Lost to Follow-up|10|||
16140767|NCT00597753|39003864|FG001|Overall Study|Lost to Follow-up|3|||
16140768|NCT00597753|39003863|FG000|Overall Study|Physician Decision|5|||
16140769|NCT00597753|39003864|FG001|Overall Study|Physician Decision|1|||
16255397|NCT02576509|39419878|FG000|Treatment Period|Participant withdrew consent|2|||
16255398|NCT02576509|39419879|FG001|Treatment Period|Participant withdrew consent|7|||
16255399|NCT02576509|39419878|FG000|Treatment Period|Lost to Follow-up|0|||
16255400|NCT02576509|39419879|FG001|Treatment Period|Lost to Follow-up|1|||
16255401|NCT02576509|39419878|FG000|Treatment Period|Maximum clinical benefit|1|||
16255402|NCT02576509|39419879|FG001|Treatment Period|Maximum clinical benefit|0|||
16255403|NCT02576509|39419878|FG000|Treatment Period|Poor/non-compliance|0|||
16255404|NCT02576509|39419879|FG001|Treatment Period|Poor/non-compliance|1|||
16255405|NCT02576509|39419878|FG000|Treatment Period|Participant no longer meets criteria|1|||
16255406|NCT02576509|39419879|FG001|Treatment Period|Participant no longer meets criteria|0|||
16255407|NCT02576509|39419878|FG000|Treatment Period|Other reason|2|||
16255408|NCT02576509|39419879|FG001|Treatment Period|Other reason|7|||
16255409|NCT02576509|39419878|FG000|Follow-up Period|Death|41|||
16255410|NCT02576509|39419879|FG001|Follow-up Period|Death|35|||
16438656|NCT02234843|40085356|FG009|Overall Study|Lost to Follow-up|0|||
16438657|NCT02735239|40085357|FG000|Overall Study|Adverse Event|0|||
16438658|NCT02735239|40085358|FG001|Overall Study|Adverse Event|0|||
16438659|NCT02735239|40085359|FG002|Overall Study|Adverse Event|4|||
16438660|NCT02735239|40085360|FG003|Overall Study|Adverse Event|0|||
16438661|NCT02735239|40085361|FG004|Overall Study|Adverse Event|0|||
16438662|NCT02735239|40085362|FG005|Overall Study|Adverse Event|0|||
16438663|NCT02735239|40085357|FG000|Overall Study|Death|1|||
16438664|NCT02735239|40085358|FG001|Overall Study|Death|1|||
16438665|NCT02735239|40085359|FG002|Overall Study|Death|0|||
16438666|NCT02735239|40085360|FG003|Overall Study|Death|0|||
16438667|NCT02735239|40085361|FG004|Overall Study|Death|0|||
16438668|NCT02735239|40085362|FG005|Overall Study|Death|0|||
16438669|NCT02735239|40085357|FG000|Overall Study|Physician Decision|0|||
16438670|NCT02735239|40085358|FG001|Overall Study|Physician Decision|0|||
16438671|NCT02735239|40085359|FG002|Overall Study|Physician Decision|1|||
16438672|NCT02735239|40085360|FG003|Overall Study|Physician Decision|0|||
16438673|NCT02735239|40085361|FG004|Overall Study|Physician Decision|0|||
16438674|NCT02735239|40085362|FG005|Overall Study|Physician Decision|0|||
16438675|NCT02735239|40085357|FG000|Overall Study|Progressive disease|3|||
16438676|NCT02735239|40085358|FG001|Overall Study|Progressive disease|1|||
16438677|NCT02735239|40085359|FG002|Overall Study|Progressive disease|3|||
16438678|NCT02735239|40085360|FG003|Overall Study|Progressive disease|0|||
16438679|NCT02735239|40085361|FG004|Overall Study|Progressive disease|0|||
16438680|NCT02735239|40085362|FG005|Overall Study|Progressive disease|2|||
16438681|NCT02735239|40085357|FG000|Overall Study|Withdrawal by Subject|0|||
16438682|NCT02735239|40085358|FG001|Overall Study|Withdrawal by Subject|1|||
16438683|NCT02735239|40085359|FG002|Overall Study|Withdrawal by Subject|0|||
16438684|NCT02735239|40085360|FG003|Overall Study|Withdrawal by Subject|0|||
16438685|NCT02735239|40085361|FG004|Overall Study|Withdrawal by Subject|0|||
16438686|NCT02735239|40085362|FG005|Overall Study|Withdrawal by Subject|0|||
16140770|NCT00597753|39003863|FG000|Overall Study|Pregnancy|1|||
16140771|NCT00597753|39003864|FG001|Overall Study|Pregnancy|0|||
16140772|NCT00597753|39003863|FG000|Overall Study|Withdrawal by Subject|35|||
16140773|NCT00597753|39003864|FG001|Overall Study|Withdrawal by Subject|12|||
16140774|NCT00597753|39003863|FG000|Overall Study|Discontinued Dialysis|0|||
16364044|NCT00724893|39818177|FG001|Overall Study|Adverse Event|142|||
16255411|NCT02576509|39419878|FG000|Follow-up Period|Participant withdrew consent|7|||
16364045|NCT00724893|39818176|FG000|Overall Study|Withdrawal by Subject|0|||
16364046|NCT00724893|39818177|FG001|Overall Study|Withdrawal by Subject|1|||
16364047|NCT00724893|39818176|FG000|Overall Study|Lack of virologic response|94|||
16364048|NCT00724893|39818177|FG001|Overall Study|Lack of virologic response|202|||
16364049|NCT00724893|39818176|FG000|Overall Study|Reason not specified|193|||
16364050|NCT00724893|39818177|FG001|Overall Study|Reason not specified|7|||
16364051|NCT00724893|39818176|FG000|Overall Study|Patient choice|0|||
16364052|NCT00724893|39818177|FG001|Overall Study|Patient choice|26|||
16364053|NCT00724893|39818176|FG000|Overall Study|Geographic reasons|0|||
16364054|NCT00724893|39818177|FG001|Overall Study|Geographic reasons|11|||
16364055|NCT00724893|39818176|FG000|Overall Study|Incarceration|0|||
16364056|NCT00724893|39818177|FG001|Overall Study|Incarceration|9|||
16364057|NCT00724893|39818176|FG000|Overall Study|Substance abuse|0|||
16438687|NCT03901144|40085366|FG000|Overall Study|Lost to Follow-up|1|||
16438688|NCT03901144|40085367|FG001|Overall Study|Lost to Follow-up|1|||
16438689|NCT03901144|40085368|FG002|Overall Study|Lost to Follow-up|1|||
16438690|NCT03901144|40085369|FG003|Overall Study|Lost to Follow-up|1|||
16438691|NCT01924845|40085370|FG000|Overall Study|Adverse Event|3|||
16438692|NCT01924845|40085370|FG000|Overall Study|Withdrawal by Subject|2|||
16438693|NCT01924845|40085370|FG000|Overall Study|Protocol Violation|1|||
16140775|NCT00597753|39003864|FG001|Overall Study|Discontinued Dialysis|1|||
16140776|NCT00597753|39003863|FG000|Overall Study|Never dosed|2|||
16140777|NCT00597753|39003864|FG001|Overall Study|Never dosed|0|||
16140778|NCT00597753|39003863|FG000|Overall Study|Noncompliance|2|||
16140779|NCT00597753|39003864|FG001|Overall Study|Noncompliance|1|||
16140780|NCT00597753|39003863|FG000|Overall Study|Relocation|17|||
16140781|NCT00597753|39003864|FG001|Overall Study|Relocation|6|||
16140782|NCT00597753|39003863|FG000|Overall Study|Renal transplant|10|||
16140783|NCT00597753|39003864|FG001|Overall Study|Renal transplant|3|||
16140784|NCT00597753|39003863|FG000|Overall Study|Site closed by sponsor|19|||
16140785|NCT00597753|39003864|FG001|Overall Study|Site closed by sponsor|7|||
16140786|NCT00597753|39003863|FG000|Overall Study|Site elected to close|2|||
16140787|NCT00597753|39003864|FG001|Overall Study|Site elected to close|4|||
16140788|NCT01840605|39003871|FG000|Overall Study|Adverse Event|0|||
16140789|NCT01840605|39003872|FG001|Overall Study|Adverse Event|1|||
16140790|NCT01840605|39003871|FG000|Overall Study|Physician Decision|2|||
16140791|NCT01840605|39003872|FG001|Overall Study|Physician Decision|1|||
16140792|NCT01446016|39003873|FG000|Overall Study|Lost to Follow-up|3|||
16140793|NCT01446016|39003873|FG000|Overall Study|Withdrawal by Subject|1|||
16140794|NCT01446016|39003873|FG000|Overall Study|Toxicity|3|||
16140795|NCT01117454|39003874|FG000|Overall Study|Pregnancy|0|||
16140796|NCT01117454|39003875|FG001|Overall Study|Pregnancy|1|||
16140797|NCT01323621|39003876|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
16140798|NCT01323621|39003877|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
16140799|NCT01323621|39003878|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
16140800|NCT01323621|39003876|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
16140801|NCT01323621|39003877|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
16140802|NCT01323621|39003878|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
16140803|NCT01323621|39003876|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
16140804|NCT01323621|39003877|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
16140805|NCT01323621|39003878|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
16140806|NCT01323621|39003876|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
16140807|NCT01323621|39003877|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
16140808|NCT01323621|39003878|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
16140809|NCT01323621|39003876|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
16140810|NCT01323621|39003877|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
16140811|NCT01323621|39003878|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
16140812|NCT01323621|39003876|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
16140813|NCT01323621|39003877|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
16140814|NCT01323621|39003878|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
16140815|NCT01323621|39003876|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
16140816|NCT01323621|39003877|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
16140817|NCT01323621|39003878|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
16140818|NCT01323621|39003876|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
16140819|NCT01323621|39003877|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
16140820|NCT01323621|39003878|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
16140821|NCT01323621|39003876|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
16140822|NCT01323621|39003877|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
16140823|NCT01323621|39003878|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
16140824|NCT01323621|39003876|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16140825|NCT01323621|39003877|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
16140826|NCT01323621|39003878|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16140827|NCT01323621|39003876|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
16140828|NCT01323621|39003877|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
16140829|NCT01323621|39003878|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
16140830|NCT01323621|39003876|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16140831|NCT01323621|39003877|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
16140832|NCT01323621|39003878|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
16438694|NCT00005780|40085371|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
16438695|NCT01308736|40085372|FG000|Overall Study|Did not attend a single session|6|||
16140833|NCT04195581|39003879|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
16140834|NCT04195581|39003879|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
16140835|NCT04195581|39003879|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
16255412|NCT02576509|39419879|FG001|Follow-up Period|Participant withdrew consent|14|||
16255413|NCT02576509|39419878|FG000|Follow-up Period|Lost to Follow-up|0|||
16255414|NCT02576509|39419879|FG001|Follow-up Period|Lost to Follow-up|1|||
16255415|NCT02576509|39419878|FG000|Follow-up Period|Other reason|1|||
16255416|NCT02576509|39419879|FG001|Follow-up Period|Other reason|2|||
16255417|NCT01937390|39419880|FG000|Overall Study|Death|2|||
16255418|NCT01937390|39419880|FG000|Overall Study|Lost to Follow-up|7|||
16255419|NCT01937390|39419880|FG000|Overall Study|Withdrawal by Subject|5|||
16364058|NCT00724893|39818177|FG001|Overall Study|Substance abuse|3|||
16364059|NCT00724893|39818176|FG000|Overall Study|Financial reasons|0|||
16364060|NCT00724893|39818177|FG001|Overall Study|Financial reasons|2|||
16140836|NCT04195581|39003879|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
16140837|NCT04195581|39003879|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
16140838|NCT04195581|39003879|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
16140839|NCT00791258|39003880|FG000|Overall Study|Adverse Event|87|||
16140840|NCT00791258|39003880|FG000|Overall Study|Lost to Follow-up|18|||
16140841|NCT00791258|39003880|FG000|Overall Study|Protocol Violation|109|||
16140842|NCT00791258|39003880|FG000|Overall Study|Withdrawal by Subject|40|||
16140843|NCT00791258|39003880|FG000|Overall Study|Did not take medication for >3 days|1|||
16140844|NCT00791258|39003880|FG000|Overall Study|subject left area|2|||
16140845|NCT00791258|39003880|FG000|Overall Study|non-compliance|3|||
16140846|NCT00791258|39003880|FG000|Overall Study|Subject incarcerated|1|||
16140847|NCT00791258|39003880|FG000|Overall Study|Subject required restricted medication|1|||
16140848|NCT00791258|39003880|FG000|Overall Study|Lack of Efficacy|1|||
16140849|NCT01968070|39003882|FG000|Period 1|Withdrawal by Subject|0|||
16140850|NCT01968070|39003883|FG001|Period 1|Withdrawal by Subject|1|||
16140851|NCT01968070|39003884|FG002|Period 1|Withdrawal by Subject|0|||
16140852|NCT01968070|39003885|FG003|Period 1|Withdrawal by Subject|0|||
16140853|NCT01968070|39003886|FG004|Period 1|Withdrawal by Subject|0|||
16140854|NCT01968070|39003887|FG005|Period 1|Withdrawal by Subject|0|||
16140855|NCT01968070|39003888|FG006|Period 1|Withdrawal by Subject|1|||
16140856|NCT01968070|39003889|FG007|Period 1|Withdrawal by Subject|0|||
16140857|NCT01968070|39003890|FG008|Period 1|Withdrawal by Subject|0|||
16140858|NCT01968070|39003891|FG009|Period 1|Withdrawal by Subject|0|||
16140859|NCT01968070|39003892|FG010|Period 1|Withdrawal by Subject|0|||
16140860|NCT01968070|39003893|FG011|Period 1|Withdrawal by Subject|0|||
16140861|NCT01968070|39003894|FG012|Period 1|Withdrawal by Subject|0|||
16140862|NCT01968070|39003895|FG013|Period 1|Withdrawal by Subject|0|||
16255420|NCT01937390|39419880|FG000|Overall Study|Fail to return|21|||
16364061|NCT00724893|39818176|FG000|Overall Study|Assigned shorter treatment|0|||
16364062|NCT00724893|39818177|FG001|Overall Study|Assigned shorter treatment|2|||
16364063|NCT00724893|39818176|FG000|Overall Study|Lost to Follow-up|0|||
16364064|NCT00724893|39818177|FG001|Overall Study|Lost to Follow-up|52|||
16364065|NCT00724893|39818176|FG000|Overall Study|Unknown, missing data|1|||
16364066|NCT00724893|39818177|FG001|Overall Study|Unknown, missing data|1|||
16364067|NCT02453048|39818178|FG000|Overall Study|Only part of initial 6 mo. study|0|||
16364068|NCT02453048|39818179|FG001|Overall Study|Only part of initial 6 mo. study|0|||
16364069|NCT02453048|39818180|FG002|Overall Study|Only part of initial 6 mo. study|0|||
16364070|NCT02453048|39818181|FG003|Overall Study|Only part of initial 6 mo. study|0|||
16364071|NCT02453048|39818182|FG004|Overall Study|Only part of initial 6 mo. study|6|||
16364072|NCT02453048|39818178|FG000|Overall Study|Lost to Follow-up|0|||
16140863|NCT01968070|39003896|FG014|Period 1|Withdrawal by Subject|0|||
16140864|NCT01968070|39003897|FG015|Period 1|Withdrawal by Subject|1|||
16140865|NCT01968070|39003898|FG016|Period 1|Withdrawal by Subject|0|||
16140866|NCT01968070|39003899|FG017|Period 1|Withdrawal by Subject|0|||
16140867|NCT01968070|39003882|FG000|Period 1|Protocol Violation|0|||
16255421|NCT01855126|39419881|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
16255422|NCT01855126|39419882|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
16255423|NCT01855126|39419881|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
16255424|NCT01855126|39419882|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
16255425|NCT02927847|39419883|FG000|Overall Study|Lost to Follow-up|1|||
16255426|NCT02927847|39419884|FG001|Overall Study|Lost to Follow-up|0|||
16255427|NCT02927847|39419883|FG000|Overall Study|Withdrawal by Subject|4|||
16255428|NCT02927847|39419884|FG001|Overall Study|Withdrawal by Subject|2|||
16255429|NCT02927847|39419883|FG000|Overall Study|PI withdrawn due to missed visits|1|||
16255430|NCT02927847|39419884|FG001|Overall Study|PI withdrawn due to missed visits|1|||
16255431|NCT00760266|39419885|FG000|Overall Study|Adverse Event|13|||
16255432|NCT00760266|39419886|FG001|Overall Study|Adverse Event|7|||
16255433|NCT00760266|39419885|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16255434|NCT00760266|39419886|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16255435|NCT00760266|39419885|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16255436|NCT00760266|39419886|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16255437|NCT00760266|39419885|FG000|Overall Study|Lack of Efficacy|2|||
16255438|NCT00760266|39419886|FG001|Overall Study|Lack of Efficacy|2|||
16255439|NCT00760266|39419885|FG000|Overall Study|Protocol deviation|2|||
16255440|NCT00760266|39419886|FG001|Overall Study|Protocol deviation|4|||
16255441|NCT00760266|39419885|FG000|Overall Study|Patient withdrew consent|3|||
16255442|NCT00760266|39419886|FG001|Overall Study|Patient withdrew consent|3|||
16255443|NCT00760266|39419885|FG000|Overall Study|Lost to Follow-up|2|||
16255444|NCT00760266|39419886|FG001|Overall Study|Lost to Follow-up|1|||
16255445|NCT00760266|39419885|FG000|Overall Study|Administrative Problems|0|||
16255446|NCT00760266|39419886|FG001|Overall Study|Administrative Problems|1|||
16255447|NCT00555009|39419894|FG000|Overall Study|Withdrawal by Subject|0|||
16255448|NCT00555009|39419895|FG001|Overall Study|Withdrawal by Subject|1|||
16255449|NCT00555009|39419894|FG000|Overall Study|Terminated by Sponsor|2|||
16255450|NCT00555009|39419895|FG001|Overall Study|Terminated by Sponsor|5|||
16255451|NCT03312530|39419896|FG000|Overall Study|Death|5|||
16255452|NCT03312530|39419897|FG001|Overall Study|Death|5|||
16255453|NCT03312530|39419898|FG002|Overall Study|Death|4|||
16255454|NCT03312530|39419899|FG003|Overall Study|Death|10|||
16255455|NCT03312530|39419900|FG004|Overall Study|Death|8|||
16255456|NCT03312530|39419896|FG000|Overall Study|Lost to Follow-up|0|||
16255457|NCT03312530|39419897|FG001|Overall Study|Lost to Follow-up|0|||
16255458|NCT03312530|39419898|FG002|Overall Study|Lost to Follow-up|0|||
16255459|NCT03312530|39419899|FG003|Overall Study|Lost to Follow-up|1|||
16255460|NCT03312530|39419900|FG004|Overall Study|Lost to Follow-up|0|||
16255461|NCT03312530|39419896|FG000|Overall Study|Participant in another sponsor study.|0|||
16255462|NCT03312530|39419897|FG001|Overall Study|Participant in another sponsor study.|0|||
16255463|NCT03312530|39419898|FG002|Overall Study|Participant in another sponsor study.|0|||
16255464|NCT03312530|39419899|FG003|Overall Study|Participant in another sponsor study.|1|||
16255465|NCT03312530|39419900|FG004|Overall Study|Participant in another sponsor study.|0|||
16255466|NCT03312530|39419896|FG000|Overall Study|Study terminated by sponsor|1|||
16255467|NCT03312530|39419897|FG001|Overall Study|Study terminated by sponsor|0|||
16255468|NCT03312530|39419898|FG002|Overall Study|Study terminated by sponsor|2|||
16255469|NCT03312530|39419899|FG003|Overall Study|Study terminated by sponsor|3|||
16255470|NCT03312530|39419900|FG004|Overall Study|Study terminated by sponsor|7|||
16255471|NCT03312530|39419896|FG000|Overall Study|Withdrawal by Subject|0|||
16255472|NCT03312530|39419897|FG001|Overall Study|Withdrawal by Subject|1|||
16255473|NCT03312530|39419898|FG002|Overall Study|Withdrawal by Subject|0|||
16255474|NCT03312530|39419899|FG003|Overall Study|Withdrawal by Subject|0|||
16255475|NCT03312530|39419900|FG004|Overall Study|Withdrawal by Subject|0|||
16255476|NCT03312530|39419896|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
16255477|NCT03312530|39419897|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
16255478|NCT03312530|39419898|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
16255479|NCT03312530|39419899|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
16255480|NCT03312530|39419900|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
16255481|NCT00796822|39419901|FG000|Overall Study|Lost to Follow-up|2|||
16255482|NCT00796822|39419902|FG001|Overall Study|Lost to Follow-up|0|||
16255483|NCT00796822|39419901|FG000|Overall Study|Adverse Event|1|||
16255484|NCT00796822|39419902|FG001|Overall Study|Adverse Event|0|||
16255485|NCT03049488|39419903|FG000|Overall Study|Lost to Follow-up|1|||
16255486|NCT03049488|39419904|FG001|Overall Study|Lost to Follow-up|1|||
16438696|NCT01308736|40085373|FG001|Overall Study|Did not attend a single session|5|||
16255487|NCT03049488|39419905|FG002|Overall Study|Lost to Follow-up|0|||
16255488|NCT03049488|39419906|FG003|Overall Study|Lost to Follow-up|0|||
16255489|NCT03049488|39419907|FG004|Overall Study|Lost to Follow-up|0|||
16438697|NCT04537793|40085374|FG000|Part B (24 Weeks)|Adverse Event|0|||
16140868|NCT01968070|39003883|FG001|Period 1|Protocol Violation|0|||
16140869|NCT01968070|39003884|FG002|Period 1|Protocol Violation|0|||
16140870|NCT01968070|39003885|FG003|Period 1|Protocol Violation|1|||
16140871|NCT01968070|39003886|FG004|Period 1|Protocol Violation|1|||
16140872|NCT01968070|39003887|FG005|Period 1|Protocol Violation|0|||
16140873|NCT01968070|39003888|FG006|Period 1|Protocol Violation|0|||
16140874|NCT01968070|39003889|FG007|Period 1|Protocol Violation|0|||
16140875|NCT01968070|39003890|FG008|Period 1|Protocol Violation|0|||
16140876|NCT01968070|39003891|FG009|Period 1|Protocol Violation|0|||
16140877|NCT01968070|39003892|FG010|Period 1|Protocol Violation|0|||
16140878|NCT01968070|39003893|FG011|Period 1|Protocol Violation|0|||
16140879|NCT01968070|39003894|FG012|Period 1|Protocol Violation|0|||
16140880|NCT01968070|39003895|FG013|Period 1|Protocol Violation|0|||
16140881|NCT01968070|39003896|FG014|Period 1|Protocol Violation|0|||
16140882|NCT01968070|39003897|FG015|Period 1|Protocol Violation|0|||
16140883|NCT01968070|39003898|FG016|Period 1|Protocol Violation|0|||
16140884|NCT01968070|39003899|FG017|Period 1|Protocol Violation|0|||
16140885|NCT01968070|39003882|FG000|Period 1|Lost to Follow-up|0|||
16140886|NCT01968070|39003883|FG001|Period 1|Lost to Follow-up|0|||
16140887|NCT01968070|39003884|FG002|Period 1|Lost to Follow-up|0|||
16140888|NCT01968070|39003885|FG003|Period 1|Lost to Follow-up|1|||
16140889|NCT01968070|39003886|FG004|Period 1|Lost to Follow-up|0|||
16140890|NCT01968070|39003887|FG005|Period 1|Lost to Follow-up|0|||
16140891|NCT01968070|39003888|FG006|Period 1|Lost to Follow-up|0|||
16140892|NCT01968070|39003889|FG007|Period 1|Lost to Follow-up|0|||
16140893|NCT01968070|39003890|FG008|Period 1|Lost to Follow-up|0|||
16140894|NCT01968070|39003891|FG009|Period 1|Lost to Follow-up|0|||
16140895|NCT01968070|39003892|FG010|Period 1|Lost to Follow-up|0|||
16140896|NCT01968070|39003893|FG011|Period 1|Lost to Follow-up|0|||
16140897|NCT01968070|39003894|FG012|Period 1|Lost to Follow-up|0|||
16140898|NCT01968070|39003895|FG013|Period 1|Lost to Follow-up|0|||
16140899|NCT01968070|39003896|FG014|Period 1|Lost to Follow-up|0|||
16140900|NCT01968070|39003897|FG015|Period 1|Lost to Follow-up|0|||
16140901|NCT01968070|39003898|FG016|Period 1|Lost to Follow-up|0|||
16140902|NCT01968070|39003899|FG017|Period 1|Lost to Follow-up|0|||
16140903|NCT01968070|39003882|FG000|Period 1|Adverse Event|0|||
16140904|NCT01968070|39003883|FG001|Period 1|Adverse Event|0|||
16140905|NCT01968070|39003884|FG002|Period 1|Adverse Event|0|||
16140906|NCT01968070|39003885|FG003|Period 1|Adverse Event|0|||
16140907|NCT01968070|39003886|FG004|Period 1|Adverse Event|0|||
16140908|NCT01968070|39003887|FG005|Period 1|Adverse Event|0|||
16140909|NCT01968070|39003888|FG006|Period 1|Adverse Event|1|||
16140910|NCT01968070|39003889|FG007|Period 1|Adverse Event|0|||
16140911|NCT01968070|39003890|FG008|Period 1|Adverse Event|0|||
16140912|NCT01968070|39003891|FG009|Period 1|Adverse Event|0|||
16140913|NCT01968070|39003892|FG010|Period 1|Adverse Event|0|||
16140914|NCT01968070|39003893|FG011|Period 1|Adverse Event|0|||
16140915|NCT01968070|39003894|FG012|Period 1|Adverse Event|0|||
16140916|NCT01968070|39003895|FG013|Period 1|Adverse Event|0|||
16140917|NCT01968070|39003896|FG014|Period 1|Adverse Event|0|||
16140918|NCT01968070|39003897|FG015|Period 1|Adverse Event|0|||
16140919|NCT01968070|39003898|FG016|Period 1|Adverse Event|0|||
16140920|NCT01968070|39003899|FG017|Period 1|Adverse Event|0|||
16140921|NCT01968070|39003882|FG000|Period 1|Physician Decision|0|||
16140922|NCT01968070|39003883|FG001|Period 1|Physician Decision|0|||
16140923|NCT01968070|39003884|FG002|Period 1|Physician Decision|0|||
16140924|NCT01968070|39003885|FG003|Period 1|Physician Decision|0|||
16140925|NCT01968070|39003886|FG004|Period 1|Physician Decision|0|||
16140926|NCT01968070|39003887|FG005|Period 1|Physician Decision|0|||
16140927|NCT01968070|39003888|FG006|Period 1|Physician Decision|0|||
16140928|NCT01968070|39003889|FG007|Period 1|Physician Decision|0|||
16140929|NCT01968070|39003890|FG008|Period 1|Physician Decision|0|||
16140930|NCT01968070|39003891|FG009|Period 1|Physician Decision|0|||
16140931|NCT01968070|39003892|FG010|Period 1|Physician Decision|0|||
16140932|NCT01968070|39003893|FG011|Period 1|Physician Decision|1|||
16140933|NCT01968070|39003894|FG012|Period 1|Physician Decision|0|||
16140934|NCT01968070|39003895|FG013|Period 1|Physician Decision|0|||
16140935|NCT01968070|39003896|FG014|Period 1|Physician Decision|0|||
16140936|NCT01968070|39003897|FG015|Period 1|Physician Decision|0|||
16140937|NCT01968070|39003898|FG016|Period 1|Physician Decision|0|||
16140938|NCT01968070|39003899|FG017|Period 1|Physician Decision|0|||
16140939|NCT01968070|39003882|FG000|Period 2|Withdrawal by Subject|0|||
16140940|NCT01968070|39003883|FG001|Period 2|Withdrawal by Subject|0|||
16140941|NCT01968070|39003884|FG002|Period 2|Withdrawal by Subject|0|||
16140942|NCT01968070|39003885|FG003|Period 2|Withdrawal by Subject|0|||
16140943|NCT01968070|39003886|FG004|Period 2|Withdrawal by Subject|1|||
16140944|NCT01968070|39003887|FG005|Period 2|Withdrawal by Subject|0|||
16140945|NCT01968070|39003888|FG006|Period 2|Withdrawal by Subject|0|||
16140946|NCT01968070|39003889|FG007|Period 2|Withdrawal by Subject|0|||
16140947|NCT01968070|39003890|FG008|Period 2|Withdrawal by Subject|0|||
16140948|NCT01968070|39003891|FG009|Period 2|Withdrawal by Subject|0|||
16140949|NCT01968070|39003892|FG010|Period 2|Withdrawal by Subject|0|||
16140950|NCT01968070|39003893|FG011|Period 2|Withdrawal by Subject|0|||
16140951|NCT01968070|39003894|FG012|Period 2|Withdrawal by Subject|0|||
16140952|NCT01968070|39003895|FG013|Period 2|Withdrawal by Subject|0|||
16438698|NCT04537793|40085375|FG001|Part B (24 Weeks)|Adverse Event|1|||
16140953|NCT01968070|39003896|FG014|Period 2|Withdrawal by Subject|0|||
16140954|NCT01968070|39003897|FG015|Period 2|Withdrawal by Subject|0|||
16140955|NCT01968070|39003898|FG016|Period 2|Withdrawal by Subject|0|||
16140956|NCT01968070|39003899|FG017|Period 2|Withdrawal by Subject|0|||
16140957|NCT00150969|39003900|FG000|24 Month Main Study|Adverse Event|3|||
16140958|NCT00150969|39003901|FG001|24 Month Main Study|Adverse Event|4|||
16140959|NCT00150969|39003900|FG000|24 Month Main Study|Death|1|||
16140960|NCT00150969|39003901|FG001|24 Month Main Study|Death|1|||
16140961|NCT00150969|39003900|FG000|24 Month Main Study|Lack of Efficacy|1|||
16140962|NCT00150969|39003901|FG001|24 Month Main Study|Lack of Efficacy|8|||
16140963|NCT00150969|39003900|FG000|24 Month Main Study|Lost to Follow-up|3|||
16140964|NCT00150969|39003901|FG001|24 Month Main Study|Lost to Follow-up|2|||
16140965|NCT00150969|39003900|FG000|24 Month Main Study|Protocol Violation|4|||
16140966|NCT00150969|39003901|FG001|24 Month Main Study|Protocol Violation|2|||
16140967|NCT00150969|39003900|FG000|24 Month Main Study|Withdrawal by Subject|7|||
16140968|NCT00150969|39003901|FG001|24 Month Main Study|Withdrawal by Subject|4|||
16140969|NCT00150969|39003900|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
16140970|NCT00150969|39003901|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
16140971|NCT00150969|39003900|FG000|24-48 Month Extension|Lack of Efficacy|0|||
16438699|NCT01323582|40085376|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
16438700|NCT01323582|40085377|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
16438701|NCT01323582|40085376|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
16438702|NCT01323582|40085377|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
16438703|NCT01323582|40085376|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
16438704|NCT01323582|40085377|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
16438705|NCT02525471|40085378|FG000|Overall Study|Screen Failure|6|||
16438706|NCT02525471|40085378|FG000|Overall Study|Withdrawal by Subject|4|||
16140972|NCT00150969|39003901|FG001|24-48 Month Extension|Lack of Efficacy|1|||
16140973|NCT00150969|39003900|FG000|24-48 Month Extension|Adverse Event|1|||
16140974|NCT00150969|39003901|FG001|24-48 Month Extension|Adverse Event|3|||
16140975|NCT00150969|39003900|FG000|24-48 Month Extension|Other Reason|81|||
16140976|NCT00150969|39003901|FG001|24-48 Month Extension|Other Reason|91|||
16140977|NCT00651157|39003903|FG000|Overall Study|Death|1|||
16140978|NCT00651157|39003903|FG000|Overall Study|Protocol Violation|1|||
16140979|NCT03085758|39003906|FG000|Overall Study|Death|26|||
16140980|NCT03085758|39003907|FG001|Overall Study|Death|24|||
16255490|NCT03049488|39419908|FG005|Overall Study|Lost to Follow-up|0|||
16438707|NCT02525471|40085378|FG000|Overall Study|Death|1|||
16438708|NCT00001832|40085379|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
16438709|NCT00001832|40085380|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
16140981|NCT03085758|39003908|FG002|Overall Study|Death|53|||
16140982|NCT03085758|39003906|FG000|Overall Study|Lost to Follow-up|1|||
16140983|NCT03085758|39003907|FG001|Overall Study|Lost to Follow-up|1|||
16140984|NCT03085758|39003908|FG002|Overall Study|Lost to Follow-up|1|||
16140985|NCT03085758|39003906|FG000|Overall Study|Withdrawal by Subject|2|||
16140986|NCT03085758|39003907|FG001|Overall Study|Withdrawal by Subject|2|||
16140987|NCT03085758|39003908|FG002|Overall Study|Withdrawal by Subject|1|||
16140988|NCT03085758|39003906|FG000|Overall Study|Refusal to recall it up to day 90|0|||
16140989|NCT03085758|39003907|FG001|Overall Study|Refusal to recall it up to day 90|0|||
16140990|NCT03085758|39003908|FG002|Overall Study|Refusal to recall it up to day 90|1|||
16140991|NCT03085758|39003906|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
16140992|NCT03085758|39003907|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
16140993|NCT03085758|39003908|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
16140994|NCT02544217|39003909|FG000|Overall Study|Withdrawal by Subject|1|||
16140995|NCT02544217|39003910|FG001|Overall Study|Withdrawal by Subject|1|||
16140996|NCT02544217|39003911|FG002|Overall Study|Withdrawal by Subject|0|||
16140997|NCT02544217|39003912|FG003|Overall Study|Withdrawal by Subject|0|||
16140998|NCT02544217|39003913|FG004|Overall Study|Withdrawal by Subject|0|||
16140999|NCT02544217|39003914|FG005|Overall Study|Withdrawal by Subject|0|||
16141000|NCT01215422|39003915|FG000|Overall Study|Relocation|1|||
16141001|NCT01215422|39003916|FG001|Overall Study|Relocation|0|||
16141002|NCT01215422|39003917|FG002|Overall Study|Relocation|0|||
16141003|NCT01215422|39003918|FG003|Overall Study|Relocation|0|||
16141004|NCT01215422|39003915|FG000|Overall Study|Failed intubations|0|||
16141005|NCT01215422|39003916|FG001|Overall Study|Failed intubations|0|||
16141006|NCT01215422|39003917|FG002|Overall Study|Failed intubations|3|||
16141007|NCT01215422|39003918|FG003|Overall Study|Failed intubations|8|||
16141008|NCT01215422|39003915|FG000|Overall Study|Did not complete all intubations|7|||
16141009|NCT01215422|39003916|FG001|Overall Study|Did not complete all intubations|0|||
16141010|NCT01215422|39003917|FG002|Overall Study|Did not complete all intubations|0|||
16141011|NCT01215422|39003918|FG003|Overall Study|Did not complete all intubations|0|||
16141012|NCT00447382|39003939|FG000|Overall Study|Adverse Event|1|||
16141013|NCT00447382|39003940|FG001|Overall Study|Adverse Event|1|||
16141014|NCT00447382|39003939|FG000|Overall Study|Lack of Efficacy|1|||
16141015|NCT00447382|39003940|FG001|Overall Study|Lack of Efficacy|0|||
16141016|NCT00447382|39003939|FG000|Overall Study|Protocol Violation|2|||
16141017|NCT00447382|39003940|FG001|Overall Study|Protocol Violation|0|||
16141018|NCT00447382|39003939|FG000|Overall Study|Unclassified|2|||
16141019|NCT00447382|39003940|FG001|Overall Study|Unclassified|5|||
16141020|NCT01174238|39003943|FG000|Overall Study|Lost to Follow-up|2|||
16141021|NCT00874770|39003944|FG000|Overall Study|Lack of Efficacy|2|||
16364073|NCT02453048|39818179|FG001|Overall Study|Lost to Follow-up|1|||
16364074|NCT02453048|39818180|FG002|Overall Study|Lost to Follow-up|2|||
16364075|NCT02453048|39818181|FG003|Overall Study|Lost to Follow-up|0|||
16364076|NCT02453048|39818182|FG004|Overall Study|Lost to Follow-up|0|||
16364077|NCT02006654|39818183|FG000|Overall Study|Withdrawal before treatment|4|||
16364078|NCT02006654|39818184|FG001|Overall Study|Withdrawal before treatment|2|||
16364079|NCT02006654|39818183|FG000|Overall Study|Adverse Event|16|||
16364080|NCT02006654|39818184|FG001|Overall Study|Adverse Event|17|||
16364081|NCT02006654|39818183|FG000|Overall Study|Death|1|||
16364082|NCT02006654|39818184|FG001|Overall Study|Death|0|||
16364083|NCT02006654|39818183|FG000|Overall Study|Withdrawal by Subject|14|||
16364084|NCT02006654|39818184|FG001|Overall Study|Withdrawal by Subject|12|||
16364085|NCT02006654|39818183|FG000|Overall Study|Protocol Violation|5|||
16364086|NCT02006654|39818184|FG001|Overall Study|Protocol Violation|8|||
16364087|NCT02006654|39818183|FG000|Overall Study|Lost to Follow-up|1|||
16364088|NCT02006654|39818184|FG001|Overall Study|Lost to Follow-up|0|||
16364089|NCT02006654|39818183|FG000|Overall Study|patient's will|2|||
16364090|NCT02006654|39818184|FG001|Overall Study|patient's will|1|||
16364091|NCT02006654|39818183|FG000|Overall Study|insufficient compliance|1|||
16364092|NCT02006654|39818184|FG001|Overall Study|insufficient compliance|0|||
16364093|NCT02006654|39818183|FG000|Overall Study|worsening cognitive condition|0|||
16364094|NCT02006654|39818184|FG001|Overall Study|worsening cognitive condition|1|||
16364095|NCT02006654|39818183|FG000|Overall Study|faecal incontinence|0|||
16364096|NCT02006654|39818184|FG001|Overall Study|faecal incontinence|1|||
16364097|NCT02006654|39818183|FG000|Overall Study|mood disorder|0|||
16364098|NCT02006654|39818184|FG001|Overall Study|mood disorder|1|||
16364099|NCT02006654|39818183|FG000|Overall Study|disallowed medication|1|||
16364100|NCT02006654|39818184|FG001|Overall Study|disallowed medication|0|||
16364101|NCT02006654|39818183|FG000|Overall Study|moving out of state|0|||
16364102|NCT02006654|39818184|FG001|Overall Study|moving out of state|1|||
16364103|NCT02233413|39818185|FG000|Overall Study|Lost to Follow-up|7|||
16364104|NCT02233413|39818186|FG001|Overall Study|Lost to Follow-up|9|||
16364105|NCT02233413|39818185|FG000|Overall Study|Withdrawal by Subject|4|||
16364106|NCT02233413|39818186|FG001|Overall Study|Withdrawal by Subject|5|||
16141022|NCT00874770|39003945|FG001|Overall Study|Lack of Efficacy|0|||
16141023|NCT00874770|39003946|FG002|Overall Study|Lack of Efficacy|0|||
16141024|NCT00874770|39003947|FG003|Overall Study|Lack of Efficacy|2|||
16141025|NCT00874770|39003944|FG000|Overall Study|Adverse Event|1|||
16141026|NCT00874770|39003945|FG001|Overall Study|Adverse Event|1|||
16141027|NCT00874770|39003946|FG002|Overall Study|Adverse Event|4|||
16141028|NCT00874770|39003947|FG003|Overall Study|Adverse Event|2|||
16364107|NCT00147238|39818189|FG000|Overall Study|Inevaluable|8|||
16141029|NCT00874770|39003944|FG000|Overall Study|Lost to Follow-up|1|||
16438710|NCT00001832|40085381|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
16438711|NCT00001832|40085382|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
16438712|NCT00001832|40085383|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
16438713|NCT00001832|40085384|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
16438714|NCT00001832|40085385|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
16438715|NCT00001832|40085386|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
16438716|NCT00001832|40085387|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
16438717|NCT00001832|40085388|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
16438718|NCT00001832|40085389|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
16438719|NCT00001832|40085390|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
16438720|NCT00001832|40085391|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
16438721|NCT00001832|40085392|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
16438722|NCT00001832|40085393|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
16438723|NCT00001832|40085379|FG000|Treatment Period|Death during treatment|0|||
16438724|NCT00001832|40085380|FG001|Treatment Period|Death during treatment|0|||
16438725|NCT00001832|40085381|FG002|Treatment Period|Death during treatment|0|||
16438726|NCT00001832|40085382|FG003|Treatment Period|Death during treatment|0|||
16438727|NCT00001832|40085383|FG004|Treatment Period|Death during treatment|0|||
16438728|NCT00001832|40085384|FG005|Treatment Period|Death during treatment|1|||
16438729|NCT00001832|40085385|FG006|Treatment Period|Death during treatment|0|||
16438730|NCT00001832|40085386|FG007|Treatment Period|Death during treatment|0|||
16438731|NCT00001832|40085387|FG008|Treatment Period|Death during treatment|0|||
16438732|NCT00001832|40085388|FG009|Treatment Period|Death during treatment|0|||
16141030|NCT00874770|39003945|FG001|Overall Study|Lost to Follow-up|0|||
16141031|NCT00874770|39003946|FG002|Overall Study|Lost to Follow-up|0|||
16141032|NCT00874770|39003947|FG003|Overall Study|Lost to Follow-up|1|||
16141033|NCT00874770|39003944|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
16141034|NCT00874770|39003945|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
16141035|NCT00874770|39003946|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
16141036|NCT00874770|39003947|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
16141037|NCT01133379|39003950|FG000|Overall Study|Withdrawal by Subject|0|||
16141038|NCT01133379|39003951|FG001|Overall Study|Withdrawal by Subject|1|||
16141039|NCT01133379|39003952|FG002|Overall Study|Withdrawal by Subject|1|||
16141040|NCT01133379|39003950|FG000|Overall Study|Lost to Follow-up|1|||
16141041|NCT01133379|39003951|FG001|Overall Study|Lost to Follow-up|1|||
16141042|NCT01133379|39003952|FG002|Overall Study|Lost to Follow-up|1|||
16141043|NCT02072434|39003953|FG000|Overall Study|Protocol Violation|10|||
16141044|NCT02072434|39003954|FG001|Overall Study|Protocol Violation|9|||
16141045|NCT02072434|39003953|FG000|Overall Study|Physician Decision|5|||
16141046|NCT02072434|39003954|FG001|Overall Study|Physician Decision|10|||
16141047|NCT02072434|39003953|FG000|Overall Study|Adverse event, serious fatal|1|||
16141048|NCT02072434|39003954|FG001|Overall Study|Adverse event, serious fatal|6|||
16141049|NCT02072434|39003953|FG000|Overall Study|Adverse Event|7|||
16141050|NCT02072434|39003954|FG001|Overall Study|Adverse Event|6|||
16141051|NCT02072434|39003953|FG000|Overall Study|Withdrawal by Subject|17|||
16141052|NCT02072434|39003954|FG001|Overall Study|Withdrawal by Subject|29|||
16141053|NCT02072434|39003953|FG000|Overall Study|Other|14|||
16141054|NCT02072434|39003954|FG001|Overall Study|Other|29|||
16141055|NCT02072434|39003953|FG000|Overall Study|Lost to Follow-up|0|||
16141056|NCT02072434|39003954|FG001|Overall Study|Lost to Follow-up|1|||
16141057|NCT01729156|39003955|FG000|Overall Study|Withdrawal by Subject|1|||
16255491|NCT03049488|39419903|FG000|Overall Study|Moved from Area|1|||
16141058|NCT01729156|39003956|FG001|Overall Study|Withdrawal by Subject|0|||
16141059|NCT01729156|39003957|FG002|Overall Study|Withdrawal by Subject|0|||
16141060|NCT02113579|39003961|FG000|Overall Study|Adverse Event|1|||
16141061|NCT02113579|39003962|FG001|Overall Study|Adverse Event|0|||
16141062|NCT02113579|39003961|FG000|Overall Study|Withdrawal by Subject|3|||
16141063|NCT02113579|39003962|FG001|Overall Study|Withdrawal by Subject|2|||
16141064|NCT02113579|39003961|FG000|Overall Study|Lost to Follow-up|6|||
16141065|NCT02113579|39003962|FG001|Overall Study|Lost to Follow-up|2|||
16141066|NCT03123250|39003963|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
16141067|NCT02536755|39003967|FG000|Overall Study|Adverse Event|4|||
16141068|NCT02322229|39003968|FG000|Overall Study|Physician Decision|2|||
16141069|NCT01207596|39003969|FG000|Overall Study|Physician Decision|4|||
16141070|NCT01207596|39003969|FG000|Overall Study|Lack of Efficacy|1|||
16141071|NCT01207596|39003969|FG000|Overall Study|Adverse Event|3|||
16141072|NCT01207596|39003969|FG000|Overall Study|Withdrawal by Subject|1|||
16141073|NCT03144804|39003970|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
16141074|NCT05395104|39003971|FG000|Overall Study|Met Liver Stopping Criteria|1|||
16141075|NCT05395104|39003971|FG000|Overall Study|Withdrawal by Subject|1|||
16141076|NCT00993954|39003972|FG000|Overall Study|Protocol Violation|21|||
16141077|NCT00993954|39003973|FG001|Overall Study|Protocol Violation|2|||
16141078|NCT00928564|39003974|FG000|Overall Study|Lost to Follow-up|6|||
16141079|NCT00928564|39003975|FG001|Overall Study|Lost to Follow-up|0|||
16141080|NCT01990534|39003982|FG000|Overall Study|Death|22|||
16141081|NCT01990534|39003982|FG000|Overall Study|Progressive disease|3|||
16141082|NCT01990534|39003982|FG000|Overall Study|Protocol Violation|1|||
16141083|NCT01990534|39003982|FG000|Overall Study|Withdrawal of Informed Consent|2|||
16141084|NCT01990534|39003982|FG000|Overall Study|Symptomatic Deterioration|1|||
16141085|NCT01990534|39003982|FG000|Overall Study|Withdrawal by Subject|3|||
16141086|NCT01990534|39003982|FG000|Overall Study|Reason not Specified|2|||
16141087|NCT01990534|39003982|FG000|Overall Study|Lost to Follow-up|1|||
16141088|NCT01387230|39003987|FG000|Overall Study|Adverse Event|0|||
16141089|NCT01387230|39003988|FG001|Overall Study|Adverse Event|1|||
16141090|NCT01387230|39003989|FG002|Overall Study|Adverse Event|3|||
16141091|NCT01387230|39003987|FG000|Overall Study|Lack of Efficacy|8|||
16141092|NCT01387230|39003988|FG001|Overall Study|Lack of Efficacy|5|||
16141093|NCT01387230|39003989|FG002|Overall Study|Lack of Efficacy|4|||
16141094|NCT01387230|39003987|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
16141095|NCT01387230|39003988|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
16141096|NCT01387230|39003989|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
16141097|NCT01387230|39003987|FG000|Overall Study|Lost to Follow-up|0|||
16141098|NCT01387230|39003988|FG001|Overall Study|Lost to Follow-up|0|||
16141099|NCT01387230|39003989|FG002|Overall Study|Lost to Follow-up|1|||
16141100|NCT01387230|39003987|FG000|Overall Study|Withdrawal by Subject|4|||
16141101|NCT01387230|39003988|FG001|Overall Study|Withdrawal by Subject|1|||
16141102|NCT01387230|39003989|FG002|Overall Study|Withdrawal by Subject|0|||
16141103|NCT00462865|39003990|FG000|Overall Study|Adverse Event|1|||
16255492|NCT03049488|39419904|FG001|Overall Study|Moved from Area|0|||
16141104|NCT01955122|39003991|FG000|Overall Study|Physician Decision|5|||
16141105|NCT01955122|39003992|FG001|Overall Study|Physician Decision|5|||
16141106|NCT03933397|39003993|FG000|Overall Study|No emergency department visit|65|||
16141107|NCT03933397|39003994|FG001|Overall Study|No emergency department visit|71|||
16141108|NCT03933397|39003993|FG000|Overall Study|Missed emergency department visit|25|||
16141109|NCT03933397|39003994|FG001|Overall Study|Missed emergency department visit|30|||
16141110|NCT03933397|39003993|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
16438733|NCT00001832|40085389|FG010|Treatment Period|Death during treatment|0|||
16438734|NCT00001832|40085390|FG011|Treatment Period|Death during treatment|0|||
16438735|NCT00001832|40085391|FG012|Treatment Period|Death during treatment|0|||
16438736|NCT00001832|40085392|FG013|Treatment Period|Death during treatment|0|||
16438737|NCT00001832|40085393|FG014|Treatment Period|Death during treatment|0|||
16438738|NCT00001832|40085379|FG000|Treatment Period|Not treated|0|||
16438739|NCT00001832|40085380|FG001|Treatment Period|Not treated|0|||
16438740|NCT00001832|40085381|FG002|Treatment Period|Not treated|0|||
16438741|NCT00001832|40085382|FG003|Treatment Period|Not treated|0|||
16438742|NCT00001832|40085383|FG004|Treatment Period|Not treated|0|||
16438743|NCT00001832|40085384|FG005|Treatment Period|Not treated|0|||
16438744|NCT00001832|40085385|FG006|Treatment Period|Not treated|0|||
16438745|NCT00001832|40085386|FG007|Treatment Period|Not treated|1|||
16438746|NCT00001832|40085387|FG008|Treatment Period|Not treated|0|||
16438747|NCT00001832|40085388|FG009|Treatment Period|Not treated|0|||
16438748|NCT00001832|40085389|FG010|Treatment Period|Not treated|0|||
16438749|NCT00001832|40085390|FG011|Treatment Period|Not treated|0|||
16438750|NCT00001832|40085391|FG012|Treatment Period|Not treated|0|||
16438751|NCT00001832|40085392|FG013|Treatment Period|Not treated|0|||
16438752|NCT00001832|40085393|FG014|Treatment Period|Not treated|0|||
16438753|NCT01535040|40085394|FG000|Overall Study|Physician Decision|0|||
16438754|NCT01535040|40085395|FG001|Overall Study|Physician Decision|1|||
16438755|NCT01535040|40085394|FG000|Overall Study|Withdrawal by Subject|13|||
16438756|NCT01535040|40085395|FG001|Overall Study|Withdrawal by Subject|10|||
16438757|NCT01535040|40085394|FG000|Overall Study|Never Started|9|||
16438758|NCT01535040|40085395|FG001|Overall Study|Never Started|4|||
16438759|NCT01535040|40085394|FG000|Overall Study|Toxicity|7|||
16438760|NCT01535040|40085395|FG001|Overall Study|Toxicity|5|||
16438761|NCT01535040|40085394|FG000|Overall Study|Multiple Reasons|1|||
16438762|NCT01535040|40085395|FG001|Overall Study|Multiple Reasons|1|||
16438763|NCT04011540|40085396|FG000|Overall Study|Lost to Follow-up|9|||
16438764|NCT04011540|40085397|FG001|Overall Study|Lost to Follow-up|6|||
16438765|NCT02859246|40085399|FG000|Overall Study|Screen fails|3|||
16438766|NCT02859246|40085399|FG000|Overall Study|Adverse Event|1|||
16438767|NCT02859246|40085399|FG000|Overall Study|Withdrawal by Subject|1|||
16438768|NCT01710345|40085400|FG000|Overall Study|Adverse Event|0|||
16438769|NCT01710345|40085401|FG001|Overall Study|Adverse Event|2|||
16438770|NCT01710345|40085402|FG002|Overall Study|Adverse Event|0|||
16438771|NCT01710345|40085400|FG000|Overall Study|Lack of Efficacy|2|||
16438772|NCT01710345|40085401|FG001|Overall Study|Lack of Efficacy|3|||
16438773|NCT01710345|40085402|FG002|Overall Study|Lack of Efficacy|1|||
16438774|NCT01710345|40085400|FG000|Overall Study|Drug Dosing Error|1|||
16438775|NCT01710345|40085401|FG001|Overall Study|Drug Dosing Error|0|||
16438776|NCT01710345|40085402|FG002|Overall Study|Drug Dosing Error|0|||
16438777|NCT00179621|40085406|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
16438778|NCT00179621|40085407|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
16438779|NCT00179621|40085408|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
16438780|NCT00179621|40085409|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
16438781|NCT00179621|40085406|FG000|Double-Blind Period|Adverse Event|2|||
16438782|NCT00179621|40085407|FG001|Double-Blind Period|Adverse Event|7|||
16438783|NCT00179621|40085408|FG002|Double-Blind Period|Adverse Event|4|||
16438784|NCT00179621|40085409|FG003|Double-Blind Period|Adverse Event|0|||
16438785|NCT00179621|40085406|FG000|Double-Blind Period|Withdrawal by Subject|2|||
16438786|NCT00179621|40085407|FG001|Double-Blind Period|Withdrawal by Subject|1|||
16438787|NCT00179621|40085408|FG002|Double-Blind Period|Withdrawal by Subject|3|||
16438788|NCT00179621|40085409|FG003|Double-Blind Period|Withdrawal by Subject|0|||
16438789|NCT00179621|40085406|FG000|Double-Blind Period|Death|0|||
16438790|NCT00179621|40085407|FG001|Double-Blind Period|Death|1|||
16255493|NCT03049488|39419905|FG002|Overall Study|Moved from Area|0|||
16255494|NCT03049488|39419906|FG003|Overall Study|Moved from Area|1|||
16255495|NCT03049488|39419907|FG004|Overall Study|Moved from Area|1|||
16255496|NCT03049488|39419908|FG005|Overall Study|Moved from Area|0|||
16255497|NCT03049488|39419903|FG000|Overall Study|Physician Decision|0|||
16255498|NCT03049488|39419904|FG001|Overall Study|Physician Decision|1|||
16255499|NCT03049488|39419905|FG002|Overall Study|Physician Decision|0|||
16255500|NCT03049488|39419906|FG003|Overall Study|Physician Decision|0|||
16255501|NCT03049488|39419907|FG004|Overall Study|Physician Decision|0|||
16255502|NCT03049488|39419908|FG005|Overall Study|Physician Decision|0|||
16255503|NCT03049488|39419903|FG000|Overall Study|Withdrawal by Subject|0|||
16255504|NCT03049488|39419904|FG001|Overall Study|Withdrawal by Subject|0|||
16255505|NCT03049488|39419905|FG002|Overall Study|Withdrawal by Subject|0|||
16255506|NCT03049488|39419906|FG003|Overall Study|Withdrawal by Subject|1|||
16255507|NCT03049488|39419907|FG004|Overall Study|Withdrawal by Subject|1|||
16255508|NCT03049488|39419908|FG005|Overall Study|Withdrawal by Subject|0|||
16255509|NCT02402166|39419909|FG000|Overall Study|Adverse Event|2|||
16255510|NCT02402166|39419909|FG000|Overall Study|Withdrawal by Subject|2|||
16364108|NCT00640289|39818192|FG000|Overall Study|Death|3|||
16364109|NCT00640289|39818192|FG000|Overall Study|Withdrawal by Subject|1|||
16255511|NCT02402166|39419909|FG000|Overall Study|Lost to Follow-up|1|||
16438791|NCT00179621|40085408|FG002|Double-Blind Period|Death|2|||
16438792|NCT00179621|40085409|FG003|Double-Blind Period|Death|0|||
16438793|NCT00179621|40085406|FG000|Double-Blind Period|Protocol Violation|1|||
16438794|NCT00179621|40085407|FG001|Double-Blind Period|Protocol Violation|0|||
16438795|NCT00179621|40085408|FG002|Double-Blind Period|Protocol Violation|0|||
16438796|NCT00179621|40085409|FG003|Double-Blind Period|Protocol Violation|0|||
16438797|NCT00179621|40085406|FG000|Double-Blind Period|Other|0|||
16438798|NCT00179621|40085407|FG001|Double-Blind Period|Other|2|||
16438799|NCT00179621|40085408|FG002|Double-Blind Period|Other|2|||
16438800|NCT00179621|40085409|FG003|Double-Blind Period|Other|0|||
16438801|NCT00179621|40085406|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
16438802|NCT00179621|40085407|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
16255512|NCT00048568|39419912|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
16255513|NCT00048568|39419913|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
16255514|NCT00048568|39419914|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
16255515|NCT00048568|39419912|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
16255516|NCT00048568|39419913|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
16255517|NCT00048568|39419914|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
16255518|NCT00048568|39419912|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
16438803|NCT00179621|40085408|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
16438804|NCT00179621|40085409|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
16438805|NCT00179621|40085406|FG000|Open-Label Period|Adverse Event|0|||
16438806|NCT00179621|40085407|FG001|Open-Label Period|Adverse Event|6|||
16438807|NCT00179621|40085408|FG002|Open-Label Period|Adverse Event|5|||
16438808|NCT00179621|40085409|FG003|Open-Label Period|Adverse Event|6|||
16438809|NCT00179621|40085406|FG000|Open-Label Period|Withdrawal by Subject|0|||
16438810|NCT00179621|40085407|FG001|Open-Label Period|Withdrawal by Subject|2|||
16438811|NCT00179621|40085408|FG002|Open-Label Period|Withdrawal by Subject|2|||
16438812|NCT00179621|40085409|FG003|Open-Label Period|Withdrawal by Subject|2|||
16438813|NCT00179621|40085406|FG000|Open-Label Period|Death|0|||
16438814|NCT00179621|40085407|FG001|Open-Label Period|Death|0|||
16438815|NCT00179621|40085408|FG002|Open-Label Period|Death|1|||
16438816|NCT00179621|40085409|FG003|Open-Label Period|Death|2|||
16438817|NCT00179621|40085406|FG000|Open-Label Period|Other|0|||
16438818|NCT00179621|40085407|FG001|Open-Label Period|Other|1|||
16438819|NCT00179621|40085408|FG002|Open-Label Period|Other|1|||
16438820|NCT00179621|40085409|FG003|Open-Label Period|Other|2|||
16438821|NCT03309020|40085410|FG000|Overall Study|Death|1|||
16438822|NCT03309020|40085411|FG001|Overall Study|Death|0|||
16438823|NCT03309020|40085410|FG000|Overall Study|Did not undergo surgery|2|||
16438824|NCT03309020|40085411|FG001|Overall Study|Did not undergo surgery|1|||
16438825|NCT02240485|40085414|FG000|3 Months Post-admission|Lost to Follow-up|1|||
16438826|NCT02240485|40085415|FG001|3 Months Post-admission|Lost to Follow-up|5|||
16438827|NCT02240485|40085414|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
16438828|NCT02240485|40085415|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
16438829|NCT02240485|40085414|FG000|9 Months Post-admission|Lost to Follow-up|3|||
16438830|NCT02240485|40085415|FG001|9 Months Post-admission|Lost to Follow-up|1|||
16438831|NCT02240485|40085414|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
16438832|NCT02240485|40085415|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
16438833|NCT02240485|40085414|FG000|18 Months Post-admission|Lost to Follow-up|1|||
16438834|NCT02240485|40085415|FG001|18 Months Post-admission|Lost to Follow-up|1|||
16438835|NCT02240485|40085414|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
16438836|NCT02240485|40085415|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
16438837|NCT01808196|40085416|FG000|Overall Study|Lost to Follow-up|1|||
16438838|NCT03633396|40085417|FG000|Overall Study|Withdrawal by Subject|4|||
16438839|NCT03633396|40085418|FG001|Overall Study|Withdrawal by Subject|4|||
16438840|NCT03633396|40085417|FG000|Overall Study|Adverse Event|1|||
16438841|NCT03633396|40085418|FG001|Overall Study|Adverse Event|1|||
16438842|NCT03633396|40085417|FG000|Overall Study|Lack of Efficacy|1|||
16438843|NCT03633396|40085418|FG001|Overall Study|Lack of Efficacy|0|||
16438844|NCT03633396|40085417|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
16438845|NCT03633396|40085418|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
16438846|NCT04529083|40085421|FG000|Overall Study|Withdrawal by Subject|3|||
16438847|NCT00683878|40085424|FG000|Overall Study|Lack of Efficacy|3|||
16438848|NCT00683878|40085425|FG001|Overall Study|Lack of Efficacy|0|||
16438849|NCT00683878|40085426|FG002|Overall Study|Lack of Efficacy|1|||
16438850|NCT00683878|40085424|FG000|Overall Study|Adverse Event|4|||
16438851|NCT00683878|40085425|FG001|Overall Study|Adverse Event|3|||
16438852|NCT00683878|40085426|FG002|Overall Study|Adverse Event|3|||
16438853|NCT00683878|40085424|FG000|Overall Study|Withdrawal by Subject|9|||
16438854|NCT00683878|40085425|FG001|Overall Study|Withdrawal by Subject|8|||
16438855|NCT00683878|40085426|FG002|Overall Study|Withdrawal by Subject|6|||
16438856|NCT00683878|40085424|FG000|Overall Study|Death|0|||
16438857|NCT00683878|40085425|FG001|Overall Study|Death|1|||
16438858|NCT00683878|40085426|FG002|Overall Study|Death|0|||
16438859|NCT00683878|40085424|FG000|Overall Study|Lost to Follow-up|4|||
16438860|NCT00683878|40085425|FG001|Overall Study|Lost to Follow-up|2|||
16438861|NCT00683878|40085426|FG002|Overall Study|Lost to Follow-up|4|||
16438862|NCT00683878|40085424|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
16438863|NCT00683878|40085425|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
16438864|NCT00683878|40085426|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
16438865|NCT02421172|40085427|FG000|Period 1|Adverse Event|1|||
16438866|NCT02421172|40085428|FG001|Period 1|Adverse Event|0|||
16438867|NCT02421172|40085429|FG002|Period 1|Adverse Event|0|||
16438868|NCT02421172|40085430|FG003|Period 1|Adverse Event|0|||
16438869|NCT02421172|40085431|FG004|Period 1|Adverse Event|0|||
16438870|NCT02421172|40085427|FG000|Period 1|Lost to Follow-up|3|||
16438871|NCT02421172|40085428|FG001|Period 1|Lost to Follow-up|1|||
16438872|NCT02421172|40085429|FG002|Period 1|Lost to Follow-up|0|||
16438873|NCT02421172|40085430|FG003|Period 1|Lost to Follow-up|0|||
16438874|NCT02421172|40085431|FG004|Period 1|Lost to Follow-up|0|||
16438875|NCT02421172|40085427|FG000|Period 1|Patient/guardian decision|0|||
16438876|NCT02421172|40085428|FG001|Period 1|Patient/guardian decision|1|||
16438877|NCT02421172|40085429|FG002|Period 1|Patient/guardian decision|0|||
16438878|NCT02421172|40085430|FG003|Period 1|Patient/guardian decision|0|||
16438879|NCT02421172|40085431|FG004|Period 1|Patient/guardian decision|0|||
16438880|NCT02421172|40085427|FG000|Period 2|Adverse Event|0|||
16438881|NCT02421172|40085428|FG001|Period 2|Adverse Event|0|||
16438882|NCT02421172|40085429|FG002|Period 2|Adverse Event|4|||
16438883|NCT02421172|40085430|FG003|Period 2|Adverse Event|0|||
16438884|NCT02421172|40085431|FG004|Period 2|Adverse Event|0|||
16438885|NCT02421172|40085427|FG000|Period 2|Lost to Follow-up|0|||
16438886|NCT02421172|40085428|FG001|Period 2|Lost to Follow-up|0|||
16141111|NCT03933397|39003994|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
16141112|NCT03933397|39003993|FG000|Overall Study|Withdrawal by Subject|1|||
16141113|NCT03933397|39003994|FG001|Overall Study|Withdrawal by Subject|0|||
16141114|NCT03933397|39003993|FG000|Overall Study|Physician Decision|1|||
16141115|NCT03933397|39003994|FG001|Overall Study|Physician Decision|1|||
16141116|NCT03933397|39003993|FG000|Overall Study|missing pain score|1|||
16141117|NCT03933397|39003994|FG001|Overall Study|missing pain score|1|||
16141118|NCT03933397|39003993|FG000|Overall Study|Confirmed COVID-19|1|||
16141119|NCT03933397|39003994|FG001|Overall Study|Confirmed COVID-19|2|||
16141120|NCT02982239|39004003|FG000|Overall Study|Lost to Follow-up|3|||
16141121|NCT02982239|39004004|FG001|Overall Study|Lost to Follow-up|2|||
16141122|NCT01444651|39004005|FG000|Overall Study|Adverse Event|3|||
16141123|NCT01444651|39004006|FG001|Overall Study|Adverse Event|2|||
16141124|NCT01444651|39004005|FG000|Overall Study|Lost to Follow-up|5|||
16141125|NCT01444651|39004006|FG001|Overall Study|Lost to Follow-up|5|||
16141126|NCT01444651|39004005|FG000|Overall Study|Non-fasting|2|||
16141127|NCT01444651|39004006|FG001|Overall Study|Non-fasting|1|||
16141128|NCT01444651|39004005|FG000|Overall Study|Missing data|1|||
16141129|NCT01444651|39004006|FG001|Overall Study|Missing data|1|||
16141130|NCT02745392|39004007|FG000|Overall Study|Lost to Follow-up|0|||
16141131|NCT02745392|39004008|FG001|Overall Study|Lost to Follow-up|1|||
16141132|NCT02745392|39004009|FG002|Overall Study|Lost to Follow-up|0|||
16141133|NCT02745392|39004010|FG003|Overall Study|Lost to Follow-up|0|||
16141134|NCT02952001|39004011|FG000|Overall Study|Adverse Event|3|||
16141135|NCT02952001|39004012|FG001|Overall Study|Adverse Event|0|||
16141136|NCT02952001|39004011|FG000|Overall Study|Prohibited therapy|10|||
16141137|NCT02952001|39004012|FG001|Overall Study|Prohibited therapy|3|||
16141138|NCT02952001|39004011|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
16438887|NCT02421172|40085429|FG002|Period 2|Lost to Follow-up|0|||
16438888|NCT02421172|40085430|FG003|Period 2|Lost to Follow-up|1|||
16141139|NCT02952001|39004012|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
16141140|NCT02986334|39004013|FG000|Overall Study|Withdrawal by Subject|0|||
16141141|NCT02986334|39004014|FG001|Overall Study|Withdrawal by Subject|1|||
16141142|NCT02986334|39004015|FG002|Overall Study|Withdrawal by Subject|2|||
16141143|NCT02986334|39004013|FG000|Overall Study|Lost to Follow-up|1|||
16141144|NCT02986334|39004014|FG001|Overall Study|Lost to Follow-up|2|||
16141145|NCT02986334|39004015|FG002|Overall Study|Lost to Follow-up|1|||
16141146|NCT02986334|39004013|FG000|Overall Study|Adverse Event|0|||
16141147|NCT02986334|39004014|FG001|Overall Study|Adverse Event|2|||
16141148|NCT02986334|39004015|FG002|Overall Study|Adverse Event|1|||
16141149|NCT02986334|39004013|FG000|Overall Study|non compliance in phone ratings|2|||
16141150|NCT02986334|39004014|FG001|Overall Study|non compliance in phone ratings|1|||
16141151|NCT02986334|39004015|FG002|Overall Study|non compliance in phone ratings|2|||
16141152|NCT02986334|39004013|FG000|Overall Study|undisclosed comorbidities|0|||
16141153|NCT02986334|39004014|FG001|Overall Study|undisclosed comorbidities|1|||
16141154|NCT02986334|39004015|FG002|Overall Study|undisclosed comorbidities|1|||
16141155|NCT02469896|39004016|FG000|Overall Study|Withdrawal by Subject|2|||
16364110|NCT00640289|39818192|FG000|Overall Study|Lost to Follow-up|1|||
16141156|NCT02469896|39004017|FG001|Overall Study|Withdrawal by Subject|0|||
16141157|NCT01372410|39004018|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
16141158|NCT01372410|39004019|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
16141159|NCT01372410|39004020|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
16141160|NCT01372410|39004021|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
16141161|NCT01372410|39004022|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
16141162|NCT01372410|39004023|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
16141163|NCT01372410|39004024|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
16141164|NCT01372410|39004025|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
16141165|NCT01372410|39004018|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
16141166|NCT01372410|39004019|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
16141167|NCT01372410|39004020|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
16141168|NCT01372410|39004021|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
16141169|NCT01372410|39004022|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
16141170|NCT01372410|39004023|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
16141171|NCT01372410|39004024|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
16141172|NCT01372410|39004025|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
16141173|NCT01372410|39004018|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16141174|NCT01372410|39004019|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16141175|NCT01372410|39004020|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16141176|NCT01372410|39004021|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16255519|NCT00048568|39419913|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
16438889|NCT02421172|40085431|FG004|Period 2|Lost to Follow-up|0|||
16438890|NCT02421172|40085427|FG000|Period 2|Patient/guardian decision|0|||
16438891|NCT02421172|40085428|FG001|Period 2|Patient/guardian decision|0|||
16438892|NCT02421172|40085429|FG002|Period 2|Patient/guardian decision|3|||
16438893|NCT02421172|40085430|FG003|Period 2|Patient/guardian decision|2|||
16438894|NCT02421172|40085431|FG004|Period 2|Patient/guardian decision|1|||
16438895|NCT02476617|40085434|FG000|Overall Study|Adverse Event|1|||
16438896|NCT02476617|40085434|FG000|Overall Study|Lost to Follow-up|1|||
16438897|NCT03353675|40085435|FG000|Overall Study|Adverse Event|4|||
16438898|NCT04349072|40085439|FG000|Randomization Period|Found ineligible post enrollment|0|||
16438899|NCT04349072|40085440|FG001|Randomization Period|Found ineligible post enrollment|1|||
16438900|NCT04349072|40085439|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
16438901|NCT04349072|40085440|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
16438902|NCT04349072|40085439|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
16438903|NCT04349072|40085440|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
16438904|NCT04349072|40085439|FG000|Treatment Period|Physician Decision|0|||
16438905|NCT04349072|40085440|FG001|Treatment Period|Physician Decision|1|||
16438906|NCT04349072|40085439|FG000|Treatment Period|Protocol Violation|0|||
16438907|NCT04349072|40085440|FG001|Treatment Period|Protocol Violation|1|||
16438908|NCT04349072|40085439|FG000|Treatment Period|Withdrawal by Subject|1|||
16438909|NCT04349072|40085440|FG001|Treatment Period|Withdrawal by Subject|1|||
16438910|NCT00642356|40085441|FG000|Overall Study|Adverse Event|1|||
16141177|NCT01372410|39004022|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
16141178|NCT01372410|39004023|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16141179|NCT01372410|39004024|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16141180|NCT01372410|39004025|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
16141181|NCT01372410|39004018|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16141182|NCT01372410|39004019|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16141183|NCT01372410|39004020|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16141184|NCT01372410|39004021|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16141185|NCT01372410|39004022|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16141186|NCT01372410|39004023|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16141187|NCT01372410|39004024|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
16141188|NCT01372410|39004025|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
16141189|NCT01372410|39004018|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
16141190|NCT01372410|39004019|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16141191|NCT01372410|39004020|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16141192|NCT01372410|39004021|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16141193|NCT01372410|39004022|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16141194|NCT01372410|39004023|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16141195|NCT01372410|39004024|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
16438911|NCT00642356|40085442|FG001|Overall Study|Adverse Event|0|||
16141196|NCT01372410|39004025|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
16141197|NCT01372410|39004018|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16141198|NCT01372410|39004019|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16141199|NCT01372410|39004020|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16141200|NCT01372410|39004021|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16141201|NCT01372410|39004022|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
16141202|NCT01372410|39004023|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16141203|NCT01372410|39004024|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16141204|NCT01372410|39004025|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
16141205|NCT01372410|39004018|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
16141206|NCT01372410|39004019|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
16141207|NCT01372410|39004020|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
16141208|NCT01372410|39004021|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
16141209|NCT01372410|39004022|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
16438912|NCT00642356|40085441|FG000|Overall Study|Protocol Violation|0|||
16438913|NCT00642356|40085442|FG001|Overall Study|Protocol Violation|3|||
16438914|NCT00642356|40085441|FG000|Overall Study|Lack of Efficacy|1|||
16438915|NCT00642356|40085442|FG001|Overall Study|Lack of Efficacy|0|||
16438916|NCT02973100|40085443|FG000|Overall Study|Adverse Event|1|||
16438917|NCT02973100|40085444|FG001|Overall Study|Adverse Event|2|||
16438918|NCT02973100|40085445|FG002|Overall Study|Adverse Event|1|||
16438919|NCT02973100|40085446|FG003|Overall Study|Adverse Event|2|||
16438920|NCT02973100|40085443|FG000|Overall Study|Lost to Follow-up|3|||
16438921|NCT02973100|40085444|FG001|Overall Study|Lost to Follow-up|1|||
16438922|NCT02973100|40085445|FG002|Overall Study|Lost to Follow-up|1|||
16438923|NCT02973100|40085446|FG003|Overall Study|Lost to Follow-up|0|||
16438924|NCT02973100|40085443|FG000|Overall Study|Withdrawal by Subject|3|||
16141210|NCT01372410|39004023|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
16438925|NCT02973100|40085444|FG001|Overall Study|Withdrawal by Subject|5|||
16438926|NCT02973100|40085445|FG002|Overall Study|Withdrawal by Subject|1|||
16141211|NCT01372410|39004024|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
16141212|NCT01372410|39004025|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
16141213|NCT01372410|39004018|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16141214|NCT01372410|39004019|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16141215|NCT01372410|39004020|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16141216|NCT01372410|39004021|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16141217|NCT01372410|39004022|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16141218|NCT01372410|39004023|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16141219|NCT01372410|39004024|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
16141220|NCT01372410|39004025|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
16141221|NCT01372410|39004018|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
16141222|NCT01372410|39004019|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
16141223|NCT01372410|39004020|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
16141224|NCT01372410|39004021|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
16141225|NCT01372410|39004022|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
16141226|NCT01372410|39004023|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
16141227|NCT01372410|39004024|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
16141228|NCT01372410|39004025|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
16141229|NCT01372410|39004018|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16141230|NCT01372410|39004019|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16141231|NCT01372410|39004020|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16141232|NCT01372410|39004021|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16141233|NCT01372410|39004022|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16141234|NCT01372410|39004023|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
16141235|NCT01372410|39004024|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16141236|NCT01372410|39004025|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
16141237|NCT04695392|39004026|FG000|Overall Study|Withdrawn by parent/guardian|0|||
16141238|NCT04695392|39004027|FG001|Overall Study|Withdrawn by parent/guardian|1|||
16141239|NCT04695392|39004026|FG000|Overall Study|Withdrawn by physician|0|||
16141240|NCT04695392|39004027|FG001|Overall Study|Withdrawn by physician|1|||
16141241|NCT01137955|39004033|FG000|Overall Study|Withdrawal by Subject|5|||
16141242|NCT01137955|39004034|FG001|Overall Study|Withdrawal by Subject|4|||
16141243|NCT01431534|39004035|FG000|Treatment Phase|Adverse Event|0|||
16141244|NCT01431534|39004036|FG001|Treatment Phase|Adverse Event|0|||
16141245|NCT01431534|39004037|FG002|Treatment Phase|Adverse Event|1|||
16141246|NCT01431534|39004035|FG000|Treatment Phase|Progressive Disease|4|||
16141247|NCT01431534|39004036|FG001|Treatment Phase|Progressive Disease|3|||
16141248|NCT01431534|39004037|FG002|Treatment Phase|Progressive Disease|10|||
16141249|NCT03836807|39004039|FG000|Overall Study|Physician Decision|1|||
16141250|NCT03836807|39004040|FG001|Overall Study|Physician Decision|0|||
16141251|NCT03310268|39004047|FG000|Overall Study|(Not specified)|1|||
16141252|NCT03310268|39004048|FG001|Overall Study|(Not specified)|5|||
16141253|NCT03310268|39004049|FG002|Overall Study|(Not specified)|0|||
16141254|NCT03785678|39004050|FG000|Overall Study|Death|44|||
16141255|NCT03785678|39004051|FG001|Overall Study|Death|42|||
16141256|NCT03785678|39004050|FG000|Overall Study|Lost to Follow-up|4|||
16141257|NCT03785678|39004051|FG001|Overall Study|Lost to Follow-up|2|||
16141258|NCT03785678|39004050|FG000|Overall Study|Physician Decision|0|||
16141259|NCT03785678|39004051|FG001|Overall Study|Physician Decision|2|||
16141260|NCT03785678|39004050|FG000|Overall Study|Withdrawal by Subject|5|||
16141261|NCT03785678|39004051|FG001|Overall Study|Withdrawal by Subject|3|||
16141262|NCT00369785|39004054|FG000|Overall Study|Physician Decision|3|||
16141263|NCT00369785|39004055|FG001|Overall Study|Physician Decision|2|||
16141264|NCT00369785|39004054|FG000|Overall Study|Death|1|||
16141265|NCT00369785|39004055|FG001|Overall Study|Death|2|||
16141266|NCT00369785|39004054|FG000|Overall Study|Withdrawal by Subject|7|||
16141267|NCT00369785|39004055|FG001|Overall Study|Withdrawal by Subject|6|||
16141268|NCT00369785|39004054|FG000|Overall Study|Toxicity|6|||
16141269|NCT00369785|39004055|FG001|Overall Study|Toxicity|4|||
16141270|NCT00369785|39004054|FG000|Overall Study|Never started|0|||
16141271|NCT00369785|39004055|FG001|Overall Study|Never started|2|||
16141272|NCT00369785|39004054|FG000|Overall Study|Progression|4|||
16141273|NCT00369785|39004055|FG001|Overall Study|Progression|4|||
16141274|NCT00369785|39004054|FG000|Overall Study|Multiple reasons|6|||
16141275|NCT00369785|39004055|FG001|Overall Study|Multiple reasons|5|||
16364111|NCT00640289|39818192|FG000|Overall Study|Data collected under different amendment|2|||
16141276|NCT02383589|39004058|FG000|Treatment Period|Adverse Event|1|||
16141277|NCT02383589|39004059|FG001|Treatment Period|Adverse Event|3|||
16141278|NCT02383589|39004058|FG000|Treatment Period|Lost to Follow-up|0|||
16141279|NCT02383589|39004059|FG001|Treatment Period|Lost to Follow-up|1|||
16141280|NCT02383589|39004058|FG000|Treatment Period|Withdrawal by Subject|0|||
16141281|NCT02383589|39004059|FG001|Treatment Period|Withdrawal by Subject|5|||
16141282|NCT02383589|39004058|FG000|Treatment Period|Non-compliance with study drug|0|||
16141283|NCT02383589|39004059|FG001|Treatment Period|Non-compliance with study drug|1|||
16141284|NCT02383589|39004058|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
16141285|NCT02383589|39004059|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
16141286|NCT02383589|39004058|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
16364112|NCT00640289|39818192|FG000|Overall Study|Transferred to another center|1|||
16141287|NCT02383589|39004059|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
16141288|NCT02383589|39004058|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
16141289|NCT02383589|39004059|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
16141290|NCT01399190|39004069|FG000|Overall Study|Not Eligible for Final Analysis|5|||
16141291|NCT01399190|39004069|FG000|Overall Study|Adverse Event|8|||
16141292|NCT01399190|39004069|FG000|Overall Study|Participant's Request|5|||
16141293|NCT01399190|39004069|FG000|Overall Study|Physician Decision|2|||
16141294|NCT01660451|39004084|FG000|Overall Study|Protocol Violation|0|||
16141295|NCT01660451|39004085|FG001|Overall Study|Protocol Violation|1|||
16141296|NCT01660451|39004086|FG002|Overall Study|Protocol Violation|1|||
16141297|NCT01660451|39004084|FG000|Overall Study|AE not associated with clinical disease progression|13|||
16141298|NCT01660451|39004085|FG001|Overall Study|AE not associated with clinical disease progression|10|||
16141299|NCT01660451|39004086|FG002|Overall Study|AE not associated with clinical disease progression|40|||
16141300|NCT01660451|39004084|FG000|Overall Study|AE associated with clinical disease progression|1|||
16141301|NCT01660451|39004085|FG001|Overall Study|AE associated with clinical disease progression|3|||
16141302|NCT01660451|39004086|FG002|Overall Study|AE associated with clinical disease progression|11|||
16141303|NCT01660451|39004084|FG000|Overall Study|Sponsor Decision|0|||
16141304|NCT01660451|39004085|FG001|Overall Study|Sponsor Decision|0|||
16438927|NCT02973100|40085446|FG003|Overall Study|Withdrawal by Subject|4|||
16438928|NCT02973100|40085443|FG000|Overall Study|Notification of change in address|0|||
16438929|NCT02973100|40085444|FG001|Overall Study|Notification of change in address|0|||
16438930|NCT02973100|40085445|FG002|Overall Study|Notification of change in address|0|||
16438931|NCT02973100|40085446|FG003|Overall Study|Notification of change in address|1|||
16438932|NCT02973100|40085443|FG000|Overall Study|Failed to attend Safety followup period|0|||
16438933|NCT02973100|40085444|FG001|Overall Study|Failed to attend Safety followup period|0|||
16438934|NCT02973100|40085445|FG002|Overall Study|Failed to attend Safety followup period|1|||
16438935|NCT02973100|40085446|FG003|Overall Study|Failed to attend Safety followup period|0|||
16438936|NCT01009060|40085447|FG000|Overall Study|Adverse Event|1|||
16438937|NCT01009060|40085448|FG001|Overall Study|Adverse Event|2|||
16438938|NCT01009060|40085447|FG000|Overall Study|Protocol Violation|0|||
16438939|NCT01009060|40085448|FG001|Overall Study|Protocol Violation|1|||
16438940|NCT01009060|40085447|FG000|Overall Study|Lost to Follow-up|1|||
16438941|NCT01009060|40085448|FG001|Overall Study|Lost to Follow-up|0|||
16438942|NCT01009060|40085447|FG000|Overall Study|Physician Decision|1|||
16438943|NCT01009060|40085448|FG001|Overall Study|Physician Decision|1|||
16438944|NCT01009060|40085447|FG000|Overall Study|Withdrawal by Subject|1|||
16438945|NCT01009060|40085448|FG001|Overall Study|Withdrawal by Subject|1|||
16438946|NCT00657046|40085449|FG000|Overall Study|Adverse Event|1|||
16438947|NCT00657046|40085450|FG001|Overall Study|Adverse Event|1|||
16438948|NCT00657046|40085451|FG002|Overall Study|Adverse Event|0|||
16438949|NCT00657046|40085449|FG000|Overall Study|Protocol Violation|2|||
16438950|NCT00657046|40085450|FG001|Overall Study|Protocol Violation|2|||
16438951|NCT00657046|40085451|FG002|Overall Study|Protocol Violation|0|||
16438952|NCT00657046|40085449|FG000|Overall Study|Withdrawal by Subject|1|||
16438953|NCT00657046|40085450|FG001|Overall Study|Withdrawal by Subject|0|||
16438954|NCT00657046|40085451|FG002|Overall Study|Withdrawal by Subject|0|||
16438955|NCT00657046|40085449|FG000|Overall Study|Death|0|||
16438956|NCT00657046|40085450|FG001|Overall Study|Death|0|||
16438957|NCT00657046|40085451|FG002|Overall Study|Death|1|||
16438958|NCT00657046|40085449|FG000|Overall Study|Surgery|0|||
16438959|NCT00657046|40085450|FG001|Overall Study|Surgery|0|||
16438960|NCT00657046|40085451|FG002|Overall Study|Surgery|1|||
16141305|NCT01660451|39004086|FG002|Overall Study|Sponsor Decision|1|||
16141306|NCT01660451|39004084|FG000|Overall Study|Protocol Deviation|0|||
16141307|NCT01660451|39004085|FG001|Overall Study|Protocol Deviation|0|||
16255520|NCT00048568|39419914|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
16255521|NCT00048568|39419912|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
16255522|NCT00048568|39419913|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
16255523|NCT00048568|39419914|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
16255524|NCT00048568|39419912|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
16255525|NCT00048568|39419913|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
16255526|NCT00048568|39419914|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
16255527|NCT00048568|39419912|FG000|Double-Blind Period Days 170 to 365|Death|1|||
16255528|NCT00048568|39419913|FG001|Double-Blind Period Days 170 to 365|Death|1|||
16255529|NCT00048568|39419914|FG002|Double-Blind Period Days 170 to 365|Death|0|||
16255530|NCT00048568|39419912|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
16255531|NCT00048568|39419913|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
16255532|NCT00048568|39419914|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
16255533|NCT00048568|39419912|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
16255534|NCT00048568|39419913|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
16255535|NCT00048568|39419914|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
16255536|NCT00048568|39419912|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
16255537|NCT00048568|39419913|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
16255538|NCT00048568|39419914|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
16255539|NCT00048568|39419912|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
16255540|NCT00048568|39419913|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
16255541|NCT00048568|39419914|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
16255542|NCT00048568|39419912|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
16255543|NCT00048568|39419913|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
16255544|NCT00048568|39419914|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
16255545|NCT00048568|39419912|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
16255546|NCT00048568|39419913|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
16255547|NCT00048568|39419914|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
16255548|NCT00048568|39419912|FG000|Open-Label Period|Death|0|||
16255549|NCT00048568|39419913|FG001|Open-Label Period|Death|0|||
16255550|NCT00048568|39419914|FG002|Open-Label Period|Death|13|||
16255551|NCT00048568|39419912|FG000|Open-Label Period|Adverse Event|0|||
16255552|NCT00048568|39419913|FG001|Open-Label Period|Adverse Event|0|||
16255553|NCT00048568|39419914|FG002|Open-Label Period|Adverse Event|49|||
16255554|NCT00048568|39419912|FG000|Open-Label Period|Lack of Efficacy|0|||
16255555|NCT00048568|39419913|FG001|Open-Label Period|Lack of Efficacy|0|||
16255556|NCT00048568|39419914|FG002|Open-Label Period|Lack of Efficacy|32|||
16255557|NCT00048568|39419912|FG000|Open-Label Period|Withdrawal by Subject|0|||
16255558|NCT00048568|39419913|FG001|Open-Label Period|Withdrawal by Subject|0|||
16255559|NCT00048568|39419914|FG002|Open-Label Period|Withdrawal by Subject|26|||
16255560|NCT00048568|39419912|FG000|Open-Label Period|Pregnancy|0|||
16255561|NCT00048568|39419913|FG001|Open-Label Period|Pregnancy|0|||
16255562|NCT00048568|39419914|FG002|Open-Label Period|Pregnancy|5|||
16255563|NCT00048568|39419912|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
16255564|NCT00048568|39419913|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
16255565|NCT00048568|39419914|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
16255566|NCT00048568|39419912|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
16255567|NCT00048568|39419913|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
16255568|NCT00048568|39419914|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
16438961|NCT00689390|40085459|FG000|Overall Study|Adverse Event|19|||
16438962|NCT00689390|40085460|FG001|Overall Study|Adverse Event|0|||
16438963|NCT00689390|40085459|FG000|Overall Study|Lost to Follow-up|179|||
16438964|NCT00689390|40085460|FG001|Overall Study|Lost to Follow-up|7|||
16438965|NCT00689390|40085459|FG000|Overall Study|Withdrawal by Subject|117|||
16438966|NCT00689390|40085460|FG001|Overall Study|Withdrawal by Subject|3|||
16438967|NCT00689390|40085459|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
16438968|NCT00689390|40085460|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
16438969|NCT00689390|40085459|FG000|Overall Study|Non-Compliance With Protocol|21|||
16438970|NCT00689390|40085460|FG001|Overall Study|Non-Compliance With Protocol|0|||
16141308|NCT01660451|39004086|FG002|Overall Study|Protocol Deviation|1|||
16141309|NCT01660451|39004084|FG000|Overall Study|Physician Decision|1|||
16141310|NCT01660451|39004085|FG001|Overall Study|Physician Decision|2|||
16141311|NCT01660451|39004086|FG002|Overall Study|Physician Decision|5|||
16141312|NCT01660451|39004084|FG000|Overall Study|Withdrawal by Subject|1|||
16141313|NCT01660451|39004085|FG001|Overall Study|Withdrawal by Subject|1|||
16141314|NCT01660451|39004086|FG002|Overall Study|Withdrawal by Subject|20|||
16141315|NCT01660451|39004084|FG000|Overall Study|Trial closure.|0|||
16141316|NCT01660451|39004085|FG001|Overall Study|Trial closure.|0|||
16141317|NCT01660451|39004086|FG002|Overall Study|Trial closure.|1|||
16141318|NCT01660451|39004084|FG000|Overall Study|Switching to other therapy|0|||
16141319|NCT01660451|39004085|FG001|Overall Study|Switching to other therapy|1|||
16141320|NCT01660451|39004086|FG002|Overall Study|Switching to other therapy|1|||
16141321|NCT01660451|39004084|FG000|Overall Study|Progressive disease - clinical progression|4|||
16141322|NCT01660451|39004085|FG001|Overall Study|Progressive disease - clinical progression|10|||
16141323|NCT01660451|39004086|FG002|Overall Study|Progressive disease - clinical progression|9|||
16141324|NCT01660451|39004084|FG000|Overall Study|Progressive disease - radiological progression|12|||
16141325|NCT01660451|39004085|FG001|Overall Study|Progressive disease - radiological progression|23|||
16141326|NCT01660451|39004086|FG002|Overall Study|Progressive disease - radiological progression|50|||
16141327|NCT01660451|39004084|FG000|Overall Study|Death|1|||
16141328|NCT01660451|39004085|FG001|Overall Study|Death|0|||
16141329|NCT01660451|39004086|FG002|Overall Study|Death|1|||
16141330|NCT01660451|39004084|FG000|Overall Study|Other|0|||
16141331|NCT01660451|39004085|FG001|Overall Study|Other|0|||
16141332|NCT01660451|39004086|FG002|Overall Study|Other|1|||
16141333|NCT00445068|39004087|FG000|Overall Study|Disease progression|26|||
16141334|NCT00445068|39004087|FG000|Overall Study|Adverse Event|5|||
16141335|NCT00445068|39004087|FG000|Overall Study|Abnormal laboratory value|2|||
16141336|NCT00445068|39004087|FG000|Overall Study|Withdrawal by Subject|2|||
16141337|NCT00445068|39004087|FG000|Overall Study|Death|1|||
16141338|NCT00068588|39004098|FG000|Overall Study|Adverse Event|0|||
16141339|NCT00068588|39004099|FG001|Overall Study|Adverse Event|0|||
16141340|NCT00068588|39004100|FG002|Overall Study|Adverse Event|2|||
16141341|NCT00068588|39004098|FG000|Overall Study|Withdrawal by Subject|0|||
16141342|NCT00068588|39004099|FG001|Overall Study|Withdrawal by Subject|0|||
16141343|NCT00068588|39004100|FG002|Overall Study|Withdrawal by Subject|1|||
16141344|NCT00068588|39004098|FG000|Overall Study|Poor KPS|0|||
16141345|NCT00068588|39004099|FG001|Overall Study|Poor KPS|0|||
16141346|NCT00068588|39004100|FG002|Overall Study|Poor KPS|1|||
16141347|NCT00517751|39004111|FG000|Overall Study|Death|3|||
16141348|NCT00517751|39004111|FG000|Overall Study|Withdrawal by Subject|37|||
16141349|NCT00517751|39004111|FG000|Overall Study|Lost to Follow-up|4|||
16141350|NCT00517751|39004111|FG000|Overall Study|patient not over due|6|||
16141351|NCT00517751|39004111|FG000|Overall Study|Patient not due for visit|76|||
16141352|NCT00517751|39004111|FG000|Overall Study|Missing|3|||
16141353|NCT00478933|39008389|FG000|Overall Study|Protocol Violation|22|||
16141354|NCT00478933|39008389|FG000|Overall Study|Informed consent not verified|3|||
16141355|NCT00478933|39008389|FG000|Overall Study|Inadequate data available|53|||
16141356|NCT04906616|39008390|FG000|Overall Study|Divorce|3|||
16141357|NCT04906616|39008391|FG001|Overall Study|Divorce|2|||
16141358|NCT03471871|39008393|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
16141359|NCT03471871|39008394|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
16141360|NCT03471871|39008395|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
16141361|NCT03471871|39008396|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
16141362|NCT03471871|39008397|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
16141363|NCT03471871|39008393|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
16141364|NCT03471871|39008394|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
16141365|NCT03471871|39008395|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
16141366|NCT03471871|39008396|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
16141367|NCT03471871|39008397|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
16141368|NCT03471871|39008393|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
16141369|NCT03471871|39008394|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
16141370|NCT03471871|39008395|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
16141371|NCT03471871|39008396|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
16141372|NCT03471871|39008397|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
16141373|NCT03471871|39008393|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
16141374|NCT03471871|39008394|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
16141375|NCT03471871|39008395|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
16141376|NCT03471871|39008396|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
16141377|NCT03471871|39008397|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
16141378|NCT03471871|39008393|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
16141379|NCT03471871|39008394|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
16141380|NCT03471871|39008395|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
16141381|NCT03471871|39008396|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
16141382|NCT03471871|39008397|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
16141383|NCT02525861|39008398|FG000|Overall Study|Adverse Event|1|||
16141384|NCT02525861|39008399|FG001|Overall Study|Adverse Event|0|||
16141385|NCT02525861|39008398|FG000|Overall Study|Withdrawal by Subject|0|||
16141386|NCT02525861|39008399|FG001|Overall Study|Withdrawal by Subject|1|||
16255569|NCT00048568|39419912|FG000|Open-Label Period|Unknown Reasons|0|||
16255570|NCT00048568|39419913|FG001|Open-Label Period|Unknown Reasons|0|||
16141387|NCT02525861|39008398|FG000|Overall Study|Physician Decision|0|||
16141388|NCT02525861|39008399|FG001|Overall Study|Physician Decision|1|||
16141389|NCT02598557|39008401|FG000|Overall Study|Withdrawal by Subject|1|||
16141390|NCT02598557|39008402|FG001|Overall Study|Withdrawal by Subject|0|||
16141391|NCT02598557|39008403|FG002|Overall Study|Withdrawal by Subject|1|||
16141392|NCT02598557|39008401|FG000|Overall Study|Participant did not start treatment|2|||
16141393|NCT02598557|39008402|FG001|Overall Study|Participant did not start treatment|1|||
16141394|NCT02598557|39008403|FG002|Overall Study|Participant did not start treatment|1|||
16255571|NCT00048568|39419914|FG002|Open-Label Period|Unknown Reasons|25|||
16255572|NCT00048568|39419912|FG000|Open-Label Period|Lost to Follow-up|0|||
16141395|NCT02598557|39008401|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
16141396|NCT02598557|39008402|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
16141397|NCT02598557|39008403|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
16141398|NCT02598557|39008401|FG000|Overall Study|Adverse Event|1|||
16141399|NCT02598557|39008402|FG001|Overall Study|Adverse Event|1|||
16141400|NCT02598557|39008403|FG002|Overall Study|Adverse Event|0|||
16141401|NCT01358760|39008404|FG000|Overall Study|Adverse Event|3|||
16141402|NCT01358760|39008405|FG001|Overall Study|Adverse Event|4|||
16141403|NCT01358760|39008406|FG002|Overall Study|Adverse Event|3|||
16141404|NCT01358760|39008404|FG000|Overall Study|Lost to Follow-up|1|||
16438971|NCT00689390|40085459|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
16438972|NCT00689390|40085460|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
16141405|NCT01358760|39008405|FG001|Overall Study|Lost to Follow-up|1|||
16141406|NCT01358760|39008406|FG002|Overall Study|Lost to Follow-up|3|||
16141407|NCT01358760|39008404|FG000|Overall Study|Withdrawal by Subject|5|||
16141408|NCT01358760|39008405|FG001|Overall Study|Withdrawal by Subject|3|||
16438973|NCT00689390|40085459|FG000|Overall Study|Administrative|37|||
16438974|NCT00689390|40085460|FG001|Overall Study|Administrative|0|||
16438975|NCT00781768|40085461|FG000|Overall Study|Not transplanted.|0|||
16438976|NCT00781768|40085462|FG001|Overall Study|Not transplanted.|2|||
16438977|NCT01766050|40085468|FG000|Overall Study|Adverse Event|1|||
16438978|NCT01766050|40085468|FG000|Overall Study|Lost to Follow-up|1|||
16438979|NCT01766050|40085468|FG000|Overall Study|Withdrawal by Subject|2|||
16438980|NCT02285855|40085469|FG000|Overall Study|Withdrawal by Subject|2|||
16438981|NCT02285855|40085470|FG001|Overall Study|Withdrawal by Subject|1|||
16438982|NCT00774046|40085471|FG000|Screening|Not eligible|56|||
16438983|NCT00774046|40085471|FG000|Enrollment|Desired other therapy/refused|28|||
16438984|NCT00774046|40085471|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
16438985|NCT01188772|40085472|FG000|Overall Study|Randomized but Not Treated|0|||
16438986|NCT01188772|40085473|FG001|Overall Study|Randomized but Not Treated|1|||
16438987|NCT01188772|40085474|FG002|Overall Study|Randomized but Not Treated|0|||
16141409|NCT01358760|39008406|FG002|Overall Study|Withdrawal by Subject|2|||
16141410|NCT01358760|39008404|FG000|Overall Study|Physician Decision|1|||
16141411|NCT01358760|39008405|FG001|Overall Study|Physician Decision|0|||
16141412|NCT01358760|39008406|FG002|Overall Study|Physician Decision|1|||
16141413|NCT01358760|39008404|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
16141414|NCT01358760|39008405|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
16141415|NCT01358760|39008406|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
16141416|NCT03374995|39008409|FG000|Overall Study|Withdrawal by Subject|0|||
16141417|NCT03374995|39008410|FG001|Overall Study|Withdrawal by Subject|1|||
16141418|NCT02119325|39008411|FG000|Washout Period 1|Adverse Event|0|||
16141419|NCT02119325|39008412|FG001|Washout Period 1|Adverse Event|1|||
16141420|NCT00292461|39008413|FG000|Overall Study|Adverse Event|4|||
16141421|NCT00292461|39008414|FG001|Overall Study|Adverse Event|2|||
16141422|NCT00292461|39008413|FG000|Overall Study|Lack of Efficacy|1|||
16141423|NCT00292461|39008414|FG001|Overall Study|Lack of Efficacy|0|||
16141424|NCT00292461|39008413|FG000|Overall Study|Withdrawal by Subject|0|||
16141425|NCT00292461|39008414|FG001|Overall Study|Withdrawal by Subject|1|||
16364113|NCT00640289|39818192|FG000|Overall Study|Missing status|5|||
16141426|NCT00292461|39008413|FG000|Overall Study|Protocol Violation|4|||
16141427|NCT00292461|39008414|FG001|Overall Study|Protocol Violation|3|||
16141428|NCT00292461|39008413|FG000|Overall Study|Lost to Follow-up|1|||
16141429|NCT00292461|39008414|FG001|Overall Study|Lost to Follow-up|0|||
16141430|NCT00726622|39008415|FG000|Overall Study|Withdrawal by Subject|16|||
16141431|NCT00726622|39008416|FG001|Overall Study|Withdrawal by Subject|2|||
16141432|NCT00726622|39008415|FG000|Overall Study|Physician Decision|0|||
16364114|NCT00819039|39818196|FG000|Overall Study|Physician Decision|1|||
16364115|NCT00819039|39818197|FG001|Overall Study|Physician Decision|0|||
16364116|NCT00819039|39818198|FG002|Overall Study|Physician Decision|1|||
16364117|NCT00819039|39818196|FG000|Overall Study|Protocol Violation|1|||
16364118|NCT00819039|39818197|FG001|Overall Study|Protocol Violation|0|||
16364119|NCT00819039|39818198|FG002|Overall Study|Protocol Violation|0|||
16364120|NCT00177671|39818202|FG000|Overall Study|Withdrawal by Subject|5|||
16364121|NCT00177671|39818203|FG001|Overall Study|Withdrawal by Subject|6|||
16364122|NCT00177671|39818202|FG000|Overall Study|medical complications|2|||
16364123|NCT00177671|39818203|FG001|Overall Study|medical complications|0|||
16364124|NCT00177671|39818202|FG000|Overall Study|Adverse Event|6|||
16364125|NCT00177671|39818203|FG001|Overall Study|Adverse Event|0|||
16364126|NCT00177671|39818202|FG000|Overall Study|Physician Decision|12|||
16364127|NCT00177671|39818203|FG001|Overall Study|Physician Decision|8|||
16364128|NCT01033071|39818204|FG000|Overall Study|Adverse Event|28|||
16364129|NCT01033071|39818205|FG001|Overall Study|Adverse Event|51|||
16364130|NCT01033071|39818206|FG002|Overall Study|Adverse Event|26|||
16364131|NCT01033071|39818204|FG000|Overall Study|Protocol Violation|0|||
16364132|NCT01033071|39818205|FG001|Overall Study|Protocol Violation|2|||
16364133|NCT01033071|39818206|FG002|Overall Study|Protocol Violation|1|||
16141433|NCT00726622|39008416|FG001|Overall Study|Physician Decision|1|||
16141434|NCT00726622|39008415|FG000|Overall Study|Metastasis|2|||
16141435|NCT00726622|39008416|FG001|Overall Study|Metastasis|0|||
16141436|NCT00943579|39008417|FG000|Overall Study|Adverse Event|4|||
16141437|NCT00943579|39008418|FG001|Overall Study|Adverse Event|3|||
16141438|NCT00943579|39008417|FG000|Overall Study|Lack of Efficacy|2|||
16141439|NCT00943579|39008418|FG001|Overall Study|Lack of Efficacy|2|||
16141440|NCT00908583|39008419|FG000|Phase 1|Withdrawal by Subject|1|||
16141441|NCT00908583|39008419|FG000|Phase 1|Adverse Event|4|||
16141442|NCT00908583|39008419|FG000|Phase 2|Physician Decision|1|||
16141443|NCT00908583|39008419|FG000|Phase 2|Adverse Event|1|||
16141444|NCT00908583|39008419|FG000|Phase 3|Adverse Event|2|||
16141445|NCT00908583|39008419|FG000|Phase 4|Adverse Event|1|||
16141446|NCT00908583|39008419|FG000|Phase 4|Physician Decision|1|||
16141447|NCT00908583|39008419|FG000|Phase 5|Adverse Event|3|||
16141448|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
16141449|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
16141450|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
16141451|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
16141452|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
16141453|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
16141454|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
16141455|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
16141456|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Death|1|||
16141457|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Death|1|||
16141458|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
16141459|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
16141460|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
16141461|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
16141462|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
16141463|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
16141464|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
16141465|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
16141466|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
16141467|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
16141468|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
16141469|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
16141470|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
16141471|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
16141472|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
16141473|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
16141474|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
16141475|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
16141476|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
16141477|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
16141478|NCT00559585|39008420|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
16141479|NCT00559585|39008421|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
16141480|NCT00559585|39008420|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
16141481|NCT00559585|39008421|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
16141482|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
16141483|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
16141484|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
16141485|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
16141486|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
16141487|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
16141488|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
16141489|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
16141490|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
16141491|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
16141492|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
16141493|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
16141494|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
16141495|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
16141496|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
16141497|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
16141498|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
16141499|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
16141500|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
16141501|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
16141502|NCT00559585|39008420|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
16141503|NCT00559585|39008421|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
16141504|NCT03715153|39008422|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
16141505|NCT03715153|39008423|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
16141506|NCT03715153|39008422|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
16141507|NCT03715153|39008423|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
16141508|NCT03715153|39008422|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
16141509|NCT03715153|39008423|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
16141510|NCT03715153|39008422|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
16141511|NCT03715153|39008423|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
16141512|NCT03715153|39008422|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
16141513|NCT03715153|39008423|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
16141514|NCT03715153|39008422|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
16141515|NCT03715153|39008423|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
16141516|NCT04556136|39008424|FG000|Overall Study|Lost to Follow-up|6|||
16141517|NCT04556136|39008425|FG001|Overall Study|Lost to Follow-up|6|||
16141518|NCT04556136|39008424|FG000|Overall Study|Physician Decision|2|||
16141519|NCT04556136|39008425|FG001|Overall Study|Physician Decision|1|||
16141520|NCT04556136|39008424|FG000|Overall Study|Withdrawal by Subject|2|||
16141521|NCT04556136|39008425|FG001|Overall Study|Withdrawal by Subject|1|||
16141522|NCT01765179|39008434|FG000|Overall Study|Adverse Event|3|||
16141523|NCT01765179|39008434|FG000|Overall Study|Lost to Follow-up|5|||
16141524|NCT01765179|39008434|FG000|Overall Study|Non-compliance with study drug|2|||
16141525|NCT01765179|39008434|FG000|Overall Study|Protocol Violation|1|||
16141526|NCT01765179|39008434|FG000|Overall Study|Withdrawal by Subject|8|||
16141527|NCT01765179|39008434|FG000|Overall Study|Hematocrit >54%|3|||
16141528|NCT01765179|39008434|FG000|Overall Study|prohibited med|1|||
16141529|NCT01765179|39008434|FG000|Overall Study|Out of country unable to finish study|1|||
16141530|NCT01765179|39008434|FG000|Overall Study|lack of venous access|1|||
16141531|NCT01765179|39008434|FG000|Overall Study|work conflict|1|||
16141532|NCT01765179|39008434|FG000|Overall Study|Ca elevated 10.6|1|||
16141533|NCT01576172|39008437|FG000|Overall Study|Ineligible|2|||
16141534|NCT01576172|39008438|FG001|Overall Study|Ineligible|1|||
16141535|NCT01576172|39008437|FG000|Overall Study|Withdrawal by Subject|2|||
16141536|NCT01576172|39008438|FG001|Overall Study|Withdrawal by Subject|0|||
16141537|NCT01576172|39008437|FG000|Overall Study|Insurance issue|1|||
16141538|NCT01576172|39008438|FG001|Overall Study|Insurance issue|0|||
16141539|NCT00995007|39008440|FG000|Overall Study|Withdrew consent|1|||
16141540|NCT00995007|39008441|FG001|Overall Study|Withdrew consent|0|||
16141541|NCT00995007|39008440|FG000|Overall Study|Refused further treatment|8|||
16141542|NCT00995007|39008441|FG001|Overall Study|Refused further treatment|2|||
16141543|NCT00995007|39008440|FG000|Overall Study|Toxicity|8|||
16141544|NCT00995007|39008441|FG001|Overall Study|Toxicity|0|||
16141545|NCT00604279|39008442|FG000|Overall Study|Lack of Efficacy|22|||
16141546|NCT00604279|39008443|FG001|Overall Study|Lack of Efficacy|9|||
16141547|NCT00604279|39008442|FG000|Overall Study|Lost to Follow-up|9|||
16141548|NCT00604279|39008443|FG001|Overall Study|Lost to Follow-up|14|||
16141549|NCT00604279|39008442|FG000|Overall Study|Pregnancy|2|||
16141550|NCT00604279|39008443|FG001|Overall Study|Pregnancy|0|||
16141551|NCT00604279|39008442|FG000|Overall Study|Protocol Violation|3|||
16141552|NCT00604279|39008443|FG001|Overall Study|Protocol Violation|1|||
16141553|NCT00604279|39008442|FG000|Overall Study|Withdrawal by Subject|16|||
16141554|NCT00604279|39008443|FG001|Overall Study|Withdrawal by Subject|5|||
16141555|NCT00604279|39008442|FG000|Overall Study|Adverse Event|4|||
16141556|NCT00604279|39008443|FG001|Overall Study|Adverse Event|5|||
16141557|NCT00604279|39008442|FG000|Overall Study|Other|8|||
16141558|NCT00604279|39008443|FG001|Overall Study|Other|4|||
16141559|NCT01306890|39008444|FG000|Overall Study|Adverse Event|2|||
16141560|NCT01306890|39008444|FG000|Overall Study|Death|1223|||
16141561|NCT01306890|39008444|FG000|Overall Study|Lost to Follow-up|58|||
16141562|NCT01306890|39008444|FG000|Overall Study|Withdrawal by Subject|88|||
16141563|NCT01306890|39008444|FG000|Overall Study|Unspecified reasons|104|||
16141564|NCT01306890|39008444|FG000|Overall Study|Study Termination|3|||
16141565|NCT01306890|39008444|FG000|Overall Study|No discontinuation documentation|41|||
16141566|NCT01807923|39008445|FG000|Overall Study|Adverse Event|2|||
16438988|NCT01188772|40085475|FG003|Overall Study|Randomized but Not Treated|0|||
16438989|NCT01188772|40085472|FG000|Overall Study|Adverse Event|0|||
16438990|NCT01188772|40085473|FG001|Overall Study|Adverse Event|1|||
16141567|NCT01807923|39008446|FG001|Overall Study|Adverse Event|1|||
16141568|NCT01807923|39008447|FG002|Overall Study|Adverse Event|2|||
16141569|NCT01807923|39008445|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
16141570|NCT01807923|39008446|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
16141571|NCT01807923|39008447|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
16141572|NCT01807923|39008445|FG000|Overall Study|Physician Decision|0|||
16141573|NCT01807923|39008446|FG001|Overall Study|Physician Decision|0|||
16141574|NCT01807923|39008447|FG002|Overall Study|Physician Decision|1|||
16141575|NCT01807923|39008445|FG000|Overall Study|Not Eligible (Genotype)|0|||
16141576|NCT01807923|39008446|FG001|Overall Study|Not Eligible (Genotype)|0|||
16141577|NCT01807923|39008447|FG002|Overall Study|Not Eligible (Genotype)|1|||
16141578|NCT01807923|39008445|FG000|Overall Study|Randomized But Not Treated|3|||
16141579|NCT01807923|39008446|FG001|Overall Study|Randomized But Not Treated|2|||
16141580|NCT01807923|39008447|FG002|Overall Study|Randomized But Not Treated|5|||
16141581|NCT02973087|39008452|FG000|Overall Study|Withdrawal by Subject|2|||
16141582|NCT02973087|39008453|FG001|Overall Study|Withdrawal by Subject|1|||
16141583|NCT02973087|39008452|FG000|Overall Study|Adverse Event|1|||
16141584|NCT02973087|39008453|FG001|Overall Study|Adverse Event|0|||
16141585|NCT02973087|39008452|FG000|Overall Study|other|1|||
16141586|NCT02973087|39008453|FG001|Overall Study|other|1|||
16141587|NCT01163721|39008455|FG000|Overall Study|Adverse Event|5|||
16141588|NCT01163721|39008456|FG001|Overall Study|Adverse Event|6|||
16141589|NCT01163721|39008455|FG000|Overall Study|Withdrawal by Subject|3|||
16141590|NCT01163721|39008456|FG001|Overall Study|Withdrawal by Subject|4|||
16141591|NCT01163721|39008455|FG000|Overall Study|Lost to Follow-up|0|||
16141592|NCT01163721|39008456|FG001|Overall Study|Lost to Follow-up|1|||
16141593|NCT01163721|39008455|FG000|Overall Study|Physician Decision|0|||
16141594|NCT01163721|39008456|FG001|Overall Study|Physician Decision|1|||
16141595|NCT02012296|39008457|FG000|Overall Study|Lack of Efficacy|0|||
16141596|NCT02012296|39008458|FG001|Overall Study|Lack of Efficacy|0|||
16141597|NCT02012296|39008459|FG002|Overall Study|Lack of Efficacy|15|||
16141598|NCT02012296|39008457|FG000|Overall Study|Adverse Event|0|||
16255573|NCT00048568|39419913|FG001|Open-Label Period|Lost to Follow-up|0|||
16255574|NCT00048568|39419914|FG002|Open-Label Period|Lost to Follow-up|7|||
16438991|NCT01188772|40085474|FG002|Overall Study|Adverse Event|2|||
16438992|NCT01188772|40085475|FG003|Overall Study|Adverse Event|0|||
16438993|NCT01188772|40085472|FG000|Overall Study|Lost to Follow-up|4|||
16141599|NCT02012296|39008458|FG001|Overall Study|Adverse Event|0|||
16141600|NCT02012296|39008459|FG002|Overall Study|Adverse Event|2|||
16141601|NCT02012296|39008457|FG000|Overall Study|Early study closure|0|||
16141602|NCT02012296|39008458|FG001|Overall Study|Early study closure|0|||
16141603|NCT02012296|39008459|FG002|Overall Study|Early study closure|5|||
16141604|NCT02012296|39008457|FG000|Overall Study|Protocol Violation|0|||
16141605|NCT02012296|39008458|FG001|Overall Study|Protocol Violation|1|||
16141606|NCT02012296|39008459|FG002|Overall Study|Protocol Violation|0|||
16141607|NCT02673619|39008460|FG000|Overall Study|Lost to Follow-up|1|||
16141608|NCT02673619|39008461|FG001|Overall Study|Lost to Follow-up|0|||
16141609|NCT02673619|39008462|FG002|Overall Study|Lost to Follow-up|0|||
16141610|NCT02673619|39008463|FG003|Overall Study|Lost to Follow-up|0|||
16141611|NCT02673619|39008460|FG000|Overall Study|Withdrawal by Subject|1|||
16141612|NCT02673619|39008461|FG001|Overall Study|Withdrawal by Subject|1|||
16141613|NCT02673619|39008462|FG002|Overall Study|Withdrawal by Subject|1|||
16438994|NCT01188772|40085473|FG001|Overall Study|Lost to Follow-up|1|||
16438995|NCT01188772|40085474|FG002|Overall Study|Lost to Follow-up|1|||
16438996|NCT01188772|40085475|FG003|Overall Study|Lost to Follow-up|1|||
16438997|NCT01188772|40085472|FG000|Overall Study|Non-responder|0|||
16438998|NCT01188772|40085473|FG001|Overall Study|Non-responder|0|||
16438999|NCT01188772|40085474|FG002|Overall Study|Non-responder|3|||
16439000|NCT01188772|40085475|FG003|Overall Study|Non-responder|0|||
16439001|NCT01188772|40085472|FG000|Overall Study|Physician Decision|0|||
16439002|NCT01188772|40085473|FG001|Overall Study|Physician Decision|0|||
16439003|NCT01188772|40085474|FG002|Overall Study|Physician Decision|1|||
16439004|NCT01188772|40085475|FG003|Overall Study|Physician Decision|0|||
16439005|NCT01188772|40085472|FG000|Overall Study|Terminated by Sponsor|0|||
16439006|NCT01188772|40085473|FG001|Overall Study|Terminated by Sponsor|0|||
16141614|NCT02673619|39008463|FG003|Overall Study|Withdrawal by Subject|0|||
16141615|NCT02673619|39008460|FG000|Overall Study|Adverse Event|0|||
16141616|NCT02673619|39008461|FG001|Overall Study|Adverse Event|0|||
16141617|NCT02673619|39008462|FG002|Overall Study|Adverse Event|1|||
16141618|NCT02673619|39008463|FG003|Overall Study|Adverse Event|0|||
16141619|NCT02673619|39008460|FG000|Overall Study|Lack of Efficacy|0|||
16141620|NCT02673619|39008461|FG001|Overall Study|Lack of Efficacy|0|||
16141621|NCT02673619|39008462|FG002|Overall Study|Lack of Efficacy|1|||
16141622|NCT02673619|39008463|FG003|Overall Study|Lack of Efficacy|0|||
16141623|NCT01301456|39008468|FG000|Stage 1|Withdrawal by Subject|0|||
16141624|NCT01301456|39008469|FG001|Stage 1|Withdrawal by Subject|0|||
16141625|NCT01301456|39008470|FG002|Stage 1|Withdrawal by Subject|1|||
16141626|NCT01301456|39008471|FG003|Stage 1|Withdrawal by Subject|0|||
16141627|NCT01301456|39008472|FG004|Stage 1|Withdrawal by Subject|1|||
16141628|NCT01301456|39008473|FG005|Stage 1|Withdrawal by Subject|0|||
16141629|NCT01301456|39008474|FG006|Stage 1|Withdrawal by Subject|0|||
16141630|NCT01301456|39008475|FG007|Stage 1|Withdrawal by Subject|0|||
16141631|NCT01301456|39008476|FG008|Stage 1|Withdrawal by Subject|0|||
16141632|NCT01301456|39008477|FG009|Stage 1|Withdrawal by Subject|0|||
16141633|NCT01301456|39008478|FG010|Stage 1|Withdrawal by Subject|0|||
16141634|NCT01301456|39008479|FG011|Stage 1|Withdrawal by Subject|0|||
16141635|NCT01301456|39008468|FG000|Stage 1|Randomized but not treated|0|||
16141636|NCT01301456|39008469|FG001|Stage 1|Randomized but not treated|0|||
16141637|NCT01301456|39008470|FG002|Stage 1|Randomized but not treated|0|||
16141638|NCT01301456|39008471|FG003|Stage 1|Randomized but not treated|0|||
16141639|NCT01301456|39008472|FG004|Stage 1|Randomized but not treated|0|||
16141640|NCT01301456|39008473|FG005|Stage 1|Randomized but not treated|0|||
16141641|NCT01301456|39008474|FG006|Stage 1|Randomized but not treated|1|||
16141642|NCT01301456|39008475|FG007|Stage 1|Randomized but not treated|0|||
16141643|NCT01301456|39008476|FG008|Stage 1|Randomized but not treated|0|||
16141644|NCT01301456|39008477|FG009|Stage 1|Randomized but not treated|0|||
16141645|NCT01301456|39008478|FG010|Stage 1|Randomized but not treated|0|||
16141646|NCT01301456|39008479|FG011|Stage 1|Randomized but not treated|0|||
16364134|NCT01033071|39818204|FG000|Overall Study|Lost to Follow-up|4|||
16141647|NCT01301456|39008468|FG000|Stage 2|Adverse Event|0|||
16141648|NCT01301456|39008469|FG001|Stage 2|Adverse Event|0|||
16141649|NCT01301456|39008470|FG002|Stage 2|Adverse Event|0|||
16141650|NCT01301456|39008471|FG003|Stage 2|Adverse Event|0|||
16141651|NCT01301456|39008472|FG004|Stage 2|Adverse Event|0|||
16141652|NCT01301456|39008473|FG005|Stage 2|Adverse Event|0|||
16141653|NCT01301456|39008474|FG006|Stage 2|Adverse Event|0|||
16141654|NCT01301456|39008475|FG007|Stage 2|Adverse Event|0|||
16141655|NCT01301456|39008476|FG008|Stage 2|Adverse Event|0|||
16141656|NCT01301456|39008477|FG009|Stage 2|Adverse Event|0|||
16364135|NCT01033071|39818205|FG001|Overall Study|Lost to Follow-up|5|||
16364136|NCT01033071|39818206|FG002|Overall Study|Lost to Follow-up|5|||
16364137|NCT01033071|39818204|FG000|Overall Study|Withdrawal by Subject|17|||
16364138|NCT01033071|39818205|FG001|Overall Study|Withdrawal by Subject|14|||
16364139|NCT01033071|39818206|FG002|Overall Study|Withdrawal by Subject|11|||
16364140|NCT01033071|39818204|FG000|Overall Study|Lack of Efficacy|0|||
16364141|NCT01033071|39818205|FG001|Overall Study|Lack of Efficacy|1|||
16364142|NCT01033071|39818206|FG002|Overall Study|Lack of Efficacy|1|||
16364143|NCT01033071|39818204|FG000|Overall Study|Other|6|||
16364144|NCT01033071|39818205|FG001|Overall Study|Other|4|||
16364145|NCT01033071|39818206|FG002|Overall Study|Other|3|||
16364146|NCT02110693|39818207|FG000|Overall Study|Withdrawal by Subject|6|||
16364147|NCT02110693|39818208|FG001|Overall Study|Withdrawal by Subject|7|||
16364148|NCT02110693|39818207|FG000|Overall Study|skipped assessment|15|||
16364149|NCT02110693|39818208|FG001|Overall Study|skipped assessment|18|||
16364150|NCT02110693|39818207|FG000|Overall Study|technical difficulties|6|||
16364151|NCT02110693|39818208|FG001|Overall Study|technical difficulties|4|||
16141657|NCT01301456|39008478|FG010|Stage 2|Adverse Event|1|||
16141658|NCT01301456|39008479|FG011|Stage 2|Adverse Event|0|||
16141659|NCT02066051|39008480|FG000|Overall Study|Subject developed active GVHD|1|||
16141660|NCT00752622|39008481|FG000|Induction Phase|Adverse Event|3|||
16141661|NCT00752622|39008481|FG000|Induction Phase|Other|3|||
16141662|NCT00752622|39008481|FG000|Induction Phase|Non-responder|14|||
16141663|NCT00752622|39008481|FG000|Induction Phase|Withdrawal by Subject|1|||
16141664|NCT00752622|39008481|FG000|Induction Phase|Premature study termination|14|||
16439007|NCT01188772|40085474|FG002|Overall Study|Terminated by Sponsor|1|||
16439008|NCT01188772|40085475|FG003|Overall Study|Terminated by Sponsor|0|||
16439009|NCT01188772|40085472|FG000|Overall Study|Treatment Failure|0|||
16439010|NCT01188772|40085473|FG001|Overall Study|Treatment Failure|0|||
16439011|NCT01188772|40085474|FG002|Overall Study|Treatment Failure|1|||
16439012|NCT01188772|40085475|FG003|Overall Study|Treatment Failure|0|||
16439013|NCT01188772|40085472|FG000|Overall Study|Virologic Failure|1|||
16439014|NCT01188772|40085473|FG001|Overall Study|Virologic Failure|0|||
16439015|NCT01188772|40085474|FG002|Overall Study|Virologic Failure|0|||
16439016|NCT01188772|40085475|FG003|Overall Study|Virologic Failure|0|||
16439017|NCT01188772|40085472|FG000|Overall Study|Withdrawal by Subject|0|||
16439018|NCT01188772|40085473|FG001|Overall Study|Withdrawal by Subject|0|||
16439019|NCT01188772|40085474|FG002|Overall Study|Withdrawal by Subject|2|||
16439020|NCT01188772|40085475|FG003|Overall Study|Withdrawal by Subject|0|||
16141665|NCT00752622|39008481|FG000|Observational Phase|Premature Study Termination|36|||
16141666|NCT00752622|39008481|FG000|Observational Phase|Non-responder|2|||
16141667|NCT00752622|39008481|FG000|Observational Phase|Withdrawal by Subject|2|||
16141668|NCT00752622|39008481|FG000|Observational Phase|Adverse Event|1|||
16141669|NCT00752622|39008481|FG000|Observational Phase|Other|2|||
16439021|NCT02714569|40085476|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
16439022|NCT02714569|40085477|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
16439023|NCT02714569|40085478|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
16439024|NCT02714569|40085479|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
16439025|NCT02714569|40085480|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
16439026|NCT02714569|40085481|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
16439027|NCT02714569|40085482|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
16439028|NCT02714569|40085483|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
16439029|NCT02714569|40085484|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
16439030|NCT02714569|40085485|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
16439031|NCT02714569|40085486|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
16439032|NCT02714569|40085476|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16439033|NCT02714569|40085477|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16439034|NCT02714569|40085478|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16439035|NCT02714569|40085479|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
16439036|NCT02714569|40085480|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16439037|NCT02714569|40085481|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16141670|NCT00752622|39008481|FG000|Interventional Phase|Non-responder|2|||
16141671|NCT00752622|39008481|FG000|Interventional Phase|Physician Decision|1|||
16141672|NCT00752622|39008481|FG000|Interventional Phase|Premature Study Termination|5|||
16141673|NCT02464228|39008486|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
16141674|NCT02464228|39008487|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
16141675|NCT02464228|39008488|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
16141676|NCT02464228|39008489|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
16141677|NCT02464228|39008486|FG000|Overall Study|Physician Decision|2|||
16141678|NCT02464228|39008487|FG001|Overall Study|Physician Decision|0|||
16141679|NCT02464228|39008488|FG002|Overall Study|Physician Decision|1|||
16141680|NCT02464228|39008489|FG003|Overall Study|Physician Decision|0|||
16141681|NCT02464228|39008486|FG000|Overall Study|Miscellaneous|1|||
16141682|NCT02464228|39008487|FG001|Overall Study|Miscellaneous|0|||
16141683|NCT02464228|39008488|FG002|Overall Study|Miscellaneous|1|||
16141684|NCT02464228|39008489|FG003|Overall Study|Miscellaneous|0|||
16141685|NCT02464228|39008486|FG000|Overall Study|Adverse Event|9|||
16141686|NCT02464228|39008487|FG001|Overall Study|Adverse Event|0|||
16141687|NCT02464228|39008488|FG002|Overall Study|Adverse Event|3|||
16141688|NCT02464228|39008489|FG003|Overall Study|Adverse Event|0|||
16141689|NCT02464228|39008486|FG000|Overall Study|Withdrawal by Subject|1|||
16141690|NCT02464228|39008487|FG001|Overall Study|Withdrawal by Subject|1|||
16141691|NCT02464228|39008488|FG002|Overall Study|Withdrawal by Subject|1|||
16141692|NCT02464228|39008489|FG003|Overall Study|Withdrawal by Subject|0|||
16141693|NCT02464228|39008486|FG000|Overall Study|Disease Progression|22|||
16141694|NCT02464228|39008487|FG001|Overall Study|Disease Progression|12|||
16141695|NCT02464228|39008488|FG002|Overall Study|Disease Progression|5|||
16141696|NCT02464228|39008489|FG003|Overall Study|Disease Progression|2|||
16141697|NCT03713034|39008492|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
16141698|NCT03713034|39008493|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
16141699|NCT00718549|39008496|FG000|Induction Phase|Disease Progression|1|||
16141700|NCT00718549|39008497|FG001|Induction Phase|Disease Progression|0|||
16141701|NCT00718549|39008498|FG002|Induction Phase|Disease Progression|0|||
16141702|NCT00718549|39008496|FG000|Induction Phase|Eligibility Criteria Violation|2|||
16141703|NCT00718549|39008497|FG001|Induction Phase|Eligibility Criteria Violation|0|||
16141704|NCT00718549|39008498|FG002|Induction Phase|Eligibility Criteria Violation|0|||
16141705|NCT00718549|39008496|FG000|Induction Phase|Early Termination - No Additional Info|59|||
16141706|NCT00718549|39008497|FG001|Induction Phase|Early Termination - No Additional Info|0|||
16141707|NCT00718549|39008498|FG002|Induction Phase|Early Termination - No Additional Info|0|||
16141708|NCT00718549|39008496|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
16141709|NCT00718549|39008497|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
16141710|NCT00718549|39008498|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
16141711|NCT00718549|39008496|FG000|Maintenance/ Observation Phase|Death|0|||
16141712|NCT00718549|39008497|FG001|Maintenance/ Observation Phase|Death|1|||
16141713|NCT00718549|39008498|FG002|Maintenance/ Observation Phase|Death|2|||
16141714|NCT00718549|39008496|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
16141715|NCT00718549|39008497|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
16141716|NCT00718549|39008498|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
16141717|NCT00718549|39008496|FG000|Maintenance/ Observation Phase|Progression|0|||
16141718|NCT00718549|39008497|FG001|Maintenance/ Observation Phase|Progression|5|||
16141719|NCT00718549|39008498|FG002|Maintenance/ Observation Phase|Progression|14|||
16141720|NCT00718549|39008496|FG000|Maintenance/ Observation Phase|Relapse|0|||
16141721|NCT00718549|39008497|FG001|Maintenance/ Observation Phase|Relapse|3|||
16141722|NCT00718549|39008498|FG002|Maintenance/ Observation Phase|Relapse|2|||
16141723|NCT02456662|39008499|FG000|Overall Study|Lost to Follow-up|2|||
16141724|NCT02456662|39008500|FG001|Overall Study|Lost to Follow-up|1|||
16141725|NCT00404066|39008501|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
16141726|NCT00404066|39008501|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
16141727|NCT01822522|39008502|FG000|Overall Study|Adverse Event|1|||
16141728|NCT01822522|39008503|FG001|Overall Study|Adverse Event|1|||
16141729|NCT01822522|39008504|FG002|Overall Study|Adverse Event|1|||
16141730|NCT01822522|39008505|FG003|Overall Study|Adverse Event|0|||
16141731|NCT01822522|39008506|FG004|Overall Study|Adverse Event|0|||
16141732|NCT01822522|39008507|FG005|Overall Study|Adverse Event|1|||
16141733|NCT01822522|39008502|FG000|Overall Study|Death|3|||
16141734|NCT01822522|39008503|FG001|Overall Study|Death|0|||
16141735|NCT01822522|39008504|FG002|Overall Study|Death|2|||
16141736|NCT01822522|39008505|FG003|Overall Study|Death|0|||
16141737|NCT01822522|39008506|FG004|Overall Study|Death|0|||
16141738|NCT01822522|39008507|FG005|Overall Study|Death|0|||
16141739|NCT01822522|39008502|FG000|Overall Study|Lost to Follow-up|0|||
16141740|NCT01822522|39008503|FG001|Overall Study|Lost to Follow-up|0|||
16141741|NCT01822522|39008504|FG002|Overall Study|Lost to Follow-up|1|||
16141742|NCT01822522|39008505|FG003|Overall Study|Lost to Follow-up|1|||
16141743|NCT01822522|39008506|FG004|Overall Study|Lost to Follow-up|0|||
16141744|NCT01822522|39008507|FG005|Overall Study|Lost to Follow-up|1|||
16141745|NCT01822522|39008502|FG000|Overall Study|Withdrawal by Subject|0|||
16141746|NCT01822522|39008503|FG001|Overall Study|Withdrawal by Subject|0|||
16141747|NCT01822522|39008504|FG002|Overall Study|Withdrawal by Subject|0|||
16141748|NCT01822522|39008505|FG003|Overall Study|Withdrawal by Subject|1|||
16141749|NCT01822522|39008506|FG004|Overall Study|Withdrawal by Subject|0|||
16141750|NCT01822522|39008507|FG005|Overall Study|Withdrawal by Subject|0|||
16141751|NCT01822522|39008502|FG000|Overall Study|Lack of Efficacy|0|||
16141752|NCT01822522|39008503|FG001|Overall Study|Lack of Efficacy|0|||
16141753|NCT01822522|39008504|FG002|Overall Study|Lack of Efficacy|0|||
16141754|NCT01822522|39008505|FG003|Overall Study|Lack of Efficacy|0|||
16141755|NCT01822522|39008506|FG004|Overall Study|Lack of Efficacy|0|||
16141756|NCT01822522|39008507|FG005|Overall Study|Lack of Efficacy|2|||
16141757|NCT01184053|39008508|FG000|Overall Study|progression while on treatment|3|||
16141758|NCT00890929|39008509|FG000|Overall Study|Death before treatment|2|||
16141759|NCT00890929|39008509|FG000|Overall Study|Withdrawal by Subject|3|||
16141760|NCT00890929|39008509|FG000|Overall Study|Physician Decision|1|||
16141761|NCT00929656|39008510|FG000|Overall Study|Lost to Follow-up|0|||
16141762|NCT00929656|39008511|FG001|Overall Study|Lost to Follow-up|1|||
16141763|NCT00122681|39008520|FG000|Overall Study|Adverse Event|20|||
16141764|NCT00122681|39008521|FG001|Overall Study|Adverse Event|16|||
16141765|NCT00122681|39008520|FG000|Overall Study|Lost to Follow-up|1080|||
16141766|NCT00122681|39008521|FG001|Overall Study|Lost to Follow-up|1097|||
16141767|NCT00122681|39008520|FG000|Overall Study|Protocol Violation|7|||
16141768|NCT00122681|39008521|FG001|Overall Study|Protocol Violation|10|||
16141769|NCT00122681|39008520|FG000|Overall Study|Withdrawal by Subject|257|||
16141770|NCT00122681|39008521|FG001|Overall Study|Withdrawal by Subject|251|||
16141771|NCT00122681|39008520|FG000|Overall Study|Personal reasons|150|||
16141772|NCT00122681|39008521|FG001|Overall Study|Personal reasons|147|||
16141773|NCT01854645|39008527|FG000|Overall Study|Protocol-Specified Criteria|13|||
16141774|NCT01854645|39008528|FG001|Overall Study|Protocol-Specified Criteria|10|||
16141775|NCT01854645|39008529|FG002|Overall Study|Protocol-Specified Criteria|8|||
16141776|NCT01854645|39008530|FG003|Overall Study|Protocol-Specified Criteria|5|||
16141777|NCT01854645|39008531|FG004|Overall Study|Protocol-Specified Criteria|7|||
16141778|NCT01854645|39008527|FG000|Overall Study|Administrative Reasons / Missing|0|||
16141779|NCT01854645|39008528|FG001|Overall Study|Administrative Reasons / Missing|0|||
16141780|NCT01854645|39008529|FG002|Overall Study|Administrative Reasons / Missing|0|||
16141781|NCT01854645|39008530|FG003|Overall Study|Administrative Reasons / Missing|1|||
16141782|NCT01854645|39008531|FG004|Overall Study|Administrative Reasons / Missing|1|||
16141783|NCT01854645|39008527|FG000|Overall Study|Protocol Violation|3|||
16141784|NCT01854645|39008528|FG001|Overall Study|Protocol Violation|0|||
16141785|NCT01854645|39008529|FG002|Overall Study|Protocol Violation|5|||
16141786|NCT01854645|39008530|FG003|Overall Study|Protocol Violation|4|||
16141787|NCT01854645|39008531|FG004|Overall Study|Protocol Violation|1|||
16141788|NCT01854645|39008527|FG000|Overall Study|Lost to Follow-up|10|||
16141789|NCT01854645|39008528|FG001|Overall Study|Lost to Follow-up|7|||
16141790|NCT01854645|39008529|FG002|Overall Study|Lost to Follow-up|8|||
16141791|NCT01854645|39008530|FG003|Overall Study|Lost to Follow-up|5|||
16141792|NCT01854645|39008531|FG004|Overall Study|Lost to Follow-up|0|||
16141793|NCT01854645|39008527|FG000|Overall Study|Physician Decision|1|||
16141794|NCT01854645|39008528|FG001|Overall Study|Physician Decision|5|||
16141795|NCT01854645|39008529|FG002|Overall Study|Physician Decision|3|||
16141796|NCT01854645|39008530|FG003|Overall Study|Physician Decision|3|||
16141797|NCT01854645|39008531|FG004|Overall Study|Physician Decision|7|||
16141798|NCT01854645|39008527|FG000|Overall Study|Withdrawal by Subject|31|||
16141799|NCT01854645|39008528|FG001|Overall Study|Withdrawal by Subject|41|||
16141800|NCT01854645|39008529|FG002|Overall Study|Withdrawal by Subject|30|||
16141801|NCT01854645|39008530|FG003|Overall Study|Withdrawal by Subject|21|||
16141802|NCT01854645|39008531|FG004|Overall Study|Withdrawal by Subject|24|||
16141803|NCT01854645|39008527|FG000|Overall Study|Lack of Efficacy|7|||
16141804|NCT01854645|39008528|FG001|Overall Study|Lack of Efficacy|12|||
16141805|NCT01854645|39008529|FG002|Overall Study|Lack of Efficacy|9|||
16141806|NCT01854645|39008530|FG003|Overall Study|Lack of Efficacy|3|||
16141807|NCT01854645|39008531|FG004|Overall Study|Lack of Efficacy|9|||
16141808|NCT01854645|39008527|FG000|Overall Study|Adverse Event|33|||
16141809|NCT01854645|39008528|FG001|Overall Study|Adverse Event|31|||
16141810|NCT01854645|39008529|FG002|Overall Study|Adverse Event|19|||
16141811|NCT01854645|39008530|FG003|Overall Study|Adverse Event|20|||
16141812|NCT01854645|39008531|FG004|Overall Study|Adverse Event|11|||
16141813|NCT03250832|39008534|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
16141814|NCT03250832|39008535|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
16141815|NCT03250832|39008536|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
16141816|NCT03250832|39008537|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
16141817|NCT03250832|39008538|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
16141818|NCT03250832|39008539|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
16141819|NCT03250832|39008540|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
16364152|NCT02110693|39818207|FG000|Overall Study|Other|1|||
16141820|NCT03250832|39008541|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
16141821|NCT03250832|39008542|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
16141822|NCT03250832|39008543|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
16141823|NCT03250832|39008544|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
16141824|NCT03250832|39008545|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
16141825|NCT03250832|39008534|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
16141826|NCT03250832|39008535|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
16141827|NCT03250832|39008536|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
16141828|NCT03250832|39008537|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
16141829|NCT03250832|39008538|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
16141830|NCT03250832|39008539|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
16141831|NCT03250832|39008540|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
16141832|NCT03250832|39008541|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
16141833|NCT03250832|39008542|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
16141834|NCT03250832|39008543|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
16141835|NCT03250832|39008544|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
16141836|NCT03250832|39008545|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
16141837|NCT03250832|39008534|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141838|NCT03250832|39008535|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141839|NCT03250832|39008536|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
16141840|NCT03250832|39008537|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141841|NCT03250832|39008538|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141842|NCT03250832|39008539|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141843|NCT03250832|39008540|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141844|NCT03250832|39008541|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141845|NCT03250832|39008542|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141846|NCT03250832|39008543|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141847|NCT03250832|39008544|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141848|NCT03250832|39008545|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
16141849|NCT03250832|39008534|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141850|NCT03250832|39008535|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141851|NCT03250832|39008536|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141852|NCT03250832|39008537|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141853|NCT03250832|39008538|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141854|NCT03250832|39008539|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141855|NCT03250832|39008540|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141856|NCT03250832|39008541|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
16141857|NCT03250832|39008542|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141858|NCT03250832|39008543|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141859|NCT03250832|39008544|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141860|NCT03250832|39008545|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
16141861|NCT03250832|39008534|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141862|NCT03250832|39008535|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141863|NCT03250832|39008536|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141864|NCT03250832|39008537|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141865|NCT03250832|39008538|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141866|NCT03250832|39008539|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141867|NCT03250832|39008540|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141868|NCT03250832|39008541|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
16141869|NCT03250832|39008542|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141870|NCT03250832|39008543|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141871|NCT03250832|39008544|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141872|NCT03250832|39008545|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
16141873|NCT03250832|39008534|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141874|NCT03250832|39008535|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141875|NCT03250832|39008536|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141876|NCT03250832|39008537|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141877|NCT03250832|39008538|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141878|NCT03250832|39008539|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141879|NCT03250832|39008540|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141880|NCT03250832|39008541|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
16141881|NCT03250832|39008542|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141882|NCT03250832|39008543|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141883|NCT03250832|39008544|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141884|NCT03250832|39008545|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
16141885|NCT03250832|39008534|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16141886|NCT03250832|39008535|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16255575|NCT02750306|39419915|FG000|Overall Study|Withdrawal by Subject|5|||
16141887|NCT03250832|39008536|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16141888|NCT03250832|39008537|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16141889|NCT03250832|39008538|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16141890|NCT03250832|39008539|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16141891|NCT03250832|39008540|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16141892|NCT03250832|39008541|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
16141893|NCT03250832|39008542|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16141894|NCT03250832|39008543|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16141895|NCT03250832|39008544|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16141896|NCT03250832|39008545|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
16141897|NCT03250832|39008534|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141898|NCT03250832|39008535|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141899|NCT03250832|39008536|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141900|NCT03250832|39008537|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141901|NCT03250832|39008538|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141902|NCT03250832|39008539|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141903|NCT03250832|39008540|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141904|NCT03250832|39008541|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
16141905|NCT03250832|39008542|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141906|NCT03250832|39008543|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141907|NCT03250832|39008544|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141908|NCT03250832|39008545|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
16141909|NCT03250832|39008534|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
16141910|NCT03250832|39008535|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
16141911|NCT03250832|39008536|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
16141912|NCT03250832|39008537|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
16141913|NCT03250832|39008538|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
16141914|NCT03250832|39008539|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
16141915|NCT03250832|39008540|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
16141916|NCT03250832|39008541|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
16141917|NCT03250832|39008542|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
16141918|NCT03250832|39008543|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
16141919|NCT03250832|39008544|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
16141920|NCT03250832|39008545|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
16141921|NCT03250832|39008534|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
16141922|NCT03250832|39008535|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
16141923|NCT03250832|39008536|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
16141924|NCT03250832|39008537|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
16141925|NCT03250832|39008538|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
16141926|NCT03250832|39008539|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
16141927|NCT03250832|39008540|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
16141928|NCT03250832|39008541|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
16141929|NCT03250832|39008542|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
16141930|NCT03250832|39008543|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
16141931|NCT03250832|39008544|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
16141932|NCT03250832|39008545|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
16141933|NCT03250832|39008534|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
16141934|NCT03250832|39008535|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
16141935|NCT03250832|39008536|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
16141936|NCT03250832|39008537|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
16141937|NCT03250832|39008538|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
16141938|NCT03250832|39008539|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
16141939|NCT03250832|39008540|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
16141940|NCT03250832|39008541|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
16141941|NCT03250832|39008542|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
16141942|NCT03250832|39008543|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
16141943|NCT03250832|39008544|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
16141944|NCT03250832|39008545|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
16141945|NCT03250832|39008534|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16141946|NCT03250832|39008535|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16141947|NCT03250832|39008536|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16141948|NCT03250832|39008537|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16141949|NCT03250832|39008538|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16141950|NCT03250832|39008539|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16141951|NCT03250832|39008540|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16364153|NCT02110693|39818208|FG001|Overall Study|Other|0|||
16141952|NCT03250832|39008541|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16141953|NCT03250832|39008542|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16141954|NCT03250832|39008543|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16141955|NCT03250832|39008544|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
16141956|NCT03250832|39008545|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
16141957|NCT00607880|39008553|FG000|Overall Study|Unable to place port due to occlusion|1|||
16141958|NCT00607880|39008554|FG001|Overall Study|Unable to place port due to occlusion|0|||
16141959|NCT01008696|39008558|FG000|Overall Study|Participant's evasion of hospital visit|5|||
16141960|NCT01008696|39008559|FG001|Overall Study|Participant's evasion of hospital visit|4|||
16141961|NCT01008696|39008558|FG000|Overall Study|Withdrawal by Subject|2|||
16141962|NCT01008696|39008559|FG001|Overall Study|Withdrawal by Subject|4|||
16141963|NCT01008696|39008558|FG000|Overall Study|Physician Decision|5|||
16141964|NCT01008696|39008559|FG001|Overall Study|Physician Decision|1|||
16141965|NCT01008696|39008558|FG000|Overall Study|Adverse Event|1|||
16141966|NCT01008696|39008559|FG001|Overall Study|Adverse Event|0|||
16255576|NCT02750306|39419916|FG001|Overall Study|Withdrawal by Subject|2|||
16255577|NCT02750306|39419915|FG000|Overall Study|Protocol Violation|1|||
16255578|NCT02750306|39419916|FG001|Overall Study|Protocol Violation|0|||
16255579|NCT02032888|39419917|FG000|Treatment Period|Poor compliance/noncompliance|1|||
16255580|NCT02032888|39419918|FG001|Treatment Period|Poor compliance/noncompliance|1|||
16255581|NCT02032888|39419919|FG002|Treatment Period|Poor compliance/noncompliance|0|||
16255582|NCT02032888|39419917|FG000|Treatment Period|Other|1|||
16255583|NCT02032888|39419918|FG001|Treatment Period|Other|1|||
16255584|NCT02032888|39419919|FG002|Treatment Period|Other|0|||
16255585|NCT02032888|39419917|FG000|Follow-up Period|Lost to Follow-up|1|||
16255586|NCT02032888|39419918|FG001|Follow-up Period|Lost to Follow-up|1|||
16255587|NCT02032888|39419919|FG002|Follow-up Period|Lost to Follow-up|0|||
16255588|NCT02032888|39419917|FG000|Follow-up Period|Death|1|||
16255589|NCT02032888|39419918|FG001|Follow-up Period|Death|1|||
16255590|NCT02032888|39419919|FG002|Follow-up Period|Death|0|||
16255591|NCT02032888|39419917|FG000|Follow-up Period|Other|1|||
16255592|NCT02032888|39419918|FG001|Follow-up Period|Other|0|||
16255593|NCT02032888|39419919|FG002|Follow-up Period|Other|0|||
16255594|NCT02536378|39419921|FG000|Overall Study|Physician Decision|0|||
16255595|NCT02536378|39419922|FG001|Overall Study|Physician Decision|2|||
16255596|NCT02536378|39419921|FG000|Overall Study|Withdrawal by Subject|0|||
16255597|NCT02536378|39419922|FG001|Overall Study|Withdrawal by Subject|1|||
16255598|NCT02536378|39419921|FG000|Overall Study|Death|1|||
16255599|NCT02536378|39419922|FG001|Overall Study|Death|2|||
16255600|NCT02536378|39419921|FG000|Overall Study|Patient refused further follow up|6|||
16255601|NCT02536378|39419922|FG001|Overall Study|Patient refused further follow up|2|||
16255602|NCT00491504|39419923|FG000|Overall Study|Adverse Event|0|||
16141967|NCT01008696|39008558|FG000|Overall Study|Participants' non-cooperation|2|||
16141968|NCT01008696|39008559|FG001|Overall Study|Participants' non-cooperation|3|||
16141969|NCT01008696|39008558|FG000|Overall Study|Other|2|||
16141970|NCT01008696|39008559|FG001|Overall Study|Other|3|||
16141971|NCT01008696|39008558|FG000|Overall Study|Other|0|||
16141972|NCT01008696|39008559|FG001|Overall Study|Other|2|||
16141973|NCT01910116|39008560|FG000|Overall Study|Adverse Event|0|||
16141974|NCT01910116|39008561|FG001|Overall Study|Adverse Event|3|||
16141975|NCT01910116|39008560|FG000|Overall Study|Lack of Efficacy|3|||
16141976|NCT01910116|39008561|FG001|Overall Study|Lack of Efficacy|4|||
16141977|NCT01910116|39008560|FG000|Overall Study|Lost to Follow-up|1|||
16141978|NCT01910116|39008561|FG001|Overall Study|Lost to Follow-up|0|||
16141979|NCT01910116|39008560|FG000|Overall Study|Protocol Violation|1|||
16141980|NCT01910116|39008561|FG001|Overall Study|Protocol Violation|2|||
16141981|NCT01910116|39008560|FG000|Overall Study|Withdrawal by Subject|8|||
16141982|NCT01910116|39008561|FG001|Overall Study|Withdrawal by Subject|3|||
16141983|NCT01910116|39008560|FG000|Overall Study|uncertain allocation|1|||
16141984|NCT01910116|39008561|FG001|Overall Study|uncertain allocation|3|||
16141985|NCT01910116|39008560|FG000|Overall Study|incomplete data|0|||
16141986|NCT01910116|39008561|FG001|Overall Study|incomplete data|1|||
16141987|NCT03496012|39008562|FG000|Overall Study|Withdrawal by Subject|2|||
16141988|NCT03496012|39008563|FG001|Overall Study|Withdrawal by Subject|0|||
16141989|NCT03496012|39008564|FG002|Overall Study|Withdrawal by Subject|2|||
16141990|NCT03496012|39008562|FG000|Overall Study|Adverse Event|0|||
16141991|NCT03496012|39008563|FG001|Overall Study|Adverse Event|0|||
16141992|NCT03496012|39008564|FG002|Overall Study|Adverse Event|1|||
16141993|NCT03496012|39008562|FG000|Overall Study|Reason Not Specified|2|||
16141994|NCT03496012|39008563|FG001|Overall Study|Reason Not Specified|0|||
16141995|NCT03496012|39008564|FG002|Overall Study|Reason Not Specified|1|||
16141996|NCT04585646|39008569|FG000|First Intervention|Physician Decision|1|||
16141997|NCT04585646|39008570|FG001|First Intervention|Physician Decision|0|||
16141998|NCT04585646|39008569|FG000|First Intervention|Lost to Follow-up|0|||
16141999|NCT04585646|39008570|FG001|First Intervention|Lost to Follow-up|3|||
16142000|NCT04585646|39008569|FG000|First Intervention|Withdrawal by Subject|0|||
16142001|NCT04585646|39008570|FG001|First Intervention|Withdrawal by Subject|1|||
16142002|NCT00932425|39008571|FG000|Overall Study|Lost to Follow-up|0|||
16142003|NCT00932425|39008572|FG001|Overall Study|Lost to Follow-up|1|||
16142004|NCT00932425|39008571|FG000|Overall Study|Withdrawal by Subject|0|||
16142005|NCT00932425|39008572|FG001|Overall Study|Withdrawal by Subject|1|||
16142006|NCT01378104|39008576|FG000|Overall Study|Adverse Event|8|||
16142007|NCT01378104|39008577|FG001|Overall Study|Adverse Event|8|||
16142008|NCT01378104|39008576|FG000|Overall Study|Lack of Efficacy|7|||
16142009|NCT01378104|39008577|FG001|Overall Study|Lack of Efficacy|5|||
16142010|NCT01378104|39008576|FG000|Overall Study|Withdrawal by Subject|12|||
16142011|NCT01378104|39008577|FG001|Overall Study|Withdrawal by Subject|13|||
16142012|NCT02303704|39008583|FG000|Overall Study|Protocol Violation|5|||
16142013|NCT02303704|39008584|FG001|Overall Study|Protocol Violation|9|||
16142014|NCT03492554|39008591|FG000|Overall Study|Protocol Violation|0|||
16142015|NCT03492554|39008592|FG001|Overall Study|Protocol Violation|14|||
16142016|NCT01138007|39008593|FG000|Overall Study|Adverse Event|4|||
16142017|NCT01138007|39008594|FG001|Overall Study|Adverse Event|12|||
16142018|NCT01138007|39008595|FG002|Overall Study|Adverse Event|9|||
16142019|NCT01138007|39008593|FG000|Overall Study|Lack of Efficacy|2|||
16142020|NCT01138007|39008594|FG001|Overall Study|Lack of Efficacy|0|||
16142021|NCT01138007|39008595|FG002|Overall Study|Lack of Efficacy|6|||
16142022|NCT01138007|39008593|FG000|Overall Study|Protocol Violation|2|||
16142023|NCT01138007|39008594|FG001|Overall Study|Protocol Violation|3|||
16142024|NCT01138007|39008595|FG002|Overall Study|Protocol Violation|2|||
16142025|NCT01138007|39008593|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
16142026|NCT01138007|39008594|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
16142027|NCT01138007|39008595|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
16142028|NCT01138007|39008593|FG000|Overall Study|Lost to Follow-up|3|||
16142029|NCT01138007|39008594|FG001|Overall Study|Lost to Follow-up|3|||
16142030|NCT01138007|39008595|FG002|Overall Study|Lost to Follow-up|5|||
16142031|NCT01138007|39008593|FG000|Overall Study|Physician Decision|0|||
16142032|NCT01138007|39008594|FG001|Overall Study|Physician Decision|5|||
16142033|NCT01138007|39008595|FG002|Overall Study|Physician Decision|3|||
16142034|NCT01138007|39008593|FG000|Overall Study|Withdrawal by Subject|5|||
16142035|NCT01138007|39008594|FG001|Overall Study|Withdrawal by Subject|6|||
16142036|NCT01138007|39008595|FG002|Overall Study|Withdrawal by Subject|15|||
16142037|NCT00935272|39008598|FG000|Overall Study|Lost to Follow-up|10|||
16142038|NCT00935272|39008599|FG001|Overall Study|Lost to Follow-up|3|||
16142039|NCT00935272|39008598|FG000|Overall Study|Withdrawal by Subject|8|||
16142040|NCT00935272|39008599|FG001|Overall Study|Withdrawal by Subject|2|||
16364154|NCT00782067|39818221|FG000|Overall Study|Adverse Event|35|||
16142041|NCT00935272|39008598|FG000|Overall Study|Physician Decision|1|||
16142042|NCT00935272|39008599|FG001|Overall Study|Physician Decision|0|||
16142043|NCT00935272|39008598|FG000|Overall Study|Protocol Violation|0|||
16142044|NCT00935272|39008599|FG001|Overall Study|Protocol Violation|1|||
16439038|NCT02714569|40085482|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16439039|NCT02714569|40085483|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16439040|NCT02714569|40085484|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16439041|NCT02714569|40085485|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16439042|NCT02714569|40085486|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
16439043|NCT02714569|40085476|FG000|Part A Third Intervention|Adverse Event|0|||
16439044|NCT02714569|40085477|FG001|Part A Third Intervention|Adverse Event|0|||
16439045|NCT02714569|40085478|FG002|Part A Third Intervention|Adverse Event|1|||
16439046|NCT02714569|40085479|FG003|Part A Third Intervention|Adverse Event|0|||
16439047|NCT02714569|40085480|FG004|Part A Third Intervention|Adverse Event|0|||
16439048|NCT02714569|40085481|FG005|Part A Third Intervention|Adverse Event|0|||
16439049|NCT02714569|40085482|FG006|Part A Third Intervention|Adverse Event|0|||
16439050|NCT02714569|40085483|FG007|Part A Third Intervention|Adverse Event|0|||
16439051|NCT02714569|40085484|FG008|Part A Third Intervention|Adverse Event|0|||
16439052|NCT02714569|40085485|FG009|Part A Third Intervention|Adverse Event|0|||
16142045|NCT01970488|39008600|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
16142046|NCT01970488|39008601|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
16142047|NCT01970488|39008602|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
16142048|NCT01970488|39008603|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
16142049|NCT01970488|39008604|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
16142050|NCT01970488|39008600|FG000|Part 1: Through Week 16|Protocol Violation|1|||
16142051|NCT01970488|39008601|FG001|Part 1: Through Week 16|Protocol Violation|2|||
16142052|NCT01970488|39008602|FG002|Part 1: Through Week 16|Protocol Violation|0|||
16142053|NCT01970488|39008603|FG003|Part 1: Through Week 16|Protocol Violation|0|||
16142054|NCT01970488|39008604|FG004|Part 1: Through Week 16|Protocol Violation|0|||
16142055|NCT01970488|39008600|FG000|Part 1: Through Week 16|Adverse Event|6|||
16142056|NCT01970488|39008601|FG001|Part 1: Through Week 16|Adverse Event|5|||
16142057|NCT01970488|39008602|FG002|Part 1: Through Week 16|Adverse Event|0|||
16142058|NCT01970488|39008603|FG003|Part 1: Through Week 16|Adverse Event|0|||
16142059|NCT01970488|39008604|FG004|Part 1: Through Week 16|Adverse Event|0|||
16142060|NCT01970488|39008600|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
16142061|NCT01970488|39008601|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
16142062|NCT01970488|39008602|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
16142063|NCT01970488|39008603|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
16142064|NCT01970488|39008604|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
16142065|NCT01970488|39008600|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
16142066|NCT01970488|39008601|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
16142067|NCT01970488|39008602|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
16142068|NCT01970488|39008603|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
16142069|NCT01970488|39008604|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
16142070|NCT01970488|39008600|FG000|Part 2: Post Week 16|Physician Decision|0|||
16142071|NCT01970488|39008601|FG001|Part 2: Post Week 16|Physician Decision|0|||
16142072|NCT01970488|39008602|FG002|Part 2: Post Week 16|Physician Decision|0|||
16142073|NCT01970488|39008603|FG003|Part 2: Post Week 16|Physician Decision|0|||
16142074|NCT01970488|39008604|FG004|Part 2: Post Week 16|Physician Decision|1|||
16142075|NCT01970488|39008600|FG000|Part 2: Post Week 16|Non-compliance|0|||
16142076|NCT01970488|39008601|FG001|Part 2: Post Week 16|Non-compliance|0|||
16142077|NCT01970488|39008602|FG002|Part 2: Post Week 16|Non-compliance|1|||
16142078|NCT01970488|39008603|FG003|Part 2: Post Week 16|Non-compliance|0|||
16142079|NCT01970488|39008604|FG004|Part 2: Post Week 16|Non-compliance|0|||
16142080|NCT01970488|39008600|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
16142081|NCT01970488|39008601|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
16142082|NCT01970488|39008602|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
16142083|NCT01970488|39008603|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
16142084|NCT01970488|39008604|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
16142085|NCT01970488|39008600|FG000|Part 2: Post Week 16|Adverse Event|0|||
16142086|NCT01970488|39008601|FG001|Part 2: Post Week 16|Adverse Event|0|||
16142087|NCT01970488|39008602|FG002|Part 2: Post Week 16|Adverse Event|5|||
16142088|NCT01970488|39008603|FG003|Part 2: Post Week 16|Adverse Event|1|||
16142089|NCT01970488|39008604|FG004|Part 2: Post Week 16|Adverse Event|1|||
16142090|NCT01970488|39008600|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
16142091|NCT01970488|39008601|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
16142092|NCT01970488|39008602|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
16142093|NCT01970488|39008603|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
16142094|NCT01970488|39008604|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
16142095|NCT01970488|39008600|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
16142096|NCT01970488|39008601|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
16142097|NCT01970488|39008602|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
16142098|NCT01970488|39008603|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
16142099|NCT01970488|39008604|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
16142100|NCT00709111|39008606|FG000|Overall Study|Withdrawal by Subject|1|||
16142101|NCT00709111|39008606|FG000|Overall Study|Unable to attend clinic visits|1|||
16142102|NCT01002339|39008608|FG000|Overall Study|Withdrawal by Subject|0|||
16142103|NCT01002339|39008609|FG001|Overall Study|Withdrawal by Subject|1|||
16142104|NCT01002339|39008610|FG002|Overall Study|Withdrawal by Subject|0|||
16142105|NCT01002339|39008608|FG000|Overall Study|Incorrect treatment assignment|0|||
16142106|NCT01002339|39008609|FG001|Overall Study|Incorrect treatment assignment|0|||
16142107|NCT01002339|39008610|FG002|Overall Study|Incorrect treatment assignment|1|||
16142108|NCT01002339|39008608|FG000|Overall Study|Protocol Violation|0|||
16142109|NCT01002339|39008609|FG001|Overall Study|Protocol Violation|0|||
16142110|NCT01002339|39008610|FG002|Overall Study|Protocol Violation|2|||
16142111|NCT01002339|39008608|FG000|Overall Study|Lung cancer detected before transplant|0|||
16142112|NCT01002339|39008609|FG001|Overall Study|Lung cancer detected before transplant|0|||
16142113|NCT01002339|39008610|FG002|Overall Study|Lung cancer detected before transplant|1|||
16142114|NCT01002339|39008608|FG000|Overall Study|Randomized. Not transplanted|0|||
16142115|NCT01002339|39008609|FG001|Overall Study|Randomized. Not transplanted|0|||
16142116|NCT01002339|39008610|FG002|Overall Study|Randomized. Not transplanted|1|||
16142117|NCT03548987|39008611|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
16142118|NCT03548987|39008612|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
16142119|NCT03548987|39008611|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
16142120|NCT03548987|39008612|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
16142121|NCT03548987|39008611|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
16142122|NCT03548987|39008612|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
16142123|NCT03548987|39008611|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
16142124|NCT03548987|39008612|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
16142125|NCT03548987|39008611|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
16142126|NCT03548987|39008612|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
16142127|NCT03548987|39008611|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
16142128|NCT03548987|39008612|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
16142129|NCT03548987|39008611|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
16142130|NCT03548987|39008612|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
16142131|NCT03548987|39008611|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
16142132|NCT03548987|39008612|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
16142133|NCT03548987|39008611|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
16142134|NCT03548987|39008612|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
16142135|NCT03548987|39008611|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
16142136|NCT03548987|39008612|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
16142137|NCT03548987|39008611|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
16142138|NCT03548987|39008612|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
16142139|NCT03548987|39008611|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
16142140|NCT03548987|39008612|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
16142141|NCT03548987|39008611|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
16142142|NCT03548987|39008612|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
16142143|NCT03548987|39008611|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
16142144|NCT03548987|39008612|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
16142145|NCT02811549|39008619|FG000|Overall Study|Lost to Follow-up|1|||
16142146|NCT02811549|39008619|FG000|Overall Study|Withdrawal by Subject|3|||
16142147|NCT02811549|39008619|FG000|Overall Study|Subject screen failed|4|||
16142148|NCT02811549|39008619|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
16142149|NCT01848353|39008620|FG000|Phase 1|Withdrawal by Subject|3|||
16142150|NCT01848353|39008621|FG001|Phase 1|Withdrawal by Subject|1|||
16255603|NCT00491504|39419924|FG001|Overall Study|Adverse Event|1|||
16255604|NCT00491504|39419925|FG002|Overall Study|Adverse Event|0|||
16255605|NCT00491504|39419926|FG003|Overall Study|Adverse Event|0|||
16255606|NCT00491504|39419923|FG000|Overall Study|Withdrawal by Subject|0|||
16255607|NCT00491504|39419924|FG001|Overall Study|Withdrawal by Subject|0|||
16255608|NCT00491504|39419925|FG002|Overall Study|Withdrawal by Subject|1|||
16255609|NCT00491504|39419926|FG003|Overall Study|Withdrawal by Subject|2|||
16255610|NCT00491504|39419923|FG000|Overall Study|Protocol Violation|0|||
16255611|NCT00491504|39419924|FG001|Overall Study|Protocol Violation|0|||
16255612|NCT00491504|39419925|FG002|Overall Study|Protocol Violation|3|||
16255613|NCT00491504|39419926|FG003|Overall Study|Protocol Violation|2|||
16255614|NCT02978326|39419933|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
16255615|NCT02978326|39419934|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
16255616|NCT02978326|39419935|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
16364155|NCT00782067|39818221|FG000|Overall Study|Subject withdrew consent|11|||
16364156|NCT00782067|39818221|FG000|Overall Study|Lost to Follow-up|2|||
16364157|NCT00782067|39818221|FG000|Overall Study|Administrative problems|14|||
16364158|NCT00782067|39818221|FG000|Overall Study|Death|9|||
16364159|NCT00782067|39818221|FG000|Overall Study|Disease progression|43|||
16255617|NCT02978326|39419933|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
16255618|NCT02978326|39419934|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
16255619|NCT02978326|39419935|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
16255620|NCT02978326|39419933|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
16255621|NCT02978326|39419934|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
16439053|NCT02714569|40085486|FG010|Part A Third Intervention|Adverse Event|0|||
16439054|NCT02714569|40085476|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
16439055|NCT02714569|40085477|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16439056|NCT02714569|40085478|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16439057|NCT02714569|40085479|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16439058|NCT02714569|40085480|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16439059|NCT02714569|40085481|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
16439060|NCT02714569|40085482|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16439061|NCT02714569|40085483|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16439062|NCT02714569|40085484|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16439063|NCT02714569|40085485|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16439064|NCT02714569|40085486|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
16439065|NCT02714569|40085476|FG000|Part B (Overall)|Lost to Follow-up|0|||
16439066|NCT02714569|40085477|FG001|Part B (Overall)|Lost to Follow-up|0|||
16439067|NCT02714569|40085478|FG002|Part B (Overall)|Lost to Follow-up|0|||
16439068|NCT02714569|40085479|FG003|Part B (Overall)|Lost to Follow-up|0|||
16439069|NCT02714569|40085480|FG004|Part B (Overall)|Lost to Follow-up|0|||
16439070|NCT02714569|40085481|FG005|Part B (Overall)|Lost to Follow-up|0|||
16439071|NCT02714569|40085482|FG006|Part B (Overall)|Lost to Follow-up|1|||
16439072|NCT02714569|40085483|FG007|Part B (Overall)|Lost to Follow-up|0|||
16439073|NCT02714569|40085484|FG008|Part B (Overall)|Lost to Follow-up|0|||
16439074|NCT02714569|40085485|FG009|Part B (Overall)|Lost to Follow-up|0|||
16439075|NCT02714569|40085486|FG010|Part B (Overall)|Lost to Follow-up|0|||
16439076|NCT02714569|40085476|FG000|Part B (Overall)|Withdrawal by Subject|0|||
16439077|NCT02714569|40085477|FG001|Part B (Overall)|Withdrawal by Subject|0|||
16439078|NCT02714569|40085478|FG002|Part B (Overall)|Withdrawal by Subject|0|||
16439079|NCT02714569|40085479|FG003|Part B (Overall)|Withdrawal by Subject|0|||
16439080|NCT02714569|40085480|FG004|Part B (Overall)|Withdrawal by Subject|0|||
16439081|NCT02714569|40085481|FG005|Part B (Overall)|Withdrawal by Subject|0|||
16439082|NCT02714569|40085482|FG006|Part B (Overall)|Withdrawal by Subject|0|||
16439083|NCT02714569|40085483|FG007|Part B (Overall)|Withdrawal by Subject|1|||
16439084|NCT02714569|40085484|FG008|Part B (Overall)|Withdrawal by Subject|0|||
16439085|NCT02714569|40085485|FG009|Part B (Overall)|Withdrawal by Subject|1|||
16439086|NCT02714569|40085486|FG010|Part B (Overall)|Withdrawal by Subject|0|||
16439087|NCT02714569|40085476|FG000|Part B (Overall)|Adverse Event|0|||
16439088|NCT02714569|40085477|FG001|Part B (Overall)|Adverse Event|0|||
16439089|NCT02714569|40085478|FG002|Part B (Overall)|Adverse Event|0|||
16439090|NCT02714569|40085479|FG003|Part B (Overall)|Adverse Event|0|||
16439091|NCT02714569|40085480|FG004|Part B (Overall)|Adverse Event|0|||
16439092|NCT02714569|40085481|FG005|Part B (Overall)|Adverse Event|0|||
16439093|NCT02714569|40085482|FG006|Part B (Overall)|Adverse Event|0|||
16439094|NCT02714569|40085483|FG007|Part B (Overall)|Adverse Event|0|||
16439095|NCT02714569|40085484|FG008|Part B (Overall)|Adverse Event|0|||
16439096|NCT02714569|40085485|FG009|Part B (Overall)|Adverse Event|1|||
16439097|NCT02714569|40085486|FG010|Part B (Overall)|Adverse Event|0|||
16439098|NCT02412306|40085487|FG000|Overall Study|Lost to Follow-up|0|||
16439099|NCT02412306|40085488|FG001|Overall Study|Lost to Follow-up|1|||
16439100|NCT02412306|40085489|FG002|Overall Study|Lost to Follow-up|0|||
16439101|NCT02412306|40085490|FG003|Overall Study|Lost to Follow-up|0|||
16439102|NCT02412306|40085491|FG004|Overall Study|Lost to Follow-up|0|||
16439103|NCT02412306|40085487|FG000|Overall Study|Withdrawal by Subject|0|||
16439104|NCT02412306|40085488|FG001|Overall Study|Withdrawal by Subject|0|||
16439105|NCT02412306|40085489|FG002|Overall Study|Withdrawal by Subject|1|||
16439106|NCT02412306|40085490|FG003|Overall Study|Withdrawal by Subject|0|||
16439107|NCT02412306|40085491|FG004|Overall Study|Withdrawal by Subject|0|||
16439108|NCT02412306|40085487|FG000|Overall Study|Death|5|||
16439109|NCT02412306|40085488|FG001|Overall Study|Death|7|||
16439110|NCT02412306|40085489|FG002|Overall Study|Death|15|||
16255622|NCT02978326|39419935|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
16255623|NCT02978326|39419933|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
16439111|NCT02412306|40085490|FG003|Overall Study|Death|0|||
16439112|NCT02412306|40085491|FG004|Overall Study|Death|2|||
16439113|NCT02177123|40085495|FG000|Overall Study|Lost to Follow-up|6|||
16439114|NCT02177123|40085495|FG000|Overall Study|Withdrawal by Subject|4|||
16439115|NCT02177123|40085495|FG000|Overall Study|Adverse Event|4|||
16439116|NCT02177123|40085495|FG000|Overall Study|Physician Decision|3|||
16439117|NCT02177123|40085495|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
16439118|NCT02177123|40085495|FG000|Overall Study|Excluded for medical reasons|2|||
16439119|NCT02177123|40085495|FG000|Overall Study|Death|1|||
16439120|NCT02177123|40085495|FG000|Overall Study|Other|1|||
16439121|NCT02177123|40085495|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
16439122|NCT01790594|40085506|FG000|Overall Study|Death|1|||
16439123|NCT01790594|40085507|FG001|Overall Study|Death|0|||
16439124|NCT01790594|40085508|FG002|Overall Study|Death|0|||
16439125|NCT01790594|40085506|FG000|Overall Study|Physician Decision|2|||
16255624|NCT02978326|39419934|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
16255625|NCT02978326|39419935|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
16255626|NCT00576901|39419936|FG000|Overall Study|Withdrawal by Subject|1|||
16255627|NCT00576901|39419936|FG000|Overall Study|Disease course|1|||
16255628|NCT00576901|39419936|FG000|Overall Study|Protocol Violation|1|||
16255629|NCT05150964|39419938|FG000|Overall Study|Lost to Follow-up|2|||
16255630|NCT01536405|39419940|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
16255631|NCT01536405|39419941|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
16255632|NCT01536405|39419940|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
16255633|NCT01536405|39419941|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
16142151|NCT01848353|39008622|FG002|Phase 1|Withdrawal by Subject|0|||
16142152|NCT01848353|39008623|FG003|Phase 1|Withdrawal by Subject|0|||
16142153|NCT01848353|39008620|FG000|Phase 2|Withdrawal by Subject|3|||
16142154|NCT01848353|39008621|FG001|Phase 2|Withdrawal by Subject|2|||
16142155|NCT01848353|39008622|FG002|Phase 2|Withdrawal by Subject|0|||
16142156|NCT01848353|39008623|FG003|Phase 2|Withdrawal by Subject|0|||
16142157|NCT01848353|39008620|FG000|Phase 3|Withdrawal by Subject|1|||
16142158|NCT01848353|39008621|FG001|Phase 3|Withdrawal by Subject|1|||
16142159|NCT01848353|39008622|FG002|Phase 3|Withdrawal by Subject|0|||
16255634|NCT01536405|39419940|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
16255635|NCT01536405|39419941|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
16255636|NCT01536405|39419940|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
16255637|NCT01536405|39419941|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
16255638|NCT01536405|39419940|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
16255639|NCT01536405|39419941|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
16255640|NCT01536405|39419940|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
16255641|NCT01536405|39419941|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
16255642|NCT01536405|39419940|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
16255643|NCT01536405|39419941|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
16255644|NCT01536405|39419940|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
16255645|NCT01536405|39419941|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
16255646|NCT01536405|39419940|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
16255647|NCT01536405|39419941|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
16255648|NCT01536405|39419940|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
16255649|NCT01536405|39419941|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
16255650|NCT01536405|39419940|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
16255651|NCT01536405|39419941|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
16255652|NCT01536405|39419940|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
16255653|NCT01536405|39419941|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
16255654|NCT01536405|39419940|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
16255655|NCT01536405|39419941|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
16255656|NCT00626548|39419945|FG000|Overall Study|Adverse Event|164|||
16255657|NCT00626548|39419946|FG001|Overall Study|Adverse Event|44|||
16255658|NCT00626548|39419945|FG000|Overall Study|Withdrawal by Subject|42|||
16255659|NCT00626548|39419946|FG001|Overall Study|Withdrawal by Subject|46|||
16255660|NCT00626548|39419945|FG000|Overall Study|Protocol Violation|4|||
16439126|NCT01790594|40085507|FG001|Overall Study|Physician Decision|1|||
16439127|NCT01790594|40085508|FG002|Overall Study|Physician Decision|0|||
16439128|NCT01790594|40085506|FG000|Overall Study|Withdrawal by Subject|2|||
16439129|NCT01790594|40085507|FG001|Overall Study|Withdrawal by Subject|0|||
16439130|NCT01790594|40085508|FG002|Overall Study|Withdrawal by Subject|0|||
16439131|NCT01790594|40085506|FG000|Overall Study|Transplant was not done|0|||
16142160|NCT01848353|39008623|FG003|Phase 3|Withdrawal by Subject|0|||
16142161|NCT00659529|39008624|FG000|Overall Study|Withdrawal by Subject|4|||
16255661|NCT00626548|39419946|FG001|Overall Study|Protocol Violation|11|||
16255662|NCT00626548|39419945|FG000|Overall Study|Lost to Follow-up|2|||
16255663|NCT00626548|39419946|FG001|Overall Study|Lost to Follow-up|2|||
16439132|NCT01790594|40085507|FG001|Overall Study|Transplant was not done|0|||
16439133|NCT01790594|40085508|FG002|Overall Study|Transplant was not done|3|||
16142162|NCT00659529|39008624|FG000|Overall Study|Protocol Violation|3|||
16142163|NCT00659529|39008624|FG000|Overall Study|Screen failure|9|||
16255664|NCT00626548|39419945|FG000|Overall Study|Other termination reason|493|||
16255665|NCT00626548|39419946|FG001|Overall Study|Other termination reason|613|||
16255666|NCT01505530|39419947|FG000|Overall Study|Progressive Disease|19|||
16255667|NCT01505530|39419948|FG001|Overall Study|Progressive Disease|17|||
16255668|NCT01505530|39419949|FG002|Overall Study|Progressive Disease|18|||
16255669|NCT01505530|39419947|FG000|Overall Study|Adverse Event|1|||
16255670|NCT01505530|39419948|FG001|Overall Study|Adverse Event|1|||
16255671|NCT01505530|39419949|FG002|Overall Study|Adverse Event|0|||
16255672|NCT01505530|39419947|FG000|Overall Study|Withdrawal by Subject|7|||
16255673|NCT01505530|39419948|FG001|Overall Study|Withdrawal by Subject|8|||
16255674|NCT01505530|39419949|FG002|Overall Study|Withdrawal by Subject|6|||
16255675|NCT01505530|39419947|FG000|Overall Study|Physician Decision|6|||
16255676|NCT01505530|39419948|FG001|Overall Study|Physician Decision|2|||
16255677|NCT01505530|39419949|FG002|Overall Study|Physician Decision|5|||
16255678|NCT01505530|39419947|FG000|Overall Study|Sponsor Decision|1|||
16255679|NCT01505530|39419948|FG001|Overall Study|Sponsor Decision|8|||
16255680|NCT01505530|39419949|FG002|Overall Study|Sponsor Decision|7|||
16255681|NCT01505530|39419947|FG000|Overall Study|Death|7|||
16255682|NCT01505530|39419948|FG001|Overall Study|Death|6|||
16255683|NCT01505530|39419949|FG002|Overall Study|Death|5|||
16255684|NCT01505530|39419947|FG000|Overall Study|entry criteria not met|0|||
16255685|NCT01505530|39419948|FG001|Overall Study|entry criteria not met|1|||
16255686|NCT01505530|39419949|FG002|Overall Study|entry criteria not met|0|||
16255687|NCT01089647|39419950|FG000|Overall Study|Lost to Follow-up|2|||
16255688|NCT01089647|39419951|FG001|Overall Study|Lost to Follow-up|2|||
16255689|NCT01089647|39419950|FG000|Overall Study|Withdrawal by Subject|2|||
16255690|NCT01089647|39419951|FG001|Overall Study|Withdrawal by Subject|1|||
16255691|NCT01089647|39419950|FG000|Overall Study|Adverse Event|0|||
16255692|NCT01089647|39419951|FG001|Overall Study|Adverse Event|1|||
16255693|NCT00677365|39419952|FG000|Overall Study|Adverse Event|2|||
16255694|NCT00677365|39419953|FG001|Overall Study|Adverse Event|1|||
16255695|NCT00677365|39419954|FG002|Overall Study|Adverse Event|1|||
16255696|NCT00677365|39419955|FG003|Overall Study|Adverse Event|2|||
16255697|NCT00677365|39419952|FG000|Overall Study|Withdrawal by Subject|0|||
16255698|NCT00677365|39419953|FG001|Overall Study|Withdrawal by Subject|0|||
16255699|NCT00677365|39419954|FG002|Overall Study|Withdrawal by Subject|1|||
16255700|NCT00677365|39419955|FG003|Overall Study|Withdrawal by Subject|0|||
16255701|NCT00677365|39419952|FG000|Overall Study|Other reason|0|||
16255702|NCT00677365|39419953|FG001|Overall Study|Other reason|0|||
16255703|NCT00677365|39419954|FG002|Overall Study|Other reason|0|||
16255704|NCT00677365|39419955|FG003|Overall Study|Other reason|1|||
16255705|NCT01682083|39419956|FG000|Overall Study|Lost to Follow-up|11|||
16255706|NCT01682083|39419957|FG001|Overall Study|Lost to Follow-up|18|||
16255707|NCT01682083|39419956|FG000|Overall Study|Withdrawal by Subject|31|||
16255708|NCT01682083|39419957|FG001|Overall Study|Withdrawal by Subject|40|||
16255709|NCT01682083|39419956|FG000|Overall Study|Death|60|||
16255710|NCT01682083|39419957|FG001|Overall Study|Death|93|||
16255711|NCT01682083|39419956|FG000|Overall Study|Physician Decision|5|||
16255712|NCT01682083|39419957|FG001|Overall Study|Physician Decision|4|||
16255713|NCT01479439|39419958|FG000|Overall Study|Adverse Event|1|||
16255714|NCT01479439|39419959|FG001|Overall Study|Adverse Event|0|||
16255715|NCT01479439|39419960|FG002|Overall Study|Adverse Event|0|||
16255716|NCT01479439|39419958|FG000|Overall Study|Lost to Follow-up|0|||
16255717|NCT01479439|39419959|FG001|Overall Study|Lost to Follow-up|1|||
16255718|NCT01479439|39419960|FG002|Overall Study|Lost to Follow-up|0|||
16255719|NCT01479439|39419958|FG000|Overall Study|Protocol Violation|0|||
16255720|NCT01479439|39419959|FG001|Overall Study|Protocol Violation|0|||
16255721|NCT01479439|39419960|FG002|Overall Study|Protocol Violation|2|||
16255722|NCT01494506|39419965|FG000|Overall Study|Lack of Efficacy|77|||
16255723|NCT01494506|39419966|FG001|Overall Study|Lack of Efficacy|83|||
16255724|NCT01494506|39419967|FG002|Overall Study|Lack of Efficacy|57|||
16255725|NCT01494506|39419965|FG000|Overall Study|Adverse Event|17|||
16255726|NCT01494506|39419966|FG001|Overall Study|Adverse Event|10|||
16255727|NCT01494506|39419967|FG002|Overall Study|Adverse Event|11|||
16255728|NCT01494506|39419965|FG000|Overall Study|Death|9|||
16255729|NCT01494506|39419966|FG001|Overall Study|Death|5|||
16255730|NCT01494506|39419967|FG002|Overall Study|Death|2|||
16255731|NCT01494506|39419965|FG000|Overall Study|Physician Decision|7|||
16255732|NCT01494506|39419966|FG001|Overall Study|Physician Decision|5|||
16255733|NCT01494506|39419967|FG002|Overall Study|Physician Decision|4|||
16255734|NCT01494506|39419965|FG000|Overall Study|Withdrawal by Subject|17|||
16255735|NCT01494506|39419966|FG001|Overall Study|Withdrawal by Subject|20|||
16255736|NCT01494506|39419967|FG002|Overall Study|Withdrawal by Subject|14|||
16255737|NCT01494506|39419965|FG000|Overall Study|Clinical Deterioration|21|||
16255738|NCT01494506|39419966|FG001|Overall Study|Clinical Deterioration|17|||
16255739|NCT01494506|39419967|FG002|Overall Study|Clinical Deterioration|13|||
16255740|NCT01494506|39419965|FG000|Overall Study|Sponsor Decision|0|||
16255741|NCT01494506|39419966|FG001|Overall Study|Sponsor Decision|0|||
16255742|NCT01494506|39419967|FG002|Overall Study|Sponsor Decision|1|||
16255743|NCT01494506|39419965|FG000|Overall Study|Other|0|||
16255744|NCT01494506|39419966|FG001|Overall Study|Other|3|||
16255745|NCT01494506|39419967|FG002|Overall Study|Other|1|||
16255746|NCT03553823|39419968|FG000|Overall Study|Physician Decision|0|||
16255747|NCT03553823|39419969|FG001|Overall Study|Physician Decision|1|||
16255748|NCT02799602|39419972|FG000|Overall Study|Protocol Violation|1|||
16255749|NCT02799602|39419973|FG001|Overall Study|Protocol Violation|0|||
16255750|NCT02799602|39419972|FG000|Overall Study|Physician Decision|5|||
16255751|NCT02799602|39419973|FG001|Overall Study|Physician Decision|6|||
16255752|NCT02799602|39419972|FG000|Overall Study|Lost to Follow-up|4|||
16255753|NCT02799602|39419973|FG001|Overall Study|Lost to Follow-up|2|||
16255754|NCT02799602|39419972|FG000|Overall Study|Additional primary malignancy|11|||
16255755|NCT02799602|39419973|FG001|Overall Study|Additional primary malignancy|6|||
16255756|NCT02799602|39419972|FG000|Overall Study|Non-compliance with study drug|14|||
16255757|NCT02799602|39419973|FG001|Overall Study|Non-compliance with study drug|12|||
16255758|NCT02799602|39419972|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
16255759|NCT02799602|39419973|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
16255760|NCT02799602|39419972|FG000|Overall Study|Withdrawal by Subject|26|||
16255761|NCT02799602|39419973|FG001|Overall Study|Withdrawal by Subject|40|||
16255762|NCT02799602|39419972|FG000|Overall Study|Progressive disease - clinical progression|131|||
16255763|NCT02799602|39419973|FG001|Overall Study|Progressive disease - clinical progression|276|||
16255764|NCT02799602|39419972|FG000|Overall Study|Progressive disease - radiological progression|90|||
16255765|NCT02799602|39419973|FG001|Overall Study|Progressive disease - radiological progression|133|||
16255766|NCT02799602|39419972|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
16255767|NCT02799602|39419973|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
16255768|NCT02799602|39419972|FG000|Overall Study|Death|9|||
16255769|NCT02799602|39419973|FG001|Overall Study|Death|5|||
16255770|NCT02799602|39419972|FG000|Overall Study|Other|287|||
16255771|NCT02799602|39419973|FG001|Overall Study|Other|118|||
16255772|NCT02799602|39419972|FG000|Overall Study|Study drug never administered|0|||
16255773|NCT02799602|39419973|FG001|Overall Study|Study drug never administered|3|||
16255774|NCT00365352|39419976|FG000|Overall Study|Adverse Event|6|||
16255775|NCT00365352|39419977|FG001|Overall Study|Adverse Event|7|||
16255776|NCT00365352|39419978|FG002|Overall Study|Adverse Event|8|||
16255777|NCT00365352|39419976|FG000|Overall Study|Participant Withdrew Consent|8|||
16255778|NCT00365352|39419977|FG001|Overall Study|Participant Withdrew Consent|3|||
16255779|NCT00365352|39419978|FG002|Overall Study|Participant Withdrew Consent|4|||
16255780|NCT00365352|39419976|FG000|Overall Study|Lack of Efficacy|3|||
16255781|NCT00365352|39419977|FG001|Overall Study|Lack of Efficacy|0|||
16255782|NCT00365352|39419978|FG002|Overall Study|Lack of Efficacy|0|||
16255783|NCT00365352|39419976|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
16255784|NCT00365352|39419977|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
16255785|NCT00365352|39419978|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
16255786|NCT00365352|39419976|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
16255787|NCT00365352|39419977|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
16255788|NCT00365352|39419978|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
16255789|NCT00365352|39419976|FG000|Overall Study|Lost to Follow-up|1|||
16255790|NCT00365352|39419977|FG001|Overall Study|Lost to Follow-up|1|||
16255791|NCT00365352|39419978|FG002|Overall Study|Lost to Follow-up|0|||
16255792|NCT00365352|39419976|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
16255793|NCT00365352|39419977|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
16255794|NCT00365352|39419978|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
16255795|NCT00623779|39419980|FG000|Overall Study|Adverse Event|1|||
16255796|NCT00623779|39419981|FG001|Overall Study|Adverse Event|3|||
16255797|NCT00623779|39419982|FG002|Overall Study|Adverse Event|0|||
16255798|NCT00623779|39419980|FG000|Overall Study|Criteria from CSR|2|||
16255799|NCT00623779|39419981|FG001|Overall Study|Criteria from CSR|0|||
16255800|NCT00623779|39419982|FG002|Overall Study|Criteria from CSR|1|||
16255801|NCT00486837|39419983|FG000|Overall Study|Withdrawal by Subject|1|||
16255802|NCT00486837|39419984|FG001|Overall Study|Withdrawal by Subject|0|||
16364160|NCT00782067|39818221|FG000|Overall Study|Protocol deviation|2|||
16255803|NCT00486837|39419983|FG000|Overall Study|Adverse Event|1|||
16255804|NCT00486837|39419984|FG001|Overall Study|Adverse Event|1|||
16255805|NCT00486837|39419983|FG000|Overall Study|Protocol Violation|4|||
16255806|NCT00486837|39419984|FG001|Overall Study|Protocol Violation|2|||
16255807|NCT00486837|39419983|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
16255808|NCT00486837|39419984|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
16255809|NCT01720264|39419985|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
16255810|NCT01720264|39419985|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
16255811|NCT01720264|39419985|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
16255812|NCT02385526|39419986|FG000|Overall Study|Withdrawal by Subject|0|||
16255813|NCT02385526|39419987|FG001|Overall Study|Withdrawal by Subject|2|||
16255814|NCT02385526|39419988|FG002|Overall Study|Withdrawal by Subject|0|||
16255815|NCT02385526|39419986|FG000|Overall Study|Lost to Follow-up|0|||
16255816|NCT02385526|39419987|FG001|Overall Study|Lost to Follow-up|1|||
16255817|NCT02385526|39419988|FG002|Overall Study|Lost to Follow-up|0|||
16255818|NCT02385526|39419986|FG000|Overall Study|Physician Decision|1|||
16255819|NCT02385526|39419987|FG001|Overall Study|Physician Decision|0|||
16255820|NCT02385526|39419988|FG002|Overall Study|Physician Decision|0|||
16255821|NCT02385526|39419986|FG000|Overall Study|Protocol Violation|1|||
16255822|NCT02385526|39419987|FG001|Overall Study|Protocol Violation|0|||
16255823|NCT02385526|39419988|FG002|Overall Study|Protocol Violation|0|||
16255824|NCT00090857|39419989|FG000|Overall Study|Lost to Follow-up|0|||
16255825|NCT00090857|39419990|FG001|Overall Study|Lost to Follow-up|1|||
16255826|NCT00090857|39419989|FG000|Overall Study|Withdrawal by Subject|2|||
16255827|NCT00090857|39419990|FG001|Overall Study|Withdrawal by Subject|0|||
16255828|NCT00090857|39419989|FG000|Overall Study|Adverse Event|2|||
16255829|NCT00090857|39419990|FG001|Overall Study|Adverse Event|2|||
16255830|NCT02143102|39419992|FG000|Overall Study|Lost to Follow-up|11|||
16255831|NCT02143102|39419993|FG001|Overall Study|Lost to Follow-up|0|||
16255832|NCT01422538|39419994|FG000|Overall Study|Lost to Follow-up|0|||
16255833|NCT01422538|39419995|FG001|Overall Study|Lost to Follow-up|1|||
16255834|NCT01422538|39419996|FG002|Overall Study|Lost to Follow-up|1|||
16255835|NCT01422538|39419994|FG000|Overall Study|Missed visit|0|||
16255836|NCT01422538|39419995|FG001|Overall Study|Missed visit|1|||
16255837|NCT01422538|39419996|FG002|Overall Study|Missed visit|1|||
16255838|NCT03184441|39419997|FG000|Overall Study|Withdrawal by Subject|1|||
16255839|NCT01769378|39419998|FG000|Overall Study|Adverse Event|10|||
16255840|NCT01769378|39419999|FG001|Overall Study|Adverse Event|0|||
16255841|NCT01769378|39419998|FG000|Overall Study|Entry criteria not met|1|||
16255842|NCT01769378|39419999|FG001|Overall Study|Entry criteria not met|0|||
16255843|NCT01769378|39419998|FG000|Overall Study|Protocol Violation|1|||
16255844|NCT01769378|39419999|FG001|Overall Study|Protocol Violation|1|||
16255845|NCT01769378|39419998|FG000|Overall Study|Withdrawal by Subject|10|||
16255846|NCT01769378|39419999|FG001|Overall Study|Withdrawal by Subject|3|||
16255847|NCT01769378|39419998|FG000|Overall Study|Sponsor Decision|1|||
16255848|NCT01769378|39419999|FG001|Overall Study|Sponsor Decision|0|||
16255849|NCT01769378|39419998|FG000|Overall Study|Lost to Follow-up|2|||
16255850|NCT01769378|39419999|FG001|Overall Study|Lost to Follow-up|0|||
16255851|NCT02458638|39420002|FG000|Overall Study|Death|309|||
16255852|NCT02458638|39420002|FG000|Overall Study|End of Cohort/End of Study|67|||
16255853|NCT02458638|39420002|FG000|Overall Study|Lost to Follow-up|31|||
16255854|NCT02458638|39420002|FG000|Overall Study|Other Reasons|4|||
16255855|NCT02458638|39420002|FG000|Overall Study|Physician Decision|1|||
16255856|NCT02458638|39420002|FG000|Overall Study|Withdrawal by Subject|47|||
16255857|NCT05546411|39420011|FG000|Overall Study|Progressive Disease|1|||
16255858|NCT05546411|39420012|FG001|Overall Study|Progressive Disease|0|||
16255859|NCT05546411|39420011|FG000|Overall Study|Adverse Event|0|||
16255860|NCT05546411|39420012|FG001|Overall Study|Adverse Event|1|||
16255861|NCT05546411|39420011|FG000|Overall Study|Metastatic disease|1|||
16255862|NCT05546411|39420012|FG001|Overall Study|Metastatic disease|0|||
16255863|NCT01210001|39420015|FG000|Overall Study|Not treated|1|||
16255864|NCT01210001|39420016|FG001|Overall Study|Not treated|0|||
16255865|NCT01210001|39420017|FG002|Overall Study|Not treated|0|||
16255866|NCT01210001|39420015|FG000|Overall Study|Adverse Event|4|||
16255867|NCT01210001|39420016|FG001|Overall Study|Adverse Event|2|||
16255868|NCT01210001|39420017|FG002|Overall Study|Adverse Event|5|||
16255869|NCT01210001|39420015|FG000|Overall Study|Non compliant with protocol|2|||
16255870|NCT01210001|39420016|FG001|Overall Study|Non compliant with protocol|2|||
16255871|NCT01210001|39420017|FG002|Overall Study|Non compliant with protocol|3|||
16255872|NCT01210001|39420015|FG000|Overall Study|Lost to Follow-up|4|||
16255873|NCT01210001|39420016|FG001|Overall Study|Lost to Follow-up|3|||
16255874|NCT01210001|39420017|FG002|Overall Study|Lost to Follow-up|2|||
16255875|NCT01210001|39420015|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
16255876|NCT01210001|39420016|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
16255877|NCT01210001|39420017|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
16255878|NCT01210001|39420015|FG000|Overall Study|Other reason not defined above|2|||
16255879|NCT01210001|39420016|FG001|Overall Study|Other reason not defined above|2|||
16255880|NCT01210001|39420017|FG002|Overall Study|Other reason not defined above|1|||
16255881|NCT05346055|39420018|FG000|Overall Study|Withdrawal by Subject|1|||
16255882|NCT05346055|39420018|FG000|Overall Study|Protocol Violation|1|||
16255883|NCT05346055|39420018|FG000|Overall Study|Therapist decision|1|||
16255884|NCT00440557|39420019|FG000|Overall Study|Withdrawal by Subject|10|||
16255885|NCT00440557|39420020|FG001|Overall Study|Withdrawal by Subject|5|||
16255886|NCT00440557|39420021|FG002|Overall Study|Withdrawal by Subject|11|||
16255887|NCT00440557|39420019|FG000|Overall Study|Lost to Follow-up|1|||
16255888|NCT00440557|39420020|FG001|Overall Study|Lost to Follow-up|2|||
16255889|NCT00440557|39420021|FG002|Overall Study|Lost to Follow-up|6|||
16255890|NCT00440557|39420019|FG000|Overall Study|Adverse Event|3|||
16255891|NCT00440557|39420020|FG001|Overall Study|Adverse Event|3|||
16255892|NCT00440557|39420021|FG002|Overall Study|Adverse Event|5|||
16255893|NCT00440557|39420019|FG000|Overall Study|Death|2|||
16255894|NCT00440557|39420020|FG001|Overall Study|Death|6|||
16255895|NCT00440557|39420021|FG002|Overall Study|Death|3|||
16255896|NCT00440557|39420019|FG000|Overall Study|Began Dialysis|4|||
16255897|NCT00440557|39420020|FG001|Overall Study|Began Dialysis|1|||
16255898|NCT00440557|39420021|FG002|Overall Study|Began Dialysis|4|||
16255899|NCT00440557|39420019|FG000|Overall Study|Principal Investigator decision|0|||
16255900|NCT00440557|39420020|FG001|Overall Study|Principal Investigator decision|3|||
16255901|NCT00440557|39420021|FG002|Overall Study|Principal Investigator decision|1|||
16255902|NCT00440557|39420019|FG000|Overall Study|Patient moved|1|||
16255903|NCT00440557|39420020|FG001|Overall Study|Patient moved|2|||
16255904|NCT00440557|39420021|FG002|Overall Study|Patient moved|1|||
16255905|NCT00440557|39420019|FG000|Overall Study|Principal Investigator's office closed|3|||
16255906|NCT00440557|39420020|FG001|Overall Study|Principal Investigator's office closed|6|||
16255907|NCT00440557|39420021|FG002|Overall Study|Principal Investigator's office closed|4|||
16255908|NCT00440557|39420019|FG000|Overall Study|Patient transferred to nursing home|0|||
16255909|NCT00440557|39420020|FG001|Overall Study|Patient transferred to nursing home|1|||
16255910|NCT00440557|39420021|FG002|Overall Study|Patient transferred to nursing home|0|||
16255911|NCT00440557|39420019|FG000|Overall Study|Patient had surgery|1|||
16255912|NCT00440557|39420020|FG001|Overall Study|Patient had surgery|0|||
16255913|NCT00440557|39420021|FG002|Overall Study|Patient had surgery|0|||
16255914|NCT04638153|39420024|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16255915|NCT04638153|39420025|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16255916|NCT04638153|39420026|FG002|Overall Study|Withdrawal by parent/guardian|1|||
16255917|NCT04638153|39420024|FG000|Overall Study|Study terminated by sponsor|4|||
16255918|NCT04638153|39420025|FG001|Overall Study|Study terminated by sponsor|2|||
16255919|NCT04638153|39420026|FG002|Overall Study|Study terminated by sponsor|14|||
16255920|NCT02146430|39420028|FG000|Overall Study|Protocol Violation|5|||
16255921|NCT02146430|39420029|FG001|Overall Study|Protocol Violation|4|||
16255922|NCT02146430|39420030|FG002|Overall Study|Protocol Violation|8|||
16255923|NCT02146430|39420031|FG003|Overall Study|Protocol Violation|6|||
16255924|NCT02146430|39420028|FG000|Overall Study|Lack of Efficacy|13|||
16255925|NCT02146430|39420029|FG001|Overall Study|Lack of Efficacy|11|||
16255926|NCT02146430|39420030|FG002|Overall Study|Lack of Efficacy|8|||
16255927|NCT02146430|39420031|FG003|Overall Study|Lack of Efficacy|5|||
16255928|NCT02146430|39420028|FG000|Overall Study|Adverse Event|20|||
16255929|NCT02146430|39420029|FG001|Overall Study|Adverse Event|40|||
16255930|NCT02146430|39420030|FG002|Overall Study|Adverse Event|32|||
16255931|NCT02146430|39420031|FG003|Overall Study|Adverse Event|49|||
16255932|NCT02146430|39420028|FG000|Overall Study|Reason missing or not reported|2|||
16255933|NCT02146430|39420029|FG001|Overall Study|Reason missing or not reported|3|||
16255934|NCT02146430|39420030|FG002|Overall Study|Reason missing or not reported|4|||
16255935|NCT02146430|39420031|FG003|Overall Study|Reason missing or not reported|5|||
16255936|NCT02146430|39420028|FG000|Overall Study|Withdrawal by Subject|27|||
16255937|NCT02146430|39420029|FG001|Overall Study|Withdrawal by Subject|29|||
16255938|NCT02146430|39420030|FG002|Overall Study|Withdrawal by Subject|30|||
16255939|NCT02146430|39420031|FG003|Overall Study|Withdrawal by Subject|34|||
16255940|NCT01196052|39420036|FG000|Overall Study|Adverse Event|9|||
16255941|NCT01196052|39420036|FG000|Overall Study|Lost to Follow-up|1|||
16255942|NCT01196052|39420036|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
16255943|NCT01196052|39420036|FG000|Overall Study|Reason not Specified|5|||
16255944|NCT01196052|39420036|FG000|Overall Study|Withdrawal by Subject|6|||
16255945|NCT03583606|39423914|FG000|Overall Study|Lost to Follow-up|0|||
16255946|NCT03583606|39423915|FG001|Overall Study|Lost to Follow-up|1|||
16255947|NCT03583606|39423916|FG002|Overall Study|Lost to Follow-up|0|||
16255948|NCT03583606|39423914|FG000|Overall Study|Ineligible at baseline|1|||
16255949|NCT03583606|39423915|FG001|Overall Study|Ineligible at baseline|0|||
16255950|NCT03583606|39423916|FG002|Overall Study|Ineligible at baseline|0|||
16255951|NCT00950872|39423920|FG000|Overall Study|Withdrawal by Subject|1|||
16255952|NCT00950872|39423920|FG000|Overall Study|Did not have surgery|2|||
16255953|NCT01531205|39423921|FG000|Overall Study|Did not proceed to surgery|1|||
16255954|NCT02228382|39423922|FG000|Overall Study|Death|5|||
16255955|NCT02228382|39423923|FG001|Overall Study|Death|7|||
16255956|NCT02228382|39423924|FG002|Overall Study|Death|5|||
16255957|NCT02228382|39423925|FG003|Overall Study|Death|0|||
16255958|NCT02228382|39423926|FG004|Overall Study|Death|2|||
16255959|NCT02228382|39423922|FG000|Overall Study|Participant refused further follow-up|0|||
16255960|NCT02228382|39423923|FG001|Overall Study|Participant refused further follow-up|0|||
16255961|NCT02228382|39423924|FG002|Overall Study|Participant refused further follow-up|1|||
16255962|NCT02228382|39423925|FG003|Overall Study|Participant refused further follow-up|0|||
16255963|NCT02228382|39423926|FG004|Overall Study|Participant refused further follow-up|0|||
16255964|NCT02228382|39423922|FG000|Overall Study|Study terminated by sponsor|3|||
16255965|NCT02228382|39423923|FG001|Overall Study|Study terminated by sponsor|5|||
16255966|NCT02228382|39423924|FG002|Overall Study|Study terminated by sponsor|7|||
16255967|NCT02228382|39423925|FG003|Overall Study|Study terminated by sponsor|0|||
16255968|NCT02228382|39423926|FG004|Overall Study|Study terminated by sponsor|0|||
16255969|NCT02228382|39423922|FG000|Overall Study|Lost to Follow-up|0|||
16255970|NCT02228382|39423923|FG001|Overall Study|Lost to Follow-up|0|||
16255971|NCT02228382|39423924|FG002|Overall Study|Lost to Follow-up|3|||
16255972|NCT02228382|39423925|FG003|Overall Study|Lost to Follow-up|1|||
16439134|NCT01790594|40085506|FG000|Overall Study|Terminated prior to week 76|0|||
16439135|NCT01790594|40085507|FG001|Overall Study|Terminated prior to week 76|2|||
16439136|NCT01790594|40085508|FG002|Overall Study|Terminated prior to week 76|0|||
16439137|NCT02898454|40085518|FG000|Overall Study|Adverse Event|4|||
16439138|NCT02898454|40085519|FG001|Overall Study|Adverse Event|1|||
16439139|NCT02898454|40085520|FG002|Overall Study|Adverse Event|2|||
16439140|NCT02898454|40085518|FG000|Overall Study|Protocol Violation|1|||
16439141|NCT02898454|40085519|FG001|Overall Study|Protocol Violation|0|||
16439142|NCT02898454|40085520|FG002|Overall Study|Protocol Violation|1|||
16439143|NCT02898454|40085518|FG000|Overall Study|Lack of Efficacy|4|||
16439144|NCT02898454|40085519|FG001|Overall Study|Lack of Efficacy|1|||
16439145|NCT02898454|40085520|FG002|Overall Study|Lack of Efficacy|0|||
16439146|NCT02898454|40085518|FG000|Overall Study|Withdrawal by Subject|6|||
16439147|NCT02898454|40085519|FG001|Overall Study|Withdrawal by Subject|3|||
16439148|NCT02898454|40085520|FG002|Overall Study|Withdrawal by Subject|3|||
16439149|NCT02898454|40085518|FG000|Overall Study|Lost to Follow-up|1|||
16439150|NCT02898454|40085519|FG001|Overall Study|Lost to Follow-up|0|||
16439151|NCT02898454|40085520|FG002|Overall Study|Lost to Follow-up|0|||
16439152|NCT02898454|40085518|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
16439153|NCT02898454|40085519|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
16439154|NCT02898454|40085520|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
16439155|NCT00985673|40085526|FG000|Overall Study|Lost to Follow-up|6|||
16439156|NCT00985673|40085527|FG001|Overall Study|Lost to Follow-up|7|||
16439157|NCT00985673|40085528|FG002|Overall Study|Lost to Follow-up|6|||
16439158|NCT00985673|40085529|FG003|Overall Study|Lost to Follow-up|10|||
16439159|NCT00985673|40085530|FG004|Overall Study|Lost to Follow-up|5|||
16439160|NCT00985673|40085531|FG005|Overall Study|Lost to Follow-up|3|||
16439161|NCT00985673|40085526|FG000|Overall Study|Withdrawal by Subject|0|||
16439162|NCT00985673|40085527|FG001|Overall Study|Withdrawal by Subject|4|||
16439163|NCT00985673|40085528|FG002|Overall Study|Withdrawal by Subject|5|||
16439164|NCT00985673|40085529|FG003|Overall Study|Withdrawal by Subject|2|||
16439165|NCT00985673|40085530|FG004|Overall Study|Withdrawal by Subject|2|||
16439166|NCT00985673|40085531|FG005|Overall Study|Withdrawal by Subject|3|||
16439167|NCT00985673|40085526|FG000|Overall Study|Other|1|||
16439168|NCT00985673|40085527|FG001|Overall Study|Other|0|||
16439169|NCT00985673|40085528|FG002|Overall Study|Other|1|||
16439170|NCT00985673|40085529|FG003|Overall Study|Other|0|||
16439171|NCT00985673|40085530|FG004|Overall Study|Other|1|||
16439172|NCT00985673|40085531|FG005|Overall Study|Other|0|||
16439173|NCT03597347|40085532|FG000|Overall Study|Withdrawal by Subject|1|||
16439174|NCT03597347|40085533|FG001|Overall Study|Withdrawal by Subject|1|||
16439175|NCT03597347|40085534|FG002|Overall Study|Withdrawal by Subject|0|||
16439176|NCT03597347|40085532|FG000|Overall Study|Withdrawal due to Covid-19|3|||
16439177|NCT03597347|40085533|FG001|Overall Study|Withdrawal due to Covid-19|0|||
16439178|NCT03597347|40085534|FG002|Overall Study|Withdrawal due to Covid-19|0|||
16439179|NCT03597347|40085532|FG000|Overall Study|Sponsor decision to terminate study|3|||
16439180|NCT03597347|40085533|FG001|Overall Study|Sponsor decision to terminate study|2|||
16439181|NCT03597347|40085534|FG002|Overall Study|Sponsor decision to terminate study|4|||
16439182|NCT02322281|40085537|FG000|Overall Study|Progressive Disease|42|||
16255973|NCT02228382|39423926|FG004|Overall Study|Lost to Follow-up|0|||
16255974|NCT02228382|39423922|FG000|Overall Study|Withdrawal by Subject|0|||
16439183|NCT02322281|40085538|FG001|Overall Study|Progressive Disease|14|||
16439184|NCT02322281|40085539|FG002|Overall Study|Progressive Disease|49|||
16439185|NCT02322281|40085537|FG000|Overall Study|Adverse Event|3|||
16439186|NCT02322281|40085538|FG001|Overall Study|Adverse Event|4|||
16439187|NCT02322281|40085539|FG002|Overall Study|Adverse Event|6|||
16439188|NCT02322281|40085537|FG000|Overall Study|Death|3|||
16439189|NCT02322281|40085538|FG001|Overall Study|Death|3|||
16439190|NCT02322281|40085539|FG002|Overall Study|Death|3|||
16439191|NCT02322281|40085537|FG000|Overall Study|Withdrawal by Subject|1|||
16439192|NCT02322281|40085538|FG001|Overall Study|Withdrawal by Subject|1|||
16439193|NCT02322281|40085539|FG002|Overall Study|Withdrawal by Subject|6|||
16439194|NCT02322281|40085537|FG000|Overall Study|Physician Decision|2|||
16439195|NCT02322281|40085538|FG001|Overall Study|Physician Decision|0|||
16255975|NCT02228382|39423923|FG001|Overall Study|Withdrawal by Subject|3|||
16439196|NCT02322281|40085539|FG002|Overall Study|Physician Decision|5|||
16255976|NCT02228382|39423924|FG002|Overall Study|Withdrawal by Subject|2|||
16255977|NCT02228382|39423925|FG003|Overall Study|Withdrawal by Subject|1|||
16255978|NCT02228382|39423926|FG004|Overall Study|Withdrawal by Subject|0|||
16255979|NCT02228382|39423922|FG000|Overall Study|Other|2|||
16255980|NCT02228382|39423923|FG001|Overall Study|Other|3|||
16255981|NCT02228382|39423924|FG002|Overall Study|Other|3|||
16255982|NCT02228382|39423925|FG003|Overall Study|Other|0|||
16255983|NCT02228382|39423926|FG004|Overall Study|Other|0|||
16255984|NCT04188106|39423936|FG000|Overall Study|Lost to Follow-up|5|||
16255985|NCT04188106|39423936|FG000|Overall Study|Non-Compliance|1|||
16255986|NCT02999178|39423937|FG000|Overall Study|Adverse Event|85|||
16255987|NCT02999178|39423938|FG001|Overall Study|Adverse Event|62|||
16255988|NCT02999178|39423937|FG000|Overall Study|Protocol Violation|1|||
16255989|NCT02999178|39423938|FG001|Overall Study|Protocol Violation|2|||
16255990|NCT02999178|39423937|FG000|Overall Study|Lost to Follow-up|0|||
16255991|NCT02999178|39423938|FG001|Overall Study|Lost to Follow-up|2|||
16255992|NCT02999178|39423937|FG000|Overall Study|Withdrawal by Subject|21|||
16255993|NCT02999178|39423938|FG001|Overall Study|Withdrawal by Subject|21|||
16255994|NCT02999178|39423937|FG000|Overall Study|Other reason not defined above|7|||
16255995|NCT02999178|39423938|FG001|Overall Study|Other reason not defined above|13|||
16255996|NCT03100149|39423941|FG000|Overall Study|Adverse Event|0|||
16255997|NCT03100149|39423942|FG001|Overall Study|Adverse Event|1|||
16255998|NCT03100149|39423943|FG002|Overall Study|Adverse Event|0|||
16255999|NCT03100149|39423941|FG000|Overall Study|Participant Moved out of Country|0|||
16256000|NCT03100149|39423942|FG001|Overall Study|Participant Moved out of Country|0|||
16256001|NCT03100149|39423943|FG002|Overall Study|Participant Moved out of Country|1|||
16256002|NCT03100149|39423941|FG000|Overall Study|Withdrawal by Subject|0|||
16256003|NCT03100149|39423942|FG001|Overall Study|Withdrawal by Subject|3|||
16256004|NCT03100149|39423943|FG002|Overall Study|Withdrawal by Subject|1|||
16256005|NCT01406795|39423944|FG000|Overall Study|Withdrawal by Subject|1|||
16256006|NCT00520741|39423945|FG000|Overall Study|Adverse Event|16|||
16256007|NCT00520741|39423946|FG001|Overall Study|Adverse Event|56|||
16256008|NCT00520741|39423945|FG000|Overall Study|Lack of Efficacy|11|||
16256009|NCT00520741|39423946|FG001|Overall Study|Lack of Efficacy|30|||
16256010|NCT00520741|39423945|FG000|Overall Study|Withdrawal by Subject|0|||
16256011|NCT00520741|39423946|FG001|Overall Study|Withdrawal by Subject|11|||
16256012|NCT00520741|39423945|FG000|Overall Study|Protocol Violation|2|||
16256013|NCT00520741|39423946|FG001|Overall Study|Protocol Violation|15|||
16256014|NCT00520741|39423945|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
16256015|NCT00520741|39423946|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
16256016|NCT00520741|39423945|FG000|Overall Study|Lost to Follow-up|4|||
16256017|NCT00520741|39423946|FG001|Overall Study|Lost to Follow-up|4|||
16256018|NCT00520741|39423945|FG000|Overall Study|Other reasons for premature termination|0|||
16256019|NCT00520741|39423946|FG001|Overall Study|Other reasons for premature termination|6|||
16256020|NCT00264797|39423947|FG000|Overall Study|Withdrawal by Subject|11|||
16256021|NCT00264797|39423948|FG001|Overall Study|Withdrawal by Subject|11|||
16256022|NCT00264797|39423947|FG000|Overall Study|Lost to Follow-up|9|||
16256023|NCT00264797|39423948|FG001|Overall Study|Lost to Follow-up|17|||
16256024|NCT00264797|39423947|FG000|Overall Study|Moved from area|3|||
16256025|NCT00264797|39423948|FG001|Overall Study|Moved from area|1|||
16256026|NCT00264797|39423947|FG000|Overall Study|Practical Problems|2|||
16256027|NCT00264797|39423948|FG001|Overall Study|Practical Problems|3|||
16256028|NCT00264797|39423947|FG000|Overall Study|Incarceration|4|||
16256029|NCT00264797|39423948|FG001|Overall Study|Incarceration|5|||
16256030|NCT00264797|39423947|FG000|Overall Study|Pressure/advice from Outsiders|1|||
16256031|NCT00264797|39423948|FG001|Overall Study|Pressure/advice from Outsiders|1|||
16256032|NCT00264797|39423947|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
16256033|NCT00264797|39423948|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
16256034|NCT00264797|39423947|FG000|Overall Study|Other|3|||
16256035|NCT00264797|39423948|FG001|Overall Study|Other|4|||
16256036|NCT04799158|39423949|FG000|Run-In Period|Adverse Event|6|||
16256037|NCT04799158|39423950|FG001|Run-In Period|Adverse Event|0|||
16256038|NCT04799158|39423951|FG002|Run-In Period|Adverse Event|0|||
16256039|NCT04799158|39423952|FG003|Run-In Period|Adverse Event|0|||
16256040|NCT04799158|39423953|FG004|Run-In Period|Adverse Event|0|||
16256041|NCT04799158|39423949|FG000|Run-In Period|Lost to Follow-up|4|||
16256042|NCT04799158|39423950|FG001|Run-In Period|Lost to Follow-up|0|||
16256043|NCT04799158|39423951|FG002|Run-In Period|Lost to Follow-up|0|||
16256044|NCT04799158|39423952|FG003|Run-In Period|Lost to Follow-up|0|||
16256045|NCT04799158|39423953|FG004|Run-In Period|Lost to Follow-up|0|||
16256046|NCT04799158|39423949|FG000|Run-In Period|Significant Protocol Deviation|1|||
16256047|NCT04799158|39423950|FG001|Run-In Period|Significant Protocol Deviation|0|||
16256048|NCT04799158|39423951|FG002|Run-In Period|Significant Protocol Deviation|0|||
16256049|NCT04799158|39423952|FG003|Run-In Period|Significant Protocol Deviation|0|||
16256050|NCT04799158|39423953|FG004|Run-In Period|Significant Protocol Deviation|0|||
16256051|NCT04799158|39423949|FG000|Run-In Period|Withdrawal by Subject|11|||
16256052|NCT04799158|39423950|FG001|Run-In Period|Withdrawal by Subject|0|||
16364161|NCT01136954|39818222|FG000|Overall Study|Adverse Event|3|||
16364162|NCT01136954|39818223|FG001|Overall Study|Adverse Event|2|||
16142164|NCT01265615|39008630|FG000|Overall Study|Protocol Violation|2|||
16142165|NCT01265615|39008631|FG001|Overall Study|Protocol Violation|2|||
16142166|NCT01265615|39008632|FG002|Overall Study|Protocol Violation|4|||
16142167|NCT01265615|39008633|FG003|Overall Study|Protocol Violation|3|||
16142168|NCT02877927|39008634|FG000|Overall Study|Adverse Event|1|||
16142169|NCT02877927|39008635|FG001|Overall Study|Adverse Event|0|||
16142170|NCT02877927|39008634|FG000|Overall Study|Lost to Follow-up|37|||
16142171|NCT02877927|39008635|FG001|Overall Study|Lost to Follow-up|38|||
16142172|NCT02877927|39008634|FG000|Overall Study|Withdrawal by Subject|11|||
16142173|NCT02877927|39008635|FG001|Overall Study|Withdrawal by Subject|12|||
16142174|NCT02877927|39008634|FG000|Overall Study|Physician Decision|0|||
16142175|NCT02877927|39008635|FG001|Overall Study|Physician Decision|1|||
16142176|NCT02877927|39008634|FG000|Overall Study|Missed EOT/PTE Visit|5|||
16142177|NCT02877927|39008635|FG001|Overall Study|Missed EOT/PTE Visit|6|||
16142178|NCT01289821|39008636|FG000|Treatment Period|Withdrawal by Subject|1|||
16142179|NCT01289821|39008636|FG000|Treatment Period|Physician Decision|3|||
16256053|NCT04799158|39423951|FG002|Run-In Period|Withdrawal by Subject|0|||
16256054|NCT04799158|39423952|FG003|Run-In Period|Withdrawal by Subject|0|||
16256055|NCT04799158|39423953|FG004|Run-In Period|Withdrawal by Subject|0|||
16256056|NCT04799158|39423949|FG000|Run-In Period|Miscellaneous|3|||
16256057|NCT04799158|39423950|FG001|Run-In Period|Miscellaneous|0|||
16256058|NCT04799158|39423951|FG002|Run-In Period|Miscellaneous|0|||
16256059|NCT04799158|39423952|FG003|Run-In Period|Miscellaneous|0|||
16256060|NCT04799158|39423953|FG004|Run-In Period|Miscellaneous|0|||
16256061|NCT04799158|39423949|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
16256062|NCT04799158|39423950|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
16256063|NCT04799158|39423951|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
16256064|NCT04799158|39423952|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
16256065|NCT04799158|39423953|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
16256066|NCT04799158|39423949|FG000|On-Demand Treatment Period|Adverse Event|0|||
16256067|NCT04799158|39423950|FG001|On-Demand Treatment Period|Adverse Event|1|||
16256068|NCT04799158|39423951|FG002|On-Demand Treatment Period|Adverse Event|0|||
16256069|NCT04799158|39423952|FG003|On-Demand Treatment Period|Adverse Event|0|||
16256070|NCT04799158|39423953|FG004|On-Demand Treatment Period|Adverse Event|1|||
16256071|NCT04799158|39423949|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
16256072|NCT04799158|39423950|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
16256073|NCT04799158|39423951|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
16256074|NCT04799158|39423952|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
16256075|NCT04799158|39423953|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
16256076|NCT04799158|39423949|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
16256077|NCT04799158|39423950|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
16256078|NCT04799158|39423951|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
16256079|NCT04799158|39423952|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
16256080|NCT04799158|39423953|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
16256081|NCT04799158|39423949|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
16256082|NCT04799158|39423950|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
16256083|NCT04799158|39423951|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
16256084|NCT04799158|39423952|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
16256085|NCT04799158|39423953|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
16256086|NCT04799158|39423949|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
16256087|NCT04799158|39423950|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
16142180|NCT01289821|39008636|FG000|Treatment Period|Adverse Event|4|||
16142181|NCT01289821|39008636|FG000|Treatment Period|Radiological Progression|43|||
16142182|NCT01289821|39008636|FG000|Treatment Period|Clinical Progression|2|||
16142183|NCT01289821|39008636|FG000|Treatment Period|Therapeutic procedure required|1|||
16142184|NCT01289821|39008636|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
16142185|NCT01289821|39008636|FG000|Safety Follow-up Period|Protocol Violation|3|||
16142186|NCT01289821|39008636|FG000|Safety Follow-up Period|Unspecified reason|1|||
16142187|NCT01289821|39008636|FG000|Survival Follow-up Period|Protocol Violation|1|||
16142188|NCT01289821|39008636|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
16142189|NCT01289821|39008636|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
16142190|NCT01102803|39008638|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
16142191|NCT01102803|39008639|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
16142192|NCT01102803|39008638|FG000|Post to Follow-Up|Lost to Follow-up|1|||
16142193|NCT01102803|39008639|FG001|Post to Follow-Up|Lost to Follow-up|3|||
16142194|NCT03224325|39008642|FG000|Overall Study|Adverse Event|1|||
16142195|NCT03224325|39008643|FG001|Overall Study|Adverse Event|0|||
16142196|NCT03224325|39008644|FG002|Overall Study|Adverse Event|0|||
16142197|NCT03224325|39008645|FG003|Overall Study|Adverse Event|0|||
16142198|NCT03224325|39008646|FG004|Overall Study|Adverse Event|0|||
16439197|NCT02322281|40085537|FG000|Overall Study|Study Terminated by Sponsor|2|||
16439198|NCT02322281|40085538|FG001|Overall Study|Study Terminated by Sponsor|0|||
16439199|NCT02322281|40085539|FG002|Overall Study|Study Terminated by Sponsor|0|||
16439200|NCT02322281|40085537|FG000|Overall Study|Missing|0|||
16439201|NCT02322281|40085538|FG001|Overall Study|Missing|0|||
16439202|NCT02322281|40085539|FG002|Overall Study|Missing|1|||
16439203|NCT02322281|40085537|FG000|Overall Study|Miscellaneous|0|||
16439204|NCT02322281|40085538|FG001|Overall Study|Miscellaneous|0|||
16439205|NCT02322281|40085539|FG002|Overall Study|Miscellaneous|4|||
16439206|NCT01052493|40085540|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
16439207|NCT01052493|40085541|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
16439208|NCT01052493|40085542|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
16439209|NCT01506271|40089342|FG000|Overall Study|Progressive disease|0|||
16439210|NCT01506271|40089343|FG001|Overall Study|Progressive disease|1|||
16439211|NCT01506271|40089344|FG002|Overall Study|Progressive disease|0|||
16439212|NCT01506271|40089342|FG000|Overall Study|Protocol Violation|3|||
16439213|NCT01506271|40089343|FG001|Overall Study|Protocol Violation|1|||
16439214|NCT01506271|40089344|FG002|Overall Study|Protocol Violation|0|||
16439215|NCT01506271|40089342|FG000|Overall Study|Death|0|||
16439216|NCT01506271|40089343|FG001|Overall Study|Death|1|||
16439217|NCT01506271|40089344|FG002|Overall Study|Death|0|||
16439218|NCT01506271|40089342|FG000|Overall Study|Adverse Event|0|||
16142199|NCT03224325|39008647|FG005|Overall Study|Adverse Event|0|||
16142200|NCT03224325|39008648|FG006|Overall Study|Adverse Event|1|||
16142201|NCT03224325|39008642|FG000|Overall Study|Withdrawal by Subject|0|||
16142202|NCT03224325|39008643|FG001|Overall Study|Withdrawal by Subject|0|||
16142203|NCT03224325|39008644|FG002|Overall Study|Withdrawal by Subject|0|||
16142204|NCT03224325|39008645|FG003|Overall Study|Withdrawal by Subject|1|||
16142205|NCT03224325|39008646|FG004|Overall Study|Withdrawal by Subject|0|||
16142206|NCT03224325|39008647|FG005|Overall Study|Withdrawal by Subject|0|||
16142207|NCT03224325|39008648|FG006|Overall Study|Withdrawal by Subject|0|||
16142208|NCT01386658|39008651|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
16142209|NCT01386658|39008652|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
16142210|NCT01386658|39008651|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
16142211|NCT01386658|39008652|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
16142212|NCT00576836|39008654|FG000|Overall Study|Death|0|||
16142213|NCT00576836|39008655|FG001|Overall Study|Death|1|||
16142214|NCT00576836|39008654|FG000|Overall Study|Physician Decision|0|||
16142215|NCT00576836|39008655|FG001|Overall Study|Physician Decision|1|||
16142216|NCT03239483|39008657|FG000|Overall Study|Lost to Follow-up|1|||
16142217|NCT03239483|39008658|FG001|Overall Study|Lost to Follow-up|0|||
16142218|NCT03239483|39008657|FG000|Overall Study|Withdrawal by Subject|1|||
16142219|NCT03239483|39008658|FG001|Overall Study|Withdrawal by Subject|0|||
16142220|NCT01211535|39008659|FG000|Overall Study|Adverse Event|0|||
16142221|NCT01211535|39008660|FG001|Overall Study|Adverse Event|1|||
16142222|NCT02805725|39008661|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
16142223|NCT02805725|39008662|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
16439219|NCT01506271|40089343|FG001|Overall Study|Adverse Event|2|||
16439220|NCT01506271|40089344|FG002|Overall Study|Adverse Event|0|||
16439221|NCT01506271|40089342|FG000|Overall Study|Insufficient supply of study drug|1|||
16439222|NCT01506271|40089343|FG001|Overall Study|Insufficient supply of study drug|0|||
16142224|NCT02805725|39008663|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
16142225|NCT02805725|39008664|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
16142226|NCT02805725|39008665|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
16142227|NCT02805725|39008661|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
16142228|NCT02805725|39008662|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
16142229|NCT02805725|39008663|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
16142230|NCT02805725|39008664|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
16439223|NCT01506271|40089344|FG002|Overall Study|Insufficient supply of study drug|0|||
16142231|NCT02805725|39008665|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
16142232|NCT02805725|39008661|FG000|Phase II|Protocol Violation|0|||
16142233|NCT02805725|39008662|FG001|Phase II|Protocol Violation|0|||
16142234|NCT02805725|39008663|FG002|Phase II|Protocol Violation|0|||
16142235|NCT02805725|39008664|FG003|Phase II|Protocol Violation|0|||
16142236|NCT02805725|39008665|FG004|Phase II|Protocol Violation|6|||
16142237|NCT00907257|39008666|FG000|Overall Study|Adverse Event|0|||
16142238|NCT00907257|39008667|FG001|Overall Study|Adverse Event|4|||
16142239|NCT00907257|39008666|FG000|Overall Study|Protocol Violation|1|||
16142240|NCT00907257|39008667|FG001|Overall Study|Protocol Violation|2|||
16142241|NCT00907257|39008666|FG000|Overall Study|Lost to Follow-up|3|||
16142242|NCT00907257|39008667|FG001|Overall Study|Lost to Follow-up|3|||
16142243|NCT00907257|39008666|FG000|Overall Study|Withdrawal by Subject|1|||
16142244|NCT00907257|39008667|FG001|Overall Study|Withdrawal by Subject|2|||
16142245|NCT00907257|39008666|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
16142246|NCT00907257|39008667|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
16142247|NCT00907257|39008666|FG000|Overall Study|Moved|1|||
16142248|NCT00907257|39008667|FG001|Overall Study|Moved|0|||
16142249|NCT00907257|39008666|FG000|Overall Study|Personal Reasons|6|||
16142250|NCT00907257|39008667|FG001|Overall Study|Personal Reasons|1|||
16142251|NCT01034540|39008668|FG000|Overall Study|Adverse Event|0|||
16142252|NCT01034540|39008669|FG001|Overall Study|Adverse Event|1|||
16142253|NCT03716050|39008671|FG000|Overall Study|Lost to Follow-up|0|||
16142254|NCT03716050|39008672|FG001|Overall Study|Lost to Follow-up|0|||
16142255|NCT03716050|39008673|FG002|Overall Study|Lost to Follow-up|1|||
16142256|NCT03716050|39008674|FG003|Overall Study|Lost to Follow-up|0|||
16142257|NCT03716050|39008675|FG004|Overall Study|Lost to Follow-up|0|||
16142258|NCT03716050|39008676|FG005|Overall Study|Lost to Follow-up|0|||
16142259|NCT03716050|39008677|FG006|Overall Study|Lost to Follow-up|0|||
16142260|NCT03716050|39008678|FG007|Overall Study|Lost to Follow-up|0|||
16142261|NCT03716050|39008671|FG000|Overall Study|Physician Decision|0|||
16142262|NCT03716050|39008672|FG001|Overall Study|Physician Decision|0|||
16142263|NCT03716050|39008673|FG002|Overall Study|Physician Decision|0|||
16142264|NCT03716050|39008674|FG003|Overall Study|Physician Decision|1|||
16142265|NCT03716050|39008675|FG004|Overall Study|Physician Decision|0|||
16142266|NCT03716050|39008676|FG005|Overall Study|Physician Decision|0|||
16142267|NCT03716050|39008677|FG006|Overall Study|Physician Decision|0|||
16142268|NCT03716050|39008678|FG007|Overall Study|Physician Decision|0|||
16142269|NCT03716050|39008671|FG000|Overall Study|Protocol Violation|0|||
16142270|NCT03716050|39008672|FG001|Overall Study|Protocol Violation|0|||
16142271|NCT03716050|39008673|FG002|Overall Study|Protocol Violation|0|||
16142272|NCT03716050|39008674|FG003|Overall Study|Protocol Violation|1|||
16142273|NCT03716050|39008675|FG004|Overall Study|Protocol Violation|0|||
16142274|NCT03716050|39008676|FG005|Overall Study|Protocol Violation|0|||
16142275|NCT03716050|39008677|FG006|Overall Study|Protocol Violation|0|||
16142276|NCT03716050|39008678|FG007|Overall Study|Protocol Violation|2|||
16142277|NCT01667107|39008681|FG000|Overall Study|Adverse Event|4|||
16142278|NCT01667107|39008682|FG001|Overall Study|Adverse Event|3|||
16142279|NCT01667107|39008681|FG000|Overall Study|Tolerability issues|0|||
16142280|NCT01667107|39008682|FG001|Overall Study|Tolerability issues|2|||
16142281|NCT01667107|39008681|FG000|Overall Study|Protocol Violation|0|||
16142282|NCT01667107|39008682|FG001|Overall Study|Protocol Violation|1|||
16142283|NCT01667107|39008681|FG000|Overall Study|Lack of Efficacy|0|||
16142284|NCT01667107|39008682|FG001|Overall Study|Lack of Efficacy|1|||
16142285|NCT00088907|39008685|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
16142286|NCT00088907|39008686|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
16142287|NCT00088907|39008685|FG000|Randomized Study (Step 1)|Adverse Event|14|||
16142288|NCT00088907|39008686|FG001|Randomized Study (Step 1)|Adverse Event|19|||
16142289|NCT00088907|39008685|FG000|Randomized Study (Step 1)|Death|11|||
16142290|NCT00088907|39008686|FG001|Randomized Study (Step 1)|Death|12|||
16142291|NCT00088907|39008685|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
16142292|NCT00088907|39008686|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
16142293|NCT00088907|39008685|FG000|Randomized Study (Step 1)|complicating disease|3|||
16142294|NCT00088907|39008686|FG001|Randomized Study (Step 1)|complicating disease|1|||
16142295|NCT00088907|39008685|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
16142296|NCT00088907|39008686|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
16142297|NCT00088907|39008685|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
16142298|NCT00088907|39008686|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
16142299|NCT00088907|39008685|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
16142300|NCT00088907|39008686|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
16142301|NCT00088907|39008685|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
16142302|NCT00088907|39008686|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
16142303|NCT00088907|39008685|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
16142304|NCT00088907|39008686|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
16142305|NCT00088907|39008685|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
16142306|NCT00088907|39008686|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
16142307|NCT02566577|39008687|FG000|Overall Study|Withdrawal by Subject|1|||
16142308|NCT02566577|39008688|FG001|Overall Study|Withdrawal by Subject|1|||
16142309|NCT02566577|39008687|FG000|Overall Study|Equipment failure|1|||
16142310|NCT02566577|39008688|FG001|Overall Study|Equipment failure|1|||
16142311|NCT02566577|39008687|FG000|Overall Study|Physical limitation|1|||
16142312|NCT02566577|39008688|FG001|Overall Study|Physical limitation|0|||
16142313|NCT04376060|39008689|FG000|Overall Study|Physician Decision|1|||
16142314|NCT02043548|39008691|FG000|Overall Study|Lack of Efficacy|1|||
16142315|NCT02043548|39008692|FG001|Overall Study|Lack of Efficacy|0|||
16142316|NCT02043548|39008691|FG000|Overall Study|Adverse Event|0|||
16142317|NCT02043548|39008692|FG001|Overall Study|Adverse Event|1|||
16142318|NCT01087957|39008693|FG000|Overall Study|Death|2|||
16142319|NCT01087957|39008694|FG001|Overall Study|Death|2|||
16142320|NCT01087957|39008693|FG000|Overall Study|Lost to Follow-up|3|||
16142321|NCT01087957|39008694|FG001|Overall Study|Lost to Follow-up|4|||
16142322|NCT01087957|39008693|FG000|Overall Study|Protocol Violation|13|||
16142323|NCT01087957|39008694|FG001|Overall Study|Protocol Violation|25|||
16142324|NCT01087957|39008693|FG000|Overall Study|Withdrawal by Subject|18|||
16142325|NCT01087957|39008694|FG001|Overall Study|Withdrawal by Subject|15|||
16142326|NCT01087957|39008693|FG000|Overall Study|Physician Decision|5|||
16142327|NCT01087957|39008694|FG001|Overall Study|Physician Decision|9|||
16142328|NCT00826111|39008695|FG000|Overall Study|Lost to Follow-up|0|||
16142329|NCT00826111|39008696|FG001|Overall Study|Lost to Follow-up|1|||
16142330|NCT00826111|39008695|FG000|Overall Study|Protocol Violation|1|||
16142331|NCT00826111|39008696|FG001|Overall Study|Protocol Violation|0|||
16142332|NCT00826111|39008695|FG000|Overall Study|Withdrawal by Subject|5|||
16142333|NCT00826111|39008696|FG001|Overall Study|Withdrawal by Subject|0|||
16142334|NCT00826111|39008695|FG000|Overall Study|Physician Decision|1|||
16142335|NCT00826111|39008696|FG001|Overall Study|Physician Decision|1|||
16142336|NCT04060563|39008721|FG000|Overall Study|Lost to Follow-up|1|||
16142337|NCT04060563|39008722|FG001|Overall Study|Lost to Follow-up|1|||
16256088|NCT04799158|39423951|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
16256089|NCT04799158|39423952|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
16256090|NCT04799158|39423953|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
16256091|NCT04799158|39423949|FG000|On-Demand Treatment Period|Miscellaneous|0|||
16256092|NCT04799158|39423950|FG001|On-Demand Treatment Period|Miscellaneous|0|||
16256093|NCT04799158|39423951|FG002|On-Demand Treatment Period|Miscellaneous|0|||
16256094|NCT04799158|39423952|FG003|On-Demand Treatment Period|Miscellaneous|0|||
16256095|NCT04799158|39423953|FG004|On-Demand Treatment Period|Miscellaneous|1|||
16256096|NCT00553280|39423954|FG000|Overall Study|Adverse Event|19|||
16256097|NCT00553280|39423954|FG000|Overall Study|Lack of Efficacy|3|||
16256098|NCT00553280|39423954|FG000|Overall Study|Withdrawal by Subject|3|||
16256099|NCT00553280|39423954|FG000|Overall Study|Physician Decision|1|||
16256100|NCT01781637|39423955|FG000|Overall Study|Adverse Event|1|||
16256101|NCT01781637|39423956|FG001|Overall Study|Adverse Event|0|||
16142338|NCT04060563|39008721|FG000|Overall Study|Physician Decision|0|||
16142339|NCT04060563|39008722|FG001|Overall Study|Physician Decision|1|||
16142340|NCT00937833|39008723|FG000|Overall Study|Protocol Violation|1|||
16142341|NCT00937833|39008724|FG001|Overall Study|Protocol Violation|2|||
16256102|NCT01781637|39423955|FG000|Overall Study|Lack of Efficacy|2|||
16142342|NCT00937833|39008723|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
16142343|NCT00937833|39008724|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
16142344|NCT00937833|39008723|FG000|Overall Study|Lost to Follow-up|10|||
16142345|NCT00937833|39008724|FG001|Overall Study|Lost to Follow-up|8|||
16142346|NCT00937833|39008723|FG000|Overall Study|Withdrawal by Subject|4|||
16142347|NCT00937833|39008724|FG001|Overall Study|Withdrawal by Subject|6|||
16142348|NCT00078325|39008725|FG000|Overall Study|Adverse Event|15|||
16142349|NCT00078325|39008726|FG001|Overall Study|Adverse Event|10|||
16142350|NCT00078325|39008727|FG002|Overall Study|Adverse Event|5|||
16142351|NCT00078325|39008725|FG000|Overall Study|Protocol Violation|2|||
16439224|NCT01506271|40089342|FG000|Overall Study|Withdrawal by Subject|0|||
16142352|NCT00078325|39008726|FG001|Overall Study|Protocol Violation|2|||
16142353|NCT00078325|39008727|FG002|Overall Study|Protocol Violation|0|||
16142354|NCT00078325|39008725|FG000|Overall Study|Withdrawal by Subject|1|||
16142355|NCT00078325|39008726|FG001|Overall Study|Withdrawal by Subject|5|||
16142356|NCT00078325|39008727|FG002|Overall Study|Withdrawal by Subject|3|||
16142357|NCT00078325|39008725|FG000|Overall Study|Lost to Follow-up|0|||
16142358|NCT00078325|39008726|FG001|Overall Study|Lost to Follow-up|1|||
16142359|NCT00078325|39008727|FG002|Overall Study|Lost to Follow-up|1|||
16142360|NCT00078325|39008725|FG000|Overall Study|Physician Decision|2|||
16142361|NCT00078325|39008726|FG001|Overall Study|Physician Decision|0|||
16142362|NCT00078325|39008727|FG002|Overall Study|Physician Decision|1|||
16142363|NCT00078325|39008725|FG000|Overall Study|Miscellaneous|1|||
16142364|NCT00078325|39008726|FG001|Overall Study|Miscellaneous|1|||
16142365|NCT00078325|39008727|FG002|Overall Study|Miscellaneous|1|||
16142366|NCT01749540|39008730|FG000|Overall Study|Protocol Violation|0|||
16142367|NCT01749540|39008731|FG001|Overall Study|Protocol Violation|0|||
16142368|NCT01749540|39008732|FG002|Overall Study|Protocol Violation|0|||
16142369|NCT01749540|39008733|FG003|Overall Study|Protocol Violation|0|||
16439225|NCT01506271|40089343|FG001|Overall Study|Withdrawal by Subject|1|||
16142370|NCT01749540|39008734|FG004|Overall Study|Protocol Violation|0|||
16142371|NCT01749540|39008735|FG005|Overall Study|Protocol Violation|1|||
16439226|NCT01506271|40089344|FG002|Overall Study|Withdrawal by Subject|1|||
16142372|NCT01749540|39008736|FG006|Overall Study|Protocol Violation|1|||
16142373|NCT01749540|39008730|FG000|Overall Study|Withdrawal by Subject|0|||
16142374|NCT01749540|39008731|FG001|Overall Study|Withdrawal by Subject|0|||
16142375|NCT01749540|39008732|FG002|Overall Study|Withdrawal by Subject|0|||
16142376|NCT01749540|39008733|FG003|Overall Study|Withdrawal by Subject|1|||
16142377|NCT01749540|39008734|FG004|Overall Study|Withdrawal by Subject|0|||
16142378|NCT01749540|39008735|FG005|Overall Study|Withdrawal by Subject|0|||
16142379|NCT01749540|39008736|FG006|Overall Study|Withdrawal by Subject|0|||
16142380|NCT01749540|39008730|FG000|Overall Study|Initiated into extension study A536-06|0|||
16142381|NCT01749540|39008731|FG001|Overall Study|Initiated into extension study A536-06|0|||
16142382|NCT01749540|39008732|FG002|Overall Study|Initiated into extension study A536-06|0|||
16142383|NCT01749540|39008733|FG003|Overall Study|Initiated into extension study A536-06|0|||
16142384|NCT01749540|39008734|FG004|Overall Study|Initiated into extension study A536-06|0|||
16142385|NCT01749540|39008735|FG005|Overall Study|Initiated into extension study A536-06|2|||
16142386|NCT01749540|39008736|FG006|Overall Study|Initiated into extension study A536-06|24|||
16142387|NCT02092350|39008737|FG000|Overall Study|Adverse Event|0|||
16142388|NCT02092350|39008738|FG001|Overall Study|Adverse Event|3|||
16142389|NCT02092350|39008737|FG000|Overall Study|Death|2|||
16142390|NCT02092350|39008738|FG001|Overall Study|Death|5|||
16142391|NCT02092350|39008737|FG000|Overall Study|Lost to Follow-up|3|||
16142392|NCT02092350|39008738|FG001|Overall Study|Lost to Follow-up|1|||
16142393|NCT02092350|39008737|FG000|Overall Study|Protocol Violation|1|||
16142394|NCT02092350|39008738|FG001|Overall Study|Protocol Violation|0|||
16439227|NCT01506271|40089342|FG000|Overall Study|Lost to Follow-up|0|||
16439228|NCT01506271|40089343|FG001|Overall Study|Lost to Follow-up|1|||
16439229|NCT01506271|40089344|FG002|Overall Study|Lost to Follow-up|2|||
16439230|NCT03253796|40089345|FG000|Period 1: Run-In|Adverse Event|4|||
16439231|NCT03253796|40089346|FG001|Period 1: Run-In|Adverse Event|0|||
16439232|NCT03253796|40089347|FG002|Period 1: Run-In|Adverse Event|0|||
16439233|NCT03253796|40089348|FG003|Period 1: Run-In|Adverse Event|0|||
16439234|NCT03253796|40089349|FG004|Period 1: Run-In|Adverse Event|0|||
16439235|NCT03253796|40089345|FG000|Period 1: Run-In|Lack of Efficacy|1|||
16439236|NCT03253796|40089346|FG001|Period 1: Run-In|Lack of Efficacy|0|||
16439237|NCT03253796|40089347|FG002|Period 1: Run-In|Lack of Efficacy|0|||
16439238|NCT03253796|40089348|FG003|Period 1: Run-In|Lack of Efficacy|0|||
16439239|NCT03253796|40089349|FG004|Period 1: Run-In|Lack of Efficacy|0|||
16439240|NCT03253796|40089345|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
16439241|NCT03253796|40089346|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
16439242|NCT03253796|40089347|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
16439243|NCT03253796|40089348|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
16439244|NCT03253796|40089349|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
16439245|NCT03253796|40089345|FG000|Period 1: Run-In|Protocol Violation|5|||
16439246|NCT03253796|40089346|FG001|Period 1: Run-In|Protocol Violation|0|||
16439247|NCT03253796|40089347|FG002|Period 1: Run-In|Protocol Violation|0|||
16439248|NCT03253796|40089348|FG003|Period 1: Run-In|Protocol Violation|0|||
16439249|NCT03253796|40089349|FG004|Period 1: Run-In|Protocol Violation|0|||
16439250|NCT03253796|40089345|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
16142395|NCT02092350|39008737|FG000|Overall Study|Physician Decision|1|||
16142396|NCT02092350|39008738|FG001|Overall Study|Physician Decision|1|||
16142397|NCT02092350|39008737|FG000|Overall Study|Screen Failure|1|||
16142398|NCT02092350|39008738|FG001|Overall Study|Screen Failure|0|||
16439251|NCT03253796|40089346|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
16439252|NCT03253796|40089347|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
16439253|NCT03253796|40089348|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
16439254|NCT03253796|40089349|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
16142399|NCT02092350|39008737|FG000|Overall Study|Withdrawal by Subject|2|||
16142400|NCT02092350|39008738|FG001|Overall Study|Withdrawal by Subject|2|||
16142401|NCT00381563|39008739|FG000|Overall Study|Withdrawal by Subject|5|||
16256103|NCT01781637|39423956|FG001|Overall Study|Lack of Efficacy|6|||
16256104|NCT01781637|39423955|FG000|Overall Study|Withdrawal by Subject|1|||
16256105|NCT01781637|39423956|FG001|Overall Study|Withdrawal by Subject|0|||
16256106|NCT00755196|39423959|FG000|Overall Study|Lost to Follow-up|1|||
16256107|NCT00755196|39423959|FG000|Overall Study|Lack of Efficiency|1|||
16256108|NCT01424722|39423960|FG000|Overall Study|Sponsor terminated investigation|2258|||
16256109|NCT00397488|39423963|FG000|Overall Study|Withdrawal by Subject|3|||
16256110|NCT00397488|39423963|FG000|Overall Study|Adverse Event|3|||
16256111|NCT00397488|39423963|FG000|Overall Study|Death|1|||
16256112|NCT01790568|39423964|FG000|Overall Study|Progression prior to transplant|0|||
16256113|NCT01790568|39423965|FG001|Overall Study|Progression prior to transplant|1|||
16256114|NCT00679367|39423966|FG000|Overall Study|Adverse Event|7|||
16439255|NCT03253796|40089345|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
16439256|NCT03253796|40089346|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
16439257|NCT03253796|40089347|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
16439258|NCT03253796|40089348|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
16439259|NCT03253796|40089349|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
16439260|NCT03253796|40089345|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
16439261|NCT03253796|40089346|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
16439262|NCT03253796|40089347|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
16439263|NCT03253796|40089348|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
16439264|NCT03253796|40089349|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
16439265|NCT03253796|40089345|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
16439266|NCT03253796|40089346|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
16439267|NCT03253796|40089347|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
16439268|NCT03253796|40089348|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
16439269|NCT03253796|40089349|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
16439270|NCT03253796|40089345|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
16439271|NCT03253796|40089346|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
16439272|NCT03253796|40089347|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
16439273|NCT03253796|40089348|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
16439274|NCT03253796|40089349|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
16439275|NCT03253796|40089345|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
16439276|NCT03253796|40089346|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
16439277|NCT03253796|40089347|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
16439278|NCT03253796|40089348|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
16439279|NCT03253796|40089349|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
16439280|NCT03253796|40089345|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
16439281|NCT03253796|40089346|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
16439282|NCT03253796|40089347|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
16439283|NCT03253796|40089348|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
16439284|NCT03253796|40089349|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
16439285|NCT01453049|40089350|FG000|Overall Study|Protocol Violation|2|||
16439286|NCT01453049|40089351|FG001|Overall Study|Protocol Violation|5|||
16439287|NCT01453049|40089350|FG000|Overall Study|Lost to Follow-up|2|||
16256115|NCT00679367|39423966|FG000|Overall Study|inability to swallow oral drugs|1|||
16256116|NCT00679367|39423966|FG000|Overall Study|Lack of Efficacy|3|||
16256117|NCT00679367|39423966|FG000|Overall Study|Withdrawal by Subject|1|||
16256118|NCT02801877|39423967|FG000|Overall Study|Lost to Follow-up|1|||
16256119|NCT02801877|39423968|FG001|Overall Study|Lost to Follow-up|1|||
16256120|NCT02801877|39423969|FG002|Overall Study|Lost to Follow-up|2|||
16256121|NCT02801877|39423970|FG003|Overall Study|Lost to Follow-up|0|||
16256122|NCT02801877|39423967|FG000|Overall Study|Never Started Treatment|2|||
16256123|NCT02801877|39423968|FG001|Overall Study|Never Started Treatment|0|||
16256124|NCT02801877|39423969|FG002|Overall Study|Never Started Treatment|4|||
16256125|NCT02801877|39423970|FG003|Overall Study|Never Started Treatment|0|||
16256126|NCT01626079|39423971|FG000|Overall Study|Death|167|||
16256127|NCT01626079|39423972|FG001|Overall Study|Death|192|||
16256128|NCT01626079|39423973|FG002|Overall Study|Death|39|||
16256129|NCT01626079|39423971|FG000|Overall Study|Withdrawal by Subject|23|||
16256130|NCT01626079|39423972|FG001|Overall Study|Withdrawal by Subject|37|||
16256131|NCT01626079|39423973|FG002|Overall Study|Withdrawal by Subject|5|||
16256132|NCT01626079|39423971|FG000|Overall Study|Lost to Follow-up|7|||
16256133|NCT01626079|39423972|FG001|Overall Study|Lost to Follow-up|4|||
16256134|NCT01626079|39423973|FG002|Overall Study|Lost to Follow-up|2|||
16256135|NCT01626079|39423971|FG000|Overall Study|Missed Visits|1|||
16256136|NCT01626079|39423972|FG001|Overall Study|Missed Visits|4|||
16256137|NCT01626079|39423973|FG002|Overall Study|Missed Visits|6|||
16256138|NCT03500692|39423975|FG000|Overall Study|Death|163|||
16256139|NCT03500692|39423975|FG000|Overall Study|Lost to Follow-up|75|||
16256140|NCT03500692|39423975|FG000|Overall Study|Termination Reasons|3|||
16256141|NCT01572948|39423978|FG000|Overall Study|Lost to Follow-up|1|||
16256142|NCT01572948|39423979|FG001|Overall Study|Lost to Follow-up|0|||
16256143|NCT01572948|39423978|FG000|Overall Study|unable to contact|0|||
16256144|NCT01572948|39423979|FG001|Overall Study|unable to contact|1|||
16256145|NCT01856309|39423982|FG000|Overall Study|Death|4|||
16256146|NCT01856309|39423983|FG001|Overall Study|Death|6|||
16256147|NCT01856309|39423984|FG002|Overall Study|Death|11|||
16256148|NCT01856309|39423985|FG003|Overall Study|Death|6|||
16256149|NCT01856309|39423982|FG000|Overall Study|Lost to Follow-up|6|||
16256150|NCT01856309|39423983|FG001|Overall Study|Lost to Follow-up|2|||
16256151|NCT01856309|39423984|FG002|Overall Study|Lost to Follow-up|4|||
16256152|NCT01856309|39423985|FG003|Overall Study|Lost to Follow-up|8|||
16364163|NCT01136954|39818222|FG000|Overall Study|Withdrawal by Subject|6|||
16256153|NCT01856309|39423982|FG000|Overall Study|Withdrawal by Subject|11|||
16256154|NCT01856309|39423983|FG001|Overall Study|Withdrawal by Subject|13|||
16256155|NCT01856309|39423984|FG002|Overall Study|Withdrawal by Subject|28|||
16256156|NCT01856309|39423985|FG003|Overall Study|Withdrawal by Subject|26|||
16256157|NCT01856309|39423982|FG000|Overall Study|Other|227|||
16256158|NCT01856309|39423983|FG001|Overall Study|Other|225|||
16256159|NCT01856309|39423984|FG002|Overall Study|Other|447|||
16256160|NCT01856309|39423985|FG003|Overall Study|Other|469|||
16256161|NCT01856309|39423982|FG000|Overall Study|Lack of Efficacy|14|||
16256162|NCT01856309|39423983|FG001|Overall Study|Lack of Efficacy|9|||
16256163|NCT01856309|39423984|FG002|Overall Study|Lack of Efficacy|40|||
16256164|NCT01856309|39423985|FG003|Overall Study|Lack of Efficacy|25|||
16256165|NCT01856309|39423982|FG000|Overall Study|Adverse Event|31|||
16256166|NCT01856309|39423983|FG001|Overall Study|Adverse Event|31|||
16256167|NCT01856309|39423984|FG002|Overall Study|Adverse Event|55|||
16256168|NCT01856309|39423985|FG003|Overall Study|Adverse Event|65|||
16256169|NCT01856309|39423982|FG000|Overall Study|Pregnancy|0|||
16256170|NCT01856309|39423983|FG001|Overall Study|Pregnancy|0|||
16256171|NCT01856309|39423984|FG002|Overall Study|Pregnancy|0|||
16256172|NCT01856309|39423985|FG003|Overall Study|Pregnancy|1|||
16256173|NCT01856309|39423982|FG000|Overall Study|Physician Decision|6|||
16256174|NCT01856309|39423983|FG001|Overall Study|Physician Decision|1|||
16256175|NCT01856309|39423984|FG002|Overall Study|Physician Decision|6|||
16256176|NCT01856309|39423985|FG003|Overall Study|Physician Decision|8|||
16256177|NCT01856309|39423982|FG000|Overall Study|Noncompliance With Study Drug|0|||
16256178|NCT01856309|39423983|FG001|Overall Study|Noncompliance With Study Drug|1|||
16256179|NCT01856309|39423984|FG002|Overall Study|Noncompliance With Study Drug|4|||
16256180|NCT01856309|39423985|FG003|Overall Study|Noncompliance With Study Drug|1|||
16256181|NCT00429364|39423988|FG000|Overall Study|Withdrawal by Subject|11|||
16256182|NCT00429364|39423989|FG001|Overall Study|Withdrawal by Subject|5|||
16256183|NCT00429364|39423988|FG000|Overall Study|Physician Decision|4|||
16256184|NCT00429364|39423989|FG001|Overall Study|Physician Decision|2|||
16256185|NCT00429364|39423988|FG000|Overall Study|Lost to Follow-up|7|||
16256186|NCT00429364|39423989|FG001|Overall Study|Lost to Follow-up|6|||
16256187|NCT00429364|39423988|FG000|Overall Study|Death|0|||
16256188|NCT00429364|39423989|FG001|Overall Study|Death|1|||
16256189|NCT00429364|39423988|FG000|Overall Study|Underwent aortic root surgery|10|||
16256190|NCT00429364|39423989|FG001|Overall Study|Underwent aortic root surgery|18|||
16256191|NCT00429364|39423988|FG000|Overall Study|Pregnancy|0|||
16256192|NCT00429364|39423989|FG001|Overall Study|Pregnancy|1|||
16256193|NCT03831048|39423990|FG000|Overall Study|Protocol Violation|9|||
16256194|NCT03831048|39423991|FG001|Overall Study|Protocol Violation|3|||
16256195|NCT03831048|39423990|FG000|Overall Study|Death|4|||
16256196|NCT03831048|39423991|FG001|Overall Study|Death|9|||
16256197|NCT03831048|39423990|FG000|Overall Study|Re-transplant|0|||
16256198|NCT03831048|39423991|FG001|Overall Study|Re-transplant|2|||
16256199|NCT03831048|39423990|FG000|Overall Study|Protocol violation and death|1|||
16256200|NCT03831048|39423991|FG001|Overall Study|Protocol violation and death|1|||
16256201|NCT03601637|39423992|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
16142402|NCT00381563|39008740|FG001|Overall Study|Withdrawal by Subject|5|||
16256202|NCT03601637|39423993|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
16256203|NCT03601637|39423992|FG000|Overall Study|Adverse Event|1|||
16256204|NCT03601637|39423993|FG001|Overall Study|Adverse Event|1|||
16256205|NCT03601637|39423992|FG000|Overall Study|Other|0|||
16256206|NCT03601637|39423993|FG001|Overall Study|Other|1|||
16256207|NCT02979353|39423998|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
16364164|NCT01136954|39818223|FG001|Overall Study|Withdrawal by Subject|2|||
16142403|NCT00381563|39008739|FG000|Overall Study|Lost to Follow-up|2|||
16364165|NCT01136954|39818222|FG000|Overall Study|Lack of Efficacy|14|||
16142404|NCT00381563|39008740|FG001|Overall Study|Lost to Follow-up|0|||
16142405|NCT00381563|39008739|FG000|Overall Study|Protocol Violation|0|||
16439288|NCT01453049|40089351|FG001|Overall Study|Lost to Follow-up|1|||
16142406|NCT00381563|39008740|FG001|Overall Study|Protocol Violation|1|||
16142407|NCT03027557|39011581|FG000|Overall Study|Adverse Event|1|||
16142408|NCT03027557|39011582|FG001|Overall Study|Adverse Event|0|||
16142409|NCT03027557|39011583|FG002|Overall Study|Adverse Event|0|||
16142410|NCT01519934|39011584|FG000|Overall Study|Lost to Follow-up|3|||
16142411|NCT04411628|39011586|FG000|Overall Study|Withdrawal by Subject|1|||
16142412|NCT04411628|39011587|FG001|Overall Study|Withdrawal by Subject|1|||
16142413|NCT04411628|39011588|FG002|Overall Study|Withdrawal by Subject|2|||
16142414|NCT04411628|39011589|FG003|Overall Study|Withdrawal by Subject|0|||
16142415|NCT04411628|39011586|FG000|Overall Study|Lost to Follow-up|0|||
16142416|NCT04411628|39011587|FG001|Overall Study|Lost to Follow-up|1|||
16142417|NCT04411628|39011588|FG002|Overall Study|Lost to Follow-up|0|||
16142418|NCT04411628|39011589|FG003|Overall Study|Lost to Follow-up|0|||
16142419|NCT01672788|39011590|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
16142420|NCT01672788|39011591|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
16142421|NCT01672788|39011592|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
16142422|NCT01672788|39011593|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
16142423|NCT02170779|39011594|FG000|Overall Study|Withdrawal by Subject|1|||
16142424|NCT02170779|39011595|FG001|Overall Study|Withdrawal by Subject|0|||
16142425|NCT02170779|39011594|FG000|Overall Study|Lost to Follow-up|0|||
16142426|NCT02170779|39011595|FG001|Overall Study|Lost to Follow-up|1|||
16142427|NCT05093322|39011596|FG000|Overall Study|Death|6|||
16142428|NCT05093322|39011597|FG001|Overall Study|Death|2|||
16142429|NCT05093322|39011596|FG000|Overall Study|Other|4|||
16142430|NCT05093322|39011597|FG001|Overall Study|Other|1|||
16142431|NCT01843972|39011598|FG000|Overall Study|Withdrawal by Subject|0|||
16142432|NCT01843972|39011599|FG001|Overall Study|Withdrawal by Subject|0|||
16142433|NCT01843972|39011600|FG002|Overall Study|Withdrawal by Subject|0|||
16142434|NCT01843972|39011601|FG003|Overall Study|Withdrawal by Subject|0|||
16142435|NCT01843972|39011602|FG004|Overall Study|Withdrawal by Subject|1|||
16142436|NCT01843972|39011603|FG005|Overall Study|Withdrawal by Subject|0|||
16142437|NCT01843972|39011604|FG006|Overall Study|Withdrawal by Subject|0|||
16142438|NCT01843972|39011605|FG007|Overall Study|Withdrawal by Subject|0|||
16142439|NCT01843972|39011606|FG008|Overall Study|Withdrawal by Subject|0|||
16142440|NCT01843972|39011607|FG009|Overall Study|Withdrawal by Subject|0|||
16142441|NCT01428661|39011608|FG000|Double-Masked Phase|Protocol Violation|9|||
16142442|NCT01428661|39011609|FG001|Double-Masked Phase|Protocol Violation|4|||
16142443|NCT01428661|39011610|FG002|Double-Masked Phase|Protocol Violation|0|||
16142444|NCT01428661|39011608|FG000|Double-Masked Phase|Adverse Event|13|||
16142445|NCT01428661|39011609|FG001|Double-Masked Phase|Adverse Event|4|||
16142446|NCT01428661|39011610|FG002|Double-Masked Phase|Adverse Event|0|||
16142447|NCT01428661|39011608|FG000|Double-Masked Phase|Lost to Follow-up|14|||
16142448|NCT01428661|39011609|FG001|Double-Masked Phase|Lost to Follow-up|14|||
16142449|NCT01428661|39011610|FG002|Double-Masked Phase|Lost to Follow-up|0|||
16142450|NCT01428661|39011608|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
16142451|NCT01428661|39011609|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
16364166|NCT01136954|39818223|FG001|Overall Study|Lack of Efficacy|13|||
16364167|NCT01136954|39818222|FG000|Overall Study|Physician Decision|0|||
16364168|NCT01136954|39818223|FG001|Overall Study|Physician Decision|1|||
16364169|NCT01136954|39818222|FG000|Overall Study|Other|1|||
16364170|NCT01136954|39818223|FG001|Overall Study|Other|3|||
16364171|NCT03807843|39818224|FG000|Overall Study|Lost to Follow-up|1|||
16364172|NCT03807843|39818225|FG001|Overall Study|Lost to Follow-up|0|||
16364173|NCT01373229|39818230|FG000|Overall Study|Death|3|||
16364174|NCT01373229|39818230|FG000|Overall Study|Physician Decision|3|||
16364175|NCT00316004|39818231|FG000|Overall Study|Subject was not given study fluid.|14|||
16364176|NCT00316004|39818232|FG001|Overall Study|Subject was not given study fluid.|14|||
16364177|NCT00316004|39818233|FG002|Overall Study|Subject was not given study fluid.|21|||
16364178|NCT02908347|39818234|FG000|Overall Study|Adverse Event|0|||
16364179|NCT02908347|39818235|FG001|Overall Study|Adverse Event|1|||
16364180|NCT02908347|39818234|FG000|Overall Study|Lost to Follow-up|1|||
16364181|NCT02908347|39818235|FG001|Overall Study|Lost to Follow-up|0|||
16364182|NCT04969289|39818236|FG000|Overall Study|Lost to Follow-up|13|||
16364183|NCT04969289|39818237|FG001|Overall Study|Lost to Follow-up|9|||
16364184|NCT02328105|39818239|FG000|Overall Study|Death|6|||
16364185|NCT02328105|39818239|FG000|Overall Study|Withdrawal by Subject|1|||
16364186|NCT02328105|39818239|FG000|Overall Study|Still On Study in Follow-Up|4|||
16364187|NCT02187055|39818240|FG000|Overall Study|Lack of Efficacy|10|||
16364188|NCT02187055|39818241|FG001|Overall Study|Lack of Efficacy|3|||
16142452|NCT01428661|39011610|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
16142453|NCT01428661|39011608|FG000|Double-Masked Phase|Lack of Efficacy|2|||
16142454|NCT01428661|39011609|FG001|Double-Masked Phase|Lack of Efficacy|1|||
16142455|NCT01428661|39011610|FG002|Double-Masked Phase|Lack of Efficacy|0|||
16142456|NCT01428661|39011608|FG000|Double-Masked Phase|*Various|1|||
16142457|NCT01428661|39011609|FG001|Double-Masked Phase|*Various|6|||
16142458|NCT01428661|39011610|FG002|Double-Masked Phase|*Various|0|||
16142459|NCT01428661|39011608|FG000|Open Label Extension|Protocol Violation|0|||
16142460|NCT01428661|39011609|FG001|Open Label Extension|Protocol Violation|0|||
16142461|NCT01428661|39011610|FG002|Open Label Extension|Protocol Violation|9|||
16142462|NCT01428661|39011608|FG000|Open Label Extension|Adverse Event|0|||
16142463|NCT01428661|39011609|FG001|Open Label Extension|Adverse Event|0|||
16142464|NCT01428661|39011610|FG002|Open Label Extension|Adverse Event|15|||
16142465|NCT01428661|39011608|FG000|Open Label Extension|Lost to Follow-up|0|||
16142466|NCT01428661|39011609|FG001|Open Label Extension|Lost to Follow-up|0|||
16142467|NCT01428661|39011610|FG002|Open Label Extension|Lost to Follow-up|38|||
16142468|NCT01428661|39011608|FG000|Open Label Extension|Withdrawal by Subject|0|||
16142469|NCT01428661|39011609|FG001|Open Label Extension|Withdrawal by Subject|0|||
16142470|NCT01428661|39011610|FG002|Open Label Extension|Withdrawal by Subject|49|||
16142471|NCT01428661|39011608|FG000|Open Label Extension|Lack of Efficacy|0|||
16142472|NCT01428661|39011609|FG001|Open Label Extension|Lack of Efficacy|0|||
16142473|NCT01428661|39011610|FG002|Open Label Extension|Lack of Efficacy|24|||
16142474|NCT01428661|39011608|FG000|Open Label Extension|**Various|0|||
16142475|NCT01428661|39011609|FG001|Open Label Extension|**Various|0|||
16142476|NCT01428661|39011610|FG002|Open Label Extension|**Various|185|||
16142477|NCT03768505|39011613|FG000|Overall Study|sponsor decision|76|||
16142478|NCT03768505|39011613|FG000|Overall Study|Death|35|||
16142479|NCT03768505|39011613|FG000|Overall Study|Other -Various|30|||
16142480|NCT03768505|39011613|FG000|Overall Study|Withdrawal by Subject|22|||
16142481|NCT03768505|39011613|FG000|Overall Study|Lost to Follow-up|6|||
16142482|NCT01055262|39011614|FG000|Overall Study|Adverse Event|5|||
16142483|NCT01055262|39011614|FG000|Overall Study|Protocol Violation|3|||
16142484|NCT01055262|39011614|FG000|Overall Study|Uncooperativeness|1|||
16142485|NCT01210690|39011616|FG000|Overall Study|Adverse Event|7|||
16142486|NCT01210690|39011616|FG000|Overall Study|Lack of Efficacy|12|||
16142487|NCT01210690|39011616|FG000|Overall Study|Lost to Follow-up|3|||
16142488|NCT01210690|39011616|FG000|Overall Study|Disease Remission|1|||
16142489|NCT01210690|39011616|FG000|Overall Study|Withdrawal by Subject|1|||
16142490|NCT01210690|39011616|FG000|Overall Study|Patient refused to swallow|1|||
16142491|NCT01210690|39011616|FG000|Overall Study|Patient could not take glucose|1|||
16142492|NCT00355056|39011617|FG000|Randomization Period|Early Termination|4|||
16142493|NCT00355056|39011618|FG001|Randomization Period|Early Termination|6|||
16142494|NCT00667355|39011620|FG000|Overall Study|Adverse Event|5|||
16142495|NCT00667355|39011620|FG000|Overall Study|Lost to Follow-up|1|||
16142496|NCT00667355|39011620|FG000|Overall Study|Other reason was not specified|5|||
16142497|NCT00931944|39011621|FG000|Overall Study|Adverse Event|4|||
16142498|NCT00931944|39011621|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
16142499|NCT00931944|39011621|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
16142500|NCT00931944|39011621|FG000|Overall Study|Death|28|||
16142501|NCT00931944|39011621|FG000|Overall Study|Other|2|||
16142502|NCT03625687|39011622|FG000|Overall Study|Death|1|||
16142503|NCT04246801|39011623|FG000|Overall Study|Adverse Event|1|||
16142504|NCT04246801|39011624|FG001|Overall Study|Adverse Event|1|||
16142505|NCT04246801|39011623|FG000|Overall Study|Protocol Violation|1|||
16142506|NCT04246801|39011624|FG001|Overall Study|Protocol Violation|1|||
16142507|NCT04246801|39011623|FG000|Overall Study|Lack of Efficacy|0|||
16142508|NCT04246801|39011624|FG001|Overall Study|Lack of Efficacy|2|||
16142509|NCT04246801|39011623|FG000|Overall Study|Lost to Follow-up|1|||
16142510|NCT04246801|39011624|FG001|Overall Study|Lost to Follow-up|1|||
16142511|NCT04246801|39011623|FG000|Overall Study|Withdrawal by Subject|2|||
16142512|NCT04246801|39011624|FG001|Overall Study|Withdrawal by Subject|1|||
16142513|NCT00545402|39011625|FG000|Overall Study|Discontinuation of treatment|17|||
16142514|NCT00545402|39011626|FG001|Overall Study|Discontinuation of treatment|9|||
16142515|NCT00545402|39011625|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
16142516|NCT00545402|39011626|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
16142517|NCT00545402|39011625|FG000|Overall Study|Death|5|||
16142518|NCT00545402|39011626|FG001|Overall Study|Death|7|||
16142519|NCT00545402|39011625|FG000|Overall Study|Graft loss|2|||
16142520|NCT00545402|39011626|FG001|Overall Study|Graft loss|4|||
16142521|NCT00545402|39011625|FG000|Overall Study|Withdrawal by Subject|0|||
16142522|NCT00545402|39011626|FG001|Overall Study|Withdrawal by Subject|1|||
16142523|NCT00545402|39011625|FG000|Overall Study|Protocol Violation|1|||
16142524|NCT00545402|39011626|FG001|Overall Study|Protocol Violation|0|||
16364189|NCT02187055|39818242|FG002|Overall Study|Lack of Efficacy|7|||
16142525|NCT00545402|39011625|FG000|Overall Study|Reason not specified|1|||
16142526|NCT00545402|39011626|FG001|Overall Study|Reason not specified|1|||
16142527|NCT01423812|39011627|FG000|Overall Study|Lost to Follow-up|2|||
16142528|NCT01423812|39011628|FG001|Overall Study|Lost to Follow-up|2|||
16142529|NCT01423812|39011627|FG000|Overall Study|Withdrawal by Subject|1|||
16142530|NCT01423812|39011628|FG001|Overall Study|Withdrawal by Subject|2|||
16142531|NCT00024167|39011631|FG000|Overall Study|Death|53|||
16142532|NCT00024167|39011632|FG001|Overall Study|Death|47|||
16142533|NCT03739762|39011634|FG000|Overall Study|Lost to Follow-up|1|||
16142534|NCT03739762|39011635|FG001|Overall Study|Lost to Follow-up|1|||
16142535|NCT03739762|39011634|FG000|Overall Study|Withdrawal by Subject|2|||
16142536|NCT03739762|39011635|FG001|Overall Study|Withdrawal by Subject|6|||
16142537|NCT00617604|39011636|FG000|Overall Study|Death|2|||
16142538|NCT00617604|39011637|FG001|Overall Study|Death|1|||
16142539|NCT00617604|39011636|FG000|Overall Study|Lost to Follow-up|1|||
16142540|NCT00617604|39011637|FG001|Overall Study|Lost to Follow-up|0|||
16142541|NCT00617604|39011636|FG000|Overall Study|Miscellaneous Reasons|8|||
16142542|NCT00617604|39011637|FG001|Overall Study|Miscellaneous Reasons|10|||
16142543|NCT00617604|39011636|FG000|Overall Study|Withdrawal by Subject|4|||
16142544|NCT00617604|39011637|FG001|Overall Study|Withdrawal by Subject|6|||
16142545|NCT00617604|39011636|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
16142546|NCT00617604|39011637|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
16142547|NCT01794520|39011638|FG000|Overall Study|Adverse events- related to progression|0|||
16142548|NCT01794520|39011639|FG001|Overall Study|Adverse events- related to progression|0|||
16142549|NCT01794520|39011640|FG002|Overall Study|Adverse events- related to progression|1|||
16142550|NCT01794520|39011641|FG003|Overall Study|Adverse events- related to progression|2|||
16142551|NCT01794520|39011642|FG004|Overall Study|Adverse events- related to progression|0|||
16142552|NCT01794520|39011643|FG005|Overall Study|Adverse events- related to progression|1|||
16142553|NCT01794520|39011644|FG006|Overall Study|Adverse events- related to progression|0|||
16142554|NCT01794520|39011638|FG000|Overall Study|Adverse event- not related to progression|1|||
16142555|NCT01794520|39011639|FG001|Overall Study|Adverse event- not related to progression|1|||
16142556|NCT01794520|39011640|FG002|Overall Study|Adverse event- not related to progression|0|||
16142557|NCT01794520|39011641|FG003|Overall Study|Adverse event- not related to progression|0|||
16142558|NCT01794520|39011642|FG004|Overall Study|Adverse event- not related to progression|2|||
16142559|NCT01794520|39011643|FG005|Overall Study|Adverse event- not related to progression|0|||
16142560|NCT01794520|39011644|FG006|Overall Study|Adverse event- not related to progression|0|||
16142561|NCT01794520|39011638|FG000|Overall Study|Progressive disease|5|||
16142562|NCT01794520|39011639|FG001|Overall Study|Progressive disease|6|||
16142563|NCT01794520|39011640|FG002|Overall Study|Progressive disease|2|||
16142564|NCT01794520|39011641|FG003|Overall Study|Progressive disease|5|||
16142565|NCT01794520|39011642|FG004|Overall Study|Progressive disease|27|||
16142566|NCT01794520|39011643|FG005|Overall Study|Progressive disease|18|||
16142567|NCT01794520|39011644|FG006|Overall Study|Progressive disease|0|||
16142568|NCT01794520|39011638|FG000|Overall Study|Withdrew consent|0|||
16142569|NCT01794520|39011639|FG001|Overall Study|Withdrew consent|0|||
16142570|NCT01794520|39011640|FG002|Overall Study|Withdrew consent|1|||
16142571|NCT01794520|39011641|FG003|Overall Study|Withdrew consent|1|||
16142572|NCT01794520|39011642|FG004|Overall Study|Withdrew consent|0|||
16142573|NCT01794520|39011643|FG005|Overall Study|Withdrew consent|0|||
16142574|NCT01794520|39011644|FG006|Overall Study|Withdrew consent|0|||
16142575|NCT01794520|39011638|FG000|Overall Study|Lost to Follow-up|0|||
16142576|NCT01794520|39011639|FG001|Overall Study|Lost to Follow-up|0|||
16142577|NCT01794520|39011640|FG002|Overall Study|Lost to Follow-up|0|||
16142578|NCT01794520|39011641|FG003|Overall Study|Lost to Follow-up|0|||
16142579|NCT01794520|39011642|FG004|Overall Study|Lost to Follow-up|1|||
16142580|NCT01794520|39011643|FG005|Overall Study|Lost to Follow-up|0|||
16142581|NCT01794520|39011644|FG006|Overall Study|Lost to Follow-up|0|||
16142582|NCT01794520|39011638|FG000|Overall Study|Toxicity|0|||
16142583|NCT01794520|39011639|FG001|Overall Study|Toxicity|2|||
16142584|NCT01794520|39011640|FG002|Overall Study|Toxicity|0|||
16142585|NCT01794520|39011641|FG003|Overall Study|Toxicity|0|||
16142586|NCT01794520|39011642|FG004|Overall Study|Toxicity|0|||
16142587|NCT01794520|39011643|FG005|Overall Study|Toxicity|0|||
16142588|NCT01794520|39011644|FG006|Overall Study|Toxicity|0|||
16142589|NCT01794520|39011638|FG000|Overall Study|Study terminated by sponsor|0|||
16142590|NCT01794520|39011639|FG001|Overall Study|Study terminated by sponsor|0|||
16142591|NCT01794520|39011640|FG002|Overall Study|Study terminated by sponsor|1|||
16142592|NCT01794520|39011641|FG003|Overall Study|Study terminated by sponsor|0|||
16142593|NCT01794520|39011642|FG004|Overall Study|Study terminated by sponsor|1|||
16142594|NCT01794520|39011643|FG005|Overall Study|Study terminated by sponsor|0|||
16142595|NCT01794520|39011644|FG006|Overall Study|Study terminated by sponsor|7|||
16142596|NCT01794520|39011638|FG000|Overall Study|Death|0|||
16142597|NCT01794520|39011639|FG001|Overall Study|Death|0|||
16142598|NCT01794520|39011640|FG002|Overall Study|Death|0|||
16142599|NCT01794520|39011641|FG003|Overall Study|Death|0|||
16142600|NCT01794520|39011642|FG004|Overall Study|Death|1|||
16142601|NCT01794520|39011643|FG005|Overall Study|Death|0|||
16142602|NCT01794520|39011644|FG006|Overall Study|Death|22|||
16142603|NCT01794520|39011638|FG000|Overall Study|Other, not specified|0|||
16142604|NCT01794520|39011639|FG001|Overall Study|Other, not specified|0|||
16142605|NCT01794520|39011640|FG002|Overall Study|Other, not specified|1|||
16142606|NCT01794520|39011641|FG003|Overall Study|Other, not specified|1|||
16142607|NCT01794520|39011642|FG004|Overall Study|Other, not specified|4|||
16142608|NCT01794520|39011643|FG005|Overall Study|Other, not specified|1|||
16142609|NCT01794520|39011644|FG006|Overall Study|Other, not specified|2|||
16142610|NCT00701090|39011646|FG000|Overall Study|Adverse Event|11|||
16142611|NCT00701090|39011647|FG001|Overall Study|Adverse Event|2|||
16142612|NCT00701090|39011646|FG000|Overall Study|Death|0|||
16142613|NCT00701090|39011647|FG001|Overall Study|Death|1|||
16142614|NCT00701090|39011646|FG000|Overall Study|Lack of Efficacy|5|||
16142615|NCT00701090|39011647|FG001|Overall Study|Lack of Efficacy|4|||
16142616|NCT00701090|39011646|FG000|Overall Study|Lost to Follow-up|9|||
16142617|NCT00701090|39011647|FG001|Overall Study|Lost to Follow-up|9|||
16142618|NCT00701090|39011646|FG000|Overall Study|Physician Decision|3|||
16142619|NCT00701090|39011647|FG001|Overall Study|Physician Decision|4|||
16142620|NCT00701090|39011646|FG000|Overall Study|Protocol Violation|2|||
16142621|NCT00701090|39011647|FG001|Overall Study|Protocol Violation|3|||
16142622|NCT00701090|39011646|FG000|Overall Study|Withdrawal by Subject|11|||
16142623|NCT00701090|39011647|FG001|Overall Study|Withdrawal by Subject|16|||
16142624|NCT00701090|39011646|FG000|Overall Study|Other|7|||
16142625|NCT00701090|39011647|FG001|Overall Study|Other|12|||
16142626|NCT01353508|39011648|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
16142627|NCT01353508|39011649|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
16142628|NCT01353508|39011650|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
16142629|NCT01353508|39011651|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
16142630|NCT01353508|39011648|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
16142631|NCT01353508|39011649|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
16142632|NCT01353508|39011650|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
16142633|NCT01353508|39011651|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
16142634|NCT02876835|39011652|FG000|Treatment Period (51.1 Month)|Other|1|||
16142635|NCT02876835|39011653|FG001|Treatment Period (51.1 Month)|Other|0|||
16142636|NCT02876835|39011652|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
16142637|NCT02876835|39011653|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
16142638|NCT02876835|39011652|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
16142639|NCT02876835|39011653|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
16142640|NCT02876835|39011652|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
16142641|NCT02876835|39011653|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
16142642|NCT00884325|39011654|FG000|Overall Study|Lost to Follow-up|1|||
16142643|NCT00884325|39011655|FG001|Overall Study|Lost to Follow-up|2|||
16142644|NCT00884325|39011654|FG000|Overall Study|Lack of Efficacy|0|||
16142645|NCT00884325|39011655|FG001|Overall Study|Lack of Efficacy|1|||
16142646|NCT00884325|39011654|FG000|Overall Study|Withdrawal by Subject|1|||
16142647|NCT00884325|39011655|FG001|Overall Study|Withdrawal by Subject|1|||
16142648|NCT00884325|39011654|FG000|Overall Study|Not provided|1|||
16142649|NCT00884325|39011655|FG001|Overall Study|Not provided|0|||
16142650|NCT00233363|39011656|FG000|Overall Study|Adverse Event|1|||
16142651|NCT00233363|39011657|FG001|Overall Study|Adverse Event|2|||
16142652|NCT00233363|39011656|FG000|Overall Study|Lack of Efficacy|0|||
16142653|NCT00233363|39011657|FG001|Overall Study|Lack of Efficacy|2|||
16142654|NCT00233363|39011656|FG000|Overall Study|Withdrawal by Subject|1|||
16142655|NCT00233363|39011657|FG001|Overall Study|Withdrawal by Subject|1|||
16142656|NCT00233363|39011656|FG000|Overall Study|Aggravation of complication|1|||
16142657|NCT00233363|39011657|FG001|Overall Study|Aggravation of complication|0|||
16142658|NCT01681628|39011658|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
16142659|NCT01681628|39011659|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
16142660|NCT01681628|39011658|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
16142661|NCT01681628|39011659|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
16142662|NCT01681628|39011658|FG000|19 Months Follow-up|Death|1|||
16142663|NCT01681628|39011659|FG001|19 Months Follow-up|Death|0|||
16142664|NCT01681628|39011658|FG000|19 Months Follow-up|Lost to Follow-up|61|||
16142665|NCT01681628|39011659|FG001|19 Months Follow-up|Lost to Follow-up|43|||
16142666|NCT04029961|39011660|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
16142667|NCT04029961|39011661|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
16142668|NCT04029961|39011660|FG000|Overall Study|Change in Treatment Course|0|||
16142669|NCT04029961|39011661|FG001|Overall Study|Change in Treatment Course|1|||
16142670|NCT00356889|39011662|FG000|Overall Study|Protocol Violation|2|||
16142671|NCT00356889|39011662|FG000|Overall Study|Adverse Event|1|||
16256208|NCT02979353|39423999|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
16142672|NCT04029116|39011663|FG000|Overall Study|Adverse Event|0|||
16142673|NCT04029116|39011664|FG001|Overall Study|Adverse Event|2|||
16142674|NCT04029116|39011663|FG000|Overall Study|Lost to Follow-up|3|||
16142675|NCT04029116|39011664|FG001|Overall Study|Lost to Follow-up|5|||
16142676|NCT04029116|39011663|FG000|Overall Study|Physician Decision|2|||
16142677|NCT04029116|39011664|FG001|Overall Study|Physician Decision|0|||
16256209|NCT02979353|39423998|FG000|Overall Study|Withdrawal by Subject|16|||
16142678|NCT04029116|39011663|FG000|Overall Study|Pregnancy|1|||
16142679|NCT04029116|39011664|FG001|Overall Study|Pregnancy|2|||
16142680|NCT04029116|39011663|FG000|Overall Study|Withdrawal by Subject|4|||
16142681|NCT04029116|39011664|FG001|Overall Study|Withdrawal by Subject|6|||
16142682|NCT04029116|39011663|FG000|Overall Study|Other|2|||
16142683|NCT04029116|39011664|FG001|Overall Study|Other|1|||
16142684|NCT02289352|39011665|FG000|Overall Study|Withdrawal by Subject|1|||
16142685|NCT02289352|39011666|FG001|Overall Study|Withdrawal by Subject|1|||
16142686|NCT02289352|39011667|FG002|Overall Study|Withdrawal by Subject|0|||
16142687|NCT02700997|39011670|FG000|Overall Study|Did not undergo CT imaging|1|||
16142688|NCT02700997|39011670|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
16142689|NCT01122576|39011671|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
16142690|NCT01122576|39011672|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
16142691|NCT01122576|39011673|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
16142692|NCT01122576|39011671|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
16142693|NCT01122576|39011672|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
16142694|NCT01122576|39011673|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
16142695|NCT01122576|39011671|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
16142696|NCT01122576|39011672|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
16142697|NCT01122576|39011673|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
16142698|NCT01536951|39011680|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16142699|NCT01536951|39011681|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16142700|NCT01536951|39011682|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
16142701|NCT01536951|39011683|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16142702|NCT01536951|39011684|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16142703|NCT01536951|39011685|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16142704|NCT01536951|39011686|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16142705|NCT01536951|39011687|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16142706|NCT01536951|39011688|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
16142707|NCT01536951|39011680|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
16142708|NCT01536951|39011681|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
16142709|NCT01536951|39011682|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
16142710|NCT01536951|39011683|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
16142711|NCT01536951|39011684|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
16142712|NCT01536951|39011685|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
16142713|NCT01536951|39011686|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
16142714|NCT01536951|39011687|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
16142715|NCT01536951|39011688|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
16142716|NCT01145495|39011689|FG000|Overall Study|Adverse Event|6|||
16142717|NCT01145495|39011689|FG000|Overall Study|Withdrawal by Subject|6|||
16256210|NCT02979353|39423999|FG001|Overall Study|Withdrawal by Subject|12|||
16256211|NCT02979353|39423998|FG000|Overall Study|Death|10|||
16256212|NCT02979353|39423999|FG001|Overall Study|Death|11|||
16256213|NCT02979353|39423998|FG000|Overall Study|Transfer to Hospice Care|19|||
16256214|NCT02979353|39423999|FG001|Overall Study|Transfer to Hospice Care|14|||
16256215|NCT02979353|39423998|FG000|Overall Study|Lost to Follow-up|1|||
16256216|NCT02979353|39423999|FG001|Overall Study|Lost to Follow-up|5|||
16256217|NCT00977106|39424000|FG000|Overall Study|Adverse Event|5|||
16256218|NCT00977106|39424001|FG001|Overall Study|Adverse Event|6|||
16256219|NCT00977106|39424000|FG000|Overall Study|Withdrawal by Subject|2|||
16256220|NCT00977106|39424001|FG001|Overall Study|Withdrawal by Subject|2|||
16256221|NCT00977106|39424000|FG000|Overall Study|Lack of Efficacy|2|||
16256222|NCT00977106|39424001|FG001|Overall Study|Lack of Efficacy|2|||
16256223|NCT00977106|39424000|FG000|Overall Study|Protocol Violation|0|||
16256224|NCT00977106|39424001|FG001|Overall Study|Protocol Violation|1|||
16256225|NCT00977106|39424000|FG000|Overall Study|Other|1|||
16256226|NCT00977106|39424001|FG001|Overall Study|Other|0|||
16256227|NCT01506323|39424002|FG000|Overall Study|Lost to Follow-up|5|||
16256228|NCT01506323|39424003|FG001|Overall Study|Lost to Follow-up|4|||
16256229|NCT01506323|39424002|FG000|Overall Study|Withdrawal by Subject|4|||
16256230|NCT01506323|39424003|FG001|Overall Study|Withdrawal by Subject|4|||
16256231|NCT01506323|39424002|FG000|Overall Study|Lack of Efficacy|1|||
16256232|NCT01506323|39424003|FG001|Overall Study|Lack of Efficacy|3|||
16256233|NCT01506323|39424002|FG000|Overall Study|Moved out of area|5|||
16256234|NCT01506323|39424003|FG001|Overall Study|Moved out of area|2|||
16256235|NCT01506323|39424002|FG000|Overall Study|Schedule or Transportation conflict|8|||
16256236|NCT01506323|39424003|FG001|Overall Study|Schedule or Transportation conflict|0|||
16256237|NCT01506323|39424002|FG000|Overall Study|Started another treatment|1|||
16256238|NCT01506323|39424003|FG001|Overall Study|Started another treatment|0|||
16256239|NCT04591626|39424004|FG000|Overall Study|Adverse Event|4|||
16256240|NCT04591626|39424005|FG001|Overall Study|Adverse Event|0|||
16256241|NCT04591626|39424004|FG000|Overall Study|Withdrawal by Subject|5|||
16256242|NCT04591626|39424005|FG001|Overall Study|Withdrawal by Subject|3|||
16142718|NCT01145495|39011689|FG000|Overall Study|Disease progression after respone|2|||
16142719|NCT00805025|39011694|FG000|Overall Study|Screened but not enrolled/treated|42|||
16142720|NCT00805025|39011694|FG000|Overall Study|Adverse Event|4|||
16142721|NCT00805025|39011694|FG000|Overall Study|Withdrawal by Subject|2|||
16142722|NCT00805025|39011694|FG000|Overall Study|Physician Decision|1|||
16142723|NCT03370471|39011695|FG000|Overall Study|Withdrawal by Subject|6|||
16142724|NCT03370471|39011696|FG001|Overall Study|Withdrawal by Subject|1|||
16142725|NCT03370471|39011695|FG000|Overall Study|Unable to access veins for blood draw|0|||
16256243|NCT04591626|39424004|FG000|Overall Study|Physician Decision|0|||
16256244|NCT04591626|39424005|FG001|Overall Study|Physician Decision|1|||
16142726|NCT03370471|39011696|FG001|Overall Study|Unable to access veins for blood draw|1|||
16256245|NCT04591626|39424004|FG000|Overall Study|Death|0|||
16256246|NCT04591626|39424005|FG001|Overall Study|Death|1|||
16142727|NCT03370471|39011695|FG000|Overall Study|Screen fail|1|||
16142728|NCT03370471|39011696|FG001|Overall Study|Screen fail|0|||
16142729|NCT01109173|39011697|FG000|Overall Study|Adverse Event|15|||
16142730|NCT01109173|39011698|FG001|Overall Study|Adverse Event|17|||
16142731|NCT01109173|39011699|FG002|Overall Study|Adverse Event|9|||
16142732|NCT01109173|39011700|FG003|Overall Study|Adverse Event|6|||
16142733|NCT01109173|39011697|FG000|Overall Study|Lost to Follow-up|0|||
16142734|NCT01109173|39011698|FG001|Overall Study|Lost to Follow-up|1|||
16142735|NCT01109173|39011699|FG002|Overall Study|Lost to Follow-up|0|||
16142736|NCT01109173|39011700|FG003|Overall Study|Lost to Follow-up|0|||
16142737|NCT01109173|39011697|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
16142738|NCT01109173|39011698|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
16142739|NCT01109173|39011699|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
16142740|NCT01109173|39011700|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
16142741|NCT01109173|39011697|FG000|Overall Study|Noncompliance|0|||
16142742|NCT01109173|39011698|FG001|Overall Study|Noncompliance|1|||
16142743|NCT01109173|39011699|FG002|Overall Study|Noncompliance|0|||
16142744|NCT01109173|39011700|FG003|Overall Study|Noncompliance|0|||
16142745|NCT01109173|39011697|FG000|Overall Study|Treatment Failure|25|||
16142746|NCT01109173|39011698|FG001|Overall Study|Treatment Failure|32|||
16142747|NCT01109173|39011699|FG002|Overall Study|Treatment Failure|69|||
16142748|NCT01109173|39011700|FG003|Overall Study|Treatment Failure|64|||
16142749|NCT01109173|39011697|FG000|Overall Study|Protocol Violation|4|||
16142750|NCT01109173|39011698|FG001|Overall Study|Protocol Violation|5|||
16142751|NCT01109173|39011699|FG002|Overall Study|Protocol Violation|1|||
16142752|NCT01109173|39011700|FG003|Overall Study|Protocol Violation|2|||
16142753|NCT01109173|39011697|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
16142754|NCT01109173|39011698|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
16142755|NCT01109173|39011699|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
16142756|NCT01109173|39011700|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
16142757|NCT01109173|39011697|FG000|Overall Study|Not Specifiied|5|||
16142758|NCT01109173|39011698|FG001|Overall Study|Not Specifiied|4|||
16142759|NCT01109173|39011699|FG002|Overall Study|Not Specifiied|9|||
16142760|NCT01109173|39011700|FG003|Overall Study|Not Specifiied|14|||
16142761|NCT02615470|39011701|FG000|Overall Study|Lost to Follow-up|21|||
16142762|NCT02615470|39011702|FG001|Overall Study|Lost to Follow-up|32|||
16142763|NCT00865904|39011703|FG000|Overall Study|Randomized but not Treated|2|||
16142764|NCT00865904|39011704|FG001|Overall Study|Randomized but not Treated|0|||
16142765|NCT00865904|39011705|FG002|Overall Study|Randomized but not Treated|0|||
16142766|NCT00865904|39011706|FG003|Overall Study|Randomized but not Treated|1|||
16142767|NCT00865904|39011707|FG004|Overall Study|Randomized but not Treated|1|||
16142768|NCT02247960|39011710|FG000|Patient Consent and Randomization|Physician Decision|2|||
16142769|NCT02247960|39011711|FG001|Patient Consent and Randomization|Physician Decision|2|||
16142770|NCT02247960|39011710|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
16256247|NCT04591626|39424004|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16256248|NCT04591626|39424005|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16256249|NCT02353169|39424006|FG000|Overall Study|QTc > 450 msec|1|||
16256250|NCT02353169|39424007|FG001|Overall Study|QTc > 450 msec|1|||
16256251|NCT02353169|39424008|FG002|Overall Study|QTc > 450 msec|1|||
16256252|NCT02353169|39424009|FG003|Overall Study|QTc > 450 msec|1|||
16256253|NCT02353169|39424006|FG000|Overall Study|OR team declined|2|||
16256254|NCT02353169|39424007|FG001|Overall Study|OR team declined|0|||
16256255|NCT02353169|39424008|FG002|Overall Study|OR team declined|0|||
16256256|NCT02353169|39424009|FG003|Overall Study|OR team declined|0|||
16256257|NCT02353169|39424006|FG000|Overall Study|Inhalational induction|0|||
16256258|NCT02353169|39424007|FG001|Overall Study|Inhalational induction|2|||
16256259|NCT02353169|39424008|FG002|Overall Study|Inhalational induction|0|||
16256260|NCT02353169|39424009|FG003|Overall Study|Inhalational induction|0|||
16256261|NCT02353169|39424006|FG000|Overall Study|ECG data error|0|||
16256262|NCT02353169|39424007|FG001|Overall Study|ECG data error|3|||
16256263|NCT02353169|39424008|FG002|Overall Study|ECG data error|2|||
16256264|NCT02353169|39424009|FG003|Overall Study|ECG data error|2|||
16256265|NCT02353169|39424006|FG000|Overall Study|Pre-op medication|0|||
16256266|NCT02353169|39424007|FG001|Overall Study|Pre-op medication|0|||
16256267|NCT02353169|39424008|FG002|Overall Study|Pre-op medication|1|||
16256268|NCT02353169|39424009|FG003|Overall Study|Pre-op medication|0|||
16256269|NCT03039023|39424010|FG000|Overall Study|Withdrawal by Subject|1|||
16256270|NCT03039023|39424011|FG001|Overall Study|Withdrawal by Subject|0|||
16256271|NCT03039023|39424012|FG002|Overall Study|Withdrawal by Subject|1|||
16256272|NCT03039023|39424013|FG003|Overall Study|Withdrawal by Subject|1|||
16256273|NCT03039023|39424014|FG004|Overall Study|Withdrawal by Subject|0|||
16256274|NCT03039023|39424010|FG000|Overall Study|Physician Decision|0|||
16256275|NCT03039023|39424011|FG001|Overall Study|Physician Decision|0|||
16256276|NCT03039023|39424012|FG002|Overall Study|Physician Decision|0|||
16256277|NCT03039023|39424013|FG003|Overall Study|Physician Decision|1|||
16256278|NCT03039023|39424014|FG004|Overall Study|Physician Decision|0|||
16256279|NCT04213326|39424015|FG000|Overall Study|Consent withdrawn|51|||
16256280|NCT04213326|39424016|FG001|Overall Study|Consent withdrawn|241|||
16256281|NCT04213326|39424015|FG000|Overall Study|Lost to Follow-up|50|||
16256282|NCT04213326|39424016|FG001|Overall Study|Lost to Follow-up|902|||
16256283|NCT04213326|39424015|FG000|Overall Study|Protocol Violation|3|||
16256284|NCT04213326|39424016|FG001|Overall Study|Protocol Violation|25|||
16256285|NCT04213326|39424015|FG000|Overall Study|Participant eligibility changed|106|||
16256286|NCT04213326|39424016|FG001|Overall Study|Participant eligibility changed|19|||
16256287|NCT04213326|39424015|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
16256288|NCT04213326|39424016|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
16256289|NCT04213326|39424015|FG000|Overall Study|Incomplete study visit|0|||
16256290|NCT04213326|39424016|FG001|Overall Study|Incomplete study visit|367|||
16256291|NCT02480764|39424027|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
16256292|NCT02480764|39424028|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
16256293|NCT02480764|39424029|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
16256294|NCT02480764|39424027|FG000|Overall Study|Major Protocol Deviation|1|||
16256295|NCT02480764|39424028|FG001|Overall Study|Major Protocol Deviation|4|||
16256296|NCT02480764|39424029|FG002|Overall Study|Major Protocol Deviation|3|||
16256297|NCT02480764|39424027|FG000|Overall Study|Lost to Follow-up|0|||
16256298|NCT02480764|39424028|FG001|Overall Study|Lost to Follow-up|1|||
16256299|NCT02480764|39424029|FG002|Overall Study|Lost to Follow-up|2|||
16256300|NCT02480764|39424027|FG000|Overall Study|Voluntary Withdrawal|6|||
16256301|NCT02480764|39424028|FG001|Overall Study|Voluntary Withdrawal|5|||
16256302|NCT02480764|39424029|FG002|Overall Study|Voluntary Withdrawal|10|||
16256303|NCT02480764|39424027|FG000|Overall Study|Lack of Efficacy|0|||
16256304|NCT02480764|39424028|FG001|Overall Study|Lack of Efficacy|3|||
16256305|NCT02480764|39424029|FG002|Overall Study|Lack of Efficacy|3|||
16256306|NCT02480764|39424027|FG000|Overall Study|Reason not Specified|0|||
16256307|NCT02480764|39424028|FG001|Overall Study|Reason not Specified|1|||
16256308|NCT02480764|39424029|FG002|Overall Study|Reason not Specified|0|||
16256309|NCT01000337|39424030|FG000|Overall Study|Lost to Follow-up|4|||
16256310|NCT01000337|39424031|FG001|Overall Study|Lost to Follow-up|3|||
16256311|NCT00561730|39424032|FG000|Overall Study|Adverse Event|2|||
16256312|NCT00561730|39424032|FG000|Overall Study|Handling of the drug|1|||
16256313|NCT00561730|39424032|FG000|Overall Study|Lost to Follow-up|5|||
16256314|NCT00561730|39424032|FG000|Overall Study|Not specified reasons|1|||
16256315|NCT00950807|39424041|FG000|Treatment Period 1|Lack of Efficacy|1|||
16256316|NCT00950807|39424042|FG001|Treatment Period 1|Lack of Efficacy|0|||
16364190|NCT02187055|39818240|FG000|Overall Study|Lost to Follow-up|2|||
16364191|NCT02187055|39818241|FG001|Overall Study|Lost to Follow-up|7|||
16256317|NCT00950807|39424043|FG002|Treatment Period 1|Lack of Efficacy|0|||
16256318|NCT00950807|39424044|FG003|Treatment Period 1|Lack of Efficacy|0|||
16256319|NCT00950807|39424045|FG004|Treatment Period 1|Lack of Efficacy|0|||
16256320|NCT00950807|39424046|FG005|Treatment Period 1|Lack of Efficacy|1|||
16256321|NCT00950807|39424047|FG006|Treatment Period 1|Lack of Efficacy|0|||
16256322|NCT00950807|39424048|FG007|Treatment Period 1|Lack of Efficacy|0|||
16256323|NCT00950807|39424049|FG008|Treatment Period 1|Lack of Efficacy|0|||
16256324|NCT00950807|39424050|FG009|Treatment Period 1|Lack of Efficacy|0|||
16256325|NCT00950807|39424041|FG000|Treatment Period 1|Protocol Violation|1|||
16256326|NCT00950807|39424042|FG001|Treatment Period 1|Protocol Violation|0|||
16256327|NCT00950807|39424043|FG002|Treatment Period 1|Protocol Violation|0|||
16256328|NCT00950807|39424044|FG003|Treatment Period 1|Protocol Violation|0|||
16256329|NCT00950807|39424045|FG004|Treatment Period 1|Protocol Violation|0|||
16256330|NCT00950807|39424046|FG005|Treatment Period 1|Protocol Violation|0|||
16256331|NCT00950807|39424047|FG006|Treatment Period 1|Protocol Violation|0|||
16256332|NCT00950807|39424048|FG007|Treatment Period 1|Protocol Violation|0|||
16256333|NCT00950807|39424049|FG008|Treatment Period 1|Protocol Violation|0|||
16256334|NCT00950807|39424050|FG009|Treatment Period 1|Protocol Violation|0|||
16256335|NCT00950807|39424041|FG000|Treatment Period 1|Lost to Follow-up|0|||
16256336|NCT00950807|39424042|FG001|Treatment Period 1|Lost to Follow-up|0|||
16256337|NCT00950807|39424043|FG002|Treatment Period 1|Lost to Follow-up|1|||
16256338|NCT00950807|39424044|FG003|Treatment Period 1|Lost to Follow-up|0|||
16439289|NCT01453049|40089350|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
16439290|NCT01453049|40089351|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
16439291|NCT01453049|40089350|FG000|Overall Study|Withdrawal by Subject|1|||
16439292|NCT01453049|40089351|FG001|Overall Study|Withdrawal by Subject|0|||
16439293|NCT01453049|40089350|FG000|Overall Study|Randomized in Error|1|||
16439294|NCT01453049|40089351|FG001|Overall Study|Randomized in Error|0|||
16439295|NCT00472108|40089352|FG000|Overall Study|Lost to Follow-up|0|||
16256339|NCT00950807|39424045|FG004|Treatment Period 1|Lost to Follow-up|0|||
16256340|NCT00950807|39424046|FG005|Treatment Period 1|Lost to Follow-up|0|||
16256341|NCT00950807|39424047|FG006|Treatment Period 1|Lost to Follow-up|0|||
16256342|NCT00950807|39424048|FG007|Treatment Period 1|Lost to Follow-up|0|||
16439296|NCT00472108|40089353|FG001|Overall Study|Lost to Follow-up|1|||
16364192|NCT02187055|39818242|FG002|Overall Study|Lost to Follow-up|3|||
16142771|NCT02247960|39011711|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
16364193|NCT02187055|39818240|FG000|Overall Study|No longer meets eligibility criteria|0|||
16364194|NCT02187055|39818241|FG001|Overall Study|No longer meets eligibility criteria|2|||
16364195|NCT02187055|39818242|FG002|Overall Study|No longer meets eligibility criteria|0|||
16256343|NCT00950807|39424049|FG008|Treatment Period 1|Lost to Follow-up|0|||
16256344|NCT00950807|39424050|FG009|Treatment Period 1|Lost to Follow-up|0|||
16256345|NCT00950807|39424041|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16256346|NCT00950807|39424042|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16256347|NCT00950807|39424043|FG002|Treatment Period 1|Withdrawal by Subject|0|||
16256348|NCT00950807|39424044|FG003|Treatment Period 1|Withdrawal by Subject|0|||
16256349|NCT00950807|39424045|FG004|Treatment Period 1|Withdrawal by Subject|1|||
16256350|NCT00950807|39424046|FG005|Treatment Period 1|Withdrawal by Subject|0|||
16256351|NCT00950807|39424047|FG006|Treatment Period 1|Withdrawal by Subject|0|||
16256352|NCT00950807|39424048|FG007|Treatment Period 1|Withdrawal by Subject|0|||
16256353|NCT00950807|39424049|FG008|Treatment Period 1|Withdrawal by Subject|1|||
16439297|NCT01576341|40089359|FG000|Overall Study|Withdrawal by Subject|24|||
16439298|NCT01576341|40089359|FG000|Overall Study|Adverse Event|10|||
16439299|NCT01576341|40089359|FG000|Overall Study|Death|21|||
16439300|NCT01576341|40089359|FG000|Overall Study|Physician Decision|2|||
16439301|NCT01576341|40089359|FG000|Overall Study|Lost to Follow-up|2|||
16439302|NCT01576341|40089359|FG000|Overall Study|Kidney transplantation|10|||
16439303|NCT01576341|40089359|FG000|Overall Study|Protocol Violation|12|||
16439304|NCT01576341|40089359|FG000|Overall Study|Other|12|||
16439305|NCT00362648|40089360|FG000|Overall Study|Adverse Event|12|||
16439306|NCT00362648|40089361|FG001|Overall Study|Adverse Event|21|||
16439307|NCT00362648|40089362|FG002|Overall Study|Adverse Event|1|||
16439308|NCT00362648|40089363|FG003|Overall Study|Adverse Event|0|||
16439309|NCT00362648|40089360|FG000|Overall Study|Lost to Follow-up|62|||
16439310|NCT00362648|40089361|FG001|Overall Study|Lost to Follow-up|69|||
16256354|NCT00950807|39424050|FG009|Treatment Period 1|Withdrawal by Subject|0|||
16364196|NCT02187055|39818240|FG000|Overall Study|No longer willing to participate|6|||
16364197|NCT02187055|39818241|FG001|Overall Study|No longer willing to participate|8|||
16364198|NCT02187055|39818242|FG002|Overall Study|No longer willing to participate|10|||
16364199|NCT02187055|39818240|FG000|Overall Study|Other|5|||
16364200|NCT02187055|39818241|FG001|Overall Study|Other|6|||
16364201|NCT02187055|39818242|FG002|Overall Study|Other|3|||
16364202|NCT02187055|39818240|FG000|Overall Study|Protocol Violation|9|||
16364203|NCT02187055|39818241|FG001|Overall Study|Protocol Violation|9|||
16364204|NCT02187055|39818242|FG002|Overall Study|Protocol Violation|4|||
16364205|NCT02187055|39818240|FG000|Overall Study|Pregnancy|3|||
16364206|NCT02187055|39818241|FG001|Overall Study|Pregnancy|1|||
16364207|NCT02187055|39818242|FG002|Overall Study|Pregnancy|0|||
16364208|NCT02187055|39818240|FG000|Overall Study|Withdrawal by Subject|11|||
16439311|NCT00362648|40089362|FG002|Overall Study|Lost to Follow-up|4|||
16364209|NCT02187055|39818241|FG001|Overall Study|Withdrawal by Subject|11|||
16439312|NCT00362648|40089363|FG003|Overall Study|Lost to Follow-up|3|||
16439313|NCT00362648|40089360|FG000|Overall Study|Protocol Violation|4|||
16439314|NCT00362648|40089361|FG001|Overall Study|Protocol Violation|2|||
16439315|NCT00362648|40089362|FG002|Overall Study|Protocol Violation|2|||
16142772|NCT02247960|39011710|FG000|Catheter Removed|Lost to Follow-up|7|||
16142773|NCT02247960|39011711|FG001|Catheter Removed|Lost to Follow-up|10|||
16142774|NCT01221727|39011712|FG000|Overall Study|Physician Decision|2|||
16256355|NCT00950807|39424041|FG000|Treatment Period 1|Adverse Event|0|||
16256356|NCT00950807|39424042|FG001|Treatment Period 1|Adverse Event|0|||
16256357|NCT00950807|39424043|FG002|Treatment Period 1|Adverse Event|0|||
16364210|NCT02187055|39818242|FG002|Overall Study|Withdrawal by Subject|11|||
16439316|NCT00362648|40089363|FG003|Overall Study|Protocol Violation|2|||
16142775|NCT01221727|39011713|FG001|Overall Study|Physician Decision|0|||
16142776|NCT01221727|39011712|FG000|Overall Study|Withdrawal by Subject|1|||
16142777|NCT01221727|39011713|FG001|Overall Study|Withdrawal by Subject|1|||
16142778|NCT02966223|39011718|FG000|Overall Study|Physician Decision|3|||
16142779|NCT02966223|39011718|FG000|Overall Study|Withdrawal by Subject|11|||
16142780|NCT02966223|39011718|FG000|Overall Study|Lost to Follow-up|1|||
16142781|NCT00909181|39011719|FG000|Overall Study|Lost to Follow-up|39|||
16142782|NCT00909181|39011720|FG001|Overall Study|Lost to Follow-up|18|||
16142783|NCT00909181|39011721|FG002|Overall Study|Lost to Follow-up|33|||
16142784|NCT04340557|39011723|FG000|Overall Study|Transferred to ICU and/or death|1|||
16142785|NCT04340557|39011724|FG001|Overall Study|Transferred to ICU and/or death|2|||
16142786|NCT02495233|39011725|FG000|Overall Study|Miscellaneous|0|||
16142787|NCT02495233|39011726|FG001|Overall Study|Miscellaneous|1|||
16142788|NCT01717989|39011727|FG000|Overall Study|Ineligibility determined|6|||
16142789|NCT01717989|39011727|FG000|Overall Study|Protocol deviation|6|||
16142790|NCT01717989|39011727|FG000|Overall Study|Withdrawal by Subject|11|||
16142791|NCT01717989|39011727|FG000|Overall Study|Physician Decision|2|||
16142792|NCT01717989|39011727|FG000|Overall Study|Lost to Follow-up|11|||
16142793|NCT01717989|39011727|FG000|Overall Study|Death|439|||
16142794|NCT01717989|39011727|FG000|Overall Study|Protocol-specified criteria|551|||
16142795|NCT01717989|39011727|FG000|Overall Study|Other|40|||
16142796|NCT00239226|39011728|FG000|Overall Study|permAF during stabilization period|0|||
16142797|NCT00239226|39011729|FG001|Overall Study|permAF during stabilization period|0|||
16142798|NCT00239226|39011730|FG002|Overall Study|permAF during stabilization period|0|||
16142799|NCT00239226|39011731|FG003|Overall Study|permAF during stabilization period|3|||
16142800|NCT00239226|39011728|FG000|Overall Study|Lost to Follow-up|1|||
16142801|NCT00239226|39011729|FG001|Overall Study|Lost to Follow-up|0|||
16142802|NCT00239226|39011730|FG002|Overall Study|Lost to Follow-up|1|||
16142803|NCT00239226|39011731|FG003|Overall Study|Lost to Follow-up|0|||
16142804|NCT00616434|39011732|FG000|Overall Study|Adverse Event|5|||
16142805|NCT00616434|39011733|FG001|Overall Study|Adverse Event|2|||
16142806|NCT00616434|39011732|FG000|Overall Study|Physician Decision|0|||
16142807|NCT00616434|39011733|FG001|Overall Study|Physician Decision|4|||
16142808|NCT00616434|39011732|FG000|Overall Study|Withdrawal by Subject|1|||
16142809|NCT00616434|39011733|FG001|Overall Study|Withdrawal by Subject|1|||
16142810|NCT00616434|39011732|FG000|Overall Study|Protocol deviation|0|||
16142811|NCT00616434|39011733|FG001|Overall Study|Protocol deviation|1|||
16439317|NCT00362648|40089360|FG000|Overall Study|Withdrawal by Subject|48|||
16439318|NCT00362648|40089361|FG001|Overall Study|Withdrawal by Subject|42|||
16439319|NCT00362648|40089362|FG002|Overall Study|Withdrawal by Subject|2|||
16439320|NCT00362648|40089363|FG003|Overall Study|Withdrawal by Subject|6|||
16142812|NCT00615836|39011734|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
16142813|NCT00615836|39011735|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
16142814|NCT00615836|39011736|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
16142815|NCT00615836|39011737|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
16142816|NCT00615836|39011738|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
16142817|NCT00615836|39011734|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
16142818|NCT00615836|39011735|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
16142819|NCT00615836|39011736|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
16142820|NCT00615836|39011737|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
16142821|NCT00615836|39011738|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
16142822|NCT00615836|39011734|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
16142823|NCT00615836|39011735|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
16142824|NCT00615836|39011736|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
16142825|NCT00615836|39011737|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
16142826|NCT00615836|39011738|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
16142827|NCT00615836|39011734|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
16142828|NCT00615836|39011735|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
16142829|NCT00615836|39011736|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
16142830|NCT00615836|39011737|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
16142831|NCT00615836|39011738|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
16142832|NCT00615836|39011734|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
16439321|NCT01667900|40089364|FG000|Part B|Death|0|||
16439322|NCT01667900|40089365|FG001|Part B|Death|0|||
16439323|NCT01667900|40089366|FG002|Part B|Death|0|||
16439324|NCT01667900|40089367|FG003|Part B|Death|0|||
16439325|NCT01667900|40089368|FG004|Part B|Death|0|||
16142833|NCT00615836|39011735|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
16142834|NCT00615836|39011736|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
16142835|NCT00615836|39011737|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
16142836|NCT00615836|39011738|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
16256358|NCT00950807|39424044|FG003|Treatment Period 1|Adverse Event|0|||
16439326|NCT01667900|40089369|FG005|Part B|Death|0|||
16439327|NCT01667900|40089370|FG006|Part B|Death|0|||
16256359|NCT00950807|39424045|FG004|Treatment Period 1|Adverse Event|0|||
16256360|NCT00950807|39424046|FG005|Treatment Period 1|Adverse Event|1|||
16256361|NCT00950807|39424047|FG006|Treatment Period 1|Adverse Event|0|||
16256362|NCT00950807|39424048|FG007|Treatment Period 1|Adverse Event|0|||
16256363|NCT00950807|39424049|FG008|Treatment Period 1|Adverse Event|0|||
16256364|NCT00950807|39424050|FG009|Treatment Period 1|Adverse Event|0|||
16256365|NCT00950807|39424041|FG000|Washout Period 1|Lack of Efficacy|0|||
16256366|NCT00950807|39424042|FG001|Washout Period 1|Lack of Efficacy|0|||
16256367|NCT00950807|39424043|FG002|Washout Period 1|Lack of Efficacy|0|||
16256368|NCT00950807|39424044|FG003|Washout Period 1|Lack of Efficacy|0|||
16256369|NCT00950807|39424045|FG004|Washout Period 1|Lack of Efficacy|0|||
16256370|NCT00950807|39424046|FG005|Washout Period 1|Lack of Efficacy|0|||
16256371|NCT00950807|39424047|FG006|Washout Period 1|Lack of Efficacy|1|||
16256372|NCT00950807|39424048|FG007|Washout Period 1|Lack of Efficacy|0|||
16256373|NCT00950807|39424049|FG008|Washout Period 1|Lack of Efficacy|0|||
16256374|NCT00950807|39424050|FG009|Washout Period 1|Lack of Efficacy|0|||
16256375|NCT00950807|39424041|FG000|Washout Period 1|Withdrawal by Subject|0|||
16256376|NCT00950807|39424042|FG001|Washout Period 1|Withdrawal by Subject|0|||
16256377|NCT00950807|39424043|FG002|Washout Period 1|Withdrawal by Subject|0|||
16256378|NCT00950807|39424044|FG003|Washout Period 1|Withdrawal by Subject|0|||
16256379|NCT00950807|39424045|FG004|Washout Period 1|Withdrawal by Subject|0|||
16256380|NCT00950807|39424046|FG005|Washout Period 1|Withdrawal by Subject|0|||
16256381|NCT00950807|39424047|FG006|Washout Period 1|Withdrawal by Subject|0|||
16256382|NCT00950807|39424048|FG007|Washout Period 1|Withdrawal by Subject|0|||
16256383|NCT00950807|39424049|FG008|Washout Period 1|Withdrawal by Subject|1|||
16142837|NCT00615836|39011734|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
16142838|NCT00615836|39011735|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
16142839|NCT00615836|39011736|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
16142840|NCT00615836|39011737|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
16142841|NCT00615836|39011738|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
16142842|NCT00615836|39011734|FG000|Extension Study (FE992026 CS31)|Other|10|||
16142843|NCT00615836|39011735|FG001|Extension Study (FE992026 CS31)|Other|7|||
16142844|NCT00615836|39011736|FG002|Extension Study (FE992026 CS31)|Other|8|||
16142845|NCT00615836|39011737|FG003|Extension Study (FE992026 CS31)|Other|8|||
16142846|NCT00615836|39011738|FG004|Extension Study (FE992026 CS31)|Other|0|||
16142847|NCT00615836|39011734|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
16142848|NCT00615836|39011735|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
16142849|NCT00615836|39011736|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
16142850|NCT00615836|39011737|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
16142851|NCT00615836|39011738|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
16142852|NCT00615836|39011734|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
16142853|NCT00615836|39011735|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
16142854|NCT00615836|39011736|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
16142855|NCT00615836|39011737|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
16256384|NCT00950807|39424050|FG009|Washout Period 1|Withdrawal by Subject|0|||
16256385|NCT00950807|39424041|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
16256386|NCT00950807|39424042|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
16256387|NCT00950807|39424043|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
16256388|NCT00950807|39424044|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
16256389|NCT00950807|39424045|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
16256390|NCT00950807|39424046|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
16256391|NCT00950807|39424047|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
16256392|NCT00950807|39424048|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
16256393|NCT00950807|39424049|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
16256394|NCT00950807|39424050|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
16256395|NCT00950807|39424041|FG000|Washout Period 1|Adverse Event|2|||
16256396|NCT00950807|39424042|FG001|Washout Period 1|Adverse Event|0|||
16256397|NCT00950807|39424043|FG002|Washout Period 1|Adverse Event|0|||
16256398|NCT00950807|39424044|FG003|Washout Period 1|Adverse Event|1|||
16256399|NCT00950807|39424045|FG004|Washout Period 1|Adverse Event|1|||
16256400|NCT00950807|39424046|FG005|Washout Period 1|Adverse Event|0|||
16256401|NCT00950807|39424047|FG006|Washout Period 1|Adverse Event|0|||
16256402|NCT00950807|39424048|FG007|Washout Period 1|Adverse Event|0|||
16256403|NCT00950807|39424049|FG008|Washout Period 1|Adverse Event|0|||
16256404|NCT00950807|39424050|FG009|Washout Period 1|Adverse Event|0|||
16256405|NCT00950807|39424041|FG000|Treatment Period 2|Lack of Efficacy|1|||
16256406|NCT00950807|39424042|FG001|Treatment Period 2|Lack of Efficacy|0|||
16256407|NCT00950807|39424043|FG002|Treatment Period 2|Lack of Efficacy|0|||
16439328|NCT01667900|40089371|FG007|Part B|Death|0|||
16256408|NCT00950807|39424044|FG003|Treatment Period 2|Lack of Efficacy|0|||
16256409|NCT00950807|39424045|FG004|Treatment Period 2|Lack of Efficacy|0|||
16256410|NCT00950807|39424046|FG005|Treatment Period 2|Lack of Efficacy|0|||
16256411|NCT00950807|39424047|FG006|Treatment Period 2|Lack of Efficacy|0|||
16256412|NCT00950807|39424048|FG007|Treatment Period 2|Lack of Efficacy|0|||
16256413|NCT00950807|39424049|FG008|Treatment Period 2|Lack of Efficacy|0|||
16256414|NCT00950807|39424050|FG009|Treatment Period 2|Lack of Efficacy|0|||
16439329|NCT01667900|40089372|FG008|Part B|Death|0|||
16142856|NCT00615836|39011738|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
16142857|NCT00992511|39011739|FG000|Overall Study|Migrated/moved from study area|1|||
16142858|NCT00992511|39011740|FG001|Overall Study|Migrated/moved from study area|0|||
16142859|NCT00992511|39011741|FG002|Overall Study|Migrated/moved from study area|1|||
16142860|NCT00992511|39011742|FG003|Overall Study|Migrated/moved from study area|2|||
16142861|NCT00992511|39011739|FG000|Overall Study|Lost to Follow-up|1|||
16142862|NCT00992511|39011740|FG001|Overall Study|Lost to Follow-up|0|||
16142863|NCT00992511|39011741|FG002|Overall Study|Lost to Follow-up|0|||
16142864|NCT00992511|39011742|FG003|Overall Study|Lost to Follow-up|2|||
16142865|NCT00992511|39011739|FG000|Overall Study|Withdrawal by Subject|0|||
16142866|NCT00992511|39011740|FG001|Overall Study|Withdrawal by Subject|0|||
16142867|NCT00992511|39011741|FG002|Overall Study|Withdrawal by Subject|1|||
16142868|NCT00992511|39011742|FG003|Overall Study|Withdrawal by Subject|1|||
16142869|NCT00633061|39011743|FG000|Overall Study|Study closed|86|||
16142870|NCT00633061|39011744|FG001|Overall Study|Study closed|0|||
16142871|NCT01237340|39011747|FG000|Overall Study|Adverse Event|3|||
16142872|NCT01237340|39011747|FG000|Overall Study|Withdrawal by Subject|1|||
16142873|NCT01237340|39011747|FG000|Overall Study|Early termination of the trial|36|||
16142874|NCT01891721|39011748|FG000|Overall Study|Lost to Follow-up|10|||
16142875|NCT01891721|39011749|FG001|Overall Study|Lost to Follow-up|5|||
16142876|NCT01891721|39011750|FG002|Overall Study|Lost to Follow-up|1|||
16142877|NCT01817751|39011761|FG000|Overall Study|Physician Decision|1|||
16142878|NCT00074581|39011762|FG000|Overall Study|Death|15|||
16142879|NCT00074581|39011763|FG001|Overall Study|Death|16|||
16142880|NCT00074581|39011762|FG000|Overall Study|Withdrawal by Subject|50|||
16364211|NCT02187055|39818240|FG000|Overall Study|Adverse Event|21|||
16256415|NCT00950807|39424041|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16256416|NCT00950807|39424042|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16256417|NCT00950807|39424043|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16256418|NCT00950807|39424044|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16256419|NCT00950807|39424045|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16256420|NCT00950807|39424046|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16256421|NCT00950807|39424047|FG006|Treatment Period 2|Withdrawal by Subject|1|||
16256422|NCT00950807|39424048|FG007|Treatment Period 2|Withdrawal by Subject|2|||
16256423|NCT00950807|39424049|FG008|Treatment Period 2|Withdrawal by Subject|0|||
16256424|NCT00950807|39424050|FG009|Treatment Period 2|Withdrawal by Subject|0|||
16256425|NCT00950807|39424041|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
16256426|NCT00950807|39424042|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16256427|NCT00950807|39424043|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16256428|NCT00950807|39424044|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16256429|NCT00950807|39424045|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16256430|NCT00950807|39424046|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16256431|NCT00950807|39424047|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16256432|NCT00950807|39424048|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16256433|NCT00950807|39424049|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16256434|NCT00950807|39424050|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
16256435|NCT00950807|39424041|FG000|Treatment Period 2|Adverse Event|0|||
16256436|NCT00950807|39424042|FG001|Treatment Period 2|Adverse Event|1|||
16256437|NCT00950807|39424043|FG002|Treatment Period 2|Adverse Event|0|||
16256438|NCT00950807|39424044|FG003|Treatment Period 2|Adverse Event|1|||
16256439|NCT00950807|39424045|FG004|Treatment Period 2|Adverse Event|0|||
16256440|NCT00950807|39424046|FG005|Treatment Period 2|Adverse Event|1|||
16256441|NCT00950807|39424047|FG006|Treatment Period 2|Adverse Event|0|||
16256442|NCT00950807|39424048|FG007|Treatment Period 2|Adverse Event|1|||
16256443|NCT00950807|39424049|FG008|Treatment Period 2|Adverse Event|0|||
16256444|NCT00950807|39424050|FG009|Treatment Period 2|Adverse Event|0|||
16256445|NCT00950807|39424041|FG000|Washout Period 2|Lack of Efficacy|1|||
16256446|NCT00950807|39424042|FG001|Washout Period 2|Lack of Efficacy|0|||
16256447|NCT00950807|39424043|FG002|Washout Period 2|Lack of Efficacy|0|||
16256448|NCT00950807|39424044|FG003|Washout Period 2|Lack of Efficacy|0|||
16256449|NCT00950807|39424045|FG004|Washout Period 2|Lack of Efficacy|0|||
16364212|NCT02187055|39818241|FG001|Overall Study|Adverse Event|26|||
16364213|NCT02187055|39818242|FG002|Overall Study|Adverse Event|36|||
16364214|NCT02187055|39818240|FG000|Overall Study|Death|2|||
16364215|NCT02187055|39818241|FG001|Overall Study|Death|0|||
16364216|NCT02187055|39818242|FG002|Overall Study|Death|0|||
16364217|NCT00857389|39818243|FG000|Overall Study|Did not proceed to transplant|2|||
16142881|NCT00074581|39011763|FG001|Overall Study|Withdrawal by Subject|49|||
16142882|NCT00074581|39011762|FG000|Overall Study|Unable to adhere to visit schedule|13|||
16142883|NCT00074581|39011763|FG001|Overall Study|Unable to adhere to visit schedule|14|||
16142884|NCT00074581|39011762|FG000|Overall Study|Relocated|14|||
16142885|NCT00074581|39011763|FG001|Overall Study|Relocated|9|||
16142886|NCT00074581|39011762|FG000|Overall Study|Were withdrawn by investigator|5|||
16142887|NCT00074581|39011763|FG001|Overall Study|Were withdrawn by investigator|2|||
16142888|NCT00074581|39011762|FG000|Overall Study|Lost to Follow-up|16|||
16142889|NCT00074581|39011763|FG001|Overall Study|Lost to Follow-up|11|||
16142890|NCT00074581|39011762|FG000|Overall Study|Ended relationship w. index participant|117|||
16142891|NCT00074581|39011763|FG001|Overall Study|Ended relationship w. index participant|106|||
16142892|NCT00074581|39011762|FG000|Overall Study|Other|14|||
16142893|NCT00074581|39011763|FG001|Overall Study|Other|19|||
16142894|NCT02511678|39011766|FG000|Overall Study|Withdrawal by Subject|2|||
16142895|NCT02511678|39011766|FG000|Overall Study|Lost to Follow-up|4|||
16142896|NCT02511678|39011766|FG000|Overall Study|Death|19|||
16142897|NCT02511678|39011766|FG000|Overall Study|Adverse Event|1|||
16364218|NCT02065557|39818244|FG000|Induction Period|Withdrawal by Subject|2|||
16364219|NCT02065557|39818245|FG001|Induction Period|Withdrawal by Subject|1|||
16364220|NCT02065557|39818246|FG002|Induction Period|Withdrawal by Subject|0|||
16364221|NCT02065557|39818247|FG003|Induction Period|Withdrawal by Subject|0|||
16364222|NCT02065557|39818248|FG004|Induction Period|Withdrawal by Subject|0|||
16142898|NCT02511678|39011766|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
16256450|NCT00950807|39424046|FG005|Washout Period 2|Lack of Efficacy|0|||
16256451|NCT00950807|39424047|FG006|Washout Period 2|Lack of Efficacy|0|||
16256452|NCT00950807|39424048|FG007|Washout Period 2|Lack of Efficacy|0|||
16256453|NCT00950807|39424049|FG008|Washout Period 2|Lack of Efficacy|0|||
16256454|NCT00950807|39424050|FG009|Washout Period 2|Lack of Efficacy|0|||
16256455|NCT00950807|39424041|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
16256456|NCT00950807|39424042|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
16256457|NCT00950807|39424043|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
16256458|NCT00950807|39424044|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
16142899|NCT02511678|39011766|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
16256459|NCT00950807|39424045|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
16256460|NCT00950807|39424046|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
16256461|NCT00950807|39424047|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
16256462|NCT00950807|39424048|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
16256463|NCT00950807|39424049|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
16256464|NCT00950807|39424050|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
16256465|NCT00950807|39424041|FG000|Washout Period 2|Adverse Event|3|||
16256466|NCT00950807|39424042|FG001|Washout Period 2|Adverse Event|0|||
16256467|NCT00950807|39424043|FG002|Washout Period 2|Adverse Event|0|||
16256468|NCT00950807|39424044|FG003|Washout Period 2|Adverse Event|1|||
16256469|NCT00950807|39424045|FG004|Washout Period 2|Adverse Event|0|||
16256470|NCT00950807|39424046|FG005|Washout Period 2|Adverse Event|0|||
16256471|NCT00950807|39424047|FG006|Washout Period 2|Adverse Event|0|||
16256472|NCT00950807|39424048|FG007|Washout Period 2|Adverse Event|0|||
16256473|NCT00950807|39424049|FG008|Washout Period 2|Adverse Event|0|||
16256474|NCT00950807|39424050|FG009|Washout Period 2|Adverse Event|0|||
16256475|NCT00950807|39424041|FG000|Treatment Period 3|Withdrawal by Subject|0|||
16256476|NCT00950807|39424042|FG001|Treatment Period 3|Withdrawal by Subject|0|||
16256477|NCT00950807|39424043|FG002|Treatment Period 3|Withdrawal by Subject|0|||
16256478|NCT00950807|39424044|FG003|Treatment Period 3|Withdrawal by Subject|0|||
16256479|NCT00950807|39424045|FG004|Treatment Period 3|Withdrawal by Subject|0|||
16256480|NCT00950807|39424046|FG005|Treatment Period 3|Withdrawal by Subject|0|||
16256481|NCT00950807|39424047|FG006|Treatment Period 3|Withdrawal by Subject|0|||
16256482|NCT00950807|39424048|FG007|Treatment Period 3|Withdrawal by Subject|0|||
16256483|NCT00950807|39424049|FG008|Treatment Period 3|Withdrawal by Subject|0|||
16256484|NCT00950807|39424050|FG009|Treatment Period 3|Withdrawal by Subject|1|||
16256485|NCT00950807|39424041|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
16256486|NCT00950807|39424042|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16256487|NCT00950807|39424043|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16256488|NCT00950807|39424044|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16256489|NCT00950807|39424045|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16256490|NCT00950807|39424046|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16256491|NCT00950807|39424047|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16256492|NCT00950807|39424048|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
16256493|NCT00950807|39424049|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16256494|NCT00950807|39424050|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
16256495|NCT00950807|39424041|FG000|Treatment Period 3|Adverse Event|0|||
16256496|NCT00950807|39424042|FG001|Treatment Period 3|Adverse Event|0|||
16256497|NCT00950807|39424043|FG002|Treatment Period 3|Adverse Event|0|||
16256498|NCT00950807|39424044|FG003|Treatment Period 3|Adverse Event|0|||
16256499|NCT00950807|39424045|FG004|Treatment Period 3|Adverse Event|0|||
16256500|NCT00950807|39424046|FG005|Treatment Period 3|Adverse Event|0|||
16256501|NCT00950807|39424047|FG006|Treatment Period 3|Adverse Event|1|||
16256502|NCT00950807|39424048|FG007|Treatment Period 3|Adverse Event|0|||
16256503|NCT00950807|39424049|FG008|Treatment Period 3|Adverse Event|0|||
16256504|NCT00950807|39424050|FG009|Treatment Period 3|Adverse Event|0|||
16256505|NCT00101582|39424051|FG000|Overall Study|Ineligibility determined|0|||
16256506|NCT00101582|39424052|FG001|Overall Study|Ineligibility determined|1|||
16256507|NCT00101582|39424051|FG000|Overall Study|Adverse Event|1|||
16256508|NCT00101582|39424052|FG001|Overall Study|Adverse Event|4|||
16256509|NCT00101582|39424051|FG000|Overall Study|Withdrawal by Subject|6|||
16256510|NCT00101582|39424052|FG001|Overall Study|Withdrawal by Subject|4|||
16256511|NCT00101582|39424051|FG000|Overall Study|Physician Decision|1|||
16256512|NCT00101582|39424052|FG001|Overall Study|Physician Decision|0|||
16256513|NCT00101582|39424051|FG000|Overall Study|Death|3|||
16256514|NCT00101582|39424052|FG001|Overall Study|Death|5|||
16142900|NCT02511678|39011766|FG000|Overall Study|Required Radiofrequency Ablation|1|||
16142901|NCT02511678|39011766|FG000|Overall Study|Biopsy was Negative|1|||
16256515|NCT00101582|39424051|FG000|Overall Study|Other|0|||
16256516|NCT00101582|39424052|FG001|Overall Study|Other|1|||
16256517|NCT02041702|39424053|FG000|Overall Study|Lost to Follow-up|1|||
16256518|NCT02041702|39424054|FG001|Overall Study|Lost to Follow-up|6|||
16439330|NCT01667900|40089373|FG009|Part B|Death|0|||
16439331|NCT01667900|40089374|FG010|Part B|Death|0|||
16439332|NCT01667900|40089375|FG011|Part B|Death|0|||
16439333|NCT01667900|40089376|FG012|Part B|Death|0|||
16439334|NCT01667900|40089377|FG013|Part B|Death|0|||
16439335|NCT01667900|40089378|FG014|Part B|Death|0|||
16439336|NCT01667900|40089379|FG015|Part B|Death|0|||
16439337|NCT01667900|40089380|FG016|Part B|Death|1|||
16439338|NCT01667900|40089381|FG017|Part B|Death|0|||
16439339|NCT01667900|40089382|FG018|Part B|Death|0|||
16439340|NCT01667900|40089383|FG019|Part B|Death|0|||
16439341|NCT01777308|40089384|FG000|Overall Study|Withdrawal by Subject|5|||
16439342|NCT01777308|40089385|FG001|Overall Study|Withdrawal by Subject|1|||
16439343|NCT01777308|40089384|FG000|Overall Study|Migrated/moved from study area|1|||
16439344|NCT01777308|40089385|FG001|Overall Study|Migrated/moved from study area|0|||
16439345|NCT01777308|40089384|FG000|Overall Study|Lost to Follow-up|7|||
16439346|NCT01777308|40089385|FG001|Overall Study|Lost to Follow-up|2|||
16439347|NCT01777308|40089384|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
16439348|NCT01777308|40089385|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
16439349|NCT00231816|40089386|FG000|Overall Study|Adverse Event|1|||
16439350|NCT00231816|40089387|FG001|Overall Study|Adverse Event|0|||
16439351|NCT00231816|40089386|FG000|Overall Study|Lost to Follow-up|8|||
16439352|NCT00231816|40089387|FG001|Overall Study|Lost to Follow-up|5|||
16439353|NCT00231816|40089386|FG000|Overall Study|Protocol Violation|2|||
16439354|NCT00231816|40089387|FG001|Overall Study|Protocol Violation|3|||
16439355|NCT00231816|40089386|FG000|Overall Study|Withdrawal by Subject|3|||
16439356|NCT00231816|40089387|FG001|Overall Study|Withdrawal by Subject|3|||
16439357|NCT00231816|40089386|FG000|Overall Study|Other|2|||
16142902|NCT02511678|39011766|FG000|Overall Study|Protocol Violation|1|||
16142903|NCT02511678|39011766|FG000|Overall Study|Received Radiation Treatment|1|||
16439358|NCT00231816|40089387|FG001|Overall Study|Other|1|||
16439359|NCT05236270|40089389|FG000|Overall Study|Lost to Follow-up|3|||
16439360|NCT05236270|40089390|FG001|Overall Study|Lost to Follow-up|2|||
16439361|NCT05236270|40089391|FG002|Overall Study|Lost to Follow-up|0|||
16439362|NCT05236270|40089392|FG003|Overall Study|Lost to Follow-up|0|||
16439363|NCT05236270|40089393|FG004|Overall Study|Lost to Follow-up|2|||
16439364|NCT05236270|40089394|FG005|Overall Study|Lost to Follow-up|0|||
16439365|NCT05236270|40089395|FG006|Overall Study|Lost to Follow-up|1|||
16439366|NCT05236270|40089396|FG007|Overall Study|Lost to Follow-up|3|||
16439367|NCT00079417|40089397|FG000|Overall Study|Physician Decision|2|||
16439368|NCT00079417|40089397|FG000|Overall Study|Ineligible|7|||
16439369|NCT00474812|40089398|FG000|Overall Study|Withdrawal by Subject|5|||
16439370|NCT00474812|40089398|FG000|Overall Study|No Initiation of treatment|2|||
16439371|NCT00886379|40089399|FG000|Overall Study|Transferred Schools|0|||
16439372|NCT00886379|40089400|FG001|Overall Study|Transferred Schools|0|||
16439373|NCT00886379|40089401|FG002|Overall Study|Transferred Schools|2|||
16142904|NCT00702325|39011767|FG000|Overall Study|Adverse Event|1|||
16142905|NCT00702325|39011768|FG001|Overall Study|Adverse Event|0|||
16142906|NCT00702325|39011767|FG000|Overall Study|Withdrawal by Subject|7|||
16142907|NCT00702325|39011768|FG001|Overall Study|Withdrawal by Subject|7|||
16142908|NCT00702325|39011767|FG000|Overall Study|Lost to Follow-up|3|||
16142909|NCT00702325|39011768|FG001|Overall Study|Lost to Follow-up|4|||
16142910|NCT00702325|39011767|FG000|Overall Study|Incorrect enrollment|5|||
16142911|NCT00702325|39011768|FG001|Overall Study|Incorrect enrollment|7|||
16142912|NCT00702325|39011767|FG000|Overall Study|Developed study discontinuation criteria|18|||
16439374|NCT00886379|40089402|FG003|Overall Study|Transferred Schools|1|||
16439375|NCT00886379|40089403|FG004|Overall Study|Transferred Schools|1|||
16142913|NCT00702325|39011768|FG001|Overall Study|Developed study discontinuation criteria|28|||
16439376|NCT00886379|40089399|FG000|Overall Study|Final blood draw not obtained|3|||
16439377|NCT00886379|40089400|FG001|Overall Study|Final blood draw not obtained|3|||
16142914|NCT00702325|39011767|FG000|Overall Study|Severe noncompliance to protocol|3|||
16142915|NCT00702325|39011768|FG001|Overall Study|Severe noncompliance to protocol|3|||
16142916|NCT00702325|39011767|FG000|Overall Study|Termination due to lab results|1|||
16142917|NCT00702325|39011768|FG001|Overall Study|Termination due to lab results|0|||
16142918|NCT00702325|39011767|FG000|Overall Study|Didn't follow study medication dosage|0|||
16142919|NCT00702325|39011768|FG001|Overall Study|Didn't follow study medication dosage|2|||
16142920|NCT00702325|39011767|FG000|Overall Study|Withdrew consent|0|||
16142921|NCT00702325|39011768|FG001|Overall Study|Withdrew consent|1|||
16142922|NCT00702325|39011767|FG000|Overall Study|Incorrectly Discontinued|0|||
16142923|NCT00702325|39011768|FG001|Overall Study|Incorrectly Discontinued|1|||
16142924|NCT02357134|39011769|FG000|Overall Study|Lost to Follow-up|1|||
16142925|NCT02357134|39011770|FG001|Overall Study|Lost to Follow-up|0|||
16142926|NCT02357134|39011771|FG002|Overall Study|Lost to Follow-up|0|||
16142927|NCT02357134|39011772|FG003|Overall Study|Lost to Follow-up|0|||
16142928|NCT02448225|39011773|FG000|Overall Study|Withdrawal by Subject|1|||
16142929|NCT02448225|39011773|FG000|Overall Study|Did not get FSPG scan|18|||
16142930|NCT02448225|39011773|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
16439378|NCT00886379|40089401|FG002|Overall Study|Final blood draw not obtained|4|||
16439379|NCT00886379|40089402|FG003|Overall Study|Final blood draw not obtained|2|||
16439380|NCT00886379|40089403|FG004|Overall Study|Final blood draw not obtained|2|||
16439381|NCT01436149|40089404|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
16439382|NCT01436149|40089405|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
16439383|NCT01436149|40089406|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
16439384|NCT01436149|40089404|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
16439385|NCT01436149|40089405|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
16439386|NCT01436149|40089406|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
16439387|NCT01436149|40089404|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
16439388|NCT01436149|40089405|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16439389|NCT01436149|40089406|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
16439390|NCT01436149|40089404|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
16439391|NCT01436149|40089405|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16439392|NCT01436149|40089406|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
16439393|NCT01436149|40089404|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
16439394|NCT01436149|40089405|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
16439395|NCT01436149|40089406|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
16439396|NCT01436149|40089404|FG000|Antidepressant Lead-in Phase|Other|119|||
16439397|NCT01436149|40089405|FG001|Antidepressant Lead-in Phase|Other|0|||
16142931|NCT02030405|39011778|FG000|Overall Study|Withdrawal by Subject|1|||
16142932|NCT02030405|39011778|FG000|Overall Study|Lost to Follow-up|1|||
16142933|NCT01200238|39011780|FG000|Overall Study|Adverse Event|2|||
16142934|NCT01200238|39011781|FG001|Overall Study|Adverse Event|1|||
16142935|NCT01200238|39011780|FG000|Overall Study|Progressive Disease|5|||
16142936|NCT01200238|39011781|FG001|Overall Study|Progressive Disease|8|||
16142937|NCT01200238|39011780|FG000|Overall Study|Withdrawal by Subject|0|||
16142938|NCT01200238|39011781|FG001|Overall Study|Withdrawal by Subject|1|||
16142939|NCT01098812|39011782|FG000|Overall Study|Death|2|||
16142940|NCT01098812|39011783|FG001|Overall Study|Death|0|||
16142941|NCT01098812|39011784|FG002|Overall Study|Death|1|||
16142942|NCT01098812|39011782|FG000|Overall Study|Lost to Follow-up|0|||
16142943|NCT01098812|39011783|FG001|Overall Study|Lost to Follow-up|1|||
16142944|NCT01098812|39011784|FG002|Overall Study|Lost to Follow-up|0|||
16142945|NCT01335009|39011785|FG000|Overall Study|Too ill to travel to study sites|1|||
16142946|NCT01335009|39011786|FG001|Overall Study|Too ill to travel to study sites|0|||
16142947|NCT01335009|39011785|FG000|Overall Study|Death|28|||
16142948|NCT01335009|39011786|FG001|Overall Study|Death|32|||
16142949|NCT01335009|39011785|FG000|Overall Study|Withdrawal by Subject|1|||
16142950|NCT01335009|39011786|FG001|Overall Study|Withdrawal by Subject|1|||
16142951|NCT01335009|39011785|FG000|Overall Study|Lost to Follow-up|1|||
16142952|NCT01335009|39011786|FG001|Overall Study|Lost to Follow-up|0|||
16142953|NCT01303965|39011789|FG000|Overall Study|Adverse Event|1|||
16142954|NCT01303965|39011790|FG001|Overall Study|Adverse Event|1|||
16142955|NCT01303965|39011789|FG000|Overall Study|Death|0|||
16142956|NCT01303965|39011790|FG001|Overall Study|Death|3|||
16256519|NCT02041702|39424053|FG000|Overall Study|Death|4|||
16439398|NCT01436149|40089406|FG002|Antidepressant Lead-in Phase|Other|0|||
16439399|NCT01436149|40089404|FG000|Randomized Phase|Adverse Event|9|||
16142957|NCT01303965|39011789|FG000|Overall Study|Withdrawal by Subject|1|||
16142958|NCT01303965|39011790|FG001|Overall Study|Withdrawal by Subject|0|||
16142959|NCT01303965|39011789|FG000|Overall Study|Disease Progression|1|||
16142960|NCT01303965|39011790|FG001|Overall Study|Disease Progression|6|||
16142961|NCT00234494|39011791|FG000|Overall Study|Protocol Violation|2|||
16142962|NCT01493557|39011794|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
16142963|NCT01493557|39011795|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
16142964|NCT01493557|39011796|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
16142965|NCT01493557|39011794|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
16142966|NCT01493557|39011795|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
16142967|NCT01493557|39011796|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
16142968|NCT01493557|39011794|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
16142969|NCT01493557|39011795|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
16142970|NCT01493557|39011796|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
16142971|NCT01493557|39011794|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
16142972|NCT01493557|39011795|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
16142973|NCT01493557|39011796|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
16142974|NCT01493557|39011794|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
16142975|NCT01493557|39011795|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
16142976|NCT01493557|39011796|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
16142977|NCT01493557|39011794|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
16142978|NCT01493557|39011795|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
16142979|NCT01493557|39011796|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
16142980|NCT01493557|39011794|FG000|Not Randomized to Management Strategies|Early termination|0|||
16142981|NCT01493557|39011795|FG001|Not Randomized to Management Strategies|Early termination|0|||
16142982|NCT01493557|39011796|FG002|Not Randomized to Management Strategies|Early termination|34|||
16142983|NCT01493557|39011794|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
16142984|NCT01493557|39011795|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
16142985|NCT01493557|39011796|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
16142986|NCT01493557|39011794|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
16142987|NCT01493557|39011795|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
16142988|NCT01493557|39011796|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
16142989|NCT01493557|39011794|FG000|Randomized to Management Strategies|Other adverse event|8|||
16142990|NCT01493557|39011795|FG001|Randomized to Management Strategies|Other adverse event|5|||
16142991|NCT01493557|39011796|FG002|Randomized to Management Strategies|Other adverse event|0|||
16142992|NCT01493557|39011794|FG000|Randomized to Management Strategies|Protocol Violation|3|||
16142993|NCT01493557|39011795|FG001|Randomized to Management Strategies|Protocol Violation|0|||
16142994|NCT01493557|39011796|FG002|Randomized to Management Strategies|Protocol Violation|0|||
16142995|NCT01493557|39011794|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
16142996|NCT01493557|39011795|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
16142997|NCT01493557|39011796|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
16142998|NCT01493557|39011794|FG000|Randomized to Management Strategies|Other than stated above|1|||
16142999|NCT01493557|39011795|FG001|Randomized to Management Strategies|Other than stated above|3|||
16143000|NCT01493557|39011796|FG002|Randomized to Management Strategies|Other than stated above|0|||
16143001|NCT01493557|39011794|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
16143002|NCT01493557|39011795|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
16143003|NCT01493557|39011796|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
16143004|NCT01493557|39011794|FG000|Adding the Second Strategy|Other adverse event|1|||
16143005|NCT01493557|39011795|FG001|Adding the Second Strategy|Other adverse event|2|||
16143006|NCT01493557|39011796|FG002|Adding the Second Strategy|Other adverse event|0|||
16143007|NCT01493557|39011794|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
16143008|NCT01493557|39011795|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
16143009|NCT01493557|39011796|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
16143010|NCT00041080|39011797|FG000|Overall Study|Adverse Event|21|||
16143011|NCT00041080|39011798|FG001|Overall Study|Adverse Event|1|||
16143012|NCT00041080|39011797|FG000|Overall Study|Withdrawal by Subject|6|||
16143013|NCT00041080|39011798|FG001|Overall Study|Withdrawal by Subject|6|||
16143014|NCT00041080|39011797|FG000|Overall Study|Concommitant Illness/Other|1|||
16143015|NCT00041080|39011798|FG001|Overall Study|Concommitant Illness/Other|2|||
16143016|NCT00041080|39011797|FG000|Overall Study|Did not start therapy|1|||
16143017|NCT00041080|39011798|FG001|Overall Study|Did not start therapy|1|||
16143018|NCT00041080|39011797|FG000|Overall Study|Ineligible|1|||
16143019|NCT00041080|39011798|FG001|Overall Study|Ineligible|0|||
16143020|NCT00375219|39011802|FG000|Overall Study|Failure to achieve a response|16|||
16143021|NCT00375219|39011803|FG001|Overall Study|Failure to achieve a response|2|||
16256520|NCT02041702|39424054|FG001|Overall Study|Death|0|||
16143022|NCT00375219|39011804|FG002|Overall Study|Failure to achieve a response|0|||
16143023|NCT00375219|39011802|FG000|Overall Study|Adverse Event|8|||
16143024|NCT00375219|39011803|FG001|Overall Study|Adverse Event|2|||
16143025|NCT00375219|39011804|FG002|Overall Study|Adverse Event|1|||
16143026|NCT00375219|39011802|FG000|Overall Study|Protocol Violation|1|||
16256521|NCT02041702|39424053|FG000|Overall Study|Withdrawal by Subject|4|||
16256522|NCT02041702|39424054|FG001|Overall Study|Withdrawal by Subject|3|||
16143027|NCT00375219|39011803|FG001|Overall Study|Protocol Violation|0|||
16256523|NCT02041702|39424053|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
16143028|NCT00375219|39011804|FG002|Overall Study|Protocol Violation|1|||
16143029|NCT00375219|39011802|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
16143030|NCT00375219|39011803|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
16143031|NCT00375219|39011804|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
16143032|NCT00375219|39011802|FG000|Overall Study|Lost to Follow-up|1|||
16143033|NCT00375219|39011803|FG001|Overall Study|Lost to Follow-up|1|||
16143034|NCT00375219|39011804|FG002|Overall Study|Lost to Follow-up|0|||
16143035|NCT00375219|39011802|FG000|Overall Study|Disease progression|18|||
16143036|NCT00375219|39011803|FG001|Overall Study|Disease progression|9|||
16143037|NCT00375219|39011804|FG002|Overall Study|Disease progression|12|||
16143038|NCT00375219|39011802|FG000|Overall Study|Death|4|||
16143039|NCT00375219|39011803|FG001|Overall Study|Death|3|||
16143040|NCT00375219|39011804|FG002|Overall Study|Death|7|||
16143041|NCT00375219|39011802|FG000|Overall Study|Hematologic resistance|1|||
16143042|NCT00375219|39011803|FG001|Overall Study|Hematologic resistance|0|||
16143043|NCT00375219|39011804|FG002|Overall Study|Hematologic resistance|0|||
16143044|NCT00375219|39011802|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
16143045|NCT00375219|39011803|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
16143046|NCT00375219|39011804|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
16143047|NCT00375219|39011802|FG000|Overall Study|Allograft|2|||
16143048|NCT00375219|39011803|FG001|Overall Study|Allograft|0|||
16143049|NCT00375219|39011804|FG002|Overall Study|Allograft|0|||
16143050|NCT00375219|39011802|FG000|Overall Study|Cord blood transplantation|1|||
16143051|NCT00375219|39011803|FG001|Overall Study|Cord blood transplantation|0|||
16143052|NCT00375219|39011804|FG002|Overall Study|Cord blood transplantation|0|||
16143053|NCT00375219|39011802|FG000|Overall Study|Withdrawal by Subject|1|||
16143054|NCT00375219|39011803|FG001|Overall Study|Withdrawal by Subject|0|||
16143055|NCT00375219|39011804|FG002|Overall Study|Withdrawal by Subject|0|||
16143056|NCT02906787|39011805|FG000|Overall Study|Withdrawal by Subject|12|||
16143057|NCT02906787|39011806|FG001|Overall Study|Withdrawal by Subject|10|||
16143058|NCT02906787|39011805|FG000|Overall Study|Missed|24|||
16143059|NCT02906787|39011806|FG001|Overall Study|Missed|22|||
16143060|NCT01022502|39011815|FG000|Overall Study|Adverse Event|1|||
16143061|NCT01022502|39011815|FG000|Overall Study|employment related reasons|1|||
16143062|NCT01022502|39011815|FG000|Overall Study|Withdrawal by Subject|1|||
16143063|NCT01521897|39011816|FG000|Overall Study|Protocol Violation|18|||
16143064|NCT01521897|39011816|FG000|Overall Study|Lost to Follow-up|5|||
16143065|NCT01458366|39011819|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
16143066|NCT01458366|39011820|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
16143067|NCT01458366|39011821|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
16143068|NCT01458366|39011822|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
16143069|NCT01458366|39011823|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
16143070|NCT01458366|39011819|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
16143071|NCT01458366|39011820|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
16143072|NCT01458366|39011821|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
16143073|NCT01458366|39011822|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
16143074|NCT01458366|39011823|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
16143075|NCT03583450|39011824|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
16143076|NCT03583450|39011825|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
16143077|NCT03675776|39011826|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
16143078|NCT03675776|39011827|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
16143079|NCT03675776|39011828|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
16143080|NCT03675776|39011826|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
16143081|NCT03675776|39011827|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
16143082|NCT03675776|39011828|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
16143083|NCT05097716|39011829|FG000|Period 1|Adverse Event|1|||
16143084|NCT05097716|39011829|FG000|Period 1|Close contact with highly-transmissible infection|1|||
16143085|NCT00727649|39011830|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
16143086|NCT00727649|39011831|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
16143087|NCT00727649|39011830|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
16143088|NCT00727649|39011831|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
16143089|NCT00727649|39011830|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
16256524|NCT02041702|39424054|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
16143090|NCT00727649|39011831|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
16143091|NCT00727649|39011830|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
16143092|NCT00727649|39011831|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
16256525|NCT02041702|39424053|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
16143093|NCT00727649|39011830|FG000|Second Intervention (4-weeks)|Death|1|||
16143094|NCT00727649|39011831|FG001|Second Intervention (4-weeks)|Death|0|||
16143095|NCT00727649|39011830|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
16364223|NCT02065557|39818249|FG005|Induction Period|Withdrawal by Subject|0|||
16143096|NCT00727649|39011831|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
16143097|NCT00727649|39011830|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
16143098|NCT00727649|39011831|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
16143099|NCT01132612|39011832|FG000|Overall Study|Death|0|||
16143100|NCT01132612|39011833|FG001|Overall Study|Death|0|||
16143101|NCT01132612|39011834|FG002|Overall Study|Death|1|||
16143102|NCT01132612|39011832|FG000|Overall Study|Protocol deviation|0|||
16143103|NCT01132612|39011833|FG001|Overall Study|Protocol deviation|0|||
16143104|NCT01132612|39011834|FG002|Overall Study|Protocol deviation|3|||
16143105|NCT01132612|39011832|FG000|Overall Study|Lost to Follow-up|2|||
16143106|NCT01132612|39011833|FG001|Overall Study|Lost to Follow-up|2|||
16143107|NCT01132612|39011834|FG002|Overall Study|Lost to Follow-up|7|||
16143108|NCT01132612|39011832|FG000|Overall Study|Adverse Event|5|||
16143109|NCT01132612|39011833|FG001|Overall Study|Adverse Event|2|||
16143110|NCT01132612|39011834|FG002|Overall Study|Adverse Event|15|||
16143111|NCT01132612|39011832|FG000|Overall Study|Withdrawal by Subject|5|||
16143112|NCT01132612|39011833|FG001|Overall Study|Withdrawal by Subject|8|||
16143113|NCT01132612|39011834|FG002|Overall Study|Withdrawal by Subject|19|||
16143114|NCT01132612|39011832|FG000|Overall Study|Administrative problems|5|||
16143115|NCT01132612|39011833|FG001|Overall Study|Administrative problems|1|||
16143116|NCT01132612|39011834|FG002|Overall Study|Administrative problems|52|||
16143117|NCT01132612|39011832|FG000|Overall Study|Lack of Efficacy|23|||
16143118|NCT01132612|39011833|FG001|Overall Study|Lack of Efficacy|22|||
16143119|NCT01132612|39011834|FG002|Overall Study|Lack of Efficacy|73|||
16143120|NCT04784897|39011835|FG000|Overall Study|Death|4|||
16143121|NCT04784897|39011836|FG001|Overall Study|Death|2|||
16143122|NCT04784897|39011837|FG002|Overall Study|Death|1|||
16143123|NCT04784897|39011835|FG000|Overall Study|Withdrawal by Subject|0|||
16143124|NCT04784897|39011836|FG001|Overall Study|Withdrawal by Subject|0|||
16143125|NCT04784897|39011837|FG002|Overall Study|Withdrawal by Subject|1|||
16143126|NCT02409290|39011838|FG000|Overall Study|Protocol Violation|3|||
16143127|NCT02409290|39011839|FG001|Overall Study|Protocol Violation|6|||
16143128|NCT02409290|39011840|FG002|Overall Study|Protocol Violation|9|||
16143129|NCT02409290|39011841|FG003|Overall Study|Protocol Violation|4|||
16143130|NCT02409290|39011838|FG000|Overall Study|No positive culture/no baseline sample|3|||
16143131|NCT02409290|39011839|FG001|Overall Study|No positive culture/no baseline sample|9|||
16143132|NCT02409290|39011840|FG002|Overall Study|No positive culture/no baseline sample|6|||
16143133|NCT02409290|39011841|FG003|Overall Study|No positive culture/no baseline sample|5|||
16143134|NCT02409290|39011838|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
16143135|NCT02409290|39011839|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
16143136|NCT02409290|39011840|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
16143137|NCT02409290|39011841|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
16143138|NCT01708291|39011845|FG000|Overall Study|fighting|2|||
16143139|NCT01708291|39011846|FG001|Overall Study|fighting|1|||
16143140|NCT00986440|39011849|FG000|Overall Study|Progressive disease|27|||
16143141|NCT00986440|39011850|FG001|Overall Study|Progressive disease|37|||
16143142|NCT00986440|39011849|FG000|Overall Study|Serious adverse event or adverse event|9|||
16143143|NCT00986440|39011850|FG001|Overall Study|Serious adverse event or adverse event|2|||
16143144|NCT00986440|39011849|FG000|Overall Study|Withdrawal by Subject|1|||
16143145|NCT00986440|39011850|FG001|Overall Study|Withdrawal by Subject|2|||
16143146|NCT00986440|39011849|FG000|Overall Study|Screen failure (not dosed)|4|||
16143147|NCT00986440|39011850|FG001|Overall Study|Screen failure (not dosed)|2|||
16143148|NCT00954421|39011851|FG000|Screening|screen failures|3|||
16143149|NCT00954421|39011851|FG000|6 Months of DBS|Withdrawal by Subject|1|||
16143150|NCT00954421|39011851|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
16143151|NCT01472380|39011852|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
16143152|NCT01472380|39011852|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
16143153|NCT00685685|39011853|FG000|Washout Period of 7 Days|Adverse Event|2|||
16143154|NCT00685685|39011854|FG001|Washout Period of 7 Days|Adverse Event|0|||
16143155|NCT00685685|39011853|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
16143156|NCT00685685|39011854|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
16143157|NCT01179672|39011855|FG000|Overall Study|Adverse Event|17|||
16143158|NCT01179672|39011856|FG001|Overall Study|Adverse Event|8|||
16143159|NCT01179672|39011855|FG000|Overall Study|Withdrawal by Subject|10|||
16143160|NCT01179672|39011856|FG001|Overall Study|Withdrawal by Subject|12|||
16143161|NCT01179672|39011855|FG000|Overall Study|Entry Criteria Not Met|0|||
16143162|NCT01179672|39011856|FG001|Overall Study|Entry Criteria Not Met|2|||
16143163|NCT01179672|39011855|FG000|Overall Study|Lost to Follow-up|0|||
16143164|NCT01179672|39011856|FG001|Overall Study|Lost to Follow-up|1|||
16143165|NCT01179672|39011855|FG000|Overall Study|Protocol Violation|2|||
16143166|NCT01179672|39011856|FG001|Overall Study|Protocol Violation|2|||
16143167|NCT01179672|39011855|FG000|Overall Study|Physician Decision|1|||
16143168|NCT01179672|39011856|FG001|Overall Study|Physician Decision|1|||
16143169|NCT01383096|39011857|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
16143170|NCT01383096|39011858|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
16143171|NCT01383096|39011859|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
16143172|NCT01383096|39011857|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
16143173|NCT01383096|39011858|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
16143174|NCT01383096|39011859|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
16143175|NCT01383096|39011857|FG000|Third Intervention (8 Days)|Elevated AST|0|||
16143176|NCT01383096|39011858|FG001|Third Intervention (8 Days)|Elevated AST|1|||
16143177|NCT01383096|39011859|FG002|Third Intervention (8 Days)|Elevated AST|0|||
16143178|NCT01383096|39011857|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
16143179|NCT01383096|39011858|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
16143180|NCT01383096|39011859|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
16143181|NCT01383096|39011857|FG000|Third Intervention (8 Days)|Adverse Event|1|||
16143182|NCT01383096|39011858|FG001|Third Intervention (8 Days)|Adverse Event|0|||
16143183|NCT01383096|39011859|FG002|Third Intervention (8 Days)|Adverse Event|0|||
16143184|NCT01383096|39011857|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
16143185|NCT01383096|39011858|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
16143186|NCT01383096|39011859|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
16143187|NCT01383096|39011857|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
16143188|NCT01383096|39011858|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
16143189|NCT01383096|39011859|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
16143190|NCT01383096|39011857|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
16143191|NCT01383096|39011858|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
16143192|NCT01383096|39011859|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
16143193|NCT01383096|39011857|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
16143194|NCT01383096|39011858|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
16143195|NCT01383096|39011859|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
16143196|NCT01383096|39011857|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
16143197|NCT01383096|39011858|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
16143198|NCT01383096|39011859|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
16143199|NCT01383096|39011857|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
16439400|NCT01436149|40089405|FG001|Randomized Phase|Adverse Event|10|||
16439401|NCT01436149|40089406|FG002|Randomized Phase|Adverse Event|11|||
16439402|NCT01436149|40089404|FG000|Randomized Phase|Protocol Violation|4|||
16439403|NCT01436149|40089405|FG001|Randomized Phase|Protocol Violation|5|||
16439404|NCT01436149|40089406|FG002|Randomized Phase|Protocol Violation|0|||
16439405|NCT01436149|40089404|FG000|Randomized Phase|Withdrawal by Subject|16|||
16439406|NCT01436149|40089405|FG001|Randomized Phase|Withdrawal by Subject|10|||
16439407|NCT01436149|40089406|FG002|Randomized Phase|Withdrawal by Subject|10|||
16439408|NCT01436149|40089404|FG000|Randomized Phase|Lost to Follow-up|34|||
16439409|NCT01436149|40089405|FG001|Randomized Phase|Lost to Follow-up|5|||
16439410|NCT01436149|40089406|FG002|Randomized Phase|Lost to Follow-up|6|||
16439411|NCT01436149|40089404|FG000|Randomized Phase|Lack of Efficacy|0|||
16439412|NCT01436149|40089405|FG001|Randomized Phase|Lack of Efficacy|0|||
16439413|NCT01436149|40089406|FG002|Randomized Phase|Lack of Efficacy|1|||
16439414|NCT01436149|40089404|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
16439415|NCT01436149|40089405|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
16439416|NCT01436149|40089406|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
16439417|NCT01436149|40089404|FG000|Randomized Phase|Other|12|||
16439418|NCT01436149|40089405|FG001|Randomized Phase|Other|5|||
16439419|NCT01436149|40089406|FG002|Randomized Phase|Other|11|||
16439420|NCT01775501|40089407|FG000|Overall Study|Discontinued prior to treatment|1|||
16439421|NCT00561652|40089408|FG000|Overall Study|Withdrawal by Subject|0|||
16439422|NCT00561652|40089409|FG001|Overall Study|Withdrawal by Subject|1|||
16439423|NCT02648204|40089410|FG000|Overall Study|Withdrawal by Subject|12|||
16439424|NCT02648204|40089411|FG001|Overall Study|Withdrawal by Subject|8|||
16439425|NCT02648204|40089412|FG002|Overall Study|Withdrawal by Subject|2|||
16439426|NCT02648204|40089413|FG003|Overall Study|Withdrawal by Subject|6|||
16439427|NCT02648204|40089410|FG000|Overall Study|Lost to Follow-up|5|||
16439428|NCT02648204|40089411|FG001|Overall Study|Lost to Follow-up|8|||
16439429|NCT02648204|40089412|FG002|Overall Study|Lost to Follow-up|4|||
16439430|NCT02648204|40089413|FG003|Overall Study|Lost to Follow-up|6|||
16439431|NCT02648204|40089410|FG000|Overall Study|Missing follow-up information|4|||
16439432|NCT02648204|40089411|FG001|Overall Study|Missing follow-up information|4|||
16439433|NCT02648204|40089412|FG002|Overall Study|Missing follow-up information|4|||
16439434|NCT02648204|40089413|FG003|Overall Study|Missing follow-up information|2|||
16439435|NCT02648204|40089410|FG000|Overall Study|Death|1|||
16439436|NCT02648204|40089411|FG001|Overall Study|Death|1|||
16143200|NCT01383096|39011858|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
16143201|NCT01383096|39011859|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
16143202|NCT03842163|39011862|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
16143203|NCT03842163|39011862|FG000|Overall Study|Scintigraphy was not performed|44|||
16143204|NCT00818389|39014572|FG000|Overall Study|Death|1|||
16439437|NCT02648204|40089412|FG002|Overall Study|Death|2|||
16439438|NCT02648204|40089413|FG003|Overall Study|Death|2|||
16439439|NCT02648204|40089410|FG000|Overall Study|Adverse Event|0|||
16143205|NCT00818389|39014573|FG001|Overall Study|Death|3|||
16143206|NCT00818389|39014572|FG000|Overall Study|ALS Disease Progression|1|||
16143207|NCT00818389|39014573|FG001|Overall Study|ALS Disease Progression|0|||
16143208|NCT00818389|39014572|FG000|Overall Study|Withdrawal by Subject|2|||
16143209|NCT00818389|39014573|FG001|Overall Study|Withdrawal by Subject|2|||
16143210|NCT00818389|39014572|FG000|Overall Study|Adverse Event|0|||
16143211|NCT00818389|39014573|FG001|Overall Study|Adverse Event|1|||
16143212|NCT04857996|39014587|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
16143213|NCT04857996|39014588|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
16143214|NCT04857996|39014587|FG000|Overall Study|Lost to Follow-up|1|||
16143215|NCT04857996|39014588|FG001|Overall Study|Lost to Follow-up|3|||
16143216|NCT04857996|39014587|FG000|Overall Study|Site Closure|1|||
16143217|NCT04857996|39014588|FG001|Overall Study|Site Closure|0|||
16143218|NCT04857996|39014587|FG000|Overall Study|Withdrawal by Subject|1|||
16143219|NCT04857996|39014588|FG001|Overall Study|Withdrawal by Subject|0|||
16143220|NCT01610687|39014589|FG000|Overall Study|Lack of Efficacy|26|||
16143221|NCT01610687|39014589|FG000|Overall Study|Adverse Event|18|||
16143222|NCT01610687|39014589|FG000|Overall Study|Moved out of area|6|||
16143223|NCT01610687|39014589|FG000|Overall Study|Withdrawal by Subject|7|||
16143224|NCT01610687|39014589|FG000|Overall Study|Lost to Follow-up|4|||
16143225|NCT01610687|39014589|FG000|Overall Study|Symptom control without study medication|2|||
16143226|NCT01610687|39014589|FG000|Overall Study|Unable to make journey|1|||
16143227|NCT01610687|39014589|FG000|Overall Study|Death|1|||
16143228|NCT01610687|39014589|FG000|Overall Study|Cannabis affecting job|1|||
16143229|NCT01610687|39014589|FG000|Overall Study|Felt more alter without study medication|1|||
16143230|NCT02717754|39014590|FG000|Overall Study|Incorrect Infusion Duration|0|||
16143231|NCT02717754|39014591|FG001|Overall Study|Incorrect Infusion Duration|0|||
16143232|NCT02717754|39014592|FG002|Overall Study|Incorrect Infusion Duration|0|||
16143233|NCT02717754|39014593|FG003|Overall Study|Incorrect Infusion Duration|10|||
16143234|NCT02717754|39014594|FG004|Overall Study|Incorrect Infusion Duration|20|||
16143235|NCT02717754|39014595|FG005|Overall Study|Incorrect Infusion Duration|20|||
16143236|NCT01829360|39014596|FG000|Overall Study|Protocol Violation|0|||
16143237|NCT01829360|39014597|FG001|Overall Study|Protocol Violation|0|||
16143238|NCT01829360|39014598|FG002|Overall Study|Protocol Violation|1|||
16143239|NCT01829360|39014599|FG003|Overall Study|Protocol Violation|0|||
16143240|NCT01816061|39014600|FG000|Overall Study|Lost to Follow-up|13|||
16143241|NCT01816061|39014601|FG001|Overall Study|Lost to Follow-up|24|||
16256526|NCT02041702|39424054|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
16256527|NCT01062256|39424055|FG000|Overall Study|Adverse Event|1|||
16256528|NCT01062256|39424056|FG001|Overall Study|Adverse Event|0|||
16256529|NCT01062256|39424057|FG002|Overall Study|Adverse Event|0|||
16256530|NCT01062256|39424055|FG000|Overall Study|Withdrawal by Subject|1|||
16256531|NCT01062256|39424056|FG001|Overall Study|Withdrawal by Subject|1|||
16256532|NCT01062256|39424057|FG002|Overall Study|Withdrawal by Subject|1|||
16256533|NCT01062256|39424055|FG000|Overall Study|Ineligible|1|||
16256534|NCT01062256|39424056|FG001|Overall Study|Ineligible|4|||
16256535|NCT01062256|39424057|FG002|Overall Study|Ineligible|3|||
16256536|NCT01062256|39424055|FG000|Overall Study|Administrative|0|||
16256537|NCT01062256|39424056|FG001|Overall Study|Administrative|2|||
16256538|NCT01062256|39424057|FG002|Overall Study|Administrative|0|||
16256539|NCT02193880|39424061|FG000|Overall Study|patients did not collect enough HPC|3|||
16256540|NCT03805438|39424063|FG000|Overall Study|Lack of Efficacy|1|||
16256541|NCT03805438|39424063|FG000|Overall Study|Protocol Violation|1|||
16256542|NCT00813293|39424064|FG000|Overall Study|Intercurrent illness|1|||
16256543|NCT00813293|39424065|FG001|Overall Study|Intercurrent illness|0|||
16256544|NCT00813293|39424064|FG000|Overall Study|Adverse Event|0|||
16256545|NCT00813293|39424065|FG001|Overall Study|Adverse Event|1|||
16364224|NCT02065557|39818244|FG000|Induction Period|Lack of Efficacy|2|||
16256546|NCT00048581|39424075|FG000|Double-Blind Period|Adverse Event|9|||
16256547|NCT00048581|39424076|FG001|Double-Blind Period|Adverse Event|5|||
16256548|NCT00048581|39424077|FG002|Double-Blind Period|Adverse Event|0|||
16364225|NCT02065557|39818245|FG001|Induction Period|Lack of Efficacy|1|||
16143242|NCT01650285|39014602|FG000|Overall Study|Adverse Event|1|||
16143243|NCT02606461|39014607|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
16143244|NCT02606461|39014608|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
16143245|NCT02606461|39014609|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
16143246|NCT02606461|39014610|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
16364226|NCT02065557|39818246|FG002|Induction Period|Lack of Efficacy|1|||
16364227|NCT02065557|39818247|FG003|Induction Period|Lack of Efficacy|0|||
16364228|NCT02065557|39818248|FG004|Induction Period|Lack of Efficacy|0|||
16364229|NCT02065557|39818249|FG005|Induction Period|Lack of Efficacy|0|||
16364230|NCT02065557|39818244|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
16364231|NCT02065557|39818245|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
16364232|NCT02065557|39818246|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
16364233|NCT02065557|39818247|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
16143247|NCT02606461|39014611|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
16143248|NCT02606461|39014612|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
16143249|NCT01438151|39014613|FG000|Overall Study|study terminated|8|||
16143250|NCT01630434|39014614|FG000|Overall Study|Donor lungs turned down|1|||
16143251|NCT01630434|39014615|FG001|Overall Study|Donor lungs turned down|0|||
16143252|NCT01630434|39014614|FG000|Overall Study|Protocol Violation|9|||
16143253|NCT01630434|39014615|FG001|Overall Study|Protocol Violation|4|||
16143254|NCT01630434|39014614|FG000|Overall Study|Death|20|||
16256549|NCT00048581|39424075|FG000|Double-Blind Period|Lack of Efficacy|14|||
16256550|NCT00048581|39424076|FG001|Double-Blind Period|Lack of Efficacy|27|||
16364234|NCT02065557|39818248|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
16143255|NCT01630434|39014615|FG001|Overall Study|Death|26|||
16256551|NCT00048581|39424077|FG002|Double-Blind Period|Lack of Efficacy|0|||
16143256|NCT00873366|39014618|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
16439440|NCT02648204|40089411|FG001|Overall Study|Adverse Event|0|||
16439441|NCT02648204|40089412|FG002|Overall Study|Adverse Event|1|||
16439442|NCT02648204|40089413|FG003|Overall Study|Adverse Event|0|||
16439443|NCT00521079|40089414|FG000|Overall Study|Adverse Event|7|||
16439444|NCT00521079|40089415|FG001|Overall Study|Adverse Event|1|||
16439445|NCT00521079|40089414|FG000|Overall Study|Lost to Follow-up|2|||
16439446|NCT00521079|40089415|FG001|Overall Study|Lost to Follow-up|1|||
16439447|NCT00521079|40089414|FG000|Overall Study|Withdrawal by Subject|5|||
16439448|NCT00521079|40089415|FG001|Overall Study|Withdrawal by Subject|3|||
16439449|NCT03617172|40089417|FG000|Overall Study|Lost to Follow-up|1|||
16439450|NCT03617172|40089418|FG001|Overall Study|Lost to Follow-up|0|||
16439451|NCT03525444|40089419|FG000|Overall Study|Adverse Event|0|||
16439452|NCT03525444|40089420|FG001|Overall Study|Adverse Event|1|||
16439453|NCT03525444|40089419|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
16439454|NCT03525444|40089420|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
16439455|NCT03525444|40089419|FG000|Overall Study|Other|0|||
16439456|NCT03525444|40089420|FG001|Overall Study|Other|1|||
16439457|NCT01342913|40089421|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
16439458|NCT01342913|40089422|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16439459|NCT01342913|40089423|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16439460|NCT01342913|40089421|FG000|2-week Run-in Period|Physician Decision|6|||
16439461|NCT01342913|40089422|FG001|2-week Run-in Period|Physician Decision|0|||
16439462|NCT01342913|40089423|FG002|2-week Run-in Period|Physician Decision|0|||
16439463|NCT01342913|40089421|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
16439464|NCT01342913|40089422|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16439465|NCT01342913|40089423|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16439466|NCT01342913|40089421|FG000|2-week Run-in Period|Adverse Event|2|||
16439467|NCT01342913|40089422|FG001|2-week Run-in Period|Adverse Event|0|||
16439468|NCT01342913|40089423|FG002|2-week Run-in Period|Adverse Event|0|||
16439469|NCT01342913|40089421|FG000|2-week Run-in Period|Protocol Violation|5|||
16439470|NCT01342913|40089422|FG001|2-week Run-in Period|Protocol Violation|0|||
16439471|NCT01342913|40089423|FG002|2-week Run-in Period|Protocol Violation|0|||
16439472|NCT01342913|40089421|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
16143257|NCT00873366|39014618|FG000|Overall Study|Off tamoxifen due to side effects|2|||
16143258|NCT00873366|39014618|FG000|Overall Study|Refused to continue DM-BT testing|3|||
16143259|NCT00798135|39014619|FG000|Overall Study|Disease progression, relapse|11|||
16143260|NCT00798135|39014619|FG000|Overall Study|Disease progression, refractory|1|||
16143261|NCT00798135|39014619|FG000|Overall Study|Physician Decision|1|||
16143262|NCT01050205|39014624|FG000|Overall Study|Lost to Follow-up|7|||
16143263|NCT01050205|39014625|FG001|Overall Study|Lost to Follow-up|1|||
16143264|NCT01050205|39014624|FG000|Overall Study|Withdrawal by Subject|1|||
16143265|NCT01050205|39014625|FG001|Overall Study|Withdrawal by Subject|1|||
16143266|NCT01050205|39014624|FG000|Overall Study|Relocated from area|1|||
16143267|NCT01050205|39014625|FG001|Overall Study|Relocated from area|2|||
16143268|NCT01050205|39014624|FG000|Overall Study|Discontinued Intervention|2|||
16143269|NCT01050205|39014625|FG001|Overall Study|Discontinued Intervention|0|||
16143270|NCT01849497|39014629|FG000|Overall Study|Withdrawal by Subject|1|||
16143271|NCT01849497|39014630|FG001|Overall Study|Withdrawal by Subject|2|||
16143272|NCT01849497|39014629|FG000|Overall Study|Sponsor Decision|0|||
16256552|NCT00048581|39424075|FG000|Double-Blind Period|Lost to Follow-up|5|||
16256553|NCT00048581|39424076|FG001|Double-Blind Period|Lost to Follow-up|0|||
16439473|NCT01342913|40089422|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
16439474|NCT01342913|40089423|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
16439475|NCT01342913|40089421|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16439476|NCT01342913|40089422|FG001|Double-Blind Treatment Period|Adverse Event|3|||
16439477|NCT01342913|40089423|FG002|Double-Blind Treatment Period|Adverse Event|6|||
16143273|NCT01849497|39014630|FG001|Overall Study|Sponsor Decision|1|||
16143274|NCT01849497|39014629|FG000|Overall Study|Lost to Follow-up|0|||
16143275|NCT01849497|39014630|FG001|Overall Study|Lost to Follow-up|1|||
16143276|NCT02982590|39014631|FG000|Overall Study|Lost to Follow-up|0|||
16143277|NCT02982590|39014632|FG001|Overall Study|Lost to Follow-up|1|||
16143278|NCT02982590|39014631|FG000|Overall Study|Death|4|||
16143279|NCT02982590|39014632|FG001|Overall Study|Death|0|||
16143280|NCT00430482|39014633|FG000|Completed Treatment|Insufficient Treatment|7|||
16143281|NCT00430482|39014634|FG001|Completed Treatment|Insufficient Treatment|11|||
16143282|NCT00436618|39014636|FG000|Overall Study|Withdrawal by Subject|5|||
16143283|NCT00436618|39014637|FG001|Overall Study|Withdrawal by Subject|8|||
16143284|NCT00436618|39014638|FG002|Overall Study|Withdrawal by Subject|11|||
16143285|NCT00436618|39014636|FG000|Overall Study|Adverse Event|8|||
16143286|NCT00436618|39014637|FG001|Overall Study|Adverse Event|8|||
16143287|NCT00436618|39014638|FG002|Overall Study|Adverse Event|9|||
16143288|NCT00436618|39014636|FG000|Overall Study|Alternate Treatment|3|||
16143289|NCT00436618|39014637|FG001|Overall Study|Alternate Treatment|4|||
16143290|NCT00436618|39014638|FG002|Overall Study|Alternate Treatment|12|||
16143291|NCT00436618|39014636|FG000|Overall Study|Other Medical Problems|3|||
16143292|NCT00436618|39014637|FG001|Overall Study|Other Medical Problems|1|||
16143293|NCT00436618|39014638|FG002|Overall Study|Other Medical Problems|7|||
16143294|NCT00436618|39014636|FG000|Overall Study|Death|4|||
16143295|NCT00436618|39014637|FG001|Overall Study|Death|2|||
16143296|NCT00436618|39014638|FG002|Overall Study|Death|3|||
16143297|NCT00436618|39014636|FG000|Overall Study|New Primary or Other Reasons|6|||
16143298|NCT00436618|39014637|FG001|Overall Study|New Primary or Other Reasons|2|||
16143299|NCT00436618|39014638|FG002|Overall Study|New Primary or Other Reasons|12|||
16143300|NCT00436618|39014636|FG000|Overall Study|Still on treatment|1|||
16143301|NCT00436618|39014637|FG001|Overall Study|Still on treatment|2|||
16143302|NCT00436618|39014638|FG002|Overall Study|Still on treatment|7|||
16143303|NCT00736034|39014640|FG000|Overall Study|Adverse Event|2|||
16143304|NCT00332839|39014644|FG000|Core (Months 0 - 12)|Administrative problems|1|||
16143305|NCT00332839|39014645|FG001|Core (Months 0 - 12)|Administrative problems|1|||
16143306|NCT00332839|39014644|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
16143307|NCT00332839|39014645|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
16143308|NCT00332839|39014644|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
16143309|NCT00332839|39014645|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
16143310|NCT00332839|39014644|FG000|Core (Months 0 - 12)|Adverse Event|5|||
16143311|NCT00332839|39014645|FG001|Core (Months 0 - 12)|Adverse Event|15|||
16143312|NCT00332839|39014644|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
16143313|NCT00332839|39014645|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
16143314|NCT00332839|39014644|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
16143315|NCT00332839|39014645|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
16143316|NCT00332839|39014644|FG000|Follow-up (Months 12 - 60)|Death|1|||
16143317|NCT00332839|39014645|FG001|Follow-up (Months 12 - 60)|Death|1|||
16143318|NCT01177683|39014646|FG000|Study Treatment|Disease Progressions during treatment|2|||
16143319|NCT01177683|39014647|FG001|Study Treatment|Disease Progressions during treatment|0|||
16143320|NCT01177683|39014648|FG002|Study Treatment|Disease Progressions during treatment|3|||
16143321|NCT01177683|39014646|FG000|Study Treatment|Adverse Event|0|||
16143322|NCT01177683|39014647|FG001|Study Treatment|Adverse Event|1|||
16143323|NCT01177683|39014648|FG002|Study Treatment|Adverse Event|12|||
16143324|NCT01177683|39014646|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
16143325|NCT01177683|39014647|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
16143326|NCT01177683|39014648|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
16143327|NCT01177683|39014646|FG000|Study Treatment|Alternative therapy|0|||
16143328|NCT01177683|39014647|FG001|Study Treatment|Alternative therapy|0|||
16143329|NCT01177683|39014648|FG002|Study Treatment|Alternative therapy|4|||
16143330|NCT01177683|39014646|FG000|Study Treatment|Physician Decision|1|||
16143331|NCT01177683|39014647|FG001|Study Treatment|Physician Decision|0|||
16143332|NCT01177683|39014648|FG002|Study Treatment|Physician Decision|1|||
16143333|NCT01177683|39014646|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
16143334|NCT01177683|39014647|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
16143335|NCT01177683|39014648|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
16364235|NCT02065557|39818249|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
16364236|NCT02065557|39818244|FG000|Induction Period|Non-Responder at Week 8|4|||
16143336|NCT01177683|39014646|FG000|Study Treatment|Symptomatic Deterioration|0|||
16143337|NCT01177683|39014647|FG001|Study Treatment|Symptomatic Deterioration|0|||
16143338|NCT01177683|39014648|FG002|Study Treatment|Symptomatic Deterioration|1|||
16143339|NCT01177683|39014646|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
16143340|NCT01177683|39014647|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
16143341|NCT01177683|39014648|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
16143342|NCT01177683|39014646|FG000|Follow up|Patient lost to follow up|0|||
16143343|NCT01177683|39014647|FG001|Follow up|Patient lost to follow up|0|||
16143344|NCT01177683|39014648|FG002|Follow up|Patient lost to follow up|2|||
16143345|NCT01177683|39014646|FG000|Follow up|Death|2|||
16143346|NCT01177683|39014647|FG001|Follow up|Death|1|||
16143347|NCT01177683|39014648|FG002|Follow up|Death|7|||
16143348|NCT01177683|39014646|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
16256554|NCT00048581|39424077|FG002|Double-Blind Period|Lost to Follow-up|0|||
16256555|NCT00048581|39424075|FG000|Double-Blind Period|Withdrawal by Subject|5|||
16256556|NCT00048581|39424076|FG001|Double-Blind Period|Withdrawal by Subject|2|||
16439478|NCT01342913|40089421|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
16439479|NCT01342913|40089422|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
16439480|NCT01342913|40089423|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
16439481|NCT01342913|40089421|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
16439482|NCT01342913|40089422|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
16439483|NCT01342913|40089423|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
16439484|NCT01342913|40089421|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16256557|NCT00048581|39424077|FG002|Double-Blind Period|Withdrawal by Subject|0|||
16256558|NCT00048581|39424075|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
16439485|NCT01342913|40089422|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
16439486|NCT01342913|40089423|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
16439487|NCT01342913|40089421|FG000|Double-Blind Treatment Period|Physician Decision|0|||
16439488|NCT01342913|40089422|FG001|Double-Blind Treatment Period|Physician Decision|2|||
16439489|NCT01342913|40089423|FG002|Double-Blind Treatment Period|Physician Decision|0|||
16439490|NCT01342913|40089421|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16256559|NCT00048581|39424076|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
16256560|NCT00048581|39424077|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
16256561|NCT00048581|39424075|FG000|Double-Blind Period|Investigator Decision|1|||
16256562|NCT00048581|39424076|FG001|Double-Blind Period|Investigator Decision|0|||
16256563|NCT00048581|39424077|FG002|Double-Blind Period|Investigator Decision|0|||
16256564|NCT00048581|39424075|FG000|Open-Label Period|Death|0|||
16256565|NCT00048581|39424076|FG001|Open-Label Period|Death|0|||
16256566|NCT00048581|39424077|FG002|Open-Label Period|Death|4|||
16256567|NCT00048581|39424075|FG000|Open-Label Period|Adverse Event|0|||
16256568|NCT00048581|39424076|FG001|Open-Label Period|Adverse Event|0|||
16256569|NCT00048581|39424077|FG002|Open-Label Period|Adverse Event|37|||
16439491|NCT01342913|40089422|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
16439492|NCT01342913|40089423|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
16439493|NCT00360230|40089428|FG000|Overall Study|Withdrawal by Subject|1|||
16439494|NCT00360230|40089429|FG001|Overall Study|Withdrawal by Subject|1|||
16439495|NCT00360230|40089430|FG002|Overall Study|Withdrawal by Subject|0|||
16439496|NCT00360230|40089431|FG003|Overall Study|Withdrawal by Subject|1|||
16439497|NCT00360230|40089432|FG004|Overall Study|Withdrawal by Subject|1|||
16439498|NCT00360230|40089433|FG005|Overall Study|Withdrawal by Subject|1|||
16439499|NCT00360230|40089434|FG006|Overall Study|Withdrawal by Subject|0|||
16439500|NCT00360230|40089428|FG000|Overall Study|Migrated|4|||
16439501|NCT00360230|40089429|FG001|Overall Study|Migrated|1|||
16439502|NCT00360230|40089430|FG002|Overall Study|Migrated|3|||
16439503|NCT00360230|40089431|FG003|Overall Study|Migrated|1|||
16439504|NCT00360230|40089432|FG004|Overall Study|Migrated|4|||
16439505|NCT00360230|40089433|FG005|Overall Study|Migrated|1|||
16256570|NCT00048581|39424075|FG000|Open-Label Period|Lack of Efficacy|0|||
16256571|NCT00048581|39424076|FG001|Open-Label Period|Lack of Efficacy|0|||
16256572|NCT00048581|39424077|FG002|Open-Label Period|Lack of Efficacy|69|||
16143349|NCT01177683|39014647|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
16143350|NCT01177683|39014648|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
16143351|NCT03805750|39014649|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
16143352|NCT03805750|39014650|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
16143353|NCT00590044|39014651|FG000|Overall Study|Withdrawal by Subject|2|||
16143354|NCT00590044|39014652|FG001|Overall Study|Withdrawal by Subject|2|||
16143355|NCT00590044|39014651|FG000|Overall Study|wrong insulin arm assigned|1|||
16143356|NCT00590044|39014652|FG001|Overall Study|wrong insulin arm assigned|0|||
16143357|NCT00590044|39014651|FG000|Overall Study|Protocol Violation|1|||
16143358|NCT00590044|39014652|FG001|Overall Study|Protocol Violation|0|||
16143359|NCT00860951|39014655|FG000|Overall Study|Withdrawal by Subject|2|||
16143360|NCT00860951|39014655|FG000|Overall Study|Lost to Follow-up|5|||
16143361|NCT03047551|39014667|FG000|Overall Study|Did not receive TAS|1|||
16439506|NCT00360230|40089434|FG006|Overall Study|Migrated|1|||
16256573|NCT00048581|39424075|FG000|Open-Label Period|Lost to Follow-up|0|||
16256574|NCT00048581|39424076|FG001|Open-Label Period|Lost to Follow-up|0|||
16256575|NCT00048581|39424077|FG002|Open-Label Period|Lost to Follow-up|14|||
16256576|NCT00048581|39424075|FG000|Open-Label Period|Withdrawal by Subject|0|||
16256577|NCT00048581|39424076|FG001|Open-Label Period|Withdrawal by Subject|0|||
16256578|NCT00048581|39424077|FG002|Open-Label Period|Withdrawal by Subject|20|||
16256579|NCT00048581|39424075|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
16256580|NCT00048581|39424076|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
16256581|NCT00048581|39424077|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
16256582|NCT00048581|39424075|FG000|Open-Label Period|Poor/Non-compliance|0|||
16256583|NCT00048581|39424076|FG001|Open-Label Period|Poor/Non-compliance|0|||
16256584|NCT00048581|39424077|FG002|Open-Label Period|Poor/Non-compliance|5|||
16256585|NCT00048581|39424075|FG000|Open-Label Period|Pregnancy|0|||
16256586|NCT00048581|39424076|FG001|Open-Label Period|Pregnancy|0|||
16256587|NCT00048581|39424077|FG002|Open-Label Period|Pregnancy|7|||
16256588|NCT00048581|39424075|FG000|Open-Label Period|Study Site Closure|0|||
16256589|NCT00048581|39424076|FG001|Open-Label Period|Study Site Closure|0|||
16256590|NCT00048581|39424077|FG002|Open-Label Period|Study Site Closure|2|||
16256591|NCT00048581|39424075|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
16256592|NCT00048581|39424076|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
16256593|NCT00048581|39424077|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
16256594|NCT00048581|39424075|FG000|Open-Label Period|Problem With Transportation To Site|0|||
16256595|NCT00048581|39424076|FG001|Open-Label Period|Problem With Transportation To Site|0|||
16256596|NCT00048581|39424077|FG002|Open-Label Period|Problem With Transportation To Site|1|||
16256597|NCT00048581|39424075|FG000|Open-Label Period|Primary Investigator Retired|0|||
16256598|NCT00048581|39424076|FG001|Open-Label Period|Primary Investigator Retired|0|||
16256599|NCT00048581|39424077|FG002|Open-Label Period|Primary Investigator Retired|2|||
16256600|NCT00048581|39424075|FG000|Open-Label Period|Study Ended By Sponsor|0|||
16256601|NCT00048581|39424076|FG001|Open-Label Period|Study Ended By Sponsor|0|||
16256602|NCT00048581|39424077|FG002|Open-Label Period|Study Ended By Sponsor|1|||
16256603|NCT00684671|39424078|FG000|Overall Study|Adverse Event|1|||
16256604|NCT00684671|39424079|FG001|Overall Study|Adverse Event|0|||
16256605|NCT00684671|39424080|FG002|Overall Study|Adverse Event|0|||
16256606|NCT00684671|39424078|FG000|Overall Study|Lost to Follow-up|1|||
16256607|NCT00684671|39424079|FG001|Overall Study|Lost to Follow-up|0|||
16256608|NCT00684671|39424080|FG002|Overall Study|Lost to Follow-up|0|||
16256609|NCT00684671|39424078|FG000|Overall Study|Alcoholic dependance|1|||
16256610|NCT00684671|39424079|FG001|Overall Study|Alcoholic dependance|0|||
16256611|NCT00684671|39424080|FG002|Overall Study|Alcoholic dependance|0|||
16256612|NCT00615069|39424081|FG000|Overall Study|Death|10|||
16256613|NCT00615069|39424081|FG000|Overall Study|Physician Decision|2|||
16256614|NCT00615069|39424081|FG000|Overall Study|Withdrawal by Subject|4|||
16256615|NCT02097290|39424082|FG000|Overall Study|Death|6|||
16256616|NCT02097290|39424082|FG000|Overall Study|Total Withdrawals|3|||
16439507|NCT00360230|40089428|FG000|Overall Study|Other|1|||
16143362|NCT03047551|39014668|FG001|Overall Study|Did not receive TAS|0|||
16439508|NCT00360230|40089429|FG001|Overall Study|Other|0|||
16439509|NCT00360230|40089430|FG002|Overall Study|Other|0|||
16143363|NCT03047551|39014667|FG000|Overall Study|Physician Decision|1|||
16143364|NCT03047551|39014668|FG001|Overall Study|Physician Decision|0|||
16143365|NCT03047551|39014667|FG000|Overall Study|Withdrawal by Subject|0|||
16143366|NCT03047551|39014668|FG001|Overall Study|Withdrawal by Subject|1|||
16143367|NCT03047551|39014667|FG000|Overall Study|Probe malfunction|0|||
16256617|NCT02097290|39424082|FG000|Overall Study|Attempt|8|||
16256618|NCT00352690|39424087|FG000|Overall Study|Determined to be ineligible|2|||
16256619|NCT00352690|39424088|FG001|Overall Study|Determined to be ineligible|0|||
16256620|NCT00462982|39424089|FG000|Overall Study|Adverse Event|1|||
16256621|NCT00462982|39424089|FG000|Overall Study|Patient Not Treated|2|||
16256622|NCT02720510|39424092|FG000|Overall Study|Study Terminated by the sponsor|2|||
16439510|NCT00360230|40089431|FG003|Overall Study|Other|0|||
16143368|NCT03047551|39014668|FG001|Overall Study|Probe malfunction|1|||
16256623|NCT02720510|39424093|FG001|Overall Study|Study Terminated by the sponsor|0|||
16256624|NCT02720510|39424092|FG000|Overall Study|Adverse Event|0|||
16256625|NCT02720510|39424093|FG001|Overall Study|Adverse Event|1|||
16256626|NCT02720510|39424092|FG000|Overall Study|Physician Decision|1|||
16256627|NCT02720510|39424093|FG001|Overall Study|Physician Decision|2|||
16256628|NCT00880568|39424107|FG000|Overall Study|Disease progression|3|||
16256629|NCT00880568|39424108|FG001|Overall Study|Disease progression|3|||
16256630|NCT00880568|39424109|FG002|Overall Study|Disease progression|3|||
16256631|NCT00880568|39424110|FG003|Overall Study|Disease progression|1|||
16256632|NCT00880568|39424111|FG004|Overall Study|Disease progression|3|||
16256633|NCT00880568|39424112|FG005|Overall Study|Disease progression|3|||
16256634|NCT00880568|39424113|FG006|Overall Study|Disease progression|5|||
16256635|NCT00880568|39424114|FG007|Overall Study|Disease progression|0|||
16256636|NCT00880568|39424115|FG008|Overall Study|Disease progression|3|||
16256637|NCT00880568|39424107|FG000|Overall Study|Adverse Event|0|||
16256638|NCT00880568|39424108|FG001|Overall Study|Adverse Event|0|||
16256639|NCT00880568|39424109|FG002|Overall Study|Adverse Event|0|||
16439511|NCT00360230|40089432|FG004|Overall Study|Other|0|||
16439512|NCT00360230|40089433|FG005|Overall Study|Other|0|||
16439513|NCT00360230|40089434|FG006|Overall Study|Other|0|||
16439514|NCT00360230|40089428|FG000|Overall Study|Protocol Violation|0|||
16439515|NCT00360230|40089429|FG001|Overall Study|Protocol Violation|0|||
16439516|NCT00360230|40089430|FG002|Overall Study|Protocol Violation|0|||
16439517|NCT00360230|40089431|FG003|Overall Study|Protocol Violation|0|||
16439518|NCT00360230|40089432|FG004|Overall Study|Protocol Violation|0|||
16439519|NCT00360230|40089433|FG005|Overall Study|Protocol Violation|1|||
16439520|NCT00360230|40089434|FG006|Overall Study|Protocol Violation|0|||
16439521|NCT00360230|40089428|FG000|Overall Study|Death|0|||
16439522|NCT00360230|40089429|FG001|Overall Study|Death|1|||
16439523|NCT00360230|40089430|FG002|Overall Study|Death|0|||
16439524|NCT00360230|40089431|FG003|Overall Study|Death|0|||
16439525|NCT00360230|40089432|FG004|Overall Study|Death|0|||
16256640|NCT00880568|39424110|FG003|Overall Study|Adverse Event|0|||
16256641|NCT00880568|39424111|FG004|Overall Study|Adverse Event|0|||
16256642|NCT00880568|39424112|FG005|Overall Study|Adverse Event|0|||
16256643|NCT00880568|39424113|FG006|Overall Study|Adverse Event|1|||
16439526|NCT00360230|40089433|FG005|Overall Study|Death|1|||
16439527|NCT00360230|40089434|FG006|Overall Study|Death|1|||
16439528|NCT02336282|40089439|FG000|Overall Study|Unrelated illness|1|||
16439529|NCT02336282|40089439|FG000|Overall Study|Uncomfortable with technology|1|||
16256644|NCT00880568|39424114|FG007|Overall Study|Adverse Event|1|||
16256645|NCT00880568|39424115|FG008|Overall Study|Adverse Event|0|||
16256646|NCT00880568|39424107|FG000|Overall Study|Withdrawal by Subject|0|||
16256647|NCT00880568|39424108|FG001|Overall Study|Withdrawal by Subject|0|||
16439530|NCT02336282|40089439|FG000|Overall Study|Lost to Follow-up|1|||
16439531|NCT02336282|40089439|FG000|Overall Study|Not enough time to complete sessions|2|||
16439532|NCT00762359|40089440|FG000|Overall Study|Adverse Event|20|||
16439533|NCT00762359|40089441|FG001|Overall Study|Adverse Event|23|||
16439534|NCT00762359|40089440|FG000|Overall Study|Protocol Violation|21|||
16439535|NCT00762359|40089441|FG001|Overall Study|Protocol Violation|13|||
16439536|NCT00762359|40089440|FG000|Overall Study|Withdrawal by Subject|13|||
16439537|NCT00762359|40089441|FG001|Overall Study|Withdrawal by Subject|10|||
16439538|NCT00762359|40089440|FG000|Overall Study|Lack of Efficacy|0|||
16439539|NCT00762359|40089441|FG001|Overall Study|Lack of Efficacy|4|||
16439540|NCT00762359|40089440|FG000|Overall Study|Institution closed|2|||
16439541|NCT00762359|40089441|FG001|Overall Study|Institution closed|3|||
16439542|NCT00762359|40089440|FG000|Overall Study|Physician Decision|2|||
16439543|NCT00762359|40089441|FG001|Overall Study|Physician Decision|3|||
16439544|NCT00762359|40089440|FG000|Overall Study|Removal|0|||
16439545|NCT00762359|40089441|FG001|Overall Study|Removal|1|||
16439546|NCT00762359|40089440|FG000|Overall Study|Withdrew consent|1|||
16439547|NCT00762359|40089441|FG001|Overall Study|Withdrew consent|0|||
16439548|NCT01217944|40089442|FG000|Overall Study|Protocol Violation|1|||
16439549|NCT01217944|40089443|FG001|Overall Study|Protocol Violation|1|||
16439550|NCT01217944|40089444|FG002|Overall Study|Protocol Violation|0|||
16439551|NCT01217944|40089442|FG000|Overall Study|Lost to Follow-up|3|||
16439552|NCT01217944|40089443|FG001|Overall Study|Lost to Follow-up|1|||
16439553|NCT01217944|40089444|FG002|Overall Study|Lost to Follow-up|0|||
16439554|NCT01217944|40089442|FG000|Overall Study|Withdrawal by Subject|1|||
16439555|NCT01217944|40089443|FG001|Overall Study|Withdrawal by Subject|2|||
16439556|NCT01217944|40089444|FG002|Overall Study|Withdrawal by Subject|0|||
16439557|NCT01217944|40089442|FG000|Overall Study|Lack of Efficacy|1|||
16439558|NCT01217944|40089443|FG001|Overall Study|Lack of Efficacy|0|||
16439559|NCT01217944|40089444|FG002|Overall Study|Lack of Efficacy|0|||
16439560|NCT00581308|40089445|FG000|Pre Discharge|Lost to Follow-up|1|||
16439561|NCT00581308|40089445|FG000|Pre Discharge|Device Removed|1|||
16439562|NCT00581308|40089445|FG000|Month 1|Lost to Follow-up|3|||
16439563|NCT00581308|40089445|FG000|Month 1|Withdrawal by Subject|2|||
16439564|NCT00581308|40089445|FG000|Month 1|Device Removed|2|||
16439565|NCT00581308|40089445|FG000|Month 1|Uknown|1|||
16439566|NCT00581308|40089445|FG000|Month 6|Lost to Follow-up|1|||
16439567|NCT00581308|40089445|FG000|Month 6|Withdrawal by Subject|2|||
16439568|NCT00581308|40089445|FG000|Month 12|Death|1|||
16439569|NCT00581308|40089445|FG000|Month 12|Lost to Follow-up|14|||
16439570|NCT00581308|40089445|FG000|Month 12|Withdrawal by Subject|3|||
16439571|NCT00581308|40089445|FG000|Month 12|Device Removed|1|||
16439572|NCT00581308|40089445|FG000|Month 12|Other|1|||
16439573|NCT01381016|40089454|FG000|Overall Study|Lost to Follow-up|1|||
16439574|NCT01381016|40089455|FG001|Overall Study|Lost to Follow-up|1|||
16439575|NCT01381016|40089454|FG000|Overall Study|Screen Failure|2|||
16439576|NCT01381016|40089455|FG001|Overall Study|Screen Failure|2|||
16439577|NCT01381016|40089454|FG000|Overall Study|Withdrawal by Subject|0|||
16439578|NCT01381016|40089455|FG001|Overall Study|Withdrawal by Subject|1|||
16439579|NCT01381016|40089454|FG000|Overall Study|Physician Decision|0|||
16439580|NCT01381016|40089455|FG001|Overall Study|Physician Decision|2|||
16439581|NCT01345240|40089456|FG000|Overall Study|Adverse Event|3|||
16439582|NCT01345240|40089457|FG001|Overall Study|Adverse Event|5|||
16439583|NCT01345240|40089458|FG002|Overall Study|Adverse Event|4|||
16439584|NCT01345240|40089459|FG003|Overall Study|Adverse Event|2|||
16439585|NCT01345240|40089460|FG004|Overall Study|Adverse Event|1|||
16439586|NCT01345240|40089456|FG000|Overall Study|Lost to Follow-up|8|||
16439587|NCT01345240|40089457|FG001|Overall Study|Lost to Follow-up|9|||
16256648|NCT00880568|39424109|FG002|Overall Study|Withdrawal by Subject|0|||
16256649|NCT00880568|39424110|FG003|Overall Study|Withdrawal by Subject|0|||
16256650|NCT00880568|39424111|FG004|Overall Study|Withdrawal by Subject|0|||
16256651|NCT00880568|39424112|FG005|Overall Study|Withdrawal by Subject|0|||
16256652|NCT00880568|39424113|FG006|Overall Study|Withdrawal by Subject|0|||
16256653|NCT00880568|39424114|FG007|Overall Study|Withdrawal by Subject|1|||
16256654|NCT00880568|39424115|FG008|Overall Study|Withdrawal by Subject|0|||
16256655|NCT00527423|39424116|FG000|Overall Study|Protocol Violation|1|||
16256656|NCT00527423|39424116|FG000|Overall Study|Adverse Event|5|||
16256657|NCT00527423|39424116|FG000|Overall Study|Physician Decision|4|||
16256658|NCT00527423|39424116|FG000|Overall Study|Withdrawal by Subject|10|||
16256659|NCT00527423|39424116|FG000|Overall Study|Lost to Follow-up|4|||
16256660|NCT00527423|39424116|FG000|Overall Study|OTHER|4|||
16256661|NCT00527423|39424116|FG000|Overall Study|Death|9|||
16256662|NCT02154529|39424117|FG000|Overall Study|Death|1|||
16256663|NCT02154529|39424118|FG001|Overall Study|Death|1|||
16256664|NCT02154529|39424119|FG002|Overall Study|Death|5|||
16256665|NCT02154529|39424120|FG003|Overall Study|Death|1|||
16256666|NCT02154529|39424117|FG000|Overall Study|Termination of study by sponsor|2|||
16256667|NCT02154529|39424118|FG001|Overall Study|Termination of study by sponsor|2|||
16256668|NCT02154529|39424119|FG002|Overall Study|Termination of study by sponsor|3|||
16256669|NCT02154529|39424120|FG003|Overall Study|Termination of study by sponsor|1|||
16256670|NCT02154529|39424117|FG000|Overall Study|Lost to Follow-up|1|||
16256671|NCT02154529|39424118|FG001|Overall Study|Lost to Follow-up|0|||
16256672|NCT02154529|39424119|FG002|Overall Study|Lost to Follow-up|0|||
16256673|NCT02154529|39424120|FG003|Overall Study|Lost to Follow-up|0|||
16256674|NCT00788125|39424121|FG000|Overall Study|Death|6|||
16256675|NCT02359890|39424131|FG000|Overall Study|Not meeting eligibility|4|||
16256676|NCT02359890|39424131|FG000|Overall Study|Never treated with study catheter|6|||
16256677|NCT01256684|39424135|FG000|Overall Study|Adverse Event|1|||
16256678|NCT01256684|39424136|FG001|Overall Study|Adverse Event|4|||
16256679|NCT01256684|39424137|FG002|Overall Study|Adverse Event|2|||
16256680|NCT01256684|39424135|FG000|Overall Study|Withdrawal by Subject|4|||
16256681|NCT01256684|39424136|FG001|Overall Study|Withdrawal by Subject|0|||
16256682|NCT01256684|39424137|FG002|Overall Study|Withdrawal by Subject|2|||
16256683|NCT01256684|39424135|FG000|Overall Study|Physician Decision|0|||
16256684|NCT01256684|39424136|FG001|Overall Study|Physician Decision|1|||
16256685|NCT01256684|39424137|FG002|Overall Study|Physician Decision|0|||
16256686|NCT01256684|39424135|FG000|Overall Study|Lack of Efficacy|0|||
16256687|NCT01256684|39424136|FG001|Overall Study|Lack of Efficacy|1|||
16256688|NCT01256684|39424137|FG002|Overall Study|Lack of Efficacy|1|||
16256689|NCT01256684|39424135|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
16256690|NCT01256684|39424136|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
16256691|NCT01256684|39424137|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
16256692|NCT01124149|39424140|FG000|Acute Phase|Withdrawal by Subject|22|||
16256693|NCT01124149|39424140|FG000|Acute Phase|Adverse Event|21|||
16256694|NCT01124149|39424140|FG000|Acute Phase|Lack of Efficacy|17|||
16256695|NCT01124149|39424140|FG000|Acute Phase|Protocol Violation|14|||
16256696|NCT01124149|39424140|FG000|Acute Phase|Lost to Follow-up|2|||
16256697|NCT01124149|39424140|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
16256698|NCT01124149|39424140|FG000|Acute Phase|Sponsor request|1|||
16256699|NCT01124149|39424140|FG000|Acute Phase|UC symptoms not ameliorated|1|||
16256700|NCT01124149|39424140|FG000|Acute Phase|Non-compliance|1|||
16256701|NCT01124149|39424140|FG000|Acute Phase|Low hemoglobin|1|||
16256702|NCT01124149|39424140|FG000|Acute Phase|Travelling to another country|1|||
16256703|NCT01124149|39424140|FG000|Acute Phase|Sponsor decision|1|||
16256704|NCT01124149|39424140|FG000|Maintenance Phase|Lack of Efficacy|40|||
16256705|NCT01124149|39424140|FG000|Maintenance Phase|Adverse Event|24|||
16256706|NCT01124149|39424140|FG000|Maintenance Phase|Lost to Follow-up|15|||
16256707|NCT01124149|39424140|FG000|Maintenance Phase|Withdrawal by Subject|10|||
16256708|NCT01124149|39424140|FG000|Maintenance Phase|Protocol Violation|5|||
16256709|NCT01124149|39424140|FG000|Maintenance Phase|Coordinator error|1|||
16256710|NCT01124149|39424140|FG000|Maintenance Phase|Non-compliance|1|||
16256711|NCT02016170|39424147|FG000|Overall Study|Adverse Event|1|||
16256712|NCT02016170|39424148|FG001|Overall Study|Adverse Event|1|||
16256713|NCT02016170|39424149|FG002|Overall Study|Adverse Event|0|||
16256714|NCT02016170|39424147|FG000|Overall Study|Protocol Violation|1|||
16256715|NCT02016170|39424148|FG001|Overall Study|Protocol Violation|0|||
16256716|NCT02016170|39424149|FG002|Overall Study|Protocol Violation|0|||
16256717|NCT03450070|39424162|FG000|Overall Study|Withdrawal by Subject|8|||
16256718|NCT00920140|39424164|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
16256719|NCT00920140|39424165|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
16256720|NCT00920140|39424166|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
16256721|NCT00920140|39424167|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
16256722|NCT00920140|39424168|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
16256723|NCT00920140|39424164|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
16256724|NCT00920140|39424165|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
16256725|NCT00920140|39424166|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
16439588|NCT01345240|40089458|FG002|Overall Study|Lost to Follow-up|14|||
16439589|NCT01345240|40089459|FG003|Overall Study|Lost to Follow-up|7|||
16439590|NCT01345240|40089460|FG004|Overall Study|Lost to Follow-up|9|||
16439591|NCT01746368|40089464|FG000|Overall Study|Lost to Follow-up|2|||
16143369|NCT03047551|39014667|FG000|Overall Study|Ineligible|0|||
16143370|NCT03047551|39014668|FG001|Overall Study|Ineligible|1|||
16143371|NCT01961349|39014671|FG000|Overall Study|Withdrawal by Subject|1|||
16143372|NCT01961349|39014672|FG001|Overall Study|Withdrawal by Subject|4|||
16143373|NCT01961349|39014673|FG002|Overall Study|Withdrawal by Subject|0|||
16143374|NCT01961349|39014671|FG000|Overall Study|Adverse Event|0|||
16143375|NCT01961349|39014672|FG001|Overall Study|Adverse Event|0|||
16143376|NCT01961349|39014673|FG002|Overall Study|Adverse Event|1|||
16143377|NCT01961349|39014671|FG000|Overall Study|registration error, personal reason etc|2|||
16143378|NCT01961349|39014672|FG001|Overall Study|registration error, personal reason etc|2|||
16143379|NCT01961349|39014673|FG002|Overall Study|registration error, personal reason etc|1|||
16143380|NCT00529451|39014674|FG000|Overall Study|Subject withdrew consent|16|||
16143381|NCT00529451|39014675|FG001|Overall Study|Subject withdrew consent|21|||
16143382|NCT00529451|39014676|FG002|Overall Study|Subject withdrew consent|13|||
16143383|NCT00529451|39014677|FG003|Overall Study|Subject withdrew consent|12|||
16143384|NCT00529451|39014674|FG000|Overall Study|Adverse Event|9|||
16143385|NCT00529451|39014675|FG001|Overall Study|Adverse Event|16|||
16143386|NCT00529451|39014676|FG002|Overall Study|Adverse Event|14|||
16143387|NCT00529451|39014677|FG003|Overall Study|Adverse Event|8|||
16143388|NCT00529451|39014674|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
16439592|NCT01746368|40089465|FG001|Overall Study|Lost to Follow-up|0|||
16439593|NCT01746368|40089464|FG000|Overall Study|Withdrawal by Subject|0|||
16439594|NCT01746368|40089465|FG001|Overall Study|Withdrawal by Subject|1|||
16439595|NCT00107653|40089466|FG000|Overall Study|Adverse Event|24|||
16439596|NCT00107653|40089467|FG001|Overall Study|Adverse Event|43|||
16439597|NCT00107653|40089466|FG000|Overall Study|Insufficient Therapeutic Response|25|||
16439598|NCT00107653|40089467|FG001|Overall Study|Insufficient Therapeutic Response|11|||
16439599|NCT00107653|40089466|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
16439600|NCT00107653|40089467|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
16439601|NCT00107653|40089466|FG000|Overall Study|Protocol Violation|1|||
16439602|NCT00107653|40089467|FG001|Overall Study|Protocol Violation|0|||
16439603|NCT00107653|40089466|FG000|Overall Study|Withdrawal by Subject|12|||
16439604|NCT00107653|40089467|FG001|Overall Study|Withdrawal by Subject|13|||
16439605|NCT00107653|40089466|FG000|Overall Study|Lost to Follow-up|13|||
16439606|NCT00107653|40089467|FG001|Overall Study|Lost to Follow-up|5|||
16439607|NCT00107653|40089466|FG000|Overall Study|Administrative Reasons|3|||
16439608|NCT00107653|40089467|FG001|Overall Study|Administrative Reasons|3|||
16439609|NCT00062439|40089474|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
16439610|NCT00062439|40089474|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
16439611|NCT00062439|40089474|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
16439612|NCT00062439|40089474|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
16439613|NCT00062439|40089474|FG000|Post Chemoradiation Assessment|Death|1|||
16439614|NCT00062439|40089474|FG000|Post Chemoradiation Assessment|Disease progression|2|||
16439615|NCT00062439|40089474|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
16439616|NCT00062439|40089474|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
16439617|NCT00062439|40089474|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
16439618|NCT00062439|40089474|FG000|Surgery|Physician Decision|4|||
16439619|NCT00062439|40089474|FG000|Surgery|Death|1|||
16439620|NCT00062439|40089474|FG000|Surgery|Adverse Event|2|||
16143389|NCT00529451|39014675|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
16143390|NCT00529451|39014676|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
16143391|NCT00529451|39014677|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
16143392|NCT00529451|39014674|FG000|Overall Study|Lost to Follow-up|4|||
16143393|NCT00529451|39014675|FG001|Overall Study|Lost to Follow-up|7|||
16143394|NCT00529451|39014676|FG002|Overall Study|Lost to Follow-up|4|||
16143395|NCT00529451|39014677|FG003|Overall Study|Lost to Follow-up|4|||
16143396|NCT00529451|39014674|FG000|Overall Study|Protocol deviation|1|||
16256726|NCT00920140|39424167|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
16256727|NCT00920140|39424168|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
16256728|NCT00920140|39424164|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
16143397|NCT00529451|39014675|FG001|Overall Study|Protocol deviation|1|||
16143398|NCT00529451|39014676|FG002|Overall Study|Protocol deviation|4|||
16143399|NCT00529451|39014677|FG003|Overall Study|Protocol deviation|1|||
16143400|NCT00529451|39014674|FG000|Overall Study|Administrative problems|1|||
16143401|NCT00529451|39014675|FG001|Overall Study|Administrative problems|1|||
16143402|NCT00529451|39014676|FG002|Overall Study|Administrative problems|0|||
16439621|NCT00062439|40089474|FG000|Consolidation Chemotherapy|Adverse Event|2|||
16439622|NCT05482308|40089475|FG000|Overall Study|Withdrawal by Subject|1|||
16439623|NCT05482308|40089476|FG001|Overall Study|Withdrawal by Subject|0|||
16439624|NCT05482308|40089475|FG000|Overall Study|No longer meets eligibility criteria|0|||
16439625|NCT05482308|40089476|FG001|Overall Study|No longer meets eligibility criteria|1|||
16143403|NCT00529451|39014677|FG003|Overall Study|Administrative problems|2|||
16143404|NCT00482703|39014680|FG000|Overall Study|Poor compliance|1|||
16143405|NCT00482703|39014681|FG001|Overall Study|Poor compliance|0|||
16143406|NCT03974334|39014682|FG000|Overall Study|Lost to Follow-up|1|||
16143407|NCT02252536|39014683|FG000|Overall Study|Lost to Follow-up|5|||
16143408|NCT02252536|39014684|FG001|Overall Study|Lost to Follow-up|3|||
16143409|NCT00418665|39014685|FG000|Treatment Period|Ineligibility determined|1|||
16143410|NCT00418665|39014686|FG001|Treatment Period|Ineligibility determined|1|||
16143411|NCT00418665|39014687|FG002|Treatment Period|Ineligibility determined|0|||
16143412|NCT00418665|39014685|FG000|Treatment Period|Adverse Event|2|||
16143413|NCT00418665|39014686|FG001|Treatment Period|Adverse Event|2|||
16143414|NCT00418665|39014687|FG002|Treatment Period|Adverse Event|0|||
16143415|NCT00418665|39014685|FG000|Treatment Period|Withdrawal by Subject|0|||
16143416|NCT00418665|39014686|FG001|Treatment Period|Withdrawal by Subject|3|||
16143417|NCT00418665|39014687|FG002|Treatment Period|Withdrawal by Subject|1|||
16143418|NCT00418665|39014685|FG000|Treatment Period|Requirement for alternative therapy|1|||
16143419|NCT00418665|39014686|FG001|Treatment Period|Requirement for alternative therapy|0|||
16143420|NCT00418665|39014687|FG002|Treatment Period|Requirement for alternative therapy|0|||
16143421|NCT00418665|39014685|FG000|Treatment Period|Physician Decision|1|||
16143422|NCT00418665|39014686|FG001|Treatment Period|Physician Decision|0|||
16143423|NCT00418665|39014687|FG002|Treatment Period|Physician Decision|3|||
16143424|NCT00418665|39014685|FG000|Treatment Extension|Adverse Event|1|||
16143425|NCT00418665|39014686|FG001|Treatment Extension|Adverse Event|0|||
16143426|NCT00418665|39014687|FG002|Treatment Extension|Adverse Event|0|||
16143427|NCT00418665|39014685|FG000|Treatment Extension|Withdrawal by Subject|1|||
16143428|NCT00418665|39014686|FG001|Treatment Extension|Withdrawal by Subject|0|||
16143429|NCT00418665|39014687|FG002|Treatment Extension|Withdrawal by Subject|0|||
16143430|NCT00418665|39014685|FG000|Treatment Extension|Requirement for alternative therapy|2|||
16143431|NCT00418665|39014686|FG001|Treatment Extension|Requirement for alternative therapy|2|||
16143432|NCT00418665|39014687|FG002|Treatment Extension|Requirement for alternative therapy|0|||
16143433|NCT00418665|39014685|FG000|Treatment Extension|Physician Decision|2|||
16143434|NCT00418665|39014686|FG001|Treatment Extension|Physician Decision|2|||
16143435|NCT00418665|39014687|FG002|Treatment Extension|Physician Decision|1|||
16143436|NCT00418665|39014685|FG000|Treatment Extension|Death|0|||
16143437|NCT00418665|39014686|FG001|Treatment Extension|Death|0|||
16143438|NCT00418665|39014687|FG002|Treatment Extension|Death|1|||
16143439|NCT00146757|39014694|FG000|Overall Study|Death|1|||
16143440|NCT00146757|39014695|FG001|Overall Study|Death|0|||
16143441|NCT00146757|39014694|FG000|Overall Study|Adverse Event|1|||
16143442|NCT00146757|39014695|FG001|Overall Study|Adverse Event|0|||
16143443|NCT03083847|39014698|FG000|Main|Physician Decision|0|||
16143444|NCT03083847|39014699|FG001|Main|Physician Decision|0|||
16143445|NCT03083847|39014700|FG002|Main|Physician Decision|0|||
16143446|NCT03083847|39014701|FG003|Main|Physician Decision|0|||
16143447|NCT03083847|39014702|FG004|Main|Physician Decision|0|||
16143448|NCT03083847|39014703|FG005|Main|Physician Decision|1|||
16143449|NCT03083847|39014704|FG006|Main|Physician Decision|0|||
16143450|NCT03083847|39014705|FG007|Main|Physician Decision|0|||
16143451|NCT03083847|39014706|FG008|Main|Physician Decision|0|||
16143452|NCT03083847|39014707|FG009|Main|Physician Decision|0|||
16143453|NCT03083847|39014698|FG000|Main|Pregnancy|0|||
16143454|NCT03083847|39014699|FG001|Main|Pregnancy|0|||
16143455|NCT03083847|39014700|FG002|Main|Pregnancy|0|||
16143456|NCT03083847|39014701|FG003|Main|Pregnancy|0|||
16143457|NCT03083847|39014702|FG004|Main|Pregnancy|0|||
16143458|NCT03083847|39014703|FG005|Main|Pregnancy|0|||
16143459|NCT03083847|39014704|FG006|Main|Pregnancy|0|||
16143460|NCT03083847|39014705|FG007|Main|Pregnancy|1|||
16143461|NCT03083847|39014706|FG008|Main|Pregnancy|0|||
16256729|NCT00920140|39424165|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
16143462|NCT03083847|39014707|FG009|Main|Pregnancy|0|||
16143463|NCT03083847|39014698|FG000|Main|Adverse Event|0|||
16364237|NCT02065557|39818245|FG001|Induction Period|Non-Responder at Week 8|4|||
16143464|NCT03083847|39014699|FG001|Main|Adverse Event|0|||
16143465|NCT03083847|39014700|FG002|Main|Adverse Event|0|||
16143466|NCT03083847|39014701|FG003|Main|Adverse Event|0|||
16143467|NCT03083847|39014702|FG004|Main|Adverse Event|0|||
16143468|NCT03083847|39014703|FG005|Main|Adverse Event|0|||
16143469|NCT03083847|39014704|FG006|Main|Adverse Event|0|||
16143470|NCT03083847|39014705|FG007|Main|Adverse Event|2|||
16143471|NCT03083847|39014706|FG008|Main|Adverse Event|0|||
16143472|NCT03083847|39014707|FG009|Main|Adverse Event|0|||
16143473|NCT03083847|39014698|FG000|Main|Withdrawal by Subject|0|||
16143474|NCT03083847|39014699|FG001|Main|Withdrawal by Subject|0|||
16143475|NCT03083847|39014700|FG002|Main|Withdrawal by Subject|0|||
16143476|NCT03083847|39014701|FG003|Main|Withdrawal by Subject|0|||
16143477|NCT03083847|39014702|FG004|Main|Withdrawal by Subject|0|||
16143478|NCT03083847|39014703|FG005|Main|Withdrawal by Subject|0|||
16143479|NCT03083847|39014704|FG006|Main|Withdrawal by Subject|1|||
16364238|NCT02065557|39818246|FG002|Induction Period|Non-Responder at Week 8|0|||
16364239|NCT02065557|39818247|FG003|Induction Period|Non-Responder at Week 8|0|||
16364240|NCT02065557|39818248|FG004|Induction Period|Non-Responder at Week 8|0|||
16143480|NCT03083847|39014705|FG007|Main|Withdrawal by Subject|1|||
16143481|NCT03083847|39014706|FG008|Main|Withdrawal by Subject|0|||
16143482|NCT03083847|39014707|FG009|Main|Withdrawal by Subject|0|||
16143483|NCT04498169|39014710|FG000|Study Completion|Adverse Event|1|||
16143484|NCT04498169|39014711|FG001|Study Completion|Adverse Event|1|||
16143485|NCT00851682|39014712|FG000|Overall Study|screen failure|5|||
16143486|NCT00851682|39014713|FG001|Overall Study|screen failure|0|||
16143487|NCT02090413|39014718|FG000|Overall Study|Adverse Event|11|||
16143488|NCT02090413|39014719|FG001|Overall Study|Adverse Event|15|||
16143489|NCT02090413|39014720|FG002|Overall Study|Adverse Event|20|||
16143490|NCT02090413|39014718|FG000|Overall Study|Flushing event|2|||
16143491|NCT02090413|39014719|FG001|Overall Study|Flushing event|0|||
16143492|NCT02090413|39014720|FG002|Overall Study|Flushing event|1|||
16143493|NCT02090413|39014718|FG000|Overall Study|Withdrawal by Subject|2|||
16143494|NCT02090413|39014719|FG001|Overall Study|Withdrawal by Subject|2|||
16143495|NCT02090413|39014720|FG002|Overall Study|Withdrawal by Subject|2|||
16143496|NCT02090413|39014718|FG000|Overall Study|Investigator Decision|1|||
16143497|NCT02090413|39014719|FG001|Overall Study|Investigator Decision|1|||
16143498|NCT02090413|39014720|FG002|Overall Study|Investigator Decision|0|||
16143499|NCT02090413|39014718|FG000|Overall Study|Other|2|||
16143500|NCT02090413|39014719|FG001|Overall Study|Other|1|||
16143501|NCT02090413|39014720|FG002|Overall Study|Other|0|||
16143502|NCT02090413|39014718|FG000|Overall Study|Lost to Follow-up|1|||
16143503|NCT02090413|39014719|FG001|Overall Study|Lost to Follow-up|1|||
16439626|NCT00435409|40089477|FG000|Overall Study|Protocol Violation|1|||
16439627|NCT00435409|40089478|FG001|Overall Study|Protocol Violation|2|||
16439628|NCT00435409|40089479|FG002|Overall Study|Protocol Violation|0|||
16439629|NCT00435409|40089477|FG000|Overall Study|Lost to Follow-up|1|||
16439630|NCT00435409|40089478|FG001|Overall Study|Lost to Follow-up|2|||
16439631|NCT00435409|40089479|FG002|Overall Study|Lost to Follow-up|0|||
16439632|NCT00435409|40089477|FG000|Overall Study|Death|8|||
16439633|NCT00435409|40089478|FG001|Overall Study|Death|6|||
16439634|NCT00435409|40089479|FG002|Overall Study|Death|6|||
16439635|NCT00435409|40089477|FG000|Overall Study|Objective progression or relapse|158|||
16439636|NCT00435409|40089478|FG001|Overall Study|Objective progression or relapse|93|||
16439637|NCT00435409|40089479|FG002|Overall Study|Objective progression or relapse|58|||
16439638|NCT00435409|40089477|FG000|Overall Study|Global deterioration of health status|0|||
16439639|NCT00435409|40089478|FG001|Overall Study|Global deterioration of health status|0|||
16439640|NCT00435409|40089479|FG002|Overall Study|Global deterioration of health status|4|||
16439641|NCT00435409|40089477|FG000|Overall Study|Withdrawal by Subject|8|||
16439642|NCT00435409|40089478|FG001|Overall Study|Withdrawal by Subject|7|||
16439643|NCT00435409|40089479|FG002|Overall Study|Withdrawal by Subject|1|||
16439644|NCT00435409|40089477|FG000|Overall Study|Other|45|||
16439645|NCT00435409|40089478|FG001|Overall Study|Other|30|||
16439646|NCT00435409|40089479|FG002|Overall Study|Other|1|||
16143504|NCT02090413|39014720|FG002|Overall Study|Lost to Follow-up|0|||
16143505|NCT00911625|39014723|FG000|Overall Study|Lost to Follow-up|7|||
16143506|NCT00911625|39014724|FG001|Overall Study|Lost to Follow-up|0|||
16143507|NCT04163900|39014728|FG000|Overall Study|Radiological disease progression|112|||
16143508|NCT04163900|39014729|FG001|Overall Study|Radiological disease progression|127|||
16143509|NCT04163900|39014728|FG000|Overall Study|Study closure|98|||
16143510|NCT04163900|39014729|FG001|Overall Study|Study closure|133|||
16143511|NCT04163900|39014728|FG000|Overall Study|Adverse Event|78|||
16143512|NCT04163900|39014729|FG001|Overall Study|Adverse Event|32|||
16439647|NCT00435409|40089477|FG000|Overall Study|Adverse Event|0|||
16439648|NCT00435409|40089478|FG001|Overall Study|Adverse Event|0|||
16439649|NCT00435409|40089479|FG002|Overall Study|Adverse Event|8|||
16439650|NCT00435409|40089477|FG000|Overall Study|Sponsor decision|0|||
16439651|NCT00435409|40089478|FG001|Overall Study|Sponsor decision|3|||
16439652|NCT00435409|40089479|FG002|Overall Study|Sponsor decision|0|||
16439653|NCT02021565|40089483|FG000|Baseline Through Intervention|Death|0|||
16143513|NCT04163900|39014728|FG000|Overall Study|Withdrawal by Subject|37|||
16143514|NCT04163900|39014729|FG001|Overall Study|Withdrawal by Subject|34|||
16143515|NCT04163900|39014728|FG000|Overall Study|Death|29|||
16143516|NCT04163900|39014729|FG001|Overall Study|Death|16|||
16143517|NCT04163900|39014728|FG000|Overall Study|Physician Decision|17|||
16143518|NCT04163900|39014729|FG001|Overall Study|Physician Decision|25|||
16143519|NCT04163900|39014728|FG000|Overall Study|Clinical disease progression|14|||
16143520|NCT04163900|39014729|FG001|Overall Study|Clinical disease progression|13|||
16143521|NCT04163900|39014728|FG000|Overall Study|Protocol Violation|3|||
16143522|NCT04163900|39014729|FG001|Overall Study|Protocol Violation|4|||
16143523|NCT04163900|39014728|FG000|Overall Study|Lost to Follow-up|0|||
16143524|NCT04163900|39014729|FG001|Overall Study|Lost to Follow-up|1|||
16143525|NCT00867113|39014734|FG000|Treatment Period|Adverse Event|15|||
16143526|NCT00867113|39014734|FG000|Treatment Period|Death|2|||
16143527|NCT00867113|39014734|FG000|Treatment Period|Withdrawal by Subject|19|||
16143528|NCT00867113|39014734|FG000|Treatment Period|Lost to Follow-up|3|||
16143529|NCT00867113|39014734|FG000|Treatment Period|Administrative problems|1|||
16143530|NCT00867113|39014734|FG000|Treatment Period|Disease progression/relapse|1|||
16143531|NCT00867113|39014734|FG000|Treatment Period|Protocol Violation|4|||
16143532|NCT00867113|39014734|FG000|Post Treatment After Survival Follow-up|Death|1|||
16143533|NCT00867113|39014734|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
16143534|NCT00867113|39014734|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
16143535|NCT00867113|39014734|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
16143536|NCT01524133|39014735|FG000|Treatment Phase|Withdrawal by Subject|13|||
16143537|NCT01524133|39014736|FG001|Treatment Phase|Withdrawal by Subject|28|||
16143538|NCT01524133|39014737|FG002|Treatment Phase|Withdrawal by Subject|31|||
16143539|NCT01524133|39014735|FG000|Treatment Phase|Physician Decision|6|||
16143540|NCT01524133|39014736|FG001|Treatment Phase|Physician Decision|3|||
16143541|NCT01524133|39014737|FG002|Treatment Phase|Physician Decision|3|||
16143542|NCT01524133|39014735|FG000|Treatment Phase|Lost to Follow-up|0|||
16143543|NCT01524133|39014736|FG001|Treatment Phase|Lost to Follow-up|1|||
16143544|NCT01524133|39014737|FG002|Treatment Phase|Lost to Follow-up|2|||
16143545|NCT01524133|39014735|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
16143546|NCT01524133|39014736|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
16143547|NCT01524133|39014737|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
16143548|NCT01524133|39014735|FG000|Overall Study 52 Weeks|Physician Decision|1|||
16143549|NCT01524133|39014736|FG001|Overall Study 52 Weeks|Physician Decision|0|||
16143550|NCT01524133|39014737|FG002|Overall Study 52 Weeks|Physician Decision|2|||
16143551|NCT01524133|39014735|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
16143552|NCT01524133|39014736|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
16143553|NCT01524133|39014737|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
16143554|NCT03627767|39014738|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
16143555|NCT03627767|39014739|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
16143556|NCT03627767|39014740|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
16143557|NCT03627767|39014741|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
16143558|NCT03627767|39014742|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
16143559|NCT03627767|39014738|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
16143560|NCT03627767|39014739|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
16143561|NCT03627767|39014740|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
16143562|NCT03627767|39014741|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
16143563|NCT03627767|39014742|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
16143564|NCT03627767|39014738|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
16143565|NCT03627767|39014739|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
16143566|NCT03627767|39014740|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
16143567|NCT03627767|39014741|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
16143568|NCT03627767|39014742|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
16143569|NCT03627767|39014738|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
16143570|NCT03627767|39014739|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
16143571|NCT03627767|39014740|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
16143572|NCT03627767|39014741|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
16143573|NCT03627767|39014742|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
16143574|NCT03627767|39014738|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
16143575|NCT03627767|39014739|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
16143576|NCT03627767|39014740|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
16143577|NCT03627767|39014741|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
16143578|NCT03627767|39014742|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
16143579|NCT03627767|39014738|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
16143580|NCT03627767|39014739|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
16143581|NCT03627767|39014740|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
16143582|NCT03627767|39014741|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
16143583|NCT03627767|39014742|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
16143584|NCT03627767|39014738|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
16143585|NCT03627767|39014739|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
16143586|NCT03627767|39014740|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
16143587|NCT03627767|39014741|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
16143588|NCT03627767|39014742|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
16143589|NCT03627767|39014738|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
16143590|NCT03627767|39014739|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
16143591|NCT03627767|39014740|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
16143592|NCT03627767|39014741|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
16143593|NCT03627767|39014742|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
16143594|NCT03627767|39014738|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
16143595|NCT03627767|39014739|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
16143596|NCT03627767|39014740|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
16143597|NCT03627767|39014741|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
16143598|NCT03627767|39014742|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
16143599|NCT03627767|39014738|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
16143600|NCT03627767|39014739|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
16143601|NCT03627767|39014740|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
16143602|NCT03627767|39014741|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
16143603|NCT03627767|39014742|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
16143604|NCT03627767|39014738|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
16143605|NCT03627767|39014739|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
16143606|NCT03627767|39014740|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
16143607|NCT03627767|39014741|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
16143608|NCT03627767|39014742|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
16143609|NCT03627767|39014738|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
16143610|NCT03627767|39014739|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
16143611|NCT03627767|39014740|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
16143612|NCT03627767|39014741|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
16143613|NCT03627767|39014742|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
16143614|NCT03627767|39014738|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
16143615|NCT03627767|39014739|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
16143616|NCT03627767|39014740|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
16256730|NCT00920140|39424166|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
16256731|NCT00920140|39424167|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
16143617|NCT03627767|39014741|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
16143618|NCT03627767|39014742|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
16143619|NCT03627767|39014738|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
16143620|NCT03627767|39014739|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
16143621|NCT03627767|39014740|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
16143622|NCT03627767|39014741|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
16143623|NCT03627767|39014742|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
16143624|NCT03627767|39014738|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
16143625|NCT03627767|39014739|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
16143626|NCT03627767|39014740|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
16143627|NCT03627767|39014741|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
16143628|NCT03627767|39014742|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
16143629|NCT03627767|39014738|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
16143630|NCT03627767|39014739|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
16143631|NCT03627767|39014740|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
16143632|NCT03627767|39014741|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
16143633|NCT03627767|39014742|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
16143634|NCT03627767|39014738|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
16143635|NCT03627767|39014739|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
16143636|NCT03627767|39014740|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
16143637|NCT03627767|39014741|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
16143638|NCT03627767|39014742|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
16143639|NCT03627767|39014738|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
16143640|NCT03627767|39014739|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
16143641|NCT03627767|39014740|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
16143642|NCT03627767|39014741|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
16143643|NCT03627767|39014742|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
16143644|NCT03627767|39014738|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
16143645|NCT03627767|39014739|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
16143646|NCT03627767|39014740|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
16143647|NCT03627767|39014741|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
16143648|NCT03627767|39014742|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
16143649|NCT03627767|39014738|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
16143650|NCT03627767|39014739|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
16143651|NCT03627767|39014740|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
16143652|NCT03627767|39014741|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
16143653|NCT03627767|39014742|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
16143654|NCT00922480|39014746|FG000|Main Study|Protocol Violation|3|||
16143655|NCT00922480|39014747|FG001|Main Study|Protocol Violation|6|||
16143656|NCT00922480|39014746|FG000|Main Study|Adverse Event|6|||
16143657|NCT00922480|39014747|FG001|Main Study|Adverse Event|7|||
16143658|NCT00922480|39014746|FG000|Main Study|Lack of Efficacy|3|||
16143659|NCT00922480|39014747|FG001|Main Study|Lack of Efficacy|0|||
16143660|NCT00922480|39014746|FG000|Main Study|Withdrawal by Subject|20|||
16143661|NCT00922480|39014747|FG001|Main Study|Withdrawal by Subject|15|||
16143662|NCT00922480|39014746|FG000|Main Study|Lost to Follow-up|5|||
16143663|NCT00922480|39014747|FG001|Main Study|Lost to Follow-up|0|||
16143664|NCT00922480|39014746|FG000|Main Study|Physician Decision|0|||
16143665|NCT00922480|39014747|FG001|Main Study|Physician Decision|1|||
16143666|NCT00922480|39014746|FG000|Extension Study|Protocol Violation|3|||
16143667|NCT00922480|39014747|FG001|Extension Study|Protocol Violation|0|||
16143668|NCT00922480|39014746|FG000|Extension Study|Adverse Event|1|||
16143669|NCT00922480|39014747|FG001|Extension Study|Adverse Event|1|||
16143670|NCT00922480|39014746|FG000|Extension Study|Withdrawal by Subject|1|||
16143671|NCT00922480|39014747|FG001|Extension Study|Withdrawal by Subject|1|||
16143672|NCT00922480|39014746|FG000|Extension Study|Others|0|||
16143673|NCT00922480|39014747|FG001|Extension Study|Others|1|||
16143674|NCT00698204|39014748|FG000|Overall Study|Withdrawal by Subject|1|||
16143675|NCT00698204|39014749|FG001|Overall Study|Withdrawal by Subject|0|||
16256732|NCT00920140|39424168|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
16143676|NCT01294150|39014757|FG000|Overall Study|Physician Decision|2|||
16143677|NCT01294150|39014758|FG001|Overall Study|Physician Decision|2|||
16143678|NCT01484977|39014759|FG000|Overall Study|Adverse Event|8|||
16143679|NCT01484977|39014759|FG000|Overall Study|Lack of Efficacy|4|||
16143680|NCT01484977|39014759|FG000|Overall Study|Protocol Violation|6|||
16256733|NCT00920140|39424164|FG000|Phase 2|Adverse Event|0|||
16256734|NCT00920140|39424165|FG001|Phase 2|Adverse Event|0|||
16256735|NCT00920140|39424166|FG002|Phase 2|Adverse Event|14|||
16143681|NCT01484977|39014759|FG000|Overall Study|Lost to Follow-up|1|||
16143682|NCT01484977|39014759|FG000|Overall Study|Withdrawal by Subject|4|||
16143683|NCT01484977|39014759|FG000|Overall Study|Subject Protocol Non-compliant|1|||
16256736|NCT00920140|39424167|FG003|Phase 2|Adverse Event|2|||
16256737|NCT00920140|39424168|FG004|Phase 2|Adverse Event|3|||
16256738|NCT00920140|39424164|FG000|Phase 2|Lack of Efficacy|0|||
16256739|NCT00920140|39424165|FG001|Phase 2|Lack of Efficacy|0|||
16256740|NCT00920140|39424166|FG002|Phase 2|Lack of Efficacy|29|||
16256741|NCT00920140|39424167|FG003|Phase 2|Lack of Efficacy|14|||
16256742|NCT00920140|39424168|FG004|Phase 2|Lack of Efficacy|5|||
16256743|NCT00920140|39424164|FG000|Phase 2|Lost to Follow-up|0|||
16256744|NCT00920140|39424165|FG001|Phase 2|Lost to Follow-up|0|||
16256745|NCT00920140|39424166|FG002|Phase 2|Lost to Follow-up|0|||
16256746|NCT00920140|39424167|FG003|Phase 2|Lost to Follow-up|1|||
16256747|NCT00920140|39424168|FG004|Phase 2|Lost to Follow-up|0|||
16256748|NCT00920140|39424164|FG000|Phase 2|Physician Decision|0|||
16256749|NCT00920140|39424165|FG001|Phase 2|Physician Decision|0|||
16256750|NCT00920140|39424166|FG002|Phase 2|Physician Decision|3|||
16256751|NCT00920140|39424167|FG003|Phase 2|Physician Decision|3|||
16256752|NCT00920140|39424168|FG004|Phase 2|Physician Decision|2|||
16256753|NCT00920140|39424164|FG000|Phase 2|Withdrawal by Subject|0|||
16256754|NCT00920140|39424165|FG001|Phase 2|Withdrawal by Subject|0|||
16256755|NCT00920140|39424166|FG002|Phase 2|Withdrawal by Subject|4|||
16256756|NCT00920140|39424167|FG003|Phase 2|Withdrawal by Subject|2|||
16256757|NCT00920140|39424168|FG004|Phase 2|Withdrawal by Subject|1|||
16256758|NCT02016300|39424170|FG000|Overall Study|Lost to Follow-up|0|||
16256759|NCT02016300|39424171|FG001|Overall Study|Lost to Follow-up|3|||
16256760|NCT03708211|39424172|FG000|Overall Study|Progressive Disease|10|||
16256761|NCT03708211|39424173|FG001|Overall Study|Progressive Disease|7|||
16256762|NCT03708211|39424172|FG000|Overall Study|Withdrawal by Subject|0|||
16256763|NCT03708211|39424173|FG001|Overall Study|Withdrawal by Subject|1|||
16256764|NCT03708211|39424172|FG000|Overall Study|Other|2|||
16256765|NCT03708211|39424173|FG001|Overall Study|Other|0|||
16256766|NCT00796510|39424174|FG000|Overall Study|Death|1|||
16256767|NCT00796510|39424175|FG001|Overall Study|Death|0|||
16256768|NCT00796510|39424174|FG000|Overall Study|Study Terminated|2|||
16256769|NCT00796510|39424175|FG001|Overall Study|Study Terminated|0|||
16256770|NCT02073643|39424176|FG000|Overall Study|Lost to Follow-up|24|||
16256771|NCT03527745|39424177|FG000|Overall Study|Lost to Follow-up|3|||
16256772|NCT03527745|39424178|FG001|Overall Study|Lost to Follow-up|6|||
16256773|NCT03527745|39424179|FG002|Overall Study|Lost to Follow-up|7|||
16256774|NCT03527745|39424180|FG003|Overall Study|Lost to Follow-up|9|||
16256775|NCT03527745|39424181|FG004|Overall Study|Lost to Follow-up|0|||
16256776|NCT03527745|39424182|FG005|Overall Study|Lost to Follow-up|2|||
16256777|NCT03527745|39424183|FG006|Overall Study|Lost to Follow-up|3|||
16256778|NCT03527745|39424184|FG007|Overall Study|Lost to Follow-up|2|||
16256779|NCT03527745|39424185|FG008|Overall Study|Lost to Follow-up|3|||
16256780|NCT03527745|39424186|FG009|Overall Study|Lost to Follow-up|2|||
16256781|NCT03527745|39424187|FG010|Overall Study|Lost to Follow-up|1|||
16256782|NCT03527745|39424188|FG011|Overall Study|Lost to Follow-up|1|||
16256783|NCT03527745|39424189|FG012|Overall Study|Lost to Follow-up|0|||
16256784|NCT03527745|39424190|FG013|Overall Study|Lost to Follow-up|0|||
16256785|NCT03527745|39424191|FG014|Overall Study|Lost to Follow-up|0|||
16256786|NCT03527745|39424192|FG015|Overall Study|Lost to Follow-up|0|||
16256787|NCT03527745|39424193|FG016|Overall Study|Lost to Follow-up|1|||
16256788|NCT03527745|39424194|FG017|Overall Study|Lost to Follow-up|0|||
16256789|NCT03527745|39424195|FG018|Overall Study|Lost to Follow-up|0|||
16256790|NCT03527745|39424196|FG019|Overall Study|Lost to Follow-up|1|||
16256791|NCT03527745|39424197|FG020|Overall Study|Lost to Follow-up|1|||
16256792|NCT03527745|39424198|FG021|Overall Study|Lost to Follow-up|5|||
16256793|NCT03527745|39424199|FG022|Overall Study|Lost to Follow-up|6|||
16256794|NCT03527745|39424200|FG023|Overall Study|Lost to Follow-up|8|||
16256795|NCT03527745|39424201|FG024|Overall Study|Lost to Follow-up|1|||
16256796|NCT03527745|39424202|FG025|Overall Study|Lost to Follow-up|3|||
16256797|NCT00727571|39424205|FG000|Overall Study|Ineligibility determined|1|||
16143684|NCT01484977|39014759|FG000|Overall Study|Moving Overseas|1|||
16256798|NCT00727571|39424206|FG001|Overall Study|Ineligibility determined|1|||
16256799|NCT00727571|39424207|FG002|Overall Study|Ineligibility determined|1|||
16256800|NCT00727571|39424208|FG003|Overall Study|Ineligibility determined|0|||
16256801|NCT00727571|39424205|FG000|Overall Study|Death|0|||
16256802|NCT00727571|39424206|FG001|Overall Study|Death|19|||
16256803|NCT00727571|39424207|FG002|Overall Study|Death|5|||
16256804|NCT00727571|39424208|FG003|Overall Study|Death|1|||
16256805|NCT00727571|39424205|FG000|Overall Study|Physician Decision|0|||
16256806|NCT00727571|39424206|FG001|Overall Study|Physician Decision|5|||
16256807|NCT00727571|39424207|FG002|Overall Study|Physician Decision|0|||
16256808|NCT00727571|39424208|FG003|Overall Study|Physician Decision|0|||
16256809|NCT00727571|39424205|FG000|Overall Study|Withdrawal by Subject|0|||
16256810|NCT00727571|39424206|FG001|Overall Study|Withdrawal by Subject|10|||
16256811|NCT00727571|39424207|FG002|Overall Study|Withdrawal by Subject|11|||
16256812|NCT00727571|39424208|FG003|Overall Study|Withdrawal by Subject|0|||
16256813|NCT00727571|39424205|FG000|Overall Study|Subject Non Compliance|0|||
16256814|NCT00727571|39424206|FG001|Overall Study|Subject Non Compliance|6|||
16256815|NCT00727571|39424207|FG002|Overall Study|Subject Non Compliance|0|||
16256816|NCT00727571|39424208|FG003|Overall Study|Subject Non Compliance|4|||
16256817|NCT00727571|39424205|FG000|Overall Study|Dismissed from nursing home|0|||
16256818|NCT00727571|39424206|FG001|Overall Study|Dismissed from nursing home|9|||
16256819|NCT00727571|39424207|FG002|Overall Study|Dismissed from nursing home|5|||
16256820|NCT00727571|39424208|FG003|Overall Study|Dismissed from nursing home|0|||
16256821|NCT00727571|39424205|FG000|Overall Study|Hospitalization|0|||
16256822|NCT00727571|39424206|FG001|Overall Study|Hospitalization|1|||
16256823|NCT00727571|39424207|FG002|Overall Study|Hospitalization|0|||
16256824|NCT00727571|39424208|FG003|Overall Study|Hospitalization|1|||
16256825|NCT00727571|39424205|FG000|Overall Study|AE not leading to hospitalization|0|||
16256826|NCT00727571|39424206|FG001|Overall Study|AE not leading to hospitalization|0|||
16256827|NCT00727571|39424207|FG002|Overall Study|AE not leading to hospitalization|2|||
16256828|NCT00727571|39424208|FG003|Overall Study|AE not leading to hospitalization|0|||
16256829|NCT00727571|39424205|FG000|Overall Study|Other|0|||
16256830|NCT00727571|39424206|FG001|Overall Study|Other|4|||
16256831|NCT00727571|39424207|FG002|Overall Study|Other|6|||
16256832|NCT00727571|39424208|FG003|Overall Study|Other|0|||
16256833|NCT01759290|39424209|FG000|Overall Study|Subjects withdrawn consent|5|||
16256834|NCT01759290|39424209|FG000|Overall Study|Physician Decision|2|||
16256835|NCT01759290|39424209|FG000|Overall Study|Death|17|||
16256836|NCT01759290|39424209|FG000|Overall Study|Lost to Follow-up|53|||
16256837|NCT01759290|39424209|FG000|Overall Study|Unknown reason|4|||
16256838|NCT04524364|39424211|FG000|Overall Study|Physician Decision|3|||
16256839|NCT04524364|39424212|FG001|Overall Study|Physician Decision|6|||
16256840|NCT04524364|39424211|FG000|Overall Study|Adverse Event|0|||
16256841|NCT04524364|39424212|FG001|Overall Study|Adverse Event|1|||
16256842|NCT04524364|39424211|FG000|Overall Study|Investigational device deficiency|0|||
16256843|NCT04524364|39424212|FG001|Overall Study|Investigational device deficiency|1|||
16256844|NCT04524364|39424211|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
16256845|NCT04524364|39424212|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
16256846|NCT04524364|39424211|FG000|Overall Study|Device unavailability|0|||
16256847|NCT04524364|39424212|FG001|Overall Study|Device unavailability|2|||
16256848|NCT04524364|39424211|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
16256849|NCT04524364|39424212|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
16256850|NCT04524364|39424211|FG000|Overall Study|Low International normalized ratio (INR)|1|||
16256851|NCT04524364|39424212|FG001|Overall Study|Low International normalized ratio (INR)|0|||
16256852|NCT03464136|39424213|FG000|Overall Study|Lost to Follow-up|5|||
16256853|NCT03464136|39424214|FG001|Overall Study|Lost to Follow-up|8|||
16256854|NCT03464136|39424213|FG000|Overall Study|Withdrawal by Subject|16|||
16256855|NCT03464136|39424214|FG001|Overall Study|Withdrawal by Subject|13|||
16256856|NCT03464136|39424213|FG000|Overall Study|Death|1|||
16256857|NCT03464136|39424214|FG001|Overall Study|Death|0|||
16256858|NCT03464136|39424213|FG000|Overall Study|Other|8|||
16256859|NCT03464136|39424214|FG001|Overall Study|Other|4|||
16256860|NCT04646109|39424217|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
16256861|NCT04646109|39424218|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
16256862|NCT01226797|39424219|FG000|Overall Study|Adverse Event|1|||
16256863|NCT01226797|39424220|FG001|Overall Study|Adverse Event|0|||
16256864|NCT01226797|39424219|FG000|Overall Study|No longer willing to participate|1|||
16256865|NCT01226797|39424220|FG001|Overall Study|No longer willing to participate|0|||
16256866|NCT01226797|39424219|FG000|Overall Study|Protocol Violation|0|||
16256867|NCT01226797|39424220|FG001|Overall Study|Protocol Violation|1|||
16256868|NCT00220337|39424221|FG000|Overall Study|Adverse Event|70|||
16256869|NCT00220337|39424221|FG000|Overall Study|Lack of Efficacy|17|||
16256870|NCT00220337|39424221|FG000|Overall Study|Withdrawal by Subject|68|||
16256871|NCT00220337|39424221|FG000|Overall Study|Protocol Violation|2|||
16256872|NCT00220337|39424221|FG000|Overall Study|Lost to Follow-up|5|||
16256873|NCT00220337|39424221|FG000|Overall Study|Other|12|||
16256874|NCT00220337|39424221|FG000|Overall Study|Unsatisfactory compliance|5|||
16256875|NCT00770510|39424222|FG000|Overall Study|Lost to Follow-up|2|||
16256876|NCT00770510|39424222|FG000|Overall Study|Pregnancy|1|||
16256877|NCT00770510|39424222|FG000|Overall Study|Withdrawal by Subject|2|||
16256878|NCT02202850|39424225|FG000|Overall Study|Other|2|||
16256879|NCT02202850|39424226|FG001|Overall Study|Other|2|||
16256880|NCT02202850|39424225|FG000|Overall Study|Enbrel treatment discontinued|15|||
16256881|NCT02202850|39424226|FG001|Overall Study|Enbrel treatment discontinued|3|||
16256882|NCT02202850|39424225|FG000|Overall Study|Lost to Follow-up|7|||
16256883|NCT02202850|39424226|FG001|Overall Study|Lost to Follow-up|1|||
16256884|NCT00577460|39424227|FG000|Overall Study|Adverse Event|11|||
16256885|NCT00577460|39424228|FG001|Overall Study|Adverse Event|7|||
16256886|NCT00577460|39424229|FG002|Overall Study|Adverse Event|14|||
16256887|NCT00577460|39424227|FG000|Overall Study|Protocol Violation|0|||
16256888|NCT00577460|39424228|FG001|Overall Study|Protocol Violation|1|||
16256889|NCT00577460|39424229|FG002|Overall Study|Protocol Violation|1|||
16256890|NCT00577460|39424227|FG000|Overall Study|Lost to Follow-up|0|||
16256891|NCT00577460|39424228|FG001|Overall Study|Lost to Follow-up|3|||
16256892|NCT00577460|39424229|FG002|Overall Study|Lost to Follow-up|4|||
16256893|NCT00577460|39424227|FG000|Overall Study|Withdrawal by Subject|5|||
16256894|NCT00577460|39424228|FG001|Overall Study|Withdrawal by Subject|5|||
16256895|NCT00577460|39424229|FG002|Overall Study|Withdrawal by Subject|6|||
16256896|NCT00577460|39424227|FG000|Overall Study|Other|0|||
16256897|NCT00577460|39424228|FG001|Overall Study|Other|3|||
16439654|NCT02021565|40089484|FG001|Baseline Through Intervention|Death|1|||
16439655|NCT02021565|40089483|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
16439656|NCT02021565|40089484|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
16439657|NCT02021565|40089483|FG000|Baseline Through Intervention|Protocol Violation|0|||
16439658|NCT02021565|40089484|FG001|Baseline Through Intervention|Protocol Violation|7|||
16439659|NCT02021565|40089483|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
16439660|NCT02021565|40089484|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
16439661|NCT02021565|40089483|FG000|3-month Follow-up|Death|3|||
16439662|NCT02021565|40089484|FG001|3-month Follow-up|Death|0|||
16439663|NCT02021565|40089483|FG000|3-month Follow-up|Withdrawal by Subject|4|||
16439664|NCT02021565|40089484|FG001|3-month Follow-up|Withdrawal by Subject|0|||
16439665|NCT02021565|40089483|FG000|3-month Follow-up|Protocol Violation|3|||
16439666|NCT02021565|40089484|FG001|3-month Follow-up|Protocol Violation|2|||
16439667|NCT01502293|40089487|FG000|Overall Study|Progressive Disease|20|||
16439668|NCT01502293|40089488|FG001|Overall Study|Progressive Disease|12|||
16439669|NCT01502293|40089489|FG002|Overall Study|Progressive Disease|2|||
16439670|NCT01502293|40089487|FG000|Overall Study|Withdrawal by Subject|3|||
16439671|NCT01502293|40089488|FG001|Overall Study|Withdrawal by Subject|3|||
16439672|NCT01502293|40089489|FG002|Overall Study|Withdrawal by Subject|1|||
16439673|NCT01502293|40089487|FG000|Overall Study|Adverse Event|0|||
16439674|NCT01502293|40089488|FG001|Overall Study|Adverse Event|2|||
16439675|NCT01502293|40089489|FG002|Overall Study|Adverse Event|0|||
16439676|NCT01502293|40089487|FG000|Overall Study|Reason Not Specified|2|||
16439677|NCT01502293|40089488|FG001|Overall Study|Reason Not Specified|0|||
16439678|NCT01502293|40089489|FG002|Overall Study|Reason Not Specified|0|||
16439679|NCT01502293|40089487|FG000|Overall Study|Physician Decision|0|||
16439680|NCT01502293|40089488|FG001|Overall Study|Physician Decision|0|||
16439681|NCT01502293|40089489|FG002|Overall Study|Physician Decision|1|||
16439682|NCT02219464|40089490|FG000|Overall Study|Withdrawal by Subject|1|||
16439683|NCT02219464|40089491|FG001|Overall Study|Withdrawal by Subject|0|||
16439684|NCT02219464|40089490|FG000|Overall Study|case cancelled|1|||
16439685|NCT02219464|40089491|FG001|Overall Study|case cancelled|0|||
16439686|NCT02219464|40089490|FG000|Overall Study|catheter malfunction|1|||
16439687|NCT02219464|40089491|FG001|Overall Study|catheter malfunction|0|||
16439688|NCT00387881|40089492|FG000|Overall Study|Lost to Follow-up|23|||
16439689|NCT00387881|40089493|FG001|Overall Study|Lost to Follow-up|23|||
16439690|NCT00387881|40089492|FG000|Overall Study|Protocol Violation|2|||
16439691|NCT00387881|40089493|FG001|Overall Study|Protocol Violation|12|||
16439692|NCT00387881|40089492|FG000|Overall Study|Withdrawal by Subject|15|||
16439693|NCT00387881|40089493|FG001|Overall Study|Withdrawal by Subject|18|||
16439694|NCT00387881|40089492|FG000|Overall Study|Sponsor terminated Study|0|||
16256898|NCT00577460|39424229|FG002|Overall Study|Other|2|||
16256899|NCT00262600|39424230|FG000|Overall Study|Lost to Follow-up|17|||
16256900|NCT00262600|39424231|FG001|Overall Study|Lost to Follow-up|31|||
16256901|NCT00262600|39424232|FG002|Overall Study|Lost to Follow-up|41|||
16256902|NCT00262600|39424230|FG000|Overall Study|Withdrawal by Subject|128|||
16256903|NCT00262600|39424231|FG001|Overall Study|Withdrawal by Subject|145|||
16256904|NCT00262600|39424232|FG002|Overall Study|Withdrawal by Subject|139|||
16256905|NCT00262600|39424230|FG000|Overall Study|Not Treated|32|||
16256906|NCT00262600|39424231|FG001|Overall Study|Not Treated|17|||
16256907|NCT00262600|39424232|FG002|Overall Study|Not Treated|24|||
16256908|NCT00262600|39424230|FG000|Overall Study|Other|58|||
16256909|NCT00262600|39424231|FG001|Overall Study|Other|59|||
16256910|NCT00262600|39424232|FG002|Overall Study|Other|62|||
16256911|NCT00117949|39427119|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
16256912|NCT00117949|39427120|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
16439695|NCT00387881|40089493|FG001|Overall Study|Sponsor terminated Study|1|||
16439696|NCT00387881|40089492|FG000|Overall Study|Not eligible|6|||
16439697|NCT00387881|40089493|FG001|Overall Study|Not eligible|7|||
16439698|NCT00387881|40089492|FG000|Overall Study|No opportunity to treat headache|32|||
16439699|NCT00387881|40089493|FG001|Overall Study|No opportunity to treat headache|34|||
16439700|NCT00387881|40089492|FG000|Overall Study|Not otherwise specified|11|||
16439701|NCT00387881|40089493|FG001|Overall Study|Not otherwise specified|7|||
16439702|NCT02182895|40089494|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
16439703|NCT02182895|40089495|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
16256913|NCT00117949|39427121|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
16256914|NCT00117949|39427122|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
16256915|NCT00117949|39427119|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
16256916|NCT00117949|39427120|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
16256917|NCT00117949|39427121|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
16256918|NCT00117949|39427122|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
16256919|NCT00117949|39427119|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
16256920|NCT00117949|39427120|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
16256921|NCT00117949|39427121|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
16256922|NCT00117949|39427122|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
16256923|NCT00117949|39427119|FG000|Overall Study|PSA increase >=10ng/mL|0|||
16256924|NCT00117949|39427120|FG001|Overall Study|PSA increase >=10ng/mL|1|||
16256925|NCT00117949|39427121|FG002|Overall Study|PSA increase >=10ng/mL|1|||
16256926|NCT00117949|39427122|FG003|Overall Study|PSA increase >=10ng/mL|0|||
16256927|NCT00117949|39427119|FG000|Overall Study|PSA reduction <=50%|0|||
16256928|NCT00117949|39427120|FG001|Overall Study|PSA reduction <=50%|2|||
16256929|NCT00117949|39427121|FG002|Overall Study|PSA reduction <=50%|2|||
16256930|NCT00117949|39427122|FG003|Overall Study|PSA reduction <=50%|4|||
16256931|NCT00117949|39427119|FG000|Overall Study|Hepatic abnormalities|0|||
16256932|NCT00117949|39427120|FG001|Overall Study|Hepatic abnormalities|1|||
16256933|NCT00117949|39427121|FG002|Overall Study|Hepatic abnormalities|0|||
16256934|NCT00117949|39427122|FG003|Overall Study|Hepatic abnormalities|1|||
16256935|NCT00454636|39427123|FG000|Overall Study|Adverse Event|10|||
16256936|NCT00454636|39427124|FG001|Overall Study|Adverse Event|6|||
16256937|NCT00454636|39427125|FG002|Overall Study|Adverse Event|9|||
16256938|NCT00454636|39427126|FG003|Overall Study|Adverse Event|15|||
16256939|NCT00454636|39427123|FG000|Overall Study|Disease Progression|11|||
16256940|NCT00454636|39427124|FG001|Overall Study|Disease Progression|12|||
16256941|NCT00454636|39427125|FG002|Overall Study|Disease Progression|4|||
16256942|NCT00454636|39427126|FG003|Overall Study|Disease Progression|11|||
16256943|NCT00454636|39427123|FG000|Overall Study|Protocol Violation|3|||
16256944|NCT00454636|39427124|FG001|Overall Study|Protocol Violation|2|||
16256945|NCT00454636|39427125|FG002|Overall Study|Protocol Violation|3|||
16256946|NCT00454636|39427126|FG003|Overall Study|Protocol Violation|3|||
16256947|NCT00454636|39427123|FG000|Overall Study|Death|6|||
16256948|NCT00454636|39427124|FG001|Overall Study|Death|1|||
16256949|NCT00454636|39427125|FG002|Overall Study|Death|1|||
16256950|NCT00454636|39427126|FG003|Overall Study|Death|1|||
16256951|NCT00454636|39427123|FG000|Overall Study|Patient refusal|1|||
16256952|NCT00454636|39427124|FG001|Overall Study|Patient refusal|1|||
16256953|NCT00454636|39427125|FG002|Overall Study|Patient refusal|3|||
16256954|NCT00454636|39427126|FG003|Overall Study|Patient refusal|2|||
16256955|NCT00454636|39427123|FG000|Overall Study|Lost to Follow-up|0|||
16256956|NCT00454636|39427124|FG001|Overall Study|Lost to Follow-up|1|||
16256957|NCT00454636|39427125|FG002|Overall Study|Lost to Follow-up|0|||
16256958|NCT00454636|39427126|FG003|Overall Study|Lost to Follow-up|0|||
16256959|NCT03227445|39427127|FG000|Period 1 (28 Days)|Adverse Event|1|||
16256960|NCT03227445|39427128|FG001|Period 1 (28 Days)|Adverse Event|2|||
16256961|NCT03227445|39427129|FG002|Period 1 (28 Days)|Adverse Event|0|||
16256962|NCT03227445|39427130|FG003|Period 1 (28 Days)|Adverse Event|1|||
16256963|NCT03227445|39427127|FG000|Period 1 (28 Days)|Protocol Violation|1|||
16256964|NCT03227445|39427128|FG001|Period 1 (28 Days)|Protocol Violation|0|||
16143685|NCT01484977|39014759|FG000|Overall Study|Low White Blood Cell Count|1|||
16143686|NCT01484977|39014759|FG000|Overall Study|Lack of Compliance|1|||
16143687|NCT01235793|39014760|FG000|Overall Study|Death|6|||
16143688|NCT01093625|39014761|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
16143689|NCT01093625|39014762|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
16143690|NCT01093625|39014761|FG000|2-Week Visit|Withdrawal by Subject|1|||
16143691|NCT01093625|39014762|FG001|2-Week Visit|Withdrawal by Subject|0|||
16143692|NCT01093625|39014761|FG000|1-Month Visit|Lost to Follow-up|2|||
16143693|NCT01093625|39014762|FG001|1-Month Visit|Lost to Follow-up|0|||
16256965|NCT03227445|39427129|FG002|Period 1 (28 Days)|Protocol Violation|0|||
16256966|NCT03227445|39427130|FG003|Period 1 (28 Days)|Protocol Violation|0|||
16256967|NCT03227445|39427127|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
16256968|NCT03227445|39427128|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
16256969|NCT03227445|39427129|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
16256970|NCT03227445|39427130|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
16256971|NCT03227445|39427127|FG000|Period 2 (28 Days)|Adverse Event|1|||
16256972|NCT03227445|39427128|FG001|Period 2 (28 Days)|Adverse Event|0|||
16143694|NCT01093625|39014761|FG000|3-Month Visit|Lost to Follow-up|2|||
16143695|NCT01093625|39014762|FG001|3-Month Visit|Lost to Follow-up|0|||
16143696|NCT01093625|39014761|FG000|6-Month Visit|Withdrawal by Subject|6|||
16143697|NCT01093625|39014762|FG001|6-Month Visit|Withdrawal by Subject|7|||
16256973|NCT03227445|39427129|FG002|Period 2 (28 Days)|Adverse Event|2|||
16256974|NCT03227445|39427130|FG003|Period 2 (28 Days)|Adverse Event|1|||
16256975|NCT03227445|39427127|FG000|Period 2 (28 Days)|Protocol Violation|0|||
16256976|NCT03227445|39427128|FG001|Period 2 (28 Days)|Protocol Violation|0|||
16256977|NCT03227445|39427129|FG002|Period 2 (28 Days)|Protocol Violation|0|||
16439704|NCT02163538|40089496|FG000|Overall Study|Protocol Violation|1|||
16439705|NCT02163538|40089497|FG001|Overall Study|Protocol Violation|0|||
16439706|NCT02163538|40089496|FG000|Overall Study|Physician Decision|0|||
16439707|NCT02163538|40089497|FG001|Overall Study|Physician Decision|1|||
16439708|NCT00984256|40089502|FG000|Overall Study|Withdrawal by Subject|0|||
16439709|NCT00984256|40089503|FG001|Overall Study|Withdrawal by Subject|1|||
16439710|NCT00005906|40089504|FG000|Overall Study|Lack of Efficacy|3|||
16439711|NCT03416868|40089505|FG000|Overall Study|Withdrawal by Subject|2|||
16439712|NCT03416868|40089505|FG000|Overall Study|Lost to Follow-up|1|||
16439713|NCT00644423|40089510|FG000|Overall Study|Lost to Follow-up|1|||
16439714|NCT00644423|40089511|FG001|Overall Study|Lost to Follow-up|1|||
16143698|NCT01093625|39014761|FG000|6-Month Visit|Lost to Follow-up|2|||
16439715|NCT01743469|40089512|FG000|Active Treatment Phase|Adverse Event|10|||
16439716|NCT01743469|40089513|FG001|Active Treatment Phase|Adverse Event|5|||
16439717|NCT01743469|40089514|FG002|Active Treatment Phase|Adverse Event|8|||
16256978|NCT03227445|39427130|FG003|Period 2 (28 Days)|Protocol Violation|1|||
16256979|NCT03227445|39427127|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
16256980|NCT03227445|39427128|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
16256981|NCT03227445|39427129|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
16256982|NCT03227445|39427130|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
16256983|NCT00076102|39427133|FG000|Overall Study|Clinical progression|1|||
16256984|NCT00076102|39427133|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
16256985|NCT00076102|39427133|FG000|Overall Study|plexiform neurofibroma surgery|1|||
16256986|NCT00076102|39427133|FG000|Overall Study|refusal of further therapy|2|||
16256987|NCT00175019|39427134|FG000|Overall Study|Adverse Event|54|||
16256988|NCT00175019|39427135|FG001|Overall Study|Adverse Event|22|||
16256989|NCT00175019|39427136|FG002|Overall Study|Adverse Event|2|||
16256990|NCT00175019|39427134|FG000|Overall Study|Protocol Violation|6|||
16256991|NCT00175019|39427135|FG001|Overall Study|Protocol Violation|3|||
16256992|NCT00175019|39427136|FG002|Overall Study|Protocol Violation|3|||
16256993|NCT00175019|39427134|FG000|Overall Study|Lost to Follow-up|42|||
16256994|NCT00175019|39427135|FG001|Overall Study|Lost to Follow-up|39|||
16256995|NCT00175019|39427136|FG002|Overall Study|Lost to Follow-up|9|||
16256996|NCT00175019|39427134|FG000|Overall Study|Did not continue under Amendment 4|1|||
16256997|NCT00175019|39427135|FG001|Overall Study|Did not continue under Amendment 4|1|||
16256998|NCT00175019|39427136|FG002|Overall Study|Did not continue under Amendment 4|2|||
16256999|NCT00175019|39427134|FG000|Overall Study|Personal Reason(s)|39|||
16257000|NCT00175019|39427135|FG001|Overall Study|Personal Reason(s)|31|||
16257001|NCT00175019|39427136|FG002|Overall Study|Personal Reason(s)|8|||
16257002|NCT00175019|39427134|FG000|Overall Study|Therapeutic Failure|10|||
16257003|NCT00175019|39427135|FG001|Overall Study|Therapeutic Failure|38|||
16257004|NCT00175019|39427136|FG002|Overall Study|Therapeutic Failure|22|||
16257005|NCT00175019|39427134|FG000|Overall Study|Gout Flare|2|||
16257006|NCT00175019|39427135|FG001|Overall Study|Gout Flare|3|||
16257007|NCT00175019|39427136|FG002|Overall Study|Gout Flare|0|||
16257008|NCT00175019|39427134|FG000|Overall Study|Reason Not Specified|40|||
16257009|NCT00175019|39427135|FG001|Overall Study|Reason Not Specified|34|||
16257010|NCT00175019|39427136|FG002|Overall Study|Reason Not Specified|11|||
16257011|NCT00552669|39427139|FG000|Overall Study|Death|3|||
16257012|NCT00552669|39427140|FG001|Overall Study|Death|7|||
16257013|NCT04885296|39427141|FG000|Period 1|Covid-19 Related|1|||
16257014|NCT04885296|39427142|FG001|Period 1|Covid-19 Related|0|||
16257015|NCT04885296|39427141|FG000|Period 1|Adverse Event|0|||
16257016|NCT04885296|39427142|FG001|Period 1|Adverse Event|1|||
16257017|NCT04885296|39427141|FG000|Period 1|Withdrawal by Subject|1|||
16257018|NCT04885296|39427142|FG001|Period 1|Withdrawal by Subject|1|||
16257019|NCT04885296|39427141|FG000|Period 1|Test Article No Longer Available|1|||
16257020|NCT04885296|39427142|FG001|Period 1|Test Article No Longer Available|0|||
16257021|NCT04885296|39427141|FG000|Period 1|Dispensed Study lens in Error|1|||
16257022|NCT04885296|39427142|FG001|Period 1|Dispensed Study lens in Error|0|||
16257023|NCT04885296|39427141|FG000|Period 1|Lost to Follow-up|1|||
16257024|NCT04885296|39427142|FG001|Period 1|Lost to Follow-up|0|||
16257025|NCT04885296|39427141|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
16257026|NCT04885296|39427142|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
16257027|NCT03603314|39427145|FG000|Overall Study|Lost to Follow-up|0|||
16257028|NCT03603314|39427146|FG001|Overall Study|Lost to Follow-up|3|||
16257029|NCT03603314|39427147|FG002|Overall Study|Lost to Follow-up|0|||
16257030|NCT03603314|39427145|FG000|Overall Study|Protocol Violation|0|||
16257031|NCT03603314|39427146|FG001|Overall Study|Protocol Violation|1|||
16257032|NCT03603314|39427147|FG002|Overall Study|Protocol Violation|0|||
16257033|NCT03603314|39427145|FG000|Overall Study|Adverse Event|2|||
16257034|NCT03603314|39427146|FG001|Overall Study|Adverse Event|0|||
16257035|NCT03603314|39427147|FG002|Overall Study|Adverse Event|0|||
16143699|NCT01093625|39014762|FG001|6-Month Visit|Lost to Follow-up|2|||
16143700|NCT01093625|39014761|FG000|1-Year Visit|Lost to Follow-up|5|||
16143701|NCT01093625|39014762|FG001|1-Year Visit|Lost to Follow-up|3|||
16143702|NCT00521053|39014763|FG000|Observation Phase|Disease Progression|55|||
16143703|NCT00521053|39014763|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
16143704|NCT00521053|39014763|FG000|Observation Phase|Death|2|||
16257036|NCT03603314|39427145|FG000|Overall Study|Physician Decision|1|||
16257037|NCT03603314|39427146|FG001|Overall Study|Physician Decision|1|||
16257038|NCT03603314|39427147|FG002|Overall Study|Physician Decision|0|||
16257039|NCT03603314|39427145|FG000|Overall Study|Withdrawal by Subject|4|||
16257040|NCT03603314|39427146|FG001|Overall Study|Withdrawal by Subject|5|||
16257041|NCT03603314|39427147|FG002|Overall Study|Withdrawal by Subject|3|||
16257042|NCT03603314|39427145|FG000|Overall Study|Other|0|||
16257043|NCT03603314|39427146|FG001|Overall Study|Other|1|||
16257044|NCT03603314|39427147|FG002|Overall Study|Other|0|||
16257045|NCT02242201|39427152|FG000|Overall Study|preoperative identified neuropathy|2|||
16257046|NCT02242201|39427153|FG001|Overall Study|preoperative identified neuropathy|0|||
16257047|NCT02242201|39427154|FG002|Overall Study|preoperative identified neuropathy|0|||
16257048|NCT02242201|39427152|FG000|Overall Study|planned post-op anticoagulation|1|||
16257049|NCT02242201|39427153|FG001|Overall Study|planned post-op anticoagulation|0|||
16257050|NCT02242201|39427154|FG002|Overall Study|planned post-op anticoagulation|0|||
16257051|NCT02242201|39427152|FG000|Overall Study|changed surgical procedure|1|||
16257052|NCT02242201|39427153|FG001|Overall Study|changed surgical procedure|0|||
16439718|NCT01743469|40089515|FG003|Active Treatment Phase|Adverse Event|1|||
16439719|NCT01743469|40089512|FG000|Active Treatment Phase|Disease Progression|40|||
16439720|NCT01743469|40089513|FG001|Active Treatment Phase|Disease Progression|47|||
16439721|NCT01743469|40089514|FG002|Active Treatment Phase|Disease Progression|30|||
16439722|NCT01743469|40089515|FG003|Active Treatment Phase|Disease Progression|20|||
16439723|NCT01743469|40089512|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
16439724|NCT01743469|40089513|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
16439725|NCT01743469|40089514|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
16439726|NCT01743469|40089515|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
16439727|NCT01743469|40089512|FG000|Active Treatment Phase|Missing|1|||
16439728|NCT01743469|40089513|FG001|Active Treatment Phase|Missing|0|||
16257053|NCT02242201|39427154|FG002|Overall Study|changed surgical procedure|0|||
16257054|NCT02242201|39427152|FG000|Overall Study|postponed surgery|0|||
16257055|NCT02242201|39427153|FG001|Overall Study|postponed surgery|0|||
16257056|NCT02242201|39427154|FG002|Overall Study|postponed surgery|1|||
16257057|NCT02242201|39427152|FG000|Overall Study|preoperative opioid consumption|0|||
16257058|NCT02242201|39427153|FG001|Overall Study|preoperative opioid consumption|1|||
16257059|NCT02242201|39427154|FG002|Overall Study|preoperative opioid consumption|0|||
16257060|NCT00436553|39427158|FG000|Overall Study|Adverse Event|4|||
16257061|NCT00436553|39427159|FG001|Overall Study|Adverse Event|3|||
16257062|NCT00436553|39427160|FG002|Overall Study|Adverse Event|4|||
16257063|NCT00436553|39427158|FG000|Overall Study|Death|3|||
16257064|NCT00436553|39427159|FG001|Overall Study|Death|1|||
16257065|NCT00436553|39427160|FG002|Overall Study|Death|3|||
16257066|NCT00436553|39427158|FG000|Overall Study|Lost to Follow-up|0|||
16257067|NCT00436553|39427159|FG001|Overall Study|Lost to Follow-up|2|||
16257068|NCT00436553|39427160|FG002|Overall Study|Lost to Follow-up|0|||
16257069|NCT00436553|39427158|FG000|Overall Study|Protocol Violation|1|||
16257070|NCT00436553|39427159|FG001|Overall Study|Protocol Violation|0|||
16257071|NCT00436553|39427160|FG002|Overall Study|Protocol Violation|0|||
16257072|NCT00436553|39427158|FG000|Overall Study|Withdrawal by Subject|5|||
16257073|NCT00436553|39427159|FG001|Overall Study|Withdrawal by Subject|6|||
16257074|NCT00436553|39427160|FG002|Overall Study|Withdrawal by Subject|3|||
16439729|NCT01743469|40089514|FG002|Active Treatment Phase|Missing|0|||
16439730|NCT01743469|40089515|FG003|Active Treatment Phase|Missing|0|||
16439731|NCT01743469|40089512|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
16143705|NCT00521053|39014763|FG000|Observation Phase|Adverse Event|1|||
16143706|NCT00521053|39014763|FG000|Observation Phase|Other non-study melanoma treatment|1|||
16143707|NCT00521053|39014763|FG000|Observation Phase|Physician Decision|1|||
16143708|NCT04275297|39014772|FG000|Overall Study|Lost to Follow-up|1|||
16143709|NCT04275297|39014773|FG001|Overall Study|Lost to Follow-up|1|||
16143710|NCT01987960|39014774|FG000|Period 1|Adverse Event|24|||
16143711|NCT01987960|39014775|FG001|Period 1|Adverse Event|0|||
16143712|NCT01987960|39014776|FG002|Period 1|Adverse Event|0|||
16143713|NCT01987960|39014777|FG003|Period 1|Adverse Event|0|||
16257075|NCT00095212|39427161|FG000|Overall Study|Withdrawal by Subject|1|||
16257076|NCT00095212|39427162|FG001|Overall Study|Withdrawal by Subject|3|||
16257077|NCT02116803|39427163|FG000|Overall Study|Adverse Event|2|||
16257078|NCT02116803|39427164|FG001|Overall Study|Adverse Event|1|||
16257079|NCT02116803|39427163|FG000|Overall Study|Physician Decision|1|||
16257080|NCT02116803|39427164|FG001|Overall Study|Physician Decision|0|||
16143714|NCT01987960|39014774|FG000|Period 1|Lack of Efficacy|4|||
16143715|NCT01987960|39014775|FG001|Period 1|Lack of Efficacy|0|||
16143716|NCT01987960|39014776|FG002|Period 1|Lack of Efficacy|0|||
16143717|NCT01987960|39014777|FG003|Period 1|Lack of Efficacy|0|||
16143718|NCT01987960|39014774|FG000|Period 1|Non-compliance with IMP|6|||
16143719|NCT01987960|39014775|FG001|Period 1|Non-compliance with IMP|0|||
16143720|NCT01987960|39014776|FG002|Period 1|Non-compliance with IMP|0|||
16143721|NCT01987960|39014777|FG003|Period 1|Non-compliance with IMP|0|||
16143722|NCT01987960|39014774|FG000|Period 1|Protocol Violation|12|||
16143723|NCT01987960|39014775|FG001|Period 1|Protocol Violation|0|||
16143724|NCT01987960|39014776|FG002|Period 1|Protocol Violation|0|||
16143725|NCT01987960|39014777|FG003|Period 1|Protocol Violation|0|||
16143726|NCT01987960|39014774|FG000|Period 1|Withdrawal by Subject|21|||
16143727|NCT01987960|39014775|FG001|Period 1|Withdrawal by Subject|0|||
16143728|NCT01987960|39014776|FG002|Period 1|Withdrawal by Subject|0|||
16143729|NCT01987960|39014777|FG003|Period 1|Withdrawal by Subject|0|||
16143730|NCT01987960|39014774|FG000|Period 1|Lost to Follow-up|40|||
16143731|NCT01987960|39014775|FG001|Period 1|Lost to Follow-up|0|||
16143732|NCT01987960|39014776|FG002|Period 1|Lost to Follow-up|0|||
16143733|NCT01987960|39014777|FG003|Period 1|Lost to Follow-up|0|||
16143734|NCT01987960|39014774|FG000|Period 1|administrative or other reason|75|||
16143735|NCT01987960|39014775|FG001|Period 1|administrative or other reason|0|||
16143736|NCT01987960|39014776|FG002|Period 1|administrative or other reason|0|||
16143737|NCT01987960|39014777|FG003|Period 1|administrative or other reason|0|||
16143738|NCT01987960|39014774|FG000|Period 1|Withdrawal of consent before treatment|4|||
16257081|NCT02116803|39427163|FG000|Overall Study|Progressive disease|4|||
16143739|NCT01987960|39014775|FG001|Period 1|Withdrawal of consent before treatment|0|||
16143740|NCT01987960|39014776|FG002|Period 1|Withdrawal of consent before treatment|0|||
16143741|NCT01987960|39014777|FG003|Period 1|Withdrawal of consent before treatment|0|||
16143742|NCT01987960|39014774|FG000|Period 2|Adverse Event|0|||
16143743|NCT01987960|39014775|FG001|Period 2|Adverse Event|0|||
16143744|NCT01987960|39014776|FG002|Period 2|Adverse Event|1|||
16143745|NCT01987960|39014777|FG003|Period 2|Adverse Event|0|||
16143746|NCT01987960|39014774|FG000|Period 2|Withdrawal by Subject|0|||
16143747|NCT01987960|39014775|FG001|Period 2|Withdrawal by Subject|0|||
16143748|NCT01987960|39014776|FG002|Period 2|Withdrawal by Subject|1|||
16143749|NCT01987960|39014777|FG003|Period 2|Withdrawal by Subject|0|||
16143750|NCT01987960|39014774|FG000|Period 2|Administrative or other reason|0|||
16143751|NCT01987960|39014775|FG001|Period 2|Administrative or other reason|5|||
16143752|NCT01987960|39014776|FG002|Period 2|Administrative or other reason|7|||
16143753|NCT01987960|39014777|FG003|Period 2|Administrative or other reason|0|||
16143754|NCT01987960|39014774|FG000|Period 3|Adverse Event|0|||
16143755|NCT01987960|39014775|FG001|Period 3|Adverse Event|0|||
16143756|NCT01987960|39014776|FG002|Period 3|Adverse Event|0|||
16143757|NCT01987960|39014777|FG003|Period 3|Adverse Event|7|||
16143758|NCT01987960|39014774|FG000|Period 3|Non-compliance with IMP|0|||
16143759|NCT01987960|39014775|FG001|Period 3|Non-compliance with IMP|0|||
16143760|NCT01987960|39014776|FG002|Period 3|Non-compliance with IMP|0|||
16143761|NCT01987960|39014777|FG003|Period 3|Non-compliance with IMP|1|||
16143762|NCT01987960|39014774|FG000|Period 3|Protocol Violation|0|||
16143763|NCT01987960|39014775|FG001|Period 3|Protocol Violation|0|||
16143764|NCT01987960|39014776|FG002|Period 3|Protocol Violation|0|||
16143765|NCT01987960|39014777|FG003|Period 3|Protocol Violation|6|||
16143766|NCT01987960|39014774|FG000|Period 3|Withdrawal by Subject|0|||
16143767|NCT01987960|39014775|FG001|Period 3|Withdrawal by Subject|0|||
16143768|NCT01987960|39014776|FG002|Period 3|Withdrawal by Subject|0|||
16143769|NCT01987960|39014777|FG003|Period 3|Withdrawal by Subject|9|||
16143770|NCT01987960|39014774|FG000|Period 3|Lost to Follow-up|0|||
16143771|NCT01987960|39014775|FG001|Period 3|Lost to Follow-up|0|||
16143772|NCT01987960|39014776|FG002|Period 3|Lost to Follow-up|0|||
16143773|NCT01987960|39014777|FG003|Period 3|Lost to Follow-up|5|||
16143774|NCT01987960|39014774|FG000|Period 3|Administrative or other reason|0|||
16143775|NCT01987960|39014775|FG001|Period 3|Administrative or other reason|0|||
16143776|NCT01987960|39014776|FG002|Period 3|Administrative or other reason|0|||
16143777|NCT01987960|39014777|FG003|Period 3|Administrative or other reason|43|||
16143778|NCT01195090|39014778|FG000|Overall Study|Adverse Event|1|||
16143779|NCT01195090|39014779|FG001|Overall Study|Adverse Event|2|||
16143780|NCT01195090|39014778|FG000|Overall Study|Lost to Follow-up|2|||
16143781|NCT01195090|39014779|FG001|Overall Study|Lost to Follow-up|2|||
16143782|NCT01195090|39014778|FG000|Overall Study|Protocol Violation|3|||
16143783|NCT01195090|39014779|FG001|Overall Study|Protocol Violation|4|||
16143799|NCT03065023|39014785|FG000|Overall Study|Progressive Disease|0|||
16143800|NCT03065023|39014786|FG001|Overall Study|Progressive Disease|1|||
16143801|NCT03065023|39014787|FG002|Overall Study|Progressive Disease|0|||
16143802|NCT03065023|39014788|FG003|Overall Study|Progressive Disease|0|||
16143803|NCT03065023|39014789|FG004|Overall Study|Progressive Disease|0|||
16143804|NCT03065023|39014785|FG000|Overall Study|Death|2|||
16143805|NCT03065023|39014786|FG001|Overall Study|Death|0|||
16143806|NCT03065023|39014787|FG002|Overall Study|Death|1|||
16143807|NCT03065023|39014788|FG003|Overall Study|Death|1|||
16143808|NCT03065023|39014789|FG004|Overall Study|Death|0|||
16143809|NCT03065023|39014785|FG000|Overall Study|Lost to Follow-up|0|||
16143810|NCT03065023|39014786|FG001|Overall Study|Lost to Follow-up|1|||
16143811|NCT03065023|39014787|FG002|Overall Study|Lost to Follow-up|0|||
16364241|NCT02065557|39818249|FG005|Induction Period|Non-Responder at Week 8|0|||
16143812|NCT03065023|39014788|FG003|Overall Study|Lost to Follow-up|0|||
16143813|NCT03065023|39014789|FG004|Overall Study|Lost to Follow-up|0|||
16143814|NCT03065023|39014785|FG000|Overall Study|Participant Decision|0|||
16143815|NCT03065023|39014786|FG001|Overall Study|Participant Decision|0|||
16143816|NCT03065023|39014787|FG002|Overall Study|Participant Decision|0|||
16143817|NCT03065023|39014788|FG003|Overall Study|Participant Decision|1|||
16143818|NCT03065023|39014789|FG004|Overall Study|Participant Decision|0|||
16143819|NCT03065023|39014785|FG000|Overall Study|Withdrawal by Subject|0|||
16143820|NCT03065023|39014786|FG001|Overall Study|Withdrawal by Subject|0|||
16143821|NCT03065023|39014787|FG002|Overall Study|Withdrawal by Subject|0|||
16143822|NCT03065023|39014788|FG003|Overall Study|Withdrawal by Subject|1|||
16143823|NCT03065023|39014789|FG004|Overall Study|Withdrawal by Subject|0|||
16143824|NCT02378220|39014790|FG000|Overall Study|Death|6|||
16143825|NCT02378220|39014791|FG001|Overall Study|Death|1|||
16143826|NCT00216203|39014794|FG000|Overall Study|Withdrawal by Subject|2|||
16143827|NCT02459769|39014795|FG000|Overall Study|Withdrawal by Subject|7|||
16143828|NCT02459769|39014796|FG001|Overall Study|Withdrawal by Subject|4|||
16143829|NCT02459769|39014797|FG002|Overall Study|Withdrawal by Subject|8|||
16143830|NCT02459769|39014798|FG003|Overall Study|Withdrawal by Subject|5|||
16143831|NCT02459769|39014795|FG000|Overall Study|Lost to Follow-up|1|||
16143832|NCT02459769|39014796|FG001|Overall Study|Lost to Follow-up|0|||
16143833|NCT02459769|39014797|FG002|Overall Study|Lost to Follow-up|1|||
16143834|NCT02459769|39014798|FG003|Overall Study|Lost to Follow-up|0|||
16143835|NCT01557348|39014799|FG000|Overall Study|Adverse Event|6|||
16143836|NCT01557348|39014800|FG001|Overall Study|Adverse Event|16|||
16143837|NCT01557348|39014799|FG000|Overall Study|Infusion reaction event|5|||
16143838|NCT01557348|39014800|FG001|Overall Study|Infusion reaction event|5|||
16143839|NCT01557348|39014799|FG000|Overall Study|Death|7|||
16143840|NCT01557348|39014800|FG001|Overall Study|Death|4|||
16143841|NCT01557348|39014799|FG000|Overall Study|Insufficient Therapeutic Response|13|||
16143842|NCT01557348|39014800|FG001|Overall Study|Insufficient Therapeutic Response|28|||
16143843|NCT01557348|39014799|FG000|Overall Study|Withdrawal by Subject|5|||
16143844|NCT01557348|39014800|FG001|Overall Study|Withdrawal by Subject|4|||
16143845|NCT01557348|39014799|FG000|Overall Study|Lost to Follow-up|26|||
16143846|NCT01557348|39014800|FG001|Overall Study|Lost to Follow-up|22|||
16143847|NCT01557348|39014799|FG000|Overall Study|Administrative|18|||
16143848|NCT01557348|39014800|FG001|Overall Study|Administrative|11|||
16143849|NCT04490395|39014803|FG000|Overall Study|Lost to Follow-up|0|||
16143850|NCT04490395|39014804|FG001|Overall Study|Lost to Follow-up|1|||
16143851|NCT00786565|39014805|FG000|Enrollment Prior to Surgery|Site Closed|3|||
16143852|NCT00786565|39014805|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
16143853|NCT00786565|39014805|FG000|Post Surgery|Abnormal macular pucker|1|||
16143854|NCT00786565|39014805|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
16143855|NCT00773136|39014806|FG000|Overall Study|Physician Decision|2|||
16143856|NCT02495844|39014809|FG000|Overall Study|Lack of Efficacy|1|||
16143857|NCT02495844|39014810|FG001|Overall Study|Lack of Efficacy|2|||
16143858|NCT02495844|39014809|FG000|Overall Study|AE, non-fatal|0|||
16143859|NCT02495844|39014810|FG001|Overall Study|AE, non-fatal|1|||
16143860|NCT02495844|39014809|FG000|Overall Study|Hepatitis Positivity|0|||
16143861|NCT02495844|39014810|FG001|Overall Study|Hepatitis Positivity|1|||
16143862|NCT04472650|39014811|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
16143863|NCT04472650|39014812|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
16143864|NCT01949155|39014814|FG000|Overall Study|Lost to Follow-up|1|||
16143865|NCT01949155|39014815|FG001|Overall Study|Lost to Follow-up|0|||
16143866|NCT01949155|39014814|FG000|Overall Study|Protocol Violation|1|||
16143867|NCT01949155|39014815|FG001|Overall Study|Protocol Violation|0|||
16143868|NCT02818920|39014818|FG000|Overall Study|Unresectable|4|||
16143869|NCT02818920|39014818|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
16143870|NCT02818920|39014818|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
16143871|NCT02818920|39014818|FG000|Overall Study|Adverse Event|3|||
16143872|NCT02818920|39014818|FG000|Overall Study|Developed Other Disease|1|||
16143873|NCT02818920|39014818|FG000|Overall Study|Refused Further Treatment|1|||
16143874|NCT03427125|39014821|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
16143875|NCT03427125|39014822|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
16143876|NCT03427125|39014823|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
16143877|NCT01506960|39014824|FG000|Overall Study|Did not meet angiographic criteria|47|||
16143878|NCT00880555|39014825|FG000|Overall Study|Physician Decision|0|||
16143879|NCT00880555|39014826|FG001|Overall Study|Physician Decision|8|||
16143880|NCT00880555|39014827|FG002|Overall Study|Physician Decision|0|||
16143881|NCT00880555|39014828|FG003|Overall Study|Physician Decision|2|||
16143882|NCT00880555|39014829|FG004|Overall Study|Physician Decision|1|||
16143883|NCT00880555|39014830|FG005|Overall Study|Physician Decision|0|||
16143884|NCT00880555|39014825|FG000|Overall Study|Withdrawal by Subject|1|||
16143885|NCT00880555|39014826|FG001|Overall Study|Withdrawal by Subject|1|||
16143886|NCT00880555|39014827|FG002|Overall Study|Withdrawal by Subject|0|||
16143887|NCT00880555|39014828|FG003|Overall Study|Withdrawal by Subject|0|||
16143888|NCT00880555|39014829|FG004|Overall Study|Withdrawal by Subject|0|||
16143889|NCT00880555|39014830|FG005|Overall Study|Withdrawal by Subject|0|||
16143890|NCT00880555|39014825|FG000|Overall Study|Lack of resources (hired rater)|9|||
16143891|NCT00880555|39014826|FG001|Overall Study|Lack of resources (hired rater)|7|||
16143892|NCT00880555|39014827|FG002|Overall Study|Lack of resources (hired rater)|5|||
16143893|NCT00880555|39014828|FG003|Overall Study|Lack of resources (hired rater)|0|||
16143894|NCT00880555|39014829|FG004|Overall Study|Lack of resources (hired rater)|0|||
16143895|NCT00880555|39014830|FG005|Overall Study|Lack of resources (hired rater)|0|||
16143896|NCT00880555|39014825|FG000|Overall Study|Death|0|||
16143897|NCT00880555|39014826|FG001|Overall Study|Death|0|||
16143898|NCT00880555|39014827|FG002|Overall Study|Death|0|||
16143899|NCT00880555|39014828|FG003|Overall Study|Death|0|||
16143900|NCT00880555|39014829|FG004|Overall Study|Death|0|||
16257082|NCT02116803|39427164|FG001|Overall Study|Progressive disease|0|||
16143901|NCT00880555|39014830|FG005|Overall Study|Death|1|||
16143902|NCT00880555|39014825|FG000|Overall Study|Lost to Follow-up|0|||
16143903|NCT00880555|39014826|FG001|Overall Study|Lost to Follow-up|1|||
16143904|NCT00880555|39014827|FG002|Overall Study|Lost to Follow-up|0|||
16143905|NCT00880555|39014828|FG003|Overall Study|Lost to Follow-up|0|||
16143906|NCT00880555|39014829|FG004|Overall Study|Lost to Follow-up|0|||
16143907|NCT00880555|39014830|FG005|Overall Study|Lost to Follow-up|0|||
16143908|NCT03794583|39014831|FG000|Overall Study|Death|8|||
16143909|NCT03794583|39014831|FG000|Overall Study|Study Terminated by Sponsor|24|||
16143910|NCT03794583|39014831|FG000|Overall Study|Withdrawal by Subject|9|||
16143911|NCT02019420|39014836|FG000|Overall Study|Did not receive study drug|2|||
16143912|NCT02019420|39014837|FG001|Overall Study|Did not receive study drug|2|||
16143913|NCT02019420|39014836|FG000|Overall Study|Withdrawal by Subject|1|||
16143914|NCT02019420|39014837|FG001|Overall Study|Withdrawal by Subject|3|||
16143915|NCT02019420|39014836|FG000|Overall Study|At request of sponsor or investigator|0|||
16143916|NCT02019420|39014837|FG001|Overall Study|At request of sponsor or investigator|1|||
16143917|NCT02019420|39014836|FG000|Overall Study|Death|104|||
16143918|NCT02019420|39014837|FG001|Overall Study|Death|99|||
16143919|NCT02019420|39014836|FG000|Overall Study|Transferred to other care facility|1|||
16143920|NCT02019420|39014837|FG001|Overall Study|Transferred to other care facility|1|||
16143921|NCT03606980|39014838|FG000|Overall Study|Lost to Follow-up|3|||
16143922|NCT03606980|39014839|FG001|Overall Study|Lost to Follow-up|2|||
16143923|NCT03606980|39014840|FG002|Overall Study|Lost to Follow-up|3|||
16143924|NCT03606980|39014838|FG000|Overall Study|Withdrawal by Subject|1|||
16143925|NCT03606980|39014839|FG001|Overall Study|Withdrawal by Subject|0|||
16143926|NCT03606980|39014840|FG002|Overall Study|Withdrawal by Subject|4|||
16143927|NCT01514136|39014841|FG000|Test Period 1; Test A|Protocol Violation|1|||
16143928|NCT01514136|39014842|FG001|Test Period 1; Test A|Protocol Violation|0|||
16143929|NCT01514136|39014843|FG002|Test Period 1; Test A|Protocol Violation|0|||
16143930|NCT01514136|39014844|FG003|Test Period 1; Test A|Protocol Violation|0|||
16143931|NCT01514136|39014845|FG004|Test Period 1; Test A|Protocol Violation|0|||
16143932|NCT01514136|39014846|FG005|Test Period 1; Test A|Protocol Violation|0|||
16143933|NCT01514136|39014847|FG006|Test Period 1; Test A|Protocol Violation|0|||
16143934|NCT01514136|39014848|FG007|Test Period 1; Test A|Protocol Violation|0|||
16143935|NCT01514136|39014841|FG000|Test Period 1; Test A|Break from study holiday|2|||
16143936|NCT01514136|39014842|FG001|Test Period 1; Test A|Break from study holiday|0|||
16143937|NCT01514136|39014843|FG002|Test Period 1; Test A|Break from study holiday|0|||
16143938|NCT01514136|39014844|FG003|Test Period 1; Test A|Break from study holiday|0|||
16143939|NCT01514136|39014845|FG004|Test Period 1; Test A|Break from study holiday|0|||
16143940|NCT01514136|39014846|FG005|Test Period 1; Test A|Break from study holiday|0|||
16143941|NCT01514136|39014847|FG006|Test Period 1; Test A|Break from study holiday|0|||
16143942|NCT01514136|39014848|FG007|Test Period 1; Test A|Break from study holiday|0|||
16143943|NCT01514136|39014841|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
16143944|NCT01514136|39014842|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
16143945|NCT01514136|39014843|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
16143946|NCT01514136|39014844|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
16143947|NCT01514136|39014845|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
16143948|NCT01514136|39014846|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
16143949|NCT01514136|39014847|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
16143950|NCT01514136|39014848|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
16143951|NCT01514136|39014841|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
16143952|NCT01514136|39014842|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
16143953|NCT01514136|39014843|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
16143954|NCT01514136|39014844|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
16143955|NCT01514136|39014845|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
16143956|NCT01514136|39014846|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
16143957|NCT01514136|39014847|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
16143958|NCT01514136|39014848|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
16143959|NCT01514136|39014841|FG000|Test Period 2; Test A*|Adverse Event|0|||
16143960|NCT01514136|39014842|FG001|Test Period 2; Test A*|Adverse Event|0|||
16143961|NCT01514136|39014843|FG002|Test Period 2; Test A*|Adverse Event|0|||
16143962|NCT01514136|39014844|FG003|Test Period 2; Test A*|Adverse Event|0|||
16143963|NCT01514136|39014845|FG004|Test Period 2; Test A*|Adverse Event|1|||
16143964|NCT01514136|39014846|FG005|Test Period 2; Test A*|Adverse Event|0|||
16143965|NCT01514136|39014847|FG006|Test Period 2; Test A*|Adverse Event|0|||
16143966|NCT01514136|39014848|FG007|Test Period 2; Test A*|Adverse Event|0|||
16143967|NCT01514136|39014841|FG000|Test Period 2; Test A*|Holiday|0|||
16143968|NCT01514136|39014842|FG001|Test Period 2; Test A*|Holiday|0|||
16143969|NCT01514136|39014843|FG002|Test Period 2; Test A*|Holiday|0|||
16143970|NCT01514136|39014844|FG003|Test Period 2; Test A*|Holiday|0|||
16143971|NCT01514136|39014845|FG004|Test Period 2; Test A*|Holiday|1|||
16143972|NCT01514136|39014846|FG005|Test Period 2; Test A*|Holiday|0|||
16143973|NCT01514136|39014847|FG006|Test Period 2; Test A*|Holiday|0|||
16143974|NCT01514136|39014848|FG007|Test Period 2; Test A*|Holiday|0|||
16257083|NCT02116803|39427163|FG000|Overall Study|Study terminated by sponsor|2|||
16257084|NCT02116803|39427164|FG001|Overall Study|Study terminated by sponsor|1|||
16439732|NCT01743469|40089513|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
16439733|NCT01743469|40089514|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
16439734|NCT01743469|40089515|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
16439735|NCT01743469|40089512|FG000|Follow-up Period - Post-Treatment|Death|43|||
16439736|NCT01743469|40089513|FG001|Follow-up Period - Post-Treatment|Death|47|||
16439737|NCT01743469|40089514|FG002|Follow-up Period - Post-Treatment|Death|22|||
16439738|NCT01743469|40089515|FG003|Follow-up Period - Post-Treatment|Death|16|||
16439739|NCT01743469|40089512|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
16439740|NCT01743469|40089513|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
16439741|NCT01743469|40089514|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
16257085|NCT02116803|39427163|FG000|Overall Study|Death|1|||
16143975|NCT01514136|39014841|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
16143976|NCT01514136|39014842|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
16143977|NCT01514136|39014843|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
16143978|NCT01514136|39014844|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
16143979|NCT01514136|39014845|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
16143980|NCT01514136|39014846|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
16143981|NCT01514136|39014847|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
16143982|NCT01514136|39014848|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
16143983|NCT01514136|39014841|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
16143984|NCT01514136|39014842|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
16143985|NCT01514136|39014843|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
16143986|NCT01514136|39014844|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
16143987|NCT01514136|39014845|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
16143988|NCT01514136|39014846|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
16143989|NCT01514136|39014847|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
16143990|NCT01514136|39014848|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
16143991|NCT01514136|39014841|FG000|Test Period 2; Test C*|holiday|0|||
16143992|NCT01514136|39014842|FG001|Test Period 2; Test C*|holiday|0|||
16143993|NCT01514136|39014843|FG002|Test Period 2; Test C*|holiday|0|||
16143994|NCT01514136|39014844|FG003|Test Period 2; Test C*|holiday|0|||
16143995|NCT01514136|39014845|FG004|Test Period 2; Test C*|holiday|0|||
16143996|NCT01514136|39014846|FG005|Test Period 2; Test C*|holiday|0|||
16143997|NCT01514136|39014847|FG006|Test Period 2; Test C*|holiday|1|||
16143998|NCT01514136|39014848|FG007|Test Period 2; Test C*|holiday|0|||
16143999|NCT01514136|39014841|FG000|Test Period 2; Test C*|Protocol Violation|0|||
16144000|NCT01514136|39014842|FG001|Test Period 2; Test C*|Protocol Violation|0|||
16144001|NCT01514136|39014843|FG002|Test Period 2; Test C*|Protocol Violation|0|||
16144002|NCT01514136|39014844|FG003|Test Period 2; Test C*|Protocol Violation|0|||
16144003|NCT01514136|39014845|FG004|Test Period 2; Test C*|Protocol Violation|0|||
16144004|NCT01514136|39014846|FG005|Test Period 2; Test C*|Protocol Violation|0|||
16144005|NCT01514136|39014847|FG006|Test Period 2; Test C*|Protocol Violation|1|||
16144006|NCT01514136|39014848|FG007|Test Period 2; Test C*|Protocol Violation|0|||
16144007|NCT01429584|39014849|FG000|Overall Study|Withdrawal by Subject|1|||
16144008|NCT01429584|39014850|FG001|Overall Study|Withdrawal by Subject|0|||
16144009|NCT01429584|39014849|FG000|Overall Study|Protocol Violation|0|||
16144010|NCT01429584|39014850|FG001|Overall Study|Protocol Violation|1|||
16144011|NCT01205438|39014851|FG000|Overall Study|Adverse Event|19|||
16144012|NCT01205438|39014852|FG001|Overall Study|Adverse Event|17|||
16144013|NCT01205438|39014853|FG002|Overall Study|Adverse Event|24|||
16144014|NCT01205438|39014851|FG000|Overall Study|Death|1|||
16144015|NCT01205438|39014852|FG001|Overall Study|Death|1|||
16144016|NCT01205438|39014853|FG002|Overall Study|Death|3|||
16144017|NCT01205438|39014851|FG000|Overall Study|Entry Criteria Not Met|16|||
16144018|NCT01205438|39014852|FG001|Overall Study|Entry Criteria Not Met|15|||
16144019|NCT01205438|39014853|FG002|Overall Study|Entry Criteria Not Met|13|||
16144020|NCT01205438|39014851|FG000|Overall Study|Lack of Efficacy|14|||
16144021|NCT01205438|39014852|FG001|Overall Study|Lack of Efficacy|11|||
16144022|NCT01205438|39014853|FG002|Overall Study|Lack of Efficacy|14|||
16144023|NCT01205438|39014851|FG000|Overall Study|Lost to Follow-up|6|||
16144024|NCT01205438|39014852|FG001|Overall Study|Lost to Follow-up|7|||
16144025|NCT01205438|39014853|FG002|Overall Study|Lost to Follow-up|8|||
16144026|NCT01205438|39014851|FG000|Overall Study|Withdrawal by Subject|19|||
16144027|NCT01205438|39014852|FG001|Overall Study|Withdrawal by Subject|25|||
16144028|NCT01205438|39014853|FG002|Overall Study|Withdrawal by Subject|19|||
16144029|NCT01205438|39014851|FG000|Overall Study|Physician Decision|0|||
16144030|NCT01205438|39014852|FG001|Overall Study|Physician Decision|3|||
16144031|NCT01205438|39014853|FG002|Overall Study|Physician Decision|2|||
16144032|NCT01205438|39014851|FG000|Overall Study|Protocol Violation|2|||
16144033|NCT01205438|39014852|FG001|Overall Study|Protocol Violation|7|||
16144034|NCT01205438|39014853|FG002|Overall Study|Protocol Violation|4|||
16144035|NCT01205438|39014851|FG000|Overall Study|Sponsor Decision|0|||
16144036|NCT01205438|39014852|FG001|Overall Study|Sponsor Decision|1|||
16144037|NCT01205438|39014853|FG002|Overall Study|Sponsor Decision|1|||
16144038|NCT02576444|39017219|FG000|Overall Study|Death|1|||
16144039|NCT02576444|39017220|FG001|Overall Study|Death|1|||
16144040|NCT02576444|39017221|FG002|Overall Study|Death|0|||
16439742|NCT01743469|40089515|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
16439743|NCT02174731|40089516|FG000|Overall Study|Participant decision|67|||
16144041|NCT02576444|39017222|FG003|Overall Study|Death|0|||
16144042|NCT02576444|39017219|FG000|Overall Study|Withdrawal by Subject|0|||
16144043|NCT02576444|39017220|FG001|Overall Study|Withdrawal by Subject|0|||
16144044|NCT02576444|39017221|FG002|Overall Study|Withdrawal by Subject|2|||
16144045|NCT02576444|39017222|FG003|Overall Study|Withdrawal by Subject|0|||
16144046|NCT02576444|39017219|FG000|Overall Study|Adverse Event|0|||
16144047|NCT02576444|39017220|FG001|Overall Study|Adverse Event|0|||
16144048|NCT02576444|39017221|FG002|Overall Study|Adverse Event|1|||
16144049|NCT02576444|39017222|FG003|Overall Study|Adverse Event|0|||
16144050|NCT02576444|39017219|FG000|Overall Study|Physician Decision|0|||
16144051|NCT02576444|39017220|FG001|Overall Study|Physician Decision|0|||
16144052|NCT02576444|39017221|FG002|Overall Study|Physician Decision|1|||
16144053|NCT02576444|39017222|FG003|Overall Study|Physician Decision|0|||
16144054|NCT02463071|39017223|FG000|Overall Study|Adverse Event|3|||
16144055|NCT02463071|39017224|FG001|Overall Study|Adverse Event|5|||
16144056|NCT02463071|39017225|FG002|Overall Study|Adverse Event|1|||
16144057|NCT02463071|39017223|FG000|Overall Study|Death|1|||
16144058|NCT02463071|39017224|FG001|Overall Study|Death|0|||
16144059|NCT02463071|39017225|FG002|Overall Study|Death|0|||
16144060|NCT02463071|39017223|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
16144061|NCT02463071|39017224|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16144062|NCT02463071|39017225|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
16144063|NCT02463071|39017223|FG000|Overall Study|Reason not specified|7|||
16144064|NCT02463071|39017224|FG001|Overall Study|Reason not specified|9|||
16144065|NCT02463071|39017225|FG002|Overall Study|Reason not specified|4|||
16144066|NCT02463071|39017223|FG000|Overall Study|Protocol Violation|0|||
16144067|NCT02463071|39017224|FG001|Overall Study|Protocol Violation|2|||
16144068|NCT02463071|39017225|FG002|Overall Study|Protocol Violation|0|||
16144069|NCT02463071|39017223|FG000|Overall Study|Lost to Follow-up|0|||
16144070|NCT02463071|39017224|FG001|Overall Study|Lost to Follow-up|0|||
16144071|NCT02463071|39017225|FG002|Overall Study|Lost to Follow-up|1|||
16144072|NCT01830855|39017226|FG000|Overall Study|Other|7|||
16144073|NCT01830855|39017227|FG001|Overall Study|Other|1|||
16144074|NCT01830855|39017228|FG002|Overall Study|Other|4|||
16144075|NCT01830855|39017229|FG003|Overall Study|Other|4|||
16144076|NCT01830855|39017226|FG000|Overall Study|Medication error without associated AE|1|||
16144077|NCT01830855|39017227|FG001|Overall Study|Medication error without associated AE|0|||
16144078|NCT01830855|39017228|FG002|Overall Study|Medication error without associated AE|0|||
16144079|NCT01830855|39017229|FG003|Overall Study|Medication error without associated AE|1|||
16144080|NCT01830855|39017226|FG000|Overall Study|Pregnancy|3|||
16144081|NCT01830855|39017227|FG001|Overall Study|Pregnancy|1|||
16144082|NCT01830855|39017228|FG002|Overall Study|Pregnancy|2|||
16144083|NCT01830855|39017229|FG003|Overall Study|Pregnancy|1|||
16144084|NCT01830855|39017226|FG000|Overall Study|No longer meets eligibility criteria|11|||
16144085|NCT01830855|39017227|FG001|Overall Study|No longer meets eligibility criteria|2|||
16144086|NCT01830855|39017228|FG002|Overall Study|No longer meets eligibility criteria|3|||
16144087|NCT01830855|39017229|FG003|Overall Study|No longer meets eligibility criteria|5|||
16144088|NCT01830855|39017226|FG000|Overall Study|Adverse Event|11|||
16144089|NCT01830855|39017227|FG001|Overall Study|Adverse Event|5|||
16144090|NCT01830855|39017228|FG002|Overall Study|Adverse Event|6|||
16144091|NCT01830855|39017229|FG003|Overall Study|Adverse Event|3|||
16144092|NCT01830855|39017226|FG000|Overall Study|Protocol deviation|10|||
16144093|NCT01830855|39017227|FG001|Overall Study|Protocol deviation|5|||
16144094|NCT01830855|39017228|FG002|Overall Study|Protocol deviation|6|||
16144095|NCT01830855|39017229|FG003|Overall Study|Protocol deviation|6|||
16144096|NCT01830855|39017226|FG000|Overall Study|Withdrawal by Subject|33|||
16144097|NCT01830855|39017227|FG001|Overall Study|Withdrawal by Subject|14|||
16144098|NCT01830855|39017228|FG002|Overall Study|Withdrawal by Subject|10|||
16144099|NCT01830855|39017229|FG003|Overall Study|Withdrawal by Subject|12|||
16144100|NCT01830855|39017226|FG000|Overall Study|No longer willing to participate|32|||
16144101|NCT01830855|39017227|FG001|Overall Study|No longer willing to participate|13|||
16144102|NCT01830855|39017228|FG002|Overall Study|No longer willing to participate|12|||
16144103|NCT01830855|39017229|FG003|Overall Study|No longer willing to participate|17|||
16144104|NCT01830855|39017226|FG000|Overall Study|Lost to Follow-up|47|||
16144105|NCT01830855|39017227|FG001|Overall Study|Lost to Follow-up|20|||
16144106|NCT01830855|39017228|FG002|Overall Study|Lost to Follow-up|23|||
16144107|NCT01830855|39017229|FG003|Overall Study|Lost to Follow-up|33|||
16144108|NCT01177384|39017232|FG000|Overall Study|Adverse Event|6|||
16144109|NCT01177384|39017233|FG001|Overall Study|Adverse Event|4|||
16144110|NCT01177384|39017232|FG000|Overall Study|Lack of Efficacy|0|||
16144111|NCT01177384|39017233|FG001|Overall Study|Lack of Efficacy|1|||
16144112|NCT01177384|39017232|FG000|Overall Study|Lost to Follow-up|3|||
16144113|NCT01177384|39017233|FG001|Overall Study|Lost to Follow-up|4|||
16144114|NCT01177384|39017232|FG000|Overall Study|Physician Decision|0|||
16144115|NCT01177384|39017233|FG001|Overall Study|Physician Decision|3|||
16144116|NCT01177384|39017232|FG000|Overall Study|Protocol Violation|0|||
16144117|NCT01177384|39017233|FG001|Overall Study|Protocol Violation|2|||
16144118|NCT01177384|39017232|FG000|Overall Study|Withdrawal by Subject|5|||
16144119|NCT01177384|39017233|FG001|Overall Study|Withdrawal by Subject|12|||
16257086|NCT02116803|39427164|FG001|Overall Study|Death|0|||
16439744|NCT02174731|40089517|FG001|Overall Study|Participant decision|64|||
16144120|NCT00853749|39017237|FG000|Overall Study|Lost to Follow-up|0|||
16144121|NCT00853749|39017238|FG001|Overall Study|Lost to Follow-up|1|||
16144122|NCT03945591|39017239|FG000|Overall Study|Participant not transplanted|1|||
16144123|NCT03945591|39017239|FG000|Overall Study|Change in treatment plan|3|||
16144124|NCT03945591|39017239|FG000|Overall Study|Adverse Event|1|||
16144125|NCT03275285|39017242|FG000|Overall Study|Ongoing|45|||
16439745|NCT02174731|40089516|FG000|Overall Study|Incorrect enrolment before randomization|0|||
16439746|NCT02174731|40089517|FG001|Overall Study|Incorrect enrolment before randomization|1|||
16439747|NCT02174731|40089516|FG000|Overall Study|Missing|2|||
16439748|NCT02174731|40089517|FG001|Overall Study|Missing|0|||
16439749|NCT00449696|40089518|FG000|Overall Study|Other Treatment Required|6|||
16439750|NCT00449696|40089519|FG001|Overall Study|Other Treatment Required|1|||
16439751|NCT00449696|40089518|FG000|Overall Study|Withdrawal by Subject|5|||
16439752|NCT00449696|40089519|FG001|Overall Study|Withdrawal by Subject|5|||
16439753|NCT00449696|40089518|FG000|Overall Study|Lost to Follow-up|2|||
16439754|NCT00449696|40089519|FG001|Overall Study|Lost to Follow-up|3|||
16439755|NCT00449696|40089518|FG000|Overall Study|Others|7|||
16439756|NCT00449696|40089519|FG001|Overall Study|Others|0|||
16439757|NCT02587221|40089520|FG000|Overall Study|Adverse Event|3|||
16439758|NCT02587221|40089521|FG001|Overall Study|Adverse Event|3|||
16439759|NCT02587221|40089520|FG000|Overall Study|Death|33|||
16439760|NCT02587221|40089521|FG001|Overall Study|Death|34|||
16439761|NCT02587221|40089520|FG000|Overall Study|Withdrawal by Subject|66|||
16439762|NCT02587221|40089521|FG001|Overall Study|Withdrawal by Subject|61|||
16439763|NCT02587221|40089520|FG000|Overall Study|Lost to Follow-up|21|||
16439764|NCT02587221|40089521|FG001|Overall Study|Lost to Follow-up|19|||
16439765|NCT02587221|40089520|FG000|Overall Study|Protocol Violation|6|||
16439766|NCT02587221|40089521|FG001|Overall Study|Protocol Violation|5|||
16439767|NCT02587221|40089520|FG000|Overall Study|Other Reason or Unspecified|2|||
16439768|NCT02587221|40089521|FG001|Overall Study|Other Reason or Unspecified|1|||
16439769|NCT00280917|40089525|FG000|Overall Study|Adverse Event|1|||
16439770|NCT00280917|40089526|FG001|Overall Study|Adverse Event|1|||
16439771|NCT00280917|40089527|FG002|Overall Study|Adverse Event|4|||
16439772|NCT00280917|40089528|FG003|Overall Study|Adverse Event|1|||
16439773|NCT00280917|40089525|FG000|Overall Study|Change Therapy|1|||
16439774|NCT00280917|40089526|FG001|Overall Study|Change Therapy|2|||
16439775|NCT00280917|40089527|FG002|Overall Study|Change Therapy|0|||
16439776|NCT00280917|40089528|FG003|Overall Study|Change Therapy|0|||
16439777|NCT00280917|40089525|FG000|Overall Study|Withdrawal by Subject|0|||
16439778|NCT00280917|40089526|FG001|Overall Study|Withdrawal by Subject|2|||
16439779|NCT00280917|40089527|FG002|Overall Study|Withdrawal by Subject|0|||
16439780|NCT00280917|40089528|FG003|Overall Study|Withdrawal by Subject|1|||
16439781|NCT00280917|40089525|FG000|Overall Study|Noncompliance|0|||
16439782|NCT00280917|40089526|FG001|Overall Study|Noncompliance|1|||
16439783|NCT00280917|40089527|FG002|Overall Study|Noncompliance|2|||
16439784|NCT00280917|40089528|FG003|Overall Study|Noncompliance|0|||
16439785|NCT03634085|40089529|FG000|Overall Study|Adverse Event|1|||
16439786|NCT03634085|40089530|FG001|Overall Study|Adverse Event|0|||
16439787|NCT03634085|40089529|FG000|Overall Study|Withdrawal by Subject|0|||
16439788|NCT03634085|40089530|FG001|Overall Study|Withdrawal by Subject|2|||
16439789|NCT03040141|40089531|FG000|Overall Study|Death|1|||
16439790|NCT03040141|40089532|FG001|Overall Study|Death|2|||
16439791|NCT03040141|40089533|FG002|Overall Study|Death|3|||
16439792|NCT03040141|40089531|FG000|Overall Study|Withdrawal by Subject|3|||
16439793|NCT03040141|40089532|FG001|Overall Study|Withdrawal by Subject|1|||
16439794|NCT03040141|40089533|FG002|Overall Study|Withdrawal by Subject|1|||
16439795|NCT03040141|40089531|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
16439796|NCT03040141|40089532|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
16439797|NCT03040141|40089533|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
16439798|NCT03040141|40089531|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
16439799|NCT03040141|40089532|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
16439800|NCT03040141|40089533|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
16439801|NCT01285401|40089534|FG000|Overall Study|Prematurely withdrawn from the study|17|||
16439802|NCT01285401|40089535|FG001|Overall Study|Prematurely withdrawn from the study|29|||
16439803|NCT01519323|40089536|FG000|Overall Study|Death|3|||
16439804|NCT01519323|40089537|FG001|Overall Study|Death|2|||
16439805|NCT01519323|40089536|FG000|Overall Study|Study terminated by sponsor|0|||
16439806|NCT01519323|40089537|FG001|Overall Study|Study terminated by sponsor|1|||
16439807|NCT02246530|40089538|FG000|Overall Study|Lost to Follow-up|4|||
16439808|NCT02246530|40089539|FG001|Overall Study|Lost to Follow-up|0|||
16439809|NCT03547518|40089540|FG000|Overall Study|Lost to Follow-up|2|||
16439810|NCT03547518|40089541|FG001|Overall Study|Lost to Follow-up|0|||
16439811|NCT03473236|40089542|FG000|Overall Study|Withdrawal by Subject|0|||
16439812|NCT03473236|40089543|FG001|Overall Study|Withdrawal by Subject|0|||
16439813|NCT03473236|40089544|FG002|Overall Study|Withdrawal by Subject|0|||
16439814|NCT03473236|40089545|FG003|Overall Study|Withdrawal by Subject|0|||
16439815|NCT03473236|40089546|FG004|Overall Study|Withdrawal by Subject|0|||
16439816|NCT03473236|40089547|FG005|Overall Study|Withdrawal by Subject|1|||
16439817|NCT03473236|40089548|FG006|Overall Study|Withdrawal by Subject|0|||
16439818|NCT03473236|40089549|FG007|Overall Study|Withdrawal by Subject|0|||
16439819|NCT03473236|40089550|FG008|Overall Study|Withdrawal by Subject|1|||
16144126|NCT03275285|39017243|FG001|Overall Study|Ongoing|69|||
16144127|NCT02321930|39017244|FG000|Overall Study|Lost to Follow-up|1|||
16144128|NCT02689284|39017245|FG000|Overall Study|Adverse Event|1|||
16144129|NCT02689284|39017246|FG001|Overall Study|Adverse Event|8|||
16144130|NCT02689284|39017245|FG000|Overall Study|Death|0|||
16144131|NCT02689284|39017246|FG001|Overall Study|Death|1|||
16144132|NCT02689284|39017245|FG000|Overall Study|Physician Decision|1|||
16144133|NCT02689284|39017246|FG001|Overall Study|Physician Decision|2|||
16144134|NCT02689284|39017245|FG000|Overall Study|Withdrawal by Subject|0|||
16144135|NCT02689284|39017246|FG001|Overall Study|Withdrawal by Subject|1|||
16144136|NCT02689284|39017245|FG000|Overall Study|progression of cancer|1|||
16144137|NCT02689284|39017246|FG001|Overall Study|progression of cancer|72|||
16144138|NCT02689284|39017245|FG000|Overall Study|decreased heart function|0|||
16144139|NCT02689284|39017246|FG001|Overall Study|decreased heart function|1|||
16144140|NCT02689284|39017245|FG000|Overall Study|concern for anemia|0|||
16144141|NCT02689284|39017246|FG001|Overall Study|concern for anemia|1|||
16144142|NCT02689284|39017245|FG000|Overall Study|no measurable cancer for evaluation|0|||
16144143|NCT02689284|39017246|FG001|Overall Study|no measurable cancer for evaluation|1|||
16144144|NCT01195545|39017251|FG000|Overall Study|Protocol Violation|4|||
16144145|NCT00403754|39017257|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
16144146|NCT00403754|39017258|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
16144147|NCT00403754|39017259|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
16144148|NCT00403754|39017260|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
16144149|NCT00403754|39017257|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
16144150|NCT00403754|39017258|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
16144151|NCT00403754|39017259|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
16144152|NCT00403754|39017260|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
16144153|NCT00789880|39017261|FG000|Overall Study|Adverse Event|0|||
16144154|NCT00789880|39017262|FG001|Overall Study|Adverse Event|0|||
16144155|NCT00789880|39017263|FG002|Overall Study|Adverse Event|0|||
16144156|NCT00789880|39017264|FG003|Overall Study|Adverse Event|0|||
16144157|NCT00789880|39017265|FG004|Overall Study|Adverse Event|1|||
16144158|NCT00789880|39017266|FG005|Overall Study|Adverse Event|0|||
16144159|NCT00789880|39017261|FG000|Overall Study|Protocol Violation|0|||
16144160|NCT00789880|39017262|FG001|Overall Study|Protocol Violation|1|||
16144161|NCT00789880|39017263|FG002|Overall Study|Protocol Violation|0|||
16144162|NCT00789880|39017264|FG003|Overall Study|Protocol Violation|1|||
16144163|NCT00789880|39017265|FG004|Overall Study|Protocol Violation|0|||
16144164|NCT00789880|39017266|FG005|Overall Study|Protocol Violation|0|||
16144165|NCT00789880|39017261|FG000|Overall Study|Withdrawal by Subject|1|||
16144166|NCT00789880|39017262|FG001|Overall Study|Withdrawal by Subject|0|||
16144167|NCT00789880|39017263|FG002|Overall Study|Withdrawal by Subject|0|||
16144168|NCT00789880|39017264|FG003|Overall Study|Withdrawal by Subject|0|||
16144169|NCT00789880|39017265|FG004|Overall Study|Withdrawal by Subject|2|||
16144170|NCT00789880|39017266|FG005|Overall Study|Withdrawal by Subject|0|||
16144171|NCT02445755|39017267|FG000|Overall Study|Withdrawal by Subject|2|||
16144172|NCT02445755|39017267|FG000|Overall Study|Protocol Violation|6|||
16144173|NCT02445755|39017267|FG000|Overall Study|Screen Failure|5|||
16144174|NCT00121108|39017272|FG000|Overall Study|Lost to Follow-up|10|||
16144175|NCT00121108|39017273|FG001|Overall Study|Lost to Follow-up|22|||
16144176|NCT00121108|39017272|FG000|Overall Study|Withdrawal by Subject|106|||
16144177|NCT00121108|39017273|FG001|Overall Study|Withdrawal by Subject|195|||
16144178|NCT00121108|39017272|FG000|Overall Study|Death|5|||
16144179|NCT00121108|39017273|FG001|Overall Study|Death|8|||
16144180|NCT02465463|39017275|FG000|Overall Study|Lost to Follow-up|2|||
16144181|NCT02465463|39017276|FG001|Overall Study|Lost to Follow-up|1|||
16144182|NCT02465463|39017275|FG000|Overall Study|Death|1|||
16144183|NCT02465463|39017276|FG001|Overall Study|Death|0|||
16144184|NCT02465463|39017275|FG000|Overall Study|Protocol Violation|1|||
16144185|NCT02465463|39017276|FG001|Overall Study|Protocol Violation|0|||
16144186|NCT03021499|39017279|FG000|Overall Study|Adverse Event|1|||
16144187|NCT03021499|39017280|FG001|Overall Study|Adverse Event|0|||
16144188|NCT03021499|39017279|FG000|Overall Study|Death|1|||
16144189|NCT03021499|39017280|FG001|Overall Study|Death|5|||
16144190|NCT03021499|39017279|FG000|Overall Study|Lack of Efficacy|0|||
16144191|NCT03021499|39017280|FG001|Overall Study|Lack of Efficacy|1|||
16144192|NCT03021499|39017279|FG000|Overall Study|Lost to Follow-up|1|||
16144193|NCT03021499|39017280|FG001|Overall Study|Lost to Follow-up|3|||
16144194|NCT03021499|39017279|FG000|Overall Study|Physician Decision|2|||
16144195|NCT03021499|39017280|FG001|Overall Study|Physician Decision|3|||
16144196|NCT03021499|39017279|FG000|Overall Study|Pregnancy|1|||
16144197|NCT03021499|39017280|FG001|Overall Study|Pregnancy|0|||
16144198|NCT03021499|39017279|FG000|Overall Study|Withdrawal by Subject|7|||
16144199|NCT03021499|39017280|FG001|Overall Study|Withdrawal by Subject|14|||
16144200|NCT03021499|39017279|FG000|Overall Study|Prohibited medication required|1|||
16144201|NCT03021499|39017280|FG001|Overall Study|Prohibited medication required|0|||
16144202|NCT03021499|39017279|FG000|Overall Study|Protocol non-compliance|1|||
16144203|NCT03021499|39017280|FG001|Overall Study|Protocol non-compliance|1|||
16144204|NCT03021499|39017279|FG000|Overall Study|None of the above|0|||
16144205|NCT03021499|39017280|FG001|Overall Study|None of the above|4|||
16144206|NCT03021499|39017279|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
16144207|NCT03021499|39017280|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
16144208|NCT01010633|39017286|FG000|Overall Study|Adverse Event|1|||
16144209|NCT01010633|39017287|FG001|Overall Study|Adverse Event|1|||
16144210|NCT01010633|39017286|FG000|Overall Study|Protocol Violation|1|||
16144211|NCT01010633|39017287|FG001|Overall Study|Protocol Violation|2|||
16144212|NCT01010633|39017286|FG000|Overall Study|Withdrawal by Subject|2|||
16144213|NCT01010633|39017287|FG001|Overall Study|Withdrawal by Subject|1|||
16144214|NCT01010633|39017286|FG000|Overall Study|Investigator decision|0|||
16144215|NCT01010633|39017287|FG001|Overall Study|Investigator decision|1|||
16144216|NCT00073528|39017288|FG000|Overall Study|Death|488|||
16144217|NCT00073528|39017289|FG001|Overall Study|Death|473|||
16144218|NCT00073528|39017288|FG000|Overall Study|Lost to Follow-up|52|||
16144219|NCT00073528|39017289|FG001|Overall Study|Lost to Follow-up|45|||
16144220|NCT00073528|39017288|FG000|Overall Study|Withdrawal by Subject|50|||
16144221|NCT00073528|39017289|FG001|Overall Study|Withdrawal by Subject|45|||
16144222|NCT00073528|39017288|FG000|Overall Study|Study terminated by Sponsor|10|||
16144223|NCT00073528|39017289|FG001|Overall Study|Study terminated by Sponsor|29|||
16144224|NCT00073528|39017288|FG000|Overall Study|Other|18|||
16144225|NCT00073528|39017289|FG001|Overall Study|Other|19|||
16144226|NCT00073528|39017288|FG000|Overall Study|Other|9|||
16144227|NCT00073528|39017289|FG001|Overall Study|Other|12|||
16144228|NCT00073528|39017288|FG000|Overall Study|Protocol Violation|3|||
16144229|NCT00073528|39017289|FG001|Overall Study|Protocol Violation|5|||
16144230|NCT01886313|39017290|FG000|Overall Study|Adverse Event|1|||
16144231|NCT01886313|39017291|FG001|Overall Study|Adverse Event|1|||
16144232|NCT01490450|39017297|FG000|Period 1|Lack of Efficacy|2|||
16144233|NCT01490450|39017298|FG001|Period 1|Lack of Efficacy|0|||
16144234|NCT01490450|39017299|FG002|Period 1|Lack of Efficacy|3|||
16144235|NCT01490450|39017300|FG003|Period 1|Lack of Efficacy|0|||
16144236|NCT01490450|39017297|FG000|Period 1|Adverse Event|0|||
16144237|NCT01490450|39017298|FG001|Period 1|Adverse Event|0|||
16144238|NCT01490450|39017299|FG002|Period 1|Adverse Event|0|||
16144239|NCT01490450|39017300|FG003|Period 1|Adverse Event|5|||
16144240|NCT01490450|39017297|FG000|Period 1|Request to discontinue treatment|1|||
16144241|NCT01490450|39017298|FG001|Period 1|Request to discontinue treatment|0|||
16144242|NCT01490450|39017299|FG002|Period 1|Request to discontinue treatment|0|||
16144243|NCT01490450|39017300|FG003|Period 1|Request to discontinue treatment|0|||
16144244|NCT01490450|39017297|FG000|Period 1|Withdrawal by Subject|0|||
16144245|NCT01490450|39017298|FG001|Period 1|Withdrawal by Subject|0|||
16144246|NCT01490450|39017299|FG002|Period 1|Withdrawal by Subject|0|||
16144247|NCT01490450|39017300|FG003|Period 1|Withdrawal by Subject|3|||
16144248|NCT01490450|39017297|FG000|Period 1|No longer met study criteria|0|||
16144249|NCT01490450|39017298|FG001|Period 1|No longer met study criteria|1|||
16144250|NCT01490450|39017299|FG002|Period 1|No longer met study criteria|1|||
16144251|NCT01490450|39017300|FG003|Period 1|No longer met study criteria|0|||
16144252|NCT01490450|39017297|FG000|Period 2|Lack of Efficacy|0|||
16144253|NCT01490450|39017298|FG001|Period 2|Lack of Efficacy|0|||
16144254|NCT01490450|39017299|FG002|Period 2|Lack of Efficacy|0|||
16144255|NCT01490450|39017300|FG003|Period 2|Lack of Efficacy|1|||
16144256|NCT01490450|39017297|FG000|Period 2|Adverse Event|1|||
16144257|NCT01490450|39017298|FG001|Period 2|Adverse Event|1|||
16144258|NCT01490450|39017299|FG002|Period 2|Adverse Event|0|||
16144259|NCT01490450|39017300|FG003|Period 2|Adverse Event|1|||
16144260|NCT01490450|39017297|FG000|Period 2|Withdrawal by Subject|1|||
16144261|NCT01490450|39017298|FG001|Period 2|Withdrawal by Subject|0|||
16144262|NCT01490450|39017299|FG002|Period 2|Withdrawal by Subject|0|||
16144263|NCT01490450|39017300|FG003|Period 2|Withdrawal by Subject|0|||
16144264|NCT01490450|39017297|FG000|Period 2|Lost to Follow-up|0|||
16144265|NCT01490450|39017298|FG001|Period 2|Lost to Follow-up|0|||
16144266|NCT01490450|39017299|FG002|Period 2|Lost to Follow-up|0|||
16144267|NCT01490450|39017300|FG003|Period 2|Lost to Follow-up|2|||
16144268|NCT01721876|39017301|FG000|Overall Study|Not treated|1|||
16144269|NCT01721876|39017302|FG001|Overall Study|Not treated|4|||
16144270|NCT01721876|39017301|FG000|Overall Study|Disease progression / relapse|123|||
16144271|NCT01721876|39017302|FG001|Overall Study|Disease progression / relapse|156|||
16144272|NCT01721876|39017301|FG000|Overall Study|Death|6|||
16144273|NCT01721876|39017302|FG001|Overall Study|Death|13|||
16144274|NCT01721876|39017301|FG000|Overall Study|Adverse Event|41|||
16144275|NCT01721876|39017302|FG001|Overall Study|Adverse Event|165|||
16144276|NCT01721876|39017301|FG000|Overall Study|Protocol Violation|2|||
16144277|NCT01721876|39017302|FG001|Overall Study|Protocol Violation|1|||
16144278|NCT01721876|39017301|FG000|Overall Study|Withdrawal by Subject|15|||
16144279|NCT01721876|39017302|FG001|Overall Study|Withdrawal by Subject|38|||
16144280|NCT01721876|39017301|FG000|Overall Study|Reason not listed|34|||
16144281|NCT01721876|39017302|FG001|Overall Study|Reason not listed|63|||
16144282|NCT01721876|39017301|FG000|Overall Study|Sponsor terminated trial|0|||
16144283|NCT01721876|39017302|FG001|Overall Study|Sponsor terminated trial|4|||
16144284|NCT01186939|39017303|FG000|Overall Study|Death|7|||
16144285|NCT01186939|39017303|FG000|Overall Study|Withdrawal by Subject|2|||
16144286|NCT01186939|39017303|FG000|Overall Study|No longer receiving clinical benefit|17|||
16144287|NCT01186939|39017303|FG000|Overall Study|Program closed|5|||
16144288|NCT01186939|39017303|FG000|Overall Study|Sponsor decision|4|||
16144289|NCT01186939|39017303|FG000|Overall Study|Started additional treatment|1|||
16144290|NCT01186939|39017303|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
16144291|NCT01186939|39017303|FG000|Overall Study|Myocardial infarction|1|||
16144292|NCT01186939|39017303|FG000|Overall Study|Bone marrow transplant|1|||
16144293|NCT01186939|39017303|FG000|Overall Study|Transformation to AML|1|||
16144294|NCT03829241|39017306|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
16144295|NCT03829241|39017307|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
16144296|NCT03829241|39017306|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
16144297|NCT03829241|39017307|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
16144298|NCT03829241|39017306|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
16144299|NCT03829241|39017307|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
16144300|NCT03829241|39017306|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
16144301|NCT03829241|39017307|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
16144302|NCT03829241|39017306|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
16144303|NCT03829241|39017307|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
16144304|NCT03829241|39017306|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
16144305|NCT03829241|39017307|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
16144306|NCT03829241|39017306|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
16144307|NCT03829241|39017307|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
16144308|NCT03829241|39017306|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
16144309|NCT03829241|39017307|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
16144310|NCT03829241|39017306|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
16144311|NCT03829241|39017307|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
16144312|NCT03829241|39017306|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
16144313|NCT03829241|39017307|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
16144314|NCT03829241|39017306|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
16144315|NCT03829241|39017307|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
16144316|NCT03829241|39017306|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
16144317|NCT03829241|39017307|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
16144318|NCT03829241|39017306|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
16144319|NCT03829241|39017307|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
16144320|NCT03829241|39017306|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
16144321|NCT03829241|39017307|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
16144322|NCT01279850|39017312|FG000|Overall Study|Protocol Violation|50|||
16144323|NCT01279850|39017312|FG000|Overall Study|No Drug Administration Information|7|||
16144324|NCT01279850|39017312|FG000|Overall Study|No Visit After Treatment|34|||
16144325|NCT00594516|39017316|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
16144326|NCT00594516|39017317|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
16144327|NCT00594516|39017318|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
16144328|NCT00594516|39017316|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
16144329|NCT00594516|39017317|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
16144330|NCT00594516|39017318|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
16144331|NCT00594516|39017316|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
16144332|NCT00594516|39017317|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
16144333|NCT00594516|39017318|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
16144334|NCT00594516|39017316|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
16144335|NCT00594516|39017317|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
16144336|NCT00594516|39017318|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
16144337|NCT00594516|39017316|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
16144338|NCT00594516|39017317|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
16144339|NCT00594516|39017318|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
16144340|NCT00594516|39017316|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
16144341|NCT00594516|39017317|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
16144342|NCT00594516|39017318|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
16144343|NCT00594516|39017316|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
16144344|NCT00594516|39017317|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
16144345|NCT00594516|39017318|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
16144346|NCT00594516|39017316|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
16144347|NCT00594516|39017317|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
16144348|NCT00594516|39017318|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
16144349|NCT00594516|39017316|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
16144350|NCT00594516|39017317|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
16144351|NCT00594516|39017318|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
16144352|NCT02224599|39017319|FG000|Overall Study|Physician Decision|1|||
16144353|NCT02224599|39017319|FG000|Overall Study|Progression of Disease|1|||
16144354|NCT00314249|39017328|FG000|Overall Study|Adverse Event|73|||
16144355|NCT00314249|39017329|FG001|Overall Study|Adverse Event|94|||
16144356|NCT00314249|39017328|FG000|Overall Study|Lack of Efficacy|33|||
16144357|NCT00314249|39017329|FG001|Overall Study|Lack of Efficacy|24|||
16144358|NCT00314249|39017328|FG000|Overall Study|Withdrawal by Subject|21|||
16144359|NCT00314249|39017329|FG001|Overall Study|Withdrawal by Subject|28|||
16144360|NCT00314249|39017328|FG000|Overall Study|Lost to Follow-up|15|||
16144361|NCT00314249|39017329|FG001|Overall Study|Lost to Follow-up|9|||
16144362|NCT00314249|39017328|FG000|Overall Study|Physician Decision|1|||
16144363|NCT00314249|39017329|FG001|Overall Study|Physician Decision|1|||
16144364|NCT00314249|39017328|FG000|Overall Study|Withdrawn for other reasons|4|||
16144365|NCT00314249|39017329|FG001|Overall Study|Withdrawn for other reasons|1|||
16144366|NCT00314249|39017328|FG000|Overall Study|Non-Compliant|5|||
16144367|NCT00314249|39017329|FG001|Overall Study|Non-Compliant|6|||
16144368|NCT01641237|39017337|FG000|Period II|Withdrawal by Subject|1|||
16144369|NCT01641237|39017338|FG001|Period II|Withdrawal by Subject|0|||
16144370|NCT01641237|39017339|FG002|Period II|Withdrawal by Subject|0|||
16144371|NCT01641237|39017340|FG003|Period II|Withdrawal by Subject|0|||
16144372|NCT01641237|39017337|FG000|Period III|Lost to Follow-up|1|||
16144373|NCT01641237|39017338|FG001|Period III|Lost to Follow-up|0|||
16144374|NCT01641237|39017339|FG002|Period III|Lost to Follow-up|0|||
16144375|NCT01641237|39017340|FG003|Period III|Lost to Follow-up|0|||
16144376|NCT00698451|39017341|FG000|Overall Study|Adverse Event|22|||
16144377|NCT00698451|39017341|FG000|Overall Study|Physician Decision|2|||
16144378|NCT00698451|39017341|FG000|Overall Study|Protocol Violation|6|||
16144379|NCT00698451|39017341|FG000|Overall Study|Withdrawal by Subject|6|||
16144380|NCT00698451|39017341|FG000|Overall Study|Disease progression|3|||
16144381|NCT02739620|39017353|FG000|Overall Study|Lost to Follow-up|3|||
16144382|NCT02739620|39017354|FG001|Overall Study|Lost to Follow-up|1|||
16144383|NCT02739620|39017353|FG000|Overall Study|Adverse Event|0|||
16144384|NCT02739620|39017354|FG001|Overall Study|Adverse Event|1|||
16144385|NCT02285998|39017355|FG000|Overall Study|Adverse Event|9|||
16144386|NCT02285998|39017356|FG001|Overall Study|Adverse Event|8|||
16144387|NCT02285998|39017355|FG000|Overall Study|Physician Decision|1|||
16144388|NCT02285998|39017356|FG001|Overall Study|Physician Decision|2|||
16144389|NCT02285998|39017355|FG000|Overall Study|Lost to Follow-up|176|||
16144390|NCT02285998|39017356|FG001|Overall Study|Lost to Follow-up|172|||
16144391|NCT02285998|39017355|FG000|Overall Study|Withdrawal by Subject|53|||
16144392|NCT02285998|39017356|FG001|Overall Study|Withdrawal by Subject|61|||
16144393|NCT02285998|39017355|FG000|Overall Study|Other Reasons|7|||
16144394|NCT02285998|39017356|FG001|Overall Study|Other Reasons|10|||
16144395|NCT02535715|39017361|FG000|Overall Study|Withdrawal by Subject|0|||
16144396|NCT02535715|39017362|FG001|Overall Study|Withdrawal by Subject|0|||
16144397|NCT02535715|39017363|FG002|Overall Study|Withdrawal by Subject|1|||
16144398|NCT00397033|39017366|FG000|Overall Study|Adverse Event|7|||
16144399|NCT00397033|39017367|FG001|Overall Study|Adverse Event|10|||
16144400|NCT00397033|39017368|FG002|Overall Study|Adverse Event|4|||
16144401|NCT00397033|39017366|FG000|Overall Study|Lack of Efficacy|22|||
16144402|NCT00397033|39017367|FG001|Overall Study|Lack of Efficacy|12|||
16144403|NCT00397033|39017368|FG002|Overall Study|Lack of Efficacy|9|||
16144404|NCT00397033|39017366|FG000|Overall Study|Lost to Follow-up|3|||
16144405|NCT00397033|39017367|FG001|Overall Study|Lost to Follow-up|3|||
16144406|NCT00397033|39017368|FG002|Overall Study|Lost to Follow-up|3|||
16144407|NCT00397033|39017366|FG000|Overall Study|Withdrawal by Subject|12|||
16144408|NCT00397033|39017367|FG001|Overall Study|Withdrawal by Subject|7|||
16144409|NCT00397033|39017368|FG002|Overall Study|Withdrawal by Subject|5|||
16144410|NCT00397033|39017366|FG000|Overall Study|Other|0|||
16144411|NCT00397033|39017367|FG001|Overall Study|Other|5|||
16144412|NCT00397033|39017368|FG002|Overall Study|Other|2|||
16144413|NCT05513625|39017369|FG000|Overall Study|Withdrawal by Subject|1|||
16144414|NCT00578136|39017370|FG000|Overall Study|Not given intervention|1|||
16144415|NCT00578136|39017371|FG001|Overall Study|Not given intervention|1|||
16144416|NCT00129623|39017374|FG000|Overall Study|Adverse Event|3|||
16144417|NCT00129623|39017375|FG001|Overall Study|Adverse Event|7|||
16144418|NCT00129623|39017374|FG000|Overall Study|Refused Treatment|5|||
16144419|NCT00129623|39017375|FG001|Overall Study|Refused Treatment|3|||
16144420|NCT00129623|39017374|FG000|Overall Study|Failure to Return|1|||
16144421|NCT00129623|39017375|FG001|Overall Study|Failure to Return|1|||
16144422|NCT00129623|39017374|FG000|Overall Study|Relocated job out of state|1|||
16144423|NCT00129623|39017375|FG001|Overall Study|Relocated job out of state|0|||
16144424|NCT00129623|39017374|FG000|Overall Study|Uncertainty to return|0|||
16144425|NCT00129623|39017375|FG001|Overall Study|Uncertainty to return|1|||
16144426|NCT02613884|39017380|FG000|Overall Study|Death|1|||
16144427|NCT02613884|39017380|FG000|Overall Study|Lost to Follow-up|1|||
16144428|NCT02546765|39017381|FG000|Overall Study|Withdrawal by Subject|0|||
16144429|NCT02546765|39017382|FG001|Overall Study|Withdrawal by Subject|1|||
16144430|NCT02546765|39017383|FG002|Overall Study|Withdrawal by Subject|0|||
16144431|NCT02546765|39017384|FG003|Overall Study|Withdrawal by Subject|0|||
16144432|NCT02014740|39017385|FG000|Overall Study|Lost to Follow-up|4|||
16144433|NCT02014740|39017386|FG001|Overall Study|Lost to Follow-up|4|||
16144434|NCT02014740|39017385|FG000|Overall Study|Withdrawal by Subject|2|||
16144435|NCT02014740|39017386|FG001|Overall Study|Withdrawal by Subject|1|||
16144436|NCT02217436|39017388|FG000|Overall Study|Protocol Violation|1|||
16144437|NCT02217436|39017389|FG001|Overall Study|Protocol Violation|1|||
16144438|NCT02217436|39017388|FG000|Overall Study|Incomplete data|0|||
16144439|NCT02217436|39017389|FG001|Overall Study|Incomplete data|1|||
16144440|NCT00882310|39017394|FG000|Overall Study|Screen Failure|10|||
16144441|NCT00882310|39017394|FG000|Overall Study|Never received treatment|1|||
16144442|NCT00882310|39017394|FG000|Overall Study|Death|6|||
16144443|NCT00882310|39017394|FG000|Overall Study|Progression of disease|4|||
16144444|NCT00882310|39017394|FG000|Overall Study|Adverse Event|1|||
16144445|NCT02708095|39017397|FG000|Overall Study|Adverse Event|4|||
16144446|NCT02708095|39017398|FG001|Overall Study|Adverse Event|10|||
16144447|NCT02708095|39017399|FG002|Overall Study|Adverse Event|11|||
16144448|NCT02708095|39017397|FG000|Overall Study|Lack of Efficacy|9|||
16144449|NCT02708095|39017398|FG001|Overall Study|Lack of Efficacy|3|||
16144450|NCT02708095|39017399|FG002|Overall Study|Lack of Efficacy|0|||
16144451|NCT02708095|39017397|FG000|Overall Study|Lost to Follow-up|2|||
16144452|NCT02708095|39017398|FG001|Overall Study|Lost to Follow-up|0|||
16144453|NCT02708095|39017399|FG002|Overall Study|Lost to Follow-up|0|||
16144454|NCT02708095|39017397|FG000|Overall Study|Physician Decision|2|||
16144455|NCT02708095|39017398|FG001|Overall Study|Physician Decision|3|||
16144456|NCT02708095|39017399|FG002|Overall Study|Physician Decision|2|||
16144457|NCT02708095|39017397|FG000|Overall Study|Protocol Violation|0|||
16144458|NCT02708095|39017398|FG001|Overall Study|Protocol Violation|0|||
16144459|NCT02708095|39017399|FG002|Overall Study|Protocol Violation|1|||
16144460|NCT02708095|39017397|FG000|Overall Study|Withdrawal by Subject|5|||
16144461|NCT02708095|39017398|FG001|Overall Study|Withdrawal by Subject|3|||
16144462|NCT02708095|39017399|FG002|Overall Study|Withdrawal by Subject|4|||
16144463|NCT00888381|39017402|FG000|Overall Study|Lost to Follow-up|0|||
16144464|NCT00888381|39017403|FG001|Overall Study|Lost to Follow-up|1|||
16144465|NCT00058552|39017404|FG000|Overall Study|Died prior to receiving treatment|4|||
16144466|NCT00058552|39017405|FG001|Overall Study|Died prior to receiving treatment|2|||
16144467|NCT00058552|39017404|FG000|Overall Study|Disease progression|52|||
16144468|NCT00058552|39017405|FG001|Overall Study|Disease progression|44|||
16144469|NCT00058552|39017404|FG000|Overall Study|Adverse Event|4|||
16144470|NCT00058552|39017405|FG001|Overall Study|Adverse Event|2|||
16144471|NCT00058552|39017404|FG000|Overall Study|Withdrawal by Subject|3|||
16144472|NCT00058552|39017405|FG001|Overall Study|Withdrawal by Subject|5|||
16144473|NCT00058552|39017404|FG000|Overall Study|Physician Decision|2|||
16144474|NCT00058552|39017405|FG001|Overall Study|Physician Decision|5|||
16144475|NCT00058552|39017404|FG000|Overall Study|Clinical disease progression|0|||
16144476|NCT00058552|39017405|FG001|Overall Study|Clinical disease progression|4|||
16144477|NCT01798992|39017406|FG000|Overall Study|Administrative withdrawal|0|||
16144478|NCT01798992|39017407|FG001|Overall Study|Administrative withdrawal|1|||
16144479|NCT01798992|39017408|FG002|Overall Study|Administrative withdrawal|0|||
16144480|NCT01798992|39017409|FG003|Overall Study|Administrative withdrawal|1|||
16144481|NCT01798992|39017406|FG000|Overall Study|Lost to Follow-up|0|||
16144482|NCT01798992|39017407|FG001|Overall Study|Lost to Follow-up|1|||
16144483|NCT01798992|39017408|FG002|Overall Study|Lost to Follow-up|1|||
16144484|NCT01798992|39017409|FG003|Overall Study|Lost to Follow-up|0|||
16144485|NCT01798992|39017406|FG000|Overall Study|Insufficient biopsy tissue|0|||
16144486|NCT01798992|39017407|FG001|Overall Study|Insufficient biopsy tissue|0|||
16144487|NCT01798992|39017408|FG002|Overall Study|Insufficient biopsy tissue|1|||
16144488|NCT01798992|39017409|FG003|Overall Study|Insufficient biopsy tissue|0|||
16144489|NCT02281357|39017413|FG000|Overall Study|Adverse Event|2|||
16144490|NCT02281357|39017414|FG001|Overall Study|Adverse Event|1|||
16144491|NCT02281357|39017413|FG000|Overall Study|Lost to Follow-up|1|||
16144492|NCT02281357|39017414|FG001|Overall Study|Lost to Follow-up|0|||
16144493|NCT02281357|39017413|FG000|Overall Study|Withdrawal by Subject|4|||
16144494|NCT02281357|39017414|FG001|Overall Study|Withdrawal by Subject|3|||
16144495|NCT02108964|39017415|FG000|Overall Study|Progressive disease|12|||
16144496|NCT02108964|39017416|FG001|Overall Study|Progressive disease|25|||
16144497|NCT02108964|39017417|FG002|Overall Study|Progressive disease|50|||
16144498|NCT02108964|39017418|FG003|Overall Study|Progressive disease|6|||
16144499|NCT02108964|39017419|FG004|Overall Study|Progressive disease|18|||
16144500|NCT02108964|39017420|FG005|Overall Study|Progressive disease|5|||
16144501|NCT02108964|39017421|FG006|Overall Study|Progressive disease|7|||
16144502|NCT02108964|39017422|FG007|Overall Study|Progressive disease|9|||
16144503|NCT02108964|39017415|FG000|Overall Study|Physician Decision|1|||
16144504|NCT02108964|39017416|FG001|Overall Study|Physician Decision|5|||
16144505|NCT02108964|39017417|FG002|Overall Study|Physician Decision|6|||
16144506|NCT02108964|39017418|FG003|Overall Study|Physician Decision|0|||
16144507|NCT02108964|39017419|FG004|Overall Study|Physician Decision|1|||
16144508|NCT02108964|39017420|FG005|Overall Study|Physician Decision|0|||
16144509|NCT02108964|39017421|FG006|Overall Study|Physician Decision|0|||
16144510|NCT02108964|39017422|FG007|Overall Study|Physician Decision|0|||
16144511|NCT02108964|39017415|FG000|Overall Study|Adverse Event|0|||
16144512|NCT02108964|39017416|FG001|Overall Study|Adverse Event|0|||
16144513|NCT02108964|39017417|FG002|Overall Study|Adverse Event|4|||
16144514|NCT02108964|39017418|FG003|Overall Study|Adverse Event|0|||
16144515|NCT02108964|39017419|FG004|Overall Study|Adverse Event|1|||
16144516|NCT02108964|39017420|FG005|Overall Study|Adverse Event|0|||
16144517|NCT02108964|39017421|FG006|Overall Study|Adverse Event|3|||
16144518|NCT02108964|39017422|FG007|Overall Study|Adverse Event|1|||
16144519|NCT02108964|39017415|FG000|Overall Study|Death|1|||
16144520|NCT02108964|39017416|FG001|Overall Study|Death|1|||
16144521|NCT02108964|39017417|FG002|Overall Study|Death|2|||
16144522|NCT02108964|39017418|FG003|Overall Study|Death|0|||
16144523|NCT02108964|39017419|FG004|Overall Study|Death|3|||
16144524|NCT02108964|39017420|FG005|Overall Study|Death|0|||
16144525|NCT02108964|39017421|FG006|Overall Study|Death|0|||
16144526|NCT02108964|39017422|FG007|Overall Study|Death|1|||
16144527|NCT02108964|39017415|FG000|Overall Study|Subject/Guardian decision|0|||
16144528|NCT02108964|39017416|FG001|Overall Study|Subject/Guardian decision|1|||
16144529|NCT02108964|39017417|FG002|Overall Study|Subject/Guardian decision|3|||
16144530|NCT02108964|39017418|FG003|Overall Study|Subject/Guardian decision|0|||
16144531|NCT02108964|39017419|FG004|Overall Study|Subject/Guardian decision|2|||
16144532|NCT02108964|39017420|FG005|Overall Study|Subject/Guardian decision|0|||
16144533|NCT02108964|39017421|FG006|Overall Study|Subject/Guardian decision|1|||
16144534|NCT02108964|39017422|FG007|Overall Study|Subject/Guardian decision|1|||
16144535|NCT00283049|39017423|FG000|Overall Study|Adverse Event|6|||
16144536|NCT00283049|39017424|FG001|Overall Study|Adverse Event|1|||
16144537|NCT00283049|39017425|FG002|Overall Study|Adverse Event|4|||
16144538|NCT00283049|39017423|FG000|Overall Study|Protocol Violation|3|||
16144539|NCT00283049|39017424|FG001|Overall Study|Protocol Violation|0|||
16144540|NCT00283049|39017425|FG002|Overall Study|Protocol Violation|3|||
16144541|NCT00283049|39017423|FG000|Overall Study|Death|1|||
16144542|NCT00283049|39017424|FG001|Overall Study|Death|1|||
16144543|NCT00283049|39017425|FG002|Overall Study|Death|1|||
16144544|NCT00283049|39017423|FG000|Overall Study|Lack of Efficacy|0|||
16144545|NCT00283049|39017424|FG001|Overall Study|Lack of Efficacy|1|||
16144546|NCT00283049|39017425|FG002|Overall Study|Lack of Efficacy|1|||
16144547|NCT00283049|39017423|FG000|Overall Study|Lost to Follow-up|4|||
16144548|NCT00283049|39017424|FG001|Overall Study|Lost to Follow-up|2|||
16144549|NCT00283049|39017425|FG002|Overall Study|Lost to Follow-up|5|||
16144550|NCT00283049|39017423|FG000|Overall Study|Withdrawal by Subject|26|||
16144551|NCT00283049|39017424|FG001|Overall Study|Withdrawal by Subject|24|||
16144552|NCT00283049|39017425|FG002|Overall Study|Withdrawal by Subject|19|||
16144553|NCT00283049|39017423|FG000|Overall Study|Discontinuation of Study|18|||
16144554|NCT00283049|39017424|FG001|Overall Study|Discontinuation of Study|16|||
16144555|NCT00283049|39017425|FG002|Overall Study|Discontinuation of Study|20|||
16144556|NCT00283049|39017423|FG000|Overall Study|No longer requires study treatment|0|||
16364242|NCT02065557|39818244|FG000|Induction Period|Adverse Event|1|||
16144557|NCT00283049|39017424|FG001|Overall Study|No longer requires study treatment|0|||
16144558|NCT00283049|39017425|FG002|Overall Study|No longer requires study treatment|1|||
16144559|NCT02684279|39017426|FG000|Overall Study|Adverse Event|87|||
16144560|NCT02684279|39017426|FG000|Overall Study|Lack of Efficacy|4|||
16144561|NCT02684279|39017426|FG000|Overall Study|Lost to Follow-up|61|||
16144562|NCT02684279|39017426|FG000|Overall Study|Protocol Violation|6|||
16364243|NCT02065557|39818245|FG001|Induction Period|Adverse Event|1|||
16144563|NCT02684279|39017426|FG000|Overall Study|Pregnancy|8|||
16144564|NCT02684279|39017426|FG000|Overall Study|Withdrawal by Subject|92|||
16144565|NCT02684279|39017426|FG000|Overall Study|non-compliance with study drug|9|||
16144566|NCT02684279|39017426|FG000|Overall Study|non compliance with study visits|2|||
16144567|NCT02684279|39017426|FG000|Overall Study|subject to have surgery|1|||
16144568|NCT02684279|39017426|FG000|Overall Study|family emergency|1|||
16144569|NCT02684279|39017426|FG000|Overall Study|Site closures|7|||
16144570|NCT02684279|39017426|FG000|Overall Study|Physician Decision|1|||
16144571|NCT01287364|39017427|FG000|Overall Study|Adverse Event|0|||
16144572|NCT01287364|39017428|FG001|Overall Study|Adverse Event|3|||
16144573|NCT01287364|39017427|FG000|Overall Study|Protocol Violation|5|||
16144574|NCT01287364|39017428|FG001|Overall Study|Protocol Violation|5|||
16144575|NCT01287364|39017427|FG000|Overall Study|Other Reason|4|||
16144576|NCT01287364|39017428|FG001|Overall Study|Other Reason|2|||
16144577|NCT03308942|39017429|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
16144578|NCT03308942|39017430|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
16144579|NCT03308942|39017431|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
16144580|NCT03308942|39017432|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
16144581|NCT03308942|39017433|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
16144582|NCT03308942|39017429|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
16144583|NCT03308942|39017430|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
16144584|NCT03308942|39017431|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
16144585|NCT03308942|39017432|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
16144586|NCT03308942|39017433|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
16144587|NCT03308942|39017429|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
16144588|NCT03308942|39017430|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
16144589|NCT03308942|39017431|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
16144590|NCT03308942|39017432|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
16144591|NCT03308942|39017433|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
16144592|NCT03308942|39017429|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
16144593|NCT03308942|39017430|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
16144594|NCT03308942|39017431|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
16144595|NCT03308942|39017432|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
16144596|NCT03308942|39017433|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
16144597|NCT03308942|39017429|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
16144598|NCT03308942|39017430|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
16144599|NCT03308942|39017431|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
16144600|NCT03308942|39017432|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
16144601|NCT03308942|39017433|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
16144602|NCT03308942|39017429|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
16144603|NCT03308942|39017430|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
16144604|NCT03308942|39017431|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
16144605|NCT03308942|39017432|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
16144606|NCT03308942|39017433|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
16144607|NCT03308942|39017429|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
16144608|NCT03308942|39017430|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
16144609|NCT03308942|39017431|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
16144610|NCT03308942|39017432|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
16144611|NCT03308942|39017433|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
16144612|NCT04422990|39017437|FG000|Overall Study|Withdrawal by Subject|0|||
16144613|NCT04422990|39017438|FG001|Overall Study|Withdrawal by Subject|1|||
16144614|NCT04422990|39017437|FG000|Overall Study|Travel|3|||
16144615|NCT04422990|39017438|FG001|Overall Study|Travel|0|||
16257087|NCT00912288|39427165|FG000|Overall Study|Death|0|||
16257088|NCT00912288|39427166|FG001|Overall Study|Death|1|||
16257089|NCT00912288|39427165|FG000|Overall Study|Adverse Event|1|||
16257090|NCT00912288|39427166|FG001|Overall Study|Adverse Event|1|||
16257091|NCT00912288|39427165|FG000|Overall Study|Lost to Follow-up|1|||
16257092|NCT00912288|39427166|FG001|Overall Study|Lost to Follow-up|0|||
16257093|NCT00912288|39427165|FG000|Overall Study|Protocol Violation|1|||
16257094|NCT00912288|39427166|FG001|Overall Study|Protocol Violation|0|||
16257095|NCT00912288|39427165|FG000|Overall Study|Withdrawal by Subject|3|||
16257096|NCT00912288|39427166|FG001|Overall Study|Withdrawal by Subject|3|||
16257097|NCT00912288|39427165|FG000|Overall Study|Study terminated by sponsor|34|||
16257098|NCT00912288|39427166|FG001|Overall Study|Study terminated by sponsor|35|||
16257099|NCT00912288|39427165|FG000|Overall Study|Other|1|||
16257100|NCT00912288|39427166|FG001|Overall Study|Other|0|||
16257101|NCT00528606|39427167|FG000|Overall Study|Withdrew consent|4|||
16257102|NCT00528606|39427168|FG001|Overall Study|Withdrew consent|3|||
16144616|NCT02349048|39017445|FG000|Overall Study|Withdrawal by Subject|4|||
16144617|NCT02349048|39017446|FG001|Overall Study|Withdrawal by Subject|0|||
16144618|NCT02349048|39017445|FG000|Overall Study|Lost to Follow-up|1|||
16144619|NCT02349048|39017446|FG001|Overall Study|Lost to Follow-up|0|||
16144620|NCT02767323|39017448|FG000|Overall Study|Withdrawal by Subject|17|||
16257103|NCT00528606|39427167|FG000|Overall Study|Lost to Follow-up|4|||
16257104|NCT00528606|39427168|FG001|Overall Study|Lost to Follow-up|1|||
16257105|NCT00528606|39427167|FG000|Overall Study|Adverse Event|3|||
16257106|NCT00528606|39427168|FG001|Overall Study|Adverse Event|0|||
16257107|NCT00528606|39427167|FG000|Overall Study|Other|2|||
16364244|NCT02065557|39818246|FG002|Induction Period|Adverse Event|0|||
16364245|NCT02065557|39818247|FG003|Induction Period|Adverse Event|0|||
16364246|NCT02065557|39818248|FG004|Induction Period|Adverse Event|0|||
16364247|NCT02065557|39818249|FG005|Induction Period|Adverse Event|0|||
16144621|NCT02767323|39017449|FG001|Overall Study|Withdrawal by Subject|5|||
16144622|NCT02767323|39017450|FG002|Overall Study|Withdrawal by Subject|13|||
16144623|NCT02767323|39017451|FG003|Overall Study|Withdrawal by Subject|0|||
16144624|NCT02767323|39017448|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
16144625|NCT02767323|39017449|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
16144626|NCT02767323|39017450|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
16144627|NCT02767323|39017451|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
16144628|NCT01302834|39017453|FG000|Overall Study|Protocol Violation|17|||
16144629|NCT01302834|39017454|FG001|Overall Study|Protocol Violation|23|||
16144630|NCT01302834|39017453|FG000|Overall Study|HIV positive|1|||
16144631|NCT01302834|39017454|FG001|Overall Study|HIV positive|3|||
16144632|NCT00102960|39017456|FG000|Overall Study|Death|23|||
16144633|NCT00102960|39017457|FG001|Overall Study|Death|11|||
16144634|NCT00102960|39017458|FG002|Overall Study|Death|11|||
16144635|NCT00102960|39017456|FG000|Overall Study|Lost to Follow-up|6|||
16144636|NCT00102960|39017457|FG001|Overall Study|Lost to Follow-up|12|||
16144637|NCT00102960|39017458|FG002|Overall Study|Lost to Follow-up|16|||
16144638|NCT00102960|39017456|FG000|Overall Study|Withdrawal by Subject|1|||
16144639|NCT00102960|39017457|FG001|Overall Study|Withdrawal by Subject|0|||
16144640|NCT00102960|39017458|FG002|Overall Study|Withdrawal by Subject|1|||
16144641|NCT01494350|39017459|FG000|Overall Study|Worsening of lesion|1|||
16144642|NCT02462928|39017460|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
16144643|NCT02462928|39017461|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
16144644|NCT02462928|39017462|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
16144645|NCT02462928|39017460|FG000|Overall Study|Adverse Event|47|||
16144646|NCT02462928|39017461|FG001|Overall Study|Adverse Event|51|||
16144647|NCT02462928|39017462|FG002|Overall Study|Adverse Event|25|||
16144648|NCT02462928|39017460|FG000|Overall Study|Lack of Efficacy|3|||
16144649|NCT02462928|39017461|FG001|Overall Study|Lack of Efficacy|8|||
16144650|NCT02462928|39017462|FG002|Overall Study|Lack of Efficacy|3|||
16144651|NCT02462928|39017460|FG000|Overall Study|Lost to Follow-up|4|||
16144652|NCT02462928|39017461|FG001|Overall Study|Lost to Follow-up|4|||
16144653|NCT02462928|39017462|FG002|Overall Study|Lost to Follow-up|1|||
16144654|NCT02462928|39017460|FG000|Overall Study|Withdrawal by Patient|31|||
16144655|NCT02462928|39017461|FG001|Overall Study|Withdrawal by Patient|21|||
16364248|NCT02065557|39818244|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
16144656|NCT02462928|39017462|FG002|Overall Study|Withdrawal by Patient|21|||
16144657|NCT02462928|39017460|FG000|Overall Study|Protocol Violation|0|||
16144658|NCT02462928|39017461|FG001|Overall Study|Protocol Violation|1|||
16364249|NCT02065557|39818245|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
16257108|NCT00528606|39427168|FG001|Overall Study|Other|0|||
16257109|NCT02684344|39427170|FG000|Overall Study|Withdrawal by Subject|0|||
16257110|NCT02684344|39427171|FG001|Overall Study|Withdrawal by Subject|1|||
16257111|NCT02907203|39427172|FG000|Overall Study|Death|1|||
16257112|NCT02907203|39427172|FG000|Overall Study|Lost to Follow-up|3|||
16257113|NCT02907203|39427172|FG000|Overall Study|Withdrawal by Subject|3|||
16257114|NCT02907203|39427172|FG000|Overall Study|Surgical bypass|1|||
16257115|NCT02319148|39427173|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
16257116|NCT02319148|39427174|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
16257117|NCT02319148|39427175|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
16257118|NCT02319148|39427176|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
16257119|NCT02319148|39427173|FG000|Second Intervention Period|No longer willing to participate|0|||
16257120|NCT02319148|39427174|FG001|Second Intervention Period|No longer willing to participate|1|||
16257121|NCT02319148|39427175|FG002|Second Intervention Period|No longer willing to participate|0|||
16257122|NCT02319148|39427176|FG003|Second Intervention Period|No longer willing to participate|0|||
16257123|NCT02319148|39427173|FG000|Second Intervention Period|Other|0|||
16257124|NCT02319148|39427174|FG001|Second Intervention Period|Other|0|||
16257125|NCT02319148|39427175|FG002|Second Intervention Period|Other|0|||
16257126|NCT02319148|39427176|FG003|Second Intervention Period|Other|1|||
16257127|NCT01619800|39427177|FG000|Overall Study|study terminated|2|||
16257128|NCT01619800|39427178|FG001|Overall Study|study terminated|0|||
16257129|NCT00406848|39427181|FG000|Overall Study|Withdrawal by Subject|27|||
16257130|NCT00406848|39427182|FG001|Overall Study|Withdrawal by Subject|22|||
16257131|NCT00406848|39427181|FG000|Overall Study|Adverse Event|38|||
16257132|NCT00406848|39427182|FG001|Overall Study|Adverse Event|7|||
16257133|NCT00406848|39427181|FG000|Overall Study|Lack of Efficacy|9|||
16257134|NCT00406848|39427182|FG001|Overall Study|Lack of Efficacy|14|||
16257135|NCT00406848|39427181|FG000|Overall Study|Protocol Violation|10|||
16257136|NCT00406848|39427182|FG001|Overall Study|Protocol Violation|6|||
16257137|NCT00406848|39427181|FG000|Overall Study|Lost to Follow-up|6|||
16257138|NCT00406848|39427182|FG001|Overall Study|Lost to Follow-up|2|||
16257139|NCT00406848|39427181|FG000|Overall Study|Physician Decision|2|||
16257140|NCT00406848|39427182|FG001|Overall Study|Physician Decision|2|||
16257141|NCT00406848|39427181|FG000|Overall Study|Sponsor Decision|1|||
16257142|NCT00406848|39427182|FG001|Overall Study|Sponsor Decision|1|||
16257143|NCT03785548|39427187|FG000|Overall Study|age > 80|1|||
16257144|NCT03785548|39427188|FG001|Overall Study|age > 80|0|||
16257145|NCT03785548|39427187|FG000|Overall Study|no Postop queries|1|||
16257146|NCT03785548|39427188|FG001|Overall Study|no Postop queries|0|||
16257147|NCT03125200|39427189|FG000|Overall Study|Study Termination|0|||
16257148|NCT03125200|39427190|FG001|Overall Study|Study Termination|0|||
16257149|NCT03125200|39427191|FG002|Overall Study|Study Termination|0|||
16257150|NCT03125200|39427192|FG003|Overall Study|Study Termination|1|||
16257151|NCT03125200|39427193|FG004|Overall Study|Study Termination|1|||
16257152|NCT03125200|39427194|FG005|Overall Study|Study Termination|2|||
16257153|NCT03125200|39427195|FG006|Overall Study|Study Termination|1|||
16257154|NCT03125200|39427189|FG000|Overall Study|Clinical Progression|0|||
16257155|NCT03125200|39427190|FG001|Overall Study|Clinical Progression|0|||
16257156|NCT03125200|39427191|FG002|Overall Study|Clinical Progression|0|||
16257157|NCT03125200|39427192|FG003|Overall Study|Clinical Progression|1|||
16257158|NCT03125200|39427193|FG004|Overall Study|Clinical Progression|0|||
16257159|NCT03125200|39427194|FG005|Overall Study|Clinical Progression|1|||
16257160|NCT03125200|39427195|FG006|Overall Study|Clinical Progression|0|||
16257161|NCT03125200|39427189|FG000|Overall Study|Progressive Disease|2|||
16257162|NCT03125200|39427190|FG001|Overall Study|Progressive Disease|1|||
16257163|NCT03125200|39427191|FG002|Overall Study|Progressive Disease|2|||
16257164|NCT03125200|39427192|FG003|Overall Study|Progressive Disease|1|||
16257165|NCT03125200|39427193|FG004|Overall Study|Progressive Disease|2|||
16257166|NCT03125200|39427194|FG005|Overall Study|Progressive Disease|0|||
16257167|NCT03125200|39427195|FG006|Overall Study|Progressive Disease|1|||
16257168|NCT03125200|39427189|FG000|Overall Study|Lack of Efficacy|0|||
16257169|NCT03125200|39427190|FG001|Overall Study|Lack of Efficacy|0|||
16257170|NCT03125200|39427191|FG002|Overall Study|Lack of Efficacy|0|||
16257171|NCT03125200|39427192|FG003|Overall Study|Lack of Efficacy|1|||
16257172|NCT03125200|39427193|FG004|Overall Study|Lack of Efficacy|0|||
16257173|NCT03125200|39427194|FG005|Overall Study|Lack of Efficacy|0|||
16257174|NCT03125200|39427195|FG006|Overall Study|Lack of Efficacy|0|||
16257175|NCT03125200|39427189|FG000|Overall Study|Toxicity|0|||
16257176|NCT03125200|39427190|FG001|Overall Study|Toxicity|0|||
16257177|NCT03125200|39427191|FG002|Overall Study|Toxicity|0|||
16257178|NCT03125200|39427192|FG003|Overall Study|Toxicity|1|||
16257179|NCT03125200|39427193|FG004|Overall Study|Toxicity|0|||
16257180|NCT03125200|39427194|FG005|Overall Study|Toxicity|0|||
16257181|NCT03125200|39427195|FG006|Overall Study|Toxicity|0|||
16257182|NCT03125200|39427189|FG000|Overall Study|Consent Withdrawn by Subject|0|||
16257183|NCT03125200|39427190|FG001|Overall Study|Consent Withdrawn by Subject|1|||
16257184|NCT03125200|39427191|FG002|Overall Study|Consent Withdrawn by Subject|0|||
16257185|NCT03125200|39427192|FG003|Overall Study|Consent Withdrawn by Subject|0|||
16257186|NCT03125200|39427193|FG004|Overall Study|Consent Withdrawn by Subject|1|||
16257187|NCT03125200|39427194|FG005|Overall Study|Consent Withdrawn by Subject|0|||
16257188|NCT03125200|39427195|FG006|Overall Study|Consent Withdrawn by Subject|1|||
16257189|NCT02152566|39427196|FG000|Overall Study|Lost to Follow-up|1|||
16257190|NCT02152566|39427196|FG000|Overall Study|Withdrawal by Subject|2|||
16257191|NCT00051025|39427197|FG000|Overall Study|Progressive Disease|1|||
16364250|NCT02065557|39818246|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
16364251|NCT02065557|39818247|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
16364252|NCT02065557|39818248|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
16364253|NCT02065557|39818249|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
16364254|NCT02065557|39818244|FG000|Maintenance Period|Withdrawal by Subject|0|||
16364255|NCT02065557|39818245|FG001|Maintenance Period|Withdrawal by Subject|0|||
16257192|NCT00051025|39427198|FG001|Overall Study|Progressive Disease|1|||
16257193|NCT00051025|39427197|FG000|Overall Study|Adverse Event|1|||
16257194|NCT00051025|39427198|FG001|Overall Study|Adverse Event|1|||
16257195|NCT00051025|39427197|FG000|Overall Study|Withdrawal by Subject|0|||
16257196|NCT00051025|39427198|FG001|Overall Study|Withdrawal by Subject|1|||
16257197|NCT00051025|39427197|FG000|Overall Study|Death|0|||
16257198|NCT00051025|39427198|FG001|Overall Study|Death|1|||
16257199|NCT00755326|39427199|FG000|Overall Study|Lost to Follow-up|2|||
16257200|NCT00755326|39427200|FG001|Overall Study|Lost to Follow-up|3|||
16257201|NCT02433678|39427203|FG000|Overall Study|Lost to Follow-up|1|||
16257202|NCT02433678|39427204|FG001|Overall Study|Lost to Follow-up|2|||
16257203|NCT02684578|39427205|FG000|Overall Study|Withdrawal by Subject|10|||
16257204|NCT02684578|39427206|FG001|Overall Study|Withdrawal by Subject|7|||
16257205|NCT02684578|39427205|FG000|Overall Study|Lost to Follow-up|0|||
16257206|NCT02684578|39427206|FG001|Overall Study|Lost to Follow-up|3|||
16257207|NCT02684578|39427205|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
16257208|NCT02684578|39427206|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
16257209|NCT02684578|39427205|FG000|Overall Study|Missing follow-up data|0|||
16257210|NCT02684578|39427206|FG001|Overall Study|Missing follow-up data|1|||
16257211|NCT01691508|39427208|FG000|Overall Study|Adverse Event|3|||
16257212|NCT01691508|39427209|FG001|Overall Study|Adverse Event|3|||
16364256|NCT02065557|39818246|FG002|Maintenance Period|Withdrawal by Subject|0|||
16144659|NCT02462928|39017462|FG002|Overall Study|Protocol Violation|0|||
16144660|NCT02462928|39017460|FG000|Overall Study|Reason not Specified|4|||
16257213|NCT01691508|39427208|FG000|Overall Study|Withdrawal by Subject|1|||
16257214|NCT01691508|39427209|FG001|Overall Study|Withdrawal by Subject|0|||
16257215|NCT00728949|39427212|FG000|Overall Study|Adverse Event|8|||
16257216|NCT00728949|39427213|FG001|Overall Study|Adverse Event|0|||
16257217|NCT00728949|39427212|FG000|Overall Study|Withdrawal by Subject|2|||
16144661|NCT02462928|39017461|FG001|Overall Study|Reason not Specified|6|||
16144662|NCT02462928|39017462|FG002|Overall Study|Reason not Specified|5|||
16144663|NCT00210184|39017464|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
16144664|NCT01668719|39017465|FG000|Phase I|On treatment|1|||
16144665|NCT01668719|39017466|FG001|Phase I|On treatment|0|||
16144666|NCT01668719|39017467|FG002|Phase I|On treatment|0|||
16144667|NCT01668719|39017465|FG000|Phase I|Adverse Event|2|||
16144668|NCT01668719|39017466|FG001|Phase I|Adverse Event|0|||
16144669|NCT01668719|39017467|FG002|Phase I|Adverse Event|0|||
16257218|NCT00728949|39427213|FG001|Overall Study|Withdrawal by Subject|2|||
16257219|NCT00728949|39427212|FG000|Overall Study|Abnormal Lab Results|0|||
16257220|NCT00728949|39427213|FG001|Overall Study|Abnormal Lab Results|2|||
16257221|NCT00728949|39427212|FG000|Overall Study|On treatment at cutoff date|1|||
16257222|NCT00728949|39427213|FG001|Overall Study|On treatment at cutoff date|0|||
16257223|NCT04407806|39427215|FG000|Overall Study|Withdrawal by Subject|1|||
16257224|NCT04407806|39427216|FG001|Overall Study|Withdrawal by Subject|2|||
16257225|NCT01648166|39427217|FG000|Overall Study|inadequate toenail samples|53|||
16257226|NCT01648166|39427218|FG001|Overall Study|inadequate toenail samples|100|||
16257227|NCT01766921|39427222|FG000|Overall Study|Administrative Reason|5|||
16257228|NCT01766921|39427223|FG001|Overall Study|Administrative Reason|5|||
16257229|NCT01766921|39427222|FG000|Overall Study|Death|1|||
16257230|NCT01766921|39427223|FG001|Overall Study|Death|1|||
16257231|NCT01766921|39427222|FG000|Overall Study|Lost to Follow-up|1|||
16257232|NCT01766921|39427223|FG001|Overall Study|Lost to Follow-up|3|||
16257233|NCT01766921|39427222|FG000|Overall Study|Unclassified|2|||
16257234|NCT01766921|39427223|FG001|Overall Study|Unclassified|2|||
16257235|NCT01766921|39427222|FG000|Overall Study|Protocol Violation|1|||
16257236|NCT01766921|39427223|FG001|Overall Study|Protocol Violation|1|||
16257237|NCT01766921|39427222|FG000|Overall Study|Withdrawal by Subject|14|||
16257238|NCT01766921|39427223|FG001|Overall Study|Withdrawal by Subject|5|||
16257239|NCT00001849|39427224|FG000|Overall Study|Death|4|||
16257240|NCT00001849|39427224|FG000|Overall Study|Lost to Follow-up|2|||
16257241|NCT00001849|39427224|FG000|Overall Study|Withdrawal by Subject|2|||
16257242|NCT00001849|39427224|FG000|Overall Study|tumor remained occult|6|||
16257243|NCT03629249|39427225|FG000|Overall Study|Study terminated by sponsor|197|||
16257244|NCT03629249|39427226|FG001|Overall Study|Study terminated by sponsor|197|||
16257245|NCT03629249|39427227|FG002|Overall Study|Study terminated by sponsor|194|||
16257246|NCT03629249|39427225|FG000|Overall Study|Protocol deviation|0|||
16257247|NCT03629249|39427226|FG001|Overall Study|Protocol deviation|2|||
16257248|NCT03629249|39427227|FG002|Overall Study|Protocol deviation|5|||
16257249|NCT03629249|39427225|FG000|Overall Study|Subject decision|1|||
16257250|NCT03629249|39427226|FG001|Overall Study|Subject decision|1|||
16257251|NCT03629249|39427227|FG002|Overall Study|Subject decision|3|||
16257252|NCT03629249|39427225|FG000|Overall Study|Adverse Event|1|||
16257253|NCT03629249|39427226|FG001|Overall Study|Adverse Event|1|||
16257254|NCT03629249|39427227|FG002|Overall Study|Adverse Event|0|||
16257255|NCT03629249|39427225|FG000|Overall Study|Death|1|||
16257256|NCT03629249|39427226|FG001|Overall Study|Death|0|||
16257257|NCT03629249|39427227|FG002|Overall Study|Death|0|||
16257258|NCT03629249|39427225|FG000|Overall Study|Physician Decision|1|||
16257259|NCT03629249|39427226|FG001|Overall Study|Physician Decision|0|||
16257260|NCT03629249|39427227|FG002|Overall Study|Physician Decision|0|||
16257261|NCT02216071|39427229|FG000|Overall Study|Withdrawal by Subject|7|||
16257262|NCT02216071|39427230|FG001|Overall Study|Withdrawal by Subject|2|||
16257263|NCT02216071|39427229|FG000|Overall Study|Lost to Follow-up|3|||
16257264|NCT02216071|39427230|FG001|Overall Study|Lost to Follow-up|3|||
16257265|NCT02216071|39427229|FG000|Overall Study|Protocol Violation|3|||
16257266|NCT02216071|39427230|FG001|Overall Study|Protocol Violation|5|||
16257267|NCT02216071|39427229|FG000|Overall Study|Other|2|||
16144670|NCT01668719|39017465|FG000|Phase I|Progression/relapse|1|||
16144671|NCT01668719|39017466|FG001|Phase I|Progression/relapse|0|||
16257268|NCT02216071|39427230|FG001|Overall Study|Other|2|||
16257269|NCT04091971|39427231|FG000|Overall Study|Withdrawal by Subject|1|||
16257270|NCT04091971|39427231|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
16257271|NCT04091971|39427231|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
16257272|NCT01139164|39427245|FG000|Overall Study|Withdrawn prior to study start|0|||
16257273|NCT01139164|39427246|FG001|Overall Study|Withdrawn prior to study start|2|||
16364257|NCT02065557|39818247|FG003|Maintenance Period|Withdrawal by Subject|0|||
16364258|NCT02065557|39818248|FG004|Maintenance Period|Withdrawal by Subject|2|||
16364259|NCT02065557|39818249|FG005|Maintenance Period|Withdrawal by Subject|1|||
16364260|NCT02065557|39818244|FG000|Maintenance Period|Lack of Efficacy|0|||
16364261|NCT02065557|39818245|FG001|Maintenance Period|Lack of Efficacy|0|||
16364262|NCT02065557|39818246|FG002|Maintenance Period|Lack of Efficacy|0|||
16364263|NCT02065557|39818247|FG003|Maintenance Period|Lack of Efficacy|0|||
16364264|NCT02065557|39818248|FG004|Maintenance Period|Lack of Efficacy|5|||
16364265|NCT02065557|39818249|FG005|Maintenance Period|Lack of Efficacy|2|||
16364266|NCT02065557|39818244|FG000|Maintenance Period|Subject Non-Compliance|0|||
16364267|NCT02065557|39818245|FG001|Maintenance Period|Subject Non-Compliance|0|||
16364268|NCT02065557|39818246|FG002|Maintenance Period|Subject Non-Compliance|0|||
16364269|NCT02065557|39818247|FG003|Maintenance Period|Subject Non-Compliance|0|||
16364270|NCT02065557|39818248|FG004|Maintenance Period|Subject Non-Compliance|0|||
16364271|NCT02065557|39818249|FG005|Maintenance Period|Subject Non-Compliance|1|||
16439820|NCT03473236|40089551|FG009|Overall Study|Withdrawal by Subject|0|||
16439821|NCT01349959|40089555|FG000|Overall Study|Adverse Event|7|||
16439822|NCT01097668|40089556|FG000|Overall Study|Withdrawal by Subject|1|||
16439823|NCT01097668|40089557|FG001|Overall Study|Withdrawal by Subject|2|||
16439824|NCT01097668|40089556|FG000|Overall Study|Lost to Follow-up|1|||
16439825|NCT01097668|40089557|FG001|Overall Study|Lost to Follow-up|0|||
16439826|NCT02163902|40089558|FG000|Overall Study|Subject's Request|3|||
16439827|NCT02163902|40089559|FG001|Overall Study|Subject's Request|4|||
16439828|NCT02163902|40089558|FG000|Overall Study|Lost to Follow-up|6|||
16439829|NCT02163902|40089559|FG001|Overall Study|Lost to Follow-up|7|||
16439830|NCT02163902|40089558|FG000|Overall Study|Administrative Decision|2|||
16439831|NCT02163902|40089559|FG001|Overall Study|Administrative Decision|2|||
16439832|NCT02647281|40089564|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16364272|NCT01179399|39818250|FG000|Overall Study|Adverse Event|1|||
16364273|NCT01179399|39818250|FG000|Overall Study|Lack of Efficacy|30|||
16439833|NCT02647281|40089565|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16439834|NCT02647281|40089566|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16439835|NCT02647281|40089567|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16439836|NCT02647281|40089568|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16439837|NCT02647281|40089569|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16439838|NCT02647281|40089570|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16439839|NCT02647281|40089571|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
16439840|NCT02647281|40089572|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
16144672|NCT01668719|39017467|FG002|Phase I|Progression/relapse|0|||
16144673|NCT01668719|39017465|FG000|Phase I|not protocol specified|2|||
16144674|NCT01668719|39017466|FG001|Phase I|not protocol specified|0|||
16144675|NCT01668719|39017467|FG002|Phase I|not protocol specified|0|||
16144676|NCT01668719|39017465|FG000|Phase II|On treatment|0|||
16144677|NCT01668719|39017466|FG001|Phase II|On treatment|4|||
16144678|NCT01668719|39017467|FG002|Phase II|On treatment|3|||
16144679|NCT01668719|39017465|FG000|Phase II|Adverse Event|0|||
16144680|NCT01668719|39017466|FG001|Phase II|Adverse Event|18|||
16144681|NCT01668719|39017467|FG002|Phase II|Adverse Event|18|||
16144682|NCT01668719|39017465|FG000|Phase II|Refusal unrelated to adverse event|0|||
16144683|NCT01668719|39017466|FG001|Phase II|Refusal unrelated to adverse event|4|||
16144684|NCT01668719|39017467|FG002|Phase II|Refusal unrelated to adverse event|1|||
16144685|NCT01668719|39017465|FG000|Phase II|Progression/relapse|0|||
16144686|NCT01668719|39017466|FG001|Phase II|Progression/relapse|13|||
16144687|NCT01668719|39017467|FG002|Phase II|Progression/relapse|17|||
16144688|NCT01668719|39017465|FG000|Phase II|Death|0|||
16144689|NCT01668719|39017466|FG001|Phase II|Death|0|||
16144690|NCT01668719|39017467|FG002|Phase II|Death|2|||
16144691|NCT01668719|39017465|FG000|Phase II|not protocol specified|0|||
16144692|NCT01668719|39017466|FG001|Phase II|not protocol specified|13|||
16144693|NCT01668719|39017467|FG002|Phase II|not protocol specified|7|||
16144694|NCT01105091|39017468|FG000|Overall Study|Death|2|||
16144695|NCT01105091|39017469|FG001|Overall Study|Death|0|||
16144696|NCT03692325|39017470|FG000|Overall Study|Adverse Event|2|||
16144697|NCT03692325|39017470|FG000|Overall Study|Progression/Recurrence|2|||
16144698|NCT00385203|39017471|FG000|Overall Study|Adverse Event|5|||
16144699|NCT00385203|39017472|FG001|Overall Study|Adverse Event|4|||
16144700|NCT00385203|39017471|FG000|Overall Study|Death|1|||
16144701|NCT00385203|39017472|FG001|Overall Study|Death|0|||
16144702|NCT00385203|39017471|FG000|Overall Study|Condition under investigation worsened|18|||
16144703|NCT00385203|39017472|FG001|Overall Study|Condition under investigation worsened|3|||
16144704|NCT00385203|39017471|FG000|Overall Study|Incorrect enrollment|2|||
16144705|NCT00385203|39017472|FG001|Overall Study|Incorrect enrollment|0|||
16144706|NCT00785044|39017475|FG000|Overall Study|Dosed at non-participating sites|152|||
16144707|NCT00785044|39017475|FG000|Overall Study|Death|77|||
16144708|NCT00785044|39017475|FG000|Overall Study|Lost to Follow-up|266|||
16144709|NCT00785044|39017475|FG000|Overall Study|Withdrawal by Subject|1|||
16144710|NCT00574145|39017476|FG000|Overall Study|Withdrawal by Subject|2|||
16144711|NCT00574145|39017477|FG001|Overall Study|Withdrawal by Subject|1|||
16144712|NCT01984164|39017480|FG000|Overall Study|Withdrawal by Subject|4|||
16144713|NCT01984164|39017481|FG001|Overall Study|Withdrawal by Subject|3|||
16144714|NCT01984164|39017480|FG000|Overall Study|Adverse Event|5|||
16144715|NCT01984164|39017481|FG001|Overall Study|Adverse Event|19|||
16144716|NCT01984164|39017480|FG000|Overall Study|Lost to Follow-up|1|||
16144717|NCT01984164|39017481|FG001|Overall Study|Lost to Follow-up|3|||
16144718|NCT01069172|39017486|FG000|Overall Study|Withdrawal by Subject|1|||
16144719|NCT01069172|39017487|FG001|Overall Study|Withdrawal by Subject|0|||
16173378|NCT01147809|39111198|FG004|Phase II (168 Days)|Protocol Violation|0|||
16173379|NCT01147809|39111199|FG005|Phase II (168 Days)|Protocol Violation|1|||
16173380|NCT01147809|39111194|FG000|Phase II (168 Days)|Physician Decision|0|||
16173381|NCT01147809|39111195|FG001|Phase II (168 Days)|Physician Decision|0|||
16173382|NCT01147809|39111196|FG002|Phase II (168 Days)|Physician Decision|0|||
16173383|NCT01147809|39111197|FG003|Phase II (168 Days)|Physician Decision|0|||
16173384|NCT01147809|39111198|FG004|Phase II (168 Days)|Physician Decision|5|||
16173385|NCT01147809|39111199|FG005|Phase II (168 Days)|Physician Decision|11|||
16173386|NCT01147809|39111194|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
16173387|NCT01147809|39111195|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
16173388|NCT01147809|39111196|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
16173389|NCT01147809|39111197|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
16173390|NCT01147809|39111198|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
16173391|NCT01147809|39111199|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
16173392|NCT01147809|39111194|FG000|Phase II (168 Days)|Ongoing|0|||
16173393|NCT01147809|39111195|FG001|Phase II (168 Days)|Ongoing|0|||
16173394|NCT01147809|39111196|FG002|Phase II (168 Days)|Ongoing|0|||
16173395|NCT01147809|39111197|FG003|Phase II (168 Days)|Ongoing|0|||
16173396|NCT01147809|39111198|FG004|Phase II (168 Days)|Ongoing|1|||
16173397|NCT01147809|39111199|FG005|Phase II (168 Days)|Ongoing|0|||
16173398|NCT01607892|39111205|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
16173399|NCT01607892|39111206|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
16173400|NCT01607892|39111207|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
16439841|NCT01844765|40089580|FG000|Overall Study|Adverse Event|6|||
16173401|NCT01607892|39111208|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
16173402|NCT01607892|39111209|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
16173403|NCT01607892|39111205|FG000|Overall Study|Death|4|||
16173404|NCT01607892|39111206|FG001|Overall Study|Death|2|||
16173405|NCT01607892|39111207|FG002|Overall Study|Death|8|||
16173406|NCT01607892|39111208|FG003|Overall Study|Death|10|||
16173407|NCT01607892|39111209|FG004|Overall Study|Death|3|||
16144720|NCT00747643|39021021|FG000|Overall Study|Withdrawal by Subject|36|||
16144721|NCT00747643|39021022|FG001|Overall Study|Withdrawal by Subject|27|||
16144722|NCT00930722|39021023|FG000|Overall Study|Lost to Follow-up|16|||
16144723|NCT00930722|39021023|FG000|Overall Study|No longer willing to participate|9|||
16144724|NCT00930722|39021023|FG000|Overall Study|Study terminated by sponsor|2|||
16144725|NCT00290290|39021026|FG000|Overall Study|Death|3|||
16144726|NCT00290290|39021027|FG001|Overall Study|Death|4|||
16144727|NCT00290290|39021026|FG000|Overall Study|Withdrawal by Subject|2|||
16144728|NCT00290290|39021027|FG001|Overall Study|Withdrawal by Subject|2|||
16144729|NCT00290290|39021026|FG000|Overall Study|Underwent clean surgical procedure|13|||
16144730|NCT00290290|39021027|FG001|Overall Study|Underwent clean surgical procedure|12|||
16144731|NCT02865018|39021032|FG000|Overall Study|Withdrawal by Subject|1|||
16144732|NCT01011439|39021033|FG000|Overall Study|Death|37|||
16144733|NCT01011439|39021033|FG000|Overall Study|Lost to Follow-up|4|||
16144734|NCT01011439|39021033|FG000|Overall Study|Withdrawal by Subject|1|||
16144735|NCT01011439|39021033|FG000|Overall Study|Sponsor's decision|15|||
16144736|NCT00307333|39021034|FG000|Overall Study|Lost to Follow-up|11|||
16144737|NCT00307333|39021035|FG001|Overall Study|Lost to Follow-up|3|||
16144738|NCT02285920|39021036|FG000|Overall Study|Kidney transplantation|2|||
16144739|NCT02285920|39021037|FG001|Overall Study|Kidney transplantation|2|||
16144740|NCT02285920|39021038|FG002|Overall Study|Kidney transplantation|2|||
16144741|NCT02285920|39021039|FG003|Overall Study|Kidney transplantation|0|||
16144742|NCT02285920|39021036|FG000|Overall Study|Change to peritoneal dialysis|0|||
16144743|NCT02285920|39021037|FG001|Overall Study|Change to peritoneal dialysis|0|||
16144744|NCT02285920|39021038|FG002|Overall Study|Change to peritoneal dialysis|1|||
16144745|NCT02285920|39021039|FG003|Overall Study|Change to peritoneal dialysis|0|||
16144746|NCT02285920|39021036|FG000|Overall Study|Transfer to non-participating unit|0|||
16144747|NCT02285920|39021037|FG001|Overall Study|Transfer to non-participating unit|1|||
16144748|NCT02285920|39021038|FG002|Overall Study|Transfer to non-participating unit|0|||
16144749|NCT02285920|39021039|FG003|Overall Study|Transfer to non-participating unit|0|||
16144750|NCT02285920|39021036|FG000|Overall Study|Dialysis discontinuation|0|||
16144751|NCT02285920|39021037|FG001|Overall Study|Dialysis discontinuation|1|||
16144752|NCT02285920|39021038|FG002|Overall Study|Dialysis discontinuation|0|||
16144753|NCT02285920|39021039|FG003|Overall Study|Dialysis discontinuation|0|||
16144754|NCT02285920|39021036|FG000|Overall Study|Death|2|||
16144755|NCT02285920|39021037|FG001|Overall Study|Death|0|||
16144756|NCT02285920|39021038|FG002|Overall Study|Death|2|||
16144757|NCT02285920|39021039|FG003|Overall Study|Death|1|||
16144758|NCT03610724|39021040|FG000|Overall Study|Death|17|||
16144759|NCT03610724|39021040|FG000|Overall Study|Lost to Follow-up|1|||
16144760|NCT03610724|39021040|FG000|Overall Study|Physician Decision|1|||
16144761|NCT03610724|39021040|FG000|Overall Study|Died prior to infusion|1|||
16144762|NCT02181816|39021044|FG000|Overall Study|Case Report Forms Uncollected|38|||
16144763|NCT02181816|39021044|FG000|Overall Study|Protocol Deviation|21|||
16144764|NCT00382018|39021045|FG000|Overall Study|Progression|0|||
16144765|NCT00382018|39021046|FG001|Overall Study|Progression|136|||
16144766|NCT00382018|39021047|FG002|Overall Study|Progression|51|||
16144767|NCT00382018|39021048|FG003|Overall Study|Progression|43|||
16144768|NCT00382018|39021045|FG000|Overall Study|Death|0|||
16144769|NCT00382018|39021046|FG001|Overall Study|Death|9|||
16144770|NCT00382018|39021047|FG002|Overall Study|Death|7|||
16144771|NCT00382018|39021048|FG003|Overall Study|Death|11|||
16144772|NCT00382018|39021045|FG000|Overall Study|Withdrawal by Subject|0|||
16144773|NCT00382018|39021046|FG001|Overall Study|Withdrawal by Subject|4|||
16144774|NCT00382018|39021047|FG002|Overall Study|Withdrawal by Subject|3|||
16144775|NCT00382018|39021048|FG003|Overall Study|Withdrawal by Subject|4|||
16144776|NCT00382018|39021045|FG000|Overall Study|Other, not protocol specified|0|||
16144777|NCT00382018|39021046|FG001|Overall Study|Other, not protocol specified|16|||
16144778|NCT00382018|39021047|FG002|Overall Study|Other, not protocol specified|3|||
16144779|NCT00382018|39021048|FG003|Overall Study|Other, not protocol specified|1|||
16144780|NCT03838198|39021049|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
16144781|NCT03838198|39021050|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
16144782|NCT03838198|39021051|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
16144783|NCT03838198|39021052|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
16144784|NCT03838198|39021049|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
16144785|NCT03838198|39021050|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
16144786|NCT03838198|39021051|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
16144787|NCT03838198|39021052|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
16144788|NCT00832117|39021053|FG000|Overall Study|Death|1|||
16144789|NCT00832117|39021053|FG000|Overall Study|Disease Progression|11|||
16144790|NCT01732796|39021054|FG000|Overall Study|Adverse Event|16|||
16144791|NCT01732796|39021055|FG001|Overall Study|Adverse Event|16|||
16144792|NCT01732796|39021056|FG002|Overall Study|Adverse Event|4|||
16144793|NCT01732796|39021054|FG000|Overall Study|Lack of Efficacy|21|||
16144794|NCT01732796|39021055|FG001|Overall Study|Lack of Efficacy|18|||
16144795|NCT01732796|39021056|FG002|Overall Study|Lack of Efficacy|5|||
16144796|NCT01732796|39021054|FG000|Overall Study|Lost to Follow-up|2|||
16144797|NCT01732796|39021055|FG001|Overall Study|Lost to Follow-up|0|||
16144798|NCT01732796|39021056|FG002|Overall Study|Lost to Follow-up|0|||
16144799|NCT01732796|39021054|FG000|Overall Study|Withdrawal by Subject|6|||
16144800|NCT01732796|39021055|FG001|Overall Study|Withdrawal by Subject|8|||
16144801|NCT01732796|39021056|FG002|Overall Study|Withdrawal by Subject|2|||
16144802|NCT01732796|39021054|FG000|Overall Study|Other reason not defined above|1|||
16144803|NCT01732796|39021055|FG001|Overall Study|Other reason not defined above|0|||
16144804|NCT01732796|39021056|FG002|Overall Study|Other reason not defined above|2|||
16144805|NCT03426787|39021057|FG000|Overall Study|Withdrawal by Subject|6|||
16144806|NCT03426787|39021057|FG000|Overall Study|Lost to Follow-up|7|||
16144807|NCT03426787|39021057|FG000|Overall Study|Unrelated to intervention death|1|||
16144808|NCT03086057|39021058|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
16144809|NCT03086057|39021059|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
16144810|NCT03086057|39021060|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
16144811|NCT03086057|39021061|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
16144812|NCT03086057|39021058|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
16144813|NCT03086057|39021059|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
16144814|NCT03086057|39021060|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
16144815|NCT03086057|39021061|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
16144816|NCT03086057|39021058|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
16144817|NCT03086057|39021059|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
16144818|NCT03086057|39021060|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
16144819|NCT03086057|39021061|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
16144820|NCT03086057|39021058|FG000|Stage 1: PrEP Uptake|Death|1|||
16144821|NCT03086057|39021059|FG001|Stage 1: PrEP Uptake|Death|0|||
16144822|NCT03086057|39021060|FG002|Stage 1: PrEP Uptake|Death|0|||
16144823|NCT03086057|39021061|FG003|Stage 1: PrEP Uptake|Death|0|||
16439842|NCT01844765|40089581|FG001|Overall Study|Adverse Event|8|||
16439843|NCT01844765|40089580|FG000|Overall Study|Withdrawal by Subject|2|||
16439844|NCT01844765|40089581|FG001|Overall Study|Withdrawal by Subject|3|||
16439845|NCT01844765|40089580|FG000|Overall Study|Disease progression|1|||
16439846|NCT01844765|40089581|FG001|Overall Study|Disease progression|0|||
16439847|NCT01844765|40089580|FG000|Overall Study|Administrative problems|3|||
16439848|NCT01844765|40089581|FG001|Overall Study|Administrative problems|4|||
16144824|NCT03086057|39021058|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
16144825|NCT03086057|39021059|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
16144826|NCT03086057|39021060|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
16144827|NCT03086057|39021061|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
16144828|NCT03086057|39021058|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
16144829|NCT03086057|39021059|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
16144830|NCT03086057|39021060|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
16144831|NCT03086057|39021061|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
16144832|NCT03086057|39021058|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
16144833|NCT03086057|39021059|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
16144834|NCT03086057|39021060|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
16257274|NCT01139164|39427247|FG002|Overall Study|Withdrawn prior to study start|0|||
16439849|NCT01844765|40089580|FG000|Overall Study|Protocol deviation|2|||
16439850|NCT01844765|40089581|FG001|Overall Study|Protocol deviation|0|||
16439851|NCT01844765|40089580|FG000|Overall Study|Untreated|1|||
16439852|NCT01844765|40089581|FG001|Overall Study|Untreated|0|||
16439853|NCT00445549|40089583|FG000|Overall Study|progressive disease|12|||
16439854|NCT00976274|40089587|FG000|Overall Study|Lost to Follow-up|5|||
16439855|NCT00976274|40089588|FG001|Overall Study|Lost to Follow-up|5|||
16439856|NCT00976274|40089587|FG000|Overall Study|Withdrawal by Subject|1|||
16439857|NCT00976274|40089588|FG001|Overall Study|Withdrawal by Subject|1|||
16439858|NCT00976274|40089587|FG000|Overall Study|Physician Decision|1|||
16439859|NCT00976274|40089588|FG001|Overall Study|Physician Decision|2|||
16144835|NCT03086057|39021061|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
16439860|NCT00713609|40089589|FG000|Overall Study|Adverse Event|2|||
16439861|NCT00713609|40089590|FG001|Overall Study|Adverse Event|0|||
16439862|NCT00713609|40089591|FG002|Overall Study|Adverse Event|2|||
16439863|NCT00713609|40089592|FG003|Overall Study|Adverse Event|2|||
16144836|NCT00578786|39021062|FG000|Overall Study|Adverse Event|27|||
16144837|NCT00578786|39021063|FG001|Overall Study|Adverse Event|37|||
16144838|NCT00578786|39021064|FG002|Overall Study|Adverse Event|17|||
16144839|NCT00578786|39021062|FG000|Overall Study|Lack of Efficacy|2|||
16144840|NCT00578786|39021063|FG001|Overall Study|Lack of Efficacy|5|||
16144841|NCT00578786|39021064|FG002|Overall Study|Lack of Efficacy|2|||
16144842|NCT00578786|39021062|FG000|Overall Study|Early Escape from Prior Study|2|||
16144843|NCT00578786|39021063|FG001|Overall Study|Early Escape from Prior Study|1|||
16144844|NCT00578786|39021064|FG002|Overall Study|Early Escape from Prior Study|2|||
16144845|NCT00578786|39021062|FG000|Overall Study|Withdrawal by Subject|7|||
16144846|NCT00578786|39021063|FG001|Overall Study|Withdrawal by Subject|8|||
16144847|NCT00578786|39021064|FG002|Overall Study|Withdrawal by Subject|5|||
16257275|NCT01424644|39427248|FG000|Overall Study|Adverse Event|2|||
16257276|NCT01424644|39427249|FG001|Overall Study|Adverse Event|0|||
16257277|NCT01424644|39427248|FG000|Overall Study|Withdrawal by Subject|9|||
16257278|NCT01424644|39427249|FG001|Overall Study|Withdrawal by Subject|12|||
16257279|NCT01424644|39427248|FG000|Overall Study|Lost to Follow-up|16|||
16257280|NCT01424644|39427249|FG001|Overall Study|Lost to Follow-up|12|||
16257281|NCT01424644|39427248|FG000|Overall Study|Protocol Violation|4|||
16257282|NCT01424644|39427249|FG001|Overall Study|Protocol Violation|3|||
16257283|NCT01424644|39427248|FG000|Overall Study|Administrative Reason|1|||
16257284|NCT01424644|39427249|FG001|Overall Study|Administrative Reason|0|||
16257285|NCT01424644|39427248|FG000|Overall Study|Unable to Classify|1|||
16257286|NCT01424644|39427249|FG001|Overall Study|Unable to Classify|0|||
16257287|NCT03897088|39427250|FG000|Overall Study|Withdrawal by Subject|12|||
16257288|NCT03897088|39427251|FG001|Overall Study|Withdrawal by Subject|12|||
16257289|NCT03897088|39427250|FG000|Overall Study|Lost to Follow-up|7|||
16257290|NCT03897088|39427251|FG001|Overall Study|Lost to Follow-up|15|||
16257291|NCT03897088|39427250|FG000|Overall Study|Sponsor Decision|1|||
16257292|NCT03897088|39427251|FG001|Overall Study|Sponsor Decision|2|||
16257293|NCT03897088|39427250|FG000|Overall Study|COVID-19|2|||
16257294|NCT03897088|39427251|FG001|Overall Study|COVID-19|0|||
16257295|NCT03897088|39427250|FG000|Overall Study|Other|3|||
16257296|NCT03897088|39427251|FG001|Overall Study|Other|0|||
16257297|NCT03897088|39427250|FG000|Overall Study|Non-compliance with Study Drug|1|||
16257298|NCT03897088|39427251|FG001|Overall Study|Non-compliance with Study Drug|1|||
16257299|NCT03897088|39427250|FG000|Overall Study|Pregnancy|0|||
16257300|NCT03897088|39427251|FG001|Overall Study|Pregnancy|1|||
16257301|NCT01367457|39427252|FG000|Overall Study|Death|2|||
16257302|NCT01367457|39427253|FG001|Overall Study|Death|0|||
16257303|NCT01367457|39427254|FG002|Overall Study|Death|0|||
16257304|NCT01367457|39427252|FG000|Overall Study|Investigator's decision|2|||
16257305|NCT01367457|39427253|FG001|Overall Study|Investigator's decision|0|||
16257306|NCT01367457|39427254|FG002|Overall Study|Investigator's decision|0|||
16257307|NCT01367457|39427252|FG000|Overall Study|Clinical decline (CD)|2|||
16257308|NCT01367457|39427253|FG001|Overall Study|Clinical decline (CD)|0|||
16257309|NCT01367457|39427254|FG002|Overall Study|Clinical decline (CD)|0|||
16257310|NCT01367457|39427252|FG000|Overall Study|Progression and death|8|||
16257311|NCT01367457|39427253|FG001|Overall Study|Progression and death|0|||
16257312|NCT01367457|39427254|FG002|Overall Study|Progression and death|0|||
16257313|NCT01367457|39427252|FG000|Overall Study|Toxicity|16|||
16257314|NCT01367457|39427253|FG001|Overall Study|Toxicity|0|||
16257315|NCT01367457|39427254|FG002|Overall Study|Toxicity|0|||
16257316|NCT01367457|39427252|FG000|Overall Study|Progression|137|||
16257317|NCT01367457|39427253|FG001|Overall Study|Progression|0|||
16257318|NCT01367457|39427254|FG002|Overall Study|Progression|0|||
16257319|NCT01367457|39427252|FG000|Overall Study|Patient asks for rest + slow progression|1|||
16257320|NCT01367457|39427253|FG001|Overall Study|Patient asks for rest + slow progression|0|||
16257321|NCT01367457|39427254|FG002|Overall Study|Patient asks for rest + slow progression|0|||
16257322|NCT01367457|39427252|FG000|Overall Study|Investigator's opinion, stable disease|1|||
16257323|NCT01367457|39427253|FG001|Overall Study|Investigator's opinion, stable disease|0|||
16257324|NCT01367457|39427254|FG002|Overall Study|Investigator's opinion, stable disease|0|||
16144848|NCT00578786|39021062|FG000|Overall Study|Protocol Violation|0|||
16144849|NCT00578786|39021063|FG001|Overall Study|Protocol Violation|3|||
16144850|NCT00578786|39021064|FG002|Overall Study|Protocol Violation|1|||
16144851|NCT00578786|39021062|FG000|Overall Study|Physician Decision|1|||
16144852|NCT00578786|39021063|FG001|Overall Study|Physician Decision|0|||
16144853|NCT00578786|39021064|FG002|Overall Study|Physician Decision|1|||
16144854|NCT00578786|39021062|FG000|Overall Study|Sponsor Decision|0|||
16144855|NCT00578786|39021063|FG001|Overall Study|Sponsor Decision|0|||
16257325|NCT01367457|39427252|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
16257326|NCT01367457|39427253|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
16257327|NCT01367457|39427254|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
16257328|NCT01367457|39427252|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
16257329|NCT01367457|39427253|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
16439864|NCT00713609|40089593|FG004|Overall Study|Adverse Event|3|||
16144856|NCT00578786|39021064|FG002|Overall Study|Sponsor Decision|1|||
16144857|NCT00578786|39021062|FG000|Overall Study|Lost to Follow-up|0|||
16144858|NCT00578786|39021063|FG001|Overall Study|Lost to Follow-up|4|||
16144859|NCT00578786|39021064|FG002|Overall Study|Lost to Follow-up|0|||
16257330|NCT01367457|39427254|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
16257331|NCT01367457|39427252|FG000|Overall Study|low grade toxicities + stable disease|1|||
16257332|NCT01367457|39427253|FG001|Overall Study|low grade toxicities + stable disease|0|||
16257333|NCT01367457|39427254|FG002|Overall Study|low grade toxicities + stable disease|0|||
16257334|NCT01367457|39427252|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
16257335|NCT01367457|39427253|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
16257336|NCT01367457|39427254|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
16257337|NCT01367457|39427252|FG000|Overall Study|Withdrawal by Subject|1|||
16257338|NCT01367457|39427253|FG001|Overall Study|Withdrawal by Subject|0|||
16257339|NCT01367457|39427254|FG002|Overall Study|Withdrawal by Subject|0|||
16257340|NCT01367457|39427252|FG000|Overall Study|CD, associated leukaemia|1|||
16257341|NCT01367457|39427253|FG001|Overall Study|CD, associated leukaemia|0|||
16439865|NCT00713609|40089594|FG005|Overall Study|Adverse Event|1|||
16439866|NCT00713609|40089589|FG000|Overall Study|Lost to Follow-up|5|||
16439867|NCT00713609|40089590|FG001|Overall Study|Lost to Follow-up|7|||
16439868|NCT00713609|40089591|FG002|Overall Study|Lost to Follow-up|5|||
16439869|NCT00713609|40089592|FG003|Overall Study|Lost to Follow-up|5|||
16439870|NCT00713609|40089593|FG004|Overall Study|Lost to Follow-up|7|||
16439871|NCT00713609|40089594|FG005|Overall Study|Lost to Follow-up|0|||
16439872|NCT00713609|40089589|FG000|Overall Study|Lack of Efficacy|1|||
16439873|NCT00713609|40089590|FG001|Overall Study|Lack of Efficacy|3|||
16144860|NCT00578786|39021062|FG000|Overall Study|Pregnancy|0|||
16144861|NCT00578786|39021063|FG001|Overall Study|Pregnancy|1|||
16144862|NCT00578786|39021064|FG002|Overall Study|Pregnancy|0|||
16144863|NCT00578786|39021062|FG000|Overall Study|Not Otherwise Specified|0|||
16144864|NCT00578786|39021063|FG001|Overall Study|Not Otherwise Specified|4|||
16144865|NCT00578786|39021064|FG002|Overall Study|Not Otherwise Specified|1|||
16144866|NCT00578786|39021062|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
16144867|NCT00578786|39021063|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
16144868|NCT00578786|39021064|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
16144869|NCT01873417|39021065|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
16144870|NCT01873417|39021065|FG000|Overall Study|Adverse Event|24|||
16144871|NCT01873417|39021065|FG000|Overall Study|Lost to Follow-up|2|||
16144872|NCT01873417|39021065|FG000|Overall Study|Withdrawal by Subject|2|||
16144873|NCT01873417|39021065|FG000|Overall Study|Physician Decision|3|||
16144874|NCT00733954|39021066|FG000|Overall Study|Lost to Follow-up|5|||
16144875|NCT00733954|39021067|FG001|Overall Study|Lost to Follow-up|2|||
16144876|NCT00733954|39021066|FG000|Overall Study|Protocol Violation|1|||
16144877|NCT00733954|39021067|FG001|Overall Study|Protocol Violation|0|||
16144878|NCT00733954|39021066|FG000|Overall Study|Withdrawal by Subject|2|||
16144879|NCT00733954|39021067|FG001|Overall Study|Withdrawal by Subject|0|||
16439874|NCT00713609|40089591|FG002|Overall Study|Lack of Efficacy|0|||
16439875|NCT00713609|40089592|FG003|Overall Study|Lack of Efficacy|0|||
16439876|NCT00713609|40089593|FG004|Overall Study|Lack of Efficacy|1|||
16439877|NCT00713609|40089594|FG005|Overall Study|Lack of Efficacy|0|||
16439878|NCT00713609|40089589|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
16439879|NCT00713609|40089590|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
16439880|NCT00713609|40089591|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
16439881|NCT00713609|40089592|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
16439882|NCT00713609|40089593|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
16439883|NCT00713609|40089594|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
16439884|NCT00713609|40089589|FG000|Overall Study|Withdrawal by Subject|6|||
16439885|NCT00713609|40089590|FG001|Overall Study|Withdrawal by Subject|1|||
16439886|NCT00713609|40089591|FG002|Overall Study|Withdrawal by Subject|5|||
16439887|NCT00713609|40089592|FG003|Overall Study|Withdrawal by Subject|1|||
16439888|NCT00713609|40089593|FG004|Overall Study|Withdrawal by Subject|5|||
16439889|NCT00713609|40089594|FG005|Overall Study|Withdrawal by Subject|7|||
16439890|NCT00713609|40089589|FG000|Overall Study|Protocol Violation|6|||
16439891|NCT00713609|40089590|FG001|Overall Study|Protocol Violation|3|||
16439892|NCT00713609|40089591|FG002|Overall Study|Protocol Violation|1|||
16439893|NCT00713609|40089592|FG003|Overall Study|Protocol Violation|1|||
16439894|NCT00713609|40089593|FG004|Overall Study|Protocol Violation|2|||
16439895|NCT00713609|40089594|FG005|Overall Study|Protocol Violation|0|||
16144880|NCT01022996|39021068|FG000|Overall Study|Adverse Event|14|||
16144881|NCT01022996|39021068|FG000|Overall Study|Withdrawal by Subject|3|||
16144882|NCT01022996|39021068|FG000|Overall Study|Lost to Follow-up|1|||
16144883|NCT01022996|39021068|FG000|Overall Study|Administrative problems|6|||
16257342|NCT01367457|39427254|FG002|Overall Study|CD, associated leukaemia|0|||
16257343|NCT01367457|39427252|FG000|Overall Study|Uncontrolled pain|1|||
16257344|NCT01367457|39427253|FG001|Overall Study|Uncontrolled pain|0|||
16439896|NCT00617734|40089602|FG000|Overall Study|Withdrew Consent|2|||
16439897|NCT00617734|40089603|FG001|Overall Study|Withdrew Consent|0|||
16439898|NCT00617734|40089602|FG000|Overall Study|Adverse Event|4|||
16439899|NCT00617734|40089603|FG001|Overall Study|Adverse Event|1|||
16439900|NCT00617734|40089602|FG000|Overall Study|Protocol Violation|1|||
16439901|NCT00617734|40089603|FG001|Overall Study|Protocol Violation|0|||
16439902|NCT00617734|40089602|FG000|Overall Study|Found Ineligible After Randomization|1|||
16439903|NCT00617734|40089603|FG001|Overall Study|Found Ineligible After Randomization|4|||
16439904|NCT00617734|40089602|FG000|Overall Study|Lost to Follow-up|0|||
16439905|NCT00617734|40089603|FG001|Overall Study|Lost to Follow-up|1|||
16439906|NCT03858049|40089604|FG000|Overall Study|Adverse Event|16|||
16439907|NCT03858049|40089605|FG001|Overall Study|Adverse Event|9|||
16439908|NCT03858049|40089604|FG000|Overall Study|Other|1|||
16439909|NCT03858049|40089605|FG001|Overall Study|Other|1|||
16364274|NCT01179399|39818250|FG000|Overall Study|Withdrawal by Subject|1|||
16364275|NCT03526250|39818251|FG000|Overall Study|Adverse Event|4|||
16364276|NCT03526250|39818251|FG000|Overall Study|Progressive Disease|16|||
16364277|NCT03526250|39818251|FG000|Overall Study|No Treatment|3|||
16364278|NCT03317496|39818255|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
16364279|NCT03317496|39818256|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
16439910|NCT02183675|40089608|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
16439911|NCT02183675|40089609|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
16439912|NCT02183675|40089610|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
16439913|NCT02183675|40089611|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
16439914|NCT02183675|40089612|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
16439915|NCT02183675|40089613|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
16439916|NCT04196686|40089614|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
16364280|NCT03317496|39818257|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
16364281|NCT03317496|39818258|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
16364282|NCT03317496|39818259|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
16144884|NCT01022996|39021068|FG000|Overall Study|Disease Progression|32|||
16144885|NCT01022996|39021068|FG000|Overall Study|Protocol Violation|1|||
16144886|NCT02830776|39021069|FG000|Overall Study|Lost to Follow-up|1|||
16144887|NCT00187096|39021075|FG000|Overall Study|unacceptable toxicity|0|||
16144888|NCT00187096|39021076|FG001|Overall Study|unacceptable toxicity|0|||
16144889|NCT00187096|39021077|FG002|Overall Study|unacceptable toxicity|1|||
16144890|NCT01086410|39021084|FG000|Overall Study|Adverse Event|1|||
16144891|NCT01086410|39021085|FG001|Overall Study|Adverse Event|0|||
16144892|NCT01086410|39021086|FG002|Overall Study|Adverse Event|0|||
16144893|NCT01086410|39021087|FG003|Overall Study|Adverse Event|2|||
16144894|NCT01086410|39021084|FG000|Overall Study|Lack of Efficacy|1|||
16144895|NCT01086410|39021085|FG001|Overall Study|Lack of Efficacy|1|||
16144896|NCT01086410|39021086|FG002|Overall Study|Lack of Efficacy|0|||
16144897|NCT01086410|39021087|FG003|Overall Study|Lack of Efficacy|0|||
16144898|NCT01086410|39021084|FG000|Overall Study|Protocol Violation|1|||
16144899|NCT01086410|39021085|FG001|Overall Study|Protocol Violation|1|||
16144900|NCT01086410|39021086|FG002|Overall Study|Protocol Violation|0|||
16144901|NCT01086410|39021087|FG003|Overall Study|Protocol Violation|0|||
16144902|NCT01086410|39021084|FG000|Overall Study|Lost to Follow-up|0|||
16144903|NCT01086410|39021085|FG001|Overall Study|Lost to Follow-up|0|||
16144904|NCT01086410|39021086|FG002|Overall Study|Lost to Follow-up|1|||
16144905|NCT01086410|39021087|FG003|Overall Study|Lost to Follow-up|0|||
16144906|NCT00601705|39021088|FG000|Overall Study|Withdrawal by Subject|1|||
16144907|NCT03227471|39021089|FG000|Overall Study|Withdrawal by Subject|0|||
16144908|NCT03227471|39021090|FG001|Overall Study|Withdrawal by Subject|0|||
16144909|NCT03227471|39021091|FG002|Overall Study|Withdrawal by Subject|0|||
16144910|NCT03227471|39021092|FG003|Overall Study|Withdrawal by Subject|0|||
16144911|NCT03227471|39021093|FG004|Overall Study|Withdrawal by Subject|1|||
16144912|NCT03227471|39021094|FG005|Overall Study|Withdrawal by Subject|0|||
16144913|NCT03227471|39021095|FG006|Overall Study|Withdrawal by Subject|0|||
16144914|NCT03227471|39021096|FG007|Overall Study|Withdrawal by Subject|0|||
16144915|NCT03227471|39021097|FG008|Overall Study|Withdrawal by Subject|0|||
16144916|NCT03227471|39021098|FG009|Overall Study|Withdrawal by Subject|0|||
16144917|NCT03227471|39021099|FG010|Overall Study|Withdrawal by Subject|0|||
16144918|NCT03227471|39021100|FG011|Overall Study|Withdrawal by Subject|0|||
16144919|NCT03227471|39021101|FG012|Overall Study|Withdrawal by Subject|1|||
16144920|NCT03227471|39021102|FG013|Overall Study|Withdrawal by Subject|0|||
16144921|NCT03227471|39021103|FG014|Overall Study|Withdrawal by Subject|0|||
16144922|NCT03227471|39021089|FG000|Overall Study|Randomized, Never Dosed|0|||
16144923|NCT03227471|39021090|FG001|Overall Study|Randomized, Never Dosed|0|||
16144924|NCT03227471|39021091|FG002|Overall Study|Randomized, Never Dosed|0|||
16144925|NCT03227471|39021092|FG003|Overall Study|Randomized, Never Dosed|0|||
16144926|NCT03227471|39021093|FG004|Overall Study|Randomized, Never Dosed|0|||
16144927|NCT03227471|39021094|FG005|Overall Study|Randomized, Never Dosed|0|||
16144928|NCT03227471|39021095|FG006|Overall Study|Randomized, Never Dosed|0|||
16144929|NCT03227471|39021096|FG007|Overall Study|Randomized, Never Dosed|0|||
16144930|NCT03227471|39021097|FG008|Overall Study|Randomized, Never Dosed|0|||
16144931|NCT03227471|39021098|FG009|Overall Study|Randomized, Never Dosed|0|||
16144932|NCT03227471|39021099|FG010|Overall Study|Randomized, Never Dosed|0|||
16144933|NCT03227471|39021100|FG011|Overall Study|Randomized, Never Dosed|0|||
16144934|NCT03227471|39021101|FG012|Overall Study|Randomized, Never Dosed|0|||
16144935|NCT03227471|39021102|FG013|Overall Study|Randomized, Never Dosed|0|||
16144936|NCT03227471|39021103|FG014|Overall Study|Randomized, Never Dosed|1|||
16144937|NCT01252810|39021104|FG000|Overall Study|Withdrawal by Subject|4|||
16144938|NCT01252810|39021105|FG001|Overall Study|Withdrawal by Subject|1|||
16439917|NCT04196686|40089615|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
16439918|NCT03744312|40089616|FG000|Overall Study|Withdrawal by Subject|0|||
16439919|NCT03744312|40089617|FG001|Overall Study|Withdrawal by Subject|1|||
16439920|NCT03744312|40089616|FG000|Overall Study|Screen fail|0|||
16439921|NCT03744312|40089617|FG001|Overall Study|Screen fail|1|||
16439922|NCT03291067|40089618|FG000|Overall Study|Adverse Event|0|||
16439923|NCT03291067|40089619|FG001|Overall Study|Adverse Event|2|||
16439924|NCT03291067|40089620|FG002|Overall Study|Adverse Event|17|||
16439925|NCT03291067|40089621|FG003|Overall Study|Adverse Event|3|||
16439926|NCT03291067|40089618|FG000|Overall Study|Lost to Follow-up|2|||
16439927|NCT03291067|40089619|FG001|Overall Study|Lost to Follow-up|1|||
16439928|NCT03291067|40089620|FG002|Overall Study|Lost to Follow-up|0|||
16439929|NCT03291067|40089621|FG003|Overall Study|Lost to Follow-up|1|||
16439930|NCT03291067|40089618|FG000|Overall Study|Physician Decision|0|||
16439931|NCT03291067|40089619|FG001|Overall Study|Physician Decision|0|||
16439932|NCT03291067|40089620|FG002|Overall Study|Physician Decision|1|||
16439933|NCT03291067|40089621|FG003|Overall Study|Physician Decision|0|||
16439934|NCT03291067|40089618|FG000|Overall Study|Protocol Violation|5|||
16439935|NCT03291067|40089619|FG001|Overall Study|Protocol Violation|3|||
16439936|NCT03291067|40089620|FG002|Overall Study|Protocol Violation|4|||
16439937|NCT03291067|40089621|FG003|Overall Study|Protocol Violation|2|||
16439938|NCT03291067|40089618|FG000|Overall Study|Withdrawal by Subject|3|||
16439939|NCT03291067|40089619|FG001|Overall Study|Withdrawal by Subject|4|||
16439940|NCT03291067|40089620|FG002|Overall Study|Withdrawal by Subject|7|||
16439941|NCT03291067|40089621|FG003|Overall Study|Withdrawal by Subject|5|||
16439942|NCT03291067|40089618|FG000|Overall Study|Other|0|||
16439943|NCT03291067|40089619|FG001|Overall Study|Other|4|||
16439944|NCT03291067|40089620|FG002|Overall Study|Other|4|||
16439945|NCT03291067|40089621|FG003|Overall Study|Other|6|||
16439946|NCT01506596|40089622|FG000|Overall Study|ineligible pathology|1|||
16439947|NCT00453154|40089623|FG000|Double BIind Maintenance|Adverse Event|0|||
16439948|NCT00453154|40089624|FG001|Double BIind Maintenance|Adverse Event|0|||
16439949|NCT00453154|40089625|FG002|Double BIind Maintenance|Adverse Event|3|||
16439950|NCT00453154|40089626|FG003|Double BIind Maintenance|Adverse Event|12|||
16439951|NCT00453154|40089623|FG000|Double BIind Maintenance|Death|0|||
16439952|NCT00453154|40089624|FG001|Double BIind Maintenance|Death|0|||
16439953|NCT00453154|40089625|FG002|Double BIind Maintenance|Death|2|||
16439954|NCT00453154|40089626|FG003|Double BIind Maintenance|Death|1|||
16439955|NCT00453154|40089623|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
16439956|NCT00453154|40089624|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
16439957|NCT00453154|40089625|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
16144939|NCT01252810|39021104|FG000|Overall Study|Lost to Follow-up|0|||
16144940|NCT01252810|39021105|FG001|Overall Study|Lost to Follow-up|1|||
16144941|NCT01252810|39021104|FG000|Overall Study|Physician Decision|2|||
16144942|NCT01252810|39021105|FG001|Overall Study|Physician Decision|1|||
16144943|NCT01252810|39021104|FG000|Overall Study|Various reasons|8|||
16144944|NCT01252810|39021105|FG001|Overall Study|Various reasons|0|||
16144945|NCT01717287|39021106|FG000|Overall Study|Lost to Follow-up|0|||
16144946|NCT01717287|39021107|FG001|Overall Study|Lost to Follow-up|2|||
16144947|NCT01717287|39021106|FG000|Overall Study|Protocol Violation|0|||
16144948|NCT01717287|39021107|FG001|Overall Study|Protocol Violation|1|||
16144949|NCT02146599|39021108|FG000|Overall Study|Failed to meet inclusion criteria|5|||
16144950|NCT00646906|39021109|FG000|Crossover Period 1|Withdrawal by Subject|1|||
16144951|NCT00646906|39021110|FG001|Crossover Period 1|Withdrawal by Subject|0|||
16144952|NCT00646906|39021111|FG002|Crossover Period 1|Withdrawal by Subject|0|||
16144953|NCT00646906|39021112|FG003|Crossover Period 1|Withdrawal by Subject|0|||
16144954|NCT00646906|39021113|FG004|Crossover Period 1|Withdrawal by Subject|0|||
16144955|NCT00646906|39021114|FG005|Crossover Period 1|Withdrawal by Subject|1|||
16144956|NCT00646906|39021115|FG006|Crossover Period 1|Withdrawal by Subject|0|||
16144957|NCT00646906|39021109|FG000|Crossover Period 2|Withdrawal by Subject|0|||
16144958|NCT00646906|39021110|FG001|Crossover Period 2|Withdrawal by Subject|1|||
16144959|NCT00646906|39021111|FG002|Crossover Period 2|Withdrawal by Subject|2|||
16144960|NCT00646906|39021112|FG003|Crossover Period 2|Withdrawal by Subject|1|||
16144961|NCT00646906|39021113|FG004|Crossover Period 2|Withdrawal by Subject|0|||
16144962|NCT00646906|39021114|FG005|Crossover Period 2|Withdrawal by Subject|0|||
16144963|NCT00646906|39021115|FG006|Crossover Period 2|Withdrawal by Subject|0|||
16257345|NCT01367457|39427254|FG002|Overall Study|Uncontrolled pain|0|||
16257346|NCT01367457|39427252|FG000|Overall Study|Overall status worsens to grade 4|1|||
16257347|NCT01367457|39427253|FG001|Overall Study|Overall status worsens to grade 4|0|||
16257348|NCT01367457|39427254|FG002|Overall Study|Overall status worsens to grade 4|0|||
16257349|NCT01367457|39427252|FG000|Overall Study|Stabilisation + frequent infections|1|||
16257350|NCT01367457|39427253|FG001|Overall Study|Stabilisation + frequent infections|0|||
16257351|NCT01367457|39427254|FG002|Overall Study|Stabilisation + frequent infections|0|||
16257352|NCT01367457|39427252|FG000|Overall Study|No clinical benefit|1|||
16257353|NCT01367457|39427253|FG001|Overall Study|No clinical benefit|0|||
16257354|NCT01367457|39427254|FG002|Overall Study|No clinical benefit|0|||
16257355|NCT01367457|39427252|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
16257356|NCT01367457|39427253|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
16257357|NCT01367457|39427254|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
16257358|NCT01367457|39427252|FG000|Overall Study|Overall decline|1|||
16257359|NCT01367457|39427253|FG001|Overall Study|Overall decline|0|||
16257360|NCT01367457|39427254|FG002|Overall Study|Overall decline|0|||
16257361|NCT01367457|39427252|FG000|Overall Study|Rejection of treatment|1|||
16257362|NCT01367457|39427253|FG001|Overall Study|Rejection of treatment|0|||
16257363|NCT01367457|39427254|FG002|Overall Study|Rejection of treatment|0|||
16257364|NCT01367457|39427252|FG000|Overall Study|Lost to Follow-up|1|||
16257365|NCT01367457|39427253|FG001|Overall Study|Lost to Follow-up|0|||
16257366|NCT01367457|39427254|FG002|Overall Study|Lost to Follow-up|0|||
16257367|NCT01367457|39427252|FG000|Overall Study|Death from septic shock|1|||
16257368|NCT01367457|39427253|FG001|Overall Study|Death from septic shock|0|||
16257369|NCT01367457|39427254|FG002|Overall Study|Death from septic shock|0|||
16257370|NCT01367457|39427252|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
16439958|NCT00453154|40089626|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
16439959|NCT00453154|40089623|FG000|Double BIind Maintenance|Progression|0|||
16439960|NCT00453154|40089624|FG001|Double BIind Maintenance|Progression|0|||
16439961|NCT00453154|40089625|FG002|Double BIind Maintenance|Progression|29|||
16439962|NCT00453154|40089626|FG003|Double BIind Maintenance|Progression|26|||
16439963|NCT00453154|40089623|FG000|Double BIind Maintenance|Medical Issues|0|||
16439964|NCT00453154|40089624|FG001|Double BIind Maintenance|Medical Issues|0|||
16439965|NCT00453154|40089625|FG002|Double BIind Maintenance|Medical Issues|3|||
16144964|NCT00646906|39021109|FG000|Crossover Period 2|Physician Decision|0|||
16144965|NCT00646906|39021110|FG001|Crossover Period 2|Physician Decision|0|||
16257371|NCT01367457|39427253|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
16439966|NCT00453154|40089626|FG003|Double BIind Maintenance|Medical Issues|1|||
16439967|NCT00453154|40089623|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
16257372|NCT01367457|39427254|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
16257373|NCT01367457|39427252|FG000|Overall Study|Patient's Wish|1|||
16257374|NCT01367457|39427253|FG001|Overall Study|Patient's Wish|0|||
16257375|NCT01367457|39427254|FG002|Overall Study|Patient's Wish|0|||
16257376|NCT01367457|39427252|FG000|Overall Study|Palliative. Overall decline|1|||
16257377|NCT01367457|39427253|FG001|Overall Study|Palliative. Overall decline|0|||
16257378|NCT01367457|39427254|FG002|Overall Study|Palliative. Overall decline|0|||
16257379|NCT01367457|39427252|FG000|Overall Study|Suspected DP/suspected active infection|1|||
16257380|NCT01367457|39427253|FG001|Overall Study|Suspected DP/suspected active infection|0|||
16257381|NCT01367457|39427254|FG002|Overall Study|Suspected DP/suspected active infection|0|||
16257382|NCT00322491|39427255|FG000|Overall Study|Adverse Event|1|||
16257383|NCT00322491|39427256|FG001|Overall Study|Adverse Event|0|||
16257384|NCT00322491|39427255|FG000|Overall Study|Death|1|||
16257385|NCT00322491|39427256|FG001|Overall Study|Death|2|||
16257386|NCT00846495|39427259|FG000|Overall Study|Lost to Follow-up|1|||
16257387|NCT00846495|39427260|FG001|Overall Study|Lost to Follow-up|0|||
16257388|NCT00846495|39427259|FG000|Overall Study|Adverse Event|5|||
16257389|NCT00846495|39427260|FG001|Overall Study|Adverse Event|1|||
16257390|NCT00846495|39427259|FG000|Overall Study|Lack of Efficacy|1|||
16257391|NCT00846495|39427260|FG001|Overall Study|Lack of Efficacy|2|||
16257392|NCT00846495|39427259|FG000|Overall Study|Physician Decision|1|||
16257393|NCT00846495|39427260|FG001|Overall Study|Physician Decision|0|||
16257394|NCT04786184|39427261|FG000|Overall Study|Adverse Event|4|||
16257395|NCT04786184|39427262|FG001|Overall Study|Adverse Event|0|||
16257396|NCT04786184|39427261|FG000|Overall Study|Withdrawal by Subject|3|||
16257397|NCT04786184|39427262|FG001|Overall Study|Withdrawal by Subject|1|||
16257398|NCT04786184|39427261|FG000|Overall Study|Lost to Follow-up|4|||
16257399|NCT04786184|39427262|FG001|Overall Study|Lost to Follow-up|2|||
16257400|NCT01936948|39427264|FG000|Overall Study|no 30-day follow-up data|0|||
16257401|NCT01936948|39427265|FG001|Overall Study|no 30-day follow-up data|3|||
16257402|NCT01936948|39427266|FG002|Overall Study|no 30-day follow-up data|3|||
16257403|NCT01936948|39427267|FG003|Overall Study|no 30-day follow-up data|3|||
16257404|NCT02899338|39427280|FG000|Overall Study|Adverse Event|1|||
16257405|NCT02899338|39427281|FG001|Overall Study|Adverse Event|2|||
16257406|NCT02899338|39427280|FG000|Overall Study|Withdrawal by Subject|2|||
16257407|NCT02899338|39427281|FG001|Overall Study|Withdrawal by Subject|0|||
16257408|NCT03127137|39427283|FG000|Overall Study|Requested sedation after consent|1|||
16257409|NCT03127137|39427284|FG001|Overall Study|Requested sedation after consent|0|||
16257410|NCT03127137|39427283|FG000|Overall Study|Malfunction in electronic data collection|1|||
16257411|NCT03127137|39427284|FG001|Overall Study|Malfunction in electronic data collection|0|||
16257412|NCT03127137|39427283|FG000|Overall Study|Post procedure testing could not be obtained|0|||
16257413|NCT03127137|39427284|FG001|Overall Study|Post procedure testing could not be obtained|1|||
16257414|NCT00162123|39427285|FG000|Overall Study|Disease progression|27|||
16257415|NCT00162123|39427286|FG001|Overall Study|Disease progression|19|||
16257416|NCT00162123|39427287|FG002|Overall Study|Disease progression|10|||
16257417|NCT00162123|39427288|FG003|Overall Study|Disease progression|4|||
16257418|NCT00162123|39427289|FG004|Overall Study|Disease progression|8|||
16257419|NCT00162123|39427290|FG005|Overall Study|Disease progression|3|||
16257420|NCT00162123|39427291|FG006|Overall Study|Disease progression|1|||
16257421|NCT00162123|39427292|FG007|Overall Study|Disease progression|0|||
16257422|NCT00162123|39427285|FG000|Overall Study|Study drug toxicity|6|||
16257423|NCT00162123|39427286|FG001|Overall Study|Study drug toxicity|1|||
16257424|NCT00162123|39427287|FG002|Overall Study|Study drug toxicity|5|||
16257425|NCT00162123|39427288|FG003|Overall Study|Study drug toxicity|0|||
16257426|NCT00162123|39427289|FG004|Overall Study|Study drug toxicity|4|||
16257427|NCT00162123|39427290|FG005|Overall Study|Study drug toxicity|1|||
16257428|NCT00162123|39427291|FG006|Overall Study|Study drug toxicity|1|||
16257429|NCT00162123|39427292|FG007|Overall Study|Study drug toxicity|0|||
16257430|NCT00162123|39427285|FG000|Overall Study|Death|3|||
16257431|NCT00162123|39427286|FG001|Overall Study|Death|3|||
16257432|NCT00162123|39427287|FG002|Overall Study|Death|1|||
16257433|NCT00162123|39427288|FG003|Overall Study|Death|1|||
16257434|NCT00162123|39427289|FG004|Overall Study|Death|1|||
16257435|NCT00162123|39427290|FG005|Overall Study|Death|1|||
16257436|NCT00162123|39427291|FG006|Overall Study|Death|0|||
16257437|NCT00162123|39427292|FG007|Overall Study|Death|0|||
16257438|NCT00162123|39427285|FG000|Overall Study|Withdrawal by Subject|2|||
16439968|NCT00453154|40089624|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
16144966|NCT00646906|39021111|FG002|Crossover Period 2|Physician Decision|0|||
16257439|NCT00162123|39427286|FG001|Overall Study|Withdrawal by Subject|0|||
16257440|NCT00162123|39427287|FG002|Overall Study|Withdrawal by Subject|2|||
16257441|NCT00162123|39427288|FG003|Overall Study|Withdrawal by Subject|1|||
16257442|NCT00162123|39427289|FG004|Overall Study|Withdrawal by Subject|1|||
16257443|NCT00162123|39427290|FG005|Overall Study|Withdrawal by Subject|2|||
16257444|NCT00162123|39427291|FG006|Overall Study|Withdrawal by Subject|1|||
16257445|NCT00162123|39427292|FG007|Overall Study|Withdrawal by Subject|0|||
16257446|NCT00162123|39427285|FG000|Overall Study|Deterioration without progression|2|||
16144967|NCT00646906|39021112|FG003|Crossover Period 2|Physician Decision|0|||
16257447|NCT00162123|39427286|FG001|Overall Study|Deterioration without progression|2|||
16257448|NCT00162123|39427287|FG002|Overall Study|Deterioration without progression|3|||
16257449|NCT00162123|39427288|FG003|Overall Study|Deterioration without progression|0|||
16257450|NCT00162123|39427289|FG004|Overall Study|Deterioration without progression|1|||
16257451|NCT00162123|39427290|FG005|Overall Study|Deterioration without progression|0|||
16257452|NCT00162123|39427291|FG006|Overall Study|Deterioration without progression|0|||
16257453|NCT00162123|39427292|FG007|Overall Study|Deterioration without progression|0|||
16257454|NCT00162123|39427285|FG000|Overall Study|Adverse Event|1|||
16257455|NCT00162123|39427286|FG001|Overall Study|Adverse Event|2|||
16257456|NCT00162123|39427287|FG002|Overall Study|Adverse Event|0|||
16257457|NCT00162123|39427288|FG003|Overall Study|Adverse Event|2|||
16257458|NCT00162123|39427289|FG004|Overall Study|Adverse Event|1|||
16257459|NCT00162123|39427290|FG005|Overall Study|Adverse Event|0|||
16257460|NCT00162123|39427291|FG006|Overall Study|Adverse Event|0|||
16257461|NCT00162123|39427292|FG007|Overall Study|Adverse Event|0|||
16257462|NCT00162123|39427285|FG000|Overall Study|Not specified (before treatment)|2|||
16257463|NCT00162123|39427286|FG001|Overall Study|Not specified (before treatment)|0|||
16257464|NCT00162123|39427287|FG002|Overall Study|Not specified (before treatment)|0|||
16257465|NCT00162123|39427288|FG003|Overall Study|Not specified (before treatment)|0|||
16257466|NCT00162123|39427289|FG004|Overall Study|Not specified (before treatment)|12|||
16257467|NCT00162123|39427290|FG005|Overall Study|Not specified (before treatment)|1|||
16257468|NCT00162123|39427291|FG006|Overall Study|Not specified (before treatment)|0|||
16257469|NCT00162123|39427292|FG007|Overall Study|Not specified (before treatment)|0|||
16257470|NCT00162123|39427285|FG000|Overall Study|Not specified (after start of treatment)|0|||
16257471|NCT00162123|39427286|FG001|Overall Study|Not specified (after start of treatment)|0|||
16257472|NCT00162123|39427287|FG002|Overall Study|Not specified (after start of treatment)|0|||
16257473|NCT00162123|39427288|FG003|Overall Study|Not specified (after start of treatment)|0|||
16257474|NCT00162123|39427289|FG004|Overall Study|Not specified (after start of treatment)|3|||
16257475|NCT00162123|39427290|FG005|Overall Study|Not specified (after start of treatment)|0|||
16257476|NCT00162123|39427291|FG006|Overall Study|Not specified (after start of treatment)|0|||
16257477|NCT00162123|39427292|FG007|Overall Study|Not specified (after start of treatment)|0|||
16257478|NCT00162123|39427285|FG000|Overall Study|Physician Decision|1|||
16257479|NCT00162123|39427286|FG001|Overall Study|Physician Decision|2|||
16257480|NCT00162123|39427287|FG002|Overall Study|Physician Decision|0|||
16257481|NCT00162123|39427288|FG003|Overall Study|Physician Decision|0|||
16257482|NCT00162123|39427289|FG004|Overall Study|Physician Decision|0|||
16257483|NCT00162123|39427290|FG005|Overall Study|Physician Decision|1|||
16257484|NCT00162123|39427291|FG006|Overall Study|Physician Decision|1|||
16257485|NCT00162123|39427292|FG007|Overall Study|Physician Decision|0|||
16257486|NCT00162123|39427285|FG000|Overall Study|Tumor assessment only (not treated)|0|||
16257487|NCT00162123|39427286|FG001|Overall Study|Tumor assessment only (not treated)|0|||
16257488|NCT00162123|39427287|FG002|Overall Study|Tumor assessment only (not treated)|0|||
16257489|NCT00162123|39427288|FG003|Overall Study|Tumor assessment only (not treated)|0|||
16257490|NCT00162123|39427289|FG004|Overall Study|Tumor assessment only (not treated)|0|||
16257491|NCT00162123|39427290|FG005|Overall Study|Tumor assessment only (not treated)|0|||
16257492|NCT00162123|39427291|FG006|Overall Study|Tumor assessment only (not treated)|0|||
16257493|NCT00162123|39427292|FG007|Overall Study|Tumor assessment only (not treated)|1|||
16257494|NCT00162123|39427285|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
16257495|NCT00162123|39427286|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
16257496|NCT00162123|39427287|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
16257497|NCT00162123|39427288|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
16257498|NCT00162123|39427289|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
16257499|NCT00162123|39427290|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
16257500|NCT00162123|39427291|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
16257501|NCT00162123|39427292|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
16257502|NCT04015232|39427293|FG000|Overall Study|Withdrawal by Subject|7|||
16257503|NCT04015232|39427294|FG001|Overall Study|Withdrawal by Subject|4|||
16257504|NCT04015232|39427293|FG000|Overall Study|Protocol Violation|1|||
16257505|NCT04015232|39427294|FG001|Overall Study|Protocol Violation|0|||
16257506|NCT04015232|39427293|FG000|Overall Study|Medical Grounds|3|||
16257507|NCT04015232|39427294|FG001|Overall Study|Medical Grounds|3|||
16257508|NCT03213210|39427295|FG000|Overall Study|Lost to Follow-up|2|||
16257509|NCT03213210|39427295|FG000|Overall Study|Study termination|3|||
16257510|NCT00723528|39427300|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
16257511|NCT00723528|39427301|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
16257512|NCT00723528|39427302|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
16257513|NCT00723528|39427303|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
16257514|NCT00723528|39427304|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
16257515|NCT00723528|39427305|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
16257516|NCT00723528|39427306|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
16257517|NCT00723528|39427300|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
16257518|NCT00723528|39427301|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
16257519|NCT00723528|39427302|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
16257520|NCT00723528|39427303|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
16257521|NCT00723528|39427304|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
16257522|NCT00723528|39427305|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
16257523|NCT00723528|39427306|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
16257524|NCT00723528|39427300|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
16257525|NCT00723528|39427301|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
16257526|NCT00723528|39427302|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
16257527|NCT00723528|39427303|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
16257528|NCT00723528|39427304|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
16257529|NCT00723528|39427305|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
16257530|NCT00723528|39427306|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
16257531|NCT00723528|39427300|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
16257532|NCT00723528|39427301|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
16257533|NCT00723528|39427302|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
16257534|NCT00723528|39427303|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
16257535|NCT00723528|39427304|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
16257536|NCT00723528|39427305|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
16257537|NCT00723528|39427306|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
16257538|NCT00723528|39427300|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
16257539|NCT00723528|39427301|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
16257540|NCT00723528|39427302|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
16257541|NCT00723528|39427303|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
16257542|NCT00723528|39427304|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
16257543|NCT00723528|39427305|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
16257544|NCT00723528|39427306|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
16257545|NCT00723528|39427300|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
16257546|NCT00723528|39427301|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
16257547|NCT00723528|39427302|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
16257548|NCT00723528|39427303|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
16257549|NCT00723528|39427304|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
16257550|NCT00723528|39427305|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
16257551|NCT00723528|39427306|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
16257552|NCT00723528|39427300|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
16257553|NCT00723528|39427301|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
16257554|NCT00723528|39427302|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
16257555|NCT00723528|39427303|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
16257556|NCT00723528|39427304|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
16257557|NCT00723528|39427305|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
16257558|NCT00723528|39427306|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
16257559|NCT00723528|39427300|FG000|Period 2: After Controlled Period|Other|0|||
16257560|NCT00723528|39427301|FG001|Period 2: After Controlled Period|Other|0|||
16257561|NCT00723528|39427302|FG002|Period 2: After Controlled Period|Other|0|||
16257562|NCT00723528|39427303|FG003|Period 2: After Controlled Period|Other|0|||
16257563|NCT00723528|39427304|FG004|Period 2: After Controlled Period|Other|1|||
16257564|NCT00723528|39427305|FG005|Period 2: After Controlled Period|Other|4|||
16257565|NCT00723528|39427306|FG006|Period 2: After Controlled Period|Other|0|||
16257566|NCT00723528|39427300|FG000|Period 2: After Controlled Period|Adverse Event|0|||
16257567|NCT00723528|39427301|FG001|Period 2: After Controlled Period|Adverse Event|0|||
16257568|NCT00723528|39427302|FG002|Period 2: After Controlled Period|Adverse Event|0|||
16257569|NCT00723528|39427303|FG003|Period 2: After Controlled Period|Adverse Event|0|||
16257570|NCT00723528|39427304|FG004|Period 2: After Controlled Period|Adverse Event|1|||
16257571|NCT00723528|39427305|FG005|Period 2: After Controlled Period|Adverse Event|0|||
16257572|NCT00723528|39427306|FG006|Period 2: After Controlled Period|Adverse Event|1|||
16257573|NCT00723528|39427300|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
16257574|NCT00723528|39427301|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
16257575|NCT00723528|39427302|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
16257576|NCT00723528|39427303|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
16257577|NCT00723528|39427304|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
16257578|NCT00723528|39427305|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
16257579|NCT00723528|39427306|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
16257580|NCT00723528|39427300|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
16257581|NCT00723528|39427301|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
16257582|NCT00723528|39427302|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
16257583|NCT00723528|39427303|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
16257584|NCT00723528|39427304|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
16257585|NCT00723528|39427305|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
16257586|NCT00723528|39427306|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
16257587|NCT04094870|39427312|FG000|Overall Study|Lost to Follow-up|1|||
16257588|NCT04094870|39427313|FG001|Overall Study|Lost to Follow-up|1|||
16257589|NCT02017964|39427314|FG000|Overall Study|Patient deemed ineligible|1|||
16257590|NCT00408902|39427315|FG000|Overall Study|Lack of Efficacy|7|||
16257591|NCT00408902|39427315|FG000|Overall Study|Adverse Event|3|||
16257592|NCT01706926|39427321|FG000|Overall Study|Lost to Follow-up|0|||
16257593|NCT01706926|39427322|FG001|Overall Study|Lost to Follow-up|0|||
16257594|NCT01706926|39427323|FG002|Overall Study|Lost to Follow-up|1|||
16257595|NCT01706926|39427324|FG003|Overall Study|Lost to Follow-up|0|||
16257596|NCT01706926|39427321|FG000|Overall Study|Withdrawal by Subject|2|||
16257597|NCT01706926|39427322|FG001|Overall Study|Withdrawal by Subject|0|||
16257598|NCT01706926|39427323|FG002|Overall Study|Withdrawal by Subject|1|||
16257599|NCT01706926|39427324|FG003|Overall Study|Withdrawal by Subject|2|||
16257600|NCT01706926|39427321|FG000|Overall Study|Other|4|||
16257601|NCT01706926|39427322|FG001|Overall Study|Other|4|||
16257602|NCT01706926|39427323|FG002|Overall Study|Other|4|||
16257603|NCT01706926|39427324|FG003|Overall Study|Other|3|||
16257604|NCT01287013|39427325|FG000|Overall Study|Non-evaluable|3|||
16257605|NCT01287013|39427326|FG001|Overall Study|Non-evaluable|5|||
16257606|NCT01287013|39427327|FG002|Overall Study|Non-evaluable|21|||
16257607|NCT00797108|39427331|FG000|Overall Study|Adverse Event|1|||
16257608|NCT00797108|39427332|FG001|Overall Study|Adverse Event|0|||
16257609|NCT00797108|39427333|FG002|Overall Study|Adverse Event|3|||
16257610|NCT00797108|39427331|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
16257611|NCT00797108|39427332|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
16257612|NCT00797108|39427333|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
16257613|NCT00797108|39427331|FG000|Overall Study|Global Deterioration of Health Status|0|||
16257614|NCT00797108|39427332|FG001|Overall Study|Global Deterioration of Health Status|1|||
16257615|NCT00797108|39427333|FG002|Overall Study|Global Deterioration of Health Status|0|||
16257616|NCT00797108|39427331|FG000|Overall Study|Lack of Efficacy|1|||
16257617|NCT00797108|39427332|FG001|Overall Study|Lack of Efficacy|0|||
16257618|NCT00797108|39427333|FG002|Overall Study|Lack of Efficacy|1|||
16257619|NCT00797108|39427331|FG000|Overall Study|Other|0|||
16257620|NCT00797108|39427332|FG001|Overall Study|Other|0|||
16257621|NCT00797108|39427333|FG002|Overall Study|Other|2|||
16257622|NCT00797108|39427331|FG000|Overall Study|Randomized but not Treated|2|||
16257623|NCT00797108|39427332|FG001|Overall Study|Randomized but not Treated|0|||
16257624|NCT00797108|39427333|FG002|Overall Study|Randomized but not Treated|0|||
16257625|NCT02246478|39427334|FG000|Multiple-dose Phase|Protocol Violation|1|||
16257626|NCT02246478|39427335|FG001|Multiple-dose Phase|Protocol Violation|0|||
16257627|NCT02246478|39427336|FG002|Multiple-dose Phase|Protocol Violation|0|||
16257628|NCT02246478|39427337|FG003|Multiple-dose Phase|Protocol Violation|1|||
16257629|NCT03093324|39427338|FG000|Overall Study|Adverse Event|4|||
16257630|NCT03093324|39427339|FG001|Overall Study|Adverse Event|15|||
16257631|NCT03093324|39427338|FG000|Overall Study|Lost to Follow-up|1|||
16257632|NCT03093324|39427339|FG001|Overall Study|Lost to Follow-up|0|||
16257633|NCT03093324|39427338|FG000|Overall Study|Protocol Deviation|2|||
16257634|NCT03093324|39427339|FG001|Overall Study|Protocol Deviation|2|||
16257635|NCT03093324|39427338|FG000|Overall Study|Withdrawal by Subject|2|||
16257636|NCT03093324|39427339|FG001|Overall Study|Withdrawal by Subject|2|||
16257637|NCT00918567|39427343|FG000|Overall Study|Lack of Efficacy|3|||
16257638|NCT00918567|39427344|FG001|Overall Study|Lack of Efficacy|1|||
16257639|NCT00918567|39427343|FG000|Overall Study|Withdrawal by Subject|1|||
16257640|NCT00918567|39427344|FG001|Overall Study|Withdrawal by Subject|1|||
16257641|NCT00918567|39427343|FG000|Overall Study|Adverse Event|1|||
16257642|NCT00918567|39427344|FG001|Overall Study|Adverse Event|0|||
16257643|NCT02626949|39427345|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
16257644|NCT02626949|39427346|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
16257645|NCT02626949|39427345|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
16257646|NCT02626949|39427346|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
16257647|NCT02626949|39427345|FG000|Enrolled|Lost to Follow-up|7|||
16257648|NCT02626949|39427346|FG001|Enrolled|Lost to Follow-up|6|||
16257649|NCT02626949|39427345|FG000|Enrolled|Withdrawal by Subject|3|||
16257650|NCT02626949|39427346|FG001|Enrolled|Withdrawal by Subject|2|||
16257651|NCT01402947|39427347|FG000|First Intervention|Adverse Event|0|||
16257652|NCT01402947|39427348|FG001|First Intervention|Adverse Event|1|||
16257653|NCT00389064|39427353|FG000|Overall Study|Adverse Event|11|||
16257654|NCT00389064|39427354|FG001|Overall Study|Adverse Event|3|||
16257655|NCT00389064|39427353|FG000|Overall Study|Lack of Efficacy|3|||
16257656|NCT00389064|39427354|FG001|Overall Study|Lack of Efficacy|14|||
16257657|NCT00389064|39427353|FG000|Overall Study|Withdrawal by Subject|17|||
16257658|NCT00389064|39427354|FG001|Overall Study|Withdrawal by Subject|27|||
16257659|NCT00389064|39427353|FG000|Overall Study|Physician Decision|2|||
16257660|NCT00389064|39427354|FG001|Overall Study|Physician Decision|2|||
16257661|NCT00389064|39427353|FG000|Overall Study|Lost to Follow-up|1|||
16257662|NCT00389064|39427354|FG001|Overall Study|Lost to Follow-up|2|||
16257663|NCT00389064|39427353|FG000|Overall Study|Protocol Violation|2|||
16257664|NCT00389064|39427354|FG001|Overall Study|Protocol Violation|0|||
16257665|NCT00389064|39427353|FG000|Overall Study|Multiple Reasons|9|||
16439969|NCT00453154|40089625|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
16439970|NCT00453154|40089626|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
16439971|NCT01680341|40089627|FG000|Overall Study|Adverse Event|3|||
16439972|NCT01680341|40089628|FG001|Overall Study|Adverse Event|2|||
16439973|NCT01680341|40089627|FG000|Overall Study|Unclassified|18|||
16439974|NCT01680341|40089628|FG001|Overall Study|Unclassified|15|||
16439975|NCT00928486|40089629|FG000|Overall Study|Adverse Event|2|||
16439976|NCT00928486|40089629|FG000|Overall Study|Disease Progression|7|||
16439977|NCT00928486|40089629|FG000|Overall Study|Withdrawal by Subject|1|||
16439978|NCT01126749|40089632|FG000|Phase 1b|Other|0|||
16439979|NCT01126749|40089633|FG001|Phase 1b|Other|1|||
16439980|NCT01126749|40089634|FG002|Phase 1b|Other|0|||
16439981|NCT01126749|40089635|FG003|Phase 1b|Other|0|||
16439982|NCT01126749|40089632|FG000|Phase 1b|Withdrawal by Subject|0|||
16439983|NCT01126749|40089633|FG001|Phase 1b|Withdrawal by Subject|1|||
16439984|NCT01126749|40089634|FG002|Phase 1b|Withdrawal by Subject|0|||
16439985|NCT01126749|40089635|FG003|Phase 1b|Withdrawal by Subject|0|||
16144968|NCT00646906|39021113|FG004|Crossover Period 2|Physician Decision|0|||
16144969|NCT00646906|39021114|FG005|Crossover Period 2|Physician Decision|0|||
16144970|NCT00646906|39021115|FG006|Crossover Period 2|Physician Decision|1|||
16144971|NCT03472924|39021116|FG000|Overall Study|Adverse Event|1|||
16144972|NCT03472924|39021117|FG001|Overall Study|Adverse Event|0|||
16144973|NCT01628107|39021118|FG000|Overall Study|Withdrawal by Subject|17|||
16144974|NCT01628107|39021118|FG000|Overall Study|Lost to Follow-up|4|||
16144975|NCT01628107|39021118|FG000|Overall Study|Adverse Event|33|||
16144976|NCT01628107|39021118|FG000|Overall Study|Physician Decision|2|||
16144977|NCT01628107|39021118|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
16144978|NCT01628107|39021118|FG000|Overall Study|Non-compliant with Study Procedures|10|||
16144979|NCT01628107|39021118|FG000|Overall Study|Not Treated|8|||
16144980|NCT01628107|39021118|FG000|Overall Study|Sponsor Decision|11|||
16144981|NCT01628107|39021118|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
16144982|NCT01628107|39021118|FG000|Overall Study|Relocated|8|||
16144983|NCT01628107|39021118|FG000|Overall Study|Kidney Transplant|9|||
16144984|NCT01628107|39021118|FG000|Overall Study|Use of Standard of Care|9|||
16144985|NCT01786603|39021119|FG000|Overall Study|Death|5|||
16144986|NCT01786603|39021120|FG001|Overall Study|Death|1|||
16144987|NCT01786603|39021119|FG000|Overall Study|Adverse Event|6|||
16144988|NCT01786603|39021120|FG001|Overall Study|Adverse Event|2|||
16144989|NCT01786603|39021119|FG000|Overall Study|Physician decision to withdraw|6|||
16144990|NCT01786603|39021120|FG001|Overall Study|Physician decision to withdraw|7|||
16144991|NCT01786603|39021119|FG000|Overall Study|Lost to Follow-up|1|||
16144992|NCT01786603|39021120|FG001|Overall Study|Lost to Follow-up|2|||
16144993|NCT00894686|39021121|FG000|Overall Study|Withdrawal by Subject|50|||
16144994|NCT00894686|39021121|FG000|Overall Study|Physician Decision|1|||
16144995|NCT00894686|39021121|FG000|Overall Study|Other|5|||
16144996|NCT00419120|39021124|FG000|Long Term Follow up Period|study ongoing|10|||
16144997|NCT01129921|39021125|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
16364283|NCT03317496|39818255|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
16144998|NCT01129921|39021126|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
16144999|NCT01129921|39021125|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
16145000|NCT01129921|39021126|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
16145001|NCT01129921|39021125|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
16145002|NCT01129921|39021126|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
16145003|NCT01129921|39021125|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
16257666|NCT00389064|39427354|FG001|Overall Study|Multiple Reasons|11|||
16364284|NCT03317496|39818256|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
16364285|NCT03317496|39818257|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
16364286|NCT03317496|39818258|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
16364287|NCT03317496|39818259|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
16364288|NCT03317496|39818255|FG000|Phase 1b Lead-in: Treatment|Death|0|||
16364289|NCT03317496|39818256|FG001|Phase 1b Lead-in: Treatment|Death|0|||
16364290|NCT03317496|39818257|FG002|Phase 1b Lead-in: Treatment|Death|1|||
16364291|NCT03317496|39818258|FG003|Phase 1b Lead-in: Treatment|Death|0|||
16364292|NCT03317496|39818259|FG004|Phase 1b Lead-in: Treatment|Death|0|||
16364293|NCT03317496|39818255|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
16364294|NCT03317496|39818256|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
16364295|NCT03317496|39818257|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
16364296|NCT03317496|39818258|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
16364297|NCT03317496|39818259|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
16364298|NCT03317496|39818255|FG000|Phase 1b Lead-in: Treatment|Other|2|||
16364299|NCT03317496|39818256|FG001|Phase 1b Lead-in: Treatment|Other|1|||
16364300|NCT03317496|39818257|FG002|Phase 1b Lead-in: Treatment|Other|0|||
16364301|NCT03317496|39818258|FG003|Phase 1b Lead-in: Treatment|Other|0|||
16364302|NCT03317496|39818259|FG004|Phase 1b Lead-in: Treatment|Other|0|||
16364303|NCT03317496|39818255|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
16364304|NCT03317496|39818256|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
16364305|NCT03317496|39818257|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
16364306|NCT03317496|39818258|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
16364307|NCT03317496|39818259|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
16364308|NCT03317496|39818255|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
16364309|NCT03317496|39818256|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
16364310|NCT03317496|39818257|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
16364311|NCT03317496|39818258|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
16364312|NCT03317496|39818259|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
16364313|NCT03317496|39818255|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
16364314|NCT03317496|39818256|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
16364315|NCT03317496|39818257|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
16364316|NCT03317496|39818258|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
16364317|NCT03317496|39818259|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
16439986|NCT01126749|40089632|FG000|Phase 1b|Death|3|||
16145004|NCT01129921|39021126|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
16145005|NCT00132496|39021127|FG000|Overall Study|Withdrawal by Subject|1|||
16145006|NCT00132496|39021128|FG001|Overall Study|Withdrawal by Subject|2|||
16145007|NCT00132496|39021127|FG000|Overall Study|Physician Decision|1|||
16145008|NCT00132496|39021128|FG001|Overall Study|Physician Decision|0|||
16145009|NCT04607148|39021129|FG000|Overall Study|Withdrawal by Subject|0|||
16145010|NCT04607148|39021130|FG001|Overall Study|Withdrawal by Subject|4|||
16145011|NCT04607148|39021131|FG002|Overall Study|Withdrawal by Subject|2|||
16145012|NCT04607148|39021132|FG003|Overall Study|Withdrawal by Subject|8|||
16145013|NCT04607148|39021129|FG000|Overall Study|Study Terminated by Sponsor|14|||
16145014|NCT04607148|39021130|FG001|Overall Study|Study Terminated by Sponsor|59|||
16145015|NCT04607148|39021131|FG002|Overall Study|Study Terminated by Sponsor|9|||
16145016|NCT04607148|39021132|FG003|Overall Study|Study Terminated by Sponsor|39|||
16145017|NCT04607148|39021129|FG000|Overall Study|Sponsor Decision|0|||
16145018|NCT04607148|39021130|FG001|Overall Study|Sponsor Decision|0|||
16145019|NCT04607148|39021131|FG002|Overall Study|Sponsor Decision|1|||
16145020|NCT04607148|39021132|FG003|Overall Study|Sponsor Decision|0|||
16145021|NCT04607148|39021129|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16145022|NCT04607148|39021130|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16145023|NCT04607148|39021131|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16145024|NCT04607148|39021132|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16145025|NCT04607148|39021129|FG000|Overall Study|Lost to Follow-up|0|||
16145026|NCT04607148|39021130|FG001|Overall Study|Lost to Follow-up|2|||
16145027|NCT04607148|39021131|FG002|Overall Study|Lost to Follow-up|0|||
16145028|NCT04607148|39021132|FG003|Overall Study|Lost to Follow-up|0|||
16145029|NCT04607148|39021129|FG000|Overall Study|Death|0|||
16145030|NCT04607148|39021130|FG001|Overall Study|Death|3|||
16145031|NCT04607148|39021131|FG002|Overall Study|Death|0|||
16145032|NCT04607148|39021132|FG003|Overall Study|Death|1|||
16145033|NCT04607148|39021129|FG000|Overall Study|Adverse Event|0|||
16145034|NCT04607148|39021130|FG001|Overall Study|Adverse Event|1|||
16145035|NCT04607148|39021131|FG002|Overall Study|Adverse Event|0|||
16145036|NCT04607148|39021132|FG003|Overall Study|Adverse Event|0|||
16145037|NCT00938717|39021133|FG000|Overall Study|Adverse Event|10|||
16145038|NCT00938717|39021134|FG001|Overall Study|Adverse Event|41|||
16145039|NCT00938717|39021133|FG000|Overall Study|Protocol Violation|11|||
16145040|NCT00938717|39021134|FG001|Overall Study|Protocol Violation|8|||
16145041|NCT00938717|39021133|FG000|Overall Study|Withdrawal by Subject|26|||
16145042|NCT00938717|39021134|FG001|Overall Study|Withdrawal by Subject|24|||
16145043|NCT00938717|39021133|FG000|Overall Study|Lost to Follow-up|13|||
16145044|NCT00938717|39021134|FG001|Overall Study|Lost to Follow-up|18|||
16145045|NCT00938717|39021133|FG000|Overall Study|Lack of Efficacy|33|||
16145046|NCT00938717|39021134|FG001|Overall Study|Lack of Efficacy|15|||
16145047|NCT00938717|39021133|FG000|Overall Study|Other reason|5|||
16145048|NCT00938717|39021134|FG001|Overall Study|Other reason|2|||
16145049|NCT01485627|39021135|FG000|Overall Study|Patient withdrew|6|||
16145050|NCT01485627|39021136|FG001|Overall Study|Patient withdrew|5|||
16145051|NCT01485627|39021135|FG000|Overall Study|Patient died|3|||
16145052|NCT01485627|39021136|FG001|Overall Study|Patient died|1|||
16145053|NCT01485627|39021135|FG000|Overall Study|Patient lost to followup|0|||
16145054|NCT01485627|39021136|FG001|Overall Study|Patient lost to followup|1|||
16145055|NCT01485627|39021135|FG000|Overall Study|Caregiver withdrew|3|||
16145056|NCT01485627|39021136|FG001|Overall Study|Caregiver withdrew|3|||
16145057|NCT01485627|39021135|FG000|Overall Study|Caregiver lost to follow up|11|||
16145058|NCT01485627|39021136|FG001|Overall Study|Caregiver lost to follow up|12|||
16145059|NCT01485627|39021135|FG000|Overall Study|Caregiver died|1|||
16145060|NCT01485627|39021136|FG001|Overall Study|Caregiver died|0|||
16145061|NCT01485627|39021135|FG000|Overall Study|caregiver was not bereaved|42|||
16145062|NCT01485627|39021136|FG001|Overall Study|caregiver was not bereaved|35|||
16145063|NCT05038020|39021137|FG000|Overall Study|Early Termination|3|||
16145064|NCT05038020|39021138|FG001|Overall Study|Early Termination|0|||
16145065|NCT02873936|39021140|FG000|Overall Study|Withdrew Consent|4|||
16145066|NCT02873936|39021141|FG001|Overall Study|Withdrew Consent|11|||
16145067|NCT02873936|39021142|FG002|Overall Study|Withdrew Consent|20|||
16145068|NCT02873936|39021140|FG000|Overall Study|Investigator's Discretion|3|||
16364318|NCT03317496|39818255|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
16145069|NCT02873936|39021141|FG001|Overall Study|Investigator's Discretion|5|||
16145070|NCT02873936|39021142|FG002|Overall Study|Investigator's Discretion|4|||
16145071|NCT02873936|39021140|FG000|Overall Study|Adverse Event|3|||
16145072|NCT02873936|39021141|FG001|Overall Study|Adverse Event|5|||
16145073|NCT02873936|39021142|FG002|Overall Study|Adverse Event|3|||
16145074|NCT02873936|39021140|FG000|Overall Study|Protocol Violation|0|||
16145075|NCT02873936|39021141|FG001|Overall Study|Protocol Violation|1|||
16145076|NCT02873936|39021142|FG002|Overall Study|Protocol Violation|3|||
16145077|NCT02873936|39021140|FG000|Overall Study|Lost to Follow-up|1|||
16145078|NCT02873936|39021141|FG001|Overall Study|Lost to Follow-up|1|||
16145079|NCT02873936|39021142|FG002|Overall Study|Lost to Follow-up|1|||
16145080|NCT02873936|39021140|FG000|Overall Study|Non-compliance With Study Drug|1|||
16145081|NCT02873936|39021141|FG001|Overall Study|Non-compliance With Study Drug|0|||
16145082|NCT02873936|39021142|FG002|Overall Study|Non-compliance With Study Drug|1|||
16145083|NCT02873936|39021140|FG000|Overall Study|Randomized but not Dosed|1|||
16145084|NCT02873936|39021141|FG001|Overall Study|Randomized but not Dosed|0|||
16145085|NCT02873936|39021142|FG002|Overall Study|Randomized but not Dosed|0|||
16145086|NCT01293968|39021143|FG000|Overall Study|non-cooperation|3|||
16145087|NCT01293968|39021144|FG001|Overall Study|non-cooperation|3|||
16145088|NCT01671111|39021145|FG000|Overall Study|Adverse Event|2|||
16145089|NCT01671111|39021145|FG000|Overall Study|Lack of Efficacy|1|||
16145090|NCT01671111|39021145|FG000|Overall Study|Withdrawal by Subject|2|||
16145091|NCT01671111|39021145|FG000|Overall Study|Physician Decision|1|||
16145092|NCT01671111|39021145|FG000|Overall Study|Other|24|||
16145093|NCT00555477|39021146|FG000|Overall Study|Adverse Event|0|||
16145094|NCT00555477|39021147|FG001|Overall Study|Adverse Event|9|||
16145095|NCT00555477|39021146|FG000|Overall Study|Withdrawal by Subject|1|||
16145096|NCT00555477|39021147|FG001|Overall Study|Withdrawal by Subject|2|||
16145097|NCT00555477|39021146|FG000|Overall Study|Physician Decision|1|||
16145098|NCT00555477|39021147|FG001|Overall Study|Physician Decision|2|||
16145099|NCT01186796|39021148|FG000|Overall Study|Adverse Event|3|||
16145100|NCT01186796|39021149|FG001|Overall Study|Adverse Event|0|||
16145101|NCT01186796|39021148|FG000|Overall Study|Withdrawal by Subject|1|||
16145102|NCT01186796|39021149|FG001|Overall Study|Withdrawal by Subject|1|||
16145103|NCT01186796|39021148|FG000|Overall Study|Protocol Violation|0|||
16145104|NCT01186796|39021149|FG001|Overall Study|Protocol Violation|1|||
16145105|NCT04251910|39021150|FG000|Overall Study|Covid 19 lockdown|0|||
16145106|NCT04251910|39021151|FG001|Overall Study|Covid 19 lockdown|5|||
16145107|NCT04251910|39021152|FG002|Overall Study|Covid 19 lockdown|0|||
16145108|NCT04251910|39021153|FG003|Overall Study|Covid 19 lockdown|4|||
16145109|NCT04251910|39021154|FG004|Overall Study|Covid 19 lockdown|0|||
16145110|NCT04251910|39021155|FG005|Overall Study|Covid 19 lockdown|0|||
16145111|NCT04251910|39021150|FG000|Overall Study|Assisted living facility was closed|0|||
16145112|NCT04251910|39021151|FG001|Overall Study|Assisted living facility was closed|0|||
16145113|NCT04251910|39021152|FG002|Overall Study|Assisted living facility was closed|0|||
16145114|NCT04251910|39021153|FG003|Overall Study|Assisted living facility was closed|0|||
16145115|NCT04251910|39021154|FG004|Overall Study|Assisted living facility was closed|1|||
16145116|NCT04251910|39021155|FG005|Overall Study|Assisted living facility was closed|0|||
16145117|NCT01365039|39021156|FG000|Overall Study|Study related symptoms and complaints|1|||
16145118|NCT01365039|39021157|FG001|Overall Study|Study related symptoms and complaints|0|||
16145119|NCT01431274|39021163|FG000|Overall Study|Adverse Event|51|||
16145120|NCT01431274|39021164|FG001|Overall Study|Adverse Event|37|||
16145121|NCT01431274|39021165|FG002|Overall Study|Adverse Event|43|||
16145122|NCT01431274|39021166|FG003|Overall Study|Adverse Event|30|||
16145123|NCT01431274|39021167|FG004|Overall Study|Adverse Event|37|||
16145124|NCT01431274|39021163|FG000|Overall Study|Consent withdrawn not due to AE|29|||
16145125|NCT01431274|39021164|FG001|Overall Study|Consent withdrawn not due to AE|20|||
16145126|NCT01431274|39021165|FG002|Overall Study|Consent withdrawn not due to AE|17|||
16145127|NCT01431274|39021166|FG003|Overall Study|Consent withdrawn not due to AE|20|||
16145128|NCT01431274|39021167|FG004|Overall Study|Consent withdrawn not due to AE|11|||
16145129|NCT01431274|39021163|FG000|Overall Study|Non compliant with protocol|5|||
16145130|NCT01431274|39021164|FG001|Overall Study|Non compliant with protocol|8|||
16145131|NCT01431274|39021165|FG002|Overall Study|Non compliant with protocol|4|||
16145132|NCT01431274|39021166|FG003|Overall Study|Non compliant with protocol|4|||
16145133|NCT01431274|39021167|FG004|Overall Study|Non compliant with protocol|4|||
16145134|NCT01431274|39021163|FG000|Overall Study|Lost to Follow-up|6|||
16145135|NCT01431274|39021164|FG001|Overall Study|Lost to Follow-up|7|||
16145136|NCT01431274|39021165|FG002|Overall Study|Lost to Follow-up|1|||
16145137|NCT01431274|39021166|FG003|Overall Study|Lost to Follow-up|4|||
16145138|NCT01431274|39021167|FG004|Overall Study|Lost to Follow-up|0|||
16145139|NCT01431274|39021163|FG000|Overall Study|Other reason not stated above|6|||
16145140|NCT01431274|39021164|FG001|Overall Study|Other reason not stated above|5|||
16145141|NCT01431274|39021165|FG002|Overall Study|Other reason not stated above|7|||
16145142|NCT01431274|39021166|FG003|Overall Study|Other reason not stated above|2|||
16145143|NCT01431274|39021167|FG004|Overall Study|Other reason not stated above|4|||
16145144|NCT01519765|39021183|FG000|Overall Study|Adverse Event|0|||
16145145|NCT01519765|39021184|FG001|Overall Study|Adverse Event|1|||
16145146|NCT01519765|39021183|FG000|Overall Study|Lack of Efficacy|2|||
16145147|NCT01519765|39021184|FG001|Overall Study|Lack of Efficacy|0|||
16145148|NCT01519765|39021183|FG000|Overall Study|Protocol Violation|1|||
16145149|NCT01519765|39021184|FG001|Overall Study|Protocol Violation|0|||
16145150|NCT01519765|39021183|FG000|Overall Study|Withdrawal by Subject|0|||
16145151|NCT01519765|39021184|FG001|Overall Study|Withdrawal by Subject|1|||
16145152|NCT04641299|39021185|FG000|Overall Study|Adverse Event|0|||
16364319|NCT03317496|39818256|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
16145153|NCT04641299|39021186|FG001|Overall Study|Adverse Event|0|||
16145154|NCT04641299|39021187|FG002|Overall Study|Adverse Event|2|||
16145155|NCT04641299|39021188|FG003|Overall Study|Adverse Event|0|||
16439987|NCT01126749|40089633|FG001|Phase 1b|Death|4|||
16145156|NCT04641299|39021185|FG000|Overall Study|Lost to Follow-up|0|||
16145157|NCT04641299|39021186|FG001|Overall Study|Lost to Follow-up|1|||
16145158|NCT04641299|39021187|FG002|Overall Study|Lost to Follow-up|0|||
16145159|NCT04641299|39021188|FG003|Overall Study|Lost to Follow-up|0|||
16145160|NCT04641299|39021185|FG000|Overall Study|Withdrawal by Subject|1|||
16145161|NCT04641299|39021186|FG001|Overall Study|Withdrawal by Subject|0|||
16145162|NCT04641299|39021187|FG002|Overall Study|Withdrawal by Subject|0|||
16145163|NCT04641299|39021188|FG003|Overall Study|Withdrawal by Subject|0|||
16145164|NCT04641299|39021185|FG000|Overall Study|Reason not given|1|||
16145165|NCT04641299|39021186|FG001|Overall Study|Reason not given|0|||
16145166|NCT04641299|39021187|FG002|Overall Study|Reason not given|0|||
16257667|NCT02924038|39427355|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
16257668|NCT02924038|39427356|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
16257669|NCT01273181|39427357|FG000|Phase I, Dose 1|Study termination|1|||
16257670|NCT01273181|39427358|FG001|Phase I, Dose 1|Study termination|0|||
16257671|NCT01273181|39427359|FG002|Phase I, Dose 1|Study termination|0|||
16145167|NCT04641299|39021188|FG003|Overall Study|Reason not given|0|||
16439988|NCT01126749|40089634|FG002|Phase 1b|Death|0|||
16439989|NCT01126749|40089635|FG003|Phase 1b|Death|0|||
16439990|NCT01126749|40089632|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
16439991|NCT01126749|40089633|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
16439992|NCT01126749|40089634|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
16439993|NCT01126749|40089635|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
16439994|NCT01126749|40089632|FG000|Phase 2|Study Termination by Sponsor|0|||
16439995|NCT01126749|40089633|FG001|Phase 2|Study Termination by Sponsor|0|||
16439996|NCT01126749|40089634|FG002|Phase 2|Study Termination by Sponsor|12|||
16439997|NCT01126749|40089635|FG003|Phase 2|Study Termination by Sponsor|6|||
16439998|NCT01126749|40089632|FG000|Phase 2|Other|0|||
16439999|NCT01126749|40089633|FG001|Phase 2|Other|0|||
16440000|NCT01126749|40089634|FG002|Phase 2|Other|4|||
16440001|NCT01126749|40089635|FG003|Phase 2|Other|2|||
16440002|NCT01126749|40089632|FG000|Phase 2|Withdrawal by Subject|0|||
16440003|NCT01126749|40089633|FG001|Phase 2|Withdrawal by Subject|0|||
16440004|NCT01126749|40089634|FG002|Phase 2|Withdrawal by Subject|0|||
16440005|NCT01126749|40089635|FG003|Phase 2|Withdrawal by Subject|2|||
16440006|NCT01126749|40089632|FG000|Phase 2|Lost to Follow-up|0|||
16440007|NCT01126749|40089633|FG001|Phase 2|Lost to Follow-up|0|||
16440008|NCT01126749|40089634|FG002|Phase 2|Lost to Follow-up|0|||
16440009|NCT01126749|40089635|FG003|Phase 2|Lost to Follow-up|1|||
16440010|NCT01126749|40089632|FG000|Phase 2|Death|0|||
16440011|NCT01126749|40089633|FG001|Phase 2|Death|0|||
16440012|NCT01126749|40089634|FG002|Phase 2|Death|22|||
16440013|NCT01126749|40089635|FG003|Phase 2|Death|22|||
16440014|NCT01126749|40089632|FG000|Phase 2|Adverse Event|0|||
16440015|NCT01126749|40089633|FG001|Phase 2|Adverse Event|0|||
16440016|NCT01126749|40089634|FG002|Phase 2|Adverse Event|0|||
16440017|NCT01126749|40089635|FG003|Phase 2|Adverse Event|1|||
16364320|NCT03317496|39818257|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
16364321|NCT03317496|39818258|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
16364322|NCT03317496|39818259|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
16364323|NCT03317496|39818255|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
16364324|NCT03317496|39818256|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
16364325|NCT03317496|39818257|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
16364326|NCT03317496|39818258|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
16364327|NCT03317496|39818259|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
16364328|NCT03317496|39818255|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
16364329|NCT03317496|39818256|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
16364330|NCT03317496|39818257|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
16364331|NCT03317496|39818258|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
16364332|NCT03317496|39818259|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
16364333|NCT03317496|39818255|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
16364334|NCT03317496|39818256|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
16364335|NCT03317496|39818257|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
16364336|NCT03317496|39818258|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
16364337|NCT03317496|39818259|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
16364338|NCT03317496|39818255|FG000|Phase 2: Treatment|Adverse Event|0|||
16364339|NCT03317496|39818256|FG001|Phase 2: Treatment|Adverse Event|0|||
16364340|NCT03317496|39818257|FG002|Phase 2: Treatment|Adverse Event|0|||
16364341|NCT03317496|39818258|FG003|Phase 2: Treatment|Adverse Event|0|||
16364342|NCT03317496|39818259|FG004|Phase 2: Treatment|Adverse Event|6|||
16364343|NCT03317496|39818255|FG000|Phase 2: Treatment|Progressive disease|0|||
16364344|NCT03317496|39818256|FG001|Phase 2: Treatment|Progressive disease|0|||
16364345|NCT03317496|39818257|FG002|Phase 2: Treatment|Progressive disease|0|||
16364346|NCT03317496|39818258|FG003|Phase 2: Treatment|Progressive disease|0|||
16364347|NCT03317496|39818259|FG004|Phase 2: Treatment|Progressive disease|22|||
16364348|NCT03317496|39818255|FG000|Phase 2: Treatment|Other|0|||
16364349|NCT03317496|39818256|FG001|Phase 2: Treatment|Other|0|||
16364350|NCT03317496|39818257|FG002|Phase 2: Treatment|Other|0|||
16364351|NCT03317496|39818258|FG003|Phase 2: Treatment|Other|0|||
16364352|NCT03317496|39818259|FG004|Phase 2: Treatment|Other|4|||
16364353|NCT03317496|39818255|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
16364354|NCT03317496|39818256|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
16364355|NCT03317496|39818257|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
16364356|NCT03317496|39818258|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
16440018|NCT00499486|40089642|FG000|Overall Study|Withdrawal by Subject|16|||
16440019|NCT04124939|40089643|FG000|Overall Study|Lost to Follow-up|1|||
16440020|NCT04124939|40089644|FG001|Overall Study|Lost to Follow-up|3|||
16440021|NCT00141453|40089645|FG000|Overall Study|Protocol Violation|6|||
16440022|NCT00141453|40089646|FG001|Overall Study|Protocol Violation|5|||
16440023|NCT01339832|40089647|FG000|Overall Study|Lost to Follow-up|3|||
16440024|NCT01339832|40089647|FG000|Overall Study|Death|11|||
16440025|NCT04416204|40089651|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
16440026|NCT04416204|40089652|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
16440027|NCT04416204|40089653|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
16257672|NCT01273181|39427360|FG003|Phase I, Dose 1|Study termination|0|||
16364357|NCT03317496|39818259|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
16364358|NCT03317496|39818255|FG000|Phase 2: Treatment|Physician Decision|0|||
16364359|NCT03317496|39818256|FG001|Phase 2: Treatment|Physician Decision|0|||
16364360|NCT03317496|39818257|FG002|Phase 2: Treatment|Physician Decision|0|||
16364361|NCT03317496|39818258|FG003|Phase 2: Treatment|Physician Decision|0|||
16364362|NCT03317496|39818259|FG004|Phase 2: Treatment|Physician Decision|1|||
16364363|NCT03317496|39818255|FG000|Phase 2: Treatment|Death|0|||
16364364|NCT03317496|39818256|FG001|Phase 2: Treatment|Death|0|||
16364365|NCT03317496|39818257|FG002|Phase 2: Treatment|Death|0|||
16364366|NCT03317496|39818258|FG003|Phase 2: Treatment|Death|0|||
16364367|NCT03317496|39818259|FG004|Phase 2: Treatment|Death|1|||
16364368|NCT03317496|39818255|FG000|Phase 2: Follow-up|Death|0|||
16364369|NCT03317496|39818256|FG001|Phase 2: Follow-up|Death|0|||
16364370|NCT03317496|39818257|FG002|Phase 2: Follow-up|Death|0|||
16364371|NCT03317496|39818258|FG003|Phase 2: Follow-up|Death|0|||
16364372|NCT03317496|39818259|FG004|Phase 2: Follow-up|Death|24|||
16364373|NCT03317496|39818255|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
16364374|NCT03317496|39818256|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
16364375|NCT03317496|39818257|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
16364376|NCT03317496|39818258|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
16364377|NCT03317496|39818259|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
16364378|NCT03317496|39818255|FG000|Phase 2: Follow-up|Other|0|||
16364379|NCT03317496|39818256|FG001|Phase 2: Follow-up|Other|0|||
16364380|NCT03317496|39818257|FG002|Phase 2: Follow-up|Other|0|||
16364381|NCT03317496|39818258|FG003|Phase 2: Follow-up|Other|0|||
16364382|NCT03317496|39818259|FG004|Phase 2: Follow-up|Other|1|||
16364383|NCT03317496|39818255|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
16364384|NCT03317496|39818256|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
16364385|NCT03317496|39818257|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
16364386|NCT03317496|39818258|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
16364387|NCT03317496|39818259|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
16364388|NCT00367458|39818260|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
16364389|NCT00367458|39818261|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
16364390|NCT00945243|39818262|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
16364391|NCT00455455|39818267|FG000|Washout|Withdrawal by Subject|0|||
16364392|NCT00455455|39818268|FG001|Washout|Withdrawal by Subject|1|||
16364393|NCT00455455|39818267|FG000|Washout|Withdrawal by Subject|1|||
16364394|NCT00455455|39818268|FG001|Washout|Withdrawal by Subject|0|||
16364395|NCT00580840|39818269|FG000|Run-in|Adverse Event|17|||
16364396|NCT00580840|39818270|FG001|Run-in|Adverse Event|0|||
16364397|NCT00580840|39818271|FG002|Run-in|Adverse Event|0|||
16364398|NCT00580840|39818272|FG003|Run-in|Adverse Event|0|||
16364399|NCT00580840|39818269|FG000|Run-in|Lack of Efficacy|93|||
16364400|NCT00580840|39818270|FG001|Run-in|Lack of Efficacy|0|||
16364401|NCT00580840|39818271|FG002|Run-in|Lack of Efficacy|0|||
16364402|NCT00580840|39818272|FG003|Run-in|Lack of Efficacy|0|||
16364403|NCT00580840|39818269|FG000|Run-in|Loss of Efficacy|1|||
16364404|NCT00580840|39818270|FG001|Run-in|Loss of Efficacy|0|||
16364405|NCT00580840|39818271|FG002|Run-in|Loss of Efficacy|0|||
16364406|NCT00580840|39818272|FG003|Run-in|Loss of Efficacy|0|||
16364407|NCT00580840|39818269|FG000|Run-in|Lost to Follow-up|4|||
16364408|NCT00580840|39818270|FG001|Run-in|Lost to Follow-up|0|||
16364409|NCT00580840|39818271|FG002|Run-in|Lost to Follow-up|0|||
16364410|NCT00580840|39818272|FG003|Run-in|Lost to Follow-up|0|||
16364411|NCT00580840|39818269|FG000|Run-in|Withdrawal by Subject|5|||
16364412|NCT00580840|39818270|FG001|Run-in|Withdrawal by Subject|0|||
16364413|NCT00580840|39818271|FG002|Run-in|Withdrawal by Subject|0|||
16364414|NCT00580840|39818272|FG003|Run-in|Withdrawal by Subject|0|||
16440028|NCT04416204|40089654|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
16440029|NCT01446159|40089656|FG000|Overall Study|Withdrawal by Subject|1|||
16440030|NCT01446159|40089657|FG001|Overall Study|Withdrawal by Subject|0|||
16440031|NCT01446159|40089658|FG002|Overall Study|Withdrawal by Subject|14|||
16440032|NCT01446159|40089659|FG003|Overall Study|Withdrawal by Subject|11|||
16440033|NCT01446159|40089656|FG000|Overall Study|Lost to Follow-up|0|||
16440034|NCT01446159|40089657|FG001|Overall Study|Lost to Follow-up|0|||
16440035|NCT01446159|40089658|FG002|Overall Study|Lost to Follow-up|1|||
16440036|NCT01446159|40089659|FG003|Overall Study|Lost to Follow-up|2|||
16440037|NCT01446159|40089656|FG000|Overall Study|Death|2|||
16440038|NCT01446159|40089657|FG001|Overall Study|Death|3|||
16440039|NCT01446159|40089658|FG002|Overall Study|Death|43|||
16440040|NCT01446159|40089659|FG003|Overall Study|Death|36|||
16440041|NCT01446159|40089656|FG000|Overall Study|Other|0|||
16145168|NCT02361944|39021189|FG000|Overall Study|surgery cancellation|0|||
16145169|NCT02361944|39021190|FG001|Overall Study|surgery cancellation|1|||
16145170|NCT01994382|39021197|FG000|Overall Study|Informed consent withdrawn|0|||
16145171|NCT01994382|39021198|FG001|Overall Study|Informed consent withdrawn|0|||
16145172|NCT01994382|39021199|FG002|Overall Study|Informed consent withdrawn|0|||
16145173|NCT01994382|39021200|FG003|Overall Study|Informed consent withdrawn|0|||
16257673|NCT01273181|39427357|FG000|Phase I, Dose 2|Death during treatment|0|||
16257674|NCT01273181|39427358|FG001|Phase I, Dose 2|Death during treatment|1|||
16257675|NCT01273181|39427359|FG002|Phase I, Dose 2|Death during treatment|0|||
16257676|NCT01273181|39427360|FG003|Phase I, Dose 2|Death during treatment|0|||
16257677|NCT01273181|39427357|FG000|Phase 2, Dose 1|Study termination|0|||
16257678|NCT01273181|39427358|FG001|Phase 2, Dose 1|Study termination|0|||
16257679|NCT01273181|39427359|FG002|Phase 2, Dose 1|Study termination|1|||
16257680|NCT01273181|39427360|FG003|Phase 2, Dose 1|Study termination|0|||
16257681|NCT01273181|39427357|FG000|Phase 2, Dose 2|Death during treatment|0|||
16257682|NCT01273181|39427358|FG001|Phase 2, Dose 2|Death during treatment|0|||
16257683|NCT01273181|39427359|FG002|Phase 2, Dose 2|Death during treatment|0|||
16257684|NCT01273181|39427360|FG003|Phase 2, Dose 2|Death during treatment|1|||
16257685|NCT01045096|39427361|FG000|Overall Study|Withdrawal by Subject|2|||
16257686|NCT01045096|39427362|FG001|Overall Study|Withdrawal by Subject|0|||
16257687|NCT01045096|39427363|FG002|Overall Study|Withdrawal by Subject|0|||
16257688|NCT01045096|39427361|FG000|Overall Study|Other|1|||
16257689|NCT01045096|39427362|FG001|Overall Study|Other|0|||
16257690|NCT01045096|39427363|FG002|Overall Study|Other|0|||
16257691|NCT03544138|39427374|FG000|Overall Study|Lost to Follow-up|29|||
16257692|NCT04652453|39427375|FG000|Overall Study|Death|8|||
16257693|NCT04652453|39427376|FG001|Overall Study|Death|2|||
16257694|NCT04652453|39427377|FG002|Overall Study|Death|0|||
16257695|NCT04652453|39427375|FG000|Overall Study|Hospice|5|||
16257696|NCT04652453|39427376|FG001|Overall Study|Hospice|5|||
16257697|NCT04652453|39427377|FG002|Overall Study|Hospice|0|||
16257698|NCT04652453|39427375|FG000|Overall Study|Withdrawal by Subject|2|||
16257699|NCT04652453|39427376|FG001|Overall Study|Withdrawal by Subject|0|||
16257700|NCT04652453|39427377|FG002|Overall Study|Withdrawal by Subject|0|||
16257701|NCT01492400|39427378|FG000|Overall Study|Miscellaneous Reasons|2|||
16257702|NCT01492400|39427379|FG001|Overall Study|Miscellaneous Reasons|3|||
16257703|NCT01492400|39427378|FG000|Overall Study|Personal Reasons|0|||
16257704|NCT01492400|39427379|FG001|Overall Study|Personal Reasons|5|||
16257705|NCT01492400|39427378|FG000|Overall Study|Lost to Follow-up|3|||
16257706|NCT01492400|39427379|FG001|Overall Study|Lost to Follow-up|1|||
16257707|NCT01492400|39427378|FG000|Overall Study|Pregnancy|0|||
16257708|NCT01492400|39427379|FG001|Overall Study|Pregnancy|1|||
16257709|NCT01492400|39427378|FG000|Overall Study|Lack of Efficacy|1|||
16257710|NCT01492400|39427379|FG001|Overall Study|Lack of Efficacy|1|||
16257711|NCT01492400|39427378|FG000|Overall Study|Adverse Event|10|||
16257712|NCT01492400|39427379|FG001|Overall Study|Adverse Event|5|||
16257713|NCT01179048|39427382|FG000|Overall Study|Withdrawn - does not allow contact|4|||
16257714|NCT01179048|39427383|FG001|Overall Study|Withdrawn - does not allow contact|8|||
16257715|NCT01179048|39427382|FG000|Overall Study|Lost to Follow-up|8|||
16257716|NCT01179048|39427383|FG001|Overall Study|Lost to Follow-up|9|||
16257717|NCT01179048|39427382|FG000|Overall Study|Alive|127|||
16257718|NCT01179048|39427383|FG001|Overall Study|Alive|142|||
16257719|NCT03830164|39427384|FG000|Overall Study|Adverse Event|0|||
16257720|NCT03830164|39427385|FG001|Overall Study|Adverse Event|2|||
16257721|NCT03830164|39427386|FG002|Overall Study|Adverse Event|0|||
16257722|NCT03830164|39427384|FG000|Overall Study|Lack of Efficacy|1|||
16257723|NCT03830164|39427385|FG001|Overall Study|Lack of Efficacy|5|||
16257724|NCT03830164|39427386|FG002|Overall Study|Lack of Efficacy|0|||
16257725|NCT03830164|39427384|FG000|Overall Study|Lost to Follow-up|0|||
16257726|NCT03830164|39427385|FG001|Overall Study|Lost to Follow-up|1|||
16364415|NCT00580840|39818269|FG000|Run-in|Other: Per Sponsor Request|2|||
16364416|NCT00580840|39818270|FG001|Run-in|Other: Per Sponsor Request|0|||
16145174|NCT01994382|39021201|FG004|Overall Study|Informed consent withdrawn|0|||
16145175|NCT01994382|39021202|FG005|Overall Study|Informed consent withdrawn|0|||
16145176|NCT01994382|39021203|FG006|Overall Study|Informed consent withdrawn|1|||
16145177|NCT01994382|39021204|FG007|Overall Study|Informed consent withdrawn|0|||
16145178|NCT01994382|39021205|FG008|Overall Study|Informed consent withdrawn|0|||
16145179|NCT01994382|39021206|FG009|Overall Study|Informed consent withdrawn|0|||
16145180|NCT01994382|39021207|FG010|Overall Study|Informed consent withdrawn|0|||
16145181|NCT01994382|39021208|FG011|Overall Study|Informed consent withdrawn|0|||
16145182|NCT01994382|39021209|FG012|Overall Study|Informed consent withdrawn|0|||
16257727|NCT03830164|39427386|FG002|Overall Study|Lost to Follow-up|0|||
16257728|NCT03830164|39427384|FG000|Overall Study|Withdrawal by Subject|1|||
16257729|NCT03830164|39427385|FG001|Overall Study|Withdrawal by Subject|0|||
16257730|NCT03830164|39427386|FG002|Overall Study|Withdrawal by Subject|0|||
16364417|NCT00580840|39818271|FG002|Run-in|Other: Per Sponsor Request|0|||
16257731|NCT04274686|39427390|FG000|Overall Study|Physician Decision|1|||
16257732|NCT04274686|39427391|FG001|Overall Study|Physician Decision|0|||
16257733|NCT00762086|39427395|FG000|Overall Study|Adverse Event|2|||
16257734|NCT00762086|39427396|FG001|Overall Study|Adverse Event|0|||
16257735|NCT00762086|39427395|FG000|Overall Study|Lost to Follow-up|0|||
16257736|NCT00762086|39427396|FG001|Overall Study|Lost to Follow-up|2|||
16257737|NCT00762086|39427395|FG000|Overall Study|Non compliance|1|||
16257738|NCT00762086|39427396|FG001|Overall Study|Non compliance|0|||
16257739|NCT00762086|39427395|FG000|Overall Study|Withdrawal by Subject|2|||
16257740|NCT00762086|39427396|FG001|Overall Study|Withdrawal by Subject|2|||
16257741|NCT00762086|39427395|FG000|Overall Study|Ineligible to participate in the study|1|||
16257742|NCT00762086|39427396|FG001|Overall Study|Ineligible to participate in the study|0|||
16257743|NCT00385684|39427397|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
16257744|NCT00385684|39427398|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
16257745|NCT00385684|39427397|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
16257746|NCT00385684|39427398|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
16257747|NCT00385684|39427397|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
16257748|NCT00385684|39427398|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
16257749|NCT02109042|39427399|FG000|Overall Study|Sponsor Decision|15|||
16257750|NCT02661295|39427417|FG000|Overall Study|Death|1|||
16257751|NCT02661295|39427417|FG000|Overall Study|Transferred Out|1|||
16257752|NCT02661295|39427417|FG000|Overall Study|Kidney Transplant|1|||
16257753|NCT02661295|39427417|FG000|Overall Study|Withdrawn due to side effects|8|||
16257754|NCT02661295|39427417|FG000|Overall Study|Withdrawn due to access type|1|||
16257755|NCT02661295|39427417|FG000|Overall Study|Withdrawn due to allergies|1|||
16257756|NCT02661295|39427417|FG000|Overall Study|Withdrawn due to non-compliance|1|||
16257757|NCT02661295|39427417|FG000|Overall Study|Withdrawal by Subject|3|||
16257758|NCT02661295|39427417|FG000|Overall Study|Failed screening|2|||
16257759|NCT02227862|39427422|FG000|Overall Study|Protocol Violation|7|||
16257760|NCT02227862|39427423|FG001|Overall Study|Protocol Violation|9|||
16257761|NCT02227862|39427422|FG000|Overall Study|Other|0|||
16257762|NCT02227862|39427423|FG001|Overall Study|Other|2|||
16257763|NCT02227862|39427422|FG000|Overall Study|Adverse Event|4|||
16257764|NCT02227862|39427423|FG001|Overall Study|Adverse Event|3|||
16257765|NCT02227862|39427422|FG000|Overall Study|Withdrawal by Subject|7|||
16257766|NCT02227862|39427423|FG001|Overall Study|Withdrawal by Subject|6|||
16257767|NCT02227862|39427422|FG000|Overall Study|Lost to Follow-up|1|||
16257768|NCT02227862|39427423|FG001|Overall Study|Lost to Follow-up|2|||
16257769|NCT00604500|39427425|FG000|Overall Study|Adverse Event|2|||
16257770|NCT00604500|39427425|FG000|Overall Study|Protocol Violation|2|||
16257771|NCT00604500|39427425|FG000|Overall Study|Treatment Failure|1|||
16257772|NCT00604500|39427425|FG000|Overall Study|Withdrawal by Subject|4|||
16257773|NCT00604500|39427425|FG000|Overall Study|Administrative|1|||
16257774|NCT00604500|39427425|FG000|Overall Study|Did not meet protocol eligibility|1|||
16257775|NCT00395226|39430334|FG000|Overall Study|Adverse Event|4|||
16257776|NCT00395226|39430335|FG001|Overall Study|Adverse Event|3|||
16257777|NCT00395226|39430334|FG000|Overall Study|Withdrawal by Subject|0|||
16257778|NCT00395226|39430335|FG001|Overall Study|Withdrawal by Subject|1|||
16257779|NCT00395226|39430334|FG000|Overall Study|Lost to Follow-up|0|||
16257780|NCT00395226|39430335|FG001|Overall Study|Lost to Follow-up|1|||
16257781|NCT02475954|39430336|FG000|Overall Study|Withdrawal by Subject|2|||
16257782|NCT02475954|39430337|FG001|Overall Study|Withdrawal by Subject|2|||
16257783|NCT02475954|39430336|FG000|Overall Study|Lost to Follow-up|11|||
16257784|NCT02475954|39430337|FG001|Overall Study|Lost to Follow-up|9|||
16257785|NCT02475954|39430336|FG000|Overall Study|Death|1|||
16257786|NCT02475954|39430337|FG001|Overall Study|Death|1|||
16257787|NCT01259869|39430338|FG000|Overall Study|Duplicated registration|1|||
16257788|NCT00154102|39430344|FG000|Overall Study|investigational study phase ongoing|7|||
16257789|NCT00154102|39430345|FG001|Overall Study|investigational study phase ongoing|2|||
16257790|NCT00958243|39430347|FG000|Overall Study|Withdrawal by Subject|0|||
16257791|NCT00958243|39430348|FG001|Overall Study|Withdrawal by Subject|1|||
16257792|NCT00958243|39430349|FG002|Overall Study|Withdrawal by Subject|3|||
16257793|NCT00958243|39430350|FG003|Overall Study|Withdrawal by Subject|1|||
16257794|NCT00958243|39430351|FG004|Overall Study|Withdrawal by Subject|1|||
16257795|NCT00958243|39430352|FG005|Overall Study|Withdrawal by Subject|5|||
16257796|NCT00958243|39430347|FG000|Overall Study|Lost to Follow-up|2|||
16257797|NCT00958243|39430348|FG001|Overall Study|Lost to Follow-up|5|||
16257798|NCT00958243|39430349|FG002|Overall Study|Lost to Follow-up|11|||
16257799|NCT00958243|39430350|FG003|Overall Study|Lost to Follow-up|2|||
16257800|NCT00958243|39430351|FG004|Overall Study|Lost to Follow-up|8|||
16257801|NCT00958243|39430352|FG005|Overall Study|Lost to Follow-up|5|||
16257802|NCT02173704|39430353|FG000|Overall Study|Adverse Event|1|||
16257803|NCT02173704|39430354|FG001|Overall Study|Adverse Event|0|||
16257804|NCT02173704|39430353|FG000|Overall Study|Lost to Follow-up|1|||
16257805|NCT02173704|39430354|FG001|Overall Study|Lost to Follow-up|0|||
16257806|NCT02173704|39430353|FG000|Overall Study|Other|1|||
16257807|NCT02173704|39430354|FG001|Overall Study|Other|0|||
16257808|NCT02173704|39430353|FG000|Overall Study|Protocol Violation|1|||
16257809|NCT02173704|39430354|FG001|Overall Study|Protocol Violation|0|||
16257810|NCT02173704|39430353|FG000|Overall Study|Withdrawal by Subject|9|||
16257811|NCT02173704|39430354|FG001|Overall Study|Withdrawal by Subject|4|||
16257812|NCT01941030|39430355|FG000|Overall Study|Death|3|||
16257813|NCT01941030|39430356|FG001|Overall Study|Death|2|||
16257814|NCT01941030|39430355|FG000|Overall Study|Lost to Follow-up|6|||
16145183|NCT01994382|39021210|FG013|Overall Study|Informed consent withdrawn|0|||
16257815|NCT01941030|39430356|FG001|Overall Study|Lost to Follow-up|5|||
16257816|NCT01941030|39430355|FG000|Overall Study|Withdrawal by Subject|4|||
16257817|NCT01941030|39430356|FG001|Overall Study|Withdrawal by Subject|6|||
16257818|NCT02883452|39430357|FG000|Overall Study|Withdrawal by Subject|1|||
16257819|NCT02883452|39430358|FG001|Overall Study|Withdrawal by Subject|1|||
16257820|NCT02883452|39430359|FG002|Overall Study|Withdrawal by Subject|3|||
16257821|NCT02883452|39430360|FG003|Overall Study|Withdrawal by Subject|0|||
16257822|NCT02883452|39430361|FG004|Overall Study|Withdrawal by Subject|2|||
16257823|NCT02883452|39430362|FG005|Overall Study|Withdrawal by Subject|5|||
16364418|NCT00580840|39818272|FG003|Run-in|Other: Per Sponsor Request|0|||
16364419|NCT00580840|39818269|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
16364420|NCT00580840|39818270|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
16364421|NCT00580840|39818271|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
16364422|NCT00580840|39818272|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
16364423|NCT00580840|39818269|FG000|Run-in|Other: Exclusionary Lab Value|1|||
16364424|NCT00580840|39818270|FG001|Run-in|Other: Exclusionary Lab Value|0|||
16364425|NCT00580840|39818271|FG002|Run-in|Other: Exclusionary Lab Value|0|||
16364426|NCT00580840|39818272|FG003|Run-in|Other: Exclusionary Lab Value|0|||
16364427|NCT00580840|39818269|FG000|Double-Blind|Adverse Event|0|||
16364428|NCT00580840|39818270|FG001|Double-Blind|Adverse Event|3|||
16364429|NCT00580840|39818271|FG002|Double-Blind|Adverse Event|4|||
16364430|NCT00580840|39818272|FG003|Double-Blind|Adverse Event|1|||
16257824|NCT02883452|39430357|FG000|Overall Study|Disease progression|1|||
16257825|NCT02883452|39430358|FG001|Overall Study|Disease progression|0|||
16257826|NCT02883452|39430359|FG002|Overall Study|Disease progression|0|||
16257827|NCT02883452|39430360|FG003|Overall Study|Disease progression|1|||
16257828|NCT02883452|39430361|FG004|Overall Study|Disease progression|4|||
16257829|NCT02883452|39430362|FG005|Overall Study|Disease progression|5|||
16257830|NCT02883452|39430357|FG000|Overall Study|Adverse Event|2|||
16257831|NCT02883452|39430358|FG001|Overall Study|Adverse Event|1|||
16257832|NCT02883452|39430359|FG002|Overall Study|Adverse Event|1|||
16257833|NCT02883452|39430360|FG003|Overall Study|Adverse Event|1|||
16257834|NCT02883452|39430361|FG004|Overall Study|Adverse Event|1|||
16257835|NCT02883452|39430362|FG005|Overall Study|Adverse Event|3|||
16257836|NCT02883452|39430357|FG000|Overall Study|Physician Decision|0|||
16257837|NCT02883452|39430358|FG001|Overall Study|Physician Decision|0|||
16257838|NCT02883452|39430359|FG002|Overall Study|Physician Decision|0|||
16257839|NCT02883452|39430360|FG003|Overall Study|Physician Decision|0|||
16257840|NCT02883452|39430361|FG004|Overall Study|Physician Decision|4|||
16257841|NCT02883452|39430362|FG005|Overall Study|Physician Decision|1|||
16257842|NCT02883452|39430357|FG000|Overall Study|Death|1|||
16257843|NCT02883452|39430358|FG001|Overall Study|Death|0|||
16257844|NCT02883452|39430359|FG002|Overall Study|Death|1|||
16257845|NCT02883452|39430360|FG003|Overall Study|Death|0|||
16257846|NCT02883452|39430361|FG004|Overall Study|Death|0|||
16257847|NCT02883452|39430362|FG005|Overall Study|Death|0|||
16257848|NCT02883452|39430357|FG000|Overall Study|Other|0|||
16257849|NCT02883452|39430358|FG001|Overall Study|Other|0|||
16257850|NCT02883452|39430359|FG002|Overall Study|Other|0|||
16257851|NCT02883452|39430360|FG003|Overall Study|Other|0|||
16257852|NCT02883452|39430361|FG004|Overall Study|Other|0|||
16257853|NCT02883452|39430362|FG005|Overall Study|Other|1|||
16257854|NCT01318499|39430363|FG000|Overall Study|Adverse Event|16|||
16257855|NCT01318499|39430364|FG001|Overall Study|Adverse Event|11|||
16145184|NCT01994382|39021211|FG014|Overall Study|Informed consent withdrawn|0|||
16145185|NCT01994382|39021212|FG015|Overall Study|Informed consent withdrawn|0|||
16145186|NCT01994382|39021213|FG016|Overall Study|Informed consent withdrawn|0|||
16145187|NCT01994382|39021197|FG000|Overall Study|Progressive disease|3|||
16145188|NCT01994382|39021198|FG001|Overall Study|Progressive disease|4|||
16145189|NCT01994382|39021199|FG002|Overall Study|Progressive disease|4|||
16145190|NCT01994382|39021200|FG003|Overall Study|Progressive disease|3|||
16145191|NCT01994382|39021201|FG004|Overall Study|Progressive disease|2|||
16145192|NCT01994382|39021202|FG005|Overall Study|Progressive disease|3|||
16145193|NCT01994382|39021203|FG006|Overall Study|Progressive disease|3|||
16145194|NCT01994382|39021204|FG007|Overall Study|Progressive disease|6|||
16145195|NCT01994382|39021205|FG008|Overall Study|Progressive disease|2|||
16145196|NCT01994382|39021206|FG009|Overall Study|Progressive disease|2|||
16145197|NCT01994382|39021207|FG010|Overall Study|Progressive disease|13|||
16145198|NCT01994382|39021208|FG011|Overall Study|Progressive disease|8|||
16145199|NCT01994382|39021209|FG012|Overall Study|Progressive disease|7|||
16145200|NCT01994382|39021210|FG013|Overall Study|Progressive disease|3|||
16145201|NCT01994382|39021211|FG014|Overall Study|Progressive disease|6|||
16145202|NCT01994382|39021212|FG015|Overall Study|Progressive disease|44|||
16145203|NCT01994382|39021213|FG016|Overall Study|Progressive disease|28|||
16145204|NCT01994382|39021197|FG000|Overall Study|Physician Decision|0|||
16145205|NCT01994382|39021198|FG001|Overall Study|Physician Decision|1|||
16145206|NCT01994382|39021199|FG002|Overall Study|Physician Decision|0|||
16145207|NCT01994382|39021200|FG003|Overall Study|Physician Decision|0|||
16145208|NCT01994382|39021201|FG004|Overall Study|Physician Decision|0|||
16145209|NCT01994382|39021202|FG005|Overall Study|Physician Decision|0|||
16145210|NCT01994382|39021203|FG006|Overall Study|Physician Decision|0|||
16145211|NCT01994382|39021204|FG007|Overall Study|Physician Decision|0|||
16145212|NCT01994382|39021205|FG008|Overall Study|Physician Decision|0|||
16145213|NCT01994382|39021206|FG009|Overall Study|Physician Decision|0|||
16145214|NCT01994382|39021207|FG010|Overall Study|Physician Decision|3|||
16145215|NCT01994382|39021208|FG011|Overall Study|Physician Decision|1|||
16145216|NCT01994382|39021209|FG012|Overall Study|Physician Decision|1|||
16145217|NCT01994382|39021210|FG013|Overall Study|Physician Decision|0|||
16145218|NCT01994382|39021211|FG014|Overall Study|Physician Decision|1|||
16145219|NCT01994382|39021212|FG015|Overall Study|Physician Decision|4|||
16145220|NCT01994382|39021213|FG016|Overall Study|Physician Decision|2|||
16145221|NCT01994382|39021197|FG000|Overall Study|Death|0|||
16145222|NCT01994382|39021198|FG001|Overall Study|Death|0|||
16145223|NCT01994382|39021199|FG002|Overall Study|Death|0|||
16145224|NCT01994382|39021200|FG003|Overall Study|Death|0|||
16145225|NCT01994382|39021201|FG004|Overall Study|Death|1|||
16145226|NCT01994382|39021202|FG005|Overall Study|Death|0|||
16145227|NCT01994382|39021203|FG006|Overall Study|Death|0|||
16145228|NCT01994382|39021204|FG007|Overall Study|Death|0|||
16145229|NCT01994382|39021205|FG008|Overall Study|Death|1|||
16145230|NCT01994382|39021206|FG009|Overall Study|Death|1|||
16145231|NCT01994382|39021207|FG010|Overall Study|Death|0|||
16145232|NCT01994382|39021208|FG011|Overall Study|Death|0|||
16145233|NCT01994382|39021209|FG012|Overall Study|Death|0|||
16145234|NCT01994382|39021210|FG013|Overall Study|Death|0|||
16145235|NCT01994382|39021211|FG014|Overall Study|Death|0|||
16145236|NCT01994382|39021212|FG015|Overall Study|Death|1|||
16145237|NCT01994382|39021213|FG016|Overall Study|Death|0|||
16145238|NCT01994382|39021197|FG000|Overall Study|Adverse Event|0|||
16145239|NCT01994382|39021198|FG001|Overall Study|Adverse Event|1|||
16145240|NCT01994382|39021199|FG002|Overall Study|Adverse Event|2|||
16145241|NCT01994382|39021200|FG003|Overall Study|Adverse Event|0|||
16145242|NCT01994382|39021201|FG004|Overall Study|Adverse Event|0|||
16145243|NCT01994382|39021202|FG005|Overall Study|Adverse Event|0|||
16145244|NCT01994382|39021203|FG006|Overall Study|Adverse Event|0|||
16145245|NCT01994382|39021204|FG007|Overall Study|Adverse Event|0|||
16145246|NCT01994382|39021205|FG008|Overall Study|Adverse Event|0|||
16145247|NCT01994382|39021206|FG009|Overall Study|Adverse Event|0|||
16145248|NCT01994382|39021207|FG010|Overall Study|Adverse Event|15|||
16440042|NCT01446159|40089657|FG001|Overall Study|Other|0|||
16440043|NCT01446159|40089658|FG002|Overall Study|Other|13|||
16440044|NCT01446159|40089659|FG003|Overall Study|Other|13|||
16440045|NCT02891174|40089660|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
16440046|NCT02891174|40089661|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
16440047|NCT02891174|40089660|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
16440048|NCT02891174|40089661|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
16440049|NCT02891174|40089660|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
16440050|NCT02891174|40089661|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
16440051|NCT02891174|40089660|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
16440052|NCT02891174|40089661|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
16440053|NCT02891174|40089660|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
16440054|NCT02891174|40089661|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
16440055|NCT02891174|40089660|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
16440056|NCT02891174|40089661|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
16145249|NCT01994382|39021208|FG011|Overall Study|Adverse Event|2|||
16145250|NCT01994382|39021209|FG012|Overall Study|Adverse Event|7|||
16145251|NCT01994382|39021210|FG013|Overall Study|Adverse Event|3|||
16145252|NCT01994382|39021211|FG014|Overall Study|Adverse Event|17|||
16145253|NCT01994382|39021212|FG015|Overall Study|Adverse Event|6|||
16145254|NCT01994382|39021213|FG016|Overall Study|Adverse Event|3|||
16145255|NCT01994382|39021197|FG000|Overall Study|Other than specified|0|||
16145256|NCT01994382|39021198|FG001|Overall Study|Other than specified|0|||
16145257|NCT01994382|39021199|FG002|Overall Study|Other than specified|0|||
16145258|NCT01994382|39021200|FG003|Overall Study|Other than specified|0|||
16145259|NCT01994382|39021201|FG004|Overall Study|Other than specified|0|||
16145260|NCT01994382|39021202|FG005|Overall Study|Other than specified|0|||
16145261|NCT01994382|39021203|FG006|Overall Study|Other than specified|0|||
16145262|NCT01994382|39021204|FG007|Overall Study|Other than specified|0|||
16145263|NCT01994382|39021205|FG008|Overall Study|Other than specified|0|||
16145264|NCT01994382|39021206|FG009|Overall Study|Other than specified|0|||
16145265|NCT01994382|39021207|FG010|Overall Study|Other than specified|2|||
16145266|NCT01994382|39021208|FG011|Overall Study|Other than specified|0|||
16145267|NCT01994382|39021209|FG012|Overall Study|Other than specified|2|||
16145268|NCT01994382|39021210|FG013|Overall Study|Other than specified|0|||
16145269|NCT01994382|39021211|FG014|Overall Study|Other than specified|0|||
16145270|NCT01994382|39021212|FG015|Overall Study|Other than specified|4|||
16145271|NCT01994382|39021213|FG016|Overall Study|Other than specified|4|||
16440057|NCT02891174|40089660|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
16440058|NCT02891174|40089661|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
16440059|NCT03305666|40089662|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
16440060|NCT03305666|40089663|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
16440061|NCT03287791|40089664|FG000|Overall Study|Insufficient Therapeutic Response|0|||
16145272|NCT01994382|39021197|FG000|Overall Study|Withdrawal by Subject|0|||
16145273|NCT01994382|39021198|FG001|Overall Study|Withdrawal by Subject|0|||
16145274|NCT01994382|39021199|FG002|Overall Study|Withdrawal by Subject|0|||
16145275|NCT01994382|39021200|FG003|Overall Study|Withdrawal by Subject|0|||
16145276|NCT01994382|39021201|FG004|Overall Study|Withdrawal by Subject|0|||
16145277|NCT01994382|39021202|FG005|Overall Study|Withdrawal by Subject|0|||
16145278|NCT01994382|39021203|FG006|Overall Study|Withdrawal by Subject|0|||
16145279|NCT01994382|39021204|FG007|Overall Study|Withdrawal by Subject|0|||
16145280|NCT01994382|39021205|FG008|Overall Study|Withdrawal by Subject|0|||
16145281|NCT01994382|39021206|FG009|Overall Study|Withdrawal by Subject|0|||
16440062|NCT03287791|40089665|FG001|Overall Study|Insufficient Therapeutic Response|0|||
16440063|NCT03287791|40089666|FG002|Overall Study|Insufficient Therapeutic Response|1|||
16440064|NCT03287791|40089664|FG000|Overall Study|Adverse Event|0|||
16440065|NCT03287791|40089665|FG001|Overall Study|Adverse Event|4|||
16440066|NCT03287791|40089666|FG002|Overall Study|Adverse Event|3|||
16440067|NCT03287791|40089664|FG000|Overall Study|Withdrawal by Subject|12|||
16440068|NCT03287791|40089665|FG001|Overall Study|Withdrawal by Subject|12|||
16440069|NCT03287791|40089666|FG002|Overall Study|Withdrawal by Subject|17|||
16440070|NCT03287791|40089664|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
16440071|NCT03287791|40089665|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
16440072|NCT03287791|40089666|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
16440073|NCT03287791|40089664|FG000|Overall Study|Lost to Follow-up|8|||
16440074|NCT03287791|40089665|FG001|Overall Study|Lost to Follow-up|14|||
16440075|NCT03287791|40089666|FG002|Overall Study|Lost to Follow-up|11|||
16440076|NCT03287791|40089664|FG000|Overall Study|Protocol Violation|7|||
16440077|NCT03287791|40089665|FG001|Overall Study|Protocol Violation|2|||
16440078|NCT03287791|40089666|FG002|Overall Study|Protocol Violation|1|||
16440079|NCT03287791|40089664|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
16440080|NCT03287791|40089665|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
16440081|NCT03287791|40089666|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
16440082|NCT03287791|40089664|FG000|Overall Study|Too much time between 2 visits|0|||
16440083|NCT03287791|40089665|FG001|Overall Study|Too much time between 2 visits|1|||
16440084|NCT03287791|40089666|FG002|Overall Study|Too much time between 2 visits|0|||
16440085|NCT03287791|40089664|FG000|Overall Study|Non-compliance|0|||
16440086|NCT03287791|40089665|FG001|Overall Study|Non-compliance|1|||
16440087|NCT03287791|40089666|FG002|Overall Study|Non-compliance|0|||
16440088|NCT03287791|40089664|FG000|Overall Study|Did not meet inclusion criteria|1|||
16440089|NCT03287791|40089665|FG001|Overall Study|Did not meet inclusion criteria|0|||
16440090|NCT03287791|40089666|FG002|Overall Study|Did not meet inclusion criteria|0|||
16440091|NCT00436332|40089668|FG000|Overall Study|Adverse Event|9|||
16440092|NCT00436332|40089668|FG000|Overall Study|Withdrawal by Subject|2|||
16440093|NCT00436332|40089668|FG000|Overall Study|Progression|59|||
16440094|NCT00436332|40089668|FG000|Overall Study|Death|2|||
16440095|NCT00436332|40089668|FG000|Overall Study|Not Protocol Specified|6|||
16440096|NCT00436332|40089668|FG000|Overall Study|Ineligible|2|||
16440097|NCT00436332|40089668|FG000|Overall Study|Never Received Treatment|3|||
16440098|NCT03770260|40089671|FG000|Overall Study|Disease progression|0|||
16440099|NCT03770260|40089672|FG001|Overall Study|Disease progression|1|||
16440100|NCT03770260|40089673|FG002|Overall Study|Disease progression|0|||
16440101|NCT03770260|40089674|FG003|Overall Study|Disease progression|0|||
16440102|NCT03092726|40089675|FG000|Overall Study|Adverse Event|3|||
16440103|NCT03092726|40089676|FG001|Overall Study|Adverse Event|10|||
16440104|NCT03092726|40089675|FG000|Overall Study|Lack of Efficacy|0|||
16440105|NCT03092726|40089676|FG001|Overall Study|Lack of Efficacy|1|||
16440106|NCT03092726|40089675|FG000|Overall Study|Lost to Follow-up|1|||
16440107|NCT03092726|40089676|FG001|Overall Study|Lost to Follow-up|0|||
16440108|NCT03092726|40089675|FG000|Overall Study|Withdrawal by Subject|5|||
16440109|NCT03092726|40089676|FG001|Overall Study|Withdrawal by Subject|3|||
16440110|NCT03041038|40089679|FG000|Overall Study|Withdrawal by Subject|4|||
16440111|NCT03041038|40089680|FG001|Overall Study|Withdrawal by Subject|0|||
16145282|NCT01994382|39021207|FG010|Overall Study|Withdrawal by Subject|6|||
16145283|NCT01994382|39021208|FG011|Overall Study|Withdrawal by Subject|0|||
16145284|NCT01994382|39021209|FG012|Overall Study|Withdrawal by Subject|2|||
16145285|NCT01994382|39021210|FG013|Overall Study|Withdrawal by Subject|0|||
16257856|NCT01318499|39430365|FG002|Overall Study|Adverse Event|6|||
16257857|NCT01318499|39430363|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
16257858|NCT01318499|39430364|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
16257859|NCT01318499|39430365|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
16257860|NCT01318499|39430363|FG000|Overall Study|Noncompliance|2|||
16257861|NCT01318499|39430364|FG001|Overall Study|Noncompliance|3|||
16257862|NCT01318499|39430365|FG002|Overall Study|Noncompliance|0|||
16257863|NCT01318499|39430363|FG000|Overall Study|Treatment Failure|19|||
16257864|NCT01318499|39430364|FG001|Overall Study|Treatment Failure|19|||
16257865|NCT01318499|39430365|FG002|Overall Study|Treatment Failure|101|||
16257866|NCT01318499|39430363|FG000|Overall Study|Protocol Violation|2|||
16257867|NCT01318499|39430364|FG001|Overall Study|Protocol Violation|4|||
16257868|NCT01318499|39430365|FG002|Overall Study|Protocol Violation|2|||
16257869|NCT01318499|39430363|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
16257870|NCT01318499|39430364|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
16257871|NCT01318499|39430365|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
16257872|NCT01318499|39430363|FG000|Overall Study|Other|7|||
16257873|NCT01318499|39430364|FG001|Overall Study|Other|10|||
16257874|NCT01318499|39430365|FG002|Overall Study|Other|22|||
16257875|NCT03627091|39430366|FG000|Overall Study|Adverse Event|0|||
16257876|NCT03627091|39430367|FG001|Overall Study|Adverse Event|0|||
16257877|NCT03627091|39430368|FG002|Overall Study|Adverse Event|2|||
16257878|NCT03627091|39430366|FG000|Overall Study|Withdrawal by Subject|2|||
16257879|NCT03627091|39430367|FG001|Overall Study|Withdrawal by Subject|0|||
16257880|NCT03627091|39430368|FG002|Overall Study|Withdrawal by Subject|2|||
16257881|NCT03627091|39430366|FG000|Overall Study|Physician Decision|2|||
16257882|NCT03627091|39430367|FG001|Overall Study|Physician Decision|0|||
16257883|NCT03627091|39430368|FG002|Overall Study|Physician Decision|0|||
16257884|NCT03627091|39430366|FG000|Overall Study|Site terminated by sponsor|0|||
16257885|NCT03627091|39430367|FG001|Overall Study|Site terminated by sponsor|1|||
16257886|NCT03627091|39430368|FG002|Overall Study|Site terminated by sponsor|0|||
16257887|NCT03627091|39430366|FG000|Overall Study|Disease relapse|7|||
16257888|NCT03627091|39430367|FG001|Overall Study|Disease relapse|5|||
16257889|NCT03627091|39430368|FG002|Overall Study|Disease relapse|1|||
16257890|NCT03627091|39430366|FG000|Overall Study|Other|1|||
16257891|NCT03627091|39430367|FG001|Overall Study|Other|0|||
16257892|NCT03627091|39430368|FG002|Overall Study|Other|0|||
16257893|NCT00454909|39430369|FG000|Overall Study|Withdrawal by Subject|1|||
16257894|NCT00454909|39430370|FG001|Overall Study|Withdrawal by Subject|0|||
16257895|NCT00454909|39430371|FG002|Overall Study|Withdrawal by Subject|0|||
16257896|NCT00454909|39430369|FG000|Overall Study|Migrated/moved from study area|0|||
16257897|NCT00454909|39430370|FG001|Overall Study|Migrated/moved from study area|0|||
16257898|NCT00454909|39430371|FG002|Overall Study|Migrated/moved from study area|1|||
16257899|NCT00454909|39430369|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
16257900|NCT00454909|39430370|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
16257901|NCT00454909|39430371|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
16257902|NCT00454909|39430369|FG000|Overall Study|Others|1|||
16257903|NCT00454909|39430370|FG001|Overall Study|Others|0|||
16257904|NCT00454909|39430371|FG002|Overall Study|Others|0|||
16257905|NCT04753437|39430374|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16257906|NCT04753437|39430375|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
16257907|NCT04753437|39430374|FG000|Overall Study|Liver Function Test Abnormalities|2|||
16257908|NCT04753437|39430375|FG001|Overall Study|Liver Function Test Abnormalities|4|||
16257909|NCT00050778|39430376|FG000|Overall Study|Adverse Event|13|||
16257910|NCT00050778|39430377|FG001|Overall Study|Adverse Event|3|||
16257911|NCT00050778|39430378|FG002|Overall Study|Adverse Event|2|||
16257912|NCT00050778|39430376|FG000|Overall Study|Death|0|||
16257913|NCT00050778|39430377|FG001|Overall Study|Death|1|||
16257914|NCT00050778|39430378|FG002|Overall Study|Death|1|||
16257915|NCT00050778|39430376|FG000|Overall Study|Lack of Efficacy|16|||
16257916|NCT00050778|39430377|FG001|Overall Study|Lack of Efficacy|2|||
16257917|NCT00050778|39430378|FG002|Overall Study|Lack of Efficacy|2|||
16257918|NCT00050778|39430376|FG000|Overall Study|Lost to Follow-up|0|||
16257919|NCT00050778|39430377|FG001|Overall Study|Lost to Follow-up|2|||
16257920|NCT00050778|39430378|FG002|Overall Study|Lost to Follow-up|4|||
16257921|NCT00050778|39430376|FG000|Overall Study|Physician Decision|3|||
16257922|NCT00050778|39430377|FG001|Overall Study|Physician Decision|0|||
16257923|NCT00050778|39430378|FG002|Overall Study|Physician Decision|2|||
16257924|NCT00050778|39430376|FG000|Overall Study|Protocol Violation|2|||
16257925|NCT00050778|39430377|FG001|Overall Study|Protocol Violation|0|||
16257926|NCT00050778|39430378|FG002|Overall Study|Protocol Violation|1|||
16257927|NCT00050778|39430376|FG000|Overall Study|Withdrawal by Subject|6|||
16257928|NCT00050778|39430377|FG001|Overall Study|Withdrawal by Subject|8|||
16257929|NCT00050778|39430378|FG002|Overall Study|Withdrawal by Subject|4|||
16145286|NCT01994382|39021211|FG014|Overall Study|Withdrawal by Subject|4|||
16145287|NCT01994382|39021212|FG015|Overall Study|Withdrawal by Subject|3|||
16145288|NCT01994382|39021213|FG016|Overall Study|Withdrawal by Subject|0|||
16145289|NCT01994382|39021197|FG000|Overall Study|Lost to Follow-up|0|||
16145290|NCT01994382|39021198|FG001|Overall Study|Lost to Follow-up|0|||
16145291|NCT01994382|39021199|FG002|Overall Study|Lost to Follow-up|0|||
16145292|NCT01994382|39021200|FG003|Overall Study|Lost to Follow-up|0|||
16145293|NCT01994382|39021201|FG004|Overall Study|Lost to Follow-up|0|||
16145294|NCT01994382|39021202|FG005|Overall Study|Lost to Follow-up|0|||
16145295|NCT01994382|39021203|FG006|Overall Study|Lost to Follow-up|0|||
16145296|NCT01994382|39021204|FG007|Overall Study|Lost to Follow-up|0|||
16145297|NCT01994382|39021205|FG008|Overall Study|Lost to Follow-up|0|||
16145298|NCT01994382|39021206|FG009|Overall Study|Lost to Follow-up|0|||
16145299|NCT01994382|39021207|FG010|Overall Study|Lost to Follow-up|1|||
16145300|NCT01994382|39021208|FG011|Overall Study|Lost to Follow-up|0|||
16145301|NCT01994382|39021209|FG012|Overall Study|Lost to Follow-up|0|||
16145302|NCT01994382|39021210|FG013|Overall Study|Lost to Follow-up|0|||
16145303|NCT01994382|39021211|FG014|Overall Study|Lost to Follow-up|0|||
16145304|NCT01994382|39021212|FG015|Overall Study|Lost to Follow-up|0|||
16145305|NCT01994382|39021213|FG016|Overall Study|Lost to Follow-up|0|||
16145306|NCT01994382|39021197|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145307|NCT01994382|39021198|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145308|NCT01994382|39021199|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145309|NCT01994382|39021200|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145310|NCT01994382|39021201|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145311|NCT01994382|39021202|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145312|NCT01994382|39021203|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145313|NCT01994382|39021204|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145314|NCT01994382|39021205|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145315|NCT01994382|39021206|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145316|NCT01994382|39021207|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
16145317|NCT01994382|39021208|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145318|NCT01994382|39021209|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
16145319|NCT01994382|39021210|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145320|NCT01994382|39021211|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
16145321|NCT01994382|39021212|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
16145322|NCT01994382|39021213|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
16145323|NCT01994382|39021197|FG000|Overall Study|Protocol violation/noncompliance|0|||
16145324|NCT01994382|39021198|FG001|Overall Study|Protocol violation/noncompliance|0|||
16145325|NCT01994382|39021199|FG002|Overall Study|Protocol violation/noncompliance|0|||
16145326|NCT01994382|39021200|FG003|Overall Study|Protocol violation/noncompliance|0|||
16145327|NCT01994382|39021201|FG004|Overall Study|Protocol violation/noncompliance|0|||
16145328|NCT01994382|39021202|FG005|Overall Study|Protocol violation/noncompliance|0|||
16145329|NCT01994382|39021203|FG006|Overall Study|Protocol violation/noncompliance|0|||
16145330|NCT01994382|39021204|FG007|Overall Study|Protocol violation/noncompliance|0|||
16145331|NCT01994382|39021205|FG008|Overall Study|Protocol violation/noncompliance|0|||
16145332|NCT01994382|39021206|FG009|Overall Study|Protocol violation/noncompliance|0|||
16145333|NCT01994382|39021207|FG010|Overall Study|Protocol violation/noncompliance|0|||
16145334|NCT01994382|39021208|FG011|Overall Study|Protocol violation/noncompliance|1|||
16145335|NCT01994382|39021209|FG012|Overall Study|Protocol violation/noncompliance|0|||
16145336|NCT01994382|39021210|FG013|Overall Study|Protocol violation/noncompliance|0|||
16145337|NCT01994382|39021211|FG014|Overall Study|Protocol violation/noncompliance|0|||
16145338|NCT01994382|39021212|FG015|Overall Study|Protocol violation/noncompliance|0|||
16145339|NCT01994382|39021213|FG016|Overall Study|Protocol violation/noncompliance|2|||
16364431|NCT00580840|39818269|FG000|Double-Blind|Loss of Efficacy|0|||
16364432|NCT00580840|39818270|FG001|Double-Blind|Loss of Efficacy|1|||
16364433|NCT00580840|39818271|FG002|Double-Blind|Loss of Efficacy|2|||
16364434|NCT00580840|39818272|FG003|Double-Blind|Loss of Efficacy|10|||
16364435|NCT00580840|39818269|FG000|Double-Blind|Lost to Follow-up|0|||
16364436|NCT00580840|39818270|FG001|Double-Blind|Lost to Follow-up|1|||
16364437|NCT00580840|39818271|FG002|Double-Blind|Lost to Follow-up|0|||
16364438|NCT00580840|39818272|FG003|Double-Blind|Lost to Follow-up|2|||
16364439|NCT00580840|39818269|FG000|Double-Blind|Withdrawal by Subject|0|||
16145340|NCT01994382|39021197|FG000|Overall Study|Rolled over to Phase 2a|0|||
16145341|NCT01994382|39021198|FG001|Overall Study|Rolled over to Phase 2a|0|||
16145342|NCT01994382|39021199|FG002|Overall Study|Rolled over to Phase 2a|1|||
16145343|NCT01994382|39021200|FG003|Overall Study|Rolled over to Phase 2a|0|||
16364440|NCT00580840|39818270|FG001|Double-Blind|Withdrawal by Subject|1|||
16364441|NCT00580840|39818271|FG002|Double-Blind|Withdrawal by Subject|2|||
16440112|NCT03041038|40089679|FG000|Overall Study|Lost to Follow-up|1|||
16440113|NCT03041038|40089680|FG001|Overall Study|Lost to Follow-up|1|||
16440114|NCT03041038|40089679|FG000|Overall Study|Protocol Violation|1|||
16440115|NCT03041038|40089680|FG001|Overall Study|Protocol Violation|1|||
16440116|NCT03337308|40089681|FG000|Overall Study|Adverse Event|2|||
16440117|NCT03337308|40089682|FG001|Overall Study|Adverse Event|3|||
16440118|NCT03337308|40089683|FG002|Overall Study|Adverse Event|3|||
16440119|NCT03337308|40089684|FG003|Overall Study|Adverse Event|1|||
16440120|NCT03337308|40089681|FG000|Overall Study|Lost to Follow-up|1|||
16440121|NCT03337308|40089682|FG001|Overall Study|Lost to Follow-up|2|||
16440122|NCT03337308|40089683|FG002|Overall Study|Lost to Follow-up|0|||
16440123|NCT03337308|40089684|FG003|Overall Study|Lost to Follow-up|0|||
16440124|NCT03337308|40089681|FG000|Overall Study|Withdrawal by Subject|2|||
16145344|NCT01994382|39021201|FG004|Overall Study|Rolled over to Phase 2a|0|||
16145345|NCT01994382|39021202|FG005|Overall Study|Rolled over to Phase 2a|0|||
16145346|NCT01994382|39021203|FG006|Overall Study|Rolled over to Phase 2a|0|||
16145347|NCT01994382|39021204|FG007|Overall Study|Rolled over to Phase 2a|0|||
16145348|NCT01994382|39021205|FG008|Overall Study|Rolled over to Phase 2a|0|||
16145349|NCT01994382|39021206|FG009|Overall Study|Rolled over to Phase 2a|2|||
16145350|NCT01994382|39021207|FG010|Overall Study|Rolled over to Phase 2a|0|||
16145351|NCT01994382|39021208|FG011|Overall Study|Rolled over to Phase 2a|0|||
16145352|NCT01994382|39021209|FG012|Overall Study|Rolled over to Phase 2a|0|||
16145353|NCT01994382|39021210|FG013|Overall Study|Rolled over to Phase 2a|0|||
16145354|NCT01994382|39021211|FG014|Overall Study|Rolled over to Phase 2a|0|||
16145355|NCT01994382|39021212|FG015|Overall Study|Rolled over to Phase 2a|0|||
16145356|NCT01994382|39021213|FG016|Overall Study|Rolled over to Phase 2a|0|||
16145357|NCT02608879|39021214|FG000|Overall Study|Lost to Follow-up|1|||
16145358|NCT02608879|39021215|FG001|Overall Study|Lost to Follow-up|0|||
16145359|NCT02608879|39021216|FG002|Overall Study|Lost to Follow-up|0|||
16145360|NCT02608879|39021214|FG000|Overall Study|Did not meet continuation criteria|0|||
16145361|NCT02608879|39021215|FG001|Overall Study|Did not meet continuation criteria|0|||
16145362|NCT02608879|39021216|FG002|Overall Study|Did not meet continuation criteria|3|||
16145363|NCT03519867|39021217|FG000|Overall Study|Adverse Event|1|||
16145364|NCT03519867|39021218|FG001|Overall Study|Adverse Event|1|||
16145365|NCT03519867|39021219|FG002|Overall Study|Adverse Event|0|||
16145366|NCT03519867|39021220|FG003|Overall Study|Adverse Event|0|||
16145367|NCT03519867|39021221|FG004|Overall Study|Adverse Event|0|||
16145368|NCT03519867|39021222|FG005|Overall Study|Adverse Event|0|||
16145369|NCT03519867|39021223|FG006|Overall Study|Adverse Event|0|||
16145370|NCT03519867|39021224|FG007|Overall Study|Adverse Event|0|||
16145371|NCT03519867|39021225|FG008|Overall Study|Adverse Event|0|||
16145372|NCT03519867|39021226|FG009|Overall Study|Adverse Event|0|||
16145373|NCT03519867|39021217|FG000|Overall Study|Protocol Violation|0|||
16440125|NCT03337308|40089682|FG001|Overall Study|Withdrawal by Subject|1|||
16440126|NCT03337308|40089683|FG002|Overall Study|Withdrawal by Subject|2|||
16440127|NCT03337308|40089684|FG003|Overall Study|Withdrawal by Subject|1|||
16440128|NCT03337308|40089681|FG000|Overall Study|Protocol Violation|0|||
16440129|NCT03337308|40089682|FG001|Overall Study|Protocol Violation|1|||
16257930|NCT00050778|39430376|FG000|Overall Study|Randomized but not treated|4|||
16257931|NCT00050778|39430377|FG001|Overall Study|Randomized but not treated|5|||
16257932|NCT00050778|39430378|FG002|Overall Study|Randomized but not treated|2|||
16257933|NCT00050778|39430376|FG000|Overall Study|Familial and personal reasons|1|||
16257934|NCT00050778|39430377|FG001|Overall Study|Familial and personal reasons|0|||
16257935|NCT00050778|39430378|FG002|Overall Study|Familial and personal reasons|0|||
16257936|NCT02374853|39430379|FG000|Overall Study|Surgery Cancelled|5|||
16257937|NCT02374853|39430380|FG001|Overall Study|Surgery Cancelled|11|||
16257938|NCT03586726|39430383|FG000|Overall Study|Withdrawal by Subject|1|||
16257939|NCT04384978|39430388|FG000|Overall Study|Withdrawal by Subject|4|||
16257940|NCT04384978|39430389|FG001|Overall Study|Withdrawal by Subject|0|||
16257941|NCT01471093|39430390|FG000|Overall Study|Adverse Event|1|||
16440130|NCT03337308|40089683|FG002|Overall Study|Protocol Violation|0|||
16257942|NCT01471093|39430391|FG001|Overall Study|Adverse Event|0|||
16440131|NCT03337308|40089684|FG003|Overall Study|Protocol Violation|0|||
16257943|NCT01471093|39430392|FG002|Overall Study|Adverse Event|0|||
16257944|NCT01471093|39430393|FG003|Overall Study|Adverse Event|0|||
16257945|NCT02726581|39430394|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
16257946|NCT02726581|39430395|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
16257947|NCT02726581|39430396|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
16257948|NCT02726581|39430394|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
16257949|NCT02726581|39430395|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
16257950|NCT02726581|39430396|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
16257951|NCT02726581|39430394|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
16257952|NCT02726581|39430395|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16257953|NCT02726581|39430396|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
16257954|NCT02726581|39430394|FG000|Treatment Period|Disease progression|47|||
16257955|NCT02726581|39430395|FG001|Treatment Period|Disease progression|50|||
16257956|NCT02726581|39430396|FG002|Treatment Period|Disease progression|16|||
16257957|NCT02726581|39430394|FG000|Treatment Period|Other reasons|9|||
16257958|NCT02726581|39430395|FG001|Treatment Period|Other reasons|8|||
16257959|NCT02726581|39430396|FG002|Treatment Period|Other reasons|2|||
16257960|NCT02726581|39430394|FG000|Treatment Period|Study drug toxicity|6|||
16257961|NCT02726581|39430395|FG001|Treatment Period|Study drug toxicity|3|||
16257962|NCT02726581|39430396|FG002|Treatment Period|Study drug toxicity|2|||
16257963|NCT02726581|39430394|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
16257964|NCT02726581|39430395|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
16257965|NCT02726581|39430396|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
16257966|NCT02726581|39430394|FG000|Treatment Period|Participant withdrew consent|3|||
16257967|NCT02726581|39430395|FG001|Treatment Period|Participant withdrew consent|1|||
16257968|NCT02726581|39430396|FG002|Treatment Period|Participant withdrew consent|1|||
16257969|NCT02726581|39430394|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
16257970|NCT02726581|39430395|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
16257971|NCT02726581|39430396|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
16257972|NCT02726581|39430394|FG000|Treatment Period|Maximum clinical benefit|0|||
16257973|NCT02726581|39430395|FG001|Treatment Period|Maximum clinical benefit|2|||
16257974|NCT02726581|39430396|FG002|Treatment Period|Maximum clinical benefit|0|||
16257975|NCT02726581|39430394|FG000|Treatment Period|Death|1|||
16257976|NCT02726581|39430395|FG001|Treatment Period|Death|0|||
16257977|NCT02726581|39430396|FG002|Treatment Period|Death|0|||
16257978|NCT02726581|39430394|FG000|Treatment Period|Poor/non-compliance|1|||
16257979|NCT02726581|39430395|FG001|Treatment Period|Poor/non-compliance|0|||
16257980|NCT02726581|39430396|FG002|Treatment Period|Poor/non-compliance|0|||
16257981|NCT02726581|39430394|FG000|Treatment Period|Participant no longer meets study criteria|0|||
16257982|NCT02726581|39430395|FG001|Treatment Period|Participant no longer meets study criteria|1|||
16257983|NCT02726581|39430396|FG002|Treatment Period|Participant no longer meets study criteria|0|||
16257984|NCT00874237|39430397|FG000|Overall Study|Physician Decision|0|||
16257985|NCT00874237|39430398|FG001|Overall Study|Physician Decision|1|||
16257986|NCT00874237|39430399|FG002|Overall Study|Physician Decision|0|||
16257987|NCT00874237|39430400|FG003|Overall Study|Physician Decision|0|||
16257988|NCT00874237|39430401|FG004|Overall Study|Physician Decision|0|||
16257989|NCT00874237|39430402|FG005|Overall Study|Physician Decision|0|||
16257990|NCT00874237|39430397|FG000|Overall Study|Withdrawal by Subject|0|||
16257991|NCT00874237|39430398|FG001|Overall Study|Withdrawal by Subject|0|||
16257992|NCT00874237|39430399|FG002|Overall Study|Withdrawal by Subject|1|||
16257993|NCT00874237|39430400|FG003|Overall Study|Withdrawal by Subject|0|||
16257994|NCT00874237|39430401|FG004|Overall Study|Withdrawal by Subject|0|||
16257995|NCT00874237|39430402|FG005|Overall Study|Withdrawal by Subject|0|||
16257996|NCT03100903|39430405|FG000|Overall Study|Withdrawal by Subject|0|||
16257997|NCT03100903|39430406|FG001|Overall Study|Withdrawal by Subject|0|||
16257998|NCT03100903|39430407|FG002|Overall Study|Withdrawal by Subject|1|||
16257999|NCT00366899|39430411|FG000|Infant Series|Withdrawal by Subject|4|||
16258000|NCT00366899|39430412|FG001|Infant Series|Withdrawal by Subject|7|||
16258001|NCT00366899|39430411|FG000|Infant Series|Protocol Violation|2|||
16258002|NCT00366899|39430412|FG001|Infant Series|Protocol Violation|1|||
16258003|NCT00366899|39430411|FG000|Infant Series|Failed to return|1|||
16258004|NCT00366899|39430412|FG001|Infant Series|Failed to return|1|||
16258005|NCT00366899|39430411|FG000|Infant Series|Lost to Follow-up|0|||
16258006|NCT00366899|39430412|FG001|Infant Series|Lost to Follow-up|2|||
16258007|NCT00366899|39430411|FG000|Infant Series|Adverse Event|0|||
16258008|NCT00366899|39430412|FG001|Infant Series|Adverse Event|1|||
16258009|NCT00366899|39430411|FG000|Infant Series|Physician Decision|1|||
16258010|NCT00366899|39430412|FG001|Infant Series|Physician Decision|0|||
16258011|NCT00366899|39430411|FG000|Infant Series|Randomized but not consented|1|||
16258012|NCT00366899|39430412|FG001|Infant Series|Randomized but not consented|0|||
16258013|NCT00366899|39430411|FG000|After Infant Series|Lost to Follow-up|4|||
16258014|NCT00366899|39430412|FG001|After Infant Series|Lost to Follow-up|3|||
16258015|NCT00366899|39430411|FG000|After Infant Series|Withdrawal by Subject|1|||
16258016|NCT00366899|39430412|FG001|After Infant Series|Withdrawal by Subject|4|||
16258017|NCT00366899|39430411|FG000|After Infant Series|Adverse Event|1|||
16258018|NCT00366899|39430412|FG001|After Infant Series|Adverse Event|2|||
16258019|NCT00366899|39430411|FG000|After Infant Series|Protocol Violation|1|||
16258020|NCT00366899|39430412|FG001|After Infant Series|Protocol Violation|0|||
16258021|NCT00366899|39430411|FG000|Toddler Dose|Withdrawal by Subject|1|||
16258022|NCT00366899|39430412|FG001|Toddler Dose|Withdrawal by Subject|1|||
16258023|NCT00366899|39430411|FG000|Toddler Dose|Protocol Violation|1|||
16258024|NCT00366899|39430412|FG001|Toddler Dose|Protocol Violation|0|||
16258025|NCT00064753|39430413|FG000|Overall Study|Death|251|||
16258026|NCT00064753|39430414|FG001|Overall Study|Death|242|||
16258027|NCT00064753|39430413|FG000|Overall Study|Withdrawal by Subject|198|||
16258028|NCT00064753|39430414|FG001|Overall Study|Withdrawal by Subject|171|||
16258029|NCT00064753|39430413|FG000|Overall Study|Lost to Follow-up|225|||
16258030|NCT00064753|39430414|FG001|Overall Study|Lost to Follow-up|235|||
16258031|NCT01469364|39430415|FG000|Overall Study|Adverse Event|1|||
16258032|NCT01469364|39430415|FG000|Overall Study|Withdrawal by Subject|1|||
16258033|NCT05593965|39430416|FG000|1st Intervention (1 Day)|Technical error|1|||
16258034|NCT05593965|39430417|FG001|1st Intervention (1 Day)|Technical error|0|||
16258035|NCT00576056|39430421|FG000|Overall Study|Adverse Event|1|||
16258036|NCT00576056|39430421|FG000|Overall Study|Death|1|||
16258037|NCT00576056|39430421|FG000|Overall Study|Lack of Efficacy|1|||
16258038|NCT00576056|39430421|FG000|Overall Study|Withdrawal by Subject|2|||
16258039|NCT00576056|39430421|FG000|Overall Study|did not meet eligibility criteria|8|||
16258040|NCT00576056|39430421|FG000|Overall Study|Physician Decision|1|||
16258041|NCT02465567|39430426|FG000|Overall Study|Adverse Event|118|||
16258042|NCT02465567|39430427|FG001|Overall Study|Adverse Event|113|||
16258043|NCT02465567|39430428|FG002|Overall Study|Adverse Event|147|||
16258044|NCT02465567|39430429|FG003|Overall Study|Adverse Event|138|||
16258045|NCT02465567|39430426|FG000|Overall Study|Lack of Efficacy|103|||
16258046|NCT02465567|39430427|FG001|Overall Study|Lack of Efficacy|102|||
16258047|NCT02465567|39430428|FG002|Overall Study|Lack of Efficacy|171|||
16258048|NCT02465567|39430429|FG003|Overall Study|Lack of Efficacy|135|||
16258049|NCT02465567|39430426|FG000|Overall Study|Withdrawal by Subject|104|||
16258050|NCT02465567|39430427|FG001|Overall Study|Withdrawal by Subject|94|||
16258051|NCT02465567|39430428|FG002|Overall Study|Withdrawal by Subject|123|||
16258052|NCT02465567|39430429|FG003|Overall Study|Withdrawal by Subject|130|||
16258053|NCT02465567|39430426|FG000|Overall Study|Physician Decision|23|||
16258054|NCT02465567|39430427|FG001|Overall Study|Physician Decision|33|||
16258055|NCT02465567|39430428|FG002|Overall Study|Physician Decision|38|||
16258056|NCT02465567|39430429|FG003|Overall Study|Physician Decision|28|||
16258057|NCT02465567|39430426|FG000|Overall Study|Major Protocol Deviation|24|||
16258058|NCT02465567|39430427|FG001|Overall Study|Major Protocol Deviation|26|||
16258059|NCT02465567|39430428|FG002|Overall Study|Major Protocol Deviation|22|||
16258060|NCT02465567|39430429|FG003|Overall Study|Major Protocol Deviation|25|||
16258061|NCT02465567|39430426|FG000|Overall Study|Lost to Follow-up|25|||
16258062|NCT02465567|39430427|FG001|Overall Study|Lost to Follow-up|21|||
16258063|NCT02465567|39430428|FG002|Overall Study|Lost to Follow-up|19|||
16258064|NCT02465567|39430429|FG003|Overall Study|Lost to Follow-up|15|||
16258065|NCT02465567|39430426|FG000|Overall Study|Protocol Specified Criteria|20|||
16258066|NCT02465567|39430427|FG001|Overall Study|Protocol Specified Criteria|10|||
16258067|NCT02465567|39430428|FG002|Overall Study|Protocol Specified Criteria|9|||
16258068|NCT02465567|39430429|FG003|Overall Study|Protocol Specified Criteria|12|||
16258069|NCT02465567|39430426|FG000|Overall Study|Administrative Reasons|12|||
16258070|NCT02465567|39430427|FG001|Overall Study|Administrative Reasons|9|||
16258071|NCT02465567|39430428|FG002|Overall Study|Administrative Reasons|11|||
16258072|NCT02465567|39430429|FG003|Overall Study|Administrative Reasons|5|||
16258073|NCT02465567|39430426|FG000|Overall Study|Randomized but not treated|1|||
16258074|NCT02465567|39430427|FG001|Overall Study|Randomized but not treated|5|||
16258075|NCT02465567|39430428|FG002|Overall Study|Randomized but not treated|4|||
16258076|NCT02465567|39430429|FG003|Overall Study|Randomized but not treated|5|||
16258077|NCT02465567|39430426|FG000|Overall Study|enrolled in >1 studies|18|||
16258078|NCT02465567|39430427|FG001|Overall Study|enrolled in >1 studies|11|||
16258079|NCT02465567|39430428|FG002|Overall Study|enrolled in >1 studies|19|||
16258080|NCT02465567|39430429|FG003|Overall Study|enrolled in >1 studies|15|||
16258081|NCT02465567|39430426|FG000|Overall Study|missing PI Signature|1|||
16258082|NCT02465567|39430427|FG001|Overall Study|missing PI Signature|0|||
16258083|NCT02465567|39430428|FG002|Overall Study|missing PI Signature|0|||
16258084|NCT02465567|39430429|FG003|Overall Study|missing PI Signature|0|||
16258085|NCT01451762|39430430|FG000|Overall Study|Lost to Follow-up|3|||
16258086|NCT01451762|39430431|FG001|Overall Study|Lost to Follow-up|6|||
16258087|NCT01451762|39430432|FG002|Overall Study|Lost to Follow-up|6|||
16258088|NCT02015390|39430438|FG000|Overall Study|Lost to Follow-up|1|||
16258089|NCT02015390|39430439|FG001|Overall Study|Lost to Follow-up|0|||
16258090|NCT02015390|39430438|FG000|Overall Study|Adverse Event|0|||
16258091|NCT02015390|39430439|FG001|Overall Study|Adverse Event|3|||
16258092|NCT02015390|39430438|FG000|Overall Study|Physician Decision|0|||
16258093|NCT02015390|39430439|FG001|Overall Study|Physician Decision|1|||
16258094|NCT02100228|39430440|FG000|Overall Study|Other|19|||
16258095|NCT02100228|39430441|FG001|Overall Study|Other|19|||
16258096|NCT02100228|39430440|FG000|Overall Study|Administrative reason|0|||
16258097|NCT02100228|39430441|FG001|Overall Study|Administrative reason|1|||
16258098|NCT02100228|39430440|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
16258099|NCT02100228|39430441|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
16258100|NCT02100228|39430440|FG000|Overall Study|Non-compliance|0|||
16258101|NCT02100228|39430441|FG001|Overall Study|Non-compliance|3|||
16258102|NCT02100228|39430440|FG000|Overall Study|Lost to Follow-up|0|||
16258103|NCT02100228|39430441|FG001|Overall Study|Lost to Follow-up|1|||
16258104|NCT02100228|39430440|FG000|Overall Study|Withdrawal by Subject|27|||
16258105|NCT02100228|39430441|FG001|Overall Study|Withdrawal by Subject|37|||
16258106|NCT02100228|39430440|FG000|Overall Study|Adverse Event|16|||
16258107|NCT02100228|39430441|FG001|Overall Study|Adverse Event|12|||
16258108|NCT02100228|39430440|FG000|Overall Study|Death|1|||
16258109|NCT02100228|39430441|FG001|Overall Study|Death|1|||
16258110|NCT04276883|39430442|FG000|Overall Study|Withdrawal by Subject|2|||
16258111|NCT04276883|39430443|FG001|Overall Study|Withdrawal by Subject|3|||
16258112|NCT04276883|39430444|FG002|Overall Study|Withdrawal by Subject|6|||
16258113|NCT04276883|39430442|FG000|Overall Study|Lost to Follow-up|1|||
16258114|NCT04276883|39430443|FG001|Overall Study|Lost to Follow-up|3|||
16258115|NCT04276883|39430444|FG002|Overall Study|Lost to Follow-up|0|||
16258116|NCT04276883|39430442|FG000|Overall Study|Adverse Event|0|||
16258117|NCT04276883|39430443|FG001|Overall Study|Adverse Event|1|||
16258118|NCT04276883|39430444|FG002|Overall Study|Adverse Event|0|||
16258119|NCT04276883|39430442|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
16258120|NCT04276883|39430443|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
16258121|NCT04276883|39430444|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
16258122|NCT00705536|39430445|FG000|Start Period 1|Withdrawal by Subject|0|||
16258123|NCT00705536|39430446|FG001|Start Period 1|Withdrawal by Subject|0|||
16258124|NCT00705536|39430447|FG002|Start Period 1|Withdrawal by Subject|0|||
16258125|NCT00705536|39430448|FG003|Start Period 1|Withdrawal by Subject|1|||
16258126|NCT04084314|39430449|FG000|Overall Study|Subject/guardian decision|91|||
16258127|NCT04084314|39430449|FG000|Overall Study|Adverse Event|24|||
16258128|NCT04084314|39430449|FG000|Overall Study|Lost to Follow-up|19|||
16258129|NCT04084314|39430449|FG000|Overall Study|New therapy for study indication|9|||
16258130|NCT04084314|39430449|FG000|Overall Study|Pregnancy|9|||
16364442|NCT00580840|39818272|FG003|Double-Blind|Withdrawal by Subject|2|||
16364443|NCT00580840|39818269|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
16258131|NCT04084314|39430449|FG000|Overall Study|Withdrawal of informed consent|8|||
16258132|NCT04084314|39430449|FG000|Overall Study|Physician Decision|4|||
16258133|NCT04084314|39430449|FG000|Overall Study|Protocol Deviation|3|||
16258134|NCT01404988|39430450|FG000|Overall Study|Death|2|||
16258135|NCT01404988|39430451|FG001|Overall Study|Death|0|||
16258136|NCT01404988|39430452|FG002|Overall Study|Death|2|||
16258137|NCT01404988|39430450|FG000|Overall Study|Adverse Event|1|||
16258138|NCT01404988|39430451|FG001|Overall Study|Adverse Event|0|||
16258139|NCT01404988|39430452|FG002|Overall Study|Adverse Event|0|||
16364444|NCT00580840|39818270|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
16258140|NCT01404988|39430450|FG000|Overall Study|Withdrawal by Subject|2|||
16258141|NCT01404988|39430451|FG001|Overall Study|Withdrawal by Subject|2|||
16258142|NCT01404988|39430452|FG002|Overall Study|Withdrawal by Subject|0|||
16258143|NCT01404988|39430450|FG000|Overall Study|Lost to Follow-up|1|||
16258144|NCT01404988|39430451|FG001|Overall Study|Lost to Follow-up|2|||
16258145|NCT01404988|39430452|FG002|Overall Study|Lost to Follow-up|1|||
16258146|NCT02670525|39430453|FG000|Overall Study|Death|94|||
16258147|NCT02670525|39430454|FG001|Overall Study|Death|14|||
16258148|NCT02670525|39430453|FG000|Overall Study|Lost to Follow-up|4|||
16364445|NCT00580840|39818271|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
16145374|NCT03519867|39021218|FG001|Overall Study|Protocol Violation|0|||
16145375|NCT03519867|39021219|FG002|Overall Study|Protocol Violation|0|||
16145376|NCT03519867|39021220|FG003|Overall Study|Protocol Violation|0|||
16145377|NCT03519867|39021221|FG004|Overall Study|Protocol Violation|0|||
16145378|NCT03519867|39021222|FG005|Overall Study|Protocol Violation|1|||
16145379|NCT03519867|39021223|FG006|Overall Study|Protocol Violation|0|||
16145380|NCT03519867|39021224|FG007|Overall Study|Protocol Violation|0|||
16145381|NCT03519867|39021225|FG008|Overall Study|Protocol Violation|0|||
16145382|NCT03519867|39021226|FG009|Overall Study|Protocol Violation|0|||
16145383|NCT03519867|39021217|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
16145384|NCT03519867|39021218|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
16145385|NCT03519867|39021219|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
16145386|NCT03519867|39021220|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
16145387|NCT03519867|39021221|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
16145388|NCT03519867|39021222|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
16145389|NCT03519867|39021223|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
16145390|NCT03519867|39021224|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
16145391|NCT03519867|39021225|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
16145392|NCT03519867|39021226|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
16145393|NCT03519867|39021217|FG000|Overall Study|Admin. of other reversal agent|1|||
16145394|NCT03519867|39021218|FG001|Overall Study|Admin. of other reversal agent|1|||
16145395|NCT03519867|39021219|FG002|Overall Study|Admin. of other reversal agent|0|||
16145396|NCT03519867|39021220|FG003|Overall Study|Admin. of other reversal agent|0|||
16145397|NCT03519867|39021221|FG004|Overall Study|Admin. of other reversal agent|0|||
16145398|NCT03519867|39021222|FG005|Overall Study|Admin. of other reversal agent|1|||
16145399|NCT03519867|39021223|FG006|Overall Study|Admin. of other reversal agent|0|||
16145400|NCT03519867|39021224|FG007|Overall Study|Admin. of other reversal agent|0|||
16145401|NCT03519867|39021225|FG008|Overall Study|Admin. of other reversal agent|0|||
16145402|NCT03519867|39021226|FG009|Overall Study|Admin. of other reversal agent|0|||
16145403|NCT03519867|39021217|FG000|Overall Study|Reason not provided|1|||
16145404|NCT03519867|39021218|FG001|Overall Study|Reason not provided|1|||
16145405|NCT03519867|39021219|FG002|Overall Study|Reason not provided|1|||
16145406|NCT03519867|39021220|FG003|Overall Study|Reason not provided|1|||
16145407|NCT03519867|39021221|FG004|Overall Study|Reason not provided|0|||
16145408|NCT03519867|39021222|FG005|Overall Study|Reason not provided|1|||
16145409|NCT03519867|39021223|FG006|Overall Study|Reason not provided|0|||
16145410|NCT03519867|39021224|FG007|Overall Study|Reason not provided|1|||
16145411|NCT03519867|39021225|FG008|Overall Study|Reason not provided|1|||
16145412|NCT03519867|39021226|FG009|Overall Study|Reason not provided|0|||
16145413|NCT03441334|39021231|FG000|Overall Study|Withdrawal by Subject|1|||
16145414|NCT03441334|39021232|FG001|Overall Study|Withdrawal by Subject|0|||
16145415|NCT03710486|39021233|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
16145416|NCT03710486|39021234|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
16145417|NCT03710486|39021233|FG000|Overall Study|Missing|0|||
16145418|NCT03710486|39021234|FG001|Overall Study|Missing|2|||
16145419|NCT03574753|39021235|FG000|Overall Study|Adverse Event|3|||
16145420|NCT03574753|39021235|FG000|Overall Study|Progression/relapse|19|||
16145421|NCT03574753|39021235|FG000|Overall Study|Death|1|||
16145422|NCT00733304|39021236|FG000|Overall Study|Adverse Event|3|||
16145423|NCT00733304|39021237|FG001|Overall Study|Adverse Event|0|||
16145424|NCT00733304|39021238|FG002|Overall Study|Adverse Event|0|||
16145425|NCT00733304|39021236|FG000|Overall Study|Lack of Efficacy|0|||
16145426|NCT00733304|39021237|FG001|Overall Study|Lack of Efficacy|0|||
16145427|NCT00733304|39021238|FG002|Overall Study|Lack of Efficacy|2|||
16145428|NCT00733304|39021236|FG000|Overall Study|Lost to Follow-up|0|||
16145429|NCT00733304|39021237|FG001|Overall Study|Lost to Follow-up|1|||
16145430|NCT00733304|39021238|FG002|Overall Study|Lost to Follow-up|0|||
16145431|NCT00733304|39021236|FG000|Overall Study|Physician Decision|3|||
16145432|NCT00733304|39021237|FG001|Overall Study|Physician Decision|1|||
16145433|NCT00733304|39021238|FG002|Overall Study|Physician Decision|3|||
16145434|NCT00733304|39021236|FG000|Overall Study|Withdrawal by Subject|1|||
16145435|NCT00733304|39021237|FG001|Overall Study|Withdrawal by Subject|1|||
16145436|NCT00733304|39021238|FG002|Overall Study|Withdrawal by Subject|0|||
16145437|NCT01007032|39021239|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
16258149|NCT02670525|39430454|FG001|Overall Study|Lost to Follow-up|1|||
16258150|NCT02670525|39430453|FG000|Overall Study|Subject withdrew consent|1|||
16258151|NCT02670525|39430454|FG001|Overall Study|Subject withdrew consent|0|||
16258152|NCT02670525|39430453|FG000|Overall Study|Unknown, data entry delayed|123|||
16258153|NCT02670525|39430454|FG001|Overall Study|Unknown, data entry delayed|78|||
16258154|NCT02495857|39430456|FG000|Overall Study|Adverse Event|5|||
16258155|NCT02495857|39430457|FG001|Overall Study|Adverse Event|0|||
16258156|NCT02495857|39430458|FG002|Overall Study|Adverse Event|1|||
16258157|NCT02495857|39430456|FG000|Overall Study|Withdrawal by Subject|9|||
16258158|NCT02495857|39430457|FG001|Overall Study|Withdrawal by Subject|6|||
16258159|NCT02495857|39430458|FG002|Overall Study|Withdrawal by Subject|10|||
16258160|NCT02495857|39430456|FG000|Overall Study|Physician Decision|0|||
16258161|NCT02495857|39430457|FG001|Overall Study|Physician Decision|1|||
16258162|NCT02495857|39430458|FG002|Overall Study|Physician Decision|0|||
16258163|NCT02495857|39430456|FG000|Overall Study|Protocol Violation|1|||
16258164|NCT02495857|39430457|FG001|Overall Study|Protocol Violation|1|||
16258165|NCT02495857|39430458|FG002|Overall Study|Protocol Violation|2|||
16258166|NCT02495857|39430456|FG000|Overall Study|Lost to Follow-up|4|||
16258167|NCT02495857|39430457|FG001|Overall Study|Lost to Follow-up|5|||
16258168|NCT02495857|39430458|FG002|Overall Study|Lost to Follow-up|3|||
16258169|NCT02495857|39430456|FG000|Overall Study|Other|3|||
16258170|NCT02495857|39430457|FG001|Overall Study|Other|3|||
16258171|NCT02495857|39430458|FG002|Overall Study|Other|2|||
16258172|NCT01411332|39430459|FG000|Enrollment|Protocol Violation|0|||
16258173|NCT01411332|39430460|FG001|Enrollment|Protocol Violation|1|||
16258174|NCT01411332|39430459|FG000|Enrollment|Withdrawal by Subject|0|||
16258175|NCT01411332|39430460|FG001|Enrollment|Withdrawal by Subject|1|||
16258176|NCT01411332|39430459|FG000|Treatment|Lost to Follow-up|1|||
16258177|NCT01411332|39430460|FG001|Treatment|Lost to Follow-up|0|||
16258178|NCT01703832|39430461|FG000|Overall Study|Withdrawal by Subject|1|||
16258179|NCT01703832|39430462|FG001|Overall Study|Withdrawal by Subject|0|||
16258180|NCT00854100|39430465|FG000|Overall Study|Inability to complete the study visits|0|||
16258181|NCT00854100|39430466|FG001|Overall Study|Inability to complete the study visits|0|||
16258182|NCT00854100|39430467|FG002|Overall Study|Inability to complete the study visits|1|||
16258183|NCT00854100|39430465|FG000|Overall Study|Lost to Follow-up|2|||
16258184|NCT00854100|39430466|FG001|Overall Study|Lost to Follow-up|0|||
16258185|NCT00854100|39430467|FG002|Overall Study|Lost to Follow-up|3|||
16258186|NCT00854100|39430465|FG000|Overall Study|Withdrawal by Subject|3|||
16364446|NCT00580840|39818272|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
16364447|NCT00580840|39818269|FG000|Double-Blind|Other: Forbidden Medication|0|||
16364448|NCT00580840|39818270|FG001|Double-Blind|Other: Forbidden Medication|0|||
16364449|NCT00580840|39818271|FG002|Double-Blind|Other: Forbidden Medication|1|||
16364450|NCT00580840|39818272|FG003|Double-Blind|Other: Forbidden Medication|0|||
16364451|NCT00441896|39818277|FG000|Overall Study|Withdrawal by Subject|0|||
16364452|NCT00441896|39818278|FG001|Overall Study|Withdrawal by Subject|0|||
16364453|NCT00441896|39818279|FG002|Overall Study|Withdrawal by Subject|0|||
16364454|NCT00441896|39818280|FG003|Overall Study|Withdrawal by Subject|1|||
16364455|NCT00441896|39818281|FG004|Overall Study|Withdrawal by Subject|0|||
16364456|NCT00441896|39818282|FG005|Overall Study|Withdrawal by Subject|0|||
16364457|NCT00441896|39818283|FG006|Overall Study|Withdrawal by Subject|0|||
16364458|NCT00441896|39818284|FG007|Overall Study|Withdrawal by Subject|0|||
16364459|NCT00441896|39818285|FG008|Overall Study|Withdrawal by Subject|0|||
16364460|NCT00441896|39818286|FG009|Overall Study|Withdrawal by Subject|0|||
16364461|NCT00441896|39818277|FG000|Overall Study|Other|0|||
16364462|NCT00441896|39818278|FG001|Overall Study|Other|0|||
16364463|NCT00441896|39818279|FG002|Overall Study|Other|0|||
16364464|NCT00441896|39818280|FG003|Overall Study|Other|0|||
16364465|NCT00441896|39818281|FG004|Overall Study|Other|1|||
16364466|NCT00441896|39818282|FG005|Overall Study|Other|0|||
16364467|NCT00441896|39818283|FG006|Overall Study|Other|0|||
16364468|NCT00441896|39818284|FG007|Overall Study|Other|0|||
16364469|NCT00441896|39818285|FG008|Overall Study|Other|0|||
16364470|NCT00441896|39818286|FG009|Overall Study|Other|0|||
16364471|NCT03600350|39818287|FG000|Overall Study|Death|1|||
16364472|NCT03600350|39818287|FG000|Overall Study|On Follow Up|18|||
16258187|NCT00854100|39430466|FG001|Overall Study|Withdrawal by Subject|1|||
16258188|NCT00854100|39430467|FG002|Overall Study|Withdrawal by Subject|2|||
16364473|NCT03801252|39818290|FG000|Overall Study|Protocol Violation|1|||
16364474|NCT03801252|39818291|FG001|Overall Study|Protocol Violation|2|||
16364475|NCT00686972|39818294|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
16364476|NCT04900272|39821350|FG000|Overall Study|Lost to Follow-up|2|||
16364477|NCT04900272|39821350|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
16258189|NCT00854100|39430465|FG000|Overall Study|Protocol Violation|2|||
16258190|NCT00854100|39430466|FG001|Overall Study|Protocol Violation|4|||
16364478|NCT04900272|39821350|FG000|Overall Study|Withdrawal by Subject|1|||
16258191|NCT00854100|39430467|FG002|Overall Study|Protocol Violation|3|||
16258192|NCT00854100|39430465|FG000|Overall Study|Adverse Event|2|||
16258193|NCT00854100|39430466|FG001|Overall Study|Adverse Event|1|||
16258194|NCT00854100|39430467|FG002|Overall Study|Adverse Event|2|||
16258195|NCT02262377|39430468|FG000|Overall Study|Lost to Follow-up|5|||
16258196|NCT02262377|39430469|FG001|Overall Study|Lost to Follow-up|6|||
16258197|NCT02262377|39430468|FG000|Overall Study|Found ineligible after enrollment|3|||
16258198|NCT02262377|39430469|FG001|Overall Study|Found ineligible after enrollment|0|||
16258199|NCT02262377|39430468|FG000|Overall Study|Withdrawal by Subject|4|||
16258200|NCT02262377|39430469|FG001|Overall Study|Withdrawal by Subject|0|||
16258201|NCT04646213|39430472|FG000|Overall Study|Physician Decision|3|||
16258202|NCT04646213|39430472|FG000|Overall Study|Withdrawal by Subject|2|||
16258203|NCT03733925|39430473|FG000|Overall Study|Lost to Follow-up|1|||
16258204|NCT03733925|39430473|FG000|Overall Study|Withdrawal by Subject|2|||
16258205|NCT03733925|39430473|FG000|Overall Study|Adverse Event|2|||
16258206|NCT03733925|39430473|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16258207|NCT03639311|39430476|FG000|Maintenance Phase|Lost to Follow-up|1|||
16258208|NCT03639311|39430477|FG001|Maintenance Phase|Lost to Follow-up|0|||
16258209|NCT03639311|39430478|FG002|Maintenance Phase|Lost to Follow-up|0|||
16258210|NCT03639311|39430476|FG000|Maintenance Phase|Adverse Event|1|||
16258211|NCT03639311|39430477|FG001|Maintenance Phase|Adverse Event|0|||
16258212|NCT03639311|39430478|FG002|Maintenance Phase|Adverse Event|0|||
16258213|NCT03639311|39430476|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
16258214|NCT03639311|39430477|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
16258215|NCT03639311|39430478|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
16258216|NCT03639311|39430476|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
16258217|NCT03639311|39430477|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
16258218|NCT03639311|39430478|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
16258219|NCT03639311|39430476|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
16258220|NCT03639311|39430477|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
16258221|NCT03639311|39430478|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
16258222|NCT03639311|39430476|FG000|Maintenance Phase|Lack of Efficacy|1|||
16258223|NCT03639311|39430477|FG001|Maintenance Phase|Lack of Efficacy|0|||
16258224|NCT03639311|39430478|FG002|Maintenance Phase|Lack of Efficacy|0|||
16258225|NCT02865538|39430479|FG000|Overall Study|Withdrawal by Subject|0|||
16440132|NCT02426580|40089685|FG000|Overall Study|Death|2|||
16440133|NCT02426580|40089686|FG001|Overall Study|Death|2|||
16440134|NCT02426580|40089685|FG000|Overall Study|Lost to Follow-up|0|||
16440135|NCT02426580|40089686|FG001|Overall Study|Lost to Follow-up|9|||
16440136|NCT02426580|40089685|FG000|Overall Study|transfer to hemodialysis|5|||
16440137|NCT02426580|40089686|FG001|Overall Study|transfer to hemodialysis|5|||
16440138|NCT02426580|40089685|FG000|Overall Study|Kidney transplant|3|||
16440139|NCT02426580|40089686|FG001|Overall Study|Kidney transplant|0|||
16145438|NCT01007032|39021240|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
16440140|NCT02426580|40089685|FG000|Overall Study|Allergic to egg white|1|||
16440141|NCT02426580|40089686|FG001|Overall Study|Allergic to egg white|0|||
16440142|NCT01075243|40089687|FG000|Overall Study|Lost to Follow-up|5|||
16440143|NCT01075243|40089688|FG001|Overall Study|Lost to Follow-up|2|||
16440144|NCT01075243|40089689|FG002|Overall Study|Lost to Follow-up|0|||
16440145|NCT01075243|40089687|FG000|Overall Study|Withdrawal by Subject|1|||
16440146|NCT01075243|40089688|FG001|Overall Study|Withdrawal by Subject|1|||
16440147|NCT01075243|40089689|FG002|Overall Study|Withdrawal by Subject|0|||
16440148|NCT02343263|40089691|FG000|Overall Study|Physician Decision|5|||
16145439|NCT01007032|39021241|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
16145440|NCT01007032|39021242|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
16145441|NCT01007032|39021239|FG000|Overall Study|Withdrawal by Subject|0|||
16145442|NCT01007032|39021240|FG001|Overall Study|Withdrawal by Subject|0|||
16145443|NCT01007032|39021241|FG002|Overall Study|Withdrawal by Subject|0|||
16145444|NCT01007032|39021242|FG003|Overall Study|Withdrawal by Subject|1|||
16145445|NCT01101438|39021243|FG000|Overall Study|Withdrawal by Subject|8|||
16145446|NCT01101438|39021244|FG001|Overall Study|Withdrawal by Subject|9|||
16440149|NCT02343263|40089692|FG001|Overall Study|Physician Decision|3|||
16440150|NCT02343263|40089693|FG002|Overall Study|Physician Decision|1|||
16440151|NCT00481832|40089694|FG000|Enrollment|Physician Decision|8|||
16440152|NCT00481832|40089694|FG000|Enrollment|Unable to collect enough stem cells|2|||
16440153|NCT00481832|40089694|FG000|Inter-transplant Period|Adverse Event|4|||
16145447|NCT02000427|39021245|FG000|Overall Study|Death|22|||
16145448|NCT02953639|39021246|FG000|Overall Study|Adverse Event|2|||
16145449|NCT02953639|39021247|FG001|Overall Study|Adverse Event|0|||
16145450|NCT02953639|39021248|FG002|Overall Study|Adverse Event|1|||
16258226|NCT02865538|39430480|FG001|Overall Study|Withdrawal by Subject|0|||
16258227|NCT02865538|39430481|FG002|Overall Study|Withdrawal by Subject|1|||
16258228|NCT02865538|39430482|FG003|Overall Study|Withdrawal by Subject|0|||
16258229|NCT02865538|39430483|FG004|Overall Study|Withdrawal by Subject|0|||
16258230|NCT02865538|39430479|FG000|Overall Study|Lost to Follow-up|1|||
16440154|NCT00481832|40089694|FG000|Inter-transplant Period|Death|3|||
16258231|NCT02865538|39430480|FG001|Overall Study|Lost to Follow-up|0|||
16258232|NCT02865538|39430481|FG002|Overall Study|Lost to Follow-up|0|||
16258233|NCT02865538|39430482|FG003|Overall Study|Lost to Follow-up|0|||
16258234|NCT02865538|39430483|FG004|Overall Study|Lost to Follow-up|0|||
16258235|NCT03952143|39430484|FG000|Lead-In Period|Adverse Event|2|||
16258236|NCT03952143|39430485|FG001|Lead-In Period|Adverse Event|0|||
16258237|NCT03952143|39430486|FG002|Lead-In Period|Adverse Event|0|||
16258238|NCT03952143|39430484|FG000|Lead-In Period|Lack of Efficacy|2|||
16258239|NCT03952143|39430485|FG001|Lead-In Period|Lack of Efficacy|0|||
16258240|NCT03952143|39430486|FG002|Lead-In Period|Lack of Efficacy|0|||
16258241|NCT03952143|39430484|FG000|Lead-In Period|Physician Decision|5|||
16258242|NCT03952143|39430485|FG001|Lead-In Period|Physician Decision|0|||
16258243|NCT03952143|39430486|FG002|Lead-In Period|Physician Decision|0|||
16440155|NCT00481832|40089694|FG000|Inter-transplant Period|Physician Decision|4|||
16440156|NCT00481832|40089694|FG000|Inter-transplant Period|Disease relapse|11|||
16440157|NCT00481832|40089694|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
16440158|NCT03224130|40089695|FG000|Overall Study|consent issue|0|||
16440159|NCT03224130|40089696|FG001|Overall Study|consent issue|1|||
16440160|NCT03341299|40092613|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
16440161|NCT03341299|40092614|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
16440162|NCT03341299|40092615|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
16440163|NCT03341299|40092616|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
16440164|NCT00627393|40092617|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
16440165|NCT00627393|40092618|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
16440166|NCT00627393|40092617|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
16440167|NCT00627393|40092618|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
16440168|NCT00627393|40092617|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
16440169|NCT00627393|40092618|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
16440170|NCT00627393|40092617|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
16440171|NCT00627393|40092618|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
16440172|NCT00262860|40092621|FG000|Overall Study|Adverse Event|2|||
16440173|NCT03096834|40092622|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
16440174|NCT03096834|40092623|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
16440175|NCT03096834|40092624|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
16440176|NCT03096834|40092625|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
16440177|NCT03096834|40092622|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
16440178|NCT03096834|40092623|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
16440179|NCT03096834|40092624|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
16440180|NCT03096834|40092625|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
16258244|NCT03952143|39430484|FG000|Lead-In Period|Protocol Violation|5|||
16258245|NCT03952143|39430485|FG001|Lead-In Period|Protocol Violation|0|||
16258246|NCT03952143|39430486|FG002|Lead-In Period|Protocol Violation|0|||
16258247|NCT03952143|39430484|FG000|Lead-In Period|Withdrawal by Subject|19|||
16145451|NCT02953639|39021246|FG000|Overall Study|Lost to Follow-up|8|||
16145452|NCT02953639|39021247|FG001|Overall Study|Lost to Follow-up|4|||
16145453|NCT02953639|39021248|FG002|Overall Study|Lost to Follow-up|3|||
16145454|NCT02953639|39021246|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16145455|NCT02953639|39021247|FG001|Overall Study|Non-Compliance With Study Drug|2|||
16440181|NCT03096834|40092622|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
16440182|NCT03096834|40092623|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
16145456|NCT02953639|39021248|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16145457|NCT02953639|39021246|FG000|Overall Study|Multiple Reasons|1|||
16440183|NCT03096834|40092624|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
16145458|NCT02953639|39021247|FG001|Overall Study|Multiple Reasons|0|||
16145459|NCT02953639|39021248|FG002|Overall Study|Multiple Reasons|1|||
16145460|NCT02953639|39021246|FG000|Overall Study|Physician Decision|1|||
16145461|NCT02953639|39021247|FG001|Overall Study|Physician Decision|0|||
16145462|NCT02953639|39021248|FG002|Overall Study|Physician Decision|0|||
16145463|NCT02953639|39021246|FG000|Overall Study|Withdrawal by Subject|7|||
16145464|NCT02953639|39021247|FG001|Overall Study|Withdrawal by Subject|8|||
16145465|NCT02953639|39021248|FG002|Overall Study|Withdrawal by Subject|10|||
16145466|NCT02953639|39021246|FG000|Overall Study|Completed or Discontinued information is missing|1|||
16145467|NCT02953639|39021247|FG001|Overall Study|Completed or Discontinued information is missing|0|||
16145468|NCT02953639|39021248|FG002|Overall Study|Completed or Discontinued information is missing|0|||
16145469|NCT04196803|39021250|FG000|Overall Study|Withdrawal by Subject|1|||
16145470|NCT04196803|39021251|FG001|Overall Study|Withdrawal by Subject|3|||
16145471|NCT04196803|39021250|FG000|Overall Study|Adverse Event|4|||
16145472|NCT04196803|39021251|FG001|Overall Study|Adverse Event|2|||
16145473|NCT04196803|39021250|FG000|Overall Study|Lost to Follow-up|0|||
16145474|NCT04196803|39021251|FG001|Overall Study|Lost to Follow-up|1|||
16145475|NCT00382720|39021252|FG000|Overall Study|Adverse Event|21|||
16145476|NCT00382720|39021253|FG001|Overall Study|Adverse Event|23|||
16145477|NCT00382720|39021254|FG002|Overall Study|Adverse Event|15|||
16145478|NCT00382720|39021252|FG000|Overall Study|Protocol Violation|2|||
16145479|NCT00382720|39021253|FG001|Overall Study|Protocol Violation|5|||
16145480|NCT00382720|39021254|FG002|Overall Study|Protocol Violation|1|||
16145481|NCT00382720|39021252|FG000|Overall Study|Death|0|||
16145482|NCT00382720|39021253|FG001|Overall Study|Death|1|||
16145483|NCT00382720|39021254|FG002|Overall Study|Death|2|||
16145484|NCT00382720|39021252|FG000|Overall Study|Progressive disease|37|||
16145485|NCT00382720|39021253|FG001|Overall Study|Progressive disease|28|||
16145486|NCT00382720|39021254|FG002|Overall Study|Progressive disease|38|||
16145487|NCT00382720|39021252|FG000|Overall Study|Withdrew consent|1|||
16145488|NCT00382720|39021253|FG001|Overall Study|Withdrew consent|1|||
16145489|NCT00382720|39021254|FG002|Overall Study|Withdrew consent|2|||
16145490|NCT00382720|39021252|FG000|Overall Study|Withdrawal by Subject|11|||
16145491|NCT00382720|39021253|FG001|Overall Study|Withdrawal by Subject|20|||
16258248|NCT03952143|39430485|FG001|Lead-In Period|Withdrawal by Subject|0|||
16258249|NCT03952143|39430486|FG002|Lead-In Period|Withdrawal by Subject|0|||
16145492|NCT00382720|39021254|FG002|Overall Study|Withdrawal by Subject|12|||
16145493|NCT00382720|39021252|FG000|Overall Study|Surgery|1|||
16145494|NCT00382720|39021253|FG001|Overall Study|Surgery|1|||
16145495|NCT00382720|39021254|FG002|Overall Study|Surgery|4|||
16145496|NCT00382720|39021252|FG000|Overall Study|Patient did not receive study medication|1|||
16145497|NCT00382720|39021253|FG001|Overall Study|Patient did not receive study medication|1|||
16145498|NCT00382720|39021254|FG002|Overall Study|Patient did not receive study medication|4|||
16145499|NCT00382720|39021252|FG000|Overall Study|Clinically progressive disease|0|||
16145500|NCT00382720|39021253|FG001|Overall Study|Clinically progressive disease|1|||
16145501|NCT00382720|39021254|FG002|Overall Study|Clinically progressive disease|0|||
16145502|NCT00382720|39021252|FG000|Overall Study|Good prognosis|0|||
16145503|NCT00382720|39021253|FG001|Overall Study|Good prognosis|1|||
16145504|NCT00382720|39021254|FG002|Overall Study|Good prognosis|0|||
16145505|NCT00382720|39021252|FG000|Overall Study|Investigator/Clinical decision|5|||
16145506|NCT00382720|39021253|FG001|Overall Study|Investigator/Clinical decision|6|||
16145507|NCT00382720|39021254|FG002|Overall Study|Investigator/Clinical decision|6|||
16145508|NCT00382720|39021252|FG000|Overall Study|Discontinued at end of study|0|||
16145509|NCT00382720|39021253|FG001|Overall Study|Discontinued at end of study|1|||
16145510|NCT00382720|39021254|FG002|Overall Study|Discontinued at end of study|2|||
16145511|NCT00589420|39021258|FG000|Overall Study|screen failure|1|||
16145512|NCT00591214|39021264|FG000|Overall Study|Physician Decision|7|||
16145513|NCT00591214|39021264|FG000|Overall Study|Withdrawal by Subject|1|||
16145514|NCT05092919|39021265|FG000|Overall Study|Lost to Follow-up|7|||
16145515|NCT05092919|39021265|FG000|Overall Study|Withdrawal by Subject|2|||
16145516|NCT00404820|39021266|FG000|Overall Study|Adverse Event|4|||
16145517|NCT00404820|39021267|FG001|Overall Study|Adverse Event|16|||
16145518|NCT00404820|39021266|FG000|Overall Study|Withdrawal by Subject|5|||
16145519|NCT00404820|39021267|FG001|Overall Study|Withdrawal by Subject|3|||
16145520|NCT00404820|39021266|FG000|Overall Study|Lost to Follow-up|7|||
16145521|NCT00404820|39021267|FG001|Overall Study|Lost to Follow-up|3|||
16145522|NCT00404820|39021266|FG000|Overall Study|Administrative problems|2|||
16145523|NCT00404820|39021267|FG001|Overall Study|Administrative problems|0|||
16145524|NCT00404820|39021266|FG000|Overall Study|Death|1|||
16145525|NCT00404820|39021267|FG001|Overall Study|Death|0|||
16145526|NCT00404820|39021266|FG000|Overall Study|Other|0|||
16145527|NCT00404820|39021267|FG001|Overall Study|Other|2|||
16364479|NCT00283959|39821351|FG000|Extension Period|Low Compliance|1|||
16364480|NCT01179516|39821352|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
16364481|NCT01179516|39821353|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
16364482|NCT01179516|39821354|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
16364483|NCT01179516|39821352|FG000|Overall Study|Lack of Efficacy|4|||
16364484|NCT01179516|39821353|FG001|Overall Study|Lack of Efficacy|2|||
16364485|NCT01179516|39821354|FG002|Overall Study|Lack of Efficacy|0|||
16364486|NCT01179516|39821352|FG000|Overall Study|Noncompliance with Study Drug|2|||
16364487|NCT01179516|39821353|FG001|Overall Study|Noncompliance with Study Drug|0|||
16364488|NCT01179516|39821354|FG002|Overall Study|Noncompliance with Study Drug|1|||
16364489|NCT01179516|39821352|FG000|Overall Study|Protocol Deviations|4|||
16364490|NCT01179516|39821353|FG001|Overall Study|Protocol Deviations|3|||
16364491|NCT01179516|39821354|FG002|Overall Study|Protocol Deviations|3|||
16364492|NCT01179516|39821352|FG000|Overall Study|Withdrawal of Consent|2|||
16364493|NCT01179516|39821353|FG001|Overall Study|Withdrawal of Consent|6|||
16364494|NCT01179516|39821354|FG002|Overall Study|Withdrawal of Consent|10|||
16364495|NCT01179516|39821352|FG000|Overall Study|Lost to Follow-up|7|||
16364496|NCT01179516|39821353|FG001|Overall Study|Lost to Follow-up|7|||
16364497|NCT01179516|39821354|FG002|Overall Study|Lost to Follow-up|3|||
16364498|NCT01179516|39821352|FG000|Overall Study|Other|2|||
16364499|NCT01179516|39821353|FG001|Overall Study|Other|0|||
16364500|NCT01179516|39821354|FG002|Overall Study|Other|2|||
16364501|NCT03881371|39821357|FG000|Overall Study|Adverse Event|8|||
16364502|NCT03881371|39821358|FG001|Overall Study|Adverse Event|9|||
16364503|NCT03881371|39821357|FG000|Overall Study|Death|1|||
16364504|NCT03881371|39821358|FG001|Overall Study|Death|0|||
16364505|NCT03881371|39821357|FG000|Overall Study|Lost to Follow-up|1|||
16364506|NCT03881371|39821358|FG001|Overall Study|Lost to Follow-up|0|||
16364507|NCT03881371|39821357|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16364508|NCT03881371|39821358|FG001|Overall Study|Non-Compliance with Study Drug|2|||
16145528|NCT00495820|39021278|FG000|Overall Study|Adverse Event|1|||
16145529|NCT00495820|39021279|FG001|Overall Study|Adverse Event|1|||
16145530|NCT00006392|39021280|FG000|Overall Study|Ineligible|11|||
16145531|NCT00006392|39021281|FG001|Overall Study|Ineligible|3|||
16145532|NCT00006392|39021282|FG002|Overall Study|Ineligible|5|||
16145533|NCT00006392|39021283|FG003|Overall Study|Ineligible|5|||
16145534|NCT00006392|39021280|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
16145535|NCT00006392|39021281|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
16145536|NCT00006392|39021282|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
16145537|NCT00006392|39021283|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
16145538|NCT02716675|39021290|FG000|Overall Study|Death|2|||
16258250|NCT03952143|39430484|FG000|Treatment Period|Adverse Event|0|||
16258251|NCT03952143|39430485|FG001|Treatment Period|Adverse Event|0|||
16258252|NCT03952143|39430486|FG002|Treatment Period|Adverse Event|1|||
16258253|NCT03952143|39430484|FG000|Treatment Period|Lost to Follow-up|0|||
16258254|NCT03952143|39430485|FG001|Treatment Period|Lost to Follow-up|2|||
16258255|NCT03952143|39430486|FG002|Treatment Period|Lost to Follow-up|0|||
16258256|NCT03952143|39430484|FG000|Treatment Period|Physician Decision|0|||
16258257|NCT03952143|39430485|FG001|Treatment Period|Physician Decision|0|||
16258258|NCT03952143|39430486|FG002|Treatment Period|Physician Decision|2|||
16258259|NCT03952143|39430484|FG000|Treatment Period|Protocol Violation|0|||
16258260|NCT03952143|39430485|FG001|Treatment Period|Protocol Violation|0|||
16258261|NCT03952143|39430486|FG002|Treatment Period|Protocol Violation|1|||
16258262|NCT03952143|39430484|FG000|Treatment Period|Withdrawal by Subject|0|||
16258263|NCT03952143|39430485|FG001|Treatment Period|Withdrawal by Subject|5|||
16258264|NCT03952143|39430486|FG002|Treatment Period|Withdrawal by Subject|26|||
16258265|NCT03952143|39430484|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
16258266|NCT03952143|39430485|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
16258267|NCT03952143|39430486|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
16440184|NCT03096834|40092625|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
16440185|NCT03096834|40092622|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
16440186|NCT03096834|40092623|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
16440187|NCT03096834|40092624|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
16440188|NCT03096834|40092625|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
16440189|NCT03096834|40092622|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
16145539|NCT02716675|39021291|FG001|Overall Study|Death|3|||
16145540|NCT02716675|39021292|FG002|Overall Study|Death|0|||
16145541|NCT02716675|39021290|FG000|Overall Study|Physician Decision|2|||
16145542|NCT02716675|39021291|FG001|Overall Study|Physician Decision|1|||
16440190|NCT03096834|40092623|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
16145543|NCT02716675|39021292|FG002|Overall Study|Physician Decision|1|||
16145544|NCT02716675|39021290|FG000|Overall Study|Lost to Follow-up|100|||
16145545|NCT02716675|39021291|FG001|Overall Study|Lost to Follow-up|87|||
16145546|NCT02716675|39021292|FG002|Overall Study|Lost to Follow-up|99|||
16145547|NCT02716675|39021290|FG000|Overall Study|Withdrawal by Subject|22|||
16145548|NCT02716675|39021291|FG001|Overall Study|Withdrawal by Subject|25|||
16145549|NCT02716675|39021292|FG002|Overall Study|Withdrawal by Subject|20|||
16145550|NCT02716675|39021290|FG000|Overall Study|Protocol Violation|0|||
16145551|NCT02716675|39021291|FG001|Overall Study|Protocol Violation|3|||
16145552|NCT02716675|39021292|FG002|Overall Study|Protocol Violation|1|||
16145553|NCT02716675|39021290|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
16145554|NCT02716675|39021291|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
16145555|NCT02716675|39021292|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
16145556|NCT02716675|39021290|FG000|Overall Study|Other|38|||
16145557|NCT02716675|39021291|FG001|Overall Study|Other|47|||
16145558|NCT02716675|39021292|FG002|Overall Study|Other|48|||
16145559|NCT01162239|39021293|FG000|Treatment Phase|Withdrawal by Subject|1|||
16145560|NCT01162239|39021294|FG001|Treatment Phase|Withdrawal by Subject|3|||
16145561|NCT01162239|39021295|FG002|Treatment Phase|Withdrawal by Subject|2|||
16145562|NCT01162239|39021296|FG003|Treatment Phase|Withdrawal by Subject|3|||
16145563|NCT01162239|39021293|FG000|Treatment Phase|Death|0|||
16145564|NCT01162239|39021294|FG001|Treatment Phase|Death|0|||
16145565|NCT01162239|39021295|FG002|Treatment Phase|Death|0|||
16145566|NCT01162239|39021296|FG003|Treatment Phase|Death|1|||
16145567|NCT01162239|39021293|FG000|Treatment Phase|Lost to Follow-up|5|||
16145568|NCT01162239|39021294|FG001|Treatment Phase|Lost to Follow-up|4|||
16145569|NCT01162239|39021295|FG002|Treatment Phase|Lost to Follow-up|2|||
16145570|NCT01162239|39021296|FG003|Treatment Phase|Lost to Follow-up|1|||
16145571|NCT01162239|39021293|FG000|Extended Follow-up|Lost to Follow-up|8|||
16258268|NCT03952143|39430484|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
16258269|NCT03952143|39430485|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
16258270|NCT03952143|39430486|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
16258271|NCT00688064|39430493|FG000|Overall Study|Protocol Violation|0|||
16440191|NCT03096834|40092624|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
16145572|NCT01162239|39021294|FG001|Extended Follow-up|Lost to Follow-up|13|||
16145573|NCT01162239|39021295|FG002|Extended Follow-up|Lost to Follow-up|8|||
16145574|NCT01162239|39021296|FG003|Extended Follow-up|Lost to Follow-up|6|||
16145575|NCT00711425|39021297|FG000|Overall Study|Protocol Violation|1|||
16145576|NCT00711425|39021297|FG000|Overall Study|Death|2|||
16145577|NCT00711425|39021297|FG000|Overall Study|Lost to Follow-up|1|||
16145578|NCT01721057|39021300|FG000|Treatment Period|Withdrawal by Subject|11|||
16145579|NCT01721057|39021301|FG001|Treatment Period|Withdrawal by Subject|5|||
16145580|NCT01721057|39021302|FG002|Treatment Period|Withdrawal by Subject|8|||
16145581|NCT01721057|39021303|FG003|Treatment Period|Withdrawal by Subject|0|||
16145582|NCT01721057|39021304|FG004|Treatment Period|Withdrawal by Subject|0|||
16145583|NCT01721057|39021305|FG005|Treatment Period|Withdrawal by Subject|0|||
16145584|NCT01721057|39021306|FG006|Treatment Period|Withdrawal by Subject|0|||
16145585|NCT01721057|39021300|FG000|Treatment Period|Adverse Event|7|||
16145586|NCT01721057|39021301|FG001|Treatment Period|Adverse Event|10|||
16145587|NCT01721057|39021302|FG002|Treatment Period|Adverse Event|12|||
16145588|NCT01721057|39021303|FG003|Treatment Period|Adverse Event|0|||
16145589|NCT01721057|39021304|FG004|Treatment Period|Adverse Event|0|||
16145590|NCT01721057|39021305|FG005|Treatment Period|Adverse Event|0|||
16145591|NCT01721057|39021306|FG006|Treatment Period|Adverse Event|0|||
16145592|NCT01721057|39021300|FG000|Treatment Period|Lack of Efficacy|7|||
16145593|NCT01721057|39021301|FG001|Treatment Period|Lack of Efficacy|3|||
16145594|NCT01721057|39021302|FG002|Treatment Period|Lack of Efficacy|0|||
16145595|NCT01721057|39021303|FG003|Treatment Period|Lack of Efficacy|0|||
16145596|NCT01721057|39021304|FG004|Treatment Period|Lack of Efficacy|0|||
16145597|NCT01721057|39021305|FG005|Treatment Period|Lack of Efficacy|0|||
16145598|NCT01721057|39021306|FG006|Treatment Period|Lack of Efficacy|0|||
16145599|NCT01721057|39021300|FG000|Treatment Period|Lost to Follow-up|1|||
16145600|NCT01721057|39021301|FG001|Treatment Period|Lost to Follow-up|0|||
16145601|NCT01721057|39021302|FG002|Treatment Period|Lost to Follow-up|0|||
16145602|NCT01721057|39021303|FG003|Treatment Period|Lost to Follow-up|0|||
16145603|NCT01721057|39021304|FG004|Treatment Period|Lost to Follow-up|0|||
16145604|NCT01721057|39021305|FG005|Treatment Period|Lost to Follow-up|0|||
16145605|NCT01721057|39021306|FG006|Treatment Period|Lost to Follow-up|0|||
16145606|NCT01721057|39021300|FG000|Treatment Period|Physician Decision|0|||
16145607|NCT01721057|39021301|FG001|Treatment Period|Physician Decision|1|||
16145608|NCT01721057|39021302|FG002|Treatment Period|Physician Decision|3|||
16145609|NCT01721057|39021303|FG003|Treatment Period|Physician Decision|0|||
16145610|NCT01721057|39021304|FG004|Treatment Period|Physician Decision|0|||
16145611|NCT01721057|39021305|FG005|Treatment Period|Physician Decision|0|||
16145612|NCT01721057|39021306|FG006|Treatment Period|Physician Decision|0|||
16145613|NCT01721057|39021300|FG000|Treatment Period|Death|2|||
16145614|NCT01721057|39021301|FG001|Treatment Period|Death|0|||
16145615|NCT01721057|39021302|FG002|Treatment Period|Death|0|||
16145616|NCT01721057|39021303|FG003|Treatment Period|Death|0|||
16145617|NCT01721057|39021304|FG004|Treatment Period|Death|0|||
16145618|NCT01721057|39021305|FG005|Treatment Period|Death|0|||
16145619|NCT01721057|39021306|FG006|Treatment Period|Death|0|||
16145620|NCT01721057|39021300|FG000|Rescue Period|Adverse Event|0|||
16145621|NCT01721057|39021301|FG001|Rescue Period|Adverse Event|0|||
16145622|NCT01721057|39021302|FG002|Rescue Period|Adverse Event|0|||
16145623|NCT01721057|39021303|FG003|Rescue Period|Adverse Event|1|||
16145624|NCT01721057|39021304|FG004|Rescue Period|Adverse Event|0|||
16145625|NCT01721057|39021305|FG005|Rescue Period|Adverse Event|0|||
16145626|NCT01721057|39021306|FG006|Rescue Period|Adverse Event|0|||
16145627|NCT01721057|39021300|FG000|Rescue Period|Lack of Efficacy|0|||
16145628|NCT01721057|39021301|FG001|Rescue Period|Lack of Efficacy|0|||
16145629|NCT01721057|39021302|FG002|Rescue Period|Lack of Efficacy|0|||
16145630|NCT01721057|39021303|FG003|Rescue Period|Lack of Efficacy|2|||
16145631|NCT01721057|39021304|FG004|Rescue Period|Lack of Efficacy|0|||
16145632|NCT01721057|39021305|FG005|Rescue Period|Lack of Efficacy|0|||
16145633|NCT01721057|39021306|FG006|Rescue Period|Lack of Efficacy|0|||
16145634|NCT00962390|39021307|FG000|Overall Study|Adverse Event|0|||
16145635|NCT00962390|39021308|FG001|Overall Study|Adverse Event|0|||
16258272|NCT00688064|39430494|FG001|Overall Study|Protocol Violation|1|||
16258273|NCT00688064|39430493|FG000|Overall Study|Adverse Event|2|||
16258274|NCT00688064|39430494|FG001|Overall Study|Adverse Event|4|||
16258275|NCT00688064|39430493|FG000|Overall Study|Withdrawal by Subject|7|||
16258276|NCT00688064|39430494|FG001|Overall Study|Withdrawal by Subject|7|||
16258277|NCT00688064|39430493|FG000|Overall Study|Lost to Follow-up|10|||
16258278|NCT00688064|39430494|FG001|Overall Study|Lost to Follow-up|10|||
16258279|NCT00688064|39430493|FG000|Overall Study|Lack of Efficacy|0|||
16258280|NCT00688064|39430494|FG001|Overall Study|Lack of Efficacy|1|||
16258281|NCT00688064|39430493|FG000|Overall Study|Pregnancy|1|||
16258282|NCT00688064|39430494|FG001|Overall Study|Pregnancy|0|||
16145636|NCT00962390|39021309|FG002|Overall Study|Adverse Event|3|||
16145637|NCT00962390|39021310|FG003|Overall Study|Adverse Event|1|||
16145638|NCT00962390|39021307|FG000|Overall Study|Lost to Follow-up|2|||
16145639|NCT00962390|39021308|FG001|Overall Study|Lost to Follow-up|2|||
16145640|NCT00962390|39021309|FG002|Overall Study|Lost to Follow-up|0|||
16145641|NCT00962390|39021310|FG003|Overall Study|Lost to Follow-up|0|||
16145642|NCT00962390|39021307|FG000|Overall Study|Protocol Violation|1|||
16145643|NCT00962390|39021308|FG001|Overall Study|Protocol Violation|0|||
16145644|NCT00962390|39021309|FG002|Overall Study|Protocol Violation|0|||
16258283|NCT00688064|39430493|FG000|Overall Study|Any other reasons|1|||
16258284|NCT00688064|39430494|FG001|Overall Study|Any other reasons|3|||
16258285|NCT00496964|39430495|FG000|Overall Study|Withdrawal by Subject|0|||
16258286|NCT00496964|39430496|FG001|Overall Study|Withdrawal by Subject|1|||
16258287|NCT01027143|39430513|FG000|Overall Study|Lost to Follow-up|9|||
16258288|NCT01027143|39430514|FG001|Overall Study|Lost to Follow-up|4|||
16258289|NCT00184600|39430515|FG000|Overall Study|Adverse Event|9|||
16258290|NCT00184600|39430516|FG001|Overall Study|Adverse Event|0|||
16258291|NCT00184600|39430517|FG002|Overall Study|Adverse Event|5|||
16258292|NCT00184600|39430515|FG000|Overall Study|Death|3|||
16258293|NCT00184600|39430516|FG001|Overall Study|Death|9|||
16258294|NCT00184600|39430517|FG002|Overall Study|Death|7|||
16258295|NCT00184600|39430515|FG000|Overall Study|Lack of Efficacy|3|||
16258296|NCT00184600|39430516|FG001|Overall Study|Lack of Efficacy|1|||
16258297|NCT00184600|39430517|FG002|Overall Study|Lack of Efficacy|3|||
16258298|NCT00184600|39430515|FG000|Overall Study|Lost to Follow-up|4|||
16258299|NCT00184600|39430516|FG001|Overall Study|Lost to Follow-up|6|||
16258300|NCT00184600|39430517|FG002|Overall Study|Lost to Follow-up|1|||
16258301|NCT00184600|39430515|FG000|Overall Study|Protocol Violation|2|||
16258302|NCT00184600|39430516|FG001|Overall Study|Protocol Violation|2|||
16258303|NCT00184600|39430517|FG002|Overall Study|Protocol Violation|3|||
16258304|NCT00184600|39430515|FG000|Overall Study|Withdrawal by Subject|20|||
16258305|NCT00184600|39430516|FG001|Overall Study|Withdrawal by Subject|28|||
16258306|NCT00184600|39430517|FG002|Overall Study|Withdrawal by Subject|12|||
16258307|NCT00184600|39430515|FG000|Overall Study|Unclassified|4|||
16258308|NCT00184600|39430516|FG001|Overall Study|Unclassified|5|||
16258309|NCT00184600|39430517|FG002|Overall Study|Unclassified|3|||
16258310|NCT02421952|39430518|FG000|Overall Study|Diary Not Returned|93|||
16258311|NCT02421952|39430518|FG000|Overall Study|Failed seriation task|13|||
16258312|NCT02421952|39430518|FG000|Overall Study|Subject uncooperative for baseline test|2|||
16258313|NCT02421952|39430518|FG000|Overall Study|Surgery cancelled|1|||
16258314|NCT00877032|39430521|FG000|Overall Study|Did not meet entrance criteria|0|||
16258315|NCT00877032|39430522|FG001|Overall Study|Did not meet entrance criteria|0|||
16258316|NCT00877032|39430523|FG002|Overall Study|Did not meet entrance criteria|0|||
16258317|NCT00877032|39430524|FG003|Overall Study|Did not meet entrance criteria|1|||
16258318|NCT00877032|39430525|FG004|Overall Study|Did not meet entrance criteria|0|||
16258319|NCT00877032|39430526|FG005|Overall Study|Did not meet entrance criteria|0|||
16258320|NCT00877032|39430527|FG006|Overall Study|Did not meet entrance criteria|2|||
16258321|NCT05612724|39430528|FG000|Overall Study|Lost to Follow-up|4|||
16258322|NCT01880593|39430529|FG000|Overall Study|Adverse Event|1|||
16258323|NCT01880593|39430530|FG001|Overall Study|Adverse Event|0|||
16258324|NCT01880593|39430529|FG000|Overall Study|Lack of Efficacy|1|||
16258325|NCT01880593|39430530|FG001|Overall Study|Lack of Efficacy|5|||
16258326|NCT01880593|39430529|FG000|Overall Study|Withdrawal by Subject|6|||
16258327|NCT01880593|39430530|FG001|Overall Study|Withdrawal by Subject|1|||
16258328|NCT01389102|39430532|FG000|Overall Study|Adverse Event|1|||
16258329|NCT01389102|39430533|FG001|Overall Study|Adverse Event|3|||
16258330|NCT01389102|39430534|FG002|Overall Study|Adverse Event|2|||
16258331|NCT01389102|39430535|FG003|Overall Study|Adverse Event|2|||
16258332|NCT01389102|39430536|FG004|Overall Study|Adverse Event|2|||
16258333|NCT01389102|39430537|FG005|Overall Study|Adverse Event|2|||
16258334|NCT01389102|39430532|FG000|Overall Study|Hurricane Katrina|4|||
16258335|NCT01389102|39430533|FG001|Overall Study|Hurricane Katrina|2|||
16258336|NCT01389102|39430534|FG002|Overall Study|Hurricane Katrina|3|||
16258337|NCT01389102|39430535|FG003|Overall Study|Hurricane Katrina|0|||
16258338|NCT01389102|39430536|FG004|Overall Study|Hurricane Katrina|3|||
16258339|NCT01389102|39430537|FG005|Overall Study|Hurricane Katrina|1|||
16258340|NCT01389102|39430532|FG000|Overall Study|Lost to Follow-up|4|||
16258341|NCT01389102|39430533|FG001|Overall Study|Lost to Follow-up|1|||
16258342|NCT01389102|39430534|FG002|Overall Study|Lost to Follow-up|1|||
16258343|NCT01389102|39430535|FG003|Overall Study|Lost to Follow-up|2|||
16258344|NCT01389102|39430536|FG004|Overall Study|Lost to Follow-up|4|||
16258345|NCT01389102|39430537|FG005|Overall Study|Lost to Follow-up|1|||
16258346|NCT01389102|39430532|FG000|Overall Study|Protocol Violation|0|||
16258347|NCT01389102|39430533|FG001|Overall Study|Protocol Violation|0|||
16258348|NCT01389102|39430534|FG002|Overall Study|Protocol Violation|3|||
16258349|NCT01389102|39430535|FG003|Overall Study|Protocol Violation|0|||
16258350|NCT01389102|39430536|FG004|Overall Study|Protocol Violation|1|||
16258351|NCT01389102|39430537|FG005|Overall Study|Protocol Violation|1|||
16258352|NCT01389102|39430532|FG000|Overall Study|Withdrawal by Subject|7|||
16258353|NCT01389102|39430533|FG001|Overall Study|Withdrawal by Subject|4|||
16258354|NCT01389102|39430534|FG002|Overall Study|Withdrawal by Subject|9|||
16258355|NCT01389102|39430535|FG003|Overall Study|Withdrawal by Subject|2|||
16258356|NCT01389102|39430536|FG004|Overall Study|Withdrawal by Subject|3|||
16258357|NCT01389102|39430537|FG005|Overall Study|Withdrawal by Subject|3|||
16258358|NCT01389102|39430532|FG000|Overall Study|Subject Traveling Out of Country|0|||
16258359|NCT01389102|39430533|FG001|Overall Study|Subject Traveling Out of Country|0|||
16258360|NCT01389102|39430534|FG002|Overall Study|Subject Traveling Out of Country|0|||
16258361|NCT01389102|39430535|FG003|Overall Study|Subject Traveling Out of Country|1|||
16258362|NCT01389102|39430536|FG004|Overall Study|Subject Traveling Out of Country|0|||
16258363|NCT01389102|39430537|FG005|Overall Study|Subject Traveling Out of Country|0|||
16258364|NCT01389102|39430532|FG000|Overall Study|Subject Moved|2|||
16258365|NCT01389102|39430533|FG001|Overall Study|Subject Moved|0|||
16258366|NCT01389102|39430534|FG002|Overall Study|Subject Moved|1|||
16258367|NCT01389102|39430535|FG003|Overall Study|Subject Moved|0|||
16258368|NCT01389102|39430536|FG004|Overall Study|Subject Moved|0|||
16258369|NCT01389102|39430537|FG005|Overall Study|Subject Moved|0|||
16258370|NCT01389102|39430532|FG000|Overall Study|Unavailable due to husband's illness|0|||
16258371|NCT01389102|39430533|FG001|Overall Study|Unavailable due to husband's illness|1|||
16258372|NCT01389102|39430534|FG002|Overall Study|Unavailable due to husband's illness|0|||
16258373|NCT01389102|39430535|FG003|Overall Study|Unavailable due to husband's illness|0|||
16258374|NCT01389102|39430536|FG004|Overall Study|Unavailable due to husband's illness|0|||
16258375|NCT01389102|39430537|FG005|Overall Study|Unavailable due to husband's illness|0|||
16258376|NCT01389102|39430532|FG000|Overall Study|Investigator Judgement|0|||
16258377|NCT01389102|39430533|FG001|Overall Study|Investigator Judgement|1|||
16258378|NCT01389102|39430534|FG002|Overall Study|Investigator Judgement|0|||
16258379|NCT01389102|39430535|FG003|Overall Study|Investigator Judgement|0|||
16258380|NCT01389102|39430536|FG004|Overall Study|Investigator Judgement|0|||
16258381|NCT01389102|39430537|FG005|Overall Study|Investigator Judgement|0|||
16258382|NCT01110005|39430538|FG000|Overall Study|ineligible|1|||
16258383|NCT01110005|39430539|FG001|Overall Study|ineligible|2|||
16258384|NCT01110005|39430538|FG000|Overall Study|missing consent|3|||
16258385|NCT01110005|39430539|FG001|Overall Study|missing consent|2|||
16258386|NCT01110005|39430538|FG000|Overall Study|Withdrawal by Subject|0|||
16258387|NCT01110005|39430539|FG001|Overall Study|Withdrawal by Subject|1|||
16258388|NCT03123471|39430540|FG000|Placebo-controlled Phase|Adverse Event|3|||
16258389|NCT03123471|39430541|FG001|Placebo-controlled Phase|Adverse Event|8|||
16258390|NCT03123471|39430540|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
16258391|NCT03123471|39430541|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
16258392|NCT03123471|39430540|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
16258393|NCT03123471|39430541|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
16258394|NCT03123471|39430540|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
16258395|NCT03123471|39430541|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
16258396|NCT03123471|39430540|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
16258397|NCT03123471|39430541|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
16258398|NCT03123471|39430540|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
16258399|NCT03123471|39430541|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
16258400|NCT03123471|39430540|FG000|Placebo-controlled Phase|Miscellaneous|0|||
16258401|NCT03123471|39430541|FG001|Placebo-controlled Phase|Miscellaneous|1|||
16258402|NCT03123471|39430540|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
16258403|NCT03123471|39430541|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
16258404|NCT03123471|39430540|FG000|Apremilast Extension Phase|Adverse Event|1|||
16258405|NCT03123471|39430541|FG001|Apremilast Extension Phase|Adverse Event|5|||
16258406|NCT03123471|39430540|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
16258407|NCT03123471|39430541|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
16258408|NCT03123471|39430540|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
16258409|NCT03123471|39430541|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
16258410|NCT01052116|39430542|FG000|Overall Study|Lost to Follow-up|11|||
16258411|NCT01052116|39430543|FG001|Overall Study|Lost to Follow-up|17|||
16258412|NCT01052116|39430542|FG000|Overall Study|Withdrawal by Subject|3|||
16258413|NCT01052116|39430543|FG001|Overall Study|Withdrawal by Subject|6|||
16258414|NCT01052116|39430542|FG000|Overall Study|Spirometry not performed|0|||
16258415|NCT01052116|39430543|FG001|Overall Study|Spirometry not performed|4|||
16258416|NCT03496623|39430544|FG000|Run-In Period (2 Weeks)|Death|1|||
16258417|NCT03496623|39430545|FG001|Run-In Period (2 Weeks)|Death|0|||
16258418|NCT03496623|39430546|FG002|Run-In Period (2 Weeks)|Death|0|||
16258419|NCT03496623|39430547|FG003|Run-In Period (2 Weeks)|Death|0|||
16258420|NCT03496623|39430548|FG004|Run-In Period (2 Weeks)|Death|0|||
16145645|NCT00962390|39021310|FG003|Overall Study|Protocol Violation|0|||
16258421|NCT03496623|39430544|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
16258422|NCT03496623|39430545|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
16258423|NCT03496623|39430546|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
16258424|NCT03496623|39430547|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
16258425|NCT03496623|39430548|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
16258426|NCT03496623|39430544|FG000|Period 1 (12 Weeks)|Death|0|||
16258427|NCT03496623|39430545|FG001|Period 1 (12 Weeks)|Death|3|||
16258428|NCT03496623|39430546|FG002|Period 1 (12 Weeks)|Death|0|||
16258429|NCT03496623|39430547|FG003|Period 1 (12 Weeks)|Death|0|||
16258430|NCT03496623|39430548|FG004|Period 1 (12 Weeks)|Death|0|||
16258431|NCT03496623|39430544|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
16258432|NCT03496623|39430545|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
16258433|NCT03496623|39430546|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
16364509|NCT03881371|39821357|FG000|Overall Study|Physician Decision|3|||
16258434|NCT03496623|39430547|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
16258435|NCT03496623|39430548|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
16258436|NCT03496623|39430544|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16258437|NCT03496623|39430545|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
16258438|NCT03496623|39430546|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
16258439|NCT03496623|39430547|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16258440|NCT03496623|39430548|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16258441|NCT03496623|39430544|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
16258442|NCT03496623|39430545|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
16258443|NCT03496623|39430546|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
16258444|NCT03496623|39430547|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
16258445|NCT03496623|39430548|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
16258446|NCT03496623|39430544|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16258447|NCT03496623|39430545|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16258448|NCT03496623|39430546|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
16258449|NCT03496623|39430547|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16258450|NCT03496623|39430548|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16258451|NCT03496623|39430544|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
16258452|NCT03496623|39430545|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
16258453|NCT03496623|39430546|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
16258454|NCT03496623|39430547|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
16258455|NCT03496623|39430548|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
16258456|NCT03496623|39430544|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16258457|NCT03496623|39430545|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
16258458|NCT03496623|39430546|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16258459|NCT03496623|39430547|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16258460|NCT03496623|39430548|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16258461|NCT01991470|39430561|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
16258462|NCT01991470|39430561|FG000|Enlite 1 Period|Adverse Event|1|||
16258463|NCT01991470|39430561|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
16258464|NCT01991470|39430561|FG000|Enlite 3 Period|Lost to Follow-up|1|||
16258465|NCT01991470|39430561|FG000|Enlite 3 Period|Physician Decision|2|||
16258466|NCT01991470|39430561|FG000|Enlite 3 Period|Physician Decision|8|||
16258467|NCT01991470|39430561|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
16258468|NCT01449630|39430564|FG000|Period 1|Physician Decision|1|||
16258469|NCT01449630|39430565|FG001|Period 1|Physician Decision|0|||
16258470|NCT01449630|39430566|FG002|Period 1|Physician Decision|0|||
16258471|NCT01449630|39430567|FG003|Period 1|Physician Decision|1|||
16258472|NCT01449630|39430568|FG004|Period 1|Physician Decision|0|||
16258473|NCT01449630|39430569|FG005|Period 1|Physician Decision|0|||
16258474|NCT01449630|39430570|FG006|Period 1|Physician Decision|0|||
16258475|NCT01449630|39430571|FG007|Period 1|Physician Decision|0|||
16364510|NCT03881371|39821358|FG001|Overall Study|Physician Decision|3|||
16364511|NCT03881371|39821357|FG000|Overall Study|Withdrawal by Subject|2|||
16364512|NCT03881371|39821358|FG001|Overall Study|Withdrawal by Subject|10|||
16364513|NCT03881371|39821357|FG000|Overall Study|Discontinuation from Study|1|||
16364514|NCT03881371|39821358|FG001|Overall Study|Discontinuation from Study|0|||
16364515|NCT01706328|39821359|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
16364516|NCT01706328|39821360|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16364517|NCT01706328|39821361|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16364518|NCT01706328|39821359|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
16364519|NCT01706328|39821360|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
16364520|NCT01706328|39821361|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
16364521|NCT01706328|39821359|FG000|2-week Run-in Period|Physician Decision|4|||
16364522|NCT01706328|39821360|FG001|2-week Run-in Period|Physician Decision|0|||
16364523|NCT01706328|39821361|FG002|2-week Run-in Period|Physician Decision|0|||
16145646|NCT00962390|39021307|FG000|Overall Study|Withdrawal by Subject|1|||
16145647|NCT00962390|39021308|FG001|Overall Study|Withdrawal by Subject|1|||
16145648|NCT00962390|39021309|FG002|Overall Study|Withdrawal by Subject|1|||
16145649|NCT00962390|39021310|FG003|Overall Study|Withdrawal by Subject|0|||
16145650|NCT02322125|39021311|FG000|Overall Study|Withdrawal by Subject|2|||
16145651|NCT01471015|39021314|FG000|Overall Study|Death|0|||
16145652|NCT01471015|39021315|FG001|Overall Study|Death|1|||
16145653|NCT01471015|39021316|FG002|Overall Study|Death|1|||
16145654|NCT03677596|39021317|FG000|Overall Study|Adverse Event|0|||
16145655|NCT03677596|39021318|FG001|Overall Study|Adverse Event|1|||
16145656|NCT03677596|39021317|FG000|Overall Study|Death|10|||
16145657|NCT03677596|39021318|FG001|Overall Study|Death|6|||
16145658|NCT03677596|39021317|FG000|Overall Study|Lost to Follow-up|0|||
16145659|NCT03677596|39021318|FG001|Overall Study|Lost to Follow-up|1|||
16145660|NCT03677596|39021317|FG000|Overall Study|Progressive Disease|8|||
16145661|NCT03677596|39021318|FG001|Overall Study|Progressive Disease|8|||
16145662|NCT03677596|39021317|FG000|Overall Study|Withdrawal by Subject|3|||
16145663|NCT03677596|39021318|FG001|Overall Study|Withdrawal by Subject|0|||
16145664|NCT03677596|39021317|FG000|Overall Study|Disease Relapse|2|||
16145665|NCT03677596|39021318|FG001|Overall Study|Disease Relapse|2|||
16145666|NCT03677596|39021317|FG000|Overall Study|Other|0|||
16145667|NCT03677596|39021318|FG001|Overall Study|Other|1|||
16145668|NCT02632721|39021323|FG000|Overall Study|Adverse Event|0|||
16145669|NCT02632721|39021324|FG001|Overall Study|Adverse Event|0|||
16145670|NCT02632721|39021325|FG002|Overall Study|Adverse Event|2|||
16145671|NCT02632721|39021326|FG003|Overall Study|Adverse Event|5|||
16145672|NCT02632721|39021327|FG004|Overall Study|Adverse Event|3|||
16145673|NCT02632721|39021323|FG000|Overall Study|Dose limiting toxicity|0|||
16145674|NCT02632721|39021324|FG001|Overall Study|Dose limiting toxicity|0|||
16145675|NCT02632721|39021325|FG002|Overall Study|Dose limiting toxicity|0|||
16145676|NCT02632721|39021326|FG003|Overall Study|Dose limiting toxicity|1|||
16145677|NCT02632721|39021327|FG004|Overall Study|Dose limiting toxicity|0|||
16145678|NCT02632721|39021323|FG000|Overall Study|Progressive disease|3|||
16145679|NCT02632721|39021324|FG001|Overall Study|Progressive disease|0|||
16145680|NCT02632721|39021325|FG002|Overall Study|Progressive disease|4|||
16145681|NCT02632721|39021326|FG003|Overall Study|Progressive disease|6|||
16145682|NCT02632721|39021327|FG004|Overall Study|Progressive disease|5|||
16145683|NCT02632721|39021323|FG000|Overall Study|Refused to continue taking trial medication|0|||
16145684|NCT02632721|39021324|FG001|Overall Study|Refused to continue taking trial medication|1|||
16145685|NCT02632721|39021325|FG002|Overall Study|Refused to continue taking trial medication|1|||
16145686|NCT02632721|39021326|FG003|Overall Study|Refused to continue taking trial medication|1|||
16440192|NCT03096834|40092625|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
16440193|NCT03096834|40092622|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
16440194|NCT03096834|40092623|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
16440195|NCT03096834|40092624|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
16440196|NCT03096834|40092625|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
16440197|NCT03096834|40092622|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
16440198|NCT03096834|40092623|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
16364524|NCT01706328|39821359|FG000|2-week Run-in Period|Adverse Event|4|||
16145687|NCT02632721|39021327|FG004|Overall Study|Refused to continue taking trial medication|2|||
16145688|NCT02632721|39021323|FG000|Overall Study|Inadequate clinical condition|0|||
16145689|NCT02632721|39021324|FG001|Overall Study|Inadequate clinical condition|0|||
16145690|NCT02632721|39021325|FG002|Overall Study|Inadequate clinical condition|0|||
16364525|NCT01706328|39821360|FG001|2-week Run-in Period|Adverse Event|0|||
16364526|NCT01706328|39821361|FG002|2-week Run-in Period|Adverse Event|0|||
16364527|NCT01706328|39821359|FG000|2-week Run-in Period|Lost to Follow-up|2|||
16364528|NCT01706328|39821360|FG001|2-week Run-in Period|Lost to Follow-up|0|||
16364529|NCT01706328|39821361|FG002|2-week Run-in Period|Lost to Follow-up|0|||
16364530|NCT01706328|39821359|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
16364531|NCT01706328|39821360|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
16364532|NCT01706328|39821361|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
16364533|NCT01706328|39821359|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
16364534|NCT01706328|39821360|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
16364535|NCT01706328|39821361|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
16440199|NCT03096834|40092624|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
16440200|NCT03096834|40092625|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
16440201|NCT03096834|40092622|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
16440202|NCT03096834|40092623|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
16440203|NCT03096834|40092624|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
16145691|NCT02632721|39021326|FG003|Overall Study|Inadequate clinical condition|0|||
16145692|NCT02632721|39021327|FG004|Overall Study|Inadequate clinical condition|1|||
16145693|NCT02632721|39021323|FG000|Overall Study|No meet eligibility|0|||
16145694|NCT02632721|39021324|FG001|Overall Study|No meet eligibility|0|||
16440204|NCT03096834|40092625|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
16440205|NCT03096834|40092622|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
16440206|NCT03096834|40092623|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
16440207|NCT03096834|40092624|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
16145695|NCT02632721|39021325|FG002|Overall Study|No meet eligibility|0|||
16440208|NCT03096834|40092625|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
16145696|NCT02632721|39021326|FG003|Overall Study|No meet eligibility|0|||
16145697|NCT02632721|39021327|FG004|Overall Study|No meet eligibility|1|||
16145698|NCT02632721|39021323|FG000|Overall Study|Allergic reaction|0|||
16145699|NCT02632721|39021324|FG001|Overall Study|Allergic reaction|0|||
16145700|NCT02632721|39021325|FG002|Overall Study|Allergic reaction|0|||
16145701|NCT02632721|39021326|FG003|Overall Study|Allergic reaction|1|||
16145702|NCT02632721|39021327|FG004|Overall Study|Allergic reaction|0|||
16145703|NCT02632721|39021323|FG000|Overall Study|Receiving Decitabine locally|0|||
16145704|NCT02632721|39021324|FG001|Overall Study|Receiving Decitabine locally|0|||
16145705|NCT02632721|39021325|FG002|Overall Study|Receiving Decitabine locally|1|||
16145706|NCT02632721|39021326|FG003|Overall Study|Receiving Decitabine locally|0|||
16145707|NCT02632721|39021327|FG004|Overall Study|Receiving Decitabine locally|0|||
16145708|NCT02632721|39021323|FG000|Overall Study|No benefit from study treatment|1|||
16145709|NCT02632721|39021324|FG001|Overall Study|No benefit from study treatment|1|||
16145710|NCT02632721|39021325|FG002|Overall Study|No benefit from study treatment|0|||
16145711|NCT02632721|39021326|FG003|Overall Study|No benefit from study treatment|0|||
16145712|NCT02632721|39021327|FG004|Overall Study|No benefit from study treatment|1|||
16145713|NCT02632721|39021323|FG000|Overall Study|Patient wish for other treatment|0|||
16145714|NCT02632721|39021324|FG001|Overall Study|Patient wish for other treatment|1|||
16145715|NCT02632721|39021325|FG002|Overall Study|Patient wish for other treatment|0|||
16145716|NCT02632721|39021326|FG003|Overall Study|Patient wish for other treatment|0|||
16145717|NCT02632721|39021327|FG004|Overall Study|Patient wish for other treatment|0|||
16145718|NCT02632721|39021323|FG000|Overall Study|Relapsed Pneumonia|0|||
16145719|NCT02632721|39021324|FG001|Overall Study|Relapsed Pneumonia|0|||
16145720|NCT02632721|39021325|FG002|Overall Study|Relapsed Pneumonia|0|||
16145721|NCT02632721|39021326|FG003|Overall Study|Relapsed Pneumonia|0|||
16440209|NCT03096834|40092622|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
16145722|NCT02632721|39021327|FG004|Overall Study|Relapsed Pneumonia|1|||
16145723|NCT02632721|39021323|FG000|Overall Study|Therapy refractory AML|0|||
16145724|NCT02632721|39021324|FG001|Overall Study|Therapy refractory AML|0|||
16145725|NCT02632721|39021325|FG002|Overall Study|Therapy refractory AML|0|||
16145726|NCT02632721|39021326|FG003|Overall Study|Therapy refractory AML|0|||
16145727|NCT02632721|39021327|FG004|Overall Study|Therapy refractory AML|1|||
16145728|NCT02632721|39021323|FG000|Overall Study|Increase of white blood cell count|0|||
16145729|NCT02632721|39021324|FG001|Overall Study|Increase of white blood cell count|0|||
16145730|NCT02632721|39021325|FG002|Overall Study|Increase of white blood cell count|0|||
16258476|NCT01449630|39430572|FG008|Period 1|Physician Decision|0|||
16258477|NCT01449630|39430564|FG000|Period 1|Sponsor Decision|0|||
16258478|NCT01449630|39430565|FG001|Period 1|Sponsor Decision|0|||
16258479|NCT01449630|39430566|FG002|Period 1|Sponsor Decision|0|||
16258480|NCT01449630|39430567|FG003|Period 1|Sponsor Decision|0|||
16258481|NCT01449630|39430568|FG004|Period 1|Sponsor Decision|0|||
16258482|NCT01449630|39430569|FG005|Period 1|Sponsor Decision|1|||
16258483|NCT01449630|39430570|FG006|Period 1|Sponsor Decision|0|||
16258484|NCT01449630|39430571|FG007|Period 1|Sponsor Decision|0|||
16440210|NCT03096834|40092623|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
16440211|NCT03096834|40092624|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
16145731|NCT02632721|39021326|FG003|Overall Study|Increase of white blood cell count|0|||
16440212|NCT03096834|40092625|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
16145732|NCT02632721|39021327|FG004|Overall Study|Increase of white blood cell count|1|||
16145733|NCT02632721|39021323|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
16145734|NCT02632721|39021324|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
16145735|NCT02632721|39021325|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
16145736|NCT02632721|39021326|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
16258485|NCT01449630|39430572|FG008|Period 1|Sponsor Decision|0|||
16258486|NCT01449630|39430564|FG000|Period 2|Sponsor Decision|0|||
16258487|NCT01449630|39430565|FG001|Period 2|Sponsor Decision|0|||
16258488|NCT01449630|39430566|FG002|Period 2|Sponsor Decision|0|||
16258489|NCT01449630|39430567|FG003|Period 2|Sponsor Decision|0|||
16145737|NCT02632721|39021327|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
16145738|NCT00455013|39021328|FG000|Short Term Period|Adverse Event|2|||
16145739|NCT00455013|39021329|FG001|Short Term Period|Adverse Event|5|||
16145740|NCT00455013|39021330|FG002|Short Term Period|Adverse Event|0|||
16145741|NCT00455013|39021328|FG000|Short Term Period|Withdrawal by Subject|0|||
16145742|NCT00455013|39021329|FG001|Short Term Period|Withdrawal by Subject|0|||
16145743|NCT00455013|39021330|FG002|Short Term Period|Withdrawal by Subject|1|||
16145744|NCT00455013|39021328|FG000|Short Term Period|Lack of Efficacy|4|||
16145745|NCT00455013|39021329|FG001|Short Term Period|Lack of Efficacy|0|||
16145746|NCT00455013|39021330|FG002|Short Term Period|Lack of Efficacy|0|||
16145747|NCT00455013|39021328|FG000|Short Term Period|Other|0|||
16145748|NCT00455013|39021329|FG001|Short Term Period|Other|0|||
16145749|NCT00455013|39021330|FG002|Short Term Period|Other|1|||
16145750|NCT00455013|39021328|FG000|Long Term Extension (LTE)|Adverse Event|0|||
16145751|NCT00455013|39021329|FG001|Long Term Extension (LTE)|Adverse Event|1|||
16145752|NCT00455013|39021330|FG002|Long Term Extension (LTE)|Adverse Event|1|||
16145753|NCT00455013|39021328|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
16145754|NCT00455013|39021329|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
16145755|NCT00455013|39021330|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
16145756|NCT00455013|39021328|FG000|Long Term Extension (LTE)|Death|1|||
16145757|NCT00455013|39021329|FG001|Long Term Extension (LTE)|Death|1|||
16145758|NCT00455013|39021330|FG002|Long Term Extension (LTE)|Death|0|||
16145759|NCT00455013|39021328|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
16145760|NCT00455013|39021329|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
16145761|NCT00455013|39021330|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
16145762|NCT00455013|39021328|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
16145763|NCT00455013|39021329|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
16145764|NCT00455013|39021330|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
16145765|NCT00455013|39021328|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
16145766|NCT00455013|39021329|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
16145767|NCT00455013|39021330|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
16145768|NCT00455013|39021328|FG000|Long Term Extension (LTE)|non-specified|0|||
16145769|NCT00455013|39021329|FG001|Long Term Extension (LTE)|non-specified|0|||
16145770|NCT00455013|39021330|FG002|Long Term Extension (LTE)|non-specified|1|||
16145771|NCT03349099|39021332|FG000|Overall Study|Physician Decision|3|||
16145772|NCT03349099|39021333|FG001|Overall Study|Physician Decision|4|||
16145773|NCT03349099|39021332|FG000|Overall Study|Stone migrated from the kidney|1|||
16145774|NCT03349099|39021333|FG001|Overall Study|Stone migrated from the kidney|0|||
16145775|NCT00467779|39021336|FG000|Stage 1|Adverse Event|1|||
16145776|NCT00467779|39021337|FG001|Stage 1|Adverse Event|0|||
16145777|NCT00467779|39021338|FG002|Stage 1|Adverse Event|0|||
16145778|NCT00467779|39021339|FG003|Stage 1|Adverse Event|0|||
16145779|NCT00467779|39021340|FG004|Stage 1|Adverse Event|0|||
16145780|NCT00467779|39021341|FG005|Stage 1|Adverse Event|1|||
16145781|NCT00467779|39021342|FG006|Stage 1|Adverse Event|2|||
16145782|NCT00467779|39021343|FG007|Stage 1|Adverse Event|1|||
16145783|NCT00467779|39021344|FG008|Stage 1|Adverse Event|0|||
16145784|NCT00467779|39021345|FG009|Stage 1|Adverse Event|0|||
16145785|NCT00467779|39021346|FG010|Stage 1|Adverse Event|0|||
16145786|NCT00467779|39021347|FG011|Stage 1|Adverse Event|0|||
16145787|NCT00467779|39021348|FG012|Stage 1|Adverse Event|0|||
16145788|NCT00467779|39021349|FG013|Stage 1|Adverse Event|0|||
16145789|NCT00467779|39021350|FG014|Stage 1|Adverse Event|0|||
16145790|NCT00467779|39021336|FG000|Stage 1|Disease Progression|2|||
16145791|NCT00467779|39021337|FG001|Stage 1|Disease Progression|2|||
16145792|NCT00467779|39021338|FG002|Stage 1|Disease Progression|2|||
16145793|NCT00467779|39021339|FG003|Stage 1|Disease Progression|3|||
16145794|NCT00467779|39021340|FG004|Stage 1|Disease Progression|2|||
16145795|NCT00467779|39021341|FG005|Stage 1|Disease Progression|2|||
16145796|NCT00467779|39021342|FG006|Stage 1|Disease Progression|4|||
16145797|NCT00467779|39021343|FG007|Stage 1|Disease Progression|5|||
16145798|NCT00467779|39021344|FG008|Stage 1|Disease Progression|0|||
16145799|NCT00467779|39021345|FG009|Stage 1|Disease Progression|0|||
16440213|NCT03096834|40092622|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
16145800|NCT00467779|39021346|FG010|Stage 1|Disease Progression|0|||
16145801|NCT00467779|39021347|FG011|Stage 1|Disease Progression|0|||
16145802|NCT00467779|39021348|FG012|Stage 1|Disease Progression|0|||
16145803|NCT00467779|39021349|FG013|Stage 1|Disease Progression|0|||
16145804|NCT00467779|39021350|FG014|Stage 1|Disease Progression|0|||
16145805|NCT00467779|39021336|FG000|Stage 1|Unspecified Reason|1|||
16440214|NCT03096834|40092623|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
16145806|NCT00467779|39021337|FG001|Stage 1|Unspecified Reason|0|||
16145807|NCT00467779|39021338|FG002|Stage 1|Unspecified Reason|1|||
16145808|NCT00467779|39021339|FG003|Stage 1|Unspecified Reason|0|||
16145809|NCT00467779|39021340|FG004|Stage 1|Unspecified Reason|1|||
16145810|NCT00467779|39021341|FG005|Stage 1|Unspecified Reason|2|||
16440215|NCT03096834|40092624|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
16145811|NCT00467779|39021342|FG006|Stage 1|Unspecified Reason|0|||
16145812|NCT00467779|39021343|FG007|Stage 1|Unspecified Reason|0|||
16145813|NCT00467779|39021344|FG008|Stage 1|Unspecified Reason|0|||
16145814|NCT00467779|39021345|FG009|Stage 1|Unspecified Reason|0|||
16145815|NCT00467779|39021346|FG010|Stage 1|Unspecified Reason|0|||
16145816|NCT00467779|39021347|FG011|Stage 1|Unspecified Reason|0|||
16145817|NCT00467779|39021348|FG012|Stage 1|Unspecified Reason|0|||
16145818|NCT00467779|39021349|FG013|Stage 1|Unspecified Reason|0|||
16145819|NCT00467779|39021350|FG014|Stage 1|Unspecified Reason|0|||
16145820|NCT00467779|39021336|FG000|Stage 1|Physician Decision|0|||
16145821|NCT00467779|39021337|FG001|Stage 1|Physician Decision|1|||
16145822|NCT00467779|39021338|FG002|Stage 1|Physician Decision|0|||
16145823|NCT00467779|39021339|FG003|Stage 1|Physician Decision|0|||
16145824|NCT00467779|39021340|FG004|Stage 1|Physician Decision|0|||
16145825|NCT00467779|39021341|FG005|Stage 1|Physician Decision|0|||
16145826|NCT00467779|39021342|FG006|Stage 1|Physician Decision|0|||
16145827|NCT00467779|39021343|FG007|Stage 1|Physician Decision|0|||
16145828|NCT00467779|39021344|FG008|Stage 1|Physician Decision|0|||
16145829|NCT00467779|39021345|FG009|Stage 1|Physician Decision|0|||
16145830|NCT00467779|39021346|FG010|Stage 1|Physician Decision|0|||
16145831|NCT00467779|39021347|FG011|Stage 1|Physician Decision|0|||
16145832|NCT00467779|39021348|FG012|Stage 1|Physician Decision|0|||
16145833|NCT00467779|39021349|FG013|Stage 1|Physician Decision|0|||
16145834|NCT00467779|39021350|FG014|Stage 1|Physician Decision|0|||
16145835|NCT00467779|39021336|FG000|Stage 1|Withdrawal by Subject|0|||
16145836|NCT00467779|39021337|FG001|Stage 1|Withdrawal by Subject|0|||
16145837|NCT00467779|39021338|FG002|Stage 1|Withdrawal by Subject|0|||
16145838|NCT00467779|39021339|FG003|Stage 1|Withdrawal by Subject|0|||
16145839|NCT00467779|39021340|FG004|Stage 1|Withdrawal by Subject|0|||
16145840|NCT00467779|39021341|FG005|Stage 1|Withdrawal by Subject|0|||
16145841|NCT00467779|39021342|FG006|Stage 1|Withdrawal by Subject|1|||
16145842|NCT00467779|39021343|FG007|Stage 1|Withdrawal by Subject|1|||
16145843|NCT00467779|39021344|FG008|Stage 1|Withdrawal by Subject|0|||
16145844|NCT00467779|39021345|FG009|Stage 1|Withdrawal by Subject|0|||
16145845|NCT00467779|39021346|FG010|Stage 1|Withdrawal by Subject|0|||
16145846|NCT00467779|39021347|FG011|Stage 1|Withdrawal by Subject|0|||
16145847|NCT00467779|39021348|FG012|Stage 1|Withdrawal by Subject|0|||
16145848|NCT00467779|39021349|FG013|Stage 1|Withdrawal by Subject|0|||
16145849|NCT00467779|39021350|FG014|Stage 1|Withdrawal by Subject|0|||
16145850|NCT00467779|39021336|FG000|Stage 1A|Adverse Event|0|||
16145851|NCT00467779|39021337|FG001|Stage 1A|Adverse Event|0|||
16145852|NCT00467779|39021338|FG002|Stage 1A|Adverse Event|0|||
16145853|NCT00467779|39021339|FG003|Stage 1A|Adverse Event|0|||
16145854|NCT00467779|39021340|FG004|Stage 1A|Adverse Event|0|||
16145855|NCT00467779|39021341|FG005|Stage 1A|Adverse Event|0|||
16145856|NCT00467779|39021342|FG006|Stage 1A|Adverse Event|0|||
16145857|NCT00467779|39021343|FG007|Stage 1A|Adverse Event|0|||
16145858|NCT00467779|39021344|FG008|Stage 1A|Adverse Event|0|||
16145859|NCT00467779|39021345|FG009|Stage 1A|Adverse Event|0|||
16145860|NCT00467779|39021346|FG010|Stage 1A|Adverse Event|0|||
16145861|NCT00467779|39021347|FG011|Stage 1A|Adverse Event|0|||
16145862|NCT00467779|39021348|FG012|Stage 1A|Adverse Event|1|||
16145863|NCT00467779|39021349|FG013|Stage 1A|Adverse Event|0|||
16145864|NCT00467779|39021350|FG014|Stage 1A|Adverse Event|0|||
16145865|NCT00467779|39021336|FG000|Stage 1A|Death|0|||
16145866|NCT00467779|39021337|FG001|Stage 1A|Death|0|||
16145867|NCT00467779|39021338|FG002|Stage 1A|Death|0|||
16145868|NCT00467779|39021339|FG003|Stage 1A|Death|0|||
16145869|NCT00467779|39021340|FG004|Stage 1A|Death|0|||
16145870|NCT00467779|39021341|FG005|Stage 1A|Death|0|||
16145871|NCT00467779|39021342|FG006|Stage 1A|Death|0|||
16145872|NCT00467779|39021343|FG007|Stage 1A|Death|0|||
16145873|NCT00467779|39021344|FG008|Stage 1A|Death|0|||
16145874|NCT00467779|39021345|FG009|Stage 1A|Death|0|||
16145875|NCT00467779|39021346|FG010|Stage 1A|Death|0|||
16145876|NCT00467779|39021347|FG011|Stage 1A|Death|1|||
16145877|NCT00467779|39021348|FG012|Stage 1A|Death|1|||
16145878|NCT00467779|39021349|FG013|Stage 1A|Death|0|||
16145879|NCT00467779|39021350|FG014|Stage 1A|Death|0|||
16145880|NCT00467779|39021336|FG000|Stage 1A|Disease Progression|0|||
16145881|NCT00467779|39021337|FG001|Stage 1A|Disease Progression|0|||
16145882|NCT00467779|39021338|FG002|Stage 1A|Disease Progression|0|||
16145883|NCT00467779|39021339|FG003|Stage 1A|Disease Progression|0|||
16145884|NCT00467779|39021340|FG004|Stage 1A|Disease Progression|0|||
16145885|NCT00467779|39021341|FG005|Stage 1A|Disease Progression|0|||
16145886|NCT00467779|39021342|FG006|Stage 1A|Disease Progression|0|||
16145887|NCT00467779|39021343|FG007|Stage 1A|Disease Progression|0|||
16145888|NCT00467779|39021344|FG008|Stage 1A|Disease Progression|0|||
16145889|NCT00467779|39021345|FG009|Stage 1A|Disease Progression|2|||
16145890|NCT00467779|39021346|FG010|Stage 1A|Disease Progression|2|||
16145891|NCT00467779|39021347|FG011|Stage 1A|Disease Progression|5|||
16145892|NCT00467779|39021348|FG012|Stage 1A|Disease Progression|2|||
16145893|NCT00467779|39021349|FG013|Stage 1A|Disease Progression|0|||
16145894|NCT00467779|39021350|FG014|Stage 1A|Disease Progression|0|||
16145895|NCT00467779|39021336|FG000|Stage 1A|Physician Decision|0|||
16145896|NCT00467779|39021337|FG001|Stage 1A|Physician Decision|0|||
16145897|NCT00467779|39021338|FG002|Stage 1A|Physician Decision|0|||
16145898|NCT00467779|39021339|FG003|Stage 1A|Physician Decision|0|||
16145899|NCT00467779|39021340|FG004|Stage 1A|Physician Decision|0|||
16145900|NCT00467779|39021341|FG005|Stage 1A|Physician Decision|0|||
16145901|NCT00467779|39021342|FG006|Stage 1A|Physician Decision|0|||
16145902|NCT00467779|39021343|FG007|Stage 1A|Physician Decision|0|||
16145903|NCT00467779|39021344|FG008|Stage 1A|Physician Decision|0|||
16145904|NCT00467779|39021345|FG009|Stage 1A|Physician Decision|1|||
16145905|NCT00467779|39021346|FG010|Stage 1A|Physician Decision|0|||
16145906|NCT00467779|39021347|FG011|Stage 1A|Physician Decision|0|||
16145907|NCT00467779|39021348|FG012|Stage 1A|Physician Decision|0|||
16145908|NCT00467779|39021349|FG013|Stage 1A|Physician Decision|0|||
16145909|NCT00467779|39021350|FG014|Stage 1A|Physician Decision|0|||
16145910|NCT00467779|39021336|FG000|Stage 1A|Withdrawal by Subject|0|||
16145911|NCT00467779|39021337|FG001|Stage 1A|Withdrawal by Subject|0|||
16145912|NCT00467779|39021338|FG002|Stage 1A|Withdrawal by Subject|0|||
16145913|NCT00467779|39021339|FG003|Stage 1A|Withdrawal by Subject|0|||
16145914|NCT00467779|39021340|FG004|Stage 1A|Withdrawal by Subject|0|||
16145915|NCT00467779|39021341|FG005|Stage 1A|Withdrawal by Subject|0|||
16145916|NCT00467779|39021342|FG006|Stage 1A|Withdrawal by Subject|0|||
16145917|NCT00467779|39021343|FG007|Stage 1A|Withdrawal by Subject|0|||
16145918|NCT00467779|39021344|FG008|Stage 1A|Withdrawal by Subject|0|||
16145919|NCT00467779|39021345|FG009|Stage 1A|Withdrawal by Subject|0|||
16145920|NCT00467779|39021346|FG010|Stage 1A|Withdrawal by Subject|1|||
16145921|NCT00467779|39021347|FG011|Stage 1A|Withdrawal by Subject|1|||
16145922|NCT00467779|39021348|FG012|Stage 1A|Withdrawal by Subject|1|||
16145923|NCT00467779|39021349|FG013|Stage 1A|Withdrawal by Subject|0|||
16145924|NCT00467779|39021350|FG014|Stage 1A|Withdrawal by Subject|0|||
16145925|NCT00467779|39021336|FG000|Stage 1A|Unspecified Reason|0|||
16145926|NCT00467779|39021337|FG001|Stage 1A|Unspecified Reason|0|||
16145927|NCT00467779|39021338|FG002|Stage 1A|Unspecified Reason|0|||
16145928|NCT00467779|39021339|FG003|Stage 1A|Unspecified Reason|0|||
16145929|NCT00467779|39021340|FG004|Stage 1A|Unspecified Reason|0|||
16145930|NCT00467779|39021341|FG005|Stage 1A|Unspecified Reason|0|||
16145931|NCT00467779|39021342|FG006|Stage 1A|Unspecified Reason|0|||
16145932|NCT00467779|39021343|FG007|Stage 1A|Unspecified Reason|0|||
16145933|NCT00467779|39021344|FG008|Stage 1A|Unspecified Reason|0|||
16145934|NCT00467779|39021345|FG009|Stage 1A|Unspecified Reason|0|||
16145935|NCT00467779|39021346|FG010|Stage 1A|Unspecified Reason|0|||
16145936|NCT00467779|39021347|FG011|Stage 1A|Unspecified Reason|1|||
16145937|NCT00467779|39021348|FG012|Stage 1A|Unspecified Reason|1|||
16145938|NCT00467779|39021349|FG013|Stage 1A|Unspecified Reason|0|||
16145939|NCT00467779|39021350|FG014|Stage 1A|Unspecified Reason|0|||
16145940|NCT00467779|39021336|FG000|Stage 2|Adverse Event|0|||
16145941|NCT00467779|39021337|FG001|Stage 2|Adverse Event|0|||
16145942|NCT00467779|39021338|FG002|Stage 2|Adverse Event|0|||
16145943|NCT00467779|39021339|FG003|Stage 2|Adverse Event|0|||
16145944|NCT00467779|39021340|FG004|Stage 2|Adverse Event|0|||
16145945|NCT00467779|39021341|FG005|Stage 2|Adverse Event|0|||
16145946|NCT00467779|39021342|FG006|Stage 2|Adverse Event|0|||
16145947|NCT00467779|39021343|FG007|Stage 2|Adverse Event|0|||
16145948|NCT00467779|39021344|FG008|Stage 2|Adverse Event|1|||
16145949|NCT00467779|39021345|FG009|Stage 2|Adverse Event|0|||
16145950|NCT00467779|39021346|FG010|Stage 2|Adverse Event|0|||
16145951|NCT00467779|39021347|FG011|Stage 2|Adverse Event|0|||
16145952|NCT00467779|39021348|FG012|Stage 2|Adverse Event|0|||
16145953|NCT00467779|39021349|FG013|Stage 2|Adverse Event|0|||
16145954|NCT00467779|39021350|FG014|Stage 2|Adverse Event|0|||
16145955|NCT00467779|39021336|FG000|Stage 2|Death|0|||
16145956|NCT00467779|39021337|FG001|Stage 2|Death|0|||
16145957|NCT00467779|39021338|FG002|Stage 2|Death|0|||
16145958|NCT00467779|39021339|FG003|Stage 2|Death|0|||
16145959|NCT00467779|39021340|FG004|Stage 2|Death|0|||
16145960|NCT00467779|39021341|FG005|Stage 2|Death|0|||
16145961|NCT00467779|39021342|FG006|Stage 2|Death|0|||
16145962|NCT00467779|39021343|FG007|Stage 2|Death|0|||
16145963|NCT00467779|39021344|FG008|Stage 2|Death|1|||
16145964|NCT00467779|39021345|FG009|Stage 2|Death|0|||
16145965|NCT00467779|39021346|FG010|Stage 2|Death|0|||
16145966|NCT00467779|39021347|FG011|Stage 2|Death|0|||
16145967|NCT00467779|39021348|FG012|Stage 2|Death|0|||
16145968|NCT00467779|39021349|FG013|Stage 2|Death|0|||
16145969|NCT00467779|39021350|FG014|Stage 2|Death|0|||
16145970|NCT00467779|39021336|FG000|Stage 2|Disease Progression|0|||
16145971|NCT00467779|39021337|FG001|Stage 2|Disease Progression|0|||
16145972|NCT00467779|39021338|FG002|Stage 2|Disease Progression|0|||
16145973|NCT00467779|39021339|FG003|Stage 2|Disease Progression|0|||
16145974|NCT00467779|39021340|FG004|Stage 2|Disease Progression|0|||
16145975|NCT00467779|39021341|FG005|Stage 2|Disease Progression|0|||
16145976|NCT00467779|39021342|FG006|Stage 2|Disease Progression|0|||
16145977|NCT00467779|39021343|FG007|Stage 2|Disease Progression|0|||
16145978|NCT00467779|39021344|FG008|Stage 2|Disease Progression|16|||
16145979|NCT00467779|39021345|FG009|Stage 2|Disease Progression|0|||
16145980|NCT00467779|39021346|FG010|Stage 2|Disease Progression|0|||
16145981|NCT00467779|39021347|FG011|Stage 2|Disease Progression|0|||
16145982|NCT00467779|39021348|FG012|Stage 2|Disease Progression|0|||
16145983|NCT00467779|39021349|FG013|Stage 2|Disease Progression|0|||
16145984|NCT00467779|39021350|FG014|Stage 2|Disease Progression|0|||
16145985|NCT00467779|39021336|FG000|Stage 2|Unspecified Reason|0|||
16145986|NCT00467779|39021337|FG001|Stage 2|Unspecified Reason|0|||
16145987|NCT00467779|39021338|FG002|Stage 2|Unspecified Reason|0|||
16145988|NCT00467779|39021339|FG003|Stage 2|Unspecified Reason|0|||
16145989|NCT00467779|39021340|FG004|Stage 2|Unspecified Reason|0|||
16145990|NCT00467779|39021341|FG005|Stage 2|Unspecified Reason|0|||
16145991|NCT00467779|39021342|FG006|Stage 2|Unspecified Reason|0|||
16145992|NCT00467779|39021343|FG007|Stage 2|Unspecified Reason|0|||
16145993|NCT00467779|39021344|FG008|Stage 2|Unspecified Reason|3|||
16145994|NCT00467779|39021345|FG009|Stage 2|Unspecified Reason|0|||
16145995|NCT00467779|39021346|FG010|Stage 2|Unspecified Reason|0|||
16145996|NCT00467779|39021347|FG011|Stage 2|Unspecified Reason|0|||
16145997|NCT00467779|39021348|FG012|Stage 2|Unspecified Reason|0|||
16145998|NCT00467779|39021349|FG013|Stage 2|Unspecified Reason|0|||
16145999|NCT00467779|39021350|FG014|Stage 2|Unspecified Reason|0|||
16146000|NCT00467779|39021336|FG000|Stage 2A|Adverse Event|0|||
16146001|NCT00467779|39021337|FG001|Stage 2A|Adverse Event|0|||
16146002|NCT00467779|39021338|FG002|Stage 2A|Adverse Event|0|||
16146003|NCT00467779|39021339|FG003|Stage 2A|Adverse Event|0|||
16146004|NCT00467779|39021340|FG004|Stage 2A|Adverse Event|0|||
16146005|NCT00467779|39021341|FG005|Stage 2A|Adverse Event|0|||
16146006|NCT00467779|39021342|FG006|Stage 2A|Adverse Event|0|||
16146007|NCT00467779|39021343|FG007|Stage 2A|Adverse Event|0|||
16146008|NCT00467779|39021344|FG008|Stage 2A|Adverse Event|0|||
16146009|NCT00467779|39021345|FG009|Stage 2A|Adverse Event|0|||
16146010|NCT00467779|39021346|FG010|Stage 2A|Adverse Event|0|||
16146011|NCT00467779|39021347|FG011|Stage 2A|Adverse Event|0|||
16146012|NCT00467779|39021348|FG012|Stage 2A|Adverse Event|0|||
16146013|NCT00467779|39021349|FG013|Stage 2A|Adverse Event|2|||
16146014|NCT00467779|39021350|FG014|Stage 2A|Adverse Event|0|||
16146015|NCT00467779|39021336|FG000|Stage 2A|Death|0|||
16146016|NCT00467779|39021337|FG001|Stage 2A|Death|0|||
16146017|NCT00467779|39021338|FG002|Stage 2A|Death|0|||
16146018|NCT00467779|39021339|FG003|Stage 2A|Death|0|||
16146019|NCT00467779|39021340|FG004|Stage 2A|Death|0|||
16146020|NCT00467779|39021341|FG005|Stage 2A|Death|0|||
16146021|NCT00467779|39021342|FG006|Stage 2A|Death|0|||
16146022|NCT00467779|39021343|FG007|Stage 2A|Death|0|||
16146023|NCT00467779|39021344|FG008|Stage 2A|Death|0|||
16146024|NCT00467779|39021345|FG009|Stage 2A|Death|0|||
16146025|NCT00467779|39021346|FG010|Stage 2A|Death|0|||
16146026|NCT00467779|39021347|FG011|Stage 2A|Death|0|||
16146027|NCT00467779|39021348|FG012|Stage 2A|Death|0|||
16146028|NCT00467779|39021349|FG013|Stage 2A|Death|1|||
16146029|NCT00467779|39021350|FG014|Stage 2A|Death|0|||
16146030|NCT00467779|39021336|FG000|Stage 2A|Disease Progression|0|||
16146031|NCT00467779|39021337|FG001|Stage 2A|Disease Progression|0|||
16146032|NCT00467779|39021338|FG002|Stage 2A|Disease Progression|0|||
16146033|NCT00467779|39021339|FG003|Stage 2A|Disease Progression|0|||
16146034|NCT00467779|39021340|FG004|Stage 2A|Disease Progression|0|||
16146035|NCT00467779|39021341|FG005|Stage 2A|Disease Progression|0|||
16146036|NCT00467779|39021342|FG006|Stage 2A|Disease Progression|0|||
16146037|NCT00467779|39021343|FG007|Stage 2A|Disease Progression|0|||
16146038|NCT00467779|39021344|FG008|Stage 2A|Disease Progression|0|||
16146039|NCT00467779|39021345|FG009|Stage 2A|Disease Progression|0|||
16146040|NCT00467779|39021346|FG010|Stage 2A|Disease Progression|0|||
16146041|NCT00467779|39021347|FG011|Stage 2A|Disease Progression|0|||
16146042|NCT00467779|39021348|FG012|Stage 2A|Disease Progression|0|||
16146043|NCT00467779|39021349|FG013|Stage 2A|Disease Progression|10|||
16146044|NCT00467779|39021350|FG014|Stage 2A|Disease Progression|0|||
16146045|NCT00467779|39021336|FG000|Stage 2A|Unspecified Reason|0|||
16146046|NCT00467779|39021337|FG001|Stage 2A|Unspecified Reason|0|||
16146047|NCT00467779|39021338|FG002|Stage 2A|Unspecified Reason|0|||
16146048|NCT00467779|39021339|FG003|Stage 2A|Unspecified Reason|0|||
16146049|NCT00467779|39021340|FG004|Stage 2A|Unspecified Reason|0|||
16146050|NCT00467779|39021341|FG005|Stage 2A|Unspecified Reason|0|||
16146051|NCT00467779|39021342|FG006|Stage 2A|Unspecified Reason|0|||
16146052|NCT00467779|39021343|FG007|Stage 2A|Unspecified Reason|0|||
16146053|NCT00467779|39021344|FG008|Stage 2A|Unspecified Reason|0|||
16146054|NCT00467779|39021345|FG009|Stage 2A|Unspecified Reason|0|||
16146055|NCT00467779|39021346|FG010|Stage 2A|Unspecified Reason|0|||
16146056|NCT00467779|39021347|FG011|Stage 2A|Unspecified Reason|0|||
16146057|NCT00467779|39021348|FG012|Stage 2A|Unspecified Reason|0|||
16146058|NCT00467779|39021349|FG013|Stage 2A|Unspecified Reason|7|||
16146059|NCT00467779|39021350|FG014|Stage 2A|Unspecified Reason|0|||
16146060|NCT00467779|39021336|FG000|Stage 2A|Withdrawal by Subject|0|||
16146061|NCT00467779|39021337|FG001|Stage 2A|Withdrawal by Subject|0|||
16146062|NCT00467779|39021338|FG002|Stage 2A|Withdrawal by Subject|0|||
16146063|NCT00467779|39021339|FG003|Stage 2A|Withdrawal by Subject|0|||
16146064|NCT00467779|39021340|FG004|Stage 2A|Withdrawal by Subject|0|||
16146065|NCT00467779|39021341|FG005|Stage 2A|Withdrawal by Subject|0|||
16146066|NCT00467779|39021342|FG006|Stage 2A|Withdrawal by Subject|0|||
16146067|NCT00467779|39021343|FG007|Stage 2A|Withdrawal by Subject|0|||
16146068|NCT00467779|39021344|FG008|Stage 2A|Withdrawal by Subject|0|||
16146069|NCT00467779|39021345|FG009|Stage 2A|Withdrawal by Subject|0|||
16146070|NCT00467779|39021346|FG010|Stage 2A|Withdrawal by Subject|0|||
16146071|NCT00467779|39021347|FG011|Stage 2A|Withdrawal by Subject|0|||
16146072|NCT00467779|39021348|FG012|Stage 2A|Withdrawal by Subject|0|||
16146073|NCT00467779|39021349|FG013|Stage 2A|Withdrawal by Subject|1|||
16146074|NCT00467779|39021350|FG014|Stage 2A|Withdrawal by Subject|0|||
16146075|NCT00467779|39021336|FG000|Stage 3|Adverse Event|0|||
16146076|NCT00467779|39021337|FG001|Stage 3|Adverse Event|0|||
16146077|NCT00467779|39021338|FG002|Stage 3|Adverse Event|0|||
16146078|NCT00467779|39021339|FG003|Stage 3|Adverse Event|0|||
16146079|NCT00467779|39021340|FG004|Stage 3|Adverse Event|0|||
16146080|NCT00467779|39021341|FG005|Stage 3|Adverse Event|0|||
16146081|NCT00467779|39021342|FG006|Stage 3|Adverse Event|0|||
16146082|NCT00467779|39021343|FG007|Stage 3|Adverse Event|0|||
16146083|NCT00467779|39021344|FG008|Stage 3|Adverse Event|0|||
16440216|NCT03096834|40092625|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
16440217|NCT03096834|40092622|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
16440218|NCT03096834|40092623|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
16440219|NCT03096834|40092624|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
16440220|NCT03096834|40092625|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
16440221|NCT03486912|40092626|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
16440222|NCT03486912|40092627|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
16440223|NCT03486912|40092628|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
16440224|NCT03486912|40092629|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
16440225|NCT03486912|40092626|FG000|Treatment Period|Withdrawal by Subject|3|||
16440226|NCT03486912|40092627|FG001|Treatment Period|Withdrawal by Subject|3|||
16440227|NCT03486912|40092628|FG002|Treatment Period|Withdrawal by Subject|3|||
16440228|NCT03486912|40092629|FG003|Treatment Period|Withdrawal by Subject|2|||
16440229|NCT03486912|40092626|FG000|Treatment Period|Other Reasons|0|||
16440230|NCT03486912|40092627|FG001|Treatment Period|Other Reasons|2|||
16440231|NCT03486912|40092628|FG002|Treatment Period|Other Reasons|1|||
16440232|NCT03486912|40092629|FG003|Treatment Period|Other Reasons|1|||
16440233|NCT03486912|40092626|FG000|Treatment Period|Adverse Event|0|||
16440234|NCT03486912|40092627|FG001|Treatment Period|Adverse Event|1|||
16440235|NCT03486912|40092628|FG002|Treatment Period|Adverse Event|1|||
16440236|NCT03486912|40092629|FG003|Treatment Period|Adverse Event|0|||
16440237|NCT03486912|40092626|FG000|Treatment Period|Lost to Follow-up|1|||
16440238|NCT03486912|40092627|FG001|Treatment Period|Lost to Follow-up|0|||
16146084|NCT00467779|39021345|FG009|Stage 3|Adverse Event|0|||
16146085|NCT00467779|39021346|FG010|Stage 3|Adverse Event|0|||
16146086|NCT00467779|39021347|FG011|Stage 3|Adverse Event|0|||
16146087|NCT00467779|39021348|FG012|Stage 3|Adverse Event|0|||
16146088|NCT00467779|39021349|FG013|Stage 3|Adverse Event|0|||
16146089|NCT00467779|39021350|FG014|Stage 3|Adverse Event|2|||
16146090|NCT00467779|39021336|FG000|Stage 3|Death|0|||
16146091|NCT00467779|39021337|FG001|Stage 3|Death|0|||
16146092|NCT00467779|39021338|FG002|Stage 3|Death|0|||
16146093|NCT00467779|39021339|FG003|Stage 3|Death|0|||
16146094|NCT00467779|39021340|FG004|Stage 3|Death|0|||
16440239|NCT03486912|40092628|FG002|Treatment Period|Lost to Follow-up|0|||
16440240|NCT03486912|40092629|FG003|Treatment Period|Lost to Follow-up|2|||
16440241|NCT00771758|40092636|FG000|Overall Study|Adverse Event|2|||
16146095|NCT00467779|39021341|FG005|Stage 3|Death|0|||
16146096|NCT00467779|39021342|FG006|Stage 3|Death|0|||
16440242|NCT00771758|40092637|FG001|Overall Study|Adverse Event|8|||
16440243|NCT00771758|40092638|FG002|Overall Study|Adverse Event|1|||
16440244|NCT00771758|40092636|FG000|Overall Study|Lack of Efficacy|0|||
16146097|NCT00467779|39021343|FG007|Stage 3|Death|0|||
16146098|NCT00467779|39021344|FG008|Stage 3|Death|0|||
16146099|NCT00467779|39021345|FG009|Stage 3|Death|0|||
16146100|NCT00467779|39021346|FG010|Stage 3|Death|0|||
16146101|NCT00467779|39021347|FG011|Stage 3|Death|0|||
16146102|NCT00467779|39021348|FG012|Stage 3|Death|0|||
16146103|NCT00467779|39021349|FG013|Stage 3|Death|0|||
16146104|NCT00467779|39021350|FG014|Stage 3|Death|1|||
16146105|NCT00467779|39021336|FG000|Stage 3|Disease Progression|0|||
16146106|NCT00467779|39021337|FG001|Stage 3|Disease Progression|0|||
16146107|NCT00467779|39021338|FG002|Stage 3|Disease Progression|0|||
16146108|NCT00467779|39021339|FG003|Stage 3|Disease Progression|0|||
16146109|NCT00467779|39021340|FG004|Stage 3|Disease Progression|0|||
16146110|NCT00467779|39021341|FG005|Stage 3|Disease Progression|0|||
16146111|NCT00467779|39021342|FG006|Stage 3|Disease Progression|0|||
16146112|NCT00467779|39021343|FG007|Stage 3|Disease Progression|0|||
16258490|NCT01449630|39430568|FG004|Period 2|Sponsor Decision|0|||
16258491|NCT01449630|39430569|FG005|Period 2|Sponsor Decision|0|||
16258492|NCT01449630|39430570|FG006|Period 2|Sponsor Decision|1|||
16258493|NCT01449630|39430571|FG007|Period 2|Sponsor Decision|0|||
16146113|NCT00467779|39021344|FG008|Stage 3|Disease Progression|0|||
16146114|NCT00467779|39021345|FG009|Stage 3|Disease Progression|0|||
16146115|NCT00467779|39021346|FG010|Stage 3|Disease Progression|0|||
16146116|NCT00467779|39021347|FG011|Stage 3|Disease Progression|0|||
16146117|NCT00467779|39021348|FG012|Stage 3|Disease Progression|0|||
16146118|NCT00467779|39021349|FG013|Stage 3|Disease Progression|0|||
16146119|NCT00467779|39021350|FG014|Stage 3|Disease Progression|9|||
16146120|NCT00467779|39021336|FG000|Stage 3|Unspecified Reason|0|||
16440245|NCT00771758|40092637|FG001|Overall Study|Lack of Efficacy|2|||
16440246|NCT00771758|40092638|FG002|Overall Study|Lack of Efficacy|1|||
16440247|NCT00771758|40092636|FG000|Overall Study|Lost to Follow-up|1|||
16440248|NCT00771758|40092637|FG001|Overall Study|Lost to Follow-up|0|||
16146121|NCT00467779|39021337|FG001|Stage 3|Unspecified Reason|0|||
16146122|NCT00467779|39021338|FG002|Stage 3|Unspecified Reason|0|||
16146123|NCT00467779|39021339|FG003|Stage 3|Unspecified Reason|0|||
16146124|NCT00467779|39021340|FG004|Stage 3|Unspecified Reason|0|||
16146125|NCT00467779|39021341|FG005|Stage 3|Unspecified Reason|0|||
16146126|NCT00467779|39021342|FG006|Stage 3|Unspecified Reason|0|||
16146127|NCT00467779|39021343|FG007|Stage 3|Unspecified Reason|0|||
16146128|NCT00467779|39021344|FG008|Stage 3|Unspecified Reason|0|||
16146129|NCT00467779|39021345|FG009|Stage 3|Unspecified Reason|0|||
16146130|NCT00467779|39021346|FG010|Stage 3|Unspecified Reason|0|||
16146131|NCT00467779|39021347|FG011|Stage 3|Unspecified Reason|0|||
16146132|NCT00467779|39021348|FG012|Stage 3|Unspecified Reason|0|||
16258494|NCT01449630|39430572|FG008|Period 2|Sponsor Decision|0|||
16440249|NCT00771758|40092638|FG002|Overall Study|Lost to Follow-up|0|||
16440250|NCT00771758|40092636|FG000|Overall Study|Protocol Violation|1|||
16440251|NCT00771758|40092637|FG001|Overall Study|Protocol Violation|0|||
16440252|NCT00771758|40092638|FG002|Overall Study|Protocol Violation|0|||
16440253|NCT00771758|40092636|FG000|Overall Study|Withdrawal by Subject|1|||
16440254|NCT00771758|40092637|FG001|Overall Study|Withdrawal by Subject|0|||
16440255|NCT00771758|40092638|FG002|Overall Study|Withdrawal by Subject|0|||
16440256|NCT00771758|40092636|FG000|Overall Study|Other|3|||
16440257|NCT00771758|40092637|FG001|Overall Study|Other|2|||
16440258|NCT00771758|40092638|FG002|Overall Study|Other|0|||
16440259|NCT00878501|40092639|FG000|Overall Study|Adverse Event|11|||
16258495|NCT03340727|39430577|FG000|Overall Study|Death|1|||
16258496|NCT03340727|39430578|FG001|Overall Study|Death|0|||
16258497|NCT03340727|39430577|FG000|Overall Study|Lost to Follow-up|31|||
16258498|NCT03340727|39430578|FG001|Overall Study|Lost to Follow-up|35|||
16440260|NCT00878501|40092640|FG001|Overall Study|Adverse Event|3|||
16440261|NCT00878501|40092641|FG002|Overall Study|Adverse Event|3|||
16440262|NCT00878501|40092639|FG000|Overall Study|Lack of Efficacy|2|||
16440263|NCT00878501|40092640|FG001|Overall Study|Lack of Efficacy|1|||
16440264|NCT00878501|40092641|FG002|Overall Study|Lack of Efficacy|0|||
16440265|NCT00878501|40092639|FG000|Overall Study|Withdrawal by Subject|2|||
16440266|NCT00878501|40092640|FG001|Overall Study|Withdrawal by Subject|1|||
16440267|NCT00878501|40092641|FG002|Overall Study|Withdrawal by Subject|2|||
16258499|NCT03340727|39430577|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
16258500|NCT03340727|39430578|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
16440268|NCT00878501|40092639|FG000|Overall Study|Protocol Violation|0|||
16258501|NCT03340727|39430577|FG000|Overall Study|Transferred to another facility|10|||
16440269|NCT00878501|40092640|FG001|Overall Study|Protocol Violation|0|||
16440270|NCT00878501|40092641|FG002|Overall Study|Protocol Violation|1|||
16440271|NCT00878501|40092639|FG000|Overall Study|Incorrect enrolment|1|||
16440272|NCT00878501|40092640|FG001|Overall Study|Incorrect enrolment|2|||
16258502|NCT03340727|39430578|FG001|Overall Study|Transferred to another facility|7|||
16258503|NCT03340727|39430577|FG000|Overall Study|Withdrawal by Subject|28|||
16258504|NCT03340727|39430578|FG001|Overall Study|Withdrawal by Subject|17|||
16258505|NCT00667862|39430582|FG000|Overall Study|Adverse Event|9|||
16258506|NCT00667862|39430582|FG000|Overall Study|Death|1|||
16258507|NCT00667862|39430582|FG000|Overall Study|Disease Progression|22|||
16258508|NCT00667862|39430582|FG000|Overall Study|Withdrawal by Subject|3|||
16258509|NCT01993030|39430583|FG000|Overall Study|Adverse Event|0|||
16258510|NCT01993030|39430584|FG001|Overall Study|Adverse Event|4|||
16258511|NCT00414765|39430585|FG000|Overall Study|Adverse Event|5|||
16258512|NCT00414765|39430586|FG001|Overall Study|Adverse Event|9|||
16258513|NCT00414765|39430585|FG000|Overall Study|Withdrawal by Subject|1|||
16258514|NCT00414765|39430586|FG001|Overall Study|Withdrawal by Subject|1|||
16258515|NCT00414765|39430585|FG000|Overall Study|Disease Progression|0|||
16258516|NCT00414765|39430586|FG001|Overall Study|Disease Progression|1|||
16258517|NCT02365207|39430587|FG000|Overall Study|Withdrawal by Subject|1|||
16258518|NCT02365207|39430587|FG000|Overall Study|Physician Decision|1|||
16258519|NCT03561883|39430588|FG000|Overall Study|Adverse Event|10|||
16258520|NCT03561883|39430589|FG001|Overall Study|Adverse Event|13|||
16258521|NCT03561883|39430588|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16258522|NCT03561883|39430589|FG001|Overall Study|Non-Compliance With Study Drug|2|||
16258523|NCT03561883|39430588|FG000|Overall Study|Protocol Violation|2|||
16258524|NCT03561883|39430589|FG001|Overall Study|Protocol Violation|3|||
16258525|NCT03561883|39430588|FG000|Overall Study|Withdrawal by Subject|14|||
16258526|NCT03561883|39430589|FG001|Overall Study|Withdrawal by Subject|6|||
16258527|NCT03561883|39430588|FG000|Overall Study|Lost to Follow-up|2|||
16258528|NCT03561883|39430589|FG001|Overall Study|Lost to Follow-up|6|||
16258529|NCT03561883|39430588|FG000|Overall Study|Study Terminated by Sponsor|12|||
16258530|NCT03561883|39430589|FG001|Overall Study|Study Terminated by Sponsor|11|||
16258531|NCT03561883|39430588|FG000|Overall Study|Physician Decision|1|||
16258532|NCT03561883|39430589|FG001|Overall Study|Physician Decision|0|||
16258533|NCT03561883|39430588|FG000|Overall Study|Randomized by Mistake|1|||
16258534|NCT03561883|39430589|FG001|Overall Study|Randomized by Mistake|0|||
16258535|NCT03561883|39430588|FG000|Overall Study|Other, Not Specified|3|||
16258536|NCT03561883|39430589|FG001|Overall Study|Other, Not Specified|2|||
16258537|NCT01066143|39430590|FG000|Overall Study|ineligible for the study|8|||
16258538|NCT03361228|39430591|FG000|Overall Study|Other|1|||
16258539|NCT03361228|39430592|FG001|Overall Study|Other|1|||
16258540|NCT03361228|39430591|FG000|Overall Study|Death|3|||
16258541|NCT03361228|39430592|FG001|Overall Study|Death|0|||
16258542|NCT02457520|39430593|FG000|Active Treatment Phase|Adverse Event|10|||
16258543|NCT02457520|39430593|FG000|Active Treatment Phase|Lost to Follow-up|8|||
16258544|NCT02457520|39430593|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
16258545|NCT02457520|39430593|FG000|Active Treatment Phase|other|4|||
16258546|NCT02457520|39430593|FG000|Active Treatment Phase|Physician Decision|1|||
16258547|NCT02457520|39430593|FG000|Active Treatment Phase|Protocol Violation|1|||
16258548|NCT02457520|39430593|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
16258549|NCT02457520|39430593|FG000|Post-treatment Period|Other: Retreatment Required|7|||
16258550|NCT02457520|39430593|FG000|Post-treatment Period|Lost to Follow-up|23|||
16258551|NCT02457520|39430593|FG000|Post-treatment Period|Other|3|||
16258552|NCT02457520|39430593|FG000|Post-treatment Period|Physician Decision|1|||
16258553|NCT02457520|39430593|FG000|Post-treatment Period|Withdrawal by Subject|14|||
16258554|NCT01044732|39430598|FG000|Overall Study|Lost to Follow-up|2|||
16258555|NCT01044732|39430599|FG001|Overall Study|Lost to Follow-up|1|||
16258556|NCT01044732|39430598|FG000|Overall Study|Physician Decision|5|||
16258557|NCT01044732|39430599|FG001|Overall Study|Physician Decision|3|||
16258558|NCT01044732|39430598|FG000|Overall Study|Protocol Violation|11|||
16258559|NCT01044732|39430599|FG001|Overall Study|Protocol Violation|12|||
16258560|NCT01044732|39430598|FG000|Overall Study|Withdrawal by Subject|0|||
16258561|NCT01044732|39430599|FG001|Overall Study|Withdrawal by Subject|1|||
16258562|NCT01044732|39430598|FG000|Overall Study|Inadequate bowel preparation|11|||
16258563|NCT01044732|39430599|FG001|Overall Study|Inadequate bowel preparation|17|||
16258564|NCT01044732|39430598|FG000|Overall Study|Inability to reach cecum|5|||
16258565|NCT01044732|39430599|FG001|Overall Study|Inability to reach cecum|2|||
16364536|NCT01706328|39821359|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
16364537|NCT01706328|39821360|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
16364538|NCT01706328|39821361|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
16364539|NCT01706328|39821359|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
16364540|NCT01706328|39821360|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
16364541|NCT01706328|39821361|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
16364542|NCT01706328|39821359|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
16364543|NCT01706328|39821360|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
16364544|NCT01706328|39821361|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
16364545|NCT01706328|39821359|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
16258566|NCT01044732|39430598|FG000|Overall Study|Technical error or malfunction|15|||
16258567|NCT01044732|39430599|FG001|Overall Study|Technical error or malfunction|14|||
16258568|NCT03657160|39430602|FG000|Overall Study|Adverse Event|5|||
16258569|NCT03657160|39430603|FG001|Overall Study|Adverse Event|6|||
16258570|NCT03657160|39430602|FG000|Overall Study|Protocol Deviation|3|||
16258571|NCT03657160|39430603|FG001|Overall Study|Protocol Deviation|0|||
16258572|NCT03657160|39430602|FG000|Overall Study|Withdrawal by Subject|18|||
16146133|NCT00467779|39021349|FG013|Stage 3|Unspecified Reason|0|||
16146134|NCT00467779|39021350|FG014|Stage 3|Unspecified Reason|5|||
16146135|NCT00003702|39021351|FG000|Overall Study|Ineligible cell types|2|||
16146136|NCT00003702|39021352|FG001|Overall Study|Ineligible cell types|2|||
16146137|NCT00003702|39021351|FG000|Overall Study|Did not meet criteria for persistence|8|||
16146138|NCT00003702|39021352|FG001|Overall Study|Did not meet criteria for persistence|5|||
16146139|NCT00003702|39021351|FG000|Overall Study|WHO score > 6|2|||
16146140|NCT00003702|39021352|FG001|Overall Study|WHO score > 6|1|||
16146141|NCT00003702|39021351|FG000|Overall Study|Inadequate documentation of disease|1|||
16146142|NCT00003702|39021352|FG001|Overall Study|Inadequate documentation of disease|3|||
16146143|NCT01131520|39021353|FG000|Overall Study|Computer problem|1|||
16146144|NCT01131520|39021354|FG001|Overall Study|Computer problem|0|||
16146145|NCT01131520|39021353|FG000|Overall Study|Counselor not available|0|||
16146146|NCT01131520|39021354|FG001|Overall Study|Counselor not available|3|||
16146147|NCT01131520|39021353|FG000|Overall Study|Subject changed history after enrollment|0|||
16146148|NCT01131520|39021354|FG001|Overall Study|Subject changed history after enrollment|1|||
16146149|NCT01509079|39021357|FG000|Overall Study|Lack of Efficacy|0|||
16146150|NCT01509079|39021358|FG001|Overall Study|Lack of Efficacy|2|||
16146151|NCT01509079|39021357|FG000|Overall Study|started an excluded medication|0|||
16258573|NCT03657160|39430603|FG001|Overall Study|Withdrawal by Subject|16|||
16258574|NCT03657160|39430602|FG000|Overall Study|Site Termination|1|||
16258575|NCT03657160|39430603|FG001|Overall Study|Site Termination|0|||
16146152|NCT01509079|39021358|FG001|Overall Study|started an excluded medication|1|||
16146153|NCT01846624|39021360|FG000|Overall Study|Died during induction, no midostaurin|1|||
16146154|NCT01015768|39021361|FG000|Overall Study|Some subject data unuseable|4|||
16146155|NCT01015768|39021362|FG001|Overall Study|Some subject data unuseable|4|||
16258576|NCT03657160|39430602|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
16258577|NCT03657160|39430603|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
16146156|NCT01147744|39021363|FG000|Overall Study|Protocol Violation|1|||
16258578|NCT03657160|39430602|FG000|Overall Study|Death|33|||
16258579|NCT03657160|39430603|FG001|Overall Study|Death|26|||
16258580|NCT03657160|39430602|FG000|Overall Study|Death (COVID-19-Related)|1|||
16258581|NCT03657160|39430603|FG001|Overall Study|Death (COVID-19-Related)|0|||
16258582|NCT03657160|39430602|FG000|Overall Study|Reason Not Specified|5|||
16146157|NCT01147744|39021364|FG001|Overall Study|Protocol Violation|0|||
16258583|NCT03657160|39430603|FG001|Overall Study|Reason Not Specified|5|||
16258584|NCT03657160|39430602|FG000|Overall Study|Other (COVID-19-Related)|0|||
16258585|NCT03657160|39430603|FG001|Overall Study|Other (COVID-19-Related)|1|||
16258586|NCT02796664|39430605|FG000|Overall Study|Withdrawal by Subject|0|||
16258587|NCT02796664|39430606|FG001|Overall Study|Withdrawal by Subject|3|||
16258588|NCT02796664|39430605|FG000|Overall Study|Noncompliance|1|||
16258589|NCT02796664|39430606|FG001|Overall Study|Noncompliance|1|||
16258590|NCT02796664|39430605|FG000|Overall Study|Death|0|||
16258591|NCT02796664|39430606|FG001|Overall Study|Death|1|||
16258592|NCT02848326|39430607|FG000|Treatment Period|Adverse Event|5|||
16364546|NCT01706328|39821360|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
16364547|NCT01706328|39821361|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
16364548|NCT01706328|39821359|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
16364549|NCT01706328|39821360|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
16364550|NCT01706328|39821361|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
16364551|NCT01910441|39821363|FG000|Overall Study|Sponsor decision|0|||
16364552|NCT01910441|39821364|FG001|Overall Study|Sponsor decision|2|||
16364553|NCT01910441|39821363|FG000|Overall Study|Lost to Follow-up|6|||
16364554|NCT01910441|39821364|FG001|Overall Study|Lost to Follow-up|5|||
16364555|NCT01910441|39821363|FG000|Overall Study|Withdrawal by Subject|0|||
16364556|NCT01910441|39821364|FG001|Overall Study|Withdrawal by Subject|1|||
16364557|NCT01910441|39821363|FG000|Overall Study|Non-compliance|0|||
16364558|NCT01910441|39821364|FG001|Overall Study|Non-compliance|1|||
16258593|NCT02848326|39430608|FG001|Treatment Period|Adverse Event|4|||
16364559|NCT01910441|39821363|FG000|Overall Study|Adverse Event|1|||
16258594|NCT02848326|39430609|FG002|Treatment Period|Adverse Event|11|||
16258595|NCT02848326|39430610|FG003|Treatment Period|Adverse Event|6|||
16146158|NCT01147744|39021365|FG002|Overall Study|Protocol Violation|1|||
16258596|NCT02848326|39430611|FG004|Treatment Period|Adverse Event|5|||
16258597|NCT02848326|39430612|FG005|Treatment Period|Adverse Event|7|||
16258598|NCT02848326|39430607|FG000|Treatment Period|Withdrawal of Consent|20|||
16258599|NCT02848326|39430608|FG001|Treatment Period|Withdrawal of Consent|6|||
16258600|NCT02848326|39430609|FG002|Treatment Period|Withdrawal of Consent|9|||
16258601|NCT02848326|39430610|FG003|Treatment Period|Withdrawal of Consent|6|||
16258602|NCT02848326|39430611|FG004|Treatment Period|Withdrawal of Consent|9|||
16258603|NCT02848326|39430612|FG005|Treatment Period|Withdrawal of Consent|6|||
16258604|NCT02848326|39430607|FG000|Treatment Period|Lost to Follow-up|5|||
16258605|NCT02848326|39430608|FG001|Treatment Period|Lost to Follow-up|1|||
16258606|NCT02848326|39430609|FG002|Treatment Period|Lost to Follow-up|11|||
16258607|NCT02848326|39430610|FG003|Treatment Period|Lost to Follow-up|7|||
16258608|NCT02848326|39430611|FG004|Treatment Period|Lost to Follow-up|2|||
16258609|NCT02848326|39430612|FG005|Treatment Period|Lost to Follow-up|3|||
16258610|NCT02848326|39430607|FG000|Treatment Period|Pregnancy|0|||
16258611|NCT02848326|39430608|FG001|Treatment Period|Pregnancy|0|||
16258612|NCT02848326|39430609|FG002|Treatment Period|Pregnancy|1|||
16258613|NCT02848326|39430610|FG003|Treatment Period|Pregnancy|1|||
16258614|NCT02848326|39430611|FG004|Treatment Period|Pregnancy|0|||
16258615|NCT02848326|39430612|FG005|Treatment Period|Pregnancy|1|||
16258616|NCT02848326|39430607|FG000|Treatment Period|Protocol Violation|4|||
16258617|NCT02848326|39430608|FG001|Treatment Period|Protocol Violation|3|||
16258618|NCT02848326|39430609|FG002|Treatment Period|Protocol Violation|4|||
16258619|NCT02848326|39430610|FG003|Treatment Period|Protocol Violation|2|||
16258620|NCT02848326|39430611|FG004|Treatment Period|Protocol Violation|3|||
16258621|NCT02848326|39430612|FG005|Treatment Period|Protocol Violation|3|||
16258622|NCT02848326|39430607|FG000|Treatment Period|Non-compliance with Study Drug|4|||
16258623|NCT02848326|39430608|FG001|Treatment Period|Non-compliance with Study Drug|0|||
16258624|NCT02848326|39430609|FG002|Treatment Period|Non-compliance with Study Drug|0|||
16146159|NCT01147744|39021366|FG003|Overall Study|Protocol Violation|0|||
16258625|NCT02848326|39430610|FG003|Treatment Period|Non-compliance with Study Drug|1|||
16258626|NCT02848326|39430611|FG004|Treatment Period|Non-compliance with Study Drug|0|||
16258627|NCT02848326|39430612|FG005|Treatment Period|Non-compliance with Study Drug|0|||
16364560|NCT01910441|39821364|FG001|Overall Study|Adverse Event|0|||
16364561|NCT01910441|39821363|FG000|Overall Study|Physician Decision|0|||
16364562|NCT01910441|39821364|FG001|Overall Study|Physician Decision|1|||
16364563|NCT03550209|39821366|FG000|Overall Study|Lost to Follow-up|1|||
16258628|NCT02848326|39430607|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
16258629|NCT02848326|39430608|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
16258630|NCT02848326|39430609|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
16258631|NCT02848326|39430610|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
16258632|NCT02848326|39430611|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
16258633|NCT02848326|39430612|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
16258634|NCT02848326|39430607|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
16258635|NCT02848326|39430608|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
16258636|NCT02848326|39430609|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
16258637|NCT02848326|39430610|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
16258638|NCT02848326|39430611|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
16258639|NCT02848326|39430612|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
16258640|NCT00620022|39430615|FG000|Treatment Period 1|Adverse Event|4|||
16258641|NCT00620022|39430616|FG001|Treatment Period 1|Adverse Event|6|||
16258642|NCT00620022|39430615|FG000|Treatment Period 1|Subject withdrew consent|1|||
16258643|NCT00620022|39430616|FG001|Treatment Period 1|Subject withdrew consent|0|||
16258644|NCT00620022|39430615|FG000|Treatment Period 2|Adverse Event|2|||
16258645|NCT00620022|39430616|FG001|Treatment Period 2|Adverse Event|2|||
16258646|NCT03883906|39430617|FG000|Overall Study|Withdrawal by Subject|2|||
16258647|NCT03883906|39430617|FG000|Overall Study|Physician Decision|5|||
16258648|NCT02682238|39430618|FG000|Overall Study|Lost to Follow-up|0|||
16258649|NCT02682238|39430619|FG001|Overall Study|Lost to Follow-up|2|||
16258650|NCT02682238|39430618|FG000|Overall Study|Withdrawal by Subject|1|||
16258651|NCT02682238|39430619|FG001|Overall Study|Withdrawal by Subject|0|||
16258652|NCT02682238|39430618|FG000|Overall Study|Adverse Event|1|||
16258653|NCT02682238|39430619|FG001|Overall Study|Adverse Event|0|||
16258654|NCT02682238|39430618|FG000|Overall Study|Non-compliance with Study Drug|1|||
16258655|NCT02682238|39430619|FG001|Overall Study|Non-compliance with Study Drug|0|||
16258656|NCT02682238|39430618|FG000|Overall Study|Non-compliance with Protocol|0|||
16258657|NCT02682238|39430619|FG001|Overall Study|Non-compliance with Protocol|2|||
16258658|NCT03747939|39430620|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
16258659|NCT03747939|39430621|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
16258660|NCT03747939|39430622|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
16258661|NCT03747939|39430623|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
16258662|NCT03747939|39430620|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
16258663|NCT03747939|39430621|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
16258664|NCT03747939|39430622|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
16258665|NCT03747939|39430623|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
16258666|NCT03747939|39430620|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
16258667|NCT03747939|39430621|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
16258668|NCT03747939|39430622|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
16258669|NCT03747939|39430623|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
16258670|NCT03747939|39430620|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
16258671|NCT03747939|39430621|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
16258672|NCT03747939|39430622|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
16258673|NCT03747939|39430623|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
16258674|NCT03747939|39430620|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
16258675|NCT03747939|39430621|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
16258676|NCT03747939|39430622|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
16364564|NCT03550209|39821367|FG001|Overall Study|Lost to Follow-up|0|||
16258677|NCT03747939|39430623|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
16258678|NCT03747939|39430620|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
16258679|NCT03747939|39430621|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
16364565|NCT03550209|39821368|FG002|Overall Study|Lost to Follow-up|1|||
16258680|NCT03747939|39430622|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
16258681|NCT03747939|39430623|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
16258682|NCT03747939|39430620|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
16258683|NCT03747939|39430621|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
16258684|NCT03747939|39430622|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
16258685|NCT03747939|39430623|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
16258686|NCT03747939|39430620|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
16258687|NCT03747939|39430621|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
16258688|NCT03747939|39430622|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
16258689|NCT03747939|39430623|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
16258690|NCT03747939|39430620|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
16258691|NCT03747939|39430621|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
16258692|NCT03747939|39430622|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
16258693|NCT03747939|39430623|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
16258694|NCT03747939|39430620|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
16258695|NCT03747939|39430621|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
16258696|NCT03747939|39430622|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
16258697|NCT03747939|39430623|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
16258698|NCT03747939|39430620|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
16258699|NCT03747939|39430621|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
16258700|NCT03747939|39430622|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
16258701|NCT03747939|39430623|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
16258702|NCT03747939|39430620|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
16258703|NCT03747939|39430621|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
16258704|NCT03747939|39430622|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
16258705|NCT03747939|39430623|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
16258706|NCT03747939|39430620|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
16258707|NCT03747939|39430621|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
16258708|NCT03747939|39430622|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
16258709|NCT03747939|39430623|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
16258710|NCT03747939|39430620|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
16258711|NCT03747939|39430621|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
16258712|NCT03747939|39430622|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
16258713|NCT03747939|39430623|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
16258714|NCT00533273|39430636|FG000|Double-blind|Withdrew consent|0|||
16258715|NCT00533273|39430637|FG001|Double-blind|Withdrew consent|2|||
16440273|NCT00878501|40092641|FG002|Overall Study|Incorrect enrolment|0|||
16440274|NCT00878501|40092639|FG000|Overall Study|Intake of prohibited concom. medication|0|||
16440275|NCT00878501|40092640|FG001|Overall Study|Intake of prohibited concom. medication|0|||
16440276|NCT00878501|40092641|FG002|Overall Study|Intake of prohibited concom. medication|1|||
16440277|NCT00878501|40092639|FG000|Overall Study|Mis-randomisation of patient|1|||
16440278|NCT00878501|40092640|FG001|Overall Study|Mis-randomisation of patient|0|||
16440279|NCT00878501|40092641|FG002|Overall Study|Mis-randomisation of patient|0|||
16440280|NCT00878501|40092639|FG000|Overall Study|Administrative|0|||
16440281|NCT00878501|40092640|FG001|Overall Study|Administrative|0|||
16440282|NCT00878501|40092641|FG002|Overall Study|Administrative|1|||
16440283|NCT02432703|40092647|FG000|Overall Study|Adverse Event|1|||
16440284|NCT02432703|40092648|FG001|Overall Study|Adverse Event|4|||
16440285|NCT02432703|40092647|FG000|Overall Study|Lack of Efficacy|1|||
16440286|NCT02432703|40092648|FG001|Overall Study|Lack of Efficacy|0|||
16440287|NCT02432703|40092647|FG000|Overall Study|Lost to Follow-up|5|||
16440288|NCT02432703|40092648|FG001|Overall Study|Lost to Follow-up|3|||
16440289|NCT02432703|40092647|FG000|Overall Study|Withdrawal by Subject|9|||
16440290|NCT02432703|40092648|FG001|Overall Study|Withdrawal by Subject|6|||
16440291|NCT02432703|40092647|FG000|Overall Study|Other|6|||
16440292|NCT02432703|40092648|FG001|Overall Study|Other|5|||
16440293|NCT00784563|40092651|FG000|Years 1 & 2|Withdrawal by Subject|3|||
16258716|NCT00533273|39430636|FG000|Open-label|Withdrawal by Subject|6|||
16258717|NCT00533273|39430637|FG001|Open-label|Withdrawal by Subject|0|||
16258718|NCT01059903|39430639|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
16258719|NCT01059903|39430640|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
16258720|NCT01697696|39430643|FG000|Overall Study|Study terminated by sponsor|0|||
16258721|NCT01697696|39430644|FG001|Overall Study|Study terminated by sponsor|3|||
16258722|NCT01697696|39430643|FG000|Overall Study|Protocol deviation|1|||
16258723|NCT01697696|39430644|FG001|Overall Study|Protocol deviation|0|||
16258724|NCT01697696|39430643|FG000|Overall Study|Physician Decision|1|||
16440294|NCT00784563|40092652|FG001|Years 1 & 2|Withdrawal by Subject|2|||
16440295|NCT00784563|40092653|FG002|Years 1 & 2|Withdrawal by Subject|0|||
16440296|NCT00784563|40092651|FG000|Years 1 & 2|Adverse Event|0|||
16440297|NCT00784563|40092652|FG001|Years 1 & 2|Adverse Event|3|||
16440298|NCT00784563|40092653|FG002|Years 1 & 2|Adverse Event|0|||
16440299|NCT00784563|40092651|FG000|Year 3|Withdrawal by Subject|0|||
16146160|NCT01147744|39021367|FG004|Overall Study|Protocol Violation|1|||
16146161|NCT01147744|39021368|FG005|Overall Study|Protocol Violation|3|||
16146162|NCT01147744|39021369|FG006|Overall Study|Protocol Violation|1|||
16146163|NCT01147744|39021363|FG000|Overall Study|Physician Decision|0|||
16146164|NCT01147744|39021364|FG001|Overall Study|Physician Decision|1|||
16146165|NCT01147744|39021365|FG002|Overall Study|Physician Decision|1|||
16146166|NCT01147744|39021366|FG003|Overall Study|Physician Decision|0|||
16146167|NCT01147744|39021367|FG004|Overall Study|Physician Decision|0|||
16146168|NCT01147744|39021368|FG005|Overall Study|Physician Decision|0|||
16146169|NCT01147744|39021369|FG006|Overall Study|Physician Decision|1|||
16146170|NCT01147744|39021363|FG000|Overall Study|Lack of Efficacy|11|||
16146171|NCT01147744|39021364|FG001|Overall Study|Lack of Efficacy|11|||
16146172|NCT01147744|39021365|FG002|Overall Study|Lack of Efficacy|9|||
16146173|NCT01147744|39021366|FG003|Overall Study|Lack of Efficacy|11|||
16146174|NCT01147744|39021367|FG004|Overall Study|Lack of Efficacy|13|||
16146175|NCT01147744|39021368|FG005|Overall Study|Lack of Efficacy|8|||
16146176|NCT01147744|39021369|FG006|Overall Study|Lack of Efficacy|7|||
16146177|NCT01147744|39021363|FG000|Overall Study|Adverse Event|1|||
16258725|NCT01697696|39430644|FG001|Overall Study|Physician Decision|0|||
16258726|NCT01697696|39430643|FG000|Overall Study|Death|4|||
16258727|NCT01697696|39430644|FG001|Overall Study|Death|2|||
16258728|NCT01697696|39430643|FG000|Overall Study|Lost to Follow-up|10|||
16258729|NCT01697696|39430644|FG001|Overall Study|Lost to Follow-up|7|||
16440300|NCT00784563|40092652|FG001|Year 3|Withdrawal by Subject|0|||
16440301|NCT00784563|40092653|FG002|Year 3|Withdrawal by Subject|2|||
16440302|NCT00784563|40092651|FG000|Year 3|Adverse Event|0|||
16440303|NCT00784563|40092652|FG001|Year 3|Adverse Event|0|||
16440304|NCT00784563|40092653|FG002|Year 3|Adverse Event|1|||
16440305|NCT02230410|40092654|FG000|Overall Study|Screen Failure|3|||
16440306|NCT02016781|40092655|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
16440307|NCT02016781|40092656|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
16440308|NCT02016781|40092655|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
16440309|NCT02016781|40092656|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
16440310|NCT02016781|40092655|FG000|Final Database Lock|Withdrawal by Subject|2|||
16440311|NCT02016781|40092656|FG001|Final Database Lock|Withdrawal by Subject|1|||
16440312|NCT02016781|40092655|FG000|Final Database Lock|Lost to Follow-up|11|||
16440313|NCT02016781|40092656|FG001|Final Database Lock|Lost to Follow-up|4|||
16440314|NCT02016781|40092655|FG000|Final Database Lock|Missing data|0|||
16440315|NCT02016781|40092656|FG001|Final Database Lock|Missing data|3|||
16440316|NCT00904969|40092659|FG000|Overall Study|Lost to Follow-up|4|||
16440317|NCT00904969|40092659|FG000|Overall Study|Withdrawal by Subject|3|||
16440318|NCT00904969|40092659|FG000|Overall Study|Additional Treatments|11|||
16440319|NCT00904969|40092659|FG000|Overall Study|Case Aborted; Subject Exited|1|||
16440320|NCT01478971|40092660|FG000|Standard of Care Period|Adverse Event|1|||
16440321|NCT01478971|40092660|FG000|Standard of Care Period|Withdrawal by Subject|3|||
16440322|NCT01478971|40092660|FG000|Standard of Care Period|Death|8|||
16440323|NCT01478971|40092660|FG000|Standard of Care Period|Lost to Follow-up|9|||
16440324|NCT01478971|40092660|FG000|Standard of Care Period|Other|4|||
16440325|NCT01478971|40092660|FG000|Peginesatide Treatment Period|Adverse Event|1|||
16440326|NCT01478971|40092660|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
16440327|NCT01478971|40092660|FG000|Peginesatide Treatment Period|Death|4|||
16440328|NCT01478971|40092660|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
16440329|NCT01478971|40092660|FG000|Peginesatide Treatment Period|Other|4|||
16440330|NCT00537394|40092662|FG000|First Year of Follow-up|Death|7|||
16440331|NCT00537394|40092663|FG001|First Year of Follow-up|Death|0|||
16440332|NCT00537394|40092664|FG002|First Year of Follow-up|Death|0|||
16440333|NCT00537394|40092662|FG000|First Year of Follow-up|Severe debilitation|1|||
16440334|NCT00537394|40092663|FG001|First Year of Follow-up|Severe debilitation|0|||
16440335|NCT00537394|40092664|FG002|First Year of Follow-up|Severe debilitation|1|||
16440336|NCT00537394|40092662|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
16440337|NCT00537394|40092663|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
16440338|NCT00537394|40092664|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
16440339|NCT00537394|40092662|FG000|First Year of Follow-up|Lost to Follow-up|1|||
16440340|NCT00537394|40092663|FG001|First Year of Follow-up|Lost to Follow-up|5|||
16440341|NCT00537394|40092664|FG002|First Year of Follow-up|Lost to Follow-up|1|||
16440342|NCT00537394|40092662|FG000|2nd Year of Follow-up|Death|4|||
16440343|NCT00537394|40092663|FG001|2nd Year of Follow-up|Death|1|||
16440344|NCT00537394|40092664|FG002|2nd Year of Follow-up|Death|2|||
16440345|NCT00537394|40092662|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
16440346|NCT00537394|40092663|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
16146178|NCT01147744|39021364|FG001|Overall Study|Adverse Event|2|||
16146179|NCT01147744|39021365|FG002|Overall Study|Adverse Event|3|||
16146180|NCT01147744|39021366|FG003|Overall Study|Adverse Event|0|||
16146181|NCT01147744|39021367|FG004|Overall Study|Adverse Event|2|||
16146182|NCT01147744|39021368|FG005|Overall Study|Adverse Event|1|||
16146183|NCT01147744|39021369|FG006|Overall Study|Adverse Event|2|||
16258730|NCT01697696|39430643|FG000|Overall Study|Subject/guardian decision|31|||
16146184|NCT01147744|39021363|FG000|Overall Study|Withdrawal by Subject|8|||
16146185|NCT01147744|39021364|FG001|Overall Study|Withdrawal by Subject|4|||
16146186|NCT01147744|39021365|FG002|Overall Study|Withdrawal by Subject|2|||
16146187|NCT01147744|39021366|FG003|Overall Study|Withdrawal by Subject|2|||
16146188|NCT01147744|39021367|FG004|Overall Study|Withdrawal by Subject|2|||
16146189|NCT01147744|39021368|FG005|Overall Study|Withdrawal by Subject|5|||
16440347|NCT00537394|40092664|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
16440348|NCT00537394|40092662|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
16440349|NCT00537394|40092663|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
16146190|NCT01147744|39021369|FG006|Overall Study|Withdrawal by Subject|2|||
16146191|NCT01147744|39021363|FG000|Overall Study|Lost to Follow-up|0|||
16146192|NCT01147744|39021364|FG001|Overall Study|Lost to Follow-up|1|||
16146193|NCT01147744|39021365|FG002|Overall Study|Lost to Follow-up|0|||
16146194|NCT01147744|39021366|FG003|Overall Study|Lost to Follow-up|0|||
16146195|NCT01147744|39021367|FG004|Overall Study|Lost to Follow-up|0|||
16146196|NCT01147744|39021368|FG005|Overall Study|Lost to Follow-up|0|||
16146197|NCT01147744|39021369|FG006|Overall Study|Lost to Follow-up|0|||
16146198|NCT01147744|39021363|FG000|Overall Study|Sponsor decision to amend protocol|7|||
16146199|NCT01147744|39021364|FG001|Overall Study|Sponsor decision to amend protocol|4|||
16440350|NCT00537394|40092664|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
16146200|NCT01147744|39021365|FG002|Overall Study|Sponsor decision to amend protocol|2|||
16146201|NCT01147744|39021366|FG003|Overall Study|Sponsor decision to amend protocol|5|||
16146202|NCT01147744|39021367|FG004|Overall Study|Sponsor decision to amend protocol|7|||
16146203|NCT01147744|39021368|FG005|Overall Study|Sponsor decision to amend protocol|2|||
16146204|NCT01147744|39021369|FG006|Overall Study|Sponsor decision to amend protocol|6|||
16146205|NCT01147744|39021363|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16146206|NCT01147744|39021364|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16146207|NCT01147744|39021365|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16146208|NCT01147744|39021366|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16146209|NCT01147744|39021367|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16440351|NCT00537394|40092662|FG000|2nd Year of Follow-up|Clinic site closure|1|||
16440352|NCT00537394|40092663|FG001|2nd Year of Follow-up|Clinic site closure|0|||
16440353|NCT00537394|40092664|FG002|2nd Year of Follow-up|Clinic site closure|0|||
16440354|NCT03095651|40092665|FG000|Overall Study|Lost to Follow-up|1|||
16440355|NCT03095651|40092666|FG001|Overall Study|Lost to Follow-up|1|||
16440356|NCT03095651|40092667|FG002|Overall Study|Lost to Follow-up|0|||
16440357|NCT03095651|40092668|FG003|Overall Study|Lost to Follow-up|1|||
16440358|NCT03095651|40092669|FG004|Overall Study|Lost to Follow-up|0|||
16440359|NCT03095651|40092670|FG005|Overall Study|Lost to Follow-up|0|||
16440360|NCT03095651|40092671|FG006|Overall Study|Lost to Follow-up|0|||
16440361|NCT03095651|40092672|FG007|Overall Study|Lost to Follow-up|0|||
16440362|NCT03095651|40092665|FG000|Overall Study|Withdrawal by Subject|0|||
16440363|NCT03095651|40092666|FG001|Overall Study|Withdrawal by Subject|0|||
16440364|NCT03095651|40092667|FG002|Overall Study|Withdrawal by Subject|0|||
16440365|NCT03095651|40092668|FG003|Overall Study|Withdrawal by Subject|0|||
16440366|NCT03095651|40092669|FG004|Overall Study|Withdrawal by Subject|0|||
16440367|NCT03095651|40092670|FG005|Overall Study|Withdrawal by Subject|1|||
16440368|NCT03095651|40092671|FG006|Overall Study|Withdrawal by Subject|0|||
16440369|NCT03095651|40092672|FG007|Overall Study|Withdrawal by Subject|0|||
16440370|NCT00882440|40092674|FG000|Overall Study|Adverse Event|2|||
16440371|NCT00882440|40092675|FG001|Overall Study|Adverse Event|2|||
16146210|NCT01147744|39021368|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16146211|NCT01147744|39021369|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16146212|NCT02428855|39021370|FG000|Overall Study|Withdrawal by Subject|2|||
16440372|NCT00882440|40092676|FG002|Overall Study|Adverse Event|2|||
16440373|NCT00882440|40092677|FG003|Overall Study|Adverse Event|1|||
16440374|NCT00882440|40092678|FG004|Overall Study|Adverse Event|1|||
16440375|NCT00882440|40092679|FG005|Overall Study|Adverse Event|4|||
16440376|NCT00882440|40092680|FG006|Overall Study|Adverse Event|2|||
16440377|NCT00882440|40092674|FG000|Overall Study|Lack of Efficacy|3|||
16440378|NCT00882440|40092675|FG001|Overall Study|Lack of Efficacy|5|||
16440379|NCT00882440|40092676|FG002|Overall Study|Lack of Efficacy|2|||
16440380|NCT00882440|40092677|FG003|Overall Study|Lack of Efficacy|0|||
16440381|NCT00882440|40092678|FG004|Overall Study|Lack of Efficacy|0|||
16440382|NCT00882440|40092679|FG005|Overall Study|Lack of Efficacy|3|||
16440383|NCT00882440|40092680|FG006|Overall Study|Lack of Efficacy|0|||
16440384|NCT00882440|40092674|FG000|Overall Study|Lost to Follow-up|2|||
16440385|NCT00882440|40092675|FG001|Overall Study|Lost to Follow-up|0|||
16440386|NCT00882440|40092676|FG002|Overall Study|Lost to Follow-up|1|||
16440387|NCT00882440|40092677|FG003|Overall Study|Lost to Follow-up|1|||
16440388|NCT00882440|40092678|FG004|Overall Study|Lost to Follow-up|1|||
16440389|NCT00882440|40092679|FG005|Overall Study|Lost to Follow-up|0|||
16440390|NCT00882440|40092680|FG006|Overall Study|Lost to Follow-up|1|||
16440391|NCT00882440|40092674|FG000|Overall Study|Protocol Violation|0|||
16440392|NCT00882440|40092675|FG001|Overall Study|Protocol Violation|0|||
16440393|NCT00882440|40092676|FG002|Overall Study|Protocol Violation|1|||
16440394|NCT00882440|40092677|FG003|Overall Study|Protocol Violation|1|||
16440395|NCT00882440|40092678|FG004|Overall Study|Protocol Violation|1|||
16440396|NCT00882440|40092679|FG005|Overall Study|Protocol Violation|0|||
16440397|NCT00882440|40092680|FG006|Overall Study|Protocol Violation|0|||
16440398|NCT00882440|40092674|FG000|Overall Study|Withdrawal by Subject|2|||
16440399|NCT00882440|40092675|FG001|Overall Study|Withdrawal by Subject|1|||
16440400|NCT00882440|40092676|FG002|Overall Study|Withdrawal by Subject|1|||
16440401|NCT00882440|40092677|FG003|Overall Study|Withdrawal by Subject|0|||
16440402|NCT00882440|40092678|FG004|Overall Study|Withdrawal by Subject|6|||
16440403|NCT00882440|40092679|FG005|Overall Study|Withdrawal by Subject|0|||
16440404|NCT00882440|40092680|FG006|Overall Study|Withdrawal by Subject|1|||
16440405|NCT00882440|40092674|FG000|Overall Study|Patient Uncooperative|2|||
16440406|NCT00882440|40092675|FG001|Overall Study|Patient Uncooperative|0|||
16440407|NCT00882440|40092676|FG002|Overall Study|Patient Uncooperative|0|||
16440408|NCT00882440|40092677|FG003|Overall Study|Patient Uncooperative|0|||
16440409|NCT00882440|40092678|FG004|Overall Study|Patient Uncooperative|1|||
16440410|NCT00882440|40092679|FG005|Overall Study|Patient Uncooperative|0|||
16440411|NCT00882440|40092680|FG006|Overall Study|Patient Uncooperative|0|||
16440412|NCT01527149|40092682|FG000|Overall Study|Death|2|||
16440413|NCT03737123|40092685|FG000|Study Treatment|Adverse Event|2|||
16258731|NCT01697696|39430644|FG001|Overall Study|Subject/guardian decision|35|||
16258732|NCT00376623|39430645|FG000|Overall Study|Progressive disease|35|||
16258733|NCT00376623|39430646|FG001|Overall Study|Progressive disease|22|||
16258734|NCT00376623|39430647|FG002|Overall Study|Progressive disease|17|||
16258735|NCT00376623|39430645|FG000|Overall Study|Lost to Follow-up|0|||
16258736|NCT00376623|39430646|FG001|Overall Study|Lost to Follow-up|1|||
16258737|NCT00376623|39430647|FG002|Overall Study|Lost to Follow-up|0|||
16258738|NCT00376623|39430645|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
16258739|NCT00376623|39430646|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
16258740|NCT00376623|39430647|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
16258741|NCT00376623|39430645|FG000|Overall Study|Not treated with BI 2536|1|||
16258742|NCT00376623|39430646|FG001|Overall Study|Not treated with BI 2536|0|||
16258743|NCT00376623|39430647|FG002|Overall Study|Not treated with BI 2536|0|||
16258744|NCT00376623|39430645|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
16258745|NCT00376623|39430646|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
16258746|NCT00376623|39430647|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
16258747|NCT00376623|39430645|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
16258748|NCT00376623|39430646|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
16258749|NCT00376623|39430647|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
16258750|NCT00376623|39430645|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
16258751|NCT00376623|39430646|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
16258752|NCT00376623|39430647|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
16258753|NCT00376623|39430645|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
16258754|NCT00376623|39430646|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
16258755|NCT00376623|39430647|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
16258756|NCT00376623|39430645|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
16258757|NCT00376623|39430646|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
16258758|NCT00376623|39430647|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
16258759|NCT00376623|39430645|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
16258760|NCT00376623|39430646|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
16258761|NCT00376623|39430647|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
16258762|NCT00376623|39430645|FG000|Overall Study|Increase of tumour markers|0|||
16258763|NCT00376623|39430646|FG001|Overall Study|Increase of tumour markers|1|||
16258764|NCT00376623|39430647|FG002|Overall Study|Increase of tumour markers|0|||
16258765|NCT00376623|39430645|FG000|Overall Study|Bone metastasis|1|||
16258766|NCT00376623|39430646|FG001|Overall Study|Bone metastasis|0|||
16258767|NCT00376623|39430647|FG002|Overall Study|Bone metastasis|0|||
16258768|NCT04060147|39433549|FG000|Overall Study|Withdrew consent|1|||
16258769|NCT02674477|39433550|FG000|Overall Study|Protocol Violation|8|||
16258770|NCT02674477|39433551|FG001|Overall Study|Protocol Violation|2|||
16258771|NCT02920996|39433552|FG000|Overall Study|Adverse Event|8|||
16258772|NCT02920996|39433553|FG001|Overall Study|Adverse Event|0|||
16258773|NCT02920996|39433552|FG000|Overall Study|Physician Decision|1|||
16258774|NCT02920996|39433553|FG001|Overall Study|Physician Decision|0|||
16258775|NCT02920996|39433552|FG000|Overall Study|Death|1|||
16258776|NCT02920996|39433553|FG001|Overall Study|Death|0|||
16258777|NCT02920996|39433552|FG000|Overall Study|Missing|1|||
16258778|NCT02920996|39433553|FG001|Overall Study|Missing|0|||
16258779|NCT02920996|39433552|FG000|Overall Study|Subject Non-Compliance|1|||
16258780|NCT02920996|39433553|FG001|Overall Study|Subject Non-Compliance|0|||
16258781|NCT01402908|39433560|FG000|Overall Study|Withdrawal by Subject|30|||
16258782|NCT01402908|39433561|FG001|Overall Study|Withdrawal by Subject|17|||
16258783|NCT01402908|39433560|FG000|Overall Study|Lost to Follow-up|3|||
16258784|NCT01402908|39433561|FG001|Overall Study|Lost to Follow-up|1|||
16258785|NCT01402908|39433560|FG000|Overall Study|Physician Decision|1|||
16258786|NCT01402908|39433561|FG001|Overall Study|Physician Decision|0|||
16440414|NCT03737123|40092686|FG001|Study Treatment|Adverse Event|0|||
16146213|NCT01543828|39021377|FG000|Treatment 2|Lost to Follow-up|1|||
16440415|NCT03737123|40092685|FG000|Study Treatment|Disease Progression|2|||
16440416|NCT03737123|40092686|FG001|Study Treatment|Disease Progression|0|||
16440417|NCT03737123|40092685|FG000|Study Treatment|Withdrawal by Subject|2|||
16440418|NCT03737123|40092686|FG001|Study Treatment|Withdrawal by Subject|0|||
16440419|NCT03737123|40092685|FG000|Follow up|Death|1|||
16440420|NCT03737123|40092686|FG001|Follow up|Death|0|||
16440421|NCT03737123|40092685|FG000|Follow up|Withdrawal by Subject|1|||
16440422|NCT03737123|40092686|FG001|Follow up|Withdrawal by Subject|0|||
16440423|NCT03737123|40092685|FG000|Follow up|Termination of study|4|||
16440424|NCT03737123|40092686|FG001|Follow up|Termination of study|0|||
16440425|NCT00129402|40092687|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
16440426|NCT00129402|40092688|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
16440427|NCT00129402|40092689|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
16440428|NCT00129402|40092690|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
16440429|NCT00129402|40092691|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
16440430|NCT00129402|40092692|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
16440431|NCT00129402|40092693|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
16440432|NCT00129402|40092687|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
16440433|NCT00129402|40092688|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
16440434|NCT00129402|40092689|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
16146214|NCT01543828|39021378|FG001|Treatment 2|Lost to Follow-up|0|||
16146215|NCT00916149|39021379|FG000|Overall Study|Lost to Follow-up|3|||
16146216|NCT00916149|39021380|FG001|Overall Study|Lost to Follow-up|2|||
16146217|NCT00916149|39021381|FG002|Overall Study|Lost to Follow-up|0|||
16146218|NCT00916149|39021379|FG000|Overall Study|Unable to place scalp EEG leads|1|||
16146219|NCT00916149|39021380|FG001|Overall Study|Unable to place scalp EEG leads|0|||
16146220|NCT00916149|39021381|FG002|Overall Study|Unable to place scalp EEG leads|0|||
16146221|NCT00474708|39024289|FG000|Overall Study|Lack of Efficacy|11|||
16146222|NCT00474708|39024290|FG001|Overall Study|Lack of Efficacy|5|||
16146223|NCT00474708|39024289|FG000|Overall Study|Suicide ideation/behavior|0|||
16146224|NCT00474708|39024290|FG001|Overall Study|Suicide ideation/behavior|1|||
16146225|NCT00474708|39024289|FG000|Overall Study|Withdrawal by Subject|7|||
16146226|NCT00474708|39024290|FG001|Overall Study|Withdrawal by Subject|0|||
16146227|NCT00474708|39024289|FG000|Overall Study|Lack of compliance|12|||
16146228|NCT00474708|39024290|FG001|Overall Study|Lack of compliance|4|||
16146229|NCT00474708|39024289|FG000|Overall Study|Lost to Follow-up|18|||
16146230|NCT00474708|39024290|FG001|Overall Study|Lost to Follow-up|9|||
16146231|NCT00474708|39024289|FG000|Overall Study|Physician Decision|9|||
16146232|NCT00474708|39024290|FG001|Overall Study|Physician Decision|6|||
16146233|NCT01069120|39024291|FG000|Overall Study|Study prematurely terminated|27|||
16146234|NCT01667081|39024304|FG000|Overall Study|Death|43|||
16146235|NCT01667081|39024305|FG001|Overall Study|Death|3|||
16258787|NCT01700621|39433566|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
16258788|NCT01700621|39433567|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
16258789|NCT01700621|39433566|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
16258790|NCT01700621|39433567|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
16258791|NCT01700621|39433566|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
16258792|NCT01700621|39433567|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
16258793|NCT00324168|39433570|FG000|Overall Study|Lost to Follow-up|19|||
16258794|NCT00324168|39433571|FG001|Overall Study|Lost to Follow-up|18|||
16258795|NCT00324168|39433570|FG000|Overall Study|Death|3|||
16258796|NCT00324168|39433571|FG001|Overall Study|Death|3|||
16258797|NCT00324168|39433570|FG000|Overall Study|Patient did not visit in f/u window|6|||
16258798|NCT00324168|39433571|FG001|Overall Study|Patient did not visit in f/u window|9|||
16258799|NCT01313273|39433572|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
16258800|NCT01313273|39433573|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
16258801|NCT01313273|39433572|FG000|Overall Study|Withdrawal by Subject|1|||
16258802|NCT01313273|39433573|FG001|Overall Study|Withdrawal by Subject|0|||
16258803|NCT01313273|39433572|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
16258804|NCT01313273|39433573|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
16258805|NCT01263704|39433574|FG000|Overall Study|Progressive disease|18|||
16258806|NCT01263704|39433574|FG000|Overall Study|Adverse Event|3|||
16258807|NCT01263704|39433574|FG000|Overall Study|Death|2|||
16258808|NCT01263704|39433574|FG000|Overall Study|Patient withdrew consent|2|||
16258809|NCT01263704|39433574|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
16258810|NCT01263704|39433574|FG000|Overall Study|Lost to Follow-up|1|||
16258811|NCT01263704|39433574|FG000|Overall Study|Colon metastases|1|||
16258812|NCT01263704|39433574|FG000|Overall Study|Principal Investigator (PI) decision|1|||
16258813|NCT01399736|39433575|FG000|Overall Study|Withdrawal by Subject|4|||
16258814|NCT01399736|39433576|FG001|Overall Study|Withdrawal by Subject|2|||
16258815|NCT01399736|39433575|FG000|Overall Study|Lost to Follow-up|0|||
16258816|NCT01399736|39433576|FG001|Overall Study|Lost to Follow-up|2|||
16258817|NCT05097326|39433577|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
16258818|NCT05097326|39433578|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
16258819|NCT01010542|39433579|FG000|Overall Study|Adverse Event|0|||
16258820|NCT01010542|39433580|FG001|Overall Study|Adverse Event|1|||
16258821|NCT01010542|39433581|FG002|Overall Study|Adverse Event|0|||
16258822|NCT01010542|39433579|FG000|Overall Study|Lost to Follow-up|0|||
16258823|NCT01010542|39433580|FG001|Overall Study|Lost to Follow-up|1|||
16258824|NCT01010542|39433581|FG002|Overall Study|Lost to Follow-up|0|||
16258825|NCT01010542|39433579|FG000|Overall Study|Withdrawal by Subject|0|||
16258826|NCT01010542|39433580|FG001|Overall Study|Withdrawal by Subject|3|||
16258827|NCT01010542|39433581|FG002|Overall Study|Withdrawal by Subject|2|||
16258828|NCT00220701|39433582|FG000|Overall Study|Lost to Follow-up|5|||
16258829|NCT00220701|39433583|FG001|Overall Study|Lost to Follow-up|4|||
16258830|NCT04488822|39433584|FG000|Overall Study|Adverse Event|8|||
16258831|NCT04488822|39433584|FG000|Overall Study|Withdrawal by Subject|1|||
16258832|NCT00302952|39433585|FG000|Overall Study|Physician Decision|1|||
16258833|NCT00302952|39433586|FG001|Overall Study|Physician Decision|1|||
16258834|NCT00302952|39433585|FG000|Overall Study|Withdrawal by Subject|2|||
16258835|NCT00302952|39433586|FG001|Overall Study|Withdrawal by Subject|3|||
16258836|NCT00302952|39433585|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
16258837|NCT00302952|39433586|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
16258838|NCT01199861|39433593|FG000|Overall Study|Administrative problems|1|||
16258839|NCT01199861|39433594|FG001|Overall Study|Administrative problems|0|||
16258840|NCT01199861|39433593|FG000|Overall Study|Adverse Event|1|||
16258841|NCT01199861|39433594|FG001|Overall Study|Adverse Event|0|||
16258842|NCT00263588|39433595|FG000|Overall Study|Death|54|||
16258843|NCT00263588|39433596|FG001|Overall Study|Death|90|||
16258844|NCT00263588|39433595|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
16258845|NCT00263588|39433596|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
16258846|NCT00263588|39433595|FG000|Overall Study|Lost to Follow-up|7|||
16258847|NCT00263588|39433596|FG001|Overall Study|Lost to Follow-up|10|||
16258848|NCT00263588|39433595|FG000|Overall Study|Withdrawal by Subject|3|||
16258849|NCT00263588|39433596|FG001|Overall Study|Withdrawal by Subject|4|||
16258850|NCT00263588|39433595|FG000|Overall Study|Protocol Violation|0|||
16258851|NCT00263588|39433596|FG001|Overall Study|Protocol Violation|1|||
16258852|NCT00263588|39433595|FG000|Overall Study|Investigator decision|7|||
16258853|NCT00263588|39433596|FG001|Overall Study|Investigator decision|15|||
16258854|NCT00263588|39433595|FG000|Overall Study|Sponsor terminated study|0|||
16258855|NCT00263588|39433596|FG001|Overall Study|Sponsor terminated study|1|||
16258856|NCT01706536|39433608|FG000|Overall Study|Withdrawal by Subject|1|||
16364566|NCT03550209|39821369|FG003|Overall Study|Lost to Follow-up|0|||
16364567|NCT03550209|39821366|FG000|Overall Study|Withdrawal by Subject|0|||
16258857|NCT01706536|39433609|FG001|Overall Study|Withdrawal by Subject|0|||
16258858|NCT01706536|39433610|FG002|Overall Study|Withdrawal by Subject|1|||
16258859|NCT01706536|39433611|FG003|Overall Study|Withdrawal by Subject|0|||
16258860|NCT01706536|39433612|FG004|Overall Study|Withdrawal by Subject|0|||
16258861|NCT01706536|39433608|FG000|Overall Study|Adverse Event|2|||
16258862|NCT01706536|39433609|FG001|Overall Study|Adverse Event|3|||
16258863|NCT01706536|39433610|FG002|Overall Study|Adverse Event|4|||
16258864|NCT01706536|39433611|FG003|Overall Study|Adverse Event|3|||
16258865|NCT01706536|39433612|FG004|Overall Study|Adverse Event|2|||
16258866|NCT01706536|39433608|FG000|Overall Study|Lack of Efficacy|1|||
16258867|NCT01706536|39433609|FG001|Overall Study|Lack of Efficacy|0|||
16258868|NCT01706536|39433610|FG002|Overall Study|Lack of Efficacy|0|||
16258869|NCT01706536|39433611|FG003|Overall Study|Lack of Efficacy|1|||
16258870|NCT01706536|39433612|FG004|Overall Study|Lack of Efficacy|0|||
16258871|NCT01706536|39433608|FG000|Overall Study|non compliance|0|||
16258872|NCT01706536|39433609|FG001|Overall Study|non compliance|1|||
16258873|NCT01706536|39433610|FG002|Overall Study|non compliance|0|||
16258874|NCT01706536|39433611|FG003|Overall Study|non compliance|0|||
16258875|NCT01706536|39433612|FG004|Overall Study|non compliance|0|||
16258876|NCT02272777|39433613|FG000|Overall Study|Adverse Event|0|||
16258877|NCT02272777|39433614|FG001|Overall Study|Adverse Event|1|||
16258878|NCT02272777|39433613|FG000|Overall Study|Withdrawal by Subject|0|||
16258879|NCT02272777|39433614|FG001|Overall Study|Withdrawal by Subject|3|||
16258880|NCT02272777|39433613|FG000|Overall Study|Lost to Follow-up|2|||
16258881|NCT02272777|39433614|FG001|Overall Study|Lost to Follow-up|0|||
16258882|NCT02272777|39433613|FG000|Overall Study|Other|2|||
16258883|NCT02272777|39433614|FG001|Overall Study|Other|0|||
16258884|NCT00105196|39433615|FG000|Overall Study|Lack of Efficacy|2|||
16258885|NCT00105196|39433616|FG001|Overall Study|Lack of Efficacy|3|||
16440435|NCT00129402|40092690|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
16440436|NCT00129402|40092691|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
16258886|NCT00105196|39433615|FG000|Overall Study|Adverse Event|11|||
16258887|NCT00105196|39433616|FG001|Overall Study|Adverse Event|3|||
16258888|NCT00105196|39433615|FG000|Overall Study|Withdrawal by Subject|6|||
16258889|NCT00105196|39433616|FG001|Overall Study|Withdrawal by Subject|6|||
16258890|NCT00105196|39433615|FG000|Overall Study|Lost to Follow-up|3|||
16258891|NCT00105196|39433616|FG001|Overall Study|Lost to Follow-up|2|||
16146236|NCT01667081|39024304|FG000|Overall Study|Lost to Follow-up|99|||
16146237|NCT01667081|39024305|FG001|Overall Study|Lost to Follow-up|48|||
16146238|NCT01667081|39024304|FG000|Overall Study|Physician Decision|16|||
16146239|NCT01667081|39024305|FG001|Overall Study|Physician Decision|2|||
16146240|NCT01667081|39024304|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
16146241|NCT01667081|39024305|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
16146242|NCT01667081|39024304|FG000|Overall Study|Withdrawal by Subject|90|||
16146243|NCT01667081|39024305|FG001|Overall Study|Withdrawal by Subject|35|||
16146244|NCT00621751|39024311|FG000|Overall Study|Adverse Event|0|||
16146245|NCT00621751|39024312|FG001|Overall Study|Adverse Event|1|||
16146246|NCT00097773|39024313|FG000|Overall Study|Lost to Follow-up|2|||
16146247|NCT00097773|39024314|FG001|Overall Study|Lost to Follow-up|2|||
16146248|NCT00097773|39024315|FG002|Overall Study|Lost to Follow-up|0|||
16146249|NCT00097773|39024316|FG003|Overall Study|Lost to Follow-up|1|||
16146250|NCT00097773|39024313|FG000|Overall Study|Physician Decision|2|||
16146251|NCT00097773|39024314|FG001|Overall Study|Physician Decision|2|||
16146252|NCT00097773|39024315|FG002|Overall Study|Physician Decision|3|||
16146253|NCT00097773|39024316|FG003|Overall Study|Physician Decision|1|||
16146254|NCT00097773|39024313|FG000|Overall Study|Withdrawal by Subject|3|||
16146255|NCT00097773|39024314|FG001|Overall Study|Withdrawal by Subject|3|||
16146256|NCT00097773|39024315|FG002|Overall Study|Withdrawal by Subject|3|||
16146257|NCT00097773|39024316|FG003|Overall Study|Withdrawal by Subject|1|||
16146258|NCT00097773|39024313|FG000|Overall Study|Adverse Event|0|||
16146259|NCT00097773|39024314|FG001|Overall Study|Adverse Event|1|||
16146260|NCT00097773|39024315|FG002|Overall Study|Adverse Event|0|||
16146261|NCT00097773|39024316|FG003|Overall Study|Adverse Event|0|||
16146262|NCT00097773|39024313|FG000|Overall Study|Other|1|||
16146263|NCT00097773|39024314|FG001|Overall Study|Other|0|||
16146264|NCT00097773|39024315|FG002|Overall Study|Other|2|||
16146265|NCT00097773|39024316|FG003|Overall Study|Other|0|||
16146266|NCT02047253|39024320|FG000|Overall Study|Lost to Follow-up|8|||
16146267|NCT02046096|39024321|FG000|Overall Study|Death|28|||
16146268|NCT02046096|39024322|FG001|Overall Study|Death|45|||
16146269|NCT02046096|39024321|FG000|Overall Study|Lost to Follow-up|9|||
16146270|NCT02046096|39024322|FG001|Overall Study|Lost to Follow-up|20|||
16146271|NCT02046096|39024321|FG000|Overall Study|Withdrawal by Subject|5|||
16146272|NCT02046096|39024322|FG001|Overall Study|Withdrawal by Subject|17|||
16146273|NCT02046096|39024321|FG000|Overall Study|Other endpoint|2|||
16146274|NCT02046096|39024322|FG001|Overall Study|Other endpoint|19|||
16146275|NCT02700412|39024325|FG000|Overall Study|Adverse Event|6|||
16146276|NCT02700412|39024325|FG000|Overall Study|Death|1|||
16146277|NCT02700412|39024325|FG000|Overall Study|Lack of Efficacy|19|||
16146278|NCT02700412|39024325|FG000|Overall Study|Protocol Violation|5|||
16146279|NCT02700412|39024325|FG000|Overall Study|Withdrawal by Subject|2|||
16146280|NCT00843518|39024326|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
16146281|NCT00843518|39024327|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
16146282|NCT00843518|39024326|FG000|Period 2 (Double-blind Treatment)|Death|0|||
16146283|NCT00843518|39024327|FG001|Period 2 (Double-blind Treatment)|Death|1|||
16146284|NCT00843518|39024326|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
16146285|NCT00843518|39024327|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
16146286|NCT00843518|39024326|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
16146287|NCT00843518|39024327|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
16146288|NCT00843518|39024326|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
16146289|NCT00843518|39024327|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
16146290|NCT00843518|39024326|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
16146291|NCT00843518|39024327|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
16146292|NCT00843518|39024326|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
16146293|NCT00843518|39024327|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
16146294|NCT01226459|39024328|FG000|Overall Study|Adverse Event|2|||
16146295|NCT01226459|39024329|FG001|Overall Study|Adverse Event|8|||
16146296|NCT01226459|39024328|FG000|Overall Study|Protocol Violation|4|||
16146297|NCT01226459|39024329|FG001|Overall Study|Protocol Violation|3|||
16146298|NCT01226459|39024328|FG000|Overall Study|Withdrawal by Subject|10|||
16146299|NCT01226459|39024329|FG001|Overall Study|Withdrawal by Subject|13|||
16146300|NCT01226459|39024328|FG000|Overall Study|Lost to Follow-up|4|||
16146301|NCT01226459|39024329|FG001|Overall Study|Lost to Follow-up|8|||
16146302|NCT01226459|39024328|FG000|Overall Study|Pregnancy|1|||
16146303|NCT01226459|39024329|FG001|Overall Study|Pregnancy|0|||
16146304|NCT00698997|39024331|FG000|Overall Study|Lost to Follow-up|3|||
16146305|NCT00698997|39024332|FG001|Overall Study|Lost to Follow-up|0|||
16146306|NCT00698997|39024331|FG000|Overall Study|Withdrawal by Subject|7|||
16146307|NCT00698997|39024332|FG001|Overall Study|Withdrawal by Subject|27|||
16146308|NCT01553188|39024335|FG000|Overall Study|Patient choice|1|||
16146309|NCT01553188|39024336|FG001|Overall Study|Patient choice|0|||
16146310|NCT01553188|39024337|FG002|Overall Study|Patient choice|0|||
16146311|NCT01553188|39024338|FG003|Overall Study|Patient choice|0|||
16146312|NCT01553188|39024335|FG000|Overall Study|Intercurrent illness and adverse event|0|||
16146313|NCT01553188|39024336|FG001|Overall Study|Intercurrent illness and adverse event|1|||
16146314|NCT01553188|39024337|FG002|Overall Study|Intercurrent illness and adverse event|2|||
16146315|NCT01553188|39024338|FG003|Overall Study|Intercurrent illness and adverse event|0|||
16146316|NCT03337542|39024345|FG000|Overall Study|Withdrew Consent|17|||
16146317|NCT03337542|39024345|FG000|Overall Study|Allergic Adverse Event|1|||
16146318|NCT03337542|39024345|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
16146319|NCT03337542|39024345|FG000|Overall Study|Lost to Follow-up|1|||
16146320|NCT03337542|39024345|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
16146321|NCT03700320|39024348|FG000|Overall Study|Adverse Event|5|||
16146322|NCT03700320|39024349|FG001|Overall Study|Adverse Event|31|||
16146323|NCT03700320|39024348|FG000|Overall Study|Lack of Efficacy|2|||
16146324|NCT03700320|39024349|FG001|Overall Study|Lack of Efficacy|5|||
16146325|NCT03700320|39024348|FG000|Overall Study|Withdrawal by Subject|29|||
16146326|NCT03700320|39024349|FG001|Overall Study|Withdrawal by Subject|75|||
16146327|NCT03700320|39024348|FG000|Overall Study|Lost to Follow-up|16|||
16146328|NCT03700320|39024349|FG001|Overall Study|Lost to Follow-up|23|||
16146329|NCT03700320|39024348|FG000|Overall Study|Pregnancy|2|||
16146330|NCT03700320|39024349|FG001|Overall Study|Pregnancy|4|||
16146331|NCT03700320|39024348|FG000|Overall Study|Protocol Deviation|7|||
16146332|NCT03700320|39024349|FG001|Overall Study|Protocol Deviation|31|||
16146333|NCT03700320|39024348|FG000|Overall Study|Non-compliance with Study Drug|1|||
16146334|NCT03700320|39024349|FG001|Overall Study|Non-compliance with Study Drug|3|||
16146335|NCT03700320|39024348|FG000|Overall Study|Reason not Specified|0|||
16146336|NCT03700320|39024349|FG001|Overall Study|Reason not Specified|1|||
16146337|NCT03807349|39024366|FG000|Overall Study|Early Study Termination|9|||
16146338|NCT03975920|39024367|FG000|Overall Study|Lost to Follow-up|1|||
16146339|NCT03975920|39024368|FG001|Overall Study|Lost to Follow-up|2|||
16146340|NCT03975920|39024367|FG000|Overall Study|Protocol Violation|1|||
16146341|NCT03975920|39024368|FG001|Overall Study|Protocol Violation|1|||
16146342|NCT03975920|39024367|FG000|Overall Study|Did not complete survey|2|||
16146343|NCT03975920|39024368|FG001|Overall Study|Did not complete survey|1|||
16146344|NCT00763971|39024369|FG000|Overall Study|Adverse Event|5|||
16146345|NCT00763971|39024370|FG001|Overall Study|Adverse Event|2|||
16146346|NCT00763971|39024371|FG002|Overall Study|Adverse Event|4|||
16146347|NCT00763971|39024369|FG000|Overall Study|Protocol Violation|3|||
16146348|NCT00763971|39024370|FG001|Overall Study|Protocol Violation|3|||
16146349|NCT00763971|39024371|FG002|Overall Study|Protocol Violation|2|||
16146350|NCT00763971|39024369|FG000|Overall Study|Withdrawal by Subject|4|||
16146351|NCT00763971|39024370|FG001|Overall Study|Withdrawal by Subject|5|||
16146352|NCT00763971|39024371|FG002|Overall Study|Withdrawal by Subject|5|||
16146353|NCT00763971|39024369|FG000|Overall Study|Lost to Follow-up|0|||
16146354|NCT00763971|39024370|FG001|Overall Study|Lost to Follow-up|1|||
16146355|NCT00763971|39024371|FG002|Overall Study|Lost to Follow-up|0|||
16146356|NCT00763971|39024369|FG000|Overall Study|Lack of Efficacy|11|||
16146357|NCT00763971|39024370|FG001|Overall Study|Lack of Efficacy|22|||
16146358|NCT00763971|39024371|FG002|Overall Study|Lack of Efficacy|54|||
16146359|NCT00763971|39024369|FG000|Overall Study|Unable to swallow capsule|2|||
16146360|NCT00763971|39024370|FG001|Overall Study|Unable to swallow capsule|1|||
16146361|NCT00763971|39024371|FG002|Overall Study|Unable to swallow capsule|1|||
16146362|NCT00763971|39024369|FG000|Overall Study|Personal reason|3|||
16146363|NCT00763971|39024370|FG001|Overall Study|Personal reason|0|||
16146364|NCT00763971|39024371|FG002|Overall Study|Personal reason|0|||
16146365|NCT00763971|39024369|FG000|Overall Study|Exclusion criteria met|1|||
16146366|NCT00763971|39024370|FG001|Overall Study|Exclusion criteria met|0|||
16146367|NCT00763971|39024371|FG002|Overall Study|Exclusion criteria met|0|||
16146368|NCT00763971|39024369|FG000|Overall Study|Sponsor decision|1|||
16146369|NCT00763971|39024370|FG001|Overall Study|Sponsor decision|0|||
16146370|NCT00763971|39024371|FG002|Overall Study|Sponsor decision|0|||
16146371|NCT00763971|39024369|FG000|Overall Study|Due to holiday season|2|||
16146372|NCT00763971|39024370|FG001|Overall Study|Due to holiday season|0|||
16146373|NCT00763971|39024371|FG002|Overall Study|Due to holiday season|1|||
16146374|NCT00763971|39024369|FG000|Overall Study|Randomization error|0|||
16146375|NCT00763971|39024370|FG001|Overall Study|Randomization error|0|||
16146376|NCT00763971|39024371|FG002|Overall Study|Randomization error|1|||
16146377|NCT00763971|39024369|FG000|Overall Study|Medical monitor decision|0|||
16146378|NCT00763971|39024370|FG001|Overall Study|Medical monitor decision|0|||
16146379|NCT00763971|39024371|FG002|Overall Study|Medical monitor decision|1|||
16146380|NCT00763971|39024369|FG000|Overall Study|Moved to another country|0|||
16146381|NCT00763971|39024370|FG001|Overall Study|Moved to another country|1|||
16146382|NCT00763971|39024371|FG002|Overall Study|Moved to another country|0|||
16146383|NCT00763971|39024369|FG000|Overall Study|Subject wanted dose reduction|0|||
16146384|NCT00763971|39024370|FG001|Overall Study|Subject wanted dose reduction|1|||
16146385|NCT00763971|39024371|FG002|Overall Study|Subject wanted dose reduction|0|||
16146386|NCT00763971|39024369|FG000|Overall Study|Lack of availability|0|||
16146387|NCT00763971|39024370|FG001|Overall Study|Lack of availability|1|||
16146388|NCT00763971|39024371|FG002|Overall Study|Lack of availability|0|||
16146389|NCT00763971|39024369|FG000|Overall Study|Performed final visit on phone|0|||
16146390|NCT00763971|39024370|FG001|Overall Study|Performed final visit on phone|1|||
16146391|NCT00763971|39024371|FG002|Overall Study|Performed final visit on phone|0|||
16146392|NCT00763971|39024369|FG000|Overall Study|Participation in 489-326 required|1|||
16146393|NCT00763971|39024370|FG001|Overall Study|Participation in 489-326 required|0|||
16146394|NCT00763971|39024371|FG002|Overall Study|Participation in 489-326 required|0|||
16146395|NCT01187550|39024382|FG000|Overall Study|Protocol Violation|3|||
16146396|NCT01187550|39024383|FG001|Overall Study|Protocol Violation|1|||
16146397|NCT01187550|39024382|FG000|Overall Study|Other|3|||
16146398|NCT01187550|39024383|FG001|Overall Study|Other|0|||
16146399|NCT01187550|39024382|FG000|Overall Study|Randomized but not treated|8|||
16146400|NCT01187550|39024383|FG001|Overall Study|Randomized but not treated|0|||
16146401|NCT00243386|39024384|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
16146402|NCT00243386|39024385|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
16146403|NCT00243386|39024386|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
16146404|NCT00243386|39024384|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
16146405|NCT00243386|39024385|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
16146406|NCT00243386|39024386|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
16146407|NCT00243386|39024384|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
16146408|NCT00243386|39024385|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
16146409|NCT00243386|39024386|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
16146410|NCT00243386|39024384|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
16146411|NCT00243386|39024385|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
16146412|NCT00243386|39024386|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
16146413|NCT00243386|39024384|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
16146414|NCT00243386|39024385|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
16146415|NCT00243386|39024386|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
16146416|NCT00243386|39024384|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
16146417|NCT00243386|39024385|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
16440437|NCT00129402|40092692|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
16146418|NCT00243386|39024386|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
16258892|NCT00105196|39433615|FG000|Overall Study|Poor/noncompliance|3|||
16146419|NCT00243386|39024384|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
16146420|NCT00243386|39024385|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
16146421|NCT00243386|39024386|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
16146422|NCT00243386|39024384|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
16146423|NCT00243386|39024385|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
16146424|NCT00243386|39024386|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
16146425|NCT01368536|39024390|FG000|Overall Study|Adverse Event|5|||
16146426|NCT01368536|39024391|FG001|Overall Study|Adverse Event|6|||
16146427|NCT01368536|39024392|FG002|Overall Study|Adverse Event|8|||
16146428|NCT01368536|39024390|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16146429|NCT01368536|39024391|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16146430|NCT01368536|39024392|FG002|Overall Study|Abnormal laboratory value(s)|2|||
16146431|NCT01368536|39024390|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16146432|NCT01368536|39024391|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16146433|NCT01368536|39024392|FG002|Overall Study|Abnormal test procedure result(s)|1|||
16146434|NCT01368536|39024390|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
16146435|NCT01368536|39024391|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16146436|NCT01368536|39024392|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
16146437|NCT01368536|39024390|FG000|Overall Study|No longer required study medication|0|||
16146438|NCT01368536|39024391|FG001|Overall Study|No longer required study medication|0|||
16146439|NCT01368536|39024392|FG002|Overall Study|No longer required study medication|1|||
16146440|NCT01368536|39024390|FG000|Overall Study|Withdrawal by Subject|2|||
16146441|NCT01368536|39024391|FG001|Overall Study|Withdrawal by Subject|5|||
16146442|NCT01368536|39024392|FG002|Overall Study|Withdrawal by Subject|4|||
16146443|NCT01368536|39024390|FG000|Overall Study|Lost to Follow-up|3|||
16146444|NCT01368536|39024391|FG001|Overall Study|Lost to Follow-up|3|||
16146445|NCT01368536|39024392|FG002|Overall Study|Lost to Follow-up|5|||
16146446|NCT01368536|39024390|FG000|Overall Study|Administrative problems|34|||
16146447|NCT01368536|39024391|FG001|Overall Study|Administrative problems|39|||
16146448|NCT01368536|39024392|FG002|Overall Study|Administrative problems|35|||
16146449|NCT01368536|39024390|FG000|Overall Study|Protocol deviation|0|||
16146450|NCT01368536|39024391|FG001|Overall Study|Protocol deviation|3|||
16146451|NCT01368536|39024392|FG002|Overall Study|Protocol deviation|1|||
16146452|NCT02819635|39024397|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
16146453|NCT02819635|39024398|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
16146454|NCT02819635|39024399|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
16146455|NCT02819635|39024400|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
16146456|NCT02819635|39024401|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
16146457|NCT02819635|39024402|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
16146458|NCT02819635|39024403|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
16146459|NCT02819635|39024404|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
16146460|NCT02819635|39024405|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
16146461|NCT02819635|39024406|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
16146462|NCT02819635|39024407|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
16146463|NCT02819635|39024408|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
16146464|NCT02819635|39024397|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16146465|NCT02819635|39024398|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16146466|NCT02819635|39024399|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16146467|NCT02819635|39024400|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16146468|NCT02819635|39024401|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
16146469|NCT02819635|39024402|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
16146470|NCT02819635|39024403|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
16146471|NCT02819635|39024404|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16146472|NCT02819635|39024405|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16258893|NCT00105196|39433616|FG001|Overall Study|Poor/noncompliance|4|||
16258894|NCT00105196|39433615|FG000|Overall Study|Protocol Violation|5|||
16258895|NCT00105196|39433616|FG001|Overall Study|Protocol Violation|2|||
16258896|NCT00105196|39433615|FG000|Overall Study|pending surgery|0|||
16258897|NCT00105196|39433616|FG001|Overall Study|pending surgery|1|||
16258898|NCT00105196|39433615|FG000|Overall Study|marijuana use|0|||
16258899|NCT00105196|39433616|FG001|Overall Study|marijuana use|1|||
16258900|NCT00105196|39433615|FG000|Overall Study|Subject became unblinded|0|||
16258901|NCT00105196|39433616|FG001|Overall Study|Subject became unblinded|1|||
16146473|NCT02819635|39024406|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16146474|NCT02819635|39024407|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16146475|NCT02819635|39024408|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
16146476|NCT02819635|39024397|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16258902|NCT01772537|39433622|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
16258903|NCT01772537|39433623|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
16258904|NCT01772537|39433624|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
16258905|NCT00591630|39433630|FG000|Overall Study|Death|0|||
16258906|NCT00591630|39433631|FG001|Overall Study|Death|0|||
16258907|NCT00591630|39433632|FG002|Overall Study|Death|1|||
16258908|NCT00591630|39433633|FG003|Overall Study|Death|0|||
16258909|NCT01439880|39433634|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
16258910|NCT01439880|39433635|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
16258911|NCT01439880|39433634|FG000|SOC-controlled Period (Year 1)|Death|2|||
16258912|NCT01439880|39433635|FG001|SOC-controlled Period (Year 1)|Death|1|||
16258913|NCT01439880|39433634|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
16258914|NCT01439880|39433635|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
16258915|NCT01439880|39433634|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
16258916|NCT01439880|39433635|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
16258917|NCT01439880|39433634|FG000|SOC-controlled Period (Year 1)|Other|8|||
16258918|NCT01439880|39433635|FG001|SOC-controlled Period (Year 1)|Other|13|||
16258919|NCT01439880|39433634|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
16258920|NCT01439880|39433635|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
16258921|NCT01439880|39433634|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
16258922|NCT01439880|39433635|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
16258923|NCT01439880|39433634|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
16258924|NCT01439880|39433635|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
16258925|NCT01439880|39433634|FG000|All-IP Period (Years 2 to 5)|Death|3|||
16258926|NCT01439880|39433635|FG001|All-IP Period (Years 2 to 5)|Death|13|||
16258927|NCT01439880|39433634|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
16258928|NCT01439880|39433635|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
16258929|NCT01439880|39433634|FG000|All-IP Period (Years 2 to 5)|Other|14|||
16258930|NCT01439880|39433635|FG001|All-IP Period (Years 2 to 5)|Other|31|||
16258931|NCT01439880|39433634|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
16258932|NCT01439880|39433635|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
16258933|NCT00386009|39433644|FG000|Overall Study|Adverse Event|0|||
16258934|NCT00386009|39433645|FG001|Overall Study|Adverse Event|2|||
16258935|NCT00386009|39433644|FG000|Overall Study|Death|1|||
16258936|NCT00386009|39433645|FG001|Overall Study|Death|0|||
16258937|NCT00386009|39433644|FG000|Overall Study|Entry Criteria Not Met|0|||
16258938|NCT00386009|39433645|FG001|Overall Study|Entry Criteria Not Met|2|||
16258939|NCT00386009|39433644|FG000|Overall Study|Lost to Follow-up|1|||
16258940|NCT00386009|39433645|FG001|Overall Study|Lost to Follow-up|1|||
16258941|NCT00386009|39433644|FG000|Overall Study|Protocol Violation|1|||
16258942|NCT00386009|39433645|FG001|Overall Study|Protocol Violation|0|||
16258943|NCT00386009|39433644|FG000|Overall Study|Sponsor Decision|1|||
16258944|NCT00386009|39433645|FG001|Overall Study|Sponsor Decision|1|||
16258945|NCT00386009|39433644|FG000|Overall Study|Withdrawal by Subject|5|||
16258946|NCT00386009|39433645|FG001|Overall Study|Withdrawal by Subject|4|||
16258947|NCT03616106|39433646|FG000|Overall Study|Removed by PI|6|||
16258948|NCT03616106|39433647|FG001|Overall Study|Removed by PI|0|||
16258949|NCT03616106|39433646|FG000|Overall Study|Withdrawal by Subject|1|||
16258950|NCT03616106|39433647|FG001|Overall Study|Withdrawal by Subject|1|||
16258951|NCT03616106|39433646|FG000|Overall Study|Lost to Follow-up|7|||
16258952|NCT03616106|39433647|FG001|Overall Study|Lost to Follow-up|0|||
16258953|NCT01544127|39433654|FG000|Overall Study|Lost to Follow-up|4|||
16258954|NCT01544127|39433655|FG001|Overall Study|Lost to Follow-up|2|||
16258955|NCT01544127|39433656|FG002|Overall Study|Lost to Follow-up|9|||
16258956|NCT01544127|39433654|FG000|Overall Study|Withdrawal by Subject|2|||
16258957|NCT01544127|39433655|FG001|Overall Study|Withdrawal by Subject|2|||
16258958|NCT01544127|39433656|FG002|Overall Study|Withdrawal by Subject|1|||
16146477|NCT02819635|39024398|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16146478|NCT02819635|39024399|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16146479|NCT02819635|39024400|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16146480|NCT02819635|39024401|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16146481|NCT02819635|39024402|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
16146482|NCT02819635|39024403|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
16146483|NCT02819635|39024404|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16146484|NCT02819635|39024405|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16146485|NCT02819635|39024406|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16146486|NCT02819635|39024407|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16146487|NCT02819635|39024408|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
16146488|NCT02819635|39024397|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146489|NCT02819635|39024398|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146490|NCT02819635|39024399|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146491|NCT02819635|39024400|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146492|NCT02819635|39024401|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146493|NCT02819635|39024402|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146494|NCT02819635|39024403|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
16146495|NCT02819635|39024404|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146496|NCT02819635|39024405|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146497|NCT02819635|39024406|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146498|NCT02819635|39024407|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146499|NCT02819635|39024408|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
16146500|NCT02819635|39024397|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
16146501|NCT02819635|39024398|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
16146502|NCT02819635|39024399|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
16146503|NCT02819635|39024400|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
16146504|NCT02819635|39024401|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
16146505|NCT02819635|39024402|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
16146506|NCT02819635|39024403|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
16146507|NCT02819635|39024404|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
16146508|NCT02819635|39024405|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
16146509|NCT02819635|39024406|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
16146510|NCT02819635|39024407|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
16146511|NCT02819635|39024408|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
16146512|NCT02819635|39024397|FG000|Substudy 2, Part 2|Adverse Event|0|||
16146513|NCT02819635|39024398|FG001|Substudy 2, Part 2|Adverse Event|0|||
16146514|NCT02819635|39024399|FG002|Substudy 2, Part 2|Adverse Event|0|||
16146515|NCT02819635|39024400|FG003|Substudy 2, Part 2|Adverse Event|0|||
16146516|NCT02819635|39024401|FG004|Substudy 2, Part 2|Adverse Event|0|||
16146517|NCT02819635|39024402|FG005|Substudy 2, Part 2|Adverse Event|4|||
16146518|NCT02819635|39024403|FG006|Substudy 2, Part 2|Adverse Event|0|||
16146519|NCT02819635|39024404|FG007|Substudy 2, Part 2|Adverse Event|0|||
16146520|NCT02819635|39024405|FG008|Substudy 2, Part 2|Adverse Event|0|||
16146521|NCT02819635|39024406|FG009|Substudy 2, Part 2|Adverse Event|0|||
16146522|NCT02819635|39024407|FG010|Substudy 2, Part 2|Adverse Event|0|||
16146523|NCT02819635|39024408|FG011|Substudy 2, Part 2|Adverse Event|0|||
16146524|NCT02819635|39024397|FG000|Substudy 2, Part 2|Withdrew consent|0|||
16146525|NCT02819635|39024398|FG001|Substudy 2, Part 2|Withdrew consent|0|||
16146526|NCT02819635|39024399|FG002|Substudy 2, Part 2|Withdrew consent|0|||
16146527|NCT02819635|39024400|FG003|Substudy 2, Part 2|Withdrew consent|0|||
16146528|NCT02819635|39024401|FG004|Substudy 2, Part 2|Withdrew consent|0|||
16146529|NCT02819635|39024402|FG005|Substudy 2, Part 2|Withdrew consent|3|||
16146530|NCT02819635|39024403|FG006|Substudy 2, Part 2|Withdrew consent|1|||
16146531|NCT02819635|39024404|FG007|Substudy 2, Part 2|Withdrew consent|0|||
16146532|NCT02819635|39024405|FG008|Substudy 2, Part 2|Withdrew consent|0|||
16146533|NCT02819635|39024406|FG009|Substudy 2, Part 2|Withdrew consent|0|||
16146534|NCT02819635|39024407|FG010|Substudy 2, Part 2|Withdrew consent|0|||
16146535|NCT02819635|39024408|FG011|Substudy 2, Part 2|Withdrew consent|0|||
16146536|NCT02819635|39024397|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
16146537|NCT02819635|39024398|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
16146538|NCT02819635|39024399|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
16146539|NCT02819635|39024400|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
16146540|NCT02819635|39024401|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
16146541|NCT02819635|39024402|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
16146542|NCT02819635|39024403|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
16146543|NCT02819635|39024404|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
16146544|NCT02819635|39024405|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
16146545|NCT02819635|39024406|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
16146546|NCT02819635|39024407|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
16146547|NCT02819635|39024408|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
16146548|NCT02819635|39024397|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146549|NCT02819635|39024398|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146550|NCT02819635|39024399|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146551|NCT02819635|39024400|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146552|NCT02819635|39024401|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146553|NCT02819635|39024402|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146554|NCT02819635|39024403|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
16146555|NCT02819635|39024404|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146556|NCT02819635|39024405|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146557|NCT02819635|39024406|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146558|NCT02819635|39024407|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146559|NCT02819635|39024408|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
16146560|NCT02819635|39024397|FG000|Substudy 2, Part 2|Other, not specified|0|||
16146561|NCT02819635|39024398|FG001|Substudy 2, Part 2|Other, not specified|0|||
16146562|NCT02819635|39024399|FG002|Substudy 2, Part 2|Other, not specified|0|||
16146563|NCT02819635|39024400|FG003|Substudy 2, Part 2|Other, not specified|0|||
16146564|NCT02819635|39024401|FG004|Substudy 2, Part 2|Other, not specified|0|||
16146565|NCT02819635|39024402|FG005|Substudy 2, Part 2|Other, not specified|4|||
16146566|NCT02819635|39024403|FG006|Substudy 2, Part 2|Other, not specified|8|||
16146567|NCT02819635|39024404|FG007|Substudy 2, Part 2|Other, not specified|0|||
16146568|NCT02819635|39024405|FG008|Substudy 2, Part 2|Other, not specified|0|||
16146569|NCT02819635|39024406|FG009|Substudy 2, Part 2|Other, not specified|0|||
16146570|NCT02819635|39024407|FG010|Substudy 2, Part 2|Other, not specified|0|||
16146571|NCT02819635|39024408|FG011|Substudy 2, Part 2|Other, not specified|0|||
16146572|NCT02819635|39024397|FG000|Substudy 3|Adverse Event|0|||
16146573|NCT02819635|39024398|FG001|Substudy 3|Adverse Event|0|||
16146574|NCT02819635|39024399|FG002|Substudy 3|Adverse Event|0|||
16146575|NCT02819635|39024400|FG003|Substudy 3|Adverse Event|0|||
16258959|NCT01544127|39433654|FG000|Overall Study|Discharged out of catchment area|1|||
16258960|NCT01544127|39433655|FG001|Overall Study|Discharged out of catchment area|1|||
16258961|NCT01544127|39433656|FG002|Overall Study|Discharged out of catchment area|1|||
16258962|NCT01544127|39433654|FG000|Overall Study|Death|1|||
16258963|NCT01544127|39433655|FG001|Overall Study|Death|0|||
16258964|NCT01544127|39433656|FG002|Overall Study|Death|0|||
16258965|NCT01544127|39433654|FG000|Overall Study|Jail or Prison|1|||
16258966|NCT01544127|39433655|FG001|Overall Study|Jail or Prison|1|||
16258967|NCT01544127|39433656|FG002|Overall Study|Jail or Prison|2|||
16258968|NCT01544127|39433654|FG000|Overall Study|Became Psychotic|1|||
16146576|NCT02819635|39024401|FG004|Substudy 3|Adverse Event|0|||
16146577|NCT02819635|39024402|FG005|Substudy 3|Adverse Event|0|||
16146578|NCT02819635|39024403|FG006|Substudy 3|Adverse Event|0|||
16146579|NCT02819635|39024404|FG007|Substudy 3|Adverse Event|0|||
16146580|NCT02819635|39024405|FG008|Substudy 3|Adverse Event|32|||
16146581|NCT02819635|39024406|FG009|Substudy 3|Adverse Event|3|||
16146582|NCT02819635|39024407|FG010|Substudy 3|Adverse Event|12|||
16146583|NCT02819635|39024408|FG011|Substudy 3|Adverse Event|18|||
16146584|NCT02819635|39024397|FG000|Substudy 3|Withdrew consent|0|||
16146585|NCT02819635|39024398|FG001|Substudy 3|Withdrew consent|0|||
16146586|NCT02819635|39024399|FG002|Substudy 3|Withdrew consent|0|||
16146587|NCT02819635|39024400|FG003|Substudy 3|Withdrew consent|0|||
16146588|NCT02819635|39024401|FG004|Substudy 3|Withdrew consent|0|||
16146589|NCT02819635|39024402|FG005|Substudy 3|Withdrew consent|0|||
16146590|NCT02819635|39024403|FG006|Substudy 3|Withdrew consent|0|||
16146591|NCT02819635|39024404|FG007|Substudy 3|Withdrew consent|0|||
16146592|NCT02819635|39024405|FG008|Substudy 3|Withdrew consent|11|||
16146593|NCT02819635|39024406|FG009|Substudy 3|Withdrew consent|1|||
16146594|NCT02819635|39024407|FG010|Substudy 3|Withdrew consent|4|||
16146595|NCT02819635|39024408|FG011|Substudy 3|Withdrew consent|9|||
16258969|NCT01544127|39433655|FG001|Overall Study|Became Psychotic|0|||
16146596|NCT02819635|39024397|FG000|Substudy 3|Lost to Follow-up|0|||
16146597|NCT02819635|39024398|FG001|Substudy 3|Lost to Follow-up|0|||
16146598|NCT02819635|39024399|FG002|Substudy 3|Lost to Follow-up|0|||
16146599|NCT02819635|39024400|FG003|Substudy 3|Lost to Follow-up|0|||
16146600|NCT02819635|39024401|FG004|Substudy 3|Lost to Follow-up|0|||
16146601|NCT02819635|39024402|FG005|Substudy 3|Lost to Follow-up|0|||
16146602|NCT02819635|39024403|FG006|Substudy 3|Lost to Follow-up|0|||
16258970|NCT01544127|39433656|FG002|Overall Study|Became Psychotic|0|||
16258971|NCT01544127|39433654|FG000|Overall Study|Researcher withdrew|1|||
16258972|NCT01544127|39433655|FG001|Overall Study|Researcher withdrew|0|||
16258973|NCT01544127|39433656|FG002|Overall Study|Researcher withdrew|0|||
16258974|NCT01544127|39433654|FG000|Overall Study|Went active duty|0|||
16258975|NCT01544127|39433655|FG001|Overall Study|Went active duty|0|||
16258976|NCT01544127|39433656|FG002|Overall Study|Went active duty|1|||
16258977|NCT03661528|39433657|FG000|Overall Study|Death|1|||
16258978|NCT03661528|39433658|FG001|Overall Study|Death|0|||
16258979|NCT03661528|39433657|FG000|Overall Study|Physician Decision|3|||
16258980|NCT03661528|39433658|FG001|Overall Study|Physician Decision|1|||
16258981|NCT03661528|39433657|FG000|Overall Study|Other than Specified|5|||
16258982|NCT03661528|39433658|FG001|Overall Study|Other than Specified|2|||
16258983|NCT03661528|39433657|FG000|Overall Study|Withdrawal by Subject|5|||
16258984|NCT03661528|39433658|FG001|Overall Study|Withdrawal by Subject|3|||
16258985|NCT03661528|39433657|FG000|Overall Study|Disease Progression|8|||
16258986|NCT03661528|39433658|FG001|Overall Study|Disease Progression|13|||
16258987|NCT03661528|39433657|FG000|Overall Study|Adverse Event|61|||
16258988|NCT03661528|39433658|FG001|Overall Study|Adverse Event|55|||
16258989|NCT00822926|39433664|FG000|Second Injection Visit|Lost to Follow-up|1|||
16258990|NCT00822926|39433665|FG001|Second Injection Visit|Lost to Follow-up|0|||
16258991|NCT00822926|39433664|FG000|Second Injection Visit|Withdrawal by Subject|0|||
16258992|NCT00822926|39433665|FG001|Second Injection Visit|Withdrawal by Subject|1|||
16258993|NCT00444145|39433666|FG000|Overall Study|Withdrawal by Subject|2|||
16258994|NCT00444145|39433666|FG000|Overall Study|Lost to Follow-up|1|||
16258995|NCT00444145|39433666|FG000|Overall Study|non-compliant|11|||
16258996|NCT00444145|39433666|FG000|Overall Study|Screen Failures|5|||
16258997|NCT04611789|39433671|FG000|Overall Study|Lost to Follow-up|1|||
16258998|NCT04611789|39433672|FG001|Overall Study|Lost to Follow-up|0|||
16258999|NCT04611789|39433673|FG002|Overall Study|Lost to Follow-up|0|||
16146603|NCT02819635|39024404|FG007|Substudy 3|Lost to Follow-up|0|||
16259000|NCT03555305|39433674|FG000|Period 1|Physician Decision|0|||
16259001|NCT03555305|39433675|FG001|Period 1|Physician Decision|1|||
16146604|NCT02819635|39024405|FG008|Substudy 3|Lost to Follow-up|1|||
16146605|NCT02819635|39024406|FG009|Substudy 3|Lost to Follow-up|0|||
16146606|NCT02819635|39024407|FG010|Substudy 3|Lost to Follow-up|1|||
16146607|NCT02819635|39024408|FG011|Substudy 3|Lost to Follow-up|1|||
16146608|NCT02819635|39024397|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146609|NCT02819635|39024398|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146610|NCT02819635|39024399|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146611|NCT02819635|39024400|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146612|NCT02819635|39024401|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146613|NCT02819635|39024402|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146614|NCT02819635|39024403|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146615|NCT02819635|39024404|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146616|NCT02819635|39024405|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146617|NCT02819635|39024406|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146618|NCT02819635|39024407|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
16146619|NCT02819635|39024408|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
16146620|NCT02819635|39024397|FG000|Substudy 3|Other, not specified|0|||
16146621|NCT02819635|39024398|FG001|Substudy 3|Other, not specified|0|||
16146622|NCT02819635|39024399|FG002|Substudy 3|Other, not specified|0|||
16146623|NCT02819635|39024400|FG003|Substudy 3|Other, not specified|0|||
16146624|NCT02819635|39024401|FG004|Substudy 3|Other, not specified|0|||
16146625|NCT02819635|39024402|FG005|Substudy 3|Other, not specified|0|||
16146626|NCT02819635|39024403|FG006|Substudy 3|Other, not specified|0|||
16146627|NCT02819635|39024404|FG007|Substudy 3|Other, not specified|0|||
16364568|NCT03550209|39821367|FG001|Overall Study|Withdrawal by Subject|3|||
16364569|NCT03550209|39821368|FG002|Overall Study|Withdrawal by Subject|1|||
16364570|NCT03550209|39821369|FG003|Overall Study|Withdrawal by Subject|2|||
16364571|NCT03550209|39821366|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
16364572|NCT03550209|39821367|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
16364573|NCT03550209|39821368|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
16146628|NCT02819635|39024405|FG008|Substudy 3|Other, not specified|202|||
16146629|NCT02819635|39024406|FG009|Substudy 3|Other, not specified|5|||
16146630|NCT02819635|39024407|FG010|Substudy 3|Other, not specified|89|||
16146631|NCT02819635|39024408|FG011|Substudy 3|Other, not specified|39|||
16146632|NCT02486653|39024409|FG000|Overall Study|Withdrawal by Subject|1|||
16146633|NCT02486653|39024410|FG001|Overall Study|Withdrawal by Subject|3|||
16146634|NCT02486653|39024409|FG000|Overall Study|Protocol Violation|1|||
16146635|NCT02486653|39024410|FG001|Overall Study|Protocol Violation|0|||
16364574|NCT03550209|39821369|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
16364575|NCT02452190|39821372|FG000|Overall Study|Withdrawal by Sponsor|1|||
16364576|NCT02452190|39821373|FG001|Overall Study|Withdrawal by Sponsor|3|||
16364577|NCT02452190|39821372|FG000|Overall Study|Pregnancy|1|||
16364578|NCT02452190|39821373|FG001|Overall Study|Pregnancy|0|||
16364579|NCT02452190|39821372|FG000|Overall Study|Investigator's Decision|2|||
16440438|NCT00129402|40092693|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
16146636|NCT02486653|39024409|FG000|Overall Study|surgery cancelled|4|||
16146637|NCT02486653|39024410|FG001|Overall Study|surgery cancelled|1|||
16146638|NCT00618410|39024411|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
16146639|NCT00618410|39024412|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
16146640|NCT00932360|39024419|FG000|Washout (One Week)|Withdrawal by Subject|0|||
16146641|NCT00932360|39024420|FG001|Washout (One Week)|Withdrawal by Subject|0|||
16146642|NCT00932360|39024421|FG002|Washout (One Week)|Withdrawal by Subject|0|||
16146643|NCT00932360|39024422|FG003|Washout (One Week)|Withdrawal by Subject|0|||
16146644|NCT00932360|39024423|FG004|Washout (One Week)|Withdrawal by Subject|2|||
16146645|NCT00932360|39024424|FG005|Washout (One Week)|Withdrawal by Subject|0|||
16146646|NCT02953340|39024425|FG000|Overall Study|Death|0|||
16146647|NCT02953340|39024426|FG001|Overall Study|Death|1|||
16146648|NCT02953340|39024425|FG000|Overall Study|Investigator Decision|3|||
16146649|NCT02953340|39024426|FG001|Overall Study|Investigator Decision|3|||
16146650|NCT02953340|39024425|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
16146651|NCT02953340|39024426|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
16146652|NCT02953340|39024425|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
16146653|NCT02953340|39024426|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
16146654|NCT02953340|39024425|FG000|Overall Study|Withdrawal by Subject|9|||
16146655|NCT02953340|39024426|FG001|Overall Study|Withdrawal by Subject|9|||
16146656|NCT02953340|39024425|FG000|Overall Study|Sponsor decision|0|||
16146657|NCT02953340|39024426|FG001|Overall Study|Sponsor decision|2|||
16146658|NCT02953340|39024425|FG000|Overall Study|Lost to Follow-up|3|||
16146659|NCT02953340|39024426|FG001|Overall Study|Lost to Follow-up|2|||
16146660|NCT02953340|39024425|FG000|Overall Study|Reason not specified|2|||
16146661|NCT02953340|39024426|FG001|Overall Study|Reason not specified|2|||
16146662|NCT00729378|39024427|FG000|Baseline|Did not complete study measurements|72|||
16146663|NCT00729378|39024428|FG001|Baseline|Did not complete study measurements|33|||
16146664|NCT00729378|39024427|FG000|Baseline|Withdrawal by Subject|66|||
16146665|NCT00729378|39024428|FG001|Baseline|Withdrawal by Subject|59|||
16146666|NCT00729378|39024427|FG000|12-months|Lost to Follow-up|100|||
16146667|NCT00729378|39024428|FG001|12-months|Lost to Follow-up|65|||
16146668|NCT00729378|39024427|FG000|24-months|Lost to Follow-up|72|||
16146669|NCT00729378|39024428|FG001|24-months|Lost to Follow-up|51|||
16146670|NCT00729378|39024427|FG000|36-months|Lost to Follow-up|15|||
16146671|NCT00729378|39024428|FG001|36-months|Lost to Follow-up|6|||
16146672|NCT03808688|39024429|FG000|Overall Study|Adverse Event|13|||
16146673|NCT03808688|39024430|FG001|Overall Study|Adverse Event|17|||
16146674|NCT03808688|39024429|FG000|Overall Study|Lack of Efficacy|2|||
16146675|NCT03808688|39024430|FG001|Overall Study|Lack of Efficacy|0|||
16146676|NCT03808688|39024429|FG000|Overall Study|Lost to Follow-up|0|||
16146677|NCT03808688|39024430|FG001|Overall Study|Lost to Follow-up|2|||
16146678|NCT03808688|39024429|FG000|Overall Study|Withdrawal by Subject|1|||
16146679|NCT03808688|39024430|FG001|Overall Study|Withdrawal by Subject|0|||
16146680|NCT03808688|39024429|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
16146681|NCT03808688|39024430|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
16146682|NCT03808688|39024429|FG000|Overall Study|IOP Too High|1|||
16146683|NCT03808688|39024430|FG001|Overall Study|IOP Too High|1|||
16146684|NCT03808688|39024429|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
16146685|NCT03808688|39024430|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
16146686|NCT03808688|39024429|FG000|Overall Study|Visit Out of Window|0|||
16146687|NCT03808688|39024430|FG001|Overall Study|Visit Out of Window|1|||
16146688|NCT03808688|39024429|FG000|Overall Study|Medication Non-Compliance|0|||
16146689|NCT03808688|39024430|FG001|Overall Study|Medication Non-Compliance|1|||
16146690|NCT00493220|39024431|FG000|Third Intervention|Withdrawal by Subject|1|||
16146691|NCT00493220|39024432|FG001|Third Intervention|Withdrawal by Subject|0|||
16146692|NCT00493220|39024433|FG002|Third Intervention|Withdrawal by Subject|0|||
16146693|NCT00493220|39024434|FG003|Third Intervention|Withdrawal by Subject|0|||
16146694|NCT00493220|39024435|FG004|Third Intervention|Withdrawal by Subject|0|||
16146695|NCT00493220|39024436|FG005|Third Intervention|Withdrawal by Subject|0|||
16146696|NCT00698932|39024437|FG000|Overall Study|Adverse Event|0|||
16146697|NCT00698932|39024438|FG001|Overall Study|Adverse Event|2|||
16259002|NCT03555305|39433674|FG000|Period 1|Adverse Event|0|||
16146698|NCT00698932|39024437|FG000|Overall Study|Incorrect enrollment|0|||
16146699|NCT00698932|39024438|FG001|Overall Study|Incorrect enrollment|2|||
16146700|NCT00698932|39024437|FG000|Overall Study|Study specific discontinuation criteria|3|||
16146701|NCT00698932|39024438|FG001|Overall Study|Study specific discontinuation criteria|4|||
16146702|NCT00698932|39024437|FG000|Overall Study|Withdrawal by Subject|11|||
16146703|NCT00698932|39024438|FG001|Overall Study|Withdrawal by Subject|23|||
16146704|NCT00698932|39024437|FG000|Overall Study|Lost to Follow-up|6|||
16146705|NCT00698932|39024438|FG001|Overall Study|Lost to Follow-up|1|||
16146706|NCT00698932|39024437|FG000|Overall Study|Severe non-compliance to protocol|1|||
16146707|NCT00698932|39024438|FG001|Overall Study|Severe non-compliance to protocol|2|||
16146708|NCT00698932|39024437|FG000|Overall Study|Safety reasons|0|||
16146709|NCT00698932|39024438|FG001|Overall Study|Safety reasons|2|||
16146710|NCT00698932|39024437|FG000|Overall Study|Death|1|||
16146711|NCT00698932|39024438|FG001|Overall Study|Death|0|||
16146712|NCT01754857|39024439|FG000|Overall Study|Adverse Event|7|||
16146713|NCT01754857|39024439|FG000|Overall Study|Disease progression|3|||
16146714|NCT01754857|39024439|FG000|Overall Study|Physician Decision|2|||
16146715|NCT01754857|39024439|FG000|Overall Study|Withdrawal by Subject|3|||
16146716|NCT01754857|39024439|FG000|Overall Study|other complicating disease|1|||
16146717|NCT01754857|39024439|FG000|Overall Study|ineligible to continue onto maintenance|1|||
16146718|NCT01754857|39024439|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
16146719|NCT01754857|39024439|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
16146720|NCT00475722|39024440|FG000|Overall Study|Withdrawal by Subject|12|||
16146721|NCT00475722|39024441|FG001|Overall Study|Withdrawal by Subject|12|||
16146722|NCT00475722|39024440|FG000|Overall Study|Protocol Violation|3|||
16146723|NCT00475722|39024441|FG001|Overall Study|Protocol Violation|0|||
16146724|NCT00750698|39024442|FG000|Overall Study|Withdrawal by Subject|1|||
16146725|NCT00750698|39024443|FG001|Overall Study|Withdrawal by Subject|0|||
16146726|NCT00750698|39024442|FG000|Overall Study|Progressive disease|5|||
16146727|NCT00750698|39024443|FG001|Overall Study|Progressive disease|2|||
16146728|NCT01045798|39024445|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
16146729|NCT01045798|39024446|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
16146730|NCT01045798|39024445|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
16146731|NCT01045798|39024446|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
16146732|NCT01045798|39024445|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
16146733|NCT01045798|39024446|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
16146734|NCT01045798|39024445|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
16146735|NCT01045798|39024446|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
16146736|NCT04206605|39024447|FG000|Overall Study|Adverse Event|0|||
16146737|NCT04206605|39024448|FG001|Overall Study|Adverse Event|1|||
16146738|NCT04206605|39024447|FG000|Overall Study|Withdrawal by Subject|1|||
16146739|NCT04206605|39024448|FG001|Overall Study|Withdrawal by Subject|0|||
16146740|NCT03631784|39024452|FG000|Overall Study|Death|48|||
16146741|NCT03631784|39024453|FG001|Overall Study|Death|28|||
16146742|NCT03631784|39024452|FG000|Overall Study|Lost to Follow-up|1|||
16146743|NCT03631784|39024453|FG001|Overall Study|Lost to Follow-up|0|||
16146744|NCT03631784|39024452|FG000|Overall Study|Withdrawal by Subject|0|||
16146745|NCT03631784|39024453|FG001|Overall Study|Withdrawal by Subject|3|||
16146746|NCT03631784|39024452|FG000|Overall Study|Participants Ongoing|63|||
16146747|NCT03631784|39024453|FG001|Overall Study|Participants Ongoing|71|||
16146748|NCT00433914|39024454|FG000|Overall Study|Withdrawal by Subject|0|||
16146749|NCT00433914|39024455|FG001|Overall Study|Withdrawal by Subject|2|||
16146750|NCT00433914|39024454|FG000|Overall Study|Lost to Follow-up|0|||
16146751|NCT00433914|39024455|FG001|Overall Study|Lost to Follow-up|1|||
16146752|NCT03155373|39024457|FG000|Overall Study|No longer required surgery|1|||
16146753|NCT03155373|39024457|FG000|Overall Study|Protocol Violation|1|||
16146754|NCT03155373|39024457|FG000|Overall Study|Death|2|||
16146755|NCT03155373|39024457|FG000|Overall Study|Withdrawal by Subject|3|||
16146756|NCT00827606|39024458|FG000|Overall Study|Protocol Violation|4|||
16146757|NCT00827606|39024459|FG001|Overall Study|Protocol Violation|3|||
16146758|NCT00827606|39024458|FG000|Overall Study|Lost to Follow-up|3|||
16146759|NCT00827606|39024459|FG001|Overall Study|Lost to Follow-up|1|||
16146760|NCT00827606|39024458|FG000|Overall Study|Withdrawal by Subject|7|||
16146761|NCT00827606|39024459|FG001|Overall Study|Withdrawal by Subject|6|||
16146762|NCT00827606|39024458|FG000|Overall Study|Pregnancy|0|||
16146763|NCT00827606|39024459|FG001|Overall Study|Pregnancy|1|||
16146764|NCT00827606|39024458|FG000|Overall Study|Other|5|||
16146765|NCT00827606|39024459|FG001|Overall Study|Other|13|||
16259003|NCT03555305|39433675|FG001|Period 1|Adverse Event|1|||
16146766|NCT00827606|39024458|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
16146767|NCT00827606|39024459|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
16146768|NCT00827606|39024458|FG000|Overall Study|Adverse Event|4|||
16146769|NCT00827606|39024459|FG001|Overall Study|Adverse Event|2|||
16146770|NCT04667377|39024460|FG000|Dose Escalation Period|Other not specified below|3|||
16146771|NCT04667377|39024461|FG001|Dose Escalation Period|Other not specified below|3|||
16146772|NCT04667377|39024462|FG002|Dose Escalation Period|Other not specified below|2|||
16146773|NCT04667377|39024463|FG003|Dose Escalation Period|Other not specified below|1|||
16146774|NCT04667377|39024464|FG004|Dose Escalation Period|Other not specified below|3|||
16146775|NCT04667377|39024460|FG000|Dose Escalation Period|Protocol Violation|2|||
16146776|NCT04667377|39024461|FG001|Dose Escalation Period|Protocol Violation|2|||
16146777|NCT04667377|39024462|FG002|Dose Escalation Period|Protocol Violation|0|||
16146778|NCT04667377|39024463|FG003|Dose Escalation Period|Protocol Violation|2|||
16146779|NCT04667377|39024464|FG004|Dose Escalation Period|Protocol Violation|1|||
16146780|NCT04667377|39024460|FG000|Dose Escalation Period|Burden of study procedures|2|||
16146781|NCT04667377|39024461|FG001|Dose Escalation Period|Burden of study procedures|1|||
16146782|NCT04667377|39024462|FG002|Dose Escalation Period|Burden of study procedures|1|||
16146783|NCT04667377|39024463|FG003|Dose Escalation Period|Burden of study procedures|1|||
16146784|NCT04667377|39024464|FG004|Dose Escalation Period|Burden of study procedures|5|||
16146785|NCT04667377|39024460|FG000|Dose Escalation Period|Change of residence|0|||
16146786|NCT04667377|39024461|FG001|Dose Escalation Period|Change of residence|0|||
16146787|NCT04667377|39024462|FG002|Dose Escalation Period|Change of residence|1|||
16146788|NCT04667377|39024463|FG003|Dose Escalation Period|Change of residence|0|||
16146789|NCT04667377|39024464|FG004|Dose Escalation Period|Change of residence|0|||
16146790|NCT04667377|39024460|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
16146791|NCT04667377|39024461|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
16146792|NCT04667377|39024462|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
16146793|NCT04667377|39024463|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
16146794|NCT04667377|39024464|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
16146795|NCT04667377|39024460|FG000|Dose Escalation Period|Adverse Event|9|||
16146796|NCT04667377|39024461|FG001|Dose Escalation Period|Adverse Event|10|||
16146797|NCT04667377|39024462|FG002|Dose Escalation Period|Adverse Event|12|||
16146798|NCT04667377|39024463|FG003|Dose Escalation Period|Adverse Event|17|||
16146799|NCT04667377|39024464|FG004|Dose Escalation Period|Adverse Event|3|||
16146800|NCT04667377|39024460|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
16146801|NCT04667377|39024461|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
16146802|NCT04667377|39024462|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
16146803|NCT04667377|39024463|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
16146804|NCT04667377|39024464|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
16146805|NCT04667377|39024460|FG000|Dose Escalation Period|Not treated|1|||
16146806|NCT04667377|39024461|FG001|Dose Escalation Period|Not treated|0|||
16146807|NCT04667377|39024462|FG002|Dose Escalation Period|Not treated|0|||
16146808|NCT04667377|39024463|FG003|Dose Escalation Period|Not treated|0|||
16146809|NCT04667377|39024464|FG004|Dose Escalation Period|Not treated|0|||
16146810|NCT04667377|39024460|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
16146811|NCT04667377|39024461|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
16146812|NCT04667377|39024462|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
16146813|NCT04667377|39024463|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
16146814|NCT04667377|39024464|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
16146815|NCT04667377|39024460|FG000|Dose Escalation Period|Lost to Follow-up|0|||
16146816|NCT04667377|39024461|FG001|Dose Escalation Period|Lost to Follow-up|1|||
16146817|NCT04667377|39024462|FG002|Dose Escalation Period|Lost to Follow-up|0|||
16146818|NCT04667377|39024463|FG003|Dose Escalation Period|Lost to Follow-up|0|||
16146819|NCT04667377|39024464|FG004|Dose Escalation Period|Lost to Follow-up|0|||
16146820|NCT04667377|39024460|FG000|Maintenance Period|Perceived lack of efficacy|0|||
16146821|NCT04667377|39024461|FG001|Maintenance Period|Perceived lack of efficacy|2|||
16146822|NCT04667377|39024462|FG002|Maintenance Period|Perceived lack of efficacy|1|||
16146823|NCT04667377|39024463|FG003|Maintenance Period|Perceived lack of efficacy|0|||
16146824|NCT04667377|39024464|FG004|Maintenance Period|Perceived lack of efficacy|1|||
16146825|NCT04667377|39024460|FG000|Maintenance Period|Adverse Event|2|||
16146826|NCT04667377|39024461|FG001|Maintenance Period|Adverse Event|8|||
16146827|NCT04667377|39024462|FG002|Maintenance Period|Adverse Event|5|||
16146828|NCT04667377|39024463|FG003|Maintenance Period|Adverse Event|4|||
16146829|NCT04667377|39024464|FG004|Maintenance Period|Adverse Event|1|||
16146830|NCT04667377|39024460|FG000|Maintenance Period|Adverse event: COVID infection|0|||
16146831|NCT04667377|39024461|FG001|Maintenance Period|Adverse event: COVID infection|1|||
16146832|NCT04667377|39024462|FG002|Maintenance Period|Adverse event: COVID infection|0|||
16146833|NCT04667377|39024463|FG003|Maintenance Period|Adverse event: COVID infection|0|||
16146834|NCT04667377|39024464|FG004|Maintenance Period|Adverse event: COVID infection|0|||
16146835|NCT04667377|39024460|FG000|Maintenance Period|COVID-related|0|||
16146836|NCT04667377|39024461|FG001|Maintenance Period|COVID-related|0|||
16146837|NCT04667377|39024462|FG002|Maintenance Period|COVID-related|1|||
16146838|NCT04667377|39024463|FG003|Maintenance Period|COVID-related|1|||
16146839|NCT04667377|39024464|FG004|Maintenance Period|COVID-related|0|||
16146840|NCT04667377|39024460|FG000|Maintenance Period|Protocol Violation|1|||
16146841|NCT04667377|39024461|FG001|Maintenance Period|Protocol Violation|0|||
16146842|NCT04667377|39024462|FG002|Maintenance Period|Protocol Violation|0|||
16146843|NCT04667377|39024463|FG003|Maintenance Period|Protocol Violation|0|||
16146844|NCT04667377|39024464|FG004|Maintenance Period|Protocol Violation|1|||
16146845|NCT04667377|39024460|FG000|Maintenance Period|Burden of study procedures|1|||
16146846|NCT04667377|39024461|FG001|Maintenance Period|Burden of study procedures|2|||
16146847|NCT04667377|39024462|FG002|Maintenance Period|Burden of study procedures|0|||
16146848|NCT04667377|39024463|FG003|Maintenance Period|Burden of study procedures|1|||
16146849|NCT04667377|39024464|FG004|Maintenance Period|Burden of study procedures|0|||
16146850|NCT04667377|39024460|FG000|Maintenance Period|Change of residence|0|||
16146851|NCT04667377|39024461|FG001|Maintenance Period|Change of residence|1|||
16146852|NCT04667377|39024462|FG002|Maintenance Period|Change of residence|0|||
16146853|NCT04667377|39024463|FG003|Maintenance Period|Change of residence|0|||
16146854|NCT04667377|39024464|FG004|Maintenance Period|Change of residence|1|||
16146855|NCT04667377|39024460|FG000|Maintenance Period|Missing|1|||
16146856|NCT04667377|39024461|FG001|Maintenance Period|Missing|0|||
16146857|NCT04667377|39024462|FG002|Maintenance Period|Missing|0|||
16146858|NCT04667377|39024463|FG003|Maintenance Period|Missing|0|||
16146859|NCT04667377|39024464|FG004|Maintenance Period|Missing|0|||
16146860|NCT04667377|39024460|FG000|Maintenance Period|Other than listed above|2|||
16146861|NCT04667377|39024461|FG001|Maintenance Period|Other than listed above|0|||
16146862|NCT04667377|39024462|FG002|Maintenance Period|Other than listed above|3|||
16146863|NCT04667377|39024463|FG003|Maintenance Period|Other than listed above|2|||
16146864|NCT04667377|39024464|FG004|Maintenance Period|Other than listed above|6|||
16146865|NCT04667377|39024460|FG000|Maintenance Period|Withdrawal by Subject|0|||
16146866|NCT04667377|39024461|FG001|Maintenance Period|Withdrawal by Subject|1|||
16146867|NCT04667377|39024462|FG002|Maintenance Period|Withdrawal by Subject|0|||
16146868|NCT04667377|39024463|FG003|Maintenance Period|Withdrawal by Subject|0|||
16146869|NCT04667377|39024464|FG004|Maintenance Period|Withdrawal by Subject|0|||
16440439|NCT00129402|40092687|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
16146870|NCT04667377|39024460|FG000|Maintenance Period|Lost to Follow-up|1|||
16146871|NCT04667377|39024461|FG001|Maintenance Period|Lost to Follow-up|0|||
16146872|NCT04667377|39024462|FG002|Maintenance Period|Lost to Follow-up|1|||
16146873|NCT04667377|39024463|FG003|Maintenance Period|Lost to Follow-up|0|||
16146874|NCT04667377|39024464|FG004|Maintenance Period|Lost to Follow-up|1|||
16146875|NCT00682448|39024465|FG000|Overall Study|Adverse Event|1|||
16146876|NCT00682448|39024466|FG001|Overall Study|Adverse Event|2|||
16146877|NCT00682448|39024465|FG000|Overall Study|Lack of Efficacy|1|||
16146878|NCT00682448|39024466|FG001|Overall Study|Lack of Efficacy|0|||
16146879|NCT00682448|39024465|FG000|Overall Study|Lost to Follow-up|1|||
16146880|NCT00682448|39024466|FG001|Overall Study|Lost to Follow-up|3|||
16146881|NCT00682448|39024465|FG000|Overall Study|Pregnancy|0|||
16146882|NCT00682448|39024466|FG001|Overall Study|Pregnancy|1|||
16146883|NCT00682448|39024465|FG000|Overall Study|Withdrawal by Subject|2|||
16146884|NCT00682448|39024466|FG001|Overall Study|Withdrawal by Subject|0|||
16146885|NCT03329196|39024474|FG000|Overall Study|Adverse Event|10|||
16146886|NCT03329196|39024475|FG001|Overall Study|Adverse Event|5|||
16146887|NCT03329196|39024474|FG000|Overall Study|Physician Decision|2|||
16146888|NCT03329196|39024475|FG001|Overall Study|Physician Decision|2|||
16146889|NCT03329196|39024474|FG000|Overall Study|Withdrawal by Subject|11|||
16146890|NCT03329196|39024475|FG001|Overall Study|Withdrawal by Subject|3|||
16146891|NCT03329196|39024474|FG000|Overall Study|Hepatic function abnormalities|0|||
16146892|NCT03329196|39024475|FG001|Overall Study|Hepatic function abnormalities|1|||
16146893|NCT03329196|39024474|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
16146894|NCT03329196|39024475|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
16146895|NCT03329196|39024474|FG000|Overall Study|Difficult to control Hb|2|||
16146896|NCT03329196|39024475|FG001|Overall Study|Difficult to control Hb|3|||
16146897|NCT03329196|39024474|FG000|Overall Study|Dialysis or renal transplant|13|||
16146898|NCT03329196|39024475|FG001|Overall Study|Dialysis or renal transplant|15|||
16146899|NCT03422172|39024476|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
16146900|NCT03422172|39024476|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
16146901|NCT03422172|39024476|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
16146902|NCT00454857|39024477|FG000|Overall Study|Withdrawal by Subject|15|||
16146903|NCT00454857|39024477|FG000|Overall Study|Lost to Follow-up|16|||
16146904|NCT00454857|39024477|FG000|Overall Study|Noncompliance|6|||
16146905|NCT00454857|39024477|FG000|Overall Study|Death|5|||
16146906|NCT00454857|39024477|FG000|Overall Study|Other|11|||
16146907|NCT00454857|39024477|FG000|Overall Study|Reason unknown|1|||
16146908|NCT00470054|39024478|FG000|Overall Study|Ineligible|1|||
16146909|NCT00295633|39024479|FG000|Overall Study|Lack of Efficacy|19|||
16146910|NCT00295633|39024480|FG001|Overall Study|Lack of Efficacy|7|||
16146911|NCT00295633|39024481|FG002|Overall Study|Lack of Efficacy|16|||
16146912|NCT00295633|39024479|FG000|Overall Study|Withdrawal of consent by subject|16|||
16146913|NCT00295633|39024480|FG001|Overall Study|Withdrawal of consent by subject|16|||
16146914|NCT00295633|39024481|FG002|Overall Study|Withdrawal of consent by subject|26|||
16146915|NCT00295633|39024479|FG000|Overall Study|Adverse Event|9|||
16146916|NCT00295633|39024480|FG001|Overall Study|Adverse Event|17|||
16146917|NCT00295633|39024481|FG002|Overall Study|Adverse Event|9|||
16146918|NCT00295633|39024479|FG000|Overall Study|Lost to Follow-up|6|||
16146919|NCT00295633|39024480|FG001|Overall Study|Lost to Follow-up|11|||
16146920|NCT00295633|39024481|FG002|Overall Study|Lost to Follow-up|7|||
16146921|NCT00295633|39024479|FG000|Overall Study|Physician Decision|9|||
16146922|NCT00295633|39024480|FG001|Overall Study|Physician Decision|10|||
16146923|NCT00295633|39024481|FG002|Overall Study|Physician Decision|8|||
16146924|NCT00295633|39024479|FG000|Overall Study|Poor/Noncompliance|2|||
16146925|NCT00295633|39024480|FG001|Overall Study|Poor/Noncompliance|2|||
16146926|NCT00295633|39024481|FG002|Overall Study|Poor/Noncompliance|6|||
16146927|NCT00295633|39024479|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
16146928|NCT00295633|39024480|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
16146929|NCT00295633|39024481|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
16146930|NCT00295633|39024479|FG000|Overall Study|Death|1|||
16146931|NCT00295633|39024480|FG001|Overall Study|Death|1|||
16146932|NCT00295633|39024481|FG002|Overall Study|Death|0|||
16146933|NCT00295633|39024479|FG000|Overall Study|Administrative reason by sponsor|0|||
16146934|NCT00295633|39024480|FG001|Overall Study|Administrative reason by sponsor|0|||
16146935|NCT00295633|39024481|FG002|Overall Study|Administrative reason by sponsor|1|||
16146936|NCT02194062|39024482|FG000|Overall Study|Lost to Follow-up|2|||
16146937|NCT02194062|39024483|FG001|Overall Study|Lost to Follow-up|2|||
16146938|NCT02194062|39024484|FG002|Overall Study|Lost to Follow-up|5|||
16146939|NCT00290186|39024492|FG000|Overall Study|Adverse Event|1|||
16146940|NCT00290186|39024493|FG001|Overall Study|Adverse Event|1|||
16146941|NCT00290186|39024492|FG000|Overall Study|Lost to Follow-up|3|||
16146942|NCT00290186|39024493|FG001|Overall Study|Lost to Follow-up|2|||
16146943|NCT00290186|39024492|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
16146944|NCT00290186|39024493|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
16146945|NCT00290186|39024492|FG000|Overall Study|Withdrawal by Subject|0|||
16146946|NCT00290186|39024493|FG001|Overall Study|Withdrawal by Subject|1|||
16146947|NCT00577642|39024494|FG000|Overall Study|Clinical Disease Progression|1|||
16146948|NCT03335163|39024495|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
16146949|NCT03335163|39024495|FG000|Overall Study|Withdrawal by Subject|18|||
16146950|NCT01490814|39024496|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
16146951|NCT01490814|39024497|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
16146952|NCT01490814|39024496|FG000|Overall Study|Physician Decision|1|||
16364580|NCT02452190|39821373|FG001|Overall Study|Investigator's Decision|0|||
16364581|NCT02452190|39821372|FG000|Overall Study|Lack of Efficacy|3|||
16364582|NCT02452190|39821373|FG001|Overall Study|Lack of Efficacy|1|||
16364583|NCT02452190|39821372|FG000|Overall Study|Lost to Follow-up|4|||
16364584|NCT02452190|39821373|FG001|Overall Study|Lost to Follow-up|3|||
16364585|NCT02452190|39821372|FG000|Overall Study|Adverse Event|2|||
16364586|NCT02452190|39821373|FG001|Overall Study|Adverse Event|5|||
16364587|NCT02452190|39821372|FG000|Overall Study|Withdrawal by Subject|20|||
16364588|NCT02452190|39821373|FG001|Overall Study|Withdrawal by Subject|11|||
16364589|NCT02452190|39821372|FG000|Overall Study|Noncompliance with study drug|1|||
16364590|NCT02452190|39821373|FG001|Overall Study|Noncompliance with study drug|0|||
16364591|NCT02452190|39821372|FG000|Overall Study|Participant traveled abroad|1|||
16364592|NCT02452190|39821373|FG001|Overall Study|Participant traveled abroad|0|||
16364593|NCT02452190|39821372|FG000|Overall Study|Death|0|||
16364594|NCT02452190|39821373|FG001|Overall Study|Death|1|||
16364595|NCT00929669|39821374|FG000|Overall Study|elevated glucose levels|1|||
16364596|NCT03670628|39821375|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
16364597|NCT03670628|39821376|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
16364598|NCT03670628|39821375|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
16364599|NCT03670628|39821376|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
16364600|NCT02114684|39821377|FG000|Overall Study|Death|6|||
16364601|NCT02114684|39821378|FG001|Overall Study|Death|4|||
16364602|NCT02114684|39821377|FG000|Overall Study|Lost to Follow-up|1|||
16364603|NCT02114684|39821378|FG001|Overall Study|Lost to Follow-up|2|||
16364604|NCT02114684|39821377|FG000|Overall Study|Withdrawal by Subject|1|||
16364605|NCT02114684|39821378|FG001|Overall Study|Withdrawal by Subject|2|||
16364606|NCT02114684|39821377|FG000|Overall Study|Relocation|3|||
16364607|NCT02114684|39821378|FG001|Overall Study|Relocation|1|||
16364608|NCT02114684|39821377|FG000|Overall Study|Rifampicin resistant on culture|0|||
16364609|NCT02114684|39821378|FG001|Overall Study|Rifampicin resistant on culture|1|||
16364610|NCT02114684|39821377|FG000|Overall Study|Patient Incarcerated|1|||
16364611|NCT02114684|39821378|FG001|Overall Study|Patient Incarcerated|0|||
16364612|NCT02875080|39821379|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
16364613|NCT02875080|39821380|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
16364614|NCT02875080|39821381|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
16364615|NCT00876395|39821384|FG000|Overall Study|Untreated|8|||
16364616|NCT00876395|39821385|FG001|Overall Study|Untreated|1|||
16364617|NCT00876395|39821384|FG000|Overall Study|Adverse Event|63|||
16364618|NCT00876395|39821385|FG001|Overall Study|Adverse Event|11|||
16364619|NCT00876395|39821384|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16364620|NCT00876395|39821385|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16364621|NCT00876395|39821384|FG000|Overall Study|Disease progression|259|||
16364622|NCT00876395|39821385|FG001|Overall Study|Disease progression|162|||
16364623|NCT00876395|39821384|FG000|Overall Study|New cancer therapy|25|||
16364624|NCT00876395|39821385|FG001|Overall Study|New cancer therapy|7|||
16364625|NCT00876395|39821384|FG000|Overall Study|Protocol Violation|5|||
16364626|NCT00876395|39821385|FG001|Overall Study|Protocol Violation|2|||
16364627|NCT00876395|39821384|FG000|Overall Study|Withdrawal by Subject|66|||
16440440|NCT00129402|40092688|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
16440441|NCT00129402|40092689|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
16440442|NCT00129402|40092690|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
16440443|NCT00129402|40092691|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
16440444|NCT00129402|40092692|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
16440445|NCT00129402|40092693|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
16440446|NCT00129402|40092687|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
16440447|NCT00129402|40092688|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
16440448|NCT00129402|40092689|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
16146953|NCT01490814|39024497|FG001|Overall Study|Physician Decision|0|||
16146954|NCT01490814|39024496|FG000|Overall Study|Withdrawal by Subject|0|||
16146955|NCT01490814|39024497|FG001|Overall Study|Withdrawal by Subject|5|||
16146956|NCT00955279|39024498|FG000|Overall Study|Other|0|||
16146957|NCT00955279|39024499|FG001|Overall Study|Other|0|||
16146958|NCT00955279|39024500|FG002|Overall Study|Other|3|||
16146959|NCT00955279|39024498|FG000|Overall Study|Death|1|||
16146960|NCT00955279|39024499|FG001|Overall Study|Death|1|||
16146961|NCT00955279|39024500|FG002|Overall Study|Death|1|||
16146962|NCT00955279|39024498|FG000|Overall Study|Lost to Follow-up|0|||
16146963|NCT00955279|39024499|FG001|Overall Study|Lost to Follow-up|3|||
16146964|NCT00955279|39024500|FG002|Overall Study|Lost to Follow-up|1|||
16146965|NCT00955279|39024498|FG000|Overall Study|Withdrawal by Subject|2|||
16146966|NCT00955279|39024499|FG001|Overall Study|Withdrawal by Subject|0|||
16146967|NCT00955279|39024500|FG002|Overall Study|Withdrawal by Subject|3|||
16146968|NCT00359021|39024501|FG000|Overall Study|Adverse Event|26|||
16146969|NCT00359021|39024502|FG001|Overall Study|Adverse Event|8|||
16440449|NCT00129402|40092690|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
16440450|NCT00129402|40092691|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
16440451|NCT00129402|40092692|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
16440452|NCT00129402|40092693|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
16146970|NCT00359021|39024501|FG000|Overall Study|Subject Non-Compliant|1|||
16146971|NCT00359021|39024502|FG001|Overall Study|Subject Non-Compliant|2|||
16259004|NCT01921062|39433676|FG000|Overall Study|Withdrawal by Subject|0|||
16259005|NCT01921062|39433677|FG001|Overall Study|Withdrawal by Subject|7|||
16259006|NCT01921062|39433676|FG000|Overall Study|Adverse Event|5|||
16259007|NCT01921062|39433677|FG001|Overall Study|Adverse Event|6|||
16259008|NCT01921062|39433676|FG000|Overall Study|Protocol Violation|0|||
16259009|NCT01921062|39433677|FG001|Overall Study|Protocol Violation|1|||
16259010|NCT01921062|39433676|FG000|Overall Study|VMIQ score > 72|4|||
16259011|NCT01921062|39433677|FG001|Overall Study|VMIQ score > 72|1|||
16259012|NCT01921062|39433676|FG000|Overall Study|Logistic error|0|||
16259013|NCT01921062|39433677|FG001|Overall Study|Logistic error|1|||
16259014|NCT00467896|39433686|FG000|Overall Study|Consent Withdrawal|18|||
16259015|NCT00467896|39433686|FG000|Overall Study|Adverse Event|7|||
16259016|NCT00467896|39433686|FG000|Overall Study|Serious Adverse Event|13|||
16259017|NCT00467896|39433686|FG000|Overall Study|Non-compliance|3|||
16259018|NCT00467896|39433686|FG000|Overall Study|Changed therapy|2|||
16259019|NCT00467896|39433686|FG000|Overall Study|Patient received transplant|2|||
16259020|NCT00467896|39433686|FG000|Overall Study|Patient had atrial septostomy|1|||
16259021|NCT00467896|39433686|FG000|Overall Study|Patient weaned off iloprost|1|||
16259022|NCT00467896|39433686|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
16259023|NCT00467896|39433686|FG000|Overall Study|Started intravenous prostacyclin|1|||
16259024|NCT00467896|39433686|FG000|Overall Study|Started inhaled Remodulin|1|||
16259025|NCT00467896|39433686|FG000|Overall Study|Patient had no improvement|1|||
16259026|NCT00282048|39433691|FG000|Overall Study|Lack of Efficacy|30|||
16259027|NCT00282048|39433691|FG000|Overall Study|Adverse Event|22|||
16259028|NCT00282048|39433691|FG000|Overall Study|Withdrawal by Subject|1|||
16259029|NCT00282048|39433691|FG000|Overall Study|Other|8|||
16259030|NCT00282048|39433691|FG000|Overall Study|Ongoing|1|||
16259031|NCT02066922|39433692|FG000|Overall Study|Adverse Event|1|||
16259032|NCT02656706|39433693|FG000|Overall Study|Insurance Denial|1|||
16440453|NCT00129402|40092687|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
16440454|NCT00129402|40092688|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
16440455|NCT00129402|40092689|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
16146972|NCT00359021|39024501|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
16146973|NCT00359021|39024502|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
16259033|NCT02996682|39433695|FG000|Overall Study|Death|0|||
16259034|NCT02996682|39433696|FG001|Overall Study|Death|3|||
16259035|NCT02170688|39433697|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
16259036|NCT02170688|39433698|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
16259037|NCT02170688|39433699|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
16259038|NCT02170688|39433700|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
16259039|NCT02170688|39433701|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
16259040|NCT02170688|39433697|FG000|Overall Study|Full dose not received|0|||
16259041|NCT02170688|39433698|FG001|Overall Study|Full dose not received|1|||
16259042|NCT02170688|39433699|FG002|Overall Study|Full dose not received|0|||
16259043|NCT02170688|39433700|FG003|Overall Study|Full dose not received|0|||
16259044|NCT02170688|39433701|FG004|Overall Study|Full dose not received|0|||
16259045|NCT02170688|39433697|FG000|Overall Study|Physician Decision|0|||
16259046|NCT02170688|39433698|FG001|Overall Study|Physician Decision|0|||
16259047|NCT02170688|39433699|FG002|Overall Study|Physician Decision|1|||
16259048|NCT02170688|39433700|FG003|Overall Study|Physician Decision|0|||
16259049|NCT02170688|39433701|FG004|Overall Study|Physician Decision|0|||
16259050|NCT00565448|39433703|FG000|Overall Study|Adverse Event|1|||
16259051|NCT00565448|39433704|FG001|Overall Study|Adverse Event|2|||
16259052|NCT00565448|39433703|FG000|Overall Study|Disease progression|1|||
16259053|NCT00565448|39433704|FG001|Overall Study|Disease progression|0|||
16259054|NCT00565448|39433703|FG000|Overall Study|Withdrawal by Subject|1|||
16259055|NCT00565448|39433704|FG001|Overall Study|Withdrawal by Subject|0|||
16259056|NCT00995553|39433705|FG000|Overall Study|Withdrawal by Subject|2|||
16259057|NCT00995553|39433706|FG001|Overall Study|Withdrawal by Subject|6|||
16259058|NCT01223365|39433708|FG000|Open-label Titration Period|Enrolled but not treated|1|||
16259059|NCT01223365|39433708|FG000|Open-label Titration Period|Adverse Event|23|||
16259060|NCT01223365|39433708|FG000|Open-label Titration Period|Lack of Efficacy|3|||
16259061|NCT01223365|39433708|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
16259062|NCT01223365|39433708|FG000|Open-label Titration Period|Protocol Violation|1|||
16259063|NCT01223365|39433708|FG000|Open-label Titration Period|Lost to Follow-up|2|||
16259064|NCT01223365|39433708|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
16259065|NCT01223365|39433708|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
16259066|NCT01223365|39433708|FG000|Open-label Titration Period|Starting physical therapy|1|||
16259067|NCT01223365|39433708|FG000|Open-label Treatment Period|Adverse Event|39|||
16259068|NCT01223365|39433708|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
16259069|NCT01223365|39433708|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
16259070|NCT01223365|39433708|FG000|Open-label Treatment Period|Protocol Violation|15|||
16259071|NCT01223365|39433708|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
16259072|NCT01223365|39433708|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
16259073|NCT01223365|39433708|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
16259074|NCT01223365|39433708|FG000|Open-label Treatment Period|Moved out of area|2|||
16259075|NCT01223365|39433708|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
16259076|NCT01223365|39433708|FG000|Open-label Treatment Period|"Out of window"|1|||
16259077|NCT01223365|39433708|FG000|Open-label Treatment Period|Starting physical therapy|1|||
16259078|NCT01223365|39433708|FG000|Open-label Treatment Period|Physician Decision|2|||
16259079|NCT00440297|39433717|FG000|Overall Study|Adverse Event|8|||
16259080|NCT00440297|39433718|FG001|Overall Study|Adverse Event|5|||
16259081|NCT00440297|39433717|FG000|Overall Study|Lost to Follow-up|1|||
16259082|NCT00440297|39433718|FG001|Overall Study|Lost to Follow-up|0|||
16259083|NCT00440297|39433717|FG000|Overall Study|Physician Decision|1|||
16259084|NCT00440297|39433718|FG001|Overall Study|Physician Decision|0|||
16259085|NCT00440297|39433717|FG000|Overall Study|Protocol Violation|11|||
16259086|NCT00440297|39433718|FG001|Overall Study|Protocol Violation|7|||
16259087|NCT00440297|39433717|FG000|Overall Study|Withdrawal by Subject|1|||
16259088|NCT00440297|39433718|FG001|Overall Study|Withdrawal by Subject|6|||
16259089|NCT00440297|39433717|FG000|Overall Study|Randomized by mistake|1|||
16259090|NCT00440297|39433718|FG001|Overall Study|Randomized by mistake|0|||
16259091|NCT03497897|39433719|FG000|Overall Study|Adverse Event|1|||
16259092|NCT03497897|39433720|FG001|Overall Study|Adverse Event|1|||
16259093|NCT03497897|39433721|FG002|Overall Study|Adverse Event|1|||
16259094|NCT03497897|39433719|FG000|Overall Study|Lost to Follow-up|2|||
16259095|NCT03497897|39433720|FG001|Overall Study|Lost to Follow-up|0|||
16259096|NCT03497897|39433721|FG002|Overall Study|Lost to Follow-up|2|||
16259097|NCT03497897|39433719|FG000|Overall Study|Physician Decision|1|||
16259098|NCT03497897|39433720|FG001|Overall Study|Physician Decision|0|||
16259099|NCT03497897|39433721|FG002|Overall Study|Physician Decision|0|||
16259100|NCT03497897|39433719|FG000|Overall Study|Subject/Guardian Decision|2|||
16259101|NCT03497897|39433720|FG001|Overall Study|Subject/Guardian Decision|1|||
16259102|NCT03497897|39433721|FG002|Overall Study|Subject/Guardian Decision|3|||
16259103|NCT00856388|39433722|FG000|Overall Study|Other|1|||
16259104|NCT03262012|39433723|FG000|Overall Study|Withdrawal by Subject|15|||
16259105|NCT03262012|39433724|FG001|Overall Study|Withdrawal by Subject|13|||
16259106|NCT03262012|39433725|FG002|Overall Study|Withdrawal by Subject|8|||
16259107|NCT03262012|39433726|FG003|Overall Study|Withdrawal by Subject|7|||
16259108|NCT03262012|39433723|FG000|Overall Study|Adverse Event|10|||
16259109|NCT03262012|39433724|FG001|Overall Study|Adverse Event|12|||
16259110|NCT03262012|39433725|FG002|Overall Study|Adverse Event|4|||
16259111|NCT03262012|39433726|FG003|Overall Study|Adverse Event|6|||
16259112|NCT03262012|39433723|FG000|Overall Study|Physician Decision|2|||
16259113|NCT03262012|39433724|FG001|Overall Study|Physician Decision|5|||
16259114|NCT03262012|39433725|FG002|Overall Study|Physician Decision|1|||
16259115|NCT03262012|39433726|FG003|Overall Study|Physician Decision|0|||
16259116|NCT03262012|39433723|FG000|Overall Study|Lack of Efficacy|0|||
16259117|NCT03262012|39433724|FG001|Overall Study|Lack of Efficacy|5|||
16259118|NCT03262012|39433725|FG002|Overall Study|Lack of Efficacy|1|||
16440456|NCT00129402|40092690|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
16440457|NCT00129402|40092691|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
16440458|NCT00129402|40092692|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
16440459|NCT00129402|40092693|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
16440460|NCT00129402|40092687|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
16440461|NCT00129402|40092688|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
16259119|NCT03262012|39433726|FG003|Overall Study|Lack of Efficacy|2|||
16259120|NCT03262012|39433723|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
16259121|NCT03262012|39433724|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
16259122|NCT03262012|39433725|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
16259123|NCT03262012|39433726|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
16259124|NCT01457053|39433728|FG000|Overall Study|Unable to undergo selected treatment|1|||
16259125|NCT01457053|39433729|FG001|Overall Study|Unable to undergo selected treatment|1|||
16259126|NCT00463606|39433734|FG000|Overall Study|Adverse Event|21|||
16259127|NCT00463606|39433735|FG001|Overall Study|Adverse Event|18|||
16259128|NCT00463606|39433736|FG002|Overall Study|Adverse Event|11|||
16259129|NCT00463606|39433734|FG000|Overall Study|Withdrawal by Subject|11|||
16259130|NCT00463606|39433735|FG001|Overall Study|Withdrawal by Subject|11|||
16259131|NCT00463606|39433736|FG002|Overall Study|Withdrawal by Subject|5|||
16259132|NCT00463606|39433734|FG000|Overall Study|Lost to Follow-up|2|||
16259133|NCT00463606|39433735|FG001|Overall Study|Lost to Follow-up|2|||
16259134|NCT00463606|39433736|FG002|Overall Study|Lost to Follow-up|3|||
16259135|NCT00463606|39433734|FG000|Overall Study|Subject noncompliance|1|||
16259136|NCT00463606|39433735|FG001|Overall Study|Subject noncompliance|1|||
16259137|NCT00463606|39433736|FG002|Overall Study|Subject noncompliance|0|||
16259138|NCT00463606|39433734|FG000|Overall Study|Subject moved out of town|1|||
16259139|NCT00463606|39433735|FG001|Overall Study|Subject moved out of town|0|||
16259140|NCT00463606|39433736|FG002|Overall Study|Subject moved out of town|0|||
16259141|NCT00463606|39433734|FG000|Overall Study|Physician Decision|0|||
16259142|NCT00463606|39433735|FG001|Overall Study|Physician Decision|1|||
16259143|NCT00463606|39433736|FG002|Overall Study|Physician Decision|0|||
16259144|NCT00463606|39433734|FG000|Overall Study|Sponsor request|0|||
16259145|NCT00463606|39433735|FG001|Overall Study|Sponsor request|1|||
16259146|NCT00463606|39433736|FG002|Overall Study|Sponsor request|0|||
16259147|NCT00463606|39433734|FG000|Overall Study|Exclusion criteria violation|2|||
16259148|NCT00463606|39433735|FG001|Overall Study|Exclusion criteria violation|0|||
16259149|NCT00463606|39433736|FG002|Overall Study|Exclusion criteria violation|0|||
16259150|NCT00463606|39433734|FG000|Overall Study|Coordinator error|1|||
16259151|NCT00463606|39433735|FG001|Overall Study|Coordinator error|0|||
16259152|NCT00463606|39433736|FG002|Overall Study|Coordinator error|0|||
16259153|NCT00463606|39433734|FG000|Overall Study|Patient randomized in error|1|||
16259154|NCT00463606|39433735|FG001|Overall Study|Patient randomized in error|0|||
16259155|NCT00463606|39433736|FG002|Overall Study|Patient randomized in error|0|||
16259156|NCT00463606|39433734|FG000|Overall Study|Participation in another ABT-335 trial|1|||
16259157|NCT00463606|39433735|FG001|Overall Study|Participation in another ABT-335 trial|0|||
16259158|NCT00463606|39433736|FG002|Overall Study|Participation in another ABT-335 trial|0|||
16259159|NCT00463606|39433734|FG000|Overall Study|Protocol Violation|0|||
16259160|NCT00463606|39433735|FG001|Overall Study|Protocol Violation|0|||
16259161|NCT00463606|39433736|FG002|Overall Study|Protocol Violation|1|||
16259162|NCT02937701|39433738|FG000|Day 1 to Week 22|Adverse Event|11|||
16259163|NCT02937701|39433739|FG001|Day 1 to Week 22|Adverse Event|14|||
16259164|NCT02937701|39433740|FG002|Day 1 to Week 22|Adverse Event|0|||
16259165|NCT02937701|39433741|FG003|Day 1 to Week 22|Adverse Event|0|||
16259166|NCT02937701|39433742|FG004|Day 1 to Week 22|Adverse Event|0|||
16259167|NCT02937701|39433738|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
16259168|NCT02937701|39433739|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
16259169|NCT02937701|39433740|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
16440462|NCT00129402|40092689|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
16259170|NCT02937701|39433741|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
16259171|NCT02937701|39433742|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
16259172|NCT02937701|39433738|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
16259173|NCT02937701|39433739|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
16259174|NCT02937701|39433740|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
16259175|NCT02937701|39433741|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
16259176|NCT02937701|39433742|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
16259177|NCT02937701|39433738|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
16259178|NCT02937701|39433739|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
16259179|NCT02937701|39433740|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
16259180|NCT02937701|39433741|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
16259181|NCT02937701|39433742|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
16259182|NCT02937701|39433738|FG000|Day 1 to Week 22|Death|1|||
16259183|NCT02937701|39433739|FG001|Day 1 to Week 22|Death|1|||
16259184|NCT02937701|39433740|FG002|Day 1 to Week 22|Death|0|||
16259185|NCT02937701|39433741|FG003|Day 1 to Week 22|Death|0|||
16259186|NCT02937701|39433742|FG004|Day 1 to Week 22|Death|0|||
16259187|NCT02937701|39433738|FG000|Day 1 to Week 22|Protocol Violation|1|||
16259188|NCT02937701|39433739|FG001|Day 1 to Week 22|Protocol Violation|1|||
16259189|NCT02937701|39433740|FG002|Day 1 to Week 22|Protocol Violation|0|||
16259190|NCT02937701|39433741|FG003|Day 1 to Week 22|Protocol Violation|0|||
16259191|NCT02937701|39433742|FG004|Day 1 to Week 22|Protocol Violation|0|||
16259192|NCT02937701|39433738|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
16259193|NCT02937701|39433739|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
16259194|NCT02937701|39433740|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
16259195|NCT02937701|39433741|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
16259196|NCT02937701|39433742|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
16259197|NCT02937701|39433738|FG000|Day 1 to Week 22|Physician Decision|2|||
16259198|NCT02937701|39433739|FG001|Day 1 to Week 22|Physician Decision|0|||
16259199|NCT02937701|39433740|FG002|Day 1 to Week 22|Physician Decision|0|||
16259200|NCT02937701|39433741|FG003|Day 1 to Week 22|Physician Decision|0|||
16259201|NCT02937701|39433742|FG004|Day 1 to Week 22|Physician Decision|0|||
16259202|NCT02937701|39433738|FG000|Day 1 to Week 22|Other|1|||
16259203|NCT02937701|39433739|FG001|Day 1 to Week 22|Other|0|||
16259204|NCT02937701|39433740|FG002|Day 1 to Week 22|Other|0|||
16259205|NCT02937701|39433741|FG003|Day 1 to Week 22|Other|0|||
16259206|NCT02937701|39433742|FG004|Day 1 to Week 22|Other|0|||
16259207|NCT02937701|39433738|FG000|Week 22 to Week 50|Adverse Event|0|||
16259208|NCT02937701|39433739|FG001|Week 22 to Week 50|Adverse Event|0|||
16259209|NCT02937701|39433740|FG002|Week 22 to Week 50|Adverse Event|10|||
16364628|NCT00876395|39821385|FG001|Overall Study|Withdrawal by Subject|33|||
16146974|NCT00359021|39024501|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
16146975|NCT00359021|39024502|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
16146976|NCT00359021|39024501|FG000|Overall Study|Withdrawal by Subject|2|||
16259210|NCT02937701|39433741|FG003|Week 22 to Week 50|Adverse Event|3|||
16259211|NCT02937701|39433742|FG004|Week 22 to Week 50|Adverse Event|3|||
16259212|NCT02937701|39433738|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
16259213|NCT02937701|39433739|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
16259214|NCT02937701|39433740|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
16259215|NCT02937701|39433741|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
16364629|NCT00876395|39821384|FG000|Overall Study|Lost to Follow-up|2|||
16364630|NCT00876395|39821385|FG001|Overall Study|Lost to Follow-up|0|||
16364631|NCT00876395|39821384|FG000|Overall Study|Administrative problems|39|||
16364632|NCT00876395|39821385|FG001|Overall Study|Administrative problems|23|||
16364633|NCT00876395|39821384|FG000|Overall Study|Death|12|||
16364634|NCT00876395|39821385|FG001|Overall Study|Death|0|||
16364635|NCT00835978|39821386|FG000|Overall Study|Death|33|||
16364636|NCT00835978|39821387|FG001|Overall Study|Death|40|||
16364637|NCT00835978|39821388|FG002|Overall Study|Death|49|||
16364638|NCT00835978|39821389|FG003|Overall Study|Death|4|||
16364639|NCT00835978|39821386|FG000|Overall Study|Lost to Follow-up|3|||
16364640|NCT00835978|39821387|FG001|Overall Study|Lost to Follow-up|4|||
16364641|NCT00835978|39821388|FG002|Overall Study|Lost to Follow-up|2|||
16364642|NCT00835978|39821389|FG003|Overall Study|Lost to Follow-up|1|||
16364643|NCT00835978|39821386|FG000|Overall Study|Other|5|||
16364644|NCT00835978|39821387|FG001|Overall Study|Other|1|||
16364645|NCT00835978|39821388|FG002|Overall Study|Other|8|||
16364646|NCT00835978|39821389|FG003|Overall Study|Other|0|||
16146977|NCT00359021|39024502|FG001|Overall Study|Withdrawal by Subject|9|||
16146978|NCT00359021|39024501|FG000|Overall Study|Lost to Follow-up|1|||
16146979|NCT00359021|39024502|FG001|Overall Study|Lost to Follow-up|0|||
16146980|NCT00359021|39024501|FG000|Overall Study|Other|4|||
16440463|NCT00129402|40092690|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
16440464|NCT00129402|40092691|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
16440465|NCT00129402|40092692|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
16440466|NCT00129402|40092693|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
16440467|NCT00129402|40092687|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
16440468|NCT00129402|40092688|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
16440469|NCT00129402|40092689|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
16440470|NCT00129402|40092690|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
16440471|NCT00129402|40092691|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
16440472|NCT00129402|40092692|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
16440473|NCT00129402|40092693|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
16440474|NCT00129402|40092687|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
16440475|NCT00129402|40092688|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
16440476|NCT00129402|40092689|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
16440477|NCT00129402|40092690|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
16440478|NCT00129402|40092691|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
16440479|NCT00129402|40092692|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
16440480|NCT00129402|40092693|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
16440481|NCT00129402|40092687|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
16440482|NCT00129402|40092688|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
16440483|NCT00129402|40092689|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
16440484|NCT00129402|40092690|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
16440485|NCT00129402|40092691|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
16440486|NCT00129402|40092692|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
16440487|NCT00129402|40092693|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
16440488|NCT00129402|40092687|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
16440489|NCT00129402|40092688|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
16440490|NCT00129402|40092689|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
16440491|NCT00129402|40092690|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
16440492|NCT00129402|40092691|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
16440493|NCT00129402|40092692|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
16146981|NCT00359021|39024502|FG001|Overall Study|Other|1|||
16146982|NCT00359021|39024501|FG000|Overall Study|Pregnancy|1|||
16146983|NCT00359021|39024502|FG001|Overall Study|Pregnancy|0|||
16146984|NCT00596947|39024503|FG000|Overall Study|study halted due to low enrollment|5|||
16146985|NCT00596947|39024504|FG001|Overall Study|study halted due to low enrollment|3|||
16146986|NCT00596947|39024503|FG000|Overall Study|Lost to Follow-up|1|||
16146987|NCT00596947|39024504|FG001|Overall Study|Lost to Follow-up|0|||
16146988|NCT02248259|39024508|FG000|Treatment Period 1|Adverse Event|0|||
16146989|NCT02248259|39024509|FG001|Treatment Period 1|Adverse Event|0|||
16146990|NCT02248259|39024510|FG002|Treatment Period 1|Adverse Event|1|||
16146991|NCT02248259|39024511|FG003|Treatment Period 1|Adverse Event|0|||
16146992|NCT01924182|39024512|FG000|Overall Study|Withdrawal by Subject|1|||
16146993|NCT01924182|39024513|FG001|Overall Study|Withdrawal by Subject|0|||
16146994|NCT01056510|39024514|FG000|Overall Study|Dropout Before Start of Treatment|1|||
16146995|NCT01056510|39024515|FG001|Overall Study|Dropout Before Start of Treatment|1|||
16146996|NCT01056510|39024514|FG000|Overall Study|Withdrawal by Subject|4|||
16146997|NCT01056510|39024515|FG001|Overall Study|Withdrawal by Subject|2|||
16146998|NCT01056510|39024514|FG000|Overall Study|Death|29|||
16146999|NCT01056510|39024515|FG001|Overall Study|Death|34|||
16147000|NCT01056510|39024514|FG000|Overall Study|Noncompliance|1|||
16147001|NCT01056510|39024515|FG001|Overall Study|Noncompliance|3|||
16147002|NCT01056510|39024514|FG000|Overall Study|Physician Decision|4|||
16147003|NCT01056510|39024515|FG001|Overall Study|Physician Decision|5|||
16147004|NCT01056510|39024514|FG000|Overall Study|Lost to Follow-up|5|||
16147005|NCT01056510|39024515|FG001|Overall Study|Lost to Follow-up|6|||
16147006|NCT01056510|39024514|FG000|Overall Study|Other|10|||
16147007|NCT01056510|39024515|FG001|Overall Study|Other|12|||
16147008|NCT01056510|39024514|FG000|Overall Study|Missing|0|||
16147009|NCT01056510|39024515|FG001|Overall Study|Missing|1|||
16147010|NCT04206020|39024516|FG000|Overall Study|Adverse Event|1|||
16440494|NCT00129402|40092693|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
16440495|NCT00129402|40092687|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
16440496|NCT00129402|40092688|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
16440497|NCT00129402|40092689|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
16440498|NCT00129402|40092690|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
16440499|NCT00129402|40092691|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
16440500|NCT00129402|40092692|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
16440501|NCT00129402|40092693|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
16440502|NCT00129402|40092687|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
16440503|NCT00129402|40092688|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
16440504|NCT00129402|40092689|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
16440505|NCT00129402|40092690|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
16440506|NCT00129402|40092691|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
16440507|NCT00129402|40092692|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
16440508|NCT00129402|40092693|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
16440509|NCT00129402|40092687|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
16440510|NCT00129402|40092688|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
16440511|NCT00129402|40092689|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
16440512|NCT00129402|40092690|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
16440513|NCT00129402|40092691|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
16440514|NCT00129402|40092692|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
16440515|NCT00129402|40092693|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
16440516|NCT04606134|40092694|FG000|Overall Study|Adverse Event|0|||
16147011|NCT04206020|39024517|FG001|Overall Study|Adverse Event|4|||
16440517|NCT04606134|40092695|FG001|Overall Study|Adverse Event|1|||
16440518|NCT02558894|40092704|FG000|Overall Study|Death; any cause, entire study duration|28|||
16440519|NCT02558894|40092705|FG001|Overall Study|Death; any cause, entire study duration|31|||
16440520|NCT02558894|40092704|FG000|Overall Study|Withdrawal by Subject|2|||
16440521|NCT02558894|40092705|FG001|Overall Study|Withdrawal by Subject|1|||
16440522|NCT02558894|40092704|FG000|Overall Study|Closure of Part A|2|||
16440523|NCT02558894|40092705|FG001|Overall Study|Closure of Part A|1|||
16440524|NCT00468169|40092706|FG000|Overall Study|Withdrawal by Subject|1|||
16440525|NCT00468169|40092707|FG001|Overall Study|Withdrawal by Subject|0|||
16440526|NCT03796728|40092717|FG000|Overall Study|Lost to Follow-up|8|||
16440527|NCT03796728|40092717|FG000|Overall Study|Reason not Specified|16|||
16440528|NCT03346434|40092718|FG000|Overall Study|Randomized in Error|0|||
16440529|NCT03346434|40092719|FG001|Overall Study|Randomized in Error|0|||
16440530|NCT03346434|40092720|FG002|Overall Study|Randomized in Error|0|||
16440531|NCT03346434|40092721|FG003|Overall Study|Randomized in Error|0|||
16440532|NCT03346434|40092722|FG004|Overall Study|Randomized in Error|1|||
16440533|NCT03346434|40092723|FG005|Overall Study|Randomized in Error|0|||
16440534|NCT03346434|40092718|FG000|Overall Study|Withdrawal by Subject|0|||
16440535|NCT03346434|40092719|FG001|Overall Study|Withdrawal by Subject|0|||
16440536|NCT03346434|40092720|FG002|Overall Study|Withdrawal by Subject|1|||
16440537|NCT03346434|40092721|FG003|Overall Study|Withdrawal by Subject|0|||
16440538|NCT03346434|40092722|FG004|Overall Study|Withdrawal by Subject|1|||
16440539|NCT03346434|40092723|FG005|Overall Study|Withdrawal by Subject|0|||
16440540|NCT03346434|40092718|FG000|Overall Study|Lost to Follow-up|0|||
16440541|NCT03346434|40092719|FG001|Overall Study|Lost to Follow-up|0|||
16440542|NCT03346434|40092720|FG002|Overall Study|Lost to Follow-up|0|||
16440543|NCT03346434|40092721|FG003|Overall Study|Lost to Follow-up|0|||
16440544|NCT03346434|40092722|FG004|Overall Study|Lost to Follow-up|1|||
16440545|NCT03346434|40092723|FG005|Overall Study|Lost to Follow-up|1|||
16440546|NCT03346434|40092718|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
16440547|NCT03346434|40092719|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
16440548|NCT03346434|40092720|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
16440549|NCT03346434|40092721|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
16440550|NCT03346434|40092722|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
16440551|NCT03346434|40092723|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
16440552|NCT00301808|40092724|FG000|Overall Study|Adverse Event|5|||
16440553|NCT00301808|40092724|FG000|Overall Study|Death|3|||
16440554|NCT00301808|40092724|FG000|Overall Study|Lack of Efficacy|4|||
16440555|NCT02546609|40092725|FG000|Overall Study|Withdrawal by Subject|0|||
16440556|NCT02546609|40092726|FG001|Overall Study|Withdrawal by Subject|1|||
16440557|NCT02546609|40092727|FG002|Overall Study|Withdrawal by Subject|2|||
16440558|NCT02546609|40092725|FG000|Overall Study|Adverse Event|0|||
16440559|NCT02546609|40092726|FG001|Overall Study|Adverse Event|6|||
16440560|NCT02546609|40092727|FG002|Overall Study|Adverse Event|1|||
16440561|NCT02546609|40092725|FG000|Overall Study|Protocol Violation|0|||
16440562|NCT02546609|40092726|FG001|Overall Study|Protocol Violation|1|||
16440563|NCT02546609|40092727|FG002|Overall Study|Protocol Violation|1|||
16440564|NCT02546609|40092725|FG000|Overall Study|Lost to Follow-up|2|||
16440565|NCT02546609|40092726|FG001|Overall Study|Lost to Follow-up|3|||
16440566|NCT02546609|40092727|FG002|Overall Study|Lost to Follow-up|1|||
16440567|NCT02546609|40092725|FG000|Overall Study|travel or work schedule restriction|0|||
16440568|NCT02546609|40092726|FG001|Overall Study|travel or work schedule restriction|0|||
16440569|NCT02546609|40092727|FG002|Overall Study|travel or work schedule restriction|2|||
16440570|NCT00948246|40092728|FG000|Overall Study|Lost to Follow-up|11|||
16440571|NCT00948246|40092728|FG000|Overall Study|Adverse Event|11|||
16440572|NCT00948246|40092728|FG000|Overall Study|Death|1|||
16440573|NCT00948246|40092728|FG000|Overall Study|Withdrawal by Subject|1|||
16440574|NCT01383928|40092731|FG000|Overall Study|Initiation of ASCT|2|||
16440575|NCT01383928|40092732|FG001|Overall Study|Initiation of ASCT|1|||
16440576|NCT01383928|40092733|FG002|Overall Study|Initiation of ASCT|18|||
16440577|NCT01383928|40092731|FG000|Overall Study|Adverse Event|1|||
16440578|NCT01383928|40092732|FG001|Overall Study|Adverse Event|2|||
16440579|NCT01383928|40092733|FG002|Overall Study|Adverse Event|8|||
16440580|NCT01383928|40092731|FG000|Overall Study|Other|1|||
16440581|NCT01383928|40092732|FG001|Overall Study|Other|3|||
16440582|NCT01383928|40092733|FG002|Overall Study|Other|4|||
16440583|NCT01383928|40092731|FG000|Overall Study|Progressive Disease|1|||
16440584|NCT01383928|40092732|FG001|Overall Study|Progressive Disease|1|||
16440585|NCT01383928|40092733|FG002|Overall Study|Progressive Disease|5|||
16440586|NCT01383928|40092731|FG000|Overall Study|Withdrawal by Subject|0|||
16440587|NCT01383928|40092732|FG001|Overall Study|Withdrawal by Subject|0|||
16440588|NCT01383928|40092733|FG002|Overall Study|Withdrawal by Subject|4|||
16440589|NCT01383928|40092731|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
16440590|NCT01383928|40092732|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
16440591|NCT01383928|40092733|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
16440592|NCT00383552|40092738|FG000|Overall Study|Adverse Event|7|||
16440593|NCT00383552|40092739|FG001|Overall Study|Adverse Event|6|||
16440594|NCT00383552|40092740|FG002|Overall Study|Adverse Event|9|||
16440595|NCT00383552|40092741|FG003|Overall Study|Adverse Event|6|||
16440596|NCT00383552|40092738|FG000|Overall Study|Lack of Efficacy|4|||
16440597|NCT00383552|40092739|FG001|Overall Study|Lack of Efficacy|13|||
16440598|NCT00383552|40092740|FG002|Overall Study|Lack of Efficacy|29|||
16440599|NCT00383552|40092741|FG003|Overall Study|Lack of Efficacy|42|||
16440600|NCT00383552|40092738|FG000|Overall Study|Lost to Follow-up|0|||
16440601|NCT00383552|40092739|FG001|Overall Study|Lost to Follow-up|1|||
16440602|NCT00383552|40092740|FG002|Overall Study|Lost to Follow-up|5|||
16440603|NCT00383552|40092741|FG003|Overall Study|Lost to Follow-up|1|||
16440604|NCT00383552|40092738|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
16440605|NCT00383552|40092739|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
16440606|NCT00383552|40092740|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
16440607|NCT00383552|40092741|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
16147012|NCT04206020|39024516|FG000|Overall Study|Protocol Violation|2|||
16147013|NCT04206020|39024517|FG001|Overall Study|Protocol Violation|0|||
16147014|NCT04206020|39024516|FG000|Overall Study|Withdrawal by Subject|2|||
16440608|NCT00383552|40092738|FG000|Overall Study|Did not wish to continue (related)|1|||
16440609|NCT00383552|40092739|FG001|Overall Study|Did not wish to continue (related)|0|||
16440610|NCT00383552|40092740|FG002|Overall Study|Did not wish to continue (related)|2|||
16440611|NCT00383552|40092741|FG003|Overall Study|Did not wish to continue (related)|3|||
16440612|NCT00383552|40092738|FG000|Overall Study|Noncompliance with the protocol|11|||
16440613|NCT00383552|40092739|FG001|Overall Study|Noncompliance with the protocol|6|||
16440614|NCT00383552|40092740|FG002|Overall Study|Noncompliance with the protocol|8|||
16440615|NCT00383552|40092741|FG003|Overall Study|Noncompliance with the protocol|10|||
16440616|NCT00383552|40092738|FG000|Overall Study|Did not meet protocol eligibility|8|||
16440617|NCT00383552|40092739|FG001|Overall Study|Did not meet protocol eligibility|6|||
16440618|NCT00383552|40092740|FG002|Overall Study|Did not meet protocol eligibility|2|||
16440619|NCT00383552|40092741|FG003|Overall Study|Did not meet protocol eligibility|3|||
16440620|NCT00383552|40092738|FG000|Overall Study|Administrative|1|||
16440621|NCT00383552|40092739|FG001|Overall Study|Administrative|0|||
16440622|NCT00383552|40092740|FG002|Overall Study|Administrative|1|||
16440623|NCT00383552|40092741|FG003|Overall Study|Administrative|1|||
16440624|NCT01903356|40092742|FG000|Overall Study|Lost to Follow-up|7|||
16440625|NCT01903356|40092742|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
16364647|NCT00835978|39821386|FG000|Overall Study|Objective progression or relapse|2|||
16364648|NCT00835978|39821387|FG001|Overall Study|Objective progression or relapse|0|||
16364649|NCT00835978|39821388|FG002|Overall Study|Objective progression or relapse|1|||
16364650|NCT00835978|39821389|FG003|Overall Study|Objective progression or relapse|0|||
16364651|NCT00835978|39821386|FG000|Overall Study|Adverse Event|1|||
16364652|NCT00835978|39821387|FG001|Overall Study|Adverse Event|0|||
16364653|NCT00835978|39821388|FG002|Overall Study|Adverse Event|1|||
16364654|NCT00835978|39821389|FG003|Overall Study|Adverse Event|0|||
16364655|NCT00835978|39821386|FG000|Overall Study|Withdrawal by Subject|0|||
16364656|NCT00835978|39821387|FG001|Overall Study|Withdrawal by Subject|3|||
16364657|NCT00835978|39821388|FG002|Overall Study|Withdrawal by Subject|0|||
16364658|NCT00835978|39821389|FG003|Overall Study|Withdrawal by Subject|5|||
16364659|NCT00835978|39821386|FG000|Overall Study|Study terminated by sponsor|12|||
16364660|NCT00835978|39821387|FG001|Overall Study|Study terminated by sponsor|8|||
16364661|NCT00835978|39821388|FG002|Overall Study|Study terminated by sponsor|30|||
16364662|NCT00835978|39821389|FG003|Overall Study|Study terminated by sponsor|0|||
16364663|NCT00765076|39821396|FG000|Overall Study|Adverse Event|1|||
16364664|NCT00765076|39821397|FG001|Overall Study|Adverse Event|0|||
16440626|NCT01903356|40092742|FG000|Overall Study|Violated the dosage and administration|3|||
16440627|NCT00739401|40092743|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
16440628|NCT00739401|40092743|FG000|Overall Study|Death|3|||
16364665|NCT00765076|39821398|FG002|Overall Study|Adverse Event|0|||
16364666|NCT00765076|39821396|FG000|Overall Study|Withdrawal by Subject|0|||
16364667|NCT00765076|39821397|FG001|Overall Study|Withdrawal by Subject|0|||
16364668|NCT00765076|39821398|FG002|Overall Study|Withdrawal by Subject|1|||
16364669|NCT03941483|39821399|FG000|Overall Study|Miscellaneous|2|||
16364670|NCT03941483|39821400|FG001|Overall Study|Miscellaneous|3|||
16364671|NCT03941483|39821401|FG002|Overall Study|Miscellaneous|0|||
16364672|NCT03941483|39821399|FG000|Overall Study|Study Terminated by Sponsor|1|||
16440629|NCT00739401|40092743|FG000|Overall Study|Withdrawal by Subject|4|||
16440630|NCT03629886|40092745|FG000|Overall Study|Migrated / moved from the study area|0|||
16364673|NCT03941483|39821400|FG001|Overall Study|Study Terminated by Sponsor|0|||
16364674|NCT03941483|39821401|FG002|Overall Study|Study Terminated by Sponsor|0|||
16364675|NCT03941483|39821399|FG000|Overall Study|Withdrawal by Subject|1|||
16364676|NCT03941483|39821400|FG001|Overall Study|Withdrawal by Subject|4|||
16364677|NCT03941483|39821401|FG002|Overall Study|Withdrawal by Subject|1|||
16364678|NCT03941483|39821399|FG000|Overall Study|Lost to Follow-up|2|||
16364679|NCT03941483|39821400|FG001|Overall Study|Lost to Follow-up|1|||
16364680|NCT03941483|39821401|FG002|Overall Study|Lost to Follow-up|8|||
16364681|NCT03941483|39821399|FG000|Overall Study|Death|3|||
16364682|NCT03941483|39821400|FG001|Overall Study|Death|2|||
16364683|NCT03941483|39821401|FG002|Overall Study|Death|6|||
16364684|NCT02513199|39821404|FG000|Treatment|Death|1|||
16364685|NCT02513199|39821404|FG000|Treatment|Lost to Follow-up|1|||
16364686|NCT02513199|39821404|FG000|Follow-Up|Death|11|||
16440631|NCT03629886|40092746|FG001|Overall Study|Migrated / moved from the study area|55|||
16440632|NCT03629886|40092745|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
16440633|NCT03629886|40092746|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
16440634|NCT03629886|40092745|FG000|Overall Study|Study vaccine not administrated|0|||
16440635|NCT03629886|40092746|FG001|Overall Study|Study vaccine not administrated|3|||
16364687|NCT01214720|39821405|FG000|Overall Study|Alive and still on treatment|34|||
16364688|NCT01214720|39821406|FG001|Overall Study|Alive and still on treatment|18|||
16364689|NCT01214720|39821405|FG000|Overall Study|Alive and in follow-up|45|||
16364690|NCT01214720|39821406|FG001|Overall Study|Alive and in follow-up|48|||
16364691|NCT01214720|39821405|FG000|Overall Study|Lost to Follow-up|6|||
16364692|NCT01214720|39821406|FG001|Overall Study|Lost to Follow-up|2|||
16364693|NCT04766333|39821409|FG000|Overall Study|Lost to Follow-up|40|||
16364694|NCT04766333|39821410|FG001|Overall Study|Lost to Follow-up|826|||
16364695|NCT00262925|39821411|FG000|Overall Study|Lack of Efficacy|3|||
16440636|NCT03629886|40092745|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
16440637|NCT03629886|40092746|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
16147015|NCT04206020|39024517|FG001|Overall Study|Withdrawal by Subject|0|||
16147016|NCT04206020|39024516|FG000|Overall Study|Lost to Follow-up|2|||
16147017|NCT04206020|39024517|FG001|Overall Study|Lost to Follow-up|0|||
16364696|NCT00262925|39821411|FG000|Overall Study|Adverse Event|4|||
16147018|NCT04206020|39024516|FG000|Overall Study|Pregnancy|0|||
16147019|NCT04206020|39024517|FG001|Overall Study|Pregnancy|1|||
16147020|NCT04206020|39024516|FG000|Overall Study|Unable to attend visits|1|||
16147021|NCT04206020|39024517|FG001|Overall Study|Unable to attend visits|2|||
16147022|NCT04233164|39024519|FG000|Overall Study|Unable to obtain specimen|0|||
16147023|NCT04233164|39024520|FG001|Overall Study|Unable to obtain specimen|1|||
16147024|NCT00754793|39024521|FG000|Overall Study|voluntary withdrawn from study|0|||
16147025|NCT00754793|39024522|FG001|Overall Study|voluntary withdrawn from study|1|||
16147026|NCT00362414|39024523|FG000|Overall Study|Death|2|||
16147027|NCT00362414|39024523|FG000|Overall Study|Adverse Event|1|||
16147028|NCT02625233|39024529|FG000|Overall Study|Adverse Event|2|||
16147029|NCT02625233|39024530|FG001|Overall Study|Adverse Event|0|||
16147030|NCT02354222|39024539|FG000|Overall Study|Adverse Event|0|||
16147031|NCT02354222|39024540|FG001|Overall Study|Adverse Event|3|||
16147032|NCT02354222|39024539|FG000|Overall Study|Physician Decision|1|||
16147033|NCT02354222|39024540|FG001|Overall Study|Physician Decision|1|||
16147034|NCT02354222|39024539|FG000|Overall Study|Pregnancy|1|||
16147035|NCT02354222|39024540|FG001|Overall Study|Pregnancy|0|||
16147036|NCT02354222|39024539|FG000|Overall Study|Withdrawal by Subject|2|||
16147037|NCT02354222|39024540|FG001|Overall Study|Withdrawal by Subject|3|||
16147038|NCT02354222|39024539|FG000|Overall Study|Conflict with the stopping criteria|0|||
16147039|NCT02354222|39024540|FG001|Overall Study|Conflict with the stopping criteria|4|||
16147040|NCT00257166|39024541|FG000|Overall Study|Adverse Event|18|||
16147041|NCT00257166|39024542|FG001|Overall Study|Adverse Event|13|||
16147042|NCT00257166|39024541|FG000|Overall Study|Laboratory abnormality|1|||
16147043|NCT00257166|39024542|FG001|Overall Study|Laboratory abnormality|0|||
16147044|NCT00257166|39024541|FG000|Overall Study|Lost to Follow-up|8|||
16147045|NCT00257166|39024542|FG001|Overall Study|Lost to Follow-up|1|||
16147046|NCT00257166|39024541|FG000|Overall Study|Withdrawal by Subject|9|||
16147047|NCT00257166|39024542|FG001|Overall Study|Withdrawal by Subject|2|||
16147048|NCT00257166|39024541|FG000|Overall Study|Other|16|||
16147049|NCT00257166|39024542|FG001|Overall Study|Other|21|||
16147050|NCT00257166|39024541|FG000|Overall Study|Randomized, but not treated|1|||
16147051|NCT00257166|39024542|FG001|Overall Study|Randomized, but not treated|0|||
16147052|NCT01877915|39024544|FG000|Overall Study|Lost to Follow-up|10|||
16147053|NCT01877915|39024545|FG001|Overall Study|Lost to Follow-up|9|||
16147054|NCT01877915|39024544|FG000|Overall Study|Withdrawal by Subject|42|||
16147055|NCT01877915|39024545|FG001|Overall Study|Withdrawal by Subject|55|||
16147056|NCT01877915|39024544|FG000|Overall Study|Other|2|||
16147057|NCT01877915|39024545|FG001|Overall Study|Other|4|||
16147058|NCT01843842|39024546|FG000|Overall Study|Do not meet inclusion criteria|1|||
16147059|NCT01843842|39024547|FG001|Overall Study|Do not meet inclusion criteria|1|||
16147060|NCT01423851|39024549|FG000|Whole Study|Disease progression|2|||
16147061|NCT01423851|39024550|FG001|Whole Study|Disease progression|1|||
16147062|NCT01423851|39024551|FG002|Whole Study|Disease progression|1|||
16147063|NCT01423851|39024552|FG003|Whole Study|Disease progression|4|||
16147064|NCT01423851|39024553|FG004|Whole Study|Disease progression|1|||
16147065|NCT01423851|39024554|FG005|Whole Study|Disease progression|3|||
16147066|NCT01423851|39024555|FG006|Whole Study|Disease progression|1|||
16147067|NCT01423851|39024556|FG007|Whole Study|Disease progression|4|||
16147068|NCT01423851|39024557|FG008|Whole Study|Disease progression|0|||
16147069|NCT01423851|39024558|FG009|Whole Study|Disease progression|2|||
16147070|NCT01423851|39024559|FG010|Whole Study|Disease progression|10|||
16147071|NCT01423851|39024549|FG000|Whole Study|Physician Decision|0|||
16147072|NCT01423851|39024550|FG001|Whole Study|Physician Decision|1|||
16364697|NCT00262925|39821411|FG000|Overall Study|Death|2|||
16364698|NCT00262925|39821411|FG000|Overall Study|alternative therapy|1|||
16364699|NCT00262925|39821411|FG000|Overall Study|Other|1|||
16364700|NCT00764517|39821415|FG000|Overall Study|Adverse Event|9|||
16364701|NCT00764517|39821416|FG001|Overall Study|Adverse Event|3|||
16364702|NCT00764517|39821415|FG000|Overall Study|Death|3|||
16147073|NCT01423851|39024551|FG002|Whole Study|Physician Decision|2|||
16147074|NCT01423851|39024552|FG003|Whole Study|Physician Decision|0|||
16147075|NCT01423851|39024553|FG004|Whole Study|Physician Decision|2|||
16147076|NCT01423851|39024554|FG005|Whole Study|Physician Decision|0|||
16364703|NCT00764517|39821416|FG001|Overall Study|Death|11|||
16147077|NCT01423851|39024555|FG006|Whole Study|Physician Decision|2|||
16147078|NCT01423851|39024556|FG007|Whole Study|Physician Decision|1|||
16147079|NCT01423851|39024557|FG008|Whole Study|Physician Decision|3|||
16147080|NCT01423851|39024558|FG009|Whole Study|Physician Decision|4|||
16147081|NCT01423851|39024559|FG010|Whole Study|Physician Decision|12|||
16147082|NCT01423851|39024549|FG000|Whole Study|Withdrawal by Subject|1|||
16147083|NCT01423851|39024550|FG001|Whole Study|Withdrawal by Subject|1|||
16364704|NCT00764517|39821415|FG000|Overall Study|Physician Decision|3|||
16147084|NCT01423851|39024551|FG002|Whole Study|Withdrawal by Subject|0|||
16147085|NCT01423851|39024552|FG003|Whole Study|Withdrawal by Subject|0|||
16147086|NCT01423851|39024553|FG004|Whole Study|Withdrawal by Subject|0|||
16147087|NCT01423851|39024554|FG005|Whole Study|Withdrawal by Subject|0|||
16147088|NCT01423851|39024555|FG006|Whole Study|Withdrawal by Subject|0|||
16147089|NCT01423851|39024556|FG007|Whole Study|Withdrawal by Subject|0|||
16147090|NCT01423851|39024557|FG008|Whole Study|Withdrawal by Subject|2|||
16147091|NCT01423851|39024558|FG009|Whole Study|Withdrawal by Subject|0|||
16147092|NCT01423851|39024559|FG010|Whole Study|Withdrawal by Subject|4|||
16147093|NCT01423851|39024549|FG000|Whole Study|Adverse Event|0|||
16147094|NCT01423851|39024550|FG001|Whole Study|Adverse Event|0|||
16147095|NCT01423851|39024551|FG002|Whole Study|Adverse Event|0|||
16147096|NCT01423851|39024552|FG003|Whole Study|Adverse Event|2|||
16147097|NCT01423851|39024553|FG004|Whole Study|Adverse Event|0|||
16147098|NCT01423851|39024554|FG005|Whole Study|Adverse Event|0|||
16147099|NCT01423851|39024555|FG006|Whole Study|Adverse Event|0|||
16147100|NCT01423851|39024556|FG007|Whole Study|Adverse Event|3|||
16147101|NCT01423851|39024557|FG008|Whole Study|Adverse Event|3|||
16147102|NCT01423851|39024558|FG009|Whole Study|Adverse Event|2|||
16147103|NCT01423851|39024559|FG010|Whole Study|Adverse Event|3|||
16147104|NCT01401842|39024563|FG000|Overall Study|Withdrawal by Subject|3|||
16147105|NCT01401842|39024564|FG001|Overall Study|Withdrawal by Subject|2|||
16147106|NCT01401842|39024563|FG000|Overall Study|academic reason|4|||
16147107|NCT01401842|39024564|FG001|Overall Study|academic reason|1|||
16147108|NCT01401842|39024563|FG000|Overall Study|changed companies|20|||
16147109|NCT01401842|39024564|FG001|Overall Study|changed companies|34|||
16147110|NCT01401842|39024563|FG000|Overall Study|discharged from US Army|3|||
16147111|NCT01401842|39024564|FG001|Overall Study|discharged from US Army|4|||
16147112|NCT01401842|39024563|FG000|Overall Study|invalid follow-up strength data|1|||
16147113|NCT01401842|39024564|FG001|Overall Study|invalid follow-up strength data|4|||
16147114|NCT01401842|39024563|FG000|Overall Study|on profile|9|||
16147115|NCT01401842|39024564|FG001|Overall Study|on profile|5|||
16147116|NCT01401842|39024563|FG000|Overall Study|other/unknown|28|||
16147117|NCT01401842|39024564|FG001|Overall Study|other/unknown|17|||
16147118|NCT01379573|39024565|FG000|Overall Study|Lost to Follow-up|1|||
16147119|NCT01379573|39024565|FG000|Overall Study|Screen Failure|10|||
16147120|NCT03007979|39024566|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
16147121|NCT00395863|39024567|FG000|Overall Study|Patients did not complete both exams|2|||
16147122|NCT00395863|39024568|FG001|Overall Study|Patients did not complete both exams|3|||
16147123|NCT02729740|39024569|FG000|Overall Study|Early Termination|130|||
16147124|NCT02729740|39024569|FG000|Overall Study|Other|1|||
16147125|NCT00290342|39024570|FG000|Overall Study|Other|0|||
16147126|NCT00290342|39024571|FG001|Overall Study|Other|1|||
16147127|NCT00290342|39024570|FG000|Overall Study|Withdrawal by Subject|6|||
16147128|NCT00290342|39024571|FG001|Overall Study|Withdrawal by Subject|4|||
16147129|NCT00290342|39024570|FG000|Overall Study|Lost to Follow-up|1|||
16147130|NCT00290342|39024571|FG001|Overall Study|Lost to Follow-up|0|||
16147131|NCT03697720|39024572|FG000|Overall Study|Lost to Follow-up|7|||
16147132|NCT04344301|39024576|FG000|Overall Study|Withdrawal by Subject|1|||
16147133|NCT04344301|39024577|FG001|Overall Study|Withdrawal by Subject|0|||
16147134|NCT04344301|39024576|FG000|Overall Study|Death|0|||
16147135|NCT04344301|39024577|FG001|Overall Study|Death|1|||
16147136|NCT00770770|39024579|FG000|Overall Study|Lost to Follow-up|1|||
16147137|NCT00770770|39024580|FG001|Overall Study|Lost to Follow-up|0|||
16147138|NCT00770770|39024579|FG000|Overall Study|Withdrawal by Subject|1|||
16147139|NCT00770770|39024580|FG001|Overall Study|Withdrawal by Subject|0|||
16147140|NCT00770770|39024579|FG000|Overall Study|Death|0|||
16147141|NCT00770770|39024580|FG001|Overall Study|Death|1|||
16147142|NCT00770770|39024579|FG000|Overall Study|Study Terminated|8|||
16147143|NCT00770770|39024580|FG001|Overall Study|Study Terminated|0|||
16147144|NCT02066311|39024581|FG000|Overall Study|Adverse Event|4|||
16147145|NCT02066311|39024581|FG000|Overall Study|Withdrawal by Subject|1|||
16147146|NCT01245387|39024584|FG000|Overall Study|Lost to Follow-up|106|||
16147147|NCT01245387|39024584|FG000|Overall Study|Lack of Efficacy|195|||
16147148|NCT01245387|39024584|FG000|Overall Study|Adverse Event|9|||
16147149|NCT01245387|39024584|FG000|Overall Study|Death|3|||
16147150|NCT01245387|39024584|FG000|Overall Study|Other|131|||
16147151|NCT01245387|39024584|FG000|Overall Study|Missing discontinuation status|369|||
16147152|NCT01092143|39024598|FG000|Overall Study|Adverse Event|10|||
16147153|NCT01092143|39024599|FG001|Overall Study|Adverse Event|5|||
16147154|NCT01092143|39024600|FG002|Overall Study|Adverse Event|1|||
16147155|NCT01092143|39024601|FG003|Overall Study|Adverse Event|4|||
16147156|NCT01092143|39024602|FG004|Overall Study|Adverse Event|3|||
16147157|NCT01092143|39024598|FG000|Overall Study|Lost to Follow-up|1|||
16147158|NCT01092143|39024599|FG001|Overall Study|Lost to Follow-up|0|||
16147159|NCT01092143|39024600|FG002|Overall Study|Lost to Follow-up|1|||
16147160|NCT01092143|39024601|FG003|Overall Study|Lost to Follow-up|0|||
16147161|NCT01092143|39024602|FG004|Overall Study|Lost to Follow-up|0|||
16147162|NCT01092143|39024598|FG000|Overall Study|Consent withdrawn|2|||
16147163|NCT01092143|39024599|FG001|Overall Study|Consent withdrawn|1|||
16147164|NCT01092143|39024600|FG002|Overall Study|Consent withdrawn|0|||
16440638|NCT03629886|40092745|FG000|Overall Study|Refused vaccination step of the study|0|||
16440639|NCT03629886|40092746|FG001|Overall Study|Refused vaccination step of the study|44|||
16440640|NCT00764699|40092747|FG000|Overall Study|PI left and study terminated|3|||
16440641|NCT02741128|40092749|FG000|Overall Study|Protocol Violation|4|||
16440642|NCT02741128|40092750|FG001|Overall Study|Protocol Violation|1|||
16440643|NCT02741128|40092749|FG000|Overall Study|Withdrawal by Subject|2|||
16440644|NCT02741128|40092750|FG001|Overall Study|Withdrawal by Subject|0|||
16440645|NCT02741128|40092749|FG000|Overall Study|Lost to Follow-up|1|||
16440646|NCT02741128|40092750|FG001|Overall Study|Lost to Follow-up|0|||
16440647|NCT03271151|40092762|FG000|Overall Study|Lost to Follow-up|1|||
16440648|NCT03271151|40092763|FG001|Overall Study|Lost to Follow-up|3|||
16440649|NCT03271151|40092762|FG000|Overall Study|Withdrawal by Subject|1|||
16440650|NCT03271151|40092763|FG001|Overall Study|Withdrawal by Subject|0|||
16440651|NCT03474107|40092764|FG000|Overall Study|Adverse Event|42|||
16440652|NCT03474107|40092765|FG001|Overall Study|Adverse Event|46|||
16440653|NCT03474107|40092764|FG000|Overall Study|Death|2|||
16440654|NCT03474107|40092765|FG001|Overall Study|Death|2|||
16440655|NCT03474107|40092764|FG000|Overall Study|Lost to Follow-up|0|||
16440656|NCT03474107|40092765|FG001|Overall Study|Lost to Follow-up|1|||
16440657|NCT03474107|40092764|FG000|Overall Study|Progressive Disease|177|||
16440658|NCT03474107|40092765|FG001|Overall Study|Progressive Disease|180|||
16440659|NCT03474107|40092764|FG000|Overall Study|Protocol Violation|1|||
16440660|NCT03474107|40092765|FG001|Overall Study|Protocol Violation|1|||
16440661|NCT03474107|40092764|FG000|Overall Study|Withdrawal by Subject|15|||
16440662|NCT03474107|40092765|FG001|Overall Study|Withdrawal by Subject|27|||
16440663|NCT03474107|40092764|FG000|Overall Study|Physician Decision|7|||
16440664|NCT03474107|40092765|FG001|Overall Study|Physician Decision|22|||
16440665|NCT03474107|40092764|FG000|Overall Study|Miscellaneous|1|||
16440666|NCT03474107|40092765|FG001|Overall Study|Miscellaneous|6|||
16440667|NCT02489318|40092766|FG000|Randomized|Withdrawal by Subject|0|||
16440668|NCT02489318|40092767|FG001|Randomized|Withdrawal by Subject|1|||
16440669|NCT02489318|40092766|FG000|Treated|Adverse Event|19|||
16440670|NCT02489318|40092767|FG001|Treated|Adverse Event|62|||
16440671|NCT02489318|40092766|FG000|Treated|Death|13|||
16440672|NCT02489318|40092767|FG001|Treated|Death|11|||
16440673|NCT02489318|40092766|FG000|Treated|Physician Decision|4|||
16440674|NCT02489318|40092767|FG001|Treated|Physician Decision|6|||
16440675|NCT02489318|40092766|FG000|Treated|Protocol Violation|1|||
16440676|NCT02489318|40092767|FG001|Treated|Protocol Violation|2|||
16440677|NCT02489318|40092766|FG000|Treated|Withdrawal by Subject|37|||
16440678|NCT02489318|40092767|FG001|Treated|Withdrawal by Subject|36|||
16440679|NCT02489318|40092766|FG000|Treated|Other: Progressive Disease|245|||
16440680|NCT02489318|40092767|FG001|Treated|Other: Progressive Disease|138|||
16440681|NCT02489318|40092766|FG000|Treated|Other|0|||
16440682|NCT02489318|40092767|FG001|Treated|Other|2|||
16440683|NCT02489318|40092766|FG000|Treated|Ongoing|0|||
16440684|NCT02489318|40092767|FG001|Treated|Ongoing|267|||
16440685|NCT05473026|40092768|FG000|Overall Study|Lost to Follow-up|5|||
16440686|NCT05473026|40092769|FG001|Overall Study|Lost to Follow-up|2|||
16440687|NCT03661723|40092772|FG000|Overall Study|Disease Progression|4|||
16440688|NCT03661723|40092773|FG001|Overall Study|Disease Progression|24|||
16440689|NCT03661723|40092774|FG002|Overall Study|Disease Progression|4|||
16440690|NCT03661723|40092775|FG003|Overall Study|Disease Progression|19|||
16440691|NCT03661723|40092772|FG000|Overall Study|Withdrawal by Subject|1|||
16440692|NCT03661723|40092773|FG001|Overall Study|Withdrawal by Subject|0|||
16440693|NCT03661723|40092774|FG002|Overall Study|Withdrawal by Subject|2|||
16440694|NCT03661723|40092775|FG003|Overall Study|Withdrawal by Subject|4|||
16440695|NCT03661723|40092772|FG000|Overall Study|Physician Decision|1|||
16440696|NCT03661723|40092773|FG001|Overall Study|Physician Decision|0|||
16440697|NCT03661723|40092774|FG002|Overall Study|Physician Decision|0|||
16440698|NCT03661723|40092775|FG003|Overall Study|Physician Decision|0|||
16440699|NCT03661723|40092772|FG000|Overall Study|Clinical Deterioration|0|||
16440700|NCT03661723|40092773|FG001|Overall Study|Clinical Deterioration|0|||
16440701|NCT03661723|40092774|FG002|Overall Study|Clinical Deterioration|0|||
16440702|NCT03661723|40092775|FG003|Overall Study|Clinical Deterioration|1|||
16440703|NCT03040999|40092776|FG000|Overall Study|Lost to Follow-up|1|||
16440704|NCT03040999|40092777|FG001|Overall Study|Lost to Follow-up|0|||
16440705|NCT03040999|40092776|FG000|Overall Study|Withdrawal by Subject|7|||
16440706|NCT03040999|40092777|FG001|Overall Study|Withdrawal by Subject|12|||
16440707|NCT03040999|40092776|FG000|Overall Study|Death|128|||
16440708|NCT03040999|40092777|FG001|Overall Study|Death|138|||
16440709|NCT03040999|40092776|FG000|Overall Study|Participants Ongoing in Trial|266|||
16440710|NCT03040999|40092777|FG001|Overall Study|Participants Ongoing in Trial|252|||
16440711|NCT02392429|40092786|FG000|Screening|Screen failure|15|||
16440712|NCT02392429|40092786|FG000|Enrolled Participants|Ineligible due to disease|3|||
16440713|NCT02392429|40092786|FG000|Enrolled Participants|Withdrawal by Subject|4|||
16440714|NCT02392429|40092786|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
16440715|NCT02392429|40092786|FG000|Evaluable|Death|5|||
16440716|NCT02392429|40092786|FG000|Evaluable|Withdrawal by Subject|1|||
16440717|NCT02392429|40092786|FG000|Evaluable|Adverse Event|1|||
16147165|NCT01092143|39024601|FG003|Overall Study|Consent withdrawn|1|||
16147166|NCT01092143|39024602|FG004|Overall Study|Consent withdrawn|3|||
16147167|NCT01092143|39024598|FG000|Overall Study|Not treated|0|||
16147168|NCT01092143|39024599|FG001|Overall Study|Not treated|0|||
16147169|NCT01092143|39024600|FG002|Overall Study|Not treated|1|||
16147170|NCT01092143|39024601|FG003|Overall Study|Not treated|0|||
16147171|NCT01092143|39024602|FG004|Overall Study|Not treated|0|||
16147172|NCT01092143|39024598|FG000|Overall Study|did not reversibility criteria|0|||
16147173|NCT01092143|39024599|FG001|Overall Study|did not reversibility criteria|0|||
16147174|NCT01092143|39024600|FG002|Overall Study|did not reversibility criteria|1|||
16147175|NCT01092143|39024601|FG003|Overall Study|did not reversibility criteria|0|||
16364705|NCT00764517|39821416|FG001|Overall Study|Physician Decision|0|||
16364706|NCT03157089|39821417|FG000|Overall Study|Treated only with pembrolizumab|1|||
16364707|NCT03157089|39821418|FG001|Overall Study|Treated only with pembrolizumab|0|||
16364708|NCT03157089|39821417|FG000|Overall Study|Adverse Event|5|||
16364709|NCT03157089|39821418|FG001|Overall Study|Adverse Event|4|||
16364710|NCT03157089|39821417|FG000|Overall Study|Progressive disease|6|||
16364711|NCT03157089|39821418|FG001|Overall Study|Progressive disease|8|||
16440718|NCT02392429|40092786|FG000|Evaluable|remission bone marrow biopsy|3|||
16147176|NCT01092143|39024602|FG004|Overall Study|did not reversibility criteria|0|||
16147177|NCT01092143|39024598|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
16147178|NCT01092143|39024599|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
16147179|NCT01092143|39024600|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
16147180|NCT01092143|39024601|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
16147181|NCT01092143|39024602|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
16147182|NCT01092143|39024598|FG000|Overall Study|Ineligible patient|1|||
16147183|NCT01092143|39024599|FG001|Overall Study|Ineligible patient|0|||
16147184|NCT01092143|39024600|FG002|Overall Study|Ineligible patient|0|||
16147185|NCT01092143|39024601|FG003|Overall Study|Ineligible patient|0|||
16147186|NCT01092143|39024602|FG004|Overall Study|Ineligible patient|0|||
16147187|NCT01092143|39024598|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
16147188|NCT01092143|39024599|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
16364712|NCT01980888|39821419|FG000|Overall Study|Study Terminated by Sponsor|116|||
16147189|NCT01092143|39024600|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
16147190|NCT01092143|39024601|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
16147191|NCT01092143|39024602|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
16147192|NCT01092143|39024598|FG000|Overall Study|Patient travel|0|||
16147193|NCT01092143|39024599|FG001|Overall Study|Patient travel|0|||
16147194|NCT01092143|39024600|FG002|Overall Study|Patient travel|0|||
16147195|NCT01092143|39024601|FG003|Overall Study|Patient travel|0|||
16147196|NCT01092143|39024602|FG004|Overall Study|Patient travel|1|||
16147197|NCT01092143|39024598|FG000|Overall Study|Non compliance with study medication|0|||
16147198|NCT01092143|39024599|FG001|Overall Study|Non compliance with study medication|0|||
16364713|NCT01980888|39821420|FG001|Overall Study|Study Terminated by Sponsor|122|||
16364714|NCT01980888|39821419|FG000|Overall Study|Withdrew Consent|17|||
16364715|NCT01980888|39821420|FG001|Overall Study|Withdrew Consent|6|||
16364716|NCT01980888|39821419|FG000|Overall Study|Investigator's Discretion|8|||
16364717|NCT01980888|39821420|FG001|Overall Study|Investigator's Discretion|3|||
16364718|NCT01980888|39821419|FG000|Overall Study|Non-Compliance with Study Drug|3|||
16364719|NCT01980888|39821420|FG001|Overall Study|Non-Compliance with Study Drug|2|||
16364720|NCT01462942|39821421|FG000|Overall Study|Adverse Event|7|||
16364721|NCT01462942|39821422|FG001|Overall Study|Adverse Event|12|||
16364722|NCT01462942|39821423|FG002|Overall Study|Adverse Event|10|||
16364723|NCT01462942|39821424|FG003|Overall Study|Adverse Event|11|||
16440719|NCT03284710|40092789|FG000|Overall Study|Withdrawal by Subject|1|||
16440720|NCT03284710|40092790|FG001|Overall Study|Withdrawal by Subject|0|||
16440721|NCT03284710|40092791|FG002|Overall Study|Withdrawal by Subject|1|||
16440722|NCT03284710|40092792|FG003|Overall Study|Withdrawal by Subject|6|||
16440723|NCT03284710|40092789|FG000|Overall Study|Lost to Follow-up|3|||
16440724|NCT03284710|40092790|FG001|Overall Study|Lost to Follow-up|3|||
16440725|NCT03284710|40092791|FG002|Overall Study|Lost to Follow-up|1|||
16440726|NCT03284710|40092792|FG003|Overall Study|Lost to Follow-up|0|||
16440727|NCT03284710|40092789|FG000|Overall Study|Physician Decision|1|||
16440728|NCT03284710|40092790|FG001|Overall Study|Physician Decision|0|||
16440729|NCT03284710|40092791|FG002|Overall Study|Physician Decision|0|||
16440730|NCT03284710|40092792|FG003|Overall Study|Physician Decision|0|||
16440731|NCT03284710|40092789|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
16440732|NCT03284710|40092790|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
16440733|NCT03284710|40092791|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
16364724|NCT01462942|39821425|FG004|Overall Study|Adverse Event|11|||
16147199|NCT01092143|39024600|FG002|Overall Study|Non compliance with study medication|0|||
16147200|NCT01092143|39024601|FG003|Overall Study|Non compliance with study medication|0|||
16147201|NCT01092143|39024602|FG004|Overall Study|Non compliance with study medication|1|||
16364725|NCT01462942|39821421|FG000|Overall Study|Other, including COPD exacerbation|3|||
16440734|NCT03284710|40092792|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
16364726|NCT01462942|39821422|FG001|Overall Study|Other, including COPD exacerbation|5|||
16364727|NCT01462942|39821423|FG002|Overall Study|Other, including COPD exacerbation|2|||
16364728|NCT01462942|39821424|FG003|Overall Study|Other, including COPD exacerbation|8|||
16147202|NCT01092143|39024598|FG000|Overall Study|Randomized by mistake|0|||
16147203|NCT01092143|39024599|FG001|Overall Study|Randomized by mistake|0|||
16147204|NCT01092143|39024600|FG002|Overall Study|Randomized by mistake|0|||
16147205|NCT01092143|39024601|FG003|Overall Study|Randomized by mistake|1|||
16147206|NCT01092143|39024602|FG004|Overall Study|Randomized by mistake|0|||
16147207|NCT01092143|39024598|FG000|Overall Study|Pregnancy|0|||
16147208|NCT01092143|39024599|FG001|Overall Study|Pregnancy|0|||
16147209|NCT01092143|39024600|FG002|Overall Study|Pregnancy|0|||
16147210|NCT01092143|39024601|FG003|Overall Study|Pregnancy|1|||
16147211|NCT01092143|39024602|FG004|Overall Study|Pregnancy|0|||
16147212|NCT02790138|39027549|FG000|Overall Study|Adverse Event|5|||
16147213|NCT02790138|39027550|FG001|Overall Study|Adverse Event|2|||
16147214|NCT02790138|39027549|FG000|Overall Study|Significant Protocol Deviation|0|||
16147215|NCT02790138|39027550|FG001|Overall Study|Significant Protocol Deviation|1|||
16147216|NCT02790138|39027549|FG000|Overall Study|Lost to Follow-up|1|||
16147217|NCT02790138|39027550|FG001|Overall Study|Lost to Follow-up|0|||
16147218|NCT02790138|39027549|FG000|Overall Study|Voluntary Withdrawal|8|||
16147219|NCT02790138|39027550|FG001|Overall Study|Voluntary Withdrawal|9|||
16147220|NCT02790138|39027549|FG000|Overall Study|Lack of Efficacy|6|||
16147221|NCT02790138|39027550|FG001|Overall Study|Lack of Efficacy|7|||
16147222|NCT02790138|39027549|FG000|Overall Study|Reason not Specified|1|||
16147223|NCT02790138|39027550|FG001|Overall Study|Reason not Specified|0|||
16147224|NCT01210807|39027551|FG000|Overall Study|Lost to Follow-up|1|||
16147225|NCT01210807|39027552|FG001|Overall Study|Lost to Follow-up|2|||
16147226|NCT01210807|39027551|FG000|Overall Study|Not implanted bilaterally|2|||
16147227|NCT01210807|39027552|FG001|Overall Study|Not implanted bilaterally|1|||
16147228|NCT00133991|39027559|FG000|Overall Study|Death|4|||
16147229|NCT02596620|39027561|FG000|Overall Study|Lost to Follow-up|1|||
16147230|NCT02596620|39027562|FG001|Overall Study|Lost to Follow-up|1|||
16147231|NCT01473563|39027565|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
16147232|NCT01538628|39027566|FG000|Overall Study|Withdrawal by Subject|1|||
16147233|NCT01538628|39027567|FG001|Overall Study|Withdrawal by Subject|1|||
16147234|NCT01538628|39027566|FG000|Overall Study|Lost to Follow-up|0|||
16147235|NCT01538628|39027567|FG001|Overall Study|Lost to Follow-up|1|||
16147236|NCT02269787|39027568|FG000|Overall Study|Lost to Follow-up|20|||
16147237|NCT02269787|39027569|FG001|Overall Study|Lost to Follow-up|6|||
16147238|NCT02269787|39027568|FG000|Overall Study|Death|2|||
16147239|NCT02269787|39027569|FG001|Overall Study|Death|3|||
16147240|NCT02269787|39027568|FG000|Overall Study|Incapacitated|0|||
16147241|NCT02269787|39027569|FG001|Overall Study|Incapacitated|1|||
16147242|NCT00916279|39027570|FG000|Overall Study|Death|2|||
16147243|NCT00916279|39027570|FG000|Overall Study|Lost to Follow-up|2|||
16147244|NCT01202279|39027571|FG000|Overall Study|Adverse Event|8|||
16147245|NCT01202279|39027572|FG001|Overall Study|Adverse Event|6|||
16147246|NCT01202279|39027571|FG000|Overall Study|Withdrawal by Subject|13|||
16147247|NCT01202279|39027572|FG001|Overall Study|Withdrawal by Subject|10|||
16147248|NCT01202279|39027571|FG000|Overall Study|Physician Decision|0|||
16147249|NCT01202279|39027572|FG001|Overall Study|Physician Decision|1|||
16147250|NCT01202279|39027571|FG000|Overall Study|Lost to Follow-up|10|||
16147251|NCT01202279|39027572|FG001|Overall Study|Lost to Follow-up|7|||
16147252|NCT01202279|39027571|FG000|Overall Study|Protocol Violation|1|||
16147253|NCT01202279|39027572|FG001|Overall Study|Protocol Violation|1|||
16147254|NCT01202279|39027571|FG000|Overall Study|study compliance|5|||
16147255|NCT01202279|39027572|FG001|Overall Study|study compliance|2|||
16147256|NCT03077685|39027573|FG000|Overall Study|Lost to Follow-up|0|||
16147257|NCT03077685|39027574|FG001|Overall Study|Lost to Follow-up|0|||
16147258|NCT03077685|39027575|FG002|Overall Study|Lost to Follow-up|0|||
16147259|NCT03077685|39027576|FG003|Overall Study|Lost to Follow-up|0|||
16147260|NCT03077685|39027577|FG004|Overall Study|Lost to Follow-up|1|||
16147261|NCT03077685|39027573|FG000|Overall Study|Death|0|||
16147262|NCT03077685|39027574|FG001|Overall Study|Death|0|||
16147263|NCT03077685|39027575|FG002|Overall Study|Death|1|||
16147264|NCT03077685|39027576|FG003|Overall Study|Death|1|||
16147265|NCT03077685|39027577|FG004|Overall Study|Death|3|||
16147266|NCT03077685|39027573|FG000|Overall Study|Withdrawal by Subject|0|||
16147267|NCT03077685|39027574|FG001|Overall Study|Withdrawal by Subject|0|||
16147268|NCT03077685|39027575|FG002|Overall Study|Withdrawal by Subject|0|||
16147269|NCT03077685|39027576|FG003|Overall Study|Withdrawal by Subject|2|||
16147270|NCT03077685|39027577|FG004|Overall Study|Withdrawal by Subject|1|||
16147271|NCT03077685|39027573|FG000|Overall Study|Physician Decision|0|||
16147272|NCT03077685|39027574|FG001|Overall Study|Physician Decision|0|||
16147273|NCT03077685|39027575|FG002|Overall Study|Physician Decision|1|||
16147274|NCT03077685|39027576|FG003|Overall Study|Physician Decision|0|||
16147275|NCT03077685|39027577|FG004|Overall Study|Physician Decision|3|||
16147276|NCT03077685|39027573|FG000|Overall Study|Disease Progression|1|||
16147277|NCT03077685|39027574|FG001|Overall Study|Disease Progression|0|||
16147278|NCT03077685|39027575|FG002|Overall Study|Disease Progression|0|||
16147279|NCT03077685|39027576|FG003|Overall Study|Disease Progression|2|||
16147280|NCT03077685|39027577|FG004|Overall Study|Disease Progression|1|||
16147281|NCT03077685|39027573|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
16147282|NCT03077685|39027574|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
16147283|NCT03077685|39027575|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
16147284|NCT03077685|39027576|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
16147285|NCT03077685|39027577|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
16147286|NCT03077685|39027573|FG000|Overall Study|Subject entered hospice care|0|||
16147287|NCT03077685|39027574|FG001|Overall Study|Subject entered hospice care|0|||
16147288|NCT03077685|39027575|FG002|Overall Study|Subject entered hospice care|0|||
16147289|NCT03077685|39027576|FG003|Overall Study|Subject entered hospice care|0|||
16147290|NCT03077685|39027577|FG004|Overall Study|Subject entered hospice care|1|||
16147291|NCT01161043|39027578|FG000|Overall Study|Withdrawal by Subject|3|||
16147292|NCT02184195|39027579|FG000|Overall Study|Patient decision|5|||
16147293|NCT02184195|39027580|FG001|Overall Study|Patient decision|2|||
16147294|NCT02184195|39027579|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16147295|NCT02184195|39027580|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16147296|NCT02184195|39027579|FG000|Overall Study|Death|67|||
16147297|NCT02184195|39027580|FG001|Overall Study|Death|44|||
16147298|NCT02184195|39027579|FG000|Overall Study|Lost to Follow-up|1|||
16147299|NCT02184195|39027580|FG001|Overall Study|Lost to Follow-up|5|||
16147300|NCT02184195|39027579|FG000|Overall Study|Other|0|||
16147301|NCT02184195|39027580|FG001|Overall Study|Other|3|||
16147302|NCT02592551|39027581|FG000|Overall Study|Not evaluable|1|||
16147303|NCT02592551|39027582|FG001|Overall Study|Not evaluable|3|||
16147304|NCT02592551|39027583|FG002|Overall Study|Not evaluable|0|||
16147305|NCT03520959|39027584|FG000|Overall Study|Study terminated by Sponsor|0|||
16147306|NCT03520959|39027585|FG001|Overall Study|Study terminated by Sponsor|1|||
16147307|NCT03199040|39027586|FG000|Overall Study|Lack of Efficacy|2|||
16147308|NCT03199040|39027587|FG001|Overall Study|Lack of Efficacy|0|||
16147309|NCT03199040|39027586|FG000|Overall Study|Withdrawal by Subject|2|||
16147310|NCT03199040|39027587|FG001|Overall Study|Withdrawal by Subject|0|||
16147311|NCT03199040|39027586|FG000|Overall Study|Adverse Event|0|||
16147312|NCT03199040|39027587|FG001|Overall Study|Adverse Event|1|||
16147313|NCT03199040|39027586|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
16147314|NCT03199040|39027587|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
16147315|NCT04353284|39027588|FG000|Overall Study|Adverse Event|1|||
16147316|NCT04353284|39027589|FG001|Overall Study|Adverse Event|1|||
16147317|NCT04353284|39027588|FG000|Overall Study|Lost to Follow-up|1|||
16147318|NCT04353284|39027589|FG001|Overall Study|Lost to Follow-up|0|||
16147319|NCT04343248|39027590|FG000|Overall Study|Withdrawal by Subject|5|||
16147320|NCT04343248|39027591|FG001|Overall Study|Withdrawal by Subject|6|||
16147321|NCT04343248|39027590|FG000|Overall Study|Death|1|||
16147322|NCT04343248|39027591|FG001|Overall Study|Death|2|||
16147323|NCT04343248|39027590|FG000|Overall Study|Lost to Follow-up|9|||
16147324|NCT04343248|39027591|FG001|Overall Study|Lost to Follow-up|6|||
16147325|NCT04343248|39027590|FG000|Overall Study|Physician Decision|0|||
16147326|NCT04343248|39027591|FG001|Overall Study|Physician Decision|1|||
16147327|NCT04343248|39027590|FG000|Overall Study|Adverse Event|1|||
16147328|NCT04343248|39027591|FG001|Overall Study|Adverse Event|0|||
16147329|NCT02737852|39027593|FG000|Overall Study|Withdrawal by Subject|2|||
16147330|NCT00445224|39027595|FG000|Specific Exercises|Withdrawal by Subject|3|||
16147331|NCT00445224|39027596|FG001|Specific Exercises|Withdrawal by Subject|3|||
16147332|NCT00445224|39027595|FG000|Specific Exercises|Withdrawal by Subject|1|||
16147333|NCT00445224|39027596|FG001|Specific Exercises|Withdrawal by Subject|0|||
16147334|NCT03684642|39027598|FG000|Overall Study|Adverse Event|6|||
16147335|NCT03684642|39027599|FG001|Overall Study|Adverse Event|15|||
16147336|NCT03684642|39027600|FG002|Overall Study|Adverse Event|11|||
16147337|NCT03684642|39027598|FG000|Overall Study|Withdrawal by Subject|35|||
16147338|NCT03684642|39027599|FG001|Overall Study|Withdrawal by Subject|53|||
16147339|NCT03684642|39027600|FG002|Overall Study|Withdrawal by Subject|23|||
16147340|NCT03684642|39027598|FG000|Overall Study|Lack of Efficacy|0|||
16147341|NCT03684642|39027599|FG001|Overall Study|Lack of Efficacy|0|||
16147342|NCT03684642|39027600|FG002|Overall Study|Lack of Efficacy|1|||
16147343|NCT03684642|39027598|FG000|Overall Study|Poor compliance to protocol|0|||
16147344|NCT03684642|39027599|FG001|Overall Study|Poor compliance to protocol|4|||
16147345|NCT03684642|39027600|FG002|Overall Study|Poor compliance to protocol|1|||
16147346|NCT03684642|39027598|FG000|Overall Study|Other than specified|62|||
16147347|NCT03684642|39027599|FG001|Overall Study|Other than specified|60|||
16147348|NCT03684642|39027600|FG002|Overall Study|Other than specified|67|||
16147349|NCT03684642|39027598|FG000|Overall Study|Randomized and not treated|0|||
16147350|NCT03684642|39027599|FG001|Overall Study|Randomized and not treated|0|||
16147351|NCT03684642|39027600|FG002|Overall Study|Randomized and not treated|1|||
16147352|NCT03684642|39027598|FG000|Overall Study|Missing completion status but alive at last contact|0|||
16147353|NCT03684642|39027599|FG001|Overall Study|Missing completion status but alive at last contact|1|||
16147354|NCT03684642|39027600|FG002|Overall Study|Missing completion status but alive at last contact|2|||
16147355|NCT00710879|39027601|FG000|Overall Study|Lost to Follow-up|2|||
16147356|NCT00710879|39027602|FG001|Overall Study|Lost to Follow-up|1|||
16147357|NCT00710879|39027601|FG000|Overall Study|Protocol Violation|0|||
16147358|NCT00710879|39027602|FG001|Overall Study|Protocol Violation|3|||
16147359|NCT01131351|39027603|FG000|Overall Study|Adverse Event|0|||
16147360|NCT01131351|39027604|FG001|Overall Study|Adverse Event|2|||
16147361|NCT01131351|39027603|FG000|Overall Study|Protocol Deviation|0|||
16147362|NCT01131351|39027604|FG001|Overall Study|Protocol Deviation|1|||
16147363|NCT00440947|39027605|FG000|36-Week Induction Phase|Adverse Event|16|||
16147364|NCT00440947|39027606|FG001|36-Week Induction Phase|Adverse Event|0|||
16259216|NCT02937701|39433742|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
16259217|NCT02937701|39433738|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
16259218|NCT02937701|39433739|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
16259219|NCT02937701|39433740|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
16259220|NCT02937701|39433741|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
16259221|NCT02937701|39433742|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
16259222|NCT02937701|39433738|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
16259223|NCT02937701|39433739|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
16259224|NCT02937701|39433740|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
16259225|NCT02937701|39433741|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
16259226|NCT02937701|39433742|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
16259227|NCT02937701|39433738|FG000|Week 22 to Week 50|Physician Decision|0|||
16259228|NCT02937701|39433739|FG001|Week 22 to Week 50|Physician Decision|0|||
16147365|NCT00440947|39027607|FG002|36-Week Induction Phase|Adverse Event|0|||
16147366|NCT00440947|39027608|FG003|36-Week Induction Phase|Adverse Event|0|||
16147367|NCT00440947|39027609|FG004|36-Week Induction Phase|Adverse Event|0|||
16147368|NCT00440947|39027605|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
16147369|NCT00440947|39027606|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
16147370|NCT00440947|39027607|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
16147371|NCT00440947|39027608|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
16147372|NCT00440947|39027609|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
16147373|NCT00440947|39027605|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
16147374|NCT00440947|39027606|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
16147375|NCT00440947|39027607|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
16147376|NCT00440947|39027608|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
16147377|NCT00440947|39027609|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
16147378|NCT00440947|39027605|FG000|36-Week Induction Phase|Non-compliance|10|||
16440735|NCT03284710|40092789|FG000|Overall Study|HIV Infection|0|||
16440736|NCT03284710|40092790|FG001|Overall Study|HIV Infection|2|||
16440737|NCT03284710|40092791|FG002|Overall Study|HIV Infection|2|||
16440738|NCT03284710|40092792|FG003|Overall Study|HIV Infection|1|||
16440739|NCT05196828|40092794|FG000|Overall Study|Withdrawal by Subject|2|||
16440740|NCT05196828|40092795|FG001|Overall Study|Withdrawal by Subject|0|||
16440741|NCT05196828|40092794|FG000|Overall Study|Lost to Follow-up|0|||
16147379|NCT00440947|39027606|FG001|36-Week Induction Phase|Non-compliance|0|||
16147380|NCT00440947|39027607|FG002|36-Week Induction Phase|Non-compliance|0|||
16147381|NCT00440947|39027608|FG003|36-Week Induction Phase|Non-compliance|0|||
16147382|NCT00440947|39027609|FG004|36-Week Induction Phase|Non-compliance|0|||
16259229|NCT02937701|39433740|FG002|Week 22 to Week 50|Physician Decision|2|||
16440742|NCT05196828|40092795|FG001|Overall Study|Lost to Follow-up|4|||
16364729|NCT01462942|39821425|FG004|Overall Study|Other, including COPD exacerbation|5|||
16364730|NCT01462942|39821421|FG000|Overall Study|Withdrawal by Subject|14|||
16364731|NCT01462942|39821422|FG001|Overall Study|Withdrawal by Subject|10|||
16364732|NCT01462942|39821423|FG002|Overall Study|Withdrawal by Subject|14|||
16364733|NCT01462942|39821424|FG003|Overall Study|Withdrawal by Subject|16|||
16364734|NCT01462942|39821425|FG004|Overall Study|Withdrawal by Subject|19|||
16364735|NCT01462942|39821421|FG000|Overall Study|Lack of Efficacy|6|||
16364736|NCT01462942|39821422|FG001|Overall Study|Lack of Efficacy|0|||
16364737|NCT01462942|39821423|FG002|Overall Study|Lack of Efficacy|4|||
16364738|NCT01462942|39821424|FG003|Overall Study|Lack of Efficacy|5|||
16364739|NCT01462942|39821425|FG004|Overall Study|Lack of Efficacy|3|||
16364740|NCT01462942|39821421|FG000|Overall Study|Lost to Follow-up|0|||
16364741|NCT01462942|39821422|FG001|Overall Study|Lost to Follow-up|1|||
16364742|NCT01462942|39821423|FG002|Overall Study|Lost to Follow-up|1|||
16364743|NCT01462942|39821424|FG003|Overall Study|Lost to Follow-up|1|||
16364744|NCT01462942|39821425|FG004|Overall Study|Lost to Follow-up|1|||
16364745|NCT01462942|39821421|FG000|Overall Study|Protocol Violation|4|||
16364746|NCT01462942|39821422|FG001|Overall Study|Protocol Violation|6|||
16364747|NCT01462942|39821423|FG002|Overall Study|Protocol Violation|9|||
16364748|NCT01462942|39821424|FG003|Overall Study|Protocol Violation|9|||
16364749|NCT01462942|39821425|FG004|Overall Study|Protocol Violation|6|||
16364750|NCT02166463|39821426|FG000|Overall Study|Lost to Follow-up|0|||
16364751|NCT02166463|39821427|FG001|Overall Study|Lost to Follow-up|1|||
16364752|NCT02166463|39821426|FG000|Overall Study|Physician Decision|10|||
16364753|NCT02166463|39821427|FG001|Overall Study|Physician Decision|10|||
16364754|NCT02166463|39821426|FG000|Overall Study|Ineligible|11|||
16364755|NCT02166463|39821427|FG001|Overall Study|Ineligible|2|||
16364756|NCT02166463|39821426|FG000|Overall Study|Progressive Disease|9|||
16364757|NCT02166463|39821427|FG001|Overall Study|Progressive Disease|6|||
16364758|NCT02166463|39821426|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
16364759|NCT02166463|39821427|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
16364760|NCT02166463|39821426|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
16364761|NCT02166463|39821427|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
16364762|NCT02166463|39821426|FG000|Overall Study|Refusal of further protocol therapy|5|||
16364763|NCT02166463|39821427|FG001|Overall Study|Refusal of further protocol therapy|6|||
16364764|NCT01900314|39821428|FG000|Overall Study|Lost to Follow-up|1|||
16364765|NCT01900314|39821429|FG001|Overall Study|Lost to Follow-up|0|||
16364766|NCT01900314|39821428|FG000|Overall Study|Protocol Violation|0|||
16364767|NCT01900314|39821429|FG001|Overall Study|Protocol Violation|1|||
16364768|NCT01900314|39821428|FG000|Overall Study|Withdrawal by Subject|3|||
16364769|NCT01900314|39821429|FG001|Overall Study|Withdrawal by Subject|3|||
16364770|NCT00784875|39821434|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
16364771|NCT00784875|39821435|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
16364772|NCT00784875|39821436|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
16364773|NCT00784875|39821437|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
16364774|NCT00784875|39821434|FG000|Period A - Baseline|Adverse Event|0|||
16440743|NCT05196828|40092794|FG000|Overall Study|Adverse Event|1|||
16440744|NCT05196828|40092795|FG001|Overall Study|Adverse Event|0|||
16440745|NCT01171898|40092798|FG000|Overall Study|Death|0|||
16440746|NCT01171898|40092799|FG001|Overall Study|Death|0|||
16440747|NCT01171898|40092800|FG002|Overall Study|Death|2|||
16440748|NCT01171898|40092801|FG003|Overall Study|Death|0|||
16440749|NCT01171898|40092798|FG000|Overall Study|Lost to Follow-up|0|||
16440750|NCT01171898|40092799|FG001|Overall Study|Lost to Follow-up|1|||
16440751|NCT01171898|40092800|FG002|Overall Study|Lost to Follow-up|1|||
16440752|NCT01171898|40092801|FG003|Overall Study|Lost to Follow-up|1|||
16440753|NCT01171898|40092798|FG000|Overall Study|Withdrawal by Subject|1|||
16440754|NCT01171898|40092799|FG001|Overall Study|Withdrawal by Subject|4|||
16440755|NCT01171898|40092800|FG002|Overall Study|Withdrawal by Subject|6|||
16440756|NCT01171898|40092801|FG003|Overall Study|Withdrawal by Subject|3|||
16440757|NCT01171898|40092798|FG000|Overall Study|Terminated by Sponsor|1|||
16440758|NCT01171898|40092799|FG001|Overall Study|Terminated by Sponsor|0|||
16440759|NCT01171898|40092800|FG002|Overall Study|Terminated by Sponsor|0|||
16440760|NCT01171898|40092801|FG003|Overall Study|Terminated by Sponsor|0|||
16440761|NCT01171898|40092798|FG000|Overall Study|Ongoing|1|||
16440762|NCT01171898|40092799|FG001|Overall Study|Ongoing|9|||
16440763|NCT01171898|40092800|FG002|Overall Study|Ongoing|3|||
16440764|NCT01171898|40092801|FG003|Overall Study|Ongoing|0|||
16440765|NCT01171898|40092798|FG000|Overall Study|Other|1|||
16440766|NCT01171898|40092799|FG001|Overall Study|Other|5|||
16440767|NCT01171898|40092800|FG002|Overall Study|Other|0|||
16440768|NCT01171898|40092801|FG003|Overall Study|Other|2|||
16440769|NCT04199351|40092802|FG000|Overall Study|Decision by sponsor|0|||
16440770|NCT04199351|40092803|FG001|Overall Study|Decision by sponsor|0|||
16440771|NCT04199351|40092804|FG002|Overall Study|Decision by sponsor|0|||
16440772|NCT04199351|40092805|FG003|Overall Study|Decision by sponsor|2|||
16440773|NCT04199351|40092806|FG004|Overall Study|Decision by sponsor|0|||
16440774|NCT04199351|40092807|FG005|Overall Study|Decision by sponsor|0|||
16147383|NCT00440947|39027605|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
16147384|NCT00440947|39027606|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
16147385|NCT00440947|39027607|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
16147386|NCT00440947|39027608|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
16147387|NCT00440947|39027609|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
16147388|NCT00440947|39027605|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
16147389|NCT00440947|39027606|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
16147390|NCT00440947|39027607|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
16147391|NCT00440947|39027608|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
16147392|NCT00440947|39027609|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
16147393|NCT00440947|39027605|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
16147394|NCT00440947|39027606|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
16147395|NCT00440947|39027607|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
16147396|NCT00440947|39027608|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
16147397|NCT00440947|39027609|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
16147398|NCT00440947|39027605|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
16147399|NCT00440947|39027606|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
16147400|NCT00440947|39027607|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
16259230|NCT02937701|39433741|FG003|Week 22 to Week 50|Physician Decision|0|||
16364775|NCT00784875|39821435|FG001|Period A - Baseline|Adverse Event|0|||
16364776|NCT00784875|39821436|FG002|Period A - Baseline|Adverse Event|0|||
16440775|NCT04199351|40092808|FG006|Overall Study|Decision by sponsor|0|||
16147401|NCT00440947|39027608|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
16364777|NCT00784875|39821437|FG003|Period A - Baseline|Adverse Event|8|||
16440776|NCT04199351|40092809|FG007|Overall Study|Decision by sponsor|0|||
16440777|NCT04199351|40092810|FG008|Overall Study|Decision by sponsor|0|||
16440778|NCT04199351|40092811|FG009|Overall Study|Decision by sponsor|6|||
16440779|NCT04199351|40092802|FG000|Overall Study|Lost to Follow-up|0|||
16440780|NCT04199351|40092803|FG001|Overall Study|Lost to Follow-up|0|||
16440781|NCT04199351|40092804|FG002|Overall Study|Lost to Follow-up|1|||
16440782|NCT04199351|40092805|FG003|Overall Study|Lost to Follow-up|0|||
16440783|NCT04199351|40092806|FG004|Overall Study|Lost to Follow-up|0|||
16440784|NCT04199351|40092807|FG005|Overall Study|Lost to Follow-up|1|||
16147402|NCT00440947|39027609|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
16147403|NCT00440947|39027605|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
16147404|NCT00440947|39027606|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
16147405|NCT00440947|39027607|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
16147406|NCT00440947|39027608|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
16147407|NCT00440947|39027609|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
16147408|NCT00440947|39027605|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
16147409|NCT00440947|39027606|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
16147410|NCT00440947|39027607|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
16147411|NCT00440947|39027608|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
16147412|NCT00440947|39027609|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
16147413|NCT00440947|39027605|FG000|36-Week Induction Phase|Incarceration|3|||
16147414|NCT00440947|39027606|FG001|36-Week Induction Phase|Incarceration|0|||
16147415|NCT00440947|39027607|FG002|36-Week Induction Phase|Incarceration|0|||
16147416|NCT00440947|39027608|FG003|36-Week Induction Phase|Incarceration|0|||
16147417|NCT00440947|39027609|FG004|36-Week Induction Phase|Incarceration|0|||
16147418|NCT00440947|39027605|FG000|36-Week Induction Phase|Pregnancy|1|||
16147419|NCT00440947|39027606|FG001|36-Week Induction Phase|Pregnancy|0|||
16147420|NCT00440947|39027607|FG002|36-Week Induction Phase|Pregnancy|0|||
16440785|NCT04199351|40092808|FG006|Overall Study|Lost to Follow-up|0|||
16440786|NCT04199351|40092809|FG007|Overall Study|Lost to Follow-up|0|||
16440787|NCT04199351|40092810|FG008|Overall Study|Lost to Follow-up|0|||
16440788|NCT04199351|40092811|FG009|Overall Study|Lost to Follow-up|0|||
16440789|NCT04199351|40092802|FG000|Overall Study|Withdrawal by Subject|0|||
16440790|NCT04199351|40092803|FG001|Overall Study|Withdrawal by Subject|1|||
16147421|NCT00440947|39027608|FG003|36-Week Induction Phase|Pregnancy|0|||
16147422|NCT00440947|39027609|FG004|36-Week Induction Phase|Pregnancy|0|||
16147423|NCT00440947|39027605|FG000|48-Week Randomization Phase|Adverse Event|0|||
16440791|NCT04199351|40092804|FG002|Overall Study|Withdrawal by Subject|0|||
16147424|NCT00440947|39027606|FG001|48-Week Randomization Phase|Adverse Event|2|||
16147425|NCT00440947|39027607|FG002|48-Week Randomization Phase|Adverse Event|5|||
16440792|NCT04199351|40092805|FG003|Overall Study|Withdrawal by Subject|0|||
16440793|NCT04199351|40092806|FG004|Overall Study|Withdrawal by Subject|1|||
16440794|NCT04199351|40092807|FG005|Overall Study|Withdrawal by Subject|4|||
16440795|NCT04199351|40092808|FG006|Overall Study|Withdrawal by Subject|2|||
16440796|NCT04199351|40092809|FG007|Overall Study|Withdrawal by Subject|0|||
16440797|NCT04199351|40092810|FG008|Overall Study|Withdrawal by Subject|3|||
16440798|NCT04199351|40092811|FG009|Overall Study|Withdrawal by Subject|0|||
16440799|NCT04439136|40092812|FG000|Overall Study|Ineligible|1|||
16440800|NCT04439136|40092812|FG000|Overall Study|Never Started Treatment|2|||
16440801|NCT04439136|40092812|FG000|Overall Study|Adverse Event|4|||
16440802|NCT04439136|40092812|FG000|Overall Study|Death|3|||
16440803|NCT04439136|40092812|FG000|Overall Study|Disease Progression|27|||
16440804|NCT04439136|40092812|FG000|Overall Study|Alternative Therapy|1|||
16440805|NCT04439136|40092812|FG000|Overall Study|Increased Tumor Burden|1|||
16440806|NCT04439136|40092812|FG000|Overall Study|Symptomatic Detrioration|1|||
16440807|NCT04869982|40092813|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
16440808|NCT04869982|40092814|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
16440809|NCT04869982|40092813|FG000|Overall Study|Migrated / moved from the study area|1|||
16440810|NCT04869982|40092814|FG001|Overall Study|Migrated / moved from the study area|1|||
16147426|NCT00440947|39027608|FG003|48-Week Randomization Phase|Adverse Event|0|||
16147427|NCT00440947|39027609|FG004|48-Week Randomization Phase|Adverse Event|0|||
16147428|NCT00440947|39027605|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
16147429|NCT00440947|39027606|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
16147430|NCT00440947|39027607|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
16147431|NCT00440947|39027608|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
16147432|NCT00440947|39027609|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
16147433|NCT00440947|39027605|FG000|48-Week Randomization Phase|Non-compliance|0|||
16147434|NCT00440947|39027606|FG001|48-Week Randomization Phase|Non-compliance|3|||
16147435|NCT00440947|39027607|FG002|48-Week Randomization Phase|Non-compliance|4|||
16147436|NCT00440947|39027608|FG003|48-Week Randomization Phase|Non-compliance|0|||
16147437|NCT00440947|39027609|FG004|48-Week Randomization Phase|Non-compliance|0|||
16147438|NCT00440947|39027605|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
16147439|NCT00440947|39027606|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
16147440|NCT00440947|39027607|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
16147441|NCT00440947|39027608|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
16147442|NCT00440947|39027609|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
16147443|NCT00440947|39027605|FG000|48-Week Randomization Phase|Protocol Violation|0|||
16147444|NCT00440947|39027606|FG001|48-Week Randomization Phase|Protocol Violation|0|||
16147445|NCT00440947|39027607|FG002|48-Week Randomization Phase|Protocol Violation|1|||
16147446|NCT00440947|39027608|FG003|48-Week Randomization Phase|Protocol Violation|0|||
16147447|NCT00440947|39027609|FG004|48-Week Randomization Phase|Protocol Violation|0|||
16147448|NCT00440947|39027605|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
16147449|NCT00440947|39027606|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
16147450|NCT00440947|39027607|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
16147451|NCT00440947|39027608|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
16147452|NCT00440947|39027609|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
16147453|NCT00440947|39027605|FG000|48-Week Randomization Phase|Pregnancy|0|||
16147454|NCT00440947|39027606|FG001|48-Week Randomization Phase|Pregnancy|0|||
16147455|NCT00440947|39027607|FG002|48-Week Randomization Phase|Pregnancy|1|||
16147456|NCT00440947|39027608|FG003|48-Week Randomization Phase|Pregnancy|0|||
16147457|NCT00440947|39027609|FG004|48-Week Randomization Phase|Pregnancy|0|||
16147458|NCT00440947|39027605|FG000|48-Week Randomization Phase|Incarceration|0|||
16147459|NCT00440947|39027606|FG001|48-Week Randomization Phase|Incarceration|3|||
16147460|NCT00440947|39027607|FG002|48-Week Randomization Phase|Incarceration|0|||
16147461|NCT00440947|39027608|FG003|48-Week Randomization Phase|Incarceration|0|||
16147462|NCT00440947|39027609|FG004|48-Week Randomization Phase|Incarceration|0|||
16147463|NCT00440947|39027605|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
16147464|NCT00440947|39027606|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
16147465|NCT00440947|39027607|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
16147466|NCT00440947|39027608|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
16147467|NCT00440947|39027609|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
16147468|NCT00440947|39027605|FG000|48-Week Randomization Phase|Physician Decision|0|||
16147469|NCT00440947|39027606|FG001|48-Week Randomization Phase|Physician Decision|2|||
16147470|NCT00440947|39027607|FG002|48-Week Randomization Phase|Physician Decision|0|||
16147471|NCT00440947|39027608|FG003|48-Week Randomization Phase|Physician Decision|0|||
16147472|NCT00440947|39027609|FG004|48-Week Randomization Phase|Physician Decision|0|||
16147473|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
16147474|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
16147475|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
16147476|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
16147477|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
16364778|NCT00784875|39821434|FG000|Period A - Baseline|Protocol Violation|0|||
16364779|NCT00784875|39821435|FG001|Period A - Baseline|Protocol Violation|0|||
16364780|NCT00784875|39821436|FG002|Period A - Baseline|Protocol Violation|0|||
16364781|NCT00784875|39821437|FG003|Period A - Baseline|Protocol Violation|25|||
16364782|NCT00784875|39821434|FG000|Period A - Baseline|Withdrawal by Subject|0|||
16364783|NCT00784875|39821435|FG001|Period A - Baseline|Withdrawal by Subject|0|||
16364784|NCT00784875|39821436|FG002|Period A - Baseline|Withdrawal by Subject|0|||
16364785|NCT00784875|39821437|FG003|Period A - Baseline|Withdrawal by Subject|27|||
16364786|NCT00784875|39821434|FG000|Period A - Baseline|Physician Decision|0|||
16364787|NCT00784875|39821435|FG001|Period A - Baseline|Physician Decision|0|||
16364788|NCT00784875|39821436|FG002|Period A - Baseline|Physician Decision|0|||
16364789|NCT00784875|39821437|FG003|Period A - Baseline|Physician Decision|2|||
16147478|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
16147479|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
16147480|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
16147481|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
16147482|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
16364790|NCT00784875|39821434|FG000|Period A - Baseline|Sponsor Decision|0|||
16147483|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
16440811|NCT04869982|40092813|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
16440812|NCT04869982|40092814|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
16440813|NCT04869982|40092813|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
16440814|NCT04869982|40092814|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
16440815|NCT04869982|40092813|FG000|Overall Study|Solicited adverse event|2|||
16440816|NCT04869982|40092814|FG001|Overall Study|Solicited adverse event|1|||
16440817|NCT02257736|40092818|FG000|Overall Study|Progressive disease|365|||
16440818|NCT02257736|40092819|FG001|Overall Study|Progressive disease|327|||
16440819|NCT02257736|40092818|FG000|Overall Study|Adverse Event|45|||
16440820|NCT02257736|40092819|FG001|Overall Study|Adverse Event|56|||
16440821|NCT02257736|40092818|FG000|Overall Study|Withdrawal by Subject|21|||
16440822|NCT02257736|40092819|FG001|Overall Study|Withdrawal by Subject|38|||
16440823|NCT02257736|40092818|FG000|Overall Study|Death|11|||
16440824|NCT02257736|40092819|FG001|Overall Study|Death|6|||
16440825|NCT02257736|40092818|FG000|Overall Study|Physician Decision|5|||
16440826|NCT02257736|40092819|FG001|Overall Study|Physician Decision|9|||
16440827|NCT02257736|40092818|FG000|Overall Study|Non-Compliance with study drug|1|||
16440828|NCT02257736|40092819|FG001|Overall Study|Non-Compliance with study drug|2|||
16440829|NCT02257736|40092818|FG000|Overall Study|Protocol Violation|1|||
16440830|NCT02257736|40092819|FG001|Overall Study|Protocol Violation|0|||
16440831|NCT02257736|40092818|FG000|Overall Study|Other|1|||
16440832|NCT02257736|40092819|FG001|Overall Study|Other|7|||
16440833|NCT02257736|40092818|FG000|Overall Study|Randomized, not treated|1|||
16440834|NCT02257736|40092819|FG001|Overall Study|Randomized, not treated|2|||
16440835|NCT04685798|40092821|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
16440836|NCT03922581|40092824|FG000|Overall Study|Lost to Follow-up|20|||
16440837|NCT03922581|40092825|FG001|Overall Study|Lost to Follow-up|9|||
16440838|NCT03922581|40092824|FG000|Overall Study|Physician Decision|1|||
16440839|NCT03922581|40092825|FG001|Overall Study|Physician Decision|1|||
16440840|NCT03922581|40092824|FG000|Overall Study|Withdrawal by Subject|1|||
16440841|NCT03922581|40092825|FG001|Overall Study|Withdrawal by Subject|0|||
16440842|NCT03724942|40092829|FG000|Overall Study|Adverse Event|20|||
16440843|NCT03724942|40092830|FG001|Overall Study|Adverse Event|14|||
16440844|NCT03724942|40092829|FG000|Overall Study|Lack of Efficacy|0|||
16440845|NCT03724942|40092830|FG001|Overall Study|Lack of Efficacy|1|||
16440846|NCT03724942|40092829|FG000|Overall Study|Physician Decision|5|||
16440847|NCT03724942|40092830|FG001|Overall Study|Physician Decision|2|||
16440848|NCT03724942|40092829|FG000|Overall Study|Protocol Violation|1|||
16440849|NCT03724942|40092830|FG001|Overall Study|Protocol Violation|0|||
16440850|NCT03724942|40092829|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
16440851|NCT03724942|40092830|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
16440852|NCT03724942|40092829|FG000|Overall Study|Withdrawal by Legal Representative|3|||
16440853|NCT03724942|40092830|FG001|Overall Study|Withdrawal by Legal Representative|0|||
16440854|NCT03759379|40092834|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
16440855|NCT03759379|40092835|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
16440856|NCT03759379|40092834|FG000|Treatment Period|Death|2|||
16440857|NCT03759379|40092835|FG001|Treatment Period|Death|3|||
16440858|NCT03759379|40092834|FG000|Treatment Period|Lost to Follow-up|1|||
16440859|NCT03759379|40092835|FG001|Treatment Period|Lost to Follow-up|0|||
16440860|NCT03759379|40092834|FG000|Treatment Period|Physician Decision|0|||
16440861|NCT03759379|40092835|FG001|Treatment Period|Physician Decision|1|||
16440862|NCT03370276|40092836|FG000|Overall Study|Death|0|||
16440863|NCT03370276|40092837|FG001|Overall Study|Death|2|||
16440864|NCT03370276|40092838|FG002|Overall Study|Death|5|||
16440865|NCT03585660|40092839|FG000|Overall Study|operator error|1|||
16440866|NCT03585660|40092839|FG000|Overall Study|technical error|2|||
16440867|NCT03585660|40092839|FG000|Overall Study|hip prosthesis|2|||
16440868|NCT03585660|40092839|FG000|Overall Study|did not undergo biopsy|8|||
16440869|NCT03585660|40092839|FG000|Overall Study|scanner problem|2|||
16147484|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
16364791|NCT00784875|39821435|FG001|Period A - Baseline|Sponsor Decision|0|||
16364792|NCT00784875|39821436|FG002|Period A - Baseline|Sponsor Decision|0|||
16364793|NCT00784875|39821437|FG003|Period A - Baseline|Sponsor Decision|113|||
16364794|NCT00784875|39821434|FG000|Period A - Baseline|Lost to Follow-up|0|||
16364795|NCT00784875|39821435|FG001|Period A - Baseline|Lost to Follow-up|0|||
16364796|NCT00784875|39821436|FG002|Period A - Baseline|Lost to Follow-up|0|||
16440870|NCT06308822|40092840|FG000|Overall Study|Mutation Status Not Confirmed|17|||
16440871|NCT06308822|40092840|FG000|Overall Study|Adverse Event|1|||
16440872|NCT06308822|40092840|FG000|Overall Study|Death|5|||
16440873|NCT06308822|40092840|FG000|Overall Study|Disease progression|8|||
16440874|NCT06308822|40092840|FG000|Overall Study|Withdrawal by Subject|1|||
16147485|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
16364797|NCT00784875|39821437|FG003|Period A - Baseline|Lost to Follow-up|2|||
16364798|NCT00784875|39821434|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
16147486|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
16147487|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
16147488|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
16147489|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
16147490|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
16147491|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
16147492|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
16147493|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
16147494|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
16147495|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
16147496|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
16147497|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
16147498|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
16147499|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
16147500|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
16147501|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
16147502|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
16147503|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
16147504|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
16147505|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
16147506|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
16147507|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
16147508|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
16147509|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
16147510|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
16147511|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
16147512|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
16147513|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
16147514|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
16147515|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
16147516|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
16147517|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
16147518|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
16147519|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
16147520|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
16147521|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
16147522|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
16147523|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
16147524|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
16259231|NCT02937701|39433742|FG004|Week 22 to Week 50|Physician Decision|1|||
16259232|NCT02937701|39433738|FG000|Week 22 to Week 50|Other|0|||
16259233|NCT02937701|39433739|FG001|Week 22 to Week 50|Other|0|||
16259234|NCT02937701|39433740|FG002|Week 22 to Week 50|Other|0|||
16259235|NCT02937701|39433741|FG003|Week 22 to Week 50|Other|0|||
16259236|NCT02937701|39433742|FG004|Week 22 to Week 50|Other|1|||
16259237|NCT04657770|39433746|FG000|Overall Study|Withdrawal by Subject|3|||
16259238|NCT04657770|39433746|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
16259239|NCT05275205|39433761|FG000|Overall Study|Adverse Event|1|||
16259240|NCT05275205|39433762|FG001|Overall Study|Adverse Event|2|||
16259241|NCT05275205|39433761|FG000|Overall Study|Physician Decision|1|||
16259242|NCT05275205|39433762|FG001|Overall Study|Physician Decision|1|||
16259243|NCT05275205|39433761|FG000|Overall Study|Withdrawal by Subject|2|||
16259244|NCT05275205|39433762|FG001|Overall Study|Withdrawal by Subject|3|||
16259245|NCT05275205|39433761|FG000|Overall Study|Death|1|||
16259246|NCT05275205|39433762|FG001|Overall Study|Death|0|||
16259247|NCT05275205|39433761|FG000|Overall Study|Patient unable to attend visits|1|||
16259248|NCT05275205|39433762|FG001|Overall Study|Patient unable to attend visits|0|||
16259249|NCT04453202|39433763|FG000|Overall Study|Adverse Event|0|||
16259250|NCT04453202|39433764|FG001|Overall Study|Adverse Event|0|||
16259251|NCT04453202|39433765|FG002|Overall Study|Adverse Event|0|||
16259252|NCT04453202|39433766|FG003|Overall Study|Adverse Event|0|||
16440875|NCT06308822|40092840|FG000|Overall Study|Physician Decision|3|||
16147525|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
16147526|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
16147527|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
16147528|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Other|0|||
16147529|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Other|0|||
16147530|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Other|0|||
16147531|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Other|1|||
16259253|NCT04453202|39433767|FG004|Overall Study|Adverse Event|0|||
16259254|NCT04453202|39433768|FG005|Overall Study|Adverse Event|0|||
16147532|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Other|0|||
16147533|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
16147534|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
16147535|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
16147536|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
16147537|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
16147538|NCT00440947|39027605|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
16147539|NCT00440947|39027606|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
16147540|NCT00440947|39027607|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
16147541|NCT00440947|39027608|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
16147542|NCT00440947|39027609|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
16147543|NCT02243865|39027613|FG000|Overall Study|Protocol Violation|1|||
16147544|NCT02243865|39027614|FG001|Overall Study|Protocol Violation|3|||
16147545|NCT02243865|39027613|FG000|Overall Study|Lost to Follow-up|1|||
16147546|NCT02243865|39027614|FG001|Overall Study|Lost to Follow-up|1|||
16147547|NCT02243865|39027613|FG000|Overall Study|Withdrawal by Subject|1|||
16147548|NCT02243865|39027614|FG001|Overall Study|Withdrawal by Subject|0|||
16147549|NCT02243865|39027613|FG000|Overall Study|Adverse Event|1|||
16147550|NCT02243865|39027614|FG001|Overall Study|Adverse Event|1|||
16147551|NCT01462435|39027616|FG000|Overall Study|Lack of Efficacy|1|||
16147552|NCT01462435|39027617|FG001|Overall Study|Lack of Efficacy|0|||
16147553|NCT01462435|39027618|FG002|Overall Study|Lack of Efficacy|0|||
16147554|NCT01462435|39027619|FG003|Overall Study|Lack of Efficacy|3|||
16147555|NCT01462435|39027616|FG000|Overall Study|Physician Decision|0|||
16147556|NCT01462435|39027617|FG001|Overall Study|Physician Decision|0|||
16147557|NCT01462435|39027618|FG002|Overall Study|Physician Decision|1|||
16147558|NCT01462435|39027619|FG003|Overall Study|Physician Decision|0|||
16147559|NCT01462435|39027616|FG000|Overall Study|Withdrawal by Subject|0|||
16147560|NCT01462435|39027617|FG001|Overall Study|Withdrawal by Subject|0|||
16147561|NCT01462435|39027618|FG002|Overall Study|Withdrawal by Subject|0|||
16147562|NCT01462435|39027619|FG003|Overall Study|Withdrawal by Subject|1|||
16147563|NCT01462435|39027616|FG000|Overall Study|Lost to Follow-up|0|||
16147564|NCT01462435|39027617|FG001|Overall Study|Lost to Follow-up|0|||
16147565|NCT01462435|39027618|FG002|Overall Study|Lost to Follow-up|0|||
16147566|NCT01462435|39027619|FG003|Overall Study|Lost to Follow-up|1|||
16147567|NCT00199836|39027620|FG000|Overall Study|Progressive Disease|5|||
16147568|NCT00199836|39027620|FG000|Overall Study|Death|1|||
16147569|NCT04416555|39027621|FG000|Overall Study|Withdrawal by Subject|0|||
16147570|NCT04416555|39027622|FG001|Overall Study|Withdrawal by Subject|3|||
16147571|NCT05082376|39027625|FG000|Overall Study|Lost to Follow-up|2|||
16147572|NCT00516048|39027626|FG000|Overall Study|Death|0|||
16147573|NCT00516048|39027627|FG001|Overall Study|Death|0|||
16147574|NCT00516048|39027628|FG002|Overall Study|Death|1|||
16147575|NCT00516048|39027626|FG000|Overall Study|Subject Decision|0|||
16147576|NCT00516048|39027627|FG001|Overall Study|Subject Decision|2|||
16147577|NCT00516048|39027628|FG002|Overall Study|Subject Decision|0|||
16147578|NCT01977820|39027634|FG000|Overall Study|Sponsor terminated the study|1|||
16147579|NCT01977820|39027635|FG001|Overall Study|Sponsor terminated the study|1|||
16147580|NCT02230254|39027638|FG000|Overall Study|Lost to Follow-up|3|||
16147581|NCT02319668|39027639|FG000|Overall Study|Other (Not specified)|0|||
16147582|NCT02319668|39027640|FG001|Overall Study|Other (Not specified)|2|||
16147583|NCT00175877|39027641|FG000|Overall Study|Adverse Event|136|||
16147584|NCT00175877|39027641|FG000|Overall Study|Withdrawal by Subject|141|||
16147585|NCT00175877|39027641|FG000|Overall Study|Lost to Follow-up|9|||
16147586|NCT00175877|39027641|FG000|Overall Study|Lack of Efficacy|26|||
16147587|NCT00175877|39027641|FG000|Overall Study|Protocol Violation|15|||
16147588|NCT00175877|39027641|FG000|Overall Study|Other Reason|20|||
16147589|NCT00175877|39027641|FG000|Overall Study|AE & Other|1|||
16147590|NCT00175877|39027641|FG000|Overall Study|Withdrawal by subject & Other|1|||
16440876|NCT04924062|40092841|FG000|Overall Study|Death|49|||
16440877|NCT04924062|40092842|FG001|Overall Study|Death|63|||
16147591|NCT01372150|39027642|FG000|Overall Study|Lack of Efficacy|3|||
16147592|NCT01372150|39027643|FG001|Overall Study|Lack of Efficacy|0|||
16147593|NCT01372150|39027644|FG002|Overall Study|Lack of Efficacy|1|||
16147594|NCT01372150|39027642|FG000|Overall Study|Lost to Follow-up|4|||
16147595|NCT01372150|39027643|FG001|Overall Study|Lost to Follow-up|5|||
16147596|NCT01372150|39027644|FG002|Overall Study|Lost to Follow-up|6|||
16147597|NCT01372150|39027642|FG000|Overall Study|Protocol Violation|1|||
16147598|NCT01372150|39027643|FG001|Overall Study|Protocol Violation|0|||
16147599|NCT01372150|39027644|FG002|Overall Study|Protocol Violation|3|||
16147600|NCT01372150|39027642|FG000|Overall Study|Withdrawal by Subject|2|||
16259255|NCT04453202|39433769|FG006|Overall Study|Adverse Event|1|||
16440878|NCT04924062|40092841|FG000|Overall Study|Participant On-going|26|||
16147601|NCT01372150|39027643|FG001|Overall Study|Withdrawal by Subject|7|||
16147602|NCT01372150|39027644|FG002|Overall Study|Withdrawal by Subject|2|||
16147603|NCT01372150|39027642|FG000|Overall Study|Other|1|||
16147604|NCT01372150|39027643|FG001|Overall Study|Other|0|||
16364799|NCT00784875|39821435|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
16364800|NCT00784875|39821436|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
16364801|NCT00784875|39821437|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
16364802|NCT00784875|39821434|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
16364803|NCT00784875|39821435|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
16364804|NCT00784875|39821436|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
16364805|NCT00784875|39821437|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
16364806|NCT00784875|39821434|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
16364807|NCT00784875|39821435|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
16364808|NCT00784875|39821436|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
16364809|NCT00784875|39821437|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
16364810|NCT00784875|39821434|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
16364811|NCT00784875|39821435|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
16364812|NCT00784875|39821436|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
16364813|NCT00784875|39821437|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
16364814|NCT00784875|39821434|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
16364815|NCT00784875|39821435|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
16364816|NCT00784875|39821436|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
16364817|NCT00784875|39821437|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
16364818|NCT00784875|39821434|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
16364819|NCT00784875|39821435|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
16364820|NCT00784875|39821436|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
16364821|NCT00784875|39821437|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
16364822|NCT00784875|39821434|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
16364823|NCT00784875|39821435|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
16364824|NCT00784875|39821436|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
16364825|NCT00784875|39821437|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
16364826|NCT00784875|39821434|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
16364827|NCT00784875|39821435|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
16364828|NCT00784875|39821436|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
16364829|NCT00784875|39821437|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
16364830|NCT00784875|39821434|FG000|Period C|Adverse Event|1|||
16364831|NCT00784875|39821435|FG001|Period C|Adverse Event|0|||
16364832|NCT00784875|39821436|FG002|Period C|Adverse Event|4|||
16364833|NCT00784875|39821437|FG003|Period C|Adverse Event|2|||
16364834|NCT00784875|39821434|FG000|Period C|Protocol Violation|0|||
16364835|NCT00784875|39821435|FG001|Period C|Protocol Violation|0|||
16364836|NCT00784875|39821436|FG002|Period C|Protocol Violation|1|||
16364837|NCT00784875|39821437|FG003|Period C|Protocol Violation|2|||
16364838|NCT00784875|39821434|FG000|Period C|Lack of Efficacy|0|||
16364839|NCT00784875|39821435|FG001|Period C|Lack of Efficacy|0|||
16364840|NCT00784875|39821436|FG002|Period C|Lack of Efficacy|1|||
16364841|NCT00784875|39821437|FG003|Period C|Lack of Efficacy|0|||
16364842|NCT00784875|39821434|FG000|Period C|Withdrawal by Subject|1|||
16364843|NCT00784875|39821435|FG001|Period C|Withdrawal by Subject|1|||
16364844|NCT00784875|39821436|FG002|Period C|Withdrawal by Subject|2|||
16364845|NCT00784875|39821437|FG003|Period C|Withdrawal by Subject|0|||
16364846|NCT00784875|39821434|FG000|Period C|Physician Decision|0|||
16364847|NCT00784875|39821435|FG001|Period C|Physician Decision|0|||
16364848|NCT00784875|39821436|FG002|Period C|Physician Decision|1|||
16364849|NCT00784875|39821437|FG003|Period C|Physician Decision|1|||
16440879|NCT04924062|40092842|FG001|Overall Study|Participant On-going|20|||
16440880|NCT03182374|40092843|FG000|Overall Study|Lost to Follow-up|3|||
16440881|NCT03182374|40092844|FG001|Overall Study|Lost to Follow-up|2|||
16440882|NCT03182374|40092843|FG000|Overall Study|Lack of Efficacy|8|||
16440883|NCT03182374|40092844|FG001|Overall Study|Lack of Efficacy|14|||
16440884|NCT03182374|40092843|FG000|Overall Study|Withdrawal by Subject|1|||
16440885|NCT03182374|40092844|FG001|Overall Study|Withdrawal by Subject|1|||
16364850|NCT00784875|39821434|FG000|Period C|Sponsor Decision|5|||
16364851|NCT00784875|39821435|FG001|Period C|Sponsor Decision|5|||
16364852|NCT00784875|39821436|FG002|Period C|Sponsor Decision|4|||
16364853|NCT00784875|39821437|FG003|Period C|Sponsor Decision|2|||
16364854|NCT00784875|39821434|FG000|Period D|Adverse Event|0|||
16364855|NCT00784875|39821435|FG001|Period D|Adverse Event|2|||
16364856|NCT00784875|39821436|FG002|Period D|Adverse Event|2|||
16364857|NCT00784875|39821437|FG003|Period D|Adverse Event|0|||
16364858|NCT00784875|39821434|FG000|Period D|Protocol Violation|1|||
16364859|NCT00784875|39821435|FG001|Period D|Protocol Violation|0|||
16364860|NCT00784875|39821436|FG002|Period D|Protocol Violation|0|||
16364861|NCT00784875|39821437|FG003|Period D|Protocol Violation|0|||
16147605|NCT01372150|39027644|FG002|Overall Study|Other|2|||
16147606|NCT01372150|39027642|FG000|Overall Study|Adverse Event|2|||
16147607|NCT01372150|39027643|FG001|Overall Study|Adverse Event|1|||
16147608|NCT01372150|39027644|FG002|Overall Study|Adverse Event|2|||
16147609|NCT01372150|39027642|FG000|Overall Study|Randomized but not treated|0|||
16147610|NCT01372150|39027643|FG001|Overall Study|Randomized but not treated|1|||
16147611|NCT01372150|39027644|FG002|Overall Study|Randomized but not treated|0|||
16147612|NCT01225731|39027645|FG000|Part 1|Did not meet eligibility criteria|1|||
16147613|NCT01225731|39027646|FG001|Part 1|Did not meet eligibility criteria|0|||
16147614|NCT01225731|39027647|FG002|Part 1|Did not meet eligibility criteria|0|||
16147615|NCT01225731|39027648|FG003|Part 1|Did not meet eligibility criteria|0|||
16147616|NCT01225731|39027649|FG004|Part 1|Did not meet eligibility criteria|1|||
16147617|NCT01225731|39027650|FG005|Part 1|Did not meet eligibility criteria|0|||
16147618|NCT01225731|39027651|FG006|Part 1|Did not meet eligibility criteria|0|||
16147619|NCT01225731|39027652|FG007|Part 1|Did not meet eligibility criteria|0|||
16147620|NCT01225731|39027653|FG008|Part 1|Did not meet eligibility criteria|0|||
16147621|NCT01225731|39027654|FG009|Part 1|Did not meet eligibility criteria|0|||
16147622|NCT01225731|39027655|FG010|Part 1|Did not meet eligibility criteria|0|||
16147623|NCT01225731|39027656|FG011|Part 1|Did not meet eligibility criteria|0|||
16147624|NCT01225731|39027657|FG012|Part 1|Did not meet eligibility criteria|0|||
16147625|NCT01225731|39027645|FG000|Part 1|Adverse Event|1|||
16147626|NCT01225731|39027646|FG001|Part 1|Adverse Event|2|||
16147627|NCT01225731|39027647|FG002|Part 1|Adverse Event|1|||
16147628|NCT01225731|39027648|FG003|Part 1|Adverse Event|1|||
16147629|NCT01225731|39027649|FG004|Part 1|Adverse Event|1|||
16147630|NCT01225731|39027650|FG005|Part 1|Adverse Event|0|||
16147631|NCT01225731|39027651|FG006|Part 1|Adverse Event|0|||
16259256|NCT04453202|39433770|FG007|Overall Study|Adverse Event|0|||
16259257|NCT04453202|39433771|FG008|Overall Study|Adverse Event|0|||
16259258|NCT04453202|39433772|FG009|Overall Study|Adverse Event|0|||
16259259|NCT04453202|39433773|FG010|Overall Study|Adverse Event|0|||
16259260|NCT04453202|39433763|FG000|Overall Study|Death|0|||
16259261|NCT04453202|39433764|FG001|Overall Study|Death|0|||
16259262|NCT04453202|39433765|FG002|Overall Study|Death|0|||
16259263|NCT04453202|39433766|FG003|Overall Study|Death|0|||
16259264|NCT04453202|39433767|FG004|Overall Study|Death|0|||
16259265|NCT04453202|39433768|FG005|Overall Study|Death|0|||
16259266|NCT04453202|39433769|FG006|Overall Study|Death|0|||
16147632|NCT01225731|39027652|FG007|Part 1|Adverse Event|0|||
16147633|NCT01225731|39027653|FG008|Part 1|Adverse Event|0|||
16259267|NCT04453202|39433770|FG007|Overall Study|Death|0|||
16259268|NCT04453202|39433771|FG008|Overall Study|Death|0|||
16259269|NCT04453202|39433772|FG009|Overall Study|Death|1|||
16259270|NCT04453202|39433773|FG010|Overall Study|Death|0|||
16259271|NCT04453202|39433763|FG000|Overall Study|Lost to Follow-up|0|||
16259272|NCT04453202|39433764|FG001|Overall Study|Lost to Follow-up|1|||
16259273|NCT04453202|39433765|FG002|Overall Study|Lost to Follow-up|0|||
16259274|NCT04453202|39433766|FG003|Overall Study|Lost to Follow-up|1|||
16259275|NCT04453202|39433767|FG004|Overall Study|Lost to Follow-up|0|||
16147634|NCT01225731|39027654|FG009|Part 1|Adverse Event|0|||
16147635|NCT01225731|39027655|FG010|Part 1|Adverse Event|0|||
16147636|NCT01225731|39027656|FG011|Part 1|Adverse Event|0|||
16147637|NCT01225731|39027657|FG012|Part 1|Adverse Event|0|||
16147638|NCT01225731|39027645|FG000|Part 1|Withdrawal by Subject|0|||
16147639|NCT01225731|39027646|FG001|Part 1|Withdrawal by Subject|3|||
16147640|NCT01225731|39027647|FG002|Part 1|Withdrawal by Subject|0|||
16147641|NCT01225731|39027648|FG003|Part 1|Withdrawal by Subject|0|||
16147642|NCT01225731|39027649|FG004|Part 1|Withdrawal by Subject|4|||
16147643|NCT01225731|39027650|FG005|Part 1|Withdrawal by Subject|0|||
16147644|NCT01225731|39027651|FG006|Part 1|Withdrawal by Subject|0|||
16147645|NCT01225731|39027652|FG007|Part 1|Withdrawal by Subject|0|||
16147646|NCT01225731|39027653|FG008|Part 1|Withdrawal by Subject|0|||
16147647|NCT01225731|39027654|FG009|Part 1|Withdrawal by Subject|0|||
16147648|NCT01225731|39027655|FG010|Part 1|Withdrawal by Subject|0|||
16147649|NCT01225731|39027656|FG011|Part 1|Withdrawal by Subject|0|||
16147650|NCT01225731|39027657|FG012|Part 1|Withdrawal by Subject|0|||
16147651|NCT01225731|39027645|FG000|Part 1|Protocol Violation|0|||
16147652|NCT01225731|39027646|FG001|Part 1|Protocol Violation|0|||
16147653|NCT01225731|39027647|FG002|Part 1|Protocol Violation|0|||
16147654|NCT01225731|39027648|FG003|Part 1|Protocol Violation|1|||
16147655|NCT01225731|39027649|FG004|Part 1|Protocol Violation|0|||
16147656|NCT01225731|39027650|FG005|Part 1|Protocol Violation|0|||
16147657|NCT01225731|39027651|FG006|Part 1|Protocol Violation|0|||
16147658|NCT01225731|39027652|FG007|Part 1|Protocol Violation|0|||
16147659|NCT01225731|39027653|FG008|Part 1|Protocol Violation|0|||
16147660|NCT01225731|39027654|FG009|Part 1|Protocol Violation|0|||
16259276|NCT04453202|39433768|FG005|Overall Study|Lost to Follow-up|0|||
16259277|NCT04453202|39433769|FG006|Overall Study|Lost to Follow-up|0|||
16259278|NCT04453202|39433770|FG007|Overall Study|Lost to Follow-up|0|||
16259279|NCT04453202|39433771|FG008|Overall Study|Lost to Follow-up|0|||
16259280|NCT04453202|39433772|FG009|Overall Study|Lost to Follow-up|1|||
16259281|NCT04453202|39433773|FG010|Overall Study|Lost to Follow-up|1|||
16259282|NCT04453202|39433763|FG000|Overall Study|Withdrawal by Subject|1|||
16259283|NCT04453202|39433764|FG001|Overall Study|Withdrawal by Subject|2|||
16259284|NCT04453202|39433765|FG002|Overall Study|Withdrawal by Subject|1|||
16259285|NCT04453202|39433766|FG003|Overall Study|Withdrawal by Subject|2|||
16259286|NCT04453202|39433767|FG004|Overall Study|Withdrawal by Subject|1|||
16259287|NCT04453202|39433768|FG005|Overall Study|Withdrawal by Subject|1|||
16259288|NCT04453202|39433769|FG006|Overall Study|Withdrawal by Subject|0|||
16259289|NCT04453202|39433770|FG007|Overall Study|Withdrawal by Subject|0|||
16259290|NCT04453202|39433771|FG008|Overall Study|Withdrawal by Subject|0|||
16259291|NCT04453202|39433772|FG009|Overall Study|Withdrawal by Subject|1|||
16259292|NCT04453202|39433773|FG010|Overall Study|Withdrawal by Subject|0|||
16259293|NCT04453202|39433763|FG000|Overall Study|Adverse Event|0|||
16259294|NCT04453202|39433764|FG001|Overall Study|Adverse Event|0|||
16259295|NCT04453202|39433765|FG002|Overall Study|Adverse Event|0|||
16259296|NCT04453202|39433766|FG003|Overall Study|Adverse Event|0|||
16259297|NCT04453202|39433767|FG004|Overall Study|Adverse Event|0|||
16259298|NCT04453202|39433768|FG005|Overall Study|Adverse Event|1|||
16259299|NCT04453202|39433769|FG006|Overall Study|Adverse Event|0|||
16259300|NCT04453202|39433770|FG007|Overall Study|Adverse Event|0|||
16259301|NCT04453202|39433771|FG008|Overall Study|Adverse Event|0|||
16259302|NCT04453202|39433772|FG009|Overall Study|Adverse Event|0|||
16259303|NCT04453202|39433773|FG010|Overall Study|Adverse Event|0|||
16259304|NCT00485472|39433774|FG000|Overall Study|Adverse Event|8|||
16259305|NCT00485472|39433775|FG001|Overall Study|Adverse Event|5|||
16259306|NCT00485472|39433774|FG000|Overall Study|Lack of Efficacy|5|||
16259307|NCT00485472|39433775|FG001|Overall Study|Lack of Efficacy|4|||
16259308|NCT00485472|39433774|FG000|Overall Study|Withdrawal by Subject|1|||
16259309|NCT00485472|39433775|FG001|Overall Study|Withdrawal by Subject|0|||
16259310|NCT00485472|39433774|FG000|Overall Study|Protocol Violation|0|||
16259311|NCT00485472|39433775|FG001|Overall Study|Protocol Violation|1|||
16259312|NCT00485472|39433774|FG000|Overall Study|Other|2|||
16259313|NCT00485472|39433775|FG001|Overall Study|Other|1|||
16259314|NCT00485472|39433774|FG000|Overall Study|Lost to Follow-up|0|||
16259315|NCT00485472|39433775|FG001|Overall Study|Lost to Follow-up|1|||
16259316|NCT01900730|39433778|FG000|Overall Study|Withdrawal by Subject|1|||
16259317|NCT01900730|39433779|FG001|Overall Study|Withdrawal by Subject|0|||
16259318|NCT01900730|39433778|FG000|Overall Study|Screen Failure|1|||
16259319|NCT01900730|39433779|FG001|Overall Study|Screen Failure|0|||
16259320|NCT03693430|39433780|FG000|Overall Study|Lost to Follow-up|3|||
16259321|NCT03693430|39433781|FG001|Overall Study|Lost to Follow-up|14|||
16259322|NCT03693430|39433780|FG000|Overall Study|Death|1|||
16259323|NCT03693430|39433781|FG001|Overall Study|Death|0|||
16259324|NCT03693430|39433780|FG000|Overall Study|Withdrawal by Subject|0|||
16259325|NCT03693430|39433781|FG001|Overall Study|Withdrawal by Subject|4|||
16259326|NCT02246920|39433783|FG000|Overall Study|Adverse Event|3|||
16259327|NCT02246920|39433784|FG001|Overall Study|Adverse Event|1|||
16259328|NCT02246920|39433785|FG002|Overall Study|Adverse Event|1|||
16259329|NCT02246920|39433783|FG000|Overall Study|Lost to Follow-up|2|||
16259330|NCT02246920|39433784|FG001|Overall Study|Lost to Follow-up|1|||
16259331|NCT02246920|39433785|FG002|Overall Study|Lost to Follow-up|0|||
16259332|NCT02246920|39433783|FG000|Overall Study|Protocol Violation|2|||
16259333|NCT02246920|39433784|FG001|Overall Study|Protocol Violation|5|||
16259334|NCT02246920|39433785|FG002|Overall Study|Protocol Violation|1|||
16259335|NCT02246920|39433783|FG000|Overall Study|Withdrawal by Subject|0|||
16259336|NCT02246920|39433784|FG001|Overall Study|Withdrawal by Subject|0|||
16259337|NCT02246920|39433785|FG002|Overall Study|Withdrawal by Subject|1|||
16259338|NCT02076022|39433786|FG000|Overall Study|Withdrawal by Subject|2|||
16259339|NCT02076022|39433787|FG001|Overall Study|Withdrawal by Subject|0|||
16259340|NCT02946385|39433790|FG000|Overall Study|Lost to Follow-up|0|||
16259341|NCT02946385|39433791|FG001|Overall Study|Lost to Follow-up|0|||
16259342|NCT02946385|39433792|FG002|Overall Study|Lost to Follow-up|3|||
16259343|NCT02946385|39433793|FG003|Overall Study|Lost to Follow-up|0|||
16259344|NCT02946385|39433794|FG004|Overall Study|Lost to Follow-up|2|||
16259345|NCT02946385|39433795|FG005|Overall Study|Lost to Follow-up|1|||
16147661|NCT01225731|39027655|FG010|Part 1|Protocol Violation|0|||
16259346|NCT02079532|39433796|FG000|Overall Study|Adverse Event|7|||
16259347|NCT02079532|39433796|FG000|Overall Study|Additional or changed therapy|2|||
16259348|NCT02079532|39433796|FG000|Overall Study|Lack of Efficacy|9|||
16259349|NCT02079532|39433796|FG000|Overall Study|Protocol Violation|3|||
16259350|NCT02079532|39433796|FG000|Overall Study|Withdrawal by Subject|1|||
16259351|NCT02079532|39433796|FG000|Overall Study|Administrative problems|1|||
16259352|NCT02079532|39433796|FG000|Overall Study|Inclusion into ReFIRST|3|||
16259353|NCT02079532|39433796|FG000|Overall Study|Other|3|||
16259354|NCT03471078|39433797|FG000|Overall Study|Withdrawal by Subject|9|||
16259355|NCT03471078|39433798|FG001|Overall Study|Withdrawal by Subject|1|||
16259356|NCT03471078|39433797|FG000|Overall Study|Adverse Event|4|||
16259357|NCT03471078|39433798|FG001|Overall Study|Adverse Event|1|||
16147662|NCT01225731|39027656|FG011|Part 1|Protocol Violation|0|||
16259358|NCT03471078|39433797|FG000|Overall Study|Physician Decision|3|||
16259359|NCT03471078|39433798|FG001|Overall Study|Physician Decision|2|||
16259360|NCT03471078|39433797|FG000|Overall Study|Death|2|||
16259361|NCT03471078|39433798|FG001|Overall Study|Death|0|||
16259362|NCT03471078|39433797|FG000|Overall Study|Other|3|||
16259363|NCT03471078|39433798|FG001|Overall Study|Other|2|||
16259364|NCT00424047|39433805|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
16259365|NCT00424047|39433806|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
16259366|NCT00424047|39433805|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
16259367|NCT00424047|39433806|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
16259368|NCT00424047|39433805|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
16259369|NCT00424047|39433806|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
16259370|NCT00424047|39433805|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
16259371|NCT00424047|39433806|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
16259372|NCT00424047|39433805|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
16259373|NCT00424047|39433806|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
16259374|NCT00424047|39433805|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
16259375|NCT00424047|39433806|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
16259376|NCT00424047|39433805|FG000|On Study at Time of Unblinding|Adverse Event|22|||
16259377|NCT00424047|39433806|FG001|On Study at Time of Unblinding|Adverse Event|12|||
16259378|NCT00424047|39433805|FG000|On Study at Time of Unblinding|Progression of disease|92|||
16259379|NCT00424047|39433806|FG001|On Study at Time of Unblinding|Progression of disease|128|||
16259380|NCT00424047|39433805|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
16259381|NCT00424047|39433806|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
16259382|NCT00424047|39433805|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
16259383|NCT00424047|39433806|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
16259384|NCT00424047|39433805|FG000|On Study at Time of Unblinding|Death|11|||
16259385|NCT00424047|39433806|FG001|On Study at Time of Unblinding|Death|11|||
16259386|NCT00424047|39433805|FG000|On Study at Time of Unblinding|Other|5|||
16259387|NCT00424047|39433806|FG001|On Study at Time of Unblinding|Other|4|||
16259388|NCT00424047|39433805|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
16364862|NCT00784875|39821434|FG000|Period D|Withdrawal by Subject|2|||
16364863|NCT00784875|39821435|FG001|Period D|Withdrawal by Subject|0|||
16364864|NCT00784875|39821436|FG002|Period D|Withdrawal by Subject|2|||
16364865|NCT00784875|39821437|FG003|Period D|Withdrawal by Subject|0|||
16364866|NCT00784875|39821434|FG000|Period D|Physician Decision|0|||
16364867|NCT00784875|39821435|FG001|Period D|Physician Decision|1|||
16364868|NCT00784875|39821436|FG002|Period D|Physician Decision|0|||
16364869|NCT00784875|39821437|FG003|Period D|Physician Decision|0|||
16364870|NCT00784875|39821434|FG000|Period D|Sponsor Decision|1|||
16364871|NCT00784875|39821435|FG001|Period D|Sponsor Decision|1|||
16364872|NCT00784875|39821436|FG002|Period D|Sponsor Decision|1|||
16364873|NCT00784875|39821437|FG003|Period D|Sponsor Decision|0|||
16364874|NCT00784875|39821434|FG000|Period D|Lost to Follow-up|1|||
16364875|NCT00784875|39821435|FG001|Period D|Lost to Follow-up|0|||
16364876|NCT00784875|39821436|FG002|Period D|Lost to Follow-up|1|||
16364877|NCT00784875|39821437|FG003|Period D|Lost to Follow-up|1|||
16364878|NCT01312129|39821438|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
16364879|NCT01312129|39821439|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
16364880|NCT00958074|39821440|FG000|Overall Study|Withdrawal by Subject|0|||
16364881|NCT00958074|39821441|FG001|Overall Study|Withdrawal by Subject|1|||
16364882|NCT01482221|39821443|FG000|Overall Study|Lack of Efficacy|1|||
16364883|NCT01482221|39821444|FG001|Overall Study|Lack of Efficacy|0|||
16364884|NCT01482221|39821445|FG002|Overall Study|Lack of Efficacy|1|||
16364885|NCT01482221|39821443|FG000|Overall Study|Lost to Follow-up|3|||
16364886|NCT01482221|39821444|FG001|Overall Study|Lost to Follow-up|2|||
16364887|NCT01482221|39821445|FG002|Overall Study|Lost to Follow-up|1|||
16364888|NCT01482221|39821443|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
16364889|NCT01482221|39821444|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
16364890|NCT01482221|39821445|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
16364891|NCT01482221|39821443|FG000|Overall Study|Condition under Investigation Worsened|3|||
16364892|NCT01482221|39821444|FG001|Overall Study|Condition under Investigation Worsened|2|||
16364893|NCT01482221|39821445|FG002|Overall Study|Condition under Investigation Worsened|4|||
16364894|NCT01482221|39821443|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
16364895|NCT01482221|39821444|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
16364896|NCT01482221|39821445|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
16364897|NCT01482221|39821443|FG000|Overall Study|Adverse Event|1|||
16364898|NCT01482221|39821444|FG001|Overall Study|Adverse Event|7|||
16364899|NCT01482221|39821445|FG002|Overall Study|Adverse Event|3|||
16364900|NCT01482221|39821443|FG000|Overall Study|Withdrawal by Subject|10|||
16259389|NCT00424047|39433806|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
16259390|NCT00424047|39433805|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
16259391|NCT00424047|39433806|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
16259392|NCT00424047|39433805|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
16259393|NCT00424047|39433806|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
16259394|NCT00424047|39433805|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
16259395|NCT00424047|39433806|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
16259396|NCT00424047|39433805|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
16259397|NCT00424047|39433806|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
16259398|NCT01876706|39433807|FG000|Overall Study|BPH Intervention|9|||
16259399|NCT01876706|39433807|FG000|Overall Study|Lost to Follow-up|7|||
16259400|NCT01876706|39433807|FG000|Overall Study|Withdrawals|6|||
16259401|NCT01876706|39433807|FG000|Overall Study|Death|3|||
16259402|NCT01860976|39433808|FG000|Blinded Treatment|Adverse Event|1|||
16259403|NCT01860976|39433809|FG001|Blinded Treatment|Adverse Event|3|||
16259404|NCT01860976|39433808|FG000|Blinded Treatment|Lack of Efficacy|5|||
16259405|NCT01860976|39433809|FG001|Blinded Treatment|Lack of Efficacy|12|||
16259406|NCT01860976|39433808|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
16259407|NCT01860976|39433809|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
16259408|NCT01860976|39433808|FG000|Blinded Treatment|Withdrawal by Subject|3|||
16259409|NCT01860976|39433809|FG001|Blinded Treatment|Withdrawal by Subject|5|||
16259410|NCT01860976|39433808|FG000|Blinded Treatment|Subject no longer met criteria|1|||
16259411|NCT01860976|39433809|FG001|Blinded Treatment|Subject no longer met criteria|0|||
16259412|NCT01860976|39433808|FG000|Blinded Treatment|Entered Open-Label in error|0|||
16259413|NCT01860976|39433809|FG001|Blinded Treatment|Entered Open-Label in error|1|||
16259414|NCT01860976|39433808|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
16259415|NCT01860976|39433809|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
16259416|NCT01860976|39433808|FG000|Open-Label|Adverse Event|2|||
16259417|NCT01860976|39433809|FG001|Open-Label|Adverse Event|4|||
16259418|NCT01860976|39433808|FG000|Open-Label|Lack of Efficacy|16|||
16259419|NCT01860976|39433809|FG001|Open-Label|Lack of Efficacy|8|||
16259420|NCT01860976|39433808|FG000|Open-Label|Lost to Follow-up|1|||
16259421|NCT01860976|39433809|FG001|Open-Label|Lost to Follow-up|2|||
16259422|NCT01860976|39433808|FG000|Open-Label|Subject request discontinue treatment|4|||
16259423|NCT01860976|39433809|FG001|Open-Label|Subject request discontinue treatment|3|||
16259424|NCT01860976|39433808|FG000|Open-Label|Withdrawal by Subject|4|||
16259425|NCT01860976|39433809|FG001|Open-Label|Withdrawal by Subject|1|||
16259426|NCT01860976|39433808|FG000|Open-Label|Other Reasons|1|||
16259427|NCT01860976|39433809|FG001|Open-Label|Other Reasons|1|||
16259428|NCT01860976|39433808|FG000|Long Term Extension|Adverse Event|4|||
16259429|NCT01860976|39433809|FG001|Long Term Extension|Adverse Event|0|||
16259430|NCT01860976|39433808|FG000|Long Term Extension|Lack of Efficacy|2|||
16259431|NCT01860976|39433809|FG001|Long Term Extension|Lack of Efficacy|0|||
16259432|NCT01860976|39433808|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
16259433|NCT01860976|39433809|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
16259434|NCT01860976|39433808|FG000|Long Term Extension|Lost to Follow-up|2|||
16259435|NCT01860976|39433809|FG001|Long Term Extension|Lost to Follow-up|0|||
16259436|NCT01860976|39433808|FG000|Long Term Extension|subject withdrew consent|7|||
16259437|NCT01860976|39433809|FG001|Long Term Extension|subject withdrew consent|0|||
16259438|NCT01396278|39433815|FG000|Overall Study|Adverse Event|0|||
16259439|NCT01396278|39433816|FG001|Overall Study|Adverse Event|0|||
16259440|NCT01396278|39433817|FG002|Overall Study|Adverse Event|0|||
16259441|NCT01396278|39433818|FG003|Overall Study|Adverse Event|2|||
16259442|NCT01396278|39433819|FG004|Overall Study|Adverse Event|0|||
16259443|NCT01396278|39433815|FG000|Overall Study|Withdraw due to trial termination|2|||
16259444|NCT01396278|39433816|FG001|Overall Study|Withdraw due to trial termination|1|||
16259445|NCT01396278|39433817|FG002|Overall Study|Withdraw due to trial termination|1|||
16259446|NCT01396278|39433818|FG003|Overall Study|Withdraw due to trial termination|0|||
16259447|NCT01396278|39433819|FG004|Overall Study|Withdraw due to trial termination|2|||
16259448|NCT03025880|39433833|FG000|Overall Study|Adverse Event|1|||
16259449|NCT03025880|39433834|FG001|Overall Study|Adverse Event|0|||
16259450|NCT03025880|39433833|FG000|Overall Study|Death|1|||
16259451|NCT03025880|39433834|FG001|Overall Study|Death|1|||
16259452|NCT03025880|39433833|FG000|Overall Study|Withdrawal by Subject|0|||
16259453|NCT03025880|39433834|FG001|Overall Study|Withdrawal by Subject|1|||
16259454|NCT03025880|39433833|FG000|Overall Study|Physician Decision|0|||
16259455|NCT03025880|39433834|FG001|Overall Study|Physician Decision|1|||
16259456|NCT03025880|39433833|FG000|Overall Study|Progressive Disease|12|||
16259457|NCT03025880|39433834|FG001|Overall Study|Progressive Disease|19|||
16259458|NCT03292653|39433837|FG000|Overall Study|Adverse Event|0|||
16259459|NCT03292653|39433838|FG001|Overall Study|Adverse Event|0|||
16259460|NCT03292653|39433839|FG002|Overall Study|Adverse Event|1|||
16259461|NCT03292653|39433837|FG000|Overall Study|Did not Receive Treatment|1|||
16259462|NCT03292653|39433838|FG001|Overall Study|Did not Receive Treatment|0|||
16259463|NCT03292653|39433839|FG002|Overall Study|Did not Receive Treatment|0|||
16259464|NCT03136380|39433840|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
16259465|NCT03136380|39433841|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
16259466|NCT03136380|39433842|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
16259467|NCT03136380|39433843|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
16259468|NCT03136380|39433844|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
16259469|NCT00860405|39433845|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
16259470|NCT00860405|39433846|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
16259471|NCT00328926|39433847|FG000|Overall Study|Pregnancy|2|||
16259472|NCT00328926|39433848|FG001|Overall Study|Pregnancy|1|||
16259473|NCT00328926|39433849|FG002|Overall Study|Pregnancy|0|||
16259474|NCT00328926|39433847|FG000|Overall Study|Lost to Follow-up|0|||
16259475|NCT00328926|39433848|FG001|Overall Study|Lost to Follow-up|1|||
16259476|NCT00328926|39433849|FG002|Overall Study|Lost to Follow-up|0|||
16259477|NCT00328926|39433847|FG000|Overall Study|Death|0|||
16259478|NCT00328926|39433848|FG001|Overall Study|Death|0|||
16259479|NCT00328926|39433849|FG002|Overall Study|Death|1|||
16259480|NCT00328926|39433847|FG000|Overall Study|In vitro fertilization treatment|0|||
16259481|NCT00328926|39433848|FG001|Overall Study|In vitro fertilization treatment|0|||
16259482|NCT00328926|39433849|FG002|Overall Study|In vitro fertilization treatment|1|||
16259483|NCT00328926|39433847|FG000|Overall Study|Lack of ovarian response|0|||
16259484|NCT00328926|39433848|FG001|Overall Study|Lack of ovarian response|1|||
16259485|NCT00328926|39433849|FG002|Overall Study|Lack of ovarian response|0|||
16259486|NCT01270503|39433851|FG000|Overall Study|Lost to Follow-up|1|||
16259487|NCT00965185|39433852|FG000|Overall Study|Lost to Follow-up|2|||
16259488|NCT00965185|39433853|FG001|Overall Study|Lost to Follow-up|0|||
16259489|NCT00965185|39433852|FG000|Overall Study|Withdrawal by Subject|0|||
16259490|NCT00965185|39433853|FG001|Overall Study|Withdrawal by Subject|1|||
16259491|NCT00450190|39436048|FG000|Overall Study|Withdrawal by Subject|2|||
16259492|NCT00323882|39436055|FG000|Overall Study|Adverse Event|2|||
16259493|NCT00323882|39436056|FG001|Overall Study|Adverse Event|1|||
16259494|NCT00323882|39436057|FG002|Overall Study|Adverse Event|1|||
16259495|NCT00323882|39436058|FG003|Overall Study|Adverse Event|1|||
16259496|NCT00323882|39436059|FG004|Overall Study|Adverse Event|3|||
16259497|NCT00323882|39436055|FG000|Overall Study|Disease Progression|6|||
16259498|NCT00323882|39436056|FG001|Overall Study|Disease Progression|4|||
16259499|NCT00323882|39436057|FG002|Overall Study|Disease Progression|10|||
16259500|NCT00323882|39436058|FG003|Overall Study|Disease Progression|5|||
16259501|NCT00323882|39436059|FG004|Overall Study|Disease Progression|22|||
16259502|NCT00323882|39436055|FG000|Overall Study|Death|0|||
16259503|NCT00323882|39436056|FG001|Overall Study|Death|1|||
16259504|NCT00323882|39436057|FG002|Overall Study|Death|1|||
16259505|NCT00323882|39436058|FG003|Overall Study|Death|0|||
16259506|NCT00323882|39436059|FG004|Overall Study|Death|5|||
16259507|NCT00323882|39436055|FG000|Overall Study|Lost to Follow-up|0|||
16259508|NCT00323882|39436056|FG001|Overall Study|Lost to Follow-up|0|||
16259509|NCT00323882|39436057|FG002|Overall Study|Lost to Follow-up|1|||
16259510|NCT00323882|39436058|FG003|Overall Study|Lost to Follow-up|0|||
16259511|NCT00323882|39436059|FG004|Overall Study|Lost to Follow-up|1|||
16259512|NCT00323882|39436055|FG000|Overall Study|Other|0|||
16259513|NCT00323882|39436056|FG001|Overall Study|Other|0|||
16259514|NCT00323882|39436057|FG002|Overall Study|Other|0|||
16259515|NCT00323882|39436058|FG003|Overall Study|Other|1|||
16259516|NCT00323882|39436059|FG004|Overall Study|Other|1|||
16259517|NCT00657553|39436060|FG000|Overall Study|low accrual, no analysis run|5|||
16259518|NCT00657553|39436061|FG001|Overall Study|low accrual, no analysis run|5|||
16259519|NCT01417078|39436062|FG000|Overall Study|Withdrawal by Subject|1|||
16259520|NCT05017480|39436066|FG000|Stage 1 Study|Withdrawal by Subject|8|||
16259521|NCT05017480|39436067|FG001|Stage 1 Study|Withdrawal by Subject|6|||
16259522|NCT05017480|39436068|FG002|Stage 1 Study|Withdrawal by Subject|0|||
16259523|NCT05017480|39436069|FG003|Stage 1 Study|Withdrawal by Subject|0|||
16259524|NCT05017480|39436070|FG004|Stage 1 Study|Withdrawal by Subject|0|||
16259525|NCT05017480|39436066|FG000|Stage 1 Study|Adverse Event|1|||
16259526|NCT05017480|39436067|FG001|Stage 1 Study|Adverse Event|1|||
16259527|NCT05017480|39436068|FG002|Stage 1 Study|Adverse Event|0|||
16259528|NCT05017480|39436069|FG003|Stage 1 Study|Adverse Event|0|||
16259529|NCT05017480|39436070|FG004|Stage 1 Study|Adverse Event|0|||
16259530|NCT05017480|39436066|FG000|Stage 1 Study|Poor Compliance|1|||
16259531|NCT05017480|39436067|FG001|Stage 1 Study|Poor Compliance|1|||
16440886|NCT03182374|40092843|FG000|Overall Study|exit for non-compliance|1|||
16259532|NCT05017480|39436068|FG002|Stage 1 Study|Poor Compliance|0|||
16259533|NCT05017480|39436069|FG003|Stage 1 Study|Poor Compliance|0|||
16259534|NCT05017480|39436070|FG004|Stage 1 Study|Poor Compliance|0|||
16259535|NCT05017480|39436066|FG000|Stage 1 Study|Physician Decision|0|||
16259536|NCT05017480|39436067|FG001|Stage 1 Study|Physician Decision|1|||
16147663|NCT01225731|39027657|FG012|Part 1|Protocol Violation|0|||
16147664|NCT01225731|39027645|FG000|Part 2|Protocol Violation|0|||
16147665|NCT01225731|39027646|FG001|Part 2|Protocol Violation|0|||
16147666|NCT01225731|39027647|FG002|Part 2|Protocol Violation|0|||
16147667|NCT01225731|39027648|FG003|Part 2|Protocol Violation|0|||
16147668|NCT01225731|39027649|FG004|Part 2|Protocol Violation|0|||
16147669|NCT01225731|39027650|FG005|Part 2|Protocol Violation|1|||
16147670|NCT01225731|39027651|FG006|Part 2|Protocol Violation|0|||
16147671|NCT01225731|39027652|FG007|Part 2|Protocol Violation|0|||
16147672|NCT01225731|39027653|FG008|Part 2|Protocol Violation|1|||
16147673|NCT01225731|39027654|FG009|Part 2|Protocol Violation|0|||
16147674|NCT01225731|39027655|FG010|Part 2|Protocol Violation|0|||
16147675|NCT01225731|39027656|FG011|Part 2|Protocol Violation|0|||
16147676|NCT01225731|39027657|FG012|Part 2|Protocol Violation|0|||
16147677|NCT01225731|39027645|FG000|Part 2|Adverse Event|0|||
16147678|NCT01225731|39027646|FG001|Part 2|Adverse Event|0|||
16147679|NCT01225731|39027647|FG002|Part 2|Adverse Event|0|||
16147680|NCT01225731|39027648|FG003|Part 2|Adverse Event|0|||
16147681|NCT01225731|39027649|FG004|Part 2|Adverse Event|0|||
16147682|NCT01225731|39027650|FG005|Part 2|Adverse Event|0|||
16147683|NCT01225731|39027651|FG006|Part 2|Adverse Event|4|||
16147684|NCT01225731|39027652|FG007|Part 2|Adverse Event|4|||
16147685|NCT01225731|39027653|FG008|Part 2|Adverse Event|2|||
16147686|NCT01225731|39027654|FG009|Part 2|Adverse Event|0|||
16147687|NCT01225731|39027655|FG010|Part 2|Adverse Event|0|||
16147688|NCT01225731|39027656|FG011|Part 2|Adverse Event|0|||
16147689|NCT01225731|39027657|FG012|Part 2|Adverse Event|0|||
16147690|NCT01225731|39027645|FG000|Part 2|Lack of Efficacy|0|||
16147691|NCT01225731|39027646|FG001|Part 2|Lack of Efficacy|0|||
16147692|NCT01225731|39027647|FG002|Part 2|Lack of Efficacy|0|||
16147693|NCT01225731|39027648|FG003|Part 2|Lack of Efficacy|0|||
16147694|NCT01225731|39027649|FG004|Part 2|Lack of Efficacy|0|||
16147695|NCT01225731|39027650|FG005|Part 2|Lack of Efficacy|1|||
16147696|NCT01225731|39027651|FG006|Part 2|Lack of Efficacy|0|||
16147697|NCT01225731|39027652|FG007|Part 2|Lack of Efficacy|12|||
16147698|NCT01225731|39027653|FG008|Part 2|Lack of Efficacy|3|||
16147699|NCT01225731|39027654|FG009|Part 2|Lack of Efficacy|0|||
16147700|NCT01225731|39027655|FG010|Part 2|Lack of Efficacy|0|||
16147701|NCT01225731|39027656|FG011|Part 2|Lack of Efficacy|0|||
16147702|NCT01225731|39027657|FG012|Part 2|Lack of Efficacy|0|||
16147703|NCT01225731|39027645|FG000|Part 2|Pregnancy|0|||
16147704|NCT01225731|39027646|FG001|Part 2|Pregnancy|0|||
16147705|NCT01225731|39027647|FG002|Part 2|Pregnancy|0|||
16147706|NCT01225731|39027648|FG003|Part 2|Pregnancy|0|||
16147707|NCT01225731|39027649|FG004|Part 2|Pregnancy|0|||
16147708|NCT01225731|39027650|FG005|Part 2|Pregnancy|0|||
16147709|NCT01225731|39027651|FG006|Part 2|Pregnancy|1|||
16147710|NCT01225731|39027652|FG007|Part 2|Pregnancy|0|||
16147711|NCT01225731|39027653|FG008|Part 2|Pregnancy|1|||
16147712|NCT01225731|39027654|FG009|Part 2|Pregnancy|0|||
16147713|NCT01225731|39027655|FG010|Part 2|Pregnancy|0|||
16147714|NCT01225731|39027656|FG011|Part 2|Pregnancy|0|||
16147715|NCT01225731|39027657|FG012|Part 2|Pregnancy|0|||
16147716|NCT01225731|39027645|FG000|Part 2|Lost to Follow-up|0|||
16147717|NCT01225731|39027646|FG001|Part 2|Lost to Follow-up|0|||
16147718|NCT01225731|39027647|FG002|Part 2|Lost to Follow-up|0|||
16147719|NCT01225731|39027648|FG003|Part 2|Lost to Follow-up|0|||
16147720|NCT01225731|39027649|FG004|Part 2|Lost to Follow-up|0|||
16147721|NCT01225731|39027650|FG005|Part 2|Lost to Follow-up|0|||
16147722|NCT01225731|39027651|FG006|Part 2|Lost to Follow-up|0|||
16147723|NCT01225731|39027652|FG007|Part 2|Lost to Follow-up|3|||
16147724|NCT01225731|39027653|FG008|Part 2|Lost to Follow-up|1|||
16147725|NCT01225731|39027654|FG009|Part 2|Lost to Follow-up|0|||
16147726|NCT01225731|39027655|FG010|Part 2|Lost to Follow-up|0|||
16147727|NCT01225731|39027656|FG011|Part 2|Lost to Follow-up|0|||
16147728|NCT01225731|39027657|FG012|Part 2|Lost to Follow-up|0|||
16147729|NCT01225731|39027645|FG000|Part 2|Physician Decision|0|||
16147730|NCT01225731|39027646|FG001|Part 2|Physician Decision|0|||
16147731|NCT01225731|39027647|FG002|Part 2|Physician Decision|0|||
16147732|NCT01225731|39027648|FG003|Part 2|Physician Decision|0|||
16147733|NCT01225731|39027649|FG004|Part 2|Physician Decision|0|||
16147734|NCT01225731|39027650|FG005|Part 2|Physician Decision|0|||
16147735|NCT01225731|39027651|FG006|Part 2|Physician Decision|0|||
16147736|NCT01225731|39027652|FG007|Part 2|Physician Decision|2|||
16147737|NCT01225731|39027653|FG008|Part 2|Physician Decision|2|||
16147738|NCT01225731|39027654|FG009|Part 2|Physician Decision|0|||
16147739|NCT01225731|39027655|FG010|Part 2|Physician Decision|0|||
16147740|NCT01225731|39027656|FG011|Part 2|Physician Decision|0|||
16259537|NCT05017480|39436068|FG002|Stage 1 Study|Physician Decision|0|||
16147741|NCT01225731|39027657|FG012|Part 2|Physician Decision|0|||
16147742|NCT01225731|39027645|FG000|Part 2|Withdrawal by Subject|0|||
16147743|NCT01225731|39027646|FG001|Part 2|Withdrawal by Subject|0|||
16147744|NCT01225731|39027647|FG002|Part 2|Withdrawal by Subject|0|||
16147745|NCT01225731|39027648|FG003|Part 2|Withdrawal by Subject|0|||
16147746|NCT01225731|39027649|FG004|Part 2|Withdrawal by Subject|0|||
16147747|NCT01225731|39027650|FG005|Part 2|Withdrawal by Subject|1|||
16147748|NCT01225731|39027651|FG006|Part 2|Withdrawal by Subject|3|||
16147749|NCT01225731|39027652|FG007|Part 2|Withdrawal by Subject|4|||
16259538|NCT05017480|39436069|FG003|Stage 1 Study|Physician Decision|0|||
16364901|NCT01482221|39821444|FG001|Overall Study|Withdrawal by Subject|7|||
16364902|NCT01482221|39821445|FG002|Overall Study|Withdrawal by Subject|12|||
16364903|NCT01482221|39821443|FG000|Overall Study|Incorrect randomization|0|||
16364904|NCT01482221|39821444|FG001|Overall Study|Incorrect randomization|1|||
16364905|NCT01482221|39821445|FG002|Overall Study|Incorrect randomization|0|||
16364906|NCT01482221|39821443|FG000|Overall Study|Physician Decision|0|||
16364907|NCT01482221|39821444|FG001|Overall Study|Physician Decision|1|||
16364908|NCT01482221|39821445|FG002|Overall Study|Physician Decision|0|||
16364909|NCT02583269|39821446|FG000|Overall Study|Patient hospitalized prior to start|1|||
16364910|NCT02583269|39821447|FG001|Overall Study|Patient hospitalized prior to start|0|||
16364911|NCT02583269|39821448|FG002|Overall Study|Patient hospitalized prior to start|0|||
16364912|NCT02583269|39821449|FG003|Overall Study|Patient hospitalized prior to start|0|||
16364913|NCT02583269|39821450|FG004|Overall Study|Patient hospitalized prior to start|0|||
16364914|NCT00853385|39821454|FG000|Overall Study|Death|0|||
16364915|NCT00853385|39821455|FG001|Overall Study|Death|0|||
16364916|NCT00853385|39821456|FG002|Overall Study|Death|0|||
16364917|NCT00853385|39821457|FG003|Overall Study|Death|0|||
16364918|NCT00853385|39821458|FG004|Overall Study|Death|1|||
16440887|NCT03182374|40092844|FG001|Overall Study|exit for non-compliance|1|||
16440888|NCT03182374|40092843|FG000|Overall Study|one subject was randomized but not treated|1|||
16440889|NCT03182374|40092844|FG001|Overall Study|one subject was randomized but not treated|0|||
16440890|NCT03182374|40092843|FG000|Overall Study|Other reasons|0|||
16440891|NCT03182374|40092844|FG001|Overall Study|Other reasons|3|||
16440892|NCT02250326|40092854|FG000|Treatment|Death|1|||
16440893|NCT02250326|40092855|FG001|Treatment|Death|13|||
16440894|NCT02250326|40092856|FG002|Treatment|Death|2|||
16440895|NCT02250326|40092854|FG000|Treatment|Adverse Event|8|||
16440896|NCT02250326|40092855|FG001|Treatment|Adverse Event|8|||
16440897|NCT02250326|40092856|FG002|Treatment|Adverse Event|9|||
16440898|NCT02250326|40092854|FG000|Treatment|Progressive Disease|42|||
16440899|NCT02250326|40092855|FG001|Treatment|Progressive Disease|40|||
16440900|NCT02250326|40092856|FG002|Treatment|Progressive Disease|47|||
16440901|NCT02250326|40092854|FG000|Treatment|Symptomatic Deterioration|9|||
16440902|NCT02250326|40092855|FG001|Treatment|Symptomatic Deterioration|4|||
16440903|NCT02250326|40092856|FG002|Treatment|Symptomatic Deterioration|10|||
16440904|NCT02250326|40092854|FG000|Treatment|Withdrawal by Subject|11|||
16440905|NCT02250326|40092855|FG001|Treatment|Withdrawal by Subject|6|||
16440906|NCT02250326|40092856|FG002|Treatment|Withdrawal by Subject|4|||
16440907|NCT02250326|40092854|FG000|Treatment|Other reasons|8|||
16440908|NCT02250326|40092855|FG001|Treatment|Other reasons|7|||
16440909|NCT02250326|40092856|FG002|Treatment|Other reasons|7|||
16440910|NCT02250326|40092854|FG000|Extension Period|Progressive Disease|0|||
16440911|NCT02250326|40092855|FG001|Extension Period|Progressive Disease|2|||
16440912|NCT02250326|40092856|FG002|Extension Period|Progressive Disease|0|||
16440913|NCT02250326|40092854|FG000|Extension Period|Withdrawal by Subject|0|||
16440914|NCT02250326|40092855|FG001|Extension Period|Withdrawal by Subject|1|||
16440915|NCT02250326|40092856|FG002|Extension Period|Withdrawal by Subject|0|||
16440916|NCT02250326|40092854|FG000|Extension Period|Withdrawal by investigator|0|||
16440917|NCT02250326|40092855|FG001|Extension Period|Withdrawal by investigator|1|||
16440918|NCT02250326|40092856|FG002|Extension Period|Withdrawal by investigator|0|||
16440919|NCT01064440|40092858|FG000|Overall Study|Lost to Follow-up|1|||
16147750|NCT01225731|39027653|FG008|Part 2|Withdrawal by Subject|1|||
16259539|NCT05017480|39436070|FG004|Stage 1 Study|Physician Decision|0|||
16259540|NCT05017480|39436066|FG000|Stage 2 Study|Withdrawal by Subject|0|||
16259541|NCT05017480|39436067|FG001|Stage 2 Study|Withdrawal by Subject|0|||
16259542|NCT05017480|39436068|FG002|Stage 2 Study|Withdrawal by Subject|6|||
16364919|NCT00853385|39821454|FG000|Overall Study|Adverse Event|24|||
16364920|NCT00853385|39821455|FG001|Overall Study|Adverse Event|24|||
16364921|NCT00853385|39821456|FG002|Overall Study|Adverse Event|2|||
16364922|NCT00853385|39821457|FG003|Overall Study|Adverse Event|5|||
16440920|NCT01064440|40092859|FG001|Overall Study|Lost to Follow-up|1|||
16440921|NCT01064440|40092860|FG002|Overall Study|Lost to Follow-up|1|||
16440922|NCT01064440|40092858|FG000|Overall Study|Non-compliance|0|||
16259543|NCT05017480|39436069|FG003|Stage 2 Study|Withdrawal by Subject|9|||
16259544|NCT05017480|39436070|FG004|Stage 2 Study|Withdrawal by Subject|11|||
16259545|NCT05017480|39436066|FG000|Stage 2 Study|Lost to Follow-up|0|||
16364923|NCT00853385|39821458|FG004|Overall Study|Adverse Event|22|||
16364924|NCT00853385|39821454|FG000|Overall Study|Lack of Efficacy|6|||
16364925|NCT00853385|39821455|FG001|Overall Study|Lack of Efficacy|7|||
16364926|NCT00853385|39821456|FG002|Overall Study|Lack of Efficacy|3|||
16364927|NCT00853385|39821457|FG003|Overall Study|Lack of Efficacy|3|||
16364928|NCT00853385|39821458|FG004|Overall Study|Lack of Efficacy|6|||
16259546|NCT05017480|39436067|FG001|Stage 2 Study|Lost to Follow-up|0|||
16259547|NCT05017480|39436068|FG002|Stage 2 Study|Lost to Follow-up|0|||
16259548|NCT05017480|39436069|FG003|Stage 2 Study|Lost to Follow-up|2|||
16259549|NCT05017480|39436070|FG004|Stage 2 Study|Lost to Follow-up|1|||
16364929|NCT00853385|39821454|FG000|Overall Study|Lost to Follow-up|2|||
16364930|NCT00853385|39821455|FG001|Overall Study|Lost to Follow-up|1|||
16364931|NCT00853385|39821456|FG002|Overall Study|Lost to Follow-up|0|||
16364932|NCT00853385|39821457|FG003|Overall Study|Lost to Follow-up|0|||
16364933|NCT00853385|39821458|FG004|Overall Study|Lost to Follow-up|0|||
16364934|NCT00853385|39821454|FG000|Overall Study|Withdrawal by Subject|4|||
16364935|NCT00853385|39821455|FG001|Overall Study|Withdrawal by Subject|2|||
16364936|NCT00853385|39821456|FG002|Overall Study|Withdrawal by Subject|0|||
16364937|NCT00853385|39821457|FG003|Overall Study|Withdrawal by Subject|1|||
16364938|NCT00853385|39821458|FG004|Overall Study|Withdrawal by Subject|1|||
16364939|NCT00853385|39821454|FG000|Overall Study|Other|18|||
16364940|NCT00853385|39821455|FG001|Overall Study|Other|9|||
16364941|NCT00853385|39821456|FG002|Overall Study|Other|4|||
16259550|NCT05017480|39436066|FG000|Stage 2 Study|Adverse Event|0|||
16259551|NCT05017480|39436067|FG001|Stage 2 Study|Adverse Event|0|||
16259552|NCT05017480|39436068|FG002|Stage 2 Study|Adverse Event|0|||
16259553|NCT05017480|39436069|FG003|Stage 2 Study|Adverse Event|1|||
16259554|NCT05017480|39436070|FG004|Stage 2 Study|Adverse Event|0|||
16259555|NCT05017480|39436066|FG000|Stage 2 Study|COVID-19|0|||
16259556|NCT05017480|39436067|FG001|Stage 2 Study|COVID-19|0|||
16259557|NCT05017480|39436068|FG002|Stage 2 Study|COVID-19|0|||
16147751|NCT01225731|39027654|FG009|Part 2|Withdrawal by Subject|0|||
16147752|NCT01225731|39027655|FG010|Part 2|Withdrawal by Subject|0|||
16147753|NCT01225731|39027656|FG011|Part 2|Withdrawal by Subject|0|||
16147754|NCT01225731|39027657|FG012|Part 2|Withdrawal by Subject|0|||
16147755|NCT01225731|39027645|FG000|Part 3|Adverse Event|0|||
16147756|NCT01225731|39027646|FG001|Part 3|Adverse Event|0|||
16147757|NCT01225731|39027647|FG002|Part 3|Adverse Event|0|||
16147758|NCT01225731|39027648|FG003|Part 3|Adverse Event|0|||
16147759|NCT01225731|39027649|FG004|Part 3|Adverse Event|0|||
16147760|NCT01225731|39027650|FG005|Part 3|Adverse Event|0|||
16147761|NCT01225731|39027651|FG006|Part 3|Adverse Event|0|||
16147762|NCT01225731|39027652|FG007|Part 3|Adverse Event|0|||
16147763|NCT01225731|39027653|FG008|Part 3|Adverse Event|0|||
16147764|NCT01225731|39027654|FG009|Part 3|Adverse Event|0|||
16147765|NCT01225731|39027655|FG010|Part 3|Adverse Event|1|||
16147766|NCT01225731|39027656|FG011|Part 3|Adverse Event|1|||
16147767|NCT01225731|39027657|FG012|Part 3|Adverse Event|0|||
16147768|NCT01225731|39027645|FG000|Part 3|Lost to Follow-up|0|||
16147769|NCT01225731|39027646|FG001|Part 3|Lost to Follow-up|0|||
16147770|NCT01225731|39027647|FG002|Part 3|Lost to Follow-up|0|||
16147771|NCT01225731|39027648|FG003|Part 3|Lost to Follow-up|0|||
16147772|NCT01225731|39027649|FG004|Part 3|Lost to Follow-up|0|||
16147773|NCT01225731|39027650|FG005|Part 3|Lost to Follow-up|0|||
16147774|NCT01225731|39027651|FG006|Part 3|Lost to Follow-up|0|||
16147775|NCT01225731|39027652|FG007|Part 3|Lost to Follow-up|0|||
16147776|NCT01225731|39027653|FG008|Part 3|Lost to Follow-up|0|||
16147777|NCT01225731|39027654|FG009|Part 3|Lost to Follow-up|0|||
16147778|NCT01225731|39027655|FG010|Part 3|Lost to Follow-up|1|||
16147779|NCT01225731|39027656|FG011|Part 3|Lost to Follow-up|2|||
16147780|NCT01225731|39027657|FG012|Part 3|Lost to Follow-up|1|||
16147781|NCT01225731|39027645|FG000|Part 3|Physician Decision|0|||
16147782|NCT01225731|39027646|FG001|Part 3|Physician Decision|0|||
16147783|NCT01225731|39027647|FG002|Part 3|Physician Decision|0|||
16147784|NCT01225731|39027648|FG003|Part 3|Physician Decision|0|||
16147785|NCT01225731|39027649|FG004|Part 3|Physician Decision|0|||
16147786|NCT01225731|39027650|FG005|Part 3|Physician Decision|0|||
16147787|NCT01225731|39027651|FG006|Part 3|Physician Decision|0|||
16147788|NCT01225731|39027652|FG007|Part 3|Physician Decision|0|||
16147789|NCT01225731|39027653|FG008|Part 3|Physician Decision|0|||
16147790|NCT01225731|39027654|FG009|Part 3|Physician Decision|0|||
16147791|NCT01225731|39027655|FG010|Part 3|Physician Decision|0|||
16364942|NCT00853385|39821457|FG003|Overall Study|Other|4|||
16147792|NCT01225731|39027656|FG011|Part 3|Physician Decision|1|||
16147793|NCT01225731|39027657|FG012|Part 3|Physician Decision|2|||
16147794|NCT01225731|39027645|FG000|Part 3|Withdrawal by Subject|0|||
16147795|NCT01225731|39027646|FG001|Part 3|Withdrawal by Subject|0|||
16259558|NCT05017480|39436069|FG003|Stage 2 Study|COVID-19|1|||
16147796|NCT01225731|39027647|FG002|Part 3|Withdrawal by Subject|0|||
16147797|NCT01225731|39027648|FG003|Part 3|Withdrawal by Subject|0|||
16364943|NCT00853385|39821458|FG004|Overall Study|Other|12|||
16147798|NCT01225731|39027649|FG004|Part 3|Withdrawal by Subject|0|||
16147799|NCT01225731|39027650|FG005|Part 3|Withdrawal by Subject|0|||
16147800|NCT01225731|39027651|FG006|Part 3|Withdrawal by Subject|0|||
16147801|NCT01225731|39027652|FG007|Part 3|Withdrawal by Subject|0|||
16147802|NCT01225731|39027653|FG008|Part 3|Withdrawal by Subject|0|||
16259559|NCT05017480|39436070|FG004|Stage 2 Study|COVID-19|0|||
16259560|NCT05017480|39436066|FG000|Stage 2 Study|Pregnancy|0|||
16147803|NCT01225731|39027654|FG009|Part 3|Withdrawal by Subject|0|||
16147804|NCT01225731|39027655|FG010|Part 3|Withdrawal by Subject|4|||
16147805|NCT01225731|39027656|FG011|Part 3|Withdrawal by Subject|6|||
16147806|NCT01225731|39027657|FG012|Part 3|Withdrawal by Subject|4|||
16147807|NCT01624259|39027658|FG000|Overall Study|Adverse Event|18|||
16147808|NCT01624259|39027659|FG001|Overall Study|Adverse Event|18|||
16147809|NCT01624259|39027658|FG000|Overall Study|Protocol Violation|1|||
16147810|NCT01624259|39027659|FG001|Overall Study|Protocol Violation|2|||
16147811|NCT01624259|39027658|FG000|Overall Study|Withdrawal by Subject|5|||
16147812|NCT01624259|39027659|FG001|Overall Study|Withdrawal by Subject|7|||
16147813|NCT01624259|39027658|FG000|Overall Study|Physician Decision|1|||
16147814|NCT01624259|39027659|FG001|Overall Study|Physician Decision|1|||
16147815|NCT01624259|39027658|FG000|Overall Study|Lost to Follow-up|2|||
16147816|NCT01624259|39027659|FG001|Overall Study|Lost to Follow-up|3|||
16147817|NCT01624259|39027658|FG000|Overall Study|Abnormal laboratory measure|3|||
16147818|NCT01624259|39027659|FG001|Overall Study|Abnormal laboratory measure|0|||
16147819|NCT03069352|39027661|FG000|Overall Study|Ongoing|12|||
16147820|NCT03069352|39027662|FG001|Overall Study|Ongoing|40|||
16147821|NCT01621542|39027663|FG000|Overall Study|Adverse Event|0|||
16147822|NCT01621542|39027664|FG001|Overall Study|Adverse Event|0|||
16147823|NCT01621542|39027665|FG002|Overall Study|Adverse Event|1|||
16147824|NCT01621542|39027666|FG003|Overall Study|Adverse Event|3|||
16147825|NCT01621542|39027667|FG004|Overall Study|Adverse Event|0|||
16147826|NCT01621542|39027668|FG005|Overall Study|Adverse Event|0|||
16259561|NCT05017480|39436067|FG001|Stage 2 Study|Pregnancy|0|||
16259562|NCT05017480|39436068|FG002|Stage 2 Study|Pregnancy|0|||
16259563|NCT05017480|39436069|FG003|Stage 2 Study|Pregnancy|0|||
16259564|NCT05017480|39436070|FG004|Stage 2 Study|Pregnancy|1|||
16259565|NCT02166697|39436071|FG000|Overall Study|Protocol Violation|347|||
16259566|NCT02731157|39436076|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
16259567|NCT04320849|39436077|FG000|Overall Study|Withdrawal by Subject|4|||
16147827|NCT01621542|39027663|FG000|Overall Study|Death|0|||
16147828|NCT01621542|39027664|FG001|Overall Study|Death|1|||
16147829|NCT01621542|39027665|FG002|Overall Study|Death|0|||
16147830|NCT01621542|39027666|FG003|Overall Study|Death|0|||
16147831|NCT01621542|39027667|FG004|Overall Study|Death|0|||
16364944|NCT02278354|39821461|FG000|Overall Study|Lost to Follow-up|2|||
16364945|NCT02278354|39821462|FG001|Overall Study|Lost to Follow-up|2|||
16364946|NCT02278354|39821461|FG000|Overall Study|Withdrawal by Subject|0|||
16364947|NCT02278354|39821462|FG001|Overall Study|Withdrawal by Subject|1|||
16364948|NCT02278354|39821461|FG000|Overall Study|<10 professional fights|2|||
16364949|NCT02278354|39821462|FG001|Overall Study|<10 professional fights|0|||
16364950|NCT00274456|39821463|FG000|Overall Study|Still on treatment|2|||
16364951|NCT00274456|39821464|FG001|Overall Study|Still on treatment|3|||
16364952|NCT00274456|39821465|FG002|Overall Study|Still on treatment|5|||
16364953|NCT00274456|39821466|FG003|Overall Study|Still on treatment|1|||
16364954|NCT00274456|39821463|FG000|Overall Study|Unacceptable toxicity|10|||
16364955|NCT00274456|39821464|FG001|Overall Study|Unacceptable toxicity|5|||
16364956|NCT00274456|39821465|FG002|Overall Study|Unacceptable toxicity|12|||
16364957|NCT00274456|39821466|FG003|Overall Study|Unacceptable toxicity|16|||
16147832|NCT01621542|39027668|FG005|Overall Study|Death|0|||
16147833|NCT01621542|39027663|FG000|Overall Study|Physician Decision|1|||
16147834|NCT01621542|39027664|FG001|Overall Study|Physician Decision|0|||
16147835|NCT01621542|39027665|FG002|Overall Study|Physician Decision|1|||
16147836|NCT01621542|39027666|FG003|Overall Study|Physician Decision|13|||
16147837|NCT01621542|39027667|FG004|Overall Study|Physician Decision|3|||
16147838|NCT01621542|39027668|FG005|Overall Study|Physician Decision|1|||
16147839|NCT01621542|39027663|FG000|Overall Study|Withdrawal by Subject|2|||
16147840|NCT01621542|39027664|FG001|Overall Study|Withdrawal by Subject|0|||
16147841|NCT01621542|39027665|FG002|Overall Study|Withdrawal by Subject|1|||
16147842|NCT01621542|39027666|FG003|Overall Study|Withdrawal by Subject|3|||
16147843|NCT01621542|39027667|FG004|Overall Study|Withdrawal by Subject|3|||
16147844|NCT01621542|39027668|FG005|Overall Study|Withdrawal by Subject|3|||
16147845|NCT01621542|39027663|FG000|Overall Study|progression/treatment failure|2|||
16147846|NCT01621542|39027664|FG001|Overall Study|progression/treatment failure|4|||
16147847|NCT01621542|39027665|FG002|Overall Study|progression/treatment failure|3|||
16147848|NCT01621542|39027666|FG003|Overall Study|progression/treatment failure|7|||
16147849|NCT01621542|39027667|FG004|Overall Study|progression/treatment failure|3|||
16147850|NCT01621542|39027668|FG005|Overall Study|progression/treatment failure|5|||
16147851|NCT01621542|39027663|FG000|Overall Study|Protocol Violation|0|||
16147852|NCT01621542|39027664|FG001|Overall Study|Protocol Violation|0|||
16147853|NCT01621542|39027665|FG002|Overall Study|Protocol Violation|0|||
16364958|NCT00274456|39821463|FG000|Overall Study|Adverse Event|0|||
16364959|NCT00274456|39821464|FG001|Overall Study|Adverse Event|1|||
16364960|NCT00274456|39821465|FG002|Overall Study|Adverse Event|2|||
16259568|NCT04320849|39436077|FG000|Overall Study|Imaging data unavailable|2|||
16259569|NCT04320849|39436077|FG000|Overall Study|Incomplete imaging|2|||
16147854|NCT01621542|39027666|FG003|Overall Study|Protocol Violation|1|||
16259570|NCT03447262|39436078|FG000|Overall Study|Adverse Event|7|||
16364961|NCT00274456|39821466|FG003|Overall Study|Adverse Event|2|||
16364962|NCT00274456|39821463|FG000|Overall Study|Physician Decision|7|||
16364963|NCT00274456|39821464|FG001|Overall Study|Physician Decision|5|||
16364964|NCT00274456|39821465|FG002|Overall Study|Physician Decision|6|||
16364965|NCT00274456|39821466|FG003|Overall Study|Physician Decision|13|||
16364966|NCT00274456|39821463|FG000|Overall Study|Lost to Follow-up|0|||
16364967|NCT00274456|39821464|FG001|Overall Study|Lost to Follow-up|0|||
16364968|NCT00274456|39821465|FG002|Overall Study|Lost to Follow-up|1|||
16364969|NCT00274456|39821466|FG003|Overall Study|Lost to Follow-up|0|||
16364970|NCT00274456|39821463|FG000|Overall Study|Withdrawal by Subject|18|||
16364971|NCT00274456|39821464|FG001|Overall Study|Withdrawal by Subject|13|||
16364972|NCT00274456|39821465|FG002|Overall Study|Withdrawal by Subject|9|||
16364973|NCT00274456|39821466|FG003|Overall Study|Withdrawal by Subject|13|||
16364974|NCT03101020|39821467|FG000|Overall Study|Lack of time to participate|1|||
16364975|NCT03101020|39821468|FG001|Overall Study|Lack of time to participate|0|||
16364976|NCT03101020|39821467|FG000|Overall Study|Ran over by a car|0|||
16364977|NCT03101020|39821468|FG001|Overall Study|Ran over by a car|1|||
16364978|NCT03101020|39821467|FG000|Overall Study|Withdrawal by Subject|0|||
16364979|NCT03101020|39821468|FG001|Overall Study|Withdrawal by Subject|2|||
16364980|NCT04602000|39821470|FG000|Overall Study|Withdrawal by Subject|3|||
16364981|NCT04602000|39821471|FG001|Overall Study|Withdrawal by Subject|6|||
16364982|NCT04602000|39821472|FG002|Overall Study|Withdrawal by Subject|3|||
16364983|NCT04602000|39821473|FG003|Overall Study|Withdrawal by Subject|27|||
16364984|NCT04602000|39821474|FG004|Overall Study|Withdrawal by Subject|39|||
16364985|NCT04602000|39821470|FG000|Overall Study|Physician Decision|1|||
16364986|NCT04602000|39821471|FG001|Overall Study|Physician Decision|0|||
16364987|NCT04602000|39821472|FG002|Overall Study|Physician Decision|0|||
16364988|NCT04602000|39821473|FG003|Overall Study|Physician Decision|2|||
16364989|NCT04602000|39821474|FG004|Overall Study|Physician Decision|2|||
16364990|NCT04602000|39821470|FG000|Overall Study|Death|0|||
16364991|NCT04602000|39821471|FG001|Overall Study|Death|1|||
16364992|NCT04602000|39821472|FG002|Overall Study|Death|0|||
16364993|NCT04602000|39821473|FG003|Overall Study|Death|1|||
16364994|NCT04602000|39821474|FG004|Overall Study|Death|2|||
16364995|NCT04602000|39821470|FG000|Overall Study|Lost to Follow-up|0|||
16364996|NCT04602000|39821471|FG001|Overall Study|Lost to Follow-up|0|||
16364997|NCT04602000|39821472|FG002|Overall Study|Lost to Follow-up|0|||
16440923|NCT01064440|40092859|FG001|Overall Study|Non-compliance|1|||
16440924|NCT01064440|40092860|FG002|Overall Study|Non-compliance|0|||
16440925|NCT01064440|40092858|FG000|Overall Study|Death|1|||
16440926|NCT01064440|40092859|FG001|Overall Study|Death|0|||
16440927|NCT01064440|40092860|FG002|Overall Study|Death|1|||
16147855|NCT01621542|39027667|FG004|Overall Study|Protocol Violation|0|||
16147856|NCT01621542|39027668|FG005|Overall Study|Protocol Violation|0|||
16147857|NCT01621542|39027663|FG000|Overall Study|study stopped by sponsor|0|||
16147858|NCT01621542|39027664|FG001|Overall Study|study stopped by sponsor|0|||
16147859|NCT01621542|39027665|FG002|Overall Study|study stopped by sponsor|0|||
16147860|NCT01621542|39027666|FG003|Overall Study|study stopped by sponsor|1|||
16259571|NCT03447262|39436078|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
16259572|NCT03447262|39436078|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
16259573|NCT03447262|39436078|FG000|Overall Study|Death|2|||
16259574|NCT03447262|39436078|FG000|Overall Study|Study Termination by Sponsor|455|||
16259575|NCT03447262|39436078|FG000|Overall Study|Other|4|||
16147861|NCT01621542|39027667|FG004|Overall Study|study stopped by sponsor|0|||
16147862|NCT01621542|39027668|FG005|Overall Study|study stopped by sponsor|0|||
16147863|NCT03901079|39027669|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
16147864|NCT00804570|39027670|FG000|Overall Study|Adverse Event|14|||
16147865|NCT00804570|39027671|FG001|Overall Study|Adverse Event|7|||
16147866|NCT00804570|39027670|FG000|Overall Study|Lack of Efficacy|0|||
16147867|NCT00804570|39027671|FG001|Overall Study|Lack of Efficacy|1|||
16147868|NCT00804570|39027670|FG000|Overall Study|Lost to Follow-up|18|||
16147869|NCT00804570|39027671|FG001|Overall Study|Lost to Follow-up|21|||
16147870|NCT00804570|39027670|FG000|Overall Study|Entry criteria not met|5|||
16259576|NCT02932878|39436079|FG000|Overall Study|Due to Lab Results|2|||
16364998|NCT04602000|39821473|FG003|Overall Study|Lost to Follow-up|3|||
16364999|NCT04602000|39821474|FG004|Overall Study|Lost to Follow-up|4|||
16365000|NCT04602000|39821470|FG000|Overall Study|Other|4|||
16365001|NCT04602000|39821471|FG001|Overall Study|Other|1|||
16365002|NCT04602000|39821472|FG002|Overall Study|Other|2|||
16365003|NCT04602000|39821473|FG003|Overall Study|Other|5|||
16365004|NCT04602000|39821474|FG004|Overall Study|Other|4|||
16365005|NCT04602000|39821470|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
16365006|NCT04602000|39821471|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
16365007|NCT04602000|39821472|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
16365008|NCT04602000|39821473|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
16365009|NCT04602000|39821474|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
16365010|NCT00720278|39821475|FG000|Overall Study|Adverse Event|5|||
16365011|NCT00720278|39821476|FG001|Overall Study|Adverse Event|3|||
16365012|NCT00720278|39821477|FG002|Overall Study|Adverse Event|4|||
16365013|NCT00720278|39821475|FG000|Overall Study|Withdrawal by Subject|0|||
16365014|NCT00720278|39821476|FG001|Overall Study|Withdrawal by Subject|1|||
16365015|NCT00720278|39821477|FG002|Overall Study|Withdrawal by Subject|0|||
16365016|NCT00720278|39821475|FG000|Overall Study|Lost to Follow-up|0|||
16365017|NCT00720278|39821476|FG001|Overall Study|Lost to Follow-up|0|||
16365018|NCT00720278|39821477|FG002|Overall Study|Lost to Follow-up|1|||
16365019|NCT00720278|39821475|FG000|Overall Study|Non-compliance|1|||
16365020|NCT00720278|39821476|FG001|Overall Study|Non-compliance|0|||
16365021|NCT00720278|39821477|FG002|Overall Study|Non-compliance|0|||
16365022|NCT00720278|39821475|FG000|Overall Study|eligibility criteria violation|1|||
16365023|NCT00720278|39821476|FG001|Overall Study|eligibility criteria violation|0|||
16365024|NCT00720278|39821477|FG002|Overall Study|eligibility criteria violation|1|||
16440928|NCT01064440|40092858|FG000|Overall Study|Withdrawal by Subject|0|||
16147871|NCT00804570|39027671|FG001|Overall Study|Entry criteria not met|5|||
16147872|NCT00804570|39027670|FG000|Overall Study|Protocol Violation|12|||
16147873|NCT00804570|39027671|FG001|Overall Study|Protocol Violation|16|||
16147874|NCT00804570|39027670|FG000|Overall Study|Physician Decision|1|||
16147875|NCT00804570|39027671|FG001|Overall Study|Physician Decision|2|||
16259577|NCT02932878|39436080|FG001|Overall Study|Due to Lab Results|1|||
16147876|NCT00804570|39027670|FG000|Overall Study|Sponsor decision|1|||
16259578|NCT03048500|39436086|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
16259579|NCT03048500|39436086|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
16259580|NCT03048500|39436086|FG000|Reached 1st Response/Continued Treatment|Death|1|||
16259581|NCT03048500|39436086|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
16259582|NCT03048500|39436086|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
16259583|NCT03048500|39436086|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
16259584|NCT03048500|39436086|FG000|Follow up for 3 Years|Death|12|||
16259585|NCT01735630|39436087|FG000|Overall Study|Adverse Event|8|||
16259586|NCT01735630|39436088|FG001|Overall Study|Adverse Event|7|||
16259587|NCT01735630|39436087|FG000|Overall Study|Lost to Follow-up|1|||
16259588|NCT01735630|39436088|FG001|Overall Study|Lost to Follow-up|0|||
16259589|NCT01735630|39436087|FG000|Overall Study|Physician Decision|0|||
16259590|NCT01735630|39436088|FG001|Overall Study|Physician Decision|1|||
16259591|NCT01735630|39436087|FG000|Overall Study|Sponsor Decision|2|||
16259592|NCT01735630|39436088|FG001|Overall Study|Sponsor Decision|1|||
16259593|NCT01735630|39436087|FG000|Overall Study|Withdrawal by Subject|7|||
16259594|NCT01735630|39436088|FG001|Overall Study|Withdrawal by Subject|9|||
16259595|NCT00441467|39436089|FG000|Overall Study|Adverse Event|6|||
16259596|NCT00441467|39436089|FG000|Overall Study|Withdrawal by Subject|3|||
16259597|NCT00441467|39436089|FG000|Overall Study|Progressive disease|9|||
16259598|NCT00301366|39436091|FG000|Overall Study|Adverse Event|1|||
16259599|NCT00419770|39436097|FG000|Overall Study|Withdrawal by Subject|5|||
16147877|NCT00804570|39027671|FG001|Overall Study|Sponsor decision|4|||
16147878|NCT00804570|39027670|FG000|Overall Study|Withdrawal by Subject|21|||
16147879|NCT00804570|39027671|FG001|Overall Study|Withdrawal by Subject|38|||
16147880|NCT01342484|39027677|FG000|Overall Study|Other Reasons|1|||
16147881|NCT01342484|39027678|FG001|Overall Study|Other Reasons|0|||
16147882|NCT01342484|39027679|FG002|Overall Study|Other Reasons|0|||
16147883|NCT01342484|39027677|FG000|Overall Study|Protocol Violation|0|||
16147884|NCT01342484|39027678|FG001|Overall Study|Protocol Violation|0|||
16147885|NCT01342484|39027679|FG002|Overall Study|Protocol Violation|1|||
16147886|NCT01342484|39027677|FG000|Overall Study|Withdrawal by Subject|1|||
16147887|NCT01342484|39027678|FG001|Overall Study|Withdrawal by Subject|0|||
16259600|NCT00419770|39436098|FG001|Overall Study|Withdrawal by Subject|1|||
16259601|NCT01882257|39436101|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
16259602|NCT01882257|39436102|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
16259603|NCT01882257|39436103|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
16147888|NCT01342484|39027679|FG002|Overall Study|Withdrawal by Subject|0|||
16147889|NCT00915772|39027686|FG000|Overall Study|Adverse Event|12|||
16147890|NCT00915772|39027687|FG001|Overall Study|Adverse Event|13|||
16147891|NCT00915772|39027688|FG002|Overall Study|Adverse Event|11|||
16147892|NCT00915772|39027686|FG000|Overall Study|Protocol Violation|4|||
16147893|NCT00915772|39027687|FG001|Overall Study|Protocol Violation|1|||
16147894|NCT00915772|39027688|FG002|Overall Study|Protocol Violation|2|||
16147895|NCT00915772|39027686|FG000|Overall Study|Lost to Follow-up|1|||
16440929|NCT01064440|40092859|FG001|Overall Study|Withdrawal by Subject|1|||
16147896|NCT00915772|39027687|FG001|Overall Study|Lost to Follow-up|2|||
16147897|NCT00915772|39027688|FG002|Overall Study|Lost to Follow-up|2|||
16147898|NCT00915772|39027686|FG000|Overall Study|Lack of Efficacy|9|||
16147899|NCT00915772|39027687|FG001|Overall Study|Lack of Efficacy|15|||
16440930|NCT01064440|40092860|FG002|Overall Study|Withdrawal by Subject|1|||
16440931|NCT01064440|40092858|FG000|Overall Study|Other: amputation|1|||
16440932|NCT01064440|40092859|FG001|Overall Study|Other: amputation|0|||
16440933|NCT01064440|40092860|FG002|Overall Study|Other: amputation|0|||
16440934|NCT00981656|40092867|FG000|Overall Study|Protocol Violation|1|||
16440935|NCT00981656|40092867|FG000|Overall Study|Did not start protocol treatment|2|||
16440936|NCT01251965|40092868|FG000|Overall Study|Participant/physician decision|1|||
16440937|NCT01251965|40092869|FG001|Overall Study|Participant/physician decision|2|||
16440938|NCT01251965|40092870|FG002|Overall Study|Participant/physician decision|0|||
16440939|NCT01251965|40092868|FG000|Overall Study|Death|0|||
16440940|NCT01251965|40092869|FG001|Overall Study|Death|0|||
16440941|NCT01251965|40092870|FG002|Overall Study|Death|11|||
16440942|NCT01280903|40092872|FG000|Overall Study|Lost to Follow-up|23|||
16440943|NCT01280903|40092873|FG001|Overall Study|Lost to Follow-up|16|||
16440944|NCT04515771|40095631|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
16440945|NCT04515771|40095632|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
16440946|NCT04515771|40095631|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
16440947|NCT04515771|40095632|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
16440948|NCT04515771|40095631|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
16440949|NCT04515771|40095632|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
16147900|NCT00915772|39027688|FG002|Overall Study|Lack of Efficacy|3|||
16147901|NCT00915772|39027686|FG000|Overall Study|Refused to continue trial medication|6|||
16147902|NCT00915772|39027687|FG001|Overall Study|Refused to continue trial medication|8|||
16147903|NCT00915772|39027688|FG002|Overall Study|Refused to continue trial medication|4|||
16147904|NCT00915772|39027686|FG000|Overall Study|Any other reason|4|||
16147905|NCT00915772|39027687|FG001|Overall Study|Any other reason|7|||
16147906|NCT00915772|39027688|FG002|Overall Study|Any other reason|7|||
16147907|NCT00829179|39027689|FG000|Overall Study|Withdrawal by Subject|1|||
16147908|NCT03523728|39027690|FG000|Stage 1 (24 Months)|Adverse Event|2|||
16147909|NCT03523728|39027691|FG001|Stage 1 (24 Months)|Adverse Event|2|||
16147910|NCT03523728|39027692|FG002|Stage 1 (24 Months)|Adverse Event|4|||
16147911|NCT03523728|39027693|FG003|Stage 1 (24 Months)|Adverse Event|0|||
16147912|NCT03523728|39027694|FG004|Stage 1 (24 Months)|Adverse Event|0|||
16147913|NCT03523728|39027690|FG000|Stage 1 (24 Months)|Progressive disease|0|||
16147914|NCT03523728|39027691|FG001|Stage 1 (24 Months)|Progressive disease|0|||
16147915|NCT03523728|39027692|FG002|Stage 1 (24 Months)|Progressive disease|1|||
16147916|NCT03523728|39027693|FG003|Stage 1 (24 Months)|Progressive disease|0|||
16147917|NCT03523728|39027694|FG004|Stage 1 (24 Months)|Progressive disease|0|||
16147918|NCT03523728|39027690|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
16259604|NCT01882257|39436101|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
16365025|NCT01171534|39821483|FG000|Overall Study|Lost to Follow-up|0|||
16365026|NCT01171534|39821484|FG001|Overall Study|Lost to Follow-up|2|||
16365027|NCT01171534|39821483|FG000|Overall Study|screen failure|0|||
16365028|NCT01171534|39821484|FG001|Overall Study|screen failure|1|||
16365029|NCT04167670|39821485|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
16365030|NCT04167670|39821486|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
16365031|NCT04167670|39821487|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
16365032|NCT04167670|39821485|FG000|Overall Study|Significant protocol deviation|3|||
16365033|NCT04167670|39821486|FG001|Overall Study|Significant protocol deviation|1|||
16365034|NCT04167670|39821487|FG002|Overall Study|Significant protocol deviation|0|||
16365035|NCT04167670|39821485|FG000|Overall Study|Lost to Follow-up|0|||
16440950|NCT03404960|40095633|FG000|Overall Study|Adverse Event|0|||
16147919|NCT03523728|39027691|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
16147920|NCT03523728|39027692|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
16365036|NCT04167670|39821486|FG001|Overall Study|Lost to Follow-up|3|||
16440951|NCT03404960|40095634|FG001|Overall Study|Adverse Event|2|||
16147921|NCT03523728|39027693|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
16147922|NCT03523728|39027694|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
16147923|NCT03523728|39027690|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
16147924|NCT03523728|39027691|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
16147925|NCT03523728|39027692|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
16147926|NCT03523728|39027693|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
16147927|NCT03523728|39027694|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
16147928|NCT03523728|39027690|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
16147929|NCT03523728|39027691|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
16147930|NCT03523728|39027692|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
16147931|NCT03523728|39027693|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
16147932|NCT03523728|39027694|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
16147933|NCT03523728|39027690|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
16147934|NCT03523728|39027691|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
16147935|NCT03523728|39027692|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
16147936|NCT03523728|39027693|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
16147937|NCT03523728|39027694|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
16147938|NCT03523728|39027690|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
16365037|NCT04167670|39821487|FG002|Overall Study|Lost to Follow-up|3|||
16147939|NCT03523728|39027691|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
16365038|NCT04167670|39821485|FG000|Overall Study|Voluntary Withdrawal|0|||
16365039|NCT04167670|39821486|FG001|Overall Study|Voluntary Withdrawal|1|||
16365040|NCT04167670|39821487|FG002|Overall Study|Voluntary Withdrawal|1|||
16365041|NCT04167670|39821485|FG000|Overall Study|Withdrawal of Consent|4|||
16365042|NCT04167670|39821486|FG001|Overall Study|Withdrawal of Consent|1|||
16365043|NCT04167670|39821487|FG002|Overall Study|Withdrawal of Consent|3|||
16365044|NCT04167670|39821485|FG000|Overall Study|Miscellaneous|7|||
16365045|NCT04167670|39821486|FG001|Overall Study|Miscellaneous|5|||
16365046|NCT04167670|39821487|FG002|Overall Study|Miscellaneous|3|||
16365047|NCT01039675|39821492|FG000|Overall Study|Adverse Event|0|||
16365048|NCT01039675|39821493|FG001|Overall Study|Adverse Event|2|||
16365049|NCT01039675|39821492|FG000|Overall Study|Lack of Efficacy|0|||
16365050|NCT01039675|39821493|FG001|Overall Study|Lack of Efficacy|2|||
16365051|NCT01039675|39821492|FG000|Overall Study|Withdrawal by Subject|0|||
16365052|NCT01039675|39821493|FG001|Overall Study|Withdrawal by Subject|1|||
16365053|NCT01039675|39821492|FG000|Overall Study|Lost to Follow-up|0|||
16365054|NCT01039675|39821493|FG001|Overall Study|Lost to Follow-up|1|||
16365055|NCT01039675|39821492|FG000|Overall Study|Physician Decision|0|||
16365056|NCT01039675|39821493|FG001|Overall Study|Physician Decision|1|||
16365057|NCT05607043|39821494|FG000|Overall Study|Lost to Follow-up|2|||
16365058|NCT01303419|39821500|FG000|Overall Study|Discontinuation of study|60|||
16365059|NCT01303419|39821500|FG000|Overall Study|Did not complete both imaging methods|5|||
16365060|NCT01303419|39821500|FG000|Overall Study|Did not meet all I/E after screening|31|||
16365061|NCT02530242|39821504|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
16365062|NCT02530242|39821505|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
16365063|NCT02293499|39821506|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
16365064|NCT02293499|39821507|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
16365065|NCT02293499|39821508|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
16365066|NCT02293499|39821506|FG000|Intervention - Camp|Withdrawal by Subject|3|||
16365067|NCT02293499|39821507|FG001|Intervention - Camp|Withdrawal by Subject|6|||
16365068|NCT02293499|39821508|FG002|Intervention - Camp|Withdrawal by Subject|2|||
16365069|NCT02293499|39821506|FG000|Intervention - Camp|these are those not showing up at camp|24|||
16365070|NCT02293499|39821507|FG001|Intervention - Camp|these are those not showing up at camp|28|||
16147940|NCT03523728|39027692|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
16147941|NCT03523728|39027693|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
16147942|NCT03523728|39027694|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
16147943|NCT03523728|39027690|FG000|Stage 2 (24 Months)|Adverse Event|0|||
16147944|NCT03523728|39027691|FG001|Stage 2 (24 Months)|Adverse Event|0|||
16147945|NCT03523728|39027692|FG002|Stage 2 (24 Months)|Adverse Event|0|||
16147946|NCT03523728|39027693|FG003|Stage 2 (24 Months)|Adverse Event|1|||
16147947|NCT03523728|39027694|FG004|Stage 2 (24 Months)|Adverse Event|2|||
16147948|NCT03523728|39027690|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
16147949|NCT03523728|39027691|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
16147950|NCT03523728|39027692|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
16147951|NCT03523728|39027693|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
16147952|NCT03523728|39027694|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
16147953|NCT03523728|39027690|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
16147954|NCT03523728|39027691|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
16147955|NCT03523728|39027692|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
16147956|NCT03523728|39027693|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
16147957|NCT03523728|39027694|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
16147958|NCT03523728|39027690|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
16147959|NCT03523728|39027691|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
16147960|NCT03523728|39027692|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
16147961|NCT03523728|39027693|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
16147962|NCT03523728|39027694|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
16147963|NCT03523728|39027690|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
16147964|NCT03523728|39027691|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
16147965|NCT03523728|39027692|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
16147966|NCT03523728|39027693|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
16147967|NCT03523728|39027694|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
16147968|NCT00917150|39027696|FG000|Overall Study|Adverse Event|12|||
16147969|NCT00917150|39027697|FG001|Overall Study|Adverse Event|7|||
16147970|NCT00917150|39027698|FG002|Overall Study|Adverse Event|12|||
16147971|NCT00917150|39027699|FG003|Overall Study|Adverse Event|11|||
16147972|NCT00917150|39027696|FG000|Overall Study|Death|1|||
16147973|NCT00917150|39027697|FG001|Overall Study|Death|4|||
16147974|NCT00917150|39027698|FG002|Overall Study|Death|3|||
16147975|NCT00917150|39027699|FG003|Overall Study|Death|2|||
16147976|NCT00917150|39027696|FG000|Overall Study|Lost to Follow-up|1|||
16147977|NCT00917150|39027697|FG001|Overall Study|Lost to Follow-up|0|||
16147978|NCT00917150|39027698|FG002|Overall Study|Lost to Follow-up|4|||
16147979|NCT00917150|39027699|FG003|Overall Study|Lost to Follow-up|2|||
16147980|NCT00917150|39027696|FG000|Overall Study|Physician Decision|0|||
16147981|NCT00917150|39027697|FG001|Overall Study|Physician Decision|2|||
16147982|NCT00917150|39027698|FG002|Overall Study|Physician Decision|0|||
16147983|NCT00917150|39027699|FG003|Overall Study|Physician Decision|1|||
16147984|NCT00917150|39027696|FG000|Overall Study|Protocol Violation|5|||
16147985|NCT00917150|39027697|FG001|Overall Study|Protocol Violation|5|||
16147986|NCT00917150|39027698|FG002|Overall Study|Protocol Violation|3|||
16147987|NCT00917150|39027699|FG003|Overall Study|Protocol Violation|5|||
16147988|NCT00917150|39027696|FG000|Overall Study|Withdrawal by Subject|15|||
16147989|NCT00917150|39027697|FG001|Overall Study|Withdrawal by Subject|16|||
16147990|NCT00917150|39027698|FG002|Overall Study|Withdrawal by Subject|18|||
16147991|NCT00917150|39027699|FG003|Overall Study|Withdrawal by Subject|11|||
16147992|NCT00917150|39027696|FG000|Overall Study|Other than specified|3|||
16147993|NCT00917150|39027697|FG001|Overall Study|Other than specified|3|||
16147994|NCT00917150|39027698|FG002|Overall Study|Other than specified|2|||
16147995|NCT00917150|39027699|FG003|Overall Study|Other than specified|2|||
16147996|NCT04534491|39027700|FG000|Overall Study|Not completed end-of-study interview|24|||
16147997|NCT04534491|39027700|FG000|Overall Study|Non-users|70|||
16147998|NCT04534491|39027700|FG000|Overall Study|Non-verifiable users|58|||
16147999|NCT04126083|39027701|FG000|Overall Study|Withdrawal by Subject|1|||
16148000|NCT00228566|39027702|FG000|Overall Study|Adverse Event|31|||
16148001|NCT00228566|39027702|FG000|Overall Study|Lack of Efficacy|14|||
16148002|NCT00228566|39027702|FG000|Overall Study|Lost to Follow-up|16|||
16148003|NCT00228566|39027702|FG000|Overall Study|Physician Decision|5|||
16148004|NCT00228566|39027702|FG000|Overall Study|Withdrawal by Subject|4|||
16148005|NCT00228566|39027702|FG000|Overall Study|Miscellaneous|1|||
16148006|NCT03179891|39027708|FG000|First Intervention|Withdrawal by Subject|1|||
16148007|NCT03179891|39027709|FG001|First Intervention|Withdrawal by Subject|1|||
16148008|NCT03179891|39027708|FG000|First Intervention|Unspecified reason|1|||
16148009|NCT03179891|39027709|FG001|First Intervention|Unspecified reason|0|||
16148010|NCT03179891|39027708|FG000|First Intervention|Protocol Violation|0|||
16148011|NCT03179891|39027709|FG001|First Intervention|Protocol Violation|1|||
16148012|NCT02437864|39027710|FG000|Overall Study|Protocol Violation|4|||
16148013|NCT02437864|39027711|FG001|Overall Study|Protocol Violation|0|||
16148014|NCT01168973|39027712|FG000|Overall Study|Progressive Disease|341|||
16148015|NCT01168973|39027713|FG001|Overall Study|Progressive Disease|429|||
16148016|NCT01168973|39027712|FG000|Overall Study|Adverse Event|94|||
16148017|NCT01168973|39027713|FG001|Overall Study|Adverse Event|55|||
16148018|NCT01168973|39027712|FG000|Overall Study|Withdrawal by Subject|90|||
16148019|NCT01168973|39027713|FG001|Overall Study|Withdrawal by Subject|53|||
16148020|NCT01168973|39027712|FG000|Overall Study|Death|42|||
16148021|NCT01168973|39027713|FG001|Overall Study|Death|45|||
16148022|NCT01168973|39027712|FG000|Overall Study|Physician Decision|37|||
16148023|NCT01168973|39027713|FG001|Overall Study|Physician Decision|19|||
16148024|NCT01168973|39027712|FG000|Overall Study|Sponsor Decision|2|||
16148025|NCT01168973|39027713|FG001|Overall Study|Sponsor Decision|1|||
16148026|NCT01168973|39027712|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
16148027|NCT01168973|39027713|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
16148028|NCT00530894|39027714|FG000|Overall Study|Death|84|||
16148029|NCT00530894|39027715|FG001|Overall Study|Death|89|||
16148030|NCT00530894|39027716|FG002|Overall Study|Death|55|||
16148031|NCT00530894|39027717|FG003|Overall Study|Death|89|||
16148032|NCT00530894|39027714|FG000|Overall Study|Lost to Follow-up|1|||
16148033|NCT00530894|39027715|FG001|Overall Study|Lost to Follow-up|3|||
16148034|NCT00530894|39027716|FG002|Overall Study|Lost to Follow-up|0|||
16148035|NCT00530894|39027717|FG003|Overall Study|Lost to Follow-up|0|||
16148036|NCT00530894|39027714|FG000|Overall Study|Withdrawal by Subject|1|||
16148037|NCT00530894|39027715|FG001|Overall Study|Withdrawal by Subject|23|||
16148038|NCT00530894|39027716|FG002|Overall Study|Withdrawal by Subject|0|||
16148039|NCT00530894|39027717|FG003|Overall Study|Withdrawal by Subject|5|||
16148040|NCT00530894|39027714|FG000|Overall Study|Alive and censored prior to 1 year|2|||
16148041|NCT00530894|39027715|FG001|Overall Study|Alive and censored prior to 1 year|0|||
16148042|NCT00530894|39027716|FG002|Overall Study|Alive and censored prior to 1 year|0|||
16148043|NCT00530894|39027717|FG003|Overall Study|Alive and censored prior to 1 year|0|||
16148044|NCT02294682|39027718|FG000|Overall Study|Could not swallow pills|1|||
16148045|NCT02294682|39027719|FG001|Overall Study|Could not swallow pills|0|||
16148046|NCT00894556|39027722|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
16148047|NCT00894556|39027723|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
16148048|NCT00894556|39027724|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
16148049|NCT00894556|39027725|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
16148050|NCT00894556|39027722|FG000|Treatment Phase|Lost to Follow-up|2|||
16148051|NCT00894556|39027723|FG001|Treatment Phase|Lost to Follow-up|3|||
16148052|NCT00894556|39027724|FG002|Treatment Phase|Lost to Follow-up|1|||
16148053|NCT00894556|39027725|FG003|Treatment Phase|Lost to Follow-up|0|||
16148054|NCT00894556|39027722|FG000|Treatment Phase|Lack of Qualifying Event|2|||
16148055|NCT00894556|39027723|FG001|Treatment Phase|Lack of Qualifying Event|1|||
16148056|NCT00894556|39027724|FG002|Treatment Phase|Lack of Qualifying Event|0|||
16148057|NCT00894556|39027725|FG003|Treatment Phase|Lack of Qualifying Event|0|||
16148058|NCT03198520|39027727|FG000|Overall Study|Physician Decision|2|||
16148059|NCT03198520|39027727|FG000|Overall Study|Protocol Violation|2|||
16148060|NCT03198520|39027727|FG000|Overall Study|Withdrawal by Subject|1|||
16148061|NCT03198520|39027727|FG000|Overall Study|Study Ended|1|||
16148062|NCT00310804|39027730|FG000|Overall Study|Lost to Follow-up|2|||
16148063|NCT00310804|39027731|FG001|Overall Study|Lost to Follow-up|0|||
16148064|NCT00310804|39027730|FG000|Overall Study|Withdrawal by Subject|3|||
16148065|NCT00310804|39027731|FG001|Overall Study|Withdrawal by Subject|0|||
16148066|NCT02109562|39027732|FG000|Overall Study|Insufficient clinical response|2|||
16148067|NCT02109562|39027733|FG001|Overall Study|Insufficient clinical response|0|||
16148068|NCT02109562|39027734|FG002|Overall Study|Insufficient clinical response|4|||
16148069|NCT02109562|39027732|FG000|Overall Study|Adverse Event|0|||
16148070|NCT02109562|39027733|FG001|Overall Study|Adverse Event|2|||
16148071|NCT02109562|39027734|FG002|Overall Study|Adverse Event|3|||
16148072|NCT02109562|39027732|FG000|Overall Study|Lost to Follow-up|1|||
16148073|NCT02109562|39027733|FG001|Overall Study|Lost to Follow-up|0|||
16148074|NCT02109562|39027734|FG002|Overall Study|Lost to Follow-up|1|||
16148075|NCT02109562|39027732|FG000|Overall Study|Protocol Violation|0|||
16148076|NCT02109562|39027733|FG001|Overall Study|Protocol Violation|3|||
16148077|NCT02109562|39027734|FG002|Overall Study|Protocol Violation|1|||
16148078|NCT02109562|39027732|FG000|Overall Study|Withdrawal by Subject|20|||
16148079|NCT02109562|39027733|FG001|Overall Study|Withdrawal by Subject|25|||
16148080|NCT02109562|39027734|FG002|Overall Study|Withdrawal by Subject|21|||
16148081|NCT02109562|39027732|FG000|Overall Study|Physician Decision|3|||
16148082|NCT02109562|39027733|FG001|Overall Study|Physician Decision|4|||
16148083|NCT02109562|39027734|FG002|Overall Study|Physician Decision|5|||
16148084|NCT03000179|39027735|FG000|Overall Study|Lost to Follow-up|2|||
16148085|NCT00525044|39027737|FG000|Overall Study|Lost to Follow-up|0|||
16148086|NCT00525044|39027738|FG001|Overall Study|Lost to Follow-up|1|||
16148087|NCT00449670|39027739|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
16148088|NCT00449670|39027740|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
16148089|NCT00449670|39027739|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
16148090|NCT00449670|39027740|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
16148091|NCT00449670|39027739|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
16148092|NCT00449670|39027740|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
16148093|NCT00449670|39027739|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
16148094|NCT00449670|39027740|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
16148095|NCT00449670|39027739|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
16148096|NCT00449670|39027740|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
16148097|NCT00449670|39027739|FG000|Booster Phase (Study no.109873)|Other|0|||
16148098|NCT00449670|39027740|FG001|Booster Phase (Study no.109873)|Other|2|||
16148099|NCT01537198|39027743|FG000|Overall Study|RSV infection|2|||
16148100|NCT01537198|39027743|FG000|Overall Study|Adverse Event|4|||
16148101|NCT01537198|39027743|FG000|Overall Study|No Further Visits to the Clinic|37|||
16148102|NCT01537198|39027743|FG000|Overall Study|Other|111|||
16148103|NCT04869345|39027744|FG000|Overall Study|Lost to Follow-up|8|||
16148104|NCT04869345|39027745|FG001|Overall Study|Lost to Follow-up|3|||
16148105|NCT00687440|39027746|FG000|Overall Study|Adverse Event|3|||
16148106|NCT00687440|39027746|FG000|Overall Study|Lost to Follow-up|3|||
16148107|NCT00687440|39027746|FG000|Overall Study|Lack of Efficacy|2|||
16148108|NCT00687440|39027746|FG000|Overall Study|Death|2|||
16148109|NCT00687440|39027746|FG000|Overall Study|Other|1|||
16148110|NCT00687440|39027746|FG000|Overall Study|Missing|1|||
16148111|NCT01230242|39027747|FG000|Overall Study|Physician Decision|2|||
16148112|NCT01230242|39027747|FG000|Overall Study|Withdrawal by Subject|1|||
16148113|NCT02101021|39027748|FG000|Overall Study|Death|4|||
16148114|NCT02101021|39027749|FG001|Overall Study|Death|3|||
16148115|NCT02101021|39027750|FG002|Overall Study|Death|6|||
16148116|NCT02101021|39027751|FG003|Overall Study|Death|0|||
16148117|NCT02101021|39027752|FG004|Overall Study|Death|3|||
16148118|NCT02101021|39027748|FG000|Overall Study|Withdrew Consent from study|1|||
16148119|NCT02101021|39027749|FG001|Overall Study|Withdrew Consent from study|1|||
16148120|NCT02101021|39027750|FG002|Overall Study|Withdrew Consent from study|0|||
16148121|NCT02101021|39027751|FG003|Overall Study|Withdrew Consent from study|2|||
16148122|NCT02101021|39027752|FG004|Overall Study|Withdrew Consent from study|0|||
16440952|NCT03404960|40095633|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
16440953|NCT03404960|40095634|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
16440954|NCT03404960|40095633|FG000|Overall Study|Bowel obstruction|0|||
16440955|NCT03404960|40095634|FG001|Overall Study|Bowel obstruction|1|||
16440956|NCT03404960|40095633|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
16440957|NCT03404960|40095634|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
16440958|NCT02177695|40095636|FG000|ITT Analysis|Ineligible|5|||
16148123|NCT02101021|39027748|FG000|Overall Study|Lost to Follow-up|1|||
16148124|NCT02101021|39027749|FG001|Overall Study|Lost to Follow-up|0|||
16440959|NCT02177695|40095637|FG001|ITT Analysis|Ineligible|5|||
16148125|NCT02101021|39027750|FG002|Overall Study|Lost to Follow-up|0|||
16148126|NCT02101021|39027751|FG003|Overall Study|Lost to Follow-up|0|||
16148127|NCT02101021|39027752|FG004|Overall Study|Lost to Follow-up|0|||
16148128|NCT02101021|39027748|FG000|Overall Study|Study Terminated by Sponsor|1|||
16148129|NCT02101021|39027749|FG001|Overall Study|Study Terminated by Sponsor|0|||
16148130|NCT02101021|39027750|FG002|Overall Study|Study Terminated by Sponsor|1|||
16148131|NCT02101021|39027751|FG003|Overall Study|Study Terminated by Sponsor|1|||
16259605|NCT01882257|39436102|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
16259606|NCT01882257|39436103|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
16259607|NCT01363765|39436104|FG000|Overall Study|non-diagnostic|2621|||
16259608|NCT01363765|39436105|FG001|Overall Study|non-diagnostic|1124|||
16259609|NCT01363765|39436104|FG000|Overall Study|duplicate records|736|||
16259610|NCT01363765|39436105|FG001|Overall Study|duplicate records|3177|||
16259611|NCT01363765|39436104|FG000|Overall Study|non-resident|156|||
16259612|NCT01363765|39436105|FG001|Overall Study|non-resident|76|||
16259613|NCT01363765|39436104|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
16259614|NCT01363765|39436105|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
16259615|NCT01363765|39436104|FG000|Overall Study|smear during intervention|2170|||
16148132|NCT02101021|39027752|FG004|Overall Study|Study Terminated by Sponsor|1|||
16148133|NCT01436084|39027755|FG000|Overall Study|Disease Progression|2|||
16148134|NCT01436084|39027755|FG000|Overall Study|Withdrawal by Subject|1|||
16148135|NCT01436084|39027755|FG000|Overall Study|Early Closure of Study|1|||
16148136|NCT01128361|39027756|FG000|Overall Study|Lost to Follow-up|0|||
16148137|NCT01128361|39027757|FG001|Overall Study|Lost to Follow-up|1|||
16148138|NCT01128361|39027756|FG000|Overall Study|Withdrawal by Subject|5|||
16148139|NCT01128361|39027757|FG001|Overall Study|Withdrawal by Subject|2|||
16148140|NCT03511053|39027760|FG000|Overall Study|Withdrawal by Subject|1|||
16148141|NCT01793142|39027761|FG000|Overall Study|Randomized not treated|7|||
16148142|NCT01553136|39027763|FG000|Overall Study|Adverse Event|3|||
16148143|NCT01553136|39027764|FG001|Overall Study|Adverse Event|2|||
16148144|NCT01553136|39027763|FG000|Overall Study|Withdrawal by Subject|2|||
16148145|NCT01553136|39027764|FG001|Overall Study|Withdrawal by Subject|3|||
16148146|NCT01553136|39027763|FG000|Overall Study|Lost to Follow-up|4|||
16148147|NCT01553136|39027764|FG001|Overall Study|Lost to Follow-up|10|||
16148148|NCT01553136|39027763|FG000|Overall Study|Physician Decision|2|||
16148149|NCT01553136|39027764|FG001|Overall Study|Physician Decision|3|||
16259616|NCT01363765|39436105|FG001|Overall Study|smear during intervention|0|||
16259617|NCT00056160|39436106|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
16440960|NCT02177695|40095636|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
16148150|NCT01553136|39027763|FG000|Overall Study|Scheduling Difficulties|5|||
16148151|NCT01553136|39027764|FG001|Overall Study|Scheduling Difficulties|4|||
16440961|NCT02177695|40095637|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
16440962|NCT02177695|40095636|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
16440963|NCT02177695|40095637|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
16440964|NCT02177695|40095636|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
16440965|NCT02177695|40095637|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
16440966|NCT03115359|40095640|FG000|Overall Study|Withdrawal by Subject|29|||
16440967|NCT03115359|40095641|FG001|Overall Study|Withdrawal by Subject|39|||
16440968|NCT03115359|40095640|FG000|Overall Study|Scheduling conflict|25|||
16440969|NCT03115359|40095641|FG001|Overall Study|Scheduling conflict|23|||
16440970|NCT03115359|40095640|FG000|Overall Study|Personal reasons including health|12|||
16148152|NCT01301950|39027765|FG000|Overall Study|Surgery was cancelled by patient|0|||
16148153|NCT01301950|39027766|FG001|Overall Study|Surgery was cancelled by patient|1|||
16148154|NCT01979536|39027767|FG000|Overall Study|Physician Decision|2|||
16148155|NCT01979536|39027768|FG001|Overall Study|Physician Decision|3|||
16148156|NCT01979536|39027767|FG000|Overall Study|Withdrawal by Subject|0|||
16148157|NCT01979536|39027768|FG001|Overall Study|Withdrawal by Subject|1|||
16148158|NCT01979536|39027767|FG000|Overall Study|Refusal|0|||
16148159|NCT01979536|39027768|FG001|Overall Study|Refusal|1|||
16148160|NCT01979536|39027767|FG000|Overall Study|Relapse|0|||
16148161|NCT01979536|39027768|FG001|Overall Study|Relapse|1|||
16148162|NCT01979536|39027767|FG000|Overall Study|Study terminated by Sponsor|0|||
16148163|NCT01979536|39027768|FG001|Overall Study|Study terminated by Sponsor|1|||
16259618|NCT00056160|39436107|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
16259619|NCT00056160|39436106|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
16259620|NCT00056160|39436107|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
16259621|NCT00056160|39436106|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
16259622|NCT00056160|39436107|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
16259623|NCT00056160|39436106|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
16259624|NCT00056160|39436107|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
16259625|NCT00056160|39436106|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
16259626|NCT00056160|39436107|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
16259627|NCT00056160|39436106|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
16259628|NCT00056160|39436107|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
16259629|NCT00056160|39436106|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
16259630|NCT00056160|39436107|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
16259631|NCT00056160|39436106|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
16259632|NCT00056160|39436107|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
16259633|NCT00056160|39436106|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
16259634|NCT00056160|39436107|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
16259635|NCT00056160|39436106|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
16259636|NCT00056160|39436107|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
16259637|NCT00056160|39436106|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
16259638|NCT00056160|39436107|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
16259639|NCT00056160|39436106|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
16259640|NCT00056160|39436107|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
16259641|NCT00056160|39436106|FG000|Final Follow-up|Transferred into expanded access study.|3|||
16259642|NCT00056160|39436107|FG001|Final Follow-up|Transferred into expanded access study.|0|||
16259643|NCT00056160|39436106|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
16259644|NCT00056160|39436107|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
16259645|NCT00056160|39436106|FG000|Final Follow-up|Adverse Event|1|||
16259646|NCT00056160|39436107|FG001|Final Follow-up|Adverse Event|0|||
16259647|NCT02930005|39436108|FG000|Overall Study|Lost to Follow-up|1|||
16259648|NCT02930005|39436109|FG001|Overall Study|Lost to Follow-up|5|||
16259649|NCT03122457|39436112|FG000|Overall Study|Withdrawal by Subject|6|||
16259650|NCT00854308|39436113|FG000|Overall Study|Disease progression|42|||
16259651|NCT00854308|39436114|FG001|Overall Study|Disease progression|50|||
16259652|NCT00854308|39436113|FG000|Overall Study|Adverse Event|8|||
16148164|NCT01979536|39027767|FG000|Overall Study|Did not start treatment|0|||
16259653|NCT00854308|39436114|FG001|Overall Study|Adverse Event|3|||
16148165|NCT01979536|39027768|FG001|Overall Study|Did not start treatment|1|||
16148166|NCT00432042|39027769|FG000|Overall Study|Protocol Violation|2|||
16148167|NCT00432042|39027770|FG001|Overall Study|Protocol Violation|0|||
16259654|NCT00854308|39436113|FG000|Overall Study|Death|2|||
16148168|NCT00432042|39027771|FG002|Overall Study|Protocol Violation|0|||
16148169|NCT00432042|39027769|FG000|Overall Study|Withdrawal by Subject|0|||
16148170|NCT00432042|39027770|FG001|Overall Study|Withdrawal by Subject|0|||
16148171|NCT00432042|39027771|FG002|Overall Study|Withdrawal by Subject|2|||
16148172|NCT00432042|39027769|FG000|Overall Study|Lost to Follow-up|5|||
16148173|NCT00432042|39027770|FG001|Overall Study|Lost to Follow-up|1|||
16148174|NCT00432042|39027771|FG002|Overall Study|Lost to Follow-up|0|||
16148175|NCT04912245|39027772|FG000|Overall Study|Withdrawal by Subject|21|||
16148176|NCT04912245|39027773|FG001|Overall Study|Withdrawal by Subject|4|||
16148177|NCT04912245|39027772|FG000|Overall Study|Lost to Follow-up|5|||
16148178|NCT04912245|39027773|FG001|Overall Study|Lost to Follow-up|11|||
16148179|NCT03861936|39027774|FG000|Overall Study|Withdrawal by Subject|4|||
16148180|NCT03861936|39027775|FG001|Overall Study|Withdrawal by Subject|1|||
16148181|NCT03861936|39027776|FG002|Overall Study|Withdrawal by Subject|3|||
16148182|NCT03861936|39027774|FG000|Overall Study|Lost to Follow-up|5|||
16148183|NCT03861936|39027775|FG001|Overall Study|Lost to Follow-up|3|||
16148184|NCT03861936|39027776|FG002|Overall Study|Lost to Follow-up|3|||
16148185|NCT03861936|39027774|FG000|Overall Study|Physician Decision|0|||
16148186|NCT03861936|39027775|FG001|Overall Study|Physician Decision|1|||
16148187|NCT03861936|39027776|FG002|Overall Study|Physician Decision|0|||
16148188|NCT03861936|39027774|FG000|Overall Study|Protocol Deviation|0|||
16148189|NCT03861936|39027775|FG001|Overall Study|Protocol Deviation|0|||
16148190|NCT03861936|39027776|FG002|Overall Study|Protocol Deviation|1|||
16148191|NCT03861936|39027774|FG000|Overall Study|Reason not Specified|5|||
16148192|NCT03861936|39027775|FG001|Overall Study|Reason not Specified|5|||
16148193|NCT03861936|39027776|FG002|Overall Study|Reason not Specified|3|||
16148194|NCT03823404|39027779|FG000|Overall Study|Lost to Follow-up|1|||
16148195|NCT03823404|39027780|FG001|Overall Study|Lost to Follow-up|2|||
16148196|NCT03823404|39027781|FG002|Overall Study|Lost to Follow-up|3|||
16148197|NCT03823404|39027779|FG000|Overall Study|Protocol Violation|2|||
16148198|NCT03823404|39027780|FG001|Overall Study|Protocol Violation|0|||
16148199|NCT03823404|39027781|FG002|Overall Study|Protocol Violation|2|||
16148200|NCT03823404|39027779|FG000|Overall Study|Adverse Event|35|||
16148201|NCT03823404|39027780|FG001|Overall Study|Adverse Event|38|||
16148202|NCT03823404|39027781|FG002|Overall Study|Adverse Event|8|||
16148203|NCT03823404|39027779|FG000|Overall Study|Withdrawal by Subject|38|||
16148204|NCT03823404|39027780|FG001|Overall Study|Withdrawal by Subject|40|||
16148205|NCT03823404|39027781|FG002|Overall Study|Withdrawal by Subject|35|||
16148206|NCT03823404|39027779|FG000|Overall Study|Death|4|||
16148207|NCT03823404|39027780|FG001|Overall Study|Death|0|||
16148208|NCT03823404|39027781|FG002|Overall Study|Death|0|||
16148209|NCT03823404|39027779|FG000|Overall Study|Other: Various reasons provided|5|||
16148210|NCT03823404|39027780|FG001|Overall Study|Other: Various reasons provided|5|||
16148211|NCT03823404|39027781|FG002|Overall Study|Other: Various reasons provided|6|||
16148212|NCT00928889|39027782|FG000|Overall Study|Lost to Follow-up|3|||
16148213|NCT00928889|39027783|FG001|Overall Study|Lost to Follow-up|1|||
16148214|NCT00928889|39027782|FG000|Overall Study|Protocol Violation|0|||
16148215|NCT00928889|39027783|FG001|Overall Study|Protocol Violation|1|||
16148216|NCT00928889|39027782|FG000|Overall Study|Adverse Event|1|||
16148217|NCT00928889|39027783|FG001|Overall Study|Adverse Event|0|||
16148218|NCT00928889|39027782|FG000|Overall Study|Other|1|||
16148219|NCT00928889|39027783|FG001|Overall Study|Other|0|||
16148220|NCT03996876|39027790|FG000|Overall Study|Incomplete Data|2|||
16148221|NCT03996876|39027791|FG001|Overall Study|Incomplete Data|4|||
16148222|NCT00942175|39027792|FG000|Overall Study|Adverse Event|2|||
16148223|NCT00942175|39027793|FG001|Overall Study|Adverse Event|1|||
16148224|NCT00942175|39027794|FG002|Overall Study|Adverse Event|0|||
16148225|NCT00942175|39027795|FG003|Overall Study|Adverse Event|0|||
16148226|NCT00942175|39027792|FG000|Overall Study|Protocol Violation|0|||
16148227|NCT00942175|39027793|FG001|Overall Study|Protocol Violation|1|||
16148228|NCT00942175|39027794|FG002|Overall Study|Protocol Violation|2|||
16148229|NCT00942175|39027795|FG003|Overall Study|Protocol Violation|0|||
16148230|NCT00942175|39027792|FG000|Overall Study|Pregnancy|0|||
16259655|NCT00854308|39436114|FG001|Overall Study|Death|5|||
16259656|NCT00854308|39436113|FG000|Overall Study|Physician Decision|6|||
16259657|NCT00854308|39436114|FG001|Overall Study|Physician Decision|6|||
16259658|NCT00854308|39436113|FG000|Overall Study|Withdrawal by Subject|4|||
16259659|NCT00854308|39436114|FG001|Overall Study|Withdrawal by Subject|2|||
16259660|NCT00854308|39436113|FG000|Overall Study|Sponsor's decision to terminate study|0|||
16259661|NCT00854308|39436114|FG001|Overall Study|Sponsor's decision to terminate study|1|||
16148231|NCT00942175|39027793|FG001|Overall Study|Pregnancy|0|||
16148232|NCT00942175|39027794|FG002|Overall Study|Pregnancy|0|||
16148233|NCT00942175|39027795|FG003|Overall Study|Pregnancy|1|||
16148234|NCT00942175|39027792|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
16148235|NCT00942175|39027793|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
16148236|NCT00942175|39027794|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
16148237|NCT00942175|39027795|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
16148238|NCT00942175|39027792|FG000|Overall Study|Low Platelet Count|0|||
16148239|NCT00942175|39027793|FG001|Overall Study|Low Platelet Count|2|||
16148240|NCT00942175|39027794|FG002|Overall Study|Low Platelet Count|0|||
16148241|NCT00942175|39027795|FG003|Overall Study|Low Platelet Count|0|||
16148242|NCT02064920|39027796|FG000|Overall Study|Adverse Event|0|||
16148243|NCT02064920|39027797|FG001|Overall Study|Adverse Event|4|||
16148244|NCT02064920|39027796|FG000|Overall Study|Physician Decision|0|||
16148245|NCT02064920|39027797|FG001|Overall Study|Physician Decision|1|||
16259662|NCT02910037|39436117|FG000|Overall Study|Withdrawal by Subject|4|||
16259663|NCT02910037|39436117|FG000|Overall Study|Lost to Follow-up|6|||
16259664|NCT03787680|39436125|FG000|Overall Study|Physician Decision|2|||
16259665|NCT03787680|39436126|FG001|Overall Study|Physician Decision|3|||
16259666|NCT03787680|39436125|FG000|Overall Study|Adverse Event|7|||
16259667|NCT03787680|39436126|FG001|Overall Study|Adverse Event|3|||
16259668|NCT03787680|39436125|FG000|Overall Study|Withdrawal by Subject|2|||
16259669|NCT03787680|39436126|FG001|Overall Study|Withdrawal by Subject|1|||
16259670|NCT01239121|39436127|FG000|Overall Study|Withdrawal by Subject|2|||
16148246|NCT02064920|39027796|FG000|Overall Study|Technical Problems|0|||
16148247|NCT02064920|39027797|FG001|Overall Study|Technical Problems|1|||
16148248|NCT02064920|39027796|FG000|Overall Study|Withdrawal by Subject|1|||
16148249|NCT02064920|39027797|FG001|Overall Study|Withdrawal by Subject|3|||
16148250|NCT01942148|39027801|FG000|Overall Study|Adverse Event|4|||
16148251|NCT01942148|39027801|FG000|Overall Study|Lack of Efficacy|2|||
16148252|NCT01942148|39027801|FG000|Overall Study|Physician Decision|11|||
16148253|NCT01942148|39027801|FG000|Overall Study|Protocol Violation|1|||
16148254|NCT01942148|39027801|FG000|Overall Study|Withdrawal by Subject|8|||
16148255|NCT01942148|39027801|FG000|Overall Study|Use of the prohibition medicine|1|||
16148256|NCT00253643|39027807|FG000|Overall Study|Withdrawal by Subject|0|||
16148257|NCT00253643|39027808|FG001|Overall Study|Withdrawal by Subject|0|||
16148258|NCT00253643|39027809|FG002|Overall Study|Withdrawal by Subject|1|||
16148259|NCT00253643|39027810|FG003|Overall Study|Withdrawal by Subject|1|||
16148260|NCT00253643|39027807|FG000|Overall Study|Non-Compliance|0|||
16148261|NCT00253643|39027808|FG001|Overall Study|Non-Compliance|0|||
16148262|NCT00253643|39027809|FG002|Overall Study|Non-Compliance|0|||
16148263|NCT00253643|39027810|FG003|Overall Study|Non-Compliance|2|||
16148264|NCT02163187|39027811|FG000|Overall Study|Device removed|1|||
16148265|NCT02163187|39027812|FG001|Overall Study|Device removed|0|||
16148266|NCT02163187|39027811|FG000|Overall Study|Progressive disease|1|||
16148267|NCT02163187|39027812|FG001|Overall Study|Progressive disease|0|||
16148268|NCT00841568|39027813|FG000|Overall Study|Adverse Event|1|||
16148269|NCT00841568|39027813|FG000|Overall Study|Death|1|||
16148270|NCT00841568|39027813|FG000|Overall Study|Withdrawal by Subject|2|||
16148271|NCT00841568|39027813|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
16148272|NCT02023242|39027814|FG000|Overall Study|Lost to Follow-up|3|||
16148273|NCT02023242|39027815|FG001|Overall Study|Lost to Follow-up|1|||
16148274|NCT02023242|39027814|FG000|Overall Study|Death|0|||
16259671|NCT01239121|39436128|FG001|Overall Study|Withdrawal by Subject|4|||
16259672|NCT01239121|39436129|FG002|Overall Study|Withdrawal by Subject|0|||
16259673|NCT02231749|39436132|FG000|Overall Study|Disease progression|229|||
16259674|NCT02231749|39436133|FG001|Overall Study|Disease progression|297|||
16259675|NCT02231749|39436132|FG000|Overall Study|Study Drug Toxicity|134|||
16259676|NCT02231749|39436133|FG001|Overall Study|Study Drug Toxicity|63|||
16259677|NCT02231749|39436132|FG000|Overall Study|Death|1|||
16259678|NCT02231749|39436133|FG001|Overall Study|Death|1|||
16440971|NCT03115359|40095641|FG001|Overall Study|Personal reasons including health|9|||
16148275|NCT02023242|39027815|FG001|Overall Study|Death|1|||
16148276|NCT01199042|39027816|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
16148277|NCT01199042|39027816|FG000|At Home (3 Months)|Lost to Follow-up|1|||
16148278|NCT00113074|39027817|FG000|Overall Study|Lost to Follow-up|10|||
16148279|NCT00113074|39027818|FG001|Overall Study|Lost to Follow-up|10|||
16148280|NCT00113074|39027819|FG002|Overall Study|Lost to Follow-up|14|||
16148281|NCT02187172|39027820|FG000|Overall Study|Lost to Follow-up|1|||
16148282|NCT02187172|39027821|FG001|Overall Study|Lost to Follow-up|2|||
16148283|NCT02187172|39027820|FG000|Overall Study|Lack of Efficacy|1|||
16148284|NCT02187172|39027821|FG001|Overall Study|Lack of Efficacy|2|||
16148285|NCT02187172|39027820|FG000|Overall Study|Adverse Event|0|||
16148286|NCT02187172|39027821|FG001|Overall Study|Adverse Event|1|||
16148287|NCT02187172|39027820|FG000|Overall Study|Physician Decision|1|||
16148288|NCT02187172|39027821|FG001|Overall Study|Physician Decision|1|||
16148289|NCT00766038|39027827|FG000|Overall Study|Lost to Follow-up|15|||
16148290|NCT00766038|39027828|FG001|Overall Study|Lost to Follow-up|14|||
16148291|NCT03281668|39027829|FG000|Overall Study|Physician Decision|1|||
16148292|NCT03281668|39027829|FG000|Overall Study|scheduling conflict, family circumstance|2|||
16148293|NCT03281668|39027829|FG000|Overall Study|Withdrawal by Subject|4|||
16148294|NCT03281668|39027829|FG000|Overall Study|Lost to Follow-up|1|||
16148295|NCT01698905|39027830|FG000|Overall Study|Adverse Event|4|||
16148296|NCT01698905|39027830|FG000|Overall Study|Physician Decision|2|||
16148297|NCT01698905|39027830|FG000|Overall Study|Pregnancy|1|||
16148298|NCT01698905|39027830|FG000|Overall Study|Protocol Violation|1|||
16148299|NCT01698905|39027830|FG000|Overall Study|Subject/guardian decision|2|||
16148300|NCT01698905|39027830|FG000|Overall Study|Death|1|||
16148301|NCT02228720|39027831|FG000|Open Label - Day 30|Lost to Follow-up|1|||
16148302|NCT02844920|39027832|FG000|Overall Study|Lost to Follow-up|2|||
16148303|NCT03061175|39027833|FG000|Baseline|Participant was deemed ineligible|1|||
16148304|NCT03061175|39027834|FG001|Baseline|Participant was deemed ineligible|0|||
16148305|NCT03061175|39027833|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
16148306|NCT03061175|39027834|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
16148307|NCT03061175|39027833|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
16148308|NCT03061175|39027834|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
16148309|NCT03061175|39027833|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
16148310|NCT03061175|39027834|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
16148311|NCT01809132|39027835|FG000|Overall Study|Withdrawal by Subject|0|||
16148312|NCT01809132|39027836|FG001|Overall Study|Withdrawal by Subject|0|||
16148313|NCT01809132|39027837|FG002|Overall Study|Withdrawal by Subject|1|||
16148314|NCT00117507|39027841|FG000|Overall Study|Adverse Event|4|||
16148315|NCT00117507|39027841|FG000|Overall Study|Abnormal laboratory values|3|||
16148316|NCT00117507|39027841|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16148317|NCT00117507|39027841|FG000|Overall Study|Patient withdrew consent|4|||
16148318|NCT00117507|39027841|FG000|Overall Study|Death|3|||
16148319|NCT01444742|39027842|FG000|Overall Study|Death|1|||
16148320|NCT01250379|39027845|FG000|Overall Study|Death|141|||
16148321|NCT01250379|39027846|FG001|Overall Study|Death|148|||
16148322|NCT01250379|39027845|FG000|Overall Study|Withdrawal by Subject|32|||
16148323|NCT01250379|39027846|FG001|Overall Study|Withdrawal by Subject|20|||
16148324|NCT01250379|39027845|FG000|Overall Study|Physician Decision|11|||
16148325|NCT01250379|39027846|FG001|Overall Study|Physician Decision|3|||
16148326|NCT01250379|39027845|FG000|Overall Study|Protocol Violation|2|||
16148327|NCT01250379|39027846|FG001|Overall Study|Protocol Violation|8|||
16148328|NCT01250379|39027845|FG000|Overall Study|Lost to Follow-up|9|||
16148329|NCT01250379|39027846|FG001|Overall Study|Lost to Follow-up|6|||
16148330|NCT01250379|39027845|FG000|Overall Study|Adverse Event|5|||
16148331|NCT01250379|39027846|FG001|Overall Study|Adverse Event|4|||
16148332|NCT01250379|39027845|FG000|Overall Study|Other|0|||
16148333|NCT01250379|39027846|FG001|Overall Study|Other|4|||
16148334|NCT01250379|39027845|FG000|Overall Study|Participant noncompliance|2|||
16148335|NCT01250379|39027846|FG001|Overall Study|Participant noncompliance|0|||
16148336|NCT02490475|39027849|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
16148337|NCT02490475|39027850|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
16148338|NCT02490475|39027851|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
16148339|NCT02490475|39027852|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
16148340|NCT02490475|39027849|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
16148341|NCT02490475|39027850|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
16148342|NCT02490475|39027851|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
16148343|NCT02490475|39027852|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
16148344|NCT02490475|39027849|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
16148345|NCT02490475|39027850|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
16148346|NCT02490475|39027851|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
16148347|NCT02490475|39027852|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
16148348|NCT02490475|39027849|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
16148349|NCT02490475|39027850|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
16148350|NCT02490475|39027851|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
16148351|NCT02490475|39027852|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
16148352|NCT02490475|39027849|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
16148353|NCT02490475|39027850|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
16148354|NCT02490475|39027851|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
16148355|NCT02490475|39027852|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
16148356|NCT02490475|39027849|FG000|Period 2: Extension Phase|Refused Treatment|0|||
16148357|NCT02490475|39027850|FG001|Period 2: Extension Phase|Refused Treatment|0|||
16148358|NCT02490475|39027851|FG002|Period 2: Extension Phase|Refused Treatment|0|||
16148359|NCT02490475|39027852|FG003|Period 2: Extension Phase|Refused Treatment|1|||
16148360|NCT02490475|39027849|FG000|Period 2: Extension Phase|Adverse Event|0|||
16148361|NCT02490475|39027850|FG001|Period 2: Extension Phase|Adverse Event|0|||
16148362|NCT02490475|39027851|FG002|Period 2: Extension Phase|Adverse Event|1|||
16148363|NCT02490475|39027852|FG003|Period 2: Extension Phase|Adverse Event|0|||
16148364|NCT02713542|39030578|FG000|Overall Study|Use of prohibited medication|14|||
16148365|NCT02713542|39030579|FG001|Overall Study|Use of prohibited medication|5|||
16148366|NCT02713542|39030578|FG000|Overall Study|Withdrawal by Subject|4|||
16148367|NCT02713542|39030579|FG001|Overall Study|Withdrawal by Subject|1|||
16148368|NCT01572675|39030580|FG000|Overall Study|End of prescribed treatment|140|||
16148369|NCT01572675|39030581|FG001|Overall Study|End of prescribed treatment|118|||
16148370|NCT01572675|39030580|FG000|Overall Study|Recovery|16|||
16148371|NCT01572675|39030581|FG001|Overall Study|Recovery|23|||
16148372|NCT01572675|39030580|FG000|Overall Study|Lack of Efficacy|31|||
16148373|NCT01572675|39030581|FG001|Overall Study|Lack of Efficacy|31|||
16148374|NCT01572675|39030580|FG000|Overall Study|Intolerance|6|||
16148375|NCT01572675|39030581|FG001|Overall Study|Intolerance|5|||
16148376|NCT01572675|39030580|FG000|Overall Study|Improved symptoms|8|||
16148377|NCT01572675|39030581|FG001|Overall Study|Improved symptoms|2|||
16148378|NCT01572675|39030580|FG000|Overall Study|Surgical intervention|3|||
16148379|NCT01572675|39030581|FG001|Overall Study|Surgical intervention|6|||
16148380|NCT01572675|39030580|FG000|Overall Study|Withdrawal by Subject|5|||
16148381|NCT01572675|39030581|FG001|Overall Study|Withdrawal by Subject|1|||
16148382|NCT01572675|39030580|FG000|Overall Study|Physician Decision|2|||
16148383|NCT01572675|39030581|FG001|Overall Study|Physician Decision|2|||
16148384|NCT01572675|39030580|FG000|Overall Study|Death unrelated to coxibs|1|||
16148385|NCT01572675|39030581|FG001|Overall Study|Death unrelated to coxibs|1|||
16148386|NCT01572675|39030580|FG000|Overall Study|Other disease detected|1|||
16148387|NCT01572675|39030581|FG001|Overall Study|Other disease detected|1|||
16148388|NCT01572675|39030580|FG000|Overall Study|Unknown reason|1|||
16148389|NCT01572675|39030581|FG001|Overall Study|Unknown reason|1|||
16148390|NCT01572675|39030580|FG000|Overall Study|Rheumatologist new evaluation|0|||
16148391|NCT01572675|39030581|FG001|Overall Study|Rheumatologist new evaluation|1|||
16148392|NCT01572675|39030580|FG000|Overall Study|Missing data|1|||
16148393|NCT01572675|39030581|FG001|Overall Study|Missing data|4|||
16148394|NCT01572675|39030580|FG000|Overall Study|Lost to Follow-up|22|||
16148395|NCT01572675|39030581|FG001|Overall Study|Lost to Follow-up|27|||
16148396|NCT02369848|39030583|FG000|Overall Study|Death|1|||
16148397|NCT02369848|39030583|FG000|Overall Study|Withdrawal by Subject|2|||
16148398|NCT02369848|39030583|FG000|Overall Study|Lost to Follow-up|1|||
16148399|NCT03016325|39030596|FG000|Treatment Period|Participant withdrew consent|0|||
16148400|NCT03016325|39030597|FG001|Treatment Period|Participant withdrew consent|1|||
16148401|NCT03016325|39030598|FG002|Treatment Period|Participant withdrew consent|0|||
16148402|NCT03016325|39030599|FG003|Treatment Period|Participant withdrew consent|0|||
16148403|NCT03016325|39030600|FG004|Treatment Period|Participant withdrew consent|0|||
16148404|NCT03016325|39030601|FG005|Treatment Period|Participant withdrew consent|0|||
16148405|NCT03016325|39030602|FG006|Treatment Period|Participant withdrew consent|0|||
16148406|NCT03016325|39030603|FG007|Treatment Period|Participant withdrew consent|0|||
16148407|NCT03016325|39030596|FG000|Treatment Period|Death|0|||
16148408|NCT03016325|39030597|FG001|Treatment Period|Death|0|||
16148409|NCT03016325|39030598|FG002|Treatment Period|Death|0|||
16148410|NCT03016325|39030599|FG003|Treatment Period|Death|0|||
16148411|NCT03016325|39030600|FG004|Treatment Period|Death|2|||
16148412|NCT03016325|39030601|FG005|Treatment Period|Death|0|||
16148413|NCT03016325|39030602|FG006|Treatment Period|Death|0|||
16148414|NCT03016325|39030603|FG007|Treatment Period|Death|0|||
16148415|NCT03016325|39030596|FG000|Treatment Period|Participant refuses assessments|0|||
16148416|NCT03016325|39030597|FG001|Treatment Period|Participant refuses assessments|0|||
16148417|NCT03016325|39030598|FG002|Treatment Period|Participant refuses assessments|1|||
16148418|NCT03016325|39030599|FG003|Treatment Period|Participant refuses assessments|0|||
16148419|NCT03016325|39030600|FG004|Treatment Period|Participant refuses assessments|0|||
16148420|NCT03016325|39030601|FG005|Treatment Period|Participant refuses assessments|0|||
16148421|NCT03016325|39030602|FG006|Treatment Period|Participant refuses assessments|0|||
16148422|NCT03016325|39030603|FG007|Treatment Period|Participant refuses assessments|0|||
16148423|NCT03016325|39030596|FG000|32-Day Follow-Up Period|Death|2|||
16148424|NCT03016325|39030597|FG001|32-Day Follow-Up Period|Death|0|||
16148425|NCT03016325|39030598|FG002|32-Day Follow-Up Period|Death|5|||
16148426|NCT03016325|39030599|FG003|32-Day Follow-Up Period|Death|6|||
16148427|NCT03016325|39030600|FG004|32-Day Follow-Up Period|Death|3|||
16148428|NCT03016325|39030601|FG005|32-Day Follow-Up Period|Death|0|||
16148429|NCT03016325|39030602|FG006|32-Day Follow-Up Period|Death|0|||
16148430|NCT03016325|39030603|FG007|32-Day Follow-Up Period|Death|0|||
16148431|NCT03016325|39030596|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
16148432|NCT03016325|39030597|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
16148433|NCT03016325|39030598|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
16148434|NCT03016325|39030599|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
16148435|NCT03016325|39030600|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
16259679|NCT02231749|39436132|FG000|Overall Study|AE unrelated to Study drug|32|||
16365071|NCT02293499|39821508|FG002|Intervention - Camp|these are those not showing up at camp|4|||
16148436|NCT03016325|39030601|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
16148437|NCT03016325|39030602|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
16148438|NCT03016325|39030603|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
16148439|NCT03016325|39030596|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
16148440|NCT03016325|39030597|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
16148441|NCT03016325|39030598|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
16148442|NCT03016325|39030599|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
16148443|NCT03016325|39030600|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
16148444|NCT03016325|39030601|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
16148445|NCT03016325|39030602|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
16148446|NCT03016325|39030603|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
16365072|NCT02293499|39821506|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
16148447|NCT03016325|39030596|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
16148448|NCT03016325|39030597|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
16148449|NCT03016325|39030598|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
16148450|NCT03016325|39030599|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
16148451|NCT03016325|39030600|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
16148452|NCT03016325|39030601|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
16148453|NCT03016325|39030602|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
16148454|NCT03016325|39030603|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
16148455|NCT03016325|39030596|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
16148456|NCT03016325|39030597|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
16148457|NCT03016325|39030598|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
16148458|NCT03016325|39030599|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
16148459|NCT03016325|39030600|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
16148460|NCT03016325|39030601|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
16148461|NCT03016325|39030602|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
16148462|NCT03016325|39030603|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
16148463|NCT03016325|39030596|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
16148464|NCT03016325|39030597|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
16148465|NCT03016325|39030598|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
16148466|NCT03016325|39030599|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
16148467|NCT03016325|39030600|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
16148468|NCT03016325|39030601|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
16148469|NCT03016325|39030602|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
16148470|NCT03016325|39030603|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
16148471|NCT03016325|39030596|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
16148472|NCT03016325|39030597|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
16148473|NCT03016325|39030598|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
16148474|NCT03016325|39030599|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
16148475|NCT03016325|39030600|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
16148476|NCT03016325|39030601|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
16148477|NCT03016325|39030602|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
16148478|NCT03016325|39030603|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
16148479|NCT03016325|39030596|FG000|182-Day Follow-Up Period|Death|3|||
16148480|NCT03016325|39030597|FG001|182-Day Follow-Up Period|Death|3|||
16148481|NCT03016325|39030598|FG002|182-Day Follow-Up Period|Death|11|||
16148482|NCT03016325|39030599|FG003|182-Day Follow-Up Period|Death|12|||
16148483|NCT03016325|39030600|FG004|182-Day Follow-Up Period|Death|9|||
16148484|NCT03016325|39030601|FG005|182-Day Follow-Up Period|Death|0|||
16148485|NCT03016325|39030602|FG006|182-Day Follow-Up Period|Death|0|||
16148486|NCT03016325|39030603|FG007|182-Day Follow-Up Period|Death|1|||
16148487|NCT03016325|39030596|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
16148488|NCT03016325|39030597|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
16148489|NCT03016325|39030598|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
16148490|NCT03016325|39030599|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
16148491|NCT03016325|39030600|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
16148492|NCT03016325|39030601|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
16148493|NCT03016325|39030602|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
16148494|NCT03016325|39030603|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
16148495|NCT03016325|39030596|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
16148496|NCT03016325|39030597|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
16148497|NCT03016325|39030598|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
16148498|NCT03016325|39030599|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
16148499|NCT03016325|39030600|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
16259680|NCT02231749|39436133|FG001|Overall Study|AE unrelated to Study drug|31|||
16259681|NCT02231749|39436132|FG000|Overall Study|Participant's request to discontinue|10|||
16148500|NCT03016325|39030601|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
16148501|NCT03016325|39030602|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
16148502|NCT03016325|39030603|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
16148503|NCT03016325|39030596|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
16148504|NCT03016325|39030597|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
16148505|NCT03016325|39030598|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
16148506|NCT03016325|39030599|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
16365073|NCT02293499|39821507|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
16365074|NCT02293499|39821508|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
16148507|NCT03016325|39030600|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
16148508|NCT03016325|39030601|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
16148509|NCT03016325|39030602|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
16148510|NCT03016325|39030603|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
16148511|NCT03016325|39030596|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
16148512|NCT03016325|39030597|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
16148513|NCT03016325|39030598|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
16148514|NCT03016325|39030599|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
16148515|NCT03016325|39030600|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
16148516|NCT03016325|39030601|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
16148517|NCT03016325|39030602|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
16148518|NCT03016325|39030603|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
16365075|NCT02293499|39821506|FG000|3 Month Follow Up|Lost to Follow-up|14|||
16365076|NCT02293499|39821507|FG001|3 Month Follow Up|Lost to Follow-up|15|||
16365077|NCT02293499|39821508|FG002|3 Month Follow Up|Lost to Follow-up|6|||
16365078|NCT02293499|39821506|FG000|6 Month Follow Up|Lost to Follow-up|17|||
16365079|NCT02293499|39821507|FG001|6 Month Follow Up|Lost to Follow-up|27|||
16365080|NCT02293499|39821508|FG002|6 Month Follow Up|Lost to Follow-up|6|||
16365081|NCT02293499|39821506|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
16365082|NCT02293499|39821507|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
16440972|NCT03115359|40095640|FG000|Overall Study|Transportation barriers|3|||
16440973|NCT03115359|40095641|FG001|Overall Study|Transportation barriers|0|||
16440974|NCT03115359|40095640|FG000|Overall Study|No longer interested|5|||
16440975|NCT03115359|40095641|FG001|Overall Study|No longer interested|4|||
16440976|NCT03115359|40095640|FG000|Overall Study|No reason provided|45|||
16440977|NCT03115359|40095641|FG001|Overall Study|No reason provided|47|||
16440978|NCT01358877|40095642|FG000|Overall Study|Death|80|||
16440979|NCT01358877|40095643|FG001|Overall Study|Death|89|||
16440980|NCT01358877|40095642|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
16148519|NCT03016325|39030596|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
16365083|NCT02293499|39821508|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
16365084|NCT02293499|39821506|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
16440981|NCT01358877|40095643|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
16440982|NCT01358877|40095642|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
16440983|NCT01358877|40095643|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
16440984|NCT01358877|40095642|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
16440985|NCT01358877|40095643|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
16440986|NCT01358877|40095642|FG000|Overall Study|Other|142|||
16440987|NCT01358877|40095643|FG001|Overall Study|Other|129|||
16440988|NCT03656562|40095644|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
16440989|NCT03656562|40095645|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
16440990|NCT03656562|40095646|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
16440991|NCT03656562|40095647|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
16440992|NCT03656562|40095644|FG000|Overall Study|Physician Decision|1|||
16440993|NCT03656562|40095645|FG001|Overall Study|Physician Decision|2|||
16440994|NCT03656562|40095646|FG002|Overall Study|Physician Decision|0|||
16440995|NCT03656562|40095647|FG003|Overall Study|Physician Decision|0|||
16440996|NCT03656562|40095644|FG000|Overall Study|Subject Decision|3|||
16440997|NCT03656562|40095645|FG001|Overall Study|Subject Decision|5|||
16259682|NCT02231749|39436133|FG001|Overall Study|Participant's request to discontinue|21|||
16259683|NCT02231749|39436132|FG000|Overall Study|Participant withdrew Consent|8|||
16259684|NCT02231749|39436133|FG001|Overall Study|Participant withdrew Consent|15|||
16259685|NCT02231749|39436132|FG000|Overall Study|Lost to Follow-up|1|||
16259686|NCT02231749|39436133|FG001|Overall Study|Lost to Follow-up|2|||
16259687|NCT02231749|39436132|FG000|Overall Study|Maximum Clinical Benefit|5|||
16259688|NCT02231749|39436133|FG001|Overall Study|Maximum Clinical Benefit|8|||
16259689|NCT02231749|39436132|FG000|Overall Study|Poor/Non-Compliance|0|||
16259690|NCT02231749|39436133|FG001|Overall Study|Poor/Non-Compliance|3|||
16259691|NCT02231749|39436132|FG000|Overall Study|Pregnancy|1|||
16259692|NCT02231749|39436133|FG001|Overall Study|Pregnancy|0|||
16259693|NCT02231749|39436132|FG000|Overall Study|other|0|||
16259694|NCT02231749|39436133|FG001|Overall Study|other|8|||
16259695|NCT02231749|39436132|FG000|Overall Study|No longer meets Study Criteria|1|||
16259696|NCT02231749|39436133|FG001|Overall Study|No longer meets Study Criteria|0|||
16259697|NCT00119379|39436136|FG000|Overall Study|Adverse Event|4|||
16259698|NCT00119379|39436137|FG001|Overall Study|Adverse Event|1|||
16259699|NCT02194998|39436141|FG000|On-HCV Treatment|Did not pick up study medication|0|||
16259700|NCT02194998|39436142|FG001|On-HCV Treatment|Did not pick up study medication|1|||
16259701|NCT02194998|39436143|FG002|On-HCV Treatment|Did not pick up study medication|0|||
16259702|NCT02194998|39436144|FG003|On-HCV Treatment|Did not pick up study medication|0|||
16259703|NCT02194998|39436141|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
16259704|NCT02194998|39436142|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
16259705|NCT02194998|39436143|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
16259706|NCT02194998|39436144|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
16259707|NCT00075478|39436145|FG000|Overall Study|not eligible|1|||
16259708|NCT00075478|39436146|FG001|Overall Study|not eligible|0|||
16259709|NCT00075478|39436145|FG000|Overall Study|Physician Decision|0|||
16259710|NCT00075478|39436146|FG001|Overall Study|Physician Decision|1|||
16259711|NCT02942264|39436147|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
16259712|NCT02942264|39436148|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
16259713|NCT02942264|39436149|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
16259714|NCT02942264|39436150|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
16259715|NCT02942264|39436151|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
16259716|NCT02942264|39436152|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
16259717|NCT02942264|39436153|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
16259718|NCT02942264|39436154|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
16259719|NCT02942264|39436155|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
16259720|NCT02942264|39436147|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
16259721|NCT02942264|39436148|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
16259722|NCT02942264|39436149|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
16259723|NCT02942264|39436150|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
16259724|NCT02942264|39436151|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
16259725|NCT02942264|39436152|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
16259726|NCT02942264|39436153|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
16259727|NCT02942264|39436154|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
16259728|NCT02942264|39436155|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
16259729|NCT03730103|39436156|FG000|Overall Study|Did not meet inclusion criteria|0|||
16259730|NCT03730103|39436157|FG001|Overall Study|Did not meet inclusion criteria|5|||
16259731|NCT01387022|39436158|FG000|Overall Study|Death|1|||
16259732|NCT01387022|39436159|FG001|Overall Study|Death|1|||
16259733|NCT01387022|39436158|FG000|Overall Study|Lost to Follow-up|0|||
16259734|NCT01387022|39436159|FG001|Overall Study|Lost to Follow-up|3|||
16259735|NCT03351335|39436160|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
16259736|NCT03351335|39436161|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
16259737|NCT03351335|39436162|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
16259738|NCT00819741|39436163|FG000|Overall Study|Adverse Event|5|||
16259739|NCT00819741|39436164|FG001|Overall Study|Adverse Event|2|||
16259740|NCT00819741|39436163|FG000|Overall Study|Lack of Efficacy|0|||
16259741|NCT00819741|39436164|FG001|Overall Study|Lack of Efficacy|2|||
16259742|NCT00819741|39436163|FG000|Overall Study|Lost to Follow-up|3|||
16259743|NCT00819741|39436164|FG001|Overall Study|Lost to Follow-up|1|||
16259744|NCT00819741|39436163|FG000|Overall Study|Protocol Violation|3|||
16259745|NCT00819741|39436164|FG001|Overall Study|Protocol Violation|4|||
16259746|NCT00819741|39436163|FG000|Overall Study|Withdrawal by Subject|2|||
16259747|NCT00819741|39436164|FG001|Overall Study|Withdrawal by Subject|2|||
16259748|NCT00819741|39436163|FG000|Overall Study|Unclassified|6|||
16259749|NCT00819741|39436164|FG001|Overall Study|Unclassified|0|||
16259750|NCT00819741|39436163|FG000|Overall Study|Reasons unknown|3|||
16259751|NCT00819741|39436164|FG001|Overall Study|Reasons unknown|3|||
16259752|NCT00336479|39436168|FG000|Overall Study|Adverse Event|8|||
16259753|NCT00336479|39436169|FG001|Overall Study|Adverse Event|11|||
16259754|NCT00336479|39436170|FG002|Overall Study|Adverse Event|18|||
16259755|NCT00336479|39436171|FG003|Overall Study|Adverse Event|4|||
16259756|NCT00336479|39436168|FG000|Overall Study|Noncompliant|1|||
16259757|NCT00336479|39436169|FG001|Overall Study|Noncompliant|7|||
16259758|NCT00336479|39436170|FG002|Overall Study|Noncompliant|3|||
16259759|NCT00336479|39436171|FG003|Overall Study|Noncompliant|0|||
16259760|NCT00336479|39436168|FG000|Overall Study|Physician Decision|2|||
16259761|NCT00336479|39436169|FG001|Overall Study|Physician Decision|3|||
16259762|NCT00336479|39436170|FG002|Overall Study|Physician Decision|1|||
16259763|NCT00336479|39436171|FG003|Overall Study|Physician Decision|0|||
16259764|NCT00336479|39436168|FG000|Overall Study|Lost to Follow-up|3|||
16259765|NCT00336479|39436169|FG001|Overall Study|Lost to Follow-up|2|||
16259766|NCT00336479|39436170|FG002|Overall Study|Lost to Follow-up|0|||
16259767|NCT00336479|39436171|FG003|Overall Study|Lost to Follow-up|0|||
16259768|NCT00336479|39436168|FG000|Overall Study|Withdrawal by Subject|3|||
16259769|NCT00336479|39436169|FG001|Overall Study|Withdrawal by Subject|2|||
16259770|NCT00336479|39436170|FG002|Overall Study|Withdrawal by Subject|3|||
16259771|NCT00336479|39436171|FG003|Overall Study|Withdrawal by Subject|0|||
16259772|NCT00336479|39436168|FG000|Overall Study|Other|0|||
16259773|NCT00336479|39436169|FG001|Overall Study|Other|0|||
16259774|NCT00336479|39436170|FG002|Overall Study|Other|1|||
16259775|NCT00336479|39436171|FG003|Overall Study|Other|0|||
16259776|NCT00336479|39436168|FG000|Overall Study|Virologic Stopping Rule|20|||
16259777|NCT00336479|39436169|FG001|Overall Study|Virologic Stopping Rule|0|||
16259778|NCT00336479|39436170|FG002|Overall Study|Virologic Stopping Rule|0|||
16259779|NCT00336479|39436171|FG003|Overall Study|Virologic Stopping Rule|0|||
16259780|NCT02637232|39436172|FG000|Overall Study|Lost to Follow-up|42|||
16259781|NCT02637232|39436172|FG000|Overall Study|Adverse Event|11|||
16259782|NCT02637232|39436172|FG000|Overall Study|patient 's decision|2|||
16259783|NCT01675622|39436177|FG000|Overall Study|Withdrawal by Subject|2|||
16259784|NCT01675622|39436178|FG001|Overall Study|Withdrawal by Subject|2|||
16259785|NCT01675622|39436177|FG000|Overall Study|Adverse Event|12|||
16259786|NCT01675622|39436178|FG001|Overall Study|Adverse Event|10|||
16259787|NCT01675622|39436177|FG000|Overall Study|Protocol Violation|4|||
16259788|NCT01675622|39436178|FG001|Overall Study|Protocol Violation|1|||
16259789|NCT01675622|39436177|FG000|Overall Study|Lack of Efficacy|2|||
16259790|NCT01675622|39436178|FG001|Overall Study|Lack of Efficacy|4|||
16259791|NCT01675622|39436177|FG000|Overall Study|Lost to Follow-up|1|||
16259792|NCT01675622|39436178|FG001|Overall Study|Lost to Follow-up|3|||
16259793|NCT01675622|39436177|FG000|Overall Study|Other|5|||
16259794|NCT01675622|39436178|FG001|Overall Study|Other|4|||
16259795|NCT00385593|39436179|FG000|Overall Study|Adverse Event|3|||
16259796|NCT00385593|39436180|FG001|Overall Study|Adverse Event|2|||
16259797|NCT00385593|39436179|FG000|Overall Study|Withdrawal by Subject|17|||
16259798|NCT00385593|39436180|FG001|Overall Study|Withdrawal by Subject|7|||
16259799|NCT00385593|39436179|FG000|Overall Study|Lost to Follow-up|12|||
16259800|NCT00385593|39436180|FG001|Overall Study|Lost to Follow-up|8|||
16259801|NCT00385593|39436179|FG000|Overall Study|Protocol Violation|7|||
16259802|NCT00385593|39436180|FG001|Overall Study|Protocol Violation|4|||
16259803|NCT00385593|39436179|FG000|Overall Study|Several reasons|17|||
16259804|NCT00385593|39436180|FG001|Overall Study|Several reasons|15|||
16259805|NCT00385593|39436179|FG000|Overall Study|Incorrect inclusion|2|||
16259806|NCT00385593|39436180|FG001|Overall Study|Incorrect inclusion|0|||
16259807|NCT00385593|39436179|FG000|Overall Study|Incorrect randomization|0|||
16259808|NCT00385593|39436180|FG001|Overall Study|Incorrect randomization|1|||
16259809|NCT01001208|39436184|FG000|Overall Study|Adverse Event|10|||
16259810|NCT01001208|39436185|FG001|Overall Study|Adverse Event|5|||
16259811|NCT01001208|39436184|FG000|Overall Study|Lost to Follow-up|5|||
16259812|NCT01001208|39436185|FG001|Overall Study|Lost to Follow-up|9|||
16259813|NCT01001208|39436184|FG000|Overall Study|Physician Decision|1|||
16259814|NCT01001208|39436185|FG001|Overall Study|Physician Decision|0|||
16259815|NCT01001208|39436184|FG000|Overall Study|Withdrawal by Subject|4|||
16259816|NCT01001208|39436185|FG001|Overall Study|Withdrawal by Subject|5|||
16259817|NCT01001208|39436184|FG000|Overall Study|Ineligibility Determined|4|||
16259818|NCT01001208|39436185|FG001|Overall Study|Ineligibility Determined|2|||
16259819|NCT01001208|39436184|FG000|Overall Study|Noncompliance|4|||
16259820|NCT01001208|39436185|FG001|Overall Study|Noncompliance|7|||
16259821|NCT01001208|39436184|FG000|Overall Study|Disease Progression|0|||
16259822|NCT01001208|39436185|FG001|Overall Study|Disease Progression|3|||
16259823|NCT01001208|39436184|FG000|Overall Study|Other|0|||
16259824|NCT01001208|39436185|FG001|Overall Study|Other|2|||
16259825|NCT02581345|39436188|FG000|Part 1: up to Week 16|Adverse Event|3|||
16259826|NCT02581345|39436189|FG001|Part 1: up to Week 16|Adverse Event|8|||
16259827|NCT02581345|39436190|FG002|Part 1: up to Week 16|Adverse Event|0|||
16259828|NCT02581345|39436191|FG003|Part 1: up to Week 16|Adverse Event|0|||
16259829|NCT02581345|39436188|FG000|Part 1: up to Week 16|Physician Decision|2|||
16259830|NCT02581345|39436189|FG001|Part 1: up to Week 16|Physician Decision|4|||
16259831|NCT02581345|39436190|FG002|Part 1: up to Week 16|Physician Decision|0|||
16259832|NCT02581345|39436191|FG003|Part 1: up to Week 16|Physician Decision|0|||
16259833|NCT02581345|39436188|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
16259834|NCT02581345|39436189|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
16259835|NCT02581345|39436190|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
16259836|NCT02581345|39436191|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
16440998|NCT03656562|40095646|FG002|Overall Study|Subject Decision|0|||
16259837|NCT02581345|39436188|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
16259838|NCT02581345|39436189|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
16259839|NCT02581345|39436190|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
16259840|NCT02581345|39436191|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
16259841|NCT02581345|39436188|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
16259842|NCT02581345|39436189|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
16259843|NCT02581345|39436190|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
16440999|NCT03656562|40095647|FG003|Overall Study|Subject Decision|2|||
16441000|NCT01286272|40095648|FG000|Overall Study|Ineligible after beginning treatment|1|||
16441001|NCT01286272|40095649|FG001|Overall Study|Ineligible after beginning treatment|3|||
16441002|NCT02814916|40095650|FG000|Overall Study|Withdrawal of consent|0|||
16148520|NCT03016325|39030597|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
16148521|NCT03016325|39030598|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
16148522|NCT03016325|39030599|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
16148523|NCT03016325|39030600|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
16148524|NCT03016325|39030601|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
16148525|NCT03016325|39030602|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
16148526|NCT03016325|39030603|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
16148527|NCT03016325|39030596|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
16148528|NCT03016325|39030597|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
16148529|NCT03016325|39030598|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
16148530|NCT03016325|39030599|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
16148531|NCT03016325|39030600|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
16148532|NCT03016325|39030601|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
16148533|NCT03016325|39030602|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
16148534|NCT03016325|39030603|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
16148535|NCT03016325|39030596|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
16148536|NCT03016325|39030597|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
16148537|NCT03016325|39030598|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
16148538|NCT03016325|39030599|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
16148539|NCT03016325|39030600|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
16148540|NCT03016325|39030601|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
16148541|NCT03016325|39030602|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
16148542|NCT03016325|39030603|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
16148543|NCT01876251|39030607|FG000|Overall Study|Clinical progression|1|||
16148544|NCT01876251|39030608|FG001|Overall Study|Clinical progression|0|||
16148545|NCT01876251|39030609|FG002|Overall Study|Clinical progression|0|||
16148546|NCT01876251|39030607|FG000|Overall Study|Death|2|||
16148547|NCT01876251|39030608|FG001|Overall Study|Death|0|||
16148548|NCT01876251|39030609|FG002|Overall Study|Death|1|||
16148549|NCT01876251|39030607|FG000|Overall Study|Participant started new treatment|1|||
16148550|NCT01876251|39030608|FG001|Overall Study|Participant started new treatment|0|||
16148551|NCT01876251|39030609|FG002|Overall Study|Participant started new treatment|1|||
16148552|NCT01876251|39030607|FG000|Overall Study|Participant refused further follow-up|0|||
16148553|NCT01876251|39030608|FG001|Overall Study|Participant refused further follow-up|0|||
16148554|NCT01876251|39030609|FG002|Overall Study|Participant refused further follow-up|1|||
16148555|NCT01876251|39030607|FG000|Overall Study|Study terminated|1|||
16148556|NCT01876251|39030608|FG001|Overall Study|Study terminated|0|||
16148557|NCT01876251|39030609|FG002|Overall Study|Study terminated|0|||
16148558|NCT01876251|39030607|FG000|Overall Study|Objective progression or relapse|10|||
16148559|NCT01876251|39030608|FG001|Overall Study|Objective progression or relapse|3|||
16148560|NCT01876251|39030609|FG002|Overall Study|Objective progression or relapse|8|||
16148561|NCT04202679|39030610|FG000|Overall Study|Adverse Event|2|||
16148562|NCT04202679|39030611|FG001|Overall Study|Adverse Event|0|||
16148563|NCT04202679|39030610|FG000|Overall Study|Poor compliance to protocol|1|||
16148564|NCT04202679|39030611|FG001|Overall Study|Poor compliance to protocol|0|||
16148565|NCT04202679|39030610|FG000|Overall Study|Withdrawal by Subject|23|||
16148566|NCT04202679|39030611|FG001|Overall Study|Withdrawal by Subject|6|||
16148567|NCT02039375|39030612|FG000|Overall Study|Lost to Follow-up|2|||
16148568|NCT00800436|39030619|FG000|Overall Study|Withdrawal by Subject|0|||
16148569|NCT00800436|39030620|FG001|Overall Study|Withdrawal by Subject|0|||
16148570|NCT00800436|39030621|FG002|Overall Study|Withdrawal by Subject|1|||
16148571|NCT00800436|39030622|FG003|Overall Study|Withdrawal by Subject|1|||
16148572|NCT00800436|39030623|FG004|Overall Study|Withdrawal by Subject|0|||
16148573|NCT00800436|39030624|FG005|Overall Study|Withdrawal by Subject|0|||
16148574|NCT00800436|39030625|FG006|Overall Study|Withdrawal by Subject|0|||
16148575|NCT00054704|39030627|FG000|Overall Study|Lack of Efficacy|2|||
16148576|NCT00054704|39030628|FG001|Overall Study|Lack of Efficacy|3|||
16148577|NCT00054704|39030627|FG000|Overall Study|Adverse Event|3|||
16148578|NCT00054704|39030628|FG001|Overall Study|Adverse Event|1|||
16148579|NCT00054704|39030627|FG000|Overall Study|Lost to Follow-up|0|||
16148580|NCT00054704|39030628|FG001|Overall Study|Lost to Follow-up|1|||
16148581|NCT04425720|39030630|FG000|Overall Study|Withdrawal by Subject|0|||
16148582|NCT04425720|39030631|FG001|Overall Study|Withdrawal by Subject|20|||
16148583|NCT01003210|39030632|FG000|Overall Study|Lost to Follow-up|1|||
16148584|NCT01003210|39030633|FG001|Overall Study|Lost to Follow-up|3|||
16148585|NCT00736255|39030636|FG000|Overall Study|Adverse Event|1|||
16148586|NCT00736255|39030637|FG001|Overall Study|Adverse Event|0|||
16441003|NCT02814916|40095651|FG001|Overall Study|Withdrawal of consent|2|||
16441004|NCT02814916|40095652|FG002|Overall Study|Withdrawal of consent|0|||
16441005|NCT02814916|40095650|FG000|Overall Study|Lost to Follow-up|0|||
16441006|NCT02814916|40095651|FG001|Overall Study|Lost to Follow-up|1|||
16441007|NCT02814916|40095652|FG002|Overall Study|Lost to Follow-up|0|||
16441008|NCT02814916|40095650|FG000|Overall Study|Other, not specified|0|||
16441009|NCT02814916|40095651|FG001|Overall Study|Other, not specified|1|||
16441010|NCT02814916|40095652|FG002|Overall Study|Other, not specified|0|||
16441011|NCT05316597|40095653|FG000|First Session|Withdrawal by Subject|0|||
16441012|NCT05316597|40095654|FG001|First Session|Withdrawal by Subject|1|||
16441013|NCT05316597|40095653|FG000|Washout Period|Lost to Follow-up|1|||
16441014|NCT05316597|40095654|FG001|Washout Period|Lost to Follow-up|2|||
16441015|NCT05316597|40095653|FG000|Washout Period|Physician Decision|1|||
16441016|NCT05316597|40095654|FG001|Washout Period|Physician Decision|1|||
16441017|NCT05316597|40095653|FG000|Washout Period|Excluded before second session|1|||
16441018|NCT05316597|40095654|FG001|Washout Period|Excluded before second session|1|||
16441019|NCT05316597|40095653|FG000|Washout Period|Withdrawal by Subject|0|||
16441020|NCT05316597|40095654|FG001|Washout Period|Withdrawal by Subject|4|||
16441021|NCT05526716|40095655|FG000|Overall Study|Death|1|||
16441022|NCT05526716|40095656|FG001|Overall Study|Death|2|||
16441023|NCT05526716|40095655|FG000|Overall Study|Lost to Follow-up|17|||
16441024|NCT05526716|40095656|FG001|Overall Study|Lost to Follow-up|15|||
16441025|NCT05526716|40095655|FG000|Overall Study|Physician Decision|0|||
16441026|NCT05526716|40095656|FG001|Overall Study|Physician Decision|1|||
16441027|NCT05526716|40095655|FG000|Overall Study|Randomized by mistake without study treatment|0|||
16441028|NCT05526716|40095656|FG001|Overall Study|Randomized by mistake without study treatment|1|||
16441029|NCT05526716|40095655|FG000|Overall Study|Withdrawal by Subject|12|||
16441030|NCT05526716|40095656|FG001|Overall Study|Withdrawal by Subject|12|||
16441031|NCT05526716|40095655|FG000|Overall Study|Not reported|0|||
16441032|NCT05526716|40095656|FG001|Overall Study|Not reported|2|||
16441033|NCT04890652|40095664|FG000|Overall Study|Withdrawal by Subject|2|||
16441034|NCT03760029|40095672|FG000|Overall Study|Death|1|||
16441035|NCT03760029|40095673|FG001|Overall Study|Death|0|||
16441036|NCT03760029|40095674|FG002|Overall Study|Death|0|||
16441037|NCT03760029|40095672|FG000|Overall Study|Lost to Follow-up|0|||
16441038|NCT03760029|40095673|FG001|Overall Study|Lost to Follow-up|2|||
16441039|NCT03760029|40095674|FG002|Overall Study|Lost to Follow-up|1|||
16441040|NCT03760029|40095672|FG000|Overall Study|Withdrawal by Subject|1|||
16441041|NCT03760029|40095673|FG001|Overall Study|Withdrawal by Subject|4|||
16441042|NCT03760029|40095674|FG002|Overall Study|Withdrawal by Subject|1|||
16441043|NCT03760029|40095672|FG000|Overall Study|Withdrawal by parent/guardian|4|||
16441044|NCT03760029|40095673|FG001|Overall Study|Withdrawal by parent/guardian|4|||
16441045|NCT03760029|40095674|FG002|Overall Study|Withdrawal by parent/guardian|1|||
16441046|NCT03760029|40095672|FG000|Overall Study|Other|2|||
16441047|NCT03760029|40095673|FG001|Overall Study|Other|1|||
16441048|NCT03760029|40095674|FG002|Overall Study|Other|0|||
16441049|NCT05543265|40095675|FG000|Overall Study|Lost to Follow-up|3|||
16441050|NCT05543265|40095676|FG001|Overall Study|Lost to Follow-up|3|||
16441051|NCT05543265|40095675|FG000|Overall Study|Withdrawal by Subject|0|||
16441052|NCT05543265|40095676|FG001|Overall Study|Withdrawal by Subject|1|||
16441053|NCT00937937|40095677|FG000|Overall Study|Adverse Event|6|||
16441054|NCT00937937|40095677|FG000|Overall Study|Withdrawal by Subject|2|||
16441055|NCT00937937|40095677|FG000|Overall Study|Progression/relapse|61|||
16441056|NCT00937937|40095677|FG000|Overall Study|Death|1|||
16441057|NCT00937937|40095677|FG000|Overall Study|Other|2|||
16441058|NCT03655132|40095678|FG000|Overall Study|Lost to Follow-up|2|||
16441059|NCT03655132|40095679|FG001|Overall Study|Lost to Follow-up|1|||
16441060|NCT03655132|40095678|FG000|Overall Study|Withdrawal by Subject|0|||
16441061|NCT03655132|40095679|FG001|Overall Study|Withdrawal by Subject|1|||
16441062|NCT03655132|40095678|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
16441063|NCT03655132|40095679|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
16441064|NCT05291520|40095681|FG000|Overall Study|Lost to Follow-up|0|||
16441065|NCT05291520|40095682|FG001|Overall Study|Lost to Follow-up|0|||
16441066|NCT05291520|40095683|FG002|Overall Study|Lost to Follow-up|1|||
16441067|NCT01231984|40095686|FG000|Study Period 1|Withdrawal by Subject|0|||
16441068|NCT01231984|40095687|FG001|Study Period 1|Withdrawal by Subject|0|||
16441069|NCT01231984|40095688|FG002|Study Period 1|Withdrawal by Subject|0|||
16441070|NCT01231984|40095689|FG003|Study Period 1|Withdrawal by Subject|1|||
16441071|NCT01231984|40095686|FG000|Study Period 1|Lost to Follow-up|1|||
16441072|NCT01231984|40095687|FG001|Study Period 1|Lost to Follow-up|1|||
16441073|NCT01231984|40095688|FG002|Study Period 1|Lost to Follow-up|1|||
16441074|NCT01231984|40095689|FG003|Study Period 1|Lost to Follow-up|0|||
16441075|NCT01231984|40095686|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
16441076|NCT01231984|40095687|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
16441077|NCT01231984|40095688|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
16441078|NCT01231984|40095689|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
16441079|NCT01231984|40095686|FG000|Study Period 1|Screen Failure|0|||
16441080|NCT01231984|40095687|FG001|Study Period 1|Screen Failure|0|||
16441081|NCT01231984|40095688|FG002|Study Period 1|Screen Failure|0|||
16441082|NCT01231984|40095689|FG003|Study Period 1|Screen Failure|1|||
16441083|NCT01231984|40095686|FG000|Study Period 1|Non-compliance with study requirements|5|||
16441084|NCT01231984|40095687|FG001|Study Period 1|Non-compliance with study requirements|0|||
16441085|NCT01231984|40095688|FG002|Study Period 1|Non-compliance with study requirements|2|||
16441086|NCT01231984|40095689|FG003|Study Period 1|Non-compliance with study requirements|1|||
16441087|NCT01231984|40095686|FG000|Study Period 1|Protocol Violation|3|||
16441088|NCT01231984|40095687|FG001|Study Period 1|Protocol Violation|4|||
16441089|NCT01231984|40095688|FG002|Study Period 1|Protocol Violation|2|||
16259844|NCT02581345|39436191|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
16259845|NCT02581345|39436188|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
16259846|NCT02581345|39436189|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
16259847|NCT02581345|39436190|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
16259848|NCT02581345|39436191|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
16259849|NCT02581345|39436188|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
16259850|NCT02581345|39436189|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
16259851|NCT02581345|39436190|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
16259852|NCT02581345|39436191|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
16259853|NCT02581345|39436188|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
16259854|NCT02581345|39436189|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
16259855|NCT02581345|39436190|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
16259856|NCT02581345|39436191|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
16259857|NCT02581345|39436188|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
16259858|NCT02581345|39436189|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
16441090|NCT01231984|40095689|FG003|Study Period 1|Protocol Violation|3|||
16441091|NCT01231984|40095686|FG000|Study Period 1|Adverse Event|1|||
16441092|NCT01231984|40095687|FG001|Study Period 1|Adverse Event|0|||
16441093|NCT01231984|40095688|FG002|Study Period 1|Adverse Event|0|||
16441094|NCT01231984|40095689|FG003|Study Period 1|Adverse Event|0|||
16441095|NCT01231984|40095686|FG000|Study Period 1|Other|0|||
16441096|NCT01231984|40095687|FG001|Study Period 1|Other|0|||
16441097|NCT01231984|40095688|FG002|Study Period 1|Other|0|||
16441098|NCT01231984|40095689|FG003|Study Period 1|Other|1|||
16441099|NCT01231984|40095686|FG000|Study Period 2|Withdrawal by Subject|1|||
16441100|NCT01231984|40095687|FG001|Study Period 2|Withdrawal by Subject|1|||
16441101|NCT01231984|40095688|FG002|Study Period 2|Withdrawal by Subject|0|||
16441102|NCT01231984|40095689|FG003|Study Period 2|Withdrawal by Subject|0|||
16441103|NCT01231984|40095686|FG000|Study Period 2|Lost to Follow-up|1|||
16441104|NCT01231984|40095687|FG001|Study Period 2|Lost to Follow-up|0|||
16441105|NCT01231984|40095688|FG002|Study Period 2|Lost to Follow-up|0|||
16441106|NCT01231984|40095689|FG003|Study Period 2|Lost to Follow-up|3|||
16441107|NCT01231984|40095686|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
16441108|NCT01231984|40095687|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
16441109|NCT01231984|40095688|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
16441110|NCT01231984|40095689|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
16441111|NCT03453164|40095690|FG000|Overall Study|Lack of Efficacy|16|||
16441112|NCT03453164|40095690|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
16441113|NCT04235140|40095693|FG000|Overall Study|Adverse Event|2|||
16441114|NCT04235140|40095693|FG000|Overall Study|Lost to Follow-up|1|||
16441115|NCT04235140|40095693|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
16441116|NCT04235140|40095693|FG000|Overall Study|Commercial drug is available for participants|7|||
16441117|NCT03379675|40095694|FG000|Overall Study|Lost to Follow-up|0|||
16441118|NCT03379675|40095695|FG001|Overall Study|Lost to Follow-up|1|||
16441119|NCT03379675|40095696|FG002|Overall Study|Lost to Follow-up|0|||
16441120|NCT03379675|40095694|FG000|Overall Study|Adverse Event|2|||
16441121|NCT03379675|40095695|FG001|Overall Study|Adverse Event|0|||
16441122|NCT03379675|40095696|FG002|Overall Study|Adverse Event|0|||
16441123|NCT03379675|40095694|FG000|Overall Study|Withdrawal by Subject|2|||
16148587|NCT00736255|39030636|FG000|Overall Study|Physician Decision|1|||
16148588|NCT00736255|39030637|FG001|Overall Study|Physician Decision|0|||
16259859|NCT02581345|39436190|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
16259860|NCT02581345|39436191|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
16259861|NCT02581345|39436188|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
16148589|NCT00736255|39030636|FG000|Overall Study|Non-compliance|1|||
16441124|NCT03379675|40095695|FG001|Overall Study|Withdrawal by Subject|1|||
16441125|NCT03379675|40095696|FG002|Overall Study|Withdrawal by Subject|2|||
16441126|NCT02927301|40095697|FG000|Overall Study|Death|39|||
16441127|NCT02927301|40095697|FG000|Overall Study|Lost to Follow-up|8|||
16441128|NCT02927301|40095697|FG000|Overall Study|Physician Decision|2|||
16441129|NCT02927301|40095697|FG000|Overall Study|Withdrawal by Subject|12|||
16441130|NCT02927301|40095697|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
16148590|NCT00736255|39030637|FG001|Overall Study|Non-compliance|1|||
16259862|NCT02581345|39436189|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
16259863|NCT02581345|39436190|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
16259864|NCT02581345|39436191|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
16259865|NCT02581345|39436188|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
16259866|NCT02581345|39436189|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
16259867|NCT02581345|39436190|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
16259868|NCT02581345|39436191|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
16259869|NCT02581345|39436188|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
16259870|NCT02581345|39436189|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
16259871|NCT02581345|39436190|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
16259872|NCT02581345|39436191|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
16259873|NCT02468778|39436193|FG000|Overall Study|Death|2|||
16259874|NCT02468778|39436194|FG001|Overall Study|Death|1|||
16259875|NCT02468778|39436195|FG002|Overall Study|Death|0|||
16259876|NCT02468778|39436193|FG000|Overall Study|Lost to Follow-up|1|||
16259877|NCT02468778|39436194|FG001|Overall Study|Lost to Follow-up|2|||
16259878|NCT02468778|39436195|FG002|Overall Study|Lost to Follow-up|2|||
16259879|NCT02468778|39436193|FG000|Overall Study|Withdrawal by Subject|0|||
16259880|NCT02468778|39436194|FG001|Overall Study|Withdrawal by Subject|1|||
16259881|NCT02468778|39436195|FG002|Overall Study|Withdrawal by Subject|1|||
16259882|NCT05419908|39436196|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
16259883|NCT05419908|39436197|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
16259884|NCT05419908|39436196|FG000|Overall Study|Serious Adverse Event|0|||
16259885|NCT05419908|39436197|FG001|Overall Study|Serious Adverse Event|2|||
16259886|NCT05419908|39436196|FG000|Overall Study|Withdrawal by Subject|2|||
16441131|NCT04388111|40095698|FG000|Overall Study|Lost to Follow-up|5|||
16441132|NCT04388111|40095699|FG001|Overall Study|Lost to Follow-up|3|||
16441133|NCT04388111|40095698|FG000|Overall Study|Adverse Event|1|||
16441134|NCT04388111|40095699|FG001|Overall Study|Adverse Event|1|||
16441135|NCT04388111|40095698|FG000|Overall Study|Protocol Violation|2|||
16441136|NCT04388111|40095699|FG001|Overall Study|Protocol Violation|4|||
16441137|NCT04388111|40095698|FG000|Overall Study|Withdrawal by Subject|1|||
16441138|NCT04388111|40095699|FG001|Overall Study|Withdrawal by Subject|0|||
16441139|NCT05176314|40095700|FG000|Overall Study|Lost to Follow-up|2|||
16441140|NCT05176314|40095700|FG000|Overall Study|Physician Decision|1|||
16441141|NCT05176314|40095700|FG000|Overall Study|Adverse Event|1|||
16441142|NCT03985761|40095701|FG000|Overall Study|Withdrawal by Subject|2|||
16441143|NCT03985761|40095702|FG001|Overall Study|Withdrawal by Subject|3|||
16441144|NCT04065048|40095703|FG000|Overall Study|Withdrawal by Subject|1|||
16441145|NCT04065048|40095704|FG001|Overall Study|Withdrawal by Subject|2|||
16441146|NCT04065048|40095705|FG002|Overall Study|Withdrawal by Subject|1|||
16441147|NCT04065048|40095706|FG003|Overall Study|Withdrawal by Subject|1|||
16441148|NCT04065048|40095703|FG000|Overall Study|Adverse Event|1|||
16441149|NCT04065048|40095704|FG001|Overall Study|Adverse Event|0|||
16441150|NCT04065048|40095705|FG002|Overall Study|Adverse Event|1|||
16441151|NCT04065048|40095706|FG003|Overall Study|Adverse Event|0|||
16441152|NCT05228470|40095707|FG000|Overall Study|Death|6|||
16441153|NCT05228470|40095708|FG001|Overall Study|Death|11|||
16441154|NCT05228470|40095707|FG000|Overall Study|Withdrawal by Subject|1|||
16441155|NCT05228470|40095708|FG001|Overall Study|Withdrawal by Subject|8|||
16441156|NCT05228470|40095707|FG000|Overall Study|Ongoing|1|||
16441157|NCT05228470|40095708|FG001|Overall Study|Ongoing|11|||
16441158|NCT03459079|40095709|FG000|Overall Study|Adverse Event|4|||
16441159|NCT03459079|40095710|FG001|Overall Study|Adverse Event|2|||
16441160|NCT03459079|40095711|FG002|Overall Study|Adverse Event|0|||
16441161|NCT03459079|40095709|FG000|Overall Study|Withdrawal by Subject|2|||
16441162|NCT03459079|40095710|FG001|Overall Study|Withdrawal by Subject|2|||
16441163|NCT03459079|40095711|FG002|Overall Study|Withdrawal by Subject|0|||
16441164|NCT03391466|40095715|FG000|Overall Study|Death|82|||
16441165|NCT03391466|40095716|FG001|Overall Study|Death|85|||
16441166|NCT03391466|40095715|FG000|Overall Study|Still on study|93|||
16441167|NCT03391466|40095716|FG001|Overall Study|Still on study|74|||
16441168|NCT03391466|40095715|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
16441169|NCT03391466|40095716|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
16441170|NCT03391466|40095715|FG000|Overall Study|Lost to Follow-up|5|||
16441171|NCT03391466|40095716|FG001|Overall Study|Lost to Follow-up|5|||
16441172|NCT03391466|40095715|FG000|Overall Study|Investigator decision|0|||
16441173|NCT03391466|40095716|FG001|Overall Study|Investigator decision|1|||
16441174|NCT03391466|40095715|FG000|Overall Study|Other|0|||
16441175|NCT03391466|40095716|FG001|Overall Study|Other|1|||
16441176|NCT04750824|40095717|FG000|Overall Study|Toxicity/intolerability|3|||
16441177|NCT04750824|40095718|FG001|Overall Study|Toxicity/intolerability|1|||
16441178|NCT04750824|40095717|FG000|Overall Study|Death|1|||
16441179|NCT04750824|40095718|FG001|Overall Study|Death|3|||
16441180|NCT04750824|40095717|FG000|Overall Study|Scheduled duration of therapy complete|1|||
16441181|NCT04750824|40095718|FG001|Overall Study|Scheduled duration of therapy complete|9|||
16441182|NCT04750824|40095717|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
16441183|NCT04750824|40095718|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
16441184|NCT02723773|40095725|FG000|Overall Study|Adverse Event|934|||
16441185|NCT02723773|40095726|FG001|Overall Study|Adverse Event|3|||
16441186|NCT02723773|40095727|FG002|Overall Study|Adverse Event|1|||
16441187|NCT02723773|40095728|FG003|Overall Study|Adverse Event|9|||
16441188|NCT02723773|40095725|FG000|Overall Study|Protocol Violation|1|||
16441189|NCT02723773|40095726|FG001|Overall Study|Protocol Violation|0|||
16441190|NCT02723773|40095727|FG002|Overall Study|Protocol Violation|0|||
16441191|NCT02723773|40095728|FG003|Overall Study|Protocol Violation|0|||
16441192|NCT02723773|40095725|FG000|Overall Study|Withdrawal by Subject|360|||
16441193|NCT02723773|40095726|FG001|Overall Study|Withdrawal by Subject|5|||
16441194|NCT02723773|40095727|FG002|Overall Study|Withdrawal by Subject|6|||
16441195|NCT02723773|40095728|FG003|Overall Study|Withdrawal by Subject|10|||
16441196|NCT02723773|40095725|FG000|Overall Study|Migrated/moved from study area|37|||
16441197|NCT02723773|40095726|FG001|Overall Study|Migrated/moved from study area|0|||
16441198|NCT02723773|40095727|FG002|Overall Study|Migrated/moved from study area|0|||
16441199|NCT02723773|40095728|FG003|Overall Study|Migrated/moved from study area|1|||
16441200|NCT02723773|40095725|FG000|Overall Study|Lost to Follow-up|198|||
16441201|NCT02723773|40095726|FG001|Overall Study|Lost to Follow-up|0|||
16441202|NCT02723773|40095727|FG002|Overall Study|Lost to Follow-up|0|||
16441203|NCT02723773|40095728|FG003|Overall Study|Lost to Follow-up|0|||
16441204|NCT02723773|40095725|FG000|Overall Study|Other|189|||
16441205|NCT02723773|40095726|FG001|Overall Study|Other|1|||
16148591|NCT03593850|39030638|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
16148592|NCT03593850|39030639|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
16148593|NCT00312221|39030641|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
16148594|NCT00312221|39030642|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
16148595|NCT00312221|39030643|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
16148596|NCT00312221|39030644|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
16148597|NCT00312221|39030641|FG000|Open-label Run-in Period|Adverse Event|74|||
16148598|NCT00312221|39030642|FG001|Open-label Run-in Period|Adverse Event|0|||
16148599|NCT00312221|39030643|FG002|Open-label Run-in Period|Adverse Event|0|||
16148600|NCT00312221|39030644|FG003|Open-label Run-in Period|Adverse Event|0|||
16148601|NCT00312221|39030641|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
16148602|NCT00312221|39030642|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
16148603|NCT00312221|39030643|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
16148604|NCT00312221|39030644|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
16148605|NCT00312221|39030641|FG000|Open-label Run-in Period|Administrative|42|||
16148606|NCT00312221|39030642|FG001|Open-label Run-in Period|Administrative|0|||
16148607|NCT00312221|39030643|FG002|Open-label Run-in Period|Administrative|0|||
16148608|NCT00312221|39030644|FG003|Open-label Run-in Period|Administrative|0|||
16148609|NCT00312221|39030641|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
16148610|NCT00312221|39030642|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
16148611|NCT00312221|39030643|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
16148612|NCT00312221|39030644|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
16148613|NCT00312221|39030641|FG000|Open-label Run-in Period|Did not qualify|5|||
16148614|NCT00312221|39030642|FG001|Open-label Run-in Period|Did not qualify|0|||
16148615|NCT00312221|39030643|FG002|Open-label Run-in Period|Did not qualify|0|||
16148616|NCT00312221|39030644|FG003|Open-label Run-in Period|Did not qualify|0|||
16148617|NCT00312221|39030641|FG000|Double-blind Phase|Withdrawal by Subject|0|||
16148618|NCT00312221|39030642|FG001|Double-blind Phase|Withdrawal by Subject|6|||
16148619|NCT00312221|39030643|FG002|Double-blind Phase|Withdrawal by Subject|8|||
16148620|NCT00312221|39030644|FG003|Double-blind Phase|Withdrawal by Subject|7|||
16148621|NCT00312221|39030641|FG000|Double-blind Phase|Adverse Event|0|||
16148622|NCT00312221|39030642|FG001|Double-blind Phase|Adverse Event|10|||
16148623|NCT00312221|39030643|FG002|Double-blind Phase|Adverse Event|19|||
16148624|NCT00312221|39030644|FG003|Double-blind Phase|Adverse Event|18|||
16148625|NCT00312221|39030641|FG000|Double-blind Phase|Lost to Follow-up|0|||
16148626|NCT00312221|39030642|FG001|Double-blind Phase|Lost to Follow-up|0|||
16148627|NCT00312221|39030643|FG002|Double-blind Phase|Lost to Follow-up|2|||
16148628|NCT00312221|39030644|FG003|Double-blind Phase|Lost to Follow-up|2|||
16148629|NCT00312221|39030641|FG000|Double-blind Phase|Administrative|0|||
16148630|NCT00312221|39030642|FG001|Double-blind Phase|Administrative|26|||
16148631|NCT00312221|39030643|FG002|Double-blind Phase|Administrative|37|||
16148632|NCT00312221|39030644|FG003|Double-blind Phase|Administrative|33|||
16148633|NCT00312221|39030641|FG000|Double-blind Phase|Lack of Efficacy|0|||
16148634|NCT00312221|39030642|FG001|Double-blind Phase|Lack of Efficacy|17|||
16148635|NCT00312221|39030643|FG002|Double-blind Phase|Lack of Efficacy|6|||
16259887|NCT05419908|39436197|FG001|Overall Study|Withdrawal by Subject|0|||
16259888|NCT05419908|39436196|FG000|Overall Study|Miscellaneous|1|||
16259889|NCT05419908|39436197|FG001|Overall Study|Miscellaneous|1|||
16259890|NCT04006171|39436198|FG000|Overall Study|Withdrawal by Subject|8|||
16259891|NCT04006171|39436199|FG001|Overall Study|Withdrawal by Subject|7|||
16259892|NCT04006171|39436198|FG000|Overall Study|missing serum samples|2|||
16259893|NCT04006171|39436199|FG001|Overall Study|missing serum samples|2|||
16259894|NCT04006171|39436198|FG000|Overall Study|insufficient sample volume|2|||
16259895|NCT04006171|39436199|FG001|Overall Study|insufficient sample volume|3|||
16259896|NCT00569374|39436205|FG000|Overall Study|Withdrawal by Subject|4|||
16259897|NCT01458405|39436209|FG000|Phase 1 (up to 12 Months)|Other|0|||
16259898|NCT01458405|39436210|FG001|Phase 1 (up to 12 Months)|Other|1|||
16259899|NCT01458405|39436211|FG002|Phase 1 (up to 12 Months)|Other|0|||
16259900|NCT01458405|39436212|FG003|Phase 1 (up to 12 Months)|Other|0|||
16259901|NCT01458405|39436209|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
16259902|NCT01458405|39436210|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
16259903|NCT01458405|39436211|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
16259904|NCT01458405|39436212|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
16259905|NCT01458405|39436209|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
16259906|NCT01458405|39436210|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
16259907|NCT01458405|39436211|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
16259908|NCT01458405|39436212|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
16259909|NCT01458405|39436209|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
16259910|NCT01458405|39436210|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
16259911|NCT01458405|39436211|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
16259912|NCT01458405|39436212|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
16259913|NCT02458469|39436213|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16259914|NCT02458469|39436214|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16259915|NCT02458469|39436215|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
16259916|NCT02458469|39436216|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16259917|NCT02458469|39436217|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16259918|NCT02458469|39436218|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
16259919|NCT02458469|39436213|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
16259920|NCT02458469|39436214|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
16259921|NCT02458469|39436215|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
16259922|NCT02458469|39436216|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
16259923|NCT02458469|39436217|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
16259924|NCT02458469|39436218|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
16259925|NCT02458469|39436213|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
16259926|NCT02458469|39436214|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
16259927|NCT02458469|39436215|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
16259928|NCT02458469|39436216|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
16259929|NCT02458469|39436217|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
16259930|NCT02458469|39436218|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
16259931|NCT03725605|39436219|FG000|Overall Study|Unsuccessful TIL expansion|2|||
16259932|NCT01734772|39436222|FG000|Overall Study|Adverse Event|1|||
16259933|NCT01734772|39436223|FG001|Overall Study|Adverse Event|2|||
16259934|NCT01734772|39436222|FG000|Overall Study|Withdrawal by Subject|0|||
16259935|NCT01734772|39436223|FG001|Overall Study|Withdrawal by Subject|1|||
16259936|NCT01434693|39436224|FG000|Overall Study|Adverse Event|1|||
16259937|NCT01434693|39436225|FG001|Overall Study|Adverse Event|0|||
16259938|NCT01434693|39436226|FG002|Overall Study|Adverse Event|0|||
16259939|NCT01434693|39436227|FG003|Overall Study|Adverse Event|0|||
16259940|NCT01434693|39436224|FG000|Overall Study|Withdrawal by Subject|1|||
16259941|NCT01434693|39436225|FG001|Overall Study|Withdrawal by Subject|0|||
16259942|NCT01434693|39436226|FG002|Overall Study|Withdrawal by Subject|1|||
16259943|NCT01434693|39436227|FG003|Overall Study|Withdrawal by Subject|1|||
16259944|NCT01434693|39436224|FG000|Overall Study|Lost to Follow-up|1|||
16259945|NCT01434693|39436225|FG001|Overall Study|Lost to Follow-up|0|||
16259946|NCT01434693|39436226|FG002|Overall Study|Lost to Follow-up|0|||
16259947|NCT01434693|39436227|FG003|Overall Study|Lost to Follow-up|0|||
16259948|NCT02178722|39436229|FG000|Overall Study|Withdrawal by Subject|0|||
16259949|NCT02178722|39436230|FG001|Overall Study|Withdrawal by Subject|0|||
16259950|NCT02178722|39436231|FG002|Overall Study|Withdrawal by Subject|0|||
16259951|NCT02178722|39436232|FG003|Overall Study|Withdrawal by Subject|2|||
16259952|NCT02178722|39436233|FG004|Overall Study|Withdrawal by Subject|33|||
16259953|NCT02178722|39436229|FG000|Overall Study|Death|2|||
16259954|NCT02178722|39436230|FG001|Overall Study|Death|13|||
16365085|NCT02293499|39821507|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
16148636|NCT00312221|39030644|FG003|Double-blind Phase|Lack of Efficacy|10|||
16148637|NCT02536313|39030645|FG000|Overall Study|Lack of Efficacy|0|||
16148638|NCT02536313|39030646|FG001|Overall Study|Lack of Efficacy|1|||
16148639|NCT02263079|39030650|FG000|Overall Study|Physician Decision|1|||
16148640|NCT02263079|39030651|FG001|Overall Study|Physician Decision|0|||
16148641|NCT02263079|39030652|FG002|Overall Study|Physician Decision|0|||
16148642|NCT02263079|39030650|FG000|Overall Study|Withdrawal by Subject|2|||
16148643|NCT02263079|39030651|FG001|Overall Study|Withdrawal by Subject|8|||
16148644|NCT02263079|39030652|FG002|Overall Study|Withdrawal by Subject|0|||
16148645|NCT03418129|39030658|FG000|Overall Study|Lost to Follow-up|11|||
16148646|NCT03418129|39030659|FG001|Overall Study|Lost to Follow-up|20|||
16148647|NCT03418129|39030660|FG002|Overall Study|Lost to Follow-up|15|||
16148648|NCT03418129|39030658|FG000|Overall Study|Withdrawal by Subject|3|||
16148649|NCT03418129|39030659|FG001|Overall Study|Withdrawal by Subject|6|||
16148650|NCT03418129|39030660|FG002|Overall Study|Withdrawal by Subject|4|||
16148651|NCT01230307|39030661|FG000|Overall Study|LVAD Placement|0|||
16148652|NCT01230307|39030662|FG001|Overall Study|LVAD Placement|2|||
16148653|NCT04353596|39030663|FG000|Overall Study|Protocol Violation|4|||
16148654|NCT04353596|39030664|FG001|Overall Study|Protocol Violation|4|||
16148655|NCT04353596|39030663|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
16148656|NCT04353596|39030664|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
16148657|NCT03891264|39030667|FG000|Overall Study|Adverse Event|1|||
16148658|NCT03891264|39030667|FG000|Overall Study|Withdrawal by Subject|2|||
16148659|NCT03891264|39030667|FG000|Overall Study|Physician Decision|2|||
16148660|NCT03034460|39030668|FG000|Overall Study|Adverse Event|0|||
16148661|NCT03034460|39030669|FG001|Overall Study|Adverse Event|1|||
16148662|NCT03034460|39030668|FG000|Overall Study|Withdrawal by Subject|2|||
16148663|NCT03034460|39030669|FG001|Overall Study|Withdrawal by Subject|2|||
16148664|NCT03034460|39030668|FG000|Overall Study|Personal Reasons|1|||
16148665|NCT03034460|39030669|FG001|Overall Study|Personal Reasons|0|||
16148666|NCT00820950|39030673|FG000|Overall Study|Scheduling Conflict|0|||
16148667|NCT00820950|39030674|FG001|Overall Study|Scheduling Conflict|0|||
16148668|NCT00820950|39030675|FG002|Overall Study|Scheduling Conflict|0|||
16259955|NCT02178722|39436231|FG002|Overall Study|Death|12|||
16148669|NCT00820950|39030676|FG003|Overall Study|Scheduling Conflict|0|||
16148670|NCT00820950|39030677|FG004|Overall Study|Scheduling Conflict|0|||
16148671|NCT00820950|39030678|FG005|Overall Study|Scheduling Conflict|0|||
16148672|NCT00820950|39030679|FG006|Overall Study|Scheduling Conflict|1|||
16148673|NCT00820950|39030680|FG007|Overall Study|Scheduling Conflict|1|||
16259956|NCT02178722|39436232|FG003|Overall Study|Death|12|||
16365086|NCT02293499|39821508|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
16259957|NCT02178722|39436233|FG004|Overall Study|Death|205|||
16259958|NCT02178722|39436229|FG000|Overall Study|Lost to Follow-up|0|||
16259959|NCT02178722|39436230|FG001|Overall Study|Lost to Follow-up|0|||
16259960|NCT02178722|39436231|FG002|Overall Study|Lost to Follow-up|0|||
16259961|NCT02178722|39436232|FG003|Overall Study|Lost to Follow-up|2|||
16259962|NCT02178722|39436233|FG004|Overall Study|Lost to Follow-up|11|||
16259963|NCT02178722|39436229|FG000|Overall Study|Study terminated by Sponsor|2|||
16259964|NCT02178722|39436230|FG001|Overall Study|Study terminated by Sponsor|7|||
16259965|NCT02178722|39436231|FG002|Overall Study|Study terminated by Sponsor|6|||
16259966|NCT02178722|39436232|FG003|Overall Study|Study terminated by Sponsor|4|||
16259967|NCT02178722|39436233|FG004|Overall Study|Study terminated by Sponsor|128|||
16259968|NCT02178722|39436229|FG000|Overall Study|Physician Decision|0|||
16259969|NCT02178722|39436230|FG001|Overall Study|Physician Decision|0|||
16259970|NCT02178722|39436231|FG002|Overall Study|Physician Decision|0|||
16259971|NCT02178722|39436232|FG003|Overall Study|Physician Decision|0|||
16365087|NCT02293499|39821506|FG000|9 Month Follow Up|Lost to Follow-up|24|||
16259972|NCT02178722|39436233|FG004|Overall Study|Physician Decision|3|||
16259973|NCT02178722|39436229|FG000|Overall Study|Other|0|||
16365088|NCT02293499|39821507|FG001|9 Month Follow Up|Lost to Follow-up|28|||
16365089|NCT02293499|39821508|FG002|9 Month Follow Up|Lost to Follow-up|4|||
16365090|NCT02293499|39821506|FG000|12 Month Follow Up|Lost to Follow-up|26|||
16365091|NCT02293499|39821507|FG001|12 Month Follow Up|Lost to Follow-up|25|||
16365092|NCT02293499|39821508|FG002|12 Month Follow Up|Lost to Follow-up|6|||
16365093|NCT02293499|39821506|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
16365094|NCT02293499|39821507|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
16365095|NCT02293499|39821508|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
16365096|NCT02293499|39821506|FG000|15 Month Follow Up|Lost to Follow-up|22|||
16365097|NCT02293499|39821507|FG001|15 Month Follow Up|Lost to Follow-up|22|||
16365098|NCT02293499|39821508|FG002|15 Month Follow Up|Lost to Follow-up|7|||
16365099|NCT00832975|39821509|FG000|Overall Study|Lost to Follow-up|7|||
16365100|NCT00832975|39821509|FG000|Overall Study|Protocol Violation|6|||
16365101|NCT00832975|39821509|FG000|Overall Study|Death|5|||
16365102|NCT00832975|39821509|FG000|Overall Study|Physician Decision|4|||
16365103|NCT00832975|39821509|FG000|Overall Study|Withdrawal by Subject|3|||
16365104|NCT00832975|39821509|FG000|Overall Study|Other reasons|14|||
16365105|NCT01432951|39821510|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
16365106|NCT01750346|39821511|FG000|Overall Study|Adverse Event|1|||
16365107|NCT01750346|39821512|FG001|Overall Study|Adverse Event|0|||
16365108|NCT01750346|39821513|FG002|Overall Study|Adverse Event|0|||
16365109|NCT02690727|39821517|FG000|Overall Study|Adverse Event|2|||
16365110|NCT02690727|39821518|FG001|Overall Study|Adverse Event|2|||
16148674|NCT00820950|39030681|FG008|Overall Study|Scheduling Conflict|0|||
16148675|NCT00820950|39030682|FG009|Overall Study|Scheduling Conflict|0|||
16148676|NCT00820950|39030673|FG000|Overall Study|Protocol Violation|1|||
16148677|NCT00820950|39030674|FG001|Overall Study|Protocol Violation|1|||
16148678|NCT00820950|39030675|FG002|Overall Study|Protocol Violation|0|||
16148679|NCT00820950|39030676|FG003|Overall Study|Protocol Violation|0|||
16148680|NCT00820950|39030677|FG004|Overall Study|Protocol Violation|0|||
16148681|NCT00820950|39030678|FG005|Overall Study|Protocol Violation|0|||
16148682|NCT00820950|39030679|FG006|Overall Study|Protocol Violation|0|||
16148683|NCT00820950|39030680|FG007|Overall Study|Protocol Violation|0|||
16148684|NCT00820950|39030681|FG008|Overall Study|Protocol Violation|0|||
16148685|NCT00820950|39030682|FG009|Overall Study|Protocol Violation|0|||
16148686|NCT00677820|39030687|FG000|Overall Study|Lost to Follow-up|1|||
16148687|NCT00677820|39030688|FG001|Overall Study|Lost to Follow-up|0|||
16148688|NCT00496730|39030689|FG000|Overall Study|Lost to Follow-up|4|||
16148689|NCT00496730|39030690|FG001|Overall Study|Lost to Follow-up|3|||
16148690|NCT00496730|39030689|FG000|Overall Study|Withdrawal by Subject|2|||
16148691|NCT00496730|39030690|FG001|Overall Study|Withdrawal by Subject|2|||
16148692|NCT04854434|39030691|FG000|Overall Study|Death|1|||
16148693|NCT04854434|39030692|FG001|Overall Study|Death|3|||
16148694|NCT04854434|39030693|FG002|Overall Study|Death|4|||
16148695|NCT04854434|39030691|FG000|Overall Study|Study Terminated by Sponsor|2|||
16148696|NCT04854434|39030692|FG001|Overall Study|Study Terminated by Sponsor|0|||
16148697|NCT04854434|39030693|FG002|Overall Study|Study Terminated by Sponsor|0|||
16148698|NCT04854434|39030691|FG000|Overall Study|Other|1|||
16148699|NCT04854434|39030692|FG001|Overall Study|Other|1|||
16148700|NCT04854434|39030693|FG002|Overall Study|Other|0|||
16148701|NCT01378858|39030694|FG000|Overall Study|Withdrawal by Subject|4|||
16148702|NCT01378858|39030695|FG001|Overall Study|Withdrawal by Subject|4|||
16148703|NCT01087775|39030696|FG000|Overall Study|failed inclusion criteria|2|||
16148704|NCT01877187|39030698|FG000|Overall Study|Death|2|||
16148705|NCT01877187|39030698|FG000|Overall Study|Withdrawal by Subject|4|||
16148706|NCT01877187|39030698|FG000|Overall Study|Lost to Follow-up|3|||
16148707|NCT01877187|39030698|FG000|Overall Study|Declining clinical status|11|||
16148708|NCT01877187|39030698|FG000|Overall Study|Liver transplant|2|||
16148709|NCT01073267|39030701|FG000|Overall Study|Disease Progression|3|||
16148710|NCT01735279|39030702|FG000|Overall Study|Lost to Follow-up|11|||
16148711|NCT01735279|39030703|FG001|Overall Study|Lost to Follow-up|8|||
16148712|NCT02663453|39030706|FG000|Overall Study|Death|4|||
16148713|NCT02663453|39030707|FG001|Overall Study|Death|4|||
16148714|NCT02663453|39030706|FG000|Overall Study|Withdrawal by Subject|1|||
16148715|NCT02663453|39030707|FG001|Overall Study|Withdrawal by Subject|0|||
16148716|NCT02807480|39030708|FG000|Overall Study|Withdrawal by Subject|14|||
16148717|NCT02807480|39030709|FG001|Overall Study|Withdrawal by Subject|10|||
16148718|NCT00282295|39030710|FG000|Overall Study|Adverse Event|0|||
16148719|NCT00282295|39030711|FG001|Overall Study|Adverse Event|1|||
16148720|NCT00282295|39030712|FG002|Overall Study|Adverse Event|0|||
16148721|NCT00282295|39030710|FG000|Overall Study|Serious Adverse Events|0|||
16148722|NCT00282295|39030711|FG001|Overall Study|Serious Adverse Events|0|||
16148723|NCT00282295|39030712|FG002|Overall Study|Serious Adverse Events|1|||
16148724|NCT00282295|39030710|FG000|Overall Study|Protocol Violation|0|||
16148725|NCT00282295|39030711|FG001|Overall Study|Protocol Violation|2|||
16148726|NCT00282295|39030712|FG002|Overall Study|Protocol Violation|1|||
16148727|NCT00282295|39030710|FG000|Overall Study|Withdrawal by Subject|2|||
16148728|NCT00282295|39030711|FG001|Overall Study|Withdrawal by Subject|6|||
16148729|NCT00282295|39030712|FG002|Overall Study|Withdrawal by Subject|4|||
16148730|NCT00282295|39030710|FG000|Overall Study|Lost to Follow-up|1|||
16148731|NCT00282295|39030711|FG001|Overall Study|Lost to Follow-up|7|||
16148732|NCT00282295|39030712|FG002|Overall Study|Lost to Follow-up|2|||
16148733|NCT00282295|39030710|FG000|Overall Study|Other|0|||
16148734|NCT00282295|39030711|FG001|Overall Study|Other|1|||
16148735|NCT00282295|39030712|FG002|Overall Study|Other|0|||
16148736|NCT04305275|39030713|FG000|Overall Study|Adverse Event|4|||
16148737|NCT04305275|39030714|FG001|Overall Study|Adverse Event|0|||
16148738|NCT04305275|39030713|FG000|Overall Study|Lost to Follow-up|1|||
16148739|NCT04305275|39030714|FG001|Overall Study|Lost to Follow-up|1|||
16148740|NCT04305275|39030713|FG000|Overall Study|Withdrawal by Participant|8|||
16148741|NCT04305275|39030714|FG001|Overall Study|Withdrawal by Participant|1|||
16148742|NCT03451084|39030721|FG000|Overall Study|Withdrawal by Subject|2|||
16148743|NCT03451084|39030722|FG001|Overall Study|Withdrawal by Subject|1|||
16148744|NCT03451084|39030723|FG002|Overall Study|Withdrawal by Subject|2|||
16148745|NCT03451084|39030724|FG003|Overall Study|Withdrawal by Subject|1|||
16148746|NCT03451084|39030721|FG000|Overall Study|Disease recurrence|0|||
16148747|NCT03451084|39030722|FG001|Overall Study|Disease recurrence|2|||
16148748|NCT03451084|39030723|FG002|Overall Study|Disease recurrence|0|||
16148749|NCT03451084|39030724|FG003|Overall Study|Disease recurrence|0|||
16148750|NCT03451084|39030721|FG000|Overall Study|Lack of Efficacy|0|||
16148751|NCT03451084|39030722|FG001|Overall Study|Lack of Efficacy|3|||
16148752|NCT03451084|39030723|FG002|Overall Study|Lack of Efficacy|0|||
16148753|NCT03451084|39030724|FG003|Overall Study|Lack of Efficacy|1|||
16148754|NCT03451084|39030721|FG000|Overall Study|Death|1|||
16148755|NCT03451084|39030722|FG001|Overall Study|Death|0|||
16148756|NCT03451084|39030723|FG002|Overall Study|Death|2|||
16148757|NCT03451084|39030724|FG003|Overall Study|Death|0|||
16441206|NCT02723773|40095727|FG002|Overall Study|Other|2|||
16441207|NCT02723773|40095728|FG003|Overall Study|Other|2|||
16441208|NCT04349891|40095729|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
16441209|NCT04349891|40095730|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
16441210|NCT04349891|40095729|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
16441211|NCT04349891|40095730|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
16441212|NCT04349891|40095729|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
16441213|NCT04349891|40095730|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
16441214|NCT04349891|40095729|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
16441215|NCT04349891|40095730|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
16441216|NCT02903771|40095731|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
16441217|NCT02903771|40095732|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
16441218|NCT02903771|40095733|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
16441219|NCT02903771|40095734|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
16441220|NCT02903771|40095735|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
16441221|NCT02903771|40095736|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
16441222|NCT02903771|40095737|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
16441223|NCT02903771|40095731|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
16441224|NCT02903771|40095732|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
16441225|NCT02903771|40095733|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
16441226|NCT02903771|40095734|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
16441227|NCT02903771|40095735|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
16441228|NCT02903771|40095736|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
16441229|NCT02903771|40095737|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
16441230|NCT02903771|40095731|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
16441231|NCT02903771|40095732|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
16441232|NCT02903771|40095733|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
16148758|NCT03451084|39030721|FG000|Overall Study|Physician Decision|0|||
16148759|NCT03451084|39030722|FG001|Overall Study|Physician Decision|0|||
16148760|NCT03451084|39030723|FG002|Overall Study|Physician Decision|2|||
16148761|NCT03451084|39030724|FG003|Overall Study|Physician Decision|2|||
16148762|NCT03451084|39030721|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
16148763|NCT03451084|39030722|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
16148764|NCT03451084|39030723|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
16148765|NCT03451084|39030724|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
16148766|NCT03302975|39030725|FG000|Overall Study|Lost to Follow-up|4|||
16148767|NCT02568475|39030734|FG000|Overall Study|Lost to Follow-up|40|||
16148768|NCT02568475|39030735|FG001|Overall Study|Lost to Follow-up|39|||
16148769|NCT02568475|39030734|FG000|Overall Study|Withdrawal by Subject|2|||
16148770|NCT02568475|39030735|FG001|Overall Study|Withdrawal by Subject|0|||
16148771|NCT02568475|39030734|FG000|Overall Study|Discharged home|4|||
16148772|NCT02568475|39030735|FG001|Overall Study|Discharged home|4|||
16148773|NCT02568475|39030734|FG000|Overall Study|Short-term: Discharge location unknown|4|||
16148774|NCT02568475|39030735|FG001|Overall Study|Short-term: Discharge location unknown|0|||
16148775|NCT02568475|39030734|FG000|Overall Study|Transferred to another facility|1|||
16148776|NCT02568475|39030735|FG001|Overall Study|Transferred to another facility|0|||
16148777|NCT01231659|39030738|FG000|Overall Study|Adverse Event|9|||
16148778|NCT01231659|39030738|FG000|Overall Study|Disease Progression|48|||
16148779|NCT01231659|39030738|FG000|Overall Study|Death|2|||
16148780|NCT01231659|39030738|FG000|Overall Study|Patient refused to complete study visit|1|||
16365111|NCT04575324|39821519|FG000|Overall Study|Lost to Follow-up|29|||
16148781|NCT01231659|39030738|FG000|Overall Study|Other protocol defined criteria|12|||
16148782|NCT03370120|39030739|FG000|Overall Study|Adverse event, non-fatal|24|||
16365112|NCT04575324|39821520|FG001|Overall Study|Lost to Follow-up|25|||
16365113|NCT04575324|39821519|FG000|Overall Study|Death|1|||
16365114|NCT04575324|39821520|FG001|Overall Study|Death|2|||
16365115|NCT04575324|39821519|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
16365116|NCT04575324|39821520|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
16365117|NCT01712516|39821523|FG000|Overall Study|Technical problems|0|||
16148783|NCT03370120|39030739|FG000|Overall Study|Withdrawal by Subject|6|||
16148784|NCT03370120|39030739|FG000|Overall Study|Lost to Follow-up|1|||
16148785|NCT03370120|39030739|FG000|Overall Study|Lack of Efficacy|37|||
16148786|NCT03370120|39030739|FG000|Overall Study|Per sponsor's instructions|1|||
16148787|NCT03370120|39030739|FG000|Overall Study|Study was terminated by parent company UCB|2|||
16148788|NCT03370120|39030739|FG000|Overall Study|The study was ended by the promoter|3|||
16148789|NCT03370120|39030739|FG000|Overall Study|Discontinuation of drug development|3|||
16148790|NCT03370120|39030739|FG000|Overall Study|End of project|2|||
16148791|NCT03370120|39030739|FG000|Overall Study|Premature study closure|2|||
16148792|NCT03370120|39030739|FG000|Overall Study|Premature program termination|1|||
16148793|NCT03370120|39030739|FG000|Overall Study|Premature study termination|7|||
16148794|NCT03370120|39030739|FG000|Overall Study|Trial terminated by sponsor|2|||
16148795|NCT03370120|39030739|FG000|Overall Study|Trial discontinued by sponsor|2|||
16148796|NCT03370120|39030739|FG000|Overall Study|Study ended|15|||
16148797|NCT03370120|39030739|FG000|Overall Study|Clinical trial has been cancelled|1|||
16148798|NCT03370120|39030739|FG000|Overall Study|End of study per sponsor decision|2|||
16148799|NCT03370120|39030739|FG000|Overall Study|Promoter's decision|2|||
16148800|NCT03370120|39030739|FG000|Overall Study|The trial has been suspended|3|||
16148801|NCT03370120|39030739|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
16148802|NCT03370120|39030739|FG000|Overall Study|Early termination by order of sponsor|2|||
16148803|NCT03370120|39030739|FG000|Overall Study|Discontinuation of the study|5|||
16148804|NCT03370120|39030739|FG000|Overall Study|End of clinical trial discontinuation|1|||
16148805|NCT03370120|39030739|FG000|Overall Study|Because the clinical trial ended halfway|4|||
16148806|NCT03370120|39030739|FG000|Overall Study|Development discontinued|5|||
16148807|NCT03370120|39030739|FG000|Overall Study|Padsenovil program closed|3|||
16148808|NCT03370120|39030739|FG000|Overall Study|End of project|2|||
16148809|NCT03370120|39030739|FG000|Overall Study|Termination of project|1|||
16148810|NCT03370120|39030739|FG000|Overall Study|The study was interrupted by sponsor|4|||
16148811|NCT03370120|39030739|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
16148812|NCT03370120|39030739|FG000|Overall Study|End of sponsor decision|1|||
16148813|NCT03370120|39030739|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
16148814|NCT03370120|39030739|FG000|Overall Study|Early termination of studies|5|||
16148815|NCT03370120|39030739|FG000|Overall Study|This study is ended early|1|||
16148816|NCT03370120|39030739|FG000|Overall Study|End of padsevonil program|2|||
16148817|NCT03370120|39030739|FG000|Overall Study|Decision of sponsor|6|||
16148818|NCT03370120|39030739|FG000|Overall Study|Asked by the sponsor|3|||
16148819|NCT03370120|39030739|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
16148820|NCT03370120|39030739|FG000|Overall Study|PI decision poor compliance from participant|1|||
16148821|NCT03370120|39030739|FG000|Overall Study|Promoter ended the study|3|||
16148822|NCT03370120|39030739|FG000|Overall Study|Premature study close by sponsor's decision|4|||
16148823|NCT03370120|39030739|FG000|Overall Study|Study terminated by sponsor|33|||
16148824|NCT03370120|39030739|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
16148825|NCT03370120|39030739|FG000|Overall Study|Sponsor decision to terminate study|63|||
16148826|NCT03370120|39030739|FG000|Overall Study|Program closure|3|||
16441233|NCT02903771|40095734|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
16441234|NCT02903771|40095735|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
16441235|NCT02903771|40095736|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
16441236|NCT02903771|40095737|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
16441237|NCT02903771|40095731|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
16441238|NCT02903771|40095732|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
16441239|NCT02903771|40095733|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
16441240|NCT02903771|40095734|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
16441241|NCT02903771|40095735|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
16441242|NCT02903771|40095736|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
16441243|NCT02903771|40095737|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
16441244|NCT02903771|40095731|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
16441245|NCT02903771|40095732|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
16441246|NCT02903771|40095733|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
16441247|NCT02903771|40095734|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
16441248|NCT02903771|40095735|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
16441249|NCT02903771|40095736|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
16441250|NCT02903771|40095737|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
16148827|NCT03370120|39030739|FG000|Overall Study|Study ended prematurely|1|||
16148828|NCT03370120|39030739|FG000|Overall Study|Study stopped by sponsor|2|||
16148829|NCT03370120|39030739|FG000|Overall Study|Program termination|55|||
16148830|NCT03370120|39030739|FG000|Overall Study|Sponsor decision|62|||
16148831|NCT03370120|39030739|FG000|Overall Study|Sponsor study closure|10|||
16148832|NCT00847145|39030744|FG000|Overall Study|AE or Death|0|||
16148833|NCT00847145|39030745|FG001|Overall Study|AE or Death|1|||
16148834|NCT00847145|39030746|FG002|Overall Study|AE or Death|1|||
16148835|NCT00847145|39030747|FG003|Overall Study|AE or Death|0|||
16441251|NCT02903771|40095731|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
16441252|NCT02903771|40095732|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
16441253|NCT02903771|40095733|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
16441254|NCT02903771|40095734|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
16441255|NCT02903771|40095735|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
16441256|NCT02903771|40095736|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
16441257|NCT02903771|40095737|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
16441258|NCT02903771|40095731|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
16441259|NCT02903771|40095732|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
16441260|NCT02903771|40095733|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
16441261|NCT02903771|40095734|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
16441262|NCT02903771|40095735|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
16441263|NCT02903771|40095736|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
16441264|NCT02903771|40095737|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
16441265|NCT02903771|40095731|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
16441266|NCT02903771|40095732|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
16441267|NCT02903771|40095733|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
16441268|NCT02903771|40095734|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
16441269|NCT02903771|40095735|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
16441270|NCT02903771|40095736|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
16441271|NCT02903771|40095737|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
16441272|NCT02903771|40095731|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
16441273|NCT02903771|40095732|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
16441274|NCT02903771|40095733|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
16441275|NCT02903771|40095734|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
16441276|NCT02903771|40095735|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
16441277|NCT02903771|40095736|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
16441278|NCT02903771|40095737|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
16441279|NCT02903771|40095731|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
16148836|NCT00847145|39030748|FG004|Overall Study|AE or Death|0|||
16148837|NCT00847145|39030749|FG005|Overall Study|AE or Death|0|||
16148838|NCT00847145|39030750|FG006|Overall Study|AE or Death|0|||
16148839|NCT00847145|39030751|FG007|Overall Study|AE or Death|0|||
16148840|NCT00847145|39030744|FG000|Overall Study|Withdrawal by Subject|3|||
16148841|NCT00847145|39030745|FG001|Overall Study|Withdrawal by Subject|4|||
16148842|NCT00847145|39030746|FG002|Overall Study|Withdrawal by Subject|6|||
16148843|NCT00847145|39030747|FG003|Overall Study|Withdrawal by Subject|1|||
16148844|NCT00847145|39030748|FG004|Overall Study|Withdrawal by Subject|0|||
16148845|NCT00847145|39030749|FG005|Overall Study|Withdrawal by Subject|0|||
16148846|NCT00847145|39030750|FG006|Overall Study|Withdrawal by Subject|1|||
16148847|NCT00847145|39030751|FG007|Overall Study|Withdrawal by Subject|1|||
16148848|NCT00847145|39030744|FG000|Overall Study|Lost to Follow-up|3|||
16148849|NCT00847145|39030745|FG001|Overall Study|Lost to Follow-up|1|||
16148850|NCT00847145|39030746|FG002|Overall Study|Lost to Follow-up|1|||
16441280|NCT02903771|40095732|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
16441281|NCT02903771|40095733|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
16441282|NCT02903771|40095734|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
16441283|NCT02903771|40095735|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
16441284|NCT02903771|40095736|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
16441285|NCT02903771|40095737|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
16441286|NCT02903771|40095731|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
16441287|NCT02903771|40095732|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
16441288|NCT02903771|40095733|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
16441289|NCT02903771|40095734|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
16441290|NCT02903771|40095735|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
16441291|NCT02903771|40095736|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
16441292|NCT02903771|40095737|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
16441293|NCT00667628|40095739|FG000|Overall Study|Lost to Follow-up|1|||
16441294|NCT00667628|40095740|FG001|Overall Study|Lost to Follow-up|0|||
16441295|NCT00667628|40095739|FG000|Overall Study|Death|6|||
16441296|NCT00667628|40095740|FG001|Overall Study|Death|6|||
16441297|NCT00667628|40095739|FG000|Overall Study|Investigator Considers in Best Interest|1|||
16441298|NCT00667628|40095740|FG001|Overall Study|Investigator Considers in Best Interest|0|||
16441299|NCT00667628|40095739|FG000|Overall Study|Sponsor Terminated Study|17|||
16441300|NCT00667628|40095740|FG001|Overall Study|Sponsor Terminated Study|21|||
16441301|NCT03264404|40095741|FG000|Overall Study|Death|2|||
16441302|NCT03264404|40095741|FG000|Overall Study|Physician Decision|1|||
16441303|NCT03264404|40095741|FG000|Overall Study|Disease Progression|28|||
16441304|NCT03264404|40095741|FG000|Overall Study|Adverse Event|1|||
16441305|NCT03264404|40095741|FG000|Overall Study|Off study prior to treatment|2|||
16441306|NCT03646123|40095742|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
16441307|NCT03646123|40095743|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
16441308|NCT03646123|40095744|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
16441309|NCT03646123|40095742|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
16441310|NCT03646123|40095743|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
16441311|NCT03646123|40095744|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
16441312|NCT03646123|40095742|FG000|Overall Study|Non-compliance to study protocol|1|||
16441313|NCT03646123|40095743|FG001|Overall Study|Non-compliance to study protocol|0|||
16441314|NCT03646123|40095744|FG002|Overall Study|Non-compliance to study protocol|0|||
16441315|NCT03646123|40095742|FG000|Overall Study|Ineligible due to progression during screening|0|||
16441316|NCT03646123|40095743|FG001|Overall Study|Ineligible due to progression during screening|0|||
16441317|NCT03646123|40095744|FG002|Overall Study|Ineligible due to progression during screening|1|||
16441318|NCT03646123|40095742|FG000|Overall Study|Withdrawal by Subject|2|||
16441319|NCT03646123|40095743|FG001|Overall Study|Withdrawal by Subject|1|||
16441320|NCT03646123|40095744|FG002|Overall Study|Withdrawal by Subject|3|||
16441321|NCT03646123|40095742|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
16441322|NCT03646123|40095743|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
16441323|NCT03646123|40095744|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
16441324|NCT03646123|40095742|FG000|Overall Study|Death|2|||
16441325|NCT03646123|40095743|FG001|Overall Study|Death|1|||
16441326|NCT03646123|40095744|FG002|Overall Study|Death|1|||
16441327|NCT03646123|40095742|FG000|Overall Study|Lost to Follow-up|4|||
16148851|NCT00847145|39030747|FG003|Overall Study|Lost to Follow-up|0|||
16441328|NCT03646123|40095743|FG001|Overall Study|Lost to Follow-up|7|||
16441329|NCT03646123|40095744|FG002|Overall Study|Lost to Follow-up|6|||
16441330|NCT03646123|40095742|FG000|Overall Study|Participants in long term follow-up|0|||
16441331|NCT03646123|40095743|FG001|Overall Study|Participants in long term follow-up|48|||
16441332|NCT03646123|40095744|FG002|Overall Study|Participants in long term follow-up|144|||
16441333|NCT05119569|40095745|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
16441334|NCT05119569|40095746|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
16441335|NCT05119569|40095747|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
16441336|NCT05119569|40095748|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
16441337|NCT05119569|40095745|FG000|Double Blind Treatment Phase|Adverse Event|6|||
16441338|NCT05119569|40095746|FG001|Double Blind Treatment Phase|Adverse Event|0|||
16441339|NCT05119569|40095747|FG002|Double Blind Treatment Phase|Adverse Event|0|||
16441340|NCT05119569|40095748|FG003|Double Blind Treatment Phase|Adverse Event|0|||
16441341|NCT05119569|40095745|FG000|Open Label Extension Phase|Ongoing in the study|0|||
16441342|NCT05119569|40095746|FG001|Open Label Extension Phase|Ongoing in the study|0|||
16441343|NCT05119569|40095747|FG002|Open Label Extension Phase|Ongoing in the study|65|||
16441344|NCT05119569|40095748|FG003|Open Label Extension Phase|Ongoing in the study|34|||
16441345|NCT02903914|40095757|FG000|Overall Study|Adverse Event|0|||
16441346|NCT02903914|40095758|FG001|Overall Study|Adverse Event|0|||
16441347|NCT02903914|40095759|FG002|Overall Study|Adverse Event|1|||
16441348|NCT02903914|40095760|FG003|Overall Study|Adverse Event|0|||
16441349|NCT02903914|40095761|FG004|Overall Study|Adverse Event|0|||
16441350|NCT02903914|40095762|FG005|Overall Study|Adverse Event|0|||
16441351|NCT02903914|40095763|FG006|Overall Study|Adverse Event|2|||
16441352|NCT02903914|40095764|FG007|Overall Study|Adverse Event|0|||
16441353|NCT02903914|40095757|FG000|Overall Study|Withdrawal by Subject|3|||
16441354|NCT02903914|40095758|FG001|Overall Study|Withdrawal by Subject|1|||
16441355|NCT02903914|40095759|FG002|Overall Study|Withdrawal by Subject|28|||
16441356|NCT02903914|40095760|FG003|Overall Study|Withdrawal by Subject|0|||
16148852|NCT00847145|39030748|FG004|Overall Study|Lost to Follow-up|4|||
16148853|NCT00847145|39030749|FG005|Overall Study|Lost to Follow-up|4|||
16148854|NCT00847145|39030750|FG006|Overall Study|Lost to Follow-up|8|||
16148855|NCT00847145|39030751|FG007|Overall Study|Lost to Follow-up|2|||
16148856|NCT00847145|39030744|FG000|Overall Study|Inappropriate enrollment|0|||
16148857|NCT00847145|39030745|FG001|Overall Study|Inappropriate enrollment|0|||
16148858|NCT00847145|39030746|FG002|Overall Study|Inappropriate enrollment|0|||
16148859|NCT00847145|39030747|FG003|Overall Study|Inappropriate enrollment|0|||
16148860|NCT00847145|39030748|FG004|Overall Study|Inappropriate enrollment|1|||
16148861|NCT00847145|39030749|FG005|Overall Study|Inappropriate enrollment|0|||
16148862|NCT00847145|39030750|FG006|Overall Study|Inappropriate enrollment|0|||
16148863|NCT00847145|39030751|FG007|Overall Study|Inappropriate enrollment|0|||
16148864|NCT00847145|39030744|FG000|Overall Study|Protocol Violation|0|||
16148865|NCT00847145|39030745|FG001|Overall Study|Protocol Violation|0|||
16148866|NCT00847145|39030746|FG002|Overall Study|Protocol Violation|3|||
16148867|NCT00847145|39030747|FG003|Overall Study|Protocol Violation|0|||
16148868|NCT00847145|39030748|FG004|Overall Study|Protocol Violation|1|||
16148869|NCT00847145|39030749|FG005|Overall Study|Protocol Violation|0|||
16148870|NCT00847145|39030750|FG006|Overall Study|Protocol Violation|0|||
16148871|NCT00847145|39030751|FG007|Overall Study|Protocol Violation|1|||
16148872|NCT04518462|39030752|FG000|Overall Study|Withdrawal by Subject|0|||
16148873|NCT04518462|39030753|FG001|Overall Study|Withdrawal by Subject|0|||
16148874|NCT04518462|39030754|FG002|Overall Study|Withdrawal by Subject|1|||
16148875|NCT04518462|39030752|FG000|Overall Study|Physician Decision|1|||
16148876|NCT04518462|39030753|FG001|Overall Study|Physician Decision|1|||
16148877|NCT04518462|39030754|FG002|Overall Study|Physician Decision|0|||
16148878|NCT00003895|39030755|FG000|Overall Study|Adverse Event|4|||
16148879|NCT00003895|39030756|FG001|Overall Study|Adverse Event|0|||
16148880|NCT00003895|39030755|FG000|Overall Study|Lack of Efficacy|1|||
16148881|NCT00003895|39030756|FG001|Overall Study|Lack of Efficacy|1|||
16148882|NCT00003895|39030755|FG000|Overall Study|Patient Vacation|2|||
16148883|NCT00003895|39030756|FG001|Overall Study|Patient Vacation|0|||
16148884|NCT00003895|39030755|FG000|Overall Study|Withdrawal by Subject|0|||
16148885|NCT00003895|39030756|FG001|Overall Study|Withdrawal by Subject|3|||
16148886|NCT02616614|39030757|FG000|Overall Study|Withdrawal by Subject|10|||
16148887|NCT02616614|39030758|FG001|Overall Study|Withdrawal by Subject|5|||
16148888|NCT02616614|39030759|FG002|Overall Study|Withdrawal by Subject|6|||
16148889|NCT02616614|39030757|FG000|Overall Study|Physician Decision|2|||
16148890|NCT02616614|39030758|FG001|Overall Study|Physician Decision|1|||
16148891|NCT02616614|39030759|FG002|Overall Study|Physician Decision|0|||
16148892|NCT02616614|39030757|FG000|Overall Study|Adverse Event|1|||
16441357|NCT02903914|40095761|FG004|Overall Study|Withdrawal by Subject|1|||
16441358|NCT02903914|40095762|FG005|Overall Study|Withdrawal by Subject|2|||
16441359|NCT02903914|40095763|FG006|Overall Study|Withdrawal by Subject|12|||
16441360|NCT02903914|40095764|FG007|Overall Study|Withdrawal by Subject|0|||
16441361|NCT02903914|40095757|FG000|Overall Study|Progressive Disease|1|||
16441362|NCT02903914|40095758|FG001|Overall Study|Progressive Disease|0|||
16148893|NCT02616614|39030758|FG001|Overall Study|Adverse Event|4|||
16148894|NCT02616614|39030759|FG002|Overall Study|Adverse Event|1|||
16148895|NCT02616614|39030757|FG000|Overall Study|Protocol Violation|0|||
16148896|NCT02616614|39030758|FG001|Overall Study|Protocol Violation|3|||
16148897|NCT02616614|39030759|FG002|Overall Study|Protocol Violation|1|||
16148898|NCT02616614|39030757|FG000|Overall Study|Prohibited Medication|12|||
16148899|NCT02616614|39030758|FG001|Overall Study|Prohibited Medication|9|||
16148900|NCT02616614|39030759|FG002|Overall Study|Prohibited Medication|5|||
16148901|NCT02616614|39030757|FG000|Overall Study|More than 3 applications missed|6|||
16148902|NCT02616614|39030758|FG001|Overall Study|More than 3 applications missed|8|||
16148903|NCT02616614|39030759|FG002|Overall Study|More than 3 applications missed|1|||
16148904|NCT02616614|39030757|FG000|Overall Study|Lost to Follow-up|31|||
16441363|NCT02903914|40095759|FG002|Overall Study|Progressive Disease|4|||
16441364|NCT02903914|40095760|FG003|Overall Study|Progressive Disease|0|||
16441365|NCT02903914|40095761|FG004|Overall Study|Progressive Disease|0|||
16441366|NCT02903914|40095762|FG005|Overall Study|Progressive Disease|0|||
16148905|NCT02616614|39030758|FG001|Overall Study|Lost to Follow-up|28|||
16148906|NCT02616614|39030759|FG002|Overall Study|Lost to Follow-up|13|||
16148907|NCT02616614|39030757|FG000|Overall Study|Pregnancy|2|||
16148908|NCT02616614|39030758|FG001|Overall Study|Pregnancy|0|||
16148909|NCT02616614|39030759|FG002|Overall Study|Pregnancy|1|||
16148910|NCT02616614|39030757|FG000|Overall Study|Other|1|||
16148911|NCT02616614|39030758|FG001|Overall Study|Other|2|||
16148912|NCT02616614|39030759|FG002|Overall Study|Other|1|||
16148913|NCT02246582|39030760|FG000|Overall Study|Withdrawal by Subject|3|||
16148914|NCT02246582|39030761|FG001|Overall Study|Withdrawal by Subject|4|||
16148915|NCT00427349|39030764|FG000|Overall Study|Lack of Efficacy|23|||
16148916|NCT00427349|39030764|FG000|Overall Study|Adverse Event|14|||
16148917|NCT00427349|39030764|FG000|Overall Study|Death|1|||
16148918|NCT00427349|39030764|FG000|Overall Study|Withdrawal by Subject|3|||
16148919|NCT00427349|39030764|FG000|Overall Study|Alternative therapy|1|||
16148920|NCT00427349|39030764|FG000|Overall Study|Other|2|||
16148921|NCT00427349|39030764|FG000|Overall Study|Ineligible|1|||
16148922|NCT00427349|39030764|FG000|Overall Study|Never started therapy|1|||
16148923|NCT00906087|39030765|FG000|Initial Washout|Withdrawal by Subject|1|||
16148924|NCT00906087|39030765|FG000|Initial Washout|Physician Decision|1|||
16148925|NCT03184077|39030766|FG000|Overall Study|Lost to Follow-up|21|||
16148926|NCT03184077|39030767|FG001|Overall Study|Lost to Follow-up|21|||
16148927|NCT01392677|39030768|FG000|Overall Study|Adverse Event|3|||
16148928|NCT01392677|39030769|FG001|Overall Study|Adverse Event|1|||
16148929|NCT01392677|39030768|FG000|Overall Study|Withdrawal by Subject|0|||
16148930|NCT01392677|39030769|FG001|Overall Study|Withdrawal by Subject|2|||
16148931|NCT01392677|39030768|FG000|Overall Study|Incorrect enrollment|2|||
16148932|NCT01392677|39030769|FG001|Overall Study|Incorrect enrollment|3|||
16148933|NCT01392677|39030768|FG000|Overall Study|Other reason|3|||
16148934|NCT01392677|39030769|FG001|Overall Study|Other reason|2|||
16148935|NCT01376778|39030770|FG000|Overall Study|Lost to Follow-up|3|||
16148936|NCT01376778|39030771|FG001|Overall Study|Lost to Follow-up|2|||
16148937|NCT00143312|39030772|FG000|Overall Study|Death|11|||
16148938|NCT00143312|39030772|FG000|Overall Study|Adverse Event|2|||
16148939|NCT00143312|39030772|FG000|Overall Study|Lost to Follow-up|1|||
16148940|NCT00143312|39030772|FG000|Overall Study|Other|1|||
16148941|NCT00143312|39030772|FG000|Overall Study|Withdrawal by Subject|1|||
16148942|NCT02634151|39030776|FG000|Overall Study|Withdrawal by Subject|1|||
16148943|NCT02634151|39030777|FG001|Overall Study|Withdrawal by Subject|0|||
16148944|NCT02634151|39030776|FG000|Overall Study|Non-Compliance|0|||
16148945|NCT02634151|39030777|FG001|Overall Study|Non-Compliance|1|||
16148946|NCT02634151|39030776|FG000|Overall Study|Other|0|||
16148947|NCT02634151|39030777|FG001|Overall Study|Other|1|||
16148948|NCT00383084|39030778|FG000|Overall Study|Withdrawal by Subject|12|||
16148949|NCT00383084|39030779|FG001|Overall Study|Withdrawal by Subject|10|||
16148950|NCT04544475|39030781|FG000|Overall Study|Withdrawal by Subject|1|||
16148951|NCT04544475|39030782|FG001|Overall Study|Withdrawal by Subject|3|||
16148952|NCT00632099|39030783|FG000|Overall Study|Lost to Follow-up|3|||
16148953|NCT00632099|39030784|FG001|Overall Study|Lost to Follow-up|3|||
16148954|NCT02054897|39030794|FG000|Overall Study|Withdrawal by Subject|2|||
16148955|NCT02054897|39030795|FG001|Overall Study|Withdrawal by Subject|0|||
16148956|NCT02054897|39030796|FG002|Overall Study|Withdrawal by Subject|2|||
16148957|NCT02054897|39030794|FG000|Overall Study|Missing follow-up information|3|||
16148958|NCT02054897|39030795|FG001|Overall Study|Missing follow-up information|5|||
16148959|NCT02054897|39030796|FG002|Overall Study|Missing follow-up information|3|||
16148960|NCT02054897|39030794|FG000|Overall Study|Lost to Follow-up|4|||
16148961|NCT02054897|39030795|FG001|Overall Study|Lost to Follow-up|2|||
16148962|NCT02054897|39030796|FG002|Overall Study|Lost to Follow-up|7|||
16148963|NCT02054897|39030794|FG000|Overall Study|Randomized but not exposed|1|||
16148964|NCT02054897|39030795|FG001|Overall Study|Randomized but not exposed|0|||
16148965|NCT02054897|39030796|FG002|Overall Study|Randomized but not exposed|0|||
16148966|NCT02603120|39030797|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
16148967|NCT02603120|39030798|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
16148968|NCT02603120|39030797|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
16148969|NCT02603120|39030798|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
16148970|NCT02603120|39030797|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
16148971|NCT02603120|39030798|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
16148972|NCT02603120|39030797|FG000|Double-Blind Treatment Phase|Death|2|||
16148973|NCT02603120|39030798|FG001|Double-Blind Treatment Phase|Death|0|||
16148974|NCT02603120|39030797|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
16148975|NCT02603120|39030798|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
16148976|NCT02603120|39030797|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
16148977|NCT02603120|39030798|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
16148978|NCT02603120|39030797|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
16148979|NCT02603120|39030798|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
16441367|NCT02903914|40095763|FG006|Overall Study|Progressive Disease|2|||
16148980|NCT02603120|39030797|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
16148981|NCT02603120|39030798|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
16148982|NCT02603120|39030797|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
16148983|NCT02603120|39030798|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
16148984|NCT02603120|39030797|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
16148985|NCT02603120|39030798|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
16148986|NCT02603120|39030797|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
16148987|NCT02603120|39030798|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
16148988|NCT02603120|39030797|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
16148989|NCT02603120|39030798|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
16148990|NCT02603120|39030797|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
16148991|NCT02603120|39030798|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
16148992|NCT02603120|39030797|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
16148993|NCT02603120|39030798|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
16148994|NCT03882970|39030799|FG000|Overall Study|Adverse Event|5|||
16148995|NCT03882970|39030800|FG001|Overall Study|Adverse Event|7|||
16148996|NCT03882970|39030801|FG002|Overall Study|Adverse Event|3|||
16148997|NCT03882970|39030802|FG003|Overall Study|Adverse Event|1|||
16148998|NCT03882970|39030799|FG000|Overall Study|Death|1|||
16148999|NCT03882970|39030800|FG001|Overall Study|Death|2|||
16149000|NCT03882970|39030801|FG002|Overall Study|Death|1|||
16149001|NCT03882970|39030802|FG003|Overall Study|Death|1|||
16149002|NCT03882970|39030799|FG000|Overall Study|Lost to Follow-up|8|||
16259974|NCT02178722|39436230|FG001|Overall Study|Other|0|||
16259975|NCT02178722|39436231|FG002|Overall Study|Other|0|||
16259976|NCT02178722|39436232|FG003|Overall Study|Other|0|||
16259977|NCT02178722|39436233|FG004|Overall Study|Other|2|||
16259978|NCT03595657|39436239|FG000|Overall Study|Adverse Event|14|||
16259979|NCT03595657|39436239|FG000|Overall Study|Death|1|||
16441368|NCT02903914|40095764|FG007|Overall Study|Progressive Disease|0|||
16441369|NCT02903914|40095757|FG000|Overall Study|Death|0|||
16441370|NCT02903914|40095758|FG001|Overall Study|Death|0|||
16441371|NCT02903914|40095759|FG002|Overall Study|Death|9|||
16441372|NCT02903914|40095760|FG003|Overall Study|Death|0|||
16259980|NCT03595657|39436239|FG000|Overall Study|Lack of Efficacy|40|||
16259981|NCT03595657|39436239|FG000|Overall Study|Withdrawal by Subject|10|||
16259982|NCT03595657|39436239|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
16259983|NCT03595657|39436239|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
16259984|NCT00214422|39436242|FG000|Overall Study|Physician Decision|2|||
16259985|NCT00214422|39436243|FG001|Overall Study|Physician Decision|0|||
16259986|NCT00214422|39436244|FG002|Overall Study|Physician Decision|0|||
16441373|NCT02903914|40095761|FG004|Overall Study|Death|1|||
16441374|NCT02903914|40095762|FG005|Overall Study|Death|3|||
16441375|NCT02903914|40095763|FG006|Overall Study|Death|24|||
16441376|NCT02903914|40095764|FG007|Overall Study|Death|2|||
16441377|NCT02903914|40095757|FG000|Overall Study|Lost to Follow-up|0|||
16441378|NCT02903914|40095758|FG001|Overall Study|Lost to Follow-up|1|||
16441379|NCT02903914|40095759|FG002|Overall Study|Lost to Follow-up|0|||
16441380|NCT02903914|40095760|FG003|Overall Study|Lost to Follow-up|0|||
16149003|NCT03882970|39030800|FG001|Overall Study|Lost to Follow-up|9|||
16149004|NCT03882970|39030801|FG002|Overall Study|Lost to Follow-up|5|||
16149005|NCT03882970|39030802|FG003|Overall Study|Lost to Follow-up|5|||
16259987|NCT00214422|39436242|FG000|Overall Study|Developed esophageal ca|1|||
16259988|NCT00214422|39436243|FG001|Overall Study|Developed esophageal ca|0|||
16259989|NCT00214422|39436244|FG002|Overall Study|Developed esophageal ca|0|||
16441381|NCT02903914|40095761|FG004|Overall Study|Lost to Follow-up|2|||
16259990|NCT00214422|39436242|FG000|Overall Study|Pt taken off study|1|||
16259991|NCT00214422|39436243|FG001|Overall Study|Pt taken off study|1|||
16149006|NCT03882970|39030799|FG000|Overall Study|Physician Decision|0|||
16149007|NCT03882970|39030800|FG001|Overall Study|Physician Decision|2|||
16149008|NCT03882970|39030801|FG002|Overall Study|Physician Decision|2|||
16441382|NCT02903914|40095762|FG005|Overall Study|Lost to Follow-up|0|||
16441383|NCT02903914|40095763|FG006|Overall Study|Lost to Follow-up|1|||
16441384|NCT02903914|40095764|FG007|Overall Study|Lost to Follow-up|0|||
16441385|NCT02903914|40095757|FG000|Overall Study|Physician Decision|0|||
16441386|NCT02903914|40095758|FG001|Overall Study|Physician Decision|0|||
16441387|NCT02903914|40095759|FG002|Overall Study|Physician Decision|1|||
16441388|NCT02903914|40095760|FG003|Overall Study|Physician Decision|0|||
16441389|NCT02903914|40095761|FG004|Overall Study|Physician Decision|0|||
16441390|NCT02903914|40095762|FG005|Overall Study|Physician Decision|0|||
16441391|NCT02903914|40095763|FG006|Overall Study|Physician Decision|1|||
16441392|NCT02903914|40095764|FG007|Overall Study|Physician Decision|0|||
16441393|NCT02903914|40095757|FG000|Overall Study|Symptomatic Deterioration|0|||
16441394|NCT02903914|40095758|FG001|Overall Study|Symptomatic Deterioration|0|||
16441395|NCT02903914|40095759|FG002|Overall Study|Symptomatic Deterioration|1|||
16441396|NCT02903914|40095760|FG003|Overall Study|Symptomatic Deterioration|0|||
16441397|NCT02903914|40095761|FG004|Overall Study|Symptomatic Deterioration|0|||
16441398|NCT02903914|40095762|FG005|Overall Study|Symptomatic Deterioration|0|||
16441399|NCT02903914|40095763|FG006|Overall Study|Symptomatic Deterioration|0|||
16149009|NCT03882970|39030802|FG003|Overall Study|Physician Decision|2|||
16149010|NCT03882970|39030799|FG000|Overall Study|Protocol Violation|2|||
16149011|NCT03882970|39030800|FG001|Overall Study|Protocol Violation|0|||
16149012|NCT03882970|39030801|FG002|Overall Study|Protocol Violation|0|||
16149013|NCT03882970|39030802|FG003|Overall Study|Protocol Violation|0|||
16149014|NCT03882970|39030799|FG000|Overall Study|Withdrawal by Subject|8|||
16149015|NCT03882970|39030800|FG001|Overall Study|Withdrawal by Subject|17|||
16149016|NCT03882970|39030801|FG002|Overall Study|Withdrawal by Subject|7|||
16149017|NCT03882970|39030802|FG003|Overall Study|Withdrawal by Subject|22|||
16149018|NCT03882970|39030799|FG000|Overall Study|Personal Reason|2|||
16149019|NCT03882970|39030800|FG001|Overall Study|Personal Reason|3|||
16149020|NCT03882970|39030801|FG002|Overall Study|Personal Reason|1|||
16149021|NCT03882970|39030802|FG003|Overall Study|Personal Reason|3|||
16149022|NCT00388505|39030803|FG000|Overall Study|Adverse Event or Death|43|||
16149023|NCT00388505|39030804|FG001|Overall Study|Adverse Event or Death|17|||
16149024|NCT00388505|39030803|FG000|Overall Study|Withdrawal by Subject|24|||
16149025|NCT00388505|39030804|FG001|Overall Study|Withdrawal by Subject|9|||
16149026|NCT00388505|39030803|FG000|Overall Study|Lost to Follow-up|5|||
16149027|NCT00388505|39030804|FG001|Overall Study|Lost to Follow-up|3|||
16149028|NCT00388505|39030803|FG000|Overall Study|Inappropriate Enrollment|0|||
16149029|NCT00388505|39030804|FG001|Overall Study|Inappropriate Enrollment|1|||
16149030|NCT00388505|39030803|FG000|Overall Study|Administrative Reason|1|||
16149031|NCT00388505|39030804|FG001|Overall Study|Administrative Reason|0|||
16149032|NCT00388505|39030803|FG000|Overall Study|Protocol Violation|6|||
16149033|NCT00388505|39030804|FG001|Overall Study|Protocol Violation|5|||
16149034|NCT00388505|39030803|FG000|Overall Study|Unable to classify|4|||
16149035|NCT00388505|39030804|FG001|Overall Study|Unable to classify|3|||
16149036|NCT02164929|39030814|FG000|Overall Study|Converted to open procedure|1|||
16149037|NCT02164929|39030815|FG001|Overall Study|Converted to open procedure|0|||
16149038|NCT02164929|39030816|FG002|Overall Study|Converted to open procedure|0|||
16149039|NCT02164929|39030817|FG003|Overall Study|Converted to open procedure|2|||
16149040|NCT02164929|39030814|FG000|Overall Study|Failed regional block|0|||
16149041|NCT02164929|39030815|FG001|Overall Study|Failed regional block|0|||
16149042|NCT02164929|39030816|FG002|Overall Study|Failed regional block|1|||
16149043|NCT02164929|39030817|FG003|Overall Study|Failed regional block|0|||
16149044|NCT00794677|39030818|FG000|First Intervention|Withdrawal by Subject|2|||
16149045|NCT00794677|39030819|FG001|First Intervention|Withdrawal by Subject|0|||
16149046|NCT04037748|39030820|FG000|Treatment Period 1|Withdrawal by Subject|3|||
16149047|NCT04037748|39030821|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16149048|NCT04037748|39030820|FG000|Treatment Period 1|Adverse Event|1|||
16149049|NCT04037748|39030821|FG001|Treatment Period 1|Adverse Event|1|||
16441400|NCT02903914|40095764|FG007|Overall Study|Symptomatic Deterioration|0|||
16441401|NCT02903914|40095757|FG000|Overall Study|New Cancer Therapy|2|||
16441402|NCT02903914|40095758|FG001|Overall Study|New Cancer Therapy|2|||
16441403|NCT02903914|40095759|FG002|Overall Study|New Cancer Therapy|21|||
16149050|NCT04037748|39030820|FG000|Treatment Period 1|Protocol Violation|4|||
16149051|NCT04037748|39030821|FG001|Treatment Period 1|Protocol Violation|5|||
16149052|NCT04037748|39030820|FG000|Treatment Period 2|Adverse Event|0|||
16149053|NCT04037748|39030821|FG001|Treatment Period 2|Adverse Event|1|||
16149054|NCT04037748|39030820|FG000|Treatment Period 2|Protocol Violation|2|||
16149055|NCT04037748|39030821|FG001|Treatment Period 2|Protocol Violation|0|||
16149056|NCT03215771|39030828|FG000|Overall Study|Withdrawal by Subject|2|||
16149057|NCT03215771|39030828|FG000|Overall Study|Physician Decision|1|||
16441404|NCT02903914|40095760|FG003|Overall Study|New Cancer Therapy|4|||
16259992|NCT00214422|39436244|FG002|Overall Study|Pt taken off study|0|||
16259993|NCT00214422|39436242|FG000|Overall Study|Disease progression on study|1|||
16259994|NCT00214422|39436243|FG001|Overall Study|Disease progression on study|0|||
16259995|NCT00214422|39436244|FG002|Overall Study|Disease progression on study|0|||
16259996|NCT00214422|39436242|FG000|Overall Study|Unable to make a radiation treatment|0|||
16259997|NCT00214422|39436243|FG001|Overall Study|Unable to make a radiation treatment|0|||
16259998|NCT00214422|39436244|FG002|Overall Study|Unable to make a radiation treatment|1|||
16259999|NCT02549092|39436245|FG000|Treatment Period|Adverse Event|2|||
16260000|NCT02549092|39436246|FG001|Treatment Period|Adverse Event|2|||
16260001|NCT02549092|39436245|FG000|Treatment Period|Withdrawal by Subject|1|||
16260002|NCT02549092|39436246|FG001|Treatment Period|Withdrawal by Subject|3|||
16260003|NCT02549092|39436245|FG000|Treatment Period|Lack of Efficacy|0|||
16260004|NCT02549092|39436246|FG001|Treatment Period|Lack of Efficacy|2|||
16260005|NCT02549092|39436245|FG000|Extension/Transition Period|Adverse Event|1|||
16260006|NCT02549092|39436246|FG001|Extension/Transition Period|Adverse Event|1|||
16260007|NCT02549092|39436245|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
16260008|NCT02549092|39436246|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
16260009|NCT02549092|39436245|FG000|Extension/Transition Period|Other, Not Specified|4|||
16260010|NCT02549092|39436246|FG001|Extension/Transition Period|Other, Not Specified|2|||
16260011|NCT01918397|39436247|FG000|Overall Study|Never started treatment|2|||
16260012|NCT01918397|39436248|FG001|Overall Study|Never started treatment|1|||
16260013|NCT01918397|39436249|FG002|Overall Study|Never started treatment|0|||
16260014|NCT01918397|39436250|FG003|Overall Study|Never started treatment|0|||
16260015|NCT01918397|39436247|FG000|Overall Study|Adverse Event|1|||
16260016|NCT01918397|39436248|FG001|Overall Study|Adverse Event|1|||
16260017|NCT01918397|39436249|FG002|Overall Study|Adverse Event|1|||
16260018|NCT01918397|39436250|FG003|Overall Study|Adverse Event|0|||
16260019|NCT01918397|39436247|FG000|Overall Study|Lack of compliance|2|||
16260020|NCT01918397|39436248|FG001|Overall Study|Lack of compliance|2|||
16260021|NCT01918397|39436249|FG002|Overall Study|Lack of compliance|3|||
16260022|NCT01918397|39436250|FG003|Overall Study|Lack of compliance|0|||
16260023|NCT01918397|39436247|FG000|Overall Study|Pregnancy|0|||
16260024|NCT01918397|39436248|FG001|Overall Study|Pregnancy|1|||
16260025|NCT01918397|39436249|FG002|Overall Study|Pregnancy|0|||
16260026|NCT01918397|39436250|FG003|Overall Study|Pregnancy|0|||
16260027|NCT01918397|39436247|FG000|Overall Study|Rifampin susceptible|0|||
16260028|NCT01918397|39436248|FG001|Overall Study|Rifampin susceptible|0|||
16260029|NCT01918397|39436249|FG002|Overall Study|Rifampin susceptible|0|||
16260030|NCT01918397|39436250|FG003|Overall Study|Rifampin susceptible|2|||
16260031|NCT01918397|39436247|FG000|Overall Study|Treatment failure|0|||
16260032|NCT01918397|39436248|FG001|Overall Study|Treatment failure|0|||
16260033|NCT01918397|39436249|FG002|Overall Study|Treatment failure|0|||
16260034|NCT01918397|39436250|FG003|Overall Study|Treatment failure|1|||
16260035|NCT01918397|39436247|FG000|Overall Study|Withdrawal by Subject|3|||
16260036|NCT01918397|39436248|FG001|Overall Study|Withdrawal by Subject|2|||
16260037|NCT01918397|39436249|FG002|Overall Study|Withdrawal by Subject|1|||
16260038|NCT01918397|39436250|FG003|Overall Study|Withdrawal by Subject|1|||
16260039|NCT01918397|39436247|FG000|Overall Study|XDR at baseline|0|||
16260040|NCT01918397|39436248|FG001|Overall Study|XDR at baseline|0|||
16260041|NCT01918397|39436249|FG002|Overall Study|XDR at baseline|1|||
16260042|NCT01918397|39436250|FG003|Overall Study|XDR at baseline|0|||
16260043|NCT01918397|39436247|FG000|Overall Study|Lost to Follow-up|2|||
16260044|NCT01918397|39436248|FG001|Overall Study|Lost to Follow-up|1|||
16260045|NCT01918397|39436249|FG002|Overall Study|Lost to Follow-up|1|||
16260046|NCT01918397|39436250|FG003|Overall Study|Lost to Follow-up|1|||
16260047|NCT01918397|39436247|FG000|Overall Study|Increased QTc|1|||
16260048|NCT01918397|39436248|FG001|Overall Study|Increased QTc|0|||
16260049|NCT01918397|39436249|FG002|Overall Study|Increased QTc|0|||
16260050|NCT01918397|39436250|FG003|Overall Study|Increased QTc|1|||
16260051|NCT01918397|39436247|FG000|Overall Study|Death|0|||
16260052|NCT01918397|39436248|FG001|Overall Study|Death|0|||
16441405|NCT02903914|40095761|FG004|Overall Study|New Cancer Therapy|3|||
16441406|NCT02903914|40095762|FG005|Overall Study|New Cancer Therapy|6|||
16441407|NCT02903914|40095763|FG006|Overall Study|New Cancer Therapy|56|||
16441408|NCT02903914|40095764|FG007|Overall Study|New Cancer Therapy|3|||
16149058|NCT00549939|39030836|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
16149059|NCT00549939|39030837|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
16149060|NCT00549939|39030838|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
16149061|NCT00549939|39030836|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
16149062|NCT00549939|39030837|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
16149063|NCT00549939|39030838|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
16149064|NCT00549939|39030836|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
16149065|NCT00549939|39030837|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
16149066|NCT00549939|39030838|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
16149067|NCT00549939|39030836|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
16149068|NCT00549939|39030837|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
16149069|NCT00549939|39030838|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
16149070|NCT00549939|39030836|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
16441409|NCT02903914|40095757|FG000|Overall Study|Didn't Return to Site|1|||
16441410|NCT02903914|40095758|FG001|Overall Study|Didn't Return to Site|0|||
16441411|NCT02903914|40095759|FG002|Overall Study|Didn't Return to Site|1|||
16441412|NCT02903914|40095760|FG003|Overall Study|Didn't Return to Site|1|||
16441413|NCT02903914|40095761|FG004|Overall Study|Didn't Return to Site|0|||
16441414|NCT02903914|40095762|FG005|Overall Study|Didn't Return to Site|0|||
16441415|NCT02903914|40095763|FG006|Overall Study|Didn't Return to Site|2|||
16441416|NCT02903914|40095764|FG007|Overall Study|Didn't Return to Site|0|||
16441417|NCT02903914|40095757|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
16441418|NCT02903914|40095758|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
16441419|NCT02903914|40095759|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
16441420|NCT02903914|40095760|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
16441421|NCT02903914|40095761|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
16441422|NCT02903914|40095762|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
16441423|NCT02903914|40095763|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
16441424|NCT02903914|40095764|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
16441425|NCT02903914|40095757|FG000|Overall Study|Follow-up Did Not Occur|0|||
16441426|NCT02903914|40095758|FG001|Overall Study|Follow-up Did Not Occur|1|||
16149071|NCT00549939|39030837|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
16441427|NCT02903914|40095759|FG002|Overall Study|Follow-up Did Not Occur|1|||
16441428|NCT02903914|40095760|FG003|Overall Study|Follow-up Did Not Occur|0|||
16441429|NCT02903914|40095761|FG004|Overall Study|Follow-up Did Not Occur|2|||
16149072|NCT00549939|39030838|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
16149073|NCT00549939|39030836|FG000|40-week Open Label Treatment Period|Other|0|||
16149074|NCT00549939|39030837|FG001|40-week Open Label Treatment Period|Other|1|||
16149075|NCT00549939|39030838|FG002|40-week Open Label Treatment Period|Other|4|||
16149076|NCT01380730|39030842|FG000|Overall Study|Death|0|||
16149077|NCT01380730|39030843|FG001|Overall Study|Death|0|||
16149078|NCT01380730|39030844|FG002|Overall Study|Death|0|||
16149079|NCT01380730|39030845|FG003|Overall Study|Death|0|||
16149080|NCT01380730|39030846|FG004|Overall Study|Death|1|||
16149081|NCT01380730|39030847|FG005|Overall Study|Death|0|||
16149082|NCT01380730|39030848|FG006|Overall Study|Death|0|||
16441430|NCT02903914|40095762|FG005|Overall Study|Follow-up Did Not Occur|0|||
16441431|NCT02903914|40095763|FG006|Overall Study|Follow-up Did Not Occur|8|||
16441432|NCT02903914|40095764|FG007|Overall Study|Follow-up Did Not Occur|0|||
16441433|NCT02903914|40095757|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
16149083|NCT01380730|39030849|FG007|Overall Study|Death|0|||
16260053|NCT01918397|39436249|FG002|Overall Study|Death|1|||
16260054|NCT01918397|39436250|FG003|Overall Study|Death|0|||
16149084|NCT01054144|39030854|FG000|Overall Study|Death|2|||
16149085|NCT02375724|39030861|FG000|Overall Study|Lack of Efficacy|1|||
16149086|NCT02375724|39030862|FG001|Overall Study|Lack of Efficacy|1|||
16149087|NCT02375724|39030861|FG000|Overall Study|Withdrawal by Subject|1|||
16149088|NCT02375724|39030862|FG001|Overall Study|Withdrawal by Subject|1|||
16149089|NCT02375724|39030861|FG000|Overall Study|Lost to Follow-up|1|||
16149090|NCT02375724|39030862|FG001|Overall Study|Lost to Follow-up|0|||
16149091|NCT02375724|39030861|FG000|Overall Study|Protocol Violation|1|||
16149092|NCT02375724|39030862|FG001|Overall Study|Protocol Violation|0|||
16149093|NCT02375724|39030861|FG000|Overall Study|Adverse Event|2|||
16441434|NCT02903914|40095758|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
16441435|NCT02903914|40095759|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
16441436|NCT02903914|40095760|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
16441437|NCT02903914|40095761|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
16441438|NCT02903914|40095762|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
16441439|NCT02903914|40095763|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
16441440|NCT02903914|40095764|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
16149094|NCT02375724|39030862|FG001|Overall Study|Adverse Event|4|||
16149095|NCT02347098|39030863|FG000|Overall Study|Death|1|||
16149096|NCT02347098|39030864|FG001|Overall Study|Death|0|||
16149097|NCT02347098|39030863|FG000|Overall Study|Withdrawal by Subject|1|||
16149098|NCT02347098|39030864|FG001|Overall Study|Withdrawal by Subject|0|||
16149099|NCT02347098|39030863|FG000|Overall Study|Lost to Follow-up|2|||
16149100|NCT02347098|39030864|FG001|Overall Study|Lost to Follow-up|2|||
16149101|NCT02347098|39030863|FG000|Overall Study|Refuse Follow-up Visit|1|||
16149102|NCT02347098|39030864|FG001|Overall Study|Refuse Follow-up Visit|5|||
16149103|NCT02347098|39030863|FG000|Overall Study|no visit due to illness|2|||
16149104|NCT02347098|39030864|FG001|Overall Study|no visit due to illness|1|||
16149105|NCT00574275|39030865|FG000|Overall Study|Randomized but not treated|2|||
16149106|NCT00574275|39030866|FG001|Overall Study|Randomized but not treated|3|||
16149107|NCT00574275|39030865|FG000|Overall Study|Adverse Event|32|||
16149108|NCT00574275|39030866|FG001|Overall Study|Adverse Event|76|||
16149109|NCT00574275|39030865|FG000|Overall Study|Disease progression|160|||
16149110|NCT00574275|39030866|FG001|Overall Study|Disease progression|146|||
16149111|NCT00574275|39030865|FG000|Overall Study|Lost to Follow-up|2|||
16149112|NCT00574275|39030866|FG001|Overall Study|Lost to Follow-up|1|||
16149113|NCT00574275|39030865|FG000|Overall Study|Study stopped based on DMC decision|62|||
16149114|NCT00574275|39030866|FG001|Overall Study|Study stopped based on DMC decision|23|||
16149115|NCT00574275|39030865|FG000|Overall Study|Withdrawal by Subject|15|||
16149116|NCT00574275|39030866|FG001|Overall Study|Withdrawal by Subject|17|||
16149117|NCT00574275|39030865|FG000|Overall Study|Error calculating tumor measurement|1|||
16149118|NCT00574275|39030866|FG001|Overall Study|Error calculating tumor measurement|0|||
16149119|NCT00574275|39030865|FG000|Overall Study|Physician Decision|1|||
16441441|NCT02903914|40095757|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
16441442|NCT02903914|40095758|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
16441443|NCT02903914|40095759|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
16441444|NCT02903914|40095760|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
16441445|NCT02903914|40095761|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
16441446|NCT02903914|40095762|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
16441447|NCT02903914|40095763|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
16441448|NCT02903914|40095764|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
16441449|NCT02903914|40095757|FG000|Overall Study|Clinical Disease Progression|0|||
16441450|NCT02903914|40095758|FG001|Overall Study|Clinical Disease Progression|0|||
16441451|NCT02903914|40095759|FG002|Overall Study|Clinical Disease Progression|2|||
16441452|NCT02903914|40095760|FG003|Overall Study|Clinical Disease Progression|0|||
16441453|NCT02903914|40095761|FG004|Overall Study|Clinical Disease Progression|0|||
16441454|NCT02903914|40095762|FG005|Overall Study|Clinical Disease Progression|0|||
16441455|NCT02903914|40095763|FG006|Overall Study|Clinical Disease Progression|0|||
16441456|NCT02903914|40095764|FG007|Overall Study|Clinical Disease Progression|0|||
16441457|NCT02903914|40095757|FG000|Overall Study|Completed Follow-up Period|0|||
16441458|NCT02903914|40095758|FG001|Overall Study|Completed Follow-up Period|0|||
16441459|NCT02903914|40095759|FG002|Overall Study|Completed Follow-up Period|6|||
16441460|NCT02903914|40095760|FG003|Overall Study|Completed Follow-up Period|2|||
16441461|NCT02903914|40095761|FG004|Overall Study|Completed Follow-up Period|1|||
16441462|NCT02903914|40095762|FG005|Overall Study|Completed Follow-up Period|0|||
16441463|NCT02903914|40095763|FG006|Overall Study|Completed Follow-up Period|9|||
16441464|NCT02903914|40095764|FG007|Overall Study|Completed Follow-up Period|1|||
16441465|NCT02903914|40095757|FG000|Overall Study|Taken off Treatment per Protocol|0|||
16441466|NCT02903914|40095758|FG001|Overall Study|Taken off Treatment per Protocol|0|||
16149120|NCT00574275|39030866|FG001|Overall Study|Physician Decision|1|||
16149121|NCT00574275|39030865|FG000|Overall Study|Protocol Violation|0|||
16149122|NCT00574275|39030866|FG001|Overall Study|Protocol Violation|1|||
16149123|NCT00574275|39030865|FG000|Overall Study|Patient and Investigator decision|0|||
16149124|NCT00574275|39030866|FG001|Overall Study|Patient and Investigator decision|1|||
16149125|NCT00574275|39030865|FG000|Overall Study|Insurance change|0|||
16149126|NCT00574275|39030866|FG001|Overall Study|Insurance change|1|||
16149127|NCT00574275|39030865|FG000|Overall Study|Operation for curative intent|0|||
16149128|NCT00574275|39030866|FG001|Overall Study|Operation for curative intent|1|||
16149129|NCT05289570|39030870|FG000|Overall Study|Physician Decision|1|||
16149130|NCT02053168|39030871|FG000|Overall Study|Withdrawal by Subject|1|||
16149131|NCT02053168|39030871|FG000|Overall Study|Physician Decision|1|||
16149132|NCT02053168|39030871|FG000|Overall Study|Lost to Follow-up|1|||
16149133|NCT03668600|39030872|FG000|Overall Study|Study Terminated by the Sponsor|157|||
16149134|NCT03668600|39030872|FG000|Overall Study|Protocol Violation|1|||
16149135|NCT03668600|39030872|FG000|Overall Study|Pregnancy|1|||
16149136|NCT03668600|39030872|FG000|Overall Study|Lost to Follow-up|7|||
16149137|NCT03668600|39030872|FG000|Overall Study|Withdrawal by Subject|56|||
16149138|NCT03668600|39030872|FG000|Overall Study|Lack of Efficacy|7|||
16149139|NCT03668600|39030872|FG000|Overall Study|Adverse Event|1|||
16149140|NCT01430455|39033403|FG000|Overall Study|Withdrawal by Subject|1|||
16149141|NCT01430455|39033403|FG000|Overall Study|Switched to follow-up phase|1|||
16149142|NCT02316340|39033407|FG000|First Progression|Clinical progression|2|||
16149143|NCT02316340|39033408|FG001|First Progression|Clinical progression|1|||
16149144|NCT02316340|39033407|FG000|First Progression|Withdrawal by Subject|1|||
16149145|NCT02316340|39033408|FG001|First Progression|Withdrawal by Subject|0|||
16149146|NCT03155997|39033409|FG000|Overall Study|Withdrawal by Subject|119|||
16149147|NCT03155997|39033410|FG001|Overall Study|Withdrawal by Subject|134|||
16149148|NCT03155997|39033409|FG000|Overall Study|Lost to Follow-up|12|||
16149149|NCT03155997|39033410|FG001|Overall Study|Lost to Follow-up|13|||
16149150|NCT03155997|39033409|FG000|Overall Study|Missing disposition data|0|||
16149151|NCT03155997|39033410|FG001|Overall Study|Missing disposition data|1|||
16149152|NCT03155997|39033409|FG000|Overall Study|On study treatment|2027|||
16149153|NCT03155997|39033410|FG001|Overall Study|On study treatment|2074|||
16149154|NCT00402649|39033416|FG000|Overall Study|Lost to Follow-up|1|||
16149155|NCT00402649|39033416|FG000|Overall Study|Withdrawal by Subject|1|||
16149156|NCT01486927|39033417|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
16149157|NCT01486927|39033417|FG000|Overall Study|Physician Decision|1|||
16149158|NCT01486927|39033417|FG000|Overall Study|50 Exposure days not reached|2|||
16149159|NCT01486927|39033417|FG000|Overall Study|Withdrawal by Subject|8|||
16149160|NCT01486927|39033417|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
16149161|NCT03044249|39033419|FG000|Overall Study|Adverse Event|4|||
16149162|NCT03044249|39033420|FG001|Overall Study|Adverse Event|9|||
16149163|NCT03044249|39033419|FG000|Overall Study|Lost to Follow-up|1|||
16149164|NCT03044249|39033420|FG001|Overall Study|Lost to Follow-up|0|||
16149165|NCT03044249|39033419|FG000|Overall Study|Non-compliance with Study Drug|1|||
16149166|NCT03044249|39033420|FG001|Overall Study|Non-compliance with Study Drug|0|||
16149167|NCT03044249|39033419|FG000|Overall Study|Study Terminated by Sponsor|2|||
16149168|NCT03044249|39033420|FG001|Overall Study|Study Terminated by Sponsor|0|||
16149169|NCT03044249|39033419|FG000|Overall Study|Withdrawal by Subject|2|||
16149170|NCT03044249|39033420|FG001|Overall Study|Withdrawal by Subject|5|||
16441467|NCT02903914|40095759|FG002|Overall Study|Taken off Treatment per Protocol|0|||
16441468|NCT02903914|40095760|FG003|Overall Study|Taken off Treatment per Protocol|0|||
16441469|NCT02903914|40095761|FG004|Overall Study|Taken off Treatment per Protocol|0|||
16441470|NCT02903914|40095762|FG005|Overall Study|Taken off Treatment per Protocol|1|||
16441471|NCT02903914|40095763|FG006|Overall Study|Taken off Treatment per Protocol|0|||
16441472|NCT02903914|40095764|FG007|Overall Study|Taken off Treatment per Protocol|0|||
16441473|NCT02903914|40095757|FG000|Overall Study|Refused Further Treatment/Contact|0|||
16441474|NCT02903914|40095758|FG001|Overall Study|Refused Further Treatment/Contact|0|||
16441475|NCT02903914|40095759|FG002|Overall Study|Refused Further Treatment/Contact|0|||
16441476|NCT02903914|40095760|FG003|Overall Study|Refused Further Treatment/Contact|0|||
16441477|NCT02903914|40095761|FG004|Overall Study|Refused Further Treatment/Contact|0|||
16441478|NCT02903914|40095762|FG005|Overall Study|Refused Further Treatment/Contact|0|||
16441479|NCT02903914|40095763|FG006|Overall Study|Refused Further Treatment/Contact|1|||
16441480|NCT02903914|40095764|FG007|Overall Study|Refused Further Treatment/Contact|0|||
16441481|NCT02903914|40095757|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
16441482|NCT02903914|40095758|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
16441483|NCT02903914|40095759|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
16441484|NCT02903914|40095760|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
16441485|NCT02903914|40095761|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
16441486|NCT02903914|40095762|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
16441487|NCT02903914|40095763|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
16149171|NCT01892163|39033421|FG000|Overall Study|Death|1|||
16149172|NCT01892163|39033422|FG001|Overall Study|Death|1|||
16149173|NCT01892163|39033421|FG000|Overall Study|Lost to Follow-up|1|||
16149174|NCT01892163|39033422|FG001|Overall Study|Lost to Follow-up|0|||
16441488|NCT02903914|40095764|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
16441489|NCT03532542|40095765|FG000|Overall Study|Death|1|||
16441490|NCT03532542|40095766|FG001|Overall Study|Death|0|||
16441491|NCT03532542|40095765|FG000|Overall Study|Study Terminated by Sponsor|41|||
16441492|NCT03532542|40095766|FG001|Overall Study|Study Terminated by Sponsor|65|||
16441493|NCT03532542|40095765|FG000|Overall Study|Withdrawal by Subject|6|||
16441494|NCT03532542|40095766|FG001|Overall Study|Withdrawal by Subject|5|||
16441495|NCT05789745|40095770|FG000|Overall Study|Withdrawal by Subject|0|||
16441496|NCT05789745|40095771|FG001|Overall Study|Withdrawal by Subject|0|||
16441497|NCT05789745|40095772|FG002|Overall Study|Withdrawal by Subject|0|||
16441498|NCT05789745|40095773|FG003|Overall Study|Withdrawal by Subject|0|||
16441499|NCT05789745|40095774|FG004|Overall Study|Withdrawal by Subject|1|||
16441500|NCT03379818|40095779|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
16441501|NCT03379818|40095780|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
16441502|NCT03379818|40095779|FG000|Overall Study|Withdrawal by Subject|2|||
16441503|NCT03379818|40095780|FG001|Overall Study|Withdrawal by Subject|3|||
16441504|NCT03379818|40095779|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
16441505|NCT03379818|40095780|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
16441506|NCT04742556|40095781|FG000|Overall Study|Withdrawal by Subject|0|||
16441507|NCT04742556|40095782|FG001|Overall Study|Withdrawal by Subject|1|||
16441508|NCT04742556|40095783|FG002|Overall Study|Withdrawal by Subject|0|||
16441509|NCT04742556|40095781|FG000|Overall Study|Adverse Event|0|||
16441510|NCT04742556|40095782|FG001|Overall Study|Adverse Event|0|||
16149175|NCT05162027|39033425|FG000|Overall Study|Adverse Event|1|||
16149176|NCT05162027|39033426|FG001|Overall Study|Adverse Event|0|||
16149177|NCT01840579|39033427|FG000|Overall Study|Status not recorded|0|||
16149178|NCT01840579|39033428|FG001|Overall Study|Status not recorded|0|||
16149179|NCT01840579|39033429|FG002|Overall Study|Status not recorded|2|||
16149180|NCT01840579|39033430|FG003|Overall Study|Status not recorded|3|||
16149181|NCT01840579|39033431|FG004|Overall Study|Status not recorded|4|||
16149182|NCT01840579|39033432|FG005|Overall Study|Status not recorded|3|||
16149183|NCT01840579|39033433|FG006|Overall Study|Status not recorded|0|||
16149184|NCT01840579|39033434|FG007|Overall Study|Status not recorded|3|||
16149185|NCT01840579|39033435|FG008|Overall Study|Status not recorded|3|||
16149186|NCT01840579|39033436|FG009|Overall Study|Status not recorded|3|||
16149187|NCT01840579|39033427|FG000|Overall Study|Progressive disease|3|||
16149188|NCT01840579|39033428|FG001|Overall Study|Progressive disease|5|||
16149189|NCT01840579|39033429|FG002|Overall Study|Progressive disease|0|||
16149190|NCT01840579|39033430|FG003|Overall Study|Progressive disease|0|||
16149191|NCT01840579|39033431|FG004|Overall Study|Progressive disease|0|||
16149192|NCT01840579|39033432|FG005|Overall Study|Progressive disease|0|||
16149193|NCT01840579|39033433|FG006|Overall Study|Progressive disease|0|||
16149194|NCT01840579|39033434|FG007|Overall Study|Progressive disease|0|||
16149195|NCT01840579|39033435|FG008|Overall Study|Progressive disease|0|||
16441511|NCT04742556|40095783|FG002|Overall Study|Adverse Event|2|||
16441512|NCT04742556|40095781|FG000|Overall Study|Clinical disease progression|0|||
16441513|NCT04742556|40095782|FG001|Overall Study|Clinical disease progression|1|||
16441514|NCT04742556|40095783|FG002|Overall Study|Clinical disease progression|2|||
16441515|NCT04742556|40095781|FG000|Overall Study|Objective disease progression|3|||
16441516|NCT04742556|40095782|FG001|Overall Study|Objective disease progression|2|||
16441517|NCT04742556|40095783|FG002|Overall Study|Objective disease progression|4|||
16441518|NCT04426318|40095784|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
16441519|NCT04426318|40095785|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
16441520|NCT04247347|40095787|FG000|Overall Study|Withdrawal by Subject|2|||
16441521|NCT04247347|40095788|FG001|Overall Study|Withdrawal by Subject|3|||
16441522|NCT04247347|40095789|FG002|Overall Study|Withdrawal by Subject|3|||
16441523|NCT04247347|40095787|FG000|Overall Study|Lost to Follow-up|1|||
16441524|NCT04247347|40095788|FG001|Overall Study|Lost to Follow-up|1|||
16441525|NCT04247347|40095789|FG002|Overall Study|Lost to Follow-up|1|||
16441526|NCT04179500|40095792|FG000|Treatment|Withdrawal by Subject|1|||
16149196|NCT01840579|39033436|FG009|Overall Study|Progressive disease|0|||
16149197|NCT01840579|39033427|FG000|Overall Study|Ongoing in study|0|||
16149198|NCT01840579|39033428|FG001|Overall Study|Ongoing in study|1|||
16149199|NCT01840579|39033429|FG002|Overall Study|Ongoing in study|0|||
16149200|NCT01840579|39033430|FG003|Overall Study|Ongoing in study|0|||
16149201|NCT01840579|39033431|FG004|Overall Study|Ongoing in study|0|||
16149202|NCT01840579|39033432|FG005|Overall Study|Ongoing in study|0|||
16149203|NCT01840579|39033433|FG006|Overall Study|Ongoing in study|0|||
16149204|NCT01840579|39033434|FG007|Overall Study|Ongoing in study|0|||
16441527|NCT04179500|40095792|FG000|Treatment|Adverse Event|2|||
16149205|NCT01840579|39033435|FG008|Overall Study|Ongoing in study|0|||
16149206|NCT01840579|39033436|FG009|Overall Study|Ongoing in study|0|||
16149207|NCT01840579|39033427|FG000|Overall Study|Death|0|||
16441528|NCT04179500|40095792|FG000|Treatment|pyrazinamide resistance|1|||
16149208|NCT01840579|39033428|FG001|Overall Study|Death|0|||
16149209|NCT01840579|39033429|FG002|Overall Study|Death|0|||
16149210|NCT01840579|39033430|FG003|Overall Study|Death|0|||
16149211|NCT01840579|39033431|FG004|Overall Study|Death|0|||
16149212|NCT01840579|39033432|FG005|Overall Study|Death|1|||
16149213|NCT01840579|39033433|FG006|Overall Study|Death|0|||
16149214|NCT01840579|39033434|FG007|Overall Study|Death|0|||
16149215|NCT01840579|39033435|FG008|Overall Study|Death|0|||
16149216|NCT01840579|39033436|FG009|Overall Study|Death|0|||
16149217|NCT01840579|39033427|FG000|Overall Study|Adverse Event|0|||
16149218|NCT01840579|39033428|FG001|Overall Study|Adverse Event|1|||
16149219|NCT01840579|39033429|FG002|Overall Study|Adverse Event|0|||
16149220|NCT01840579|39033430|FG003|Overall Study|Adverse Event|0|||
16149221|NCT01840579|39033431|FG004|Overall Study|Adverse Event|0|||
16149222|NCT01840579|39033432|FG005|Overall Study|Adverse Event|0|||
16149223|NCT01840579|39033433|FG006|Overall Study|Adverse Event|0|||
16149224|NCT01840579|39033434|FG007|Overall Study|Adverse Event|0|||
16149225|NCT01840579|39033435|FG008|Overall Study|Adverse Event|0|||
16149226|NCT01840579|39033436|FG009|Overall Study|Adverse Event|0|||
16149227|NCT01840579|39033427|FG000|Overall Study|Follow-up ended by Sponsor|0|||
16149228|NCT01840579|39033428|FG001|Overall Study|Follow-up ended by Sponsor|0|||
16149229|NCT01840579|39033429|FG002|Overall Study|Follow-up ended by Sponsor|0|||
16149230|NCT01840579|39033430|FG003|Overall Study|Follow-up ended by Sponsor|0|||
16149231|NCT01840579|39033431|FG004|Overall Study|Follow-up ended by Sponsor|0|||
16149232|NCT01840579|39033432|FG005|Overall Study|Follow-up ended by Sponsor|0|||
16149233|NCT01840579|39033433|FG006|Overall Study|Follow-up ended by Sponsor|2|||
16149234|NCT01840579|39033434|FG007|Overall Study|Follow-up ended by Sponsor|0|||
16149235|NCT01840579|39033435|FG008|Overall Study|Follow-up ended by Sponsor|0|||
16149236|NCT01840579|39033436|FG009|Overall Study|Follow-up ended by Sponsor|0|||
16149237|NCT03349775|39033438|FG000|Overall Study|Side Effects|1|||
16149238|NCT03349775|39033439|FG001|Overall Study|Side Effects|2|||
16149239|NCT03349775|39033438|FG000|Overall Study|Withdrawal by Subject|1|||
16149240|NCT03349775|39033439|FG001|Overall Study|Withdrawal by Subject|1|||
16149241|NCT03349775|39033438|FG000|Overall Study|No primary outcome measurements|0|||
16149242|NCT03349775|39033439|FG001|Overall Study|No primary outcome measurements|1|||
16149243|NCT01439555|39033442|FG000|Overall Study|Protocol Violation|1|||
16149244|NCT01349465|39033447|FG000|Overall Study|Adverse Event|1|||
16149245|NCT01349465|39033448|FG001|Overall Study|Adverse Event|0|||
16149246|NCT01349465|39033447|FG000|Overall Study|Death|3|||
16149247|NCT01349465|39033448|FG001|Overall Study|Death|0|||
16149248|NCT01349465|39033447|FG000|Overall Study|Lost to Follow-up|10|||
16149249|NCT01349465|39033448|FG001|Overall Study|Lost to Follow-up|1|||
16149250|NCT01349465|39033447|FG000|Overall Study|Withdrawal by Subject|4|||
16149251|NCT01349465|39033448|FG001|Overall Study|Withdrawal by Subject|2|||
16149252|NCT01349465|39033447|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
16149253|NCT01349465|39033448|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
16149254|NCT01469182|39033458|FG000|Overall Study|Adverse Event|21|||
16149255|NCT01469182|39033459|FG001|Overall Study|Adverse Event|3|||
16149256|NCT01469182|39033458|FG000|Overall Study|Lost to Follow-up|3|||
16149257|NCT01469182|39033459|FG001|Overall Study|Lost to Follow-up|0|||
16149258|NCT01469182|39033458|FG000|Overall Study|Withdrawal by Subject|4|||
16149259|NCT01469182|39033459|FG001|Overall Study|Withdrawal by Subject|1|||
16149260|NCT01469182|39033458|FG000|Overall Study|Protocol Violation|4|||
16149261|NCT01469182|39033459|FG001|Overall Study|Protocol Violation|2|||
16149262|NCT01469182|39033458|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
16149263|NCT01469182|39033459|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
16149264|NCT00645593|39033460|FG000|Overall Study|Later found to be ineligible|1|||
16149265|NCT00645593|39033461|FG001|Overall Study|Later found to be ineligible|0|||
16149266|NCT01081912|39033462|FG000|Conversion/Titration|Adverse Event|47|||
16149267|NCT01081912|39033463|FG001|Conversion/Titration|Adverse Event|0|||
16149268|NCT01081912|39033464|FG002|Conversion/Titration|Adverse Event|0|||
16149269|NCT01081912|39033462|FG000|Conversion/Titration|Lack of Efficacy|17|||
16149270|NCT01081912|39033463|FG001|Conversion/Titration|Lack of Efficacy|0|||
16149271|NCT01081912|39033464|FG002|Conversion/Titration|Lack of Efficacy|0|||
16149272|NCT01081912|39033462|FG000|Conversion/Titration|Lost to Follow-up|5|||
16149273|NCT01081912|39033463|FG001|Conversion/Titration|Lost to Follow-up|0|||
16149274|NCT01081912|39033464|FG002|Conversion/Titration|Lost to Follow-up|0|||
16149275|NCT01081912|39033462|FG000|Conversion/Titration|Physician Decision|2|||
16149276|NCT01081912|39033463|FG001|Conversion/Titration|Physician Decision|0|||
16149277|NCT01081912|39033464|FG002|Conversion/Titration|Physician Decision|0|||
16149278|NCT01081912|39033462|FG000|Conversion/Titration|Protocol Violation|67|||
16149279|NCT01081912|39033463|FG001|Conversion/Titration|Protocol Violation|0|||
16149280|NCT01081912|39033464|FG002|Conversion/Titration|Protocol Violation|0|||
16149281|NCT01081912|39033462|FG000|Conversion/Titration|Withdrawal by Subject|23|||
16149282|NCT01081912|39033463|FG001|Conversion/Titration|Withdrawal by Subject|0|||
16149283|NCT01081912|39033464|FG002|Conversion/Titration|Withdrawal by Subject|0|||
16149284|NCT01081912|39033462|FG000|Conversion/Titration|Non-Compliance|47|||
16149285|NCT01081912|39033463|FG001|Conversion/Titration|Non-Compliance|0|||
16149286|NCT01081912|39033464|FG002|Conversion/Titration|Non-Compliance|0|||
16149287|NCT01081912|39033462|FG000|Maintenance Treatment|Adverse Event|0|||
16149288|NCT01081912|39033463|FG001|Maintenance Treatment|Adverse Event|2|||
16149289|NCT01081912|39033464|FG002|Maintenance Treatment|Adverse Event|12|||
16149290|NCT01081912|39033462|FG000|Maintenance Treatment|Lack of Efficacy|0|||
16149291|NCT01081912|39033463|FG001|Maintenance Treatment|Lack of Efficacy|14|||
16149292|NCT01081912|39033464|FG002|Maintenance Treatment|Lack of Efficacy|64|||
16149293|NCT01081912|39033462|FG000|Maintenance Treatment|Lost to Follow-up|0|||
16149294|NCT01081912|39033463|FG001|Maintenance Treatment|Lost to Follow-up|1|||
16149295|NCT01081912|39033464|FG002|Maintenance Treatment|Lost to Follow-up|0|||
16149296|NCT01081912|39033462|FG000|Maintenance Treatment|Physician Decision|0|||
16149297|NCT01081912|39033463|FG001|Maintenance Treatment|Physician Decision|0|||
16149298|NCT01081912|39033464|FG002|Maintenance Treatment|Physician Decision|1|||
16149299|NCT01081912|39033462|FG000|Maintenance Treatment|Protocol Violation|0|||
16149300|NCT01081912|39033463|FG001|Maintenance Treatment|Protocol Violation|1|||
16149301|NCT01081912|39033464|FG002|Maintenance Treatment|Protocol Violation|2|||
16149302|NCT01081912|39033462|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
16441529|NCT04663321|40095793|FG000|Overall Study|Study terminated by Sponsor|2|||
16441530|NCT04663321|40095794|FG001|Overall Study|Study terminated by Sponsor|1|||
16441531|NCT04663321|40095795|FG002|Overall Study|Study terminated by Sponsor|2|||
16441532|NCT04663321|40095793|FG000|Overall Study|Withdrawal by Subject|10|||
16441533|NCT04663321|40095794|FG001|Overall Study|Withdrawal by Subject|3|||
16441534|NCT04663321|40095795|FG002|Overall Study|Withdrawal by Subject|2|||
16441535|NCT04663321|40095793|FG000|Overall Study|Not provided|0|||
16441536|NCT04663321|40095794|FG001|Overall Study|Not provided|0|||
16441537|NCT04663321|40095795|FG002|Overall Study|Not provided|1|||
16441538|NCT04617782|40095796|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
16441539|NCT04617782|40095796|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
16441540|NCT04617782|40095796|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
16441541|NCT04617782|40095796|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
16441542|NCT04617782|40095796|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
16149303|NCT01081912|39033463|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
16149304|NCT01081912|39033464|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
16149305|NCT01081912|39033462|FG000|Maintenance Treatment|Non-Compliance|0|||
16441543|NCT04617782|40095796|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
16441544|NCT02476916|40095797|FG000|Core Period|Adverse Event|2|||
16441545|NCT02476916|40095798|FG001|Core Period|Adverse Event|2|||
16441546|NCT02476916|40095797|FG000|Core Period|Investigator decision|1|||
16441547|NCT02476916|40095798|FG001|Core Period|Investigator decision|1|||
16441548|NCT02476916|40095797|FG000|Core Period|Withdrawal by Subject|3|||
16149306|NCT01081912|39033463|FG001|Maintenance Treatment|Non-Compliance|4|||
16149307|NCT01081912|39033464|FG002|Maintenance Treatment|Non-Compliance|7|||
16149308|NCT01081912|39033462|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
16149309|NCT01081912|39033463|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
16149310|NCT01081912|39033464|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
16149311|NCT03654976|39033470|FG000|Overall Study|Withdrawal by Subject|12|||
16441549|NCT02476916|40095798|FG001|Core Period|Withdrawal by Subject|0|||
16441550|NCT02476916|40095797|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
16441551|NCT02476916|40095798|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
16441552|NCT02476916|40095797|FG000|Extension Period|On Treatment|12|||
16441553|NCT02476916|40095798|FG001|Extension Period|On Treatment|17|||
16441554|NCT05280717|40095799|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
16441555|NCT05280717|40095800|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
16441556|NCT05280717|40095801|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
16441557|NCT05280717|40095802|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
16441558|NCT05280717|40095803|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
16441559|NCT05280717|40095804|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
16441560|NCT05280717|40095805|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
16441561|NCT05280717|40095799|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
16441562|NCT05280717|40095800|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
16441563|NCT05280717|40095801|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
16441564|NCT05280717|40095802|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
16441565|NCT05280717|40095803|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
16441566|NCT05280717|40095804|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
16441567|NCT05280717|40095805|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
16441568|NCT05280717|40095799|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
16441569|NCT05280717|40095800|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
16441570|NCT05280717|40095801|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
16441571|NCT05280717|40095802|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
16149312|NCT03654976|39033471|FG001|Overall Study|Withdrawal by Subject|11|||
16149313|NCT03654976|39033470|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
16149314|NCT03654976|39033471|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
16149315|NCT03654976|39033470|FG000|Overall Study|Adverse Event|5|||
16149316|NCT03654976|39033471|FG001|Overall Study|Adverse Event|0|||
16149317|NCT03654976|39033470|FG000|Overall Study|Lost to Follow-up|2|||
16441572|NCT05280717|40095803|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
16441573|NCT05280717|40095804|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
16441574|NCT05280717|40095805|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
16441575|NCT05280717|40095799|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
16441576|NCT05280717|40095800|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
16149318|NCT03654976|39033471|FG001|Overall Study|Lost to Follow-up|0|||
16149319|NCT03654976|39033470|FG000|Overall Study|Lack of Efficacy|0|||
16149320|NCT03654976|39033471|FG001|Overall Study|Lack of Efficacy|1|||
16149321|NCT03029143|39033472|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
16149322|NCT03029143|39033473|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
16149323|NCT03029143|39033474|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
16149324|NCT03029143|39033472|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
16149325|NCT03029143|39033473|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
16149326|NCT03029143|39033474|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
16260055|NCT01918397|39436247|FG000|Overall Study|Involved in another investigative trial|0|||
16260056|NCT01918397|39436248|FG001|Overall Study|Involved in another investigative trial|0|||
16260057|NCT01918397|39436249|FG002|Overall Study|Involved in another investigative trial|0|||
16260058|NCT01918397|39436250|FG003|Overall Study|Involved in another investigative trial|1|||
16260059|NCT00862979|39436252|FG000|Overall Study|Adverse Event|6|||
16260060|NCT00862979|39436253|FG001|Overall Study|Adverse Event|3|||
16260061|NCT00862979|39436252|FG000|Overall Study|Protocol Violation|0|||
16260062|NCT00862979|39436253|FG001|Overall Study|Protocol Violation|1|||
16260063|NCT00862979|39436252|FG000|Overall Study|Patient withdrew consent|2|||
16260064|NCT00862979|39436253|FG001|Overall Study|Patient withdrew consent|1|||
16260065|NCT00862979|39436252|FG000|Overall Study|Administrative problems|0|||
16260066|NCT00862979|39436253|FG001|Overall Study|Administrative problems|1|||
16260067|NCT00862979|39436252|FG000|Overall Study|Death|0|||
16260068|NCT00862979|39436253|FG001|Overall Study|Death|1|||
16260069|NCT02127281|39436257|FG000|Overall Study|Lost to Follow-up|1|||
16260070|NCT02127281|39436258|FG001|Overall Study|Lost to Follow-up|0|||
16260071|NCT00855738|39436267|FG000|Overall Study|Lost to Follow-up|2|||
16260072|NCT00855738|39436267|FG000|Overall Study|Adverse Event|1|||
16260073|NCT00855738|39436267|FG000|Overall Study|Subject Defaulted|1|||
16260074|NCT00855738|39436267|FG000|Overall Study|Death|1|||
16260075|NCT02587962|39436268|FG000|Overall Study|Adverse Event|0|||
16260076|NCT02587962|39436269|FG001|Overall Study|Adverse Event|0|||
16260077|NCT02587962|39436270|FG002|Overall Study|Adverse Event|1|||
16260078|NCT02587962|39436271|FG003|Overall Study|Adverse Event|0|||
16260079|NCT02587962|39436272|FG004|Overall Study|Adverse Event|0|||
16260080|NCT02587962|39436268|FG000|Overall Study|Withdrawal by Subject|0|||
16260081|NCT02587962|39436269|FG001|Overall Study|Withdrawal by Subject|0|||
16260082|NCT02587962|39436270|FG002|Overall Study|Withdrawal by Subject|1|||
16260083|NCT02587962|39436271|FG003|Overall Study|Withdrawal by Subject|1|||
16260084|NCT02587962|39436272|FG004|Overall Study|Withdrawal by Subject|4|||
16260085|NCT02587962|39436268|FG000|Overall Study|Radiological progression|2|||
16260086|NCT02587962|39436269|FG001|Overall Study|Radiological progression|2|||
16260087|NCT02587962|39436270|FG002|Overall Study|Radiological progression|2|||
16260088|NCT02587962|39436271|FG003|Overall Study|Radiological progression|5|||
16260089|NCT02587962|39436272|FG004|Overall Study|Radiological progression|10|||
16260090|NCT02587962|39436268|FG000|Overall Study|Clinical progression|0|||
16260091|NCT02587962|39436269|FG001|Overall Study|Clinical progression|1|||
16260092|NCT02587962|39436270|FG002|Overall Study|Clinical progression|2|||
16260093|NCT02587962|39436271|FG003|Overall Study|Clinical progression|0|||
16260094|NCT02587962|39436272|FG004|Overall Study|Clinical progression|1|||
16260095|NCT01710657|39436273|FG000|Overall Study|Lost to Follow-up|2|||
16260096|NCT01710657|39436274|FG001|Overall Study|Lost to Follow-up|0|||
16260097|NCT01710657|39436275|FG002|Overall Study|Lost to Follow-up|1|||
16260098|NCT01710657|39436273|FG000|Overall Study|Protocol Violation|2|||
16260099|NCT01710657|39436274|FG001|Overall Study|Protocol Violation|2|||
16260100|NCT01710657|39436275|FG002|Overall Study|Protocol Violation|0|||
16260101|NCT01710657|39436273|FG000|Overall Study|Adverse Event|14|||
16260102|NCT01710657|39436274|FG001|Overall Study|Adverse Event|8|||
16260103|NCT01710657|39436275|FG002|Overall Study|Adverse Event|28|||
16260104|NCT01710657|39436273|FG000|Overall Study|Withdrawal by Subject|0|||
16260105|NCT01710657|39436274|FG001|Overall Study|Withdrawal by Subject|1|||
16260106|NCT01710657|39436275|FG002|Overall Study|Withdrawal by Subject|2|||
16260107|NCT01710657|39436273|FG000|Overall Study|Lack of Efficacy|0|||
16260108|NCT01710657|39436274|FG001|Overall Study|Lack of Efficacy|1|||
16260109|NCT01710657|39436275|FG002|Overall Study|Lack of Efficacy|1|||
16260110|NCT02645409|39436276|FG000|Overall Study|Withdrawal by Subject|3|||
16260111|NCT02645409|39436277|FG001|Overall Study|Withdrawal by Subject|0|||
16260112|NCT02645409|39436276|FG000|Overall Study|Physician Decision|1|||
16260113|NCT02645409|39436277|FG001|Overall Study|Physician Decision|0|||
16260114|NCT02438722|39436280|FG000|Overall Study|Adverse Event|12|||
16260115|NCT02438722|39436281|FG001|Overall Study|Adverse Event|9|||
16260116|NCT02438722|39436280|FG000|Overall Study|Refusal unrelated to AE|2|||
16260117|NCT02438722|39436281|FG001|Overall Study|Refusal unrelated to AE|5|||
16260118|NCT02438722|39436280|FG000|Overall Study|Disease progression/relapse|46|||
16260119|NCT02438722|39436281|FG001|Overall Study|Disease progression/relapse|51|||
16260120|NCT02438722|39436280|FG000|Overall Study|Death|0|||
16260121|NCT02438722|39436281|FG001|Overall Study|Death|3|||
16260122|NCT02438722|39436280|FG000|Overall Study|Physician Decision|2|||
16260123|NCT02438722|39436281|FG001|Overall Study|Physician Decision|2|||
16260124|NCT02438722|39436280|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
16260125|NCT02438722|39436281|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
16260126|NCT02438722|39436280|FG000|Overall Study|Withdrawal by Subject|0|||
16260127|NCT02438722|39436281|FG001|Overall Study|Withdrawal by Subject|1|||
16260128|NCT02438722|39436280|FG000|Overall Study|On protocol treatment|15|||
16260129|NCT02438722|39436281|FG001|Overall Study|On protocol treatment|14|||
16260130|NCT02438722|39436280|FG000|Overall Study|Did not receive protocol treatment|5|||
16260131|NCT02438722|39436281|FG001|Overall Study|Did not receive protocol treatment|0|||
16260132|NCT00414466|39436284|FG000|Overall Study|Adverse Event|0|||
16260133|NCT00414466|39436285|FG001|Overall Study|Adverse Event|0|||
16441577|NCT05280717|40095801|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
16441578|NCT05280717|40095802|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
16441579|NCT05280717|40095803|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
16441580|NCT05280717|40095804|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
16441581|NCT05280717|40095805|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
16441582|NCT05280717|40095799|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
16441583|NCT05280717|40095800|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
16441584|NCT05280717|40095801|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
16441585|NCT05280717|40095802|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
16441586|NCT05280717|40095803|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
16441587|NCT05280717|40095804|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
16441588|NCT05280717|40095805|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
16441589|NCT05280717|40095799|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
16441590|NCT05280717|40095800|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
16441591|NCT05280717|40095801|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
16441592|NCT05280717|40095802|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
16441593|NCT05280717|40095803|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
16441594|NCT05280717|40095804|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
16441595|NCT05280717|40095805|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
16441596|NCT00394095|40095812|FG000|Overall Study|Adverse Event|1|||
16441597|NCT00394095|40095813|FG001|Overall Study|Adverse Event|0|||
16441598|NCT02435212|40095814|FG000|Core Phase|Adverse Event|8|||
16441599|NCT02435212|40095815|FG001|Core Phase|Adverse Event|5|||
16441600|NCT02435212|40095814|FG000|Core Phase|Withdrawal by Subject|3|||
16441601|NCT02435212|40095815|FG001|Core Phase|Withdrawal by Subject|0|||
16441602|NCT02435212|40095814|FG000|Core Phase|Withdrawal by parent/guardian|9|||
16441603|NCT02435212|40095815|FG001|Core Phase|Withdrawal by parent/guardian|4|||
16441604|NCT02435212|40095814|FG000|Core Phase|Protocol Violation|1|||
16441605|NCT02435212|40095815|FG001|Core Phase|Protocol Violation|2|||
16441606|NCT02435212|40095814|FG000|Core Phase|Physician Decision|3|||
16441607|NCT02435212|40095815|FG001|Core Phase|Physician Decision|0|||
16441608|NCT02435212|40095814|FG000|Core Phase|Lost to Follow-up|0|||
16441609|NCT02435212|40095815|FG001|Core Phase|Lost to Follow-up|1|||
16441610|NCT02435212|40095814|FG000|Core Phase|Lack of Efficacy|0|||
16441611|NCT02435212|40095815|FG001|Core Phase|Lack of Efficacy|1|||
16441612|NCT02435212|40095814|FG000|Core Phase|Recovery|1|||
16441613|NCT02435212|40095815|FG001|Core Phase|Recovery|0|||
16441614|NCT02435212|40095814|FG000|Optional Extension Phase|Adverse Event|3|||
16441615|NCT02435212|40095815|FG001|Optional Extension Phase|Adverse Event|9|||
16441616|NCT02435212|40095814|FG000|Optional Extension Phase|Physician Decision|6|||
16441617|NCT02435212|40095815|FG001|Optional Extension Phase|Physician Decision|8|||
16441618|NCT02435212|40095814|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
16441619|NCT02435212|40095815|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
16441620|NCT02435212|40095814|FG000|Optional Extension Phase|Lack of Efficacy|2|||
16441621|NCT02435212|40095815|FG001|Optional Extension Phase|Lack of Efficacy|3|||
16441622|NCT02435212|40095814|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
16441623|NCT02435212|40095815|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
16441624|NCT02435212|40095814|FG000|Optional Extension Phase|Protocol Violation|0|||
16441625|NCT02435212|40095815|FG001|Optional Extension Phase|Protocol Violation|1|||
16441626|NCT02435212|40095814|FG000|Optional Extension Phase|Recovery|1|||
16441627|NCT02435212|40095815|FG001|Optional Extension Phase|Recovery|1|||
16260134|NCT00414466|39436286|FG002|Overall Study|Adverse Event|1|||
16441628|NCT02435212|40095814|FG000|Optional Extension Phase|Death|1|||
16441629|NCT02435212|40095815|FG001|Optional Extension Phase|Death|0|||
16149327|NCT03029143|39033472|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
16149328|NCT03029143|39033473|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
16149329|NCT03029143|39033474|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
16149330|NCT03029143|39033472|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
16149331|NCT03029143|39033473|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
16149332|NCT03029143|39033474|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
16149333|NCT03029143|39033472|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
16149334|NCT03029143|39033473|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
16149335|NCT03029143|39033474|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
16149336|NCT03029143|39033472|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
16149337|NCT03029143|39033473|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
16149338|NCT03029143|39033474|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
16149339|NCT03029143|39033472|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
16149340|NCT03029143|39033473|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
16149341|NCT03029143|39033474|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
16149342|NCT03029143|39033472|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
16149343|NCT03029143|39033473|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
16149344|NCT03029143|39033474|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
16149345|NCT03029143|39033472|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
16149346|NCT03029143|39033473|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
16149347|NCT03029143|39033474|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
16149348|NCT03029143|39033472|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
16149349|NCT03029143|39033473|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
16149350|NCT03029143|39033474|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
16149351|NCT03029143|39033472|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
16149352|NCT03029143|39033473|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
16149353|NCT03029143|39033474|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
16149354|NCT03921424|39033475|FG000|Overall Study|Lost to Follow-up|0|||
16149355|NCT03921424|39033476|FG001|Overall Study|Lost to Follow-up|1|||
16149356|NCT03921424|39033475|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
16149357|NCT03921424|39033476|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
16149358|NCT02289950|39033478|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
16149359|NCT02289950|39033479|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
16149360|NCT02289950|39033478|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
16149361|NCT02289950|39033479|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
16149362|NCT02289950|39033478|FG000|Overall Study|Lost to Follow-up|1|||
16149363|NCT02289950|39033479|FG001|Overall Study|Lost to Follow-up|0|||
16149364|NCT02289950|39033478|FG000|Overall Study|Physician Decision|9|||
16149365|NCT02289950|39033479|FG001|Overall Study|Physician Decision|3|||
16149366|NCT02289950|39033478|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
16149367|NCT02289950|39033479|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
16149368|NCT02289950|39033478|FG000|Overall Study|Withdrawal by Subject|1|||
16149369|NCT02289950|39033479|FG001|Overall Study|Withdrawal by Subject|3|||
16149370|NCT02289950|39033478|FG000|Overall Study|Test article held for greater than 28 days|0|||
16149371|NCT02289950|39033479|FG001|Overall Study|Test article held for greater than 28 days|1|||
16149372|NCT02289950|39033478|FG000|Overall Study|Adverse Event|11|||
16149373|NCT02289950|39033479|FG001|Overall Study|Adverse Event|3|||
16149374|NCT02289950|39033478|FG000|Overall Study|Death|1|||
16149375|NCT02289950|39033479|FG001|Overall Study|Death|1|||
16149376|NCT02289950|39033478|FG000|Overall Study|Other|5|||
16260135|NCT00414466|39436287|FG003|Overall Study|Adverse Event|1|||
16149377|NCT02289950|39033479|FG001|Overall Study|Other|2|||
16149378|NCT02289950|39033478|FG000|Overall Study|Not Treated|2|||
16149379|NCT02289950|39033479|FG001|Overall Study|Not Treated|1|||
16149380|NCT00974675|39033480|FG000|Overall Study|Adverse Event|2|||
16149381|NCT00974675|39033481|FG001|Overall Study|Adverse Event|1|||
16260136|NCT00414466|39436284|FG000|Overall Study|Lack of Efficacy|1|||
16260137|NCT00414466|39436285|FG001|Overall Study|Lack of Efficacy|0|||
16260138|NCT00414466|39436286|FG002|Overall Study|Lack of Efficacy|0|||
16260139|NCT00414466|39436287|FG003|Overall Study|Lack of Efficacy|0|||
16260140|NCT00414466|39436284|FG000|Overall Study|Withdrawn by Sponsor|1|||
16260141|NCT00414466|39436285|FG001|Overall Study|Withdrawn by Sponsor|0|||
16260142|NCT00414466|39436286|FG002|Overall Study|Withdrawn by Sponsor|0|||
16260143|NCT00414466|39436287|FG003|Overall Study|Withdrawn by Sponsor|0|||
16260144|NCT02473640|39436288|FG000|Treatment Period 1|Adverse Event|1|||
16260145|NCT00984126|39436289|FG000|Overall Study|Protocol Violation|0|||
16260146|NCT00984126|39436290|FG001|Overall Study|Protocol Violation|0|||
16260147|NCT00984126|39436291|FG002|Overall Study|Protocol Violation|1|||
16260148|NCT00984126|39436292|FG003|Overall Study|Protocol Violation|2|||
16260149|NCT00984126|39436289|FG000|Overall Study|Adverse Event|0|||
16441630|NCT02435212|40095814|FG000|Optional Extension Phase|Technical problems|2|||
16441631|NCT02435212|40095815|FG001|Optional Extension Phase|Technical problems|0|||
16441632|NCT03106779|40095816|FG000|Overall Study|Lack of Efficacy|33|||
16441633|NCT03106779|40095817|FG001|Overall Study|Lack of Efficacy|24|||
16441634|NCT03106779|40095816|FG000|Overall Study|Adverse Event|8|||
16441635|NCT03106779|40095817|FG001|Overall Study|Adverse Event|16|||
16441636|NCT03106779|40095816|FG000|Overall Study|Physician Decision|10|||
16149382|NCT00974675|39033482|FG002|Overall Study|Adverse Event|1|||
16149383|NCT00974675|39033483|FG003|Overall Study|Adverse Event|1|||
16149384|NCT00974675|39033480|FG000|Overall Study|Physician Decision|0|||
16149385|NCT00974675|39033481|FG001|Overall Study|Physician Decision|0|||
16260150|NCT00984126|39436290|FG001|Overall Study|Adverse Event|0|||
16260151|NCT00984126|39436291|FG002|Overall Study|Adverse Event|0|||
16260152|NCT00984126|39436292|FG003|Overall Study|Adverse Event|2|||
16260153|NCT00984126|39436289|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
16441637|NCT03106779|40095817|FG001|Overall Study|Physician Decision|6|||
16441638|NCT03106779|40095816|FG000|Overall Study|Patient/guardian decision|4|||
16441639|NCT03106779|40095817|FG001|Overall Study|Patient/guardian decision|3|||
16441640|NCT03106779|40095816|FG000|Overall Study|Progressive disease|1|||
16441641|NCT03106779|40095817|FG001|Overall Study|Progressive disease|3|||
16441642|NCT03106779|40095816|FG000|Overall Study|Lost to Follow-up|1|||
16441643|NCT03106779|40095817|FG001|Overall Study|Lost to Follow-up|2|||
16149386|NCT00974675|39033482|FG002|Overall Study|Physician Decision|1|||
16441644|NCT03106779|40095816|FG000|Overall Study|Death|1|||
16441645|NCT03106779|40095817|FG001|Overall Study|Death|0|||
16260154|NCT00984126|39436290|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
16260155|NCT00984126|39436291|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
16260156|NCT00984126|39436292|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
16260157|NCT00984126|39436289|FG000|Overall Study|Withdrawal criteria|0|||
16260158|NCT00984126|39436290|FG001|Overall Study|Withdrawal criteria|1|||
16260159|NCT00984126|39436291|FG002|Overall Study|Withdrawal criteria|3|||
16260160|NCT00984126|39436292|FG003|Overall Study|Withdrawal criteria|9|||
16260161|NCT03099538|39436294|FG000|Overall Study|Lack of Efficacy|3|||
16260162|NCT01839279|39436295|FG000|Overall Study|Adverse Event|4|||
16260163|NCT01839279|39436296|FG001|Overall Study|Adverse Event|1|||
16260164|NCT01839279|39436297|FG002|Overall Study|Adverse Event|1|||
16260165|NCT01839279|39436295|FG000|Overall Study|Withdrawal by Subject|4|||
16260166|NCT01839279|39436296|FG001|Overall Study|Withdrawal by Subject|1|||
16260167|NCT01839279|39436297|FG002|Overall Study|Withdrawal by Subject|1|||
16260168|NCT01839279|39436295|FG000|Overall Study|Classified as 'Other'|5|||
16260169|NCT01839279|39436296|FG001|Overall Study|Classified as 'Other'|0|||
16260170|NCT01839279|39436297|FG002|Overall Study|Classified as 'Other'|0|||
16260171|NCT01448057|39436302|FG000|Overall Study|Protocol Violation|3|||
16260172|NCT01448057|39436303|FG001|Overall Study|Protocol Violation|2|||
16260173|NCT01448057|39436302|FG000|Overall Study|Lost to Follow-up|3|||
16260174|NCT01448057|39436303|FG001|Overall Study|Lost to Follow-up|0|||
16260175|NCT01448057|39436302|FG000|Overall Study|Adverse Event|0|||
16260176|NCT01448057|39436303|FG001|Overall Study|Adverse Event|2|||
16260177|NCT01448057|39436302|FG000|Overall Study|Withdrawal by Subject|2|||
16260178|NCT01448057|39436303|FG001|Overall Study|Withdrawal by Subject|0|||
16260179|NCT02008565|39436304|FG000|Overall Study|Protocol Violation|1|||
16260180|NCT02008565|39436305|FG001|Overall Study|Protocol Violation|1|||
16260181|NCT02008565|39436306|FG002|Overall Study|Protocol Violation|2|||
16260182|NCT02008565|39436307|FG003|Overall Study|Protocol Violation|0|||
16260183|NCT00358449|39439440|FG000|Overall Study|Adverse Event|1|||
16260184|NCT00358449|39439441|FG001|Overall Study|Adverse Event|0|||
16260185|NCT00358449|39439442|FG002|Overall Study|Adverse Event|1|||
16260186|NCT00358449|39439440|FG000|Overall Study|Lost to Follow-up|1|||
16260187|NCT00358449|39439441|FG001|Overall Study|Lost to Follow-up|0|||
16260188|NCT00358449|39439442|FG002|Overall Study|Lost to Follow-up|0|||
16260189|NCT00358449|39439440|FG000|Overall Study|Withdrawal by Subject|2|||
16260190|NCT00358449|39439441|FG001|Overall Study|Withdrawal by Subject|0|||
16260191|NCT00358449|39439442|FG002|Overall Study|Withdrawal by Subject|0|||
16260192|NCT00358449|39439440|FG000|Overall Study|Lack of Efficacy|0|||
16260193|NCT00358449|39439441|FG001|Overall Study|Lack of Efficacy|1|||
16260194|NCT00358449|39439442|FG002|Overall Study|Lack of Efficacy|0|||
16260195|NCT00358449|39439440|FG000|Overall Study|Steriod Inhaler was Increased|0|||
16260196|NCT00358449|39439441|FG001|Overall Study|Steriod Inhaler was Increased|0|||
16365118|NCT01712516|39821524|FG001|Overall Study|Technical problems|0|||
16365119|NCT01712516|39821525|FG002|Overall Study|Technical problems|0|||
16365120|NCT01712516|39821526|FG003|Overall Study|Technical problems|2|||
16365121|NCT01712516|39821523|FG000|Overall Study|Lost to Follow-up|0|||
16365122|NCT01712516|39821524|FG001|Overall Study|Lost to Follow-up|0|||
16365123|NCT01712516|39821525|FG002|Overall Study|Lost to Follow-up|2|||
16365124|NCT01712516|39821526|FG003|Overall Study|Lost to Follow-up|1|||
16365125|NCT01712516|39821523|FG000|Overall Study|Death|0|||
16365126|NCT01712516|39821524|FG001|Overall Study|Death|1|||
16365127|NCT01712516|39821525|FG002|Overall Study|Death|0|||
16365128|NCT01712516|39821526|FG003|Overall Study|Death|0|||
16365129|NCT01712516|39821523|FG000|Overall Study|Protocol deviation|1|||
16365130|NCT01712516|39821524|FG001|Overall Study|Protocol deviation|0|||
16365131|NCT01712516|39821525|FG002|Overall Study|Protocol deviation|1|||
16365132|NCT01712516|39821526|FG003|Overall Study|Protocol deviation|0|||
16365133|NCT01712516|39821523|FG000|Overall Study|Physician Decision|2|||
16365134|NCT01712516|39821524|FG001|Overall Study|Physician Decision|0|||
16365135|NCT01712516|39821525|FG002|Overall Study|Physician Decision|0|||
16365136|NCT01712516|39821526|FG003|Overall Study|Physician Decision|1|||
16365137|NCT01712516|39821523|FG000|Overall Study|Withdrawal by Subject|3|||
16365138|NCT01712516|39821524|FG001|Overall Study|Withdrawal by Subject|9|||
16260197|NCT00358449|39439442|FG002|Overall Study|Steriod Inhaler was Increased|1|||
16260198|NCT03880266|39439443|FG000|Overall Study|Withdrawal by Subject|0|||
16365139|NCT01712516|39821525|FG002|Overall Study|Withdrawal by Subject|3|||
16365140|NCT01712516|39821526|FG003|Overall Study|Withdrawal by Subject|9|||
16365141|NCT00472641|39821527|FG000|Overall Study|Lack of Efficacy|3|||
16365142|NCT00472641|39821527|FG000|Overall Study|Adverse Event|3|||
16260199|NCT03880266|39439444|FG001|Overall Study|Withdrawal by Subject|1|||
16260200|NCT03880266|39439445|FG002|Overall Study|Withdrawal by Subject|1|||
16260201|NCT03880266|39439446|FG003|Overall Study|Withdrawal by Subject|0|||
16260202|NCT03880266|39439447|FG004|Overall Study|Withdrawal by Subject|0|||
16365143|NCT00472641|39821527|FG000|Overall Study|Lost to Follow-up|1|||
16365144|NCT02100631|39821528|FG000|Overall Study|Withdrawal by Subject|1|||
16365145|NCT02100631|39821529|FG001|Overall Study|Withdrawal by Subject|0|||
16441646|NCT03106779|40095816|FG000|Overall Study|Protocol Violation|1|||
16441647|NCT03106779|40095817|FG001|Overall Study|Protocol Violation|0|||
16441648|NCT03106779|40095816|FG000|Overall Study|Not treated|1|||
16441649|NCT03106779|40095817|FG001|Overall Study|Not treated|0|||
16441650|NCT04244253|40095829|FG000|Overall Study|Adverse Event|2|||
16441651|NCT04244253|40095830|FG001|Overall Study|Adverse Event|2|||
16441652|NCT04244253|40095831|FG002|Overall Study|Adverse Event|4|||
16441653|NCT04244253|40095829|FG000|Overall Study|Protocol Violation|1|||
16149387|NCT00974675|39033483|FG003|Overall Study|Physician Decision|0|||
16149388|NCT00974675|39033480|FG000|Overall Study|Participant on holiday; unable to attend|0|||
16149389|NCT00974675|39033481|FG001|Overall Study|Participant on holiday; unable to attend|0|||
16149390|NCT00974675|39033482|FG002|Overall Study|Participant on holiday; unable to attend|0|||
16149391|NCT00974675|39033483|FG003|Overall Study|Participant on holiday; unable to attend|1|||
16149392|NCT02256540|39033484|FG000|Overall Study|Withdrawal by Subject|0|||
16149393|NCT02256540|39033485|FG001|Overall Study|Withdrawal by Subject|1|||
16149394|NCT02256540|39033486|FG002|Overall Study|Withdrawal by Subject|1|||
16149395|NCT02256540|39033484|FG000|Overall Study|Back pain preventing exercise|0|||
16149396|NCT02256540|39033485|FG001|Overall Study|Back pain preventing exercise|0|||
16149397|NCT02256540|39033486|FG002|Overall Study|Back pain preventing exercise|1|||
16149398|NCT02121262|39033492|FG000|Overall Study|Adverse Event|6|||
16149399|NCT02121262|39033493|FG001|Overall Study|Adverse Event|3|||
16149400|NCT02121262|39033492|FG000|Overall Study|Lack of Efficacy|3|||
16149401|NCT02121262|39033493|FG001|Overall Study|Lack of Efficacy|0|||
16149402|NCT02121262|39033492|FG000|Overall Study|Personal Reasons|19|||
16149403|NCT02121262|39033493|FG001|Overall Study|Personal Reasons|5|||
16149404|NCT02121262|39033492|FG000|Overall Study|Protocol Violation|1|||
16149405|NCT02121262|39033493|FG001|Overall Study|Protocol Violation|1|||
16149406|NCT02121262|39033492|FG000|Overall Study|Participant Dropped-out|0|||
16149407|NCT02121262|39033493|FG001|Overall Study|Participant Dropped-out|1|||
16149408|NCT02121262|39033492|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
16149409|NCT02121262|39033493|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
16149410|NCT02121262|39033492|FG000|Overall Study|Consent Withdrawn|1|||
16149411|NCT02121262|39033493|FG001|Overall Study|Consent Withdrawn|0|||
16149412|NCT00530270|39033497|FG000|Overall Study|Protocol Violation|1|||
16149413|NCT00530270|39033498|FG001|Overall Study|Protocol Violation|0|||
16149414|NCT01505634|39033503|FG000|Overall Study|Withdrawal by Subject|2|||
16149415|NCT01505634|39033504|FG001|Overall Study|Withdrawal by Subject|5|||
16149416|NCT01505634|39033505|FG002|Overall Study|Withdrawal by Subject|1|||
16149417|NCT01505634|39033503|FG000|Overall Study|Physician Decision|1|||
16149418|NCT01505634|39033504|FG001|Overall Study|Physician Decision|1|||
16149419|NCT01505634|39033505|FG002|Overall Study|Physician Decision|0|||
16149420|NCT01505634|39033503|FG000|Overall Study|Adverse Event|1|||
16149421|NCT01505634|39033504|FG001|Overall Study|Adverse Event|0|||
16149422|NCT01505634|39033505|FG002|Overall Study|Adverse Event|0|||
16149423|NCT01505634|39033503|FG000|Overall Study|Insufficient supply of drug at site|1|||
16149424|NCT01505634|39033504|FG001|Overall Study|Insufficient supply of drug at site|0|||
16149425|NCT01505634|39033505|FG002|Overall Study|Insufficient supply of drug at site|0|||
16149426|NCT01505634|39033503|FG000|Overall Study|Protocol Violation|2|||
16149427|NCT01505634|39033504|FG001|Overall Study|Protocol Violation|0|||
16149428|NCT01505634|39033505|FG002|Overall Study|Protocol Violation|0|||
16149429|NCT01505634|39033503|FG000|Overall Study|Lost to Follow-up|1|||
16149430|NCT01505634|39033504|FG001|Overall Study|Lost to Follow-up|4|||
16149431|NCT01505634|39033505|FG002|Overall Study|Lost to Follow-up|4|||
16149432|NCT01505634|39033503|FG000|Overall Study|Death|1|||
16149433|NCT01505634|39033504|FG001|Overall Study|Death|0|||
16260203|NCT03880266|39439448|FG005|Overall Study|Withdrawal by Subject|0|||
16149434|NCT01505634|39033505|FG002|Overall Study|Death|0|||
16149435|NCT01505634|39033503|FG000|Overall Study|In a conflict zone|0|||
16260204|NCT03880266|39439449|FG006|Overall Study|Withdrawal by Subject|0|||
16260205|NCT03880266|39439450|FG007|Overall Study|Withdrawal by Subject|0|||
16260206|NCT01395030|39439452|FG000|Overall Study|Did not complete FCH PET/CT|7|||
16149436|NCT01505634|39033504|FG001|Overall Study|In a conflict zone|0|||
16149437|NCT01505634|39033505|FG002|Overall Study|In a conflict zone|1|||
16149438|NCT01543152|39033506|FG000|Overall Study|Withdrawal by Subject|0|||
16149439|NCT01543152|39033507|FG001|Overall Study|Withdrawal by Subject|2|||
16149440|NCT01543152|39033508|FG002|Overall Study|Withdrawal by Subject|0|||
16149441|NCT01543152|39033509|FG003|Overall Study|Withdrawal by Subject|0|||
16149442|NCT01543152|39033510|FG004|Overall Study|Withdrawal by Subject|0|||
16149443|NCT00876187|39033520|FG000|Overall Study|Adverse Event|14|||
16149444|NCT00876187|39033521|FG001|Overall Study|Adverse Event|12|||
16149445|NCT00876187|39033522|FG002|Overall Study|Adverse Event|19|||
16149446|NCT00876187|39033523|FG003|Overall Study|Adverse Event|29|||
16149447|NCT00876187|39033524|FG004|Overall Study|Adverse Event|10|||
16149448|NCT00876187|39033520|FG000|Overall Study|Lack of Efficacy|59|||
16149449|NCT00876187|39033521|FG001|Overall Study|Lack of Efficacy|34|||
16149450|NCT00876187|39033522|FG002|Overall Study|Lack of Efficacy|45|||
16149451|NCT00876187|39033523|FG003|Overall Study|Lack of Efficacy|34|||
16149452|NCT00876187|39033524|FG004|Overall Study|Lack of Efficacy|59|||
16149453|NCT00876187|39033520|FG000|Overall Study|Lost to Follow-up|9|||
16149454|NCT00876187|39033521|FG001|Overall Study|Lost to Follow-up|10|||
16149455|NCT00876187|39033522|FG002|Overall Study|Lost to Follow-up|8|||
16149456|NCT00876187|39033523|FG003|Overall Study|Lost to Follow-up|8|||
16149457|NCT00876187|39033524|FG004|Overall Study|Lost to Follow-up|11|||
16149458|NCT00876187|39033520|FG000|Overall Study|Protocol Violation|6|||
16149459|NCT00876187|39033521|FG001|Overall Study|Protocol Violation|7|||
16149460|NCT00876187|39033522|FG002|Overall Study|Protocol Violation|7|||
16149461|NCT00876187|39033523|FG003|Overall Study|Protocol Violation|6|||
16149462|NCT00876187|39033524|FG004|Overall Study|Protocol Violation|3|||
16149463|NCT00876187|39033520|FG000|Overall Study|Withdrawal by Subject|16|||
16149464|NCT00876187|39033521|FG001|Overall Study|Withdrawal by Subject|26|||
16149465|NCT00876187|39033522|FG002|Overall Study|Withdrawal by Subject|32|||
16149466|NCT00876187|39033523|FG003|Overall Study|Withdrawal by Subject|38|||
16149467|NCT00876187|39033524|FG004|Overall Study|Withdrawal by Subject|37|||
16149468|NCT00876187|39033520|FG000|Overall Study|Entered extension study|101|||
16149469|NCT00876187|39033521|FG001|Overall Study|Entered extension study|120|||
16149470|NCT00876187|39033522|FG002|Overall Study|Entered extension study|156|||
16149471|NCT00876187|39033523|FG003|Overall Study|Entered extension study|151|||
16149472|NCT00876187|39033524|FG004|Overall Study|Entered extension study|144|||
16149473|NCT00876187|39033520|FG000|Overall Study|Randomized but not treated|3|||
16149474|NCT00876187|39033521|FG001|Overall Study|Randomized but not treated|1|||
16149475|NCT00876187|39033522|FG002|Overall Study|Randomized but not treated|3|||
16149476|NCT00876187|39033523|FG003|Overall Study|Randomized but not treated|2|||
16149477|NCT00876187|39033524|FG004|Overall Study|Randomized but not treated|3|||
16149478|NCT00876187|39033520|FG000|Overall Study|Other|2|||
16149479|NCT00876187|39033521|FG001|Overall Study|Other|5|||
16149480|NCT00876187|39033522|FG002|Overall Study|Other|9|||
16149481|NCT00876187|39033523|FG003|Overall Study|Other|7|||
16149482|NCT00876187|39033524|FG004|Overall Study|Other|4|||
16149483|NCT04770389|39033525|FG000|Overall Study|Adverse Event|1|||
16149484|NCT04770389|39033526|FG001|Overall Study|Adverse Event|2|||
16149485|NCT04770389|39033527|FG002|Overall Study|Adverse Event|0|||
16149486|NCT04770389|39033528|FG003|Overall Study|Adverse Event|1|||
16149487|NCT04770389|39033525|FG000|Overall Study|Withdrawal by Subject|0|||
16149488|NCT04770389|39033526|FG001|Overall Study|Withdrawal by Subject|2|||
16149489|NCT04770389|39033527|FG002|Overall Study|Withdrawal by Subject|1|||
16149490|NCT04770389|39033528|FG003|Overall Study|Withdrawal by Subject|0|||
16149491|NCT04770389|39033525|FG000|Overall Study|Failed attempt to draw blood|1|||
16149492|NCT04770389|39033526|FG001|Overall Study|Failed attempt to draw blood|0|||
16149493|NCT04770389|39033527|FG002|Overall Study|Failed attempt to draw blood|0|||
16149494|NCT04770389|39033528|FG003|Overall Study|Failed attempt to draw blood|0|||
16149495|NCT04770389|39033525|FG000|Overall Study|Left the country|0|||
16149496|NCT04770389|39033526|FG001|Overall Study|Left the country|0|||
16149497|NCT04770389|39033527|FG002|Overall Study|Left the country|1|||
16149498|NCT04770389|39033528|FG003|Overall Study|Left the country|2|||
16149499|NCT04770389|39033525|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
16149500|NCT04770389|39033526|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
16149501|NCT04770389|39033527|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
16441654|NCT04244253|40095830|FG001|Overall Study|Protocol Violation|2|||
16441655|NCT04244253|40095831|FG002|Overall Study|Protocol Violation|1|||
16149502|NCT04770389|39033528|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
16149503|NCT04770389|39033525|FG000|Overall Study|Lost to Follow-up|0|||
16149504|NCT04770389|39033526|FG001|Overall Study|Lost to Follow-up|0|||
16149505|NCT04770389|39033527|FG002|Overall Study|Lost to Follow-up|0|||
16149506|NCT04770389|39033528|FG003|Overall Study|Lost to Follow-up|1|||
16149507|NCT04770389|39033525|FG000|Overall Study|Moved away from study site|0|||
16149508|NCT04770389|39033526|FG001|Overall Study|Moved away from study site|1|||
16149509|NCT04770389|39033527|FG002|Overall Study|Moved away from study site|0|||
16149510|NCT04770389|39033528|FG003|Overall Study|Moved away from study site|0|||
16149511|NCT02829138|39033529|FG000|Overall Study|Withdrawal by Subject|1|||
16149512|NCT02829138|39033530|FG001|Overall Study|Withdrawal by Subject|0|||
16149513|NCT02116777|39033535|FG000|Overall Study|Adverse Event|0|||
16149514|NCT02116777|39033536|FG001|Overall Study|Adverse Event|0|||
16149515|NCT02116777|39033537|FG002|Overall Study|Adverse Event|0|||
16149516|NCT02116777|39033538|FG003|Overall Study|Adverse Event|0|||
16149517|NCT02116777|39033539|FG004|Overall Study|Adverse Event|2|||
16149518|NCT02116777|39033540|FG005|Overall Study|Adverse Event|2|||
16149519|NCT02116777|39033541|FG006|Overall Study|Adverse Event|0|||
16149520|NCT02116777|39033535|FG000|Overall Study|Death|0|||
16149521|NCT02116777|39033536|FG001|Overall Study|Death|0|||
16149522|NCT02116777|39033537|FG002|Overall Study|Death|0|||
16149523|NCT02116777|39033538|FG003|Overall Study|Death|1|||
16149524|NCT02116777|39033539|FG004|Overall Study|Death|0|||
16149525|NCT02116777|39033540|FG005|Overall Study|Death|0|||
16149526|NCT02116777|39033541|FG006|Overall Study|Death|0|||
16149527|NCT02116777|39033535|FG000|Overall Study|Lack of Efficacy|3|||
16149528|NCT02116777|39033536|FG001|Overall Study|Lack of Efficacy|3|||
16149529|NCT02116777|39033537|FG002|Overall Study|Lack of Efficacy|3|||
16149530|NCT02116777|39033538|FG003|Overall Study|Lack of Efficacy|8|||
16149531|NCT02116777|39033539|FG004|Overall Study|Lack of Efficacy|4|||
16149532|NCT02116777|39033540|FG005|Overall Study|Lack of Efficacy|1|||
16149533|NCT02116777|39033541|FG006|Overall Study|Lack of Efficacy|9|||
16149534|NCT02116777|39033535|FG000|Overall Study|Physician Decision|0|||
16149535|NCT02116777|39033536|FG001|Overall Study|Physician Decision|0|||
16149536|NCT02116777|39033537|FG002|Overall Study|Physician Decision|0|||
16149537|NCT02116777|39033538|FG003|Overall Study|Physician Decision|2|||
16149538|NCT02116777|39033539|FG004|Overall Study|Physician Decision|0|||
16441656|NCT04244253|40095829|FG000|Overall Study|Withdrawal by Subject|0|||
16441657|NCT04244253|40095830|FG001|Overall Study|Withdrawal by Subject|1|||
16441658|NCT04244253|40095831|FG002|Overall Study|Withdrawal by Subject|6|||
16441659|NCT04244253|40095829|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16441660|NCT04244253|40095830|FG001|Overall Study|Non-Compliance With Study Drug|0|||
16441661|NCT04244253|40095831|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16441662|NCT03199976|40095833|FG000|Overall Study|Lack of Efficacy|3|||
16149539|NCT02116777|39033540|FG005|Overall Study|Physician Decision|0|||
16149540|NCT02116777|39033541|FG006|Overall Study|Physician Decision|0|||
16149541|NCT02116777|39033535|FG000|Overall Study|Protocol Violation|0|||
16149542|NCT02116777|39033536|FG001|Overall Study|Protocol Violation|0|||
16365146|NCT02100631|39821530|FG002|Overall Study|Withdrawal by Subject|0|||
16365147|NCT02100631|39821528|FG000|Overall Study|Lost to Follow-up|3|||
16365148|NCT02100631|39821529|FG001|Overall Study|Lost to Follow-up|4|||
16365149|NCT02100631|39821530|FG002|Overall Study|Lost to Follow-up|0|||
16365150|NCT02100631|39821528|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
16365151|NCT02100631|39821529|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
16365152|NCT02100631|39821530|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
16365153|NCT00870727|39821531|FG000|Overall Study|Lost to Follow-up|0|||
16365154|NCT00870727|39821532|FG001|Overall Study|Lost to Follow-up|1|||
16365155|NCT00870727|39821531|FG000|Overall Study|Lack of Efficacy|1|||
16365156|NCT00870727|39821532|FG001|Overall Study|Lack of Efficacy|3|||
16365157|NCT00870727|39821531|FG000|Overall Study|Adverse Event|0|||
16365158|NCT00870727|39821532|FG001|Overall Study|Adverse Event|1|||
16365159|NCT00963235|39821536|FG000|Overall Study|Withdrawal by Subject|22|||
16365160|NCT00963235|39821536|FG000|Overall Study|Lost to Follow-up|14|||
16149543|NCT02116777|39033537|FG002|Overall Study|Protocol Violation|0|||
16149544|NCT02116777|39033538|FG003|Overall Study|Protocol Violation|1|||
16149545|NCT02116777|39033539|FG004|Overall Study|Protocol Violation|0|||
16149546|NCT02116777|39033540|FG005|Overall Study|Protocol Violation|0|||
16365161|NCT00963235|39821536|FG000|Overall Study|Failed to return|9|||
16441663|NCT03199976|40095834|FG001|Overall Study|Lack of Efficacy|6|||
16441664|NCT03199976|40095835|FG002|Overall Study|Lack of Efficacy|13|||
16441665|NCT03199976|40095833|FG000|Overall Study|Withdrawal by Subject|1|||
16441666|NCT03199976|40095834|FG001|Overall Study|Withdrawal by Subject|0|||
16441667|NCT03199976|40095835|FG002|Overall Study|Withdrawal by Subject|0|||
16441668|NCT03199976|40095833|FG000|Overall Study|Lost to Follow-up|0|||
16441669|NCT03199976|40095834|FG001|Overall Study|Lost to Follow-up|1|||
16441670|NCT03199976|40095835|FG002|Overall Study|Lost to Follow-up|1|||
16441671|NCT04551989|40095837|FG000|Overall Study|Adverse Event|4|||
16441672|NCT04551989|40095837|FG000|Overall Study|Protocol Violation|3|||
16441673|NCT04551989|40095837|FG000|Overall Study|Lost to Follow-up|1|||
16441674|NCT04551989|40095837|FG000|Overall Study|Physician Decision|3|||
16441675|NCT03988400|40097589|FG000|Overall Study|Adverse Event|1|||
16441676|NCT03988400|40097590|FG001|Overall Study|Adverse Event|0|||
16441677|NCT03988400|40097589|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
16441678|NCT03988400|40097590|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
16441679|NCT03988400|40097589|FG000|Overall Study|Lost to Follow-up|0|||
16441680|NCT03988400|40097590|FG001|Overall Study|Lost to Follow-up|1|||
16441681|NCT05323084|40097592|FG000|Period 2 - Washout|Lost to Follow-up|0|||
16441682|NCT05323084|40097593|FG001|Period 2 - Washout|Lost to Follow-up|1|||
16441683|NCT04538664|40097595|FG000|Overall Study|Withdrawal by Subject|5|||
16441684|NCT04538664|40097596|FG001|Overall Study|Withdrawal by Subject|9|||
16441685|NCT04538664|40097595|FG000|Overall Study|Lost to Follow-up|2|||
16441686|NCT04538664|40097596|FG001|Overall Study|Lost to Follow-up|1|||
16365162|NCT00963235|39821536|FG000|Overall Study|Protocol Violation|7|||
16365163|NCT00963235|39821536|FG000|Overall Study|Adverse Event|5|||
16365164|NCT00963235|39821536|FG000|Overall Study|Physician Decision|2|||
16365165|NCT00963235|39821536|FG000|Overall Study|Other|1|||
16365166|NCT01588509|39821537|FG000|Overall Study|Lost to Follow-up|1|||
16365167|NCT01588509|39821538|FG001|Overall Study|Lost to Follow-up|0|||
16365168|NCT01562444|39821539|FG000|Overall Study|Did not meet entry criteria|2|||
16365169|NCT01562444|39821540|FG001|Overall Study|Did not meet entry criteria|0|||
16365170|NCT01562444|39821541|FG002|Overall Study|Did not meet entry criteria|3|||
16365171|NCT01562444|39821539|FG000|Overall Study|Did not comply with blood draw schedule|1|||
16365172|NCT01562444|39821540|FG001|Overall Study|Did not comply with blood draw schedule|0|||
16365173|NCT01562444|39821541|FG002|Overall Study|Did not comply with blood draw schedule|1|||
16365174|NCT01562444|39821539|FG000|Overall Study|Unavailable serological results|0|||
16365175|NCT01562444|39821540|FG001|Overall Study|Unavailable serological results|2|||
16365176|NCT01562444|39821541|FG002|Overall Study|Unavailable serological results|2|||
16365177|NCT01562444|39821539|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
16365178|NCT01562444|39821540|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
16365179|NCT01562444|39821541|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
16365180|NCT01562444|39821539|FG000|Overall Study|Protocol forbidden medication|1|||
16365181|NCT01562444|39821540|FG001|Overall Study|Protocol forbidden medication|0|||
16441687|NCT04538664|40097595|FG000|Overall Study|Ongoing|106|||
16441688|NCT04538664|40097596|FG001|Overall Study|Ongoing|115|||
16441689|NCT03570892|40097597|FG000|Overall Study|Death|51|||
16149547|NCT02116777|39033541|FG006|Overall Study|Protocol Violation|0|||
16365182|NCT01562444|39821541|FG002|Overall Study|Protocol forbidden medication|0|||
16365183|NCT00941928|39821546|FG000|Overall Study|Withdrawal by Subject|1|||
16365184|NCT00941928|39821546|FG000|Overall Study|Disease Progression|1|||
16365185|NCT03387046|39821549|FG000|Overall Study|Adverse Event|1|||
16365186|NCT03387046|39821550|FG001|Overall Study|Adverse Event|1|||
16365187|NCT00462462|39821551|FG000|Overall Study|Physician Decision|0|||
16365188|NCT00462462|39821552|FG001|Overall Study|Physician Decision|1|||
16365189|NCT01800058|39821553|FG000|Overall Study|Lost to Follow-up|1|||
16365190|NCT00421993|39821554|FG000|Overall Study|Withdrawal by Subject|22|||
16365191|NCT00421993|39821555|FG001|Overall Study|Withdrawal by Subject|23|||
16365192|NCT00421993|39821556|FG002|Overall Study|Withdrawal by Subject|23|||
16365193|NCT00421993|39821557|FG003|Overall Study|Withdrawal by Subject|24|||
16365194|NCT00421993|39821554|FG000|Overall Study|Lost to Follow-up|18|||
16365195|NCT00421993|39821555|FG001|Overall Study|Lost to Follow-up|19|||
16365196|NCT00421993|39821556|FG002|Overall Study|Lost to Follow-up|22|||
16365197|NCT00421993|39821557|FG003|Overall Study|Lost to Follow-up|20|||
16365198|NCT00421993|39821554|FG000|Overall Study|Adverse Event|11|||
16260207|NCT02678286|39439458|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
16260208|NCT02678286|39439459|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
16260209|NCT02678286|39439458|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
16260210|NCT02678286|39439459|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
16260211|NCT02678286|39439458|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
16260212|NCT02678286|39439459|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
16260213|NCT02678286|39439458|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
16260214|NCT02678286|39439459|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
16260215|NCT02678286|39439458|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
16260216|NCT02678286|39439459|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
16260217|NCT01403194|39439460|FG000|Overall Study|Screen Failure|2|||
16260218|NCT01403194|39439460|FG000|Overall Study|Lost to Follow-up|8|||
16260219|NCT03164772|39439468|FG000|Overall Study|Death|4|||
16260220|NCT03164772|39439469|FG001|Overall Study|Death|2|||
16260221|NCT03164772|39439468|FG000|Overall Study|Adverse Event|1|||
16260222|NCT03164772|39439469|FG001|Overall Study|Adverse Event|4|||
16260223|NCT03164772|39439468|FG000|Overall Study|Progressive Disease|11|||
16260224|NCT03164772|39439469|FG001|Overall Study|Progressive Disease|21|||
16260225|NCT03164772|39439468|FG000|Overall Study|Physician Decision|2|||
16260226|NCT03164772|39439469|FG001|Overall Study|Physician Decision|0|||
16260227|NCT03164772|39439468|FG000|Overall Study|Withdrawal by Subject|0|||
16260228|NCT03164772|39439469|FG001|Overall Study|Withdrawal by Subject|4|||
16260229|NCT00858845|39439472|FG000|Overall Study|Patient underwent heart transplant.|0|||
16260230|NCT00858845|39439473|FG001|Overall Study|Patient underwent heart transplant.|1|||
16260231|NCT03134222|39439474|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
16260232|NCT03134222|39439475|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
16260233|NCT03134222|39439476|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
16260234|NCT03134222|39439477|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
16260235|NCT03134222|39439478|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
16260236|NCT03134222|39439474|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
16260237|NCT03134222|39439475|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
16260238|NCT03134222|39439476|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
16260239|NCT03134222|39439477|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
16260240|NCT03134222|39439478|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
16260241|NCT03134222|39439474|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
16365199|NCT00421993|39821555|FG001|Overall Study|Adverse Event|1|||
16365200|NCT00421993|39821556|FG002|Overall Study|Adverse Event|6|||
16260242|NCT03134222|39439475|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
16260243|NCT03134222|39439476|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
16260244|NCT03134222|39439477|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
16260245|NCT03134222|39439478|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
16365201|NCT00421993|39821557|FG003|Overall Study|Adverse Event|4|||
16365202|NCT00421993|39821554|FG000|Overall Study|Protocol Violation|2|||
16365203|NCT00421993|39821555|FG001|Overall Study|Protocol Violation|2|||
16365204|NCT00421993|39821556|FG002|Overall Study|Protocol Violation|0|||
16365205|NCT00421993|39821557|FG003|Overall Study|Protocol Violation|1|||
16365206|NCT00421993|39821554|FG000|Overall Study|Lack of Efficacy|0|||
16365207|NCT00421993|39821555|FG001|Overall Study|Lack of Efficacy|3|||
16365208|NCT00421993|39821556|FG002|Overall Study|Lack of Efficacy|0|||
16365209|NCT00421993|39821557|FG003|Overall Study|Lack of Efficacy|5|||
16365210|NCT00421993|39821554|FG000|Overall Study|Pregnancy|0|||
16365211|NCT00421993|39821555|FG001|Overall Study|Pregnancy|1|||
16365212|NCT00421993|39821556|FG002|Overall Study|Pregnancy|1|||
16365213|NCT00421993|39821557|FG003|Overall Study|Pregnancy|2|||
16365214|NCT00421993|39821554|FG000|Overall Study|Subject transportation issues|0|||
16365215|NCT00421993|39821555|FG001|Overall Study|Subject transportation issues|0|||
16365216|NCT00421993|39821556|FG002|Overall Study|Subject transportation issues|0|||
16365217|NCT00421993|39821557|FG003|Overall Study|Subject transportation issues|1|||
16365218|NCT02665117|39821558|FG000|Overall Study|Physician Decision|1|||
16365219|NCT02665117|39821559|FG001|Overall Study|Physician Decision|0|||
16365220|NCT03188185|39821560|FG000|Stage 1|Adverse Event|4|||
16365221|NCT03188185|39821561|FG001|Stage 1|Adverse Event|12|||
16365222|NCT03188185|39821562|FG002|Stage 1|Adverse Event|0|||
16365223|NCT03188185|39821563|FG003|Stage 1|Adverse Event|0|||
16365224|NCT03188185|39821560|FG000|Stage 1|Lack of Efficacy|0|||
16365225|NCT03188185|39821561|FG001|Stage 1|Lack of Efficacy|2|||
16365226|NCT03188185|39821562|FG002|Stage 1|Lack of Efficacy|0|||
16365227|NCT03188185|39821563|FG003|Stage 1|Lack of Efficacy|0|||
16149548|NCT02116777|39033535|FG000|Overall Study|Withdrawal by Subject|0|||
16149549|NCT02116777|39033536|FG001|Overall Study|Withdrawal by Subject|0|||
16149550|NCT02116777|39033537|FG002|Overall Study|Withdrawal by Subject|0|||
16149551|NCT02116777|39033538|FG003|Overall Study|Withdrawal by Subject|1|||
16149552|NCT02116777|39033539|FG004|Overall Study|Withdrawal by Subject|0|||
16149553|NCT02116777|39033540|FG005|Overall Study|Withdrawal by Subject|0|||
16149554|NCT02116777|39033541|FG006|Overall Study|Withdrawal by Subject|0|||
16149555|NCT02943564|39033542|FG000|Overall Study|Miscellaneous Reasons|0|||
16149556|NCT02943564|39033543|FG001|Overall Study|Miscellaneous Reasons|0|||
16149557|NCT02943564|39033544|FG002|Overall Study|Miscellaneous Reasons|3|||
16149558|NCT02943564|39033542|FG000|Overall Study|Site terminated by sponsor|0|||
16149559|NCT02943564|39033543|FG001|Overall Study|Site terminated by sponsor|1|||
16149560|NCT02943564|39033544|FG002|Overall Study|Site terminated by sponsor|0|||
16149561|NCT02943564|39033542|FG000|Overall Study|Non-compliance with study drug|0|||
16149562|NCT02943564|39033543|FG001|Overall Study|Non-compliance with study drug|1|||
16149563|NCT02943564|39033544|FG002|Overall Study|Non-compliance with study drug|0|||
16149564|NCT02943564|39033542|FG000|Overall Study|Pregnancy|0|||
16149565|NCT02943564|39033543|FG001|Overall Study|Pregnancy|1|||
16149566|NCT02943564|39033544|FG002|Overall Study|Pregnancy|1|||
16149567|NCT02943564|39033542|FG000|Overall Study|Protocol Violation|2|||
16149568|NCT02943564|39033543|FG001|Overall Study|Protocol Violation|2|||
16149569|NCT02943564|39033544|FG002|Overall Study|Protocol Violation|2|||
16149570|NCT02943564|39033542|FG000|Overall Study|Lost to Follow-up|1|||
16149571|NCT02943564|39033543|FG001|Overall Study|Lost to Follow-up|0|||
16149572|NCT02943564|39033544|FG002|Overall Study|Lost to Follow-up|0|||
16149573|NCT02943564|39033542|FG000|Overall Study|Withdrawal by Subject|6|||
16149574|NCT02943564|39033543|FG001|Overall Study|Withdrawal by Subject|5|||
16149575|NCT02943564|39033544|FG002|Overall Study|Withdrawal by Subject|2|||
16149576|NCT02943564|39033542|FG000|Overall Study|Adverse Event|1|||
16149577|NCT02943564|39033543|FG001|Overall Study|Adverse Event|2|||
16149578|NCT02943564|39033544|FG002|Overall Study|Adverse Event|1|||
16149579|NCT02943564|39033542|FG000|Overall Study|Lack of Efficacy|0|||
16149580|NCT02943564|39033543|FG001|Overall Study|Lack of Efficacy|1|||
16149581|NCT02943564|39033544|FG002|Overall Study|Lack of Efficacy|0|||
16149582|NCT01449461|39033545|FG000|Overall Study|Adverse Event|0|||
16149583|NCT01449461|39033546|FG001|Overall Study|Adverse Event|3|||
16149584|NCT01449461|39033547|FG002|Overall Study|Adverse Event|2|||
16149585|NCT01449461|39033548|FG003|Overall Study|Adverse Event|3|||
16149586|NCT01449461|39033549|FG004|Overall Study|Adverse Event|4|||
16149587|NCT01449461|39033550|FG005|Overall Study|Adverse Event|4|||
16149588|NCT01449461|39033545|FG000|Overall Study|Death|0|||
16149589|NCT01449461|39033546|FG001|Overall Study|Death|2|||
16149590|NCT01449461|39033547|FG002|Overall Study|Death|0|||
16149591|NCT01449461|39033548|FG003|Overall Study|Death|0|||
16149592|NCT01449461|39033549|FG004|Overall Study|Death|7|||
16149593|NCT01449461|39033550|FG005|Overall Study|Death|1|||
16149594|NCT01449461|39033545|FG000|Overall Study|Physician Decision|0|||
16149595|NCT01449461|39033546|FG001|Overall Study|Physician Decision|1|||
16149596|NCT01449461|39033547|FG002|Overall Study|Physician Decision|0|||
16149597|NCT01449461|39033548|FG003|Overall Study|Physician Decision|4|||
16365228|NCT03188185|39821560|FG000|Stage 1|Lost to Follow-up|6|||
16365229|NCT03188185|39821561|FG001|Stage 1|Lost to Follow-up|1|||
16365230|NCT03188185|39821562|FG002|Stage 1|Lost to Follow-up|0|||
16365231|NCT03188185|39821563|FG003|Stage 1|Lost to Follow-up|0|||
16365232|NCT03188185|39821560|FG000|Stage 1|Withdrawal by Subject|9|||
16365233|NCT03188185|39821561|FG001|Stage 1|Withdrawal by Subject|0|||
16365234|NCT03188185|39821562|FG002|Stage 1|Withdrawal by Subject|0|||
16365235|NCT03188185|39821563|FG003|Stage 1|Withdrawal by Subject|0|||
16149598|NCT01449461|39033549|FG004|Overall Study|Physician Decision|1|||
16149599|NCT01449461|39033550|FG005|Overall Study|Physician Decision|0|||
16149600|NCT01449461|39033545|FG000|Overall Study|Documented Progressive Disease|4|||
16149601|NCT01449461|39033546|FG001|Overall Study|Documented Progressive Disease|7|||
16149602|NCT01449461|39033547|FG002|Overall Study|Documented Progressive Disease|14|||
16149603|NCT01449461|39033548|FG003|Overall Study|Documented Progressive Disease|15|||
16149604|NCT01449461|39033549|FG004|Overall Study|Documented Progressive Disease|24|||
16149605|NCT01449461|39033550|FG005|Overall Study|Documented Progressive Disease|5|||
16149606|NCT01449461|39033545|FG000|Overall Study|Clinical Progressive Disease|2|||
16149607|NCT01449461|39033546|FG001|Overall Study|Clinical Progressive Disease|2|||
16149608|NCT01449461|39033547|FG002|Overall Study|Clinical Progressive Disease|0|||
16149609|NCT01449461|39033548|FG003|Overall Study|Clinical Progressive Disease|3|||
16149610|NCT01449461|39033549|FG004|Overall Study|Clinical Progressive Disease|4|||
16149611|NCT01449461|39033550|FG005|Overall Study|Clinical Progressive Disease|2|||
16149612|NCT01449461|39033545|FG000|Overall Study|Protocol Violation|0|||
16149613|NCT01449461|39033546|FG001|Overall Study|Protocol Violation|0|||
16149614|NCT01449461|39033547|FG002|Overall Study|Protocol Violation|0|||
16149615|NCT01449461|39033548|FG003|Overall Study|Protocol Violation|1|||
16149616|NCT01449461|39033549|FG004|Overall Study|Protocol Violation|0|||
16149617|NCT01449461|39033550|FG005|Overall Study|Protocol Violation|0|||
16149618|NCT01449461|39033545|FG000|Overall Study|Site Terminated by Sponsor|0|||
16149619|NCT01449461|39033546|FG001|Overall Study|Site Terminated by Sponsor|1|||
16149620|NCT01449461|39033547|FG002|Overall Study|Site Terminated by Sponsor|2|||
16149621|NCT01449461|39033548|FG003|Overall Study|Site Terminated by Sponsor|3|||
16149622|NCT01449461|39033549|FG004|Overall Study|Site Terminated by Sponsor|4|||
16149623|NCT01449461|39033550|FG005|Overall Study|Site Terminated by Sponsor|1|||
16149624|NCT01449461|39033545|FG000|Overall Study|Withdrawal by Subject|0|||
16149625|NCT01449461|39033546|FG001|Overall Study|Withdrawal by Subject|1|||
16149626|NCT01449461|39033547|FG002|Overall Study|Withdrawal by Subject|0|||
16149627|NCT01449461|39033548|FG003|Overall Study|Withdrawal by Subject|0|||
16149628|NCT01449461|39033549|FG004|Overall Study|Withdrawal by Subject|2|||
16149629|NCT01449461|39033550|FG005|Overall Study|Withdrawal by Subject|1|||
16149630|NCT01449461|39033545|FG000|Overall Study|Reason not Specified|0|||
16149631|NCT01449461|39033546|FG001|Overall Study|Reason not Specified|1|||
16149632|NCT01449461|39033547|FG002|Overall Study|Reason not Specified|0|||
16149633|NCT01449461|39033548|FG003|Overall Study|Reason not Specified|3|||
16149634|NCT01449461|39033549|FG004|Overall Study|Reason not Specified|2|||
16149635|NCT01449461|39033550|FG005|Overall Study|Reason not Specified|1|||
16149636|NCT01299376|39033551|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
16149637|NCT01299376|39033552|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
16149638|NCT01299376|39033551|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
16149639|NCT01299376|39033552|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
16149640|NCT01299376|39033551|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
16149641|NCT01299376|39033552|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
16149642|NCT01299376|39033551|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
16149643|NCT01299376|39033552|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
16149644|NCT01299376|39033551|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
16149645|NCT01299376|39033552|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
16149646|NCT01299376|39033551|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
16149647|NCT01299376|39033552|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
16149648|NCT01299376|39033551|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
16149649|NCT01299376|39033552|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
16149650|NCT01299376|39033551|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
16149651|NCT01299376|39033552|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
16149652|NCT01299376|39033551|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
16149653|NCT01299376|39033552|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
16149654|NCT01299376|39033551|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
16149655|NCT01299376|39033552|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
16149656|NCT01299376|39033551|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
16149657|NCT01299376|39033552|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
16149658|NCT02161575|39033553|FG000|Overall Study|Protocol Violation|8|||
16149659|NCT02161575|39033553|FG000|Overall Study|Lack of Efficacy|1|||
16149660|NCT02161575|39033553|FG000|Overall Study|Adverse Event|2|||
16260246|NCT03134222|39439474|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
16149661|NCT01967628|39033554|FG000|Overall Study|Withdrawal by Subject|2|||
16149662|NCT01967628|39033555|FG001|Overall Study|Withdrawal by Subject|0|||
16149663|NCT01967628|39033554|FG000|Overall Study|Unable to complete bronchoscopy|4|||
16149664|NCT01967628|39033555|FG001|Overall Study|Unable to complete bronchoscopy|6|||
16149665|NCT01967628|39033554|FG000|Overall Study|Lost to Follow-up|1|||
16149666|NCT01967628|39033555|FG001|Overall Study|Lost to Follow-up|0|||
16260247|NCT03134222|39439475|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
16149667|NCT01967628|39033554|FG000|Overall Study|Low protein concentration in sample|20|||
16149668|NCT01967628|39033555|FG001|Overall Study|Low protein concentration in sample|25|||
16149669|NCT00388973|39033556|FG000|Overall Study|Adverse Event|16|||
16149670|NCT00388973|39033557|FG001|Overall Study|Adverse Event|6|||
16149671|NCT00388973|39033556|FG000|Overall Study|Lack of Efficacy|1|||
16149672|NCT00388973|39033557|FG001|Overall Study|Lack of Efficacy|12|||
16149673|NCT00388973|39033556|FG000|Overall Study|Protocol Violation|3|||
16149674|NCT00388973|39033557|FG001|Overall Study|Protocol Violation|0|||
16149675|NCT00388973|39033556|FG000|Overall Study|Withdrawal by Subject|14|||
16149676|NCT00388973|39033557|FG001|Overall Study|Withdrawal by Subject|17|||
16149677|NCT00388973|39033556|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
16149678|NCT00388973|39033557|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
16149679|NCT00388973|39033556|FG000|Overall Study|Did not complete 61 days of treatment|5|||
16149680|NCT00388973|39033557|FG001|Overall Study|Did not complete 61 days of treatment|4|||
16149681|NCT00388973|39033556|FG000|Overall Study|Left region|0|||
16149682|NCT00388973|39033557|FG001|Overall Study|Left region|1|||
16149683|NCT00388973|39033556|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
16149684|NCT00388973|39033557|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
16149685|NCT02663271|39033560|FG000|Overall Study|Withdrawal by Subject|5|||
16149686|NCT02663271|39033560|FG000|Overall Study|Lack of Efficacy|1|||
16149687|NCT00636675|39033561|FG000|Overall Study|Lost to Follow-up|121|||
16149688|NCT00636675|39033562|FG001|Overall Study|Lost to Follow-up|31|||
16149689|NCT00636675|39033561|FG000|Overall Study|Withdrawal by Subject|19|||
16149690|NCT00636675|39033562|FG001|Overall Study|Withdrawal by Subject|10|||
16149691|NCT00766090|39033563|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149692|NCT00766090|39033564|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149693|NCT00766090|39033565|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149694|NCT00766090|39033566|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149695|NCT00766090|39033567|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149696|NCT00766090|39033568|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149697|NCT00766090|39033569|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149698|NCT00766090|39033570|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149699|NCT00766090|39033571|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
16149700|NCT00766090|39033572|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149701|NCT00766090|39033573|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149702|NCT00766090|39033574|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
16149703|NCT00766090|39033563|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
16149704|NCT00766090|39033564|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16149705|NCT00766090|39033565|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16149706|NCT00766090|39033566|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16149707|NCT00766090|39033567|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16149708|NCT00766090|39033568|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16149709|NCT00766090|39033569|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16149710|NCT00766090|39033570|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16149711|NCT00766090|39033571|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16149712|NCT00766090|39033572|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16365236|NCT03188185|39821560|FG000|Stage 1|Identified as a professional patient|0|||
16365237|NCT03188185|39821561|FG001|Stage 1|Identified as a professional patient|1|||
16365238|NCT03188185|39821562|FG002|Stage 1|Identified as a professional patient|0|||
16365239|NCT03188185|39821563|FG003|Stage 1|Identified as a professional patient|0|||
16365240|NCT03188185|39821560|FG000|Stage 2|Adverse Event|0|||
16365241|NCT03188185|39821561|FG001|Stage 2|Adverse Event|0|||
16365242|NCT03188185|39821562|FG002|Stage 2|Adverse Event|2|||
16365243|NCT03188185|39821563|FG003|Stage 2|Adverse Event|4|||
16365244|NCT03188185|39821560|FG000|Stage 2|Lack of Efficacy|0|||
16365245|NCT03188185|39821561|FG001|Stage 2|Lack of Efficacy|0|||
16365246|NCT03188185|39821562|FG002|Stage 2|Lack of Efficacy|3|||
16365247|NCT03188185|39821563|FG003|Stage 2|Lack of Efficacy|0|||
16365248|NCT03188185|39821560|FG000|Stage 2|Lost to Follow-up|0|||
16365249|NCT03188185|39821561|FG001|Stage 2|Lost to Follow-up|0|||
16365250|NCT03188185|39821562|FG002|Stage 2|Lost to Follow-up|1|||
16365251|NCT03188185|39821563|FG003|Stage 2|Lost to Follow-up|0|||
16365252|NCT03188185|39821560|FG000|Stage 2|Physician Decision|0|||
16365253|NCT03188185|39821561|FG001|Stage 2|Physician Decision|0|||
16365254|NCT03188185|39821562|FG002|Stage 2|Physician Decision|0|||
16365255|NCT03188185|39821563|FG003|Stage 2|Physician Decision|1|||
16365256|NCT03188185|39821560|FG000|Stage 2|Withdrawal by Subject|0|||
16441690|NCT03570892|40097598|FG001|Overall Study|Death|45|||
16441691|NCT03570892|40097597|FG000|Overall Study|Subject decision|5|||
16365257|NCT03188185|39821561|FG001|Stage 2|Withdrawal by Subject|0|||
16365258|NCT03188185|39821562|FG002|Stage 2|Withdrawal by Subject|3|||
16365259|NCT03188185|39821563|FG003|Stage 2|Withdrawal by Subject|1|||
16365260|NCT00827242|39821564|FG000|Overall Study|Withdrawal by Subject|2|||
16365261|NCT00827242|39821565|FG001|Overall Study|Withdrawal by Subject|4|||
16365262|NCT00827242|39821564|FG000|Overall Study|Protocol Violation|1|||
16365263|NCT00827242|39821565|FG001|Overall Study|Protocol Violation|3|||
16365264|NCT00827242|39821564|FG000|Overall Study|Lost to Follow-up|0|||
16365265|NCT00827242|39821565|FG001|Overall Study|Lost to Follow-up|3|||
16365266|NCT00827242|39821564|FG000|Overall Study|Adverse Event Excluding Death|2|||
16365267|NCT00827242|39821565|FG001|Overall Study|Adverse Event Excluding Death|1|||
16365268|NCT00827242|39821564|FG000|Overall Study|Entry Criteria Not Met|4|||
16365269|NCT00827242|39821565|FG001|Overall Study|Entry Criteria Not Met|1|||
16441692|NCT03570892|40097598|FG001|Overall Study|Subject decision|3|||
16441693|NCT03570892|40097597|FG000|Overall Study|Protocol Violation|1|||
16441694|NCT03570892|40097598|FG001|Overall Study|Protocol Violation|4|||
16441695|NCT03570892|40097597|FG000|Overall Study|Physician Decision|0|||
16441696|NCT03570892|40097598|FG001|Overall Study|Physician Decision|2|||
16441697|NCT00107198|40097600|FG000|Overall Study|Lack of Efficacy|28|||
16441698|NCT00107198|40097600|FG000|Overall Study|Lost to Follow-up|12|||
16441699|NCT00107198|40097600|FG000|Overall Study|Protocol Violation|1|||
16441700|NCT00107198|40097600|FG000|Overall Study|Withdrawal by Subject|6|||
16441701|NCT00107198|40097600|FG000|Overall Study|Ineligible|5|||
16441702|NCT03227757|40097601|FG000|Overall Study|Death|7|||
16365270|NCT00827242|39821564|FG000|Overall Study|Physician Decision|2|||
16365271|NCT00827242|39821565|FG001|Overall Study|Physician Decision|0|||
16441703|NCT03227757|40097601|FG000|Overall Study|Withdrawal|5|||
16441704|NCT03227757|40097601|FG000|Overall Study|Missed visits|4|||
16441705|NCT06303167|40097603|FG000|Overall Study|Ineligible|1|||
16260248|NCT03134222|39439476|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
16260249|NCT03134222|39439477|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
16260250|NCT03134222|39439478|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
16260251|NCT03134222|39439474|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
16260252|NCT03134222|39439475|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
16149713|NCT00766090|39033573|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16149714|NCT00766090|39033574|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
16149715|NCT00766090|39033563|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
16149716|NCT00766090|39033564|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16149717|NCT00766090|39033565|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16149718|NCT00766090|39033566|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
16149719|NCT00766090|39033567|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16149720|NCT00766090|39033568|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16149721|NCT00766090|39033569|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16149722|NCT00766090|39033570|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16149723|NCT00766090|39033571|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16149724|NCT00766090|39033572|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16149725|NCT00766090|39033573|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16149726|NCT00766090|39033574|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
16149727|NCT00766090|39033563|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149728|NCT00766090|39033564|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149729|NCT00766090|39033565|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
16149730|NCT00766090|39033566|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149731|NCT00766090|39033567|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149732|NCT00766090|39033568|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149733|NCT00766090|39033569|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149734|NCT00766090|39033570|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149735|NCT00766090|39033571|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149736|NCT00766090|39033572|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149737|NCT00766090|39033573|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149738|NCT00766090|39033574|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
16149739|NCT00766090|39033563|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16149740|NCT00766090|39033564|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16149741|NCT00766090|39033565|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16149742|NCT00766090|39033566|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16149743|NCT00766090|39033567|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
16260253|NCT03134222|39439476|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
16260254|NCT03134222|39439477|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
16260255|NCT03134222|39439478|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
16260256|NCT03134222|39439474|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
16260257|NCT03134222|39439475|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
16260258|NCT03134222|39439476|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
16260259|NCT03134222|39439477|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
16260260|NCT03134222|39439478|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
16260261|NCT03134222|39439474|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
16260262|NCT03134222|39439475|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
16260263|NCT03134222|39439476|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
16260264|NCT03134222|39439477|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
16260265|NCT03134222|39439478|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
16260266|NCT03134222|39439474|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
16260267|NCT03134222|39439475|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
16260268|NCT03134222|39439476|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
16260269|NCT03134222|39439477|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
16260270|NCT03134222|39439478|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
16260271|NCT01661686|39439479|FG000|Overall Study|Lost to Follow-up|2|||
16260272|NCT01661686|39439480|FG001|Overall Study|Lost to Follow-up|1|||
16260273|NCT01661686|39439479|FG000|Overall Study|did not receive allocated intervention|0|||
16260274|NCT01661686|39439480|FG001|Overall Study|did not receive allocated intervention|1|||
16260275|NCT00437658|39439481|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
16260276|NCT00437658|39439482|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
16260277|NCT00437658|39439483|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
16260278|NCT00437658|39439481|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
16260279|NCT00437658|39439482|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
16260280|NCT00437658|39439483|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
16260281|NCT00437658|39439481|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
16260282|NCT00437658|39439482|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
16260283|NCT00437658|39439483|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
16260284|NCT00437658|39439481|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
16260285|NCT00437658|39439482|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
16260286|NCT00437658|39439483|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
16260287|NCT00437658|39439481|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
16260288|NCT00437658|39439482|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
16260289|NCT00437658|39439483|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
16260290|NCT00437658|39439481|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
16260291|NCT00437658|39439482|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
16260292|NCT00437658|39439483|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
16260293|NCT00437658|39439481|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
16260294|NCT00437658|39439482|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
16260295|NCT00437658|39439483|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
16260296|NCT00437658|39439481|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
16260297|NCT00437658|39439482|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
16260298|NCT00437658|39439483|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
16260299|NCT00437658|39439481|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
16260300|NCT00437658|39439482|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
16260301|NCT00437658|39439483|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
16260302|NCT00437658|39439481|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
16260303|NCT00437658|39439482|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
16260304|NCT00437658|39439483|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
16260305|NCT00437658|39439481|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
16365272|NCT00827242|39821564|FG000|Overall Study|Death|1|||
16260306|NCT00437658|39439482|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
16260307|NCT00437658|39439483|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
16260308|NCT00437658|39439481|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
16260309|NCT00437658|39439482|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
16260310|NCT00437658|39439483|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
16260311|NCT02188303|39439485|FG000|Overall Study|Adverse Event|0|||
16260312|NCT02188303|39439486|FG001|Overall Study|Adverse Event|0|||
16260313|NCT02188303|39439487|FG002|Overall Study|Adverse Event|0|||
16260314|NCT02188303|39439488|FG003|Overall Study|Adverse Event|0|||
16260315|NCT02188303|39439489|FG004|Overall Study|Adverse Event|0|||
16260316|NCT02188303|39439490|FG005|Overall Study|Adverse Event|2|||
16260317|NCT02188303|39439491|FG006|Overall Study|Adverse Event|0|||
16260318|NCT02188303|39439492|FG007|Overall Study|Adverse Event|2|||
16260319|NCT02188303|39439485|FG000|Overall Study|Dose Termination Criteria Met|0|||
16260320|NCT02188303|39439486|FG001|Overall Study|Dose Termination Criteria Met|0|||
16260321|NCT02188303|39439487|FG002|Overall Study|Dose Termination Criteria Met|0|||
16260322|NCT02188303|39439488|FG003|Overall Study|Dose Termination Criteria Met|0|||
16260323|NCT02188303|39439489|FG004|Overall Study|Dose Termination Criteria Met|0|||
16260324|NCT02188303|39439490|FG005|Overall Study|Dose Termination Criteria Met|0|||
16260325|NCT02188303|39439491|FG006|Overall Study|Dose Termination Criteria Met|2|||
16260326|NCT02188303|39439492|FG007|Overall Study|Dose Termination Criteria Met|4|||
16260327|NCT01546545|39439493|FG000|Overall Study|Withdrawal by Subject|1|||
16260328|NCT01604850|39439495|FG000|Overall Study|Enrolled but never treated|0|||
16260329|NCT01604850|39439496|FG001|Overall Study|Enrolled but never treated|1|||
16260330|NCT01604850|39439495|FG000|Overall Study|Efficacy Failure|50|||
16260331|NCT01604850|39439496|FG001|Overall Study|Efficacy Failure|29|||
16260332|NCT01604850|39439495|FG000|Overall Study|Lost to Follow-up|1|||
16260333|NCT01604850|39439496|FG001|Overall Study|Lost to Follow-up|0|||
16260334|NCT01604850|39439495|FG000|Overall Study|Subject withdrew consent|1|||
16260335|NCT01604850|39439496|FG001|Overall Study|Subject withdrew consent|0|||
16260336|NCT02781727|39439497|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
16260337|NCT02781727|39439498|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
16260338|NCT02781727|39439497|FG000|Treatment Period|Withdrawal by Subject|1|||
16260339|NCT02781727|39439498|FG001|Treatment Period|Withdrawal by Subject|0|||
16260340|NCT02781727|39439497|FG000|Treatment Period|Lost to Follow-up|0|||
16260341|NCT02781727|39439498|FG001|Treatment Period|Lost to Follow-up|1|||
16260342|NCT02728102|39439500|FG000|Overall Study|Death|3|||
16260343|NCT02728102|39439501|FG001|Overall Study|Death|0|||
16260344|NCT02728102|39439502|FG002|Overall Study|Death|1|||
16260345|NCT02728102|39439500|FG000|Overall Study|Withdrawal by Subject|0|||
16260346|NCT02728102|39439501|FG001|Overall Study|Withdrawal by Subject|2|||
16260347|NCT02728102|39439502|FG002|Overall Study|Withdrawal by Subject|3|||
16260348|NCT02728102|39439500|FG000|Overall Study|Physician Decision|1|||
16260349|NCT02728102|39439501|FG001|Overall Study|Physician Decision|1|||
16260350|NCT02728102|39439502|FG002|Overall Study|Physician Decision|0|||
16260351|NCT02728102|39439500|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
16260352|NCT02728102|39439501|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
16260353|NCT02728102|39439502|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
16260354|NCT02728102|39439500|FG000|Overall Study|Covid|0|||
16260355|NCT02728102|39439501|FG001|Overall Study|Covid|0|||
16260356|NCT02728102|39439502|FG002|Overall Study|Covid|1|||
16260357|NCT02924883|39439503|FG000|Overall Study|Death|39|||
16260358|NCT02924883|39439504|FG001|Overall Study|Death|20|||
16260359|NCT02924883|39439503|FG000|Overall Study|Lost to Follow-up|1|||
16260360|NCT02924883|39439504|FG001|Overall Study|Lost to Follow-up|0|||
16260361|NCT02924883|39439503|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
16260362|NCT02924883|39439504|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
16260363|NCT02924883|39439503|FG000|Overall Study|Protocol Violation|1|||
16260364|NCT02924883|39439504|FG001|Overall Study|Protocol Violation|0|||
16260365|NCT02924883|39439503|FG000|Overall Study|Withdrawal by Subject|22|||
16260366|NCT02924883|39439504|FG001|Overall Study|Withdrawal by Subject|16|||
16149744|NCT00766090|39033568|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16149745|NCT00766090|39033569|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16149746|NCT00766090|39033570|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16149747|NCT00766090|39033571|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16149748|NCT00766090|39033572|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16149749|NCT00766090|39033573|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16441706|NCT06303167|40097603|FG000|Overall Study|Never start protocol therapy|2|||
16441707|NCT06303167|40097603|FG000|Overall Study|Disease progression|16|||
16441708|NCT04532528|40097606|FG000|Overall Study|Adverse Event|12|||
16441709|NCT04532528|40097607|FG001|Overall Study|Adverse Event|17|||
16441710|NCT04532528|40097606|FG000|Overall Study|Withdrawal of consent|16|||
16441711|NCT04532528|40097607|FG001|Overall Study|Withdrawal of consent|17|||
16441712|NCT04532528|40097606|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
16441713|NCT04532528|40097607|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
16441714|NCT04532528|40097606|FG000|Overall Study|Lost to Follow-up|69|||
16441715|NCT04532528|40097607|FG001|Overall Study|Lost to Follow-up|68|||
16441716|NCT04532528|40097606|FG000|Overall Study|Administrative problems|12|||
16441717|NCT04532528|40097607|FG001|Overall Study|Administrative problems|14|||
16441718|NCT04532528|40097606|FG000|Overall Study|Death|3|||
16441719|NCT04532528|40097607|FG001|Overall Study|Death|3|||
16441720|NCT04532528|40097606|FG000|Overall Study|Other|38|||
16441721|NCT04532528|40097607|FG001|Overall Study|Other|46|||
16441722|NCT03103542|40097608|FG000|Overall Study|Physician Decision|2|||
16149750|NCT00766090|39033574|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
16149751|NCT00766090|39033563|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149752|NCT00766090|39033564|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149753|NCT00766090|39033565|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
16149754|NCT00766090|39033566|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149755|NCT00766090|39033567|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149756|NCT00766090|39033568|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149757|NCT00766090|39033569|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149758|NCT00766090|39033570|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149759|NCT00766090|39033571|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149760|NCT00766090|39033572|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149761|NCT00766090|39033573|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149762|NCT00766090|39033574|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
16149763|NCT00766090|39033563|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
16149764|NCT00766090|39033564|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
16149765|NCT00766090|39033565|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
16149766|NCT00766090|39033566|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
16149767|NCT00766090|39033567|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
16149768|NCT00766090|39033568|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
16149769|NCT00766090|39033569|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
16149770|NCT00766090|39033570|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
16149771|NCT00766090|39033571|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
16149772|NCT00766090|39033572|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
16149773|NCT00766090|39033573|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
16149774|NCT00766090|39033574|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
16149775|NCT00766090|39033563|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149776|NCT00766090|39033564|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149777|NCT00766090|39033565|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149778|NCT00766090|39033566|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149779|NCT00766090|39033567|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149780|NCT00766090|39033568|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
16149781|NCT00766090|39033569|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149782|NCT00766090|39033570|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149783|NCT00766090|39033571|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149784|NCT00766090|39033572|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149785|NCT00766090|39033573|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149786|NCT00766090|39033574|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
16149787|NCT00766090|39033563|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16149788|NCT00766090|39033564|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
16149789|NCT00766090|39033565|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16149790|NCT00766090|39033566|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
16149791|NCT00766090|39033567|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16149792|NCT00766090|39033568|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16149793|NCT00766090|39033569|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16149794|NCT00766090|39033570|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16441723|NCT03103542|40097608|FG000|Overall Study|Adverse Event|2|||
16441724|NCT03103542|40097608|FG000|Overall Study|Other|2|||
16149795|NCT00766090|39033571|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16260367|NCT02924883|39439503|FG000|Overall Study|Progressive Disease|1|||
16441725|NCT03103542|40097608|FG000|Overall Study|Withdrawal by Subject|1|||
16441726|NCT03562195|40097611|FG000|Overall Study|Adverse Event|0|||
16441727|NCT03562195|40097612|FG001|Overall Study|Adverse Event|6|||
16149796|NCT00766090|39033572|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16149797|NCT00766090|39033573|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
16149798|NCT00766090|39033574|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
16149799|NCT00766090|39033563|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149800|NCT00766090|39033564|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149801|NCT00766090|39033565|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149802|NCT00766090|39033566|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149803|NCT00766090|39033567|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
16149804|NCT00766090|39033568|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149805|NCT00766090|39033569|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149806|NCT00766090|39033570|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149807|NCT00766090|39033571|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149808|NCT00766090|39033572|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149809|NCT00766090|39033573|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149810|NCT00766090|39033574|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
16149811|NCT01517893|39033576|FG000|Overall Study|Withdrawal by Subject|3|||
16149812|NCT01517893|39033577|FG001|Overall Study|Withdrawal by Subject|0|||
16149813|NCT00544648|39033578|FG000|Overall Study|Withdrawal by Subject|1|||
16149814|NCT00544648|39033579|FG001|Overall Study|Withdrawal by Subject|0|||
16149815|NCT00544648|39033578|FG000|Overall Study|Adverse Event|1|||
16149816|NCT00544648|39033579|FG001|Overall Study|Adverse Event|1|||
16149817|NCT00544648|39033578|FG000|Overall Study|progression of disease|1|||
16365273|NCT00827242|39821565|FG001|Overall Study|Death|0|||
16365274|NCT00827242|39821564|FG000|Overall Study|Lack of Efficacy|1|||
16365275|NCT00827242|39821565|FG001|Overall Study|Lack of Efficacy|0|||
16365276|NCT00614393|39821566|FG000|Overall Study|Adverse Event|20|||
16365277|NCT00614393|39821567|FG001|Overall Study|Adverse Event|2|||
16365278|NCT00614393|39821568|FG002|Overall Study|Adverse Event|3|||
16365279|NCT00614393|39821569|FG003|Overall Study|Adverse Event|13|||
16365280|NCT00614393|39821570|FG004|Overall Study|Adverse Event|21|||
16365281|NCT00614393|39821566|FG000|Overall Study|Lost to Follow-up|0|||
16365282|NCT00614393|39821567|FG001|Overall Study|Lost to Follow-up|0|||
16365283|NCT00614393|39821568|FG002|Overall Study|Lost to Follow-up|0|||
16365284|NCT00614393|39821569|FG003|Overall Study|Lost to Follow-up|1|||
16365285|NCT00614393|39821570|FG004|Overall Study|Lost to Follow-up|2|||
16365286|NCT00614393|39821566|FG000|Overall Study|Physician Decision|17|||
16365287|NCT00614393|39821567|FG001|Overall Study|Physician Decision|0|||
16365288|NCT00614393|39821568|FG002|Overall Study|Physician Decision|1|||
16365289|NCT00614393|39821569|FG003|Overall Study|Physician Decision|8|||
16365290|NCT00614393|39821570|FG004|Overall Study|Physician Decision|9|||
16365291|NCT00614393|39821566|FG000|Overall Study|Progressive Disease|118|||
16365292|NCT00614393|39821567|FG001|Overall Study|Progressive Disease|5|||
16365293|NCT00614393|39821568|FG002|Overall Study|Progressive Disease|5|||
16149818|NCT00544648|39033579|FG001|Overall Study|progression of disease|0|||
16149819|NCT01368042|39033584|FG000|Overall Study|Death|14|||
16149820|NCT01368042|39033584|FG000|Overall Study|Protocol Violation|11|||
16365294|NCT00614393|39821569|FG003|Overall Study|Progressive Disease|138|||
16365295|NCT00614393|39821570|FG004|Overall Study|Progressive Disease|130|||
16365296|NCT00614393|39821566|FG000|Overall Study|Protocol Violation|1|||
16365297|NCT00614393|39821567|FG001|Overall Study|Protocol Violation|0|||
16149821|NCT01368042|39033584|FG000|Overall Study|Lost to Follow-up|4|||
16149822|NCT01368042|39033584|FG000|Overall Study|Transplanted|1|||
16149823|NCT02716987|39033585|FG000|Overall Study|Ligand synthesis failure|0|||
16149824|NCT02716987|39033586|FG001|Overall Study|Ligand synthesis failure|0|||
16149825|NCT02716987|39033587|FG002|Overall Study|Ligand synthesis failure|1|||
16149826|NCT02716987|39033588|FG003|Overall Study|Ligand synthesis failure|0|||
16149827|NCT02716987|39033589|FG004|Overall Study|Ligand synthesis failure|0|||
16149828|NCT02716987|39033590|FG005|Overall Study|Ligand synthesis failure|0|||
16149829|NCT02716987|39033585|FG000|Overall Study|Withdrawal by Subject|0|||
16149830|NCT02716987|39033586|FG001|Overall Study|Withdrawal by Subject|0|||
16149831|NCT02716987|39033587|FG002|Overall Study|Withdrawal by Subject|0|||
16149832|NCT02716987|39033588|FG003|Overall Study|Withdrawal by Subject|0|||
16149833|NCT02716987|39033589|FG004|Overall Study|Withdrawal by Subject|1|||
16149834|NCT02716987|39033590|FG005|Overall Study|Withdrawal by Subject|1|||
16149835|NCT00880399|39033591|FG000|Overall Study|Adverse Event|4|||
16149836|NCT00880399|39033592|FG001|Overall Study|Adverse Event|6|||
16149837|NCT00880399|39033593|FG002|Overall Study|Adverse Event|5|||
16149838|NCT00880399|39033591|FG000|Overall Study|Lack of Efficacy|1|||
16149839|NCT00880399|39033592|FG001|Overall Study|Lack of Efficacy|4|||
16149840|NCT00880399|39033593|FG002|Overall Study|Lack of Efficacy|2|||
16149841|NCT00880399|39033591|FG000|Overall Study|Protocol Violation|4|||
16149842|NCT00880399|39033592|FG001|Overall Study|Protocol Violation|4|||
16149843|NCT00880399|39033593|FG002|Overall Study|Protocol Violation|6|||
16149844|NCT00880399|39033591|FG000|Overall Study|Study closed/terminated|3|||
16149845|NCT00880399|39033592|FG001|Overall Study|Study closed/terminated|7|||
16149846|NCT00880399|39033593|FG002|Overall Study|Study closed/terminated|4|||
16149847|NCT00880399|39033591|FG000|Overall Study|Lost to Follow-up|8|||
16149848|NCT00880399|39033592|FG001|Overall Study|Lost to Follow-up|5|||
16149849|NCT00880399|39033593|FG002|Overall Study|Lost to Follow-up|3|||
16149850|NCT00880399|39033591|FG000|Overall Study|Physician Decision|5|||
16149851|NCT00880399|39033592|FG001|Overall Study|Physician Decision|0|||
16149852|NCT00880399|39033593|FG002|Overall Study|Physician Decision|3|||
16149853|NCT00880399|39033591|FG000|Overall Study|Withdrawal by Subject|6|||
16149854|NCT00880399|39033592|FG001|Overall Study|Withdrawal by Subject|3|||
16149855|NCT00880399|39033593|FG002|Overall Study|Withdrawal by Subject|3|||
16149856|NCT01617070|39033595|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
16149857|NCT01858532|39033596|FG000|Overall Study|Adverse Event|58|||
16149858|NCT01858532|39033597|FG001|Overall Study|Adverse Event|50|||
16149859|NCT01858532|39033598|FG002|Overall Study|Adverse Event|23|||
16149860|NCT01858532|39033599|FG003|Overall Study|Adverse Event|28|||
16149861|NCT01858532|39033596|FG000|Overall Study|Withdrew consent|71|||
16149862|NCT01858532|39033597|FG001|Overall Study|Withdrew consent|93|||
16149863|NCT01858532|39033598|FG002|Overall Study|Withdrew consent|46|||
16149864|NCT01858532|39033599|FG003|Overall Study|Withdrew consent|27|||
16149865|NCT01858532|39033596|FG000|Overall Study|Lost to Follow-up|17|||
16149866|NCT01858532|39033597|FG001|Overall Study|Lost to Follow-up|26|||
16149867|NCT01858532|39033598|FG002|Overall Study|Lost to Follow-up|11|||
16149868|NCT01858532|39033599|FG003|Overall Study|Lost to Follow-up|14|||
16149869|NCT01858532|39033596|FG000|Overall Study|Deterioration of medical status|3|||
16149870|NCT01858532|39033597|FG001|Overall Study|Deterioration of medical status|4|||
16149871|NCT01858532|39033598|FG002|Overall Study|Deterioration of medical status|3|||
16149872|NCT01858532|39033599|FG003|Overall Study|Deterioration of medical status|7|||
16149873|NCT01858532|39033596|FG000|Overall Study|Investigator request|3|||
16149874|NCT01858532|39033597|FG001|Overall Study|Investigator request|4|||
16149875|NCT01858532|39033598|FG002|Overall Study|Investigator request|2|||
16149876|NCT01858532|39033599|FG003|Overall Study|Investigator request|6|||
16149877|NCT01858532|39033596|FG000|Overall Study|Other, not specified|29|||
16149878|NCT01858532|39033597|FG001|Overall Study|Other, not specified|15|||
16260368|NCT02924883|39439504|FG001|Overall Study|Progressive Disease|0|||
16260369|NCT02924883|39439503|FG000|Overall Study|Study Terminated by Sponsor|69|||
16260370|NCT02924883|39439504|FG001|Overall Study|Study Terminated by Sponsor|32|||
16260371|NCT01838941|39439505|FG000|Overall Study|Adverse Event|1|||
16260372|NCT01838941|39439505|FG000|Overall Study|Withdrawal by Subject|1|||
16260373|NCT00651820|39439506|FG000|Overall Study|Lost to Follow-up|2|||
16149879|NCT01858532|39033598|FG002|Overall Study|Other, not specified|13|||
16260374|NCT02107092|39439507|FG000|Overall Study|Miscellaneous|3|||
16260375|NCT02107092|39439507|FG000|Overall Study|Subject compliance|3|||
16149880|NCT01858532|39033599|FG003|Overall Study|Other, not specified|11|||
16149881|NCT02665052|39033600|FG000|Overall Study|Lost to Follow-up|1|||
16149882|NCT02665052|39033601|FG001|Overall Study|Lost to Follow-up|0|||
16149883|NCT02665052|39033602|FG002|Overall Study|Lost to Follow-up|0|||
16149884|NCT02665052|39033603|FG003|Overall Study|Lost to Follow-up|0|||
16149885|NCT02665052|39033600|FG000|Overall Study|Withdrawal by Subject|1|||
16149886|NCT02665052|39033601|FG001|Overall Study|Withdrawal by Subject|1|||
16149887|NCT02665052|39033602|FG002|Overall Study|Withdrawal by Subject|0|||
16149888|NCT02665052|39033603|FG003|Overall Study|Withdrawal by Subject|5|||
16149889|NCT02665052|39033600|FG000|Overall Study|Adverse Event|1|||
16260376|NCT02107092|39439507|FG000|Overall Study|Hypo-or hyperkalemia|2|||
16149890|NCT02665052|39033601|FG001|Overall Study|Adverse Event|1|||
16149891|NCT02665052|39033602|FG002|Overall Study|Adverse Event|0|||
16149892|NCT02665052|39033603|FG003|Overall Study|Adverse Event|0|||
16149893|NCT00806195|39033607|FG000|Overall Study|Death|6|||
16149894|NCT00806195|39033608|FG001|Overall Study|Death|0|||
16149895|NCT00806195|39033609|FG002|Overall Study|Death|1|||
16149896|NCT00806195|39033610|FG003|Overall Study|Death|0|||
16149897|NCT00806195|39033607|FG000|Overall Study|Adverse Event|25|||
16149898|NCT00806195|39033608|FG001|Overall Study|Adverse Event|5|||
16149899|NCT00806195|39033609|FG002|Overall Study|Adverse Event|11|||
16149900|NCT00806195|39033610|FG003|Overall Study|Adverse Event|2|||
16149901|NCT00806195|39033607|FG000|Overall Study|Withdrawal by Subject|119|||
16365298|NCT00614393|39821568|FG002|Overall Study|Protocol Violation|0|||
16365299|NCT00614393|39821569|FG003|Overall Study|Protocol Violation|0|||
16365300|NCT00614393|39821570|FG004|Overall Study|Protocol Violation|0|||
16365301|NCT00614393|39821566|FG000|Overall Study|Terminated by Sponsor|0|||
16260377|NCT02107092|39439507|FG000|Overall Study|Met ECG withdrawal criteria|3|||
16260378|NCT02107092|39439507|FG000|Overall Study|Physician Decision|3|||
16260379|NCT02107092|39439507|FG000|Overall Study|Lost to Follow-up|2|||
16260380|NCT02107092|39439507|FG000|Overall Study|Withdrawal by Subject|9|||
16260381|NCT02107092|39439507|FG000|Overall Study|Adverse Event|7|||
16260382|NCT02107092|39439507|FG000|Overall Study|Expected progression of CKD|12|||
16260383|NCT01273805|39439508|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
16260384|NCT01273805|39439509|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
16260385|NCT03018249|39439514|FG000|Overall Study|Withdrawal by Subject|2|||
16260386|NCT03018249|39439515|FG001|Overall Study|Withdrawal by Subject|2|||
16260387|NCT02395822|39439516|FG000|Overall Study|Withdrawal by Subject|1|||
16260388|NCT02395822|39439516|FG000|Overall Study|Death|1|||
16365302|NCT00614393|39821567|FG001|Overall Study|Terminated by Sponsor|0|||
16365303|NCT00614393|39821568|FG002|Overall Study|Terminated by Sponsor|0|||
16365304|NCT00614393|39821569|FG003|Overall Study|Terminated by Sponsor|0|||
16365305|NCT00614393|39821570|FG004|Overall Study|Terminated by Sponsor|1|||
16365306|NCT00614393|39821566|FG000|Overall Study|Withdrawal by Subject|20|||
16365307|NCT00614393|39821567|FG001|Overall Study|Withdrawal by Subject|1|||
16365308|NCT00614393|39821568|FG002|Overall Study|Withdrawal by Subject|1|||
16365309|NCT00614393|39821569|FG003|Overall Study|Withdrawal by Subject|16|||
16365310|NCT00614393|39821570|FG004|Overall Study|Withdrawal by Subject|13|||
16365311|NCT00614393|39821566|FG000|Overall Study|Other|4|||
16365312|NCT00614393|39821567|FG001|Overall Study|Other|0|||
16365313|NCT00614393|39821568|FG002|Overall Study|Other|0|||
16365314|NCT00614393|39821569|FG003|Overall Study|Other|4|||
16365315|NCT00614393|39821570|FG004|Overall Study|Other|2|||
16365316|NCT00614393|39821566|FG000|Overall Study|Not Treated|0|||
16365317|NCT00614393|39821567|FG001|Overall Study|Not Treated|0|||
16365318|NCT00614393|39821568|FG002|Overall Study|Not Treated|0|||
16365319|NCT00614393|39821569|FG003|Overall Study|Not Treated|0|||
16365320|NCT00614393|39821570|FG004|Overall Study|Not Treated|2|||
16365321|NCT02335944|39821574|FG000|Treatment Phase|Progressive Disease|2|||
16365322|NCT02335944|39821575|FG001|Treatment Phase|Progressive Disease|5|||
16365323|NCT02335944|39821576|FG002|Treatment Phase|Progressive Disease|2|||
16365324|NCT02335944|39821577|FG003|Treatment Phase|Progressive Disease|11|||
16365325|NCT02335944|39821578|FG004|Treatment Phase|Progressive Disease|4|||
16365326|NCT02335944|39821579|FG005|Treatment Phase|Progressive Disease|25|||
16365327|NCT02335944|39821580|FG006|Treatment Phase|Progressive Disease|2|||
16365328|NCT02335944|39821581|FG007|Treatment Phase|Progressive Disease|30|||
16365329|NCT02335944|39821582|FG008|Treatment Phase|Progressive Disease|27|||
16365330|NCT02335944|39821583|FG009|Treatment Phase|Progressive Disease|0|||
16365331|NCT02335944|39821574|FG000|Treatment Phase|Adverse Event|2|||
16365332|NCT02335944|39821575|FG001|Treatment Phase|Adverse Event|0|||
16365333|NCT02335944|39821576|FG002|Treatment Phase|Adverse Event|0|||
16365334|NCT02335944|39821577|FG003|Treatment Phase|Adverse Event|2|||
16365335|NCT02335944|39821578|FG004|Treatment Phase|Adverse Event|1|||
16365336|NCT02335944|39821579|FG005|Treatment Phase|Adverse Event|15|||
16365337|NCT02335944|39821580|FG006|Treatment Phase|Adverse Event|0|||
16365338|NCT02335944|39821581|FG007|Treatment Phase|Adverse Event|5|||
16149902|NCT00806195|39033608|FG001|Overall Study|Withdrawal by Subject|31|||
16149903|NCT00806195|39033609|FG002|Overall Study|Withdrawal by Subject|76|||
16149904|NCT00806195|39033610|FG003|Overall Study|Withdrawal by Subject|35|||
16260389|NCT02530905|39439517|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
16149905|NCT00806195|39033607|FG000|Overall Study|Lost to Follow-up|217|||
16365339|NCT02335944|39821582|FG008|Treatment Phase|Adverse Event|7|||
16365340|NCT02335944|39821583|FG009|Treatment Phase|Adverse Event|0|||
16365341|NCT02335944|39821574|FG000|Treatment Phase|Physician Decision|0|||
16365342|NCT02335944|39821575|FG001|Treatment Phase|Physician Decision|0|||
16365343|NCT02335944|39821576|FG002|Treatment Phase|Physician Decision|0|||
16365344|NCT02335944|39821577|FG003|Treatment Phase|Physician Decision|1|||
16365345|NCT02335944|39821578|FG004|Treatment Phase|Physician Decision|0|||
16365346|NCT02335944|39821579|FG005|Treatment Phase|Physician Decision|6|||
16365347|NCT02335944|39821580|FG006|Treatment Phase|Physician Decision|1|||
16149906|NCT00806195|39033608|FG001|Overall Study|Lost to Follow-up|66|||
16149907|NCT00806195|39033609|FG002|Overall Study|Lost to Follow-up|90|||
16149908|NCT00806195|39033610|FG003|Overall Study|Lost to Follow-up|34|||
16149909|NCT00806195|39033607|FG000|Overall Study|Inappropriate Enrollment|0|||
16149910|NCT00806195|39033608|FG001|Overall Study|Inappropriate Enrollment|1|||
16149911|NCT00806195|39033609|FG002|Overall Study|Inappropriate Enrollment|0|||
16149912|NCT00806195|39033610|FG003|Overall Study|Inappropriate Enrollment|0|||
16149913|NCT00806195|39033607|FG000|Overall Study|Administrative Reason|113|||
16149914|NCT00806195|39033608|FG001|Overall Study|Administrative Reason|35|||
16149915|NCT00806195|39033609|FG002|Overall Study|Administrative Reason|66|||
16149916|NCT00806195|39033610|FG003|Overall Study|Administrative Reason|26|||
16149917|NCT00806195|39033607|FG000|Overall Study|Protocol Violation|34|||
16149918|NCT00806195|39033608|FG001|Overall Study|Protocol Violation|24|||
16149919|NCT00806195|39033609|FG002|Overall Study|Protocol Violation|26|||
16149920|NCT00806195|39033610|FG003|Overall Study|Protocol Violation|9|||
16149921|NCT00823823|39033614|FG000|Overall Study|Lost to Follow-up|3|||
16149922|NCT00823823|39033615|FG001|Overall Study|Lost to Follow-up|1|||
16149923|NCT00823823|39033614|FG000|Overall Study|Protocol Violation|5|||
16149924|NCT00823823|39033615|FG001|Overall Study|Protocol Violation|5|||
16149925|NCT01549275|39033617|FG000|Overall Study|Lost to Follow-up|1|||
16149926|NCT01549275|39033618|FG001|Overall Study|Lost to Follow-up|0|||
16149927|NCT02257372|39033628|FG000|Overall Study|Adverse Event|3|||
16149928|NCT02257372|39033629|FG001|Overall Study|Adverse Event|7|||
16149929|NCT02257372|39033628|FG000|Overall Study|Lack of Efficacy|2|||
16149930|NCT02257372|39033629|FG001|Overall Study|Lack of Efficacy|1|||
16149931|NCT02257372|39033628|FG000|Overall Study|Protocol Violation|1|||
16365348|NCT02335944|39821581|FG007|Treatment Phase|Physician Decision|2|||
16365349|NCT02335944|39821582|FG008|Treatment Phase|Physician Decision|1|||
16365350|NCT02335944|39821583|FG009|Treatment Phase|Physician Decision|0|||
16365351|NCT02335944|39821574|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
16365352|NCT02335944|39821575|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
16365353|NCT02335944|39821576|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
16365354|NCT02335944|39821577|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
16365355|NCT02335944|39821578|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
16365356|NCT02335944|39821579|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
16365357|NCT02335944|39821580|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
16365358|NCT02335944|39821581|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
16365359|NCT02335944|39821582|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
16365360|NCT02335944|39821583|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
16365361|NCT02335944|39821574|FG000|Treatment Phase|Subject/Guardian Decision|0|||
16365362|NCT02335944|39821575|FG001|Treatment Phase|Subject/Guardian Decision|0|||
16365363|NCT02335944|39821576|FG002|Treatment Phase|Subject/Guardian Decision|1|||
16365364|NCT02335944|39821577|FG003|Treatment Phase|Subject/Guardian Decision|0|||
16365365|NCT02335944|39821578|FG004|Treatment Phase|Subject/Guardian Decision|0|||
16365366|NCT02335944|39821579|FG005|Treatment Phase|Subject/Guardian Decision|1|||
16365367|NCT02335944|39821580|FG006|Treatment Phase|Subject/Guardian Decision|0|||
16365368|NCT02335944|39821581|FG007|Treatment Phase|Subject/Guardian Decision|4|||
16365369|NCT02335944|39821582|FG008|Treatment Phase|Subject/Guardian Decision|0|||
16365370|NCT02335944|39821583|FG009|Treatment Phase|Subject/Guardian Decision|0|||
16365371|NCT02335944|39821574|FG000|Post-treatment Follow-up|Progressive Disease|0|||
16365372|NCT02335944|39821575|FG001|Post-treatment Follow-up|Progressive Disease|0|||
16365373|NCT02335944|39821576|FG002|Post-treatment Follow-up|Progressive Disease|0|||
16365374|NCT02335944|39821577|FG003|Post-treatment Follow-up|Progressive Disease|1|||
16365375|NCT02335944|39821578|FG004|Post-treatment Follow-up|Progressive Disease|0|||
16365376|NCT02335944|39821579|FG005|Post-treatment Follow-up|Progressive Disease|9|||
16365377|NCT02335944|39821580|FG006|Post-treatment Follow-up|Progressive Disease|0|||
16365378|NCT02335944|39821581|FG007|Post-treatment Follow-up|Progressive Disease|2|||
16365379|NCT02335944|39821582|FG008|Post-treatment Follow-up|Progressive Disease|3|||
16365380|NCT02335944|39821583|FG009|Post-treatment Follow-up|Progressive Disease|0|||
16365381|NCT02335944|39821574|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
16365382|NCT02335944|39821575|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
16365383|NCT02335944|39821576|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
16365384|NCT02335944|39821577|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
16365385|NCT02335944|39821578|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
16365386|NCT02335944|39821579|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
16365387|NCT02335944|39821580|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
16365388|NCT02335944|39821581|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
16149932|NCT02257372|39033629|FG001|Overall Study|Protocol Violation|1|||
16260390|NCT02530905|39439518|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
16365389|NCT02335944|39821582|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
16365390|NCT02335944|39821583|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
16149933|NCT02257372|39033628|FG000|Overall Study|Lost to Follow-up|0|||
16149934|NCT02257372|39033629|FG001|Overall Study|Lost to Follow-up|1|||
16441728|NCT03562195|40097611|FG000|Overall Study|Lack of Efficacy|0|||
16441729|NCT03562195|40097612|FG001|Overall Study|Lack of Efficacy|5|||
16441730|NCT03562195|40097611|FG000|Overall Study|Protocol Violation|0|||
16441731|NCT03562195|40097612|FG001|Overall Study|Protocol Violation|1|||
16441732|NCT03562195|40097611|FG000|Overall Study|Lost to Follow-up|0|||
16441733|NCT03562195|40097612|FG001|Overall Study|Lost to Follow-up|1|||
16441734|NCT03562195|40097611|FG000|Overall Study|Physician Decision|1|||
16441735|NCT03562195|40097612|FG001|Overall Study|Physician Decision|0|||
16441736|NCT03562195|40097611|FG000|Overall Study|Withdrawal by Subject|3|||
16441737|NCT03562195|40097612|FG001|Overall Study|Withdrawal by Subject|0|||
16441738|NCT03818035|40097613|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
16441739|NCT03818035|40097614|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
16441740|NCT03818035|40097615|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
16441741|NCT03818035|40097616|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
16441742|NCT03818035|40097613|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
16441743|NCT03818035|40097614|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
16441744|NCT03818035|40097615|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
16441745|NCT03818035|40097616|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
16441746|NCT03818035|40097613|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
16441747|NCT03818035|40097614|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
16441748|NCT03818035|40097615|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
16441749|NCT03818035|40097616|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
16441750|NCT03818035|40097613|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
16441751|NCT03818035|40097614|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
16441752|NCT03818035|40097615|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
16441753|NCT03818035|40097616|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
16441754|NCT03818035|40097613|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
16441755|NCT03818035|40097614|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
16441756|NCT03818035|40097615|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
16441757|NCT03818035|40097616|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
16441758|NCT03818035|40097613|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
16441759|NCT03818035|40097614|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
16441760|NCT03818035|40097615|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
16149935|NCT02257372|39033628|FG000|Overall Study|Withdrew consent|1|||
16149936|NCT02257372|39033629|FG001|Overall Study|Withdrew consent|0|||
16149937|NCT04053868|39033630|FG000|Overall Study|Withdrawal by Subject|1|||
16149938|NCT04053868|39033631|FG001|Overall Study|Withdrawal by Subject|0|||
16149939|NCT03829657|39033632|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
16149940|NCT03829657|39033633|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
16149941|NCT03829657|39033634|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
16149942|NCT03829657|39033635|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
16149943|NCT03829657|39033636|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
16149944|NCT03829657|39033632|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
16149945|NCT03829657|39033633|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
16149946|NCT03829657|39033634|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
16149947|NCT03829657|39033635|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
16149948|NCT03829657|39033636|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
16149949|NCT03829657|39033632|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
16149950|NCT03829657|39033633|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
16149951|NCT03829657|39033634|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
16149952|NCT03829657|39033635|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
16149953|NCT03829657|39033636|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
16149954|NCT03829657|39033632|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
16149955|NCT03829657|39033633|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
16149956|NCT03829657|39033634|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
16149957|NCT03829657|39033635|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
16149958|NCT03829657|39033636|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
16149959|NCT03829657|39033632|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
16149960|NCT03829657|39033633|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
16149961|NCT03829657|39033634|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
16149962|NCT03829657|39033635|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
16149963|NCT03829657|39033636|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
16149964|NCT03829657|39033632|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
16441761|NCT03818035|40097616|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
16441762|NCT03818035|40097613|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
16441763|NCT03818035|40097614|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
16441764|NCT03818035|40097615|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
16441765|NCT03818035|40097616|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
16365391|NCT02335944|39821574|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
16365392|NCT02335944|39821575|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
16365393|NCT02335944|39821576|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
16365394|NCT02335944|39821577|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
16365395|NCT02335944|39821578|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
16365396|NCT02335944|39821579|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
16365397|NCT02335944|39821580|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
16365398|NCT02335944|39821581|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
16365399|NCT02335944|39821582|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
16365400|NCT02335944|39821583|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
16365401|NCT02335944|39821574|FG000|Post-treatment Follow-up|Adverse Event|0|||
16365402|NCT02335944|39821575|FG001|Post-treatment Follow-up|Adverse Event|0|||
16365403|NCT02335944|39821576|FG002|Post-treatment Follow-up|Adverse Event|0|||
16365404|NCT02335944|39821577|FG003|Post-treatment Follow-up|Adverse Event|0|||
16365405|NCT02335944|39821578|FG004|Post-treatment Follow-up|Adverse Event|0|||
16365406|NCT02335944|39821579|FG005|Post-treatment Follow-up|Adverse Event|1|||
16441766|NCT03818035|40097613|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
16441767|NCT03818035|40097614|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
16441768|NCT03818035|40097615|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
16441769|NCT03818035|40097616|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
16441770|NCT03818035|40097613|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
16441771|NCT03818035|40097614|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
16441772|NCT03818035|40097615|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
16365407|NCT02335944|39821580|FG006|Post-treatment Follow-up|Adverse Event|0|||
16365408|NCT02335944|39821581|FG007|Post-treatment Follow-up|Adverse Event|0|||
16365409|NCT02335944|39821582|FG008|Post-treatment Follow-up|Adverse Event|0|||
16365410|NCT02335944|39821583|FG009|Post-treatment Follow-up|Adverse Event|0|||
16365411|NCT02335944|39821574|FG000|Post-treatment Follow-up|Death|0|||
16365412|NCT02335944|39821575|FG001|Post-treatment Follow-up|Death|0|||
16365413|NCT02335944|39821576|FG002|Post-treatment Follow-up|Death|0|||
16365414|NCT02335944|39821577|FG003|Post-treatment Follow-up|Death|1|||
16365415|NCT02335944|39821578|FG004|Post-treatment Follow-up|Death|0|||
16365416|NCT02335944|39821579|FG005|Post-treatment Follow-up|Death|1|||
16365417|NCT02335944|39821580|FG006|Post-treatment Follow-up|Death|0|||
16365418|NCT02335944|39821581|FG007|Post-treatment Follow-up|Death|0|||
16365419|NCT02335944|39821582|FG008|Post-treatment Follow-up|Death|0|||
16365420|NCT02335944|39821583|FG009|Post-treatment Follow-up|Death|0|||
16365421|NCT02335944|39821574|FG000|Post-treatment Follow-up|Physician Decision|1|||
16365422|NCT02335944|39821575|FG001|Post-treatment Follow-up|Physician Decision|0|||
16365423|NCT02335944|39821576|FG002|Post-treatment Follow-up|Physician Decision|0|||
16365424|NCT02335944|39821577|FG003|Post-treatment Follow-up|Physician Decision|0|||
16365425|NCT02335944|39821578|FG004|Post-treatment Follow-up|Physician Decision|0|||
16365426|NCT02335944|39821579|FG005|Post-treatment Follow-up|Physician Decision|0|||
16365427|NCT02335944|39821580|FG006|Post-treatment Follow-up|Physician Decision|0|||
16365428|NCT02335944|39821581|FG007|Post-treatment Follow-up|Physician Decision|1|||
16365429|NCT02335944|39821582|FG008|Post-treatment Follow-up|Physician Decision|0|||
16365430|NCT02335944|39821583|FG009|Post-treatment Follow-up|Physician Decision|0|||
16365431|NCT02448043|39821589|FG000|Overall Study|Withdrawal by Subject|2|||
16365432|NCT02448043|39821590|FG001|Overall Study|Withdrawal by Subject|2|||
16365433|NCT02448043|39821589|FG000|Overall Study|Protocol Violation|1|||
16365434|NCT02448043|39821590|FG001|Overall Study|Protocol Violation|2|||
16441773|NCT03818035|40097616|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
16149965|NCT03829657|39033633|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
16149966|NCT03829657|39033634|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
16149967|NCT03829657|39033635|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
16149968|NCT03829657|39033636|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
16149969|NCT03829657|39033632|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
16149970|NCT03829657|39033633|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
16149971|NCT03829657|39033634|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
16149972|NCT03829657|39033635|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
16149973|NCT03829657|39033636|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
16149974|NCT03829657|39033632|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
16149975|NCT03829657|39033633|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
16149976|NCT03829657|39033634|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
16149977|NCT03829657|39033635|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
16149978|NCT03829657|39033636|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
16149979|NCT03829657|39033632|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
16149980|NCT03829657|39033633|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
16149981|NCT03829657|39033634|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
16149982|NCT03829657|39033635|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
16149983|NCT03829657|39033636|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
16149984|NCT03829657|39033632|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
16149985|NCT03829657|39033633|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
16149986|NCT03829657|39033634|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
16149987|NCT03829657|39033635|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
16149988|NCT03829657|39033636|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
16149989|NCT02230384|39033639|FG000|Phase 1|Lost to Follow-up|1|||
16149990|NCT02230384|39033640|FG001|Phase 1|Lost to Follow-up|0|||
16149991|NCT02230384|39033639|FG000|Phase 1|Physician Decision|0|||
16149992|NCT02230384|39033640|FG001|Phase 1|Physician Decision|1|||
16149993|NCT02230384|39033639|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
16149994|NCT02230384|39033640|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
16149995|NCT02230384|39033639|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
16149996|NCT02230384|39033640|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
16149997|NCT02230384|39033639|FG000|Phase 2 - Switch|Adverse Event|2|||
16149998|NCT02230384|39033640|FG001|Phase 2 - Switch|Adverse Event|0|||
16149999|NCT04143009|39033641|FG000|Pilot Trial|Lost to Follow-up|0|||
16150000|NCT04143009|39033642|FG001|Pilot Trial|Lost to Follow-up|1|||
16150001|NCT04143009|39033643|FG002|Pilot Trial|Lost to Follow-up|1|||
16150002|NCT05376215|39033646|FG000|Overall Study|Withdrawal by Subject|2|||
16150003|NCT05376215|39033647|FG001|Overall Study|Withdrawal by Subject|1|||
16150004|NCT05376215|39033646|FG000|Overall Study|Lost to Follow-up|0|||
16150005|NCT05376215|39033647|FG001|Overall Study|Lost to Follow-up|1|||
16150006|NCT02554903|39033663|FG000|Overall Study|Death|1|||
16150007|NCT02554903|39033664|FG001|Overall Study|Death|1|||
16150008|NCT02554903|39033663|FG000|Overall Study|Physician Decision|2|||
16150009|NCT02554903|39033664|FG001|Overall Study|Physician Decision|2|||
16150010|NCT02554903|39033663|FG000|Overall Study|Heart Transplant|1|||
16150011|NCT02554903|39033664|FG001|Overall Study|Heart Transplant|2|||
16150012|NCT01923285|39033669|FG000|Overall Study|Withdrawal by Subject|7|||
16150013|NCT01923285|39033670|FG001|Overall Study|Withdrawal by Subject|6|||
16150014|NCT01294579|39036142|FG000|Overall Study|Disease progression|12|||
16150015|NCT01294579|39036142|FG000|Overall Study|Adverse Event|11|||
16150016|NCT01294579|39036142|FG000|Overall Study|Study closed/terminated|3|||
16150017|NCT01294579|39036142|FG000|Overall Study|Lost to Follow-up|1|||
16150018|NCT01294579|39036142|FG000|Overall Study|Physician Decision|3|||
16150019|NCT01294579|39036142|FG000|Overall Study|Withdrawal by Subject|5|||
16150020|NCT02311153|39036143|FG000|Overall Study|Lost to Follow-up|5|||
16150021|NCT02311153|39036144|FG001|Overall Study|Lost to Follow-up|7|||
16150022|NCT02159729|39036145|FG000|Overall Study|Adverse Event|0|||
16150023|NCT02159729|39036146|FG001|Overall Study|Adverse Event|1|||
16150024|NCT02159729|39036145|FG000|Overall Study|Subject's Request|13|||
16150025|NCT02159729|39036146|FG001|Overall Study|Subject's Request|10|||
16150026|NCT02159729|39036145|FG000|Overall Study|Lost to Follow-up|24|||
16150027|NCT02159729|39036146|FG001|Overall Study|Lost to Follow-up|9|||
16150028|NCT02159729|39036145|FG000|Overall Study|Non compliance|2|||
16150029|NCT02159729|39036146|FG001|Overall Study|Non compliance|0|||
16150030|NCT02159729|39036145|FG000|Overall Study|Other Unspecified|3|||
16150031|NCT02159729|39036146|FG001|Overall Study|Other Unspecified|1|||
16150032|NCT00706134|39036149|FG000|Overall Study|Adverse Event|8|||
16150033|NCT00706134|39036150|FG001|Overall Study|Adverse Event|7|||
16150034|NCT00706134|39036151|FG002|Overall Study|Adverse Event|2|||
16150035|NCT00706134|39036152|FG003|Overall Study|Adverse Event|3|||
16150036|NCT00706134|39036149|FG000|Overall Study|Lost to Follow-up|0|||
16150037|NCT00706134|39036150|FG001|Overall Study|Lost to Follow-up|1|||
16150038|NCT00706134|39036151|FG002|Overall Study|Lost to Follow-up|0|||
16260391|NCT02530905|39439519|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
16260392|NCT03338972|39439524|FG000|Overall Study|Death|1|||
16260393|NCT03338972|39439525|FG001|Overall Study|Death|1|||
16260394|NCT03338972|39439526|FG002|Overall Study|Death|0|||
16260395|NCT03338972|39439527|FG003|Overall Study|Death|0|||
16260396|NCT03338972|39439524|FG000|Overall Study|Withdrawal by Subject|1|||
16260397|NCT03338972|39439525|FG001|Overall Study|Withdrawal by Subject|0|||
16260398|NCT03338972|39439526|FG002|Overall Study|Withdrawal by Subject|0|||
16260399|NCT03338972|39439527|FG003|Overall Study|Withdrawal by Subject|0|||
16260400|NCT02087904|39439528|FG000|Overall Study|Did Not Receive Study Drug|0|||
16260401|NCT02087904|39439529|FG001|Overall Study|Did Not Receive Study Drug|0|||
16260402|NCT02087904|39439530|FG002|Overall Study|Did Not Receive Study Drug|2|||
16260403|NCT02087904|39439531|FG003|Overall Study|Did Not Receive Study Drug|1|||
16260404|NCT02087904|39439528|FG000|Overall Study|Adverse Event|8|||
16260405|NCT02087904|39439529|FG001|Overall Study|Adverse Event|4|||
16260406|NCT02087904|39439530|FG002|Overall Study|Adverse Event|4|||
16260407|NCT02087904|39439531|FG003|Overall Study|Adverse Event|12|||
16260408|NCT02087904|39439528|FG000|Overall Study|Lack of Efficacy|3|||
16260409|NCT02087904|39439529|FG001|Overall Study|Lack of Efficacy|6|||
16260410|NCT02087904|39439530|FG002|Overall Study|Lack of Efficacy|3|||
16260411|NCT02087904|39439531|FG003|Overall Study|Lack of Efficacy|2|||
16260412|NCT02087904|39439528|FG000|Overall Study|Other|6|||
16260413|NCT02087904|39439529|FG001|Overall Study|Other|2|||
16260414|NCT02087904|39439530|FG002|Overall Study|Other|4|||
16260415|NCT02087904|39439531|FG003|Overall Study|Other|4|||
16260416|NCT02087904|39439528|FG000|Overall Study|Withdrawal by Subject|8|||
16260417|NCT02087904|39439529|FG001|Overall Study|Withdrawal by Subject|3|||
16260418|NCT02087904|39439530|FG002|Overall Study|Withdrawal by Subject|7|||
16260419|NCT02087904|39439531|FG003|Overall Study|Withdrawal by Subject|4|||
16260420|NCT02087904|39439528|FG000|Overall Study|Lost to Follow-up|0|||
16260421|NCT02087904|39439529|FG001|Overall Study|Lost to Follow-up|4|||
16260422|NCT02087904|39439530|FG002|Overall Study|Lost to Follow-up|2|||
16260423|NCT02087904|39439531|FG003|Overall Study|Lost to Follow-up|2|||
16260424|NCT00119015|39439532|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
16260425|NCT00119015|39439533|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
16260426|NCT00119015|39439534|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
16260427|NCT02327130|39439543|FG000|Overall Study|Discharged in less than 5 days|5|||
16260428|NCT02327130|39439543|FG000|Overall Study|Physician Decision|2|||
16260429|NCT02327130|39439543|FG000|Overall Study|Unable to provide breath sample|1|||
16260430|NCT02327130|39439543|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
16260431|NCT02327130|39439543|FG000|Overall Study|Met exclusion criteria|3|||
16260432|NCT01353664|39439546|FG000|Overall Study|Other|3|||
16260433|NCT01353664|39439546|FG000|Overall Study|Disease Progression|16|||
16260434|NCT00814463|39439547|FG000|Overall Study|Lost to Follow-up|1|||
16260435|NCT02648347|39439548|FG000|Overall Study|Death|174|||
16260436|NCT02648347|39439549|FG001|Overall Study|Death|167|||
16260437|NCT02648347|39439548|FG000|Overall Study|Withdrawal by Subject|16|||
16260438|NCT02648347|39439549|FG001|Overall Study|Withdrawal by Subject|9|||
16260439|NCT02648347|39439548|FG000|Overall Study|Lost to Follow-up|18|||
16260440|NCT02648347|39439549|FG001|Overall Study|Lost to Follow-up|21|||
16260441|NCT02648347|39439548|FG000|Overall Study|Missing|1|||
16260442|NCT02648347|39439549|FG001|Overall Study|Missing|0|||
16260443|NCT03351244|39439550|FG000|Overall Study|Adverse Event|7|||
16260444|NCT03351244|39439551|FG001|Overall Study|Adverse Event|11|||
16260445|NCT03351244|39439552|FG002|Overall Study|Adverse Event|12|||
16260446|NCT03351244|39439550|FG000|Overall Study|Investigator's decision|0|||
16260447|NCT03351244|39439551|FG001|Overall Study|Investigator's decision|0|||
16260448|NCT03351244|39439552|FG002|Overall Study|Investigator's decision|2|||
16260449|NCT03351244|39439550|FG000|Overall Study|System error|0|||
16260450|NCT03351244|39439551|FG001|Overall Study|System error|0|||
16260451|NCT03351244|39439552|FG002|Overall Study|System error|2|||
16260452|NCT03351244|39439550|FG000|Overall Study|COVID-19 restrictions|3|||
16260453|NCT03351244|39439551|FG001|Overall Study|COVID-19 restrictions|0|||
16260454|NCT03351244|39439552|FG002|Overall Study|COVID-19 restrictions|1|||
16260455|NCT03351244|39439550|FG000|Overall Study|Non-compliance|2|||
16260456|NCT03351244|39439551|FG001|Overall Study|Non-compliance|5|||
16260457|NCT03351244|39439552|FG002|Overall Study|Non-compliance|0|||
16260458|NCT03351244|39439550|FG000|Overall Study|Withdrawal by Subject|11|||
16260459|NCT03351244|39439551|FG001|Overall Study|Withdrawal by Subject|16|||
16260460|NCT03351244|39439552|FG002|Overall Study|Withdrawal by Subject|13|||
16260461|NCT03351244|39439550|FG000|Overall Study|Lost to Follow-up|2|||
16260462|NCT03351244|39439551|FG001|Overall Study|Lost to Follow-up|6|||
16260463|NCT03351244|39439552|FG002|Overall Study|Lost to Follow-up|4|||
16260464|NCT03351244|39439550|FG000|Overall Study|Protocol Violation|2|||
16260465|NCT03351244|39439551|FG001|Overall Study|Protocol Violation|2|||
16260466|NCT03351244|39439552|FG002|Overall Study|Protocol Violation|0|||
16260467|NCT03480425|39439555|FG000|Overall Study|Force transducer technical failure|1|||
16260468|NCT00696020|39439559|FG000|Overall Study|Adverse Event|3|||
16260469|NCT00696020|39439560|FG001|Overall Study|Adverse Event|1|||
16260470|NCT00696020|39439561|FG002|Overall Study|Adverse Event|2|||
16260471|NCT00696020|39439562|FG003|Overall Study|Adverse Event|1|||
16260472|NCT00696020|39439559|FG000|Overall Study|Lack of Efficacy|1|||
16260473|NCT00696020|39439560|FG001|Overall Study|Lack of Efficacy|0|||
16260474|NCT00696020|39439561|FG002|Overall Study|Lack of Efficacy|0|||
16260475|NCT00696020|39439562|FG003|Overall Study|Lack of Efficacy|0|||
16260476|NCT00696020|39439559|FG000|Overall Study|Protocol Violation|0|||
16260477|NCT00696020|39439560|FG001|Overall Study|Protocol Violation|0|||
16260478|NCT00696020|39439561|FG002|Overall Study|Protocol Violation|0|||
16260479|NCT00696020|39439562|FG003|Overall Study|Protocol Violation|1|||
16260480|NCT00696020|39439559|FG000|Overall Study|Withdrawal by Subject|0|||
16260481|NCT00696020|39439560|FG001|Overall Study|Withdrawal by Subject|1|||
16260482|NCT00696020|39439561|FG002|Overall Study|Withdrawal by Subject|0|||
16260483|NCT00696020|39439562|FG003|Overall Study|Withdrawal by Subject|1|||
16260484|NCT00696020|39439559|FG000|Overall Study|Other not stated above|0|||
16260485|NCT00696020|39439560|FG001|Overall Study|Other not stated above|0|||
16260486|NCT00696020|39439561|FG002|Overall Study|Other not stated above|1|||
16260487|NCT00696020|39439562|FG003|Overall Study|Other not stated above|1|||
16260488|NCT01387737|39439563|FG000|Overall Study|Adverse Event|20|||
16260489|NCT01387737|39439564|FG001|Overall Study|Adverse Event|30|||
16260490|NCT01387737|39439563|FG000|Overall Study|Lack of Efficacy|1|||
16260491|NCT01387737|39439564|FG001|Overall Study|Lack of Efficacy|0|||
16260492|NCT01387737|39439563|FG000|Overall Study|Physician Decision|3|||
16260493|NCT01387737|39439564|FG001|Overall Study|Physician Decision|10|||
16441774|NCT03818035|40097613|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
16441775|NCT03818035|40097614|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
16441776|NCT03818035|40097615|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
16260494|NCT01387737|39439563|FG000|Overall Study|Withdrawal by Subject|27|||
16260495|NCT01387737|39439564|FG001|Overall Study|Withdrawal by Subject|31|||
16260496|NCT01387737|39439563|FG000|Overall Study|Clearly not eligible for the study|1|||
16260497|NCT01387737|39439564|FG001|Overall Study|Clearly not eligible for the study|3|||
16260498|NCT02760368|39439565|FG000|Overall Study|Withdrawal by Subject|8|||
16260499|NCT02760368|39439566|FG001|Overall Study|Withdrawal by Subject|12|||
16260500|NCT02760368|39439567|FG002|Overall Study|Withdrawal by Subject|9|||
16260501|NCT02760368|39439565|FG000|Overall Study|Screen Failure|0|||
16260502|NCT02760368|39439566|FG001|Overall Study|Screen Failure|0|||
16260503|NCT02760368|39439567|FG002|Overall Study|Screen Failure|1|||
16260504|NCT02760368|39439565|FG000|Overall Study|Death|0|||
16260505|NCT02760368|39439566|FG001|Overall Study|Death|1|||
16260506|NCT02760368|39439567|FG002|Overall Study|Death|0|||
16260507|NCT02760368|39439565|FG000|Overall Study|Withdrawal by Sponsor|0|||
16260508|NCT02760368|39439566|FG001|Overall Study|Withdrawal by Sponsor|0|||
16260509|NCT02760368|39439567|FG002|Overall Study|Withdrawal by Sponsor|1|||
16260510|NCT00669942|39439568|FG000|Parts 2 and 3|Adverse Event|0|||
16260511|NCT00669942|39439569|FG001|Parts 2 and 3|Adverse Event|0|||
16260512|NCT00669942|39439570|FG002|Parts 2 and 3|Adverse Event|0|||
16260513|NCT00669942|39439571|FG003|Parts 2 and 3|Adverse Event|0|||
16260514|NCT00669942|39439572|FG004|Parts 2 and 3|Adverse Event|0|||
16260515|NCT00669942|39439573|FG005|Parts 2 and 3|Adverse Event|0|||
16260516|NCT00669942|39439574|FG006|Parts 2 and 3|Adverse Event|0|||
16260517|NCT00669942|39439575|FG007|Parts 2 and 3|Adverse Event|2|||
16260518|NCT00669942|39439576|FG008|Parts 2 and 3|Adverse Event|1|||
16260519|NCT00669942|39439577|FG009|Parts 2 and 3|Adverse Event|0|||
16260520|NCT00669942|39439578|FG010|Parts 2 and 3|Adverse Event|0|||
16260521|NCT00669942|39439579|FG011|Parts 2 and 3|Adverse Event|0|||
16441777|NCT03818035|40097616|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
16441778|NCT03818035|40097613|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
16441779|NCT03818035|40097614|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
16441780|NCT03818035|40097615|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
16441781|NCT03818035|40097616|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
16441782|NCT03818035|40097613|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
16441783|NCT03818035|40097614|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
16441784|NCT03818035|40097615|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
16441785|NCT03818035|40097616|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
16441786|NCT03818035|40097613|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
16441787|NCT03818035|40097614|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
16441788|NCT03818035|40097615|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
16441789|NCT03818035|40097616|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
16260522|NCT00669942|39439568|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
16260523|NCT00669942|39439569|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
16260524|NCT00669942|39439570|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
16260525|NCT00669942|39439571|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
16260526|NCT00669942|39439572|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
16260527|NCT00669942|39439573|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
16260528|NCT00669942|39439574|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
16260529|NCT00669942|39439575|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
16260530|NCT00669942|39439576|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
16260531|NCT00669942|39439577|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
16260532|NCT00669942|39439578|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
16260533|NCT00669942|39439579|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
16260534|NCT00669942|39439568|FG000|Parts 2 and 3|Protocol Violation|0|||
16260535|NCT00669942|39439569|FG001|Parts 2 and 3|Protocol Violation|0|||
16260536|NCT00669942|39439570|FG002|Parts 2 and 3|Protocol Violation|0|||
16260537|NCT00669942|39439571|FG003|Parts 2 and 3|Protocol Violation|0|||
16260538|NCT00669942|39439572|FG004|Parts 2 and 3|Protocol Violation|0|||
16260539|NCT00669942|39439573|FG005|Parts 2 and 3|Protocol Violation|1|||
16260540|NCT00669942|39439574|FG006|Parts 2 and 3|Protocol Violation|0|||
16260541|NCT00669942|39439575|FG007|Parts 2 and 3|Protocol Violation|0|||
16260542|NCT00669942|39439576|FG008|Parts 2 and 3|Protocol Violation|0|||
16260543|NCT00669942|39439577|FG009|Parts 2 and 3|Protocol Violation|0|||
16260544|NCT00669942|39439578|FG010|Parts 2 and 3|Protocol Violation|0|||
16260545|NCT00669942|39439579|FG011|Parts 2 and 3|Protocol Violation|0|||
16260546|NCT00448591|39439580|FG000|Overall Study|Withdrawal by Subject|178|||
16260547|NCT00448591|39439580|FG000|Overall Study|Progressive Disease|1382|||
16260548|NCT00448591|39439580|FG000|Overall Study|Adverse Event|382|||
16260549|NCT00448591|39439580|FG000|Overall Study|Protocol Violation|41|||
16260550|NCT00448591|39439580|FG000|Overall Study|Lost to Follow-up|19|||
16260551|NCT00448591|39439580|FG000|Overall Study|Treatment Regimen Completed|70|||
16260552|NCT00448591|39439580|FG000|Overall Study|Other|154|||
16260553|NCT00448591|39439580|FG000|Overall Study|Termination of Study|70|||
16260554|NCT03546842|39439581|FG000|Overall Study|Protocol Violation|1|||
16260555|NCT03546842|39439581|FG000|Overall Study|Withdrawal by Subject|2|||
16260556|NCT02331394|39439585|FG000|Overall Study|Disease progression|1|||
16260557|NCT01328093|39439586|FG000|Double-Blind Phase|Adverse Event|78|||
16260558|NCT01328093|39439587|FG001|Double-Blind Phase|Adverse Event|15|||
16260559|NCT01328093|39439586|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
16260560|NCT01328093|39439587|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
16260561|NCT01328093|39439586|FG000|Double-Blind Phase|Lost to Follow-up|39|||
16260562|NCT01328093|39439587|FG001|Double-Blind Phase|Lost to Follow-up|14|||
16260563|NCT01328093|39439586|FG000|Double-Blind Phase|Protocol Violation|30|||
16150039|NCT00706134|39036152|FG003|Overall Study|Lost to Follow-up|0|||
16260564|NCT01328093|39439587|FG001|Double-Blind Phase|Protocol Violation|10|||
16260565|NCT01328093|39439586|FG000|Double-Blind Phase|Lack of Efficacy|55|||
16260566|NCT01328093|39439587|FG001|Double-Blind Phase|Lack of Efficacy|13|||
16260567|NCT01328093|39439586|FG000|Double-Blind Phase|Sponsor Decision|17|||
16260568|NCT01328093|39439587|FG001|Double-Blind Phase|Sponsor Decision|3|||
16260569|NCT01328093|39439586|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
16260570|NCT01328093|39439587|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
16260571|NCT01328093|39439586|FG000|Double-Blind Phase|Scheduling conflict|8|||
16260572|NCT01328093|39439587|FG001|Double-Blind Phase|Scheduling conflict|3|||
16260573|NCT01328093|39439586|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
16260574|NCT01328093|39439587|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
16260575|NCT01328093|39439586|FG000|Double-Blind Phase|Death|1|||
16260576|NCT01328093|39439587|FG001|Double-Blind Phase|Death|0|||
16260577|NCT01328093|39439586|FG000|Open-Label Phase|Sponsor Decision|98|||
16260578|NCT01328093|39439587|FG001|Open-Label Phase|Sponsor Decision|34|||
16260579|NCT01328093|39439586|FG000|Open-Label Phase|Protocol Violation|8|||
16260580|NCT01328093|39439587|FG001|Open-Label Phase|Protocol Violation|3|||
16260581|NCT01328093|39439586|FG000|Open-Label Phase|Lost to Follow-up|10|||
16260582|NCT01328093|39439587|FG001|Open-Label Phase|Lost to Follow-up|1|||
16260583|NCT01328093|39439586|FG000|Open-Label Phase|Adverse Event|10|||
16260584|NCT01328093|39439587|FG001|Open-Label Phase|Adverse Event|4|||
16260585|NCT01328093|39439586|FG000|Open-Label Phase|Lack of Efficacy|5|||
16260586|NCT01328093|39439587|FG001|Open-Label Phase|Lack of Efficacy|6|||
16260587|NCT01328093|39439586|FG000|Open-Label Phase|Withdrawal by Subject|4|||
16260588|NCT01328093|39439587|FG001|Open-Label Phase|Withdrawal by Subject|1|||
16260589|NCT01328093|39439586|FG000|Open-Label Phase|Scheduling conflict|2|||
16260590|NCT01328093|39439587|FG001|Open-Label Phase|Scheduling conflict|1|||
16260591|NCT01328093|39439586|FG000|Open-Label Phase|Subject is moving or has moved|2|||
16260592|NCT01328093|39439587|FG001|Open-Label Phase|Subject is moving or has moved|0|||
16260593|NCT01328093|39439586|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
16260594|NCT01328093|39439587|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
16260595|NCT01391793|39439594|FG000|Overall Study|Ineligible|3|||
16260596|NCT01391793|39439595|FG001|Overall Study|Ineligible|0|||
16260597|NCT01391793|39439594|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
16260598|NCT01391793|39439595|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
16260599|NCT01391793|39439594|FG000|Overall Study|No DMSA|73|||
16260600|NCT01391793|39439595|FG001|Overall Study|No DMSA|57|||
16260601|NCT01035060|39439606|FG000|Overall Study|Lost to Follow-up|0|||
16260602|NCT01035060|39439607|FG001|Overall Study|Lost to Follow-up|7|||
16260603|NCT01035060|39439606|FG000|Overall Study|Did not quality after 2nd screening|14|||
16260604|NCT01035060|39439607|FG001|Overall Study|Did not quality after 2nd screening|1|||
16260605|NCT01035060|39439606|FG000|Overall Study|Withdrawal by Subject|8|||
16260606|NCT01035060|39439607|FG001|Overall Study|Withdrawal by Subject|6|||
16260607|NCT01035060|39439606|FG000|Overall Study|Physician Decision|2|||
16260608|NCT01035060|39439607|FG001|Overall Study|Physician Decision|0|||
16260609|NCT00707161|39439610|FG000|Overall Study|Physician Decision|6|||
16260610|NCT03568461|39439611|FG000|Overall Study|Death|7|||
16260611|NCT03568461|39439611|FG000|Overall Study|Physician Decision|5|||
16260612|NCT03568461|39439611|FG000|Overall Study|Subject decision|5|||
16260613|NCT03568461|39439611|FG000|Overall Study|Lost to Follow-up|1|||
16260614|NCT02419937|39439612|FG000|Overall Study|Lost to Follow-up|1|||
16260615|NCT02419937|39439613|FG001|Overall Study|Lost to Follow-up|0|||
16260616|NCT00392665|39439614|FG000|Overall Study|Death|16|||
16260617|NCT00392665|39439615|FG001|Overall Study|Death|14|||
16260618|NCT00392665|39439614|FG000|Overall Study|Lost to Follow-up|1|||
16260619|NCT00392665|39439615|FG001|Overall Study|Lost to Follow-up|1|||
16260620|NCT00893464|39439628|FG000|Overall Study|Did not complete therapy/experience PD|0|||
16260621|NCT00893464|39439629|FG001|Overall Study|Did not complete therapy/experience PD|0|||
16260622|NCT00893464|39439630|FG002|Overall Study|Did not complete therapy/experience PD|0|||
16260623|NCT00893464|39439631|FG003|Overall Study|Did not complete therapy/experience PD|0|||
16260624|NCT00893464|39439632|FG004|Overall Study|Did not complete therapy/experience PD|0|||
16260625|NCT00893464|39439633|FG005|Overall Study|Did not complete therapy/experience PD|0|||
16260626|NCT00893464|39439634|FG006|Overall Study|Did not complete therapy/experience PD|2|||
16260627|NCT00893464|39439635|FG007|Overall Study|Did not complete therapy/experience PD|2|||
16260628|NCT01722877|39439638|FG000|Overall Study|Death|1|||
16260629|NCT01722877|39439638|FG000|Overall Study|Lost to Follow-up|1|||
16260630|NCT01215981|39439639|FG000|Overall Study|Physician Decision|0|||
16260631|NCT01215981|39439640|FG001|Overall Study|Physician Decision|1|||
16260632|NCT01215981|39439639|FG000|Overall Study|Protocol Violation|1|||
16260633|NCT01215981|39439640|FG001|Overall Study|Protocol Violation|0|||
16260634|NCT01215981|39439639|FG000|Overall Study|Withdrawal by Subject|1|||
16260635|NCT01215981|39439640|FG001|Overall Study|Withdrawal by Subject|0|||
16260636|NCT03478397|39439644|FG000|Overall Study|Refused to participate|31|||
16260637|NCT03478397|39439645|FG001|Overall Study|Refused to participate|7|||
16260638|NCT03243630|39439646|FG000|Overall Study|Protocol Violation|1|||
16260639|NCT03243630|39439646|FG000|Overall Study|Physician Decision|1|||
16260640|NCT01615198|39439648|FG000|Overall Study|Withdrawal by Subject|5|||
16260641|NCT01615198|39439649|FG001|Overall Study|Withdrawal by Subject|5|||
16260642|NCT01615198|39439648|FG000|Overall Study|Protocol deviation|1|||
16260643|NCT01615198|39439649|FG001|Overall Study|Protocol deviation|1|||
16260644|NCT01615198|39439648|FG000|Overall Study|Physician Decision|5|||
16260645|NCT01615198|39439649|FG001|Overall Study|Physician Decision|1|||
16260646|NCT01615198|39439648|FG000|Overall Study|Lost to Follow-up|1|||
16260647|NCT01615198|39439649|FG001|Overall Study|Lost to Follow-up|1|||
16260648|NCT01615198|39439648|FG000|Overall Study|Lack of Efficacy|1|||
16260649|NCT01615198|39439649|FG001|Overall Study|Lack of Efficacy|6|||
16260650|NCT01615198|39439648|FG000|Overall Study|Adverse Event|11|||
16260651|NCT01615198|39439649|FG001|Overall Study|Adverse Event|5|||
16260652|NCT03329027|39439650|FG000|Overall Study|Lost to Follow-up|1|||
16260653|NCT03329027|39439651|FG001|Overall Study|Lost to Follow-up|0|||
16260654|NCT03329027|39439652|FG002|Overall Study|Lost to Follow-up|1|||
16260655|NCT03329027|39439650|FG000|Overall Study|Protocol Violation|9|||
16260656|NCT03329027|39439651|FG001|Overall Study|Protocol Violation|5|||
16260657|NCT03329027|39439652|FG002|Overall Study|Protocol Violation|7|||
16260658|NCT01294917|39439653|FG000|Overall Study|Relocation|5|||
16260659|NCT01294917|39439653|FG000|Overall Study|Inconvenience|1|||
16441790|NCT03818035|40097613|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
16260660|NCT00630305|39439654|FG000|Overall Study|Withdrawal by Subject|1|||
16260661|NCT00630305|39439654|FG000|Overall Study|Inability to insert contact lens|1|||
16260662|NCT03002077|39439656|FG000|Overall Study|Non-compliance with Study Drug|4|||
16260663|NCT03002077|39439656|FG000|Overall Study|Non-compliance w/Background ADT|1|||
16150040|NCT00706134|39036149|FG000|Overall Study|Protocol Violation|0|||
16150041|NCT00706134|39036150|FG001|Overall Study|Protocol Violation|6|||
16150042|NCT00706134|39036151|FG002|Overall Study|Protocol Violation|0|||
16150043|NCT00706134|39036152|FG003|Overall Study|Protocol Violation|3|||
16150044|NCT00706134|39036149|FG000|Overall Study|Withdrawal by Subject|1|||
16150045|NCT00706134|39036150|FG001|Overall Study|Withdrawal by Subject|2|||
16150046|NCT00706134|39036151|FG002|Overall Study|Withdrawal by Subject|1|||
16150047|NCT00706134|39036152|FG003|Overall Study|Withdrawal by Subject|0|||
16150048|NCT00706134|39036149|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
16150049|NCT00706134|39036150|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16150050|NCT00706134|39036151|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
16150051|NCT00706134|39036152|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
16150052|NCT00706134|39036149|FG000|Overall Study|Did not meet study criteria|2|||
16150053|NCT00706134|39036150|FG001|Overall Study|Did not meet study criteria|0|||
16150054|NCT00706134|39036151|FG002|Overall Study|Did not meet study criteria|0|||
16150055|NCT00706134|39036152|FG003|Overall Study|Did not meet study criteria|0|||
16150056|NCT01820364|39036153|FG000|Part I: LGX818|Death|1|||
16150057|NCT01820364|39036154|FG001|Part I: LGX818|Death|0|||
16150058|NCT01820364|39036153|FG000|Part I: LGX818|Administrative Problems|3|||
16150059|NCT01820364|39036154|FG001|Part I: LGX818|Administrative Problems|0|||
16150060|NCT01820364|39036153|FG000|Part I: LGX818|Adverse Event|6|||
16150061|NCT01820364|39036154|FG001|Part I: LGX818|Adverse Event|0|||
16150062|NCT01820364|39036153|FG000|Part I: LGX818|Disease Progression|4|||
16150063|NCT01820364|39036154|FG001|Part I: LGX818|Disease Progression|0|||
16150064|NCT01820364|39036153|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
16150065|NCT01820364|39036154|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
16150066|NCT03127384|39036155|FG000|Overall Study|Lost to Follow-up|4|||
16150067|NCT03127384|39036155|FG000|Overall Study|Subject request|2|||
16150068|NCT01347554|39036156|FG000|Overall Study|Lack of Efficacy|7|||
16150069|NCT01347554|39036157|FG001|Overall Study|Lack of Efficacy|11|||
16150070|NCT02234284|39036161|FG000|Overall Study|Death|4|||
16150071|NCT02234284|39036162|FG001|Overall Study|Death|2|||
16150072|NCT02234284|39036161|FG000|Overall Study|Withdrawal by Subject|1|||
16150073|NCT02234284|39036162|FG001|Overall Study|Withdrawal by Subject|0|||
16150074|NCT02234284|39036161|FG000|Overall Study|Lost to Follow-up|20|||
16150075|NCT02234284|39036162|FG001|Overall Study|Lost to Follow-up|7|||
16150076|NCT01380379|39036163|FG000|Overall Study|Pregnancy|1|||
16150077|NCT01835015|39036165|FG000|Overall Study|Adverse Event|0|||
16150078|NCT01835015|39036166|FG001|Overall Study|Adverse Event|0|||
16150079|NCT01835015|39036167|FG002|Overall Study|Adverse Event|1|||
16150080|NCT01835015|39036168|FG003|Overall Study|Adverse Event|0|||
16150081|NCT01835015|39036169|FG004|Overall Study|Adverse Event|0|||
16260664|NCT03002077|39439656|FG000|Overall Study|Study Terminated by Sponsor|257|||
16260665|NCT03002077|39439656|FG000|Overall Study|Site Terminated by Sponsor|5|||
16260666|NCT03002077|39439656|FG000|Overall Study|Miscellaneous Reasons|10|||
16260667|NCT03002077|39439656|FG000|Overall Study|Adverse Event|23|||
16260668|NCT03002077|39439656|FG000|Overall Study|Lack of Efficacy|20|||
16260669|NCT03002077|39439656|FG000|Overall Study|Withdrawal by Subject|72|||
16260670|NCT03002077|39439656|FG000|Overall Study|Lost to Follow-up|21|||
16260671|NCT03002077|39439656|FG000|Overall Study|Pregnancy|4|||
16260672|NCT03002077|39439656|FG000|Overall Study|Protocol Violation|21|||
16260673|NCT01987765|39439657|FG000|Overall Study|Protocol Violation|65|||
16260674|NCT01987765|39439657|FG000|Overall Study|Lost to Follow-up|37|||
16260675|NCT03235739|39439659|FG000|Overall Study|Withdrawal by Subject|2|||
16260676|NCT03235739|39439660|FG001|Overall Study|Withdrawal by Subject|2|||
16260677|NCT03235739|39439659|FG000|Overall Study|Physician Decision|0|||
16260678|NCT03235739|39439660|FG001|Overall Study|Physician Decision|1|||
16260679|NCT01085045|39439662|FG000|Part A|Withdrawal by Subject|4|||
16260680|NCT01085045|39439662|FG000|Part A|Adverse Event|6|||
16260681|NCT01085045|39439662|FG000|Part A|Protocol Violation|1|||
16260682|NCT01085045|39439662|FG000|Part A|Protocol Specified Criteria|7|||
16260683|NCT01085045|39439662|FG000|Part B|Withdrawal by Subject|2|||
16260684|NCT01085045|39439662|FG000|Part B|Protocol Specified Criteria|6|||
16260685|NCT01085045|39439662|FG000|Part B|Lost to Follow-up|1|||
16260686|NCT01085045|39439662|FG000|Part B|Adverse Event|6|||
16260687|NCT03699020|39439666|FG000|Overall Study|Withdrawal by Subject|3|||
16260688|NCT03699020|39439667|FG001|Overall Study|Withdrawal by Subject|2|||
16260689|NCT00274937|39439668|FG000|Overall Study|Physician Decision|10|||
16260690|NCT00274937|39439668|FG000|Overall Study|Withdrawal by Subject|6|||
16260691|NCT00274937|39439668|FG000|Overall Study|Progressive Disease|4|||
16260692|NCT00635492|39439670|FG000|Overall Study|Death|12|||
16150082|NCT02114268|39036170|FG000|Overall Study|Lost to Follow-up|4|||
16150083|NCT02114268|39036171|FG001|Overall Study|Lost to Follow-up|1|||
16150084|NCT02114268|39036172|FG002|Overall Study|Lost to Follow-up|1|||
16150085|NCT02114268|39036173|FG003|Overall Study|Lost to Follow-up|0|||
16150086|NCT02114268|39036174|FG004|Overall Study|Lost to Follow-up|0|||
16150087|NCT02114268|39036175|FG005|Overall Study|Lost to Follow-up|2|||
16150088|NCT02114268|39036170|FG000|Overall Study|Withdrawal by Subject|1|||
16150089|NCT02114268|39036171|FG001|Overall Study|Withdrawal by Subject|0|||
16150090|NCT02114268|39036172|FG002|Overall Study|Withdrawal by Subject|0|||
16150091|NCT02114268|39036173|FG003|Overall Study|Withdrawal by Subject|0|||
16150092|NCT02114268|39036174|FG004|Overall Study|Withdrawal by Subject|0|||
16150093|NCT02114268|39036175|FG005|Overall Study|Withdrawal by Subject|1|||
16260693|NCT00635492|39439671|FG001|Overall Study|Death|40|||
16260694|NCT00635492|39439670|FG000|Overall Study|Lost to Follow-up|151|||
16260695|NCT00635492|39439671|FG001|Overall Study|Lost to Follow-up|172|||
16260696|NCT00635492|39439670|FG000|Overall Study|Physician Decision|32|||
16150094|NCT02114268|39036170|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
16260697|NCT00635492|39439671|FG001|Overall Study|Physician Decision|22|||
16150095|NCT02114268|39036171|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
16150096|NCT02114268|39036172|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
16260698|NCT00635492|39439670|FG000|Overall Study|Sponsor decision|2|||
16260699|NCT00635492|39439671|FG001|Overall Study|Sponsor decision|3|||
16260700|NCT00635492|39439670|FG000|Overall Study|Withdrawal by Subject|82|||
16150097|NCT02114268|39036173|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
16150098|NCT02114268|39036174|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
16150099|NCT02114268|39036175|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
16365435|NCT03439839|39821595|FG000|Overall Study|Death|3|||
16365436|NCT03439839|39821596|FG001|Overall Study|Death|0|||
16365437|NCT01995201|39821597|FG000|From Baseline Until Week 24|Adverse Event|4|||
16365438|NCT01995201|39821598|FG001|From Baseline Until Week 24|Adverse Event|15|||
16365439|NCT01995201|39821599|FG002|From Baseline Until Week 24|Adverse Event|0|||
16365440|NCT01995201|39821600|FG003|From Baseline Until Week 24|Adverse Event|0|||
16365441|NCT01995201|39821601|FG004|From Baseline Until Week 24|Adverse Event|0|||
16365442|NCT01995201|39821602|FG005|From Baseline Until Week 24|Adverse Event|0|||
16365443|NCT01995201|39821603|FG006|From Baseline Until Week 24|Adverse Event|0|||
16365444|NCT01995201|39821597|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16365445|NCT01995201|39821598|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
16365446|NCT01995201|39821599|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16365447|NCT01995201|39821600|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16365448|NCT01995201|39821601|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16365449|NCT01995201|39821602|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16365450|NCT01995201|39821603|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
16365451|NCT01995201|39821597|FG000|From Baseline Until Week 24|Death|0|||
16150100|NCT04744207|39036176|FG000|Treatment|Withdrawal by Subject|2|||
16150101|NCT04744207|39036177|FG001|Treatment|Withdrawal by Subject|0|||
16150102|NCT04744207|39036176|FG000|Treatment|Adverse Event|1|||
16150103|NCT04744207|39036177|FG001|Treatment|Adverse Event|2|||
16150104|NCT04050670|39036178|FG000|Period 3|Physician Decision|0|||
16150105|NCT04050670|39036179|FG001|Period 3|Physician Decision|1|||
16150106|NCT04050670|39036180|FG002|Period 3|Physician Decision|0|||
16150107|NCT00257725|39036183|FG000|Overall Study|Adverse Event|3|||
16150108|NCT02411539|39036184|FG000|Overall Study|Lost to Follow-up|2|||
16150109|NCT02411539|39036185|FG001|Overall Study|Lost to Follow-up|0|||
16150110|NCT02411539|39036184|FG000|Overall Study|Confounding medical condition|0|||
16150111|NCT02411539|39036185|FG001|Overall Study|Confounding medical condition|1|||
16150112|NCT01999465|39036189|FG000|Overall Study|Lost to Follow-up|0|||
16150113|NCT01999465|39036190|FG001|Overall Study|Lost to Follow-up|2|||
16150114|NCT01999465|39036189|FG000|Overall Study|Protocol Violation|0|||
16150115|NCT01999465|39036190|FG001|Overall Study|Protocol Violation|1|||
16150116|NCT02300298|39036191|FG000|Disposition for Nintedanib|Progressive disease|10|||
16150117|NCT02300298|39036192|FG001|Disposition for Nintedanib|Progressive disease|0|||
16150118|NCT02300298|39036191|FG000|Disposition for Docetaxel|Progressive disease|0|||
16150119|NCT02300298|39036192|FG001|Disposition for Docetaxel|Progressive disease|6|||
16150120|NCT02300298|39036191|FG000|Disposition for Docetaxel|other adverse event|0|||
16150121|NCT02300298|39036192|FG001|Disposition for Docetaxel|other adverse event|4|||
16150122|NCT00282334|39036193|FG000|Overall Study|Withdrawal by Subject|8|||
16150123|NCT00282334|39036194|FG001|Overall Study|Withdrawal by Subject|5|||
16150124|NCT03150862|39036195|FG000|Overall Study|Death|2|||
16150125|NCT03150862|39036196|FG001|Overall Study|Death|7|||
16150126|NCT03150862|39036197|FG002|Overall Study|Death|8|||
16150127|NCT03150862|39036198|FG003|Overall Study|Death|27|||
16150128|NCT03150862|39036199|FG004|Overall Study|Death|4|||
16150129|NCT03150862|39036200|FG005|Overall Study|Death|8|||
16150130|NCT03150862|39036201|FG006|Overall Study|Death|6|||
16150131|NCT03150862|39036202|FG007|Overall Study|Death|21|||
16150132|NCT03150862|39036195|FG000|Overall Study|Withdrawal by Subject|1|||
16150133|NCT03150862|39036196|FG001|Overall Study|Withdrawal by Subject|1|||
16150134|NCT03150862|39036197|FG002|Overall Study|Withdrawal by Subject|0|||
16150135|NCT03150862|39036198|FG003|Overall Study|Withdrawal by Subject|3|||
16150136|NCT03150862|39036199|FG004|Overall Study|Withdrawal by Subject|1|||
16150137|NCT03150862|39036200|FG005|Overall Study|Withdrawal by Subject|1|||
16150138|NCT03150862|39036201|FG006|Overall Study|Withdrawal by Subject|1|||
16150139|NCT03150862|39036202|FG007|Overall Study|Withdrawal by Subject|3|||
16150140|NCT03150862|39036195|FG000|Overall Study|Lost to Follow-up|0|||
16150141|NCT03150862|39036196|FG001|Overall Study|Lost to Follow-up|0|||
16150142|NCT03150862|39036197|FG002|Overall Study|Lost to Follow-up|1|||
16150143|NCT03150862|39036198|FG003|Overall Study|Lost to Follow-up|0|||
16150144|NCT03150862|39036199|FG004|Overall Study|Lost to Follow-up|0|||
16150145|NCT03150862|39036200|FG005|Overall Study|Lost to Follow-up|0|||
16150146|NCT03150862|39036201|FG006|Overall Study|Lost to Follow-up|0|||
16150147|NCT03150862|39036202|FG007|Overall Study|Lost to Follow-up|2|||
16150148|NCT03150862|39036195|FG000|Overall Study|Sponsor's decision|0|||
16150149|NCT03150862|39036196|FG001|Overall Study|Sponsor's decision|0|||
16150150|NCT03150862|39036197|FG002|Overall Study|Sponsor's decision|0|||
16150151|NCT03150862|39036198|FG003|Overall Study|Sponsor's decision|10|||
16150152|NCT03150862|39036199|FG004|Overall Study|Sponsor's decision|3|||
16150153|NCT03150862|39036200|FG005|Overall Study|Sponsor's decision|0|||
16150154|NCT03150862|39036201|FG006|Overall Study|Sponsor's decision|1|||
16150155|NCT03150862|39036202|FG007|Overall Study|Sponsor's decision|1|||
16150156|NCT03150862|39036195|FG000|Overall Study|Change in Methylation status|0|||
16150157|NCT03150862|39036196|FG001|Overall Study|Change in Methylation status|0|||
16150158|NCT03150862|39036197|FG002|Overall Study|Change in Methylation status|0|||
16150159|NCT03150862|39036198|FG003|Overall Study|Change in Methylation status|0|||
16150160|NCT03150862|39036199|FG004|Overall Study|Change in Methylation status|1|||
16150161|NCT03150862|39036200|FG005|Overall Study|Change in Methylation status|0|||
16150162|NCT03150862|39036201|FG006|Overall Study|Change in Methylation status|0|||
16150163|NCT03150862|39036202|FG007|Overall Study|Change in Methylation status|0|||
16150164|NCT03150862|39036195|FG000|Overall Study|Roll over in to Long Term Extension|0|||
16150165|NCT03150862|39036196|FG001|Overall Study|Roll over in to Long Term Extension|0|||
16150166|NCT03150862|39036197|FG002|Overall Study|Roll over in to Long Term Extension|0|||
16150167|NCT03150862|39036198|FG003|Overall Study|Roll over in to Long Term Extension|0|||
16365452|NCT01995201|39821598|FG001|From Baseline Until Week 24|Death|1|||
16150168|NCT03150862|39036199|FG004|Overall Study|Roll over in to Long Term Extension|0|||
16150169|NCT03150862|39036200|FG005|Overall Study|Roll over in to Long Term Extension|0|||
16150170|NCT03150862|39036201|FG006|Overall Study|Roll over in to Long Term Extension|0|||
16150171|NCT03150862|39036202|FG007|Overall Study|Roll over in to Long Term Extension|1|||
16150172|NCT03150862|39036195|FG000|Overall Study|Progressive Disease|0|||
16365453|NCT01995201|39821599|FG002|From Baseline Until Week 24|Death|0|||
16365454|NCT01995201|39821600|FG003|From Baseline Until Week 24|Death|0|||
16150173|NCT03150862|39036196|FG001|Overall Study|Progressive Disease|0|||
16150174|NCT03150862|39036197|FG002|Overall Study|Progressive Disease|0|||
16150175|NCT03150862|39036198|FG003|Overall Study|Progressive Disease|0|||
16150176|NCT03150862|39036199|FG004|Overall Study|Progressive Disease|0|||
16150177|NCT03150862|39036200|FG005|Overall Study|Progressive Disease|0|||
16150178|NCT03150862|39036201|FG006|Overall Study|Progressive Disease|0|||
16150179|NCT03150862|39036202|FG007|Overall Study|Progressive Disease|2|||
16150180|NCT01379274|39036203|FG000|Overall Study|funding withdrawn|1|||
16150181|NCT01236573|39036208|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16150182|NCT01236573|39036209|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16150183|NCT01236573|39036210|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16150184|NCT01236573|39036211|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16150185|NCT01236573|39036212|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16150186|NCT01236573|39036213|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16150187|NCT01236573|39036214|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
16150188|NCT01236573|39036215|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16150189|NCT01236573|39036216|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
16150190|NCT01236573|39036217|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
16150191|NCT01236573|39036218|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
16150192|NCT01236573|39036208|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16150193|NCT01236573|39036209|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16150194|NCT01236573|39036210|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16150195|NCT01236573|39036211|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16150196|NCT01236573|39036212|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16150197|NCT01236573|39036213|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16150198|NCT01236573|39036214|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16150199|NCT01236573|39036215|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16150200|NCT01236573|39036216|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
16150201|NCT01236573|39036217|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16150202|NCT01236573|39036218|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
16150203|NCT01236573|39036208|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16150204|NCT01236573|39036209|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16150205|NCT01236573|39036210|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16150206|NCT01236573|39036211|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16150207|NCT01236573|39036212|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16150208|NCT01236573|39036213|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16150209|NCT01236573|39036214|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16150210|NCT01236573|39036215|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16150211|NCT01236573|39036216|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16150212|NCT01236573|39036217|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
16150213|NCT01236573|39036218|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
16150214|NCT00912028|39036222|FG000|Overall Study|Lost to Follow-up|2|||
16150215|NCT00912028|39036223|FG001|Overall Study|Lost to Follow-up|3|||
16150216|NCT00912028|39036224|FG002|Overall Study|Lost to Follow-up|0|||
16150217|NCT00912028|39036225|FG003|Overall Study|Lost to Follow-up|1|||
16150218|NCT00912028|39036226|FG004|Overall Study|Lost to Follow-up|3|||
16150219|NCT00912028|39036222|FG000|Overall Study|Withdrawal by Subject|3|||
16150220|NCT00912028|39036223|FG001|Overall Study|Withdrawal by Subject|0|||
16150221|NCT00912028|39036224|FG002|Overall Study|Withdrawal by Subject|0|||
16150222|NCT00912028|39036225|FG003|Overall Study|Withdrawal by Subject|0|||
16150223|NCT00912028|39036226|FG004|Overall Study|Withdrawal by Subject|0|||
16150224|NCT00294060|39036227|FG000|Overall Study|Death|225|||
16441791|NCT03818035|40097614|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
16441792|NCT03818035|40097615|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
16441793|NCT03818035|40097616|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
16441794|NCT03818035|40097613|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
16441795|NCT03818035|40097614|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
16441796|NCT03818035|40097615|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
16441797|NCT03818035|40097616|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
16441798|NCT00687596|40097617|FG000|Overall Study|Adverse Event (AE)|10|||
16441799|NCT00687596|40097618|FG001|Overall Study|Adverse Event (AE)|3|||
16441800|NCT00687596|40097617|FG000|Overall Study|Radiological Disease Progression|6|||
16441801|NCT00687596|40097618|FG001|Overall Study|Radiological Disease Progression|2|||
16365455|NCT01995201|39821601|FG004|From Baseline Until Week 24|Death|0|||
16365456|NCT01995201|39821602|FG005|From Baseline Until Week 24|Death|0|||
16441802|NCT00687596|40097617|FG000|Overall Study|Clinical Disease Progression|1|||
16441803|NCT00687596|40097618|FG001|Overall Study|Clinical Disease Progression|3|||
16441804|NCT00687596|40097617|FG000|Overall Study|Investigator Discretion|3|||
16441805|NCT00687596|40097618|FG001|Overall Study|Investigator Discretion|1|||
16441806|NCT00687596|40097617|FG000|Overall Study|Sponsor Terminated Study|6|||
16441807|NCT00687596|40097618|FG001|Overall Study|Sponsor Terminated Study|17|||
16441808|NCT05137041|40097619|FG000|Overall Study|Lost to Follow-up|1|||
16441809|NCT05137041|40097620|FG001|Overall Study|Lost to Follow-up|1|||
16441810|NCT05137041|40097619|FG000|Overall Study|Withdrawal by Subject|0|||
16441811|NCT05137041|40097620|FG001|Overall Study|Withdrawal by Subject|2|||
16441812|NCT05137041|40097619|FG000|Overall Study|Reason not Specified|0|||
16441813|NCT05137041|40097620|FG001|Overall Study|Reason not Specified|1|||
16441814|NCT02529852|40097621|FG000|Overall Study|Withdrawal by Subject|2|||
16441815|NCT04613362|40097626|FG000|3 Month Follow-up|Lost to Follow-up|1|||
16365457|NCT01995201|39821603|FG006|From Baseline Until Week 24|Death|0|||
16365458|NCT01995201|39821597|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
16365459|NCT01995201|39821598|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
16365460|NCT01995201|39821599|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
16365461|NCT01995201|39821600|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
16365462|NCT01995201|39821601|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
16365463|NCT01995201|39821602|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
16365464|NCT01995201|39821603|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
16365465|NCT01995201|39821597|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
16365466|NCT01995201|39821598|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
16365467|NCT01995201|39821599|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
16365468|NCT01995201|39821600|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
16365469|NCT01995201|39821601|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
16365470|NCT01995201|39821602|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
16365471|NCT01995201|39821603|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
16365472|NCT01995201|39821597|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
16365473|NCT01995201|39821598|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
16365474|NCT01995201|39821599|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
16365475|NCT01995201|39821600|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
16365476|NCT01995201|39821601|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
16365477|NCT01995201|39821602|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
16365478|NCT01995201|39821603|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
16365479|NCT01995201|39821597|FG000|From Baseline Until Week 24|Physician Decision|0|||
16365480|NCT01995201|39821598|FG001|From Baseline Until Week 24|Physician Decision|2|||
16365481|NCT01995201|39821599|FG002|From Baseline Until Week 24|Physician Decision|0|||
16365482|NCT01995201|39821600|FG003|From Baseline Until Week 24|Physician Decision|0|||
16365483|NCT01995201|39821601|FG004|From Baseline Until Week 24|Physician Decision|0|||
16365484|NCT01995201|39821602|FG005|From Baseline Until Week 24|Physician Decision|0|||
16365485|NCT01995201|39821603|FG006|From Baseline Until Week 24|Physician Decision|0|||
16365486|NCT01995201|39821597|FG000|From Baseline Until Week 24|Protocol Violation|0|||
16365487|NCT01995201|39821598|FG001|From Baseline Until Week 24|Protocol Violation|9|||
16441816|NCT04613362|40097627|FG001|3 Month Follow-up|Lost to Follow-up|2|||
16441817|NCT04613362|40097626|FG000|6 Month Follow-up|Lost to Follow-up|0|||
16365488|NCT01995201|39821599|FG002|From Baseline Until Week 24|Protocol Violation|0|||
16365489|NCT01995201|39821600|FG003|From Baseline Until Week 24|Protocol Violation|0|||
16365490|NCT01995201|39821601|FG004|From Baseline Until Week 24|Protocol Violation|0|||
16365491|NCT01995201|39821602|FG005|From Baseline Until Week 24|Protocol Violation|0|||
16365492|NCT01995201|39821603|FG006|From Baseline Until Week 24|Protocol Violation|0|||
16365493|NCT01995201|39821597|FG000|From Week 24 Until Week 48|Adverse Event|0|||
16365494|NCT01995201|39821598|FG001|From Week 24 Until Week 48|Adverse Event|0|||
16441818|NCT04613362|40097627|FG001|6 Month Follow-up|Lost to Follow-up|1|||
16441819|NCT06271993|40097628|FG000|Overall Study|Not reactive to histamine|5|||
16441820|NCT06271993|40097629|FG001|Overall Study|Not reactive to histamine|5|||
16441821|NCT06271993|40097630|FG002|Overall Study|Not reactive to histamine|5|||
16441822|NCT02087423|40097631|FG000|Overall Study|Withdrawal by Subject|20|||
16441823|NCT02087423|40097632|FG001|Overall Study|Withdrawal by Subject|20|||
16441824|NCT02087423|40097633|FG002|Overall Study|Withdrawal by Subject|3|||
16441825|NCT02087423|40097631|FG000|Overall Study|Death|68|||
16441826|NCT02087423|40097632|FG001|Overall Study|Death|207|||
16441827|NCT02087423|40097633|FG002|Overall Study|Death|40|||
16441828|NCT02087423|40097631|FG000|Overall Study|Lost to Follow-up|0|||
16441829|NCT02087423|40097632|FG001|Overall Study|Lost to Follow-up|2|||
16441830|NCT02087423|40097633|FG002|Overall Study|Lost to Follow-up|0|||
16441831|NCT02087423|40097631|FG000|Overall Study|Terminated from study at final DCO|23|||
16441832|NCT02087423|40097632|FG001|Overall Study|Terminated from study at final DCO|36|||
16441833|NCT02087423|40097633|FG002|Overall Study|Terminated from study at final DCO|25|||
16441834|NCT02953652|40097634|FG000|Overall Study|Adverse Event|18|||
16441835|NCT02953652|40097634|FG000|Overall Study|Withdrawal by Subject|6|||
16150225|NCT00294060|39036227|FG000|Overall Study|Other|59|||
16150226|NCT00294060|39036227|FG000|Overall Study|Lost to Follow-up|55|||
16150227|NCT00294060|39036227|FG000|Overall Study|Withdrawal by Subject|11|||
16150228|NCT00294060|39036227|FG000|Overall Study|Physician Decision|797|||
16150229|NCT00294060|39036227|FG000|Overall Study|Medical condition|3|||
16150230|NCT00294060|39036227|FG000|Overall Study|Device explanted/not replaced|23|||
16150231|NCT04179734|39036228|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
16150232|NCT04179734|39036229|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
16150233|NCT04179734|39036228|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
16150234|NCT04179734|39036229|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
16150235|NCT02113436|39036230|FG000|Period 1: 8 Weeks|Adverse Event|1|||
16150236|NCT02113436|39036231|FG001|Period 1: 8 Weeks|Adverse Event|0|||
16150237|NCT02113436|39036232|FG002|Period 1: 8 Weeks|Adverse Event|0|||
16150238|NCT02113436|39036233|FG003|Period 1: 8 Weeks|Adverse Event|0|||
16150239|NCT02113436|39036230|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
16150240|NCT02113436|39036231|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
16150241|NCT02113436|39036232|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
16150242|NCT02113436|39036233|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
16150243|NCT02113436|39036230|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
16150244|NCT02113436|39036231|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
16150245|NCT02113436|39036232|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
16150246|NCT02113436|39036233|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
16150247|NCT02113436|39036230|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
16150248|NCT02113436|39036231|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
16150249|NCT02113436|39036232|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
16150250|NCT02113436|39036233|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
16150251|NCT02113436|39036230|FG000|Period 2: 16 Weeks|Adverse Event|0|||
16150252|NCT02113436|39036231|FG001|Period 2: 16 Weeks|Adverse Event|0|||
16150253|NCT02113436|39036232|FG002|Period 2: 16 Weeks|Adverse Event|4|||
16150254|NCT02113436|39036233|FG003|Period 2: 16 Weeks|Adverse Event|5|||
16150255|NCT02113436|39036230|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
16150256|NCT02113436|39036231|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
16150257|NCT02113436|39036232|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
16150258|NCT02113436|39036233|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
16150259|NCT02113436|39036230|FG000|Period 2: 16 Weeks|Physician Decision|0|||
16150260|NCT02113436|39036231|FG001|Period 2: 16 Weeks|Physician Decision|0|||
16150261|NCT02113436|39036232|FG002|Period 2: 16 Weeks|Physician Decision|2|||
16150262|NCT02113436|39036233|FG003|Period 2: 16 Weeks|Physician Decision|0|||
16150263|NCT02113436|39036230|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
16150264|NCT02113436|39036231|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
16150265|NCT02113436|39036232|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
16150266|NCT02113436|39036233|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
16150267|NCT04995055|39036241|FG000|Period 1|COVID-19 Related|1|||
16150268|NCT04995055|39036242|FG001|Period 1|COVID-19 Related|0|||
16150269|NCT04995055|39036241|FG000|Period 1|Withdrawal by Subject|0|||
16365495|NCT01995201|39821599|FG002|From Week 24 Until Week 48|Adverse Event|2|||
16365496|NCT01995201|39821600|FG003|From Week 24 Until Week 48|Adverse Event|1|||
16365497|NCT01995201|39821601|FG004|From Week 24 Until Week 48|Adverse Event|1|||
16365498|NCT01995201|39821602|FG005|From Week 24 Until Week 48|Adverse Event|3|||
16365499|NCT01995201|39821603|FG006|From Week 24 Until Week 48|Adverse Event|1|||
16365500|NCT01995201|39821597|FG000|From Week 24 Until Week 48|Death|0|||
16365501|NCT01995201|39821598|FG001|From Week 24 Until Week 48|Death|0|||
16365502|NCT01995201|39821599|FG002|From Week 24 Until Week 48|Death|0|||
16150270|NCT04995055|39036242|FG001|Period 1|Withdrawal by Subject|1|||
16150271|NCT04995055|39036241|FG000|Period 1|Subject discontinued due to timing|4|||
16150272|NCT04995055|39036242|FG001|Period 1|Subject discontinued due to timing|4|||
16150273|NCT00652366|39036243|FG000|Overall Study|Adverse Event|8|||
16150274|NCT00652366|39036244|FG001|Overall Study|Adverse Event|4|||
16150275|NCT00652366|39036245|FG002|Overall Study|Adverse Event|7|||
16441836|NCT02953652|40097634|FG000|Overall Study|Protocol Violation|1|||
16441837|NCT02953652|40097634|FG000|Overall Study|Disease Progression|27|||
16441838|NCT02384551|40097635|FG000|Overall Study|Lost to Follow-up|13|||
16150276|NCT00652366|39036246|FG003|Overall Study|Adverse Event|17|||
16150277|NCT00652366|39036247|FG004|Overall Study|Adverse Event|13|||
16150278|NCT00652366|39036243|FG000|Overall Study|Death|5|||
16150279|NCT00652366|39036244|FG001|Overall Study|Death|4|||
16150280|NCT00652366|39036245|FG002|Overall Study|Death|1|||
16150281|NCT00652366|39036246|FG003|Overall Study|Death|8|||
16150282|NCT00652366|39036247|FG004|Overall Study|Death|5|||
16150283|NCT00652366|39036243|FG000|Overall Study|Lack of Efficacy|84|||
16150284|NCT00652366|39036244|FG001|Overall Study|Lack of Efficacy|58|||
16150285|NCT00652366|39036245|FG002|Overall Study|Lack of Efficacy|53|||
16150286|NCT00652366|39036246|FG003|Overall Study|Lack of Efficacy|133|||
16150287|NCT00652366|39036247|FG004|Overall Study|Lack of Efficacy|13|||
16150288|NCT00652366|39036243|FG000|Overall Study|Violation of Selection Criteria|0|||
16150289|NCT00652366|39036244|FG001|Overall Study|Violation of Selection Criteria|0|||
16150290|NCT00652366|39036245|FG002|Overall Study|Violation of Selection Criteria|1|||
16150291|NCT00652366|39036246|FG003|Overall Study|Violation of Selection Criteria|0|||
16150292|NCT00652366|39036247|FG004|Overall Study|Violation of Selection Criteria|0|||
16150293|NCT00652366|39036243|FG000|Overall Study|Protocol Violation|1|||
16150294|NCT00652366|39036244|FG001|Overall Study|Protocol Violation|0|||
16150295|NCT00652366|39036245|FG002|Overall Study|Protocol Violation|0|||
16150296|NCT00652366|39036246|FG003|Overall Study|Protocol Violation|0|||
16150297|NCT00652366|39036247|FG004|Overall Study|Protocol Violation|0|||
16150298|NCT00652366|39036243|FG000|Overall Study|Refused treatment|3|||
16150299|NCT00652366|39036244|FG001|Overall Study|Refused treatment|7|||
16150300|NCT00652366|39036245|FG002|Overall Study|Refused treatment|6|||
16150301|NCT00652366|39036246|FG003|Overall Study|Refused treatment|17|||
16150302|NCT00652366|39036247|FG004|Overall Study|Refused treatment|5|||
16150303|NCT00652366|39036243|FG000|Overall Study|Other|5|||
16150304|NCT00652366|39036244|FG001|Overall Study|Other|2|||
16150305|NCT00652366|39036245|FG002|Overall Study|Other|3|||
16150306|NCT00652366|39036246|FG003|Overall Study|Other|4|||
16150307|NCT00652366|39036247|FG004|Overall Study|Other|0|||
16150308|NCT03703102|39036248|FG000|Overall Study|Adverse Event|4|||
16150309|NCT03703102|39036249|FG001|Overall Study|Adverse Event|3|||
16150310|NCT03703102|39036250|FG002|Overall Study|Adverse Event|7|||
16150311|NCT03703102|39036251|FG003|Overall Study|Adverse Event|3|||
16150312|NCT03703102|39036252|FG004|Overall Study|Adverse Event|13|||
16150313|NCT03703102|39036248|FG000|Overall Study|Lack of Efficacy|4|||
16150314|NCT03703102|39036249|FG001|Overall Study|Lack of Efficacy|0|||
16150315|NCT03703102|39036250|FG002|Overall Study|Lack of Efficacy|1|||
16150316|NCT03703102|39036251|FG003|Overall Study|Lack of Efficacy|4|||
16150317|NCT03703102|39036252|FG004|Overall Study|Lack of Efficacy|1|||
16150318|NCT03703102|39036248|FG000|Overall Study|Lost to Follow-up|0|||
16150319|NCT03703102|39036249|FG001|Overall Study|Lost to Follow-up|0|||
16150320|NCT03703102|39036250|FG002|Overall Study|Lost to Follow-up|1|||
16150321|NCT03703102|39036251|FG003|Overall Study|Lost to Follow-up|2|||
16150322|NCT03703102|39036252|FG004|Overall Study|Lost to Follow-up|2|||
16150323|NCT03703102|39036248|FG000|Overall Study|Physician Decision|2|||
16150324|NCT03703102|39036249|FG001|Overall Study|Physician Decision|2|||
16150325|NCT03703102|39036250|FG002|Overall Study|Physician Decision|2|||
16150326|NCT03703102|39036251|FG003|Overall Study|Physician Decision|2|||
16150327|NCT03703102|39036252|FG004|Overall Study|Physician Decision|4|||
16150328|NCT03703102|39036248|FG000|Overall Study|Withdrawal by Subject|7|||
16150329|NCT03703102|39036249|FG001|Overall Study|Withdrawal by Subject|5|||
16150330|NCT03703102|39036250|FG002|Overall Study|Withdrawal by Subject|5|||
16150331|NCT03703102|39036251|FG003|Overall Study|Withdrawal by Subject|5|||
16150332|NCT03703102|39036252|FG004|Overall Study|Withdrawal by Subject|9|||
16150333|NCT03703102|39036248|FG000|Overall Study|Ineligibility|0|||
16150334|NCT03703102|39036249|FG001|Overall Study|Ineligibility|0|||
16150335|NCT03703102|39036250|FG002|Overall Study|Ineligibility|1|||
16150336|NCT03703102|39036251|FG003|Overall Study|Ineligibility|0|||
16150337|NCT03703102|39036252|FG004|Overall Study|Ineligibility|0|||
16150338|NCT03703102|39036248|FG000|Overall Study|Protocol Deviation|4|||
16150339|NCT03703102|39036249|FG001|Overall Study|Protocol Deviation|4|||
16150340|NCT03703102|39036250|FG002|Overall Study|Protocol Deviation|3|||
16150341|NCT03703102|39036251|FG003|Overall Study|Protocol Deviation|0|||
16365503|NCT01995201|39821600|FG003|From Week 24 Until Week 48|Death|0|||
16365504|NCT01995201|39821601|FG004|From Week 24 Until Week 48|Death|0|||
16150342|NCT03703102|39036252|FG004|Overall Study|Protocol Deviation|0|||
16150343|NCT03703102|39036248|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16150344|NCT03703102|39036249|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16150345|NCT03703102|39036250|FG002|Overall Study|Non-Compliance with Study Drug|2|||
16150346|NCT03703102|39036251|FG003|Overall Study|Non-Compliance with Study Drug|1|||
16150347|NCT03703102|39036252|FG004|Overall Study|Non-Compliance with Study Drug|4|||
16150348|NCT01357655|39036253|FG000|Overall Study|Administrative Reason by Sponsor|45|||
16150349|NCT01357655|39036254|FG001|Overall Study|Administrative Reason by Sponsor|0|||
16150350|NCT01357655|39036253|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
16150351|NCT01357655|39036254|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16150352|NCT01357655|39036253|FG000|Overall Study|Disease Progression|1|||
16150353|NCT01357655|39036254|FG001|Overall Study|Disease Progression|0|||
16150354|NCT01357655|39036253|FG000|Overall Study|Lost to Follow-up|2|||
16441839|NCT02384551|40097636|FG001|Overall Study|Lost to Follow-up|14|||
16441840|NCT02384551|40097637|FG002|Overall Study|Lost to Follow-up|14|||
16441841|NCT02384551|40097638|FG003|Overall Study|Lost to Follow-up|14|||
16441842|NCT01084252|40097641|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441843|NCT01084252|40097642|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441844|NCT01084252|40097643|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441845|NCT01084252|40097644|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441846|NCT01084252|40097645|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441847|NCT01084252|40097646|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16365505|NCT01995201|39821602|FG005|From Week 24 Until Week 48|Death|2|||
16365506|NCT01995201|39821603|FG006|From Week 24 Until Week 48|Death|0|||
16365507|NCT01995201|39821597|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
16365508|NCT01995201|39821598|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
16150355|NCT01357655|39036254|FG001|Overall Study|Lost to Follow-up|0|||
16150356|NCT01357655|39036253|FG000|Overall Study|Maximum Clinical Benefit|2|||
16150357|NCT01357655|39036254|FG001|Overall Study|Maximum Clinical Benefit|0|||
16365509|NCT01995201|39821599|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
16365510|NCT01995201|39821600|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
16365511|NCT01995201|39821601|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
16365512|NCT01995201|39821602|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
16365513|NCT01995201|39821603|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
16365514|NCT01995201|39821597|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
16365515|NCT01995201|39821598|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
16365516|NCT01995201|39821599|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
16365517|NCT01995201|39821600|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
16365518|NCT01995201|39821601|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
16365519|NCT01995201|39821602|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
16365520|NCT01995201|39821603|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
16365521|NCT01995201|39821597|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
16365522|NCT01995201|39821598|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
16365523|NCT01995201|39821599|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
16365524|NCT01995201|39821600|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
16365525|NCT01995201|39821601|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
16365526|NCT01995201|39821602|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
16365527|NCT01995201|39821603|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
16441848|NCT01084252|40097647|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441849|NCT01084252|40097648|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441850|NCT01084252|40097649|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441851|NCT01084252|40097650|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441852|NCT01084252|40097651|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441853|NCT01084252|40097652|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441854|NCT01084252|40097653|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
16441855|NCT01084252|40097654|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
16441856|NCT02562235|40097659|FG000|Overall Study|Adverse Event|3|||
16441857|NCT02513563|40097665|FG000|Overall Study|Death|4|||
16441858|NCT02513563|40097665|FG000|Overall Study|Withdrawal by Subject|4|||
16441859|NCT02513563|40097665|FG000|Overall Study|Physician Decision|1|||
16441860|NCT03259230|40097666|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
16441861|NCT03259230|40097667|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
16150358|NCT01357655|39036253|FG000|Overall Study|Reason Unspecified|1|||
16150359|NCT01357655|39036254|FG001|Overall Study|Reason Unspecified|0|||
16150360|NCT01357655|39036253|FG000|Overall Study|Study Drug Toxicity|11|||
16150361|NCT01357655|39036254|FG001|Overall Study|Study Drug Toxicity|0|||
16150362|NCT01357655|39036253|FG000|Overall Study|Subject Withdrew Consent|1|||
16150363|NCT01357655|39036254|FG001|Overall Study|Subject Withdrew Consent|0|||
16150364|NCT02573870|39036255|FG000|Overall Study|Adverse Event|0|||
16150365|NCT02573870|39036256|FG001|Overall Study|Adverse Event|2|||
16150366|NCT02573870|39036255|FG000|Overall Study|Lack of Efficacy|0|||
16150367|NCT02573870|39036256|FG001|Overall Study|Lack of Efficacy|1|||
16150368|NCT02573870|39036255|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
16150369|NCT02573870|39036256|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
16365528|NCT01995201|39821597|FG000|From Week 24 Until Week 48|Physician Decision|0|||
16441862|NCT01708954|40097668|FG000|Step 1|Disease progression|26|||
16150370|NCT02573870|39036255|FG000|Overall Study|Lost to Follow-up|0|||
16441863|NCT01708954|40097669|FG001|Step 1|Disease progression|17|||
16150371|NCT02573870|39036256|FG001|Overall Study|Lost to Follow-up|1|||
16150372|NCT02573870|39036255|FG000|Overall Study|Other: Fail to Meet Visit|0|||
16150373|NCT02573870|39036256|FG001|Overall Study|Other: Fail to Meet Visit|2|||
16150374|NCT02004262|39036258|FG000|Overall Study|Death|67|||
16441864|NCT01708954|40097670|FG002|Step 1|Disease progression|14|||
16441865|NCT01708954|40097668|FG000|Step 1|Adverse Event|3|||
16441866|NCT01708954|40097669|FG001|Step 1|Adverse Event|11|||
16441867|NCT01708954|40097670|FG002|Step 1|Adverse Event|13|||
16441868|NCT01708954|40097668|FG000|Step 1|Death|3|||
16441869|NCT01708954|40097669|FG001|Step 1|Death|2|||
16441870|NCT01708954|40097670|FG002|Step 1|Death|3|||
16441871|NCT01708954|40097668|FG000|Step 1|Withdrawal by Subject|2|||
16441872|NCT01708954|40097669|FG001|Step 1|Withdrawal by Subject|5|||
16441873|NCT01708954|40097670|FG002|Step 1|Withdrawal by Subject|3|||
16441874|NCT01708954|40097668|FG000|Step 1|Other complicating disease|0|||
16441875|NCT01708954|40097669|FG001|Step 1|Other complicating disease|2|||
16441876|NCT01708954|40097670|FG002|Step 1|Other complicating disease|0|||
16441877|NCT01708954|40097668|FG000|Step 1|Crossed over to Step 2|2|||
16441878|NCT01708954|40097669|FG001|Step 1|Crossed over to Step 2|0|||
16441879|NCT01708954|40097670|FG002|Step 1|Crossed over to Step 2|0|||
16441880|NCT01708954|40097668|FG000|Step 1|Symptomatic deterioration|1|||
16441881|NCT01708954|40097669|FG001|Step 1|Symptomatic deterioration|0|||
16441882|NCT01708954|40097670|FG002|Step 1|Symptomatic deterioration|1|||
16441883|NCT01708954|40097668|FG000|Step 1|Off-treatment reason not submitted|1|||
16441884|NCT01708954|40097669|FG001|Step 1|Off-treatment reason not submitted|1|||
16441885|NCT01708954|40097670|FG002|Step 1|Off-treatment reason not submitted|1|||
16441886|NCT01708954|40097668|FG000|Step 1|Ineligible or never received treatment|4|||
16441887|NCT01708954|40097669|FG001|Step 1|Ineligible or never received treatment|2|||
16441888|NCT01708954|40097670|FG002|Step 1|Ineligible or never received treatment|8|||
16441889|NCT01708954|40097668|FG000|Step 2|Disease progression|9|||
16441890|NCT01708954|40097669|FG001|Step 2|Disease progression|4|||
16150375|NCT02004262|39036259|FG001|Overall Study|Death|64|||
16150376|NCT02004262|39036260|FG002|Overall Study|Death|66|||
16150377|NCT02004262|39036261|FG003|Overall Study|Death|28|||
16150378|NCT02004262|39036262|FG004|Overall Study|Death|29|||
16150379|NCT02004262|39036263|FG005|Overall Study|Death|22|||
16150380|NCT02004262|39036258|FG000|Overall Study|Withdrawal by Subject|1|||
16150381|NCT02004262|39036259|FG001|Overall Study|Withdrawal by Subject|0|||
16150382|NCT02004262|39036260|FG002|Overall Study|Withdrawal by Subject|4|||
16150383|NCT02004262|39036261|FG003|Overall Study|Withdrawal by Subject|0|||
16150384|NCT02004262|39036262|FG004|Overall Study|Withdrawal by Subject|1|||
16150385|NCT02004262|39036263|FG005|Overall Study|Withdrawal by Subject|3|||
16150386|NCT02004262|39036258|FG000|Overall Study|Lost to Follow-up|1|||
16150387|NCT02004262|39036259|FG001|Overall Study|Lost to Follow-up|1|||
16150388|NCT02004262|39036260|FG002|Overall Study|Lost to Follow-up|0|||
16150389|NCT02004262|39036261|FG003|Overall Study|Lost to Follow-up|0|||
16150390|NCT02004262|39036262|FG004|Overall Study|Lost to Follow-up|0|||
16150391|NCT02004262|39036263|FG005|Overall Study|Lost to Follow-up|0|||
16150392|NCT02004262|39036258|FG000|Overall Study|Study Terminated by Sponsor|4|||
16150393|NCT02004262|39036259|FG001|Overall Study|Study Terminated by Sponsor|3|||
16150394|NCT02004262|39036260|FG002|Overall Study|Study Terminated by Sponsor|2|||
16150395|NCT02004262|39036261|FG003|Overall Study|Study Terminated by Sponsor|1|||
16150396|NCT02004262|39036262|FG004|Overall Study|Study Terminated by Sponsor|1|||
16150397|NCT02004262|39036263|FG005|Overall Study|Study Terminated by Sponsor|5|||
16150398|NCT03462576|39036268|FG000|Overall Study|Protocol Violation|5|||
16150399|NCT03462576|39036269|FG001|Overall Study|Protocol Violation|11|||
16150400|NCT03462576|39036270|FG002|Overall Study|Protocol Violation|7|||
16150401|NCT03462576|39036268|FG000|Overall Study|Device Malfunction|0|||
16150402|NCT03462576|39036269|FG001|Overall Study|Device Malfunction|0|||
16150403|NCT03462576|39036270|FG002|Overall Study|Device Malfunction|1|||
16150404|NCT01670539|39036273|FG000|Overall Study|Death|3|||
16150405|NCT01670539|39036274|FG001|Overall Study|Death|5|||
16150406|NCT01670539|39036273|FG000|Overall Study|Withdrawal by Subject|3|||
16150407|NCT01670539|39036274|FG001|Overall Study|Withdrawal by Subject|0|||
16150408|NCT00688155|39036275|FG000|Overall Study|Withdrawal by Subject|2|||
16150409|NCT00688155|39036276|FG001|Overall Study|Withdrawal by Subject|2|||
16150410|NCT00688155|39036277|FG002|Overall Study|Withdrawal by Subject|1|||
16150411|NCT00688155|39036278|FG003|Overall Study|Withdrawal by Subject|1|||
16150412|NCT03104075|39036279|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
16150413|NCT03104075|39036280|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
16150414|NCT04818593|39036281|FG000|Overall Study|Low Oocyte Yield|8|||
16441891|NCT01708954|40097670|FG002|Step 2|Disease progression|0|||
16441892|NCT01708954|40097668|FG000|Step 2|Adverse Event|3|||
16441893|NCT01708954|40097669|FG001|Step 2|Adverse Event|2|||
16441894|NCT01708954|40097670|FG002|Step 2|Adverse Event|0|||
16441895|NCT01708954|40097668|FG000|Step 2|Withdrawal by Subject|1|||
16441896|NCT01708954|40097669|FG001|Step 2|Withdrawal by Subject|1|||
16441897|NCT01708954|40097670|FG002|Step 2|Withdrawal by Subject|0|||
16441898|NCT05384171|40097671|FG000|Overall Study|Lost to Follow-up|9|||
16150415|NCT04818593|39036282|FG001|Overall Study|Low Oocyte Yield|8|||
16150416|NCT04818593|39036281|FG000|Overall Study|Not ICSI Insemination|7|||
16150417|NCT04818593|39036282|FG001|Overall Study|Not ICSI Insemination|7|||
16150418|NCT04818593|39036281|FG000|Overall Study|Poor Sperm Quality|2|||
16441899|NCT05384171|40097672|FG001|Overall Study|Lost to Follow-up|9|||
16441900|NCT05384171|40097671|FG000|Overall Study|Withdrawal by Subject|3|||
16150419|NCT04818593|39036282|FG001|Overall Study|Poor Sperm Quality|2|||
16150420|NCT04818593|39036281|FG000|Overall Study|Withdrawal by Subject|2|||
16150421|NCT04818593|39036282|FG001|Overall Study|Withdrawal by Subject|2|||
16150422|NCT04818593|39036281|FG000|Overall Study|Conversion to IUI due to low response|1|||
16150423|NCT04818593|39036282|FG001|Overall Study|Conversion to IUI due to low response|1|||
16260701|NCT00635492|39439671|FG001|Overall Study|Withdrawal by Subject|45|||
16260702|NCT02459951|39439672|FG000|Overall Study|Unable to meet holding requirement|1|||
16260703|NCT01390844|39439673|FG000|Treatment Phase|Adverse Event|12|||
16260704|NCT01390844|39439674|FG001|Treatment Phase|Adverse Event|2|||
16260705|NCT01390844|39439675|FG002|Treatment Phase|Adverse Event|3|||
16260706|NCT01390844|39439676|FG003|Treatment Phase|Adverse Event|2|||
16150424|NCT00365456|39036285|FG000|Trial Period I (12 Months)|Adverse Event|84|||
16150425|NCT00365456|39036286|FG001|Trial Period I (12 Months)|Adverse Event|0|||
16150426|NCT00365456|39036285|FG000|Trial Period I (12 Months)|Non-compliance|3|||
16150427|NCT00365456|39036286|FG001|Trial Period I (12 Months)|Non-compliance|0|||
16150428|NCT00365456|39036285|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
16150429|NCT00365456|39036286|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
16150430|NCT00365456|39036285|FG000|Trial Period I (12 Months)|Other|11|||
16150431|NCT00365456|39036286|FG001|Trial Period I (12 Months)|Other|0|||
16150432|NCT00365456|39036285|FG000|Trial Period II (12 Months)|Adverse Event|0|||
16150433|NCT00365456|39036286|FG001|Trial Period II (12 Months)|Adverse Event|6|||
16150434|NCT00365456|39036285|FG000|Trial Period II (12 Months)|Non-compliance|0|||
16150435|NCT00365456|39036286|FG001|Trial Period II (12 Months)|Non-compliance|2|||
16150436|NCT00365456|39036285|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
16150437|NCT00365456|39036286|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
16150438|NCT00365456|39036285|FG000|Trial Period II (12 Months)|Other|0|||
16150439|NCT00365456|39036286|FG001|Trial Period II (12 Months)|Other|1|||
16150440|NCT00365456|39036285|FG000|Trial Period III (12 Months)|Adverse Event|13|||
16150441|NCT00365456|39036286|FG001|Trial Period III (12 Months)|Adverse Event|3|||
16150442|NCT00365456|39036285|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
16150443|NCT00365456|39036286|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
16150444|NCT00365456|39036285|FG000|Trial Period III (12 Months)|Other|1|||
16150445|NCT00365456|39036286|FG001|Trial Period III (12 Months)|Other|1|||
16150446|NCT02898259|39036287|FG000|Overall Study|Adverse Event|0|||
16150447|NCT02898259|39036288|FG001|Overall Study|Adverse Event|0|||
16150448|NCT02898259|39036289|FG002|Overall Study|Adverse Event|1|||
16260707|NCT01390844|39439673|FG000|Treatment Phase|Treatment Failure|23|||
16150449|NCT02898259|39036290|FG003|Overall Study|Adverse Event|0|||
16260708|NCT01390844|39439674|FG001|Treatment Phase|Treatment Failure|25|||
16260709|NCT01390844|39439675|FG002|Treatment Phase|Treatment Failure|10|||
16260710|NCT01390844|39439676|FG003|Treatment Phase|Treatment Failure|13|||
16260711|NCT01390844|39439673|FG000|Treatment Phase|Non-Medical Reasons|5|||
16260712|NCT01390844|39439674|FG001|Treatment Phase|Non-Medical Reasons|1|||
16441901|NCT05384171|40097672|FG001|Overall Study|Withdrawal by Subject|0|||
16441902|NCT05498649|40097673|FG000|Overall Study|Lost to Follow-up|1|||
16441903|NCT02242942|40097676|FG000|Overall Study|Death|17|||
16441904|NCT02242942|40097677|FG001|Overall Study|Death|20|||
16441905|NCT02242942|40097678|FG002|Overall Study|Death|2|||
16441906|NCT02242942|40097676|FG000|Overall Study|Physician Decision|1|||
16441907|NCT02242942|40097677|FG001|Overall Study|Physician Decision|0|||
16441908|NCT02242942|40097678|FG002|Overall Study|Physician Decision|0|||
16441909|NCT02242942|40097676|FG000|Overall Study|Withdrawal by Subject|8|||
16441910|NCT02242942|40097677|FG001|Overall Study|Withdrawal by Subject|10|||
16441911|NCT02242942|40097678|FG002|Overall Study|Withdrawal by Subject|0|||
16441912|NCT02242942|40097676|FG000|Overall Study|On-going in Study|190|||
16441913|NCT02242942|40097677|FG001|Overall Study|On-going in Study|186|||
16441914|NCT02242942|40097678|FG002|Overall Study|On-going in Study|11|||
16441915|NCT00703014|40097680|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
16441916|NCT00703014|40097681|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
16260713|NCT01390844|39439675|FG002|Treatment Phase|Non-Medical Reasons|8|||
16260714|NCT01390844|39439676|FG003|Treatment Phase|Non-Medical Reasons|1|||
16260715|NCT01390844|39439673|FG000|Treatment Phase|Non-GCP Compliant|0|||
16260716|NCT01390844|39439674|FG001|Treatment Phase|Non-GCP Compliant|0|||
16260717|NCT01390844|39439675|FG002|Treatment Phase|Non-GCP Compliant|10|||
16260718|NCT01390844|39439676|FG003|Treatment Phase|Non-GCP Compliant|3|||
16260719|NCT01390844|39439673|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
16260720|NCT01390844|39439674|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
16260721|NCT01390844|39439675|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
16260722|NCT01390844|39439676|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
16260723|NCT01496183|39439680|FG000|Overall Study|Physician Decision|3|||
16260724|NCT01496183|39439681|FG001|Overall Study|Physician Decision|1|||
16260725|NCT01496183|39439680|FG000|Overall Study|Withdrawal by Subject|0|||
16260726|NCT01496183|39439681|FG001|Overall Study|Withdrawal by Subject|1|||
16260727|NCT01171989|39439683|FG000|Overall Study|Lost to Follow-up|0|||
16260728|NCT01171989|39439684|FG001|Overall Study|Lost to Follow-up|0|||
16260729|NCT01171989|39439685|FG002|Overall Study|Lost to Follow-up|1|||
16260730|NCT01866319|39439686|FG000|Overall Study|Adverse Event|12|||
16260731|NCT01866319|39439687|FG001|Overall Study|Adverse Event|5|||
16260732|NCT01866319|39439688|FG002|Overall Study|Adverse Event|9|||
16260733|NCT01866319|39439686|FG000|Overall Study|Clinical progression|3|||
16260734|NCT01866319|39439687|FG001|Overall Study|Clinical progression|2|||
16260735|NCT01866319|39439688|FG002|Overall Study|Clinical progression|2|||
16260736|NCT01866319|39439686|FG000|Overall Study|Death|153|||
16260737|NCT01866319|39439687|FG001|Overall Study|Death|154|||
16260738|NCT01866319|39439688|FG002|Overall Study|Death|147|||
16260739|NCT01866319|39439686|FG000|Overall Study|Lost to Follow-up|6|||
16260740|NCT01866319|39439687|FG001|Overall Study|Lost to Follow-up|3|||
16260741|NCT01866319|39439688|FG002|Overall Study|Lost to Follow-up|8|||
16260742|NCT01866319|39439686|FG000|Overall Study|Physician Decision|1|||
16260743|NCT01866319|39439687|FG001|Overall Study|Physician Decision|0|||
16260744|NCT01866319|39439688|FG002|Overall Study|Physician Decision|1|||
16441917|NCT00703014|40097682|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
16441918|NCT00703014|40097683|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
16441919|NCT00703014|40097680|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
16441920|NCT00703014|40097681|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
16441921|NCT00703014|40097682|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
16441922|NCT00703014|40097683|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
16441923|NCT04676022|40097684|FG000|Overall Study|Screen Failure/|1|||
16441924|NCT04676022|40097685|FG001|Overall Study|Screen Failure/|1|||
16441925|NCT04676022|40097686|FG002|Overall Study|Screen Failure/|85|||
16441926|NCT04676022|40097684|FG000|Overall Study|Lost to Follow-up|1|||
16260745|NCT01866319|39439686|FG000|Overall Study|Protocol Violation|0|||
16260746|NCT01866319|39439687|FG001|Overall Study|Protocol Violation|0|||
16260747|NCT01866319|39439688|FG002|Overall Study|Protocol Violation|1|||
16441927|NCT04676022|40097685|FG001|Overall Study|Lost to Follow-up|1|||
16441928|NCT04676022|40097686|FG002|Overall Study|Lost to Follow-up|0|||
16441929|NCT04676022|40097684|FG000|Overall Study|Adverse Event|2|||
16441930|NCT04676022|40097685|FG001|Overall Study|Adverse Event|0|||
16260748|NCT01866319|39439686|FG000|Overall Study|Withdrawal by Subject|32|||
16260749|NCT01866319|39439687|FG001|Overall Study|Withdrawal by Subject|14|||
16260750|NCT01866319|39439688|FG002|Overall Study|Withdrawal by Subject|12|||
16260751|NCT00746798|39439689|FG000|Overall Study|Protocol Violation|0|||
16260752|NCT00746798|39439690|FG001|Overall Study|Protocol Violation|1|||
16260753|NCT00746798|39439691|FG002|Overall Study|Protocol Violation|0|||
16260754|NCT00746798|39439692|FG003|Overall Study|Protocol Violation|0|||
16260755|NCT00746798|39439689|FG000|Overall Study|Withdrawal by Subject|0|||
16260756|NCT00746798|39439690|FG001|Overall Study|Withdrawal by Subject|1|||
16260757|NCT00746798|39439691|FG002|Overall Study|Withdrawal by Subject|1|||
16260758|NCT00746798|39439692|FG003|Overall Study|Withdrawal by Subject|0|||
16260759|NCT00746798|39439689|FG000|Overall Study|Death|0|||
16260760|NCT00746798|39439690|FG001|Overall Study|Death|0|||
16260761|NCT00746798|39439691|FG002|Overall Study|Death|2|||
16260762|NCT00746798|39439692|FG003|Overall Study|Death|0|||
16260763|NCT00746798|39439689|FG000|Overall Study|Participant unable to return for visit|1|||
16260764|NCT00746798|39439690|FG001|Overall Study|Participant unable to return for visit|0|||
16260765|NCT00746798|39439691|FG002|Overall Study|Participant unable to return for visit|0|||
16260766|NCT00746798|39439692|FG003|Overall Study|Participant unable to return for visit|0|||
16260767|NCT02780687|39439693|FG000|Overall Study|Adverse Event|1|||
16260768|NCT02780687|39439694|FG001|Overall Study|Adverse Event|1|||
16260769|NCT02780687|39439693|FG000|Overall Study|Withdrawal by Subject|2|||
16260770|NCT02780687|39439694|FG001|Overall Study|Withdrawal by Subject|1|||
16260771|NCT02780687|39439693|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
16260772|NCT02780687|39439694|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
16260773|NCT02780687|39439693|FG000|Overall Study|progressive disease|29|||
16260774|NCT02780687|39439694|FG001|Overall Study|progressive disease|6|||
16260775|NCT01511939|39439695|FG000|Overall Study|Withdrawal by Subject|2|||
16365529|NCT01995201|39821598|FG001|From Week 24 Until Week 48|Physician Decision|0|||
16365530|NCT01995201|39821599|FG002|From Week 24 Until Week 48|Physician Decision|0|||
16365531|NCT01995201|39821600|FG003|From Week 24 Until Week 48|Physician Decision|0|||
16365532|NCT01995201|39821601|FG004|From Week 24 Until Week 48|Physician Decision|1|||
16365533|NCT01995201|39821602|FG005|From Week 24 Until Week 48|Physician Decision|0|||
16365534|NCT01995201|39821603|FG006|From Week 24 Until Week 48|Physician Decision|0|||
16441931|NCT04676022|40097686|FG002|Overall Study|Adverse Event|1|||
16441932|NCT04676022|40097684|FG000|Overall Study|Physician Decision|2|||
16441933|NCT04676022|40097685|FG001|Overall Study|Physician Decision|0|||
16441934|NCT04676022|40097686|FG002|Overall Study|Physician Decision|1|||
16441935|NCT04676022|40097684|FG000|Overall Study|Withdrawal by Subject|3|||
16150450|NCT02898259|39036291|FG004|Overall Study|Adverse Event|0|||
16365535|NCT01995201|39821597|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
16365536|NCT01995201|39821598|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
16365537|NCT01995201|39821599|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
16365538|NCT01995201|39821600|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
16365539|NCT01995201|39821601|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
16365540|NCT01995201|39821602|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
16365541|NCT01995201|39821603|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
16365542|NCT01774370|39821604|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
16365543|NCT01774370|39821604|FG000|Overall Study|Administered prior to the contract date|4|||
16365544|NCT01774370|39821604|FG000|Overall Study|Subjects of contraindications|34|||
16365545|NCT01774370|39821604|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
16365546|NCT01774370|39821604|FG000|Overall Study|Follow-up failure|34|||
16365547|NCT00855582|39821607|FG000|Overall Study|Adverse Event|2|||
16365548|NCT00855582|39821608|FG001|Overall Study|Adverse Event|6|||
16365549|NCT00855582|39821609|FG002|Overall Study|Adverse Event|3|||
16365550|NCT00855582|39821607|FG000|Overall Study|Death|1|||
16365551|NCT00855582|39821608|FG001|Overall Study|Death|0|||
16365552|NCT00855582|39821609|FG002|Overall Study|Death|0|||
16365553|NCT00855582|39821607|FG000|Overall Study|Lack of Efficacy|1|||
16365554|NCT00855582|39821608|FG001|Overall Study|Lack of Efficacy|3|||
16365555|NCT00855582|39821609|FG002|Overall Study|Lack of Efficacy|8|||
16365556|NCT00855582|39821607|FG000|Overall Study|Lost to Follow-up|1|||
16365557|NCT00855582|39821608|FG001|Overall Study|Lost to Follow-up|3|||
16365558|NCT00855582|39821609|FG002|Overall Study|Lost to Follow-up|1|||
16365559|NCT00855582|39821607|FG000|Overall Study|Physician Decision|0|||
16365560|NCT00855582|39821608|FG001|Overall Study|Physician Decision|0|||
16365561|NCT00855582|39821609|FG002|Overall Study|Physician Decision|1|||
16365562|NCT00855582|39821607|FG000|Overall Study|Protocol Violation|6|||
16365563|NCT00855582|39821608|FG001|Overall Study|Protocol Violation|2|||
16365564|NCT00855582|39821609|FG002|Overall Study|Protocol Violation|6|||
16365565|NCT00855582|39821607|FG000|Overall Study|Entry Criteria Not Met|8|||
16365566|NCT00855582|39821608|FG001|Overall Study|Entry Criteria Not Met|6|||
16365567|NCT00855582|39821609|FG002|Overall Study|Entry Criteria Not Met|3|||
16441936|NCT04676022|40097685|FG001|Overall Study|Withdrawal by Subject|1|||
16441937|NCT04676022|40097686|FG002|Overall Study|Withdrawal by Subject|6|||
16260776|NCT01511939|39439696|FG001|Overall Study|Withdrawal by Subject|1|||
16260777|NCT01511939|39439697|FG002|Overall Study|Withdrawal by Subject|0|||
16260778|NCT00096265|39439698|FG000|Overall Study|Ineligible|1|||
16260779|NCT00096265|39439699|FG001|Overall Study|Ineligible|0|||
16260780|NCT00096265|39439700|FG002|Overall Study|Ineligible|0|||
16260781|NCT02719522|39439703|FG000|Overall Study|Implant Failure|4|||
16260782|NCT02719522|39439703|FG000|Overall Study|Death|2|||
16260783|NCT02719522|39439703|FG000|Overall Study|Lost to Follow-up|5|||
16260784|NCT01781286|39439704|FG000|Overall Study|Lost to Follow-up|0|||
16260785|NCT01781286|39439705|FG001|Overall Study|Lost to Follow-up|0|||
16260786|NCT01781286|39439706|FG002|Overall Study|Lost to Follow-up|0|||
16260787|NCT01781286|39439707|FG003|Overall Study|Lost to Follow-up|0|||
16260788|NCT01781286|39439708|FG004|Overall Study|Lost to Follow-up|0|||
16260789|NCT01781286|39439709|FG005|Overall Study|Lost to Follow-up|1|||
16260790|NCT01781286|39439704|FG000|Overall Study|Time Constraints|2|||
16260791|NCT01781286|39439705|FG001|Overall Study|Time Constraints|0|||
16260792|NCT01781286|39439706|FG002|Overall Study|Time Constraints|2|||
16260793|NCT01781286|39439707|FG003|Overall Study|Time Constraints|0|||
16260794|NCT01781286|39439708|FG004|Overall Study|Time Constraints|0|||
16260795|NCT01781286|39439709|FG005|Overall Study|Time Constraints|0|||
16260796|NCT01781286|39439704|FG000|Overall Study|Noncompliance|0|||
16260797|NCT01781286|39439705|FG001|Overall Study|Noncompliance|0|||
16260798|NCT01781286|39439706|FG002|Overall Study|Noncompliance|0|||
16260799|NCT01781286|39439707|FG003|Overall Study|Noncompliance|1|||
16260800|NCT01781286|39439708|FG004|Overall Study|Noncompliance|0|||
16260801|NCT01781286|39439709|FG005|Overall Study|Noncompliance|0|||
16260802|NCT00579670|39439710|FG000|Overall Study|Death|1|||
16260803|NCT00579670|39439711|FG001|Overall Study|Death|0|||
16260804|NCT00579670|39439712|FG002|Overall Study|Death|0|||
16260805|NCT00579670|39439713|FG003|Overall Study|Death|0|||
16260806|NCT00579670|39439714|FG004|Overall Study|Death|0|||
16260807|NCT00579670|39439710|FG000|Overall Study|Adverse Event|1|||
16260808|NCT00579670|39439711|FG001|Overall Study|Adverse Event|0|||
16260809|NCT00579670|39439712|FG002|Overall Study|Adverse Event|1|||
16260810|NCT00579670|39439713|FG003|Overall Study|Adverse Event|2|||
16260811|NCT00579670|39439714|FG004|Overall Study|Adverse Event|0|||
16260812|NCT00579670|39439710|FG000|Overall Study|Lack of Efficacy|0|||
16260813|NCT00579670|39439711|FG001|Overall Study|Lack of Efficacy|0|||
16260814|NCT00579670|39439712|FG002|Overall Study|Lack of Efficacy|1|||
16260815|NCT00579670|39439713|FG003|Overall Study|Lack of Efficacy|14|||
16260816|NCT00579670|39439714|FG004|Overall Study|Lack of Efficacy|0|||
16260817|NCT00579670|39439710|FG000|Overall Study|Lost to Follow-up|0|||
16260818|NCT00579670|39439711|FG001|Overall Study|Lost to Follow-up|1|||
16260819|NCT00579670|39439712|FG002|Overall Study|Lost to Follow-up|0|||
16260820|NCT00579670|39439713|FG003|Overall Study|Lost to Follow-up|4|||
16260821|NCT00579670|39439714|FG004|Overall Study|Lost to Follow-up|0|||
16260822|NCT00579670|39439710|FG000|Overall Study|Other|0|||
16260823|NCT00579670|39439711|FG001|Overall Study|Other|0|||
16260824|NCT00579670|39439712|FG002|Overall Study|Other|1|||
16260825|NCT00579670|39439713|FG003|Overall Study|Other|2|||
16260826|NCT00579670|39439714|FG004|Overall Study|Other|0|||
16260827|NCT00579670|39439710|FG000|Overall Study|Withdrawal by Subject|0|||
16365568|NCT00855582|39821607|FG000|Overall Study|Withdrawal by Subject|7|||
16260828|NCT00579670|39439711|FG001|Overall Study|Withdrawal by Subject|0|||
16260829|NCT00579670|39439712|FG002|Overall Study|Withdrawal by Subject|1|||
16260830|NCT00579670|39439713|FG003|Overall Study|Withdrawal by Subject|0|||
16260831|NCT00579670|39439714|FG004|Overall Study|Withdrawal by Subject|0|||
16260832|NCT01974141|39439716|FG000|Overall Study|Other Reasons|28|||
16260833|NCT01974141|39439717|FG001|Overall Study|Other Reasons|18|||
16260834|NCT01974141|39439716|FG000|Overall Study|Protocol Violation|2|||
16260835|NCT01974141|39439717|FG001|Overall Study|Protocol Violation|6|||
16260836|NCT01974141|39439716|FG000|Overall Study|Personal Reasons|21|||
16260837|NCT01974141|39439717|FG001|Overall Study|Personal Reasons|20|||
16260838|NCT01974141|39439716|FG000|Overall Study|Lost to Follow-up|38|||
16260839|NCT01974141|39439717|FG001|Overall Study|Lost to Follow-up|29|||
16260840|NCT01974141|39439716|FG000|Overall Study|Pregnancy|3|||
16260841|NCT01974141|39439717|FG001|Overall Study|Pregnancy|3|||
16260842|NCT01974141|39439716|FG000|Overall Study|Lack of Efficacy|0|||
16260843|NCT01974141|39439717|FG001|Overall Study|Lack of Efficacy|1|||
16260844|NCT01974141|39439716|FG000|Overall Study|Adverse Event|4|||
16260845|NCT01974141|39439717|FG001|Overall Study|Adverse Event|5|||
16260846|NCT02481830|39439726|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
16260847|NCT02481830|39439727|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
16365569|NCT00855582|39821608|FG001|Overall Study|Withdrawal by Subject|4|||
16365570|NCT00855582|39821609|FG002|Overall Study|Withdrawal by Subject|8|||
16365571|NCT02497755|39821612|FG000|Overall Study|Protocol Violation|1|||
16365572|NCT02497755|39821613|FG001|Overall Study|Protocol Violation|0|||
16365573|NCT03462680|39821615|FG000|Overall Study|Withdrawal by Subject|3|||
16365574|NCT03462680|39821616|FG001|Overall Study|Withdrawal by Subject|5|||
16365575|NCT00976027|39821618|FG000|Overall Study|Serious Adverse Event|36|||
16365576|NCT00976027|39821619|FG001|Overall Study|Serious Adverse Event|17|||
16365577|NCT00976027|39821618|FG000|Overall Study|Adverse Event|0|||
16365578|NCT00976027|39821619|FG001|Overall Study|Adverse Event|2|||
16365579|NCT00976027|39821618|FG000|Overall Study|Protocol Violation|60|||
16365580|NCT00976027|39821619|FG001|Overall Study|Protocol Violation|27|||
16365581|NCT00976027|39821618|FG000|Overall Study|Lost to Follow-up|208|||
16365582|NCT00976027|39821619|FG001|Overall Study|Lost to Follow-up|103|||
16365583|NCT00976027|39821618|FG000|Overall Study|Withdrawal by Subject|107|||
16441938|NCT04676022|40097684|FG000|Overall Study|Will not move forward with permanent implant|6|||
16441939|NCT04676022|40097685|FG001|Overall Study|Will not move forward with permanent implant|0|||
16441940|NCT04676022|40097686|FG002|Overall Study|Will not move forward with permanent implant|0|||
16441941|NCT04676022|40097684|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
16441942|NCT04676022|40097685|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
16441943|NCT04676022|40097686|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
16441944|NCT04819945|40097687|FG000|Overall Study|Lost to Follow-up|1|||
16441945|NCT03524612|40097688|FG000|Overall Study|Lack of Efficacy|10|||
16441946|NCT03524612|40097688|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
16441947|NCT03524612|40097688|FG000|Overall Study|Adverse Event|10|||
16441948|NCT03524612|40097688|FG000|Overall Study|Withdrawal by Subject|7|||
16441949|NCT03524612|40097688|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
16441950|NCT03524612|40097688|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
16441951|NCT03524612|40097688|FG000|Overall Study|New therapy for study indication|6|||
16441952|NCT03524612|40097688|FG000|Overall Study|Death|3|||
16441953|NCT03524612|40097688|FG000|Overall Study|Lost to Follow-up|2|||
16365584|NCT00976027|39821619|FG001|Overall Study|Withdrawal by Subject|66|||
16365585|NCT03086343|39821623|FG000|Period 1|Adverse Event|7|||
16365586|NCT03086343|39821624|FG001|Period 1|Adverse Event|7|||
16365587|NCT03086343|39821625|FG002|Period 1|Adverse Event|0|||
16365588|NCT03086343|39821626|FG003|Period 1|Adverse Event|1|||
16365589|NCT03086343|39821623|FG000|Period 1|Withdrawal by Subject|6|||
16441954|NCT03524612|40097688|FG000|Overall Study|Protocol Violation|1|||
16441955|NCT05106959|40097689|FG000|Overall Study|Lost to Follow-up|1|||
16441956|NCT02063724|40097691|FG000|Overall Study|Disease progression|1|||
16260848|NCT02481830|39439726|FG000|Pre-treatment|Withdrawal by Subject|0|||
16365590|NCT03086343|39821624|FG001|Period 1|Withdrawal by Subject|10|||
16150451|NCT02898259|39036287|FG000|Overall Study|Lack of Efficacy|1|||
16260849|NCT02481830|39439727|FG001|Pre-treatment|Withdrawal by Subject|10|||
16365591|NCT03086343|39821625|FG002|Period 1|Withdrawal by Subject|0|||
16365592|NCT03086343|39821626|FG003|Period 1|Withdrawal by Subject|0|||
16150452|NCT02898259|39036288|FG001|Overall Study|Lack of Efficacy|1|||
16150453|NCT02898259|39036289|FG002|Overall Study|Lack of Efficacy|3|||
16150454|NCT02898259|39036290|FG003|Overall Study|Lack of Efficacy|0|||
16150455|NCT02898259|39036291|FG004|Overall Study|Lack of Efficacy|0|||
16150456|NCT02898259|39036287|FG000|Overall Study|Lost to Follow-up|0|||
16150457|NCT02898259|39036288|FG001|Overall Study|Lost to Follow-up|0|||
16150458|NCT02898259|39036289|FG002|Overall Study|Lost to Follow-up|1|||
16150459|NCT02898259|39036290|FG003|Overall Study|Lost to Follow-up|0|||
16150460|NCT02898259|39036291|FG004|Overall Study|Lost to Follow-up|0|||
16150461|NCT02898259|39036287|FG000|Overall Study|Transformation before study began|0|||
16150462|NCT02898259|39036288|FG001|Overall Study|Transformation before study began|0|||
16150463|NCT02898259|39036289|FG002|Overall Study|Transformation before study began|0|||
16150464|NCT02898259|39036290|FG003|Overall Study|Transformation before study began|1|||
16150465|NCT02898259|39036291|FG004|Overall Study|Transformation before study began|0|||
16150466|NCT04066491|39036298|FG000|Overall Study|Randomized, not treated|0|||
16150467|NCT04066491|39036299|FG001|Overall Study|Randomized, not treated|0|||
16150468|NCT04066491|39036300|FG002|Overall Study|Randomized, not treated|2|||
16150469|NCT01146873|39036301|FG000|Overall Study|Transfer out|0|||
16150470|NCT01146873|39036302|FG001|Overall Study|Transfer out|6|||
16150471|NCT00689871|39036305|FG000|Overall Study|Lost to Follow-up|123|||
16150472|NCT00689871|39036306|FG001|Overall Study|Lost to Follow-up|13|||
16150473|NCT00689871|39036307|FG002|Overall Study|Lost to Follow-up|37|||
16150474|NCT00689871|39036308|FG003|Overall Study|Lost to Follow-up|1|||
16150475|NCT00689871|39036305|FG000|Overall Study|Explanted of All Study Devices|36|||
16150476|NCT00689871|39036306|FG001|Overall Study|Explanted of All Study Devices|25|||
16150477|NCT00689871|39036307|FG002|Overall Study|Explanted of All Study Devices|29|||
16150478|NCT00689871|39036308|FG003|Overall Study|Explanted of All Study Devices|3|||
16150479|NCT00689871|39036305|FG000|Overall Study|Withdrawal by Subject|13|||
16150480|NCT00689871|39036306|FG001|Overall Study|Withdrawal by Subject|3|||
16150481|NCT00689871|39036307|FG002|Overall Study|Withdrawal by Subject|4|||
16150482|NCT00689871|39036308|FG003|Overall Study|Withdrawal by Subject|1|||
16150483|NCT00689871|39036305|FG000|Overall Study|Death|1|||
16150484|NCT00689871|39036306|FG001|Overall Study|Death|10|||
16150485|NCT00689871|39036307|FG002|Overall Study|Death|2|||
16150486|NCT00689871|39036308|FG003|Overall Study|Death|2|||
16150487|NCT00689871|39036305|FG000|Overall Study|Physician Decision|2|||
16150488|NCT00689871|39036306|FG001|Overall Study|Physician Decision|1|||
16260850|NCT02481830|39439726|FG000|Pre-treatment|Disease Progression|1|||
16260851|NCT02481830|39439727|FG001|Pre-treatment|Disease Progression|1|||
16260852|NCT02481830|39439726|FG000|Pre-treatment|Other reasons|0|||
16260853|NCT02481830|39439727|FG001|Pre-treatment|Other reasons|1|||
16260854|NCT02481830|39439726|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
16260855|NCT02481830|39439727|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
16260856|NCT02481830|39439726|FG000|Treatment|Disease Progression|233|||
16365593|NCT03086343|39821623|FG000|Period 1|Lost to Follow-up|1|||
16150489|NCT00689871|39036307|FG002|Overall Study|Physician Decision|1|||
16150490|NCT00689871|39036308|FG003|Overall Study|Physician Decision|0|||
16150491|NCT00096785|39036309|FG000|Overall Study|Lost to Follow-up|1|||
16150492|NCT00096785|39036310|FG001|Overall Study|Lost to Follow-up|0|||
16150493|NCT00096785|39036309|FG000|Overall Study|Withdrawal by Subject|0|||
16150494|NCT00096785|39036310|FG001|Overall Study|Withdrawal by Subject|1|||
16150495|NCT00096785|39036309|FG000|Overall Study|Relocated|1|||
16150496|NCT00096785|39036310|FG001|Overall Study|Relocated|0|||
16150497|NCT00607386|39036313|FG000|Overall Study|Physician Decision|1|||
16150498|NCT01982292|39036314|FG000|Overall Study|Adverse Event|2|||
16150499|NCT01982292|39036315|FG001|Overall Study|Adverse Event|0|||
16150500|NCT01982292|39036314|FG000|Overall Study|Death|1|||
16150501|NCT01982292|39036315|FG001|Overall Study|Death|0|||
16150502|NCT01982292|39036314|FG000|Overall Study|Lost to Follow-up|2|||
16150503|NCT01982292|39036315|FG001|Overall Study|Lost to Follow-up|0|||
16150504|NCT01982292|39036314|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
16150505|NCT01982292|39036315|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
16150506|NCT01982292|39036314|FG000|Overall Study|Protocol Deviation|1|||
16150507|NCT01982292|39036315|FG001|Overall Study|Protocol Deviation|0|||
16260857|NCT02481830|39439727|FG001|Treatment|Disease Progression|171|||
16260858|NCT02481830|39439726|FG000|Treatment|Study drug toxicity|18|||
16260859|NCT02481830|39439727|FG001|Treatment|Study drug toxicity|38|||
16365594|NCT03086343|39821624|FG001|Period 1|Lost to Follow-up|3|||
16150508|NCT01982292|39036314|FG000|Overall Study|Patient/Guardian Decision|3|||
16150509|NCT01982292|39036315|FG001|Overall Study|Patient/Guardian Decision|1|||
16150510|NCT01982292|39036314|FG000|Overall Study|Technical Problems|2|||
16150511|NCT01982292|39036315|FG001|Overall Study|Technical Problems|0|||
16150512|NCT01648790|39036318|FG000|Treatment 3|Withdrawal by Subject|0|||
16150513|NCT01648790|39036319|FG001|Treatment 3|Withdrawal by Subject|0|||
16150514|NCT01648790|39036320|FG002|Treatment 3|Withdrawal by Subject|0|||
16150515|NCT01648790|39036321|FG003|Treatment 3|Withdrawal by Subject|1|||
16150516|NCT01648790|39036322|FG004|Treatment 3|Withdrawal by Subject|0|||
16150517|NCT01516970|39036323|FG000|Overall Study|Lost to Follow-up|7|||
16150518|NCT01516970|39036324|FG001|Overall Study|Lost to Follow-up|8|||
16150519|NCT01516970|39036323|FG000|Overall Study|Adverse Event|1|||
16150520|NCT01516970|39036324|FG001|Overall Study|Adverse Event|5|||
16150521|NCT01516970|39036323|FG000|Overall Study|Withdrawal by Subject|1|||
16150522|NCT01516970|39036324|FG001|Overall Study|Withdrawal by Subject|1|||
16150523|NCT01516970|39036323|FG000|Overall Study|Other|9|||
16150524|NCT01516970|39036324|FG001|Overall Study|Other|7|||
16150525|NCT05418673|39036325|FG000|Overall Study|Study Terminated by Sponsor|2|||
16150526|NCT05418673|39036326|FG001|Overall Study|Study Terminated by Sponsor|4|||
16150527|NCT05418673|39036325|FG000|Overall Study|Lost to Follow-up|1|||
16150528|NCT05418673|39036326|FG001|Overall Study|Lost to Follow-up|0|||
16150529|NCT00794157|39036329|FG000|Overall Study|Adverse Event|4|||
16150530|NCT00794157|39036330|FG001|Overall Study|Adverse Event|1|||
16150531|NCT00794157|39036331|FG002|Overall Study|Adverse Event|8|||
16150532|NCT00794157|39036329|FG000|Overall Study|Subject withdrew consent|2|||
16150533|NCT00794157|39036330|FG001|Overall Study|Subject withdrew consent|0|||
16150534|NCT00794157|39036331|FG002|Overall Study|Subject withdrew consent|3|||
16150535|NCT00794157|39036329|FG000|Overall Study|Lost to Follow-up|2|||
16150536|NCT00794157|39036330|FG001|Overall Study|Lost to Follow-up|0|||
16150537|NCT00794157|39036331|FG002|Overall Study|Lost to Follow-up|1|||
16150538|NCT00794157|39036329|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16150539|NCT00794157|39036330|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16150540|NCT00794157|39036331|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
16150541|NCT00794157|39036329|FG000|Overall Study|Administrative problems|1|||
16150542|NCT00794157|39036330|FG001|Overall Study|Administrative problems|7|||
16150543|NCT00794157|39036331|FG002|Overall Study|Administrative problems|4|||
16150544|NCT00794157|39036329|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16150545|NCT00794157|39036330|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16150546|NCT00794157|39036331|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16150547|NCT00794157|39036329|FG000|Overall Study|Protocol deviation|0|||
16150548|NCT00794157|39036330|FG001|Overall Study|Protocol deviation|1|||
16150549|NCT00794157|39036331|FG002|Overall Study|Protocol deviation|1|||
16150550|NCT01422915|39036332|FG000|Overall Study|Adverse Event|1|||
16150551|NCT01081249|39036340|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
16150552|NCT01081249|39036341|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
16150553|NCT04439175|39036348|FG000|Overall Study|Never started treatment|4|||
16150554|NCT04439175|39036348|FG000|Overall Study|Ineligible|5|||
16150555|NCT04439175|39036348|FG000|Overall Study|Adverse Event|6|||
16150556|NCT04439175|39036348|FG000|Overall Study|Death|4|||
16150557|NCT04439175|39036348|FG000|Overall Study|Disease progression|44|||
16150558|NCT04439175|39036348|FG000|Overall Study|Withdrawal by Subject|4|||
16150559|NCT04439175|39036348|FG000|Overall Study|Alternative Therapy|1|||
16150560|NCT04439175|39036348|FG000|Overall Study|Other|2|||
16150561|NCT00708123|39036349|FG000|Period 1|Protocol Violation|0|||
16150562|NCT00708123|39036350|FG001|Period 1|Protocol Violation|1|||
16150563|NCT00708123|39036351|FG002|Period 1|Protocol Violation|0|||
16150564|NCT00708123|39036352|FG003|Period 1|Protocol Violation|1|||
16150565|NCT00708123|39036353|FG004|Period 1|Protocol Violation|0|||
16150566|NCT00708123|39036349|FG000|Period 1|Adverse Event|0|||
16150567|NCT00708123|39036350|FG001|Period 1|Adverse Event|0|||
16150568|NCT00708123|39036351|FG002|Period 1|Adverse Event|1|||
16150569|NCT00708123|39036352|FG003|Period 1|Adverse Event|0|||
16150570|NCT00708123|39036353|FG004|Period 1|Adverse Event|0|||
16150571|NCT00708123|39036349|FG000|Period 2|Protocol Violation|0|||
16150572|NCT00708123|39036350|FG001|Period 2|Protocol Violation|0|||
16150573|NCT00708123|39036351|FG002|Period 2|Protocol Violation|0|||
16150574|NCT00708123|39036352|FG003|Period 2|Protocol Violation|1|||
16260860|NCT02481830|39439726|FG000|Treatment|Death|1|||
16150575|NCT00708123|39036353|FG004|Period 2|Protocol Violation|0|||
16150576|NCT00708123|39036349|FG000|Period 2|Other Reason|1|||
16150577|NCT00708123|39036350|FG001|Period 2|Other Reason|0|||
16150578|NCT00708123|39036351|FG002|Period 2|Other Reason|0|||
16150579|NCT00708123|39036352|FG003|Period 2|Other Reason|0|||
16150580|NCT00708123|39036353|FG004|Period 2|Other Reason|0|||
16150581|NCT00708123|39036349|FG000|Period 3|Lost to Follow-up|0|||
16150582|NCT00708123|39036350|FG001|Period 3|Lost to Follow-up|0|||
16150583|NCT00708123|39036351|FG002|Period 3|Lost to Follow-up|1|||
16150584|NCT00708123|39036352|FG003|Period 3|Lost to Follow-up|1|||
16150585|NCT00708123|39036353|FG004|Period 3|Lost to Follow-up|0|||
16150586|NCT00708123|39036349|FG000|Period 4|Protocol Violation|0|||
16150587|NCT00708123|39036350|FG001|Period 4|Protocol Violation|1|||
16150588|NCT00708123|39036351|FG002|Period 4|Protocol Violation|0|||
16150589|NCT00708123|39036352|FG003|Period 4|Protocol Violation|0|||
16150590|NCT00708123|39036353|FG004|Period 4|Protocol Violation|0|||
16150591|NCT00545298|39036354|FG000|Overall Study|Issues with Standard of Care|2|||
16150592|NCT00545298|39036355|FG001|Overall Study|Issues with Standard of Care|0|||
16150593|NCT00545298|39036356|FG002|Overall Study|Issues with Standard of Care|1|||
16150594|NCT00808236|39036361|FG000|Overall Study|Was not resuscitated|50|||
16150595|NCT00808236|39036362|FG001|Overall Study|Was not resuscitated|56|||
16150596|NCT00808236|39036361|FG000|Overall Study|Pre-defined exclusion|13|||
16150597|NCT00808236|39036362|FG001|Overall Study|Pre-defined exclusion|3|||
16150598|NCT00808236|39036361|FG000|Overall Study|Lost to Follow-up|1|||
16150599|NCT00808236|39036362|FG001|Overall Study|Lost to Follow-up|1|||
16150600|NCT00808236|39036361|FG000|Overall Study|Physician Decision|0|||
16150601|NCT00808236|39036362|FG001|Overall Study|Physician Decision|1|||
16150602|NCT00808236|39036361|FG000|Overall Study|Death|18|||
16150603|NCT00808236|39036362|FG001|Overall Study|Death|30|||
16150604|NCT01040351|39036363|FG000|Overall Study|poor ovarian response|1|||
16150605|NCT01040351|39036364|FG001|Overall Study|poor ovarian response|2|||
16150606|NCT01585272|39036365|FG000|Overall Study|Adverse Event|22|||
16150607|NCT01585272|39036365|FG000|Overall Study|Protocol Violation|7|||
16150608|NCT01585272|39036365|FG000|Overall Study|Withdrawal by Subject|10|||
16150609|NCT02374099|39036366|FG000|Overall Study|Adverse Event|1|||
16150610|NCT02374099|39036367|FG001|Overall Study|Adverse Event|0|||
16150611|NCT02374099|39036366|FG000|Overall Study|Progressive Disease|35|||
16150612|NCT02374099|39036367|FG001|Overall Study|Progressive Disease|40|||
16150613|NCT02374099|39036366|FG000|Overall Study|Withdrawal by Subject|5|||
16150614|NCT02374099|39036367|FG001|Overall Study|Withdrawal by Subject|1|||
16150615|NCT02374099|39036366|FG000|Overall Study|Miscellaneous|2|||
16365595|NCT03086343|39821625|FG002|Period 1|Lost to Follow-up|1|||
16365596|NCT03086343|39821626|FG003|Period 1|Lost to Follow-up|0|||
16365597|NCT03086343|39821623|FG000|Period 1|Other, Not Specified|10|||
16365598|NCT03086343|39821624|FG001|Period 1|Other, Not Specified|12|||
16365599|NCT03086343|39821625|FG002|Period 1|Other, Not Specified|2|||
16365600|NCT03086343|39821626|FG003|Period 1|Other, Not Specified|1|||
16365601|NCT03086343|39821623|FG000|Period 1|Missing|1|||
16365602|NCT03086343|39821624|FG001|Period 1|Missing|0|||
16365603|NCT03086343|39821625|FG002|Period 1|Missing|0|||
16441957|NCT05083351|40097692|FG000|Overall Study|Adverse Event|3|||
16441958|NCT05083351|40097692|FG000|Overall Study|Did not meet data inclusion criteria|8|||
16441959|NCT05083351|40097692|FG000|Overall Study|Did not meet eligibility criteria|19|||
16150616|NCT02374099|39036367|FG001|Overall Study|Miscellaneous|3|||
16150617|NCT02374099|39036366|FG000|Overall Study|Randomized, but not treated|2|||
16150618|NCT02374099|39036367|FG001|Overall Study|Randomized, but not treated|1|||
16365604|NCT03086343|39821626|FG003|Period 1|Missing|0|||
16441960|NCT05083351|40097692|FG000|Overall Study|Study Staff Decision|19|||
16441961|NCT02101775|40097696|FG000|Overall Study|Adverse Event|4|||
16441962|NCT02101775|40097697|FG001|Overall Study|Adverse Event|0|||
16441963|NCT02101775|40097698|FG002|Overall Study|Adverse Event|0|||
16441964|NCT02101775|40097696|FG000|Overall Study|Admission to Hospital|0|||
16441965|NCT02101775|40097697|FG001|Overall Study|Admission to Hospital|1|||
16441966|NCT02101775|40097698|FG002|Overall Study|Admission to Hospital|0|||
16441967|NCT05131204|40097701|FG000|Overall Study|Sponsor request|2|||
16441968|NCT05131204|40097702|FG001|Overall Study|Sponsor request|1|||
16441969|NCT03119259|40097703|FG000|Overall Study|Withdrawn as no longer eligible|1|||
16441970|NCT03119259|40097704|FG001|Overall Study|Withdrawn as no longer eligible|0|||
16441971|NCT03119259|40097703|FG000|Overall Study|Withdrawal by Subject|4|||
16441972|NCT03119259|40097704|FG001|Overall Study|Withdrawal by Subject|2|||
16441973|NCT03119259|40097703|FG000|Overall Study|Lost to Follow-up|0|||
16150619|NCT02374099|39036366|FG000|Overall Study|Study Terminated by Sponsor|3|||
16365605|NCT03086343|39821623|FG000|Period 2|Adverse Event|20|||
16441974|NCT03119259|40097704|FG001|Overall Study|Lost to Follow-up|1|||
16441975|NCT04097678|40097707|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
16365606|NCT03086343|39821624|FG001|Period 2|Adverse Event|11|||
16441976|NCT04097678|40097708|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
16441977|NCT04629508|40097711|FG000|Overall Study|Adverse Event|1|||
16150620|NCT02374099|39036367|FG001|Overall Study|Study Terminated by Sponsor|4|||
16150621|NCT01476475|39036368|FG000|Overall Study|Adverse Event|6|||
16365607|NCT03086343|39821625|FG002|Period 2|Adverse Event|1|||
16441978|NCT04629508|40097711|FG000|Overall Study|Death|2|||
16441979|NCT04629508|40097711|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
16441980|NCT04698343|40097712|FG000|Overall Study|Withdrawal by Subject|6|||
16441981|NCT04698343|40097712|FG000|Overall Study|Physician Decision|2|||
16441982|NCT04698343|40097712|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
16441983|NCT04698343|40097712|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
16441984|NCT04698343|40097712|FG000|Overall Study|Personal reasons|3|||
16441985|NCT04698343|40097712|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
16441986|NCT04423718|40097713|FG000|Overall Study|Adverse Event|6|||
16441987|NCT04423718|40097714|FG001|Overall Study|Adverse Event|2|||
16441988|NCT04423718|40097715|FG002|Overall Study|Adverse Event|5|||
16441989|NCT04423718|40097713|FG000|Overall Study|Physician Decision|1|||
16441990|NCT04423718|40097714|FG001|Overall Study|Physician Decision|4|||
16441991|NCT04423718|40097715|FG002|Overall Study|Physician Decision|1|||
16441992|NCT04423718|40097713|FG000|Overall Study|Protocol Violation|0|||
16365608|NCT03086343|39821626|FG003|Period 2|Adverse Event|2|||
16365609|NCT03086343|39821623|FG000|Period 2|Withdrawal by Subject|15|||
16365610|NCT03086343|39821624|FG001|Period 2|Withdrawal by Subject|25|||
16365611|NCT03086343|39821625|FG002|Period 2|Withdrawal by Subject|2|||
16365612|NCT03086343|39821626|FG003|Period 2|Withdrawal by Subject|2|||
16441993|NCT04423718|40097714|FG001|Overall Study|Protocol Violation|1|||
16441994|NCT04423718|40097715|FG002|Overall Study|Protocol Violation|1|||
16441995|NCT04423718|40097713|FG000|Overall Study|Lost to Follow-up|1|||
16441996|NCT04423718|40097714|FG001|Overall Study|Lost to Follow-up|1|||
16441997|NCT04423718|40097715|FG002|Overall Study|Lost to Follow-up|2|||
16441998|NCT04423718|40097713|FG000|Overall Study|Lack of Efficacy|2|||
16441999|NCT04423718|40097714|FG001|Overall Study|Lack of Efficacy|0|||
16442000|NCT04423718|40097715|FG002|Overall Study|Lack of Efficacy|0|||
16442001|NCT04423718|40097713|FG000|Overall Study|Withdrawal by Subject|6|||
16442002|NCT04423718|40097714|FG001|Overall Study|Withdrawal by Subject|8|||
16442003|NCT04423718|40097715|FG002|Overall Study|Withdrawal by Subject|14|||
16442004|NCT04423718|40097713|FG000|Overall Study|Death|5|||
16150622|NCT01476475|39036369|FG001|Overall Study|Adverse Event|0|||
16150623|NCT01476475|39036368|FG000|Overall Study|Poor compliance to protocol|1|||
16150624|NCT01476475|39036369|FG001|Overall Study|Poor compliance to protocol|1|||
16150625|NCT01476475|39036368|FG000|Overall Study|Other reasons|4|||
16150626|NCT01476475|39036369|FG001|Overall Study|Other reasons|2|||
16150627|NCT03028870|39036370|FG000|Overall Study|Adverse Event|7|||
16150628|NCT03028870|39036371|FG001|Overall Study|Adverse Event|4|||
16150629|NCT03028870|39036372|FG002|Overall Study|Adverse Event|3|||
16150630|NCT03028870|39036373|FG003|Overall Study|Adverse Event|3|||
16150631|NCT03028870|39036370|FG000|Overall Study|Withdrawal by Subject|1|||
16150632|NCT03028870|39036371|FG001|Overall Study|Withdrawal by Subject|1|||
16150633|NCT03028870|39036372|FG002|Overall Study|Withdrawal by Subject|1|||
16365613|NCT03086343|39821623|FG000|Period 2|Lost to Follow-up|6|||
16365614|NCT03086343|39821624|FG001|Period 2|Lost to Follow-up|11|||
16365615|NCT03086343|39821625|FG002|Period 2|Lost to Follow-up|1|||
16365616|NCT03086343|39821626|FG003|Period 2|Lost to Follow-up|0|||
16365617|NCT03086343|39821623|FG000|Period 2|COVID-19 Infection|5|||
16365618|NCT03086343|39821624|FG001|Period 2|COVID-19 Infection|0|||
16365619|NCT03086343|39821625|FG002|Period 2|COVID-19 Infection|0|||
16365620|NCT03086343|39821626|FG003|Period 2|COVID-19 Infection|0|||
16365621|NCT03086343|39821623|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
16365622|NCT03086343|39821624|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
16365623|NCT03086343|39821625|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
16365624|NCT03086343|39821626|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
16365625|NCT03086343|39821623|FG000|Period 2|Other, Not Specified|23|||
16365626|NCT03086343|39821624|FG001|Period 2|Other, Not Specified|22|||
16365627|NCT03086343|39821625|FG002|Period 2|Other, Not Specified|2|||
16365628|NCT03086343|39821626|FG003|Period 2|Other, Not Specified|4|||
16365629|NCT01696968|39821627|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
16365630|NCT01696968|39821628|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
16365631|NCT01696968|39821627|FG000|Overall Study|Died Before Randomization|3|||
16365632|NCT01696968|39821628|FG001|Overall Study|Died Before Randomization|8|||
16365633|NCT01696968|39821627|FG000|Overall Study|Died Before ASU (Control)|278|||
16365634|NCT01696968|39821628|FG001|Overall Study|Died Before ASU (Control)|0|||
16442005|NCT04423718|40097714|FG001|Overall Study|Death|3|||
16442006|NCT04423718|40097715|FG002|Overall Study|Death|2|||
16442007|NCT04423718|40097713|FG000|Overall Study|COVID-19 pandemic|2|||
16442008|NCT04423718|40097714|FG001|Overall Study|COVID-19 pandemic|2|||
16365635|NCT01696968|39821627|FG000|Overall Study|Refused ASU (Control)|920|||
16365636|NCT01696968|39821628|FG001|Overall Study|Refused ASU (Control)|0|||
16442009|NCT04423718|40097715|FG002|Overall Study|COVID-19 pandemic|2|||
16150634|NCT03028870|39036373|FG003|Overall Study|Withdrawal by Subject|2|||
16150635|NCT03028870|39036370|FG000|Overall Study|Lost to Follow-up|1|||
16365637|NCT01696968|39821627|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
16442010|NCT04423718|40097713|FG000|Overall Study|Other|6|||
16442011|NCT04423718|40097714|FG001|Overall Study|Other|2|||
16442012|NCT04423718|40097715|FG002|Overall Study|Other|2|||
16150636|NCT03028870|39036371|FG001|Overall Study|Lost to Follow-up|0|||
16150637|NCT03028870|39036372|FG002|Overall Study|Lost to Follow-up|0|||
16150638|NCT03028870|39036373|FG003|Overall Study|Lost to Follow-up|0|||
16150639|NCT03028870|39036370|FG000|Overall Study|Lack of Efficacy|3|||
16150640|NCT03028870|39036371|FG001|Overall Study|Lack of Efficacy|0|||
16150641|NCT03028870|39036372|FG002|Overall Study|Lack of Efficacy|0|||
16150642|NCT03028870|39036373|FG003|Overall Study|Lack of Efficacy|0|||
16150643|NCT03028870|39036370|FG000|Overall Study|Administrative|5|||
16150644|NCT03028870|39036371|FG001|Overall Study|Administrative|5|||
16150645|NCT03028870|39036372|FG002|Overall Study|Administrative|12|||
16150646|NCT03028870|39036373|FG003|Overall Study|Administrative|4|||
16150647|NCT00361270|39036376|FG000|Overall Study|Death|0|||
16150648|NCT00361270|39036377|FG001|Overall Study|Death|0|||
16150649|NCT00361270|39036378|FG002|Overall Study|Death|0|||
16150650|NCT00361270|39036379|FG003|Overall Study|Death|2|||
16150651|NCT00361270|39036376|FG000|Overall Study|Lost to Follow-up|4|||
16150652|NCT00361270|39036377|FG001|Overall Study|Lost to Follow-up|1|||
16150653|NCT00361270|39036378|FG002|Overall Study|Lost to Follow-up|0|||
16150654|NCT00361270|39036379|FG003|Overall Study|Lost to Follow-up|0|||
16150655|NCT00361270|39036376|FG000|Overall Study|Physician Decision|0|||
16150656|NCT00361270|39036377|FG001|Overall Study|Physician Decision|0|||
16150657|NCT00361270|39036378|FG002|Overall Study|Physician Decision|1|||
16150658|NCT00361270|39036379|FG003|Overall Study|Physician Decision|0|||
16150659|NCT00361270|39036376|FG000|Overall Study|Protocol Violation|9|||
16150660|NCT00361270|39036377|FG001|Overall Study|Protocol Violation|4|||
16150661|NCT00361270|39036378|FG002|Overall Study|Protocol Violation|5|||
16150662|NCT00361270|39036379|FG003|Overall Study|Protocol Violation|4|||
16150663|NCT00361270|39036376|FG000|Overall Study|Withdrawal by Subject|6|||
16150664|NCT00361270|39036377|FG001|Overall Study|Withdrawal by Subject|6|||
16150665|NCT00361270|39036378|FG002|Overall Study|Withdrawal by Subject|3|||
16150666|NCT00361270|39036379|FG003|Overall Study|Withdrawal by Subject|7|||
16150667|NCT00361270|39036376|FG000|Overall Study|Afraid of Hypnosis|1|||
16150668|NCT00361270|39036377|FG001|Overall Study|Afraid of Hypnosis|2|||
16150669|NCT00361270|39036378|FG002|Overall Study|Afraid of Hypnosis|0|||
16150670|NCT00361270|39036379|FG003|Overall Study|Afraid of Hypnosis|0|||
16150671|NCT00361270|39036376|FG000|Overall Study|Problems with Transportation|4|||
16150672|NCT00361270|39036377|FG001|Overall Study|Problems with Transportation|0|||
16150673|NCT00361270|39036378|FG002|Overall Study|Problems with Transportation|0|||
16150674|NCT00361270|39036379|FG003|Overall Study|Problems with Transportation|0|||
16150675|NCT00361270|39036376|FG000|Overall Study|Adverse Event|0|||
16442013|NCT04423718|40097713|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
16442014|NCT04423718|40097714|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
16442015|NCT04423718|40097715|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
16442016|NCT02140047|40097716|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16442017|NCT02140047|40097717|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16442018|NCT02140047|40097718|FG002|Overall Study|Withdrawal by parent/guardian|0|||
16442019|NCT04218240|40097719|FG000|Overall Study|Withdrawal by Subject|6|||
16442020|NCT04218240|40097720|FG001|Overall Study|Withdrawal by Subject|0|||
16442021|NCT04218240|40097719|FG000|Overall Study|Lack of Efficacy|24|||
16442022|NCT04218240|40097720|FG001|Overall Study|Lack of Efficacy|19|||
16442023|NCT04218240|40097719|FG000|Overall Study|Physician Decision|0|||
16442024|NCT04218240|40097720|FG001|Overall Study|Physician Decision|1|||
16442025|NCT04218240|40097719|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
16442026|NCT04218240|40097720|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
16442027|NCT04913610|40097721|FG000|Randomized Participants|Did Not Receive Treatment|0|||
16442028|NCT04913610|40097722|FG001|Randomized Participants|Did Not Receive Treatment|0|||
16150676|NCT00361270|39036377|FG001|Overall Study|Adverse Event|1|||
16150677|NCT00361270|39036378|FG002|Overall Study|Adverse Event|1|||
16150678|NCT00361270|39036379|FG003|Overall Study|Adverse Event|0|||
16150679|NCT03803059|39036380|FG000|Overall Study|Protocol Violation|2|||
16150680|NCT03803059|39036380|FG000|Overall Study|Lost to Follow-up|1|||
16150681|NCT00528021|39036384|FG000|Overall Study|Lack of Efficacy|17|||
16442029|NCT04913610|40097723|FG002|Randomized Participants|Did Not Receive Treatment|1|||
16442030|NCT04913610|40097724|FG003|Randomized Participants|Did Not Receive Treatment|1|||
16442031|NCT04913610|40097725|FG004|Randomized Participants|Did Not Receive Treatment|0|||
16442032|NCT04913610|40097721|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
16442033|NCT04913610|40097722|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
16442034|NCT04913610|40097723|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
16442035|NCT04913610|40097724|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
16442036|NCT04913610|40097725|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
16442037|NCT01065454|40097726|FG000|Treatment|Adverse Event|7|||
16442038|NCT01065454|40097727|FG001|Treatment|Adverse Event|4|||
16442039|NCT01065454|40097728|FG002|Treatment|Adverse Event|3|||
16442040|NCT01065454|40097729|FG003|Treatment|Adverse Event|6|||
16442041|NCT01065454|40097726|FG000|Treatment|Death|1|||
16442042|NCT01065454|40097727|FG001|Treatment|Death|0|||
16442043|NCT01065454|40097728|FG002|Treatment|Death|0|||
16442044|NCT01065454|40097729|FG003|Treatment|Death|0|||
16442045|NCT01065454|40097726|FG000|Treatment|Non-compliance|1|||
16442046|NCT01065454|40097727|FG001|Treatment|Non-compliance|0|||
16442047|NCT01065454|40097728|FG002|Treatment|Non-compliance|0|||
16442048|NCT01065454|40097729|FG003|Treatment|Non-compliance|1|||
16442049|NCT01065454|40097726|FG000|Treatment|Protocol Decision|0|||
16442050|NCT01065454|40097727|FG001|Treatment|Protocol Decision|0|||
16442051|NCT01065454|40097728|FG002|Treatment|Protocol Decision|3|||
16442052|NCT01065454|40097729|FG003|Treatment|Protocol Decision|2|||
16442053|NCT01065454|40097726|FG000|Treatment|Protocol Violation|1|||
16442054|NCT01065454|40097727|FG001|Treatment|Protocol Violation|0|||
16442055|NCT01065454|40097728|FG002|Treatment|Protocol Violation|1|||
16442056|NCT01065454|40097729|FG003|Treatment|Protocol Violation|0|||
16442057|NCT01065454|40097726|FG000|Treatment|Withdrawal by Subject|3|||
16442058|NCT01065454|40097727|FG001|Treatment|Withdrawal by Subject|1|||
16442059|NCT01065454|40097728|FG002|Treatment|Withdrawal by Subject|2|||
16442060|NCT01065454|40097729|FG003|Treatment|Withdrawal by Subject|3|||
16442061|NCT01065454|40097726|FG000|Follow up|Adverse Event|1|||
16442062|NCT01065454|40097727|FG001|Follow up|Adverse Event|0|||
16442063|NCT01065454|40097728|FG002|Follow up|Adverse Event|0|||
16442064|NCT01065454|40097729|FG003|Follow up|Adverse Event|1|||
16442065|NCT01065454|40097726|FG000|Follow up|Death|0|||
16442066|NCT01065454|40097727|FG001|Follow up|Death|1|||
16442067|NCT01065454|40097728|FG002|Follow up|Death|1|||
16442068|NCT01065454|40097729|FG003|Follow up|Death|0|||
16150682|NCT00528021|39036385|FG001|Overall Study|Lack of Efficacy|13|||
16150683|NCT00528021|39036386|FG002|Overall Study|Lack of Efficacy|7|||
16150684|NCT00528021|39036387|FG003|Overall Study|Lack of Efficacy|9|||
16150685|NCT03719690|39036388|FG000|Overall Study|Withdrawal by Subject|5|||
16150686|NCT03719690|39036389|FG001|Overall Study|Withdrawal by Subject|10|||
16150687|NCT03719690|39036388|FG000|Overall Study|Death|40|||
16150688|NCT03719690|39036389|FG001|Overall Study|Death|149|||
16150689|NCT03719690|39036388|FG000|Overall Study|Miscellaneous|12|||
16150690|NCT03719690|39036389|FG001|Overall Study|Miscellaneous|56|||
16442069|NCT01065454|40097726|FG000|Follow up|Lost to Follow-up|0|||
16442070|NCT01065454|40097727|FG001|Follow up|Lost to Follow-up|0|||
16442071|NCT01065454|40097728|FG002|Follow up|Lost to Follow-up|0|||
16442072|NCT01065454|40097729|FG003|Follow up|Lost to Follow-up|1|||
16442073|NCT01065454|40097726|FG000|Follow up|Progressive disease|0|||
16442074|NCT01065454|40097727|FG001|Follow up|Progressive disease|0|||
16442075|NCT01065454|40097728|FG002|Follow up|Progressive disease|0|||
16442076|NCT01065454|40097729|FG003|Follow up|Progressive disease|1|||
16442077|NCT01065454|40097726|FG000|Follow up|Withdrawal by Subject|1|||
16442078|NCT01065454|40097727|FG001|Follow up|Withdrawal by Subject|1|||
16150691|NCT03719690|39036388|FG000|Overall Study|Lost to Follow-up|2|||
16150692|NCT03719690|39036389|FG001|Overall Study|Lost to Follow-up|18|||
16150693|NCT03719690|39036388|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
16150694|NCT03719690|39036389|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
16150695|NCT00993265|39036393|FG000|Overall Study|Adverse Event|1|||
16150696|NCT00993265|39036394|FG001|Overall Study|Adverse Event|0|||
16442079|NCT01065454|40097728|FG002|Follow up|Withdrawal by Subject|1|||
16442080|NCT01065454|40097729|FG003|Follow up|Withdrawal by Subject|0|||
16442081|NCT01065454|40097726|FG000|Follow up|study ongoing|37|||
16442082|NCT01065454|40097727|FG001|Follow up|study ongoing|22|||
16442083|NCT01065454|40097728|FG002|Follow up|study ongoing|15|||
16442084|NCT01065454|40097729|FG003|Follow up|study ongoing|41|||
16150697|NCT00993265|39036393|FG000|Overall Study|Changed dose of concomitant drug|2|||
16442085|NCT01134614|40097731|FG000|Overall Study|Still on treatment as of March 2013|21|||
16442086|NCT01134614|40097732|FG001|Overall Study|Still on treatment as of March 2013|13|||
16442087|NCT01134614|40097731|FG000|Overall Study|Progressive disease|60|||
16442088|NCT01134614|40097732|FG001|Overall Study|Progressive disease|54|||
16442089|NCT01134614|40097731|FG000|Overall Study|Adverse Event|26|||
16442090|NCT01134614|40097732|FG001|Overall Study|Adverse Event|39|||
16442091|NCT01134614|40097731|FG000|Overall Study|Death|5|||
16442092|NCT01134614|40097732|FG001|Overall Study|Death|8|||
16442093|NCT01134614|40097731|FG000|Overall Study|Withdrawal by Subject|3|||
16442094|NCT01134614|40097732|FG001|Overall Study|Withdrawal by Subject|2|||
16442095|NCT01134614|40097731|FG000|Overall Study|Alternative therapy|2|||
16442096|NCT01134614|40097732|FG001|Overall Study|Alternative therapy|0|||
16442097|NCT01134614|40097731|FG000|Overall Study|Complicating disease|2|||
16442098|NCT01134614|40097732|FG001|Overall Study|Complicating disease|1|||
16442099|NCT01134614|40097731|FG000|Overall Study|Physician's decision|0|||
16442100|NCT01134614|40097732|FG001|Overall Study|Physician's decision|1|||
16442101|NCT01134614|40097731|FG000|Overall Study|Never started treatment|4|||
16442102|NCT01134614|40097732|FG001|Overall Study|Never started treatment|1|||
16442103|NCT01134614|40097731|FG000|Overall Study|Pt received tx not allowed on study|0|||
16442104|NCT01134614|40097732|FG001|Overall Study|Pt received tx not allowed on study|1|||
16442105|NCT01134614|40097731|FG000|Overall Study|Symptomatic deterioration|0|||
16442106|NCT01134614|40097732|FG001|Overall Study|Symptomatic deterioration|1|||
16442107|NCT01134614|40097731|FG000|Overall Study|Patient in hospice care|0|||
16442108|NCT01134614|40097732|FG001|Overall Study|Patient in hospice care|1|||
16442109|NCT01772472|40099738|FG000|Overall Study|Death|56|||
16442110|NCT01772472|40099739|FG001|Overall Study|Death|42|||
16442111|NCT01772472|40099738|FG000|Overall Study|Physician Decision|1|||
16442112|NCT01772472|40099739|FG001|Overall Study|Physician Decision|3|||
16442113|NCT01772472|40099738|FG000|Overall Study|Other|5|||
16442114|NCT01772472|40099739|FG001|Overall Study|Other|5|||
16442115|NCT01772472|40099738|FG000|Overall Study|Lost to Follow-up|12|||
16442116|NCT01772472|40099739|FG001|Overall Study|Lost to Follow-up|8|||
16442117|NCT01772472|40099738|FG000|Overall Study|Withdrawal by Subject|72|||
16442118|NCT01772472|40099739|FG001|Overall Study|Withdrawal by Subject|50|||
16150698|NCT00993265|39036394|FG001|Overall Study|Changed dose of concomitant drug|0|||
16150699|NCT00993265|39036393|FG000|Overall Study|Non-compliant with study medication|1|||
16150700|NCT00993265|39036394|FG001|Overall Study|Non-compliant with study medication|0|||
16150701|NCT03680911|39036395|FG000|At Home Treatment|Study Termination|3|||
16150702|NCT03680911|39036396|FG001|At Home Treatment|Study Termination|0|||
16150703|NCT03680911|39036395|FG000|At Home Treatment|Lost to Follow-up|0|||
16150704|NCT03680911|39036396|FG001|At Home Treatment|Lost to Follow-up|1|||
16150705|NCT03680911|39036395|FG000|At Home Treatment|Withdrawal by Subject|0|||
16150706|NCT03680911|39036396|FG001|At Home Treatment|Withdrawal by Subject|2|||
16150707|NCT03680911|39036395|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
16150708|NCT03680911|39036396|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
16150709|NCT01205230|39036398|FG000|Overall Study|Adverse Event|4|||
16150710|NCT01205230|39036399|FG001|Overall Study|Adverse Event|0|||
16150711|NCT01205230|39036398|FG000|Overall Study|Physician Decision|1|||
16150712|NCT01205230|39036399|FG001|Overall Study|Physician Decision|0|||
16150713|NCT01438489|39036404|FG000|Overall Study|Lost to Follow-up|4|||
16150714|NCT01438489|39036405|FG001|Overall Study|Lost to Follow-up|2|||
16150715|NCT01438489|39036406|FG002|Overall Study|Lost to Follow-up|2|||
16150716|NCT01438489|39036404|FG000|Overall Study|Withdrawal by Subject|11|||
16150717|NCT01438489|39036405|FG001|Overall Study|Withdrawal by Subject|3|||
16150718|NCT01438489|39036406|FG002|Overall Study|Withdrawal by Subject|8|||
16150719|NCT01438489|39036404|FG000|Overall Study|Death|0|||
16150720|NCT01438489|39036405|FG001|Overall Study|Death|0|||
16150721|NCT01438489|39036406|FG002|Overall Study|Death|1|||
16150722|NCT01438489|39036404|FG000|Overall Study|Sponsor decision|4|||
16150723|NCT01438489|39036405|FG001|Overall Study|Sponsor decision|1|||
16150724|NCT01438489|39036406|FG002|Overall Study|Sponsor decision|4|||
16150725|NCT01438489|39036404|FG000|Overall Study|Subject choice/Subject moved|2|||
16150726|NCT01438489|39036405|FG001|Overall Study|Subject choice/Subject moved|1|||
16150727|NCT01438489|39036406|FG002|Overall Study|Subject choice/Subject moved|1|||
16150728|NCT01438489|39036404|FG000|Overall Study|Investigator decision|0|||
16150729|NCT01438489|39036405|FG001|Overall Study|Investigator decision|1|||
16150730|NCT01438489|39036406|FG002|Overall Study|Investigator decision|0|||
16150731|NCT01438489|39036404|FG000|Overall Study|AE/SAEs|2|||
16150732|NCT01438489|39036405|FG001|Overall Study|AE/SAEs|1|||
16150733|NCT01438489|39036406|FG002|Overall Study|AE/SAEs|1|||
16150734|NCT01438489|39036404|FG000|Overall Study|Received prohibited medication|1|||
16150735|NCT01438489|39036405|FG001|Overall Study|Received prohibited medication|0|||
16150736|NCT01438489|39036406|FG002|Overall Study|Received prohibited medication|0|||
16150737|NCT01438489|39036404|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
16260861|NCT02481830|39439727|FG001|Treatment|Death|1|||
16260862|NCT02481830|39439726|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
16150738|NCT01438489|39036405|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
16150739|NCT01438489|39036406|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
16150740|NCT01438489|39036404|FG000|Overall Study|Inadequate venous access|0|||
16150741|NCT01438489|39036405|FG001|Overall Study|Inadequate venous access|2|||
16150742|NCT01438489|39036406|FG002|Overall Study|Inadequate venous access|0|||
16442119|NCT01772472|40099738|FG000|Overall Study|Ongoing|597|||
16442120|NCT01772472|40099739|FG001|Overall Study|Ongoing|635|||
16442121|NCT05635461|40099740|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
16442122|NCT05635461|40099741|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
16442123|NCT05635461|40099742|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
16442124|NCT05635461|40099743|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
16442125|NCT05635461|40099744|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
16442126|NCT05635461|40099745|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
16442127|NCT05635461|40099740|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
16442128|NCT05635461|40099741|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
16442129|NCT05635461|40099742|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
16442130|NCT05635461|40099743|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
16442131|NCT05635461|40099744|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
16442132|NCT05635461|40099745|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
16442133|NCT05635461|40099740|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
16442134|NCT05635461|40099741|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
16442135|NCT05635461|40099742|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
16442136|NCT05635461|40099743|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
16442137|NCT05635461|40099744|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
16442138|NCT05635461|40099745|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
16442139|NCT04739982|40099748|FG000|Overall Study|Lost to Follow-up|176|||
16442140|NCT04739982|40099749|FG001|Overall Study|Lost to Follow-up|65|||
16442141|NCT04739982|40099748|FG000|Overall Study|Withdrawal by Subject|19|||
16442142|NCT04739982|40099749|FG001|Overall Study|Withdrawal by Subject|0|||
16442143|NCT04739982|40099748|FG000|Overall Study|Protocol Violation|0|||
16442144|NCT04739982|40099749|FG001|Overall Study|Protocol Violation|5|||
16442145|NCT03904693|40099756|FG000|Overall Study|Death|0|||
16442146|NCT03904693|40099757|FG001|Overall Study|Death|0|||
16442147|NCT03904693|40099758|FG002|Overall Study|Death|3|||
16442148|NCT03904693|40099756|FG000|Overall Study|Physician Decision|0|||
16442149|NCT03904693|40099757|FG001|Overall Study|Physician Decision|0|||
16442150|NCT03904693|40099758|FG002|Overall Study|Physician Decision|2|||
16442151|NCT03904693|40099756|FG000|Overall Study|Withdrawal by Subject|0|||
16442152|NCT03904693|40099757|FG001|Overall Study|Withdrawal by Subject|1|||
16442153|NCT03904693|40099758|FG002|Overall Study|Withdrawal by Subject|4|||
16442154|NCT04914364|40099759|FG000|Overall Study|No longer eligible for study|1|||
16442155|NCT04914364|40099759|FG000|Overall Study|Lost to Follow-up|2|||
16442156|NCT02358473|40099760|FG000|Overall Study|Disease Progession|6|||
16442157|NCT02358473|40099760|FG000|Overall Study|Adverse Event|3|||
16442158|NCT02358473|40099760|FG000|Overall Study|Withdrawal by Subject|2|||
16442159|NCT02358473|40099760|FG000|Overall Study|Physician Decision|2|||
16442160|NCT04109547|40099763|FG000|Overall Study|Withdrawal by Subject|3|||
16442161|NCT04109547|40099764|FG001|Overall Study|Withdrawal by Subject|2|||
16442162|NCT04109547|40099765|FG002|Overall Study|Withdrawal by Subject|6|||
16442163|NCT04109547|40099766|FG003|Overall Study|Withdrawal by Subject|6|||
16442164|NCT04109547|40099763|FG000|Overall Study|Lost to Follow-up|0|||
16442165|NCT04109547|40099764|FG001|Overall Study|Lost to Follow-up|0|||
16442166|NCT04109547|40099765|FG002|Overall Study|Lost to Follow-up|0|||
16442167|NCT04109547|40099766|FG003|Overall Study|Lost to Follow-up|1|||
16442168|NCT04109547|40099763|FG000|Overall Study|Physician Decision|1|||
16442169|NCT04109547|40099764|FG001|Overall Study|Physician Decision|2|||
16442170|NCT04109547|40099765|FG002|Overall Study|Physician Decision|0|||
16150743|NCT00631020|39036408|FG000|Overall Study|Lost to Follow-up|7|||
16150744|NCT00631020|39036408|FG000|Overall Study|Incarcerated|1|||
16150745|NCT02664272|39036411|FG000|Overall Study|Fluoroscopic images not made available|2|||
16150746|NCT01394627|39036412|FG000|First Intervention (1 Day)|poor intravenous access|0|||
16150747|NCT01394627|39036413|FG001|First Intervention (1 Day)|poor intravenous access|1|||
16150748|NCT01394627|39036412|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
16150749|NCT01394627|39036413|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
16150750|NCT02687542|39036414|FG000|Overall Study|Medication error without associated AEs|0|||
16442171|NCT04109547|40099766|FG003|Overall Study|Physician Decision|0|||
16442172|NCT03777982|40099767|FG000|Overall Study|Physician Decision|0|||
16442173|NCT03777982|40099768|FG001|Overall Study|Physician Decision|1|||
16442174|NCT03995368|40099770|FG000|Overall Study|Lost to Follow-up|1|||
16442175|NCT03995368|40099771|FG001|Overall Study|Lost to Follow-up|4|||
16442176|NCT03995368|40099772|FG002|Overall Study|Lost to Follow-up|1|||
16442177|NCT03995368|40099770|FG000|Overall Study|Did not meet inclusion criteria|1|||
16442178|NCT03995368|40099771|FG001|Overall Study|Did not meet inclusion criteria|6|||
16442179|NCT03995368|40099772|FG002|Overall Study|Did not meet inclusion criteria|3|||
16442180|NCT03995368|40099770|FG000|Overall Study|Withdrawal by Subject|0|||
16442181|NCT03995368|40099771|FG001|Overall Study|Withdrawal by Subject|1|||
16442182|NCT03995368|40099772|FG002|Overall Study|Withdrawal by Subject|1|||
16442183|NCT04949191|40099773|FG000|Overall Study|Non-compliance with Study Drug|1|||
16150751|NCT02687542|39036415|FG001|Overall Study|Medication error without associated AEs|0|||
16150752|NCT02687542|39036416|FG002|Overall Study|Medication error without associated AEs|0|||
16150753|NCT02687542|39036417|FG003|Overall Study|Medication error without associated AEs|0|||
16150754|NCT02687542|39036418|FG004|Overall Study|Medication error without associated AEs|1|||
16150755|NCT02687542|39036414|FG000|Overall Study|Lost to Follow-up|0|||
16150756|NCT02687542|39036415|FG001|Overall Study|Lost to Follow-up|0|||
16150757|NCT02687542|39036416|FG002|Overall Study|Lost to Follow-up|0|||
16150758|NCT02687542|39036417|FG003|Overall Study|Lost to Follow-up|0|||
16150759|NCT02687542|39036418|FG004|Overall Study|Lost to Follow-up|1|||
16150760|NCT02687542|39036414|FG000|Overall Study|Protocol Violation|0|||
16150761|NCT02687542|39036415|FG001|Overall Study|Protocol Violation|1|||
16150762|NCT02687542|39036416|FG002|Overall Study|Protocol Violation|0|||
16150763|NCT02687542|39036417|FG003|Overall Study|Protocol Violation|0|||
16150764|NCT02687542|39036418|FG004|Overall Study|Protocol Violation|0|||
16260863|NCT02481830|39439727|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
16260864|NCT02481830|39439726|FG000|Treatment|Participants request to discontinue Study treatment|6|||
16442184|NCT04949191|40099774|FG001|Overall Study|Non-compliance with Study Drug|0|||
16150765|NCT02687542|39036414|FG000|Overall Study|Other|5|||
16150766|NCT02687542|39036415|FG001|Overall Study|Other|9|||
16150767|NCT02687542|39036416|FG002|Overall Study|Other|10|||
16150768|NCT02687542|39036417|FG003|Overall Study|Other|6|||
16442185|NCT04949191|40099775|FG002|Overall Study|Non-compliance with Study Drug|0|||
16260865|NCT02481830|39439727|FG001|Treatment|Participants request to discontinue Study treatment|34|||
16260866|NCT02481830|39439726|FG000|Treatment|Withdrawal by Subject|2|||
16150769|NCT02687542|39036418|FG004|Overall Study|Other|5|||
16150770|NCT02687542|39036414|FG000|Overall Study|Adverse Event|3|||
16150771|NCT02687542|39036415|FG001|Overall Study|Adverse Event|1|||
16150772|NCT02687542|39036416|FG002|Overall Study|Adverse Event|3|||
16150773|NCT02687542|39036417|FG003|Overall Study|Adverse Event|2|||
16150774|NCT02687542|39036418|FG004|Overall Study|Adverse Event|9|||
16150775|NCT02687542|39036414|FG000|Overall Study|Withdrawal by Subject|0|||
16150776|NCT02687542|39036415|FG001|Overall Study|Withdrawal by Subject|1|||
16150777|NCT02687542|39036416|FG002|Overall Study|Withdrawal by Subject|1|||
16150778|NCT02687542|39036417|FG003|Overall Study|Withdrawal by Subject|2|||
16150779|NCT02687542|39036418|FG004|Overall Study|Withdrawal by Subject|4|||
16150780|NCT01014689|39036419|FG000|Overall Study|Lack of Efficacy|0|||
16150781|NCT01014689|39036420|FG001|Overall Study|Lack of Efficacy|1|||
16150782|NCT01014689|39036419|FG000|Overall Study|Adverse Event|3|||
16150783|NCT01014689|39036420|FG001|Overall Study|Adverse Event|0|||
16150784|NCT01014689|39036419|FG000|Overall Study|Withdrawal by Subject|5|||
16150785|NCT01014689|39036420|FG001|Overall Study|Withdrawal by Subject|4|||
16150786|NCT01014689|39036419|FG000|Overall Study|Protocol Violation|1|||
16150787|NCT01014689|39036420|FG001|Overall Study|Protocol Violation|1|||
16150788|NCT01014689|39036419|FG000|Overall Study|Lost to Follow-up|3|||
16150789|NCT01014689|39036420|FG001|Overall Study|Lost to Follow-up|7|||
16150790|NCT01014689|39036419|FG000|Overall Study|Pregnancy|1|||
16150791|NCT01014689|39036420|FG001|Overall Study|Pregnancy|0|||
16150792|NCT00889265|39036426|FG000|Overall Study|Adverse Event|1|||
16150793|NCT00889265|39036426|FG000|Overall Study|Lost to Follow-up|5|||
16150794|NCT00889265|39036426|FG000|Overall Study|Protocol Violation|1|||
16150795|NCT04712110|39040179|FG000|Overall Study|Lost to Follow-up|0|||
16150796|NCT04712110|39040180|FG001|Overall Study|Lost to Follow-up|1|||
16150797|NCT04712110|39040179|FG000|Overall Study|Withdrawal by Subject|0|||
16150798|NCT04712110|39040180|FG001|Overall Study|Withdrawal by Subject|4|||
16150799|NCT04712110|39040179|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
16150800|NCT04712110|39040180|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
16150801|NCT00845650|39040185|FG000|Overall Study|Withdrawal by Subject|0|||
16150802|NCT00845650|39040186|FG001|Overall Study|Withdrawal by Subject|0|||
16150803|NCT00845650|39040187|FG002|Overall Study|Withdrawal by Subject|0|||
16150804|NCT00845650|39040188|FG003|Overall Study|Withdrawal by Subject|0|||
16150805|NCT00845650|39040189|FG004|Overall Study|Withdrawal by Subject|2|||
16260867|NCT02481830|39439727|FG001|Treatment|Withdrawal by Subject|3|||
16260868|NCT02481830|39439726|FG000|Treatment|Lost to Follow-up|1|||
16260869|NCT02481830|39439727|FG001|Treatment|Lost to Follow-up|0|||
16260870|NCT02481830|39439726|FG000|Treatment|Maximum Clinical Benefit|0|||
16260871|NCT02481830|39439727|FG001|Treatment|Maximum Clinical Benefit|5|||
16260872|NCT02481830|39439726|FG000|Treatment|Administrative reason by sponsor|1|||
16260873|NCT02481830|39439727|FG001|Treatment|Administrative reason by sponsor|1|||
16260874|NCT02481830|39439726|FG000|Treatment|Other reasons|6|||
16260875|NCT02481830|39439727|FG001|Treatment|Other reasons|1|||
16260876|NCT03991494|39439728|FG000|Overall Study|Progressive Disease|4|||
16260877|NCT00863746|39439729|FG000|Treatment|Not treated|4|||
16260878|NCT00863746|39439730|FG001|Treatment|Not treated|2|||
16260879|NCT00863746|39439729|FG000|Treatment|Adverse Event|41|||
16260880|NCT00863746|39439730|FG001|Treatment|Adverse Event|16|||
16260881|NCT00863746|39439729|FG000|Treatment|non-compliant with study medication|4|||
16260882|NCT00863746|39439730|FG001|Treatment|non-compliant with study medication|0|||
16260883|NCT00863746|39439729|FG000|Treatment|Consent withdrawn|15|||
16260884|NCT00863746|39439730|FG001|Treatment|Consent withdrawn|14|||
16260885|NCT00863746|39439729|FG000|Treatment|Lost to Follow-up|1|||
16442186|NCT04949191|40099776|FG003|Overall Study|Non-compliance with Study Drug|0|||
16260886|NCT00863746|39439730|FG001|Treatment|Lost to Follow-up|0|||
16442187|NCT04949191|40099773|FG000|Overall Study|Progressive Disease|0|||
16442188|NCT04949191|40099774|FG001|Overall Study|Progressive Disease|1|||
16442189|NCT04949191|40099775|FG002|Overall Study|Progressive Disease|0|||
16442190|NCT04949191|40099776|FG003|Overall Study|Progressive Disease|0|||
16260887|NCT00863746|39439729|FG000|Treatment|Protocol Violation|5|||
16260888|NCT00863746|39439730|FG001|Treatment|Protocol Violation|3|||
16260889|NCT00863746|39439729|FG000|Treatment|Other|1|||
16260890|NCT00863746|39439730|FG001|Treatment|Other|0|||
16260891|NCT00863746|39439729|FG000|Survival Follow up|Death|244|||
16260892|NCT00863746|39439730|FG001|Survival Follow up|Death|271|||
16260893|NCT00863746|39439729|FG000|Survival Follow up|Lost to Follow-up|2|||
16260894|NCT00863746|39439730|FG001|Survival Follow up|Lost to Follow-up|1|||
16260895|NCT00863746|39439729|FG000|Survival Follow up|Consent Withdrawn|7|||
16260896|NCT00863746|39439730|FG001|Survival Follow up|Consent Withdrawn|8|||
16260897|NCT01079988|39439731|FG000|Overall Study|Lost to Follow-up|0|||
16260898|NCT01079988|39439732|FG001|Overall Study|Lost to Follow-up|0|||
16260899|NCT01079988|39439733|FG002|Overall Study|Lost to Follow-up|0|||
16260900|NCT01079988|39439734|FG003|Overall Study|Lost to Follow-up|1|||
16260901|NCT01079988|39439735|FG004|Overall Study|Lost to Follow-up|0|||
16260902|NCT01079988|39439731|FG000|Overall Study|Lack of Efficacy|1|||
16260903|NCT01079988|39439732|FG001|Overall Study|Lack of Efficacy|0|||
16260904|NCT01079988|39439733|FG002|Overall Study|Lack of Efficacy|0|||
16260905|NCT01079988|39439734|FG003|Overall Study|Lack of Efficacy|0|||
16260906|NCT01079988|39439735|FG004|Overall Study|Lack of Efficacy|0|||
16260907|NCT01079988|39439731|FG000|Overall Study|Other|0|||
16260908|NCT01079988|39439732|FG001|Overall Study|Other|0|||
16442191|NCT04949191|40099773|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
16442192|NCT04949191|40099774|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
16442193|NCT04949191|40099775|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
16442194|NCT04949191|40099776|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
16260909|NCT01079988|39439733|FG002|Overall Study|Other|0|||
16260910|NCT01079988|39439734|FG003|Overall Study|Other|2|||
16260911|NCT01079988|39439735|FG004|Overall Study|Other|1|||
16260912|NCT04088760|39439736|FG000|Overall Study|Physician Decision|1|||
16260913|NCT00296647|39439737|FG000|Overall Study|Death|4|||
16260914|NCT00296647|39439738|FG001|Overall Study|Death|1|||
16260915|NCT00296647|39439739|FG002|Overall Study|Death|2|||
16260916|NCT00296647|39439740|FG003|Overall Study|Death|1|||
16260917|NCT00296647|39439741|FG004|Overall Study|Death|1|||
16260918|NCT00296647|39439737|FG000|Overall Study|Withdrawal by Subject|28|||
16260919|NCT00296647|39439738|FG001|Overall Study|Withdrawal by Subject|27|||
16260920|NCT00296647|39439739|FG002|Overall Study|Withdrawal by Subject|32|||
16260921|NCT00296647|39439740|FG003|Overall Study|Withdrawal by Subject|16|||
16260922|NCT00296647|39439741|FG004|Overall Study|Withdrawal by Subject|19|||
16260923|NCT02089685|39439747|FG000|Overall Study|Adverse Event|1|||
16260924|NCT02089685|39439748|FG001|Overall Study|Adverse Event|0|||
16442195|NCT04949191|40099773|FG000|Overall Study|Sponsor Terminated Study|0|||
16260925|NCT02089685|39439749|FG002|Overall Study|Adverse Event|0|||
16260926|NCT02089685|39439750|FG003|Overall Study|Adverse Event|0|||
16260927|NCT02089685|39439751|FG004|Overall Study|Adverse Event|1|||
16260928|NCT02089685|39439752|FG005|Overall Study|Adverse Event|0|||
16260929|NCT02089685|39439747|FG000|Overall Study|Clinical Progression|4|||
16260930|NCT02089685|39439748|FG001|Overall Study|Clinical Progression|0|||
16260931|NCT02089685|39439749|FG002|Overall Study|Clinical Progression|0|||
16260932|NCT02089685|39439750|FG003|Overall Study|Clinical Progression|5|||
16260933|NCT02089685|39439751|FG004|Overall Study|Clinical Progression|1|||
16260934|NCT02089685|39439752|FG005|Overall Study|Clinical Progression|2|||
16260935|NCT02089685|39439747|FG000|Overall Study|Excluded Medication|1|||
16260936|NCT02089685|39439748|FG001|Overall Study|Excluded Medication|0|||
16260937|NCT02089685|39439749|FG002|Overall Study|Excluded Medication|0|||
16260938|NCT02089685|39439750|FG003|Overall Study|Excluded Medication|11|||
16260939|NCT02089685|39439751|FG004|Overall Study|Excluded Medication|2|||
16260940|NCT02089685|39439752|FG005|Overall Study|Excluded Medication|1|||
16260941|NCT02089685|39439747|FG000|Overall Study|Progressive disease|13|||
16260942|NCT02089685|39439748|FG001|Overall Study|Progressive disease|10|||
16260943|NCT02089685|39439749|FG002|Overall Study|Progressive disease|3|||
16260944|NCT02089685|39439750|FG003|Overall Study|Progressive disease|51|||
16260945|NCT02089685|39439751|FG004|Overall Study|Progressive disease|17|||
16260946|NCT02089685|39439752|FG005|Overall Study|Progressive disease|12|||
16260947|NCT02089685|39439747|FG000|Overall Study|Follow up ended by sponsor|2|||
16260948|NCT02089685|39439748|FG001|Overall Study|Follow up ended by sponsor|2|||
16260949|NCT02089685|39439749|FG002|Overall Study|Follow up ended by sponsor|0|||
16260950|NCT02089685|39439750|FG003|Overall Study|Follow up ended by sponsor|70|||
16260951|NCT02089685|39439751|FG004|Overall Study|Follow up ended by sponsor|26|||
16260952|NCT02089685|39439752|FG005|Overall Study|Follow up ended by sponsor|26|||
16260953|NCT02089685|39439747|FG000|Overall Study|Withdrawal by Subject|0|||
16260954|NCT02089685|39439748|FG001|Overall Study|Withdrawal by Subject|2|||
16260955|NCT02089685|39439749|FG002|Overall Study|Withdrawal by Subject|0|||
16260956|NCT02089685|39439750|FG003|Overall Study|Withdrawal by Subject|8|||
16260957|NCT02089685|39439751|FG004|Overall Study|Withdrawal by Subject|1|||
16260958|NCT02089685|39439752|FG005|Overall Study|Withdrawal by Subject|1|||
16260959|NCT02089685|39439747|FG000|Overall Study|Status not recorded|1|||
16260960|NCT02089685|39439748|FG001|Overall Study|Status not recorded|0|||
16260961|NCT02089685|39439749|FG002|Overall Study|Status not recorded|0|||
16150806|NCT00845650|39040190|FG005|Overall Study|Withdrawal by Subject|0|||
16260962|NCT02089685|39439750|FG003|Overall Study|Status not recorded|0|||
16260963|NCT02089685|39439751|FG004|Overall Study|Status not recorded|1|||
16260964|NCT02089685|39439752|FG005|Overall Study|Status not recorded|0|||
16260965|NCT02089685|39439747|FG000|Overall Study|Death|0|||
16260966|NCT02089685|39439748|FG001|Overall Study|Death|0|||
16260967|NCT02089685|39439749|FG002|Overall Study|Death|0|||
16260968|NCT02089685|39439750|FG003|Overall Study|Death|7|||
16260969|NCT02089685|39439751|FG004|Overall Study|Death|2|||
16260970|NCT02089685|39439752|FG005|Overall Study|Death|5|||
16260971|NCT02089685|39439747|FG000|Overall Study|Lost to Follow-up|0|||
16260972|NCT02089685|39439748|FG001|Overall Study|Lost to Follow-up|0|||
16260973|NCT02089685|39439749|FG002|Overall Study|Lost to Follow-up|0|||
16260974|NCT02089685|39439750|FG003|Overall Study|Lost to Follow-up|1|||
16260975|NCT02089685|39439751|FG004|Overall Study|Lost to Follow-up|0|||
16260976|NCT02089685|39439752|FG005|Overall Study|Lost to Follow-up|0|||
16260977|NCT02089685|39439747|FG000|Overall Study|Physician Decision|0|||
16260978|NCT02089685|39439748|FG001|Overall Study|Physician Decision|0|||
16260979|NCT02089685|39439749|FG002|Overall Study|Physician Decision|0|||
16260980|NCT02089685|39439750|FG003|Overall Study|Physician Decision|0|||
16260981|NCT02089685|39439751|FG004|Overall Study|Physician Decision|0|||
16260982|NCT02089685|39439752|FG005|Overall Study|Physician Decision|4|||
16260983|NCT02089685|39439747|FG000|Overall Study|Screen failure|1|||
16260984|NCT02089685|39439748|FG001|Overall Study|Screen failure|0|||
16260985|NCT02089685|39439749|FG002|Overall Study|Screen failure|0|||
16260986|NCT02089685|39439750|FG003|Overall Study|Screen failure|0|||
16260987|NCT02089685|39439751|FG004|Overall Study|Screen failure|0|||
16260988|NCT02089685|39439752|FG005|Overall Study|Screen failure|0|||
16260989|NCT00520130|39439756|FG000|Overall Study|Disease progression on study|4|||
16260990|NCT00520130|39439757|FG001|Overall Study|Disease progression on study|0|||
16260991|NCT00520130|39439756|FG000|Overall Study|Physician Decision|1|||
16260992|NCT00520130|39439757|FG001|Overall Study|Physician Decision|1|||
16260993|NCT02682602|39439760|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
16260994|NCT02682602|39439761|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
16442196|NCT04949191|40099774|FG001|Overall Study|Sponsor Terminated Study|0|||
16150807|NCT00845650|39040185|FG000|Overall Study|Lost to Follow-up|0|||
16150808|NCT00845650|39040186|FG001|Overall Study|Lost to Follow-up|0|||
16442197|NCT04949191|40099775|FG002|Overall Study|Sponsor Terminated Study|1|||
16442198|NCT04949191|40099776|FG003|Overall Study|Sponsor Terminated Study|1|||
16442199|NCT05169710|40099787|FG000|Overall Study|Adverse Event|1|||
16442200|NCT05169710|40099788|FG001|Overall Study|Adverse Event|2|||
16442201|NCT05169710|40099789|FG002|Overall Study|Adverse Event|2|||
16442202|NCT05169710|40099787|FG000|Overall Study|Lost to Follow-up|0|||
16442203|NCT05169710|40099788|FG001|Overall Study|Lost to Follow-up|0|||
16442204|NCT05169710|40099789|FG002|Overall Study|Lost to Follow-up|1|||
16442205|NCT05169710|40099787|FG000|Overall Study|Withdrawal by Subject|2|||
16442206|NCT05169710|40099788|FG001|Overall Study|Withdrawal by Subject|1|||
16442207|NCT05169710|40099789|FG002|Overall Study|Withdrawal by Subject|0|||
16150809|NCT00845650|39040187|FG002|Overall Study|Lost to Follow-up|3|||
16150810|NCT00845650|39040188|FG003|Overall Study|Lost to Follow-up|1|||
16150811|NCT00845650|39040189|FG004|Overall Study|Lost to Follow-up|0|||
16150812|NCT00845650|39040190|FG005|Overall Study|Lost to Follow-up|1|||
16150813|NCT00845650|39040185|FG000|Overall Study|Sponsor hold on dosing|0|||
16150814|NCT00845650|39040186|FG001|Overall Study|Sponsor hold on dosing|0|||
16150815|NCT00845650|39040187|FG002|Overall Study|Sponsor hold on dosing|0|||
16150816|NCT00845650|39040188|FG003|Overall Study|Sponsor hold on dosing|0|||
16150817|NCT00845650|39040189|FG004|Overall Study|Sponsor hold on dosing|1|||
16150818|NCT00845650|39040190|FG005|Overall Study|Sponsor hold on dosing|1|||
16150819|NCT00845650|39040185|FG000|Overall Study|Unable to access IV line|1|||
16150820|NCT00845650|39040186|FG001|Overall Study|Unable to access IV line|0|||
16150821|NCT00845650|39040187|FG002|Overall Study|Unable to access IV line|0|||
16150822|NCT00845650|39040188|FG003|Overall Study|Unable to access IV line|0|||
16150823|NCT00845650|39040189|FG004|Overall Study|Unable to access IV line|0|||
16150824|NCT00845650|39040190|FG005|Overall Study|Unable to access IV line|0|||
16150825|NCT02969187|39040191|FG000|Overall Study|Physician Decision|12|||
16150826|NCT02969187|39040192|FG001|Overall Study|Physician Decision|13|||
16150827|NCT01227902|39040196|FG000|Overall Study|Adverse Event|12|||
16150828|NCT01227902|39040197|FG001|Overall Study|Adverse Event|8|||
16150829|NCT01227902|39040198|FG002|Overall Study|Adverse Event|11|||
16150830|NCT01227902|39040199|FG003|Overall Study|Adverse Event|4|||
16150831|NCT01227902|39040196|FG000|Overall Study|Lack of Efficacy|1|||
16150832|NCT01227902|39040197|FG001|Overall Study|Lack of Efficacy|2|||
16150833|NCT01227902|39040198|FG002|Overall Study|Lack of Efficacy|2|||
16150834|NCT01227902|39040199|FG003|Overall Study|Lack of Efficacy|1|||
16150835|NCT01227902|39040196|FG000|Overall Study|Protocol Violation|1|||
16150836|NCT01227902|39040197|FG001|Overall Study|Protocol Violation|0|||
16150837|NCT01227902|39040198|FG002|Overall Study|Protocol Violation|0|||
16150838|NCT01227902|39040199|FG003|Overall Study|Protocol Violation|0|||
16150839|NCT01227902|39040196|FG000|Overall Study|Lost to Follow-up|0|||
16150840|NCT01227902|39040197|FG001|Overall Study|Lost to Follow-up|0|||
16150841|NCT01227902|39040198|FG002|Overall Study|Lost to Follow-up|1|||
16150842|NCT01227902|39040199|FG003|Overall Study|Lost to Follow-up|2|||
16150843|NCT01227902|39040196|FG000|Overall Study|Physician Decision|0|||
16150844|NCT01227902|39040197|FG001|Overall Study|Physician Decision|1|||
16150845|NCT01227902|39040198|FG002|Overall Study|Physician Decision|1|||
16150846|NCT01227902|39040199|FG003|Overall Study|Physician Decision|0|||
16150847|NCT01227902|39040196|FG000|Overall Study|Withdrawal by Subject|4|||
16150848|NCT01227902|39040197|FG001|Overall Study|Withdrawal by Subject|2|||
16150849|NCT01227902|39040198|FG002|Overall Study|Withdrawal by Subject|4|||
16150850|NCT01227902|39040199|FG003|Overall Study|Withdrawal by Subject|3|||
16150851|NCT04194528|39040200|FG000|Overall Study|Adverse Event|1|||
16150852|NCT01183143|39040201|FG000|Overall Study|Protocol Violation|115|||
16150853|NCT01183143|39040201|FG000|Overall Study|Withdrawal by Subject|19|||
16150854|NCT01183143|39040201|FG000|Overall Study|Subject Questionnaires not returned|5|||
16150855|NCT01183143|39040201|FG000|Overall Study|Subjects enrolled, but not treated|11|||
16150856|NCT02270242|39040202|FG000|Overall Study|Withdrawal by Subject|18|||
16150857|NCT02270242|39040203|FG001|Overall Study|Withdrawal by Subject|25|||
16150858|NCT02270242|39040202|FG000|Overall Study|Lost to Follow-up|41|||
16442208|NCT05169710|40099787|FG000|Overall Study|Other Study Discontinuation Reason|0|||
16260995|NCT02682602|39439760|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
16260996|NCT02682602|39439761|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
16260997|NCT03274466|39439764|FG000|Overall Study|Withdrawal by Subject|7|||
16260998|NCT03274466|39439765|FG001|Overall Study|Withdrawal by Subject|3|||
16260999|NCT03274466|39439764|FG000|Overall Study|Protocol Specified Withdrawal|5|||
16261000|NCT03274466|39439765|FG001|Overall Study|Protocol Specified Withdrawal|11|||
16261001|NCT03274466|39439764|FG000|Overall Study|Lost to Follow-up|5|||
16261002|NCT03274466|39439765|FG001|Overall Study|Lost to Follow-up|7|||
16261003|NCT03274466|39439764|FG000|Overall Study|Subject Non-compliance|0|||
16261004|NCT03274466|39439765|FG001|Overall Study|Subject Non-compliance|1|||
16261005|NCT03274466|39439764|FG000|Overall Study|Adverse Event|3|||
16261006|NCT03274466|39439765|FG001|Overall Study|Adverse Event|3|||
16261007|NCT03274466|39439764|FG000|Overall Study|Physician Decision|0|||
16261008|NCT03274466|39439765|FG001|Overall Study|Physician Decision|1|||
16261009|NCT03274466|39439764|FG000|Overall Study|Protocol Violation|3|||
16261010|NCT03274466|39439765|FG001|Overall Study|Protocol Violation|3|||
16261011|NCT01536574|39439767|FG000|Overall Study|Adverse Event|4|||
16261012|NCT01536574|39439768|FG001|Overall Study|Adverse Event|5|||
16261013|NCT01536574|39439767|FG000|Overall Study|Withdrawal by Subject|1|||
16261014|NCT01536574|39439768|FG001|Overall Study|Withdrawal by Subject|2|||
16261015|NCT01536574|39439767|FG000|Overall Study|Lack of Efficacy|1|||
16261016|NCT01536574|39439768|FG001|Overall Study|Lack of Efficacy|0|||
16261017|NCT02914600|39439771|FG000|Overall Study|Adverse Event|298|||
16261018|NCT02914600|39439772|FG001|Overall Study|Adverse Event|35|||
16261019|NCT02914600|39439773|FG002|Overall Study|Adverse Event|25|||
16261020|NCT02914600|39439771|FG000|Overall Study|Sponsors decision|287|||
16261021|NCT02914600|39439772|FG001|Overall Study|Sponsors decision|41|||
16261022|NCT02914600|39439773|FG002|Overall Study|Sponsors decision|12|||
16261023|NCT02914600|39439771|FG000|Overall Study|Withdrawal by Subject|158|||
16261024|NCT02914600|39439772|FG001|Overall Study|Withdrawal by Subject|20|||
16261025|NCT02914600|39439773|FG002|Overall Study|Withdrawal by Subject|18|||
16261026|NCT02914600|39439771|FG000|Overall Study|Investigators discretion|169|||
16261027|NCT02914600|39439772|FG001|Overall Study|Investigators discretion|14|||
16261028|NCT02914600|39439773|FG002|Overall Study|Investigators discretion|13|||
16261029|NCT02914600|39439771|FG000|Overall Study|Lost to Follow-up|10|||
16261030|NCT02914600|39439772|FG001|Overall Study|Lost to Follow-up|4|||
16261031|NCT02914600|39439773|FG002|Overall Study|Lost to Follow-up|0|||
16261032|NCT02914600|39439771|FG000|Overall Study|Pregnancy|8|||
16261033|NCT02914600|39439772|FG001|Overall Study|Pregnancy|0|||
16261034|NCT02914600|39439773|FG002|Overall Study|Pregnancy|0|||
16261035|NCT02914600|39439771|FG000|Overall Study|Protocol Violation|5|||
16261036|NCT02914600|39439772|FG001|Overall Study|Protocol Violation|3|||
16261037|NCT02914600|39439773|FG002|Overall Study|Protocol Violation|0|||
16261038|NCT02914600|39439771|FG000|Overall Study|Non-compliance with study drug|6|||
16261039|NCT02914600|39439772|FG001|Overall Study|Non-compliance with study drug|1|||
16261040|NCT02914600|39439773|FG002|Overall Study|Non-compliance with study drug|0|||
16261041|NCT02914600|39439771|FG000|Overall Study|Death|3|||
16261042|NCT02914600|39439772|FG001|Overall Study|Death|1|||
16261043|NCT02914600|39439773|FG002|Overall Study|Death|1|||
16261044|NCT02914600|39439771|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
16261045|NCT02914600|39439772|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
16261046|NCT02914600|39439773|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
16261047|NCT02914600|39439771|FG000|Overall Study|Enrolled but not treated|1|||
16442209|NCT05169710|40099788|FG001|Overall Study|Other Study Discontinuation Reason|2|||
16442210|NCT05169710|40099789|FG002|Overall Study|Other Study Discontinuation Reason|0|||
16442211|NCT04102098|40099790|FG000|Main Study Period|Ongoing in study|302|||
16442212|NCT04102098|40099791|FG001|Main Study Period|Ongoing in study|291|||
16442213|NCT04102098|40099790|FG000|Main Study Period|Death|20|||
16442214|NCT04102098|40099791|FG001|Main Study Period|Death|27|||
16442215|NCT04102098|40099790|FG000|Main Study Period|Lost to Follow-up|1|||
16442216|NCT04102098|40099791|FG001|Main Study Period|Lost to Follow-up|1|||
16442217|NCT04102098|40099790|FG000|Main Study Period|Physician Decision|0|||
16442218|NCT04102098|40099791|FG001|Main Study Period|Physician Decision|1|||
16442219|NCT04102098|40099790|FG000|Main Study Period|Withdrawal by Subject|11|||
16150859|NCT02270242|39040203|FG001|Overall Study|Lost to Follow-up|27|||
16261048|NCT02914600|39439772|FG001|Overall Study|Enrolled but not treated|0|||
16261049|NCT02914600|39439773|FG002|Overall Study|Enrolled but not treated|0|||
16261050|NCT00150462|39442947|FG000|Overall Study|Disease Progression or Relapse|3|||
16261051|NCT00150462|39442948|FG001|Overall Study|Disease Progression or Relapse|1|||
16261052|NCT00150462|39442949|FG002|Overall Study|Disease Progression or Relapse|2|||
16261053|NCT00150462|39442950|FG003|Overall Study|Disease Progression or Relapse|1|||
16261054|NCT00150462|39442951|FG004|Overall Study|Disease Progression or Relapse|2|||
16261055|NCT00150462|39442952|FG005|Overall Study|Disease Progression or Relapse|2|||
16261056|NCT00150462|39442953|FG006|Overall Study|Disease Progression or Relapse|3|||
16150860|NCT02270242|39040202|FG000|Overall Study|Physician Decision|0|||
16150861|NCT02270242|39040203|FG001|Overall Study|Physician Decision|1|||
16261057|NCT00150462|39442954|FG007|Overall Study|Disease Progression or Relapse|5|||
16261058|NCT00150462|39442955|FG008|Overall Study|Disease Progression or Relapse|5|||
16261059|NCT00150462|39442956|FG009|Overall Study|Disease Progression or Relapse|3|||
16261060|NCT00150462|39442957|FG010|Overall Study|Disease Progression or Relapse|2|||
16261061|NCT00150462|39442947|FG000|Overall Study|Withdrawal by Subject|0|||
16261062|NCT00150462|39442948|FG001|Overall Study|Withdrawal by Subject|1|||
16261063|NCT00150462|39442949|FG002|Overall Study|Withdrawal by Subject|1|||
16261064|NCT00150462|39442950|FG003|Overall Study|Withdrawal by Subject|0|||
16261065|NCT00150462|39442951|FG004|Overall Study|Withdrawal by Subject|1|||
16261066|NCT00150462|39442952|FG005|Overall Study|Withdrawal by Subject|2|||
16261067|NCT00150462|39442953|FG006|Overall Study|Withdrawal by Subject|0|||
16261068|NCT00150462|39442954|FG007|Overall Study|Withdrawal by Subject|1|||
16150862|NCT00401375|39040205|FG000|Overall Study|Protocol Violation|2|||
16261069|NCT00150462|39442955|FG008|Overall Study|Withdrawal by Subject|0|||
16150863|NCT00401375|39040206|FG001|Overall Study|Protocol Violation|2|||
16150864|NCT00401375|39040207|FG002|Overall Study|Protocol Violation|1|||
16150865|NCT00401375|39040205|FG000|Overall Study|Adverse Event|6|||
16150866|NCT00401375|39040206|FG001|Overall Study|Adverse Event|11|||
16150867|NCT00401375|39040207|FG002|Overall Study|Adverse Event|10|||
16150868|NCT00401375|39040205|FG000|Overall Study|Withdrawal by Subject|9|||
16150869|NCT00401375|39040206|FG001|Overall Study|Withdrawal by Subject|7|||
16150870|NCT00401375|39040207|FG002|Overall Study|Withdrawal by Subject|7|||
16150871|NCT00401375|39040205|FG000|Overall Study|Lost to Follow-up|0|||
16150872|NCT00401375|39040206|FG001|Overall Study|Lost to Follow-up|1|||
16150873|NCT00401375|39040207|FG002|Overall Study|Lost to Follow-up|1|||
16150874|NCT00401375|39040205|FG000|Overall Study|Other than specified|2|||
16150875|NCT00401375|39040206|FG001|Overall Study|Other than specified|1|||
16150876|NCT00401375|39040207|FG002|Overall Study|Other than specified|3|||
16150877|NCT00401375|39040205|FG000|Overall Study|Randomized but not treated|3|||
16150878|NCT00401375|39040206|FG001|Overall Study|Randomized but not treated|3|||
16150879|NCT00401375|39040207|FG002|Overall Study|Randomized but not treated|3|||
16150880|NCT02025907|39040208|FG000|Overall Study|Lack of Efficacy|1|||
16150881|NCT02025907|39040209|FG001|Overall Study|Lack of Efficacy|0|||
16150882|NCT02025907|39040208|FG000|Overall Study|Withdrawal by Subject|15|||
16150883|NCT02025907|39040209|FG001|Overall Study|Withdrawal by Subject|8|||
16150884|NCT02025907|39040208|FG000|Overall Study|Protocol Violation|2|||
16150885|NCT02025907|39040209|FG001|Overall Study|Protocol Violation|0|||
16150886|NCT02025907|39040208|FG000|Overall Study|Physician Decision|2|||
16150887|NCT02025907|39040209|FG001|Overall Study|Physician Decision|0|||
16150888|NCT02025907|39040208|FG000|Overall Study|Lost to Follow-up|2|||
16150889|NCT02025907|39040209|FG001|Overall Study|Lost to Follow-up|2|||
16150890|NCT02025907|39040208|FG000|Overall Study|Adverse Event|3|||
16150891|NCT02025907|39040209|FG001|Overall Study|Adverse Event|1|||
16150892|NCT02025907|39040208|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
16150893|NCT02025907|39040209|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
16150894|NCT00715026|39040210|FG000|Overall Study|Withdrawal by Subject|5|||
16150895|NCT00715026|39040210|FG000|Overall Study|Lost to Follow-up|3|||
16150896|NCT00715026|39040210|FG000|Overall Study|Protocol Violation|1|||
16150897|NCT00715026|39040210|FG000|Overall Study|Surgery done on non-study consented hip|1|||
16150898|NCT00268437|39040211|FG000|Overall Study|Ineligible|1|||
16150899|NCT01911442|39040212|FG000|Overall Study|Adverse Event|2|||
16150900|NCT01911442|39040213|FG001|Overall Study|Adverse Event|2|||
16150901|NCT01911442|39040214|FG002|Overall Study|Adverse Event|4|||
16150902|NCT01911442|39040212|FG000|Overall Study|Lack of Efficacy|1|||
16150903|NCT01911442|39040213|FG001|Overall Study|Lack of Efficacy|1|||
16150904|NCT01911442|39040214|FG002|Overall Study|Lack of Efficacy|1|||
16150905|NCT01911442|39040212|FG000|Overall Study|Lost to Follow-up|2|||
16150906|NCT01911442|39040213|FG001|Overall Study|Lost to Follow-up|0|||
16150907|NCT01911442|39040214|FG002|Overall Study|Lost to Follow-up|1|||
16150908|NCT01911442|39040212|FG000|Overall Study|Withdrawal by Subject|1|||
16150909|NCT01911442|39040213|FG001|Overall Study|Withdrawal by Subject|0|||
16150910|NCT01911442|39040214|FG002|Overall Study|Withdrawal by Subject|6|||
16150911|NCT01911442|39040212|FG000|Overall Study|Mother's Work Schedule|0|||
16150912|NCT01911442|39040213|FG001|Overall Study|Mother's Work Schedule|1|||
16150913|NCT01911442|39040214|FG002|Overall Study|Mother's Work Schedule|0|||
16150914|NCT01627899|39040215|FG000|Overall Study|Study terminated early by sponsor.|5|||
16150915|NCT00117598|39040216|FG000|Prior to Treatment Cross Over|Death|40|||
16150916|NCT00117598|39040217|FG001|Prior to Treatment Cross Over|Death|41|||
16150917|NCT00117598|39040218|FG002|Prior to Treatment Cross Over|Death|37|||
16150918|NCT00117598|39040219|FG003|Prior to Treatment Cross Over|Death|0|||
16150919|NCT00117598|39040220|FG004|Prior to Treatment Cross Over|Death|0|||
16150920|NCT00117598|39040216|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
16150921|NCT00117598|39040217|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
16150922|NCT00117598|39040218|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
16150923|NCT00117598|39040219|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
16150924|NCT00117598|39040220|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
16150925|NCT00117598|39040216|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
16150926|NCT00117598|39040217|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
16150927|NCT00117598|39040218|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
16150928|NCT00117598|39040219|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
16150929|NCT00117598|39040220|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
16150930|NCT00117598|39040216|FG000|Prior to Treatment Cross Over|Other|15|||
16150931|NCT00117598|39040217|FG001|Prior to Treatment Cross Over|Other|9|||
16442220|NCT04102098|40099791|FG001|Main Study Period|Withdrawal by Subject|14|||
16442221|NCT04102098|40099790|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
16442222|NCT04102098|40099791|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
16442223|NCT04102098|40099790|FG000|Crossover: AS Who Crossed Over|Death|11|||
16442224|NCT04102098|40099791|FG001|Crossover: AS Who Crossed Over|Death|0|||
16442225|NCT04102098|40099790|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
16442226|NCT04102098|40099791|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
16442227|NCT04531176|40099792|FG000|Overall Study|Study was stopped early|24|||
16442228|NCT04531176|40099793|FG001|Overall Study|Study was stopped early|26|||
16442229|NCT04531176|40099794|FG002|Overall Study|Study was stopped early|24|||
16442230|NCT01210313|40099803|FG000|Overall Study|Withdrawal by Subject|3|||
16442231|NCT01210313|40099803|FG000|Overall Study|Adverse Event|2|||
16442232|NCT01210313|40099803|FG000|Overall Study|Distant recurrence|4|||
16442233|NCT01210313|40099803|FG000|Overall Study|Non-compliance|7|||
16442234|NCT05121766|40099804|FG000|Overall Study|Covid reinfection|3|||
16442235|NCT05121766|40099805|FG001|Overall Study|Covid reinfection|0|||
16442236|NCT05121766|40099804|FG000|Overall Study|Withdrawal by Subject|3|||
16442237|NCT05121766|40099805|FG001|Overall Study|Withdrawal by Subject|1|||
16150932|NCT00117598|39040218|FG002|Prior to Treatment Cross Over|Other|9|||
16150933|NCT00117598|39040219|FG003|Prior to Treatment Cross Over|Other|0|||
16150934|NCT00117598|39040220|FG004|Prior to Treatment Cross Over|Other|0|||
16150935|NCT00117598|39040216|FG000|After Treament Cross Over|Death|0|||
16150936|NCT00117598|39040217|FG001|After Treament Cross Over|Death|0|||
16150937|NCT00117598|39040218|FG002|After Treament Cross Over|Death|0|||
16150938|NCT00117598|39040219|FG003|After Treament Cross Over|Death|1|||
16150939|NCT00117598|39040220|FG004|After Treament Cross Over|Death|2|||
16442238|NCT05121766|40099804|FG000|Overall Study|Adverse Event|2|||
16442239|NCT05121766|40099805|FG001|Overall Study|Adverse Event|4|||
16442240|NCT05121766|40099804|FG000|Overall Study|Lost to Follow-up|0|||
16442241|NCT05121766|40099805|FG001|Overall Study|Lost to Follow-up|1|||
16442242|NCT02589938|40099807|FG000|Overall Study|Withdrawal by Subject|11|||
16442243|NCT02589938|40099808|FG001|Overall Study|Withdrawal by Subject|5|||
16442244|NCT02589938|40099809|FG002|Overall Study|Withdrawal by Subject|6|||
16442245|NCT02589938|40099807|FG000|Overall Study|Lost to Follow-up|3|||
16442246|NCT02589938|40099808|FG001|Overall Study|Lost to Follow-up|3|||
16442247|NCT02589938|40099809|FG002|Overall Study|Lost to Follow-up|3|||
16442248|NCT02589938|40099807|FG000|Overall Study|Death|1|||
16442249|NCT02589938|40099808|FG001|Overall Study|Death|0|||
16442250|NCT02589938|40099809|FG002|Overall Study|Death|1|||
16442251|NCT02589938|40099807|FG000|Overall Study|Protocol Violation|6|||
16442252|NCT02589938|40099808|FG001|Overall Study|Protocol Violation|2|||
16442253|NCT02589938|40099809|FG002|Overall Study|Protocol Violation|3|||
16442254|NCT02589938|40099807|FG000|Overall Study|Physician Decision|1|||
16442255|NCT02589938|40099808|FG001|Overall Study|Physician Decision|0|||
16442256|NCT02589938|40099809|FG002|Overall Study|Physician Decision|0|||
16442257|NCT02589938|40099807|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
16442258|NCT02589938|40099808|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
16442259|NCT02589938|40099809|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
16442260|NCT03019406|40099811|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
16442261|NCT03019406|40099812|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
16442262|NCT03019406|40099813|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
16442263|NCT03019406|40099814|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
16261070|NCT00150462|39442956|FG009|Overall Study|Withdrawal by Subject|1|||
16442264|NCT03882021|40099820|FG000|Enrollment|Procedure aborted/cancelled|2|||
16442265|NCT03882021|40099820|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
16442266|NCT03882021|40099820|FG000|Enrollment to 3-Month|Death|1|||
16442267|NCT03882021|40099820|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
16442268|NCT03882021|40099820|FG000|Enrollment to 3-Month|Missed Visit|4|||
16442269|NCT03882021|40099820|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
16442270|NCT03882021|40099820|FG000|6-Month to 12-Month Visit|Death|1|||
16442271|NCT03882021|40099820|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
16442272|NCT04227899|40099821|FG000|Overall Study|Withdrawal by Subject|6|||
16442273|NCT04227899|40099822|FG001|Overall Study|Withdrawal by Subject|3|||
16442274|NCT04227899|40099821|FG000|Overall Study|Death|12|||
16442275|NCT04227899|40099822|FG001|Overall Study|Death|6|||
16442276|NCT04227899|40099821|FG000|Overall Study|Lost to Follow-up|2|||
16442277|NCT04227899|40099822|FG001|Overall Study|Lost to Follow-up|1|||
16442278|NCT01415882|40099823|FG000|Overall Study|Ineligible|1|||
16442279|NCT01415882|40099824|FG001|Overall Study|Ineligible|0|||
16442280|NCT01415882|40099825|FG002|Overall Study|Ineligible|0|||
16442281|NCT01415882|40099826|FG003|Overall Study|Ineligible|3|||
16442282|NCT01415882|40099827|FG004|Overall Study|Ineligible|0|||
16442283|NCT01415882|40099823|FG000|Overall Study|Withdrawal by Subject|0|||
16442284|NCT01415882|40099824|FG001|Overall Study|Withdrawal by Subject|1|||
16442285|NCT01415882|40099825|FG002|Overall Study|Withdrawal by Subject|0|||
16442286|NCT01415882|40099826|FG003|Overall Study|Withdrawal by Subject|1|||
16442287|NCT01415882|40099827|FG004|Overall Study|Withdrawal by Subject|0|||
16442288|NCT02475681|40099831|FG000|Overall Study|Death|16|||
16442289|NCT02475681|40099832|FG001|Overall Study|Death|6|||
16442290|NCT02475681|40099833|FG002|Overall Study|Death|9|||
16442291|NCT02475681|40099831|FG000|Overall Study|Physician Decision|0|||
16442292|NCT02475681|40099832|FG001|Overall Study|Physician Decision|3|||
16442293|NCT02475681|40099833|FG002|Overall Study|Physician Decision|1|||
16442294|NCT02475681|40099831|FG000|Overall Study|Withdrawal by Subject|12|||
16442295|NCT02475681|40099832|FG001|Overall Study|Withdrawal by Subject|6|||
16442296|NCT02475681|40099833|FG002|Overall Study|Withdrawal by Subject|9|||
16442297|NCT02475681|40099831|FG000|Overall Study|Lost to Follow-up|2|||
16442298|NCT02475681|40099832|FG001|Overall Study|Lost to Follow-up|1|||
16442299|NCT02475681|40099833|FG002|Overall Study|Lost to Follow-up|3|||
16442300|NCT02475681|40099831|FG000|Overall Study|Ongoing in Study|0|||
16442301|NCT02475681|40099832|FG001|Overall Study|Ongoing in Study|163|||
16442302|NCT02475681|40099833|FG002|Overall Study|Ongoing in Study|157|||
16442303|NCT02475681|40099831|FG000|Overall Study|Reasons other than above listed|2|||
16442304|NCT02475681|40099832|FG001|Overall Study|Reasons other than above listed|0|||
16442305|NCT02475681|40099833|FG002|Overall Study|Reasons other than above listed|0|||
16442306|NCT02129699|40099835|FG000|Overall Study|Did not start treatment|3|||
16442307|NCT02129699|40099836|FG001|Overall Study|Did not start treatment|2|||
16442308|NCT05249582|40099837|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
16442309|NCT05249582|40099838|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
16442310|NCT05249582|40099837|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
16442311|NCT05249582|40099838|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
16442312|NCT05249582|40099837|FG000|Overall Study|Declined to use virtual reality headset|1|||
16442313|NCT05249582|40099838|FG001|Overall Study|Declined to use virtual reality headset|0|||
16442314|NCT03748823|40099839|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
16442315|NCT03748823|40099840|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
16442316|NCT03748823|40099839|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
16442317|NCT03748823|40099840|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
16442318|NCT03748823|40099839|FG000|Extension Period|Withdrawal by Subject|9|||
16442319|NCT03748823|40099840|FG001|Extension Period|Withdrawal by Subject|12|||
16442320|NCT03748823|40099839|FG000|Extension Period|Death|2|||
16442321|NCT03748823|40099840|FG001|Extension Period|Death|2|||
16442322|NCT03748823|40099839|FG000|Extension Period|Other than Specified|0|||
16442323|NCT03748823|40099840|FG001|Extension Period|Other than Specified|1|||
16442324|NCT03748823|40099839|FG000|Extension Period|Protocol Violation|1|||
16442325|NCT03748823|40099840|FG001|Extension Period|Protocol Violation|0|||
16442326|NCT03748823|40099839|FG000|Extension Period|Lost to Follow-up|0|||
16442327|NCT03748823|40099840|FG001|Extension Period|Lost to Follow-up|1|||
16442328|NCT03748823|40099839|FG000|Extension Period|Lack of Efficacy|0|||
16442329|NCT03748823|40099840|FG001|Extension Period|Lack of Efficacy|1|||
16442330|NCT03748823|40099839|FG000|Extension Period|Physician Decision|1|||
16442331|NCT03748823|40099840|FG001|Extension Period|Physician Decision|2|||
16442332|NCT03279081|40099841|FG000|Overall Study|Withdrawal by Subject|12|||
16442333|NCT03279081|40099842|FG001|Overall Study|Withdrawal by Subject|20|||
16442334|NCT03279081|40099841|FG000|Overall Study|Physician Decision|4|||
16442335|NCT03279081|40099842|FG001|Overall Study|Physician Decision|1|||
16442336|NCT03279081|40099841|FG000|Overall Study|Lost to Follow-up|8|||
16442337|NCT03279081|40099842|FG001|Overall Study|Lost to Follow-up|8|||
16442338|NCT03279081|40099841|FG000|Overall Study|Death|0|||
16442339|NCT03279081|40099842|FG001|Overall Study|Death|1|||
16442340|NCT03279081|40099841|FG000|Overall Study|Adverse Event|1|||
16442341|NCT03279081|40099842|FG001|Overall Study|Adverse Event|0|||
16365638|NCT01696968|39821628|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
16365639|NCT02782104|39821631|FG000|Overall Study|Other|215|||
16365640|NCT02782104|39821631|FG000|Overall Study|Induction Day 28 Non Responder|9|||
16365641|NCT02782104|39821631|FG000|Overall Study|Non-Compliance with Study Drug|2|||
16365642|NCT02782104|39821631|FG000|Overall Study|Death|8|||
16365643|NCT02782104|39821631|FG000|Overall Study|Pregnancy|6|||
16365644|NCT02782104|39821631|FG000|Overall Study|Withdrawal by Subject|63|||
16365645|NCT02782104|39821631|FG000|Overall Study|Protocol Violation|7|||
16365646|NCT02782104|39821631|FG000|Overall Study|Lack of Efficacy|61|||
16365647|NCT02782104|39821631|FG000|Overall Study|Lost to Follow-up|23|||
16365648|NCT02782104|39821631|FG000|Overall Study|Adverse Event|74|||
16365649|NCT02691572|39821632|FG000|Overall Study|Withdrawal by Subject|1|||
16442342|NCT03279081|40099841|FG000|Overall Study|Reason not Specified|14|||
16442343|NCT03279081|40099842|FG001|Overall Study|Reason not Specified|4|||
16442344|NCT02731638|40099843|FG000|Overall Study|Lost to Follow-up|6|||
16442345|NCT02731638|40099844|FG001|Overall Study|Lost to Follow-up|9|||
16442346|NCT05058365|40099845|FG000|Overall Study|Migration|1|||
16442347|NCT05058365|40099846|FG001|Overall Study|Migration|1|||
16442348|NCT04338321|40099847|FG000|Overall Study|Adverse Event|4|||
16442349|NCT04338321|40099848|FG001|Overall Study|Adverse Event|10|||
16442350|NCT04338321|40099847|FG000|Overall Study|Death|1|||
16442351|NCT04338321|40099848|FG001|Overall Study|Death|1|||
16442352|NCT04338321|40099847|FG000|Overall Study|Lost to Follow-up|4|||
16442353|NCT04338321|40099848|FG001|Overall Study|Lost to Follow-up|9|||
16442354|NCT04338321|40099847|FG000|Overall Study|Withdrawal by Subject|45|||
16442355|NCT04338321|40099848|FG001|Overall Study|Withdrawal by Subject|69|||
16442356|NCT04338321|40099847|FG000|Overall Study|Physician Decision|5|||
16442357|NCT04338321|40099848|FG001|Overall Study|Physician Decision|9|||
16442358|NCT04338321|40099847|FG000|Overall Study|Other|3|||
16442359|NCT04338321|40099848|FG001|Overall Study|Other|10|||
16365650|NCT02691572|39821633|FG001|Overall Study|Withdrawal by Subject|0|||
16150940|NCT00117598|39040216|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
16150941|NCT00117598|39040217|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
16150942|NCT00117598|39040218|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
16150943|NCT00117598|39040219|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
16150944|NCT00117598|39040220|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
16150945|NCT00117598|39040216|FG000|After Treament Cross Over|Other|0|||
16150946|NCT00117598|39040217|FG001|After Treament Cross Over|Other|0|||
16150947|NCT00117598|39040218|FG002|After Treament Cross Over|Other|0|||
16150948|NCT00117598|39040219|FG003|After Treament Cross Over|Other|1|||
16150949|NCT00117598|39040220|FG004|After Treament Cross Over|Other|2|||
16150950|NCT01033825|39040226|FG000|Overall Study|Withdrawal by Subject|2|||
16261071|NCT00150462|39442957|FG010|Overall Study|Withdrawal by Subject|0|||
16365651|NCT02691572|39821632|FG000|Overall Study|Protocol Violation|0|||
16365652|NCT02691572|39821633|FG001|Overall Study|Protocol Violation|1|||
16365653|NCT01138046|39825304|FG000|Overall Study|Withdrawal due to death|6|||
16365654|NCT03822416|39825309|FG000|Overall Study|Lost to Follow-up|1|||
16365655|NCT03822416|39825310|FG001|Overall Study|Lost to Follow-up|0|||
16365656|NCT03822416|39825309|FG000|Overall Study|Withdrawal by Subject|0|||
16442360|NCT05082857|40099849|FG000|Overall Study|participants relocated and could not continue|2|||
16365657|NCT03822416|39825310|FG001|Overall Study|Withdrawal by Subject|1|||
16150951|NCT01033825|39040227|FG001|Overall Study|Withdrawal by Subject|3|||
16150952|NCT01033825|39040228|FG002|Overall Study|Withdrawal by Subject|2|||
16365658|NCT00541229|39825311|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
16365659|NCT00541229|39825312|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
16365660|NCT00541229|39825313|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
16365661|NCT00541229|39825314|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
16365662|NCT00541229|39825315|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
16365663|NCT00541229|39825316|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
16365664|NCT00541229|39825311|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
16365665|NCT00541229|39825312|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
16261072|NCT00150462|39442947|FG000|Overall Study|Death|0|||
16261073|NCT00150462|39442948|FG001|Overall Study|Death|1|||
16261074|NCT00150462|39442949|FG002|Overall Study|Death|0|||
16261075|NCT00150462|39442950|FG003|Overall Study|Death|0|||
16261076|NCT00150462|39442951|FG004|Overall Study|Death|0|||
16261077|NCT00150462|39442952|FG005|Overall Study|Death|0|||
16261078|NCT00150462|39442953|FG006|Overall Study|Death|0|||
16261079|NCT00150462|39442954|FG007|Overall Study|Death|0|||
16261080|NCT00150462|39442955|FG008|Overall Study|Death|1|||
16261081|NCT00150462|39442956|FG009|Overall Study|Death|0|||
16261082|NCT00150462|39442957|FG010|Overall Study|Death|0|||
16261083|NCT00150462|39442947|FG000|Overall Study|Adverse Event|0|||
16261084|NCT00150462|39442948|FG001|Overall Study|Adverse Event|0|||
16261085|NCT00150462|39442949|FG002|Overall Study|Adverse Event|0|||
16365666|NCT00541229|39825313|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
16365667|NCT00541229|39825314|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
16365668|NCT00541229|39825315|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
16365669|NCT00541229|39825316|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
16365670|NCT00541229|39825311|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
16365671|NCT00541229|39825312|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
16365672|NCT00541229|39825313|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
16365673|NCT00541229|39825314|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
16365674|NCT00541229|39825315|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
16365675|NCT00541229|39825316|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
16365676|NCT00541229|39825311|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
16365677|NCT00541229|39825312|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
16365678|NCT00541229|39825313|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
16365679|NCT00541229|39825314|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
16365680|NCT00541229|39825315|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
16365681|NCT00541229|39825316|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
16365682|NCT00541229|39825311|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
16365683|NCT00541229|39825312|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
16365684|NCT00541229|39825313|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
16442361|NCT05082857|40099850|FG001|Overall Study|participants relocated and could not continue|1|||
16261086|NCT00150462|39442950|FG003|Overall Study|Adverse Event|1|||
16261087|NCT00150462|39442951|FG004|Overall Study|Adverse Event|0|||
16365685|NCT00541229|39825314|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
16365686|NCT00541229|39825315|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
16365687|NCT00541229|39825316|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
16442362|NCT05082857|40099849|FG000|Overall Study|Lost to Follow-up|1|||
16261088|NCT00150462|39442952|FG005|Overall Study|Adverse Event|0|||
16261089|NCT00150462|39442953|FG006|Overall Study|Adverse Event|0|||
16150953|NCT01033825|39040229|FG003|Overall Study|Withdrawal by Subject|1|||
16150954|NCT01033825|39040230|FG004|Overall Study|Withdrawal by Subject|1|||
16150955|NCT01033825|39040231|FG005|Overall Study|Withdrawal by Subject|0|||
16150956|NCT01033825|39040232|FG006|Overall Study|Withdrawal by Subject|0|||
16442363|NCT05082857|40099850|FG001|Overall Study|Lost to Follow-up|3|||
16442364|NCT03104868|40099851|FG000|6 Week Follow up|Lost to Follow-up|5|||
16442365|NCT03104868|40099852|FG001|6 Week Follow up|Lost to Follow-up|8|||
16442366|NCT03104868|40099851|FG000|6 Week Follow up|Death|1|||
16442367|NCT03104868|40099852|FG001|6 Week Follow up|Death|1|||
16442368|NCT03104868|40099851|FG000|6 Week Follow up|Withdrawal by Subject|7|||
16442369|NCT03104868|40099852|FG001|6 Week Follow up|Withdrawal by Subject|6|||
16442370|NCT03104868|40099851|FG000|6 Week Follow up|Completed Later Timepoint|24|||
16442371|NCT03104868|40099852|FG001|6 Week Follow up|Completed Later Timepoint|22|||
16442372|NCT03104868|40099851|FG000|6 Month Follow up|Lost to Follow-up|2|||
16442373|NCT03104868|40099852|FG001|6 Month Follow up|Lost to Follow-up|2|||
16442374|NCT03104868|40099851|FG000|6 Month Follow up|Death|0|||
16442375|NCT03104868|40099852|FG001|6 Month Follow up|Death|1|||
16442376|NCT03104868|40099851|FG000|6 Month Follow up|Completed Later Timepoint|22|||
16442377|NCT03104868|40099852|FG001|6 Month Follow up|Completed Later Timepoint|32|||
16442378|NCT03104868|40099851|FG000|12 Month Follow up|Lost to Follow-up|1|||
16442379|NCT03104868|40099852|FG001|12 Month Follow up|Lost to Follow-up|2|||
16442380|NCT03104868|40099851|FG000|12 Month Follow up|Death|0|||
16442381|NCT03104868|40099852|FG001|12 Month Follow up|Death|1|||
16442382|NCT03104868|40099851|FG000|12 Month Follow up|Withdrawal by Subject|0|||
16442383|NCT03104868|40099852|FG001|12 Month Follow up|Withdrawal by Subject|3|||
16442384|NCT03104868|40099851|FG000|12 Month Follow up|Completed Later Timepoint|32|||
16442385|NCT03104868|40099852|FG001|12 Month Follow up|Completed Later Timepoint|29|||
16442386|NCT03104868|40099851|FG000|18 Month Follow up|Lost to Follow-up|7|||
16442387|NCT03104868|40099852|FG001|18 Month Follow up|Lost to Follow-up|11|||
16442388|NCT03104868|40099851|FG000|18 Month Follow up|Death|2|||
16442389|NCT03104868|40099852|FG001|18 Month Follow up|Death|1|||
16442390|NCT03104868|40099851|FG000|18 Month Follow up|Withdrawal by Subject|1|||
16442391|NCT03104868|40099852|FG001|18 Month Follow up|Withdrawal by Subject|2|||
16442392|NCT03104868|40099851|FG000|18 Month Follow up|Graft Loss|1|||
16442393|NCT03104868|40099852|FG001|18 Month Follow up|Graft Loss|1|||
16442394|NCT03104868|40099851|FG000|18 Month Follow up|Completed Later Timepoint|19|||
16150957|NCT01033825|39040226|FG000|Overall Study|Adverse Event|0|||
16150958|NCT01033825|39040227|FG001|Overall Study|Adverse Event|0|||
16150959|NCT01033825|39040228|FG002|Overall Study|Adverse Event|0|||
16150960|NCT01033825|39040229|FG003|Overall Study|Adverse Event|1|||
16150961|NCT01033825|39040230|FG004|Overall Study|Adverse Event|0|||
16150962|NCT01033825|39040231|FG005|Overall Study|Adverse Event|0|||
16150963|NCT01033825|39040232|FG006|Overall Study|Adverse Event|0|||
16150964|NCT01033825|39040226|FG000|Overall Study|Protocol Violation|1|||
16150965|NCT01033825|39040227|FG001|Overall Study|Protocol Violation|0|||
16150966|NCT01033825|39040228|FG002|Overall Study|Protocol Violation|0|||
16150967|NCT01033825|39040229|FG003|Overall Study|Protocol Violation|0|||
16442395|NCT03104868|40099852|FG001|18 Month Follow up|Completed Later Timepoint|20|||
16442396|NCT03104868|40099851|FG000|24 Month Follow up|Lost to Follow-up|15|||
16442397|NCT03104868|40099852|FG001|24 Month Follow up|Lost to Follow-up|16|||
16442398|NCT03104868|40099851|FG000|24 Month Follow up|Death|3|||
16150968|NCT01033825|39040230|FG004|Overall Study|Protocol Violation|0|||
16150969|NCT01033825|39040231|FG005|Overall Study|Protocol Violation|0|||
16150970|NCT01033825|39040232|FG006|Overall Study|Protocol Violation|0|||
16150971|NCT01033825|39040226|FG000|Overall Study|Other|0|||
16150972|NCT01033825|39040227|FG001|Overall Study|Other|0|||
16150973|NCT01033825|39040228|FG002|Overall Study|Other|0|||
16150974|NCT01033825|39040229|FG003|Overall Study|Other|0|||
16150975|NCT01033825|39040230|FG004|Overall Study|Other|1|||
16150976|NCT01033825|39040231|FG005|Overall Study|Other|0|||
16150977|NCT01033825|39040232|FG006|Overall Study|Other|0|||
16150978|NCT01066585|39040234|FG000|Overall Study|Protocol Violation|1|||
16150979|NCT01066585|39040235|FG001|Overall Study|Protocol Violation|0|||
16150980|NCT01066585|39040234|FG000|Overall Study|Withdrawal by Subject|0|||
16150981|NCT01066585|39040235|FG001|Overall Study|Withdrawal by Subject|3|||
16150982|NCT01197521|39040245|FG000|Overall Study|Not reported|24|||
16150983|NCT01197521|39040246|FG001|Overall Study|Not reported|25|||
16150984|NCT01197521|39040247|FG002|Overall Study|Not reported|21|||
16261090|NCT00150462|39442954|FG007|Overall Study|Adverse Event|2|||
16442399|NCT03104868|40099852|FG001|24 Month Follow up|Death|2|||
16442400|NCT03104868|40099851|FG000|24 Month Follow up|Withdrawal by Subject|1|||
16442401|NCT03104868|40099852|FG001|24 Month Follow up|Withdrawal by Subject|0|||
16442402|NCT03104868|40099851|FG000|24 Month Follow up|Graft Loss|2|||
16442403|NCT03104868|40099852|FG001|24 Month Follow up|Graft Loss|0|||
16442404|NCT04408989|40099853|FG000|Overall Study|Lost to Follow-up|0|||
16442405|NCT04408989|40099854|FG001|Overall Study|Lost to Follow-up|0|||
16442406|NCT04408989|40099855|FG002|Overall Study|Lost to Follow-up|1|||
16442407|NCT04408989|40099853|FG000|Overall Study|Withdrawal by Subject|0|||
16442408|NCT04408989|40099854|FG001|Overall Study|Withdrawal by Subject|0|||
16442409|NCT04408989|40099855|FG002|Overall Study|Withdrawal by Subject|2|||
16442410|NCT04003636|40099856|FG000|Overall Study|Death|409|||
16442411|NCT04003636|40099857|FG001|Overall Study|Death|443|||
16442412|NCT04003636|40099856|FG000|Overall Study|Lost to Follow-up|0|||
16442413|NCT04003636|40099857|FG001|Overall Study|Lost to Follow-up|1|||
16442414|NCT04003636|40099856|FG000|Overall Study|Withdrawal by Subject|5|||
16442415|NCT04003636|40099857|FG001|Overall Study|Withdrawal by Subject|2|||
16442416|NCT04003636|40099856|FG000|Overall Study|Participant On-going|119|||
16442417|NCT04003636|40099857|FG001|Overall Study|Participant On-going|90|||
16442418|NCT04672239|40099858|FG000|Week 2 Survey|Failed survey check items|1|||
16442419|NCT04672239|40099859|FG001|Week 2 Survey|Failed survey check items|2|||
16442420|NCT04672239|40099860|FG002|Week 2 Survey|Failed survey check items|3|||
16442421|NCT04672239|40099858|FG000|Week 2 Survey|Partially completed survey|7|||
16442422|NCT04672239|40099859|FG001|Week 2 Survey|Partially completed survey|1|||
16442423|NCT04672239|40099860|FG002|Week 2 Survey|Partially completed survey|4|||
16442424|NCT04672239|40099858|FG000|Week 2 Survey|Withdrawal by Subject|0|||
16442425|NCT04672239|40099859|FG001|Week 2 Survey|Withdrawal by Subject|1|||
16442426|NCT04672239|40099860|FG002|Week 2 Survey|Withdrawal by Subject|0|||
16442427|NCT04672239|40099858|FG000|Week 2 Survey|Lost to Follow-up|3|||
16442428|NCT04672239|40099859|FG001|Week 2 Survey|Lost to Follow-up|2|||
16442429|NCT04672239|40099860|FG002|Week 2 Survey|Lost to Follow-up|5|||
16442430|NCT04672239|40099858|FG000|Week 6 Survey|Failed survey check items|2|||
16442431|NCT04672239|40099859|FG001|Week 6 Survey|Failed survey check items|2|||
16442432|NCT04672239|40099860|FG002|Week 6 Survey|Failed survey check items|2|||
16442433|NCT04672239|40099858|FG000|Week 6 Survey|Partially completed survey|3|||
16442434|NCT04672239|40099859|FG001|Week 6 Survey|Partially completed survey|3|||
16442435|NCT04672239|40099860|FG002|Week 6 Survey|Partially completed survey|2|||
16442436|NCT04672239|40099858|FG000|Week 6 Survey|Withdrawal by Subject|1|||
16442437|NCT04672239|40099859|FG001|Week 6 Survey|Withdrawal by Subject|1|||
16442438|NCT04672239|40099860|FG002|Week 6 Survey|Withdrawal by Subject|1|||
16442439|NCT04672239|40099858|FG000|Week 6 Survey|Withdrawn by PI|0|||
16442440|NCT04672239|40099859|FG001|Week 6 Survey|Withdrawn by PI|1|||
16442441|NCT04672239|40099860|FG002|Week 6 Survey|Withdrawn by PI|0|||
16150985|NCT01197521|39040245|FG000|Overall Study|Enrolment in long term extension|42|||
16442442|NCT04672239|40099858|FG000|Week 6 Survey|Lost to Follow-up|12|||
16150986|NCT01197521|39040246|FG001|Overall Study|Enrolment in long term extension|36|||
16150987|NCT01197521|39040247|FG002|Overall Study|Enrolment in long term extension|87|||
16150988|NCT01197521|39040245|FG000|Overall Study|Severe non-compliance to protocol|1|||
16442443|NCT04672239|40099859|FG001|Week 6 Survey|Lost to Follow-up|2|||
16442444|NCT04672239|40099860|FG002|Week 6 Survey|Lost to Follow-up|5|||
16442445|NCT04672239|40099858|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
16442446|NCT04672239|40099859|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
16365688|NCT00541229|39825311|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
16365689|NCT00541229|39825312|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
16365690|NCT00541229|39825313|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
16150989|NCT01197521|39040246|FG001|Overall Study|Severe non-compliance to protocol|3|||
16150990|NCT01197521|39040247|FG002|Overall Study|Severe non-compliance to protocol|3|||
16150991|NCT01197521|39040245|FG000|Overall Study|Lack of therapeutic response|2|||
16150992|NCT01197521|39040246|FG001|Overall Study|Lack of therapeutic response|3|||
16150993|NCT01197521|39040247|FG002|Overall Study|Lack of therapeutic response|4|||
16150994|NCT01197521|39040245|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
16150995|NCT01197521|39040246|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
16150996|NCT01197521|39040247|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
16150997|NCT01197521|39040245|FG000|Overall Study|Lost to Follow-up|3|||
16150998|NCT01197521|39040246|FG001|Overall Study|Lost to Follow-up|2|||
16150999|NCT01197521|39040247|FG002|Overall Study|Lost to Follow-up|2|||
16151000|NCT01197521|39040245|FG000|Overall Study|Adverse Event|25|||
16151001|NCT01197521|39040246|FG001|Overall Study|Adverse Event|28|||
16151002|NCT01197521|39040247|FG002|Overall Study|Adverse Event|24|||
16151003|NCT00751400|39040250|FG000|Overall Study|Lost to Follow-up|10|||
16151004|NCT00434421|39040254|FG000|Overall Study|Withdrawal by Subject|1|||
16151005|NCT00434421|39040254|FG000|Overall Study|Non-compliance with study treatment|1|||
16151006|NCT00971178|39040259|FG000|Overall Study|Lost to Follow-up|2|||
16151007|NCT00971178|39040260|FG001|Overall Study|Lost to Follow-up|2|||
16151008|NCT00971178|39040261|FG002|Overall Study|Lost to Follow-up|2|||
16151009|NCT01838616|39040263|FG000|Titration Period|Adverse Event|18|||
16151010|NCT01838616|39040264|FG001|Titration Period|Adverse Event|48|||
16151011|NCT01838616|39040263|FG000|Titration Period|Lack of Efficacy|5|||
16151012|NCT01838616|39040264|FG001|Titration Period|Lack of Efficacy|12|||
16151013|NCT01838616|39040263|FG000|Titration Period|Withdrawal by Subject|5|||
16365691|NCT00541229|39825314|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
16365692|NCT00541229|39825315|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
16365693|NCT00541229|39825316|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
16365694|NCT00541229|39825311|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
16365695|NCT00541229|39825312|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
16365696|NCT00541229|39825313|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
16365697|NCT00541229|39825314|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
16365698|NCT00541229|39825315|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
16365699|NCT00541229|39825316|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
16365700|NCT00541229|39825311|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
16365701|NCT00541229|39825312|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
16365702|NCT00541229|39825313|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
16365703|NCT00541229|39825314|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
16365704|NCT00541229|39825315|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
16365705|NCT00541229|39825316|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
16365706|NCT00541229|39825311|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
16365707|NCT00541229|39825312|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
16151014|NCT01838616|39040264|FG001|Titration Period|Withdrawal by Subject|5|||
16151015|NCT01838616|39040263|FG000|Titration Period|Technical problems|1|||
16151016|NCT01838616|39040264|FG001|Titration Period|Technical problems|0|||
16151017|NCT01838616|39040263|FG000|Titration Period|Other|1|||
16151018|NCT01838616|39040264|FG001|Titration Period|Other|0|||
16151019|NCT01838616|39040263|FG000|Titration Period|Protocol Violation|0|||
16151020|NCT01838616|39040264|FG001|Titration Period|Protocol Violation|1|||
16151021|NCT01838616|39040263|FG000|Continuation Period|Lack of Efficacy|3|||
16151022|NCT01838616|39040264|FG001|Continuation Period|Lack of Efficacy|5|||
16151023|NCT01838616|39040263|FG000|Continuation Period|Adverse Event|8|||
16151024|NCT01838616|39040264|FG001|Continuation Period|Adverse Event|4|||
16151025|NCT01838616|39040263|FG000|Continuation Period|Protocol Violation|2|||
16151026|NCT01838616|39040264|FG001|Continuation Period|Protocol Violation|0|||
16151027|NCT01838616|39040263|FG000|Continuation Period|Lost to Follow-up|1|||
16151028|NCT01838616|39040264|FG001|Continuation Period|Lost to Follow-up|0|||
16151029|NCT01838616|39040263|FG000|Continuation Period|Withdrawal by Subject|0|||
16151030|NCT01838616|39040264|FG001|Continuation Period|Withdrawal by Subject|4|||
16151031|NCT01838616|39040263|FG000|Continuation Period|Technical problems|0|||
16151032|NCT01838616|39040264|FG001|Continuation Period|Technical problems|1|||
16151033|NCT01838616|39040263|FG000|Pick-up Arm|Lack of Efficacy|4|||
16151034|NCT01838616|39040264|FG001|Pick-up Arm|Lack of Efficacy|0|||
16151035|NCT01838616|39040263|FG000|Pick-up Arm|Adverse Event|9|||
16151036|NCT01838616|39040264|FG001|Pick-up Arm|Adverse Event|0|||
16151037|NCT01838616|39040263|FG000|Pick-up Arm|Withdrawal by Subject|1|||
16151038|NCT01838616|39040264|FG001|Pick-up Arm|Withdrawal by Subject|0|||
16151039|NCT01838616|39040263|FG000|Pick-up Arm|Technical problems|1|||
16151040|NCT01838616|39040264|FG001|Pick-up Arm|Technical problems|0|||
16151041|NCT04649255|39040265|FG000|Overall Study|Death|9|||
16151042|NCT04649255|39040265|FG000|Overall Study|Withdrawal by Subject|1|||
16151043|NCT00307151|39040266|FG000|Overall Study|Death|4|||
16151044|NCT00307151|39040267|FG001|Overall Study|Death|3|||
16151045|NCT00307151|39040268|FG002|Overall Study|Death|10|||
16151046|NCT00307151|39040269|FG003|Overall Study|Death|3|||
16151047|NCT00307151|39040266|FG000|Overall Study|Severe debilitation, unable to continue|1|||
16151048|NCT00307151|39040267|FG001|Overall Study|Severe debilitation, unable to continue|0|||
16151049|NCT00307151|39040268|FG002|Overall Study|Severe debilitation, unable to continue|0|||
16151050|NCT00307151|39040269|FG003|Overall Study|Severe debilitation, unable to continue|0|||
16151051|NCT00307151|39040266|FG000|Overall Study|Subject unable to get to clinic|1|||
16151052|NCT00307151|39040267|FG001|Overall Study|Subject unable to get to clinic|0|||
16151053|NCT00307151|39040268|FG002|Overall Study|Subject unable to get to clinic|6|||
16151054|NCT00307151|39040269|FG003|Overall Study|Subject unable to get to clinic|2|||
16151055|NCT00307151|39040266|FG000|Overall Study|Withdrew consent|0|||
16151056|NCT00307151|39040267|FG001|Overall Study|Withdrew consent|1|||
16151057|NCT00307151|39040268|FG002|Overall Study|Withdrew consent|1|||
16151058|NCT00307151|39040269|FG003|Overall Study|Withdrew consent|3|||
16261091|NCT00150462|39442955|FG008|Overall Study|Adverse Event|0|||
16151059|NCT00307151|39040266|FG000|Overall Study|Not willing to adhere to study reqs|2|||
16151060|NCT00307151|39040267|FG001|Overall Study|Not willing to adhere to study reqs|0|||
16151061|NCT00307151|39040268|FG002|Overall Study|Not willing to adhere to study reqs|2|||
16365708|NCT00541229|39825313|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
16442447|NCT04672239|40099860|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
16442448|NCT04672239|40099858|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
16442449|NCT04672239|40099859|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
16442450|NCT04672239|40099860|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
16442451|NCT04672239|40099858|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
16442452|NCT04672239|40099859|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
16442453|NCT04672239|40099860|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
16442454|NCT04672239|40099858|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
16442455|NCT04672239|40099859|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
16442456|NCT04672239|40099860|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
16442457|NCT04672239|40099858|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
16151062|NCT00307151|39040269|FG003|Overall Study|Not willing to adhere to study reqs|2|||
16365709|NCT00541229|39825314|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
16365710|NCT00541229|39825315|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
16365711|NCT00541229|39825316|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
16365712|NCT00541229|39825311|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
16365713|NCT00541229|39825312|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
16365714|NCT00541229|39825313|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
16365715|NCT00541229|39825314|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
16365716|NCT00541229|39825315|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
16365717|NCT00541229|39825316|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
16365718|NCT00541229|39825311|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
16365719|NCT00541229|39825312|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
16365720|NCT00541229|39825313|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
16365721|NCT00541229|39825314|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
16365722|NCT00541229|39825315|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
16365723|NCT00541229|39825316|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
16365724|NCT00541229|39825311|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
16365725|NCT00541229|39825312|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
16261092|NCT00150462|39442956|FG009|Overall Study|Adverse Event|1|||
16261093|NCT00150462|39442957|FG010|Overall Study|Adverse Event|0|||
16261094|NCT00150462|39442947|FG000|Overall Study|Physician Decision|0|||
16261095|NCT00150462|39442948|FG001|Overall Study|Physician Decision|0|||
16261096|NCT00150462|39442949|FG002|Overall Study|Physician Decision|1|||
16261097|NCT00150462|39442950|FG003|Overall Study|Physician Decision|1|||
16261098|NCT00150462|39442951|FG004|Overall Study|Physician Decision|0|||
16261099|NCT00150462|39442952|FG005|Overall Study|Physician Decision|0|||
16261100|NCT00150462|39442953|FG006|Overall Study|Physician Decision|0|||
16261101|NCT00150462|39442954|FG007|Overall Study|Physician Decision|0|||
16261102|NCT00150462|39442955|FG008|Overall Study|Physician Decision|0|||
16261103|NCT00150462|39442956|FG009|Overall Study|Physician Decision|0|||
16261104|NCT00150462|39442957|FG010|Overall Study|Physician Decision|0|||
16261105|NCT00150462|39442947|FG000|Overall Study|Other|0|||
16261106|NCT00150462|39442948|FG001|Overall Study|Other|0|||
16261107|NCT00150462|39442949|FG002|Overall Study|Other|0|||
16261108|NCT00150462|39442950|FG003|Overall Study|Other|0|||
16261109|NCT00150462|39442951|FG004|Overall Study|Other|0|||
16261110|NCT00150462|39442952|FG005|Overall Study|Other|0|||
16261111|NCT00150462|39442953|FG006|Overall Study|Other|0|||
16261112|NCT00150462|39442954|FG007|Overall Study|Other|0|||
16261113|NCT00150462|39442955|FG008|Overall Study|Other|0|||
16365726|NCT00541229|39825313|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
16261114|NCT00150462|39442956|FG009|Overall Study|Other|1|||
16261115|NCT00150462|39442957|FG010|Overall Study|Other|1|||
16261116|NCT02336165|39442965|FG000|Overall Study|Death|3|||
16261117|NCT02336165|39442966|FG001|Overall Study|Death|0|||
16261118|NCT02336165|39442967|FG002|Overall Study|Death|0|||
16261119|NCT02336165|39442968|FG003|Overall Study|Death|0|||
16261120|NCT02336165|39442969|FG004|Overall Study|Death|1|||
16365727|NCT00541229|39825314|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
16365728|NCT00541229|39825315|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
16365729|NCT00541229|39825316|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
16365730|NCT00541229|39825311|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
16365731|NCT00541229|39825312|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
16365732|NCT00541229|39825313|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
16365733|NCT00541229|39825314|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
16365734|NCT00541229|39825315|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
16365735|NCT00541229|39825316|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
16365736|NCT00541229|39825311|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
16365737|NCT00541229|39825312|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
16365738|NCT00541229|39825313|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
16365739|NCT00541229|39825314|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
16365740|NCT00541229|39825315|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
16365741|NCT00541229|39825316|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
16365742|NCT00541229|39825311|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
16365743|NCT00541229|39825312|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
16365744|NCT00541229|39825313|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
16365745|NCT00541229|39825314|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
16365746|NCT00541229|39825315|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
16365747|NCT00541229|39825316|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
16365748|NCT00541229|39825311|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
16365749|NCT00541229|39825312|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
16365750|NCT00541229|39825313|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
16365751|NCT00541229|39825314|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
16365752|NCT00541229|39825315|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
16365753|NCT00541229|39825316|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
16365754|NCT00435942|39825317|FG000|Overall Study|Death|17|||
16365755|NCT00435942|39825318|FG001|Overall Study|Death|10|||
16365756|NCT00435942|39825317|FG000|Overall Study|Withdrawal by Subject|2|||
16365757|NCT00435942|39825318|FG001|Overall Study|Withdrawal by Subject|0|||
16365758|NCT00435942|39825317|FG000|Overall Study|Lost to Follow-up|0|||
16365759|NCT00435942|39825318|FG001|Overall Study|Lost to Follow-up|16|||
16365760|NCT00435942|39825317|FG000|Overall Study|Conversion to Open Repair|1|||
16365761|NCT00435942|39825318|FG001|Overall Study|Conversion to Open Repair|0|||
16365762|NCT00435942|39825317|FG000|Overall Study|Technical Failure|3|||
16365763|NCT00435942|39825318|FG001|Overall Study|Technical Failure|0|||
16365764|NCT00435942|39825317|FG000|Overall Study|Other|0|||
16365765|NCT00435942|39825318|FG001|Overall Study|Other|1|||
16365766|NCT03345004|39825322|FG000|Overall Study|Physician Decision|1|||
16365767|NCT03345004|39825323|FG001|Overall Study|Physician Decision|0|||
16365768|NCT03345004|39825322|FG000|Overall Study|Withdrawal by Subject|0|||
16365769|NCT03345004|39825323|FG001|Overall Study|Withdrawal by Subject|1|||
16261121|NCT02336165|39442965|FG000|Overall Study|Physician Decision|2|||
16261122|NCT02336165|39442966|FG001|Overall Study|Physician Decision|2|||
16261123|NCT02336165|39442967|FG002|Overall Study|Physician Decision|1|||
16261124|NCT02336165|39442968|FG003|Overall Study|Physician Decision|1|||
16261125|NCT02336165|39442969|FG004|Overall Study|Physician Decision|0|||
16261126|NCT02336165|39442965|FG000|Overall Study|Withdrawal by Subject|0|||
16261127|NCT02336165|39442966|FG001|Overall Study|Withdrawal by Subject|0|||
16261128|NCT02336165|39442967|FG002|Overall Study|Withdrawal by Subject|1|||
16261129|NCT02336165|39442968|FG003|Overall Study|Withdrawal by Subject|0|||
16261130|NCT02336165|39442969|FG004|Overall Study|Withdrawal by Subject|1|||
16261131|NCT02336165|39442965|FG000|Overall Study|Adverse Event|4|||
16442458|NCT04672239|40099859|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
16442459|NCT04672239|40099860|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
16261132|NCT02336165|39442966|FG001|Overall Study|Adverse Event|1|||
16261133|NCT02336165|39442967|FG002|Overall Study|Adverse Event|2|||
16261134|NCT02336165|39442968|FG003|Overall Study|Adverse Event|4|||
16261135|NCT02336165|39442969|FG004|Overall Study|Adverse Event|1|||
16261136|NCT02336165|39442965|FG000|Overall Study|Progressive disease|23|||
16261137|NCT02336165|39442966|FG001|Overall Study|Progressive disease|22|||
16261138|NCT02336165|39442967|FG002|Overall Study|Progressive disease|27|||
16261139|NCT02336165|39442968|FG003|Overall Study|Progressive disease|24|||
16261140|NCT02336165|39442969|FG004|Overall Study|Progressive disease|19|||
16261141|NCT02336165|39442965|FG000|Overall Study|Non-compliance|1|||
16261142|NCT02336165|39442966|FG001|Overall Study|Non-compliance|0|||
16261143|NCT02336165|39442967|FG002|Overall Study|Non-compliance|0|||
16261144|NCT02336165|39442968|FG003|Overall Study|Non-compliance|1|||
16261145|NCT02336165|39442969|FG004|Overall Study|Non-compliance|0|||
16261146|NCT02336165|39442965|FG000|Overall Study|Other|1|||
16261147|NCT02336165|39442966|FG001|Overall Study|Other|0|||
16261148|NCT02336165|39442967|FG002|Overall Study|Other|0|||
16261149|NCT02336165|39442968|FG003|Overall Study|Other|1|||
16261150|NCT02336165|39442969|FG004|Overall Study|Other|0|||
16261151|NCT01401647|39442971|FG000|Overall Study|Withdrawal by Subject|1|||
16261152|NCT01401647|39442972|FG001|Overall Study|Withdrawal by Subject|5|||
16261153|NCT01401647|39442973|FG002|Overall Study|Withdrawal by Subject|2|||
16261154|NCT01401647|39442971|FG000|Overall Study|Lost to Follow-up|3|||
16261155|NCT01401647|39442972|FG001|Overall Study|Lost to Follow-up|3|||
16261156|NCT01401647|39442973|FG002|Overall Study|Lost to Follow-up|1|||
16261157|NCT01864174|39442983|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
16365770|NCT01625182|39825324|FG000|Overall Study|Administrative problems|1|||
16365771|NCT01625182|39825325|FG001|Overall Study|Administrative problems|0|||
16365772|NCT01625182|39825324|FG000|Overall Study|Protocol deviation|0|||
16365773|NCT01625182|39825325|FG001|Overall Study|Protocol deviation|2|||
16365774|NCT01625182|39825324|FG000|Overall Study|Adverse Event|2|||
16442460|NCT04672239|40099858|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
16442461|NCT04672239|40099859|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
16365775|NCT01625182|39825325|FG001|Overall Study|Adverse Event|0|||
16365776|NCT01625182|39825324|FG000|Overall Study|Withdrawal by Subject|5|||
16365777|NCT01625182|39825325|FG001|Overall Study|Withdrawal by Subject|1|||
16365778|NCT01625182|39825324|FG000|Overall Study|Lack of Efficacy|12|||
16365779|NCT01625182|39825325|FG001|Overall Study|Lack of Efficacy|8|||
16365780|NCT02441283|39825327|FG000|Overall Study|Withdrew consent|15|||
16365781|NCT02441283|39825327|FG000|Overall Study|Lost to Follow-up|42|||
16365782|NCT02441283|39825327|FG000|Overall Study|Death|1|||
16365783|NCT02441283|39825327|FG000|Overall Study|Other, not specified|32|||
16365784|NCT04727749|39825328|FG000|Overall Study|Lost to Follow-up|10|||
16365785|NCT04727749|39825329|FG001|Overall Study|Lost to Follow-up|3|||
16365786|NCT04810962|39825330|FG000|Overall Study|Adverse Event|0|||
16365787|NCT04810962|39825331|FG001|Overall Study|Adverse Event|1|||
16365788|NCT04810962|39825330|FG000|Overall Study|Lost to Follow-up|2|||
16365789|NCT04810962|39825331|FG001|Overall Study|Lost to Follow-up|1|||
16365790|NCT04810962|39825330|FG000|Overall Study|Physician Decision|1|||
16365791|NCT04810962|39825331|FG001|Overall Study|Physician Decision|0|||
16365792|NCT04810962|39825330|FG000|Overall Study|Withdrawal by Subject|1|||
16365793|NCT04810962|39825331|FG001|Overall Study|Withdrawal by Subject|3|||
16365794|NCT04810962|39825330|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
16365795|NCT04810962|39825331|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
16261158|NCT01864174|39442984|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
16261159|NCT01864174|39442983|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
16261160|NCT01864174|39442984|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
16261161|NCT01864174|39442983|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
16261162|NCT01864174|39442984|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
16261163|NCT01864174|39442983|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
16261164|NCT01864174|39442984|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
16261165|NCT01864174|39442983|FG000|Double Blind - Compliant Randomized|Death|1|||
16261166|NCT01864174|39442984|FG001|Double Blind - Compliant Randomized|Death|0|||
16261167|NCT01864174|39442983|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
16261168|NCT01864174|39442984|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
16261169|NCT01864174|39442983|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
16261170|NCT01864174|39442984|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
16261171|NCT01864174|39442983|FG000|Double Blind - Compliant Randomized|Other|6|||
16261172|NCT01864174|39442984|FG001|Double Blind - Compliant Randomized|Other|10|||
16261173|NCT01864174|39442983|FG000|Off Treatment Follow-Up|Other|2|||
16261174|NCT01864174|39442984|FG001|Off Treatment Follow-Up|Other|0|||
16261175|NCT01864174|39442983|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
16261176|NCT01864174|39442984|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
16261177|NCT00336024|39442990|FG000|Overall Study|Death|2|||
16261178|NCT00336024|39442991|FG001|Overall Study|Death|1|||
16261179|NCT00336024|39442990|FG000|Overall Study|Physician Decision|4|||
16261180|NCT00336024|39442991|FG001|Overall Study|Physician Decision|1|||
16261181|NCT00336024|39442990|FG000|Overall Study|Protocol Violation|1|||
16261182|NCT00336024|39442991|FG001|Overall Study|Protocol Violation|0|||
16261183|NCT00336024|39442990|FG000|Overall Study|Withdrawal by Subject|1|||
16261184|NCT00336024|39442991|FG001|Overall Study|Withdrawal by Subject|2|||
16261185|NCT00336024|39442990|FG000|Overall Study|Failure to fulfill consolidation|1|||
16261186|NCT00336024|39442991|FG001|Overall Study|Failure to fulfill consolidation|1|||
16261187|NCT00336024|39442990|FG000|Overall Study|Progressive Disease|4|||
16261188|NCT00336024|39442991|FG001|Overall Study|Progressive Disease|7|||
16261189|NCT00336024|39442990|FG000|Overall Study|Ineligible|7|||
16261190|NCT00336024|39442991|FG001|Overall Study|Ineligible|7|||
16261191|NCT03500341|39442994|FG000|Overall Study|Withdrawn prior to Completion|2|||
16261192|NCT01471522|39442996|FG000|Overall Study|Withdrawal by Subject|28|||
16261193|NCT01471522|39442997|FG001|Overall Study|Withdrawal by Subject|22|||
16261194|NCT01471522|39442996|FG000|Overall Study|Lost to Follow-up|36|||
16261195|NCT01471522|39442997|FG001|Overall Study|Lost to Follow-up|26|||
16261196|NCT02770820|39442998|FG000|Overall Study|Death|1|||
16261197|NCT02770820|39442998|FG000|Overall Study|Physician Decision|2|||
16261198|NCT00905840|39443002|FG000|Overall Study|Lost to Follow-up|11|||
16261199|NCT00905840|39443002|FG000|Overall Study|Death|3|||
16261200|NCT00905840|39443002|FG000|Overall Study|Withdrawal by Subject|1|||
16261201|NCT00905840|39443002|FG000|Overall Study|Adverse Event|1|||
16261202|NCT01185821|39443003|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16261203|NCT01185821|39443004|FG001|Overall Study|Abnormal laboratory value(s)|2|||
16261204|NCT01185821|39443005|FG002|Overall Study|Abnormal laboratory value(s)|1|||
16261205|NCT01185821|39443006|FG003|Overall Study|Abnormal laboratory value(s)|0|||
16261206|NCT01185821|39443007|FG004|Overall Study|Abnormal laboratory value(s)|0|||
16261207|NCT01185821|39443003|FG000|Overall Study|Protocol Violation|0|||
16261208|NCT01185821|39443004|FG001|Overall Study|Protocol Violation|0|||
16261209|NCT01185821|39443005|FG002|Overall Study|Protocol Violation|0|||
16261210|NCT01185821|39443006|FG003|Overall Study|Protocol Violation|1|||
16261211|NCT01185821|39443007|FG004|Overall Study|Protocol Violation|1|||
16261212|NCT01185821|39443003|FG000|Overall Study|Abnormal test procedure result|0|||
16261213|NCT01185821|39443004|FG001|Overall Study|Abnormal test procedure result|0|||
16261214|NCT01185821|39443005|FG002|Overall Study|Abnormal test procedure result|0|||
16261215|NCT01185821|39443006|FG003|Overall Study|Abnormal test procedure result|0|||
16261216|NCT01185821|39443007|FG004|Overall Study|Abnormal test procedure result|1|||
16261217|NCT01185821|39443003|FG000|Overall Study|Death|0|||
16261218|NCT01185821|39443004|FG001|Overall Study|Death|1|||
16261219|NCT01185821|39443005|FG002|Overall Study|Death|0|||
16261220|NCT01185821|39443006|FG003|Overall Study|Death|0|||
16261221|NCT01185821|39443007|FG004|Overall Study|Death|0|||
16261222|NCT01185821|39443003|FG000|Overall Study|Condition no longer required study drug|0|||
16261223|NCT01185821|39443004|FG001|Overall Study|Condition no longer required study drug|0|||
16261224|NCT01185821|39443005|FG002|Overall Study|Condition no longer required study drug|0|||
16261225|NCT01185821|39443006|FG003|Overall Study|Condition no longer required study drug|0|||
16261226|NCT01185821|39443007|FG004|Overall Study|Condition no longer required study drug|1|||
16261227|NCT01185821|39443003|FG000|Overall Study|Adverse Event|2|||
16261228|NCT01185821|39443004|FG001|Overall Study|Adverse Event|3|||
16261229|NCT01185821|39443005|FG002|Overall Study|Adverse Event|1|||
16261230|NCT01185821|39443006|FG003|Overall Study|Adverse Event|2|||
16261231|NCT01185821|39443007|FG004|Overall Study|Adverse Event|5|||
16261232|NCT01185821|39443003|FG000|Overall Study|Lack of Efficacy|0|||
16261233|NCT01185821|39443004|FG001|Overall Study|Lack of Efficacy|0|||
16261234|NCT01185821|39443005|FG002|Overall Study|Lack of Efficacy|3|||
16261235|NCT01185821|39443006|FG003|Overall Study|Lack of Efficacy|0|||
16261236|NCT01185821|39443007|FG004|Overall Study|Lack of Efficacy|9|||
16261237|NCT01185821|39443003|FG000|Overall Study|Withdrawal by Subject|3|||
16261238|NCT01185821|39443004|FG001|Overall Study|Withdrawal by Subject|2|||
16261239|NCT01185821|39443005|FG002|Overall Study|Withdrawal by Subject|2|||
16261240|NCT01185821|39443006|FG003|Overall Study|Withdrawal by Subject|1|||
16261241|NCT01185821|39443007|FG004|Overall Study|Withdrawal by Subject|3|||
16261242|NCT01185821|39443003|FG000|Overall Study|Lost to Follow-up|1|||
16261243|NCT01185821|39443004|FG001|Overall Study|Lost to Follow-up|1|||
16261244|NCT01185821|39443005|FG002|Overall Study|Lost to Follow-up|2|||
16261245|NCT01185821|39443006|FG003|Overall Study|Lost to Follow-up|1|||
16151063|NCT00307151|39040266|FG000|Overall Study|Clinic unable to contact subject|3|||
16151064|NCT00307151|39040267|FG001|Overall Study|Clinic unable to contact subject|3|||
16151065|NCT00307151|39040268|FG002|Overall Study|Clinic unable to contact subject|1|||
16151066|NCT00307151|39040269|FG003|Overall Study|Clinic unable to contact subject|1|||
16151067|NCT00766532|39040275|FG000|Overall Study|Protocol Violation|2|||
16151068|NCT01356407|39040276|FG000|Overall Study|Lost to Follow-up|2|||
16151069|NCT01356407|39040277|FG001|Overall Study|Lost to Follow-up|0|||
16151070|NCT01356407|39040276|FG000|Overall Study|Patient Withdrew Consent|2|||
16151071|NCT01356407|39040277|FG001|Overall Study|Patient Withdrew Consent|1|||
16151072|NCT01356407|39040276|FG000|Overall Study|Could not afford IMP administration|0|||
16151073|NCT01356407|39040277|FG001|Overall Study|Could not afford IMP administration|1|||
16151074|NCT01356407|39040276|FG000|Overall Study|Not complete Endoscopy|2|||
16151075|NCT01356407|39040277|FG001|Overall Study|Not complete Endoscopy|2|||
16151076|NCT00343889|39040280|FG000|Overall Study|Lost to Follow-up|2|||
16151077|NCT00343889|39040281|FG001|Overall Study|Lost to Follow-up|0|||
16151078|NCT00343889|39040280|FG000|Overall Study|Withdrawal by Subject|0|||
16151079|NCT00343889|39040281|FG001|Overall Study|Withdrawal by Subject|1|||
16151080|NCT00343889|39040280|FG000|Overall Study|Protocol Violation|1|||
16151081|NCT00343889|39040281|FG001|Overall Study|Protocol Violation|0|||
16151082|NCT02484911|39040284|FG000|Overall Study|Withdrawal by Subject|2|||
16151083|NCT02484911|39040285|FG001|Overall Study|Withdrawal by Subject|1|||
16151084|NCT02484911|39040284|FG000|Overall Study|Protocol Violation|2|||
16151085|NCT02484911|39040285|FG001|Overall Study|Protocol Violation|1|||
16151086|NCT01918007|39040289|FG000|Overall Study|Baseline oximetry not acceptable|11|||
16151087|NCT01918007|39040290|FG001|Overall Study|Baseline oximetry not acceptable|7|||
16151088|NCT01918007|39040289|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
16151089|NCT01918007|39040290|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
16151090|NCT01918007|39040289|FG000|Overall Study|Lost to Follow-up|4|||
16151091|NCT01918007|39040290|FG001|Overall Study|Lost to Follow-up|7|||
16151092|NCT02667275|39040291|FG000|Overall Study|Protocol Violation|11|||
16151093|NCT02667275|39040292|FG001|Overall Study|Protocol Violation|7|||
16151094|NCT02667275|39040291|FG000|Overall Study|Lost to Follow-up|0|||
16151095|NCT02667275|39040292|FG001|Overall Study|Lost to Follow-up|2|||
16151096|NCT02667275|39040291|FG000|Overall Study|Withdrawal by Subject|0|||
16151097|NCT02667275|39040292|FG001|Overall Study|Withdrawal by Subject|5|||
16151098|NCT02667275|39040291|FG000|Overall Study|Discontinued early without completing|0|||
16151099|NCT02667275|39040292|FG001|Overall Study|Discontinued early without completing|1|||
16151100|NCT02289742|39040293|FG000|First Wear Period|Adverse event prior to treatment|0|||
16151101|NCT02289742|39040294|FG001|First Wear Period|Adverse event prior to treatment|1|||
16151102|NCT02289742|39040295|FG002|First Wear Period|Adverse event prior to treatment|0|||
16151103|NCT02289742|39040296|FG003|First Wear Period|Adverse event prior to treatment|0|||
16151104|NCT02289742|39040293|FG000|First Wear Period|Adverse Event|0|||
16151105|NCT02289742|39040294|FG001|First Wear Period|Adverse Event|0|||
16151106|NCT02289742|39040295|FG002|First Wear Period|Adverse Event|1|||
16151107|NCT02289742|39040296|FG003|First Wear Period|Adverse Event|0|||
16151108|NCT02289742|39040293|FG000|First Wear Period|Other prior to treatment|0|||
16151109|NCT02289742|39040294|FG001|First Wear Period|Other prior to treatment|0|||
16151110|NCT02289742|39040295|FG002|First Wear Period|Other prior to treatment|0|||
16151111|NCT02289742|39040296|FG003|First Wear Period|Other prior to treatment|1|||
16151112|NCT02289742|39040293|FG000|Third Wear Period|Adverse Event|0|||
16151113|NCT02289742|39040294|FG001|Third Wear Period|Adverse Event|1|||
16261246|NCT01185821|39443007|FG004|Overall Study|Lost to Follow-up|2|||
16261247|NCT01185821|39443003|FG000|Overall Study|Administrative problems|0|||
16151114|NCT02289742|39040295|FG002|Third Wear Period|Adverse Event|0|||
16151115|NCT02289742|39040296|FG003|Third Wear Period|Adverse Event|0|||
16151116|NCT02289742|39040293|FG000|Third Wear Period|Reason not given|0|||
16151117|NCT02289742|39040294|FG001|Third Wear Period|Reason not given|0|||
16151118|NCT02289742|39040295|FG002|Third Wear Period|Reason not given|0|||
16151119|NCT02289742|39040296|FG003|Third Wear Period|Reason not given|1|||
16151120|NCT01358864|39040297|FG000|Overall Study|Adverse Event|0|||
16151121|NCT01358864|39040298|FG001|Overall Study|Adverse Event|6|||
16151122|NCT01358864|39040299|FG002|Overall Study|Adverse Event|9|||
16151123|NCT01358864|39040300|FG003|Overall Study|Adverse Event|0|||
16151124|NCT01358864|39040301|FG004|Overall Study|Adverse Event|4|||
16151125|NCT01358864|39040302|FG005|Overall Study|Adverse Event|8|||
16151126|NCT01358864|39040303|FG006|Overall Study|Adverse Event|12|||
16151127|NCT01358864|39040304|FG007|Overall Study|Adverse Event|7|||
16151128|NCT01358864|39040297|FG000|Overall Study|Lack of Efficacy|26|||
16151129|NCT01358864|39040298|FG001|Overall Study|Lack of Efficacy|3|||
16151130|NCT01358864|39040299|FG002|Overall Study|Lack of Efficacy|4|||
16151131|NCT01358864|39040300|FG003|Overall Study|Lack of Efficacy|19|||
16151132|NCT01358864|39040301|FG004|Overall Study|Lack of Efficacy|7|||
16151133|NCT01358864|39040302|FG005|Overall Study|Lack of Efficacy|4|||
16151134|NCT01358864|39040303|FG006|Overall Study|Lack of Efficacy|49|||
16151135|NCT01358864|39040304|FG007|Overall Study|Lack of Efficacy|44|||
16151136|NCT01358864|39040297|FG000|Overall Study|Lost to Follow-up|0|||
16151137|NCT01358864|39040298|FG001|Overall Study|Lost to Follow-up|0|||
16151138|NCT01358864|39040299|FG002|Overall Study|Lost to Follow-up|1|||
16151139|NCT01358864|39040300|FG003|Overall Study|Lost to Follow-up|0|||
16151140|NCT01358864|39040301|FG004|Overall Study|Lost to Follow-up|0|||
16151141|NCT01358864|39040302|FG005|Overall Study|Lost to Follow-up|0|||
16151142|NCT01358864|39040303|FG006|Overall Study|Lost to Follow-up|0|||
16151143|NCT01358864|39040304|FG007|Overall Study|Lost to Follow-up|1|||
16151144|NCT01358864|39040297|FG000|Overall Study|Withdrawal by Subject|3|||
16151145|NCT01358864|39040298|FG001|Overall Study|Withdrawal by Subject|4|||
16151146|NCT01358864|39040299|FG002|Overall Study|Withdrawal by Subject|2|||
16151147|NCT01358864|39040300|FG003|Overall Study|Withdrawal by Subject|0|||
16151148|NCT01358864|39040301|FG004|Overall Study|Withdrawal by Subject|0|||
16151149|NCT01358864|39040302|FG005|Overall Study|Withdrawal by Subject|1|||
16151150|NCT01358864|39040303|FG006|Overall Study|Withdrawal by Subject|1|||
16151151|NCT01358864|39040304|FG007|Overall Study|Withdrawal by Subject|3|||
16151152|NCT01358864|39040297|FG000|Overall Study|Other reason not defined above|2|||
16151153|NCT01358864|39040298|FG001|Overall Study|Other reason not defined above|0|||
16151154|NCT01358864|39040299|FG002|Overall Study|Other reason not defined above|0|||
16151155|NCT01358864|39040300|FG003|Overall Study|Other reason not defined above|0|||
16151156|NCT01358864|39040301|FG004|Overall Study|Other reason not defined above|0|||
16151157|NCT01358864|39040302|FG005|Overall Study|Other reason not defined above|0|||
16151158|NCT01358864|39040303|FG006|Overall Study|Other reason not defined above|2|||
16151159|NCT01358864|39040304|FG007|Overall Study|Other reason not defined above|0|||
16151160|NCT01358864|39040297|FG000|Overall Study|Not treated|0|||
16151161|NCT01358864|39040298|FG001|Overall Study|Not treated|0|||
16151162|NCT01358864|39040299|FG002|Overall Study|Not treated|0|||
16151163|NCT01358864|39040300|FG003|Overall Study|Not treated|0|||
16151164|NCT01358864|39040301|FG004|Overall Study|Not treated|0|||
16151165|NCT01358864|39040302|FG005|Overall Study|Not treated|0|||
16151166|NCT01358864|39040303|FG006|Overall Study|Not treated|1|||
16151167|NCT01358864|39040304|FG007|Overall Study|Not treated|0|||
16151168|NCT02839265|39040307|FG000|Overall Study|Screen Failure|2|||
16151169|NCT02839265|39040307|FG000|Overall Study|Death|1|||
16151170|NCT02839265|39040307|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
16151171|NCT02285777|39040308|FG000|Overall Study|Withdrawal by Subject|1|||
16151172|NCT02285777|39040309|FG001|Overall Study|Withdrawal by Subject|1|||
16151173|NCT02285777|39040308|FG000|Overall Study|Lost to Follow-up|4|||
16151174|NCT02285777|39040309|FG001|Overall Study|Lost to Follow-up|2|||
16151175|NCT00950664|39040310|FG000|First Intervention|Lost to Follow-up|1|||
16151176|NCT00950664|39040311|FG001|First Intervention|Lost to Follow-up|3|||
16151177|NCT00950664|39040310|FG000|First Intervention|Withdrawal by Subject|2|||
16151178|NCT00950664|39040311|FG001|First Intervention|Withdrawal by Subject|2|||
16151179|NCT00405067|39040317|FG000|Overall Study|Adverse Event|4|||
16261248|NCT01185821|39443004|FG001|Overall Study|Administrative problems|0|||
16261249|NCT01185821|39443005|FG002|Overall Study|Administrative problems|1|||
16261250|NCT01185821|39443006|FG003|Overall Study|Administrative problems|1|||
16151180|NCT00405067|39040318|FG001|Overall Study|Adverse Event|9|||
16151181|NCT00405067|39040319|FG002|Overall Study|Adverse Event|4|||
16151182|NCT00405067|39040317|FG000|Overall Study|Lost to Follow-up|0|||
16151183|NCT00405067|39040318|FG001|Overall Study|Lost to Follow-up|0|||
16151184|NCT00405067|39040319|FG002|Overall Study|Lost to Follow-up|1|||
16151185|NCT00761306|39040320|FG000|Overall Study|Adverse Event|5|||
16151186|NCT00761306|39040320|FG000|Overall Study|Lack of Efficacy|4|||
16151187|NCT00761306|39040320|FG000|Overall Study|Protocol Violation|2|||
16261251|NCT01185821|39443007|FG004|Overall Study|Administrative problems|2|||
16151188|NCT00761306|39040320|FG000|Overall Study|Withdrawal of Consent|3|||
16151189|NCT00761306|39040320|FG000|Overall Study|Lost to Follow-up|1|||
16151190|NCT00761306|39040320|FG000|Overall Study|Administrative or Other Reasons|5|||
16151191|NCT00424749|39040321|FG000|Overall Study|Withdrawal by Subject|1|||
16151192|NCT00271817|39040324|FG000|Part 1|Adverse Event|68|||
16151193|NCT00271817|39040325|FG001|Part 1|Adverse Event|25|||
16151194|NCT00271817|39040326|FG002|Part 1|Adverse Event|156|||
16151195|NCT00271817|39040324|FG000|Part 1|Lost to Follow-up|6|||
16151196|NCT00271817|39040325|FG001|Part 1|Lost to Follow-up|8|||
16151197|NCT00271817|39040326|FG002|Part 1|Lost to Follow-up|24|||
16151198|NCT00271817|39040324|FG000|Part 1|Protocol Violation|5|||
16151199|NCT00271817|39040325|FG001|Part 1|Protocol Violation|4|||
16151200|NCT00271817|39040326|FG002|Part 1|Protocol Violation|7|||
16151201|NCT00271817|39040324|FG000|Part 1|Patient Moved|3|||
16151202|NCT00271817|39040325|FG001|Part 1|Patient Moved|1|||
16151203|NCT00271817|39040326|FG002|Part 1|Patient Moved|5|||
16151204|NCT00271817|39040324|FG000|Part 1|Withdrawal by Subject|23|||
16151205|NCT00271817|39040325|FG001|Part 1|Withdrawal by Subject|17|||
16151206|NCT00271817|39040326|FG002|Part 1|Withdrawal by Subject|45|||
16151207|NCT00271817|39040324|FG000|Part 1|LDL < 50 mg/dL|1|||
16151208|NCT00271817|39040325|FG001|Part 1|LDL < 50 mg/dL|4|||
16151209|NCT00271817|39040326|FG002|Part 1|LDL < 50 mg/dL|48|||
16151210|NCT00271817|39040324|FG000|Part 2|Adverse Event|0|||
16151211|NCT00271817|39040325|FG001|Part 2|Adverse Event|17|||
16151212|NCT00271817|39040326|FG002|Part 2|Adverse Event|33|||
16151213|NCT00271817|39040324|FG000|Part 2|Lack of Efficacy|0|||
16151214|NCT00271817|39040325|FG001|Part 2|Lack of Efficacy|1|||
16151215|NCT00271817|39040326|FG002|Part 2|Lack of Efficacy|6|||
16151216|NCT00271817|39040324|FG000|Part 2|Lost to Follow-up|0|||
16151217|NCT00271817|39040325|FG001|Part 2|Lost to Follow-up|6|||
16151218|NCT00271817|39040326|FG002|Part 2|Lost to Follow-up|18|||
16151219|NCT00271817|39040324|FG000|Part 2|Protocol Violation|0|||
16151220|NCT00271817|39040325|FG001|Part 2|Protocol Violation|3|||
16151221|NCT00271817|39040326|FG002|Part 2|Protocol Violation|5|||
16151222|NCT00271817|39040324|FG000|Part 2|Patient Moved|0|||
16151223|NCT00271817|39040325|FG001|Part 2|Patient Moved|0|||
16151224|NCT00271817|39040326|FG002|Part 2|Patient Moved|5|||
16151225|NCT00271817|39040324|FG000|Part 2|Withdrawal by Subject|0|||
16151226|NCT00271817|39040325|FG001|Part 2|Withdrawal by Subject|2|||
16151227|NCT00271817|39040326|FG002|Part 2|Withdrawal by Subject|13|||
16151228|NCT00271817|39040324|FG000|Part 2|LDL < 50 mg/dL|0|||
16151229|NCT00271817|39040325|FG001|Part 2|LDL < 50 mg/dL|3|||
16151230|NCT00271817|39040326|FG002|Part 2|LDL < 50 mg/dL|4|||
16151231|NCT00531752|39040340|FG000|First Double-blind Intervention Period|Adverse Event|2|||
16151232|NCT00531752|39040341|FG001|First Double-blind Intervention Period|Adverse Event|0|||
16151233|NCT00531752|39040342|FG002|First Double-blind Intervention Period|Adverse Event|1|||
16151234|NCT00531752|39040343|FG003|First Double-blind Intervention Period|Adverse Event|1|||
16151235|NCT00531752|39040340|FG000|First Double-blind Intervention Period|Other|1|||
16151236|NCT00531752|39040341|FG001|First Double-blind Intervention Period|Other|4|||
16151237|NCT00531752|39040342|FG002|First Double-blind Intervention Period|Other|4|||
16151238|NCT00531752|39040343|FG003|First Double-blind Intervention Period|Other|0|||
16151239|NCT00531752|39040340|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
16151240|NCT00531752|39040341|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
16151241|NCT00531752|39040342|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
16151242|NCT00531752|39040343|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
16151243|NCT00531752|39040340|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
16151244|NCT00531752|39040341|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
16151245|NCT00531752|39040342|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
16151246|NCT00531752|39040343|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
16151247|NCT00531752|39040340|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
16151248|NCT00531752|39040341|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
16151249|NCT00531752|39040342|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
16151250|NCT00531752|39040343|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
16151251|NCT00531752|39040340|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
16151252|NCT00531752|39040341|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
16151253|NCT00531752|39040342|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
16151254|NCT00531752|39040343|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
16151255|NCT00531752|39040340|FG000|Second Double-blind Intervention Period|Other|1|||
16151256|NCT00531752|39040341|FG001|Second Double-blind Intervention Period|Other|1|||
16151257|NCT00531752|39040342|FG002|Second Double-blind Intervention Period|Other|0|||
16151258|NCT00531752|39040343|FG003|Second Double-blind Intervention Period|Other|0|||
16151259|NCT00531752|39040340|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
16151260|NCT00531752|39040341|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
16151261|NCT00531752|39040342|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
16151262|NCT00531752|39040343|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
16261252|NCT02058498|39443008|FG000|Overall Study|Withdrawal by Subject|4|||
16151263|NCT00531752|39040340|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
16151264|NCT00531752|39040341|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
16151265|NCT00531752|39040342|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
16442462|NCT04672239|40099860|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
16442463|NCT04672239|40099858|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
16442464|NCT04672239|40099859|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
16442465|NCT04672239|40099860|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
16442466|NCT02642042|40099861|FG000|Overall Study|Adverse Event|22|||
16442467|NCT02642042|40099861|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
16442468|NCT02642042|40099861|FG000|Overall Study|Progression/Relapse|28|||
16442469|NCT02642042|40099861|FG000|Overall Study|Death|1|||
16151266|NCT00531752|39040343|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
16151267|NCT02231164|39040344|FG000|Overall Study|Adverse Event|1|||
16151268|NCT02231164|39040345|FG001|Overall Study|Adverse Event|1|||
16151269|NCT02231164|39040344|FG000|Overall Study|Lack of Efficacy|4|||
16151270|NCT02231164|39040345|FG001|Overall Study|Lack of Efficacy|3|||
16151271|NCT02231164|39040344|FG000|Overall Study|Withdrawal by Subject|1|||
16151272|NCT02231164|39040345|FG001|Overall Study|Withdrawal by Subject|2|||
16151273|NCT04640272|39040346|FG000|Overall Study|Subject moved out of area|1|||
16151274|NCT04486950|39040347|FG000|Overall Study|Lost to Follow-up|0|||
16151275|NCT04486950|39040348|FG001|Overall Study|Lost to Follow-up|0|||
16151276|NCT04486950|39040349|FG002|Overall Study|Lost to Follow-up|0|||
16151277|NCT04486950|39040350|FG003|Overall Study|Lost to Follow-up|0|||
16151278|NCT04486950|39040351|FG004|Overall Study|Lost to Follow-up|0|||
16151279|NCT04486950|39040352|FG005|Overall Study|Lost to Follow-up|1|||
16151280|NCT04486950|39040353|FG006|Overall Study|Lost to Follow-up|0|||
16151281|NCT00930761|39040355|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
16151282|NCT00930761|39040356|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
16151283|NCT00930761|39040355|FG000|Overall Study|less than 3 music therapy sessions|0|||
16151284|NCT00930761|39040356|FG001|Overall Study|less than 3 music therapy sessions|3|||
16151285|NCT01075412|39040359|FG000|Overall Study|Withdrawal by Subject|0|||
16151286|NCT01075412|39040360|FG001|Overall Study|Withdrawal by Subject|1|||
16151287|NCT04013529|39040361|FG000|Overall Study|Withdrawal by Subject|1|||
16151288|NCT04013529|39040362|FG001|Overall Study|Withdrawal by Subject|1|||
16151289|NCT00490451|39040363|FG000|Overall Study|Adverse Event|3|||
16151290|NCT00490451|39040364|FG001|Overall Study|Adverse Event|3|||
16151291|NCT00490451|39040363|FG000|Overall Study|Death|3|||
16151292|NCT00490451|39040364|FG001|Overall Study|Death|1|||
16151293|NCT00490451|39040363|FG000|Overall Study|Withdrawal by Subject|2|||
16151294|NCT00490451|39040364|FG001|Overall Study|Withdrawal by Subject|0|||
16151295|NCT00490451|39040363|FG000|Overall Study|Investigator Decision|1|||
16151296|NCT00490451|39040364|FG001|Overall Study|Investigator Decision|0|||
16151297|NCT00490451|39040363|FG000|Overall Study|Protocol Violation|1|||
16151298|NCT00490451|39040364|FG001|Overall Study|Protocol Violation|0|||
16365796|NCT02097277|39825333|FG000|Overall Study|Subject no longer meets study criteria|0|||
16365797|NCT02097277|39825334|FG001|Overall Study|Subject no longer meets study criteria|1|||
16365798|NCT02097277|39825335|FG002|Overall Study|Subject no longer meets study criteria|0|||
16365799|NCT02097277|39825336|FG003|Overall Study|Subject no longer meets study criteria|1|||
16365800|NCT02097277|39825337|FG004|Overall Study|Subject no longer meets study criteria|0|||
16365801|NCT02097277|39825333|FG000|Overall Study|Subject request to discontinue treatment|0|||
16365802|NCT02097277|39825334|FG001|Overall Study|Subject request to discontinue treatment|0|||
16365803|NCT02097277|39825335|FG002|Overall Study|Subject request to discontinue treatment|0|||
16365804|NCT02097277|39825336|FG003|Overall Study|Subject request to discontinue treatment|0|||
16365805|NCT02097277|39825337|FG004|Overall Study|Subject request to discontinue treatment|1|||
16365806|NCT02097277|39825333|FG000|Overall Study|Lost to Follow-up|0|||
16365807|NCT02097277|39825334|FG001|Overall Study|Lost to Follow-up|1|||
16365808|NCT02097277|39825335|FG002|Overall Study|Lost to Follow-up|1|||
16365809|NCT02097277|39825336|FG003|Overall Study|Lost to Follow-up|0|||
16365810|NCT02097277|39825337|FG004|Overall Study|Lost to Follow-up|0|||
16365811|NCT02097277|39825333|FG000|Overall Study|Withdrawal by Subject|2|||
16365812|NCT02097277|39825334|FG001|Overall Study|Withdrawal by Subject|1|||
16365813|NCT02097277|39825335|FG002|Overall Study|Withdrawal by Subject|0|||
16365814|NCT02097277|39825336|FG003|Overall Study|Withdrawal by Subject|1|||
16365815|NCT02097277|39825337|FG004|Overall Study|Withdrawal by Subject|0|||
16365816|NCT02097277|39825333|FG000|Overall Study|Adverse Event|0|||
16365817|NCT02097277|39825334|FG001|Overall Study|Adverse Event|0|||
16365818|NCT02097277|39825335|FG002|Overall Study|Adverse Event|1|||
16365819|NCT02097277|39825336|FG003|Overall Study|Adverse Event|2|||
16365820|NCT02097277|39825337|FG004|Overall Study|Adverse Event|0|||
16365821|NCT04615507|39825338|FG000|Period 1|Covid-19 exposure|2|||
16365822|NCT04615507|39825339|FG001|Period 1|Covid-19 exposure|1|||
16365823|NCT04615507|39825338|FG000|Period 2|Covid-19 exposure|0|||
16151299|NCT00490451|39040363|FG000|Overall Study|Progressive Disease|53|||
16151300|NCT00490451|39040364|FG001|Overall Study|Progressive Disease|34|||
16151301|NCT03332498|39040365|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
16151302|NCT03332498|39040366|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
16151303|NCT03332498|39040367|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
16151304|NCT05003622|39040368|FG000|Overall Study|Progressive disease|2|||
16151305|NCT05003622|39040368|FG000|Overall Study|Withdrawal by Subject|1|||
16151306|NCT00838331|39040369|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
16151307|NCT02142738|39040370|FG000|Overall Study|Adverse Event|13|||
16151308|NCT02142738|39040371|FG001|Overall Study|Adverse Event|9|||
16365824|NCT04615507|39825339|FG001|Period 2|Covid-19 exposure|1|||
16365825|NCT04615507|39825338|FG000|Period 2|Protocol Violation|1|||
16365826|NCT04615507|39825339|FG001|Period 2|Protocol Violation|0|||
16365827|NCT04615507|39825338|FG000|Period 2|Withdrawal by Subject|1|||
16442470|NCT02642042|40099861|FG000|Overall Study|Not Protocol Specified|2|||
16442471|NCT02002598|40099862|FG000|Dose Level 1|Withdrawal by Subject|1|||
16442472|NCT02002598|40099863|FG001|Dose Level 1|Withdrawal by Subject|0|||
16442473|NCT02002598|40099864|FG002|Dose Level 1|Withdrawal by Subject|0|||
16442474|NCT02002598|40099865|FG003|Dose Level 1|Withdrawal by Subject|0|||
16442475|NCT02002598|40099866|FG004|Dose Level 1|Withdrawal by Subject|0|||
16442476|NCT02340026|40099867|FG000|Treatment Phase|Withdrawal by Subject|2|||
16442477|NCT02340026|40099868|FG001|Treatment Phase|Withdrawal by Subject|2|||
16442478|NCT02340026|40099867|FG000|Follow-up Phase|Lost to Follow-up|1|||
16442479|NCT02340026|40099868|FG001|Follow-up Phase|Lost to Follow-up|0|||
16442480|NCT03532451|40099871|FG000|Overall Study|Withdrawal by Subject|0|||
16442481|NCT03532451|40099872|FG001|Overall Study|Withdrawal by Subject|1|||
16442482|NCT03532451|40099871|FG000|Overall Study|Did not undergo surgery|1|||
16442483|NCT03532451|40099872|FG001|Overall Study|Did not undergo surgery|1|||
16442484|NCT03955146|40099880|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
16442485|NCT03955146|40099881|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
16365828|NCT04615507|39825339|FG001|Period 2|Withdrawal by Subject|0|||
16365829|NCT04615507|39825338|FG000|Period 2|Adverse Event|0|||
16365830|NCT04615507|39825339|FG001|Period 2|Adverse Event|1|||
16365831|NCT04615507|39825338|FG000|Period 3|Covid-19 exposure|0|||
16365832|NCT04615507|39825339|FG001|Period 3|Covid-19 exposure|1|||
16365833|NCT00800540|39825340|FG000|Period One: 6 Weeks|Noncompliance|1|||
16365834|NCT00800540|39825341|FG001|Period One: 6 Weeks|Noncompliance|0|||
16365835|NCT00800540|39825340|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
16365836|NCT00800540|39825341|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
16365837|NCT00800540|39825340|FG000|Period 2: 6 Weeks|Adverse Event|0|||
16442486|NCT03955146|40099882|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
16442487|NCT03955146|40099883|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
16442488|NCT03955146|40099880|FG000|DB Period (48 Weeks)|Adverse Event|2|||
16442489|NCT03955146|40099881|FG001|DB Period (48 Weeks)|Adverse Event|5|||
16442490|NCT03955146|40099882|FG002|DB Period (48 Weeks)|Adverse Event|1|||
16442491|NCT03955146|40099883|FG003|DB Period (48 Weeks)|Adverse Event|2|||
16442492|NCT03955146|40099880|FG000|DB Period (48 Weeks)|Death|13|||
16442493|NCT03955146|40099881|FG001|DB Period (48 Weeks)|Death|17|||
16442494|NCT03955146|40099882|FG002|DB Period (48 Weeks)|Death|1|||
16442495|NCT03955146|40099883|FG003|DB Period (48 Weeks)|Death|0|||
16442496|NCT03955146|40099880|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
16442497|NCT03955146|40099881|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
16442498|NCT03955146|40099882|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
16442499|NCT03955146|40099883|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
16442500|NCT03955146|40099880|FG000|DB Period (48 Weeks)|Disease Progression|2|||
16442501|NCT03955146|40099881|FG001|DB Period (48 Weeks)|Disease Progression|0|||
16442502|NCT03955146|40099882|FG002|DB Period (48 Weeks)|Disease Progression|0|||
16442503|NCT03955146|40099883|FG003|DB Period (48 Weeks)|Disease Progression|0|||
16442504|NCT03955146|40099880|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
16442505|NCT03955146|40099881|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
16365838|NCT00800540|39825341|FG001|Period 2: 6 Weeks|Adverse Event|1|||
16365839|NCT00221104|39825342|FG000|Overall Study|Adverse Event|1|||
16365840|NCT00221104|39825343|FG001|Overall Study|Adverse Event|0|||
16365841|NCT00221104|39825342|FG000|Overall Study|Physician Decision|1|||
16365842|NCT00221104|39825343|FG001|Overall Study|Physician Decision|0|||
16365843|NCT00221104|39825342|FG000|Overall Study|Protocol Violation|2|||
16365844|NCT00221104|39825343|FG001|Overall Study|Protocol Violation|0|||
16442506|NCT03955146|40099882|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
16442507|NCT03955146|40099883|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
16151309|NCT02142738|39040370|FG000|Overall Study|Death|92|||
16151310|NCT02142738|39040371|FG001|Overall Study|Death|112|||
16151311|NCT02142738|39040370|FG000|Overall Study|Lost to Follow-up|0|||
16365845|NCT00221104|39825342|FG000|Overall Study|Withdrawal by Subject|42|||
16365846|NCT00221104|39825343|FG001|Overall Study|Withdrawal by Subject|29|||
16365847|NCT00221104|39825342|FG000|Overall Study|Others|37|||
16365848|NCT00221104|39825343|FG001|Overall Study|Others|47|||
16442508|NCT03955146|40099880|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
16442509|NCT03955146|40099881|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
16442510|NCT03955146|40099882|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
16442511|NCT03955146|40099883|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
16442512|NCT03955146|40099880|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
16442513|NCT03955146|40099881|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
16442514|NCT03955146|40099882|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
16442515|NCT03955146|40099883|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
16442516|NCT03955146|40099880|FG000|DB Period (48 Weeks)|Participant Decision|9|||
16442517|NCT03955146|40099881|FG001|DB Period (48 Weeks)|Participant Decision|12|||
16442518|NCT03955146|40099882|FG002|DB Period (48 Weeks)|Participant Decision|1|||
16442519|NCT03955146|40099883|FG003|DB Period (48 Weeks)|Participant Decision|1|||
16442520|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
16442521|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
16442522|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
16442523|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
16442524|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
16442525|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
16442526|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
16442527|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
16442528|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
16442529|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
16442530|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
16442531|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
16442532|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
16442533|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
16442534|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
16442535|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
16442536|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
16442537|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
16442538|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
16442539|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
16442540|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
16442541|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
16442542|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
16442543|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
16442544|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
16442545|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
16442546|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
16442547|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
16442548|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
16442549|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
16442550|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
16442551|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
16442552|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
16442553|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
16442554|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
16442555|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
16151312|NCT02142738|39040371|FG001|Overall Study|Lost to Follow-up|3|||
16151313|NCT02142738|39040370|FG000|Overall Study|Withdrawal by Subject|6|||
16151314|NCT02142738|39040371|FG001|Overall Study|Withdrawal by Subject|7|||
16151315|NCT02142738|39040370|FG000|Overall Study|Follow up ended by sponsor|43|||
16151316|NCT02142738|39040371|FG001|Overall Study|Follow up ended by sponsor|20|||
16151317|NCT01251653|39040372|FG000|Overall Study|Progressive Disease|1|||
16151318|NCT01251653|39040373|FG001|Overall Study|Progressive Disease|7|||
16151319|NCT01251653|39040374|FG002|Overall Study|Progressive Disease|16|||
16151320|NCT01251653|39040375|FG003|Overall Study|Progressive Disease|4|||
16151321|NCT01251653|39040376|FG004|Overall Study|Progressive Disease|0|||
16151322|NCT01251653|39040377|FG005|Overall Study|Progressive Disease|17|||
16151323|NCT01251653|39040378|FG006|Overall Study|Progressive Disease|14|||
16151324|NCT01251653|39040379|FG007|Overall Study|Progressive Disease|7|||
16151325|NCT01251653|39040380|FG008|Overall Study|Progressive Disease|5|||
16151326|NCT01251653|39040372|FG000|Overall Study|Dose-limiting toxicity|0|||
16151327|NCT01251653|39040373|FG001|Overall Study|Dose-limiting toxicity|1|||
16151328|NCT01251653|39040374|FG002|Overall Study|Dose-limiting toxicity|1|||
16151329|NCT01251653|39040375|FG003|Overall Study|Dose-limiting toxicity|1|||
16151330|NCT01251653|39040376|FG004|Overall Study|Dose-limiting toxicity|0|||
16151331|NCT01251653|39040377|FG005|Overall Study|Dose-limiting toxicity|0|||
16151332|NCT01251653|39040378|FG006|Overall Study|Dose-limiting toxicity|2|||
16151333|NCT01251653|39040379|FG007|Overall Study|Dose-limiting toxicity|0|||
16151334|NCT01251653|39040380|FG008|Overall Study|Dose-limiting toxicity|0|||
16151335|NCT01251653|39040372|FG000|Overall Study|Adverse Event|1|||
16151336|NCT01251653|39040373|FG001|Overall Study|Adverse Event|0|||
16151337|NCT01251653|39040374|FG002|Overall Study|Adverse Event|2|||
16151338|NCT01251653|39040375|FG003|Overall Study|Adverse Event|1|||
16151339|NCT01251653|39040376|FG004|Overall Study|Adverse Event|1|||
16151340|NCT01251653|39040377|FG005|Overall Study|Adverse Event|0|||
16151341|NCT01251653|39040378|FG006|Overall Study|Adverse Event|2|||
16151342|NCT01251653|39040379|FG007|Overall Study|Adverse Event|2|||
16151343|NCT01251653|39040380|FG008|Overall Study|Adverse Event|1|||
16151344|NCT01251653|39040372|FG000|Overall Study|Withdrawal by Subject|1|||
16151345|NCT01251653|39040373|FG001|Overall Study|Withdrawal by Subject|0|||
16151346|NCT01251653|39040374|FG002|Overall Study|Withdrawal by Subject|1|||
16151347|NCT01251653|39040375|FG003|Overall Study|Withdrawal by Subject|0|||
16151348|NCT01251653|39040376|FG004|Overall Study|Withdrawal by Subject|1|||
16151349|NCT01251653|39040377|FG005|Overall Study|Withdrawal by Subject|1|||
16151350|NCT01251653|39040378|FG006|Overall Study|Withdrawal by Subject|0|||
16151351|NCT01251653|39040379|FG007|Overall Study|Withdrawal by Subject|1|||
16151352|NCT01251653|39040380|FG008|Overall Study|Withdrawal by Subject|0|||
16151353|NCT01251653|39040372|FG000|Overall Study|Other reason not mentioned above|0|||
16151354|NCT01251653|39040373|FG001|Overall Study|Other reason not mentioned above|0|||
16151355|NCT01251653|39040374|FG002|Overall Study|Other reason not mentioned above|0|||
16261253|NCT00537030|39443012|FG000|Overall Study|Physician Decision|2|||
16261254|NCT00537030|39443012|FG000|Overall Study|Withdrawal by Subject|2|||
16261255|NCT00537030|39443012|FG000|Overall Study|≥ Grade 2 allergy|7|||
16261256|NCT00537030|39443012|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
16261257|NCT00537030|39443012|FG000|Overall Study|Ineligible|2|||
16261258|NCT00537030|39443012|FG000|Overall Study|Inevaluable|2|||
16261259|NCT01513174|39443013|FG000|Overall Study|Inclusion Error|1|||
16261260|NCT01513174|39443014|FG001|Overall Study|Inclusion Error|7|||
16261261|NCT01513174|39443013|FG000|Overall Study|Not receive study treatment|3|||
16261262|NCT01513174|39443014|FG001|Overall Study|Not receive study treatment|1|||
16261263|NCT04526210|39443016|FG000|Overall Study|Sponsor decision|7|||
16261264|NCT04526210|39443017|FG001|Overall Study|Sponsor decision|5|||
16261265|NCT04526210|39443016|FG000|Overall Study|Withdrawal by Subject|3|||
16261266|NCT04526210|39443017|FG001|Overall Study|Withdrawal by Subject|2|||
16261267|NCT03420300|39443018|FG000|Overall Study|Death|2|||
16261268|NCT02289963|39443019|FG000|Overall Study|Adverse Event|1|||
16261269|NCT02289963|39443020|FG001|Overall Study|Adverse Event|2|||
16261270|NCT02289963|39443019|FG000|Overall Study|Poor compliance to protocol|1|||
16261271|NCT02289963|39443020|FG001|Overall Study|Poor compliance to protocol|0|||
16261272|NCT02289963|39443019|FG000|Overall Study|Withdrawal by Subject|1|||
16261273|NCT02289963|39443020|FG001|Overall Study|Withdrawal by Subject|0|||
16261274|NCT02289963|39443019|FG000|Overall Study|Last injection missed|2|||
16261275|NCT02289963|39443020|FG001|Overall Study|Last injection missed|2|||
16261276|NCT02289963|39443019|FG000|Overall Study|End treatment visit outside visit window|0|||
16261277|NCT02289963|39443020|FG001|Overall Study|End treatment visit outside visit window|4|||
16261278|NCT02289963|39443019|FG000|Overall Study|Other than specified above|0|||
16261279|NCT02289963|39443020|FG001|Overall Study|Other than specified above|2|||
16261280|NCT01804270|39443023|FG000|Overall Study|Withdrawal by Subject|1|||
16261281|NCT01804270|39443024|FG001|Overall Study|Withdrawal by Subject|1|||
16261282|NCT02043132|39443027|FG000|Overall Study|Lost to Follow-up|1|||
16261283|NCT02043132|39443028|FG001|Overall Study|Lost to Follow-up|1|||
16261284|NCT02043132|39443027|FG000|Overall Study|screen failures|4|||
16261285|NCT02043132|39443028|FG001|Overall Study|screen failures|8|||
16261286|NCT00320112|39443029|FG000|Overall Study|Lost to Follow-up|3|||
16261287|NCT00320112|39443030|FG001|Overall Study|Lost to Follow-up|4|||
16261288|NCT00320112|39443029|FG000|Overall Study|Withdrawal by Subject|3|||
16261289|NCT00320112|39443030|FG001|Overall Study|Withdrawal by Subject|0|||
16261290|NCT00320112|39443029|FG000|Overall Study|Death|2|||
16261291|NCT00320112|39443030|FG001|Overall Study|Death|1|||
16261292|NCT01029340|39443031|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
16261293|NCT01029340|39443032|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
16261294|NCT01029340|39443033|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
16261295|NCT01029340|39443034|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
16261296|NCT01029340|39443035|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
16261297|NCT01029340|39443036|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
16261298|NCT01029340|39443031|FG000|Part B Treatment Period|Protocol Violation|0|||
16151356|NCT01251653|39040375|FG003|Overall Study|Other reason not mentioned above|0|||
16151357|NCT01251653|39040376|FG004|Overall Study|Other reason not mentioned above|0|||
16151358|NCT01251653|39040377|FG005|Overall Study|Other reason not mentioned above|0|||
16151359|NCT01251653|39040378|FG006|Overall Study|Other reason not mentioned above|0|||
16261299|NCT01029340|39443032|FG001|Part B Treatment Period|Protocol Violation|0|||
16151360|NCT01251653|39040379|FG007|Overall Study|Other reason not mentioned above|2|||
16261300|NCT01029340|39443033|FG002|Part B Treatment Period|Protocol Violation|1|||
16261301|NCT01029340|39443034|FG003|Part B Treatment Period|Protocol Violation|0|||
16151361|NCT01251653|39040380|FG008|Overall Study|Other reason not mentioned above|0|||
16151362|NCT03693625|39040381|FG000|Overall Study|Adverse Event|2|||
16151363|NCT03693625|39040382|FG001|Overall Study|Adverse Event|0|||
16151364|NCT03693625|39040381|FG000|Overall Study|Study Terminated By Sponsor|20|||
16151365|NCT03693625|39040382|FG001|Overall Study|Study Terminated By Sponsor|7|||
16151366|NCT03693625|39040381|FG000|Overall Study|Withdrawal by Subject|1|||
16151367|NCT03693625|39040382|FG001|Overall Study|Withdrawal by Subject|1|||
16151368|NCT03159091|39040385|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
16151369|NCT03159091|39040386|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
16151370|NCT03159091|39040385|FG000|Overall Study|Patient has taken no dose of study drug|0|||
16151371|NCT03159091|39040386|FG001|Overall Study|Patient has taken no dose of study drug|1|||
16151372|NCT00814892|39040389|FG000|Overall Study|Disease Progression|1|||
16151373|NCT00814892|39040389|FG000|Overall Study|Study Termination|1|||
16151374|NCT03024970|39040390|FG000|First Intervention|Adverse Event|1|||
16151375|NCT03024970|39040391|FG001|First Intervention|Adverse Event|0|||
16151376|NCT03024970|39040390|FG000|Second Intervention|Lost to Follow-up|1|||
16151377|NCT03024970|39040391|FG001|Second Intervention|Lost to Follow-up|0|||
16151378|NCT02577146|39040392|FG000|Overall Study|Lost to Follow-up|8|||
16151379|NCT02577146|39040392|FG000|Overall Study|Physician Decision|3|||
16151380|NCT02577146|39040392|FG000|Overall Study|Screen Failure|17|||
16151381|NCT02553265|39040393|FG000|Enrollment|Death|0|||
16151382|NCT02553265|39040394|FG001|Enrollment|Death|0|||
16151383|NCT02553265|39040395|FG002|Enrollment|Death|1|||
16151384|NCT02553265|39040393|FG000|First Intervention (28 Days)|Adverse Event|1|||
16151385|NCT02553265|39040394|FG001|First Intervention (28 Days)|Adverse Event|0|||
16151386|NCT02553265|39040395|FG002|First Intervention (28 Days)|Adverse Event|0|||
16151387|NCT02553265|39040393|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
16151388|NCT02553265|39040394|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
16151389|NCT02553265|39040395|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
16151390|NCT02553265|39040393|FG000|Second Intervention (28 Days)|Adverse Event|1|||
16151391|NCT02553265|39040394|FG001|Second Intervention (28 Days)|Adverse Event|0|||
16151392|NCT02553265|39040395|FG002|Second Intervention (28 Days)|Adverse Event|0|||
16151393|NCT02553265|39040393|FG000|Third Intervention (28 Days)|Adverse Event|1|||
16151394|NCT02553265|39040394|FG001|Third Intervention (28 Days)|Adverse Event|0|||
16151395|NCT02553265|39040395|FG002|Third Intervention (28 Days)|Adverse Event|0|||
16151396|NCT02553265|39040393|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
16151397|NCT02553265|39040394|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
16151398|NCT02553265|39040395|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
16151399|NCT00923130|39040396|FG000|Overall Study|Stopped treatment due to progression|17|||
16151400|NCT00923130|39040396|FG000|Overall Study|Death|1|||
16151401|NCT00923130|39040396|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
16151402|NCT00923130|39040396|FG000|Overall Study|Switched to alternative treatment|2|||
16151403|NCT00923130|39040396|FG000|Overall Study|Refused further treatment|2|||
16151404|NCT01274715|39040397|FG000|Overall Study|Lost to Follow-up|1|||
16151405|NCT01274715|39040397|FG000|Overall Study|After consent, met exclusion criteria.|1|||
16151406|NCT01274715|39040397|FG000|Overall Study|After consent, met exclusion criteria.|1|||
16151407|NCT01274715|39040397|FG000|Overall Study|After consent, met exclusion criteria.|1|||
16151408|NCT04329702|39040398|FG000|Overall Study|illness|3|||
16151409|NCT04329702|39040399|FG001|Overall Study|illness|4|||
16151410|NCT04329702|39040400|FG002|Overall Study|illness|0|||
16151411|NCT04329702|39040398|FG000|Overall Study|Lost to Follow-up|0|||
16151412|NCT04329702|39040399|FG001|Overall Study|Lost to Follow-up|0|||
16151413|NCT04329702|39040400|FG002|Overall Study|Lost to Follow-up|2|||
16151414|NCT04329702|39040398|FG000|Overall Study|Death|0|||
16151415|NCT04329702|39040399|FG001|Overall Study|Death|2|||
16151416|NCT04329702|39040400|FG002|Overall Study|Death|0|||
16151417|NCT01265797|39040403|FG000|Run-in Month|Withdrawal by Subject|0|||
16151418|NCT01265797|39040404|FG001|Run-in Month|Withdrawal by Subject|4|||
16151419|NCT01265797|39040403|FG000|Run-in Month|1st seizure during run-in month|0|||
16151420|NCT01265797|39040404|FG001|Run-in Month|1st seizure during run-in month|1|||
16151421|NCT01265797|39040403|FG000|Blinded Month|Lack of Efficacy|5|||
16151422|NCT01265797|39040404|FG001|Blinded Month|Lack of Efficacy|0|||
16151423|NCT01265797|39040403|FG000|Blinded Month|Lost to Follow-up|1|||
16151424|NCT01265797|39040404|FG001|Blinded Month|Lost to Follow-up|0|||
16151425|NCT01265797|39040403|FG000|Blinded Month|Protocol Violation|2|||
16151426|NCT01265797|39040404|FG001|Blinded Month|Protocol Violation|1|||
16151427|NCT01265797|39040403|FG000|Blinded Month|Adverse Event|2|||
16151428|NCT01265797|39040404|FG001|Blinded Month|Adverse Event|0|||
16151429|NCT01265797|39040403|FG000|Blinded Month|Diary data incomplete|0|||
16151430|NCT01265797|39040404|FG001|Blinded Month|Diary data incomplete|1|||
16151431|NCT01265797|39040403|FG000|Open Label Month|Lost to Follow-up|0|||
16151432|NCT01265797|39040404|FG001|Open Label Month|Lost to Follow-up|1|||
16151433|NCT00492752|39040407|FG000|Double Blind Treatment|Death|13|||
16151434|NCT00492752|39040408|FG001|Double Blind Treatment|Death|0|||
16151435|NCT00492752|39040409|FG002|Double Blind Treatment|Death|2|||
16151436|NCT00492752|39040410|FG003|Double Blind Treatment|Death|0|||
16151437|NCT00492752|39040407|FG000|Double Blind Treatment|Adverse Event|1|||
16151438|NCT00492752|39040408|FG001|Double Blind Treatment|Adverse Event|0|||
16151439|NCT00492752|39040409|FG002|Double Blind Treatment|Adverse Event|0|||
16151440|NCT00492752|39040410|FG003|Double Blind Treatment|Adverse Event|0|||
16151441|NCT00492752|39040407|FG000|Double Blind Treatment|Protocol Violation|0|||
16151442|NCT00492752|39040408|FG001|Double Blind Treatment|Protocol Violation|0|||
16151443|NCT00492752|39040409|FG002|Double Blind Treatment|Protocol Violation|1|||
16151444|NCT00492752|39040410|FG003|Double Blind Treatment|Protocol Violation|0|||
16151445|NCT00492752|39040407|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
16151446|NCT00492752|39040408|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
16151447|NCT00492752|39040409|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
16151448|NCT00492752|39040410|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
16151449|NCT00492752|39040407|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
16151450|NCT00492752|39040408|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
16151451|NCT00492752|39040409|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
16151452|NCT00492752|39040410|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
16151453|NCT00492752|39040407|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
16151454|NCT00492752|39040408|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
16151455|NCT00492752|39040409|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
16151456|NCT00492752|39040410|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
16151457|NCT00492752|39040407|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
16151458|NCT00492752|39040408|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
16151459|NCT00492752|39040409|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
16151460|NCT00492752|39040410|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
16151461|NCT00492752|39040407|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
16151462|NCT00492752|39040408|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
16151463|NCT00492752|39040409|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
16151464|NCT00492752|39040410|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
16151465|NCT00492752|39040407|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
16151466|NCT00492752|39040408|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
16151467|NCT00492752|39040409|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
16151468|NCT00492752|39040410|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
16151469|NCT00492752|39040407|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
16151470|NCT00492752|39040408|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
16151471|NCT00492752|39040409|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
16151472|NCT00492752|39040410|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
16151473|NCT00492752|39040407|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
16151474|NCT00492752|39040408|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
16151475|NCT00492752|39040409|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
16151476|NCT00492752|39040410|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
16151477|NCT01834274|39040420|FG000|Overall Study|Study Termination|41|||
16151478|NCT01834274|39040421|FG001|Overall Study|Study Termination|38|||
16151479|NCT01834274|39040420|FG000|Overall Study|Withdrawal by Subject|1|||
16151480|NCT01834274|39040421|FG001|Overall Study|Withdrawal by Subject|1|||
16151481|NCT01834274|39040420|FG000|Overall Study|Lost to Follow-up|3|||
16151482|NCT01834274|39040421|FG001|Overall Study|Lost to Follow-up|1|||
16151483|NCT01834274|39040420|FG000|Overall Study|Other|2|||
16151484|NCT01834274|39040421|FG001|Overall Study|Other|1|||
16151485|NCT00488982|39040422|FG000|Course 1|Physician Decision|0|||
16151486|NCT00488982|39040423|FG001|Course 1|Physician Decision|2|||
16151487|NCT00488982|39040424|FG002|Course 1|Physician Decision|4|||
16151488|NCT00488982|39040422|FG000|Course 1|Withdrawal by Subject|0|||
16151489|NCT00488982|39040423|FG001|Course 1|Withdrawal by Subject|8|||
16151490|NCT00488982|39040424|FG002|Course 1|Withdrawal by Subject|2|||
16151491|NCT00488982|39040422|FG000|Course 1|nonprotocol therapy|0|||
16151492|NCT00488982|39040423|FG001|Course 1|nonprotocol therapy|2|||
16151493|NCT00488982|39040424|FG002|Course 1|nonprotocol therapy|2|||
16151494|NCT00488982|39040422|FG000|Course 1|Adverse Event|0|||
16151495|NCT00488982|39040423|FG001|Course 1|Adverse Event|0|||
16151496|NCT00488982|39040424|FG002|Course 1|Adverse Event|6|||
16151497|NCT00769184|39040425|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
16151498|NCT00769184|39040426|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
16151499|NCT00769184|39040425|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
16151500|NCT00769184|39040426|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
16151501|NCT00769184|39040425|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
16151502|NCT00769184|39040426|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
16151503|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
16151504|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
16261302|NCT01029340|39443035|FG004|Part B Treatment Period|Protocol Violation|0|||
16261303|NCT01029340|39443036|FG005|Part B Treatment Period|Protocol Violation|0|||
16261304|NCT01029340|39443031|FG000|Extension Period|Adverse Event|0|||
16261305|NCT01029340|39443032|FG001|Extension Period|Adverse Event|0|||
16261306|NCT01029340|39443033|FG002|Extension Period|Adverse Event|0|||
16261307|NCT01029340|39443034|FG003|Extension Period|Adverse Event|0|||
16261308|NCT01029340|39443035|FG004|Extension Period|Adverse Event|0|||
16261309|NCT01029340|39443036|FG005|Extension Period|Adverse Event|1|||
16261310|NCT01029340|39443031|FG000|Extension Period|starting another study|0|||
16261311|NCT01029340|39443032|FG001|Extension Period|starting another study|0|||
16261312|NCT01029340|39443033|FG002|Extension Period|starting another study|0|||
16261313|NCT01029340|39443034|FG003|Extension Period|starting another study|0|||
16261314|NCT01029340|39443035|FG004|Extension Period|starting another study|0|||
16261315|NCT01029340|39443036|FG005|Extension Period|starting another study|8|||
16261316|NCT01029340|39443031|FG000|Extension Period|non-compliance|0|||
16261317|NCT01029340|39443032|FG001|Extension Period|non-compliance|0|||
16151505|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
16151506|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
16151507|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
16151508|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
16151509|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
16151510|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
16151511|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
16442556|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
16442557|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
16442558|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
16151512|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
16151513|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
16151514|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
16261318|NCT01029340|39443033|FG002|Extension Period|non-compliance|0|||
16261319|NCT01029340|39443034|FG003|Extension Period|non-compliance|0|||
16261320|NCT01029340|39443035|FG004|Extension Period|non-compliance|0|||
16261321|NCT01029340|39443036|FG005|Extension Period|non-compliance|1|||
16261322|NCT01029340|39443031|FG000|Extension Period|Withdrawal by Subject|0|||
16261323|NCT01029340|39443032|FG001|Extension Period|Withdrawal by Subject|0|||
16261324|NCT01029340|39443033|FG002|Extension Period|Withdrawal by Subject|0|||
16261325|NCT01029340|39443034|FG003|Extension Period|Withdrawal by Subject|0|||
16261326|NCT01029340|39443035|FG004|Extension Period|Withdrawal by Subject|0|||
16261327|NCT01029340|39443036|FG005|Extension Period|Withdrawal by Subject|1|||
16261328|NCT01029340|39443031|FG000|Extension Period|Physician Decision|0|||
16261329|NCT01029340|39443032|FG001|Extension Period|Physician Decision|0|||
16261330|NCT01029340|39443033|FG002|Extension Period|Physician Decision|0|||
16261331|NCT01029340|39443034|FG003|Extension Period|Physician Decision|0|||
16261332|NCT01029340|39443035|FG004|Extension Period|Physician Decision|0|||
16261333|NCT01029340|39443036|FG005|Extension Period|Physician Decision|1|||
16261334|NCT01214850|39443037|FG000|Overall Study|Withdrawal by Subject|38|||
16261335|NCT01214850|39443038|FG001|Overall Study|Withdrawal by Subject|31|||
16261336|NCT01214850|39443039|FG002|Overall Study|Withdrawal by Subject|28|||
16261337|NCT01214850|39443037|FG000|Overall Study|Lost to Follow-up|124|||
16261338|NCT01214850|39443038|FG001|Overall Study|Lost to Follow-up|98|||
16261339|NCT01214850|39443039|FG002|Overall Study|Lost to Follow-up|123|||
16261340|NCT01214850|39443037|FG000|Overall Study|Protocol Violation|5|||
16261341|NCT01214850|39443038|FG001|Overall Study|Protocol Violation|5|||
16261342|NCT01214850|39443039|FG002|Overall Study|Protocol Violation|6|||
16261343|NCT01214850|39443037|FG000|Overall Study|Adverse event or death|11|||
16261344|NCT01214850|39443038|FG001|Overall Study|Adverse event or death|8|||
16261345|NCT01214850|39443039|FG002|Overall Study|Adverse event or death|3|||
16261346|NCT01214850|39443037|FG000|Overall Study|Inappropriate enrollment|2|||
16261347|NCT01214850|39443038|FG001|Overall Study|Inappropriate enrollment|1|||
16261348|NCT01214850|39443039|FG002|Overall Study|Inappropriate enrollment|0|||
16261349|NCT01214850|39443037|FG000|Overall Study|Administrative reason|1|||
16261350|NCT01214850|39443038|FG001|Overall Study|Administrative reason|0|||
16261351|NCT01214850|39443039|FG002|Overall Study|Administrative reason|0|||
16261352|NCT01214850|39443037|FG000|Overall Study|Unable to classify|2|||
16261353|NCT01214850|39443038|FG001|Overall Study|Unable to classify|1|||
16261354|NCT01214850|39443039|FG002|Overall Study|Unable to classify|1|||
16261355|NCT02388191|39443040|FG000|Overall Study|Patient did not receive IUD|1|||
16442559|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
16261356|NCT02388191|39443041|FG001|Overall Study|Patient did not receive IUD|0|||
16261357|NCT00004562|39443042|FG000|Overall Study|Lost to Follow-up|102|||
16442560|NCT03955146|40099880|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
16151515|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
16261358|NCT00004562|39443043|FG001|Overall Study|Lost to Follow-up|91|||
16261359|NCT00585689|39443044|FG000|Overall Study|Received different ABI-007 schedule|3|||
16261360|NCT00585689|39443044|FG000|Overall Study|Adverse Event|1|||
16261361|NCT00585689|39443044|FG000|Overall Study|Patient Declined Surgery|1|||
16261362|NCT00585689|39443044|FG000|Overall Study|Patient had unresectable disease|1|||
16261363|NCT00585689|39443044|FG000|Overall Study|Death|1|||
16261364|NCT04869787|39443047|FG000|Screening|Physician Decision|1|||
16261365|NCT04869787|39443047|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
16261366|NCT01313780|39443049|FG000|Overall Study|Lack of Efficacy|4|||
16261367|NCT01313780|39443050|FG001|Overall Study|Lack of Efficacy|2|||
16261368|NCT01313780|39443049|FG000|Overall Study|Adverse Event|6|||
16261369|NCT01313780|39443050|FG001|Overall Study|Adverse Event|11|||
16261370|NCT01313780|39443049|FG000|Overall Study|Withdrawal by Subject|2|||
16261371|NCT01313780|39443050|FG001|Overall Study|Withdrawal by Subject|8|||
16261372|NCT01313780|39443049|FG000|Overall Study|Protocol Violation|10|||
16261373|NCT01313780|39443050|FG001|Overall Study|Protocol Violation|4|||
16261374|NCT01313780|39443049|FG000|Overall Study|missing data|3|||
16261375|NCT01313780|39443050|FG001|Overall Study|missing data|3|||
16261376|NCT00003659|39443051|FG000|Overall Study|Withdrawal by Subject|3|||
16261377|NCT00259012|39443055|FG000|Overall Study|Adverse Event|0|||
16261378|NCT00259012|39443056|FG001|Overall Study|Adverse Event|1|||
16261379|NCT00259012|39443055|FG000|Overall Study|Withdrawal by Subject|1|||
16261380|NCT00259012|39443056|FG001|Overall Study|Withdrawal by Subject|0|||
16261381|NCT00259012|39443055|FG000|Overall Study|Physician Decision|0|||
16261382|NCT00259012|39443056|FG001|Overall Study|Physician Decision|1|||
16261383|NCT00259012|39443055|FG000|Overall Study|Lost to Follow-up|0|||
16261384|NCT00259012|39443056|FG001|Overall Study|Lost to Follow-up|1|||
16261385|NCT00259012|39443055|FG000|Overall Study|Protocol Violation|1|||
16261386|NCT00259012|39443056|FG001|Overall Study|Protocol Violation|1|||
16261387|NCT00268905|39443057|FG000|Overall Study|Adverse Event|3|||
16261388|NCT00268905|39443058|FG001|Overall Study|Adverse Event|0|||
16261389|NCT00268905|39443059|FG002|Overall Study|Adverse Event|4|||
16261390|NCT00268905|39443057|FG000|Overall Study|Lost to Follow-up|0|||
16261391|NCT00268905|39443058|FG001|Overall Study|Lost to Follow-up|1|||
16442561|NCT03955146|40099881|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
16442562|NCT03955146|40099882|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
16442563|NCT03955146|40099883|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
16442564|NCT01522976|40099884|FG000|Overall Study|Ineligible|4|||
16442565|NCT01522976|40099885|FG001|Overall Study|Ineligible|0|||
16442566|NCT01522976|40099886|FG002|Overall Study|Ineligible|1|||
16442567|NCT01522976|40099884|FG000|Overall Study|Death|7|||
16151516|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
16151517|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
16151518|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
16151519|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
16151520|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
16151521|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
16151522|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
16151523|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
16151524|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
16151525|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
16151526|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
16151527|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
16151528|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
16442568|NCT01522976|40099885|FG001|Overall Study|Death|6|||
16442569|NCT01522976|40099886|FG002|Overall Study|Death|2|||
16442570|NCT01522976|40099884|FG000|Overall Study|Still on treatment|9|||
16151529|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
16261392|NCT00268905|39443059|FG002|Overall Study|Lost to Follow-up|0|||
16261393|NCT00268905|39443057|FG000|Overall Study|Withdrawal by Subject|0|||
16261394|NCT00268905|39443058|FG001|Overall Study|Withdrawal by Subject|0|||
16442571|NCT01522976|40099885|FG001|Overall Study|Still on treatment|9|||
16442572|NCT01522976|40099886|FG002|Overall Study|Still on treatment|6|||
16442573|NCT01522976|40099884|FG000|Overall Study|Disease progression|28|||
16442574|NCT01522976|40099885|FG001|Overall Study|Disease progression|30|||
16442575|NCT01522976|40099886|FG002|Overall Study|Disease progression|25|||
16442576|NCT01522976|40099884|FG000|Overall Study|Adverse Event|17|||
16442577|NCT01522976|40099885|FG001|Overall Study|Adverse Event|7|||
16442578|NCT01522976|40099886|FG002|Overall Study|Adverse Event|18|||
16442579|NCT01522976|40099884|FG000|Overall Study|Refusal unrelated to adverse event|10|||
16261395|NCT00268905|39443059|FG002|Overall Study|Withdrawal by Subject|3|||
16442580|NCT01522976|40099885|FG001|Overall Study|Refusal unrelated to adverse event|13|||
16442581|NCT01522976|40099886|FG002|Overall Study|Refusal unrelated to adverse event|14|||
16151530|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
16261396|NCT00268905|39443057|FG000|Overall Study|Progressive Disease|28|||
16261397|NCT00268905|39443058|FG001|Overall Study|Progressive Disease|4|||
16261398|NCT00268905|39443059|FG002|Overall Study|Progressive Disease|3|||
16261399|NCT00268905|39443057|FG000|Overall Study|Physician Decision|3|||
16442582|NCT01522976|40099884|FG000|Overall Study|Not protocol specified|22|||
16261400|NCT00268905|39443058|FG001|Overall Study|Physician Decision|0|||
16261401|NCT00268905|39443059|FG002|Overall Study|Physician Decision|1|||
16261402|NCT00268905|39443057|FG000|Overall Study|Clinical Progression|9|||
16261403|NCT00268905|39443058|FG001|Overall Study|Clinical Progression|4|||
16261404|NCT00268905|39443059|FG002|Overall Study|Clinical Progression|1|||
16261405|NCT02089997|39443067|FG000|Overall Study|Case report forms uncollected|99|||
16261406|NCT02089997|39443067|FG000|Overall Study|Protocol Violation|147|||
16261407|NCT04129346|39443068|FG000|Overall Study|Death|1|||
16261408|NCT04129346|39443069|FG001|Overall Study|Death|0|||
16261409|NCT03912337|39443073|FG000|Overall Study|Withdrawal of Consent From Study|1|||
16261410|NCT03912337|39443074|FG001|Overall Study|Withdrawal of Consent From Study|0|||
16261411|NCT03912337|39443073|FG000|Overall Study|Lost to Follow-up|1|||
16261412|NCT03912337|39443074|FG001|Overall Study|Lost to Follow-up|1|||
16261413|NCT01435265|39443075|FG000|Overall Study|Lost to Follow-up|0|||
16261414|NCT01435265|39443076|FG001|Overall Study|Lost to Follow-up|1|||
16261415|NCT04405570|39443077|FG000|Overall Study|Adverse Event|0|||
16261416|NCT04405570|39443078|FG001|Overall Study|Adverse Event|1|||
16261417|NCT04405570|39443079|FG002|Overall Study|Adverse Event|1|||
16261418|NCT04405570|39443080|FG003|Overall Study|Adverse Event|1|||
16151531|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
16151532|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
16151533|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
16151534|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
16151535|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
16151536|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
16151537|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
16151538|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
16151539|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
16151540|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
16151541|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
16151542|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
16151543|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
16151544|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
16151545|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
16151546|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
16151547|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
16151548|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
16151549|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
16151550|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
16151551|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
16151552|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
16151553|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
16151554|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
16151555|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
16151556|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
16151557|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
16151558|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
16261419|NCT04405570|39443077|FG000|Overall Study|Lost to Follow-up|0|||
16261420|NCT04405570|39443078|FG001|Overall Study|Lost to Follow-up|1|||
16261421|NCT04405570|39443079|FG002|Overall Study|Lost to Follow-up|0|||
16261422|NCT04405570|39443080|FG003|Overall Study|Lost to Follow-up|0|||
16261423|NCT04405570|39443077|FG000|Overall Study|Physician Decision|0|||
16151559|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
16151560|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
16151561|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
16151562|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
16151563|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
16151564|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
16151565|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
16151566|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
16151567|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
16151568|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
16151569|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
16151570|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
16151571|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
16151572|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
16151573|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
16151574|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
16151575|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
16151576|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
16151577|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
16151578|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
16151579|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
16151580|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
16151581|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
16151582|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
16151583|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
16151584|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
16151585|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
16151586|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
16151587|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
16151588|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
16151589|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
16151590|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
16151591|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
16151592|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
16151593|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
16151594|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
16151595|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
16151596|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
16151597|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
16151598|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
16151599|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
16151600|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
16151601|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
16151602|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
16151603|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
16151604|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
16151605|NCT00111800|39040427|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
16151606|NCT00111800|39040428|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
16151607|NCT00111800|39040429|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
16151608|NCT00111800|39040430|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
16151609|NCT00111800|39040431|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
16151610|NCT00111800|39040432|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
16151611|NCT00111800|39040427|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
16151612|NCT00111800|39040428|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
16151613|NCT00111800|39040429|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
16151614|NCT00111800|39040430|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
16151615|NCT00111800|39040431|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
16151616|NCT00111800|39040432|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
16151617|NCT00111800|39040427|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
16151618|NCT00111800|39040428|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
16151619|NCT00111800|39040429|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
16151620|NCT00111800|39040430|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
16151621|NCT00111800|39040431|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
16151622|NCT00111800|39040432|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
16151623|NCT00111800|39040427|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
16151624|NCT00111800|39040428|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
16151625|NCT00111800|39040429|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
16151626|NCT00111800|39040430|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
16151627|NCT00111800|39040431|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
16151628|NCT00111800|39040432|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
16151629|NCT00111800|39040427|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
16151630|NCT00111800|39040428|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
16151631|NCT00111800|39040429|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
16151632|NCT00111800|39040430|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
16151633|NCT00111800|39040431|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
16151634|NCT00111800|39040432|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
16151635|NCT00111800|39040427|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
16151636|NCT00111800|39040428|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
16151637|NCT00111800|39040429|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
16151638|NCT00111800|39040430|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
16151639|NCT00111800|39040431|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
16151640|NCT00111800|39040432|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
16151641|NCT00111800|39040427|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
16151642|NCT00111800|39040428|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
16151643|NCT00111800|39040429|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
16151644|NCT00111800|39040430|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
16151645|NCT00111800|39040431|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
16151646|NCT00111800|39040432|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
16151647|NCT00111800|39040427|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
16151648|NCT00111800|39040428|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
16151649|NCT00111800|39040429|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
16151650|NCT00111800|39040430|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
16151651|NCT00111800|39040431|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
16151652|NCT00111800|39040432|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
16151653|NCT00111800|39040427|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
16151654|NCT00111800|39040428|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
16151655|NCT00111800|39040429|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
16151656|NCT00111800|39040430|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
16151657|NCT00111800|39040431|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
16151658|NCT00111800|39040432|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
16151659|NCT04419610|39040433|FG000|Overall Study|Withdrawal by Subject|3|||
16151660|NCT04419610|39040434|FG001|Overall Study|Withdrawal by Subject|1|||
16151661|NCT04419610|39040433|FG000|Overall Study|Adverse Event|1|||
16151662|NCT04419610|39040434|FG001|Overall Study|Adverse Event|0|||
16151663|NCT04419610|39040433|FG000|Overall Study|discharged early|1|||
16151664|NCT04419610|39040434|FG001|Overall Study|discharged early|1|||
16151665|NCT05661851|39040435|FG000|Overall Study|Protocol Violation|1|||
16151666|NCT05661851|39040436|FG001|Overall Study|Protocol Violation|1|||
16151667|NCT05661851|39040435|FG000|Overall Study|Covid-19 Related|3|||
16151668|NCT05661851|39040436|FG001|Overall Study|Covid-19 Related|4|||
16151669|NCT05661851|39040435|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
16151670|NCT05661851|39040436|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
16151671|NCT05661851|39040435|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
16151672|NCT05661851|39040436|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
16151673|NCT00176605|39040437|FG000|Overall Study|Withdrawal by Subject|2|||
16151674|NCT01549002|39040438|FG000|Overall Study|Excessive pain|0|||
16151675|NCT01549002|39040439|FG001|Overall Study|Excessive pain|2|||
16151676|NCT01549002|39040438|FG000|Overall Study|Moderate sedation required|0|||
16151677|NCT01549002|39040439|FG001|Overall Study|Moderate sedation required|2|||
16151678|NCT04050982|39040440|FG000|Overall Study|Did not meet eligibility criteria|0|||
16151679|NCT04050982|39040441|FG001|Overall Study|Did not meet eligibility criteria|1|||
16151680|NCT04050982|39040442|FG002|Overall Study|Did not meet eligibility criteria|0|||
16151681|NCT04050982|39040440|FG000|Overall Study|Withdrawal by Subject|1|||
16151682|NCT04050982|39040441|FG001|Overall Study|Withdrawal by Subject|0|||
16151683|NCT04050982|39040442|FG002|Overall Study|Withdrawal by Subject|0|||
16151684|NCT04050982|39040440|FG000|Overall Study|Unable to enroll on platform|1|||
16151685|NCT04050982|39040441|FG001|Overall Study|Unable to enroll on platform|0|||
16151686|NCT04050982|39040442|FG002|Overall Study|Unable to enroll on platform|0|||
16151687|NCT01111851|39040446|FG000|Overall Study|All planned PET scans were not obtained.|2|||
16151688|NCT01111851|39040447|FG001|Overall Study|All planned PET scans were not obtained.|0|||
16151689|NCT00129766|39040450|FG000|Overall Study|Death|3|||
16151690|NCT00129766|39040451|FG001|Overall Study|Death|8|||
16151691|NCT00129766|39040450|FG000|Overall Study|Withdrawal of consent|31|||
16151692|NCT00129766|39040451|FG001|Overall Study|Withdrawal of consent|30|||
16151693|NCT00129766|39040450|FG000|Overall Study|Lost to Follow-up|26|||
16151694|NCT00129766|39040451|FG001|Overall Study|Lost to Follow-up|21|||
16151695|NCT00960843|39040452|FG000|Overall Study|Lost to Follow-up|2|||
16151696|NCT00960843|39040453|FG001|Overall Study|Lost to Follow-up|0|||
16151697|NCT00960843|39040452|FG000|Overall Study|Protocol Violation|0|||
16151698|NCT00960843|39040453|FG001|Overall Study|Protocol Violation|4|||
16151699|NCT00960843|39040452|FG000|Overall Study|Repeated needle dislodgment|0|||
16151700|NCT00960843|39040453|FG001|Overall Study|Repeated needle dislodgment|1|||
16151701|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
16151702|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
16151703|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
16151704|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
16151705|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
16151706|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
16151707|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
16151708|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
16151709|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
16151710|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
16151711|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
16151712|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
16151713|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
16151714|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
16151715|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
16151716|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
16151717|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
16151718|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
16151719|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
16151720|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
16151721|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
16151722|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
16151723|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
16151724|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
16151725|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Death|2|||
16151726|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Death|1|||
16151727|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Death|0|||
16151728|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Death|0|||
16151729|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
16151730|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
16151731|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
16151732|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
16151733|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
16151734|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
16151735|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
16151736|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
16151737|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
16151738|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
16151739|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
16151740|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
16151741|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
16151742|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
16442583|NCT01522976|40099885|FG001|Overall Study|Not protocol specified|27|||
16442584|NCT01522976|40099886|FG002|Overall Study|Not protocol specified|27|||
16442585|NCT04058067|40099887|FG000|Overall Study|Adverse Event|2|||
16151743|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
16151744|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
16151745|NCT01940471|39040454|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
16151746|NCT01940471|39040455|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
16151747|NCT01940471|39040456|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
16442586|NCT04058067|40099888|FG001|Overall Study|Adverse Event|0|||
16442587|NCT04058067|40099887|FG000|Overall Study|Death|0|||
16365849|NCT00165698|39825345|FG000|Overall Study|Adverse Event|2|||
16365850|NCT00165698|39825346|FG001|Overall Study|Adverse Event|10|||
16365851|NCT00165698|39825345|FG000|Overall Study|Lost to Follow-up|2|||
16365852|NCT00165698|39825346|FG001|Overall Study|Lost to Follow-up|2|||
16365853|NCT00165698|39825345|FG000|Overall Study|Withdrawal by Subject|2|||
16365854|NCT00165698|39825346|FG001|Overall Study|Withdrawal by Subject|1|||
16365855|NCT00165698|39825345|FG000|Overall Study|Protocol Violation|1|||
16365856|NCT00165698|39825346|FG001|Overall Study|Protocol Violation|0|||
16365857|NCT00165698|39825345|FG000|Overall Study|Not Taken/Lost the medicine|1|||
16365858|NCT00165698|39825346|FG001|Overall Study|Not Taken/Lost the medicine|2|||
16365859|NCT01028391|39825347|FG000|Overall Study|Adverse Event|4|||
16365860|NCT01028391|39825348|FG001|Overall Study|Adverse Event|0|||
16365861|NCT01028391|39825347|FG000|Overall Study|Lack of Efficacy|0|||
16365862|NCT01028391|39825348|FG001|Overall Study|Lack of Efficacy|2|||
16365863|NCT01028391|39825347|FG000|Overall Study|Lost to Follow-up|3|||
16365864|NCT01028391|39825348|FG001|Overall Study|Lost to Follow-up|4|||
16365865|NCT01028391|39825347|FG000|Overall Study|Physician Decision|0|||
16365866|NCT01028391|39825348|FG001|Overall Study|Physician Decision|1|||
16365867|NCT01028391|39825347|FG000|Overall Study|Withdrawal by Subject|6|||
16365868|NCT01028391|39825348|FG001|Overall Study|Withdrawal by Subject|3|||
16365869|NCT01028391|39825347|FG000|Overall Study|Needed excluded medication|1|||
16365870|NCT01028391|39825348|FG001|Overall Study|Needed excluded medication|1|||
16365871|NCT03607695|39825351|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
16365872|NCT03607695|39825351|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
16365873|NCT00632359|39825352|FG000|Overall Study|Withdrawal by Subject|2|||
16365874|NCT00081458|39825356|FG000|Overall Study|Adverse Event|1|||
16365875|NCT00081458|39825357|FG001|Overall Study|Adverse Event|5|||
16365876|NCT00081458|39825358|FG002|Overall Study|Adverse Event|2|||
16365877|NCT00081458|39825356|FG000|Overall Study|Withdrawal by Subject|0|||
16365878|NCT00081458|39825357|FG001|Overall Study|Withdrawal by Subject|3|||
16365879|NCT00081458|39825358|FG002|Overall Study|Withdrawal by Subject|1|||
16365880|NCT00081458|39825356|FG000|Overall Study|Randomized but not dosed|0|||
16365881|NCT00081458|39825357|FG001|Overall Study|Randomized but not dosed|0|||
16365882|NCT00081458|39825358|FG002|Overall Study|Randomized but not dosed|1|||
16365883|NCT02811159|39825367|FG000|Treatment Course 1|Lost to Follow-up|1|||
16365884|NCT00485303|39825368|FG000|Overall Study|Adverse Event|5|||
16365885|NCT00485303|39825368|FG000|Overall Study|Progressive Disease|44|||
16365886|NCT00485303|39825368|FG000|Overall Study|Other|3|||
16365887|NCT00485303|39825368|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
16365888|NCT00485303|39825368|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
16365889|NCT03003468|39825369|FG000|Overall Study|Withdrawal by Subject|0|||
16365890|NCT03003468|39825370|FG001|Overall Study|Withdrawal by Subject|0|||
16365891|NCT03003468|39825371|FG002|Overall Study|Withdrawal by Subject|1|||
16365892|NCT03003468|39825369|FG000|Overall Study|No measurable lesions|0|||
16365893|NCT03003468|39825370|FG001|Overall Study|No measurable lesions|0|||
16365894|NCT03003468|39825371|FG002|Overall Study|No measurable lesions|1|||
16365895|NCT05436288|39825372|FG000|Overall Study|Lost to Follow-up|1|||
16365896|NCT05436288|39825372|FG000|Overall Study|Adverse Event|1|||
16365897|NCT02421510|39825373|FG000|Overall Study|Other|4|||
16365898|NCT02421510|39825374|FG001|Overall Study|Other|2|||
16365899|NCT02421510|39825375|FG002|Overall Study|Other|3|||
16365900|NCT02421510|39825373|FG000|Overall Study|Protocol Violation|1|||
16365901|NCT02421510|39825374|FG001|Overall Study|Protocol Violation|2|||
16365902|NCT02421510|39825375|FG002|Overall Study|Protocol Violation|0|||
16365903|NCT02421510|39825373|FG000|Overall Study|Death|1|||
16365904|NCT02421510|39825374|FG001|Overall Study|Death|0|||
16365905|NCT02421510|39825375|FG002|Overall Study|Death|0|||
16365906|NCT02421510|39825373|FG000|Overall Study|Noncompliance with study drug|1|||
16365907|NCT02421510|39825374|FG001|Overall Study|Noncompliance with study drug|0|||
16365908|NCT02421510|39825375|FG002|Overall Study|Noncompliance with study drug|0|||
16365909|NCT02421510|39825373|FG000|Overall Study|Physician Decision|1|||
16365910|NCT02421510|39825374|FG001|Overall Study|Physician Decision|1|||
16365911|NCT02421510|39825375|FG002|Overall Study|Physician Decision|3|||
16365912|NCT02421510|39825373|FG000|Overall Study|Adverse Event|9|||
16365913|NCT02421510|39825374|FG001|Overall Study|Adverse Event|10|||
16365914|NCT02421510|39825375|FG002|Overall Study|Adverse Event|18|||
16365915|NCT02421510|39825373|FG000|Overall Study|Pregnancy|1|||
16365916|NCT02421510|39825374|FG001|Overall Study|Pregnancy|1|||
16151748|NCT01940471|39040457|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
16151749|NCT01940471|39040454|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
16151750|NCT01940471|39040455|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
16151751|NCT01940471|39040456|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
16151752|NCT01940471|39040457|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
16151753|NCT01940471|39040454|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
16261424|NCT04405570|39443078|FG001|Overall Study|Physician Decision|0|||
16261425|NCT04405570|39443079|FG002|Overall Study|Physician Decision|1|||
16261426|NCT04405570|39443080|FG003|Overall Study|Physician Decision|0|||
16365917|NCT02421510|39825375|FG002|Overall Study|Pregnancy|0|||
16365918|NCT02421510|39825373|FG000|Overall Study|Withdrawal by Subject|14|||
16365919|NCT02421510|39825374|FG001|Overall Study|Withdrawal by Subject|18|||
16365920|NCT02421510|39825375|FG002|Overall Study|Withdrawal by Subject|12|||
16365921|NCT02421510|39825373|FG000|Overall Study|Lost to Follow-up|1|||
16365922|NCT02421510|39825374|FG001|Overall Study|Lost to Follow-up|1|||
16365923|NCT02421510|39825375|FG002|Overall Study|Lost to Follow-up|0|||
16365924|NCT02927145|39825376|FG000|Initial Recruitment|Withdrawal by Subject|0|||
16365925|NCT02927145|39825377|FG001|Initial Recruitment|Withdrawal by Subject|1|||
16365926|NCT02927145|39825378|FG002|Initial Recruitment|Withdrawal by Subject|1|||
16365927|NCT02927145|39825379|FG003|Initial Recruitment|Withdrawal by Subject|4|||
16261427|NCT04405570|39443077|FG000|Overall Study|Withdrawal by Subject|0|||
16261428|NCT04405570|39443078|FG001|Overall Study|Withdrawal by Subject|1|||
16261429|NCT04405570|39443079|FG002|Overall Study|Withdrawal by Subject|1|||
16261430|NCT04405570|39443080|FG003|Overall Study|Withdrawal by Subject|0|||
16261431|NCT04405570|39443077|FG000|Overall Study|Randomized not dosed|0|||
16261432|NCT04405570|39443078|FG001|Overall Study|Randomized not dosed|2|||
16261433|NCT04405570|39443079|FG002|Overall Study|Randomized not dosed|0|||
16261434|NCT04405570|39443080|FG003|Overall Study|Randomized not dosed|0|||
16261435|NCT02794974|39443081|FG000|Overall Study|Physician Decision|0|||
16261436|NCT02794974|39443082|FG001|Overall Study|Physician Decision|1|||
16261437|NCT03206177|39443083|FG000|Overall Study|Withdrawal by Subject|1|||
16261438|NCT02373098|39443084|FG000|Overall Study|Lost to Follow-up|1|||
16261439|NCT02373098|39443085|FG001|Overall Study|Lost to Follow-up|0|||
16261440|NCT02373098|39443084|FG000|Overall Study|Protocol Violation|3|||
16261441|NCT02373098|39443085|FG001|Overall Study|Protocol Violation|0|||
16261442|NCT02373098|39443084|FG000|Overall Study|Withdrawal by Subject|5|||
16261443|NCT02373098|39443085|FG001|Overall Study|Withdrawal by Subject|0|||
16261444|NCT02373098|39443084|FG000|Overall Study|Adverse Event|3|||
16261445|NCT02373098|39443085|FG001|Overall Study|Adverse Event|0|||
16261446|NCT02847650|39443088|FG000|Overall Study|Adverse Event|2|||
16261447|NCT02847650|39443089|FG001|Overall Study|Adverse Event|4|||
16261448|NCT02847650|39443088|FG000|Overall Study|Lost to Follow-up|1|||
16261449|NCT02847650|39443089|FG001|Overall Study|Lost to Follow-up|0|||
16261450|NCT02847650|39443088|FG000|Overall Study|Protocol Violation|0|||
16261451|NCT02847650|39443089|FG001|Overall Study|Protocol Violation|1|||
16261452|NCT02847650|39443088|FG000|Overall Study|Withdrawal by Subject|1|||
16261453|NCT02847650|39443089|FG001|Overall Study|Withdrawal by Subject|1|||
16261454|NCT00609674|39443095|FG000|Overall Study|Adverse Event|1|||
16261455|NCT00609674|39443096|FG001|Overall Study|Adverse Event|1|||
16261456|NCT00609674|39443095|FG000|Overall Study|Protocol Violation|3|||
16261457|NCT00609674|39443096|FG001|Overall Study|Protocol Violation|5|||
16261458|NCT00609674|39443095|FG000|Overall Study|Lost to Follow-up|1|||
16261459|NCT00609674|39443096|FG001|Overall Study|Lost to Follow-up|0|||
16261460|NCT00609674|39443095|FG000|Overall Study|Withdrew consent|2|||
16261461|NCT00609674|39443096|FG001|Overall Study|Withdrew consent|1|||
16261462|NCT02024932|39443099|FG000|Overall Study|Adverse Event|2|||
16261463|NCT02024932|39443100|FG001|Overall Study|Adverse Event|3|||
16261464|NCT02024932|39443101|FG002|Overall Study|Adverse Event|0|||
16261465|NCT02024932|39443102|FG003|Overall Study|Adverse Event|0|||
16261466|NCT02024932|39443103|FG004|Overall Study|Adverse Event|2|||
16261467|NCT02024932|39443104|FG005|Overall Study|Adverse Event|0|||
16261468|NCT02024932|39443099|FG000|Overall Study|Abnormal laboratory value|0|||
16261469|NCT02024932|39443100|FG001|Overall Study|Abnormal laboratory value|0|||
16261470|NCT02024932|39443101|FG002|Overall Study|Abnormal laboratory value|0|||
16261471|NCT02024932|39443102|FG003|Overall Study|Abnormal laboratory value|2|||
16261472|NCT02024932|39443103|FG004|Overall Study|Abnormal laboratory value|0|||
16261473|NCT02024932|39443104|FG005|Overall Study|Abnormal laboratory value|0|||
16261474|NCT00727961|39443105|FG000|Overall Study|Lost to Follow-up|1|||
16261475|NCT00727961|39443105|FG000|Overall Study|Adverse Event|4|||
16261476|NCT00727961|39443105|FG000|Overall Study|Patient's refusal|2|||
16261477|NCT00727961|39443105|FG000|Overall Study|Progression|30|||
16261478|NCT02909907|39443107|FG000|Overall Study|Withdrawal by Subject|0|||
16261479|NCT02909907|39443108|FG001|Overall Study|Withdrawal by Subject|1|||
16261480|NCT02918877|39443109|FG000|Overall Study|Withdrawal by Subject|2|||
16261481|NCT02918877|39443110|FG001|Overall Study|Withdrawal by Subject|2|||
16261482|NCT02918877|39443109|FG000|Overall Study|Surgery cancelled|1|||
16261483|NCT02918877|39443110|FG001|Overall Study|Surgery cancelled|0|||
16261484|NCT02918877|39443109|FG000|Overall Study|Physician Decision|1|||
16261485|NCT02918877|39443110|FG001|Overall Study|Physician Decision|0|||
16261486|NCT02918877|39443109|FG000|Overall Study|Received intraoperative steroids|1|||
16261487|NCT02918877|39443110|FG001|Overall Study|Received intraoperative steroids|0|||
16261488|NCT02918877|39443109|FG000|Overall Study|Unable to obtain lab samples|1|||
16261489|NCT02918877|39443110|FG001|Overall Study|Unable to obtain lab samples|0|||
16261490|NCT02918877|39443109|FG000|Overall Study|Unsafe to perform BAL|0|||
16261491|NCT02918877|39443110|FG001|Overall Study|Unsafe to perform BAL|1|||
16261492|NCT00617305|39443111|FG000|Overall Study|Adverse Event|4|||
16261493|NCT00617305|39443112|FG001|Overall Study|Adverse Event|0|||
16261494|NCT00617305|39443113|FG002|Overall Study|Adverse Event|0|||
16261495|NCT00617305|39443111|FG000|Overall Study|Death|1|||
16261496|NCT00617305|39443112|FG001|Overall Study|Death|0|||
16261497|NCT00617305|39443113|FG002|Overall Study|Death|0|||
16261498|NCT00617305|39443111|FG000|Overall Study|Physician Decision|1|||
16261499|NCT00617305|39443112|FG001|Overall Study|Physician Decision|0|||
16261500|NCT00617305|39443113|FG002|Overall Study|Physician Decision|0|||
16261501|NCT00617305|39443111|FG000|Overall Study|Protocol Violation|1|||
16261502|NCT00617305|39443112|FG001|Overall Study|Protocol Violation|0|||
16261503|NCT00617305|39443113|FG002|Overall Study|Protocol Violation|1|||
16261504|NCT00617305|39443111|FG000|Overall Study|Withdrawal by Subject|1|||
16261505|NCT00617305|39443112|FG001|Overall Study|Withdrawal by Subject|0|||
16261506|NCT00617305|39443113|FG002|Overall Study|Withdrawal by Subject|0|||
16261507|NCT00473330|39443118|FG000|Core Study|Adverse Event|4|||
16261508|NCT00473330|39443119|FG001|Core Study|Adverse Event|4|||
16261509|NCT00473330|39443120|FG002|Core Study|Adverse Event|1|||
16261510|NCT00473330|39443118|FG000|Core Study|Death|6|||
16261511|NCT00473330|39443119|FG001|Core Study|Death|4|||
16261512|NCT00473330|39443120|FG002|Core Study|Death|4|||
16261513|NCT00473330|39443118|FG000|Core Study|Lost to Follow-up|5|||
16261514|NCT00473330|39443119|FG001|Core Study|Lost to Follow-up|5|||
16261515|NCT00473330|39443120|FG002|Core Study|Lost to Follow-up|10|||
16261516|NCT00473330|39443118|FG000|Core Study|Physician Decision|2|||
16261517|NCT00473330|39443119|FG001|Core Study|Physician Decision|1|||
16261518|NCT00473330|39443120|FG002|Core Study|Physician Decision|3|||
16261519|NCT00473330|39443118|FG000|Core Study|Subject Non-compliance|1|||
16261520|NCT00473330|39443119|FG001|Core Study|Subject Non-compliance|2|||
16261521|NCT00473330|39443120|FG002|Core Study|Subject Non-compliance|1|||
16261522|NCT00473330|39443118|FG000|Core Study|Subject Required Other Therapy|0|||
16261523|NCT00473330|39443119|FG001|Core Study|Subject Required Other Therapy|1|||
16261524|NCT00473330|39443120|FG002|Core Study|Subject Required Other Therapy|3|||
16261525|NCT00473330|39443118|FG000|Core Study|Subject's Decision|9|||
16261526|NCT00473330|39443119|FG001|Core Study|Subject's Decision|8|||
16261527|NCT00473330|39443120|FG002|Core Study|Subject's Decision|19|||
16261528|NCT00473330|39443118|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
16261529|NCT00473330|39443119|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
16261530|NCT00473330|39443120|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
16261531|NCT00473330|39443118|FG000|Open-label Extension Through Month 48|Death|2|||
16261532|NCT00473330|39443119|FG001|Open-label Extension Through Month 48|Death|0|||
16442588|NCT04058067|40099888|FG001|Overall Study|Death|1|||
16442589|NCT04058067|40099887|FG000|Overall Study|Physician Decision|3|||
16442590|NCT04058067|40099888|FG001|Overall Study|Physician Decision|1|||
16442591|NCT04058067|40099887|FG000|Overall Study|Protocol Violation|0|||
16442592|NCT04058067|40099888|FG001|Overall Study|Protocol Violation|1|||
16442593|NCT04058067|40099887|FG000|Overall Study|Withdrawal by Subject|7|||
16442594|NCT04058067|40099888|FG001|Overall Study|Withdrawal by Subject|8|||
16442595|NCT03779334|40099889|FG000|Overall Study|Withdrawal by Subject|3|||
16442596|NCT03779334|40099890|FG001|Overall Study|Withdrawal by Subject|0|||
16442597|NCT03779334|40099891|FG002|Overall Study|Withdrawal by Subject|0|||
16442598|NCT03779334|40099889|FG000|Overall Study|Ongoing in Study|5|||
16442599|NCT03779334|40099890|FG001|Overall Study|Ongoing in Study|13|||
16442600|NCT03779334|40099891|FG002|Overall Study|Ongoing in Study|5|||
16442601|NCT05135767|40099904|FG000|Baseline|Lost to Follow-up|1|||
16442602|NCT05135767|40099905|FG001|Baseline|Lost to Follow-up|1|||
16442603|NCT05135767|40099904|FG000|Baseline|Withdrawal by Subject|0|||
16151754|NCT01940471|39040455|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
16151755|NCT01940471|39040456|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
16151756|NCT01940471|39040457|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
16151757|NCT01940471|39040454|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
16151758|NCT01940471|39040455|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
16151759|NCT01940471|39040456|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
16151760|NCT01940471|39040457|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
16151761|NCT01940471|39040454|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
16151762|NCT01940471|39040455|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
16151763|NCT01940471|39040456|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
16151764|NCT01940471|39040457|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
16151765|NCT01940471|39040454|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
16151766|NCT01940471|39040455|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
16151767|NCT01940471|39040456|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
16151768|NCT01940471|39040457|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
16151769|NCT01940471|39040454|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
16151770|NCT01940471|39040455|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
16151771|NCT01940471|39040456|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
16151772|NCT01940471|39040457|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
16151773|NCT01940471|39040454|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
16151774|NCT01940471|39040455|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
16151775|NCT01940471|39040456|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
16151776|NCT01940471|39040457|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
16151777|NCT01940471|39040454|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
16442604|NCT05135767|40099905|FG001|Baseline|Withdrawal by Subject|2|||
16442605|NCT05135767|40099904|FG000|Active Study Phase|Lost to Follow-up|2|||
16442606|NCT05135767|40099905|FG001|Active Study Phase|Lost to Follow-up|0|||
16442607|NCT02052778|40099908|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
16442608|NCT02052778|40099909|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
16442609|NCT02052778|40099910|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
16442610|NCT02052778|40099911|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
16151778|NCT01940471|39040455|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
16151779|NCT01940471|39040456|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
16151780|NCT01940471|39040457|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
16151781|NCT01940471|39040454|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
16151782|NCT01940471|39040455|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
16151783|NCT01940471|39040456|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
16151784|NCT01940471|39040457|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
16151785|NCT02343159|39040465|FG000|Overall Study|Early Study Termination|16|||
16151786|NCT02343159|39040466|FG001|Overall Study|Early Study Termination|19|||
16151787|NCT02343159|39040467|FG002|Overall Study|Early Study Termination|23|||
16442611|NCT02052778|40099912|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
16442612|NCT02052778|40099913|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
16442613|NCT02052778|40099914|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
16442614|NCT02052778|40099915|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
16442615|NCT02052778|40099916|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
16442616|NCT02052778|40099917|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
16442617|NCT02052778|40099918|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
16442618|NCT02052778|40099919|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
16442619|NCT02052778|40099920|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
16442620|NCT02052778|40099921|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
16442621|NCT02052778|40099922|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
16442622|NCT02052778|40099923|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
16442623|NCT02052778|40099924|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
16442624|NCT02052778|40099925|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
16442625|NCT02052778|40099926|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
16442626|NCT02052778|40099927|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
16442627|NCT02052778|40099928|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
16442628|NCT02052778|40099929|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
16442629|NCT02052778|40099930|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
16442630|NCT02052778|40099908|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
16442631|NCT02052778|40099909|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
16442632|NCT02052778|40099910|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
16151788|NCT02343159|39040465|FG000|Overall Study|Physician Decision|2|||
16151789|NCT02343159|39040466|FG001|Overall Study|Physician Decision|0|||
16151790|NCT02343159|39040467|FG002|Overall Study|Physician Decision|1|||
16151791|NCT02343159|39040465|FG000|Overall Study|Withdrawal by Subject|3|||
16151792|NCT02343159|39040466|FG001|Overall Study|Withdrawal by Subject|0|||
16151793|NCT02343159|39040467|FG002|Overall Study|Withdrawal by Subject|2|||
16151794|NCT02343159|39040465|FG000|Overall Study|Lost to Follow-up|0|||
16151795|NCT02343159|39040466|FG001|Overall Study|Lost to Follow-up|2|||
16151796|NCT02343159|39040467|FG002|Overall Study|Lost to Follow-up|2|||
16151797|NCT02343159|39040465|FG000|Overall Study|Adverse Event|4|||
16151798|NCT02343159|39040466|FG001|Overall Study|Adverse Event|4|||
16151799|NCT02343159|39040467|FG002|Overall Study|Adverse Event|2|||
16442633|NCT02052778|40099911|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
16442634|NCT02052778|40099912|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
16442635|NCT02052778|40099913|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
16442636|NCT02052778|40099914|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
16442637|NCT02052778|40099915|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
16442638|NCT02052778|40099916|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
16442639|NCT02052778|40099917|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16442640|NCT02052778|40099918|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16442641|NCT02052778|40099919|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
16442642|NCT02052778|40099920|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
16442643|NCT02052778|40099921|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
16151800|NCT02343159|39040465|FG000|Overall Study|Sponsor Decision|0|||
16151801|NCT02343159|39040466|FG001|Overall Study|Sponsor Decision|1|||
16151802|NCT02343159|39040467|FG002|Overall Study|Sponsor Decision|0|||
16151803|NCT02343159|39040465|FG000|Overall Study|Enrollment Error|1|||
16151804|NCT02343159|39040466|FG001|Overall Study|Enrollment Error|0|||
16365928|NCT02927145|39825380|FG004|Initial Recruitment|Withdrawal by Subject|1|||
16365929|NCT02927145|39825381|FG005|Initial Recruitment|Withdrawal by Subject|1|||
16365930|NCT02927145|39825382|FG006|Initial Recruitment|Withdrawal by Subject|0|||
16365931|NCT02927145|39825383|FG007|Initial Recruitment|Withdrawal by Subject|0|||
16365932|NCT02927145|39825384|FG008|Initial Recruitment|Withdrawal by Subject|2|||
16365933|NCT02927145|39825376|FG000|Initial Recruitment|Adverse Event|0|||
16365934|NCT02927145|39825377|FG001|Initial Recruitment|Adverse Event|0|||
16365935|NCT02927145|39825378|FG002|Initial Recruitment|Adverse Event|0|||
16365936|NCT02927145|39825379|FG003|Initial Recruitment|Adverse Event|0|||
16365937|NCT02927145|39825380|FG004|Initial Recruitment|Adverse Event|2|||
16365938|NCT02927145|39825381|FG005|Initial Recruitment|Adverse Event|0|||
16365939|NCT02927145|39825382|FG006|Initial Recruitment|Adverse Event|0|||
16365940|NCT02927145|39825383|FG007|Initial Recruitment|Adverse Event|0|||
16365941|NCT02927145|39825384|FG008|Initial Recruitment|Adverse Event|0|||
16365942|NCT02927145|39825376|FG000|Invitation for Additional Challenge|Pregnancy|0|||
16365943|NCT02927145|39825377|FG001|Invitation for Additional Challenge|Pregnancy|0|||
16365944|NCT02927145|39825378|FG002|Invitation for Additional Challenge|Pregnancy|0|||
16365945|NCT02927145|39825379|FG003|Invitation for Additional Challenge|Pregnancy|0|||
16365946|NCT02927145|39825380|FG004|Invitation for Additional Challenge|Pregnancy|0|||
16365947|NCT02927145|39825381|FG005|Invitation for Additional Challenge|Pregnancy|0|||
16365948|NCT02927145|39825382|FG006|Invitation for Additional Challenge|Pregnancy|1|||
16365949|NCT02927145|39825383|FG007|Invitation for Additional Challenge|Pregnancy|0|||
16365950|NCT02927145|39825384|FG008|Invitation for Additional Challenge|Pregnancy|0|||
16365951|NCT02181738|39825385|FG000|Overall Study|Participant Withdrew Consent|2|||
16442644|NCT02052778|40099922|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16442645|NCT02052778|40099923|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16442646|NCT02052778|40099924|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16442647|NCT02052778|40099925|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16442648|NCT02052778|40099926|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16442649|NCT02052778|40099927|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16442650|NCT02052778|40099928|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16442651|NCT02052778|40099929|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16442652|NCT02052778|40099930|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
16151805|NCT02343159|39040467|FG002|Overall Study|Enrollment Error|0|||
16151806|NCT01309659|39040483|FG000|Overall Study|Protocol Violation|0|||
16151807|NCT01309659|39040484|FG001|Overall Study|Protocol Violation|1|||
16151808|NCT00357500|39044030|FG000|Overall Study|Adverse Event|3|||
16151809|NCT00357500|39044030|FG000|Overall Study|Withdrawal by Subject|5|||
16151810|NCT00357500|39044030|FG000|Overall Study|Progressive Disease|65|||
16151811|NCT00357500|39044030|FG000|Overall Study|Not Started Protocol Therapy|4|||
16151812|NCT02232802|39044038|FG000|Period 1|Sponsor request|1|||
16151813|NCT02232802|39044039|FG001|Period 1|Sponsor request|0|||
16151814|NCT02232802|39044038|FG000|Period 1|Adverse Event|1|||
16365952|NCT02181738|39825386|FG001|Overall Study|Participant Withdrew Consent|1|||
16365953|NCT02181738|39825387|FG002|Overall Study|Participant Withdrew Consent|1|||
16365954|NCT02181738|39825388|FG003|Overall Study|Participant Withdrew Consent|1|||
16365955|NCT02181738|39825385|FG000|Overall Study|Lost to Follow-up|1|||
16365956|NCT02181738|39825386|FG001|Overall Study|Lost to Follow-up|2|||
16365957|NCT02181738|39825387|FG002|Overall Study|Lost to Follow-up|1|||
16365958|NCT02181738|39825388|FG003|Overall Study|Lost to Follow-up|1|||
16365959|NCT02181738|39825385|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
16365960|NCT02181738|39825386|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
16365961|NCT02181738|39825387|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
16365962|NCT02181738|39825388|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
16365963|NCT02181738|39825385|FG000|Overall Study|Poor/Non-Compliance|1|||
16442653|NCT02052778|40099908|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442654|NCT02052778|40099909|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442655|NCT02052778|40099910|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442656|NCT02052778|40099911|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442657|NCT02052778|40099912|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442658|NCT02052778|40099913|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442659|NCT02052778|40099914|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442660|NCT02052778|40099915|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442661|NCT02052778|40099916|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442662|NCT02052778|40099917|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442663|NCT02052778|40099918|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442664|NCT02052778|40099919|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442665|NCT02052778|40099920|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442666|NCT02052778|40099921|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
16442667|NCT02052778|40099922|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442668|NCT02052778|40099923|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442669|NCT02052778|40099924|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442670|NCT02052778|40099925|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442671|NCT02052778|40099926|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442672|NCT02052778|40099927|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442673|NCT02052778|40099928|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442674|NCT02052778|40099929|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16151815|NCT02232802|39044039|FG001|Period 1|Adverse Event|1|||
16151816|NCT01502709|39044042|FG000|Overall Study|Lost to Follow-up|4|||
16151817|NCT01502709|39044043|FG001|Overall Study|Lost to Follow-up|0|||
16151818|NCT00550680|39044044|FG000|Overall Study|Administrative Reasons|1|||
16151819|NCT00550680|39044044|FG000|Overall Study|Adverse Event|5|||
16151820|NCT00550680|39044044|FG000|Overall Study|Death|3|||
16151821|NCT00550680|39044044|FG000|Overall Study|Early Improvement|1|||
16151822|NCT00550680|39044044|FG000|Overall Study|Lost to Follow-up|3|||
16151823|NCT00550680|39044044|FG000|Overall Study|Lack of Efficacy|1|||
16151824|NCT00550680|39044044|FG000|Overall Study|Other|10|||
16151825|NCT00550680|39044044|FG000|Overall Study|Protocol Violation|7|||
16151826|NCT00550680|39044044|FG000|Overall Study|Refused Treatment|19|||
16151827|NCT00550680|39044044|FG000|Overall Study|Screen Failure|6|||
16151828|NCT00573430|39044045|FG000|Overall Study|Incorrect enrollment of randomization|0|||
16151829|NCT00573430|39044046|FG001|Overall Study|Incorrect enrollment of randomization|4|||
16151830|NCT00573430|39044047|FG002|Overall Study|Incorrect enrollment of randomization|3|||
16151831|NCT00573430|39044045|FG000|Overall Study|Adverse Event|0|||
16151832|NCT00573430|39044046|FG001|Overall Study|Adverse Event|0|||
16151833|NCT00573430|39044047|FG002|Overall Study|Adverse Event|2|||
16151834|NCT00573430|39044045|FG000|Overall Study|Withdrawal by Subject|1|||
16151835|NCT00573430|39044046|FG001|Overall Study|Withdrawal by Subject|0|||
16151836|NCT00573430|39044047|FG002|Overall Study|Withdrawal by Subject|1|||
16151837|NCT00573430|39044045|FG000|Overall Study|Protocol Violation|0|||
16151838|NCT00573430|39044046|FG001|Overall Study|Protocol Violation|1|||
16151839|NCT00573430|39044047|FG002|Overall Study|Protocol Violation|1|||
16151840|NCT00573430|39044045|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16151841|NCT00573430|39044046|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16151842|NCT00573430|39044047|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
16151843|NCT01372384|39044049|FG000|Overall Study|Progression of disease|3|||
16151844|NCT00879229|39044050|FG000|Overall Study|Study terminated by Sponsor|13|||
16151845|NCT00879229|39044051|FG001|Overall Study|Study terminated by Sponsor|12|||
16151846|NCT00879229|39044050|FG000|Overall Study|Death|4|||
16151847|NCT00879229|39044051|FG001|Overall Study|Death|2|||
16151848|NCT00879229|39044050|FG000|Overall Study|Adverse Event|2|||
16151849|NCT00879229|39044051|FG001|Overall Study|Adverse Event|0|||
16151850|NCT00879229|39044050|FG000|Overall Study|Withdrawal by Subject|1|||
16151851|NCT00879229|39044051|FG001|Overall Study|Withdrawal by Subject|0|||
16151852|NCT00879229|39044050|FG000|Overall Study|Clinical status did not improve|1|||
16151853|NCT00879229|39044051|FG001|Overall Study|Clinical status did not improve|0|||
16151854|NCT00879229|39044050|FG000|Overall Study|Other|1|||
16151855|NCT00879229|39044051|FG001|Overall Study|Other|0|||
16151856|NCT04169373|39044052|FG000|Week 1 to Week 14|Adverse Event|1|||
16151857|NCT04169373|39044053|FG001|Week 1 to Week 14|Adverse Event|0|||
16151858|NCT04169373|39044054|FG002|Week 1 to Week 14|Adverse Event|1|||
16151859|NCT04169373|39044055|FG003|Week 1 to Week 14|Adverse Event|2|||
16151860|NCT04169373|39044052|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
16151861|NCT04169373|39044053|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
16151862|NCT04169373|39044054|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
16151863|NCT04169373|39044055|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
16151864|NCT04169373|39044052|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
16151865|NCT04169373|39044053|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
16151866|NCT04169373|39044054|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
16151867|NCT04169373|39044055|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
16151868|NCT04169373|39044052|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
16151869|NCT04169373|39044053|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
16151870|NCT04169373|39044054|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
16151871|NCT04169373|39044055|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
16151872|NCT04169373|39044052|FG000|Week 1 to Week 14|Other|1|||
16151873|NCT04169373|39044053|FG001|Week 1 to Week 14|Other|3|||
16151874|NCT04169373|39044054|FG002|Week 1 to Week 14|Other|3|||
16151875|NCT04169373|39044055|FG003|Week 1 to Week 14|Other|5|||
16151876|NCT04169373|39044052|FG000|Week 14 to Week 52|Adverse Event|1|||
16151877|NCT04169373|39044053|FG001|Week 14 to Week 52|Adverse Event|0|||
16151878|NCT04169373|39044054|FG002|Week 14 to Week 52|Adverse Event|0|||
16151879|NCT04169373|39044055|FG003|Week 14 to Week 52|Adverse Event|1|||
16151880|NCT04169373|39044052|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
16151881|NCT04169373|39044053|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
16151882|NCT04169373|39044054|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
16151883|NCT04169373|39044055|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
16151884|NCT04169373|39044052|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
16151885|NCT04169373|39044053|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
16151886|NCT04169373|39044054|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
16151887|NCT04169373|39044055|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
16151888|NCT04169373|39044052|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
16151889|NCT04169373|39044053|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
16151890|NCT04169373|39044054|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
16151891|NCT04169373|39044055|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
16151892|NCT04169373|39044052|FG000|Week 14 to Week 52|Other|4|||
16151893|NCT04169373|39044053|FG001|Week 14 to Week 52|Other|5|||
16151894|NCT04169373|39044054|FG002|Week 14 to Week 52|Other|4|||
16442675|NCT02052778|40099930|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
16442676|NCT02052778|40099908|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
16442677|NCT02052778|40099909|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
16442678|NCT02052778|40099910|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
16442679|NCT02052778|40099911|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
16442680|NCT02052778|40099912|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
16442681|NCT02052778|40099913|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
16442682|NCT02052778|40099914|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
16442683|NCT02052778|40099915|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
16442684|NCT02052778|40099916|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
16442685|NCT02052778|40099917|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
16442686|NCT02052778|40099918|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
16442687|NCT02052778|40099919|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
16442688|NCT02052778|40099920|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
16442689|NCT02052778|40099921|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
16442690|NCT02052778|40099922|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
16442691|NCT02052778|40099923|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
16442692|NCT02052778|40099924|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
16442693|NCT02052778|40099925|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
16442694|NCT02052778|40099926|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
16442695|NCT02052778|40099927|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
16442696|NCT02052778|40099928|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
16442697|NCT02052778|40099929|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
16442698|NCT02052778|40099930|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
16442699|NCT02052778|40099908|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442700|NCT02052778|40099909|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442701|NCT02052778|40099910|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442702|NCT02052778|40099911|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442703|NCT02052778|40099912|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442704|NCT02052778|40099913|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442705|NCT02052778|40099914|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442706|NCT02052778|40099915|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442707|NCT02052778|40099916|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
16151895|NCT04169373|39044055|FG003|Week 14 to Week 52|Other|5|||
16151896|NCT04169373|39044052|FG000|Week 14 to Week 52|Ongoing|0|||
16151897|NCT04169373|39044053|FG001|Week 14 to Week 52|Ongoing|1|||
16151898|NCT04169373|39044054|FG002|Week 14 to Week 52|Ongoing|0|||
16151899|NCT04169373|39044055|FG003|Week 14 to Week 52|Ongoing|0|||
16151900|NCT03581786|39044056|FG000|Overall Study|Death|17|||
16151901|NCT03581786|39044057|FG001|Overall Study|Death|12|||
16442708|NCT02052778|40099917|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442709|NCT02052778|40099918|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442710|NCT02052778|40099919|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442711|NCT02052778|40099920|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442712|NCT02052778|40099921|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
16442713|NCT02052778|40099922|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442714|NCT02052778|40099923|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442715|NCT02052778|40099924|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442716|NCT02052778|40099925|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442717|NCT02052778|40099926|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442718|NCT02052778|40099927|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442719|NCT02052778|40099928|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442720|NCT02052778|40099929|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442721|NCT02052778|40099930|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
16442722|NCT02052778|40099908|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442723|NCT02052778|40099909|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442724|NCT02052778|40099910|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442725|NCT02052778|40099911|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442726|NCT02052778|40099912|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442727|NCT02052778|40099913|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
16442728|NCT02052778|40099914|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442729|NCT02052778|40099915|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442730|NCT02052778|40099916|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442731|NCT02052778|40099917|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442732|NCT02052778|40099918|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442733|NCT02052778|40099919|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442734|NCT02052778|40099920|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
16442735|NCT02052778|40099921|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442736|NCT02052778|40099922|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442737|NCT02052778|40099923|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442738|NCT02052778|40099924|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16151902|NCT03581786|39044056|FG000|Overall Study|Withdrawal by Subject|2|||
16151903|NCT03581786|39044057|FG001|Overall Study|Withdrawal by Subject|4|||
16151904|NCT03581786|39044056|FG000|Overall Study|Lost to Follow-up|1|||
16151905|NCT03581786|39044057|FG001|Overall Study|Lost to Follow-up|0|||
16151906|NCT03581786|39044056|FG000|Overall Study|reason other than specified above|0|||
16151907|NCT03581786|39044057|FG001|Overall Study|reason other than specified above|1|||
16151908|NCT03581786|39044056|FG000|Overall Study|Ongoing in the study|123|||
16151909|NCT03581786|39044057|FG001|Overall Study|Ongoing in the study|129|||
16151910|NCT02813694|39044058|FG000|Overall Study|Physician Decision|0|||
16151911|NCT02813694|39044059|FG001|Overall Study|Physician Decision|1|||
16151912|NCT02813694|39044058|FG000|Overall Study|Withdrawal by Subject|10|||
16151913|NCT02813694|39044059|FG001|Overall Study|Withdrawal by Subject|9|||
16151914|NCT02813694|39044058|FG000|Overall Study|Lost to Follow-up|1|||
16151915|NCT02813694|39044059|FG001|Overall Study|Lost to Follow-up|1|||
16151916|NCT02813694|39044058|FG000|Overall Study|Death|3|||
16151917|NCT02813694|39044059|FG001|Overall Study|Death|3|||
16151918|NCT02813694|39044058|FG000|Overall Study|Randomized- did not receive study drug|2|||
16151919|NCT02813694|39044059|FG001|Overall Study|Randomized- did not receive study drug|0|||
16151920|NCT02813694|39044058|FG000|Overall Study|Patient hospitalized|1|||
16151921|NCT02813694|39044059|FG001|Overall Study|Patient hospitalized|0|||
16261533|NCT00473330|39443120|FG002|Open-label Extension Through Month 48|Death|0|||
16261534|NCT00473330|39443118|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
16261535|NCT00473330|39443119|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
16261536|NCT00473330|39443120|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
16261537|NCT00473330|39443118|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
16261538|NCT00473330|39443119|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
16261539|NCT00473330|39443120|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
16261540|NCT00473330|39443118|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
16261541|NCT00473330|39443119|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
16261542|NCT00473330|39443120|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
16261543|NCT00473330|39443118|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
16261544|NCT00473330|39443119|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
16261545|NCT00473330|39443120|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
16261546|NCT00473330|39443118|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
16261547|NCT00473330|39443119|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
16261548|NCT00473330|39443120|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
16261549|NCT00473330|39443118|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
16261550|NCT00473330|39443119|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
16261551|NCT00473330|39443120|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
16261552|NCT00473330|39443118|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
16261553|NCT00473330|39443119|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
16261554|NCT00473330|39443120|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
16261555|NCT00473330|39443118|FG000|Open-label Extension Through Month 60|Death|2|||
16261556|NCT00473330|39443119|FG001|Open-label Extension Through Month 60|Death|2|||
16261557|NCT00473330|39443120|FG002|Open-label Extension Through Month 60|Death|1|||
16261558|NCT00473330|39443118|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
16261559|NCT00473330|39443119|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
16261560|NCT00473330|39443120|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
16261561|NCT00473330|39443118|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
16261562|NCT00473330|39443119|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
16261563|NCT00473330|39443120|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
16261564|NCT00473330|39443118|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
16261565|NCT00473330|39443119|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
16261566|NCT00473330|39443120|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
16261567|NCT00473330|39443118|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
16261568|NCT00473330|39443119|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
16261569|NCT00473330|39443120|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
16261570|NCT00473330|39443118|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
16261571|NCT00473330|39443119|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
16261572|NCT00473330|39443120|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
16261573|NCT00473330|39443118|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
16261574|NCT00473330|39443119|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
16261575|NCT00473330|39443120|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
16261576|NCT02392195|39443121|FG000|Overall Study|Lost to Follow-up|4|||
16261577|NCT02392195|39443121|FG000|Overall Study|Withdrawal by Subject|4|||
16261578|NCT02739997|39443122|FG000|Overall Study|Death|1|||
16261579|NCT02739997|39443122|FG000|Overall Study|Withdrawal by Subject|1|||
16261580|NCT03752528|39443123|FG000|Part A|Lost to Follow-up|1|||
16261581|NCT03752528|39443123|FG000|Part A|Protocol Violation|1|||
16151922|NCT03374189|39044060|FG000|Overall Study|Lost to Follow-up|1|||
16151923|NCT03374189|39044061|FG001|Overall Study|Lost to Follow-up|0|||
16261582|NCT03752528|39443123|FG000|Part B|Protocol Violation|1|||
16261583|NCT03752528|39443123|FG000|Part B|Study terminated by sponsor|3|||
16261584|NCT01175018|39443126|FG000|Overall Study|Adverse Event|3|||
16261585|NCT01175018|39443127|FG001|Overall Study|Adverse Event|1|||
16261586|NCT02605928|39443128|FG000|Overall Study|Model tuning phase|28|||
16261587|NCT02605928|39443128|FG000|Overall Study|Lack of Efficacy|5|||
16261588|NCT01602419|39443129|FG000|Overall Study|Not treated with Wilate|9|||
16261589|NCT01602419|39443129|FG000|Overall Study|Adverse Drug Reaction|4|||
16261590|NCT01602419|39443129|FG000|Overall Study|Insurance issues|3|||
16261591|NCT01602419|39443129|FG000|Overall Study|Changed treatment centre|1|||
16261592|NCT01602419|39443129|FG000|Overall Study|Treatment centre closed|1|||
16261593|NCT01602419|39443129|FG000|Overall Study|Withdrawal by Subject|5|||
16261594|NCT01602419|39443129|FG000|Overall Study|Lost to Follow-up|6|||
16261595|NCT00625443|39443130|FG000|Overall Study|Adverse Event|1|||
16261596|NCT00625443|39443131|FG001|Overall Study|Adverse Event|4|||
16261597|NCT00625443|39443132|FG002|Overall Study|Adverse Event|0|||
16261598|NCT00625443|39443130|FG000|Overall Study|Non-compliance with protocol|0|||
16261599|NCT00625443|39443131|FG001|Overall Study|Non-compliance with protocol|1|||
16261600|NCT00625443|39443132|FG002|Overall Study|Non-compliance with protocol|0|||
16261601|NCT00625443|39443130|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
16261602|NCT00625443|39443131|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
16261603|NCT00625443|39443132|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
16261604|NCT00625443|39443130|FG000|Overall Study|Withdrawal by Subject|0|||
16261605|NCT00625443|39443131|FG001|Overall Study|Withdrawal by Subject|1|||
16261606|NCT00625443|39443132|FG002|Overall Study|Withdrawal by Subject|2|||
16261607|NCT00625443|39443130|FG000|Overall Study|Physician Decision|0|||
16261608|NCT00625443|39443131|FG001|Overall Study|Physician Decision|4|||
16261609|NCT00625443|39443132|FG002|Overall Study|Physician Decision|2|||
16261610|NCT00625443|39443130|FG000|Overall Study|Other|0|||
16261611|NCT00625443|39443131|FG001|Overall Study|Other|1|||
16261612|NCT00625443|39443132|FG002|Overall Study|Other|1|||
16261613|NCT01667679|39443137|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
16261614|NCT01667679|39443138|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
16261615|NCT01667679|39443137|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
16261616|NCT01667679|39443138|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
16261617|NCT01667679|39443137|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
16261618|NCT01667679|39443138|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
16261619|NCT01667679|39443137|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
16261620|NCT01667679|39443138|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
16261621|NCT01667679|39443137|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
16261622|NCT01667679|39443138|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
16261623|NCT01667679|39443137|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
16261624|NCT01667679|39443138|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
16261625|NCT01667679|39443137|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
16261626|NCT01667679|39443138|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
16261627|NCT01667679|39443137|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
16261628|NCT01667679|39443138|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
16261629|NCT01667679|39443137|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
16261630|NCT01667679|39443138|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
16261631|NCT01667679|39443137|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
16261632|NCT01667679|39443138|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
16261633|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
16261634|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
16261635|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
16261636|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
16261637|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
16261638|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
16261639|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
16261640|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
16261641|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
16261642|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
16261643|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
16261644|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
16261645|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
16261646|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
16261647|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
16261648|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
16261649|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
16261650|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
16261651|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
16261652|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
16261653|NCT01667679|39443137|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
16261654|NCT01667679|39443138|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
16261655|NCT01042522|39443139|FG000|Overall Study|Adverse Event|1|||
16261656|NCT01042522|39443140|FG001|Overall Study|Adverse Event|2|||
16261657|NCT01042522|39443139|FG000|Overall Study|Disease Progression|5|||
16261658|NCT01042522|39443140|FG001|Overall Study|Disease Progression|0|||
16261659|NCT01042522|39443139|FG000|Overall Study|Death|1|||
16261660|NCT01042522|39443140|FG001|Overall Study|Death|0|||
16261661|NCT01042522|39443139|FG000|Overall Study|Patient Refused|0|||
16261662|NCT01042522|39443140|FG001|Overall Study|Patient Refused|3|||
16261663|NCT01042522|39443139|FG000|Overall Study|Withdrawal by Subject|1|||
16261664|NCT01042522|39443140|FG001|Overall Study|Withdrawal by Subject|1|||
16261665|NCT03021018|39443141|FG000|Overall Study|Adverse Event|1|||
16261666|NCT03021018|39443142|FG001|Overall Study|Adverse Event|0|||
16261667|NCT03021018|39443143|FG002|Overall Study|Adverse Event|0|||
16261668|NCT03021018|39443141|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
16261669|NCT03021018|39443142|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
16261670|NCT03021018|39443143|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
16261671|NCT04349917|39443147|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
16261672|NCT04349917|39443148|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
16261673|NCT04349917|39443147|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
16261674|NCT04349917|39443148|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
16261675|NCT00286754|39443149|FG000|Overall Study|Adverse Event|2|||
16261676|NCT00286754|39443150|FG001|Overall Study|Adverse Event|2|||
16261677|NCT00286754|39443151|FG002|Overall Study|Adverse Event|3|||
16261678|NCT00286754|39443149|FG000|Overall Study|Withdrawal by Subject|6|||
16261679|NCT00286754|39443150|FG001|Overall Study|Withdrawal by Subject|2|||
16261680|NCT00286754|39443151|FG002|Overall Study|Withdrawal by Subject|0|||
16261681|NCT00286754|39443149|FG000|Overall Study|Lost to Follow-up|12|||
16261682|NCT00286754|39443150|FG001|Overall Study|Lost to Follow-up|14|||
16261683|NCT00286754|39443151|FG002|Overall Study|Lost to Follow-up|6|||
16261684|NCT00286754|39443149|FG000|Overall Study|Moved out of state|0|||
16261685|NCT00286754|39443150|FG001|Overall Study|Moved out of state|0|||
16261686|NCT00286754|39443151|FG002|Overall Study|Moved out of state|1|||
16261687|NCT02098876|39443152|FG000|Overall Study|Withdrawal by Subject|5|||
16261688|NCT02098876|39443153|FG001|Overall Study|Withdrawal by Subject|5|||
16261689|NCT03733730|39443154|FG000|Overall Study|Lost to Follow-up|1|||
16261690|NCT03733730|39443155|FG001|Overall Study|Lost to Follow-up|32|||
16261691|NCT03733730|39443154|FG000|Overall Study|Other|1|||
16261692|NCT03733730|39443155|FG001|Overall Study|Other|0|||
16261693|NCT03733730|39443154|FG000|Overall Study|Adverse Event|0|||
16261694|NCT03733730|39443155|FG001|Overall Study|Adverse Event|4|||
16261695|NCT03733730|39443154|FG000|Overall Study|Death|0|||
16261696|NCT03733730|39443155|FG001|Overall Study|Death|5|||
16261697|NCT03733730|39443154|FG000|Overall Study|Withdrawal by Subject|0|||
16261698|NCT03733730|39443155|FG001|Overall Study|Withdrawal by Subject|8|||
16261699|NCT04175808|39443156|FG000|Part A|Miscellaneous|2|||
16261700|NCT04175808|39443157|FG001|Part A|Miscellaneous|0|||
16261701|NCT04175808|39443158|FG002|Part A|Miscellaneous|0|||
16261702|NCT04175808|39443159|FG003|Part A|Miscellaneous|0|||
16261703|NCT04175808|39443160|FG004|Part A|Miscellaneous|0|||
16261704|NCT04175808|39443161|FG005|Part A|Miscellaneous|0|||
16151924|NCT00094770|39044062|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
16151925|NCT00094770|39044063|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
16151926|NCT00094770|39044062|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
16151927|NCT00094770|39044063|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
16151928|NCT00094770|39044062|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
16151929|NCT00094770|39044063|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
16151930|NCT00094770|39044062|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
16151931|NCT00094770|39044063|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
16151932|NCT00094770|39044062|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
16151933|NCT00094770|39044063|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
16151934|NCT00094770|39044062|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
16151935|NCT00094770|39044063|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
16151936|NCT00094770|39044062|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
16261705|NCT04175808|39443162|FG006|Part A|Miscellaneous|0|||
16261706|NCT00086996|39443163|FG000|Overall Study|Adverse Event|29|||
16261707|NCT00086996|39443163|FG000|Overall Study|Death|4|||
16151937|NCT00094770|39044063|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
16261708|NCT00086996|39443163|FG000|Overall Study|progression/relapse|7|||
16261709|NCT00086996|39443163|FG000|Overall Study|Withdrawal by Subject|13|||
16261710|NCT00086996|39443163|FG000|Overall Study|Other|6|||
16261711|NCT00086996|39443163|FG000|Overall Study|not eligible|5|||
16261712|NCT03567174|39443167|FG000|Overall Study|Death|24|||
16261713|NCT03567174|39443168|FG001|Overall Study|Death|31|||
16261714|NCT03567174|39443167|FG000|Overall Study|Lost to Follow-up|165|||
16151938|NCT00094770|39044062|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
16151939|NCT00094770|39044063|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
16151940|NCT00094770|39044062|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
16151941|NCT00094770|39044063|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
16151942|NCT00094770|39044062|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
16151943|NCT00094770|39044063|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
16151944|NCT00094770|39044062|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
16151945|NCT00094770|39044063|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
16151946|NCT00094770|39044062|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
16151947|NCT00094770|39044063|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
16151948|NCT00094770|39044062|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
16151949|NCT00094770|39044063|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
16151950|NCT00094770|39044062|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
16151951|NCT00094770|39044063|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
16151952|NCT00094770|39044062|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
16151953|NCT00094770|39044063|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
16151954|NCT00094770|39044062|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
16151955|NCT00094770|39044063|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
16151956|NCT00094770|39044062|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
16151957|NCT00094770|39044063|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
16151958|NCT00094770|39044062|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
16151959|NCT00094770|39044063|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
16151960|NCT01560780|39044064|FG000|Overall Study|Death|2|||
16151961|NCT01560780|39044065|FG001|Overall Study|Death|1|||
16151962|NCT01560780|39044064|FG000|Overall Study|Patient Preference|11|||
16151963|NCT01560780|39044065|FG001|Overall Study|Patient Preference|11|||
16151964|NCT02846532|39044070|FG000|Overall Study|Lost to Follow-up|0|||
16151965|NCT02846532|39044071|FG001|Overall Study|Lost to Follow-up|1|||
16151966|NCT02846532|39044072|FG002|Overall Study|Lost to Follow-up|1|||
16151967|NCT02846532|39044070|FG000|Overall Study|Withdrawal by Subject|1|||
16151968|NCT02846532|39044071|FG001|Overall Study|Withdrawal by Subject|2|||
16151969|NCT02846532|39044072|FG002|Overall Study|Withdrawal by Subject|0|||
16151970|NCT00562354|39044073|FG000|Overall Study|Physician Decision|0|||
16151971|NCT00562354|39044074|FG001|Overall Study|Physician Decision|1|||
16151972|NCT00562354|39044073|FG000|Overall Study|Lost to Follow-up|0|||
16151973|NCT00562354|39044074|FG001|Overall Study|Lost to Follow-up|1|||
16151974|NCT00003535|39044079|FG000|Overall Study|Not evaluable|5|||
16151975|NCT01471782|39044080|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
16151976|NCT01471782|39044081|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
16151977|NCT01471782|39044082|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
16151978|NCT01471782|39044083|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
16151979|NCT01471782|39044084|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
16151980|NCT01471782|39044085|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
16151981|NCT01471782|39044080|FG000|Overall Study|Lack of Efficacy|1|||
16151982|NCT01471782|39044081|FG001|Overall Study|Lack of Efficacy|2|||
16151983|NCT01471782|39044082|FG002|Overall Study|Lack of Efficacy|1|||
16151984|NCT01471782|39044083|FG003|Overall Study|Lack of Efficacy|1|||
16151985|NCT01471782|39044084|FG004|Overall Study|Lack of Efficacy|5|||
16151986|NCT01471782|39044085|FG005|Overall Study|Lack of Efficacy|18|||
16151987|NCT01471782|39044080|FG000|Overall Study|Adverse Event|1|||
16151988|NCT01471782|39044081|FG001|Overall Study|Adverse Event|1|||
16151989|NCT01471782|39044082|FG002|Overall Study|Adverse Event|2|||
16151990|NCT01471782|39044083|FG003|Overall Study|Adverse Event|2|||
16151991|NCT01471782|39044084|FG004|Overall Study|Adverse Event|3|||
16151992|NCT01471782|39044085|FG005|Overall Study|Adverse Event|1|||
16151993|NCT01471782|39044080|FG000|Overall Study|Other|0|||
16151994|NCT01471782|39044081|FG001|Overall Study|Other|0|||
16151995|NCT01471782|39044082|FG002|Overall Study|Other|1|||
16151996|NCT01471782|39044083|FG003|Overall Study|Other|1|||
16151997|NCT01471782|39044084|FG004|Overall Study|Other|6|||
16151998|NCT01471782|39044085|FG005|Overall Study|Other|5|||
16151999|NCT01471782|39044080|FG000|Overall Study|Change of Chemotherapy|1|||
16152000|NCT01471782|39044081|FG001|Overall Study|Change of Chemotherapy|1|||
16152001|NCT01471782|39044082|FG002|Overall Study|Change of Chemotherapy|0|||
16152002|NCT01471782|39044083|FG003|Overall Study|Change of Chemotherapy|0|||
16152003|NCT01471782|39044084|FG004|Overall Study|Change of Chemotherapy|1|||
16152004|NCT01471782|39044085|FG005|Overall Study|Change of Chemotherapy|4|||
16152005|NCT01471782|39044080|FG000|Overall Study|Disease Relapse|0|||
16152006|NCT01471782|39044081|FG001|Overall Study|Disease Relapse|0|||
16152007|NCT01471782|39044082|FG002|Overall Study|Disease Relapse|0|||
16152008|NCT01471782|39044083|FG003|Overall Study|Disease Relapse|1|||
16152009|NCT01471782|39044084|FG004|Overall Study|Disease Relapse|2|||
16152010|NCT01471782|39044085|FG005|Overall Study|Disease Relapse|1|||
16152011|NCT01471782|39044080|FG000|Overall Study|Physician Decision|0|||
16152012|NCT01471782|39044081|FG001|Overall Study|Physician Decision|0|||
16152013|NCT01471782|39044082|FG002|Overall Study|Physician Decision|0|||
16152014|NCT01471782|39044083|FG003|Overall Study|Physician Decision|0|||
16152015|NCT01471782|39044084|FG004|Overall Study|Physician Decision|3|||
16152016|NCT01471782|39044085|FG005|Overall Study|Physician Decision|8|||
16152017|NCT01471782|39044080|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16152018|NCT01471782|39044081|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16152019|NCT01471782|39044082|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16152020|NCT01471782|39044083|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
16152021|NCT01471782|39044084|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
16152022|NCT01471782|39044085|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
16152023|NCT01471782|39044080|FG000|Overall Study|Death|0|||
16152024|NCT01471782|39044081|FG001|Overall Study|Death|0|||
16152025|NCT01471782|39044082|FG002|Overall Study|Death|0|||
16152026|NCT01471782|39044083|FG003|Overall Study|Death|0|||
16152027|NCT01471782|39044084|FG004|Overall Study|Death|0|||
16152028|NCT01471782|39044085|FG005|Overall Study|Death|1|||
16152029|NCT03785925|39044088|FG000|Overall Study|Withdrawal by Subject|15|||
16152030|NCT03785925|39044088|FG000|Overall Study|Lost to Follow-up|1|||
16152031|NCT00219284|39044093|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
16152032|NCT00219284|39044094|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
16152033|NCT00219284|39044093|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
16152034|NCT00219284|39044094|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
16152035|NCT00219284|39044093|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
16152036|NCT00219284|39044094|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
16152037|NCT00219284|39044093|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
16152038|NCT00219284|39044094|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
16152039|NCT00219284|39044093|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
16152040|NCT00219284|39044094|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
16152041|NCT00219284|39044093|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
16152042|NCT00219284|39044094|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
16152043|NCT00219284|39044093|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
16152044|NCT00219284|39044094|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
16152045|NCT00219284|39044093|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
16152046|NCT00219284|39044094|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
16152047|NCT00219284|39044093|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
16152048|NCT00219284|39044094|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
16152049|NCT03923426|39044095|FG000|Overall Study|Other|19|||
16152050|NCT03923426|39044095|FG000|Overall Study|Lost to Follow-up|16|||
16152051|NCT03923426|39044095|FG000|Overall Study|Death|107|||
16152052|NCT03923426|39044095|FG000|Overall Study|Incomplete response to question|13|||
16152053|NCT02287623|39044096|FG000|Overall Study|Protocol Violation|0|||
16152054|NCT02287623|39044097|FG001|Overall Study|Protocol Violation|1|||
16152055|NCT01692275|39044099|FG000|Overall Study|Lost to Follow-up|57|||
16152056|NCT01692275|39044100|FG001|Overall Study|Lost to Follow-up|48|||
16152057|NCT01692275|39044099|FG000|Overall Study|Withdrawal by Subject|9|||
16152058|NCT01692275|39044100|FG001|Overall Study|Withdrawal by Subject|11|||
16152059|NCT01566773|39044101|FG000|Overall Study|Protocol specified criteria|4|||
16152060|NCT01566773|39044101|FG000|Overall Study|Protocol Violation|4|||
16152061|NCT01566773|39044101|FG000|Overall Study|Withdrawal by Subject|9|||
16152062|NCT01566773|39044101|FG000|Overall Study|Administrative reason|1|||
16152063|NCT01566773|39044101|FG000|Overall Study|Adverse Event|10|||
16152064|NCT01566773|39044101|FG000|Overall Study|Physician Decision|2|||
16152065|NCT02980224|39044102|FG000|Overall Study|Adverse Event|4|||
16152066|NCT02980224|39044103|FG001|Overall Study|Adverse Event|1|||
16152067|NCT02980224|39044102|FG000|Overall Study|Withdrawal by Subject|0|||
16152068|NCT02980224|39044103|FG001|Overall Study|Withdrawal by Subject|2|||
16152069|NCT00885703|39044104|FG000|Overall Study|Death|9|||
16152070|NCT00885703|39044105|FG001|Overall Study|Death|7|||
16152071|NCT00885703|39044106|FG002|Overall Study|Death|8|||
16152072|NCT00885703|39044107|FG003|Overall Study|Death|7|||
16152073|NCT00885703|39044108|FG004|Overall Study|Death|7|||
16152074|NCT00885703|39044109|FG005|Overall Study|Death|8|||
16152075|NCT00885703|39044110|FG006|Overall Study|Death|4|||
16152076|NCT00885703|39044104|FG000|Overall Study|Lost to Follow-up|0|||
16152077|NCT00885703|39044105|FG001|Overall Study|Lost to Follow-up|0|||
16152078|NCT00885703|39044106|FG002|Overall Study|Lost to Follow-up|1|||
16152079|NCT00885703|39044107|FG003|Overall Study|Lost to Follow-up|0|||
16152080|NCT00885703|39044108|FG004|Overall Study|Lost to Follow-up|0|||
16152081|NCT00885703|39044109|FG005|Overall Study|Lost to Follow-up|1|||
16152082|NCT00885703|39044110|FG006|Overall Study|Lost to Follow-up|0|||
16152083|NCT00885703|39044104|FG000|Overall Study|Withdrawal by Subject|0|||
16152084|NCT00885703|39044105|FG001|Overall Study|Withdrawal by Subject|0|||
16152085|NCT00885703|39044106|FG002|Overall Study|Withdrawal by Subject|0|||
16152086|NCT00885703|39044107|FG003|Overall Study|Withdrawal by Subject|1|||
16152087|NCT00885703|39044108|FG004|Overall Study|Withdrawal by Subject|3|||
16152088|NCT00885703|39044109|FG005|Overall Study|Withdrawal by Subject|1|||
16152089|NCT00885703|39044110|FG006|Overall Study|Withdrawal by Subject|1|||
16152090|NCT00885703|39044104|FG000|Overall Study|Ineligible (no CM)|1|||
16152091|NCT00885703|39044105|FG001|Overall Study|Ineligible (no CM)|3|||
16152092|NCT00885703|39044106|FG002|Overall Study|Ineligible (no CM)|2|||
16152093|NCT00885703|39044107|FG003|Overall Study|Ineligible (no CM)|1|||
16152094|NCT00885703|39044108|FG004|Overall Study|Ineligible (no CM)|2|||
16152095|NCT00885703|39044109|FG005|Overall Study|Ineligible (no CM)|3|||
16152096|NCT00885703|39044110|FG006|Overall Study|Ineligible (no CM)|1|||
16152097|NCT02581202|39044112|FG000|Overall Study|Lack of Efficacy|2|||
16152098|NCT02581202|39044112|FG000|Overall Study|Withdrawal by Subject|4|||
16152099|NCT02581202|39044112|FG000|Overall Study|Lost to Follow-up|5|||
16152100|NCT02581202|39044112|FG000|Overall Study|Pregnancy|3|||
16152101|NCT00964743|39044113|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
16152102|NCT01227187|39044125|FG000|Overall Study|Physician Decision|0|||
16152103|NCT01227187|39044126|FG001|Overall Study|Physician Decision|0|||
16152104|NCT01227187|39044127|FG002|Overall Study|Physician Decision|0|||
16152105|NCT01227187|39044128|FG003|Overall Study|Physician Decision|1|||
16152106|NCT03915951|39044135|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
16152107|NCT03915951|39044136|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
16261715|NCT03567174|39443168|FG001|Overall Study|Lost to Follow-up|174|||
16261716|NCT03673670|39443169|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
16261717|NCT03673670|39443170|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
16261718|NCT03673670|39443171|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
16261719|NCT03673670|39443172|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
16261720|NCT03673670|39443173|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
16261721|NCT03673670|39443174|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
16261722|NCT03673670|39443169|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
16261723|NCT03673670|39443170|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
16261724|NCT03673670|39443171|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
16261725|NCT03673670|39443172|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
16261726|NCT03673670|39443173|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
16261727|NCT03673670|39443174|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
16261728|NCT03673670|39443169|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
16261729|NCT03673670|39443170|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
16261730|NCT03673670|39443171|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
16261731|NCT03673670|39443172|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
16261732|NCT03673670|39443173|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
16261733|NCT03673670|39443174|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
16261734|NCT03673670|39443169|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
16261735|NCT03673670|39443170|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
16261736|NCT03673670|39443171|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
16261737|NCT03673670|39443172|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
16261738|NCT03673670|39443173|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
16261739|NCT03673670|39443174|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
16261740|NCT03673670|39443169|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
16365964|NCT02181738|39825386|FG001|Overall Study|Poor/Non-Compliance|0|||
16152108|NCT03915951|39044135|FG000|Overall Study|Adverse Event|12|||
16152109|NCT03915951|39044136|FG001|Overall Study|Adverse Event|6|||
16152110|NCT03915951|39044135|FG000|Overall Study|Disease progression (radiological)|17|||
16152111|NCT03915951|39044136|FG001|Overall Study|Disease progression (radiological)|15|||
16152112|NCT03915951|39044135|FG000|Overall Study|Disease progression (clinical)|4|||
16152113|NCT03915951|39044136|FG001|Overall Study|Disease progression (clinical)|1|||
16261741|NCT03673670|39443170|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
16261742|NCT03673670|39443171|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
16261743|NCT03673670|39443172|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
16261744|NCT03673670|39443173|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
16261745|NCT03673670|39443174|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
16261746|NCT03673670|39443169|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
16261747|NCT03673670|39443170|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
16261748|NCT03673670|39443171|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
16261749|NCT03673670|39443172|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
16261750|NCT03673670|39443173|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
16261751|NCT03673670|39443174|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
16261752|NCT03673670|39443169|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
16261753|NCT03673670|39443170|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
16261754|NCT03673670|39443171|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
16442739|NCT02052778|40099925|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442740|NCT02052778|40099926|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442741|NCT02052778|40099927|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442742|NCT02052778|40099928|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442743|NCT02052778|40099929|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442744|NCT02052778|40099930|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
16442745|NCT02052778|40099908|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442746|NCT02052778|40099909|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442747|NCT02052778|40099910|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442748|NCT02052778|40099911|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442749|NCT02052778|40099912|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442750|NCT02052778|40099913|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442751|NCT02052778|40099914|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442752|NCT02052778|40099915|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442753|NCT02052778|40099916|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442754|NCT02052778|40099917|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442755|NCT02052778|40099918|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442756|NCT02052778|40099919|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442757|NCT02052778|40099920|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442758|NCT02052778|40099921|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442759|NCT02052778|40099922|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
16442760|NCT02052778|40099923|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
16442761|NCT02052778|40099924|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
16442762|NCT02052778|40099925|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
16442763|NCT02052778|40099926|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
16442764|NCT02052778|40099927|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
16442765|NCT02052778|40099928|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
16152114|NCT03915951|39044135|FG000|Overall Study|Patient decision|0|||
16152115|NCT03915951|39044136|FG001|Overall Study|Patient decision|4|||
16152116|NCT03915951|39044135|FG000|Overall Study|Investigator decision|0|||
16442766|NCT02052778|40099929|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
16442767|NCT02052778|40099930|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
16442768|NCT02052778|40099908|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442769|NCT02052778|40099909|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442770|NCT02052778|40099910|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442771|NCT02052778|40099911|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16261755|NCT03673670|39443172|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
16261756|NCT03673670|39443173|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
16261757|NCT03673670|39443174|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
16261758|NCT00960297|39443175|FG000|Overall Study|Physician Decision|1|||
16261759|NCT00960297|39443175|FG000|Overall Study|Venous port infection|1|||
16261760|NCT00960297|39443175|FG000|Overall Study|Disease progression|1|||
16261761|NCT05067647|39443188|FG000|Overall Study|Lost to Follow-up|1|||
16261762|NCT03929393|39443189|FG000|Overall Study|Death|1|||
16261763|NCT03929393|39443190|FG001|Overall Study|Death|0|||
16442772|NCT02052778|40099912|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442773|NCT02052778|40099913|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442774|NCT02052778|40099914|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442775|NCT02052778|40099915|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442776|NCT02052778|40099916|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442777|NCT02052778|40099917|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442778|NCT02052778|40099918|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442779|NCT02052778|40099919|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442780|NCT02052778|40099920|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442781|NCT02052778|40099921|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442782|NCT02052778|40099922|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
16442783|NCT02052778|40099923|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
16442784|NCT02052778|40099924|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442785|NCT02052778|40099925|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
16442786|NCT02052778|40099926|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
16442787|NCT02052778|40099927|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
16442788|NCT02052778|40099928|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
16442789|NCT02052778|40099929|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
16442790|NCT02052778|40099930|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
16442791|NCT02052778|40099908|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442792|NCT02052778|40099909|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442793|NCT02052778|40099910|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442794|NCT02052778|40099911|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442795|NCT02052778|40099912|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442796|NCT02052778|40099913|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442797|NCT02052778|40099914|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442798|NCT02052778|40099915|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442799|NCT02052778|40099916|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442800|NCT02052778|40099917|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442801|NCT02052778|40099918|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442802|NCT02052778|40099919|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442803|NCT02052778|40099920|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442804|NCT02052778|40099921|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442805|NCT02052778|40099922|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
16442806|NCT02052778|40099923|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
16442807|NCT02052778|40099924|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
16261764|NCT03929393|39443189|FG000|Overall Study|Time Commitment|2|||
16261765|NCT03929393|39443190|FG001|Overall Study|Time Commitment|5|||
16152117|NCT03915951|39044136|FG001|Overall Study|Investigator decision|1|||
16152118|NCT03915951|39044135|FG000|Overall Study|Consent withdrawn|1|||
16152119|NCT03915951|39044136|FG001|Overall Study|Consent withdrawn|1|||
16152120|NCT03915951|39044135|FG000|Overall Study|Death|0|||
16152121|NCT03915951|39044136|FG001|Overall Study|Death|3|||
16152122|NCT02915523|39044137|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
16152123|NCT02915523|39044138|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
16152124|NCT02915523|39044139|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
16152125|NCT02915523|39044140|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
16152126|NCT02915523|39044137|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
16152127|NCT02915523|39044138|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
16152128|NCT02915523|39044139|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
16442808|NCT02052778|40099925|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16152129|NCT02915523|39044140|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
16152130|NCT02915523|39044137|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
16152131|NCT02915523|39044138|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
16152132|NCT02915523|39044139|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
16152133|NCT02915523|39044140|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
16152134|NCT02915523|39044137|FG000|Expansion Phase (Phase 2)|Death|0|||
16152135|NCT02915523|39044138|FG001|Expansion Phase (Phase 2)|Death|0|||
16152136|NCT02915523|39044139|FG002|Expansion Phase (Phase 2)|Death|26|||
16152137|NCT02915523|39044140|FG003|Expansion Phase (Phase 2)|Death|53|||
16152138|NCT02915523|39044137|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
16152139|NCT02915523|39044138|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
16152140|NCT02915523|39044139|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
16152141|NCT02915523|39044140|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
16152142|NCT02915523|39044137|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
16152143|NCT02915523|39044138|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
16152144|NCT02915523|39044139|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
16152145|NCT02915523|39044140|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
16152146|NCT02915523|39044137|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
16152147|NCT02915523|39044138|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
16152148|NCT02915523|39044139|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
16152149|NCT02915523|39044140|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
16152150|NCT01356589|39044142|FG000|Overall Study|Enrolled, but not treated|3|||
16152151|NCT01356589|39044142|FG000|Overall Study|Dose data not recorded|2|||
16152152|NCT02703311|39044143|FG000|Overall Study|Death|5|||
16152153|NCT02703311|39044143|FG000|Overall Study|Withdrawal by Subject|3|||
16152154|NCT01251367|39044144|FG000|Overall Study|Protocol Violation|1|||
16152155|NCT01251367|39044144|FG000|Overall Study|Lack of Efficacy|2|||
16152156|NCT01251367|39044144|FG000|Overall Study|Adverse Event|19|||
16152157|NCT01251367|39044144|FG000|Overall Study|Withdrawal by Subject|36|||
16152158|NCT01251367|39044144|FG000|Overall Study|Lost to Follow-up|5|||
16152159|NCT01251367|39044144|FG000|Overall Study|Subject Required Alternative Treatment|7|||
16152160|NCT01251367|39044144|FG000|Overall Study|No Study Drug Available|1|||
16152161|NCT01251367|39044144|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
16152162|NCT01251367|39044144|FG000|Overall Study|End of Study Visit Performed in Error|1|||
16442809|NCT02052778|40099926|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
16442810|NCT02052778|40099927|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
16442811|NCT02052778|40099928|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442812|NCT02052778|40099929|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442813|NCT02052778|40099930|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
16442814|NCT02052778|40099908|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442815|NCT02052778|40099909|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442816|NCT02052778|40099910|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16152163|NCT03134599|39044148|FG000|Week 1|Lost to Follow-up|0|||
16152164|NCT03134599|39044149|FG001|Week 1|Lost to Follow-up|0|||
16152165|NCT03134599|39044150|FG002|Week 1|Lost to Follow-up|0|||
16442817|NCT02052778|40099911|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16152166|NCT03134599|39044151|FG003|Week 1|Lost to Follow-up|0|||
16152167|NCT03134599|39044152|FG004|Week 1|Lost to Follow-up|1|||
16442818|NCT02052778|40099912|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442819|NCT02052778|40099913|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442820|NCT02052778|40099914|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442821|NCT02052778|40099915|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442822|NCT02052778|40099916|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442823|NCT02052778|40099917|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442824|NCT02052778|40099918|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442825|NCT02052778|40099919|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442826|NCT02052778|40099920|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442827|NCT02052778|40099921|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442828|NCT02052778|40099922|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
16442829|NCT02052778|40099923|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
16442830|NCT02052778|40099924|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442831|NCT02052778|40099925|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442832|NCT02052778|40099926|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442833|NCT02052778|40099927|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442834|NCT02052778|40099928|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442835|NCT02052778|40099929|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442836|NCT02052778|40099930|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
16442837|NCT02052778|40099908|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442838|NCT02052778|40099909|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442839|NCT02052778|40099910|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442840|NCT02052778|40099911|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442841|NCT02052778|40099912|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442842|NCT02052778|40099913|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442843|NCT02052778|40099914|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442844|NCT02052778|40099915|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442845|NCT02052778|40099916|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442846|NCT02052778|40099917|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442847|NCT02052778|40099918|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442848|NCT02052778|40099919|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442849|NCT02052778|40099920|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442850|NCT02052778|40099921|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442851|NCT02052778|40099922|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
16442852|NCT02052778|40099923|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
16442853|NCT02052778|40099924|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442854|NCT02052778|40099925|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442855|NCT02052778|40099926|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442856|NCT02052778|40099927|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
16442857|NCT02052778|40099928|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442858|NCT02052778|40099929|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442859|NCT02052778|40099930|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
16442860|NCT02052778|40099908|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
16442861|NCT02052778|40099909|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
16442862|NCT02052778|40099910|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
16442863|NCT02052778|40099911|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
16442864|NCT02052778|40099912|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
16442865|NCT02052778|40099913|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
16442866|NCT02052778|40099914|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
16442867|NCT02052778|40099915|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
16442868|NCT02052778|40099916|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
16442869|NCT02052778|40099917|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
16442870|NCT02052778|40099918|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
16442871|NCT02052778|40099919|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
16442872|NCT02052778|40099920|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
16442873|NCT02052778|40099921|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
16442874|NCT02052778|40099922|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
16365965|NCT02181738|39825387|FG002|Overall Study|Poor/Non-Compliance|2|||
16365966|NCT02181738|39825388|FG003|Overall Study|Poor/Non-Compliance|1|||
16365967|NCT02181738|39825385|FG000|Overall Study|Disease Progression|28|||
16365968|NCT02181738|39825386|FG001|Overall Study|Disease Progression|35|||
16365969|NCT02181738|39825387|FG002|Overall Study|Disease Progression|40|||
16365970|NCT02181738|39825388|FG003|Overall Study|Disease Progression|0|||
16365971|NCT02181738|39825385|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
16365972|NCT02181738|39825386|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
16365973|NCT02181738|39825387|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
16365974|NCT02181738|39825388|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
16365975|NCT02181738|39825385|FG000|Overall Study|Study Drug Toxicity|6|||
16365976|NCT02181738|39825386|FG001|Overall Study|Study Drug Toxicity|11|||
16365977|NCT02181738|39825387|FG002|Overall Study|Study Drug Toxicity|8|||
16365978|NCT02181738|39825388|FG003|Overall Study|Study Drug Toxicity|1|||
16365979|NCT02181738|39825385|FG000|Overall Study|Other Reasons|14|||
16365980|NCT02181738|39825386|FG001|Overall Study|Other Reasons|16|||
16365981|NCT02181738|39825387|FG002|Overall Study|Other Reasons|28|||
16365982|NCT02181738|39825388|FG003|Overall Study|Other Reasons|0|||
16365983|NCT02181738|39825385|FG000|Overall Study|Maximum Clinical Benefit|3|||
16365984|NCT02181738|39825386|FG001|Overall Study|Maximum Clinical Benefit|0|||
16365985|NCT02181738|39825387|FG002|Overall Study|Maximum Clinical Benefit|1|||
16365986|NCT02181738|39825388|FG003|Overall Study|Maximum Clinical Benefit|0|||
16365987|NCT02181738|39825385|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
16365988|NCT02181738|39825386|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
16365989|NCT02181738|39825387|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
16365990|NCT02181738|39825388|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
16365991|NCT00790036|39825389|FG000|Overall Study|Abnormal lab values|3|||
16365992|NCT00790036|39825390|FG001|Overall Study|Abnormal lab values|2|||
16365993|NCT00790036|39825389|FG000|Overall Study|Administrative problems|5|||
16365994|NCT00790036|39825390|FG001|Overall Study|Administrative problems|9|||
16365995|NCT00790036|39825389|FG000|Overall Study|Adverse Event|113|||
16365996|NCT00790036|39825390|FG001|Overall Study|Adverse Event|44|||
16365997|NCT00790036|39825389|FG000|Overall Study|Death|1|||
16365998|NCT00790036|39825390|FG001|Overall Study|Death|0|||
16365999|NCT00790036|39825389|FG000|Overall Study|Disease progression|24|||
16366000|NCT00790036|39825390|FG001|Overall Study|Disease progression|48|||
16366001|NCT00790036|39825389|FG000|Overall Study|Lost to Follow-up|1|||
16366002|NCT00790036|39825390|FG001|Overall Study|Lost to Follow-up|2|||
16366003|NCT00790036|39825389|FG000|Overall Study|Protocol Violation|10|||
16366004|NCT00790036|39825390|FG001|Overall Study|Protocol Violation|2|||
16366005|NCT00790036|39825389|FG000|Overall Study|Withdrawal by Subject|18|||
16366006|NCT00790036|39825390|FG001|Overall Study|Withdrawal by Subject|7|||
16366007|NCT00790036|39825389|FG000|Overall Study|Subject/guardian decision|20|||
16366008|NCT00790036|39825390|FG001|Overall Study|Subject/guardian decision|7|||
16366009|NCT00447278|39825391|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
16366010|NCT00447278|39825392|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
16366011|NCT00447278|39825391|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
16366012|NCT00447278|39825392|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
16366013|NCT00447278|39825391|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
16366014|NCT00447278|39825392|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
16442875|NCT02052778|40099923|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
16442876|NCT02052778|40099924|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
16442877|NCT02052778|40099925|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
16442878|NCT02052778|40099926|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
16442879|NCT02052778|40099927|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
16442880|NCT02052778|40099928|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
16442881|NCT02052778|40099929|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
16442882|NCT02052778|40099930|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
16442883|NCT02052778|40099908|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442884|NCT02052778|40099909|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442885|NCT02052778|40099910|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442886|NCT02052778|40099911|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442887|NCT02052778|40099912|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442888|NCT02052778|40099913|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442889|NCT02052778|40099914|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442890|NCT02052778|40099915|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442891|NCT02052778|40099916|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442892|NCT02052778|40099917|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442893|NCT02052778|40099918|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442894|NCT02052778|40099919|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442895|NCT02052778|40099920|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442896|NCT02052778|40099921|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442897|NCT02052778|40099922|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
16442898|NCT02052778|40099923|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
16442899|NCT02052778|40099924|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
16442900|NCT02052778|40099925|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442901|NCT02052778|40099926|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
16442902|NCT02052778|40099927|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442903|NCT02052778|40099928|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442904|NCT02052778|40099929|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442905|NCT02052778|40099930|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
16442906|NCT02052778|40099908|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442907|NCT02052778|40099909|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442908|NCT02052778|40099910|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442909|NCT02052778|40099911|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16152168|NCT03134599|39044153|FG005|Week 1|Lost to Follow-up|0|||
16152169|NCT03134599|39044148|FG000|Week 2|Lost to Follow-up|1|||
16152170|NCT03134599|39044149|FG001|Week 2|Lost to Follow-up|0|||
16152171|NCT03134599|39044150|FG002|Week 2|Lost to Follow-up|0|||
16152172|NCT03134599|39044151|FG003|Week 2|Lost to Follow-up|1|||
16442910|NCT02052778|40099912|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442911|NCT02052778|40099913|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16152173|NCT03134599|39044152|FG004|Week 2|Lost to Follow-up|1|||
16152174|NCT03134599|39044153|FG005|Week 2|Lost to Follow-up|0|||
16152175|NCT03134599|39044148|FG000|Week 3|Lost to Follow-up|0|||
16152176|NCT03134599|39044149|FG001|Week 3|Lost to Follow-up|0|||
16152177|NCT03134599|39044150|FG002|Week 3|Lost to Follow-up|0|||
16152178|NCT03134599|39044151|FG003|Week 3|Lost to Follow-up|1|||
16442912|NCT02052778|40099914|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442913|NCT02052778|40099915|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442914|NCT02052778|40099916|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442915|NCT02052778|40099917|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442916|NCT02052778|40099918|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442917|NCT02052778|40099919|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442918|NCT02052778|40099920|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442919|NCT02052778|40099921|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442920|NCT02052778|40099922|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442921|NCT02052778|40099923|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442922|NCT02052778|40099924|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442923|NCT02052778|40099925|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442924|NCT02052778|40099926|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442925|NCT02052778|40099927|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442926|NCT02052778|40099928|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442927|NCT02052778|40099929|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
16442928|NCT02052778|40099930|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
16442929|NCT02052778|40099908|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442930|NCT02052778|40099909|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442931|NCT02052778|40099910|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442932|NCT02052778|40099911|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16152179|NCT03134599|39044152|FG004|Week 3|Lost to Follow-up|0|||
16152180|NCT03134599|39044153|FG005|Week 3|Lost to Follow-up|1|||
16152181|NCT03681119|39044154|FG000|Overall Study|No specific reason|4|||
16152182|NCT03681119|39044155|FG001|Overall Study|No specific reason|0|||
16152183|NCT03681119|39044154|FG000|Overall Study|Sickness|2|||
16152184|NCT03681119|39044155|FG001|Overall Study|Sickness|0|||
16152185|NCT00777101|39044156|FG000|Overall Study|Death|48|||
16152186|NCT00777101|39044157|FG001|Overall Study|Death|43|||
16152187|NCT00777101|39044156|FG000|Overall Study|Withdrawal by Subject|11|||
16152188|NCT00777101|39044157|FG001|Overall Study|Withdrawal by Subject|6|||
16261766|NCT03929393|39443189|FG000|Overall Study|Motor Vehicle Accident|0|||
16152189|NCT00777101|39044156|FG000|Overall Study|Lost to Follow-up|2|||
16152190|NCT00777101|39044157|FG001|Overall Study|Lost to Follow-up|1|||
16261767|NCT03929393|39443190|FG001|Overall Study|Motor Vehicle Accident|1|||
16261768|NCT03929393|39443189|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
16261769|NCT03929393|39443190|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
16261770|NCT03929393|39443189|FG000|Overall Study|Other|1|||
16261771|NCT03929393|39443190|FG001|Overall Study|Other|3|||
16261772|NCT01061866|39443193|FG000|Overall Study|Adverse Event|2|||
16261773|NCT04567186|39443194|FG000|Period 1|COVID-19 related|1|||
16261774|NCT04567186|39443195|FG001|Period 1|COVID-19 related|0|||
16261775|NCT04567186|39443194|FG000|Period 1|Protocol Violation|0|||
16261776|NCT04567186|39443195|FG001|Period 1|Protocol Violation|1|||
16261777|NCT04567186|39443194|FG000|Period 1|Adverse Event|0|||
16261778|NCT04567186|39443195|FG001|Period 1|Adverse Event|2|||
16261779|NCT04567186|39443194|FG000|Period 2|COVID-19 Related|0|||
16152191|NCT00777101|39044156|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
16261780|NCT04567186|39443195|FG001|Period 2|COVID-19 Related|1|||
16261781|NCT04567186|39443194|FG000|Period 2|Protocol Violation|0|||
16152192|NCT00777101|39044157|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
16152193|NCT00777101|39044156|FG000|Overall Study|Failed to Return|0|||
16152194|NCT00777101|39044157|FG001|Overall Study|Failed to Return|1|||
16261782|NCT04567186|39443195|FG001|Period 2|Protocol Violation|1|||
16152195|NCT01650636|39044159|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
16152196|NCT01650636|39044160|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
16152197|NCT01650636|39044159|FG000|Washout up to 5 Months|Physician Decision|2|||
16152198|NCT01650636|39044160|FG001|Washout up to 5 Months|Physician Decision|2|||
16152199|NCT01650636|39044159|FG000|Washout up to 5 Months|Death|1|||
16152200|NCT01650636|39044160|FG001|Washout up to 5 Months|Death|0|||
16152201|NCT01650636|39044159|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
16152202|NCT01650636|39044160|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
16152203|NCT01650636|39044159|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
16152204|NCT01650636|39044160|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
16152205|NCT01650636|39044159|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
16152206|NCT01650636|39044160|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
16152207|NCT02636582|39044161|FG000|Overall Study|Surgical Pathology|1|||
16152208|NCT02636582|39044162|FG001|Overall Study|Surgical Pathology|0|||
16152209|NCT04096274|39044163|FG000|Phase I|Lost to Follow-up|5|||
16152210|NCT04096274|39044164|FG001|Phase I|Lost to Follow-up|5|||
16152211|NCT04096274|39044163|FG000|Phase II|Lost to Follow-up|11|||
16152212|NCT04096274|39044164|FG001|Phase II|Lost to Follow-up|11|||
16152213|NCT02018822|39044167|FG000|Overall Study|filling replaced by crown|0|||
16152214|NCT02018822|39044168|FG001|Overall Study|filling replaced by crown|1|||
16152215|NCT02018822|39044169|FG002|Overall Study|filling replaced by crown|0|||
16152216|NCT02018822|39044167|FG000|Overall Study|Physician Decision|0|||
16152217|NCT02018822|39044168|FG001|Overall Study|Physician Decision|1|||
16152218|NCT02018822|39044169|FG002|Overall Study|Physician Decision|1|||
16152219|NCT02018822|39044167|FG000|Overall Study|Lost to Follow-up|6|||
16152220|NCT02018822|39044168|FG001|Overall Study|Lost to Follow-up|6|||
16152221|NCT02018822|39044169|FG002|Overall Study|Lost to Follow-up|5|||
16152222|NCT01970501|39044170|FG000|Overall Study|Discontinuation of study by sponsor|16|||
16442933|NCT02052778|40099912|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442934|NCT02052778|40099913|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442935|NCT02052778|40099914|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442936|NCT02052778|40099915|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442937|NCT02052778|40099916|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16152223|NCT01970501|39044171|FG001|Overall Study|Discontinuation of study by sponsor|14|||
16442938|NCT02052778|40099917|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442939|NCT02052778|40099918|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16261783|NCT04567186|39443194|FG000|Period 2|Lost to Follow-up|0|||
16152224|NCT01970501|39044170|FG000|Overall Study|Withdrawal by Subject|6|||
16152225|NCT01970501|39044171|FG001|Overall Study|Withdrawal by Subject|7|||
16442940|NCT02052778|40099919|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442941|NCT02052778|40099920|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442942|NCT02052778|40099921|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442943|NCT02052778|40099922|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442944|NCT02052778|40099923|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442945|NCT02052778|40099924|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442946|NCT02052778|40099925|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442947|NCT02052778|40099926|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442948|NCT02052778|40099927|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442949|NCT02052778|40099928|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16442950|NCT02052778|40099929|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
16152226|NCT01970501|39044170|FG000|Overall Study|Adverse Event|2|||
16442951|NCT02052778|40099930|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
16442952|NCT02052778|40099908|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442953|NCT02052778|40099909|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442954|NCT02052778|40099910|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442955|NCT02052778|40099911|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442956|NCT02052778|40099912|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442957|NCT02052778|40099913|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442958|NCT02052778|40099914|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442959|NCT02052778|40099915|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442960|NCT02052778|40099916|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442961|NCT02052778|40099917|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442962|NCT02052778|40099918|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442963|NCT02052778|40099919|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16152227|NCT01970501|39044171|FG001|Overall Study|Adverse Event|4|||
16152228|NCT01970501|39044170|FG000|Overall Study|Death|1|||
16152229|NCT01970501|39044171|FG001|Overall Study|Death|3|||
16152230|NCT01970501|39044170|FG000|Overall Study|Physician Decision|2|||
16152231|NCT01970501|39044171|FG001|Overall Study|Physician Decision|0|||
16152232|NCT00542269|39044172|FG000|Overall Study|Adverse Event|10|||
16152233|NCT00542269|39044173|FG001|Overall Study|Adverse Event|4|||
16152234|NCT00542269|39044174|FG002|Overall Study|Adverse Event|5|||
16152235|NCT00542269|39044172|FG000|Overall Study|Protocol Violation|1|||
16152236|NCT00542269|39044173|FG001|Overall Study|Protocol Violation|1|||
16152237|NCT00542269|39044174|FG002|Overall Study|Protocol Violation|0|||
16152238|NCT00542269|39044172|FG000|Overall Study|Withdrawal by Subject|1|||
16152239|NCT00542269|39044173|FG001|Overall Study|Withdrawal by Subject|0|||
16152240|NCT00542269|39044174|FG002|Overall Study|Withdrawal by Subject|0|||
16152241|NCT00542269|39044172|FG000|Overall Study|Administrative problems|1|||
16152242|NCT00542269|39044173|FG001|Overall Study|Administrative problems|1|||
16152243|NCT00542269|39044174|FG002|Overall Study|Administrative problems|1|||
16152244|NCT03864653|39044175|FG000|Overall Study|Withdrawal by Subject|1|||
16152245|NCT00781911|39044179|FG000|Overall Study|Adverse Event|4|||
16152246|NCT00781911|39044180|FG001|Overall Study|Adverse Event|4|||
16152247|NCT00781911|39044179|FG000|Overall Study|Withdrawal by Subject|1|||
16152248|NCT00781911|39044180|FG001|Overall Study|Withdrawal by Subject|2|||
16152249|NCT00781911|39044179|FG000|Overall Study|Physician Decision|0|||
16152250|NCT00781911|39044180|FG001|Overall Study|Physician Decision|2|||
16152251|NCT00781911|39044179|FG000|Overall Study|Sponsor Decision|1|||
16152252|NCT00781911|39044180|FG001|Overall Study|Sponsor Decision|0|||
16152253|NCT03201458|39044181|FG000|Overall Study|No longer eligible|2|||
16152254|NCT03201458|39044182|FG001|Overall Study|No longer eligible|5|||
16152255|NCT03201458|39044181|FG000|Overall Study|Health event before starting|1|||
16152256|NCT03201458|39044182|FG001|Overall Study|Health event before starting|0|||
16152257|NCT03201458|39044181|FG000|Overall Study|Physician Decision|1|||
16152258|NCT03201458|39044182|FG001|Overall Study|Physician Decision|0|||
16152259|NCT03221751|39044183|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
16152260|NCT03221751|39044184|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
16152261|NCT01744665|39044185|FG000|Monitoring Phase|Adverse Event|4|||
16152262|NCT01744665|39044185|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
16152263|NCT01744665|39044185|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
16152264|NCT01744665|39044185|FG000|Monitoring Phase|Withdrawal by Subject|5|||
16152265|NCT01744665|39044185|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
16152266|NCT01744665|39044185|FG000|Consolidation Phase|Adverse Event|2|||
16152267|NCT01744665|39044185|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
16152268|NCT01744665|39044185|FG000|Consolidation Phase|Withdrawal by Subject|4|||
16152269|NCT01744665|39044185|FG000|Consolidation Phase|Administrative problems|9|||
16152270|NCT01744665|39044185|FG000|Re-initiation Phase|Administrative problems|10|||
16152271|NCT01744665|39044185|FG000|Re-initiation Phase|Adverse Event|1|||
16152272|NCT01744665|39044185|FG000|Re-initiation Phase|No longer required treatment|1|||
16152273|NCT01744665|39044185|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
16152274|NCT04317274|39044186|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
16152275|NCT04317274|39044187|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
16152276|NCT04317274|39044188|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
16152277|NCT04317274|39044189|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
16152278|NCT01097746|39044190|FG000|Overall Study|Adverse Event|4|||
16152279|NCT01097746|39044190|FG000|Overall Study|taken off study before any treatment given|1|||
16152280|NCT02069899|39044191|FG000|Overall Study|Adverse Event|6|||
16152281|NCT02069899|39044192|FG001|Overall Study|Adverse Event|0|||
16152282|NCT02069899|39044193|FG002|Overall Study|Adverse Event|1|||
16152283|NCT02069899|39044191|FG000|Overall Study|Withdrawal by Participant|2|||
16152284|NCT02069899|39044192|FG001|Overall Study|Withdrawal by Participant|0|||
16152285|NCT02069899|39044193|FG002|Overall Study|Withdrawal by Participant|0|||
16152286|NCT02069899|39044191|FG000|Overall Study|Lost to Follow-up|1|||
16152287|NCT02069899|39044192|FG001|Overall Study|Lost to Follow-up|0|||
16152288|NCT02069899|39044193|FG002|Overall Study|Lost to Follow-up|1|||
16152289|NCT02069899|39044191|FG000|Overall Study|Other|4|||
16152290|NCT02069899|39044192|FG001|Overall Study|Other|0|||
16152291|NCT02069899|39044193|FG002|Overall Study|Other|0|||
16152292|NCT02069899|39044191|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
16152293|NCT02069899|39044192|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
16152294|NCT02069899|39044193|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
16152295|NCT02069899|39044191|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
16442964|NCT02052778|40099920|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442965|NCT02052778|40099921|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442966|NCT02052778|40099922|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442967|NCT02052778|40099923|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442968|NCT02052778|40099924|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442969|NCT02052778|40099925|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442970|NCT02052778|40099926|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16152296|NCT02069899|39044192|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
16152297|NCT02069899|39044193|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
16152298|NCT00961220|39044194|FG000|Overall Study|Adverse Event|3|||
16152299|NCT00961220|39044194|FG000|Overall Study|Lack of Efficacy|1|||
16152300|NCT00961220|39044194|FG000|Overall Study|No IV access for O6BG|1|||
16152301|NCT00961220|39044194|FG000|Overall Study|O6BG no longer supplied|1|||
16152302|NCT00961220|39044194|FG000|Overall Study|Complete Response prior to 12 courses|1|||
16152303|NCT00879645|39044195|FG000|Overall Study|Adverse Event|1|||
16152304|NCT00879645|39044196|FG001|Overall Study|Adverse Event|0|||
16152305|NCT00879645|39044197|FG002|Overall Study|Adverse Event|0|||
16152306|NCT00879645|39044198|FG003|Overall Study|Adverse Event|0|||
16152307|NCT02055820|39044199|FG000|Phase I: Dose-Finding|Death|1|||
16152308|NCT02055820|39044200|FG001|Phase I: Dose-Finding|Death|0|||
16152309|NCT02055820|39044201|FG002|Phase I: Dose-Finding|Death|1|||
16152310|NCT02055820|39044202|FG003|Phase I: Dose-Finding|Death|2|||
16152311|NCT02055820|39044203|FG004|Phase I: Dose-Finding|Death|0|||
16152312|NCT02055820|39044204|FG005|Phase I: Dose-Finding|Death|1|||
16152313|NCT02055820|39044205|FG006|Phase I: Dose-Finding|Death|1|||
16152314|NCT02055820|39044206|FG007|Phase I: Dose-Finding|Death|0|||
16152315|NCT02055820|39044207|FG008|Phase I: Dose-Finding|Death|0|||
16152316|NCT02055820|39044208|FG009|Phase I: Dose-Finding|Death|0|||
16152317|NCT02055820|39044199|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16152318|NCT02055820|39044200|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16152319|NCT02055820|39044201|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16152320|NCT02055820|39044202|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16152321|NCT02055820|39044203|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16152322|NCT02055820|39044204|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
16152323|NCT02055820|39044205|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16152324|NCT02055820|39044206|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16152325|NCT02055820|39044207|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16152326|NCT02055820|39044208|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
16152327|NCT02055820|39044199|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
16152328|NCT02055820|39044200|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
16152329|NCT02055820|39044201|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
16152330|NCT02055820|39044202|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
16152331|NCT02055820|39044203|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
16152332|NCT02055820|39044204|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
16152333|NCT02055820|39044205|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
16152334|NCT02055820|39044206|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
16152335|NCT02055820|39044207|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
16152336|NCT02055820|39044208|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
16152337|NCT02055820|39044199|FG000|Phase II: Expansion|Death|0|||
16152338|NCT02055820|39044200|FG001|Phase II: Expansion|Death|0|||
16152339|NCT02055820|39044201|FG002|Phase II: Expansion|Death|0|||
16442971|NCT02052778|40099927|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442972|NCT02052778|40099928|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442973|NCT02052778|40099929|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
16442974|NCT02052778|40099930|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
16442975|NCT02052778|40099908|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442976|NCT02052778|40099909|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16152340|NCT02055820|39044202|FG003|Phase II: Expansion|Death|0|||
16442977|NCT02052778|40099910|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16152341|NCT02055820|39044203|FG004|Phase II: Expansion|Death|33|||
16152342|NCT02055820|39044204|FG005|Phase II: Expansion|Death|0|||
16152343|NCT02055820|39044205|FG006|Phase II: Expansion|Death|0|||
16152344|NCT02055820|39044206|FG007|Phase II: Expansion|Death|0|||
16152345|NCT02055820|39044207|FG008|Phase II: Expansion|Death|0|||
16152346|NCT02055820|39044208|FG009|Phase II: Expansion|Death|0|||
16152347|NCT02055820|39044199|FG000|Phase II: Expansion|Lost to Follow-up|0|||
16152348|NCT02055820|39044200|FG001|Phase II: Expansion|Lost to Follow-up|0|||
16152349|NCT02055820|39044201|FG002|Phase II: Expansion|Lost to Follow-up|0|||
16152350|NCT02055820|39044202|FG003|Phase II: Expansion|Lost to Follow-up|0|||
16152351|NCT02055820|39044203|FG004|Phase II: Expansion|Lost to Follow-up|4|||
16152352|NCT02055820|39044204|FG005|Phase II: Expansion|Lost to Follow-up|0|||
16152353|NCT02055820|39044205|FG006|Phase II: Expansion|Lost to Follow-up|0|||
16152354|NCT02055820|39044206|FG007|Phase II: Expansion|Lost to Follow-up|0|||
16152355|NCT02055820|39044207|FG008|Phase II: Expansion|Lost to Follow-up|0|||
16152356|NCT02055820|39044208|FG009|Phase II: Expansion|Lost to Follow-up|0|||
16152357|NCT02055820|39044199|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
16152358|NCT02055820|39044200|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
16152359|NCT02055820|39044201|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
16152360|NCT02055820|39044202|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
16442978|NCT02052778|40099911|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442979|NCT02052778|40099912|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442980|NCT02052778|40099913|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442981|NCT02052778|40099914|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442982|NCT02052778|40099915|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442983|NCT02052778|40099916|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442984|NCT02052778|40099917|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442985|NCT02052778|40099918|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442986|NCT02052778|40099919|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442987|NCT02052778|40099920|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442988|NCT02052778|40099921|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442989|NCT02052778|40099922|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442990|NCT02052778|40099923|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442991|NCT02052778|40099924|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442992|NCT02052778|40099925|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442993|NCT02052778|40099926|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442994|NCT02052778|40099927|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442995|NCT02052778|40099928|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442996|NCT02052778|40099929|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
16442997|NCT02052778|40099930|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
16442998|NCT02052778|40099908|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16442999|NCT02052778|40099909|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443000|NCT02052778|40099910|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443001|NCT02052778|40099911|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443002|NCT02052778|40099912|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443003|NCT02052778|40099913|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443004|NCT02052778|40099914|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443005|NCT02052778|40099915|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16152361|NCT02055820|39044203|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
16152362|NCT02055820|39044204|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
16152363|NCT02055820|39044205|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
16152364|NCT02055820|39044206|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
16152365|NCT02055820|39044207|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
16152366|NCT02055820|39044208|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
16152367|NCT00609986|39044209|FG000|Overall Study|Did not receive transplant or treatment|8|||
16152368|NCT00609986|39044210|FG001|Overall Study|Did not receive transplant or treatment|3|||
16443006|NCT02052778|40099916|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443007|NCT02052778|40099917|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443008|NCT02052778|40099918|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443009|NCT02052778|40099919|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443010|NCT02052778|40099920|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443011|NCT02052778|40099921|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443012|NCT02052778|40099922|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443013|NCT02052778|40099923|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16152369|NCT01328951|39044214|FG000|Overall Study|Disease Progression|17|||
16152370|NCT01328951|39044215|FG001|Overall Study|Disease Progression|14|||
16152371|NCT01328951|39044214|FG000|Overall Study|Adverse Event|2|||
16152372|NCT01328951|39044215|FG001|Overall Study|Adverse Event|0|||
16152373|NCT01328951|39044214|FG000|Overall Study|Death|243|||
16152374|NCT01328951|39044215|FG001|Overall Study|Death|258|||
16152375|NCT01328951|39044214|FG000|Overall Study|Lost to Follow-up|6|||
16152376|NCT01328951|39044215|FG001|Overall Study|Lost to Follow-up|7|||
16261784|NCT04567186|39443195|FG001|Period 2|Lost to Follow-up|1|||
16261785|NCT04567186|39443194|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
16261786|NCT04567186|39443195|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
16261787|NCT05376319|39443202|FG000|Overall Study|Funding termination|2|||
16261788|NCT05376319|39443203|FG001|Overall Study|Funding termination|4|||
16261789|NCT02139826|39443204|FG000|Overall Study|Adverse Event|1|||
16261790|NCT00864097|39443207|FG000|Overall Study|Death|0|||
16261791|NCT00864097|39443208|FG001|Overall Study|Death|1|||
16261792|NCT00864097|39443209|FG002|Overall Study|Death|0|||
16261793|NCT00864097|39443210|FG003|Overall Study|Death|0|||
16261794|NCT00864097|39443207|FG000|Overall Study|Adverse Event|6|||
16261795|NCT00864097|39443208|FG001|Overall Study|Adverse Event|8|||
16261796|NCT00864097|39443209|FG002|Overall Study|Adverse Event|11|||
16152377|NCT01328951|39044214|FG000|Overall Study|Withdrawal by Subject|6|||
16152378|NCT01328951|39044215|FG001|Overall Study|Withdrawal by Subject|6|||
16261797|NCT00864097|39443210|FG003|Overall Study|Adverse Event|9|||
16261798|NCT00864097|39443207|FG000|Overall Study|Lack of Efficacy|9|||
16261799|NCT00864097|39443208|FG001|Overall Study|Lack of Efficacy|3|||
16261800|NCT00864097|39443209|FG002|Overall Study|Lack of Efficacy|7|||
16261801|NCT00864097|39443210|FG003|Overall Study|Lack of Efficacy|2|||
16261802|NCT00864097|39443207|FG000|Overall Study|Lost to Follow-up|0|||
16261803|NCT00864097|39443208|FG001|Overall Study|Lost to Follow-up|1|||
16261804|NCT00864097|39443209|FG002|Overall Study|Lost to Follow-up|0|||
16261805|NCT00864097|39443210|FG003|Overall Study|Lost to Follow-up|1|||
16261806|NCT00864097|39443207|FG000|Overall Study|Withdrawal by Subject|15|||
16261807|NCT00864097|39443208|FG001|Overall Study|Withdrawal by Subject|11|||
16261808|NCT00864097|39443209|FG002|Overall Study|Withdrawal by Subject|11|||
16261809|NCT00864097|39443210|FG003|Overall Study|Withdrawal by Subject|12|||
16261810|NCT00864097|39443207|FG000|Overall Study|Protocol Violation|2|||
16261811|NCT00864097|39443208|FG001|Overall Study|Protocol Violation|1|||
16443014|NCT02052778|40099924|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443015|NCT02052778|40099925|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443016|NCT02052778|40099926|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443017|NCT02052778|40099927|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443018|NCT02052778|40099928|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16443019|NCT02052778|40099929|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
16152379|NCT01328951|39044214|FG000|Overall Study|Study Closed by the Sponsor|36|||
16152380|NCT01328951|39044215|FG001|Overall Study|Study Closed by the Sponsor|31|||
16152381|NCT01328951|39044214|FG000|Overall Study|Other|11|||
16152382|NCT01328951|39044215|FG001|Overall Study|Other|6|||
16152383|NCT00317109|39044216|FG000|Overall Study|Withdrawal by Subject|2|||
16152384|NCT00317109|39044217|FG001|Overall Study|Withdrawal by Subject|0|||
16261812|NCT00864097|39443209|FG002|Overall Study|Protocol Violation|0|||
16261813|NCT00864097|39443210|FG003|Overall Study|Protocol Violation|1|||
16443020|NCT02052778|40099930|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
16443021|NCT02052778|40099908|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
16443022|NCT02052778|40099909|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
16443023|NCT02052778|40099910|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
16443024|NCT02052778|40099911|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
16261814|NCT00864097|39443207|FG000|Overall Study|Terminated by sponsor|105|||
16152385|NCT00317109|39044216|FG000|Overall Study|Migated/moved from study area|1|||
16152386|NCT00317109|39044217|FG001|Overall Study|Migated/moved from study area|0|||
16152387|NCT01761292|39044218|FG000|Part 1|Adverse Event|1|||
16152388|NCT01761292|39044218|FG000|Part 1|not receiving treatment in Part 1|1|||
16261815|NCT00864097|39443208|FG001|Overall Study|Terminated by sponsor|112|||
16261816|NCT00864097|39443209|FG002|Overall Study|Terminated by sponsor|102|||
16261817|NCT00864097|39443210|FG003|Overall Study|Terminated by sponsor|99|||
16261818|NCT00864097|39443207|FG000|Overall Study|Randomized but not treated|2|||
16261819|NCT00864097|39443208|FG001|Overall Study|Randomized but not treated|0|||
16443025|NCT02052778|40099912|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
16261820|NCT00864097|39443209|FG002|Overall Study|Randomized but not treated|1|||
16261821|NCT00864097|39443210|FG003|Overall Study|Randomized but not treated|0|||
16261822|NCT00864097|39443207|FG000|Overall Study|Other|0|||
16261823|NCT00864097|39443208|FG001|Overall Study|Other|0|||
16261824|NCT00864097|39443209|FG002|Overall Study|Other|0|||
16261825|NCT00864097|39443210|FG003|Overall Study|Other|1|||
16261826|NCT03135834|39443211|FG000|Stage 1|Adverse Event|1|||
16261827|NCT03135834|39443212|FG001|Stage 1|Adverse Event|2|||
16261828|NCT03135834|39443213|FG002|Stage 1|Adverse Event|2|||
16261829|NCT03135834|39443214|FG003|Stage 1|Adverse Event|1|||
16261830|NCT03135834|39443211|FG000|Stage 1|Death|1|||
16261831|NCT03135834|39443212|FG001|Stage 1|Death|0|||
16261832|NCT03135834|39443213|FG002|Stage 1|Death|0|||
16261833|NCT03135834|39443214|FG003|Stage 1|Death|0|||
16261834|NCT03135834|39443211|FG000|Stage 1|Lost to Follow-up|17|||
16261835|NCT03135834|39443212|FG001|Stage 1|Lost to Follow-up|24|||
16261836|NCT03135834|39443213|FG002|Stage 1|Lost to Follow-up|21|||
16261837|NCT03135834|39443214|FG003|Stage 1|Lost to Follow-up|38|||
16261838|NCT03135834|39443211|FG000|Stage 1|No longer met eligibility criteria|1|||
16261839|NCT03135834|39443212|FG001|Stage 1|No longer met eligibility criteria|6|||
16261840|NCT03135834|39443213|FG002|Stage 1|No longer met eligibility criteria|2|||
16261841|NCT03135834|39443214|FG003|Stage 1|No longer met eligibility criteria|5|||
16261842|NCT03135834|39443211|FG000|Stage 1|Other|0|||
16261843|NCT03135834|39443212|FG001|Stage 1|Other|2|||
16261844|NCT03135834|39443213|FG002|Stage 1|Other|1|||
16261845|NCT03135834|39443214|FG003|Stage 1|Other|0|||
16261846|NCT03135834|39443211|FG000|Stage 1|Physician Decision|0|||
16261847|NCT03135834|39443212|FG001|Stage 1|Physician Decision|1|||
16261848|NCT03135834|39443213|FG002|Stage 1|Physician Decision|0|||
16261849|NCT03135834|39443214|FG003|Stage 1|Physician Decision|0|||
16261850|NCT03135834|39443211|FG000|Stage 1|Pregnancy|0|||
16261851|NCT03135834|39443212|FG001|Stage 1|Pregnancy|4|||
16261852|NCT03135834|39443213|FG002|Stage 1|Pregnancy|2|||
16261853|NCT03135834|39443214|FG003|Stage 1|Pregnancy|4|||
16261854|NCT03135834|39443211|FG000|Stage 1|Protocol Violation|1|||
16261855|NCT03135834|39443212|FG001|Stage 1|Protocol Violation|1|||
16261856|NCT03135834|39443213|FG002|Stage 1|Protocol Violation|2|||
16261857|NCT03135834|39443214|FG003|Stage 1|Protocol Violation|1|||
16261858|NCT03135834|39443211|FG000|Stage 1|Withdrawal by parent/guardian|2|||
16261859|NCT03135834|39443212|FG001|Stage 1|Withdrawal by parent/guardian|10|||
16261860|NCT03135834|39443213|FG002|Stage 1|Withdrawal by parent/guardian|2|||
16261861|NCT03135834|39443214|FG003|Stage 1|Withdrawal by parent/guardian|1|||
16261862|NCT03135834|39443211|FG000|Stage 1|Withdrawal by Subject|16|||
16261863|NCT03135834|39443212|FG001|Stage 1|Withdrawal by Subject|22|||
16261864|NCT03135834|39443213|FG002|Stage 1|Withdrawal by Subject|7|||
16261865|NCT03135834|39443214|FG003|Stage 1|Withdrawal by Subject|10|||
16261866|NCT03135834|39443211|FG000|Stage 1|Randomized but not Vaccinated|0|||
16261867|NCT03135834|39443212|FG001|Stage 1|Randomized but not Vaccinated|3|||
16152389|NCT01761292|39044218|FG000|Extension 1|Withdrawal by Subject|1|||
16261868|NCT03135834|39443213|FG002|Stage 1|Randomized but not Vaccinated|1|||
16261869|NCT03135834|39443214|FG003|Stage 1|Randomized but not Vaccinated|6|||
16366015|NCT00447278|39825391|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
16261870|NCT03135834|39443211|FG000|Stage 2|Lost to Follow-up|0|||
16261871|NCT03135834|39443212|FG001|Stage 2|Lost to Follow-up|1|||
16261872|NCT03135834|39443213|FG002|Stage 2|Lost to Follow-up|0|||
16261873|NCT03135834|39443214|FG003|Stage 2|Lost to Follow-up|0|||
16261874|NCT03135834|39443211|FG000|Stage 2|Withdrawal by Subject|0|||
16261875|NCT03135834|39443212|FG001|Stage 2|Withdrawal by Subject|1|||
16261876|NCT03135834|39443213|FG002|Stage 2|Withdrawal by Subject|0|||
16261877|NCT03135834|39443214|FG003|Stage 2|Withdrawal by Subject|0|||
16261878|NCT03135834|39443211|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
16261879|NCT03135834|39443212|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
16261880|NCT03135834|39443213|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
16366016|NCT00447278|39825392|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
16366017|NCT00447278|39825391|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
16366018|NCT00447278|39825392|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
16366019|NCT00447278|39825391|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
16366020|NCT00447278|39825392|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
16366021|NCT00447278|39825391|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
16366022|NCT00447278|39825392|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
16366023|NCT00447278|39825391|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
16366024|NCT00447278|39825392|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
16366025|NCT00447278|39825391|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
16366026|NCT00447278|39825392|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
16366027|NCT00447278|39825391|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
16366028|NCT00447278|39825392|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
16366029|NCT00447278|39825391|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
16366030|NCT00447278|39825392|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
16443026|NCT02052778|40099913|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
16443027|NCT02052778|40099914|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
16443028|NCT02052778|40099915|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
16443029|NCT02052778|40099916|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
16443030|NCT02052778|40099917|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
16443031|NCT02052778|40099918|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
16443032|NCT02052778|40099919|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
16443033|NCT02052778|40099920|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
16443034|NCT02052778|40099921|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
16443035|NCT02052778|40099922|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
16443036|NCT02052778|40099923|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
16443037|NCT02052778|40099924|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
16443038|NCT02052778|40099925|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
16443039|NCT02052778|40099926|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
16443040|NCT02052778|40099927|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
16443041|NCT02052778|40099928|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
16443042|NCT02052778|40099929|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
16443043|NCT02052778|40099930|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
16443044|NCT02052778|40099908|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443045|NCT02052778|40099909|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443046|NCT02052778|40099910|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443047|NCT02052778|40099911|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443048|NCT02052778|40099912|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443049|NCT02052778|40099913|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443050|NCT02052778|40099914|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443051|NCT02052778|40099915|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443052|NCT02052778|40099916|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443053|NCT02052778|40099917|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443054|NCT02052778|40099918|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443055|NCT02052778|40099919|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443056|NCT02052778|40099920|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443057|NCT02052778|40099921|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443058|NCT02052778|40099922|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443059|NCT02052778|40099923|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443060|NCT02052778|40099924|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443061|NCT02052778|40099925|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443062|NCT02052778|40099926|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443063|NCT02052778|40099927|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443064|NCT02052778|40099928|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443065|NCT02052778|40099929|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
16443066|NCT02052778|40099930|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
16443067|NCT03210714|40099931|FG000|Overall Study|Adverse Event|6|||
16443068|NCT03210714|40099931|FG000|Overall Study|Physician Decision|1|||
16443069|NCT03210714|40099931|FG000|Overall Study|Progressive disease|11|||
16443070|NCT03210714|40099931|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
16443071|NCT02018562|40099932|FG000|Overall Study|Withdrawal by Subject|2|||
16443072|NCT02018562|40099933|FG001|Overall Study|Withdrawal by Subject|0|||
16443073|NCT02018562|40099932|FG000|Overall Study|Discharged prior to study completion|1|||
16152390|NCT00563186|39044219|FG000|Overall Study|LOS<48 hours|97|||
16152391|NCT00563186|39044220|FG001|Overall Study|LOS<48 hours|74|||
16152392|NCT00563186|39044219|FG000|Overall Study|Incomplete data|1|||
16152393|NCT00563186|39044220|FG001|Overall Study|Incomplete data|1|||
16152394|NCT01524198|39044221|FG000|Overall Study|Protocol Violation|8|||
16152395|NCT01524198|39044222|FG001|Overall Study|Protocol Violation|6|||
16152396|NCT01524198|39044221|FG000|Overall Study|Withdrawal by Subject|15|||
16152397|NCT01524198|39044222|FG001|Overall Study|Withdrawal by Subject|10|||
16152398|NCT01765920|39044226|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
16152399|NCT01765920|39044227|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
16152400|NCT01765920|39044226|FG000|Overall Study|Patient code disclosure|0|||
16152401|NCT01765920|39044227|FG001|Overall Study|Patient code disclosure|1|||
16152402|NCT03287219|39044228|FG000|Overall Study|Protocol Violation|0|||
16152403|NCT03287219|39044229|FG001|Overall Study|Protocol Violation|2|||
16152404|NCT02431702|39044230|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
16152405|NCT02431702|39044231|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
16152406|NCT02431702|39044232|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
16152407|NCT02431702|39044233|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
16152408|NCT02431702|39044234|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
16152409|NCT02431702|39044235|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
16152410|NCT02431702|39044236|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
16152411|NCT02431702|39044230|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
16152412|NCT02431702|39044231|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
16152413|NCT02431702|39044232|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
16152414|NCT02431702|39044233|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
16152415|NCT02431702|39044234|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
16152416|NCT02431702|39044235|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
16152417|NCT02431702|39044236|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
16152418|NCT02431702|39044230|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
16152419|NCT02431702|39044231|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
16152420|NCT02431702|39044232|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
16152421|NCT02431702|39044233|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
16152422|NCT02431702|39044234|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
16152423|NCT02431702|39044235|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
16152424|NCT02431702|39044236|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
16443074|NCT02018562|40099933|FG001|Overall Study|Discharged prior to study completion|0|||
16443075|NCT04038359|40099936|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
16443076|NCT04038359|40099937|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
16443077|NCT04038359|40099936|FG000|Overall Study|Death|8|||
16443078|NCT04038359|40099937|FG001|Overall Study|Death|7|||
16443079|NCT04038359|40099936|FG000|Overall Study|Lost to Follow-up|3|||
16443080|NCT04038359|40099937|FG001|Overall Study|Lost to Follow-up|0|||
16443081|NCT04038359|40099936|FG000|Overall Study|Participant Moved|1|||
16443082|NCT04038359|40099937|FG001|Overall Study|Participant Moved|0|||
16443083|NCT04038359|40099936|FG000|Overall Study|Withdrawal by Subject|4|||
16443084|NCT04038359|40099937|FG001|Overall Study|Withdrawal by Subject|3|||
16443085|NCT04038359|40099936|FG000|Overall Study|Physician Decision|3|||
16443086|NCT04038359|40099937|FG001|Overall Study|Physician Decision|2|||
16443087|NCT04038359|40099936|FG000|Overall Study|Adverse Event|0|||
16443088|NCT04038359|40099937|FG001|Overall Study|Adverse Event|2|||
16443089|NCT04038359|40099936|FG000|Overall Study|Progressive Disease|0|||
16443090|NCT04038359|40099937|FG001|Overall Study|Progressive Disease|1|||
16443091|NCT03157830|40099938|FG000|Overall Study|Lost to Follow-up|1|||
16443092|NCT03157830|40099938|FG000|Overall Study|Withdrawal by Subject|1|||
16443093|NCT03462719|40099949|FG000|Overall Study|Withdrawal by Subject|4|||
16443094|NCT03462719|40099950|FG001|Overall Study|Withdrawal by Subject|3|||
16443095|NCT03462719|40099949|FG000|Overall Study|Ongoing|87|||
16443096|NCT03462719|40099950|FG001|Overall Study|Ongoing|72|||
16443097|NCT03899259|40099953|FG000|Overall Study|Adverse Event|5|||
16443098|NCT03899259|40099954|FG001|Overall Study|Adverse Event|4|||
16443099|NCT03899259|40099955|FG002|Overall Study|Adverse Event|6|||
16443100|NCT03899259|40099953|FG000|Overall Study|Lack of Efficacy|5|||
16443101|NCT03899259|40099954|FG001|Overall Study|Lack of Efficacy|0|||
16443102|NCT03899259|40099955|FG002|Overall Study|Lack of Efficacy|2|||
16152425|NCT02431702|39044230|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
16152426|NCT02431702|39044231|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
16152427|NCT02431702|39044232|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
16152428|NCT02431702|39044233|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
16443103|NCT03899259|40099953|FG000|Overall Study|Pregnancy|3|||
16443104|NCT03899259|40099954|FG001|Overall Study|Pregnancy|0|||
16443105|NCT03899259|40099955|FG002|Overall Study|Pregnancy|1|||
16443106|NCT03899259|40099953|FG000|Overall Study|Physician Decision|0|||
16443107|NCT03899259|40099954|FG001|Overall Study|Physician Decision|1|||
16443108|NCT03899259|40099955|FG002|Overall Study|Physician Decision|0|||
16443109|NCT03899259|40099953|FG000|Overall Study|Protocol Deviation|1|||
16443110|NCT03899259|40099954|FG001|Overall Study|Protocol Deviation|1|||
16443111|NCT03899259|40099955|FG002|Overall Study|Protocol Deviation|1|||
16443112|NCT03899259|40099953|FG000|Overall Study|Withdrawal by Subject|8|||
16443113|NCT03899259|40099954|FG001|Overall Study|Withdrawal by Subject|10|||
16443114|NCT03899259|40099955|FG002|Overall Study|Withdrawal by Subject|12|||
16443115|NCT03899259|40099953|FG000|Overall Study|Lost to Follow-up|5|||
16443116|NCT03899259|40099954|FG001|Overall Study|Lost to Follow-up|6|||
16443117|NCT03899259|40099955|FG002|Overall Study|Lost to Follow-up|2|||
16443118|NCT03899259|40099953|FG000|Overall Study|Lack of Adherence|1|||
16443119|NCT03899259|40099954|FG001|Overall Study|Lack of Adherence|0|||
16443120|NCT03899259|40099955|FG002|Overall Study|Lack of Adherence|0|||
16443121|NCT03899259|40099953|FG000|Overall Study|Screen Failure|1|||
16443122|NCT03899259|40099954|FG001|Overall Study|Screen Failure|0|||
16443123|NCT03899259|40099955|FG002|Overall Study|Screen Failure|0|||
16443124|NCT03899259|40099953|FG000|Overall Study|Ongoing Study Participation|127|||
16443125|NCT03899259|40099954|FG001|Overall Study|Ongoing Study Participation|134|||
16443126|NCT03899259|40099955|FG002|Overall Study|Ongoing Study Participation|210|||
16443127|NCT00392327|40099956|FG000|Overall Study|Death|1|||
16443128|NCT00392327|40099957|FG001|Overall Study|Death|0|||
16443129|NCT00392327|40099958|FG002|Overall Study|Death|1|||
16443130|NCT00392327|40099959|FG003|Overall Study|Death|0|||
16443131|NCT00392327|40099960|FG004|Overall Study|Death|0|||
16443132|NCT00392327|40099961|FG005|Overall Study|Death|0|||
16443133|NCT00392327|40099962|FG006|Overall Study|Death|0|||
16443134|NCT00392327|40099963|FG007|Overall Study|Death|0|||
16443135|NCT00392327|40099956|FG000|Overall Study|Lack of Efficacy|8|||
16443136|NCT00392327|40099957|FG001|Overall Study|Lack of Efficacy|8|||
16443137|NCT00392327|40099958|FG002|Overall Study|Lack of Efficacy|9|||
16443138|NCT00392327|40099959|FG003|Overall Study|Lack of Efficacy|6|||
16443139|NCT00392327|40099960|FG004|Overall Study|Lack of Efficacy|3|||
16443140|NCT00392327|40099961|FG005|Overall Study|Lack of Efficacy|3|||
16443141|NCT00392327|40099962|FG006|Overall Study|Lack of Efficacy|3|||
16443142|NCT00392327|40099963|FG007|Overall Study|Lack of Efficacy|3|||
16443143|NCT00392327|40099956|FG000|Overall Study|Physician Decision|3|||
16443144|NCT00392327|40099957|FG001|Overall Study|Physician Decision|5|||
16443145|NCT00392327|40099958|FG002|Overall Study|Physician Decision|2|||
16443146|NCT00392327|40099959|FG003|Overall Study|Physician Decision|2|||
16443147|NCT00392327|40099960|FG004|Overall Study|Physician Decision|0|||
16443148|NCT00392327|40099961|FG005|Overall Study|Physician Decision|1|||
16443149|NCT00392327|40099962|FG006|Overall Study|Physician Decision|5|||
16443150|NCT00392327|40099963|FG007|Overall Study|Physician Decision|3|||
16443151|NCT00392327|40099956|FG000|Overall Study|Protocol Violation|0|||
16443152|NCT00392327|40099957|FG001|Overall Study|Protocol Violation|0|||
16443153|NCT00392327|40099958|FG002|Overall Study|Protocol Violation|1|||
16443154|NCT00392327|40099959|FG003|Overall Study|Protocol Violation|0|||
16443155|NCT00392327|40099960|FG004|Overall Study|Protocol Violation|0|||
16443156|NCT00392327|40099961|FG005|Overall Study|Protocol Violation|0|||
16443157|NCT00392327|40099962|FG006|Overall Study|Protocol Violation|0|||
16443158|NCT00392327|40099963|FG007|Overall Study|Protocol Violation|0|||
16443159|NCT00392327|40099956|FG000|Overall Study|Withdrawal by Subject|3|||
16443160|NCT00392327|40099957|FG001|Overall Study|Withdrawal by Subject|2|||
16443161|NCT00392327|40099958|FG002|Overall Study|Withdrawal by Subject|4|||
16443162|NCT00392327|40099959|FG003|Overall Study|Withdrawal by Subject|6|||
16443163|NCT00392327|40099960|FG004|Overall Study|Withdrawal by Subject|0|||
16443164|NCT00392327|40099961|FG005|Overall Study|Withdrawal by Subject|1|||
16443165|NCT00392327|40099962|FG006|Overall Study|Withdrawal by Subject|1|||
16443166|NCT00392327|40099963|FG007|Overall Study|Withdrawal by Subject|5|||
16443167|NCT00392327|40099956|FG000|Overall Study|Ineligible|0|||
16443168|NCT00392327|40099957|FG001|Overall Study|Ineligible|4|||
16443169|NCT00392327|40099958|FG002|Overall Study|Ineligible|3|||
16443170|NCT00392327|40099959|FG003|Overall Study|Ineligible|2|||
16443171|NCT00392327|40099960|FG004|Overall Study|Ineligible|0|||
16443172|NCT00392327|40099961|FG005|Overall Study|Ineligible|0|||
16443173|NCT00392327|40099962|FG006|Overall Study|Ineligible|0|||
16443174|NCT00392327|40099963|FG007|Overall Study|Ineligible|0|||
16443175|NCT05468814|40099967|FG000|Overall Study|Lost to Follow-up|5|||
16443176|NCT05468814|40099968|FG001|Overall Study|Lost to Follow-up|6|||
16443177|NCT02197234|40102270|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
16443178|NCT02197234|40102270|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
16443179|NCT02197234|40102270|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
16443180|NCT02197234|40102270|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
16443181|NCT02197234|40102270|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
16443182|NCT02197234|40102270|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
16443183|NCT04973449|40102273|FG000|Overall Study|Withdrawal by Subject|3|||
16443184|NCT04973449|40102274|FG001|Overall Study|Withdrawal by Subject|3|||
16443185|NCT04973449|40102275|FG002|Overall Study|Withdrawal by Subject|2|||
16443186|NCT04973449|40102276|FG003|Overall Study|Withdrawal by Subject|5|||
16443187|NCT04973449|40102277|FG004|Overall Study|Withdrawal by Subject|5|||
16443188|NCT04973449|40102278|FG005|Overall Study|Withdrawal by Subject|4|||
16443189|NCT04973449|40102279|FG006|Overall Study|Withdrawal by Subject|7|||
16443190|NCT04973449|40102280|FG007|Overall Study|Withdrawal by Subject|5|||
16443191|NCT04973449|40102273|FG000|Overall Study|Lost to Follow-up|15|||
16443192|NCT04973449|40102274|FG001|Overall Study|Lost to Follow-up|16|||
16443193|NCT04973449|40102275|FG002|Overall Study|Lost to Follow-up|16|||
16443194|NCT04973449|40102276|FG003|Overall Study|Lost to Follow-up|13|||
16443195|NCT04973449|40102277|FG004|Overall Study|Lost to Follow-up|5|||
16443196|NCT04973449|40102278|FG005|Overall Study|Lost to Follow-up|6|||
16443197|NCT04973449|40102279|FG006|Overall Study|Lost to Follow-up|10|||
16443198|NCT04973449|40102280|FG007|Overall Study|Lost to Follow-up|6|||
16443199|NCT04973449|40102273|FG000|Overall Study|Death|1|||
16443200|NCT04973449|40102274|FG001|Overall Study|Death|0|||
16443201|NCT04973449|40102275|FG002|Overall Study|Death|0|||
16443202|NCT04973449|40102276|FG003|Overall Study|Death|0|||
16443203|NCT04973449|40102277|FG004|Overall Study|Death|0|||
16443204|NCT04973449|40102278|FG005|Overall Study|Death|1|||
16443205|NCT04973449|40102279|FG006|Overall Study|Death|0|||
16443206|NCT04973449|40102280|FG007|Overall Study|Death|0|||
16443207|NCT04973449|40102273|FG000|Overall Study|Other|1|||
16443208|NCT04973449|40102274|FG001|Overall Study|Other|1|||
16443209|NCT04973449|40102275|FG002|Overall Study|Other|2|||
16443210|NCT04973449|40102276|FG003|Overall Study|Other|1|||
16443211|NCT04973449|40102277|FG004|Overall Study|Other|4|||
16443212|NCT04973449|40102278|FG005|Overall Study|Other|0|||
16443213|NCT04973449|40102279|FG006|Overall Study|Other|2|||
16443214|NCT04973449|40102280|FG007|Overall Study|Other|2|||
16443215|NCT03668873|40102283|FG000|Overall Study|Lost to Follow-up|6|||
16443216|NCT03668873|40102284|FG001|Overall Study|Lost to Follow-up|3|||
16443217|NCT03755934|40102285|FG000|Overall Study|Adverse Event|4|||
16443218|NCT03755934|40102286|FG001|Overall Study|Adverse Event|1|||
16443219|NCT03755934|40102287|FG002|Overall Study|Adverse Event|1|||
16443220|NCT03755934|40102288|FG003|Overall Study|Adverse Event|3|||
16443221|NCT03755934|40102285|FG000|Overall Study|Physician Decision|2|||
16443222|NCT03755934|40102286|FG001|Overall Study|Physician Decision|0|||
16443223|NCT03755934|40102287|FG002|Overall Study|Physician Decision|0|||
16443224|NCT03755934|40102288|FG003|Overall Study|Physician Decision|1|||
16443225|NCT03755934|40102285|FG000|Overall Study|Withdrawal by Subject|5|||
16443226|NCT03755934|40102286|FG001|Overall Study|Withdrawal by Subject|0|||
16443227|NCT03755934|40102287|FG002|Overall Study|Withdrawal by Subject|0|||
16443228|NCT03755934|40102288|FG003|Overall Study|Withdrawal by Subject|1|||
16443229|NCT03755934|40102285|FG000|Overall Study|Other|3|||
16443230|NCT03755934|40102286|FG001|Overall Study|Other|1|||
16443231|NCT03755934|40102287|FG002|Overall Study|Other|3|||
16443232|NCT03755934|40102288|FG003|Overall Study|Other|1|||
16443233|NCT01946204|40102289|FG000|Overall Study|Death|38|||
16443234|NCT01946204|40102290|FG001|Overall Study|Death|59|||
16443235|NCT01946204|40102289|FG000|Overall Study|Withdrawal by Subject|37|||
16443236|NCT01946204|40102290|FG001|Overall Study|Withdrawal by Subject|50|||
16443237|NCT01946204|40102289|FG000|Overall Study|Lost to Follow-up|3|||
16443238|NCT01946204|40102290|FG001|Overall Study|Lost to Follow-up|7|||
16443239|NCT01946204|40102289|FG000|Overall Study|Ongoing|316|||
16443240|NCT01946204|40102290|FG001|Overall Study|Ongoing|687|||
16443241|NCT01946204|40102289|FG000|Overall Study|Other|7|||
16443242|NCT01946204|40102290|FG001|Overall Study|Other|3|||
16443243|NCT03521570|40102293|FG000|Overall Study|Not eligible|11|||
16443244|NCT02004236|40102294|FG000|Overall Study|Lack of Efficacy|0|||
16443245|NCT02004236|40102295|FG001|Overall Study|Lack of Efficacy|0|||
16443246|NCT02004236|40102296|FG002|Overall Study|Lack of Efficacy|16|||
16443247|NCT04952597|40102297|FG000|Overall Study|Death|12|||
16443248|NCT04952597|40102298|FG001|Overall Study|Death|13|||
16443249|NCT04952597|40102299|FG002|Overall Study|Death|14|||
16443250|NCT04952597|40102297|FG000|Overall Study|Withdrawal by Subject|1|||
16443251|NCT04952597|40102298|FG001|Overall Study|Withdrawal by Subject|0|||
16443252|NCT04952597|40102299|FG002|Overall Study|Withdrawal by Subject|3|||
16443253|NCT04952597|40102297|FG000|Overall Study|Lost to Follow-up|0|||
16443254|NCT04952597|40102298|FG001|Overall Study|Lost to Follow-up|1|||
16443255|NCT04952597|40102299|FG002|Overall Study|Lost to Follow-up|1|||
16443256|NCT01263769|40102302|FG000|Overall Study|Non-Compliant with treatment|1|||
16443257|NCT03675126|40102303|FG000|Overall Study|Study Terminated by Sponsor|9|||
16443258|NCT03675126|40102303|FG000|Overall Study|Death|2|||
16443259|NCT03675126|40102303|FG000|Overall Study|Withdrawal by Subject|4|||
16443260|NCT01346358|40102310|FG000|Overall Study|Withdrawal by Subject|1|||
16443261|NCT01346358|40102311|FG001|Overall Study|Withdrawal by Subject|0|||
16443262|NCT01346358|40102312|FG002|Overall Study|Withdrawal by Subject|1|||
16443263|NCT01346358|40102313|FG003|Overall Study|Withdrawal by Subject|1|||
16443264|NCT01346358|40102314|FG004|Overall Study|Withdrawal by Subject|0|||
16443265|NCT01346358|40102315|FG005|Overall Study|Withdrawal by Subject|2|||
16443266|NCT01346358|40102316|FG006|Overall Study|Withdrawal by Subject|1|||
16443267|NCT01346358|40102317|FG007|Overall Study|Withdrawal by Subject|1|||
16443268|NCT01346358|40102318|FG008|Overall Study|Withdrawal by Subject|1|||
16443269|NCT01346358|40102310|FG000|Overall Study|Adverse Event|1|||
16443270|NCT01346358|40102311|FG001|Overall Study|Adverse Event|0|||
16443271|NCT01346358|40102312|FG002|Overall Study|Adverse Event|0|||
16443272|NCT01346358|40102313|FG003|Overall Study|Adverse Event|0|||
16443273|NCT01346358|40102314|FG004|Overall Study|Adverse Event|1|||
16443274|NCT01346358|40102315|FG005|Overall Study|Adverse Event|0|||
16443275|NCT01346358|40102316|FG006|Overall Study|Adverse Event|0|||
16443276|NCT01346358|40102317|FG007|Overall Study|Adverse Event|0|||
16443277|NCT01346358|40102318|FG008|Overall Study|Adverse Event|1|||
16443278|NCT01346358|40102310|FG000|Overall Study|Non-Compliance|0|||
16443279|NCT01346358|40102311|FG001|Overall Study|Non-Compliance|0|||
16443280|NCT01346358|40102312|FG002|Overall Study|Non-Compliance|0|||
16443281|NCT01346358|40102313|FG003|Overall Study|Non-Compliance|0|||
16443282|NCT01346358|40102314|FG004|Overall Study|Non-Compliance|0|||
16443283|NCT01346358|40102315|FG005|Overall Study|Non-Compliance|0|||
16443284|NCT01346358|40102316|FG006|Overall Study|Non-Compliance|0|||
16443285|NCT01346358|40102317|FG007|Overall Study|Non-Compliance|2|||
16443286|NCT01346358|40102318|FG008|Overall Study|Non-Compliance|0|||
16443287|NCT01346358|40102310|FG000|Overall Study|Physician Decision|0|||
16443288|NCT01346358|40102311|FG001|Overall Study|Physician Decision|1|||
16443289|NCT01346358|40102312|FG002|Overall Study|Physician Decision|0|||
16443290|NCT01346358|40102313|FG003|Overall Study|Physician Decision|0|||
16443291|NCT01346358|40102314|FG004|Overall Study|Physician Decision|0|||
16443292|NCT01346358|40102315|FG005|Overall Study|Physician Decision|0|||
16443293|NCT01346358|40102316|FG006|Overall Study|Physician Decision|0|||
16443294|NCT01346358|40102317|FG007|Overall Study|Physician Decision|1|||
16443295|NCT01346358|40102318|FG008|Overall Study|Physician Decision|1|||
16443296|NCT03317405|40102327|FG000|Overall Study|Withdrawal by Subject|1|||
16443297|NCT03317405|40102328|FG001|Overall Study|Withdrawal by Subject|0|||
16443298|NCT03317405|40102329|FG002|Overall Study|Withdrawal by Subject|0|||
16443299|NCT03317405|40102327|FG000|Overall Study|Physician Decision|0|||
16443300|NCT03317405|40102328|FG001|Overall Study|Physician Decision|0|||
16443301|NCT03317405|40102329|FG002|Overall Study|Physician Decision|1|||
16443302|NCT03317405|40102327|FG000|Overall Study|Surgery Rescheduled|0|||
16443303|NCT03317405|40102328|FG001|Overall Study|Surgery Rescheduled|1|||
16443304|NCT03317405|40102329|FG002|Overall Study|Surgery Rescheduled|0|||
16443305|NCT02521285|40102331|FG000|Overall Study|Lost to Follow-up|1|||
16443306|NCT02521285|40102332|FG001|Overall Study|Lost to Follow-up|1|||
16443307|NCT02521285|40102331|FG000|Overall Study|Withdrawal by Subject|1|||
16443308|NCT02521285|40102332|FG001|Overall Study|Withdrawal by Subject|1|||
16443309|NCT02521285|40102331|FG000|Overall Study|Adverse Event|0|||
16443310|NCT02521285|40102332|FG001|Overall Study|Adverse Event|1|||
16443311|NCT02397096|40102339|FG000|Day 1 to Week 24|Adverse Event|7|||
16443312|NCT02397096|40102340|FG001|Day 1 to Week 24|Adverse Event|1|||
16443313|NCT02397096|40102339|FG000|Day 1 to Week 24|Death|1|||
16443314|NCT02397096|40102340|FG001|Day 1 to Week 24|Death|0|||
16443315|NCT02397096|40102339|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
16443316|NCT02397096|40102340|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
16443317|NCT02397096|40102339|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
16443318|NCT02397096|40102340|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
16443319|NCT02397096|40102339|FG000|Day 1 to Week 24|Physician Decision|2|||
16443320|NCT02397096|40102340|FG001|Day 1 to Week 24|Physician Decision|3|||
16443321|NCT02397096|40102339|FG000|Day 1 to Week 24|Protocol Violation|1|||
16443322|NCT02397096|40102340|FG001|Day 1 to Week 24|Protocol Violation|4|||
16443323|NCT02397096|40102339|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
16443324|NCT02397096|40102340|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
16443325|NCT02397096|40102339|FG000|Day 1 to Week 24|Randomized, not treated|3|||
16443326|NCT02397096|40102340|FG001|Day 1 to Week 24|Randomized, not treated|0|||
16443327|NCT02397096|40102339|FG000|Week 24 to Week 48|Adverse Event|6|||
16443328|NCT02397096|40102340|FG001|Week 24 to Week 48|Adverse Event|2|||
16443329|NCT02397096|40102339|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
16443330|NCT02397096|40102340|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
16443331|NCT02397096|40102339|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
16443332|NCT02397096|40102340|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
16443333|NCT02397096|40102339|FG000|Week 24 to Week 48|Physician Decision|2|||
16443334|NCT02397096|40102340|FG001|Week 24 to Week 48|Physician Decision|1|||
16443335|NCT02397096|40102339|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
16443336|NCT02397096|40102340|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
16443337|NCT02397096|40102339|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
16443338|NCT02397096|40102340|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
16443339|NCT02397096|40102339|FG000|Study Extension 1|Adverse Event|7|||
16443340|NCT02397096|40102340|FG001|Study Extension 1|Adverse Event|5|||
16443341|NCT02397096|40102339|FG000|Study Extension 1|Death|1|||
16443342|NCT02397096|40102340|FG001|Study Extension 1|Death|0|||
16443343|NCT02397096|40102339|FG000|Study Extension 1|Lack of Efficacy|2|||
16443344|NCT02397096|40102340|FG001|Study Extension 1|Lack of Efficacy|5|||
16443345|NCT02397096|40102339|FG000|Study Extension 1|Lost to Follow-up|2|||
16443346|NCT02397096|40102340|FG001|Study Extension 1|Lost to Follow-up|3|||
16443347|NCT02397096|40102339|FG000|Study Extension 1|Non-compliance with study drug|3|||
16443348|NCT02397096|40102340|FG001|Study Extension 1|Non-compliance with study drug|0|||
16443349|NCT02397096|40102339|FG000|Study Extension 1|Physician Decision|4|||
16443350|NCT02397096|40102340|FG001|Study Extension 1|Physician Decision|2|||
16443351|NCT02397096|40102339|FG000|Study Extension 1|Pregnancy|1|||
16443352|NCT02397096|40102340|FG001|Study Extension 1|Pregnancy|0|||
16443353|NCT02397096|40102339|FG000|Study Extension 1|Protocol Violation|0|||
16443354|NCT02397096|40102340|FG001|Study Extension 1|Protocol Violation|1|||
16443355|NCT02397096|40102339|FG000|Study Extension 1|Withdrawal by Subject|21|||
16443356|NCT02397096|40102340|FG001|Study Extension 1|Withdrawal by Subject|7|||
16443357|NCT02397096|40102339|FG000|Study Extension 2|Adverse Event|3|||
16152429|NCT02431702|39044234|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
16152430|NCT02431702|39044235|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
16152431|NCT02431702|39044236|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
16152432|NCT02431702|39044230|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
16152433|NCT02431702|39044231|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
16152434|NCT02431702|39044232|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
16152435|NCT02431702|39044233|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
16152436|NCT02431702|39044234|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
16152437|NCT02431702|39044235|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
16152438|NCT02431702|39044236|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
16152439|NCT02431702|39044230|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
16152440|NCT02431702|39044231|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
16152441|NCT02431702|39044232|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
16152442|NCT02431702|39044233|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
16152443|NCT02431702|39044234|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
16152444|NCT02431702|39044235|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
16152445|NCT02431702|39044236|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
16152446|NCT02431702|39044230|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
16152447|NCT02431702|39044231|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
16443358|NCT02397096|40102340|FG001|Study Extension 2|Adverse Event|3|||
16443359|NCT02397096|40102339|FG000|Study Extension 2|Availability of study medication locally|152|||
16443360|NCT02397096|40102340|FG001|Study Extension 2|Availability of study medication locally|64|||
16443361|NCT02397096|40102339|FG000|Study Extension 2|Death|2|||
16443362|NCT02397096|40102340|FG001|Study Extension 2|Death|0|||
16443363|NCT02397096|40102339|FG000|Study Extension 2|Lack of Efficacy|1|||
16443364|NCT02397096|40102340|FG001|Study Extension 2|Lack of Efficacy|0|||
16152448|NCT02431702|39044232|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
16152449|NCT02431702|39044233|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
16152450|NCT02431702|39044234|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
16152451|NCT02431702|39044235|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
16152452|NCT02431702|39044236|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
16443365|NCT02397096|40102339|FG000|Study Extension 2|Lost to Follow-up|2|||
16443366|NCT02397096|40102340|FG001|Study Extension 2|Lost to Follow-up|1|||
16443367|NCT02397096|40102339|FG000|Study Extension 2|Non-compliance with study drug|1|||
16443368|NCT02397096|40102340|FG001|Study Extension 2|Non-compliance with study drug|0|||
16443369|NCT02397096|40102339|FG000|Study Extension 2|Physician Decision|2|||
16443370|NCT02397096|40102340|FG001|Study Extension 2|Physician Decision|5|||
16443371|NCT02397096|40102339|FG000|Study Extension 2|Pregnancy|1|||
16443372|NCT02397096|40102340|FG001|Study Extension 2|Pregnancy|0|||
16443373|NCT02397096|40102339|FG000|Study Extension 2|Withdrawal by Subject|10|||
16443374|NCT02397096|40102340|FG001|Study Extension 2|Withdrawal by Subject|3|||
16443375|NCT02397096|40102339|FG000|Study Extension 3|Adverse Event|1|||
16443376|NCT02397096|40102340|FG001|Study Extension 3|Adverse Event|0|||
16443377|NCT02397096|40102339|FG000|Study Extension 3|Availability of study medication locally|11|||
16443378|NCT02397096|40102340|FG001|Study Extension 3|Availability of study medication locally|3|||
16443379|NCT02397096|40102339|FG000|Study Extension 3|Lost to Follow-up|1|||
16443380|NCT02397096|40102340|FG001|Study Extension 3|Lost to Follow-up|0|||
16443381|NCT02397096|40102339|FG000|Study Extension 3|Withdrawal by Subject|2|||
16443382|NCT02397096|40102340|FG001|Study Extension 3|Withdrawal by Subject|1|||
16443383|NCT03748641|40102351|FG000|Overall Study|Ongoing|155|||
16443384|NCT03748641|40102352|FG001|Overall Study|Ongoing|148|||
16443385|NCT03748641|40102353|FG002|Overall Study|Ongoing|66|||
16443386|NCT03748641|40102354|FG003|Overall Study|Ongoing|79|||
16443387|NCT03748641|40102355|FG004|Overall Study|Ongoing|84|||
16443388|NCT03748641|40102351|FG000|Overall Study|Death|54|||
16443389|NCT03748641|40102352|FG001|Overall Study|Death|59|||
16443390|NCT03748641|40102353|FG002|Overall Study|Death|51|||
16443391|NCT03748641|40102354|FG003|Overall Study|Death|42|||
16443392|NCT03748641|40102355|FG004|Overall Study|Death|9|||
16443393|NCT03748641|40102351|FG000|Overall Study|Lost to Follow-up|0|||
16443394|NCT03748641|40102352|FG001|Overall Study|Lost to Follow-up|2|||
16443395|NCT03748641|40102353|FG002|Overall Study|Lost to Follow-up|1|||
16443396|NCT03748641|40102354|FG003|Overall Study|Lost to Follow-up|0|||
16443397|NCT03748641|40102355|FG004|Overall Study|Lost to Follow-up|0|||
16443398|NCT03748641|40102351|FG000|Overall Study|Withdrawal by Subject|3|||
16443399|NCT03748641|40102352|FG001|Overall Study|Withdrawal by Subject|2|||
16443400|NCT03748641|40102353|FG002|Overall Study|Withdrawal by Subject|5|||
16443401|NCT03748641|40102354|FG003|Overall Study|Withdrawal by Subject|3|||
16443402|NCT03748641|40102355|FG004|Overall Study|Withdrawal by Subject|2|||
16443403|NCT04298697|40102356|FG000|Overall Study|Lost to Follow-up|5|||
16443404|NCT04298697|40102357|FG001|Overall Study|Lost to Follow-up|5|||
16443405|NCT04298697|40102358|FG002|Overall Study|Lost to Follow-up|1|||
16443406|NCT04298697|40102359|FG003|Overall Study|Lost to Follow-up|0|||
16443407|NCT04298697|40102356|FG000|Overall Study|Withdrawal by Subject|0|||
16443408|NCT04298697|40102357|FG001|Overall Study|Withdrawal by Subject|3|||
16443409|NCT04298697|40102358|FG002|Overall Study|Withdrawal by Subject|2|||
16443410|NCT04298697|40102359|FG003|Overall Study|Withdrawal by Subject|3|||
16443411|NCT03473743|40102362|FG000|Overall Study|Withdrawal by Subject|0|||
16152453|NCT02431702|39044230|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
16152454|NCT02431702|39044231|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
16443412|NCT03473743|40102363|FG001|Overall Study|Withdrawal by Subject|0|||
16443413|NCT03473743|40102364|FG002|Overall Study|Withdrawal by Subject|0|||
16443414|NCT03473743|40102365|FG003|Overall Study|Withdrawal by Subject|0|||
16443415|NCT03473743|40102366|FG004|Overall Study|Withdrawal by Subject|0|||
16443416|NCT03473743|40102367|FG005|Overall Study|Withdrawal by Subject|0|||
16443417|NCT03473743|40102368|FG006|Overall Study|Withdrawal by Subject|0|||
16152455|NCT02431702|39044232|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
16152456|NCT02431702|39044233|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
16152457|NCT02431702|39044234|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
16152458|NCT02431702|39044235|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
16152459|NCT02431702|39044236|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
16152460|NCT02431702|39044230|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
16152461|NCT02431702|39044231|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
16152462|NCT02431702|39044232|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
16152463|NCT02431702|39044233|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
16152464|NCT02431702|39044234|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
16152465|NCT02431702|39044235|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
16152466|NCT02431702|39044236|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
16152467|NCT02431702|39044230|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
16152468|NCT02431702|39044231|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
16152469|NCT02431702|39044232|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
16152470|NCT02431702|39044233|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
16152471|NCT02431702|39044234|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
16152472|NCT02431702|39044235|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
16152473|NCT02431702|39044236|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
16152474|NCT02431702|39044230|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
16152475|NCT02431702|39044231|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
16152476|NCT02431702|39044232|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
16152477|NCT02431702|39044233|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
16152478|NCT02431702|39044234|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
16443418|NCT03473743|40102369|FG007|Overall Study|Withdrawal by Subject|3|||
16443419|NCT03473743|40102362|FG000|Overall Study|Other|0|||
16443420|NCT03473743|40102363|FG001|Overall Study|Other|0|||
16443421|NCT03473743|40102364|FG002|Overall Study|Other|0|||
16443422|NCT03473743|40102365|FG003|Overall Study|Other|1|||
16443423|NCT03473743|40102366|FG004|Overall Study|Other|0|||
16443424|NCT03473743|40102367|FG005|Overall Study|Other|0|||
16443425|NCT03473743|40102368|FG006|Overall Study|Other|0|||
16443426|NCT03473743|40102369|FG007|Overall Study|Other|0|||
16443427|NCT03473743|40102362|FG000|Overall Study|Ongoing|0|||
16443428|NCT03473743|40102363|FG001|Overall Study|Ongoing|0|||
16443429|NCT03473743|40102364|FG002|Overall Study|Ongoing|6|||
16443430|NCT03473743|40102365|FG003|Overall Study|Ongoing|8|||
16443431|NCT03473743|40102366|FG004|Overall Study|Ongoing|1|||
16443432|NCT03473743|40102367|FG005|Overall Study|Ongoing|1|||
16443433|NCT03473743|40102368|FG006|Overall Study|Ongoing|22|||
16443434|NCT03473743|40102369|FG007|Overall Study|Ongoing|24|||
16443435|NCT03473743|40102362|FG000|Overall Study|Randomized but not treated|0|||
16443436|NCT03473743|40102363|FG001|Overall Study|Randomized but not treated|0|||
16443437|NCT03473743|40102364|FG002|Overall Study|Randomized but not treated|0|||
16443438|NCT03473743|40102365|FG003|Overall Study|Randomized but not treated|0|||
16443439|NCT03473743|40102366|FG004|Overall Study|Randomized but not treated|0|||
16443440|NCT03473743|40102367|FG005|Overall Study|Randomized but not treated|0|||
16443441|NCT03473743|40102368|FG006|Overall Study|Randomized but not treated|1|||
16443442|NCT03473743|40102369|FG007|Overall Study|Randomized but not treated|1|||
16443443|NCT02003924|40102370|FG000|Double-blind Phase|Lost to Follow-up|2|||
16443444|NCT02003924|40102371|FG001|Double-blind Phase|Lost to Follow-up|1|||
16443445|NCT02003924|40102372|FG002|Double-blind Phase|Lost to Follow-up|0|||
16443446|NCT02003924|40102370|FG000|Double-blind Phase|Protocol Violation|1|||
16443447|NCT02003924|40102371|FG001|Double-blind Phase|Protocol Violation|2|||
16443448|NCT02003924|40102372|FG002|Double-blind Phase|Protocol Violation|0|||
16443449|NCT02003924|40102370|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
16443450|NCT02003924|40102371|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
16443451|NCT02003924|40102372|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
16443452|NCT02003924|40102370|FG000|Double-blind Phase|Disease Progression|229|||
16443453|NCT02003924|40102371|FG001|Double-blind Phase|Disease Progression|247|||
16443454|NCT02003924|40102372|FG002|Double-blind Phase|Disease Progression|0|||
16443455|NCT02003924|40102370|FG000|Double-blind Phase|Adverse Event|120|||
16443456|NCT02003924|40102371|FG001|Double-blind Phase|Adverse Event|31|||
16443457|NCT02003924|40102372|FG002|Double-blind Phase|Adverse Event|0|||
16443458|NCT02003924|40102370|FG000|Double-blind Phase|Randomized But not Treated|3|||
16443459|NCT02003924|40102371|FG001|Double-blind Phase|Randomized But not Treated|3|||
16443460|NCT02003924|40102372|FG002|Double-blind Phase|Randomized But not Treated|0|||
16443461|NCT02003924|40102370|FG000|Double-blind Phase|Other|29|||
16443462|NCT02003924|40102371|FG001|Double-blind Phase|Other|50|||
16443463|NCT02003924|40102372|FG002|Double-blind Phase|Other|0|||
16443464|NCT02003924|40102370|FG000|Open-label Phase|Lost to Follow-up|0|||
16443465|NCT02003924|40102371|FG001|Open-label Phase|Lost to Follow-up|0|||
16443466|NCT02003924|40102372|FG002|Open-label Phase|Lost to Follow-up|1|||
16443467|NCT02003924|40102370|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
16443468|NCT02003924|40102371|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
16443469|NCT02003924|40102372|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
16443470|NCT02003924|40102370|FG000|Open-label Phase|Disease Progression|59|||
16443471|NCT02003924|40102371|FG001|Open-label Phase|Disease Progression|0|||
16443472|NCT02003924|40102372|FG002|Open-label Phase|Disease Progression|5|||
16443473|NCT02003924|40102370|FG000|Open-label Phase|Adverse Event|25|||
16443474|NCT02003924|40102371|FG001|Open-label Phase|Adverse Event|0|||
16443475|NCT02003924|40102372|FG002|Open-label Phase|Adverse Event|10|||
16443476|NCT02003924|40102370|FG000|Open-label Phase|Other|7|||
16443477|NCT02003924|40102371|FG001|Open-label Phase|Other|0|||
16443478|NCT02003924|40102372|FG002|Open-label Phase|Other|0|||
16443479|NCT02003924|40102370|FG000|Long-term Follow-up Phase|Death|288|||
16443480|NCT02003924|40102371|FG001|Long-term Follow-up Phase|Death|174|||
16443481|NCT02003924|40102372|FG002|Long-term Follow-up Phase|Death|4|||
16443482|NCT02003924|40102370|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
16443483|NCT02003924|40102371|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
16443484|NCT02003924|40102372|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
16443485|NCT02003924|40102370|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
16443486|NCT02003924|40102371|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
16443487|NCT02003924|40102372|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
16443488|NCT02003924|40102370|FG000|Long-term Follow-up Phase|Other|5|||
16443489|NCT02003924|40102371|FG001|Long-term Follow-up Phase|Other|2|||
16443490|NCT02003924|40102372|FG002|Long-term Follow-up Phase|Other|1|||
16443491|NCT05567783|40102379|FG000|Overall Study|Death|2|||
16443492|NCT05567783|40102380|FG001|Overall Study|Death|3|||
16443493|NCT05567783|40102381|FG002|Overall Study|Death|0|||
16443494|NCT05567783|40102379|FG000|Overall Study|Lost to Follow-up|25|||
16443495|NCT05567783|40102380|FG001|Overall Study|Lost to Follow-up|19|||
16443496|NCT05567783|40102381|FG002|Overall Study|Lost to Follow-up|17|||
16443497|NCT05567783|40102379|FG000|Overall Study|Physician Decision|10|||
16443498|NCT05567783|40102380|FG001|Overall Study|Physician Decision|7|||
16443499|NCT05567783|40102381|FG002|Overall Study|Physician Decision|9|||
16443500|NCT05567783|40102379|FG000|Overall Study|Study Terminated by Sponsor|924|||
16443501|NCT05567783|40102380|FG001|Overall Study|Study Terminated by Sponsor|937|||
16443502|NCT05567783|40102381|FG002|Overall Study|Study Terminated by Sponsor|941|||
16443503|NCT05567783|40102379|FG000|Overall Study|Withdrawal by Subject|23|||
16443504|NCT05567783|40102380|FG001|Overall Study|Withdrawal by Subject|27|||
16443505|NCT05567783|40102381|FG002|Overall Study|Withdrawal by Subject|24|||
16443506|NCT05567783|40102379|FG000|Overall Study|Incarcerated|1|||
16443507|NCT05567783|40102380|FG001|Overall Study|Incarcerated|0|||
16443508|NCT05567783|40102381|FG002|Overall Study|Incarcerated|0|||
16443509|NCT05567783|40102379|FG000|Overall Study|Participant randomized in error|4|||
16443510|NCT05567783|40102380|FG001|Overall Study|Participant randomized in error|2|||
16443511|NCT05567783|40102381|FG002|Overall Study|Participant randomized in error|2|||
16443512|NCT04905134|40102382|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
16443513|NCT04905134|40102382|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
16443514|NCT04439539|40102383|FG000|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|1|||
16443515|NCT04439539|40102384|FG001|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|0|||
16443516|NCT04439539|40102385|FG002|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|2|||
16443517|NCT04439539|40102383|FG000|Follow-up (FU): FU Week 0 to 48|Ongoing|0|||
16443518|NCT04439539|40102384|FG001|Follow-up (FU): FU Week 0 to 48|Ongoing|5|||
16443519|NCT04439539|40102385|FG002|Follow-up (FU): FU Week 0 to 48|Ongoing|17|||
16443520|NCT04439539|40102383|FG000|Follow-up (FU): FU Week 0 to 48|Other|0|||
16443521|NCT04439539|40102384|FG001|Follow-up (FU): FU Week 0 to 48|Other|1|||
16443522|NCT04439539|40102385|FG002|Follow-up (FU): FU Week 0 to 48|Other|0|||
16443523|NCT00400179|40102386|FG000|Overall Study|Adverse Event|2|||
16443524|NCT00400179|40102387|FG001|Overall Study|Adverse Event|2|||
16443525|NCT00400179|40102386|FG000|Overall Study|Death|1|||
16443526|NCT00400179|40102387|FG001|Overall Study|Death|2|||
16443527|NCT00400179|40102386|FG000|Overall Study|Withdrew Consent|1|||
16443528|NCT00400179|40102387|FG001|Overall Study|Withdrew Consent|5|||
16443529|NCT00400179|40102386|FG000|Overall Study|Disease progression|1|||
16443530|NCT00400179|40102387|FG001|Overall Study|Disease progression|1|||
16443531|NCT00400179|40102386|FG000|Overall Study|Intercurrent illness|0|||
16443532|NCT00400179|40102387|FG001|Overall Study|Intercurrent illness|1|||
16443533|NCT00400179|40102386|FG000|Overall Study|Investigator judgment|0|||
16443534|NCT00400179|40102387|FG001|Overall Study|Investigator judgment|1|||
16152479|NCT02431702|39044235|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
16152480|NCT02431702|39044236|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
16152481|NCT02431702|39044230|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
16152482|NCT02431702|39044231|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
16152483|NCT02431702|39044232|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
16152484|NCT02431702|39044233|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
16152485|NCT02431702|39044234|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
16152486|NCT02431702|39044235|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
16152487|NCT02431702|39044236|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
16152488|NCT02431702|39044230|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
16152489|NCT02431702|39044231|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
16152490|NCT02431702|39044232|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
16152491|NCT02431702|39044233|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
16152492|NCT02431702|39044234|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
16152493|NCT02431702|39044235|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
16152494|NCT02431702|39044236|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
16152495|NCT02431702|39044230|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
16152496|NCT02431702|39044231|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
16152497|NCT02431702|39044232|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
16152498|NCT02431702|39044233|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
16152499|NCT02431702|39044234|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
16152500|NCT02431702|39044235|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
16152501|NCT02431702|39044236|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
16152502|NCT02431702|39044230|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
16152503|NCT02431702|39044231|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
16152504|NCT02431702|39044232|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
16152505|NCT02431702|39044233|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
16152506|NCT02431702|39044234|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
16152507|NCT02431702|39044235|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
16152508|NCT02431702|39044236|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
16152509|NCT01785160|39044242|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
16152510|NCT01785160|39044242|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
16152511|NCT03223428|39044243|FG000|Overall Study|No longer taking Xermelo|27|||
16152512|NCT03223428|39044243|FG000|Overall Study|Declined Consent|1|||
16152513|NCT03223428|39044243|FG000|Overall Study|Non-responders|56|||
16152514|NCT03223428|39044243|FG000|Overall Study|Withdrawal by Subject|14|||
16152515|NCT01187953|39044246|FG000|Overall Study|Death|11|||
16152516|NCT01187953|39044247|FG001|Overall Study|Death|13|||
16152517|NCT01187953|39044246|FG000|Overall Study|Adverse Event|1|||
16152518|NCT01187953|39044247|FG001|Overall Study|Adverse Event|2|||
16261881|NCT03135834|39443214|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
16261882|NCT03135834|39443211|FG000|Stage 2|Did not receive Booster Vaccination|1|||
16261883|NCT03135834|39443212|FG001|Stage 2|Did not receive Booster Vaccination|1|||
16261884|NCT03135834|39443213|FG002|Stage 2|Did not receive Booster Vaccination|0|||
16261885|NCT03135834|39443214|FG003|Stage 2|Did not receive Booster Vaccination|0|||
16261886|NCT01355081|39443215|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
16261887|NCT01355081|39443216|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
16261888|NCT01355081|39443217|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
16261889|NCT01355081|39443215|FG000|Overall Study|Major Protocol Deviation|0|||
16152519|NCT01187953|39044246|FG000|Overall Study|Lost to Follow-up|0|||
16261890|NCT01355081|39443216|FG001|Overall Study|Major Protocol Deviation|1|||
16261891|NCT01355081|39443217|FG002|Overall Study|Major Protocol Deviation|0|||
16261892|NCT01355081|39443215|FG000|Overall Study|Lost to Follow-up|0|||
16261893|NCT01355081|39443216|FG001|Overall Study|Lost to Follow-up|0|||
16261894|NCT01355081|39443217|FG002|Overall Study|Lost to Follow-up|1|||
16261895|NCT01355081|39443215|FG000|Overall Study|Withdrawal of Consent|2|||
16261896|NCT01355081|39443216|FG001|Overall Study|Withdrawal of Consent|3|||
16261897|NCT01355081|39443217|FG002|Overall Study|Withdrawal of Consent|3|||
16261898|NCT01355081|39443215|FG000|Overall Study|Lack of Efficacy|2|||
16261899|NCT01355081|39443216|FG001|Overall Study|Lack of Efficacy|1|||
16261900|NCT01355081|39443217|FG002|Overall Study|Lack of Efficacy|1|||
16261901|NCT01355081|39443215|FG000|Overall Study|Non Compliance with Study Medication|0|||
16261902|NCT01355081|39443216|FG001|Overall Study|Non Compliance with Study Medication|1|||
16261903|NCT01355081|39443217|FG002|Overall Study|Non Compliance with Study Medication|0|||
16261904|NCT00488774|39443218|FG000|Overall Study|Withdrawal of consent|2|||
16261905|NCT00488774|39443219|FG001|Overall Study|Withdrawal of consent|2|||
16261906|NCT00488774|39443220|FG002|Overall Study|Withdrawal of consent|2|||
16261907|NCT00488774|39443221|FG003|Overall Study|Withdrawal of consent|0|||
16261908|NCT00488774|39443218|FG000|Overall Study|Other|6|||
16261909|NCT00488774|39443219|FG001|Overall Study|Other|3|||
16261910|NCT00488774|39443220|FG002|Overall Study|Other|2|||
16261911|NCT00488774|39443221|FG003|Overall Study|Other|2|||
16261912|NCT00488774|39443218|FG000|Overall Study|Lost to Follow-up|0|||
16261913|NCT00488774|39443219|FG001|Overall Study|Lost to Follow-up|0|||
16261914|NCT00488774|39443220|FG002|Overall Study|Lost to Follow-up|1|||
16261915|NCT00488774|39443221|FG003|Overall Study|Lost to Follow-up|1|||
16261916|NCT01981720|39443222|FG000|Overall Study|Adverse Event|1|||
16261917|NCT01981720|39443222|FG000|Overall Study|Withdrawal by Subject|3|||
16261918|NCT01981720|39443222|FG000|Overall Study|Pregnancy|1|||
16261919|NCT00550537|39443226|FG000|Overall Study|Death|18|||
16152520|NCT01187953|39044247|FG001|Overall Study|Lost to Follow-up|3|||
16261920|NCT00550537|39443226|FG000|Overall Study|Adverse Event|20|||
16261921|NCT00550537|39443226|FG000|Overall Study|Disease progression before|46|||
16261922|NCT00550537|39443226|FG000|Overall Study|Withdrawal by Subject|7|||
16261923|NCT00550537|39443226|FG000|Overall Study|Change in treatment plan|4|||
16261924|NCT00550537|39443226|FG000|Overall Study|Other complicating ilness|3|||
16261925|NCT00550537|39443226|FG000|Overall Study|Declining performance status|2|||
16261926|NCT00550537|39443226|FG000|Overall Study|Treated closer to home|4|||
16152521|NCT01187953|39044246|FG000|Overall Study|Withdrawal by Subject|3|||
16152522|NCT01187953|39044247|FG001|Overall Study|Withdrawal by Subject|3|||
16152523|NCT03994211|39044248|FG000|Core Phase|Adverse Event|0|||
16152524|NCT03994211|39044249|FG001|Core Phase|Adverse Event|1|||
16152525|NCT03994211|39044250|FG002|Core Phase|Adverse Event|0|||
16152526|NCT03994211|39044248|FG000|Extension Phase|Adverse Event|0|||
16152527|NCT03994211|39044249|FG001|Extension Phase|Adverse Event|0|||
16152528|NCT03994211|39044250|FG002|Extension Phase|Adverse Event|1|||
16152529|NCT03994211|39044248|FG000|Extension Phase|Physician Decision|0|||
16152530|NCT03994211|39044249|FG001|Extension Phase|Physician Decision|0|||
16152531|NCT03994211|39044250|FG002|Extension Phase|Physician Decision|1|||
16152532|NCT03994211|39044248|FG000|Extension Phase|Progressive Disease|0|||
16152533|NCT03994211|39044249|FG001|Extension Phase|Progressive Disease|0|||
16152534|NCT03994211|39044250|FG002|Extension Phase|Progressive Disease|20|||
16152535|NCT03994211|39044248|FG000|Extension Phase|Withdrawal by Subject|0|||
16152536|NCT03994211|39044249|FG001|Extension Phase|Withdrawal by Subject|0|||
16152537|NCT03994211|39044250|FG002|Extension Phase|Withdrawal by Subject|2|||
16152538|NCT00915681|39044252|FG000|Overall Study|Screening failures|46|||
16152539|NCT02321436|39044253|FG000|Overall Study|Withdrawal by Subject|1|||
16152540|NCT02321436|39044254|FG001|Overall Study|Withdrawal by Subject|0|||
16152541|NCT02321436|39044253|FG000|Overall Study|Lost to Follow-up|0|||
16152542|NCT02321436|39044254|FG001|Overall Study|Lost to Follow-up|1|||
16152543|NCT01577186|39044255|FG000|Overall Study|Adverse Event|23|||
16152544|NCT01577186|39044255|FG000|Overall Study|Death|1|||
16152545|NCT01577186|39044255|FG000|Overall Study|Lost to Follow-up|28|||
16152546|NCT01577186|39044255|FG000|Overall Study|Withdrawal by Subject|35|||
16152547|NCT01577186|39044255|FG000|Overall Study|Insufficient Response|18|||
16152548|NCT01577186|39044255|FG000|Overall Study|Ineligible to Continue|15|||
16152549|NCT01577186|39044255|FG000|Overall Study|Non-Compliant|8|||
16152550|NCT01577186|39044255|FG000|Overall Study|Other|2|||
16152551|NCT01026831|39044256|FG000|Overall Study|Adverse Event|4|||
16443535|NCT00400179|40102386|FG000|Overall Study|Randomization error/patient ineligible|1|||
16443536|NCT00400179|40102387|FG001|Overall Study|Randomization error/patient ineligible|6|||
16443537|NCT03804528|40102388|FG000|Overall Study|Time Commitment|18|||
16443538|NCT03804528|40102388|FG000|Overall Study|Health Reasons|5|||
16152552|NCT01026831|39044257|FG001|Overall Study|Adverse Event|3|||
16152553|NCT01026831|39044256|FG000|Overall Study|Lost to Follow-up|2|||
16443539|NCT02365597|40102389|FG000|Overall Study|Lost to Follow-up|0|||
16443540|NCT02365597|40102390|FG001|Overall Study|Lost to Follow-up|1|||
16152554|NCT01026831|39044257|FG001|Overall Study|Lost to Follow-up|0|||
16152555|NCT01026831|39044256|FG000|Overall Study|Physician Decision|1|||
16152556|NCT01026831|39044257|FG001|Overall Study|Physician Decision|1|||
16152557|NCT01026831|39044256|FG000|Overall Study|Protocol Violation|0|||
16152558|NCT01026831|39044257|FG001|Overall Study|Protocol Violation|2|||
16152559|NCT01026831|39044256|FG000|Overall Study|Withdrawal by Subject|7|||
16152560|NCT01026831|39044257|FG001|Overall Study|Withdrawal by Subject|5|||
16152561|NCT01263483|39044259|FG000|Overall Study|Adverse Event|4|||
16152562|NCT01263483|39044260|FG001|Overall Study|Adverse Event|0|||
16152563|NCT01263483|39044261|FG002|Overall Study|Adverse Event|3|||
16152564|NCT01263483|39044259|FG000|Overall Study|Withdrawal by Subject|1|||
16443541|NCT02365597|40102391|FG002|Overall Study|Lost to Follow-up|0|||
16443542|NCT02365597|40102392|FG003|Overall Study|Lost to Follow-up|1|||
16443543|NCT02365597|40102389|FG000|Overall Study|Withdrawal by Subject|1|||
16443544|NCT02365597|40102390|FG001|Overall Study|Withdrawal by Subject|8|||
16152565|NCT01263483|39044260|FG001|Overall Study|Withdrawal by Subject|0|||
16152566|NCT01263483|39044261|FG002|Overall Study|Withdrawal by Subject|0|||
16261927|NCT03988803|39443227|FG000|Period 2|Prematurely discontinued from medication|2|||
16152567|NCT01263483|39044259|FG000|Overall Study|Lack of Efficacy|2|||
16152568|NCT01263483|39044260|FG001|Overall Study|Lack of Efficacy|0|||
16152569|NCT01263483|39044261|FG002|Overall Study|Lack of Efficacy|0|||
16152570|NCT01263483|39044259|FG000|Overall Study|Protocol Violation|0|||
16152571|NCT01263483|39044260|FG001|Overall Study|Protocol Violation|1|||
16152572|NCT01263483|39044261|FG002|Overall Study|Protocol Violation|1|||
16152573|NCT01263483|39044259|FG000|Overall Study|Participant Unavailability|0|||
16152574|NCT01263483|39044260|FG001|Overall Study|Participant Unavailability|1|||
16152575|NCT01263483|39044261|FG002|Overall Study|Participant Unavailability|1|||
16152576|NCT00886600|39044262|FG000|Double-blind Monotherapy|Adverse Event|1|||
16152577|NCT00886600|39044263|FG001|Double-blind Monotherapy|Adverse Event|1|||
16152578|NCT00886600|39044264|FG002|Double-blind Monotherapy|Adverse Event|1|||
16152579|NCT00886600|39044265|FG003|Double-blind Monotherapy|Adverse Event|1|||
16152580|NCT00886600|39044262|FG000|Double-blind Monotherapy|Protocol Violation|0|||
16152581|NCT00886600|39044263|FG001|Double-blind Monotherapy|Protocol Violation|0|||
16152582|NCT00886600|39044264|FG002|Double-blind Monotherapy|Protocol Violation|0|||
16152583|NCT00886600|39044265|FG003|Double-blind Monotherapy|Protocol Violation|1|||
16152584|NCT00886600|39044262|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
16152585|NCT00886600|39044263|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
16261928|NCT03988803|39443227|FG000|Period 2|Adverse Event|1|||
16261929|NCT00735904|39443228|FG000|Overall Study|Adverse Event|3|||
16261930|NCT00735904|39443228|FG000|Overall Study|Death|20|||
16261931|NCT00735904|39443228|FG000|Overall Study|Protocol Violation|1|||
16261932|NCT00735904|39443228|FG000|Overall Study|Withdrawal by Subject|1|||
16261933|NCT00735904|39443228|FG000|Overall Study|Study Terminated by Sponsor|5|||
16261934|NCT00735904|39443228|FG000|Overall Study|Other|8|||
16261935|NCT02189941|39443237|FG000|Overall Study|Non-compliance|0|||
16261936|NCT02189941|39443238|FG001|Overall Study|Non-compliance|0|||
16261937|NCT02189941|39443239|FG002|Overall Study|Non-compliance|1|||
16443545|NCT02365597|40102391|FG002|Overall Study|Withdrawal by Subject|5|||
16443546|NCT02365597|40102392|FG003|Overall Study|Withdrawal by Subject|1|||
16261938|NCT00416520|39443240|FG000|Open-label Period|Adverse Event|28|||
16261939|NCT00416520|39443241|FG001|Open-label Period|Adverse Event|10|||
16261940|NCT00416520|39443242|FG002|Open-label Period|Adverse Event|0|||
16261941|NCT00416520|39443243|FG003|Open-label Period|Adverse Event|0|||
16261942|NCT00416520|39443240|FG000|Open-label Period|Death|2|||
16261943|NCT00416520|39443241|FG001|Open-label Period|Death|1|||
16261944|NCT00416520|39443242|FG002|Open-label Period|Death|0|||
16261945|NCT00416520|39443243|FG003|Open-label Period|Death|0|||
16261946|NCT00416520|39443240|FG000|Open-label Period|Lack of Efficacy|8|||
16261947|NCT00416520|39443241|FG001|Open-label Period|Lack of Efficacy|1|||
16261948|NCT00416520|39443242|FG002|Open-label Period|Lack of Efficacy|0|||
16261949|NCT00416520|39443243|FG003|Open-label Period|Lack of Efficacy|0|||
16261950|NCT00416520|39443240|FG000|Open-label Period|Protocol Violation|3|||
16261951|NCT00416520|39443241|FG001|Open-label Period|Protocol Violation|3|||
16261952|NCT00416520|39443242|FG002|Open-label Period|Protocol Violation|0|||
16261953|NCT00416520|39443243|FG003|Open-label Period|Protocol Violation|0|||
16261954|NCT00416520|39443240|FG000|Open-label Period|Withdrawal by Subject|16|||
16261955|NCT00416520|39443241|FG001|Open-label Period|Withdrawal by Subject|5|||
16261956|NCT00416520|39443242|FG002|Open-label Period|Withdrawal by Subject|0|||
16443547|NCT02365597|40102389|FG000|Overall Study|Sponsor's decision|1|||
16443548|NCT02365597|40102390|FG001|Overall Study|Sponsor's decision|3|||
16443549|NCT02365597|40102391|FG002|Overall Study|Sponsor's decision|13|||
16443550|NCT02365597|40102392|FG003|Overall Study|Sponsor's decision|0|||
16443551|NCT02365597|40102389|FG000|Overall Study|Other|0|||
16443552|NCT02365597|40102390|FG001|Overall Study|Other|4|||
16443553|NCT02365597|40102391|FG002|Overall Study|Other|0|||
16443554|NCT02365597|40102392|FG003|Overall Study|Other|0|||
16443555|NCT02365597|40102389|FG000|Overall Study|Enrolled but not treated|0|||
16152586|NCT00886600|39044264|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
16152587|NCT00886600|39044265|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
16152588|NCT00886600|39044262|FG000|Combination Therapy Period|Adverse Event|0|||
16261957|NCT00416520|39443243|FG003|Open-label Period|Withdrawal by Subject|0|||
16261958|NCT00416520|39443240|FG000|Open-label Period|Other Reasons|3|||
16261959|NCT00416520|39443241|FG001|Open-label Period|Other Reasons|12|||
16443556|NCT02365597|40102390|FG001|Overall Study|Enrolled but not treated|1|||
16443557|NCT02365597|40102391|FG002|Overall Study|Enrolled but not treated|1|||
16443558|NCT02365597|40102392|FG003|Overall Study|Enrolled but not treated|0|||
16261960|NCT00416520|39443242|FG002|Open-label Period|Other Reasons|0|||
16261961|NCT00416520|39443243|FG003|Open-label Period|Other Reasons|0|||
16261962|NCT00416520|39443240|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
16261963|NCT00416520|39443241|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
16261964|NCT00416520|39443242|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
16443559|NCT02365597|40102389|FG000|Overall Study|Ongoing|0|||
16152589|NCT00886600|39044263|FG001|Combination Therapy Period|Adverse Event|0|||
16152590|NCT00886600|39044264|FG002|Combination Therapy Period|Adverse Event|1|||
16152591|NCT00886600|39044265|FG003|Combination Therapy Period|Adverse Event|0|||
16152592|NCT00886600|39044262|FG000|Combination Therapy Period|Protocol Violation|0|||
16152593|NCT00886600|39044263|FG001|Combination Therapy Period|Protocol Violation|0|||
16152594|NCT00886600|39044264|FG002|Combination Therapy Period|Protocol Violation|1|||
16152595|NCT00886600|39044265|FG003|Combination Therapy Period|Protocol Violation|0|||
16152596|NCT03317795|39044266|FG000|Overall Study|IUD Expulsion|1|||
16152597|NCT03317795|39044267|FG001|Overall Study|IUD Expulsion|0|||
16152598|NCT03317795|39044266|FG000|Overall Study|Lost to Follow-up|1|||
16152599|NCT03317795|39044267|FG001|Overall Study|Lost to Follow-up|3|||
16152600|NCT03317795|39044266|FG000|Overall Study|Treatment change|0|||
16152601|NCT03317795|39044267|FG001|Overall Study|Treatment change|3|||
16152602|NCT03317795|39044266|FG000|Overall Study|Intolerance of medication|0|||
16152603|NCT03317795|39044267|FG001|Overall Study|Intolerance of medication|1|||
16152604|NCT00957528|39044268|FG000|Overall Study|Protocol Violation|0|||
16152605|NCT00957528|39044269|FG001|Overall Study|Protocol Violation|1|||
16152606|NCT00957528|39044270|FG002|Overall Study|Protocol Violation|0|||
16152607|NCT00957528|39044268|FG000|Overall Study|Withdrawal by Subject|0|||
16152608|NCT00957528|39044269|FG001|Overall Study|Withdrawal by Subject|0|||
16152609|NCT00957528|39044270|FG002|Overall Study|Withdrawal by Subject|1|||
16152610|NCT04623242|39044271|FG000|Overall Study|Withdrawal by Subject|7|||
16443560|NCT02365597|40102390|FG001|Overall Study|Ongoing|0|||
16152611|NCT04623242|39044272|FG001|Overall Study|Withdrawal by Subject|12|||
16152612|NCT04623242|39044273|FG002|Overall Study|Withdrawal by Subject|5|||
16152613|NCT04623242|39044274|FG003|Overall Study|Withdrawal by Subject|7|||
16152614|NCT04623242|39044275|FG004|Overall Study|Withdrawal by Subject|0|||
16152615|NCT04623242|39044271|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
16152616|NCT04623242|39044272|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
16152617|NCT04623242|39044273|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
16152618|NCT04623242|39044274|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
16152619|NCT04623242|39044275|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
16152620|NCT04623242|39044271|FG000|Overall Study|Subject unblinded to mutation status|0|||
16152621|NCT04623242|39044272|FG001|Overall Study|Subject unblinded to mutation status|0|||
16152622|NCT04623242|39044273|FG002|Overall Study|Subject unblinded to mutation status|0|||
16152623|NCT04623242|39044274|FG003|Overall Study|Subject unblinded to mutation status|13|||
16152624|NCT04623242|39044275|FG004|Overall Study|Subject unblinded to mutation status|0|||
16152625|NCT00631371|39044276|FG000|Overall Study|Lost to Follow-up|24|||
16152626|NCT00631371|39044277|FG001|Overall Study|Lost to Follow-up|19|||
16152627|NCT00631371|39044276|FG000|Overall Study|Other reason|5|||
16152628|NCT00631371|39044277|FG001|Overall Study|Other reason|12|||
16152629|NCT00631371|39044276|FG000|Overall Study|subject request|38|||
16152630|NCT00631371|39044277|FG001|Overall Study|subject request|45|||
16152631|NCT00631371|39044276|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
16152632|NCT00631371|39044277|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
16152633|NCT00631371|39044276|FG000|Overall Study|Death|263|||
16152634|NCT00631371|39044277|FG001|Overall Study|Death|239|||
16152635|NCT01827670|39044280|FG000|Overall Study|Withdrawal of Consent|3|||
16152636|NCT01827670|39044281|FG001|Overall Study|Withdrawal of Consent|2|||
16152637|NCT01827670|39044280|FG000|Overall Study|Lost to Follow-up|0|||
16152638|NCT01827670|39044281|FG001|Overall Study|Lost to Follow-up|1|||
16152639|NCT00517829|39044286|FG000|Overall Study|Adverse Event|22|||
16152640|NCT00517829|39044287|FG001|Overall Study|Adverse Event|34|||
16152641|NCT00517829|39044286|FG000|Overall Study|Disease Progression|39|||
16152642|NCT00517829|39044287|FG001|Overall Study|Disease Progression|32|||
16152643|NCT00517829|39044286|FG000|Overall Study|Patient Request|6|||
16152644|NCT00517829|39044287|FG001|Overall Study|Patient Request|5|||
16152645|NCT00517829|39044286|FG000|Overall Study|Investigator Request|5|||
16152646|NCT00517829|39044287|FG001|Overall Study|Investigator Request|3|||
16152647|NCT00517829|39044286|FG000|Overall Study|Other|3|||
16152648|NCT00517829|39044287|FG001|Overall Study|Other|1|||
16152649|NCT01986920|39044288|FG000|A- 101 25%|Withdrawal by Subject|1|||
16152650|NCT01986920|39044289|FG001|A- 101 25%|Withdrawal by Subject|0|||
16152651|NCT01986920|39044290|FG002|A- 101 25%|Withdrawal by Subject|0|||
16152652|NCT01986920|39044291|FG003|A- 101 25%|Withdrawal by Subject|0|||
16152653|NCT01986920|39044288|FG000|A-101 32.5%|Withdrawal by Subject|0|||
16152654|NCT01986920|39044289|FG001|A-101 32.5%|Withdrawal by Subject|1|||
16152655|NCT01986920|39044290|FG002|A-101 32.5%|Withdrawal by Subject|0|||
16152656|NCT01986920|39044291|FG003|A-101 32.5%|Withdrawal by Subject|0|||
16366031|NCT00447278|39825391|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
16443561|NCT02365597|40102391|FG002|Overall Study|Ongoing|0|||
16366032|NCT00447278|39825392|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
16152657|NCT01986920|39044288|FG000|A-101 40%|Withdrawal by Subject|0|||
16152658|NCT01986920|39044289|FG001|A-101 40%|Withdrawal by Subject|0|||
16152659|NCT01986920|39044290|FG002|A-101 40%|Withdrawal by Subject|1|||
16152660|NCT01986920|39044291|FG003|A-101 40%|Withdrawal by Subject|0|||
16152661|NCT01986920|39044288|FG000|Placebo|Withdrawal by Subject|0|||
16152662|NCT01986920|39044289|FG001|Placebo|Withdrawal by Subject|0|||
16152663|NCT01986920|39044290|FG002|Placebo|Withdrawal by Subject|0|||
16152664|NCT01986920|39044291|FG003|Placebo|Withdrawal by Subject|1|||
16152665|NCT00807742|39044292|FG000|Overall Study|Death|9|||
16152666|NCT00807742|39044293|FG001|Overall Study|Death|2|||
16152667|NCT00807742|39044292|FG000|Overall Study|Withdrawal by Subject|2|||
16443562|NCT02365597|40102392|FG003|Overall Study|Ongoing|17|||
16443563|NCT04025710|40102393|FG000|Overall Study|Death|3|||
16443564|NCT04025710|40102393|FG000|Overall Study|Lost to Follow-up|5|||
16443565|NCT04025710|40102393|FG000|Overall Study|Withdrawal by Subject|1|||
16443566|NCT04025710|40102393|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
16443567|NCT04025710|40102393|FG000|Overall Study|Drop-out according to protocol|34|||
16443568|NCT05712460|40102394|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443569|NCT05712460|40102395|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443570|NCT05712460|40102396|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443571|NCT05712460|40102397|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443572|NCT05712460|40102398|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443573|NCT05712460|40102399|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443574|NCT05712460|40102400|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443575|NCT05712460|40102401|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
16443576|NCT05712460|40102402|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443577|NCT05712460|40102403|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443578|NCT05712460|40102404|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443579|NCT05712460|40102405|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
16443580|NCT02694185|40102406|FG000|Overall Study|Withdrawal by Subject|45|||
16443581|NCT02694185|40102407|FG001|Overall Study|Withdrawal by Subject|0|||
16443582|NCT05131165|40102409|FG000|Overall Study|Death|1|||
16443583|NCT05131165|40102410|FG001|Overall Study|Death|1|||
16443584|NCT05131165|40102411|FG002|Overall Study|Death|0|||
16443585|NCT05131165|40102409|FG000|Overall Study|Lost to Follow-up|2|||
16443586|NCT05131165|40102410|FG001|Overall Study|Lost to Follow-up|2|||
16443587|NCT05131165|40102411|FG002|Overall Study|Lost to Follow-up|5|||
16443588|NCT05131165|40102409|FG000|Overall Study|Transferred out of clinic|1|||
16443589|NCT05131165|40102410|FG001|Overall Study|Transferred out of clinic|0|||
16443590|NCT05131165|40102411|FG002|Overall Study|Transferred out of clinic|3|||
16443591|NCT05131165|40102409|FG000|Overall Study|Dropped out|1|||
16443592|NCT05131165|40102410|FG001|Overall Study|Dropped out|2|||
16152668|NCT00807742|39044293|FG001|Overall Study|Withdrawal by Subject|1|||
16152669|NCT00807742|39044292|FG000|Overall Study|Lost to Follow-up|35|||
16152670|NCT00807742|39044293|FG001|Overall Study|Lost to Follow-up|51|||
16152671|NCT00640328|39044295|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
16152672|NCT00640328|39044296|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
16443593|NCT05131165|40102411|FG002|Overall Study|Dropped out|0|||
16443594|NCT05408429|40102420|FG000|Overall Study|Lost to Follow-up|1|||
16443595|NCT05408429|40102421|FG001|Overall Study|Lost to Follow-up|1|||
16443596|NCT05408429|40102422|FG002|Overall Study|Lost to Follow-up|0|||
16443597|NCT05408429|40102420|FG000|Overall Study|Withdrawal by Subject|5|||
16443598|NCT05408429|40102421|FG001|Overall Study|Withdrawal by Subject|0|||
16443599|NCT05408429|40102422|FG002|Overall Study|Withdrawal by Subject|1|||
16443600|NCT01607957|40102423|FG000|Overall Study|Not treated|1|||
16443601|NCT01607957|40102424|FG001|Overall Study|Not treated|1|||
16443602|NCT01607957|40102423|FG000|Overall Study|Death|367|||
16443603|NCT01607957|40102424|FG001|Overall Study|Death|211|||
16443604|NCT01607957|40102423|FG000|Overall Study|Lost to Follow-up|3|||
16443605|NCT01607957|40102424|FG001|Overall Study|Lost to Follow-up|3|||
16443606|NCT01607957|40102423|FG000|Overall Study|Participant refusal|1|||
16443607|NCT01607957|40102424|FG001|Overall Study|Participant refusal|0|||
16443608|NCT05720897|40102425|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
16443609|NCT05720897|40102426|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
16443610|NCT01652235|40102427|FG000|Overall Study|Death|9|||
16443611|NCT01652235|40102427|FG000|Overall Study|Lost to Follow-up|5|||
16443612|NCT01652235|40102427|FG000|Overall Study|Withdrawal by Subject|2|||
16443613|NCT03692052|40102428|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
16443614|NCT03692052|40102428|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
16443615|NCT03692052|40102428|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
16443616|NCT03692052|40102428|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
16443617|NCT00651742|40102430|FG000|Overall Study|Objective Disease Progression|22|||
16152673|NCT00640328|39044297|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
16152674|NCT00640328|39044298|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
16152675|NCT00640328|39044299|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
16152676|NCT00640328|39044300|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
16152677|NCT00640328|39044295|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
16152678|NCT00640328|39044296|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
16152679|NCT00640328|39044297|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
16366033|NCT00447278|39825391|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
16366034|NCT00447278|39825392|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
16366035|NCT00447278|39825391|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
16366036|NCT00447278|39825392|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
16366037|NCT02260986|39825393|FG000|Overall Study|Adverse Event|24|||
16366038|NCT02260986|39825394|FG001|Overall Study|Adverse Event|0|||
16366039|NCT02260986|39825395|FG002|Overall Study|Adverse Event|11|||
16366040|NCT02260986|39825393|FG000|Overall Study|Lack of Efficacy|27|||
16366041|NCT02260986|39825394|FG001|Overall Study|Lack of Efficacy|3|||
16366042|NCT02260986|39825395|FG002|Overall Study|Lack of Efficacy|0|||
16366043|NCT02260986|39825393|FG000|Overall Study|Protocol Violation|14|||
16366044|NCT02260986|39825394|FG001|Overall Study|Protocol Violation|5|||
16366045|NCT02260986|39825395|FG002|Overall Study|Protocol Violation|16|||
16366046|NCT02260986|39825393|FG000|Overall Study|Car accident|0|||
16366047|NCT02260986|39825394|FG001|Overall Study|Car accident|0|||
16366048|NCT02260986|39825395|FG002|Overall Study|Car accident|1|||
16366049|NCT02260986|39825393|FG000|Overall Study|Withdrawal by Subject|17|||
16366050|NCT02260986|39825394|FG001|Overall Study|Withdrawal by Subject|4|||
16366051|NCT02260986|39825395|FG002|Overall Study|Withdrawal by Subject|9|||
16366052|NCT02260986|39825393|FG000|Overall Study|Incorrect randomization|0|||
16366053|NCT02260986|39825394|FG001|Overall Study|Incorrect randomization|1|||
16366054|NCT02260986|39825395|FG002|Overall Study|Incorrect randomization|0|||
16366055|NCT02260986|39825393|FG000|Overall Study|Lack of investigation product supply|2|||
16366056|NCT02260986|39825394|FG001|Overall Study|Lack of investigation product supply|0|||
16366057|NCT02260986|39825395|FG002|Overall Study|Lack of investigation product supply|1|||
16366058|NCT02260986|39825393|FG000|Overall Study|Lost to Follow-up|4|||
16366059|NCT02260986|39825394|FG001|Overall Study|Lost to Follow-up|0|||
16366060|NCT02260986|39825395|FG002|Overall Study|Lost to Follow-up|3|||
16366061|NCT02260986|39825393|FG000|Overall Study|Pregnancy|2|||
16366062|NCT02260986|39825394|FG001|Overall Study|Pregnancy|0|||
16366063|NCT02260986|39825395|FG002|Overall Study|Pregnancy|0|||
16366064|NCT00141921|39825396|FG000|Overall Study|Remain on Study|28|||
16366065|NCT00141921|39825396|FG000|Overall Study|Withdrawal by Subject|42|||
16366066|NCT00141921|39825396|FG000|Overall Study|Lost to Follow-up|19|||
16366067|NCT00141921|39825396|FG000|Overall Study|Noncompliance|17|||
16366068|NCT00141921|39825396|FG000|Overall Study|Disease Progression|7|||
16366069|NCT00141921|39825396|FG000|Overall Study|Protocol Deviation|7|||
16366070|NCT00141921|39825396|FG000|Overall Study|Adverse Event|5|||
16366071|NCT00141921|39825396|FG000|Overall Study|Administrative Decision|2|||
16366072|NCT00141921|39825396|FG000|Overall Study|Pregnancy|4|||
16366073|NCT00141921|39825396|FG000|Overall Study|Ineligibility Determined|2|||
16366074|NCT00141921|39825396|FG000|Overall Study|Other|8|||
16152680|NCT00640328|39044298|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
16152681|NCT00640328|39044299|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
16152682|NCT00640328|39044300|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
16152683|NCT00640328|39044295|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
16152684|NCT00640328|39044296|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
16152685|NCT00640328|39044297|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
16152686|NCT00640328|39044298|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
16152687|NCT00640328|39044299|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
16152688|NCT00640328|39044300|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
16152689|NCT00640328|39044295|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
16152690|NCT00640328|39044296|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
16152691|NCT00640328|39044297|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
16152692|NCT00640328|39044298|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
16152693|NCT00640328|39044299|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
16152694|NCT00640328|39044300|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
16152695|NCT01439282|39044301|FG000|Overall Study|Adverse Event|5|||
16152696|NCT01439282|39044302|FG001|Overall Study|Adverse Event|0|||
16152697|NCT01439282|39044301|FG000|Overall Study|Withdrawal by Subject|2|||
16152698|NCT01439282|39044302|FG001|Overall Study|Withdrawal by Subject|0|||
16152699|NCT01439282|39044301|FG000|Overall Study|Other|1|||
16152700|NCT01439282|39044302|FG001|Overall Study|Other|1|||
16152701|NCT02192827|39044305|FG000|Overall Study|Lost to Follow-up|25|||
16152702|NCT02192827|39044306|FG001|Overall Study|Lost to Follow-up|27|||
16152703|NCT02192827|39044305|FG000|Overall Study|Given additional steroids with admission|13|||
16152704|NCT02192827|39044306|FG001|Overall Study|Given additional steroids with admission|11|||
16152705|NCT04839380|39044307|FG000|Overall Study|Withdrawal by Subject|2|||
16152706|NCT04839380|39044307|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
16152707|NCT00606320|39044314|FG000|Overall Study|Adverse Event|3|||
16152708|NCT00606320|39044314|FG000|Overall Study|Lack of Efficacy|5|||
16152709|NCT00606320|39044314|FG000|Overall Study|Physician Decision|7|||
16152710|NCT00606320|39044314|FG000|Overall Study|Protocol Violation|8|||
16152711|NCT00606320|39044314|FG000|Overall Study|Withdrawal by Subject|10|||
16152712|NCT00606320|39044314|FG000|Overall Study|Progression to depressive phase|4|||
16152713|NCT00066703|39044315|FG000|Overall Study|Adverse Event|80|||
16152714|NCT00066703|39044316|FG001|Overall Study|Adverse Event|111|||
16152715|NCT00066703|39044315|FG000|Overall Study|Death|3|||
16152716|NCT00066703|39044316|FG001|Overall Study|Death|0|||
16152717|NCT00066703|39044315|FG000|Overall Study|Lack of Efficacy|114|||
16152718|NCT00066703|39044316|FG001|Overall Study|Lack of Efficacy|69|||
16152719|NCT00066703|39044315|FG000|Overall Study|Lost to Follow-up|31|||
16152720|NCT00066703|39044316|FG001|Overall Study|Lost to Follow-up|28|||
16152721|NCT00066703|39044315|FG000|Overall Study|Withdrawal by Subject|38|||
16152722|NCT00066703|39044316|FG001|Overall Study|Withdrawal by Subject|63|||
16152723|NCT00066703|39044315|FG000|Overall Study|Treatment ongoing|346|||
16152724|NCT00066703|39044316|FG001|Overall Study|Treatment ongoing|311|||
16152725|NCT00840086|39044317|FG000|Overall Study|Adverse Event|1|||
16152726|NCT00840086|39044317|FG000|Overall Study|Protocol Violation|2|||
16152727|NCT00840086|39044317|FG000|Overall Study|Lost to Follow-up|1|||
16152728|NCT01756040|39044318|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
16152729|NCT01756040|39044318|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
16366075|NCT03679884|39825403|FG000|Overall Study|Other|12|||
16366076|NCT03679884|39825404|FG001|Overall Study|Other|12|||
16366077|NCT03679884|39825405|FG002|Overall Study|Other|12|||
16366078|NCT03679884|39825406|FG003|Overall Study|Other|7|||
16366079|NCT03679884|39825407|FG004|Overall Study|Other|8|||
16366080|NCT03679884|39825403|FG000|Overall Study|Lack of Efficacy|15|||
16366081|NCT03679884|39825404|FG001|Overall Study|Lack of Efficacy|29|||
16366082|NCT03679884|39825405|FG002|Overall Study|Lack of Efficacy|13|||
16366083|NCT03679884|39825406|FG003|Overall Study|Lack of Efficacy|29|||
16366084|NCT03679884|39825407|FG004|Overall Study|Lack of Efficacy|10|||
16366085|NCT03679884|39825403|FG000|Overall Study|Death|1|||
16366086|NCT03679884|39825404|FG001|Overall Study|Death|0|||
16366087|NCT03679884|39825405|FG002|Overall Study|Death|0|||
16366088|NCT03679884|39825406|FG003|Overall Study|Death|0|||
16366089|NCT03679884|39825407|FG004|Overall Study|Death|0|||
16366090|NCT03679884|39825403|FG000|Overall Study|Adverse Event|2|||
16366091|NCT03679884|39825404|FG001|Overall Study|Adverse Event|10|||
16366092|NCT03679884|39825405|FG002|Overall Study|Adverse Event|9|||
16366093|NCT03679884|39825406|FG003|Overall Study|Adverse Event|6|||
16366094|NCT03679884|39825407|FG004|Overall Study|Adverse Event|6|||
16366095|NCT03679884|39825403|FG000|Overall Study|Withdrawal by Subject|12|||
16366096|NCT03679884|39825404|FG001|Overall Study|Withdrawal by Subject|23|||
16366097|NCT03679884|39825405|FG002|Overall Study|Withdrawal by Subject|8|||
16366098|NCT03679884|39825406|FG003|Overall Study|Withdrawal by Subject|8|||
16443618|NCT00651742|40102430|FG000|Overall Study|Toxicity|3|||
16443619|NCT00651742|40102430|FG000|Overall Study|Investigator Judgment|1|||
16443620|NCT00651742|40102430|FG000|Overall Study|Withdrawal of Consent|1|||
16443621|NCT00651742|40102430|FG000|Overall Study|Enrolled but not treated|1|||
16443622|NCT01864018|40102431|FG000|Overall Study|Ineligible|3|||
16443623|NCT01864018|40102432|FG001|Overall Study|Ineligible|1|||
16443624|NCT05615922|40102433|FG000|Overall Study|Lost to Follow-up|1|||
16443625|NCT03652636|40102436|FG000|Overall Study|Withdrawal by Subject|7|||
16443626|NCT05430854|40102441|FG000|Overall Study|Trial terminated by Sponsor|39|||
16443627|NCT05430854|40102442|FG001|Overall Study|Trial terminated by Sponsor|50|||
16443628|NCT05430854|40102443|FG002|Overall Study|Trial terminated by Sponsor|46|||
16443629|NCT05430854|40102441|FG000|Overall Study|Withdrawal by Subject|0|||
16443630|NCT05430854|40102442|FG001|Overall Study|Withdrawal by Subject|3|||
16443631|NCT05430854|40102443|FG002|Overall Study|Withdrawal by Subject|0|||
16443632|NCT02420717|40102446|FG000|Overall Study|Did not receive all study medication|2|||
16443633|NCT02420717|40102447|FG001|Overall Study|Did not receive all study medication|0|||
16443634|NCT02420717|40102448|FG002|Overall Study|Did not receive all study medication|0|||
16443635|NCT04179175|40102449|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
16443636|NCT04179175|40102450|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
16443637|NCT04179175|40102451|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
16443638|NCT04179175|40102452|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
16443639|NCT04179175|40102453|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
16443640|NCT04179175|40102454|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
16443641|NCT04179175|40102449|FG000|Overall Study|Adverse Event|5|||
16443642|NCT04179175|40102450|FG001|Overall Study|Adverse Event|3|||
16443643|NCT04179175|40102451|FG002|Overall Study|Adverse Event|3|||
16443644|NCT04179175|40102452|FG003|Overall Study|Adverse Event|4|||
16443645|NCT04179175|40102453|FG004|Overall Study|Adverse Event|6|||
16443646|NCT04179175|40102454|FG005|Overall Study|Adverse Event|6|||
16443647|NCT04179175|40102449|FG000|Overall Study|Lack of Efficacy|5|||
16443648|NCT04179175|40102450|FG001|Overall Study|Lack of Efficacy|1|||
16443649|NCT04179175|40102451|FG002|Overall Study|Lack of Efficacy|3|||
16443650|NCT04179175|40102452|FG003|Overall Study|Lack of Efficacy|2|||
16443651|NCT04179175|40102453|FG004|Overall Study|Lack of Efficacy|18|||
16152730|NCT01756040|39044318|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
16152731|NCT00552175|39044319|FG000|Overall Study|Lack of Efficacy|2|||
16152732|NCT00552175|39044320|FG001|Overall Study|Lack of Efficacy|0|||
16152733|NCT00552175|39044321|FG002|Overall Study|Lack of Efficacy|1|||
16152734|NCT00552175|39044319|FG000|Overall Study|Adverse Event|9|||
16152735|NCT00552175|39044320|FG001|Overall Study|Adverse Event|9|||
16152736|NCT00552175|39044321|FG002|Overall Study|Adverse Event|10|||
16152737|NCT00552175|39044319|FG000|Overall Study|Withdrawal by Subject|2|||
16152738|NCT00552175|39044320|FG001|Overall Study|Withdrawal by Subject|2|||
16152739|NCT00552175|39044321|FG002|Overall Study|Withdrawal by Subject|1|||
16152740|NCT00552175|39044319|FG000|Overall Study|Lost to Follow-up|0|||
16152741|NCT00552175|39044320|FG001|Overall Study|Lost to Follow-up|0|||
16152742|NCT00552175|39044321|FG002|Overall Study|Lost to Follow-up|1|||
16152743|NCT00552175|39044319|FG000|Overall Study|Entry Criteria Not Met|1|||
16152744|NCT00552175|39044320|FG001|Overall Study|Entry Criteria Not Met|1|||
16152745|NCT00552175|39044321|FG002|Overall Study|Entry Criteria Not Met|0|||
16152746|NCT00552175|39044319|FG000|Overall Study|Reason Not Specified|3|||
16152747|NCT00552175|39044320|FG001|Overall Study|Reason Not Specified|1|||
16152748|NCT00552175|39044321|FG002|Overall Study|Reason Not Specified|1|||
16152749|NCT02463409|39044326|FG000|Overall Study|Withdrawal by Subject|1|||
16152750|NCT02463409|39044326|FG000|Overall Study|Screen failure|1|||
16152751|NCT03962101|39044328|FG000|Overall Study|Adverse Event|1|||
16152752|NCT03962101|39044328|FG000|Overall Study|Physician Decision|2|||
16152753|NCT03962101|39044328|FG000|Overall Study|Not related to medical events|1|||
16152754|NCT02037295|39044329|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
16152755|NCT02037295|39044330|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
16261965|NCT00416520|39443243|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
16443652|NCT04179175|40102454|FG005|Overall Study|Lack of Efficacy|7|||
16443653|NCT04179175|40102449|FG000|Overall Study|Lost to Follow-up|5|||
16443654|NCT04179175|40102450|FG001|Overall Study|Lost to Follow-up|3|||
16443655|NCT04179175|40102451|FG002|Overall Study|Lost to Follow-up|2|||
16443656|NCT04179175|40102452|FG003|Overall Study|Lost to Follow-up|2|||
16152756|NCT02037295|39044331|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
16152757|NCT02037295|39044332|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
16152758|NCT01714687|39044333|FG000|Overall Study|Withdrawal by Subject|1|||
16152759|NCT01714687|39044334|FG001|Overall Study|Withdrawal by Subject|0|||
16152760|NCT01714687|39044333|FG000|Overall Study|Lost to Follow-up|2|||
16152761|NCT01714687|39044334|FG001|Overall Study|Lost to Follow-up|4|||
16152762|NCT01140451|39044338|FG000|Overall Study|Withdrawal by Subject|26|||
16152763|NCT01140451|39044339|FG001|Overall Study|Withdrawal by Subject|33|||
16152764|NCT01140451|39044338|FG000|Overall Study|Adverse Event|2|||
16152765|NCT01140451|39044339|FG001|Overall Study|Adverse Event|6|||
16152766|NCT01140451|39044338|FG000|Overall Study|Physician Decision|5|||
16152767|NCT01140451|39044339|FG001|Overall Study|Physician Decision|3|||
16152768|NCT01140451|39044338|FG000|Overall Study|Lost to Follow-up|2|||
16152769|NCT01140451|39044339|FG001|Overall Study|Lost to Follow-up|0|||
16152770|NCT01140451|39044338|FG000|Overall Study|Participants Planning Pregnancy|3|||
16152771|NCT01140451|39044339|FG001|Overall Study|Participants Planning Pregnancy|0|||
16152772|NCT02595723|39044344|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
16152773|NCT02595723|39044345|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
16152774|NCT02595723|39044346|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
16152775|NCT02595723|39044344|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
16152776|NCT02595723|39044345|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
16152777|NCT02595723|39044346|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
16152778|NCT01308008|39047931|FG000|4 Weeks|Illness, disinterest, time|9|||
16152779|NCT01308008|39047932|FG001|4 Weeks|Illness, disinterest, time|2|||
16152780|NCT04003389|39047935|FG000|Overall Study|Adverse Event|27|||
16152781|NCT04003389|39047936|FG001|Overall Study|Adverse Event|34|||
16152782|NCT04003389|39047937|FG002|Overall Study|Adverse Event|28|||
16152783|NCT04003389|39047935|FG000|Overall Study|Lost to Follow-up|39|||
16152784|NCT04003389|39047936|FG001|Overall Study|Lost to Follow-up|30|||
16152785|NCT04003389|39047937|FG002|Overall Study|Lost to Follow-up|33|||
16152786|NCT04003389|39047935|FG000|Overall Study|Protocol Violation|1|||
16152787|NCT04003389|39047936|FG001|Overall Study|Protocol Violation|6|||
16152788|NCT04003389|39047937|FG002|Overall Study|Protocol Violation|5|||
16152789|NCT04003389|39047935|FG000|Overall Study|Withdrawal by Subject|119|||
16152790|NCT04003389|39047936|FG001|Overall Study|Withdrawal by Subject|79|||
16152791|NCT04003389|39047937|FG002|Overall Study|Withdrawal by Subject|85|||
16152792|NCT04003389|39047935|FG000|Overall Study|Miscellaneous|14|||
16152793|NCT04003389|39047936|FG001|Overall Study|Miscellaneous|11|||
16152794|NCT04003389|39047937|FG002|Overall Study|Miscellaneous|14|||
16152795|NCT04003389|39047935|FG000|Overall Study|Participant did not receive study drug|1|||
16152796|NCT04003389|39047936|FG001|Overall Study|Participant did not receive study drug|0|||
16152797|NCT04003389|39047937|FG002|Overall Study|Participant did not receive study drug|0|||
16152798|NCT04707157|39047940|FG000|Overall Study|Adverse Event|12|||
16152799|NCT04707157|39047941|FG001|Overall Study|Adverse Event|3|||
16152800|NCT04707157|39047940|FG000|Overall Study|Lost to Follow-up|2|||
16152801|NCT04707157|39047941|FG001|Overall Study|Lost to Follow-up|0|||
16152802|NCT04707157|39047940|FG000|Overall Study|Sponsor's decision|1|||
16152803|NCT04707157|39047941|FG001|Overall Study|Sponsor's decision|0|||
16152804|NCT04707157|39047940|FG000|Overall Study|Physician Decision|8|||
16152805|NCT04707157|39047941|FG001|Overall Study|Physician Decision|5|||
16152806|NCT04707157|39047940|FG000|Overall Study|Protocol Deviation|1|||
16152807|NCT04707157|39047941|FG001|Overall Study|Protocol Deviation|0|||
16152808|NCT04707157|39047940|FG000|Overall Study|Withdrawal by Subject|1|||
16152809|NCT04707157|39047941|FG001|Overall Study|Withdrawal by Subject|1|||
16152810|NCT01119248|39047944|FG000|Overall Study|Physician Decision|5|||
16152811|NCT02941627|39047945|FG000|Overall Study|Death|1|||
16152812|NCT02941627|39047945|FG000|Overall Study|Surgical failure|1|||
16152813|NCT02941627|39047945|FG000|Overall Study|cholesteatoma prevented implantation|1|||
16152814|NCT03962738|39047946|FG000|Overall Study|Protocol Deviation|3|||
16152815|NCT03962738|39047947|FG001|Overall Study|Protocol Deviation|0|||
16152816|NCT03962738|39047948|FG002|Overall Study|Protocol Deviation|1|||
16152817|NCT03962738|39047949|FG003|Overall Study|Protocol Deviation|1|||
16152818|NCT03962738|39047946|FG000|Overall Study|Withdrawal by Subject|4|||
16152819|NCT03962738|39047947|FG001|Overall Study|Withdrawal by Subject|0|||
16152820|NCT03962738|39047948|FG002|Overall Study|Withdrawal by Subject|0|||
16152821|NCT03962738|39047949|FG003|Overall Study|Withdrawal by Subject|0|||
16152822|NCT03962738|39047946|FG000|Overall Study|Lost to Follow-up|0|||
16152823|NCT03962738|39047947|FG001|Overall Study|Lost to Follow-up|0|||
16152824|NCT03962738|39047948|FG002|Overall Study|Lost to Follow-up|1|||
16152825|NCT03962738|39047949|FG003|Overall Study|Lost to Follow-up|0|||
16152826|NCT01032915|39047952|FG000|Overall Study|Adverse Event|2|||
16152827|NCT01032915|39047953|FG001|Overall Study|Adverse Event|2|||
16152828|NCT01032915|39047954|FG002|Overall Study|Adverse Event|1|||
16152829|NCT01032915|39047955|FG003|Overall Study|Adverse Event|1|||
16152830|NCT01032915|39047952|FG000|Overall Study|Abnormal test procedure result|0|||
16152831|NCT01032915|39047953|FG001|Overall Study|Abnormal test procedure result|0|||
16152832|NCT01032915|39047954|FG002|Overall Study|Abnormal test procedure result|1|||
16152833|NCT01032915|39047955|FG003|Overall Study|Abnormal test procedure result|0|||
16152834|NCT01032915|39047952|FG000|Overall Study|Withdrawal by Subject|0|||
16152835|NCT01032915|39047953|FG001|Overall Study|Withdrawal by Subject|3|||
16152836|NCT01032915|39047954|FG002|Overall Study|Withdrawal by Subject|1|||
16152837|NCT01032915|39047955|FG003|Overall Study|Withdrawal by Subject|1|||
16152838|NCT01032915|39047952|FG000|Overall Study|Administrative reasons|5|||
16152839|NCT01032915|39047953|FG001|Overall Study|Administrative reasons|6|||
16152840|NCT01032915|39047954|FG002|Overall Study|Administrative reasons|4|||
16152841|NCT01032915|39047955|FG003|Overall Study|Administrative reasons|4|||
16152842|NCT01032915|39047952|FG000|Overall Study|Protocol Violation|1|||
16152843|NCT01032915|39047953|FG001|Overall Study|Protocol Violation|0|||
16152844|NCT01032915|39047954|FG002|Overall Study|Protocol Violation|0|||
16152845|NCT01032915|39047955|FG003|Overall Study|Protocol Violation|1|||
16443657|NCT04179175|40102453|FG004|Overall Study|Lost to Follow-up|4|||
16443658|NCT04179175|40102454|FG005|Overall Study|Lost to Follow-up|5|||
16443659|NCT04179175|40102449|FG000|Overall Study|Physician Decision|2|||
16443660|NCT04179175|40102450|FG001|Overall Study|Physician Decision|0|||
16443661|NCT04179175|40102451|FG002|Overall Study|Physician Decision|2|||
16443662|NCT04179175|40102452|FG003|Overall Study|Physician Decision|3|||
16443663|NCT04179175|40102453|FG004|Overall Study|Physician Decision|1|||
16443664|NCT04179175|40102454|FG005|Overall Study|Physician Decision|1|||
16443665|NCT04179175|40102449|FG000|Overall Study|Pregnancy|3|||
16443666|NCT04179175|40102450|FG001|Overall Study|Pregnancy|0|||
16443667|NCT04179175|40102451|FG002|Overall Study|Pregnancy|3|||
16443668|NCT04179175|40102452|FG003|Overall Study|Pregnancy|0|||
16443669|NCT04179175|40102453|FG004|Overall Study|Pregnancy|1|||
16443670|NCT04179175|40102454|FG005|Overall Study|Pregnancy|2|||
16443671|NCT04179175|40102449|FG000|Overall Study|Withdrawal by Subject|22|||
16443672|NCT04179175|40102450|FG001|Overall Study|Withdrawal by Subject|10|||
16443673|NCT04179175|40102451|FG002|Overall Study|Withdrawal by Subject|12|||
16443674|NCT04179175|40102452|FG003|Overall Study|Withdrawal by Subject|8|||
16443675|NCT04179175|40102453|FG004|Overall Study|Withdrawal by Subject|23|||
16443676|NCT04179175|40102454|FG005|Overall Study|Withdrawal by Subject|31|||
16443677|NCT04179175|40102449|FG000|Overall Study|Technical problems|0|||
16152846|NCT03152019|39047956|FG000|Overall Study|Adverse Event|0|||
16152847|NCT03152019|39047957|FG001|Overall Study|Adverse Event|1|||
16152848|NCT02325219|39047958|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
16152849|NCT02325219|39047959|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
16152850|NCT02325219|39047960|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
16152851|NCT02325219|39047961|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
16443678|NCT04179175|40102450|FG001|Overall Study|Technical problems|0|||
16443679|NCT04179175|40102451|FG002|Overall Study|Technical problems|1|||
16443680|NCT04179175|40102452|FG003|Overall Study|Technical problems|1|||
16443681|NCT04179175|40102453|FG004|Overall Study|Technical problems|0|||
16152852|NCT02325219|39047962|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
16152853|NCT02325219|39047958|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
16152854|NCT02325219|39047959|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
16152855|NCT02325219|39047960|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16152856|NCT02325219|39047961|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16152857|NCT02325219|39047962|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
16152858|NCT02325219|39047958|FG000|Controlled Period (Week 0 - 16)|Other|0|||
16152859|NCT02325219|39047959|FG001|Controlled Period (Week 0 - 16)|Other|0|||
16152860|NCT02325219|39047960|FG002|Controlled Period (Week 0 - 16)|Other|1|||
16152861|NCT02325219|39047961|FG003|Controlled Period (Week 0 - 16)|Other|0|||
16152862|NCT02325219|39047962|FG004|Controlled Period (Week 0 - 16)|Other|0|||
16152863|NCT02325219|39047958|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
16152864|NCT02325219|39047959|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
16152865|NCT02325219|39047960|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
16152866|NCT02325219|39047961|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
16152867|NCT02325219|39047962|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
16152868|NCT02325219|39047958|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
16152869|NCT02325219|39047959|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
16152870|NCT02325219|39047960|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
16152871|NCT02325219|39047961|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
16152872|NCT02325219|39047962|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
16152873|NCT02325219|39047958|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16152874|NCT02325219|39047959|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
16152875|NCT02325219|39047960|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16152876|NCT02325219|39047961|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16152877|NCT02325219|39047962|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
16152878|NCT02064387|39047972|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
16152879|NCT02064387|39047973|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
16152880|NCT02064387|39047974|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
16152881|NCT02064387|39047975|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
16152882|NCT02064387|39047976|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
16152883|NCT02064387|39047977|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
16152884|NCT02064387|39047978|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
16152885|NCT02064387|39047979|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
16152886|NCT02064387|39047980|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
16152887|NCT02064387|39047981|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
16152888|NCT02064387|39047982|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
16152889|NCT02064387|39047983|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
16152890|NCT02064387|39047972|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152891|NCT02064387|39047973|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152892|NCT02064387|39047974|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152893|NCT02064387|39047975|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152894|NCT02064387|39047976|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152895|NCT02064387|39047977|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152896|NCT02064387|39047978|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152897|NCT02064387|39047979|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
16152898|NCT02064387|39047980|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152899|NCT02064387|39047981|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152900|NCT02064387|39047982|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152901|NCT02064387|39047983|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
16152902|NCT02064387|39047972|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152903|NCT02064387|39047973|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152904|NCT02064387|39047974|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152905|NCT02064387|39047975|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152906|NCT02064387|39047976|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152907|NCT02064387|39047977|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152908|NCT02064387|39047978|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152909|NCT02064387|39047979|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152910|NCT02064387|39047980|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
16152911|NCT02064387|39047981|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152912|NCT02064387|39047982|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152913|NCT02064387|39047983|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
16152914|NCT02064387|39047972|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
16152915|NCT02064387|39047973|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
16366099|NCT03679884|39825407|FG004|Overall Study|Withdrawal by Subject|9|||
16366100|NCT03679884|39825403|FG000|Overall Study|Lost to Follow-up|1|||
16152916|NCT02064387|39047974|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
16443682|NCT04179175|40102454|FG005|Overall Study|Technical problems|0|||
16443683|NCT01838395|40102455|FG000|Overall Study|Withdrawal by Subject|0|||
16443684|NCT01838395|40102456|FG001|Overall Study|Withdrawal by Subject|0|||
16443685|NCT01838395|40102457|FG002|Overall Study|Withdrawal by Subject|0|||
16443686|NCT01838395|40102458|FG003|Overall Study|Withdrawal by Subject|0|||
16443687|NCT01838395|40102459|FG004|Overall Study|Withdrawal by Subject|1|||
16443688|NCT01838395|40102460|FG005|Overall Study|Withdrawal by Subject|0|||
16443689|NCT01838395|40102455|FG000|Overall Study|Death|0|||
16443690|NCT01838395|40102456|FG001|Overall Study|Death|0|||
16443691|NCT01838395|40102457|FG002|Overall Study|Death|1|||
16443692|NCT01838395|40102458|FG003|Overall Study|Death|0|||
16443693|NCT01838395|40102459|FG004|Overall Study|Death|0|||
16443694|NCT01838395|40102460|FG005|Overall Study|Death|0|||
16443695|NCT01838395|40102455|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
16443696|NCT01838395|40102456|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
16443697|NCT01838395|40102457|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
16443698|NCT01838395|40102458|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
16443699|NCT01838395|40102459|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
16443700|NCT01838395|40102460|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
16443701|NCT01394016|40102461|FG000|Overall Study|Progressive Disease|2|||
16443702|NCT01394016|40102462|FG001|Overall Study|Progressive Disease|0|||
16443703|NCT01394016|40102463|FG002|Overall Study|Progressive Disease|0|||
16443704|NCT01394016|40102464|FG003|Overall Study|Progressive Disease|0|||
16443705|NCT01394016|40102465|FG004|Overall Study|Progressive Disease|0|||
16443706|NCT01394016|40102466|FG005|Overall Study|Progressive Disease|0|||
16443707|NCT01394016|40102467|FG006|Overall Study|Progressive Disease|0|||
16443708|NCT01394016|40102468|FG007|Overall Study|Progressive Disease|0|||
16443709|NCT01394016|40102469|FG008|Overall Study|Progressive Disease|0|||
16443710|NCT01394016|40102470|FG009|Overall Study|Progressive Disease|0|||
16443711|NCT01394016|40102471|FG010|Overall Study|Progressive Disease|0|||
16443712|NCT01394016|40102472|FG011|Overall Study|Progressive Disease|0|||
16443713|NCT01394016|40102473|FG012|Overall Study|Progressive Disease|0|||
16443714|NCT01394016|40102474|FG013|Overall Study|Progressive Disease|0|||
16443715|NCT01394016|40102475|FG014|Overall Study|Progressive Disease|0|||
16443716|NCT01394016|40102476|FG015|Overall Study|Progressive Disease|0|||
16443717|NCT01394016|40102477|FG016|Overall Study|Progressive Disease|0|||
16443718|NCT01394016|40102478|FG017|Overall Study|Progressive Disease|0|||
16443719|NCT01394016|40102479|FG018|Overall Study|Progressive Disease|0|||
16443720|NCT01394016|40102461|FG000|Overall Study|Withdrawal by Subject|0|||
16443721|NCT01394016|40102462|FG001|Overall Study|Withdrawal by Subject|0|||
16443722|NCT01394016|40102463|FG002|Overall Study|Withdrawal by Subject|0|||
16443723|NCT01394016|40102464|FG003|Overall Study|Withdrawal by Subject|0|||
16443724|NCT01394016|40102465|FG004|Overall Study|Withdrawal by Subject|0|||
16443725|NCT01394016|40102466|FG005|Overall Study|Withdrawal by Subject|0|||
16443726|NCT01394016|40102467|FG006|Overall Study|Withdrawal by Subject|0|||
16152917|NCT02064387|39047975|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
16152918|NCT02064387|39047976|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
16152919|NCT02064387|39047977|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
16152920|NCT02064387|39047978|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
16152921|NCT02064387|39047979|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
16152922|NCT02064387|39047980|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
16152923|NCT02064387|39047981|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
16152924|NCT02064387|39047982|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
16152925|NCT02064387|39047983|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
16152926|NCT02064387|39047972|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16152927|NCT02064387|39047973|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16152928|NCT02064387|39047974|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16152929|NCT02064387|39047975|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16152930|NCT02064387|39047976|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16152931|NCT02064387|39047977|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16152932|NCT02064387|39047978|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16152933|NCT02064387|39047979|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16152934|NCT02064387|39047980|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16152935|NCT02064387|39047981|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16152936|NCT02064387|39047982|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
16152937|NCT02064387|39047983|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
16443727|NCT01394016|40102468|FG007|Overall Study|Withdrawal by Subject|1|||
16152938|NCT00139776|39047984|FG000|Period I|Did not enter Period II|575|||
16152939|NCT00139776|39047985|FG001|Period I|Did not enter Period II|0|||
16443728|NCT01394016|40102469|FG008|Overall Study|Withdrawal by Subject|1|||
16443729|NCT01394016|40102470|FG009|Overall Study|Withdrawal by Subject|1|||
16152940|NCT00139776|39047986|FG002|Period I|Did not enter Period II|0|||
16152941|NCT00139776|39047987|FG003|Period I|Did not enter Period II|0|||
16152942|NCT00139776|39047984|FG000|Period II|Not Randomized into Period III|0|||
16152943|NCT00139776|39047985|FG001|Period II|Not Randomized into Period III|322|||
16152944|NCT00139776|39047986|FG002|Period II|Not Randomized into Period III|0|||
16152945|NCT00139776|39047987|FG003|Period II|Not Randomized into Period III|0|||
16152946|NCT00139776|39047984|FG000|Period III|Adverse Event|0|||
16152947|NCT00139776|39047985|FG001|Period III|Adverse Event|0|||
16152948|NCT00139776|39047986|FG002|Period III|Adverse Event|22|||
16152949|NCT00139776|39047987|FG003|Period III|Adverse Event|23|||
16152950|NCT00139776|39047984|FG000|Period III|Other|0|||
16152951|NCT00139776|39047985|FG001|Period III|Other|0|||
16152952|NCT00139776|39047986|FG002|Period III|Other|23|||
16152953|NCT00139776|39047987|FG003|Period III|Other|34|||
16152954|NCT00139776|39047984|FG000|Period III|Lack of Efficacy|0|||
16152955|NCT00139776|39047985|FG001|Period III|Lack of Efficacy|0|||
16152956|NCT00139776|39047986|FG002|Period III|Lack of Efficacy|10|||
16152957|NCT00139776|39047987|FG003|Period III|Lack of Efficacy|24|||
16152958|NCT00139776|39047984|FG000|Period III|Lost to Follow-up|0|||
16152959|NCT00139776|39047985|FG001|Period III|Lost to Follow-up|0|||
16152960|NCT00139776|39047986|FG002|Period III|Lost to Follow-up|5|||
16152961|NCT00139776|39047987|FG003|Period III|Lost to Follow-up|4|||
16152962|NCT00139776|39047984|FG000|Period III|Withdrawal by Subject|0|||
16152963|NCT00139776|39047985|FG001|Period III|Withdrawal by Subject|0|||
16152964|NCT00139776|39047986|FG002|Period III|Withdrawal by Subject|16|||
16152965|NCT00139776|39047987|FG003|Period III|Withdrawal by Subject|21|||
16152966|NCT00326209|39047989|FG000|Overall Study|Adverse Event|28|||
16152967|NCT00326209|39047989|FG000|Overall Study|Withdrawal by Subject|22|||
16152968|NCT00326209|39047989|FG000|Overall Study|Lack of Efficacy|31|||
16152969|NCT00326209|39047989|FG000|Overall Study|Lost to Follow-up|18|||
16152970|NCT00326209|39047989|FG000|Overall Study|Participant non-compliant|6|||
16152971|NCT00326209|39047989|FG000|Overall Study|Sponsor closed study|173|||
16152972|NCT00326209|39047989|FG000|Overall Study|Prohibited medication use|1|||
16152973|NCT00326209|39047989|FG000|Overall Study|Violation of entry criteria|1|||
16152974|NCT00326209|39047989|FG000|Overall Study|Withdrawn in error|1|||
16152975|NCT00326209|39047989|FG000|Overall Study|Pregnancy|1|||
16152976|NCT00788372|39047990|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
16152977|NCT00788372|39047990|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
16152978|NCT00788372|39047990|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
16152979|NCT00788372|39047990|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
16152980|NCT00788372|39047990|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
16152981|NCT00788372|39047990|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
16152982|NCT00788372|39047990|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
16152983|NCT00131469|39047991|FG000|Overall Study|Withdrawal by Subject|3|||
16152984|NCT00131469|39047992|FG001|Overall Study|Withdrawal by Subject|4|||
16152985|NCT00131469|39047991|FG000|Overall Study|Protocol Violation|3|||
16152986|NCT00131469|39047992|FG001|Overall Study|Protocol Violation|1|||
16152987|NCT00131469|39047991|FG000|Overall Study|Death|0|||
16152988|NCT00131469|39047992|FG001|Overall Study|Death|1|||
16152989|NCT00131469|39047991|FG000|Overall Study|Lost to Follow-up|0|||
16152990|NCT00131469|39047992|FG001|Overall Study|Lost to Follow-up|1|||
16152991|NCT00131469|39047991|FG000|Overall Study|scan not analyzable|3|||
16152992|NCT00131469|39047992|FG001|Overall Study|scan not analyzable|6|||
16152993|NCT02728830|39047999|FG000|Overall Study|Exclusionary Surgery|9|||
16152994|NCT02728830|39047999|FG000|Overall Study|Exclusionary Pathology|6|||
16152995|NCT02728830|39047999|FG000|Overall Study|Physician Decision|3|||
16152996|NCT02728830|39047999|FG000|Overall Study|Withdrawal by Subject|2|||
16152997|NCT02728830|39047999|FG000|Overall Study|Lost to Follow-up|1|||
16152998|NCT02728830|39047999|FG000|Overall Study|Exclusionary Lab Values|1|||
16152999|NCT02728830|39047999|FG000|Overall Study|Contraindicated Illness|1|||
16153000|NCT02728830|39047999|FG000|Overall Study|Language Barrier|1|||
16153001|NCT00825162|39048000|FG000|Overall Study|Withdrawal by Subject|11|||
16153002|NCT00825162|39048001|FG001|Overall Study|Withdrawal by Subject|13|||
16153003|NCT00825162|39048002|FG002|Overall Study|Withdrawal by Subject|3|||
16153004|NCT00825162|39048000|FG000|Overall Study|Lost to Follow-up|9|||
16153005|NCT00825162|39048001|FG001|Overall Study|Lost to Follow-up|6|||
16153006|NCT00825162|39048002|FG002|Overall Study|Lost to Follow-up|3|||
16153007|NCT00825162|39048000|FG000|Overall Study|Physician Decision|2|||
16443730|NCT01394016|40102471|FG010|Overall Study|Withdrawal by Subject|4|||
16443731|NCT01394016|40102472|FG011|Overall Study|Withdrawal by Subject|0|||
16443732|NCT01394016|40102473|FG012|Overall Study|Withdrawal by Subject|0|||
16443733|NCT01394016|40102474|FG013|Overall Study|Withdrawal by Subject|3|||
16443734|NCT01394016|40102475|FG014|Overall Study|Withdrawal by Subject|1|||
16443735|NCT01394016|40102476|FG015|Overall Study|Withdrawal by Subject|3|||
16443736|NCT01394016|40102477|FG016|Overall Study|Withdrawal by Subject|1|||
16261966|NCT00416520|39443240|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
16261967|NCT00416520|39443241|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
16261968|NCT00416520|39443242|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
16261969|NCT00416520|39443243|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
16261970|NCT00416520|39443240|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
16261971|NCT00416520|39443241|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
16261972|NCT00416520|39443242|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
16261973|NCT00416520|39443243|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
16261974|NCT01118312|39443244|FG000|Overall Study|Lost to Follow-up|33|||
16261975|NCT01118312|39443245|FG001|Overall Study|Lost to Follow-up|32|||
16261976|NCT01118312|39443244|FG000|Overall Study|Withdrawal by Subject|1|||
16261977|NCT01118312|39443245|FG001|Overall Study|Withdrawal by Subject|3|||
16261978|NCT02079766|39443256|FG000|Overall Study|Physician Decision|1|||
16261979|NCT02079766|39443257|FG001|Overall Study|Physician Decision|0|||
16261980|NCT02079766|39443256|FG000|Overall Study|Withdrawal by Subject|1|||
16261981|NCT02079766|39443257|FG001|Overall Study|Withdrawal by Subject|0|||
16261982|NCT00573066|39445763|FG000|Overall Study|Exclusion criteria|18|||
16261983|NCT00573066|39445763|FG000|Overall Study|IV malfunction|1|||
16261984|NCT00573066|39445763|FG000|Overall Study|Postoperative bleeding|1|||
16261985|NCT03365375|39445765|FG000|Overall Study|Withdrawal by Subject|0|||
16261986|NCT03365375|39445766|FG001|Overall Study|Withdrawal by Subject|1|||
16261987|NCT03365375|39445765|FG000|Overall Study|Lost to Follow-up|0|||
16261988|NCT03365375|39445766|FG001|Overall Study|Lost to Follow-up|4|||
16261989|NCT05341622|39445775|FG000|Overall Study|Death|0|||
16261990|NCT05341622|39445776|FG001|Overall Study|Death|0|||
16261991|NCT05341622|39445777|FG002|Overall Study|Death|0|||
16261992|NCT05341622|39445778|FG003|Overall Study|Death|0|||
16261993|NCT05341622|39445779|FG004|Overall Study|Death|1|||
16261994|NCT05341622|39445780|FG005|Overall Study|Death|0|||
16443737|NCT01394016|40102478|FG017|Overall Study|Withdrawal by Subject|1|||
16443738|NCT01394016|40102479|FG018|Overall Study|Withdrawal by Subject|2|||
16153008|NCT00825162|39048001|FG001|Overall Study|Physician Decision|0|||
16153009|NCT00825162|39048002|FG002|Overall Study|Physician Decision|0|||
16153010|NCT00825162|39048000|FG000|Overall Study|Move away from the study area|1|||
16153011|NCT00825162|39048001|FG001|Overall Study|Move away from the study area|0|||
16153012|NCT00825162|39048002|FG002|Overall Study|Move away from the study area|0|||
16153013|NCT00825162|39048000|FG000|Overall Study|Unable to attend the study visit|5|||
16153014|NCT00825162|39048001|FG001|Overall Study|Unable to attend the study visit|2|||
16153015|NCT00825162|39048002|FG002|Overall Study|Unable to attend the study visit|0|||
16153016|NCT03688880|39048003|FG000|Overall Study|Withdrawal by Subject|0|||
16153017|NCT03688880|39048004|FG001|Overall Study|Withdrawal by Subject|2|||
16153018|NCT03688880|39048003|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
16153019|NCT03688880|39048004|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
16153020|NCT03688880|39048003|FG000|Overall Study|Lost to Follow-up|4|||
16153021|NCT03688880|39048004|FG001|Overall Study|Lost to Follow-up|7|||
16153022|NCT03688880|39048003|FG000|Overall Study|Adverse Event|0|||
16153023|NCT03688880|39048004|FG001|Overall Study|Adverse Event|2|||
16443739|NCT01394016|40102461|FG000|Overall Study|Adverse Event|0|||
16443740|NCT01394016|40102462|FG001|Overall Study|Adverse Event|0|||
16443741|NCT01394016|40102463|FG002|Overall Study|Adverse Event|0|||
16443742|NCT01394016|40102464|FG003|Overall Study|Adverse Event|0|||
16443743|NCT01394016|40102465|FG004|Overall Study|Adverse Event|0|||
16443744|NCT01394016|40102466|FG005|Overall Study|Adverse Event|0|||
16443745|NCT01394016|40102467|FG006|Overall Study|Adverse Event|0|||
16443746|NCT01394016|40102468|FG007|Overall Study|Adverse Event|0|||
16443747|NCT01394016|40102469|FG008|Overall Study|Adverse Event|0|||
16153024|NCT03688880|39048003|FG000|Overall Study|Device deficiencies|0|||
16153025|NCT03688880|39048004|FG001|Overall Study|Device deficiencies|2|||
16153026|NCT03688880|39048003|FG000|Overall Study|Other|10|||
16261995|NCT05341622|39445781|FG006|Overall Study|Death|0|||
16261996|NCT05341622|39445782|FG007|Overall Study|Death|1|||
16443748|NCT01394016|40102470|FG009|Overall Study|Adverse Event|1|||
16443749|NCT01394016|40102471|FG010|Overall Study|Adverse Event|0|||
16443750|NCT01394016|40102472|FG011|Overall Study|Adverse Event|0|||
16261997|NCT05341622|39445775|FG000|Overall Study|Invalid Address|0|||
16261998|NCT05341622|39445776|FG001|Overall Study|Invalid Address|1|||
16261999|NCT05341622|39445777|FG002|Overall Study|Invalid Address|0|||
16262000|NCT05341622|39445778|FG003|Overall Study|Invalid Address|0|||
16443751|NCT01394016|40102473|FG012|Overall Study|Adverse Event|0|||
16443752|NCT01394016|40102474|FG013|Overall Study|Adverse Event|0|||
16443753|NCT01394016|40102475|FG014|Overall Study|Adverse Event|0|||
16443754|NCT01394016|40102476|FG015|Overall Study|Adverse Event|0|||
16443755|NCT01394016|40102477|FG016|Overall Study|Adverse Event|1|||
16443756|NCT01394016|40102478|FG017|Overall Study|Adverse Event|1|||
16443757|NCT01394016|40102479|FG018|Overall Study|Adverse Event|0|||
16443758|NCT01394016|40102461|FG000|Overall Study|Sponsor Decision|0|||
16443759|NCT01394016|40102462|FG001|Overall Study|Sponsor Decision|0|||
16443760|NCT01394016|40102463|FG002|Overall Study|Sponsor Decision|0|||
16443761|NCT01394016|40102464|FG003|Overall Study|Sponsor Decision|0|||
16153027|NCT03688880|39048004|FG001|Overall Study|Other|16|||
16153028|NCT01181011|39048005|FG000|Overall Study|Adverse Event|2|||
16153029|NCT01181011|39048005|FG000|Overall Study|Lost to Follow-up|1|||
16153030|NCT00562588|39048010|FG000|Overall Study|Adverse Event|40|||
16153031|NCT00562588|39048011|FG001|Overall Study|Adverse Event|58|||
16153032|NCT00562588|39048010|FG000|Overall Study|Protocol Violation|30|||
16153033|NCT00562588|39048011|FG001|Overall Study|Protocol Violation|26|||
16153034|NCT00562588|39048010|FG000|Overall Study|Lost to Follow-up|12|||
16153035|NCT00562588|39048011|FG001|Overall Study|Lost to Follow-up|4|||
16153036|NCT00562588|39048010|FG000|Overall Study|Withdrawal by Subject|10|||
16153037|NCT00562588|39048011|FG001|Overall Study|Withdrawal by Subject|9|||
16153038|NCT00562588|39048010|FG000|Overall Study|Other|0|||
16153039|NCT00562588|39048011|FG001|Overall Study|Other|2|||
16153040|NCT02871778|39048012|FG000|Part A: Treatment Period 1|Adverse Event|1|||
16153041|NCT02871778|39048013|FG001|Part A: Treatment Period 1|Adverse Event|1|||
16153042|NCT02871778|39048014|FG002|Part A: Treatment Period 1|Adverse Event|1|||
16153043|NCT02871778|39048015|FG003|Part A: Treatment Period 1|Adverse Event|0|||
16153044|NCT02871778|39048016|FG004|Part A: Treatment Period 1|Adverse Event|0|||
16443762|NCT01394016|40102465|FG004|Overall Study|Sponsor Decision|0|||
16443763|NCT01394016|40102466|FG005|Overall Study|Sponsor Decision|0|||
16443764|NCT01394016|40102467|FG006|Overall Study|Sponsor Decision|0|||
16443765|NCT01394016|40102468|FG007|Overall Study|Sponsor Decision|0|||
16443766|NCT01394016|40102469|FG008|Overall Study|Sponsor Decision|0|||
16153045|NCT02871778|39048017|FG005|Part A: Treatment Period 1|Adverse Event|0|||
16153046|NCT02871778|39048018|FG006|Part A: Treatment Period 1|Adverse Event|0|||
16153047|NCT02871778|39048019|FG007|Part A: Treatment Period 1|Adverse Event|0|||
16153048|NCT02871778|39048012|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
16153049|NCT02871778|39048013|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
16153050|NCT02871778|39048014|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
16153051|NCT02871778|39048015|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
16153052|NCT02871778|39048016|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
16153053|NCT02871778|39048017|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
16153054|NCT02871778|39048018|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
16153055|NCT02871778|39048019|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
16153056|NCT02871778|39048012|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
16153057|NCT02871778|39048013|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
16153058|NCT02871778|39048014|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
16153059|NCT02871778|39048015|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
16153060|NCT02871778|39048016|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
16153061|NCT02871778|39048017|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
16153062|NCT02871778|39048018|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
16153063|NCT02871778|39048019|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
16153064|NCT02871778|39048012|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
16153065|NCT02871778|39048013|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
16153066|NCT02871778|39048014|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
16153067|NCT02871778|39048015|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
16443767|NCT01394016|40102470|FG009|Overall Study|Sponsor Decision|0|||
16443768|NCT01394016|40102471|FG010|Overall Study|Sponsor Decision|0|||
16443769|NCT01394016|40102472|FG011|Overall Study|Sponsor Decision|0|||
16153068|NCT02871778|39048016|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
16153069|NCT02871778|39048017|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
16153070|NCT02871778|39048018|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
16153071|NCT02871778|39048019|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
16153072|NCT02871778|39048012|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
16153073|NCT02871778|39048013|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
16153074|NCT02871778|39048014|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
16153075|NCT02871778|39048015|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
16153076|NCT02871778|39048016|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
16153077|NCT02871778|39048017|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
16153078|NCT02871778|39048018|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
16153079|NCT02871778|39048019|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
16153080|NCT02871778|39048012|FG000|Part A: Treatment Period 2|Adverse Event|2|||
16153081|NCT02871778|39048013|FG001|Part A: Treatment Period 2|Adverse Event|2|||
16153082|NCT02871778|39048014|FG002|Part A: Treatment Period 2|Adverse Event|0|||
16153083|NCT02871778|39048015|FG003|Part A: Treatment Period 2|Adverse Event|0|||
16153084|NCT02871778|39048016|FG004|Part A: Treatment Period 2|Adverse Event|0|||
16153085|NCT02871778|39048017|FG005|Part A: Treatment Period 2|Adverse Event|0|||
16153086|NCT02871778|39048018|FG006|Part A: Treatment Period 2|Adverse Event|0|||
16153087|NCT02871778|39048019|FG007|Part A: Treatment Period 2|Adverse Event|0|||
16153088|NCT02871778|39048012|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
16153089|NCT02871778|39048013|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
16153090|NCT02871778|39048014|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
16153091|NCT02871778|39048015|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
16153092|NCT02871778|39048016|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
16153093|NCT02871778|39048017|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
16153094|NCT02871778|39048018|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
16153095|NCT02871778|39048019|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
16153096|NCT02871778|39048012|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
16153097|NCT02871778|39048013|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
16153098|NCT02871778|39048014|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
16153099|NCT02871778|39048015|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
16153100|NCT02871778|39048016|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
16153101|NCT02871778|39048017|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
16153102|NCT02871778|39048018|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
16153103|NCT02871778|39048019|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
16153104|NCT02871778|39048012|FG000|Part B: Treatment Period 3|Adverse Event|0|||
16153105|NCT02871778|39048013|FG001|Part B: Treatment Period 3|Adverse Event|0|||
16153106|NCT02871778|39048014|FG002|Part B: Treatment Period 3|Adverse Event|0|||
16443770|NCT01394016|40102473|FG012|Overall Study|Sponsor Decision|1|||
16443771|NCT01394016|40102474|FG013|Overall Study|Sponsor Decision|0|||
16443772|NCT01394016|40102475|FG014|Overall Study|Sponsor Decision|0|||
16443773|NCT01394016|40102476|FG015|Overall Study|Sponsor Decision|0|||
16443774|NCT01394016|40102477|FG016|Overall Study|Sponsor Decision|0|||
16443775|NCT01394016|40102478|FG017|Overall Study|Sponsor Decision|0|||
16153107|NCT02871778|39048015|FG003|Part B: Treatment Period 3|Adverse Event|0|||
16153108|NCT02871778|39048016|FG004|Part B: Treatment Period 3|Adverse Event|1|||
16153109|NCT02871778|39048017|FG005|Part B: Treatment Period 3|Adverse Event|1|||
16443776|NCT01394016|40102479|FG018|Overall Study|Sponsor Decision|0|||
16443777|NCT01394016|40102461|FG000|Overall Study|Lost to Follow-up|0|||
16443778|NCT01394016|40102462|FG001|Overall Study|Lost to Follow-up|0|||
16443779|NCT01394016|40102463|FG002|Overall Study|Lost to Follow-up|0|||
16443780|NCT01394016|40102464|FG003|Overall Study|Lost to Follow-up|0|||
16153110|NCT02871778|39048018|FG006|Part B: Treatment Period 3|Adverse Event|1|||
16153111|NCT02871778|39048019|FG007|Part B: Treatment Period 3|Adverse Event|0|||
16443781|NCT01394016|40102465|FG004|Overall Study|Lost to Follow-up|0|||
16443782|NCT01394016|40102466|FG005|Overall Study|Lost to Follow-up|0|||
16443783|NCT01394016|40102467|FG006|Overall Study|Lost to Follow-up|0|||
16443784|NCT01394016|40102468|FG007|Overall Study|Lost to Follow-up|0|||
16153112|NCT04697628|39048027|FG000|Overall Study|Withdrawal by Subject|17|||
16153113|NCT04697628|39048028|FG001|Overall Study|Withdrawal by Subject|23|||
16153114|NCT04697628|39048027|FG000|Overall Study|Lost to Follow-up|0|||
16153115|NCT04697628|39048028|FG001|Overall Study|Lost to Follow-up|4|||
16153116|NCT04697628|39048027|FG000|Overall Study|On-going in study|122|||
16153117|NCT04697628|39048028|FG001|Overall Study|On-going in study|91|||
16153118|NCT02969707|39048029|FG000|Overall Study|Adverse Event|1|||
16153119|NCT02969707|39048030|FG001|Overall Study|Adverse Event|2|||
16153120|NCT02969707|39048029|FG000|Overall Study|Lost to Follow-up|3|||
16153121|NCT02969707|39048030|FG001|Overall Study|Lost to Follow-up|0|||
16153122|NCT02969707|39048029|FG000|Overall Study|Physician Decision|0|||
16153123|NCT02969707|39048030|FG001|Overall Study|Physician Decision|1|||
16153124|NCT02969707|39048029|FG000|Overall Study|Protocol Violation|1|||
16153125|NCT02969707|39048030|FG001|Overall Study|Protocol Violation|1|||
16153126|NCT02969707|39048029|FG000|Overall Study|Withdrawal by Subject|3|||
16153127|NCT02969707|39048030|FG001|Overall Study|Withdrawal by Subject|4|||
16153128|NCT01999582|39048033|FG000|Overall Study|Withdrawal by Subject|0|||
16153129|NCT01999582|39048034|FG001|Overall Study|Withdrawal by Subject|0|||
16153130|NCT01999582|39048035|FG002|Overall Study|Withdrawal by Subject|0|||
16153131|NCT01999582|39048036|FG003|Overall Study|Withdrawal by Subject|1|||
16153132|NCT01999582|39048037|FG004|Overall Study|Withdrawal by Subject|0|||
16153133|NCT01999582|39048038|FG005|Overall Study|Withdrawal by Subject|0|||
16153134|NCT01999582|39048033|FG000|Overall Study|Adverse Event|0|||
16443785|NCT01394016|40102469|FG008|Overall Study|Lost to Follow-up|0|||
16443786|NCT01394016|40102470|FG009|Overall Study|Lost to Follow-up|0|||
16153135|NCT01999582|39048034|FG001|Overall Study|Adverse Event|0|||
16153136|NCT01999582|39048035|FG002|Overall Study|Adverse Event|3|||
16153137|NCT01999582|39048036|FG003|Overall Study|Adverse Event|0|||
16153138|NCT01999582|39048037|FG004|Overall Study|Adverse Event|1|||
16153139|NCT01999582|39048038|FG005|Overall Study|Adverse Event|0|||
16153140|NCT01999582|39048033|FG000|Overall Study|Other Reasons|1|||
16153141|NCT01999582|39048034|FG001|Overall Study|Other Reasons|0|||
16153142|NCT01999582|39048035|FG002|Overall Study|Other Reasons|3|||
16153143|NCT01999582|39048036|FG003|Overall Study|Other Reasons|1|||
16153144|NCT01999582|39048037|FG004|Overall Study|Other Reasons|1|||
16153145|NCT01999582|39048038|FG005|Overall Study|Other Reasons|2|||
16153146|NCT01999582|39048033|FG000|Overall Study|Protocol Violation|1|||
16153147|NCT01999582|39048034|FG001|Overall Study|Protocol Violation|0|||
16153148|NCT01999582|39048035|FG002|Overall Study|Protocol Violation|0|||
16153149|NCT01999582|39048036|FG003|Overall Study|Protocol Violation|0|||
16443787|NCT01394016|40102471|FG010|Overall Study|Lost to Follow-up|0|||
16443788|NCT01394016|40102472|FG011|Overall Study|Lost to Follow-up|0|||
16153150|NCT01999582|39048037|FG004|Overall Study|Protocol Violation|0|||
16153151|NCT01999582|39048038|FG005|Overall Study|Protocol Violation|1|||
16153152|NCT01999582|39048033|FG000|Overall Study|Lack of Efficacy|1|||
16153153|NCT01999582|39048034|FG001|Overall Study|Lack of Efficacy|3|||
16153154|NCT01999582|39048035|FG002|Overall Study|Lack of Efficacy|0|||
16153155|NCT01999582|39048036|FG003|Overall Study|Lack of Efficacy|1|||
16153156|NCT01999582|39048037|FG004|Overall Study|Lack of Efficacy|0|||
16153157|NCT01999582|39048038|FG005|Overall Study|Lack of Efficacy|0|||
16153158|NCT00750737|39048039|FG000|Overall Study|Withdrawal by Subject|3|||
16153159|NCT00750737|39048040|FG001|Overall Study|Withdrawal by Subject|3|||
16153160|NCT01321710|39048043|FG000|Overall Study|Lost to Follow-up|4|||
16153161|NCT01321710|39048044|FG001|Overall Study|Lost to Follow-up|5|||
16153162|NCT01321710|39048045|FG002|Overall Study|Lost to Follow-up|0|||
16153163|NCT00975156|39048046|FG000|Overall Study|Protocol Violation|0|||
16153164|NCT00975156|39048047|FG001|Overall Study|Protocol Violation|1|||
16153165|NCT00677014|39048052|FG000|Overall Study|Lost to Follow-up|20|||
16153166|NCT00677014|39048053|FG001|Overall Study|Lost to Follow-up|12|||
16153167|NCT00677014|39048054|FG002|Overall Study|Lost to Follow-up|24|||
16153168|NCT00677014|39048052|FG000|Overall Study|Death|6|||
16153169|NCT00677014|39048053|FG001|Overall Study|Death|15|||
16153170|NCT00677014|39048054|FG002|Overall Study|Death|7|||
16153171|NCT00677014|39048052|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
16153172|NCT00677014|39048053|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
16153173|NCT00677014|39048054|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
16153174|NCT02614859|39048055|FG000|Overall Study|Physician Decision|0|||
16153175|NCT02614859|39048056|FG001|Overall Study|Physician Decision|1|||
16153176|NCT02821715|39048061|FG000|Overall Study|Protocol Violation|1|||
16153177|NCT02821715|39048062|FG001|Overall Study|Protocol Violation|0|||
16153178|NCT02821715|39048063|FG002|Overall Study|Protocol Violation|0|||
16153179|NCT02821715|39048064|FG003|Overall Study|Protocol Violation|0|||
16153180|NCT02821715|39048065|FG004|Overall Study|Protocol Violation|0|||
16153181|NCT02821715|39048066|FG005|Overall Study|Protocol Violation|0|||
16153182|NCT02234479|39048073|FG000|Overall Study|Withdrawal by Subject|1|||
16153183|NCT02234479|39048074|FG001|Overall Study|Withdrawal by Subject|3|||
16153184|NCT00769002|39048080|FG000|Overall Study|Study was not completed, no data|9|||
16153185|NCT00769002|39048081|FG001|Overall Study|Study was not completed, no data|9|||
16153186|NCT02255409|39048085|FG000|Overall Study|Administrative Reason|3|||
16153187|NCT02255409|39048086|FG001|Overall Study|Administrative Reason|7|||
16153188|NCT02255409|39048085|FG000|Overall Study|Withdrawal by Subject|1|||
16153189|NCT02255409|39048086|FG001|Overall Study|Withdrawal by Subject|5|||
16153190|NCT02255409|39048085|FG000|Overall Study|Lost to Follow-up|10|||
16153191|NCT02255409|39048086|FG001|Overall Study|Lost to Follow-up|19|||
16153192|NCT01212185|39048090|FG000|Overall Study|Protocol Violation|2|||
16153193|NCT01212185|39048091|FG001|Overall Study|Protocol Violation|1|||
16153194|NCT03363321|39048092|FG000|Overall Study|Withdrawal by Subject|0|||
16153195|NCT03363321|39048093|FG001|Overall Study|Withdrawal by Subject|1|||
16153196|NCT03363321|39048094|FG002|Overall Study|Withdrawal by Subject|0|||
16153197|NCT03363321|39048095|FG003|Overall Study|Withdrawal by Subject|1|||
16153198|NCT03363321|39048096|FG004|Overall Study|Withdrawal by Subject|0|||
16153199|NCT01709149|39048097|FG000|Open-label Lead-in Phase|Adverse Event|109|||
16153200|NCT01709149|39048098|FG001|Open-label Lead-in Phase|Adverse Event|0|||
16153201|NCT01709149|39048099|FG002|Open-label Lead-in Phase|Adverse Event|0|||
16153202|NCT01709149|39048097|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
16153203|NCT01709149|39048098|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
16153204|NCT01709149|39048099|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
16153205|NCT01709149|39048097|FG000|Open-label Lead-in Phase|Death|1|||
16153206|NCT01709149|39048098|FG001|Open-label Lead-in Phase|Death|0|||
16153207|NCT01709149|39048099|FG002|Open-label Lead-in Phase|Death|0|||
16153208|NCT01709149|39048097|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
16153209|NCT01709149|39048098|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
16153210|NCT01709149|39048099|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
16153211|NCT01709149|39048097|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
16153212|NCT01709149|39048098|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
16153213|NCT01709149|39048099|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
16153214|NCT01709149|39048097|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16153215|NCT01709149|39048098|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
16153216|NCT01709149|39048099|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
16153217|NCT01709149|39048097|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
16153218|NCT01709149|39048098|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
16153219|NCT01709149|39048099|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
16153220|NCT01709149|39048097|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
16153221|NCT01709149|39048098|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
16153222|NCT01709149|39048099|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
16153223|NCT01709149|39048097|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
16153224|NCT01709149|39048098|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
16153225|NCT01709149|39048099|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
16153226|NCT01709149|39048097|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16153227|NCT01709149|39048098|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
16153228|NCT01709149|39048099|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16153229|NCT01611974|39048100|FG000|Overall Study|Death|10|||
16153230|NCT01611974|39048101|FG001|Overall Study|Death|12|||
16153231|NCT01611974|39048102|FG002|Overall Study|Death|10|||
16153232|NCT01611974|39048100|FG000|Overall Study|Lost to Follow-up|0|||
16153233|NCT01611974|39048101|FG001|Overall Study|Lost to Follow-up|1|||
16153234|NCT01611974|39048102|FG002|Overall Study|Lost to Follow-up|0|||
16153235|NCT01611974|39048100|FG000|Overall Study|Physician Decision|5|||
16153236|NCT01611974|39048101|FG001|Overall Study|Physician Decision|1|||
16153237|NCT01611974|39048102|FG002|Overall Study|Physician Decision|2|||
16153238|NCT01611974|39048100|FG000|Overall Study|Withdrawal by Subject|0|||
16153239|NCT01611974|39048101|FG001|Overall Study|Withdrawal by Subject|1|||
16153240|NCT01611974|39048102|FG002|Overall Study|Withdrawal by Subject|4|||
16153241|NCT01984268|39048110|FG000|Overall Study|Study Terminated|15|||
16153242|NCT03200366|39048111|FG000|Patient Navigation Intervention Given|Death|0|||
16153243|NCT03200366|39048112|FG001|Patient Navigation Intervention Given|Death|2|||
16153244|NCT03200366|39048113|FG002|Patient Navigation Intervention Given|Death|0|||
16153245|NCT03200366|39048111|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
16153246|NCT03200366|39048112|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
16153247|NCT03200366|39048113|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
16153248|NCT03200366|39048111|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
16153249|NCT03200366|39048112|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
16153250|NCT03200366|39048113|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
16153251|NCT03200366|39048111|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
16153252|NCT03200366|39048112|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
16262001|NCT05341622|39445779|FG004|Overall Study|Invalid Address|0|||
16262002|NCT05341622|39445780|FG005|Overall Study|Invalid Address|0|||
16262003|NCT05341622|39445781|FG006|Overall Study|Invalid Address|0|||
16262004|NCT05341622|39445782|FG007|Overall Study|Invalid Address|0|||
16262005|NCT05341622|39445775|FG000|Overall Study|Ineligible|26|||
16262006|NCT05341622|39445776|FG001|Overall Study|Ineligible|21|||
16262007|NCT05341622|39445777|FG002|Overall Study|Ineligible|28|||
16262008|NCT05341622|39445778|FG003|Overall Study|Ineligible|24|||
16262009|NCT05341622|39445779|FG004|Overall Study|Ineligible|29|||
16262010|NCT05341622|39445780|FG005|Overall Study|Ineligible|31|||
16262011|NCT05341622|39445781|FG006|Overall Study|Ineligible|28|||
16262012|NCT05341622|39445782|FG007|Overall Study|Ineligible|26|||
16262013|NCT00467363|39445787|FG000|Overall Study|Lost to Follow-up|80|||
16262014|NCT00467363|39445788|FG001|Overall Study|Lost to Follow-up|70|||
16262015|NCT03606174|39445789|FG000|Overall Study|Death|37|||
16262016|NCT03606174|39445790|FG001|Overall Study|Death|15|||
16262017|NCT03606174|39445791|FG002|Overall Study|Death|15|||
16262018|NCT03606174|39445792|FG003|Overall Study|Death|7|||
16262019|NCT03606174|39445793|FG004|Overall Study|Death|35|||
16262020|NCT03606174|39445794|FG005|Overall Study|Death|12|||
16262021|NCT03606174|39445795|FG006|Overall Study|Death|35|||
16262022|NCT03606174|39445796|FG007|Overall Study|Death|8|||
16262023|NCT03606174|39445797|FG008|Overall Study|Death|5|||
16262024|NCT03606174|39445798|FG009|Overall Study|Death|3|||
16262025|NCT03606174|39445799|FG010|Overall Study|Death|0|||
16262026|NCT03606174|39445789|FG000|Overall Study|Lost to Follow-up|0|||
16262027|NCT03606174|39445790|FG001|Overall Study|Lost to Follow-up|0|||
16262028|NCT03606174|39445791|FG002|Overall Study|Lost to Follow-up|0|||
16262029|NCT03606174|39445792|FG003|Overall Study|Lost to Follow-up|0|||
16262030|NCT03606174|39445793|FG004|Overall Study|Lost to Follow-up|1|||
16262031|NCT03606174|39445794|FG005|Overall Study|Lost to Follow-up|1|||
16262032|NCT03606174|39445795|FG006|Overall Study|Lost to Follow-up|0|||
16262033|NCT03606174|39445796|FG007|Overall Study|Lost to Follow-up|0|||
16262034|NCT03606174|39445797|FG008|Overall Study|Lost to Follow-up|0|||
16262035|NCT03606174|39445798|FG009|Overall Study|Lost to Follow-up|0|||
16262036|NCT03606174|39445799|FG010|Overall Study|Lost to Follow-up|0|||
16262037|NCT03606174|39445789|FG000|Overall Study|Withdrawal by Subject|6|||
16262038|NCT03606174|39445790|FG001|Overall Study|Withdrawal by Subject|0|||
16262039|NCT03606174|39445791|FG002|Overall Study|Withdrawal by Subject|0|||
16443789|NCT01394016|40102473|FG012|Overall Study|Lost to Follow-up|0|||
16443790|NCT01394016|40102474|FG013|Overall Study|Lost to Follow-up|0|||
16443791|NCT01394016|40102475|FG014|Overall Study|Lost to Follow-up|0|||
16443792|NCT01394016|40102476|FG015|Overall Study|Lost to Follow-up|0|||
16443793|NCT01394016|40102477|FG016|Overall Study|Lost to Follow-up|0|||
16443794|NCT01394016|40102478|FG017|Overall Study|Lost to Follow-up|0|||
16443795|NCT01394016|40102479|FG018|Overall Study|Lost to Follow-up|1|||
16443796|NCT03674411|40102484|FG000|Overall Study|Non-treatment|4|||
16443797|NCT05239494|40102486|FG000|Overall Study|Lost to Follow-up|1|||
16443798|NCT02783690|40102487|FG000|Overall Study|Withdrawal by Subject|3|||
16443799|NCT02783690|40102488|FG001|Overall Study|Withdrawal by Subject|3|||
16443800|NCT04825678|40102489|FG000|Overall Study|Decision by Sponsor|2|||
16443801|NCT04825678|40102490|FG001|Overall Study|Decision by Sponsor|3|||
16443802|NCT04825678|40102489|FG000|Overall Study|Withdrawal of Consent From Study|7|||
16443803|NCT04825678|40102490|FG001|Overall Study|Withdrawal of Consent From Study|9|||
16443804|NCT04825678|40102489|FG000|Overall Study|Lost to Follow-up|3|||
16443805|NCT04825678|40102490|FG001|Overall Study|Lost to Follow-up|4|||
16443806|NCT04825678|40102489|FG000|Overall Study|Never Received Investigational Product|1|||
16443807|NCT04825678|40102490|FG001|Overall Study|Never Received Investigational Product|1|||
16443808|NCT01074970|40104348|FG000|Overall Study|Never Treated|0|||
16443809|NCT01074970|40104349|FG001|Overall Study|Never Treated|0|||
16443810|NCT01074970|40104350|FG002|Overall Study|Never Treated|8|||
16443811|NCT01074970|40104351|FG003|Overall Study|Never Treated|1|||
16443812|NCT01074970|40104348|FG000|Overall Study|Adverse Event|1|||
16443813|NCT01074970|40104349|FG001|Overall Study|Adverse Event|0|||
16443814|NCT01074970|40104350|FG002|Overall Study|Adverse Event|4|||
16443815|NCT01074970|40104351|FG003|Overall Study|Adverse Event|3|||
16443816|NCT01074970|40104348|FG000|Overall Study|Disease progression during treatment|3|||
16262040|NCT03606174|39445792|FG003|Overall Study|Withdrawal by Subject|1|||
16262041|NCT03606174|39445793|FG004|Overall Study|Withdrawal by Subject|2|||
16262042|NCT03606174|39445794|FG005|Overall Study|Withdrawal by Subject|1|||
16262043|NCT03606174|39445795|FG006|Overall Study|Withdrawal by Subject|4|||
16443817|NCT01074970|40104349|FG001|Overall Study|Disease progression during treatment|1|||
16443818|NCT01074970|40104350|FG002|Overall Study|Disease progression during treatment|2|||
16443819|NCT01074970|40104351|FG003|Overall Study|Disease progression during treatment|9|||
16262044|NCT03606174|39445796|FG007|Overall Study|Withdrawal by Subject|0|||
16262045|NCT03606174|39445797|FG008|Overall Study|Withdrawal by Subject|0|||
16262046|NCT03606174|39445798|FG009|Overall Study|Withdrawal by Subject|0|||
16443820|NCT01074970|40104348|FG000|Overall Study|Lost to Follow-up|0|||
16443821|NCT01074970|40104349|FG001|Overall Study|Lost to Follow-up|0|||
16262047|NCT03606174|39445799|FG010|Overall Study|Withdrawal by Subject|1|||
16262048|NCT03606174|39445789|FG000|Overall Study|Study Terminated by Sponsor|5|||
16262049|NCT03606174|39445790|FG001|Overall Study|Study Terminated by Sponsor|7|||
16262050|NCT03606174|39445791|FG002|Overall Study|Study Terminated by Sponsor|3|||
16443822|NCT01074970|40104350|FG002|Overall Study|Lost to Follow-up|1|||
16443823|NCT01074970|40104351|FG003|Overall Study|Lost to Follow-up|0|||
16443824|NCT01074970|40104348|FG000|Overall Study|Withdrawal by Subject|0|||
16443825|NCT01074970|40104349|FG001|Overall Study|Withdrawal by Subject|0|||
16443826|NCT01074970|40104350|FG002|Overall Study|Withdrawal by Subject|6|||
16443827|NCT01074970|40104351|FG003|Overall Study|Withdrawal by Subject|4|||
16443828|NCT02603887|40104353|FG000|Stage 1|Adverse Event|4|||
16443829|NCT02603887|40104353|FG000|Stage 1|Disease progression|1|||
16443830|NCT02603887|40104353|FG000|Stage 2|FDA guidance|1|||
16443831|NCT03818256|40104354|FG000|Overall Study|Withdrawal by Subject|2|||
16443832|NCT03818256|40104355|FG001|Overall Study|Withdrawal by Subject|2|||
16443833|NCT03818256|40104354|FG000|Overall Study|Adverse Event|3|||
16443834|NCT03818256|40104355|FG001|Overall Study|Adverse Event|1|||
16443835|NCT03818256|40104354|FG000|Overall Study|Lost to Follow-up|0|||
16443836|NCT03818256|40104355|FG001|Overall Study|Lost to Follow-up|5|||
16443837|NCT03818256|40104354|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
16443838|NCT03818256|40104355|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
16153253|NCT03200366|39048113|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
16153254|NCT03200366|39048111|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
16153255|NCT03200366|39048112|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
16153256|NCT03200366|39048113|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
16153257|NCT03200366|39048111|FG000|6 Month Post-Baseline Interview|Death|1|||
16153258|NCT03200366|39048112|FG001|6 Month Post-Baseline Interview|Death|1|||
16153259|NCT03200366|39048113|FG002|6 Month Post-Baseline Interview|Death|1|||
16153260|NCT03200366|39048111|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
16153261|NCT03200366|39048112|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
16153262|NCT03200366|39048113|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
16153263|NCT03200366|39048111|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
16153264|NCT03200366|39048112|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
16153265|NCT03200366|39048113|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
16153266|NCT03200366|39048111|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
16153267|NCT03200366|39048112|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
16153268|NCT03200366|39048113|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
16153269|NCT03200366|39048111|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
16153270|NCT03200366|39048112|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
16153271|NCT03200366|39048113|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
16153272|NCT03200366|39048111|FG000|9 Month Post-Baseline Interview|Death|1|||
16153273|NCT03200366|39048112|FG001|9 Month Post-Baseline Interview|Death|1|||
16153274|NCT03200366|39048113|FG002|9 Month Post-Baseline Interview|Death|1|||
16153275|NCT03200366|39048111|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
16153276|NCT03200366|39048112|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
16153277|NCT03200366|39048113|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
16153278|NCT03200366|39048111|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
16153279|NCT03200366|39048112|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
16153280|NCT03200366|39048113|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
16153281|NCT03200366|39048111|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
16153282|NCT03200366|39048112|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
16153283|NCT03200366|39048113|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
16153284|NCT02833974|39048114|FG000|Overall Study|Lost to Follow-up|1|||
16153285|NCT02833974|39048115|FG001|Overall Study|Lost to Follow-up|0|||
16153286|NCT02833974|39048114|FG000|Overall Study|Adverse Event|0|||
16153287|NCT02833974|39048115|FG001|Overall Study|Adverse Event|3|||
16153288|NCT00262522|39048116|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
16153289|NCT00262522|39048117|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
16153290|NCT00262522|39048118|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
16153291|NCT00262522|39048119|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
16153292|NCT00262522|39048116|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
16153293|NCT00262522|39048117|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
16153294|NCT00262522|39048118|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
16153295|NCT00262522|39048119|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
16153296|NCT00262522|39048116|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
16153297|NCT00262522|39048117|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
16153298|NCT00262522|39048118|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
16153299|NCT00262522|39048119|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
16153300|NCT00262522|39048116|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
16443839|NCT03818256|40104354|FG000|Overall Study|Not reporting for scheduled visits|1|||
16443840|NCT03818256|40104355|FG001|Overall Study|Not reporting for scheduled visits|0|||
16443841|NCT03818256|40104354|FG000|Overall Study|Non-compliant with investigational product|1|||
16443842|NCT03818256|40104355|FG001|Overall Study|Non-compliant with investigational product|0|||
16443843|NCT05375929|40104358|FG000|Treatment Phase (12 Weeks)|Ongoing|17|||
16262051|NCT03606174|39445792|FG003|Overall Study|Study Terminated by Sponsor|0|||
16262052|NCT03606174|39445793|FG004|Overall Study|Study Terminated by Sponsor|11|||
16262053|NCT03606174|39445794|FG005|Overall Study|Study Terminated by Sponsor|6|||
16262054|NCT03606174|39445795|FG006|Overall Study|Study Terminated by Sponsor|12|||
16262055|NCT03606174|39445796|FG007|Overall Study|Study Terminated by Sponsor|1|||
16262056|NCT03606174|39445797|FG008|Overall Study|Study Terminated by Sponsor|3|||
16262057|NCT03606174|39445798|FG009|Overall Study|Study Terminated by Sponsor|1|||
16262058|NCT03606174|39445799|FG010|Overall Study|Study Terminated by Sponsor|2|||
16262059|NCT03606174|39445789|FG000|Overall Study|Miscellaneous|1|||
16262060|NCT03606174|39445790|FG001|Overall Study|Miscellaneous|1|||
16262061|NCT03606174|39445791|FG002|Overall Study|Miscellaneous|0|||
16262062|NCT03606174|39445792|FG003|Overall Study|Miscellaneous|1|||
16262063|NCT03606174|39445793|FG004|Overall Study|Miscellaneous|4|||
16262064|NCT03606174|39445794|FG005|Overall Study|Miscellaneous|7|||
16262065|NCT03606174|39445795|FG006|Overall Study|Miscellaneous|5|||
16262066|NCT03606174|39445796|FG007|Overall Study|Miscellaneous|0|||
16262067|NCT03606174|39445797|FG008|Overall Study|Miscellaneous|0|||
16262068|NCT03606174|39445798|FG009|Overall Study|Miscellaneous|0|||
16262069|NCT03606174|39445799|FG010|Overall Study|Miscellaneous|1|||
16262070|NCT03194217|39445800|FG000|Overall Study|Adverse Event|0|||
16262071|NCT03194217|39445801|FG001|Overall Study|Adverse Event|2|||
16262072|NCT03194217|39445802|FG002|Overall Study|Adverse Event|3|||
16262073|NCT03194217|39445803|FG003|Overall Study|Adverse Event|3|||
16262074|NCT03194217|39445800|FG000|Overall Study|Failure to meet randomisation criteria|0|||
16262075|NCT03194217|39445801|FG001|Overall Study|Failure to meet randomisation criteria|0|||
16262076|NCT03194217|39445802|FG002|Overall Study|Failure to meet randomisation criteria|0|||
16262077|NCT03194217|39445803|FG003|Overall Study|Failure to meet randomisation criteria|1|||
16262078|NCT03194217|39445800|FG000|Overall Study|Other|0|||
16262079|NCT03194217|39445801|FG001|Overall Study|Other|1|||
16262080|NCT03194217|39445802|FG002|Overall Study|Other|1|||
16262081|NCT03194217|39445803|FG003|Overall Study|Other|0|||
16262082|NCT00465270|39445804|FG000|Overall Study|Death|7|||
16262083|NCT00465270|39445805|FG001|Overall Study|Death|11|||
16262084|NCT00465270|39445804|FG000|Overall Study|Withdrawal by Subject|34|||
16262085|NCT00465270|39445805|FG001|Overall Study|Withdrawal by Subject|78|||
16262086|NCT00465270|39445804|FG000|Overall Study|Lost to Follow-up|60|||
16262087|NCT00465270|39445805|FG001|Overall Study|Lost to Follow-up|67|||
16262088|NCT00465270|39445804|FG000|Overall Study|Investigator request|3|||
16262089|NCT00465270|39445805|FG001|Overall Study|Investigator request|4|||
16262090|NCT00950989|39445806|FG000|Overall Study|Death|0|||
16262091|NCT00950989|39445807|FG001|Overall Study|Death|0|||
16262092|NCT00950989|39445808|FG002|Overall Study|Death|1|||
16262093|NCT00950989|39445809|FG003|Overall Study|Death|0|||
16262094|NCT00950989|39445806|FG000|Overall Study|Administrative Decision|0|||
16262095|NCT00950989|39445807|FG001|Overall Study|Administrative Decision|1|||
16262096|NCT00950989|39445808|FG002|Overall Study|Administrative Decision|0|||
16262097|NCT00950989|39445809|FG003|Overall Study|Administrative Decision|0|||
16262098|NCT00950989|39445806|FG000|Overall Study|Disease Progression|0|||
16262099|NCT00950989|39445807|FG001|Overall Study|Disease Progression|0|||
16262100|NCT00950989|39445808|FG002|Overall Study|Disease Progression|1|||
16262101|NCT00950989|39445809|FG003|Overall Study|Disease Progression|0|||
16366101|NCT03679884|39825404|FG001|Overall Study|Lost to Follow-up|4|||
16262102|NCT00950989|39445806|FG000|Overall Study|Withdrawal by Subject|2|||
16262103|NCT00950989|39445807|FG001|Overall Study|Withdrawal by Subject|1|||
16262104|NCT00950989|39445808|FG002|Overall Study|Withdrawal by Subject|0|||
16262105|NCT00950989|39445809|FG003|Overall Study|Withdrawal by Subject|0|||
16262106|NCT00950989|39445806|FG000|Overall Study|Adverse Event|2|||
16262107|NCT00950989|39445807|FG001|Overall Study|Adverse Event|1|||
16366102|NCT03679884|39825405|FG002|Overall Study|Lost to Follow-up|2|||
16366103|NCT03679884|39825406|FG003|Overall Study|Lost to Follow-up|0|||
16366104|NCT03679884|39825407|FG004|Overall Study|Lost to Follow-up|3|||
16366105|NCT00514917|39825408|FG000|Overall Study|Death|4|||
16366106|NCT00514917|39825409|FG001|Overall Study|Death|10|||
16366107|NCT00514917|39825408|FG000|Overall Study|Protocol Violation|1|||
16366108|NCT00514917|39825409|FG001|Overall Study|Protocol Violation|0|||
16366109|NCT00514917|39825408|FG000|Overall Study|Lost to Follow-up|4|||
16366110|NCT00514917|39825409|FG001|Overall Study|Lost to Follow-up|3|||
16366111|NCT00514917|39825408|FG000|Overall Study|Withdrawal by Subject|18|||
16366112|NCT00514917|39825409|FG001|Overall Study|Withdrawal by Subject|16|||
16366113|NCT00514917|39825408|FG000|Overall Study|Discontinued due to study closure|88|||
16366114|NCT00514917|39825409|FG001|Overall Study|Discontinued due to study closure|81|||
16153301|NCT00262522|39048117|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
16153302|NCT00262522|39048118|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
16153303|NCT00262522|39048119|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
16153304|NCT00262522|39048116|FG000|Study Start Through 8 Weeks|Death|1|||
16153305|NCT00262522|39048117|FG001|Study Start Through 8 Weeks|Death|0|||
16153306|NCT00262522|39048118|FG002|Study Start Through 8 Weeks|Death|0|||
16153307|NCT00262522|39048119|FG003|Study Start Through 8 Weeks|Death|0|||
16153308|NCT00262522|39048116|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
16153309|NCT00262522|39048117|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
16153310|NCT00262522|39048118|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
16153311|NCT00262522|39048119|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
16153312|NCT00262522|39048116|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
16153313|NCT00262522|39048117|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
16153314|NCT00262522|39048118|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
16153315|NCT00262522|39048119|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
16153316|NCT00262522|39048116|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
16153317|NCT00262522|39048117|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
16153318|NCT00262522|39048118|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
16153319|NCT00262522|39048119|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
16153320|NCT00262522|39048116|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
16153321|NCT00262522|39048117|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
16153322|NCT00262522|39048118|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
16153323|NCT00262522|39048119|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
16153324|NCT00262522|39048116|FG000|Study Start Through 48 Weeks|Death|2|||
16153325|NCT00262522|39048117|FG001|Study Start Through 48 Weeks|Death|0|||
16153326|NCT00262522|39048118|FG002|Study Start Through 48 Weeks|Death|1|||
16153327|NCT00262522|39048119|FG003|Study Start Through 48 Weeks|Death|0|||
16153328|NCT00262522|39048116|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
16153329|NCT00262522|39048117|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
16153330|NCT00262522|39048118|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
16153331|NCT00262522|39048119|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
16153332|NCT00262522|39048116|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
16153333|NCT00262522|39048117|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
16153334|NCT00262522|39048118|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
16153335|NCT00262522|39048119|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
16366115|NCT00514917|39825408|FG000|Overall Study|Undefined|11|||
16366116|NCT00514917|39825409|FG001|Overall Study|Undefined|5|||
16366117|NCT00690898|39825411|FG000|SCREENING|Screen failure|18|||
16366118|NCT00690898|39825411|FG000|TREATMENT|Adverse Event|3|||
16262108|NCT00950989|39445808|FG002|Overall Study|Adverse Event|1|||
16262109|NCT00950989|39445809|FG003|Overall Study|Adverse Event|0|||
16262110|NCT00995410|39445810|FG000|Overall Study|Adverse Event|51|||
16262111|NCT00995410|39445810|FG000|Overall Study|Withdrawal by Subject|7|||
16262112|NCT00995410|39445810|FG000|Overall Study|Lost to Follow-up|2|||
16262113|NCT00995410|39445810|FG000|Overall Study|Misc|28|||
16262114|NCT02817841|39445813|FG000|Overall Study|Lost to Follow-up|287|||
16262115|NCT02817841|39445813|FG000|Overall Study|Withdrawal by Subject|183|||
16262116|NCT02817841|39445813|FG000|Overall Study|Adverse event not related to bleeding|131|||
16262117|NCT02817841|39445813|FG000|Overall Study|Adverse event related to bleeding|51|||
16262118|NCT02817841|39445813|FG000|Overall Study|Pregnancy|32|||
16262119|NCT02817841|39445813|FG000|Overall Study|Pregnancy wish|17|||
16262120|NCT02817841|39445813|FG000|Overall Study|Other reasons|53|||
16262121|NCT02817841|39445813|FG000|Overall Study|Protocol Violation|94|||
16262122|NCT01244620|39445814|FG000|Overall Study|Study terminated|4|||
16262123|NCT01244620|39445815|FG001|Overall Study|Study terminated|4|||
16262124|NCT01244620|39445816|FG002|Overall Study|Study terminated|4|||
16262125|NCT01244620|39445817|FG003|Overall Study|Study terminated|4|||
16262126|NCT00694551|39445825|FG000|Overall Study|Disease Progression|1|||
16262127|NCT00694551|39445826|FG001|Overall Study|Disease Progression|0|||
16262128|NCT00694551|39445827|FG002|Overall Study|Disease Progression|1|||
16262129|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Adverse Event|11|||
16262130|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Adverse Event|23|||
16262131|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Adverse Event|29|||
16262132|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Adverse Event|2|||
16262133|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Adverse Event|8|||
16262134|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
16262135|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
16262136|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
16262137|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
16262138|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
16262139|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
16262140|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
16262141|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
16262142|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
16262143|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
16262144|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
16262145|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
16262146|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
16262147|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
16262148|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
16262149|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
16262150|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
16262151|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
16262152|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
16262153|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
16262154|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
16262155|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
16366119|NCT00690898|39825411|FG000|TREATMENT|Lack of Efficacy|18|||
16262156|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
16262157|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
16262158|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
16262159|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
16262160|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
16262161|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
16262162|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
16262163|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
16262164|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Move|0|||
16262165|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Move|1|||
16262166|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Move|0|||
16262167|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Move|0|||
16262168|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Move|0|||
16262169|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
16262170|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
16262171|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
16262172|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
16262173|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
16262174|NCT00318461|39445828|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
16262175|NCT00318461|39445829|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
16262176|NCT00318461|39445830|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
16262177|NCT00318461|39445831|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
16262178|NCT00318461|39445832|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
16262179|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Work commitment|0|||
16262180|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Work commitment|0|||
16262181|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Work commitment|0|||
16262182|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Work commitment|0|||
16262183|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Work commitment|1|||
16262184|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Investigator decision|0|||
16262185|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Investigator decision|0|||
16262186|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Investigator decision|0|||
16262187|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Investigator decision|0|||
16262188|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Investigator decision|1|||
16262189|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Lack of time|1|||
16262190|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Lack of time|0|||
16262191|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Lack of time|0|||
16262192|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Lack of time|0|||
16262193|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Lack of time|0|||
16262194|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
16262195|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
16262196|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
16262197|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
16262198|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
16262199|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
16262200|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
16262201|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
16262202|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
16262203|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
16262204|NCT00318461|39445828|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
16262205|NCT00318461|39445829|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
16262206|NCT00318461|39445830|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
16262207|NCT00318461|39445831|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
16262208|NCT00318461|39445832|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
16262209|NCT00318461|39445828|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
16262210|NCT00318461|39445829|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
16262211|NCT00318461|39445830|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
16262212|NCT00318461|39445831|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
16262213|NCT00318461|39445832|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
16262214|NCT00318461|39445828|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
16262215|NCT00318461|39445829|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
16366120|NCT00690898|39825411|FG000|TREATMENT|Withdrawal by Subject|4|||
16262216|NCT00318461|39445830|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
16262217|NCT00318461|39445831|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
16262218|NCT00318461|39445832|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
16262219|NCT00318461|39445828|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
16262220|NCT00318461|39445829|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
16262221|NCT00318461|39445830|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
16262222|NCT00318461|39445831|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
16262223|NCT00318461|39445832|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
16262224|NCT00318461|39445828|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
16262225|NCT00318461|39445829|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
16262226|NCT00318461|39445830|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
16262227|NCT00318461|39445831|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
16262228|NCT00318461|39445832|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
16262229|NCT00318461|39445828|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
16262230|NCT00318461|39445829|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
16262231|NCT00318461|39445830|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
16262232|NCT00318461|39445831|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
16262233|NCT00318461|39445832|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
16262234|NCT04627038|39445838|FG000|Overall Study|Adverse Event|36|||
16262235|NCT04627038|39445839|FG001|Overall Study|Adverse Event|8|||
16262236|NCT04627038|39445838|FG000|Overall Study|Lost to Follow-up|1|||
16262237|NCT04627038|39445839|FG001|Overall Study|Lost to Follow-up|0|||
16262238|NCT04627038|39445838|FG000|Overall Study|Physician Decision|0|||
16262239|NCT04627038|39445839|FG001|Overall Study|Physician Decision|1|||
16262240|NCT04627038|39445838|FG000|Overall Study|Protocol Violation|3|||
16262241|NCT04627038|39445839|FG001|Overall Study|Protocol Violation|1|||
16262242|NCT04627038|39445838|FG000|Overall Study|Withdrawal by Subject|13|||
16262243|NCT04627038|39445839|FG001|Overall Study|Withdrawal by Subject|3|||
16262244|NCT04627038|39445838|FG000|Overall Study|Non-compliance with study drug|0|||
16262245|NCT04627038|39445839|FG001|Overall Study|Non-compliance with study drug|1|||
16262246|NCT04627038|39445838|FG000|Overall Study|Prohibited Concomitant Medication|1|||
16262247|NCT04627038|39445839|FG001|Overall Study|Prohibited Concomitant Medication|0|||
16262248|NCT02612337|39445840|FG000|Overall Study|Lack of Efficacy|1|||
16262249|NCT02612337|39445841|FG001|Overall Study|Lack of Efficacy|0|||
16262250|NCT02612337|39445840|FG000|Overall Study|Withdrawal by Subject|2|||
16262251|NCT02612337|39445841|FG001|Overall Study|Withdrawal by Subject|2|||
16366121|NCT00690898|39825411|FG000|TREATMENT|Other (not otherwise specified)|1|||
16366122|NCT01668537|39825414|FG000|Overall Study|Request to Discontinue Prematurely|1|||
16366123|NCT01668537|39825415|FG001|Overall Study|Request to Discontinue Prematurely|1|||
16366124|NCT01668537|39825414|FG000|Overall Study|Subject unwilling/unable to comply|5|||
16366125|NCT01668537|39825415|FG001|Overall Study|Subject unwilling/unable to comply|0|||
16366126|NCT01668537|39825414|FG000|Overall Study|Reason Precludes Participation|1|||
16366127|NCT01668537|39825415|FG001|Overall Study|Reason Precludes Participation|0|||
16366128|NCT01668537|39825414|FG000|Overall Study|Lost to Follow-up|13|||
16366129|NCT01668537|39825415|FG001|Overall Study|Lost to Follow-up|6|||
16366130|NCT01668537|39825414|FG000|Overall Study|Other|2|||
16366131|NCT01668537|39825415|FG001|Overall Study|Other|3|||
16366132|NCT02612155|39825417|FG000|Overall Study|Death|1|||
16366133|NCT02612155|39825418|FG001|Overall Study|Death|1|||
16366134|NCT02612155|39825417|FG000|Overall Study|Lost to Follow-up|2|||
16366135|NCT02612155|39825418|FG001|Overall Study|Lost to Follow-up|2|||
16366136|NCT01334515|39825419|FG000|Overall Study|Adverse Event|1|||
16366137|NCT01334515|39825420|FG001|Overall Study|Adverse Event|6|||
16366138|NCT01334515|39825419|FG000|Overall Study|Death|1|||
16366139|NCT01334515|39825420|FG001|Overall Study|Death|0|||
16366140|NCT01334515|39825419|FG000|Overall Study|Lack of Efficacy|8|||
16366141|NCT01334515|39825420|FG001|Overall Study|Lack of Efficacy|21|||
16366142|NCT01334515|39825419|FG000|Overall Study|Physician Decision|1|||
16366143|NCT01334515|39825420|FG001|Overall Study|Physician Decision|1|||
16366144|NCT01334515|39825419|FG000|Overall Study|Withdrawal by Subject|1|||
16366145|NCT01334515|39825420|FG001|Overall Study|Withdrawal by Subject|1|||
16366146|NCT02487199|39825427|FG000|Overall Study|Withdrew Consent|0|||
16366147|NCT02487199|39825428|FG001|Overall Study|Withdrew Consent|1|||
16366148|NCT00866320|39825429|FG000|Overall Study|Withdrawal by Subject|4|||
16366149|NCT00866320|39825429|FG000|Overall Study|Death|2|||
16366150|NCT01200355|39825430|FG000|Overall Study|Death|7|||
16366151|NCT01200355|39825431|FG001|Overall Study|Death|2|||
16366152|NCT00915525|39825432|FG000|Overall Study|Protocol Violation|9|||
16366153|NCT00915525|39825433|FG001|Overall Study|Protocol Violation|4|||
16366154|NCT00915525|39825432|FG000|Overall Study|Withdrawal by Subject|59|||
16366155|NCT00915525|39825433|FG001|Overall Study|Withdrawal by Subject|21|||
16366156|NCT00915525|39825432|FG000|Overall Study|Lost to Follow-up|27|||
16366157|NCT00915525|39825433|FG001|Overall Study|Lost to Follow-up|16|||
16262252|NCT02612337|39445840|FG000|Overall Study|Did not receive study drug|0|||
16262253|NCT02612337|39445841|FG001|Overall Study|Did not receive study drug|1|||
16153336|NCT00262522|39048116|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
16153337|NCT00262522|39048117|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
16153338|NCT00262522|39048118|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
16153339|NCT00262522|39048119|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
16443844|NCT05375929|40104359|FG001|Treatment Phase (12 Weeks)|Ongoing|15|||
16443845|NCT05375929|40104358|FG000|Treatment Phase (12 Weeks)|Adverse Event|1|||
16443846|NCT05375929|40104359|FG001|Treatment Phase (12 Weeks)|Adverse Event|0|||
16443847|NCT05375929|40104358|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
16443848|NCT05375929|40104359|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
16443849|NCT05375929|40104358|FG000|Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
16153340|NCT00262522|39048116|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
16153341|NCT00262522|39048117|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
16153342|NCT00262522|39048118|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
16153343|NCT00262522|39048119|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
16153344|NCT00262522|39048116|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
16153345|NCT00262522|39048117|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
16153346|NCT00262522|39048118|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
16153347|NCT00262522|39048119|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
16153348|NCT00262522|39048116|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
16153349|NCT00262522|39048117|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
16153350|NCT00262522|39048118|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
16153351|NCT00262522|39048119|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
16153352|NCT00262522|39048116|FG000|Study Start Through 96 Weeks|Death|2|||
16153353|NCT00262522|39048117|FG001|Study Start Through 96 Weeks|Death|0|||
16153354|NCT00262522|39048118|FG002|Study Start Through 96 Weeks|Death|2|||
16153355|NCT00262522|39048119|FG003|Study Start Through 96 Weeks|Death|0|||
16153356|NCT00262522|39048116|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
16153357|NCT00262522|39048117|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
16153358|NCT00262522|39048118|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
16153359|NCT00262522|39048119|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
16153360|NCT00262522|39048116|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
16153361|NCT00262522|39048117|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
16153362|NCT00262522|39048118|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
16153363|NCT00262522|39048119|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
16153364|NCT00762892|39048120|FG000|Overall Study|Lost to Follow-up|2|||
16153365|NCT00762892|39048121|FG001|Overall Study|Lost to Follow-up|5|||
16153366|NCT00762892|39048120|FG000|Overall Study|Withdrawal by Subject|0|||
16153367|NCT00762892|39048121|FG001|Overall Study|Withdrawal by Subject|1|||
16153368|NCT00762892|39048120|FG000|Overall Study|Death|1|||
16262254|NCT04419311|39445844|FG000|Overall Study|Lost to Follow-up|1|||
16262255|NCT04419311|39445845|FG001|Overall Study|Lost to Follow-up|0|||
16262256|NCT00772941|39445846|FG000|Overall Study|CRFs not available|195|||
16262257|NCT00772941|39445846|FG000|Overall Study|Study not completed|16|||
16262258|NCT00772941|39445846|FG000|Overall Study|Missed Visits|374|||
16262259|NCT00772941|39445846|FG000|Overall Study|Poor Compliance|7|||
16262260|NCT00772941|39445846|FG000|Overall Study|GPSP Violation|90|||
16262261|NCT05041361|39445848|FG000|Overall Study|Lost to Follow-up|1|||
16262262|NCT05041361|39445849|FG001|Overall Study|Lost to Follow-up|3|||
16262263|NCT00986245|39445850|FG000|First Intervention|Poor compliance|8|||
16262264|NCT00986245|39445851|FG001|First Intervention|Poor compliance|4|||
16262265|NCT00986245|39445850|FG000|First Intervention|Lack of Efficacy|1|||
16366158|NCT00915525|39825432|FG000|Overall Study|Pregnancy|2|||
16366159|NCT00915525|39825433|FG001|Overall Study|Pregnancy|0|||
16366160|NCT00915525|39825432|FG000|Overall Study|Lack of Efficacy|15|||
16366161|NCT00915525|39825433|FG001|Overall Study|Lack of Efficacy|32|||
16366162|NCT00915525|39825432|FG000|Overall Study|Adverse Event|29|||
16366163|NCT00915525|39825433|FG001|Overall Study|Adverse Event|13|||
16366164|NCT00915525|39825432|FG000|Overall Study|Missing|12|||
16366165|NCT00915525|39825433|FG001|Overall Study|Missing|1|||
16366166|NCT00915525|39825432|FG000|Overall Study|Other Reason|35|||
16366167|NCT00915525|39825433|FG001|Overall Study|Other Reason|12|||
16366168|NCT00915525|39825432|FG000|Overall Study|Site Closed|27|||
16366169|NCT00915525|39825433|FG001|Overall Study|Site Closed|9|||
16366170|NCT00915525|39825432|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
16366171|NCT00915525|39825433|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
16366172|NCT00915525|39825432|FG000|Overall Study|Study Burden|28|||
16366173|NCT00915525|39825433|FG001|Overall Study|Study Burden|12|||
16443850|NCT05375929|40104359|FG001|Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
16153369|NCT00762892|39048121|FG001|Overall Study|Death|0|||
16153370|NCT00762892|39048120|FG000|Overall Study|Pregnancy|1|||
16153371|NCT00762892|39048121|FG001|Overall Study|Pregnancy|0|||
16153372|NCT00762892|39048120|FG000|Overall Study|Incarceration|1|||
16153373|NCT00762892|39048121|FG001|Overall Study|Incarceration|0|||
16153374|NCT02193074|39048122|FG000|Overall Study|Withdrawal by Subject|1|||
16153375|NCT02193074|39048123|FG001|Overall Study|Withdrawal by Subject|2|||
16153376|NCT02193074|39048122|FG000|Overall Study|Adverse Event|16|||
16153377|NCT02193074|39048123|FG001|Overall Study|Adverse Event|13|||
16153378|NCT03313076|39048124|FG000|Overall Study|Withdrawal by Subject|2|||
16153379|NCT03313076|39048125|FG001|Overall Study|Withdrawal by Subject|0|||
16153380|NCT03313076|39048126|FG002|Overall Study|Withdrawal by Subject|0|||
16153381|NCT03313076|39048127|FG003|Overall Study|Withdrawal by Subject|0|||
16153382|NCT03313076|39048124|FG000|Overall Study|Lost to Follow-up|0|||
16153383|NCT03313076|39048125|FG001|Overall Study|Lost to Follow-up|2|||
16153384|NCT03313076|39048126|FG002|Overall Study|Lost to Follow-up|2|||
16153385|NCT03313076|39048127|FG003|Overall Study|Lost to Follow-up|2|||
16153386|NCT00957008|39048128|FG000|Overall Study|Withdrawal by Subject|13|||
16153387|NCT00957008|39048129|FG001|Overall Study|Withdrawal by Subject|10|||
16153388|NCT00957008|39048130|FG002|Overall Study|Withdrawal by Subject|12|||
16153389|NCT00957008|39048131|FG003|Overall Study|Withdrawal by Subject|16|||
16153390|NCT00957008|39048128|FG000|Overall Study|Lost to Follow-up|3|||
16153391|NCT00957008|39048129|FG001|Overall Study|Lost to Follow-up|1|||
16153392|NCT00957008|39048130|FG002|Overall Study|Lost to Follow-up|3|||
16153393|NCT00957008|39048131|FG003|Overall Study|Lost to Follow-up|4|||
16153394|NCT00957008|39048128|FG000|Overall Study|Physician Decision|1|||
16153395|NCT00957008|39048129|FG001|Overall Study|Physician Decision|0|||
16153396|NCT00957008|39048130|FG002|Overall Study|Physician Decision|1|||
16153397|NCT00957008|39048131|FG003|Overall Study|Physician Decision|1|||
16153398|NCT00957008|39048128|FG000|Overall Study|Relocated; Family conflict|4|||
16366174|NCT00915525|39825432|FG000|Overall Study|Non-Compliance|3|||
16153399|NCT00957008|39048129|FG001|Overall Study|Relocated; Family conflict|1|||
16153400|NCT00957008|39048130|FG002|Overall Study|Relocated; Family conflict|1|||
16153401|NCT00957008|39048131|FG003|Overall Study|Relocated; Family conflict|3|||
16153402|NCT02970292|39048132|FG000|Overall Study|Physician Decision|1|||
16153403|NCT02970292|39048133|FG001|Overall Study|Physician Decision|1|||
16153404|NCT02970292|39048132|FG000|Overall Study|Withdrawal by Subject|11|||
16153405|NCT02970292|39048133|FG001|Overall Study|Withdrawal by Subject|5|||
16366175|NCT00915525|39825433|FG001|Overall Study|Non-Compliance|1|||
16366176|NCT00915525|39825432|FG000|Overall Study|Patient Moved|15|||
16366177|NCT00915525|39825433|FG001|Overall Study|Patient Moved|9|||
16366178|NCT00460798|39825436|FG000|Overall Study|Death|59|||
16366179|NCT00460798|39825436|FG000|Overall Study|Adverse Event|27|||
16366180|NCT00460798|39825436|FG000|Overall Study|Lost to Follow-up|19|||
16366181|NCT00460798|39825436|FG000|Overall Study|Progressive Disease|99|||
16366182|NCT00460798|39825436|FG000|Overall Study|Other|27|||
16366183|NCT00460798|39825436|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
16366184|NCT00460798|39825436|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
16366185|NCT02852434|39825437|FG000|Overall Study|Withdrawal by Subject|0|||
16366186|NCT02852434|39825438|FG001|Overall Study|Withdrawal by Subject|1|||
16366187|NCT02852434|39825437|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
16366188|NCT02852434|39825438|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
16366189|NCT00509600|39825439|FG000|Overall Study|Adverse Event|1|||
16366190|NCT01013753|39825442|FG000|Overall Study|Adverse Event|8|||
16366191|NCT01013753|39825442|FG000|Overall Study|Protocol Violation|3|||
16366192|NCT01013753|39825442|FG000|Overall Study|Lost to Follow-up|1|||
16366193|NCT01013753|39825442|FG000|Overall Study|Withdrawal by Subject|2|||
16366194|NCT01013753|39825442|FG000|Overall Study|Other|2|||
16366195|NCT01452789|39825447|FG000|Overall Study|Withdrawal by Subject|3|||
16366196|NCT01452789|39825448|FG001|Overall Study|Withdrawal by Subject|2|||
16366197|NCT01026038|39825449|FG000|Overall Study|Lost to Follow-up|1|||
16366198|NCT01026038|39825450|FG001|Overall Study|Lost to Follow-up|1|||
16366199|NCT01026038|39825451|FG002|Overall Study|Lost to Follow-up|0|||
16366200|NCT00083915|39825454|FG000|Overall Study|Death|6|||
16366201|NCT00083915|39825455|FG001|Overall Study|Death|3|||
16366202|NCT00083915|39825454|FG000|Overall Study|Physician Decision|11|||
16366203|NCT00083915|39825455|FG001|Overall Study|Physician Decision|6|||
16366204|NCT00083915|39825454|FG000|Overall Study|Withdrawal by Subject|8|||
16366205|NCT00083915|39825455|FG001|Overall Study|Withdrawal by Subject|3|||
16366206|NCT00083915|39825454|FG000|Overall Study|disease progression|18|||
16366207|NCT00083915|39825455|FG001|Overall Study|disease progression|23|||
16366208|NCT00083915|39825454|FG000|Overall Study|Failure to collect|3|||
16366209|NCT00083915|39825455|FG001|Overall Study|Failure to collect|0|||
16153406|NCT02970292|39048132|FG000|Overall Study|Noncompliance with study drug|2|||
16153407|NCT02970292|39048133|FG001|Overall Study|Noncompliance with study drug|2|||
16153408|NCT02970292|39048132|FG000|Overall Study|Adverse Event|5|||
16153409|NCT02970292|39048133|FG001|Overall Study|Adverse Event|0|||
16153410|NCT02970292|39048132|FG000|Overall Study|Lack of Efficacy|1|||
16153411|NCT02970292|39048133|FG001|Overall Study|Lack of Efficacy|0|||
16153412|NCT02970292|39048132|FG000|Overall Study|Lost to Follow-up|1|||
16153413|NCT02970292|39048133|FG001|Overall Study|Lost to Follow-up|0|||
16153414|NCT02970292|39048132|FG000|Overall Study|Protocol Violation|2|||
16153415|NCT02970292|39048133|FG001|Overall Study|Protocol Violation|0|||
16153416|NCT02970292|39048132|FG000|Overall Study|Other|1|||
16153417|NCT02970292|39048133|FG001|Overall Study|Other|0|||
16153418|NCT00514514|39048134|FG000|Pre-phase|Death|10|||
16153419|NCT00514514|39048135|FG001|Pre-phase|Death|0|||
16153420|NCT00514514|39048136|FG002|Pre-phase|Death|0|||
16153421|NCT00514514|39048134|FG000|Pre-phase|administrative problems|2|||
16153422|NCT00514514|39048135|FG001|Pre-phase|administrative problems|0|||
16153423|NCT00514514|39048136|FG002|Pre-phase|administrative problems|0|||
16153424|NCT00514514|39048134|FG000|Pre-phase|Protocol Violation|6|||
16153425|NCT00514514|39048135|FG001|Pre-phase|Protocol Violation|0|||
16153426|NCT00514514|39048136|FG002|Pre-phase|Protocol Violation|0|||
16153427|NCT00514514|39048134|FG000|Pre-phase|condition no longer requires study drug|7|||
16153428|NCT00514514|39048135|FG001|Pre-phase|condition no longer requires study drug|0|||
16153429|NCT00514514|39048136|FG002|Pre-phase|condition no longer requires study drug|0|||
16366210|NCT00083915|39825454|FG000|Overall Study|No response|3|||
16153430|NCT00514514|39048134|FG000|Pre-phase|abnormal test procedure results|15|||
16153431|NCT00514514|39048135|FG001|Pre-phase|abnormal test procedure results|0|||
16153432|NCT00514514|39048136|FG002|Pre-phase|abnormal test procedure results|0|||
16153433|NCT00514514|39048134|FG000|Pre-phase|Lost to Follow-up|2|||
16153434|NCT00514514|39048135|FG001|Pre-phase|Lost to Follow-up|0|||
16153435|NCT00514514|39048136|FG002|Pre-phase|Lost to Follow-up|0|||
16153436|NCT00514514|39048134|FG000|Pre-phase|abnormal lab values|23|||
16153437|NCT00514514|39048135|FG001|Pre-phase|abnormal lab values|0|||
16153438|NCT00514514|39048136|FG002|Pre-phase|abnormal lab values|0|||
16153439|NCT00514514|39048134|FG000|Pre-phase|Lack of Efficacy|35|||
16153440|NCT00514514|39048135|FG001|Pre-phase|Lack of Efficacy|0|||
16153441|NCT00514514|39048136|FG002|Pre-phase|Lack of Efficacy|0|||
16153442|NCT00514514|39048134|FG000|Pre-phase|Adverse Event|137|||
16443851|NCT05375929|40104358|FG000|Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
16443852|NCT05375929|40104359|FG001|Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
16443853|NCT05375929|40104358|FG000|Follow-up (4 Weeks)|Lost to Follow-up|1|||
16443854|NCT05375929|40104359|FG001|Follow-up (4 Weeks)|Lost to Follow-up|0|||
16443855|NCT05375929|40104358|FG000|Follow-up (4 Weeks)|Did not complete study follow-up|0|||
16443856|NCT05375929|40104359|FG001|Follow-up (4 Weeks)|Did not complete study follow-up|1|||
16443857|NCT03221556|40104360|FG000|Allocation|post-randomization exclusion|0|||
16443858|NCT03221556|40104361|FG001|Allocation|post-randomization exclusion|1|||
16443859|NCT03221556|40104360|FG000|Follow-Up|Withdrawal by Subject|0|||
16443860|NCT03221556|40104361|FG001|Follow-Up|Withdrawal by Subject|1|||
16443861|NCT04780061|40104362|FG000|Overall Study|Withdrawal by Subject|5|||
16443862|NCT04780061|40104363|FG001|Overall Study|Withdrawal by Subject|8|||
16443863|NCT04780061|40104362|FG000|Overall Study|Adverse Event|2|||
16443864|NCT04780061|40104363|FG001|Overall Study|Adverse Event|2|||
16153443|NCT00514514|39048135|FG001|Pre-phase|Adverse Event|0|||
16366211|NCT00083915|39825455|FG001|Overall Study|No response|1|||
16443865|NCT04780061|40104362|FG000|Overall Study|Lost to Follow-up|1|||
16443866|NCT04780061|40104363|FG001|Overall Study|Lost to Follow-up|5|||
16366212|NCT00083915|39825454|FG000|Overall Study|Insurance issues|1|||
16366213|NCT00083915|39825455|FG001|Overall Study|Insurance issues|1|||
16366214|NCT03298061|39825460|FG000|Overall Study|Adverse Event|3|||
16366215|NCT03298061|39825460|FG000|Overall Study|Lack of Efficacy|6|||
16366216|NCT03298061|39825460|FG000|Overall Study|Protocol Violation|1|||
16366217|NCT03298061|39825460|FG000|Overall Study|Physician Decision|7|||
16366218|NCT03298061|39825460|FG000|Overall Study|Withdrawal by Subject|10|||
16366219|NCT02842866|39825462|FG000|Overall Study|Serious Adverse Event|0|||
16366220|NCT02842866|39825463|FG001|Overall Study|Serious Adverse Event|1|||
16366221|NCT02842866|39825462|FG000|Overall Study|Protocol Violation|4|||
16366222|NCT02842866|39825463|FG001|Overall Study|Protocol Violation|2|||
16366223|NCT02842866|39825462|FG000|Overall Study|Lost to Follow-up|2|||
16366224|NCT02842866|39825463|FG001|Overall Study|Lost to Follow-up|0|||
16366225|NCT02842866|39825462|FG000|Overall Study|Withdrawal by Subject|1|||
16366226|NCT02842866|39825463|FG001|Overall Study|Withdrawal by Subject|0|||
16366227|NCT04871113|39825464|FG000|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
16366228|NCT04871113|39825465|FG001|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
16366229|NCT04871113|39825466|FG002|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
16366230|NCT04871113|39825467|FG003|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
16366231|NCT04871113|39825468|FG004|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
16366232|NCT04871113|39825469|FG005|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|7|||
16366233|NCT04871113|39825470|FG006|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|5|||
16366234|NCT04871113|39825471|FG007|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
16366235|NCT04871113|39825472|FG008|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
16366236|NCT04871113|39825473|FG009|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
16366237|NCT04871113|39825464|FG000|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
16366238|NCT04871113|39825465|FG001|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
16366239|NCT04871113|39825466|FG002|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
16366240|NCT04871113|39825467|FG003|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
16366241|NCT04871113|39825468|FG004|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
16366242|NCT04871113|39825469|FG005|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
16366243|NCT04871113|39825470|FG006|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|1|||
16366244|NCT04871113|39825471|FG007|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
16366245|NCT04871113|39825472|FG008|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
16366246|NCT04871113|39825473|FG009|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
16366247|NCT01132755|39825476|FG000|Overall Study|Procedure not done due to medical reason|23|||
16366248|NCT01132755|39825476|FG000|Overall Study|Protocol Violation|15|||
16366249|NCT01132755|39825476|FG000|Overall Study|Withdrawal by Subject|4|||
16366250|NCT00864513|39825477|FG000|Overall Study|Withdrawal by Subject|3|||
16366251|NCT01970371|39825480|FG000|Overall Study|Death|8|||
16366252|NCT01970371|39825481|FG001|Overall Study|Death|13|||
16366253|NCT01970371|39825482|FG002|Overall Study|Death|12|||
16366254|NCT01970371|39825480|FG000|Overall Study|Lost to Follow-up|0|||
16443867|NCT03312231|40104366|FG000|Overall Study|Lost to Follow-up|2|||
16443868|NCT03312231|40104367|FG001|Overall Study|Lost to Follow-up|6|||
16366255|NCT01970371|39825481|FG001|Overall Study|Lost to Follow-up|0|||
16366256|NCT01970371|39825482|FG002|Overall Study|Lost to Follow-up|1|||
16153444|NCT00514514|39048136|FG002|Pre-phase|Adverse Event|0|||
16153445|NCT00514514|39048134|FG000|Pre-phase|Withdrawal by Subject|66|||
16153446|NCT00514514|39048135|FG001|Pre-phase|Withdrawal by Subject|0|||
16153447|NCT00514514|39048136|FG002|Pre-phase|Withdrawal by Subject|0|||
16153448|NCT00514514|39048134|FG000|Randomized - 9 Month|Death|3|||
16153449|NCT00514514|39048135|FG001|Randomized - 9 Month|Death|2|||
16153450|NCT00514514|39048136|FG002|Randomized - 9 Month|Death|2|||
16443869|NCT03312231|40104368|FG002|Overall Study|Lost to Follow-up|1|||
16153451|NCT00514514|39048134|FG000|Randomized - 9 Month|Administrative problems|1|||
16153452|NCT00514514|39048135|FG001|Randomized - 9 Month|Administrative problems|1|||
16153453|NCT00514514|39048136|FG002|Randomized - 9 Month|Administrative problems|2|||
16153454|NCT00514514|39048134|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
16153455|NCT00514514|39048135|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
16153456|NCT00514514|39048136|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
16153457|NCT00514514|39048134|FG000|Randomized - 9 Month|Protocol Violation|1|||
16153458|NCT00514514|39048135|FG001|Randomized - 9 Month|Protocol Violation|1|||
16153459|NCT00514514|39048136|FG002|Randomized - 9 Month|Protocol Violation|0|||
16153460|NCT00514514|39048134|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
16366257|NCT04795323|39825486|FG000|Overall Study|Did not interact with TARA|1|||
16366258|NCT04795323|39825487|FG001|Overall Study|Did not interact with TARA|0|||
16366259|NCT00393367|39825491|FG000|Overall Study|Protocol Violation|2|||
16366260|NCT00393367|39825492|FG001|Overall Study|Protocol Violation|5|||
16366261|NCT00393367|39825491|FG000|Overall Study|Withdrawal by Subject|0|||
16366262|NCT00393367|39825492|FG001|Overall Study|Withdrawal by Subject|2|||
16366263|NCT00250718|39825493|FG000|Overall Study|Death|1|||
16366264|NCT00250718|39825493|FG000|Overall Study|Adverse Event|1|||
16366265|NCT00250718|39825493|FG000|Overall Study|Withdrawal by Subject|1|||
16366266|NCT00407030|39825495|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
16366267|NCT00407030|39825496|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
16366268|NCT00407030|39825497|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
16366269|NCT00407030|39825495|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
16366270|NCT00407030|39825496|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
16366271|NCT00407030|39825497|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
16366272|NCT00407030|39825495|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
16366273|NCT00407030|39825496|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
16366274|NCT00407030|39825497|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
16366275|NCT00407030|39825495|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
16366276|NCT00407030|39825496|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
16366277|NCT00407030|39825497|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
16366278|NCT00407030|39825495|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
16366279|NCT00407030|39825496|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
16366280|NCT00407030|39825497|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
16366281|NCT00407030|39825495|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
16366282|NCT00407030|39825496|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
16366283|NCT00407030|39825497|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
16366284|NCT00407030|39825495|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
16366285|NCT00407030|39825496|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
16153461|NCT00514514|39048135|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
16153462|NCT00514514|39048136|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
16153463|NCT00514514|39048134|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
16153464|NCT00514514|39048135|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
16153465|NCT00514514|39048136|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
16153466|NCT00514514|39048134|FG000|Randomized - 9 Month|Adverse Event|25|||
16153467|NCT00514514|39048135|FG001|Randomized - 9 Month|Adverse Event|44|||
16153468|NCT00514514|39048136|FG002|Randomized - 9 Month|Adverse Event|27|||
16153469|NCT00514514|39048134|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
16153470|NCT00514514|39048135|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
16153471|NCT00514514|39048136|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
16153472|NCT00514514|39048134|FG000|Extension - 4 Years|Lost to Follow-up|12|||
16153473|NCT00514514|39048135|FG001|Extension - 4 Years|Lost to Follow-up|10|||
16153474|NCT00514514|39048136|FG002|Extension - 4 Years|Lost to Follow-up|9|||
16153475|NCT00514514|39048134|FG000|Extension - 4 Years|Administrative problems|3|||
16153476|NCT00514514|39048135|FG001|Extension - 4 Years|Administrative problems|1|||
16153477|NCT00514514|39048136|FG002|Extension - 4 Years|Administrative problems|1|||
16153478|NCT00514514|39048134|FG000|Extension - 4 Years|Death|8|||
16153479|NCT00514514|39048135|FG001|Extension - 4 Years|Death|3|||
16153480|NCT00514514|39048136|FG002|Extension - 4 Years|Death|6|||
16153481|NCT00514514|39048134|FG000|Extension - 4 Years|Adverse Event|9|||
16153482|NCT00514514|39048135|FG001|Extension - 4 Years|Adverse Event|6|||
16153483|NCT00514514|39048136|FG002|Extension - 4 Years|Adverse Event|3|||
16153484|NCT00925015|39048137|FG000|Overall Study|Adverse Event|1|||
16153485|NCT00925015|39048138|FG001|Overall Study|Adverse Event|2|||
16153486|NCT00925015|39048139|FG002|Overall Study|Adverse Event|1|||
16153487|NCT00925015|39048137|FG000|Overall Study|Physician Decision|0|||
16153488|NCT00925015|39048138|FG001|Overall Study|Physician Decision|1|||
16153489|NCT00925015|39048139|FG002|Overall Study|Physician Decision|0|||
16153490|NCT00925015|39048137|FG000|Overall Study|Progressive Disease|7|||
16153491|NCT00925015|39048138|FG001|Overall Study|Progressive Disease|3|||
16153492|NCT00925015|39048139|FG002|Overall Study|Progressive Disease|4|||
16153493|NCT00925015|39048137|FG000|Overall Study|Withdrawal by Subject|0|||
16153494|NCT00925015|39048138|FG001|Overall Study|Withdrawal by Subject|0|||
16153495|NCT00925015|39048139|FG002|Overall Study|Withdrawal by Subject|1|||
16153496|NCT04418076|39048140|FG000|Overall Study|Death|1|||
16153497|NCT04418076|39048141|FG001|Overall Study|Death|0|||
16153498|NCT04418076|39048142|FG002|Overall Study|Death|0|||
16153499|NCT04418076|39048143|FG003|Overall Study|Death|0|||
16153500|NCT04418076|39048140|FG000|Overall Study|Lost to Follow-up|2|||
16153501|NCT04418076|39048141|FG001|Overall Study|Lost to Follow-up|5|||
16153502|NCT04418076|39048142|FG002|Overall Study|Lost to Follow-up|1|||
16153503|NCT04418076|39048143|FG003|Overall Study|Lost to Follow-up|2|||
16153504|NCT04418076|39048140|FG000|Overall Study|Withdrawal by Subject|1|||
16153505|NCT04418076|39048141|FG001|Overall Study|Withdrawal by Subject|0|||
16153506|NCT04418076|39048142|FG002|Overall Study|Withdrawal by Subject|1|||
16153507|NCT04418076|39048143|FG003|Overall Study|Withdrawal by Subject|1|||
16153508|NCT04418076|39048140|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
16153509|NCT04418076|39048141|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
16153510|NCT04418076|39048142|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
16153511|NCT04418076|39048143|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
16153512|NCT01624662|39048144|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
16153513|NCT01624662|39048145|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
16153514|NCT01624662|39048146|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
16153515|NCT01624662|39048147|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
16153516|NCT01624662|39048144|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
16153517|NCT01624662|39048145|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
16153518|NCT01624662|39048146|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
16153519|NCT01624662|39048147|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
16153520|NCT01624662|39048144|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
16153521|NCT01624662|39048145|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
16153522|NCT01624662|39048146|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
16153523|NCT01624662|39048147|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
16262266|NCT00986245|39445851|FG001|First Intervention|Lack of Efficacy|2|||
16262267|NCT00986245|39445850|FG000|First Intervention|Withdrawal by Subject|0|||
16262268|NCT00986245|39445851|FG001|First Intervention|Withdrawal by Subject|1|||
16443870|NCT03312231|40104369|FG003|Overall Study|Lost to Follow-up|3|||
16443871|NCT03312231|40104370|FG004|Overall Study|Lost to Follow-up|1|||
16443872|NCT03312231|40104366|FG000|Overall Study|Withdrawal by Subject|0|||
16443873|NCT03312231|40104367|FG001|Overall Study|Withdrawal by Subject|3|||
16262269|NCT00986245|39445850|FG000|First Intervention|Protocol Violation|0|||
16262270|NCT00986245|39445851|FG001|First Intervention|Protocol Violation|1|||
16262271|NCT00986245|39445850|FG000|First Intervention|Out of indication|1|||
16262272|NCT00986245|39445851|FG001|First Intervention|Out of indication|0|||
16262273|NCT00986245|39445850|FG000|Second Intervention|Poor compliance|1|||
16262274|NCT00986245|39445851|FG001|Second Intervention|Poor compliance|0|||
16262275|NCT00986245|39445850|FG000|Second Intervention|Lost to Follow-up|1|||
16262276|NCT00986245|39445851|FG001|Second Intervention|Lost to Follow-up|0|||
16262277|NCT00986245|39445850|FG000|Second Intervention|Protocol Violation|0|||
16262278|NCT00986245|39445851|FG001|Second Intervention|Protocol Violation|1|||
16262279|NCT02724462|39445852|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
16262280|NCT02724462|39445853|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
16262281|NCT02724462|39445852|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
16262282|NCT02724462|39445853|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
16262283|NCT02724462|39445852|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
16262284|NCT02724462|39445853|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
16262285|NCT02724462|39445852|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
16262286|NCT02724462|39445853|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
16262287|NCT02724462|39445852|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
16262288|NCT02724462|39445853|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
16262289|NCT02724462|39445852|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
16262290|NCT02724462|39445853|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
16262291|NCT03707912|39445854|FG000|Overall Study|Violation of inclusion criteria|1|||
16262292|NCT03707912|39445855|FG001|Overall Study|Violation of inclusion criteria|0|||
16262293|NCT03020641|39445860|FG000|Overall Study|Lost to Follow-up|0|||
16262294|NCT03020641|39445861|FG001|Overall Study|Lost to Follow-up|1|||
16262295|NCT03020641|39445860|FG000|Overall Study|Converted to open surgery|2|||
16262296|NCT03020641|39445861|FG001|Overall Study|Converted to open surgery|1|||
16262297|NCT03020641|39445860|FG000|Overall Study|for surgery not performed|0|||
16262298|NCT03020641|39445861|FG001|Overall Study|for surgery not performed|1|||
16262299|NCT01265056|39445863|FG000|Initial Study Period|Withdrawal by Subject|1|||
16262300|NCT01265056|39445864|FG001|Initial Study Period|Withdrawal by Subject|1|||
16262301|NCT01265056|39445863|FG000|Initial Study Period|Withdrawal by Subject|1|||
16262302|NCT01265056|39445864|FG001|Initial Study Period|Withdrawal by Subject|1|||
16262303|NCT01265056|39445863|FG000|Follow up|Lost to Follow-up|7|||
16262304|NCT01265056|39445864|FG001|Follow up|Lost to Follow-up|3|||
16262305|NCT01136174|39445865|FG000|Overall Study|Adverse Event|0|||
16262306|NCT01136174|39445866|FG001|Overall Study|Adverse Event|0|||
16262307|NCT01136174|39445867|FG002|Overall Study|Adverse Event|0|||
16262308|NCT01136174|39445868|FG003|Overall Study|Adverse Event|4|||
16262309|NCT01629381|39445869|FG000|Overall Study|Withdrawal by Subject|2|||
16262310|NCT01629381|39445870|FG001|Overall Study|Withdrawal by Subject|5|||
16262311|NCT01185548|39445873|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
16262312|NCT03128723|39445880|FG000|Overall Study|Withdrawal by Subject|2|||
16262313|NCT01182415|39445884|FG000|Overall Study|Lost to Follow-up|1|||
16262314|NCT00102440|39445885|FG000|Overall Study|Lost to Follow-up|25|||
16262315|NCT00102440|39445886|FG001|Overall Study|Lost to Follow-up|18|||
16262316|NCT00102440|39445887|FG002|Overall Study|Lost to Follow-up|21|||
16262317|NCT00102440|39445885|FG000|Overall Study|Adverse Event|16|||
16262318|NCT00102440|39445886|FG001|Overall Study|Adverse Event|23|||
16262319|NCT00102440|39445887|FG002|Overall Study|Adverse Event|8|||
16262320|NCT00102440|39445885|FG000|Overall Study|Gout Flare|10|||
16262321|NCT00102440|39445886|FG001|Overall Study|Gout Flare|28|||
16262322|NCT00102440|39445887|FG002|Overall Study|Gout Flare|9|||
16262323|NCT00102440|39445885|FG000|Overall Study|Personal Reason(s)|19|||
16262324|NCT00102440|39445886|FG001|Overall Study|Personal Reason(s)|13|||
16262325|NCT00102440|39445887|FG002|Overall Study|Personal Reason(s)|13|||
16443874|NCT03312231|40104368|FG002|Overall Study|Withdrawal by Subject|1|||
16443875|NCT03312231|40104369|FG003|Overall Study|Withdrawal by Subject|0|||
16262326|NCT00102440|39445885|FG000|Overall Study|Other|11|||
16262327|NCT00102440|39445886|FG001|Overall Study|Other|14|||
16262328|NCT00102440|39445887|FG002|Overall Study|Other|14|||
16262329|NCT00102440|39445885|FG000|Overall Study|Protocol Violation|7|||
16262330|NCT00102440|39445886|FG001|Overall Study|Protocol Violation|2|||
16443876|NCT03312231|40104370|FG004|Overall Study|Withdrawal by Subject|0|||
16262331|NCT00102440|39445887|FG002|Overall Study|Protocol Violation|1|||
16262332|NCT03195491|39445888|FG000|Overall Study|Study drug toxicity|25|||
16262333|NCT03195491|39445889|FG001|Overall Study|Study drug toxicity|3|||
16262334|NCT03195491|39445888|FG000|Overall Study|Maximum clinical benefit|5|||
16262335|NCT03195491|39445889|FG001|Overall Study|Maximum clinical benefit|0|||
16262336|NCT03195491|39445888|FG000|Overall Study|Lost to Follow-up|1|||
16443877|NCT03312231|40104366|FG000|Overall Study|Death|0|||
16443878|NCT03312231|40104367|FG001|Overall Study|Death|1|||
16443879|NCT03312231|40104368|FG002|Overall Study|Death|1|||
16443880|NCT03312231|40104369|FG003|Overall Study|Death|0|||
16262337|NCT03195491|39445889|FG001|Overall Study|Lost to Follow-up|0|||
16262338|NCT03195491|39445888|FG000|Overall Study|Death|3|||
16262339|NCT03195491|39445889|FG001|Overall Study|Death|0|||
16262340|NCT03195491|39445888|FG000|Overall Study|Adverse event unrelated to study drug|19|||
16443881|NCT03312231|40104370|FG004|Overall Study|Death|0|||
16443882|NCT03312231|40104366|FG000|Overall Study|Study Vaccination not Received|1|||
16443883|NCT03312231|40104367|FG001|Overall Study|Study Vaccination not Received|1|||
16443884|NCT03312231|40104368|FG002|Overall Study|Study Vaccination not Received|1|||
16443885|NCT03312231|40104369|FG003|Overall Study|Study Vaccination not Received|0|||
16443886|NCT03312231|40104370|FG004|Overall Study|Study Vaccination not Received|0|||
16443887|NCT04123470|40104375|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
16443888|NCT04123470|40104376|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
16262341|NCT03195491|39445889|FG001|Overall Study|Adverse event unrelated to study drug|2|||
16262342|NCT03195491|39445888|FG000|Overall Study|Disease progression|266|||
16262343|NCT03195491|39445889|FG001|Overall Study|Disease progression|8|||
16262344|NCT03195491|39445888|FG000|Overall Study|Other reasons|10|||
16262345|NCT03195491|39445889|FG001|Overall Study|Other reasons|0|||
16262346|NCT03195491|39445888|FG000|Overall Study|Participant withdrew consent|8|||
16262347|NCT03195491|39445889|FG001|Overall Study|Participant withdrew consent|1|||
16262348|NCT03195491|39445888|FG000|Overall Study|Participant no longer meets study criteria|0|||
16262349|NCT03195491|39445889|FG001|Overall Study|Participant no longer meets study criteria|1|||
16262350|NCT03195491|39445888|FG000|Overall Study|Participant request to discontinue study treatment|10|||
16262351|NCT03195491|39445889|FG001|Overall Study|Participant request to discontinue study treatment|0|||
16262352|NCT01841554|39445890|FG000|Overall Study|Death|7|||
16262353|NCT01841554|39445890|FG000|Overall Study|No Implantation|1|||
16262354|NCT01841554|39445890|FG000|Overall Study|Discontinued Follow Up|5|||
16443889|NCT04123470|40104375|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
16443890|NCT04123470|40104376|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
16443891|NCT04123470|40104375|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
16443892|NCT04123470|40104376|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
16443893|NCT04123470|40104375|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
16443894|NCT04123470|40104376|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
16262355|NCT01841554|39445890|FG000|Overall Study|Study exit due to secondary intervention|6|||
16262356|NCT00319735|39445891|FG000|Overall Study|Death|2|||
16262357|NCT02472366|39445892|FG000|Overall Study|Lost to Follow-up|1|||
16262358|NCT02472366|39445893|FG001|Overall Study|Lost to Follow-up|0|||
16262359|NCT01037114|39445894|FG000|Year 20|Others|1|||
16443895|NCT01724346|40104391|FG000|Overall Study|Death|42|||
16443896|NCT01724346|40104392|FG001|Overall Study|Death|42|||
16443897|NCT01724346|40104391|FG000|Overall Study|Lost to Follow-up|5|||
16443898|NCT01724346|40104392|FG001|Overall Study|Lost to Follow-up|1|||
16443899|NCT01724346|40104391|FG000|Overall Study|Withdrawal by Subject|27|||
16443900|NCT01724346|40104392|FG001|Overall Study|Withdrawal by Subject|19|||
16443901|NCT01724346|40104391|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
16443902|NCT01724346|40104392|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
16443903|NCT03435211|40104395|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
16262360|NCT03482882|39445902|FG000|Overall Study|Adverse Event|3|||
16153524|NCT01624662|39048144|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
16153525|NCT01624662|39048145|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
16153526|NCT01624662|39048146|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
16153527|NCT01624662|39048147|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
16153528|NCT01624662|39048144|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
16153529|NCT01624662|39048145|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
16153530|NCT01624662|39048146|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
16153531|NCT01624662|39048147|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
16153532|NCT01624662|39048144|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16153533|NCT01624662|39048145|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
16153534|NCT01624662|39048146|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16153535|NCT01624662|39048147|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16153536|NCT01624662|39048144|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
16153537|NCT01624662|39048145|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
16153538|NCT01624662|39048146|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
16153539|NCT01624662|39048147|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
16153540|NCT00939783|39048148|FG000|Overall Study|Death|6|||
16153541|NCT00939783|39048148|FG000|Overall Study|Adverse Event|39|||
16153542|NCT00939783|39048148|FG000|Overall Study|Study Terminated by Sponsor|498|||
16153543|NCT00939783|39048148|FG000|Overall Study|Withdrawal by Subject|78|||
16153544|NCT00939783|39048148|FG000|Overall Study|Other|16|||
16443904|NCT03997383|40104396|FG000|Double-blind Treatment Period|Adverse Event|4|||
16443905|NCT03997383|40104397|FG001|Double-blind Treatment Period|Adverse Event|3|||
16443906|NCT03997383|40104396|FG000|Double-blind Treatment Period|Death|4|||
16443907|NCT03997383|40104397|FG001|Double-blind Treatment Period|Death|4|||
16443908|NCT03997383|40104396|FG000|Double-blind Treatment Period|Physician Decision|2|||
16443909|NCT03997383|40104397|FG001|Double-blind Treatment Period|Physician Decision|0|||
16443910|NCT03997383|40104396|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
16443911|NCT03997383|40104397|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
16443912|NCT03997383|40104396|FG000|Open-label Extension Period|Ongoing|148|||
16153545|NCT00939783|39048148|FG000|Overall Study|Lost to Follow-up|8|||
16153546|NCT00939783|39048148|FG000|Overall Study|Protocol Violation|3|||
16153547|NCT00939783|39048148|FG000|Overall Study|Enrolled but not treated|1|||
16153548|NCT02236520|39048149|FG000|Overall Study|Physician Decision|0|||
16153549|NCT02236520|39048150|FG001|Overall Study|Physician Decision|5|||
16153550|NCT02236520|39048151|FG002|Overall Study|Physician Decision|0|||
16153551|NCT02236520|39048152|FG003|Overall Study|Physician Decision|0|||
16153552|NCT02236520|39048149|FG000|Overall Study|Withdrawal by Subject|1|||
16443913|NCT03997383|40104397|FG001|Open-label Extension Period|Ongoing|151|||
16443914|NCT03997383|40104396|FG000|Open-label Extension Period|Adverse Event|4|||
16443915|NCT03997383|40104397|FG001|Open-label Extension Period|Adverse Event|1|||
16443916|NCT03997383|40104396|FG000|Open-label Extension Period|Death|8|||
16443917|NCT03997383|40104397|FG001|Open-label Extension Period|Death|9|||
16443918|NCT03997383|40104396|FG000|Open-label Extension Period|Physician Decision|1|||
16443919|NCT03997383|40104397|FG001|Open-label Extension Period|Physician Decision|1|||
16443920|NCT03997383|40104396|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
16153553|NCT02236520|39048150|FG001|Overall Study|Withdrawal by Subject|0|||
16153554|NCT02236520|39048151|FG002|Overall Study|Withdrawal by Subject|0|||
16443921|NCT03997383|40104397|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
16443922|NCT03997383|40104396|FG000|Open-label Extension Period|Reason Not Specified|2|||
16443923|NCT03997383|40104397|FG001|Open-label Extension Period|Reason Not Specified|0|||
16443924|NCT02205736|40104398|FG000|Overall Study|Lost to Follow-up|106|||
16443925|NCT03497676|40104399|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
16443926|NCT03497676|40104400|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
16443927|NCT03497676|40104401|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
16443928|NCT03497676|40104402|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
16443929|NCT03497676|40104399|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
16443930|NCT03497676|40104400|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
16443931|NCT03497676|40104401|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
16443932|NCT03497676|40104402|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
16443933|NCT03497676|40104399|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
16443934|NCT03497676|40104400|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
16443935|NCT03497676|40104401|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
16443936|NCT03497676|40104402|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
16443937|NCT03497676|40104399|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
16443938|NCT03497676|40104400|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
16443939|NCT03497676|40104401|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
16153555|NCT02236520|39048152|FG003|Overall Study|Withdrawal by Subject|1|||
16153556|NCT02236520|39048149|FG000|Overall Study|Pregnancy|1|||
16153557|NCT02236520|39048150|FG001|Overall Study|Pregnancy|0|||
16153558|NCT02236520|39048151|FG002|Overall Study|Pregnancy|0|||
16153559|NCT02236520|39048152|FG003|Overall Study|Pregnancy|0|||
16153560|NCT01118351|39048157|FG000|Overall Study|Adverse Event|3|||
16153561|NCT01118351|39048157|FG000|Overall Study|Withdrawal by Subject|1|||
16153562|NCT00714285|39048158|FG000|Overall Study|Lost to Follow-up|0|||
16443940|NCT03497676|40104402|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
16153563|NCT00714285|39048159|FG001|Overall Study|Lost to Follow-up|2|||
16153564|NCT00714285|39048160|FG002|Overall Study|Lost to Follow-up|0|||
16366286|NCT00407030|39825497|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
16366287|NCT00407030|39825495|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
16366288|NCT00407030|39825496|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
16366289|NCT00407030|39825497|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
16366290|NCT00407030|39825495|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
16262361|NCT03482882|39445902|FG000|Overall Study|Lost to Follow-up|1|||
16262362|NCT03482882|39445902|FG000|Overall Study|Protocol Violation|2|||
16262363|NCT03482882|39445902|FG000|Overall Study|Not further specified|1|||
16262364|NCT01370733|39445903|FG000|Overall Study|Withdrawal by Subject|8|||
16262365|NCT01370733|39445904|FG001|Overall Study|Withdrawal by Subject|8|||
16262366|NCT01370733|39445903|FG000|Overall Study|Lost to Follow-up|3|||
16262367|NCT01370733|39445904|FG001|Overall Study|Lost to Follow-up|0|||
16262368|NCT01370733|39445903|FG000|Overall Study|Adverse Event|2|||
16262369|NCT01370733|39445904|FG001|Overall Study|Adverse Event|4|||
16262370|NCT01370733|39445903|FG000|Overall Study|Lack of Efficacy|3|||
16262371|NCT01370733|39445904|FG001|Overall Study|Lack of Efficacy|5|||
16262372|NCT01370733|39445903|FG000|Overall Study|Physician Decision|0|||
16262373|NCT01370733|39445904|FG001|Overall Study|Physician Decision|2|||
16262374|NCT01370733|39445903|FG000|Overall Study|Protocol Violation|1|||
16262375|NCT01370733|39445904|FG001|Overall Study|Protocol Violation|3|||
16262376|NCT00933686|39445905|FG000|Overall Study|Protocol Violation|0|||
16262377|NCT00933686|39445906|FG001|Overall Study|Protocol Violation|1|||
16262378|NCT00933686|39445905|FG000|Overall Study|Lost to Follow-up|2|||
16262379|NCT00933686|39445906|FG001|Overall Study|Lost to Follow-up|2|||
16262380|NCT00933686|39445905|FG000|Overall Study|Withdrawal by Subject|6|||
16262381|NCT00933686|39445906|FG001|Overall Study|Withdrawal by Subject|5|||
16366291|NCT00407030|39825496|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
16262382|NCT00933686|39445905|FG000|Overall Study|Adverse Event|1|||
16366292|NCT00407030|39825497|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
16366293|NCT00407030|39825495|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
16366294|NCT00407030|39825496|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
16366295|NCT00407030|39825497|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
16366296|NCT00407030|39825495|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
16366297|NCT00407030|39825496|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
16366298|NCT00407030|39825497|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
16366299|NCT00407030|39825495|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
16366300|NCT00407030|39825496|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
16366301|NCT00407030|39825497|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
16366302|NCT00407030|39825495|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
16366303|NCT00407030|39825496|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
16366304|NCT00407030|39825497|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
16366305|NCT00986232|39825498|FG000|Overall Study|Adverse Event|1|||
16366306|NCT00986232|39825499|FG001|Overall Study|Adverse Event|2|||
16366307|NCT00986232|39825500|FG002|Overall Study|Adverse Event|3|||
16366308|NCT00986232|39825501|FG003|Overall Study|Adverse Event|0|||
16366309|NCT00986232|39825498|FG000|Overall Study|Lost to Follow-up|19|||
16366310|NCT00986232|39825499|FG001|Overall Study|Lost to Follow-up|12|||
16366311|NCT00986232|39825500|FG002|Overall Study|Lost to Follow-up|12|||
16366312|NCT00986232|39825501|FG003|Overall Study|Lost to Follow-up|7|||
16366313|NCT00986232|39825498|FG000|Overall Study|Protocol Violation|2|||
16366314|NCT00986232|39825499|FG001|Overall Study|Protocol Violation|3|||
16366315|NCT00986232|39825500|FG002|Overall Study|Protocol Violation|0|||
16366316|NCT00986232|39825501|FG003|Overall Study|Protocol Violation|1|||
16366317|NCT00986232|39825498|FG000|Overall Study|Withdrawal by Subject|13|||
16366318|NCT00986232|39825499|FG001|Overall Study|Withdrawal by Subject|16|||
16366319|NCT00986232|39825500|FG002|Overall Study|Withdrawal by Subject|12|||
16366320|NCT00986232|39825501|FG003|Overall Study|Withdrawal by Subject|3|||
16366321|NCT00986232|39825498|FG000|Overall Study|Missed one or more bleeds|13|||
16366322|NCT00986232|39825499|FG001|Overall Study|Missed one or more bleeds|10|||
16366323|NCT00986232|39825500|FG002|Overall Study|Missed one or more bleeds|6|||
16366324|NCT00986232|39825501|FG003|Overall Study|Missed one or more bleeds|7|||
16366325|NCT00986232|39825498|FG000|Overall Study|Incomplete safety follow-up|3|||
16366326|NCT00986232|39825499|FG001|Overall Study|Incomplete safety follow-up|7|||
16366327|NCT00986232|39825500|FG002|Overall Study|Incomplete safety follow-up|2|||
16366328|NCT00986232|39825501|FG003|Overall Study|Incomplete safety follow-up|2|||
16366329|NCT03207867|39825502|FG000|Overall Study|Adverse Event|1|||
16366330|NCT03207867|39825503|FG001|Overall Study|Adverse Event|0|||
16366331|NCT03207867|39825504|FG002|Overall Study|Adverse Event|1|||
16366332|NCT03207867|39825505|FG003|Overall Study|Adverse Event|0|||
16366333|NCT03207867|39825506|FG004|Overall Study|Adverse Event|0|||
16366334|NCT03207867|39825507|FG005|Overall Study|Adverse Event|2|||
16366335|NCT03207867|39825508|FG006|Overall Study|Adverse Event|1|||
16366336|NCT03207867|39825509|FG007|Overall Study|Adverse Event|1|||
16366337|NCT03207867|39825510|FG008|Overall Study|Adverse Event|2|||
16366338|NCT03207867|39825511|FG009|Overall Study|Adverse Event|2|||
16366339|NCT03207867|39825512|FG010|Overall Study|Adverse Event|0|||
16366340|NCT03207867|39825513|FG011|Overall Study|Adverse Event|0|||
16366341|NCT03207867|39825514|FG012|Overall Study|Adverse Event|0|||
16366342|NCT03207867|39825515|FG013|Overall Study|Adverse Event|0|||
16366343|NCT03207867|39825516|FG014|Overall Study|Adverse Event|0|||
16366344|NCT03207867|39825517|FG015|Overall Study|Adverse Event|0|||
16366345|NCT03207867|39825518|FG016|Overall Study|Adverse Event|3|||
16366346|NCT03207867|39825519|FG017|Overall Study|Adverse Event|1|||
16366347|NCT03207867|39825520|FG018|Overall Study|Adverse Event|2|||
16366348|NCT03207867|39825521|FG019|Overall Study|Adverse Event|1|||
16366349|NCT03207867|39825522|FG020|Overall Study|Adverse Event|0|||
16366350|NCT03207867|39825523|FG021|Overall Study|Adverse Event|0|||
16366351|NCT03207867|39825524|FG022|Overall Study|Adverse Event|0|||
16366352|NCT03207867|39825525|FG023|Overall Study|Adverse Event|0|||
16366353|NCT03207867|39825502|FG000|Overall Study|Death|0|||
16366354|NCT03207867|39825503|FG001|Overall Study|Death|0|||
16366355|NCT03207867|39825504|FG002|Overall Study|Death|0|||
16366356|NCT03207867|39825505|FG003|Overall Study|Death|0|||
16366357|NCT03207867|39825506|FG004|Overall Study|Death|0|||
16366358|NCT03207867|39825507|FG005|Overall Study|Death|1|||
16366359|NCT03207867|39825508|FG006|Overall Study|Death|0|||
16366360|NCT03207867|39825509|FG007|Overall Study|Death|3|||
16366361|NCT03207867|39825510|FG008|Overall Study|Death|1|||
16366362|NCT03207867|39825511|FG009|Overall Study|Death|2|||
16366363|NCT03207867|39825512|FG010|Overall Study|Death|0|||
16366364|NCT03207867|39825513|FG011|Overall Study|Death|1|||
16366365|NCT03207867|39825514|FG012|Overall Study|Death|0|||
16366366|NCT03207867|39825515|FG013|Overall Study|Death|1|||
16366367|NCT03207867|39825516|FG014|Overall Study|Death|0|||
16366368|NCT03207867|39825517|FG015|Overall Study|Death|0|||
16366369|NCT03207867|39825518|FG016|Overall Study|Death|0|||
16366370|NCT03207867|39825519|FG017|Overall Study|Death|2|||
16366371|NCT03207867|39825520|FG018|Overall Study|Death|0|||
16366372|NCT03207867|39825521|FG019|Overall Study|Death|1|||
16366373|NCT03207867|39825522|FG020|Overall Study|Death|0|||
16366374|NCT03207867|39825523|FG021|Overall Study|Death|0|||
16366375|NCT03207867|39825524|FG022|Overall Study|Death|0|||
16366376|NCT03207867|39825525|FG023|Overall Study|Death|0|||
16366377|NCT03207867|39825502|FG000|Overall Study|Physician Decision|3|||
16366378|NCT03207867|39825503|FG001|Overall Study|Physician Decision|5|||
16153565|NCT00714285|39048161|FG003|Overall Study|Lost to Follow-up|1|||
16262383|NCT00933686|39445906|FG001|Overall Study|Adverse Event|1|||
16366379|NCT03207867|39825504|FG002|Overall Study|Physician Decision|0|||
16153566|NCT00714285|39048158|FG000|Overall Study|Migrated/moved from study area|0|||
16153567|NCT00714285|39048159|FG001|Overall Study|Migrated/moved from study area|1|||
16153568|NCT00714285|39048160|FG002|Overall Study|Migrated/moved from study area|0|||
16262384|NCT00933686|39445905|FG000|Overall Study|Physician Decision|1|||
16366380|NCT03207867|39825505|FG003|Overall Study|Physician Decision|3|||
16366381|NCT03207867|39825506|FG004|Overall Study|Physician Decision|2|||
16366382|NCT03207867|39825507|FG005|Overall Study|Physician Decision|0|||
16366383|NCT03207867|39825508|FG006|Overall Study|Physician Decision|0|||
16366384|NCT03207867|39825509|FG007|Overall Study|Physician Decision|0|||
16366385|NCT03207867|39825510|FG008|Overall Study|Physician Decision|4|||
16366386|NCT03207867|39825511|FG009|Overall Study|Physician Decision|2|||
16366387|NCT03207867|39825512|FG010|Overall Study|Physician Decision|0|||
16366388|NCT03207867|39825513|FG011|Overall Study|Physician Decision|4|||
16366389|NCT03207867|39825514|FG012|Overall Study|Physician Decision|0|||
16366390|NCT03207867|39825515|FG013|Overall Study|Physician Decision|0|||
16366391|NCT03207867|39825516|FG014|Overall Study|Physician Decision|2|||
16366392|NCT03207867|39825517|FG015|Overall Study|Physician Decision|1|||
16366393|NCT03207867|39825518|FG016|Overall Study|Physician Decision|1|||
16366394|NCT03207867|39825519|FG017|Overall Study|Physician Decision|2|||
16366395|NCT03207867|39825520|FG018|Overall Study|Physician Decision|1|||
16366396|NCT03207867|39825521|FG019|Overall Study|Physician Decision|3|||
16366397|NCT03207867|39825522|FG020|Overall Study|Physician Decision|0|||
16366398|NCT03207867|39825523|FG021|Overall Study|Physician Decision|0|||
16366399|NCT03207867|39825524|FG022|Overall Study|Physician Decision|0|||
16366400|NCT03207867|39825525|FG023|Overall Study|Physician Decision|0|||
16153569|NCT00714285|39048161|FG003|Overall Study|Migrated/moved from study area|0|||
16153570|NCT03357731|39048164|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
16153571|NCT03357731|39048165|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
16153572|NCT03357731|39048166|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
16153573|NCT03357731|39048167|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
16153574|NCT03357731|39048168|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
16153575|NCT03357731|39048169|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
16153576|NCT03357731|39048164|FG000|Overall Study|Acute bradycardia and hypotension|0|||
16153577|NCT03357731|39048165|FG001|Overall Study|Acute bradycardia and hypotension|0|||
16153578|NCT03357731|39048166|FG002|Overall Study|Acute bradycardia and hypotension|0|||
16153579|NCT03357731|39048167|FG003|Overall Study|Acute bradycardia and hypotension|1|||
16153580|NCT03357731|39048168|FG004|Overall Study|Acute bradycardia and hypotension|0|||
16153581|NCT03357731|39048169|FG005|Overall Study|Acute bradycardia and hypotension|0|||
16153582|NCT03357731|39048164|FG000|Overall Study|Adverse Event|0|||
16153583|NCT03357731|39048165|FG001|Overall Study|Adverse Event|0|||
16153584|NCT03357731|39048166|FG002|Overall Study|Adverse Event|0|||
16153585|NCT03357731|39048167|FG003|Overall Study|Adverse Event|0|||
16153586|NCT03357731|39048168|FG004|Overall Study|Adverse Event|0|||
16153587|NCT03357731|39048169|FG005|Overall Study|Adverse Event|1|||
16153588|NCT03357731|39048164|FG000|Overall Study|Hypotension|0|||
16153589|NCT03357731|39048165|FG001|Overall Study|Hypotension|0|||
16153590|NCT03357731|39048166|FG002|Overall Study|Hypotension|1|||
16153591|NCT03357731|39048167|FG003|Overall Study|Hypotension|1|||
16153592|NCT03357731|39048168|FG004|Overall Study|Hypotension|0|||
16153593|NCT03357731|39048169|FG005|Overall Study|Hypotension|0|||
16153594|NCT03357731|39048164|FG000|Overall Study|Lost to Follow-up|0|||
16153595|NCT03357731|39048165|FG001|Overall Study|Lost to Follow-up|0|||
16153596|NCT03357731|39048166|FG002|Overall Study|Lost to Follow-up|0|||
16153597|NCT03357731|39048167|FG003|Overall Study|Lost to Follow-up|1|||
16153598|NCT03357731|39048168|FG004|Overall Study|Lost to Follow-up|0|||
16153599|NCT03357731|39048169|FG005|Overall Study|Lost to Follow-up|0|||
16153600|NCT00833053|39048170|FG000|Overall Study|Adverse Event|4|||
16153601|NCT00833053|39048171|FG001|Overall Study|Adverse Event|0|||
16443941|NCT03497676|40104399|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
16443942|NCT03497676|40104400|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
16443943|NCT03497676|40104401|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
16443944|NCT03497676|40104402|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
16443945|NCT03497676|40104399|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
16443946|NCT03497676|40104400|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
16443947|NCT03497676|40104401|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
16443948|NCT03497676|40104402|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
16443949|NCT03497676|40104399|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
16443950|NCT03497676|40104400|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
16443951|NCT03497676|40104401|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
16443952|NCT03497676|40104402|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
16443953|NCT03497676|40104399|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
16443954|NCT03497676|40104400|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
16443955|NCT03497676|40104401|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
16443956|NCT03497676|40104402|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
16443957|NCT00829426|40104412|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
16443958|NCT00829426|40104413|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
16443959|NCT02611687|40104414|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
16443960|NCT02611687|40104415|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
16443961|NCT04583618|40104416|FG000|Overall Study|Adverse Event|0|||
16443962|NCT04583618|40104417|FG001|Overall Study|Adverse Event|0|||
16443963|NCT04583618|40104418|FG002|Overall Study|Adverse Event|1|||
16443964|NCT04583618|40104419|FG003|Overall Study|Adverse Event|0|||
16443965|NCT04583618|40104420|FG004|Overall Study|Adverse Event|0|||
16443966|NCT04583618|40104416|FG000|Overall Study|Protocol deviation|1|||
16443967|NCT04583618|40104417|FG001|Overall Study|Protocol deviation|1|||
16443968|NCT04583618|40104418|FG002|Overall Study|Protocol deviation|1|||
16443969|NCT04583618|40104419|FG003|Overall Study|Protocol deviation|0|||
16443970|NCT04583618|40104420|FG004|Overall Study|Protocol deviation|0|||
16443971|NCT04583618|40104416|FG000|Overall Study|Withdrawal by Subject|2|||
16443972|NCT04583618|40104417|FG001|Overall Study|Withdrawal by Subject|1|||
16443973|NCT04583618|40104418|FG002|Overall Study|Withdrawal by Subject|3|||
16443974|NCT04583618|40104419|FG003|Overall Study|Withdrawal by Subject|1|||
16443975|NCT04583618|40104420|FG004|Overall Study|Withdrawal by Subject|1|||
16443976|NCT04583618|40104416|FG000|Overall Study|Lost to Follow-up|0|||
16443977|NCT04583618|40104417|FG001|Overall Study|Lost to Follow-up|1|||
16443978|NCT04583618|40104418|FG002|Overall Study|Lost to Follow-up|3|||
16443979|NCT04583618|40104419|FG003|Overall Study|Lost to Follow-up|1|||
16443980|NCT04583618|40104420|FG004|Overall Study|Lost to Follow-up|1|||
16443981|NCT04576988|40104421|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
16443982|NCT04576988|40104422|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
16443983|NCT04576988|40104421|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
16443984|NCT04576988|40104422|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
16443985|NCT04576988|40104421|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
16443986|NCT04576988|40104422|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
16443987|NCT04576988|40104421|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
16443988|NCT04576988|40104422|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
16443989|NCT04576988|40104421|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
16443990|NCT04576988|40104422|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
16443991|NCT04576988|40104421|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
16443992|NCT04576988|40104422|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
16443993|NCT04576988|40104421|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
16443994|NCT04576988|40104422|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
16443995|NCT04576988|40104421|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
16443996|NCT04576988|40104422|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
16443997|NCT04576988|40104421|FG000|Long Term Double Blind (LTDB)|Death|2|||
16443998|NCT04576988|40104422|FG001|Long Term Double Blind (LTDB)|Death|1|||
16443999|NCT04576988|40104421|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
16444000|NCT04576988|40104422|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
16444001|NCT01473134|40104423|FG000|Overall Study|Lost to Follow-up|21|||
16444002|NCT01473134|40104424|FG001|Overall Study|Lost to Follow-up|13|||
16444003|NCT01473134|40104423|FG000|Overall Study|Protocol Violation|32|||
16444004|NCT01473134|40104424|FG001|Overall Study|Protocol Violation|19|||
16444005|NCT01473134|40104423|FG000|Overall Study|Withdrawal by Subject|1|||
16444006|NCT01473134|40104424|FG001|Overall Study|Withdrawal by Subject|2|||
16444007|NCT01473134|40104423|FG000|Overall Study|Death|0|||
16444008|NCT01473134|40104424|FG001|Overall Study|Death|1|||
16444009|NCT01473134|40104423|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
16444010|NCT01473134|40104424|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
16153602|NCT00833053|39048170|FG000|Overall Study|Treatment Failure|3|||
16153603|NCT00833053|39048171|FG001|Overall Study|Treatment Failure|1|||
16153604|NCT00833053|39048170|FG000|Overall Study|Withdrawal by Subject|0|||
16153605|NCT00833053|39048171|FG001|Overall Study|Withdrawal by Subject|1|||
16153606|NCT00833053|39048170|FG000|Overall Study|Protocol Violation|2|||
16153607|NCT00833053|39048171|FG001|Overall Study|Protocol Violation|1|||
16153608|NCT02199080|39048172|FG000|Overall Study|Protocol Violation|12|||
16153609|NCT00346073|39048173|FG000|Overall Study|Serious Adverse Event|2|||
16153610|NCT00346073|39048174|FG001|Overall Study|Serious Adverse Event|0|||
16153611|NCT00346073|39048173|FG000|Overall Study|Lost to Follow-up|39|||
16153612|NCT00346073|39048174|FG001|Overall Study|Lost to Follow-up|24|||
16153613|NCT02255422|39048177|FG000|Overall Study|Withdrawal by Subject|0|||
16153614|NCT02255422|39048178|FG001|Overall Study|Withdrawal by Subject|0|||
16153615|NCT02255422|39048179|FG002|Overall Study|Withdrawal by Subject|0|||
16153616|NCT02255422|39048180|FG003|Overall Study|Withdrawal by Subject|0|||
16153617|NCT02255422|39048181|FG004|Overall Study|Withdrawal by Subject|0|||
16153618|NCT02255422|39048182|FG005|Overall Study|Withdrawal by Subject|0|||
16153619|NCT02255422|39048183|FG006|Overall Study|Withdrawal by Subject|2|||
16153620|NCT02255422|39048177|FG000|Overall Study|Lost to Follow-up|0|||
16153621|NCT02255422|39048178|FG001|Overall Study|Lost to Follow-up|0|||
16153622|NCT02255422|39048179|FG002|Overall Study|Lost to Follow-up|1|||
16153623|NCT02255422|39048180|FG003|Overall Study|Lost to Follow-up|0|||
16153624|NCT02255422|39048181|FG004|Overall Study|Lost to Follow-up|0|||
16153625|NCT02255422|39048182|FG005|Overall Study|Lost to Follow-up|0|||
16153626|NCT02255422|39048183|FG006|Overall Study|Lost to Follow-up|0|||
16153627|NCT04360551|39048184|FG000|Overall Study|Withdrawal by Subject|1|||
16153628|NCT04360551|39048185|FG001|Overall Study|Withdrawal by Subject|0|||
16153629|NCT04225923|39048188|FG000|Overall Study|Protocol Violation|1|||
16153630|NCT04225923|39048189|FG001|Overall Study|Protocol Violation|0|||
16153631|NCT04225923|39048190|FG002|Overall Study|Protocol Violation|1|||
16153632|NCT04225923|39048188|FG000|Overall Study|Withdrawal by Subject|4|||
16153633|NCT04225923|39048189|FG001|Overall Study|Withdrawal by Subject|1|||
16153634|NCT04225923|39048190|FG002|Overall Study|Withdrawal by Subject|3|||
16153635|NCT04225923|39048188|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
16153636|NCT04225923|39048189|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
16153637|NCT04225923|39048190|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
16153638|NCT03286842|39048195|FG000|Overall Study|Patients rolled over to another study|80|||
16153639|NCT04688775|39048196|FG000|Placebo-controlled Period|Randomized, not treated|1|||
16153640|NCT04688775|39048197|FG001|Placebo-controlled Period|Randomized, not treated|1|||
16153641|NCT04688775|39048198|FG002|Placebo-controlled Period|Randomized, not treated|0|||
16153642|NCT04688775|39048199|FG003|Placebo-controlled Period|Randomized, not treated|0|||
16153643|NCT04688775|39048196|FG000|Placebo-controlled Period|Adverse Event|2|||
16153644|NCT04688775|39048197|FG001|Placebo-controlled Period|Adverse Event|0|||
16153645|NCT04688775|39048198|FG002|Placebo-controlled Period|Adverse Event|0|||
16153646|NCT04688775|39048199|FG003|Placebo-controlled Period|Adverse Event|0|||
16153647|NCT04688775|39048196|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
16153648|NCT04688775|39048197|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
16153649|NCT04688775|39048198|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
16153650|NCT04688775|39048199|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
16153651|NCT04688775|39048196|FG000|Placebo-controlled Period|Protocol Violation|0|||
16153652|NCT04688775|39048197|FG001|Placebo-controlled Period|Protocol Violation|1|||
16153653|NCT04688775|39048198|FG002|Placebo-controlled Period|Protocol Violation|0|||
16153654|NCT04688775|39048199|FG003|Placebo-controlled Period|Protocol Violation|0|||
16153655|NCT04688775|39048196|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
16153656|NCT04688775|39048197|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
16153657|NCT04688775|39048198|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
16153658|NCT04688775|39048199|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
16153659|NCT04688775|39048196|FG000|Placebo-controlled Period|Other reasons|0|||
16153660|NCT04688775|39048197|FG001|Placebo-controlled Period|Other reasons|1|||
16153661|NCT04688775|39048198|FG002|Placebo-controlled Period|Other reasons|0|||
16153662|NCT04688775|39048199|FG003|Placebo-controlled Period|Other reasons|0|||
16153663|NCT04688775|39048196|FG000|Delayed Start Period|Adverse Event|0|||
16153664|NCT04688775|39048197|FG001|Delayed Start Period|Adverse Event|0|||
16153665|NCT04688775|39048198|FG002|Delayed Start Period|Adverse Event|1|||
16153666|NCT04688775|39048199|FG003|Delayed Start Period|Adverse Event|0|||
16153667|NCT04688775|39048196|FG000|Delayed Start Period|Lack of Efficacy|0|||
16153668|NCT04688775|39048197|FG001|Delayed Start Period|Lack of Efficacy|0|||
16153669|NCT04688775|39048198|FG002|Delayed Start Period|Lack of Efficacy|0|||
16153670|NCT04688775|39048199|FG003|Delayed Start Period|Lack of Efficacy|3|||
16153671|NCT04688775|39048196|FG000|Delayed Start Period|Withdrawal by Subject|0|||
16153672|NCT04688775|39048197|FG001|Delayed Start Period|Withdrawal by Subject|0|||
16262385|NCT00933686|39445906|FG001|Overall Study|Physician Decision|0|||
16262386|NCT00933686|39445905|FG000|Overall Study|Failure to show up at endpoint visits|0|||
16262387|NCT00933686|39445906|FG001|Overall Study|Failure to show up at endpoint visits|2|||
16262388|NCT02193165|39445907|FG000|4 Week Product Use|Lost to Follow-up|1|||
16262389|NCT02193165|39445908|FG001|4 Week Product Use|Lost to Follow-up|1|||
16262390|NCT02193165|39445909|FG002|4 Week Product Use|Lost to Follow-up|1|||
16262391|NCT02193165|39445907|FG000|6 Week Product Use|Lost to Follow-up|0|||
16262392|NCT02193165|39445908|FG001|6 Week Product Use|Lost to Follow-up|1|||
16262393|NCT02193165|39445909|FG002|6 Week Product Use|Lost to Follow-up|0|||
16262394|NCT01383486|39445911|FG000|Overall Study|Lost to Follow-up|10|||
16444011|NCT03043794|40104425|FG000|Overall Study|Lost to Follow-up|1|||
16444012|NCT04966013|40104426|FG000|Overall Study|Withdrawal by Subject|0|||
16444013|NCT04966013|40104427|FG001|Overall Study|Withdrawal by Subject|2|||
16444014|NCT04966013|40104428|FG002|Overall Study|Withdrawal by Subject|1|||
16444015|NCT04966013|40104426|FG000|Overall Study|Adverse Event|2|||
16444016|NCT04966013|40104427|FG001|Overall Study|Adverse Event|1|||
16444017|NCT04966013|40104428|FG002|Overall Study|Adverse Event|1|||
16444018|NCT01602666|40104429|FG000|Induction Chemotherapy|Death|2|||
16444019|NCT01602666|40104430|FG001|Induction Chemotherapy|Death|1|||
16444020|NCT01602666|40104429|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
16153673|NCT04688775|39048198|FG002|Delayed Start Period|Withdrawal by Subject|2|||
16444021|NCT01602666|40104430|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
16444022|NCT01602666|40104429|FG000|Induction Chemotherapy|Physician Decision|12|||
16444023|NCT01602666|40104430|FG001|Induction Chemotherapy|Physician Decision|5|||
16444024|NCT01602666|40104429|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
16444025|NCT01602666|40104430|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
16444026|NCT01602666|40104429|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
16444027|NCT01602666|40104430|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
16444028|NCT01602666|40104429|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
16444029|NCT01602666|40104430|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
16444030|NCT01602666|40104429|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
16444031|NCT01602666|40104430|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
16444032|NCT01602666|40104429|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
16444033|NCT01602666|40104430|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
16444034|NCT01602666|40104429|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
16444035|NCT01602666|40104430|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
16444036|NCT01602666|40104429|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
16444037|NCT01602666|40104430|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
16444038|NCT01602666|40104429|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
16262395|NCT01383486|39445911|FG000|Overall Study|Incomplete information for analysis|2|||
16262396|NCT01383486|39445911|FG000|Overall Study|Did not take any product|6|||
16262397|NCT03375463|39445912|FG000|Period 1|Lost to Follow-up|0|||
16262398|NCT03375463|39445913|FG001|Period 1|Lost to Follow-up|0|||
16262399|NCT03375463|39445914|FG002|Period 1|Lost to Follow-up|1|||
16262400|NCT03375463|39445915|FG003|Period 1|Lost to Follow-up|0|||
16262401|NCT03375463|39445916|FG004|Period 1|Lost to Follow-up|0|||
16262402|NCT03375463|39445917|FG005|Period 1|Lost to Follow-up|0|||
16262403|NCT03375463|39445912|FG000|Period 1|Adverse Event|0|||
16262404|NCT03375463|39445913|FG001|Period 1|Adverse Event|0|||
16262405|NCT03375463|39445914|FG002|Period 1|Adverse Event|0|||
16262406|NCT03375463|39445915|FG003|Period 1|Adverse Event|0|||
16262407|NCT03375463|39445916|FG004|Period 1|Adverse Event|1|||
16262408|NCT03375463|39445917|FG005|Period 1|Adverse Event|0|||
16262409|NCT03375463|39445912|FG000|Period 2|Lost to Follow-up|1|||
16262410|NCT03375463|39445913|FG001|Period 2|Lost to Follow-up|1|||
16262411|NCT03375463|39445914|FG002|Period 2|Lost to Follow-up|0|||
16262412|NCT03375463|39445915|FG003|Period 2|Lost to Follow-up|0|||
16262413|NCT03375463|39445916|FG004|Period 2|Lost to Follow-up|0|||
16262414|NCT03375463|39445917|FG005|Period 2|Lost to Follow-up|0|||
16262415|NCT02943447|39445919|FG000|Blinded Study Phase|Withdrew Consent|1|||
16262416|NCT02943447|39445920|FG001|Blinded Study Phase|Withdrew Consent|2|||
16262417|NCT02943447|39445921|FG002|Blinded Study Phase|Withdrew Consent|1|||
16262418|NCT02943447|39445919|FG000|Blinded Study Phase|Adverse Event|3|||
16262419|NCT02943447|39445920|FG001|Blinded Study Phase|Adverse Event|0|||
16262420|NCT02943447|39445921|FG002|Blinded Study Phase|Adverse Event|0|||
16262421|NCT02943447|39445919|FG000|Blinded Study Phase|Investigator's discretion|1|||
16262422|NCT02943447|39445920|FG001|Blinded Study Phase|Investigator's discretion|0|||
16262423|NCT02943447|39445921|FG002|Blinded Study Phase|Investigator's discretion|0|||
16262424|NCT02943447|39445919|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
16262425|NCT02943447|39445920|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
16262426|NCT02943447|39445921|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
16262427|NCT02943447|39445919|FG000|Open-Label Extension Phase|Adverse Event|4|||
16262428|NCT02943447|39445920|FG001|Open-Label Extension Phase|Adverse Event|7|||
16262429|NCT02943447|39445921|FG002|Open-Label Extension Phase|Adverse Event|3|||
16262430|NCT02943447|39445919|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
16262431|NCT02943447|39445920|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
16262432|NCT02943447|39445921|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
16262433|NCT02943447|39445919|FG000|Open-Label Extension Phase|Withdrew consent|1|||
16262434|NCT02943447|39445920|FG001|Open-Label Extension Phase|Withdrew consent|1|||
16262435|NCT02943447|39445921|FG002|Open-Label Extension Phase|Withdrew consent|1|||
16262436|NCT02943447|39445919|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
16262437|NCT02943447|39445920|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
16262438|NCT02943447|39445921|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
16262439|NCT02294786|39445922|FG000|Overall Study|Withdrawal by Subject|0|||
16262440|NCT02294786|39445923|FG001|Overall Study|Withdrawal by Subject|1|||
16262441|NCT02294786|39445922|FG000|Overall Study|Physician Decision|6|||
16262442|NCT02294786|39445923|FG001|Overall Study|Physician Decision|7|||
16153674|NCT04688775|39048199|FG003|Delayed Start Period|Withdrawal by Subject|4|||
16262443|NCT02294786|39445922|FG000|Overall Study|Lost to Follow-up|1|||
16262444|NCT02294786|39445923|FG001|Overall Study|Lost to Follow-up|2|||
16262445|NCT02294786|39445922|FG000|Overall Study|Protocol Violation|1|||
16262446|NCT02294786|39445923|FG001|Overall Study|Protocol Violation|0|||
16262447|NCT02294786|39445922|FG000|Overall Study|Adverse Event|1|||
16262448|NCT02294786|39445923|FG001|Overall Study|Adverse Event|1|||
16262449|NCT02294786|39445922|FG000|Overall Study|Death|2|||
16262450|NCT02294786|39445923|FG001|Overall Study|Death|3|||
16262451|NCT02422264|39445926|FG000|Overall Study|Serious Adverse Event|1|||
16262452|NCT02422264|39445927|FG001|Overall Study|Serious Adverse Event|0|||
16262453|NCT02422264|39445926|FG000|Overall Study|Withdrawal by Subject|1|||
16262454|NCT02422264|39445927|FG001|Overall Study|Withdrawal by Subject|2|||
16262455|NCT02422264|39445926|FG000|Overall Study|Migrated/moved from study area|3|||
16262456|NCT02422264|39445927|FG001|Overall Study|Migrated/moved from study area|1|||
16262457|NCT02422264|39445926|FG000|Overall Study|Subject vaccinated outside of the study|0|||
16262458|NCT02422264|39445927|FG001|Overall Study|Subject vaccinated outside of the study|1|||
16262459|NCT02646124|39445930|FG000|Overall Study|Lost to Follow-up|0|||
16262460|NCT02646124|39445931|FG001|Overall Study|Lost to Follow-up|2|||
16262461|NCT02445339|39445934|FG000|Overall Study|Physician Decision|1|||
16262462|NCT02445339|39445935|FG001|Overall Study|Physician Decision|0|||
16262463|NCT02445339|39445934|FG000|Overall Study|Lost to Follow-up|11|||
16262464|NCT02445339|39445935|FG001|Overall Study|Lost to Follow-up|15|||
16262465|NCT00468286|39445936|FG000|Overall Study|Adverse Event|1|||
16262466|NCT00468286|39445937|FG001|Overall Study|Adverse Event|6|||
16262467|NCT00468286|39445936|FG000|Overall Study|Protocol Violation|2|||
16262468|NCT00468286|39445937|FG001|Overall Study|Protocol Violation|2|||
16262469|NCT00468286|39445936|FG000|Overall Study|Withdrawal by Subject|4|||
16262470|NCT00468286|39445937|FG001|Overall Study|Withdrawal by Subject|3|||
16262471|NCT00468286|39445936|FG000|Overall Study|Physician Decision|0|||
16262472|NCT00468286|39445937|FG001|Overall Study|Physician Decision|1|||
16262473|NCT00448019|39445938|FG000|Overall Study|Withdrawal by Subject|3|||
16262474|NCT00448019|39445938|FG000|Overall Study|Disease progression|1|||
16262475|NCT00448019|39445938|FG000|Overall Study|Death|2|||
16262476|NCT00448019|39445938|FG000|Overall Study|Insurance Issues|1|||
16262477|NCT00505622|39445946|FG000|Overall Study|Adverse Event|5|||
16262478|NCT00505622|39445947|FG001|Overall Study|Adverse Event|6|||
16262479|NCT00505622|39445948|FG002|Overall Study|Adverse Event|4|||
16262480|NCT00505622|39445946|FG000|Overall Study|Protocol Violation|1|||
16262481|NCT00505622|39445947|FG001|Overall Study|Protocol Violation|1|||
16262482|NCT00505622|39445948|FG002|Overall Study|Protocol Violation|0|||
16262483|NCT00505622|39445946|FG000|Overall Study|Withdrawal by Subject|0|||
16262484|NCT00505622|39445947|FG001|Overall Study|Withdrawal by Subject|3|||
16262485|NCT00505622|39445948|FG002|Overall Study|Withdrawal by Subject|2|||
16262486|NCT00505622|39445946|FG000|Overall Study|Study termination by sponsor|115|||
16262487|NCT00505622|39445947|FG001|Overall Study|Study termination by sponsor|98|||
16262488|NCT00505622|39445948|FG002|Overall Study|Study termination by sponsor|90|||
16262489|NCT04185909|39445949|FG000|Overall Study|Lost to Follow-up|1|||
16262490|NCT02424097|39445950|FG000|Overall Study|Lost to Follow-up|1|||
16262491|NCT02424097|39445951|FG001|Overall Study|Lost to Follow-up|2|||
16262492|NCT02009163|39445953|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
16262493|NCT02009163|39445954|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
16262494|NCT02009163|39445955|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
16262495|NCT02009163|39445953|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
16262496|NCT02009163|39445954|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
16262497|NCT02009163|39445955|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
16262498|NCT02009163|39445953|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
16262499|NCT02009163|39445954|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
16262500|NCT02009163|39445955|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
16262501|NCT02009163|39445953|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
16262502|NCT02009163|39445954|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
16262503|NCT02009163|39445955|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
16262504|NCT02009163|39445953|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
16262505|NCT02009163|39445954|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
16262506|NCT02009163|39445955|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
16262507|NCT02009163|39445953|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
16366401|NCT03207867|39825502|FG000|Overall Study|Progressive Disease|7|||
16262508|NCT02009163|39445954|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
16262509|NCT02009163|39445955|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
16262510|NCT02009163|39445953|FG000|Open-label Period (Non-randomized)|Other|13|||
16262511|NCT02009163|39445954|FG001|Open-label Period (Non-randomized)|Other|0|||
16262512|NCT02009163|39445955|FG002|Open-label Period (Non-randomized)|Other|0|||
16262513|NCT02009163|39445953|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
16262514|NCT02009163|39445954|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
16262515|NCT02009163|39445955|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
16262516|NCT02009163|39445953|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
16262517|NCT02009163|39445954|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
16262518|NCT02009163|39445955|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
16262519|NCT02009163|39445953|FG000|Randomized-withdrawal Period|Adverse Event|0|||
16262520|NCT02009163|39445954|FG001|Randomized-withdrawal Period|Adverse Event|0|||
16262521|NCT02009163|39445955|FG002|Randomized-withdrawal Period|Adverse Event|6|||
16262522|NCT02009163|39445953|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
16262523|NCT02009163|39445954|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
16262524|NCT02009163|39445955|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
16262525|NCT02009163|39445953|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
16262526|NCT02009163|39445954|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
16262527|NCT02009163|39445955|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
16262528|NCT02009163|39445953|FG000|Randomized-withdrawal Period|Pregnancy|0|||
16262529|NCT02009163|39445954|FG001|Randomized-withdrawal Period|Pregnancy|0|||
16262530|NCT02009163|39445955|FG002|Randomized-withdrawal Period|Pregnancy|2|||
16262531|NCT02009163|39445953|FG000|Randomized-withdrawal Period|Other|0|||
16262532|NCT02009163|39445954|FG001|Randomized-withdrawal Period|Other|9|||
16262533|NCT02009163|39445955|FG002|Randomized-withdrawal Period|Other|5|||
16262534|NCT03020615|39445956|FG000|Overall Study|Physician Decision|3|||
16262535|NCT03020615|39445957|FG001|Overall Study|Physician Decision|1|||
16262536|NCT03020615|39445958|FG002|Overall Study|Physician Decision|2|||
16262537|NCT03020615|39445956|FG000|Overall Study|Parent/guardian/patient choice|3|||
16262538|NCT03020615|39445957|FG001|Overall Study|Parent/guardian/patient choice|0|||
16262539|NCT03020615|39445958|FG002|Overall Study|Parent/guardian/patient choice|4|||
16262540|NCT03020615|39445956|FG000|Overall Study|Screen failure|0|||
16262541|NCT03020615|39445957|FG001|Overall Study|Screen failure|0|||
16262542|NCT03020615|39445958|FG002|Overall Study|Screen failure|1|||
16262543|NCT03020615|39445956|FG000|Overall Study|Death|1|||
16262544|NCT03020615|39445957|FG001|Overall Study|Death|0|||
16262545|NCT03020615|39445958|FG002|Overall Study|Death|0|||
16262546|NCT03020615|39445956|FG000|Overall Study|Lost to Follow-up|0|||
16262547|NCT03020615|39445957|FG001|Overall Study|Lost to Follow-up|1|||
16262548|NCT03020615|39445958|FG002|Overall Study|Lost to Follow-up|0|||
16262549|NCT02979522|39445967|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
16262550|NCT02979522|39445968|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
16262551|NCT02979522|39445967|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
16262552|NCT02979522|39445968|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
16262553|NCT03041025|39445969|FG000|Overall Study|Adverse Event|0|||
16262554|NCT03041025|39445970|FG001|Overall Study|Adverse Event|0|||
16262555|NCT03041025|39445971|FG002|Overall Study|Adverse Event|1|||
16262556|NCT03041025|39445969|FG000|Overall Study|Lost to Follow-up|1|||
16262557|NCT03041025|39445970|FG001|Overall Study|Lost to Follow-up|0|||
16262558|NCT03041025|39445971|FG002|Overall Study|Lost to Follow-up|0|||
16262559|NCT03041025|39445969|FG000|Overall Study|Withdrawal by Subject|0|||
16262560|NCT03041025|39445970|FG001|Overall Study|Withdrawal by Subject|0|||
16262561|NCT03041025|39445971|FG002|Overall Study|Withdrawal by Subject|1|||
16262562|NCT02511782|39445978|FG000|Overall Study|Withdrawal by Subject|1|||
16262563|NCT02511782|39445979|FG001|Overall Study|Withdrawal by Subject|0|||
16262564|NCT02511782|39445980|FG002|Overall Study|Withdrawal by Subject|0|||
16262565|NCT03236311|39445981|FG000|Overall Study|Study terminated by sponsor|0|||
16262566|NCT03236311|39445982|FG001|Overall Study|Study terminated by sponsor|2|||
16262567|NCT03236311|39445981|FG000|Overall Study|Adverse Event|0|||
16262568|NCT03236311|39445982|FG001|Overall Study|Adverse Event|1|||
16366402|NCT03207867|39825503|FG001|Overall Study|Progressive Disease|7|||
16366403|NCT03207867|39825504|FG002|Overall Study|Progressive Disease|9|||
16366404|NCT03207867|39825505|FG003|Overall Study|Progressive Disease|10|||
16366405|NCT03207867|39825506|FG004|Overall Study|Progressive Disease|11|||
16366406|NCT03207867|39825507|FG005|Overall Study|Progressive Disease|10|||
16366407|NCT03207867|39825508|FG006|Overall Study|Progressive Disease|9|||
16366408|NCT03207867|39825509|FG007|Overall Study|Progressive Disease|8|||
16366409|NCT03207867|39825510|FG008|Overall Study|Progressive Disease|19|||
16366410|NCT03207867|39825511|FG009|Overall Study|Progressive Disease|23|||
16262569|NCT00365846|39445985|FG000|Overall Study|Lost to Follow-up|1|||
16366411|NCT03207867|39825512|FG010|Overall Study|Progressive Disease|2|||
16366412|NCT03207867|39825513|FG011|Overall Study|Progressive Disease|24|||
16366413|NCT03207867|39825514|FG012|Overall Study|Progressive Disease|3|||
16366414|NCT03207867|39825515|FG013|Overall Study|Progressive Disease|11|||
16366415|NCT03207867|39825516|FG014|Overall Study|Progressive Disease|9|||
16366416|NCT03207867|39825517|FG015|Overall Study|Progressive Disease|5|||
16444039|NCT01602666|40104430|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
16444040|NCT01648751|40104431|FG000|Overall Study|Withdrawal by Subject|2|||
16444041|NCT01648751|40104432|FG001|Overall Study|Withdrawal by Subject|3|||
16444042|NCT02991768|40104433|FG000|Overall Study|Physician Decision|4|||
16444043|NCT04076059|40104434|FG000|Double Blind Phase|Progressive disease|22|||
16444044|NCT04076059|40104435|FG001|Double Blind Phase|Progressive disease|26|||
16366417|NCT03207867|39825518|FG016|Overall Study|Progressive Disease|10|||
16366418|NCT03207867|39825519|FG017|Overall Study|Progressive Disease|14|||
16366419|NCT03207867|39825520|FG018|Overall Study|Progressive Disease|13|||
16366420|NCT03207867|39825521|FG019|Overall Study|Progressive Disease|14|||
16366421|NCT03207867|39825522|FG020|Overall Study|Progressive Disease|6|||
16366422|NCT03207867|39825523|FG021|Overall Study|Progressive Disease|3|||
16444045|NCT04076059|40104436|FG002|Double Blind Phase|Progressive disease|0|||
16444046|NCT04076059|40104434|FG000|Double Blind Phase|Withdrawal by Subject|4|||
16366423|NCT03207867|39825524|FG022|Overall Study|Progressive Disease|3|||
16262570|NCT02301975|39445986|FG000|Overall Study|Adverse Event|8|||
16444047|NCT04076059|40104435|FG001|Double Blind Phase|Withdrawal by Subject|11|||
16153675|NCT04688775|39048196|FG000|Delayed Start Period|Lost to Follow-up|0|||
16153676|NCT04688775|39048197|FG001|Delayed Start Period|Lost to Follow-up|0|||
16153677|NCT04688775|39048198|FG002|Delayed Start Period|Lost to Follow-up|2|||
16153678|NCT04688775|39048199|FG003|Delayed Start Period|Lost to Follow-up|1|||
16153679|NCT04688775|39048196|FG000|Delayed Start Period|other reasons|0|||
16153680|NCT04688775|39048197|FG001|Delayed Start Period|other reasons|0|||
16153681|NCT04688775|39048198|FG002|Delayed Start Period|other reasons|1|||
16153682|NCT04688775|39048199|FG003|Delayed Start Period|other reasons|0|||
16153683|NCT00137111|39048204|FG000|Total Therapy|Death|35|||
16153684|NCT00137111|39048205|FG001|Total Therapy|Death|0|||
16153685|NCT00137111|39048206|FG002|Total Therapy|Death|0|||
16153686|NCT00137111|39048207|FG003|Total Therapy|Death|0|||
16153687|NCT00137111|39048204|FG000|Total Therapy|Non Compliance|5|||
16153688|NCT00137111|39048205|FG001|Total Therapy|Non Compliance|0|||
16153689|NCT00137111|39048206|FG002|Total Therapy|Non Compliance|0|||
16153690|NCT00137111|39048207|FG003|Total Therapy|Non Compliance|0|||
16153691|NCT02250274|39048208|FG000|Overall Study|Insufficient blood draw amount|7|||
16153692|NCT02250274|39048209|FG001|Overall Study|Insufficient blood draw amount|6|||
16153693|NCT04153188|39048210|FG000|Overall Study|Lost to Follow-up|1|||
16153694|NCT04153188|39048211|FG001|Overall Study|Lost to Follow-up|1|||
16153695|NCT04153188|39048210|FG000|Overall Study|Withdrawal by Subject|2|||
16153696|NCT04153188|39048211|FG001|Overall Study|Withdrawal by Subject|0|||
16153697|NCT04153188|39048210|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
16153698|NCT04153188|39048211|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
16153699|NCT03703882|39048212|FG000|Overall Study|Adverse Event|1|||
16153700|NCT03703882|39048213|FG001|Overall Study|Adverse Event|0|||
16153701|NCT03703882|39048212|FG000|Overall Study|Lost to Follow-up|0|||
16153702|NCT03703882|39048213|FG001|Overall Study|Lost to Follow-up|2|||
16153703|NCT03703882|39048212|FG000|Overall Study|Non-compliance with study drug|0|||
16153704|NCT03703882|39048213|FG001|Overall Study|Non-compliance with study drug|1|||
16153705|NCT03703882|39048212|FG000|Overall Study|Physician Decision|0|||
16153706|NCT03703882|39048213|FG001|Overall Study|Physician Decision|1|||
16153707|NCT03703882|39048212|FG000|Overall Study|Progressive disease|1|||
16153708|NCT03703882|39048213|FG001|Overall Study|Progressive disease|0|||
16153709|NCT03703882|39048212|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16153710|NCT03703882|39048213|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16153711|NCT03703882|39048212|FG000|Overall Study|Starting another treatment|0|||
16153712|NCT03703882|39048213|FG001|Overall Study|Starting another treatment|1|||
16153713|NCT03703882|39048212|FG000|Overall Study|noncompliance with study procedures|0|||
16153714|NCT03703882|39048213|FG001|Overall Study|noncompliance with study procedures|1|||
16153715|NCT00250835|39048214|FG000|Overall Study|Withdrawal by Subject|1|||
16153716|NCT02830880|39048218|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
16153717|NCT02830880|39048218|FG000|Overall Study|Death|1|||
16153718|NCT02830880|39048218|FG000|Overall Study|Physician Decision|1|||
16153719|NCT02646982|39048221|FG000|Overall Study|Adverse Event|1|||
16444048|NCT04076059|40104436|FG002|Double Blind Phase|Withdrawal by Subject|0|||
16444049|NCT04076059|40104434|FG000|Double Blind Phase|Death|1|||
16444050|NCT04076059|40104435|FG001|Double Blind Phase|Death|1|||
16444051|NCT04076059|40104436|FG002|Double Blind Phase|Death|0|||
16444052|NCT04076059|40104434|FG000|Double Blind Phase|Lost to Follow-up|1|||
16444053|NCT04076059|40104435|FG001|Double Blind Phase|Lost to Follow-up|0|||
16444054|NCT04076059|40104436|FG002|Double Blind Phase|Lost to Follow-up|0|||
16444055|NCT04076059|40104434|FG000|Double Blind Phase|Adverse Event|5|||
16444056|NCT04076059|40104435|FG001|Double Blind Phase|Adverse Event|1|||
16444057|NCT04076059|40104436|FG002|Double Blind Phase|Adverse Event|0|||
16444058|NCT04076059|40104434|FG000|Double Blind Phase|Ongoing Participants|82|||
16444059|NCT04076059|40104435|FG001|Double Blind Phase|Ongoing Participants|18|||
16444060|NCT04076059|40104436|FG002|Double Blind Phase|Ongoing Participants|0|||
16444061|NCT04076059|40104434|FG000|Double Blind Phase|Miscellaneous|3|||
16444062|NCT04076059|40104435|FG001|Double Blind Phase|Miscellaneous|1|||
16153720|NCT02646982|39048222|FG001|Overall Study|Adverse Event|1|||
16153721|NCT02646982|39048221|FG000|Overall Study|Withdrawal by Subject|2|||
16153722|NCT02646982|39048222|FG001|Overall Study|Withdrawal by Subject|1|||
16153723|NCT01131676|39048223|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
16153724|NCT01131676|39048224|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
16153725|NCT01131676|39048225|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
16153726|NCT01131676|39048223|FG000|Discontinuation From Treatment|Not treated|4|||
16153727|NCT01131676|39048224|FG001|Discontinuation From Treatment|Not treated|2|||
16153728|NCT01131676|39048225|FG002|Discontinuation From Treatment|Not treated|2|||
16153729|NCT01131676|39048223|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
16153730|NCT01131676|39048224|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
16153731|NCT01131676|39048225|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
16153732|NCT01131676|39048223|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
16153733|NCT01131676|39048224|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
16153734|NCT01131676|39048225|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
16153735|NCT01131676|39048223|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
16153736|NCT01131676|39048224|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
16153737|NCT01131676|39048225|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
16153738|NCT01131676|39048223|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
16153739|NCT01131676|39048224|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
16153740|NCT01131676|39048225|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
16153741|NCT01131676|39048223|FG000|Discontinuation From Treatment|Other than those specified|162|||
16153742|NCT01131676|39048224|FG001|Discontinuation From Treatment|Other than those specified|142|||
16153743|NCT01131676|39048225|FG002|Discontinuation From Treatment|Other than those specified|125|||
16153744|NCT01131676|39048223|FG000|Discontinuation From Treatment|Adverse Event|303|||
16153745|NCT01131676|39048224|FG001|Discontinuation From Treatment|Adverse Event|267|||
16153746|NCT01131676|39048225|FG002|Discontinuation From Treatment|Adverse Event|273|||
16153747|NCT01131676|39048223|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
16153748|NCT01131676|39048224|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
16153749|NCT01131676|39048225|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
16153750|NCT01131676|39048223|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
16153751|NCT01131676|39048224|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
16153752|NCT01131676|39048225|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
16153753|NCT01131676|39048223|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
16153754|NCT01131676|39048224|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
16153755|NCT01131676|39048225|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
16153756|NCT01131676|39048223|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
16153757|NCT01131676|39048224|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
16153758|NCT01131676|39048225|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
16153759|NCT01131676|39048223|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
16153760|NCT01131676|39048224|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
16153761|NCT01131676|39048225|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
16153762|NCT01131676|39048223|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
16153763|NCT01131676|39048224|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
16153764|NCT01131676|39048225|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
16153765|NCT00790907|39048226|FG000|Overall Study|Adverse Event|9|||
16153766|NCT00790907|39048227|FG001|Overall Study|Adverse Event|7|||
16153767|NCT00790907|39048228|FG002|Overall Study|Adverse Event|6|||
16153768|NCT00790907|39048226|FG000|Overall Study|Physician Decision|304|||
16153769|NCT00790907|39048227|FG001|Overall Study|Physician Decision|271|||
16153770|NCT00790907|39048228|FG002|Overall Study|Physician Decision|255|||
16153771|NCT00790907|39048226|FG000|Overall Study|Withdrawal by Subject|1|||
16153772|NCT00790907|39048227|FG001|Overall Study|Withdrawal by Subject|7|||
16153773|NCT00790907|39048228|FG002|Overall Study|Withdrawal by Subject|5|||
16153774|NCT00790907|39048226|FG000|Overall Study|Bleeding Event|11|||
16153775|NCT00790907|39048227|FG001|Overall Study|Bleeding Event|16|||
16153776|NCT00790907|39048228|FG002|Overall Study|Bleeding Event|21|||
16153777|NCT00790907|39048226|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
16153778|NCT00790907|39048227|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
16153779|NCT00790907|39048228|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
16153780|NCT00790907|39048226|FG000|Overall Study|Qualifying Condition Not Present|29|||
16153781|NCT00790907|39048227|FG001|Overall Study|Qualifying Condition Not Present|14|||
16153782|NCT00790907|39048228|FG002|Overall Study|Qualifying Condition Not Present|16|||
16262571|NCT02301975|39445987|FG001|Overall Study|Adverse Event|3|||
16262572|NCT02301975|39445988|FG002|Overall Study|Adverse Event|2|||
16262573|NCT02301975|39445986|FG000|Overall Study|Lack of Efficacy|1|||
16153783|NCT00790907|39048226|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
16153784|NCT00790907|39048227|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
16153785|NCT00790907|39048228|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
16153786|NCT00790907|39048226|FG000|Overall Study|Did Not Receive Study Drug|10|||
16153787|NCT00790907|39048227|FG001|Overall Study|Did Not Receive Study Drug|0|||
16153788|NCT00790907|39048228|FG002|Overall Study|Did Not Receive Study Drug|0|||
16153789|NCT01439204|39048229|FG000|Overall Study|Withdrawal by Subject|0|||
16153790|NCT01439204|39048230|FG001|Overall Study|Withdrawal by Subject|1|||
16153791|NCT01439204|39048229|FG000|Overall Study|Lost to Follow-up|0|||
16153792|NCT01439204|39048230|FG001|Overall Study|Lost to Follow-up|2|||
16153793|NCT01439204|39048229|FG000|Overall Study|No longer meets study criteria|1|||
16153794|NCT01439204|39048230|FG001|Overall Study|No longer meets study criteria|0|||
16153795|NCT01439204|39048229|FG000|Overall Study|poor/non-compliance|3|||
16153796|NCT01439204|39048230|FG001|Overall Study|poor/non-compliance|0|||
16153797|NCT03073980|39048231|FG000|Overall Study|Lost to Follow-up|10|||
16153798|NCT03073980|39048232|FG001|Overall Study|Lost to Follow-up|2|||
16153799|NCT03073980|39048233|FG002|Overall Study|Lost to Follow-up|9|||
16153800|NCT03073980|39048231|FG000|Overall Study|No post-procedure data|0|||
16153801|NCT03073980|39048232|FG001|Overall Study|No post-procedure data|0|||
16153802|NCT03073980|39048233|FG002|Overall Study|No post-procedure data|2|||
16153803|NCT01417195|39048234|FG000|Overall Study|Stimulation failure|1|||
16153804|NCT01417195|39048235|FG001|Overall Study|Stimulation failure|0|||
16153805|NCT01417195|39048234|FG000|Overall Study|No embryos for transfer|0|||
16153806|NCT01417195|39048235|FG001|Overall Study|No embryos for transfer|1|||
16153807|NCT01417195|39048234|FG000|Overall Study|No transfer due to risk of OHSS|1|||
16153808|NCT01417195|39048235|FG001|Overall Study|No transfer due to risk of OHSS|0|||
16153809|NCT01417195|39048234|FG000|Overall Study|No transfer due to elevated progesterone|1|||
16153810|NCT01417195|39048235|FG001|Overall Study|No transfer due to elevated progesterone|0|||
16153811|NCT00545064|39048236|FG000|Overall Study|Lost to Follow-up|3|||
16153812|NCT00545064|39048236|FG000|Overall Study|Withdrawal by Subject|2|||
16153813|NCT00545064|39048236|FG000|Overall Study|did not complete course of treatment|1|||
16153814|NCT00545064|39048236|FG000|Overall Study|cancel all appointments, no rebooking|1|||
16153815|NCT00545064|39048236|FG000|Overall Study|inclement weather|1|||
16153816|NCT01246583|39048239|FG000|Overall Study|Lost to Follow-up|0|||
16153817|NCT01246583|39048240|FG001|Overall Study|Lost to Follow-up|0|||
16153818|NCT01246583|39048241|FG002|Overall Study|Lost to Follow-up|0|||
16153819|NCT01246583|39048242|FG003|Overall Study|Lost to Follow-up|1|||
16153820|NCT01246583|39048239|FG000|Overall Study|Protocol Violation|0|||
16153821|NCT01246583|39048240|FG001|Overall Study|Protocol Violation|0|||
16153822|NCT01246583|39048241|FG002|Overall Study|Protocol Violation|1|||
16153823|NCT01246583|39048242|FG003|Overall Study|Protocol Violation|0|||
16153824|NCT01246583|39048239|FG000|Overall Study|Withdrawal by Subject|1|||
16153825|NCT01246583|39048240|FG001|Overall Study|Withdrawal by Subject|0|||
16153826|NCT01246583|39048241|FG002|Overall Study|Withdrawal by Subject|0|||
16153827|NCT01246583|39048242|FG003|Overall Study|Withdrawal by Subject|0|||
16153828|NCT03782376|39048249|FG000|Overall Study|Lost to Follow-up|2|||
16153829|NCT03782376|39048250|FG001|Overall Study|Lost to Follow-up|2|||
16153830|NCT03782376|39048249|FG000|Overall Study|Withdrawal by Subject|7|||
16153831|NCT03782376|39048250|FG001|Overall Study|Withdrawal by Subject|11|||
16153832|NCT03782376|39048249|FG000|Overall Study|Death|1|||
16366424|NCT03207867|39825525|FG023|Overall Study|Progressive Disease|3|||
16366425|NCT03207867|39825502|FG000|Overall Study|Patient/guardian Decision|0|||
16366426|NCT03207867|39825503|FG001|Overall Study|Patient/guardian Decision|0|||
16153833|NCT03782376|39048250|FG001|Overall Study|Death|0|||
16153834|NCT03782376|39048249|FG000|Overall Study|Other|16|||
16153835|NCT03782376|39048250|FG001|Overall Study|Other|17|||
16153836|NCT00441974|39048251|FG000|Overall Study|Adverse Event|6|||
16262574|NCT02301975|39445987|FG001|Overall Study|Lack of Efficacy|1|||
16366427|NCT03207867|39825504|FG002|Overall Study|Patient/guardian Decision|1|||
16366428|NCT03207867|39825505|FG003|Overall Study|Patient/guardian Decision|1|||
16366429|NCT03207867|39825506|FG004|Overall Study|Patient/guardian Decision|1|||
16366430|NCT03207867|39825507|FG005|Overall Study|Patient/guardian Decision|2|||
16366431|NCT03207867|39825508|FG006|Overall Study|Patient/guardian Decision|1|||
16153837|NCT00441974|39048251|FG000|Overall Study|Consent Withdrawn|35|||
16153838|NCT00441974|39048251|FG000|Overall Study|Lost to Follow-up|80|||
16153839|NCT00441974|39048251|FG000|Overall Study|Protocol Violation|7|||
16153840|NCT05299359|39048256|FG000|Overall Study|Ongoing in Study|149|||
16366432|NCT03207867|39825509|FG007|Overall Study|Patient/guardian Decision|0|||
16153841|NCT05299359|39048256|FG000|Overall Study|Other|1|||
16153842|NCT01453855|39048257|FG000|Overall Study|Adverse Event|3|||
16153843|NCT01453855|39048258|FG001|Overall Study|Adverse Event|4|||
16153844|NCT01453855|39048257|FG000|Overall Study|Lost to Follow-up|2|||
16153845|NCT01453855|39048258|FG001|Overall Study|Lost to Follow-up|1|||
16153846|NCT01453855|39048257|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
16153847|NCT01453855|39048258|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
16153848|NCT01453855|39048257|FG000|Overall Study|Noncompliance|1|||
16153849|NCT01453855|39048258|FG001|Overall Study|Noncompliance|0|||
16153850|NCT01453855|39048257|FG000|Overall Study|Inadequate Control of IOP|1|||
16153851|NCT01453855|39048258|FG001|Overall Study|Inadequate Control of IOP|5|||
16153852|NCT01453855|39048257|FG000|Overall Study|Other|0|||
16153853|NCT01453855|39048258|FG001|Overall Study|Other|1|||
16153854|NCT02081534|39048259|FG000|Overall Study|Adverse Event|5|||
16153855|NCT02081534|39048260|FG001|Overall Study|Adverse Event|4|||
16153856|NCT02081534|39048261|FG002|Overall Study|Adverse Event|3|||
16153857|NCT02081534|39048262|FG003|Overall Study|Adverse Event|10|||
16153858|NCT02081534|39048263|FG004|Overall Study|Adverse Event|2|||
16153859|NCT02081534|39048264|FG005|Overall Study|Adverse Event|8|||
16153860|NCT02081534|39048265|FG006|Overall Study|Adverse Event|2|||
16153861|NCT02081534|39048259|FG000|Overall Study|Withdrawal by Subject|0|||
16153862|NCT02081534|39048260|FG001|Overall Study|Withdrawal by Subject|1|||
16153863|NCT02081534|39048261|FG002|Overall Study|Withdrawal by Subject|1|||
16153864|NCT02081534|39048262|FG003|Overall Study|Withdrawal by Subject|1|||
16153865|NCT02081534|39048263|FG004|Overall Study|Withdrawal by Subject|1|||
16153866|NCT02081534|39048264|FG005|Overall Study|Withdrawal by Subject|0|||
16153867|NCT02081534|39048265|FG006|Overall Study|Withdrawal by Subject|1|||
16153868|NCT02081534|39048259|FG000|Overall Study|Protocol Violation|0|||
16153869|NCT02081534|39048260|FG001|Overall Study|Protocol Violation|3|||
16153870|NCT02081534|39048261|FG002|Overall Study|Protocol Violation|0|||
16153871|NCT02081534|39048262|FG003|Overall Study|Protocol Violation|0|||
16153872|NCT02081534|39048263|FG004|Overall Study|Protocol Violation|0|||
16153873|NCT02081534|39048264|FG005|Overall Study|Protocol Violation|0|||
16153874|NCT02081534|39048265|FG006|Overall Study|Protocol Violation|1|||
16153875|NCT02081534|39048259|FG000|Overall Study|Lost to Follow-up|0|||
16153876|NCT02081534|39048260|FG001|Overall Study|Lost to Follow-up|0|||
16153877|NCT02081534|39048261|FG002|Overall Study|Lost to Follow-up|0|||
16262575|NCT02301975|39445988|FG002|Overall Study|Lack of Efficacy|1|||
16153878|NCT02081534|39048262|FG003|Overall Study|Lost to Follow-up|2|||
16153879|NCT02081534|39048263|FG004|Overall Study|Lost to Follow-up|1|||
16153880|NCT02081534|39048264|FG005|Overall Study|Lost to Follow-up|1|||
16153881|NCT02081534|39048265|FG006|Overall Study|Lost to Follow-up|0|||
16153882|NCT02443883|39048266|FG000|Overall Study|Adverse Event|0|||
16153883|NCT02443883|39048267|FG001|Overall Study|Adverse Event|1|||
16153884|NCT02443883|39048268|FG002|Overall Study|Adverse Event|0|||
16153885|NCT02443883|39048269|FG003|Overall Study|Adverse Event|0|||
16153886|NCT02443883|39048266|FG000|Overall Study|Lost to Follow-up|3|||
16153887|NCT02443883|39048267|FG001|Overall Study|Lost to Follow-up|2|||
16153888|NCT02443883|39048268|FG002|Overall Study|Lost to Follow-up|1|||
16153889|NCT02443883|39048269|FG003|Overall Study|Lost to Follow-up|0|||
16153890|NCT02443883|39048266|FG000|Overall Study|Physician Decision|1|||
16153891|NCT02443883|39048267|FG001|Overall Study|Physician Decision|1|||
16153892|NCT02443883|39048268|FG002|Overall Study|Physician Decision|0|||
16153893|NCT02443883|39048269|FG003|Overall Study|Physician Decision|3|||
16153894|NCT02443883|39048266|FG000|Overall Study|Withdrawal by Subject|1|||
16153895|NCT02443883|39048267|FG001|Overall Study|Withdrawal by Subject|0|||
16153896|NCT02443883|39048268|FG002|Overall Study|Withdrawal by Subject|0|||
16153897|NCT02443883|39048269|FG003|Overall Study|Withdrawal by Subject|2|||
16153898|NCT02443883|39048266|FG000|Overall Study|Randomized, but never treated|1|||
16153899|NCT02443883|39048267|FG001|Overall Study|Randomized, but never treated|0|||
16153900|NCT02443883|39048268|FG002|Overall Study|Randomized, but never treated|0|||
16153901|NCT02443883|39048269|FG003|Overall Study|Randomized, but never treated|0|||
16153902|NCT02187471|39048274|FG000|Overall Study|Protocol Violation|4|||
16262576|NCT02301975|39445986|FG000|Overall Study|Protocol Violation|3|||
16262577|NCT02301975|39445987|FG001|Overall Study|Protocol Violation|5|||
16262578|NCT02301975|39445988|FG002|Overall Study|Protocol Violation|3|||
16262579|NCT02301975|39445986|FG000|Overall Study|Lost to Follow-up|0|||
16262580|NCT02301975|39445987|FG001|Overall Study|Lost to Follow-up|2|||
16262581|NCT02301975|39445988|FG002|Overall Study|Lost to Follow-up|2|||
16262582|NCT02301975|39445986|FG000|Overall Study|Physician Decision|4|||
16262583|NCT02301975|39445987|FG001|Overall Study|Physician Decision|2|||
16262584|NCT02301975|39445988|FG002|Overall Study|Physician Decision|3|||
16262585|NCT02301975|39445986|FG000|Overall Study|Withdrawal by Subject|15|||
16262586|NCT02301975|39445987|FG001|Overall Study|Withdrawal by Subject|12|||
16262587|NCT02301975|39445988|FG002|Overall Study|Withdrawal by Subject|11|||
16366433|NCT03207867|39825510|FG008|Overall Study|Patient/guardian Decision|1|||
16366434|NCT03207867|39825511|FG009|Overall Study|Patient/guardian Decision|0|||
16153903|NCT02187471|39048275|FG001|Overall Study|Protocol Violation|5|||
16153904|NCT02187471|39048276|FG002|Overall Study|Protocol Violation|4|||
16153905|NCT02187471|39048277|FG003|Overall Study|Protocol Violation|4|||
16262588|NCT01959672|39445989|FG000|Overall Study|Death|1|||
16262589|NCT02255097|39445992|FG000|Overall Study|Death|151|||
16153906|NCT02187471|39048274|FG000|Overall Study|Missing|0|||
16153907|NCT02187471|39048275|FG001|Overall Study|Missing|0|||
16153908|NCT02187471|39048276|FG002|Overall Study|Missing|0|||
16153909|NCT02187471|39048277|FG003|Overall Study|Missing|1|||
16153910|NCT02187471|39048274|FG000|Overall Study|Lack of Efficacy|18|||
16153911|NCT02187471|39048275|FG001|Overall Study|Lack of Efficacy|9|||
16262590|NCT02255097|39445992|FG000|Overall Study|Lost to Follow-up|5|||
16153912|NCT02187471|39048276|FG002|Overall Study|Lack of Efficacy|13|||
16153913|NCT02187471|39048277|FG003|Overall Study|Lack of Efficacy|11|||
16153914|NCT02187471|39048274|FG000|Overall Study|Adverse Event|24|||
16153915|NCT02187471|39048275|FG001|Overall Study|Adverse Event|34|||
16153916|NCT02187471|39048276|FG002|Overall Study|Adverse Event|44|||
16153917|NCT02187471|39048277|FG003|Overall Study|Adverse Event|36|||
16153918|NCT02187471|39048274|FG000|Overall Study|Withdrawal by Subject|23|||
16153919|NCT02187471|39048275|FG001|Overall Study|Withdrawal by Subject|29|||
16153920|NCT02187471|39048276|FG002|Overall Study|Withdrawal by Subject|22|||
16153921|NCT02187471|39048277|FG003|Overall Study|Withdrawal by Subject|24|||
16153922|NCT02187471|39048274|FG000|Overall Study|Other|7|||
16153923|NCT02187471|39048275|FG001|Overall Study|Other|5|||
16153924|NCT02187471|39048276|FG002|Overall Study|Other|3|||
16153925|NCT02187471|39048277|FG003|Overall Study|Other|4|||
16153926|NCT02095535|39048278|FG000|Recruitment|Protocol Violation|2|||
16153927|NCT01087905|39048280|FG000|Overall Study|Lost to Follow-up|24|||
16153928|NCT01087905|39048281|FG001|Overall Study|Lost to Follow-up|28|||
16153929|NCT01087905|39048282|FG002|Overall Study|Lost to Follow-up|18|||
16153930|NCT01087905|39048283|FG003|Overall Study|Lost to Follow-up|31|||
16153931|NCT01087905|39048284|FG004|Overall Study|Lost to Follow-up|27|||
16153932|NCT01087905|39048285|FG005|Overall Study|Lost to Follow-up|25|||
16153933|NCT01087905|39048286|FG006|Overall Study|Lost to Follow-up|20|||
16153934|NCT01087905|39048287|FG007|Overall Study|Lost to Follow-up|24|||
16153935|NCT01087905|39048280|FG000|Overall Study|Withdrawal by Subject|5|||
16153936|NCT01087905|39048281|FG001|Overall Study|Withdrawal by Subject|4|||
16153937|NCT01087905|39048282|FG002|Overall Study|Withdrawal by Subject|4|||
16153938|NCT01087905|39048283|FG003|Overall Study|Withdrawal by Subject|5|||
16153939|NCT01087905|39048284|FG004|Overall Study|Withdrawal by Subject|4|||
16153940|NCT01087905|39048285|FG005|Overall Study|Withdrawal by Subject|3|||
16153941|NCT01087905|39048286|FG006|Overall Study|Withdrawal by Subject|3|||
16153942|NCT01087905|39048287|FG007|Overall Study|Withdrawal by Subject|5|||
16153943|NCT01508702|39048290|FG000|Overall Study|Adverse Event|7|||
16153944|NCT01508702|39048291|FG001|Overall Study|Adverse Event|3|||
16153945|NCT01508702|39048290|FG000|Overall Study|Gout flare|2|||
16153946|NCT01508702|39048291|FG001|Overall Study|Gout flare|0|||
16153947|NCT01508702|39048290|FG000|Overall Study|Protocol Violation|2|||
16153948|NCT01508702|39048291|FG001|Overall Study|Protocol Violation|1|||
16153949|NCT01508702|39048290|FG000|Overall Study|Lost to Follow-up|1|||
16153950|NCT01508702|39048291|FG001|Overall Study|Lost to Follow-up|2|||
16262591|NCT02255097|39445992|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
16262592|NCT02255097|39445992|FG000|Overall Study|Withdrawal by Subject|7|||
16262593|NCT02255097|39445992|FG000|Overall Study|Allocated but not treated|1|||
16262594|NCT00857623|39445993|FG000|Overall Study|Adverse Event|5|||
16262595|NCT00857623|39445994|FG001|Overall Study|Adverse Event|2|||
16262596|NCT00857623|39445993|FG000|Overall Study|Study-specific discontinuation criteria|5|||
16262597|NCT00857623|39445994|FG001|Overall Study|Study-specific discontinuation criteria|3|||
16262598|NCT00857623|39445993|FG000|Overall Study|Withdrawal by Subject|2|||
16262599|NCT00857623|39445994|FG001|Overall Study|Withdrawal by Subject|1|||
16262600|NCT00857623|39445993|FG000|Overall Study|Lack of Efficacy|1|||
16262601|NCT00857623|39445994|FG001|Overall Study|Lack of Efficacy|1|||
16262602|NCT00857623|39445993|FG000|Overall Study|Severe non-compliance to protocol|1|||
16262603|NCT00857623|39445994|FG001|Overall Study|Severe non-compliance to protocol|1|||
16262604|NCT00857623|39445993|FG000|Overall Study|Intake of prohibited medication|0|||
16262605|NCT00857623|39445994|FG001|Overall Study|Intake of prohibited medication|1|||
16262606|NCT00857623|39445993|FG000|Overall Study|Positive for HEP C|0|||
16262607|NCT00857623|39445994|FG001|Overall Study|Positive for HEP C|1|||
16262608|NCT02937870|39445996|FG000|Overall Study|Adverse Event|1|||
16262609|NCT02937870|39445996|FG000|Overall Study|Protocol Deviation|2|||
16262610|NCT03031847|39445997|FG000|Overall Study|Death|1|||
16366435|NCT03207867|39825512|FG010|Overall Study|Patient/guardian Decision|0|||
16153951|NCT01508702|39048290|FG000|Overall Study|Withdrawal by Subject|11|||
16153952|NCT01508702|39048291|FG001|Overall Study|Withdrawal by Subject|7|||
16153953|NCT01773109|39048293|FG000|Overall Study|Symptomatic Progression|2|||
16153954|NCT01773109|39048293|FG000|Overall Study|Death|1|||
16153955|NCT01970995|39048297|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
16153956|NCT01970995|39048298|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
16153957|NCT01970995|39048299|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
16153958|NCT01970995|39048297|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
16262611|NCT03031847|39445998|FG001|Overall Study|Death|1|||
16366436|NCT03207867|39825513|FG011|Overall Study|Patient/guardian Decision|1|||
16366437|NCT03207867|39825514|FG012|Overall Study|Patient/guardian Decision|0|||
16366438|NCT03207867|39825515|FG013|Overall Study|Patient/guardian Decision|1|||
16366439|NCT03207867|39825516|FG014|Overall Study|Patient/guardian Decision|2|||
16366440|NCT03207867|39825517|FG015|Overall Study|Patient/guardian Decision|0|||
16366441|NCT03207867|39825518|FG016|Overall Study|Patient/guardian Decision|1|||
16366442|NCT03207867|39825519|FG017|Overall Study|Patient/guardian Decision|3|||
16366443|NCT03207867|39825520|FG018|Overall Study|Patient/guardian Decision|4|||
16153959|NCT01970995|39048298|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
16153960|NCT01970995|39048299|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
16366444|NCT03207867|39825521|FG019|Overall Study|Patient/guardian Decision|1|||
16366445|NCT03207867|39825522|FG020|Overall Study|Patient/guardian Decision|0|||
16366446|NCT03207867|39825523|FG021|Overall Study|Patient/guardian Decision|0|||
16366447|NCT03207867|39825524|FG022|Overall Study|Patient/guardian Decision|0|||
16366448|NCT03207867|39825525|FG023|Overall Study|Patient/guardian Decision|0|||
16366449|NCT01104766|39825529|FG000|Overall Study|Did not meet inc/exc criteria|1|||
16366450|NCT01104766|39825530|FG001|Overall Study|Did not meet inc/exc criteria|0|||
16366451|NCT01104766|39825531|FG002|Overall Study|Did not meet inc/exc criteria|0|||
16366452|NCT01104766|39825532|FG003|Overall Study|Did not meet inc/exc criteria|0|||
16366453|NCT01104766|39825529|FG000|Overall Study|Adverse Event|17|||
16366454|NCT01104766|39825530|FG001|Overall Study|Adverse Event|15|||
16366455|NCT01104766|39825531|FG002|Overall Study|Adverse Event|20|||
16366456|NCT01104766|39825532|FG003|Overall Study|Adverse Event|14|||
16366457|NCT01104766|39825529|FG000|Overall Study|Lack of Efficacy|20|||
16366458|NCT01104766|39825530|FG001|Overall Study|Lack of Efficacy|15|||
16366459|NCT01104766|39825531|FG002|Overall Study|Lack of Efficacy|14|||
16366460|NCT01104766|39825532|FG003|Overall Study|Lack of Efficacy|8|||
16366461|NCT01104766|39825529|FG000|Overall Study|Protocol Violation|2|||
16366462|NCT01104766|39825530|FG001|Overall Study|Protocol Violation|0|||
16366463|NCT01104766|39825531|FG002|Overall Study|Protocol Violation|0|||
16366464|NCT01104766|39825532|FG003|Overall Study|Protocol Violation|0|||
16366465|NCT01104766|39825529|FG000|Overall Study|Withdrawal by Subject|17|||
16366466|NCT01104766|39825530|FG001|Overall Study|Withdrawal by Subject|19|||
16366467|NCT01104766|39825531|FG002|Overall Study|Withdrawal by Subject|25|||
16366468|NCT01104766|39825532|FG003|Overall Study|Withdrawal by Subject|15|||
16366469|NCT01104766|39825529|FG000|Overall Study|Lost to Follow-up|1|||
16366470|NCT01104766|39825530|FG001|Overall Study|Lost to Follow-up|2|||
16366471|NCT01104766|39825531|FG002|Overall Study|Lost to Follow-up|1|||
16366472|NCT01104766|39825532|FG003|Overall Study|Lost to Follow-up|1|||
16366473|NCT03684057|39825533|FG000|Overall Study|Withdrawal by Subject|4|||
16366474|NCT03684057|39825534|FG001|Overall Study|Withdrawal by Subject|5|||
16366475|NCT02836769|39825535|FG000|Overall Study|Lost to Follow-up|10|||
16366476|NCT02836769|39825535|FG000|Overall Study|Medical withdrawal|2|||
16444063|NCT04076059|40104436|FG002|Double Blind Phase|Miscellaneous|0|||
16444064|NCT04076059|40104434|FG000|Double Blind Phase|Protocol Deviation|1|||
16153961|NCT02551159|39048301|FG000|Overall Study|Death|352|||
16153962|NCT02551159|39048302|FG001|Overall Study|Death|174|||
16153963|NCT02551159|39048303|FG002|Overall Study|Death|161|||
16153964|NCT02551159|39048301|FG000|Overall Study|Withdrawal by Subject|8|||
16153965|NCT02551159|39048302|FG001|Overall Study|Withdrawal by Subject|5|||
16153966|NCT02551159|39048303|FG002|Overall Study|Withdrawal by Subject|16|||
16153967|NCT02551159|39048301|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
16153968|NCT02551159|39048302|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
16153969|NCT02551159|39048303|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
16153970|NCT02016820|39048305|FG000|Overall Study|Lost to Follow-up|2|||
16153971|NCT02016820|39048306|FG001|Overall Study|Lost to Follow-up|4|||
16153972|NCT01326546|39048307|FG000|Overall Study|Lost to Follow-up|8|||
16153973|NCT01326546|39048308|FG001|Overall Study|Lost to Follow-up|7|||
16153974|NCT01326546|39048307|FG000|Overall Study|Protocol Violation|3|||
16153975|NCT01326546|39048308|FG001|Overall Study|Protocol Violation|4|||
16153976|NCT01326546|39048307|FG000|Overall Study|Pregnancy|0|||
16153977|NCT01326546|39048308|FG001|Overall Study|Pregnancy|1|||
16153978|NCT01326546|39048307|FG000|Overall Study|Adverse Event|1|||
16153979|NCT01326546|39048308|FG001|Overall Study|Adverse Event|0|||
16153980|NCT01326546|39048307|FG000|Overall Study|Withdrawal by Subject|5|||
16153981|NCT01326546|39048308|FG001|Overall Study|Withdrawal by Subject|1|||
16153982|NCT03765138|39048309|FG000|Overall Study|Lost to Follow-up|1|||
16153983|NCT00393887|39051311|FG000|Overall Study|Physician Decision|5|||
16153984|NCT00393887|39051312|FG001|Overall Study|Physician Decision|0|||
16153985|NCT00393887|39051311|FG000|Overall Study|Lost to Follow-up|11|||
16153986|NCT00393887|39051312|FG001|Overall Study|Lost to Follow-up|9|||
16153987|NCT00135668|39051315|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
16153988|NCT00135668|39051316|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
16153989|NCT00135668|39051317|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
16153990|NCT00135668|39051318|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
16153991|NCT01079182|39051319|FG000|Overall Study|Lost to Follow-up|1634|||
16153992|NCT01079182|39051319|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
16153993|NCT01079182|39051319|FG000|Overall Study|Lack of Efficacy|514|||
16153994|NCT01079182|39051319|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
16153995|NCT01079182|39051319|FG000|Overall Study|Reasons not Evaluated|271|||
16262612|NCT03031847|39445999|FG002|Overall Study|Death|2|||
16262613|NCT03031847|39446000|FG003|Overall Study|Death|3|||
16262614|NCT03031847|39445997|FG000|Overall Study|Lost to Follow-up|1|||
16262615|NCT03031847|39445998|FG001|Overall Study|Lost to Follow-up|1|||
16262616|NCT03031847|39445999|FG002|Overall Study|Lost to Follow-up|2|||
16262617|NCT03031847|39446000|FG003|Overall Study|Lost to Follow-up|3|||
16262618|NCT00446563|39446001|FG000|Overall Study|Adverse Event|4|||
16262619|NCT00446563|39446002|FG001|Overall Study|Adverse Event|3|||
16262620|NCT00446563|39446001|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16366477|NCT02836769|39825535|FG000|Overall Study|Withdrawal by Subject|3|||
16366478|NCT01044498|39825536|FG000|Overall Study|Withdrew consent|1|||
16366479|NCT01044498|39825537|FG001|Overall Study|Withdrew consent|1|||
16366480|NCT01044498|39825536|FG000|Overall Study|Adverse Event|1|||
16366481|NCT01044498|39825537|FG001|Overall Study|Adverse Event|1|||
16366482|NCT01044498|39825536|FG000|Overall Study|Other|1|||
16366483|NCT01044498|39825537|FG001|Overall Study|Other|0|||
16366484|NCT01510756|39825538|FG000|Overall Study|Death|1|||
16366485|NCT01510756|39825538|FG000|Overall Study|Lack of Efficacy|2|||
16366486|NCT01510756|39825538|FG000|Overall Study|Physician Decision|1|||
16366487|NCT00337194|39825539|FG000|Overall Study|Adverse Event|5|||
16366488|NCT00337194|39825540|FG001|Overall Study|Adverse Event|1|||
16444065|NCT04076059|40104435|FG001|Double Blind Phase|Protocol Deviation|1|||
16444066|NCT04076059|40104436|FG002|Double Blind Phase|Protocol Deviation|0|||
16444067|NCT04076059|40104434|FG000|Double Blind Phase|Did not take study drug|1|||
16444068|NCT04076059|40104435|FG001|Double Blind Phase|Did not take study drug|1|||
16444069|NCT04076059|40104436|FG002|Double Blind Phase|Did not take study drug|0|||
16444070|NCT04076059|40104434|FG000|Open Label Phase|Progressive disease|0|||
16153996|NCT03594227|39051322|FG000|Overall Study|Adverse Event|2|||
16153997|NCT03594227|39051323|FG001|Overall Study|Adverse Event|1|||
16153998|NCT03594227|39051324|FG002|Overall Study|Adverse Event|0|||
16153999|NCT03594227|39051325|FG003|Overall Study|Adverse Event|2|||
16154000|NCT03594227|39051322|FG000|Overall Study|Lost to Follow-up|1|||
16154001|NCT03594227|39051323|FG001|Overall Study|Lost to Follow-up|1|||
16154002|NCT03594227|39051324|FG002|Overall Study|Lost to Follow-up|1|||
16154003|NCT03594227|39051325|FG003|Overall Study|Lost to Follow-up|0|||
16154004|NCT03594227|39051322|FG000|Overall Study|Withdrawal by Subject|1|||
16154005|NCT03594227|39051323|FG001|Overall Study|Withdrawal by Subject|1|||
16262621|NCT00446563|39446002|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16366489|NCT00337194|39825539|FG000|Overall Study|Death|2|||
16366490|NCT00337194|39825540|FG001|Overall Study|Death|0|||
16366491|NCT00337194|39825539|FG000|Overall Study|Withdrawal by Subject|1|||
16366492|NCT00337194|39825540|FG001|Overall Study|Withdrawal by Subject|0|||
16262622|NCT00446563|39446001|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16262623|NCT00446563|39446002|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16262624|NCT00446563|39446001|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16262625|NCT00446563|39446002|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16262626|NCT00446563|39446001|FG000|Overall Study|Withdrawal by Subject|2|||
16262627|NCT00446563|39446002|FG001|Overall Study|Withdrawal by Subject|1|||
16262628|NCT00446563|39446001|FG000|Overall Study|Administrative problems|0|||
16262629|NCT00446563|39446002|FG001|Overall Study|Administrative problems|1|||
16262630|NCT01591785|39446003|FG000|Overall Study|worsening condition|1|||
16262631|NCT01591785|39446004|FG001|Overall Study|worsening condition|2|||
16262632|NCT01591785|39446003|FG000|Overall Study|Protocol Violation|2|||
16262633|NCT01591785|39446004|FG001|Overall Study|Protocol Violation|0|||
16262634|NCT01591785|39446003|FG000|Overall Study|Lost to Follow-up|1|||
16262635|NCT01591785|39446004|FG001|Overall Study|Lost to Follow-up|0|||
16262636|NCT00163657|39449507|FG000|Overall Study|Death|12|||
16262637|NCT00163657|39449508|FG001|Overall Study|Death|14|||
16262638|NCT00163657|39449509|FG002|Overall Study|Death|19|||
16262639|NCT00163657|39449507|FG000|Overall Study|graft loss|4|||
16262640|NCT00163657|39449508|FG001|Overall Study|graft loss|1|||
16262641|NCT00163657|39449509|FG002|Overall Study|graft loss|2|||
16262642|NCT00163657|39449507|FG000|Overall Study|Withdrawal by Subject|2|||
16262643|NCT00163657|39449508|FG001|Overall Study|Withdrawal by Subject|3|||
16262644|NCT00163657|39449509|FG002|Overall Study|Withdrawal by Subject|2|||
16262645|NCT00163657|39449507|FG000|Overall Study|Physician Decision|0|||
16262646|NCT00163657|39449508|FG001|Overall Study|Physician Decision|1|||
16262647|NCT00163657|39449509|FG002|Overall Study|Physician Decision|1|||
16262648|NCT00163657|39449507|FG000|Overall Study|Non Compliance|1|||
16262649|NCT00163657|39449508|FG001|Overall Study|Non Compliance|0|||
16262650|NCT00163657|39449509|FG002|Overall Study|Non Compliance|0|||
16262651|NCT00163657|39449507|FG000|Overall Study|Lost to Follow-up|1|||
16262652|NCT00163657|39449508|FG001|Overall Study|Lost to Follow-up|3|||
16262653|NCT00163657|39449509|FG002|Overall Study|Lost to Follow-up|10|||
16262654|NCT00163657|39449507|FG000|Overall Study|Other reason|0|||
16262655|NCT00163657|39449508|FG001|Overall Study|Other reason|1|||
16262656|NCT00163657|39449509|FG002|Overall Study|Other reason|3|||
16262657|NCT01648582|39449510|FG000|Overall Study|Adverse Event|6|||
16262658|NCT01648582|39449511|FG001|Overall Study|Adverse Event|11|||
16262659|NCT01648582|39449512|FG002|Overall Study|Adverse Event|2|||
16262660|NCT01648582|39449510|FG000|Overall Study|Lost to Follow-up|9|||
16262661|NCT01648582|39449511|FG001|Overall Study|Lost to Follow-up|6|||
16262662|NCT01648582|39449512|FG002|Overall Study|Lost to Follow-up|8|||
16262663|NCT01648582|39449510|FG000|Overall Study|Protocol Violation|1|||
16262664|NCT01648582|39449511|FG001|Overall Study|Protocol Violation|2|||
16262665|NCT01648582|39449512|FG002|Overall Study|Protocol Violation|1|||
16262666|NCT01648582|39449510|FG000|Overall Study|Withdrawal by Subject|15|||
16262667|NCT01648582|39449511|FG001|Overall Study|Withdrawal by Subject|17|||
16262668|NCT01648582|39449512|FG002|Overall Study|Withdrawal by Subject|17|||
16262669|NCT01648582|39449510|FG000|Overall Study|Physician Decision|0|||
16262670|NCT01648582|39449511|FG001|Overall Study|Physician Decision|1|||
16262671|NCT01648582|39449512|FG002|Overall Study|Physician Decision|3|||
16262672|NCT01648582|39449510|FG000|Overall Study|Death|1|||
16262673|NCT01648582|39449511|FG001|Overall Study|Death|0|||
16262674|NCT01648582|39449512|FG002|Overall Study|Death|0|||
16262675|NCT01648582|39449510|FG000|Overall Study|Sponsor Decision|0|||
16262676|NCT01648582|39449511|FG001|Overall Study|Sponsor Decision|1|||
16262677|NCT01648582|39449512|FG002|Overall Study|Sponsor Decision|1|||
16262678|NCT01139047|39449513|FG000|Overall Study|Withdrawal by Subject|1|||
16262679|NCT02563561|39449514|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
16262680|NCT02563561|39449515|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
16366493|NCT00337194|39825539|FG000|Overall Study|Disease progression|1|||
16366494|NCT00337194|39825540|FG001|Overall Study|Disease progression|2|||
16366495|NCT00337194|39825539|FG000|Overall Study|Subsequent non-protocol therapy|3|||
16366496|NCT00337194|39825540|FG001|Overall Study|Subsequent non-protocol therapy|1|||
16366497|NCT02568423|39825548|FG000|Overall Study|Lost to Follow-up|0|||
16366498|NCT02568423|39825549|FG001|Overall Study|Lost to Follow-up|2|||
16366499|NCT02568423|39825550|FG002|Overall Study|Lost to Follow-up|0|||
16366500|NCT02568423|39825551|FG003|Overall Study|Lost to Follow-up|0|||
16366501|NCT02568423|39825552|FG004|Overall Study|Lost to Follow-up|0|||
16366502|NCT02568423|39825553|FG005|Overall Study|Lost to Follow-up|0|||
16366503|NCT02568423|39825554|FG006|Overall Study|Lost to Follow-up|0|||
16366504|NCT02568423|39825555|FG007|Overall Study|Lost to Follow-up|0|||
16366505|NCT02568423|39825548|FG000|Overall Study|Physician Decision|0|||
16366506|NCT02568423|39825549|FG001|Overall Study|Physician Decision|0|||
16366507|NCT02568423|39825550|FG002|Overall Study|Physician Decision|0|||
16366508|NCT02568423|39825551|FG003|Overall Study|Physician Decision|0|||
16366509|NCT02568423|39825552|FG004|Overall Study|Physician Decision|0|||
16366510|NCT02568423|39825553|FG005|Overall Study|Physician Decision|1|||
16262681|NCT02563561|39449516|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
16262682|NCT02563561|39449514|FG000|Overall Study|Withdrew of Consent|1|||
16366511|NCT02568423|39825554|FG006|Overall Study|Physician Decision|0|||
16366512|NCT02568423|39825555|FG007|Overall Study|Physician Decision|0|||
16366513|NCT01875237|39825556|FG000|Overall Study|GVDH before DLI|1|||
16366514|NCT01875237|39825557|FG001|Overall Study|GVDH before DLI|0|||
16366515|NCT01875237|39825556|FG000|Overall Study|DLI cells could not be produced|1|||
16366516|NCT01875237|39825557|FG001|Overall Study|DLI cells could not be produced|0|||
16366517|NCT02595749|39825558|FG000|Overall Study|Withdrawal by Subject|12|||
16366518|NCT02595749|39825559|FG001|Overall Study|Withdrawal by Subject|7|||
16366519|NCT02405962|39825560|FG000|Overall Study|Lost to Follow-up|1|||
16366520|NCT02405962|39825561|FG001|Overall Study|Lost to Follow-up|4|||
16366521|NCT02405962|39825560|FG000|Overall Study|A participant has moved to another place|0|||
16366522|NCT02405962|39825561|FG001|Overall Study|A participant has moved to another place|1|||
16366523|NCT02178956|39825562|FG000|Overall Study|Lost to Follow-up|4|||
16366524|NCT02178956|39825563|FG001|Overall Study|Lost to Follow-up|4|||
16366525|NCT02178956|39825562|FG000|Overall Study|Sponsor terminated study|49|||
16366526|NCT02178956|39825563|FG001|Overall Study|Sponsor terminated study|58|||
16366527|NCT02178956|39825562|FG000|Overall Study|Withdrawal by Subject|15|||
16366528|NCT02178956|39825563|FG001|Overall Study|Withdrawal by Subject|11|||
16366529|NCT02178956|39825562|FG000|Overall Study|Various Reasons|3|||
16366530|NCT02178956|39825563|FG001|Overall Study|Various Reasons|5|||
16366531|NCT01555931|39825566|FG000|Overall Study|Lost to Follow-up|2|||
16366532|NCT01555931|39825567|FG001|Overall Study|Lost to Follow-up|5|||
16366533|NCT03301714|39825570|FG000|Overall Study|Lost to Follow-up|10|||
16366534|NCT03301714|39825571|FG001|Overall Study|Lost to Follow-up|4|||
16366535|NCT03301714|39825572|FG002|Overall Study|Lost to Follow-up|4|||
16366536|NCT03301714|39825570|FG000|Overall Study|Did not receive allocated intervention|0|||
16366537|NCT03301714|39825571|FG001|Overall Study|Did not receive allocated intervention|2|||
16366538|NCT03301714|39825572|FG002|Overall Study|Did not receive allocated intervention|3|||
16444071|NCT04076059|40104435|FG001|Open Label Phase|Progressive disease|0|||
16444072|NCT04076059|40104436|FG002|Open Label Phase|Progressive disease|7|||
16444073|NCT04076059|40104434|FG000|Open Label Phase|Withdrawal by Subject|0|||
16366539|NCT01105130|39825573|FG000|Overall Study|Withdrawal by Subject|4|||
16366540|NCT01105130|39825574|FG001|Overall Study|Withdrawal by Subject|6|||
16366541|NCT01105130|39825575|FG002|Overall Study|Withdrawal by Subject|2|||
16366542|NCT01105130|39825573|FG000|Overall Study|Never Started|2|||
16366543|NCT01105130|39825574|FG001|Overall Study|Never Started|2|||
16366544|NCT01105130|39825575|FG002|Overall Study|Never Started|4|||
16366545|NCT01105130|39825573|FG000|Overall Study|Toxicity|1|||
16366546|NCT01105130|39825574|FG001|Overall Study|Toxicity|3|||
16366547|NCT01105130|39825575|FG002|Overall Study|Toxicity|2|||
16366548|NCT01105130|39825573|FG000|Overall Study|Multiple Reasons|3|||
16366549|NCT01105130|39825574|FG001|Overall Study|Multiple Reasons|0|||
16366550|NCT01105130|39825575|FG002|Overall Study|Multiple Reasons|2|||
16366551|NCT03093870|39825576|FG000|Overall Study|Withdrawal by Subject|2|||
16366552|NCT03093870|39825577|FG001|Overall Study|Withdrawal by Subject|6|||
16366553|NCT03093870|39825578|FG002|Overall Study|Withdrawal by Subject|5|||
16366554|NCT03093870|39825576|FG000|Overall Study|Death|1|||
16366555|NCT03093870|39825577|FG001|Overall Study|Death|35|||
16366556|NCT03093870|39825578|FG002|Overall Study|Death|35|||
16366557|NCT03093870|39825576|FG000|Overall Study|Radiographic disease progression|10|||
16366558|NCT03093870|39825577|FG001|Overall Study|Radiographic disease progression|0|||
16366559|NCT03093870|39825578|FG002|Overall Study|Radiographic disease progression|0|||
16366560|NCT03093870|39825576|FG000|Overall Study|Clinical disease progression|1|||
16366561|NCT03093870|39825577|FG001|Overall Study|Clinical disease progression|0|||
16366562|NCT03093870|39825578|FG002|Overall Study|Clinical disease progression|0|||
16444074|NCT04076059|40104435|FG001|Open Label Phase|Withdrawal by Subject|0|||
16444075|NCT04076059|40104436|FG002|Open Label Phase|Withdrawal by Subject|3|||
16444076|NCT04076059|40104434|FG000|Open Label Phase|Death|0|||
16444077|NCT04076059|40104435|FG001|Open Label Phase|Death|0|||
16366563|NCT03093870|39825576|FG000|Overall Study|Physician Decision|2|||
16366564|NCT03093870|39825577|FG001|Overall Study|Physician Decision|0|||
16366565|NCT03093870|39825578|FG002|Overall Study|Physician Decision|0|||
16366566|NCT03093870|39825576|FG000|Overall Study|Adverse Event|7|||
16366567|NCT03093870|39825577|FG001|Overall Study|Adverse Event|0|||
16366568|NCT03093870|39825578|FG002|Overall Study|Adverse Event|0|||
16366569|NCT03093870|39825576|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
16366570|NCT03093870|39825577|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
16366571|NCT03093870|39825578|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
16366572|NCT03093870|39825576|FG000|Overall Study|Lost to Follow-up|0|||
16366573|NCT03093870|39825577|FG001|Overall Study|Lost to Follow-up|0|||
16366574|NCT03093870|39825578|FG002|Overall Study|Lost to Follow-up|1|||
16444078|NCT04076059|40104436|FG002|Open Label Phase|Death|2|||
16444079|NCT04076059|40104434|FG000|Open Label Phase|Ongoing Participants|0|||
16444080|NCT04076059|40104435|FG001|Open Label Phase|Ongoing Participants|0|||
16262683|NCT02563561|39449515|FG001|Overall Study|Withdrew of Consent|1|||
16262684|NCT02563561|39449516|FG002|Overall Study|Withdrew of Consent|2|||
16262685|NCT02563561|39449514|FG000|Overall Study|Lost to Follow-up|1|||
16262686|NCT02563561|39449515|FG001|Overall Study|Lost to Follow-up|1|||
16262687|NCT02563561|39449516|FG002|Overall Study|Lost to Follow-up|0|||
16262688|NCT02563561|39449514|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
16262689|NCT02563561|39449515|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
16262690|NCT02563561|39449516|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
16262691|NCT02563561|39449514|FG000|Overall Study|Investigator Decision|3|||
16262692|NCT02563561|39449515|FG001|Overall Study|Investigator Decision|4|||
16262693|NCT02563561|39449516|FG002|Overall Study|Investigator Decision|2|||
16262694|NCT02563561|39449514|FG000|Overall Study|Sponsor Decision|5|||
16262695|NCT02563561|39449515|FG001|Overall Study|Sponsor Decision|2|||
16262696|NCT02563561|39449516|FG002|Overall Study|Sponsor Decision|4|||
16366575|NCT03329001|39825579|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
16366576|NCT03329001|39825580|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
16366577|NCT03329001|39825581|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
16444081|NCT04076059|40104436|FG002|Open Label Phase|Ongoing Participants|11|||
16444082|NCT03431350|40104437|FG000|Overall Study|ONGOING|0|||
16444083|NCT03431350|40104438|FG001|Overall Study|ONGOING|0|||
16444084|NCT03431350|40104439|FG002|Overall Study|ONGOING|2|||
16444085|NCT03431350|40104440|FG003|Overall Study|ONGOING|0|||
16444086|NCT03431350|40104441|FG004|Overall Study|ONGOING|1|||
16444087|NCT03431350|40104442|FG005|Overall Study|ONGOING|3|||
16444088|NCT03431350|40104443|FG006|Overall Study|ONGOING|0|||
16444089|NCT03431350|40104444|FG007|Overall Study|ONGOING|1|||
16444090|NCT03431350|40104445|FG008|Overall Study|ONGOING|3|||
16444091|NCT03431350|40104446|FG009|Overall Study|ONGOING|4|||
16444092|NCT03431350|40104447|FG010|Overall Study|ONGOING|2|||
16444093|NCT03431350|40104448|FG011|Overall Study|ONGOING|1|||
16444094|NCT03431350|40104437|FG000|Overall Study|Death|6|||
16444095|NCT03431350|40104438|FG001|Overall Study|Death|5|||
16444096|NCT03431350|40104439|FG002|Overall Study|Death|18|||
16444097|NCT03431350|40104440|FG003|Overall Study|Death|7|||
16444098|NCT03431350|40104441|FG004|Overall Study|Death|4|||
16444099|NCT03431350|40104442|FG005|Overall Study|Death|3|||
16444100|NCT03431350|40104443|FG006|Overall Study|Death|2|||
16444101|NCT03431350|40104444|FG007|Overall Study|Death|0|||
16444102|NCT03431350|40104445|FG008|Overall Study|Death|0|||
16444103|NCT03431350|40104446|FG009|Overall Study|Death|0|||
16444104|NCT03431350|40104447|FG010|Overall Study|Death|4|||
16444105|NCT03431350|40104448|FG011|Overall Study|Death|0|||
16444106|NCT03431350|40104437|FG000|Overall Study|Lost to Follow-up|0|||
16444107|NCT03431350|40104438|FG001|Overall Study|Lost to Follow-up|1|||
16444108|NCT03431350|40104439|FG002|Overall Study|Lost to Follow-up|0|||
16444109|NCT03431350|40104440|FG003|Overall Study|Lost to Follow-up|0|||
16366578|NCT03329001|39825582|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
16366579|NCT03329001|39825583|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
16366580|NCT03329001|39825584|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
16366581|NCT03329001|39825585|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
16366582|NCT03329001|39825586|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
16366583|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
16366584|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
16366585|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
16366586|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
16366587|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
16366588|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
16366589|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
16366590|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
16366591|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
16366592|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
16366593|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
16366594|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
16366595|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
16366596|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
16444110|NCT03431350|40104441|FG004|Overall Study|Lost to Follow-up|0|||
16444111|NCT03431350|40104442|FG005|Overall Study|Lost to Follow-up|0|||
16444112|NCT03431350|40104443|FG006|Overall Study|Lost to Follow-up|0|||
16444113|NCT03431350|40104444|FG007|Overall Study|Lost to Follow-up|0|||
16444114|NCT03431350|40104445|FG008|Overall Study|Lost to Follow-up|0|||
16444115|NCT03431350|40104446|FG009|Overall Study|Lost to Follow-up|0|||
16444116|NCT03431350|40104447|FG010|Overall Study|Lost to Follow-up|0|||
16444117|NCT03431350|40104448|FG011|Overall Study|Lost to Follow-up|0|||
16444118|NCT03431350|40104437|FG000|Overall Study|Withdrawal by Subject|0|||
16444119|NCT03431350|40104438|FG001|Overall Study|Withdrawal by Subject|0|||
16444120|NCT03431350|40104439|FG002|Overall Study|Withdrawal by Subject|0|||
16444121|NCT03431350|40104440|FG003|Overall Study|Withdrawal by Subject|1|||
16154006|NCT03594227|39051324|FG002|Overall Study|Withdrawal by Subject|1|||
16154007|NCT03594227|39051325|FG003|Overall Study|Withdrawal by Subject|1|||
16154008|NCT03594227|39051322|FG000|Overall Study|Pregnancy|0|||
16154009|NCT03594227|39051323|FG001|Overall Study|Pregnancy|1|||
16154010|NCT03594227|39051324|FG002|Overall Study|Pregnancy|0|||
16154011|NCT03594227|39051325|FG003|Overall Study|Pregnancy|0|||
16154012|NCT03594227|39051322|FG000|Overall Study|Sponsor Decision|0|||
16154013|NCT03594227|39051323|FG001|Overall Study|Sponsor Decision|0|||
16154014|NCT03594227|39051324|FG002|Overall Study|Sponsor Decision|0|||
16154015|NCT03594227|39051325|FG003|Overall Study|Sponsor Decision|1|||
16154016|NCT03594227|39051322|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
16154017|NCT03594227|39051323|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
16444122|NCT03431350|40104441|FG004|Overall Study|Withdrawal by Subject|1|||
16444123|NCT03431350|40104442|FG005|Overall Study|Withdrawal by Subject|1|||
16444124|NCT03431350|40104443|FG006|Overall Study|Withdrawal by Subject|0|||
16444125|NCT03431350|40104444|FG007|Overall Study|Withdrawal by Subject|0|||
16444126|NCT03431350|40104445|FG008|Overall Study|Withdrawal by Subject|0|||
16154018|NCT03594227|39051324|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
16154019|NCT03594227|39051325|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
16366597|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
16366598|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
16366599|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
16366600|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
16366601|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
16366602|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
16366603|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
16366604|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
16366605|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
16366606|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
16366607|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
16366608|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
16366609|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
16366610|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
16366611|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
16366612|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
16366613|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
16444127|NCT03431350|40104446|FG009|Overall Study|Withdrawal by Subject|2|||
16444128|NCT03431350|40104447|FG010|Overall Study|Withdrawal by Subject|0|||
16154020|NCT00081159|39051326|FG000|Overall Study|Withdrawal by Subject|0|||
16154021|NCT00081159|39051327|FG001|Overall Study|Withdrawal by Subject|3|||
16154022|NCT00081159|39051326|FG000|Overall Study|Myelosuppression prior to treatment|0|||
16154023|NCT00081159|39051327|FG001|Overall Study|Myelosuppression prior to treatment|1|||
16154024|NCT00081159|39051326|FG000|Overall Study|Lost to Follow-up|2|||
16154025|NCT00081159|39051327|FG001|Overall Study|Lost to Follow-up|1|||
16154026|NCT03499028|39051328|FG000|Overall Study|Lost to Follow-up|12|||
16154027|NCT03499028|39051329|FG001|Overall Study|Lost to Follow-up|9|||
16154028|NCT03499028|39051328|FG000|Overall Study|Withdrawal by Subject|5|||
16154029|NCT03499028|39051329|FG001|Overall Study|Withdrawal by Subject|8|||
16154030|NCT03499028|39051328|FG000|Overall Study|Unplanned SNF discharge|5|||
16154031|NCT03499028|39051329|FG001|Overall Study|Unplanned SNF discharge|8|||
16154032|NCT03099187|39051330|FG000|Double-blind Treatment|Adverse Event|19|||
16154033|NCT03099187|39051331|FG001|Double-blind Treatment|Adverse Event|1|||
16154034|NCT03099187|39051332|FG002|Double-blind Treatment|Adverse Event|0|||
16154035|NCT03099187|39051333|FG003|Double-blind Treatment|Adverse Event|0|||
16154036|NCT03099187|39051330|FG000|Double-blind Treatment|Death|1|||
16154037|NCT03099187|39051331|FG001|Double-blind Treatment|Death|3|||
16154038|NCT03099187|39051332|FG002|Double-blind Treatment|Death|0|||
16154039|NCT03099187|39051333|FG003|Double-blind Treatment|Death|0|||
16154040|NCT03099187|39051330|FG000|Double-blind Treatment|Lack of Efficacy|1|||
16154041|NCT03099187|39051331|FG001|Double-blind Treatment|Lack of Efficacy|0|||
16154042|NCT03099187|39051332|FG002|Double-blind Treatment|Lack of Efficacy|0|||
16154043|NCT03099187|39051333|FG003|Double-blind Treatment|Lack of Efficacy|0|||
16154044|NCT03099187|39051330|FG000|Double-blind Treatment|Physician Decision|2|||
16154045|NCT03099187|39051331|FG001|Double-blind Treatment|Physician Decision|1|||
16154046|NCT03099187|39051332|FG002|Double-blind Treatment|Physician Decision|0|||
16154047|NCT03099187|39051333|FG003|Double-blind Treatment|Physician Decision|0|||
16154048|NCT03099187|39051330|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
16154049|NCT03099187|39051331|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
16154050|NCT03099187|39051332|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
16154051|NCT03099187|39051333|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
16154052|NCT03099187|39051330|FG000|Double-blind Treatment|Lung transplantation|0|||
16154053|NCT03099187|39051331|FG001|Double-blind Treatment|Lung transplantation|1|||
16154054|NCT03099187|39051332|FG002|Double-blind Treatment|Lung transplantation|0|||
16154055|NCT03099187|39051333|FG003|Double-blind Treatment|Lung transplantation|0|||
16154056|NCT03099187|39051330|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
16154057|NCT03099187|39051331|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
16154058|NCT03099187|39051332|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
16154059|NCT03099187|39051333|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
16154060|NCT03099187|39051330|FG000|Double-blind Treatment|Disease progression|0|||
16154061|NCT03099187|39051331|FG001|Double-blind Treatment|Disease progression|1|||
16154062|NCT03099187|39051332|FG002|Double-blind Treatment|Disease progression|0|||
16154063|NCT03099187|39051333|FG003|Double-blind Treatment|Disease progression|0|||
16154064|NCT03099187|39051330|FG000|Double-blind Treatment|Randomization error|0|||
16154065|NCT03099187|39051331|FG001|Double-blind Treatment|Randomization error|2|||
16154066|NCT03099187|39051332|FG002|Double-blind Treatment|Randomization error|0|||
16154067|NCT03099187|39051333|FG003|Double-blind Treatment|Randomization error|0|||
16154068|NCT03099187|39051330|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
16154069|NCT03099187|39051331|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
16154070|NCT03099187|39051332|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
16154071|NCT03099187|39051333|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
16154072|NCT03099187|39051330|FG000|12-month Safety Follow-up|Adverse Event|0|||
16154073|NCT03099187|39051331|FG001|12-month Safety Follow-up|Adverse Event|0|||
16154074|NCT03099187|39051332|FG002|12-month Safety Follow-up|Adverse Event|5|||
16154075|NCT03099187|39051333|FG003|12-month Safety Follow-up|Adverse Event|12|||
16154076|NCT03099187|39051330|FG000|12-month Safety Follow-up|Death|0|||
16154077|NCT03099187|39051331|FG001|12-month Safety Follow-up|Death|0|||
16154078|NCT03099187|39051332|FG002|12-month Safety Follow-up|Death|7|||
16154079|NCT03099187|39051333|FG003|12-month Safety Follow-up|Death|9|||
16154080|NCT03099187|39051330|FG000|12-month Safety Follow-up|Lung transplantation|0|||
16154081|NCT03099187|39051331|FG001|12-month Safety Follow-up|Lung transplantation|0|||
16154082|NCT03099187|39051332|FG002|12-month Safety Follow-up|Lung transplantation|2|||
16154083|NCT03099187|39051333|FG003|12-month Safety Follow-up|Lung transplantation|1|||
16154084|NCT03099187|39051330|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
16154085|NCT03099187|39051331|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
16154086|NCT03099187|39051332|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
16154087|NCT03099187|39051333|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
16154088|NCT03099187|39051330|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
16154089|NCT03099187|39051331|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
16262697|NCT02563561|39449514|FG000|Overall Study|Other|1|||
16262698|NCT02563561|39449515|FG001|Overall Study|Other|5|||
16154090|NCT03099187|39051332|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
16262699|NCT02563561|39449516|FG002|Overall Study|Other|2|||
16154091|NCT03099187|39051333|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
16154092|NCT03099187|39051330|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
16154093|NCT03099187|39051331|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
16154094|NCT03099187|39051332|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
16154095|NCT03099187|39051333|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
16154096|NCT03099187|39051330|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
16154097|NCT03099187|39051331|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
16154098|NCT03099187|39051332|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
16154099|NCT03099187|39051333|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
16154100|NCT00720109|39051334|FG000|Induction Period|Did not meet eligibility criteria|3|||
16154101|NCT00720109|39051335|FG001|Induction Period|Did not meet eligibility criteria|0|||
16154102|NCT00720109|39051336|FG002|Induction Period|Did not meet eligibility criteria|0|||
16154103|NCT00720109|39051334|FG000|Induction Period|Bone Marrow Transplant|2|||
16154104|NCT00720109|39051335|FG001|Induction Period|Bone Marrow Transplant|0|||
16154105|NCT00720109|39051336|FG002|Induction Period|Bone Marrow Transplant|0|||
16154106|NCT00720109|39051334|FG000|Induction Period|Physician Decision|1|||
16154107|NCT00720109|39051335|FG001|Induction Period|Physician Decision|0|||
16154108|NCT00720109|39051336|FG002|Induction Period|Physician Decision|0|||
16154109|NCT00720109|39051334|FG000|Risk Stratification Period|Adverse Event|0|||
16154110|NCT00720109|39051335|FG001|Risk Stratification Period|Adverse Event|1|||
16154111|NCT00720109|39051336|FG002|Risk Stratification Period|Adverse Event|0|||
16154112|NCT00720109|39051334|FG000|Risk Stratification Period|Physician Decision|0|||
16154113|NCT00720109|39051335|FG001|Risk Stratification Period|Physician Decision|2|||
16154114|NCT00720109|39051336|FG002|Risk Stratification Period|Physician Decision|1|||
16154115|NCT00720109|39051334|FG000|Risk Stratification Period|Bone marrow transplant|0|||
16154116|NCT00720109|39051335|FG001|Risk Stratification Period|Bone marrow transplant|9|||
16154117|NCT00720109|39051336|FG002|Risk Stratification Period|Bone marrow transplant|7|||
16154118|NCT00720109|39051334|FG000|Risk Stratification Period|Disease progression or relapse|0|||
16154119|NCT00720109|39051335|FG001|Risk Stratification Period|Disease progression or relapse|2|||
16154120|NCT00720109|39051336|FG002|Risk Stratification Period|Disease progression or relapse|0|||
16154121|NCT00720109|39051334|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
16154122|NCT00720109|39051335|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
16154123|NCT00720109|39051336|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
16154124|NCT02258451|39051337|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
16154125|NCT02258451|39051338|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
16154126|NCT02258451|39051337|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
16154127|NCT02258451|39051338|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
16154128|NCT02258451|39051337|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
16154129|NCT02258451|39051338|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
16154130|NCT02258451|39051337|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
16154131|NCT02258451|39051338|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
16154132|NCT02258451|39051337|FG000|Overall Study|Discontinuation all treatment due to death|4|||
16154133|NCT02258451|39051338|FG001|Overall Study|Discontinuation all treatment due to death|3|||
16154134|NCT02258451|39051337|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
16154135|NCT02258451|39051338|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
16154136|NCT02258451|39051337|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
16154137|NCT02258451|39051338|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
16154138|NCT02258451|39051337|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
16154139|NCT02258451|39051338|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
16154140|NCT02258451|39051337|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
16154141|NCT02258451|39051338|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
16154142|NCT02258451|39051337|FG000|Overall Study|Other reason|1|||
16154143|NCT02258451|39051338|FG001|Overall Study|Other reason|1|||
16154144|NCT02258451|39051337|FG000|Overall Study|Never treated|2|||
16154145|NCT02258451|39051338|FG001|Overall Study|Never treated|3|||
16154146|NCT03631732|39051339|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
16154147|NCT03631732|39051340|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
16154148|NCT03631732|39051339|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
16154149|NCT03631732|39051340|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
16154150|NCT03631732|39051339|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
16154151|NCT03631732|39051340|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
16154152|NCT03631732|39051339|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
16154153|NCT03631732|39051340|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
16154154|NCT03631732|39051339|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
16154155|NCT03631732|39051340|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
16154156|NCT03631732|39051339|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
16154157|NCT03631732|39051340|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
16154158|NCT03631732|39051339|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
16154159|NCT03631732|39051340|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
16154160|NCT03631732|39051339|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
16154161|NCT03631732|39051340|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
16154162|NCT03631732|39051339|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
16154163|NCT03631732|39051340|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
16444129|NCT03431350|40104448|FG011|Overall Study|Withdrawal by Subject|1|||
16444130|NCT03431350|40104437|FG000|Overall Study|Other|0|||
16154164|NCT03631732|39051339|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
16154165|NCT03631732|39051340|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
16154166|NCT00574288|39051342|FG000|Overall Study|Adverse Event|2|||
16154167|NCT00574288|39051343|FG001|Overall Study|Adverse Event|0|||
16154168|NCT00574288|39051344|FG002|Overall Study|Adverse Event|0|||
16154169|NCT00574288|39051345|FG003|Overall Study|Adverse Event|0|||
16154170|NCT00574288|39051346|FG004|Overall Study|Adverse Event|1|||
16154171|NCT00574288|39051347|FG005|Overall Study|Adverse Event|0|||
16154172|NCT00574288|39051348|FG006|Overall Study|Adverse Event|0|||
16154173|NCT00574288|39051342|FG000|Overall Study|Death|0|||
16154174|NCT00574288|39051343|FG001|Overall Study|Death|0|||
16154175|NCT00574288|39051344|FG002|Overall Study|Death|0|||
16154176|NCT00574288|39051345|FG003|Overall Study|Death|0|||
16154177|NCT00574288|39051346|FG004|Overall Study|Death|0|||
16154178|NCT00574288|39051347|FG005|Overall Study|Death|25|||
16154179|NCT00574288|39051348|FG006|Overall Study|Death|21|||
16154180|NCT00574288|39051342|FG000|Overall Study|Lost to Follow-up|0|||
16154181|NCT00574288|39051343|FG001|Overall Study|Lost to Follow-up|0|||
16154182|NCT00574288|39051344|FG002|Overall Study|Lost to Follow-up|0|||
16154183|NCT00574288|39051345|FG003|Overall Study|Lost to Follow-up|0|||
16154184|NCT00574288|39051346|FG004|Overall Study|Lost to Follow-up|0|||
16154185|NCT00574288|39051347|FG005|Overall Study|Lost to Follow-up|1|||
16154186|NCT00574288|39051348|FG006|Overall Study|Lost to Follow-up|2|||
16154187|NCT00574288|39051342|FG000|Overall Study|Study Terminated By Sponsor|0|||
16154188|NCT00574288|39051343|FG001|Overall Study|Study Terminated By Sponsor|0|||
16154189|NCT00574288|39051344|FG002|Overall Study|Study Terminated By Sponsor|0|||
16154190|NCT00574288|39051345|FG003|Overall Study|Study Terminated By Sponsor|0|||
16154191|NCT00574288|39051346|FG004|Overall Study|Study Terminated By Sponsor|0|||
16154192|NCT00574288|39051347|FG005|Overall Study|Study Terminated By Sponsor|0|||
16154193|NCT00574288|39051348|FG006|Overall Study|Study Terminated By Sponsor|5|||
16154194|NCT00574288|39051342|FG000|Overall Study|Progressive Disease|17|||
16154195|NCT00574288|39051343|FG001|Overall Study|Progressive Disease|2|||
16154196|NCT00574288|39051344|FG002|Overall Study|Progressive Disease|3|||
16154197|NCT00574288|39051345|FG003|Overall Study|Progressive Disease|2|||
16154198|NCT00574288|39051346|FG004|Overall Study|Progressive Disease|1|||
16154199|NCT00574288|39051347|FG005|Overall Study|Progressive Disease|0|||
16154200|NCT00574288|39051348|FG006|Overall Study|Progressive Disease|0|||
16154201|NCT00574288|39051342|FG000|Overall Study|Other|1|||
16154202|NCT00574288|39051343|FG001|Overall Study|Other|1|||
16154203|NCT00574288|39051344|FG002|Overall Study|Other|0|||
16154204|NCT00574288|39051345|FG003|Overall Study|Other|0|||
16154205|NCT00574288|39051346|FG004|Overall Study|Other|0|||
16154206|NCT00574288|39051347|FG005|Overall Study|Other|0|||
16154207|NCT00574288|39051348|FG006|Overall Study|Other|0|||
16154208|NCT02554019|39051349|FG000|Overall Study|Withdrawal by Subject|1|||
16154209|NCT02554019|39051350|FG001|Overall Study|Withdrawal by Subject|0|||
16154210|NCT02554019|39051351|FG002|Overall Study|Withdrawal by Subject|2|||
16154211|NCT02554019|39051349|FG000|Overall Study|Adverse Event|1|||
16154212|NCT02554019|39051350|FG001|Overall Study|Adverse Event|0|||
16154213|NCT02554019|39051351|FG002|Overall Study|Adverse Event|0|||
16154214|NCT01391000|39051354|FG000|Overall Study|Lost to Follow-up|2|||
16154215|NCT01391000|39051355|FG001|Overall Study|Lost to Follow-up|0|||
16154216|NCT00271596|39051364|FG000|Overall Study|Protocol Violation|1|||
16154217|NCT00271596|39051365|FG001|Overall Study|Protocol Violation|0|||
16154218|NCT00271596|39051364|FG000|Overall Study|Withdrawal by Subject|0|||
16154219|NCT00271596|39051365|FG001|Overall Study|Withdrawal by Subject|1|||
16154220|NCT02628873|39051366|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
16154221|NCT02628873|39051367|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
16154222|NCT02628873|39051366|FG000|Second Test (1 Hour)|Physician Decision|1|||
16154223|NCT02628873|39051367|FG001|Second Test (1 Hour)|Physician Decision|0|||
16154224|NCT00143455|39051368|FG000|Cohort 1|Adverse Event|8|||
16154225|NCT00143455|39051369|FG001|Cohort 1|Adverse Event|4|||
16154226|NCT00143455|39051370|FG002|Cohort 1|Adverse Event|0|||
16154227|NCT00143455|39051371|FG003|Cohort 1|Adverse Event|0|||
16154228|NCT00143455|39051368|FG000|Cohort 1|Death|5|||
16154229|NCT00143455|39051369|FG001|Cohort 1|Death|2|||
16154230|NCT00143455|39051370|FG002|Cohort 1|Death|0|||
16154231|NCT00143455|39051371|FG003|Cohort 1|Death|0|||
16154232|NCT00143455|39051368|FG000|Cohort 1|Progressive Disease|0|||
16154233|NCT00143455|39051369|FG001|Cohort 1|Progressive Disease|6|||
16154234|NCT00143455|39051370|FG002|Cohort 1|Progressive Disease|0|||
16154235|NCT00143455|39051371|FG003|Cohort 1|Progressive Disease|0|||
16154236|NCT00143455|39051368|FG000|Cohort 1|Withdrawal by Subject|1|||
16154237|NCT00143455|39051369|FG001|Cohort 1|Withdrawal by Subject|4|||
16154238|NCT00143455|39051370|FG002|Cohort 1|Withdrawal by Subject|0|||
16154239|NCT00143455|39051371|FG003|Cohort 1|Withdrawal by Subject|0|||
16154240|NCT00143455|39051368|FG000|Cohort 1|Randomized But Not Treated|0|||
16154241|NCT00143455|39051369|FG001|Cohort 1|Randomized But Not Treated|1|||
16154242|NCT00143455|39051370|FG002|Cohort 1|Randomized But Not Treated|0|||
16154243|NCT00143455|39051371|FG003|Cohort 1|Randomized But Not Treated|0|||
16154244|NCT00143455|39051368|FG000|Cohort 2|Adverse Event|0|||
16154245|NCT00143455|39051369|FG001|Cohort 2|Adverse Event|0|||
16154246|NCT00143455|39051370|FG002|Cohort 2|Adverse Event|42|||
16154247|NCT00143455|39051371|FG003|Cohort 2|Adverse Event|30|||
16154248|NCT00143455|39051368|FG000|Cohort 2|No Longer Required Study Treatment|0|||
16154249|NCT00143455|39051369|FG001|Cohort 2|No Longer Required Study Treatment|0|||
16154250|NCT00143455|39051370|FG002|Cohort 2|No Longer Required Study Treatment|1|||
16444131|NCT03431350|40104438|FG001|Overall Study|Other|0|||
16444132|NCT03431350|40104439|FG002|Overall Study|Other|1|||
16444133|NCT03431350|40104440|FG003|Overall Study|Other|3|||
16444134|NCT03431350|40104441|FG004|Overall Study|Other|2|||
16444135|NCT03431350|40104442|FG005|Overall Study|Other|2|||
16444136|NCT03431350|40104443|FG006|Overall Study|Other|4|||
16444137|NCT03431350|40104444|FG007|Overall Study|Other|0|||
16444138|NCT03431350|40104445|FG008|Overall Study|Other|14|||
16444139|NCT03431350|40104446|FG009|Overall Study|Other|11|||
16444140|NCT03431350|40104447|FG010|Overall Study|Other|11|||
16444141|NCT03431350|40104448|FG011|Overall Study|Other|15|||
16444142|NCT04659044|40104449|FG000|Induction|Physician Decision|1|||
16444143|NCT04659044|40104449|FG000|Induction|Adverse Event|2|||
16444144|NCT01063751|40104450|FG000|Overall Study|Site terminated|45|||
16444145|NCT01063751|40104450|FG000|Overall Study|Lost to Follow-up|28|||
16444146|NCT01063751|40104450|FG000|Overall Study|Withdrawal by Subject|25|||
16444147|NCT01063751|40104450|FG000|Overall Study|Revision|6|||
16444148|NCT01063751|40104450|FG000|Overall Study|Death|12|||
16444149|NCT01063751|40104450|FG000|Overall Study|Physician Decision|4|||
16444150|NCT01063751|40104450|FG000|Overall Study|Active|91|||
16444151|NCT03819049|40104455|FG000|Overall Study|Lost to Follow-up|1|||
16444152|NCT03819049|40104456|FG001|Overall Study|Lost to Follow-up|2|||
16444153|NCT03819049|40104457|FG002|Overall Study|Lost to Follow-up|9|||
16444154|NCT03819049|40104458|FG003|Overall Study|Lost to Follow-up|0|||
16444155|NCT03819049|40104459|FG004|Overall Study|Lost to Follow-up|3|||
16444156|NCT03819049|40104460|FG005|Overall Study|Lost to Follow-up|1|||
16154251|NCT00143455|39051371|FG003|Cohort 2|No Longer Required Study Treatment|0|||
16444157|NCT03819049|40104461|FG006|Overall Study|Lost to Follow-up|0|||
16444158|NCT03819049|40104455|FG000|Overall Study|Withdrawal by Subject|0|||
16154252|NCT00143455|39051368|FG000|Cohort 2|Protocol Violation|0|||
16154253|NCT00143455|39051369|FG001|Cohort 2|Protocol Violation|0|||
16154254|NCT00143455|39051370|FG002|Cohort 2|Protocol Violation|1|||
16154255|NCT00143455|39051371|FG003|Cohort 2|Protocol Violation|1|||
16154256|NCT00143455|39051368|FG000|Cohort 2|Lost to Follow-up|0|||
16154257|NCT00143455|39051369|FG001|Cohort 2|Lost to Follow-up|0|||
16154258|NCT00143455|39051370|FG002|Cohort 2|Lost to Follow-up|1|||
16154259|NCT00143455|39051371|FG003|Cohort 2|Lost to Follow-up|4|||
16154260|NCT00143455|39051368|FG000|Cohort 2|Death|0|||
16154261|NCT00143455|39051369|FG001|Cohort 2|Death|0|||
16154262|NCT00143455|39051370|FG002|Cohort 2|Death|20|||
16444159|NCT03819049|40104456|FG001|Overall Study|Withdrawal by Subject|0|||
16444160|NCT03819049|40104457|FG002|Overall Study|Withdrawal by Subject|18|||
16444161|NCT03819049|40104458|FG003|Overall Study|Withdrawal by Subject|0|||
16444162|NCT03819049|40104459|FG004|Overall Study|Withdrawal by Subject|10|||
16444163|NCT03819049|40104460|FG005|Overall Study|Withdrawal by Subject|9|||
16444164|NCT03819049|40104461|FG006|Overall Study|Withdrawal by Subject|1|||
16154263|NCT00143455|39051371|FG003|Cohort 2|Death|12|||
16154264|NCT00143455|39051368|FG000|Cohort 2|Progressive Disease|0|||
16154265|NCT00143455|39051369|FG001|Cohort 2|Progressive Disease|0|||
16154266|NCT00143455|39051370|FG002|Cohort 2|Progressive Disease|20|||
16444165|NCT03819049|40104455|FG000|Overall Study|Ongoing|0|||
16444166|NCT03819049|40104456|FG001|Overall Study|Ongoing|0|||
16444167|NCT03819049|40104457|FG002|Overall Study|Ongoing|75|||
16444168|NCT03819049|40104458|FG003|Overall Study|Ongoing|0|||
16444169|NCT03819049|40104459|FG004|Overall Study|Ongoing|41|||
16444170|NCT03819049|40104460|FG005|Overall Study|Ongoing|0|||
16154267|NCT00143455|39051371|FG003|Cohort 2|Progressive Disease|27|||
16154268|NCT00143455|39051368|FG000|Cohort 2|Withdrawal by Subject|0|||
16444171|NCT03819049|40104461|FG006|Overall Study|Ongoing|0|||
16444172|NCT03819049|40104455|FG000|Overall Study|Other|0|||
16444173|NCT03819049|40104456|FG001|Overall Study|Other|0|||
16444174|NCT03819049|40104457|FG002|Overall Study|Other|2|||
16444175|NCT03819049|40104458|FG003|Overall Study|Other|0|||
16444176|NCT03819049|40104459|FG004|Overall Study|Other|0|||
16444177|NCT03819049|40104460|FG005|Overall Study|Other|0|||
16444178|NCT03819049|40104461|FG006|Overall Study|Other|0|||
16444179|NCT03819049|40104455|FG000|Overall Study|Randomized but not vaccinated|0|||
16154269|NCT00143455|39051369|FG001|Cohort 2|Withdrawal by Subject|0|||
16154270|NCT00143455|39051370|FG002|Cohort 2|Withdrawal by Subject|13|||
16444180|NCT03819049|40104456|FG001|Overall Study|Randomized but not vaccinated|0|||
16444181|NCT03819049|40104457|FG002|Overall Study|Randomized but not vaccinated|0|||
16444182|NCT03819049|40104458|FG003|Overall Study|Randomized but not vaccinated|1|||
16444183|NCT03819049|40104459|FG004|Overall Study|Randomized but not vaccinated|0|||
16444184|NCT03819049|40104460|FG005|Overall Study|Randomized but not vaccinated|2|||
16444185|NCT03819049|40104461|FG006|Overall Study|Randomized but not vaccinated|1|||
16444186|NCT03819049|40104455|FG000|Overall Study|Physician Decision|0|||
16444187|NCT03819049|40104456|FG001|Overall Study|Physician Decision|0|||
16444188|NCT03819049|40104457|FG002|Overall Study|Physician Decision|0|||
16444189|NCT03819049|40104458|FG003|Overall Study|Physician Decision|0|||
16444190|NCT03819049|40104459|FG004|Overall Study|Physician Decision|0|||
16444191|NCT03819049|40104460|FG005|Overall Study|Physician Decision|0|||
16444192|NCT03819049|40104461|FG006|Overall Study|Physician Decision|1|||
16444193|NCT03173248|40104462|FG000|Overall Study|Death|28|||
16262700|NCT03197883|39449520|FG000|Overall Study|Adverse Event|1|||
16444194|NCT03173248|40104463|FG001|Overall Study|Death|46|||
16154271|NCT00143455|39051371|FG003|Cohort 2|Withdrawal by Subject|12|||
16154272|NCT00143455|39051368|FG000|Cohort 2|Other|0|||
16154273|NCT00143455|39051369|FG001|Cohort 2|Other|0|||
16154274|NCT00143455|39051370|FG002|Cohort 2|Other|7|||
16154275|NCT00143455|39051371|FG003|Cohort 2|Other|6|||
16154276|NCT00143455|39051368|FG000|Cohort 2|Randomized But Not Treated|0|||
16154277|NCT00143455|39051369|FG001|Cohort 2|Randomized But Not Treated|0|||
16154278|NCT00143455|39051370|FG002|Cohort 2|Randomized But Not Treated|1|||
16154279|NCT00143455|39051371|FG003|Cohort 2|Randomized But Not Treated|1|||
16154280|NCT01239342|39051372|FG000|Overall Study|Adverse Event|1|||
16154281|NCT01239342|39051373|FG001|Overall Study|Adverse Event|0|||
16154282|NCT01239342|39051372|FG000|Overall Study|Withdrawal by Subject|1|||
16154283|NCT01239342|39051373|FG001|Overall Study|Withdrawal by Subject|5|||
16154284|NCT01239342|39051372|FG000|Overall Study|Reason Unknown|1|||
16154285|NCT01239342|39051373|FG001|Overall Study|Reason Unknown|1|||
16154286|NCT00254501|39051374|FG000|Overall Study|Lost to Follow-up|1|||
16154287|NCT00254501|39051375|FG001|Overall Study|Lost to Follow-up|1|||
16154288|NCT00644787|39051376|FG000|Period 1: Titration Phase|Adverse Event|11|||
16154289|NCT00644787|39051377|FG001|Period 1: Titration Phase|Adverse Event|0|||
16154290|NCT00644787|39051378|FG002|Period 1: Titration Phase|Adverse Event|0|||
16154291|NCT00644787|39051376|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
16154292|NCT00644787|39051377|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
16154293|NCT00644787|39051378|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
16154294|NCT00644787|39051376|FG000|Period 1: Titration Phase|Physician Decision|1|||
16154295|NCT00644787|39051377|FG001|Period 1: Titration Phase|Physician Decision|0|||
16154296|NCT00644787|39051378|FG002|Period 1: Titration Phase|Physician Decision|0|||
16154297|NCT00644787|39051376|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
16154298|NCT00644787|39051377|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
16154299|NCT00644787|39051378|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
16154300|NCT00644787|39051376|FG000|Period 1: Titration Phase|Worsening of complications|1|||
16154301|NCT00644787|39051377|FG001|Period 1: Titration Phase|Worsening of complications|0|||
16154302|NCT00644787|39051378|FG002|Period 1: Titration Phase|Worsening of complications|0|||
16154303|NCT00644787|39051376|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
16154304|NCT00644787|39051377|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
16154305|NCT00644787|39051378|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
16154306|NCT00644787|39051376|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
16154307|NCT00644787|39051377|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
16154308|NCT00644787|39051378|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
16154309|NCT00644787|39051376|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
16154310|NCT00644787|39051377|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
16154311|NCT00644787|39051378|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
16154312|NCT00644787|39051376|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
16154313|NCT00644787|39051377|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
16154314|NCT00644787|39051378|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
16154315|NCT00644787|39051376|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
16154316|NCT00644787|39051377|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
16154317|NCT00644787|39051378|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
16154318|NCT00644787|39051376|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
16444195|NCT03173248|40104462|FG000|Overall Study|Lost to Follow-up|0|||
16444196|NCT03173248|40104463|FG001|Overall Study|Lost to Follow-up|1|||
16444197|NCT03173248|40104462|FG000|Overall Study|Withdrawal by Subject|6|||
16444198|NCT03173248|40104463|FG001|Overall Study|Withdrawal by Subject|4|||
16154319|NCT00644787|39051377|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
16154320|NCT00644787|39051378|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
16154321|NCT00644787|39051376|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
16154322|NCT00644787|39051377|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
16154323|NCT00644787|39051378|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
16154324|NCT02474082|39051379|FG000|Overall Study|Adverse Event|2|||
16154325|NCT02474082|39051380|FG001|Overall Study|Adverse Event|32|||
16154326|NCT02474082|39051379|FG000|Overall Study|Withdrawal of informed consent|1|||
16154327|NCT02474082|39051380|FG001|Overall Study|Withdrawal of informed consent|11|||
16444199|NCT03173248|40104462|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
16444200|NCT03173248|40104463|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
16444201|NCT04945733|40104467|FG000|Overall Study|Physician Decision|1|||
16444202|NCT04945733|40104468|FG001|Overall Study|Physician Decision|3|||
16444203|NCT04945733|40104469|FG002|Overall Study|Physician Decision|0|||
16444204|NCT04945733|40104467|FG000|Overall Study|Withdrawal by Subject|3|||
16444205|NCT04945733|40104468|FG001|Overall Study|Withdrawal by Subject|3|||
16444206|NCT04945733|40104469|FG002|Overall Study|Withdrawal by Subject|0|||
16444207|NCT02023086|40104471|FG000|Overall Study|Withdrawal by Subject|2|||
16444208|NCT02023086|40104472|FG001|Overall Study|Withdrawal by Subject|0|||
16444209|NCT03205423|40104473|FG000|Overall Study|Personal|1|||
16444210|NCT03205423|40104474|FG001|Overall Study|Personal|1|||
16444211|NCT03205423|40104473|FG000|Overall Study|Physician Decision|0|||
16154328|NCT02474082|39051379|FG000|Overall Study|Lost to Follow-up|2|||
16154329|NCT02474082|39051380|FG001|Overall Study|Lost to Follow-up|2|||
16154330|NCT02474082|39051379|FG000|Overall Study|Dose tapering not achieved|0|||
16154331|NCT02474082|39051380|FG001|Overall Study|Dose tapering not achieved|4|||
16154332|NCT02474082|39051379|FG000|Overall Study|Participant/guardian decision|1|||
16154333|NCT02474082|39051380|FG001|Overall Study|Participant/guardian decision|2|||
16154334|NCT02474082|39051379|FG000|Overall Study|Non-compliance with study treatment|0|||
16154335|NCT02474082|39051380|FG001|Overall Study|Non-compliance with study treatment|2|||
16154336|NCT02474082|39051379|FG000|Overall Study|Protocol deviation|0|||
16154337|NCT02474082|39051380|FG001|Overall Study|Protocol deviation|1|||
16154338|NCT00761514|39051384|FG000|Overall Study|Adverse Event|1|||
16154339|NCT00761514|39051384|FG000|Overall Study|Withdrawal by Subject|2|||
16154340|NCT00761514|39051384|FG000|Overall Study|Lost to Follow-up|1|||
16154341|NCT00761514|39051384|FG000|Overall Study|Health insurance didn't cover study drug|1|||
16154342|NCT00761514|39051384|FG000|Overall Study|Problem complying with study visit|1|||
16154343|NCT00761514|39051384|FG000|Overall Study|Unable to pay for medications|1|||
16154344|NCT03652662|39051385|FG000|Overall Study|Withdrawal by Subject|2|||
16154345|NCT03652662|39051386|FG001|Overall Study|Withdrawal by Subject|1|||
16154346|NCT03652662|39051385|FG000|Overall Study|Lost to Follow-up|1|||
16154347|NCT03652662|39051386|FG001|Overall Study|Lost to Follow-up|0|||
16154348|NCT02787863|39051390|FG000|Overall Study|Death|1|||
16154349|NCT02787863|39051391|FG001|Overall Study|Death|0|||
16154350|NCT02787863|39051392|FG002|Overall Study|Death|1|||
16154351|NCT02787863|39051393|FG003|Overall Study|Death|0|||
16154352|NCT02787863|39051394|FG004|Overall Study|Death|0|||
16154353|NCT02787863|39051395|FG005|Overall Study|Death|0|||
16154354|NCT02787863|39051396|FG006|Overall Study|Death|0|||
16154355|NCT02787863|39051397|FG007|Overall Study|Death|0|||
16154356|NCT02787863|39051390|FG000|Overall Study|Withdrawal by Subject|0|||
16154357|NCT02787863|39051391|FG001|Overall Study|Withdrawal by Subject|1|||
16154358|NCT02787863|39051392|FG002|Overall Study|Withdrawal by Subject|1|||
16154359|NCT02787863|39051393|FG003|Overall Study|Withdrawal by Subject|0|||
16154360|NCT02787863|39051394|FG004|Overall Study|Withdrawal by Subject|0|||
16154361|NCT02787863|39051395|FG005|Overall Study|Withdrawal by Subject|0|||
16154362|NCT02787863|39051396|FG006|Overall Study|Withdrawal by Subject|0|||
16154363|NCT02787863|39051397|FG007|Overall Study|Withdrawal by Subject|0|||
16154364|NCT00811135|39051401|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
16154365|NCT00811135|39051401|FG000|Overall Study|Death|3|||
16154366|NCT00811135|39051401|FG000|Overall Study|Protocol Violation|2|||
16154367|NCT00811135|39051401|FG000|Overall Study|Violation of Selection Criteria|1|||
16154368|NCT00811135|39051401|FG000|Overall Study|Refused Treatment|1|||
16262701|NCT03197883|39449521|FG001|Overall Study|Adverse Event|1|||
16444212|NCT03205423|40104474|FG001|Overall Study|Physician Decision|2|||
16444213|NCT04288089|40104478|FG000|Overall Study|Ongoing Treatment|2|||
16154369|NCT00811135|39051401|FG000|Overall Study|Withdrawal by Subject|3|||
16154370|NCT00811135|39051401|FG000|Overall Study|Administrative/Other Unspecified|11|||
16154371|NCT00811135|39051401|FG000|Overall Study|Ongoing|59|||
16154372|NCT00490568|39051403|FG000|Overall Study|Adverse Event|116|||
16154373|NCT00490568|39051403|FG000|Overall Study|Lost to Follow-up|13|||
16154374|NCT00490568|39051403|FG000|Overall Study|Protocol Violation|45|||
16154375|NCT00490568|39051403|FG000|Overall Study|Withdrawal by Subject|135|||
16154376|NCT00490568|39051403|FG000|Overall Study|Still in the study at termination|974|||
16154377|NCT00490568|39051403|FG000|Overall Study|Other|1|||
16154378|NCT00490568|39051403|FG000|Overall Study|Exclusion criteria met|1|||
16154379|NCT00490568|39051403|FG000|Overall Study|Caregiver related|20|||
16154380|NCT00490568|39051403|FG000|Overall Study|Abnormal ECG|25|||
16444214|NCT04288089|40104479|FG001|Overall Study|Ongoing Treatment|1|||
16444215|NCT04288089|40104480|FG002|Overall Study|Ongoing Treatment|1|||
16444216|NCT04288089|40104481|FG003|Overall Study|Ongoing Treatment|4|||
16444217|NCT02855125|40104482|FG000|Overall Study|Withdrawal by Subject|2|||
16444218|NCT02855125|40104483|FG001|Overall Study|Withdrawal by Subject|2|||
16444219|NCT02855125|40104482|FG000|Overall Study|Clinical Disease Progression|5|||
16444220|NCT02855125|40104483|FG001|Overall Study|Clinical Disease Progression|4|||
16154381|NCT00490568|39051403|FG000|Overall Study|Participant refused follow-up|9|||
16154382|NCT00490568|39051403|FG000|Overall Study|Legal representative withdrew consent|1|||
16154383|NCT00490568|39051403|FG000|Overall Study|Disease progression|4|||
16154384|NCT00490568|39051403|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
16154385|NCT00490568|39051403|FG000|Overall Study|Investigator decision|3|||
16154386|NCT00490568|39051403|FG000|Overall Study|Non-Compliance|7|||
16444221|NCT02855125|40104482|FG000|Overall Study|Radiologic Disease Progression|36|||
16154387|NCT00490568|39051403|FG000|Overall Study|Efficacy related|3|||
16154388|NCT00490568|39051403|FG000|Overall Study|Participant died|1|||
16154389|NCT00490568|39051403|FG000|Overall Study|Participant withdrawal due to surgery|1|||
16154390|NCT04294719|39051405|FG000|Overall Study|Withdrawal by Subject|1|||
16154391|NCT00094055|39051406|FG000|Overall Study|Adverse Event|11|||
16444222|NCT02855125|40104483|FG001|Overall Study|Radiologic Disease Progression|39|||
16262702|NCT03197883|39449520|FG000|Overall Study|Lost to Follow-up|1|||
16262703|NCT03197883|39449521|FG001|Overall Study|Lost to Follow-up|0|||
16262704|NCT03197883|39449520|FG000|Overall Study|Protocol Violation|1|||
16262705|NCT03197883|39449521|FG001|Overall Study|Protocol Violation|0|||
16262706|NCT03197883|39449520|FG000|Overall Study|Other (Not Specified)|0|||
16262707|NCT03197883|39449521|FG001|Overall Study|Other (Not Specified)|5|||
16262708|NCT00935012|39449525|FG000|Overall Study|Death|19|||
16262709|NCT00935012|39449525|FG000|Overall Study|Withdrawal by Subject|3|||
16262710|NCT00935012|39449525|FG000|Overall Study|Other|5|||
16262711|NCT00935012|39449525|FG000|Overall Study|Adverse Event|2|||
16262712|NCT01675765|39449526|FG000|Overall Study|Progressive disease|4|||
16262713|NCT01675765|39449527|FG001|Overall Study|Progressive disease|4|||
16262714|NCT01675765|39449526|FG000|Overall Study|Adverse Event|1|||
16262715|NCT01675765|39449527|FG001|Overall Study|Adverse Event|2|||
16262716|NCT01675765|39449526|FG000|Overall Study|Withdrawal by Subject|2|||
16262717|NCT01675765|39449527|FG001|Overall Study|Withdrawal by Subject|0|||
16262718|NCT01675765|39449526|FG000|Overall Study|Death|1|||
16262719|NCT01675765|39449527|FG001|Overall Study|Death|0|||
16262720|NCT01675765|39449526|FG000|Overall Study|Clinical progression|3|||
16262721|NCT01675765|39449527|FG001|Overall Study|Clinical progression|2|||
16262722|NCT03173547|39449528|FG000|Overall Study|Adverse Event|2|||
16262723|NCT03173547|39449529|FG001|Overall Study|Adverse Event|0|||
16262724|NCT03173547|39449528|FG000|Overall Study|Withdrawal by Subject|2|||
16262725|NCT03173547|39449529|FG001|Overall Study|Withdrawal by Subject|2|||
16262726|NCT02294604|39449530|FG000|Overall Study|Did not provide samples for culture|0|||
16262727|NCT02294604|39449531|FG001|Overall Study|Did not provide samples for culture|1|||
16262728|NCT02294604|39449532|FG002|Overall Study|Did not provide samples for culture|0|||
16262729|NCT02294604|39449530|FG000|Overall Study|Culture contamination|1|||
16262730|NCT02294604|39449531|FG001|Overall Study|Culture contamination|2|||
16262731|NCT02294604|39449532|FG002|Overall Study|Culture contamination|0|||
16262732|NCT01380782|39449533|FG000|Overall Study|Adverse Event|0|||
16262733|NCT01380782|39449534|FG001|Overall Study|Adverse Event|1|||
16262734|NCT01380782|39449535|FG002|Overall Study|Adverse Event|0|||
16262735|NCT01380782|39449536|FG003|Overall Study|Adverse Event|0|||
16262736|NCT01380782|39449533|FG000|Overall Study|Death|1|||
16262737|NCT01380782|39449534|FG001|Overall Study|Death|0|||
16262738|NCT01380782|39449535|FG002|Overall Study|Death|0|||
16262739|NCT01380782|39449536|FG003|Overall Study|Death|0|||
16262740|NCT01380782|39449533|FG000|Overall Study|Lack of Efficacy|10|||
16262741|NCT01380782|39449534|FG001|Overall Study|Lack of Efficacy|9|||
16262742|NCT01380782|39449535|FG002|Overall Study|Lack of Efficacy|10|||
16262743|NCT01380782|39449536|FG003|Overall Study|Lack of Efficacy|3|||
16262744|NCT01380782|39449533|FG000|Overall Study|Physician Decision|1|||
16262745|NCT01380782|39449534|FG001|Overall Study|Physician Decision|0|||
16262746|NCT01380782|39449535|FG002|Overall Study|Physician Decision|0|||
16262747|NCT01380782|39449536|FG003|Overall Study|Physician Decision|0|||
16262748|NCT01380782|39449533|FG000|Overall Study|Withdrawal by Subject|0|||
16262749|NCT01380782|39449534|FG001|Overall Study|Withdrawal by Subject|0|||
16262750|NCT01380782|39449535|FG002|Overall Study|Withdrawal by Subject|1|||
16262751|NCT01380782|39449536|FG003|Overall Study|Withdrawal by Subject|1|||
16262752|NCT02514122|39449539|FG000|Overall Study|Withdrawal by Subject|2|||
16262753|NCT02514122|39449540|FG001|Overall Study|Withdrawal by Subject|0|||
16262754|NCT01547286|39449545|FG000|Overall Study|Did not meet all eligibility criteria|1|||
16262755|NCT01547286|39449545|FG000|Overall Study|Physician Decision|1|||
16262756|NCT01444378|39449546|FG000|Overall Study|Lost to Follow-up|1|||
16262757|NCT01444378|39449546|FG000|Overall Study|Withdrawal by Subject|1|||
16262758|NCT01444378|39449546|FG000|Overall Study|Death|3|||
16262759|NCT01444378|39449546|FG000|Overall Study|Administrative Closure Of The Study|2|||
16262760|NCT01444378|39449546|FG000|Overall Study|Missed Visits|10|||
16262761|NCT02441309|39449549|FG000|Overall Study|Disease progression|2|||
16262762|NCT02441309|39449550|FG001|Overall Study|Disease progression|1|||
16262763|NCT02441309|39449551|FG002|Overall Study|Disease progression|2|||
16262764|NCT02441309|39449549|FG000|Overall Study|Adverse Event|0|||
16444223|NCT02855125|40104482|FG000|Overall Study|Adverse Event|11|||
16262765|NCT02441309|39449550|FG001|Overall Study|Adverse Event|1|||
16262766|NCT02441309|39449551|FG002|Overall Study|Adverse Event|0|||
16262767|NCT02441309|39449549|FG000|Overall Study|Withdrawal by Subject|1|||
16262768|NCT02441309|39449550|FG001|Overall Study|Withdrawal by Subject|0|||
16262769|NCT02441309|39449551|FG002|Overall Study|Withdrawal by Subject|1|||
16262770|NCT01746017|39449552|FG000|Period 1|Withdrawal by Subject|0|||
16262771|NCT01746017|39449553|FG001|Period 1|Withdrawal by Subject|0|||
16262772|NCT01746017|39449554|FG002|Period 1|Withdrawal by Subject|0|||
16262773|NCT01746017|39449555|FG003|Period 1|Withdrawal by Subject|0|||
16262774|NCT01746017|39449556|FG004|Period 1|Withdrawal by Subject|0|||
16262775|NCT01746017|39449557|FG005|Period 1|Withdrawal by Subject|0|||
16262776|NCT01746017|39449558|FG006|Period 1|Withdrawal by Subject|1|||
16262777|NCT01746017|39449559|FG007|Period 1|Withdrawal by Subject|0|||
16262778|NCT01746017|39449560|FG008|Period 1|Withdrawal by Subject|0|||
16262779|NCT01746017|39449561|FG009|Period 1|Withdrawal by Subject|0|||
16262780|NCT01746017|39449562|FG010|Period 1|Withdrawal by Subject|0|||
16262781|NCT01746017|39449552|FG000|Period 3|Withdrawal by Subject|0|||
16262782|NCT01746017|39449553|FG001|Period 3|Withdrawal by Subject|0|||
16262783|NCT01746017|39449554|FG002|Period 3|Withdrawal by Subject|0|||
16262784|NCT01746017|39449555|FG003|Period 3|Withdrawal by Subject|0|||
16262785|NCT01746017|39449556|FG004|Period 3|Withdrawal by Subject|0|||
16262786|NCT01746017|39449557|FG005|Period 3|Withdrawal by Subject|1|||
16262787|NCT01746017|39449558|FG006|Period 3|Withdrawal by Subject|0|||
16262788|NCT01746017|39449559|FG007|Period 3|Withdrawal by Subject|0|||
16262789|NCT01746017|39449560|FG008|Period 3|Withdrawal by Subject|0|||
16262790|NCT01746017|39449561|FG009|Period 3|Withdrawal by Subject|0|||
16262791|NCT01746017|39449562|FG010|Period 3|Withdrawal by Subject|0|||
16262792|NCT02140060|39449563|FG000|Overall Study|Adverse Event|0|||
16262793|NCT02140060|39449564|FG001|Overall Study|Adverse Event|0|||
16262794|NCT02140060|39449565|FG002|Overall Study|Adverse Event|0|||
16262795|NCT02140060|39449566|FG003|Overall Study|Adverse Event|1|||
16262796|NCT02140060|39449567|FG004|Overall Study|Adverse Event|1|||
16262797|NCT02140060|39449568|FG005|Overall Study|Adverse Event|1|||
16262798|NCT02140060|39449563|FG000|Overall Study|Lack of Efficacy|0|||
16262799|NCT02140060|39449564|FG001|Overall Study|Lack of Efficacy|0|||
16262800|NCT02140060|39449565|FG002|Overall Study|Lack of Efficacy|0|||
16262801|NCT02140060|39449566|FG003|Overall Study|Lack of Efficacy|1|||
16262802|NCT02140060|39449567|FG004|Overall Study|Lack of Efficacy|0|||
16262803|NCT02140060|39449568|FG005|Overall Study|Lack of Efficacy|0|||
16262804|NCT01723397|39449570|FG000|Study Period 1|Protocol Violation|0|||
16262805|NCT01723397|39449571|FG001|Study Period 1|Protocol Violation|1|||
16262806|NCT01723397|39449570|FG000|Study Period 2|Protocol Violation|0|||
16262807|NCT01723397|39449571|FG001|Study Period 2|Protocol Violation|1|||
16262808|NCT02732210|39449572|FG000|Overall Study|Site Closed|0|||
16262809|NCT02732210|39449573|FG001|Overall Study|Site Closed|11|||
16262810|NCT02732210|39449572|FG000|Overall Study|Study Ended|13|||
16262811|NCT02732210|39449573|FG001|Overall Study|Study Ended|13|||
16262812|NCT02732210|39449572|FG000|Overall Study|Withdrawal by Subject|28|||
16262813|NCT02732210|39449573|FG001|Overall Study|Withdrawal by Subject|87|||
16262814|NCT02732210|39449572|FG000|Overall Study|Lost to Follow-up|5|||
16262815|NCT02732210|39449573|FG001|Overall Study|Lost to Follow-up|57|||
16262816|NCT02732210|39449572|FG000|Overall Study|Death|4|||
16262817|NCT02732210|39449573|FG001|Overall Study|Death|15|||
16262818|NCT02732210|39449572|FG000|Overall Study|Other|35|||
16262819|NCT02732210|39449573|FG001|Overall Study|Other|103|||
16262820|NCT02732210|39449572|FG000|Overall Study|Missing|0|||
16262821|NCT02732210|39449573|FG001|Overall Study|Missing|8|||
16262822|NCT03247972|39449582|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
16262823|NCT03247972|39449582|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
16262824|NCT02493868|39449583|FG000|Induction Phase: DE Participants|Adverse Event|22|||
16262825|NCT02493868|39449584|FG001|Induction Phase: DE Participants|Adverse Event|0|||
16262826|NCT02493868|39449583|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
16262827|NCT02493868|39449584|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
16262828|NCT02493868|39449583|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
16262829|NCT02493868|39449584|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
16262830|NCT02493868|39449583|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
16262831|NCT02493868|39449584|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
16262832|NCT02493868|39449583|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
16262833|NCT02493868|39449584|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
16262834|NCT02493868|39449583|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
16262835|NCT02493868|39449584|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
16262836|NCT02493868|39449583|FG000|Induction Phase: DE Participants|Other|8|||
16262837|NCT02493868|39449584|FG001|Induction Phase: DE Participants|Other|0|||
16262838|NCT02493868|39449583|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
16262839|NCT02493868|39449584|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
16262840|NCT02493868|39449583|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
16262841|NCT02493868|39449584|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
16262842|NCT02493868|39449583|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
16262843|NCT02493868|39449584|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
16262844|NCT02493868|39449583|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
16262845|NCT02493868|39449584|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
16262846|NCT02493868|39449583|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
16262847|NCT02493868|39449584|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
16262848|NCT02493868|39449583|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
16262849|NCT02493868|39449584|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
16262850|NCT02493868|39449583|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
16262851|NCT02493868|39449584|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
16262852|NCT02493868|39449583|FG000|Optimization Phase: DE+TE Participants|Other|10|||
16444224|NCT02855125|40104483|FG001|Overall Study|Adverse Event|7|||
16262853|NCT02493868|39449584|FG001|Optimization Phase: DE+TE Participants|Other|2|||
16262854|NCT02493868|39449583|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
16262855|NCT02493868|39449584|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
16262856|NCT02493868|39449583|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
16262857|NCT02493868|39449584|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
16262858|NCT02493868|39449583|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
16262859|NCT02493868|39449584|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
16262860|NCT02493868|39449583|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
16262861|NCT02493868|39449584|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
16262862|NCT02493868|39449583|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
16262863|NCT02493868|39449584|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
16262864|NCT02493868|39449583|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
16262865|NCT02493868|39449584|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
16262866|NCT02493868|39449583|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
16262867|NCT02493868|39449584|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
16262868|NCT02493868|39449583|FG000|Follow-up Phase|Lost to Follow-up|1|||
16262869|NCT02493868|39449584|FG001|Follow-up Phase|Lost to Follow-up|0|||
16262870|NCT02493868|39449583|FG000|Follow-up Phase|Withdrawal by Subject|3|||
16262871|NCT02493868|39449584|FG001|Follow-up Phase|Withdrawal by Subject|0|||
16262872|NCT02493868|39449583|FG000|Follow-up Phase|Investigator Decision|5|||
16262873|NCT02493868|39449584|FG001|Follow-up Phase|Investigator Decision|1|||
16262874|NCT02493868|39449583|FG000|Follow-up Phase|Other|2|||
16262875|NCT02493868|39449584|FG001|Follow-up Phase|Other|1|||
16262876|NCT01534520|39449589|FG000|Overall Study|Adverse Event|0|||
16262877|NCT01534520|39449590|FG001|Overall Study|Adverse Event|1|||
16262878|NCT01294787|39449591|FG000|Period 1|Adverse Event|0|||
16262879|NCT01294787|39449592|FG001|Period 1|Adverse Event|0|||
16262880|NCT01294787|39449593|FG002|Period 1|Adverse Event|0|||
16262881|NCT01294787|39449594|FG003|Period 1|Adverse Event|0|||
16366614|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
16366615|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
16262882|NCT01294787|39449595|FG004|Period 1|Adverse Event|1|||
16262883|NCT01294787|39449596|FG005|Period 1|Adverse Event|0|||
16262884|NCT01294787|39449591|FG000|Period 1|Withdrawal by Subject|0|||
16262885|NCT01294787|39449592|FG001|Period 1|Withdrawal by Subject|0|||
16262886|NCT01294787|39449593|FG002|Period 1|Withdrawal by Subject|0|||
16262887|NCT01294787|39449594|FG003|Period 1|Withdrawal by Subject|1|||
16262888|NCT01294787|39449595|FG004|Period 1|Withdrawal by Subject|1|||
16262889|NCT01294787|39449596|FG005|Period 1|Withdrawal by Subject|1|||
16262890|NCT01294787|39449591|FG000|Period 1|Administrative problem|0|||
16262891|NCT01294787|39449592|FG001|Period 1|Administrative problem|0|||
16262892|NCT01294787|39449593|FG002|Period 1|Administrative problem|1|||
16262893|NCT01294787|39449594|FG003|Period 1|Administrative problem|0|||
16262894|NCT01294787|39449595|FG004|Period 1|Administrative problem|0|||
16262895|NCT01294787|39449596|FG005|Period 1|Administrative problem|1|||
16262896|NCT01294787|39449591|FG000|Period 2|Adverse Event|0|||
16262897|NCT01294787|39449592|FG001|Period 2|Adverse Event|3|||
16262898|NCT01294787|39449593|FG002|Period 2|Adverse Event|0|||
16262899|NCT01294787|39449594|FG003|Period 2|Adverse Event|1|||
16262900|NCT01294787|39449595|FG004|Period 2|Adverse Event|0|||
16262901|NCT01294787|39449596|FG005|Period 2|Adverse Event|0|||
16262902|NCT01294787|39449591|FG000|Period 2|No longer needs study drug|0|||
16262903|NCT01294787|39449592|FG001|Period 2|No longer needs study drug|0|||
16262904|NCT01294787|39449593|FG002|Period 2|No longer needs study drug|0|||
16262905|NCT01294787|39449594|FG003|Period 2|No longer needs study drug|1|||
16262906|NCT01294787|39449595|FG004|Period 2|No longer needs study drug|0|||
16154392|NCT00094055|39051406|FG000|Overall Study|Death|4|||
16154393|NCT00094055|39051406|FG000|Overall Study|Lack of Efficacy|17|||
16154394|NCT00094055|39051406|FG000|Overall Study|Lost to Follow-up|2|||
16154395|NCT00094055|39051406|FG000|Overall Study|progressive disease|2|||
16154396|NCT00094055|39051406|FG000|Overall Study|clinical progression|1|||
16154397|NCT00094055|39051406|FG000|Overall Study|roll-over to another study|14|||
16154398|NCT00094055|39051406|FG000|Overall Study|Withdrawal by Subject|9|||
16154399|NCT04093531|39051407|FG000|Overall Study|failed screening|4|||
16154400|NCT03809611|39051408|FG000|Overall Study|Withdrawal by Subject|1|||
16154401|NCT03809611|39051409|FG001|Overall Study|Withdrawal by Subject|1|||
16154402|NCT01652885|39051410|FG000|Overall Study|Adverse Event|1|||
16154403|NCT03124784|39051413|FG000|Overall Study|Adverse Event|1|||
16154404|NCT03124784|39051413|FG000|Overall Study|Computer/Equip Malfunction|1|||
16154405|NCT02109484|39051414|FG000|Overall Study|Lost to Follow-up|0|||
16154406|NCT02109484|39051415|FG001|Overall Study|Lost to Follow-up|0|||
16154407|NCT02109484|39051416|FG002|Overall Study|Lost to Follow-up|0|||
16154408|NCT02109484|39051417|FG003|Overall Study|Lost to Follow-up|1|||
16154409|NCT02109484|39051418|FG004|Overall Study|Lost to Follow-up|1|||
16154410|NCT02109484|39051419|FG005|Overall Study|Lost to Follow-up|0|||
16154411|NCT02109484|39051420|FG006|Overall Study|Lost to Follow-up|1|||
16154412|NCT02109484|39051421|FG007|Overall Study|Lost to Follow-up|0|||
16154413|NCT02109484|39051414|FG000|Overall Study|Withdrawal by Subject|0|||
16154414|NCT02109484|39051415|FG001|Overall Study|Withdrawal by Subject|0|||
16154415|NCT02109484|39051416|FG002|Overall Study|Withdrawal by Subject|0|||
16154416|NCT02109484|39051417|FG003|Overall Study|Withdrawal by Subject|0|||
16154417|NCT02109484|39051418|FG004|Overall Study|Withdrawal by Subject|1|||
16154418|NCT02109484|39051419|FG005|Overall Study|Withdrawal by Subject|1|||
16154419|NCT02109484|39051420|FG006|Overall Study|Withdrawal by Subject|1|||
16154420|NCT02109484|39051421|FG007|Overall Study|Withdrawal by Subject|0|||
16154421|NCT02109484|39051414|FG000|Overall Study|Physician Decision|0|||
16154422|NCT02109484|39051415|FG001|Overall Study|Physician Decision|0|||
16154423|NCT02109484|39051416|FG002|Overall Study|Physician Decision|0|||
16154424|NCT02109484|39051417|FG003|Overall Study|Physician Decision|0|||
16154425|NCT02109484|39051418|FG004|Overall Study|Physician Decision|2|||
16154426|NCT02109484|39051419|FG005|Overall Study|Physician Decision|0|||
16154427|NCT02109484|39051420|FG006|Overall Study|Physician Decision|0|||
16154428|NCT02109484|39051421|FG007|Overall Study|Physician Decision|0|||
16154429|NCT02109484|39051414|FG000|Overall Study|Death|0|||
16154430|NCT02109484|39051415|FG001|Overall Study|Death|0|||
16154431|NCT02109484|39051416|FG002|Overall Study|Death|0|||
16154432|NCT02109484|39051417|FG003|Overall Study|Death|0|||
16154433|NCT02109484|39051418|FG004|Overall Study|Death|0|||
16154434|NCT02109484|39051419|FG005|Overall Study|Death|0|||
16154435|NCT02109484|39051420|FG006|Overall Study|Death|0|||
16154436|NCT02109484|39051421|FG007|Overall Study|Death|2|||
16154437|NCT02109484|39051414|FG000|Overall Study|Moved away from study area|0|||
16154438|NCT02109484|39051415|FG001|Overall Study|Moved away from study area|0|||
16154439|NCT02109484|39051416|FG002|Overall Study|Moved away from study area|0|||
16154440|NCT02109484|39051417|FG003|Overall Study|Moved away from study area|0|||
16154441|NCT02109484|39051418|FG004|Overall Study|Moved away from study area|0|||
16154442|NCT02109484|39051419|FG005|Overall Study|Moved away from study area|0|||
16154443|NCT02109484|39051420|FG006|Overall Study|Moved away from study area|1|||
16154444|NCT02109484|39051421|FG007|Overall Study|Moved away from study area|1|||
16154445|NCT00535132|39051422|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
16262907|NCT01294787|39449596|FG005|Period 2|No longer needs study drug|0|||
16262908|NCT01294787|39449591|FG000|Period 3|Adverse Event|0|||
16262909|NCT01294787|39449592|FG001|Period 3|Adverse Event|0|||
16262910|NCT01294787|39449593|FG002|Period 3|Adverse Event|0|||
16262911|NCT01294787|39449594|FG003|Period 3|Adverse Event|0|||
16262912|NCT01294787|39449595|FG004|Period 3|Adverse Event|1|||
16262913|NCT01294787|39449596|FG005|Period 3|Adverse Event|0|||
16262914|NCT04499963|39449598|FG000|Overall Study|Adverse Event|3|||
16262915|NCT04499963|39449599|FG001|Overall Study|Adverse Event|0|||
16262916|NCT04499963|39449598|FG000|Overall Study|Death|3|||
16262917|NCT04499963|39449599|FG001|Overall Study|Death|0|||
16262918|NCT04499963|39449598|FG000|Overall Study|Lack of Efficacy|7|||
16262919|NCT04499963|39449599|FG001|Overall Study|Lack of Efficacy|0|||
16262920|NCT04499963|39449598|FG000|Overall Study|Lost to Follow-up|2|||
16262921|NCT04499963|39449599|FG001|Overall Study|Lost to Follow-up|0|||
16262922|NCT02890992|39449605|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
16262923|NCT02890992|39449606|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
16262924|NCT02890992|39449607|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
16262925|NCT02890992|39449608|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
16262926|NCT02890992|39449609|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
16262927|NCT02890992|39449610|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
16262928|NCT02890992|39449611|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
16262929|NCT02890992|39449612|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
16262930|NCT02890992|39449605|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
16262931|NCT02890992|39449606|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
16262932|NCT02890992|39449607|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
16262933|NCT02890992|39449608|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
16262934|NCT02890992|39449609|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
16262935|NCT02890992|39449610|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
16262936|NCT02890992|39449611|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
16262937|NCT02890992|39449612|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
16262938|NCT02890992|39449605|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
16262939|NCT02890992|39449606|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
16262940|NCT02890992|39449607|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
16262941|NCT02890992|39449608|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
16262942|NCT02890992|39449609|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
16262943|NCT02890992|39449610|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
16262944|NCT02890992|39449611|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
16262945|NCT02890992|39449612|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
16262946|NCT01949662|39449614|FG000|Overall Study|Death|9|||
16262947|NCT01949662|39449615|FG001|Overall Study|Death|7|||
16262948|NCT01949662|39449614|FG000|Overall Study|Discharged before an agitation event|8|||
16262949|NCT01949662|39449615|FG001|Overall Study|Discharged before an agitation event|3|||
16262950|NCT01949662|39449614|FG000|Overall Study|Dropped out|1|||
16262951|NCT01949662|39449615|FG001|Overall Study|Dropped out|3|||
16262952|NCT01949662|39449614|FG000|Overall Study|Ineligible|0|||
16262953|NCT01949662|39449615|FG001|Overall Study|Ineligible|1|||
16262954|NCT01136382|39449616|FG000|Overall Study|Other|8|||
16262955|NCT01136382|39449617|FG001|Overall Study|Other|3|||
16262956|NCT01136382|39449616|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
16262957|NCT01136382|39449617|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
16444225|NCT02855125|40104482|FG000|Overall Study|Physician Decision|1|||
16444226|NCT02855125|40104483|FG001|Overall Study|Physician Decision|0|||
16444227|NCT02855125|40104482|FG000|Overall Study|On Treatment|9|||
16444228|NCT02855125|40104483|FG001|Overall Study|On Treatment|11|||
16444229|NCT02855125|40104482|FG000|Overall Study|Randomized but not treated|0|||
16444230|NCT02855125|40104483|FG001|Overall Study|Randomized but not treated|1|||
16444231|NCT00626106|40104484|FG000|Overall Study|Withdrawal by Subject|2|||
16444232|NCT00626106|40104485|FG001|Overall Study|Withdrawal by Subject|1|||
16444233|NCT00626106|40104484|FG000|Overall Study|Lost to Follow-up|1|||
16444234|NCT00626106|40104485|FG001|Overall Study|Lost to Follow-up|4|||
16444235|NCT00626106|40104484|FG000|Overall Study|Death|64|||
16444236|NCT00626106|40104485|FG001|Overall Study|Death|19|||
16444237|NCT03919773|40104486|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
16444238|NCT03919773|40104487|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
16444239|NCT03919773|40104486|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
16444240|NCT03919773|40104487|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
16444241|NCT03239340|40104496|FG000|Overall Study|Other|26|||
16444242|NCT03239340|40104496|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
16444243|NCT03239340|40104496|FG000|Overall Study|Death|40|||
16444244|NCT03239340|40104496|FG000|Overall Study|Lost to Follow-up|2|||
16444245|NCT03239340|40104496|FG000|Overall Study|Physician Decision|16|||
16444246|NCT03239340|40104496|FG000|Overall Study|Withdrawal by Subject|27|||
16444247|NCT03467750|40104499|FG000|Overall Study|Surgery canceled|1|||
16444248|NCT03467750|40104500|FG001|Overall Study|Surgery canceled|0|||
16444249|NCT03467750|40104499|FG000|Overall Study|Protocol Violation|1|||
16444250|NCT03467750|40104500|FG001|Overall Study|Protocol Violation|1|||
16444251|NCT03467750|40104499|FG000|Overall Study|Withdrawal by Subject|0|||
16444252|NCT03467750|40104500|FG001|Overall Study|Withdrawal by Subject|1|||
16444253|NCT04325828|40104501|FG000|Overall Study|Ongoing|26|||
16444254|NCT01116648|40104503|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
16262958|NCT01136382|39449616|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
16262959|NCT01136382|39449617|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
16262960|NCT01136382|39449616|FG000|Overall Study|Withdrawal by Subject|4|||
16262961|NCT01136382|39449617|FG001|Overall Study|Withdrawal by Subject|1|||
16262962|NCT01900626|39449622|FG000|Overall Study|study was closed due to low enrollment|1|||
16262963|NCT01900626|39449623|FG001|Overall Study|study was closed due to low enrollment|1|||
16262964|NCT02196675|39449624|FG000|Overall Study|Withdrawal by Subject|1|||
16262965|NCT02196675|39449625|FG001|Overall Study|Withdrawal by Subject|0|||
16262966|NCT02196675|39449626|FG002|Overall Study|Withdrawal by Subject|0|||
16262967|NCT02196675|39449624|FG000|Overall Study|Intra-operative surgical exclusion|1|||
16262968|NCT02196675|39449625|FG001|Overall Study|Intra-operative surgical exclusion|1|||
16262969|NCT02196675|39449626|FG002|Overall Study|Intra-operative surgical exclusion|0|||
16262970|NCT02196675|39449624|FG000|Overall Study|Protocol Violation|0|||
16262971|NCT02196675|39449625|FG001|Overall Study|Protocol Violation|1|||
16154446|NCT00535132|39051423|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
16262972|NCT02196675|39449626|FG002|Overall Study|Protocol Violation|0|||
16262973|NCT02196675|39449624|FG000|Overall Study|Death|0|||
16444255|NCT01116648|40104504|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
16444256|NCT01116648|40104505|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
16444257|NCT01116648|40104506|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
16444258|NCT01116648|40104507|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
16444259|NCT01116648|40104508|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
16444260|NCT01116648|40104509|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
16444261|NCT01116648|40104510|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
16444262|NCT01116648|40104511|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
16444263|NCT01116648|40104512|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
16444264|NCT01116648|40104513|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
16444265|NCT01116648|40104514|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
16444266|NCT01116648|40104515|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
16444267|NCT01116648|40104516|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
16444268|NCT01116648|40104517|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
16444269|NCT04163016|40104518|FG000|Enrollment|Adverse Event|1|||
16262974|NCT02196675|39449625|FG001|Overall Study|Death|0|||
16262975|NCT02196675|39449626|FG002|Overall Study|Death|1|||
16262976|NCT01854047|39449627|FG000|Overall Study|Lack of Efficacy|1|||
16262977|NCT01854047|39449628|FG001|Overall Study|Lack of Efficacy|0|||
16262978|NCT01854047|39449629|FG002|Overall Study|Lack of Efficacy|0|||
16262979|NCT01854047|39449630|FG003|Overall Study|Lack of Efficacy|0|||
16262980|NCT01854047|39449631|FG004|Overall Study|Lack of Efficacy|0|||
16262981|NCT01854047|39449627|FG000|Overall Study|Poor compliance to protocol|3|||
16262982|NCT01854047|39449628|FG001|Overall Study|Poor compliance to protocol|0|||
16262983|NCT01854047|39449629|FG002|Overall Study|Poor compliance to protocol|2|||
16262984|NCT01854047|39449630|FG003|Overall Study|Poor compliance to protocol|0|||
16262985|NCT01854047|39449631|FG004|Overall Study|Poor compliance to protocol|0|||
16262986|NCT01854047|39449627|FG000|Overall Study|Adverse Event|5|||
16262987|NCT01854047|39449628|FG001|Overall Study|Adverse Event|4|||
16262988|NCT01854047|39449629|FG002|Overall Study|Adverse Event|6|||
16262989|NCT01854047|39449630|FG003|Overall Study|Adverse Event|10|||
16262990|NCT01854047|39449631|FG004|Overall Study|Adverse Event|7|||
16366616|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
16366617|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
16366618|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
16366619|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
16366620|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
16366621|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
16366622|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
16366623|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
16366624|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
16366625|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
16366626|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
16366627|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
16366628|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
16366629|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
16366630|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
16366631|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
16366632|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
16366633|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
16366634|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
16366635|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
16366636|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
16366637|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
16366638|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
16366639|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
16262991|NCT01854047|39449627|FG000|Overall Study|Randomized but not treated|0|||
16262992|NCT01854047|39449628|FG001|Overall Study|Randomized but not treated|1|||
16262993|NCT01854047|39449629|FG002|Overall Study|Randomized but not treated|2|||
16262994|NCT01854047|39449630|FG003|Overall Study|Randomized but not treated|0|||
16262995|NCT01854047|39449631|FG004|Overall Study|Randomized but not treated|4|||
16262996|NCT01854047|39449627|FG000|Overall Study|Other than specified above|3|||
16262997|NCT01854047|39449628|FG001|Overall Study|Other than specified above|3|||
16262998|NCT01854047|39449629|FG002|Overall Study|Other than specified above|3|||
16262999|NCT01854047|39449630|FG003|Overall Study|Other than specified above|5|||
16263000|NCT01854047|39449631|FG004|Overall Study|Other than specified above|8|||
16263001|NCT01792635|39449632|FG000|Part B|Adverse Event|0|||
16263002|NCT01792635|39449633|FG001|Part B|Adverse Event|0|||
16263003|NCT01792635|39449634|FG002|Part B|Adverse Event|1|||
16263004|NCT01792635|39449632|FG000|Part B|Study terminated|0|||
16263005|NCT01792635|39449633|FG001|Part B|Study terminated|4|||
16263006|NCT01792635|39449634|FG002|Part B|Study terminated|3|||
16263007|NCT02128997|39449635|FG000|Overall Study|Lost to Follow-up|6|||
16263008|NCT02128997|39449636|FG001|Overall Study|Lost to Follow-up|11|||
16263009|NCT02412852|39449637|FG000|Overall Study|Withdrawal by Subject|0|||
16263010|NCT02412852|39449638|FG001|Overall Study|Withdrawal by Subject|1|||
16263011|NCT02412852|39449639|FG002|Overall Study|Withdrawal by Subject|0|||
16263012|NCT02412852|39449640|FG003|Overall Study|Withdrawal by Subject|0|||
16263013|NCT02412852|39449637|FG000|Overall Study|Physician Decision|0|||
16263014|NCT02412852|39449638|FG001|Overall Study|Physician Decision|0|||
16263015|NCT02412852|39449639|FG002|Overall Study|Physician Decision|0|||
16263016|NCT02412852|39449640|FG003|Overall Study|Physician Decision|1|||
16263017|NCT00624065|39449641|FG000|Overall Study|Adverse Event|5|||
16263018|NCT00624065|39449642|FG001|Overall Study|Adverse Event|6|||
16263019|NCT00624065|39449641|FG000|Overall Study|Lost to Follow-up|4|||
16263020|NCT00624065|39449642|FG001|Overall Study|Lost to Follow-up|1|||
16263021|NCT00624065|39449641|FG000|Overall Study|Consent withdrawn|6|||
16263022|NCT00624065|39449642|FG001|Overall Study|Consent withdrawn|5|||
16263023|NCT00624065|39449641|FG000|Overall Study|Lack of Efficacy|0|||
16263024|NCT00624065|39449642|FG001|Overall Study|Lack of Efficacy|3|||
16263025|NCT00624065|39449641|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
16263026|NCT00624065|39449642|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
16263027|NCT03017885|39449643|FG000|Overall Study|Adverse Event|2|||
16263028|NCT03017885|39449644|FG001|Overall Study|Adverse Event|0|||
16263029|NCT03017885|39449645|FG002|Overall Study|Adverse Event|0|||
16263030|NCT03017885|39449646|FG003|Overall Study|Adverse Event|0|||
16263031|NCT03017885|39449647|FG004|Overall Study|Adverse Event|0|||
16263032|NCT03017885|39449648|FG005|Overall Study|Adverse Event|0|||
16263033|NCT03017885|39449643|FG000|Overall Study|Progression of disease|4|||
16263034|NCT03017885|39449644|FG001|Overall Study|Progression of disease|3|||
16263035|NCT03017885|39449645|FG002|Overall Study|Progression of disease|4|||
16263036|NCT03017885|39449646|FG003|Overall Study|Progression of disease|0|||
16263037|NCT03017885|39449647|FG004|Overall Study|Progression of disease|0|||
16263038|NCT03017885|39449648|FG005|Overall Study|Progression of disease|0|||
16263039|NCT03017885|39449643|FG000|Overall Study|Other than listed|1|||
16263040|NCT03017885|39449644|FG001|Overall Study|Other than listed|2|||
16263041|NCT03017885|39449645|FG002|Overall Study|Other than listed|1|||
16263042|NCT03017885|39449646|FG003|Overall Study|Other than listed|0|||
16263043|NCT03017885|39449647|FG004|Overall Study|Other than listed|0|||
16263044|NCT03017885|39449648|FG005|Overall Study|Other than listed|0|||
16263045|NCT03017885|39449643|FG000|Overall Study|Lost to Follow-up|2|||
16263046|NCT03017885|39449644|FG001|Overall Study|Lost to Follow-up|0|||
16263047|NCT03017885|39449645|FG002|Overall Study|Lost to Follow-up|3|||
16263048|NCT03017885|39449646|FG003|Overall Study|Lost to Follow-up|0|||
16263049|NCT03017885|39449647|FG004|Overall Study|Lost to Follow-up|0|||
16263050|NCT03017885|39449648|FG005|Overall Study|Lost to Follow-up|0|||
16263051|NCT03017885|39449643|FG000|Overall Study|Change to other anti-cancer therapy|0|||
16263052|NCT03017885|39449644|FG001|Overall Study|Change to other anti-cancer therapy|0|||
16263053|NCT03017885|39449645|FG002|Overall Study|Change to other anti-cancer therapy|1|||
16263054|NCT03017885|39449646|FG003|Overall Study|Change to other anti-cancer therapy|0|||
16263055|NCT03017885|39449647|FG004|Overall Study|Change to other anti-cancer therapy|0|||
16154447|NCT00535132|39051422|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
16263056|NCT03017885|39449648|FG005|Overall Study|Change to other anti-cancer therapy|0|||
16263057|NCT04669262|39449649|FG000|Overall Study|Withdrawal by Subject|0|||
16263058|NCT04669262|39449650|FG001|Overall Study|Withdrawal by Subject|0|||
16263059|NCT04669262|39449651|FG002|Overall Study|Withdrawal by Subject|0|||
16263060|NCT04669262|39449652|FG003|Overall Study|Withdrawal by Subject|1|||
16263061|NCT04669262|39449649|FG000|Overall Study|Randomized but Not Treated|0|||
16263062|NCT04669262|39449650|FG001|Overall Study|Randomized but Not Treated|1|||
16263063|NCT04669262|39449651|FG002|Overall Study|Randomized but Not Treated|0|||
16263064|NCT04669262|39449652|FG003|Overall Study|Randomized but Not Treated|0|||
16263065|NCT02159950|39449653|FG000|Overall Study|Adverse Event|0|||
16263066|NCT02159950|39449654|FG001|Overall Study|Adverse Event|1|||
16263067|NCT02159950|39449653|FG000|Overall Study|Progression|0|||
16263068|NCT02159950|39449654|FG001|Overall Study|Progression|1|||
16263069|NCT00904215|39449655|FG000|Overall Study|Adverse Event|25|||
16263070|NCT00904215|39449655|FG000|Overall Study|Protocol Violation|10|||
16444270|NCT04163016|40104519|FG001|Enrollment|Adverse Event|0|||
16444271|NCT04163016|40104520|FG002|Enrollment|Adverse Event|0|||
16444272|NCT04163016|40104521|FG003|Enrollment|Adverse Event|0|||
16444273|NCT04163016|40104518|FG000|Treatment|Adverse Event|0|||
16444274|NCT04163016|40104519|FG001|Treatment|Adverse Event|1|||
16444275|NCT04163016|40104520|FG002|Treatment|Adverse Event|0|||
16444276|NCT04163016|40104521|FG003|Treatment|Adverse Event|0|||
16444277|NCT04163016|40104518|FG000|Treatment|Withdrawal by Subject|0|||
16444278|NCT04163016|40104519|FG001|Treatment|Withdrawal by Subject|2|||
16444279|NCT04163016|40104520|FG002|Treatment|Withdrawal by Subject|0|||
16444280|NCT04163016|40104521|FG003|Treatment|Withdrawal by Subject|0|||
16444281|NCT04163016|40104518|FG000|Treatment|Indeterminate TB-test|0|||
16444282|NCT04163016|40104519|FG001|Treatment|Indeterminate TB-test|0|||
16444283|NCT04163016|40104520|FG002|Treatment|Indeterminate TB-test|0|||
16444284|NCT04163016|40104521|FG003|Treatment|Indeterminate TB-test|1|||
16444285|NCT04163016|40104518|FG000|Treatment|Participant did not want to continue in study|0|||
16444286|NCT04163016|40104519|FG001|Treatment|Participant did not want to continue in study|0|||
16444287|NCT04163016|40104520|FG002|Treatment|Participant did not want to continue in study|0|||
16154448|NCT00535132|39051423|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
16154449|NCT03603496|39051441|FG000|Overall Study|Death|19|||
16154450|NCT03603496|39051442|FG001|Overall Study|Death|24|||
16154451|NCT03603496|39051441|FG000|Overall Study|Lost to Follow-up|141|||
16154452|NCT03603496|39051442|FG001|Overall Study|Lost to Follow-up|141|||
16154453|NCT03603496|39051441|FG000|Overall Study|Withdrawal by Subject|26|||
16154454|NCT03603496|39051442|FG001|Overall Study|Withdrawal by Subject|20|||
16154455|NCT00960661|39051443|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
16154456|NCT00960661|39051444|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
16154457|NCT00960661|39051445|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
16154458|NCT00960661|39051443|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
16154459|NCT00960661|39051444|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
16154460|NCT00960661|39051445|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
16154461|NCT00960661|39051443|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
16154462|NCT00960661|39051444|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
16154463|NCT00960661|39051445|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
16154464|NCT00960661|39051443|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
16154465|NCT00960661|39051444|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
16263071|NCT00904215|39449655|FG000|Overall Study|Lost to Follow-up|63|||
16263072|NCT00904215|39449655|FG000|Overall Study|Withdrawal by Subject|9|||
16263073|NCT00904215|39449655|FG000|Overall Study|Other|28|||
16263074|NCT01878292|39449658|FG000|Randomized|Protocol Violation|1|||
16263075|NCT01878292|39449659|FG001|Randomized|Protocol Violation|0|||
16263076|NCT01878292|39449660|FG002|Randomized|Protocol Violation|0|||
16263077|NCT01878292|39449658|FG000|Randomized|Lost to Follow-up|1|||
16263078|NCT01878292|39449659|FG001|Randomized|Lost to Follow-up|0|||
16263079|NCT01878292|39449660|FG002|Randomized|Lost to Follow-up|0|||
16263080|NCT01878292|39449658|FG000|Randomized|Adverse Event|1|||
16444288|NCT04163016|40104521|FG003|Treatment|Participant did not want to continue in study|1|||
16263081|NCT01878292|39449659|FG001|Randomized|Adverse Event|0|||
16263082|NCT01878292|39449660|FG002|Randomized|Adverse Event|0|||
16263083|NCT01878292|39449658|FG000|Double-blind Treatment Period|Other Reasons|2|||
16263084|NCT01878292|39449659|FG001|Double-blind Treatment Period|Other Reasons|0|||
16263085|NCT01878292|39449660|FG002|Double-blind Treatment Period|Other Reasons|0|||
16154466|NCT00960661|39051445|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
16154467|NCT00960661|39051443|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
16154468|NCT00960661|39051444|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
16154469|NCT00960661|39051445|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
16154470|NCT00960661|39051443|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
16154471|NCT00960661|39051444|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
16154472|NCT00960661|39051445|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
16154473|NCT00960661|39051443|FG000|Interventional Phase|Adverse Event|0|||
16154474|NCT00960661|39051444|FG001|Interventional Phase|Adverse Event|17|||
16154475|NCT00960661|39051445|FG002|Interventional Phase|Adverse Event|8|||
16154476|NCT00960661|39051443|FG000|Interventional Phase|Death|0|||
16154477|NCT00960661|39051444|FG001|Interventional Phase|Death|1|||
16154478|NCT00960661|39051445|FG002|Interventional Phase|Death|0|||
16154479|NCT00960661|39051443|FG000|Interventional Phase|Lost to Follow-up|0|||
16154480|NCT00960661|39051444|FG001|Interventional Phase|Lost to Follow-up|0|||
16154481|NCT00960661|39051445|FG002|Interventional Phase|Lost to Follow-up|2|||
16154482|NCT00960661|39051443|FG000|Interventional Phase|entry criteria not met|0|||
16154483|NCT00960661|39051444|FG001|Interventional Phase|entry criteria not met|3|||
16154484|NCT00960661|39051445|FG002|Interventional Phase|entry criteria not met|0|||
16154485|NCT00960661|39051443|FG000|Interventional Phase|Protocol Violation|0|||
16154486|NCT00960661|39051444|FG001|Interventional Phase|Protocol Violation|7|||
16154487|NCT00960661|39051445|FG002|Interventional Phase|Protocol Violation|2|||
16154488|NCT00960661|39051443|FG000|Interventional Phase|Withdrawal by Subject|0|||
16154489|NCT00960661|39051444|FG001|Interventional Phase|Withdrawal by Subject|18|||
16154490|NCT00960661|39051445|FG002|Interventional Phase|Withdrawal by Subject|29|||
16154491|NCT00960661|39051443|FG000|Interventional Phase|Physician Decision|0|||
16154492|NCT00960661|39051444|FG001|Interventional Phase|Physician Decision|3|||
16154493|NCT00960661|39051445|FG002|Interventional Phase|Physician Decision|5|||
16154494|NCT00960661|39051443|FG000|Interventional Phase|sponsor decision|0|||
16154495|NCT00960661|39051444|FG001|Interventional Phase|sponsor decision|1|||
16154496|NCT00960661|39051445|FG002|Interventional Phase|sponsor decision|0|||
16154497|NCT00960661|39051443|FG000|Interventional Phase|Lack of Efficacy|0|||
16154498|NCT00960661|39051444|FG001|Interventional Phase|Lack of Efficacy|2|||
16154499|NCT00960661|39051445|FG002|Interventional Phase|Lack of Efficacy|0|||
16154500|NCT00385255|39051446|FG000|Overall Study|Serious Adverse Event|1|||
16154501|NCT00385255|39051447|FG001|Overall Study|Serious Adverse Event|2|||
16154502|NCT00385255|39051446|FG000|Overall Study|Protocol Violation|0|||
16154503|NCT00385255|39051447|FG001|Overall Study|Protocol Violation|4|||
16154504|NCT00385255|39051446|FG000|Overall Study|Withdrawal by Subject|0|||
16154505|NCT00385255|39051447|FG001|Overall Study|Withdrawal by Subject|8|||
16154506|NCT00385255|39051446|FG000|Overall Study|Migrated/moved from study area|0|||
16154507|NCT00385255|39051447|FG001|Overall Study|Migrated/moved from study area|1|||
16154508|NCT00385255|39051446|FG000|Overall Study|Lost to Follow-up|20|||
16154509|NCT00385255|39051447|FG001|Overall Study|Lost to Follow-up|58|||
16154510|NCT00075400|39051448|FG000|Overall Study|Ineligible: wrong primary|1|||
16154511|NCT00075400|39051448|FG000|Overall Study|Never treated|2|||
16154512|NCT01967537|39051451|FG000|Overall Study|Withdrawal by Subject|52|||
16154513|NCT01967537|39051451|FG000|Overall Study|Refuse treatment|2|||
16154514|NCT01967537|39051451|FG000|Overall Study|Lost to Follow-up|6|||
16444289|NCT04500158|40104522|FG000|Overall Study|Physician Decision|17|||
16444290|NCT04500158|40104523|FG001|Overall Study|Physician Decision|11|||
16154515|NCT01058096|39051458|FG000|Double-blind Treatment Phase|Adverse Event|11|||
16263086|NCT01878292|39449658|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
16263087|NCT01878292|39449659|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
16263088|NCT01878292|39449660|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
16263089|NCT01878292|39449658|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
16263090|NCT01878292|39449659|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
16263091|NCT01878292|39449660|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
16263092|NCT01878292|39449658|FG000|Double-blind Treatment Period|Protocol Violation|3|||
16263093|NCT01878292|39449659|FG001|Double-blind Treatment Period|Protocol Violation|4|||
16154516|NCT01058096|39051459|FG001|Double-blind Treatment Phase|Adverse Event|15|||
16263094|NCT01878292|39449660|FG002|Double-blind Treatment Period|Protocol Violation|2|||
16263095|NCT01878292|39449658|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
16263096|NCT01878292|39449659|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
16263097|NCT01878292|39449660|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
16263098|NCT01878292|39449658|FG000|Double-blind Treatment Period|Adverse Event|4|||
16154517|NCT01058096|39051458|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
16154518|NCT01058096|39051459|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
16263099|NCT01878292|39449659|FG001|Double-blind Treatment Period|Adverse Event|9|||
16444291|NCT03492177|40105131|FG000|Overall Study|Adverse Event|1|||
16154519|NCT01058096|39051458|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
16263100|NCT01878292|39449660|FG002|Double-blind Treatment Period|Adverse Event|8|||
16263101|NCT01878292|39449658|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
16154520|NCT01058096|39051459|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
16444292|NCT03492177|40105132|FG001|Overall Study|Adverse Event|0|||
16444293|NCT03492177|40105133|FG002|Overall Study|Adverse Event|0|||
16444294|NCT03492177|40105131|FG000|Overall Study|Death|3|||
16444295|NCT03492177|40105132|FG001|Overall Study|Death|0|||
16444296|NCT03492177|40105133|FG002|Overall Study|Death|3|||
16444297|NCT03492177|40105131|FG000|Overall Study|Lack of Efficacy|1|||
16444298|NCT03492177|40105132|FG001|Overall Study|Lack of Efficacy|2|||
16444299|NCT03492177|40105133|FG002|Overall Study|Lack of Efficacy|0|||
16154521|NCT01058096|39051458|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
16154522|NCT01058096|39051459|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
16154523|NCT01058096|39051458|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
16154524|NCT01058096|39051459|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
16154525|NCT01058096|39051458|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
16154526|NCT01058096|39051459|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
16154527|NCT01368835|39051460|FG000|Overall Study|Inclusion criteria/photography quality|22|||
16154528|NCT01368835|39051460|FG000|Overall Study|Lost to Follow-up|11|||
16154529|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
16154530|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
16154531|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
16154532|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
16154533|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
16154534|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
16154535|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
16154536|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
16154537|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
16154538|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
16154539|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
16154540|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
16154541|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
16154542|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
16154543|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
16154544|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
16154545|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
16154546|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
16154547|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
16154548|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
16154549|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
16154550|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
16154551|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
16154552|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
16154553|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
16154554|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
16154555|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
16154556|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
16154557|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
16154558|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
16154559|NCT00784654|39051461|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
16154560|NCT00784654|39051462|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
16154561|NCT00784654|39051463|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
16154562|NCT00784654|39051461|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
16154563|NCT00784654|39051462|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
16154564|NCT00784654|39051463|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
16154565|NCT00784654|39051461|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
16154566|NCT00784654|39051462|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
16154567|NCT00784654|39051463|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
16154568|NCT00784654|39051461|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
16154569|NCT00784654|39051462|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
16154570|NCT00784654|39051463|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
16154571|NCT00784654|39051461|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
16154572|NCT00784654|39051462|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
16154573|NCT00784654|39051463|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
16154574|NCT00784654|39051461|FG000|Randomized Withdrawal Period|Adverse Event|0|||
16444300|NCT03492177|40105131|FG000|Overall Study|Other|1|||
16444301|NCT03492177|40105132|FG001|Overall Study|Other|0|||
16444302|NCT03492177|40105133|FG002|Overall Study|Other|0|||
16444303|NCT03492177|40105131|FG000|Overall Study|Ongoing|16|||
16444304|NCT03492177|40105132|FG001|Overall Study|Ongoing|19|||
16444305|NCT03492177|40105133|FG002|Overall Study|Ongoing|17|||
16154575|NCT00784654|39051462|FG001|Randomized Withdrawal Period|Adverse Event|1|||
16154576|NCT00784654|39051463|FG002|Randomized Withdrawal Period|Adverse Event|1|||
16444306|NCT01285557|40105134|FG000|Overall Study|Death|173|||
16444307|NCT01285557|40105135|FG001|Overall Study|Death|90|||
16444308|NCT01285557|40105134|FG000|Overall Study|Lost to Follow-up|6|||
16444309|NCT01285557|40105135|FG001|Overall Study|Lost to Follow-up|2|||
16444310|NCT01285557|40105134|FG000|Overall Study|Withdrew Consent|6|||
16444311|NCT01285557|40105135|FG001|Overall Study|Withdrew Consent|1|||
16444312|NCT01285557|40105134|FG000|Overall Study|Sponsor Study Termination|23|||
16444313|NCT01285557|40105135|FG001|Overall Study|Sponsor Study Termination|13|||
16444314|NCT01285557|40105134|FG000|Overall Study|Randomized but not treated|1|||
16444315|NCT01285557|40105135|FG001|Overall Study|Randomized but not treated|1|||
16444316|NCT01285557|40105134|FG000|Overall Study|Study follow-up ongoing|28|||
16444317|NCT01285557|40105135|FG001|Overall Study|Study follow-up ongoing|14|||
16444318|NCT01285557|40105134|FG000|Overall Study|Sponsor Decision|2|||
16444319|NCT01285557|40105135|FG001|Overall Study|Sponsor Decision|1|||
16444320|NCT01967238|40105138|FG000|Overall Study|Adverse Event|1|||
16444321|NCT01967238|40105139|FG001|Overall Study|Adverse Event|1|||
16444322|NCT01967238|40105140|FG002|Overall Study|Adverse Event|0|||
16444323|NCT01967238|40105138|FG000|Overall Study|Lost to Follow-up|1|||
16444324|NCT01967238|40105139|FG001|Overall Study|Lost to Follow-up|0|||
16444325|NCT01967238|40105140|FG002|Overall Study|Lost to Follow-up|1|||
16444326|NCT01967238|40105138|FG000|Overall Study|Withdrawal by Subject|0|||
16444327|NCT01967238|40105139|FG001|Overall Study|Withdrawal by Subject|0|||
16444328|NCT01967238|40105140|FG002|Overall Study|Withdrawal by Subject|1|||
16444329|NCT04929249|40105141|FG000|Overall Study|Adverse Event|2|||
16444330|NCT04929249|40105142|FG001|Overall Study|Adverse Event|1|||
16444331|NCT04929249|40105141|FG000|Overall Study|Death|2|||
16444332|NCT04929249|40105142|FG001|Overall Study|Death|1|||
16444333|NCT04929249|40105141|FG000|Overall Study|Lost to Follow-up|3|||
16154577|NCT00784654|39051461|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
16154578|NCT00784654|39051462|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
16154579|NCT00784654|39051463|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
16154580|NCT00784654|39051461|FG000|Randomized Withdrawal Period|Family reasons|0|||
16154581|NCT00784654|39051462|FG001|Randomized Withdrawal Period|Family reasons|0|||
16154582|NCT00784654|39051463|FG002|Randomized Withdrawal Period|Family reasons|1|||
16154583|NCT00390546|39051464|FG000|Overall Study|Renal impairment|1|||
16154584|NCT00390546|39051465|FG001|Overall Study|Renal impairment|0|||
16154585|NCT00390546|39051464|FG000|Overall Study|Physician Decision|5|||
16154586|NCT00390546|39051465|FG001|Overall Study|Physician Decision|5|||
16154587|NCT01883635|39051467|FG000|Overall Study|Withdrawal by Subject|4|||
16154588|NCT01883635|39051468|FG001|Overall Study|Withdrawal by Subject|0|||
16154589|NCT03021642|39051469|FG000|Washout Period (21 Days)|Adverse Event|1|||
16154590|NCT03021642|39051470|FG001|Washout Period (21 Days)|Adverse Event|1|||
16154591|NCT00763815|39051471|FG000|Overall Study|Adverse Event|14|||
16154592|NCT00763815|39051472|FG001|Overall Study|Adverse Event|29|||
16154593|NCT00763815|39051471|FG000|Overall Study|Lack of Efficacy|10|||
16154594|NCT00763815|39051472|FG001|Overall Study|Lack of Efficacy|11|||
16154595|NCT00763815|39051471|FG000|Overall Study|Poor Compliance to Protocol|6|||
16154596|NCT00763815|39051472|FG001|Overall Study|Poor Compliance to Protocol|6|||
16154597|NCT00763815|39051471|FG000|Overall Study|Lost to Follow-up|2|||
16154598|NCT00763815|39051472|FG001|Overall Study|Lost to Follow-up|4|||
16154599|NCT00763815|39051471|FG000|Overall Study|Early Termination|1|||
16154600|NCT00763815|39051472|FG001|Overall Study|Early Termination|0|||
16154601|NCT00763815|39051471|FG000|Overall Study|Familial and Personal Reasons|9|||
16154602|NCT00763815|39051472|FG001|Overall Study|Familial and Personal Reasons|16|||
16154603|NCT00763815|39051471|FG000|Overall Study|Physician Decision|1|||
16154604|NCT00763815|39051472|FG001|Overall Study|Physician Decision|0|||
16154605|NCT00763815|39051471|FG000|Overall Study|Withdrawal by Subject|7|||
16154606|NCT00763815|39051472|FG001|Overall Study|Withdrawal by Subject|12|||
16154607|NCT00763815|39051471|FG000|Overall Study|Protocol Violation|2|||
16154608|NCT00763815|39051472|FG001|Overall Study|Protocol Violation|5|||
16444334|NCT04929249|40105142|FG001|Overall Study|Lost to Follow-up|11|||
16444335|NCT04929249|40105141|FG000|Overall Study|Technical problems|0|||
16154609|NCT00763815|39051471|FG000|Overall Study|Sponsor's Decision|0|||
16154610|NCT00763815|39051472|FG001|Overall Study|Sponsor's Decision|1|||
16154611|NCT00473343|39051477|FG000|Overall Study|Adverse Event|9|||
16154612|NCT00473343|39051477|FG000|Overall Study|Lost to Follow-up|8|||
16444336|NCT04929249|40105142|FG001|Overall Study|Technical problems|1|||
16444337|NCT04929249|40105141|FG000|Overall Study|Subject decision|6|||
16154613|NCT00473343|39051477|FG000|Overall Study|Treatment failure|27|||
16154614|NCT00473343|39051477|FG000|Overall Study|Withdrew consent|3|||
16444338|NCT04929249|40105142|FG001|Overall Study|Subject decision|8|||
16444339|NCT04929249|40105141|FG000|Overall Study|Withdrew consent|0|||
16444340|NCT04929249|40105142|FG001|Overall Study|Withdrew consent|8|||
16154615|NCT00473343|39051477|FG000|Overall Study|Other un-specified reason|3|||
16154616|NCT01152021|39051478|FG000|Overall Study|Adverse Event|4|||
16154617|NCT01152021|39051479|FG001|Overall Study|Adverse Event|4|||
16154618|NCT01152021|39051478|FG000|Overall Study|Study drug had expired|1|||
16154619|NCT01152021|39051479|FG001|Overall Study|Study drug had expired|0|||
16154620|NCT01152021|39051478|FG000|Overall Study|Physician Decision|1|||
16154621|NCT01152021|39051479|FG001|Overall Study|Physician Decision|1|||
16154622|NCT01152021|39051478|FG000|Overall Study|No access to study drug in Pharmacy|0|||
16154623|NCT01152021|39051479|FG001|Overall Study|No access to study drug in Pharmacy|1|||
16154624|NCT00583362|39051480|FG000|Overall Study|Adverse Event|44|||
16154625|NCT00583362|39051480|FG000|Overall Study|Lack of Efficacy|22|||
16154626|NCT00583362|39051480|FG000|Overall Study|Lost to Follow-up|4|||
16154627|NCT00583362|39051480|FG000|Overall Study|Non-compliance with study drug|28|||
16154628|NCT00583362|39051480|FG000|Overall Study|Pregnancy|7|||
16154629|NCT00583362|39051480|FG000|Overall Study|Miscommunication of visit window|5|||
16154630|NCT00583362|39051480|FG000|Overall Study|Current site closed|7|||
16154631|NCT00583362|39051480|FG000|Overall Study|Subject not dosed in LBSL99|1|||
16154632|NCT00583362|39051480|FG000|Overall Study|Subject moved out of the country/state|2|||
16154633|NCT00583362|39051480|FG000|Overall Study|Missed visits due to staff changes|1|||
16154634|NCT00583362|39051480|FG000|Overall Study|Misunderstanding of protocol|1|||
16154635|NCT00583362|39051480|FG000|Overall Study|Behavioral problems and non-compliance|1|||
16154636|NCT00583362|39051480|FG000|Overall Study|Sponsor request due to missed doses|1|||
16154637|NCT00583362|39051480|FG000|Overall Study|Physician Decision|19|||
16154638|NCT00583362|39051480|FG000|Overall Study|Protocol Violation|2|||
16154639|NCT00583362|39051480|FG000|Overall Study|Withdrawal by Subject|57|||
16154640|NCT00916357|39051481|FG000|Period 1|Withdrawal by Subject|1|||
16154641|NCT00916357|39051482|FG001|Period 1|Withdrawal by Subject|0|||
16154642|NCT00916357|39051483|FG002|Period 1|Withdrawal by Subject|0|||
16154643|NCT00916357|39051484|FG003|Period 1|Withdrawal by Subject|0|||
16154644|NCT00916357|39051485|FG004|Period 1|Withdrawal by Subject|0|||
16154645|NCT00916357|39051486|FG005|Period 1|Withdrawal by Subject|0|||
16154646|NCT00916357|39051481|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
16154647|NCT00916357|39051482|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
16154648|NCT00916357|39051483|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
16154649|NCT00916357|39051484|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
16154650|NCT00916357|39051485|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
16154651|NCT00916357|39051486|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
16154652|NCT02457637|39051487|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
16154653|NCT01576549|39051494|FG000|Overall Study|Sponsor Decision|2|||
16154654|NCT04029519|39051501|FG000|Overall Study|Protocol Violation|1|||
16154655|NCT04029519|39051501|FG000|Overall Study|Withdrawal by Subject|3|||
16154656|NCT04029519|39051501|FG000|Overall Study|Lost to Follow-up|1|||
16154657|NCT03440814|39051504|FG000|Overall Study|Adverse Event|2|||
16154658|NCT03440814|39051505|FG001|Overall Study|Adverse Event|1|||
16154659|NCT03440814|39051504|FG000|Overall Study|Lost to Follow-up|2|||
16154660|NCT03440814|39051505|FG001|Overall Study|Lost to Follow-up|0|||
16154661|NCT03440814|39051504|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
16154662|NCT03440814|39051505|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
16154663|NCT00513409|39051508|FG000|Overall Study|Adverse Event|0|||
16154664|NCT00513409|39051509|FG001|Overall Study|Adverse Event|1|||
16154665|NCT00513409|39051508|FG000|Overall Study|Withdrawal by Subject|0|||
16154666|NCT00513409|39051509|FG001|Overall Study|Withdrawal by Subject|2|||
16154667|NCT00513409|39051508|FG000|Overall Study|Lost to Follow-up|0|||
16154668|NCT00513409|39051509|FG001|Overall Study|Lost to Follow-up|1|||
16154669|NCT00513409|39051508|FG000|Overall Study|Physician Decision|1|||
16154670|NCT00513409|39051509|FG001|Overall Study|Physician Decision|0|||
16154671|NCT00513409|39051508|FG000|Overall Study|Visit 3 not done|1|||
16154672|NCT00513409|39051509|FG001|Overall Study|Visit 3 not done|2|||
16154673|NCT03116698|39051512|FG000|Overall Study|Adverse Event|1|||
16154674|NCT03116698|39051513|FG001|Overall Study|Adverse Event|1|||
16263102|NCT01878292|39449659|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
16263103|NCT01878292|39449660|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
16154675|NCT03116698|39051514|FG002|Overall Study|Adverse Event|1|||
16154676|NCT03116698|39051515|FG003|Overall Study|Adverse Event|0|||
16154677|NCT03116698|39051512|FG000|Overall Study|Withdrawal by Subject|1|||
16154678|NCT03116698|39051513|FG001|Overall Study|Withdrawal by Subject|4|||
16154679|NCT03116698|39051514|FG002|Overall Study|Withdrawal by Subject|5|||
16154680|NCT03116698|39051515|FG003|Overall Study|Withdrawal by Subject|2|||
16154681|NCT03116698|39051512|FG000|Overall Study|Lost to Follow-up|2|||
16154682|NCT03116698|39051513|FG001|Overall Study|Lost to Follow-up|0|||
16154683|NCT03116698|39051514|FG002|Overall Study|Lost to Follow-up|0|||
16154684|NCT03116698|39051515|FG003|Overall Study|Lost to Follow-up|0|||
16154685|NCT03116698|39051512|FG000|Overall Study|Physician Decision|1|||
16154686|NCT03116698|39051513|FG001|Overall Study|Physician Decision|1|||
16154687|NCT03116698|39051514|FG002|Overall Study|Physician Decision|0|||
16154688|NCT03116698|39051515|FG003|Overall Study|Physician Decision|0|||
16154689|NCT03116698|39051512|FG000|Overall Study|Protocol Violation|1|||
16154690|NCT03116698|39051513|FG001|Overall Study|Protocol Violation|0|||
16154691|NCT03116698|39051514|FG002|Overall Study|Protocol Violation|0|||
16154692|NCT03116698|39051515|FG003|Overall Study|Protocol Violation|0|||
16154693|NCT03116698|39051512|FG000|Overall Study|Death|0|||
16154694|NCT03116698|39051513|FG001|Overall Study|Death|0|||
16154695|NCT03116698|39051514|FG002|Overall Study|Death|2|||
16154696|NCT03116698|39051515|FG003|Overall Study|Death|0|||
16154697|NCT00835237|39051516|FG000|Overall Study|Lost to Follow-up|4|||
16154698|NCT00835237|39051517|FG001|Overall Study|Lost to Follow-up|0|||
16154699|NCT00835237|39051516|FG000|Overall Study|Withdrawal by Subject|2|||
16154700|NCT00835237|39051517|FG001|Overall Study|Withdrawal by Subject|0|||
16154701|NCT03571646|39051518|FG000|Overall Study|Adverse Event|1|||
16154702|NCT03571646|39051519|FG001|Overall Study|Adverse Event|0|||
16154703|NCT03571646|39051518|FG000|Overall Study|Withdrawal by Subject|1|||
16154704|NCT03571646|39051519|FG001|Overall Study|Withdrawal by Subject|1|||
16154705|NCT01425008|39051531|FG000|Dose Escalation Phase|Progressive Disease|2|||
16154706|NCT01425008|39051532|FG001|Dose Escalation Phase|Progressive Disease|3|||
16154707|NCT01425008|39051533|FG002|Dose Escalation Phase|Progressive Disease|2|||
16154708|NCT01425008|39051534|FG003|Dose Escalation Phase|Progressive Disease|3|||
16154709|NCT01425008|39051535|FG004|Dose Escalation Phase|Progressive Disease|5|||
16154710|NCT01425008|39051536|FG005|Dose Escalation Phase|Progressive Disease|4|||
16154711|NCT01425008|39051537|FG006|Dose Escalation Phase|Progressive Disease|0|||
16154712|NCT01425008|39051538|FG007|Dose Escalation Phase|Progressive Disease|2|||
16154713|NCT01425008|39051539|FG008|Dose Escalation Phase|Progressive Disease|6|||
16154714|NCT01425008|39051540|FG009|Dose Escalation Phase|Progressive Disease|2|||
16154715|NCT01425008|39051541|FG010|Dose Escalation Phase|Progressive Disease|0|||
16154716|NCT01425008|39051542|FG011|Dose Escalation Phase|Progressive Disease|0|||
16154717|NCT01425008|39051543|FG012|Dose Escalation Phase|Progressive Disease|0|||
16154718|NCT01425008|39051544|FG013|Dose Escalation Phase|Progressive Disease|0|||
16154719|NCT01425008|39051545|FG014|Dose Escalation Phase|Progressive Disease|0|||
16154720|NCT01425008|39051546|FG015|Dose Escalation Phase|Progressive Disease|0|||
16154721|NCT01425008|39051547|FG016|Dose Escalation Phase|Progressive Disease|0|||
16154722|NCT01425008|39051548|FG017|Dose Escalation Phase|Progressive Disease|0|||
16154723|NCT01425008|39051549|FG018|Dose Escalation Phase|Progressive Disease|0|||
16154724|NCT01425008|39051531|FG000|Dose Escalation Phase|Adverse Event|2|||
16154725|NCT01425008|39051532|FG001|Dose Escalation Phase|Adverse Event|0|||
16154726|NCT01425008|39051533|FG002|Dose Escalation Phase|Adverse Event|0|||
16154727|NCT01425008|39051534|FG003|Dose Escalation Phase|Adverse Event|0|||
16154728|NCT01425008|39051535|FG004|Dose Escalation Phase|Adverse Event|0|||
16154729|NCT01425008|39051536|FG005|Dose Escalation Phase|Adverse Event|2|||
16154730|NCT01425008|39051537|FG006|Dose Escalation Phase|Adverse Event|0|||
16154731|NCT01425008|39051538|FG007|Dose Escalation Phase|Adverse Event|0|||
16154732|NCT01425008|39051539|FG008|Dose Escalation Phase|Adverse Event|2|||
16154733|NCT01425008|39051540|FG009|Dose Escalation Phase|Adverse Event|0|||
16154734|NCT01425008|39051541|FG010|Dose Escalation Phase|Adverse Event|0|||
16154735|NCT01425008|39051542|FG011|Dose Escalation Phase|Adverse Event|0|||
16154736|NCT01425008|39051543|FG012|Dose Escalation Phase|Adverse Event|0|||
16154737|NCT01425008|39051544|FG013|Dose Escalation Phase|Adverse Event|0|||
16154738|NCT01425008|39051545|FG014|Dose Escalation Phase|Adverse Event|0|||
16154739|NCT01425008|39051546|FG015|Dose Escalation Phase|Adverse Event|0|||
16154740|NCT01425008|39051547|FG016|Dose Escalation Phase|Adverse Event|0|||
16154741|NCT01425008|39051548|FG017|Dose Escalation Phase|Adverse Event|0|||
16154742|NCT01425008|39051549|FG018|Dose Escalation Phase|Adverse Event|0|||
16154743|NCT01425008|39051531|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154744|NCT01425008|39051532|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154745|NCT01425008|39051533|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154746|NCT01425008|39051534|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154747|NCT01425008|39051535|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
16154748|NCT01425008|39051536|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154749|NCT01425008|39051537|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
16154750|NCT01425008|39051538|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
16154751|NCT01425008|39051539|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
16154752|NCT01425008|39051540|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154753|NCT01425008|39051541|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154754|NCT01425008|39051542|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154755|NCT01425008|39051543|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154756|NCT01425008|39051544|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154757|NCT01425008|39051545|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154758|NCT01425008|39051546|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154759|NCT01425008|39051547|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154760|NCT01425008|39051548|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154761|NCT01425008|39051549|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
16154762|NCT01425008|39051531|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
16154763|NCT01425008|39051532|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
16154764|NCT01425008|39051533|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
16154765|NCT01425008|39051534|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16154766|NCT01425008|39051535|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
16154767|NCT01425008|39051536|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
16154768|NCT01425008|39051537|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
16154769|NCT01425008|39051538|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
16154770|NCT01425008|39051539|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
16154771|NCT01425008|39051540|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
16154772|NCT01425008|39051541|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
16263104|NCT02131129|39449670|FG000|Overall Study|Withdrawal by Subject|1|||
16263105|NCT02131129|39449671|FG001|Overall Study|Withdrawal by Subject|0|||
16263106|NCT01844375|39449676|FG000|Overall Study|Protocol Violation|1|||
16263107|NCT01844375|39449677|FG001|Overall Study|Protocol Violation|1|||
16263108|NCT02554877|39449678|FG000|Overall Study|Adverse Event|2|||
16263109|NCT02554877|39449679|FG001|Overall Study|Adverse Event|0|||
16263110|NCT02554877|39449680|FG002|Overall Study|Adverse Event|0|||
16263111|NCT02554877|39449681|FG003|Overall Study|Adverse Event|1|||
16263112|NCT02554877|39449678|FG000|Overall Study|Lost to Follow-up|1|||
16263113|NCT02554877|39449679|FG001|Overall Study|Lost to Follow-up|1|||
16263114|NCT02554877|39449680|FG002|Overall Study|Lost to Follow-up|1|||
16263115|NCT02554877|39449681|FG003|Overall Study|Lost to Follow-up|2|||
16263116|NCT02554877|39449678|FG000|Overall Study|Did not meet entrance criteria|0|||
16263117|NCT02554877|39449679|FG001|Overall Study|Did not meet entrance criteria|0|||
16263118|NCT02554877|39449680|FG002|Overall Study|Did not meet entrance criteria|1|||
16263119|NCT02554877|39449681|FG003|Overall Study|Did not meet entrance criteria|0|||
16263120|NCT02554877|39449678|FG000|Overall Study|No longer met eligibility criteria|1|||
16263121|NCT02554877|39449679|FG001|Overall Study|No longer met eligibility criteria|0|||
16263122|NCT02554877|39449680|FG002|Overall Study|No longer met eligibility criteria|1|||
16263123|NCT02554877|39449681|FG003|Overall Study|No longer met eligibility criteria|1|||
16263124|NCT02554877|39449678|FG000|Overall Study|Protocol Violation|3|||
16263125|NCT02554877|39449679|FG001|Overall Study|Protocol Violation|1|||
16263126|NCT02554877|39449680|FG002|Overall Study|Protocol Violation|1|||
16263127|NCT02554877|39449681|FG003|Overall Study|Protocol Violation|0|||
16263128|NCT02554877|39449678|FG000|Overall Study|Other|1|||
16263129|NCT02554877|39449679|FG001|Overall Study|Other|3|||
16263130|NCT02554877|39449680|FG002|Overall Study|Other|0|||
16444341|NCT04467905|40105143|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
16444342|NCT04467905|40105144|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
16444343|NCT04467905|40105145|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
16444344|NCT04467905|40105143|FG000|Overall Study|Conversion to SR|0|||
16154773|NCT01425008|39051542|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
16263131|NCT02554877|39449681|FG003|Overall Study|Other|3|||
16263132|NCT02554877|39449678|FG000|Overall Study|Insufficient clinical response|4|||
16263133|NCT02554877|39449679|FG001|Overall Study|Insufficient clinical response|0|||
16263134|NCT02554877|39449680|FG002|Overall Study|Insufficient clinical response|0|||
16263135|NCT02554877|39449681|FG003|Overall Study|Insufficient clinical response|0|||
16263136|NCT02554877|39449678|FG000|Overall Study|No longer willing to participate|0|||
16263137|NCT02554877|39449679|FG001|Overall Study|No longer willing to participate|2|||
16263138|NCT02554877|39449680|FG002|Overall Study|No longer willing to participate|2|||
16263139|NCT02554877|39449681|FG003|Overall Study|No longer willing to participate|0|||
16263140|NCT00519194|39449682|FG000|Overall Study|Withdrawal by Subject|9|||
16263141|NCT00519194|39449682|FG000|Overall Study|Death|9|||
16366640|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
16366641|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
16366642|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
16366643|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
16366644|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
16366645|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
16366646|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
16366647|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
16366648|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
16366649|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
16366650|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
16366651|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
16366652|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
16366653|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
16366654|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
16366655|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
16154774|NCT01425008|39051543|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
16154775|NCT01425008|39051544|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
16154776|NCT01425008|39051545|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
16154777|NCT01425008|39051546|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
16154778|NCT01425008|39051547|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
16154779|NCT01425008|39051548|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
16154780|NCT01425008|39051549|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
16154781|NCT01425008|39051531|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154782|NCT01425008|39051532|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154783|NCT01425008|39051533|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
16154784|NCT01425008|39051534|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154785|NCT01425008|39051535|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154786|NCT01425008|39051536|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154787|NCT01425008|39051537|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154788|NCT01425008|39051538|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154789|NCT01425008|39051539|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
16154790|NCT01425008|39051540|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
16154791|NCT01425008|39051541|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154792|NCT01425008|39051542|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154793|NCT01425008|39051543|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154794|NCT01425008|39051544|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154795|NCT01425008|39051545|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154796|NCT01425008|39051546|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154797|NCT01425008|39051547|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154798|NCT01425008|39051548|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154799|NCT01425008|39051549|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
16154800|NCT01425008|39051531|FG000|Dose Escalation Phase|Other|0|||
16154801|NCT01425008|39051532|FG001|Dose Escalation Phase|Other|0|||
16154802|NCT01425008|39051533|FG002|Dose Escalation Phase|Other|0|||
16154803|NCT01425008|39051534|FG003|Dose Escalation Phase|Other|0|||
16154804|NCT01425008|39051535|FG004|Dose Escalation Phase|Other|0|||
16154805|NCT01425008|39051536|FG005|Dose Escalation Phase|Other|0|||
16154806|NCT01425008|39051537|FG006|Dose Escalation Phase|Other|0|||
16154807|NCT01425008|39051538|FG007|Dose Escalation Phase|Other|0|||
16154808|NCT01425008|39051539|FG008|Dose Escalation Phase|Other|1|||
16154809|NCT01425008|39051540|FG009|Dose Escalation Phase|Other|0|||
16154810|NCT01425008|39051541|FG010|Dose Escalation Phase|Other|0|||
16154811|NCT01425008|39051542|FG011|Dose Escalation Phase|Other|0|||
16154812|NCT01425008|39051543|FG012|Dose Escalation Phase|Other|0|||
16154813|NCT01425008|39051544|FG013|Dose Escalation Phase|Other|0|||
16154814|NCT01425008|39051545|FG014|Dose Escalation Phase|Other|0|||
16154815|NCT01425008|39051546|FG015|Dose Escalation Phase|Other|0|||
16154816|NCT01425008|39051547|FG016|Dose Escalation Phase|Other|0|||
16154817|NCT01425008|39051548|FG017|Dose Escalation Phase|Other|0|||
16154818|NCT01425008|39051549|FG018|Dose Escalation Phase|Other|0|||
16154819|NCT01425008|39051531|FG000|Dose Expansion Phase|Progressive Disease|0|||
16154820|NCT01425008|39051532|FG001|Dose Expansion Phase|Progressive Disease|0|||
16154821|NCT01425008|39051533|FG002|Dose Expansion Phase|Progressive Disease|0|||
16154822|NCT01425008|39051534|FG003|Dose Expansion Phase|Progressive Disease|0|||
16154823|NCT01425008|39051535|FG004|Dose Expansion Phase|Progressive Disease|0|||
16263142|NCT00519194|39449682|FG000|Overall Study|Lost to Follow-up|3|||
16263143|NCT00001703|39449685|FG000|Overall Study|progressed disease|2|||
16263144|NCT00001703|39449685|FG000|Overall Study|No evidence of disease|1|||
16263145|NCT00001703|39449685|FG000|Overall Study|recurrent disease|2|||
16263146|NCT00211757|39449686|FG000|Overall Study|Withdrawal by Subject|1|||
16263147|NCT00211757|39449687|FG001|Overall Study|Withdrawal by Subject|1|||
16263148|NCT00211757|39449686|FG000|Overall Study|Lack of Efficacy|0|||
16263149|NCT00211757|39449687|FG001|Overall Study|Lack of Efficacy|1|||
16263150|NCT01244126|39449688|FG000|Overall Study|Protocol Violation|3|||
16263151|NCT01244126|39449689|FG001|Overall Study|Protocol Violation|3|||
16263152|NCT01244126|39449690|FG002|Overall Study|Protocol Violation|9|||
16263153|NCT01520909|39449696|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
16263154|NCT01520909|39449697|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
16263155|NCT01520909|39449698|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
16263156|NCT01520909|39449696|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
16366656|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
16366657|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
16154824|NCT01425008|39051536|FG005|Dose Expansion Phase|Progressive Disease|0|||
16154825|NCT01425008|39051537|FG006|Dose Expansion Phase|Progressive Disease|0|||
16263157|NCT01520909|39449697|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
16263158|NCT01520909|39449698|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
16263159|NCT01520909|39449696|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
16263160|NCT01520909|39449697|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
16263161|NCT01520909|39449698|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
16263162|NCT01520909|39449696|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
16263163|NCT01520909|39449697|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
16273168|NCT01751087|39484429|FG001|Overall Study|Withdrawal by Subject|0|||
16444345|NCT04467905|40105144|FG001|Overall Study|Conversion to SR|0|||
16154826|NCT01425008|39051538|FG007|Dose Expansion Phase|Progressive Disease|0|||
16444346|NCT04467905|40105145|FG002|Overall Study|Conversion to SR|3|||
16444347|NCT04467905|40105143|FG000|Overall Study|Technical issue with Holter ECG|0|||
16444348|NCT04467905|40105144|FG001|Overall Study|Technical issue with Holter ECG|0|||
16444349|NCT04467905|40105145|FG002|Overall Study|Technical issue with Holter ECG|3|||
16444350|NCT04467905|40105143|FG000|Overall Study|Hemodynamic instability|0|||
16444351|NCT04467905|40105144|FG001|Overall Study|Hemodynamic instability|0|||
16444352|NCT04467905|40105145|FG002|Overall Study|Hemodynamic instability|1|||
16444353|NCT04467905|40105143|FG000|Overall Study|Site misinterpretation of protocol|0|||
16444354|NCT04467905|40105144|FG001|Overall Study|Site misinterpretation of protocol|0|||
16444355|NCT04467905|40105145|FG002|Overall Study|Site misinterpretation of protocol|1|||
16444356|NCT04163341|40105147|FG000|Overall Study|Withdrawal by Subject|2|||
16444357|NCT04163341|40105148|FG001|Overall Study|Withdrawal by Subject|0|||
16444358|NCT04163341|40105147|FG000|Overall Study|Lost to Follow-up|3|||
16444359|NCT04163341|40105148|FG001|Overall Study|Lost to Follow-up|4|||
16444360|NCT01231906|40105149|FG000|Overall Study|Lack of Efficacy|75|||
16444361|NCT01231906|40105150|FG001|Overall Study|Lack of Efficacy|68|||
16444362|NCT01231906|40105149|FG000|Overall Study|Lost to Follow-up|1|||
16444363|NCT01231906|40105150|FG001|Overall Study|Lost to Follow-up|0|||
16444364|NCT01231906|40105149|FG000|Overall Study|Physician Decision|34|||
16444365|NCT01231906|40105150|FG001|Overall Study|Physician Decision|24|||
16444366|NCT01231906|40105149|FG000|Overall Study|Withdrawal by Subject|0|||
16444367|NCT01231906|40105150|FG001|Overall Study|Withdrawal by Subject|4|||
16154827|NCT01425008|39051539|FG008|Dose Expansion Phase|Progressive Disease|0|||
16154828|NCT01425008|39051540|FG009|Dose Expansion Phase|Progressive Disease|0|||
16444368|NCT01231906|40105149|FG000|Overall Study|Ineligible|10|||
16444369|NCT01231906|40105150|FG001|Overall Study|Ineligible|3|||
16444370|NCT01231906|40105149|FG000|Overall Study|No treatment|1|||
16444371|NCT01231906|40105150|FG001|Overall Study|No treatment|2|||
16444372|NCT02421939|40105151|FG000|Overall Study|Progressive disease|70|||
16444373|NCT02421939|40105152|FG001|Overall Study|Progressive disease|16|||
16444374|NCT02421939|40105151|FG000|Overall Study|Lack of Efficacy|21|||
16444375|NCT02421939|40105152|FG001|Overall Study|Lack of Efficacy|31|||
16444376|NCT02421939|40105151|FG000|Overall Study|Death|36|||
16444377|NCT02421939|40105152|FG001|Overall Study|Death|10|||
16444378|NCT02421939|40105151|FG000|Overall Study|Disease relapse|33|||
16444379|NCT02421939|40105152|FG001|Overall Study|Disease relapse|2|||
16444380|NCT02421939|40105151|FG000|Overall Study|Adverse Event|28|||
16444381|NCT02421939|40105152|FG001|Overall Study|Adverse Event|5|||
16444382|NCT02421939|40105151|FG000|Overall Study|Withdrawal by Subject|5|||
16444383|NCT02421939|40105152|FG001|Overall Study|Withdrawal by Subject|24|||
16444384|NCT02421939|40105151|FG000|Overall Study|Physician Decision|11|||
16444385|NCT02421939|40105152|FG001|Overall Study|Physician Decision|11|||
16444386|NCT02421939|40105151|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
16444387|NCT02421939|40105152|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
16444388|NCT02421939|40105151|FG000|Overall Study|Miscellaneous|4|||
16444389|NCT02421939|40105152|FG001|Overall Study|Miscellaneous|5|||
16444390|NCT02421939|40105151|FG000|Overall Study|Protocol deviation|1|||
16444391|NCT02421939|40105152|FG001|Overall Study|Protocol deviation|1|||
16444392|NCT04245111|40105153|FG000|Overall Study|Lost to Follow-up|5|||
16444393|NCT04245111|40105154|FG001|Overall Study|Lost to Follow-up|1|||
16444394|NCT04245111|40105155|FG002|Overall Study|Lost to Follow-up|1|||
16154829|NCT01425008|39051541|FG010|Dose Expansion Phase|Progressive Disease|10|||
16154830|NCT01425008|39051542|FG011|Dose Expansion Phase|Progressive Disease|4|||
16154831|NCT01425008|39051543|FG012|Dose Expansion Phase|Progressive Disease|12|||
16154832|NCT01425008|39051544|FG013|Dose Expansion Phase|Progressive Disease|1|||
16154833|NCT01425008|39051545|FG014|Dose Expansion Phase|Progressive Disease|5|||
16154834|NCT01425008|39051546|FG015|Dose Expansion Phase|Progressive Disease|8|||
16154835|NCT01425008|39051547|FG016|Dose Expansion Phase|Progressive Disease|9|||
16154836|NCT01425008|39051548|FG017|Dose Expansion Phase|Progressive Disease|2|||
16154837|NCT01425008|39051549|FG018|Dose Expansion Phase|Progressive Disease|10|||
16154838|NCT01425008|39051531|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
16154839|NCT01425008|39051532|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
16154840|NCT01425008|39051533|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
16444395|NCT03164616|40105156|FG000|Overall Study|Death|250|||
16444396|NCT03164616|40105157|FG001|Overall Study|Death|264|||
16444397|NCT03164616|40105158|FG002|Overall Study|Death|279|||
16444398|NCT03164616|40105156|FG000|Overall Study|Lost to Follow-up|2|||
16444399|NCT03164616|40105157|FG001|Overall Study|Lost to Follow-up|2|||
16444400|NCT03164616|40105158|FG002|Overall Study|Lost to Follow-up|2|||
16444401|NCT03164616|40105156|FG000|Overall Study|Withdrawal by Subject|6|||
16444402|NCT03164616|40105157|FG001|Overall Study|Withdrawal by Subject|7|||
16444403|NCT03164616|40105158|FG002|Overall Study|Withdrawal by Subject|16|||
16444404|NCT00980538|40105159|FG000|Overall Study|Lost to Follow-up|20|||
16444405|NCT00980538|40105159|FG000|Overall Study|Sponsor's Decision|4|||
16444406|NCT00980538|40105159|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
16444407|NCT00980538|40105159|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
16154841|NCT01425008|39051534|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
16444408|NCT00980538|40105159|FG000|Overall Study|Switch to Commercially Available Medication|25|||
16444409|NCT00980538|40105159|FG000|Overall Study|Participant Non-Compliant|9|||
16444410|NCT00980538|40105159|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
16444411|NCT00980538|40105159|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
16444412|NCT00980538|40105159|FG000|Overall Study|Other|60|||
16444413|NCT00980538|40105159|FG000|Overall Study|Other|1|||
16444414|NCT02257528|40105162|FG000|Overall Study|Never received study treatment|1|||
16154842|NCT01425008|39051535|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
16154843|NCT01425008|39051536|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
16154844|NCT01425008|39051537|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
16154845|NCT01425008|39051538|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
16154846|NCT01425008|39051539|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
16154847|NCT01425008|39051540|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
16154848|NCT01425008|39051541|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
16154849|NCT01425008|39051542|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
16154850|NCT01425008|39051543|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
16154851|NCT01425008|39051544|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
16154852|NCT01425008|39051545|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
16154853|NCT01425008|39051546|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
16154854|NCT01425008|39051547|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
16154855|NCT01425008|39051548|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
16154856|NCT01425008|39051549|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
16154857|NCT01425008|39051531|FG000|Dose Expansion Phase|Other|0|||
16154858|NCT01425008|39051532|FG001|Dose Expansion Phase|Other|0|||
16154859|NCT01425008|39051533|FG002|Dose Expansion Phase|Other|0|||
16154860|NCT01425008|39051534|FG003|Dose Expansion Phase|Other|0|||
16154861|NCT01425008|39051535|FG004|Dose Expansion Phase|Other|0|||
16154862|NCT01425008|39051536|FG005|Dose Expansion Phase|Other|0|||
16154863|NCT01425008|39051537|FG006|Dose Expansion Phase|Other|0|||
16154864|NCT01425008|39051538|FG007|Dose Expansion Phase|Other|0|||
16154865|NCT01425008|39051539|FG008|Dose Expansion Phase|Other|0|||
16154866|NCT01425008|39051540|FG009|Dose Expansion Phase|Other|0|||
16154867|NCT01425008|39051541|FG010|Dose Expansion Phase|Other|0|||
16154868|NCT01425008|39051542|FG011|Dose Expansion Phase|Other|0|||
16154869|NCT01425008|39051543|FG012|Dose Expansion Phase|Other|1|||
16154870|NCT01425008|39051544|FG013|Dose Expansion Phase|Other|0|||
16154871|NCT01425008|39051545|FG014|Dose Expansion Phase|Other|0|||
16154872|NCT01425008|39051546|FG015|Dose Expansion Phase|Other|0|||
16154873|NCT01425008|39051547|FG016|Dose Expansion Phase|Other|2|||
16154874|NCT01425008|39051548|FG017|Dose Expansion Phase|Other|0|||
16154875|NCT01425008|39051549|FG018|Dose Expansion Phase|Other|4|||
16154876|NCT01425008|39051531|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154877|NCT01425008|39051532|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154878|NCT01425008|39051533|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154879|NCT01425008|39051534|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154880|NCT01425008|39051535|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154881|NCT01425008|39051536|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154882|NCT01425008|39051537|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154883|NCT01425008|39051538|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154884|NCT01425008|39051539|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154885|NCT01425008|39051540|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154886|NCT01425008|39051541|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
16154887|NCT01425008|39051542|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
16154888|NCT01425008|39051543|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154889|NCT01425008|39051544|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154890|NCT01425008|39051545|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154891|NCT01425008|39051546|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
16154892|NCT01425008|39051547|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
16154893|NCT01425008|39051548|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
16154894|NCT01425008|39051549|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
16154895|NCT01425008|39051531|FG000|Dose Expansion Phase|Adverse Event|0|||
16154896|NCT01425008|39051532|FG001|Dose Expansion Phase|Adverse Event|0|||
16154897|NCT01425008|39051533|FG002|Dose Expansion Phase|Adverse Event|0|||
16154898|NCT01425008|39051534|FG003|Dose Expansion Phase|Adverse Event|0|||
16154899|NCT01425008|39051535|FG004|Dose Expansion Phase|Adverse Event|0|||
16154900|NCT01425008|39051536|FG005|Dose Expansion Phase|Adverse Event|0|||
16444415|NCT00769379|40105163|FG000|Overall Study|No follow up data mapped to Other.|3|||
16154901|NCT01425008|39051537|FG006|Dose Expansion Phase|Adverse Event|0|||
16154902|NCT01425008|39051538|FG007|Dose Expansion Phase|Adverse Event|0|||
16154903|NCT01425008|39051539|FG008|Dose Expansion Phase|Adverse Event|0|||
16154904|NCT01425008|39051540|FG009|Dose Expansion Phase|Adverse Event|0|||
16154905|NCT01425008|39051541|FG010|Dose Expansion Phase|Adverse Event|2|||
16154906|NCT01425008|39051542|FG011|Dose Expansion Phase|Adverse Event|3|||
16154907|NCT01425008|39051543|FG012|Dose Expansion Phase|Adverse Event|3|||
16154908|NCT01425008|39051544|FG013|Dose Expansion Phase|Adverse Event|0|||
16154909|NCT01425008|39051545|FG014|Dose Expansion Phase|Adverse Event|1|||
16444416|NCT00769379|40105164|FG001|Overall Study|No follow up data mapped to Other.|13|||
16444417|NCT02252172|40105165|FG000|Overall Study|Lost to Follow-up|3|||
16444418|NCT02252172|40105166|FG001|Overall Study|Lost to Follow-up|1|||
16444419|NCT02252172|40105165|FG000|Overall Study|Ongoing|276|||
16154910|NCT01425008|39051546|FG015|Dose Expansion Phase|Adverse Event|1|||
16444420|NCT02252172|40105166|FG001|Overall Study|Ongoing|298|||
16444421|NCT05417438|40105172|FG000|Overall Study|Withdrawal by Subject|3|||
16444422|NCT03173560|40105173|FG000|Overall Study|Ongoing on Treatment|38|||
16444423|NCT03173560|40105174|FG001|Overall Study|Ongoing on Treatment|50|||
16444424|NCT03173560|40105173|FG000|Overall Study|Ongoing Survival Follow-up|56|||
16444425|NCT03173560|40105174|FG001|Overall Study|Ongoing Survival Follow-up|57|||
16444426|NCT03173560|40105173|FG000|Overall Study|Lost to Follow-up|1|||
16444427|NCT03173560|40105174|FG001|Overall Study|Lost to Follow-up|4|||
16444428|NCT03173560|40105173|FG000|Overall Study|Withdrawal by Subject|10|||
16444429|NCT03173560|40105174|FG001|Overall Study|Withdrawal by Subject|5|||
16444430|NCT03173560|40105173|FG000|Overall Study|Other|0|||
16444431|NCT03173560|40105174|FG001|Overall Study|Other|1|||
16444432|NCT03067077|40105932|FG000|Overall Study|Did not receive surgery|4|||
16444433|NCT03067077|40105933|FG001|Overall Study|Did not receive surgery|5|||
16444434|NCT03067077|40105932|FG000|Overall Study|Lost to Follow-up|3|||
16444435|NCT03067077|40105933|FG001|Overall Study|Lost to Follow-up|2|||
16444436|NCT00536744|40105934|FG000|Overall Study|Adverse Event|13|||
16444437|NCT00536744|40105935|FG001|Overall Study|Adverse Event|10|||
16444438|NCT00536744|40105934|FG000|Overall Study|Death|2|||
16444439|NCT00536744|40105935|FG001|Overall Study|Death|1|||
16444440|NCT00536744|40105934|FG000|Overall Study|Physician Decision|3|||
16444441|NCT00536744|40105935|FG001|Overall Study|Physician Decision|1|||
16444442|NCT00536744|40105934|FG000|Overall Study|Lost to Follow-up|3|||
16444443|NCT00536744|40105935|FG001|Overall Study|Lost to Follow-up|5|||
16444444|NCT00536744|40105934|FG000|Overall Study|Withdrawal by Subject|7|||
16444445|NCT00536744|40105935|FG001|Overall Study|Withdrawal by Subject|8|||
16444446|NCT00536744|40105934|FG000|Overall Study|PI tried alternative treatment|1|||
16444447|NCT00536744|40105935|FG001|Overall Study|PI tried alternative treatment|3|||
16444448|NCT02277444|40105936|FG000|Overall Study|Adverse Event|10|||
16444449|NCT02277444|40105936|FG000|Overall Study|Withdrawal by Subject|3|||
16444450|NCT02277444|40105936|FG000|Overall Study|Other|1|||
16444451|NCT02277444|40105936|FG000|Overall Study|Enrolled and not Treated|3|||
16444452|NCT02277444|40105936|FG000|Overall Study|Ongoing|113|||
16444453|NCT02085460|40105937|FG000|Overall Study|Adverse Event|2|||
16444454|NCT02085460|40105938|FG001|Overall Study|Adverse Event|2|||
16444455|NCT02085460|40105939|FG002|Overall Study|Adverse Event|1|||
16444456|NCT02085460|40105937|FG000|Overall Study|Physician Decision|1|||
16444457|NCT02085460|40105938|FG001|Overall Study|Physician Decision|1|||
16444458|NCT02085460|40105939|FG002|Overall Study|Physician Decision|2|||
16444459|NCT02085460|40105937|FG000|Overall Study|Withdrawal by Subject|11|||
16444460|NCT02085460|40105938|FG001|Overall Study|Withdrawal by Subject|5|||
16444461|NCT02085460|40105939|FG002|Overall Study|Withdrawal by Subject|7|||
16444462|NCT04949490|40105940|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
16444463|NCT04949490|40105941|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
16444464|NCT04949490|40105942|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
16154911|NCT01425008|39051547|FG016|Dose Expansion Phase|Adverse Event|5|||
16154912|NCT01425008|39051548|FG017|Dose Expansion Phase|Adverse Event|0|||
16154913|NCT01425008|39051549|FG018|Dose Expansion Phase|Adverse Event|3|||
16154914|NCT01425008|39051531|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
16154915|NCT01425008|39051532|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
16154916|NCT01425008|39051533|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
16154917|NCT01425008|39051534|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
16154918|NCT01425008|39051535|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
16154919|NCT01425008|39051536|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
16154920|NCT01425008|39051537|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
16154921|NCT01425008|39051538|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
16273169|NCT01751087|39484430|FG002|Overall Study|Withdrawal by Subject|0|||
16444465|NCT04949490|40105943|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
16444466|NCT04949490|40105944|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
16444467|NCT04949490|40105945|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
16444468|NCT04949490|40105940|FG000|Group A and Group B|Withdrawal by Subject|0|||
16444469|NCT04949490|40105941|FG001|Group A and Group B|Withdrawal by Subject|0|||
16444470|NCT04949490|40105942|FG002|Group A and Group B|Withdrawal by Subject|1|||
16154922|NCT01425008|39051539|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
16154923|NCT01425008|39051540|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
16154924|NCT01425008|39051541|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
16154925|NCT01425008|39051542|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
16154926|NCT01425008|39051543|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
16154927|NCT01425008|39051544|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
16154928|NCT01425008|39051545|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
16154929|NCT01425008|39051546|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
16154930|NCT01425008|39051547|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
16154931|NCT01425008|39051548|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
16154932|NCT01425008|39051549|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
16154933|NCT01425008|39051531|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154934|NCT01425008|39051532|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154935|NCT01425008|39051533|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154936|NCT01425008|39051534|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154937|NCT01425008|39051535|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154938|NCT01425008|39051536|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154939|NCT01425008|39051537|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154940|NCT01425008|39051538|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154941|NCT01425008|39051539|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154942|NCT01425008|39051540|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154943|NCT01425008|39051541|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154944|NCT01425008|39051542|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154945|NCT01425008|39051543|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154946|NCT01425008|39051544|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154947|NCT01425008|39051545|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154948|NCT01425008|39051546|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154949|NCT01425008|39051547|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154950|NCT01425008|39051548|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
16154951|NCT01425008|39051549|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
16154952|NCT05054114|39051550|FG000|Overall Study|Protocol Violation|13|||
16154953|NCT05054114|39051551|FG001|Overall Study|Protocol Violation|1|||
16154954|NCT05054114|39051550|FG000|Overall Study|Pregnancy|0|||
16154955|NCT05054114|39051551|FG001|Overall Study|Pregnancy|1|||
16154956|NCT01081795|39051552|FG000|Overall Study|Adverse Event|18|||
16154957|NCT01081795|39051553|FG001|Overall Study|Adverse Event|23|||
16154958|NCT01081795|39051554|FG002|Overall Study|Adverse Event|6|||
16154959|NCT01081795|39051552|FG000|Overall Study|Lack of Efficacy|7|||
16154960|NCT01081795|39051553|FG001|Overall Study|Lack of Efficacy|5|||
16154961|NCT01081795|39051554|FG002|Overall Study|Lack of Efficacy|19|||
16154962|NCT01081795|39051552|FG000|Overall Study|Subject's schedule|1|||
16154963|NCT01081795|39051553|FG001|Overall Study|Subject's schedule|1|||
16154964|NCT01081795|39051554|FG002|Overall Study|Subject's schedule|2|||
16154965|NCT01081795|39051552|FG000|Overall Study|Revocation of informed consent|2|||
16154966|NCT01081795|39051553|FG001|Overall Study|Revocation of informed consent|0|||
16154967|NCT01081795|39051554|FG002|Overall Study|Revocation of informed consent|0|||
16154968|NCT01081795|39051552|FG000|Overall Study|Ineligible for participation|1|||
16154969|NCT01081795|39051553|FG001|Overall Study|Ineligible for participation|0|||
16154970|NCT01081795|39051554|FG002|Overall Study|Ineligible for participation|0|||
16154971|NCT01081795|39051552|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
16154972|NCT01081795|39051553|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
16154973|NCT01081795|39051554|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
16154974|NCT01081795|39051552|FG000|Overall Study|Using drug with restricted days of use|2|||
16154975|NCT01081795|39051553|FG001|Overall Study|Using drug with restricted days of use|3|||
16154976|NCT01081795|39051554|FG002|Overall Study|Using drug with restricted days of use|2|||
16154977|NCT01081795|39051552|FG000|Overall Study|Other|1|||
16154978|NCT01081795|39051553|FG001|Overall Study|Other|2|||
16154979|NCT01081795|39051554|FG002|Overall Study|Other|0|||
16154980|NCT01180660|39051555|FG000|Overall Study|Changed to open surgery|1|||
16154981|NCT01180660|39051556|FG001|Overall Study|Changed to open surgery|0|||
16154982|NCT00546052|39051557|FG000|Overall Study|Adverse Event|47|||
16154983|NCT00546052|39051557|FG000|Overall Study|Lost to Follow-up|144|||
16154984|NCT00546052|39051557|FG000|Overall Study|Protocol Violation|9|||
16154985|NCT00546052|39051557|FG000|Overall Study|Withdrawal by Subject|20|||
16154986|NCT00546052|39051557|FG000|Overall Study|Non Compliance|7|||
16154987|NCT03548051|39051560|FG000|Overall Study|Death|1|||
16154988|NCT03548051|39051561|FG001|Overall Study|Death|1|||
16154989|NCT03548051|39051560|FG000|Overall Study|Withdrawal by Subject|1|||
16154990|NCT03548051|39051561|FG001|Overall Study|Withdrawal by Subject|0|||
16154991|NCT04288154|39051562|FG000|Overall Study|Withdrawal by Subject|9|||
16154992|NCT04288154|39051563|FG001|Overall Study|Withdrawal by Subject|9|||
16366658|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
16154993|NCT00411554|39051564|FG000|Overall Study|Adverse Event|2|||
16154994|NCT00411554|39051565|FG001|Overall Study|Adverse Event|4|||
16154995|NCT00411554|39051564|FG000|Overall Study|Lack of Efficacy|2|||
16154996|NCT00411554|39051565|FG001|Overall Study|Lack of Efficacy|5|||
16154997|NCT00411554|39051564|FG000|Overall Study|Withdrawal by Subject|3|||
16154998|NCT00411554|39051565|FG001|Overall Study|Withdrawal by Subject|0|||
16154999|NCT00411554|39051564|FG000|Overall Study|Patient Moved|1|||
16155000|NCT00411554|39051565|FG001|Overall Study|Patient Moved|0|||
16155001|NCT02937818|39051566|FG000|Overall Study|Participants decision|2|||
16155002|NCT02937818|39051567|FG001|Overall Study|Participants decision|1|||
16155003|NCT02937818|39051568|FG002|Overall Study|Participants decision|1|||
16155004|NCT02937818|39051569|FG003|Overall Study|Participants decision|1|||
16155005|NCT02937818|39051566|FG000|Overall Study|Adverse Event|2|||
16155006|NCT02937818|39051567|FG001|Overall Study|Adverse Event|4|||
16155007|NCT02937818|39051568|FG002|Overall Study|Adverse Event|1|||
16155008|NCT02937818|39051569|FG003|Overall Study|Adverse Event|1|||
16155009|NCT02937818|39051566|FG000|Overall Study|Disease progression|17|||
16155010|NCT02937818|39051567|FG001|Overall Study|Disease progression|15|||
16155011|NCT02937818|39051568|FG002|Overall Study|Disease progression|7|||
16155012|NCT02937818|39051569|FG003|Overall Study|Disease progression|19|||
16155013|NCT02937818|39051566|FG000|Overall Study|Condition under investigation worsened|0|||
16155014|NCT02937818|39051567|FG001|Overall Study|Condition under investigation worsened|0|||
16155015|NCT02937818|39051568|FG002|Overall Study|Condition under investigation worsened|1|||
16155016|NCT02937818|39051569|FG003|Overall Study|Condition under investigation worsened|0|||
16155017|NCT03972969|39051570|FG000|3-month Follow-up|Death|1|||
16155018|NCT03972969|39051571|FG001|3-month Follow-up|Death|1|||
16155019|NCT03972969|39051572|FG002|3-month Follow-up|Death|0|||
16155020|NCT03972969|39051570|FG000|6-month Follow-up|Death|1|||
16155021|NCT03972969|39051571|FG001|6-month Follow-up|Death|1|||
16155022|NCT03972969|39051572|FG002|6-month Follow-up|Death|1|||
16155023|NCT03972969|39051570|FG000|6-month Follow-up|Lost to Follow-up|2|||
16366659|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
16366660|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
16366661|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
16366662|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
16366663|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
16155024|NCT03972969|39051571|FG001|6-month Follow-up|Lost to Follow-up|2|||
16155025|NCT03972969|39051572|FG002|6-month Follow-up|Lost to Follow-up|2|||
16155026|NCT02424253|39051573|FG000|Overall Study|Other, unspecified|1|||
16155027|NCT02424253|39051574|FG001|Overall Study|Other, unspecified|0|||
16155028|NCT02424253|39051573|FG000|Overall Study|Compliance problems|1|||
16155029|NCT02424253|39051574|FG001|Overall Study|Compliance problems|0|||
16155030|NCT02424253|39051573|FG000|Overall Study|Physician Decision|2|||
16155031|NCT02424253|39051574|FG001|Overall Study|Physician Decision|0|||
16155032|NCT02424253|39051573|FG000|Overall Study|Lack of Efficacy|0|||
16155033|NCT02424253|39051574|FG001|Overall Study|Lack of Efficacy|7|||
16155034|NCT02424253|39051573|FG000|Overall Study|Adverse Event|2|||
16155035|NCT02424253|39051574|FG001|Overall Study|Adverse Event|0|||
16155036|NCT02424253|39051573|FG000|Overall Study|Consent withdrawn by subject|4|||
16263164|NCT01520909|39449698|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
16263165|NCT00312663|39449699|FG000|Immunization Phase|Adverse Event|0|||
16263166|NCT00312663|39449700|FG001|Immunization Phase|Adverse Event|1|||
16263167|NCT00312663|39449701|FG002|Immunization Phase|Adverse Event|0|||
16263168|NCT02409355|39449706|FG000|Overall Study|Withdrawal by Subject|1|||
16263169|NCT02409355|39449707|FG001|Overall Study|Withdrawal by Subject|0|||
16263170|NCT02409355|39449706|FG000|Overall Study|Death|1|||
16263171|NCT02409355|39449707|FG001|Overall Study|Death|1|||
16263172|NCT02409355|39449706|FG000|Overall Study|Study terminated by Sponsor|2|||
16263173|NCT02409355|39449707|FG001|Overall Study|Study terminated by Sponsor|3|||
16263174|NCT03686033|39449708|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
16263175|NCT03686033|39449709|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
16263176|NCT03686033|39449710|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
16263177|NCT03686033|39449711|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
16263178|NCT03686033|39449712|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
16263179|NCT03686033|39449713|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
16263180|NCT00089661|39449720|FG000|Overall Study|Adverse Event|0|||
16263181|NCT00089661|39449721|FG001|Overall Study|Adverse Event|2|||
16263182|NCT00089661|39449720|FG000|Overall Study|Death|1|||
16263183|NCT00089661|39449721|FG001|Overall Study|Death|0|||
16263184|NCT00089661|39449720|FG000|Overall Study|Lost to Follow-up|0|||
16263185|NCT00089661|39449721|FG001|Overall Study|Lost to Follow-up|3|||
16263186|NCT00089661|39449720|FG000|Overall Study|Withdrawal by Subject|11|||
16263187|NCT00089661|39449721|FG001|Overall Study|Withdrawal by Subject|9|||
16263188|NCT00089661|39449720|FG000|Overall Study|Disease progression|1|||
16263189|NCT00089661|39449721|FG001|Overall Study|Disease progression|3|||
16263190|NCT00089661|39449720|FG000|Overall Study|Ineligibility determined|4|||
16263191|NCT00089661|39449721|FG001|Overall Study|Ineligibility determined|4|||
16263192|NCT00089661|39449720|FG000|Overall Study|Noncompliance|2|||
16263193|NCT00089661|39449721|FG001|Overall Study|Noncompliance|4|||
16263194|NCT00089661|39449720|FG000|Overall Study|Other|2|||
16263195|NCT00089661|39449721|FG001|Overall Study|Other|1|||
16263196|NCT01498120|39449723|FG000|Overall Study|Lost to Follow-up|1|||
16263197|NCT01498120|39449723|FG000|Overall Study|Withdrawal by Subject|5|||
16263198|NCT01498120|39449723|FG000|Overall Study|AE, non-serious non-fatal|3|||
16263199|NCT01498120|39449723|FG000|Overall Study|Other|4|||
16155037|NCT02424253|39051574|FG001|Overall Study|Consent withdrawn by subject|1|||
16155038|NCT02424253|39051573|FG000|Overall Study|Lost to Follow-up|1|||
16155039|NCT02424253|39051574|FG001|Overall Study|Lost to Follow-up|1|||
16263200|NCT03075761|39449724|FG000|Overall Study|Lost to Follow-up|1|||
16263201|NCT03075761|39449725|FG001|Overall Study|Lost to Follow-up|6|||
16263202|NCT02711852|39449726|FG000|Overall Study|Death|5|||
16263203|NCT02711852|39449726|FG000|Overall Study|Lost to Follow-up|1|||
16263204|NCT02711852|39449726|FG000|Overall Study|Completed follow-up|3|||
16444471|NCT04949490|40105943|FG003|Group A and Group B|Withdrawal by Subject|0|||
16155040|NCT01536860|39051575|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
16155041|NCT01536860|39051576|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
16263205|NCT02711852|39449726|FG000|Overall Study|Withdrawal by Subject|1|||
16263206|NCT03600805|39449729|FG000|Overall Study|Adverse Event|2|||
16263207|NCT03600805|39449730|FG001|Overall Study|Adverse Event|1|||
16263208|NCT03600805|39449731|FG002|Overall Study|Adverse Event|1|||
16263209|NCT03600805|39449732|FG003|Overall Study|Adverse Event|7|||
16263210|NCT03600805|39449729|FG000|Overall Study|Lack of Efficacy|2|||
16263211|NCT03600805|39449730|FG001|Overall Study|Lack of Efficacy|1|||
16263212|NCT03600805|39449731|FG002|Overall Study|Lack of Efficacy|0|||
16263213|NCT03600805|39449732|FG003|Overall Study|Lack of Efficacy|0|||
16263214|NCT03600805|39449729|FG000|Overall Study|Withdrawal by Subject|1|||
16263215|NCT03600805|39449730|FG001|Overall Study|Withdrawal by Subject|0|||
16263216|NCT03600805|39449731|FG002|Overall Study|Withdrawal by Subject|0|||
16263217|NCT03600805|39449732|FG003|Overall Study|Withdrawal by Subject|1|||
16263218|NCT03600805|39449729|FG000|Overall Study|Other unspecified|14|||
16263219|NCT03600805|39449730|FG001|Overall Study|Other unspecified|6|||
16263220|NCT03600805|39449731|FG002|Overall Study|Other unspecified|7|||
16263221|NCT03600805|39449732|FG003|Overall Study|Other unspecified|11|||
16263222|NCT02077465|39449735|FG000|Overall Study|Withdrew Consent|0|||
16263223|NCT02077465|39449736|FG001|Overall Study|Withdrew Consent|1|||
16263224|NCT02077465|39449735|FG000|Overall Study|Lost to Follow-up|1|||
16263225|NCT02077465|39449736|FG001|Overall Study|Lost to Follow-up|0|||
16263226|NCT03649477|39449739|FG000|Overall Study|Adverse Event|2|||
16263227|NCT03649477|39449740|FG001|Overall Study|Adverse Event|0|||
16263228|NCT03649477|39449741|FG002|Overall Study|Adverse Event|0|||
16263229|NCT05099380|39449742|FG000|Overall Study|Subject enrolled in error|1|||
16263230|NCT05099380|39449743|FG001|Overall Study|Subject enrolled in error|0|||
16263231|NCT05099380|39449742|FG000|Overall Study|Study Procedure|1|||
16263232|NCT05099380|39449743|FG001|Overall Study|Study Procedure|0|||
16263233|NCT05099380|39449742|FG000|Overall Study|Protocol Violation|1|||
16263234|NCT05099380|39449743|FG001|Overall Study|Protocol Violation|0|||
16263235|NCT05099380|39449742|FG000|Overall Study|Adverse Event|1|||
16263236|NCT05099380|39449743|FG001|Overall Study|Adverse Event|1|||
16263237|NCT05099380|39449742|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
16263238|NCT05099380|39449743|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
16263239|NCT01576042|39449744|FG000|Overall Study|Physician Decision|2|||
16263240|NCT01576042|39449745|FG001|Overall Study|Physician Decision|0|||
16263241|NCT01778010|39449748|FG000|Overall Study|Withdrawal by Subject|2|||
16263242|NCT01778010|39449748|FG000|Overall Study|abnormal ECG before meds|1|||
16263243|NCT01778010|39449748|FG000|Overall Study|Arrested|1|||
16263244|NCT01778010|39449748|FG000|Overall Study|rash while on placebo|1|||
16263245|NCT00252720|39449749|FG000|Overall Study|Withdrawal by Subject|95|||
16263246|NCT00252720|39449750|FG001|Overall Study|Withdrawal by Subject|97|||
16263247|NCT00252720|39449749|FG000|Overall Study|Death|7|||
16263248|NCT00252720|39449750|FG001|Overall Study|Death|8|||
16263249|NCT00252720|39449749|FG000|Overall Study|Moving|23|||
16263250|NCT00252720|39449750|FG001|Overall Study|Moving|42|||
16263251|NCT00252720|39449749|FG000|Overall Study|Mainly patients lost to follow-up|7|||
16263252|NCT00252720|39449750|FG001|Overall Study|Mainly patients lost to follow-up|18|||
16263253|NCT00934050|39449751|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
16263254|NCT00934050|39449752|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
16263255|NCT00934050|39449753|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
16263256|NCT00934050|39449754|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
16263257|NCT00934050|39449755|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
16263258|NCT00934050|39449756|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
16263259|NCT00934050|39449751|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
16263260|NCT00934050|39449752|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
16263261|NCT00934050|39449753|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
16263262|NCT00934050|39449754|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
16263263|NCT00934050|39449755|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
16263264|NCT00934050|39449756|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
16263265|NCT00934050|39449751|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
16263266|NCT00934050|39449752|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
16263267|NCT00934050|39449753|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
16263268|NCT00934050|39449754|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
16263269|NCT00934050|39449755|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
16263270|NCT00934050|39449756|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
16263271|NCT00934050|39449751|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
16263272|NCT00934050|39449752|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
16263273|NCT00934050|39449753|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
16263274|NCT00934050|39449754|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
16263275|NCT00934050|39449755|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
16263276|NCT00934050|39449756|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
16263277|NCT00934050|39449751|FG000|Enrolled After 15 Dec 2009|Death|0|||
16263278|NCT00934050|39449752|FG001|Enrolled After 15 Dec 2009|Death|0|||
16263279|NCT00934050|39449753|FG002|Enrolled After 15 Dec 2009|Death|0|||
16263280|NCT00934050|39449754|FG003|Enrolled After 15 Dec 2009|Death|0|||
16263281|NCT00934050|39449755|FG004|Enrolled After 15 Dec 2009|Death|0|||
16263282|NCT00934050|39449756|FG005|Enrolled After 15 Dec 2009|Death|1|||
16263283|NCT00934050|39449751|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
16263284|NCT00934050|39449752|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
16263285|NCT00934050|39449753|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
16263286|NCT00934050|39449754|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
16263287|NCT00934050|39449755|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
16263288|NCT00934050|39449756|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
16263289|NCT00934050|39449751|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
16263290|NCT00934050|39449752|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
16263291|NCT00934050|39449753|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
16263292|NCT00934050|39449754|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
16263293|NCT00934050|39449755|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
16263294|NCT00934050|39449756|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
16263295|NCT02246166|39449757|FG000|Overall Study|Protocol Violation|1|||
16263296|NCT02246166|39449758|FG001|Overall Study|Protocol Violation|0|||
16263297|NCT02193178|39449759|FG000|Overall Study|Lost to Follow-up|1|||
16263298|NCT02193178|39449759|FG000|Overall Study|Dry eyes|1|||
16263299|NCT01705574|39449760|FG000|Double-Blind Phase|Lost to Follow-up|12|||
16263300|NCT01705574|39449761|FG001|Double-Blind Phase|Lost to Follow-up|16|||
16263301|NCT01705574|39449762|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16263302|NCT01705574|39449763|FG003|Double-Blind Phase|Lost to Follow-up|0|||
16263303|NCT01705574|39449760|FG000|Double-Blind Phase|Adverse Event|3|||
16263304|NCT01705574|39449761|FG001|Double-Blind Phase|Adverse Event|10|||
16263305|NCT01705574|39449762|FG002|Double-Blind Phase|Adverse Event|0|||
16263306|NCT01705574|39449763|FG003|Double-Blind Phase|Adverse Event|0|||
16263307|NCT01705574|39449760|FG000|Double-Blind Phase|Withdrew Consent|8|||
16263308|NCT01705574|39449761|FG001|Double-Blind Phase|Withdrew Consent|5|||
16263309|NCT01705574|39449762|FG002|Double-Blind Phase|Withdrew Consent|0|||
16263310|NCT01705574|39449763|FG003|Double-Blind Phase|Withdrew Consent|0|||
16263311|NCT01705574|39449760|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
16263312|NCT01705574|39449761|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
16263313|NCT01705574|39449762|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
16263314|NCT01705574|39449763|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
16263315|NCT01705574|39449760|FG000|Double-Blind Phase|Pregnancy|1|||
16263316|NCT01705574|39449761|FG001|Double-Blind Phase|Pregnancy|1|||
16263317|NCT01705574|39449762|FG002|Double-Blind Phase|Pregnancy|0|||
16263318|NCT01705574|39449763|FG003|Double-Blind Phase|Pregnancy|0|||
16263319|NCT01705574|39449760|FG000|Double-Blind Phase|Protocol Violation|1|||
16263320|NCT01705574|39449761|FG001|Double-Blind Phase|Protocol Violation|0|||
16263321|NCT01705574|39449762|FG002|Double-Blind Phase|Protocol Violation|0|||
16263322|NCT01705574|39449763|FG003|Double-Blind Phase|Protocol Violation|0|||
16263323|NCT01705574|39449760|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
16263324|NCT01705574|39449761|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
16263325|NCT01705574|39449762|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
16263326|NCT01705574|39449763|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
16263327|NCT01705574|39449760|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
16263328|NCT01705574|39449761|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
16263329|NCT01705574|39449762|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
16263330|NCT01705574|39449763|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
16263331|NCT01705574|39449760|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
16263332|NCT01705574|39449761|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
16263333|NCT01705574|39449762|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
16263334|NCT01705574|39449763|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
16263335|NCT01705574|39449760|FG000|Open-Label Extension Phase|Adverse Event|3|||
16263336|NCT01705574|39449761|FG001|Open-Label Extension Phase|Adverse Event|0|||
16366664|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
16366665|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
16366666|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
16366667|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
16366668|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
16366669|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
16366670|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
16366671|NCT03329001|39825579|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
16366672|NCT03329001|39825580|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
16366673|NCT03329001|39825581|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
16366674|NCT03329001|39825582|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
16155042|NCT01536860|39051577|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
16155043|NCT03505021|39051578|FG000|Overall Study|Protocol Violation|1|||
16155044|NCT03505021|39051579|FG001|Overall Study|Protocol Violation|0|||
16155045|NCT03505021|39051578|FG000|Overall Study|Death|9|||
16155046|NCT03505021|39051579|FG001|Overall Study|Death|8|||
16155047|NCT03505021|39051578|FG000|Overall Study|Consent withdrawn by subject|6|||
16155048|NCT03505021|39051579|FG001|Overall Study|Consent withdrawn by subject|1|||
16155049|NCT03505021|39051578|FG000|Overall Study|Lost to Follow-up|5|||
16155050|NCT03505021|39051579|FG001|Overall Study|Lost to Follow-up|3|||
16155051|NCT03505021|39051578|FG000|Overall Study|Adverse Event|26|||
16155052|NCT03505021|39051579|FG001|Overall Study|Adverse Event|9|||
16155053|NCT03505021|39051578|FG000|Overall Study|Disease progression|33|||
16155054|NCT03505021|39051579|FG001|Overall Study|Disease progression|17|||
16155055|NCT03505021|39051578|FG000|Overall Study|Other|11|||
16155056|NCT03505021|39051579|FG001|Overall Study|Other|5|||
16155057|NCT03505021|39051578|FG000|Overall Study|Personal reason|21|||
16155058|NCT03505021|39051579|FG001|Overall Study|Personal reason|12|||
16155059|NCT02918864|39051580|FG000|Overall Study|Withdrawal by Subject|1|||
16155060|NCT02918864|39051581|FG001|Overall Study|Withdrawal by Subject|1|||
16155061|NCT02918864|39051580|FG000|Overall Study|Lost to Follow-up|3|||
16155062|NCT02918864|39051581|FG001|Overall Study|Lost to Follow-up|2|||
16155063|NCT03355300|39051582|FG000|Overall Study|Physician Decision|0|||
16155064|NCT03355300|39051583|FG001|Overall Study|Physician Decision|1|||
16155065|NCT03355300|39051582|FG000|Overall Study|Lack of Efficacy|2|||
16155066|NCT03355300|39051583|FG001|Overall Study|Lack of Efficacy|1|||
16155067|NCT03355300|39051582|FG000|Overall Study|Other reason|1|||
16155068|NCT03355300|39051583|FG001|Overall Study|Other reason|0|||
16155069|NCT00450723|39051584|FG000|Overall Study|Physician Decision|5|||
16155070|NCT01489527|39051586|FG000|Overall Study|Pregnancy|9|||
16155071|NCT01489527|39051587|FG001|Overall Study|Pregnancy|14|||
16155072|NCT01489527|39051586|FG000|Overall Study|Participant moved|6|||
16155073|NCT01489527|39051587|FG001|Overall Study|Participant moved|7|||
16155074|NCT01489527|39051586|FG000|Overall Study|Withdrawal by Subject|0|||
16155075|NCT01489527|39051587|FG001|Overall Study|Withdrawal by Subject|4|||
16155076|NCT01489527|39051586|FG000|Overall Study|Lost to Follow-up|5|||
16155077|NCT01489527|39051587|FG001|Overall Study|Lost to Follow-up|1|||
16155078|NCT01489527|39051586|FG000|Overall Study|Procedures|1|||
16155079|NCT01489527|39051587|FG001|Overall Study|Procedures|0|||
16155080|NCT01489527|39051586|FG000|Overall Study|Not compliant|1|||
16155081|NCT01489527|39051587|FG001|Overall Study|Not compliant|0|||
16155082|NCT02590588|39051588|FG000|Overall Study|Adverse Event|1|||
16155083|NCT03699007|39051596|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
16155084|NCT03699007|39051597|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
16155085|NCT03699007|39051596|FG000|6-month Follow Up|Lost to Follow-up|2|||
16155086|NCT03699007|39051597|FG001|6-month Follow Up|Lost to Follow-up|3|||
16155087|NCT00258674|39051598|FG000|Overall Study|Death|32|||
16155088|NCT00258674|39051599|FG001|Overall Study|Death|53|||
16155089|NCT00258674|39051600|FG002|Overall Study|Death|34|||
16155090|NCT01033734|39051601|FG000|Overall Study|Withdrawal by Subject|1|||
16155091|NCT02695628|39051602|FG000|Overall Study|Withdrawal by Subject|1|||
16444472|NCT04949490|40105944|FG004|Group A and Group B|Withdrawal by Subject|0|||
16155092|NCT03548935|39054264|FG000|Overall Study|Withdrawal by Subject|26|||
16155093|NCT03548935|39054265|FG001|Overall Study|Withdrawal by Subject|17|||
16155094|NCT03548935|39054264|FG000|Overall Study|Lost to Follow-up|39|||
16155095|NCT03548935|39054265|FG001|Overall Study|Lost to Follow-up|28|||
16155096|NCT03548935|39054264|FG000|Overall Study|Death|1|||
16155097|NCT03548935|39054265|FG001|Overall Study|Death|1|||
16155098|NCT00501007|39054266|FG000|Overall Study|Inclusion criteria not met.|29|||
16155099|NCT00501007|39054267|FG001|Overall Study|Inclusion criteria not met.|25|||
16155100|NCT03691974|39054268|FG000|Overall Study|Physician Decision|1|||
16155101|NCT03691974|39054269|FG001|Overall Study|Physician Decision|0|||
16155102|NCT03691974|39054268|FG000|Overall Study|Adverse Event|1|||
16155103|NCT03691974|39054269|FG001|Overall Study|Adverse Event|0|||
16155104|NCT03691974|39054268|FG000|Overall Study|Withdrawal by Subject|11|||
16155105|NCT03691974|39054269|FG001|Overall Study|Withdrawal by Subject|9|||
16155106|NCT03691974|39054268|FG000|Overall Study|Protocol Violation|1|||
16155107|NCT03691974|39054269|FG001|Overall Study|Protocol Violation|0|||
16155108|NCT03691974|39054268|FG000|Overall Study|Lost to Follow-up|8|||
16155109|NCT03691974|39054269|FG001|Overall Study|Lost to Follow-up|7|||
16155110|NCT01888640|39054270|FG000|Overall Study|Lost to Follow-up|1|||
16155111|NCT01888640|39054271|FG001|Overall Study|Lost to Follow-up|2|||
16444473|NCT04949490|40105945|FG005|Group A and Group B|Withdrawal by Subject|0|||
16444474|NCT04949490|40105940|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
16444475|NCT04949490|40105941|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
16444476|NCT04949490|40105942|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
16155112|NCT01888640|39054272|FG002|Overall Study|Lost to Follow-up|0|||
16444477|NCT04949490|40105943|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
16444478|NCT04949490|40105944|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
16444479|NCT04949490|40105945|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
16444480|NCT04949490|40105940|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
16444481|NCT04949490|40105941|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
16155113|NCT01888640|39054270|FG000|Overall Study|Withdrawal by Subject|15|||
16155114|NCT01888640|39054271|FG001|Overall Study|Withdrawal by Subject|11|||
16155115|NCT01888640|39054272|FG002|Overall Study|Withdrawal by Subject|4|||
16155116|NCT01888640|39054270|FG000|Overall Study|Minimum dose not met|10|||
16155117|NCT01888640|39054271|FG001|Overall Study|Minimum dose not met|16|||
16155118|NCT01888640|39054272|FG002|Overall Study|Minimum dose not met|0|||
16155119|NCT01888640|39054270|FG000|Overall Study|Given wrong unit (placebo)|1|||
16155120|NCT01888640|39054271|FG001|Overall Study|Given wrong unit (placebo)|0|||
16155121|NCT01888640|39054272|FG002|Overall Study|Given wrong unit (placebo)|0|||
16155122|NCT01888640|39054270|FG000|Overall Study|Excluded for prior TENS|0|||
16155123|NCT01888640|39054271|FG001|Overall Study|Excluded for prior TENS|1|||
16155124|NCT01888640|39054272|FG002|Overall Study|Excluded for prior TENS|0|||
16155125|NCT01888640|39054270|FG000|Overall Study|Researcher Termination of Participant|0|||
16155126|NCT01888640|39054271|FG001|Overall Study|Researcher Termination of Participant|1|||
16155127|NCT01888640|39054272|FG002|Overall Study|Researcher Termination of Participant|1|||
16155128|NCT00004259|39054273|FG000|Overall Study|Protocol Violation|1|||
16155129|NCT00004259|39054274|FG001|Overall Study|Protocol Violation|2|||
16155130|NCT00004259|39054275|FG002|Overall Study|Protocol Violation|0|||
16155131|NCT00004259|39054276|FG003|Overall Study|Protocol Violation|0|||
16155132|NCT00004259|39054273|FG000|Overall Study|Withdrawal by Subject|0|||
16155133|NCT00004259|39054274|FG001|Overall Study|Withdrawal by Subject|2|||
16155134|NCT00004259|39054275|FG002|Overall Study|Withdrawal by Subject|0|||
16155135|NCT00004259|39054276|FG003|Overall Study|Withdrawal by Subject|0|||
16155136|NCT01496066|39054278|FG000|Overall Study|Lost to Follow-up|8|||
16155137|NCT01496066|39054279|FG001|Overall Study|Lost to Follow-up|5|||
16155138|NCT01496066|39054278|FG000|Overall Study|Explant|3|||
16155139|NCT01496066|39054279|FG001|Overall Study|Explant|0|||
16155140|NCT01496066|39054278|FG000|Overall Study|Death|1|||
16155141|NCT01496066|39054279|FG001|Overall Study|Death|4|||
16155142|NCT00487539|39054280|FG000|Overall Study|Adverse Event|3|||
16155143|NCT00487539|39054281|FG001|Overall Study|Adverse Event|2|||
16155144|NCT00487539|39054282|FG002|Overall Study|Adverse Event|1|||
16444482|NCT04949490|40105942|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
16444483|NCT04949490|40105943|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
16444484|NCT04949490|40105944|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
16444485|NCT04949490|40105945|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
16444486|NCT05299528|40105948|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
16444487|NCT05299528|40105949|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
16444488|NCT05299528|40105950|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
16444489|NCT05299528|40105951|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
16444490|NCT05299528|40105952|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
16444491|NCT05299528|40105953|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
16444492|NCT05299528|40105954|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
16444493|NCT05299528|40105948|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
16444494|NCT05299528|40105949|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
16444495|NCT05299528|40105950|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
16444496|NCT05299528|40105951|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
16444497|NCT05299528|40105952|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
16444498|NCT05299528|40105953|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
16444499|NCT05299528|40105954|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
16366675|NCT03329001|39825583|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
16366676|NCT03329001|39825584|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
16444500|NCT05299528|40105948|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
16444501|NCT05299528|40105949|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
16366677|NCT03329001|39825585|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
16366678|NCT03329001|39825586|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
16366679|NCT03329001|39825579|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
16366680|NCT03329001|39825580|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
16366681|NCT03329001|39825581|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
16366682|NCT03329001|39825582|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
16366683|NCT03329001|39825583|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
16366684|NCT03329001|39825584|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
16366685|NCT03329001|39825585|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
16366686|NCT03329001|39825586|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
16366687|NCT03329001|39825579|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
16366688|NCT03329001|39825580|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
16366689|NCT03329001|39825581|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
16366690|NCT03329001|39825582|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
16366691|NCT03329001|39825583|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
16366692|NCT03329001|39825584|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
16444502|NCT05299528|40105950|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
16366693|NCT03329001|39825585|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
16444503|NCT05299528|40105951|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
16155145|NCT00487539|39054283|FG003|Overall Study|Adverse Event|1|||
16155146|NCT00487539|39054280|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16155147|NCT00487539|39054281|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16155148|NCT00487539|39054282|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16155149|NCT00487539|39054283|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
16155150|NCT00487539|39054280|FG000|Overall Study|Other|3|||
16155151|NCT00487539|39054281|FG001|Overall Study|Other|1|||
16155152|NCT00487539|39054282|FG002|Overall Study|Other|2|||
16155153|NCT00487539|39054283|FG003|Overall Study|Other|2|||
16155154|NCT00088374|39054284|FG000|Overall Study|patient did not receive any 17AAG|1|||
16155155|NCT00088374|39054284|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
16155156|NCT03075527|39054285|FG000|Overall Study|Ongoing treatment|2|||
16155157|NCT00522431|39054286|FG000|Overall Study|Adverse Event|5|||
16155158|NCT00522431|39054286|FG000|Overall Study|Protocol Violation|2|||
16155159|NCT00522431|39054286|FG000|Overall Study|Withdrawal by Subject|2|||
16155160|NCT00522431|39054286|FG000|Overall Study|Subject non-compliance|1|||
16155161|NCT00522431|39054286|FG000|Overall Study|Other/unknown|1|||
16155162|NCT04036708|39054290|FG000|Overall Study|Lost to Follow-up|14|||
16155163|NCT04036708|39054291|FG001|Overall Study|Lost to Follow-up|4|||
16155164|NCT04036708|39054292|FG002|Overall Study|Lost to Follow-up|14|||
16155165|NCT04036708|39054293|FG003|Overall Study|Lost to Follow-up|4|||
16155166|NCT00264875|39054296|FG000|Overall Study|Adverse Event|6|||
16155167|NCT00264875|39054296|FG000|Overall Study|Lost to Follow-up|6|||
16155168|NCT00264875|39054296|FG000|Overall Study|Protocol Violation|11|||
16155169|NCT00264875|39054296|FG000|Overall Study|Withdrawal by Subject|7|||
16155170|NCT02797808|39054298|FG000|Overall Study|Withdrawal by Subject|1|||
16155171|NCT02797808|39054299|FG001|Overall Study|Withdrawal by Subject|1|||
16155172|NCT02797808|39054298|FG000|Overall Study|Physician Decision|6|||
16155173|NCT02797808|39054299|FG001|Overall Study|Physician Decision|2|||
16155174|NCT01278745|39054300|FG000|Overall Study|Death|2|||
16155175|NCT01278745|39054301|FG001|Overall Study|Death|5|||
16155176|NCT01278745|39054302|FG002|Overall Study|Death|7|||
16155177|NCT01278745|39054303|FG003|Overall Study|Death|0|||
16155178|NCT01278745|39054300|FG000|Overall Study|Physician Decision|1|||
16155179|NCT01278745|39054301|FG001|Overall Study|Physician Decision|0|||
16155180|NCT01278745|39054302|FG002|Overall Study|Physician Decision|0|||
16155181|NCT01278745|39054303|FG003|Overall Study|Physician Decision|9|||
16155182|NCT01278745|39054300|FG000|Overall Study|Withdrawal by Subject|1|||
16155183|NCT01278745|39054301|FG001|Overall Study|Withdrawal by Subject|1|||
16155184|NCT01278745|39054302|FG002|Overall Study|Withdrawal by Subject|5|||
16155185|NCT01278745|39054303|FG003|Overall Study|Withdrawal by Subject|1|||
16155186|NCT01278745|39054300|FG000|Overall Study|Sponsor Decision|1|||
16155187|NCT01278745|39054301|FG001|Overall Study|Sponsor Decision|0|||
16155188|NCT01278745|39054302|FG002|Overall Study|Sponsor Decision|62|||
16155189|NCT01278745|39054303|FG003|Overall Study|Sponsor Decision|6|||
16155190|NCT01278745|39054300|FG000|Overall Study|Ineligible|0|||
16155191|NCT01278745|39054301|FG001|Overall Study|Ineligible|0|||
16155192|NCT01278745|39054302|FG002|Overall Study|Ineligible|42|||
16155193|NCT01278745|39054303|FG003|Overall Study|Ineligible|61|||
16155194|NCT01278745|39054300|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
16155195|NCT01278745|39054301|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
16155196|NCT01278745|39054302|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
16155197|NCT01278745|39054303|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
16155198|NCT00879697|39054305|FG000|Overall Study|Physician Decision|2|||
16155199|NCT00879697|39054306|FG001|Overall Study|Physician Decision|2|||
16444504|NCT05299528|40105952|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
16444505|NCT05299528|40105953|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
16444506|NCT05299528|40105954|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
16444507|NCT05523089|40105955|FG000|Overall Study|Withdrawal by Subject|1|||
16444508|NCT05523089|40105956|FG001|Overall Study|Withdrawal by Subject|0|||
16444509|NCT05523089|40105957|FG002|Overall Study|Withdrawal by Subject|0|||
16444510|NCT05523089|40105955|FG000|Overall Study|Lost to Follow-up|1|||
16444511|NCT05523089|40105956|FG001|Overall Study|Lost to Follow-up|0|||
16444512|NCT05523089|40105957|FG002|Overall Study|Lost to Follow-up|0|||
16444513|NCT02638220|40105958|FG000|Overall Study|Lost to Follow-up|6|||
16444514|NCT02638220|40105958|FG000|Overall Study|Withdrawal by Subject|3|||
16444515|NCT02638220|40105958|FG000|Overall Study|Physician Decision|1|||
16444516|NCT02638220|40105958|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
16444517|NCT02060721|40105959|FG000|Overall Study|Lost to Follow-up|1|||
16444518|NCT02060721|40105959|FG000|Overall Study|Physician Decision|2|||
16444519|NCT02060721|40105959|FG000|Overall Study|Death|14|||
16155200|NCT03011333|39054307|FG000|Overall Study|Lost to Follow-up|0|||
16155201|NCT03011333|39054308|FG001|Overall Study|Lost to Follow-up|1|||
16444520|NCT02060721|40105959|FG000|Overall Study|Withdrawal by Subject|2|||
16444521|NCT02060721|40105959|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
16155202|NCT03011333|39054309|FG002|Overall Study|Lost to Follow-up|0|||
16155203|NCT03011333|39054310|FG003|Overall Study|Lost to Follow-up|1|||
16155204|NCT03011333|39054311|FG004|Overall Study|Lost to Follow-up|4|||
16155205|NCT03011333|39054312|FG005|Overall Study|Lost to Follow-up|4|||
16155206|NCT03011333|39054313|FG006|Overall Study|Lost to Follow-up|5|||
16155207|NCT02751502|39054314|FG000|Overall Study|Lack of funding|4|||
16155208|NCT03861559|39054315|FG000|Overall Study|Adverse Event|0|||
16155209|NCT03861559|39054316|FG001|Overall Study|Adverse Event|2|||
16155210|NCT03861559|39054315|FG000|Overall Study|Treatment failure|0|||
16155211|NCT03861559|39054316|FG001|Overall Study|Treatment failure|2|||
16155212|NCT03861559|39054315|FG000|Overall Study|Noncompliance|1|||
16155213|NCT03861559|39054316|FG001|Overall Study|Noncompliance|1|||
16155214|NCT03861559|39054315|FG000|Overall Study|Did not meet eligibility requirements|1|||
16155215|NCT03861559|39054316|FG001|Overall Study|Did not meet eligibility requirements|0|||
16155216|NCT02462473|39054319|FG000|Overall Study|Death|1|||
16155217|NCT02462473|39054319|FG000|Overall Study|Other|3|||
16155218|NCT01594853|39054334|FG000|Overall Study|Withdrawal by Subject|1|||
16155219|NCT01594853|39054335|FG001|Overall Study|Withdrawal by Subject|1|||
16155220|NCT01594853|39054334|FG000|Overall Study|Lost to Follow-up|1|||
16155221|NCT01594853|39054335|FG001|Overall Study|Lost to Follow-up|1|||
16155222|NCT01594853|39054334|FG000|Overall Study|noncompliance with exercise|0|||
16155223|NCT01594853|39054335|FG001|Overall Study|noncompliance with exercise|1|||
16155224|NCT00243659|39054336|FG000|Overall Study|Withdrawal by Subject|1|||
16155225|NCT00243659|39054337|FG001|Overall Study|Withdrawal by Subject|1|||
16155226|NCT00243659|39054336|FG000|Overall Study|Protocol Violation|1|||
16263337|NCT01705574|39449762|FG002|Open-Label Extension Phase|Adverse Event|0|||
16263338|NCT01705574|39449763|FG003|Open-Label Extension Phase|Adverse Event|1|||
16263339|NCT01705574|39449760|FG000|Open-Label Extension Phase|Death|2|||
16263340|NCT01705574|39449761|FG001|Open-Label Extension Phase|Death|0|||
16263341|NCT01705574|39449762|FG002|Open-Label Extension Phase|Death|1|||
16263342|NCT01705574|39449763|FG003|Open-Label Extension Phase|Death|0|||
16263343|NCT01705574|39449760|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
16263344|NCT01705574|39449761|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
16263345|NCT01705574|39449762|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
16263346|NCT01705574|39449763|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
16263347|NCT01705574|39449760|FG000|Open-Label Extension Phase|Physician Decision|0|||
16263348|NCT01705574|39449761|FG001|Open-Label Extension Phase|Physician Decision|0|||
16263349|NCT01705574|39449762|FG002|Open-Label Extension Phase|Physician Decision|2|||
16263350|NCT01705574|39449763|FG003|Open-Label Extension Phase|Physician Decision|0|||
16263351|NCT01705574|39449760|FG000|Open-Label Extension Phase|Pregnancy|0|||
16263352|NCT01705574|39449761|FG001|Open-Label Extension Phase|Pregnancy|0|||
16263353|NCT01705574|39449762|FG002|Open-Label Extension Phase|Pregnancy|1|||
16263354|NCT01705574|39449763|FG003|Open-Label Extension Phase|Pregnancy|1|||
16263355|NCT03868891|39449764|FG000|Overall Study|Adverse Event|1|||
16263356|NCT03868891|39449765|FG001|Overall Study|Adverse Event|0|||
16263357|NCT03868891|39449764|FG000|Overall Study|Lost to Follow-up|2|||
16263358|NCT03868891|39449765|FG001|Overall Study|Lost to Follow-up|1|||
16263359|NCT03868891|39449764|FG000|Overall Study|COVID-19 Restrictions|1|||
16263360|NCT03868891|39449765|FG001|Overall Study|COVID-19 Restrictions|2|||
16263361|NCT03772522|39449768|FG000|Pre-intervention|Withdrawal by Subject|3|||
16263362|NCT03772522|39449769|FG001|Pre-intervention|Withdrawal by Subject|4|||
16263363|NCT03772522|39449768|FG000|Intervention|Withdrawal by Subject|1|||
16263364|NCT03772522|39449769|FG001|Intervention|Withdrawal by Subject|0|||
16263365|NCT03772522|39449768|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
16263366|NCT03772522|39449769|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
16263367|NCT00796653|39449771|FG000|Overall Study|Adverse Event|19|||
16263368|NCT00796653|39449772|FG001|Overall Study|Adverse Event|16|||
16263369|NCT00796653|39449773|FG002|Overall Study|Adverse Event|16|||
16263370|NCT00796653|39449774|FG003|Overall Study|Adverse Event|16|||
16263371|NCT00796653|39449771|FG000|Overall Study|Lost to Follow-up|2|||
16263372|NCT00796653|39449772|FG001|Overall Study|Lost to Follow-up|1|||
16263373|NCT00796653|39449773|FG002|Overall Study|Lost to Follow-up|2|||
16263374|NCT00796653|39449774|FG003|Overall Study|Lost to Follow-up|3|||
16263375|NCT00796653|39449771|FG000|Overall Study|Withdrawal by Subject|16|||
16263376|NCT00796653|39449772|FG001|Overall Study|Withdrawal by Subject|8|||
16263377|NCT00796653|39449773|FG002|Overall Study|Withdrawal by Subject|8|||
16263378|NCT00796653|39449774|FG003|Overall Study|Withdrawal by Subject|13|||
16263379|NCT00796653|39449771|FG000|Overall Study|Lack of Efficacy|8|||
16155227|NCT00243659|39054337|FG001|Overall Study|Protocol Violation|2|||
16263380|NCT00796653|39449772|FG001|Overall Study|Lack of Efficacy|1|||
16263381|NCT00796653|39449773|FG002|Overall Study|Lack of Efficacy|3|||
16263382|NCT00796653|39449774|FG003|Overall Study|Lack of Efficacy|2|||
16263383|NCT00796653|39449771|FG000|Overall Study|Non compliance with protocol|2|||
16263384|NCT00796653|39449772|FG001|Overall Study|Non compliance with protocol|2|||
16263385|NCT00796653|39449773|FG002|Overall Study|Non compliance with protocol|0|||
16263386|NCT00796653|39449774|FG003|Overall Study|Non compliance with protocol|2|||
16263387|NCT00796653|39449771|FG000|Overall Study|Other reason not described above|4|||
16263388|NCT00796653|39449772|FG001|Overall Study|Other reason not described above|9|||
16155228|NCT03461757|39054338|FG000|Overall Study|Adverse Event|1|||
16155229|NCT03461757|39054339|FG001|Overall Study|Adverse Event|0|||
16155230|NCT03461757|39054338|FG000|Overall Study|Lost to Follow-up|13|||
16155231|NCT03461757|39054339|FG001|Overall Study|Lost to Follow-up|7|||
16155232|NCT03461757|39054338|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
16155233|NCT03461757|39054339|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
16155234|NCT03461757|39054338|FG000|Overall Study|Non-compliance with study treatment|0|||
16155235|NCT03461757|39054339|FG001|Overall Study|Non-compliance with study treatment|1|||
16155236|NCT03461757|39054338|FG000|Overall Study|Pregnancy|2|||
16155237|NCT03461757|39054339|FG001|Overall Study|Pregnancy|0|||
16155238|NCT03461757|39054338|FG000|Overall Study|Protocol Violation|1|||
16155239|NCT03461757|39054339|FG001|Overall Study|Protocol Violation|1|||
16155240|NCT03461757|39054338|FG000|Overall Study|Withdrawal by Subject|7|||
16155241|NCT03461757|39054339|FG001|Overall Study|Withdrawal by Subject|7|||
16155242|NCT03461757|39054338|FG000|Overall Study|Other Reasons|1|||
16155243|NCT03461757|39054339|FG001|Overall Study|Other Reasons|4|||
16155244|NCT00732303|39054340|FG000|Overall Study|Study Terminated|2|||
16155245|NCT03776175|39054341|FG000|Treatment Period (42 Days)|Adverse Event|0|||
16155246|NCT03776175|39054342|FG001|Treatment Period (42 Days)|Adverse Event|1|||
16155247|NCT03776175|39054343|FG002|Treatment Period (42 Days)|Adverse Event|1|||
16155248|NCT03776175|39054344|FG003|Treatment Period (42 Days)|Adverse Event|0|||
16155249|NCT03776175|39054341|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
16155250|NCT03776175|39054342|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
16155251|NCT03776175|39054343|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
16155252|NCT03776175|39054344|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
16155253|NCT03776175|39054341|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
16155254|NCT03776175|39054342|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
16155255|NCT03776175|39054343|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
16155256|NCT03776175|39054344|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
16155257|NCT03776175|39054341|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
16155258|NCT03776175|39054342|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
16155259|NCT03776175|39054343|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
16155260|NCT03776175|39054344|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
16155261|NCT03776175|39054341|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
16155262|NCT03776175|39054342|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
16155263|NCT03776175|39054343|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
16155264|NCT03776175|39054344|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
16444522|NCT04272242|40105960|FG000|Overall Study|Withdrawal by Subject|3|||
16444523|NCT04272242|40105960|FG000|Overall Study|Lost to Follow-up|1|||
16444524|NCT04272242|40105960|FG000|Overall Study|Adverse Event|1|||
16444525|NCT02864394|40105966|FG000|Overall Study|Death|184|||
16444526|NCT02864394|40105967|FG001|Overall Study|Death|189|||
16444527|NCT02864394|40105966|FG000|Overall Study|Lost to Follow-up|0|||
16444528|NCT02864394|40105967|FG001|Overall Study|Lost to Follow-up|2|||
16444529|NCT02864394|40105966|FG000|Overall Study|Sponsor Decision|26|||
16444530|NCT02864394|40105967|FG001|Overall Study|Sponsor Decision|11|||
16444531|NCT02864394|40105966|FG000|Overall Study|Withdrawal by Subject|3|||
16444532|NCT02864394|40105967|FG001|Overall Study|Withdrawal by Subject|10|||
16444533|NCT03299166|40105969|FG000|Overall Study|Adverse Event|9|||
16444534|NCT03299166|40105970|FG001|Overall Study|Adverse Event|4|||
16444535|NCT03299166|40105969|FG000|Overall Study|Withdrawal by Subject|6|||
16444536|NCT03299166|40105970|FG001|Overall Study|Withdrawal by Subject|5|||
16444537|NCT03299166|40105969|FG000|Overall Study|Physician Decision|1|||
16444538|NCT03299166|40105970|FG001|Overall Study|Physician Decision|1|||
16444539|NCT03299166|40105969|FG000|Overall Study|Sponsor Decision|3|||
16444540|NCT03299166|40105970|FG001|Overall Study|Sponsor Decision|0|||
16444541|NCT03299166|40105969|FG000|Overall Study|Lost to Follow-up|2|||
16444542|NCT03299166|40105970|FG001|Overall Study|Lost to Follow-up|4|||
16444543|NCT03299166|40105969|FG000|Overall Study|Randomization Error|0|||
16444544|NCT03299166|40105970|FG001|Overall Study|Randomization Error|1|||
16444545|NCT03299166|40105969|FG000|Overall Study|Subject unable to return due to COVID|1|||
16444546|NCT03299166|40105970|FG001|Overall Study|Subject unable to return due to COVID|0|||
16444547|NCT03299166|40105969|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
16444548|NCT03299166|40105970|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
16444549|NCT03425643|40105971|FG000|Overall Study|Withdrawal by Subject|10|||
16444550|NCT03425643|40105972|FG001|Overall Study|Withdrawal by Subject|12|||
16444551|NCT03425643|40105971|FG000|Overall Study|Lost to Follow-up|2|||
16444552|NCT03425643|40105972|FG001|Overall Study|Lost to Follow-up|0|||
16444553|NCT03425643|40105971|FG000|Overall Study|Death|109|||
16444554|NCT03425643|40105972|FG001|Overall Study|Death|141|||
16155265|NCT03776175|39054341|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
16155266|NCT03776175|39054342|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
16444555|NCT03425643|40105971|FG000|Overall Study|Ongoing in study|276|||
16444556|NCT03425643|40105972|FG001|Overall Study|Ongoing in study|247|||
16444557|NCT03493464|40105973|FG000|Overall Study|Surgery not performed|1|||
16155267|NCT03776175|39054343|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
16155268|NCT03776175|39054344|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
16155269|NCT00408694|39054345|FG000|Overall Study|Ineligible|1|||
16155270|NCT00408694|39054345|FG000|Overall Study|No protocol treatment|1|||
16155271|NCT03259074|39054346|FG000|Overall Study|Adverse Event|9|||
16155272|NCT03259074|39054347|FG001|Overall Study|Adverse Event|12|||
16155273|NCT03259074|39054348|FG002|Overall Study|Adverse Event|8|||
16155274|NCT03259074|39054346|FG000|Overall Study|Death|1|||
16155275|NCT03259074|39054347|FG001|Overall Study|Death|1|||
16155276|NCT03259074|39054348|FG002|Overall Study|Death|3|||
16155277|NCT03259074|39054346|FG000|Overall Study|Lost to Follow-up|2|||
16155278|NCT03259074|39054347|FG001|Overall Study|Lost to Follow-up|4|||
16155279|NCT03259074|39054348|FG002|Overall Study|Lost to Follow-up|3|||
16155280|NCT03259074|39054346|FG000|Overall Study|New Therapy For Study Indication|1|||
16155281|NCT03259074|39054347|FG001|Overall Study|New Therapy For Study Indication|2|||
16155282|NCT03259074|39054348|FG002|Overall Study|New Therapy For Study Indication|2|||
16155283|NCT03259074|39054346|FG000|Overall Study|Physician Decision|4|||
16155284|NCT03259074|39054347|FG001|Overall Study|Physician Decision|12|||
16155285|NCT03259074|39054348|FG002|Overall Study|Physician Decision|10|||
16155286|NCT03259074|39054346|FG000|Overall Study|Pregnancy|1|||
16155287|NCT03259074|39054347|FG001|Overall Study|Pregnancy|1|||
16155288|NCT03259074|39054348|FG002|Overall Study|Pregnancy|0|||
16155289|NCT03259074|39054346|FG000|Overall Study|Progressive Disease|1|||
16155290|NCT03259074|39054347|FG001|Overall Study|Progressive Disease|0|||
16155291|NCT03259074|39054348|FG002|Overall Study|Progressive Disease|0|||
16155292|NCT03259074|39054346|FG000|Overall Study|Protocol Deviation|1|||
16155293|NCT03259074|39054347|FG001|Overall Study|Protocol Deviation|1|||
16155294|NCT03259074|39054348|FG002|Overall Study|Protocol Deviation|3|||
16155295|NCT03259074|39054346|FG000|Overall Study|Subject/Guardian Decision|13|||
16155296|NCT03259074|39054347|FG001|Overall Study|Subject/Guardian Decision|16|||
16155297|NCT03259074|39054348|FG002|Overall Study|Subject/Guardian Decision|14|||
16155298|NCT01137773|39054349|FG000|Overall Study|Death|3|||
16155299|NCT01137773|39054350|FG001|Overall Study|Death|3|||
16155300|NCT01137773|39054349|FG000|Overall Study|Lost to Follow-up|6|||
16155301|NCT01137773|39054350|FG001|Overall Study|Lost to Follow-up|0|||
16155302|NCT04718974|39054353|FG000|Overall Study|Death|0|||
16155303|NCT04718974|39054354|FG001|Overall Study|Death|2|||
16155304|NCT04718974|39054353|FG000|Overall Study|Lost to Follow-up|10|||
16155305|NCT04718974|39054354|FG001|Overall Study|Lost to Follow-up|20|||
16155306|NCT04718974|39054353|FG000|Overall Study|Transferred out|2|||
16155307|NCT04718974|39054354|FG001|Overall Study|Transferred out|4|||
16155308|NCT03917823|39054355|FG000|Overall Study|Lost to Follow-up|1|||
16155309|NCT03917823|39054356|FG001|Overall Study|Lost to Follow-up|1|||
16155310|NCT03917823|39054355|FG000|Overall Study|Withdrawal by Subject|0|||
16155311|NCT03917823|39054356|FG001|Overall Study|Withdrawal by Subject|1|||
16155312|NCT00774345|39054357|FG000|Pre-treatment|Other reasons|2|||
16155313|NCT00774345|39054358|FG001|Pre-treatment|Other reasons|0|||
16155314|NCT00774345|39054357|FG000|Treatment|Adverse Event|61|||
16155315|NCT00774345|39054358|FG001|Treatment|Adverse Event|15|||
16155316|NCT00774345|39054357|FG000|Treatment|Progressive Disease without histologic transformation|51|||
16155317|NCT00774345|39054358|FG001|Treatment|Progressive Disease without histologic transformation|111|||
16155318|NCT00774345|39054357|FG000|Treatment|Progressive Disease with histologic transformation|4|||
16155319|NCT00774345|39054358|FG001|Treatment|Progressive Disease with histologic transformation|2|||
16155320|NCT00774345|39054357|FG000|Treatment|Withdrawal by Subject|5|||
16155321|NCT00774345|39054358|FG001|Treatment|Withdrawal by Subject|2|||
16155322|NCT00774345|39054357|FG000|Treatment|Lost to Follow-up|1|||
16155323|NCT00774345|39054358|FG001|Treatment|Lost to Follow-up|1|||
16155324|NCT00774345|39054357|FG000|Treatment|Death|4|||
16155325|NCT00774345|39054358|FG001|Treatment|Death|0|||
16155326|NCT00774345|39054357|FG000|Treatment|Other Reasons|32|||
16155327|NCT00774345|39054358|FG001|Treatment|Other Reasons|26|||
16444558|NCT04774094|40105974|FG000|Overall Study|Other|2|||
16444559|NCT04774094|40105974|FG000|Overall Study|Withdrawal by Subject|9|||
16444560|NCT04774094|40105974|FG000|Overall Study|Lost to Follow-up|7|||
16444561|NCT04774094|40105974|FG000|Overall Study|Lack of Efficacy|5|||
16444562|NCT04774094|40105974|FG000|Overall Study|Death|17|||
16444563|NCT04774094|40105974|FG000|Overall Study|Adverse Event|4|||
16444564|NCT03204188|40105980|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
16155328|NCT00996944|39054359|FG000|Double-blind Treatment Period|Adverse Event|2|||
16155329|NCT00996944|39054360|FG001|Double-blind Treatment Period|Adverse Event|1|||
16155330|NCT00996944|39054359|FG000|Double-blind Treatment Period|Protocol Violation|1|||
16155331|NCT00996944|39054360|FG001|Double-blind Treatment Period|Protocol Violation|0|||
16155332|NCT00996944|39054359|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
16155333|NCT00996944|39054360|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
16155334|NCT00996944|39054359|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
16155335|NCT00996944|39054360|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
16155336|NCT00996944|39054359|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
16155337|NCT00996944|39054360|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
16155338|NCT03927105|39054361|FG000|Overall Study|Death|1|||
16155339|NCT03927105|39054361|FG000|Overall Study|In observation for potential re-treatment|2|||
16155340|NCT03927105|39054361|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
16155341|NCT00749996|39054370|FG000|Overall Study|Lost to Follow-up|7|||
16155342|NCT00749996|39054371|FG001|Overall Study|Lost to Follow-up|4|||
16155343|NCT00749996|39054370|FG000|Overall Study|Withdrawal by Subject|5|||
16155344|NCT00749996|39054371|FG001|Overall Study|Withdrawal by Subject|4|||
16155345|NCT00749996|39054370|FG000|Overall Study|Protocol Violation|2|||
16155346|NCT00749996|39054371|FG001|Overall Study|Protocol Violation|3|||
16155347|NCT00749996|39054370|FG000|Overall Study|Physician Decision|2|||
16155348|NCT00749996|39054371|FG001|Overall Study|Physician Decision|0|||
16155349|NCT00749996|39054370|FG000|Overall Study|Pregnancy|0|||
16155350|NCT00749996|39054371|FG001|Overall Study|Pregnancy|2|||
16444565|NCT03204188|40105980|FG000|Immunotherapy Phase (1 Year)|Death|1|||
16155351|NCT00749996|39054370|FG000|Overall Study|Adverse Event|1|||
16155352|NCT00749996|39054371|FG001|Overall Study|Adverse Event|0|||
16155353|NCT00749996|39054370|FG000|Overall Study|Death|1|||
16155354|NCT00749996|39054371|FG001|Overall Study|Death|0|||
16155355|NCT05121480|39054372|FG000|Overall Study|Lack of Efficacy|2|||
16444566|NCT03204188|40105980|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
16444567|NCT03204188|40105980|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
16444568|NCT00905164|40105981|FG000|Period 1|Protocol Violation|0|||
16444569|NCT00905164|40105982|FG001|Period 1|Protocol Violation|1|||
16444570|NCT04874155|40105984|FG000|Overall Study|Lost to Follow-up|1|||
16444571|NCT04874155|40105985|FG001|Overall Study|Lost to Follow-up|1|||
16444572|NCT04874155|40105984|FG000|Overall Study|Withdrawal by Subject|2|||
16444573|NCT04874155|40105985|FG001|Overall Study|Withdrawal by Subject|2|||
16444574|NCT02782949|40105988|FG000|Overall Study|Protocol Violation|1|||
16444575|NCT02782949|40105989|FG001|Overall Study|Protocol Violation|0|||
16444576|NCT02782949|40105988|FG000|Overall Study|Withdrawal by Subject|0|||
16444577|NCT02782949|40105989|FG001|Overall Study|Withdrawal by Subject|1|||
16444578|NCT04323124|40105993|FG000|Overall Study|Adverse Event|0|||
16444579|NCT04323124|40105994|FG001|Overall Study|Adverse Event|0|||
16444580|NCT04323124|40105995|FG002|Overall Study|Adverse Event|0|||
16444581|NCT04323124|40105996|FG003|Overall Study|Adverse Event|0|||
16444582|NCT04323124|40105997|FG004|Overall Study|Adverse Event|0|||
16444583|NCT04323124|40105998|FG005|Overall Study|Adverse Event|1|||
16444584|NCT04323124|40105999|FG006|Overall Study|Adverse Event|0|||
16444585|NCT04323124|40106000|FG007|Overall Study|Adverse Event|1|||
16444586|NCT04323124|40106001|FG008|Overall Study|Adverse Event|1|||
16444587|NCT04323124|40106002|FG009|Overall Study|Adverse Event|0|||
16444588|NCT04323124|40106003|FG010|Overall Study|Adverse Event|0|||
16444589|NCT04323124|40106004|FG011|Overall Study|Adverse Event|0|||
16444590|NCT04323124|40106005|FG012|Overall Study|Adverse Event|0|||
16444591|NCT04323124|40106006|FG013|Overall Study|Adverse Event|0|||
16444592|NCT04323124|40106007|FG014|Overall Study|Adverse Event|0|||
16444593|NCT04323124|40105993|FG000|Overall Study|Other|0|||
16444594|NCT04323124|40105994|FG001|Overall Study|Other|0|||
16444595|NCT04323124|40105995|FG002|Overall Study|Other|0|||
16444596|NCT04323124|40105996|FG003|Overall Study|Other|0|||
16444597|NCT04323124|40105997|FG004|Overall Study|Other|1|||
16444598|NCT04323124|40105998|FG005|Overall Study|Other|0|||
16444599|NCT04323124|40105999|FG006|Overall Study|Other|0|||
16444600|NCT04323124|40106000|FG007|Overall Study|Other|0|||
16444601|NCT04323124|40106001|FG008|Overall Study|Other|1|||
16444602|NCT04323124|40106002|FG009|Overall Study|Other|0|||
16444603|NCT04323124|40106003|FG010|Overall Study|Other|0|||
16444604|NCT04323124|40106004|FG011|Overall Study|Other|0|||
16444605|NCT04323124|40106005|FG012|Overall Study|Other|0|||
16444606|NCT04323124|40106006|FG013|Overall Study|Other|0|||
16444607|NCT04323124|40106007|FG014|Overall Study|Other|0|||
16444608|NCT04323124|40105993|FG000|Overall Study|Coming from a red zone (COVID)|0|||
16444609|NCT04323124|40105994|FG001|Overall Study|Coming from a red zone (COVID)|0|||
16444610|NCT04323124|40105995|FG002|Overall Study|Coming from a red zone (COVID)|0|||
16444611|NCT04323124|40105996|FG003|Overall Study|Coming from a red zone (COVID)|0|||
16444612|NCT04323124|40105997|FG004|Overall Study|Coming from a red zone (COVID)|1|||
16444613|NCT04323124|40105998|FG005|Overall Study|Coming from a red zone (COVID)|1|||
16444614|NCT04323124|40105999|FG006|Overall Study|Coming from a red zone (COVID)|0|||
16444615|NCT04323124|40106000|FG007|Overall Study|Coming from a red zone (COVID)|0|||
16444616|NCT04323124|40106001|FG008|Overall Study|Coming from a red zone (COVID)|0|||
16444617|NCT04323124|40106002|FG009|Overall Study|Coming from a red zone (COVID)|0|||
16444618|NCT04323124|40106003|FG010|Overall Study|Coming from a red zone (COVID)|0|||
16155356|NCT05121480|39054373|FG001|Overall Study|Lack of Efficacy|2|||
16155357|NCT05121480|39054374|FG002|Overall Study|Lack of Efficacy|1|||
16155358|NCT05121480|39054375|FG003|Overall Study|Lack of Efficacy|4|||
16444619|NCT04323124|40106004|FG011|Overall Study|Coming from a red zone (COVID)|0|||
16444620|NCT04323124|40106005|FG012|Overall Study|Coming from a red zone (COVID)|0|||
16155359|NCT05121480|39054376|FG004|Overall Study|Lack of Efficacy|0|||
16444621|NCT04323124|40106006|FG013|Overall Study|Coming from a red zone (COVID)|0|||
16444622|NCT04323124|40106007|FG014|Overall Study|Coming from a red zone (COVID)|0|||
16444623|NCT04323124|40105993|FG000|Overall Study|No longer meets eligibility criteria|0|||
16444624|NCT04323124|40105994|FG001|Overall Study|No longer meets eligibility criteria|0|||
16444625|NCT04323124|40105995|FG002|Overall Study|No longer meets eligibility criteria|0|||
16444626|NCT04323124|40105996|FG003|Overall Study|No longer meets eligibility criteria|0|||
16444627|NCT04323124|40105997|FG004|Overall Study|No longer meets eligibility criteria|0|||
16444628|NCT04323124|40105998|FG005|Overall Study|No longer meets eligibility criteria|0|||
16444629|NCT04323124|40105999|FG006|Overall Study|No longer meets eligibility criteria|0|||
16444630|NCT04323124|40106000|FG007|Overall Study|No longer meets eligibility criteria|1|||
16444631|NCT04323124|40106001|FG008|Overall Study|No longer meets eligibility criteria|0|||
16444632|NCT04323124|40106002|FG009|Overall Study|No longer meets eligibility criteria|0|||
16444633|NCT04323124|40106003|FG010|Overall Study|No longer meets eligibility criteria|0|||
16444634|NCT04323124|40106004|FG011|Overall Study|No longer meets eligibility criteria|0|||
16444635|NCT04323124|40106005|FG012|Overall Study|No longer meets eligibility criteria|0|||
16444636|NCT04323124|40106006|FG013|Overall Study|No longer meets eligibility criteria|1|||
16444637|NCT04323124|40106007|FG014|Overall Study|No longer meets eligibility criteria|1|||
16444638|NCT04323124|40105993|FG000|Overall Study|Study terminated by sponsor|0|||
16444639|NCT04323124|40105994|FG001|Overall Study|Study terminated by sponsor|0|||
16444640|NCT04323124|40105995|FG002|Overall Study|Study terminated by sponsor|0|||
16444641|NCT04323124|40105996|FG003|Overall Study|Study terminated by sponsor|0|||
16444642|NCT04323124|40105997|FG004|Overall Study|Study terminated by sponsor|0|||
16444643|NCT04323124|40105998|FG005|Overall Study|Study terminated by sponsor|0|||
16444644|NCT04323124|40105999|FG006|Overall Study|Study terminated by sponsor|0|||
16444645|NCT04323124|40106000|FG007|Overall Study|Study terminated by sponsor|0|||
16444646|NCT04323124|40106001|FG008|Overall Study|Study terminated by sponsor|0|||
16444647|NCT04323124|40106002|FG009|Overall Study|Study terminated by sponsor|0|||
16444648|NCT04323124|40106003|FG010|Overall Study|Study terminated by sponsor|0|||
16444649|NCT04323124|40106004|FG011|Overall Study|Study terminated by sponsor|2|||
16444650|NCT04323124|40106005|FG012|Overall Study|Study terminated by sponsor|1|||
16444651|NCT04323124|40106006|FG013|Overall Study|Study terminated by sponsor|0|||
16444652|NCT04323124|40106007|FG014|Overall Study|Study terminated by sponsor|0|||
16444653|NCT02514083|40106014|FG000|Overall Study|Adverse Event|1|||
16444654|NCT02484391|40108449|FG000|Overall Study|Lack of Efficacy|15|||
16444655|NCT02484391|40108450|FG001|Overall Study|Lack of Efficacy|14|||
16444656|NCT02484391|40108451|FG002|Overall Study|Lack of Efficacy|3|||
16155360|NCT05121480|39054377|FG005|Overall Study|Lack of Efficacy|1|||
16155361|NCT05121480|39054378|FG006|Overall Study|Lack of Efficacy|0|||
16155362|NCT05121480|39054379|FG007|Overall Study|Lack of Efficacy|2|||
16155363|NCT05121480|39054372|FG000|Overall Study|Treatment Failure|0|||
16155364|NCT05121480|39054373|FG001|Overall Study|Treatment Failure|2|||
16155365|NCT05121480|39054374|FG002|Overall Study|Treatment Failure|0|||
16155366|NCT05121480|39054375|FG003|Overall Study|Treatment Failure|1|||
16155367|NCT05121480|39054376|FG004|Overall Study|Treatment Failure|0|||
16155368|NCT05121480|39054377|FG005|Overall Study|Treatment Failure|0|||
16155369|NCT05121480|39054378|FG006|Overall Study|Treatment Failure|0|||
16155370|NCT05121480|39054379|FG007|Overall Study|Treatment Failure|0|||
16155371|NCT05121480|39054372|FG000|Overall Study|Adverse Event|0|||
16155372|NCT05121480|39054373|FG001|Overall Study|Adverse Event|1|||
16155373|NCT05121480|39054374|FG002|Overall Study|Adverse Event|0|||
16155374|NCT05121480|39054375|FG003|Overall Study|Adverse Event|5|||
16155375|NCT05121480|39054376|FG004|Overall Study|Adverse Event|3|||
16155376|NCT05121480|39054377|FG005|Overall Study|Adverse Event|2|||
16155377|NCT05121480|39054378|FG006|Overall Study|Adverse Event|0|||
16155378|NCT05121480|39054379|FG007|Overall Study|Adverse Event|4|||
16155379|NCT05121480|39054372|FG000|Overall Study|Withdrawal by Subject|4|||
16155380|NCT05121480|39054373|FG001|Overall Study|Withdrawal by Subject|9|||
16155381|NCT05121480|39054374|FG002|Overall Study|Withdrawal by Subject|1|||
16155382|NCT05121480|39054375|FG003|Overall Study|Withdrawal by Subject|8|||
16155383|NCT05121480|39054376|FG004|Overall Study|Withdrawal by Subject|0|||
16155384|NCT05121480|39054377|FG005|Overall Study|Withdrawal by Subject|9|||
16155385|NCT05121480|39054378|FG006|Overall Study|Withdrawal by Subject|0|||
16155386|NCT05121480|39054379|FG007|Overall Study|Withdrawal by Subject|4|||
16155387|NCT05121480|39054372|FG000|Overall Study|Non-compliance with the protocol|0|||
16155388|NCT05121480|39054373|FG001|Overall Study|Non-compliance with the protocol|0|||
16155389|NCT05121480|39054374|FG002|Overall Study|Non-compliance with the protocol|0|||
16155390|NCT05121480|39054375|FG003|Overall Study|Non-compliance with the protocol|0|||
16155391|NCT05121480|39054376|FG004|Overall Study|Non-compliance with the protocol|1|||
16155392|NCT05121480|39054377|FG005|Overall Study|Non-compliance with the protocol|6|||
16155393|NCT05121480|39054378|FG006|Overall Study|Non-compliance with the protocol|0|||
16155394|NCT05121480|39054379|FG007|Overall Study|Non-compliance with the protocol|1|||
16444657|NCT02484391|40108449|FG000|Overall Study|Lost to Follow-up|0|||
16444658|NCT02484391|40108450|FG001|Overall Study|Lost to Follow-up|0|||
16444659|NCT02484391|40108451|FG002|Overall Study|Lost to Follow-up|2|||
16155395|NCT05121480|39054372|FG000|Overall Study|Lost to Follow-up|0|||
16155396|NCT05121480|39054373|FG001|Overall Study|Lost to Follow-up|4|||
16155397|NCT05121480|39054374|FG002|Overall Study|Lost to Follow-up|1|||
16155398|NCT05121480|39054375|FG003|Overall Study|Lost to Follow-up|3|||
16155399|NCT05121480|39054376|FG004|Overall Study|Lost to Follow-up|1|||
16155400|NCT05121480|39054377|FG005|Overall Study|Lost to Follow-up|1|||
16155401|NCT05121480|39054378|FG006|Overall Study|Lost to Follow-up|1|||
16155402|NCT05121480|39054379|FG007|Overall Study|Lost to Follow-up|4|||
16155403|NCT05121480|39054372|FG000|Overall Study|Physician Decision|0|||
16155404|NCT05121480|39054373|FG001|Overall Study|Physician Decision|0|||
16155405|NCT05121480|39054374|FG002|Overall Study|Physician Decision|0|||
16155406|NCT05121480|39054375|FG003|Overall Study|Physician Decision|0|||
16155407|NCT05121480|39054376|FG004|Overall Study|Physician Decision|0|||
16155408|NCT05121480|39054377|FG005|Overall Study|Physician Decision|1|||
16155409|NCT05121480|39054378|FG006|Overall Study|Physician Decision|0|||
16155410|NCT05121480|39054379|FG007|Overall Study|Physician Decision|1|||
16155411|NCT05121480|39054372|FG000|Overall Study|Other Reason|0|||
16155412|NCT05121480|39054373|FG001|Overall Study|Other Reason|0|||
16155413|NCT05121480|39054374|FG002|Overall Study|Other Reason|0|||
16155414|NCT05121480|39054375|FG003|Overall Study|Other Reason|0|||
16155415|NCT05121480|39054376|FG004|Overall Study|Other Reason|0|||
16155416|NCT05121480|39054377|FG005|Overall Study|Other Reason|1|||
16155417|NCT05121480|39054378|FG006|Overall Study|Other Reason|1|||
16155418|NCT05121480|39054379|FG007|Overall Study|Other Reason|1|||
16155419|NCT02124564|39054380|FG000|Treatment Period|Adverse Event|2|||
16155420|NCT02124564|39054380|FG000|Treatment Period|Lack of Efficacy|3|||
16155421|NCT02124564|39054380|FG000|Treatment Period|Withdrawal by Subject|2|||
16155422|NCT03775421|39054381|FG000|Overall Study|Lost to Follow-up|2|||
16155423|NCT03775421|39054381|FG000|Overall Study|Withdrawal by Subject|10|||
16155424|NCT03775421|39054381|FG000|Overall Study|Physician Decision|3|||
16155425|NCT03775421|39054381|FG000|Overall Study|Death|1|||
16155426|NCT03775421|39054381|FG000|Overall Study|Study Terminated by Sponsor|94|||
16155427|NCT02161211|39054388|FG000|Overall Study|Lost to Follow-up|21|||
16155428|NCT02161211|39054389|FG001|Overall Study|Lost to Follow-up|27|||
16155429|NCT02161211|39054390|FG002|Overall Study|Lost to Follow-up|21|||
16155430|NCT02161211|39054388|FG000|Overall Study|Dropped|12|||
16155431|NCT02161211|39054389|FG001|Overall Study|Dropped|5|||
16155432|NCT02161211|39054390|FG002|Overall Study|Dropped|9|||
16155433|NCT03033875|39054391|FG000|Overall Study|Withdrawal by Subject|5|||
16155434|NCT03033875|39054392|FG001|Overall Study|Withdrawal by Subject|9|||
16155435|NCT03033875|39054393|FG002|Overall Study|Withdrawal by Subject|4|||
16155436|NCT03033875|39054391|FG000|Overall Study|Other|14|||
16155437|NCT03033875|39054392|FG001|Overall Study|Other|15|||
16155438|NCT03033875|39054393|FG002|Overall Study|Other|8|||
16155439|NCT00971945|39054394|FG000|Overall Study|Progressive Disease|3|||
16155440|NCT00971945|39054394|FG000|Overall Study|Change in treatment policy|1|||
16155441|NCT00971945|39054394|FG000|Overall Study|Other reasons|2|||
16155442|NCT03178487|39054395|FG000|Period 1|Adverse Event|1|||
16155443|NCT03178487|39054396|FG001|Period 1|Adverse Event|2|||
16155444|NCT03178487|39054395|FG000|Period 1|Withdrawal by Subject|2|||
16155445|NCT03178487|39054396|FG001|Period 1|Withdrawal by Subject|1|||
16155446|NCT03178487|39054395|FG000|Period 1|Lost to Follow-up|1|||
16155447|NCT03178487|39054396|FG001|Period 1|Lost to Follow-up|0|||
16155448|NCT03178487|39054395|FG000|Period 1|Other|0|||
16155449|NCT03178487|39054396|FG001|Period 1|Other|1|||
16155450|NCT03178487|39054395|FG000|Period 2|Adverse Event|4|||
16155451|NCT03178487|39054396|FG001|Period 2|Adverse Event|4|||
16155452|NCT03178487|39054395|FG000|Period 2|Withdrawal by Subject|6|||
16155453|NCT03178487|39054396|FG001|Period 2|Withdrawal by Subject|6|||
16155454|NCT03178487|39054395|FG000|Period 2|Lost to Follow-up|2|||
16155455|NCT03178487|39054396|FG001|Period 2|Lost to Follow-up|2|||
16155456|NCT03178487|39054395|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
16444660|NCT02484391|40108449|FG000|Overall Study|Physician Decision|1|||
16444661|NCT02484391|40108450|FG001|Overall Study|Physician Decision|3|||
16444662|NCT02484391|40108451|FG002|Overall Study|Physician Decision|0|||
16444663|NCT02484391|40108449|FG000|Overall Study|Went to Transplant|5|||
16444664|NCT02484391|40108450|FG001|Overall Study|Went to Transplant|3|||
16155457|NCT03178487|39054396|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
16155458|NCT03178487|39054395|FG000|Period 2|Other|8|||
16155459|NCT03178487|39054396|FG001|Period 2|Other|7|||
16155460|NCT00914927|39054397|FG000|Overall Study|Adverse Event|0|||
16263389|NCT00796653|39449773|FG002|Overall Study|Other reason not described above|7|||
16155461|NCT00914927|39054398|FG001|Overall Study|Adverse Event|0|||
16155462|NCT00914927|39054399|FG002|Overall Study|Adverse Event|0|||
16444665|NCT02484391|40108451|FG002|Overall Study|Went to Transplant|2|||
16155463|NCT00914927|39054400|FG003|Overall Study|Adverse Event|0|||
16155464|NCT00914927|39054401|FG004|Overall Study|Adverse Event|1|||
16155465|NCT00914927|39054402|FG005|Overall Study|Adverse Event|0|||
16155466|NCT00914927|39054403|FG006|Overall Study|Adverse Event|0|||
16155467|NCT00914927|39054397|FG000|Overall Study|Withdrawal by Subject|0|||
16155468|NCT00914927|39054398|FG001|Overall Study|Withdrawal by Subject|1|||
16155469|NCT00914927|39054399|FG002|Overall Study|Withdrawal by Subject|0|||
16444666|NCT04730804|40108453|FG000|Overall Study|Physician Decision|0|||
16444667|NCT04730804|40108454|FG001|Overall Study|Physician Decision|0|||
16444668|NCT04730804|40108455|FG002|Overall Study|Physician Decision|0|||
16444669|NCT04730804|40108456|FG003|Overall Study|Physician Decision|0|||
16444670|NCT04730804|40108457|FG004|Overall Study|Physician Decision|0|||
16444671|NCT04730804|40108458|FG005|Overall Study|Physician Decision|1|||
16155470|NCT00914927|39054400|FG003|Overall Study|Withdrawal by Subject|1|||
16155471|NCT00914927|39054401|FG004|Overall Study|Withdrawal by Subject|0|||
16155472|NCT00914927|39054402|FG005|Overall Study|Withdrawal by Subject|0|||
16155473|NCT00914927|39054403|FG006|Overall Study|Withdrawal by Subject|0|||
16155474|NCT00914927|39054397|FG000|Overall Study|Lost to Follow-up|0|||
16155475|NCT00914927|39054398|FG001|Overall Study|Lost to Follow-up|0|||
16155476|NCT00914927|39054399|FG002|Overall Study|Lost to Follow-up|0|||
16155477|NCT00914927|39054400|FG003|Overall Study|Lost to Follow-up|1|||
16155478|NCT00914927|39054401|FG004|Overall Study|Lost to Follow-up|0|||
16155479|NCT00914927|39054402|FG005|Overall Study|Lost to Follow-up|0|||
16155480|NCT00914927|39054403|FG006|Overall Study|Lost to Follow-up|0|||
16155481|NCT00914927|39054397|FG000|Overall Study|Administrative/Other|2|||
16155482|NCT00914927|39054398|FG001|Overall Study|Administrative/Other|1|||
16155483|NCT00914927|39054399|FG002|Overall Study|Administrative/Other|0|||
16155484|NCT00914927|39054400|FG003|Overall Study|Administrative/Other|0|||
16155485|NCT00914927|39054401|FG004|Overall Study|Administrative/Other|1|||
16155486|NCT00914927|39054402|FG005|Overall Study|Administrative/Other|0|||
16155487|NCT00914927|39054403|FG006|Overall Study|Administrative/Other|0|||
16155488|NCT00746252|39054404|FG000|Overall Study|weight gain >7.5 %|1|||
16155489|NCT00746252|39054405|FG001|Overall Study|weight gain >7.5 %|2|||
16155490|NCT02239939|39054406|FG000|Overall Study|Adverse Event|1|||
16155491|NCT02239939|39054407|FG001|Overall Study|Adverse Event|0|||
16155492|NCT02239939|39054406|FG000|Overall Study|Withdrawal by Subject|1|||
16155493|NCT02239939|39054407|FG001|Overall Study|Withdrawal by Subject|1|||
16155494|NCT02239939|39054406|FG000|Overall Study|Lost to Follow-up|0|||
16155495|NCT02239939|39054407|FG001|Overall Study|Lost to Follow-up|1|||
16155496|NCT02919436|39054408|FG000|Overall Study|Did not undergo surgery|16|||
16155497|NCT02919436|39054409|FG001|Overall Study|Did not undergo surgery|20|||
16155498|NCT02919436|39054408|FG000|Overall Study|Enrolled before trial registration|44|||
16155499|NCT02919436|39054409|FG001|Overall Study|Enrolled before trial registration|33|||
16155500|NCT03468855|39054410|FG000|Overall Study|Adverse Event|2|||
16155501|NCT03468855|39054410|FG000|Overall Study|Lost to Follow-up|5|||
16155502|NCT03468855|39054410|FG000|Overall Study|Withdrawal by Subject|3|||
16155503|NCT03468855|39054410|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
16155504|NCT01452152|39054411|FG000|Overall Study|Study termination by sponsor|5|||
16155505|NCT01452152|39054412|FG001|Overall Study|Study termination by sponsor|0|||
16155506|NCT01452152|39054413|FG002|Overall Study|Study termination by sponsor|4|||
16155507|NCT03723707|39054414|FG000|Overall Study|Death|32|||
16155508|NCT03723707|39054415|FG001|Overall Study|Death|32|||
16155509|NCT03723707|39054414|FG000|Overall Study|Admitted to long term care|12|||
16155510|NCT03723707|39054415|FG001|Overall Study|Admitted to long term care|12|||
16155511|NCT03723707|39054414|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
16155512|NCT03723707|39054415|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
16155513|NCT03723707|39054414|FG000|Overall Study|Lost to Follow-up|40|||
16155514|NCT03723707|39054415|FG001|Overall Study|Lost to Follow-up|22|||
16155515|NCT03723707|39054414|FG000|Overall Study|Discontinued after study closure|24|||
16155516|NCT03723707|39054415|FG001|Overall Study|Discontinued after study closure|12|||
16155517|NCT00498173|39054418|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
16155518|NCT00498173|39054419|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
16155519|NCT00498173|39054420|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
16155520|NCT01318109|39054421|FG000|Overall Study|Adverse Event|0|||
16155521|NCT01318109|39054422|FG001|Overall Study|Adverse Event|2|||
16155522|NCT01318109|39054423|FG002|Overall Study|Adverse Event|0|||
16155523|NCT01318109|39054421|FG000|Overall Study|Withdrawal by Subject|1|||
16155524|NCT01318109|39054422|FG001|Overall Study|Withdrawal by Subject|0|||
16155525|NCT01318109|39054423|FG002|Overall Study|Withdrawal by Subject|0|||
16155526|NCT01318109|39054421|FG000|Overall Study|Schedule Conflict|0|||
16155527|NCT01318109|39054422|FG001|Overall Study|Schedule Conflict|1|||
16155528|NCT01318109|39054423|FG002|Overall Study|Schedule Conflict|0|||
16155529|NCT00333359|39054428|FG000|Overall Study|Adverse Event|29|||
16155530|NCT00333359|39054429|FG001|Overall Study|Adverse Event|35|||
16155531|NCT00333359|39054428|FG000|Overall Study|Withdrawal by Subject|19|||
16155532|NCT00333359|39054429|FG001|Overall Study|Withdrawal by Subject|37|||
16155533|NCT00333359|39054428|FG000|Overall Study|Physician Decision|2|||
16155534|NCT00333359|39054429|FG001|Overall Study|Physician Decision|2|||
16155535|NCT00333359|39054428|FG000|Overall Study|Protocol Non-compliance|2|||
16155536|NCT00333359|39054429|FG001|Overall Study|Protocol Non-compliance|8|||
16444672|NCT04730804|40108453|FG000|Overall Study|Withdrawal by Subject|0|||
16155537|NCT00333359|39054428|FG000|Overall Study|Lost to Follow-up|15|||
16444673|NCT04730804|40108454|FG001|Overall Study|Withdrawal by Subject|0|||
16263390|NCT00796653|39449774|FG003|Overall Study|Other reason not described above|4|||
16263391|NCT00445003|39449777|FG000|Overall Study|Death|1|||
16263392|NCT00445003|39449778|FG001|Overall Study|Death|2|||
16263393|NCT00445003|39449779|FG002|Overall Study|Death|1|||
16366694|NCT03329001|39825586|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
16366695|NCT03329001|39825579|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
16366696|NCT03329001|39825580|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
16366697|NCT03329001|39825581|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
16366698|NCT03329001|39825582|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
16366699|NCT03329001|39825583|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
16366700|NCT03329001|39825584|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
16366701|NCT03329001|39825585|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
16366702|NCT03329001|39825586|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
16366703|NCT03329001|39825579|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
16366704|NCT03329001|39825580|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
16366705|NCT03329001|39825581|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
16366706|NCT03329001|39825582|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
16366707|NCT03329001|39825583|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
16366708|NCT03329001|39825584|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
16366709|NCT03329001|39825585|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
16366710|NCT03329001|39825586|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
16366711|NCT03329001|39825579|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
16366712|NCT03329001|39825580|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
16444674|NCT04730804|40108455|FG002|Overall Study|Withdrawal by Subject|0|||
16263394|NCT00445003|39449777|FG000|Overall Study|Missed Visit|3|||
16263395|NCT00445003|39449778|FG001|Overall Study|Missed Visit|5|||
16263396|NCT00445003|39449779|FG002|Overall Study|Missed Visit|1|||
16263397|NCT00445003|39449777|FG000|Overall Study|Dropped|1|||
16263398|NCT00445003|39449778|FG001|Overall Study|Dropped|3|||
16263399|NCT00445003|39449779|FG002|Overall Study|Dropped|2|||
16263400|NCT00537979|39449780|FG000|Overall Study|Adverse Event|2|||
16263401|NCT00537979|39449781|FG001|Overall Study|Adverse Event|2|||
16263402|NCT00537979|39449780|FG000|Overall Study|Withdrawal by Subject|1|||
16263403|NCT00537979|39449781|FG001|Overall Study|Withdrawal by Subject|4|||
16263404|NCT00537979|39449780|FG000|Overall Study|Lost to Follow-up|1|||
16263405|NCT00537979|39449781|FG001|Overall Study|Lost to Follow-up|4|||
16263406|NCT00537979|39449780|FG000|Overall Study|Lack of Efficacy|0|||
16366713|NCT03329001|39825581|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
16366714|NCT03329001|39825582|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
16366715|NCT03329001|39825583|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
16366716|NCT03329001|39825584|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
16366717|NCT03329001|39825585|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
16366718|NCT03329001|39825586|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
16366719|NCT03329001|39825579|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
16366720|NCT03329001|39825580|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
16366721|NCT03329001|39825581|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
16366722|NCT03329001|39825582|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
16366723|NCT03329001|39825583|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
16366724|NCT03329001|39825584|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
16444675|NCT04730804|40108456|FG003|Overall Study|Withdrawal by Subject|0|||
16444676|NCT04730804|40108457|FG004|Overall Study|Withdrawal by Subject|1|||
16444677|NCT04730804|40108458|FG005|Overall Study|Withdrawal by Subject|2|||
16444678|NCT02681523|40108459|FG000|Overall Study|Adverse Event|1|||
16444679|NCT02681523|40108459|FG000|Overall Study|Patient Non-compliance|1|||
16444680|NCT02374450|40108460|FG000|Overall Study|Protocol Violation|0|||
16444681|NCT02374450|40108461|FG001|Overall Study|Protocol Violation|1|||
16444682|NCT02374450|40108462|FG002|Overall Study|Protocol Violation|0|||
16444683|NCT02374450|40108460|FG000|Overall Study|Withdrawal by Subject|91|||
16444684|NCT02374450|40108461|FG001|Overall Study|Withdrawal by Subject|110|||
16444685|NCT02374450|40108462|FG002|Overall Study|Withdrawal by Subject|4|||
16444686|NCT02374450|40108460|FG000|Overall Study|Lost to Follow-up|168|||
16444687|NCT02374450|40108461|FG001|Overall Study|Lost to Follow-up|194|||
16444688|NCT02374450|40108462|FG002|Overall Study|Lost to Follow-up|138|||
16444689|NCT02374450|40108460|FG000|Overall Study|Death|173|||
16444690|NCT02374450|40108461|FG001|Overall Study|Death|185|||
16444691|NCT02374450|40108462|FG002|Overall Study|Death|81|||
16444692|NCT02374450|40108460|FG000|Overall Study|Migrated from the study area|538|||
16444693|NCT02374450|40108461|FG001|Overall Study|Migrated from the study area|648|||
16444694|NCT02374450|40108462|FG002|Overall Study|Migrated from the study area|181|||
16444695|NCT02374450|40108460|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
16444696|NCT02374450|40108461|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
16444697|NCT02374450|40108462|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
16444698|NCT02374450|40108460|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
16444699|NCT02374450|40108461|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
16444700|NCT02374450|40108462|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
16444701|NCT02374450|40108460|FG000|Overall Study|Other|0|||
16444702|NCT02374450|40108461|FG001|Overall Study|Other|21|||
16444703|NCT02374450|40108462|FG002|Overall Study|Other|79|||
16444704|NCT05767749|40108471|FG000|Overall Study|Withdrawal by Subject|0|||
16444705|NCT05767749|40108472|FG001|Overall Study|Withdrawal by Subject|0|||
16444706|NCT05767749|40108473|FG002|Overall Study|Withdrawal by Subject|2|||
16444707|NCT05767749|40108474|FG003|Overall Study|Withdrawal by Subject|2|||
16444708|NCT05767749|40108475|FG004|Overall Study|Withdrawal by Subject|2|||
16444709|NCT05767749|40108476|FG005|Overall Study|Withdrawal by Subject|2|||
16444710|NCT02613507|40108483|FG000|Overall Study|Disease Progression|237|||
16444711|NCT02613507|40108484|FG001|Overall Study|Disease Progression|109|||
16444712|NCT02613507|40108483|FG000|Overall Study|Study Drug Toxicity|15|||
16444713|NCT02613507|40108484|FG001|Overall Study|Study Drug Toxicity|14|||
16444714|NCT02613507|40108483|FG000|Overall Study|Death|3|||
16444715|NCT02613507|40108484|FG001|Overall Study|Death|0|||
16444716|NCT02613507|40108483|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
16444717|NCT02613507|40108484|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
16444718|NCT02613507|40108483|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
16366725|NCT03329001|39825585|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
16366726|NCT03329001|39825586|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
16366727|NCT03329001|39825579|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
16444719|NCT02613507|40108484|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
16444720|NCT02613507|40108483|FG000|Overall Study|Participant Withdrew Consent|0|||
16444721|NCT02613507|40108484|FG001|Overall Study|Participant Withdrew Consent|2|||
16444722|NCT02613507|40108483|FG000|Overall Study|Lost to Follow-up|1|||
16444723|NCT02613507|40108484|FG001|Overall Study|Lost to Follow-up|0|||
16444724|NCT02613507|40108483|FG000|Overall Study|Maximum Clinical Benefit|4|||
16155538|NCT00333359|39054429|FG001|Overall Study|Lost to Follow-up|25|||
16155539|NCT00333359|39054428|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
16444725|NCT02613507|40108484|FG001|Overall Study|Maximum Clinical Benefit|10|||
16155540|NCT00333359|39054429|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
16155541|NCT00333359|39054428|FG000|Overall Study|Treatment Failure|3|||
16155542|NCT00333359|39054429|FG001|Overall Study|Treatment Failure|8|||
16155543|NCT00333359|39054428|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
16155544|NCT00333359|39054429|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
16155545|NCT01136655|39054430|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
16155546|NCT01136655|39054430|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
16155547|NCT01136655|39054430|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
16155548|NCT01136655|39054430|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
16155549|NCT01562548|39054431|FG000|Overall Study|Lost to Follow-up|0|||
16155550|NCT01562548|39054432|FG001|Overall Study|Lost to Follow-up|0|||
16155551|NCT01562548|39054433|FG002|Overall Study|Lost to Follow-up|1|||
16155552|NCT01562548|39054434|FG003|Overall Study|Lost to Follow-up|0|||
16155553|NCT02286947|39054436|FG000|Overall Study|Withdrawal by Subject|2|||
16155554|NCT00584194|39054441|FG000|Overall Study|Other|135|||
16155555|NCT00993928|39054442|FG000|Overall Study|Withdrawal by Subject|4|||
16155556|NCT00993928|39054443|FG001|Overall Study|Withdrawal by Subject|7|||
16155557|NCT00993928|39054442|FG000|Overall Study|ineligible|1|||
16155558|NCT00993928|39054443|FG001|Overall Study|ineligible|0|||
16155559|NCT03048422|39054444|FG000|Overall Study|Death|1|||
16155560|NCT03048422|39054445|FG001|Overall Study|Death|0|||
16155561|NCT03048422|39054446|FG002|Overall Study|Death|0|||
16155562|NCT03048422|39054444|FG000|Overall Study|Lost to Follow-up|5|||
16155563|NCT03048422|39054445|FG001|Overall Study|Lost to Follow-up|0|||
16155564|NCT03048422|39054446|FG002|Overall Study|Lost to Follow-up|1|||
16155565|NCT03048422|39054444|FG000|Overall Study|Withdrawal by Subject|5|||
16155566|NCT03048422|39054445|FG001|Overall Study|Withdrawal by Subject|7|||
16155567|NCT03048422|39054446|FG002|Overall Study|Withdrawal by Subject|4|||
16155568|NCT03048422|39054444|FG000|Overall Study|Moved|3|||
16155569|NCT03048422|39054445|FG001|Overall Study|Moved|2|||
16155570|NCT03048422|39054446|FG002|Overall Study|Moved|2|||
16155571|NCT03048422|39054444|FG000|Overall Study|Noncompliant with Study Requirements|2|||
16155572|NCT03048422|39054445|FG001|Overall Study|Noncompliant with Study Requirements|1|||
16155573|NCT03048422|39054446|FG002|Overall Study|Noncompliant with Study Requirements|2|||
16155574|NCT03048422|39054444|FG000|Overall Study|Not Able to Get to Clinic|1|||
16155575|NCT03048422|39054445|FG001|Overall Study|Not Able to Get to Clinic|0|||
16155576|NCT03048422|39054446|FG002|Overall Study|Not Able to Get to Clinic|0|||
16155577|NCT00082888|39054447|FG000|Overall Study|Ineligible|1|||
16155578|NCT00082888|39054448|FG001|Overall Study|Ineligible|0|||
16155579|NCT00082888|39054449|FG002|Overall Study|Ineligible|0|||
16263407|NCT00537979|39449781|FG001|Overall Study|Lack of Efficacy|1|||
16155580|NCT00845728|39054450|FG000|Overall Study|Abnormal laboratory value (s)|2|||
16155581|NCT00845728|39054451|FG001|Overall Study|Abnormal laboratory value (s)|2|||
16155582|NCT00845728|39054450|FG000|Overall Study|Patient's inability to use the device|4|||
16155583|NCT00845728|39054451|FG001|Overall Study|Patient's inability to use the device|6|||
16155584|NCT00845728|39054450|FG000|Overall Study|Abnormal test procedure result (s)|7|||
16263408|NCT00537979|39449780|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
16155585|NCT00845728|39054451|FG001|Overall Study|Abnormal test procedure result (s)|2|||
16155586|NCT00845728|39054450|FG000|Overall Study|Lost to Follow-up|22|||
16155587|NCT00845728|39054451|FG001|Overall Study|Lost to Follow-up|13|||
16155588|NCT00845728|39054450|FG000|Overall Study|Death|24|||
16155589|NCT00845728|39054451|FG001|Overall Study|Death|26|||
16155590|NCT00845728|39054450|FG000|Overall Study|Administrative Problems|34|||
16155591|NCT00845728|39054451|FG001|Overall Study|Administrative Problems|26|||
16155592|NCT00845728|39054450|FG000|Overall Study|Protocol Violation|36|||
16155593|NCT00845728|39054451|FG001|Overall Study|Protocol Violation|24|||
16155594|NCT00845728|39054450|FG000|Overall Study|Lack of Efficacy|51|||
16155595|NCT00845728|39054451|FG001|Overall Study|Lack of Efficacy|39|||
16155596|NCT00845728|39054450|FG000|Overall Study|Adverse Event|101|||
16155597|NCT00845728|39054451|FG001|Overall Study|Adverse Event|96|||
16155598|NCT00845728|39054450|FG000|Overall Study|Withdrawal by Subject|105|||
16155599|NCT00845728|39054451|FG001|Overall Study|Withdrawal by Subject|108|||
16155600|NCT01848288|39054456|FG000|Overall Study|Death|1|||
16155601|NCT01848288|39054456|FG000|Overall Study|Protocol Violation|1|||
16155602|NCT01848288|39054456|FG000|Overall Study|Withdrawal by Subject|1|||
16155603|NCT01277549|39054457|FG000|Overall Study|Failed to meet eligibility criteria|13|||
16155604|NCT01277549|39054458|FG001|Overall Study|Failed to meet eligibility criteria|9|||
16155605|NCT01277549|39054457|FG000|Overall Study|Withdrawal by Subject|1|||
16155606|NCT01277549|39054458|FG001|Overall Study|Withdrawal by Subject|3|||
16155607|NCT01277549|39054457|FG000|Overall Study|Protocol Violation|10|||
16155608|NCT01277549|39054458|FG001|Overall Study|Protocol Violation|1|||
16155609|NCT01277549|39054457|FG000|Overall Study|Physician Decision|2|||
16155610|NCT01277549|39054458|FG001|Overall Study|Physician Decision|1|||
16155611|NCT00430508|39054459|FG000|Overall Study|Adverse Event|2|||
16155612|NCT00430508|39054460|FG001|Overall Study|Adverse Event|3|||
16155613|NCT00430508|39054461|FG002|Overall Study|Adverse Event|5|||
16155614|NCT00430508|39054462|FG003|Overall Study|Adverse Event|3|||
16155615|NCT00430508|39054459|FG000|Overall Study|Withdrawal by Subject|0|||
16155616|NCT00430508|39054460|FG001|Overall Study|Withdrawal by Subject|1|||
16155617|NCT00430508|39054461|FG002|Overall Study|Withdrawal by Subject|1|||
16155618|NCT00430508|39054462|FG003|Overall Study|Withdrawal by Subject|1|||
16155619|NCT00430508|39054459|FG000|Overall Study|responder at visit 4|0|||
16155620|NCT00430508|39054460|FG001|Overall Study|responder at visit 4|0|||
16155621|NCT00430508|39054461|FG002|Overall Study|responder at visit 4|2|||
16155622|NCT00430508|39054462|FG003|Overall Study|responder at visit 4|0|||
16155623|NCT00430508|39054459|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
16155624|NCT00430508|39054460|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
16366728|NCT03329001|39825580|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
16155625|NCT00430508|39054461|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
16155626|NCT00430508|39054462|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
16155627|NCT00430508|39054459|FG000|Overall Study|Other|1|||
16155628|NCT00430508|39054460|FG001|Overall Study|Other|1|||
16155629|NCT00430508|39054461|FG002|Overall Study|Other|3|||
16155630|NCT00430508|39054462|FG003|Overall Study|Other|0|||
16155631|NCT03074474|39054463|FG000|Overall Study|Lost to Follow-up|10|||
16155632|NCT03074474|39054463|FG000|Overall Study|Withdrawal by Subject|10|||
16155633|NCT03074474|39054463|FG000|Overall Study|Death|4|||
16366729|NCT03329001|39825581|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
16366730|NCT03329001|39825582|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
16366731|NCT03329001|39825583|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
16366732|NCT03329001|39825584|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
16366733|NCT03329001|39825585|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
16366734|NCT03329001|39825586|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
16366735|NCT03329001|39825579|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
16366736|NCT03329001|39825580|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
16366737|NCT03329001|39825581|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
16366738|NCT03329001|39825582|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
16366739|NCT03329001|39825583|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
16366740|NCT03329001|39825584|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
16366741|NCT03329001|39825585|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
16366742|NCT03329001|39825586|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
16366743|NCT03329001|39825579|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
16366744|NCT03329001|39825580|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
16366745|NCT03329001|39825581|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
16366746|NCT03329001|39825582|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
16366747|NCT03329001|39825583|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
16366748|NCT03329001|39825584|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
16366749|NCT03329001|39825585|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
16366750|NCT03329001|39825586|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
16366751|NCT03329001|39825579|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
16366752|NCT03329001|39825580|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
16366753|NCT03329001|39825581|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
16366754|NCT03329001|39825582|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
16366755|NCT03329001|39825583|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
16366756|NCT03329001|39825584|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
16366757|NCT03329001|39825585|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
16366758|NCT03329001|39825586|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
16366759|NCT03329001|39825579|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
16366760|NCT03329001|39825580|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
16366761|NCT03329001|39825581|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
16366762|NCT03329001|39825582|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
16366763|NCT03329001|39825583|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
16366764|NCT03329001|39825584|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
16366765|NCT03329001|39825585|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
16366766|NCT03329001|39825586|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
16366767|NCT03329001|39825579|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
16366768|NCT03329001|39825580|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
16366769|NCT03329001|39825581|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
16366770|NCT03329001|39825582|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
16366771|NCT03329001|39825583|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
16366772|NCT03329001|39825584|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
16366773|NCT03329001|39825585|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
16366774|NCT03329001|39825586|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
16366775|NCT03329001|39825579|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
16366776|NCT03329001|39825580|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
16366777|NCT03329001|39825581|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
16366778|NCT03329001|39825582|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
16366779|NCT03329001|39825583|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
16366780|NCT03329001|39825584|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
16366781|NCT03329001|39825585|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
16366782|NCT03329001|39825586|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
16366783|NCT03329001|39825579|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
16366784|NCT03329001|39825580|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
16366785|NCT03329001|39825581|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
16366786|NCT03329001|39825582|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
16366787|NCT03329001|39825583|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
16366788|NCT03329001|39825584|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
16366789|NCT03329001|39825585|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
16366790|NCT03329001|39825586|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
16366791|NCT03329001|39825579|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
16155634|NCT03074474|39054463|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
16155635|NCT01709435|39054464|FG000|Overall Study|Adverse Event|1|||
16155636|NCT01709435|39054465|FG001|Overall Study|Adverse Event|1|||
16155637|NCT01709435|39054466|FG002|Overall Study|Adverse Event|1|||
16155638|NCT01709435|39054467|FG003|Overall Study|Adverse Event|0|||
16155639|NCT01709435|39054468|FG004|Overall Study|Adverse Event|0|||
16155640|NCT01709435|39054469|FG005|Overall Study|Adverse Event|1|||
16155641|NCT01709435|39054464|FG000|Overall Study|Lack of Efficacy|5|||
16155642|NCT01709435|39054465|FG001|Overall Study|Lack of Efficacy|7|||
16155643|NCT01709435|39054466|FG002|Overall Study|Lack of Efficacy|2|||
16155644|NCT01709435|39054467|FG003|Overall Study|Lack of Efficacy|2|||
16155645|NCT01709435|39054468|FG004|Overall Study|Lack of Efficacy|6|||
16155646|NCT01709435|39054469|FG005|Overall Study|Lack of Efficacy|3|||
16155647|NCT01709435|39054464|FG000|Overall Study|Physician Decision|0|||
16155648|NCT01709435|39054465|FG001|Overall Study|Physician Decision|1|||
16155649|NCT01709435|39054466|FG002|Overall Study|Physician Decision|0|||
16155650|NCT01709435|39054467|FG003|Overall Study|Physician Decision|1|||
16155651|NCT01709435|39054468|FG004|Overall Study|Physician Decision|2|||
16155652|NCT01709435|39054469|FG005|Overall Study|Physician Decision|0|||
16155653|NCT01709435|39054464|FG000|Overall Study|Withdrawal by Subject|0|||
16155654|NCT01709435|39054465|FG001|Overall Study|Withdrawal by Subject|0|||
16155655|NCT01709435|39054466|FG002|Overall Study|Withdrawal by Subject|3|||
16155656|NCT01709435|39054467|FG003|Overall Study|Withdrawal by Subject|0|||
16155657|NCT01709435|39054468|FG004|Overall Study|Withdrawal by Subject|2|||
16155658|NCT01709435|39054469|FG005|Overall Study|Withdrawal by Subject|2|||
16155659|NCT01006265|39054470|FG000|Overall Study|Lost to Follow-up|1|||
16155660|NCT01006265|39054471|FG001|Overall Study|Lost to Follow-up|0|||
16155661|NCT01006265|39054472|FG002|Overall Study|Lost to Follow-up|1|||
16155662|NCT01006265|39054473|FG003|Overall Study|Lost to Follow-up|0|||
16155663|NCT01006265|39054470|FG000|Overall Study|Withdrawal by Subject|4|||
16155664|NCT01006265|39054471|FG001|Overall Study|Withdrawal by Subject|7|||
16155665|NCT01006265|39054472|FG002|Overall Study|Withdrawal by Subject|5|||
16155666|NCT01006265|39054473|FG003|Overall Study|Withdrawal by Subject|5|||
16155667|NCT01006265|39054470|FG000|Overall Study|Administrative reason|1|||
16155668|NCT01006265|39054471|FG001|Overall Study|Administrative reason|2|||
16155669|NCT01006265|39054472|FG002|Overall Study|Administrative reason|3|||
16155670|NCT01006265|39054473|FG003|Overall Study|Administrative reason|0|||
16155671|NCT00446511|39054474|FG000|Overall Study|Adverse Event|7|||
16155672|NCT00446511|39054475|FG001|Overall Study|Adverse Event|2|||
16155673|NCT00446511|39054476|FG002|Overall Study|Adverse Event|3|||
16155674|NCT00446511|39054477|FG003|Overall Study|Adverse Event|1|||
16155675|NCT00446511|39054474|FG000|Overall Study|Protocol Violation|0|||
16155676|NCT00446511|39054475|FG001|Overall Study|Protocol Violation|0|||
16155677|NCT00446511|39054476|FG002|Overall Study|Protocol Violation|0|||
16155678|NCT00446511|39054477|FG003|Overall Study|Protocol Violation|1|||
16155679|NCT00446511|39054474|FG000|Overall Study|Withdrawal by Subject|0|||
16155680|NCT00446511|39054475|FG001|Overall Study|Withdrawal by Subject|0|||
16155681|NCT00446511|39054476|FG002|Overall Study|Withdrawal by Subject|0|||
16155682|NCT00446511|39054477|FG003|Overall Study|Withdrawal by Subject|3|||
16155683|NCT00446511|39054474|FG000|Overall Study|Administrative Problems|3|||
16155684|NCT00446511|39054475|FG001|Overall Study|Administrative Problems|0|||
16155685|NCT00446511|39054476|FG002|Overall Study|Administrative Problems|4|||
16155686|NCT00446511|39054477|FG003|Overall Study|Administrative Problems|1|||
16155687|NCT04342871|39054478|FG000|Overall Study|Death|4|||
16155688|NCT04342871|39054478|FG000|Overall Study|Clinical deterioration/illness progression|2|||
16155689|NCT04342871|39054478|FG000|Overall Study|Did not complete baseline assessments|5|||
16155690|NCT04342871|39054478|FG000|Overall Study|Lost to Follow-up|13|||
16155691|NCT01157364|39054480|FG000|Overall Study|Other Reasons|1|||
16155692|NCT01157364|39054481|FG001|Overall Study|Other Reasons|1|||
16155693|NCT01157364|39054482|FG002|Overall Study|Other Reasons|2|||
16155694|NCT01157364|39054483|FG003|Overall Study|Other Reasons|1|||
16155695|NCT01157364|39054484|FG004|Overall Study|Other Reasons|0|||
16155696|NCT01157364|39054485|FG005|Overall Study|Other Reasons|0|||
16155697|NCT01157364|39054480|FG000|Overall Study|Personal Reasons|0|||
16155698|NCT01157364|39054481|FG001|Overall Study|Personal Reasons|2|||
16155699|NCT01157364|39054482|FG002|Overall Study|Personal Reasons|0|||
16155700|NCT01157364|39054483|FG003|Overall Study|Personal Reasons|0|||
16155701|NCT01157364|39054484|FG004|Overall Study|Personal Reasons|1|||
16155702|NCT01157364|39054485|FG005|Overall Study|Personal Reasons|1|||
16155703|NCT01157364|39054480|FG000|Overall Study|Lost to Follow-up|1|||
16155704|NCT01157364|39054481|FG001|Overall Study|Lost to Follow-up|0|||
16155705|NCT01157364|39054482|FG002|Overall Study|Lost to Follow-up|1|||
16155706|NCT01157364|39054483|FG003|Overall Study|Lost to Follow-up|0|||
16155707|NCT01157364|39054484|FG004|Overall Study|Lost to Follow-up|0|||
16155708|NCT01157364|39054485|FG005|Overall Study|Lost to Follow-up|0|||
16155709|NCT01157364|39054480|FG000|Overall Study|Lack of Efficacy|0|||
16155710|NCT01157364|39054481|FG001|Overall Study|Lack of Efficacy|0|||
16155711|NCT01157364|39054482|FG002|Overall Study|Lack of Efficacy|0|||
16155712|NCT01157364|39054483|FG003|Overall Study|Lack of Efficacy|1|||
16366792|NCT03329001|39825580|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
16155713|NCT01157364|39054484|FG004|Overall Study|Lack of Efficacy|0|||
16155714|NCT01157364|39054485|FG005|Overall Study|Lack of Efficacy|0|||
16155715|NCT01157364|39054480|FG000|Overall Study|Adverse Event|0|||
16155716|NCT01157364|39054481|FG001|Overall Study|Adverse Event|1|||
16155717|NCT01157364|39054482|FG002|Overall Study|Adverse Event|1|||
16155718|NCT01157364|39054483|FG003|Overall Study|Adverse Event|0|||
16155719|NCT01157364|39054484|FG004|Overall Study|Adverse Event|1|||
16155720|NCT01157364|39054485|FG005|Overall Study|Adverse Event|0|||
16155721|NCT00457015|39054486|FG000|Overall Study|Left study site against medical advice|0|||
16155722|NCT00457015|39054487|FG001|Overall Study|Left study site against medical advice|1|||
16155723|NCT01399788|39054488|FG000|First Intervention Period|Adverse Event|1|||
16155724|NCT01399788|39054489|FG001|First Intervention Period|Adverse Event|0|||
16155725|NCT01661140|39054490|FG000|Open-Label Period|Adverse Event|44|||
16155726|NCT01661140|39054491|FG001|Open-Label Period|Adverse Event|0|||
16155727|NCT01661140|39054492|FG002|Open-Label Period|Adverse Event|0|||
16155728|NCT01661140|39054490|FG000|Open-Label Period|Protocol Violation|3|||
16155729|NCT01661140|39054491|FG001|Open-Label Period|Protocol Violation|0|||
16155730|NCT01661140|39054492|FG002|Open-Label Period|Protocol Violation|0|||
16155731|NCT01661140|39054490|FG000|Open-Label Period|Withdrawal by Subject|5|||
16155732|NCT01661140|39054491|FG001|Open-Label Period|Withdrawal by Subject|0|||
16155733|NCT01661140|39054492|FG002|Open-Label Period|Withdrawal by Subject|0|||
16155734|NCT01661140|39054490|FG000|Open-Label Period|Investigator Decision|3|||
16155735|NCT01661140|39054491|FG001|Open-Label Period|Investigator Decision|0|||
16155736|NCT01661140|39054492|FG002|Open-Label Period|Investigator Decision|0|||
16155737|NCT01661140|39054490|FG000|Open-Label Period|Death|1|||
16155738|NCT01661140|39054491|FG001|Open-Label Period|Death|0|||
16155739|NCT01661140|39054492|FG002|Open-Label Period|Death|0|||
16155740|NCT01661140|39054490|FG000|Open-Label Period|Administrative/Other|1|||
16155741|NCT01661140|39054491|FG001|Open-Label Period|Administrative/Other|0|||
16155742|NCT01661140|39054492|FG002|Open-Label Period|Administrative/Other|0|||
16155743|NCT01661140|39054490|FG000|Open-Label Period|Sponsor termination|16|||
16155744|NCT01661140|39054491|FG001|Open-Label Period|Sponsor termination|0|||
16155745|NCT01661140|39054492|FG002|Open-Label Period|Sponsor termination|0|||
16155746|NCT01661140|39054490|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
16155747|NCT01661140|39054491|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
16155748|NCT01661140|39054492|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
16155749|NCT01661140|39054490|FG000|Open-Label Period|Lost to Follow-up|2|||
16155750|NCT01661140|39054491|FG001|Open-Label Period|Lost to Follow-up|0|||
16155751|NCT01661140|39054492|FG002|Open-Label Period|Lost to Follow-up|0|||
16155752|NCT01661140|39054490|FG000|Double-Blind Period|Refused Treatment|0|||
16155753|NCT01661140|39054491|FG001|Double-Blind Period|Refused Treatment|0|||
16155754|NCT01661140|39054492|FG002|Double-Blind Period|Refused Treatment|1|||
16155755|NCT01661140|39054490|FG000|Double-Blind Period|Adverse Event|0|||
16155756|NCT01661140|39054491|FG001|Double-Blind Period|Adverse Event|16|||
16155757|NCT01661140|39054492|FG002|Double-Blind Period|Adverse Event|18|||
16155758|NCT01661140|39054490|FG000|Double-Blind Period|Protocol Violation|0|||
16155759|NCT01661140|39054491|FG001|Double-Blind Period|Protocol Violation|2|||
16155760|NCT01661140|39054492|FG002|Double-Blind Period|Protocol Violation|3|||
16155761|NCT01661140|39054490|FG000|Double-Blind Period|Withdrawal by Subject|0|||
16155762|NCT01661140|39054491|FG001|Double-Blind Period|Withdrawal by Subject|1|||
16155763|NCT01661140|39054492|FG002|Double-Blind Period|Withdrawal by Subject|3|||
16366793|NCT03329001|39825581|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
16366794|NCT03329001|39825582|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
16366795|NCT03329001|39825583|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
16366796|NCT03329001|39825584|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
16366797|NCT03329001|39825585|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
16366798|NCT03329001|39825586|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
16366799|NCT03329001|39825579|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
16366800|NCT03329001|39825580|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
16366801|NCT03329001|39825581|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
16366802|NCT03329001|39825582|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
16366803|NCT03329001|39825583|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
16366804|NCT03329001|39825584|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
16155764|NCT01661140|39054490|FG000|Double-Blind Period|Investigator's Decision|0|||
16155765|NCT01661140|39054491|FG001|Double-Blind Period|Investigator's Decision|1|||
16155766|NCT01661140|39054492|FG002|Double-Blind Period|Investigator's Decision|2|||
16155767|NCT01661140|39054490|FG000|Double-Blind Period|Sponsor Termination|0|||
16155768|NCT01661140|39054491|FG001|Double-Blind Period|Sponsor Termination|14|||
16155769|NCT01661140|39054492|FG002|Double-Blind Period|Sponsor Termination|17|||
16155770|NCT01661140|39054490|FG000|Double-Blind Period|Administrative/Other|0|||
16155771|NCT01661140|39054491|FG001|Double-Blind Period|Administrative/Other|7|||
16155772|NCT01661140|39054492|FG002|Double-Blind Period|Administrative/Other|6|||
16155773|NCT02436876|39054493|FG000|Overall Study|Lost to Follow-up|0|||
16155774|NCT02436876|39054494|FG001|Overall Study|Lost to Follow-up|1|||
16366805|NCT03329001|39825585|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
16155775|NCT02436876|39054495|FG002|Overall Study|Lost to Follow-up|1|||
16155776|NCT02436876|39054496|FG003|Overall Study|Lost to Follow-up|1|||
16155777|NCT02436876|39054493|FG000|Overall Study|Withdrawal by Subject|1|||
16155778|NCT02436876|39054494|FG001|Overall Study|Withdrawal by Subject|0|||
16155779|NCT02436876|39054495|FG002|Overall Study|Withdrawal by Subject|0|||
16155780|NCT02436876|39054496|FG003|Overall Study|Withdrawal by Subject|1|||
16155781|NCT02436876|39054493|FG000|Overall Study|Physician Decision|0|||
16155782|NCT02436876|39054494|FG001|Overall Study|Physician Decision|2|||
16155783|NCT02436876|39054495|FG002|Overall Study|Physician Decision|1|||
16155784|NCT02436876|39054496|FG003|Overall Study|Physician Decision|0|||
16155785|NCT02436876|39054493|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
16155786|NCT02436876|39054494|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
16155787|NCT02436876|39054495|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
16155788|NCT02436876|39054496|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
16155789|NCT03655756|39054497|FG000|Overall Study|Death|1|||
16155790|NCT00253630|39054498|FG000|Overall Study|ineligible|2|||
16155791|NCT02370615|39054504|FG000|Overall Study|Adverse Event|1|||
16155792|NCT02370615|39054505|FG001|Overall Study|Adverse Event|0|||
16444726|NCT02613507|40108483|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
16444727|NCT02613507|40108484|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
16444728|NCT02613507|40108483|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
16444729|NCT02613507|40108484|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
16444730|NCT02613507|40108483|FG000|Overall Study|Randomized but not Treated|1|||
16444731|NCT02613507|40108484|FG001|Overall Study|Randomized but not Treated|10|||
16444732|NCT03278249|40108485|FG000|Overall Study|Withdrawal by Subject|2|||
16444733|NCT03278249|40108485|FG000|Overall Study|Lost to Follow-up|1|||
16444734|NCT02017405|40108486|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
16444735|NCT02017405|40108487|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
16444736|NCT02017405|40108488|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
16444737|NCT02017405|40108489|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
16155793|NCT04042103|39054508|FG000|Overall Study|Lost to Follow-up|1|||
16155794|NCT04042103|39054508|FG000|Overall Study|Withdrawal by Subject|1|||
16155795|NCT00772954|39054509|FG000|Overall Study|Adverse Event|0|||
16155796|NCT00772954|39054510|FG001|Overall Study|Adverse Event|0|||
16155797|NCT00772954|39054511|FG002|Overall Study|Adverse Event|1|||
16155798|NCT01285908|39054512|FG000|Baseline Measurement|unable to insert catheter|1|||
16155799|NCT01285908|39054513|FG001|Baseline Measurement|unable to insert catheter|0|||
16155800|NCT01285908|39054514|FG002|Baseline Measurement|unable to insert catheter|0|||
16155801|NCT01285908|39054512|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
16155802|NCT01285908|39054513|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
16155803|NCT01285908|39054514|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
16155804|NCT01285908|39054512|FG000|Baseline Measurement|unable to tolerate procedure|1|||
16155805|NCT01285908|39054513|FG001|Baseline Measurement|unable to tolerate procedure|0|||
16155806|NCT01285908|39054514|FG002|Baseline Measurement|unable to tolerate procedure|0|||
16155807|NCT00980200|39054515|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
16155808|NCT00980200|39054516|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
16155809|NCT00980200|39054517|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
16155810|NCT00980200|39054518|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
16155811|NCT00980200|39054519|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
16155812|NCT00980200|39054515|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
16155813|NCT00980200|39054516|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
16155814|NCT00980200|39054517|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
16155815|NCT00980200|39054518|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
16155816|NCT00980200|39054519|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
16155817|NCT03577730|39054520|FG000|Overall Study|Physician Decision|3|||
16155818|NCT03577730|39054521|FG001|Overall Study|Physician Decision|1|||
16155819|NCT03577730|39054520|FG000|Overall Study|Did not receive allocated intervention|1|||
16155820|NCT03577730|39054521|FG001|Overall Study|Did not receive allocated intervention|0|||
16155821|NCT01227044|39054522|FG000|Overall Study|Lost to Follow-up|5|||
16155822|NCT01227044|39054523|FG001|Overall Study|Lost to Follow-up|7|||
16155823|NCT01227044|39054522|FG000|Overall Study|Discontinued Intervention|1|||
16155824|NCT01227044|39054523|FG001|Overall Study|Discontinued Intervention|2|||
16155825|NCT01389752|39054526|FG000|Study Period 1|Sponsor decision|0|||
16155826|NCT01389752|39054527|FG001|Study Period 1|Sponsor decision|2|||
16155827|NCT01389752|39054526|FG000|Study Period 2|Sponsor decision|1|||
16444738|NCT02017405|40108490|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
16155828|NCT01389752|39054527|FG001|Study Period 2|Sponsor decision|0|||
16155829|NCT00262873|39054528|FG000|Overall Study|Adverse Event|3|||
16155830|NCT00262873|39054528|FG000|Overall Study|Withdrawal by Subject|5|||
16155831|NCT00414453|39054529|FG000|Overall Study|Abnormal lab work|16|||
16155832|NCT04247061|39054530|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
16155833|NCT04247061|39054530|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
16273170|NCT01751087|39484428|FG000|Overall Study|Physician Decision|0|||
16155834|NCT04247061|39054530|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
16155835|NCT01500278|39054531|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
16155836|NCT01500278|39054532|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
16155837|NCT01500278|39054531|FG000|Week 0 - Week 12|Protocol Violation|10|||
16155838|NCT01500278|39054532|FG001|Week 0 - Week 12|Protocol Violation|16|||
16155839|NCT01500278|39054531|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
16155840|NCT01500278|39054532|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
16155841|NCT01500278|39054531|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
16155842|NCT01500278|39054532|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
16155843|NCT01500278|39054531|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
16155844|NCT01500278|39054532|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
16155845|NCT01500278|39054531|FG000|Week 0 - Week 12|Patient decision|1|||
16444739|NCT02017405|40108491|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
16444740|NCT02017405|40108486|FG000|Open-label Phase|Adverse Event|1|||
16444741|NCT02017405|40108487|FG001|Open-label Phase|Adverse Event|1|||
16444742|NCT02017405|40108488|FG002|Open-label Phase|Adverse Event|0|||
16444743|NCT02017405|40108489|FG003|Open-label Phase|Adverse Event|0|||
16444744|NCT02017405|40108490|FG004|Open-label Phase|Adverse Event|0|||
16444745|NCT02017405|40108491|FG005|Open-label Phase|Adverse Event|0|||
16444746|NCT01064648|40108492|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
16444747|NCT01064648|40108493|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
16444748|NCT01064648|40108494|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
16444749|NCT01064648|40108495|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
16444750|NCT01064648|40108492|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
16444751|NCT01064648|40108493|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
16444752|NCT01064648|40108494|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
16444753|NCT01064648|40108495|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
16444754|NCT01064648|40108492|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
16444755|NCT01064648|40108493|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
16444756|NCT01064648|40108494|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
16444757|NCT01064648|40108495|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
16444758|NCT01064648|40108492|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
16444759|NCT01064648|40108493|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
16444760|NCT01064648|40108494|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
16444761|NCT01064648|40108495|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
16444762|NCT01064648|40108492|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
16444763|NCT01064648|40108493|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
16444764|NCT01064648|40108494|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
16444765|NCT01064648|40108495|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
16444766|NCT01064648|40108492|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
16444767|NCT01064648|40108493|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
16444768|NCT01064648|40108494|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
16444769|NCT01064648|40108495|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
16444770|NCT01064648|40108492|FG000|Phase II|Adverse Event|0|||
16155846|NCT01500278|39054532|FG001|Week 0 - Week 12|Patient decision|0|||
16155847|NCT01500278|39054531|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
16155848|NCT01500278|39054532|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
16155849|NCT01500278|39054531|FG000|Week 0 - Week 12|Investigator decision|1|||
16155850|NCT01500278|39054532|FG001|Week 0 - Week 12|Investigator decision|0|||
16155851|NCT01500278|39054531|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
16155852|NCT01500278|39054532|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
16155853|NCT01500278|39054531|FG000|Week 0 - Week 12|Sponsor decision|1|||
16155854|NCT01500278|39054532|FG001|Week 0 - Week 12|Sponsor decision|0|||
16155855|NCT01500278|39054531|FG000|Week 0 - Week 12|Personal reason|0|||
16155856|NCT01500278|39054532|FG001|Week 0 - Week 12|Personal reason|1|||
16155857|NCT01500278|39054531|FG000|Week 0 - Week 12|Other serious disease|0|||
16155858|NCT01500278|39054532|FG001|Week 0 - Week 12|Other serious disease|1|||
16155859|NCT01500278|39054531|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
16155860|NCT01500278|39054532|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
16155861|NCT01500278|39054531|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
16155862|NCT01500278|39054532|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
16155863|NCT01500278|39054531|FG000|Week 13 - Week 104|Protocol Violation|6|||
16155864|NCT01500278|39054532|FG001|Week 13 - Week 104|Protocol Violation|6|||
16155865|NCT01500278|39054531|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
16155866|NCT01500278|39054532|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
16155867|NCT01500278|39054531|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
16155868|NCT01500278|39054532|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
16155869|NCT01500278|39054531|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
16155870|NCT01500278|39054532|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
16155871|NCT01500278|39054531|FG000|Week 13 - Week 104|Non/bad compliance|7|||
16155872|NCT01500278|39054532|FG001|Week 13 - Week 104|Non/bad compliance|5|||
16155873|NCT01500278|39054531|FG000|Week 13 - Week 104|Recurrent infections|1|||
16155874|NCT01500278|39054532|FG001|Week 13 - Week 104|Recurrent infections|0|||
16155875|NCT01500278|39054531|FG000|Week 13 - Week 104|False positive test|1|||
16155876|NCT01500278|39054532|FG001|Week 13 - Week 104|False positive test|2|||
16155877|NCT01500278|39054531|FG000|Week 13 - Week 104|Sponsor request|4|||
16155878|NCT01500278|39054532|FG001|Week 13 - Week 104|Sponsor request|0|||
16155879|NCT01500278|39054531|FG000|Week 13 - Week 104|Withdrawn in error|1|||
16155880|NCT01500278|39054532|FG001|Week 13 - Week 104|Withdrawn in error|0|||
16155881|NCT01500278|39054531|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
16155882|NCT01500278|39054532|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
16155883|NCT01500278|39054531|FG000|Week 13 - Week 104|Protocol deviation|1|||
16155884|NCT01500278|39054532|FG001|Week 13 - Week 104|Protocol deviation|0|||
16155885|NCT01500278|39054531|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
16155886|NCT01500278|39054532|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
16155887|NCT01500278|39054531|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
16155888|NCT01500278|39054532|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
16155889|NCT01500278|39054531|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
16155890|NCT01500278|39054532|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
16155891|NCT01500278|39054531|FG000|Week 13 - Week 104|Relocation|0|||
16155892|NCT01500278|39054532|FG001|Week 13 - Week 104|Relocation|1|||
16155893|NCT01500278|39054531|FG000|Week 13 - Week 104|Sponsor decision|0|||
16155894|NCT01500278|39054532|FG001|Week 13 - Week 104|Sponsor decision|2|||
16155895|NCT01500278|39054531|FG000|Week 13 - Week 104|Medical monitor decision|0|||
16155896|NCT01500278|39054532|FG001|Week 13 - Week 104|Medical monitor decision|2|||
16155897|NCT01500278|39054531|FG000|Week 13 - Week 104|Personal reason|0|||
16155898|NCT01500278|39054532|FG001|Week 13 - Week 104|Personal reason|1|||
16155899|NCT01500278|39054531|FG000|Week 13 - Week 104|Not completed|0|||
16155900|NCT01500278|39054532|FG001|Week 13 - Week 104|Not completed|1|||
16155901|NCT01500278|39054531|FG000|Week 13 - Week 104|Death|2|||
16155902|NCT01500278|39054532|FG001|Week 13 - Week 104|Death|4|||
16155903|NCT01500278|39054531|FG000|Week 13 - Week 104|Adverse Event|54|||
16155904|NCT01500278|39054532|FG001|Week 13 - Week 104|Adverse Event|54|||
16155905|NCT03113500|39054533|FG000|Overall Study|Withdrawal by Subject|1|||
16155906|NCT03368170|39054534|FG000|Overall Study|Adverse Event|2|||
16155907|NCT03368170|39054535|FG001|Overall Study|Adverse Event|1|||
16155908|NCT00772668|39054540|FG000|Overall Study|Physician Decision|3|||
16155909|NCT02347176|39054546|FG000|Overall Study|Lost to Follow-up|2|||
16155910|NCT02347176|39054547|FG001|Overall Study|Lost to Follow-up|3|||
16155911|NCT02347176|39054548|FG002|Overall Study|Lost to Follow-up|1|||
16155912|NCT02347176|39054549|FG003|Overall Study|Lost to Follow-up|1|||
16155913|NCT02347176|39054546|FG000|Overall Study|Withdrawal by Subject|9|||
16155914|NCT02347176|39054547|FG001|Overall Study|Withdrawal by Subject|5|||
16366806|NCT03329001|39825586|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
16155915|NCT02347176|39054548|FG002|Overall Study|Withdrawal by Subject|5|||
16155916|NCT02347176|39054549|FG003|Overall Study|Withdrawal by Subject|3|||
16155917|NCT02347176|39054546|FG000|Overall Study|Other|1|||
16155918|NCT02347176|39054547|FG001|Overall Study|Other|2|||
16155919|NCT02347176|39054548|FG002|Overall Study|Other|2|||
16155920|NCT02347176|39054549|FG003|Overall Study|Other|0|||
16155921|NCT01890421|39054550|FG000|Overall Study|Adverse Event|1|||
16155922|NCT01890421|39054550|FG000|Overall Study|Other reason|10|||
16155923|NCT03509350|39054551|FG000|Overall Study|Withdrawal by Subject|0|||
16155924|NCT03509350|39054552|FG001|Overall Study|Withdrawal by Subject|2|||
16155925|NCT03839459|39054553|FG000|Overall Study|Withdrawal by Subject|2|||
16155926|NCT03839459|39054553|FG000|Overall Study|progression of disease|3|||
16155927|NCT00223496|39057455|FG000|Overall Study|screen failure|9|||
16155928|NCT00223496|39057455|FG000|Overall Study|Lost to Follow-up|4|||
16155929|NCT00223496|39057455|FG000|Overall Study|Lack of Efficacy|6|||
16155930|NCT00223496|39057455|FG000|Overall Study|Withdrawal by Subject|1|||
16155931|NCT00223496|39057455|FG000|Overall Study|Physician Decision|2|||
16155932|NCT01806779|39057459|FG000|Overall Study|Physician Decision|2|||
16155933|NCT01806779|39057460|FG001|Overall Study|Physician Decision|0|||
16155934|NCT01806779|39057461|FG002|Overall Study|Physician Decision|1|||
16155935|NCT01806779|39057459|FG000|Overall Study|Lack of Efficacy|1|||
16155936|NCT01806779|39057460|FG001|Overall Study|Lack of Efficacy|1|||
16155937|NCT01806779|39057461|FG002|Overall Study|Lack of Efficacy|0|||
16155938|NCT01806779|39057459|FG000|Overall Study|Lost to Follow-up|19|||
16155939|NCT01806779|39057460|FG001|Overall Study|Lost to Follow-up|20|||
16155940|NCT01806779|39057461|FG002|Overall Study|Lost to Follow-up|0|||
16155941|NCT01806779|39057459|FG000|Overall Study|Withdrawal by Subject|20|||
16155942|NCT01806779|39057460|FG001|Overall Study|Withdrawal by Subject|23|||
16155943|NCT01806779|39057461|FG002|Overall Study|Withdrawal by Subject|22|||
16155944|NCT04962022|39057462|FG000|Period 1|Withdrawal by Subject|1|||
16155945|NCT04962022|39057463|FG001|Period 1|Withdrawal by Subject|0|||
16155946|NCT00691483|39057468|FG000|Overall Study|Adverse Event|14|||
16155947|NCT00691483|39057469|FG001|Overall Study|Adverse Event|6|||
16155948|NCT00691483|39057468|FG000|Overall Study|Lost to Follow-up|17|||
16155949|NCT00691483|39057469|FG001|Overall Study|Lost to Follow-up|10|||
16155950|NCT00691483|39057468|FG000|Overall Study|Withdrawal by Subject|24|||
16155951|NCT00691483|39057469|FG001|Overall Study|Withdrawal by Subject|7|||
16155952|NCT00691483|39057468|FG000|Overall Study|Other known cause|6|||
16155953|NCT00691483|39057469|FG001|Overall Study|Other known cause|1|||
16155954|NCT00691483|39057468|FG000|Overall Study|Randomized by not treated|7|||
16155955|NCT00691483|39057469|FG001|Overall Study|Randomized by not treated|1|||
16155956|NCT03354663|39057478|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
16155957|NCT03354663|39057478|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
16155958|NCT03354663|39057478|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
16155959|NCT03354663|39057478|FG000|Completed 30-day Visit|Missed Visit|1|||
16366807|NCT02401230|39825587|FG000|Overall Study|Adverse Event|3|||
16366808|NCT02401230|39825588|FG001|Overall Study|Adverse Event|2|||
16366809|NCT02401230|39825589|FG002|Overall Study|Adverse Event|0|||
16366810|NCT02401230|39825587|FG000|Overall Study|Withdrawal by Subject|2|||
16366811|NCT02401230|39825588|FG001|Overall Study|Withdrawal by Subject|1|||
16366812|NCT02401230|39825589|FG002|Overall Study|Withdrawal by Subject|1|||
16155960|NCT02966509|39057480|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
16155961|NCT02966509|39057481|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
16155962|NCT02966509|39057480|FG000|Baseline Satisfaction Survey|Death|0|||
16155963|NCT02966509|39057481|FG001|Baseline Satisfaction Survey|Death|1|||
16155964|NCT02966509|39057480|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
16155965|NCT02966509|39057481|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
16366813|NCT02401230|39825587|FG000|Overall Study|Lost to Follow-up|1|||
16155966|NCT02966509|39057480|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
16155967|NCT02966509|39057481|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
16155968|NCT02966509|39057480|FG000|6 Month Satisfaction Decision Survey|Death|22|||
16273171|NCT01751087|39484429|FG001|Overall Study|Physician Decision|0|||
16366814|NCT02401230|39825588|FG001|Overall Study|Lost to Follow-up|3|||
16366815|NCT02401230|39825589|FG002|Overall Study|Lost to Follow-up|3|||
16366816|NCT01149538|39825590|FG000|Overall Study|Lost to Follow-up|0|||
16366817|NCT01149538|39825591|FG001|Overall Study|Lost to Follow-up|1|||
16366818|NCT01149538|39825590|FG000|Overall Study|Withdrawal by Subject|5|||
16366819|NCT01149538|39825591|FG001|Overall Study|Withdrawal by Subject|3|||
16366820|NCT01751685|39825592|FG000|6-mo Followup|Missed study visit|1|||
16366821|NCT01751685|39825593|FG001|6-mo Followup|Missed study visit|0|||
16366822|NCT01751685|39825592|FG000|6-mo Followup|Withdrawal by Subject|2|||
16366823|NCT01751685|39825593|FG001|6-mo Followup|Withdrawal by Subject|2|||
16366824|NCT01751685|39825592|FG000|6-mo Followup|Lost to Follow-up|0|||
16366825|NCT01751685|39825593|FG001|6-mo Followup|Lost to Follow-up|1|||
16366826|NCT01751685|39825592|FG000|12-mo Followup|Lost to Follow-up|5|||
16366827|NCT01751685|39825593|FG001|12-mo Followup|Lost to Follow-up|0|||
16366828|NCT03483103|39825594|FG000|Pre-Treatment Phase|Other reasons|1|||
16366829|NCT03483103|39825594|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
16366830|NCT03483103|39825594|FG000|Pre-Treatment Phase|Disease-related complications|1|||
16366831|NCT03483103|39825594|FG000|Pre-Treatment Phase|Death|5|||
16366832|NCT03483103|39825594|FG000|Treatment Phase|Withdrawal by Subject|7|||
16366833|NCT03483103|39825594|FG000|Treatment Phase|Other reasons|1|||
16366834|NCT03483103|39825594|FG000|Treatment Phase|Death|23|||
16366835|NCT03483103|39825594|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
16366836|NCT03483103|39825594|FG000|Treatment Phase|Received nonconforming product|1|||
16366837|NCT01257542|39825595|FG000|Overall Study|Protocol Violation|3|||
16366838|NCT01257542|39825596|FG001|Overall Study|Protocol Violation|5|||
16366839|NCT01257542|39825595|FG000|Overall Study|Withdrawal by Subject|0|||
16366840|NCT01257542|39825596|FG001|Overall Study|Withdrawal by Subject|2|||
16366841|NCT00363467|39825597|FG000|Overall Study|Physician Decision|1|||
16366842|NCT02315625|39825598|FG000|First Intervention|Disease Progression|1|||
16366843|NCT02315625|39825599|FG001|First Intervention|Disease Progression|0|||
16366844|NCT02315625|39825598|FG000|Second Intervention|Physician Decision|2|||
16366845|NCT02315625|39825599|FG001|Second Intervention|Physician Decision|1|||
16366846|NCT02315625|39825598|FG000|Second Intervention|Study closure|1|||
16366847|NCT02315625|39825599|FG001|Second Intervention|Study closure|0|||
16366848|NCT02315625|39825598|FG000|Second Intervention|Disease Progression|1|||
16366849|NCT02315625|39825599|FG001|Second Intervention|Disease Progression|0|||
16366850|NCT02246777|39825600|FG000|Overall Study|Adverse Event|2|||
16366851|NCT02246777|39825600|FG000|Overall Study|Change of residence|1|||
16366852|NCT00699751|39825601|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
16366853|NCT00699751|39825602|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
16366854|NCT00699751|39825601|FG000|Period 1: Without/Before Drug Switch|Death|28|||
16366855|NCT00699751|39825602|FG001|Period 1: Without/Before Drug Switch|Death|29|||
16366856|NCT00699751|39825601|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
16366857|NCT00699751|39825602|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
16366858|NCT00699751|39825601|FG000|Period 1: Without/Before Drug Switch|Other|30|||
16366859|NCT00699751|39825602|FG001|Period 1: Without/Before Drug Switch|Other|20|||
16366860|NCT00699751|39825601|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
16366861|NCT00699751|39825602|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
16366862|NCT00699751|39825601|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
16366863|NCT00699751|39825602|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
16366864|NCT00699751|39825601|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
16366865|NCT00699751|39825602|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
16366866|NCT00699751|39825601|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
16366867|NCT00699751|39825602|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
16366868|NCT01432327|39825603|FG000|Posttest 3 Months|depression|3|||
16366869|NCT01432327|39825604|FG001|Posttest 3 Months|depression|0|||
16366870|NCT01432327|39825605|FG002|Posttest 3 Months|depression|0|||
16366871|NCT01432327|39825606|FG003|Posttest 3 Months|depression|0|||
16366872|NCT01432327|39825603|FG000|Posttest 3 Months|Lost to Follow-up|1|||
16366873|NCT01432327|39825604|FG001|Posttest 3 Months|Lost to Follow-up|0|||
16366874|NCT01432327|39825605|FG002|Posttest 3 Months|Lost to Follow-up|2|||
16366875|NCT01432327|39825606|FG003|Posttest 3 Months|Lost to Follow-up|1|||
16366876|NCT01432327|39825603|FG000|Posttest 3 Months|Allergic reaction|0|||
16366877|NCT01432327|39825604|FG001|Posttest 3 Months|Allergic reaction|2|||
16366878|NCT01432327|39825605|FG002|Posttest 3 Months|Allergic reaction|0|||
16366879|NCT01432327|39825606|FG003|Posttest 3 Months|Allergic reaction|0|||
16366880|NCT01432327|39825603|FG000|Posttest 6 Months|Lost to Follow-up|0|||
16366881|NCT01432327|39825604|FG001|Posttest 6 Months|Lost to Follow-up|0|||
16366882|NCT01432327|39825605|FG002|Posttest 6 Months|Lost to Follow-up|3|||
16366883|NCT01432327|39825606|FG003|Posttest 6 Months|Lost to Follow-up|2|||
16366884|NCT01432327|39825603|FG000|Posttest 6 Months|Allergic reaction|0|||
16366885|NCT01432327|39825604|FG001|Posttest 6 Months|Allergic reaction|0|||
16366886|NCT01432327|39825605|FG002|Posttest 6 Months|Allergic reaction|1|||
16366887|NCT01432327|39825606|FG003|Posttest 6 Months|Allergic reaction|0|||
16366888|NCT01432327|39825603|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
16366889|NCT01432327|39825604|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
16366890|NCT01432327|39825605|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
16366891|NCT01432327|39825606|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
16366892|NCT01432327|39825603|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
16366893|NCT01432327|39825604|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
16366894|NCT01432327|39825605|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
16366895|NCT01432327|39825606|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
16366896|NCT01432327|39825603|FG000|Posttest 1 Year|Lost to Follow-up|0|||
16366897|NCT01432327|39825604|FG001|Posttest 1 Year|Lost to Follow-up|0|||
16366898|NCT01432327|39825605|FG002|Posttest 1 Year|Lost to Follow-up|4|||
16366899|NCT01432327|39825606|FG003|Posttest 1 Year|Lost to Follow-up|2|||
16366900|NCT01432327|39825603|FG000|Posttest 1 Year|Allergic reaction|0|||
16366901|NCT01432327|39825604|FG001|Posttest 1 Year|Allergic reaction|0|||
16366902|NCT01432327|39825605|FG002|Posttest 1 Year|Allergic reaction|1|||
16366903|NCT01432327|39825606|FG003|Posttest 1 Year|Allergic reaction|1|||
16366904|NCT02299167|39825607|FG000|Overall Study|patients were excluded from the study|11|||
16366905|NCT05350423|39825611|FG000|Overall Study|Lost to Follow-up|3|||
16366906|NCT05350423|39825612|FG001|Overall Study|Lost to Follow-up|3|||
16366907|NCT05350423|39825611|FG000|Overall Study|screen failure|5|||
16366908|NCT05350423|39825612|FG001|Overall Study|screen failure|6|||
16366909|NCT01925794|39825616|FG000|180 Days|Death|2|||
16366910|NCT01925794|39825616|FG000|180 Days|Withdrawal by Subject|2|||
16366911|NCT01925794|39825616|FG000|270 Days|Death|2|||
16366912|NCT01925794|39825616|FG000|270 Days|Protocol Violation|3|||
16366913|NCT01860404|39825619|FG000|Overall Study|Lost to Follow-up|3|||
16366914|NCT01860404|39825620|FG001|Overall Study|Lost to Follow-up|4|||
16366915|NCT01860404|39825621|FG002|Overall Study|Lost to Follow-up|1|||
16366916|NCT01860404|39825622|FG003|Overall Study|Lost to Follow-up|6|||
16366917|NCT01860404|39825623|FG004|Overall Study|Lost to Follow-up|4|||
16366918|NCT01860404|39825619|FG000|Overall Study|Withdrawal by Subject|0|||
16366919|NCT01860404|39825620|FG001|Overall Study|Withdrawal by Subject|0|||
16366920|NCT01860404|39825621|FG002|Overall Study|Withdrawal by Subject|4|||
16366921|NCT01860404|39825622|FG003|Overall Study|Withdrawal by Subject|0|||
16366922|NCT01860404|39825623|FG004|Overall Study|Withdrawal by Subject|0|||
16366923|NCT01027416|39825624|FG000|Overall Study|Withdrawal by Subject|0|||
16366924|NCT01027416|39825625|FG001|Overall Study|Withdrawal by Subject|1|||
16366925|NCT01027416|39825624|FG000|Overall Study|Physician Decision|1|||
16366926|NCT01027416|39825625|FG001|Overall Study|Physician Decision|4|||
16366927|NCT02309359|39825629|FG000|Overall Study|Adverse Event|4|||
16366928|NCT02309359|39825630|FG001|Overall Study|Adverse Event|5|||
16366929|NCT02309359|39825631|FG002|Overall Study|Adverse Event|5|||
16366930|NCT02309359|39825632|FG003|Overall Study|Adverse Event|4|||
16366931|NCT02309359|39825633|FG004|Overall Study|Adverse Event|4|||
16366932|NCT02309359|39825629|FG000|Overall Study|Death|1|||
16366933|NCT02309359|39825630|FG001|Overall Study|Death|0|||
16366934|NCT02309359|39825631|FG002|Overall Study|Death|0|||
16366935|NCT02309359|39825632|FG003|Overall Study|Death|0|||
16366936|NCT02309359|39825633|FG004|Overall Study|Death|0|||
16366937|NCT02309359|39825629|FG000|Overall Study|Withdrawal by Subject|2|||
16366938|NCT02309359|39825630|FG001|Overall Study|Withdrawal by Subject|2|||
16366939|NCT02309359|39825631|FG002|Overall Study|Withdrawal by Subject|4|||
16366940|NCT02309359|39825632|FG003|Overall Study|Withdrawal by Subject|4|||
16366941|NCT02309359|39825633|FG004|Overall Study|Withdrawal by Subject|0|||
16366942|NCT02309359|39825629|FG000|Overall Study|Lack of Efficacy|3|||
16366943|NCT02309359|39825630|FG001|Overall Study|Lack of Efficacy|1|||
16366944|NCT02309359|39825631|FG002|Overall Study|Lack of Efficacy|0|||
16366945|NCT02309359|39825632|FG003|Overall Study|Lack of Efficacy|0|||
16366946|NCT02309359|39825633|FG004|Overall Study|Lack of Efficacy|3|||
16366947|NCT02309359|39825629|FG000|Overall Study|Lost to Follow-up|0|||
16366948|NCT02309359|39825630|FG001|Overall Study|Lost to Follow-up|0|||
16366949|NCT02309359|39825631|FG002|Overall Study|Lost to Follow-up|0|||
16366950|NCT02309359|39825632|FG003|Overall Study|Lost to Follow-up|1|||
16366951|NCT02309359|39825633|FG004|Overall Study|Lost to Follow-up|0|||
16366952|NCT02309359|39825629|FG000|Overall Study|Other|2|||
16366953|NCT02309359|39825630|FG001|Overall Study|Other|0|||
16366954|NCT02309359|39825631|FG002|Overall Study|Other|2|||
16366955|NCT02309359|39825632|FG003|Overall Study|Other|3|||
16366956|NCT02309359|39825633|FG004|Overall Study|Other|2|||
16366957|NCT01922011|39825634|FG000|Overall Study|Protocol Violation|0|||
16366958|NCT01922011|39825635|FG001|Overall Study|Protocol Violation|1|||
16366959|NCT01922011|39825634|FG000|Overall Study|Physician Decision|0|||
16366960|NCT01922011|39825635|FG001|Overall Study|Physician Decision|1|||
16366961|NCT01922011|39825634|FG000|Overall Study|Parent/Guardian Decision|3|||
16366962|NCT01922011|39825635|FG001|Overall Study|Parent/Guardian Decision|0|||
16366963|NCT01922011|39825634|FG000|Overall Study|Lost to Follow-up|0|||
16366964|NCT01922011|39825635|FG001|Overall Study|Lost to Follow-up|1|||
16366965|NCT01922011|39825634|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
16155969|NCT02966509|39057481|FG001|6 Month Satisfaction Decision Survey|Death|25|||
16366966|NCT01922011|39825635|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
16366967|NCT01922011|39825634|FG000|Overall Study|Not Treated|1|||
16366968|NCT01922011|39825635|FG001|Overall Study|Not Treated|0|||
16366969|NCT01922011|39825634|FG000|Overall Study|Lack of willing home health agency|1|||
16366970|NCT01922011|39825635|FG001|Overall Study|Lack of willing home health agency|0|||
16366971|NCT01922011|39825634|FG000|Overall Study|Randomized in error|1|||
16366972|NCT01922011|39825635|FG001|Overall Study|Randomized in error|0|||
16366973|NCT00191100|39825638|FG000|Overall Study|Adverse Event|18|||
16366974|NCT00191100|39825639|FG001|Overall Study|Adverse Event|1|||
16366975|NCT00191100|39825638|FG000|Overall Study|Lost to Follow-up|2|||
16366976|NCT00191100|39825639|FG001|Overall Study|Lost to Follow-up|0|||
16366977|NCT00191100|39825638|FG000|Overall Study|Patient Moved|0|||
16366978|NCT00191100|39825639|FG001|Overall Study|Patient Moved|1|||
16366979|NCT00191100|39825638|FG000|Overall Study|Withdrawal by Subject|9|||
16366980|NCT00191100|39825639|FG001|Overall Study|Withdrawal by Subject|3|||
16366981|NCT00191100|39825638|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
16366982|NCT00191100|39825639|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
16366983|NCT00191100|39825638|FG000|Overall Study|Clinical Relapse|2|||
16366984|NCT00191100|39825639|FG001|Overall Study|Clinical Relapse|1|||
16366985|NCT00191100|39825638|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
16366986|NCT00191100|39825639|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
16366987|NCT00191100|39825638|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
16366988|NCT00191100|39825639|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
16366989|NCT00191100|39825638|FG000|Overall Study|Physician Decision|3|||
16366990|NCT00191100|39825639|FG001|Overall Study|Physician Decision|1|||
16366991|NCT00191100|39825638|FG000|Overall Study|Death from Study Drug Toxicity|2|||
16366992|NCT00191100|39825639|FG001|Overall Study|Death from Study Drug Toxicity|0|||
16366993|NCT00191100|39825638|FG000|Overall Study|Protocol Violation|1|||
16366994|NCT00191100|39825639|FG001|Overall Study|Protocol Violation|1|||
16366995|NCT00191100|39825638|FG000|Overall Study|Death from Other Cause|1|||
16366996|NCT00191100|39825639|FG001|Overall Study|Death from Other Cause|0|||
16366997|NCT00191100|39825638|FG000|Overall Study|Reason Not Specified|0|||
16366998|NCT00191100|39825639|FG001|Overall Study|Reason Not Specified|1|||
16366999|NCT01531153|39825640|FG000|Overall Study|Withdrawal by Subject|10|||
16367000|NCT01531153|39825641|FG001|Overall Study|Withdrawal by Subject|9|||
16367001|NCT01531153|39825642|FG002|Overall Study|Withdrawal by Subject|15|||
16367002|NCT00968968|39825643|FG000|Overall Study|Study closed/terminated|10|||
16367003|NCT00968968|39825644|FG001|Overall Study|Study closed/terminated|10|||
16367004|NCT00968968|39825643|FG000|Overall Study|Protocol defined stopping criteria|3|||
16367005|NCT00968968|39825644|FG001|Overall Study|Protocol defined stopping criteria|1|||
16367006|NCT00968968|39825643|FG000|Overall Study|Withdrawal by Subject|2|||
16367007|NCT00968968|39825644|FG001|Overall Study|Withdrawal by Subject|0|||
16367008|NCT00968968|39825643|FG000|Overall Study|Physician Decision|1|||
16367009|NCT00968968|39825644|FG001|Overall Study|Physician Decision|2|||
16367010|NCT00968968|39825643|FG000|Overall Study|Lost to Follow-up|0|||
16367011|NCT00968968|39825644|FG001|Overall Study|Lost to Follow-up|1|||
16367012|NCT03677401|39825647|FG000|Overall Study|Adverse Event|4|||
16367013|NCT03677401|39825648|FG001|Overall Study|Adverse Event|14|||
16367014|NCT03677401|39825647|FG000|Overall Study|Lack of Efficacy|3|||
16367015|NCT03677401|39825648|FG001|Overall Study|Lack of Efficacy|1|||
16367016|NCT03677401|39825647|FG000|Overall Study|Withdrawal by Subject|2|||
16367017|NCT03677401|39825648|FG001|Overall Study|Withdrawal by Subject|2|||
16367018|NCT03677401|39825647|FG000|Overall Study|Sponsor decision|0|||
16367019|NCT03677401|39825648|FG001|Overall Study|Sponsor decision|1|||
16367020|NCT03677401|39825647|FG000|Overall Study|Reason Unspecified|1|||
16367021|NCT03677401|39825648|FG001|Overall Study|Reason Unspecified|0|||
16367022|NCT02709369|39828733|FG000|Overall Study|Lost to Follow-up|15|||
16367023|NCT02709369|39828733|FG000|Overall Study|Withdrawal by Subject|10|||
16367024|NCT02709369|39828733|FG000|Overall Study|Did not received intervention|2|||
16367025|NCT02774278|39828738|FG000|Overall Study|Lack of Efficacy|199|||
16367026|NCT02774278|39828738|FG000|Overall Study|Death|29|||
16367027|NCT02774278|39828738|FG000|Overall Study|Adverse event/intercurrent illness|16|||
16367028|NCT02774278|39828738|FG000|Overall Study|Refused treatment/did not cooperate|9|||
16367029|NCT02774278|39828738|FG000|Overall Study|Administrative reasons|6|||
16367030|NCT02774278|39828738|FG000|Overall Study|Withdrawal by Subject|3|||
16367031|NCT02774278|39828738|FG000|Overall Study|Protocol Violation|2|||
16367032|NCT01311661|39828739|FG000|Overall Study|Adverse Event|2|||
16367033|NCT01311661|39828739|FG000|Overall Study|Protocol Violation|3|||
16367034|NCT01311661|39828739|FG000|Overall Study|Withdrawal by Subject|2|||
16367035|NCT00433290|39828740|FG000|Overall Study|Adverse Event|24|||
16367036|NCT00433290|39828741|FG001|Overall Study|Adverse Event|7|||
16367037|NCT00433290|39828740|FG000|Overall Study|Lack of Efficacy|1|||
16367038|NCT00433290|39828741|FG001|Overall Study|Lack of Efficacy|5|||
16444771|NCT01064648|40108493|FG001|Phase II|Adverse Event|0|||
16444772|NCT01064648|40108494|FG002|Phase II|Adverse Event|15|||
16444773|NCT01064648|40108495|FG003|Phase II|Adverse Event|8|||
16444774|NCT01064648|40108492|FG000|Phase II|Death|0|||
16444775|NCT01064648|40108493|FG001|Phase II|Death|0|||
16444776|NCT01064648|40108494|FG002|Phase II|Death|4|||
16444777|NCT01064648|40108495|FG003|Phase II|Death|5|||
16444778|NCT01064648|40108492|FG000|Phase II|Withdrawal by Subject|0|||
16444779|NCT01064648|40108493|FG001|Phase II|Withdrawal by Subject|0|||
16444780|NCT01064648|40108494|FG002|Phase II|Withdrawal by Subject|2|||
16444781|NCT01064648|40108495|FG003|Phase II|Withdrawal by Subject|5|||
16444782|NCT01064648|40108492|FG000|Phase II|Progression|0|||
16444783|NCT01064648|40108493|FG001|Phase II|Progression|0|||
16444784|NCT01064648|40108494|FG002|Phase II|Progression|21|||
16444785|NCT01064648|40108495|FG003|Phase II|Progression|27|||
16444786|NCT01064648|40108492|FG000|Phase II|Non-protocol specified|0|||
16444787|NCT01064648|40108493|FG001|Phase II|Non-protocol specified|0|||
16444788|NCT01064648|40108494|FG002|Phase II|Non-protocol specified|5|||
16444789|NCT01064648|40108495|FG003|Phase II|Non-protocol specified|3|||
16444790|NCT01064648|40108492|FG000|Phase II|Under Review|0|||
16444791|NCT01064648|40108493|FG001|Phase II|Under Review|0|||
16444792|NCT01064648|40108494|FG002|Phase II|Under Review|2|||
16444793|NCT01064648|40108495|FG003|Phase II|Under Review|0|||
16444794|NCT05232682|40108497|FG000|Overall Study|Lost to Follow-up|2|||
16444795|NCT00541658|40108498|FG000|Overall Study|Adverse Event|28|||
16444796|NCT00541658|40108499|FG001|Overall Study|Adverse Event|37|||
16444797|NCT00541658|40108500|FG002|Overall Study|Adverse Event|25|||
16444798|NCT00541658|40108498|FG000|Overall Study|Physician Decision|0|||
16444799|NCT00541658|40108499|FG001|Overall Study|Physician Decision|0|||
16444800|NCT00541658|40108500|FG002|Overall Study|Physician Decision|4|||
16444801|NCT00541658|40108498|FG000|Overall Study|Lost to Follow-up|3|||
16444802|NCT00541658|40108499|FG001|Overall Study|Lost to Follow-up|3|||
16444803|NCT00541658|40108500|FG002|Overall Study|Lost to Follow-up|6|||
16444804|NCT00541658|40108498|FG000|Overall Study|Protocol Violation|0|||
16444805|NCT00541658|40108499|FG001|Overall Study|Protocol Violation|1|||
16444806|NCT00541658|40108500|FG002|Overall Study|Protocol Violation|1|||
16444807|NCT00541658|40108498|FG000|Overall Study|Withdrawal by Subject|28|||
16444808|NCT00541658|40108499|FG001|Overall Study|Withdrawal by Subject|32|||
16444809|NCT00541658|40108500|FG002|Overall Study|Withdrawal by Subject|32|||
16444810|NCT00541658|40108498|FG000|Overall Study|Took No Study Drug|1|||
16444811|NCT00541658|40108499|FG001|Overall Study|Took No Study Drug|0|||
16444812|NCT00541658|40108500|FG002|Overall Study|Took No Study Drug|0|||
16444813|NCT02006472|40108502|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
16444814|NCT02006472|40108503|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
16444815|NCT02006472|40108504|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
16444816|NCT02006472|40108505|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
16444817|NCT02006472|40108506|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
16444818|NCT02006472|40108502|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
16444819|NCT02006472|40108503|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
16444820|NCT02006472|40108504|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
16444821|NCT02006472|40108505|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
16444822|NCT02006472|40108506|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
16444823|NCT02006472|40108502|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
16444824|NCT02006472|40108503|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
16444825|NCT02006472|40108504|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
16444826|NCT02006472|40108505|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
16444827|NCT02006472|40108506|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
16444828|NCT02006472|40108502|FG000|Period 1 (Through Week 26)|Other|1|||
16444829|NCT02006472|40108503|FG001|Period 1 (Through Week 26)|Other|5|||
16444830|NCT02006472|40108504|FG002|Period 1 (Through Week 26)|Other|0|||
16444831|NCT02006472|40108505|FG003|Period 1 (Through Week 26)|Other|2|||
16444832|NCT02006472|40108506|FG004|Period 1 (Through Week 26)|Other|3|||
16444833|NCT02006472|40108502|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
16444834|NCT02006472|40108503|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
16444835|NCT02006472|40108504|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
16444836|NCT02006472|40108505|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
16444837|NCT02006472|40108506|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
16155970|NCT02966509|39057480|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
16444838|NCT02006472|40108502|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
16444839|NCT02006472|40108503|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
16444840|NCT02006472|40108504|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
16444841|NCT02006472|40108505|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
16444842|NCT02006472|40108506|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
16444843|NCT02006472|40108502|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
16444844|NCT02006472|40108503|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
16444845|NCT02006472|40108504|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
16444846|NCT02006472|40108505|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
16444847|NCT02006472|40108506|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
16155971|NCT02966509|39057481|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
16155972|NCT02966509|39057480|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
16155973|NCT02966509|39057481|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
16155974|NCT02966509|39057480|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
16155975|NCT02966509|39057481|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
16155976|NCT02966509|39057480|FG000|6 Month Satisfaction Survey|Death|36|||
16155977|NCT02966509|39057481|FG001|6 Month Satisfaction Survey|Death|33|||
16155978|NCT02966509|39057480|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
16155979|NCT02966509|39057481|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
16155980|NCT02966509|39057480|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
16155981|NCT02966509|39057481|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
16155982|NCT02966509|39057480|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
16155983|NCT02966509|39057481|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
16155984|NCT02966509|39057480|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
16155985|NCT02966509|39057481|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
16155986|NCT02966509|39057480|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
16155987|NCT02966509|39057481|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
16155988|NCT00264238|39057482|FG000|Overall Study|Protocol Violation|1|||
16155989|NCT03311711|39057483|FG000|Overall Study|Death|1|||
16155990|NCT03311711|39057484|FG001|Overall Study|Death|0|||
16155991|NCT03311711|39057485|FG002|Overall Study|Death|0|||
16155992|NCT03311711|39057486|FG003|Overall Study|Death|0|||
16155993|NCT03311711|39057487|FG004|Overall Study|Death|0|||
16155994|NCT03311711|39057488|FG005|Overall Study|Death|0|||
16367039|NCT00433290|39828740|FG000|Overall Study|Withdrawal by Subject|4|||
16367040|NCT00433290|39828741|FG001|Overall Study|Withdrawal by Subject|2|||
16367041|NCT00433290|39828740|FG000|Overall Study|Protocol Violation|3|||
16367042|NCT00433290|39828741|FG001|Overall Study|Protocol Violation|2|||
16367043|NCT00433290|39828740|FG000|Overall Study|Physician Decision|2|||
16367044|NCT00433290|39828741|FG001|Overall Study|Physician Decision|0|||
16367045|NCT00433290|39828740|FG000|Overall Study|Entry Criteria Not Met|0|||
16367046|NCT00433290|39828741|FG001|Overall Study|Entry Criteria Not Met|1|||
16367047|NCT00433290|39828740|FG000|Overall Study|Lost to Follow-up|1|||
16367048|NCT00433290|39828741|FG001|Overall Study|Lost to Follow-up|0|||
16367049|NCT01481779|39828742|FG000|Overall Study|Adverse Event|23|||
16367050|NCT01481779|39828743|FG001|Overall Study|Adverse Event|5|||
16367051|NCT01481779|39828742|FG000|Overall Study|Lost to Follow-up|3|||
16367052|NCT01481779|39828743|FG001|Overall Study|Lost to Follow-up|2|||
16367053|NCT01481779|39828742|FG000|Overall Study|Protocol Violation|2|||
16367054|NCT01481779|39828743|FG001|Overall Study|Protocol Violation|3|||
16367055|NCT01481779|39828742|FG000|Overall Study|Withdrawal by Subject|26|||
16367056|NCT01481779|39828743|FG001|Overall Study|Withdrawal by Subject|13|||
16367057|NCT01481779|39828742|FG000|Overall Study|Physician Decision|13|||
16367058|NCT01481779|39828743|FG001|Overall Study|Physician Decision|4|||
16367059|NCT01481779|39828742|FG000|Overall Study|Sponsor Decision|3|||
16367060|NCT01481779|39828743|FG001|Overall Study|Sponsor Decision|1|||
16367061|NCT01129128|39828753|FG000|Overall Study|Lost to Follow-up|2|||
16367062|NCT01129128|39828754|FG001|Overall Study|Lost to Follow-up|2|||
16367063|NCT01129128|39828755|FG002|Overall Study|Lost to Follow-up|1|||
16367064|NCT01129128|39828753|FG000|Overall Study|Protocol Violation|0|||
16367065|NCT01129128|39828754|FG001|Overall Study|Protocol Violation|1|||
16367066|NCT01129128|39828755|FG002|Overall Study|Protocol Violation|0|||
16367067|NCT01129128|39828753|FG000|Overall Study|Withdrawal by Subject|0|||
16367068|NCT01129128|39828754|FG001|Overall Study|Withdrawal by Subject|1|||
16444848|NCT02006472|40108502|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
16155995|NCT03311711|39057489|FG006|Overall Study|Death|1|||
16155996|NCT03311711|39057490|FG007|Overall Study|Death|0|||
16155997|NCT03311711|39057491|FG008|Overall Study|Death|1|||
16155998|NCT03311711|39057492|FG009|Overall Study|Death|0|||
16155999|NCT03311711|39057483|FG000|Overall Study|Death of dyad partner|0|||
16156000|NCT03311711|39057484|FG001|Overall Study|Death of dyad partner|1|||
16367069|NCT01129128|39828755|FG002|Overall Study|Withdrawal by Subject|3|||
16367070|NCT01129128|39828753|FG000|Overall Study|Physician Decision|1|||
16367071|NCT01129128|39828754|FG001|Overall Study|Physician Decision|0|||
16367072|NCT01129128|39828755|FG002|Overall Study|Physician Decision|0|||
16367073|NCT04000724|39828758|FG000|Overall Study|Withdrawal by Subject|5|||
16156001|NCT03311711|39057485|FG002|Overall Study|Death of dyad partner|0|||
16156002|NCT03311711|39057486|FG003|Overall Study|Death of dyad partner|0|||
16156003|NCT03311711|39057487|FG004|Overall Study|Death of dyad partner|0|||
16156004|NCT03311711|39057488|FG005|Overall Study|Death of dyad partner|0|||
16156005|NCT03311711|39057489|FG006|Overall Study|Death of dyad partner|0|||
16156006|NCT03311711|39057490|FG007|Overall Study|Death of dyad partner|1|||
16156007|NCT03311711|39057491|FG008|Overall Study|Death of dyad partner|0|||
16156008|NCT03311711|39057492|FG009|Overall Study|Death of dyad partner|1|||
16156009|NCT03311711|39057483|FG000|Overall Study|Lost to Follow-up|2|||
16156010|NCT03311711|39057484|FG001|Overall Study|Lost to Follow-up|2|||
16156011|NCT03311711|39057485|FG002|Overall Study|Lost to Follow-up|0|||
16156012|NCT03311711|39057486|FG003|Overall Study|Lost to Follow-up|0|||
16156013|NCT03311711|39057487|FG004|Overall Study|Lost to Follow-up|0|||
16156014|NCT03311711|39057488|FG005|Overall Study|Lost to Follow-up|0|||
16156015|NCT03311711|39057489|FG006|Overall Study|Lost to Follow-up|1|||
16156016|NCT03311711|39057490|FG007|Overall Study|Lost to Follow-up|1|||
16156017|NCT03311711|39057491|FG008|Overall Study|Lost to Follow-up|0|||
16156018|NCT03311711|39057492|FG009|Overall Study|Lost to Follow-up|0|||
16156019|NCT03311711|39057483|FG000|Overall Study|Withdrawal by Subject|1|||
16156020|NCT03311711|39057484|FG001|Overall Study|Withdrawal by Subject|1|||
16156021|NCT03311711|39057485|FG002|Overall Study|Withdrawal by Subject|0|||
16156022|NCT03311711|39057486|FG003|Overall Study|Withdrawal by Subject|0|||
16156023|NCT03311711|39057487|FG004|Overall Study|Withdrawal by Subject|0|||
16156024|NCT03311711|39057488|FG005|Overall Study|Withdrawal by Subject|0|||
16156025|NCT03311711|39057489|FG006|Overall Study|Withdrawal by Subject|3|||
16156026|NCT03311711|39057490|FG007|Overall Study|Withdrawal by Subject|3|||
16156027|NCT03311711|39057491|FG008|Overall Study|Withdrawal by Subject|0|||
16156028|NCT03311711|39057492|FG009|Overall Study|Withdrawal by Subject|0|||
16156029|NCT00283595|39057494|FG000|Overall Study|Withdrawal by Subject|1|||
16156030|NCT00283595|39057495|FG001|Overall Study|Withdrawal by Subject|2|||
16156031|NCT02290873|39057498|FG000|Overall Study|Withdrawal by Subject|0|||
16156032|NCT02290873|39057499|FG001|Overall Study|Withdrawal by Subject|1|||
16156033|NCT02290873|39057500|FG002|Overall Study|Withdrawal by Subject|1|||
16156034|NCT02290873|39057498|FG000|Overall Study|Nellcor device error|1|||
16156035|NCT02290873|39057499|FG001|Overall Study|Nellcor device error|0|||
16156036|NCT02290873|39057500|FG002|Overall Study|Nellcor device error|0|||
16156037|NCT02290873|39057498|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
16156038|NCT02290873|39057499|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
16156039|NCT02290873|39057500|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
16156040|NCT02290873|39057498|FG000|Overall Study|Protocol Violation|0|||
16156041|NCT02290873|39057499|FG001|Overall Study|Protocol Violation|0|||
16156042|NCT02290873|39057500|FG002|Overall Study|Protocol Violation|1|||
16156043|NCT03728309|39057501|FG000|Overall Study|Randomized but not Treated|0|||
16156044|NCT03728309|39057502|FG001|Overall Study|Randomized but not Treated|1|||
16156045|NCT03728309|39057501|FG000|Overall Study|Adverse Event|0|||
16156046|NCT03728309|39057502|FG001|Overall Study|Adverse Event|1|||
16156047|NCT03728309|39057501|FG000|Overall Study|Withdrawal by Subject|2|||
16156048|NCT03728309|39057502|FG001|Overall Study|Withdrawal by Subject|8|||
16156049|NCT03728309|39057501|FG000|Overall Study|Lost to Follow-up|9|||
16156050|NCT03728309|39057502|FG001|Overall Study|Lost to Follow-up|10|||
16444849|NCT02006472|40108503|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
16444850|NCT02006472|40108504|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
16444851|NCT02006472|40108505|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
16444852|NCT02006472|40108506|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
16444853|NCT02006472|40108502|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
16444854|NCT02006472|40108503|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
16444855|NCT02006472|40108504|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
16444856|NCT02006472|40108505|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
16444857|NCT02006472|40108506|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
16444858|NCT02006472|40108502|FG000|Period 2 (Through Week 52)|Other|0|||
16444859|NCT02006472|40108503|FG001|Period 2 (Through Week 52)|Other|1|||
16444860|NCT02006472|40108504|FG002|Period 2 (Through Week 52)|Other|0|||
16444861|NCT02006472|40108505|FG003|Period 2 (Through Week 52)|Other|1|||
16444862|NCT02006472|40108506|FG004|Period 2 (Through Week 52)|Other|0|||
16156051|NCT03728309|39057501|FG000|Overall Study|Protocol Deviation|0|||
16156052|NCT03728309|39057502|FG001|Overall Study|Protocol Deviation|1|||
16156053|NCT03728309|39057501|FG000|Overall Study|Due to COVID|1|||
16156054|NCT03728309|39057502|FG001|Overall Study|Due to COVID|3|||
16156055|NCT01074190|39057507|FG000|Overall Study|Emergency Cesarean Delivery|1|||
16156056|NCT01074190|39057508|FG001|Overall Study|Emergency Cesarean Delivery|2|||
16156057|NCT01074190|39057509|FG002|Overall Study|Emergency Cesarean Delivery|1|||
16156058|NCT01074190|39057507|FG000|Overall Study|Protocol Violation|2|||
16156059|NCT01074190|39057508|FG001|Overall Study|Protocol Violation|1|||
16156060|NCT01074190|39057509|FG002|Overall Study|Protocol Violation|0|||
16156061|NCT01074190|39057507|FG000|Overall Study|Delivered in under 90 minutes|0|||
16444863|NCT02006472|40108502|FG000|Period 2 (Through Week 52)|Not treated|0|||
16444864|NCT02006472|40108503|FG001|Period 2 (Through Week 52)|Not treated|0|||
16367074|NCT04000724|39828759|FG001|Overall Study|Withdrawal by Subject|3|||
16367075|NCT04000724|39828760|FG002|Overall Study|Withdrawal by Subject|4|||
16367076|NCT04000724|39828758|FG000|Overall Study|Lost to Follow-up|11|||
16367077|NCT04000724|39828759|FG001|Overall Study|Lost to Follow-up|7|||
16367078|NCT04000724|39828760|FG002|Overall Study|Lost to Follow-up|13|||
16367079|NCT03320369|39828761|FG000|Overall Study|Adverse Event|1|||
16367080|NCT03320369|39828761|FG000|Overall Study|Withdrawal by Subject|2|||
16367081|NCT03520387|39828762|FG000|Pre-Randomization|Withdrawal by Subject|1|||
16367082|NCT03520387|39828763|FG001|Pre-Randomization|Withdrawal by Subject|0|||
16367083|NCT03520387|39828764|FG002|Pre-Randomization|Withdrawal by Subject|0|||
16367084|NCT03520387|39828765|FG003|Pre-Randomization|Withdrawal by Subject|0|||
16367085|NCT03520387|39828766|FG004|Pre-Randomization|Withdrawal by Subject|0|||
16367086|NCT03520387|39828762|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
16367087|NCT03520387|39828763|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
16367088|NCT03520387|39828764|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
16367089|NCT03520387|39828765|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
16367090|NCT03520387|39828766|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
16367091|NCT03147287|39828769|FG000|Overall Study|Randomized Not Treated|2|||
16367092|NCT03147287|39828770|FG001|Overall Study|Randomized Not Treated|1|||
16367093|NCT03147287|39828771|FG002|Overall Study|Randomized Not Treated|1|||
16367094|NCT03147287|39828769|FG000|Overall Study|Progressive Disease RECIST|31|||
16367095|NCT03147287|39828770|FG001|Overall Study|Progressive Disease RECIST|72|||
16367096|NCT03147287|39828771|FG002|Overall Study|Progressive Disease RECIST|32|||
16367097|NCT03147287|39828769|FG000|Overall Study|Progressive Disease not RECIST|13|||
16367098|NCT03147287|39828770|FG001|Overall Study|Progressive Disease not RECIST|21|||
16367099|NCT03147287|39828771|FG002|Overall Study|Progressive Disease not RECIST|13|||
16367100|NCT03147287|39828769|FG000|Overall Study|Physician Decision|1|||
16367101|NCT03147287|39828770|FG001|Overall Study|Physician Decision|2|||
16367102|NCT03147287|39828771|FG002|Overall Study|Physician Decision|1|||
16367103|NCT03147287|39828769|FG000|Overall Study|Intercurrent illness|0|||
16367104|NCT03147287|39828770|FG001|Overall Study|Intercurrent illness|1|||
16367105|NCT03147287|39828771|FG002|Overall Study|Intercurrent illness|0|||
16367106|NCT03147287|39828769|FG000|Overall Study|Withdrawal by Subject|2|||
16367107|NCT03147287|39828770|FG001|Overall Study|Withdrawal by Subject|3|||
16367108|NCT03147287|39828771|FG002|Overall Study|Withdrawal by Subject|2|||
16367109|NCT03147287|39828769|FG000|Overall Study|Patient Non-Compliance|0|||
16367110|NCT03147287|39828770|FG001|Overall Study|Patient Non-Compliance|2|||
16367111|NCT03147287|39828771|FG002|Overall Study|Patient Non-Compliance|0|||
16367112|NCT03147287|39828769|FG000|Overall Study|Patient moved|0|||
16367113|NCT03147287|39828770|FG001|Overall Study|Patient moved|1|||
16367114|NCT03147287|39828771|FG002|Overall Study|Patient moved|0|||
16367115|NCT03147287|39828769|FG000|Overall Study|Arm A crossover without PD|1|||
16367116|NCT03147287|39828770|FG001|Overall Study|Arm A crossover without PD|0|||
16367117|NCT03147287|39828771|FG002|Overall Study|Arm A crossover without PD|0|||
16367118|NCT03147287|39828769|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
16367119|NCT03147287|39828770|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
16367120|NCT03147287|39828771|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
16367121|NCT01341470|39828772|FG000|Overall Study|Sponsor decision|0|||
16367122|NCT01341470|39828773|FG001|Overall Study|Sponsor decision|0|||
16367123|NCT01341470|39828774|FG002|Overall Study|Sponsor decision|1|||
16367124|NCT01341470|39828775|FG003|Overall Study|Sponsor decision|1|||
16367125|NCT01341470|39828776|FG004|Overall Study|Sponsor decision|0|||
16367126|NCT01341470|39828777|FG005|Overall Study|Sponsor decision|1|||
16156062|NCT01074190|39057508|FG001|Overall Study|Delivered in under 90 minutes|2|||
16156063|NCT01074190|39057509|FG002|Overall Study|Delivered in under 90 minutes|1|||
16156064|NCT01074190|39057507|FG000|Overall Study|Subject withdrew consent|1|||
16156065|NCT01074190|39057508|FG001|Overall Study|Subject withdrew consent|1|||
16156066|NCT01074190|39057509|FG002|Overall Study|Subject withdrew consent|1|||
16156067|NCT04091087|39057513|FG000|Overall Study|Not treated|1|||
16156068|NCT04091087|39057514|FG001|Overall Study|Not treated|0|||
16156069|NCT04091087|39057513|FG000|Overall Study|Adverse Event|4|||
16156070|NCT04091087|39057514|FG001|Overall Study|Adverse Event|4|||
16156071|NCT04091087|39057513|FG000|Overall Study|Protocol Violation|0|||
16156072|NCT04091087|39057514|FG001|Overall Study|Protocol Violation|1|||
16156073|NCT04091087|39057513|FG000|Overall Study|Withdrawal by Subject|5|||
16156074|NCT04091087|39057514|FG001|Overall Study|Withdrawal by Subject|2|||
16156075|NCT00844753|39057515|FG000|Overall Study|Lack of Efficacy|1|||
16156076|NCT00844753|39057516|FG001|Overall Study|Lack of Efficacy|0|||
16156077|NCT00844753|39057517|FG002|Overall Study|Lack of Efficacy|2|||
16156078|NCT00844753|39057518|FG003|Overall Study|Lack of Efficacy|2|||
16156079|NCT00844753|39057515|FG000|Overall Study|Adverse Event|3|||
16156080|NCT00844753|39057516|FG001|Overall Study|Adverse Event|2|||
16156081|NCT00844753|39057517|FG002|Overall Study|Adverse Event|5|||
16156082|NCT00844753|39057518|FG003|Overall Study|Adverse Event|5|||
16156083|NCT00844753|39057515|FG000|Overall Study|Lost to Follow-up|1|||
16156084|NCT00844753|39057516|FG001|Overall Study|Lost to Follow-up|1|||
16156085|NCT00844753|39057517|FG002|Overall Study|Lost to Follow-up|0|||
16156086|NCT00844753|39057518|FG003|Overall Study|Lost to Follow-up|1|||
16156087|NCT00844753|39057515|FG000|Overall Study|could not swallow medication|2|||
16156088|NCT00844753|39057516|FG001|Overall Study|could not swallow medication|0|||
16156089|NCT00844753|39057517|FG002|Overall Study|could not swallow medication|0|||
16156090|NCT00844753|39057518|FG003|Overall Study|could not swallow medication|0|||
16156091|NCT00844753|39057515|FG000|Overall Study|Withdrawal by Subject|1|||
16156092|NCT00844753|39057516|FG001|Overall Study|Withdrawal by Subject|0|||
16156093|NCT00844753|39057517|FG002|Overall Study|Withdrawal by Subject|0|||
16156094|NCT00844753|39057518|FG003|Overall Study|Withdrawal by Subject|3|||
16156095|NCT03245450|39057519|FG000|Overall Study|Radiological disease progression|3|||
16156096|NCT03245450|39057520|FG001|Overall Study|Radiological disease progression|3|||
16156097|NCT03245450|39057521|FG002|Overall Study|Radiological disease progression|2|||
16156098|NCT03245450|39057522|FG003|Overall Study|Radiological disease progression|2|||
16156099|NCT03245450|39057523|FG004|Overall Study|Radiological disease progression|7|||
16156100|NCT03245450|39057524|FG005|Overall Study|Radiological disease progression|6|||
16156101|NCT03245450|39057525|FG006|Overall Study|Radiological disease progression|6|||
16156102|NCT03245450|39057519|FG000|Overall Study|Clinical disease progression|0|||
16156103|NCT03245450|39057520|FG001|Overall Study|Clinical disease progression|0|||
16156104|NCT03245450|39057521|FG002|Overall Study|Clinical disease progression|1|||
16156105|NCT03245450|39057522|FG003|Overall Study|Clinical disease progression|0|||
16156106|NCT03245450|39057523|FG004|Overall Study|Clinical disease progression|0|||
16156107|NCT03245450|39057524|FG005|Overall Study|Clinical disease progression|2|||
16156108|NCT03245450|39057525|FG006|Overall Study|Clinical disease progression|0|||
16156109|NCT03245450|39057519|FG000|Overall Study|Other|0|||
16156110|NCT03245450|39057520|FG001|Overall Study|Other|0|||
16156111|NCT03245450|39057521|FG002|Overall Study|Other|0|||
16156112|NCT03245450|39057522|FG003|Overall Study|Other|1|||
16156113|NCT03245450|39057523|FG004|Overall Study|Other|1|||
16156114|NCT03245450|39057524|FG005|Overall Study|Other|1|||
16156115|NCT03245450|39057525|FG006|Overall Study|Other|1|||
16156116|NCT03245450|39057519|FG000|Overall Study|Withdrawal by Subject|0|||
16156117|NCT03245450|39057520|FG001|Overall Study|Withdrawal by Subject|1|||
16156118|NCT03245450|39057521|FG002|Overall Study|Withdrawal by Subject|0|||
16156119|NCT03245450|39057522|FG003|Overall Study|Withdrawal by Subject|0|||
16156120|NCT03245450|39057523|FG004|Overall Study|Withdrawal by Subject|0|||
16156121|NCT03245450|39057524|FG005|Overall Study|Withdrawal by Subject|0|||
16156122|NCT03245450|39057525|FG006|Overall Study|Withdrawal by Subject|0|||
16156123|NCT03245450|39057519|FG000|Overall Study|Adverse Event|0|||
16156124|NCT03245450|39057520|FG001|Overall Study|Adverse Event|0|||
16156125|NCT03245450|39057521|FG002|Overall Study|Adverse Event|0|||
16156126|NCT03245450|39057522|FG003|Overall Study|Adverse Event|0|||
16156127|NCT03245450|39057523|FG004|Overall Study|Adverse Event|1|||
16156128|NCT03245450|39057524|FG005|Overall Study|Adverse Event|0|||
16156129|NCT03245450|39057525|FG006|Overall Study|Adverse Event|2|||
16156130|NCT01535729|39057527|FG000|Overall Study|Withdrawal by Subject|2|||
16156131|NCT01535729|39057527|FG000|Overall Study|Disease progression|230|||
16156132|NCT01535729|39057527|FG000|Overall Study|Discontinued treatment|25|||
16156133|NCT01535729|39057527|FG000|Overall Study|Lost to Follow-up|8|||
16156134|NCT01535729|39057527|FG000|Overall Study|Death|52|||
16156135|NCT01535729|39057527|FG000|Overall Study|Other|19|||
16156136|NCT01535729|39057527|FG000|Overall Study|Did not sign informed consent|1|||
16156137|NCT01535729|39057527|FG000|Overall Study|No previous chemotherapy|33|||
16156138|NCT01535729|39057527|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
16156139|NCT01535729|39057527|FG000|Overall Study|Protocol Violation|11|||
16156140|NCT01535729|39057527|FG000|Overall Study|Screening failure|1|||
16156141|NCT01535729|39057527|FG000|Overall Study|Not treated|9|||
16156142|NCT01535729|39057527|FG000|Overall Study|No participant record available|5|||
16156143|NCT01618214|39057528|FG000|Overall Study|Adverse Event|3|||
16156144|NCT01618214|39057529|FG001|Overall Study|Adverse Event|1|||
16156145|NCT01618214|39057528|FG000|Overall Study|Lack of Efficacy|1|||
16156146|NCT01618214|39057529|FG001|Overall Study|Lack of Efficacy|1|||
16156147|NCT01618214|39057528|FG000|Overall Study|Protocol Violation|1|||
16156148|NCT01618214|39057529|FG001|Overall Study|Protocol Violation|4|||
16156149|NCT01618214|39057528|FG000|Overall Study|Withdrawal Criteria|1|||
16156150|NCT01618214|39057529|FG001|Overall Study|Withdrawal Criteria|2|||
16156151|NCT01618214|39057528|FG000|Overall Study|Unclassified|4|||
16156152|NCT01618214|39057529|FG001|Overall Study|Unclassified|5|||
16156153|NCT03595553|39057530|FG000|Overall Study|Withdrawal by Subject|20|||
16156154|NCT03595553|39057531|FG001|Overall Study|Withdrawal by Subject|8|||
16156155|NCT03595553|39057530|FG000|Overall Study|Physician Decision|3|||
16156156|NCT03595553|39057531|FG001|Overall Study|Physician Decision|2|||
16156157|NCT03595553|39057530|FG000|Overall Study|Adverse Event|2|||
16156158|NCT03595553|39057531|FG001|Overall Study|Adverse Event|5|||
16156159|NCT03595553|39057530|FG000|Overall Study|Death|24|||
16156160|NCT03595553|39057531|FG001|Overall Study|Death|22|||
16156161|NCT03595553|39057530|FG000|Overall Study|Lost to Follow-up|6|||
16156162|NCT03595553|39057531|FG001|Overall Study|Lost to Follow-up|7|||
16156163|NCT03595553|39057530|FG000|Overall Study|Other as indicated in CSR|3|||
16156164|NCT03595553|39057531|FG001|Overall Study|Other as indicated in CSR|3|||
16156165|NCT03595553|39057530|FG000|Overall Study|Sponsor Decision|0|||
16156166|NCT03595553|39057531|FG001|Overall Study|Sponsor Decision|1|||
16156167|NCT02788747|39057532|FG000|Overall Study|Adverse Event|1|||
16156168|NCT02788747|39057533|FG001|Overall Study|Adverse Event|0|||
16156169|NCT02788747|39057534|FG002|Overall Study|Adverse Event|0|||
16156170|NCT02425826|39057535|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
16156171|NCT02425826|39057536|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
16156172|NCT02425826|39057537|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
16367127|NCT01363076|39828780|FG000|Overall Study|Withdrawal by Subject|0|||
16367128|NCT01363076|39828781|FG001|Overall Study|Withdrawal by Subject|1|||
16367129|NCT00884949|39828783|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
16367130|NCT00884949|39828783|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
16367131|NCT03767894|39828786|FG000|Overall Study|Withdrawal by Subject|1|||
16367132|NCT02397837|39828787|FG000|Overall Study|Withdrawal by Subject|6|||
16367133|NCT02397837|39828788|FG001|Overall Study|Withdrawal by Subject|5|||
16367134|NCT02397837|39828787|FG000|Overall Study|Physician Decision|1|||
16367135|NCT02397837|39828788|FG001|Overall Study|Physician Decision|1|||
16367136|NCT00927472|39828789|FG000|Overall Study|Withdrawal by Subject|10|||
16367137|NCT00927472|39828790|FG001|Overall Study|Withdrawal by Subject|11|||
16367138|NCT00927472|39828789|FG000|Overall Study|Lost to Follow-up|1|||
16367139|NCT00927472|39828790|FG001|Overall Study|Lost to Follow-up|6|||
16367140|NCT00927472|39828789|FG000|Overall Study|Protocol Violation|0|||
16367141|NCT00927472|39828790|FG001|Overall Study|Protocol Violation|1|||
16367142|NCT00927472|39828789|FG000|Overall Study|Post treatment Assessment out of window|0|||
16367143|NCT00927472|39828790|FG001|Overall Study|Post treatment Assessment out of window|4|||
16367144|NCT01121926|39828791|FG000|First Intervention Period|Adverse Event|1|||
16367145|NCT01121926|39828792|FG001|First Intervention Period|Adverse Event|0|||
16367146|NCT01121926|39828791|FG000|Washout Period|Adverse Event|0|||
16367147|NCT01121926|39828792|FG001|Washout Period|Adverse Event|1|||
16367148|NCT01121926|39828791|FG000|Washout Period|Positive pregnancy test|0|||
16367149|NCT01121926|39828792|FG001|Washout Period|Positive pregnancy test|1|||
16367150|NCT00694161|39828793|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
16367151|NCT00694161|39828793|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
16367152|NCT00694161|39828793|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
16367153|NCT02034591|39828797|FG000|Overall Study|Withdrawal by Subject|0|||
16367154|NCT02034591|39828798|FG001|Overall Study|Withdrawal by Subject|0|||
16367155|NCT02034591|39828799|FG002|Overall Study|Withdrawal by Subject|0|||
16367156|NCT02034591|39828800|FG003|Overall Study|Withdrawal by Subject|0|||
16367157|NCT02034591|39828801|FG004|Overall Study|Withdrawal by Subject|1|||
16367158|NCT02034591|39828802|FG005|Overall Study|Withdrawal by Subject|0|||
16156173|NCT02425826|39057535|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
16156174|NCT02425826|39057536|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
16367159|NCT02932943|39828803|FG000|Overall Study|Lost to Follow-up|0|||
16367160|NCT02932943|39828804|FG001|Overall Study|Lost to Follow-up|2|||
16367161|NCT02932943|39828803|FG000|Overall Study|Adverse Event|2|||
16367162|NCT02932943|39828804|FG001|Overall Study|Adverse Event|2|||
16156175|NCT02425826|39057537|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
16156176|NCT02425826|39057535|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
16156177|NCT02425826|39057536|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
16367163|NCT02932943|39828803|FG000|Overall Study|Withdrawal by Subject|3|||
16156178|NCT02425826|39057537|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
16156179|NCT02425826|39057535|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
16156180|NCT02425826|39057536|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
16156181|NCT02425826|39057537|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
16156182|NCT02425826|39057535|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
16156183|NCT02425826|39057536|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
16156184|NCT02425826|39057537|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
16156185|NCT02425826|39057535|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
16156186|NCT02425826|39057536|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
16156187|NCT02425826|39057537|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
16156188|NCT02425826|39057535|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
16156189|NCT02425826|39057536|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
16156190|NCT02425826|39057537|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
16156191|NCT02425826|39057535|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
16156192|NCT02425826|39057536|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
16156193|NCT02425826|39057537|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
16156194|NCT02425826|39057535|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
16367164|NCT02932943|39828804|FG001|Overall Study|Withdrawal by Subject|3|||
16367165|NCT03325439|39828806|FG000|Overall Study|Ineligibility|3|||
16367166|NCT03655470|39828809|FG000|Overall Study|Lost to Follow-up|6|||
16367167|NCT03655470|39828810|FG001|Overall Study|Lost to Follow-up|7|||
16367168|NCT03501277|39828811|FG000|Intervention Period 1 (4 Days)|Other|0|||
16367169|NCT03501277|39828812|FG001|Intervention Period 1 (4 Days)|Other|0|||
16367170|NCT03501277|39828813|FG002|Intervention Period 1 (4 Days)|Other|1|||
16367171|NCT03501277|39828814|FG003|Intervention Period 1 (4 Days)|Other|0|||
16367172|NCT03501277|39828811|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
16367173|NCT03501277|39828812|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
16367174|NCT03501277|39828813|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
16367175|NCT03501277|39828814|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
16367176|NCT03501277|39828811|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
16367177|NCT03501277|39828812|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
16367178|NCT03501277|39828813|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
16367179|NCT03501277|39828814|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
16367180|NCT03501277|39828811|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
16367181|NCT03501277|39828812|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
16367182|NCT03501277|39828813|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
16367183|NCT03501277|39828814|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
16367184|NCT00286455|39828815|FG000|Overall Study|Hyperglycemia rescue|19|||
16367185|NCT00286455|39828816|FG001|Overall Study|Hyperglycemia rescue|13|||
16367186|NCT00286455|39828817|FG002|Overall Study|Hyperglycemia rescue|10|||
16367187|NCT00286455|39828815|FG000|Overall Study|Adverse Event|1|||
16367188|NCT00286455|39828816|FG001|Overall Study|Adverse Event|3|||
16367189|NCT00286455|39828817|FG002|Overall Study|Adverse Event|2|||
16367190|NCT00286455|39828815|FG000|Overall Study|Lost to Follow-up|0|||
16367191|NCT00286455|39828816|FG001|Overall Study|Lost to Follow-up|3|||
16367192|NCT00286455|39828817|FG002|Overall Study|Lost to Follow-up|3|||
16367193|NCT00286455|39828815|FG000|Overall Study|Physician Decision|3|||
16367194|NCT00286455|39828816|FG001|Overall Study|Physician Decision|0|||
16367195|NCT00286455|39828817|FG002|Overall Study|Physician Decision|2|||
16367196|NCT00286455|39828815|FG000|Overall Study|Protocol Violation|1|||
16367197|NCT00286455|39828816|FG001|Overall Study|Protocol Violation|1|||
16444865|NCT02006472|40108504|FG002|Period 2 (Through Week 52)|Not treated|2|||
16444866|NCT02006472|40108505|FG003|Period 2 (Through Week 52)|Not treated|0|||
16444867|NCT02006472|40108506|FG004|Period 2 (Through Week 52)|Not treated|0|||
16444868|NCT02006472|40108502|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
16444869|NCT02006472|40108503|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
16444870|NCT02006472|40108504|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
16444871|NCT02006472|40108505|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
16444872|NCT02006472|40108506|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
16444873|NCT02006472|40108502|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
16444874|NCT02006472|40108503|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
16444875|NCT02006472|40108504|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
16444876|NCT02006472|40108505|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
16444877|NCT02006472|40108506|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
16444878|NCT00911170|40108507|FG000|Treatment Period|Randomized in error|1|||
16444879|NCT00911170|40108508|FG001|Treatment Period|Randomized in error|1|||
16444880|NCT00911170|40108507|FG000|Treatment Period|Ineligibility determined|1|||
16444881|NCT00911170|40108508|FG001|Treatment Period|Ineligibility determined|3|||
16444882|NCT00911170|40108507|FG000|Treatment Period|Protocol deviation|1|||
16444883|NCT00911170|40108508|FG001|Treatment Period|Protocol deviation|2|||
16444884|NCT00911170|40108507|FG000|Treatment Period|Adverse Event|9|||
16444885|NCT00911170|40108508|FG001|Treatment Period|Adverse Event|10|||
16444886|NCT00911170|40108507|FG000|Treatment Period|Withdrawal by Subject|4|||
16444887|NCT00911170|40108508|FG001|Treatment Period|Withdrawal by Subject|4|||
16444888|NCT00911170|40108507|FG000|Treatment Period|Disease progression|0|||
16444889|NCT00911170|40108508|FG001|Treatment Period|Disease progression|2|||
16444890|NCT00911170|40108507|FG000|Treatment Period|Physician Decision|5|||
16444891|NCT00911170|40108508|FG001|Treatment Period|Physician Decision|5|||
16444892|NCT00911170|40108507|FG000|Treatment Period|Lost to Follow-up|0|||
16444893|NCT00911170|40108508|FG001|Treatment Period|Lost to Follow-up|1|||
16444894|NCT00911170|40108507|FG000|Treatment Period|Death|6|||
16273172|NCT01751087|39484430|FG002|Overall Study|Physician Decision|1|||
16273173|NCT00674128|39484434|FG000|Overall Study|Withdrawal by Subject|25|||
16273174|NCT00674128|39484435|FG001|Overall Study|Withdrawal by Subject|23|||
16273175|NCT01562613|39484436|FG000|Overall Study|Lost to Follow-up|2|||
16273176|NCT01562613|39484436|FG000|Overall Study|Withdrawal by Subject|2|||
16273177|NCT01370863|39484439|FG000|Overall Study|Adverse Event|1|||
16273178|NCT01370863|39484440|FG001|Overall Study|Adverse Event|1|||
16273179|NCT01370863|39484439|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
16273180|NCT01370863|39484440|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
16273181|NCT01370863|39484439|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
16273182|NCT01370863|39484440|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
16273183|NCT00876265|39484445|FG000|Overall Study|Miscellaneous reasons|4|||
16273184|NCT00876265|39484445|FG000|Overall Study|Lost to Follow-up|6|||
16273185|NCT00876265|39484445|FG000|Overall Study|Withdrawal by Subject|2|||
16273186|NCT02359864|39484446|FG000|Overall Study|Withdrawal by Subject|1|||
16273187|NCT02359864|39484447|FG001|Overall Study|Withdrawal by Subject|0|||
16273188|NCT00367133|39484448|FG000|2 Years|Death|20|||
16273189|NCT00367133|39484449|FG001|2 Years|Death|12|||
16273190|NCT00367133|39484450|FG002|2 Years|Death|12|||
16273191|NCT00367133|39484448|FG000|2 Years|Dropped|34|||
16273192|NCT00367133|39484449|FG001|2 Years|Dropped|19|||
16273193|NCT00367133|39484450|FG002|2 Years|Dropped|33|||
16273194|NCT00367133|39484448|FG000|2 Years|Missed visit|4|||
16156195|NCT02425826|39057536|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
16156196|NCT02425826|39057537|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
16156197|NCT02425826|39057535|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
16156198|NCT02425826|39057536|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
16156199|NCT02425826|39057537|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
16156200|NCT03124563|39057539|FG000|Overall Study|Lost to Follow-up|1|||
16156201|NCT03124563|39057540|FG001|Overall Study|Lost to Follow-up|1|||
16156202|NCT03124563|39057539|FG000|Overall Study|Withdrawal by Subject|1|||
16156203|NCT03124563|39057540|FG001|Overall Study|Withdrawal by Subject|1|||
16156204|NCT00884273|39057541|FG000|Overall Study|Adverse Event|0|||
16156205|NCT00884273|39057542|FG001|Overall Study|Adverse Event|2|||
16156206|NCT00884273|39057541|FG000|Overall Study|Protocol Violation|1|||
16156207|NCT00884273|39057542|FG001|Overall Study|Protocol Violation|3|||
16156208|NCT00884273|39057541|FG000|Overall Study|Practical reasons|1|||
16156209|NCT00884273|39057542|FG001|Overall Study|Practical reasons|0|||
16156210|NCT00852995|39057543|FG000|Overall Study|Adverse Event|1|||
16156211|NCT00852995|39057544|FG001|Overall Study|Adverse Event|0|||
16156212|NCT00852995|39057545|FG002|Overall Study|Adverse Event|4|||
16156213|NCT00852995|39057546|FG003|Overall Study|Adverse Event|0|||
16156214|NCT00852995|39057547|FG004|Overall Study|Adverse Event|0|||
16156215|NCT00852995|39057543|FG000|Overall Study|Lost to Follow-up|0|||
16156216|NCT00852995|39057544|FG001|Overall Study|Lost to Follow-up|1|||
16156217|NCT00852995|39057545|FG002|Overall Study|Lost to Follow-up|1|||
16156218|NCT00852995|39057546|FG003|Overall Study|Lost to Follow-up|0|||
16156219|NCT00852995|39057547|FG004|Overall Study|Lost to Follow-up|0|||
16156220|NCT00852995|39057543|FG000|Overall Study|Withdrawal by Subject|4|||
16156221|NCT00852995|39057544|FG001|Overall Study|Withdrawal by Subject|0|||
16156222|NCT00852995|39057545|FG002|Overall Study|Withdrawal by Subject|0|||
16156223|NCT00852995|39057546|FG003|Overall Study|Withdrawal by Subject|1|||
16156224|NCT00852995|39057547|FG004|Overall Study|Withdrawal by Subject|2|||
16156225|NCT00852995|39057543|FG000|Overall Study|Non-Compliance|0|||
16156226|NCT00852995|39057544|FG001|Overall Study|Non-Compliance|0|||
16156227|NCT00852995|39057545|FG002|Overall Study|Non-Compliance|0|||
16156228|NCT00852995|39057546|FG003|Overall Study|Non-Compliance|2|||
16156229|NCT00852995|39057547|FG004|Overall Study|Non-Compliance|0|||
16156230|NCT00852995|39057543|FG000|Overall Study|Progressive Disease|1|||
16156231|NCT00852995|39057544|FG001|Overall Study|Progressive Disease|0|||
16156232|NCT00852995|39057545|FG002|Overall Study|Progressive Disease|0|||
16156233|NCT00852995|39057546|FG003|Overall Study|Progressive Disease|2|||
16156234|NCT00852995|39057547|FG004|Overall Study|Progressive Disease|1|||
16156235|NCT00852995|39057543|FG000|Overall Study|Physician Decision|1|||
16156236|NCT00852995|39057544|FG001|Overall Study|Physician Decision|0|||
16156237|NCT00852995|39057545|FG002|Overall Study|Physician Decision|0|||
16156238|NCT00852995|39057546|FG003|Overall Study|Physician Decision|0|||
16156239|NCT00852995|39057547|FG004|Overall Study|Physician Decision|0|||
16156240|NCT00852995|39057543|FG000|Overall Study|Protocol Violation|0|||
16156241|NCT00852995|39057544|FG001|Overall Study|Protocol Violation|0|||
16156242|NCT00852995|39057545|FG002|Overall Study|Protocol Violation|0|||
16156243|NCT00852995|39057546|FG003|Overall Study|Protocol Violation|0|||
16156244|NCT00852995|39057547|FG004|Overall Study|Protocol Violation|1|||
16156245|NCT00852995|39057543|FG000|Overall Study|Moved Out of Area|1|||
16156246|NCT00852995|39057544|FG001|Overall Study|Moved Out of Area|0|||
16156247|NCT00852995|39057545|FG002|Overall Study|Moved Out of Area|0|||
16156248|NCT00852995|39057546|FG003|Overall Study|Moved Out of Area|0|||
16156249|NCT00852995|39057547|FG004|Overall Study|Moved Out of Area|0|||
16156250|NCT01391507|39057548|FG000|Overall Study|Death|0|||
16156251|NCT01391507|39057549|FG001|Overall Study|Death|0|||
16156252|NCT01391507|39057550|FG002|Overall Study|Death|0|||
16156253|NCT01391507|39057551|FG003|Overall Study|Death|1|||
16156254|NCT01391507|39057548|FG000|Overall Study|Adverse Event|1|||
16156255|NCT01391507|39057549|FG001|Overall Study|Adverse Event|1|||
16156256|NCT01391507|39057550|FG002|Overall Study|Adverse Event|2|||
16156257|NCT01391507|39057551|FG003|Overall Study|Adverse Event|2|||
16156258|NCT01391507|39057548|FG000|Overall Study|Withdrawal by Subject|1|||
16156259|NCT01391507|39057549|FG001|Overall Study|Withdrawal by Subject|2|||
16156260|NCT01391507|39057550|FG002|Overall Study|Withdrawal by Subject|1|||
16156261|NCT01391507|39057551|FG003|Overall Study|Withdrawal by Subject|1|||
16156262|NCT01391507|39057548|FG000|Overall Study|Lack of Efficacy|0|||
16156263|NCT01391507|39057549|FG001|Overall Study|Lack of Efficacy|0|||
16156264|NCT01391507|39057550|FG002|Overall Study|Lack of Efficacy|0|||
16156265|NCT01391507|39057551|FG003|Overall Study|Lack of Efficacy|1|||
16156266|NCT01391507|39057548|FG000|Overall Study|Protocol Violation|2|||
16156267|NCT01391507|39057549|FG001|Overall Study|Protocol Violation|1|||
16156268|NCT01391507|39057550|FG002|Overall Study|Protocol Violation|1|||
16156269|NCT01391507|39057551|FG003|Overall Study|Protocol Violation|2|||
16156270|NCT01464307|39057552|FG000|Main Period|Death|0|||
16156271|NCT01464307|39057553|FG001|Main Period|Death|1|||
16156272|NCT01464307|39057552|FG000|Main Period|Adverse Event|6|||
16156273|NCT01464307|39057553|FG001|Main Period|Adverse Event|1|||
16156274|NCT01464307|39057552|FG000|Main Period|Lack of Efficacy|2|||
16156275|NCT01464307|39057553|FG001|Main Period|Lack of Efficacy|0|||
16156276|NCT01464307|39057552|FG000|Main Period|Withdrawal by Subject|5|||
16156277|NCT01464307|39057553|FG001|Main Period|Withdrawal by Subject|2|||
16156278|NCT01464307|39057552|FG000|Main Period|Predefined discontinuation criteria|2|||
16156279|NCT01464307|39057553|FG001|Main Period|Predefined discontinuation criteria|1|||
16156280|NCT01464307|39057552|FG000|Open-Label Extension Period|Adverse Event|15|||
16156281|NCT01464307|39057553|FG001|Open-Label Extension Period|Adverse Event|0|||
16156282|NCT01464307|39057552|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
16156283|NCT01464307|39057553|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
16156284|NCT01464307|39057552|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
16156285|NCT01464307|39057553|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
16156286|NCT01464307|39057552|FG000|Open-Label Extension Period|Death|1|||
16156287|NCT01464307|39057553|FG001|Open-Label Extension Period|Death|0|||
16156288|NCT01464307|39057552|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
16156289|NCT01464307|39057553|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
16156290|NCT01464307|39057552|FG000|Open-Label Extension Period|Non-compliance|9|||
16156291|NCT01464307|39057553|FG001|Open-Label Extension Period|Non-compliance|0|||
16156292|NCT01464307|39057552|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
16156293|NCT01464307|39057553|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
16156294|NCT00183274|39057554|FG000|Phase 1: Open-Label|Adverse Event|31|||
16156295|NCT00183274|39057555|FG001|Phase 1: Open-Label|Adverse Event|0|||
16156296|NCT00183274|39057556|FG002|Phase 1: Open-Label|Adverse Event|0|||
16156297|NCT00183274|39057557|FG003|Phase 1: Open-Label|Adverse Event|0|||
16156298|NCT00183274|39057558|FG004|Phase 1: Open-Label|Adverse Event|0|||
16156299|NCT00183274|39057559|FG005|Phase 1: Open-Label|Adverse Event|0|||
16156300|NCT00183274|39057554|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
16156301|NCT00183274|39057555|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
16156302|NCT00183274|39057556|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
16156303|NCT00183274|39057557|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
16156304|NCT00183274|39057558|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
16156305|NCT00183274|39057559|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
16156306|NCT00183274|39057554|FG000|Phase 1: Open-Label|Protocol Violation|11|||
16156307|NCT00183274|39057555|FG001|Phase 1: Open-Label|Protocol Violation|0|||
16156308|NCT00183274|39057556|FG002|Phase 1: Open-Label|Protocol Violation|0|||
16156309|NCT00183274|39057557|FG003|Phase 1: Open-Label|Protocol Violation|0|||
16156310|NCT00183274|39057558|FG004|Phase 1: Open-Label|Protocol Violation|0|||
16156311|NCT00183274|39057559|FG005|Phase 1: Open-Label|Protocol Violation|0|||
16156312|NCT00183274|39057554|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
16156313|NCT00183274|39057555|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
16156314|NCT00183274|39057556|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
16156315|NCT00183274|39057557|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
16156316|NCT00183274|39057558|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
16156317|NCT00183274|39057559|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
16156318|NCT00183274|39057554|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
16156319|NCT00183274|39057555|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
16156320|NCT00183274|39057556|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
16156321|NCT00183274|39057557|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
16156322|NCT00183274|39057558|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
16156323|NCT00183274|39057559|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
16156324|NCT00183274|39057554|FG000|Phase 1: Open-Label|Other|9|||
16156325|NCT00183274|39057555|FG001|Phase 1: Open-Label|Other|0|||
16156326|NCT00183274|39057556|FG002|Phase 1: Open-Label|Other|0|||
16156327|NCT00183274|39057557|FG003|Phase 1: Open-Label|Other|0|||
16156328|NCT00183274|39057558|FG004|Phase 1: Open-Label|Other|0|||
16156329|NCT00183274|39057559|FG005|Phase 1: Open-Label|Other|0|||
16156330|NCT00183274|39057554|FG000|Phase 2: Double-Blind|Relapsed|0|||
16156331|NCT00183274|39057555|FG001|Phase 2: Double-Blind|Relapsed|8|||
16156332|NCT00183274|39057556|FG002|Phase 2: Double-Blind|Relapsed|29|||
16156333|NCT00183274|39057557|FG003|Phase 2: Double-Blind|Relapsed|0|||
16156334|NCT00183274|39057558|FG004|Phase 2: Double-Blind|Relapsed|0|||
16156335|NCT00183274|39057559|FG005|Phase 2: Double-Blind|Relapsed|0|||
16156336|NCT00183274|39057554|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
16156337|NCT00183274|39057555|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
16156338|NCT00183274|39057556|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
16156339|NCT00183274|39057557|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
16156340|NCT00183274|39057558|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
16156341|NCT00183274|39057559|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
16156342|NCT00183274|39057554|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
16156343|NCT00183274|39057555|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
16156344|NCT00183274|39057556|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
16156345|NCT00183274|39057557|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
16156346|NCT00183274|39057558|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
16156347|NCT00183274|39057559|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
16156348|NCT00183274|39057554|FG000|Phase 3: Double-Blind|Relapsed|0|||
16156349|NCT00183274|39057555|FG001|Phase 3: Double-Blind|Relapsed|0|||
16156350|NCT00183274|39057556|FG002|Phase 3: Double-Blind|Relapsed|0|||
16156351|NCT00183274|39057557|FG003|Phase 3: Double-Blind|Relapsed|1|||
16156352|NCT00183274|39057558|FG004|Phase 3: Double-Blind|Relapsed|11|||
16156353|NCT00183274|39057559|FG005|Phase 3: Double-Blind|Relapsed|2|||
16156354|NCT03237065|39057564|FG000|Overall Study|Adverse Event|0|||
16156355|NCT03237065|39057565|FG001|Overall Study|Adverse Event|2|||
16156356|NCT03237065|39057564|FG000|Overall Study|Protocol Violation|0|||
16156357|NCT03237065|39057565|FG001|Overall Study|Protocol Violation|1|||
16156358|NCT03237065|39057564|FG000|Overall Study|Withdrawal by Subject|3|||
16156359|NCT03237065|39057565|FG001|Overall Study|Withdrawal by Subject|0|||
16156360|NCT03237065|39057564|FG000|Overall Study|Lost to Follow-up|1|||
16156361|NCT03237065|39057565|FG001|Overall Study|Lost to Follow-up|0|||
16156362|NCT03237065|39057564|FG000|Overall Study|Unable to obtain venous access|0|||
16156363|NCT03237065|39057565|FG001|Overall Study|Unable to obtain venous access|1|||
16156364|NCT03110900|39057566|FG000|Overall Study|Sponsor withdrew|1|||
16156365|NCT03110900|39057567|FG001|Overall Study|Sponsor withdrew|1|||
16156366|NCT01339559|39057568|FG000|Overall Study|Adverse Event|92|||
16156367|NCT01339559|39057568|FG000|Overall Study|Death|5|||
16156368|NCT01339559|39057568|FG000|Overall Study|Lack of Efficacy|164|||
16156369|NCT01339559|39057568|FG000|Overall Study|Lost to Follow-up|22|||
16367198|NCT00286455|39828817|FG002|Overall Study|Protocol Violation|0|||
16367199|NCT00286455|39828815|FG000|Overall Study|Participant Non-compliance|1|||
16367200|NCT00286455|39828816|FG001|Overall Study|Participant Non-compliance|0|||
16367201|NCT00286455|39828817|FG002|Overall Study|Participant Non-compliance|0|||
16367202|NCT00286455|39828815|FG000|Overall Study|Withdrawal by Subject|0|||
16367203|NCT00286455|39828816|FG001|Overall Study|Withdrawal by Subject|8|||
16367204|NCT00286455|39828817|FG002|Overall Study|Withdrawal by Subject|7|||
16367205|NCT01290731|39828818|FG000|Overall Study|Withdrawal by Subject|1|||
16367206|NCT01181128|39828820|FG000|Overall Study|Withdrawal by Subject|2|||
16367207|NCT01181128|39828821|FG001|Overall Study|Withdrawal by Subject|2|||
16367208|NCT01181128|39828822|FG002|Overall Study|Withdrawal by Subject|0|||
16367209|NCT01181128|39828820|FG000|Overall Study|Death|1|||
16156370|NCT01339559|39057568|FG000|Overall Study|Subject choice|89|||
16156371|NCT01339559|39057568|FG000|Overall Study|Protocol Violation|15|||
16156372|NCT01339559|39057568|FG000|Overall Study|Study closure at site|1|||
16156373|NCT01339559|39057568|FG000|Overall Study|Incarcerated|2|||
16156374|NCT01339559|39057568|FG000|Overall Study|Epilepsy surgery|1|||
16156375|NCT01339559|39057568|FG000|Overall Study|Pregnancy planned|2|||
16156376|NCT01339559|39057568|FG000|Overall Study|Left the country|1|||
16367210|NCT01181128|39828821|FG001|Overall Study|Death|0|||
16367211|NCT01181128|39828822|FG002|Overall Study|Death|0|||
16367212|NCT01181128|39828820|FG000|Overall Study|Physician Decision|2|||
16367213|NCT01181128|39828821|FG001|Overall Study|Physician Decision|0|||
16367214|NCT01181128|39828822|FG002|Overall Study|Physician Decision|0|||
16367215|NCT01181128|39828820|FG000|Overall Study|Adverse Event|0|||
16367216|NCT01181128|39828821|FG001|Overall Study|Adverse Event|2|||
16367217|NCT01181128|39828822|FG002|Overall Study|Adverse Event|0|||
16367218|NCT01181128|39828820|FG000|Overall Study|Other|1|||
16367219|NCT01181128|39828821|FG001|Overall Study|Other|1|||
16367220|NCT01181128|39828822|FG002|Overall Study|Other|1|||
16444895|NCT00911170|40108508|FG001|Treatment Period|Death|9|||
16444896|NCT00911170|40108507|FG000|Long Term Follow-Up|Continuing in study|274|||
16444897|NCT00911170|40108508|FG001|Long Term Follow-Up|Continuing in study|269|||
16444898|NCT00911170|40108507|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
16444899|NCT00911170|40108508|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
16444900|NCT00911170|40108507|FG000|Long Term Follow-Up|Physician Decision|5|||
16444901|NCT00911170|40108508|FG001|Long Term Follow-Up|Physician Decision|4|||
16444902|NCT00911170|40108507|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
16444903|NCT00911170|40108508|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
16444904|NCT00911170|40108507|FG000|Long Term Follow-Up|Death|116|||
16444905|NCT00911170|40108508|FG001|Long Term Follow-Up|Death|121|||
16444906|NCT03722238|40108509|FG000|Overall Study|Protocol Violation|1|||
16444907|NCT03722238|40108510|FG001|Overall Study|Protocol Violation|0|||
16444908|NCT03722238|40108509|FG000|Overall Study|Physician Decision|1|||
16444909|NCT03722238|40108510|FG001|Overall Study|Physician Decision|0|||
16444910|NCT03722238|40108509|FG000|Overall Study|Death|1|||
16444911|NCT03722238|40108510|FG001|Overall Study|Death|0|||
16444912|NCT03722238|40108509|FG000|Overall Study|Lost to Follow-up|6|||
16444913|NCT03722238|40108510|FG001|Overall Study|Lost to Follow-up|0|||
16444914|NCT03722238|40108509|FG000|Overall Study|Partial missing data|44|||
16444915|NCT03722238|40108510|FG001|Overall Study|Partial missing data|1|||
16444916|NCT03722238|40108509|FG000|Overall Study|Withdrawal by Subject|2|||
16444917|NCT03722238|40108510|FG001|Overall Study|Withdrawal by Subject|0|||
16444918|NCT03722238|40108509|FG000|Overall Study|Other|4|||
16444919|NCT03722238|40108510|FG001|Overall Study|Other|0|||
16444920|NCT03722238|40108509|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
16444921|NCT03722238|40108510|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
16444922|NCT03722238|40108509|FG000|Overall Study|Did not meet risk classification group criteria|90|||
16444923|NCT03722238|40108510|FG001|Overall Study|Did not meet risk classification group criteria|0|||
16444924|NCT03722238|40108509|FG000|Overall Study|Did not sign consent|17|||
16444925|NCT03722238|40108510|FG001|Overall Study|Did not sign consent|0|||
16444926|NCT03722238|40108509|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
16444927|NCT03722238|40108510|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
16444928|NCT03722238|40108509|FG000|Overall Study|Not willing to purchase study medication|142|||
16444929|NCT03722238|40108510|FG001|Overall Study|Not willing to purchase study medication|0|||
16444930|NCT03722238|40108509|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
16444931|NCT03722238|40108510|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
16444932|NCT00992108|40108513|FG000|Overall Study|Lost to Follow-up|0|||
16444933|NCT00992108|40108514|FG001|Overall Study|Lost to Follow-up|1|||
16444934|NCT01499355|40108518|FG000|Run-In Period|Study Termination|15|||
16444935|NCT01499355|40108519|FG001|Run-In Period|Study Termination|0|||
16444936|NCT01499355|40108520|FG002|Run-In Period|Study Termination|0|||
16444937|NCT01499355|40108521|FG003|Run-In Period|Study Termination|0|||
16444938|NCT01499355|40108518|FG000|Run-In Period|Other|3|||
16444939|NCT01499355|40108519|FG001|Run-In Period|Other|0|||
16444940|NCT01499355|40108520|FG002|Run-In Period|Other|0|||
16444941|NCT01499355|40108521|FG003|Run-In Period|Other|0|||
16444942|NCT01499355|40108518|FG000|Run-In Period|Death|2|||
16444943|NCT01499355|40108519|FG001|Run-In Period|Death|0|||
16444944|NCT01499355|40108520|FG002|Run-In Period|Death|0|||
16444945|NCT01499355|40108521|FG003|Run-In Period|Death|0|||
16444946|NCT01499355|40108518|FG000|Run-In Period|Investigator Decision|2|||
16444947|NCT01499355|40108519|FG001|Run-In Period|Investigator Decision|0|||
16367221|NCT04380753|39828823|FG000|Overall Study|Participants continuing study|4|||
16367222|NCT04380753|39828823|FG000|Overall Study|Death|2|||
16367223|NCT00186888|39828824|FG000|Overall Study|Toxicity|0|||
16444948|NCT01499355|40108520|FG002|Run-In Period|Investigator Decision|0|||
16444949|NCT01499355|40108521|FG003|Run-In Period|Investigator Decision|0|||
16444950|NCT01499355|40108518|FG000|Run-In Period|Consent Withdrawn|1|||
16444951|NCT01499355|40108519|FG001|Run-In Period|Consent Withdrawn|0|||
16444952|NCT01499355|40108520|FG002|Run-In Period|Consent Withdrawn|0|||
16444953|NCT01499355|40108521|FG003|Run-In Period|Consent Withdrawn|0|||
16444954|NCT01499355|40108518|FG000|Run-In Period|Adverse Event|8|||
16444955|NCT01499355|40108519|FG001|Run-In Period|Adverse Event|0|||
16444956|NCT01499355|40108520|FG002|Run-In Period|Adverse Event|0|||
16444957|NCT01499355|40108521|FG003|Run-In Period|Adverse Event|0|||
16444958|NCT01499355|40108518|FG000|Double-Blind Period|Adverse Event|0|||
16367224|NCT00186888|39828825|FG001|Overall Study|Toxicity|1|||
16444959|NCT01499355|40108519|FG001|Double-Blind Period|Adverse Event|2|||
16444960|NCT01499355|40108520|FG002|Double-Blind Period|Adverse Event|3|||
16444961|NCT01499355|40108521|FG003|Double-Blind Period|Adverse Event|2|||
16444962|NCT01499355|40108518|FG000|Double-Blind Period|Study Termination|0|||
16444963|NCT01499355|40108519|FG001|Double-Blind Period|Study Termination|18|||
16367225|NCT00186888|39828826|FG002|Overall Study|Toxicity|0|||
16367226|NCT00186888|39828824|FG000|Overall Study|Relapse or progression of disease|4|||
16367227|NCT00186888|39828825|FG001|Overall Study|Relapse or progression of disease|2|||
16367228|NCT00186888|39828826|FG002|Overall Study|Relapse or progression of disease|0|||
16367229|NCT03723070|39828827|FG000|Overall Study|Lost to Follow-up|2|||
16367230|NCT03723070|39828827|FG000|Overall Study|Physician Decision|1|||
16367231|NCT03723070|39828827|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
16367232|NCT04401293|39828831|FG000|Overall Study|Withdrawal by Subject|1|||
16367233|NCT04401293|39828832|FG001|Overall Study|Withdrawal by Subject|3|||
16367234|NCT01001104|39828833|FG000|Overall Study|Adverse Event|2|||
16367235|NCT01001104|39828834|FG001|Overall Study|Adverse Event|1|||
16444964|NCT01499355|40108520|FG002|Double-Blind Period|Study Termination|16|||
16156377|NCT01339559|39057568|FG000|Overall Study|Investigator decision|2|||
16156378|NCT01339559|39057568|FG000|Overall Study|Patient didn't wish to continue|1|||
16156379|NCT01339559|39057568|FG000|Overall Study|PI decision|1|||
16156380|NCT02500121|39057569|FG000|Overall Study|Lost to Follow-up|0|||
16156381|NCT02500121|39057570|FG001|Overall Study|Lost to Follow-up|1|||
16156382|NCT02500121|39057569|FG000|Overall Study|Withdrawal by Subject|1|||
16156383|NCT02500121|39057570|FG001|Overall Study|Withdrawal by Subject|1|||
16156384|NCT02500121|39057569|FG000|Overall Study|Death|26|||
16156385|NCT02500121|39057570|FG001|Overall Study|Death|24|||
16156386|NCT04417894|39057571|FG000|Overall Study|Lost to Follow-up|3|||
16156387|NCT04417894|39057572|FG001|Overall Study|Lost to Follow-up|0|||
16156388|NCT04417894|39057571|FG000|Overall Study|Withdrawal by Subject|7|||
16156389|NCT04417894|39057572|FG001|Overall Study|Withdrawal by Subject|6|||
16156390|NCT04417894|39057571|FG000|Overall Study|Lack of Efficacy|3|||
16156391|NCT04417894|39057572|FG001|Overall Study|Lack of Efficacy|1|||
16156392|NCT02669017|39057575|FG000|Overall Study|Death|1|||
16156393|NCT02669017|39057576|FG001|Overall Study|Death|2|||
16156394|NCT02669017|39057577|FG002|Overall Study|Death|2|||
16156395|NCT02669017|39057578|FG003|Overall Study|Death|3|||
16156396|NCT02669017|39057579|FG004|Overall Study|Death|8|||
16156397|NCT02669017|39057580|FG005|Overall Study|Death|18|||
16156398|NCT02669017|39057581|FG006|Overall Study|Death|10|||
16156399|NCT02669017|39057582|FG007|Overall Study|Death|47|||
16156400|NCT02669017|39057583|FG008|Overall Study|Death|20|||
16156401|NCT02669017|39057575|FG000|Overall Study|Withdrawal by Subject|0|||
16156402|NCT02669017|39057576|FG001|Overall Study|Withdrawal by Subject|0|||
16156403|NCT02669017|39057577|FG002|Overall Study|Withdrawal by Subject|0|||
16156404|NCT02669017|39057578|FG003|Overall Study|Withdrawal by Subject|1|||
16156405|NCT02669017|39057579|FG004|Overall Study|Withdrawal by Subject|2|||
16156406|NCT02669017|39057580|FG005|Overall Study|Withdrawal by Subject|0|||
16156407|NCT02669017|39057581|FG006|Overall Study|Withdrawal by Subject|0|||
16156408|NCT02669017|39057582|FG007|Overall Study|Withdrawal by Subject|2|||
16156409|NCT02669017|39057583|FG008|Overall Study|Withdrawal by Subject|2|||
16156410|NCT02669017|39057575|FG000|Overall Study|Lost to Follow-up|0|||
16156411|NCT02669017|39057576|FG001|Overall Study|Lost to Follow-up|0|||
16156412|NCT02669017|39057577|FG002|Overall Study|Lost to Follow-up|0|||
16156413|NCT02669017|39057578|FG003|Overall Study|Lost to Follow-up|0|||
16156414|NCT02669017|39057579|FG004|Overall Study|Lost to Follow-up|0|||
16156415|NCT02669017|39057580|FG005|Overall Study|Lost to Follow-up|0|||
16444965|NCT01499355|40108521|FG003|Double-Blind Period|Study Termination|14|||
16444966|NCT01499355|40108518|FG000|Double-Blind Period|Other|0|||
16444967|NCT01499355|40108519|FG001|Double-Blind Period|Other|1|||
16444968|NCT01499355|40108520|FG002|Double-Blind Period|Other|2|||
16444969|NCT01499355|40108521|FG003|Double-Blind Period|Other|2|||
16444970|NCT01499355|40108518|FG000|Double-Blind Period|Death|0|||
16444971|NCT01499355|40108519|FG001|Double-Blind Period|Death|1|||
16156416|NCT02669017|39057581|FG006|Overall Study|Lost to Follow-up|0|||
16156417|NCT02669017|39057582|FG007|Overall Study|Lost to Follow-up|0|||
16156418|NCT02669017|39057583|FG008|Overall Study|Lost to Follow-up|1|||
16156419|NCT02669017|39057575|FG000|Overall Study|Miscellaneous|0|||
16156420|NCT02669017|39057576|FG001|Overall Study|Miscellaneous|0|||
16156421|NCT02669017|39057577|FG002|Overall Study|Miscellaneous|0|||
16156422|NCT02669017|39057578|FG003|Overall Study|Miscellaneous|0|||
16156423|NCT02669017|39057579|FG004|Overall Study|Miscellaneous|2|||
16367236|NCT01001104|39828835|FG002|Overall Study|Adverse Event|0|||
16367237|NCT01001104|39828836|FG003|Overall Study|Adverse Event|0|||
16367238|NCT01001104|39828833|FG000|Overall Study|Lost to Follow-up|0|||
16444972|NCT01499355|40108520|FG002|Double-Blind Period|Death|0|||
16444973|NCT01499355|40108521|FG003|Double-Blind Period|Death|0|||
16444974|NCT01499355|40108518|FG000|Double-Blind Period|Investigator Decision|0|||
16156424|NCT02669017|39057580|FG005|Overall Study|Miscellaneous|1|||
16156425|NCT02669017|39057581|FG006|Overall Study|Miscellaneous|1|||
16156426|NCT02669017|39057582|FG007|Overall Study|Miscellaneous|13|||
16156427|NCT02669017|39057583|FG008|Overall Study|Miscellaneous|2|||
16156428|NCT01902290|39057584|FG000|Overall Study|Withdrawal by Subject|19|||
16156429|NCT01902290|39057585|FG001|Overall Study|Withdrawal by Subject|27|||
16156430|NCT01902290|39057584|FG000|Overall Study|Lost to Follow-up|2|||
16156431|NCT01902290|39057585|FG001|Overall Study|Lost to Follow-up|2|||
16156432|NCT01902290|39057584|FG000|Overall Study|Death|1|||
16156433|NCT01902290|39057585|FG001|Overall Study|Death|0|||
16156434|NCT01902290|39057584|FG000|Overall Study|Sponsor Decision|26|||
16156435|NCT01902290|39057585|FG001|Overall Study|Sponsor Decision|24|||
16156436|NCT00817531|39057586|FG000|Overall Study|Adverse Event|1|||
16156437|NCT00817531|39057586|FG000|Overall Study|Lack of Efficacy|1|||
16156438|NCT02175680|39057587|FG000|Overall Study|non-compliance|1|||
16156439|NCT02175680|39057587|FG000|Overall Study|other non-medical reason|1|||
16156440|NCT00513500|39057588|FG000|Overall Study|Lost to Follow-up|35|||
16156441|NCT00513500|39057589|FG001|Overall Study|Lost to Follow-up|39|||
16156442|NCT00513500|39057588|FG000|Overall Study|Death|2|||
16156443|NCT00513500|39057589|FG001|Overall Study|Death|1|||
16156444|NCT00513500|39057588|FG000|Overall Study|Hospitalized|4|||
16156445|NCT00513500|39057589|FG001|Overall Study|Hospitalized|14|||
16156446|NCT00866307|39057592|FG000|Induction|Adverse Event|5|||
16156447|NCT00866307|39057593|FG001|Induction|Adverse Event|0|||
16156448|NCT00866307|39057594|FG002|Induction|Adverse Event|0|||
16156449|NCT00866307|39057592|FG000|Induction|Death|2|||
16156450|NCT00866307|39057593|FG001|Induction|Death|0|||
16156451|NCT00866307|39057594|FG002|Induction|Death|0|||
16156452|NCT00866307|39057592|FG000|Induction|Physician Decision|5|||
16156453|NCT00866307|39057593|FG001|Induction|Physician Decision|0|||
16156454|NCT00866307|39057594|FG002|Induction|Physician Decision|0|||
16156455|NCT00866307|39057592|FG000|Induction|Progressive Disease|1|||
16156456|NCT00866307|39057593|FG001|Induction|Progressive Disease|0|||
16156457|NCT00866307|39057594|FG002|Induction|Progressive Disease|0|||
16156458|NCT00866307|39057592|FG000|Induction|Identification of Patients with Day 29 M|3|||
16156459|NCT00866307|39057593|FG001|Induction|Identification of Patients with Day 29 M|0|||
16156460|NCT00866307|39057594|FG002|Induction|Identification of Patients with Day 29 M|0|||
16156461|NCT00866307|39057592|FG000|Induction|Inadequate cytognetic samples th|1|||
16156462|NCT00866307|39057593|FG001|Induction|Inadequate cytognetic samples th|0|||
16156463|NCT00866307|39057594|FG002|Induction|Inadequate cytognetic samples th|0|||
16156464|NCT00866307|39057592|FG000|Induction|Improper post-induction consent|2|||
16156465|NCT00866307|39057593|FG001|Induction|Improper post-induction consent|0|||
16156466|NCT00866307|39057594|FG002|Induction|Improper post-induction consent|0|||
16156467|NCT00866307|39057592|FG000|Induction|Study was closed at the time|1|||
16156468|NCT00866307|39057593|FG001|Induction|Study was closed at the time|0|||
16156469|NCT00866307|39057594|FG002|Induction|Study was closed at the time|0|||
16156470|NCT00866307|39057592|FG000|Consolidation/Maintenance|Adverse Event|0|||
16156471|NCT00866307|39057593|FG001|Consolidation/Maintenance|Adverse Event|0|||
16156472|NCT00866307|39057594|FG002|Consolidation/Maintenance|Adverse Event|8|||
16156473|NCT00866307|39057592|FG000|Consolidation/Maintenance|Death|0|||
16156474|NCT00866307|39057593|FG001|Consolidation/Maintenance|Death|0|||
16156475|NCT00866307|39057594|FG002|Consolidation/Maintenance|Death|1|||
16156476|NCT00866307|39057592|FG000|Consolidation/Maintenance|Physician Decision|0|||
16156477|NCT00866307|39057593|FG001|Consolidation/Maintenance|Physician Decision|3|||
16156478|NCT00866307|39057594|FG002|Consolidation/Maintenance|Physician Decision|2|||
16156479|NCT00866307|39057592|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
16156480|NCT00866307|39057593|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
16156481|NCT00866307|39057594|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
16156482|NCT00866307|39057592|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
16156483|NCT00866307|39057593|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
16156484|NCT00866307|39057594|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
16156485|NCT00866307|39057592|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
16156486|NCT00866307|39057593|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
16156487|NCT00866307|39057594|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
16156488|NCT00866307|39057592|FG000|Consolidation/Maintenance|Therapy error|0|||
16156489|NCT00866307|39057593|FG001|Consolidation/Maintenance|Therapy error|1|||
16156490|NCT00866307|39057594|FG002|Consolidation/Maintenance|Therapy error|0|||
16156491|NCT00866307|39057592|FG000|Consolidation/Maintenance|Non-compliance|0|||
16156492|NCT00866307|39057593|FG001|Consolidation/Maintenance|Non-compliance|0|||
16156493|NCT00866307|39057594|FG002|Consolidation/Maintenance|Non-compliance|1|||
16156494|NCT00866307|39057592|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
16156495|NCT00866307|39057593|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
16156496|NCT00866307|39057594|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
16156497|NCT00053417|39057597|FG000|Overall Study|Adverse Event|1|||
16156498|NCT00053417|39057598|FG001|Overall Study|Adverse Event|0|||
16156499|NCT00053417|39057599|FG002|Overall Study|Adverse Event|1|||
16156500|NCT00053417|39057600|FG003|Overall Study|Adverse Event|5|||
16156501|NCT00053417|39057597|FG000|Overall Study|Non-Compliance|0|||
16156502|NCT00053417|39057598|FG001|Overall Study|Non-Compliance|0|||
16156503|NCT00053417|39057599|FG002|Overall Study|Non-Compliance|0|||
16444975|NCT01499355|40108519|FG001|Double-Blind Period|Investigator Decision|0|||
16156504|NCT00053417|39057600|FG003|Overall Study|Non-Compliance|1|||
16156505|NCT00053417|39057597|FG000|Overall Study|Withdrawal by Subject|0|||
16156506|NCT00053417|39057598|FG001|Overall Study|Withdrawal by Subject|1|||
16156507|NCT00053417|39057599|FG002|Overall Study|Withdrawal by Subject|0|||
16156508|NCT00053417|39057600|FG003|Overall Study|Withdrawal by Subject|0|||
16156509|NCT00053417|39057597|FG000|Overall Study|Lost to Follow-up|1|||
16156510|NCT00053417|39057598|FG001|Overall Study|Lost to Follow-up|1|||
16156511|NCT00053417|39057599|FG002|Overall Study|Lost to Follow-up|0|||
16156512|NCT00053417|39057600|FG003|Overall Study|Lost to Follow-up|0|||
16156513|NCT01425203|39057602|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
16156514|NCT01425203|39057603|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
16156515|NCT01425203|39057604|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
16156516|NCT01425203|39057602|FG000|Treatment Phase|Failure at futility timepoint|8|||
16156517|NCT01425203|39057603|FG001|Treatment Phase|Failure at futility timepoint|27|||
16156518|NCT01425203|39057604|FG002|Treatment Phase|Failure at futility timepoint|0|||
16156519|NCT01425203|39057602|FG000|Treatment Phase|Other virologic failure criteria|5|||
16367239|NCT01001104|39828834|FG001|Overall Study|Lost to Follow-up|0|||
16367240|NCT01001104|39828835|FG002|Overall Study|Lost to Follow-up|1|||
16367241|NCT01001104|39828836|FG003|Overall Study|Lost to Follow-up|0|||
16367242|NCT01001104|39828833|FG000|Overall Study|Entry Criteria Not Met|0|||
16367243|NCT01001104|39828834|FG001|Overall Study|Entry Criteria Not Met|0|||
16367244|NCT01001104|39828835|FG002|Overall Study|Entry Criteria Not Met|0|||
16367245|NCT01001104|39828836|FG003|Overall Study|Entry Criteria Not Met|1|||
16367246|NCT01001104|39828833|FG000|Overall Study|Withdrawal by Subject|0|||
16367247|NCT01001104|39828834|FG001|Overall Study|Withdrawal by Subject|0|||
16367248|NCT01001104|39828835|FG002|Overall Study|Withdrawal by Subject|0|||
16367249|NCT01001104|39828836|FG003|Overall Study|Withdrawal by Subject|2|||
16367250|NCT00726557|39828839|FG000|Overall Study|Screening failure|4|||
16367251|NCT00726557|39828839|FG000|Overall Study|No end of treatment documentation|37|||
16367252|NCT00726557|39828839|FG000|Overall Study|No follow-up documentation available|55|||
16367253|NCT00726557|39828839|FG000|Overall Study|Treatment less than 3 months|17|||
16367254|NCT00726557|39828839|FG000|Overall Study|Inclusion criteria not met|15|||
16367255|NCT01107457|39828843|FG000|Part A|Adverse Event|1|||
16367256|NCT01107457|39828844|FG001|Part A|Adverse Event|2|||
16367257|NCT01107457|39828845|FG002|Part A|Adverse Event|1|||
16367258|NCT01107457|39828846|FG003|Part A|Adverse Event|0|||
16367259|NCT01107457|39828847|FG004|Part A|Adverse Event|0|||
16367260|NCT01107457|39828848|FG005|Part A|Adverse Event|0|||
16367261|NCT01107457|39828843|FG000|Part A|Withdrawal by Subject|3|||
16367262|NCT01107457|39828844|FG001|Part A|Withdrawal by Subject|3|||
16367263|NCT01107457|39828845|FG002|Part A|Withdrawal by Subject|0|||
16367264|NCT01107457|39828846|FG003|Part A|Withdrawal by Subject|3|||
16367265|NCT01107457|39828847|FG004|Part A|Withdrawal by Subject|1|||
16367266|NCT01107457|39828848|FG005|Part A|Withdrawal by Subject|0|||
16367267|NCT01107457|39828843|FG000|Part A|Lost to Follow-up|0|||
16367268|NCT01107457|39828844|FG001|Part A|Lost to Follow-up|1|||
16367269|NCT01107457|39828845|FG002|Part A|Lost to Follow-up|0|||
16367270|NCT01107457|39828846|FG003|Part A|Lost to Follow-up|0|||
16367271|NCT01107457|39828847|FG004|Part A|Lost to Follow-up|0|||
16367272|NCT01107457|39828848|FG005|Part A|Lost to Follow-up|0|||
16367273|NCT01107457|39828843|FG000|Part A|Lack of Efficacy|1|||
16367274|NCT01107457|39828844|FG001|Part A|Lack of Efficacy|0|||
16156520|NCT01425203|39057603|FG001|Treatment Phase|Other virologic failure criteria|3|||
16156521|NCT01425203|39057604|FG002|Treatment Phase|Other virologic failure criteria|0|||
16156522|NCT01425203|39057602|FG000|Treatment Phase|Unidentified reasons|11|||
16156523|NCT01425203|39057603|FG001|Treatment Phase|Unidentified reasons|5|||
16367275|NCT01107457|39828845|FG002|Part A|Lack of Efficacy|0|||
16156524|NCT01425203|39057604|FG002|Treatment Phase|Unidentified reasons|0|||
16156525|NCT01425203|39057602|FG000|Treatment Phase|Did not receive treatment|0|||
16156526|NCT01425203|39057603|FG001|Treatment Phase|Did not receive treatment|1|||
16156527|NCT01425203|39057604|FG002|Treatment Phase|Did not receive treatment|0|||
16156528|NCT01425203|39057602|FG000|Crossover Phase|Failure at futility timepoint|0|||
16156529|NCT01425203|39057603|FG001|Crossover Phase|Failure at futility timepoint|0|||
16156530|NCT01425203|39057604|FG002|Crossover Phase|Failure at futility timepoint|3|||
16156531|NCT01425203|39057602|FG000|Crossover Phase|Other virologic failure criteria|0|||
16367276|NCT01107457|39828846|FG003|Part A|Lack of Efficacy|0|||
16156532|NCT01425203|39057603|FG001|Crossover Phase|Other virologic failure criteria|0|||
16156533|NCT01425203|39057604|FG002|Crossover Phase|Other virologic failure criteria|3|||
16156534|NCT01934556|39057605|FG000|Overall Study|Withdrawal by Subject|0|||
16156535|NCT01934556|39057606|FG001|Overall Study|Withdrawal by Subject|1|||
16367277|NCT01107457|39828847|FG004|Part A|Lack of Efficacy|0|||
16367278|NCT01107457|39828848|FG005|Part A|Lack of Efficacy|0|||
16367279|NCT01107457|39828843|FG000|Part A|Protocol Violation|0|||
16367280|NCT01107457|39828844|FG001|Part A|Protocol Violation|1|||
16367281|NCT01107457|39828845|FG002|Part A|Protocol Violation|0|||
16367282|NCT01107457|39828846|FG003|Part A|Protocol Violation|0|||
16367283|NCT01107457|39828847|FG004|Part A|Protocol Violation|0|||
16367284|NCT01107457|39828848|FG005|Part A|Protocol Violation|0|||
16156536|NCT01934556|39057607|FG002|Overall Study|Withdrawal by Subject|1|||
16156537|NCT01934556|39057605|FG000|Overall Study|Lost to Follow-up|4|||
16156538|NCT01934556|39057606|FG001|Overall Study|Lost to Follow-up|10|||
16156539|NCT01934556|39057607|FG002|Overall Study|Lost to Follow-up|7|||
16156540|NCT01934556|39057605|FG000|Overall Study|Death|1|||
16156541|NCT01934556|39057606|FG001|Overall Study|Death|5|||
16156542|NCT01934556|39057607|FG002|Overall Study|Death|2|||
16367285|NCT01107457|39828843|FG000|Part B and C|Adverse Event|0|||
16367286|NCT01107457|39828844|FG001|Part B and C|Adverse Event|0|||
16367287|NCT01107457|39828845|FG002|Part B and C|Adverse Event|0|||
16367288|NCT01107457|39828846|FG003|Part B and C|Adverse Event|0|||
16367289|NCT01107457|39828847|FG004|Part B and C|Adverse Event|0|||
16156543|NCT03988907|39057611|FG000|Overall Study|Unable to complete visit|0|||
16156544|NCT03988907|39057612|FG001|Overall Study|Unable to complete visit|1|||
16156545|NCT00049673|39057613|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
16156546|NCT00049673|39057614|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
16156547|NCT01700192|39057615|FG000|Overall Study|Adverse Event|73|||
16156548|NCT01700192|39057616|FG001|Overall Study|Adverse Event|18|||
16156549|NCT01700192|39057615|FG000|Overall Study|Lack of Efficacy|1|||
16156550|NCT01700192|39057616|FG001|Overall Study|Lack of Efficacy|0|||
16156551|NCT01700192|39057615|FG000|Overall Study|Lost to Follow-up|42|||
16156552|NCT01700192|39057616|FG001|Overall Study|Lost to Follow-up|29|||
16156553|NCT01700192|39057615|FG000|Overall Study|Noncompliance with study drug|0|||
16156554|NCT01700192|39057616|FG001|Overall Study|Noncompliance with study drug|5|||
16156555|NCT01700192|39057615|FG000|Overall Study|Physician Decision|2|||
16156556|NCT01700192|39057616|FG001|Overall Study|Physician Decision|3|||
16156557|NCT01700192|39057615|FG000|Overall Study|Pregnancy|1|||
16156558|NCT01700192|39057616|FG001|Overall Study|Pregnancy|4|||
16156559|NCT01700192|39057615|FG000|Overall Study|Progressive disease|1|||
16156560|NCT01700192|39057616|FG001|Overall Study|Progressive disease|0|||
16156561|NCT01700192|39057615|FG000|Overall Study|Protocol Violation|3|||
16156562|NCT01700192|39057616|FG001|Overall Study|Protocol Violation|4|||
16156563|NCT01700192|39057615|FG000|Overall Study|Technical problems|0|||
16156564|NCT01700192|39057616|FG001|Overall Study|Technical problems|1|||
16156565|NCT01700192|39057615|FG000|Overall Study|Withdrawal by Subject|56|||
16156566|NCT01700192|39057616|FG001|Overall Study|Withdrawal by Subject|64|||
16156567|NCT01700192|39057615|FG000|Overall Study|Never received study drug|1|||
16156568|NCT01700192|39057616|FG001|Overall Study|Never received study drug|0|||
16156569|NCT01414257|39057617|FG000|Overall Study|No Visit After First Day of Treatment|12|||
16156570|NCT01414257|39057617|FG000|Overall Study|Protocol Violation|10|||
16156571|NCT01692301|39057618|FG000|Overall Study|Adverse Event|15|||
16156572|NCT01692301|39057619|FG001|Overall Study|Adverse Event|12|||
16156573|NCT01692301|39057618|FG000|Overall Study|Death|1|||
16156574|NCT01692301|39057619|FG001|Overall Study|Death|2|||
16156575|NCT01692301|39057618|FG000|Overall Study|Lack of Efficacy|0|||
16156576|NCT01692301|39057619|FG001|Overall Study|Lack of Efficacy|5|||
16156577|NCT01692301|39057618|FG000|Overall Study|Non-compliance with study treatment|1|||
16156578|NCT01692301|39057619|FG001|Overall Study|Non-compliance with study treatment|2|||
16156579|NCT01692301|39057618|FG000|Overall Study|Protocol deviation|9|||
16156580|NCT01692301|39057619|FG001|Overall Study|Protocol deviation|2|||
16156581|NCT01692301|39057618|FG000|Overall Study|Patient/guardian decision|16|||
16156582|NCT01692301|39057619|FG001|Overall Study|Patient/guardian decision|15|||
16156583|NCT01692301|39057618|FG000|Overall Study|Technical problems|0|||
16156584|NCT01692301|39057619|FG001|Overall Study|Technical problems|1|||
16156585|NCT01692301|39057618|FG000|Overall Study|Physician Decision|2|||
16156586|NCT01692301|39057619|FG001|Overall Study|Physician Decision|2|||
16156587|NCT01692301|39057618|FG000|Overall Study|Lost to Follow-up|1|||
16156588|NCT01692301|39057619|FG001|Overall Study|Lost to Follow-up|1|||
16156589|NCT01133171|39057620|FG000|Overall Study|Withdrawal by Subject|1|||
16367290|NCT01107457|39828848|FG005|Part B and C|Adverse Event|12|||
16367291|NCT01107457|39828843|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
16156590|NCT01133171|39057621|FG001|Overall Study|Withdrawal by Subject|2|||
16156591|NCT01133171|39057622|FG002|Overall Study|Withdrawal by Subject|0|||
16156592|NCT01659320|39057623|FG000|Overall Study|Withdrawal by Subject|2|||
16156593|NCT01659320|39057623|FG000|Overall Study|Physician Decision|1|||
16156594|NCT02699892|39057628|FG000|Overall Study|Other|36|||
16367292|NCT01107457|39828844|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
16367293|NCT01107457|39828845|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
16367294|NCT01107457|39828846|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
16367295|NCT01107457|39828847|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
16367296|NCT01107457|39828848|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
16367297|NCT01107457|39828843|FG000|Part B and C|Physician Decision|0|||
16367298|NCT01107457|39828844|FG001|Part B and C|Physician Decision|0|||
16367299|NCT01107457|39828845|FG002|Part B and C|Physician Decision|0|||
16367300|NCT01107457|39828846|FG003|Part B and C|Physician Decision|0|||
16367301|NCT01107457|39828847|FG004|Part B and C|Physician Decision|0|||
16367302|NCT01107457|39828848|FG005|Part B and C|Physician Decision|3|||
16367303|NCT01107457|39828843|FG000|Part B and C|Lack of Efficacy|0|||
16367304|NCT01107457|39828844|FG001|Part B and C|Lack of Efficacy|0|||
16367305|NCT01107457|39828845|FG002|Part B and C|Lack of Efficacy|0|||
16367306|NCT01107457|39828846|FG003|Part B and C|Lack of Efficacy|0|||
16367307|NCT01107457|39828847|FG004|Part B and C|Lack of Efficacy|0|||
16367308|NCT01107457|39828848|FG005|Part B and C|Lack of Efficacy|7|||
16367309|NCT01107457|39828843|FG000|Part B and C|Lost to Follow-up|0|||
16367310|NCT01107457|39828844|FG001|Part B and C|Lost to Follow-up|0|||
16367311|NCT01107457|39828845|FG002|Part B and C|Lost to Follow-up|0|||
16367312|NCT01107457|39828846|FG003|Part B and C|Lost to Follow-up|0|||
16367313|NCT01107457|39828847|FG004|Part B and C|Lost to Follow-up|0|||
16367314|NCT01107457|39828848|FG005|Part B and C|Lost to Follow-up|10|||
16367315|NCT01107457|39828843|FG000|Part B and C|Protocol Violation|0|||
16367316|NCT01107457|39828844|FG001|Part B and C|Protocol Violation|0|||
16367317|NCT01107457|39828845|FG002|Part B and C|Protocol Violation|0|||
16367318|NCT01107457|39828846|FG003|Part B and C|Protocol Violation|0|||
16367319|NCT01107457|39828847|FG004|Part B and C|Protocol Violation|0|||
16367320|NCT01107457|39828848|FG005|Part B and C|Protocol Violation|1|||
16367321|NCT01107457|39828843|FG000|Part B and C|Sponsor Decision|0|||
16367322|NCT01107457|39828844|FG001|Part B and C|Sponsor Decision|0|||
16367323|NCT01107457|39828845|FG002|Part B and C|Sponsor Decision|0|||
16367324|NCT01107457|39828846|FG003|Part B and C|Sponsor Decision|0|||
16367325|NCT01107457|39828847|FG004|Part B and C|Sponsor Decision|0|||
16367326|NCT01107457|39828848|FG005|Part B and C|Sponsor Decision|66|||
16367327|NCT01107457|39828843|FG000|Part B and C|Withdrawal by Subject|0|||
16367328|NCT01107457|39828844|FG001|Part B and C|Withdrawal by Subject|0|||
16367329|NCT01107457|39828845|FG002|Part B and C|Withdrawal by Subject|0|||
16367330|NCT01107457|39828846|FG003|Part B and C|Withdrawal by Subject|0|||
16367331|NCT01107457|39828847|FG004|Part B and C|Withdrawal by Subject|0|||
16367332|NCT01107457|39828848|FG005|Part B and C|Withdrawal by Subject|16|||
16367333|NCT01107457|39828843|FG000|Part B and C|Clinical Relapse|0|||
16367334|NCT01107457|39828844|FG001|Part B and C|Clinical Relapse|0|||
16367335|NCT01107457|39828845|FG002|Part B and C|Clinical Relapse|0|||
16367336|NCT01107457|39828846|FG003|Part B and C|Clinical Relapse|0|||
16367337|NCT01107457|39828847|FG004|Part B and C|Clinical Relapse|0|||
16367338|NCT01107457|39828848|FG005|Part B and C|Clinical Relapse|4|||
16156595|NCT04660643|39057629|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
16156596|NCT04660643|39057630|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
16156597|NCT04660643|39057631|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
16156598|NCT04660643|39057629|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
16156599|NCT04660643|39057630|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
16156600|NCT04660643|39057631|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
16156601|NCT04660643|39057629|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
16156602|NCT04660643|39057630|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
16156603|NCT04660643|39057631|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
16156604|NCT04660643|39057629|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
16156605|NCT04660643|39057630|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
16156606|NCT04660643|39057631|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
16156607|NCT04660643|39057629|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
16156608|NCT04660643|39057630|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
16156609|NCT04660643|39057631|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
16156610|NCT04660643|39057629|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
16156611|NCT04660643|39057630|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
16156612|NCT04660643|39057631|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
16156613|NCT04660643|39057629|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
16156614|NCT04660643|39057630|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
16156615|NCT04660643|39057631|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
16156616|NCT04660643|39057629|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
16156617|NCT04660643|39057630|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
16156618|NCT04660643|39057631|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
16156619|NCT04660643|39057629|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
16156620|NCT04660643|39057630|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
16156621|NCT04660643|39057631|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
16444976|NCT01499355|40108520|FG002|Double-Blind Period|Investigator Decision|3|||
16156622|NCT04660643|39057629|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
16156623|NCT04660643|39057630|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
16156624|NCT04660643|39057631|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
16156625|NCT04660643|39057629|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
16367339|NCT00849472|39828850|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
16367340|NCT00849472|39828850|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
16367341|NCT00849472|39828850|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
16367342|NCT00849472|39828850|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
16367343|NCT00849472|39828850|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
16367344|NCT00849472|39828850|FG000|Weekly Paclitaxel|Disease Progression|1|||
16367345|NCT00849472|39828850|FG000|Weekly Paclitaxel|Adverse Event|11|||
16367346|NCT00849472|39828850|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
16367347|NCT00849472|39828850|FG000|Weekly Paclitaxel|Physician Decision|3|||
16367348|NCT00849472|39828850|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
16367349|NCT00849472|39828850|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
16367350|NCT00849472|39828850|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
16367351|NCT00849472|39828850|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
16367352|NCT00849472|39828850|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
16367353|NCT00849472|39828850|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
16367354|NCT00849472|39828850|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
16367355|NCT00849472|39828850|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
16367356|NCT02609633|39828851|FG000|Overall Study|Consent Withdrawn|0|||
16367357|NCT02609633|39828852|FG001|Overall Study|Consent Withdrawn|1|||
16367358|NCT02609633|39828851|FG000|Overall Study|Protocol Deviation|1|||
16367359|NCT02609633|39828852|FG001|Overall Study|Protocol Deviation|0|||
16367360|NCT02609633|39828851|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
16367361|NCT02609633|39828852|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
16367362|NCT02609633|39828851|FG000|Overall Study|Reason not Specified|2|||
16444977|NCT01499355|40108521|FG003|Double-Blind Period|Investigator Decision|3|||
16444978|NCT01499355|40108518|FG000|Double-Blind Period|Consent Withdrawn|0|||
16444979|NCT01499355|40108519|FG001|Double-Blind Period|Consent Withdrawn|0|||
16444980|NCT01499355|40108520|FG002|Double-Blind Period|Consent Withdrawn|1|||
16444981|NCT01499355|40108521|FG003|Double-Blind Period|Consent Withdrawn|2|||
16444982|NCT01499355|40108518|FG000|Double-Blind Period|Lost to Follow-up|0|||
16444983|NCT01499355|40108519|FG001|Double-Blind Period|Lost to Follow-up|1|||
16444984|NCT01499355|40108520|FG002|Double-Blind Period|Lost to Follow-up|0|||
16444985|NCT01499355|40108521|FG003|Double-Blind Period|Lost to Follow-up|0|||
16444986|NCT01283139|40108522|FG000|Overall Study|Lost to Follow-up|5|||
16444987|NCT01283139|40108523|FG001|Overall Study|Lost to Follow-up|2|||
16444988|NCT01283139|40108524|FG002|Overall Study|Lost to Follow-up|3|||
16367363|NCT02609633|39828852|FG001|Overall Study|Reason not Specified|1|||
16367364|NCT01479530|39828853|FG000|Overall Study|Adverse Event|5|||
16367365|NCT01479530|39828854|FG001|Overall Study|Adverse Event|6|||
16367366|NCT01479530|39828853|FG000|Overall Study|Lack of Efficacy|0|||
16367367|NCT01479530|39828854|FG001|Overall Study|Lack of Efficacy|1|||
16367368|NCT01479530|39828853|FG000|Overall Study|Protocol Violation|2|||
16367369|NCT01479530|39828854|FG001|Overall Study|Protocol Violation|3|||
16367370|NCT01479530|39828853|FG000|Overall Study|Withdrawal of Consent|3|||
16367371|NCT01479530|39828854|FG001|Overall Study|Withdrawal of Consent|2|||
16367372|NCT00577408|39828856|FG000|Overall Study|Stopped attending study visits|9|||
16367373|NCT00577408|39828857|FG001|Overall Study|Stopped attending study visits|11|||
16367374|NCT00577408|39828856|FG000|Overall Study|Continued opioid use|3|||
16367375|NCT00577408|39828857|FG001|Overall Study|Continued opioid use|2|||
16367376|NCT00577408|39828856|FG000|Overall Study|Non-compliance with study meds|0|||
16367377|NCT00577408|39828857|FG001|Overall Study|Non-compliance with study meds|3|||
16367378|NCT00577408|39828856|FG000|Overall Study|Refused Oral Naltrexone|0|||
16367379|NCT00577408|39828857|FG001|Overall Study|Refused Oral Naltrexone|1|||
16367380|NCT00577408|39828856|FG000|Overall Study|Moved out of state|0|||
16367381|NCT00577408|39828857|FG001|Overall Study|Moved out of state|1|||
16367382|NCT00577408|39828856|FG000|Overall Study|Scheduling Issues|0|||
16367383|NCT00577408|39828857|FG001|Overall Study|Scheduling Issues|3|||
16367384|NCT00577408|39828856|FG000|Overall Study|Death|0|||
16367385|NCT00577408|39828857|FG001|Overall Study|Death|1|||
16367386|NCT00577408|39828856|FG000|Overall Study|Psychiatric hospitalization|0|||
16367387|NCT00577408|39828857|FG001|Overall Study|Psychiatric hospitalization|1|||
16367388|NCT00454142|39828860|FG000|Overall Study|Withdrawal by Subject|1|||
16367389|NCT02403271|39828861|FG000|Period 1|Other varied reasons|1|||
16367390|NCT02403271|39828862|FG001|Period 1|Other varied reasons|0|||
16367391|NCT02403271|39828861|FG000|Period 2|Withdrawal by Subject|0|||
16367392|NCT02403271|39828862|FG001|Period 2|Withdrawal by Subject|14|||
16367393|NCT02403271|39828861|FG000|Period 2|Death|0|||
16367394|NCT02403271|39828862|FG001|Period 2|Death|84|||
16367395|NCT02403271|39828861|FG000|Period 2|Lost to Follow-up|0|||
16367396|NCT02403271|39828862|FG001|Period 2|Lost to Follow-up|2|||
16367397|NCT02403271|39828861|FG000|Period 2|Study Terminated by Sponsor|0|||
16367398|NCT02403271|39828862|FG001|Period 2|Study Terminated by Sponsor|14|||
16367399|NCT02403271|39828861|FG000|Period 2|Other varied reasons|0|||
16367400|NCT02403271|39828862|FG001|Period 2|Other varied reasons|10|||
16367401|NCT02949934|39828863|FG000|Natural Drinking Period|Adverse Event|1|||
16367402|NCT02949934|39828864|FG001|Natural Drinking Period|Adverse Event|0|||
16367403|NCT02949934|39828865|FG002|Natural Drinking Period|Adverse Event|0|||
16367404|NCT02949934|39828866|FG003|Natural Drinking Period|Adverse Event|1|||
16367405|NCT02949934|39828867|FG004|Natural Drinking Period|Adverse Event|0|||
16444989|NCT01283139|40108525|FG003|Overall Study|Lost to Follow-up|1|||
16444990|NCT01283139|40108522|FG000|Overall Study|Withdrawal by Subject|8|||
16444991|NCT01283139|40108523|FG001|Overall Study|Withdrawal by Subject|8|||
16444992|NCT01283139|40108524|FG002|Overall Study|Withdrawal by Subject|6|||
16444993|NCT01283139|40108525|FG003|Overall Study|Withdrawal by Subject|8|||
16444994|NCT01283139|40108522|FG000|Overall Study|Death|2|||
16444995|NCT01283139|40108523|FG001|Overall Study|Death|0|||
16444996|NCT01283139|40108524|FG002|Overall Study|Death|2|||
16444997|NCT01283139|40108525|FG003|Overall Study|Death|2|||
16444998|NCT01283139|40108522|FG000|Overall Study|Lack of Efficacy|1|||
16444999|NCT01283139|40108523|FG001|Overall Study|Lack of Efficacy|2|||
16445000|NCT01283139|40108524|FG002|Overall Study|Lack of Efficacy|2|||
16445001|NCT01283139|40108525|FG003|Overall Study|Lack of Efficacy|1|||
16445002|NCT01283139|40108522|FG000|Overall Study|Early termination due to AE/SAE|1|||
16445003|NCT01283139|40108523|FG001|Overall Study|Early termination due to AE/SAE|1|||
16445004|NCT01283139|40108524|FG002|Overall Study|Early termination due to AE/SAE|0|||
16445005|NCT01283139|40108525|FG003|Overall Study|Early termination due to AE/SAE|0|||
16445006|NCT01283139|40108522|FG000|Overall Study|Participant's refusal to continue|0|||
16445007|NCT01283139|40108523|FG001|Overall Study|Participant's refusal to continue|3|||
16445008|NCT01283139|40108524|FG002|Overall Study|Participant's refusal to continue|1|||
16445009|NCT01283139|40108525|FG003|Overall Study|Participant's refusal to continue|1|||
16445010|NCT01283139|40108522|FG000|Overall Study|Pregnancy|0|||
16445011|NCT01283139|40108523|FG001|Overall Study|Pregnancy|1|||
16445012|NCT01283139|40108524|FG002|Overall Study|Pregnancy|1|||
16445013|NCT01283139|40108525|FG003|Overall Study|Pregnancy|0|||
16445014|NCT01283139|40108522|FG000|Overall Study|Missed follow-up visit|0|||
16445015|NCT01283139|40108523|FG001|Overall Study|Missed follow-up visit|1|||
16445016|NCT01283139|40108524|FG002|Overall Study|Missed follow-up visit|2|||
16445017|NCT01283139|40108525|FG003|Overall Study|Missed follow-up visit|2|||
16445018|NCT01283139|40108522|FG000|Overall Study|Participant randomized in error|0|||
16445019|NCT01283139|40108523|FG001|Overall Study|Participant randomized in error|0|||
16445020|NCT01283139|40108524|FG002|Overall Study|Participant randomized in error|1|||
16445021|NCT01283139|40108525|FG003|Overall Study|Participant randomized in error|0|||
16445022|NCT00092417|40108530|FG000|Overall Study|Lost to Follow-up|2|||
16445023|NCT00092417|40108531|FG001|Overall Study|Lost to Follow-up|0|||
16445024|NCT00092417|40108530|FG000|Overall Study|Withdrawal by Subject|2|||
16445025|NCT00092417|40108531|FG001|Overall Study|Withdrawal by Subject|1|||
16367406|NCT02949934|39828868|FG005|Natural Drinking Period|Adverse Event|0|||
16367407|NCT02949934|39828863|FG000|Natural Drinking Period|Lost to Follow-up|0|||
16367408|NCT02949934|39828864|FG001|Natural Drinking Period|Lost to Follow-up|0|||
16367409|NCT02949934|39828865|FG002|Natural Drinking Period|Lost to Follow-up|0|||
16367410|NCT02949934|39828866|FG003|Natural Drinking Period|Lost to Follow-up|0|||
16445026|NCT00092417|40108530|FG000|Overall Study|Other|1|||
16445027|NCT00092417|40108531|FG001|Overall Study|Other|0|||
16445028|NCT02946580|40108536|FG000|Overall Study|Withdrawal by Subject|1|||
16445029|NCT02946580|40108537|FG001|Overall Study|Withdrawal by Subject|2|||
16445030|NCT02946580|40108536|FG000|Overall Study|Adverse Event|0|||
16445031|NCT02946580|40108537|FG001|Overall Study|Adverse Event|2|||
16445032|NCT02946580|40108536|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
16445033|NCT02946580|40108537|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
16367411|NCT02949934|39828867|FG004|Natural Drinking Period|Lost to Follow-up|1|||
16367412|NCT02949934|39828868|FG005|Natural Drinking Period|Lost to Follow-up|0|||
16367413|NCT02949934|39828863|FG000|Neuroimaging|Protocol Violation|2|||
16367414|NCT02949934|39828864|FG001|Neuroimaging|Protocol Violation|0|||
16367415|NCT02949934|39828865|FG002|Neuroimaging|Protocol Violation|0|||
16367416|NCT02949934|39828866|FG003|Neuroimaging|Protocol Violation|0|||
16367417|NCT02949934|39828867|FG004|Neuroimaging|Protocol Violation|1|||
16367418|NCT02949934|39828868|FG005|Neuroimaging|Protocol Violation|0|||
16367419|NCT02949934|39828863|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
16367420|NCT02949934|39828864|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
16367421|NCT02949934|39828865|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
16445034|NCT03938259|40108538|FG000|Overall Study|unable to establish baseline for ventilation|1|||
16445035|NCT03938259|40108539|FG001|Overall Study|unable to establish baseline for ventilation|1|||
16445036|NCT01001221|40108540|FG000|Overall Study|Adverse Event|1|||
16445037|NCT01001221|40108541|FG001|Overall Study|Adverse Event|2|||
16445038|NCT01001221|40108542|FG002|Overall Study|Adverse Event|0|||
16445039|NCT01001221|40108543|FG003|Overall Study|Adverse Event|2|||
16445040|NCT01001221|40108544|FG004|Overall Study|Adverse Event|0|||
16445041|NCT01001221|40108540|FG000|Overall Study|Disease progression|3|||
16445042|NCT01001221|40108541|FG001|Overall Study|Disease progression|2|||
16445043|NCT01001221|40108542|FG002|Overall Study|Disease progression|2|||
16445044|NCT01001221|40108543|FG003|Overall Study|Disease progression|4|||
16445045|NCT01001221|40108544|FG004|Overall Study|Disease progression|0|||
16156626|NCT04660643|39057630|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
16156627|NCT04660643|39057631|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
16156628|NCT04660643|39057629|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
16156629|NCT04660643|39057630|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
16156630|NCT04660643|39057631|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
16156631|NCT04660643|39057629|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
16156632|NCT04660643|39057630|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
16156633|NCT04660643|39057631|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
16156634|NCT04660643|39057629|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
16156635|NCT04660643|39057630|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
16156636|NCT04660643|39057631|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
16156637|NCT04660643|39057629|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
16156638|NCT04660643|39057630|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
16156639|NCT04660643|39057631|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
16156640|NCT04660643|39057629|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
16156641|NCT04660643|39057630|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
16156642|NCT04660643|39057631|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
16156643|NCT00999908|39057634|FG000|Treatment Period 1|Subject withdrew consent|2|||
16156644|NCT00999908|39057635|FG001|Treatment Period 1|Subject withdrew consent|0|||
16156645|NCT00999908|39057636|FG002|Treatment Period 1|Subject withdrew consent|0|||
16156646|NCT00999908|39057634|FG000|Treatment Period 2|Protocol Violation|1|||
16156647|NCT00999908|39057635|FG001|Treatment Period 2|Protocol Violation|0|||
16156648|NCT00999908|39057636|FG002|Treatment Period 2|Protocol Violation|0|||
16156649|NCT01100437|39057637|FG000|Titration/Stabilization|Adverse Event|0|||
16156650|NCT01100437|39057638|FG001|Titration/Stabilization|Adverse Event|0|||
16156651|NCT01100437|39057639|FG002|Titration/Stabilization|Adverse Event|4|||
16156652|NCT01100437|39057637|FG000|Titration/Stabilization|Non-compliance|0|||
16156653|NCT01100437|39057638|FG001|Titration/Stabilization|Non-compliance|0|||
16156654|NCT01100437|39057639|FG002|Titration/Stabilization|Non-compliance|1|||
16156655|NCT01100437|39057637|FG000|Titration/Stabilization|Sponsor canceled study|0|||
16156656|NCT01100437|39057638|FG001|Titration/Stabilization|Sponsor canceled study|0|||
16156657|NCT01100437|39057639|FG002|Titration/Stabilization|Sponsor canceled study|1|||
16156658|NCT01100437|39057637|FG000|Maintenance|Withdrawal by Subject|0|||
16156659|NCT01100437|39057638|FG001|Maintenance|Withdrawal by Subject|0|||
16156660|NCT01100437|39057639|FG002|Maintenance|Withdrawal by Subject|1|||
16156661|NCT01100437|39057637|FG000|Maintenance|Sponsor termination of study|0|||
16156662|NCT01100437|39057638|FG001|Maintenance|Sponsor termination of study|0|||
16156663|NCT01100437|39057639|FG002|Maintenance|Sponsor termination of study|1|||
16156664|NCT04238481|39057640|FG000|Overall Study|Miscellaneous|0|||
16156665|NCT04238481|39057641|FG001|Overall Study|Miscellaneous|1|||
16156666|NCT04238481|39057642|FG002|Overall Study|Miscellaneous|0|||
16156667|NCT04238481|39057643|FG003|Overall Study|Miscellaneous|0|||
16156668|NCT02363686|39057644|FG000|Overall Study|Withdrawal by Subject|22|||
16156669|NCT02363686|39057644|FG000|Overall Study|incomplete FEES examinations|13|||
16156670|NCT02838420|39057653|FG000|Overall Study|Ongoing in Study|113|||
16156671|NCT02838420|39057654|FG001|Overall Study|Ongoing in Study|45|||
16156672|NCT02838420|39057653|FG000|Overall Study|Lost to Follow-up|1|||
16156673|NCT02838420|39057654|FG001|Overall Study|Lost to Follow-up|0|||
16367422|NCT02949934|39828866|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
16445046|NCT01001221|40108540|FG000|Overall Study|Other|1|||
16445047|NCT01001221|40108541|FG001|Overall Study|Other|1|||
16156674|NCT02838420|39057653|FG000|Overall Study|Withdrawal by Subject|3|||
16156675|NCT02838420|39057654|FG001|Overall Study|Withdrawal by Subject|4|||
16156676|NCT02838420|39057653|FG000|Overall Study|Death|8|||
16156677|NCT02838420|39057654|FG001|Overall Study|Death|13|||
16156678|NCT01294800|39057655|FG000|Overall Study|Adverse Event|7|||
16156679|NCT01294800|39057656|FG001|Overall Study|Adverse Event|6|||
16156680|NCT01294800|39057657|FG002|Overall Study|Adverse Event|12|||
16156681|NCT01294800|39057658|FG003|Overall Study|Adverse Event|5|||
16156682|NCT01294800|39057655|FG000|Overall Study|Subject Withdrew Consent|2|||
16156683|NCT01294800|39057656|FG001|Overall Study|Subject Withdrew Consent|2|||
16156684|NCT01294800|39057657|FG002|Overall Study|Subject Withdrew Consent|2|||
16156685|NCT01294800|39057658|FG003|Overall Study|Subject Withdrew Consent|11|||
16156686|NCT01294800|39057655|FG000|Overall Study|Lost to Follow-up|0|||
16156687|NCT01294800|39057656|FG001|Overall Study|Lost to Follow-up|0|||
16156688|NCT01294800|39057657|FG002|Overall Study|Lost to Follow-up|1|||
16156689|NCT01294800|39057658|FG003|Overall Study|Lost to Follow-up|0|||
16156690|NCT01294800|39057655|FG000|Overall Study|Non-compliance With Protocol|0|||
16156691|NCT01294800|39057656|FG001|Overall Study|Non-compliance With Protocol|1|||
16156692|NCT01294800|39057657|FG002|Overall Study|Non-compliance With Protocol|1|||
16156693|NCT01294800|39057658|FG003|Overall Study|Non-compliance With Protocol|0|||
16156694|NCT01294800|39057655|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
16156695|NCT01294800|39057656|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
16156696|NCT01294800|39057657|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
16156697|NCT01294800|39057658|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
16156698|NCT00193063|39057661|FG000|Overall Study|Lack of Efficacy|3|||
16156699|NCT00193063|39057661|FG000|Overall Study|Adverse Event|1|||
16156700|NCT00713700|39057664|FG000|Overall Study|Lost to Follow-up|3|||
16156701|NCT00713700|39057664|FG000|Overall Study|Withdrawal by Subject|1|||
16156702|NCT04951037|39057665|FG000|Overall Study|Lost to Follow-up|16|||
16156703|NCT04951037|39057665|FG000|Overall Study|Withdrawal by Subject|5|||
16156704|NCT04951037|39057665|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
16156705|NCT01390272|39057666|FG000|Overall Study|Death|3|||
16156706|NCT01390272|39057667|FG001|Overall Study|Death|2|||
16156707|NCT01390272|39057666|FG000|Overall Study|Withdrawal by Subject|9|||
16156708|NCT01390272|39057667|FG001|Overall Study|Withdrawal by Subject|5|||
16156709|NCT01390272|39057666|FG000|Overall Study|Patient moved, no longer eligible|5|||
16156710|NCT01390272|39057667|FG001|Overall Study|Patient moved, no longer eligible|8|||
16156711|NCT03670953|39057668|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
16156712|NCT03670953|39057669|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
16156713|NCT03670953|39057670|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
16156714|NCT03670953|39057671|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
16156715|NCT03670953|39057668|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
16156716|NCT03670953|39057669|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
16156717|NCT03670953|39057670|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
16156718|NCT03670953|39057671|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
16156719|NCT03670953|39057668|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
16156720|NCT03670953|39057669|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
16156721|NCT03670953|39057670|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
16156722|NCT03670953|39057671|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
16156723|NCT03670953|39057668|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
16156724|NCT03670953|39057669|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
16156725|NCT03670953|39057670|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
16156726|NCT03670953|39057671|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
16156727|NCT03670953|39057668|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
16156728|NCT03670953|39057669|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
16156729|NCT03670953|39057670|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
16156730|NCT03670953|39057671|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
16156731|NCT03670953|39057668|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
16156732|NCT03670953|39057669|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
16156733|NCT03670953|39057670|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
16156734|NCT03670953|39057671|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
16156735|NCT03670953|39057668|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
16156736|NCT03670953|39057669|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
16156737|NCT03670953|39057670|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
16156738|NCT03670953|39057671|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
16156739|NCT03670953|39057668|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
16156740|NCT03670953|39057669|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
16156741|NCT03670953|39057670|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
16156742|NCT03670953|39057671|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
16156743|NCT03670953|39057668|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
16156744|NCT03670953|39057669|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
16156745|NCT03670953|39057670|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
16156746|NCT03670953|39057671|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
16367423|NCT02949934|39828867|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
16367424|NCT02949934|39828868|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
16367425|NCT02949934|39828863|FG000|Neuroimaging|Not scanned|0|||
16367426|NCT02949934|39828864|FG001|Neuroimaging|Not scanned|0|||
16367427|NCT02949934|39828865|FG002|Neuroimaging|Not scanned|1|||
16367428|NCT02949934|39828866|FG003|Neuroimaging|Not scanned|0|||
16367429|NCT02949934|39828867|FG004|Neuroimaging|Not scanned|0|||
16367430|NCT02949934|39828868|FG005|Neuroimaging|Not scanned|2|||
16367431|NCT02949934|39828863|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
16367432|NCT02949934|39828864|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
16367433|NCT02949934|39828865|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
16367434|NCT02949934|39828866|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
16367435|NCT02949934|39828867|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
16367436|NCT02949934|39828868|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
16367437|NCT02949934|39828863|FG000|Bar Laboratory|Adverse Event|1|||
16367438|NCT02949934|39828864|FG001|Bar Laboratory|Adverse Event|0|||
16367439|NCT02949934|39828865|FG002|Bar Laboratory|Adverse Event|2|||
16367440|NCT02949934|39828866|FG003|Bar Laboratory|Adverse Event|0|||
16367441|NCT02949934|39828867|FG004|Bar Laboratory|Adverse Event|1|||
16367442|NCT02949934|39828868|FG005|Bar Laboratory|Adverse Event|0|||
16367443|NCT02949934|39828863|FG000|Bar Laboratory|Protocol Violation|0|||
16156747|NCT03670953|39057668|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
16156748|NCT03670953|39057669|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
16156749|NCT03670953|39057670|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
16156750|NCT03670953|39057671|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
16156751|NCT03670953|39057668|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
16156752|NCT03670953|39057669|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
16156753|NCT03670953|39057670|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
16156754|NCT03670953|39057671|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
16156755|NCT03670953|39057668|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
16367444|NCT02949934|39828864|FG001|Bar Laboratory|Protocol Violation|0|||
16367445|NCT02949934|39828865|FG002|Bar Laboratory|Protocol Violation|0|||
16367446|NCT02949934|39828866|FG003|Bar Laboratory|Protocol Violation|1|||
16367447|NCT02949934|39828867|FG004|Bar Laboratory|Protocol Violation|0|||
16367448|NCT02949934|39828868|FG005|Bar Laboratory|Protocol Violation|0|||
16367449|NCT00294398|39828869|FG000|Overall Study|Lost to Follow-up|21|||
16367450|NCT00294398|39828870|FG001|Overall Study|Lost to Follow-up|26|||
16367451|NCT01185366|39828874|FG000|First Line Therapy|Insurance Coverage Denied|1|||
16367452|NCT01185366|39828875|FG001|First Line Therapy|Insurance Coverage Denied|1|||
16367453|NCT01185366|39828874|FG000|First Line Therapy|Withdrawal by Subject|1|||
16367454|NCT01185366|39828875|FG001|First Line Therapy|Withdrawal by Subject|0|||
16367455|NCT01185366|39828874|FG000|First Line Therapy|Lack of Metastatic Site|1|||
16367456|NCT01185366|39828875|FG001|First Line Therapy|Lack of Metastatic Site|0|||
16367457|NCT01185366|39828874|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
16367458|NCT01185366|39828875|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
16367459|NCT01185366|39828874|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
16367460|NCT01185366|39828875|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
16367461|NCT01185366|39828874|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
16367462|NCT01185366|39828875|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
16367463|NCT01185366|39828874|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
16367464|NCT01185366|39828875|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
16367465|NCT01945242|39828876|FG000|Overall Study|Physician Decision|3|||
16367466|NCT01945242|39828877|FG001|Overall Study|Physician Decision|3|||
16367467|NCT02930941|39828879|FG000|Overall Study|Lost to Follow-up|1|||
16367468|NCT02930941|39828880|FG001|Overall Study|Lost to Follow-up|2|||
16367469|NCT02311478|39828887|FG000|Overall Study|Withdrawal by Subject|1|||
16367470|NCT02311478|39828887|FG000|Overall Study|Lost to Follow-up|5|||
16367471|NCT02311478|39828887|FG000|Overall Study|Failed IUD Insertion|1|||
16367472|NCT05064800|39828888|FG000|Period 3|Withdrawal by Subject|0|||
16367473|NCT05064800|39828889|FG001|Period 3|Withdrawal by Subject|0|||
16367474|NCT05064800|39828890|FG002|Period 3|Withdrawal by Subject|0|||
16367475|NCT05064800|39828891|FG003|Period 3|Withdrawal by Subject|0|||
16367476|NCT05064800|39828892|FG004|Period 3|Withdrawal by Subject|1|||
16367477|NCT05064800|39828893|FG005|Period 3|Withdrawal by Subject|0|||
16367478|NCT01905683|39828894|FG000|Overall Study|Protocol Violation|1|||
16367479|NCT01905683|39828894|FG000|Overall Study|Re-injection criteria not met; others|13|||
16367480|NCT01905683|39828894|FG000|Overall Study|Physician Decision|1|||
16367481|NCT01905683|39828894|FG000|Overall Study|Lack of Efficacy|8|||
16367482|NCT01905683|39828894|FG000|Overall Study|Withdrawal by Subject|20|||
16367483|NCT01905683|39828894|FG000|Overall Study|Adverse Event|4|||
16367484|NCT01905683|39828894|FG000|Overall Study|Lost to Follow-up|4|||
16367485|NCT01807520|39828895|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
16367486|NCT01807520|39828896|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
16367487|NCT01807520|39828897|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
16367488|NCT01807520|39828898|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
16367489|NCT01807520|39828899|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
16367490|NCT01807520|39828900|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
16367491|NCT01807520|39828901|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
16367492|NCT01807520|39828895|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
16367493|NCT01807520|39828896|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
16367494|NCT01807520|39828897|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
16367495|NCT01807520|39828898|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
16367496|NCT01807520|39828899|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
16367497|NCT01807520|39828900|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
16367498|NCT01807520|39828901|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
16367499|NCT01807520|39828895|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16367500|NCT01807520|39828896|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16367501|NCT01807520|39828897|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
16367502|NCT01807520|39828898|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16367503|NCT01807520|39828899|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16367504|NCT01807520|39828900|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16367505|NCT01807520|39828901|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
16367506|NCT01807520|39828895|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
16367507|NCT01807520|39828896|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16367508|NCT01807520|39828897|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16367509|NCT01807520|39828898|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16367510|NCT01807520|39828899|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16367511|NCT01807520|39828900|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16367512|NCT01807520|39828901|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
16367513|NCT01807520|39828895|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16367514|NCT01807520|39828896|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16445048|NCT01001221|40108542|FG002|Overall Study|Other|0|||
16445049|NCT01001221|40108543|FG003|Overall Study|Other|0|||
16367515|NCT01807520|39828897|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
16445050|NCT01001221|40108544|FG004|Overall Study|Other|0|||
16367516|NCT01807520|39828898|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16367517|NCT01807520|39828899|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16367518|NCT01807520|39828900|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16367519|NCT01807520|39828901|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
16367520|NCT01807520|39828895|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
16367521|NCT01807520|39828896|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16367522|NCT01807520|39828897|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16367523|NCT01807520|39828898|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16367524|NCT01807520|39828899|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16367525|NCT01807520|39828900|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16367526|NCT01807520|39828901|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
16367527|NCT01807520|39828895|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
16367528|NCT01807520|39828896|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
16367529|NCT01807520|39828897|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
16367530|NCT01807520|39828898|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
16367531|NCT01807520|39828899|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
16367532|NCT01807520|39828900|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
16367533|NCT01807520|39828901|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
16367534|NCT01807520|39828895|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16367535|NCT01807520|39828896|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16367536|NCT01807520|39828897|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16367537|NCT01807520|39828898|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
16156756|NCT03670953|39057669|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
16156757|NCT03670953|39057670|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
16156758|NCT03670953|39057671|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
16156759|NCT03670953|39057668|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
16156760|NCT03670953|39057669|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
16156761|NCT03670953|39057670|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
16156762|NCT03670953|39057671|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
16156763|NCT03670953|39057668|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
16156764|NCT03670953|39057669|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
16156765|NCT03670953|39057670|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
16156766|NCT03670953|39057671|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
16156767|NCT03670953|39057668|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
16156768|NCT03670953|39057669|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
16156769|NCT03670953|39057670|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
16156770|NCT03670953|39057671|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
16156771|NCT03670953|39057668|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
16156772|NCT03670953|39057669|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
16156773|NCT03670953|39057670|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
16156774|NCT03670953|39057671|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
16156775|NCT03670953|39057668|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
16367538|NCT01807520|39828899|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16367539|NCT01807520|39828900|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16367540|NCT01807520|39828901|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
16367541|NCT01807520|39828895|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
16367542|NCT01807520|39828896|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16367543|NCT01807520|39828897|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16367544|NCT01807520|39828898|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16367545|NCT01807520|39828899|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16367546|NCT01807520|39828900|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16367547|NCT01807520|39828901|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
16367548|NCT01807520|39828895|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16367549|NCT01807520|39828896|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
16156776|NCT03670953|39057669|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
16156777|NCT03670953|39057670|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
16156778|NCT03670953|39057671|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
16156779|NCT03670953|39057668|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
16156780|NCT03670953|39057669|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
16156781|NCT03670953|39057670|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
16156782|NCT03670953|39057671|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
16156783|NCT00523991|39057672|FG000|Overall Study|Adverse Event|6|||
16156784|NCT00523991|39057673|FG001|Overall Study|Adverse Event|5|||
16156785|NCT00523991|39057672|FG000|Overall Study|Protocol Violation|1|||
16156786|NCT00523991|39057673|FG001|Overall Study|Protocol Violation|4|||
16156787|NCT00523991|39057672|FG000|Overall Study|Lost to Follow-up|4|||
16156788|NCT00523991|39057673|FG001|Overall Study|Lost to Follow-up|1|||
16156789|NCT00523991|39057672|FG000|Overall Study|Withdrawal by Subject|7|||
16156790|NCT00523991|39057673|FG001|Overall Study|Withdrawal by Subject|17|||
16156791|NCT00523991|39057672|FG000|Overall Study|Other reason (not specified)|3|||
16156792|NCT00523991|39057673|FG001|Overall Study|Other reason (not specified)|0|||
16156793|NCT01902966|39057675|FG000|Overall Study|Death|1|||
16156794|NCT01902966|39057675|FG000|Overall Study|Physician Decision|1|||
16156795|NCT01902966|39057675|FG000|Overall Study|Withdrawal by Subject|1|||
16156796|NCT02228590|39057676|FG000|Overall Study|Withdrawal by Subject|1|||
16156797|NCT01687712|39057677|FG000|Cycle 1|Not Biochemically Pregnant|386|||
16156798|NCT01687712|39057678|FG001|Cycle 1|Not Biochemically Pregnant|348|||
16156799|NCT01687712|39057677|FG000|Cycle 1|Early Pregnancy Loss|43|||
16156800|NCT01687712|39057678|FG001|Cycle 1|Early Pregnancy Loss|60|||
16156801|NCT01687712|39057677|FG000|Cycle 1|Ectopic Pregnancy|5|||
16156802|NCT01687712|39057678|FG001|Cycle 1|Ectopic Pregnancy|5|||
16156803|NCT01687712|39057677|FG000|Cycle 1|Heterotropic Pregnancy|1|||
16156804|NCT01687712|39057678|FG001|Cycle 1|Heterotropic Pregnancy|0|||
16156805|NCT01687712|39057677|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
16156806|NCT01687712|39057678|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
16156807|NCT01687712|39057677|FG000|Cycle 1|Abortion|3|||
16156808|NCT01687712|39057678|FG001|Cycle 1|Abortion|0|||
16156809|NCT01687712|39057677|FG000|Cycle 1|Intrauterine Fetal Death|0|||
16156810|NCT01687712|39057678|FG001|Cycle 1|Intrauterine Fetal Death|1|||
16156811|NCT01687712|39057677|FG000|Cycle 1|Lost to Follow-up|1|||
16156812|NCT01687712|39057678|FG001|Cycle 1|Lost to Follow-up|1|||
16156813|NCT01687712|39057677|FG000|Cycle 2|Not Biochemically Pregnant|74|||
16156814|NCT01687712|39057678|FG001|Cycle 2|Not Biochemically Pregnant|77|||
16156815|NCT01687712|39057677|FG000|Cycle 2|Early Pregnancy Loss|18|||
16156816|NCT01687712|39057678|FG001|Cycle 2|Early Pregnancy Loss|16|||
16156817|NCT01687712|39057677|FG000|Cycle 2|Ectopic Pregnancy|0|||
16367550|NCT01807520|39828897|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16367551|NCT01807520|39828898|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16367552|NCT01807520|39828899|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16367553|NCT01807520|39828900|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16367554|NCT01807520|39828901|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
16367555|NCT01807520|39828895|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
16367556|NCT01807520|39828896|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
16367557|NCT01807520|39828897|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
16367558|NCT01807520|39828898|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
16367559|NCT01807520|39828899|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
16367560|NCT01807520|39828900|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
16367561|NCT01807520|39828901|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
16367562|NCT01807520|39828895|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
16367563|NCT01807520|39828896|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
16367564|NCT01807520|39828897|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
16367565|NCT01807520|39828898|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
16367566|NCT01807520|39828899|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
16367567|NCT01807520|39828900|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
16367568|NCT01807520|39828901|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
16367569|NCT01807520|39828895|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
16367570|NCT01807520|39828896|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
16367571|NCT01807520|39828897|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
16367572|NCT01807520|39828898|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
16367573|NCT01807520|39828899|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
16367574|NCT01807520|39828900|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
16367575|NCT01807520|39828901|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
16367576|NCT01807520|39828895|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
16367577|NCT01807520|39828896|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
16367578|NCT01807520|39828897|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
16367579|NCT01807520|39828898|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
16367580|NCT01807520|39828899|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
16367581|NCT01807520|39828900|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
16367582|NCT01807520|39828901|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
16367583|NCT01807520|39828895|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16367584|NCT01807520|39828896|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16367585|NCT01807520|39828897|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16367586|NCT01807520|39828898|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16367587|NCT01807520|39828899|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16367588|NCT01807520|39828900|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
16367589|NCT01807520|39828901|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
16367590|NCT01807520|39828895|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16367591|NCT01807520|39828896|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16367592|NCT01807520|39828897|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16367593|NCT01807520|39828898|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16367594|NCT01807520|39828899|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16367595|NCT01807520|39828900|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
16367596|NCT01807520|39828901|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
16367597|NCT01807520|39828895|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
16367598|NCT01807520|39828896|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
16367599|NCT01807520|39828897|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
16367600|NCT01807520|39828898|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
16367601|NCT01807520|39828899|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
16445051|NCT01001221|40108540|FG000|Overall Study|Not treated; protocol exclusion|0|||
16445052|NCT01001221|40108541|FG001|Overall Study|Not treated; protocol exclusion|0|||
16445053|NCT01001221|40108542|FG002|Overall Study|Not treated; protocol exclusion|1|||
16445054|NCT01001221|40108543|FG003|Overall Study|Not treated; protocol exclusion|0|||
16445055|NCT01001221|40108544|FG004|Overall Study|Not treated; protocol exclusion|0|||
16445056|NCT01972217|40108545|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
16445057|NCT01972217|40108546|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
16445058|NCT01972217|40108547|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
16445059|NCT01972217|40108548|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
16445060|NCT01972217|40108545|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
16445061|NCT01972217|40108546|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
16445062|NCT01972217|40108547|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
16445063|NCT01972217|40108548|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
16445064|NCT01972217|40108545|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
16445065|NCT01972217|40108546|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
16445066|NCT01972217|40108547|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
16445067|NCT01972217|40108548|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
16445068|NCT01972217|40108545|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
16445069|NCT01972217|40108546|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
16445070|NCT01972217|40108547|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
16445071|NCT01972217|40108548|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
16445072|NCT01972217|40108545|FG000|Part B Double-blind, Randomised Period|Death|0|||
16445073|NCT01972217|40108546|FG001|Part B Double-blind, Randomised Period|Death|0|||
16445074|NCT01972217|40108547|FG002|Part B Double-blind, Randomised Period|Death|43|||
16156818|NCT01687712|39057678|FG001|Cycle 2|Ectopic Pregnancy|1|||
16156819|NCT01687712|39057677|FG000|Cycle 2|Still Birth|1|||
16156820|NCT01687712|39057678|FG001|Cycle 2|Still Birth|0|||
16156821|NCT01687712|39057677|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
16156822|NCT01687712|39057678|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
16156823|NCT01687712|39057677|FG000|Cycle 3|Not Biochemically Pregnant|21|||
16156824|NCT01687712|39057678|FG001|Cycle 3|Not Biochemically Pregnant|22|||
16156825|NCT01687712|39057677|FG000|Cycle 3|Early Pregnancy Loss|1|||
16156826|NCT01687712|39057678|FG001|Cycle 3|Early Pregnancy Loss|2|||
16156827|NCT01687712|39057677|FG000|Cycle 3|Ectopic Pregnancy|1|||
16156828|NCT01687712|39057678|FG001|Cycle 3|Ectopic Pregnancy|0|||
16156829|NCT01687712|39057677|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
16156830|NCT01687712|39057678|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
16156831|NCT00797823|39057679|FG000|First Period (Initial Randomization)|Physician Decision|1|||
16156832|NCT00797823|39057680|FG001|First Period (Initial Randomization)|Physician Decision|0|||
16156833|NCT00797823|39057681|FG002|First Period (Initial Randomization)|Physician Decision|0|||
16156834|NCT04101331|39057685|FG000|Overall Study|Adverse Event|7|||
16156835|NCT04101331|39057685|FG000|Overall Study|Disease progression|79|||
16156836|NCT04101331|39057685|FG000|Overall Study|Withdrawal by Subject|1|||
16156837|NCT04101331|39057685|FG000|Overall Study|Investigator decision|6|||
16156838|NCT04101331|39057685|FG000|Overall Study|Death|6|||
16156839|NCT04101331|39057685|FG000|Overall Study|Allogenic transplant|1|||
16156840|NCT01340209|39057686|FG000|Overall Study|Adverse Event|1|||
16156841|NCT01340209|39057687|FG001|Overall Study|Adverse Event|1|||
16156842|NCT01340209|39057688|FG002|Overall Study|Adverse Event|2|||
16367602|NCT01807520|39828900|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
16367603|NCT01807520|39828901|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
16367604|NCT00976898|39828904|FG000|Overall Study|Protocol Violation|1|||
16367605|NCT00976898|39828904|FG000|Overall Study|Adverse Event|1|||
16367606|NCT00976898|39828904|FG000|Overall Study|Physician Decision|1|||
16367607|NCT00976898|39828904|FG000|Overall Study|Liver Transplant|1|||
16367608|NCT00976898|39828904|FG000|Overall Study|Progressive Disease|1|||
16367609|NCT04307394|39828909|FG000|Overall Study|Lost to Follow-up|3|||
16367610|NCT04307394|39828909|FG000|Overall Study|Withdrawal by Subject|2|||
16367611|NCT01947933|39828910|FG000|Overall Study|Withdrawal by Subject|0|||
16367612|NCT01947933|39828911|FG001|Overall Study|Withdrawal by Subject|0|||
16367613|NCT01947933|39828912|FG002|Overall Study|Withdrawal by Subject|1|||
16367614|NCT01947933|39828913|FG003|Overall Study|Withdrawal by Subject|0|||
16367615|NCT01947933|39828914|FG004|Overall Study|Withdrawal by Subject|0|||
16367616|NCT01947933|39828915|FG005|Overall Study|Withdrawal by Subject|0|||
16367617|NCT01947933|39828916|FG006|Overall Study|Withdrawal by Subject|0|||
16367618|NCT01947933|39828917|FG007|Overall Study|Withdrawal by Subject|0|||
16156843|NCT01340209|39057686|FG000|Overall Study|Protocol Violation|1|||
16156844|NCT01340209|39057687|FG001|Overall Study|Protocol Violation|2|||
16156845|NCT01340209|39057688|FG002|Overall Study|Protocol Violation|1|||
16156846|NCT01340209|39057686|FG000|Overall Study|Withdrawal by Subject|0|||
16367619|NCT01947933|39828918|FG008|Overall Study|Withdrawal by Subject|0|||
16367620|NCT01947933|39828910|FG000|Overall Study|Lost to Follow-up|0|||
16156847|NCT01340209|39057687|FG001|Overall Study|Withdrawal by Subject|0|||
16156848|NCT01340209|39057688|FG002|Overall Study|Withdrawal by Subject|1|||
16156849|NCT01340209|39057686|FG000|Overall Study|Other reason not defined above|3|||
16156850|NCT01340209|39057687|FG001|Overall Study|Other reason not defined above|5|||
16156851|NCT01340209|39057688|FG002|Overall Study|Other reason not defined above|4|||
16156852|NCT01617460|39057691|FG000|Overall Study|Adverse Event|10|||
16156853|NCT01617460|39057691|FG000|Overall Study|Physician Decision|16|||
16156854|NCT01617460|39057691|FG000|Overall Study|Protocol Violation|5|||
16156855|NCT01617460|39057691|FG000|Overall Study|Withdrawal by Subject|9|||
16156856|NCT00252057|39057694|FG000|Overall Study|Withdrawal by Subject|2|||
16156857|NCT00252057|39057695|FG001|Overall Study|Withdrawal by Subject|5|||
16156858|NCT00252057|39057694|FG000|Overall Study|Death|1|||
16156859|NCT00252057|39057695|FG001|Overall Study|Death|2|||
16156860|NCT00252057|39057694|FG000|Overall Study|Participant previously enrolled|0|||
16156861|NCT00252057|39057695|FG001|Overall Study|Participant previously enrolled|1|||
16156862|NCT02318667|39057707|FG000|Overall Study|Adverse Event|1|||
16156863|NCT02318667|39057707|FG000|Overall Study|Lack of Efficacy|6|||
16156864|NCT02318667|39057707|FG000|Overall Study|Protocol Violation|2|||
16156865|NCT02926209|39057712|FG000|Study Cohort|Poor Bowel Preparation|1|||
16156866|NCT02926209|39057713|FG001|Study Cohort|Poor Bowel Preparation|0|||
16156867|NCT04942925|39057714|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
16156868|NCT04942925|39057715|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
16156869|NCT04942925|39057714|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
16156870|NCT04942925|39057715|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
16156871|NCT04677959|39057720|FG000|Overall Study|Adverse Event|1|||
16156872|NCT04677959|39057721|FG001|Overall Study|Adverse Event|9|||
16156873|NCT04677959|39057720|FG000|Overall Study|Withdrawal by Subject|2|||
16156874|NCT04677959|39057721|FG001|Overall Study|Withdrawal by Subject|15|||
16156875|NCT04677959|39057720|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16156876|NCT04677959|39057721|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16156877|NCT04677959|39057720|FG000|Overall Study|Non-compliance with study drug|0|||
16156878|NCT04677959|39057721|FG001|Overall Study|Non-compliance with study drug|2|||
16156879|NCT04677959|39057720|FG000|Overall Study|Protocol deviation|0|||
16156880|NCT04677959|39057721|FG001|Overall Study|Protocol deviation|11|||
16156881|NCT04677959|39057720|FG000|Overall Study|Lost to Follow-up|9|||
16156882|NCT04677959|39057721|FG001|Overall Study|Lost to Follow-up|13|||
16156883|NCT04677959|39057720|FG000|Overall Study|Other than specified|0|||
16156884|NCT04677959|39057721|FG001|Overall Study|Other than specified|8|||
16156885|NCT01780662|39057722|FG000|Overall Study|Adverse Event|1|||
16156886|NCT01780662|39057723|FG001|Overall Study|Adverse Event|0|||
16156887|NCT01780662|39057724|FG002|Overall Study|Adverse Event|2|||
16156888|NCT01780662|39057722|FG000|Overall Study|Physician Decision|0|||
16156889|NCT01780662|39057723|FG001|Overall Study|Physician Decision|5|||
16156890|NCT01780662|39057724|FG002|Overall Study|Physician Decision|7|||
16156891|NCT01780662|39057722|FG000|Overall Study|Protocol Violation|0|||
16156892|NCT01780662|39057723|FG001|Overall Study|Protocol Violation|1|||
16156893|NCT01780662|39057724|FG002|Overall Study|Protocol Violation|0|||
16156894|NCT01780662|39057722|FG000|Overall Study|Ineligible|0|||
16156895|NCT01780662|39057723|FG001|Overall Study|Ineligible|0|||
16156896|NCT01780662|39057724|FG002|Overall Study|Ineligible|1|||
16156897|NCT03310970|39057725|FG000|Overall Study|Withdrawal by Subject|0|||
16156898|NCT03310970|39057726|FG001|Overall Study|Withdrawal by Subject|1|||
16156899|NCT00861744|39057727|FG000|Overall Study|Adverse Event|0|||
16156900|NCT00861744|39057728|FG001|Overall Study|Adverse Event|0|||
16156901|NCT00861744|39057729|FG002|Overall Study|Adverse Event|0|||
16156902|NCT00861744|39057730|FG003|Overall Study|Adverse Event|1|||
16156903|NCT00861744|39057727|FG000|Overall Study|Lost to Follow-up|7|||
16156904|NCT00861744|39057728|FG001|Overall Study|Lost to Follow-up|19|||
16156905|NCT00861744|39057729|FG002|Overall Study|Lost to Follow-up|17|||
16156906|NCT00861744|39057730|FG003|Overall Study|Lost to Follow-up|12|||
16156907|NCT00861744|39057727|FG000|Overall Study|Withdrawal by Subject|10|||
16156908|NCT00861744|39057728|FG001|Overall Study|Withdrawal by Subject|6|||
16156909|NCT00861744|39057729|FG002|Overall Study|Withdrawal by Subject|6|||
16156910|NCT00861744|39057730|FG003|Overall Study|Withdrawal by Subject|19|||
16156911|NCT00861744|39057727|FG000|Overall Study|Protocol Violation|0|||
16156912|NCT00861744|39057728|FG001|Overall Study|Protocol Violation|1|||
16156913|NCT00861744|39057729|FG002|Overall Study|Protocol Violation|0|||
16156914|NCT00861744|39057730|FG003|Overall Study|Protocol Violation|0|||
16156915|NCT00861744|39057727|FG000|Overall Study|Migration from study area|0|||
16156916|NCT00861744|39057728|FG001|Overall Study|Migration from study area|3|||
16156917|NCT00861744|39057729|FG002|Overall Study|Migration from study area|1|||
16156918|NCT00861744|39057730|FG003|Overall Study|Migration from study area|0|||
16156919|NCT00861744|39057727|FG000|Overall Study|Blood draws|0|||
16156920|NCT00861744|39057728|FG001|Overall Study|Blood draws|0|||
16156921|NCT00861744|39057729|FG002|Overall Study|Blood draws|0|||
16156922|NCT00861744|39057730|FG003|Overall Study|Blood draws|1|||
16156923|NCT01265550|39057735|FG000|Pre Randomization|Withdrawal by Subject|0|||
16156924|NCT01265550|39057736|FG001|Pre Randomization|Withdrawal by Subject|0|||
16445075|NCT01972217|40108548|FG003|Part B Double-blind, Randomised Period|Death|44|||
16445076|NCT01972217|40108545|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
16445077|NCT01972217|40108546|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
16445078|NCT01972217|40108547|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
16445079|NCT01972217|40108548|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
16445080|NCT01972217|40108545|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
16445081|NCT01972217|40108546|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
16445082|NCT01972217|40108547|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
16445083|NCT01972217|40108548|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
16445084|NCT01972217|40108545|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
16445085|NCT01972217|40108546|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
16445086|NCT01972217|40108547|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
16445087|NCT01972217|40108548|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
16445088|NCT01972217|40108545|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
16445089|NCT01972217|40108546|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
16445090|NCT01972217|40108547|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
16445091|NCT01972217|40108548|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
16445092|NCT00087152|40108551|FG000|Overall Study|Ineligible|6|||
16445093|NCT02081677|40108552|FG000|Overall Study|Adverse Event|0|||
16445094|NCT02081677|40108553|FG001|Overall Study|Adverse Event|0|||
16445095|NCT02081677|40108554|FG002|Overall Study|Adverse Event|1|||
16445096|NCT02081677|40108555|FG003|Overall Study|Adverse Event|0|||
16445097|NCT02081677|40108552|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16445098|NCT02081677|40108553|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16445099|NCT02081677|40108554|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
16445100|NCT02081677|40108555|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
16445101|NCT02081677|40108552|FG000|Overall Study|Not comfortable with lens care system|1|||
16445102|NCT02081677|40108553|FG001|Overall Study|Not comfortable with lens care system|0|||
16445103|NCT02081677|40108554|FG002|Overall Study|Not comfortable with lens care system|0|||
16445104|NCT02081677|40108555|FG003|Overall Study|Not comfortable with lens care system|0|||
16445105|NCT02081677|40108552|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
16445106|NCT02081677|40108553|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
16445107|NCT02081677|40108554|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
16445108|NCT02081677|40108555|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
16445109|NCT02749422|40108556|FG000|Overall Study|Lost to Follow-up|0|||
16445110|NCT02749422|40108557|FG001|Overall Study|Lost to Follow-up|2|||
16445111|NCT02749422|40108556|FG000|Overall Study|Ineligible|0|||
16445112|NCT02749422|40108557|FG001|Overall Study|Ineligible|1|||
16445113|NCT02072668|40108558|FG000|Second Intervention|Lost to Follow-up|1|||
16445114|NCT02072668|40108559|FG001|Second Intervention|Lost to Follow-up|0|||
16445115|NCT00836693|40108560|FG000|Overall Study|Adverse Event|4|||
16445116|NCT00836693|40108561|FG001|Overall Study|Adverse Event|1|||
16445117|NCT00836693|40108560|FG000|Overall Study|Sponsor Decision|0|||
16445118|NCT00836693|40108561|FG001|Overall Study|Sponsor Decision|1|||
16445119|NCT00836693|40108560|FG000|Overall Study|Physician Decision|2|||
16445120|NCT00836693|40108561|FG001|Overall Study|Physician Decision|0|||
16445121|NCT00836693|40108560|FG000|Overall Study|Withdrawal by Subject|9|||
16445122|NCT00836693|40108561|FG001|Overall Study|Withdrawal by Subject|4|||
16445123|NCT00836693|40108560|FG000|Overall Study|Protocol Violation|1|||
16445124|NCT00836693|40108561|FG001|Overall Study|Protocol Violation|0|||
16445125|NCT00836693|40108560|FG000|Overall Study|Lost to Follow-up|1|||
16445126|NCT00836693|40108561|FG001|Overall Study|Lost to Follow-up|0|||
16445127|NCT03198715|40108564|FG000|Overall Study|Death|0|||
16445128|NCT03198715|40108565|FG001|Overall Study|Death|0|||
16445129|NCT03198715|40108566|FG002|Overall Study|Death|1|||
16445130|NCT03198715|40108567|FG003|Overall Study|Death|0|||
16445131|NCT03198715|40108568|FG004|Overall Study|Death|2|||
16445132|NCT03198715|40108564|FG000|Overall Study|Other|0|||
16445133|NCT03198715|40108565|FG001|Overall Study|Other|1|||
16445134|NCT03198715|40108566|FG002|Overall Study|Other|1|||
16445135|NCT03198715|40108567|FG003|Overall Study|Other|0|||
16445136|NCT03198715|40108568|FG004|Overall Study|Other|0|||
16445137|NCT04639245|40108570|FG000|Overall Study|Death|1|||
16445138|NCT03414983|40108572|FG000|Pre-Treatment|Other reasons|1|||
16445139|NCT03414983|40108573|FG001|Pre-Treatment|Other reasons|0|||
16445140|NCT03414983|40108572|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
16445141|NCT03414983|40108573|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
16445142|NCT03414983|40108572|FG000|Pre-Treatment|Participant withdrew consent|1|||
16445143|NCT03414983|40108573|FG001|Pre-Treatment|Participant withdrew consent|3|||
16445144|NCT03414983|40108572|FG000|Treatment|Participant withdrew consent|4|||
16445145|NCT03414983|40108573|FG001|Treatment|Participant withdrew consent|3|||
16445146|NCT03414983|40108572|FG000|Treatment|Participant request to discontinue study treatment|8|||
16445147|NCT03414983|40108573|FG001|Treatment|Participant request to discontinue study treatment|10|||
16445148|NCT03414983|40108572|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
16445149|NCT03414983|40108573|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
16445150|NCT03414983|40108572|FG000|Treatment|Death|0|||
16445151|NCT03414983|40108573|FG001|Treatment|Death|1|||
16445152|NCT03414983|40108572|FG000|Treatment|Study Drug Toxicity|10|||
16445153|NCT03414983|40108573|FG001|Treatment|Study Drug Toxicity|5|||
16445154|NCT03414983|40108572|FG000|Treatment|Disease Progression|75|||
16445155|NCT03414983|40108573|FG001|Treatment|Disease Progression|29|||
16445156|NCT03414983|40108572|FG000|Treatment|Not reported|1|||
16445157|NCT03414983|40108573|FG001|Treatment|Not reported|0|||
16445158|NCT03414983|40108572|FG000|Treatment|Other reasons|3|||
16445159|NCT03414983|40108573|FG001|Treatment|Other reasons|2|||
16445160|NCT03414983|40108572|FG000|Treatment|Poor/non-compliance|2|||
16445161|NCT03414983|40108573|FG001|Treatment|Poor/non-compliance|0|||
16445162|NCT03414983|40108572|FG000|Treatment|Maximum clinical benefit|5|||
16445163|NCT03414983|40108573|FG001|Treatment|Maximum clinical benefit|9|||
16445164|NCT03414983|40108572|FG000|Treatment|Lost to Follow-up|0|||
16445165|NCT03414983|40108573|FG001|Treatment|Lost to Follow-up|1|||
16445166|NCT03414983|40108572|FG000|Treatment|Administrative reasons by sponsor|1|||
16445167|NCT03414983|40108573|FG001|Treatment|Administrative reasons by sponsor|0|||
16445168|NCT02121535|40108575|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
16445169|NCT02121535|40108576|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
16156925|NCT01265550|39057737|FG002|Pre Randomization|Withdrawal by Subject|0|||
16445170|NCT02121535|40108575|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
16445171|NCT02121535|40108576|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
16445172|NCT02120898|40108577|FG000|Overall Study|Withdrawal by Subject|4|||
16445173|NCT02120898|40108578|FG001|Overall Study|Withdrawal by Subject|2|||
16445174|NCT02120898|40108579|FG002|Overall Study|Withdrawal by Subject|2|||
16445175|NCT02120898|40108577|FG000|Overall Study|Non-compliance with study drug|3|||
16445176|NCT02120898|40108578|FG001|Overall Study|Non-compliance with study drug|0|||
16445177|NCT02120898|40108579|FG002|Overall Study|Non-compliance with study drug|0|||
16445178|NCT02120898|40108577|FG000|Overall Study|Adverse Event|1|||
16445179|NCT02120898|40108578|FG001|Overall Study|Adverse Event|2|||
16445180|NCT02120898|40108579|FG002|Overall Study|Adverse Event|1|||
16445181|NCT02120898|40108577|FG000|Overall Study|Protocol Violation|1|||
16445182|NCT02120898|40108578|FG001|Overall Study|Protocol Violation|2|||
16445183|NCT02120898|40108579|FG002|Overall Study|Protocol Violation|0|||
16445184|NCT02120898|40108577|FG000|Overall Study|Lost to Follow-up|0|||
16445185|NCT02120898|40108578|FG001|Overall Study|Lost to Follow-up|0|||
16445186|NCT02120898|40108579|FG002|Overall Study|Lost to Follow-up|1|||
16156926|NCT01265550|39057738|FG003|Pre Randomization|Withdrawal by Subject|70|||
16156927|NCT01265550|39057735|FG000|Pre Randomization|Technical Exclusions|0|||
16156928|NCT01265550|39057736|FG001|Pre Randomization|Technical Exclusions|0|||
16156929|NCT01265550|39057737|FG002|Pre Randomization|Technical Exclusions|0|||
16156930|NCT01265550|39057738|FG003|Pre Randomization|Technical Exclusions|54|||
16156931|NCT01265550|39057735|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
16156932|NCT01265550|39057736|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
16156933|NCT01265550|39057737|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
16156934|NCT01265550|39057738|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
16156935|NCT01265550|39057735|FG000|Pre Randomization|Non-GERD organic disorders|0|||
16156936|NCT01265550|39057736|FG001|Pre Randomization|Non-GERD organic disorders|0|||
16156937|NCT01265550|39057737|FG002|Pre Randomization|Non-GERD organic disorders|0|||
16156938|NCT01265550|39057738|FG003|Pre Randomization|Non-GERD organic disorders|23|||
16156939|NCT01265550|39057735|FG000|Pre Randomization|Functional heartburn|0|||
16156940|NCT01265550|39057736|FG001|Pre Randomization|Functional heartburn|0|||
16156941|NCT01265550|39057737|FG002|Pre Randomization|Functional heartburn|0|||
16156942|NCT01265550|39057738|FG003|Pre Randomization|Functional heartburn|99|||
16156943|NCT03657043|39057743|FG000|Overall Study|Withdrawal by Subject|1|||
16156944|NCT03657043|39057744|FG001|Overall Study|Withdrawal by Subject|1|||
16156945|NCT03657043|39057745|FG002|Overall Study|Withdrawal by Subject|0|||
16156946|NCT03657043|39057746|FG003|Overall Study|Withdrawal by Subject|0|||
16156947|NCT03657043|39057747|FG004|Overall Study|Withdrawal by Subject|4|||
16156948|NCT03657043|39057743|FG000|Overall Study|Study closure by Sponsor|0|||
16367621|NCT01947933|39828911|FG001|Overall Study|Lost to Follow-up|0|||
16367622|NCT01947933|39828912|FG002|Overall Study|Lost to Follow-up|0|||
16367623|NCT01947933|39828913|FG003|Overall Study|Lost to Follow-up|0|||
16156949|NCT03657043|39057744|FG001|Overall Study|Study closure by Sponsor|2|||
16156950|NCT03657043|39057745|FG002|Overall Study|Study closure by Sponsor|0|||
16156951|NCT03657043|39057746|FG003|Overall Study|Study closure by Sponsor|0|||
16156952|NCT03657043|39057747|FG004|Overall Study|Study closure by Sponsor|17|||
16156953|NCT03657043|39057743|FG000|Overall Study|Lost to Follow-up|0|||
16156954|NCT03657043|39057744|FG001|Overall Study|Lost to Follow-up|0|||
16156955|NCT03657043|39057745|FG002|Overall Study|Lost to Follow-up|0|||
16156956|NCT03657043|39057746|FG003|Overall Study|Lost to Follow-up|0|||
16156957|NCT03657043|39057747|FG004|Overall Study|Lost to Follow-up|4|||
16156958|NCT03657043|39057743|FG000|Overall Study|Death|6|||
16156959|NCT03657043|39057744|FG001|Overall Study|Death|5|||
16156960|NCT03657043|39057745|FG002|Overall Study|Death|0|||
16156961|NCT03657043|39057746|FG003|Overall Study|Death|0|||
16156962|NCT03657043|39057747|FG004|Overall Study|Death|53|||
16156963|NCT03657043|39057743|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
16156964|NCT03657043|39057744|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
16156965|NCT03657043|39057745|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
16156966|NCT03657043|39057746|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
16156967|NCT03657043|39057747|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
16156968|NCT03657043|39057743|FG000|Overall Study|Adverse Event|0|||
16156969|NCT03657043|39057744|FG001|Overall Study|Adverse Event|0|||
16156970|NCT03657043|39057745|FG002|Overall Study|Adverse Event|0|||
16156971|NCT03657043|39057746|FG003|Overall Study|Adverse Event|0|||
16156972|NCT03657043|39057747|FG004|Overall Study|Adverse Event|2|||
16156973|NCT03657043|39057743|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
16156974|NCT03657043|39057744|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
16156975|NCT03657043|39057745|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
16367624|NCT01947933|39828914|FG004|Overall Study|Lost to Follow-up|0|||
16367625|NCT01947933|39828915|FG005|Overall Study|Lost to Follow-up|0|||
16367626|NCT01947933|39828916|FG006|Overall Study|Lost to Follow-up|0|||
16367627|NCT01947933|39828917|FG007|Overall Study|Lost to Follow-up|0|||
16367628|NCT01947933|39828918|FG008|Overall Study|Lost to Follow-up|1|||
16367629|NCT00471354|39828919|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
16367630|NCT00471354|39828919|FG000|Overall Study|Adverse Event|13|||
16367631|NCT00471354|39828919|FG000|Overall Study|Protocol Violation|12|||
16367632|NCT00471354|39828919|FG000|Overall Study|Withdrawal by Subject|1|||
16367633|NCT00471354|39828919|FG000|Overall Study|Physician Decision|4|||
16367634|NCT00471354|39828919|FG000|Overall Study|Sponsor Decision|1|||
16367635|NCT00471354|39828919|FG000|Overall Study|Lost to Follow-up|3|||
16367636|NCT00471354|39828919|FG000|Overall Study|Lack of Efficacy|5|||
16367637|NCT00471354|39828919|FG000|Overall Study|Patient/Caregiver Decision|12|||
16367638|NCT00962650|39828920|FG000|Overall Study|Transgastric DP was not completed|2|||
16367639|NCT02447029|39828921|FG000|Overall Study|Withdrawal by Subject|3|||
16367640|NCT02447029|39828922|FG001|Overall Study|Withdrawal by Subject|2|||
16156976|NCT03657043|39057746|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
16156977|NCT03657043|39057747|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
16367641|NCT01704079|39828925|FG000|Overall Study|Withdrawal by Subject|5|||
16367642|NCT01704079|39828926|FG001|Overall Study|Withdrawal by Subject|7|||
16367643|NCT01704079|39828925|FG000|Overall Study|Lost to Follow-up|2|||
16367644|NCT01704079|39828926|FG001|Overall Study|Lost to Follow-up|5|||
16367645|NCT01704079|39828925|FG000|Overall Study|Adverse Event|4|||
16367646|NCT01704079|39828926|FG001|Overall Study|Adverse Event|7|||
16367647|NCT01704079|39828925|FG000|Overall Study|Protocol Violation|1|||
16367648|NCT01704079|39828926|FG001|Overall Study|Protocol Violation|0|||
16367649|NCT01704079|39828925|FG000|Overall Study|Subject noncompliance|2|||
16367650|NCT01704079|39828926|FG001|Overall Study|Subject noncompliance|3|||
16367651|NCT01704079|39828925|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
16367652|NCT01704079|39828926|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
16367653|NCT01002105|39828927|FG000|Overall Study|Lost to Follow-up|10|||
16367654|NCT01002105|39828928|FG001|Overall Study|Lost to Follow-up|16|||
16367655|NCT01002105|39828927|FG000|Overall Study|non compliance|5|||
16367656|NCT01002105|39828928|FG001|Overall Study|non compliance|3|||
16367657|NCT01002105|39828927|FG000|Overall Study|condition worsened|4|||
16367658|NCT01002105|39828928|FG001|Overall Study|condition worsened|2|||
16367659|NCT00429299|39828929|FG000|Overall Study|Disease Progression|1|||
16367660|NCT00429299|39828930|FG001|Overall Study|Disease Progression|1|||
16367661|NCT00429299|39828931|FG002|Overall Study|Disease Progression|0|||
16367662|NCT00429299|39828929|FG000|Overall Study|Adverse Event|2|||
16367663|NCT00429299|39828930|FG001|Overall Study|Adverse Event|5|||
16367664|NCT00429299|39828931|FG002|Overall Study|Adverse Event|1|||
16367665|NCT00429299|39828929|FG000|Overall Study|Protocol Violation|1|||
16367666|NCT00429299|39828930|FG001|Overall Study|Protocol Violation|0|||
16367667|NCT00429299|39828931|FG002|Overall Study|Protocol Violation|0|||
16367668|NCT00429299|39828929|FG000|Overall Study|Withdrawal by Subject|0|||
16367669|NCT00429299|39828930|FG001|Overall Study|Withdrawal by Subject|1|||
16367670|NCT00429299|39828931|FG002|Overall Study|Withdrawal by Subject|3|||
16367671|NCT00805532|39828932|FG000|Overall Study|invalid data|0|||
16367672|NCT00805532|39828933|FG001|Overall Study|invalid data|1|||
16367673|NCT03600428|39828934|FG000|Overall Study|Not eligible|0|||
16367674|NCT03600428|39828935|FG001|Overall Study|Not eligible|1|||
16367675|NCT03600428|39828934|FG000|Overall Study|Lost to Follow-up|5|||
16367676|NCT03600428|39828935|FG001|Overall Study|Lost to Follow-up|4|||
16367677|NCT00114777|39828936|FG000|Randomization to Month 36|Death|10|||
16445187|NCT03610269|40108580|FG000|Overall Study|Physician Decision|10|||
16445188|NCT03610269|40108580|FG000|Overall Study|Protocol Violation|1|||
16445189|NCT03610269|40108580|FG000|Overall Study|Unable to draw blood|1|||
16445190|NCT03610269|40108580|FG000|Overall Study|Screen fail|4|||
16445191|NCT05050318|40108581|FG000|Overall Study|Protocol Deviation|1|||
16445192|NCT05050318|40108582|FG001|Overall Study|Protocol Deviation|0|||
16445193|NCT05050318|40108583|FG002|Overall Study|Protocol Deviation|0|||
16445194|NCT01597596|40108590|FG000|Overall Study|Study terminated by sponsor|1|||
16445195|NCT01597596|40108591|FG001|Overall Study|Study terminated by sponsor|0|||
16445196|NCT01597596|40108590|FG000|Overall Study|Physician Decision|0|||
16445197|NCT01597596|40108591|FG001|Overall Study|Physician Decision|1|||
16445198|NCT02488915|40108592|FG000|Overall Study|Death|21|||
16445199|NCT02488915|40108592|FG000|Overall Study|Lost to Follow-up|4|||
16445200|NCT02488915|40108592|FG000|Overall Study|Withdrawal by Subject|1|||
16445201|NCT00335777|40108594|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
16445202|NCT00335777|40108594|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
16445203|NCT00335777|40108594|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
16445204|NCT00335777|40108594|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
16445205|NCT00335777|40108594|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
16445206|NCT01393821|40108597|FG000|Overall Study|Cancel|1|||
16445207|NCT01393821|40108598|FG001|Overall Study|Cancel|1|||
16445208|NCT01393821|40108597|FG000|Overall Study|not evaluable for primary endpoint|4|||
16445209|NCT01393821|40108598|FG001|Overall Study|not evaluable for primary endpoint|2|||
16445210|NCT01292486|40108599|FG000|Overall Study|Protocol Violation|2|||
16445211|NCT01292486|40108599|FG000|Overall Study|Did not meet screening criteria|2|||
16445212|NCT01292486|40108599|FG000|Overall Study|Adverse Event|1|||
16445213|NCT01292486|40108599|FG000|Overall Study|Physician Decision|1|||
16445214|NCT00551642|40108601|FG000|Treatment Period|Protocol Deviation|6|||
16445215|NCT00551642|40108602|FG001|Treatment Period|Protocol Deviation|11|||
16445216|NCT00551642|40108601|FG000|Treatment Period|Delivery device failure|1|||
16367678|NCT00114777|39828937|FG001|Randomization to Month 36|Death|4|||
16367679|NCT00114777|39828938|FG002|Randomization to Month 36|Death|3|||
16367680|NCT00114777|39828936|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
16367681|NCT00114777|39828937|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
16367682|NCT00114777|39828938|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
16367683|NCT00114777|39828936|FG000|Randomization to Month 36|Lack of Efficacy|19|||
16445217|NCT00551642|40108602|FG001|Treatment Period|Delivery device failure|3|||
16445218|NCT00551642|40108601|FG000|Treatment Period|Physician Decision|0|||
16445219|NCT00551642|40108602|FG001|Treatment Period|Physician Decision|1|||
16445220|NCT00551642|40108601|FG000|Treatment Period|Death|33|||
16445221|NCT00551642|40108602|FG001|Treatment Period|Death|31|||
16445222|NCT00551642|40108601|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
16445223|NCT00551642|40108602|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
16445224|NCT00551642|40108601|FG000|Treatment Period|Adverse Event|15|||
16445225|NCT00551642|40108602|FG001|Treatment Period|Adverse Event|12|||
16445226|NCT00551642|40108601|FG000|Treatment Period|Withdrawal by Subject|2|||
16445227|NCT00551642|40108602|FG001|Treatment Period|Withdrawal by Subject|1|||
16445228|NCT00762164|40108603|FG000|Overall Study|Lost to Follow-up|1|||
16445229|NCT00762164|40108604|FG001|Overall Study|Lost to Follow-up|1|||
16367684|NCT00114777|39828937|FG001|Randomization to Month 36|Lack of Efficacy|15|||
16367685|NCT00114777|39828938|FG002|Randomization to Month 36|Lack of Efficacy|17|||
16367686|NCT00114777|39828936|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
16367687|NCT00114777|39828937|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
16367688|NCT00114777|39828938|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
16367689|NCT00114777|39828936|FG000|Randomization to Month 36|Adverse Event|34|||
16367690|NCT00114777|39828937|FG001|Randomization to Month 36|Adverse Event|35|||
16367691|NCT00114777|39828938|FG002|Randomization to Month 36|Adverse Event|44|||
16367692|NCT00114777|39828936|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
16367693|NCT00114777|39828937|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
16367694|NCT00114777|39828938|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
16367695|NCT00114777|39828936|FG000|Randomization to Month 36|Other|9|||
16367696|NCT00114777|39828937|FG001|Randomization to Month 36|Other|3|||
16367697|NCT00114777|39828938|FG002|Randomization to Month 36|Other|12|||
16367698|NCT00114777|39828936|FG000|Long-Term Extension to Month 84|Death|8|||
16156978|NCT03657043|39057743|FG000|Overall Study|Withdrawal - declined follow-up|0|||
16156979|NCT03657043|39057744|FG001|Overall Study|Withdrawal - declined follow-up|0|||
16367699|NCT00114777|39828937|FG001|Long-Term Extension to Month 84|Death|13|||
16367700|NCT00114777|39828938|FG002|Long-Term Extension to Month 84|Death|7|||
16367701|NCT00114777|39828936|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
16367702|NCT00114777|39828937|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
16367703|NCT00114777|39828938|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
16367704|NCT00114777|39828936|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
16367705|NCT00114777|39828937|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
16367706|NCT00114777|39828938|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
16367707|NCT00114777|39828936|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
16367708|NCT00114777|39828937|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
16367709|NCT00114777|39828938|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
16367710|NCT00114777|39828936|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
16367711|NCT00114777|39828937|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
16367712|NCT00114777|39828938|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
16367713|NCT00114777|39828936|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
16367714|NCT00114777|39828937|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
16367715|NCT00114777|39828938|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
16367716|NCT00114777|39828936|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
16367717|NCT00114777|39828937|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
16367718|NCT00114777|39828938|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
16367719|NCT00114777|39828936|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
16367720|NCT00114777|39828937|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
16367721|NCT00114777|39828938|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
16367722|NCT00114777|39828936|FG000|Long-Term Extension to Month 84|Other|2|||
16367723|NCT00114777|39828937|FG001|Long-Term Extension to Month 84|Other|0|||
16367724|NCT00114777|39828938|FG002|Long-Term Extension to Month 84|Other|2|||
16367725|NCT02232698|39828940|FG000|Overall Study|Pregnancy|1|||
16367726|NCT02232698|39828941|FG001|Overall Study|Pregnancy|1|||
16367727|NCT02232698|39828940|FG000|Overall Study|Met exclusion criteria|1|||
16367728|NCT02232698|39828941|FG001|Overall Study|Met exclusion criteria|1|||
16367729|NCT02232698|39828940|FG000|Overall Study|Had device-associated symptoms|7|||
16367730|NCT02232698|39828941|FG001|Overall Study|Had device-associated symptoms|0|||
16445230|NCT00762164|40108603|FG000|Overall Study|Discontinued medication|2|||
16445231|NCT00762164|40108604|FG001|Overall Study|Discontinued medication|0|||
16156980|NCT03657043|39057745|FG002|Overall Study|Withdrawal - declined follow-up|0|||
16367731|NCT02232698|39828940|FG000|Overall Study|Non-compliance with study device|1|||
16367732|NCT02232698|39828941|FG001|Overall Study|Non-compliance with study device|4|||
16367733|NCT02232698|39828940|FG000|Overall Study|Allocated to control group|0|||
16367734|NCT02232698|39828941|FG001|Overall Study|Allocated to control group|3|||
16445232|NCT00762164|40108603|FG000|Overall Study|Withdrawal by Subject|0|||
16367735|NCT02232698|39828940|FG000|Overall Study|Withdrawal by Subject|0|||
16367736|NCT02232698|39828941|FG001|Overall Study|Withdrawal by Subject|11|||
16367737|NCT01091259|39828942|FG000|Overall Study|Adverse Event|3|||
16367738|NCT01091259|39828942|FG000|Overall Study|Lack of Efficacy|2|||
16367739|NCT02300610|39828943|FG000|Overall Study|Withdrawal by Subject|1|||
16367740|NCT02300610|39828944|FG001|Overall Study|Withdrawal by Subject|0|||
16367741|NCT02300610|39828945|FG002|Overall Study|Withdrawal by Subject|1|||
16367742|NCT02393755|39828949|FG000|Overall Study|Withdrawal by Subject|0|||
16367743|NCT02393755|39828950|FG001|Overall Study|Withdrawal by Subject|3|||
16367744|NCT02393755|39828949|FG000|Overall Study|Adverse Event|0|||
16367745|NCT02393755|39828950|FG001|Overall Study|Adverse Event|2|||
16367746|NCT02393755|39828949|FG000|Overall Study|Physician Decision|0|||
16367747|NCT02393755|39828950|FG001|Overall Study|Physician Decision|2|||
16367748|NCT02018887|39828951|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
16367749|NCT02018887|39828952|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16367750|NCT02018887|39828953|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16367751|NCT02018887|39828954|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16367752|NCT02018887|39828955|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16367753|NCT02018887|39828956|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16367754|NCT02018887|39828957|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16367755|NCT02018887|39828958|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16367756|NCT02018887|39828959|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16367757|NCT02018887|39828960|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16367758|NCT02018887|39828961|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
16367759|NCT02018887|39828951|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16367760|NCT02018887|39828952|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16367761|NCT02018887|39828953|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16367762|NCT02018887|39828954|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16367763|NCT02018887|39828955|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
16156981|NCT03657043|39057746|FG003|Overall Study|Withdrawal - declined follow-up|0|||
16156982|NCT03657043|39057747|FG004|Overall Study|Withdrawal - declined follow-up|1|||
16156983|NCT04766021|39061324|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
16156984|NCT04766021|39061324|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
16156985|NCT04327388|39061325|FG000|Overall Study|Adverse Event|17|||
16156986|NCT04327388|39061326|FG001|Overall Study|Adverse Event|18|||
16156987|NCT04327388|39061327|FG002|Overall Study|Adverse Event|9|||
16156988|NCT04327388|39061325|FG000|Overall Study|Other|1|||
16156989|NCT04327388|39061326|FG001|Overall Study|Other|2|||
16156990|NCT04327388|39061327|FG002|Overall Study|Other|0|||
16156991|NCT04327388|39061325|FG000|Overall Study|Randomized and not treated|2|||
16156992|NCT04327388|39061326|FG001|Overall Study|Randomized and not treated|0|||
16156993|NCT04327388|39061327|FG002|Overall Study|Randomized and not treated|2|||
16156994|NCT01396005|39061328|FG000|Overall Study|Withdrawal by Subject|0|||
16156995|NCT01396005|39061329|FG001|Overall Study|Withdrawal by Subject|1|||
16156996|NCT01396005|39061328|FG000|Overall Study|Non-compliance with protocol|0|||
16156997|NCT01396005|39061329|FG001|Overall Study|Non-compliance with protocol|1|||
16156998|NCT01148537|39061330|FG000|Overall Study|Withdrawal by Subject|1|||
16156999|NCT01148537|39061331|FG001|Overall Study|Withdrawal by Subject|0|||
16157000|NCT01148537|39061332|FG002|Overall Study|Withdrawal by Subject|2|||
16157001|NCT01148537|39061330|FG000|Overall Study|Adverse Event|2|||
16157002|NCT01148537|39061331|FG001|Overall Study|Adverse Event|0|||
16157003|NCT01148537|39061332|FG002|Overall Study|Adverse Event|1|||
16157004|NCT00953758|39061334|FG000|Overall Study|Death|2|||
16157005|NCT00953758|39061335|FG001|Overall Study|Death|0|||
16157006|NCT00953758|39061336|FG002|Overall Study|Death|1|||
16157007|NCT00953758|39061337|FG003|Overall Study|Death|1|||
16367764|NCT02018887|39828956|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16367765|NCT02018887|39828957|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
16367766|NCT02018887|39828958|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
16367767|NCT02018887|39828959|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16367768|NCT02018887|39828960|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16367769|NCT02018887|39828961|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
16367770|NCT02018887|39828951|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
16367771|NCT02018887|39828952|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
16367772|NCT02018887|39828953|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
16367773|NCT02018887|39828954|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
16367774|NCT02018887|39828955|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
16367775|NCT02018887|39828956|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
16367776|NCT02018887|39828957|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
16367777|NCT02018887|39828958|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
16367778|NCT02018887|39828959|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
16367779|NCT02018887|39828960|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
16367780|NCT02018887|39828961|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
16367781|NCT02018887|39828951|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
16367782|NCT02018887|39828952|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
16367783|NCT02018887|39828953|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
16367784|NCT02018887|39828954|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
16157008|NCT00953758|39061338|FG004|Overall Study|Death|1|||
16157009|NCT00953758|39061339|FG005|Overall Study|Death|1|||
16157010|NCT00953758|39061340|FG006|Overall Study|Death|1|||
16367785|NCT02018887|39828955|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
16367786|NCT02018887|39828956|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
16157011|NCT00953758|39061341|FG007|Overall Study|Death|3|||
16157012|NCT00953758|39061342|FG008|Overall Study|Death|1|||
16157013|NCT00953758|39061343|FG009|Overall Study|Death|0|||
16157014|NCT00953758|39061334|FG000|Overall Study|Participant refused further follow-up|0|||
16157015|NCT00953758|39061335|FG001|Overall Study|Participant refused further follow-up|0|||
16157016|NCT00953758|39061336|FG002|Overall Study|Participant refused further follow-up|1|||
16157017|NCT00953758|39061337|FG003|Overall Study|Participant refused further follow-up|0|||
16157018|NCT00953758|39061338|FG004|Overall Study|Participant refused further follow-up|3|||
16157019|NCT00953758|39061339|FG005|Overall Study|Participant refused further follow-up|0|||
16157020|NCT00953758|39061340|FG006|Overall Study|Participant refused further follow-up|0|||
16157021|NCT00953758|39061341|FG007|Overall Study|Participant refused further follow-up|0|||
16157022|NCT00953758|39061342|FG008|Overall Study|Participant refused further follow-up|1|||
16157023|NCT00953758|39061343|FG009|Overall Study|Participant refused further follow-up|0|||
16157024|NCT00953758|39061334|FG000|Overall Study|Lost to Follow-up|0|||
16157025|NCT00953758|39061335|FG001|Overall Study|Lost to Follow-up|0|||
16157026|NCT00953758|39061336|FG002|Overall Study|Lost to Follow-up|0|||
16157027|NCT00953758|39061337|FG003|Overall Study|Lost to Follow-up|1|||
16157028|NCT00953758|39061338|FG004|Overall Study|Lost to Follow-up|0|||
16157029|NCT00953758|39061339|FG005|Overall Study|Lost to Follow-up|0|||
16157030|NCT00953758|39061340|FG006|Overall Study|Lost to Follow-up|0|||
16157031|NCT00953758|39061341|FG007|Overall Study|Lost to Follow-up|1|||
16157032|NCT00953758|39061342|FG008|Overall Study|Lost to Follow-up|0|||
16157033|NCT00953758|39061343|FG009|Overall Study|Lost to Follow-up|1|||
16157034|NCT00953758|39061334|FG000|Overall Study|Physician Decision|0|||
16157035|NCT00953758|39061335|FG001|Overall Study|Physician Decision|0|||
16157036|NCT00953758|39061336|FG002|Overall Study|Physician Decision|0|||
16157037|NCT00953758|39061337|FG003|Overall Study|Physician Decision|0|||
16157038|NCT00953758|39061338|FG004|Overall Study|Physician Decision|1|||
16157039|NCT00953758|39061339|FG005|Overall Study|Physician Decision|0|||
16157040|NCT00953758|39061340|FG006|Overall Study|Physician Decision|0|||
16157041|NCT00953758|39061341|FG007|Overall Study|Physician Decision|0|||
16157042|NCT00953758|39061342|FG008|Overall Study|Physician Decision|0|||
16157043|NCT00953758|39061343|FG009|Overall Study|Physician Decision|0|||
16157044|NCT00953758|39061334|FG000|Overall Study|Disease progression|0|||
16157045|NCT00953758|39061335|FG001|Overall Study|Disease progression|0|||
16157046|NCT00953758|39061336|FG002|Overall Study|Disease progression|0|||
16157047|NCT00953758|39061337|FG003|Overall Study|Disease progression|0|||
16157048|NCT00953758|39061338|FG004|Overall Study|Disease progression|1|||
16157049|NCT00953758|39061339|FG005|Overall Study|Disease progression|0|||
16157050|NCT00953758|39061340|FG006|Overall Study|Disease progression|0|||
16157051|NCT00953758|39061341|FG007|Overall Study|Disease progression|0|||
16157052|NCT00953758|39061342|FG008|Overall Study|Disease progression|0|||
16157053|NCT00953758|39061343|FG009|Overall Study|Disease progression|0|||
16157054|NCT00953758|39061334|FG000|Overall Study|Participant went for transplant|0|||
16157055|NCT00953758|39061335|FG001|Overall Study|Participant went for transplant|0|||
16157056|NCT00953758|39061336|FG002|Overall Study|Participant went for transplant|0|||
16157057|NCT00953758|39061337|FG003|Overall Study|Participant went for transplant|0|||
16157058|NCT00953758|39061338|FG004|Overall Study|Participant went for transplant|0|||
16157059|NCT00953758|39061339|FG005|Overall Study|Participant went for transplant|0|||
16157060|NCT00953758|39061340|FG006|Overall Study|Participant went for transplant|0|||
16157061|NCT00953758|39061341|FG007|Overall Study|Participant went for transplant|0|||
16157062|NCT00953758|39061342|FG008|Overall Study|Participant went for transplant|1|||
16157063|NCT00953758|39061343|FG009|Overall Study|Participant went for transplant|0|||
16157064|NCT01073566|39061346|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
16157065|NCT01073566|39061347|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
16157066|NCT00109707|39061348|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
16157067|NCT00109707|39061349|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
16157068|NCT00109707|39061350|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
16157069|NCT00109707|39061348|FG000|Overall Study|Abnormal laboratory values|1|||
16157070|NCT00109707|39061349|FG001|Overall Study|Abnormal laboratory values|0|||
16157071|NCT00109707|39061350|FG002|Overall Study|Abnormal laboratory values|0|||
16157072|NCT00109707|39061348|FG000|Overall Study|Administrative problems|2|||
16157073|NCT00109707|39061349|FG001|Overall Study|Administrative problems|0|||
16157074|NCT00109707|39061350|FG002|Overall Study|Administrative problems|1|||
16157075|NCT00109707|39061348|FG000|Overall Study|Adverse Event|10|||
16157076|NCT00109707|39061349|FG001|Overall Study|Adverse Event|2|||
16157077|NCT00109707|39061350|FG002|Overall Study|Adverse Event|3|||
16157078|NCT00109707|39061348|FG000|Overall Study|Death|4|||
16367787|NCT02018887|39828957|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
16367788|NCT02018887|39828958|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
16367789|NCT02018887|39828959|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
16367790|NCT02018887|39828960|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
16157079|NCT00109707|39061349|FG001|Overall Study|Death|0|||
16157080|NCT00109707|39061350|FG002|Overall Study|Death|0|||
16157081|NCT00109707|39061348|FG000|Overall Study|Disease progression|12|||
16157082|NCT00109707|39061349|FG001|Overall Study|Disease progression|4|||
16157083|NCT00109707|39061350|FG002|Overall Study|Disease progression|3|||
16157084|NCT00109707|39061348|FG000|Overall Study|Lost to Follow-up|3|||
16157085|NCT00109707|39061349|FG001|Overall Study|Lost to Follow-up|0|||
16157086|NCT00109707|39061350|FG002|Overall Study|Lost to Follow-up|0|||
16367791|NCT02018887|39828961|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
16367792|NCT01617967|39828962|FG000|Overall Study|Protocol Violation|0|||
16367793|NCT01617967|39828963|FG001|Overall Study|Protocol Violation|0|||
16367794|NCT01617967|39828964|FG002|Overall Study|Protocol Violation|0|||
16367795|NCT01617967|39828965|FG003|Overall Study|Protocol Violation|1|||
16367796|NCT01617967|39828966|FG004|Overall Study|Protocol Violation|0|||
16367797|NCT01617967|39828967|FG005|Overall Study|Protocol Violation|0|||
16367798|NCT01617967|39828962|FG000|Overall Study|Withdrawal by Subject|0|||
16367799|NCT01617967|39828963|FG001|Overall Study|Withdrawal by Subject|0|||
16367800|NCT01617967|39828964|FG002|Overall Study|Withdrawal by Subject|0|||
16367801|NCT01617967|39828965|FG003|Overall Study|Withdrawal by Subject|0|||
16367802|NCT01617967|39828966|FG004|Overall Study|Withdrawal by Subject|0|||
16157087|NCT00109707|39061348|FG000|Overall Study|Protocol Violation|1|||
16157088|NCT00109707|39061349|FG001|Overall Study|Protocol Violation|0|||
16157089|NCT00109707|39061350|FG002|Overall Study|Protocol Violation|0|||
16157090|NCT00109707|39061348|FG000|Overall Study|Patient withdrew consent|6|||
16157091|NCT00109707|39061349|FG001|Overall Study|Patient withdrew consent|1|||
16157092|NCT00109707|39061350|FG002|Overall Study|Patient withdrew consent|0|||
16367803|NCT01617967|39828967|FG005|Overall Study|Withdrawal by Subject|1|||
16367804|NCT01617967|39828962|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
16367805|NCT01617967|39828963|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
16367806|NCT01617967|39828964|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
16367807|NCT01617967|39828965|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
16367808|NCT01617967|39828966|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
16367809|NCT01617967|39828967|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
16367810|NCT03601052|39828968|FG000|Overall Study|Lost to Follow-up|2|||
16367811|NCT03197129|39828972|FG000|Overall Study|did not answer the VPT: shyness|4|||
16367812|NCT03197129|39828973|FG001|Overall Study|did not answer the VPT: shyness|5|||
16367813|NCT00676052|39828974|FG000|Overall Study|Adverse Event|0|||
16367814|NCT00676052|39828975|FG001|Overall Study|Adverse Event|1|||
16367815|NCT00676052|39828976|FG002|Overall Study|Adverse Event|1|||
16367816|NCT00676052|39828977|FG003|Overall Study|Adverse Event|2|||
16367817|NCT00676052|39828978|FG004|Overall Study|Adverse Event|2|||
16367818|NCT00676052|39828979|FG005|Overall Study|Adverse Event|2|||
16367819|NCT00676052|39828974|FG000|Overall Study|Lack of Efficacy|2|||
16367820|NCT00676052|39828975|FG001|Overall Study|Lack of Efficacy|2|||
16367821|NCT00676052|39828976|FG002|Overall Study|Lack of Efficacy|1|||
16367822|NCT00676052|39828977|FG003|Overall Study|Lack of Efficacy|1|||
16367823|NCT00676052|39828978|FG004|Overall Study|Lack of Efficacy|2|||
16367824|NCT00676052|39828979|FG005|Overall Study|Lack of Efficacy|1|||
16445233|NCT00762164|40108604|FG001|Overall Study|Withdrawal by Subject|1|||
16157093|NCT01967550|39061353|FG000|Overall Study|Withdrawal by Subject|1|||
16157094|NCT01967550|39061354|FG001|Overall Study|Withdrawal by Subject|0|||
16157095|NCT01967550|39061353|FG000|Overall Study|Adverse Event|2|||
16157096|NCT01967550|39061354|FG001|Overall Study|Adverse Event|0|||
16157097|NCT01967550|39061353|FG000|Overall Study|Protocol Violation|2|||
16157098|NCT01967550|39061354|FG001|Overall Study|Protocol Violation|1|||
16157099|NCT01967550|39061353|FG000|Overall Study|Non Compliance|0|||
16157100|NCT01967550|39061354|FG001|Overall Study|Non Compliance|1|||
16367825|NCT00676052|39828974|FG000|Overall Study|Protocol Violation|5|||
16367826|NCT00676052|39828975|FG001|Overall Study|Protocol Violation|3|||
16367827|NCT00676052|39828976|FG002|Overall Study|Protocol Violation|2|||
16367828|NCT00676052|39828977|FG003|Overall Study|Protocol Violation|2|||
16367829|NCT00676052|39828978|FG004|Overall Study|Protocol Violation|1|||
16367830|NCT00676052|39828979|FG005|Overall Study|Protocol Violation|2|||
16367831|NCT00676052|39828974|FG000|Overall Study|Lost to Follow-up|0|||
16367832|NCT00676052|39828975|FG001|Overall Study|Lost to Follow-up|0|||
16367833|NCT00676052|39828976|FG002|Overall Study|Lost to Follow-up|0|||
16367834|NCT00676052|39828977|FG003|Overall Study|Lost to Follow-up|0|||
16367835|NCT00676052|39828978|FG004|Overall Study|Lost to Follow-up|1|||
16367836|NCT00676052|39828979|FG005|Overall Study|Lost to Follow-up|0|||
16367837|NCT00676052|39828974|FG000|Overall Study|Physician Decision|1|||
16157101|NCT00812214|39061355|FG000|Overall Study|Lost to Follow-up|3|||
16367838|NCT00676052|39828975|FG001|Overall Study|Physician Decision|1|||
16367839|NCT00676052|39828976|FG002|Overall Study|Physician Decision|1|||
16157102|NCT00812214|39061356|FG001|Overall Study|Lost to Follow-up|1|||
16157103|NCT01437397|39061360|FG000|Overall Study|Lost to Follow-up|9|||
16157104|NCT01437397|39061361|FG001|Overall Study|Lost to Follow-up|4|||
16157105|NCT01437397|39061362|FG002|Overall Study|Lost to Follow-up|2|||
16157106|NCT01437397|39061363|FG003|Overall Study|Lost to Follow-up|4|||
16157107|NCT01437397|39061364|FG004|Overall Study|Lost to Follow-up|5|||
16157108|NCT01437397|39061360|FG000|Overall Study|Withdrawal by Subject|11|||
16157109|NCT01437397|39061361|FG001|Overall Study|Withdrawal by Subject|12|||
16157110|NCT01437397|39061362|FG002|Overall Study|Withdrawal by Subject|24|||
16157111|NCT01437397|39061363|FG003|Overall Study|Withdrawal by Subject|11|||
16157112|NCT01437397|39061364|FG004|Overall Study|Withdrawal by Subject|22|||
16157113|NCT01437397|39061360|FG000|Overall Study|Protocol Violation|10|||
16157114|NCT01437397|39061361|FG001|Overall Study|Protocol Violation|12|||
16157115|NCT01437397|39061362|FG002|Overall Study|Protocol Violation|13|||
16157116|NCT01437397|39061363|FG003|Overall Study|Protocol Violation|21|||
16157117|NCT01437397|39061364|FG004|Overall Study|Protocol Violation|19|||
16157118|NCT01437397|39061360|FG000|Overall Study|Lack of Efficacy|5|||
16157119|NCT01437397|39061361|FG001|Overall Study|Lack of Efficacy|4|||
16157120|NCT01437397|39061362|FG002|Overall Study|Lack of Efficacy|8|||
16157121|NCT01437397|39061363|FG003|Overall Study|Lack of Efficacy|10|||
16157122|NCT01437397|39061364|FG004|Overall Study|Lack of Efficacy|20|||
16157123|NCT01437397|39061360|FG000|Overall Study|Adverse Event|21|||
16157124|NCT01437397|39061361|FG001|Overall Study|Adverse Event|22|||
16157125|NCT01437397|39061362|FG002|Overall Study|Adverse Event|16|||
16157126|NCT01437397|39061363|FG003|Overall Study|Adverse Event|14|||
16157127|NCT01437397|39061364|FG004|Overall Study|Adverse Event|21|||
16157128|NCT01437397|39061360|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
16157129|NCT01437397|39061361|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
16157130|NCT01437397|39061362|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
16157131|NCT01437397|39061363|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
16157132|NCT01437397|39061364|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
16157133|NCT01580488|39061365|FG000|Overall Study|Withdrawal by Subject|1|||
16157134|NCT04677712|39061366|FG000|Overall Study|Lost to Follow-up|0|||
16157135|NCT04677712|39061367|FG001|Overall Study|Lost to Follow-up|1|||
16157136|NCT04677712|39061368|FG002|Overall Study|Lost to Follow-up|0|||
16445234|NCT01419236|40108605|FG000|Overall Study|Adverse Event|1|||
16157137|NCT04677712|39061369|FG003|Overall Study|Lost to Follow-up|0|||
16157138|NCT04677712|39061370|FG004|Overall Study|Lost to Follow-up|0|||
16157139|NCT04677712|39061371|FG005|Overall Study|Lost to Follow-up|0|||
16157140|NCT00085735|39061372|FG000|Overall Study|Adverse Event|1|||
16157141|NCT00085735|39061373|FG001|Overall Study|Adverse Event|0|||
16367840|NCT00676052|39828977|FG003|Overall Study|Physician Decision|0|||
16367841|NCT00676052|39828978|FG004|Overall Study|Physician Decision|0|||
16367842|NCT00676052|39828979|FG005|Overall Study|Physician Decision|1|||
16367843|NCT00676052|39828974|FG000|Overall Study|Withdrawal by Subject|1|||
16367844|NCT00676052|39828975|FG001|Overall Study|Withdrawal by Subject|0|||
16367845|NCT00676052|39828976|FG002|Overall Study|Withdrawal by Subject|1|||
16367846|NCT00676052|39828977|FG003|Overall Study|Withdrawal by Subject|0|||
16367847|NCT00676052|39828978|FG004|Overall Study|Withdrawal by Subject|0|||
16367848|NCT00676052|39828979|FG005|Overall Study|Withdrawal by Subject|0|||
16367849|NCT00774748|39828980|FG000|Overall Study|Lost to Follow-up|3|||
16367850|NCT03720847|39828981|FG000|Washout|Physician Decision|1|||
16367851|NCT03720847|39828982|FG001|Washout|Physician Decision|2|||
16367852|NCT02916927|39828984|FG000|Overall Study|Discharged prior to study drug receipt|0|||
16367853|NCT02916927|39828985|FG001|Overall Study|Discharged prior to study drug receipt|2|||
16367854|NCT02916927|39828984|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
16367855|NCT02916927|39828985|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
16367856|NCT02916927|39828984|FG000|Overall Study|Withdrawal before first time point|1|||
16367857|NCT02916927|39828985|FG001|Overall Study|Withdrawal before first time point|0|||
16367858|NCT02582632|39828987|FG000|Overall Study|Other|1|||
16367859|NCT02697422|39828990|FG000|Overall Study|Declined exit survey|9|||
16157142|NCT00085735|39061374|FG002|Overall Study|Adverse Event|0|||
16157143|NCT00085735|39061375|FG003|Overall Study|Adverse Event|0|||
16157144|NCT00085735|39061376|FG004|Overall Study|Adverse Event|0|||
16157145|NCT00085735|39061377|FG005|Overall Study|Adverse Event|0|||
16157146|NCT00085735|39061372|FG000|Overall Study|Lack of Efficacy|2|||
16157147|NCT00085735|39061373|FG001|Overall Study|Lack of Efficacy|4|||
16157148|NCT00085735|39061374|FG002|Overall Study|Lack of Efficacy|6|||
16157149|NCT00085735|39061375|FG003|Overall Study|Lack of Efficacy|3|||
16157150|NCT00085735|39061376|FG004|Overall Study|Lack of Efficacy|4|||
16157151|NCT00085735|39061377|FG005|Overall Study|Lack of Efficacy|3|||
16157152|NCT00085735|39061372|FG000|Overall Study|Lost to Follow-up|0|||
16157153|NCT00085735|39061373|FG001|Overall Study|Lost to Follow-up|1|||
16157154|NCT00085735|39061374|FG002|Overall Study|Lost to Follow-up|0|||
16157155|NCT00085735|39061375|FG003|Overall Study|Lost to Follow-up|0|||
16157156|NCT00085735|39061376|FG004|Overall Study|Lost to Follow-up|1|||
16157157|NCT00085735|39061377|FG005|Overall Study|Lost to Follow-up|0|||
16157158|NCT00085735|39061372|FG000|Overall Study|Physician Decision|2|||
16157159|NCT00085735|39061373|FG001|Overall Study|Physician Decision|3|||
16157160|NCT00085735|39061374|FG002|Overall Study|Physician Decision|2|||
16157161|NCT00085735|39061375|FG003|Overall Study|Physician Decision|3|||
16157162|NCT00085735|39061376|FG004|Overall Study|Physician Decision|11|||
16157163|NCT00085735|39061377|FG005|Overall Study|Physician Decision|8|||
16157164|NCT00085735|39061372|FG000|Overall Study|Protocol Violation|1|||
16157165|NCT00085735|39061373|FG001|Overall Study|Protocol Violation|0|||
16157166|NCT00085735|39061374|FG002|Overall Study|Protocol Violation|0|||
16157167|NCT00085735|39061375|FG003|Overall Study|Protocol Violation|0|||
16157168|NCT00085735|39061376|FG004|Overall Study|Protocol Violation|0|||
16157169|NCT00085735|39061377|FG005|Overall Study|Protocol Violation|0|||
16157170|NCT00085735|39061372|FG000|Overall Study|Withdrawal by Subject|1|||
16157171|NCT00085735|39061373|FG001|Overall Study|Withdrawal by Subject|0|||
16157172|NCT00085735|39061374|FG002|Overall Study|Withdrawal by Subject|4|||
16157173|NCT00085735|39061375|FG003|Overall Study|Withdrawal by Subject|5|||
16157174|NCT00085735|39061376|FG004|Overall Study|Withdrawal by Subject|7|||
16157175|NCT00085735|39061377|FG005|Overall Study|Withdrawal by Subject|8|||
16157176|NCT00085735|39061372|FG000|Overall Study|Patient ineligible|1|||
16157177|NCT00085735|39061373|FG001|Overall Study|Patient ineligible|0|||
16157178|NCT00085735|39061374|FG002|Overall Study|Patient ineligible|3|||
16157179|NCT00085735|39061375|FG003|Overall Study|Patient ineligible|7|||
16157180|NCT00085735|39061376|FG004|Overall Study|Patient ineligible|17|||
16157181|NCT00085735|39061377|FG005|Overall Study|Patient ineligible|8|||
16157182|NCT00085735|39061372|FG000|Overall Study|Excess residual disease|2|||
16157183|NCT00085735|39061373|FG001|Overall Study|Excess residual disease|2|||
16157184|NCT00085735|39061374|FG002|Overall Study|Excess residual disease|1|||
16157185|NCT00085735|39061375|FG003|Overall Study|Excess residual disease|1|||
16157186|NCT00085735|39061376|FG004|Overall Study|Excess residual disease|1|||
16157187|NCT00085735|39061377|FG005|Overall Study|Excess residual disease|4|||
16157188|NCT00085735|39061372|FG000|Overall Study|Reason not documented|1|||
16157189|NCT00085735|39061373|FG001|Overall Study|Reason not documented|0|||
16157190|NCT00085735|39061374|FG002|Overall Study|Reason not documented|1|||
16157191|NCT00085735|39061375|FG003|Overall Study|Reason not documented|0|||
16157192|NCT00085735|39061376|FG004|Overall Study|Reason not documented|1|||
16157193|NCT00085735|39061377|FG005|Overall Study|Reason not documented|0|||
16157194|NCT00085735|39061372|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
16157195|NCT00085735|39061373|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
16157196|NCT00085735|39061374|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
16157197|NCT00085735|39061375|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
16157198|NCT00085735|39061376|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
16157199|NCT00085735|39061377|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
16157200|NCT02568046|39061379|FG000|Overall Study|Adverse Event|0|||
16157201|NCT02568046|39061380|FG001|Overall Study|Adverse Event|1|||
16157202|NCT02568046|39061379|FG000|Overall Study|Death|2|||
16157203|NCT02568046|39061380|FG001|Overall Study|Death|0|||
16157204|NCT02568046|39061379|FG000|Overall Study|Progressive Disease|1|||
16157205|NCT02568046|39061380|FG001|Overall Study|Progressive Disease|0|||
16157206|NCT02568046|39061379|FG000|Overall Study|Withdrawal by Subject|2|||
16157207|NCT02568046|39061380|FG001|Overall Study|Withdrawal by Subject|1|||
16157208|NCT02568046|39061379|FG000|Overall Study|Other Events|0|||
16157209|NCT02568046|39061380|FG001|Overall Study|Other Events|1|||
16157210|NCT00268242|39061381|FG000|Overall Study|Death|1|||
16157211|NCT00429858|39061384|FG000|Overall Study|Withdrawal by Subject|1|||
16157212|NCT00429858|39061384|FG000|Overall Study|Study Termination|1|||
16157213|NCT00623428|39061385|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
16157214|NCT00623428|39061386|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
16157215|NCT00623428|39061385|FG000|Treatment Period|Death|0|||
16157216|NCT00623428|39061386|FG001|Treatment Period|Death|1|||
16157217|NCT00623428|39061385|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
16157218|NCT00623428|39061386|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
16157219|NCT00623428|39061385|FG000|Treatment Period|Insufficient therapeutic response|0|||
16157220|NCT00623428|39061386|FG001|Treatment Period|Insufficient therapeutic response|2|||
16157221|NCT00623428|39061385|FG000|Treatment Period|Other|0|||
16157222|NCT00623428|39061386|FG001|Treatment Period|Other|1|||
16157223|NCT00623428|39061385|FG000|Treatment Period|Withdrawal by Subject|0|||
16157224|NCT00623428|39061386|FG001|Treatment Period|Withdrawal by Subject|1|||
16157225|NCT00623428|39061385|FG000|Follow-up Period|Relapse post-treatment|11|||
16157226|NCT00623428|39061386|FG001|Follow-up Period|Relapse post-treatment|3|||
16157227|NCT00623428|39061385|FG000|Follow-up Period|Failure to return|10|||
16157228|NCT00623428|39061386|FG001|Follow-up Period|Failure to return|2|||
16445235|NCT01419236|40108606|FG001|Overall Study|Adverse Event|0|||
16445236|NCT01419236|40108605|FG000|Overall Study|Lack of Efficacy|0|||
16445237|NCT01419236|40108606|FG001|Overall Study|Lack of Efficacy|1|||
16445238|NCT01419236|40108605|FG000|Overall Study|Lost to Follow-up|1|||
16445239|NCT01419236|40108606|FG001|Overall Study|Lost to Follow-up|0|||
16445240|NCT01419236|40108605|FG000|Overall Study|Physician Decision|1|||
16445241|NCT01419236|40108606|FG001|Overall Study|Physician Decision|0|||
16445242|NCT01419236|40108605|FG000|Overall Study|Withdrawal by Subject|1|||
16445243|NCT01419236|40108606|FG001|Overall Study|Withdrawal by Subject|4|||
16445244|NCT01419236|40108605|FG000|Overall Study|Entry Criteria Not Met|1|||
16445245|NCT01419236|40108606|FG001|Overall Study|Entry Criteria Not Met|0|||
16367860|NCT02697422|39828991|FG001|Overall Study|Declined exit survey|2|||
16367861|NCT02697422|39828990|FG000|Overall Study|Lost to Follow-up|13|||
16367862|NCT02697422|39828991|FG001|Overall Study|Lost to Follow-up|8|||
16367863|NCT02697422|39828990|FG000|Overall Study|Death|2|||
16367864|NCT02697422|39828991|FG001|Overall Study|Death|1|||
16367865|NCT02697422|39828990|FG000|Overall Study|Withdrawal by Subject|0|||
16367866|NCT02697422|39828991|FG001|Overall Study|Withdrawal by Subject|1|||
16367867|NCT02697422|39828990|FG000|Overall Study|Physician Decision|1|||
16367868|NCT02697422|39828991|FG001|Overall Study|Physician Decision|1|||
16367869|NCT02697422|39828990|FG000|Overall Study|Exit survey data lost|1|||
16367870|NCT02697422|39828991|FG001|Overall Study|Exit survey data lost|0|||
16367871|NCT00997126|39828992|FG000|Overall Study|Physician Decision|7|||
16367872|NCT00997126|39828993|FG001|Overall Study|Physician Decision|11|||
16367873|NCT03624036|39829003|FG000|Overall Study|Death|2|||
16367874|NCT03624036|39829004|FG001|Overall Study|Death|3|||
16367875|NCT03624036|39829005|FG002|Overall Study|Death|0|||
16367876|NCT03624036|39829006|FG003|Overall Study|Death|1|||
16367877|NCT03624036|39829003|FG000|Overall Study|Withdrawal by Subject|1|||
16367878|NCT03624036|39829004|FG001|Overall Study|Withdrawal by Subject|0|||
16367879|NCT03624036|39829005|FG002|Overall Study|Withdrawal by Subject|1|||
16367880|NCT03624036|39829006|FG003|Overall Study|Withdrawal by Subject|0|||
16367881|NCT03624036|39829003|FG000|Overall Study|Enrolled but Never Treated|1|||
16445246|NCT03350672|40108607|FG000|Overall Study|Withdrawal by Subject|7|||
16157229|NCT00623428|39061385|FG000|Follow-up Period|Patient withdrew consent|5|||
16367882|NCT03624036|39829004|FG001|Overall Study|Enrolled but Never Treated|0|||
16367883|NCT03624036|39829005|FG002|Overall Study|Enrolled but Never Treated|0|||
16367884|NCT03624036|39829006|FG003|Overall Study|Enrolled but Never Treated|0|||
16367885|NCT03624036|39829003|FG000|Overall Study|Reason not Specified|3|||
16367886|NCT03624036|39829004|FG001|Overall Study|Reason not Specified|0|||
16367887|NCT03624036|39829005|FG002|Overall Study|Reason not Specified|2|||
16445247|NCT03350672|40108608|FG001|Overall Study|Withdrawal by Subject|0|||
16445248|NCT03350672|40108609|FG002|Overall Study|Withdrawal by Subject|0|||
16367888|NCT03624036|39829006|FG003|Overall Study|Reason not Specified|2|||
16367889|NCT01859741|39829013|FG000|Overall Study|Death|3|||
16367890|NCT01859741|39829014|FG001|Overall Study|Death|2|||
16367891|NCT01859741|39829015|FG002|Overall Study|Death|4|||
16367892|NCT01859741|39829016|FG003|Overall Study|Death|3|||
16367893|NCT01859741|39829017|FG004|Overall Study|Death|5|||
16367894|NCT01859741|39829018|FG005|Overall Study|Death|4|||
16367895|NCT01859741|39829019|FG006|Overall Study|Death|51|||
16367896|NCT01859741|39829020|FG007|Overall Study|Death|51|||
16367897|NCT01859741|39829013|FG000|Overall Study|Lost to Follow-up|0|||
16367898|NCT01859741|39829014|FG001|Overall Study|Lost to Follow-up|0|||
16367899|NCT01859741|39829015|FG002|Overall Study|Lost to Follow-up|0|||
16367900|NCT01859741|39829016|FG003|Overall Study|Lost to Follow-up|0|||
16367901|NCT01859741|39829017|FG004|Overall Study|Lost to Follow-up|0|||
16367902|NCT01859741|39829018|FG005|Overall Study|Lost to Follow-up|1|||
16367903|NCT01859741|39829019|FG006|Overall Study|Lost to Follow-up|0|||
16367904|NCT01859741|39829020|FG007|Overall Study|Lost to Follow-up|4|||
16445249|NCT01744977|40108610|FG000|Overall Study|Withdrawal by Subject|1|||
16445250|NCT01744977|40108611|FG001|Overall Study|Withdrawal by Subject|2|||
16445251|NCT01744977|40108610|FG000|Overall Study|Death|2|||
16445252|NCT01744977|40108611|FG001|Overall Study|Death|3|||
16445253|NCT01744977|40108610|FG000|Overall Study|Lost to Follow-up|2|||
16445254|NCT01744977|40108611|FG001|Overall Study|Lost to Follow-up|0|||
16445255|NCT01744977|40108610|FG000|Overall Study|No longer meets inclusion|6|||
16445256|NCT01744977|40108611|FG001|Overall Study|No longer meets inclusion|0|||
16445257|NCT02151058|40108620|FG000|Overall Study|Withdrawal by Subject|1|||
16157230|NCT00623428|39061386|FG001|Follow-up Period|Patient withdrew consent|4|||
16157231|NCT00623428|39061385|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
16367905|NCT01859741|39829013|FG000|Overall Study|Withdrawal by Subject|0|||
16367906|NCT01859741|39829014|FG001|Overall Study|Withdrawal by Subject|1|||
16064968|NCT04096365|38729630|FG000|Overall Study|Adverse Event|1|||
16064985|NCT03646669|38729639|FG000|Overall Study|Withdrawal by Subject|5|||
16064986|NCT03646669|38729640|FG001|Overall Study|Withdrawal by Subject|0|||
16064987|NCT01238575|38729641|FG000|Overall Study|Lack of Efficacy|2|||
16064988|NCT01238575|38729642|FG001|Overall Study|Lack of Efficacy|4|||
16064989|NCT01238575|38729641|FG000|Overall Study|Adverse Event|2|||
16064990|NCT01238575|38729642|FG001|Overall Study|Adverse Event|0|||
16367907|NCT01859741|39829015|FG002|Overall Study|Withdrawal by Subject|2|||
16367908|NCT01859741|39829016|FG003|Overall Study|Withdrawal by Subject|0|||
16367909|NCT01859741|39829017|FG004|Overall Study|Withdrawal by Subject|0|||
16367910|NCT01859741|39829018|FG005|Overall Study|Withdrawal by Subject|1|||
16367911|NCT01859741|39829019|FG006|Overall Study|Withdrawal by Subject|1|||
16445258|NCT02151058|40108621|FG001|Overall Study|Withdrawal by Subject|1|||
16445259|NCT02151058|40108622|FG002|Overall Study|Withdrawal by Subject|3|||
16157232|NCT00623428|39061386|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
16157233|NCT00623428|39061385|FG000|Follow-up Period|Did not cooperate|0|||
16157234|NCT00623428|39061386|FG001|Follow-up Period|Did not cooperate|3|||
16157235|NCT00623428|39061385|FG000|Follow-up Period|Reason not specified|1|||
16157236|NCT00623428|39061386|FG001|Follow-up Period|Reason not specified|1|||
16157237|NCT00623428|39061385|FG000|Follow-up Period|Death|0|||
16157238|NCT00623428|39061386|FG001|Follow-up Period|Death|1|||
16157239|NCT00075504|39061387|FG000|Overall Study|Withdrawal by Subject|9|||
16157240|NCT00075504|39061388|FG001|Overall Study|Withdrawal by Subject|7|||
16157241|NCT01681433|39061391|FG000|Overall Study|Lack of Efficacy|23|||
16157242|NCT01681433|39061392|FG001|Overall Study|Lack of Efficacy|23|||
16157243|NCT01681433|39061391|FG000|Overall Study|Withdrawal by Subject|5|||
16157244|NCT01681433|39061392|FG001|Overall Study|Withdrawal by Subject|5|||
16157245|NCT01681433|39061391|FG000|Overall Study|Protocol Violation|2|||
16157246|NCT01681433|39061392|FG001|Overall Study|Protocol Violation|0|||
16157247|NCT01681433|39061391|FG000|Overall Study|Adverse Event|2|||
16157248|NCT01681433|39061392|FG001|Overall Study|Adverse Event|4|||
16157249|NCT01681433|39061391|FG000|Overall Study|Lost to Follow-up|0|||
16157250|NCT01681433|39061392|FG001|Overall Study|Lost to Follow-up|1|||
16157251|NCT01394939|39061393|FG000|Overall Study|Adverse Event|1|||
16157252|NCT01394939|39061394|FG001|Overall Study|Adverse Event|3|||
16065021|NCT00999661|38729657|FG000|Overall Study|Lost to Follow-up|59|||
16065022|NCT00999661|38729657|FG000|Overall Study|Adverse Event|1|||
16065023|NCT00999661|38729657|FG000|Overall Study|Withdrawal by Subject|1|||
16065024|NCT00999661|38729657|FG000|Overall Study|Not meeting eligibility criteria|9|||
16157253|NCT01394939|39061395|FG002|Overall Study|Adverse Event|0|||
16157254|NCT01394939|39061396|FG003|Overall Study|Adverse Event|2|||
16157255|NCT01394939|39061393|FG000|Overall Study|Death|0|||
16157256|NCT01394939|39061394|FG001|Overall Study|Death|2|||
16157257|NCT01394939|39061395|FG002|Overall Study|Death|0|||
16157258|NCT01394939|39061396|FG003|Overall Study|Death|0|||
16157259|NCT01394939|39061393|FG000|Overall Study|Physician Decision|0|||
16157260|NCT01394939|39061394|FG001|Overall Study|Physician Decision|1|||
16157261|NCT01394939|39061395|FG002|Overall Study|Physician Decision|0|||
16157262|NCT01394939|39061396|FG003|Overall Study|Physician Decision|0|||
16157263|NCT01394939|39061393|FG000|Overall Study|Withdrawal by Subject|0|||
16157264|NCT01394939|39061394|FG001|Overall Study|Withdrawal by Subject|2|||
16157265|NCT01394939|39061395|FG002|Overall Study|Withdrawal by Subject|0|||
16157266|NCT01394939|39061396|FG003|Overall Study|Withdrawal by Subject|2|||
16157267|NCT01394939|39061393|FG000|Overall Study|Others|0|||
16157268|NCT01394939|39061394|FG001|Overall Study|Others|2|||
16157269|NCT01394939|39061395|FG002|Overall Study|Others|0|||
16157270|NCT01394939|39061396|FG003|Overall Study|Others|3|||
16157271|NCT03436862|39061401|FG000|Overall Study|Adverse Event|4|||
16157272|NCT03436862|39061401|FG000|Overall Study|Progressive Disease|2|||
16157273|NCT02482129|39061402|FG000|Overall Study|Adverse Event-prior to treatment|0|||
16157274|NCT02482129|39061403|FG001|Overall Study|Adverse Event-prior to treatment|1|||
16157275|NCT02482129|39061402|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
16157276|NCT02482129|39061403|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
16157277|NCT02482129|39061402|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
16157278|NCT02482129|39061403|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
16157279|NCT02482129|39061402|FG000|Overall Study|Criteria not met-prior to treatment|1|||
16157280|NCT02482129|39061403|FG001|Overall Study|Criteria not met-prior to treatment|0|||
16157281|NCT02482129|39061402|FG000|Overall Study|Adverse Event|1|||
16157282|NCT02482129|39061403|FG001|Overall Study|Adverse Event|0|||
16157283|NCT02482129|39061402|FG000|Overall Study|Withdrawal by Subject|2|||
16157284|NCT02482129|39061403|FG001|Overall Study|Withdrawal by Subject|0|||
16157285|NCT02482129|39061402|FG000|Overall Study|Criteria not met|1|||
16157286|NCT02482129|39061403|FG001|Overall Study|Criteria not met|0|||
16157287|NCT03529773|39061405|FG000|Overall Study|Adverse Event|0|||
16157288|NCT03529773|39061406|FG001|Overall Study|Adverse Event|0|||
16157289|NCT03529773|39061407|FG002|Overall Study|Adverse Event|0|||
16157290|NCT03529773|39061408|FG003|Overall Study|Adverse Event|0|||
16157291|NCT03529773|39061409|FG004|Overall Study|Adverse Event|0|||
16157292|NCT03529773|39061410|FG005|Overall Study|Adverse Event|0|||
16157293|NCT03529773|39061411|FG006|Overall Study|Adverse Event|0|||
16157294|NCT03529773|39061412|FG007|Overall Study|Adverse Event|0|||
16157295|NCT03529773|39061413|FG008|Overall Study|Adverse Event|0|||
16157296|NCT03529773|39061414|FG009|Overall Study|Adverse Event|0|||
16157297|NCT03529773|39061415|FG010|Overall Study|Adverse Event|0|||
16157298|NCT03529773|39061416|FG011|Overall Study|Adverse Event|0|||
16157299|NCT03529773|39061417|FG012|Overall Study|Adverse Event|0|||
16157300|NCT03529773|39061418|FG013|Overall Study|Adverse Event|0|||
16157301|NCT03529773|39061419|FG014|Overall Study|Adverse Event|0|||
16157302|NCT03529773|39061420|FG015|Overall Study|Adverse Event|0|||
16157303|NCT03529773|39061421|FG016|Overall Study|Adverse Event|0|||
16157304|NCT03529773|39061422|FG017|Overall Study|Adverse Event|0|||
16157305|NCT03529773|39061423|FG018|Overall Study|Adverse Event|0|||
16157306|NCT03529773|39061424|FG019|Overall Study|Adverse Event|0|||
16157307|NCT03529773|39061425|FG020|Overall Study|Adverse Event|0|||
16157308|NCT03529773|39061426|FG021|Overall Study|Adverse Event|0|||
16157309|NCT03529773|39061427|FG022|Overall Study|Adverse Event|0|||
16157310|NCT03529773|39061428|FG023|Overall Study|Adverse Event|0|||
16157311|NCT03529773|39061429|FG024|Overall Study|Adverse Event|0|||
16157312|NCT03529773|39061430|FG025|Overall Study|Adverse Event|0|||
16157313|NCT03529773|39061431|FG026|Overall Study|Adverse Event|0|||
16157314|NCT03529773|39061432|FG027|Overall Study|Adverse Event|0|||
16157315|NCT03529773|39061433|FG028|Overall Study|Adverse Event|0|||
16157316|NCT03529773|39061434|FG029|Overall Study|Adverse Event|0|||
16157317|NCT03529773|39061435|FG030|Overall Study|Adverse Event|1|||
16157318|NCT03529773|39061436|FG031|Overall Study|Adverse Event|0|||
16157319|NCT03529773|39061437|FG032|Overall Study|Adverse Event|0|||
16157320|NCT03529773|39061438|FG033|Overall Study|Adverse Event|0|||
16157321|NCT03529773|39061439|FG034|Overall Study|Adverse Event|0|||
16157322|NCT03529773|39061440|FG035|Overall Study|Adverse Event|1|||
16157323|NCT03529773|39061441|FG036|Overall Study|Adverse Event|0|||
16157324|NCT03529773|39061442|FG037|Overall Study|Adverse Event|0|||
16157325|NCT03529773|39061443|FG038|Overall Study|Adverse Event|1|||
16157326|NCT03529773|39061444|FG039|Overall Study|Adverse Event|1|||
16157327|NCT03529773|39061405|FG000|Overall Study|Death|0|||
16157328|NCT03529773|39061406|FG001|Overall Study|Death|0|||
16157329|NCT03529773|39061407|FG002|Overall Study|Death|0|||
16157330|NCT03529773|39061408|FG003|Overall Study|Death|0|||
16157331|NCT03529773|39061409|FG004|Overall Study|Death|0|||
16157332|NCT03529773|39061410|FG005|Overall Study|Death|0|||
16157333|NCT03529773|39061411|FG006|Overall Study|Death|0|||
16157334|NCT03529773|39061412|FG007|Overall Study|Death|0|||
16157335|NCT03529773|39061413|FG008|Overall Study|Death|0|||
16157336|NCT03529773|39061414|FG009|Overall Study|Death|0|||
16157337|NCT03529773|39061415|FG010|Overall Study|Death|0|||
16157338|NCT03529773|39061416|FG011|Overall Study|Death|0|||
16367912|NCT01859741|39829020|FG007|Overall Study|Withdrawal by Subject|1|||
16367913|NCT01859741|39829013|FG000|Overall Study|Study Terminated by Sponsor|0|||
16367914|NCT01859741|39829014|FG001|Overall Study|Study Terminated by Sponsor|0|||
16367915|NCT01859741|39829015|FG002|Overall Study|Study Terminated by Sponsor|0|||
16367916|NCT01859741|39829016|FG003|Overall Study|Study Terminated by Sponsor|0|||
16367917|NCT01859741|39829017|FG004|Overall Study|Study Terminated by Sponsor|1|||
16367918|NCT01859741|39829018|FG005|Overall Study|Study Terminated by Sponsor|0|||
16367919|NCT01859741|39829019|FG006|Overall Study|Study Terminated by Sponsor|16|||
16367920|NCT01859741|39829020|FG007|Overall Study|Study Terminated by Sponsor|14|||
16367921|NCT01859741|39829013|FG000|Overall Study|Other|0|||
16367922|NCT01859741|39829014|FG001|Overall Study|Other|0|||
16367923|NCT01859741|39829015|FG002|Overall Study|Other|0|||
16367924|NCT01859741|39829016|FG003|Overall Study|Other|0|||
16367925|NCT01859741|39829017|FG004|Overall Study|Other|0|||
16367926|NCT01859741|39829018|FG005|Overall Study|Other|0|||
16367927|NCT01859741|39829019|FG006|Overall Study|Other|2|||
16367928|NCT01859741|39829020|FG007|Overall Study|Other|0|||
16445260|NCT02151058|40108620|FG000|Overall Study|Lost to Follow-up|1|||
16445261|NCT02151058|40108621|FG001|Overall Study|Lost to Follow-up|0|||
16445262|NCT02151058|40108622|FG002|Overall Study|Lost to Follow-up|2|||
16445263|NCT03558737|40108623|FG000|Overall Study|Death|1|||
16445264|NCT03558737|40108624|FG001|Overall Study|Death|1|||
16445265|NCT02992288|40108625|FG000|Overall Study|Adverse Event|8|||
16445266|NCT02992288|40108626|FG001|Overall Study|Adverse Event|2|||
16445267|NCT02992288|40108627|FG002|Overall Study|Adverse Event|2|||
16445268|NCT02992288|40108628|FG003|Overall Study|Adverse Event|2|||
16445269|NCT02992288|40108629|FG004|Overall Study|Adverse Event|2|||
16445270|NCT02992288|40108630|FG005|Overall Study|Adverse Event|7|||
16445271|NCT02992288|40108625|FG000|Overall Study|Non-compliance with study drug|0|||
16445272|NCT02992288|40108626|FG001|Overall Study|Non-compliance with study drug|1|||
16157339|NCT03529773|39061417|FG012|Overall Study|Death|1|||
16367929|NCT03637374|39829021|FG000|Overall Study|Death|2|||
16367930|NCT03637374|39829022|FG001|Overall Study|Death|0|||
16367931|NCT01695772|39829023|FG000|Overall Study|Withdrawal by Subject|18|||
16367932|NCT01695772|39829023|FG000|Overall Study|Progressive Disease|8|||
16367933|NCT01695772|39829023|FG000|Overall Study|Investigator Decision|5|||
16445273|NCT02992288|40108627|FG002|Overall Study|Non-compliance with study drug|1|||
16445274|NCT02992288|40108628|FG003|Overall Study|Non-compliance with study drug|0|||
16445275|NCT02992288|40108629|FG004|Overall Study|Non-compliance with study drug|1|||
16157340|NCT03529773|39061418|FG013|Overall Study|Death|0|||
16157341|NCT03529773|39061419|FG014|Overall Study|Death|0|||
16157342|NCT03529773|39061420|FG015|Overall Study|Death|0|||
16157343|NCT03529773|39061421|FG016|Overall Study|Death|0|||
16157344|NCT03529773|39061422|FG017|Overall Study|Death|0|||
16157345|NCT03529773|39061423|FG018|Overall Study|Death|0|||
16157346|NCT03529773|39061424|FG019|Overall Study|Death|1|||
16157347|NCT03529773|39061425|FG020|Overall Study|Death|0|||
16157348|NCT03529773|39061426|FG021|Overall Study|Death|0|||
16157349|NCT03529773|39061427|FG022|Overall Study|Death|1|||
16157350|NCT03529773|39061428|FG023|Overall Study|Death|0|||
16157351|NCT03529773|39061429|FG024|Overall Study|Death|0|||
16157352|NCT03529773|39061430|FG025|Overall Study|Death|0|||
16157353|NCT03529773|39061431|FG026|Overall Study|Death|0|||
16157354|NCT03529773|39061432|FG027|Overall Study|Death|0|||
16157355|NCT03529773|39061433|FG028|Overall Study|Death|0|||
16157356|NCT03529773|39061434|FG029|Overall Study|Death|0|||
16157357|NCT03529773|39061435|FG030|Overall Study|Death|0|||
16157358|NCT03529773|39061436|FG031|Overall Study|Death|0|||
16157359|NCT03529773|39061437|FG032|Overall Study|Death|0|||
16157360|NCT03529773|39061438|FG033|Overall Study|Death|1|||
16157361|NCT03529773|39061439|FG034|Overall Study|Death|1|||
16157362|NCT03529773|39061440|FG035|Overall Study|Death|0|||
16157363|NCT03529773|39061441|FG036|Overall Study|Death|1|||
16157364|NCT03529773|39061442|FG037|Overall Study|Death|0|||
16157365|NCT03529773|39061443|FG038|Overall Study|Death|0|||
16157366|NCT03529773|39061444|FG039|Overall Study|Death|0|||
16157367|NCT03529773|39061405|FG000|Overall Study|Lost to Follow-up|0|||
16157368|NCT03529773|39061406|FG001|Overall Study|Lost to Follow-up|0|||
16157369|NCT03529773|39061407|FG002|Overall Study|Lost to Follow-up|1|||
16157370|NCT03529773|39061408|FG003|Overall Study|Lost to Follow-up|0|||
16157371|NCT03529773|39061409|FG004|Overall Study|Lost to Follow-up|1|||
16157372|NCT03529773|39061410|FG005|Overall Study|Lost to Follow-up|1|||
16065169|NCT00149630|38729710|FG000|Overall Study|Incarceration|2|||
16065170|NCT00149630|38729711|FG001|Overall Study|Incarceration|0|||
16065171|NCT00149630|38729710|FG000|Overall Study|Treatment Programs|4|||
16065172|NCT00149630|38729711|FG001|Overall Study|Treatment Programs|5|||
16065173|NCT00149630|38729710|FG000|Overall Study|Adverse Event|2|||
16065174|NCT00149630|38729711|FG001|Overall Study|Adverse Event|0|||
16065175|NCT03246672|38729712|FG000|Overall Study|Lost to Follow-up|2|||
16157373|NCT03529773|39061411|FG006|Overall Study|Lost to Follow-up|0|||
16157374|NCT03529773|39061412|FG007|Overall Study|Lost to Follow-up|0|||
16157375|NCT03529773|39061413|FG008|Overall Study|Lost to Follow-up|0|||
16157376|NCT03529773|39061414|FG009|Overall Study|Lost to Follow-up|0|||
16157377|NCT03529773|39061415|FG010|Overall Study|Lost to Follow-up|0|||
16157378|NCT03529773|39061416|FG011|Overall Study|Lost to Follow-up|0|||
16157379|NCT03529773|39061417|FG012|Overall Study|Lost to Follow-up|0|||
16157380|NCT03529773|39061418|FG013|Overall Study|Lost to Follow-up|1|||
16157381|NCT03529773|39061419|FG014|Overall Study|Lost to Follow-up|4|||
16157382|NCT03529773|39061420|FG015|Overall Study|Lost to Follow-up|1|||
16157383|NCT03529773|39061421|FG016|Overall Study|Lost to Follow-up|1|||
16157384|NCT03529773|39061422|FG017|Overall Study|Lost to Follow-up|0|||
16157385|NCT03529773|39061423|FG018|Overall Study|Lost to Follow-up|1|||
16157386|NCT03529773|39061424|FG019|Overall Study|Lost to Follow-up|1|||
16157387|NCT03529773|39061425|FG020|Overall Study|Lost to Follow-up|2|||
16157388|NCT03529773|39061426|FG021|Overall Study|Lost to Follow-up|4|||
16157389|NCT03529773|39061427|FG022|Overall Study|Lost to Follow-up|3|||
16445276|NCT02992288|40108630|FG005|Overall Study|Non-compliance with study drug|0|||
16157390|NCT03529773|39061428|FG023|Overall Study|Lost to Follow-up|4|||
16157391|NCT03529773|39061429|FG024|Overall Study|Lost to Follow-up|3|||
16157392|NCT03529773|39061430|FG025|Overall Study|Lost to Follow-up|5|||
16157393|NCT03529773|39061431|FG026|Overall Study|Lost to Follow-up|5|||
16157394|NCT03529773|39061432|FG027|Overall Study|Lost to Follow-up|0|||
16157395|NCT03529773|39061433|FG028|Overall Study|Lost to Follow-up|0|||
16157396|NCT03529773|39061434|FG029|Overall Study|Lost to Follow-up|0|||
16157397|NCT03529773|39061435|FG030|Overall Study|Lost to Follow-up|1|||
16157398|NCT03529773|39061436|FG031|Overall Study|Lost to Follow-up|0|||
16157399|NCT03529773|39061437|FG032|Overall Study|Lost to Follow-up|0|||
16157400|NCT03529773|39061438|FG033|Overall Study|Lost to Follow-up|1|||
16157401|NCT03529773|39061439|FG034|Overall Study|Lost to Follow-up|1|||
16157402|NCT03529773|39061440|FG035|Overall Study|Lost to Follow-up|0|||
16157403|NCT03529773|39061441|FG036|Overall Study|Lost to Follow-up|0|||
16157404|NCT03529773|39061442|FG037|Overall Study|Lost to Follow-up|3|||
16157405|NCT03529773|39061443|FG038|Overall Study|Lost to Follow-up|1|||
16157406|NCT03529773|39061444|FG039|Overall Study|Lost to Follow-up|1|||
16157407|NCT03529773|39061405|FG000|Overall Study|No longer meets eligibility criteria|0|||
16157408|NCT03529773|39061406|FG001|Overall Study|No longer meets eligibility criteria|0|||
16157409|NCT03529773|39061407|FG002|Overall Study|No longer meets eligibility criteria|0|||
16157410|NCT03529773|39061408|FG003|Overall Study|No longer meets eligibility criteria|0|||
16157411|NCT03529773|39061409|FG004|Overall Study|No longer meets eligibility criteria|0|||
16157412|NCT03529773|39061410|FG005|Overall Study|No longer meets eligibility criteria|0|||
16157413|NCT03529773|39061411|FG006|Overall Study|No longer meets eligibility criteria|0|||
16157414|NCT03529773|39061412|FG007|Overall Study|No longer meets eligibility criteria|0|||
16157415|NCT03529773|39061413|FG008|Overall Study|No longer meets eligibility criteria|0|||
16157416|NCT03529773|39061414|FG009|Overall Study|No longer meets eligibility criteria|0|||
16157417|NCT03529773|39061415|FG010|Overall Study|No longer meets eligibility criteria|0|||
16157418|NCT03529773|39061416|FG011|Overall Study|No longer meets eligibility criteria|0|||
16157419|NCT03529773|39061417|FG012|Overall Study|No longer meets eligibility criteria|0|||
16157420|NCT03529773|39061418|FG013|Overall Study|No longer meets eligibility criteria|0|||
16157421|NCT03529773|39061419|FG014|Overall Study|No longer meets eligibility criteria|0|||
16157422|NCT03529773|39061420|FG015|Overall Study|No longer meets eligibility criteria|0|||
16157423|NCT03529773|39061421|FG016|Overall Study|No longer meets eligibility criteria|0|||
16157424|NCT03529773|39061422|FG017|Overall Study|No longer meets eligibility criteria|0|||
16157425|NCT03529773|39061423|FG018|Overall Study|No longer meets eligibility criteria|0|||
16157426|NCT03529773|39061424|FG019|Overall Study|No longer meets eligibility criteria|0|||
16157427|NCT03529773|39061425|FG020|Overall Study|No longer meets eligibility criteria|0|||
16157428|NCT03529773|39061426|FG021|Overall Study|No longer meets eligibility criteria|0|||
16157429|NCT03529773|39061427|FG022|Overall Study|No longer meets eligibility criteria|1|||
16157430|NCT03529773|39061428|FG023|Overall Study|No longer meets eligibility criteria|0|||
16157431|NCT03529773|39061429|FG024|Overall Study|No longer meets eligibility criteria|0|||
16157432|NCT03529773|39061430|FG025|Overall Study|No longer meets eligibility criteria|0|||
16157433|NCT03529773|39061431|FG026|Overall Study|No longer meets eligibility criteria|0|||
16157434|NCT03529773|39061432|FG027|Overall Study|No longer meets eligibility criteria|0|||
16157435|NCT03529773|39061433|FG028|Overall Study|No longer meets eligibility criteria|0|||
16157436|NCT03529773|39061434|FG029|Overall Study|No longer meets eligibility criteria|0|||
16157437|NCT03529773|39061435|FG030|Overall Study|No longer meets eligibility criteria|0|||
16157438|NCT03529773|39061436|FG031|Overall Study|No longer meets eligibility criteria|0|||
16157439|NCT03529773|39061437|FG032|Overall Study|No longer meets eligibility criteria|0|||
16157440|NCT03529773|39061438|FG033|Overall Study|No longer meets eligibility criteria|0|||
16445277|NCT02992288|40108625|FG000|Overall Study|Physician Decision|3|||
16157441|NCT03529773|39061439|FG034|Overall Study|No longer meets eligibility criteria|0|||
16157442|NCT03529773|39061440|FG035|Overall Study|No longer meets eligibility criteria|0|||
16157443|NCT03529773|39061441|FG036|Overall Study|No longer meets eligibility criteria|0|||
16157444|NCT03529773|39061442|FG037|Overall Study|No longer meets eligibility criteria|0|||
16157445|NCT03529773|39061443|FG038|Overall Study|No longer meets eligibility criteria|1|||
16157446|NCT03529773|39061444|FG039|Overall Study|No longer meets eligibility criteria|0|||
16157447|NCT03529773|39061405|FG000|Overall Study|Other|0|||
16157448|NCT03529773|39061406|FG001|Overall Study|Other|0|||
16157449|NCT03529773|39061407|FG002|Overall Study|Other|0|||
16157450|NCT03529773|39061408|FG003|Overall Study|Other|0|||
16157451|NCT03529773|39061409|FG004|Overall Study|Other|0|||
16157452|NCT03529773|39061410|FG005|Overall Study|Other|0|||
16157453|NCT03529773|39061411|FG006|Overall Study|Other|0|||
16157454|NCT03529773|39061412|FG007|Overall Study|Other|0|||
16157455|NCT03529773|39061413|FG008|Overall Study|Other|0|||
16157456|NCT03529773|39061414|FG009|Overall Study|Other|0|||
16157457|NCT03529773|39061415|FG010|Overall Study|Other|0|||
16157458|NCT03529773|39061416|FG011|Overall Study|Other|0|||
16157459|NCT03529773|39061417|FG012|Overall Study|Other|1|||
16157460|NCT03529773|39061418|FG013|Overall Study|Other|0|||
16157461|NCT03529773|39061419|FG014|Overall Study|Other|2|||
16157462|NCT03529773|39061420|FG015|Overall Study|Other|0|||
16157463|NCT03529773|39061421|FG016|Overall Study|Other|0|||
16157464|NCT03529773|39061422|FG017|Overall Study|Other|3|||
16157465|NCT03529773|39061423|FG018|Overall Study|Other|0|||
16445278|NCT02992288|40108626|FG001|Overall Study|Physician Decision|0|||
16445279|NCT02992288|40108627|FG002|Overall Study|Physician Decision|1|||
16445280|NCT02992288|40108628|FG003|Overall Study|Physician Decision|0|||
16157466|NCT03529773|39061424|FG019|Overall Study|Other|0|||
16157467|NCT03529773|39061425|FG020|Overall Study|Other|1|||
16157468|NCT03529773|39061426|FG021|Overall Study|Other|0|||
16157469|NCT03529773|39061427|FG022|Overall Study|Other|1|||
16157470|NCT03529773|39061428|FG023|Overall Study|Other|0|||
16157471|NCT03529773|39061429|FG024|Overall Study|Other|3|||
16367934|NCT01695772|39829023|FG000|Overall Study|Lost to Follow-up|4|||
16157472|NCT03529773|39061430|FG025|Overall Study|Other|2|||
16157473|NCT03529773|39061431|FG026|Overall Study|Other|2|||
16157474|NCT03529773|39061432|FG027|Overall Study|Other|0|||
16157475|NCT03529773|39061433|FG028|Overall Study|Other|0|||
16157476|NCT03529773|39061434|FG029|Overall Study|Other|0|||
16157477|NCT03529773|39061435|FG030|Overall Study|Other|0|||
16157478|NCT03529773|39061436|FG031|Overall Study|Other|0|||
16157479|NCT03529773|39061437|FG032|Overall Study|Other|0|||
16157480|NCT03529773|39061438|FG033|Overall Study|Other|0|||
16157481|NCT03529773|39061439|FG034|Overall Study|Other|1|||
16157482|NCT03529773|39061440|FG035|Overall Study|Other|1|||
16157483|NCT03529773|39061441|FG036|Overall Study|Other|0|||
16157484|NCT03529773|39061442|FG037|Overall Study|Other|0|||
16157485|NCT03529773|39061443|FG038|Overall Study|Other|0|||
16157486|NCT03529773|39061444|FG039|Overall Study|Other|0|||
16157487|NCT03529773|39061405|FG000|Overall Study|Physician Decision|0|||
16157488|NCT03529773|39061406|FG001|Overall Study|Physician Decision|0|||
16157489|NCT03529773|39061407|FG002|Overall Study|Physician Decision|0|||
16157490|NCT03529773|39061408|FG003|Overall Study|Physician Decision|0|||
16157491|NCT03529773|39061409|FG004|Overall Study|Physician Decision|0|||
16157492|NCT03529773|39061410|FG005|Overall Study|Physician Decision|0|||
16157493|NCT03529773|39061411|FG006|Overall Study|Physician Decision|0|||
16157494|NCT03529773|39061412|FG007|Overall Study|Physician Decision|0|||
16367935|NCT01695772|39829023|FG000|Overall Study|Protocol Violation|2|||
16367936|NCT01695772|39829023|FG000|Overall Study|Unspecified Reason|1|||
16367937|NCT01136915|39829024|FG000|Overall Study|Lost to Follow-up|2|||
16367938|NCT01136915|39829025|FG001|Overall Study|Lost to Follow-up|0|||
16367939|NCT01136915|39829024|FG000|Overall Study|Exclusion criterion met|0|||
16367940|NCT01136915|39829025|FG001|Overall Study|Exclusion criterion met|1|||
16367941|NCT01755637|39829029|FG000|Period 1|Adverse Event|0|||
16367942|NCT01755637|39829030|FG001|Period 1|Adverse Event|1|||
16445281|NCT02992288|40108629|FG004|Overall Study|Physician Decision|0|||
16445282|NCT02992288|40108630|FG005|Overall Study|Physician Decision|1|||
16445283|NCT02992288|40108625|FG000|Overall Study|Death|2|||
16445284|NCT02992288|40108626|FG001|Overall Study|Death|0|||
16445285|NCT02992288|40108627|FG002|Overall Study|Death|2|||
16157495|NCT03529773|39061413|FG008|Overall Study|Physician Decision|0|||
16157496|NCT03529773|39061414|FG009|Overall Study|Physician Decision|0|||
16367943|NCT00920816|39829031|FG000|Overall Study|Death|116|||
16445286|NCT02992288|40108628|FG003|Overall Study|Death|1|||
16445287|NCT02992288|40108629|FG004|Overall Study|Death|2|||
16157497|NCT03529773|39061415|FG010|Overall Study|Physician Decision|0|||
16157498|NCT03529773|39061416|FG011|Overall Study|Physician Decision|0|||
16445288|NCT02992288|40108630|FG005|Overall Study|Death|0|||
16157499|NCT03529773|39061417|FG012|Overall Study|Physician Decision|0|||
16157500|NCT03529773|39061418|FG013|Overall Study|Physician Decision|0|||
16157501|NCT03529773|39061419|FG014|Overall Study|Physician Decision|0|||
16367944|NCT00920816|39829032|FG001|Overall Study|Death|63|||
16367945|NCT00920816|39829033|FG002|Overall Study|Death|8|||
16367946|NCT00920816|39829034|FG003|Overall Study|Death|3|||
16445289|NCT02992288|40108625|FG000|Overall Study|Lost to Follow-up|0|||
16445290|NCT02992288|40108626|FG001|Overall Study|Lost to Follow-up|0|||
16445291|NCT02992288|40108627|FG002|Overall Study|Lost to Follow-up|0|||
16445292|NCT02992288|40108628|FG003|Overall Study|Lost to Follow-up|1|||
16445293|NCT02992288|40108629|FG004|Overall Study|Lost to Follow-up|0|||
16445294|NCT02992288|40108630|FG005|Overall Study|Lost to Follow-up|0|||
16445295|NCT02992288|40108625|FG000|Overall Study|Protocol Violation|0|||
16445296|NCT02992288|40108626|FG001|Overall Study|Protocol Violation|0|||
16445297|NCT02992288|40108627|FG002|Overall Study|Protocol Violation|0|||
16445298|NCT02992288|40108628|FG003|Overall Study|Protocol Violation|0|||
16445299|NCT02992288|40108629|FG004|Overall Study|Protocol Violation|0|||
16445300|NCT02992288|40108630|FG005|Overall Study|Protocol Violation|1|||
16445301|NCT02992288|40108625|FG000|Overall Study|Withdrawal by Subject|4|||
16445302|NCT02992288|40108626|FG001|Overall Study|Withdrawal by Subject|2|||
16445303|NCT02992288|40108627|FG002|Overall Study|Withdrawal by Subject|1|||
16445304|NCT02992288|40108628|FG003|Overall Study|Withdrawal by Subject|5|||
16445305|NCT02992288|40108629|FG004|Overall Study|Withdrawal by Subject|3|||
16445306|NCT02992288|40108630|FG005|Overall Study|Withdrawal by Subject|4|||
16445307|NCT01709721|40108631|FG000|Open Label Phase|Withdrawal by Subject|0|||
16445308|NCT01709721|40108632|FG001|Open Label Phase|Withdrawal by Subject|0|||
16445309|NCT01709721|40108633|FG002|Open Label Phase|Withdrawal by Subject|5|||
16445310|NCT01709721|40108631|FG000|Open Label Phase|Adverse Event|0|||
16445311|NCT01709721|40108632|FG001|Open Label Phase|Adverse Event|0|||
16445312|NCT01709721|40108633|FG002|Open Label Phase|Adverse Event|8|||
16445313|NCT01709721|40108631|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
16445314|NCT01709721|40108632|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
16445315|NCT01709721|40108633|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
16445316|NCT01709721|40108631|FG000|Open Label Phase|Investigator Decision|0|||
16445317|NCT01709721|40108632|FG001|Open Label Phase|Investigator Decision|0|||
16445318|NCT01709721|40108633|FG002|Open Label Phase|Investigator Decision|1|||
16445319|NCT01709721|40108631|FG000|Open Label Phase|Sponsor Decision|0|||
16445320|NCT01709721|40108632|FG001|Open Label Phase|Sponsor Decision|0|||
16445321|NCT01709721|40108633|FG002|Open Label Phase|Sponsor Decision|2|||
16445322|NCT01709721|40108631|FG000|Open Label Phase|Protocol Violation|0|||
16445323|NCT01709721|40108632|FG001|Open Label Phase|Protocol Violation|0|||
16445324|NCT01709721|40108633|FG002|Open Label Phase|Protocol Violation|1|||
16445325|NCT01709721|40108631|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
16445326|NCT01709721|40108632|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
16445327|NCT01709721|40108633|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
16445328|NCT01709721|40108631|FG000|Open Label Phase|Inadequate Pain Control|0|||
16445329|NCT01709721|40108632|FG001|Open Label Phase|Inadequate Pain Control|0|||
16445330|NCT01709721|40108633|FG002|Open Label Phase|Inadequate Pain Control|37|||
16445331|NCT01709721|40108631|FG000|Open Label Phase|Other, Specify in text field in database|0|||
16445332|NCT01709721|40108632|FG001|Open Label Phase|Other, Specify in text field in database|0|||
16445333|NCT01709721|40108633|FG002|Open Label Phase|Other, Specify in text field in database|14|||
16445334|NCT01709721|40108631|FG000|Randomized Phase|Adverse Event|0|||
16445335|NCT01709721|40108632|FG001|Randomized Phase|Adverse Event|1|||
16445336|NCT01709721|40108633|FG002|Randomized Phase|Adverse Event|0|||
16445337|NCT01709721|40108631|FG000|Randomized Phase|Lost to Follow-up|1|||
16445338|NCT01709721|40108632|FG001|Randomized Phase|Lost to Follow-up|0|||
16445339|NCT01709721|40108633|FG002|Randomized Phase|Lost to Follow-up|0|||
16445340|NCT01709721|40108631|FG000|Randomized Phase|Inadequate Pain Control|1|||
16445341|NCT01709721|40108632|FG001|Randomized Phase|Inadequate Pain Control|2|||
16445342|NCT01709721|40108633|FG002|Randomized Phase|Inadequate Pain Control|0|||
16445343|NCT01709721|40108631|FG000|Randomized Phase|Other, Specify text field in database|1|||
16445344|NCT01709721|40108632|FG001|Randomized Phase|Other, Specify text field in database|3|||
16445345|NCT01709721|40108633|FG002|Randomized Phase|Other, Specify text field in database|0|||
16157502|NCT03529773|39061420|FG015|Overall Study|Physician Decision|0|||
16157503|NCT03529773|39061421|FG016|Overall Study|Physician Decision|0|||
16157504|NCT03529773|39061422|FG017|Overall Study|Physician Decision|0|||
16157505|NCT03529773|39061423|FG018|Overall Study|Physician Decision|0|||
16157506|NCT03529773|39061424|FG019|Overall Study|Physician Decision|1|||
16157507|NCT03529773|39061425|FG020|Overall Study|Physician Decision|1|||
16157508|NCT03529773|39061426|FG021|Overall Study|Physician Decision|0|||
16157509|NCT03529773|39061427|FG022|Overall Study|Physician Decision|0|||
16157510|NCT03529773|39061428|FG023|Overall Study|Physician Decision|0|||
16157511|NCT03529773|39061429|FG024|Overall Study|Physician Decision|0|||
16157512|NCT03529773|39061430|FG025|Overall Study|Physician Decision|0|||
16445346|NCT02057250|40108634|FG000|AID Assessment Phase|Adverse Event|3|||
16157513|NCT03529773|39061431|FG026|Overall Study|Physician Decision|0|||
16157514|NCT03529773|39061432|FG027|Overall Study|Physician Decision|0|||
16157515|NCT03529773|39061433|FG028|Overall Study|Physician Decision|0|||
16157516|NCT03529773|39061434|FG029|Overall Study|Physician Decision|0|||
16157517|NCT03529773|39061435|FG030|Overall Study|Physician Decision|0|||
16157518|NCT03529773|39061436|FG031|Overall Study|Physician Decision|0|||
16157519|NCT03529773|39061437|FG032|Overall Study|Physician Decision|0|||
16157520|NCT03529773|39061438|FG033|Overall Study|Physician Decision|0|||
16157521|NCT03529773|39061439|FG034|Overall Study|Physician Decision|0|||
16157522|NCT03529773|39061440|FG035|Overall Study|Physician Decision|0|||
16157523|NCT03529773|39061441|FG036|Overall Study|Physician Decision|0|||
16157524|NCT03529773|39061442|FG037|Overall Study|Physician Decision|0|||
16157525|NCT03529773|39061443|FG038|Overall Study|Physician Decision|0|||
16157526|NCT03529773|39061444|FG039|Overall Study|Physician Decision|0|||
16157527|NCT03529773|39061405|FG000|Overall Study|Protocol Violation|0|||
16157528|NCT03529773|39061406|FG001|Overall Study|Protocol Violation|0|||
16157529|NCT03529773|39061407|FG002|Overall Study|Protocol Violation|0|||
16157530|NCT03529773|39061408|FG003|Overall Study|Protocol Violation|0|||
16157531|NCT03529773|39061409|FG004|Overall Study|Protocol Violation|0|||
16157532|NCT03529773|39061410|FG005|Overall Study|Protocol Violation|0|||
16157533|NCT03529773|39061411|FG006|Overall Study|Protocol Violation|0|||
16157534|NCT03529773|39061412|FG007|Overall Study|Protocol Violation|0|||
16157535|NCT03529773|39061413|FG008|Overall Study|Protocol Violation|0|||
16157536|NCT03529773|39061414|FG009|Overall Study|Protocol Violation|0|||
16157537|NCT03529773|39061415|FG010|Overall Study|Protocol Violation|0|||
16157538|NCT03529773|39061416|FG011|Overall Study|Protocol Violation|0|||
16157539|NCT03529773|39061417|FG012|Overall Study|Protocol Violation|0|||
16157540|NCT03529773|39061418|FG013|Overall Study|Protocol Violation|0|||
16157541|NCT03529773|39061419|FG014|Overall Study|Protocol Violation|0|||
16157542|NCT03529773|39061420|FG015|Overall Study|Protocol Violation|0|||
16157543|NCT03529773|39061421|FG016|Overall Study|Protocol Violation|0|||
16157544|NCT03529773|39061422|FG017|Overall Study|Protocol Violation|0|||
16157545|NCT03529773|39061423|FG018|Overall Study|Protocol Violation|0|||
16157546|NCT03529773|39061424|FG019|Overall Study|Protocol Violation|0|||
16157547|NCT03529773|39061425|FG020|Overall Study|Protocol Violation|0|||
16157548|NCT03529773|39061426|FG021|Overall Study|Protocol Violation|0|||
16157549|NCT03529773|39061427|FG022|Overall Study|Protocol Violation|0|||
16157550|NCT03529773|39061428|FG023|Overall Study|Protocol Violation|0|||
16157551|NCT03529773|39061429|FG024|Overall Study|Protocol Violation|0|||
16445347|NCT02057250|40108635|FG001|AID Assessment Phase|Adverse Event|2|||
16445348|NCT02057250|40108636|FG002|AID Assessment Phase|Adverse Event|6|||
16445349|NCT02057250|40108637|FG003|AID Assessment Phase|Adverse Event|1|||
16445350|NCT02057250|40108638|FG004|AID Assessment Phase|Adverse Event|0|||
16445351|NCT02057250|40108634|FG000|AID Assessment Phase|Other than specified above|1|||
16445352|NCT02057250|40108635|FG001|AID Assessment Phase|Other than specified above|1|||
16445353|NCT02057250|40108636|FG002|AID Assessment Phase|Other than specified above|1|||
16445354|NCT02057250|40108637|FG003|AID Assessment Phase|Other than specified above|1|||
16445355|NCT02057250|40108638|FG004|AID Assessment Phase|Other than specified above|0|||
16445356|NCT02057250|40108634|FG000|Extension Phase|Adverse Event|0|||
16445357|NCT02057250|40108635|FG001|Extension Phase|Adverse Event|0|||
16445358|NCT02057250|40108636|FG002|Extension Phase|Adverse Event|0|||
16445359|NCT02057250|40108637|FG003|Extension Phase|Adverse Event|0|||
16157552|NCT03529773|39061430|FG025|Overall Study|Protocol Violation|0|||
16157553|NCT03529773|39061431|FG026|Overall Study|Protocol Violation|0|||
16157554|NCT03529773|39061432|FG027|Overall Study|Protocol Violation|0|||
16445360|NCT02057250|40108638|FG004|Extension Phase|Adverse Event|15|||
16157555|NCT03529773|39061433|FG028|Overall Study|Protocol Violation|0|||
16157556|NCT03529773|39061434|FG029|Overall Study|Protocol Violation|0|||
16157557|NCT03529773|39061435|FG030|Overall Study|Protocol Violation|1|||
16157558|NCT03529773|39061436|FG031|Overall Study|Protocol Violation|0|||
16445361|NCT02057250|40108634|FG000|Extension Phase|Lack of Efficacy|0|||
16445362|NCT02057250|40108635|FG001|Extension Phase|Lack of Efficacy|0|||
16157559|NCT03529773|39061437|FG032|Overall Study|Protocol Violation|0|||
16157560|NCT03529773|39061438|FG033|Overall Study|Protocol Violation|0|||
16157561|NCT03529773|39061439|FG034|Overall Study|Protocol Violation|0|||
16157562|NCT03529773|39061440|FG035|Overall Study|Protocol Violation|0|||
16157563|NCT03529773|39061441|FG036|Overall Study|Protocol Violation|0|||
16157564|NCT03529773|39061442|FG037|Overall Study|Protocol Violation|0|||
16157565|NCT03529773|39061443|FG038|Overall Study|Protocol Violation|0|||
16157566|NCT03529773|39061444|FG039|Overall Study|Protocol Violation|0|||
16157567|NCT03529773|39061405|FG000|Overall Study|Withdrawal by Subject|0|||
16157568|NCT03529773|39061406|FG001|Overall Study|Withdrawal by Subject|0|||
16157569|NCT03529773|39061407|FG002|Overall Study|Withdrawal by Subject|0|||
16157570|NCT03529773|39061408|FG003|Overall Study|Withdrawal by Subject|0|||
16157571|NCT03529773|39061409|FG004|Overall Study|Withdrawal by Subject|0|||
16157572|NCT03529773|39061410|FG005|Overall Study|Withdrawal by Subject|0|||
16157573|NCT03529773|39061411|FG006|Overall Study|Withdrawal by Subject|0|||
16157574|NCT03529773|39061412|FG007|Overall Study|Withdrawal by Subject|1|||
16157575|NCT03529773|39061413|FG008|Overall Study|Withdrawal by Subject|0|||
16157576|NCT03529773|39061414|FG009|Overall Study|Withdrawal by Subject|1|||
16157577|NCT03529773|39061415|FG010|Overall Study|Withdrawal by Subject|1|||
16157578|NCT03529773|39061416|FG011|Overall Study|Withdrawal by Subject|0|||
16157579|NCT03529773|39061417|FG012|Overall Study|Withdrawal by Subject|0|||
16157580|NCT03529773|39061418|FG013|Overall Study|Withdrawal by Subject|0|||
16157581|NCT03529773|39061419|FG014|Overall Study|Withdrawal by Subject|0|||
16157582|NCT03529773|39061420|FG015|Overall Study|Withdrawal by Subject|3|||
16157583|NCT03529773|39061421|FG016|Overall Study|Withdrawal by Subject|0|||
16157584|NCT03529773|39061422|FG017|Overall Study|Withdrawal by Subject|2|||
16157585|NCT03529773|39061423|FG018|Overall Study|Withdrawal by Subject|3|||
16157586|NCT03529773|39061424|FG019|Overall Study|Withdrawal by Subject|1|||
16157587|NCT03529773|39061425|FG020|Overall Study|Withdrawal by Subject|3|||
16157588|NCT03529773|39061426|FG021|Overall Study|Withdrawal by Subject|1|||
16157589|NCT03529773|39061427|FG022|Overall Study|Withdrawal by Subject|1|||
16157590|NCT03529773|39061428|FG023|Overall Study|Withdrawal by Subject|2|||
16157591|NCT03529773|39061429|FG024|Overall Study|Withdrawal by Subject|2|||
16157592|NCT03529773|39061430|FG025|Overall Study|Withdrawal by Subject|4|||
16157593|NCT03529773|39061431|FG026|Overall Study|Withdrawal by Subject|2|||
16157594|NCT03529773|39061432|FG027|Overall Study|Withdrawal by Subject|1|||
16157595|NCT03529773|39061433|FG028|Overall Study|Withdrawal by Subject|1|||
16157596|NCT03529773|39061434|FG029|Overall Study|Withdrawal by Subject|0|||
16157597|NCT03529773|39061435|FG030|Overall Study|Withdrawal by Subject|0|||
16157598|NCT03529773|39061436|FG031|Overall Study|Withdrawal by Subject|0|||
16157599|NCT03529773|39061437|FG032|Overall Study|Withdrawal by Subject|0|||
16157600|NCT03529773|39061438|FG033|Overall Study|Withdrawal by Subject|0|||
16157601|NCT03529773|39061439|FG034|Overall Study|Withdrawal by Subject|1|||
16157602|NCT03529773|39061440|FG035|Overall Study|Withdrawal by Subject|2|||
16157603|NCT03529773|39061441|FG036|Overall Study|Withdrawal by Subject|0|||
16157604|NCT03529773|39061442|FG037|Overall Study|Withdrawal by Subject|2|||
16157605|NCT03529773|39061443|FG038|Overall Study|Withdrawal by Subject|1|||
16157606|NCT03529773|39061444|FG039|Overall Study|Withdrawal by Subject|1|||
16157607|NCT03529773|39061405|FG000|Overall Study|Screen Failure|0|||
16157608|NCT03529773|39061406|FG001|Overall Study|Screen Failure|0|||
16157609|NCT03529773|39061407|FG002|Overall Study|Screen Failure|0|||
16157610|NCT03529773|39061408|FG003|Overall Study|Screen Failure|0|||
16157611|NCT03529773|39061409|FG004|Overall Study|Screen Failure|0|||
16157612|NCT03529773|39061410|FG005|Overall Study|Screen Failure|0|||
16157613|NCT03529773|39061411|FG006|Overall Study|Screen Failure|0|||
16157614|NCT03529773|39061412|FG007|Overall Study|Screen Failure|0|||
16157615|NCT03529773|39061413|FG008|Overall Study|Screen Failure|0|||
16157616|NCT03529773|39061414|FG009|Overall Study|Screen Failure|0|||
16157617|NCT03529773|39061415|FG010|Overall Study|Screen Failure|0|||
16157618|NCT03529773|39061416|FG011|Overall Study|Screen Failure|0|||
16157619|NCT03529773|39061417|FG012|Overall Study|Screen Failure|0|||
16157620|NCT03529773|39061418|FG013|Overall Study|Screen Failure|0|||
16157621|NCT03529773|39061419|FG014|Overall Study|Screen Failure|0|||
16157622|NCT03529773|39061420|FG015|Overall Study|Screen Failure|0|||
16157623|NCT03529773|39061421|FG016|Overall Study|Screen Failure|0|||
16157624|NCT03529773|39061422|FG017|Overall Study|Screen Failure|0|||
16157625|NCT03529773|39061423|FG018|Overall Study|Screen Failure|0|||
16157626|NCT03529773|39061424|FG019|Overall Study|Screen Failure|0|||
16157627|NCT03529773|39061425|FG020|Overall Study|Screen Failure|0|||
16157628|NCT03529773|39061426|FG021|Overall Study|Screen Failure|0|||
16157629|NCT03529773|39061427|FG022|Overall Study|Screen Failure|0|||
16157630|NCT03529773|39061428|FG023|Overall Study|Screen Failure|0|||
16157631|NCT03529773|39061429|FG024|Overall Study|Screen Failure|0|||
16157632|NCT03529773|39061430|FG025|Overall Study|Screen Failure|0|||
16157633|NCT03529773|39061431|FG026|Overall Study|Screen Failure|0|||
16157634|NCT03529773|39061432|FG027|Overall Study|Screen Failure|0|||
16157635|NCT03529773|39061433|FG028|Overall Study|Screen Failure|0|||
16157636|NCT03529773|39061434|FG029|Overall Study|Screen Failure|0|||
16157637|NCT03529773|39061435|FG030|Overall Study|Screen Failure|0|||
16157638|NCT03529773|39061436|FG031|Overall Study|Screen Failure|0|||
16157639|NCT03529773|39061437|FG032|Overall Study|Screen Failure|0|||
16157640|NCT03529773|39061438|FG033|Overall Study|Screen Failure|0|||
16157641|NCT03529773|39061439|FG034|Overall Study|Screen Failure|0|||
16157642|NCT03529773|39061440|FG035|Overall Study|Screen Failure|0|||
16157643|NCT03529773|39061441|FG036|Overall Study|Screen Failure|1|||
16157644|NCT03529773|39061442|FG037|Overall Study|Screen Failure|1|||
16157645|NCT03529773|39061443|FG038|Overall Study|Screen Failure|0|||
16157646|NCT03529773|39061444|FG039|Overall Study|Screen Failure|1|||
16157647|NCT03529773|39061405|FG000|Overall Study|Randomized but not vaccinated|0|||
16157648|NCT03529773|39061406|FG001|Overall Study|Randomized but not vaccinated|0|||
16157649|NCT03529773|39061407|FG002|Overall Study|Randomized but not vaccinated|0|||
16157650|NCT03529773|39061408|FG003|Overall Study|Randomized but not vaccinated|0|||
16157651|NCT03529773|39061409|FG004|Overall Study|Randomized but not vaccinated|0|||
16157652|NCT03529773|39061410|FG005|Overall Study|Randomized but not vaccinated|0|||
16157653|NCT03529773|39061411|FG006|Overall Study|Randomized but not vaccinated|0|||
16157654|NCT03529773|39061412|FG007|Overall Study|Randomized but not vaccinated|0|||
16157655|NCT03529773|39061413|FG008|Overall Study|Randomized but not vaccinated|0|||
16157656|NCT03529773|39061414|FG009|Overall Study|Randomized but not vaccinated|0|||
16157657|NCT03529773|39061415|FG010|Overall Study|Randomized but not vaccinated|0|||
16157658|NCT03529773|39061416|FG011|Overall Study|Randomized but not vaccinated|0|||
16157659|NCT03529773|39061417|FG012|Overall Study|Randomized but not vaccinated|0|||
16157660|NCT03529773|39061418|FG013|Overall Study|Randomized but not vaccinated|0|||
16157661|NCT03529773|39061419|FG014|Overall Study|Randomized but not vaccinated|0|||
16157662|NCT03529773|39061420|FG015|Overall Study|Randomized but not vaccinated|0|||
16157663|NCT03529773|39061421|FG016|Overall Study|Randomized but not vaccinated|0|||
16157664|NCT03529773|39061422|FG017|Overall Study|Randomized but not vaccinated|1|||
16157665|NCT03529773|39061423|FG018|Overall Study|Randomized but not vaccinated|0|||
16157666|NCT03529773|39061424|FG019|Overall Study|Randomized but not vaccinated|0|||
16157667|NCT03529773|39061425|FG020|Overall Study|Randomized but not vaccinated|0|||
16157668|NCT03529773|39061426|FG021|Overall Study|Randomized but not vaccinated|0|||
16157669|NCT03529773|39061427|FG022|Overall Study|Randomized but not vaccinated|0|||
16157670|NCT03529773|39061428|FG023|Overall Study|Randomized but not vaccinated|0|||
16157671|NCT03529773|39061429|FG024|Overall Study|Randomized but not vaccinated|0|||
16157672|NCT03529773|39061430|FG025|Overall Study|Randomized but not vaccinated|0|||
16157673|NCT03529773|39061431|FG026|Overall Study|Randomized but not vaccinated|0|||
16157674|NCT03529773|39061432|FG027|Overall Study|Randomized but not vaccinated|1|||
16157675|NCT03529773|39061433|FG028|Overall Study|Randomized but not vaccinated|0|||
16157676|NCT03529773|39061434|FG029|Overall Study|Randomized but not vaccinated|0|||
16157677|NCT03529773|39061435|FG030|Overall Study|Randomized but not vaccinated|0|||
16157678|NCT03529773|39061436|FG031|Overall Study|Randomized but not vaccinated|0|||
16157679|NCT03529773|39061437|FG032|Overall Study|Randomized but not vaccinated|0|||
16157680|NCT03529773|39061438|FG033|Overall Study|Randomized but not vaccinated|0|||
16157681|NCT03529773|39061439|FG034|Overall Study|Randomized but not vaccinated|0|||
16157682|NCT03529773|39061440|FG035|Overall Study|Randomized but not vaccinated|0|||
16157683|NCT03529773|39061441|FG036|Overall Study|Randomized but not vaccinated|0|||
16157684|NCT03529773|39061442|FG037|Overall Study|Randomized but not vaccinated|0|||
16157685|NCT03529773|39061443|FG038|Overall Study|Randomized but not vaccinated|0|||
16157686|NCT03529773|39061444|FG039|Overall Study|Randomized but not vaccinated|0|||
16157687|NCT04599062|39061445|FG000|Overall Study|Physician Decision|1|||
16157688|NCT04599062|39061446|FG001|Overall Study|Physician Decision|0|||
16157689|NCT02268058|39061447|FG000|Overall Study|Protocol Violation|1|||
16157690|NCT02268058|39061448|FG001|Overall Study|Protocol Violation|0|||
16157691|NCT02268058|39061449|FG002|Overall Study|Protocol Violation|0|||
16157692|NCT02268058|39061450|FG003|Overall Study|Protocol Violation|0|||
16157693|NCT02810964|39061451|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
16157694|NCT02810964|39061452|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
16157695|NCT02810964|39061451|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
16367947|NCT00920816|39829031|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
16445363|NCT02057250|40108636|FG002|Extension Phase|Lack of Efficacy|0|||
16157696|NCT02810964|39061452|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
16157697|NCT02810964|39061451|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
16157698|NCT02810964|39061452|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
16157699|NCT02810964|39061451|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
16157700|NCT02810964|39061452|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
16157701|NCT01964352|39061454|FG000|Overall Study|Adverse Event|13|||
16157702|NCT01964352|39061455|FG001|Overall Study|Adverse Event|3|||
16157703|NCT01964352|39061456|FG002|Overall Study|Adverse Event|4|||
16157704|NCT01964352|39061457|FG003|Overall Study|Adverse Event|3|||
16157705|NCT01964352|39061454|FG000|Overall Study|Lack of Efficacy|6|||
16157706|NCT01964352|39061455|FG001|Overall Study|Lack of Efficacy|0|||
16157707|NCT01964352|39061456|FG002|Overall Study|Lack of Efficacy|0|||
16157708|NCT01964352|39061457|FG003|Overall Study|Lack of Efficacy|0|||
16157709|NCT01964352|39061454|FG000|Overall Study|Protocol Violation|2|||
16157710|NCT01964352|39061455|FG001|Overall Study|Protocol Violation|4|||
16157711|NCT01964352|39061456|FG002|Overall Study|Protocol Violation|0|||
16157712|NCT01964352|39061457|FG003|Overall Study|Protocol Violation|2|||
16157713|NCT01964352|39061454|FG000|Overall Study|Lost to Follow-up|1|||
16157714|NCT01964352|39061455|FG001|Overall Study|Lost to Follow-up|0|||
16157715|NCT01964352|39061456|FG002|Overall Study|Lost to Follow-up|0|||
16157716|NCT01964352|39061457|FG003|Overall Study|Lost to Follow-up|1|||
16157717|NCT01964352|39061454|FG000|Overall Study|Withdrawal by Subject|4|||
16157718|NCT01964352|39061455|FG001|Overall Study|Withdrawal by Subject|2|||
16157719|NCT01964352|39061456|FG002|Overall Study|Withdrawal by Subject|1|||
16157720|NCT01964352|39061457|FG003|Overall Study|Withdrawal by Subject|0|||
16157721|NCT01964352|39061454|FG000|Overall Study|Other than stated above|0|||
16157722|NCT01964352|39061455|FG001|Overall Study|Other than stated above|2|||
16157723|NCT01964352|39061456|FG002|Overall Study|Other than stated above|1|||
16157724|NCT01964352|39061457|FG003|Overall Study|Other than stated above|2|||
16157725|NCT01836783|39061458|FG000|Overall Study|Withdrawal by Subject|0|||
16157726|NCT01836783|39061459|FG001|Overall Study|Withdrawal by Subject|2|||
16157727|NCT00267748|39061460|FG000|Non-randomized Period|Progressive disease|10|||
16157728|NCT00267748|39061461|FG001|Non-randomized Period|Progressive disease|0|||
16157729|NCT00267748|39061462|FG002|Non-randomized Period|Progressive disease|0|||
16157730|NCT00267748|39061460|FG000|Non-randomized Period|Adverse Event|8|||
16157731|NCT00267748|39061461|FG001|Non-randomized Period|Adverse Event|0|||
16445364|NCT02057250|40108637|FG003|Extension Phase|Lack of Efficacy|0|||
16445365|NCT02057250|40108638|FG004|Extension Phase|Lack of Efficacy|10|||
16445366|NCT02057250|40108634|FG000|Extension Phase|Entered in this period but not treated|0|||
16445367|NCT02057250|40108635|FG001|Extension Phase|Entered in this period but not treated|0|||
16445368|NCT02057250|40108636|FG002|Extension Phase|Entered in this period but not treated|0|||
16445369|NCT02057250|40108637|FG003|Extension Phase|Entered in this period but not treated|0|||
16445370|NCT02057250|40108638|FG004|Extension Phase|Entered in this period but not treated|4|||
16445371|NCT02057250|40108634|FG000|Extension Phase|Other than specified above|0|||
16445372|NCT02057250|40108635|FG001|Extension Phase|Other than specified above|0|||
16445373|NCT02057250|40108636|FG002|Extension Phase|Other than specified above|0|||
16445374|NCT02057250|40108637|FG003|Extension Phase|Other than specified above|0|||
16445375|NCT02057250|40108638|FG004|Extension Phase|Other than specified above|7|||
16445376|NCT01099267|40108639|FG000|MDS-003 Study|Adverse Event|37|||
16445377|NCT01099267|40108639|FG000|MDS-003 Study|Lack of Efficacy|52|||
16445378|NCT01099267|40108639|FG000|MDS-003 Study|Withdrawal by Subject|8|||
16445379|NCT01099267|40108639|FG000|MDS-003 Study|Lost to Follow-up|1|||
16445380|NCT01099267|40108639|FG000|MDS-003 Study|Death|11|||
16445381|NCT01099267|40108639|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
16445382|NCT01099267|40108639|FG000|MDS-003 Study|Disease Progression|7|||
16445383|NCT01099267|40108639|FG000|MDS-003 Study|Investigator Decision|2|||
16445384|NCT01099267|40108639|FG000|MDS-003 Study|Non-Compliance|2|||
16445385|NCT01099267|40108639|FG000|MDS-003 Study|Loss of Response|1|||
16445386|NCT01099267|40108639|FG000|MDS-003 Study|Secondary Malign Disease|1|||
16445387|NCT03413891|40108640|FG000|Overall Study|Lost to Follow-up|2|||
16445388|NCT03413891|40108641|FG001|Overall Study|Lost to Follow-up|1|||
16445389|NCT03413891|40108640|FG000|Overall Study|Protocol Violation|0|||
16445390|NCT03413891|40108641|FG001|Overall Study|Protocol Violation|1|||
16445391|NCT00385671|40108648|FG000|Overall Study|Adverse Event|14|||
16445392|NCT00385671|40108649|FG001|Overall Study|Adverse Event|27|||
16445393|NCT00385671|40108650|FG002|Overall Study|Adverse Event|18|||
16445394|NCT00385671|40108648|FG000|Overall Study|Lack of Efficacy|5|||
16445395|NCT00385671|40108649|FG001|Overall Study|Lack of Efficacy|9|||
16445396|NCT00385671|40108650|FG002|Overall Study|Lack of Efficacy|5|||
16445397|NCT00385671|40108648|FG000|Overall Study|Lost to Follow-up|6|||
16445398|NCT00385671|40108649|FG001|Overall Study|Lost to Follow-up|6|||
16157732|NCT00267748|39061462|FG002|Non-randomized Period|Adverse Event|0|||
16157733|NCT00267748|39061460|FG000|Non-randomized Period|Death|1|||
16157734|NCT00267748|39061461|FG001|Non-randomized Period|Death|0|||
16157735|NCT00267748|39061462|FG002|Non-randomized Period|Death|0|||
16157736|NCT00267748|39061460|FG000|Non-randomized Period|Participant not willing to participate|1|||
16157737|NCT00267748|39061461|FG001|Non-randomized Period|Participant not willing to participate|0|||
16065375|NCT01606189|38729793|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
16065376|NCT01606189|38729794|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
16065377|NCT01606189|38729795|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
16065378|NCT01606189|38729796|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
16065379|NCT01606189|38729797|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
16065380|NCT01606189|38729798|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
16065381|NCT01606189|38729793|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
16065382|NCT01606189|38729794|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
16065383|NCT01606189|38729795|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
16065384|NCT01606189|38729796|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
16065385|NCT01606189|38729797|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
16065386|NCT01606189|38729798|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
16445399|NCT00385671|40108650|FG002|Overall Study|Lost to Follow-up|5|||
16445400|NCT00385671|40108648|FG000|Overall Study|Physician Decision|2|||
16445401|NCT00385671|40108649|FG001|Overall Study|Physician Decision|1|||
16445402|NCT00385671|40108650|FG002|Overall Study|Physician Decision|2|||
16445403|NCT00385671|40108648|FG000|Overall Study|Protocol Violation|5|||
16445404|NCT00385671|40108649|FG001|Overall Study|Protocol Violation|2|||
16445405|NCT00385671|40108650|FG002|Overall Study|Protocol Violation|1|||
16445406|NCT00385671|40108648|FG000|Overall Study|Sponsor Decision|2|||
16445407|NCT00385671|40108649|FG001|Overall Study|Sponsor Decision|2|||
16445408|NCT00385671|40108650|FG002|Overall Study|Sponsor Decision|1|||
16445409|NCT00385671|40108648|FG000|Overall Study|Withdrawal by Subject|4|||
16445410|NCT00385671|40108649|FG001|Overall Study|Withdrawal by Subject|4|||
16445411|NCT00385671|40108650|FG002|Overall Study|Withdrawal by Subject|4|||
16445412|NCT00726063|40108655|FG000|Overall Study|Adverse Event|9|||
16445413|NCT00726063|40108656|FG001|Overall Study|Adverse Event|7|||
16445414|NCT04456504|40108657|FG000|Overall Study|Lost to Follow-up|2|||
16445415|NCT03592186|40108658|FG000|Overall Study|Withdrawal by Subject|1|||
16445416|NCT03592186|40108659|FG001|Overall Study|Withdrawal by Subject|0|||
16445417|NCT03592186|40108658|FG000|Overall Study|Lost to Follow-up|16|||
16445418|NCT03592186|40108659|FG001|Overall Study|Lost to Follow-up|11|||
16445419|NCT00307801|40108660|FG000|Overall Study|Adverse Event|12|||
16445420|NCT00307801|40108661|FG001|Overall Study|Adverse Event|4|||
16445421|NCT00307801|40108660|FG000|Overall Study|Withdrawal by Subject|9|||
16445422|NCT00307801|40108661|FG001|Overall Study|Withdrawal by Subject|4|||
16445423|NCT00307801|40108660|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
16157738|NCT00267748|39061462|FG002|Non-randomized Period|Participant not willing to participate|0|||
16157739|NCT00267748|39061460|FG000|Non-randomized Period|Other|3|||
16157740|NCT00267748|39061461|FG001|Non-randomized Period|Other|0|||
16157741|NCT00267748|39061462|FG002|Non-randomized Period|Other|0|||
16157742|NCT00267748|39061460|FG000|Randomized Period|Death|0|||
16157743|NCT00267748|39061461|FG001|Randomized Period|Death|2|||
16157744|NCT00267748|39061462|FG002|Randomized Period|Death|3|||
16157745|NCT00267748|39061460|FG000|Randomized Period|Adverse Event|0|||
16157746|NCT00267748|39061461|FG001|Randomized Period|Adverse Event|23|||
16157747|NCT00267748|39061462|FG002|Randomized Period|Adverse Event|25|||
16157748|NCT00267748|39061460|FG000|Randomized Period|Global deterioration of health status|0|||
16157749|NCT00267748|39061461|FG001|Randomized Period|Global deterioration of health status|6|||
16157750|NCT00267748|39061462|FG002|Randomized Period|Global deterioration of health status|7|||
16157751|NCT00267748|39061460|FG000|Randomized Period|Lost to Follow-up|0|||
16157752|NCT00267748|39061461|FG001|Randomized Period|Lost to Follow-up|1|||
16157753|NCT00267748|39061462|FG002|Randomized Period|Lost to Follow-up|0|||
16157754|NCT00267748|39061460|FG000|Randomized Period|Objective progression or relapse|0|||
16157755|NCT00267748|39061461|FG001|Randomized Period|Objective progression or relapse|77|||
16157756|NCT00267748|39061462|FG002|Randomized Period|Objective progression or relapse|86|||
16157757|NCT00267748|39061460|FG000|Randomized Period|Withdrawal by Subject|0|||
16157758|NCT00267748|39061461|FG001|Randomized Period|Withdrawal by Subject|9|||
16157759|NCT00267748|39061462|FG002|Randomized Period|Withdrawal by Subject|2|||
16157760|NCT00267748|39061460|FG000|Randomized Period|Other|0|||
16157761|NCT00267748|39061461|FG001|Randomized Period|Other|9|||
16157762|NCT00267748|39061462|FG002|Randomized Period|Other|6|||
16157763|NCT00267748|39061460|FG000|Randomized Period|randomized but not treated|0|||
16157764|NCT00267748|39061461|FG001|Randomized Period|randomized but not treated|0|||
16157765|NCT00267748|39061462|FG002|Randomized Period|randomized but not treated|3|||
16157766|NCT01678144|39061463|FG000|Stage 1: MAR Classic|Adverse Event|1|||
16157767|NCT01780831|39061464|FG000|Overall Study|Withdrawal by Subject|0|||
16157768|NCT01780831|39061465|FG001|Overall Study|Withdrawal by Subject|0|||
16157769|NCT01780831|39061466|FG002|Overall Study|Withdrawal by Subject|4|||
16157770|NCT01780831|39061467|FG003|Overall Study|Withdrawal by Subject|0|||
16157771|NCT01780831|39061464|FG000|Overall Study|Lost to Follow-up|0|||
16157772|NCT01780831|39061465|FG001|Overall Study|Lost to Follow-up|0|||
16157773|NCT01780831|39061466|FG002|Overall Study|Lost to Follow-up|0|||
16157774|NCT01780831|39061467|FG003|Overall Study|Lost to Follow-up|1|||
16157775|NCT01049035|39061468|FG000|Overall Study|Serious adverse event|0|||
16157776|NCT01049035|39061469|FG001|Overall Study|Serious adverse event|1|||
16157777|NCT01049035|39061470|FG002|Overall Study|Serious adverse event|1|||
16157778|NCT01049035|39061471|FG003|Overall Study|Serious adverse event|2|||
16157779|NCT01049035|39061472|FG004|Overall Study|Serious adverse event|0|||
16157780|NCT01049035|39061473|FG005|Overall Study|Serious adverse event|0|||
16157781|NCT01049035|39061474|FG006|Overall Study|Serious adverse event|0|||
16157782|NCT01049035|39061468|FG000|Overall Study|Other adverse event (AE)|0|||
16157783|NCT01049035|39061469|FG001|Overall Study|Other adverse event (AE)|0|||
16157784|NCT01049035|39061470|FG002|Overall Study|Other adverse event (AE)|0|||
16157785|NCT01049035|39061471|FG003|Overall Study|Other adverse event (AE)|1|||
16157786|NCT01049035|39061472|FG004|Overall Study|Other adverse event (AE)|0|||
16367948|NCT00920816|39829032|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
16445424|NCT00307801|40108661|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
16157787|NCT01049035|39061473|FG005|Overall Study|Other adverse event (AE)|0|||
16157788|NCT01049035|39061474|FG006|Overall Study|Other adverse event (AE)|0|||
16157789|NCT01049035|39061468|FG000|Overall Study|Non-compliance with the protocol|12|||
16367949|NCT00920816|39829033|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
16367950|NCT00920816|39829034|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
16367951|NCT00920816|39829031|FG000|Overall Study|Global deterioration of health status|2|||
16367952|NCT00920816|39829032|FG001|Overall Study|Global deterioration of health status|0|||
16367953|NCT00920816|39829033|FG002|Overall Study|Global deterioration of health status|0|||
16367954|NCT00920816|39829034|FG003|Overall Study|Global deterioration of health status|0|||
16367955|NCT00920816|39829031|FG000|Overall Study|Objective progression or relapse|6|||
16367956|NCT00920816|39829032|FG001|Overall Study|Objective progression or relapse|2|||
16367957|NCT00920816|39829033|FG002|Overall Study|Objective progression or relapse|0|||
16367958|NCT00920816|39829034|FG003|Overall Study|Objective progression or relapse|0|||
16367959|NCT00920816|39829031|FG000|Overall Study|Other|26|||
16367960|NCT00920816|39829032|FG001|Overall Study|Other|15|||
16367961|NCT00920816|39829033|FG002|Overall Study|Other|1|||
16367962|NCT00920816|39829034|FG003|Overall Study|Other|2|||
16367963|NCT00920816|39829031|FG000|Overall Study|Lost to Follow-up|11|||
16367964|NCT00920816|39829032|FG001|Overall Study|Lost to Follow-up|2|||
16367965|NCT00920816|39829033|FG002|Overall Study|Lost to Follow-up|0|||
16367966|NCT00920816|39829034|FG003|Overall Study|Lost to Follow-up|0|||
16367967|NCT00920816|39829031|FG000|Overall Study|Adverse Event|1|||
16367968|NCT00920816|39829032|FG001|Overall Study|Adverse Event|1|||
16367969|NCT00920816|39829033|FG002|Overall Study|Adverse Event|1|||
16367970|NCT00920816|39829034|FG003|Overall Study|Adverse Event|0|||
16367971|NCT00920816|39829031|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
16367972|NCT00920816|39829032|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
16367973|NCT00920816|39829033|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
16367974|NCT00920816|39829034|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
16367975|NCT00920816|39829031|FG000|Overall Study|Randomized but not treated|3|||
16367976|NCT00920816|39829032|FG001|Overall Study|Randomized but not treated|0|||
16367977|NCT00920816|39829033|FG002|Overall Study|Randomized but not treated|0|||
16367978|NCT00920816|39829034|FG003|Overall Study|Randomized but not treated|0|||
16367979|NCT00021255|39833044|FG000|Overall Study|Death|1|||
16367980|NCT00021255|39833045|FG001|Overall Study|Death|0|||
16367981|NCT00021255|39833046|FG002|Overall Study|Death|2|||
16367982|NCT00021255|39833044|FG000|Overall Study|Breast cancer relapse|5|||
16367983|NCT00021255|39833045|FG001|Overall Study|Breast cancer relapse|18|||
16367984|NCT00021255|39833046|FG002|Overall Study|Breast cancer relapse|11|||
16367985|NCT00021255|39833044|FG000|Overall Study|Second primary malignancy|0|||
16367986|NCT00021255|39833045|FG001|Overall Study|Second primary malignancy|4|||
16367987|NCT00021255|39833046|FG002|Overall Study|Second primary malignancy|1|||
16367988|NCT00021255|39833044|FG000|Overall Study|Withdrawal by Subject|41|||
16367989|NCT00021255|39833045|FG001|Overall Study|Withdrawal by Subject|64|||
16367990|NCT00021255|39833046|FG002|Overall Study|Withdrawal by Subject|26|||
16367991|NCT00021255|39833044|FG000|Overall Study|Lost to Follow-up|0|||
16367992|NCT00021255|39833045|FG001|Overall Study|Lost to Follow-up|2|||
16367993|NCT00021255|39833046|FG002|Overall Study|Lost to Follow-up|3|||
16367994|NCT00021255|39833044|FG000|Overall Study|Cardiac toxicity|0|||
16367995|NCT00021255|39833045|FG001|Overall Study|Cardiac toxicity|61|||
16367996|NCT00021255|39833046|FG002|Overall Study|Cardiac toxicity|32|||
16367997|NCT00021255|39833044|FG000|Overall Study|Herceptin toxicity|0|||
16367998|NCT00021255|39833045|FG001|Overall Study|Herceptin toxicity|22|||
16367999|NCT00021255|39833046|FG002|Overall Study|Herceptin toxicity|6|||
16368000|NCT00021255|39833044|FG000|Overall Study|Adverse Event|46|||
16368001|NCT00021255|39833045|FG001|Overall Study|Adverse Event|30|||
16368002|NCT00021255|39833046|FG002|Overall Study|Adverse Event|18|||
16368003|NCT00021255|39833044|FG000|Overall Study|Protocol Violation|0|||
16368004|NCT00021255|39833045|FG001|Overall Study|Protocol Violation|2|||
16368005|NCT00021255|39833046|FG002|Overall Study|Protocol Violation|0|||
16368006|NCT00021255|39833044|FG000|Overall Study|Other than specified above|0|||
16368007|NCT00021255|39833045|FG001|Overall Study|Other than specified above|38|||
16368008|NCT00021255|39833046|FG002|Overall Study|Other than specified above|19|||
16368009|NCT00021255|39833044|FG000|Overall Study|Missing|0|||
16368010|NCT00021255|39833045|FG001|Overall Study|Missing|27|||
16368011|NCT00021255|39833046|FG002|Overall Study|Missing|13|||
16368012|NCT00021255|39833044|FG000|Overall Study|Randomized but not treated|28|||
16368013|NCT00021255|39833045|FG001|Overall Study|Randomized but not treated|2|||
16368014|NCT00021255|39833046|FG002|Overall Study|Randomized but not treated|18|||
16368015|NCT02400736|39833048|FG000|Overall Study|Lost to Follow-up|6|||
16368016|NCT02400736|39833049|FG001|Overall Study|Lost to Follow-up|6|||
16368017|NCT02400736|39833048|FG000|Overall Study|Withdrawal by Subject|2|||
16368018|NCT02400736|39833049|FG001|Overall Study|Withdrawal by Subject|1|||
16368019|NCT02400736|39833048|FG000|Overall Study|Moved from the area|3|||
16368020|NCT02400736|39833049|FG001|Overall Study|Moved from the area|1|||
16368021|NCT02923180|39833055|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
16368022|NCT02923180|39833055|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
16368023|NCT01027845|39833056|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
16368024|NCT01027845|39833057|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
16368025|NCT01027845|39833058|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
16368026|NCT01027845|39833059|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
16368027|NCT01027845|39833056|FG000|Primary Vaccination Phase|Adverse Event|1|||
16368028|NCT01027845|39833057|FG001|Primary Vaccination Phase|Adverse Event|0|||
16368029|NCT01027845|39833058|FG002|Primary Vaccination Phase|Adverse Event|0|||
16368030|NCT01027845|39833059|FG003|Primary Vaccination Phase|Adverse Event|0|||
16368031|NCT01027845|39833056|FG000|Primary Vaccination Phase|Protocol Violation|1|||
16368032|NCT01027845|39833057|FG001|Primary Vaccination Phase|Protocol Violation|0|||
16368033|NCT01027845|39833058|FG002|Primary Vaccination Phase|Protocol Violation|0|||
16368034|NCT01027845|39833059|FG003|Primary Vaccination Phase|Protocol Violation|0|||
16368035|NCT01027845|39833056|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
16368036|NCT01027845|39833057|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
16368037|NCT01027845|39833058|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
16368038|NCT01027845|39833059|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
16368039|NCT01027845|39833056|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
16368040|NCT01027845|39833057|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
16368041|NCT01027845|39833058|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
16368042|NCT01027845|39833059|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
16368043|NCT01027845|39833056|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
16368044|NCT01027845|39833057|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
16368045|NCT01027845|39833058|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
16368046|NCT01027845|39833059|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
16368047|NCT00992394|39833063|FG000|Overall Study|Lack of Efficacy|6|||
16368048|NCT00992394|39833064|FG001|Overall Study|Lack of Efficacy|3|||
16368049|NCT00992394|39833063|FG000|Overall Study|Adverse Event|4|||
16368050|NCT00992394|39833064|FG001|Overall Study|Adverse Event|5|||
16368051|NCT00992394|39833063|FG000|Overall Study|Withdrawal by Subject|8|||
16368052|NCT00992394|39833064|FG001|Overall Study|Withdrawal by Subject|2|||
16368053|NCT00992394|39833063|FG000|Overall Study|Physician Decision|1|||
16368054|NCT00992394|39833064|FG001|Overall Study|Physician Decision|0|||
16368055|NCT00992394|39833063|FG000|Overall Study|Protocol Violation|2|||
16368056|NCT00992394|39833064|FG001|Overall Study|Protocol Violation|4|||
16368057|NCT00992394|39833063|FG000|Overall Study|Lost to Follow-up|2|||
16368058|NCT00992394|39833064|FG001|Overall Study|Lost to Follow-up|0|||
16368059|NCT00992394|39833063|FG000|Overall Study|Other event|1|||
16368060|NCT00992394|39833064|FG001|Overall Study|Other event|0|||
16368061|NCT03286504|39833077|FG000|Overall Study|Lost to Follow-up|19|||
16368062|NCT03286504|39833078|FG001|Overall Study|Lost to Follow-up|16|||
16368063|NCT03695094|39833081|FG000|Overall Study|Adverse Event|1|||
16368064|NCT03695094|39833082|FG001|Overall Study|Adverse Event|1|||
16368065|NCT03695094|39833081|FG000|Overall Study|Withdrawal by Subject|1|||
16368066|NCT03695094|39833082|FG001|Overall Study|Withdrawal by Subject|0|||
16368067|NCT01483651|39833088|FG000|Overall Study|Withdrawal by Subject|0|||
16368068|NCT01483651|39833089|FG001|Overall Study|Withdrawal by Subject|1|||
16368069|NCT01483651|39833090|FG002|Overall Study|Withdrawal by Subject|1|||
16368070|NCT01483651|39833091|FG003|Overall Study|Withdrawal by Subject|0|||
16368071|NCT01483651|39833092|FG004|Overall Study|Withdrawal by Subject|0|||
16368072|NCT01483651|39833093|FG005|Overall Study|Withdrawal by Subject|1|||
16368073|NCT04518410|39833106|FG000|Overall Study|Lost to Follow-up|1|||
16368074|NCT04518410|39833107|FG001|Overall Study|Lost to Follow-up|1|||
16368075|NCT04518410|39833108|FG002|Overall Study|Lost to Follow-up|8|||
16368076|NCT04518410|39833109|FG003|Overall Study|Lost to Follow-up|5|||
16368077|NCT04518410|39833110|FG004|Overall Study|Lost to Follow-up|92|||
16368078|NCT04518410|39833111|FG005|Overall Study|Lost to Follow-up|25|||
16368079|NCT04518410|39833112|FG006|Overall Study|Lost to Follow-up|25|||
16368080|NCT04518410|39833113|FG007|Overall Study|Lost to Follow-up|3|||
16368081|NCT04518410|39833114|FG008|Overall Study|Lost to Follow-up|2|||
16368082|NCT04518410|39833115|FG009|Overall Study|Lost to Follow-up|13|||
16368083|NCT04518410|39833116|FG010|Overall Study|Lost to Follow-up|9|||
16368084|NCT04518410|39833117|FG011|Overall Study|Lost to Follow-up|13|||
16368085|NCT04518410|39833118|FG012|Overall Study|Lost to Follow-up|9|||
16368086|NCT04518410|39833119|FG013|Overall Study|Lost to Follow-up|13|||
16368087|NCT04518410|39833120|FG014|Overall Study|Lost to Follow-up|8|||
16368088|NCT04518410|39833121|FG015|Overall Study|Lost to Follow-up|10|||
16368089|NCT04518410|39833122|FG016|Overall Study|Lost to Follow-up|6|||
16368090|NCT04518410|39833123|FG017|Overall Study|Lost to Follow-up|13|||
16368091|NCT04518410|39833124|FG018|Overall Study|Lost to Follow-up|21|||
16368092|NCT04518410|39833125|FG019|Overall Study|Lost to Follow-up|6|||
16368093|NCT04518410|39833126|FG020|Overall Study|Lost to Follow-up|7|||
16368094|NCT04518410|39833127|FG021|Overall Study|Lost to Follow-up|21|||
16368095|NCT04518410|39833128|FG022|Overall Study|Lost to Follow-up|1|||
16368096|NCT04518410|39833129|FG023|Overall Study|Lost to Follow-up|7|||
16368097|NCT04518410|39833130|FG024|Overall Study|Lost to Follow-up|6|||
16368098|NCT04518410|39833106|FG000|Overall Study|Withdrawal by Subject|1|||
16368099|NCT04518410|39833107|FG001|Overall Study|Withdrawal by Subject|2|||
16368100|NCT04518410|39833108|FG002|Overall Study|Withdrawal by Subject|2|||
16368101|NCT04518410|39833109|FG003|Overall Study|Withdrawal by Subject|3|||
16368102|NCT04518410|39833110|FG004|Overall Study|Withdrawal by Subject|20|||
16368103|NCT04518410|39833111|FG005|Overall Study|Withdrawal by Subject|20|||
16368104|NCT04518410|39833112|FG006|Overall Study|Withdrawal by Subject|25|||
16368105|NCT04518410|39833113|FG007|Overall Study|Withdrawal by Subject|6|||
16368106|NCT04518410|39833114|FG008|Overall Study|Withdrawal by Subject|1|||
16368107|NCT04518410|39833115|FG009|Overall Study|Withdrawal by Subject|12|||
16368108|NCT04518410|39833116|FG010|Overall Study|Withdrawal by Subject|5|||
16368109|NCT04518410|39833117|FG011|Overall Study|Withdrawal by Subject|7|||
16368110|NCT04518410|39833118|FG012|Overall Study|Withdrawal by Subject|2|||
16368111|NCT04518410|39833119|FG013|Overall Study|Withdrawal by Subject|13|||
16368112|NCT04518410|39833120|FG014|Overall Study|Withdrawal by Subject|4|||
16368113|NCT04518410|39833121|FG015|Overall Study|Withdrawal by Subject|9|||
16368114|NCT04518410|39833122|FG016|Overall Study|Withdrawal by Subject|0|||
16368115|NCT04518410|39833123|FG017|Overall Study|Withdrawal by Subject|15|||
16368116|NCT04518410|39833124|FG018|Overall Study|Withdrawal by Subject|12|||
16368117|NCT04518410|39833125|FG019|Overall Study|Withdrawal by Subject|9|||
16368118|NCT04518410|39833126|FG020|Overall Study|Withdrawal by Subject|14|||
16368119|NCT04518410|39833127|FG021|Overall Study|Withdrawal by Subject|3|||
16368120|NCT04518410|39833128|FG022|Overall Study|Withdrawal by Subject|2|||
16368121|NCT04518410|39833129|FG023|Overall Study|Withdrawal by Subject|9|||
16368122|NCT04518410|39833130|FG024|Overall Study|Withdrawal by Subject|8|||
16368123|NCT04518410|39833106|FG000|Overall Study|Other|1|||
16368124|NCT04518410|39833107|FG001|Overall Study|Other|0|||
16368125|NCT04518410|39833108|FG002|Overall Study|Other|0|||
16368126|NCT04518410|39833109|FG003|Overall Study|Other|1|||
16368127|NCT04518410|39833110|FG004|Overall Study|Other|6|||
16368128|NCT04518410|39833111|FG005|Overall Study|Other|6|||
16368129|NCT04518410|39833112|FG006|Overall Study|Other|5|||
16368130|NCT04518410|39833113|FG007|Overall Study|Other|2|||
16368131|NCT04518410|39833114|FG008|Overall Study|Other|0|||
16368132|NCT04518410|39833115|FG009|Overall Study|Other|1|||
16368133|NCT04518410|39833116|FG010|Overall Study|Other|0|||
16368134|NCT04518410|39833117|FG011|Overall Study|Other|2|||
16368135|NCT04518410|39833118|FG012|Overall Study|Other|0|||
16368136|NCT04518410|39833119|FG013|Overall Study|Other|0|||
16368137|NCT04518410|39833120|FG014|Overall Study|Other|0|||
16368138|NCT04518410|39833121|FG015|Overall Study|Other|3|||
16368139|NCT04518410|39833122|FG016|Overall Study|Other|1|||
16368140|NCT04518410|39833123|FG017|Overall Study|Other|1|||
16445425|NCT00307801|40108660|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
16445426|NCT00307801|40108661|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
16273195|NCT00367133|39484449|FG001|2 Years|Missed visit|5|||
16368141|NCT04518410|39833124|FG018|Overall Study|Other|1|||
16368142|NCT04518410|39833125|FG019|Overall Study|Other|0|||
16368143|NCT04518410|39833126|FG020|Overall Study|Other|1|||
16368144|NCT04518410|39833127|FG021|Overall Study|Other|0|||
16368145|NCT04518410|39833128|FG022|Overall Study|Other|1|||
16368146|NCT04518410|39833129|FG023|Overall Study|Other|2|||
16368147|NCT04518410|39833130|FG024|Overall Study|Other|2|||
16368148|NCT04518410|39833106|FG000|Overall Study|Protocol Violation|0|||
16368149|NCT04518410|39833107|FG001|Overall Study|Protocol Violation|0|||
16368150|NCT04518410|39833108|FG002|Overall Study|Protocol Violation|0|||
16368151|NCT04518410|39833109|FG003|Overall Study|Protocol Violation|2|||
16368152|NCT04518410|39833110|FG004|Overall Study|Protocol Violation|17|||
16368153|NCT04518410|39833111|FG005|Overall Study|Protocol Violation|1|||
16368154|NCT04518410|39833112|FG006|Overall Study|Protocol Violation|2|||
16368155|NCT04518410|39833113|FG007|Overall Study|Protocol Violation|1|||
16368156|NCT04518410|39833114|FG008|Overall Study|Protocol Violation|0|||
16368157|NCT04518410|39833115|FG009|Overall Study|Protocol Violation|0|||
16368158|NCT04518410|39833116|FG010|Overall Study|Protocol Violation|0|||
16368159|NCT04518410|39833117|FG011|Overall Study|Protocol Violation|0|||
16368160|NCT04518410|39833118|FG012|Overall Study|Protocol Violation|0|||
16368161|NCT04518410|39833119|FG013|Overall Study|Protocol Violation|0|||
16368162|NCT04518410|39833120|FG014|Overall Study|Protocol Violation|0|||
16368163|NCT04518410|39833121|FG015|Overall Study|Protocol Violation|0|||
16368164|NCT04518410|39833122|FG016|Overall Study|Protocol Violation|1|||
16368165|NCT04518410|39833123|FG017|Overall Study|Protocol Violation|1|||
16368166|NCT04518410|39833124|FG018|Overall Study|Protocol Violation|0|||
16368167|NCT04518410|39833125|FG019|Overall Study|Protocol Violation|0|||
16368168|NCT04518410|39833126|FG020|Overall Study|Protocol Violation|1|||
16368169|NCT04518410|39833127|FG021|Overall Study|Protocol Violation|2|||
16368170|NCT04518410|39833128|FG022|Overall Study|Protocol Violation|0|||
16368171|NCT04518410|39833129|FG023|Overall Study|Protocol Violation|3|||
16368172|NCT04518410|39833130|FG024|Overall Study|Protocol Violation|0|||
16368173|NCT04518410|39833106|FG000|Overall Study|Death|0|||
16368174|NCT04518410|39833107|FG001|Overall Study|Death|0|||
16368175|NCT04518410|39833108|FG002|Overall Study|Death|0|||
16368176|NCT04518410|39833109|FG003|Overall Study|Death|0|||
16368177|NCT04518410|39833110|FG004|Overall Study|Death|12|||
16368178|NCT04518410|39833111|FG005|Overall Study|Death|2|||
16368179|NCT04518410|39833112|FG006|Overall Study|Death|11|||
16368180|NCT04518410|39833113|FG007|Overall Study|Death|0|||
16368181|NCT04518410|39833114|FG008|Overall Study|Death|1|||
16368182|NCT04518410|39833115|FG009|Overall Study|Death|0|||
16368183|NCT04518410|39833116|FG010|Overall Study|Death|0|||
16368184|NCT04518410|39833117|FG011|Overall Study|Death|0|||
16368185|NCT04518410|39833118|FG012|Overall Study|Death|0|||
16368186|NCT04518410|39833119|FG013|Overall Study|Death|1|||
16368187|NCT04518410|39833120|FG014|Overall Study|Death|1|||
16368188|NCT04518410|39833121|FG015|Overall Study|Death|0|||
16368189|NCT04518410|39833122|FG016|Overall Study|Death|0|||
16368190|NCT04518410|39833123|FG017|Overall Study|Death|1|||
16368191|NCT04518410|39833124|FG018|Overall Study|Death|4|||
16368192|NCT04518410|39833125|FG019|Overall Study|Death|4|||
16368193|NCT04518410|39833126|FG020|Overall Study|Death|1|||
16368194|NCT04518410|39833127|FG021|Overall Study|Death|0|||
16368195|NCT04518410|39833128|FG022|Overall Study|Death|0|||
16368196|NCT04518410|39833129|FG023|Overall Study|Death|0|||
16368197|NCT04518410|39833130|FG024|Overall Study|Death|0|||
16368198|NCT04518410|39833106|FG000|Overall Study|Requirement to start alternative therapy|0|||
16368199|NCT04518410|39833107|FG001|Overall Study|Requirement to start alternative therapy|0|||
16368200|NCT04518410|39833108|FG002|Overall Study|Requirement to start alternative therapy|1|||
16368201|NCT04518410|39833109|FG003|Overall Study|Requirement to start alternative therapy|0|||
16368202|NCT04518410|39833110|FG004|Overall Study|Requirement to start alternative therapy|0|||
16368203|NCT04518410|39833111|FG005|Overall Study|Requirement to start alternative therapy|0|||
16368204|NCT04518410|39833112|FG006|Overall Study|Requirement to start alternative therapy|0|||
16368205|NCT04518410|39833113|FG007|Overall Study|Requirement to start alternative therapy|0|||
16368206|NCT04518410|39833114|FG008|Overall Study|Requirement to start alternative therapy|0|||
16368207|NCT04518410|39833115|FG009|Overall Study|Requirement to start alternative therapy|0|||
16368208|NCT04518410|39833116|FG010|Overall Study|Requirement to start alternative therapy|0|||
16368209|NCT04518410|39833117|FG011|Overall Study|Requirement to start alternative therapy|0|||
16368210|NCT04518410|39833118|FG012|Overall Study|Requirement to start alternative therapy|0|||
16368211|NCT04518410|39833119|FG013|Overall Study|Requirement to start alternative therapy|0|||
16368212|NCT04518410|39833120|FG014|Overall Study|Requirement to start alternative therapy|0|||
16368213|NCT04518410|39833121|FG015|Overall Study|Requirement to start alternative therapy|0|||
16368214|NCT04518410|39833122|FG016|Overall Study|Requirement to start alternative therapy|0|||
16368215|NCT04518410|39833123|FG017|Overall Study|Requirement to start alternative therapy|0|||
16368216|NCT04518410|39833124|FG018|Overall Study|Requirement to start alternative therapy|0|||
16368217|NCT04518410|39833125|FG019|Overall Study|Requirement to start alternative therapy|0|||
16368218|NCT04518410|39833126|FG020|Overall Study|Requirement to start alternative therapy|0|||
16368219|NCT04518410|39833127|FG021|Overall Study|Requirement to start alternative therapy|0|||
16368220|NCT04518410|39833128|FG022|Overall Study|Requirement to start alternative therapy|0|||
16368221|NCT04518410|39833129|FG023|Overall Study|Requirement to start alternative therapy|0|||
16368222|NCT04518410|39833130|FG024|Overall Study|Requirement to start alternative therapy|0|||
16368223|NCT04518410|39833106|FG000|Overall Study|Randomized but not treated|0|||
16368224|NCT04518410|39833107|FG001|Overall Study|Randomized but not treated|0|||
16368225|NCT04518410|39833108|FG002|Overall Study|Randomized but not treated|0|||
16368226|NCT04518410|39833109|FG003|Overall Study|Randomized but not treated|2|||
16368227|NCT04518410|39833110|FG004|Overall Study|Randomized but not treated|6|||
16368228|NCT04518410|39833111|FG005|Overall Study|Randomized but not treated|4|||
16368229|NCT04518410|39833112|FG006|Overall Study|Randomized but not treated|3|||
16368230|NCT04518410|39833113|FG007|Overall Study|Randomized but not treated|3|||
16368231|NCT04518410|39833114|FG008|Overall Study|Randomized but not treated|0|||
16368232|NCT04518410|39833115|FG009|Overall Study|Randomized but not treated|4|||
16368233|NCT04518410|39833116|FG010|Overall Study|Randomized but not treated|0|||
16368234|NCT04518410|39833117|FG011|Overall Study|Randomized but not treated|0|||
16368235|NCT04518410|39833118|FG012|Overall Study|Randomized but not treated|1|||
16368236|NCT04518410|39833119|FG013|Overall Study|Randomized but not treated|3|||
16368237|NCT04518410|39833120|FG014|Overall Study|Randomized but not treated|3|||
16368238|NCT04518410|39833121|FG015|Overall Study|Randomized but not treated|3|||
16368239|NCT04518410|39833122|FG016|Overall Study|Randomized but not treated|4|||
16368240|NCT04518410|39833123|FG017|Overall Study|Randomized but not treated|5|||
16368241|NCT04518410|39833124|FG018|Overall Study|Randomized but not treated|4|||
16368242|NCT04518410|39833125|FG019|Overall Study|Randomized but not treated|0|||
16368243|NCT04518410|39833126|FG020|Overall Study|Randomized but not treated|0|||
16368244|NCT04518410|39833127|FG021|Overall Study|Randomized but not treated|5|||
16368245|NCT04518410|39833128|FG022|Overall Study|Randomized but not treated|0|||
16368246|NCT04518410|39833129|FG023|Overall Study|Randomized but not treated|3|||
16368247|NCT04518410|39833130|FG024|Overall Study|Randomized but not treated|1|||
16368248|NCT04518410|39833106|FG000|Overall Study|Screen Fail but Randomized|0|||
16368249|NCT04518410|39833107|FG001|Overall Study|Screen Fail but Randomized|0|||
16368250|NCT04518410|39833108|FG002|Overall Study|Screen Fail but Randomized|0|||
16368251|NCT04518410|39833109|FG003|Overall Study|Screen Fail but Randomized|0|||
16368252|NCT04518410|39833110|FG004|Overall Study|Screen Fail but Randomized|2|||
16368253|NCT04518410|39833111|FG005|Overall Study|Screen Fail but Randomized|0|||
16368254|NCT04518410|39833112|FG006|Overall Study|Screen Fail but Randomized|0|||
16368255|NCT04518410|39833113|FG007|Overall Study|Screen Fail but Randomized|0|||
16368256|NCT04518410|39833114|FG008|Overall Study|Screen Fail but Randomized|0|||
16157790|NCT01049035|39061469|FG001|Overall Study|Non-compliance with the protocol|6|||
16157791|NCT01049035|39061470|FG002|Overall Study|Non-compliance with the protocol|14|||
16368257|NCT04518410|39833115|FG009|Overall Study|Screen Fail but Randomized|0|||
16368258|NCT04518410|39833116|FG010|Overall Study|Screen Fail but Randomized|0|||
16368259|NCT04518410|39833117|FG011|Overall Study|Screen Fail but Randomized|0|||
16368260|NCT04518410|39833118|FG012|Overall Study|Screen Fail but Randomized|0|||
16368261|NCT04518410|39833119|FG013|Overall Study|Screen Fail but Randomized|0|||
16368262|NCT04518410|39833120|FG014|Overall Study|Screen Fail but Randomized|0|||
16368263|NCT04518410|39833121|FG015|Overall Study|Screen Fail but Randomized|0|||
16368264|NCT04518410|39833122|FG016|Overall Study|Screen Fail but Randomized|0|||
16157792|NCT01049035|39061471|FG003|Overall Study|Non-compliance with the protocol|5|||
16157793|NCT01049035|39061472|FG004|Overall Study|Non-compliance with the protocol|3|||
16157794|NCT01049035|39061473|FG005|Overall Study|Non-compliance with the protocol|4|||
16157795|NCT01049035|39061474|FG006|Overall Study|Non-compliance with the protocol|10|||
16157796|NCT01049035|39061468|FG000|Overall Study|Lost to Follow-up|5|||
16157797|NCT01049035|39061469|FG001|Overall Study|Lost to Follow-up|4|||
16157798|NCT01049035|39061470|FG002|Overall Study|Lost to Follow-up|4|||
16157799|NCT01049035|39061471|FG003|Overall Study|Lost to Follow-up|1|||
16157800|NCT01049035|39061472|FG004|Overall Study|Lost to Follow-up|0|||
16157801|NCT01049035|39061473|FG005|Overall Study|Lost to Follow-up|3|||
16157802|NCT01049035|39061474|FG006|Overall Study|Lost to Follow-up|3|||
16157803|NCT01049035|39061468|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
16157804|NCT01049035|39061469|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
16157805|NCT01049035|39061470|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
16157806|NCT01049035|39061471|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
16157807|NCT01049035|39061472|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
16445427|NCT00307801|40108660|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
16157808|NCT01049035|39061473|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
16157809|NCT01049035|39061474|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
16368265|NCT04518410|39833123|FG017|Overall Study|Screen Fail but Randomized|0|||
16368266|NCT04518410|39833124|FG018|Overall Study|Screen Fail but Randomized|0|||
16368267|NCT04518410|39833125|FG019|Overall Study|Screen Fail but Randomized|0|||
16368268|NCT04518410|39833126|FG020|Overall Study|Screen Fail but Randomized|0|||
16368269|NCT04518410|39833127|FG021|Overall Study|Screen Fail but Randomized|0|||
16368270|NCT04518410|39833128|FG022|Overall Study|Screen Fail but Randomized|0|||
16368271|NCT04518410|39833129|FG023|Overall Study|Screen Fail but Randomized|0|||
16368272|NCT04518410|39833130|FG024|Overall Study|Screen Fail but Randomized|0|||
16368273|NCT04518410|39833106|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
16368274|NCT04518410|39833107|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
16368275|NCT04518410|39833108|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
16368276|NCT04518410|39833109|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
16368277|NCT04518410|39833110|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
16368278|NCT04518410|39833111|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
16368279|NCT04518410|39833112|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
16368280|NCT04518410|39833113|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
16368281|NCT04518410|39833114|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
16368282|NCT04518410|39833115|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
16368283|NCT04518410|39833116|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
16368284|NCT04518410|39833117|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
16368285|NCT04518410|39833118|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
16368286|NCT04518410|39833119|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
16368287|NCT04518410|39833120|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
16368288|NCT04518410|39833121|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
16368289|NCT04518410|39833122|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
16157810|NCT03709654|39061475|FG000|Overall Study|Lost to Follow-up|1|||
16157811|NCT03709654|39061476|FG001|Overall Study|Lost to Follow-up|1|||
16157812|NCT03709654|39061475|FG000|Overall Study|Withdrawal by Subject|1|||
16157813|NCT03709654|39061476|FG001|Overall Study|Withdrawal by Subject|1|||
16157814|NCT03709654|39061475|FG000|Overall Study|Adverse Event|1|||
16157815|NCT03709654|39061476|FG001|Overall Study|Adverse Event|0|||
16157816|NCT01314716|39061477|FG000|Double-Blind Phase|Randomized but not treated|1|||
16157817|NCT01314716|39061478|FG001|Double-Blind Phase|Randomized but not treated|1|||
16157818|NCT01314716|39061477|FG000|Double-Blind Phase|Adverse Event|10|||
16157819|NCT01314716|39061478|FG001|Double-Blind Phase|Adverse Event|4|||
16157820|NCT01314716|39061477|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
16157821|NCT01314716|39061478|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
16157822|NCT01314716|39061477|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16157823|NCT01314716|39061478|FG001|Double-Blind Phase|Lost to Follow-up|1|||
16157824|NCT01314716|39061477|FG000|Double-Blind Phase|Sponsor request|1|||
16157825|NCT01314716|39061478|FG001|Double-Blind Phase|Sponsor request|2|||
16157826|NCT01314716|39061477|FG000|Double-Blind Phase|Physician Decision|0|||
16157827|NCT01314716|39061478|FG001|Double-Blind Phase|Physician Decision|1|||
16157828|NCT01314716|39061477|FG000|Open-Label Phase|Adverse Event|4|||
16157829|NCT01314716|39061478|FG001|Open-Label Phase|Adverse Event|6|||
16157830|NCT01314716|39061477|FG000|Open-Label Phase|Withdrawal by Subject|1|||
16157831|NCT01314716|39061478|FG001|Open-Label Phase|Withdrawal by Subject|2|||
16157832|NCT01314716|39061477|FG000|Open-Label Phase|Physician Decision|5|||
16157833|NCT01314716|39061478|FG001|Open-Label Phase|Physician Decision|4|||
16157834|NCT04899232|39061479|FG000|Screening Period|Physician Decision|1|||
16157835|NCT04899232|39061480|FG001|Screening Period|Physician Decision|0|||
16157836|NCT04899232|39061481|FG002|Screening Period|Physician Decision|0|||
16157837|NCT04899232|39061479|FG000|Screening Period|Withdrawal by Subject|1|||
16157838|NCT04899232|39061480|FG001|Screening Period|Withdrawal by Subject|0|||
16157839|NCT04899232|39061481|FG002|Screening Period|Withdrawal by Subject|0|||
16157840|NCT04899232|39061479|FG000|Screening Period|Participant discharged before receiving intervention|3|||
16157841|NCT04899232|39061480|FG001|Screening Period|Participant discharged before receiving intervention|0|||
16157842|NCT04899232|39061481|FG002|Screening Period|Participant discharged before receiving intervention|0|||
16157843|NCT01411085|39061485|FG000|Overall Study|Physician Decision|1|||
16157844|NCT01411085|39061485|FG000|Overall Study|Protocol Violation|1|||
16157845|NCT01411085|39061485|FG000|Overall Study|Adverse Event|1|||
16157846|NCT01110200|39061486|FG000|Overall Study|Adverse Event|28|||
16157847|NCT01110200|39061487|FG001|Overall Study|Adverse Event|28|||
16157848|NCT01110200|39061486|FG000|Overall Study|Withdrawal by Subject|25|||
16157849|NCT01110200|39061487|FG001|Overall Study|Withdrawal by Subject|32|||
16157850|NCT01110200|39061486|FG000|Overall Study|Lack of Efficacy|16|||
16157851|NCT01110200|39061487|FG001|Overall Study|Lack of Efficacy|25|||
16157852|NCT01110200|39061486|FG000|Overall Study|Protocol Violation|14|||
16157853|NCT01110200|39061487|FG001|Overall Study|Protocol Violation|12|||
16157854|NCT01110200|39061486|FG000|Overall Study|Physician Decision|13|||
16368290|NCT04518410|39833123|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
16368291|NCT04518410|39833124|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
16368292|NCT04518410|39833125|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
16368293|NCT04518410|39833126|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
16368294|NCT04518410|39833127|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
16368295|NCT04518410|39833128|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
16368296|NCT04518410|39833129|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
16368297|NCT04518410|39833130|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
16368298|NCT04518410|39833106|FG000|Overall Study|Dual Enrolled Subject|0|||
16368299|NCT04518410|39833107|FG001|Overall Study|Dual Enrolled Subject|0|||
16368300|NCT04518410|39833108|FG002|Overall Study|Dual Enrolled Subject|0|||
16368301|NCT04518410|39833109|FG003|Overall Study|Dual Enrolled Subject|0|||
16368302|NCT04518410|39833110|FG004|Overall Study|Dual Enrolled Subject|0|||
16368303|NCT04518410|39833111|FG005|Overall Study|Dual Enrolled Subject|0|||
16157855|NCT01110200|39061487|FG001|Overall Study|Physician Decision|17|||
16157856|NCT01110200|39061486|FG000|Overall Study|Lost to Follow-up|10|||
16157857|NCT01110200|39061487|FG001|Overall Study|Lost to Follow-up|7|||
16157858|NCT02429414|39061488|FG000|Overall Study|Physician Decision|0|||
16157859|NCT02429414|39061489|FG001|Overall Study|Physician Decision|1|||
16157860|NCT03557281|39061490|FG000|Overall Study|Investigator discretion|0|||
16157861|NCT03557281|39061491|FG001|Overall Study|Investigator discretion|0|||
16157862|NCT03557281|39061492|FG002|Overall Study|Investigator discretion|1|||
16157863|NCT03557281|39061493|FG003|Overall Study|Investigator discretion|0|||
16157864|NCT03557281|39061494|FG004|Overall Study|Investigator discretion|0|||
16157865|NCT03557281|39061490|FG000|Overall Study|Withdrawal by Subject|0|||
16157866|NCT03557281|39061491|FG001|Overall Study|Withdrawal by Subject|1|||
16157867|NCT03557281|39061492|FG002|Overall Study|Withdrawal by Subject|1|||
16157868|NCT03557281|39061493|FG003|Overall Study|Withdrawal by Subject|1|||
16157869|NCT03557281|39061494|FG004|Overall Study|Withdrawal by Subject|2|||
16065500|NCT00871429|38732749|FG000|Overall Study|Lost to Follow-up|6|||
16065501|NCT00871429|38732749|FG000|Overall Study|Withdrawal by Subject|17|||
16065502|NCT00871429|38732749|FG000|Overall Study|Questionnaire not completed|1|||
16065503|NCT00335556|38732758|FG000|Overall Study|Death|0|||
16065504|NCT00335556|38732759|FG001|Overall Study|Death|5|||
16065505|NCT00335556|38732760|FG002|Overall Study|Death|0|||
16065506|NCT00335556|38732761|FG003|Overall Study|Death|0|||
16065507|NCT00335556|38732762|FG004|Overall Study|Death|1|||
16065508|NCT00335556|38732763|FG005|Overall Study|Death|0|||
16065509|NCT00335556|38732758|FG000|Overall Study|Lack of Efficacy|0|||
16157870|NCT03557281|39061490|FG000|Overall Study|Randomized, but did not receive treatment|0|||
16157871|NCT03557281|39061491|FG001|Overall Study|Randomized, but did not receive treatment|0|||
16157872|NCT03557281|39061492|FG002|Overall Study|Randomized, but did not receive treatment|0|||
16157873|NCT03557281|39061493|FG003|Overall Study|Randomized, but did not receive treatment|0|||
16157874|NCT03557281|39061494|FG004|Overall Study|Randomized, but did not receive treatment|1|||
16157875|NCT01306045|39061495|FG000|Met General Eligibility Criteria|Screen failures|193|||
16157876|NCT01306045|39061496|FG001|Met General Eligibility Criteria|Screen failures|11|||
16157877|NCT01306045|39061497|FG002|Met General Eligibility Criteria|Screen failures|8|||
16157878|NCT03548558|39061498|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
16157879|NCT03548558|39061499|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
16157880|NCT03548558|39061500|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
16157881|NCT03548558|39061501|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
16157882|NCT03548558|39061502|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
16157883|NCT03548558|39061503|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
16157884|NCT03548558|39061504|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
16157885|NCT03548558|39061498|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
16157886|NCT03548558|39061499|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
16157887|NCT03548558|39061500|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
16157888|NCT03548558|39061501|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
16157889|NCT03548558|39061502|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
16157890|NCT03548558|39061503|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
16065510|NCT00335556|38732759|FG001|Overall Study|Lack of Efficacy|19|||
16065511|NCT00335556|38732760|FG002|Overall Study|Lack of Efficacy|3|||
16157891|NCT03548558|39061504|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
16157892|NCT03548558|39061498|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
16157893|NCT03548558|39061499|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
16273196|NCT00367133|39484450|FG002|2 Years|Missed visit|4|||
16157894|NCT03548558|39061500|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
16157895|NCT03548558|39061501|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
16368304|NCT04518410|39833112|FG006|Overall Study|Dual Enrolled Subject|0|||
16065512|NCT00335556|38732761|FG003|Overall Study|Lack of Efficacy|3|||
16065513|NCT00335556|38732762|FG004|Overall Study|Lack of Efficacy|0|||
16065514|NCT00335556|38732763|FG005|Overall Study|Lack of Efficacy|1|||
16065515|NCT00335556|38732758|FG000|Overall Study|Physician Decision|0|||
16065516|NCT00335556|38732759|FG001|Overall Study|Physician Decision|6|||
16065517|NCT00335556|38732760|FG002|Overall Study|Physician Decision|2|||
16065518|NCT00335556|38732761|FG003|Overall Study|Physician Decision|1|||
16065519|NCT00335556|38732762|FG004|Overall Study|Physician Decision|0|||
16065520|NCT00335556|38732763|FG005|Overall Study|Physician Decision|0|||
16065521|NCT00335556|38732758|FG000|Overall Study|Ineligible|2|||
16065522|NCT00335556|38732759|FG001|Overall Study|Ineligible|0|||
16065523|NCT00335556|38732760|FG002|Overall Study|Ineligible|0|||
16065524|NCT00335556|38732761|FG003|Overall Study|Ineligible|0|||
16065525|NCT00335556|38732762|FG004|Overall Study|Ineligible|0|||
16065526|NCT00335556|38732763|FG005|Overall Study|Ineligible|0|||
16065527|NCT00335556|38732758|FG000|Overall Study|Refusal of further protocol therapy|0|||
16065528|NCT00335556|38732759|FG001|Overall Study|Refusal of further protocol therapy|4|||
16065529|NCT00335556|38732760|FG002|Overall Study|Refusal of further protocol therapy|0|||
16065530|NCT00335556|38732761|FG003|Overall Study|Refusal of further protocol therapy|1|||
16065531|NCT00335556|38732762|FG004|Overall Study|Refusal of further protocol therapy|0|||
16065532|NCT00335556|38732763|FG005|Overall Study|Refusal of further protocol therapy|0|||
16065533|NCT01729871|38732766|FG000|Overall Study|Adverse Event|7|||
16065534|NCT01729871|38732767|FG001|Overall Study|Adverse Event|7|||
16065535|NCT01729871|38732766|FG000|Overall Study|Death|0|||
16065536|NCT01729871|38732767|FG001|Overall Study|Death|1|||
16065537|NCT01729871|38732766|FG000|Overall Study|Lack of Efficacy|0|||
16065538|NCT01729871|38732767|FG001|Overall Study|Lack of Efficacy|1|||
16065539|NCT01729871|38732766|FG000|Overall Study|Physician Decision|0|||
16065540|NCT01729871|38732767|FG001|Overall Study|Physician Decision|2|||
16065541|NCT01729871|38732766|FG000|Overall Study|Protocol Violation|1|||
16065542|NCT01729871|38732767|FG001|Overall Study|Protocol Violation|0|||
16065543|NCT01729871|38732766|FG000|Overall Study|Withdrawal by Subject|0|||
16065544|NCT01729871|38732767|FG001|Overall Study|Withdrawal by Subject|3|||
16065545|NCT01729871|38732766|FG000|Overall Study|Other|4|||
16065546|NCT01729871|38732767|FG001|Overall Study|Other|9|||
16065547|NCT02335268|38732771|FG000|Overall Study|Physician Decision|5|||
16065548|NCT02335268|38732772|FG001|Overall Study|Physician Decision|1|||
16065549|NCT02335268|38732771|FG000|Overall Study|Lack of Efficacy|2|||
16065550|NCT02335268|38732772|FG001|Overall Study|Lack of Efficacy|1|||
16065551|NCT02335268|38732771|FG000|Overall Study|Adverse Event|5|||
16065552|NCT02335268|38732772|FG001|Overall Study|Adverse Event|2|||
16065553|NCT02335268|38732771|FG000|Overall Study|increase blasts|2|||
16065554|NCT02335268|38732772|FG001|Overall Study|increase blasts|0|||
16065555|NCT02335268|38732771|FG000|Overall Study|Withdrawal by Subject|3|||
16065556|NCT02335268|38732772|FG001|Overall Study|Withdrawal by Subject|2|||
16065557|NCT00498186|38732777|FG000|Overall Study|Protocol Violation|10|||
16065558|NCT00498186|38732777|FG000|Overall Study|Lack of Efficacy|31|||
16065559|NCT00498186|38732777|FG000|Overall Study|Adverse Event|89|||
16065560|NCT00498186|38732777|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
16065561|NCT00498186|38732777|FG000|Overall Study|Withdrawal by Subject|18|||
16065562|NCT00498186|38732777|FG000|Overall Study|Lost to Follow-up|3|||
16065563|NCT00498186|38732777|FG000|Overall Study|Other|10|||
16065564|NCT01311648|38732778|FG000|Main Study|Protocol Violation|0|||
16065565|NCT01311648|38732779|FG001|Main Study|Protocol Violation|1|||
16065566|NCT01311648|38732778|FG000|Main Study|Adverse Event|0|||
16065567|NCT01311648|38732779|FG001|Main Study|Adverse Event|1|||
16065568|NCT01311648|38732778|FG000|Main Study|Inhibitor management|0|||
16065569|NCT01311648|38732779|FG001|Main Study|Inhibitor management|17|||
16065570|NCT01311648|38732778|FG000|Main Study|Withdrawal by Subject|0|||
16065571|NCT01311648|38732779|FG001|Main Study|Withdrawal by Subject|2|||
16065572|NCT01311648|38732778|FG000|Extension Study|Physician Decision|0|||
16065573|NCT01311648|38732779|FG001|Extension Study|Physician Decision|1|||
16065574|NCT01311648|38732778|FG000|Extension Study|ITI therapy with marketed product|0|||
16065575|NCT01311648|38732779|FG001|Extension Study|ITI therapy with marketed product|1|||
16065576|NCT01311648|38732778|FG000|Extension Study|Incorrect visit planning|0|||
16065577|NCT01311648|38732779|FG001|Extension Study|Incorrect visit planning|1|||
16065578|NCT01311648|38732778|FG000|Extension Study|Family's decision|0|||
16065579|NCT01311648|38732779|FG001|Extension Study|Family's decision|1|||
16065580|NCT01311648|38732778|FG000|Extension Study|Failure of ITI therapy|0|||
16065581|NCT01311648|38732779|FG001|Extension Study|Failure of ITI therapy|3|||
16065582|NCT01311648|38732778|FG000|Extension Study|Long travel|0|||
16065583|NCT01311648|38732779|FG001|Extension Study|Long travel|1|||
16065584|NCT01311648|38732778|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
16065585|NCT01311648|38732779|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
16368305|NCT04518410|39833113|FG007|Overall Study|Dual Enrolled Subject|0|||
16065586|NCT01311648|38732778|FG000|Extension Study|Withdrawal by Subject|0|||
16157896|NCT03548558|39061502|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
16157897|NCT03548558|39061503|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
16157898|NCT03548558|39061504|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
16157899|NCT03548558|39061498|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
16157900|NCT03548558|39061499|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
16157901|NCT03548558|39061500|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
16157902|NCT03548558|39061501|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
16157903|NCT03548558|39061502|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
16157904|NCT03548558|39061503|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
16157905|NCT03548558|39061504|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
16157906|NCT03548558|39061498|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
16157907|NCT03548558|39061499|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
16157908|NCT03548558|39061500|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
16157909|NCT03548558|39061501|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
16157910|NCT03548558|39061502|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
16157911|NCT03548558|39061503|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
16157912|NCT03548558|39061504|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
16157913|NCT03548558|39061498|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
16157914|NCT03548558|39061499|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
16157915|NCT03548558|39061500|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
16157916|NCT03548558|39061501|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
16157917|NCT03548558|39061502|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
16157918|NCT03548558|39061503|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
16157919|NCT03548558|39061504|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
16157920|NCT02002975|39061508|FG000|Overall Study|Case Report Forms Uncollected|135|||
16157921|NCT02002975|39061508|FG000|Overall Study|Protocol Deviation|437|||
16157922|NCT00805480|39061509|FG000|Overall Study|Withdrawal by Subject|13|||
16157923|NCT00805480|39061510|FG001|Overall Study|Withdrawal by Subject|5|||
16157924|NCT00805480|39061511|FG002|Overall Study|Withdrawal by Subject|11|||
16157925|NCT00805480|39061512|FG003|Overall Study|Withdrawal by Subject|5|||
16157926|NCT00805480|39061509|FG000|Overall Study|Lost to Follow-up|1|||
16157927|NCT00805480|39061510|FG001|Overall Study|Lost to Follow-up|2|||
16157928|NCT00805480|39061511|FG002|Overall Study|Lost to Follow-up|0|||
16157929|NCT00805480|39061512|FG003|Overall Study|Lost to Follow-up|0|||
16157930|NCT00805480|39061509|FG000|Overall Study|Adverse Event|0|||
16157931|NCT00805480|39061510|FG001|Overall Study|Adverse Event|0|||
16157932|NCT00805480|39061511|FG002|Overall Study|Adverse Event|1|||
16157933|NCT00805480|39061512|FG003|Overall Study|Adverse Event|0|||
16157934|NCT02573155|39061513|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
16157935|NCT02573155|39061514|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
16157936|NCT02573155|39061513|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
16157937|NCT02573155|39061514|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
16157938|NCT02573155|39061513|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
16157939|NCT02573155|39061514|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
16157940|NCT02573155|39061513|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
16157941|NCT02573155|39061514|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
16157942|NCT02573155|39061513|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
16157943|NCT02573155|39061514|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
16157944|NCT02573155|39061513|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
16157945|NCT02573155|39061514|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
16157946|NCT02573155|39061513|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
16157947|NCT02573155|39061514|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
16157948|NCT02573155|39061513|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
16157949|NCT02573155|39061514|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
16157950|NCT03031301|39061517|FG000|Overall Study|Protocol Violation|4|||
16157951|NCT03031301|39061518|FG001|Overall Study|Protocol Violation|8|||
16157952|NCT03031301|39061517|FG000|Overall Study|Withdrawal by Subject|7|||
16157953|NCT03031301|39061518|FG001|Overall Study|Withdrawal by Subject|4|||
16157954|NCT03031301|39061517|FG000|Overall Study|Lost to Follow-up|4|||
16157955|NCT03031301|39061518|FG001|Overall Study|Lost to Follow-up|12|||
16157956|NCT03031301|39061517|FG000|Overall Study|Noncompliance|1|||
16157957|NCT03031301|39061518|FG001|Overall Study|Noncompliance|3|||
16157958|NCT03031301|39061517|FG000|Overall Study|Technical issue|1|||
16157959|NCT03031301|39061518|FG001|Overall Study|Technical issue|1|||
16157960|NCT03031301|39061517|FG000|Overall Study|Adverse Event|1|||
16157961|NCT03031301|39061518|FG001|Overall Study|Adverse Event|0|||
16157962|NCT00927095|39061519|FG000|Overall Study|Adverse Event|3|||
16157963|NCT00927095|39061520|FG001|Overall Study|Adverse Event|1|||
16157964|NCT00927095|39061521|FG002|Overall Study|Adverse Event|0|||
16157965|NCT00927095|39061519|FG000|Overall Study|Withdrawal by Subject|2|||
16157966|NCT00927095|39061520|FG001|Overall Study|Withdrawal by Subject|1|||
16157967|NCT00927095|39061521|FG002|Overall Study|Withdrawal by Subject|1|||
16157968|NCT00927095|39061519|FG000|Overall Study|Physician Decision|1|||
16157969|NCT00927095|39061520|FG001|Overall Study|Physician Decision|2|||
16157970|NCT00927095|39061521|FG002|Overall Study|Physician Decision|1|||
16157971|NCT01290692|39061522|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
16157972|NCT02415712|39061523|FG000|Overall Study|Protocol Violation|16|||
16157973|NCT01098071|39061524|FG000|Overall Study|Surgery (adenoidectomy)|2|||
16157974|NCT01098071|39061524|FG000|Overall Study|Lost to Follow-up|13|||
16157975|NCT00290433|39061526|FG000|Overall Study|Disease Progression|13|||
16157976|NCT00290433|39061526|FG000|Overall Study|Adverse Event|14|||
16157977|NCT00290433|39061526|FG000|Overall Study|Withdrawal by Subject|1|||
16157978|NCT00290433|39061526|FG000|Overall Study|Non-Compliance|1|||
16157979|NCT00290433|39061526|FG000|Overall Study|Congestive Heart Failure|1|||
16157980|NCT00290433|39061526|FG000|Overall Study|Transplant in CR|5|||
16157981|NCT00290433|39061526|FG000|Overall Study|Unrelated Infection/Death|1|||
16157982|NCT00708500|39061528|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
16157983|NCT00708500|39061529|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
16157984|NCT00708500|39061530|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
16157985|NCT00708500|39061528|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
16157986|NCT00708500|39061529|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
16157987|NCT00708500|39061530|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
16157988|NCT00708500|39061528|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
16157989|NCT00708500|39061529|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
16157990|NCT00708500|39061530|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
16157991|NCT00708500|39061528|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
16157992|NCT00708500|39061529|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
16157993|NCT00708500|39061530|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
16157994|NCT00708500|39061528|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
16157995|NCT00708500|39061529|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
16157996|NCT00708500|39061530|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
16157997|NCT00708500|39061528|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
16157998|NCT00708500|39061529|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
16157999|NCT00708500|39061530|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
16158000|NCT00708500|39061528|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
16158001|NCT00708500|39061529|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
16158002|NCT00708500|39061530|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
16158003|NCT00708500|39061528|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
16158004|NCT00708500|39061529|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
16158005|NCT00708500|39061530|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
16158006|NCT00708500|39061528|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
16158007|NCT00708500|39061529|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
16158008|NCT00708500|39061530|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
16158009|NCT00708500|39061528|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
16158010|NCT00708500|39061529|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
16158011|NCT00708500|39061530|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
16158012|NCT00708500|39061528|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
16158013|NCT00708500|39061529|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
16158014|NCT00708500|39061530|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
16065587|NCT01311648|38732779|FG001|Extension Study|Withdrawal by Subject|1|||
16065588|NCT01311648|38732778|FG000|Extension Study|Inhibitor management|0|||
16065589|NCT01311648|38732779|FG001|Extension Study|Inhibitor management|2|||
16065590|NCT03971357|38732784|FG000|Overall Study|Lack of Efficacy|0|||
16065591|NCT03971357|38732785|FG001|Overall Study|Lack of Efficacy|1|||
16065592|NCT01123161|38732788|FG000|Overall Study|Lost to Follow-up|1|||
16065593|NCT01123161|38732789|FG001|Overall Study|Lost to Follow-up|0|||
16065594|NCT01123161|38732788|FG000|Overall Study|Withdrawal by Subject|1|||
16065595|NCT01123161|38732789|FG001|Overall Study|Withdrawal by Subject|0|||
16065596|NCT00448864|38732790|FG000|Overall Study|Death|1|||
16065597|NCT00448864|38732791|FG001|Overall Study|Death|0|||
16065598|NCT00448864|38732792|FG002|Overall Study|Death|0|||
16065599|NCT00448864|38732790|FG000|Overall Study|Lost to Follow-up|3|||
16065600|NCT00448864|38732791|FG001|Overall Study|Lost to Follow-up|1|||
16065601|NCT00448864|38732792|FG002|Overall Study|Lost to Follow-up|0|||
16065602|NCT00448864|38732790|FG000|Overall Study|Physician Decision|1|||
16065603|NCT00448864|38732791|FG001|Overall Study|Physician Decision|0|||
16065604|NCT00448864|38732792|FG002|Overall Study|Physician Decision|1|||
16065605|NCT00448864|38732790|FG000|Overall Study|Withdrawal by Subject|0|||
16065606|NCT00448864|38732791|FG001|Overall Study|Withdrawal by Subject|2|||
16065607|NCT00448864|38732792|FG002|Overall Study|Withdrawal by Subject|0|||
16065608|NCT00448864|38732790|FG000|Overall Study|Protocol Violation|0|||
16065609|NCT00448864|38732791|FG001|Overall Study|Protocol Violation|2|||
16065610|NCT00448864|38732792|FG002|Overall Study|Protocol Violation|0|||
16065611|NCT00088465|38732793|FG000|Overall Study|Withdrawal by Subject|290|||
16065612|NCT00088465|38732793|FG000|Overall Study|Adverse Event|77|||
16065613|NCT00088465|38732793|FG000|Overall Study|Lost to Follow-up|57|||
16065614|NCT00088465|38732793|FG000|Overall Study|Physician Decision|45|||
16065615|NCT00088465|38732793|FG000|Overall Study|Sponsor Decision|37|||
16158015|NCT00708500|39061528|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
16158016|NCT00708500|39061529|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
16158017|NCT00708500|39061530|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
16158018|NCT00708500|39061528|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
16158019|NCT00708500|39061529|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
16158020|NCT00708500|39061530|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
16158021|NCT00708500|39061528|FG000|FOLLOWUP|Adverse Event|0|||
16158022|NCT00708500|39061529|FG001|FOLLOWUP|Adverse Event|1|||
16158023|NCT00708500|39061530|FG002|FOLLOWUP|Adverse Event|0|||
16158024|NCT00708500|39061528|FG000|FOLLOWUP|Lost to Follow-up|1|||
16158025|NCT00708500|39061529|FG001|FOLLOWUP|Lost to Follow-up|6|||
16158026|NCT00708500|39061530|FG002|FOLLOWUP|Lost to Follow-up|4|||
16158027|NCT00708500|39061528|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
16158028|NCT00708500|39061529|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
16158029|NCT00708500|39061530|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
16158030|NCT00708500|39061528|FG000|FOLLOWUP|Subject withdrew consent|31|||
16158031|NCT00708500|39061529|FG001|FOLLOWUP|Subject withdrew consent|4|||
16158032|NCT00708500|39061530|FG002|FOLLOWUP|Subject withdrew consent|5|||
16158033|NCT00708500|39061528|FG000|FOLLOWUP|Non-compliance with protocol|5|||
16158034|NCT00708500|39061529|FG001|FOLLOWUP|Non-compliance with protocol|0|||
16158035|NCT00708500|39061530|FG002|FOLLOWUP|Non-compliance with protocol|1|||
16158036|NCT02222207|39061531|FG000|Overall Study|Death|1|||
16158037|NCT02222207|39061531|FG000|Overall Study|Other reasons|2|||
16158038|NCT02222207|39061531|FG000|Overall Study|Adverse Event|1|||
16158039|NCT01784965|39061532|FG000|Overall Study|Withdrawal by Subject|6|||
16158040|NCT01784965|39061533|FG001|Overall Study|Withdrawal by Subject|3|||
16158041|NCT01784965|39061532|FG000|Overall Study|Adverse Event|0|||
16158042|NCT01784965|39061533|FG001|Overall Study|Adverse Event|8|||
16158043|NCT00288080|39061534|FG000|Overall Study|Withdrawal by Subject|1|||
16158044|NCT00288080|39061535|FG001|Overall Study|Withdrawal by Subject|3|||
16158045|NCT00288080|39061534|FG000|Overall Study|Protocol Violation|25|||
16158046|NCT00288080|39061535|FG001|Overall Study|Protocol Violation|20|||
16158047|NCT00464334|39061541|FG000|Overall Study|Adverse Event|0|||
16158048|NCT00464334|39061542|FG001|Overall Study|Adverse Event|0|||
16158049|NCT00464334|39061543|FG002|Overall Study|Adverse Event|0|||
16158050|NCT00464334|39061544|FG003|Overall Study|Adverse Event|1|||
16158051|NCT00464334|39061545|FG004|Overall Study|Adverse Event|1|||
16158052|NCT00464334|39061546|FG005|Overall Study|Adverse Event|1|||
16368306|NCT04518410|39833114|FG008|Overall Study|Dual Enrolled Subject|0|||
16065616|NCT00088465|38732793|FG000|Overall Study|Lack of Efficacy|27|||
16065617|NCT00088465|38732793|FG000|Overall Study|Protocol Violation|17|||
16065618|NCT00088465|38732793|FG000|Overall Study|Death|11|||
16065619|NCT01940887|38732800|FG000|Year 1|Protocol Violation|0|||
16158053|NCT00464334|39061547|FG006|Overall Study|Adverse Event|0|||
16158054|NCT00464334|39061548|FG007|Overall Study|Adverse Event|0|||
16158055|NCT00464334|39061549|FG008|Overall Study|Adverse Event|2|||
16368307|NCT04518410|39833115|FG009|Overall Study|Dual Enrolled Subject|0|||
16368308|NCT04518410|39833116|FG010|Overall Study|Dual Enrolled Subject|0|||
16368309|NCT04518410|39833117|FG011|Overall Study|Dual Enrolled Subject|0|||
16368310|NCT04518410|39833118|FG012|Overall Study|Dual Enrolled Subject|0|||
16368311|NCT04518410|39833119|FG013|Overall Study|Dual Enrolled Subject|0|||
16368312|NCT04518410|39833120|FG014|Overall Study|Dual Enrolled Subject|0|||
16368313|NCT04518410|39833121|FG015|Overall Study|Dual Enrolled Subject|0|||
16368314|NCT04518410|39833122|FG016|Overall Study|Dual Enrolled Subject|0|||
16368315|NCT04518410|39833123|FG017|Overall Study|Dual Enrolled Subject|1|||
16368316|NCT04518410|39833124|FG018|Overall Study|Dual Enrolled Subject|0|||
16368317|NCT04518410|39833125|FG019|Overall Study|Dual Enrolled Subject|0|||
16368318|NCT04518410|39833126|FG020|Overall Study|Dual Enrolled Subject|0|||
16368319|NCT04518410|39833127|FG021|Overall Study|Dual Enrolled Subject|0|||
16368320|NCT04518410|39833128|FG022|Overall Study|Dual Enrolled Subject|0|||
16368321|NCT04518410|39833129|FG023|Overall Study|Dual Enrolled Subject|0|||
16368322|NCT04518410|39833130|FG024|Overall Study|Dual Enrolled Subject|0|||
16368323|NCT00853047|39833136|FG000|Core Phase|Participant Request|0|||
16368324|NCT00853047|39833137|FG001|Core Phase|Participant Request|0|||
16368325|NCT00853047|39833138|FG002|Core Phase|Participant Request|0|||
16368326|NCT00853047|39833139|FG003|Core Phase|Participant Request|1|||
16368327|NCT00853047|39833140|FG004|Core Phase|Participant Request|0|||
16445428|NCT00307801|40108661|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
16445429|NCT00307801|40108660|FG000|Overall Study|Wrong Randomization|1|||
16445430|NCT00307801|40108661|FG001|Overall Study|Wrong Randomization|0|||
16445431|NCT00307801|40108660|FG000|Overall Study|Lack of Efficacy|0|||
16445432|NCT00307801|40108661|FG001|Overall Study|Lack of Efficacy|2|||
16445433|NCT00307801|40108660|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
16445434|NCT00307801|40108661|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
16445435|NCT00307801|40108660|FG000|Overall Study|Frustration with e-diary|1|||
16445436|NCT00307801|40108661|FG001|Overall Study|Frustration with e-diary|0|||
16445437|NCT00307801|40108660|FG000|Overall Study|Protocol Violation|3|||
16445438|NCT00307801|40108661|FG001|Overall Study|Protocol Violation|2|||
16445439|NCT00307801|40108660|FG000|Overall Study|No reason specified|2|||
16445440|NCT00307801|40108661|FG001|Overall Study|No reason specified|0|||
16445441|NCT00307801|40108660|FG000|Overall Study|Pregnancy|0|||
16445442|NCT00307801|40108661|FG001|Overall Study|Pregnancy|1|||
16445443|NCT00535496|40108666|FG000|Overall Study|Lost to Follow-up|0|||
16445444|NCT00535496|40108667|FG001|Overall Study|Lost to Follow-up|1|||
16445445|NCT00535496|40108668|FG002|Overall Study|Lost to Follow-up|0|||
16445446|NCT00535496|40108669|FG003|Overall Study|Lost to Follow-up|0|||
16445447|NCT00535496|40108666|FG000|Overall Study|Not treated with sugammadex|0|||
16445448|NCT00535496|40108667|FG001|Overall Study|Not treated with sugammadex|1|||
16445449|NCT00535496|40108668|FG002|Overall Study|Not treated with sugammadex|0|||
16445450|NCT00535496|40108669|FG003|Overall Study|Not treated with sugammadex|0|||
16445451|NCT01033019|40108674|FG000|Overall Study|Withdrawal by Subject|1|||
16445452|NCT01033019|40108675|FG001|Overall Study|Withdrawal by Subject|0|||
16445453|NCT01285323|40108676|FG000|Overall Study|Adverse Event|9|||
16445454|NCT01285323|40108677|FG001|Overall Study|Adverse Event|8|||
16445455|NCT01285323|40108676|FG000|Overall Study|Lack of Efficacy|4|||
16445456|NCT01285323|40108677|FG001|Overall Study|Lack of Efficacy|2|||
16445457|NCT01285323|40108676|FG000|Overall Study|Withdrawal by Subject|15|||
16445458|NCT01285323|40108677|FG001|Overall Study|Withdrawal by Subject|11|||
16445459|NCT01285323|40108676|FG000|Overall Study|Protocol Violation|1|||
16445460|NCT01285323|40108677|FG001|Overall Study|Protocol Violation|2|||
16445461|NCT01285323|40108676|FG000|Overall Study|Non-compliance with study procedures|2|||
16445462|NCT01285323|40108677|FG001|Overall Study|Non-compliance with study procedures|3|||
16445463|NCT01285323|40108676|FG000|Overall Study|Lost to Follow-up|1|||
16445464|NCT01285323|40108677|FG001|Overall Study|Lost to Follow-up|1|||
16445465|NCT01285323|40108676|FG000|Overall Study|Other|1|||
16445466|NCT01285323|40108677|FG001|Overall Study|Other|3|||
16445467|NCT03598036|40108683|FG000|Overall Study|Withdrawal by Subject|1|||
16445468|NCT03598036|40108684|FG001|Overall Study|Withdrawal by Subject|0|||
16445469|NCT01521117|40108685|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
16445470|NCT01521117|40108686|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
16065620|NCT01940887|38732801|FG001|Year 1|Protocol Violation|1|||
16065621|NCT01940887|38732800|FG000|Year 1|Physician Decision|7|||
16065622|NCT01940887|38732801|FG001|Year 1|Physician Decision|3|||
16065623|NCT01940887|38732800|FG000|Year 1|Death|5|||
16065624|NCT01940887|38732801|FG001|Year 1|Death|3|||
16065625|NCT01940887|38732800|FG000|Year 1|Adverse Event|7|||
16065626|NCT01940887|38732801|FG001|Year 1|Adverse Event|6|||
16065627|NCT01940887|38732800|FG000|Year 1|Withdrawal by Subject|18|||
16065628|NCT01940887|38732801|FG001|Year 1|Withdrawal by Subject|9|||
16065629|NCT01940887|38732800|FG000|Year 1|Lost to Follow-up|2|||
16065630|NCT01940887|38732801|FG001|Year 1|Lost to Follow-up|1|||
16065631|NCT01940887|38732800|FG000|Year 2|Physician Decision|8|||
16065632|NCT01940887|38732801|FG001|Year 2|Physician Decision|1|||
16065633|NCT01940887|38732800|FG000|Year 2|Death|0|||
16065634|NCT01940887|38732801|FG001|Year 2|Death|2|||
16445471|NCT01521117|40108685|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
16445472|NCT01521117|40108686|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
16445473|NCT01521117|40108685|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
16445474|NCT01521117|40108686|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
16445475|NCT05530252|40108687|FG000|Overall Study|Lost to Follow-up|1|||
16065635|NCT01940887|38732800|FG000|Year 2|Sponsor Decision, early termination|192|||
16065636|NCT01940887|38732801|FG001|Year 2|Sponsor Decision, early termination|203|||
16445476|NCT05530252|40108688|FG001|Overall Study|Lost to Follow-up|1|||
16445477|NCT05530252|40108689|FG002|Overall Study|Lost to Follow-up|1|||
16445478|NCT01474317|40108690|FG000|Overall Study|Adverse Event|1|||
16065637|NCT01940887|38732800|FG000|Year 2|Adverse Event|8|||
16065638|NCT01940887|38732801|FG001|Year 2|Adverse Event|2|||
16445479|NCT01474317|40108690|FG000|Overall Study|Subject ineligible for study|1|||
16445480|NCT00089297|40108694|FG000|Overall Study|Adverse Event|9|||
16445481|NCT00089297|40108694|FG000|Overall Study|Death|1|||
16445482|NCT00089297|40108694|FG000|Overall Study|Withdrawal by Subject|12|||
16445483|NCT00089297|40108694|FG000|Overall Study|Disease progression|2|||
16445484|NCT00089297|40108694|FG000|Overall Study|Ineligible|11|||
16445485|NCT00089297|40108694|FG000|Overall Study|Secondary malignancy|1|||
16065639|NCT01940887|38732800|FG000|Year 2|Withdrawal by Subject|8|||
16065640|NCT01940887|38732801|FG001|Year 2|Withdrawal by Subject|8|||
16065641|NCT01940887|38732800|FG000|Year 2|Lost to Follow-up|1|||
16158056|NCT00464334|39061550|FG009|Overall Study|Adverse Event|1|||
16158057|NCT00464334|39061551|FG010|Overall Study|Adverse Event|2|||
16158058|NCT00464334|39061541|FG000|Overall Study|Lack of Efficacy|0|||
16158059|NCT00464334|39061542|FG001|Overall Study|Lack of Efficacy|1|||
16158060|NCT00464334|39061543|FG002|Overall Study|Lack of Efficacy|0|||
16158061|NCT00464334|39061544|FG003|Overall Study|Lack of Efficacy|0|||
16158062|NCT00464334|39061545|FG004|Overall Study|Lack of Efficacy|0|||
16158063|NCT00464334|39061546|FG005|Overall Study|Lack of Efficacy|0|||
16158064|NCT00464334|39061547|FG006|Overall Study|Lack of Efficacy|0|||
16158065|NCT00464334|39061548|FG007|Overall Study|Lack of Efficacy|0|||
16158066|NCT00464334|39061549|FG008|Overall Study|Lack of Efficacy|0|||
16158067|NCT00464334|39061550|FG009|Overall Study|Lack of Efficacy|0|||
16158068|NCT00464334|39061551|FG010|Overall Study|Lack of Efficacy|0|||
16158069|NCT00464334|39061541|FG000|Overall Study|Lost to Follow-up|0|||
16158070|NCT00464334|39061542|FG001|Overall Study|Lost to Follow-up|0|||
16158071|NCT00464334|39061543|FG002|Overall Study|Lost to Follow-up|1|||
16158072|NCT00464334|39061544|FG003|Overall Study|Lost to Follow-up|0|||
16158073|NCT00464334|39061545|FG004|Overall Study|Lost to Follow-up|1|||
16158074|NCT00464334|39061546|FG005|Overall Study|Lost to Follow-up|0|||
16158075|NCT00464334|39061547|FG006|Overall Study|Lost to Follow-up|1|||
16158076|NCT00464334|39061548|FG007|Overall Study|Lost to Follow-up|0|||
16158077|NCT00464334|39061549|FG008|Overall Study|Lost to Follow-up|0|||
16158078|NCT00464334|39061550|FG009|Overall Study|Lost to Follow-up|0|||
16158079|NCT00464334|39061551|FG010|Overall Study|Lost to Follow-up|2|||
16158080|NCT00464334|39061541|FG000|Overall Study|Progressive Disease|0|||
16158081|NCT00464334|39061542|FG001|Overall Study|Progressive Disease|0|||
16158082|NCT00464334|39061543|FG002|Overall Study|Progressive Disease|0|||
16158083|NCT00464334|39061544|FG003|Overall Study|Progressive Disease|0|||
16158084|NCT00464334|39061545|FG004|Overall Study|Progressive Disease|0|||
16158085|NCT00464334|39061546|FG005|Overall Study|Progressive Disease|1|||
16158086|NCT00464334|39061547|FG006|Overall Study|Progressive Disease|0|||
16158087|NCT00464334|39061548|FG007|Overall Study|Progressive Disease|0|||
16158088|NCT00464334|39061549|FG008|Overall Study|Progressive Disease|1|||
16158089|NCT00464334|39061550|FG009|Overall Study|Progressive Disease|0|||
16158090|NCT00464334|39061551|FG010|Overall Study|Progressive Disease|0|||
16158091|NCT00464334|39061541|FG000|Overall Study|Study Terminated by Sponsor|0|||
16158092|NCT00464334|39061542|FG001|Overall Study|Study Terminated by Sponsor|0|||
16158093|NCT00464334|39061543|FG002|Overall Study|Study Terminated by Sponsor|0|||
16158094|NCT00464334|39061544|FG003|Overall Study|Study Terminated by Sponsor|1|||
16158095|NCT00464334|39061545|FG004|Overall Study|Study Terminated by Sponsor|0|||
16158096|NCT00464334|39061546|FG005|Overall Study|Study Terminated by Sponsor|0|||
16158097|NCT00464334|39061547|FG006|Overall Study|Study Terminated by Sponsor|0|||
16158098|NCT00464334|39061548|FG007|Overall Study|Study Terminated by Sponsor|0|||
16158099|NCT00464334|39061549|FG008|Overall Study|Study Terminated by Sponsor|0|||
16158100|NCT00464334|39061550|FG009|Overall Study|Study Terminated by Sponsor|0|||
16158101|NCT00464334|39061551|FG010|Overall Study|Study Terminated by Sponsor|0|||
16158102|NCT00464334|39061541|FG000|Overall Study|Withdrawal by Subject|1|||
16158103|NCT00464334|39061542|FG001|Overall Study|Withdrawal by Subject|7|||
16158104|NCT00464334|39061543|FG002|Overall Study|Withdrawal by Subject|4|||
16158105|NCT00464334|39061544|FG003|Overall Study|Withdrawal by Subject|2|||
16158106|NCT00464334|39061545|FG004|Overall Study|Withdrawal by Subject|2|||
16158107|NCT00464334|39061546|FG005|Overall Study|Withdrawal by Subject|2|||
16158108|NCT00464334|39061547|FG006|Overall Study|Withdrawal by Subject|2|||
16158109|NCT00464334|39061548|FG007|Overall Study|Withdrawal by Subject|1|||
16158110|NCT00464334|39061549|FG008|Overall Study|Withdrawal by Subject|3|||
16158111|NCT00464334|39061550|FG009|Overall Study|Withdrawal by Subject|0|||
16158112|NCT00464334|39061551|FG010|Overall Study|Withdrawal by Subject|0|||
16158113|NCT00711100|39061561|FG000|Overall Study|Lack of Efficacy|5|||
16158114|NCT00711100|39061561|FG000|Overall Study|Withdrawal by Subject|8|||
16158115|NCT02474329|39061562|FG000|Overall Study|Withdraw or did not contribute data.|13|||
16158116|NCT01614093|39061563|FG000|Overall Study|Withdrawal by Subject|1|||
16158117|NCT01543087|39061566|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
16158118|NCT01543087|39061567|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
16158119|NCT01543087|39061568|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
16158120|NCT01543087|39061569|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
16158121|NCT01543087|39061570|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
16158122|NCT01543087|39061571|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
16158123|NCT01543087|39061566|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
16158124|NCT01543087|39061567|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
16158125|NCT01543087|39061568|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
16158126|NCT01543087|39061569|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
16158127|NCT01543087|39061570|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
16158128|NCT01543087|39061571|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
16158129|NCT01543087|39061566|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
16158130|NCT01543087|39061567|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
16158131|NCT01543087|39061568|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
16445486|NCT00089297|40108694|FG000|Overall Study|IRB approval not ready|1|||
16445487|NCT00089297|40108694|FG000|Overall Study|Non-compliance|1|||
16445488|NCT00906204|40108695|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
16445489|NCT00906204|40108696|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
16445490|NCT00906204|40108695|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
16445491|NCT00906204|40108696|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
16445492|NCT00906204|40108695|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
16158132|NCT01543087|39061569|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
16158133|NCT01543087|39061570|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
16158134|NCT01543087|39061571|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
16158135|NCT01543087|39061566|FG000|Stage 1 (48 Months)|Other than specified|5|||
16158136|NCT01543087|39061567|FG001|Stage 1 (48 Months)|Other than specified|0|||
16158137|NCT01543087|39061568|FG002|Stage 1 (48 Months)|Other than specified|9|||
16158138|NCT01543087|39061569|FG003|Stage 1 (48 Months)|Other than specified|0|||
16158139|NCT01543087|39061570|FG004|Stage 1 (48 Months)|Other than specified|0|||
16158140|NCT01543087|39061571|FG005|Stage 1 (48 Months)|Other than specified|0|||
16158141|NCT01543087|39061566|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
16158142|NCT01543087|39061567|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
16158143|NCT01543087|39061568|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
16158144|NCT01543087|39061569|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
16158145|NCT01543087|39061570|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
16158146|NCT01543087|39061571|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
16065642|NCT01940887|38732801|FG001|Year 2|Lost to Follow-up|6|||
16065643|NCT01582243|38732815|FG000|Overall Study|Withdrawal by Subject|1|||
16065644|NCT01582243|38732815|FG000|Overall Study|Adverse Event|1|||
16065645|NCT01582243|38732815|FG000|Overall Study|Lost to Follow-up|1|||
16158147|NCT01543087|39061566|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
16158148|NCT01543087|39061567|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
16158149|NCT01543087|39061568|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
16065646|NCT00940017|38732822|FG000|Overall Study|did not meet entrance criteria|3|||
16065647|NCT00940017|38732822|FG000|Overall Study|Adverse Event|1|||
16158150|NCT01543087|39061569|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
16158151|NCT01543087|39061570|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
16158152|NCT01543087|39061571|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
16158153|NCT01543087|39061566|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
16158154|NCT01543087|39061567|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
16158155|NCT01543087|39061568|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
16158156|NCT01543087|39061569|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
16158157|NCT01543087|39061570|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
16158158|NCT01543087|39061571|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
16158159|NCT00695565|39061572|FG000|Overall Study|Lost to Follow-up|4|||
16158160|NCT00695565|39061573|FG001|Overall Study|Lost to Follow-up|4|||
16158161|NCT00695565|39061572|FG000|Overall Study|Adverse Event|3|||
16158162|NCT00695565|39061573|FG001|Overall Study|Adverse Event|1|||
16158163|NCT00695565|39061572|FG000|Overall Study|Protocol Violation|3|||
16158164|NCT00695565|39061573|FG001|Overall Study|Protocol Violation|1|||
16158165|NCT00695565|39061572|FG000|Overall Study|Withdrawal by Subject|1|||
16158166|NCT00695565|39061573|FG001|Overall Study|Withdrawal by Subject|1|||
16158167|NCT00695565|39061572|FG000|Overall Study|Lack of Efficacy|1|||
16445493|NCT00906204|40108696|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
16445494|NCT00906204|40108695|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
16445495|NCT00906204|40108696|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
16065648|NCT05310084|38732823|FG000|Overall Study|Withdrawal by Subject|2|||
16065649|NCT05310084|38732824|FG001|Overall Study|Withdrawal by Subject|3|||
16065650|NCT05310084|38732823|FG000|Overall Study|Participant availability|0|||
16065651|NCT05310084|38732824|FG001|Overall Study|Participant availability|4|||
16065652|NCT05310084|38732823|FG000|Overall Study|Lost to Follow-up|1|||
16065653|NCT05310084|38732824|FG001|Overall Study|Lost to Follow-up|1|||
16065654|NCT05310084|38732823|FG000|Overall Study|Adverse Event|1|||
16065655|NCT05310084|38732824|FG001|Overall Study|Adverse Event|1|||
16065656|NCT05310084|38732823|FG000|Overall Study|Randomized but not vaccinated|4|||
16065657|NCT05310084|38732824|FG001|Overall Study|Randomized but not vaccinated|2|||
16065658|NCT02320253|38732826|FG000|Overall Study|Withdrawal by Subject|3|||
16158168|NCT00695565|39061573|FG001|Overall Study|Lack of Efficacy|1|||
16158169|NCT00695565|39061572|FG000|Overall Study|Subject did not follow instructions|1|||
16158170|NCT00695565|39061573|FG001|Overall Study|Subject did not follow instructions|1|||
16158171|NCT01895322|39061574|FG000|Overall Study|Adverse Event|1|||
16158172|NCT01895322|39061574|FG000|Overall Study|Withdrawal by Subject|2|||
16065659|NCT02320253|38732827|FG001|Overall Study|Withdrawal by Subject|0|||
16065660|NCT02320253|38732828|FG002|Overall Study|Withdrawal by Subject|0|||
16065661|NCT02320253|38732826|FG000|Overall Study|Lost to Follow-up|2|||
16065662|NCT02320253|38732827|FG001|Overall Study|Lost to Follow-up|2|||
16065663|NCT02320253|38732828|FG002|Overall Study|Lost to Follow-up|1|||
16158173|NCT01895322|39061574|FG000|Overall Study|Protocol Violation|10|||
16158174|NCT01777152|39061575|FG000|Overall Study|Withdrawal by Subject|22|||
16158175|NCT01777152|39061576|FG001|Overall Study|Withdrawal by Subject|16|||
16158176|NCT01777152|39061575|FG000|Overall Study|Lost to Follow-up|3|||
16158177|NCT01777152|39061576|FG001|Overall Study|Lost to Follow-up|5|||
16158178|NCT01777152|39061575|FG000|Overall Study|Death|68|||
16158179|NCT01777152|39061576|FG001|Overall Study|Death|89|||
16158180|NCT01777152|39061575|FG000|Overall Study|Not eligible, no study drug received|1|||
16158181|NCT01777152|39061576|FG001|Overall Study|Not eligible, no study drug received|0|||
16158182|NCT01777152|39061575|FG000|Overall Study|Change of diagnosis|1|||
16158183|NCT01777152|39061576|FG001|Overall Study|Change of diagnosis|0|||
16158184|NCT02182687|39061578|FG000|Overall Study|Withdrawal by Subject|4|||
16158185|NCT02182687|39061579|FG001|Overall Study|Withdrawal by Subject|0|||
16158186|NCT02182687|39061578|FG000|Overall Study|Adverse Event|1|||
16158187|NCT02182687|39061579|FG001|Overall Study|Adverse Event|0|||
16158188|NCT02182687|39061578|FG000|Overall Study|Lost to Follow-up|0|||
16158189|NCT02182687|39061579|FG001|Overall Study|Lost to Follow-up|1|||
16158190|NCT03325673|39061580|FG000|Overall Study|Adverse Event|4|||
16158191|NCT03325673|39061581|FG001|Overall Study|Adverse Event|0|||
16158192|NCT02499146|39061582|FG000|Overall Study|Lost to Follow-up|1|||
16158193|NCT02499146|39061582|FG000|Overall Study|Withdrawal by Subject|1|||
16158194|NCT02499146|39061582|FG000|Overall Study|Other|2|||
16368328|NCT00853047|39833141|FG005|Core Phase|Participant Request|0|||
16368329|NCT00853047|39833136|FG000|Open-Label Extension Phase|Participant Request|0|||
16368330|NCT00853047|39833137|FG001|Open-Label Extension Phase|Participant Request|0|||
16368331|NCT00853047|39833138|FG002|Open-Label Extension Phase|Participant Request|0|||
16368332|NCT00853047|39833139|FG003|Open-Label Extension Phase|Participant Request|0|||
16368333|NCT00853047|39833140|FG004|Open-Label Extension Phase|Participant Request|0|||
16368334|NCT00853047|39833141|FG005|Open-Label Extension Phase|Participant Request|7|||
16368335|NCT00853047|39833136|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
16368336|NCT00853047|39833137|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
16368337|NCT00853047|39833138|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
16368338|NCT00853047|39833139|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
16368339|NCT00853047|39833140|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
16368340|NCT00853047|39833141|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
16368341|NCT00853047|39833136|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
16368342|NCT00853047|39833137|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
16368343|NCT00853047|39833138|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
16368344|NCT00853047|39833139|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
16368345|NCT00853047|39833140|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
16368346|NCT00853047|39833141|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
16368347|NCT00853047|39833136|FG000|Open-Label Extension Phase|Investigator Decision|0|||
16368348|NCT00853047|39833137|FG001|Open-Label Extension Phase|Investigator Decision|0|||
16368349|NCT00853047|39833138|FG002|Open-Label Extension Phase|Investigator Decision|0|||
16368350|NCT00853047|39833139|FG003|Open-Label Extension Phase|Investigator Decision|0|||
16368351|NCT00853047|39833140|FG004|Open-Label Extension Phase|Investigator Decision|0|||
16368352|NCT00853047|39833141|FG005|Open-Label Extension Phase|Investigator Decision|1|||
16368353|NCT00853047|39833136|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
16368354|NCT00853047|39833137|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
16368355|NCT00853047|39833138|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
16368356|NCT00853047|39833139|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
16368357|NCT00853047|39833140|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
16368358|NCT00853047|39833141|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
16368359|NCT00191152|39833142|FG000|Initial Treatment|Adverse Event|43|||
16368360|NCT00191152|39833143|FG001|Initial Treatment|Adverse Event|67|||
16368361|NCT00191152|39833142|FG000|Initial Treatment|Physician Decision|40|||
16368362|NCT00191152|39833143|FG001|Initial Treatment|Physician Decision|31|||
16368363|NCT00191152|39833142|FG000|Initial Treatment|Withdrawal by Subject|40|||
16368364|NCT00191152|39833143|FG001|Initial Treatment|Withdrawal by Subject|28|||
16368365|NCT00191152|39833142|FG000|Initial Treatment|Lost to Follow-up|0|||
16368366|NCT00191152|39833143|FG001|Initial Treatment|Lost to Follow-up|6|||
16368367|NCT00191152|39833142|FG000|Initial Treatment|Other|18|||
16368368|NCT00191152|39833143|FG001|Initial Treatment|Other|21|||
16158195|NCT02499146|39061582|FG000|Overall Study|Ongoing at date of cut-off|9|||
16158196|NCT02499146|39061582|FG000|Overall Study|Began other treatment/therapy|13|||
16158197|NCT00789529|39061585|FG000|Overall Study|Withdrawal by Subject|0|||
16158198|NCT00789529|39061586|FG001|Overall Study|Withdrawal by Subject|1|||
16368369|NCT00191152|39833142|FG000|Crossover Treatment|Adverse Event|8|||
16368370|NCT00191152|39833143|FG001|Crossover Treatment|Adverse Event|8|||
16368371|NCT00191152|39833142|FG000|Crossover Treatment|Physician Decision|7|||
16368372|NCT00191152|39833143|FG001|Crossover Treatment|Physician Decision|7|||
16368373|NCT00191152|39833142|FG000|Crossover Treatment|Withdrawal by Subject|6|||
16368374|NCT00191152|39833143|FG001|Crossover Treatment|Withdrawal by Subject|9|||
16368375|NCT00191152|39833142|FG000|Crossover Treatment|Lost to Follow-up|2|||
16368376|NCT00191152|39833143|FG001|Crossover Treatment|Lost to Follow-up|1|||
16368377|NCT00191152|39833142|FG000|Crossover Treatment|Other|4|||
16368378|NCT00191152|39833143|FG001|Crossover Treatment|Other|3|||
16368379|NCT03123588|39833146|FG000|Overall Study|Study Terminated by Sponsor|2|||
16368380|NCT03123588|39833147|FG001|Overall Study|Study Terminated by Sponsor|5|||
16368381|NCT03123588|39833146|FG000|Overall Study|Withdrawal by Subject|1|||
16368382|NCT03123588|39833147|FG001|Overall Study|Withdrawal by Subject|0|||
16368383|NCT03123588|39833146|FG000|Overall Study|Adverse Event|1|||
16368384|NCT03123588|39833147|FG001|Overall Study|Adverse Event|0|||
16065664|NCT02320253|38732826|FG000|Overall Study|Death|1|||
16368385|NCT03123588|39833146|FG000|Overall Study|Physician Decision|2|||
16368386|NCT03123588|39833147|FG001|Overall Study|Physician Decision|1|||
16368387|NCT03994120|39833148|FG000|Overall Study|Lost to Follow-up|3|||
16368388|NCT03994120|39833149|FG001|Overall Study|Lost to Follow-up|1|||
16368389|NCT03558672|39833150|FG000|Overall Study|Study Early Termination|10|||
16368390|NCT02412657|39833151|FG000|Overall Study|Lost to Follow-up|1|||
16368391|NCT02412657|39833152|FG001|Overall Study|Lost to Follow-up|0|||
16368392|NCT02412657|39833153|FG002|Overall Study|Lost to Follow-up|0|||
16368393|NCT02412657|39833151|FG000|Overall Study|Protocol Violation|0|||
16368394|NCT02412657|39833152|FG001|Overall Study|Protocol Violation|2|||
16368395|NCT02412657|39833153|FG002|Overall Study|Protocol Violation|3|||
16368396|NCT01370538|39833161|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
16368397|NCT01370538|39833162|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
16368398|NCT01370538|39833161|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16368399|NCT01370538|39833162|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16368400|NCT01370538|39833161|FG000|Overall Study|Adverse Event|1|||
16368401|NCT01370538|39833162|FG001|Overall Study|Adverse Event|0|||
16368402|NCT01370538|39833161|FG000|Overall Study|Protocol Violation|8|||
16368403|NCT01370538|39833162|FG001|Overall Study|Protocol Violation|5|||
16368404|NCT01370538|39833161|FG000|Overall Study|Development of study specific withdrawal|1|||
16368405|NCT01370538|39833162|FG001|Overall Study|Development of study specific withdrawal|1|||
16368406|NCT01370538|39833161|FG000|Overall Study|Lost to follow up|6|||
16368407|NCT01370538|39833162|FG001|Overall Study|Lost to follow up|10|||
16368408|NCT00387127|39833169|FG000|Overall Study|Lost to Follow-up|0|||
16368409|NCT00387127|39833170|FG001|Overall Study|Lost to Follow-up|4|||
16368410|NCT00387127|39833169|FG000|Overall Study|Death|16|||
16368411|NCT00387127|39833170|FG001|Overall Study|Death|16|||
16368412|NCT00387127|39833169|FG000|Overall Study|Physician Decision|0|||
16368413|NCT00387127|39833170|FG001|Overall Study|Physician Decision|1|||
16368414|NCT00387127|39833169|FG000|Overall Study|Withdrawal by Subject|3|||
16368415|NCT00387127|39833170|FG001|Overall Study|Withdrawal by Subject|2|||
16368416|NCT00387127|39833169|FG000|Overall Study|Required by Protocol Amendment #4|12|||
16368417|NCT00387127|39833170|FG001|Overall Study|Required by Protocol Amendment #4|10|||
16368418|NCT00387127|39833169|FG000|Overall Study|Serious Adverse Event|1|||
16368419|NCT00387127|39833170|FG001|Overall Study|Serious Adverse Event|1|||
16368420|NCT00387127|39833169|FG000|Overall Study|Sponsor Unblinded|1|||
16368421|NCT00387127|39833170|FG001|Overall Study|Sponsor Unblinded|0|||
16368422|NCT02788045|39833171|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
16368423|NCT02788045|39833172|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
16368424|NCT02788045|39833173|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
16368425|NCT02788045|39833171|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
16368426|NCT02788045|39833172|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
16368427|NCT02788045|39833173|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
16368428|NCT02788045|39833171|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
16368429|NCT02788045|39833172|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
16368430|NCT02788045|39833173|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
16368431|NCT02788045|39833171|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
16368432|NCT02788045|39833172|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
16368433|NCT02788045|39833173|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
16368434|NCT02788045|39833171|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
16368435|NCT02788045|39833172|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
16368436|NCT02788045|39833173|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
16368437|NCT02788045|39833171|FG000|Main Study (Up to Week 72)|Other|3|||
16368438|NCT02788045|39833172|FG001|Main Study (Up to Week 72)|Other|0|||
16368439|NCT02788045|39833173|FG002|Main Study (Up to Week 72)|Other|0|||
16368440|NCT02788045|39833171|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
16368441|NCT02788045|39833172|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
16445496|NCT00906204|40108695|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
16368442|NCT02788045|39833173|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
16368443|NCT02788045|39833171|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
16368444|NCT02788045|39833172|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
16368445|NCT02788045|39833173|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
16368446|NCT02788045|39833171|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
16368447|NCT02788045|39833172|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
16368448|NCT02788045|39833173|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
16368449|NCT00416949|39833174|FG000|Overall Study|Patients refused to participate|5|||
16368450|NCT00694122|39833175|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
16368451|NCT00694122|39833176|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
16368452|NCT00694122|39833175|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
16368453|NCT00694122|39833176|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
16368454|NCT00694122|39833175|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
16368455|NCT00694122|39833176|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
16368456|NCT02638493|39833187|FG000|Overall Study|Inability to provide semen samples|2|||
16368457|NCT02638493|39833188|FG001|Overall Study|Inability to provide semen samples|0|||
16368458|NCT02638493|39833189|FG002|Overall Study|Inability to provide semen samples|0|||
16368459|NCT00888849|39833191|FG000|Overall Study|Death|4|||
16368460|NCT00888849|39833192|FG001|Overall Study|Death|7|||
16368461|NCT00888849|39833191|FG000|Overall Study|Lost to Follow-up|1|||
16368462|NCT00888849|39833192|FG001|Overall Study|Lost to Follow-up|2|||
16368463|NCT00875667|39833193|FG000|Overall Study|Adverse Event|29|||
16368464|NCT00875667|39833194|FG001|Overall Study|Adverse Event|10|||
16368465|NCT00875667|39833193|FG000|Overall Study|Withdrawal by Subject|17|||
16368466|NCT00875667|39833194|FG001|Overall Study|Withdrawal by Subject|5|||
16368467|NCT00875667|39833193|FG000|Overall Study|Death|7|||
16368468|NCT00875667|39833194|FG001|Overall Study|Death|2|||
16368469|NCT00875667|39833193|FG000|Overall Study|Protocol Violation|2|||
16368470|NCT00875667|39833194|FG001|Overall Study|Protocol Violation|0|||
16368471|NCT00875667|39833193|FG000|Overall Study|Disease Progression|100|||
16368472|NCT00875667|39833194|FG001|Overall Study|Disease Progression|49|||
16368473|NCT00875667|39833193|FG000|Overall Study|Miscellaneous|12|||
16368474|NCT00875667|39833194|FG001|Overall Study|Miscellaneous|6|||
16368475|NCT00875667|39833193|FG000|Overall Study|Randomized but no Study Drug Given|3|||
16368476|NCT00875667|39833194|FG001|Overall Study|Randomized but no Study Drug Given|1|||
16368477|NCT02112552|39833195|FG000|Overall Study|Withdrawal by Subject|1|||
16368478|NCT02112552|39833195|FG000|Overall Study|Adverse Event|1|||
16368479|NCT00790933|39833198|FG000|Overall Study|Adverse Event|94|||
16368480|NCT00790933|39833199|FG001|Overall Study|Adverse Event|119|||
16368481|NCT00790933|39833200|FG002|Overall Study|Adverse Event|65|||
16368482|NCT00790933|39833201|FG003|Overall Study|Adverse Event|5|||
16368483|NCT00790933|39833202|FG004|Overall Study|Adverse Event|69|||
16368484|NCT00790933|39833198|FG000|Overall Study|Protocol Violation(s)|8|||
16368485|NCT00790933|39833199|FG001|Overall Study|Protocol Violation(s)|18|||
16368486|NCT00790933|39833200|FG002|Overall Study|Protocol Violation(s)|7|||
16368487|NCT00790933|39833201|FG003|Overall Study|Protocol Violation(s)|0|||
16368488|NCT00790933|39833202|FG004|Overall Study|Protocol Violation(s)|12|||
16368489|NCT00790933|39833198|FG000|Overall Study|Lack of Efficacy|192|||
16368490|NCT00790933|39833199|FG001|Overall Study|Lack of Efficacy|176|||
16368491|NCT00790933|39833200|FG002|Overall Study|Lack of Efficacy|130|||
16368492|NCT00790933|39833201|FG003|Overall Study|Lack of Efficacy|1|||
16368493|NCT00790933|39833202|FG004|Overall Study|Lack of Efficacy|121|||
16368494|NCT00790933|39833198|FG000|Overall Study|Study Terminated by Sponsor|0|||
16368495|NCT00790933|39833199|FG001|Overall Study|Study Terminated by Sponsor|0|||
16368496|NCT00790933|39833200|FG002|Overall Study|Study Terminated by Sponsor|1|||
16368497|NCT00790933|39833201|FG003|Overall Study|Study Terminated by Sponsor|0|||
16368498|NCT00790933|39833202|FG004|Overall Study|Study Terminated by Sponsor|0|||
16368499|NCT00790933|39833198|FG000|Overall Study|Withdrawal by Subject|123|||
16368500|NCT00790933|39833199|FG001|Overall Study|Withdrawal by Subject|120|||
16368501|NCT00790933|39833200|FG002|Overall Study|Withdrawal by Subject|52|||
16368502|NCT00790933|39833201|FG003|Overall Study|Withdrawal by Subject|6|||
16368503|NCT00790933|39833202|FG004|Overall Study|Withdrawal by Subject|50|||
16368504|NCT00790933|39833198|FG000|Overall Study|Lost to Follow-up|13|||
16065665|NCT02320253|38732827|FG001|Overall Study|Death|0|||
16065666|NCT02320253|38732828|FG002|Overall Study|Death|1|||
16065667|NCT02373813|38732829|FG000|Run-In Period|Other, Not Specified|5|||
16065668|NCT02373813|38732830|FG001|Run-In Period|Other, Not Specified|0|||
16065669|NCT02373813|38732831|FG002|Run-In Period|Other, Not Specified|0|||
16065670|NCT02373813|38732832|FG003|Run-In Period|Other, Not Specified|0|||
16065671|NCT02373813|38732829|FG000|Run-In Period|Withdrawal by Subject|16|||
16065672|NCT02373813|38732830|FG001|Run-In Period|Withdrawal by Subject|0|||
16065673|NCT02373813|38732831|FG002|Run-In Period|Withdrawal by Subject|0|||
16065674|NCT02373813|38732832|FG003|Run-In Period|Withdrawal by Subject|0|||
16065675|NCT02373813|38732829|FG000|Run-In Period|Decision by Sponsor|11|||
16065676|NCT02373813|38732830|FG001|Run-In Period|Decision by Sponsor|0|||
16368505|NCT00790933|39833199|FG001|Overall Study|Lost to Follow-up|31|||
16368506|NCT00790933|39833200|FG002|Overall Study|Lost to Follow-up|10|||
16368507|NCT00790933|39833201|FG003|Overall Study|Lost to Follow-up|1|||
16368508|NCT00790933|39833202|FG004|Overall Study|Lost to Follow-up|15|||
16065677|NCT02373813|38732831|FG002|Run-In Period|Decision by Sponsor|0|||
16065678|NCT02373813|38732832|FG003|Run-In Period|Decision by Sponsor|0|||
16065679|NCT02373813|38732829|FG000|Run-In Period|Protocol Violation|75|||
16368509|NCT00790933|39833198|FG000|Overall Study|Reason Not Specified|8|||
16368510|NCT00790933|39833199|FG001|Overall Study|Reason Not Specified|16|||
16368511|NCT00790933|39833200|FG002|Overall Study|Reason Not Specified|4|||
16065680|NCT02373813|38732830|FG001|Run-In Period|Protocol Violation|0|||
16065681|NCT02373813|38732831|FG002|Run-In Period|Protocol Violation|0|||
16065682|NCT02373813|38732832|FG003|Run-In Period|Protocol Violation|0|||
16065683|NCT02373813|38732829|FG000|Run-In Period|Lost to Follow-up|2|||
16065684|NCT02373813|38732830|FG001|Run-In Period|Lost to Follow-up|0|||
16065685|NCT02373813|38732831|FG002|Run-In Period|Lost to Follow-up|0|||
16065686|NCT02373813|38732832|FG003|Run-In Period|Lost to Follow-up|0|||
16065687|NCT02373813|38732829|FG000|Run-In Period|Adverse Event|3|||
16065688|NCT02373813|38732830|FG001|Run-In Period|Adverse Event|0|||
16065689|NCT02373813|38732831|FG002|Run-In Period|Adverse Event|0|||
16368512|NCT00790933|39833201|FG003|Overall Study|Reason Not Specified|1|||
16368513|NCT00790933|39833202|FG004|Overall Study|Reason Not Specified|9|||
16368514|NCT01783938|39833203|FG000|Overall Study|Disease Progression|18|||
16368515|NCT01783938|39833204|FG001|Overall Study|Disease Progression|41|||
16368516|NCT01783938|39833203|FG000|Overall Study|Study Drug Toxicity|27|||
16368517|NCT01783938|39833204|FG001|Overall Study|Study Drug Toxicity|14|||
16368518|NCT01783938|39833203|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
16368519|NCT01783938|39833204|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
16368520|NCT01783938|39833203|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
16368521|NCT01783938|39833204|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
16368522|NCT01783938|39833203|FG000|Overall Study|Participant Withdrew Consent|2|||
16368523|NCT01783938|39833204|FG001|Overall Study|Participant Withdrew Consent|0|||
16368524|NCT01783938|39833203|FG000|Overall Study|Maximum Clinical Benefit|1|||
16368525|NCT01783938|39833204|FG001|Overall Study|Maximum Clinical Benefit|0|||
16368526|NCT01783938|39833203|FG000|Overall Study|Other Reasons|3|||
16368527|NCT01783938|39833204|FG001|Overall Study|Other Reasons|1|||
16368528|NCT03743194|39833209|FG000|Overall Study|Protocol Violation|7|||
16368529|NCT03743194|39833210|FG001|Overall Study|Protocol Violation|7|||
16368530|NCT03743194|39833209|FG000|Overall Study|Physician Decision|0|||
16368531|NCT03743194|39833210|FG001|Overall Study|Physician Decision|2|||
16368532|NCT03259308|39833211|FG000|Overall Study|Adverse Event|5|||
16368533|NCT03259308|39833212|FG001|Overall Study|Adverse Event|4|||
16368534|NCT03259308|39833213|FG002|Overall Study|Adverse Event|1|||
16368535|NCT03259308|39833211|FG000|Overall Study|Withdrawal by Subject|2|||
16368536|NCT03259308|39833212|FG001|Overall Study|Withdrawal by Subject|1|||
16368537|NCT03259308|39833213|FG002|Overall Study|Withdrawal by Subject|3|||
16368538|NCT03259308|39833211|FG000|Overall Study|Lost to Follow-up|0|||
16368539|NCT03259308|39833212|FG001|Overall Study|Lost to Follow-up|0|||
16368540|NCT03259308|39833213|FG002|Overall Study|Lost to Follow-up|1|||
16368541|NCT03259308|39833211|FG000|Overall Study|Pregnancy|0|||
16368542|NCT03259308|39833212|FG001|Overall Study|Pregnancy|0|||
16368543|NCT03259308|39833213|FG002|Overall Study|Pregnancy|1|||
16368544|NCT03259308|39833211|FG000|Overall Study|Protocol Deviation|0|||
16368545|NCT03259308|39833212|FG001|Overall Study|Protocol Deviation|3|||
16368546|NCT03259308|39833213|FG002|Overall Study|Protocol Deviation|0|||
16368547|NCT03259308|39833211|FG000|Overall Study|Lack of Efficacy|0|||
16445497|NCT00906204|40108696|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
16445498|NCT01256788|40108699|FG000|Overall Study|Lost to Follow-up|5|||
16445499|NCT01256788|40108700|FG001|Overall Study|Lost to Follow-up|8|||
16445500|NCT01256788|40108701|FG002|Overall Study|Lost to Follow-up|3|||
16445501|NCT01084655|40108704|FG000|Overall Study|Radiographic disease progression|3|||
16445502|NCT01084655|40108705|FG001|Overall Study|Radiographic disease progression|2|||
16445503|NCT01084655|40108706|FG002|Overall Study|Radiographic disease progression|8|||
16445504|NCT01084655|40108704|FG000|Overall Study|Withdrawal by Subject|1|||
16445505|NCT01084655|40108705|FG001|Overall Study|Withdrawal by Subject|0|||
16445506|NCT01084655|40108706|FG002|Overall Study|Withdrawal by Subject|4|||
16445507|NCT01084655|40108704|FG000|Overall Study|Adverse Event|2|||
16445508|NCT01084655|40108705|FG001|Overall Study|Adverse Event|1|||
16445509|NCT01084655|40108706|FG002|Overall Study|Adverse Event|2|||
16445510|NCT01084655|40108704|FG000|Overall Study|Other|0|||
16445511|NCT01084655|40108705|FG001|Overall Study|Other|3|||
16445512|NCT01084655|40108706|FG002|Overall Study|Other|2|||
16445513|NCT01084655|40108704|FG000|Overall Study|Symptomatic deterioration|0|||
16445514|NCT01084655|40108705|FG001|Overall Study|Symptomatic deterioration|0|||
16445515|NCT01084655|40108706|FG002|Overall Study|Symptomatic deterioration|2|||
16445516|NCT01084655|40108704|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
16445517|NCT01084655|40108705|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
16445518|NCT01084655|40108706|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
16445519|NCT02158546|40111522|FG000|Overall Study|Physician Decision|0|||
16445520|NCT02158546|40111523|FG001|Overall Study|Physician Decision|1|||
16445521|NCT02158546|40111524|FG002|Overall Study|Physician Decision|0|||
16065690|NCT02373813|38732832|FG003|Run-In Period|Adverse Event|0|||
16445522|NCT02158546|40111525|FG003|Overall Study|Physician Decision|0|||
16445523|NCT02158546|40111522|FG000|Overall Study|Non-compliance|0|||
16065691|NCT02373813|38732829|FG000|Run-In Period|Noncompliance|1|||
16065692|NCT02373813|38732830|FG001|Run-In Period|Noncompliance|0|||
16065693|NCT02373813|38732831|FG002|Run-In Period|Noncompliance|0|||
16445524|NCT02158546|40111523|FG001|Overall Study|Non-compliance|1|||
16368548|NCT03259308|39833212|FG001|Overall Study|Lack of Efficacy|0|||
16368549|NCT03259308|39833213|FG002|Overall Study|Lack of Efficacy|1|||
16368550|NCT00356590|39833217|FG000|Overall Study|Adverse Event|54|||
16368551|NCT00356590|39833217|FG000|Overall Study|Death|10|||
16368552|NCT00356590|39833217|FG000|Overall Study|Lost to Follow-up|35|||
16368553|NCT00356590|39833217|FG000|Overall Study|Physician Decision|46|||
16368554|NCT00356590|39833217|FG000|Overall Study|Withdrawal by Subject|41|||
16368555|NCT00356590|39833217|FG000|Overall Study|Completed month 12 only|2|||
16368556|NCT00356590|39833217|FG000|Overall Study|Protocol issues|6|||
16368557|NCT00356590|39833217|FG000|Overall Study|Response status|28|||
16368558|NCT00356590|39833217|FG000|Overall Study|Other|52|||
16368559|NCT00025233|39833218|FG000|Overall Study|Ineligible: wrong cell type|1|||
16368560|NCT00025233|39833218|FG000|Overall Study|Ineligible: wrong primary|1|||
16368561|NCT00025233|39833218|FG000|Overall Study|Ineligible: improper prior treatment|1|||
16368562|NCT00025233|39833218|FG000|Overall Study|Never treated|1|||
16368563|NCT00120250|39833225|FG000|Overall Study|Lost to Follow-up|1|||
16368564|NCT00120250|39833226|FG001|Overall Study|Lost to Follow-up|1|||
16368565|NCT00120250|39833225|FG000|Overall Study|Protocol Violation|0|||
16368566|NCT00120250|39833226|FG001|Overall Study|Protocol Violation|1|||
16368567|NCT00599313|39833234|FG000|Overall Study|Adverse Event|19|||
16368568|NCT00599313|39833234|FG000|Overall Study|Disease Progression|12|||
16368569|NCT00599313|39833234|FG000|Overall Study|Patient Request|4|||
16368570|NCT00599313|39833234|FG000|Overall Study|Ineligible|1|||
16368571|NCT01362270|39833235|FG000|Overall Study|Withdrawal by Subject|1|||
16368572|NCT01362270|39833236|FG001|Overall Study|Withdrawal by Subject|0|||
16368573|NCT01362270|39833235|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
16368574|NCT01362270|39833236|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
16368575|NCT01362270|39833235|FG000|Overall Study|Met excl. criteria before 1st session|1|||
16368576|NCT01362270|39833236|FG001|Overall Study|Met excl. criteria before 1st session|1|||
16368577|NCT01239680|39833237|FG000|Overall Study|Withdrawal by Subject|2|||
16368578|NCT01239680|39833238|FG001|Overall Study|Withdrawal by Subject|0|||
16368579|NCT04137887|39833239|FG000|Overall Study|Death|102|||
16368580|NCT04137887|39833240|FG001|Overall Study|Death|92|||
16368581|NCT04137887|39833239|FG000|Overall Study|Withdrawal by Subject|2|||
16368582|NCT04137887|39833240|FG001|Overall Study|Withdrawal by Subject|3|||
16368583|NCT04137887|39833239|FG000|Overall Study|Randomized but not treated|0|||
16368584|NCT04137887|39833240|FG001|Overall Study|Randomized but not treated|1|||
16368585|NCT00327171|39833241|FG000|Overall Study|Did not receive study medication|3|||
16368586|NCT00327171|39833242|FG001|Overall Study|Did not receive study medication|0|||
16368587|NCT00327171|39833241|FG000|Overall Study|Adverse Event|23|||
16368588|NCT00327171|39833242|FG001|Overall Study|Adverse Event|23|||
16368589|NCT00327171|39833241|FG000|Overall Study|Disease progression/lack of efficacy|68|||
16368590|NCT00327171|39833242|FG001|Overall Study|Disease progression/lack of efficacy|69|||
16368591|NCT00327171|39833241|FG000|Overall Study|Investigator/participant request|1|||
16368592|NCT00327171|39833242|FG001|Overall Study|Investigator/participant request|8|||
16065694|NCT02373813|38732832|FG003|Run-In Period|Noncompliance|0|||
16065695|NCT02373813|38732829|FG000|Run-In Period|Ineligibility Determined|3|||
16368593|NCT00327171|39833241|FG000|Overall Study|Clinical progression|12|||
16368594|NCT00327171|39833242|FG001|Overall Study|Clinical progression|8|||
16368595|NCT00327171|39833241|FG000|Overall Study|Undisclosed history of ischemia|0|||
16368596|NCT00327171|39833242|FG001|Overall Study|Undisclosed history of ischemia|1|||
16368597|NCT00327171|39833241|FG000|Overall Study|Other|1|||
16368598|NCT00327171|39833242|FG001|Overall Study|Other|0|||
16368599|NCT02316613|39833243|FG000|Overall Study|Death|63|||
16368600|NCT02316613|39833243|FG000|Overall Study|Lost to Follow-up|9|||
16368601|NCT02316613|39833243|FG000|Overall Study|Lymphoma transformation|2|||
16368602|NCT02316613|39833243|FG000|Overall Study|Participant moved/changed medical team|11|||
16368603|NCT02316613|39833243|FG000|Overall Study|No data and duplicate cases|5|||
16368604|NCT02316613|39833243|FG000|Overall Study|Did not met selection criteria|14|||
16368605|NCT02762604|39833246|FG000|Overall Study|Lost to Follow-up|2|||
16368606|NCT02762604|39833247|FG001|Overall Study|Lost to Follow-up|7|||
16368607|NCT02762604|39833246|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
16368608|NCT02762604|39833247|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
16368609|NCT00498485|39833248|FG000|Overall Study|Adverse Event|1|||
16368610|NCT00498485|39833249|FG001|Overall Study|Adverse Event|5|||
16368611|NCT01436500|39833250|FG000|Overall Study|Death|1|||
16368612|NCT01436500|39833251|FG001|Overall Study|Death|0|||
16368613|NCT01436500|39833252|FG002|Overall Study|Death|0|||
16368614|NCT01436500|39833253|FG003|Overall Study|Death|0|||
16368615|NCT01436500|39833254|FG004|Overall Study|Death|0|||
16368616|NCT01436500|39833250|FG000|Overall Study|Adverse Event|0|||
16368617|NCT01436500|39833251|FG001|Overall Study|Adverse Event|2|||
16065696|NCT02373813|38732830|FG001|Run-In Period|Ineligibility Determined|0|||
16368618|NCT01436500|39833252|FG002|Overall Study|Adverse Event|2|||
16368619|NCT01436500|39833253|FG003|Overall Study|Adverse Event|0|||
16368620|NCT01436500|39833254|FG004|Overall Study|Adverse Event|1|||
16368621|NCT01436500|39833250|FG000|Overall Study|Withdrawal by Subject|0|||
16368622|NCT01436500|39833251|FG001|Overall Study|Withdrawal by Subject|0|||
16368623|NCT01436500|39833252|FG002|Overall Study|Withdrawal by Subject|2|||
16368624|NCT01436500|39833253|FG003|Overall Study|Withdrawal by Subject|0|||
16368625|NCT01436500|39833254|FG004|Overall Study|Withdrawal by Subject|2|||
16368626|NCT01436500|39833250|FG000|Overall Study|Physician Decision|0|||
16368627|NCT01436500|39833251|FG001|Overall Study|Physician Decision|0|||
16368628|NCT01436500|39833252|FG002|Overall Study|Physician Decision|1|||
16368629|NCT01436500|39833253|FG003|Overall Study|Physician Decision|0|||
16368630|NCT01436500|39833254|FG004|Overall Study|Physician Decision|0|||
16368631|NCT01436500|39833250|FG000|Overall Study|liver transplant|1|||
16368632|NCT01436500|39833251|FG001|Overall Study|liver transplant|0|||
16368633|NCT01436500|39833252|FG002|Overall Study|liver transplant|0|||
16368634|NCT01436500|39833253|FG003|Overall Study|liver transplant|0|||
16368635|NCT01436500|39833254|FG004|Overall Study|liver transplant|0|||
16368636|NCT01436500|39833250|FG000|Overall Study|initiation of dialysis|0|||
16368637|NCT01436500|39833251|FG001|Overall Study|initiation of dialysis|0|||
16368638|NCT01436500|39833252|FG002|Overall Study|initiation of dialysis|0|||
16368639|NCT01436500|39833253|FG003|Overall Study|initiation of dialysis|0|||
16368640|NCT01436500|39833254|FG004|Overall Study|initiation of dialysis|1|||
16368641|NCT01436500|39833250|FG000|Overall Study|discontinued study drug|1|||
16065697|NCT02373813|38732831|FG002|Run-In Period|Ineligibility Determined|0|||
16065698|NCT02373813|38732832|FG003|Run-In Period|Ineligibility Determined|0|||
16065699|NCT02373813|38732829|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
16065700|NCT02373813|38732830|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
16065701|NCT02373813|38732831|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
16065702|NCT02373813|38732832|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
16368642|NCT01436500|39833251|FG001|Overall Study|discontinued study drug|0|||
16368643|NCT01436500|39833252|FG002|Overall Study|discontinued study drug|0|||
16368644|NCT01436500|39833253|FG003|Overall Study|discontinued study drug|0|||
16368645|NCT01436500|39833254|FG004|Overall Study|discontinued study drug|0|||
16368646|NCT01436500|39833250|FG000|Overall Study|Other|0|||
16368647|NCT01436500|39833251|FG001|Overall Study|Other|1|||
16368648|NCT01436500|39833252|FG002|Overall Study|Other|0|||
16368649|NCT01436500|39833253|FG003|Overall Study|Other|1|||
16368650|NCT01436500|39833254|FG004|Overall Study|Other|0|||
16368651|NCT03349515|39833255|FG000|Overall Study|Lack of Efficacy|2|||
16368652|NCT03349515|39833256|FG001|Overall Study|Lack of Efficacy|0|||
16368653|NCT03349515|39833255|FG000|Overall Study|Physician Decision|3|||
16368654|NCT03349515|39833256|FG001|Overall Study|Physician Decision|1|||
16368655|NCT00103506|39833257|FG000|Overall Study|Study closed by sponsor|34|||
16368656|NCT00103506|39833258|FG001|Overall Study|Study closed by sponsor|37|||
16368657|NCT00103506|39833257|FG000|Overall Study|Death|257|||
16368658|NCT00103506|39833258|FG001|Overall Study|Death|253|||
16368659|NCT00103506|39833257|FG000|Overall Study|Lost to Follow-up|13|||
16368660|NCT00103506|39833258|FG001|Overall Study|Lost to Follow-up|13|||
16368661|NCT00103506|39833257|FG000|Overall Study|Withdrawal by Subject|18|||
16368662|NCT00103506|39833258|FG001|Overall Study|Withdrawal by Subject|21|||
16368663|NCT01564407|39833268|FG000|Overall Study|Lost to Follow-up|0|||
16368664|NCT01564407|39833269|FG001|Overall Study|Lost to Follow-up|1|||
16368665|NCT01564407|39833270|FG002|Overall Study|Lost to Follow-up|0|||
16368666|NCT01564407|39833271|FG003|Overall Study|Lost to Follow-up|0|||
16368667|NCT01564407|39833272|FG004|Overall Study|Lost to Follow-up|0|||
16065703|NCT02373813|38732829|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
16065704|NCT02373813|38732830|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
16065705|NCT02373813|38732831|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
16065706|NCT02373813|38732832|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
16065707|NCT02373813|38732829|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
16065708|NCT02373813|38732830|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
16065709|NCT02373813|38732831|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
16065710|NCT02373813|38732832|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
16065711|NCT02373813|38732829|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
16065712|NCT02373813|38732830|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
16065713|NCT02373813|38732831|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
16065714|NCT02373813|38732832|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
16368668|NCT01564407|39833268|FG000|Overall Study|Withdrawal by Subject|0|||
16065715|NCT03531905|38732833|FG000|Overall Study|Withdrawal by Subject|3|||
16368669|NCT01564407|39833269|FG001|Overall Study|Withdrawal by Subject|1|||
16368670|NCT01564407|39833270|FG002|Overall Study|Withdrawal by Subject|0|||
16368671|NCT01564407|39833271|FG003|Overall Study|Withdrawal by Subject|0|||
16368672|NCT01564407|39833272|FG004|Overall Study|Withdrawal by Subject|0|||
16368673|NCT01564407|39833268|FG000|Overall Study|funding lost, study ended|0|||
16368674|NCT01564407|39833269|FG001|Overall Study|funding lost, study ended|0|||
16368675|NCT01564407|39833270|FG002|Overall Study|funding lost, study ended|0|||
16065716|NCT03531905|38732834|FG001|Overall Study|Withdrawal by Subject|3|||
16368676|NCT01564407|39833271|FG003|Overall Study|funding lost, study ended|1|||
16368677|NCT01564407|39833272|FG004|Overall Study|funding lost, study ended|0|||
16445525|NCT02158546|40111524|FG002|Overall Study|Non-compliance|0|||
16445526|NCT02158546|40111525|FG003|Overall Study|Non-compliance|1|||
16445527|NCT02158546|40111522|FG000|Overall Study|Failure to meet eligibility criteria|0|||
16445528|NCT02158546|40111523|FG001|Overall Study|Failure to meet eligibility criteria|1|||
16445529|NCT02158546|40111524|FG002|Overall Study|Failure to meet eligibility criteria|0|||
16158199|NCT00789529|39061585|FG000|Overall Study|Other Reason|1|||
16158200|NCT00789529|39061586|FG001|Overall Study|Other Reason|0|||
16158201|NCT00874120|39061587|FG000|First Intervention|Adverse Event|0|||
16158202|NCT00874120|39061588|FG001|First Intervention|Adverse Event|1|||
16158203|NCT00874120|39061587|FG000|First Intervention|Withdrawal by Subject|2|||
16445530|NCT02158546|40111525|FG003|Overall Study|Failure to meet eligibility criteria|0|||
16445531|NCT02158546|40111522|FG000|Overall Study|Lack of Efficacy|1|||
16445532|NCT02158546|40111523|FG001|Overall Study|Lack of Efficacy|1|||
16445533|NCT02158546|40111524|FG002|Overall Study|Lack of Efficacy|0|||
16445534|NCT02158546|40111525|FG003|Overall Study|Lack of Efficacy|0|||
16445535|NCT02158546|40111522|FG000|Overall Study|Adverse Event|2|||
16445536|NCT02158546|40111523|FG001|Overall Study|Adverse Event|2|||
16445537|NCT02158546|40111524|FG002|Overall Study|Adverse Event|0|||
16445538|NCT02158546|40111525|FG003|Overall Study|Adverse Event|0|||
16445539|NCT02158546|40111522|FG000|Overall Study|Withdrawal by Subject|6|||
16445540|NCT02158546|40111523|FG001|Overall Study|Withdrawal by Subject|2|||
16445541|NCT02158546|40111524|FG002|Overall Study|Withdrawal by Subject|1|||
16445542|NCT02158546|40111525|FG003|Overall Study|Withdrawal by Subject|0|||
16445543|NCT02158546|40111522|FG000|Overall Study|Lost to Follow-up|5|||
16445544|NCT02158546|40111523|FG001|Overall Study|Lost to Follow-up|4|||
16445545|NCT02158546|40111524|FG002|Overall Study|Lost to Follow-up|0|||
16445546|NCT02158546|40111525|FG003|Overall Study|Lost to Follow-up|1|||
16445547|NCT02158546|40111522|FG000|Overall Study|Site Excluded|5|||
16445548|NCT02158546|40111523|FG001|Overall Study|Site Excluded|5|||
16445549|NCT02158546|40111524|FG002|Overall Study|Site Excluded|3|||
16445550|NCT02158546|40111525|FG003|Overall Study|Site Excluded|4|||
16445551|NCT00538902|40111533|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
16445552|NCT00538902|40111534|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
16445553|NCT00538902|40111535|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
16065717|NCT03531905|38732835|FG002|Overall Study|Withdrawal by Subject|2|||
16158204|NCT00874120|39061588|FG001|First Intervention|Withdrawal by Subject|0|||
16158205|NCT00874120|39061587|FG000|First Intervention|Lost to Follow-up|0|||
16158206|NCT00874120|39061588|FG001|First Intervention|Lost to Follow-up|1|||
16158207|NCT00874120|39061587|FG000|First Intervention|Protocol Violation|3|||
16158208|NCT00874120|39061588|FG001|First Intervention|Protocol Violation|0|||
16158209|NCT00874120|39061587|FG000|First Intervention|positive drug test|1|||
16158210|NCT00874120|39061588|FG001|First Intervention|positive drug test|0|||
16158211|NCT00874120|39061587|FG000|Second Intervention|Withdrawal by Subject|1|||
16065718|NCT03531905|38732833|FG000|Overall Study|Lost to Follow-up|2|||
16065719|NCT03531905|38732834|FG001|Overall Study|Lost to Follow-up|2|||
16065720|NCT03531905|38732835|FG002|Overall Study|Lost to Follow-up|1|||
16065721|NCT03531905|38732833|FG000|Overall Study|Participant was out of town|1|||
16065722|NCT03531905|38732834|FG001|Overall Study|Participant was out of town|0|||
16065723|NCT03531905|38732835|FG002|Overall Study|Participant was out of town|0|||
16065724|NCT03531905|38732833|FG000|Overall Study|Could not speak with the participant|1|||
16065725|NCT03531905|38732834|FG001|Overall Study|Could not speak with the participant|0|||
16065726|NCT03531905|38732835|FG002|Overall Study|Could not speak with the participant|0|||
16158212|NCT00874120|39061588|FG001|Second Intervention|Withdrawal by Subject|0|||
16158213|NCT00874120|39061587|FG000|Second Intervention|Protocol Violation|1|||
16158214|NCT00874120|39061588|FG001|Second Intervention|Protocol Violation|0|||
16158215|NCT01736579|39061590|FG000|Overall Study|Termination of Study by Sponsor|2|||
16158216|NCT01736579|39061591|FG001|Overall Study|Termination of Study by Sponsor|2|||
16158217|NCT01360554|39061592|FG000|Overall Study|Death|359|||
16158218|NCT01360554|39061593|FG001|Overall Study|Death|371|||
16158219|NCT01360554|39061592|FG000|Overall Study|Lost to Follow-up|4|||
16158220|NCT01360554|39061593|FG001|Overall Study|Lost to Follow-up|4|||
16158221|NCT01360554|39061592|FG000|Overall Study|Withdrawal by Subject|23|||
16158222|NCT01360554|39061593|FG001|Overall Study|Withdrawal by Subject|24|||
16158223|NCT01360554|39061592|FG000|Overall Study|Study terminated by sponsor|49|||
16158224|NCT01360554|39061593|FG001|Overall Study|Study terminated by sponsor|37|||
16158225|NCT01360554|39061592|FG000|Overall Study|Other, not specified|1|||
16158226|NCT01360554|39061593|FG001|Overall Study|Other, not specified|0|||
16158227|NCT01360554|39061592|FG000|Overall Study|Randomized but not treated.|3|||
16158228|NCT01360554|39061593|FG001|Overall Study|Randomized but not treated.|3|||
16158229|NCT03979274|39061599|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16158230|NCT03979274|39061600|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16158231|NCT05490771|39061601|FG000|Overall Study|Disease progression|18|||
16158232|NCT05490771|39061601|FG000|Overall Study|Adverse Event|3|||
16158233|NCT05490771|39061601|FG000|Overall Study|Other complicating disease|1|||
16065727|NCT01939158|38732839|FG000|Overall Study|Adverse Event|1|||
16065728|NCT01939158|38732840|FG001|Overall Study|Adverse Event|0|||
16445554|NCT00538902|40111533|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
16445555|NCT00538902|40111534|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
16445556|NCT00538902|40111535|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
16445557|NCT00538902|40111533|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
16445558|NCT00538902|40111534|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
16158234|NCT05490771|39061601|FG000|Overall Study|Withdrawal by Subject|3|||
16158235|NCT05490771|39061601|FG000|Overall Study|Physician Decision|1|||
16158236|NCT05490771|39061601|FG000|Overall Study|Still on treatment|2|||
16158237|NCT05490771|39061601|FG000|Overall Study|Never start protocol therapy|5|||
16158238|NCT05490771|39061601|FG000|Overall Study|Ineligible|2|||
16158239|NCT02559687|39061602|FG000|Overall Study|Death|112|||
16158240|NCT02559687|39061602|FG000|Overall Study|Sponsor Decision|5|||
16158241|NCT02559687|39061602|FG000|Overall Study|Withdrawal by Subject|4|||
16158242|NCT01395394|39061603|FG000|Baseline Study Visit|Protocol Violation|1|||
16445559|NCT00538902|40111535|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
16445560|NCT00538902|40111533|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
16445561|NCT00538902|40111534|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
16445562|NCT00538902|40111535|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
16445563|NCT00538902|40111533|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
16158243|NCT01395394|39061604|FG001|Baseline Study Visit|Protocol Violation|0|||
16158244|NCT01395394|39061605|FG002|Baseline Study Visit|Protocol Violation|0|||
16368678|NCT01902303|39833273|FG000|Overall Study|Adverse Event|0|||
16368679|NCT01902303|39833274|FG001|Overall Study|Adverse Event|1|||
16368680|NCT01902303|39833273|FG000|Overall Study|Lost to Follow-up|0|||
16368681|NCT01902303|39833274|FG001|Overall Study|Lost to Follow-up|1|||
16368682|NCT01902303|39833273|FG000|Overall Study|Protocol Violation|2|||
16368683|NCT01902303|39833274|FG001|Overall Study|Protocol Violation|2|||
16368684|NCT01902303|39833273|FG000|Overall Study|subject lost investigational product|0|||
16368685|NCT01902303|39833274|FG001|Overall Study|subject lost investigational product|1|||
16368686|NCT01902303|39833273|FG000|Overall Study|Did not develop a cold sore|21|||
16368687|NCT01902303|39833274|FG001|Overall Study|Did not develop a cold sore|19|||
16368688|NCT00552058|39833277|FG000|Overall Study|Adverse Event|8|||
16368689|NCT00552058|39833278|FG001|Overall Study|Adverse Event|7|||
16368690|NCT00552058|39833277|FG000|Overall Study|Lack of Efficacy|1|||
16368691|NCT00552058|39833278|FG001|Overall Study|Lack of Efficacy|5|||
16368692|NCT00552058|39833277|FG000|Overall Study|Lost to Follow-up|1|||
16368693|NCT00552058|39833278|FG001|Overall Study|Lost to Follow-up|0|||
16368694|NCT00552058|39833277|FG000|Overall Study|Withdrawal by Subject|4|||
16368695|NCT00552058|39833278|FG001|Overall Study|Withdrawal by Subject|4|||
16368696|NCT00552058|39833277|FG000|Overall Study|Other: Protocol Violation|0|||
16368697|NCT00552058|39833278|FG001|Overall Study|Other: Protocol Violation|1|||
16368698|NCT00552058|39833277|FG000|Overall Study|Other: Non Compliance|1|||
16368699|NCT00552058|39833278|FG001|Overall Study|Other: Non Compliance|2|||
16368700|NCT00552058|39833277|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
16368701|NCT00552058|39833278|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
16368702|NCT00552058|39833277|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
16368703|NCT00552058|39833278|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
16368704|NCT00552058|39833277|FG000|Overall Study|Other: Positive Stool Result|0|||
16368705|NCT00552058|39833278|FG001|Overall Study|Other: Positive Stool Result|1|||
16368706|NCT00552058|39833277|FG000|Overall Study|Other: Randomized in error|0|||
16368707|NCT00552058|39833278|FG001|Overall Study|Other: Randomized in error|1|||
16368708|NCT00552058|39833277|FG000|Overall Study|Other: Sponsors Decision|0|||
16368709|NCT00552058|39833278|FG001|Overall Study|Other: Sponsors Decision|1|||
16368710|NCT00552058|39833277|FG000|Overall Study|Other: Early Roll Over|1|||
16368711|NCT00552058|39833278|FG001|Overall Study|Other: Early Roll Over|0|||
16368712|NCT01771913|39833279|FG000|Overall Study|Withdrawal by Subject|1|||
16368713|NCT01771913|39833280|FG001|Overall Study|Withdrawal by Subject|0|||
16368714|NCT01757847|39833283|FG000|Overall Study|Withdrawal by Subject|3|||
16368715|NCT01757847|39833284|FG001|Overall Study|Withdrawal by Subject|4|||
16368716|NCT01567085|39833285|FG000|Overall Study|Death|6|||
16368717|NCT01567085|39833285|FG000|Overall Study|Adverse Event|6|||
16368718|NCT01567085|39833285|FG000|Overall Study|Lost to Follow-up|3|||
16368719|NCT01567085|39833285|FG000|Overall Study|Graft loss|2|||
16368720|NCT01567085|39833285|FG000|Overall Study|Renal transplantectomy|1|||
16368721|NCT01567085|39833285|FG000|Overall Study|Returned to chronic dialysis|1|||
16368722|NCT01567085|39833285|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
16368723|NCT01327703|39833291|FG000|Second Treatment Period|Adverse Event|1|||
16368724|NCT01327703|39833292|FG001|Second Treatment Period|Adverse Event|1|||
16368725|NCT01327703|39833291|FG000|Second Treatment Period|Protocol Violation|0|||
16368726|NCT01327703|39833292|FG001|Second Treatment Period|Protocol Violation|1|||
16368727|NCT00120874|39833293|FG000|Overall Study|Death|0|||
16368728|NCT00120874|39833294|FG001|Overall Study|Death|1|||
16445564|NCT00538902|40111534|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
16445565|NCT00538902|40111535|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
16445566|NCT00538902|40111533|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
16445567|NCT00538902|40111534|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
16445568|NCT00538902|40111535|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
16445569|NCT00538902|40111533|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
16445570|NCT00538902|40111534|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
16445571|NCT00538902|40111535|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
16445572|NCT00538902|40111533|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
16445573|NCT00538902|40111534|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
16445574|NCT00538902|40111535|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
16445575|NCT01056822|40111536|FG000|Overall Study|Adverse Event|0|||
16445576|NCT01056822|40111537|FG001|Overall Study|Adverse Event|1|||
16445577|NCT01056822|40111536|FG000|Overall Study|Protocol Violation|6|||
16445578|NCT01056822|40111537|FG001|Overall Study|Protocol Violation|5|||
16445579|NCT01056822|40111536|FG000|Overall Study|Withdrawal by Subject|1|||
16445580|NCT01056822|40111537|FG001|Overall Study|Withdrawal by Subject|1|||
16445581|NCT01056822|40111536|FG000|Overall Study|Lost to Follow-up|1|||
16445582|NCT01056822|40111537|FG001|Overall Study|Lost to Follow-up|0|||
16445583|NCT03944577|40111538|FG000|Overall Study|Adverse Event|3|||
16445584|NCT02458313|40111539|FG000|Overall Study|Withdrawal by Subject|6|||
16445585|NCT02458313|40111540|FG001|Overall Study|Withdrawal by Subject|8|||
16445586|NCT02458313|40111539|FG000|Overall Study|Excluded for motion during MRI|1|||
16445587|NCT02458313|40111540|FG001|Overall Study|Excluded for motion during MRI|2|||
16445588|NCT04106557|40111541|FG000|Overall Study|Physician Decision|0|||
16445589|NCT04106557|40111542|FG001|Overall Study|Physician Decision|1|||
16445590|NCT04106557|40111543|FG002|Overall Study|Physician Decision|0|||
16065729|NCT01939158|38732841|FG002|Overall Study|Adverse Event|0|||
16065730|NCT01939158|38732842|FG003|Overall Study|Adverse Event|0|||
16445591|NCT04106557|40111541|FG000|Overall Study|Protocol Violation|0|||
16445592|NCT04106557|40111542|FG001|Overall Study|Protocol Violation|1|||
16065731|NCT01939158|38732839|FG000|Overall Study|Withdrawal by Subject|22|||
16065732|NCT01939158|38732840|FG001|Overall Study|Withdrawal by Subject|25|||
16065733|NCT01939158|38732841|FG002|Overall Study|Withdrawal by Subject|15|||
16065734|NCT01939158|38732842|FG003|Overall Study|Withdrawal by Subject|17|||
16065735|NCT01939158|38732839|FG000|Overall Study|Migrated/moved from study area|5|||
16065736|NCT01939158|38732840|FG001|Overall Study|Migrated/moved from study area|7|||
16065737|NCT01939158|38732841|FG002|Overall Study|Migrated/moved from study area|3|||
16065738|NCT01939158|38732842|FG003|Overall Study|Migrated/moved from study area|6|||
16065739|NCT01939158|38732839|FG000|Overall Study|Lost to Follow-up|18|||
16065740|NCT01939158|38732840|FG001|Overall Study|Lost to Follow-up|17|||
16065741|NCT01939158|38732841|FG002|Overall Study|Lost to Follow-up|17|||
16065742|NCT01939158|38732842|FG003|Overall Study|Lost to Follow-up|17|||
16065743|NCT01939158|38732839|FG000|Overall Study|Death|0|||
16065744|NCT01939158|38732840|FG001|Overall Study|Death|0|||
16065745|NCT01939158|38732841|FG002|Overall Study|Death|1|||
16065746|NCT01939158|38732842|FG003|Overall Study|Death|1|||
16065747|NCT01939158|38732839|FG000|Overall Study|No longer meets eligibility criteria|0|||
16065748|NCT01939158|38732840|FG001|Overall Study|No longer meets eligibility criteria|0|||
16065749|NCT01939158|38732841|FG002|Overall Study|No longer meets eligibility criteria|1|||
16065750|NCT01939158|38732842|FG003|Overall Study|No longer meets eligibility criteria|0|||
16158245|NCT02770547|39061609|FG000|Overall Study|Patient non-compliant|1|||
16445593|NCT04106557|40111543|FG002|Overall Study|Protocol Violation|0|||
16445594|NCT00004563|40111560|FG000|Overall Study|Withdrawal by Subject|20|||
16445595|NCT00004563|40111561|FG001|Overall Study|Withdrawal by Subject|16|||
16445596|NCT00004563|40111560|FG000|Overall Study|Lack of Efficacy|3|||
16445597|NCT00004563|40111561|FG001|Overall Study|Lack of Efficacy|5|||
16445598|NCT00004563|40111560|FG000|Overall Study|Death|2|||
16445599|NCT00004563|40111561|FG001|Overall Study|Death|3|||
16445600|NCT02419001|40111563|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
16445601|NCT02419001|40111564|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
16445602|NCT04634253|40111568|FG000|Overall Study|Adverse Event|1|||
16445603|NCT04634253|40111569|FG001|Overall Study|Adverse Event|1|||
16445604|NCT04634253|40111570|FG002|Overall Study|Adverse Event|0|||
16445605|NCT04634253|40111568|FG000|Overall Study|Physician Decision|0|||
16445606|NCT04634253|40111569|FG001|Overall Study|Physician Decision|1|||
16445607|NCT04634253|40111570|FG002|Overall Study|Physician Decision|0|||
16445608|NCT04634253|40111568|FG000|Overall Study|Withdrawal by Subject|1|||
16445609|NCT04634253|40111569|FG001|Overall Study|Withdrawal by Subject|0|||
16445610|NCT04634253|40111570|FG002|Overall Study|Withdrawal by Subject|3|||
16065751|NCT01939158|38732839|FG000|Overall Study|Other|1|||
16065752|NCT01939158|38732840|FG001|Overall Study|Other|3|||
16065753|NCT01939158|38732841|FG002|Overall Study|Other|4|||
16065754|NCT01939158|38732842|FG003|Overall Study|Other|3|||
16065755|NCT04011384|38732843|FG000|Overall Study|Withdrawal by Subject|2|||
16445611|NCT03780244|40111575|FG000|Overall Study|Lost to Follow-up|1|||
16445612|NCT03780244|40111576|FG001|Overall Study|Lost to Follow-up|0|||
16445613|NCT01980017|40111577|FG000|Overall Study|Lost to Follow-up|30|||
16445614|NCT01980017|40111578|FG001|Overall Study|Lost to Follow-up|21|||
16445615|NCT01980017|40111577|FG000|Overall Study|Death|0|||
16445616|NCT01980017|40111578|FG001|Overall Study|Death|1|||
16445617|NCT00361296|40111580|FG000|Overall Study|Physician Decision|1|||
16445618|NCT00361296|40111580|FG000|Overall Study|Lack of Efficacy|2|||
16445619|NCT01615939|40111587|FG000|Overall Study|Lost to Follow-up|5|||
16445620|NCT01615939|40111588|FG001|Overall Study|Lost to Follow-up|0|||
16445621|NCT02158442|40111589|FG000|Overall Study|Withdrawal by Subject|1|||
16445622|NCT02158442|40111590|FG001|Overall Study|Withdrawal by Subject|0|||
16445623|NCT02158442|40111589|FG000|Overall Study|Perfusion staff not available|1|||
16445624|NCT02158442|40111590|FG001|Overall Study|Perfusion staff not available|0|||
16445625|NCT02807402|40111593|FG000|Overall Study|Failure to Return|1|||
16445626|NCT02807402|40111593|FG000|Overall Study|Death|3|||
16445627|NCT02807402|40111593|FG000|Overall Study|Other|2|||
16445628|NCT01347112|40111594|FG000|Overall Study|Withdrawal by Subject|1|||
16445629|NCT01347112|40111595|FG001|Overall Study|Withdrawal by Subject|7|||
16158246|NCT02770547|39061610|FG001|Overall Study|Patient non-compliant|0|||
16158247|NCT02770547|39061609|FG000|Overall Study|Adverse Event|0|||
16158248|NCT02770547|39061610|FG001|Overall Study|Adverse Event|1|||
16158249|NCT00205855|39061612|FG000|Overall Study|Only received temporary implants|16|||
16158250|NCT00205855|39061612|FG000|Overall Study|Withdrawal by Subject|5|||
16158251|NCT01870401|39061615|FG000|Overall Study|Death|48|||
16158252|NCT01870401|39061616|FG001|Overall Study|Death|24|||
16158253|NCT01870401|39061615|FG000|Overall Study|Withdrawal by Subject|39|||
16158254|NCT01870401|39061616|FG001|Overall Study|Withdrawal by Subject|26|||
16158255|NCT01870401|39061615|FG000|Overall Study|Lost to Follow-up|19|||
16158256|NCT01870401|39061616|FG001|Overall Study|Lost to Follow-up|14|||
16445630|NCT01347112|40111594|FG000|Overall Study|Lost to Follow-up|3|||
16445631|NCT01347112|40111595|FG001|Overall Study|Lost to Follow-up|5|||
16445632|NCT00914849|40111600|FG000|Overall Study|Withdrawal by Subject|1|||
16445633|NCT00914849|40111601|FG001|Overall Study|Withdrawal by Subject|0|||
16445634|NCT00914849|40111600|FG000|Overall Study|Not eligible|0|||
16445635|NCT00914849|40111601|FG001|Overall Study|Not eligible|1|||
16445636|NCT05038982|40111610|FG000|Overall Study|Withdrawal by Subject|0|||
16445637|NCT05038982|40111611|FG001|Overall Study|Withdrawal by Subject|2|||
16445638|NCT00630838|40111612|FG000|Overall Study|Death|0|||
16445639|NCT00630838|40111613|FG001|Overall Study|Death|1|||
16445640|NCT00630838|40111612|FG000|Overall Study|Lost to Follow-up|0|||
16445641|NCT00630838|40111613|FG001|Overall Study|Lost to Follow-up|1|||
16445642|NCT03011099|40111615|FG000|Overall Study|Withdrawal by Subject|0|||
16445643|NCT03011099|40111616|FG001|Overall Study|Withdrawal by Subject|2|||
16445644|NCT02536976|40111617|FG000|Overall Study|Physician Decision|0|||
16445645|NCT02536976|40111618|FG001|Overall Study|Physician Decision|1|||
16445646|NCT00696072|40111619|FG000|Overall Study|continuing active treatment|10|||
16445647|NCT00696072|40111620|FG001|Overall Study|continuing active treatment|13|||
16445648|NCT00696072|40111619|FG000|Overall Study|Adverse Event|10|||
16445649|NCT00696072|40111620|FG001|Overall Study|Adverse Event|6|||
16445650|NCT00696072|40111619|FG000|Overall Study|Patient Request|3|||
16445651|NCT00696072|40111620|FG001|Overall Study|Patient Request|7|||
16445652|NCT00696072|40111619|FG000|Overall Study|Investigator Request|1|||
16445653|NCT00696072|40111620|FG001|Overall Study|Investigator Request|4|||
16445654|NCT00696072|40111619|FG000|Overall Study|Sponsor Request|0|||
16445655|NCT00696072|40111620|FG001|Overall Study|Sponsor Request|1|||
16445656|NCT00696072|40111619|FG000|Overall Study|Disease Progression|32|||
16445657|NCT00696072|40111620|FG001|Overall Study|Disease Progression|30|||
16445658|NCT00696072|40111619|FG000|Overall Study|Non-specified|1|||
16445659|NCT00696072|40111620|FG001|Overall Study|Non-specified|2|||
16445660|NCT02420821|40111621|FG000|Overall Study|Lost to Follow-up|6|||
16445661|NCT02420821|40111622|FG001|Overall Study|Lost to Follow-up|6|||
16445662|NCT02420821|40111621|FG000|Overall Study|Non-compliance|0|||
16445663|NCT02420821|40111622|FG001|Overall Study|Non-compliance|2|||
16445664|NCT02420821|40111621|FG000|Overall Study|Physician Decision|6|||
16445665|NCT02420821|40111622|FG001|Overall Study|Physician Decision|2|||
16445666|NCT02420821|40111621|FG000|Overall Study|Withdrawal by Subject|32|||
16445667|NCT02420821|40111622|FG001|Overall Study|Withdrawal by Subject|25|||
16445668|NCT02420821|40111621|FG000|Overall Study|Death|270|||
16445669|NCT02420821|40111622|FG001|Overall Study|Death|263|||
16158257|NCT01870401|39061615|FG000|Overall Study|Other|9|||
16158258|NCT01870401|39061616|FG001|Overall Study|Other|7|||
16158259|NCT01870401|39061615|FG000|Overall Study|On-going in the Study|35|||
16158260|NCT01870401|39061616|FG001|Overall Study|On-going in the Study|25|||
16158261|NCT02486757|39061617|FG000|Overall Study|Lost to Follow-up|1|||
16445670|NCT02420821|40111621|FG000|Overall Study|Study Terminated By Sponsor|145|||
16445671|NCT02420821|40111622|FG001|Overall Study|Study Terminated By Sponsor|149|||
16445672|NCT02420821|40111621|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
16445673|NCT02420821|40111622|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
16445674|NCT02420821|40111621|FG000|Overall Study|Adverse Event|0|||
16445675|NCT02420821|40111622|FG001|Overall Study|Adverse Event|1|||
16445676|NCT02420821|40111621|FG000|Overall Study|Protinuria|0|||
16445677|NCT02420821|40111622|FG001|Overall Study|Protinuria|1|||
16445678|NCT02420821|40111621|FG000|Overall Study|Progressive Disease|1|||
16445679|NCT02420821|40111622|FG001|Overall Study|Progressive Disease|1|||
16445680|NCT02420821|40111621|FG000|Overall Study|Disease Progression|0|||
16445681|NCT02420821|40111622|FG001|Overall Study|Disease Progression|1|||
16445682|NCT02420821|40111621|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
16445683|NCT02420821|40111622|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
16445684|NCT03361137|40111625|FG000|Overall Study|Reason not specified|1|||
16445685|NCT03361137|40111626|FG001|Overall Study|Reason not specified|0|||
16445686|NCT03361137|40111627|FG002|Overall Study|Reason not specified|0|||
16445687|NCT03361137|40111628|FG003|Overall Study|Reason not specified|0|||
16445688|NCT03361137|40111629|FG004|Overall Study|Reason not specified|0|||
16445689|NCT01959503|40111631|FG000|Overall Study|Death|2|||
16445690|NCT01959503|40111632|FG001|Overall Study|Death|1|||
16445691|NCT01959503|40111631|FG000|Overall Study|Randomized but not treated|1|||
16445692|NCT01959503|40111632|FG001|Overall Study|Randomized but not treated|1|||
16445693|NCT04411667|40111644|FG000|Overall Study|Physician Decision|1|||
16445694|NCT04411667|40111645|FG001|Overall Study|Physician Decision|0|||
16445695|NCT00885170|40111647|FG000|Overall Study|Adverse Event|12|||
16445696|NCT00885170|40111648|FG001|Overall Study|Adverse Event|4|||
16445697|NCT00885170|40111647|FG000|Overall Study|Excessive bone loss|6|||
16445698|NCT00885170|40111648|FG001|Overall Study|Excessive bone loss|3|||
16445699|NCT00885170|40111647|FG000|Overall Study|Lost to Follow-up|2|||
16445700|NCT00885170|40111648|FG001|Overall Study|Lost to Follow-up|1|||
16445701|NCT00885170|40111647|FG000|Overall Study|Physician Decision|2|||
16445702|NCT00885170|40111648|FG001|Overall Study|Physician Decision|1|||
16445703|NCT00885170|40111647|FG000|Overall Study|Protocol Violation|3|||
16445704|NCT00885170|40111648|FG001|Overall Study|Protocol Violation|1|||
16445705|NCT00885170|40111647|FG000|Overall Study|Withdrawal by Subject|13|||
16445706|NCT00885170|40111648|FG001|Overall Study|Withdrawal by Subject|13|||
16445707|NCT00763035|40111651|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
16445708|NCT00763035|40111652|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
16445709|NCT00763035|40111651|FG000|First Intervention|Adverse Event|0|||
16445710|NCT00763035|40111652|FG001|First Intervention|Adverse Event|1|||
16445711|NCT00763035|40111651|FG000|Second Intervention|Adverse Event|1|||
16445712|NCT00763035|40111652|FG001|Second Intervention|Adverse Event|0|||
16445713|NCT00763035|40111651|FG000|Second Intervention|Physician Decision|2|||
16445714|NCT00763035|40111652|FG001|Second Intervention|Physician Decision|0|||
16445715|NCT01600326|40111653|FG000|Overall Study|Lost to Follow-up|1|||
16445716|NCT01600326|40111654|FG001|Overall Study|Lost to Follow-up|1|||
16445717|NCT00453206|40111656|FG000|Overall Study|Death|1|||
16445718|NCT04498832|40111657|FG000|Overall Study|Adverse Event|1|||
16445719|NCT04498832|40111658|FG001|Overall Study|Adverse Event|3|||
16445720|NCT04498832|40111657|FG000|Overall Study|Withdrawal by Subject|0|||
16445721|NCT04498832|40111658|FG001|Overall Study|Withdrawal by Subject|1|||
16445722|NCT00303069|40111659|FG000|Overall Study|Lost to Follow-up|1|||
16445723|NCT00303069|40111660|FG001|Overall Study|Lost to Follow-up|0|||
16445724|NCT00303069|40111661|FG002|Overall Study|Lost to Follow-up|0|||
16445725|NCT00303069|40111662|FG003|Overall Study|Lost to Follow-up|2|||
16445726|NCT00303069|40111659|FG000|Overall Study|subject moved|1|||
16445727|NCT00303069|40111660|FG001|Overall Study|subject moved|0|||
16445728|NCT00303069|40111661|FG002|Overall Study|subject moved|0|||
16445729|NCT00303069|40111662|FG003|Overall Study|subject moved|0|||
16445730|NCT00303069|40111659|FG000|Overall Study|Recruitment into Army Reserves|0|||
16445731|NCT00303069|40111660|FG001|Overall Study|Recruitment into Army Reserves|0|||
16445732|NCT00303069|40111661|FG002|Overall Study|Recruitment into Army Reserves|1|||
16445733|NCT00303069|40111662|FG003|Overall Study|Recruitment into Army Reserves|0|||
16445734|NCT01149096|40111666|FG000|Overall Study|Lost to Follow-up|0|||
16445735|NCT01149096|40111667|FG001|Overall Study|Lost to Follow-up|1|||
16445736|NCT00966654|40111668|FG000|Overall Study|Study was terminated,PI left institution|12|||
16445737|NCT00904982|40111669|FG000|Overall Study|Withdrawal by Subject|2|||
16445738|NCT00904982|40111670|FG001|Overall Study|Withdrawal by Subject|0|||
16445739|NCT00904982|40111671|FG002|Overall Study|Withdrawal by Subject|0|||
16445740|NCT00904982|40111672|FG003|Overall Study|Withdrawal by Subject|0|||
16445741|NCT01389596|40111673|FG000|Overall Study|Protocol Violation|3|||
16445742|NCT01389596|40111674|FG001|Overall Study|Protocol Violation|4|||
16445743|NCT01389596|40111675|FG002|Overall Study|Protocol Violation|3|||
16445744|NCT01389596|40111673|FG000|Overall Study|Withdrawal by Subject|1|||
16445745|NCT01389596|40111674|FG001|Overall Study|Withdrawal by Subject|2|||
16445746|NCT01389596|40111675|FG002|Overall Study|Withdrawal by Subject|2|||
16445747|NCT01389596|40111673|FG000|Overall Study|Insufficient Clinical Response|3|||
16445748|NCT01389596|40111674|FG001|Overall Study|Insufficient Clinical Response|4|||
16445749|NCT01389596|40111675|FG002|Overall Study|Insufficient Clinical Response|5|||
16445750|NCT01389596|40111673|FG000|Overall Study|Adverse Event|1|||
16065756|NCT04011384|38732844|FG001|Overall Study|Withdrawal by Subject|0|||
16065757|NCT02347943|38732845|FG000|Overall Study|Study was cancelled|140|||
16065758|NCT02347943|38732846|FG001|Overall Study|Study was cancelled|67|||
16065759|NCT02347943|38732847|FG002|Overall Study|Study was cancelled|45|||
16065760|NCT00751790|38732848|FG000|Overall Study|Lost to Follow-up|1|||
16065761|NCT00751790|38732848|FG000|Overall Study|Death|3|||
16158262|NCT01060059|39061619|FG000|Overall Study|Adverse Event|1|||
16158263|NCT01060059|39061620|FG001|Overall Study|Adverse Event|1|||
16158264|NCT01060059|39061619|FG000|Overall Study|Death|2|||
16158265|NCT01060059|39061620|FG001|Overall Study|Death|3|||
16158266|NCT01060059|39061619|FG000|Overall Study|Lost to Follow-up|18|||
16158267|NCT01060059|39061620|FG001|Overall Study|Lost to Follow-up|34|||
16158268|NCT01060059|39061619|FG000|Overall Study|entry criteria not met|4|||
16158269|NCT01060059|39061620|FG001|Overall Study|entry criteria not met|3|||
16158270|NCT01060059|39061619|FG000|Overall Study|Withdrawal by Subject|35|||
16158271|NCT01060059|39061620|FG001|Overall Study|Withdrawal by Subject|23|||
16158272|NCT01060059|39061619|FG000|Overall Study|lack of glycemic control|2|||
16158273|NCT01060059|39061620|FG001|Overall Study|lack of glycemic control|1|||
16158274|NCT01060059|39061619|FG000|Overall Study|lack of compliance|5|||
16158275|NCT01060059|39061620|FG001|Overall Study|lack of compliance|2|||
16065762|NCT00751790|38732848|FG000|Overall Study|Withdrawal by Subject|1|||
16065763|NCT03582137|38732849|FG000|Overall Study|Adverse Event|1|||
16158276|NCT01908101|39061621|FG000|Overall Study|Physician Decision|1|||
16158277|NCT01908101|39061621|FG000|Overall Study|Withdrawal by Subject|1|||
16158278|NCT01908101|39061621|FG000|Overall Study|Incorrect Diagnosis|2|||
16158279|NCT01908101|39061621|FG000|Overall Study|Incorrect Starting Dose|1|||
16158280|NCT01908101|39061621|FG000|Overall Study|Did not complete the first cycle|4|||
16158281|NCT03665285|39061633|FG000|Overall Study|Started New Anticancer Treatment|1|||
16158282|NCT03665285|39061634|FG001|Overall Study|Started New Anticancer Treatment|1|||
16158283|NCT03665285|39061635|FG002|Overall Study|Started New Anticancer Treatment|2|||
16158284|NCT03665285|39061636|FG003|Overall Study|Started New Anticancer Treatment|4|||
16158285|NCT03665285|39061637|FG004|Overall Study|Started New Anticancer Treatment|1|||
16158286|NCT03665285|39061638|FG005|Overall Study|Started New Anticancer Treatment|1|||
16158287|NCT03665285|39061639|FG006|Overall Study|Started New Anticancer Treatment|2|||
16158288|NCT03665285|39061640|FG007|Overall Study|Started New Anticancer Treatment|15|||
16158289|NCT03665285|39061641|FG008|Overall Study|Started New Anticancer Treatment|1|||
16158290|NCT03665285|39061633|FG000|Overall Study|Disease Progression|0|||
16158291|NCT03665285|39061634|FG001|Overall Study|Disease Progression|0|||
16158292|NCT03665285|39061635|FG002|Overall Study|Disease Progression|3|||
16158293|NCT03665285|39061636|FG003|Overall Study|Disease Progression|1|||
16158294|NCT03665285|39061637|FG004|Overall Study|Disease Progression|0|||
16158295|NCT03665285|39061638|FG005|Overall Study|Disease Progression|0|||
16158296|NCT03665285|39061639|FG006|Overall Study|Disease Progression|0|||
16158297|NCT03665285|39061640|FG007|Overall Study|Disease Progression|7|||
16158298|NCT03665285|39061641|FG008|Overall Study|Disease Progression|1|||
16158299|NCT03665285|39061633|FG000|Overall Study|Hospice|0|||
16158300|NCT03665285|39061634|FG001|Overall Study|Hospice|0|||
16158301|NCT03665285|39061635|FG002|Overall Study|Hospice|0|||
16158302|NCT03665285|39061636|FG003|Overall Study|Hospice|0|||
16368729|NCT01049828|39833295|FG000|Overall Study|Claustrophibia and Frustration|2|||
16368730|NCT04339972|39833296|FG000|Overall Study|Scheduling Issues|3|||
16368731|NCT04339972|39833297|FG001|Overall Study|Scheduling Issues|3|||
16368732|NCT04339972|39833296|FG000|Overall Study|dropout|1|||
16368733|NCT04339972|39833297|FG001|Overall Study|dropout|1|||
16368734|NCT04339972|39833296|FG000|Overall Study|Technical issues|1|||
16368735|NCT04339972|39833297|FG001|Overall Study|Technical issues|0|||
16368736|NCT04339972|39833296|FG000|Overall Study|Claustraphobia|0|||
16065764|NCT03582137|38732850|FG001|Overall Study|Adverse Event|0|||
16065765|NCT01124617|38732854|FG000|Overall Study|Adverse Event|5|||
16065766|NCT01124617|38732855|FG001|Overall Study|Adverse Event|2|||
16065767|NCT01124617|38732854|FG000|Overall Study|Lack of Efficacy|2|||
16065768|NCT01124617|38732855|FG001|Overall Study|Lack of Efficacy|1|||
16065769|NCT01124617|38732854|FG000|Overall Study|Protocol Violation|1|||
16065770|NCT01124617|38732855|FG001|Overall Study|Protocol Violation|1|||
16065771|NCT01124617|38732854|FG000|Overall Study|Withdrawal by Subject|9|||
16065772|NCT01124617|38732855|FG001|Overall Study|Withdrawal by Subject|1|||
16158303|NCT03665285|39061637|FG004|Overall Study|Hospice|0|||
16158304|NCT03665285|39061638|FG005|Overall Study|Hospice|0|||
16158305|NCT03665285|39061639|FG006|Overall Study|Hospice|0|||
16158306|NCT03665285|39061640|FG007|Overall Study|Hospice|2|||
16158307|NCT03665285|39061641|FG008|Overall Study|Hospice|0|||
16158308|NCT03665285|39061633|FG000|Overall Study|Withdrawal by Subject|0|||
16158309|NCT03665285|39061634|FG001|Overall Study|Withdrawal by Subject|0|||
16065773|NCT01124617|38732854|FG000|Overall Study|Other|2|||
16065774|NCT01124617|38732855|FG001|Overall Study|Other|1|||
16065775|NCT03836664|38732856|FG000|Overall Study|Didn't complete forms and lost drug|3|||
16065776|NCT03836664|38732857|FG001|Overall Study|Didn't complete forms and lost drug|3|||
16065777|NCT02368886|38732861|FG000|Overall Study|Cancel|1|||
16368737|NCT04339972|39833297|FG001|Overall Study|Claustraphobia|1|||
16158310|NCT03665285|39061635|FG002|Overall Study|Withdrawal by Subject|0|||
16158311|NCT03665285|39061636|FG003|Overall Study|Withdrawal by Subject|0|||
16158312|NCT03665285|39061637|FG004|Overall Study|Withdrawal by Subject|1|||
16158313|NCT03665285|39061638|FG005|Overall Study|Withdrawal by Subject|0|||
16158314|NCT03665285|39061639|FG006|Overall Study|Withdrawal by Subject|0|||
16158315|NCT03665285|39061640|FG007|Overall Study|Withdrawal by Subject|2|||
16158316|NCT03665285|39061641|FG008|Overall Study|Withdrawal by Subject|0|||
16158317|NCT03665285|39061633|FG000|Overall Study|Physician Decision|0|||
16158318|NCT03665285|39061634|FG001|Overall Study|Physician Decision|0|||
16158319|NCT03665285|39061635|FG002|Overall Study|Physician Decision|0|||
16158320|NCT03665285|39061636|FG003|Overall Study|Physician Decision|0|||
16158321|NCT03665285|39061637|FG004|Overall Study|Physician Decision|0|||
16158322|NCT03665285|39061638|FG005|Overall Study|Physician Decision|0|||
16158323|NCT03665285|39061639|FG006|Overall Study|Physician Decision|0|||
16158324|NCT03665285|39061640|FG007|Overall Study|Physician Decision|2|||
16158325|NCT03665285|39061641|FG008|Overall Study|Physician Decision|0|||
16158326|NCT01338415|39061642|FG000|Core + Extension|Adverse Event|8|||
16158327|NCT01338415|39061643|FG001|Core + Extension|Adverse Event|6|||
16158328|NCT01338415|39061644|FG002|Core + Extension|Adverse Event|0|||
16158329|NCT01338415|39061642|FG000|Core + Extension|Withdrawal by Subject|1|||
16158330|NCT01338415|39061643|FG001|Core + Extension|Withdrawal by Subject|1|||
16158331|NCT01338415|39061644|FG002|Core + Extension|Withdrawal by Subject|0|||
16158332|NCT01338415|39061642|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
16158333|NCT01338415|39061643|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
16158334|NCT01338415|39061644|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
16158335|NCT01338415|39061642|FG000|Core + Extension|Other (administrative reason)|1|||
16158336|NCT01338415|39061643|FG001|Core + Extension|Other (administrative reason)|0|||
16158337|NCT01338415|39061644|FG002|Core + Extension|Other (administrative reason)|0|||
16158338|NCT01338415|39061642|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
16158339|NCT01338415|39061643|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
16158340|NCT01338415|39061644|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
16158341|NCT01338415|39061642|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
16158342|NCT01338415|39061643|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
16158343|NCT01338415|39061644|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
16158344|NCT01338415|39061642|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
16158345|NCT01338415|39061643|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
16158346|NCT01338415|39061644|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
16158347|NCT01338415|39061642|FG000|Exceptional Use Treatment Period|Death|0|||
16158348|NCT01338415|39061643|FG001|Exceptional Use Treatment Period|Death|0|||
16158349|NCT01338415|39061644|FG002|Exceptional Use Treatment Period|Death|1|||
16158350|NCT02595450|39061645|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
16158351|NCT02595450|39061645|FG000|Overall Study|Enrolled, but not treated|8|||
16158352|NCT00179309|39061646|FG000|Treatment|Toxicity|2|||
16158353|NCT00179309|39061647|FG001|Treatment|Toxicity|3|||
16158354|NCT00179309|39061646|FG000|Treatment|Withdrawal by Subject|1|||
16158355|NCT00179309|39061647|FG001|Treatment|Withdrawal by Subject|2|||
16158356|NCT00179309|39061646|FG000|Treatment|Allergy|1|||
16158357|NCT00179309|39061647|FG001|Treatment|Allergy|0|||
16158358|NCT04191382|39061648|FG000|Overall Study|Withdrawal by Subject|1|||
16158359|NCT04191382|39061649|FG001|Overall Study|Withdrawal by Subject|0|||
16158360|NCT04191382|39061650|FG002|Overall Study|Withdrawal by Subject|0|||
16158361|NCT00841763|39061651|FG000|Overall Study|Withdrawal by Subject|60|||
16158362|NCT00841763|39061652|FG001|Overall Study|Withdrawal by Subject|17|||
16158363|NCT00841763|39061653|FG002|Overall Study|Withdrawal by Subject|4|||
16158364|NCT00841763|39061654|FG003|Overall Study|Withdrawal by Subject|1|||
16158365|NCT00841763|39061651|FG000|Overall Study|Adverse Event|9|||
16158366|NCT00841763|39061652|FG001|Overall Study|Adverse Event|10|||
16158367|NCT00841763|39061653|FG002|Overall Study|Adverse Event|3|||
16158368|NCT00841763|39061654|FG003|Overall Study|Adverse Event|2|||
16158369|NCT00841763|39061651|FG000|Overall Study|Lost to Follow-up|63|||
16158370|NCT00841763|39061652|FG001|Overall Study|Lost to Follow-up|25|||
16158371|NCT00841763|39061653|FG002|Overall Study|Lost to Follow-up|0|||
16158372|NCT00841763|39061654|FG003|Overall Study|Lost to Follow-up|0|||
16158373|NCT00841763|39061651|FG000|Overall Study|Protocol Violation|20|||
16158374|NCT00841763|39061652|FG001|Overall Study|Protocol Violation|3|||
16158375|NCT00841763|39061653|FG002|Overall Study|Protocol Violation|1|||
16158376|NCT00841763|39061654|FG003|Overall Study|Protocol Violation|0|||
16158377|NCT00841763|39061651|FG000|Overall Study|Administrative Reasons|3|||
16158378|NCT00841763|39061652|FG001|Overall Study|Administrative Reasons|1|||
16158379|NCT00841763|39061653|FG002|Overall Study|Administrative Reasons|0|||
16158380|NCT00841763|39061654|FG003|Overall Study|Administrative Reasons|0|||
16158381|NCT00841763|39061651|FG000|Overall Study|Unable to Classify|7|||
16158382|NCT00841763|39061652|FG001|Overall Study|Unable to Classify|1|||
16158383|NCT00841763|39061653|FG002|Overall Study|Unable to Classify|0|||
16065778|NCT02368886|38732862|FG001|Overall Study|Cancel|1|||
16158384|NCT00841763|39061654|FG003|Overall Study|Unable to Classify|0|||
16158385|NCT00623480|39064793|FG000|Overall Study|Lost to Follow-up|0|||
16158386|NCT00623480|39064794|FG001|Overall Study|Lost to Follow-up|1|||
16158387|NCT00623480|39064793|FG000|Overall Study|Withdrawal by Subject|2|||
16158388|NCT00623480|39064794|FG001|Overall Study|Withdrawal by Subject|4|||
16158389|NCT00623480|39064793|FG000|Overall Study|Lack of Efficacy|1|||
16158390|NCT00623480|39064794|FG001|Overall Study|Lack of Efficacy|0|||
16158391|NCT00623480|39064793|FG000|Overall Study|Non-compliant with study medication|4|||
16158392|NCT00623480|39064794|FG001|Overall Study|Non-compliant with study medication|0|||
16158393|NCT00623480|39064793|FG000|Overall Study|Protocol Violation|0|||
16158394|NCT00623480|39064794|FG001|Overall Study|Protocol Violation|1|||
16158395|NCT00623480|39064793|FG000|Overall Study|Site closed by sponsor|0|||
16158396|NCT00623480|39064794|FG001|Overall Study|Site closed by sponsor|1|||
16158397|NCT01514682|39064795|FG000|Overall Study|Withdrawal by Subject|2|||
16158398|NCT01514682|39064796|FG001|Overall Study|Withdrawal by Subject|3|||
16158399|NCT01514682|39064795|FG000|Overall Study|Physician Decision|4|||
16158400|NCT01514682|39064796|FG001|Overall Study|Physician Decision|3|||
16158401|NCT02068547|39064802|FG000|Overall Study|Lost to Follow-up|3|||
16158402|NCT02068547|39064803|FG001|Overall Study|Lost to Follow-up|3|||
16158403|NCT02068547|39064802|FG000|Overall Study|Physician Decision|1|||
16158404|NCT02068547|39064803|FG001|Overall Study|Physician Decision|0|||
16158405|NCT02828358|39064809|FG000|Overall Study|Physician Decision|7|||
16158406|NCT02828358|39064810|FG001|Overall Study|Physician Decision|1|||
16158407|NCT02828358|39064809|FG000|Overall Study|Treatment Failure|6|||
16158408|NCT02828358|39064810|FG001|Overall Study|Treatment Failure|0|||
16158409|NCT02828358|39064809|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
16158410|NCT02828358|39064810|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
16158411|NCT02828358|39064809|FG000|Overall Study|Refusal of further protocol therapy|2|||
16158412|NCT02828358|39064810|FG001|Overall Study|Refusal of further protocol therapy|0|||
16158413|NCT02828358|39064809|FG000|Overall Study|Relapse|25|||
16158414|NCT02828358|39064810|FG001|Overall Study|Relapse|0|||
16158415|NCT02828358|39064809|FG000|Overall Study|Still on therapy|5|||
16158416|NCT02828358|39064810|FG001|Overall Study|Still on therapy|0|||
16158417|NCT01445678|39064815|FG000|Overall Study|Adverse Event|12|||
16158418|NCT01445678|39064816|FG001|Overall Study|Adverse Event|8|||
16158419|NCT01445678|39064815|FG000|Overall Study|Lack of Efficacy|0|||
16158420|NCT01445678|39064816|FG001|Overall Study|Lack of Efficacy|2|||
16158421|NCT01445678|39064815|FG000|Overall Study|Lost to Follow-up|8|||
16158422|NCT01445678|39064816|FG001|Overall Study|Lost to Follow-up|5|||
16158423|NCT01445678|39064815|FG000|Overall Study|Protocol Violation|1|||
16158424|NCT01445678|39064816|FG001|Overall Study|Protocol Violation|1|||
16158425|NCT01445678|39064815|FG000|Overall Study|Withdrawal by Subject|9|||
16158426|NCT01445678|39064816|FG001|Overall Study|Withdrawal by Subject|5|||
16158427|NCT01035905|39064817|FG000|Overall Study|Lack of Efficacy|1|||
16158428|NCT01035905|39064818|FG001|Overall Study|Lack of Efficacy|1|||
16158429|NCT01978093|39064819|FG000|Overall Study|Death|1|||
16158430|NCT01978093|39064820|FG001|Overall Study|Death|0|||
16158431|NCT01978093|39064819|FG000|Overall Study|Adverse Event|0|||
16158432|NCT01978093|39064820|FG001|Overall Study|Adverse Event|5|||
16158433|NCT01978093|39064819|FG000|Overall Study|Protocol Violation|8|||
16158434|NCT01978093|39064820|FG001|Overall Study|Protocol Violation|2|||
16158435|NCT01978093|39064819|FG000|Overall Study|Withdrawal by Subject|29|||
16158436|NCT01978093|39064820|FG001|Overall Study|Withdrawal by Subject|25|||
16158437|NCT01978093|39064819|FG000|Overall Study|Lost to Follow-up|11|||
16158438|NCT01978093|39064820|FG001|Overall Study|Lost to Follow-up|15|||
16158439|NCT01978093|39064819|FG000|Overall Study|Migrated/moved from study area|11|||
16158440|NCT01978093|39064820|FG001|Overall Study|Migrated/moved from study area|13|||
16158441|NCT01978093|39064819|FG000|Overall Study|Loss of kaiser coverage|4|||
16158442|NCT01978093|39064820|FG001|Overall Study|Loss of kaiser coverage|10|||
16158443|NCT01978093|39064819|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
16158444|NCT01978093|39064820|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
16158445|NCT01978093|39064819|FG000|Overall Study|Mother lost custody of child|0|||
16158446|NCT01978093|39064820|FG001|Overall Study|Mother lost custody of child|1|||
16158447|NCT01978093|39064819|FG000|Overall Study|Child was in care of grandmother|0|||
16158448|NCT01978093|39064820|FG001|Overall Study|Child was in care of grandmother|1|||
16158449|NCT01978093|39064819|FG000|Overall Study|N/A for vaccine administration|0|||
16368738|NCT01227395|39833298|FG000|Overall Study|Protocol Violation|0|||
16158450|NCT01978093|39064820|FG001|Overall Study|N/A for vaccine administration|1|||
16158451|NCT01534533|39064821|FG000|Overall Study|Lost to Follow-up|3|||
16158452|NCT01534533|39064822|FG001|Overall Study|Lost to Follow-up|0|||
16368739|NCT01227395|39833299|FG001|Overall Study|Protocol Violation|1|||
16158453|NCT01534533|39064823|FG002|Overall Study|Lost to Follow-up|4|||
16158454|NCT01534533|39064824|FG003|Overall Study|Lost to Follow-up|3|||
16158455|NCT01534533|39064821|FG000|Overall Study|Withdrawal by Subject|5|||
16158456|NCT01534533|39064822|FG001|Overall Study|Withdrawal by Subject|3|||
16065779|NCT02368886|38732863|FG002|Overall Study|Cancel|1|||
16158457|NCT01534533|39064823|FG002|Overall Study|Withdrawal by Subject|4|||
16368740|NCT03022630|39833303|FG000|Overall Study|Death|9|||
16158458|NCT01534533|39064824|FG003|Overall Study|Withdrawal by Subject|1|||
16158459|NCT01929408|39064828|FG000|Overall Study|received HCT as initial treatment|8|||
16158460|NCT00433329|39064829|FG000|Overall Study|Adverse Event|9|||
16445751|NCT01389596|40111674|FG001|Overall Study|Adverse Event|4|||
16445752|NCT01389596|40111675|FG002|Overall Study|Adverse Event|0|||
16445753|NCT01389596|40111673|FG000|Overall Study|Death|0|||
16445754|NCT01389596|40111674|FG001|Overall Study|Death|1|||
16445755|NCT01389596|40111675|FG002|Overall Study|Death|0|||
16445756|NCT01389596|40111673|FG000|Overall Study|Other Unspecified|2|||
16065780|NCT02368886|38732864|FG003|Overall Study|Cancel|3|||
16065781|NCT02368886|38732861|FG000|Overall Study|Ineligible|0|||
16065782|NCT02368886|38732862|FG001|Overall Study|Ineligible|0|||
16065783|NCT02368886|38732863|FG002|Overall Study|Ineligible|0|||
16065784|NCT02368886|38732864|FG003|Overall Study|Ineligible|1|||
16065785|NCT01511250|38732865|FG000|Overall Study|Withdrawal of Consent|1|||
16065786|NCT01511250|38732866|FG001|Overall Study|Withdrawal of Consent|0|||
16065787|NCT01511250|38732867|FG002|Overall Study|Withdrawal of Consent|0|||
16065788|NCT01511250|38732868|FG003|Overall Study|Withdrawal of Consent|0|||
16065789|NCT01511250|38732869|FG004|Overall Study|Withdrawal of Consent|0|||
16065790|NCT01511250|38732870|FG005|Overall Study|Withdrawal of Consent|0|||
16065791|NCT01511250|38732871|FG006|Overall Study|Withdrawal of Consent|0|||
16065792|NCT01511250|38732872|FG007|Overall Study|Withdrawal of Consent|1|||
16065793|NCT01511250|38732873|FG008|Overall Study|Withdrawal of Consent|1|||
16065794|NCT01511250|38732874|FG009|Overall Study|Withdrawal of Consent|0|||
16065795|NCT01511250|38732865|FG000|Overall Study|Sponsor/Investigator Decision|1|||
16065796|NCT01511250|38732866|FG001|Overall Study|Sponsor/Investigator Decision|0|||
16065797|NCT01511250|38732867|FG002|Overall Study|Sponsor/Investigator Decision|0|||
16065798|NCT01511250|38732868|FG003|Overall Study|Sponsor/Investigator Decision|0|||
16065799|NCT01511250|38732869|FG004|Overall Study|Sponsor/Investigator Decision|0|||
16065800|NCT01511250|38732870|FG005|Overall Study|Sponsor/Investigator Decision|0|||
16065801|NCT01511250|38732871|FG006|Overall Study|Sponsor/Investigator Decision|0|||
16065802|NCT01511250|38732872|FG007|Overall Study|Sponsor/Investigator Decision|0|||
16065803|NCT01511250|38732873|FG008|Overall Study|Sponsor/Investigator Decision|0|||
16065804|NCT01511250|38732874|FG009|Overall Study|Sponsor/Investigator Decision|0|||
16065805|NCT01511250|38732865|FG000|Overall Study|Lost to Follow-up|7|||
16065806|NCT01511250|38732866|FG001|Overall Study|Lost to Follow-up|3|||
16065807|NCT01511250|38732867|FG002|Overall Study|Lost to Follow-up|3|||
16065808|NCT01511250|38732868|FG003|Overall Study|Lost to Follow-up|3|||
16065809|NCT01511250|38732869|FG004|Overall Study|Lost to Follow-up|0|||
16065810|NCT01511250|38732870|FG005|Overall Study|Lost to Follow-up|0|||
16065811|NCT01511250|38732871|FG006|Overall Study|Lost to Follow-up|2|||
16065812|NCT01511250|38732872|FG007|Overall Study|Lost to Follow-up|3|||
16065813|NCT01511250|38732873|FG008|Overall Study|Lost to Follow-up|13|||
16065814|NCT01511250|38732874|FG009|Overall Study|Lost to Follow-up|5|||
16065815|NCT01511250|38732865|FG000|Overall Study|Protocol Violation|0|||
16065816|NCT01511250|38732866|FG001|Overall Study|Protocol Violation|2|||
16065817|NCT01511250|38732867|FG002|Overall Study|Protocol Violation|1|||
16065818|NCT01511250|38732868|FG003|Overall Study|Protocol Violation|0|||
16065819|NCT01511250|38732869|FG004|Overall Study|Protocol Violation|0|||
16065820|NCT01511250|38732870|FG005|Overall Study|Protocol Violation|0|||
16065821|NCT01511250|38732871|FG006|Overall Study|Protocol Violation|0|||
16065822|NCT01511250|38732872|FG007|Overall Study|Protocol Violation|0|||
16065823|NCT01511250|38732873|FG008|Overall Study|Protocol Violation|0|||
16065824|NCT01511250|38732874|FG009|Overall Study|Protocol Violation|0|||
16065825|NCT01192295|38732880|FG000|Overall Study|Adverse Event|3|||
16065826|NCT01192295|38732881|FG001|Overall Study|Adverse Event|7|||
16065827|NCT01192295|38732880|FG000|Overall Study|Withdrawal by Subject|3|||
16065828|NCT01192295|38732881|FG001|Overall Study|Withdrawal by Subject|4|||
16065829|NCT01192295|38732880|FG000|Overall Study|Lost to Follow-up|0|||
16065830|NCT01192295|38732881|FG001|Overall Study|Lost to Follow-up|1|||
16065831|NCT01192295|38732880|FG000|Overall Study|Lack of Efficacy|0|||
16065832|NCT01192295|38732881|FG001|Overall Study|Lack of Efficacy|5|||
16065833|NCT01192295|38732880|FG000|Overall Study|Administrative|4|||
16065834|NCT01192295|38732881|FG001|Overall Study|Administrative|6|||
16065835|NCT03771898|38732884|FG000|Overall Study|Adverse Event|1|||
16065836|NCT03771898|38732885|FG001|Overall Study|Adverse Event|0|||
16065837|NCT03771898|38732886|FG002|Overall Study|Adverse Event|0|||
16065838|NCT03771898|38732887|FG003|Overall Study|Adverse Event|0|||
16065839|NCT03771898|38732888|FG004|Overall Study|Adverse Event|0|||
16065840|NCT03771898|38732884|FG000|Overall Study|Lost to Follow-up|1|||
16065841|NCT03771898|38732885|FG001|Overall Study|Lost to Follow-up|1|||
16065842|NCT03771898|38732886|FG002|Overall Study|Lost to Follow-up|1|||
16065843|NCT03771898|38732887|FG003|Overall Study|Lost to Follow-up|0|||
16065844|NCT03771898|38732888|FG004|Overall Study|Lost to Follow-up|0|||
16065845|NCT03771898|38732884|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16065846|NCT03771898|38732885|FG001|Overall Study|Withdrawal by parent/guardian|1|||
16158461|NCT00433329|39064829|FG000|Overall Study|Death|4|||
16158462|NCT00433329|39064829|FG000|Overall Study|Withdrew consent|3|||
16158463|NCT00433329|39064829|FG000|Overall Study|Discontinued sildenafil|2|||
16158464|NCT00433329|39064829|FG000|Overall Study|Moved out of state|1|||
16158465|NCT00433329|39064829|FG000|Overall Study|Lost to Follow-up|1|||
16158466|NCT00433329|39064829|FG000|Overall Study|Physician Decision|1|||
16158467|NCT02599961|39064830|FG000|Overall Study|Withdrawal by Subject|1|||
16158468|NCT02599961|39064830|FG000|Overall Study|Subject Non-Compliance|2|||
16158469|NCT02599961|39064830|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
16158470|NCT02599961|39064830|FG000|Overall Study|Other, Not Specified|3|||
16158471|NCT04142983|39064835|FG000|Overall Study|Lost to Follow-up|73|||
16158472|NCT04142983|39064835|FG000|Overall Study|Withdrawal by Subject|10|||
16158473|NCT04142983|39064835|FG000|Overall Study|Physician Decision|1|||
16158474|NCT04142983|39064835|FG000|Overall Study|Adverse Event|1|||
16158475|NCT04142983|39064835|FG000|Overall Study|No longer eligible|4|||
16158476|NCT04142983|39064835|FG000|Overall Study|Screen Failure|10|||
16158477|NCT02706873|39064836|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
16158478|NCT02706873|39064837|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
16158479|NCT02706873|39064838|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
16158480|NCT02706873|39064839|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
16158481|NCT02706873|39064836|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
16158482|NCT02706873|39064837|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
16158483|NCT02706873|39064838|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
16158484|NCT02706873|39064839|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
16158485|NCT02706873|39064836|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
16158486|NCT02706873|39064837|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
16158487|NCT02706873|39064838|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
16158488|NCT02706873|39064839|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
16158489|NCT02706873|39064836|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
16158490|NCT02706873|39064837|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
16158491|NCT02706873|39064838|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
16158492|NCT02706873|39064839|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
16158493|NCT02706873|39064836|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
16158494|NCT02706873|39064837|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
16158495|NCT02706873|39064838|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
16158496|NCT02706873|39064839|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
16158497|NCT02706873|39064836|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
16158498|NCT02706873|39064837|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
16158499|NCT02706873|39064838|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
16158500|NCT02706873|39064839|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
16158501|NCT02706873|39064836|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
16158502|NCT02706873|39064837|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
16158503|NCT02706873|39064838|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
16158504|NCT02706873|39064839|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
16158505|NCT02706873|39064836|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
16158506|NCT02706873|39064837|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
16158507|NCT02706873|39064838|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
16158508|NCT02706873|39064839|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
16065847|NCT03771898|38732886|FG002|Overall Study|Withdrawal by parent/guardian|0|||
16065848|NCT03771898|38732887|FG003|Overall Study|Withdrawal by parent/guardian|0|||
16065849|NCT03771898|38732888|FG004|Overall Study|Withdrawal by parent/guardian|0|||
16065850|NCT03771898|38732884|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
16065851|NCT03771898|38732885|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
16065852|NCT03771898|38732886|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
16065853|NCT03771898|38732887|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
16065854|NCT03771898|38732888|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
16065855|NCT01369355|38732889|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
16065856|NCT01369355|38732890|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
16065857|NCT01369355|38732891|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
16065858|NCT01369355|38732892|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
16158509|NCT02706873|39064836|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
16158510|NCT02706873|39064837|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
16158511|NCT02706873|39064838|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
16158512|NCT02706873|39064839|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
16158513|NCT02706873|39064836|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
16158514|NCT02706873|39064837|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
16158515|NCT02706873|39064838|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
16158516|NCT02706873|39064839|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
16158517|NCT02706873|39064836|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
16158518|NCT02706873|39064837|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
16158519|NCT02706873|39064838|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
16065859|NCT01369355|38732893|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
16065860|NCT01369355|38732894|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
16065861|NCT01369355|38732895|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
16065862|NCT01369355|38732896|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
16065863|NCT01369355|38732897|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
16065864|NCT01369355|38732889|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
16065865|NCT01369355|38732890|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
16065866|NCT01369355|38732891|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
16065867|NCT01369355|38732892|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
16065868|NCT01369355|38732893|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
16065869|NCT01369355|38732894|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
16065870|NCT01369355|38732895|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
16065871|NCT01369355|38732896|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
16065872|NCT01369355|38732897|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
16065873|NCT01369355|38732889|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
16065874|NCT01369355|38732890|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
16065875|NCT01369355|38732891|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
16065876|NCT01369355|38732892|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
16065877|NCT01369355|38732893|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
16065878|NCT01369355|38732894|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
16065879|NCT01369355|38732895|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
16065880|NCT01369355|38732896|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
16065881|NCT01369355|38732897|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
16065882|NCT01369355|38732889|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
16065883|NCT01369355|38732890|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
16065884|NCT01369355|38732891|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
16065885|NCT01369355|38732892|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
16065886|NCT01369355|38732893|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
16065887|NCT01369355|38732894|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
16065888|NCT01369355|38732895|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
16065889|NCT01369355|38732896|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
16065890|NCT01369355|38732897|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
16065891|NCT01369355|38732889|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
16065892|NCT01369355|38732890|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
16065893|NCT01369355|38732891|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
16065894|NCT01369355|38732892|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
16065895|NCT01369355|38732893|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
16065896|NCT01369355|38732894|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
16065897|NCT01369355|38732895|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
16065898|NCT01369355|38732896|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
16065899|NCT01369355|38732897|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
16065900|NCT01369355|38732889|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
16065901|NCT01369355|38732890|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
16065902|NCT01369355|38732891|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
16065903|NCT01369355|38732892|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
16065904|NCT01369355|38732893|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
16065905|NCT01369355|38732894|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
16065906|NCT01369355|38732895|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
16065907|NCT01369355|38732896|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
16065908|NCT01369355|38732897|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
16065909|NCT01369355|38732889|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
16065910|NCT01369355|38732890|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
16065911|NCT01369355|38732891|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
16065912|NCT01369355|38732892|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
16065913|NCT01369355|38732893|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
16065914|NCT01369355|38732894|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
16065915|NCT01369355|38732895|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
16065916|NCT01369355|38732896|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
16065917|NCT01369355|38732897|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
16065918|NCT01369355|38732889|FG000|Long-term Extension (Week 44-272)|Death|0|||
16065919|NCT01369355|38732890|FG001|Long-term Extension (Week 44-272)|Death|0|||
16065920|NCT01369355|38732891|FG002|Long-term Extension (Week 44-272)|Death|0|||
16065921|NCT01369355|38732892|FG003|Long-term Extension (Week 44-272)|Death|0|||
16065922|NCT01369355|38732893|FG004|Long-term Extension (Week 44-272)|Death|0|||
16065923|NCT01369355|38732894|FG005|Long-term Extension (Week 44-272)|Death|0|||
16065924|NCT01369355|38732895|FG006|Long-term Extension (Week 44-272)|Death|0|||
16065925|NCT01369355|38732896|FG007|Long-term Extension (Week 44-272)|Death|1|||
16065926|NCT01369355|38732897|FG008|Long-term Extension (Week 44-272)|Death|3|||
16065927|NCT01369355|38732889|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
16158520|NCT02706873|39064839|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
16368741|NCT03022630|39833304|FG001|Overall Study|Death|7|||
16368742|NCT03022630|39833303|FG000|Overall Study|Withdrawal by Subject|0|||
16368743|NCT03022630|39833304|FG001|Overall Study|Withdrawal by Subject|5|||
16368744|NCT02547935|39833305|FG000|Overall Study|Other|0|||
16368745|NCT02547935|39833306|FG001|Overall Study|Other|1|||
16368746|NCT02547935|39833307|FG002|Overall Study|Other|0|||
16368747|NCT02547935|39833305|FG000|Overall Study|Withdrawal by Subject|2|||
16368748|NCT02547935|39833306|FG001|Overall Study|Withdrawal by Subject|3|||
16368749|NCT02547935|39833307|FG002|Overall Study|Withdrawal by Subject|4|||
16368750|NCT02547935|39833305|FG000|Overall Study|Screen Failure|2|||
16368751|NCT02547935|39833306|FG001|Overall Study|Screen Failure|0|||
16368752|NCT02547935|39833307|FG002|Overall Study|Screen Failure|0|||
16368753|NCT02547935|39833305|FG000|Overall Study|Physician Decision|0|||
16368754|NCT02547935|39833306|FG001|Overall Study|Physician Decision|1|||
16368755|NCT02547935|39833307|FG002|Overall Study|Physician Decision|0|||
16368756|NCT02547935|39833305|FG000|Overall Study|Lost to Follow-up|0|||
16368757|NCT02547935|39833306|FG001|Overall Study|Lost to Follow-up|2|||
16065928|NCT01369355|38732890|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
16368758|NCT02547935|39833307|FG002|Overall Study|Lost to Follow-up|1|||
16368759|NCT02547935|39833305|FG000|Overall Study|Death|1|||
16368760|NCT02547935|39833306|FG001|Overall Study|Death|1|||
16368761|NCT02547935|39833307|FG002|Overall Study|Death|0|||
16368762|NCT01068912|39833308|FG000|Overall Study|Adverse Event|2|||
16368763|NCT01068912|39833309|FG001|Overall Study|Adverse Event|3|||
16368764|NCT01068912|39833310|FG002|Overall Study|Adverse Event|2|||
16368765|NCT01068912|39833308|FG000|Overall Study|Withdrawal by Subject|5|||
16368766|NCT01068912|39833309|FG001|Overall Study|Withdrawal by Subject|6|||
16368767|NCT01068912|39833310|FG002|Overall Study|Withdrawal by Subject|6|||
16368768|NCT01068912|39833308|FG000|Overall Study|Lost to Follow-up|3|||
16368769|NCT01068912|39833309|FG001|Overall Study|Lost to Follow-up|7|||
16368770|NCT01068912|39833310|FG002|Overall Study|Lost to Follow-up|3|||
16368771|NCT01068912|39833308|FG000|Overall Study|Protocol Violation|0|||
16368772|NCT01068912|39833309|FG001|Overall Study|Protocol Violation|2|||
16368773|NCT01068912|39833310|FG002|Overall Study|Protocol Violation|0|||
16368774|NCT01068912|39833308|FG000|Overall Study|aggravation influenza|1|||
16368775|NCT01068912|39833309|FG001|Overall Study|aggravation influenza|1|||
16368776|NCT01068912|39833310|FG002|Overall Study|aggravation influenza|1|||
16368777|NCT01068912|39833308|FG000|Overall Study|other underlying illness|0|||
16368778|NCT01068912|39833309|FG001|Overall Study|other underlying illness|3|||
16065929|NCT01369355|38732891|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
16065930|NCT01369355|38732892|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
16065931|NCT01369355|38732893|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
16065932|NCT01369355|38732894|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
16065933|NCT01369355|38732895|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
16065934|NCT01369355|38732896|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
16065935|NCT01369355|38732897|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
16065936|NCT01369355|38732889|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
16065937|NCT01369355|38732890|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
16065938|NCT01369355|38732891|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
16065939|NCT01369355|38732892|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
16065940|NCT01369355|38732893|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
16065941|NCT01369355|38732894|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
16065942|NCT01369355|38732895|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
16065943|NCT01369355|38732896|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
16065944|NCT01369355|38732897|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
16065945|NCT01369355|38732889|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
16065946|NCT01369355|38732890|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
16065947|NCT01369355|38732891|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
16065948|NCT01369355|38732892|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
16065949|NCT01369355|38732893|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
16065950|NCT01369355|38732894|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
16065951|NCT01369355|38732895|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
16368779|NCT01068912|39833310|FG002|Overall Study|other underlying illness|3|||
16368780|NCT02370394|39833311|FG000|Overall Study|Lost to Follow-up|2|||
16065952|NCT01369355|38732896|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
16065953|NCT01369355|38732897|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
16368781|NCT02370394|39833312|FG001|Overall Study|Lost to Follow-up|1|||
16368782|NCT02370394|39833311|FG000|Overall Study|Withdrawal by Subject|0|||
16368783|NCT02370394|39833312|FG001|Overall Study|Withdrawal by Subject|1|||
16368784|NCT02265744|39833313|FG000|Overall Study|Poor/Non-compliance|1|||
16368785|NCT02265744|39833314|FG001|Overall Study|Poor/Non-compliance|1|||
16065954|NCT01369355|38732889|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
16368786|NCT02265744|39833315|FG002|Overall Study|Poor/Non-compliance|0|||
16368787|NCT02265744|39833316|FG003|Overall Study|Poor/Non-compliance|0|||
16065955|NCT01369355|38732890|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
16065956|NCT01369355|38732891|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
16065957|NCT01369355|38732892|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
16065958|NCT01369355|38732893|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
16065959|NCT01369355|38732894|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
16065960|NCT01369355|38732895|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
16368788|NCT02265744|39833317|FG004|Overall Study|Poor/Non-compliance|2|||
16368789|NCT02265744|39833313|FG000|Overall Study|Lost to Follow-up|0|||
16368790|NCT02265744|39833314|FG001|Overall Study|Lost to Follow-up|0|||
16368791|NCT02265744|39833315|FG002|Overall Study|Lost to Follow-up|0|||
16368792|NCT02265744|39833316|FG003|Overall Study|Lost to Follow-up|1|||
16368793|NCT02265744|39833317|FG004|Overall Study|Lost to Follow-up|0|||
16368794|NCT02265744|39833313|FG000|Overall Study|Death|0|||
16368795|NCT02265744|39833314|FG001|Overall Study|Death|0|||
16368796|NCT02265744|39833315|FG002|Overall Study|Death|0|||
16368797|NCT02265744|39833316|FG003|Overall Study|Death|2|||
16368798|NCT02265744|39833317|FG004|Overall Study|Death|0|||
16368799|NCT02265744|39833313|FG000|Overall Study|Withdrawal by Subject|2|||
16368800|NCT02265744|39833314|FG001|Overall Study|Withdrawal by Subject|0|||
16368801|NCT02265744|39833315|FG002|Overall Study|Withdrawal by Subject|0|||
16368802|NCT02265744|39833316|FG003|Overall Study|Withdrawal by Subject|2|||
16368803|NCT02265744|39833317|FG004|Overall Study|Withdrawal by Subject|0|||
16368804|NCT02265744|39833313|FG000|Overall Study|Participant request to discontinue|2|||
16368805|NCT02265744|39833314|FG001|Overall Study|Participant request to discontinue|2|||
16368806|NCT02265744|39833315|FG002|Overall Study|Participant request to discontinue|2|||
16368807|NCT02265744|39833316|FG003|Overall Study|Participant request to discontinue|0|||
16368808|NCT02265744|39833317|FG004|Overall Study|Participant request to discontinue|0|||
16368809|NCT02265744|39833313|FG000|Overall Study|Adverse Event|8|||
16368810|NCT02265744|39833314|FG001|Overall Study|Adverse Event|4|||
16445757|NCT01389596|40111674|FG001|Overall Study|Other Unspecified|1|||
16065961|NCT01369355|38732896|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
16065962|NCT01369355|38732897|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
16065963|NCT01369355|38732889|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
16065964|NCT01369355|38732890|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
16065965|NCT01369355|38732891|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
16065966|NCT01369355|38732892|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
16065967|NCT01369355|38732893|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
16065968|NCT01369355|38732894|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
16065969|NCT01369355|38732895|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
16065970|NCT01369355|38732896|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
16065971|NCT01369355|38732897|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
16065972|NCT01369355|38732889|FG000|Long-term Extension (Week 44-272)|Other|0|||
16065973|NCT01369355|38732890|FG001|Long-term Extension (Week 44-272)|Other|0|||
16065974|NCT01369355|38732891|FG002|Long-term Extension (Week 44-272)|Other|0|||
16065975|NCT01369355|38732892|FG003|Long-term Extension (Week 44-272)|Other|0|||
16065976|NCT01369355|38732893|FG004|Long-term Extension (Week 44-272)|Other|0|||
16065977|NCT01369355|38732894|FG005|Long-term Extension (Week 44-272)|Other|0|||
16065978|NCT01369355|38732895|FG006|Long-term Extension (Week 44-272)|Other|110|||
16065979|NCT01369355|38732896|FG007|Long-term Extension (Week 44-272)|Other|9|||
16065980|NCT01369355|38732897|FG008|Long-term Extension (Week 44-272)|Other|17|||
16065981|NCT01536262|38732901|FG000|Overall Study|Adverse Event|6|||
16065982|NCT01536262|38732902|FG001|Overall Study|Adverse Event|1|||
16065983|NCT01536262|38732903|FG002|Overall Study|Adverse Event|2|||
16065984|NCT01536262|38732901|FG000|Overall Study|Withdrawal by Subject|1|||
16065985|NCT01536262|38732902|FG001|Overall Study|Withdrawal by Subject|1|||
16065986|NCT01536262|38732903|FG002|Overall Study|Withdrawal by Subject|0|||
16065987|NCT01536262|38732901|FG000|Overall Study|Other than stated above|1|||
16065988|NCT01536262|38732902|FG001|Overall Study|Other than stated above|0|||
16065989|NCT01536262|38732903|FG002|Overall Study|Other than stated above|0|||
16065990|NCT00994279|38732904|FG000|Overall Study|Withdrawal by Subject|2|||
16065991|NCT00994279|38732905|FG001|Overall Study|Withdrawal by Subject|2|||
16065992|NCT00994279|38732904|FG000|Overall Study|Toxicity|1|||
16065993|NCT00994279|38732905|FG001|Overall Study|Toxicity|0|||
16065994|NCT00994279|38732904|FG000|Overall Study|Multiple reasons|1|||
16445758|NCT01389596|40111675|FG002|Overall Study|Other Unspecified|0|||
16065995|NCT00994279|38732905|FG001|Overall Study|Multiple reasons|3|||
16065996|NCT01008748|38732906|FG000|Overall Study|Lost to Follow-up|80|||
16065997|NCT01008748|38732906|FG000|Overall Study|Other|1|||
16065998|NCT04978363|38732907|FG000|Overall Study|Other medical issues unrelated to the study|0|||
16065999|NCT04978363|38732908|FG001|Overall Study|Other medical issues unrelated to the study|0|||
16066000|NCT04978363|38732909|FG002|Overall Study|Other medical issues unrelated to the study|0|||
16368811|NCT02265744|39833315|FG002|Overall Study|Adverse Event|9|||
16368812|NCT02265744|39833316|FG003|Overall Study|Adverse Event|8|||
16368813|NCT02265744|39833317|FG004|Overall Study|Adverse Event|2|||
16066001|NCT04978363|38732910|FG003|Overall Study|Other medical issues unrelated to the study|0|||
16066002|NCT04978363|38732911|FG004|Overall Study|Other medical issues unrelated to the study|1|||
16066003|NCT04978363|38732912|FG005|Overall Study|Other medical issues unrelated to the study|0|||
16066004|NCT04978363|38732913|FG006|Overall Study|Other medical issues unrelated to the study|0|||
16066005|NCT04978363|38732914|FG007|Overall Study|Other medical issues unrelated to the study|0|||
16066006|NCT04978363|38732915|FG008|Overall Study|Other medical issues unrelated to the study|0|||
16066007|NCT04978363|38732916|FG009|Overall Study|Other medical issues unrelated to the study|0|||
16066008|NCT04978363|38732917|FG010|Overall Study|Other medical issues unrelated to the study|0|||
16066009|NCT04978363|38732907|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
16066010|NCT04978363|38732908|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
16066011|NCT04978363|38732909|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
16066012|NCT04978363|38732910|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
16066013|NCT04978363|38732911|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
16066014|NCT04978363|38732912|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
16066015|NCT04978363|38732913|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
16066016|NCT04978363|38732914|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
16066017|NCT04978363|38732915|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
16066018|NCT04978363|38732916|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
16066019|NCT04978363|38732917|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
16066020|NCT04978363|38732907|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
16066021|NCT04978363|38732908|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
16158521|NCT02706873|39064836|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
16158522|NCT02706873|39064837|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
16158523|NCT02706873|39064838|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
16158524|NCT02706873|39064839|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
16158525|NCT02706873|39064836|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
16158526|NCT02706873|39064837|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
16158527|NCT02706873|39064838|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
16158528|NCT02706873|39064839|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
16158529|NCT02831673|39064840|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
16158530|NCT02831673|39064841|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
16158531|NCT02831673|39064842|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
16158532|NCT02831673|39064843|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
16158533|NCT02831673|39064844|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
16158534|NCT02831673|39064840|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
16158535|NCT02831673|39064841|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
16158536|NCT02831673|39064842|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
16158537|NCT02831673|39064843|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
16158538|NCT02831673|39064844|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
16158539|NCT02831673|39064840|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
16066022|NCT04978363|38732909|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
16158540|NCT02831673|39064841|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
16158541|NCT02831673|39064842|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
16445759|NCT01454102|40111676|FG000|Overall Study|Continuing in the treatment period|0|||
16445760|NCT01454102|40111677|FG001|Overall Study|Continuing in the treatment period|0|||
16158542|NCT02831673|39064843|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
16158543|NCT02831673|39064844|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
16158544|NCT02831673|39064840|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
16158545|NCT02831673|39064841|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
16158546|NCT02831673|39064842|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
16158547|NCT02831673|39064843|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
16158548|NCT02831673|39064844|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
16158549|NCT02831673|39064840|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
16158550|NCT02831673|39064841|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
16445761|NCT01454102|40111678|FG002|Overall Study|Continuing in the treatment period|0|||
16445762|NCT01454102|40111679|FG003|Overall Study|Continuing in the treatment period|0|||
16445763|NCT01454102|40111680|FG004|Overall Study|Continuing in the treatment period|3|||
16445764|NCT01454102|40111681|FG005|Overall Study|Continuing in the treatment period|3|||
16445765|NCT01454102|40111682|FG006|Overall Study|Continuing in the treatment period|2|||
16445766|NCT01454102|40111683|FG007|Overall Study|Continuing in the treatment period|0|||
16445767|NCT01454102|40111684|FG008|Overall Study|Continuing in the treatment period|1|||
16445768|NCT01454102|40111685|FG009|Overall Study|Continuing in the treatment period|0|||
16158551|NCT02831673|39064842|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
16445769|NCT01454102|40111686|FG010|Overall Study|Continuing in the treatment period|0|||
16445770|NCT01454102|40111687|FG011|Overall Study|Continuing in the treatment period|4|||
16445771|NCT01454102|40111688|FG012|Overall Study|Continuing in the treatment period|7|||
16445772|NCT01454102|40111689|FG013|Overall Study|Continuing in the treatment period|4|||
16445773|NCT01454102|40111690|FG014|Overall Study|Continuing in the treatment period|3|||
16445774|NCT01454102|40111691|FG015|Overall Study|Continuing in the treatment period|1|||
16445775|NCT00091949|40111692|FG000|Overall Study|Withdrawal by Subject|117|||
16445776|NCT00091949|40111693|FG001|Overall Study|Withdrawal by Subject|110|||
16445777|NCT00091949|40111692|FG000|Overall Study|Lost to Follow-up|58|||
16445778|NCT00091949|40111693|FG001|Overall Study|Lost to Follow-up|41|||
16445779|NCT01614249|40111696|FG000|Overall Study|Lost to Follow-up|11|||
16445780|NCT01614249|40111697|FG001|Overall Study|Lost to Follow-up|23|||
16445781|NCT00887809|40111698|FG000|Overall Study|Patient Not Treated|3|||
16445782|NCT00887809|40111699|FG001|Overall Study|Patient Not Treated|0|||
16445783|NCT00887809|40111698|FG000|Overall Study|Death|1|||
16445784|NCT00887809|40111699|FG001|Overall Study|Death|0|||
16445785|NCT03051178|40111700|FG000|Overall Study|Withdrawal by Subject|5|||
16445786|NCT00423579|40111701|FG000|Overall Study|Lost to Follow-up|3|||
16445787|NCT00423579|40111702|FG001|Overall Study|Lost to Follow-up|0|||
16445788|NCT00423579|40111701|FG000|Overall Study|Protocol Violation|1|||
16445789|NCT00423579|40111702|FG001|Overall Study|Protocol Violation|3|||
16445790|NCT00423579|40111701|FG000|Overall Study|Diagnosis of diabetes|0|||
16445791|NCT00423579|40111702|FG001|Overall Study|Diagnosis of diabetes|1|||
16445792|NCT01457703|40111705|FG000|Overall Study|Screen Failure|5|||
16445793|NCT01457703|40111706|FG001|Overall Study|Screen Failure|7|||
16445794|NCT01457703|40111705|FG000|Overall Study|Withdrawal by Subject|1|||
16445795|NCT01457703|40111706|FG001|Overall Study|Withdrawal by Subject|4|||
16445796|NCT02443688|40111707|FG000|Overall Study|Adverse Event|2|||
16445797|NCT02443688|40111708|FG001|Overall Study|Adverse Event|3|||
16445798|NCT02443688|40111709|FG002|Overall Study|Adverse Event|2|||
16445799|NCT02443688|40111707|FG000|Overall Study|Lost to Follow-up|1|||
16445800|NCT02443688|40111708|FG001|Overall Study|Lost to Follow-up|0|||
16445801|NCT02443688|40111709|FG002|Overall Study|Lost to Follow-up|0|||
16445802|NCT02443688|40111707|FG000|Overall Study|Physician Decision|3|||
16445803|NCT02443688|40111708|FG001|Overall Study|Physician Decision|0|||
16445804|NCT02443688|40111709|FG002|Overall Study|Physician Decision|1|||
16445805|NCT02443688|40111707|FG000|Overall Study|Pregnancy|0|||
16445806|NCT02443688|40111708|FG001|Overall Study|Pregnancy|0|||
16445807|NCT02443688|40111709|FG002|Overall Study|Pregnancy|1|||
16445808|NCT02443688|40111707|FG000|Overall Study|Withdrawal by Subject|3|||
16445809|NCT02443688|40111708|FG001|Overall Study|Withdrawal by Subject|3|||
16445810|NCT02443688|40111709|FG002|Overall Study|Withdrawal by Subject|4|||
16445811|NCT02443688|40111707|FG000|Overall Study|Non-compliance with study drug|1|||
16445812|NCT02443688|40111708|FG001|Overall Study|Non-compliance with study drug|2|||
16445813|NCT02443688|40111709|FG002|Overall Study|Non-compliance with study drug|4|||
16445814|NCT02443688|40111707|FG000|Overall Study|Sponsor Request|2|||
16445815|NCT02443688|40111708|FG001|Overall Study|Sponsor Request|1|||
16445816|NCT02443688|40111709|FG002|Overall Study|Sponsor Request|0|||
16445817|NCT02606643|40111712|FG000|Overall Study|did not meet inclusion criteria|1|||
16445818|NCT02606643|40111713|FG001|Overall Study|did not meet inclusion criteria|3|||
16445819|NCT02892344|40111714|FG000|Overall Study|Protocol deviation|3|||
16445820|NCT02892344|40111715|FG001|Overall Study|Protocol deviation|4|||
16445821|NCT02892344|40111714|FG000|Overall Study|Adverse Event|1|||
16066023|NCT04978363|38732910|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
16066024|NCT04978363|38732911|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
16445822|NCT02892344|40111715|FG001|Overall Study|Adverse Event|8|||
16445823|NCT02892344|40111714|FG000|Overall Study|Lost to Follow-up|0|||
16445824|NCT02892344|40111715|FG001|Overall Study|Lost to Follow-up|1|||
16445825|NCT02892344|40111714|FG000|Overall Study|Non-compliance with study treatment|0|||
16445826|NCT02892344|40111715|FG001|Overall Study|Non-compliance with study treatment|1|||
16066025|NCT04978363|38732912|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
16066026|NCT04978363|38732913|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
16066027|NCT04978363|38732914|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
16066028|NCT04978363|38732915|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
16066029|NCT04978363|38732916|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
16066030|NCT04978363|38732917|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
16066031|NCT02757885|38732919|FG000|Overall Study|Screen Failures|4|||
16066032|NCT01304706|38732920|FG000|Overall Study|Adverse Event|2|||
16066033|NCT01304706|38732920|FG000|Overall Study|Lack of Efficacy|1|||
16066034|NCT01304706|38732920|FG000|Overall Study|Death|3|||
16066035|NCT01304706|38732920|FG000|Overall Study|Withdrawal by Subject|3|||
16066036|NCT01304706|38732920|FG000|Overall Study|Lost to Follow-up|7|||
16066037|NCT01304706|38732920|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
16066038|NCT01700530|38732921|FG000|Overall Study|Withdrawal by Subject|0|||
16158552|NCT02831673|39064843|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
16445827|NCT02892344|40111714|FG000|Overall Study|Physician Decision|0|||
16445828|NCT02892344|40111715|FG001|Overall Study|Physician Decision|2|||
16445829|NCT02892344|40111714|FG000|Overall Study|Subject/guardian decision|0|||
16066039|NCT01700530|38732922|FG001|Overall Study|Withdrawal by Subject|3|||
16066040|NCT01700530|38732923|FG002|Overall Study|Withdrawal by Subject|1|||
16066041|NCT04034251|38732924|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
16066042|NCT04034251|38732925|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
16066043|NCT04034251|38732926|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
16066044|NCT01244828|38732927|FG000|Overall Study|Adverse Event|37|||
16066045|NCT01244828|38732927|FG000|Overall Study|Withdrawal by Subject|31|||
16066046|NCT01244828|38732927|FG000|Overall Study|Lack of Efficacy|7|||
16066047|NCT01244828|38732927|FG000|Overall Study|Lost to Follow-up|2|||
16066048|NCT01244828|38732927|FG000|Overall Study|Other reason (not specified)|1|||
16066049|NCT03772314|38732929|FG000|Overall Study|Adverse Event|7|||
16066050|NCT03772314|38732930|FG001|Overall Study|Adverse Event|2|||
16066051|NCT03085017|38732932|FG000|Overall Study|Death|0|||
16066052|NCT03085017|38732933|FG001|Overall Study|Death|3|||
16066053|NCT00367237|38732934|FG000|Overall Study|Adverse Event|7|||
16066054|NCT00367237|38732935|FG001|Overall Study|Adverse Event|2|||
16066055|NCT00367237|38732934|FG000|Overall Study|Lost to Follow-up|1|||
16066056|NCT00367237|38732935|FG001|Overall Study|Lost to Follow-up|0|||
16066057|NCT00367237|38732934|FG000|Overall Study|Withdrawal by Subject|0|||
16066058|NCT00367237|38732935|FG001|Overall Study|Withdrawal by Subject|4|||
16066059|NCT00367237|38732934|FG000|Overall Study|Protocol Violation|2|||
16066060|NCT00367237|38732935|FG001|Overall Study|Protocol Violation|5|||
16158553|NCT02831673|39064844|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
16445830|NCT02892344|40111715|FG001|Overall Study|Subject/guardian decision|4|||
16445831|NCT02892344|40111714|FG000|Overall Study|Technical problems|0|||
16445832|NCT02892344|40111715|FG001|Overall Study|Technical problems|1|||
16445833|NCT02612779|40111716|FG000|Overall Study|Administrative reason by sponsor|4|||
16445834|NCT02612779|40111717|FG001|Overall Study|Administrative reason by sponsor|1|||
16445835|NCT02612779|40111716|FG000|Overall Study|No longer meet study criteria|0|||
16445836|NCT02612779|40111717|FG001|Overall Study|No longer meet study criteria|1|||
16445837|NCT02612779|40111716|FG000|Overall Study|Disease progression|29|||
16445838|NCT02612779|40111717|FG001|Overall Study|Disease progression|2|||
16445839|NCT02612779|40111716|FG000|Overall Study|Study drug toxicity|10|||
16445840|NCT02612779|40111717|FG001|Overall Study|Study drug toxicity|1|||
16445841|NCT02612779|40111716|FG000|Overall Study|Death|1|||
16445842|NCT02612779|40111717|FG001|Overall Study|Death|0|||
16445843|NCT02612779|40111716|FG000|Overall Study|Adverse event unrelated to study drug|5|||
16445844|NCT02612779|40111717|FG001|Overall Study|Adverse event unrelated to study drug|0|||
16445845|NCT02612779|40111716|FG000|Overall Study|Participant withdrew consent|4|||
16445846|NCT02612779|40111717|FG001|Overall Study|Participant withdrew consent|0|||
16445847|NCT02612779|40111716|FG000|Overall Study|Lost to Follow-up|1|||
16445848|NCT02612779|40111717|FG001|Overall Study|Lost to Follow-up|0|||
16445849|NCT02612779|40111716|FG000|Overall Study|Maximum clinical benefit|10|||
16445850|NCT02612779|40111717|FG001|Overall Study|Maximum clinical benefit|1|||
16445851|NCT02612779|40111716|FG000|Overall Study|Other reasons|4|||
16445852|NCT02612779|40111717|FG001|Overall Study|Other reasons|0|||
16445853|NCT00831181|40111718|FG000|Overall Study|Adverse Event|12|||
16445854|NCT01131507|40111719|FG000|Overall Study|Adverse Event|1|||
16445855|NCT01131507|40111719|FG000|Overall Study|Lost to Follow-up|1|||
16445856|NCT01131507|40111719|FG000|Overall Study|Withdrawal by Subject|1|||
16445857|NCT01217229|40111720|FG000|Overall Study|Adverse Event|1|||
16445858|NCT01217229|40111720|FG000|Overall Study|Disease progression, deterioration|2|||
16445859|NCT01217229|40111720|FG000|Overall Study|Disease progression, Cheson criteria|14|||
16445860|NCT01217229|40111720|FG000|Overall Study|Protocol Violation|1|||
16445861|NCT01217229|40111720|FG000|Overall Study|Disease progression not confirmed|2|||
16066061|NCT04034238|38732936|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
16066062|NCT04034238|38732937|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
16066063|NCT04034238|38732938|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
16158554|NCT02831673|39064840|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
16158555|NCT02831673|39064841|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
16158556|NCT02831673|39064842|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
16158557|NCT02831673|39064843|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
16158558|NCT02831673|39064844|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
16158559|NCT02831673|39064840|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
16368814|NCT02265744|39833313|FG000|Overall Study|Lack of Efficacy|2|||
16368815|NCT02265744|39833314|FG001|Overall Study|Lack of Efficacy|4|||
16368816|NCT02265744|39833315|FG002|Overall Study|Lack of Efficacy|3|||
16158560|NCT02831673|39064841|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
16158561|NCT02831673|39064842|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
16368817|NCT02265744|39833316|FG003|Overall Study|Lack of Efficacy|4|||
16368818|NCT02265744|39833317|FG004|Overall Study|Lack of Efficacy|5|||
16368819|NCT02265744|39833313|FG000|Overall Study|Reason not provided by Investigator|1|||
16368820|NCT02265744|39833314|FG001|Overall Study|Reason not provided by Investigator|0|||
16263409|NCT00537979|39449781|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
16263410|NCT00537979|39449780|FG000|Overall Study|Death|0|||
16263411|NCT00537979|39449781|FG001|Overall Study|Death|3|||
16263412|NCT00537979|39449780|FG000|Overall Study|Kidney transplant|0|||
16263413|NCT00537979|39449781|FG001|Overall Study|Kidney transplant|3|||
16263414|NCT00537979|39449780|FG000|Overall Study|Heart failure|0|||
16263415|NCT00537979|39449781|FG001|Overall Study|Heart failure|1|||
16445862|NCT00199381|40111727|FG000|Overall Study|Withdrawal by Subject|38|||
16445863|NCT00199381|40111727|FG000|Overall Study|Adverse Event|73|||
16445864|NCT00199381|40111727|FG000|Overall Study|Protocol Violation|6|||
16445865|NCT00199381|40111727|FG000|Overall Study|Lack of Efficacy|27|||
16263416|NCT01190930|39449788|FG000|Induction|Adverse Event|17|||
16445866|NCT00199381|40111727|FG000|Overall Study|Not including due to early termination|37|||
16445867|NCT00199381|40111727|FG000|Overall Study|Study termination by Sponsor|323|||
16445868|NCT00935584|40111729|FG000|Overall Study|Withdrawal by Subject|9|||
16445869|NCT00935584|40111730|FG001|Overall Study|Withdrawal by Subject|0|||
16445870|NCT00935584|40111729|FG000|Overall Study|Death|3|||
16445871|NCT00935584|40111730|FG001|Overall Study|Death|0|||
16445872|NCT00935584|40111729|FG000|Overall Study|Lost to Follow-up|8|||
16445873|NCT00935584|40111730|FG001|Overall Study|Lost to Follow-up|0|||
16445874|NCT00935584|40111729|FG000|Overall Study|No show|9|||
16445875|NCT00935584|40111730|FG001|Overall Study|No show|0|||
16445876|NCT00935584|40111729|FG000|Overall Study|Relocated|3|||
16445877|NCT00935584|40111730|FG001|Overall Study|Relocated|0|||
16445878|NCT00935584|40111729|FG000|Overall Study|Patient changed provider|3|||
16445879|NCT00935584|40111730|FG001|Overall Study|Patient changed provider|0|||
16445880|NCT00935584|40111729|FG000|Overall Study|Provider dropped out of study|14|||
16445881|NCT00935584|40111730|FG001|Overall Study|Provider dropped out of study|4|||
16445882|NCT00459316|40111731|FG000|Steps 1 & 2|Other eligibility failure|1|||
16445883|NCT00459316|40111732|FG001|Steps 1 & 2|Other eligibility failure|1|||
16445884|NCT00459316|40111733|FG002|Steps 1 & 2|Other eligibility failure|0|||
16445885|NCT00459316|40111731|FG000|Steps 1 & 2|Death|1|||
16445886|NCT00459316|40111732|FG001|Steps 1 & 2|Death|1|||
16445887|NCT00459316|40111733|FG002|Steps 1 & 2|Death|0|||
16445888|NCT00459316|40111731|FG000|Steps 1 & 2|Not able to get to clinic|7|||
16445889|NCT00459316|40111732|FG001|Steps 1 & 2|Not able to get to clinic|4|||
16445890|NCT00459316|40111733|FG002|Steps 1 & 2|Not able to get to clinic|0|||
16445891|NCT00459316|40111731|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
16445892|NCT00459316|40111732|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
16066064|NCT04034238|38732939|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
16066065|NCT04034238|38732936|FG000|Dose Escalation Phase|Screen failures|0|||
16066066|NCT04034238|38732937|FG001|Dose Escalation Phase|Screen failures|0|||
16066067|NCT04034238|38732938|FG002|Dose Escalation Phase|Screen failures|0|||
16066068|NCT04034238|38732939|FG003|Dose Escalation Phase|Screen failures|2|||
16066069|NCT04034238|38732936|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
16066070|NCT04034238|38732937|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
16066071|NCT04034238|38732938|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
16066072|NCT04034238|38732939|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
16066073|NCT04034238|38732936|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
16066074|NCT04034238|38732937|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
16066075|NCT04034238|38732938|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
16066076|NCT04034238|38732939|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
16066077|NCT02263885|38732940|FG000|Overall Study|Withdrawal by Subject|7|||
16066078|NCT02263885|38732940|FG000|Overall Study|Alternative Treatment|3|||
16066079|NCT02049437|38732941|FG000|Period 1|Adverse Event|1|||
16066080|NCT02049437|38732942|FG001|Period 1|Adverse Event|1|||
16066081|NCT02049437|38732941|FG000|Period 1|Adverse Event|1|||
16066082|NCT02049437|38732942|FG001|Period 1|Adverse Event|0|||
16066083|NCT05233085|38732943|FG000|Overall Study|Adverse Event|1|||
16066084|NCT05233085|38732944|FG001|Overall Study|Adverse Event|0|||
16066085|NCT05233085|38732945|FG002|Overall Study|Adverse Event|0|||
16066086|NCT05233085|38732946|FG003|Overall Study|Adverse Event|0|||
16066087|NCT01268566|38732953|FG000|Overall Study|Lost to Follow-up|1|||
16066088|NCT01268566|38732953|FG000|Overall Study|Withdrawal by Subject|12|||
16066089|NCT01268566|38732953|FG000|Overall Study|Death|30|||
16445893|NCT00459316|40111733|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
16445894|NCT00459316|40111731|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
16445895|NCT00459316|40111732|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
16445896|NCT00459316|40111733|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
16066090|NCT02107274|38732966|FG000|Treatment vs. Placebo|Adverse Event|3|||
16066091|NCT02107274|38732967|FG001|Treatment vs. Placebo|Adverse Event|0|||
16066092|NCT02107274|38732966|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
16066093|NCT02107274|38732967|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
16263417|NCT01190930|39449789|FG001|Induction|Adverse Event|0|||
16263418|NCT01190930|39449790|FG002|Induction|Adverse Event|0|||
16445897|NCT00459316|40111731|FG000|Steps 1 & 2|Lost to Follow-up|5|||
16158562|NCT02831673|39064843|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
16158563|NCT02831673|39064844|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
16158564|NCT02831673|39064840|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
16158565|NCT02831673|39064841|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
16158566|NCT02831673|39064842|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
16158567|NCT02831673|39064843|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
16158568|NCT02831673|39064844|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
16368821|NCT02265744|39833315|FG002|Overall Study|Reason not provided by Investigator|0|||
16158569|NCT02831673|39064840|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
16158570|NCT02831673|39064841|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
16158571|NCT02831673|39064842|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
16158572|NCT02831673|39064843|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
16158573|NCT02831673|39064844|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
16158574|NCT02831673|39064840|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
16158575|NCT02831673|39064841|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
16158576|NCT02831673|39064842|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
16158577|NCT02831673|39064843|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
16158578|NCT02831673|39064844|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
16158579|NCT02831673|39064840|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
16158580|NCT02831673|39064841|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
16158581|NCT02831673|39064842|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
16158582|NCT02831673|39064843|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
16158583|NCT02831673|39064844|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
16158584|NCT02831673|39064840|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
16158585|NCT02831673|39064841|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
16158586|NCT02831673|39064842|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
16158587|NCT02831673|39064843|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
16158588|NCT02831673|39064844|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
16158589|NCT02831673|39064840|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
16158590|NCT02831673|39064841|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
16158591|NCT02831673|39064842|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
16158592|NCT02831673|39064843|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
16158593|NCT02831673|39064844|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
16158594|NCT02831673|39064840|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
16158595|NCT02831673|39064841|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
16158596|NCT02831673|39064842|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
16158597|NCT02831673|39064843|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
16158598|NCT02831673|39064844|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
16158599|NCT02831673|39064840|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
16158600|NCT02831673|39064841|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
16158601|NCT02831673|39064842|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
16158602|NCT02831673|39064843|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
16158603|NCT02831673|39064844|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
16158604|NCT02831673|39064840|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
16158605|NCT02831673|39064841|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
16158606|NCT02831673|39064842|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
16158607|NCT02831673|39064843|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
16368822|NCT02265744|39833316|FG003|Overall Study|Reason not provided by Investigator|2|||
16368823|NCT02265744|39833317|FG004|Overall Study|Reason not provided by Investigator|0|||
16368824|NCT02265744|39833313|FG000|Overall Study|Administrative reason by sponsor|3|||
16368825|NCT02265744|39833314|FG001|Overall Study|Administrative reason by sponsor|2|||
16368826|NCT02265744|39833315|FG002|Overall Study|Administrative reason by sponsor|2|||
16368827|NCT02265744|39833316|FG003|Overall Study|Administrative reason by sponsor|3|||
16368828|NCT02265744|39833317|FG004|Overall Study|Administrative reason by sponsor|3|||
16368829|NCT02265744|39833313|FG000|Overall Study|Subject no longer meets study criteria|0|||
16368830|NCT02265744|39833314|FG001|Overall Study|Subject no longer meets study criteria|0|||
16368831|NCT02265744|39833315|FG002|Overall Study|Subject no longer meets study criteria|0|||
16368832|NCT02265744|39833316|FG003|Overall Study|Subject no longer meets study criteria|0|||
16368833|NCT02265744|39833317|FG004|Overall Study|Subject no longer meets study criteria|1|||
16368834|NCT02265744|39833313|FG000|Overall Study|Pregnancy|1|||
16368835|NCT02265744|39833314|FG001|Overall Study|Pregnancy|2|||
16368836|NCT02265744|39833315|FG002|Overall Study|Pregnancy|1|||
16368837|NCT02265744|39833316|FG003|Overall Study|Pregnancy|1|||
16445898|NCT00459316|40111732|FG001|Steps 1 & 2|Lost to Follow-up|0|||
16158608|NCT02831673|39064844|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
16158609|NCT02831673|39064840|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
16158610|NCT02831673|39064841|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
16158611|NCT02831673|39064842|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
16158612|NCT02831673|39064843|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
16158613|NCT02831673|39064844|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
16158614|NCT02831673|39064840|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
16158615|NCT02831673|39064841|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
16158616|NCT02831673|39064842|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
16158617|NCT02831673|39064843|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
16158618|NCT02831673|39064844|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
16158619|NCT02831673|39064840|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
16158620|NCT02831673|39064841|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
16158621|NCT02831673|39064842|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
16158622|NCT02831673|39064843|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
16158623|NCT02831673|39064844|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
16158624|NCT02831673|39064840|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
16158625|NCT02831673|39064841|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
16158626|NCT02831673|39064842|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
16158627|NCT02831673|39064843|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
16158628|NCT02831673|39064844|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
16158629|NCT02678390|39064845|FG000|AE (1 Day)|Withdrawal by Subject|0|||
16158630|NCT02678390|39064846|FG001|AE (1 Day)|Withdrawal by Subject|1|||
16158631|NCT00880893|39064847|FG000|Overall Study|Protocol Violation|13|||
16158632|NCT00880893|39064848|FG001|Overall Study|Protocol Violation|1|||
16158633|NCT00880893|39064847|FG000|Overall Study|Withdrawal by Subject|15|||
16158634|NCT00880893|39064848|FG001|Overall Study|Withdrawal by Subject|11|||
16158635|NCT00880893|39064847|FG000|Overall Study|Lost to Follow-up|76|||
16158636|NCT00880893|39064848|FG001|Overall Study|Lost to Follow-up|33|||
16158637|NCT00880893|39064847|FG000|Overall Study|Serious adverse event|3|||
16158638|NCT00880893|39064848|FG001|Overall Study|Serious adverse event|0|||
16158639|NCT01273883|39064849|FG000|First Intervention|Adverse Event|2|||
16158640|NCT01273883|39064850|FG001|First Intervention|Adverse Event|1|||
16158641|NCT01273883|39064849|FG000|Second Intervention|Lost to Follow-up|1|||
16158642|NCT01273883|39064850|FG001|Second Intervention|Lost to Follow-up|1|||
16158643|NCT01273883|39064849|FG000|Second Intervention|Lack of Efficacy|1|||
16158644|NCT01273883|39064850|FG001|Second Intervention|Lack of Efficacy|0|||
16158645|NCT03006848|39064852|FG000|Overall Study|Adverse Event|1|||
16158646|NCT03006848|39064852|FG000|Overall Study|Physician Decision|1|||
16158647|NCT03006848|39064852|FG000|Overall Study|Lack of Efficacy|16|||
16158648|NCT02597946|39064853|FG000|Overall Study|Withdrawal by Subject|1|||
16158649|NCT02597946|39064853|FG000|Overall Study|Progressive disease|16|||
16158650|NCT02597946|39064853|FG000|Overall Study|Other than above|1|||
16158651|NCT03948178|39064858|FG000|Overall Study|Protocol Violation|1|||
16158652|NCT03948178|39064858|FG000|Overall Study|Lost to Follow-up|2|||
16158653|NCT03948178|39064858|FG000|Overall Study|Withdrawal by Subject|2|||
16158654|NCT03948178|39064858|FG000|Overall Study|Reason not known|2|||
16158655|NCT03948178|39064858|FG000|Overall Study|Personal reason|14|||
16158656|NCT03948178|39064858|FG000|Overall Study|Disease progression|30|||
16158657|NCT03948178|39064858|FG000|Overall Study|Adverse Event|12|||
16158658|NCT03948178|39064858|FG000|Overall Study|Sponsor terminated study|164|||
16158659|NCT01263639|39064859|FG000|Overall Study|Lost to Follow-up|66|||
16158660|NCT01263639|39064860|FG001|Overall Study|Lost to Follow-up|70|||
16158661|NCT01263639|39064859|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
16158662|NCT01263639|39064860|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
16158663|NCT02229552|39064861|FG000|Baseline|Withdrawal by Subject|6|||
16158664|NCT02229552|39064861|FG000|1-year Follow up|Withdrawal by Subject|7|||
16158665|NCT02229552|39064861|FG000|1-year Follow up|Lost to Follow-up|18|||
16158666|NCT02229552|39064861|FG000|2-Year Follow up|Withdrawal by Subject|9|||
16158667|NCT02229552|39064861|FG000|2-Year Follow up|Lost to Follow-up|17|||
16158668|NCT00936208|39064865|FG000|Overall Study|Protocol Violation|37|||
16158669|NCT00936208|39064866|FG001|Overall Study|Protocol Violation|22|||
16158670|NCT02937350|39064867|FG000|Overall Study|Withdrawal by Subject|0|||
16158671|NCT02937350|39064868|FG001|Overall Study|Withdrawal by Subject|1|||
16158672|NCT02937350|39064869|FG002|Overall Study|Withdrawal by Subject|0|||
16158673|NCT01375764|39064876|FG000|Overall Study|Lost to Follow-up|0|||
16158674|NCT01375764|39064877|FG001|Overall Study|Lost to Follow-up|1|||
16158675|NCT01375764|39064878|FG002|Overall Study|Lost to Follow-up|0|||
16158676|NCT01375764|39064879|FG003|Overall Study|Lost to Follow-up|0|||
16158677|NCT01375764|39064880|FG004|Overall Study|Lost to Follow-up|0|||
16158678|NCT01375764|39064876|FG000|Overall Study|Withdrawal by Subject|2|||
16158679|NCT01375764|39064877|FG001|Overall Study|Withdrawal by Subject|0|||
16158680|NCT01375764|39064878|FG002|Overall Study|Withdrawal by Subject|0|||
16158681|NCT01375764|39064879|FG003|Overall Study|Withdrawal by Subject|0|||
16066094|NCT02107274|38732966|FG000|Control Phase|Lost to Follow-up|1|||
16066095|NCT02107274|38732967|FG001|Control Phase|Lost to Follow-up|1|||
16066096|NCT02107274|38732966|FG000|Control Phase|Death|2|||
16066097|NCT02107274|38732967|FG001|Control Phase|Death|0|||
16066098|NCT02107274|38732966|FG000|Control Phase|Adverse Event|0|||
16066099|NCT02107274|38732967|FG001|Control Phase|Adverse Event|1|||
16066100|NCT00303303|38732968|FG000|Overall Study|Withdrawal by Subject|0|||
16066101|NCT00303303|38732969|FG001|Overall Study|Withdrawal by Subject|0|||
16066102|NCT00303303|38732970|FG002|Overall Study|Withdrawal by Subject|1|||
16066103|NCT04476043|38732973|FG000|Overall Study|Withdrawal by Subject|1|||
16066104|NCT04476043|38732974|FG001|Overall Study|Withdrawal by Subject|3|||
16066105|NCT04476043|38732975|FG002|Overall Study|Withdrawal by Subject|4|||
16066106|NCT04476043|38732976|FG003|Overall Study|Withdrawal by Subject|1|||
16066107|NCT04476043|38732973|FG000|Overall Study|Lost to Follow-up|1|||
16066108|NCT04476043|38732974|FG001|Overall Study|Lost to Follow-up|1|||
16066109|NCT04476043|38732975|FG002|Overall Study|Lost to Follow-up|2|||
16066110|NCT04476043|38732976|FG003|Overall Study|Lost to Follow-up|1|||
16066111|NCT04476043|38732973|FG000|Overall Study|Adverse Event|2|||
16066112|NCT04476043|38732974|FG001|Overall Study|Adverse Event|0|||
16066113|NCT04476043|38732975|FG002|Overall Study|Adverse Event|1|||
16066114|NCT04476043|38732976|FG003|Overall Study|Adverse Event|0|||
16066115|NCT04476043|38732973|FG000|Overall Study|Protocol Violation|0|||
16066116|NCT04476043|38732974|FG001|Overall Study|Protocol Violation|1|||
16066117|NCT04476043|38732975|FG002|Overall Study|Protocol Violation|0|||
16066118|NCT04476043|38732976|FG003|Overall Study|Protocol Violation|0|||
16066119|NCT01240356|38732977|FG000|Overall Study|Withdrawal by Subject|2|||
16066120|NCT01240356|38732978|FG001|Overall Study|Withdrawal by Subject|0|||
16066121|NCT01240356|38732977|FG000|Overall Study|MRI contraindication|1|||
16066122|NCT01240356|38732978|FG001|Overall Study|MRI contraindication|0|||
16066123|NCT02317705|38732979|FG000|Overall Study|Withdrawal by Subject|3|||
16066124|NCT02317705|38732979|FG000|Overall Study|Physician Decision|1|||
16066125|NCT02317705|38732979|FG000|Overall Study|Drug not usable|1|||
16066126|NCT00852475|38732980|FG000|Overall Study|Lost to Follow-up|3|||
16066127|NCT00852475|38732981|FG001|Overall Study|Lost to Follow-up|4|||
16066128|NCT00184028|38732982|FG000|Overall Study|Death|1|||
16066129|NCT00184028|38732982|FG000|Overall Study|Lack of Efficacy|4|||
16066130|NCT00184028|38732982|FG000|Overall Study|Adverse Event|2|||
16066131|NCT00184028|38732982|FG000|Overall Study|Withdrawal by Subject|1|||
16066132|NCT00184028|38732982|FG000|Overall Study|Non-compliance|2|||
16066133|NCT00672256|38732987|FG000|Overall Study|PI dropped, bad data|44|||
16066134|NCT00783718|38732990|FG000|Induction Phase|Adverse Event|4|||
16066135|NCT00783718|38732991|FG001|Induction Phase|Adverse Event|0|||
16066136|NCT00783718|38732992|FG002|Induction Phase|Adverse Event|7|||
16066137|NCT00783718|38732993|FG003|Induction Phase|Adverse Event|0|||
16066138|NCT00783718|38732994|FG004|Induction Phase|Adverse Event|0|||
16066139|NCT00783718|38732995|FG005|Induction Phase|Adverse Event|0|||
16066140|NCT00783718|38732996|FG006|Induction Phase|Adverse Event|0|||
16066141|NCT00783718|38732990|FG000|Induction Phase|Protocol Violation|1|||
16066142|NCT00783718|38732991|FG001|Induction Phase|Protocol Violation|1|||
16066143|NCT00783718|38732992|FG002|Induction Phase|Protocol Violation|6|||
16066144|NCT00783718|38732993|FG003|Induction Phase|Protocol Violation|0|||
16066145|NCT00783718|38732994|FG004|Induction Phase|Protocol Violation|0|||
16066146|NCT00783718|38732995|FG005|Induction Phase|Protocol Violation|0|||
16066147|NCT00783718|38732996|FG006|Induction Phase|Protocol Violation|0|||
16066148|NCT00783718|38732990|FG000|Induction Phase|Lack of Efficacy|5|||
16066149|NCT00783718|38732991|FG001|Induction Phase|Lack of Efficacy|2|||
16066150|NCT00783718|38732992|FG002|Induction Phase|Lack of Efficacy|14|||
16066151|NCT00783718|38732993|FG003|Induction Phase|Lack of Efficacy|0|||
16066152|NCT00783718|38732994|FG004|Induction Phase|Lack of Efficacy|0|||
16066153|NCT00783718|38732995|FG005|Induction Phase|Lack of Efficacy|0|||
16066154|NCT00783718|38732996|FG006|Induction Phase|Lack of Efficacy|0|||
16066155|NCT00783718|38732990|FG000|Induction Phase|Withdrawal by Subject|3|||
16066156|NCT00783718|38732991|FG001|Induction Phase|Withdrawal by Subject|4|||
16066157|NCT00783718|38732992|FG002|Induction Phase|Withdrawal by Subject|8|||
16066158|NCT00783718|38732993|FG003|Induction Phase|Withdrawal by Subject|0|||
16066159|NCT00783718|38732994|FG004|Induction Phase|Withdrawal by Subject|0|||
16066160|NCT00783718|38732995|FG005|Induction Phase|Withdrawal by Subject|0|||
16066161|NCT00783718|38732996|FG006|Induction Phase|Withdrawal by Subject|0|||
16066162|NCT00783718|38732990|FG000|Induction Phase|Lost to Follow-up|1|||
16066163|NCT00783718|38732991|FG001|Induction Phase|Lost to Follow-up|0|||
16158682|NCT01375764|39064880|FG004|Overall Study|Withdrawal by Subject|1|||
16066164|NCT00783718|38732992|FG002|Induction Phase|Lost to Follow-up|1|||
16066165|NCT00783718|38732993|FG003|Induction Phase|Lost to Follow-up|0|||
16066166|NCT00783718|38732994|FG004|Induction Phase|Lost to Follow-up|0|||
16066167|NCT00783718|38732995|FG005|Induction Phase|Lost to Follow-up|0|||
16066168|NCT00783718|38732996|FG006|Induction Phase|Lost to Follow-up|0|||
16066169|NCT00783718|38732990|FG000|Maintenance Phase|Adverse Event|12|||
16066170|NCT00783718|38732991|FG001|Maintenance Phase|Adverse Event|0|||
16066171|NCT00783718|38732992|FG002|Maintenance Phase|Adverse Event|0|||
16158683|NCT01375764|39064876|FG000|Overall Study|Other|0|||
16158684|NCT01375764|39064877|FG001|Overall Study|Other|0|||
16158685|NCT01375764|39064878|FG002|Overall Study|Other|0|||
16158686|NCT01375764|39064879|FG003|Overall Study|Other|1|||
16158687|NCT01375764|39064880|FG004|Overall Study|Other|0|||
16158688|NCT01634555|39064881|FG000|Overall Study|Adverse Event|3|||
16158689|NCT01634555|39064881|FG000|Overall Study|Physician Decision|1|||
16158690|NCT00159861|39064882|FG000|Core Study - 16 Weeks|Death|3|||
16158691|NCT00159861|39064883|FG001|Core Study - 16 Weeks|Death|0|||
16158692|NCT00159861|39064882|FG000|Core Study - 16 Weeks|Adverse Event|12|||
16158693|NCT00159861|39064883|FG001|Core Study - 16 Weeks|Adverse Event|6|||
16158694|NCT00159861|39064882|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
16158695|NCT00159861|39064883|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
16158696|NCT00159861|39064882|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
16158697|NCT00159861|39064883|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
16158698|NCT00159861|39064882|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
16158699|NCT00159861|39064883|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
16158700|NCT00159861|39064882|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
16158701|NCT00159861|39064883|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
16066172|NCT00783718|38732993|FG003|Maintenance Phase|Adverse Event|15|||
16066173|NCT00783718|38732994|FG004|Maintenance Phase|Adverse Event|7|||
16066174|NCT00783718|38732995|FG005|Maintenance Phase|Adverse Event|6|||
16066175|NCT00783718|38732996|FG006|Maintenance Phase|Adverse Event|16|||
16066176|NCT00783718|38732990|FG000|Maintenance Phase|Protocol Violation|1|||
16066177|NCT00783718|38732991|FG001|Maintenance Phase|Protocol Violation|0|||
16066178|NCT00783718|38732992|FG002|Maintenance Phase|Protocol Violation|0|||
16066179|NCT00783718|38732993|FG003|Maintenance Phase|Protocol Violation|0|||
16066180|NCT00783718|38732994|FG004|Maintenance Phase|Protocol Violation|0|||
16066181|NCT00783718|38732995|FG005|Maintenance Phase|Protocol Violation|0|||
16066182|NCT00783718|38732996|FG006|Maintenance Phase|Protocol Violation|2|||
16066183|NCT00783718|38732990|FG000|Maintenance Phase|Lack of Efficacy|83|||
16066184|NCT00783718|38732991|FG001|Maintenance Phase|Lack of Efficacy|0|||
16066185|NCT00783718|38732992|FG002|Maintenance Phase|Lack of Efficacy|0|||
16066186|NCT00783718|38732993|FG003|Maintenance Phase|Lack of Efficacy|61|||
16066187|NCT00783718|38732994|FG004|Maintenance Phase|Lack of Efficacy|31|||
16066188|NCT00783718|38732995|FG005|Maintenance Phase|Lack of Efficacy|33|||
16066189|NCT00783718|38732996|FG006|Maintenance Phase|Lack of Efficacy|155|||
16066190|NCT00783718|38732990|FG000|Maintenance Phase|Withdrawal by Subject|6|||
16066191|NCT00783718|38732991|FG001|Maintenance Phase|Withdrawal by Subject|0|||
16066192|NCT00783718|38732992|FG002|Maintenance Phase|Withdrawal by Subject|0|||
16066193|NCT00783718|38732993|FG003|Maintenance Phase|Withdrawal by Subject|2|||
16066194|NCT00783718|38732994|FG004|Maintenance Phase|Withdrawal by Subject|5|||
16066195|NCT00783718|38732995|FG005|Maintenance Phase|Withdrawal by Subject|2|||
16066196|NCT00783718|38732996|FG006|Maintenance Phase|Withdrawal by Subject|20|||
16066197|NCT00783718|38732990|FG000|Maintenance Phase|Lost to Follow-up|3|||
16066198|NCT00783718|38732991|FG001|Maintenance Phase|Lost to Follow-up|0|||
16066199|NCT00783718|38732992|FG002|Maintenance Phase|Lost to Follow-up|0|||
16066200|NCT00783718|38732993|FG003|Maintenance Phase|Lost to Follow-up|0|||
16066201|NCT00783718|38732994|FG004|Maintenance Phase|Lost to Follow-up|2|||
16066202|NCT00783718|38732995|FG005|Maintenance Phase|Lost to Follow-up|0|||
16066203|NCT00783718|38732996|FG006|Maintenance Phase|Lost to Follow-up|2|||
16066204|NCT00724061|38733000|FG000|Dose Escalation Phase|Adverse Event|2|||
16066205|NCT00724061|38733000|FG000|Dose Escalation Phase|Disease Progression|3|||
16066206|NCT01890967|38733010|FG000|Overall Study|Adverse Event|3|||
16066207|NCT01890967|38733011|FG001|Overall Study|Adverse Event|3|||
16066208|NCT01890967|38733012|FG002|Overall Study|Adverse Event|3|||
16066209|NCT01890967|38733013|FG003|Overall Study|Adverse Event|2|||
16066210|NCT01890967|38733014|FG004|Overall Study|Adverse Event|1|||
16066211|NCT01890967|38733015|FG005|Overall Study|Adverse Event|7|||
16066212|NCT01890967|38733010|FG000|Overall Study|Death|1|||
16066213|NCT01890967|38733011|FG001|Overall Study|Death|0|||
16066214|NCT01890967|38733012|FG002|Overall Study|Death|0|||
16066215|NCT01890967|38733013|FG003|Overall Study|Death|0|||
16066216|NCT01890967|38733014|FG004|Overall Study|Death|0|||
16066217|NCT01890967|38733015|FG005|Overall Study|Death|0|||
16066218|NCT01890967|38733010|FG000|Overall Study|Lost to Follow-up|1|||
16066219|NCT01890967|38733011|FG001|Overall Study|Lost to Follow-up|1|||
16066220|NCT01890967|38733012|FG002|Overall Study|Lost to Follow-up|1|||
16066221|NCT01890967|38733013|FG003|Overall Study|Lost to Follow-up|1|||
16066222|NCT01890967|38733014|FG004|Overall Study|Lost to Follow-up|0|||
16066223|NCT01890967|38733015|FG005|Overall Study|Lost to Follow-up|1|||
16066224|NCT01890967|38733010|FG000|Overall Study|Protocol Violation|0|||
16066225|NCT01890967|38733011|FG001|Overall Study|Protocol Violation|3|||
16066226|NCT01890967|38733012|FG002|Overall Study|Protocol Violation|3|||
16066227|NCT01890967|38733013|FG003|Overall Study|Protocol Violation|2|||
16066228|NCT01890967|38733014|FG004|Overall Study|Protocol Violation|4|||
16158702|NCT00159861|39064882|FG000|Extension Study - up to 3 Years|Death|24|||
16066229|NCT01890967|38733015|FG005|Overall Study|Protocol Violation|1|||
16066230|NCT01890967|38733010|FG000|Overall Study|Sponsor Decision|2|||
16368838|NCT02265744|39833317|FG004|Overall Study|Pregnancy|0|||
16368839|NCT00604383|39833318|FG000|Overall Study|Withdrawal by Subject|33|||
16368840|NCT00604383|39833319|FG001|Overall Study|Withdrawal by Subject|31|||
16368841|NCT00604383|39833318|FG000|Overall Study|Lost to Follow-up|24|||
16368842|NCT00604383|39833319|FG001|Overall Study|Lost to Follow-up|19|||
16445899|NCT00459316|40111733|FG002|Steps 1 & 2|Lost to Follow-up|2|||
16445900|NCT00459316|40111731|FG000|Step 3|Withdrawal by Subject|3|||
16445901|NCT00459316|40111732|FG001|Step 3|Withdrawal by Subject|0|||
16445902|NCT00459316|40111733|FG002|Step 3|Withdrawal by Subject|1|||
16445903|NCT00684021|40111734|FG000|Overall Study|MRI Contraindicated|1|||
16445904|NCT00684021|40111735|FG001|Overall Study|MRI Contraindicated|1|||
16368843|NCT00604383|39833318|FG000|Overall Study|Death|14|||
16368844|NCT00604383|39833319|FG001|Overall Study|Death|22|||
16368845|NCT00604383|39833318|FG000|Overall Study|Adverse Event|16|||
16368846|NCT00604383|39833319|FG001|Overall Study|Adverse Event|9|||
16368847|NCT00604383|39833318|FG000|Overall Study|Physician Decision|0|||
16368848|NCT00604383|39833319|FG001|Overall Study|Physician Decision|3|||
16368849|NCT01145222|39833320|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
16368850|NCT01145222|39833321|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
16368851|NCT01145222|39833322|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
16368852|NCT01145222|39833323|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
16368853|NCT01145222|39833320|FG000|Overall Study|Poor bowel preparation|0|||
16368854|NCT01145222|39833321|FG001|Overall Study|Poor bowel preparation|0|||
16368855|NCT01145222|39833322|FG002|Overall Study|Poor bowel preparation|0|||
16368856|NCT01145222|39833323|FG003|Overall Study|Poor bowel preparation|1|||
16368857|NCT00683384|39833327|FG000|Overall Study|Death|1|||
16368858|NCT00683384|39833327|FG000|Overall Study|Adverse Event|1|||
16066231|NCT01890967|38733011|FG001|Overall Study|Sponsor Decision|0|||
16368859|NCT00898807|39833329|FG000|Overall Study|Withdrawal by Subject|5|||
16445905|NCT00684021|40111736|FG002|Overall Study|MRI Contraindicated|1|||
16066232|NCT01890967|38733012|FG002|Overall Study|Sponsor Decision|1|||
16066233|NCT01890967|38733013|FG003|Overall Study|Sponsor Decision|3|||
16368860|NCT00898807|39833330|FG001|Overall Study|Withdrawal by Subject|3|||
16368861|NCT00898807|39833329|FG000|Overall Study|Family pressure to discontinue|2|||
16368862|NCT00898807|39833330|FG001|Overall Study|Family pressure to discontinue|2|||
16368863|NCT00898807|39833329|FG000|Overall Study|Lost to Follow-up|1|||
16368864|NCT00898807|39833330|FG001|Overall Study|Lost to Follow-up|3|||
16368865|NCT00898807|39833329|FG000|Overall Study|Death|0|||
16368866|NCT00898807|39833330|FG001|Overall Study|Death|1|||
16368867|NCT00876343|39833337|FG000|Overall Study|Adverse Event|7|||
16368868|NCT00876343|39833338|FG001|Overall Study|Adverse Event|8|||
16368869|NCT00876343|39833339|FG002|Overall Study|Adverse Event|2|||
16368870|NCT00876343|39833337|FG000|Overall Study|Withdrawal by Subject|4|||
16368871|NCT00876343|39833338|FG001|Overall Study|Withdrawal by Subject|4|||
16368872|NCT00876343|39833339|FG002|Overall Study|Withdrawal by Subject|3|||
16445906|NCT00684021|40111737|FG003|Overall Study|MRI Contraindicated|0|||
16445907|NCT00684021|40111734|FG000|Overall Study|MRI not performed|0|||
16445908|NCT00684021|40111735|FG001|Overall Study|MRI not performed|1|||
16066234|NCT01890967|38733014|FG004|Overall Study|Sponsor Decision|2|||
16066235|NCT01890967|38733015|FG005|Overall Study|Sponsor Decision|3|||
16066236|NCT01890967|38733010|FG000|Overall Study|Withdrawal by Subject|3|||
16066237|NCT01890967|38733011|FG001|Overall Study|Withdrawal by Subject|4|||
16066238|NCT01890967|38733012|FG002|Overall Study|Withdrawal by Subject|2|||
16066239|NCT01890967|38733013|FG003|Overall Study|Withdrawal by Subject|3|||
16066240|NCT01890967|38733014|FG004|Overall Study|Withdrawal by Subject|3|||
16066241|NCT01890967|38733015|FG005|Overall Study|Withdrawal by Subject|1|||
16066242|NCT01304147|38733017|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
16066243|NCT01304147|38733018|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
16066244|NCT01556243|38733019|FG000|Overall Study|Ineligible|34|||
16066245|NCT01556243|38733019|FG000|Overall Study|Converted to mastectomy|14|||
16066246|NCT01556243|38733019|FG000|Overall Study|Unable to achieve negative margins|2|||
16066247|NCT01556243|38733019|FG000|Overall Study|Withdrawal by Subject|16|||
16263419|NCT01190930|39449791|FG003|Induction|Adverse Event|0|||
16368873|NCT00876343|39833337|FG000|Overall Study|Lack of Efficacy|0|||
16368874|NCT00876343|39833338|FG001|Overall Study|Lack of Efficacy|0|||
16368875|NCT00876343|39833339|FG002|Overall Study|Lack of Efficacy|1|||
16445909|NCT00684021|40111736|FG002|Overall Study|MRI not performed|1|||
16445910|NCT00684021|40111737|FG003|Overall Study|MRI not performed|2|||
16445911|NCT00684021|40111734|FG000|Overall Study|Death|1|||
16066248|NCT00209027|38733020|FG000|Overall Study|study terminated|10|||
16066249|NCT00209027|38733021|FG001|Overall Study|study terminated|0|||
16066250|NCT02938442|38733022|FG000|Overall Study|Death|0|||
16066251|NCT02938442|38733023|FG001|Overall Study|Death|1|||
16066252|NCT02938442|38733022|FG000|Overall Study|Lost to Follow-up|0|||
16066253|NCT02938442|38733023|FG001|Overall Study|Lost to Follow-up|1|||
16066254|NCT02938442|38733022|FG000|Overall Study|Physician Decision|0|||
16066255|NCT02938442|38733023|FG001|Overall Study|Physician Decision|1|||
16368876|NCT00876343|39833337|FG000|Overall Study|Protocol Violation|4|||
16445912|NCT00684021|40111735|FG001|Overall Study|Death|0|||
16368877|NCT00876343|39833338|FG001|Overall Study|Protocol Violation|1|||
16368878|NCT00876343|39833339|FG002|Overall Study|Protocol Violation|1|||
16368879|NCT00876343|39833337|FG000|Overall Study|Physician Decision|0|||
16368880|NCT00876343|39833338|FG001|Overall Study|Physician Decision|1|||
16368881|NCT00876343|39833339|FG002|Overall Study|Physician Decision|1|||
16368882|NCT00876343|39833337|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
16368883|NCT00876343|39833338|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
16368884|NCT00876343|39833339|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
16368885|NCT00876343|39833337|FG000|Overall Study|Change of residence or other commitments|2|||
16368886|NCT00876343|39833338|FG001|Overall Study|Change of residence or other commitments|2|||
16368887|NCT00876343|39833339|FG002|Overall Study|Change of residence or other commitments|3|||
16368888|NCT03033901|39833340|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
16368889|NCT03033901|39833340|FG000|Overall Study|Refused PSG|23|||
16368890|NCT03033901|39833340|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
16445913|NCT00684021|40111736|FG002|Overall Study|Death|0|||
16445914|NCT00684021|40111737|FG003|Overall Study|Death|0|||
16445915|NCT02351817|40111738|FG000|Period 1|Adverse Event|1|||
16445916|NCT02351817|40111739|FG001|Period 1|Adverse Event|2|||
16368891|NCT03033901|39833340|FG000|Overall Study|Missing Oximetry Data|3|||
16445917|NCT02351817|40111738|FG000|Period 1|Lack of Efficacy|0|||
16066256|NCT02938442|38733022|FG000|Overall Study|Withdrawal by Subject|2|||
16066257|NCT02938442|38733023|FG001|Overall Study|Withdrawal by Subject|0|||
16263420|NCT01190930|39449792|FG004|Induction|Adverse Event|0|||
16368892|NCT01243424|39833341|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
16368893|NCT01243424|39833342|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
16445918|NCT02351817|40111739|FG001|Period 1|Lack of Efficacy|1|||
16368894|NCT01243424|39833341|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
16368895|NCT01243424|39833342|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
16368896|NCT01243424|39833341|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
16368897|NCT01243424|39833342|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
16368898|NCT01243424|39833341|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
16368899|NCT01243424|39833342|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
16368900|NCT01243424|39833341|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
16368901|NCT01243424|39833342|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
16368902|NCT01243424|39833341|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
16368903|NCT01243424|39833342|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
16368904|NCT01243424|39833341|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
16368905|NCT01243424|39833342|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
16368906|NCT01243424|39833341|FG000|Discontinuation From Treatment|Not treated|5|||
16368907|NCT01243424|39833342|FG001|Discontinuation From Treatment|Not treated|4|||
16368908|NCT01243424|39833341|FG000|Discontinuation From Treatment|Adverse Event|457|||
16368909|NCT01243424|39833342|FG001|Discontinuation From Treatment|Adverse Event|523|||
16368910|NCT01243424|39833341|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
16368911|NCT01243424|39833342|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
16368912|NCT01243424|39833341|FG000|Discontinuation From Treatment|Protocol Violation|46|||
16368913|NCT01243424|39833342|FG001|Discontinuation From Treatment|Protocol Violation|47|||
16368914|NCT01243424|39833341|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
16368915|NCT01243424|39833342|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
16368916|NCT01243424|39833341|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
16368917|NCT01243424|39833342|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
16368918|NCT01243424|39833341|FG000|Discontinuation From Treatment|Other than listed above|230|||
16368919|NCT01243424|39833342|FG001|Discontinuation From Treatment|Other than listed above|211|||
16368920|NCT01732692|39833343|FG000|Overall Study|Adverse Event|0|||
16368921|NCT01732692|39833344|FG001|Overall Study|Adverse Event|1|||
16368922|NCT00981175|39833345|FG000|Primary Dose Vaccination|Adverse Event|1|||
16368923|NCT00981175|39833346|FG001|Primary Dose Vaccination|Adverse Event|0|||
16368924|NCT00981175|39833345|FG000|Primary Dose Vaccination|Protocol Violation|0|||
16368925|NCT00981175|39833346|FG001|Primary Dose Vaccination|Protocol Violation|1|||
16368926|NCT00981175|39833345|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
16368927|NCT00981175|39833346|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
16368928|NCT00981175|39833345|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
16368929|NCT00981175|39833346|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
16368930|NCT00629239|39833348|FG000|Overall Study|Adverse Event|7|||
16368931|NCT00629239|39833349|FG001|Overall Study|Adverse Event|4|||
16368932|NCT00629239|39833348|FG000|Overall Study|Physician Decision|1|||
16368933|NCT00629239|39833349|FG001|Overall Study|Physician Decision|0|||
16445919|NCT02351817|40111738|FG000|Period 2|Adverse Event|0|||
16445920|NCT02351817|40111739|FG001|Period 2|Adverse Event|2|||
16445921|NCT02351817|40111738|FG000|Period 2|Protocol Violation|1|||
16066258|NCT00832780|38733026|FG000|Overall Study|Death|16|||
16066259|NCT00832780|38733026|FG000|Overall Study|Lost to Follow-up|4|||
16368934|NCT04491994|39833361|FG000|Overall Study|Withdrawal by Subject|10|||
16368935|NCT04491994|39833362|FG001|Overall Study|Withdrawal by Subject|5|||
16368936|NCT04491994|39833361|FG000|Overall Study|developed fever > 3 days|4|||
16368937|NCT04491994|39833362|FG001|Overall Study|developed fever > 3 days|1|||
16368938|NCT04491994|39833361|FG000|Overall Study|Protocol Violation|11|||
16368939|NCT04491994|39833362|FG001|Overall Study|Protocol Violation|2|||
16368940|NCT04491994|39833361|FG000|Overall Study|Lost to Follow-up|4|||
16368941|NCT04491994|39833362|FG001|Overall Study|Lost to Follow-up|3|||
16368942|NCT00585585|39833364|FG000|Overall Study|Adverse Event|1|||
16368943|NCT00639379|39836089|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
16445922|NCT02351817|40111739|FG001|Period 2|Protocol Violation|0|||
16445923|NCT01499940|40111743|FG000|Overall Study|Study was withdrawn before completion.|9|||
16445924|NCT00318643|40111744|FG000|Overall Study|Adverse Event|0|||
16445925|NCT00318643|40111745|FG001|Overall Study|Adverse Event|0|||
16445926|NCT00318643|40111746|FG002|Overall Study|Adverse Event|0|||
16445927|NCT00318643|40111747|FG003|Overall Study|Adverse Event|0|||
16445928|NCT00318643|40111748|FG004|Overall Study|Adverse Event|1|||
16445929|NCT00318643|40111744|FG000|Overall Study|Participant's Decision|0|||
16445930|NCT00318643|40111745|FG001|Overall Study|Participant's Decision|0|||
16445931|NCT00318643|40111746|FG002|Overall Study|Participant's Decision|0|||
16445932|NCT00318643|40111747|FG003|Overall Study|Participant's Decision|0|||
16368944|NCT00639379|39836090|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
16368945|NCT00639379|39836089|FG000|Period 1 - 2 Weeks|lens issue|3|||
16368946|NCT00639379|39836090|FG001|Period 1 - 2 Weeks|lens issue|0|||
16368947|NCT00004859|39836095|FG000|Overall Study|Lack of Efficacy|43|||
16368948|NCT00004859|39836096|FG001|Overall Study|Lack of Efficacy|113|||
16368949|NCT00004859|39836095|FG000|Overall Study|Adverse Event|31|||
16368950|NCT00004859|39836096|FG001|Overall Study|Adverse Event|93|||
16368951|NCT00004859|39836095|FG000|Overall Study|Death|5|||
16368952|NCT00004859|39836096|FG001|Overall Study|Death|5|||
16368953|NCT00004859|39836095|FG000|Overall Study|Withdrawal by Subject|7|||
16368954|NCT00004859|39836096|FG001|Overall Study|Withdrawal by Subject|33|||
16368955|NCT00004859|39836095|FG000|Overall Study|Protocol Violation|2|||
16368956|NCT00004859|39836096|FG001|Overall Study|Protocol Violation|2|||
16368957|NCT00004859|39836095|FG000|Overall Study|other disease|0|||
16368958|NCT00004859|39836096|FG001|Overall Study|other disease|3|||
16368959|NCT00004859|39836095|FG000|Overall Study|error|3|||
16368960|NCT00004859|39836096|FG001|Overall Study|error|1|||
16368961|NCT00004859|39836095|FG000|Overall Study|missing data|14|||
16368962|NCT00004859|39836096|FG001|Overall Study|missing data|11|||
16368963|NCT00004859|39836095|FG000|Overall Study|Other|13|||
16368964|NCT00004859|39836096|FG001|Overall Study|Other|21|||
16368965|NCT02068599|39836097|FG000|Overall Study|Adverse Event|4|||
16368966|NCT02068599|39836098|FG001|Overall Study|Adverse Event|1|||
16368967|NCT02068599|39836099|FG002|Overall Study|Adverse Event|1|||
16368968|NCT02068599|39836097|FG000|Overall Study|Withdrawal by Subject|2|||
16368969|NCT02068599|39836098|FG001|Overall Study|Withdrawal by Subject|7|||
16368970|NCT02068599|39836099|FG002|Overall Study|Withdrawal by Subject|5|||
16368971|NCT02068599|39836097|FG000|Overall Study|Protocol Violation|4|||
16368972|NCT02068599|39836098|FG001|Overall Study|Protocol Violation|2|||
16368973|NCT02068599|39836099|FG002|Overall Study|Protocol Violation|3|||
16368974|NCT02068599|39836097|FG000|Overall Study|Lost to Follow-up|1|||
16368975|NCT02068599|39836098|FG001|Overall Study|Lost to Follow-up|0|||
16368976|NCT02068599|39836099|FG002|Overall Study|Lost to Follow-up|0|||
16368977|NCT02068599|39836097|FG000|Overall Study|Lack of Efficacy|0|||
16368978|NCT02068599|39836098|FG001|Overall Study|Lack of Efficacy|0|||
16368979|NCT02068599|39836099|FG002|Overall Study|Lack of Efficacy|3|||
16368980|NCT02068599|39836097|FG000|Overall Study|Noncompliance|0|||
16368981|NCT02068599|39836098|FG001|Overall Study|Noncompliance|0|||
16368982|NCT02068599|39836099|FG002|Overall Study|Noncompliance|1|||
16368983|NCT00382070|39836100|FG000|Overall Study|No follow up data mapped to Other|17|||
16368984|NCT00382070|39836101|FG001|Overall Study|No follow up data mapped to Other|19|||
16368985|NCT00382070|39836100|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
16368986|NCT00382070|39836101|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
16368987|NCT00382070|39836100|FG000|Overall Study|No clinical assessment|9|||
16368988|NCT00382070|39836101|FG001|Overall Study|No clinical assessment|11|||
16445933|NCT00318643|40111748|FG004|Overall Study|Participant's Decision|1|||
16445934|NCT00318643|40111744|FG000|Overall Study|Investigator's Decision|0|||
16368989|NCT01967277|39836106|FG000|Overall Study|Lost to Follow-up|1|||
16368990|NCT01967277|39836107|FG001|Overall Study|Lost to Follow-up|2|||
16368991|NCT01967277|39836106|FG000|Overall Study|Unrelated illness|0|||
16368992|NCT01967277|39836107|FG001|Overall Study|Unrelated illness|1|||
16445935|NCT00318643|40111745|FG001|Overall Study|Investigator's Decision|0|||
16368993|NCT00927186|39836110|FG000|12 Months Primary Study|Adverse Event|5|||
16368994|NCT00927186|39836111|FG001|12 Months Primary Study|Adverse Event|2|||
16368995|NCT00927186|39836110|FG000|12 Months Primary Study|Lost to Follow-up|1|||
16368996|NCT00927186|39836111|FG001|12 Months Primary Study|Lost to Follow-up|0|||
16368997|NCT00927186|39836110|FG000|12 Months Primary Study|Protocol Violation|0|||
16368998|NCT00927186|39836111|FG001|12 Months Primary Study|Protocol Violation|1|||
16368999|NCT00927186|39836110|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
16369000|NCT00927186|39836111|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
16369001|NCT01058005|39836112|FG000|Overall Study|Adverse Event|0|||
16369002|NCT01058005|39836113|FG001|Overall Study|Adverse Event|2|||
16369003|NCT01058005|39836114|FG002|Overall Study|Adverse Event|1|||
16369004|NCT01058005|39836112|FG000|Overall Study|Physician Decision|2|||
16369005|NCT01058005|39836113|FG001|Overall Study|Physician Decision|2|||
16369006|NCT01058005|39836114|FG002|Overall Study|Physician Decision|0|||
16369007|NCT01058005|39836112|FG000|Overall Study|Withdrawal by Subject|4|||
16369008|NCT01058005|39836113|FG001|Overall Study|Withdrawal by Subject|5|||
16369009|NCT01058005|39836114|FG002|Overall Study|Withdrawal by Subject|11|||
16369010|NCT01058005|39836112|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
16369011|NCT01058005|39836113|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
16369012|NCT01058005|39836114|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
16369013|NCT01058005|39836112|FG000|Overall Study|Reason Missing|5|||
16369014|NCT01058005|39836113|FG001|Overall Study|Reason Missing|3|||
16369015|NCT01058005|39836114|FG002|Overall Study|Reason Missing|1|||
16066260|NCT00832780|38733026|FG000|Overall Study|no reason given|2|||
16066261|NCT00832780|38733026|FG000|Overall Study|other complicating condition|2|||
16066262|NCT00832780|38733026|FG000|Overall Study|Physician Decision|1|||
16066263|NCT00058058|38733029|FG000|Overall Study|Withdrawal by Subject|4|||
16066264|NCT00058058|38733029|FG000|Overall Study|Ineligible|20|||
16066265|NCT00058058|38733029|FG000|Overall Study|Claustrophobic|5|||
16369016|NCT00601107|39836115|FG000|Overall Study|Adverse Event|0|||
16369017|NCT00601107|39836116|FG001|Overall Study|Adverse Event|1|||
16369018|NCT00601107|39836117|FG002|Overall Study|Adverse Event|3|||
16369019|NCT00601107|39836118|FG003|Overall Study|Adverse Event|0|||
16369020|NCT00601107|39836115|FG000|Overall Study|Withdrawal by Subject|5|||
16369021|NCT00601107|39836116|FG001|Overall Study|Withdrawal by Subject|4|||
16369022|NCT00601107|39836117|FG002|Overall Study|Withdrawal by Subject|7|||
16369023|NCT00601107|39836118|FG003|Overall Study|Withdrawal by Subject|4|||
16369024|NCT00601107|39836115|FG000|Overall Study|Lost to Follow-up|3|||
16369025|NCT00601107|39836116|FG001|Overall Study|Lost to Follow-up|3|||
16369026|NCT00601107|39836117|FG002|Overall Study|Lost to Follow-up|0|||
16369027|NCT00601107|39836118|FG003|Overall Study|Lost to Follow-up|3|||
16369028|NCT00601107|39836115|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
16369029|NCT00601107|39836116|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
16369030|NCT00601107|39836117|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
16369031|NCT00601107|39836118|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
16369032|NCT00601107|39836115|FG000|Overall Study|Worsening of Psoriasis|4|||
16369033|NCT00601107|39836116|FG001|Overall Study|Worsening of Psoriasis|1|||
16369034|NCT00601107|39836117|FG002|Overall Study|Worsening of Psoriasis|1|||
16369035|NCT00601107|39836118|FG003|Overall Study|Worsening of Psoriasis|4|||
16369036|NCT00601107|39836115|FG000|Overall Study|Undefined|1|||
16369037|NCT00601107|39836116|FG001|Overall Study|Undefined|0|||
16369038|NCT00601107|39836117|FG002|Overall Study|Undefined|1|||
16369039|NCT00601107|39836118|FG003|Overall Study|Undefined|0|||
16369040|NCT03515837|39836119|FG000|Overall Study|Death|214|||
16369041|NCT03515837|39836120|FG001|Overall Study|Death|221|||
16369042|NCT03515837|39836119|FG000|Overall Study|Lost to Follow-up|0|||
16369043|NCT03515837|39836120|FG001|Overall Study|Lost to Follow-up|1|||
16369044|NCT03515837|39836119|FG000|Overall Study|Ongoing|31|||
16369045|NCT03515837|39836120|FG001|Overall Study|Ongoing|21|||
16369046|NCT03515837|39836119|FG000|Overall Study|Withdrawal by Subject|0|||
16369047|NCT03515837|39836120|FG001|Overall Study|Withdrawal by Subject|4|||
16066266|NCT00058058|38733029|FG000|Overall Study|technical issues|6|||
16066267|NCT00058058|38733029|FG000|Overall Study|Poor positioning, illness,pain|3|||
16066268|NCT04091672|38733030|FG000|Overall Study|Death|6|||
16066269|NCT04091672|38733031|FG001|Overall Study|Death|6|||
16066270|NCT04091672|38733030|FG000|Overall Study|Lost to Follow-up|7|||
16066271|NCT04091672|38733031|FG001|Overall Study|Lost to Follow-up|7|||
16066272|NCT04091672|38733030|FG000|Overall Study|Withdrawal by Subject|3|||
16066273|NCT04091672|38733031|FG001|Overall Study|Withdrawal by Subject|3|||
16066274|NCT04091672|38733030|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
16369048|NCT01946802|39836122|FG000|Overall Study|Death|1|||
16369049|NCT01946802|39836122|FG000|Overall Study|Withdrawal by Subject|2|||
16369050|NCT01946802|39836122|FG000|Overall Study|Combined septic shock|1|||
16369051|NCT01946802|39836122|FG000|Overall Study|Protocol Violation|1|||
16369052|NCT00290758|39836123|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
16369053|NCT00290758|39836124|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
16369054|NCT00290758|39836123|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
16066275|NCT04091672|38733031|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
16066276|NCT02256969|38733032|FG000|Overall Study|Screenfailed or withdrew|2|||
16066277|NCT02256969|38733033|FG001|Overall Study|Screenfailed or withdrew|1|||
16066278|NCT02256969|38733034|FG002|Overall Study|Screenfailed or withdrew|1|||
16066279|NCT00906698|38733035|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
16369055|NCT00290758|39836124|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
16369056|NCT00290758|39836123|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
16369057|NCT00290758|39836124|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
16369058|NCT00290758|39836123|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
16369059|NCT00290758|39836124|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
16369060|NCT00290758|39836123|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
16369061|NCT00290758|39836124|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
16369062|NCT00290758|39836123|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
16369063|NCT00290758|39836124|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
16369064|NCT00290758|39836123|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
16369065|NCT00290758|39836124|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
16369066|NCT00290758|39836123|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
16369067|NCT00290758|39836124|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
16369068|NCT03097315|39836125|FG000|Overall Study|Withdrawal by Subject|1|||
16369069|NCT00122187|39836126|FG000|Overall Study|Withdrew because of resource limitations|2|||
16369070|NCT00122187|39836127|FG001|Overall Study|Withdrew because of resource limitations|2|||
16369071|NCT01913470|39836131|FG000|Overall Study|Lost to Follow-up|0|||
16369072|NCT01913470|39836132|FG001|Overall Study|Lost to Follow-up|1|||
16369073|NCT01913470|39836131|FG000|Overall Study|Physician Decision|0|||
16369074|NCT01913470|39836132|FG001|Overall Study|Physician Decision|1|||
16369075|NCT01913470|39836131|FG000|Overall Study|Withdrawal by Subject|0|||
16369076|NCT01913470|39836132|FG001|Overall Study|Withdrawal by Subject|1|||
16369077|NCT00456612|39836133|FG000|Overall Study|Withdrawal by Subject|3|||
16369078|NCT00368550|39836134|FG000|Overall Study|Adverse Event|7|||
16369079|NCT00368550|39836135|FG001|Overall Study|Adverse Event|4|||
16369080|NCT00368550|39836134|FG000|Overall Study|Lack of Efficacy|4|||
16369081|NCT00368550|39836135|FG001|Overall Study|Lack of Efficacy|9|||
16369082|NCT00368550|39836134|FG000|Overall Study|Withdrawal by Subject|17|||
16369083|NCT00368550|39836135|FG001|Overall Study|Withdrawal by Subject|10|||
16369084|NCT00266812|39836138|FG000|Overall Study|Disease Progression|9|||
16369085|NCT00266812|39836139|FG001|Overall Study|Disease Progression|3|||
16369086|NCT00266812|39836138|FG000|Overall Study|Death|5|||
16369087|NCT00266812|39836139|FG001|Overall Study|Death|4|||
16369088|NCT00266812|39836138|FG000|Overall Study|Adverse Event|3|||
16369089|NCT00266812|39836139|FG001|Overall Study|Adverse Event|1|||
16369090|NCT00266812|39836138|FG000|Overall Study|Protocol Violation|0|||
16369091|NCT00266812|39836139|FG001|Overall Study|Protocol Violation|1|||
16369092|NCT00266812|39836138|FG000|Overall Study|Withdrawal by Subject|0|||
16369093|NCT00266812|39836139|FG001|Overall Study|Withdrawal by Subject|2|||
16369094|NCT00266812|39836138|FG000|Overall Study|Discontinued before starting study drug|4|||
16369095|NCT00266812|39836139|FG001|Overall Study|Discontinued before starting study drug|0|||
16369096|NCT01530256|39836140|FG000|Overall Study|Death|2|||
16369097|NCT03828383|39836141|FG000|Overall Study|Lost to Follow-up|3|||
16369098|NCT03828383|39836142|FG001|Overall Study|Lost to Follow-up|2|||
16369099|NCT03828383|39836141|FG000|Overall Study|Withdrawal by Subject|4|||
16369100|NCT03828383|39836142|FG001|Overall Study|Withdrawal by Subject|5|||
16369101|NCT01155323|39836145|FG000|First Intervention|exclusion criteria|1|||
16369102|NCT01155323|39836146|FG001|First Intervention|exclusion criteria|1|||
16369103|NCT01155323|39836145|FG000|Second Intervention|Lost to Follow-up|1|||
16369104|NCT01155323|39836146|FG001|Second Intervention|Lost to Follow-up|1|||
16369105|NCT01331005|39836149|FG000|Overall Study|Lost to Follow-up|2|||
16369106|NCT01331005|39836150|FG001|Overall Study|Lost to Follow-up|1|||
16369107|NCT01331005|39836149|FG000|Overall Study|Withdrawal by Subject|2|||
16369108|NCT01331005|39836150|FG001|Overall Study|Withdrawal by Subject|3|||
16369109|NCT00290238|39836151|FG000|Overall Study|Study terminated|27|||
16369110|NCT00290238|39836152|FG001|Overall Study|Study terminated|27|||
16369111|NCT00290238|39836151|FG000|Overall Study|Lost to Follow-up|0|||
16369112|NCT00290238|39836152|FG001|Overall Study|Lost to Follow-up|1|||
16369113|NCT00290238|39836151|FG000|Overall Study|Withdrawal by Subject|15|||
16369114|NCT00290238|39836152|FG001|Overall Study|Withdrawal by Subject|13|||
16369115|NCT00574951|39836155|FG000|Overall Study|Ineligible - improper prior treatment|1|||
16369116|NCT00153920|39836158|FG000|Overall Study|Adverse Event|9|||
16369117|NCT00153920|39836158|FG000|Overall Study|Progressive Disease|9|||
16369118|NCT00153920|39836158|FG000|Overall Study|Physician Decision|3|||
16369119|NCT00153920|39836158|FG000|Overall Study|Lack of Response|3|||
16369120|NCT00153920|39836158|FG000|Overall Study|Death|2|||
16369121|NCT00153920|39836158|FG000|Overall Study|Withdrawal by Subject|1|||
16066280|NCT00906698|38733036|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
16066281|NCT00906698|38733037|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
16066282|NCT00906698|38733038|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
16066283|NCT00906698|38733039|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
16369122|NCT00153920|39836158|FG000|Overall Study|Non-Protocol Therapy|1|||
16369123|NCT00153920|39836158|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
16369124|NCT00153920|39836158|FG000|Overall Study|Progressive Disease before Trt|1|||
16369125|NCT01011283|39836159|FG000|Overall Study|Adverse Event|4|||
16369126|NCT01011283|39836160|FG001|Overall Study|Adverse Event|2|||
16369127|NCT01011283|39836159|FG000|Overall Study|Progressive Disease|0|||
16369128|NCT01011283|39836160|FG001|Overall Study|Progressive Disease|2|||
16369129|NCT01011283|39836159|FG000|Overall Study|Terminated by Sponsor|5|||
16369130|NCT01011283|39836160|FG001|Overall Study|Terminated by Sponsor|5|||
16369131|NCT01011283|39836159|FG000|Overall Study|Other|2|||
16369132|NCT01011283|39836160|FG001|Overall Study|Other|2|||
16369133|NCT01281306|39836171|FG000|Overall Study|Lack of Efficacy|0|||
16369134|NCT01281306|39836172|FG001|Overall Study|Lack of Efficacy|1|||
16369135|NCT01281306|39836173|FG002|Overall Study|Lack of Efficacy|3|||
16369136|NCT01281306|39836174|FG003|Overall Study|Lack of Efficacy|0|||
16369137|NCT01281306|39836175|FG004|Overall Study|Lack of Efficacy|2|||
16369138|NCT01281306|39836176|FG005|Overall Study|Lack of Efficacy|0|||
16369139|NCT01281306|39836177|FG006|Overall Study|Lack of Efficacy|1|||
16369140|NCT01281306|39836171|FG000|Overall Study|Withdrawal by Subject|1|||
16369141|NCT01281306|39836172|FG001|Overall Study|Withdrawal by Subject|0|||
16369142|NCT01281306|39836173|FG002|Overall Study|Withdrawal by Subject|2|||
16369143|NCT01281306|39836174|FG003|Overall Study|Withdrawal by Subject|4|||
16369144|NCT01281306|39836175|FG004|Overall Study|Withdrawal by Subject|1|||
16369145|NCT01281306|39836176|FG005|Overall Study|Withdrawal by Subject|3|||
16369146|NCT01281306|39836177|FG006|Overall Study|Withdrawal by Subject|1|||
16369147|NCT01281306|39836171|FG000|Overall Study|Protocol deviation|0|||
16369148|NCT01281306|39836172|FG001|Overall Study|Protocol deviation|1|||
16445936|NCT00318643|40111746|FG002|Overall Study|Investigator's Decision|0|||
16445937|NCT00318643|40111747|FG003|Overall Study|Investigator's Decision|0|||
16445938|NCT00318643|40111748|FG004|Overall Study|Investigator's Decision|1|||
16445939|NCT02388269|40111749|FG000|Overall Study|Adverse Event|2|||
16445940|NCT02388269|40111750|FG001|Overall Study|Adverse Event|0|||
16445941|NCT02388269|40111751|FG002|Overall Study|Adverse Event|0|||
16445942|NCT02388269|40111749|FG000|Overall Study|Withdrawal by Subject|1|||
16066284|NCT00906698|38733040|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
16066285|NCT00906698|38733035|FG000|Overall Study|Adverse Event|0|||
16066286|NCT00906698|38733036|FG001|Overall Study|Adverse Event|0|||
16066287|NCT00906698|38733037|FG002|Overall Study|Adverse Event|2|||
16066288|NCT00906698|38733038|FG003|Overall Study|Adverse Event|0|||
16066289|NCT00906698|38733039|FG004|Overall Study|Adverse Event|4|||
16066290|NCT00906698|38733040|FG005|Overall Study|Adverse Event|1|||
16066291|NCT00906698|38733035|FG000|Overall Study|Disease progression|3|||
16066292|NCT00906698|38733036|FG001|Overall Study|Disease progression|12|||
16066293|NCT00906698|38733037|FG002|Overall Study|Disease progression|4|||
16066294|NCT00906698|38733038|FG003|Overall Study|Disease progression|4|||
16066295|NCT00906698|38733039|FG004|Overall Study|Disease progression|12|||
16066296|NCT00906698|38733040|FG005|Overall Study|Disease progression|4|||
16066297|NCT00906698|38733035|FG000|Overall Study|Withdrawal by Subject|0|||
16066298|NCT00906698|38733036|FG001|Overall Study|Withdrawal by Subject|0|||
16445943|NCT02388269|40111750|FG001|Overall Study|Withdrawal by Subject|2|||
16445944|NCT02388269|40111751|FG002|Overall Study|Withdrawal by Subject|0|||
16445945|NCT02388269|40111749|FG000|Overall Study|less than 50% stimulations|1|||
16445946|NCT02388269|40111750|FG001|Overall Study|less than 50% stimulations|0|||
16445947|NCT02388269|40111751|FG002|Overall Study|less than 50% stimulations|0|||
16445948|NCT02388269|40111749|FG000|Overall Study|no diary data|3|||
16445949|NCT02388269|40111750|FG001|Overall Study|no diary data|0|||
16445950|NCT02388269|40111751|FG002|Overall Study|no diary data|0|||
16445951|NCT02388269|40111749|FG000|Overall Study|Protocol Violation|2|||
16445952|NCT02388269|40111750|FG001|Overall Study|Protocol Violation|0|||
16445953|NCT02388269|40111751|FG002|Overall Study|Protocol Violation|0|||
16445954|NCT02388269|40111749|FG000|Overall Study|Screen Failure|0|||
16445955|NCT02388269|40111750|FG001|Overall Study|Screen Failure|0|||
16445956|NCT02388269|40111751|FG002|Overall Study|Screen Failure|10|||
16445957|NCT00561925|40111752|FG000|14 Day Lead-In Period|Adverse Event|38|||
16445958|NCT00561925|40111753|FG001|14 Day Lead-In Period|Adverse Event|0|||
16445959|NCT00561925|40111754|FG002|14 Day Lead-In Period|Adverse Event|0|||
16066299|NCT00906698|38733037|FG002|Overall Study|Withdrawal by Subject|0|||
16445960|NCT00561925|40111755|FG003|14 Day Lead-In Period|Adverse Event|0|||
16445961|NCT00561925|40111756|FG004|14 Day Lead-In Period|Adverse Event|0|||
16445962|NCT00561925|40111752|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
16445963|NCT00561925|40111753|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
16445964|NCT00561925|40111754|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
16066300|NCT00906698|38733038|FG003|Overall Study|Withdrawal by Subject|0|||
16445965|NCT00561925|40111755|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
16445966|NCT00561925|40111756|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
16066301|NCT00906698|38733039|FG004|Overall Study|Withdrawal by Subject|1|||
16066302|NCT00906698|38733040|FG005|Overall Study|Withdrawal by Subject|0|||
16066303|NCT00906698|38733035|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
16066304|NCT00906698|38733036|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
16445967|NCT00561925|40111752|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
16369149|NCT01281306|39836173|FG002|Overall Study|Protocol deviation|1|||
16369150|NCT01281306|39836174|FG003|Overall Study|Protocol deviation|1|||
16369151|NCT01281306|39836175|FG004|Overall Study|Protocol deviation|1|||
16369152|NCT01281306|39836176|FG005|Overall Study|Protocol deviation|0|||
16066305|NCT00906698|38733037|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
16066306|NCT00906698|38733038|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
16066307|NCT00906698|38733039|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
16066308|NCT00906698|38733040|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
16066309|NCT04550039|38733041|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
16066310|NCT04550039|38733042|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
16066311|NCT04550039|38733041|FG000|Overall Study|patient self-withdrew from study|0|||
16066312|NCT04550039|38733042|FG001|Overall Study|patient self-withdrew from study|1|||
16066313|NCT04438785|38733046|FG000|Overall Study|change of weight, give up intervention|2|||
16066314|NCT04438785|38733047|FG001|Overall Study|change of weight, give up intervention|10|||
16066315|NCT01096056|38733058|FG000|Overall Study|Lost to Follow-up|0|||
16066316|NCT01096056|38733059|FG001|Overall Study|Lost to Follow-up|1|||
16369153|NCT01281306|39836177|FG006|Overall Study|Protocol deviation|0|||
16369154|NCT01281306|39836171|FG000|Overall Study|Condition no longer requires study drug|1|||
16369155|NCT01281306|39836172|FG001|Overall Study|Condition no longer requires study drug|0|||
16369156|NCT01281306|39836173|FG002|Overall Study|Condition no longer requires study drug|0|||
16369157|NCT01281306|39836174|FG003|Overall Study|Condition no longer requires study drug|0|||
16369158|NCT01281306|39836175|FG004|Overall Study|Condition no longer requires study drug|0|||
16369159|NCT01281306|39836176|FG005|Overall Study|Condition no longer requires study drug|1|||
16369160|NCT01281306|39836177|FG006|Overall Study|Condition no longer requires study drug|1|||
16369161|NCT01281306|39836171|FG000|Overall Study|Lost to Follow-up|1|||
16369162|NCT01281306|39836172|FG001|Overall Study|Lost to Follow-up|0|||
16369163|NCT01281306|39836173|FG002|Overall Study|Lost to Follow-up|0|||
16369164|NCT01281306|39836174|FG003|Overall Study|Lost to Follow-up|2|||
16369165|NCT01281306|39836175|FG004|Overall Study|Lost to Follow-up|0|||
16369166|NCT01281306|39836176|FG005|Overall Study|Lost to Follow-up|0|||
16369167|NCT01281306|39836177|FG006|Overall Study|Lost to Follow-up|1|||
16369168|NCT01281306|39836171|FG000|Overall Study|Death|1|||
16369169|NCT01281306|39836172|FG001|Overall Study|Death|0|||
16369170|NCT01281306|39836173|FG002|Overall Study|Death|0|||
16369171|NCT01281306|39836174|FG003|Overall Study|Death|0|||
16369172|NCT01281306|39836175|FG004|Overall Study|Death|0|||
16369173|NCT01281306|39836176|FG005|Overall Study|Death|0|||
16369174|NCT01281306|39836177|FG006|Overall Study|Death|0|||
16369175|NCT01281306|39836171|FG000|Overall Study|Adverse Event|3|||
16369176|NCT01281306|39836172|FG001|Overall Study|Adverse Event|2|||
16369177|NCT01281306|39836173|FG002|Overall Study|Adverse Event|2|||
16369178|NCT01281306|39836174|FG003|Overall Study|Adverse Event|3|||
16369179|NCT01281306|39836175|FG004|Overall Study|Adverse Event|5|||
16369180|NCT01281306|39836176|FG005|Overall Study|Adverse Event|3|||
16369181|NCT01281306|39836177|FG006|Overall Study|Adverse Event|3|||
16369182|NCT01281306|39836171|FG000|Overall Study|Randomized in error|1|||
16369183|NCT01281306|39836172|FG001|Overall Study|Randomized in error|0|||
16369184|NCT01281306|39836173|FG002|Overall Study|Randomized in error|0|||
16369185|NCT01281306|39836174|FG003|Overall Study|Randomized in error|1|||
16369186|NCT01281306|39836175|FG004|Overall Study|Randomized in error|0|||
16369187|NCT01281306|39836176|FG005|Overall Study|Randomized in error|0|||
16369188|NCT01281306|39836177|FG006|Overall Study|Randomized in error|0|||
16369189|NCT01239745|39836181|FG000|Overall Study|Study terminated by sponsor|45|||
16369190|NCT01239745|39836181|FG000|Overall Study|Adverse Event|1|||
16369191|NCT00992836|39836182|FG000|Overall Study|Lost to Follow-up|1|||
16369192|NCT00992836|39836182|FG000|Overall Study|Withdrawal by Subject|2|||
16369193|NCT00992836|39836182|FG000|Overall Study|Protocol Violation|2|||
16066317|NCT03201809|38733060|FG000|Overall Study|Lost to Follow-up|2|||
16066318|NCT03201809|38733061|FG001|Overall Study|Lost to Follow-up|0|||
16066319|NCT02892409|38733062|FG000|Overall Study|Adverse Event|1|||
16066320|NCT02892409|38733063|FG001|Overall Study|Adverse Event|0|||
16066321|NCT02892409|38733062|FG000|Overall Study|Withdrawal by Subject|2|||
16066322|NCT02892409|38733063|FG001|Overall Study|Withdrawal by Subject|1|||
16369194|NCT01174459|39836183|FG000|Overall Study|case report form (CRF) not collected|5|||
16369195|NCT01245049|39836184|FG000|Overall Study|Migrated/moved from study area|0|||
16369196|NCT01245049|39836185|FG001|Overall Study|Migrated/moved from study area|1|||
16369197|NCT01245049|39836184|FG000|Overall Study|Withdrawal by Subject|0|||
16369198|NCT01245049|39836185|FG001|Overall Study|Withdrawal by Subject|1|||
16369199|NCT01245049|39836184|FG000|Overall Study|Lost to Follow-up|1|||
16369200|NCT01245049|39836185|FG001|Overall Study|Lost to Follow-up|2|||
16369201|NCT01112267|39836186|FG000|Overall Study|Adverse Event|24|||
16369202|NCT01112267|39836187|FG001|Overall Study|Adverse Event|6|||
16369203|NCT01112267|39836186|FG000|Overall Study|Withdrawal by Subject|3|||
16369204|NCT01112267|39836187|FG001|Overall Study|Withdrawal by Subject|5|||
16066323|NCT01388543|38736363|FG000|Day 14|Adverse Event|1|||
16369205|NCT01112267|39836186|FG000|Overall Study|Protocol Violation|5|||
16369206|NCT01112267|39836187|FG001|Overall Study|Protocol Violation|3|||
16369207|NCT01112267|39836186|FG000|Overall Study|Participants not compliant|1|||
16369208|NCT01112267|39836187|FG001|Overall Study|Participants not compliant|2|||
16369209|NCT01112267|39836186|FG000|Overall Study|Participants not receive any study drug|1|||
16369210|NCT01112267|39836187|FG001|Overall Study|Participants not receive any study drug|2|||
16369211|NCT04289298|39836192|FG000|Overall Study|Lost to Follow-up|5|||
16369212|NCT04289298|39836193|FG001|Overall Study|Lost to Follow-up|0|||
16369213|NCT04289298|39836192|FG000|Overall Study|Withdrawal by Subject|2|||
16369214|NCT04289298|39836193|FG001|Overall Study|Withdrawal by Subject|0|||
16369215|NCT03422718|39836194|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
16369216|NCT03422718|39836195|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
16369217|NCT03422718|39836196|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
16369218|NCT03422718|39836197|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
16369219|NCT03422718|39836198|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
16369220|NCT03422718|39836199|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
16369221|NCT03422718|39836200|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
16369222|NCT03422718|39836201|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
16369223|NCT03422718|39836194|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
16369224|NCT03422718|39836195|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
16369225|NCT03422718|39836196|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
16369226|NCT03422718|39836197|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
16369227|NCT03422718|39836198|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
16369228|NCT03422718|39836199|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
16369229|NCT03422718|39836200|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
16369230|NCT03422718|39836201|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
16369231|NCT03422718|39836194|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
16369232|NCT03422718|39836195|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
16369233|NCT03422718|39836196|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
16369234|NCT03422718|39836197|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
16369235|NCT03422718|39836198|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
16369236|NCT03422718|39836199|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
16369237|NCT03422718|39836200|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
16369238|NCT03422718|39836201|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
16369239|NCT03422718|39836194|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
16369240|NCT03422718|39836195|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
16369241|NCT03422718|39836196|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
16369242|NCT03422718|39836197|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
16369243|NCT03422718|39836198|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
16369244|NCT03422718|39836199|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
16369245|NCT03422718|39836200|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
16369246|NCT03422718|39836201|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
16369247|NCT03422718|39836194|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
16369248|NCT03422718|39836195|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
16369249|NCT03422718|39836196|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
16369250|NCT03422718|39836197|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
16369251|NCT03422718|39836198|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
16369252|NCT03422718|39836199|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
16066324|NCT01388543|38736364|FG001|Day 14|Adverse Event|4|||
16066325|NCT01242085|38736367|FG000|Overall Study|Withdrawal by Subject|4|||
16066326|NCT01242085|38736368|FG001|Overall Study|Withdrawal by Subject|2|||
16066327|NCT01242085|38736369|FG002|Overall Study|Withdrawal by Subject|0|||
16066328|NCT01242085|38736367|FG000|Overall Study|medically unable to have surgery|4|||
16066329|NCT01242085|38736368|FG001|Overall Study|medically unable to have surgery|5|||
16066330|NCT01242085|38736369|FG002|Overall Study|medically unable to have surgery|0|||
16066331|NCT01168401|38736370|FG000|Overall Study|Lost to Follow-up|1|||
16066332|NCT01168401|38736371|FG001|Overall Study|Lost to Follow-up|1|||
16066333|NCT01168401|38736372|FG002|Overall Study|Lost to Follow-up|2|||
16066334|NCT01168401|38736373|FG003|Overall Study|Lost to Follow-up|1|||
16066335|NCT01168401|38736374|FG004|Overall Study|Lost to Follow-up|0|||
16066336|NCT01168401|38736375|FG005|Overall Study|Lost to Follow-up|0|||
16066337|NCT01168401|38736376|FG006|Overall Study|Lost to Follow-up|0|||
16066338|NCT01168401|38736377|FG007|Overall Study|Lost to Follow-up|0|||
16066339|NCT01168401|38736378|FG008|Overall Study|Lost to Follow-up|0|||
16066340|NCT01168401|38736379|FG009|Overall Study|Lost to Follow-up|0|||
16066341|NCT01168401|38736380|FG010|Overall Study|Lost to Follow-up|0|||
16066342|NCT01168401|38736370|FG000|Overall Study|Withdrawal by Subject|0|||
16369253|NCT03422718|39836200|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
16369254|NCT03422718|39836201|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
16066343|NCT01168401|38736371|FG001|Overall Study|Withdrawal by Subject|0|||
16066344|NCT01168401|38736372|FG002|Overall Study|Withdrawal by Subject|0|||
16066345|NCT01168401|38736373|FG003|Overall Study|Withdrawal by Subject|1|||
16066346|NCT01168401|38736374|FG004|Overall Study|Withdrawal by Subject|0|||
16066347|NCT01168401|38736375|FG005|Overall Study|Withdrawal by Subject|0|||
16066348|NCT01168401|38736376|FG006|Overall Study|Withdrawal by Subject|0|||
16369255|NCT03422718|39836194|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
16369256|NCT03422718|39836195|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
16369257|NCT03422718|39836196|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
16369258|NCT03422718|39836197|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
16369259|NCT03422718|39836198|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
16369260|NCT03422718|39836199|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
16369261|NCT03422718|39836200|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
16369262|NCT03422718|39836201|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
16369263|NCT02314247|39836202|FG000|Overall Study|Adverse Event|2|||
16369264|NCT02314247|39836203|FG001|Overall Study|Adverse Event|1|||
16066349|NCT01168401|38736377|FG007|Overall Study|Withdrawal by Subject|0|||
16066350|NCT01168401|38736378|FG008|Overall Study|Withdrawal by Subject|0|||
16066351|NCT01168401|38736379|FG009|Overall Study|Withdrawal by Subject|0|||
16066352|NCT01168401|38736380|FG010|Overall Study|Withdrawal by Subject|0|||
16066353|NCT00093795|38736383|FG000|Overall Study|No follow up data|20|||
16066354|NCT00093795|38736384|FG001|Overall Study|No follow up data|16|||
16066355|NCT00093795|38736385|FG002|Overall Study|No follow up data|17|||
16066356|NCT01656304|38736388|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
16066357|NCT04391309|38736389|FG000|Overall Study|Death|1|||
16066358|NCT04391309|38736390|FG001|Overall Study|Death|1|||
16066359|NCT04391309|38736389|FG000|Overall Study|Lost to Follow-up|3|||
16066360|NCT04391309|38736390|FG001|Overall Study|Lost to Follow-up|2|||
16066361|NCT04391309|38736389|FG000|Overall Study|Withdrawal by Subject|2|||
16066362|NCT04391309|38736390|FG001|Overall Study|Withdrawal by Subject|2|||
16066363|NCT01878890|38736396|FG000|Overall Study|Protocol Violation|0|||
16066364|NCT01878890|38736397|FG001|Overall Study|Protocol Violation|1|||
16066365|NCT01878890|38736398|FG002|Overall Study|Protocol Violation|0|||
16066366|NCT01878890|38736399|FG003|Overall Study|Protocol Violation|0|||
16066367|NCT00515086|38736400|FG000|Overall Study|Adverse Event|1|||
16066368|NCT00515086|38736401|FG001|Overall Study|Adverse Event|1|||
16066369|NCT00515086|38736402|FG002|Overall Study|Adverse Event|2|||
16158703|NCT00159861|39064883|FG001|Extension Study - up to 3 Years|Death|28|||
16158704|NCT00159861|39064882|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
16158705|NCT00159861|39064883|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
16158706|NCT00159861|39064882|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
16158707|NCT00159861|39064883|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
16158708|NCT00159861|39064882|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
16158709|NCT00159861|39064883|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
16158710|NCT00159861|39064882|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
16158711|NCT00159861|39064883|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
16158712|NCT01707693|39064884|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
16158713|NCT01707693|39064885|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
16158714|NCT01707693|39064884|FG000|Overall Study Allocation|Protocol Violation|4|||
16158715|NCT01707693|39064885|FG001|Overall Study Allocation|Protocol Violation|3|||
16158716|NCT01707693|39064884|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
16158717|NCT01707693|39064885|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
16158718|NCT01707693|39064884|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
16158719|NCT01707693|39064885|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
16263421|NCT01190930|39449793|FG005|Induction|Adverse Event|0|||
16263422|NCT01190930|39449794|FG006|Induction|Adverse Event|0|||
16263423|NCT01190930|39449795|FG007|Induction|Adverse Event|0|||
16263424|NCT01190930|39449796|FG008|Induction|Adverse Event|0|||
16263425|NCT01190930|39449797|FG009|Induction|Adverse Event|0|||
16263426|NCT01190930|39449788|FG000|Induction|Death|34|||
16263427|NCT01190930|39449789|FG001|Induction|Death|0|||
16263428|NCT01190930|39449790|FG002|Induction|Death|0|||
16263429|NCT01190930|39449791|FG003|Induction|Death|0|||
16263430|NCT01190930|39449792|FG004|Induction|Death|0|||
16263431|NCT01190930|39449793|FG005|Induction|Death|0|||
16263432|NCT01190930|39449794|FG006|Induction|Death|0|||
16263433|NCT01190930|39449795|FG007|Induction|Death|0|||
16263434|NCT01190930|39449796|FG008|Induction|Death|0|||
16263435|NCT01190930|39449797|FG009|Induction|Death|0|||
16066370|NCT00515086|38736403|FG003|Overall Study|Adverse Event|3|||
16066371|NCT00515086|38736400|FG000|Overall Study|Administrative|1|||
16263436|NCT01190930|39449788|FG000|Induction|Lost to Follow-up|1|||
16263437|NCT01190930|39449789|FG001|Induction|Lost to Follow-up|0|||
16263438|NCT01190930|39449790|FG002|Induction|Lost to Follow-up|0|||
16263439|NCT01190930|39449791|FG003|Induction|Lost to Follow-up|0|||
16263440|NCT01190930|39449792|FG004|Induction|Lost to Follow-up|0|||
16369265|NCT02314247|39836204|FG002|Overall Study|Adverse Event|0|||
16158720|NCT04081363|39064888|FG000|Overall Study|Withdrawal by Subject|1|||
16263441|NCT01190930|39449793|FG005|Induction|Lost to Follow-up|0|||
16066372|NCT00515086|38736401|FG001|Overall Study|Administrative|1|||
16066373|NCT00515086|38736402|FG002|Overall Study|Administrative|0|||
16066374|NCT00515086|38736403|FG003|Overall Study|Administrative|0|||
16066375|NCT00515086|38736400|FG000|Overall Study|Withdrawal by Subject|1|||
16066376|NCT00515086|38736401|FG001|Overall Study|Withdrawal by Subject|0|||
16066377|NCT00515086|38736402|FG002|Overall Study|Withdrawal by Subject|0|||
16066378|NCT00515086|38736403|FG003|Overall Study|Withdrawal by Subject|1|||
16066379|NCT00515086|38736400|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
16066380|NCT00515086|38736401|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16066381|NCT00515086|38736402|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
16066382|NCT00515086|38736403|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
16066383|NCT00515086|38736400|FG000|Overall Study|Lost to Follow-up|1|||
16066384|NCT00515086|38736401|FG001|Overall Study|Lost to Follow-up|0|||
16066385|NCT00515086|38736402|FG002|Overall Study|Lost to Follow-up|0|||
16066386|NCT00515086|38736403|FG003|Overall Study|Lost to Follow-up|0|||
16066387|NCT00515086|38736400|FG000|Overall Study|Study drug no longer required|0|||
16066388|NCT00515086|38736401|FG001|Overall Study|Study drug no longer required|1|||
16066389|NCT00515086|38736402|FG002|Overall Study|Study drug no longer required|0|||
16066390|NCT00515086|38736403|FG003|Overall Study|Study drug no longer required|0|||
16066391|NCT00515086|38736400|FG000|Overall Study|Death|2|||
16066392|NCT00515086|38736401|FG001|Overall Study|Death|0|||
16066393|NCT00515086|38736402|FG002|Overall Study|Death|0|||
16066394|NCT00515086|38736403|FG003|Overall Study|Death|0|||
16066395|NCT05780047|38736414|FG000|Overall Study|Did not submit baseline urine test kit|226|||
16066396|NCT05780047|38736414|FG000|Overall Study|Lost to Follow-up|34|||
16066397|NCT05780047|38736414|FG000|Overall Study|Did not submit second urine test kit|124|||
16066398|NCT01195675|38736417|FG000|Overall Study|Adverse Event|1|||
16066399|NCT01195675|38736417|FG000|Overall Study|Withdrawal by Subject|2|||
16066400|NCT02846415|38736418|FG000|Overall Study|Lost to Follow-up|2|||
16066401|NCT02846415|38736419|FG001|Overall Study|Lost to Follow-up|0|||
16066402|NCT02846415|38736418|FG000|Overall Study|Withdrawal by Subject|1|||
16066403|NCT02846415|38736419|FG001|Overall Study|Withdrawal by Subject|1|||
16066404|NCT02374957|38736420|FG000|Overall Study|Patient did not complete forms correctly|1|||
16066405|NCT02374957|38736421|FG001|Overall Study|Patient did not complete forms correctly|0|||
16066406|NCT01649427|38736424|FG000|Overall Study|Adverse Event|1|||
16066407|NCT01649427|38736425|FG001|Overall Study|Adverse Event|1|||
16066408|NCT01649427|38736424|FG000|Overall Study|Withdrawal by Subject|8|||
16066409|NCT01649427|38736425|FG001|Overall Study|Withdrawal by Subject|7|||
16066410|NCT01649427|38736424|FG000|Overall Study|Lost to Follow-up|0|||
16066411|NCT01649427|38736425|FG001|Overall Study|Lost to Follow-up|1|||
16066412|NCT01649427|38736424|FG000|Overall Study|Graft loss|0|||
16066413|NCT01649427|38736425|FG001|Overall Study|Graft loss|1|||
16066414|NCT01649427|38736424|FG000|Overall Study|Surgical problems during nephrectomy|2|||
16066415|NCT01649427|38736425|FG001|Overall Study|Surgical problems during nephrectomy|2|||
16066416|NCT01106287|38736426|FG000|Overall Study|Adverse Event|1|||
16066417|NCT01106287|38736427|FG001|Overall Study|Adverse Event|0|||
16066418|NCT01106287|38736428|FG002|Overall Study|Adverse Event|0|||
16066419|NCT01106287|38736429|FG003|Overall Study|Adverse Event|0|||
16066420|NCT00578227|38736433|FG000|Overall Study|Lost to Follow-up|0|||
16066421|NCT00578227|38736434|FG001|Overall Study|Lost to Follow-up|1|||
16066422|NCT00578227|38736435|FG002|Overall Study|Lost to Follow-up|1|||
16066423|NCT00578227|38736433|FG000|Overall Study|Withdrawal by Subject|5|||
16066424|NCT00578227|38736434|FG001|Overall Study|Withdrawal by Subject|1|||
16066425|NCT00578227|38736435|FG002|Overall Study|Withdrawal by Subject|3|||
16066426|NCT00797225|38736442|FG000|Weeks 1 to 12|Adverse Event|0|||
16066427|NCT00797225|38736443|FG001|Weeks 1 to 12|Adverse Event|0|||
16066428|NCT00797225|38736444|FG002|Weeks 1 to 12|Adverse Event|1|||
16066429|NCT00797225|38736445|FG003|Weeks 1 to 12|Adverse Event|0|||
16066430|NCT00797225|38736446|FG004|Weeks 1 to 12|Adverse Event|0|||
16066431|NCT00797225|38736447|FG005|Weeks 1 to 12|Adverse Event|0|||
16066432|NCT00797225|38736448|FG006|Weeks 1 to 12|Adverse Event|0|||
16066433|NCT00797225|38736449|FG007|Weeks 1 to 12|Adverse Event|0|||
16066434|NCT00797225|38736442|FG000|Weeks 1 to 12|Non-compliance|0|||
16066435|NCT00797225|38736443|FG001|Weeks 1 to 12|Non-compliance|1|||
16066436|NCT00797225|38736444|FG002|Weeks 1 to 12|Non-compliance|0|||
16066437|NCT00797225|38736445|FG003|Weeks 1 to 12|Non-compliance|0|||
16066438|NCT00797225|38736446|FG004|Weeks 1 to 12|Non-compliance|0|||
16066439|NCT00797225|38736447|FG005|Weeks 1 to 12|Non-compliance|0|||
16066440|NCT00797225|38736448|FG006|Weeks 1 to 12|Non-compliance|0|||
16066441|NCT00797225|38736449|FG007|Weeks 1 to 12|Non-compliance|0|||
16066442|NCT00797225|38736442|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
16066443|NCT00797225|38736443|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
16066444|NCT00797225|38736444|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
16066445|NCT00797225|38736445|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
16066446|NCT00797225|38736446|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
16066447|NCT00797225|38736447|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
16158721|NCT04081363|39064889|FG001|Overall Study|Withdrawal by Subject|0|||
16158722|NCT04673786|39064897|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
16158723|NCT04673786|39064898|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
16158724|NCT04673786|39064899|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
16158725|NCT04673786|39064897|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
16158726|NCT04673786|39064898|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
16158727|NCT04673786|39064899|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
16158728|NCT04673786|39064897|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
16158729|NCT04673786|39064898|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
16158730|NCT04673786|39064899|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
16158731|NCT04673786|39064897|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
16158732|NCT04673786|39064898|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
16158733|NCT04673786|39064899|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
16158734|NCT04673786|39064897|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
16158735|NCT04673786|39064898|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
16158736|NCT04673786|39064899|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
16158737|NCT04673786|39064897|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
16158738|NCT04673786|39064898|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
16158739|NCT04673786|39064899|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
16158740|NCT02556255|39064900|FG000|Overall Study|Lost to Follow-up|4|||
16158741|NCT01064167|39064901|FG000|Overall Study|Protocol Violation|14|||
16158742|NCT01064167|39064902|FG001|Overall Study|Protocol Violation|15|||
16158743|NCT01500057|39064903|FG000|Overall Study|Lost to Follow-up|6|||
16158744|NCT01500057|39064904|FG001|Overall Study|Lost to Follow-up|4|||
16158745|NCT00075023|39064916|FG000|Pilot Study|Physician Decision|1|||
16158746|NCT00075023|39064917|FG001|Pilot Study|Physician Decision|2|||
16158747|NCT00075023|39064916|FG000|Pilot Study|Withdrawal by Subject|1|||
16158748|NCT00075023|39064917|FG001|Pilot Study|Withdrawal by Subject|0|||
16158749|NCT00590590|39064918|FG000|Overall Study|Lack of Efficacy|1|||
16158750|NCT00590590|39064919|FG001|Overall Study|Lack of Efficacy|2|||
16158751|NCT00590590|39064920|FG002|Overall Study|Lack of Efficacy|0|||
16158752|NCT00590590|39064918|FG000|Overall Study|Adverse Event|1|||
16158753|NCT00590590|39064919|FG001|Overall Study|Adverse Event|0|||
16158754|NCT00590590|39064920|FG002|Overall Study|Adverse Event|0|||
16158755|NCT00590590|39064918|FG000|Overall Study|Protocol Violation|0|||
16158756|NCT00590590|39064919|FG001|Overall Study|Protocol Violation|0|||
16158757|NCT00590590|39064920|FG002|Overall Study|Protocol Violation|2|||
16158758|NCT00590590|39064918|FG000|Overall Study|Lost to Follow-up|4|||
16158759|NCT00590590|39064919|FG001|Overall Study|Lost to Follow-up|1|||
16158760|NCT00590590|39064920|FG002|Overall Study|Lost to Follow-up|2|||
16158761|NCT00590590|39064918|FG000|Overall Study|Withdrawal by Subject|0|||
16158762|NCT00590590|39064919|FG001|Overall Study|Withdrawal by Subject|1|||
16158763|NCT00590590|39064920|FG002|Overall Study|Withdrawal by Subject|1|||
16158764|NCT00590590|39064918|FG000|Overall Study|Did not complete due to study closure|1|||
16158765|NCT00590590|39064919|FG001|Overall Study|Did not complete due to study closure|1|||
16158766|NCT00590590|39064920|FG002|Overall Study|Did not complete due to study closure|1|||
16445968|NCT00561925|40111753|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
16445969|NCT00561925|40111754|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
16445970|NCT00561925|40111755|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
16445971|NCT00561925|40111756|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
16066448|NCT00797225|38736448|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
16066449|NCT00797225|38736449|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
16066450|NCT00797225|38736442|FG000|Weeks 1 to 12|Sponsor Decision|1|||
16445972|NCT00561925|40111752|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
16445973|NCT00561925|40111753|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
16445974|NCT00561925|40111754|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
16445975|NCT00561925|40111755|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
16445976|NCT00561925|40111756|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
16066451|NCT00797225|38736443|FG001|Weeks 1 to 12|Sponsor Decision|0|||
16066452|NCT00797225|38736444|FG002|Weeks 1 to 12|Sponsor Decision|0|||
16066453|NCT00797225|38736445|FG003|Weeks 1 to 12|Sponsor Decision|0|||
16066454|NCT00797225|38736446|FG004|Weeks 1 to 12|Sponsor Decision|0|||
16066455|NCT00797225|38736447|FG005|Weeks 1 to 12|Sponsor Decision|0|||
16066456|NCT00797225|38736448|FG006|Weeks 1 to 12|Sponsor Decision|0|||
16158767|NCT00590590|39064918|FG000|Overall Study|Did not complete study|0|||
16158768|NCT00590590|39064919|FG001|Overall Study|Did not complete study|1|||
16158769|NCT00590590|39064920|FG002|Overall Study|Did not complete study|0|||
16066457|NCT00797225|38736449|FG007|Weeks 1 to 12|Sponsor Decision|0|||
16158770|NCT01537211|39064922|FG000|Overall Study|Lost to Follow-up|0|||
16158771|NCT01537211|39064923|FG001|Overall Study|Lost to Follow-up|1|||
16158772|NCT00278993|39064924|FG000|Overall Study|Adverse Event|24|||
16263442|NCT01190930|39449794|FG006|Induction|Lost to Follow-up|0|||
16066458|NCT00797225|38736442|FG000|Weeks 13 to 24|Non-compliance|0|||
16066459|NCT00797225|38736443|FG001|Weeks 13 to 24|Non-compliance|2|||
16066460|NCT00797225|38736444|FG002|Weeks 13 to 24|Non-compliance|0|||
16066461|NCT00797225|38736445|FG003|Weeks 13 to 24|Non-compliance|0|||
16066462|NCT00797225|38736446|FG004|Weeks 13 to 24|Non-compliance|0|||
16066463|NCT00797225|38736447|FG005|Weeks 13 to 24|Non-compliance|0|||
16445977|NCT00561925|40111752|FG000|14 Day Lead-In Period|Other|5|||
16445978|NCT00561925|40111753|FG001|14 Day Lead-In Period|Other|0|||
16445979|NCT00561925|40111754|FG002|14 Day Lead-In Period|Other|0|||
16445980|NCT00561925|40111755|FG003|14 Day Lead-In Period|Other|0|||
16445981|NCT00561925|40111756|FG004|14 Day Lead-In Period|Other|0|||
16445982|NCT00561925|40111752|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
16445983|NCT00561925|40111753|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
16445984|NCT00561925|40111754|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
16445985|NCT00561925|40111755|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
16445986|NCT00561925|40111756|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
16445987|NCT00561925|40111752|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
16445988|NCT00561925|40111753|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
16445989|NCT00561925|40111754|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
16445990|NCT00561925|40111755|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
16445991|NCT00561925|40111756|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
16445992|NCT00561925|40111752|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
16445993|NCT00561925|40111753|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
16445994|NCT00561925|40111754|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
16445995|NCT00561925|40111755|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
16445996|NCT00561925|40111756|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
16445997|NCT00561925|40111752|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
16445998|NCT00561925|40111753|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
16445999|NCT00561925|40111754|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
16446000|NCT00561925|40111755|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
16446001|NCT00561925|40111756|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
16446002|NCT00561925|40111752|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
16446003|NCT00561925|40111753|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
16446004|NCT00561925|40111754|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
16446005|NCT00561925|40111755|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
16446006|NCT00561925|40111756|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
16446007|NCT00561925|40111752|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
16446008|NCT00561925|40111753|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
16446009|NCT00561925|40111754|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
16446010|NCT00561925|40111755|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
16446011|NCT00561925|40111756|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
16446012|NCT00561925|40111752|FG000|144-week Double-blind, Double-dummy|Death|0|||
16446013|NCT00561925|40111753|FG001|144-week Double-blind, Double-dummy|Death|6|||
16446014|NCT00561925|40111754|FG002|144-week Double-blind, Double-dummy|Death|3|||
16446015|NCT00561925|40111755|FG003|144-week Double-blind, Double-dummy|Death|0|||
16446016|NCT00561925|40111756|FG004|144-week Double-blind, Double-dummy|Death|0|||
16446017|NCT00561925|40111752|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
16446018|NCT00561925|40111753|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
16446019|NCT00561925|40111754|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
16446020|NCT00561925|40111755|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
16446021|NCT00561925|40111756|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
16446022|NCT00561925|40111752|FG000|144-week Double-blind, Double-dummy|Other|0|||
16446023|NCT00561925|40111753|FG001|144-week Double-blind, Double-dummy|Other|8|||
16446024|NCT00561925|40111754|FG002|144-week Double-blind, Double-dummy|Other|11|||
16446025|NCT00561925|40111755|FG003|144-week Double-blind, Double-dummy|Other|0|||
16446026|NCT00561925|40111756|FG004|144-week Double-blind, Double-dummy|Other|0|||
16446027|NCT00561925|40111752|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
16446028|NCT00561925|40111753|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
16446029|NCT00561925|40111754|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
16446030|NCT00561925|40111755|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
16446031|NCT00561925|40111756|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
16446032|NCT04944992|40111757|FG000|Overall Study|Lost to Follow-up|1|||
16446033|NCT04944992|40111758|FG001|Overall Study|Lost to Follow-up|1|||
16446034|NCT04944992|40111757|FG000|Overall Study|Physician Decision|1|||
16446035|NCT04944992|40111758|FG001|Overall Study|Physician Decision|0|||
16446036|NCT04944992|40111757|FG000|Overall Study|Withdrawal by Subject|6|||
16446037|NCT04944992|40111758|FG001|Overall Study|Withdrawal by Subject|1|||
16446038|NCT01748292|40111760|FG000|Overall Study|Adverse Event|2|||
16446039|NCT01748292|40111761|FG001|Overall Study|Adverse Event|4|||
16446040|NCT01748292|40111760|FG000|Overall Study|Lost to Follow-up|0|||
16446041|NCT01748292|40111761|FG001|Overall Study|Lost to Follow-up|3|||
16446042|NCT01748292|40111760|FG000|Overall Study|Death|0|||
16066464|NCT00797225|38736448|FG006|Weeks 13 to 24|Non-compliance|0|||
16446043|NCT01748292|40111761|FG001|Overall Study|Death|3|||
16446044|NCT01748292|40111760|FG000|Overall Study|Withdrawal by Subject|0|||
16446045|NCT01748292|40111761|FG001|Overall Study|Withdrawal by Subject|2|||
16446046|NCT02796170|40111762|FG000|Overall Study|Lost to Follow-up|3|||
16446047|NCT02796170|40111763|FG001|Overall Study|Lost to Follow-up|0|||
16446048|NCT02153086|40111764|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
16446049|NCT02153086|40111764|FG000|Overall Study|Other|2|||
16446050|NCT01491607|40111765|FG000|Overall Study|Lost to Follow-up|7|||
16446051|NCT01491607|40111765|FG000|Overall Study|Withdrawal by Subject|3|||
16446052|NCT00791934|40111766|FG000|Overall Study|Withdrawal by Subject|2|||
16446053|NCT00791934|40111766|FG000|Overall Study|Did not consent for extended follow-up|13|||
16446054|NCT00425269|40111767|FG000|Overall Study|Pregnancy|5|||
16446055|NCT00425269|40111768|FG001|Overall Study|Pregnancy|7|||
16446056|NCT00425269|40111767|FG000|Overall Study|Lost to Follow-up|9|||
16446057|NCT00425269|40111768|FG001|Overall Study|Lost to Follow-up|9|||
16446058|NCT00425269|40111767|FG000|Overall Study|moved or medical reason|5|||
16446059|NCT00425269|40111768|FG001|Overall Study|moved or medical reason|4|||
16446060|NCT02603146|40111776|FG000|Overall Study|Lost to Follow-up|5|||
16066465|NCT00797225|38736449|FG007|Weeks 13 to 24|Non-compliance|0|||
16066466|NCT00797225|38736442|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
16066467|NCT00797225|38736443|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
16066468|NCT00797225|38736444|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
16066469|NCT00797225|38736445|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
16066470|NCT00797225|38736446|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
16066471|NCT00797225|38736447|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
16066472|NCT00797225|38736448|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
16066473|NCT00797225|38736449|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
16066474|NCT00797225|38736442|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
16066475|NCT00797225|38736443|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
16066476|NCT00797225|38736444|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
16066477|NCT00797225|38736445|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
16066478|NCT00797225|38736446|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
16066479|NCT00797225|38736447|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
16066480|NCT00797225|38736448|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
16066481|NCT00797225|38736449|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
16066482|NCT00797225|38736442|FG000|Weeks 13 to 24|Adverse Event|0|||
16066483|NCT00797225|38736443|FG001|Weeks 13 to 24|Adverse Event|1|||
16066484|NCT00797225|38736444|FG002|Weeks 13 to 24|Adverse Event|0|||
16066485|NCT00797225|38736445|FG003|Weeks 13 to 24|Adverse Event|0|||
16066486|NCT00797225|38736446|FG004|Weeks 13 to 24|Adverse Event|0|||
16066487|NCT00797225|38736447|FG005|Weeks 13 to 24|Adverse Event|0|||
16066488|NCT00797225|38736448|FG006|Weeks 13 to 24|Adverse Event|1|||
16066489|NCT00797225|38736449|FG007|Weeks 13 to 24|Adverse Event|0|||
16066490|NCT00797225|38736442|FG000|Weeks 13 to 24|Sponsor Decision|0|||
16066491|NCT00797225|38736443|FG001|Weeks 13 to 24|Sponsor Decision|0|||
16066492|NCT00797225|38736444|FG002|Weeks 13 to 24|Sponsor Decision|0|||
16066493|NCT00797225|38736445|FG003|Weeks 13 to 24|Sponsor Decision|0|||
16066494|NCT00797225|38736446|FG004|Weeks 13 to 24|Sponsor Decision|0|||
16066495|NCT00797225|38736447|FG005|Weeks 13 to 24|Sponsor Decision|0|||
16066496|NCT00797225|38736448|FG006|Weeks 13 to 24|Sponsor Decision|1|||
16066497|NCT00797225|38736449|FG007|Weeks 13 to 24|Sponsor Decision|0|||
16066498|NCT01253200|38736450|FG000|Overall Study|Death|1|||
16066499|NCT01253200|38736451|FG001|Overall Study|Death|0|||
16066500|NCT01253200|38736452|FG002|Overall Study|Death|0|||
16066501|NCT01253200|38736453|FG003|Overall Study|Death|0|||
16066502|NCT01253200|38736454|FG004|Overall Study|Death|0|||
16066503|NCT01253200|38736450|FG000|Overall Study|Lost to Follow-up|1|||
16066504|NCT01253200|38736451|FG001|Overall Study|Lost to Follow-up|1|||
16066505|NCT01253200|38736452|FG002|Overall Study|Lost to Follow-up|0|||
16066506|NCT01253200|38736453|FG003|Overall Study|Lost to Follow-up|0|||
16066507|NCT01253200|38736454|FG004|Overall Study|Lost to Follow-up|0|||
16066508|NCT01253200|38736450|FG000|Overall Study|Withdrawal by Subject|2|||
16066509|NCT01253200|38736451|FG001|Overall Study|Withdrawal by Subject|0|||
16066510|NCT01253200|38736452|FG002|Overall Study|Withdrawal by Subject|0|||
16066511|NCT01253200|38736453|FG003|Overall Study|Withdrawal by Subject|0|||
16066512|NCT01253200|38736454|FG004|Overall Study|Withdrawal by Subject|0|||
16446061|NCT02603146|40111777|FG001|Overall Study|Lost to Follow-up|6|||
16066513|NCT01253200|38736450|FG000|Overall Study|Protocol Violation|1|||
16066514|NCT01253200|38736451|FG001|Overall Study|Protocol Violation|4|||
16066515|NCT01253200|38736452|FG002|Overall Study|Protocol Violation|0|||
16446062|NCT02603146|40111776|FG000|Overall Study|Withdrawal by Subject|8|||
16066516|NCT01253200|38736453|FG003|Overall Study|Protocol Violation|0|||
16066517|NCT01253200|38736454|FG004|Overall Study|Protocol Violation|5|||
16066518|NCT01253200|38736450|FG000|Overall Study|intents|10|||
16066519|NCT01253200|38736451|FG001|Overall Study|intents|10|||
16066520|NCT01253200|38736452|FG002|Overall Study|intents|1|||
16066521|NCT01253200|38736453|FG003|Overall Study|intents|3|||
16066522|NCT01253200|38736454|FG004|Overall Study|intents|0|||
16066523|NCT01253200|38736450|FG000|Overall Study|Attempts|6|||
16066524|NCT01253200|38736451|FG001|Overall Study|Attempts|4|||
16158773|NCT00278993|39064924|FG000|Overall Study|Withdrawal by Subject|5|||
16158774|NCT00278993|39064924|FG000|Overall Study|Progressive Disease|65|||
16158775|NCT00278993|39064924|FG000|Overall Study|Physician Decision|9|||
16158776|NCT00278993|39064924|FG000|Overall Study|Not Otherwise Specified|4|||
16158777|NCT03451773|39064925|FG000|Overall Study|Death on study|1|||
16158778|NCT03451773|39064926|FG001|Overall Study|Death on study|5|||
16158779|NCT03451773|39064925|FG000|Overall Study|Death during follow-up period|0|||
16158780|NCT03451773|39064926|FG001|Overall Study|Death during follow-up period|1|||
16158781|NCT00150592|39064927|FG000|Overall Study|Adverse Event|4|||
16158782|NCT00150592|39064928|FG001|Overall Study|Adverse Event|1|||
16158783|NCT00150592|39064927|FG000|Overall Study|Protocol Violation|1|||
16158784|NCT00150592|39064928|FG001|Overall Study|Protocol Violation|0|||
16158785|NCT00150592|39064927|FG000|Overall Study|Withdrawal by Subject|1|||
16158786|NCT00150592|39064928|FG001|Overall Study|Withdrawal by Subject|2|||
16158787|NCT00150592|39064927|FG000|Overall Study|Non-compliance|1|||
16158788|NCT00150592|39064928|FG001|Overall Study|Non-compliance|0|||
16158789|NCT01816243|39064943|FG000|Overall Study|Adverse Event|6|||
16263443|NCT01190930|39449795|FG007|Induction|Lost to Follow-up|0|||
16066525|NCT01253200|38736452|FG002|Overall Study|Attempts|1|||
16066526|NCT01253200|38736453|FG003|Overall Study|Attempts|2|||
16066527|NCT01253200|38736454|FG004|Overall Study|Attempts|0|||
16066528|NCT02042443|38736455|FG000|Overall Study|Adverse Event|2|||
16066529|NCT02042443|38736456|FG001|Overall Study|Adverse Event|1|||
16066530|NCT02042443|38736455|FG000|Overall Study|Withdrawal by Subject|0|||
16066531|NCT02042443|38736456|FG001|Overall Study|Withdrawal by Subject|1|||
16066532|NCT02042443|38736455|FG000|Overall Study|Progression|21|||
16066533|NCT02042443|38736456|FG001|Overall Study|Progression|17|||
16066534|NCT02042443|38736455|FG000|Overall Study|not protocol specified|1|||
16066535|NCT02042443|38736456|FG001|Overall Study|not protocol specified|1|||
16066536|NCT02042443|38736455|FG000|Overall Study|Not eligible/not analyzable|3|||
16066537|NCT02042443|38736456|FG001|Overall Study|Not eligible/not analyzable|6|||
16066538|NCT02095158|38736458|FG000|Overall Study|Adverse Event|14|||
16066539|NCT02095158|38736458|FG000|Overall Study|Lack of Efficacy|3|||
16066540|NCT02095158|38736458|FG000|Overall Study|Pregnancy|1|||
16066541|NCT02095158|38736458|FG000|Overall Study|Lost to Follow-up|20|||
16066542|NCT02095158|38736458|FG000|Overall Study|Personal Reasons|35|||
16066543|NCT02095158|38736458|FG000|Overall Study|Protocol Violation|1|||
16066544|NCT02095158|38736458|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16066545|NCT00543725|38736460|FG000|Overall Study|Adverse Event|18|||
16066546|NCT00543725|38736461|FG001|Overall Study|Adverse Event|27|||
16066547|NCT00543725|38736460|FG000|Overall Study|Sponsor's Decision|0|||
16066548|NCT00543725|38736461|FG001|Overall Study|Sponsor's Decision|1|||
16066549|NCT00543725|38736460|FG000|Overall Study|Subject Non-Compliant|4|||
16066550|NCT00543725|38736461|FG001|Overall Study|Subject Non-Compliant|4|||
16066551|NCT00543725|38736460|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
16066552|NCT00543725|38736461|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
16066553|NCT00543725|38736460|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
16066554|NCT00543725|38736461|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
16066555|NCT00543725|38736460|FG000|Overall Study|Protocol Violation|0|||
16066556|NCT00543725|38736461|FG001|Overall Study|Protocol Violation|1|||
16066557|NCT00543725|38736460|FG000|Overall Study|Withdrawal by Subject|4|||
16066558|NCT00543725|38736461|FG001|Overall Study|Withdrawal by Subject|13|||
16066559|NCT00543725|38736460|FG000|Overall Study|Lost to Follow-up|15|||
16066560|NCT00543725|38736461|FG001|Overall Study|Lost to Follow-up|11|||
16066561|NCT00543725|38736460|FG000|Overall Study|Other|3|||
16066562|NCT00543725|38736461|FG001|Overall Study|Other|3|||
16066563|NCT02688621|38736465|FG000|Overall Study|Pregnancy|1|||
16066564|NCT02688621|38736466|FG001|Overall Study|Pregnancy|3|||
16066565|NCT02688621|38736465|FG000|Overall Study|Lost to Follow-up|38|||
16066566|NCT02688621|38736466|FG001|Overall Study|Lost to Follow-up|15|||
16066567|NCT02688621|38736465|FG000|Overall Study|Withdrawal by Subject|1|||
16066568|NCT02688621|38736466|FG001|Overall Study|Withdrawal by Subject|0|||
16066569|NCT01474538|38736467|FG000|Treatment Period 1|Death|1|||
16066570|NCT01474538|38736468|FG001|Treatment Period 1|Death|0|||
16066571|NCT01474538|38736467|FG000|Treatment Period 1|Physician Decision|1|||
16066572|NCT01474538|38736468|FG001|Treatment Period 1|Physician Decision|0|||
16066573|NCT01474538|38736467|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16066574|NCT01474538|38736468|FG001|Treatment Period 1|Withdrawal by Subject|3|||
16066575|NCT01474538|38736467|FG000|Treatment Period 1|Protocol Violation|0|||
16066576|NCT01474538|38736468|FG001|Treatment Period 1|Protocol Violation|1|||
16066577|NCT01474538|38736467|FG000|Treatment Period 2|Death|1|||
16158790|NCT01816243|39064943|FG000|Overall Study|Lost to Follow-up|1|||
16158791|NCT01816243|39064943|FG000|Overall Study|Lack of Efficacy|1|||
16158792|NCT01816243|39064943|FG000|Overall Study|Not eligible for the study|1|||
16158793|NCT01816243|39064943|FG000|Overall Study|Amputation|3|||
16066578|NCT01474538|38736468|FG001|Treatment Period 2|Death|0|||
16066579|NCT01474538|38736467|FG000|Treatment Period 2|Adverse Event|1|||
16066580|NCT01474538|38736468|FG001|Treatment Period 2|Adverse Event|1|||
16066581|NCT01474538|38736467|FG000|Treatment Period 2|Withdrawal by Subject|2|||
16369266|NCT02314247|39836202|FG000|Overall Study|Withdrawal by Subject|1|||
16369267|NCT02314247|39836203|FG001|Overall Study|Withdrawal by Subject|3|||
16369268|NCT02314247|39836204|FG002|Overall Study|Withdrawal by Subject|1|||
16369269|NCT02314247|39836202|FG000|Overall Study|Progression of Disease|6|||
16369270|NCT02314247|39836203|FG001|Overall Study|Progression of Disease|2|||
16369271|NCT02314247|39836204|FG002|Overall Study|Progression of Disease|0|||
16369272|NCT00105508|39836208|FG000|Overall Study|Prephase Dropout|1|||
16369273|NCT00105508|39836209|FG001|Overall Study|Prephase Dropout|0|||
16369274|NCT00105508|39836208|FG000|Overall Study|Adverse Event|16|||
16369275|NCT00105508|39836209|FG001|Overall Study|Adverse Event|19|||
16369276|NCT00105508|39836208|FG000|Overall Study|Insufficient Efficacy|1|||
16369277|NCT00105508|39836209|FG001|Overall Study|Insufficient Efficacy|0|||
16369278|NCT00105508|39836208|FG000|Overall Study|Withdrawal by Subject|10|||
16369279|NCT00105508|39836209|FG001|Overall Study|Withdrawal by Subject|6|||
16369280|NCT00105508|39836208|FG000|Overall Study|Lost to Follow-up|3|||
16369281|NCT00105508|39836209|FG001|Overall Study|Lost to Follow-up|0|||
16369282|NCT00105508|39836208|FG000|Overall Study|Protocol Violation|1|||
16369283|NCT00105508|39836209|FG001|Overall Study|Protocol Violation|2|||
16369284|NCT00105508|39836208|FG000|Overall Study|Other|8|||
16369285|NCT00105508|39836209|FG001|Overall Study|Other|9|||
16369286|NCT02287025|39836210|FG000|Overall Study|Not treated|2|||
16369287|NCT02287025|39836211|FG001|Overall Study|Not treated|0|||
16369288|NCT02287025|39836210|FG000|Overall Study|Progression of disease|3|||
16369289|NCT02287025|39836211|FG001|Overall Study|Progression of disease|2|||
16369290|NCT02287025|39836210|FG000|Overall Study|Adverse Event|2|||
16369291|NCT02287025|39836211|FG001|Overall Study|Adverse Event|4|||
16369292|NCT02287025|39836210|FG000|Overall Study|Withdrawal by Subject|2|||
16369293|NCT02287025|39836211|FG001|Overall Study|Withdrawal by Subject|2|||
16369294|NCT02287025|39836210|FG000|Overall Study|Screening failed|1|||
16369295|NCT02287025|39836211|FG001|Overall Study|Screening failed|1|||
16369296|NCT03055195|39836212|FG000|Overall Study|Lack of Efficacy|1|||
16369297|NCT03055195|39836213|FG001|Overall Study|Lack of Efficacy|0|||
16369298|NCT03055195|39836212|FG000|Overall Study|Withdrawal by Subject|6|||
16369299|NCT03055195|39836213|FG001|Overall Study|Withdrawal by Subject|7|||
16369300|NCT03055195|39836212|FG000|Overall Study|Study Terminated by Sponsor|2|||
16369301|NCT03055195|39836213|FG001|Overall Study|Study Terminated by Sponsor|6|||
16369302|NCT03055195|39836212|FG000|Overall Study|Protocol Violation|2|||
16369303|NCT03055195|39836213|FG001|Overall Study|Protocol Violation|1|||
16369304|NCT03055195|39836212|FG000|Overall Study|Physician Decision|1|||
16369305|NCT03055195|39836213|FG001|Overall Study|Physician Decision|0|||
16066582|NCT01474538|38736468|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16066583|NCT01474538|38736467|FG000|Treatment Period 2|Sponsor decision|1|||
16066584|NCT01474538|38736468|FG001|Treatment Period 2|Sponsor decision|0|||
16066585|NCT01474538|38736467|FG000|Treatment Period 2|Physician Decision|0|||
16066586|NCT01474538|38736468|FG001|Treatment Period 2|Physician Decision|1|||
16066587|NCT01474538|38736467|FG000|Treatment Period 2|Protocol Violation|1|||
16066588|NCT01474538|38736468|FG001|Treatment Period 2|Protocol Violation|0|||
16066589|NCT02096003|38736469|FG000|Overall Study|Protocol Violation|0|||
16066590|NCT02096003|38736470|FG001|Overall Study|Protocol Violation|2|||
16066591|NCT02096003|38736469|FG000|Overall Study|additional surgery|2|||
16066592|NCT02096003|38736470|FG001|Overall Study|additional surgery|1|||
16066593|NCT01250002|38736472|FG000|Overall Study|Change to open surgical procedure|4|||
16066594|NCT01250002|38736473|FG001|Overall Study|Change to open surgical procedure|3|||
16066595|NCT01562743|38736474|FG000|Overall Study|Adverse Event|29|||
16066596|NCT01562743|38736474|FG000|Overall Study|Lack of Efficacy|3|||
16066597|NCT01562743|38736474|FG000|Overall Study|Withdrawal by Subject|13|||
16066598|NCT01562743|38736474|FG000|Overall Study|Protocol Violation|1|||
16066599|NCT01562743|38736474|FG000|Overall Study|Discontinuation criteria|2|||
16066600|NCT01562743|38736474|FG000|Overall Study|Lost to Follow-up|2|||
16066601|NCT01562743|38736474|FG000|Overall Study|Physician Decision|2|||
16066602|NCT02424344|38736484|FG000|Overall Study|Lack of Efficacy|0|||
16066603|NCT02424344|38736485|FG001|Overall Study|Lack of Efficacy|1|||
16066604|NCT02424344|38736484|FG000|Overall Study|Withdrawal by Subject|2|||
16066605|NCT02424344|38736485|FG001|Overall Study|Withdrawal by Subject|1|||
16066606|NCT02424344|38736484|FG000|Overall Study|Lost to Follow-up|1|||
16066607|NCT02424344|38736485|FG001|Overall Study|Lost to Follow-up|0|||
16066608|NCT02424344|38736484|FG000|Overall Study|Adverse Event|4|||
16369306|NCT00284934|39836214|FG000|Overall Study|Adverse Event|1|||
16369307|NCT00284934|39836215|FG001|Overall Study|Adverse Event|2|||
16369308|NCT00284934|39836214|FG000|Overall Study|Other reasons|3|||
16369309|NCT00284934|39836215|FG001|Overall Study|Other reasons|1|||
16446063|NCT02603146|40111777|FG001|Overall Study|Withdrawal by Subject|10|||
16066609|NCT02424344|38736485|FG001|Overall Study|Adverse Event|8|||
16066610|NCT03178201|38736486|FG000|Overall Study|Off study|5|||
16066611|NCT02365298|38736487|FG000|Period 2|incorrect Rx dispensed|1|||
16369310|NCT02323334|39836216|FG000|Period 3|Lost to Follow-up|0|||
16369311|NCT02323334|39836217|FG001|Period 3|Lost to Follow-up|0|||
16369312|NCT02323334|39836218|FG002|Period 3|Lost to Follow-up|1|||
16369313|NCT02323334|39836219|FG003|Period 3|Lost to Follow-up|0|||
16066612|NCT02365298|38736488|FG001|Period 2|incorrect Rx dispensed|0|||
16066613|NCT02365298|38736487|FG000|Period 2|Discontinued at request of Sponsor|1|||
16066614|NCT02365298|38736488|FG001|Period 2|Discontinued at request of Sponsor|0|||
16066615|NCT02365298|38736487|FG000|Period 2|Test Article longer available|0|||
16066616|NCT02365298|38736488|FG001|Period 2|Test Article longer available|1|||
16369314|NCT02323334|39836220|FG004|Period 3|Lost to Follow-up|0|||
16369315|NCT02323334|39836221|FG005|Period 3|Lost to Follow-up|0|||
16369316|NCT02323334|39836222|FG006|Period 3|Lost to Follow-up|0|||
16369317|NCT02323334|39836223|FG007|Period 3|Lost to Follow-up|0|||
16369318|NCT02323334|39836224|FG008|Period 3|Lost to Follow-up|0|||
16369319|NCT02323334|39836225|FG009|Period 3|Lost to Follow-up|0|||
16369320|NCT02323334|39836226|FG010|Period 3|Lost to Follow-up|0|||
16369321|NCT02323334|39836227|FG011|Period 3|Lost to Follow-up|0|||
16369322|NCT02323334|39836228|FG012|Period 3|Lost to Follow-up|0|||
16369323|NCT02323334|39836229|FG013|Period 3|Lost to Follow-up|0|||
16369324|NCT02323334|39836230|FG014|Period 3|Lost to Follow-up|0|||
16369325|NCT02323334|39836231|FG015|Period 3|Lost to Follow-up|0|||
16369326|NCT02323334|39836232|FG016|Period 3|Lost to Follow-up|0|||
16369327|NCT02323334|39836216|FG000|Period 3|Withdrawal by Subject|1|||
16369328|NCT02323334|39836217|FG001|Period 3|Withdrawal by Subject|0|||
16369329|NCT02323334|39836218|FG002|Period 3|Withdrawal by Subject|0|||
16066617|NCT02365298|38736487|FG000|Period 2|Protocol Violation|0|||
16066618|NCT02365298|38736488|FG001|Period 2|Protocol Violation|1|||
16066619|NCT00582790|38736491|FG000|Overall Study|Rapid progression of disease|1|||
16066620|NCT01773122|38736492|FG000|Overall Study|Due to amended age eligibility criteria|3|||
16066621|NCT01773122|38736493|FG001|Overall Study|Due to amended age eligibility criteria|1|||
16066622|NCT01773122|38736494|FG002|Overall Study|Due to amended age eligibility criteria|0|||
16066623|NCT01773122|38736495|FG003|Overall Study|Due to amended age eligibility criteria|1|||
16066624|NCT00819910|38736498|FG000|Overall Study|Adverse Event|0|||
16066625|NCT00819910|38736499|FG001|Overall Study|Adverse Event|0|||
16066626|NCT00819910|38736500|FG002|Overall Study|Adverse Event|2|||
16066627|NCT00819910|38736501|FG003|Overall Study|Adverse Event|1|||
16066628|NCT00819910|38736498|FG000|Overall Study|Withdrawal by Subject|1|||
16066629|NCT00819910|38736499|FG001|Overall Study|Withdrawal by Subject|1|||
16066630|NCT00819910|38736500|FG002|Overall Study|Withdrawal by Subject|1|||
16066631|NCT00819910|38736501|FG003|Overall Study|Withdrawal by Subject|0|||
16066632|NCT00819910|38736498|FG000|Overall Study|Lost to Follow-up|1|||
16066633|NCT00819910|38736499|FG001|Overall Study|Lost to Follow-up|0|||
16066634|NCT00819910|38736500|FG002|Overall Study|Lost to Follow-up|0|||
16066635|NCT00819910|38736501|FG003|Overall Study|Lost to Follow-up|0|||
16066636|NCT02952261|38736502|FG000|Overall Study|Withdrawal by Subject|4|||
16066637|NCT02952261|38736503|FG001|Overall Study|Withdrawal by Subject|5|||
16066638|NCT02952261|38736502|FG000|Overall Study|Protocol Violation|1|||
16066639|NCT02952261|38736503|FG001|Overall Study|Protocol Violation|0|||
16066640|NCT01119703|38736504|FG000|Overall Study|Adverse Event|0|||
16066641|NCT01119703|38736505|FG001|Overall Study|Adverse Event|1|||
16066642|NCT01427907|38736508|FG000|Overall Study|Withdrawal by Subject|3|||
16066643|NCT01427907|38736509|FG001|Overall Study|Withdrawal by Subject|4|||
16066644|NCT00462943|38736513|FG000|Overall Study|Failure to achieve a response|5|||
16066645|NCT00462943|38736514|FG001|Overall Study|Failure to achieve a response|5|||
16066646|NCT00462943|38736515|FG002|Overall Study|Failure to achieve a response|1|||
16066647|NCT00462943|38736513|FG000|Overall Study|Adverse Event|6|||
16066648|NCT00462943|38736514|FG001|Overall Study|Adverse Event|4|||
16066649|NCT00462943|38736515|FG002|Overall Study|Adverse Event|1|||
16066650|NCT00462943|38736513|FG000|Overall Study|Protocol Violation|1|||
16066651|NCT00462943|38736514|FG001|Overall Study|Protocol Violation|0|||
16066652|NCT00462943|38736515|FG002|Overall Study|Protocol Violation|0|||
16066653|NCT00462943|38736513|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
16066654|NCT00462943|38736514|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
16066655|NCT00462943|38736515|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
16066656|NCT00462943|38736513|FG000|Overall Study|Disease Progression|15|||
16066657|NCT00462943|38736514|FG001|Overall Study|Disease Progression|15|||
16066658|NCT00462943|38736515|FG002|Overall Study|Disease Progression|9|||
16066659|NCT00462943|38736513|FG000|Overall Study|Death|5|||
16066660|NCT00462943|38736514|FG001|Overall Study|Death|2|||
16066661|NCT00462943|38736515|FG002|Overall Study|Death|7|||
16066662|NCT00462943|38736513|FG000|Overall Study|Stem Cell Transplant|1|||
16066663|NCT00462943|38736514|FG001|Overall Study|Stem Cell Transplant|1|||
16066664|NCT00462943|38736515|FG002|Overall Study|Stem Cell Transplant|0|||
16369330|NCT02323334|39836219|FG003|Period 3|Withdrawal by Subject|0|||
16369331|NCT02323334|39836220|FG004|Period 3|Withdrawal by Subject|0|||
16263444|NCT01190930|39449796|FG008|Induction|Lost to Follow-up|0|||
16066665|NCT00462943|38736513|FG000|Overall Study|Bone Marrow Transplant|1|||
16369332|NCT02323334|39836221|FG005|Period 3|Withdrawal by Subject|0|||
16369333|NCT02323334|39836222|FG006|Period 3|Withdrawal by Subject|0|||
16369334|NCT02323334|39836223|FG007|Period 3|Withdrawal by Subject|0|||
16369335|NCT02323334|39836224|FG008|Period 3|Withdrawal by Subject|0|||
16369336|NCT02323334|39836225|FG009|Period 3|Withdrawal by Subject|0|||
16158794|NCT01583374|39064949|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
16158795|NCT01583374|39064950|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
16158796|NCT01583374|39064951|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
16158797|NCT01583374|39064952|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16158798|NCT01583374|39064953|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16158799|NCT01583374|39064954|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16158800|NCT01583374|39064955|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16158801|NCT01583374|39064956|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16158802|NCT01583374|39064957|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
16158803|NCT01583374|39064949|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
16158804|NCT01583374|39064950|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
16158805|NCT01583374|39064951|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
16158806|NCT01583374|39064952|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16158807|NCT01583374|39064953|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16158808|NCT01583374|39064954|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16158809|NCT01583374|39064955|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16158810|NCT01583374|39064956|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16158811|NCT01583374|39064957|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
16158812|NCT01583374|39064949|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
16158813|NCT01583374|39064950|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
16158814|NCT01583374|39064951|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16158815|NCT01583374|39064952|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16158816|NCT01583374|39064953|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16158817|NCT01583374|39064954|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16158818|NCT01583374|39064955|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16158819|NCT01583374|39064956|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16158820|NCT01583374|39064957|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
16158821|NCT01583374|39064949|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
16158822|NCT01583374|39064950|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
16158823|NCT01583374|39064951|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
16158824|NCT01583374|39064952|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16158825|NCT01583374|39064953|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16446064|NCT02603146|40111776|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
16446065|NCT02603146|40111777|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
16446066|NCT02603146|40111776|FG000|Overall Study|Participant moved|2|||
16446067|NCT02603146|40111777|FG001|Overall Study|Participant moved|0|||
16446068|NCT02603146|40111776|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
16446069|NCT02603146|40111777|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
16446070|NCT01662102|40111778|FG000|Overall Study|Sponsor's decision|1|||
16446071|NCT01662102|40111779|FG001|Overall Study|Sponsor's decision|0|||
16446072|NCT03591406|40111780|FG000|Overall Study|Adverse Event|5|||
16446073|NCT03591406|40111781|FG001|Overall Study|Adverse Event|3|||
16446074|NCT03591406|40111780|FG000|Overall Study|Protocol Violation|2|||
16446075|NCT03591406|40111781|FG001|Overall Study|Protocol Violation|1|||
16446076|NCT03591406|40111780|FG000|Overall Study|Withdrawal by Subject|0|||
16446077|NCT03591406|40111781|FG001|Overall Study|Withdrawal by Subject|5|||
16446078|NCT01409707|40111782|FG000|Overall Study|Withdrawal by Subject|5|||
16446079|NCT01409707|40111783|FG001|Overall Study|Withdrawal by Subject|17|||
16446080|NCT01409707|40111784|FG002|Overall Study|Withdrawal by Subject|16|||
16446081|NCT04154904|40111790|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
16446082|NCT04154904|40111791|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
16446083|NCT04154904|40111792|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
16446084|NCT03219723|40111793|FG000|Overall Study|Case Report Forms Uncollected|6|||
16446085|NCT03219723|40111793|FG000|Overall Study|Protocol Deviation|4|||
16446086|NCT04558125|40111794|FG000|Overall Study|Death|1|||
16446087|NCT02144610|40111795|FG000|Overall Study|Physician Decision|1|||
16446088|NCT02144610|40111796|FG001|Overall Study|Physician Decision|0|||
16446089|NCT02144610|40111795|FG000|Overall Study|Withdrawal by Subject|1|||
16446090|NCT02144610|40111796|FG001|Overall Study|Withdrawal by Subject|5|||
16446091|NCT02144610|40111795|FG000|Overall Study|Death|2|||
16446092|NCT02144610|40111796|FG001|Overall Study|Death|2|||
16446093|NCT02144610|40111795|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
16446094|NCT02144610|40111796|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
16446095|NCT02144610|40111795|FG000|Overall Study|Other|0|||
16066666|NCT00462943|38736514|FG001|Overall Study|Bone Marrow Transplant|0|||
16066667|NCT00462943|38736515|FG002|Overall Study|Bone Marrow Transplant|0|||
16066668|NCT00462943|38736513|FG000|Overall Study|Required Lymphocyte Infusion|1|||
16066669|NCT00462943|38736514|FG001|Overall Study|Required Lymphocyte Infusion|0|||
16158826|NCT01583374|39064954|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16158827|NCT01583374|39064955|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16158828|NCT01583374|39064956|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16158829|NCT01583374|39064957|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
16158830|NCT01583374|39064949|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
16158831|NCT01583374|39064950|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
16158832|NCT01583374|39064951|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16158833|NCT01583374|39064952|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16158834|NCT01583374|39064953|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16158835|NCT01583374|39064954|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16158836|NCT01583374|39064955|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16158837|NCT01583374|39064956|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16158838|NCT01583374|39064957|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
16158839|NCT01583374|39064949|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16158840|NCT01583374|39064950|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16158841|NCT01583374|39064951|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
16158842|NCT01583374|39064952|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16158843|NCT01583374|39064953|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16158844|NCT01583374|39064954|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16158845|NCT01583374|39064955|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16158846|NCT01583374|39064956|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16158847|NCT01583374|39064957|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
16158848|NCT01583374|39064949|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
16158849|NCT01583374|39064950|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
16158850|NCT01583374|39064951|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
16158851|NCT01583374|39064952|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
16158852|NCT01583374|39064953|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
16158853|NCT01583374|39064954|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
16158854|NCT01583374|39064955|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
16158855|NCT01583374|39064956|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
16158856|NCT01583374|39064957|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
16158857|NCT01583374|39064949|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16158858|NCT01583374|39064950|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16158859|NCT01583374|39064951|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16158860|NCT01583374|39064952|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16158861|NCT01583374|39064953|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16158862|NCT01583374|39064954|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16158863|NCT01583374|39064955|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16158864|NCT01583374|39064956|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
16158865|NCT01583374|39064957|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
16158866|NCT01583374|39064949|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
16158867|NCT01583374|39064950|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
16158868|NCT01583374|39064951|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
16158869|NCT01583374|39064952|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
16158870|NCT01583374|39064953|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
16158871|NCT01583374|39064954|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
16158872|NCT01583374|39064955|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
16158873|NCT01583374|39064956|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
16158874|NCT01583374|39064957|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
16158875|NCT01583374|39064949|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
16158876|NCT01583374|39064950|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
16158877|NCT01583374|39064951|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
16158878|NCT01583374|39064952|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
16158879|NCT01583374|39064953|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
16158880|NCT01583374|39064954|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
16158881|NCT01583374|39064955|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
16158882|NCT01583374|39064956|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
16158883|NCT01583374|39064957|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
16158884|NCT01583374|39064949|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16158885|NCT01583374|39064950|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
16158886|NCT01583374|39064951|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
16158887|NCT01583374|39064952|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16158888|NCT01583374|39064953|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
16158889|NCT01583374|39064954|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16158890|NCT01583374|39064955|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16263445|NCT01190930|39449797|FG009|Induction|Lost to Follow-up|0|||
16263446|NCT01190930|39449788|FG000|Induction|Physician Decision|125|||
16446096|NCT02144610|40111796|FG001|Overall Study|Other|1|||
16446097|NCT00412984|40111801|FG000|Overall Study|Death|331|||
16446098|NCT00412984|40111802|FG001|Overall Study|Death|349|||
16446099|NCT00412984|40111801|FG000|Overall Study|Adverse Event|679|||
16446100|NCT00412984|40111802|FG001|Overall Study|Adverse Event|738|||
16446101|NCT00412984|40111801|FG000|Overall Study|Withdrawal by Subject|921|||
16446102|NCT00412984|40111802|FG001|Overall Study|Withdrawal by Subject|989|||
16446103|NCT00412984|40111801|FG000|Overall Study|Lost to Follow-up|51|||
16446104|NCT00412984|40111802|FG001|Overall Study|Lost to Follow-up|39|||
16446105|NCT00412984|40111801|FG000|Overall Study|Poor/Noncompliance|57|||
16446106|NCT00412984|40111802|FG001|Overall Study|Poor/Noncompliance|77|||
16446107|NCT00412984|40111801|FG000|Overall Study|Pregnancy|1|||
16446108|NCT00412984|40111802|FG001|Overall Study|Pregnancy|0|||
16446109|NCT00412984|40111801|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
16066670|NCT00462943|38736515|FG002|Overall Study|Required Lymphocyte Infusion|0|||
16066671|NCT00462943|38736513|FG000|Overall Study|Transplant - not specified|1|||
16066672|NCT00462943|38736514|FG001|Overall Study|Transplant - not specified|0|||
16066673|NCT00462943|38736515|FG002|Overall Study|Transplant - not specified|1|||
16066674|NCT00462943|38736513|FG000|Overall Study|Physician Decision|1|||
16066675|NCT00462943|38736514|FG001|Overall Study|Physician Decision|0|||
16066676|NCT00462943|38736515|FG002|Overall Study|Physician Decision|0|||
16066677|NCT00462943|38736513|FG000|Overall Study|Withdrawal by Subject|0|||
16066678|NCT00462943|38736514|FG001|Overall Study|Withdrawal by Subject|1|||
16066679|NCT00462943|38736515|FG002|Overall Study|Withdrawal by Subject|0|||
16066680|NCT03566680|38736518|FG000|Overall Study|Pregnancy|1|||
16066681|NCT03566680|38736518|FG000|Overall Study|Lost to Follow-up|13|||
16066682|NCT03566680|38736518|FG000|Overall Study|Withdrawal by Subject|3|||
16066683|NCT00849147|38736519|FG000|Overall Study|Withdrawal by Subject|1|||
16066684|NCT00849147|38736519|FG000|Overall Study|Protocol Violation|2|||
16066685|NCT00849147|38736519|FG000|Overall Study|Disease Relapse/Progression|2|||
16066686|NCT01674569|38736520|FG000|Overall Study|Adverse Event|0|||
16066687|NCT01674569|38736521|FG001|Overall Study|Adverse Event|2|||
16066688|NCT01674569|38736522|FG002|Overall Study|Adverse Event|0|||
16066689|NCT01674569|38736523|FG003|Overall Study|Adverse Event|1|||
16066690|NCT01674569|38736524|FG004|Overall Study|Adverse Event|2|||
16066691|NCT01674569|38736525|FG005|Overall Study|Adverse Event|2|||
16066692|NCT01674569|38736520|FG000|Overall Study|Protocol Violation|0|||
16066693|NCT01674569|38736521|FG001|Overall Study|Protocol Violation|1|||
16066694|NCT01674569|38736522|FG002|Overall Study|Protocol Violation|1|||
16066695|NCT01674569|38736523|FG003|Overall Study|Protocol Violation|0|||
16066696|NCT01674569|38736524|FG004|Overall Study|Protocol Violation|0|||
16066697|NCT01674569|38736525|FG005|Overall Study|Protocol Violation|0|||
16066698|NCT01674569|38736520|FG000|Overall Study|Withdrawal by Subject|0|||
16066699|NCT01674569|38736521|FG001|Overall Study|Withdrawal by Subject|0|||
16066700|NCT01674569|38736522|FG002|Overall Study|Withdrawal by Subject|1|||
16066701|NCT01674569|38736523|FG003|Overall Study|Withdrawal by Subject|0|||
16066702|NCT01674569|38736524|FG004|Overall Study|Withdrawal by Subject|0|||
16066703|NCT01674569|38736525|FG005|Overall Study|Withdrawal by Subject|0|||
16066704|NCT01941316|38736531|FG000|Overall Study|Adverse Event|0|||
16066705|NCT01941316|38736532|FG001|Overall Study|Adverse Event|1|||
16066706|NCT01941316|38736533|FG002|Overall Study|Adverse Event|0|||
16066707|NCT01941316|38736534|FG003|Overall Study|Adverse Event|7|||
16066708|NCT01941316|38736531|FG000|Overall Study|Progressive Disease|3|||
16066709|NCT01941316|38736532|FG001|Overall Study|Progressive Disease|6|||
16066710|NCT01941316|38736533|FG002|Overall Study|Progressive Disease|2|||
16066711|NCT01941316|38736534|FG003|Overall Study|Progressive Disease|29|||
16158891|NCT01583374|39064956|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16158892|NCT01583374|39064957|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
16158893|NCT01583374|39064949|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16158894|NCT01583374|39064950|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16158895|NCT01583374|39064951|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
16158896|NCT01583374|39064952|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16158897|NCT01583374|39064953|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
16158898|NCT01583374|39064954|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
16158899|NCT01583374|39064955|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16158900|NCT01583374|39064956|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16158901|NCT01583374|39064957|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
16158902|NCT01583374|39064949|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
16263447|NCT01190930|39449789|FG001|Induction|Physician Decision|3|||
16066712|NCT01941316|38736531|FG000|Overall Study|Withdrawal by Subject|0|||
16066713|NCT01941316|38736532|FG001|Overall Study|Withdrawal by Subject|2|||
16066714|NCT01941316|38736533|FG002|Overall Study|Withdrawal by Subject|1|||
16066715|NCT01941316|38736534|FG003|Overall Study|Withdrawal by Subject|8|||
16066716|NCT01941316|38736531|FG000|Overall Study|Death|0|||
16446110|NCT00412984|40111802|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
16066717|NCT01941316|38736532|FG001|Overall Study|Death|0|||
16158903|NCT01583374|39064950|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
16158904|NCT01583374|39064951|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
16158905|NCT01583374|39064952|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
16158906|NCT01583374|39064953|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
16158907|NCT01583374|39064954|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
16158908|NCT01583374|39064955|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
16158909|NCT01583374|39064956|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
16158910|NCT01583374|39064957|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
16158911|NCT01583374|39064949|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
16158912|NCT01583374|39064950|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
16158913|NCT01583374|39064951|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
16158914|NCT01583374|39064952|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
16158915|NCT01583374|39064953|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
16158916|NCT01583374|39064954|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
16158917|NCT01583374|39064955|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
16158918|NCT01583374|39064956|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
16158919|NCT01583374|39064957|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
16158920|NCT01583374|39064949|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16158921|NCT01583374|39064950|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16158922|NCT01583374|39064951|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16158923|NCT01583374|39064952|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16158924|NCT01583374|39064953|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
16158925|NCT01583374|39064954|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16158926|NCT01583374|39064955|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
16158927|NCT01583374|39064956|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
16158928|NCT01583374|39064957|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
16158929|NCT01583374|39064949|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
16263448|NCT01190930|39449790|FG002|Induction|Physician Decision|0|||
16369337|NCT02323334|39836226|FG010|Period 3|Withdrawal by Subject|0|||
16369338|NCT02323334|39836227|FG011|Period 3|Withdrawal by Subject|0|||
16369339|NCT02323334|39836228|FG012|Period 3|Withdrawal by Subject|0|||
16369340|NCT02323334|39836229|FG013|Period 3|Withdrawal by Subject|0|||
16369341|NCT02323334|39836230|FG014|Period 3|Withdrawal by Subject|0|||
16369342|NCT02323334|39836231|FG015|Period 3|Withdrawal by Subject|0|||
16369343|NCT02323334|39836232|FG016|Period 3|Withdrawal by Subject|0|||
16066718|NCT01941316|38736533|FG002|Overall Study|Death|0|||
16066719|NCT01941316|38736534|FG003|Overall Study|Death|3|||
16066720|NCT01941316|38736531|FG000|Overall Study|Physician Decision|0|||
16066721|NCT01941316|38736532|FG001|Overall Study|Physician Decision|0|||
16066722|NCT01941316|38736533|FG002|Overall Study|Physician Decision|0|||
16066723|NCT01941316|38736534|FG003|Overall Study|Physician Decision|3|||
16066724|NCT01941316|38736531|FG000|Overall Study|Protocol Violation|0|||
16066725|NCT01941316|38736532|FG001|Overall Study|Protocol Violation|0|||
16066726|NCT01941316|38736533|FG002|Overall Study|Protocol Violation|0|||
16066727|NCT01941316|38736534|FG003|Overall Study|Protocol Violation|3|||
16066728|NCT01941316|38736531|FG000|Overall Study|Intercurrent illness|0|||
16066729|NCT01941316|38736532|FG001|Overall Study|Intercurrent illness|0|||
16066730|NCT01941316|38736533|FG002|Overall Study|Intercurrent illness|0|||
16066731|NCT01941316|38736534|FG003|Overall Study|Intercurrent illness|1|||
16066732|NCT01941316|38736531|FG000|Overall Study|Other, not specified|0|||
16066733|NCT01941316|38736532|FG001|Overall Study|Other, not specified|0|||
16066734|NCT01941316|38736533|FG002|Overall Study|Other, not specified|0|||
16066735|NCT01941316|38736534|FG003|Overall Study|Other, not specified|1|||
16066736|NCT02028884|38736537|FG000|Double-blind Period|Adverse Event|5|||
16066737|NCT02028884|38736538|FG001|Double-blind Period|Adverse Event|3|||
16066738|NCT02028884|38736539|FG002|Double-blind Period|Adverse Event|0|||
16066739|NCT02028884|38736537|FG000|Double-blind Period|Eligibility Violation|1|||
16066740|NCT02028884|38736538|FG001|Double-blind Period|Eligibility Violation|0|||
16066741|NCT02028884|38736539|FG002|Double-blind Period|Eligibility Violation|0|||
16066742|NCT02028884|38736537|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
16066743|NCT02028884|38736538|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
16066744|NCT02028884|38736539|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
16066745|NCT02028884|38736537|FG000|Double-blind Period|Withdrawal by Subject|2|||
16066746|NCT02028884|38736538|FG001|Double-blind Period|Withdrawal by Subject|0|||
16066747|NCT02028884|38736539|FG002|Double-blind Period|Withdrawal by Subject|0|||
16066748|NCT02028884|38736537|FG000|Open-label Extension Period|Adverse Event|3|||
16066749|NCT02028884|38736538|FG001|Open-label Extension Period|Adverse Event|1|||
16066750|NCT02028884|38736539|FG002|Open-label Extension Period|Adverse Event|0|||
16066751|NCT02028884|38736537|FG000|Open-label Extension Period|Lack of Efficacy|3|||
16066752|NCT02028884|38736538|FG001|Open-label Extension Period|Lack of Efficacy|0|||
16066753|NCT02028884|38736539|FG002|Open-label Extension Period|Lack of Efficacy|0|||
16446111|NCT00412984|40111801|FG000|Overall Study|Administrative Reason by Sponsor|11|||
16446112|NCT00412984|40111802|FG001|Overall Study|Administrative Reason by Sponsor|8|||
16446113|NCT00412984|40111801|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
16446114|NCT00412984|40111802|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
16446115|NCT00412984|40111801|FG000|Overall Study|Other Reason|80|||
16446116|NCT00412984|40111802|FG001|Overall Study|Other Reason|92|||
16446117|NCT00412984|40111801|FG000|Overall Study|Not Reported|11|||
16446118|NCT00412984|40111802|FG001|Overall Study|Not Reported|12|||
16446119|NCT00371150|40111803|FG000|Overall Study|Lost to Follow-up|3|||
16446120|NCT00371150|40111804|FG001|Overall Study|Lost to Follow-up|2|||
16446121|NCT01710501|40111806|FG000|Overall Study|Lost to Follow-up|2|||
16446122|NCT01710501|40111807|FG001|Overall Study|Lost to Follow-up|0|||
16446123|NCT01710501|40111808|FG002|Overall Study|Lost to Follow-up|0|||
16446124|NCT00888173|40111811|FG000|Overall Study|Wrong Primary|1|||
16446125|NCT00888173|40111811|FG000|Overall Study|Ineligible: required test not done|1|||
16446126|NCT03094416|40111812|FG000|Run-in|Screening failure|8|||
16446127|NCT03094416|40111812|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
16446128|NCT03094416|40111812|FG000|Run-in|Withdrawal by Subject|3|||
16446129|NCT03094416|40111812|FG000|Treatment Period|Withdrawal by Subject|2|||
16446130|NCT00734149|40111813|FG000|Overall Study|Withdrawal by Subject|1|||
16446131|NCT01942837|40111816|FG000|Overall Study|Death|1|||
16446132|NCT01942837|40111816|FG000|Overall Study|Symptomatic or radiographic progression|49|||
16446133|NCT01942837|40111816|FG000|Overall Study|Adverse Event|6|||
16158930|NCT01583374|39064950|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
16158931|NCT01583374|39064951|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
16158932|NCT01583374|39064952|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
16158933|NCT01583374|39064953|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
16158934|NCT01583374|39064954|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
16158935|NCT01583374|39064955|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
16158936|NCT01583374|39064956|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
16158937|NCT01583374|39064957|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
16066754|NCT02028884|38736537|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
16066755|NCT02028884|38736538|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
16066756|NCT02028884|38736539|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
16066757|NCT02028884|38736537|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
16263449|NCT01190930|39449791|FG003|Induction|Physician Decision|0|||
16263450|NCT01190930|39449792|FG004|Induction|Physician Decision|0|||
16066758|NCT02028884|38736538|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
16066759|NCT02028884|38736539|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
16066760|NCT02028884|38736537|FG000|Open-label Extension Period|Switched to another treatment option|3|||
16066761|NCT02028884|38736538|FG001|Open-label Extension Period|Switched to another treatment option|0|||
16066762|NCT02028884|38736539|FG002|Open-label Extension Period|Switched to another treatment option|0|||
16066763|NCT01033643|38736540|FG000|Overall Study|Withdrew Consent|0|||
16066764|NCT01033643|38736541|FG001|Overall Study|Withdrew Consent|3|||
16066765|NCT01033643|38736542|FG002|Overall Study|Withdrew Consent|0|||
16066766|NCT01033643|38736543|FG003|Overall Study|Withdrew Consent|0|||
16066767|NCT01033643|38736544|FG004|Overall Study|Withdrew Consent|0|||
16066768|NCT01033643|38736545|FG005|Overall Study|Withdrew Consent|1|||
16066769|NCT00410384|38736546|FG000|Overall Study|Withdrawal by Subject|28|||
16066770|NCT00410384|38736547|FG001|Overall Study|Withdrawal by Subject|17|||
16446134|NCT01942837|40111816|FG000|Overall Study|Physician Decision|3|||
16066771|NCT00410384|38736548|FG002|Overall Study|Withdrawal by Subject|20|||
16066772|NCT00410384|38736546|FG000|Overall Study|Adverse Event|23|||
16066773|NCT00410384|38736547|FG001|Overall Study|Adverse Event|18|||
16263451|NCT01190930|39449793|FG005|Induction|Physician Decision|0|||
16263452|NCT01190930|39449794|FG006|Induction|Physician Decision|0|||
16263453|NCT01190930|39449795|FG007|Induction|Physician Decision|0|||
16263454|NCT01190930|39449796|FG008|Induction|Physician Decision|0|||
16263455|NCT01190930|39449797|FG009|Induction|Physician Decision|0|||
16263456|NCT01190930|39449788|FG000|Induction|Withdrawal by Subject|9|||
16263457|NCT01190930|39449789|FG001|Induction|Withdrawal by Subject|0|||
16263458|NCT01190930|39449790|FG002|Induction|Withdrawal by Subject|0|||
16263459|NCT01190930|39449791|FG003|Induction|Withdrawal by Subject|0|||
16263460|NCT01190930|39449792|FG004|Induction|Withdrawal by Subject|0|||
16263461|NCT01190930|39449793|FG005|Induction|Withdrawal by Subject|0|||
16263462|NCT01190930|39449794|FG006|Induction|Withdrawal by Subject|0|||
16263463|NCT01190930|39449795|FG007|Induction|Withdrawal by Subject|0|||
16263464|NCT01190930|39449796|FG008|Induction|Withdrawal by Subject|0|||
16263465|NCT01190930|39449797|FG009|Induction|Withdrawal by Subject|0|||
16263466|NCT01190930|39449788|FG000|Induction|Refusal|235|||
16263467|NCT01190930|39449789|FG001|Induction|Refusal|0|||
16446135|NCT01942837|40111816|FG000|Overall Study|Withdrawal by Subject|2|||
16446136|NCT01942837|40111816|FG000|Overall Study|Intercurrent Illness|1|||
16066774|NCT00410384|38736548|FG002|Overall Study|Adverse Event|23|||
16446137|NCT01942837|40111816|FG000|Overall Study|On treatment|3|||
16369344|NCT03770455|39836233|FG000|Overall Study|Screen failures|3|||
16369345|NCT01111292|39836236|FG000|Treatment|Physician Decision|1|||
16369346|NCT01111292|39836237|FG001|Treatment|Physician Decision|1|||
16369347|NCT00450749|39836246|FG000|Overall Study|Withdrawal by Subject|0|||
16369348|NCT00450749|39836247|FG001|Overall Study|Withdrawal by Subject|0|||
16369349|NCT00450749|39836248|FG002|Overall Study|Withdrawal by Subject|2|||
16369350|NCT00450749|39836246|FG000|Overall Study|Noncompliant|0|||
16446138|NCT01942837|40111816|FG000|Overall Study|Never initiate the treatment|2|||
16446139|NCT03155841|40111822|FG000|Overall Study|Protocol Violation|3|||
16446140|NCT03155841|40111823|FG001|Overall Study|Protocol Violation|4|||
16446141|NCT00456846|40111829|FG000|Overall Study|Adverse Event|2|||
16446142|NCT00456846|40111830|FG001|Overall Study|Adverse Event|15|||
16446143|NCT00456846|40111829|FG000|Overall Study|Physician Decision|11|||
16446144|NCT00456846|40111830|FG001|Overall Study|Physician Decision|6|||
16446145|NCT00456846|40111829|FG000|Overall Study|Protocol Deviation|2|||
16446146|NCT00456846|40111830|FG001|Overall Study|Protocol Deviation|0|||
16446147|NCT00456846|40111829|FG000|Overall Study|Participant Discretion|1|||
16446148|NCT00456846|40111830|FG001|Overall Study|Participant Discretion|5|||
16446149|NCT00456846|40111829|FG000|Overall Study|Other|0|||
16446150|NCT00456846|40111830|FG001|Overall Study|Other|2|||
16446151|NCT00744497|40111831|FG000|Overall Study|Withdrawal by Subject|21|||
16446152|NCT00744497|40111832|FG001|Overall Study|Withdrawal by Subject|18|||
16446153|NCT00744497|40111831|FG000|Overall Study|Death|11|||
16446154|NCT00744497|40111832|FG001|Overall Study|Death|9|||
16446155|NCT00744497|40111831|FG000|Overall Study|Lost to Follow-up|4|||
16446156|NCT00744497|40111832|FG001|Overall Study|Lost to Follow-up|2|||
16446157|NCT00744497|40111831|FG000|Overall Study|Poor compliance/noncompliance|9|||
16446158|NCT00744497|40111832|FG001|Overall Study|Poor compliance/noncompliance|5|||
16446159|NCT00744497|40111831|FG000|Overall Study|No longer meets study criteria|7|||
16446160|NCT00744497|40111832|FG001|Overall Study|No longer meets study criteria|3|||
16446161|NCT00744497|40111831|FG000|Overall Study|Administrative Reason By Sponsor|25|||
16446162|NCT00744497|40111832|FG001|Overall Study|Administrative Reason By Sponsor|8|||
16446163|NCT00744497|40111831|FG000|Overall Study|Disease progression|312|||
16446164|NCT00744497|40111832|FG001|Overall Study|Disease progression|219|||
16446165|NCT00744497|40111831|FG000|Overall Study|Study drug toxicity|68|||
16446166|NCT00744497|40111832|FG001|Overall Study|Study drug toxicity|141|||
16446167|NCT00744497|40111831|FG000|Overall Study|Adverse event unrelated to study drug|78|||
16446168|NCT00744497|40111832|FG001|Overall Study|Adverse event unrelated to study drug|122|||
16446169|NCT00744497|40111831|FG000|Overall Study|Patient requested to stop study drug|65|||
16369351|NCT00450749|39836247|FG001|Overall Study|Noncompliant|1|||
16369352|NCT00450749|39836248|FG002|Overall Study|Noncompliant|0|||
16369353|NCT03760068|39836249|FG000|Overall Study|Withdrawal by Subject|7|||
16369354|NCT03760068|39836250|FG001|Overall Study|Withdrawal by Subject|8|||
16369355|NCT03760068|39836249|FG000|Overall Study|Adverse Event|1|||
16369356|NCT03760068|39836250|FG001|Overall Study|Adverse Event|2|||
16369357|NCT03760068|39836249|FG000|Overall Study|Administrative Decision by Sponsor|0|||
16369358|NCT03760068|39836250|FG001|Overall Study|Administrative Decision by Sponsor|2|||
16369359|NCT03760068|39836249|FG000|Overall Study|Physician Decision|1|||
16369360|NCT03760068|39836250|FG001|Overall Study|Physician Decision|2|||
16369361|NCT03760068|39836249|FG000|Overall Study|Lost to Follow-up|4|||
16369362|NCT03760068|39836250|FG001|Overall Study|Lost to Follow-up|9|||
16369363|NCT03760068|39836249|FG000|Overall Study|Subject Moved Out of State|1|||
16369364|NCT03760068|39836250|FG001|Overall Study|Subject Moved Out of State|0|||
16369365|NCT04964388|39836253|FG000|Overall Study|Lost to Follow-up|3|||
16446170|NCT00744497|40111832|FG001|Overall Study|Patient requested to stop study drug|80|||
16369366|NCT04964388|39836254|FG001|Overall Study|Lost to Follow-up|2|||
16369367|NCT04069520|39836255|FG000|Overall Study|Lost to Follow-up|0|||
16369368|NCT04069520|39836256|FG001|Overall Study|Lost to Follow-up|2|||
16369369|NCT04069520|39836255|FG000|Overall Study|Withdrawal by Subject|0|||
16369370|NCT04069520|39836256|FG001|Overall Study|Withdrawal by Subject|1|||
16066775|NCT00410384|38736546|FG000|Overall Study|Lack of Efficacy|20|||
16066776|NCT00410384|38736547|FG001|Overall Study|Lack of Efficacy|12|||
16066777|NCT00410384|38736548|FG002|Overall Study|Lack of Efficacy|17|||
16066778|NCT00410384|38736546|FG000|Overall Study|Lack of Compliance|2|||
16066779|NCT00410384|38736547|FG001|Overall Study|Lack of Compliance|2|||
16066780|NCT00410384|38736548|FG002|Overall Study|Lack of Compliance|2|||
16369371|NCT04069520|39836255|FG000|Overall Study|Prior Injury|1|||
16369372|NCT04069520|39836256|FG001|Overall Study|Prior Injury|0|||
16369373|NCT04069520|39836255|FG000|Overall Study|Orthodontia|1|||
16066781|NCT00410384|38736546|FG000|Overall Study|Lost to Follow-up|4|||
16066782|NCT00410384|38736547|FG001|Overall Study|Lost to Follow-up|6|||
16066783|NCT00410384|38736548|FG002|Overall Study|Lost to Follow-up|6|||
16369374|NCT04069520|39836256|FG001|Overall Study|Orthodontia|0|||
16066784|NCT00410384|38736546|FG000|Overall Study|Protocol Violation|6|||
16369375|NCT04069520|39836255|FG000|Overall Study|Cut from team|0|||
16369376|NCT04069520|39836256|FG001|Overall Study|Cut from team|2|||
16446171|NCT00744497|40111831|FG000|Overall Study|Maximum clinical benefit|141|||
16446172|NCT00744497|40111832|FG001|Overall Study|Maximum clinical benefit|142|||
16369377|NCT04398134|39836265|FG000|Overall Study|Adverse Event|0|||
16369378|NCT04398134|39836266|FG001|Overall Study|Adverse Event|0|||
16369379|NCT04398134|39836267|FG002|Overall Study|Adverse Event|1|||
16369380|NCT04398134|39836268|FG003|Overall Study|Adverse Event|0|||
16369381|NCT04398134|39836265|FG000|Overall Study|Withdrawal by Subject|2|||
16369382|NCT04398134|39836266|FG001|Overall Study|Withdrawal by Subject|0|||
16369383|NCT04398134|39836267|FG002|Overall Study|Withdrawal by Subject|0|||
16369384|NCT04398134|39836268|FG003|Overall Study|Withdrawal by Subject|1|||
16369385|NCT04398134|39836265|FG000|Overall Study|Study Terminated by Sponsor|30|||
16369386|NCT04398134|39836266|FG001|Overall Study|Study Terminated by Sponsor|11|||
16369387|NCT04398134|39836267|FG002|Overall Study|Study Terminated by Sponsor|32|||
16369388|NCT04398134|39836268|FG003|Overall Study|Study Terminated by Sponsor|11|||
16369389|NCT03142451|39836269|FG000|Overall Study|Adverse Event|5|||
16369390|NCT03142451|39836270|FG001|Overall Study|Adverse Event|2|||
16369391|NCT03142451|39836269|FG000|Overall Study|Lost to Follow-up|25|||
16369392|NCT03142451|39836270|FG001|Overall Study|Lost to Follow-up|8|||
16369393|NCT03142451|39836269|FG000|Overall Study|Participant request|24|||
16369394|NCT03142451|39836270|FG001|Overall Study|Participant request|12|||
16369395|NCT03142451|39836269|FG000|Overall Study|Protocol Violation|3|||
16369396|NCT03142451|39836270|FG001|Overall Study|Protocol Violation|1|||
16369397|NCT03142451|39836269|FG000|Overall Study|Other|1|||
16369398|NCT03142451|39836270|FG001|Overall Study|Other|1|||
16369399|NCT01397747|39836273|FG000|Overall Study|Multitarget DNA test excluded|689|||
16369400|NCT01397747|39836273|FG000|Overall Study|Colonoscopy excluded|304|||
16369401|NCT01397747|39836273|FG000|Overall Study|FIT excluded|34|||
16369402|NCT00837330|39836274|FG000|Overall Study|Lost to Follow-up|1|||
16369403|NCT00837330|39836275|FG001|Overall Study|Lost to Follow-up|3|||
16369404|NCT01052428|39836276|FG000|Overall Study|Death|1|||
16369405|NCT01052428|39836277|FG001|Overall Study|Death|0|||
16369406|NCT01052428|39836276|FG000|Overall Study|Withdrawal by Subject|0|||
16369407|NCT01052428|39836277|FG001|Overall Study|Withdrawal by Subject|1|||
16369408|NCT02691663|39836278|FG000|Overall Study|Screen failure after baseline|2|||
16369409|NCT02691663|39836279|FG001|Overall Study|Screen failure after baseline|2|||
16369410|NCT02691663|39836278|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
16369411|NCT02691663|39836279|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
16369412|NCT02691663|39836278|FG000|Overall Study|Withdrawn after Follow up 2|1|||
16369413|NCT02691663|39836279|FG001|Overall Study|Withdrawn after Follow up 2|1|||
16369414|NCT02691663|39836278|FG000|Overall Study|Lost to Follow-up|3|||
16369415|NCT02691663|39836279|FG001|Overall Study|Lost to Follow-up|2|||
16369416|NCT01793935|39836281|FG000|Overall Study|Pregnancy|1|||
16369417|NCT01793935|39836282|FG001|Overall Study|Pregnancy|0|||
16369418|NCT01793935|39836281|FG000|Overall Study|Protocol Violation|2|||
16369419|NCT01793935|39836282|FG001|Overall Study|Protocol Violation|1|||
16369420|NCT01793935|39836281|FG000|Overall Study|Adverse Event|2|||
16369421|NCT01793935|39836282|FG001|Overall Study|Adverse Event|0|||
16369422|NCT01793935|39836281|FG000|Overall Study|Patient did not take study medication|1|||
16369423|NCT01793935|39836282|FG001|Overall Study|Patient did not take study medication|1|||
16369424|NCT01793935|39836281|FG000|Overall Study|Lost to Follow-up|0|||
16369425|NCT01793935|39836282|FG001|Overall Study|Lost to Follow-up|1|||
16066785|NCT00410384|38736547|FG001|Overall Study|Protocol Violation|6|||
16066786|NCT00410384|38736548|FG002|Overall Study|Protocol Violation|6|||
16066787|NCT00410384|38736546|FG000|Overall Study|Physician Decision|3|||
16066788|NCT00410384|38736547|FG001|Overall Study|Physician Decision|3|||
16066789|NCT00410384|38736548|FG002|Overall Study|Physician Decision|4|||
16066790|NCT00410384|38736546|FG000|Overall Study|Other|3|||
16066791|NCT00410384|38736547|FG001|Overall Study|Other|8|||
16066792|NCT00410384|38736548|FG002|Overall Study|Other|4|||
16066793|NCT01686932|38736551|FG000|Period 1|Adverse Event|1|||
16066794|NCT01686932|38736552|FG001|Period 1|Adverse Event|1|||
16066795|NCT01582945|38736553|FG000|Overall Study|Intolerable side-effects|1|||
16066796|NCT01582945|38736553|FG000|Overall Study|Scheduling conflicts|1|||
16066797|NCT00823979|38736558|FG000|Overall Study|Lack of Efficacy|13|||
16066798|NCT00823979|38736559|FG001|Overall Study|Lack of Efficacy|16|||
16066799|NCT00823979|38736560|FG002|Overall Study|Lack of Efficacy|9|||
16066800|NCT00823979|38736558|FG000|Overall Study|Lost to Follow-up|2|||
16066801|NCT00823979|38736559|FG001|Overall Study|Lost to Follow-up|1|||
16369426|NCT00549328|39836284|FG000|Overall Study|Adverse Event|2|||
16066802|NCT00823979|38736560|FG002|Overall Study|Lost to Follow-up|0|||
16066803|NCT00823979|38736558|FG000|Overall Study|Withdrawal by Subject|2|||
16066804|NCT00823979|38736559|FG001|Overall Study|Withdrawal by Subject|3|||
16369427|NCT00549328|39836284|FG000|Overall Study|Disease Progression|10|||
16369428|NCT00549328|39836284|FG000|Overall Study|Death|1|||
16369429|NCT00549328|39836284|FG000|Overall Study|Use of Prohibited Medication|1|||
16369430|NCT01756235|39836286|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
16369431|NCT03111732|39836293|FG000|Overall Study|Enrolled in different study|1|||
16369432|NCT03111732|39836293|FG000|Overall Study|Progressive disease|3|||
16369433|NCT03111732|39836293|FG000|Overall Study|Withdrawal by Subject|1|||
16369434|NCT04925934|39836294|FG000|Overall Study|Adverse Event|1|||
16369435|NCT04925934|39836295|FG001|Overall Study|Adverse Event|0|||
16066805|NCT00823979|38736560|FG002|Overall Study|Withdrawal by Subject|2|||
16066806|NCT00823979|38736558|FG000|Overall Study|Protocol Violation|1|||
16066807|NCT00823979|38736559|FG001|Overall Study|Protocol Violation|1|||
16066808|NCT00823979|38736560|FG002|Overall Study|Protocol Violation|0|||
16066809|NCT00823979|38736558|FG000|Overall Study|Pregnancy|0|||
16066810|NCT00823979|38736559|FG001|Overall Study|Pregnancy|1|||
16066811|NCT00823979|38736560|FG002|Overall Study|Pregnancy|0|||
16066812|NCT00823979|38736558|FG000|Overall Study|Adverse Event|0|||
16066813|NCT00823979|38736559|FG001|Overall Study|Adverse Event|2|||
16066814|NCT00823979|38736560|FG002|Overall Study|Adverse Event|4|||
16066815|NCT00823979|38736558|FG000|Overall Study|Other|2|||
16066816|NCT00823979|38736559|FG001|Overall Study|Other|0|||
16066817|NCT00823979|38736560|FG002|Overall Study|Other|1|||
16066818|NCT00823979|38736558|FG000|Overall Study|Randomized but not Treated|4|||
16066819|NCT00823979|38736559|FG001|Overall Study|Randomized but not Treated|3|||
16066820|NCT00823979|38736560|FG002|Overall Study|Randomized but not Treated|1|||
16066821|NCT00823979|38736558|FG000|Overall Study|Study Terminated by Sponsor|5|||
16066822|NCT00823979|38736559|FG001|Overall Study|Study Terminated by Sponsor|5|||
16066823|NCT00823979|38736560|FG002|Overall Study|Study Terminated by Sponsor|7|||
16066824|NCT01616563|38736561|FG000|Overall Study|Lost to Follow-up|40|||
16066825|NCT02459964|38736562|FG000|Overall Study|Withdrawal by Subject|0|||
16066826|NCT02459964|38736563|FG001|Overall Study|Withdrawal by Subject|0|||
16066827|NCT02459964|38736564|FG002|Overall Study|Withdrawal by Subject|1|||
16066828|NCT02459964|38736562|FG000|Overall Study|Abnormal EKG changes|0|||
16066829|NCT02459964|38736563|FG001|Overall Study|Abnormal EKG changes|0|||
16066830|NCT02459964|38736564|FG002|Overall Study|Abnormal EKG changes|1|||
16066831|NCT01515319|38736565|FG000|Overall Study|Withdrawal by Subject|0|||
16066832|NCT01515319|38736566|FG001|Overall Study|Withdrawal by Subject|0|||
16066833|NCT01515319|38736567|FG002|Overall Study|Withdrawal by Subject|0|||
16158938|NCT01583374|39064949|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
16158939|NCT01583374|39064950|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
16158940|NCT01583374|39064951|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
16158941|NCT01583374|39064952|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
16158942|NCT01583374|39064953|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
16158943|NCT01583374|39064954|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
16158944|NCT01583374|39064955|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
16158945|NCT01583374|39064956|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
16158946|NCT01583374|39064957|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
16158947|NCT01583374|39064949|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
16158948|NCT01583374|39064950|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
16446173|NCT00744497|40111831|FG000|Overall Study|Not defined|19|||
16446174|NCT00744497|40111832|FG001|Overall Study|Not defined|13|||
16158949|NCT01583374|39064951|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
16158950|NCT01583374|39064952|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
16158951|NCT01583374|39064953|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
16158952|NCT01583374|39064954|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
16158953|NCT01583374|39064955|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
16158954|NCT01583374|39064956|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
16158955|NCT01583374|39064957|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
16158956|NCT01583374|39064949|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
16066834|NCT01515319|38736568|FG003|Overall Study|Withdrawal by Subject|0|||
16158957|NCT01583374|39064950|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
16158958|NCT01583374|39064951|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
16158959|NCT01583374|39064952|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
16158960|NCT01583374|39064953|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
16263468|NCT01190930|39449790|FG002|Induction|Refusal|0|||
16446175|NCT02392624|40115168|FG000|Overall Study|Withdrawal by Subject|15|||
16446176|NCT02392624|40115169|FG001|Overall Study|Withdrawal by Subject|12|||
16446177|NCT02392624|40115170|FG002|Overall Study|Withdrawal by Subject|9|||
16446178|NCT02392624|40115168|FG000|Overall Study|Adverse Event|4|||
16446179|NCT02392624|40115169|FG001|Overall Study|Adverse Event|1|||
16446180|NCT02392624|40115170|FG002|Overall Study|Adverse Event|2|||
16446181|NCT02392624|40115168|FG000|Overall Study|Pregnancy|1|||
16446182|NCT02392624|40115169|FG001|Overall Study|Pregnancy|0|||
16446183|NCT02392624|40115170|FG002|Overall Study|Pregnancy|0|||
16446184|NCT02392624|40115168|FG000|Overall Study|Protocol Violation|0|||
16446185|NCT02392624|40115169|FG001|Overall Study|Protocol Violation|0|||
16446186|NCT02392624|40115170|FG002|Overall Study|Protocol Violation|1|||
16446187|NCT02392624|40115168|FG000|Overall Study|Sponsor/Investigator Decision|2|||
16446188|NCT02392624|40115169|FG001|Overall Study|Sponsor/Investigator Decision|1|||
16446189|NCT02392624|40115170|FG002|Overall Study|Sponsor/Investigator Decision|0|||
16446190|NCT02392624|40115168|FG000|Overall Study|Other|49|||
16446191|NCT02392624|40115169|FG001|Overall Study|Other|1|||
16446192|NCT02392624|40115170|FG002|Overall Study|Other|1|||
16446193|NCT00787644|40115171|FG000|Overall Study|Lost to Follow-up|1|||
16446194|NCT00787644|40115172|FG001|Overall Study|Lost to Follow-up|1|||
16446195|NCT00787644|40115171|FG000|Overall Study|Withdrawal by Subject|1|||
16446196|NCT00787644|40115172|FG001|Overall Study|Withdrawal by Subject|1|||
16446197|NCT01532986|40115173|FG000|Overall Study|Death|9|||
16446198|NCT01532986|40115174|FG001|Overall Study|Death|9|||
16446199|NCT01532986|40115173|FG000|Overall Study|Withdrawal by Subject|7|||
16446200|NCT01532986|40115174|FG001|Overall Study|Withdrawal by Subject|10|||
16446201|NCT01532986|40115173|FG000|Overall Study|Physician Decision|7|||
16446202|NCT01532986|40115174|FG001|Overall Study|Physician Decision|5|||
16446203|NCT01498068|40115175|FG000|Overall Study|Withdrawal by Subject|1|||
16446204|NCT01498068|40115176|FG001|Overall Study|Withdrawal by Subject|1|||
16158961|NCT01583374|39064954|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
16158962|NCT01583374|39064955|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
16158963|NCT01583374|39064956|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
16158964|NCT01583374|39064957|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
16158965|NCT02264990|39064960|FG000|Overall Study|Death|255|||
16158966|NCT02264990|39064961|FG001|Overall Study|Death|250|||
16158967|NCT02264990|39064960|FG000|Overall Study|Withdrawal by Subject|4|||
16158968|NCT02264990|39064961|FG001|Overall Study|Withdrawal by Subject|5|||
16158969|NCT02264990|39064960|FG000|Overall Study|Lost to Follow-up|1|||
16158970|NCT02264990|39064961|FG001|Overall Study|Lost to Follow-up|3|||
16158971|NCT02264990|39064960|FG000|Overall Study|Other|0|||
16158972|NCT02264990|39064961|FG001|Overall Study|Other|1|||
16158973|NCT01127165|39064962|FG000|Overall Study|Adverse Event|2|||
16158974|NCT01127165|39064963|FG001|Overall Study|Adverse Event|2|||
16158975|NCT01127165|39064962|FG000|Overall Study|Lack of Efficacy|10|||
16158976|NCT01127165|39064963|FG001|Overall Study|Lack of Efficacy|8|||
16158977|NCT01127165|39064962|FG000|Overall Study|Lost to Follow-up|3|||
16158978|NCT01127165|39064963|FG001|Overall Study|Lost to Follow-up|5|||
16158979|NCT01127165|39064962|FG000|Overall Study|Withdrawal by Subject|1|||
16158980|NCT01127165|39064963|FG001|Overall Study|Withdrawal by Subject|3|||
16158981|NCT01127165|39064962|FG000|Overall Study|Protocol Violation|0|||
16158982|NCT01127165|39064963|FG001|Overall Study|Protocol Violation|1|||
16158983|NCT00291551|39064964|FG000|Overall Study|Death|7|||
16158984|NCT00291551|39064964|FG000|Overall Study|Withdrawal by Subject|6|||
16158985|NCT00666458|39064965|FG000|Overall Study|Adverse Event|8|||
16158986|NCT00666458|39064966|FG001|Overall Study|Adverse Event|7|||
16158987|NCT00666458|39064965|FG000|Overall Study|Withdrawal by Subject|5|||
16158988|NCT00666458|39064966|FG001|Overall Study|Withdrawal by Subject|4|||
16158989|NCT00666458|39064965|FG000|Overall Study|Lost to Follow-up|0|||
16158990|NCT00666458|39064966|FG001|Overall Study|Lost to Follow-up|3|||
16158991|NCT00666458|39064965|FG000|Overall Study|Administrative reason by sponsor|1|||
16158992|NCT00666458|39064966|FG001|Overall Study|Administrative reason by sponsor|1|||
16158993|NCT00666458|39064965|FG000|Overall Study|Incorrect enrollment|7|||
16158994|NCT00666458|39064966|FG001|Overall Study|Incorrect enrollment|1|||
16158995|NCT00666458|39064965|FG000|Overall Study|Study specific discontinuation criteria|14|||
16158996|NCT00666458|39064966|FG001|Overall Study|Study specific discontinuation criteria|7|||
16263469|NCT01190930|39449791|FG003|Induction|Refusal|0|||
16263470|NCT01190930|39449792|FG004|Induction|Refusal|0|||
16446205|NCT02691507|40115177|FG000|Overall Study|Missed Visit 3|0|||
16446206|NCT02691507|40115178|FG001|Overall Study|Missed Visit 3|1|||
16446207|NCT02079246|40115179|FG000|OLEX|Withdrawal before treatment|1|||
16446208|NCT02079246|40115180|FG001|OLEX|Withdrawal before treatment|0|||
16158997|NCT00666458|39064965|FG000|Overall Study|Severe non-compliance to the protocol|1|||
16158998|NCT00666458|39064966|FG001|Overall Study|Severe non-compliance to the protocol|1|||
16158999|NCT00666458|39064965|FG000|Overall Study|Safety reasons|1|||
16159000|NCT00666458|39064966|FG001|Overall Study|Safety reasons|0|||
16159001|NCT00666458|39064965|FG000|Overall Study|Medical history of anemia|1|||
16263471|NCT01190930|39449793|FG005|Induction|Refusal|0|||
16446209|NCT02079246|40115179|FG000|OLEX|Death|11|||
16159002|NCT00666458|39064966|FG001|Overall Study|Medical history of anemia|0|||
16159003|NCT01462266|39064967|FG000|Overall Study|Adverse Event|7|||
16159004|NCT01462266|39064968|FG001|Overall Study|Adverse Event|6|||
16159005|NCT01462266|39064967|FG000|Overall Study|Death|2|||
16159006|NCT01462266|39064968|FG001|Overall Study|Death|1|||
16159007|NCT01462266|39064967|FG000|Overall Study|Lack of Efficacy|0|||
16159008|NCT01462266|39064968|FG001|Overall Study|Lack of Efficacy|2|||
16159009|NCT01462266|39064967|FG000|Overall Study|Lost to Follow-up|4|||
16159010|NCT01462266|39064968|FG001|Overall Study|Lost to Follow-up|3|||
16159011|NCT01462266|39064967|FG000|Overall Study|Non-compliance with study drug|3|||
16159012|NCT01462266|39064968|FG001|Overall Study|Non-compliance with study drug|0|||
16159013|NCT01462266|39064967|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
16159014|NCT01462266|39064968|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
16159015|NCT01462266|39064967|FG000|Overall Study|Physician Decision|2|||
16159016|NCT01462266|39064968|FG001|Overall Study|Physician Decision|5|||
16159017|NCT01462266|39064967|FG000|Overall Study|Protocol Violation|1|||
16159018|NCT01462266|39064968|FG001|Overall Study|Protocol Violation|3|||
16159019|NCT01462266|39064967|FG000|Overall Study|Withdrawal by Subject|7|||
16159020|NCT01462266|39064968|FG001|Overall Study|Withdrawal by Subject|2|||
16159021|NCT01462266|39064967|FG000|Overall Study|Screen failure|1|||
16159022|NCT01462266|39064968|FG001|Overall Study|Screen failure|1|||
16159023|NCT00915343|39064969|FG000|Part B - Open Label Period|Treatment switch|0|||
16159024|NCT00915343|39064970|FG001|Part B - Open Label Period|Treatment switch|0|||
16159025|NCT00915343|39064971|FG002|Part B - Open Label Period|Treatment switch|1|||
16159026|NCT00915343|39064969|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
16159027|NCT00915343|39064970|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
16159028|NCT00915343|39064971|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
16159029|NCT01534676|39064972|FG000|Overall Study|Study closed due to poor enrollment|2|||
16159030|NCT01534676|39064973|FG001|Overall Study|Study closed due to poor enrollment|1|||
16159031|NCT01568593|39064976|FG000|Overall Study|Lack of Efficacy|4|||
16159032|NCT01568593|39064977|FG001|Overall Study|Lack of Efficacy|1|||
16159033|NCT01568593|39064976|FG000|Overall Study|Adverse Event|3|||
16159034|NCT01568593|39064977|FG001|Overall Study|Adverse Event|2|||
16159035|NCT01446419|39064978|FG000|Overall Study|Death|1|||
16159036|NCT01446419|39064979|FG001|Overall Study|Death|0|||
16159037|NCT01446419|39064978|FG000|Overall Study|Withdrawal by Subject|1|||
16159038|NCT01446419|39064979|FG001|Overall Study|Withdrawal by Subject|1|||
16159039|NCT01446419|39064978|FG000|Overall Study|Terminated per protocol|3|||
16159040|NCT01446419|39064979|FG001|Overall Study|Terminated per protocol|0|||
16159041|NCT04315181|39064982|FG000|Overall Study|Non-responsive to drug conditions.|1|||
16159042|NCT02135692|39064983|FG000|Overall Study|Adverse Event|3|||
16159043|NCT02135692|39064983|FG000|Overall Study|Lack of Efficacy|2|||
16159044|NCT02135692|39064983|FG000|Overall Study|Protocol Violation|2|||
16159045|NCT02135692|39064983|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
16159046|NCT02135692|39064983|FG000|Overall Study|Product commercially available|159|||
16159047|NCT02135692|39064983|FG000|Overall Study|Study closed/terminated|153|||
16159048|NCT02135692|39064983|FG000|Overall Study|Lost to Follow-up|4|||
16159049|NCT02135692|39064983|FG000|Overall Study|Withdrawal by Subject|15|||
16159050|NCT02889796|39064984|FG000|Overall Study|Withdrew Consent|18|||
16159051|NCT02889796|39064985|FG001|Overall Study|Withdrew Consent|29|||
16159052|NCT02889796|39064986|FG002|Overall Study|Withdrew Consent|20|||
16159053|NCT02889796|39064987|FG003|Overall Study|Withdrew Consent|1|||
16159054|NCT02889796|39064988|FG004|Overall Study|Withdrew Consent|2|||
16159055|NCT02889796|39064989|FG005|Overall Study|Withdrew Consent|35|||
16159056|NCT02889796|39064984|FG000|Overall Study|Investigator's Discretion|10|||
16159057|NCT02889796|39064985|FG001|Overall Study|Investigator's Discretion|9|||
16159058|NCT02889796|39064986|FG002|Overall Study|Investigator's Discretion|10|||
16159059|NCT02889796|39064987|FG003|Overall Study|Investigator's Discretion|3|||
16159060|NCT02889796|39064988|FG004|Overall Study|Investigator's Discretion|0|||
16159061|NCT02889796|39064989|FG005|Overall Study|Investigator's Discretion|15|||
16159062|NCT02889796|39064984|FG000|Overall Study|Adverse Event|17|||
16159063|NCT02889796|39064985|FG001|Overall Study|Adverse Event|8|||
16159064|NCT02889796|39064986|FG002|Overall Study|Adverse Event|8|||
16159065|NCT02889796|39064987|FG003|Overall Study|Adverse Event|4|||
16159066|NCT02889796|39064988|FG004|Overall Study|Adverse Event|1|||
16159067|NCT02889796|39064989|FG005|Overall Study|Adverse Event|7|||
16159068|NCT02889796|39064984|FG000|Overall Study|Lost to Follow-up|5|||
16159069|NCT02889796|39064985|FG001|Overall Study|Lost to Follow-up|7|||
16159070|NCT02889796|39064986|FG002|Overall Study|Lost to Follow-up|2|||
16159071|NCT02889796|39064987|FG003|Overall Study|Lost to Follow-up|0|||
16159072|NCT02889796|39064988|FG004|Overall Study|Lost to Follow-up|2|||
16159073|NCT02889796|39064989|FG005|Overall Study|Lost to Follow-up|6|||
16159074|NCT02889796|39064984|FG000|Overall Study|Protocol Violation|0|||
16159075|NCT02889796|39064985|FG001|Overall Study|Protocol Violation|1|||
16159076|NCT02889796|39064986|FG002|Overall Study|Protocol Violation|3|||
16159077|NCT02889796|39064987|FG003|Overall Study|Protocol Violation|0|||
16159078|NCT02889796|39064988|FG004|Overall Study|Protocol Violation|0|||
16159079|NCT02889796|39064989|FG005|Overall Study|Protocol Violation|4|||
16159080|NCT02889796|39064984|FG000|Overall Study|Non-compliance With Study Drug|0|||
16159081|NCT02889796|39064985|FG001|Overall Study|Non-compliance With Study Drug|2|||
16159082|NCT02889796|39064986|FG002|Overall Study|Non-compliance With Study Drug|0|||
16159083|NCT02889796|39064987|FG003|Overall Study|Non-compliance With Study Drug|0|||
16159084|NCT02889796|39064988|FG004|Overall Study|Non-compliance With Study Drug|1|||
16159085|NCT02889796|39064989|FG005|Overall Study|Non-compliance With Study Drug|2|||
16159086|NCT02889796|39064984|FG000|Overall Study|Death|1|||
16159087|NCT02889796|39064985|FG001|Overall Study|Death|1|||
16159088|NCT02889796|39064986|FG002|Overall Study|Death|0|||
16159089|NCT02889796|39064987|FG003|Overall Study|Death|1|||
16159090|NCT02889796|39064988|FG004|Overall Study|Death|0|||
16159091|NCT02889796|39064989|FG005|Overall Study|Death|1|||
16159092|NCT02889796|39064984|FG000|Overall Study|Pregnancy|0|||
16159093|NCT02889796|39064985|FG001|Overall Study|Pregnancy|1|||
16159094|NCT02889796|39064986|FG002|Overall Study|Pregnancy|1|||
16159095|NCT02889796|39064987|FG003|Overall Study|Pregnancy|0|||
16159096|NCT02889796|39064988|FG004|Overall Study|Pregnancy|0|||
16159097|NCT02889796|39064989|FG005|Overall Study|Pregnancy|0|||
16159098|NCT02889796|39064984|FG000|Overall Study|Randomized but not Dosed|2|||
16159099|NCT02889796|39064985|FG001|Overall Study|Randomized but not Dosed|0|||
16159100|NCT02889796|39064986|FG002|Overall Study|Randomized but not Dosed|0|||
16159101|NCT02889796|39064987|FG003|Overall Study|Randomized but not Dosed|0|||
16159102|NCT02889796|39064988|FG004|Overall Study|Randomized but not Dosed|0|||
16159103|NCT02889796|39064989|FG005|Overall Study|Randomized but not Dosed|2|||
16159104|NCT01926782|39064995|FG000|Overall Study|Participant moved|2|||
16159105|NCT01926782|39064996|FG001|Overall Study|Participant moved|0|||
16159106|NCT01926782|39064997|FG002|Overall Study|Participant moved|1|||
16159107|NCT01926782|39064998|FG003|Overall Study|Participant moved|1|||
16159108|NCT01926782|39064999|FG004|Overall Study|Participant moved|0|||
16159109|NCT01926782|39065000|FG005|Overall Study|Participant moved|3|||
16159110|NCT01926782|39064995|FG000|Overall Study|Physician Decision|0|||
16159111|NCT01926782|39064996|FG001|Overall Study|Physician Decision|2|||
16159112|NCT01926782|39064997|FG002|Overall Study|Physician Decision|1|||
16159113|NCT01926782|39064998|FG003|Overall Study|Physician Decision|1|||
16159114|NCT01926782|39064999|FG004|Overall Study|Physician Decision|0|||
16159115|NCT01926782|39065000|FG005|Overall Study|Physician Decision|0|||
16159116|NCT01926782|39064995|FG000|Overall Study|Other than specified|2|||
16159117|NCT01926782|39064996|FG001|Overall Study|Other than specified|3|||
16159118|NCT01926782|39064997|FG002|Overall Study|Other than specified|5|||
16159119|NCT01926782|39064998|FG003|Overall Study|Other than specified|12|||
16066835|NCT01515319|38736569|FG004|Overall Study|Withdrawal by Subject|0|||
16066836|NCT01515319|38736570|FG005|Overall Study|Withdrawal by Subject|0|||
16066837|NCT01515319|38736571|FG006|Overall Study|Withdrawal by Subject|1|||
16066838|NCT01515319|38736572|FG007|Overall Study|Withdrawal by Subject|0|||
16066839|NCT01515319|38736573|FG008|Overall Study|Withdrawal by Subject|0|||
16066840|NCT01515319|38736574|FG009|Overall Study|Withdrawal by Subject|0|||
16066841|NCT01515319|38736565|FG000|Overall Study|Adverse Event|0|||
16066842|NCT01515319|38736566|FG001|Overall Study|Adverse Event|0|||
16066843|NCT01515319|38736567|FG002|Overall Study|Adverse Event|0|||
16066844|NCT01515319|38736568|FG003|Overall Study|Adverse Event|0|||
16066845|NCT01515319|38736569|FG004|Overall Study|Adverse Event|0|||
16066846|NCT01515319|38736570|FG005|Overall Study|Adverse Event|0|||
16066847|NCT01515319|38736571|FG006|Overall Study|Adverse Event|0|||
16066848|NCT01515319|38736572|FG007|Overall Study|Adverse Event|0|||
16066849|NCT01515319|38736573|FG008|Overall Study|Adverse Event|3|||
16066850|NCT01515319|38736574|FG009|Overall Study|Adverse Event|0|||
16066851|NCT01515319|38736565|FG000|Overall Study|Protocol Violation|0|||
16066852|NCT01515319|38736566|FG001|Overall Study|Protocol Violation|0|||
16066853|NCT01515319|38736567|FG002|Overall Study|Protocol Violation|0|||
16066854|NCT01515319|38736568|FG003|Overall Study|Protocol Violation|0|||
16066855|NCT01515319|38736569|FG004|Overall Study|Protocol Violation|0|||
16066856|NCT01515319|38736570|FG005|Overall Study|Protocol Violation|0|||
16066857|NCT01515319|38736571|FG006|Overall Study|Protocol Violation|0|||
16066858|NCT01515319|38736572|FG007|Overall Study|Protocol Violation|0|||
16066859|NCT01515319|38736573|FG008|Overall Study|Protocol Violation|2|||
16066860|NCT01515319|38736574|FG009|Overall Study|Protocol Violation|0|||
16066861|NCT00015457|38736575|FG000|First Intervention|Adverse Event|0|||
16159120|NCT01926782|39064999|FG004|Overall Study|Other than specified|4|||
16159121|NCT01926782|39065000|FG005|Overall Study|Other than specified|11|||
16159122|NCT01926782|39064995|FG000|Overall Study|Adverse Event|13|||
16159123|NCT01926782|39064996|FG001|Overall Study|Adverse Event|4|||
16159124|NCT01926782|39064997|FG002|Overall Study|Adverse Event|17|||
16159125|NCT01926782|39064998|FG003|Overall Study|Adverse Event|4|||
16066862|NCT00015457|38736576|FG001|First Intervention|Adverse Event|2|||
16066863|NCT00015457|38736575|FG000|First Intervention|Lack of Efficacy|0|||
16066864|NCT00015457|38736576|FG001|First Intervention|Lack of Efficacy|1|||
16159126|NCT01926782|39064999|FG004|Overall Study|Adverse Event|3|||
16159127|NCT01926782|39065000|FG005|Overall Study|Adverse Event|14|||
16159128|NCT01926782|39064995|FG000|Overall Study|Poor compliance to protocol|5|||
16263472|NCT01190930|39449794|FG006|Induction|Refusal|0|||
16066865|NCT00015457|38736575|FG000|Second Intervention|Withdrawal by Subject|1|||
16066866|NCT00015457|38736576|FG001|Second Intervention|Withdrawal by Subject|0|||
16066867|NCT02724020|38736579|FG000|Overall Study|Death|16|||
16066868|NCT02724020|38736580|FG001|Overall Study|Death|18|||
16066869|NCT02724020|38736581|FG002|Overall Study|Death|19|||
16159129|NCT01926782|39064996|FG001|Overall Study|Poor compliance to protocol|3|||
16159130|NCT01926782|39064997|FG002|Overall Study|Poor compliance to protocol|8|||
16159131|NCT01926782|39064998|FG003|Overall Study|Poor compliance to protocol|0|||
16159132|NCT01926782|39064999|FG004|Overall Study|Poor compliance to protocol|1|||
16159133|NCT01926782|39065000|FG005|Overall Study|Poor compliance to protocol|6|||
16159134|NCT01926782|39064995|FG000|Overall Study|Randomized and not treated|0|||
16159135|NCT01926782|39064996|FG001|Overall Study|Randomized and not treated|0|||
16159136|NCT01926782|39064997|FG002|Overall Study|Randomized and not treated|0|||
16159137|NCT01926782|39064998|FG003|Overall Study|Randomized and not treated|1|||
16159138|NCT01926782|39064999|FG004|Overall Study|Randomized and not treated|0|||
16159139|NCT01926782|39065000|FG005|Overall Study|Randomized and not treated|0|||
16159140|NCT01926782|39064995|FG000|Overall Study|Withdrawal by Subject|6|||
16159141|NCT01926782|39064996|FG001|Overall Study|Withdrawal by Subject|1|||
16159142|NCT01926782|39064997|FG002|Overall Study|Withdrawal by Subject|8|||
16159143|NCT01926782|39064998|FG003|Overall Study|Withdrawal by Subject|1|||
16263473|NCT01190930|39449795|FG007|Induction|Refusal|0|||
16263474|NCT01190930|39449796|FG008|Induction|Refusal|0|||
16263475|NCT01190930|39449797|FG009|Induction|Refusal|0|||
16263476|NCT01190930|39449788|FG000|Induction|Inevaluable|23|||
16263477|NCT01190930|39449789|FG001|Induction|Inevaluable|1|||
16263478|NCT01190930|39449790|FG002|Induction|Inevaluable|0|||
16263479|NCT01190930|39449791|FG003|Induction|Inevaluable|0|||
16263480|NCT01190930|39449792|FG004|Induction|Inevaluable|0|||
16263481|NCT01190930|39449793|FG005|Induction|Inevaluable|0|||
16263482|NCT01190930|39449794|FG006|Induction|Inevaluable|0|||
16263483|NCT01190930|39449795|FG007|Induction|Inevaluable|0|||
16263484|NCT01190930|39449796|FG008|Induction|Inevaluable|0|||
16263485|NCT01190930|39449797|FG009|Induction|Inevaluable|0|||
16263486|NCT01190930|39449788|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
16066870|NCT02724020|38736579|FG000|Overall Study|Lost to Follow-up|0|||
16066871|NCT02724020|38736580|FG001|Overall Study|Lost to Follow-up|3|||
16066872|NCT02724020|38736581|FG002|Overall Study|Lost to Follow-up|0|||
16066873|NCT02724020|38736579|FG000|Overall Study|Site Terminated by Sponsor|15|||
16066874|NCT02724020|38736580|FG001|Overall Study|Site Terminated by Sponsor|8|||
16066875|NCT02724020|38736581|FG002|Overall Study|Site Terminated by Sponsor|8|||
16066876|NCT02724020|38736579|FG000|Overall Study|Withdrawal by Subject|1|||
16066877|NCT02724020|38736580|FG001|Overall Study|Withdrawal by Subject|3|||
16263487|NCT01190930|39449789|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16263488|NCT01190930|39449790|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16263489|NCT01190930|39449791|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16263490|NCT01190930|39449792|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16263491|NCT01190930|39449793|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16263492|NCT01190930|39449794|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16263493|NCT01190930|39449795|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16263494|NCT01190930|39449796|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16263495|NCT01190930|39449797|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
16263496|NCT01190930|39449788|FG000|Induction|High Risk Downs|80|||
16263497|NCT01190930|39449789|FG001|Induction|High Risk Downs|0|||
16263498|NCT01190930|39449790|FG002|Induction|High Risk Downs|0|||
16263499|NCT01190930|39449791|FG003|Induction|High Risk Downs|0|||
16263500|NCT01190930|39449792|FG004|Induction|High Risk Downs|0|||
16263501|NCT01190930|39449793|FG005|Induction|High Risk Downs|0|||
16263502|NCT01190930|39449794|FG006|Induction|High Risk Downs|0|||
16263503|NCT01190930|39449795|FG007|Induction|High Risk Downs|0|||
16263504|NCT01190930|39449796|FG008|Induction|High Risk Downs|0|||
16263505|NCT01190930|39449797|FG009|Induction|High Risk Downs|0|||
16263506|NCT01190930|39449788|FG000|Induction|Enrollment onto another COG Protocol|1|||
16263507|NCT01190930|39449789|FG001|Induction|Enrollment onto another COG Protocol|0|||
16263508|NCT01190930|39449790|FG002|Induction|Enrollment onto another COG Protocol|0|||
16263509|NCT01190930|39449791|FG003|Induction|Enrollment onto another COG Protocol|0|||
16263510|NCT01190930|39449792|FG004|Induction|Enrollment onto another COG Protocol|0|||
16263511|NCT01190930|39449793|FG005|Induction|Enrollment onto another COG Protocol|0|||
16066878|NCT02724020|38736581|FG002|Overall Study|Withdrawal by Subject|5|||
16066879|NCT00577629|38736587|FG000|Treatment Period|Death|1|||
16066880|NCT00577629|38736587|FG000|Long Term Follow-Up|Death|15|||
16263512|NCT01190930|39449794|FG006|Induction|Enrollment onto another COG Protocol|0|||
16066881|NCT00577629|38736587|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
16263513|NCT01190930|39449795|FG007|Induction|Enrollment onto another COG Protocol|0|||
16263514|NCT01190930|39449796|FG008|Induction|Enrollment onto another COG Protocol|0|||
16263515|NCT01190930|39449797|FG009|Induction|Enrollment onto another COG Protocol|0|||
16263516|NCT01190930|39449788|FG000|Induction|Average Risk|1847|||
16263517|NCT01190930|39449789|FG001|Induction|Average Risk|0|||
16263518|NCT01190930|39449790|FG002|Induction|Average Risk|0|||
16263519|NCT01190930|39449791|FG003|Induction|Average Risk|0|||
16369436|NCT04925934|39836296|FG002|Overall Study|Adverse Event|0|||
16369437|NCT04925934|39836294|FG000|Overall Study|Lost to Follow-up|2|||
16369438|NCT04925934|39836295|FG001|Overall Study|Lost to Follow-up|0|||
16369439|NCT04925934|39836296|FG002|Overall Study|Lost to Follow-up|1|||
16369440|NCT04925934|39836294|FG000|Overall Study|Death|0|||
16369441|NCT04925934|39836295|FG001|Overall Study|Death|1|||
16369442|NCT04925934|39836296|FG002|Overall Study|Death|0|||
16369443|NCT04925934|39836294|FG000|Overall Study|Withdrawal by Subject|8|||
16369444|NCT04925934|39836295|FG001|Overall Study|Withdrawal by Subject|5|||
16369445|NCT04925934|39836296|FG002|Overall Study|Withdrawal by Subject|9|||
16369446|NCT04925934|39836294|FG000|Overall Study|Other|2|||
16369447|NCT04925934|39836295|FG001|Overall Study|Other|2|||
16369448|NCT04925934|39836296|FG002|Overall Study|Other|2|||
16369449|NCT04925934|39836294|FG000|Overall Study|Eastern European Conflict|7|||
16369450|NCT04925934|39836295|FG001|Overall Study|Eastern European Conflict|3|||
16369451|NCT04925934|39836296|FG002|Overall Study|Eastern European Conflict|2|||
16369452|NCT03520569|39836297|FG000|Overall Study|Withdrawal by Subject|1|||
16369453|NCT04243837|39836298|FG000|Overall Study|Adverse Event|2|||
16369454|NCT04243837|39836299|FG001|Overall Study|Adverse Event|1|||
16369455|NCT04243837|39836298|FG000|Overall Study|Withdrawal by Subject|4|||
16369456|NCT04243837|39836299|FG001|Overall Study|Withdrawal by Subject|2|||
16369457|NCT04243837|39836298|FG000|Overall Study|Covid-19 lock down|1|||
16369458|NCT04243837|39836299|FG001|Overall Study|Covid-19 lock down|0|||
16369459|NCT04243837|39836298|FG000|Overall Study|Study Terminated by Sponsor|11|||
16369460|NCT04243837|39836299|FG001|Overall Study|Study Terminated by Sponsor|12|||
16369461|NCT01363440|39836302|FG000|Overall Study|Adverse Event|5|||
16369462|NCT01363440|39836303|FG001|Overall Study|Adverse Event|4|||
16369463|NCT01363440|39836304|FG002|Overall Study|Adverse Event|4|||
16369464|NCT01363440|39836302|FG000|Overall Study|Death|3|||
16369465|NCT01363440|39836303|FG001|Overall Study|Death|7|||
16369466|NCT01363440|39836304|FG002|Overall Study|Death|5|||
16369467|NCT01363440|39836302|FG000|Overall Study|Withdrawal by Subject|9|||
16369468|NCT01363440|39836303|FG001|Overall Study|Withdrawal by Subject|11|||
16369469|NCT01363440|39836304|FG002|Overall Study|Withdrawal by Subject|11|||
16369470|NCT01363440|39836302|FG000|Overall Study|Lost to Follow-up|2|||
16369471|NCT01363440|39836303|FG001|Overall Study|Lost to Follow-up|4|||
16369472|NCT01363440|39836304|FG002|Overall Study|Lost to Follow-up|5|||
16369473|NCT01363440|39836302|FG000|Overall Study|Other|4|||
16369474|NCT01363440|39836303|FG001|Overall Study|Other|5|||
16369475|NCT01363440|39836304|FG002|Overall Study|Other|2|||
16369476|NCT00728182|39836305|FG000|Overall Study|Adverse Event|1|||
16369477|NCT00728182|39836306|FG001|Overall Study|Adverse Event|0|||
16369478|NCT00728182|39836305|FG000|Overall Study|Lost to Follow-up|2|||
16369479|NCT00728182|39836306|FG001|Overall Study|Lost to Follow-up|0|||
16369480|NCT00728182|39836305|FG000|Overall Study|Death|0|||
16369481|NCT00728182|39836306|FG001|Overall Study|Death|2|||
16369482|NCT00728182|39836305|FG000|Overall Study|Protocol Noncompliance|0|||
16369483|NCT00728182|39836306|FG001|Overall Study|Protocol Noncompliance|1|||
16369484|NCT04115059|39836310|FG000|Overall Study|Withdrawal by Subject|1|||
16369485|NCT04115059|39836310|FG000|Overall Study|Lack of Efficacy|2|||
16369486|NCT00504309|39836314|FG000|Overall Study|Death|0|||
16369487|NCT00504309|39836315|FG001|Overall Study|Death|0|||
16369488|NCT00504309|39836316|FG002|Overall Study|Death|0|||
16369489|NCT00504309|39836317|FG003|Overall Study|Death|0|||
16369490|NCT00504309|39836318|FG004|Overall Study|Death|1|||
16369491|NCT00504309|39836319|FG005|Overall Study|Death|0|||
16369492|NCT00504309|39836314|FG000|Overall Study|Withdrawal by Subject|0|||
16369493|NCT00504309|39836315|FG001|Overall Study|Withdrawal by Subject|0|||
16369494|NCT00504309|39836316|FG002|Overall Study|Withdrawal by Subject|1|||
16369495|NCT00504309|39836317|FG003|Overall Study|Withdrawal by Subject|0|||
16369496|NCT00504309|39836318|FG004|Overall Study|Withdrawal by Subject|0|||
16369497|NCT00504309|39836319|FG005|Overall Study|Withdrawal by Subject|0|||
16159144|NCT01926782|39064999|FG004|Overall Study|Withdrawal by Subject|0|||
16369498|NCT02506036|39836320|FG000|First Intervention (4-6 Weeks)|Death|1|||
16369499|NCT02506036|39836321|FG001|First Intervention (4-6 Weeks)|Death|0|||
16369500|NCT02506036|39836320|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
16369501|NCT02506036|39836321|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
16369502|NCT02506036|39836320|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
16369503|NCT02506036|39836321|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
16369504|NCT02337946|39836322|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
16369505|NCT02337946|39836323|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
16369506|NCT02337946|39836324|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
16369507|NCT02337946|39836322|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
16369508|NCT02337946|39836323|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
16369509|NCT02337946|39836324|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
16369510|NCT02337946|39836322|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
16369511|NCT02337946|39836323|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
16369512|NCT02337946|39836324|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
16369513|NCT02337946|39836322|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
16369514|NCT02337946|39836323|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
16369515|NCT02337946|39836324|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
16369516|NCT02337946|39836322|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
16369517|NCT02337946|39836323|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
16369518|NCT02337946|39836324|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
16369519|NCT02337946|39836322|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
16369520|NCT02337946|39836323|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
16369521|NCT02337946|39836324|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
16369522|NCT02337946|39836322|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
16369523|NCT02337946|39836323|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
16369524|NCT02337946|39836324|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
16369525|NCT02337946|39836322|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
16369526|NCT02337946|39836323|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
16369527|NCT02337946|39836324|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
16369528|NCT02337946|39836322|FG000|In-between Period|Without Informed Consent|1|||
16369529|NCT02337946|39836323|FG001|In-between Period|Without Informed Consent|0|||
16369530|NCT02337946|39836324|FG002|In-between Period|Without Informed Consent|0|||
16369531|NCT02337946|39836322|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
16369532|NCT02337946|39836323|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
16369533|NCT02337946|39836324|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
16369534|NCT02337946|39836322|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
16369535|NCT02337946|39836323|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
16369536|NCT02337946|39836324|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
16369537|NCT02337946|39836322|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
16369538|NCT02337946|39836323|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
16369539|NCT02337946|39836324|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
16369540|NCT02337946|39836322|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
16369541|NCT02337946|39836323|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
16369542|NCT02337946|39836324|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
16369543|NCT02337946|39836322|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
16369544|NCT02337946|39836323|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
16369545|NCT02337946|39836324|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
16369546|NCT02337946|39836322|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
16066882|NCT00577629|38736587|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
16066883|NCT00577629|38736587|FG000|Long Term Follow-Up|Physician Decision|1|||
16066884|NCT00819234|38736590|FG000|Overall Study|Withdrawal by Subject|8|||
16066885|NCT00819234|38736591|FG001|Overall Study|Withdrawal by Subject|13|||
16066886|NCT00819234|38736592|FG002|Overall Study|Withdrawal by Subject|6|||
16066887|NCT00819234|38736593|FG003|Overall Study|Withdrawal by Subject|3|||
16066888|NCT00819234|38736594|FG004|Overall Study|Withdrawal by Subject|0|||
16446210|NCT02079246|40115180|FG001|OLEX|Death|0|||
16446211|NCT02079246|40115179|FG000|OLEX|Adverse Event|66|||
16446212|NCT02079246|40115180|FG001|OLEX|Adverse Event|0|||
16066889|NCT00819234|38736595|FG005|Overall Study|Withdrawal by Subject|4|||
16066890|NCT00819234|38736596|FG006|Overall Study|Withdrawal by Subject|4|||
16066891|NCT00819234|38736597|FG007|Overall Study|Withdrawal by Subject|8|||
16066892|NCT00819234|38736598|FG008|Overall Study|Withdrawal by Subject|5|||
16066893|NCT00819234|38736599|FG009|Overall Study|Withdrawal by Subject|3|||
16066894|NCT00819234|38736590|FG000|Overall Study|Adverse Event|0|||
16066895|NCT00819234|38736591|FG001|Overall Study|Adverse Event|0|||
16066896|NCT00819234|38736592|FG002|Overall Study|Adverse Event|1|||
16066897|NCT00819234|38736593|FG003|Overall Study|Adverse Event|0|||
16066898|NCT00819234|38736594|FG004|Overall Study|Adverse Event|0|||
16446213|NCT02079246|40115179|FG000|OLEX|Withdrawal by Subject|60|||
16446214|NCT02079246|40115180|FG001|OLEX|Withdrawal by Subject|0|||
16066899|NCT00819234|38736595|FG005|Overall Study|Adverse Event|2|||
16066900|NCT00819234|38736596|FG006|Overall Study|Adverse Event|0|||
16066901|NCT00819234|38736597|FG007|Overall Study|Adverse Event|0|||
16066902|NCT00819234|38736598|FG008|Overall Study|Adverse Event|0|||
16066903|NCT00819234|38736599|FG009|Overall Study|Adverse Event|0|||
16066904|NCT00819234|38736590|FG000|Overall Study|Physician Decision|0|||
16066905|NCT00819234|38736591|FG001|Overall Study|Physician Decision|0|||
16066906|NCT00819234|38736592|FG002|Overall Study|Physician Decision|0|||
16066907|NCT00819234|38736593|FG003|Overall Study|Physician Decision|1|||
16066908|NCT00819234|38736594|FG004|Overall Study|Physician Decision|0|||
16066909|NCT00819234|38736595|FG005|Overall Study|Physician Decision|0|||
16369547|NCT02337946|39836323|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
16369548|NCT02337946|39836324|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
16446215|NCT02079246|40115179|FG000|OLEX|Lost to Follow-up|6|||
16446216|NCT02079246|40115180|FG001|OLEX|Lost to Follow-up|0|||
16066910|NCT00819234|38736596|FG006|Overall Study|Physician Decision|0|||
16066911|NCT00819234|38736597|FG007|Overall Study|Physician Decision|0|||
16159145|NCT01926782|39065000|FG005|Overall Study|Withdrawal by Subject|5|||
16159146|NCT01926782|39064995|FG000|Overall Study|Related to study drug administration|0|||
16159147|NCT01926782|39064996|FG001|Overall Study|Related to study drug administration|0|||
16159148|NCT01926782|39064997|FG002|Overall Study|Related to study drug administration|0|||
16159149|NCT01926782|39064998|FG003|Overall Study|Related to study drug administration|0|||
16159150|NCT01926782|39064999|FG004|Overall Study|Related to study drug administration|0|||
16159151|NCT01926782|39065000|FG005|Overall Study|Related to study drug administration|2|||
16159152|NCT01662895|39065001|FG000|Overall Study|Lost to Follow-up|0|||
16159153|NCT01662895|39065002|FG001|Overall Study|Lost to Follow-up|1|||
16446217|NCT02079246|40115179|FG000|OLEX|Protocol Violation|6|||
16446218|NCT02079246|40115180|FG001|OLEX|Protocol Violation|0|||
16446219|NCT02079246|40115179|FG000|OLEX|Lack of Efficacy|3|||
16446220|NCT02079246|40115180|FG001|OLEX|Lack of Efficacy|0|||
16446221|NCT02079246|40115179|FG000|OLEX|Results of the lead-in studies|58|||
16446222|NCT02079246|40115180|FG001|OLEX|Results of the lead-in studies|0|||
16446223|NCT02079246|40115179|FG000|OLEX|Other: Disallowed medication|8|||
16446224|NCT02079246|40115180|FG001|OLEX|Other: Disallowed medication|0|||
16446225|NCT02079246|40115179|FG000|OLEX|Other: Insufficient compliance|2|||
16159154|NCT00401752|39065003|FG000|Overall Study|Adverse Event|2|||
16369549|NCT02619812|39836326|FG000|Overall Study|Withdrawal by Subject|0|||
16369550|NCT02619812|39836327|FG001|Overall Study|Withdrawal by Subject|0|||
16369551|NCT02619812|39836328|FG002|Overall Study|Withdrawal by Subject|1|||
16369552|NCT02619812|39836329|FG003|Overall Study|Withdrawal by Subject|2|||
16369553|NCT03339453|39836330|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
16369554|NCT03339453|39836331|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
16369555|NCT01829165|39836332|FG000|Overall Study|Did not complete intervention|2|||
16369556|NCT01829165|39836333|FG001|Overall Study|Did not complete intervention|0|||
16369557|NCT00368849|39836337|FG000|Overall Study|Withdrawal by Subject|0|||
16369558|NCT00368849|39836338|FG001|Overall Study|Withdrawal by Subject|1|||
16369559|NCT00368849|39836337|FG000|Overall Study|Physician Decision|0|||
16369560|NCT00368849|39836338|FG001|Overall Study|Physician Decision|1|||
16369561|NCT01198548|39836339|FG000|Overall Study|Disease Progression|9|||
16369562|NCT01198548|39836339|FG000|Overall Study|Administrative Decision|1|||
16369563|NCT01180777|39836340|FG000|Overall Study|Protocol Violation|6|||
16369564|NCT01180777|39836340|FG000|Overall Study|Poor lens fit|4|||
16369565|NCT01180777|39836340|FG000|Overall Study|Lost to Follow-up|1|||
16369566|NCT01180777|39836340|FG000|Overall Study|Adverse Event|1|||
16369567|NCT00296335|39836342|FG000|Overall Study|Recurrence|3|||
16369568|NCT00296335|39836343|FG001|Overall Study|Recurrence|51|||
16369569|NCT00296335|39836342|FG000|Overall Study|Adverse Event|17|||
16369570|NCT00296335|39836343|FG001|Overall Study|Adverse Event|27|||
16369571|NCT00296335|39836342|FG000|Overall Study|Lost to Follow-up|7|||
16369572|NCT00296335|39836343|FG001|Overall Study|Lost to Follow-up|33|||
16369573|NCT00296335|39836342|FG000|Overall Study|Physician Decision|3|||
16369574|NCT00296335|39836343|FG001|Overall Study|Physician Decision|11|||
16369575|NCT02070991|39836353|FG000|Overall Study|Death|2|||
16369576|NCT02070991|39836354|FG001|Overall Study|Death|0|||
16369577|NCT02070991|39836353|FG000|Overall Study|Withdrawal by Subject|1|||
16369578|NCT02070991|39836354|FG001|Overall Study|Withdrawal by Subject|0|||
16369579|NCT01390584|39836355|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
16369580|NCT01390584|39836356|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
16369581|NCT01390584|39836357|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
16369582|NCT04706403|39836360|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
16369583|NCT04706403|39836361|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
16369584|NCT04706403|39836362|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
16369585|NCT04706403|39836363|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
16369586|NCT04706403|39836364|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
16369587|NCT00977561|39836365|FG000|Overall Study|Death|3|||
16369588|NCT00977561|39836366|FG001|Overall Study|Death|2|||
16369589|NCT00977561|39836365|FG000|Overall Study|Study terminated|0|||
16369590|NCT00977561|39836366|FG001|Overall Study|Study terminated|2|||
16369591|NCT00977561|39836365|FG000|Overall Study|Other|2|||
16369592|NCT00977561|39836366|FG001|Overall Study|Other|0|||
16369593|NCT00541775|39836369|FG000|Overall Study|Adverse Event|3|||
16369594|NCT00541775|39836370|FG001|Overall Study|Adverse Event|2|||
16369595|NCT00541775|39836371|FG002|Overall Study|Adverse Event|1|||
16369596|NCT00541775|39836369|FG000|Overall Study|Lack of Efficacy|0|||
16369597|NCT00541775|39836370|FG001|Overall Study|Lack of Efficacy|0|||
16369598|NCT00541775|39836371|FG002|Overall Study|Lack of Efficacy|3|||
16369599|NCT00541775|39836369|FG000|Overall Study|Lost to Follow-up|0|||
16369600|NCT00541775|39836370|FG001|Overall Study|Lost to Follow-up|0|||
16369601|NCT00541775|39836371|FG002|Overall Study|Lost to Follow-up|2|||
16446226|NCT02079246|40115180|FG001|OLEX|Other: Insufficient compliance|0|||
16446227|NCT02079246|40115179|FG000|OLEX|Other: Caregiver unavailable|3|||
16446228|NCT02079246|40115180|FG001|OLEX|Other: Caregiver unavailable|0|||
16159155|NCT00401752|39065004|FG001|Overall Study|Adverse Event|5|||
16159156|NCT00401752|39065003|FG000|Overall Study|Withdrawal by Subject|2|||
16159157|NCT00401752|39065004|FG001|Overall Study|Withdrawal by Subject|6|||
16159158|NCT00401752|39065003|FG000|Overall Study|Lost to Follow-up|1|||
16159159|NCT00401752|39065004|FG001|Overall Study|Lost to Follow-up|4|||
16159160|NCT00401752|39065003|FG000|Overall Study|Development of any exclusion criteria|4|||
16159161|NCT00401752|39065004|FG001|Overall Study|Development of any exclusion criteria|2|||
16159162|NCT00401752|39065003|FG000|Overall Study|Physician Decision|1|||
16159163|NCT00401752|39065004|FG001|Overall Study|Physician Decision|1|||
16159164|NCT00700271|39065014|FG000|Overall Study|Adverse Event|4|||
16159165|NCT00700271|39065015|FG001|Overall Study|Adverse Event|6|||
16159166|NCT00700271|39065014|FG000|Overall Study|Protocol Violation|1|||
16159167|NCT00700271|39065015|FG001|Overall Study|Protocol Violation|0|||
16159168|NCT00700271|39065014|FG000|Overall Study|Administrative Reasons|1|||
16159169|NCT00700271|39065015|FG001|Overall Study|Administrative Reasons|0|||
16159170|NCT00700271|39065014|FG000|Overall Study|Withdrawal by Subject|6|||
16159171|NCT00700271|39065015|FG001|Overall Study|Withdrawal by Subject|4|||
16159172|NCT00700271|39065014|FG000|Overall Study|Lost to Follow-up|2|||
16159173|NCT00700271|39065015|FG001|Overall Study|Lost to Follow-up|2|||
16159174|NCT02665286|39065018|FG000|Overall Study|Lost to Follow-up|3|||
16159175|NCT02665286|39065019|FG001|Overall Study|Lost to Follow-up|2|||
16159176|NCT02665286|39065020|FG002|Overall Study|Lost to Follow-up|1|||
16159177|NCT01665144|39065023|FG000|Core Part|Withdrawal by Subject|96|||
16159178|NCT01665144|39065024|FG001|Core Part|Withdrawal by Subject|77|||
16446229|NCT02079246|40115179|FG000|OLEX|Other: Coordinator decision|1|||
16446230|NCT02079246|40115180|FG001|OLEX|Other: Coordinator decision|0|||
16446231|NCT02079246|40115179|FG000|OLEX|Other: Worsening of condition|1|||
16446232|NCT02079246|40115180|FG001|OLEX|Other: Worsening of condition|0|||
16446233|NCT02079246|40115179|FG000|OLEX|Other: Moved to nursing home|1|||
16446234|NCT02079246|40115180|FG001|OLEX|Other: Moved to nursing home|0|||
16446235|NCT02079246|40115179|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
16446236|NCT02079246|40115180|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
16446237|NCT02079246|40115179|FG000|OLEX-MEM|Adverse Event|0|||
16446238|NCT02079246|40115180|FG001|OLEX-MEM|Adverse Event|6|||
16446239|NCT02079246|40115179|FG000|OLEX-MEM|Withdrawal by Subject|0|||
16446240|NCT02079246|40115180|FG001|OLEX-MEM|Withdrawal by Subject|7|||
16446241|NCT02079246|40115179|FG000|OLEX-MEM|Protocol Violation|0|||
16446242|NCT02079246|40115180|FG001|OLEX-MEM|Protocol Violation|2|||
16446243|NCT02079246|40115179|FG000|OLEX-MEM|Lost to Follow-up|0|||
16446244|NCT02079246|40115180|FG001|OLEX-MEM|Lost to Follow-up|1|||
16446245|NCT02079246|40115179|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
16446246|NCT02079246|40115180|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
16446247|NCT00949702|40115183|FG000|Overall Study|Death|40|||
16446248|NCT00949702|40115183|FG000|Overall Study|Disease progression|7|||
16066912|NCT00819234|38736598|FG008|Overall Study|Physician Decision|0|||
16066913|NCT00819234|38736599|FG009|Overall Study|Physician Decision|2|||
16066914|NCT00819234|38736590|FG000|Overall Study|Protocol Violation|0|||
16066915|NCT00819234|38736591|FG001|Overall Study|Protocol Violation|0|||
16066916|NCT00819234|38736592|FG002|Overall Study|Protocol Violation|1|||
16066917|NCT00819234|38736593|FG003|Overall Study|Protocol Violation|0|||
16066918|NCT00819234|38736594|FG004|Overall Study|Protocol Violation|0|||
16446249|NCT00949702|40115183|FG000|Overall Study|Withdrawal of consent|1|||
16446250|NCT00283296|40115187|FG000|Overall Study|in-home trial not completed|5|||
16446251|NCT01352715|40115188|FG000|Overall Study|Death|3|||
16446252|NCT01352715|40115189|FG001|Overall Study|Death|3|||
16446253|NCT01352715|40115188|FG000|Overall Study|Lost to Follow-up|5|||
16446254|NCT01352715|40115189|FG001|Overall Study|Lost to Follow-up|7|||
16446255|NCT01352715|40115188|FG000|Overall Study|Withdrawal by Subject|4|||
16446256|NCT01352715|40115189|FG001|Overall Study|Withdrawal by Subject|8|||
16446257|NCT01352715|40115188|FG000|Overall Study|site closure|16|||
16446258|NCT01352715|40115189|FG001|Overall Study|site closure|15|||
16066919|NCT00819234|38736595|FG005|Overall Study|Protocol Violation|0|||
16066920|NCT00819234|38736596|FG006|Overall Study|Protocol Violation|0|||
16066921|NCT00819234|38736597|FG007|Overall Study|Protocol Violation|0|||
16066922|NCT00819234|38736598|FG008|Overall Study|Protocol Violation|0|||
16159179|NCT01665144|39065025|FG002|Core Part|Withdrawal by Subject|0|||
16159180|NCT01665144|39065023|FG000|Core Part|Adverse Event|45|||
16446259|NCT01352715|40115188|FG000|Overall Study|no final visit in closeout period|15|||
16446260|NCT01352715|40115189|FG001|Overall Study|no final visit in closeout period|12|||
16446261|NCT01352715|40115188|FG000|Overall Study|major ineligibility|2|||
16159181|NCT01665144|39065024|FG001|Core Part|Adverse Event|18|||
16159182|NCT01665144|39065025|FG002|Core Part|Adverse Event|0|||
16159183|NCT01665144|39065023|FG000|Core Part|Lack of Efficacy|16|||
16159184|NCT01665144|39065024|FG001|Core Part|Lack of Efficacy|11|||
16446262|NCT01352715|40115189|FG001|Overall Study|major ineligibility|1|||
16446263|NCT04308291|40115190|FG000|Run-In Phase|Withdrawal by Subject|4|||
16446264|NCT04308291|40115190|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
16446265|NCT04308291|40115190|FG000|Study Phase 6-M|Physician Decision|2|||
16159185|NCT01665144|39065025|FG002|Core Part|Lack of Efficacy|0|||
16066923|NCT00819234|38736599|FG009|Overall Study|Protocol Violation|0|||
16066924|NCT00819234|38736590|FG000|Overall Study|Lost to Follow-up|2|||
16066925|NCT00819234|38736591|FG001|Overall Study|Lost to Follow-up|2|||
16066926|NCT00819234|38736592|FG002|Overall Study|Lost to Follow-up|0|||
16066927|NCT00819234|38736593|FG003|Overall Study|Lost to Follow-up|2|||
16066928|NCT00819234|38736594|FG004|Overall Study|Lost to Follow-up|1|||
16066929|NCT00819234|38736595|FG005|Overall Study|Lost to Follow-up|1|||
16066930|NCT00819234|38736596|FG006|Overall Study|Lost to Follow-up|1|||
16066931|NCT00819234|38736597|FG007|Overall Study|Lost to Follow-up|1|||
16066932|NCT00819234|38736598|FG008|Overall Study|Lost to Follow-up|1|||
16066933|NCT00819234|38736599|FG009|Overall Study|Lost to Follow-up|2|||
16066934|NCT00072475|38736603|FG000|Overall Study|Adverse Event|44|||
16066935|NCT00072475|38736603|FG000|Overall Study|Death|3|||
16066936|NCT00072475|38736603|FG000|Overall Study|Withdrawal by Subject|46|||
16066937|NCT00072475|38736603|FG000|Overall Study|Patient/Investigator Decision|4|||
16066938|NCT01141660|38736606|FG000|Overall Study|Physician Decision|0|||
16066939|NCT01141660|38736607|FG001|Overall Study|Physician Decision|12|||
16066940|NCT00282438|38736609|FG000|Overall Study|Lack of Efficacy|1|||
16066941|NCT00282438|38736610|FG001|Overall Study|Lack of Efficacy|0|||
16066942|NCT00282438|38736609|FG000|Overall Study|Death|0|||
16066943|NCT00282438|38736610|FG001|Overall Study|Death|1|||
16066944|NCT00797862|38736611|FG000|Overall Study|Adverse Event|86|||
16066945|NCT00797862|38736612|FG001|Overall Study|Adverse Event|44|||
16066946|NCT00797862|38736613|FG002|Overall Study|Adverse Event|58|||
16066947|NCT00797862|38736611|FG000|Overall Study|Abnormal Test Procedure Result|0|||
16066948|NCT00797862|38736612|FG001|Overall Study|Abnormal Test Procedure Result|1|||
16066949|NCT00797862|38736613|FG002|Overall Study|Abnormal Test Procedure Result|1|||
16066950|NCT00797862|38736611|FG000|Overall Study|Lack of Efficacy|1|||
16066951|NCT00797862|38736612|FG001|Overall Study|Lack of Efficacy|7|||
16066952|NCT00797862|38736613|FG002|Overall Study|Lack of Efficacy|6|||
16066953|NCT00797862|38736611|FG000|Overall Study|No longer required study medication|1|||
16066954|NCT00797862|38736612|FG001|Overall Study|No longer required study medication|0|||
16066955|NCT00797862|38736613|FG002|Overall Study|No longer required study medication|0|||
16066956|NCT00797862|38736611|FG000|Overall Study|Withdrawal by Subject|14|||
16066957|NCT00797862|38736612|FG001|Overall Study|Withdrawal by Subject|7|||
16066958|NCT00797862|38736613|FG002|Overall Study|Withdrawal by Subject|7|||
16066959|NCT00797862|38736611|FG000|Overall Study|Lost to Follow-up|11|||
16446266|NCT04308291|40115190|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
16446267|NCT04308291|40115190|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
16446268|NCT04308291|40115190|FG000|Study Phase 12-M|Physician Decision|2|||
16446269|NCT04308291|40115190|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
16446270|NCT01721044|40115203|FG000|Treatment Period|Adverse Event|7|||
16446271|NCT01721044|40115204|FG001|Treatment Period|Adverse Event|7|||
16446272|NCT01721044|40115205|FG002|Treatment Period|Adverse Event|10|||
16446273|NCT01721044|40115203|FG000|Treatment Period|Death|0|||
16446274|NCT01721044|40115204|FG001|Treatment Period|Death|0|||
16159186|NCT01665144|39065023|FG000|Core Part|Lost to Follow-up|9|||
16066960|NCT00797862|38736612|FG001|Overall Study|Lost to Follow-up|0|||
16066961|NCT00797862|38736613|FG002|Overall Study|Lost to Follow-up|5|||
16066962|NCT00797862|38736611|FG000|Overall Study|Administrative Problem|4|||
16066963|NCT00797862|38736612|FG001|Overall Study|Administrative Problem|0|||
16066964|NCT00797862|38736613|FG002|Overall Study|Administrative Problem|0|||
16066965|NCT00797862|38736611|FG000|Overall Study|Protocol Violation|4|||
16066966|NCT00797862|38736612|FG001|Overall Study|Protocol Violation|6|||
16066967|NCT00797862|38736613|FG002|Overall Study|Protocol Violation|8|||
16066968|NCT00797862|38736611|FG000|Overall Study|Mis-randomized|3|||
16066969|NCT00797862|38736612|FG001|Overall Study|Mis-randomized|3|||
16066970|NCT00797862|38736613|FG002|Overall Study|Mis-randomized|1|||
16066971|NCT00162942|38736614|FG000|Overall Study|Adverse Event|10|||
16066972|NCT00162942|38736615|FG001|Overall Study|Adverse Event|6|||
16066973|NCT00162942|38736614|FG000|Overall Study|Death|1|||
16066974|NCT00162942|38736615|FG001|Overall Study|Death|0|||
16066975|NCT00162942|38736614|FG000|Overall Study|Withdrawal by Subject|3|||
16066976|NCT00162942|38736615|FG001|Overall Study|Withdrawal by Subject|6|||
16066977|NCT00162942|38736614|FG000|Overall Study|Physician Decision|1|||
16066978|NCT00162942|38736615|FG001|Overall Study|Physician Decision|0|||
16066979|NCT00162942|38736614|FG000|Overall Study|Enter Open-Label Study|76|||
16066980|NCT00162942|38736615|FG001|Overall Study|Enter Open-Label Study|35|||
16066981|NCT00162942|38736614|FG000|Overall Study|Alternate Therapy|6|||
16066982|NCT00162942|38736615|FG001|Overall Study|Alternate Therapy|2|||
16066983|NCT00162942|38736614|FG000|Overall Study|Lack of Efficacy|1|||
16066984|NCT00162942|38736615|FG001|Overall Study|Lack of Efficacy|0|||
16159187|NCT01665144|39065024|FG001|Core Part|Lost to Follow-up|8|||
16066985|NCT00162942|38736614|FG000|Overall Study|Flare During Active Treatment|7|||
16066986|NCT00162942|38736615|FG001|Overall Study|Flare During Active Treatment|3|||
16066987|NCT00162942|38736614|FG000|Overall Study|2 or more consecutive treatments missed|1|||
16066988|NCT00162942|38736615|FG001|Overall Study|2 or more consecutive treatments missed|0|||
16066989|NCT02322216|38736616|FG000|Overall Study|Adverse Event|1|||
16159188|NCT01665144|39065025|FG002|Core Part|Lost to Follow-up|0|||
16159189|NCT01665144|39065023|FG000|Core Part|Physician Decision|13|||
16159190|NCT01665144|39065024|FG001|Core Part|Physician Decision|1|||
16159191|NCT01665144|39065025|FG002|Core Part|Physician Decision|0|||
16159192|NCT01665144|39065023|FG000|Core Part|Progressive disease|8|||
16159193|NCT01665144|39065024|FG001|Core Part|Progressive disease|4|||
16159194|NCT01665144|39065025|FG002|Core Part|Progressive disease|0|||
16159195|NCT01665144|39065023|FG000|Core Part|Non-compliance with study treatment|5|||
16159196|NCT01665144|39065024|FG001|Core Part|Non-compliance with study treatment|0|||
16159197|NCT01665144|39065025|FG002|Core Part|Non-compliance with study treatment|0|||
16159198|NCT01665144|39065023|FG000|Core Part|Death|3|||
16159199|NCT01665144|39065024|FG001|Core Part|Death|1|||
16159200|NCT01665144|39065025|FG002|Core Part|Death|0|||
16159201|NCT01665144|39065023|FG000|Core Part|Protocol deviation|3|||
16159202|NCT01665144|39065024|FG001|Core Part|Protocol deviation|1|||
16159203|NCT01665144|39065025|FG002|Core Part|Protocol deviation|0|||
16159204|NCT01665144|39065023|FG000|Core Part|New therapy for study indication|2|||
16159205|NCT01665144|39065024|FG001|Core Part|New therapy for study indication|1|||
16159206|NCT01665144|39065025|FG002|Core Part|New therapy for study indication|0|||
16159207|NCT01665144|39065023|FG000|Core Part|Technical problems|2|||
16159208|NCT01665144|39065024|FG001|Core Part|Technical problems|0|||
16159209|NCT01665144|39065025|FG002|Core Part|Technical problems|0|||
16263520|NCT01190930|39449792|FG004|Induction|Average Risk|0|||
16263521|NCT01190930|39449793|FG005|Induction|Average Risk|0|||
16263522|NCT01190930|39449794|FG006|Induction|Average Risk|0|||
16263523|NCT01190930|39449795|FG007|Induction|Average Risk|0|||
16263524|NCT01190930|39449796|FG008|Induction|Average Risk|0|||
16263525|NCT01190930|39449797|FG009|Induction|Average Risk|0|||
16263526|NCT01190930|39449788|FG000|Induction|High Risk|1227|||
16263527|NCT01190930|39449789|FG001|Induction|High Risk|0|||
16263528|NCT01190930|39449790|FG002|Induction|High Risk|0|||
16263529|NCT01190930|39449791|FG003|Induction|High Risk|0|||
16263530|NCT01190930|39449792|FG004|Induction|High Risk|0|||
16263531|NCT01190930|39449793|FG005|Induction|High Risk|0|||
16263532|NCT01190930|39449794|FG006|Induction|High Risk|0|||
16263533|NCT01190930|39449795|FG007|Induction|High Risk|0|||
16263534|NCT01190930|39449796|FG008|Induction|High Risk|0|||
16263535|NCT01190930|39449797|FG009|Induction|High Risk|0|||
16263536|NCT01190930|39449788|FG000|Induction|Low Risk|443|||
16263537|NCT01190930|39449789|FG001|Induction|Low Risk|0|||
16263538|NCT01190930|39449790|FG002|Induction|Low Risk|0|||
16263539|NCT01190930|39449791|FG003|Induction|Low Risk|0|||
16263540|NCT01190930|39449792|FG004|Induction|Low Risk|0|||
16263541|NCT01190930|39449793|FG005|Induction|Low Risk|0|||
16263542|NCT01190930|39449794|FG006|Induction|Low Risk|0|||
16263543|NCT01190930|39449795|FG007|Induction|Low Risk|0|||
16263544|NCT01190930|39449796|FG008|Induction|Low Risk|0|||
16263545|NCT01190930|39449797|FG009|Induction|Low Risk|0|||
16263546|NCT01190930|39449788|FG000|Induction|Very High Risk|1012|||
16263547|NCT01190930|39449789|FG001|Induction|Very High Risk|0|||
16263548|NCT01190930|39449790|FG002|Induction|Very High Risk|0|||
16263549|NCT01190930|39449791|FG003|Induction|Very High Risk|0|||
16263550|NCT01190930|39449792|FG004|Induction|Very High Risk|0|||
16263551|NCT01190930|39449793|FG005|Induction|Very High Risk|0|||
16263552|NCT01190930|39449794|FG006|Induction|Very High Risk|0|||
16263553|NCT01190930|39449795|FG007|Induction|Very High Risk|0|||
16263554|NCT01190930|39449796|FG008|Induction|Very High Risk|0|||
16263555|NCT01190930|39449797|FG009|Induction|Very High Risk|0|||
16263556|NCT01190930|39449788|FG000|Induction|Philadelphia chromosome-positive|99|||
16263557|NCT01190930|39449789|FG001|Induction|Philadelphia chromosome-positive|0|||
16263558|NCT01190930|39449790|FG002|Induction|Philadelphia chromosome-positive|0|||
16263559|NCT01190930|39449791|FG003|Induction|Philadelphia chromosome-positive|0|||
16263560|NCT01190930|39449792|FG004|Induction|Philadelphia chromosome-positive|0|||
16263561|NCT01190930|39449793|FG005|Induction|Philadelphia chromosome-positive|0|||
16263562|NCT01190930|39449794|FG006|Induction|Philadelphia chromosome-positive|0|||
16263563|NCT01190930|39449795|FG007|Induction|Philadelphia chromosome-positive|0|||
16263564|NCT01190930|39449796|FG008|Induction|Philadelphia chromosome-positive|0|||
16263565|NCT01190930|39449797|FG009|Induction|Philadelphia chromosome-positive|0|||
16263566|NCT01190930|39449788|FG000|Induction|Incomplete Induction data|63|||
16263567|NCT01190930|39449789|FG001|Induction|Incomplete Induction data|0|||
16263568|NCT01190930|39449790|FG002|Induction|Incomplete Induction data|0|||
16263569|NCT01190930|39449791|FG003|Induction|Incomplete Induction data|0|||
16263570|NCT01190930|39449792|FG004|Induction|Incomplete Induction data|0|||
16263571|NCT01190930|39449793|FG005|Induction|Incomplete Induction data|0|||
16263572|NCT01190930|39449794|FG006|Induction|Incomplete Induction data|0|||
16263573|NCT01190930|39449795|FG007|Induction|Incomplete Induction data|0|||
16263574|NCT01190930|39449796|FG008|Induction|Incomplete Induction data|0|||
16159210|NCT01665144|39065023|FG000|Extension Part|Patient/guardian decision|180|||
16159211|NCT01665144|39065024|FG001|Extension Part|Patient/guardian decision|0|||
16263575|NCT01190930|39449797|FG009|Induction|Incomplete Induction data|0|||
16263576|NCT01190930|39449788|FG000|Induction|Progressive disease|0|||
16446275|NCT01721044|40115205|FG002|Treatment Period|Death|1|||
16446276|NCT01721044|40115203|FG000|Treatment Period|Lack of Efficacy|16|||
16446277|NCT01721044|40115204|FG001|Treatment Period|Lack of Efficacy|4|||
16446278|NCT01721044|40115205|FG002|Treatment Period|Lack of Efficacy|4|||
16446279|NCT01721044|40115203|FG000|Treatment Period|Lost to Follow-up|0|||
16446280|NCT01721044|40115204|FG001|Treatment Period|Lost to Follow-up|0|||
16446281|NCT01721044|40115205|FG002|Treatment Period|Lost to Follow-up|1|||
16446282|NCT01721044|40115203|FG000|Treatment Period|Physician Decision|1|||
16446283|NCT01721044|40115204|FG001|Treatment Period|Physician Decision|0|||
16446284|NCT01721044|40115205|FG002|Treatment Period|Physician Decision|2|||
16263577|NCT01190930|39449789|FG001|Induction|Progressive disease|1|||
16066990|NCT02322216|38736617|FG001|Overall Study|Adverse Event|0|||
16263578|NCT01190930|39449790|FG002|Induction|Progressive disease|0|||
16066991|NCT02322216|38736616|FG000|Overall Study|Withdrawal by Subject|1|||
16066992|NCT02322216|38736617|FG001|Overall Study|Withdrawal by Subject|4|||
16263579|NCT01190930|39449791|FG003|Induction|Progressive disease|0|||
16263580|NCT01190930|39449792|FG004|Induction|Progressive disease|0|||
16263581|NCT01190930|39449793|FG005|Induction|Progressive disease|0|||
16263582|NCT01190930|39449794|FG006|Induction|Progressive disease|0|||
16263583|NCT01190930|39449795|FG007|Induction|Progressive disease|0|||
16263584|NCT01190930|39449796|FG008|Induction|Progressive disease|0|||
16263585|NCT01190930|39449797|FG009|Induction|Progressive disease|0|||
16263586|NCT01190930|39449788|FG000|Induction|No treatment|3|||
16263587|NCT01190930|39449789|FG001|Induction|No treatment|0|||
16263588|NCT01190930|39449790|FG002|Induction|No treatment|0|||
16263589|NCT01190930|39449791|FG003|Induction|No treatment|0|||
16263590|NCT01190930|39449792|FG004|Induction|No treatment|0|||
16263591|NCT01190930|39449793|FG005|Induction|No treatment|0|||
16263592|NCT01190930|39449794|FG006|Induction|No treatment|0|||
16263593|NCT01190930|39449795|FG007|Induction|No treatment|0|||
16263594|NCT01190930|39449796|FG008|Induction|No treatment|0|||
16263595|NCT01190930|39449797|FG009|Induction|No treatment|0|||
16159212|NCT01665144|39065025|FG002|Extension Part|Patient/guardian decision|98|||
16263596|NCT01190930|39449788|FG000|Induction|Ineligible|69|||
16263597|NCT01190930|39449789|FG001|Induction|Ineligible|4|||
16263598|NCT01190930|39449790|FG002|Induction|Ineligible|0|||
16263599|NCT01190930|39449791|FG003|Induction|Ineligible|0|||
16263600|NCT01190930|39449792|FG004|Induction|Ineligible|0|||
16263601|NCT01190930|39449793|FG005|Induction|Ineligible|0|||
16263602|NCT01190930|39449794|FG006|Induction|Ineligible|0|||
16263603|NCT01190930|39449795|FG007|Induction|Ineligible|0|||
16263604|NCT01190930|39449796|FG008|Induction|Ineligible|0|||
16263605|NCT01190930|39449797|FG009|Induction|Ineligible|0|||
16263606|NCT01190930|39449788|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
16263607|NCT01190930|39449789|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
16263608|NCT01190930|39449790|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
16263609|NCT01190930|39449791|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
16263610|NCT01190930|39449792|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
16263611|NCT01190930|39449793|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
16263612|NCT01190930|39449794|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
16066993|NCT04730947|38736621|FG000|Overall Study|Withdrawal by Subject|0|||
16066994|NCT04730947|38736622|FG001|Overall Study|Withdrawal by Subject|1|||
16066995|NCT00480441|38736623|FG000|Screening|Not Eligible|37|||
16066996|NCT00480441|38736624|FG001|Screening|Not Eligible|0|||
16066997|NCT00480441|38736625|FG002|Screening|Not Eligible|0|||
16263613|NCT01190930|39449795|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
16066998|NCT00480441|38736623|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
16066999|NCT00480441|38736624|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
16067000|NCT00480441|38736625|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
16067001|NCT00480441|38736623|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
16067002|NCT00480441|38736624|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
16067003|NCT00480441|38736625|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
16067004|NCT00480441|38736623|FG000|Baseline Functional MRI|physical contraindication|4|||
16067005|NCT00480441|38736624|FG001|Baseline Functional MRI|physical contraindication|0|||
16067006|NCT00480441|38736625|FG002|Baseline Functional MRI|physical contraindication|0|||
16067007|NCT00480441|38736623|FG000|Randomization|Lost to Follow-up|0|||
16067008|NCT00480441|38736624|FG001|Randomization|Lost to Follow-up|7|||
16067009|NCT00480441|38736625|FG002|Randomization|Lost to Follow-up|2|||
16446285|NCT01721044|40115203|FG000|Treatment Period|Protocol Violation|1|||
16446286|NCT01721044|40115204|FG001|Treatment Period|Protocol Violation|0|||
16067010|NCT02908464|38736627|FG000|Overall Study|Withdrawal by Subject|2|||
16067011|NCT02908464|38736628|FG001|Overall Study|Withdrawal by Subject|1|||
16159213|NCT01665144|39065023|FG000|Extension Part|Adverse Event|104|||
16263614|NCT01190930|39449796|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
16263615|NCT01190930|39449797|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
16263616|NCT01190930|39449788|FG000|Post Induction Pre-Maintenance|Death|0|||
16263617|NCT01190930|39449789|FG001|Post Induction Pre-Maintenance|Death|0|||
16263618|NCT01190930|39449790|FG002|Post Induction Pre-Maintenance|Death|8|||
16446287|NCT01721044|40115205|FG002|Treatment Period|Protocol Violation|0|||
16263619|NCT01190930|39449791|FG003|Post Induction Pre-Maintenance|Death|4|||
16263620|NCT01190930|39449792|FG004|Post Induction Pre-Maintenance|Death|0|||
16263621|NCT01190930|39449793|FG005|Post Induction Pre-Maintenance|Death|0|||
16263622|NCT01190930|39449794|FG006|Post Induction Pre-Maintenance|Death|0|||
16263623|NCT01190930|39449795|FG007|Post Induction Pre-Maintenance|Death|0|||
16446288|NCT01721044|40115203|FG000|Treatment Period|Withdrawal by Subject|7|||
16446289|NCT01721044|40115204|FG001|Treatment Period|Withdrawal by Subject|6|||
16446290|NCT01721044|40115205|FG002|Treatment Period|Withdrawal by Subject|1|||
16446291|NCT01295814|40115206|FG000|Overall Study|Lack of Efficacy|0|||
16446292|NCT01295814|40115207|FG001|Overall Study|Lack of Efficacy|2|||
16446293|NCT01295814|40115206|FG000|Overall Study|Withdrawal by Subject|2|||
16067012|NCT02908464|38736627|FG000|Overall Study|Found ineligible after randomization|0|||
16067013|NCT02908464|38736628|FG001|Overall Study|Found ineligible after randomization|2|||
16263624|NCT01190930|39449796|FG008|Post Induction Pre-Maintenance|Death|0|||
16263625|NCT01190930|39449797|FG009|Post Induction Pre-Maintenance|Death|0|||
16263626|NCT01190930|39449788|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
16067014|NCT03095508|38736631|FG000|Overall Study|Adverse Event|0|||
16263627|NCT01190930|39449789|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
16263628|NCT01190930|39449790|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
16263629|NCT01190930|39449791|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
16263630|NCT01190930|39449792|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
16263631|NCT01190930|39449793|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
16263632|NCT01190930|39449794|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
16263633|NCT01190930|39449795|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
16263634|NCT01190930|39449796|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
16263635|NCT01190930|39449797|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
16263636|NCT01190930|39449788|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16263637|NCT01190930|39449789|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
16263638|NCT01190930|39449790|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
16263639|NCT01190930|39449791|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
16263640|NCT01190930|39449792|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16263641|NCT01190930|39449793|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16263642|NCT01190930|39449794|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16263643|NCT01190930|39449795|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16263644|NCT01190930|39449796|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16263645|NCT01190930|39449797|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
16263646|NCT01190930|39449788|FG000|Post Induction Pre-Maintenance|Refusal|0|||
16263647|NCT01190930|39449789|FG001|Post Induction Pre-Maintenance|Refusal|2|||
16263648|NCT01190930|39449790|FG002|Post Induction Pre-Maintenance|Refusal|694|||
16263649|NCT01190930|39449791|FG003|Post Induction Pre-Maintenance|Refusal|4|||
16263650|NCT01190930|39449792|FG004|Post Induction Pre-Maintenance|Refusal|0|||
16263651|NCT01190930|39449793|FG005|Post Induction Pre-Maintenance|Refusal|3|||
16263652|NCT01190930|39449794|FG006|Post Induction Pre-Maintenance|Refusal|0|||
16263653|NCT01190930|39449795|FG007|Post Induction Pre-Maintenance|Refusal|0|||
16263654|NCT01190930|39449796|FG008|Post Induction Pre-Maintenance|Refusal|0|||
16263655|NCT01190930|39449797|FG009|Post Induction Pre-Maintenance|Refusal|0|||
16446294|NCT01295814|40115207|FG001|Overall Study|Withdrawal by Subject|0|||
16067015|NCT03095508|38736632|FG001|Overall Study|Adverse Event|1|||
16067016|NCT00241644|38736633|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
16067017|NCT00241644|38736634|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
16067018|NCT00241644|38736635|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
16067019|NCT00241644|38736636|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
16067020|NCT00241644|38736633|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
16067021|NCT00241644|38736634|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
16067022|NCT00241644|38736635|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
16067023|NCT00241644|38736636|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
16067024|NCT00241644|38736633|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
16067025|NCT00241644|38736634|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
16067026|NCT00241644|38736635|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
16067027|NCT00241644|38736636|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
16067028|NCT00241644|38736633|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
16067029|NCT00241644|38736634|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
16067030|NCT00241644|38736635|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
16067031|NCT00241644|38736636|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
16067032|NCT00241644|38736633|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
16067033|NCT00241644|38736634|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
16067034|NCT00241644|38736635|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
16159214|NCT01665144|39065024|FG001|Extension Part|Adverse Event|0|||
16263656|NCT01190930|39449788|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
16263657|NCT01190930|39449789|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
16263658|NCT01190930|39449790|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
16067035|NCT00241644|38736636|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
16067036|NCT00241644|38736633|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
16067037|NCT00241644|38736634|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
16067038|NCT00241644|38736635|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
16067039|NCT00241644|38736636|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
16067040|NCT00241644|38736633|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
16067041|NCT00241644|38736634|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
16067042|NCT00241644|38736635|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
16067043|NCT00241644|38736636|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
16067044|NCT00241644|38736633|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
16067045|NCT00241644|38736634|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
16067046|NCT00241644|38736635|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
16067047|NCT00241644|38736636|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
16067048|NCT00241644|38736633|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
16067049|NCT00241644|38736634|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
16067050|NCT00241644|38736635|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
16067051|NCT00241644|38736636|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
16067052|NCT00241644|38736633|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
16067053|NCT00241644|38736634|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
16067054|NCT00241644|38736635|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
16067055|NCT00241644|38736636|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
16067056|NCT00241644|38736633|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
16067057|NCT00241644|38736634|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
16067058|NCT00241644|38736635|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
16067059|NCT00241644|38736636|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
16067060|NCT00241644|38736633|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
16067061|NCT00241644|38736634|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
16067062|NCT00241644|38736635|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
16263659|NCT01190930|39449791|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
16263660|NCT01190930|39449792|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
16263661|NCT01190930|39449793|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
16263662|NCT01190930|39449794|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
16263663|NCT01190930|39449795|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
16263664|NCT01190930|39449796|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
16263665|NCT01190930|39449797|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
16263666|NCT01190930|39449788|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16446295|NCT01294553|40115208|FG000|Overall Study|Duplicated Participants|1|||
16446296|NCT01294553|40115208|FG000|Overall Study|Protocol Violation|268|||
16446297|NCT03771664|40115209|FG000|Overall Study|Adverse Event|1|||
16446298|NCT03771664|40115210|FG001|Overall Study|Adverse Event|0|||
16446299|NCT03771664|40115209|FG000|Overall Study|Lost to Follow-up|1|||
16263667|NCT01190930|39449789|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
16263668|NCT01190930|39449790|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16263669|NCT01190930|39449791|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16263670|NCT01190930|39449792|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16263671|NCT01190930|39449793|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16263672|NCT01190930|39449794|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16263673|NCT01190930|39449795|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16263674|NCT01190930|39449796|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16263675|NCT01190930|39449797|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
16263676|NCT01190930|39449788|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
16263677|NCT01190930|39449789|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
16263678|NCT01190930|39449790|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
16263679|NCT01190930|39449791|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
16263680|NCT01190930|39449792|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
16263681|NCT01190930|39449793|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
16263682|NCT01190930|39449794|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
16263683|NCT01190930|39449795|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
16263684|NCT01190930|39449796|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
16263685|NCT01190930|39449797|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
16263686|NCT01190930|39449788|FG000|Post Induction Pre-Maintenance|Relapse|0|||
16263687|NCT01190930|39449789|FG001|Post Induction Pre-Maintenance|Relapse|0|||
16263688|NCT01190930|39449790|FG002|Post Induction Pre-Maintenance|Relapse|1|||
16446300|NCT03771664|40115210|FG001|Overall Study|Lost to Follow-up|0|||
16067063|NCT00241644|38736636|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
16067064|NCT00241644|38736633|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
16369602|NCT00541775|39836369|FG000|Overall Study|Protocol Violation|1|||
16369603|NCT00541775|39836370|FG001|Overall Study|Protocol Violation|0|||
16369604|NCT00541775|39836371|FG002|Overall Study|Protocol Violation|0|||
16369605|NCT00541775|39836369|FG000|Overall Study|Withdrawal by Subject and Other|5|||
16369606|NCT00541775|39836370|FG001|Overall Study|Withdrawal by Subject and Other|0|||
16369607|NCT00541775|39836371|FG002|Overall Study|Withdrawal by Subject and Other|2|||
16159215|NCT01665144|39065025|FG002|Extension Part|Adverse Event|59|||
16159216|NCT01665144|39065023|FG000|Extension Part|Study closed early|42|||
16159217|NCT01665144|39065024|FG001|Extension Part|Study closed early|0|||
16159218|NCT01665144|39065025|FG002|Extension Part|Study closed early|19|||
16159219|NCT01665144|39065023|FG000|Extension Part|Progressive disease|36|||
16159220|NCT01665144|39065024|FG001|Extension Part|Progressive disease|0|||
16159221|NCT01665144|39065025|FG002|Extension Part|Progressive disease|14|||
16369608|NCT03473301|39836372|FG000|Overall Study|Protocol Violation|4|||
16067065|NCT00241644|38736634|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
16446301|NCT03771664|40115209|FG000|Overall Study|Withdrawal by Participant|1|||
16067066|NCT00241644|38736635|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
16067067|NCT00241644|38736636|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
16369609|NCT03473301|39836373|FG001|Overall Study|Protocol Violation|0|||
16369610|NCT03473301|39836374|FG002|Overall Study|Protocol Violation|0|||
16369611|NCT03473301|39836372|FG000|Overall Study|Withdrawal by Subject|0|||
16369612|NCT03473301|39836373|FG001|Overall Study|Withdrawal by Subject|1|||
16369613|NCT03473301|39836374|FG002|Overall Study|Withdrawal by Subject|0|||
16369614|NCT03473301|39836372|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
16369615|NCT03473301|39836373|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
16369616|NCT03473301|39836374|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
16369617|NCT01350973|39836375|FG000|Overall Study|Adverse Event|4|||
16369618|NCT01350973|39836376|FG001|Overall Study|Adverse Event|7|||
16369619|NCT01350973|39836377|FG002|Overall Study|Adverse Event|7|||
16369620|NCT01350973|39836375|FG000|Overall Study|Voluntary Withdrawal|2|||
16369621|NCT01350973|39836376|FG001|Overall Study|Voluntary Withdrawal|1|||
16369622|NCT01350973|39836377|FG002|Overall Study|Voluntary Withdrawal|1|||
16369623|NCT00127933|39836378|FG000|Overall Study|Randomized but not dosed|1|||
16369624|NCT00127933|39836379|FG001|Overall Study|Randomized but not dosed|0|||
16369625|NCT03142750|39839576|FG000|Overall Study|Lost to Follow-up|4|||
16369626|NCT03142750|39839577|FG001|Overall Study|Lost to Follow-up|1|||
16369627|NCT00985790|39839582|FG000|Overall Study|Withdrawal by Subject|1|||
16369628|NCT00985790|39839583|FG001|Overall Study|Withdrawal by Subject|1|||
16369629|NCT00985790|39839582|FG000|Overall Study|Lost to Follow-up|6|||
16369630|NCT00985790|39839583|FG001|Overall Study|Lost to Follow-up|7|||
16369631|NCT01666314|39839586|FG000|Overall Study|Adverse Event|3|||
16369632|NCT01666314|39839587|FG001|Overall Study|Adverse Event|13|||
16369633|NCT01666314|39839588|FG002|Overall Study|Adverse Event|7|||
16369634|NCT01666314|39839589|FG003|Overall Study|Adverse Event|7|||
16369635|NCT01666314|39839586|FG000|Overall Study|Progressive Disease|11|||
16369636|NCT01666314|39839587|FG001|Overall Study|Progressive Disease|9|||
16369637|NCT01666314|39839588|FG002|Overall Study|Progressive Disease|19|||
16369638|NCT01666314|39839589|FG003|Overall Study|Progressive Disease|20|||
16369639|NCT01666314|39839586|FG000|Overall Study|Symptomatic Deterioration|1|||
16067068|NCT01323660|38736643|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
16067069|NCT01323660|38736644|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
16067070|NCT01323660|38736645|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
16067071|NCT01323660|38736646|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
16067072|NCT01323660|38736647|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
16067073|NCT01323660|38736648|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
16067074|NCT01323660|38736643|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
16067075|NCT01323660|38736644|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
16067076|NCT01323660|38736645|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
16067077|NCT01323660|38736646|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
16067078|NCT01323660|38736647|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
16067079|NCT01323660|38736648|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
16067080|NCT01323660|38736643|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
16159222|NCT01665144|39065023|FG000|Extension Part|Lack of Efficacy|37|||
16159223|NCT01665144|39065024|FG001|Extension Part|Lack of Efficacy|0|||
16159224|NCT01665144|39065025|FG002|Extension Part|Lack of Efficacy|12|||
16159225|NCT01665144|39065023|FG000|Extension Part|Physician Decision|29|||
16159226|NCT01665144|39065024|FG001|Extension Part|Physician Decision|0|||
16159227|NCT01665144|39065025|FG002|Extension Part|Physician Decision|13|||
16159228|NCT01665144|39065023|FG000|Extension Part|Technical problems|20|||
16369640|NCT01666314|39839587|FG001|Overall Study|Symptomatic Deterioration|0|||
16369641|NCT01666314|39839588|FG002|Overall Study|Symptomatic Deterioration|2|||
16067081|NCT01323660|38736644|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
16159229|NCT01665144|39065024|FG001|Extension Part|Technical problems|0|||
16159230|NCT01665144|39065025|FG002|Extension Part|Technical problems|8|||
16369642|NCT01666314|39839589|FG003|Overall Study|Symptomatic Deterioration|0|||
16159231|NCT01665144|39065023|FG000|Extension Part|Death|20|||
16159232|NCT01665144|39065024|FG001|Extension Part|Death|0|||
16159233|NCT01665144|39065025|FG002|Extension Part|Death|4|||
16159234|NCT01665144|39065023|FG000|Extension Part|Missing|12|||
16159235|NCT01665144|39065024|FG001|Extension Part|Missing|0|||
16159236|NCT01665144|39065025|FG002|Extension Part|Missing|6|||
16159237|NCT01665144|39065023|FG000|Extension Part|Lost to Follow-up|9|||
16263689|NCT01190930|39449791|FG003|Post Induction Pre-Maintenance|Relapse|0|||
16159238|NCT01665144|39065024|FG001|Extension Part|Lost to Follow-up|0|||
16159239|NCT01665144|39065025|FG002|Extension Part|Lost to Follow-up|5|||
16159240|NCT01665144|39065023|FG000|Extension Part|New therapy for study indication|3|||
16159241|NCT01665144|39065024|FG001|Extension Part|New therapy for study indication|0|||
16159242|NCT01665144|39065025|FG002|Extension Part|New therapy for study indication|2|||
16159243|NCT01665144|39065023|FG000|Extension Part|Protocol deviation|3|||
16159244|NCT01665144|39065024|FG001|Extension Part|Protocol deviation|0|||
16159245|NCT01665144|39065025|FG002|Extension Part|Protocol deviation|0|||
16159246|NCT00424827|39065026|FG000|Overall Study|Adverse Event|1|||
16159247|NCT04356183|39065029|FG000|Overall Study|Lost to Follow-up|1|||
16159248|NCT04356183|39065030|FG001|Overall Study|Lost to Follow-up|0|||
16159249|NCT04356183|39065029|FG000|Overall Study|Withdrawal by Subject|1|||
16159250|NCT04356183|39065030|FG001|Overall Study|Withdrawal by Subject|1|||
16159251|NCT02627495|39065031|FG000|Overall Study|Withdrawal by Subject|4|||
16159252|NCT01738971|39065032|FG000|Overall Study|Lost to Follow-up|19|||
16159253|NCT01738971|39065033|FG001|Overall Study|Lost to Follow-up|30|||
16159254|NCT01738971|39065034|FG002|Overall Study|Lost to Follow-up|17|||
16159255|NCT02105454|39065037|FG000|Overall Study|Withdrawal by Subject|1|||
16159256|NCT00132132|39065038|FG000|Overall Study|Lost to Follow-up|7|||
16159257|NCT00132132|39065039|FG001|Overall Study|Lost to Follow-up|2|||
16159258|NCT01604265|39065040|FG000|Overall Study|Adverse Event|1|||
16159259|NCT01604265|39065041|FG001|Overall Study|Adverse Event|0|||
16159260|NCT01604265|39065040|FG000|Overall Study|Withdrawal by Subject|1|||
16159261|NCT01604265|39065041|FG001|Overall Study|Withdrawal by Subject|0|||
16159262|NCT00903175|39065044|FG000|Period 1 - First Line|Adverse Event|36|||
16159263|NCT00903175|39065045|FG001|Period 1 - First Line|Adverse Event|50|||
16159264|NCT00903175|39065044|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
16159265|NCT00903175|39065045|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
16159266|NCT00903175|39065044|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
16159267|NCT00903175|39065045|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
16159268|NCT00903175|39065044|FG000|Period 1 - First Line|Protocol Violation|3|||
16159269|NCT00903175|39065045|FG001|Period 1 - First Line|Protocol Violation|3|||
16159270|NCT00903175|39065044|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
16263690|NCT01190930|39449792|FG004|Post Induction Pre-Maintenance|Relapse|0|||
16263691|NCT01190930|39449793|FG005|Post Induction Pre-Maintenance|Relapse|0|||
16263692|NCT01190930|39449794|FG006|Post Induction Pre-Maintenance|Relapse|0|||
16263693|NCT01190930|39449795|FG007|Post Induction Pre-Maintenance|Relapse|0|||
16263694|NCT01190930|39449796|FG008|Post Induction Pre-Maintenance|Relapse|0|||
16263695|NCT01190930|39449797|FG009|Post Induction Pre-Maintenance|Relapse|0|||
16263696|NCT01190930|39449788|FG000|Maintenance|Adverse Event|0|||
16263697|NCT01190930|39449789|FG001|Maintenance|Adverse Event|0|||
16159271|NCT00903175|39065045|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
16159272|NCT00903175|39065044|FG000|Period 1 - First Line|Administrative problems|12|||
16159273|NCT00903175|39065045|FG001|Period 1 - First Line|Administrative problems|13|||
16159274|NCT00903175|39065044|FG000|Period 1 - First Line|Death|17|||
16263698|NCT01190930|39449790|FG002|Maintenance|Adverse Event|0|||
16263699|NCT01190930|39449791|FG003|Maintenance|Adverse Event|0|||
16263700|NCT01190930|39449792|FG004|Maintenance|Adverse Event|0|||
16263701|NCT01190930|39449793|FG005|Maintenance|Adverse Event|1|||
16263702|NCT01190930|39449794|FG006|Maintenance|Adverse Event|1|||
16263703|NCT01190930|39449795|FG007|Maintenance|Adverse Event|3|||
16263704|NCT01190930|39449796|FG008|Maintenance|Adverse Event|3|||
16263705|NCT01190930|39449797|FG009|Maintenance|Adverse Event|0|||
16263706|NCT01190930|39449788|FG000|Maintenance|Death|0|||
16263707|NCT01190930|39449789|FG001|Maintenance|Death|0|||
16263708|NCT01190930|39449790|FG002|Maintenance|Death|0|||
16263709|NCT01190930|39449791|FG003|Maintenance|Death|1|||
16263710|NCT01190930|39449792|FG004|Maintenance|Death|0|||
16159275|NCT00903175|39065045|FG001|Period 1 - First Line|Death|10|||
16159276|NCT00903175|39065044|FG000|Period 2 - Second Line|Missing|1|||
16159277|NCT00903175|39065045|FG001|Period 2 - Second Line|Missing|0|||
16159278|NCT00903175|39065044|FG000|Period 2 - Second Line|Adverse Event|16|||
16263711|NCT01190930|39449793|FG005|Maintenance|Death|0|||
16263712|NCT01190930|39449794|FG006|Maintenance|Death|2|||
16263713|NCT01190930|39449795|FG007|Maintenance|Death|2|||
16263714|NCT01190930|39449796|FG008|Maintenance|Death|2|||
16159279|NCT00903175|39065045|FG001|Period 2 - Second Line|Adverse Event|20|||
16159280|NCT00903175|39065044|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
16263715|NCT01190930|39449797|FG009|Maintenance|Death|2|||
16263716|NCT01190930|39449788|FG000|Maintenance|Lost to Follow-up|0|||
16263717|NCT01190930|39449789|FG001|Maintenance|Lost to Follow-up|0|||
16263718|NCT01190930|39449790|FG002|Maintenance|Lost to Follow-up|0|||
16369643|NCT01666314|39839586|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
16369644|NCT01666314|39839587|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
16369645|NCT01666314|39839588|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
16369646|NCT01666314|39839589|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
16369647|NCT01666314|39839586|FG000|Overall Study|Withdrawal by Subject|1|||
16369648|NCT01666314|39839587|FG001|Overall Study|Withdrawal by Subject|1|||
16369649|NCT01666314|39839588|FG002|Overall Study|Withdrawal by Subject|2|||
16369650|NCT01666314|39839589|FG003|Overall Study|Withdrawal by Subject|3|||
16369651|NCT01666314|39839586|FG000|Overall Study|Reason not Specified|10|||
16369652|NCT01666314|39839587|FG001|Overall Study|Reason not Specified|7|||
16369653|NCT01666314|39839588|FG002|Overall Study|Reason not Specified|5|||
16369654|NCT01666314|39839589|FG003|Overall Study|Reason not Specified|5|||
16369655|NCT01410604|39839590|FG000|Overall Study|Adverse Event|2|||
16369656|NCT01410604|39839591|FG001|Overall Study|Adverse Event|1|||
16369657|NCT01410604|39839590|FG000|Overall Study|Lost to Follow-up|1|||
16369658|NCT01410604|39839591|FG001|Overall Study|Lost to Follow-up|0|||
16369659|NCT01410604|39839590|FG000|Overall Study|Physician Decision|0|||
16369660|NCT01410604|39839591|FG001|Overall Study|Physician Decision|1|||
16369661|NCT02755090|39839592|FG000|Overall Study|equipment malfunction|1|||
16369662|NCT02755090|39839593|FG001|Overall Study|equipment malfunction|0|||
16369663|NCT04149353|39839594|FG000|Overall Study|Study terminated|1|||
16369664|NCT01108796|39839595|FG000|Overall Study|Adverse Event|0|||
16369665|NCT01108796|39839596|FG001|Overall Study|Adverse Event|1|||
16369666|NCT01108796|39839595|FG000|Overall Study|Lost to Follow-up|7|||
16369667|NCT01108796|39839596|FG001|Overall Study|Lost to Follow-up|6|||
16369668|NCT03331562|39839597|FG000|Overall Study|Adverse Event|2|||
16369669|NCT03331562|39839598|FG001|Overall Study|Adverse Event|0|||
16369670|NCT03331562|39839597|FG000|Overall Study|Death|1|||
16369671|NCT03331562|39839598|FG001|Overall Study|Death|0|||
16369672|NCT03722030|39839599|FG000|Overall Study|Withdrawal by Subject|1|||
16369673|NCT03722030|39839600|FG001|Overall Study|Withdrawal by Subject|0|||
16369674|NCT01524705|39839605|FG000|Overall Study|Adverse Event|2|||
16369675|NCT01524705|39839606|FG001|Overall Study|Adverse Event|0|||
16369676|NCT01524705|39839605|FG000|Overall Study|Death|1|||
16369677|NCT01524705|39839606|FG001|Overall Study|Death|0|||
16369678|NCT01524705|39839605|FG000|Overall Study|Lost to Follow-up|0|||
16369679|NCT01524705|39839606|FG001|Overall Study|Lost to Follow-up|1|||
16369680|NCT01524705|39839605|FG000|Overall Study|Withdrawal by Subject|0|||
16369681|NCT01524705|39839606|FG001|Overall Study|Withdrawal by Subject|1|||
16369682|NCT01524705|39839605|FG000|Overall Study|Pancreatic Cancer|0|||
16369683|NCT01524705|39839606|FG001|Overall Study|Pancreatic Cancer|1|||
16369684|NCT00313170|39839607|FG000|Overall Study|Death|2|||
16369685|NCT00313170|39839608|FG001|Overall Study|Death|4|||
16369686|NCT00313170|39839609|FG002|Overall Study|Death|2|||
16369687|NCT00313170|39839607|FG000|Overall Study|Adverse Event|1|||
16369688|NCT00313170|39839608|FG001|Overall Study|Adverse Event|2|||
16369689|NCT00313170|39839609|FG002|Overall Study|Adverse Event|0|||
16369690|NCT00313170|39839607|FG000|Overall Study|Disease progression|31|||
16369691|NCT00313170|39839608|FG001|Overall Study|Disease progression|26|||
16369692|NCT00313170|39839609|FG002|Overall Study|Disease progression|27|||
16369693|NCT00313170|39839607|FG000|Overall Study|Withdrawal by Subject|1|||
16369694|NCT00313170|39839608|FG001|Overall Study|Withdrawal by Subject|0|||
16369695|NCT00313170|39839609|FG002|Overall Study|Withdrawal by Subject|1|||
16369696|NCT00313170|39839607|FG000|Overall Study|Incorrect enrollment|0|||
16369697|NCT00313170|39839608|FG001|Overall Study|Incorrect enrollment|2|||
16369698|NCT00313170|39839609|FG002|Overall Study|Incorrect enrollment|1|||
16369699|NCT00313170|39839607|FG000|Overall Study|Lost to Follow-up|0|||
16369700|NCT00313170|39839608|FG001|Overall Study|Lost to Follow-up|0|||
16369701|NCT00313170|39839609|FG002|Overall Study|Lost to Follow-up|1|||
16369702|NCT00313170|39839607|FG000|Overall Study|Progression (investigators opinion)|1|||
16369703|NCT00313170|39839608|FG001|Overall Study|Progression (investigators opinion)|0|||
16369704|NCT00313170|39839609|FG002|Overall Study|Progression (investigators opinion)|0|||
16369705|NCT02153827|39839615|FG000|Overall Study|Lost to Follow-up|3|||
16369706|NCT02153827|39839616|FG001|Overall Study|Lost to Follow-up|9|||
16369707|NCT04913675|39839617|FG000|Main Study (Up to Week 36)|Death|0|||
16369708|NCT04913675|39839618|FG001|Main Study (Up to Week 36)|Death|2|||
16369709|NCT04913675|39839619|FG002|Main Study (Up to Week 36)|Death|2|||
16369710|NCT04913675|39839620|FG003|Main Study (Up to Week 36)|Death|0|||
16263719|NCT01190930|39449791|FG003|Maintenance|Lost to Follow-up|0|||
16369711|NCT04913675|39839617|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
16369712|NCT04913675|39839618|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
16369713|NCT04913675|39839619|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
16369714|NCT04913675|39839620|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
16369715|NCT04913675|39839617|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
16369716|NCT04913675|39839618|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
16369717|NCT04913675|39839619|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
16369718|NCT04913675|39839620|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
16369719|NCT04913675|39839617|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
16369720|NCT04913675|39839618|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
16369721|NCT04913675|39839619|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
16369722|NCT04913675|39839620|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
16369723|NCT04913675|39839617|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
16369724|NCT04913675|39839618|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
16369725|NCT04913675|39839619|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
16369726|NCT04913675|39839620|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
16369727|NCT04193527|39839621|FG000|Overall Study|Other|1|||
16369728|NCT04193527|39839622|FG001|Overall Study|Other|1|||
16369729|NCT04193527|39839623|FG002|Overall Study|Other|0|||
16369730|NCT01905267|39839624|FG000|Overall Study|Physician Decision|2|||
16369731|NCT01905267|39839625|FG001|Overall Study|Physician Decision|2|||
16369732|NCT02606253|39839631|FG000|Overall Study|Adverse Event|2|||
16369733|NCT02606253|39839632|FG001|Overall Study|Adverse Event|0|||
16369734|NCT02606253|39839633|FG002|Overall Study|Adverse Event|0|||
16369735|NCT02606253|39839631|FG000|Overall Study|Protocol Violation|2|||
16369736|NCT02606253|39839632|FG001|Overall Study|Protocol Violation|1|||
16369737|NCT02606253|39839633|FG002|Overall Study|Protocol Violation|0|||
16369738|NCT02606253|39839631|FG000|Overall Study|Physician Decision|1|||
16369739|NCT02606253|39839632|FG001|Overall Study|Physician Decision|1|||
16369740|NCT02606253|39839633|FG002|Overall Study|Physician Decision|0|||
16067082|NCT01323660|38736645|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
16067083|NCT01323660|38736646|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
16067084|NCT01323660|38736647|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
16446302|NCT03771664|40115210|FG001|Overall Study|Withdrawal by Participant|4|||
16446303|NCT03771664|40115209|FG000|Overall Study|Randomized but not Treated|0|||
16446304|NCT03771664|40115210|FG001|Overall Study|Randomized but not Treated|1|||
16446305|NCT00830440|40115217|FG000|Overall Study|Protocol Violation|1|||
16446306|NCT00830440|40115218|FG001|Overall Study|Protocol Violation|0|||
16446307|NCT00830440|40115217|FG000|Overall Study|Withdrawal by Subject|1|||
16446308|NCT00830440|40115218|FG001|Overall Study|Withdrawal by Subject|0|||
16446309|NCT00830440|40115217|FG000|Overall Study|unsuccessful procedure|4|||
16446310|NCT00830440|40115218|FG001|Overall Study|unsuccessful procedure|0|||
16446311|NCT00830440|40115217|FG000|Overall Study|Adverse Event|2|||
16446312|NCT00830440|40115218|FG001|Overall Study|Adverse Event|0|||
16369741|NCT00770484|39839634|FG000|Overall Study|Withdrawal by Subject|1|||
16369742|NCT00770484|39839635|FG001|Overall Study|Withdrawal by Subject|0|||
16369743|NCT02280499|39839640|FG000|Overall Study|Death|14|||
16369744|NCT02280499|39839640|FG000|Overall Study|Lost to Follow-up|42|||
16369745|NCT02280499|39839640|FG000|Overall Study|Adverse Event|5|||
16369746|NCT00308685|39839643|FG000|Overall Study|Lost to Follow-up|1|||
16369747|NCT00308685|39839644|FG001|Overall Study|Lost to Follow-up|0|||
16369748|NCT00308685|39839643|FG000|Overall Study|Need to administer prohibited medication|1|||
16369749|NCT00308685|39839644|FG001|Overall Study|Need to administer prohibited medication|2|||
16369750|NCT00308685|39839643|FG000|Overall Study|Other than specified|1|||
16369751|NCT00308685|39839644|FG001|Overall Study|Other than specified|3|||
16369752|NCT01851369|39839647|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369753|NCT01851369|39839648|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369754|NCT01851369|39839649|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369755|NCT01851369|39839650|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369756|NCT01851369|39839651|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369757|NCT01851369|39839652|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
16369758|NCT01851369|39839653|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369759|NCT01851369|39839654|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369760|NCT01851369|39839655|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369761|NCT01851369|39839656|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369762|NCT01851369|39839657|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369763|NCT01851369|39839658|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369764|NCT01851369|39839659|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
16369765|NCT01671059|39839660|FG000|Overall Study|Adverse Event|4|||
16369766|NCT01671059|39839660|FG000|Overall Study|Lack of Efficacy|1|||
16369767|NCT00478140|39839672|FG000|Overall Study|Clinical Disease Progression|1|||
16369768|NCT02218268|39839673|FG000|24 Hour Washout|Physician Decision|11|||
16369769|NCT02218268|39839674|FG001|24 Hour Washout|Physician Decision|9|||
16369770|NCT00530075|39839675|FG000|Overall Study|Adverse Event|1|||
16369771|NCT00530075|39839675|FG000|Overall Study|Death|1|||
16369772|NCT00530075|39839675|FG000|Overall Study|Lack of Efficacy|3|||
16446313|NCT02326155|40115221|FG000|Overall Study|Adverse Event|21|||
16446314|NCT02326155|40115222|FG001|Overall Study|Adverse Event|5|||
16067085|NCT01323660|38736648|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
16067086|NCT01323660|38736643|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16446315|NCT02326155|40115221|FG000|Overall Study|Death|3|||
16446316|NCT02326155|40115222|FG001|Overall Study|Death|0|||
16446317|NCT02326155|40115221|FG000|Overall Study|Lack of Efficacy|49|||
16446318|NCT02326155|40115222|FG001|Overall Study|Lack of Efficacy|5|||
16446319|NCT02326155|40115221|FG000|Overall Study|Lost to Follow-up|14|||
16446320|NCT02326155|40115222|FG001|Overall Study|Lost to Follow-up|3|||
16446321|NCT02326155|40115221|FG000|Overall Study|Protocol Violation|2|||
16446322|NCT02326155|40115222|FG001|Overall Study|Protocol Violation|0|||
16446323|NCT02326155|40115221|FG000|Overall Study|Withdrawal by Subject|34|||
16446324|NCT02326155|40115222|FG001|Overall Study|Withdrawal by Subject|11|||
16446325|NCT02326155|40115221|FG000|Overall Study|Disease progression|37|||
16446326|NCT02326155|40115222|FG001|Overall Study|Disease progression|4|||
16446327|NCT02326155|40115221|FG000|Overall Study|Study close|188|||
16446328|NCT02326155|40115222|FG001|Overall Study|Study close|21|||
16446329|NCT02326155|40115221|FG000|Overall Study|except for study close|46|||
16446330|NCT02326155|40115222|FG001|Overall Study|except for study close|13|||
16446331|NCT02202759|40115226|FG000|Overall Study|Study Terminated by Sponsor|3|||
16446332|NCT02202759|40115227|FG001|Overall Study|Study Terminated by Sponsor|3|||
16446333|NCT02202759|40115228|FG002|Overall Study|Study Terminated by Sponsor|3|||
16446334|NCT02202759|40115226|FG000|Overall Study|Withdrawal by Subject|2|||
16446335|NCT02202759|40115227|FG001|Overall Study|Withdrawal by Subject|1|||
16446336|NCT02202759|40115228|FG002|Overall Study|Withdrawal by Subject|1|||
16446337|NCT02202759|40115226|FG000|Overall Study|Reason not Specified|4|||
16446338|NCT02202759|40115227|FG001|Overall Study|Reason not Specified|11|||
16446339|NCT02202759|40115228|FG002|Overall Study|Reason not Specified|10|||
16446340|NCT02954536|40115229|FG000|Overall Study|Adverse Event|2|||
16446341|NCT02954536|40115229|FG000|Overall Study|Death|12|||
16446342|NCT02636595|40115230|FG000|Overall Study|Lost to Follow-up|1|||
16446343|NCT02636595|40115230|FG000|Overall Study|Other|1|||
16446344|NCT01652534|40115231|FG000|Overall Study|Lack of Efficacy|1|||
16446345|NCT01652534|40115232|FG001|Overall Study|Lack of Efficacy|0|||
16446346|NCT01586364|40115235|FG000|Overall Study|Withdrawal by Subject|40|||
16446347|NCT01586364|40115235|FG000|Overall Study|Adverse Event|37|||
16446348|NCT01586364|40115235|FG000|Overall Study|Lost to Follow-up|17|||
16446349|NCT01586364|40115235|FG000|Overall Study|Protocol Violation|16|||
16446350|NCT01586364|40115235|FG000|Overall Study|Lack of Efficacy|1|||
16446351|NCT01586364|40115235|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
16446352|NCT01586364|40115235|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
16446353|NCT01586364|40115235|FG000|Overall Study|Other-Site closure due to PI illness|1|||
16446354|NCT01586364|40115235|FG000|Overall Study|Other-PI discretion, site closing|2|||
16159281|NCT00903175|39065045|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
16159282|NCT00903175|39065044|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
16159283|NCT00903175|39065045|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
16159284|NCT00903175|39065044|FG000|Period 2 - Second Line|Administrative problems|19|||
16159285|NCT00903175|39065045|FG001|Period 2 - Second Line|Administrative problems|9|||
16159286|NCT00903175|39065044|FG000|Period 2 - Second Line|Death|5|||
16159287|NCT00903175|39065045|FG001|Period 2 - Second Line|Death|2|||
16159288|NCT03047980|39065051|FG000|Overall Study|Adverse Event|1|||
16159289|NCT01294670|39065052|FG000|Overall Study|Not treated|1|||
16159290|NCT01294670|39065053|FG001|Overall Study|Not treated|0|||
16159291|NCT01294670|39065054|FG002|Overall Study|Not treated|0|||
16159292|NCT01294670|39065055|FG003|Overall Study|Not treated|0|||
16159293|NCT01294670|39065056|FG004|Overall Study|Not treated|0|||
16263720|NCT01190930|39449792|FG004|Maintenance|Lost to Follow-up|0|||
16263721|NCT01190930|39449793|FG005|Maintenance|Lost to Follow-up|0|||
16263722|NCT01190930|39449794|FG006|Maintenance|Lost to Follow-up|1|||
16263723|NCT01190930|39449795|FG007|Maintenance|Lost to Follow-up|1|||
16263724|NCT01190930|39449796|FG008|Maintenance|Lost to Follow-up|1|||
16263725|NCT01190930|39449797|FG009|Maintenance|Lost to Follow-up|0|||
16263726|NCT01190930|39449788|FG000|Maintenance|Physician Decision|0|||
16263727|NCT01190930|39449789|FG001|Maintenance|Physician Decision|1|||
16263728|NCT01190930|39449790|FG002|Maintenance|Physician Decision|0|||
16263729|NCT01190930|39449791|FG003|Maintenance|Physician Decision|5|||
16159294|NCT01344876|39065057|FG000|Overall Study|Adverse Event|0|||
16159295|NCT01344876|39065058|FG001|Overall Study|Adverse Event|0|||
16159296|NCT01344876|39065059|FG002|Overall Study|Adverse Event|0|||
16159297|NCT01344876|39065060|FG003|Overall Study|Adverse Event|0|||
16263730|NCT01190930|39449792|FG004|Maintenance|Physician Decision|9|||
16263731|NCT01190930|39449793|FG005|Maintenance|Physician Decision|4|||
16263732|NCT01190930|39449794|FG006|Maintenance|Physician Decision|8|||
16446355|NCT01586364|40115235|FG000|Overall Study|Other-Not specified|1|||
16446356|NCT01520506|40115236|FG000|Overall Study|Missed Visit|4|||
16446357|NCT01520506|40115236|FG000|Overall Study|Lost to Follow-up|1|||
16446358|NCT01520506|40115236|FG000|Overall Study|Withdrawal by Subject|1|||
16446359|NCT03331315|40115244|FG000|Overall Study|Physician Decision|18|||
16446360|NCT03331315|40115245|FG001|Overall Study|Physician Decision|14|||
16159298|NCT01344876|39065061|FG004|Overall Study|Adverse Event|1|||
16263733|NCT01190930|39449795|FG007|Maintenance|Physician Decision|8|||
16446361|NCT01614886|40115248|FG000|Overall Study|Adverse Event|15|||
16446362|NCT01614886|40115249|FG001|Overall Study|Adverse Event|20|||
16446363|NCT01614886|40115248|FG000|Overall Study|Withdrawal by Subject|4|||
16446364|NCT01614886|40115249|FG001|Overall Study|Withdrawal by Subject|4|||
16446365|NCT01614886|40115248|FG000|Overall Study|Death|1|||
16159299|NCT01344876|39065057|FG000|Overall Study|Withdrawal by Subject|0|||
16159300|NCT01344876|39065058|FG001|Overall Study|Withdrawal by Subject|0|||
16159301|NCT01344876|39065059|FG002|Overall Study|Withdrawal by Subject|1|||
16159302|NCT01344876|39065060|FG003|Overall Study|Withdrawal by Subject|0|||
16159303|NCT01344876|39065061|FG004|Overall Study|Withdrawal by Subject|0|||
16067087|NCT01323660|38736644|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16159304|NCT01344876|39065057|FG000|Overall Study|Definite progression of primary disease|1|||
16159305|NCT01344876|39065058|FG001|Overall Study|Definite progression of primary disease|0|||
16159306|NCT01344876|39065059|FG002|Overall Study|Definite progression of primary disease|0|||
16159307|NCT01344876|39065060|FG003|Overall Study|Definite progression of primary disease|3|||
16159308|NCT01344876|39065061|FG004|Overall Study|Definite progression of primary disease|0|||
16159309|NCT03344003|39065062|FG000|Overall Study|Switched to alternative treatment|1|||
16159310|NCT03344003|39065063|FG001|Overall Study|Switched to alternative treatment|0|||
16263734|NCT01190930|39449796|FG008|Maintenance|Physician Decision|10|||
16263735|NCT01190930|39449797|FG009|Maintenance|Physician Decision|17|||
16263736|NCT01190930|39449788|FG000|Maintenance|Withdrawal by Subject|0|||
16263737|NCT01190930|39449789|FG001|Maintenance|Withdrawal by Subject|0|||
16263738|NCT01190930|39449790|FG002|Maintenance|Withdrawal by Subject|0|||
16067088|NCT01323660|38736645|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16067089|NCT01323660|38736646|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16067090|NCT01323660|38736647|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
16067091|NCT01323660|38736648|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
16067092|NCT01323660|38736643|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16067093|NCT01323660|38736644|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16067094|NCT01323660|38736645|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16067095|NCT01323660|38736646|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16067096|NCT01323660|38736647|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
16067097|NCT01323660|38736648|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16067098|NCT01323660|38736643|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
16067099|NCT01323660|38736644|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16067100|NCT01323660|38736645|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
16067101|NCT01323660|38736646|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
16067102|NCT01323660|38736647|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
16067103|NCT01323660|38736648|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16067104|NCT01323660|38736643|FG000|Washout Period (14 Days)|Adverse Event|0|||
16067105|NCT01323660|38736644|FG001|Washout Period (14 Days)|Adverse Event|0|||
16067106|NCT01323660|38736645|FG002|Washout Period (14 Days)|Adverse Event|0|||
16067107|NCT01323660|38736646|FG003|Washout Period (14 Days)|Adverse Event|0|||
16067108|NCT01323660|38736647|FG004|Washout Period (14 Days)|Adverse Event|1|||
16263739|NCT01190930|39449791|FG003|Maintenance|Withdrawal by Subject|0|||
16263740|NCT01190930|39449792|FG004|Maintenance|Withdrawal by Subject|0|||
16263741|NCT01190930|39449793|FG005|Maintenance|Withdrawal by Subject|0|||
16446366|NCT01614886|40115249|FG001|Overall Study|Death|0|||
16446367|NCT01614886|40115248|FG000|Overall Study|Protocol deviation|0|||
16263742|NCT01190930|39449794|FG006|Maintenance|Withdrawal by Subject|2|||
16263743|NCT01190930|39449795|FG007|Maintenance|Withdrawal by Subject|1|||
16263744|NCT01190930|39449796|FG008|Maintenance|Withdrawal by Subject|4|||
16263745|NCT01190930|39449797|FG009|Maintenance|Withdrawal by Subject|1|||
16446368|NCT01614886|40115249|FG001|Overall Study|Protocol deviation|2|||
16446369|NCT03112603|40115252|FG000|End of Randomization Period|Lost to Follow-up|3|||
16446370|NCT03112603|40115253|FG001|End of Randomization Period|Lost to Follow-up|0|||
16446371|NCT03112603|40115254|FG002|End of Randomization Period|Lost to Follow-up|0|||
16446372|NCT03112603|40115252|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
16446373|NCT03112603|40115253|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
16446374|NCT03112603|40115254|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
16446375|NCT03112603|40115252|FG000|End of Randomization Period|Physician Decision|43|||
16446376|NCT03112603|40115253|FG001|End of Randomization Period|Physician Decision|18|||
16446377|NCT03112603|40115254|FG002|End of Randomization Period|Physician Decision|0|||
16067109|NCT01323660|38736648|FG005|Washout Period (14 Days)|Adverse Event|0|||
16067110|NCT01323660|38736643|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
16067111|NCT01323660|38736644|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
16159311|NCT03344003|39065062|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
16263746|NCT01190930|39449788|FG000|Maintenance|Refusal|0|||
16263747|NCT01190930|39449789|FG001|Maintenance|Refusal|1|||
16263748|NCT01190930|39449790|FG002|Maintenance|Refusal|0|||
16446378|NCT03112603|40115252|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
16446379|NCT03112603|40115253|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
16067112|NCT01323660|38736645|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
16067113|NCT01323660|38736646|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
16067114|NCT01323660|38736647|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
16067115|NCT01323660|38736648|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
16067116|NCT01323660|38736643|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
16067117|NCT01323660|38736644|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
16067118|NCT01323660|38736645|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
16067119|NCT01323660|38736646|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
16067120|NCT01323660|38736647|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
16067121|NCT01323660|38736648|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
16067122|NCT01323660|38736643|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
16067123|NCT01323660|38736644|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
16067124|NCT01323660|38736645|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
16067125|NCT01323660|38736646|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
16067126|NCT01323660|38736647|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
16067127|NCT01323660|38736648|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
16067128|NCT01323660|38736643|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
16067129|NCT01323660|38736644|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
16067130|NCT01323660|38736645|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
16067131|NCT01323660|38736646|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
16067132|NCT01323660|38736647|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
16067133|NCT01323660|38736648|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
16067134|NCT01323660|38736643|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
16067135|NCT01323660|38736644|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
16067136|NCT01323660|38736645|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
16067137|NCT01323660|38736646|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
16067138|NCT01323660|38736647|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
16067139|NCT01323660|38736648|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
16067140|NCT01323660|38736643|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16067141|NCT01323660|38736644|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16067142|NCT01323660|38736645|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16067143|NCT01323660|38736646|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16067144|NCT01323660|38736647|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
16067145|NCT01323660|38736648|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16067146|NCT02065245|38736651|FG000|Infusion 1|Lost to Follow-up|0|||
16067147|NCT02065245|38736652|FG001|Infusion 1|Lost to Follow-up|0|||
16067148|NCT02065245|38736653|FG002|Infusion 1|Lost to Follow-up|0|||
16067149|NCT02065245|38736654|FG003|Infusion 1|Lost to Follow-up|0|||
16067150|NCT02065245|38736655|FG004|Infusion 1|Lost to Follow-up|0|||
16067151|NCT02065245|38736656|FG005|Infusion 1|Lost to Follow-up|0|||
16067152|NCT02065245|38736657|FG006|Infusion 1|Lost to Follow-up|1|||
16067153|NCT02065245|38736651|FG000|Infusion 1|Death|0|||
16067154|NCT02065245|38736652|FG001|Infusion 1|Death|0|||
16067155|NCT02065245|38736653|FG002|Infusion 1|Death|1|||
16067156|NCT02065245|38736654|FG003|Infusion 1|Death|0|||
16369773|NCT00530075|39839675|FG000|Overall Study|Protocol Violation|1|||
16369774|NCT00530075|39839675|FG000|Overall Study|Withdrawal by Subject|1|||
16369775|NCT02336503|39839678|FG000|Overall Study|Lost to Follow-up|0|||
16369776|NCT02336503|39839679|FG001|Overall Study|Lost to Follow-up|3|||
16369777|NCT02336503|39839680|FG002|Overall Study|Lost to Follow-up|0|||
16369778|NCT02336503|39839681|FG003|Overall Study|Lost to Follow-up|2|||
16369779|NCT02336503|39839678|FG000|Overall Study|Withdrawal by Subject|2|||
16369780|NCT02336503|39839679|FG001|Overall Study|Withdrawal by Subject|0|||
16369781|NCT02336503|39839680|FG002|Overall Study|Withdrawal by Subject|0|||
16369782|NCT02336503|39839681|FG003|Overall Study|Withdrawal by Subject|4|||
16369783|NCT02336503|39839678|FG000|Overall Study|Adverse Event|0|||
16369784|NCT02336503|39839679|FG001|Overall Study|Adverse Event|0|||
16369785|NCT02336503|39839680|FG002|Overall Study|Adverse Event|1|||
16369786|NCT02336503|39839681|FG003|Overall Study|Adverse Event|0|||
16369787|NCT02320396|39839682|FG000|Overall Study|Adverse Event|2|||
16369788|NCT02320396|39839683|FG001|Overall Study|Adverse Event|2|||
16369789|NCT02320396|39839682|FG000|Overall Study|Pregnancy|0|||
16369790|NCT02320396|39839683|FG001|Overall Study|Pregnancy|1|||
16369791|NCT02320396|39839682|FG000|Overall Study|Protocol Violation|0|||
16369792|NCT02320396|39839683|FG001|Overall Study|Protocol Violation|1|||
16369793|NCT02320396|39839682|FG000|Overall Study|Withdrawal by Subject|2|||
16369794|NCT02320396|39839683|FG001|Overall Study|Withdrawal by Subject|0|||
16369795|NCT01727154|39839684|FG000|Overall Study|Death|17|||
16067157|NCT02065245|38736655|FG004|Infusion 1|Death|1|||
16067158|NCT02065245|38736656|FG005|Infusion 1|Death|0|||
16067159|NCT02065245|38736657|FG006|Infusion 1|Death|0|||
16067160|NCT02065245|38736651|FG000|Infusion 2|Death|0|||
16067161|NCT02065245|38736652|FG001|Infusion 2|Death|0|||
16067162|NCT02065245|38736653|FG002|Infusion 2|Death|0|||
16067163|NCT02065245|38736654|FG003|Infusion 2|Death|0|||
16067164|NCT02065245|38736655|FG004|Infusion 2|Death|0|||
16067165|NCT02065245|38736656|FG005|Infusion 2|Death|0|||
16369796|NCT01727154|39839684|FG000|Overall Study|Withdrawal by Subject|14|||
16369797|NCT01727154|39839684|FG000|Overall Study|Subject Withdrew Consent|18|||
16369798|NCT01727154|39839684|FG000|Overall Study|Study Terminated|6|||
16369799|NCT01727154|39839684|FG000|Overall Study|No Discontinuation Documentation|4|||
16369800|NCT01960842|39839685|FG000|Overall Study|Adverse Event|1|||
16369801|NCT01960842|39839685|FG000|Overall Study|Withdrawal by Subject|2|||
16369802|NCT02573467|39839689|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
16369803|NCT02573467|39839690|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
16369804|NCT02573467|39839691|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
16369805|NCT02573467|39839692|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
16369806|NCT02573467|39839689|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
16369807|NCT02573467|39839690|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
16369808|NCT02573467|39839691|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
16369809|NCT02573467|39839692|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
16369810|NCT02573467|39839689|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
16067166|NCT02065245|38736657|FG006|Infusion 2|Death|1|||
16067167|NCT02065245|38736651|FG000|Infusion 3|Lost to Follow-up|1|||
16067168|NCT02065245|38736652|FG001|Infusion 3|Lost to Follow-up|1|||
16067169|NCT02065245|38736653|FG002|Infusion 3|Lost to Follow-up|0|||
16067170|NCT02065245|38736654|FG003|Infusion 3|Lost to Follow-up|0|||
16067171|NCT02065245|38736655|FG004|Infusion 3|Lost to Follow-up|0|||
16067172|NCT02065245|38736656|FG005|Infusion 3|Lost to Follow-up|0|||
16067173|NCT02065245|38736657|FG006|Infusion 3|Lost to Follow-up|0|||
16067174|NCT01072929|38736658|FG000|Overall Study|Adverse Event|8|||
16067175|NCT01072929|38736659|FG001|Overall Study|Adverse Event|11|||
16067176|NCT01072929|38736660|FG002|Overall Study|Adverse Event|2|||
16067177|NCT01072929|38736658|FG000|Overall Study|Lack of Efficacy|7|||
16067178|NCT01072929|38736659|FG001|Overall Study|Lack of Efficacy|4|||
16263749|NCT01190930|39449791|FG003|Maintenance|Refusal|2|||
16067179|NCT01072929|38736660|FG002|Overall Study|Lack of Efficacy|0|||
16263750|NCT01190930|39449792|FG004|Maintenance|Refusal|0|||
16263751|NCT01190930|39449793|FG005|Maintenance|Refusal|4|||
16263752|NCT01190930|39449794|FG006|Maintenance|Refusal|5|||
16263753|NCT01190930|39449795|FG007|Maintenance|Refusal|17|||
16263754|NCT01190930|39449796|FG008|Maintenance|Refusal|13|||
16263755|NCT01190930|39449797|FG009|Maintenance|Refusal|6|||
16263756|NCT01190930|39449788|FG000|Maintenance|second malignant neoplasm|0|||
16263757|NCT01190930|39449789|FG001|Maintenance|second malignant neoplasm|0|||
16263758|NCT01190930|39449790|FG002|Maintenance|second malignant neoplasm|0|||
16263759|NCT01190930|39449791|FG003|Maintenance|second malignant neoplasm|1|||
16263760|NCT01190930|39449792|FG004|Maintenance|second malignant neoplasm|0|||
16263761|NCT01190930|39449793|FG005|Maintenance|second malignant neoplasm|1|||
16263762|NCT01190930|39449794|FG006|Maintenance|second malignant neoplasm|0|||
16263763|NCT01190930|39449795|FG007|Maintenance|second malignant neoplasm|0|||
16263764|NCT01190930|39449796|FG008|Maintenance|second malignant neoplasm|1|||
16263765|NCT01190930|39449797|FG009|Maintenance|second malignant neoplasm|0|||
16263766|NCT01190930|39449788|FG000|Maintenance|Inevaluable|0|||
16263767|NCT01190930|39449789|FG001|Maintenance|Inevaluable|0|||
16263768|NCT01190930|39449790|FG002|Maintenance|Inevaluable|0|||
16263769|NCT01190930|39449791|FG003|Maintenance|Inevaluable|0|||
16263770|NCT01190930|39449792|FG004|Maintenance|Inevaluable|0|||
16263771|NCT01190930|39449793|FG005|Maintenance|Inevaluable|1|||
16067180|NCT01072929|38736658|FG000|Overall Study|Withdrawal by Subject|7|||
16067181|NCT01072929|38736659|FG001|Overall Study|Withdrawal by Subject|15|||
16067182|NCT01072929|38736660|FG002|Overall Study|Withdrawal by Subject|3|||
16067183|NCT01072929|38736658|FG000|Overall Study|Protocol Violation|13|||
16067184|NCT01072929|38736659|FG001|Overall Study|Protocol Violation|11|||
16067185|NCT01072929|38736660|FG002|Overall Study|Protocol Violation|2|||
16067186|NCT01072929|38736658|FG000|Overall Study|Lost to Follow-up|8|||
16067187|NCT01072929|38736659|FG001|Overall Study|Lost to Follow-up|4|||
16067188|NCT01072929|38736660|FG002|Overall Study|Lost to Follow-up|1|||
16067189|NCT01072929|38736658|FG000|Overall Study|Noncompliance with study medication|0|||
16067190|NCT01072929|38736659|FG001|Overall Study|Noncompliance with study medication|3|||
16159312|NCT03344003|39065063|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
16263772|NCT01190930|39449794|FG006|Maintenance|Inevaluable|1|||
16263773|NCT01190930|39449795|FG007|Maintenance|Inevaluable|1|||
16263774|NCT01190930|39449796|FG008|Maintenance|Inevaluable|0|||
16369811|NCT02573467|39839690|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
16263775|NCT01190930|39449797|FG009|Maintenance|Inevaluable|0|||
16067191|NCT01072929|38736660|FG002|Overall Study|Noncompliance with study medication|0|||
16067192|NCT01072929|38736658|FG000|Overall Study|Noncompliance with study procedures|1|||
16067193|NCT01072929|38736659|FG001|Overall Study|Noncompliance with study procedures|0|||
16067194|NCT01072929|38736660|FG002|Overall Study|Noncompliance with study procedures|1|||
16067195|NCT01072929|38736658|FG000|Overall Study|Other|0|||
16067196|NCT01072929|38736659|FG001|Overall Study|Other|3|||
16263776|NCT01190930|39449788|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
16263777|NCT01190930|39449789|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
16067197|NCT01072929|38736660|FG002|Overall Study|Other|0|||
16067198|NCT00430677|38736662|FG000|Short-term Period|Death|1|||
16067199|NCT00430677|38736663|FG001|Short-term Period|Death|1|||
16067200|NCT00430677|38736664|FG002|Short-term Period|Death|5|||
16067201|NCT00430677|38736662|FG000|Short-term Period|Adverse Event|15|||
16067202|NCT00430677|38736663|FG001|Short-term Period|Adverse Event|13|||
16067203|NCT00430677|38736664|FG002|Short-term Period|Adverse Event|9|||
16067204|NCT00430677|38736662|FG000|Short-term Period|Lack of Efficacy|5|||
16067205|NCT00430677|38736663|FG001|Short-term Period|Lack of Efficacy|6|||
16067206|NCT00430677|38736664|FG002|Short-term Period|Lack of Efficacy|4|||
16446380|NCT03112603|40115254|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
16446381|NCT03112603|40115252|FG000|End of Randomization Period|Death|10|||
16446382|NCT03112603|40115253|FG001|End of Randomization Period|Death|7|||
16446383|NCT03112603|40115254|FG002|End of Randomization Period|Death|0|||
16446384|NCT03112603|40115252|FG000|End of Randomization Period|Disease Relapse|12|||
16446385|NCT03112603|40115253|FG001|End of Randomization Period|Disease Relapse|7|||
16446386|NCT03112603|40115254|FG002|End of Randomization Period|Disease Relapse|0|||
16446387|NCT03112603|40115252|FG000|End of Randomization Period|Lack of Efficacy|25|||
16446388|NCT03112603|40115253|FG001|End of Randomization Period|Lack of Efficacy|77|||
16446389|NCT03112603|40115254|FG002|End of Randomization Period|Lack of Efficacy|0|||
16446390|NCT03112603|40115252|FG000|End of Randomization Period|Adverse Event|32|||
16446391|NCT03112603|40115253|FG001|End of Randomization Period|Adverse Event|12|||
16446392|NCT03112603|40115254|FG002|End of Randomization Period|Adverse Event|0|||
16446393|NCT03112603|40115252|FG000|End of Cross Over Period|Death|0|||
16446394|NCT03112603|40115253|FG001|End of Cross Over Period|Death|0|||
16446395|NCT03112603|40115254|FG002|End of Cross Over Period|Death|2|||
16067207|NCT00430677|38736662|FG000|Short-term Period|Withdrawal by Subject|1|||
16067208|NCT00430677|38736663|FG001|Short-term Period|Withdrawal by Subject|1|||
16446396|NCT03112603|40115252|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
16446397|NCT03112603|40115253|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
16446398|NCT03112603|40115254|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
16446399|NCT03112603|40115252|FG000|End of Cross Over Period|Physician Decision|0|||
16446400|NCT03112603|40115253|FG001|End of Cross Over Period|Physician Decision|0|||
16446401|NCT03112603|40115254|FG002|End of Cross Over Period|Physician Decision|29|||
16446402|NCT03112603|40115252|FG000|End of Cross Over Period|Lack of Efficacy|0|||
16446403|NCT03112603|40115253|FG001|End of Cross Over Period|Lack of Efficacy|0|||
16446404|NCT03112603|40115254|FG002|End of Cross Over Period|Lack of Efficacy|8|||
16446405|NCT03112603|40115252|FG000|End of Cross Over Period|Adverse Event|0|||
16067209|NCT00430677|38736664|FG002|Short-term Period|Withdrawal by Subject|2|||
16067210|NCT00430677|38736662|FG000|Short-term Period|Participant no longer met study criteria|1|||
16067211|NCT00430677|38736663|FG001|Short-term Period|Participant no longer met study criteria|1|||
16067212|NCT00430677|38736664|FG002|Short-term Period|Participant no longer met study criteria|2|||
16067213|NCT00430677|38736662|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
16067214|NCT00430677|38736663|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
16067215|NCT00430677|38736664|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
16067216|NCT00430677|38736662|FG000|Short-term Period|Pregnancy|0|||
16067217|NCT00430677|38736663|FG001|Short-term Period|Pregnancy|2|||
16067218|NCT00430677|38736664|FG002|Short-term Period|Pregnancy|0|||
16067219|NCT00430677|38736662|FG000|Long-term Extension Period|Death|1|||
16067220|NCT00430677|38736663|FG001|Long-term Extension Period|Death|0|||
16067221|NCT00430677|38736664|FG002|Long-term Extension Period|Death|0|||
16067222|NCT00430677|38736662|FG000|Long-term Extension Period|Adverse Event|3|||
16067223|NCT00430677|38736663|FG001|Long-term Extension Period|Adverse Event|2|||
16067224|NCT00430677|38736664|FG002|Long-term Extension Period|Adverse Event|5|||
16067225|NCT00430677|38736662|FG000|Long-term Extension Period|Lack of Efficacy|5|||
16067226|NCT00430677|38736663|FG001|Long-term Extension Period|Lack of Efficacy|3|||
16067227|NCT00430677|38736664|FG002|Long-term Extension Period|Lack of Efficacy|8|||
16067228|NCT00430677|38736662|FG000|Long-term Extension Period|Lost to Follow-up|1|||
16067229|NCT00430677|38736663|FG001|Long-term Extension Period|Lost to Follow-up|1|||
16067230|NCT00430677|38736664|FG002|Long-term Extension Period|Lost to Follow-up|1|||
16067231|NCT00430677|38736662|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
16067232|NCT00430677|38736663|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
16067233|NCT00430677|38736664|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
16067234|NCT00430677|38736662|FG000|Long-term Extension Period|Pregnancy|1|||
16067235|NCT00430677|38736663|FG001|Long-term Extension Period|Pregnancy|1|||
16067236|NCT00430677|38736664|FG002|Long-term Extension Period|Pregnancy|0|||
16067237|NCT00430677|38736662|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
16159313|NCT03189446|39065066|FG000|Overall Study|Adverse Event|2|||
16446406|NCT03112603|40115253|FG001|End of Cross Over Period|Adverse Event|0|||
16446407|NCT03112603|40115254|FG002|End of Cross Over Period|Adverse Event|6|||
16446408|NCT03112603|40115252|FG000|End of Cross Over Period|Disease Relapse|0|||
16446409|NCT03112603|40115253|FG001|End of Cross Over Period|Disease Relapse|0|||
16446410|NCT03112603|40115254|FG002|End of Cross Over Period|Disease Relapse|2|||
16446411|NCT01198795|40115259|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
16446412|NCT01198795|40115259|FG000|Overall Study|Withdrawal by Subject|17|||
16446413|NCT01198795|40115259|FG000|Overall Study|Lost to Follow-up|15|||
16446414|NCT01198795|40115259|FG000|Overall Study|Adverse Event|9|||
16446415|NCT01198795|40115259|FG000|Overall Study|Lack of Efficacy|5|||
16446416|NCT01198795|40115259|FG000|Overall Study|Protocol Violation|2|||
16446417|NCT01198795|40115259|FG000|Overall Study|Other Reason|4|||
16446418|NCT00686712|40115260|FG000|Overall Study|Protocol Violation|8|||
16446419|NCT00686712|40115261|FG001|Overall Study|Protocol Violation|8|||
16446420|NCT00686712|40115262|FG002|Overall Study|Protocol Violation|10|||
16446421|NCT00686712|40115260|FG000|Overall Study|Lost to Follow-up|1|||
16446422|NCT00686712|40115261|FG001|Overall Study|Lost to Follow-up|2|||
16446423|NCT00686712|40115262|FG002|Overall Study|Lost to Follow-up|3|||
16446424|NCT00686712|40115260|FG000|Overall Study|Adverse Event|1|||
16446425|NCT00686712|40115261|FG001|Overall Study|Adverse Event|1|||
16446426|NCT00686712|40115262|FG002|Overall Study|Adverse Event|0|||
16446427|NCT00926237|40115274|FG000|Overall Study|Withdrawal by Subject|2|||
16446428|NCT00926237|40115275|FG001|Overall Study|Withdrawal by Subject|1|||
16446429|NCT01001325|40115276|FG000|Overall Study|Lost to Follow-up|16|||
16446430|NCT01001325|40115277|FG001|Overall Study|Lost to Follow-up|10|||
16446431|NCT01001325|40115276|FG000|Overall Study|Protocol Violation|2|||
16446432|NCT01001325|40115277|FG001|Overall Study|Protocol Violation|0|||
16446433|NCT00260533|40115280|FG000|Overall Study|Other|3|||
16446434|NCT00260533|40115281|FG001|Overall Study|Other|3|||
16446435|NCT03873116|40115283|FG000|Part 1|Study drug discontinuation due to rash|0|||
16446436|NCT03873116|40115284|FG001|Part 1|Study drug discontinuation due to rash|0|||
16446437|NCT03873116|40115285|FG002|Part 1|Study drug discontinuation due to rash|0|||
16446438|NCT03873116|40115286|FG003|Part 1|Study drug discontinuation due to rash|0|||
16446439|NCT03873116|40115287|FG004|Part 1|Study drug discontinuation due to rash|0|||
16446440|NCT03873116|40115288|FG005|Part 1|Study drug discontinuation due to rash|1|||
16446441|NCT03873116|40115283|FG000|Part 2|Withdrawal by Subject|0|||
16446442|NCT03873116|40115284|FG001|Part 2|Withdrawal by Subject|0|||
16446443|NCT03873116|40115285|FG002|Part 2|Withdrawal by Subject|1|||
16446444|NCT03873116|40115286|FG003|Part 2|Withdrawal by Subject|0|||
16446445|NCT03873116|40115287|FG004|Part 2|Withdrawal by Subject|0|||
16446446|NCT03873116|40115288|FG005|Part 2|Withdrawal by Subject|0|||
16446447|NCT03873116|40115283|FG000|Part 2|Lab abnormality or AE|0|||
16446448|NCT03873116|40115284|FG001|Part 2|Lab abnormality or AE|0|||
16446449|NCT03873116|40115285|FG002|Part 2|Lab abnormality or AE|0|||
16446450|NCT03873116|40115286|FG003|Part 2|Lab abnormality or AE|0|||
16446451|NCT03873116|40115287|FG004|Part 2|Lab abnormality or AE|1|||
16446452|NCT03873116|40115288|FG005|Part 2|Lab abnormality or AE|0|||
16446453|NCT03873116|40115283|FG000|Part 3|Withdrawal by Subject|0|||
16446454|NCT03873116|40115284|FG001|Part 3|Withdrawal by Subject|0|||
16446455|NCT03873116|40115285|FG002|Part 3|Withdrawal by Subject|0|||
16446456|NCT03873116|40115286|FG003|Part 3|Withdrawal by Subject|0|||
16446457|NCT03873116|40115287|FG004|Part 3|Withdrawal by Subject|1|||
16446458|NCT03873116|40115288|FG005|Part 3|Withdrawal by Subject|0|||
16446459|NCT01207414|40115289|FG000|Overall Study|Adverse Event|25|||
16446460|NCT01207414|40115290|FG001|Overall Study|Adverse Event|39|||
16446461|NCT01207414|40115289|FG000|Overall Study|Abnormal test procedure results|0|||
16446462|NCT01207414|40115290|FG001|Overall Study|Abnormal test procedure results|1|||
16263778|NCT01190930|39449790|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
16263779|NCT01190930|39449791|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
16263780|NCT01190930|39449792|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
16263781|NCT01190930|39449793|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
16263782|NCT01190930|39449794|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
16263783|NCT01190930|39449795|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
16263784|NCT01190930|39449796|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
16263785|NCT01190930|39449797|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
16263786|NCT01190930|39449788|FG000|Maintenance|Relapse|0|||
16263787|NCT01190930|39449789|FG001|Maintenance|Relapse|0|||
16263788|NCT01190930|39449790|FG002|Maintenance|Relapse|0|||
16263789|NCT01190930|39449791|FG003|Maintenance|Relapse|2|||
16446463|NCT01207414|40115289|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
16446464|NCT01207414|40115290|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
16446465|NCT01207414|40115289|FG000|Overall Study|Patient withdrew consent|14|||
16446466|NCT01207414|40115290|FG001|Overall Study|Patient withdrew consent|11|||
16067238|NCT00430677|38736663|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
16446467|NCT01207414|40115289|FG000|Overall Study|Lost to Follow-up|15|||
16446468|NCT01207414|40115290|FG001|Overall Study|Lost to Follow-up|17|||
16446469|NCT01207414|40115289|FG000|Overall Study|Administrative problems|1|||
16446470|NCT01207414|40115290|FG001|Overall Study|Administrative problems|1|||
16446471|NCT01207414|40115289|FG000|Overall Study|Protocol deviation|12|||
16446472|NCT01207414|40115290|FG001|Overall Study|Protocol deviation|9|||
16446473|NCT01207414|40115289|FG000|Overall Study|Randomized in error|1|||
16446474|NCT01207414|40115290|FG001|Overall Study|Randomized in error|0|||
16263790|NCT01190930|39449792|FG004|Maintenance|Relapse|0|||
16446475|NCT04313244|40115295|FG000|Overall Study|Withdrawal of Consent|3|||
16263791|NCT01190930|39449793|FG005|Maintenance|Relapse|1|||
16263792|NCT01190930|39449794|FG006|Maintenance|Relapse|6|||
16263793|NCT01190930|39449795|FG007|Maintenance|Relapse|13|||
16263794|NCT01190930|39449796|FG008|Maintenance|Relapse|11|||
16263795|NCT01190930|39449797|FG009|Maintenance|Relapse|11|||
16263796|NCT01190930|39449788|FG000|Maintenance|Still on therapy|0|||
16263797|NCT01190930|39449789|FG001|Maintenance|Still on therapy|8|||
16263798|NCT01190930|39449790|FG002|Maintenance|Still on therapy|0|||
16263799|NCT01190930|39449791|FG003|Maintenance|Still on therapy|29|||
16263800|NCT01190930|39449792|FG004|Maintenance|Still on therapy|0|||
16263801|NCT01190930|39449793|FG005|Maintenance|Still on therapy|0|||
16263802|NCT01190930|39449794|FG006|Maintenance|Still on therapy|0|||
16263803|NCT01190930|39449795|FG007|Maintenance|Still on therapy|0|||
16263804|NCT01190930|39449796|FG008|Maintenance|Still on therapy|0|||
16263805|NCT01190930|39449797|FG009|Maintenance|Still on therapy|0|||
16263806|NCT01535222|39449804|FG000|Overall Study|Inclusion/exclusion|0|||
16263807|NCT01535222|39449805|FG001|Overall Study|Inclusion/exclusion|0|||
16263808|NCT01535222|39449806|FG002|Overall Study|Inclusion/exclusion|1|||
16263809|NCT01535222|39449807|FG003|Overall Study|Inclusion/exclusion|0|||
16263810|NCT01535222|39449808|FG004|Overall Study|Inclusion/exclusion|0|||
16263811|NCT01535222|39449809|FG005|Overall Study|Inclusion/exclusion|0|||
16263812|NCT02414152|39449810|FG000|Overall Study|Withdrawal by Subject|1|||
16263813|NCT02414152|39449810|FG000|Overall Study|Lack of Efficacy|1|||
16263814|NCT00939003|39449812|FG000|Double-blind Treatment Period|Adverse Event|1|||
16263815|NCT00939003|39449813|FG001|Double-blind Treatment Period|Adverse Event|1|||
16263816|NCT00939003|39449812|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
16263817|NCT00939003|39449813|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
16263818|NCT00939003|39449812|FG000|Double-blind Treatment Period|Pregnancy|0|||
16263819|NCT00939003|39449813|FG001|Double-blind Treatment Period|Pregnancy|1|||
16263820|NCT00939003|39449812|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
16263821|NCT00939003|39449813|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
16263822|NCT00939003|39449812|FG000|Open-label Treatment Period|Adverse Event|4|||
16263823|NCT00939003|39449813|FG001|Open-label Treatment Period|Adverse Event|8|||
16263824|NCT00939003|39449812|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
16263825|NCT00939003|39449813|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
16263826|NCT00939003|39449812|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
16263827|NCT00939003|39449813|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
16263828|NCT00939003|39449812|FG000|Open-label Treatment Period|Pregnancy|1|||
16263829|NCT00939003|39449813|FG001|Open-label Treatment Period|Pregnancy|1|||
16369812|NCT02573467|39839691|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
16369813|NCT02573467|39839692|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
16369814|NCT02573467|39839689|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
16369815|NCT02573467|39839690|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
16369816|NCT02573467|39839691|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
16369817|NCT02573467|39839692|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
16369818|NCT02573467|39839689|FG000|Post-treatment Follow up Epoch|Death|1|||
16369819|NCT02573467|39839690|FG001|Post-treatment Follow up Epoch|Death|1|||
16369820|NCT02573467|39839691|FG002|Post-treatment Follow up Epoch|Death|0|||
16369821|NCT02573467|39839692|FG003|Post-treatment Follow up Epoch|Death|1|||
16369822|NCT02573467|39839689|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
16369823|NCT02573467|39839690|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
16067239|NCT00430677|38736664|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
16067240|NCT00430677|38736662|FG000|Long-term Extension Period|Other|2|||
16067241|NCT00430677|38736663|FG001|Long-term Extension Period|Other|1|||
16067242|NCT00430677|38736664|FG002|Long-term Extension Period|Other|1|||
16067243|NCT00430677|38736662|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
16067244|NCT00430677|38736663|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
16067245|NCT00430677|38736664|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
16067246|NCT02219490|38736665|FG000|Overall Study|Adverse Event|24|||
16067247|NCT02219490|38736665|FG000|Overall Study|Withdrew consent|96|||
16067248|NCT02219490|38736665|FG000|Overall Study|Lost to Follow-up|126|||
16263830|NCT00939003|39449812|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
16263831|NCT00939003|39449813|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
16263832|NCT00939003|39449812|FG000|Open-label Treatment Period|Site Closure|3|||
16263833|NCT00939003|39449813|FG001|Open-label Treatment Period|Site Closure|4|||
16067249|NCT02219490|38736665|FG000|Overall Study|COVID-19 infection|2|||
16067250|NCT02219490|38736665|FG000|Overall Study|COVID-19 logistical restrictions|33|||
16067251|NCT02219490|38736665|FG000|Overall Study|Other, not specified|57|||
16263834|NCT02146105|39449818|FG000|Overall Study|Adverse Event|1|||
16263835|NCT02146105|39449818|FG000|Overall Study|Withdrawal by Subject|5|||
16263836|NCT02832063|39449821|FG000|Overall Study|Adverse Event|2|||
16263837|NCT02832063|39449822|FG001|Overall Study|Adverse Event|1|||
16263838|NCT02832063|39449821|FG000|Overall Study|Physician Decision|5|||
16263839|NCT02832063|39449822|FG001|Overall Study|Physician Decision|7|||
16263840|NCT02832063|39449821|FG000|Overall Study|Lost to Follow-up|15|||
16067252|NCT00569946|38736666|FG000|Overall Study|Adverse Event|16|||
16067253|NCT00569946|38736666|FG000|Overall Study|Objective Progression or Relapse|42|||
16067254|NCT00569946|38736666|FG000|Overall Study|Global Deterioration of Health Status|1|||
16067255|NCT01017120|38736667|FG000|Overall Study|Adverse Event|9|||
16067256|NCT01017120|38736668|FG001|Overall Study|Adverse Event|0|||
16067257|NCT01017120|38736667|FG000|Overall Study|Lost to Follow-up|13|||
16067258|NCT01017120|38736668|FG001|Overall Study|Lost to Follow-up|11|||
16067259|NCT01017120|38736667|FG000|Overall Study|Lack of Efficacy|1|||
16067260|NCT01017120|38736668|FG001|Overall Study|Lack of Efficacy|0|||
16263841|NCT02832063|39449822|FG001|Overall Study|Lost to Follow-up|8|||
16263842|NCT02832063|39449821|FG000|Overall Study|Withdrawal by Subject|10|||
16263843|NCT02832063|39449822|FG001|Overall Study|Withdrawal by Subject|21|||
16263844|NCT02832063|39449821|FG000|Overall Study|Other|2|||
16263845|NCT02832063|39449822|FG001|Overall Study|Other|1|||
16263846|NCT03514017|39453068|FG000|Overall Study|Death|1|||
16446476|NCT04313244|40115296|FG001|Overall Study|Withdrawal of Consent|3|||
16446477|NCT04313244|40115295|FG000|Overall Study|Met Exclusion Criteria|1|||
16446478|NCT04313244|40115296|FG001|Overall Study|Met Exclusion Criteria|0|||
16446479|NCT04313244|40115295|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
16446480|NCT04313244|40115296|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
16446481|NCT02379728|40115297|FG000|Overall Study|Lost to Follow-up|1|||
16446482|NCT02379728|40115298|FG001|Overall Study|Lost to Follow-up|0|||
16446483|NCT02379728|40115299|FG002|Overall Study|Lost to Follow-up|3|||
16446484|NCT02379728|40115300|FG003|Overall Study|Lost to Follow-up|0|||
16446485|NCT02379728|40115297|FG000|Overall Study|Withdrawal by Subject|5|||
16446486|NCT02379728|40115298|FG001|Overall Study|Withdrawal by Subject|0|||
16446487|NCT02379728|40115299|FG002|Overall Study|Withdrawal by Subject|5|||
16067261|NCT01017120|38736667|FG000|Overall Study|Withdrawal by Subject|39|||
16067262|NCT01017120|38736668|FG001|Overall Study|Withdrawal by Subject|21|||
16067263|NCT01017120|38736667|FG000|Overall Study|Pregnancy|1|||
16263847|NCT03514017|39453068|FG000|Overall Study|Adverse Event|1|||
16263848|NCT00773253|39453069|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
16263849|NCT00773253|39453070|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
16263850|NCT03552393|39453071|FG000|Core Period|Kidney Transplant|1|||
16263851|NCT03552393|39453071|FG000|Core Period|Prohibited Medication|1|||
16263852|NCT03552393|39453071|FG000|Safety Extension Period|Kidney Transplant|4|||
16263853|NCT00477594|39453072|FG000|Year 1 and Year 2|Adverse Event|4|||
16263854|NCT00477594|39453073|FG001|Year 1 and Year 2|Adverse Event|2|||
16263855|NCT00477594|39453072|FG000|Year 1 and Year 2|Physician Decision|2|||
16263856|NCT00477594|39453073|FG001|Year 1 and Year 2|Physician Decision|1|||
16263857|NCT00477594|39453072|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
16263858|NCT00477594|39453073|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
16263859|NCT00477594|39453072|FG000|Year 1 and Year 2|Other|1|||
16263860|NCT00477594|39453073|FG001|Year 1 and Year 2|Other|0|||
16263861|NCT00477594|39453072|FG000|Year 3|Adverse Event|1|||
16263862|NCT00477594|39453073|FG001|Year 3|Adverse Event|0|||
16263863|NCT00477594|39453072|FG000|Year 3|Withdrawal by Subject|1|||
16263864|NCT00477594|39453073|FG001|Year 3|Withdrawal by Subject|0|||
16263865|NCT00477594|39453072|FG000|Follow-up Period|Withdrawal by Subject|2|||
16263866|NCT00477594|39453073|FG001|Follow-up Period|Withdrawal by Subject|1|||
16263867|NCT00477594|39453072|FG000|Follow-up Period|Other|1|||
16263868|NCT00477594|39453073|FG001|Follow-up Period|Other|0|||
16263869|NCT03437265|39453074|FG000|Overall Study|Protocol Violation|6|||
16263870|NCT00678639|39453083|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
16263871|NCT00678639|39453084|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
16263872|NCT02436005|39453085|FG000|Second Intervention|Adverse Event|0|||
16369824|NCT02573467|39839691|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
16369825|NCT02573467|39839692|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
16369826|NCT02573467|39839689|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
16369827|NCT02573467|39839690|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
16369828|NCT02573467|39839691|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
16369829|NCT02573467|39839692|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
16369830|NCT01521364|39839703|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
16369831|NCT01521364|39839703|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
16369832|NCT00834587|39839704|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
16369833|NCT00834587|39839705|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
16369834|NCT00356421|39839706|FG000|Overall Study|Lack of Efficacy|3|||
16067264|NCT01017120|38736668|FG001|Overall Study|Pregnancy|1|||
16067265|NCT01017120|38736667|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
16263873|NCT02436005|39453086|FG001|Second Intervention|Adverse Event|1|||
16263874|NCT00787254|39453087|FG000|Overall Study|Adverse Event|24|||
16263875|NCT00787254|39453088|FG001|Overall Study|Adverse Event|23|||
16263876|NCT00787254|39453087|FG000|Overall Study|Protocol Violation|26|||
16369835|NCT00356421|39839707|FG001|Overall Study|Lack of Efficacy|0|||
16446488|NCT02379728|40115300|FG003|Overall Study|Withdrawal by Subject|3|||
16446489|NCT02379728|40115297|FG000|Overall Study|Protocol Violation|0|||
16446490|NCT02379728|40115298|FG001|Overall Study|Protocol Violation|0|||
16263877|NCT00787254|39453088|FG001|Overall Study|Protocol Violation|23|||
16263878|NCT00787254|39453087|FG000|Overall Study|Withdrawal by Subject|16|||
16263879|NCT00787254|39453088|FG001|Overall Study|Withdrawal by Subject|11|||
16263880|NCT00787254|39453087|FG000|Overall Study|Lack of Efficacy|4|||
16263881|NCT00787254|39453088|FG001|Overall Study|Lack of Efficacy|15|||
16263882|NCT00787254|39453087|FG000|Overall Study|NSAIDs discontinuation|1|||
16263883|NCT00787254|39453088|FG001|Overall Study|NSAIDs discontinuation|2|||
16263884|NCT00787254|39453087|FG000|Overall Study|Institution closed|1|||
16263885|NCT00787254|39453088|FG001|Overall Study|Institution closed|0|||
16263886|NCT00787254|39453087|FG000|Overall Study|Physician Decision|4|||
16263887|NCT00787254|39453088|FG001|Overall Study|Physician Decision|8|||
16263888|NCT02321098|39453092|FG000|12 Weeks Treament|Lost to Follow-up|1|||
16263889|NCT02321098|39453093|FG001|12 Weeks Treament|Lost to Follow-up|1|||
16369836|NCT00356421|39839706|FG000|Overall Study|Withdrawal by Subject|9|||
16369837|NCT00356421|39839707|FG001|Overall Study|Withdrawal by Subject|2|||
16159314|NCT03189446|39065066|FG000|Overall Study|Withdrawal by Subject|2|||
16159315|NCT03189446|39065066|FG000|Overall Study|Physician Decision|1|||
16159316|NCT03084536|39065067|FG000|Overall Study|Determined to be ineligible|0|||
16159317|NCT03084536|39065068|FG001|Overall Study|Determined to be ineligible|0|||
16263890|NCT02321098|39453094|FG002|12 Weeks Treament|Lost to Follow-up|0|||
16369838|NCT00356421|39839706|FG000|Overall Study|Related to study drug|15|||
16446491|NCT02379728|40115299|FG002|Overall Study|Protocol Violation|2|||
16446492|NCT02379728|40115300|FG003|Overall Study|Protocol Violation|0|||
16369839|NCT00356421|39839707|FG001|Overall Study|Related to study drug|12|||
16369840|NCT00356421|39839706|FG000|Overall Study|Not related to study drug|5|||
16369841|NCT00356421|39839707|FG001|Overall Study|Not related to study drug|3|||
16369842|NCT03418675|39839709|FG000|Overall Study|Lost to Follow-up|13|||
16369843|NCT03418675|39839710|FG001|Overall Study|Lost to Follow-up|10|||
16369844|NCT03418675|39839709|FG000|Overall Study|Adverse Event|2|||
16369845|NCT03418675|39839710|FG001|Overall Study|Adverse Event|0|||
16369846|NCT01699685|39839711|FG000|Period 1|Adverse Event|1|||
16369847|NCT01699685|39839712|FG001|Period 1|Adverse Event|1|||
16369848|NCT01699685|39839711|FG000|Period 1|Medical or ethical, noncompliance|2|||
16369849|NCT01699685|39839712|FG001|Period 1|Medical or ethical, noncompliance|0|||
16369850|NCT01699685|39839711|FG000|Period 1|Other|0|||
16369851|NCT01699685|39839712|FG001|Period 1|Other|1|||
16369852|NCT01699685|39839711|FG000|Period 1|Patient request|0|||
16369853|NCT01699685|39839712|FG001|Period 1|Patient request|1|||
16369854|NCT01699685|39839711|FG000|Period 2|Lost to Follow-up|1|||
16369855|NCT01699685|39839712|FG001|Period 2|Lost to Follow-up|0|||
16369856|NCT01208051|39839716|FG000|Total Enrollment|Withdrawal by Subject|0|||
16369857|NCT01208051|39839717|FG001|Total Enrollment|Withdrawal by Subject|1|||
16369858|NCT01208051|39839718|FG002|Total Enrollment|Withdrawal by Subject|0|||
16369859|NCT01208051|39839719|FG003|Total Enrollment|Withdrawal by Subject|0|||
16369860|NCT01208051|39839720|FG004|Total Enrollment|Withdrawal by Subject|2|||
16446493|NCT02220920|40115301|FG000|Overall Study|Adverse Event|1|||
16067266|NCT01017120|38736668|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
16067267|NCT01017120|38736667|FG000|Overall Study|Relocated Out of Town|0|||
16067268|NCT01017120|38736668|FG001|Overall Study|Relocated Out of Town|2|||
16067269|NCT01017120|38736667|FG000|Overall Study|Protocol Violation|1|||
16067270|NCT01017120|38736668|FG001|Overall Study|Protocol Violation|0|||
16067271|NCT01017120|38736667|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
16067272|NCT01017120|38736668|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
16067273|NCT03829332|38736669|FG000|Overall Study|Death|145|||
16067274|NCT03829332|38736670|FG001|Overall Study|Death|135|||
16067275|NCT03829332|38736669|FG000|Overall Study|Withdrawal by Subject|10|||
16067276|NCT03829332|38736670|FG001|Overall Study|Withdrawal by Subject|4|||
16067277|NCT03829332|38736669|FG000|Overall Study|Ongoing in Study|154|||
16067278|NCT03829332|38736670|FG001|Overall Study|Ongoing in Study|175|||
16067279|NCT00712166|38739409|FG000|Overall Study|Noncompliance|0|||
16067280|NCT00712166|38739410|FG001|Overall Study|Noncompliance|1|||
16067281|NCT04531540|38739414|FG000|Overall Study|Adverse Event|1|||
16067282|NCT04531540|38739414|FG000|Overall Study|Protocol Violation|3|||
16067283|NCT04531540|38739414|FG000|Overall Study|Withdrawal by Subject|4|||
16067284|NCT04531540|38739414|FG000|Overall Study|Found to be Ineligible|1|||
16067285|NCT00881335|38739420|FG000|Overall Study|Lost to Follow-up|3|||
16067286|NCT00881335|38739421|FG001|Overall Study|Lost to Follow-up|2|||
16067287|NCT02724878|38739422|FG000|Overall Study|Still on Active Therapy|15|||
16159318|NCT03084536|39065069|FG002|Overall Study|Determined to be ineligible|16|||
16263891|NCT02321098|39453092|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
16159319|NCT03084536|39065067|FG000|Overall Study|Withdrawal by Subject|0|||
16369861|NCT01208051|39839716|FG000|Total Enrollment|Brain metastases|0|||
16369862|NCT01208051|39839717|FG001|Total Enrollment|Brain metastases|0|||
16369863|NCT01208051|39839718|FG002|Total Enrollment|Brain metastases|1|||
16067288|NCT02724878|38739422|FG000|Overall Study|Disease Progression|31|||
16067289|NCT02724878|38739422|FG000|Overall Study|Toxicity|5|||
16263892|NCT02321098|39453093|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
16067290|NCT02724878|38739422|FG000|Overall Study|Death|1|||
16446494|NCT02220920|40115302|FG001|Overall Study|Adverse Event|0|||
16159320|NCT03084536|39065068|FG001|Overall Study|Withdrawal by Subject|0|||
16159321|NCT03084536|39065069|FG002|Overall Study|Withdrawal by Subject|4|||
16159322|NCT03084536|39065067|FG000|Overall Study|Physician Decision|0|||
16159323|NCT03084536|39065068|FG001|Overall Study|Physician Decision|0|||
16159324|NCT03084536|39065069|FG002|Overall Study|Physician Decision|3|||
16159325|NCT03084536|39065067|FG000|Overall Study|Death|0|||
16159326|NCT03084536|39065068|FG001|Overall Study|Death|0|||
16159327|NCT03084536|39065069|FG002|Overall Study|Death|1|||
16159328|NCT03084536|39065067|FG000|Overall Study|Lost to Follow-up|0|||
16067291|NCT02724878|38739422|FG000|Overall Study|Withdrawal by Subject|4|||
16067292|NCT02724878|38739422|FG000|Overall Study|Lost to Follow-up|2|||
16067293|NCT02724878|38739422|FG000|Overall Study|Protocol Violation|1|||
16067294|NCT02724878|38739422|FG000|Overall Study|Ineligible for Study Drug|5|||
16067295|NCT02724878|38739422|FG000|Overall Study|not started|1|||
16067296|NCT01684046|38739423|FG000|Period 1, First 30 Days|Adverse Event|0|||
16067297|NCT01684046|38739424|FG001|Period 1, First 30 Days|Adverse Event|2|||
16067298|NCT00349908|38739425|FG000|Overall Study|Withdrawal by Subject|0|||
16067299|NCT00349908|38739426|FG001|Overall Study|Withdrawal by Subject|4|||
16067300|NCT03239210|38739427|FG000|Overall Study|Lost to Follow-up|2|||
16067301|NCT03239210|38739428|FG001|Overall Study|Lost to Follow-up|2|||
16067302|NCT03239210|38739427|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
16067303|NCT03239210|38739428|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
16067304|NCT03239210|38739427|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
16067305|NCT03239210|38739428|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
16067306|NCT01345292|38739429|FG000|Overall Study|Withdrawal by Subject|2|||
16067307|NCT01345292|38739430|FG001|Overall Study|Withdrawal by Subject|0|||
16067308|NCT01345292|38739431|FG002|Overall Study|Withdrawal by Subject|1|||
16067309|NCT03722446|38739432|FG000|Overall Study|Protocol Violation|15|||
16067310|NCT03722446|38739433|FG001|Overall Study|Protocol Violation|2|||
16067311|NCT02377362|38739434|FG000|Part A Second Treatment|Protocol Violation|0|||
16067312|NCT02377362|38739435|FG001|Part A Second Treatment|Protocol Violation|0|||
16067313|NCT02377362|38739436|FG002|Part A Second Treatment|Protocol Violation|0|||
16067314|NCT02377362|38739437|FG003|Part A Second Treatment|Protocol Violation|0|||
16067315|NCT02377362|38739438|FG004|Part A Second Treatment|Protocol Violation|1|||
16067316|NCT02377362|38739439|FG005|Part A Second Treatment|Protocol Violation|0|||
16067317|NCT02377362|38739440|FG006|Part A Second Treatment|Protocol Violation|0|||
16067318|NCT02377362|38739441|FG007|Part A Second Treatment|Protocol Violation|0|||
16067319|NCT02377362|38739442|FG008|Part A Second Treatment|Protocol Violation|0|||
16067320|NCT02377362|38739443|FG009|Part A Second Treatment|Protocol Violation|0|||
16067321|NCT02377362|38739444|FG010|Part A Second Treatment|Protocol Violation|0|||
16067322|NCT02377362|38739445|FG011|Part A Second Treatment|Protocol Violation|0|||
16067323|NCT02377362|38739446|FG012|Part A Second Treatment|Protocol Violation|0|||
16067324|NCT02377362|38739434|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
16067325|NCT02377362|38739435|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
16067326|NCT02377362|38739436|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
16067327|NCT02377362|38739437|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
16067328|NCT02377362|38739438|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
16067329|NCT02377362|38739439|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
16067330|NCT02377362|38739440|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
16067331|NCT02377362|38739441|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
16067332|NCT02377362|38739442|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
16067333|NCT02377362|38739443|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
16067334|NCT02377362|38739444|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
16067335|NCT02377362|38739445|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
16067336|NCT02377362|38739446|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
16067337|NCT02377362|38739434|FG000|Part B Overall|Protocol Violation|0|||
16067338|NCT02377362|38739435|FG001|Part B Overall|Protocol Violation|0|||
16067339|NCT02377362|38739436|FG002|Part B Overall|Protocol Violation|0|||
16067340|NCT02377362|38739437|FG003|Part B Overall|Protocol Violation|0|||
16067341|NCT02377362|38739438|FG004|Part B Overall|Protocol Violation|0|||
16067342|NCT02377362|38739439|FG005|Part B Overall|Protocol Violation|0|||
16067343|NCT02377362|38739440|FG006|Part B Overall|Protocol Violation|0|||
16067344|NCT02377362|38739441|FG007|Part B Overall|Protocol Violation|0|||
16067345|NCT02377362|38739442|FG008|Part B Overall|Protocol Violation|0|||
16067346|NCT02377362|38739443|FG009|Part B Overall|Protocol Violation|1|||
16067347|NCT02377362|38739444|FG010|Part B Overall|Protocol Violation|0|||
16067348|NCT02377362|38739445|FG011|Part B Overall|Protocol Violation|0|||
16067349|NCT02377362|38739446|FG012|Part B Overall|Protocol Violation|0|||
16067350|NCT02377362|38739434|FG000|Part B Overall|Adverse Event|0|||
16067351|NCT02377362|38739435|FG001|Part B Overall|Adverse Event|0|||
16159329|NCT03084536|39065068|FG001|Overall Study|Lost to Follow-up|0|||
16159330|NCT03084536|39065069|FG002|Overall Study|Lost to Follow-up|1|||
16159331|NCT03084536|39065067|FG000|Overall Study|Protocol Violation|0|||
16067352|NCT02377362|38739436|FG002|Part B Overall|Adverse Event|0|||
16067353|NCT02377362|38739437|FG003|Part B Overall|Adverse Event|0|||
16067354|NCT02377362|38739438|FG004|Part B Overall|Adverse Event|0|||
16067355|NCT02377362|38739439|FG005|Part B Overall|Adverse Event|0|||
16067356|NCT02377362|38739440|FG006|Part B Overall|Adverse Event|1|||
16067357|NCT02377362|38739441|FG007|Part B Overall|Adverse Event|1|||
16067358|NCT02377362|38739442|FG008|Part B Overall|Adverse Event|0|||
16067359|NCT02377362|38739443|FG009|Part B Overall|Adverse Event|0|||
16067360|NCT02377362|38739444|FG010|Part B Overall|Adverse Event|0|||
16067361|NCT02377362|38739445|FG011|Part B Overall|Adverse Event|0|||
16067362|NCT02377362|38739446|FG012|Part B Overall|Adverse Event|0|||
16067363|NCT02377362|38739434|FG000|Part B Overall|Withdrawal by Subject|0|||
16067364|NCT02377362|38739435|FG001|Part B Overall|Withdrawal by Subject|0|||
16067365|NCT02377362|38739436|FG002|Part B Overall|Withdrawal by Subject|0|||
16067366|NCT02377362|38739437|FG003|Part B Overall|Withdrawal by Subject|0|||
16067367|NCT02377362|38739438|FG004|Part B Overall|Withdrawal by Subject|0|||
16067368|NCT02377362|38739439|FG005|Part B Overall|Withdrawal by Subject|0|||
16067369|NCT02377362|38739440|FG006|Part B Overall|Withdrawal by Subject|1|||
16067370|NCT02377362|38739441|FG007|Part B Overall|Withdrawal by Subject|0|||
16067371|NCT02377362|38739442|FG008|Part B Overall|Withdrawal by Subject|0|||
16067372|NCT02377362|38739443|FG009|Part B Overall|Withdrawal by Subject|0|||
16067373|NCT02377362|38739444|FG010|Part B Overall|Withdrawal by Subject|0|||
16067374|NCT02377362|38739445|FG011|Part B Overall|Withdrawal by Subject|1|||
16067375|NCT02377362|38739446|FG012|Part B Overall|Withdrawal by Subject|0|||
16067376|NCT00594932|38739448|FG000|First 3 Months|Withdrawal by Subject|1|||
16067377|NCT00594932|38739449|FG001|First 3 Months|Withdrawal by Subject|3|||
16067378|NCT00594932|38739448|FG000|Final 3 Months|Withdrawal by Subject|4|||
16067379|NCT00594932|38739449|FG001|Final 3 Months|Withdrawal by Subject|3|||
16446495|NCT02220920|40115301|FG000|Overall Study|Lack of Efficacy|0|||
16446496|NCT02220920|40115302|FG001|Overall Study|Lack of Efficacy|1|||
16446497|NCT02220920|40115301|FG000|Overall Study|Withdrawal by Subject|1|||
16446498|NCT02220920|40115302|FG001|Overall Study|Withdrawal by Subject|0|||
16446499|NCT02220920|40115301|FG000|Overall Study|Conflict with the stopping criteria|1|||
16446500|NCT02220920|40115302|FG001|Overall Study|Conflict with the stopping criteria|2|||
16446501|NCT00928408|40115303|FG000|Overall Study|Other|2|||
16446502|NCT00928408|40115303|FG000|Overall Study|Withdrawal by Subject|4|||
16446503|NCT00928408|40115303|FG000|Overall Study|Death|5|||
16446504|NCT00928408|40115303|FG000|Overall Study|Lost to Follow-up|12|||
16446505|NCT01553084|40115304|FG000|Overall Study|Withdrawal by Subject|15|||
16446506|NCT01553084|40115305|FG001|Overall Study|Withdrawal by Subject|13|||
16446507|NCT01553084|40115306|FG002|Overall Study|Withdrawal by Subject|35|||
16446508|NCT02491684|40115307|FG000|Treatment Phase|Adverse Event|2|||
16446509|NCT02491684|40115308|FG001|Treatment Phase|Adverse Event|2|||
16446510|NCT02491684|40115307|FG000|Treatment Phase|Incorrect randomisation|1|||
16446511|NCT02491684|40115308|FG001|Treatment Phase|Incorrect randomisation|0|||
16446512|NCT02491684|40115307|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
16446513|NCT02491684|40115308|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
16446514|NCT04177823|40115309|FG000|Overall Study|Physician Decision|1|||
16446515|NCT04177823|40115309|FG000|Overall Study|Withdrawal by Subject|1|||
16446516|NCT01310777|40115313|FG000|Overall Study|Adverse Event|23|||
16446517|NCT01310777|40115314|FG001|Overall Study|Adverse Event|1|||
16446518|NCT01310777|40115315|FG002|Overall Study|Adverse Event|15|||
16446519|NCT01310777|40115313|FG000|Overall Study|Lost to Follow-up|0|||
16446520|NCT01310777|40115314|FG001|Overall Study|Lost to Follow-up|4|||
16067380|NCT00991276|38739454|FG000|First Intervention Period|Adverse Event|0|||
16067381|NCT00991276|38739455|FG001|First Intervention Period|Adverse Event|1|||
16067382|NCT00991276|38739456|FG002|First Intervention Period|Adverse Event|0|||
16067383|NCT00991276|38739457|FG003|First Intervention Period|Adverse Event|1|||
16067384|NCT00991276|38739458|FG004|First Intervention Period|Adverse Event|0|||
16067385|NCT00991276|38739459|FG005|First Intervention Period|Adverse Event|0|||
16067386|NCT00991276|38739454|FG000|First Intervention Period|Protocol Violation|0|||
16067387|NCT00991276|38739455|FG001|First Intervention Period|Protocol Violation|0|||
16067388|NCT00991276|38739456|FG002|First Intervention Period|Protocol Violation|0|||
16067389|NCT00991276|38739457|FG003|First Intervention Period|Protocol Violation|0|||
16067390|NCT00991276|38739458|FG004|First Intervention Period|Protocol Violation|2|||
16446521|NCT01310777|40115315|FG002|Overall Study|Lost to Follow-up|1|||
16067391|NCT00991276|38739459|FG005|First Intervention Period|Protocol Violation|0|||
16067392|NCT00991276|38739454|FG000|First Intervention Period|Insufficient clinical response|0|||
16067393|NCT00991276|38739455|FG001|First Intervention Period|Insufficient clinical response|0|||
16067394|NCT00991276|38739456|FG002|First Intervention Period|Insufficient clinical response|0|||
16067395|NCT00991276|38739457|FG003|First Intervention Period|Insufficient clinical response|0|||
16067396|NCT00991276|38739458|FG004|First Intervention Period|Insufficient clinical response|1|||
16067397|NCT00991276|38739459|FG005|First Intervention Period|Insufficient clinical response|0|||
16446522|NCT01310777|40115313|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
16446523|NCT01310777|40115314|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
16446524|NCT01310777|40115315|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
16446525|NCT01310777|40115313|FG000|Overall Study|Inadequate Control of IOP|5|||
16446526|NCT01310777|40115314|FG001|Overall Study|Inadequate Control of IOP|7|||
16446527|NCT01310777|40115315|FG002|Overall Study|Inadequate Control of IOP|10|||
16446528|NCT01310777|40115313|FG000|Overall Study|Other|4|||
16446529|NCT01310777|40115314|FG001|Overall Study|Other|1|||
16446530|NCT01310777|40115315|FG002|Overall Study|Other|2|||
16446531|NCT02651675|40115316|FG000|Overall Study|Death|0|||
16446532|NCT02651675|40115317|FG001|Overall Study|Death|0|||
16446533|NCT02651675|40115318|FG002|Overall Study|Death|1|||
16446534|NCT00918255|40115320|FG000|Overall Study|Adverse Event|1|||
16446535|NCT00918255|40115321|FG001|Overall Study|Adverse Event|0|||
16446536|NCT00918255|40115322|FG002|Overall Study|Adverse Event|0|||
16067398|NCT00991276|38739454|FG000|First Intervention Period|Other|0|||
16067399|NCT00991276|38739455|FG001|First Intervention Period|Other|0|||
16067400|NCT00991276|38739456|FG002|First Intervention Period|Other|0|||
16159332|NCT03084536|39065068|FG001|Overall Study|Protocol Violation|0|||
16446537|NCT00918255|40115320|FG000|Overall Study|Withdrawal by Subject|1|||
16446538|NCT00918255|40115321|FG001|Overall Study|Withdrawal by Subject|0|||
16446539|NCT00918255|40115322|FG002|Overall Study|Withdrawal by Subject|2|||
16446540|NCT00918255|40115320|FG000|Overall Study|Lack of Efficacy|1|||
16446541|NCT00918255|40115321|FG001|Overall Study|Lack of Efficacy|0|||
16446542|NCT00918255|40115322|FG002|Overall Study|Lack of Efficacy|0|||
16446543|NCT00918255|40115320|FG000|Overall Study|Lost to Follow-up|1|||
16446544|NCT00918255|40115321|FG001|Overall Study|Lost to Follow-up|0|||
16446545|NCT00918255|40115322|FG002|Overall Study|Lost to Follow-up|2|||
16446546|NCT00918255|40115320|FG000|Overall Study|Exceeded allowed number of interventions|0|||
16446547|NCT00918255|40115321|FG001|Overall Study|Exceeded allowed number of interventions|0|||
16446548|NCT00918255|40115322|FG002|Overall Study|Exceeded allowed number of interventions|1|||
16446549|NCT00918255|40115320|FG000|Overall Study|Non-compliance|1|||
16446550|NCT00918255|40115321|FG001|Overall Study|Non-compliance|0|||
16446551|NCT00918255|40115322|FG002|Overall Study|Non-compliance|0|||
16446552|NCT00918255|40115320|FG000|Overall Study|Investigator discretion|1|||
16446553|NCT00918255|40115321|FG001|Overall Study|Investigator discretion|0|||
16446554|NCT00918255|40115322|FG002|Overall Study|Investigator discretion|0|||
16446555|NCT00389610|40115323|FG000|Overall Study|Disease Progression|0|||
16446556|NCT00389610|40115324|FG001|Overall Study|Disease Progression|19|||
16446557|NCT00389610|40115323|FG000|Overall Study|Death|0|||
16446558|NCT00389610|40115324|FG001|Overall Study|Death|1|||
16446559|NCT00389610|40115323|FG000|Overall Study|Physician Decision|0|||
16446560|NCT00389610|40115324|FG001|Overall Study|Physician Decision|1|||
16159333|NCT03084536|39065069|FG002|Overall Study|Protocol Violation|1|||
16159334|NCT03084536|39065067|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
16159335|NCT03084536|39065068|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
16159336|NCT03084536|39065069|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
16159337|NCT01844895|39065070|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
16159338|NCT01844895|39065070|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
16159339|NCT01844895|39065070|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
16159340|NCT01844895|39065070|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
16159341|NCT01844895|39065070|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
16159342|NCT01844895|39065070|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
16067401|NCT00991276|38739457|FG003|First Intervention Period|Other|1|||
16067402|NCT00991276|38739458|FG004|First Intervention Period|Other|1|||
16067403|NCT00991276|38739459|FG005|First Intervention Period|Other|0|||
16159343|NCT01844895|39065070|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
16159344|NCT00730639|39065071|FG000|Overall Study|Adverse Event|3|||
16159345|NCT00730639|39065072|FG001|Overall Study|Adverse Event|0|||
16159346|NCT00730639|39065073|FG002|Overall Study|Adverse Event|9|||
16159347|NCT00730639|39065074|FG003|Overall Study|Adverse Event|8|||
16159348|NCT00730639|39065075|FG004|Overall Study|Adverse Event|23|||
16159349|NCT00730639|39065071|FG000|Overall Study|Complete Response|0|||
16159350|NCT00730639|39065072|FG001|Overall Study|Complete Response|0|||
16159351|NCT00730639|39065073|FG002|Overall Study|Complete Response|2|||
16446561|NCT00389610|40115323|FG000|Overall Study|Withdrawal by Subject|0|||
16446562|NCT00389610|40115324|FG001|Overall Study|Withdrawal by Subject|1|||
16446563|NCT01668784|40115325|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
16446564|NCT01668784|40115326|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
16446565|NCT01668784|40115325|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
16446566|NCT01668784|40115326|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
16446567|NCT01668784|40115325|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
16067404|NCT00991276|38739454|FG000|First Intervention Period|Withdrawal by Subject|0|||
16446568|NCT01668784|40115326|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
16067405|NCT00991276|38739455|FG001|First Intervention Period|Withdrawal by Subject|1|||
16159352|NCT00730639|39065074|FG003|Overall Study|Complete Response|2|||
16159353|NCT00730639|39065075|FG004|Overall Study|Complete Response|1|||
16159354|NCT00730639|39065071|FG000|Overall Study|Completed Maximum Cycles|0|||
16067406|NCT00991276|38739456|FG002|First Intervention Period|Withdrawal by Subject|0|||
16067407|NCT00991276|38739457|FG003|First Intervention Period|Withdrawal by Subject|1|||
16067408|NCT00991276|38739458|FG004|First Intervention Period|Withdrawal by Subject|0|||
16067409|NCT00991276|38739459|FG005|First Intervention Period|Withdrawal by Subject|1|||
16067410|NCT00991276|38739454|FG000|First Intervention Period|Lost to Follow-up|0|||
16067411|NCT00991276|38739455|FG001|First Intervention Period|Lost to Follow-up|1|||
16067412|NCT00991276|38739456|FG002|First Intervention Period|Lost to Follow-up|0|||
16067413|NCT00991276|38739457|FG003|First Intervention Period|Lost to Follow-up|1|||
16067414|NCT00991276|38739458|FG004|First Intervention Period|Lost to Follow-up|0|||
16067415|NCT00991276|38739459|FG005|First Intervention Period|Lost to Follow-up|0|||
16067416|NCT00991276|38739454|FG000|Second Intervention Period|Adverse Event|0|||
16067417|NCT00991276|38739455|FG001|Second Intervention Period|Adverse Event|2|||
16067418|NCT00991276|38739456|FG002|Second Intervention Period|Adverse Event|0|||
16067419|NCT00991276|38739457|FG003|Second Intervention Period|Adverse Event|1|||
16067420|NCT00991276|38739458|FG004|Second Intervention Period|Adverse Event|1|||
16067421|NCT00991276|38739459|FG005|Second Intervention Period|Adverse Event|0|||
16067422|NCT00991276|38739454|FG000|Second Intervention Period|Protocol Violation|1|||
16067423|NCT00991276|38739455|FG001|Second Intervention Period|Protocol Violation|0|||
16067424|NCT00991276|38739456|FG002|Second Intervention Period|Protocol Violation|0|||
16067425|NCT00991276|38739457|FG003|Second Intervention Period|Protocol Violation|0|||
16067426|NCT00991276|38739458|FG004|Second Intervention Period|Protocol Violation|0|||
16067427|NCT00991276|38739459|FG005|Second Intervention Period|Protocol Violation|0|||
16067428|NCT00991276|38739454|FG000|Second Intervention Period|Other|0|||
16067429|NCT00991276|38739455|FG001|Second Intervention Period|Other|0|||
16067430|NCT00991276|38739456|FG002|Second Intervention Period|Other|0|||
16067431|NCT00991276|38739457|FG003|Second Intervention Period|Other|1|||
16067432|NCT00991276|38739458|FG004|Second Intervention Period|Other|0|||
16067433|NCT00991276|38739459|FG005|Second Intervention Period|Other|1|||
16067434|NCT00991276|38739454|FG000|Third Intervention Period|Protocol Violation|1|||
16067435|NCT00991276|38739455|FG001|Third Intervention Period|Protocol Violation|0|||
16067436|NCT00991276|38739456|FG002|Third Intervention Period|Protocol Violation|0|||
16067437|NCT00991276|38739457|FG003|Third Intervention Period|Protocol Violation|0|||
16067438|NCT00991276|38739458|FG004|Third Intervention Period|Protocol Violation|0|||
16067439|NCT00991276|38739459|FG005|Third Intervention Period|Protocol Violation|0|||
16067440|NCT00991276|38739454|FG000|Third Intervention Period|Other|0|||
16067441|NCT00991276|38739455|FG001|Third Intervention Period|Other|0|||
16067442|NCT00991276|38739456|FG002|Third Intervention Period|Other|0|||
16067443|NCT00991276|38739457|FG003|Third Intervention Period|Other|0|||
16067444|NCT00991276|38739458|FG004|Third Intervention Period|Other|0|||
16067445|NCT00991276|38739459|FG005|Third Intervention Period|Other|1|||
16067446|NCT00991276|38739454|FG000|Third Intervention Period|Adverse Event|0|||
16067447|NCT00991276|38739455|FG001|Third Intervention Period|Adverse Event|0|||
16067448|NCT00991276|38739456|FG002|Third Intervention Period|Adverse Event|1|||
16067449|NCT00991276|38739457|FG003|Third Intervention Period|Adverse Event|0|||
16067450|NCT00991276|38739458|FG004|Third Intervention Period|Adverse Event|0|||
16067451|NCT00991276|38739459|FG005|Third Intervention Period|Adverse Event|0|||
16067452|NCT00991276|38739454|FG000|Third Intervention Period|Withdrawal by Subject|0|||
16067453|NCT00991276|38739455|FG001|Third Intervention Period|Withdrawal by Subject|0|||
16067454|NCT00991276|38739456|FG002|Third Intervention Period|Withdrawal by Subject|0|||
16067455|NCT00991276|38739457|FG003|Third Intervention Period|Withdrawal by Subject|1|||
16067456|NCT00991276|38739458|FG004|Third Intervention Period|Withdrawal by Subject|0|||
16067457|NCT00991276|38739459|FG005|Third Intervention Period|Withdrawal by Subject|0|||
16067458|NCT01027286|38739460|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
16067459|NCT01027286|38739461|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
16067460|NCT01027286|38739460|FG000|Overall Study|Lost to Follow-up|0|||
16067461|NCT01027286|38739461|FG001|Overall Study|Lost to Follow-up|1|||
16067462|NCT03383887|38739462|FG000|Overall Study|Lost to Follow-up|0|||
16067463|NCT03383887|38739463|FG001|Overall Study|Lost to Follow-up|1|||
16067464|NCT00995709|38739464|FG000|Overall Study|Adverse Event|4|||
16067465|NCT00995709|38739465|FG001|Overall Study|Adverse Event|2|||
16067466|NCT00995709|38739466|FG002|Overall Study|Adverse Event|0|||
16067467|NCT00995709|38739464|FG000|Overall Study|Lack of Efficacy|0|||
16067468|NCT00995709|38739465|FG001|Overall Study|Lack of Efficacy|1|||
16067469|NCT00995709|38739466|FG002|Overall Study|Lack of Efficacy|4|||
16067470|NCT00995709|38739464|FG000|Overall Study|Withdrawal by Subject|0|||
16067471|NCT00995709|38739465|FG001|Overall Study|Withdrawal by Subject|4|||
16067472|NCT00995709|38739466|FG002|Overall Study|Withdrawal by Subject|1|||
16067473|NCT00995709|38739464|FG000|Overall Study|Lost to Follow-up|1|||
16067474|NCT00995709|38739465|FG001|Overall Study|Lost to Follow-up|0|||
16067475|NCT00995709|38739466|FG002|Overall Study|Lost to Follow-up|0|||
16067476|NCT00995709|38739464|FG000|Overall Study|Death|0|||
16067477|NCT00995709|38739465|FG001|Overall Study|Death|1|||
16067478|NCT00995709|38739466|FG002|Overall Study|Death|0|||
16067479|NCT00995709|38739464|FG000|Overall Study|Protocol Violation|2|||
16263893|NCT02321098|39453094|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
16067480|NCT00995709|38739465|FG001|Overall Study|Protocol Violation|1|||
16067481|NCT00995709|38739466|FG002|Overall Study|Protocol Violation|0|||
16067482|NCT00613301|38739471|FG000|Overall Study|Adverse Event|49|||
16067483|NCT00613301|38739471|FG000|Overall Study|Lost to Follow-up|88|||
16067484|NCT00613301|38739471|FG000|Overall Study|Withdrawal by Subject|5|||
16067485|NCT00613301|38739471|FG000|Overall Study|Death|6|||
16067486|NCT00613301|38739471|FG000|Overall Study|Lack of Efficacy|13|||
16067487|NCT00613301|38739471|FG000|Overall Study|Physician Decision|2|||
16067488|NCT00613301|38739471|FG000|Overall Study|No data was collected|53|||
16067489|NCT00613301|38739471|FG000|Overall Study|Irregularly enrolled patients|12|||
16067490|NCT01094171|38739478|FG000|Overall Study|Lost to Follow-up|2|||
16067491|NCT01094171|38739478|FG000|Overall Study|Informed consent withdrawal|4|||
16067492|NCT01094171|38739478|FG000|Overall Study|Migration from the study area|3|||
16067493|NCT01094171|38739478|FG000|Overall Study|Other|1|||
16067494|NCT02138916|38739486|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
16067495|NCT02138916|38739487|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
16067496|NCT02138916|38739488|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
16067497|NCT02138916|38739486|FG000|Overall Study|Death|14|||
16067498|NCT02138916|38739487|FG001|Overall Study|Death|11|||
16067499|NCT02138916|38739488|FG002|Overall Study|Death|12|||
16159355|NCT00730639|39065072|FG001|Overall Study|Completed Maximum Cycles|0|||
16159356|NCT00730639|39065073|FG002|Overall Study|Completed Maximum Cycles|11|||
16159357|NCT00730639|39065074|FG003|Overall Study|Completed Maximum Cycles|3|||
16159358|NCT00730639|39065075|FG004|Overall Study|Completed Maximum Cycles|6|||
16446569|NCT01668784|40115325|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
16446570|NCT01668784|40115326|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
16446571|NCT01668784|40115325|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
16446572|NCT01668784|40115326|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
16446573|NCT01668784|40115325|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
16446574|NCT01668784|40115326|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
16446575|NCT01668784|40115325|FG000|Treatment Period|Disease Progression|316|||
16446576|NCT01668784|40115326|FG001|Treatment Period|Disease Progression|293|||
16446577|NCT01668784|40115325|FG000|Treatment Period|Study Drug Toxicity|46|||
16446578|NCT01668784|40115326|FG001|Treatment Period|Study Drug Toxicity|53|||
16446579|NCT01668784|40115325|FG000|Treatment Period|Death|1|||
16446580|NCT01668784|40115326|FG001|Treatment Period|Death|1|||
16446581|NCT01668784|40115325|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
16446582|NCT01668784|40115326|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
16446583|NCT01668784|40115325|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
16446584|NCT01668784|40115326|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
16446585|NCT01668784|40115325|FG000|Treatment Period|Withdrawal by Subject|5|||
16446586|NCT01668784|40115326|FG001|Treatment Period|Withdrawal by Subject|3|||
16446587|NCT01668784|40115325|FG000|Treatment Period|Maximal Clinical Benefit|3|||
16446588|NCT01668784|40115326|FG001|Treatment Period|Maximal Clinical Benefit|3|||
16446589|NCT01668784|40115325|FG000|Treatment Period|Other|2|||
16446590|NCT01668784|40115326|FG001|Treatment Period|Other|8|||
16159359|NCT00730639|39065071|FG000|Overall Study|Death|0|||
16159360|NCT00730639|39065072|FG001|Overall Study|Death|0|||
16159361|NCT00730639|39065073|FG002|Overall Study|Death|0|||
16159362|NCT00730639|39065074|FG003|Overall Study|Death|0|||
16159363|NCT00730639|39065075|FG004|Overall Study|Death|2|||
16159364|NCT00730639|39065071|FG000|Overall Study|Disease Progression|12|||
16159365|NCT00730639|39065072|FG001|Overall Study|Disease Progression|13|||
16159366|NCT00730639|39065073|FG002|Overall Study|Disease Progression|48|||
16159367|NCT00730639|39065074|FG003|Overall Study|Disease Progression|32|||
16159368|NCT00730639|39065075|FG004|Overall Study|Disease Progression|88|||
16446591|NCT01668784|40115325|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
16446592|NCT01668784|40115326|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
16446593|NCT01907854|40115338|FG000|Overall Study|Protocol Violation|1|||
16446594|NCT01907854|40115339|FG001|Overall Study|Protocol Violation|1|||
16446595|NCT01907854|40115338|FG000|Overall Study|Withdrawal by Subject|9|||
16446596|NCT01907854|40115339|FG001|Overall Study|Withdrawal by Subject|7|||
16067500|NCT02138916|38739486|FG000|Overall Study|Withdrawal by Subject|27|||
16446597|NCT01907854|40115338|FG000|Overall Study|Lost to Follow-up|2|||
16446598|NCT01907854|40115339|FG001|Overall Study|Lost to Follow-up|2|||
16446599|NCT01907854|40115338|FG000|Overall Study|Unclassified|4|||
16446600|NCT01907854|40115339|FG001|Overall Study|Unclassified|3|||
16446601|NCT00912197|40115342|FG000|Overall Study|Withdrawal by Subject|3|||
16446602|NCT00912197|40115343|FG001|Overall Study|Withdrawal by Subject|3|||
16067501|NCT02138916|38739487|FG001|Overall Study|Withdrawal by Subject|31|||
16067502|NCT02138916|38739488|FG002|Overall Study|Withdrawal by Subject|32|||
16067503|NCT02138916|38739486|FG000|Overall Study|Study specific withdrawal criteria|0|||
16159369|NCT00730639|39065071|FG000|Overall Study|non-specified|0|||
16159370|NCT00730639|39065072|FG001|Overall Study|non-specified|0|||
16159371|NCT00730639|39065073|FG002|Overall Study|non-specified|4|||
16159372|NCT00730639|39065074|FG003|Overall Study|non-specified|2|||
16159373|NCT00730639|39065075|FG004|Overall Study|non-specified|3|||
16159374|NCT00730639|39065071|FG000|Overall Study|Protocol Violation|0|||
16159375|NCT00730639|39065072|FG001|Overall Study|Protocol Violation|0|||
16159376|NCT00730639|39065073|FG002|Overall Study|Protocol Violation|1|||
16159377|NCT00730639|39065074|FG003|Overall Study|Protocol Violation|0|||
16159378|NCT00730639|39065075|FG004|Overall Study|Protocol Violation|0|||
16159379|NCT00730639|39065071|FG000|Overall Study|Withdrawal by Subject|0|||
16159380|NCT00730639|39065072|FG001|Overall Study|Withdrawal by Subject|0|||
16159381|NCT00730639|39065073|FG002|Overall Study|Withdrawal by Subject|6|||
16159382|NCT00730639|39065074|FG003|Overall Study|Withdrawal by Subject|3|||
16159383|NCT00730639|39065075|FG004|Overall Study|Withdrawal by Subject|4|||
16159384|NCT00730639|39065071|FG000|Overall Study|Treatment on-going|2|||
16159385|NCT00730639|39065072|FG001|Overall Study|Treatment on-going|5|||
16159386|NCT00730639|39065073|FG002|Overall Study|Treatment on-going|5|||
16159387|NCT00730639|39065074|FG003|Overall Study|Treatment on-going|4|||
16159388|NCT00730639|39065075|FG004|Overall Study|Treatment on-going|4|||
16159389|NCT01834729|39065076|FG000|Overall Study|Did not return bowel diaries|0|||
16159390|NCT01834729|39065077|FG001|Overall Study|Did not return bowel diaries|0|||
16159391|NCT01834729|39065078|FG002|Overall Study|Did not return bowel diaries|3|||
16159392|NCT01834729|39065079|FG003|Overall Study|Did not return bowel diaries|0|||
16159393|NCT01834729|39065076|FG000|Overall Study|Withdrawal by Subject|1|||
16159394|NCT01834729|39065077|FG001|Overall Study|Withdrawal by Subject|1|||
16159395|NCT01834729|39065078|FG002|Overall Study|Withdrawal by Subject|0|||
16159396|NCT01834729|39065079|FG003|Overall Study|Withdrawal by Subject|0|||
16159397|NCT01834729|39065076|FG000|Overall Study|Adverse Event|0|||
16159398|NCT01834729|39065077|FG001|Overall Study|Adverse Event|0|||
16159399|NCT01834729|39065078|FG002|Overall Study|Adverse Event|0|||
16159400|NCT01834729|39065079|FG003|Overall Study|Adverse Event|2|||
16159401|NCT00820898|39065089|FG000|Overall Study|Inelgible - wrong primary site|1|||
16159402|NCT00744874|39065094|FG000|Overall Study|Lost to Follow-up|1|||
16159403|NCT00744874|39065094|FG000|Overall Study|Withdrawal by Subject|1|||
16159404|NCT00744874|39065094|FG000|Overall Study|Study Device not available at procedure|1|||
16159405|NCT00744874|39065094|FG000|Overall Study|Unable to accomodate schedule|1|||
16159406|NCT03969888|39065099|FG000|Overall Study|Never Received Study Drug|0|||
16159407|NCT03969888|39065100|FG001|Overall Study|Never Received Study Drug|0|||
16159408|NCT03969888|39065101|FG002|Overall Study|Never Received Study Drug|1|||
16159409|NCT03969888|39065102|FG003|Overall Study|Never Received Study Drug|0|||
16159410|NCT03969888|39065103|FG004|Overall Study|Never Received Study Drug|0|||
16159411|NCT03969888|39065104|FG005|Overall Study|Never Received Study Drug|0|||
16159412|NCT03969888|39065105|FG006|Overall Study|Never Received Study Drug|1|||
16159413|NCT03969888|39065106|FG007|Overall Study|Never Received Study Drug|0|||
16159414|NCT03969888|39065099|FG000|Overall Study|Reason Not Specified|0|||
16159415|NCT03969888|39065100|FG001|Overall Study|Reason Not Specified|0|||
16159416|NCT03969888|39065101|FG002|Overall Study|Reason Not Specified|0|||
16159417|NCT03969888|39065102|FG003|Overall Study|Reason Not Specified|0|||
16159418|NCT03969888|39065103|FG004|Overall Study|Reason Not Specified|0|||
16159419|NCT03969888|39065104|FG005|Overall Study|Reason Not Specified|0|||
16159420|NCT03969888|39065105|FG006|Overall Study|Reason Not Specified|0|||
16159421|NCT03969888|39065106|FG007|Overall Study|Reason Not Specified|1|||
16159422|NCT02631538|39068268|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
16159423|NCT02631538|39068269|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
16159424|NCT02631538|39068270|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
16159425|NCT02631538|39068271|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
16159426|NCT02631538|39068268|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
16159427|NCT02631538|39068269|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
16159428|NCT02631538|39068270|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
16159429|NCT02631538|39068271|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
16159430|NCT02631538|39068268|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
16159431|NCT02631538|39068269|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
16159432|NCT02631538|39068270|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
16159433|NCT02631538|39068271|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
16159434|NCT02631538|39068268|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
16159435|NCT02631538|39068269|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
16159436|NCT02631538|39068270|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
16159437|NCT02631538|39068271|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
16159438|NCT02631538|39068268|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
16159439|NCT02631538|39068269|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
16159440|NCT02631538|39068270|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
16159441|NCT02631538|39068271|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
16159442|NCT02631538|39068268|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
16159443|NCT02631538|39068269|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
16159444|NCT02631538|39068270|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
16369864|NCT01208051|39839719|FG003|Total Enrollment|Brain metastases|0|||
16159445|NCT02631538|39068271|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
16159446|NCT01745146|39068275|FG000|Overall Study|Withdrawal by Subject|1|||
16159447|NCT01745146|39068276|FG001|Overall Study|Withdrawal by Subject|3|||
16067504|NCT02138916|38739487|FG001|Overall Study|Study specific withdrawal criteria|0|||
16067505|NCT02138916|38739488|FG002|Overall Study|Study specific withdrawal criteria|1|||
16159448|NCT01745146|39068275|FG000|Overall Study|Lost to Follow-up|2|||
16159449|NCT01745146|39068276|FG001|Overall Study|Lost to Follow-up|0|||
16159450|NCT01157078|39068277|FG000|Overall Study|Withdrawal by Subject|12|||
16159451|NCT01157078|39068278|FG001|Overall Study|Withdrawal by Subject|14|||
16159452|NCT01157078|39068277|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16159453|NCT01157078|39068278|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
16159454|NCT01157078|39068277|FG000|Overall Study|Adverse Event|6|||
16159455|NCT01157078|39068278|FG001|Overall Study|Adverse Event|6|||
16159456|NCT01157078|39068277|FG000|Overall Study|Severe non-compliance to protocol|2|||
16159457|NCT01157078|39068278|FG001|Overall Study|Severe non-compliance to protocol|4|||
16159458|NCT01157078|39068277|FG000|Overall Study|Condition under investigation worsened|0|||
16159459|NCT01157078|39068278|FG001|Overall Study|Condition under investigation worsened|1|||
16159460|NCT01157078|39068277|FG000|Overall Study|Lack of Efficacy|2|||
16159461|NCT01157078|39068278|FG001|Overall Study|Lack of Efficacy|0|||
16159462|NCT01157078|39068277|FG000|Overall Study|Study-specific withdrawal criteria|2|||
16159463|NCT01157078|39068278|FG001|Overall Study|Study-specific withdrawal criteria|2|||
16159464|NCT01157078|39068277|FG000|Overall Study|Lost to Follow-up|7|||
16159465|NCT01157078|39068278|FG001|Overall Study|Lost to Follow-up|5|||
16067506|NCT02138916|38739486|FG000|Overall Study|incorrect enrolment|1|||
16067507|NCT02138916|38739487|FG001|Overall Study|incorrect enrolment|1|||
16067508|NCT02138916|38739488|FG002|Overall Study|incorrect enrolment|0|||
16067509|NCT02138916|38739486|FG000|Overall Study|Severe non-compliance|1|||
16067510|NCT02138916|38739487|FG001|Overall Study|Severe non-compliance|2|||
16067511|NCT02138916|38739488|FG002|Overall Study|Severe non-compliance|1|||
16067512|NCT02138916|38739486|FG000|Overall Study|Lost to Follow-up|4|||
16067513|NCT02138916|38739487|FG001|Overall Study|Lost to Follow-up|2|||
16067514|NCT02138916|38739488|FG002|Overall Study|Lost to Follow-up|3|||
16067515|NCT02138916|38739486|FG000|Overall Study|Adverse Event|4|||
16067516|NCT02138916|38739487|FG001|Overall Study|Adverse Event|4|||
16067517|NCT02138916|38739488|FG002|Overall Study|Adverse Event|3|||
16067518|NCT00052962|38739491|FG000|Overall Study|Not evaluable|0|||
16067519|NCT00052962|38739492|FG001|Overall Study|Not evaluable|2|||
16067520|NCT00052962|38739491|FG000|Overall Study|Not randomized/not evaluable|1|||
16067521|NCT00052962|38739492|FG001|Overall Study|Not randomized/not evaluable|0|||
16067522|NCT01688973|38739493|FG000|Overall Study|Ineligible|2|||
16067523|NCT01688973|38739494|FG001|Overall Study|Ineligible|3|||
16067524|NCT00550732|38739495|FG000|Overall Study|Death|4|||
16067525|NCT00550732|38739495|FG000|Overall Study|Withdrawal by Subject|2|||
16067526|NCT00550732|38739495|FG000|Overall Study|Physician Decision|2|||
16067527|NCT00550732|38739495|FG000|Overall Study|Lost to Follow-up|1|||
16067528|NCT00550732|38739495|FG000|Overall Study|Palliative care|1|||
16067529|NCT00550732|38739495|FG000|Overall Study|Adverse Event|1|||
16067530|NCT00868231|38739496|FG000|Treatment Period 1|Adverse Event|0|||
16067531|NCT00868231|38739497|FG001|Treatment Period 1|Adverse Event|0|||
16067532|NCT00868231|38739498|FG002|Treatment Period 1|Adverse Event|0|||
16067533|NCT00868231|38739499|FG003|Treatment Period 1|Adverse Event|0|||
16067534|NCT00868231|38739500|FG004|Treatment Period 1|Adverse Event|1|||
16067535|NCT00868231|38739501|FG005|Treatment Period 1|Adverse Event|0|||
16067536|NCT00868231|38739496|FG000|Treatment Period 2|Adverse Event|1|||
16067537|NCT00868231|38739497|FG001|Treatment Period 2|Adverse Event|0|||
16067538|NCT00868231|38739498|FG002|Treatment Period 2|Adverse Event|0|||
16067539|NCT00868231|38739499|FG003|Treatment Period 2|Adverse Event|0|||
16067540|NCT00868231|38739500|FG004|Treatment Period 2|Adverse Event|0|||
16067541|NCT00868231|38739501|FG005|Treatment Period 2|Adverse Event|0|||
16067542|NCT00868231|38739496|FG000|Treatment Period 3|Adverse Event|0|||
16067543|NCT00868231|38739497|FG001|Treatment Period 3|Adverse Event|0|||
16067544|NCT00868231|38739498|FG002|Treatment Period 3|Adverse Event|1|||
16446603|NCT00174187|40115344|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
16067545|NCT00868231|38739499|FG003|Treatment Period 3|Adverse Event|0|||
16067546|NCT00868231|38739500|FG004|Treatment Period 3|Adverse Event|0|||
16067547|NCT00868231|38739501|FG005|Treatment Period 3|Adverse Event|0|||
16067548|NCT02857283|38739502|FG000|First Exposure|Withdrawal by Subject|1|||
16067549|NCT02857283|38739503|FG001|First Exposure|Withdrawal by Subject|0|||
16067550|NCT00465361|38739504|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
16067551|NCT00836810|38739506|FG000|Overall Study|New diagnosis|1|||
16067552|NCT00836810|38739507|FG001|Overall Study|New diagnosis|0|||
16067553|NCT00531479|38739508|FG000|Overall Study|Death|68|||
16159466|NCT01157078|39068277|FG000|Overall Study|Other|2|||
16159467|NCT01157078|39068278|FG001|Overall Study|Other|4|||
16159468|NCT01913483|39068279|FG000|Overall Study|Withdrawal by Subject|1|||
16159469|NCT01913483|39068280|FG001|Overall Study|Withdrawal by Subject|2|||
16067554|NCT00531479|38739509|FG001|Overall Study|Death|71|||
16067555|NCT00531479|38739508|FG000|Overall Study|Lost to Follow-up|0|||
16159470|NCT01913483|39068279|FG000|Overall Study|Lost to Follow-up|6|||
16159471|NCT01913483|39068280|FG001|Overall Study|Lost to Follow-up|3|||
16159472|NCT01913483|39068279|FG000|Overall Study|Death|14|||
16159473|NCT01913483|39068280|FG001|Overall Study|Death|17|||
16159474|NCT01784861|39068281|FG000|Overall Study|Adverse Event|0|||
16159475|NCT01784861|39068282|FG001|Overall Study|Adverse Event|0|||
16159476|NCT01784861|39068283|FG002|Overall Study|Adverse Event|1|||
16159477|NCT01784861|39068284|FG003|Overall Study|Adverse Event|2|||
16159478|NCT01784861|39068285|FG004|Overall Study|Adverse Event|1|||
16159479|NCT01784861|39068286|FG005|Overall Study|Adverse Event|0|||
16159480|NCT01784861|39068281|FG000|Overall Study|Withdrawal by Subject|0|||
16159481|NCT01784861|39068282|FG001|Overall Study|Withdrawal by Subject|0|||
16159482|NCT01784861|39068283|FG002|Overall Study|Withdrawal by Subject|0|||
16159483|NCT01784861|39068284|FG003|Overall Study|Withdrawal by Subject|1|||
16159484|NCT01784861|39068285|FG004|Overall Study|Withdrawal by Subject|0|||
16159485|NCT01784861|39068286|FG005|Overall Study|Withdrawal by Subject|0|||
16159486|NCT01784861|39068281|FG000|Overall Study|Physician Decision|0|||
16159487|NCT01784861|39068282|FG001|Overall Study|Physician Decision|0|||
16159488|NCT01784861|39068283|FG002|Overall Study|Physician Decision|0|||
16159489|NCT01784861|39068284|FG003|Overall Study|Physician Decision|2|||
16159490|NCT01784861|39068285|FG004|Overall Study|Physician Decision|0|||
16159491|NCT01784861|39068286|FG005|Overall Study|Physician Decision|1|||
16159492|NCT00429585|39068289|FG000|Overall Study|Death|1|||
16159493|NCT00429585|39068290|FG001|Overall Study|Death|0|||
16159494|NCT00429585|39068289|FG000|Overall Study|Lost to Follow-up|27|||
16159495|NCT00429585|39068290|FG001|Overall Study|Lost to Follow-up|20|||
16159496|NCT00429585|39068289|FG000|Overall Study|Physician Decision|2|||
16159497|NCT00429585|39068290|FG001|Overall Study|Physician Decision|0|||
16159498|NCT02971670|39068294|FG000|Overall Study|Withdrawal by Subject|4|||
16159499|NCT02971670|39068295|FG001|Overall Study|Withdrawal by Subject|1|||
16159500|NCT02971670|39068296|FG002|Overall Study|Withdrawal by Subject|1|||
16159501|NCT02971670|39068297|FG003|Overall Study|Withdrawal by Subject|2|||
16159502|NCT00606086|39068298|FG000|Overall Study|Adverse Event|1|||
16159503|NCT00606086|39068299|FG001|Overall Study|Adverse Event|1|||
16159504|NCT00606086|39068298|FG000|Overall Study|Lost to Follow-up|4|||
16159505|NCT00606086|39068299|FG001|Overall Study|Lost to Follow-up|8|||
16159506|NCT00606086|39068298|FG000|Overall Study|Protocol Violation|1|||
16159507|NCT00606086|39068299|FG001|Overall Study|Protocol Violation|0|||
16159508|NCT00606086|39068298|FG000|Overall Study|Withdrawal by Subject|5|||
16067556|NCT00531479|38739509|FG001|Overall Study|Lost to Follow-up|2|||
16067557|NCT00531479|38739508|FG000|Overall Study|Other|0|||
16067558|NCT00531479|38739509|FG001|Overall Study|Other|1|||
16067559|NCT00531479|38739508|FG000|Overall Study|Withdrawal by Subject|6|||
16067560|NCT00531479|38739509|FG001|Overall Study|Withdrawal by Subject|6|||
16067561|NCT00531479|38739508|FG000|Overall Study|Did not receive treatment|2|||
16067562|NCT00531479|38739509|FG001|Overall Study|Did not receive treatment|3|||
16067563|NCT00359619|38739513|FG000|Overall Study|Adverse Event|0|||
16067564|NCT00359619|38739514|FG001|Overall Study|Adverse Event|0|||
16067565|NCT00359619|38739515|FG002|Overall Study|Adverse Event|1|||
16067566|NCT00359619|38739516|FG003|Overall Study|Adverse Event|0|||
16067567|NCT00359619|38739517|FG004|Overall Study|Adverse Event|0|||
16067568|NCT00359619|38739518|FG005|Overall Study|Adverse Event|0|||
16067569|NCT00359619|38739519|FG006|Overall Study|Adverse Event|1|||
16067570|NCT00359619|38739513|FG000|Overall Study|Withdrawal by Subject|3|||
16067571|NCT00359619|38739514|FG001|Overall Study|Withdrawal by Subject|1|||
16067572|NCT00359619|38739515|FG002|Overall Study|Withdrawal by Subject|4|||
16067573|NCT00359619|38739516|FG003|Overall Study|Withdrawal by Subject|2|||
16067574|NCT00359619|38739517|FG004|Overall Study|Withdrawal by Subject|2|||
16067575|NCT00359619|38739518|FG005|Overall Study|Withdrawal by Subject|0|||
16067576|NCT00359619|38739519|FG006|Overall Study|Withdrawal by Subject|3|||
16067577|NCT00359619|38739513|FG000|Overall Study|Other|1|||
16067578|NCT00359619|38739514|FG001|Overall Study|Other|0|||
16067579|NCT00359619|38739515|FG002|Overall Study|Other|0|||
16067580|NCT00359619|38739516|FG003|Overall Study|Other|0|||
16067581|NCT00359619|38739517|FG004|Overall Study|Other|0|||
16067582|NCT00359619|38739518|FG005|Overall Study|Other|0|||
16067583|NCT00359619|38739519|FG006|Overall Study|Other|0|||
16067584|NCT00359619|38739513|FG000|Overall Study|Lost to Follow-up|4|||
16067585|NCT00359619|38739514|FG001|Overall Study|Lost to Follow-up|4|||
16067586|NCT00359619|38739515|FG002|Overall Study|Lost to Follow-up|2|||
16067587|NCT00359619|38739516|FG003|Overall Study|Lost to Follow-up|1|||
16067588|NCT00359619|38739517|FG004|Overall Study|Lost to Follow-up|1|||
16067589|NCT00359619|38739518|FG005|Overall Study|Lost to Follow-up|5|||
16067590|NCT00359619|38739519|FG006|Overall Study|Lost to Follow-up|0|||
16067591|NCT02123966|38739522|FG000|Overall Study|Intercurrent Illness|1|||
16067592|NCT01772719|38739523|FG000|Overall Study|Withdrawal by Subject|3|||
16067593|NCT01772719|38739523|FG000|Overall Study|Adverse Event|2|||
16067594|NCT01772719|38739523|FG000|Overall Study|Protocol Violation|1|||
16067595|NCT01772719|38739523|FG000|Overall Study|Lost to Follow-up|1|||
16159509|NCT00606086|39068299|FG001|Overall Study|Withdrawal by Subject|3|||
16159510|NCT00606086|39068298|FG000|Overall Study|Non-compliance|0|||
16159511|NCT00606086|39068299|FG001|Overall Study|Non-compliance|1|||
16159512|NCT00606086|39068298|FG000|Overall Study|Randomized, not treated|1|||
16159513|NCT00606086|39068299|FG001|Overall Study|Randomized, not treated|2|||
16159514|NCT01764633|39068300|FG000|Overall Study|Withdrawal by Subject|105|||
16159515|NCT01764633|39068301|FG001|Overall Study|Withdrawal by Subject|88|||
16159516|NCT01764633|39068300|FG000|Overall Study|Lost to Follow-up|13|||
16159517|NCT01764633|39068301|FG001|Overall Study|Lost to Follow-up|5|||
16159518|NCT00452699|39068302|FG000|Overall Study|Adverse Event|10|||
16159519|NCT00452699|39068303|FG001|Overall Study|Adverse Event|3|||
16159520|NCT00452699|39068302|FG000|Overall Study|Lack of Efficacy|6|||
16159521|NCT00452699|39068303|FG001|Overall Study|Lack of Efficacy|4|||
16159522|NCT00452699|39068302|FG000|Overall Study|Lost to Follow-up|6|||
16159523|NCT00452699|39068303|FG001|Overall Study|Lost to Follow-up|9|||
16159524|NCT00452699|39068302|FG000|Overall Study|Protocol Violation|21|||
16159525|NCT00452699|39068303|FG001|Overall Study|Protocol Violation|25|||
16159526|NCT00452699|39068302|FG000|Overall Study|Withdrawal by Subject|26|||
16067596|NCT01789203|38739528|FG000|Overall Study|Adverse Event|2|||
16067597|NCT01789203|38739529|FG001|Overall Study|Adverse Event|2|||
16067598|NCT01789203|38739528|FG000|Overall Study|Withdrawal by Subject|1|||
16067599|NCT01789203|38739529|FG001|Overall Study|Withdrawal by Subject|0|||
16067600|NCT01789203|38739528|FG000|Overall Study|Death|1|||
16067601|NCT01789203|38739529|FG001|Overall Study|Death|0|||
16067602|NCT01789203|38739528|FG000|Overall Study|Protocol Violation|2|||
16067603|NCT01789203|38739529|FG001|Overall Study|Protocol Violation|1|||
16067604|NCT01789203|38739528|FG000|Overall Study|Other|1|||
16067605|NCT01789203|38739529|FG001|Overall Study|Other|1|||
16067606|NCT01789203|38739528|FG000|Overall Study|patient non-adherent|2|||
16067607|NCT01789203|38739529|FG001|Overall Study|patient non-adherent|0|||
16067608|NCT05305040|38739530|FG000|Overall Study|Not Dosed|37|||
16067609|NCT05305040|38739531|FG001|Overall Study|Not Dosed|37|||
16067610|NCT05305040|38739530|FG000|Overall Study|Study Closure|34|||
16067611|NCT05305040|38739531|FG001|Overall Study|Study Closure|46|||
16067612|NCT05305040|38739530|FG000|Overall Study|Death|14|||
16067613|NCT05305040|38739531|FG001|Overall Study|Death|13|||
16067614|NCT05305040|38739530|FG000|Overall Study|Withdrawal by Subject|15|||
16067615|NCT05305040|38739531|FG001|Overall Study|Withdrawal by Subject|10|||
16067616|NCT05305040|38739530|FG000|Overall Study|Other|13|||
16067617|NCT05305040|38739531|FG001|Overall Study|Other|10|||
16067618|NCT05305040|38739530|FG000|Overall Study|Primary Malignancy Relapse|3|||
16067619|NCT05305040|38739531|FG001|Overall Study|Primary Malignancy Relapse|4|||
16067620|NCT05305040|38739530|FG000|Overall Study|Adverse Event|3|||
16067621|NCT05305040|38739531|FG001|Overall Study|Adverse Event|3|||
16067622|NCT05305040|38739530|FG000|Overall Study|Lost to Follow-up|2|||
16067623|NCT05305040|38739531|FG001|Overall Study|Lost to Follow-up|1|||
16067624|NCT05305040|38739530|FG000|Overall Study|Graft versus host disease|2|||
16067625|NCT05305040|38739531|FG001|Overall Study|Graft versus host disease|0|||
16067626|NCT05305040|38739530|FG000|Overall Study|Investigator's Decision|1|||
16067627|NCT05305040|38739531|FG001|Overall Study|Investigator's Decision|1|||
16067628|NCT05305040|38739530|FG000|Overall Study|COVID-19 Reasons|1|||
16067629|NCT05305040|38739531|FG001|Overall Study|COVID-19 Reasons|0|||
16067630|NCT05349864|38739532|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
16067631|NCT05349864|38739533|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
16067632|NCT03102242|38739534|FG000|Overall Study|Adverse Event|2|||
16067633|NCT01257503|38739542|FG000|Overall Study|Lost to Follow-up|7|||
16067634|NCT01257503|38739543|FG001|Overall Study|Lost to Follow-up|10|||
16067635|NCT01257503|38739542|FG000|Overall Study|Over 5 years old at enrollment|0|||
16067636|NCT01257503|38739543|FG001|Overall Study|Over 5 years old at enrollment|1|||
16067637|NCT01257503|38739542|FG000|Overall Study|strep culture positive at enrollment|1|||
16067638|NCT01257503|38739543|FG001|Overall Study|strep culture positive at enrollment|0|||
16067639|NCT01720043|38739547|FG000|Overall Study|Withdrawal by Subject|1|||
16067640|NCT02540213|38739548|FG000|Overall Study|Death/adverse event|18|||
16067641|NCT02540213|38739548|FG000|Overall Study|Administrative reasons|3|||
16067642|NCT02540213|38739548|FG000|Overall Study|Kidney transplant|3|||
16067643|NCT02540213|38739548|FG000|Overall Study|Lack of Efficacy|6|||
16067644|NCT02540213|38739548|FG000|Overall Study|Consent withdrawn|7|||
16067645|NCT02540213|38739548|FG000|Overall Study|Enrolled but not treated|2|||
16067646|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
16067647|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
16067648|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16067649|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16067650|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16067651|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16067652|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16159527|NCT00452699|39068303|FG001|Overall Study|Withdrawal by Subject|25|||
16159528|NCT00452699|39068302|FG000|Overall Study|Other|12|||
16159529|NCT00452699|39068303|FG001|Overall Study|Other|7|||
16159530|NCT01297270|39068304|FG000|Overall Study|Adverse Event|19|||
16159531|NCT01297270|39068305|FG001|Overall Study|Adverse Event|32|||
16159532|NCT01297270|39068306|FG002|Overall Study|Adverse Event|5|||
16159533|NCT01297270|39068304|FG000|Overall Study|Lack of Efficacy|15|||
16159534|NCT01297270|39068305|FG001|Overall Study|Lack of Efficacy|17|||
16159535|NCT01297270|39068306|FG002|Overall Study|Lack of Efficacy|15|||
16159536|NCT01297270|39068304|FG000|Overall Study|Lost to Follow-up|1|||
16159537|NCT01297270|39068305|FG001|Overall Study|Lost to Follow-up|2|||
16159538|NCT01297270|39068306|FG002|Overall Study|Lost to Follow-up|1|||
16159539|NCT01297270|39068304|FG000|Overall Study|Protocol Violation|0|||
16159540|NCT01297270|39068305|FG001|Overall Study|Protocol Violation|2|||
16159541|NCT01297270|39068306|FG002|Overall Study|Protocol Violation|0|||
16159542|NCT01297270|39068304|FG000|Overall Study|Withdrawal by Subject|7|||
16159543|NCT01297270|39068305|FG001|Overall Study|Withdrawal by Subject|15|||
16159544|NCT01297270|39068306|FG002|Overall Study|Withdrawal by Subject|7|||
16159545|NCT01297270|39068304|FG000|Overall Study|Other reason not defined above|3|||
16159546|NCT01297270|39068305|FG001|Overall Study|Other reason not defined above|3|||
16159547|NCT01297270|39068306|FG002|Overall Study|Other reason not defined above|1|||
16159548|NCT01297270|39068304|FG000|Overall Study|Not treated|0|||
16159549|NCT01297270|39068305|FG001|Overall Study|Not treated|1|||
16067653|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16159550|NCT01297270|39068306|FG002|Overall Study|Not treated|0|||
16159551|NCT03551743|39068307|FG000|Overall Study|Adverse Event|1|||
16159552|NCT03551743|39068308|FG001|Overall Study|Adverse Event|0|||
16159553|NCT03551743|39068309|FG002|Overall Study|Adverse Event|0|||
16159554|NCT03551743|39068310|FG003|Overall Study|Adverse Event|0|||
16159555|NCT03551743|39068307|FG000|Overall Study|Withdrawal by Subject|1|||
16159556|NCT03551743|39068308|FG001|Overall Study|Withdrawal by Subject|0|||
16159557|NCT03551743|39068309|FG002|Overall Study|Withdrawal by Subject|0|||
16159558|NCT03551743|39068310|FG003|Overall Study|Withdrawal by Subject|0|||
16159559|NCT01323478|39068314|FG000|Overall Study|Adverse Event|7|||
16159560|NCT01323478|39068314|FG000|Overall Study|Lack of Efficacy|4|||
16159561|NCT01323478|39068314|FG000|Overall Study|Non-compliance With Study Product|3|||
16067654|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16067655|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16067656|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16067657|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16067658|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16067659|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
16067660|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
16067661|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
16067662|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067663|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067664|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067665|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067666|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067667|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067668|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067669|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067670|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067671|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067672|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067673|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
16067674|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
16067675|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
16067676|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067677|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067678|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067679|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067680|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067681|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067682|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16159562|NCT01323478|39068314|FG000|Overall Study|Protocol Violation|1|||
16159563|NCT01323478|39068314|FG000|Overall Study|Withdrawal of Consent|1|||
16159564|NCT01323478|39068314|FG000|Overall Study|Administrative or Other Reasons|8|||
16159565|NCT04161131|39068315|FG000|Overall Study|Ineligible|2|||
16159566|NCT04161131|39068315|FG000|Overall Study|Lost to Follow-up|4|||
16159567|NCT03115151|39068316|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
16159568|NCT03115151|39068317|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
16067683|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067684|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067685|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067686|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067687|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
16067688|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
16067689|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
16067690|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067691|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067692|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067693|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067694|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067695|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067696|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067697|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067698|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067699|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067700|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067701|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
16067702|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
16067703|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
16067704|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16067705|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16067706|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16067707|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16067708|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16067709|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16067710|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16067711|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16159569|NCT03115151|39068316|FG000|Overall Study|Epidural catheter removal|1|||
16159570|NCT03115151|39068317|FG001|Overall Study|Epidural catheter removal|0|||
16159571|NCT03115151|39068316|FG000|Overall Study|Withdrawal by Subject|0|||
16159572|NCT03115151|39068317|FG001|Overall Study|Withdrawal by Subject|1|||
16159573|NCT03115151|39068316|FG000|Overall Study|Intervention not received according to the protocol.|1|||
16159574|NCT03115151|39068317|FG001|Overall Study|Intervention not received according to the protocol.|1|||
16159575|NCT03115151|39068316|FG000|Overall Study|Physician Decision|1|||
16159576|NCT03115151|39068317|FG001|Overall Study|Physician Decision|0|||
16159577|NCT03115151|39068316|FG000|Overall Study|Randomization not applied|1|||
16159578|NCT03115151|39068317|FG001|Overall Study|Randomization not applied|1|||
16159579|NCT02682901|39068320|FG000|Overall Study|Adverse Event|10|||
16159580|NCT02682901|39068321|FG001|Overall Study|Adverse Event|3|||
16159581|NCT02682901|39068320|FG000|Overall Study|Lack of Efficacy|0|||
16159582|NCT02682901|39068321|FG001|Overall Study|Lack of Efficacy|1|||
16159583|NCT00105443|39068329|FG000|Double-Blind Treatment|Adverse Event|1|||
16159584|NCT00105443|39068330|FG001|Double-Blind Treatment|Adverse Event|0|||
16159585|NCT00105443|39068331|FG002|Double-Blind Treatment|Adverse Event|0|||
16159586|NCT00105443|39068332|FG003|Double-Blind Treatment|Adverse Event|0|||
16159587|NCT00105443|39068329|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
16159588|NCT00105443|39068330|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
16159589|NCT00105443|39068331|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
16159590|NCT00105443|39068332|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
16159591|NCT00105443|39068329|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
16159592|NCT00105443|39068330|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
16159593|NCT00105443|39068331|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
16159594|NCT00105443|39068332|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
16159595|NCT00105443|39068329|FG000|Double-Blind Treatment|Physician Decision|1|||
16159596|NCT00105443|39068330|FG001|Double-Blind Treatment|Physician Decision|0|||
16159597|NCT00105443|39068331|FG002|Double-Blind Treatment|Physician Decision|2|||
16159598|NCT00105443|39068332|FG003|Double-Blind Treatment|Physician Decision|0|||
16159599|NCT00105443|39068329|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
16159600|NCT00105443|39068330|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
16159601|NCT00105443|39068331|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
16159602|NCT00105443|39068332|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
16159603|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
16446604|NCT00174187|40115345|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
16159604|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
16159605|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
16159606|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
16067712|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16067713|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16369865|NCT01208051|39839720|FG004|Total Enrollment|Brain metastases|0|||
16369866|NCT00433537|39839727|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
16369867|NCT00433537|39839728|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
16369868|NCT00433537|39839729|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
16369869|NCT00433537|39839727|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
16369870|NCT00433537|39839728|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
16369871|NCT00433537|39839729|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
16369872|NCT00433537|39839727|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
16369873|NCT00433537|39839728|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
16369874|NCT00433537|39839729|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
16369875|NCT00433537|39839727|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
16446605|NCT00174187|40115346|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
16446606|NCT00174187|40115344|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
16067714|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16067715|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
16067716|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
16067717|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
16067718|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067719|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16446607|NCT00174187|40115345|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
16446608|NCT00174187|40115346|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
16446609|NCT00174187|40115344|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
16446610|NCT00174187|40115345|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
16446611|NCT00174187|40115346|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
16446612|NCT00174187|40115344|FG000|Period 1 (up to 3 Years)|Other|0|||
16446613|NCT00174187|40115345|FG001|Period 1 (up to 3 Years)|Other|1|||
16446614|NCT00174187|40115346|FG002|Period 1 (up to 3 Years)|Other|0|||
16446615|NCT00174187|40115344|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
16446616|NCT00174187|40115345|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
16446617|NCT00174187|40115346|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
16446618|NCT00174187|40115344|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
16446619|NCT00174187|40115345|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
16446620|NCT00174187|40115346|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
16446621|NCT00174187|40115344|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
16446622|NCT00174187|40115345|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
16446623|NCT00174187|40115346|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
16067720|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067721|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067722|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067723|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067724|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067725|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067726|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067727|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067728|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067729|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
16067730|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
16067731|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
16067732|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067733|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067734|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067735|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067736|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067737|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067738|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067739|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067740|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067741|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067742|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067743|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
16067744|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
16067745|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
16067746|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16067747|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16369876|NCT00433537|39839728|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
16369877|NCT00433537|39839729|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
16369878|NCT00433537|39839727|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
16159607|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
16159608|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
16159609|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
16159610|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
16446624|NCT00174187|40115344|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
16446625|NCT00174187|40115345|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
16446626|NCT00174187|40115346|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
16446627|NCT00174187|40115344|FG000|Period 2 (After 3 Years)|Other|0|||
16446628|NCT00174187|40115345|FG001|Period 2 (After 3 Years)|Other|0|||
16446629|NCT00174187|40115346|FG002|Period 2 (After 3 Years)|Other|5|||
16446630|NCT01796197|40115347|FG000|Overall Study|Lost to Follow-up|1|||
16446631|NCT01796197|40115347|FG000|Overall Study|Lack of Efficacy|1|||
16446632|NCT01642589|40115350|FG000|Overall Study|Withdrawal by Subject|1|||
16446633|NCT01642589|40115351|FG001|Overall Study|Withdrawal by Subject|1|||
16446634|NCT01704599|40115352|FG000|Overall Study|Adverse Event|1|||
16446635|NCT02156076|40115353|FG000|Treatment Period|no longer meets study criteria|0|||
16446636|NCT02156076|40115354|FG001|Treatment Period|no longer meets study criteria|0|||
16446637|NCT02156076|40115355|FG002|Treatment Period|no longer meets study criteria|1|||
16446638|NCT02156076|40115356|FG003|Treatment Period|no longer meets study criteria|0|||
16446639|NCT02156076|40115353|FG000|Treatment Period|Poor/non-compliance|0|||
16446640|NCT02156076|40115354|FG001|Treatment Period|Poor/non-compliance|1|||
16446641|NCT02156076|40115355|FG002|Treatment Period|Poor/non-compliance|0|||
16446642|NCT02156076|40115356|FG003|Treatment Period|Poor/non-compliance|0|||
16446643|NCT02156076|40115353|FG000|Treatment Period|Lost to Follow-up|0|||
16446644|NCT02156076|40115354|FG001|Treatment Period|Lost to Follow-up|0|||
16446645|NCT02156076|40115355|FG002|Treatment Period|Lost to Follow-up|0|||
16446646|NCT02156076|40115356|FG003|Treatment Period|Lost to Follow-up|1|||
16446647|NCT02156076|40115353|FG000|Treatment Period|Withdrawal by Subject|0|||
16446648|NCT02156076|40115354|FG001|Treatment Period|Withdrawal by Subject|0|||
16446649|NCT02156076|40115355|FG002|Treatment Period|Withdrawal by Subject|1|||
16446650|NCT02156076|40115356|FG003|Treatment Period|Withdrawal by Subject|0|||
16446651|NCT02156076|40115353|FG000|Treatment Period|Subject request to discontinue treatment|0|||
16446652|NCT02156076|40115354|FG001|Treatment Period|Subject request to discontinue treatment|1|||
16446653|NCT02156076|40115355|FG002|Treatment Period|Subject request to discontinue treatment|0|||
16446654|NCT02156076|40115356|FG003|Treatment Period|Subject request to discontinue treatment|0|||
16446655|NCT02156076|40115353|FG000|Treatment Period|Adverse Event|0|||
16446656|NCT02156076|40115354|FG001|Treatment Period|Adverse Event|0|||
16446657|NCT02156076|40115355|FG002|Treatment Period|Adverse Event|0|||
16446658|NCT02156076|40115356|FG003|Treatment Period|Adverse Event|1|||
16446659|NCT02156076|40115353|FG000|Follow-up Period|Withdrawal by Subject|1|||
16446660|NCT02156076|40115354|FG001|Follow-up Period|Withdrawal by Subject|0|||
16446661|NCT02156076|40115355|FG002|Follow-up Period|Withdrawal by Subject|0|||
16446662|NCT02156076|40115356|FG003|Follow-up Period|Withdrawal by Subject|0|||
16446663|NCT04314284|40115357|FG000|Overall Study|Withdrawal by Subject|4|||
16446664|NCT04314284|40115358|FG001|Overall Study|Withdrawal by Subject|7|||
16446665|NCT04314284|40115357|FG000|Overall Study|Consented but did not complete survey|0|||
16446666|NCT04314284|40115358|FG001|Overall Study|Consented but did not complete survey|6|||
16159611|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
16159612|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
16159613|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
16159614|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
16159615|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
16159616|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
16159617|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
16159618|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
16159619|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
16159620|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
16159621|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
16159622|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
16159623|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
16159624|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
16159625|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
16159626|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
16159627|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
16159628|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
16173408|NCT01607892|39111205|FG000|Overall Study|Investigator discretion|2|||
16446667|NCT01106690|40115362|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
16446668|NCT01106690|40115363|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
16446669|NCT01106690|40115364|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
16446670|NCT01106690|40115362|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
16446671|NCT01106690|40115363|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
16446672|NCT01106690|40115364|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
16446673|NCT01106690|40115362|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
16446674|NCT01106690|40115363|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
16446675|NCT01106690|40115364|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
16446676|NCT01106690|40115362|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
16159629|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
16159630|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
16159631|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
16159632|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
16159633|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
16159634|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
16159635|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
16159636|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
16159637|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
16159638|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
16159639|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
16159640|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
16159641|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
16159642|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
16159643|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
16159644|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
16159645|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
16159646|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
16159647|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
16159648|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
16159649|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
16159650|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
16159651|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
16159652|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
16159653|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
16159654|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
16159655|NCT00105443|39068329|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
16159656|NCT00105443|39068330|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
16159657|NCT00105443|39068331|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
16159658|NCT00105443|39068332|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
16159659|NCT02531646|39068334|FG000|Overall Study|equip. image processing issue|5|||
16159660|NCT02531646|39068335|FG001|Overall Study|equip. image processing issue|1|||
16159661|NCT02531646|39068336|FG002|Overall Study|equip. image processing issue|0|||
16159662|NCT01587079|39068337|FG000|Overall Study|Protocol-specified criteria|9|||
16159663|NCT01587079|39068337|FG000|Overall Study|Protocol Violation|5|||
16159664|NCT01587079|39068337|FG000|Overall Study|Lost to Follow-up|2|||
16159665|NCT01587079|39068337|FG000|Overall Study|Physician Decision|2|||
16159666|NCT01587079|39068337|FG000|Overall Study|Withdrawal by Subject|7|||
16159667|NCT01587079|39068337|FG000|Overall Study|Adverse Event|14|||
16159668|NCT01783678|39068350|FG000|Overall Study|Randomized but Not Treated|0|||
16159669|NCT01783678|39068351|FG001|Overall Study|Randomized but Not Treated|0|||
16159670|NCT01783678|39068352|FG002|Overall Study|Randomized but Not Treated|0|||
16159671|NCT01783678|39068353|FG003|Overall Study|Randomized but Not Treated|1|||
16159672|NCT01783678|39068354|FG004|Overall Study|Randomized but Not Treated|0|||
16159673|NCT01783678|39068355|FG005|Overall Study|Randomized but Not Treated|0|||
16159674|NCT01783678|39068350|FG000|Overall Study|Lack of Efficacy|1|||
16159675|NCT01783678|39068351|FG001|Overall Study|Lack of Efficacy|13|||
16159676|NCT01783678|39068352|FG002|Overall Study|Lack of Efficacy|1|||
16159677|NCT01783678|39068353|FG003|Overall Study|Lack of Efficacy|3|||
16159678|NCT01783678|39068354|FG004|Overall Study|Lack of Efficacy|6|||
16159679|NCT01783678|39068355|FG005|Overall Study|Lack of Efficacy|5|||
16159680|NCT01783678|39068350|FG000|Overall Study|Lost to Follow-up|0|||
16159681|NCT01783678|39068351|FG001|Overall Study|Lost to Follow-up|4|||
16159682|NCT01783678|39068352|FG002|Overall Study|Lost to Follow-up|0|||
16159683|NCT01783678|39068353|FG003|Overall Study|Lost to Follow-up|2|||
16159684|NCT01783678|39068354|FG004|Overall Study|Lost to Follow-up|1|||
16159685|NCT01783678|39068355|FG005|Overall Study|Lost to Follow-up|0|||
16159686|NCT01783678|39068350|FG000|Overall Study|Withdrew Consent|1|||
16159687|NCT01783678|39068351|FG001|Overall Study|Withdrew Consent|1|||
16446677|NCT01106690|40115363|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
16159688|NCT01783678|39068352|FG002|Overall Study|Withdrew Consent|0|||
16446678|NCT01106690|40115364|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
16446679|NCT01106690|40115362|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
16446680|NCT01106690|40115363|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
16446681|NCT01106690|40115364|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
16446682|NCT01106690|40115362|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16446683|NCT01106690|40115363|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
16446684|NCT01106690|40115364|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
16446685|NCT01106690|40115362|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
16446686|NCT01106690|40115363|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16446687|NCT01106690|40115364|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
16446688|NCT01106690|40115362|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
16446689|NCT01106690|40115363|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
16446690|NCT01106690|40115364|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
16446691|NCT01106690|40115362|FG000|Core Period: Baseline to Week 26|Other|10|||
16446692|NCT01106690|40115363|FG001|Core Period: Baseline to Week 26|Other|2|||
16446693|NCT01106690|40115364|FG002|Core Period: Baseline to Week 26|Other|6|||
16446694|NCT01106690|40115362|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
16446695|NCT01106690|40115363|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
16446696|NCT01106690|40115364|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
16446697|NCT01106690|40115362|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
16159689|NCT01783678|39068353|FG003|Overall Study|Withdrew Consent|2|||
16159690|NCT01783678|39068354|FG004|Overall Study|Withdrew Consent|0|||
16159691|NCT01783678|39068355|FG005|Overall Study|Withdrew Consent|0|||
16446698|NCT01106690|40115363|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16446699|NCT01106690|40115364|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
16446700|NCT01106690|40115362|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
16446701|NCT01106690|40115363|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
16446702|NCT01106690|40115364|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
16446703|NCT01106690|40115362|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
16446704|NCT01106690|40115363|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
16446705|NCT01106690|40115364|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
16446706|NCT01106690|40115362|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
16446707|NCT01106690|40115363|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
16446708|NCT01106690|40115364|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
16446709|NCT01106690|40115362|FG000|Extension Period: Week 26 to Week 52|Other|8|||
16446710|NCT01106690|40115363|FG001|Extension Period: Week 26 to Week 52|Other|3|||
16446711|NCT01106690|40115364|FG002|Extension Period: Week 26 to Week 52|Other|4|||
16446712|NCT01106690|40115362|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
16446713|NCT01106690|40115363|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16446714|NCT01106690|40115364|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
16446715|NCT00706238|40115365|FG000|Overall Study|Disease progression|4|||
16446716|NCT00706238|40115365|FG000|Overall Study|Other|1|||
16446717|NCT00656513|40115366|FG000|Overall Study|Protocol Violation|1|||
16446718|NCT00656513|40115367|FG001|Overall Study|Protocol Violation|0|||
16446719|NCT00656513|40115368|FG002|Overall Study|Protocol Violation|2|||
16446720|NCT00656513|40115366|FG000|Overall Study|Withdrawal by Subject|0|||
16446721|NCT00656513|40115367|FG001|Overall Study|Withdrawal by Subject|11|||
16446722|NCT00656513|40115368|FG002|Overall Study|Withdrawal by Subject|4|||
16446723|NCT00656513|40115366|FG000|Overall Study|Death|0|||
16446724|NCT00656513|40115367|FG001|Overall Study|Death|0|||
16446725|NCT00656513|40115368|FG002|Overall Study|Death|1|||
16446726|NCT00656513|40115366|FG000|Overall Study|Missing data|0|||
16446727|NCT00656513|40115367|FG001|Overall Study|Missing data|11|||
16446728|NCT00656513|40115368|FG002|Overall Study|Missing data|9|||
16446729|NCT00656513|40115366|FG000|Overall Study|Incomplete treatment|3|||
16446730|NCT00656513|40115367|FG001|Overall Study|Incomplete treatment|0|||
16446731|NCT00656513|40115368|FG002|Overall Study|Incomplete treatment|0|||
16446732|NCT00656513|40115366|FG000|Overall Study|Treatment completed outside of timeframe|0|||
16446733|NCT00656513|40115367|FG001|Overall Study|Treatment completed outside of timeframe|3|||
16446734|NCT00656513|40115368|FG002|Overall Study|Treatment completed outside of timeframe|1|||
16446735|NCT00656513|40115366|FG000|Overall Study|Missing baseline form|0|||
16446736|NCT00656513|40115367|FG001|Overall Study|Missing baseline form|5|||
16159692|NCT02684981|39068356|FG000|Overall Study|Permanently discontinued the treatment|157|||
16159693|NCT02684981|39068357|FG001|Overall Study|Permanently discontinued the treatment|161|||
16159694|NCT02684981|39068358|FG002|Overall Study|Permanently discontinued the treatment|110|||
16159695|NCT02684981|39068356|FG000|Overall Study|Other|83|||
16159696|NCT02684981|39068357|FG001|Overall Study|Other|49|||
16159697|NCT02684981|39068358|FG002|Overall Study|Other|17|||
16159698|NCT01325428|39068359|FG000|Part A|Progressive disease according to RECIST|9|||
16446737|NCT00656513|40115368|FG002|Overall Study|Missing baseline form|5|||
16446738|NCT00927953|40115369|FG000|Overall Study|Death|2|||
16446739|NCT00927953|40115370|FG001|Overall Study|Death|1|||
16446740|NCT02557139|40115375|FG000|Overall Study|Significant liver elevation|1|||
16446741|NCT02557139|40115376|FG001|Overall Study|Significant liver elevation|0|||
16446742|NCT02557139|40115377|FG002|Overall Study|Significant liver elevation|1|||
16446743|NCT02557139|40115375|FG000|Overall Study|Withdrawal by Subject|1|||
16067748|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16067749|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16067750|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16067751|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16159699|NCT01325428|39068359|FG000|Part A|Clinical signs, symptoms of progression|2|||
16159700|NCT01325428|39068359|FG000|Part A|Other adverse event|1|||
16159701|NCT01325428|39068359|FG000|Part A|Refused continue taking trial medication|2|||
16446744|NCT02557139|40115376|FG001|Overall Study|Withdrawal by Subject|0|||
16446745|NCT02557139|40115377|FG002|Overall Study|Withdrawal by Subject|0|||
16446746|NCT02557139|40115375|FG000|Overall Study|Illness of prohibited medication|0|||
16446747|NCT02557139|40115376|FG001|Overall Study|Illness of prohibited medication|0|||
16446748|NCT02557139|40115377|FG002|Overall Study|Illness of prohibited medication|1|||
16446749|NCT02059278|40115380|FG000|Overall Study|Adverse Event|1|||
16446750|NCT02059278|40115381|FG001|Overall Study|Adverse Event|1|||
16446751|NCT02059278|40115380|FG000|Overall Study|Lost to Follow-up|1|||
16446752|NCT02059278|40115381|FG001|Overall Study|Lost to Follow-up|0|||
16446753|NCT02059278|40115380|FG000|Overall Study|Withdrawal by Subject|0|||
16446754|NCT02059278|40115381|FG001|Overall Study|Withdrawal by Subject|3|||
16446755|NCT02059278|40115380|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
16446756|NCT02059278|40115381|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
16446757|NCT01761877|40115382|FG000|Overall Study|Adverse Event|7|||
16446758|NCT01761877|40115383|FG001|Overall Study|Adverse Event|0|||
16446759|NCT01761877|40115382|FG000|Overall Study|Withdrawal by Subject|6|||
16446760|NCT01761877|40115383|FG001|Overall Study|Withdrawal by Subject|4|||
16446761|NCT01761877|40115382|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
16446762|NCT01761877|40115383|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
16446763|NCT01761877|40115382|FG000|Overall Study|Death|0|||
16446764|NCT01761877|40115383|FG001|Overall Study|Death|1|||
16446765|NCT01761877|40115382|FG000|Overall Study|MRI intolerant|1|||
16446766|NCT01761877|40115383|FG001|Overall Study|MRI intolerant|6|||
16446767|NCT02066181|40115386|FG000|Overall Study|Withdrawal by Subject|1|||
16446768|NCT02066181|40115387|FG001|Overall Study|Withdrawal by Subject|1|||
16446769|NCT02345070|40115388|FG000|Overall Study|Adverse Event|12|||
16446770|NCT02345070|40115389|FG001|Overall Study|Adverse Event|8|||
16446771|NCT02345070|40115390|FG002|Overall Study|Adverse Event|16|||
16446772|NCT02345070|40115388|FG000|Overall Study|Poor compliance to protocol|2|||
16446773|NCT02345070|40115389|FG001|Overall Study|Poor compliance to protocol|0|||
16446774|NCT02345070|40115390|FG002|Overall Study|Poor compliance to protocol|0|||
16446775|NCT02345070|40115388|FG000|Overall Study|Other than specified above|6|||
16446776|NCT02345070|40115389|FG001|Overall Study|Other than specified above|3|||
16446777|NCT02345070|40115390|FG002|Overall Study|Other than specified above|7|||
16446778|NCT02863419|40115391|FG000|Overall Study|Lost to Follow-up|0|||
16446779|NCT02863419|40115392|FG001|Overall Study|Lost to Follow-up|1|||
16446780|NCT02863419|40115393|FG002|Overall Study|Lost to Follow-up|4|||
16446781|NCT02863419|40115391|FG000|Overall Study|Withdrawal by Subject|5|||
16446782|NCT02863419|40115392|FG001|Overall Study|Withdrawal by Subject|5|||
16446783|NCT02863419|40115393|FG002|Overall Study|Withdrawal by Subject|3|||
16446784|NCT02863419|40115391|FG000|Overall Study|Died|3|||
16446785|NCT02863419|40115392|FG001|Overall Study|Died|4|||
16446786|NCT02863419|40115393|FG002|Overall Study|Died|1|||
16446787|NCT03175367|40115396|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
16446788|NCT03175367|40115397|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
16446789|NCT03175367|40115398|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
16446790|NCT03175367|40115399|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
16446791|NCT03175367|40115400|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
16446792|NCT03175367|40115401|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
16067752|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16067753|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16067754|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16067755|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16067756|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16067757|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
16067758|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
16067759|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
16446793|NCT03175367|40115402|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
16446794|NCT03175367|40115396|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
16159702|NCT01325428|39068359|FG000|Part A|Other reason not defined above|2|||
16159703|NCT01325428|39068359|FG000|Part B|Refused continue taking trial medication|2|||
16159704|NCT01325428|39068359|FG000|Part B|Other reason not defined above|1|||
16159705|NCT01789970|39068360|FG000|Open-label Titration Period|Adverse Event|68|||
16159706|NCT01789970|39068361|FG001|Open-label Titration Period|Adverse Event|0|||
16159707|NCT01789970|39068362|FG002|Open-label Titration Period|Adverse Event|0|||
16159708|NCT01789970|39068360|FG000|Open-label Titration Period|Lack of Efficacy|31|||
16159709|NCT01789970|39068361|FG001|Open-label Titration Period|Lack of Efficacy|0|||
16159710|NCT01789970|39068362|FG002|Open-label Titration Period|Lack of Efficacy|0|||
16159711|NCT01789970|39068360|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
16159712|NCT01789970|39068361|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
16159713|NCT01789970|39068362|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
16159714|NCT01789970|39068360|FG000|Open-label Titration Period|Protocol Violation|18|||
16159715|NCT01789970|39068361|FG001|Open-label Titration Period|Protocol Violation|0|||
16159716|NCT01789970|39068362|FG002|Open-label Titration Period|Protocol Violation|0|||
16067760|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16067761|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16067762|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16067763|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16067764|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16067765|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16067766|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16067767|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16446795|NCT03175367|40115397|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
16067768|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16159717|NCT01789970|39068360|FG000|Open-label Titration Period|Lost to Follow-up|5|||
16159718|NCT01789970|39068361|FG001|Open-label Titration Period|Lost to Follow-up|0|||
16159719|NCT01789970|39068362|FG002|Open-label Titration Period|Lost to Follow-up|0|||
16159720|NCT01789970|39068360|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
16159721|NCT01789970|39068361|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
16159722|NCT01789970|39068362|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
16159723|NCT01789970|39068360|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
16159724|NCT01789970|39068361|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
16159725|NCT01789970|39068362|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
16159726|NCT01789970|39068360|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
16159727|NCT01789970|39068361|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
16159728|NCT01789970|39068362|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
16159729|NCT01789970|39068360|FG000|Open-label Titration Period|Pregnancy|2|||
16159730|NCT01789970|39068361|FG001|Open-label Titration Period|Pregnancy|0|||
16159731|NCT01789970|39068362|FG002|Open-label Titration Period|Pregnancy|0|||
16159732|NCT01789970|39068360|FG000|Open-label Titration Period|Other|76|||
16159733|NCT01789970|39068361|FG001|Open-label Titration Period|Other|0|||
16159734|NCT01789970|39068362|FG002|Open-label Titration Period|Other|0|||
16159735|NCT01789970|39068360|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
16159736|NCT01789970|39068361|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
16159737|NCT01789970|39068362|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
16159738|NCT01789970|39068360|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
16159739|NCT01789970|39068361|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
16159740|NCT01789970|39068362|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
16159741|NCT01789970|39068360|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
16159742|NCT01789970|39068361|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
16159743|NCT01789970|39068362|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
16159744|NCT01789970|39068360|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
16159745|NCT01789970|39068361|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
16159746|NCT01789970|39068362|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
16159747|NCT01789970|39068360|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
16159748|NCT01789970|39068361|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
16159749|NCT01789970|39068362|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
16159750|NCT01789970|39068360|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
16159751|NCT01789970|39068361|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
16159752|NCT01789970|39068362|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
16159753|NCT01789970|39068360|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
16159754|NCT01789970|39068361|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
16159755|NCT01789970|39068362|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
16159756|NCT01789970|39068360|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
16159757|NCT01789970|39068361|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
16159758|NCT01789970|39068362|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
16446796|NCT03175367|40115398|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
16446797|NCT03175367|40115399|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
16446798|NCT03175367|40115400|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
16067769|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16067770|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16067771|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
16067772|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
16067773|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
16067774|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16446799|NCT03175367|40115401|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
16446800|NCT03175367|40115402|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
16446801|NCT03175367|40115396|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
16446802|NCT03175367|40115397|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
16446803|NCT03175367|40115398|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
16446804|NCT03175367|40115399|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
16446805|NCT03175367|40115400|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
16446806|NCT03175367|40115401|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
16446807|NCT03175367|40115402|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
16446808|NCT03175367|40115396|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
16446809|NCT03175367|40115397|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
16446810|NCT03175367|40115398|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
16446811|NCT03175367|40115399|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
16446812|NCT03175367|40115400|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
16446813|NCT03175367|40115401|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
16446814|NCT03175367|40115402|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
16446815|NCT03175367|40115396|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16446816|NCT03175367|40115397|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16446817|NCT03175367|40115398|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
16446818|NCT03175367|40115399|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16446819|NCT03175367|40115400|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
16446820|NCT03175367|40115401|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16446821|NCT03175367|40115402|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16446822|NCT03175367|40115396|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16446823|NCT03175367|40115397|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16446824|NCT03175367|40115398|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16446825|NCT03175367|40115399|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16446826|NCT03175367|40115400|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16067775|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067776|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067777|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067778|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067779|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067780|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067781|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067782|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067783|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067784|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067785|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
16067786|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
16067787|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
16067788|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067789|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067790|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067791|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067792|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067793|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067794|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067795|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067796|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067797|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067798|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067799|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
16067800|NCT03982199|38739549|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
16446827|NCT03175367|40115401|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
16446828|NCT03175367|40115402|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
16446829|NCT03175367|40115396|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16446830|NCT03175367|40115397|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16446831|NCT03175367|40115398|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16446832|NCT03175367|40115399|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16446833|NCT03175367|40115400|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16446834|NCT03175367|40115401|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
16446835|NCT03175367|40115402|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
16446836|NCT03962491|40115403|FG000|Overall Study|Lost to Follow-up|4|||
16159759|NCT01789970|39068360|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
16159760|NCT01789970|39068361|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
16159761|NCT01789970|39068362|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
16159762|NCT01789970|39068360|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
16159763|NCT01789970|39068361|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
16159764|NCT01789970|39068362|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
16159765|NCT01789970|39068360|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
16159766|NCT01789970|39068361|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
16159767|NCT01789970|39068362|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
16159768|NCT01903837|39068366|FG000|Part A|Withdrawal by Subject|4|||
16159769|NCT01903837|39068367|FG001|Part A|Withdrawal by Subject|9|||
16159770|NCT01903837|39068368|FG002|Part A|Withdrawal by Subject|8|||
16446837|NCT03962491|40115404|FG001|Overall Study|Lost to Follow-up|5|||
16446838|NCT01526733|40115405|FG000|Phase 1|Protocol Violation|1|||
16446839|NCT01526733|40115406|FG001|Phase 1|Protocol Violation|0|||
16446840|NCT01526733|40115405|FG000|Phase 1|Withdrawal by Subject|1|||
16067801|NCT03982199|38739550|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
16067802|NCT03982199|38739551|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067803|NCT03982199|38739552|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067804|NCT03982199|38739553|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067805|NCT03982199|38739554|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067806|NCT03982199|38739555|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067807|NCT03982199|38739556|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16159771|NCT01903837|39068369|FG003|Part A|Withdrawal by Subject|5|||
16159772|NCT01903837|39068366|FG000|Part A|Adverse Event|3|||
16159773|NCT01903837|39068367|FG001|Part A|Adverse Event|6|||
16159774|NCT01903837|39068368|FG002|Part A|Adverse Event|9|||
16159775|NCT01903837|39068369|FG003|Part A|Adverse Event|6|||
16446841|NCT01526733|40115406|FG001|Phase 1|Withdrawal by Subject|1|||
16446842|NCT00724698|40115407|FG000|Overall Study|Adverse Event|9|||
16446843|NCT00724698|40115407|FG000|Overall Study|Failure of Therapy|4|||
16446844|NCT00724698|40115407|FG000|Overall Study|Poor Compliance|16|||
16446845|NCT00724698|40115407|FG000|Overall Study|Lost to Follow-up|36|||
16446846|NCT00724698|40115407|FG000|Overall Study|No Info|25|||
16446847|NCT02141295|40115408|FG000|Overall Study|Adverse Event|1|||
16446848|NCT02141295|40115409|FG001|Overall Study|Adverse Event|18|||
16446849|NCT02141295|40115410|FG002|Overall Study|Adverse Event|11|||
16446850|NCT02141295|40115408|FG000|Overall Study|Physician Decision|2|||
16446851|NCT02141295|40115409|FG001|Overall Study|Physician Decision|19|||
16446852|NCT02141295|40115410|FG002|Overall Study|Physician Decision|14|||
16446853|NCT02141295|40115408|FG000|Overall Study|Study terminated by sponsor|0|||
16446854|NCT02141295|40115409|FG001|Overall Study|Study terminated by sponsor|6|||
16446855|NCT02141295|40115410|FG002|Overall Study|Study terminated by sponsor|6|||
16446856|NCT02141295|40115408|FG000|Overall Study|Non-compliance|0|||
16446857|NCT02141295|40115409|FG001|Overall Study|Non-compliance|1|||
16446858|NCT02141295|40115410|FG002|Overall Study|Non-compliance|0|||
16446859|NCT02141295|40115408|FG000|Overall Study|Progressive disease|3|||
16446860|NCT02141295|40115409|FG001|Overall Study|Progressive disease|32|||
16446861|NCT02141295|40115410|FG002|Overall Study|Progressive disease|50|||
16446862|NCT02141295|40115408|FG000|Overall Study|Reason not specified|0|||
16446863|NCT02141295|40115409|FG001|Overall Study|Reason not specified|9|||
16446864|NCT02141295|40115410|FG002|Overall Study|Reason not specified|10|||
16446865|NCT02141295|40115408|FG000|Overall Study|Withdrawal by Subject|0|||
16159776|NCT01903837|39068366|FG000|Part A|Lost to Follow-up|9|||
16159777|NCT01903837|39068367|FG001|Part A|Lost to Follow-up|7|||
16446866|NCT02141295|40115409|FG001|Overall Study|Withdrawal by Subject|9|||
16446867|NCT02141295|40115410|FG002|Overall Study|Withdrawal by Subject|4|||
16159778|NCT01903837|39068368|FG002|Part A|Lost to Follow-up|7|||
16159779|NCT01903837|39068369|FG003|Part A|Lost to Follow-up|2|||
16159780|NCT01903837|39068366|FG000|Part A|Non-compliance with study drug|1|||
16446868|NCT01868997|40115413|FG000|Overall Study|Adverse Event|2|||
16446869|NCT01868997|40115414|FG001|Overall Study|Adverse Event|5|||
16446870|NCT01868997|40115413|FG000|Overall Study|Lack of Efficacy|2|||
16446871|NCT01868997|40115414|FG001|Overall Study|Lack of Efficacy|0|||
16446872|NCT01868997|40115413|FG000|Overall Study|Other|3|||
16067808|NCT03982199|38739557|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067809|NCT03982199|38739558|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067810|NCT03982199|38739559|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067811|NCT03982199|38739560|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067812|NCT03982199|38739561|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067813|NCT03982199|38739562|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
16067814|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067815|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067816|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067817|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
16067818|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067819|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067820|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067821|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067822|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067823|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067824|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067825|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067826|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067827|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
16067828|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067829|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067830|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
16067831|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067832|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16369879|NCT00433537|39839728|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
16369880|NCT00433537|39839729|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
16369881|NCT00433537|39839727|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
16369882|NCT00433537|39839728|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
16369883|NCT00433537|39839729|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
16369884|NCT00433537|39839727|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
16369885|NCT00433537|39839728|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
16369886|NCT00433537|39839729|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
16369887|NCT00433537|39839727|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
16369888|NCT00433537|39839728|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
16369889|NCT00433537|39839729|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
16369890|NCT00433537|39839727|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
16369891|NCT00433537|39839728|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
16369892|NCT00433537|39839729|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
16369893|NCT02945046|39839730|FG000|Overall Study|Adverse Event|1|||
16369894|NCT02945046|39839731|FG001|Overall Study|Adverse Event|0|||
16369895|NCT02945046|39839732|FG002|Overall Study|Adverse Event|2|||
16369896|NCT02945046|39839730|FG000|Overall Study|Withdrawal by Subject|3|||
16369897|NCT02945046|39839731|FG001|Overall Study|Withdrawal by Subject|3|||
16369898|NCT02945046|39839732|FG002|Overall Study|Withdrawal by Subject|3|||
16369899|NCT02945046|39839730|FG000|Overall Study|Protocol Violation|2|||
16369900|NCT02945046|39839731|FG001|Overall Study|Protocol Violation|3|||
16369901|NCT02945046|39839732|FG002|Overall Study|Protocol Violation|2|||
16369902|NCT02945046|39839730|FG000|Overall Study|Lost to Follow-up|1|||
16369903|NCT02945046|39839731|FG001|Overall Study|Lost to Follow-up|1|||
16369904|NCT02945046|39839732|FG002|Overall Study|Lost to Follow-up|0|||
16369905|NCT02945046|39839730|FG000|Overall Study|Lack of Efficacy|1|||
16369906|NCT02945046|39839731|FG001|Overall Study|Lack of Efficacy|2|||
16369907|NCT02945046|39839732|FG002|Overall Study|Lack of Efficacy|1|||
16369908|NCT02945046|39839730|FG000|Overall Study|Other than specified|5|||
16369909|NCT02945046|39839731|FG001|Overall Study|Other than specified|4|||
16369910|NCT02945046|39839732|FG002|Overall Study|Other than specified|7|||
16369911|NCT01898091|39839737|FG000|Overall Study|Lost to Follow-up|1|||
16369912|NCT01898091|39839738|FG001|Overall Study|Lost to Follow-up|1|||
16369913|NCT01898091|39839737|FG000|Overall Study|Withdrawal by Subject|1|||
16369914|NCT01898091|39839738|FG001|Overall Study|Withdrawal by Subject|5|||
16369915|NCT01734928|39839741|FG000|Randomization|Physician Decision|0|||
16369916|NCT01734928|39839742|FG001|Randomization|Physician Decision|1|||
16369917|NCT01734928|39839741|FG000|Randomization|clinical progression|0|||
16369918|NCT01734928|39839742|FG001|Randomization|clinical progression|1|||
16369919|NCT01734928|39839741|FG000|Randomization|progressive disease|0|||
16369920|NCT01734928|39839742|FG001|Randomization|progressive disease|2|||
16369921|NCT01734928|39839741|FG000|Randomization|Withdrew informed consent|0|||
16369922|NCT01734928|39839742|FG001|Randomization|Withdrew informed consent|4|||
16369923|NCT01734928|39839741|FG000|Randomization|Death|1|||
16067833|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067834|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067835|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067836|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067837|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067838|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067839|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067840|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067841|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
16067842|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16067843|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16067844|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
16067845|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16067846|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16067847|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16159781|NCT01903837|39068367|FG001|Part A|Non-compliance with study drug|4|||
16159782|NCT01903837|39068368|FG002|Part A|Non-compliance with study drug|4|||
16159783|NCT01903837|39068369|FG003|Part A|Non-compliance with study drug|0|||
16159784|NCT01903837|39068366|FG000|Part A|Physician Decision|1|||
16159785|NCT01903837|39068367|FG001|Part A|Physician Decision|1|||
16159786|NCT01903837|39068368|FG002|Part A|Physician Decision|0|||
16159787|NCT01903837|39068369|FG003|Part A|Physician Decision|0|||
16159788|NCT01903837|39068366|FG000|Part A|Protocol Violation|1|||
16159789|NCT01903837|39068367|FG001|Part A|Protocol Violation|1|||
16159790|NCT01903837|39068368|FG002|Part A|Protocol Violation|0|||
16159791|NCT01903837|39068369|FG003|Part A|Protocol Violation|0|||
16263894|NCT02321098|39453092|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
16263895|NCT02321098|39453093|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
16263896|NCT02321098|39453094|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
16263897|NCT02321098|39453092|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
16067848|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16067849|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16067850|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16067851|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16263898|NCT02321098|39453093|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
16263899|NCT02321098|39453094|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
16263900|NCT00365365|39453095|FG000|Overall Study|Randomized but not treated|0|||
16263901|NCT00365365|39453096|FG001|Overall Study|Randomized but not treated|2|||
16369924|NCT01734928|39839742|FG001|Randomization|Death|0|||
16369925|NCT01734928|39839741|FG000|Randomization|Randomization error|1|||
16369926|NCT01734928|39839742|FG001|Randomization|Randomization error|0|||
16369927|NCT01734928|39839741|FG000|Randomization|Lost to Follow-up|1|||
16369928|NCT01734928|39839742|FG001|Randomization|Lost to Follow-up|0|||
16369929|NCT01734928|39839741|FG000|Treatment Period|Lost to Follow-up|0|||
16369930|NCT01734928|39839742|FG001|Treatment Period|Lost to Follow-up|2|||
16369931|NCT01734928|39839741|FG000|Treatment Period|Progressive Disease|167|||
16369932|NCT01734928|39839742|FG001|Treatment Period|Progressive Disease|165|||
16369933|NCT01734928|39839741|FG000|Treatment Period|Adverse Event|39|||
16369934|NCT01734928|39839742|FG001|Treatment Period|Adverse Event|52|||
16369935|NCT01734928|39839741|FG000|Treatment Period|Withdrawal of Consent|25|||
16369936|NCT01734928|39839742|FG001|Treatment Period|Withdrawal of Consent|22|||
16369937|NCT01734928|39839741|FG000|Treatment Period|Death|20|||
16369938|NCT01734928|39839742|FG001|Treatment Period|Death|9|||
16369939|NCT01734928|39839741|FG000|Treatment Period|Other Reasons|27|||
16369940|NCT01734928|39839742|FG001|Treatment Period|Other Reasons|19|||
16369941|NCT01734928|39839741|FG000|Treatment Period|Pregnancy|0|||
16369942|NCT01734928|39839742|FG001|Treatment Period|Pregnancy|1|||
16369943|NCT01646216|39839743|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
16369944|NCT01646216|39839744|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
16369945|NCT01646216|39839743|FG000|Overall Study|Did not complete training|0|||
16369946|NCT01646216|39839744|FG001|Overall Study|Did not complete training|2|||
16369947|NCT01646216|39839743|FG000|Overall Study|Investigator decision|1|||
16369948|NCT01646216|39839744|FG001|Overall Study|Investigator decision|1|||
16067852|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16159792|NCT01903837|39068366|FG000|Part B|Lost to Follow-up|0|||
16159793|NCT01903837|39068367|FG001|Part B|Lost to Follow-up|3|||
16159794|NCT01903837|39068368|FG002|Part B|Lost to Follow-up|3|||
16159795|NCT01903837|39068369|FG003|Part B|Lost to Follow-up|4|||
16263902|NCT00365365|39453097|FG002|Overall Study|Randomized but not treated|0|||
16369949|NCT00544882|39839745|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
16369950|NCT00544882|39839746|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
16369951|NCT00544882|39839747|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
16369952|NCT00544882|39839745|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
16446873|NCT01868997|40115414|FG001|Overall Study|Other|1|||
16263903|NCT00365365|39453095|FG000|Overall Study|Poor compliance to protocol|0|||
16263904|NCT00365365|39453096|FG001|Overall Study|Poor compliance to protocol|1|||
16263905|NCT00365365|39453097|FG002|Overall Study|Poor compliance to protocol|0|||
16263906|NCT00365365|39453095|FG000|Overall Study|Lost to Follow-up|3|||
16263907|NCT00365365|39453096|FG001|Overall Study|Lost to Follow-up|3|||
16263908|NCT00365365|39453097|FG002|Overall Study|Lost to Follow-up|3|||
16263909|NCT00365365|39453095|FG000|Overall Study|Death|1|||
16263910|NCT00365365|39453096|FG001|Overall Study|Death|3|||
16263911|NCT00365365|39453097|FG002|Overall Study|Death|0|||
16263912|NCT00365365|39453095|FG000|Overall Study|Subject's request|11|||
16263913|NCT00365365|39453096|FG001|Overall Study|Subject's request|13|||
16263914|NCT00365365|39453097|FG002|Overall Study|Subject's request|1|||
16263915|NCT00365365|39453095|FG000|Overall Study|Disease progression/relapse|9|||
16067853|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16067854|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16263916|NCT00365365|39453096|FG001|Overall Study|Disease progression/relapse|6|||
16263917|NCT00365365|39453097|FG002|Overall Study|Disease progression/relapse|7|||
16263918|NCT00365365|39453095|FG000|Overall Study|Adverse Event|6|||
16263919|NCT00365365|39453096|FG001|Overall Study|Adverse Event|6|||
16263920|NCT00365365|39453097|FG002|Overall Study|Adverse Event|3|||
16263921|NCT00365365|39453095|FG000|Overall Study|Moved|2|||
16067855|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
16263922|NCT00365365|39453096|FG001|Overall Study|Moved|0|||
16263923|NCT00365365|39453097|FG002|Overall Study|Moved|0|||
16263924|NCT00365365|39453095|FG000|Overall Study|New cancer|1|||
16263925|NCT00365365|39453096|FG001|Overall Study|New cancer|0|||
16067856|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16263926|NCT00365365|39453097|FG002|Overall Study|New cancer|0|||
16067857|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067858|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
16067859|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
16067860|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067861|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067862|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067863|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067864|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067865|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067866|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067867|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067868|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067869|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
16067870|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067871|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067872|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067873|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
16067874|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067875|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067876|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067877|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067878|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067879|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067880|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067881|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067882|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067883|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
16067884|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16067885|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16067886|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
16067887|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
16067888|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16067889|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16067890|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16067891|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16263927|NCT00365365|39453095|FG000|Overall Study|Withdrew consent|1|||
16263928|NCT00365365|39453096|FG001|Overall Study|Withdrew consent|1|||
16263929|NCT00365365|39453097|FG002|Overall Study|Withdrew consent|0|||
16263930|NCT00365365|39453095|FG000|Overall Study|Second malignancy|0|||
16263931|NCT00365365|39453096|FG001|Overall Study|Second malignancy|1|||
16263932|NCT00365365|39453097|FG002|Overall Study|Second malignancy|0|||
16263933|NCT00365365|39453095|FG000|Overall Study|Patient/physician decision|0|||
16159796|NCT01903837|39068366|FG000|Part B|Withdrawal by Subject|1|||
16159797|NCT01903837|39068367|FG001|Part B|Withdrawal by Subject|2|||
16159798|NCT01903837|39068368|FG002|Part B|Withdrawal by Subject|0|||
16159799|NCT01903837|39068369|FG003|Part B|Withdrawal by Subject|3|||
16159800|NCT01903837|39068366|FG000|Part B|Adverse Event|3|||
16159801|NCT01903837|39068367|FG001|Part B|Adverse Event|0|||
16159802|NCT01903837|39068368|FG002|Part B|Adverse Event|2|||
16159803|NCT01903837|39068369|FG003|Part B|Adverse Event|0|||
16159804|NCT01903837|39068366|FG000|Part B|Non-compliance with study drug|2|||
16159805|NCT01903837|39068367|FG001|Part B|Non-compliance with study drug|0|||
16159806|NCT01903837|39068368|FG002|Part B|Non-compliance with study drug|0|||
16159807|NCT01903837|39068369|FG003|Part B|Non-compliance with study drug|1|||
16159808|NCT01903837|39068366|FG000|Part B|Incarceration|2|||
16159809|NCT01903837|39068367|FG001|Part B|Incarceration|0|||
16159810|NCT01903837|39068368|FG002|Part B|Incarceration|0|||
16159811|NCT01903837|39068369|FG003|Part B|Incarceration|1|||
16369953|NCT00544882|39839746|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
16369954|NCT00544882|39839747|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
16067892|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16159812|NCT01903837|39068366|FG000|Part B|Physician Decision|1|||
16159813|NCT01903837|39068367|FG001|Part B|Physician Decision|0|||
16159814|NCT01903837|39068368|FG002|Part B|Physician Decision|0|||
16159815|NCT01903837|39068369|FG003|Part B|Physician Decision|2|||
16067893|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16067894|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16067895|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16067896|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16067897|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
16067898|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067899|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067900|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16159816|NCT01903837|39068366|FG000|Part B|Lack of Efficacy|0|||
16159817|NCT01903837|39068367|FG001|Part B|Lack of Efficacy|1|||
16159818|NCT01903837|39068368|FG002|Part B|Lack of Efficacy|0|||
16159819|NCT01903837|39068369|FG003|Part B|Lack of Efficacy|0|||
16159820|NCT01703858|39068370|FG000|Overall Study|Withdrawal by Subject|0|||
16159821|NCT01703858|39068371|FG001|Overall Study|Withdrawal by Subject|1|||
16369955|NCT00544882|39839745|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
16369956|NCT00544882|39839746|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
16369957|NCT00544882|39839747|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
16369958|NCT00544882|39839745|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
16369959|NCT00544882|39839746|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
16369960|NCT00544882|39839747|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
16369961|NCT00544882|39839745|FG000|Cycle 3: Follow-up|Noncompliance|0|||
16369962|NCT00544882|39839746|FG001|Cycle 3: Follow-up|Noncompliance|1|||
16369963|NCT00544882|39839747|FG002|Cycle 3: Follow-up|Noncompliance|0|||
16369964|NCT00544882|39839745|FG000|Cycle 3: Follow-up|Pregnancy|0|||
16446874|NCT01354314|40115415|FG000|Overall Study|Lost to Follow-up|1|||
16446875|NCT01354314|40115416|FG001|Overall Study|Lost to Follow-up|0|||
16446876|NCT01354314|40115417|FG002|Overall Study|Lost to Follow-up|1|||
16446877|NCT01354314|40115418|FG003|Overall Study|Lost to Follow-up|1|||
16446878|NCT01354314|40115415|FG000|Overall Study|Withdrawal by Subject|0|||
16446879|NCT01354314|40115416|FG001|Overall Study|Withdrawal by Subject|0|||
16446880|NCT01354314|40115417|FG002|Overall Study|Withdrawal by Subject|1|||
16067901|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067902|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067903|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067904|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067905|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067906|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
16067907|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067908|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067909|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16446881|NCT01354314|40115418|FG003|Overall Study|Withdrawal by Subject|0|||
16446882|NCT01354314|40115415|FG000|Overall Study|Adverse Event|0|||
16446883|NCT01354314|40115416|FG001|Overall Study|Adverse Event|0|||
16067910|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067911|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
16067912|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16159822|NCT01703858|39068372|FG002|Overall Study|Withdrawal by Subject|0|||
16159823|NCT04372927|39068375|FG000|Overall Study|Death|1|||
16369965|NCT00544882|39839746|FG001|Cycle 3: Follow-up|Pregnancy|1|||
16369966|NCT00544882|39839747|FG002|Cycle 3: Follow-up|Pregnancy|0|||
16159824|NCT03273166|39068380|FG000|Overall Study|Withdrawn prior to Completion|31|||
16159825|NCT02658812|39068383|FG000|Overall Study|Disease Progression|7|||
16159826|NCT02658812|39068383|FG000|Overall Study|Unrelated to study treatment|1|||
16067913|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067914|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067915|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067916|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067917|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067918|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067919|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067920|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
16446884|NCT01354314|40115417|FG002|Overall Study|Adverse Event|0|||
16446885|NCT01354314|40115418|FG003|Overall Study|Adverse Event|1|||
16446886|NCT01354314|40115415|FG000|Overall Study|Protocol Violation|1|||
16446887|NCT01354314|40115416|FG001|Overall Study|Protocol Violation|1|||
16446888|NCT01354314|40115417|FG002|Overall Study|Protocol Violation|0|||
16446889|NCT01354314|40115418|FG003|Overall Study|Protocol Violation|0|||
16369967|NCT02536794|39839748|FG000|Reached 1st Response Assessment|Adverse Event|2|||
16369968|NCT02536794|39839748|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
16369969|NCT02536794|39839748|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
16369970|NCT02536794|39839748|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
16369971|NCT02536794|39839748|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
16369972|NCT02536794|39839748|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
16369973|NCT02782468|39839749|FG000|Overall Study|Progressive Disease|2|||
16369974|NCT02782468|39839750|FG001|Overall Study|Progressive Disease|5|||
16369975|NCT02782468|39839751|FG002|Overall Study|Progressive Disease|0|||
16369976|NCT02782468|39839752|FG003|Overall Study|Progressive Disease|4|||
16369977|NCT02782468|39839749|FG000|Overall Study|Adverse Event|0|||
16369978|NCT02782468|39839750|FG001|Overall Study|Adverse Event|2|||
16369979|NCT02782468|39839751|FG002|Overall Study|Adverse Event|2|||
16369980|NCT02782468|39839752|FG003|Overall Study|Adverse Event|3|||
16369981|NCT02782468|39839749|FG000|Overall Study|Other|0|||
16369982|NCT02782468|39839750|FG001|Overall Study|Other|0|||
16369983|NCT02782468|39839751|FG002|Overall Study|Other|1|||
16369984|NCT02782468|39839752|FG003|Overall Study|Other|1|||
16369985|NCT02782468|39839749|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
16369986|NCT02782468|39839750|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
16369987|NCT02782468|39839751|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
16369988|NCT02782468|39839752|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
16369989|NCT02782468|39839749|FG000|Overall Study|Symptomatic Deterioration|0|||
16369990|NCT02782468|39839750|FG001|Overall Study|Symptomatic Deterioration|0|||
16369991|NCT02782468|39839751|FG002|Overall Study|Symptomatic Deterioration|0|||
16369992|NCT02782468|39839752|FG003|Overall Study|Symptomatic Deterioration|1|||
16369993|NCT02782468|39839749|FG000|Overall Study|Withdrawal by Subject|1|||
16369994|NCT02782468|39839750|FG001|Overall Study|Withdrawal by Subject|0|||
16369995|NCT02782468|39839751|FG002|Overall Study|Withdrawal by Subject|0|||
16369996|NCT02782468|39839752|FG003|Overall Study|Withdrawal by Subject|0|||
16369997|NCT00930176|39839754|FG000|Overall Study|Death|1|||
16369998|NCT02318277|39839758|FG000|Overall Study|Physician Decision|0|||
16369999|NCT02318277|39839759|FG001|Overall Study|Physician Decision|0|||
16370000|NCT02318277|39839760|FG002|Overall Study|Physician Decision|0|||
16370001|NCT02318277|39839761|FG003|Overall Study|Physician Decision|0|||
16370002|NCT02318277|39839762|FG004|Overall Study|Physician Decision|0|||
16370003|NCT02318277|39839763|FG005|Overall Study|Physician Decision|0|||
16370004|NCT02318277|39839764|FG006|Overall Study|Physician Decision|0|||
16370005|NCT02318277|39839765|FG007|Overall Study|Physician Decision|1|||
16370006|NCT02318277|39839758|FG000|Overall Study|Other|0|||
16370007|NCT02318277|39839759|FG001|Overall Study|Other|0|||
16370008|NCT02318277|39839760|FG002|Overall Study|Other|0|||
16370009|NCT02318277|39839761|FG003|Overall Study|Other|0|||
16370010|NCT02318277|39839762|FG004|Overall Study|Other|0|||
16370011|NCT02318277|39839763|FG005|Overall Study|Other|0|||
16370012|NCT02318277|39839764|FG006|Overall Study|Other|1|||
16370013|NCT02318277|39839765|FG007|Overall Study|Other|0|||
16446890|NCT01354314|40115415|FG000|Overall Study|Less than 90% Adherence|4|||
16446891|NCT01354314|40115416|FG001|Overall Study|Less than 90% Adherence|2|||
16446892|NCT01354314|40115417|FG002|Overall Study|Less than 90% Adherence|6|||
16446893|NCT01354314|40115418|FG003|Overall Study|Less than 90% Adherence|4|||
16446894|NCT01600716|40115419|FG000|Overall Study|Other Reasons|3|||
16446895|NCT01600716|40115420|FG001|Overall Study|Other Reasons|1|||
16446896|NCT01600716|40115419|FG000|Overall Study|Personal Reasons|0|||
16446897|NCT01600716|40115420|FG001|Overall Study|Personal Reasons|2|||
16446898|NCT01600716|40115419|FG000|Overall Study|Lost to Follow-up|0|||
16159827|NCT02658812|39068383|FG000|Overall Study|Adverse Event|1|||
16370014|NCT02318277|39839758|FG000|Overall Study|Withdrawal by Subject|0|||
16446899|NCT01600716|40115420|FG001|Overall Study|Lost to Follow-up|2|||
16370015|NCT02318277|39839759|FG001|Overall Study|Withdrawal by Subject|0|||
16370016|NCT02318277|39839760|FG002|Overall Study|Withdrawal by Subject|1|||
16159828|NCT01857869|39068384|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
16159829|NCT01857869|39068385|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
16159830|NCT01857869|39068386|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
16159831|NCT01857869|39068387|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
16159832|NCT01857869|39068388|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
16159833|NCT01857869|39068389|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
16159834|NCT01857869|39068390|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
16159835|NCT01857869|39068391|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
16159836|NCT01857869|39068392|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
16263934|NCT00365365|39453096|FG001|Overall Study|Patient/physician decision|0|||
16263935|NCT00365365|39453097|FG002|Overall Study|Patient/physician decision|1|||
16263936|NCT05038293|39453105|FG000|Overall Study|device was not operating properly for one subject.|1|||
16263937|NCT05038293|39453106|FG001|Overall Study|device was not operating properly for one subject.|0|||
16263938|NCT05038293|39453105|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
16263939|NCT05038293|39453106|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
16263940|NCT04206332|39453107|FG000|Part A|Lost to Follow-up|0|||
16263941|NCT04206332|39453108|FG001|Part A|Lost to Follow-up|1|||
16263942|NCT04206332|39453109|FG002|Part A|Lost to Follow-up|0|||
16263943|NCT04206332|39453110|FG003|Part A|Lost to Follow-up|0|||
16263944|NCT04206332|39453111|FG004|Part A|Lost to Follow-up|0|||
16263945|NCT04206332|39453112|FG005|Part A|Lost to Follow-up|0|||
16263946|NCT04206332|39453113|FG006|Part A|Lost to Follow-up|0|||
16263947|NCT04206332|39453114|FG007|Part A|Lost to Follow-up|0|||
16263948|NCT04206332|39453115|FG008|Part A|Lost to Follow-up|0|||
16263949|NCT04206332|39453116|FG009|Part A|Lost to Follow-up|0|||
16263950|NCT04206332|39453117|FG010|Part A|Lost to Follow-up|0|||
16263951|NCT04206332|39453118|FG011|Part A|Lost to Follow-up|0|||
16263952|NCT04206332|39453119|FG012|Part A|Lost to Follow-up|0|||
16263953|NCT04206332|39453120|FG013|Part A|Lost to Follow-up|0|||
16263954|NCT04206332|39453121|FG014|Part A|Lost to Follow-up|0|||
16263955|NCT04206332|39453122|FG015|Part A|Lost to Follow-up|0|||
16263956|NCT04206332|39453123|FG016|Part A|Lost to Follow-up|0|||
16263957|NCT04206332|39453107|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263958|NCT04206332|39453108|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263959|NCT04206332|39453109|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263960|NCT04206332|39453110|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263961|NCT04206332|39453111|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263962|NCT04206332|39453112|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
16263963|NCT04206332|39453113|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263964|NCT04206332|39453114|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263965|NCT04206332|39453115|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263966|NCT04206332|39453116|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263967|NCT04206332|39453117|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263968|NCT04206332|39453118|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263969|NCT04206332|39453119|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263970|NCT04206332|39453120|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263971|NCT04206332|39453121|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263972|NCT04206332|39453122|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263973|NCT04206332|39453123|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
16263974|NCT04206332|39453107|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263975|NCT04206332|39453108|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263976|NCT04206332|39453109|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263977|NCT04206332|39453110|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263978|NCT04206332|39453111|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263979|NCT04206332|39453112|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263980|NCT04206332|39453113|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263981|NCT04206332|39453114|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
16370017|NCT02318277|39839761|FG003|Overall Study|Withdrawal by Subject|0|||
16370018|NCT02318277|39839762|FG004|Overall Study|Withdrawal by Subject|1|||
16370019|NCT02318277|39839763|FG005|Overall Study|Withdrawal by Subject|1|||
16370020|NCT02318277|39839764|FG006|Overall Study|Withdrawal by Subject|6|||
16370021|NCT02318277|39839765|FG007|Overall Study|Withdrawal by Subject|14|||
16159837|NCT01857869|39068393|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
16159838|NCT01857869|39068384|FG000|Primary/Challenge Phase|Pregnancy|1|||
16263982|NCT04206332|39453115|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263983|NCT04206332|39453116|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263984|NCT04206332|39453117|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
16263985|NCT04206332|39453118|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263986|NCT04206332|39453119|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263987|NCT04206332|39453120|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263988|NCT04206332|39453121|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263989|NCT04206332|39453122|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263990|NCT04206332|39453123|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263991|NCT04206332|39453107|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263992|NCT04206332|39453108|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263993|NCT04206332|39453109|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263994|NCT04206332|39453110|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263995|NCT04206332|39453111|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263996|NCT04206332|39453112|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263997|NCT04206332|39453113|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263998|NCT04206332|39453114|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16263999|NCT04206332|39453115|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16264000|NCT04206332|39453116|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16264001|NCT04206332|39453117|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16264002|NCT04206332|39453118|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16264003|NCT04206332|39453119|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16264004|NCT04206332|39453120|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16264005|NCT04206332|39453121|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16264006|NCT04206332|39453122|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
16264007|NCT04206332|39453123|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
16264008|NCT04206332|39453107|FG000|Part C|Withdrawal by Subject|0|||
16264009|NCT04206332|39453108|FG001|Part C|Withdrawal by Subject|0|||
16446900|NCT01600716|40115419|FG000|Overall Study|Pregnancy|1|||
16264010|NCT04206332|39453109|FG002|Part C|Withdrawal by Subject|0|||
16264011|NCT04206332|39453110|FG003|Part C|Withdrawal by Subject|0|||
16264012|NCT04206332|39453111|FG004|Part C|Withdrawal by Subject|0|||
16446901|NCT01600716|40115420|FG001|Overall Study|Pregnancy|0|||
16446902|NCT01600716|40115419|FG000|Overall Study|Lack of Efficacy|2|||
16446903|NCT01600716|40115420|FG001|Overall Study|Lack of Efficacy|1|||
16446904|NCT01600716|40115419|FG000|Overall Study|Adverse Event|1|||
16446905|NCT01600716|40115420|FG001|Overall Study|Adverse Event|1|||
16446906|NCT03971422|40115421|FG000|Overall Study|Lost to Follow-up|0|||
16446907|NCT03971422|40115422|FG001|Overall Study|Lost to Follow-up|1|||
16446908|NCT03971422|40115423|FG002|Overall Study|Lost to Follow-up|0|||
16446909|NCT03971422|40115421|FG000|Overall Study|Lack of Efficacy|5|||
16446910|NCT03971422|40115422|FG001|Overall Study|Lack of Efficacy|1|||
16264013|NCT04206332|39453112|FG005|Part C|Withdrawal by Subject|0|||
16264014|NCT04206332|39453113|FG006|Part C|Withdrawal by Subject|0|||
16264015|NCT04206332|39453114|FG007|Part C|Withdrawal by Subject|0|||
16264016|NCT04206332|39453115|FG008|Part C|Withdrawal by Subject|0|||
16446911|NCT03971422|40115423|FG002|Overall Study|Lack of Efficacy|1|||
16446912|NCT03971422|40115421|FG000|Overall Study|Adverse event, not fatal|2|||
16446913|NCT03971422|40115422|FG001|Overall Study|Adverse event, not fatal|2|||
16446914|NCT03971422|40115423|FG002|Overall Study|Adverse event, not fatal|5|||
16446915|NCT03971422|40115421|FG000|Overall Study|Worsening of MG Symptoms|1|||
16446916|NCT03971422|40115422|FG001|Overall Study|Worsening of MG Symptoms|4|||
16446917|NCT03971422|40115423|FG002|Overall Study|Worsening of MG Symptoms|2|||
16446918|NCT03971422|40115421|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
16446919|NCT03971422|40115422|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
16446920|NCT03971422|40115423|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
16446921|NCT03971422|40115421|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
16446922|NCT03971422|40115422|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
16446923|NCT03971422|40115423|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
16446924|NCT03971422|40115421|FG000|Overall Study|Due to COVID-19 pandemic|0|||
16446925|NCT03971422|40115422|FG001|Overall Study|Due to COVID-19 pandemic|1|||
16446926|NCT03971422|40115423|FG002|Overall Study|Due to COVID-19 pandemic|1|||
16446927|NCT02038933|40115426|FG000|Overall Study|Disease progression|104|||
16446928|NCT02038933|40115426|FG000|Overall Study|Study drug toxicity|6|||
16446929|NCT02038933|40115426|FG000|Overall Study|Adverse event unrelated to study drug|6|||
16446930|NCT02038933|40115426|FG000|Overall Study|Participant request to discontinue treatment|2|||
16370022|NCT02318277|39839758|FG000|Overall Study|Participant trial terminated by sponsor|0|||
16370023|NCT02318277|39839759|FG001|Overall Study|Participant trial terminated by sponsor|0|||
16446931|NCT02038933|40115426|FG000|Overall Study|Lost to Follow-up|1|||
16446932|NCT02038933|40115426|FG000|Overall Study|Other reasons|2|||
16159839|NCT01857869|39068385|FG001|Primary/Challenge Phase|Pregnancy|0|||
16159840|NCT01857869|39068386|FG002|Primary/Challenge Phase|Pregnancy|0|||
16159841|NCT01857869|39068387|FG003|Primary/Challenge Phase|Pregnancy|0|||
16159842|NCT01857869|39068388|FG004|Primary/Challenge Phase|Pregnancy|0|||
16370024|NCT02318277|39839760|FG002|Overall Study|Participant trial terminated by sponsor|1|||
16370025|NCT02318277|39839761|FG003|Overall Study|Participant trial terminated by sponsor|0|||
16370026|NCT02318277|39839762|FG004|Overall Study|Participant trial terminated by sponsor|1|||
16370027|NCT02318277|39839763|FG005|Overall Study|Participant trial terminated by sponsor|2|||
16370028|NCT02318277|39839764|FG006|Overall Study|Participant trial terminated by sponsor|5|||
16370029|NCT02318277|39839765|FG007|Overall Study|Participant trial terminated by sponsor|16|||
16370030|NCT02318277|39839758|FG000|Overall Study|Lost to Follow-up|1|||
16370031|NCT02318277|39839759|FG001|Overall Study|Lost to Follow-up|0|||
16370032|NCT02318277|39839760|FG002|Overall Study|Lost to Follow-up|1|||
16370033|NCT02318277|39839761|FG003|Overall Study|Lost to Follow-up|0|||
16370034|NCT02318277|39839762|FG004|Overall Study|Lost to Follow-up|0|||
16370035|NCT02318277|39839763|FG005|Overall Study|Lost to Follow-up|0|||
16370036|NCT02318277|39839764|FG006|Overall Study|Lost to Follow-up|3|||
16370037|NCT02318277|39839765|FG007|Overall Study|Lost to Follow-up|4|||
16370038|NCT02318277|39839758|FG000|Overall Study|Death|5|||
16370039|NCT02318277|39839759|FG001|Overall Study|Death|3|||
16370040|NCT02318277|39839760|FG002|Overall Study|Death|1|||
16370041|NCT02318277|39839761|FG003|Overall Study|Death|4|||
16370042|NCT02318277|39839762|FG004|Overall Study|Death|6|||
16370043|NCT02318277|39839763|FG005|Overall Study|Death|5|||
16370044|NCT02318277|39839764|FG006|Overall Study|Death|34|||
16370045|NCT02318277|39839765|FG007|Overall Study|Death|58|||
16370046|NCT02318277|39839758|FG000|Overall Study|Transitioned to Hospice|0|||
16370047|NCT02318277|39839759|FG001|Overall Study|Transitioned to Hospice|0|||
16370048|NCT02318277|39839760|FG002|Overall Study|Transitioned to Hospice|0|||
16370049|NCT02318277|39839761|FG003|Overall Study|Transitioned to Hospice|0|||
16370050|NCT02318277|39839762|FG004|Overall Study|Transitioned to Hospice|0|||
16370051|NCT02318277|39839763|FG005|Overall Study|Transitioned to Hospice|1|||
16370052|NCT02318277|39839764|FG006|Overall Study|Transitioned to Hospice|0|||
16370053|NCT02318277|39839765|FG007|Overall Study|Transitioned to Hospice|0|||
16370054|NCT04914000|39839773|FG000|Overall Study|Lost to Follow-up|8|||
16370055|NCT04914000|39839773|FG000|Overall Study|Withdrawal by Subject|1|||
16370056|NCT00785629|39839777|FG000|Overall Study|Adverse Event|2|||
16370057|NCT00785629|39839778|FG001|Overall Study|Adverse Event|1|||
16370058|NCT00785629|39839779|FG002|Overall Study|Adverse Event|1|||
16370059|NCT00785629|39839780|FG003|Overall Study|Adverse Event|5|||
16370060|NCT00785629|39839777|FG000|Overall Study|Protocol Violation|1|||
16370061|NCT00785629|39839778|FG001|Overall Study|Protocol Violation|2|||
16370062|NCT00785629|39839779|FG002|Overall Study|Protocol Violation|4|||
16370063|NCT00785629|39839780|FG003|Overall Study|Protocol Violation|5|||
16370064|NCT00785629|39839777|FG000|Overall Study|administrative decision|5|||
16370065|NCT00785629|39839778|FG001|Overall Study|administrative decision|1|||
16370066|NCT00785629|39839779|FG002|Overall Study|administrative decision|3|||
16370067|NCT00785629|39839780|FG003|Overall Study|administrative decision|4|||
16370068|NCT00785629|39839777|FG000|Overall Study|Withdrawal by Subject|0|||
16370069|NCT00785629|39839778|FG001|Overall Study|Withdrawal by Subject|1|||
16370070|NCT00785629|39839779|FG002|Overall Study|Withdrawal by Subject|2|||
16370071|NCT00785629|39839780|FG003|Overall Study|Withdrawal by Subject|2|||
16370072|NCT00003456|39839781|FG000|Overall Study|Not evaluable|8|||
16370073|NCT02827708|39839784|FG000|Overall Study|Lost to Follow-up|3|||
16370074|NCT02827708|39839785|FG001|Overall Study|Lost to Follow-up|1|||
16370075|NCT02827708|39839784|FG000|Overall Study|Withdrawal by Subject|1|||
16370076|NCT02827708|39839785|FG001|Overall Study|Withdrawal by Subject|2|||
16370077|NCT02827708|39839784|FG000|Overall Study|Death|1|||
16370078|NCT02827708|39839785|FG001|Overall Study|Death|2|||
16370079|NCT00066170|39839786|FG000|Overall Study|Adverse Event|2|||
16370080|NCT00066170|39839787|FG001|Overall Study|Adverse Event|4|||
16370081|NCT00066170|39839788|FG002|Overall Study|Adverse Event|1|||
16446933|NCT01317472|40115427|FG000|Overall Study|Withdrawal by Subject|1|||
16370082|NCT00066170|39839789|FG003|Overall Study|Adverse Event|7|||
16370083|NCT00066170|39839786|FG000|Overall Study|Serious Adverse Event|0|||
16370084|NCT00066170|39839787|FG001|Overall Study|Serious Adverse Event|0|||
16370085|NCT00066170|39839788|FG002|Overall Study|Serious Adverse Event|1|||
16370086|NCT00066170|39839789|FG003|Overall Study|Serious Adverse Event|1|||
16370087|NCT00066170|39839786|FG000|Overall Study|Lost to Follow-up|0|||
16370088|NCT00066170|39839787|FG001|Overall Study|Lost to Follow-up|1|||
16370089|NCT00066170|39839788|FG002|Overall Study|Lost to Follow-up|0|||
16264017|NCT04206332|39453116|FG009|Part C|Withdrawal by Subject|0|||
16264018|NCT04206332|39453117|FG010|Part C|Withdrawal by Subject|0|||
16264019|NCT04206332|39453118|FG011|Part C|Withdrawal by Subject|0|||
16264020|NCT04206332|39453119|FG012|Part C|Withdrawal by Subject|0|||
16264021|NCT04206332|39453120|FG013|Part C|Withdrawal by Subject|0|||
16264022|NCT04206332|39453121|FG014|Part C|Withdrawal by Subject|2|||
16264023|NCT04206332|39453122|FG015|Part C|Withdrawal by Subject|0|||
16264024|NCT04206332|39453123|FG016|Part C|Withdrawal by Subject|0|||
16264025|NCT03181594|39453127|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
16264026|NCT03181594|39453127|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
16264027|NCT03181594|39453127|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
16264028|NCT03181594|39453127|FG000|Initial Study Protocol (12-month FU)|Death|1|||
16264029|NCT03181594|39453127|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
16264030|NCT03181594|39453127|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
16264031|NCT02543203|39453128|FG000|Overall Study|Unpalatable Fragrance|2|||
16264032|NCT02543203|39453129|FG001|Overall Study|Unpalatable Fragrance|2|||
16264033|NCT02543203|39453128|FG000|Overall Study|Lost to Follow-up|1|||
16264034|NCT02543203|39453129|FG001|Overall Study|Lost to Follow-up|0|||
16264035|NCT02543203|39453128|FG000|Overall Study|Increased Irritability|1|||
16264036|NCT02543203|39453129|FG001|Overall Study|Increased Irritability|0|||
16264037|NCT02543203|39453128|FG000|Overall Study|Family|1|||
16264038|NCT02543203|39453129|FG001|Overall Study|Family|2|||
16264039|NCT02543203|39453128|FG000|Overall Study|Negative Behavior|1|||
16264040|NCT02543203|39453129|FG001|Overall Study|Negative Behavior|0|||
16264041|NCT02543203|39453128|FG000|Overall Study|Withdrawal by Subject|0|||
16264042|NCT02543203|39453129|FG001|Overall Study|Withdrawal by Subject|1|||
16264043|NCT01768858|39453130|FG000|Overall Study|Lost to Follow-up|9|||
16264044|NCT01768858|39453130|FG000|Overall Study|Lack of Efficacy|8|||
16264045|NCT01768858|39453130|FG000|Overall Study|Serious Adverse Event|1|||
16264046|NCT01768858|39453130|FG000|Overall Study|Participant moved to Germany|1|||
16264047|NCT01768858|39453130|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
16264048|NCT01768858|39453130|FG000|Overall Study|Exanthema|1|||
16264049|NCT01768858|39453130|FG000|Overall Study|Withdrawal by Subject|1|||
16264050|NCT01518972|39453131|FG000|Overall Study|Lost to Follow-up|2|||
16264051|NCT01518972|39453132|FG001|Overall Study|Lost to Follow-up|1|||
16264052|NCT01518972|39453131|FG000|Overall Study|Withdrawal by Subject|1|||
16264053|NCT01518972|39453132|FG001|Overall Study|Withdrawal by Subject|0|||
16264054|NCT01518972|39453131|FG000|Overall Study|Moved from area|1|||
16264055|NCT01518972|39453132|FG001|Overall Study|Moved from area|0|||
16264056|NCT01518972|39453131|FG000|Overall Study|Transportation problems|1|||
16264057|NCT01518972|39453132|FG001|Overall Study|Transportation problems|0|||
16264058|NCT01518972|39453131|FG000|Overall Study|Exclusionary medical condition|1|||
16264059|NCT01518972|39453132|FG001|Overall Study|Exclusionary medical condition|0|||
16264060|NCT01518972|39453131|FG000|Overall Study|Missed safety visits|0|||
16264061|NCT01518972|39453132|FG001|Overall Study|Missed safety visits|1|||
16264062|NCT01518972|39453131|FG000|Overall Study|Exclusionary medication|0|||
16264063|NCT01518972|39453132|FG001|Overall Study|Exclusionary medication|1|||
16264064|NCT01518972|39453131|FG000|Overall Study|Declined medication starting on day 12|0|||
16264065|NCT01518972|39453132|FG001|Overall Study|Declined medication starting on day 12|1|||
16264066|NCT01190865|39453134|FG000|Overall Study|Withdrawal by Subject|1|||
16264067|NCT01190865|39453134|FG000|Overall Study|Non-compliance|2|||
16264068|NCT04000815|39453135|FG000|Overall Study|Lost to Follow-up|9|||
16264069|NCT04000815|39453136|FG001|Overall Study|Lost to Follow-up|2|||
16264070|NCT04000815|39453137|FG002|Overall Study|Lost to Follow-up|3|||
16264071|NCT04000815|39453135|FG000|Overall Study|Withdrawal by Subject|4|||
16264072|NCT04000815|39453136|FG001|Overall Study|Withdrawal by Subject|3|||
16264073|NCT04000815|39453137|FG002|Overall Study|Withdrawal by Subject|2|||
16264074|NCT04000815|39453135|FG000|Overall Study|Right ovarian cyst occured|1|||
16264075|NCT04000815|39453136|FG001|Overall Study|Right ovarian cyst occured|0|||
16264076|NCT04000815|39453137|FG002|Overall Study|Right ovarian cyst occured|0|||
16264077|NCT04000815|39453135|FG000|Overall Study|Hypertension occured on follow up|0|||
16370090|NCT00066170|39839789|FG003|Overall Study|Lost to Follow-up|0|||
16159843|NCT01857869|39068389|FG005|Primary/Challenge Phase|Pregnancy|0|||
16264078|NCT04000815|39453136|FG001|Overall Study|Hypertension occured on follow up|0|||
16264079|NCT04000815|39453137|FG002|Overall Study|Hypertension occured on follow up|2|||
16264080|NCT03154047|39453140|FG000|Overall Study|Death|1|||
16264081|NCT03154047|39453140|FG000|Overall Study|Study terminated by sponsor|76|||
16264082|NCT03154047|39453140|FG000|Overall Study|Withdrawal by Subject|3|||
16264083|NCT02453386|39453141|FG000|Overall Study|Adverse Event|22|||
16264084|NCT02453386|39453142|FG001|Overall Study|Adverse Event|30|||
16264085|NCT02453386|39453143|FG002|Overall Study|Adverse Event|15|||
16264086|NCT02453386|39453141|FG000|Overall Study|Protocol Violation|1|||
16264087|NCT02453386|39453142|FG001|Overall Study|Protocol Violation|0|||
16370091|NCT00066170|39839786|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
16264088|NCT02453386|39453143|FG002|Overall Study|Protocol Violation|1|||
16264089|NCT02453386|39453141|FG000|Overall Study|Withdrawal by Subject|10|||
16264090|NCT02453386|39453142|FG001|Overall Study|Withdrawal by Subject|9|||
16264091|NCT02453386|39453143|FG002|Overall Study|Withdrawal by Subject|9|||
16264092|NCT02453386|39453141|FG000|Overall Study|Sponsor Terminated Study|14|||
16264093|NCT02453386|39453142|FG001|Overall Study|Sponsor Terminated Study|8|||
16264094|NCT02453386|39453143|FG002|Overall Study|Sponsor Terminated Study|11|||
16264095|NCT02453386|39453141|FG000|Overall Study|Subject Terminated by Sponsor|1|||
16264096|NCT02453386|39453142|FG001|Overall Study|Subject Terminated by Sponsor|1|||
16264097|NCT02453386|39453143|FG002|Overall Study|Subject Terminated by Sponsor|1|||
16264098|NCT02453386|39453141|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
16264099|NCT02453386|39453142|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
16264100|NCT02453386|39453143|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
16264101|NCT02453386|39453141|FG000|Overall Study|Lost to Follow-up|0|||
16264102|NCT02453386|39453142|FG001|Overall Study|Lost to Follow-up|0|||
16264103|NCT02453386|39453143|FG002|Overall Study|Lost to Follow-up|1|||
16264104|NCT02453386|39453141|FG000|Overall Study|Other|1|||
16264105|NCT02453386|39453142|FG001|Overall Study|Other|0|||
16264106|NCT02453386|39453143|FG002|Overall Study|Other|1|||
16264107|NCT01108094|39453144|FG000|Overall Study|Adverse Event|2|||
16264108|NCT01108094|39453145|FG001|Overall Study|Adverse Event|0|||
16264109|NCT01108094|39453146|FG002|Overall Study|Adverse Event|0|||
16264110|NCT01108094|39453147|FG003|Overall Study|Adverse Event|0|||
16264111|NCT01108094|39453144|FG000|Overall Study|Withdrawal by Subject|1|||
16264112|NCT01108094|39453145|FG001|Overall Study|Withdrawal by Subject|0|||
16264113|NCT01108094|39453146|FG002|Overall Study|Withdrawal by Subject|0|||
16264114|NCT01108094|39453147|FG003|Overall Study|Withdrawal by Subject|0|||
16264115|NCT01045161|39453152|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
16264116|NCT01045161|39453153|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
16264117|NCT01045161|39453154|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
16264118|NCT01045161|39453152|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
16264119|NCT01045161|39453153|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
16264120|NCT01045161|39453154|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
16264121|NCT01045161|39453152|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
16159844|NCT01857869|39068390|FG006|Primary/Challenge Phase|Pregnancy|0|||
16159845|NCT01857869|39068391|FG007|Primary/Challenge Phase|Pregnancy|0|||
16264122|NCT01045161|39453153|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
16264123|NCT01045161|39453154|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
16264124|NCT01045161|39453152|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
16264125|NCT01045161|39453153|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
16264126|NCT01045161|39453154|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
16264127|NCT01045161|39453152|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
16264128|NCT01045161|39453153|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
16264129|NCT01045161|39453154|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
16264130|NCT01045161|39453152|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
16264131|NCT01045161|39453153|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
16264132|NCT01045161|39453154|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
16264133|NCT01045161|39453152|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
16264134|NCT01045161|39453153|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
16264135|NCT01045161|39453154|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
16264136|NCT01045161|39453152|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
16264137|NCT01045161|39453153|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
16264138|NCT01045161|39453154|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
16264139|NCT01045161|39453152|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
16264140|NCT01045161|39453153|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
16264141|NCT01045161|39453154|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
16264142|NCT01045161|39453152|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
16264143|NCT01045161|39453153|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
16067921|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067922|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067923|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067924|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067925|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
16067926|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067927|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067928|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067929|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067930|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16159846|NCT01857869|39068392|FG008|Primary/Challenge Phase|Pregnancy|0|||
16159847|NCT01857869|39068393|FG009|Primary/Challenge Phase|Pregnancy|0|||
16370092|NCT00066170|39839787|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
16370093|NCT00066170|39839788|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
16370094|NCT00066170|39839789|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
16370095|NCT00066170|39839786|FG000|Overall Study|Protocol Violation|3|||
16370096|NCT00066170|39839787|FG001|Overall Study|Protocol Violation|0|||
16370097|NCT00066170|39839788|FG002|Overall Study|Protocol Violation|0|||
16370098|NCT00066170|39839789|FG003|Overall Study|Protocol Violation|0|||
16446934|NCT01317472|40115428|FG001|Overall Study|Withdrawal by Subject|0|||
16446935|NCT01317472|40115427|FG000|Overall Study|Unrelated hospitalization|1|||
16446936|NCT01317472|40115428|FG001|Overall Study|Unrelated hospitalization|0|||
16446937|NCT01803607|40115429|FG000|Overall Study|Adverse Event|5|||
16446938|NCT01803607|40115430|FG001|Overall Study|Adverse Event|3|||
16446939|NCT01803607|40115429|FG000|Overall Study|Lack of Efficacy|0|||
16446940|NCT01803607|40115430|FG001|Overall Study|Lack of Efficacy|1|||
16446941|NCT01803607|40115429|FG000|Overall Study|Protocol Violation|3|||
16446942|NCT01803607|40115430|FG001|Overall Study|Protocol Violation|2|||
16159848|NCT01857869|39068384|FG000|Primary/Challenge Phase|Protocol Violation|1|||
16159849|NCT01857869|39068385|FG001|Primary/Challenge Phase|Protocol Violation|0|||
16159850|NCT01857869|39068386|FG002|Primary/Challenge Phase|Protocol Violation|0|||
16159851|NCT01857869|39068387|FG003|Primary/Challenge Phase|Protocol Violation|0|||
16159852|NCT01857869|39068388|FG004|Primary/Challenge Phase|Protocol Violation|0|||
16446943|NCT01803607|40115429|FG000|Overall Study|Study terminated by sponsor|54|||
16446944|NCT01803607|40115430|FG001|Overall Study|Study terminated by sponsor|56|||
16446945|NCT01803607|40115429|FG000|Overall Study|Withdrawal by Subject|6|||
16446946|NCT01803607|40115430|FG001|Overall Study|Withdrawal by Subject|5|||
16446947|NCT02266888|40115433|FG000|Overall Study|Death|2|||
16446948|NCT02266888|40115434|FG001|Overall Study|Death|2|||
16446949|NCT02266888|40115435|FG002|Overall Study|Death|4|||
16067931|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067932|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067933|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067934|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
16067935|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067936|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067937|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067938|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067939|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
16067940|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067941|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16446950|NCT02266888|40115436|FG003|Overall Study|Death|2|||
16446951|NCT02266888|40115433|FG000|Overall Study|Physician Decision|0|||
16446952|NCT02266888|40115434|FG001|Overall Study|Physician Decision|1|||
16067942|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067943|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067944|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067945|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067946|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067947|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067948|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
16067949|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16159853|NCT01857869|39068389|FG005|Primary/Challenge Phase|Protocol Violation|0|||
16159854|NCT01857869|39068390|FG006|Primary/Challenge Phase|Protocol Violation|0|||
16159855|NCT01857869|39068391|FG007|Primary/Challenge Phase|Protocol Violation|0|||
16159856|NCT01857869|39068392|FG008|Primary/Challenge Phase|Protocol Violation|0|||
16159857|NCT01857869|39068393|FG009|Primary/Challenge Phase|Protocol Violation|0|||
16159858|NCT01857869|39068384|FG000|Primary/Challenge Phase|Other|1|||
16159859|NCT01857869|39068385|FG001|Primary/Challenge Phase|Other|1|||
16159860|NCT01857869|39068386|FG002|Primary/Challenge Phase|Other|0|||
16159861|NCT01857869|39068387|FG003|Primary/Challenge Phase|Other|0|||
16159862|NCT01857869|39068388|FG004|Primary/Challenge Phase|Other|0|||
16159863|NCT01857869|39068389|FG005|Primary/Challenge Phase|Other|0|||
16159864|NCT01857869|39068390|FG006|Primary/Challenge Phase|Other|0|||
16159865|NCT01857869|39068391|FG007|Primary/Challenge Phase|Other|0|||
16159866|NCT01857869|39068392|FG008|Primary/Challenge Phase|Other|0|||
16159867|NCT01857869|39068393|FG009|Primary/Challenge Phase|Other|0|||
16159868|NCT01857869|39068384|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16159869|NCT01857869|39068385|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16159870|NCT01857869|39068386|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16159871|NCT01857869|39068387|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
16370099|NCT00066170|39839786|FG000|Overall Study|Other|1|||
16446953|NCT02266888|40115435|FG002|Overall Study|Physician Decision|2|||
16446954|NCT02266888|40115436|FG003|Overall Study|Physician Decision|2|||
16446955|NCT02266888|40115433|FG000|Overall Study|Study Terminated|5|||
16446956|NCT02266888|40115434|FG001|Overall Study|Study Terminated|1|||
16446957|NCT02266888|40115435|FG002|Overall Study|Study Terminated|0|||
16446958|NCT02266888|40115436|FG003|Overall Study|Study Terminated|0|||
16446959|NCT02266888|40115433|FG000|Overall Study|No Longer Eligible|0|||
16446960|NCT02266888|40115434|FG001|Overall Study|No Longer Eligible|0|||
16446961|NCT02266888|40115435|FG002|Overall Study|No Longer Eligible|0|||
16446962|NCT02266888|40115436|FG003|Overall Study|No Longer Eligible|2|||
16159872|NCT01857869|39068388|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16159873|NCT01857869|39068389|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16159874|NCT01857869|39068390|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16159875|NCT01857869|39068391|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16159876|NCT01857869|39068392|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16159877|NCT01857869|39068393|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
16159878|NCT01857869|39068384|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16159879|NCT01857869|39068385|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16159880|NCT01857869|39068386|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16159881|NCT01857869|39068387|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
16159882|NCT01857869|39068388|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16159883|NCT01857869|39068389|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16159884|NCT01857869|39068390|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16159885|NCT01857869|39068391|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16159886|NCT01857869|39068392|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16159887|NCT01857869|39068393|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
16159888|NCT02301403|39068394|FG000|Overall Study|Withdrawal by Subject|28|||
16159889|NCT02301403|39068395|FG001|Overall Study|Withdrawal by Subject|41|||
16159890|NCT01121393|39068396|FG000|Overall Study|Progressive disease|201|||
16159891|NCT01121393|39068397|FG001|Overall Study|Progressive disease|20|||
16159892|NCT01121393|39068396|FG000|Overall Study|Other Adverse events|24|||
16159893|NCT01121393|39068397|FG001|Overall Study|Other Adverse events|45|||
16159894|NCT01121393|39068396|FG000|Overall Study|Non-compliant with protocol|0|||
16159895|NCT01121393|39068397|FG001|Overall Study|Non-compliant with protocol|3|||
16159896|NCT01121393|39068396|FG000|Overall Study|Lost to Follow-up|1|||
16159897|NCT01121393|39068397|FG001|Overall Study|Lost to Follow-up|0|||
16159898|NCT01121393|39068396|FG000|Overall Study|Refused cont. medication|7|||
16159899|NCT01121393|39068397|FG001|Overall Study|Refused cont. medication|7|||
16159900|NCT01121393|39068396|FG000|Overall Study|Not treated|3|||
16159901|NCT01121393|39068397|FG001|Overall Study|Not treated|9|||
16159902|NCT01121393|39068396|FG000|Overall Study|Other than listed|6|||
16159903|NCT01121393|39068397|FG001|Overall Study|Other than listed|0|||
16159904|NCT00705939|39068401|FG000|Overall Study|Protocol Violation|0|||
16159905|NCT00705939|39068402|FG001|Overall Study|Protocol Violation|0|||
16159906|NCT00705939|39068403|FG002|Overall Study|Protocol Violation|1|||
16159907|NCT00705939|39068401|FG000|Overall Study|Withdrawal by Subject|0|||
16159908|NCT00705939|39068402|FG001|Overall Study|Withdrawal by Subject|1|||
16159909|NCT00705939|39068403|FG002|Overall Study|Withdrawal by Subject|3|||
16159910|NCT00705939|39068401|FG000|Overall Study|Physician Decision|0|||
16159911|NCT00705939|39068402|FG001|Overall Study|Physician Decision|1|||
16159912|NCT00705939|39068403|FG002|Overall Study|Physician Decision|0|||
16159913|NCT00797732|39068404|FG000|Overall Study|Withdrawal by Subject|3|||
16159914|NCT00797732|39068405|FG001|Overall Study|Withdrawal by Subject|3|||
16159915|NCT00797732|39068406|FG002|Overall Study|Withdrawal by Subject|0|||
16159916|NCT00797732|39068404|FG000|Overall Study|Lost to Follow-up|1|||
16159917|NCT00797732|39068405|FG001|Overall Study|Lost to Follow-up|0|||
16159918|NCT00797732|39068406|FG002|Overall Study|Lost to Follow-up|0|||
16159919|NCT00797732|39068404|FG000|Overall Study|Death|1|||
16159920|NCT00797732|39068405|FG001|Overall Study|Death|0|||
16159921|NCT00797732|39068406|FG002|Overall Study|Death|0|||
16159922|NCT00797732|39068404|FG000|Overall Study|Not meet inclusion criteria|0|||
16159923|NCT00797732|39068405|FG001|Overall Study|Not meet inclusion criteria|0|||
16159924|NCT00797732|39068406|FG002|Overall Study|Not meet inclusion criteria|7|||
16159925|NCT00797732|39068404|FG000|Overall Study|Excluded due to time constraints|0|||
16159926|NCT00797732|39068405|FG001|Overall Study|Excluded due to time constraints|0|||
16159927|NCT00797732|39068406|FG002|Overall Study|Excluded due to time constraints|24|||
16159928|NCT00797732|39068404|FG000|Overall Study|Refused to Participate|0|||
16159929|NCT00797732|39068405|FG001|Overall Study|Refused to Participate|0|||
16159930|NCT00797732|39068406|FG002|Overall Study|Refused to Participate|123|||
16159931|NCT02104583|39068412|FG000|Overall Study|New ICD or CRT-D implanted|2|||
16159932|NCT02104583|39068413|FG001|Overall Study|New ICD or CRT-D implanted|0|||
16159933|NCT02104583|39068414|FG002|Overall Study|New ICD or CRT-D implanted|1|||
16159934|NCT02104583|39068415|FG003|Overall Study|New ICD or CRT-D implanted|0|||
16159935|NCT02104583|39068416|FG004|Overall Study|New ICD or CRT-D implanted|0|||
16159936|NCT02104583|39068412|FG000|Overall Study|Death|2|||
16159937|NCT02104583|39068413|FG001|Overall Study|Death|1|||
16159938|NCT02104583|39068414|FG002|Overall Study|Death|3|||
16446963|NCT02266888|40115433|FG000|Overall Study|Randomization Closed|0|||
16159939|NCT02104583|39068415|FG003|Overall Study|Death|3|||
16159940|NCT02104583|39068416|FG004|Overall Study|Death|5|||
16159941|NCT02104583|39068412|FG000|Overall Study|Subject required cardiac ablation|6|||
16159942|NCT02104583|39068413|FG001|Overall Study|Subject required cardiac ablation|4|||
16159943|NCT02104583|39068414|FG002|Overall Study|Subject required cardiac ablation|4|||
16159944|NCT02104583|39068415|FG003|Overall Study|Subject required cardiac ablation|5|||
16159945|NCT02104583|39068416|FG004|Overall Study|Subject required cardiac ablation|4|||
16159946|NCT02104583|39068412|FG000|Overall Study|Subject required prohibited medication|0|||
16159947|NCT02104583|39068413|FG001|Overall Study|Subject required prohibited medication|1|||
16159948|NCT02104583|39068414|FG002|Overall Study|Subject required prohibited medication|1|||
16159949|NCT02104583|39068415|FG003|Overall Study|Subject required prohibited medication|0|||
16159950|NCT02104583|39068416|FG004|Overall Study|Subject required prohibited medication|1|||
16159951|NCT02104583|39068412|FG000|Overall Study|Withdrew Consent|3|||
16159952|NCT02104583|39068413|FG001|Overall Study|Withdrew Consent|2|||
16159953|NCT02104583|39068414|FG002|Overall Study|Withdrew Consent|0|||
16159954|NCT02104583|39068415|FG003|Overall Study|Withdrew Consent|2|||
16159955|NCT02104583|39068416|FG004|Overall Study|Withdrew Consent|1|||
16159956|NCT02104583|39068412|FG000|Overall Study|Investigator's Discretion|1|||
16159957|NCT02104583|39068413|FG001|Overall Study|Investigator's Discretion|0|||
16159958|NCT02104583|39068414|FG002|Overall Study|Investigator's Discretion|0|||
16159959|NCT02104583|39068415|FG003|Overall Study|Investigator's Discretion|0|||
16159960|NCT02104583|39068416|FG004|Overall Study|Investigator's Discretion|0|||
16159961|NCT02104583|39068412|FG000|Overall Study|Protocol Violation|0|||
16159962|NCT02104583|39068413|FG001|Overall Study|Protocol Violation|0|||
16159963|NCT02104583|39068414|FG002|Overall Study|Protocol Violation|1|||
16159964|NCT02104583|39068415|FG003|Overall Study|Protocol Violation|0|||
16159965|NCT02104583|39068416|FG004|Overall Study|Protocol Violation|0|||
16159966|NCT02104583|39068412|FG000|Overall Study|Adverse Event|3|||
16159967|NCT02104583|39068413|FG001|Overall Study|Adverse Event|3|||
16159968|NCT02104583|39068414|FG002|Overall Study|Adverse Event|6|||
16159969|NCT02104583|39068415|FG003|Overall Study|Adverse Event|6|||
16159970|NCT02104583|39068416|FG004|Overall Study|Adverse Event|1|||
16159971|NCT02104583|39068412|FG000|Overall Study|Lost to Follow-up|1|||
16159972|NCT02104583|39068413|FG001|Overall Study|Lost to Follow-up|0|||
16159973|NCT02104583|39068414|FG002|Overall Study|Lost to Follow-up|0|||
16159974|NCT02104583|39068415|FG003|Overall Study|Lost to Follow-up|0|||
16159975|NCT02104583|39068416|FG004|Overall Study|Lost to Follow-up|0|||
16159976|NCT02104583|39068412|FG000|Overall Study|Randomized but Never Treated|0|||
16159977|NCT02104583|39068413|FG001|Overall Study|Randomized but Never Treated|0|||
16159978|NCT02104583|39068414|FG002|Overall Study|Randomized but Never Treated|0|||
16159979|NCT02104583|39068415|FG003|Overall Study|Randomized but Never Treated|1|||
16159980|NCT02104583|39068416|FG004|Overall Study|Randomized but Never Treated|0|||
16159981|NCT00512798|39068417|FG000|Overall Study|Death|0|||
16159982|NCT00512798|39068418|FG001|Overall Study|Death|3|||
16159983|NCT00512798|39068417|FG000|Overall Study|Adverse Event|2|||
16159984|NCT00512798|39068418|FG001|Overall Study|Adverse Event|4|||
16159985|NCT00512798|39068417|FG000|Overall Study|Progression of disease|14|||
16159986|NCT00512798|39068418|FG001|Overall Study|Progression of disease|20|||
16159987|NCT00512798|39068417|FG000|Overall Study|Withdrawal by Subject|3|||
16159988|NCT00512798|39068418|FG001|Overall Study|Withdrawal by Subject|0|||
16159989|NCT00091832|39068421|FG000|Overall Study|Physician Decision|1|||
16159990|NCT00091832|39068422|FG001|Overall Study|Physician Decision|0|||
16159991|NCT00091832|39068423|FG002|Overall Study|Physician Decision|0|||
16159992|NCT00091832|39068424|FG003|Overall Study|Physician Decision|0|||
16159993|NCT00091832|39068425|FG004|Overall Study|Physician Decision|0|||
16159994|NCT00091832|39068426|FG005|Overall Study|Physician Decision|0|||
16159995|NCT00091832|39068421|FG000|Overall Study|Adverse Event|0|||
16067950|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067951|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067952|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067953|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
16067954|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067955|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067956|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067957|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067958|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067959|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067960|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067961|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067962|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
16067963|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067964|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067965|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067966|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16159996|NCT00091832|39068422|FG001|Overall Study|Adverse Event|0|||
16159997|NCT00091832|39068423|FG002|Overall Study|Adverse Event|0|||
16159998|NCT00091832|39068424|FG003|Overall Study|Adverse Event|1|||
16159999|NCT00091832|39068425|FG004|Overall Study|Adverse Event|3|||
16160000|NCT00091832|39068426|FG005|Overall Study|Adverse Event|0|||
16160001|NCT00091832|39068421|FG000|Overall Study|Withdrawal by Subject|4|||
16160002|NCT00091832|39068422|FG001|Overall Study|Withdrawal by Subject|5|||
16160003|NCT00091832|39068423|FG002|Overall Study|Withdrawal by Subject|0|||
16160004|NCT00091832|39068424|FG003|Overall Study|Withdrawal by Subject|1|||
16160005|NCT00091832|39068425|FG004|Overall Study|Withdrawal by Subject|3|||
16160006|NCT00091832|39068426|FG005|Overall Study|Withdrawal by Subject|1|||
16160007|NCT00091832|39068421|FG000|Overall Study|Death|6|||
16160008|NCT00091832|39068422|FG001|Overall Study|Death|4|||
16160009|NCT00091832|39068423|FG002|Overall Study|Death|5|||
16160010|NCT00091832|39068424|FG003|Overall Study|Death|8|||
16160011|NCT00091832|39068425|FG004|Overall Study|Death|5|||
16160012|NCT00091832|39068426|FG005|Overall Study|Death|6|||
16160013|NCT00091832|39068421|FG000|Overall Study|Disease Progression|2|||
16160014|NCT00091832|39068422|FG001|Overall Study|Disease Progression|0|||
16160015|NCT00091832|39068423|FG002|Overall Study|Disease Progression|0|||
16160016|NCT00091832|39068424|FG003|Overall Study|Disease Progression|1|||
16160017|NCT00091832|39068425|FG004|Overall Study|Disease Progression|1|||
16264144|NCT01045161|39453154|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
16264145|NCT01045161|39453152|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
16264146|NCT01045161|39453153|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
16264147|NCT01045161|39453154|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
16264148|NCT01045161|39453152|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
16264149|NCT01045161|39453153|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
16264150|NCT01045161|39453154|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
16264151|NCT01045161|39453152|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
16446964|NCT02266888|40115434|FG001|Overall Study|Randomization Closed|0|||
16446965|NCT02266888|40115435|FG002|Overall Study|Randomization Closed|4|||
16264152|NCT01045161|39453153|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
16264153|NCT01045161|39453154|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
16370100|NCT00066170|39839787|FG001|Overall Study|Other|5|||
16370101|NCT00066170|39839788|FG002|Overall Study|Other|2|||
16370102|NCT00066170|39839789|FG003|Overall Study|Other|0|||
16370103|NCT04389671|39839790|FG000|Overall Study|Death|7|||
16370104|NCT04073407|39839796|FG000|Part 1|Withdrawal by Subject|1|||
16370105|NCT04073407|39839797|FG001|Part 1|Withdrawal by Subject|0|||
16370106|NCT04073407|39839796|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
16370107|NCT04073407|39839797|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
16264154|NCT01045161|39453152|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
16370108|NCT04073407|39839796|FG000|Part 2|Withdrawal by Subject|0|||
16370109|NCT04073407|39839797|FG001|Part 2|Withdrawal by Subject|1|||
16370110|NCT03808909|39839798|FG000|Overall Study|Lost to Follow-up|3|||
16370111|NCT03808909|39839799|FG001|Overall Study|Lost to Follow-up|0|||
16370112|NCT01263028|39839805|FG000|Overall Study|Withdrawal by Subject|1|||
16370113|NCT01263028|39839805|FG000|Overall Study|Adverse Event|1|||
16370114|NCT01263028|39839805|FG000|Overall Study|Study terminated due to low enrollment.|4|||
16370115|NCT02989389|39839806|FG000|Period 1|Lost to Follow-up|0|||
16370116|NCT02989389|39839807|FG001|Period 1|Lost to Follow-up|1|||
16370117|NCT02989389|39839808|FG002|Period 1|Lost to Follow-up|0|||
16370118|NCT02989389|39839809|FG003|Period 1|Lost to Follow-up|0|||
16370119|NCT02989389|39839810|FG004|Period 1|Lost to Follow-up|0|||
16264155|NCT01045161|39453153|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
16264156|NCT01045161|39453154|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
16264157|NCT00359281|39453161|FG000|Overall Study|Adverse Event|1|||
16264158|NCT00359281|39453162|FG001|Overall Study|Adverse Event|0|||
16264159|NCT00359281|39453163|FG002|Overall Study|Adverse Event|0|||
16264160|NCT00359281|39453164|FG003|Overall Study|Adverse Event|0|||
16264161|NCT00359281|39453165|FG004|Overall Study|Adverse Event|0|||
16264162|NCT00359281|39453166|FG005|Overall Study|Adverse Event|0|||
16264163|NCT00359281|39453167|FG006|Overall Study|Adverse Event|1|||
16264164|NCT00359281|39453168|FG007|Overall Study|Adverse Event|0|||
16264165|NCT00359281|39453169|FG008|Overall Study|Adverse Event|0|||
16264166|NCT00359281|39453161|FG000|Overall Study|Withdrawal by Subject|0|||
16264167|NCT00359281|39453162|FG001|Overall Study|Withdrawal by Subject|0|||
16370120|NCT02989389|39839811|FG005|Period 1|Lost to Follow-up|0|||
16446966|NCT02266888|40115436|FG003|Overall Study|Randomization Closed|0|||
16160018|NCT00091832|39068426|FG005|Overall Study|Disease Progression|2|||
16264168|NCT00359281|39453163|FG002|Overall Study|Withdrawal by Subject|0|||
16264169|NCT00359281|39453164|FG003|Overall Study|Withdrawal by Subject|0|||
16370121|NCT02989389|39839812|FG006|Period 1|Lost to Follow-up|0|||
16370122|NCT02989389|39839813|FG007|Period 1|Lost to Follow-up|0|||
16160019|NCT00091832|39068421|FG000|Overall Study|Ineligibility Determined|0|||
16370123|NCT02989389|39839814|FG008|Period 1|Lost to Follow-up|0|||
16370124|NCT02989389|39839815|FG009|Period 1|Lost to Follow-up|0|||
16370125|NCT02989389|39839806|FG000|Period 1|Physician Decision|0|||
16370126|NCT02989389|39839807|FG001|Period 1|Physician Decision|0|||
16370127|NCT02989389|39839808|FG002|Period 1|Physician Decision|0|||
16370128|NCT02989389|39839809|FG003|Period 1|Physician Decision|0|||
16370129|NCT02989389|39839810|FG004|Period 1|Physician Decision|0|||
16370130|NCT02989389|39839811|FG005|Period 1|Physician Decision|0|||
16370131|NCT02989389|39839812|FG006|Period 1|Physician Decision|0|||
16370132|NCT02989389|39839813|FG007|Period 1|Physician Decision|0|||
16370133|NCT02989389|39839814|FG008|Period 1|Physician Decision|1|||
16370134|NCT02989389|39839815|FG009|Period 1|Physician Decision|0|||
16370135|NCT02384460|39839816|FG000|Overall Study|Protocol Violation|0|||
16370136|NCT02384460|39839817|FG001|Overall Study|Protocol Violation|1|||
16370137|NCT02384460|39839816|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
16370138|NCT02384460|39839817|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
16370139|NCT02384460|39839816|FG000|Overall Study|Adverse Event|5|||
16446967|NCT02266888|40115433|FG000|Overall Study|Personnel unavailable at transplant|0|||
16446968|NCT02266888|40115434|FG001|Overall Study|Personnel unavailable at transplant|0|||
16446969|NCT02266888|40115435|FG002|Overall Study|Personnel unavailable at transplant|0|||
16446970|NCT02266888|40115436|FG003|Overall Study|Personnel unavailable at transplant|1|||
16067967|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
16067968|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16067969|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16067970|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16446971|NCT02266888|40115433|FG000|Overall Study|Transfer of care|0|||
16446972|NCT02266888|40115434|FG001|Overall Study|Transfer of care|0|||
16446973|NCT02266888|40115435|FG002|Overall Study|Transfer of care|1|||
16446974|NCT02266888|40115436|FG003|Overall Study|Transfer of care|0|||
16446975|NCT03058146|40115438|FG000|Overall Study|Withdrawal by Subject|4|||
16067971|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16067972|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16067973|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
16264170|NCT00359281|39453165|FG004|Overall Study|Withdrawal by Subject|0|||
16264171|NCT00359281|39453166|FG005|Overall Study|Withdrawal by Subject|0|||
16264172|NCT00359281|39453167|FG006|Overall Study|Withdrawal by Subject|1|||
16264173|NCT00359281|39453168|FG007|Overall Study|Withdrawal by Subject|0|||
16264174|NCT00359281|39453169|FG008|Overall Study|Withdrawal by Subject|0|||
16264175|NCT00556322|39453173|FG000|Overall Study|Insufficient therapeutic response|158|||
16264176|NCT00556322|39453174|FG001|Overall Study|Insufficient therapeutic response|168|||
16264177|NCT00556322|39453173|FG000|Overall Study|Adverse Event|7|||
16264178|NCT00556322|39453174|FG001|Overall Study|Adverse Event|4|||
16264179|NCT00556322|39453173|FG000|Overall Study|Other|4|||
16264180|NCT00556322|39453174|FG001|Overall Study|Other|1|||
16264181|NCT00556322|39453173|FG000|Overall Study|Lost to Follow-up|5|||
16264182|NCT00556322|39453174|FG001|Overall Study|Lost to Follow-up|3|||
16264183|NCT00556322|39453173|FG000|Overall Study|Withdrawal by Subject|19|||
16264184|NCT00556322|39453174|FG001|Overall Study|Withdrawal by Subject|7|||
16264185|NCT00556322|39453173|FG000|Overall Study|Protocol Violation|5|||
16264186|NCT00556322|39453174|FG001|Overall Study|Protocol Violation|1|||
16264187|NCT00556322|39453173|FG000|Overall Study|Ongoing at data cutoff|3|||
16264188|NCT00556322|39453174|FG001|Overall Study|Ongoing at data cutoff|5|||
16264189|NCT00556322|39453173|FG000|Overall Study|Death|20|||
16264190|NCT00556322|39453174|FG001|Overall Study|Death|14|||
16264191|NCT01473953|39453175|FG000|Overall Study|Other|1|||
16264192|NCT01473953|39453176|FG001|Overall Study|Other|0|||
16264193|NCT01473953|39453177|FG002|Overall Study|Other|0|||
16264194|NCT01473953|39453178|FG003|Overall Study|Other|0|||
16264195|NCT01473953|39453179|FG004|Overall Study|Other|0|||
16264196|NCT00968812|39453180|FG000|Overall Study|Adverse Event|30|||
16264197|NCT00968812|39453181|FG001|Overall Study|Adverse Event|46|||
16264198|NCT00968812|39453182|FG002|Overall Study|Adverse Event|33|||
16264199|NCT00968812|39453180|FG000|Overall Study|Death|2|||
16264200|NCT00968812|39453181|FG001|Overall Study|Death|2|||
16264201|NCT00968812|39453182|FG002|Overall Study|Death|1|||
16264202|NCT00968812|39453180|FG000|Overall Study|Lack of Efficacy|9|||
16264203|NCT00968812|39453181|FG001|Overall Study|Lack of Efficacy|7|||
16264204|NCT00968812|39453182|FG002|Overall Study|Lack of Efficacy|16|||
16264205|NCT00968812|39453180|FG000|Overall Study|Lost to Follow-up|17|||
16264206|NCT00968812|39453181|FG001|Overall Study|Lost to Follow-up|12|||
16370140|NCT02384460|39839817|FG001|Overall Study|Adverse Event|2|||
16370141|NCT02384460|39839816|FG000|Overall Study|Withdrawal by Subject|0|||
16446976|NCT03058146|40115439|FG001|Overall Study|Withdrawal by Subject|1|||
16446977|NCT03058146|40115438|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
16446978|NCT03058146|40115439|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
16264207|NCT00968812|39453182|FG002|Overall Study|Lost to Follow-up|11|||
16264208|NCT00968812|39453180|FG000|Overall Study|Physician Decision|8|||
16264209|NCT00968812|39453181|FG001|Overall Study|Physician Decision|5|||
16264210|NCT00968812|39453182|FG002|Overall Study|Physician Decision|9|||
16264211|NCT00968812|39453180|FG000|Overall Study|Protocol Violation|7|||
16264212|NCT00968812|39453181|FG001|Overall Study|Protocol Violation|4|||
16264213|NCT00968812|39453182|FG002|Overall Study|Protocol Violation|3|||
16264214|NCT00968812|39453180|FG000|Overall Study|Withdrawal by Subject|17|||
16264215|NCT00968812|39453181|FG001|Overall Study|Withdrawal by Subject|23|||
16264216|NCT00968812|39453182|FG002|Overall Study|Withdrawal by Subject|25|||
16264217|NCT00968812|39453180|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
16264218|NCT00968812|39453181|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
16264219|NCT00968812|39453182|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
16264220|NCT00968812|39453180|FG000|Overall Study|Noncompliance with study drug|4|||
16264221|NCT00968812|39453181|FG001|Overall Study|Noncompliance with study drug|1|||
16264222|NCT00968812|39453182|FG002|Overall Study|Noncompliance with study drug|6|||
16264223|NCT00968812|39453180|FG000|Overall Study|Unable to take rescue therapy|12|||
16264224|NCT00968812|39453181|FG001|Overall Study|Unable to take rescue therapy|12|||
16264225|NCT00968812|39453182|FG002|Overall Study|Unable to take rescue therapy|17|||
16264226|NCT00968812|39453180|FG000|Overall Study|Other|25|||
16264227|NCT00968812|39453181|FG001|Overall Study|Other|37|||
16264228|NCT00968812|39453182|FG002|Overall Study|Other|40|||
16264229|NCT04510285|39453183|FG000|Overall Study|Death|1|||
16264230|NCT01913405|39453184|FG000|Overall Study|Withdrawal by Subject|1|||
16264231|NCT01913405|39453184|FG000|Overall Study|Adverse Event|1|||
16264232|NCT00927069|39453186|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
16264233|NCT00927069|39453187|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
16264234|NCT00927069|39453188|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
16264235|NCT00927069|39453189|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
16264236|NCT00927069|39453186|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
16264237|NCT00927069|39453187|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
16264238|NCT00927069|39453188|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
16264239|NCT00927069|39453189|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
16264240|NCT00927069|39453186|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
16264241|NCT00927069|39453187|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
16264242|NCT00927069|39453188|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
16264243|NCT00927069|39453189|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
16264244|NCT00927069|39453186|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
16264245|NCT00927069|39453187|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
16264246|NCT00927069|39453188|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
16264247|NCT00927069|39453189|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
16264248|NCT00927069|39453186|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
16264249|NCT00927069|39453187|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
16264250|NCT00927069|39453188|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
16264251|NCT00927069|39453189|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
16264252|NCT01097577|39453190|FG000|Overall Study|Adverse Event|0|||
16264253|NCT01097577|39453191|FG001|Overall Study|Adverse Event|1|||
16264254|NCT00610363|39453194|FG000|Overall Study|Non-compliance with protocol|0|||
16264255|NCT00610363|39453195|FG001|Overall Study|Non-compliance with protocol|1|||
16264256|NCT00610363|39453194|FG000|Overall Study|Adverse Event|3|||
16264257|NCT00610363|39453195|FG001|Overall Study|Adverse Event|1|||
16264258|NCT00610363|39453194|FG000|Overall Study|Lack of Efficacy|2|||
16264259|NCT00610363|39453195|FG001|Overall Study|Lack of Efficacy|0|||
16264260|NCT00610363|39453194|FG000|Overall Study|Lost to Follow-up|4|||
16264261|NCT00610363|39453195|FG001|Overall Study|Lost to Follow-up|0|||
16264262|NCT00610363|39453194|FG000|Overall Study|Withdrawal by Subject|1|||
16264263|NCT00610363|39453195|FG001|Overall Study|Withdrawal by Subject|0|||
16264264|NCT00610363|39453194|FG000|Overall Study|Other than specified above|1|||
16264265|NCT00610363|39453195|FG001|Overall Study|Other than specified above|1|||
16264266|NCT01534663|39453196|FG000|Overall Study|Lost to Follow-up|0|||
16264267|NCT01534663|39453197|FG001|Overall Study|Lost to Follow-up|2|||
16264268|NCT01534663|39453196|FG000|Overall Study|Adverse Event|2|||
16264269|NCT01534663|39453197|FG001|Overall Study|Adverse Event|1|||
16264270|NCT00312897|39453200|FG000|Overall Study|Adverse Event|1|||
16264271|NCT00312897|39453201|FG001|Overall Study|Adverse Event|0|||
16264272|NCT00312897|39453200|FG000|Overall Study|Lost to Follow-up|2|||
16264273|NCT00312897|39453201|FG001|Overall Study|Lost to Follow-up|0|||
16264274|NCT00312897|39453200|FG000|Overall Study|Physician Decision|1|||
16264275|NCT00312897|39453201|FG001|Overall Study|Physician Decision|0|||
16264276|NCT00312897|39453200|FG000|Overall Study|Withdrawal by Subject|1|||
16446979|NCT01435382|40115440|FG000|Overall Study|Lost to Follow-up|1|||
16264277|NCT00312897|39453201|FG001|Overall Study|Withdrawal by Subject|3|||
16264278|NCT00312897|39453200|FG000|Overall Study|Pregnancy|1|||
16264279|NCT00312897|39453201|FG001|Overall Study|Pregnancy|0|||
16264280|NCT00312897|39453200|FG000|Overall Study|discontinued prior to getting treatment|0|||
16264281|NCT00312897|39453201|FG001|Overall Study|discontinued prior to getting treatment|3|||
16264282|NCT04173247|39453202|FG000|Overall Study|Withdrawal by Subject|0|||
16264283|NCT04173247|39453203|FG001|Overall Study|Withdrawal by Subject|2|||
16264284|NCT04173247|39453202|FG000|Overall Study|Death|1|||
16264285|NCT04173247|39453203|FG001|Overall Study|Death|0|||
16264286|NCT04173247|39453202|FG000|Overall Study|Physician Decision|1|||
16264287|NCT04173247|39453203|FG001|Overall Study|Physician Decision|0|||
16264288|NCT03925532|39453208|FG000|Overall Study|Lost to Follow-up|1|||
16264289|NCT04720664|39453209|FG000|Overall Study|Adverse Event|2|||
16264290|NCT04720664|39453209|FG000|Overall Study|Lack of Efficacy|9|||
16264291|NCT01208337|39453210|FG000|Overall Study|Death|3|||
16264292|NCT02865122|39453217|FG000|Overall Study|Adverse Event|1|||
16264293|NCT02865122|39453218|FG001|Overall Study|Adverse Event|0|||
16264294|NCT02865122|39453219|FG002|Overall Study|Adverse Event|0|||
16264295|NCT02622386|39453220|FG000|First Assignment|Withdrawal by Subject|3|||
16264296|NCT02622386|39453221|FG001|First Assignment|Withdrawal by Subject|2|||
16264297|NCT02622386|39453220|FG000|Washout|Withdrawal by Subject|4|||
16264298|NCT02622386|39453221|FG001|Washout|Withdrawal by Subject|4|||
16264299|NCT02622386|39453220|FG000|Second Assignment|Withdrawal by Subject|0|||
16264300|NCT02622386|39453221|FG001|Second Assignment|Withdrawal by Subject|2|||
16264301|NCT04166630|39453223|FG000|Overall Study|Withdrawal by Subject|0|||
16264302|NCT04166630|39453224|FG001|Overall Study|Withdrawal by Subject|1|||
16264303|NCT00239577|39453225|FG000|Primary Phase|Adverse Event|0|||
16264304|NCT00239577|39453226|FG001|Primary Phase|Adverse Event|0|||
16264305|NCT00239577|39453227|FG002|Primary Phase|Adverse Event|1|||
16264306|NCT00239577|39453228|FG003|Primary Phase|Adverse Event|0|||
16264307|NCT00239577|39453225|FG000|Primary Phase|Other|5|||
16264308|NCT00239577|39453226|FG001|Primary Phase|Other|3|||
16264309|NCT00239577|39453227|FG002|Primary Phase|Other|2|||
16264310|NCT00239577|39453228|FG003|Primary Phase|Other|0|||
16264311|NCT03459807|39453234|FG000|Overall Study|Withdrawal due to transplant|0|||
16264312|NCT03459807|39453235|FG001|Overall Study|Withdrawal due to transplant|1|||
16264313|NCT01111461|39453236|FG000|Overall Study|Adverse Event|32|||
16264314|NCT01111461|39453236|FG000|Overall Study|Participant choice|11|||
16264315|NCT01111461|39453236|FG000|Overall Study|Lost to Follow-up|1|||
16264316|NCT01111461|39453236|FG000|Overall Study|Withdrawal by Subject|1|||
16264317|NCT01111461|39453236|FG000|Overall Study|Other|6|||
16264318|NCT01472341|39453249|FG000|Overall Study|Started insulin therapy|55|||
16264319|NCT01472341|39453249|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
16264320|NCT01472341|39453249|FG000|Overall Study|Withdrawal by Subject|39|||
16264321|NCT01472341|39453249|FG000|Overall Study|Lost to Follow-up|52|||
16264322|NCT01472341|39453249|FG000|Overall Study|Laboratory parameters unavailable|25|||
16264323|NCT01472341|39453249|FG000|Overall Study|Death|9|||
16264324|NCT01597245|39453254|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
16264325|NCT01597245|39453255|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
16264326|NCT01597245|39453256|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
16264327|NCT01597245|39453257|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
16264328|NCT01597245|39453258|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264329|NCT01597245|39453259|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264330|NCT01597245|39453260|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264331|NCT01597245|39453261|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264332|NCT01597245|39453262|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264333|NCT01597245|39453263|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264334|NCT01597245|39453264|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264335|NCT01597245|39453265|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264336|NCT01597245|39453266|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264337|NCT01597245|39453267|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264338|NCT01597245|39453268|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264339|NCT01597245|39453269|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264340|NCT01597245|39453270|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264341|NCT01597245|39453271|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264342|NCT01597245|39453272|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264343|NCT01597245|39453273|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264344|NCT01597245|39453274|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
16264345|NCT01597245|39453254|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
16264346|NCT01597245|39453255|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
16264347|NCT01597245|39453256|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
16264348|NCT01597245|39453257|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
16264349|NCT01597245|39453258|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264350|NCT01597245|39453259|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264351|NCT01597245|39453260|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264352|NCT01597245|39453261|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264353|NCT01597245|39453262|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264354|NCT01597245|39453263|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264355|NCT01597245|39453264|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264356|NCT01597245|39453265|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264357|NCT01597245|39453266|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264358|NCT01597245|39453267|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264359|NCT01597245|39453268|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264360|NCT01597245|39453269|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264361|NCT01597245|39453270|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264362|NCT01597245|39453271|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264363|NCT01597245|39453272|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264364|NCT01597245|39453273|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264365|NCT01597245|39453274|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
16264366|NCT01597245|39453254|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
16264367|NCT01597245|39453255|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
16264368|NCT01597245|39453256|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
16264369|NCT01597245|39453257|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
16264370|NCT01597245|39453258|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264371|NCT01597245|39453259|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264372|NCT01597245|39453260|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264373|NCT01597245|39453261|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264374|NCT01597245|39453262|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264375|NCT01597245|39453263|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264376|NCT01597245|39453264|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264377|NCT01597245|39453265|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264378|NCT01597245|39453266|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264379|NCT01597245|39453267|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264380|NCT01597245|39453268|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264381|NCT01597245|39453269|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264382|NCT01597245|39453270|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264383|NCT01597245|39453271|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264384|NCT01597245|39453272|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264385|NCT01597245|39453273|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264386|NCT01597245|39453274|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
16264387|NCT01597245|39453254|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
16264388|NCT01597245|39453255|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
16067974|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16067975|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
16067976|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
16067977|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16067978|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16446980|NCT01435382|40115441|FG001|Overall Study|Lost to Follow-up|0|||
16446981|NCT01435382|40115442|FG002|Overall Study|Lost to Follow-up|1|||
16446982|NCT01435382|40115443|FG003|Overall Study|Lost to Follow-up|0|||
16446983|NCT01435382|40115440|FG000|Overall Study|Withdrawal by Subject|0|||
16446984|NCT01435382|40115441|FG001|Overall Study|Withdrawal by Subject|2|||
16446985|NCT01435382|40115442|FG002|Overall Study|Withdrawal by Subject|0|||
16446986|NCT01435382|40115443|FG003|Overall Study|Withdrawal by Subject|1|||
16446987|NCT01318915|40115444|FG000|Overall Study|Lost to Follow-up|1|||
16446988|NCT03877510|40115445|FG000|Overall Study|Death|6|||
16446989|NCT03877510|40115445|FG000|Overall Study|Lost to Follow-up|2|||
16446990|NCT03877510|40115445|FG000|Overall Study|Non-compliance with study drug|2|||
16446991|NCT03877510|40115445|FG000|Overall Study|Lack of Efficacy|14|||
16446992|NCT03877510|40115445|FG000|Overall Study|Adverse Event|20|||
16446993|NCT03877510|40115445|FG000|Overall Study|Withdrawal by Subject|22|||
16446994|NCT03877510|40115445|FG000|Overall Study|Miscellaneous|1|||
16446995|NCT01046396|40115451|FG000|Overall Study|Withdrawal by Subject|5|||
16446996|NCT00474487|40115452|FG000|Overall Study|Withdrawal by Subject|6|||
16446997|NCT00474487|40115453|FG001|Overall Study|Withdrawal by Subject|0|||
16446998|NCT00474487|40115454|FG002|Overall Study|Withdrawal by Subject|0|||
16446999|NCT00474487|40115455|FG003|Overall Study|Withdrawal by Subject|0|||
16447000|NCT00474487|40115452|FG000|Overall Study|Lost to Follow-up|20|||
16447001|NCT00474487|40115453|FG001|Overall Study|Lost to Follow-up|1|||
16447002|NCT00474487|40115454|FG002|Overall Study|Lost to Follow-up|7|||
16447003|NCT00474487|40115455|FG003|Overall Study|Lost to Follow-up|0|||
16447004|NCT00474487|40115452|FG000|Overall Study|Inappropriate enrollment|4|||
16067979|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16067980|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16264389|NCT01597245|39453256|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
16447005|NCT00474487|40115453|FG001|Overall Study|Inappropriate enrollment|0|||
16067981|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
16067982|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16447006|NCT00474487|40115454|FG002|Overall Study|Inappropriate enrollment|7|||
16447007|NCT00474487|40115455|FG003|Overall Study|Inappropriate enrollment|0|||
16447008|NCT00474487|40115452|FG000|Overall Study|Death|0|||
16370142|NCT02384460|39839817|FG001|Overall Study|Withdrawal by Subject|3|||
16370143|NCT02384460|39839816|FG000|Overall Study|Elective medical treatment|1|||
16370144|NCT02384460|39839817|FG001|Overall Study|Elective medical treatment|0|||
16370145|NCT02384460|39839816|FG000|Overall Study|Non-compliance|1|||
16370146|NCT02384460|39839817|FG001|Overall Study|Non-compliance|0|||
16370147|NCT03478787|39839818|FG000|Overall Study|Adverse Event|5|||
16370148|NCT03478787|39839819|FG001|Overall Study|Adverse Event|1|||
16264390|NCT01597245|39453257|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264391|NCT01597245|39453258|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264392|NCT01597245|39453259|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264393|NCT01597245|39453260|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264394|NCT01597245|39453261|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264395|NCT01597245|39453262|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264396|NCT01597245|39453263|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264397|NCT01597245|39453264|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264398|NCT01597245|39453265|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264399|NCT01597245|39453266|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16370149|NCT03478787|39839818|FG000|Overall Study|Protocol Violation|3|||
16370150|NCT03478787|39839819|FG001|Overall Study|Protocol Violation|0|||
16370151|NCT03478787|39839818|FG000|Overall Study|Lack of Efficacy|7|||
16370152|NCT03478787|39839819|FG001|Overall Study|Lack of Efficacy|1|||
16370153|NCT03478787|39839818|FG000|Overall Study|Lost to Follow-up|9|||
16370154|NCT03478787|39839819|FG001|Overall Study|Lost to Follow-up|5|||
16370155|NCT03478787|39839818|FG000|Overall Study|Withdrawal by Subject|2|||
16370156|NCT03478787|39839819|FG001|Overall Study|Withdrawal by Subject|6|||
16370157|NCT03478787|39839818|FG000|Overall Study|Other, Not Specified|3|||
16264400|NCT01597245|39453267|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16370158|NCT03478787|39839819|FG001|Overall Study|Other, Not Specified|0|||
16370159|NCT00663351|39839823|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
16370160|NCT00663351|39839824|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
16447009|NCT00474487|40115453|FG001|Overall Study|Death|1|||
16447010|NCT00474487|40115454|FG002|Overall Study|Death|0|||
16447011|NCT00474487|40115455|FG003|Overall Study|Death|0|||
16447012|NCT03448406|40115456|FG000|Overall Study|Noncompliance of scheduled visits|1|||
16447013|NCT03448406|40115457|FG001|Overall Study|Noncompliance of scheduled visits|2|||
16447014|NCT03448406|40115456|FG000|Overall Study|Withdrawal by Subject|1|||
16447015|NCT03448406|40115457|FG001|Overall Study|Withdrawal by Subject|2|||
16447016|NCT03448406|40115456|FG000|Overall Study|Protocol Violation|1|||
16447017|NCT03448406|40115457|FG001|Overall Study|Protocol Violation|0|||
16447018|NCT03448406|40115456|FG000|Overall Study|Adverse Event|8|||
16447019|NCT03448406|40115457|FG001|Overall Study|Adverse Event|9|||
16447020|NCT01194830|40115458|FG000|Overall Study|Adverse Event|3|||
16447021|NCT01194830|40115459|FG001|Overall Study|Adverse Event|2|||
16447022|NCT01194830|40115458|FG000|Overall Study|Protocol Violation|5|||
16447023|NCT01194830|40115459|FG001|Overall Study|Protocol Violation|4|||
16447024|NCT01194830|40115458|FG000|Overall Study|Lost to Follow-up|9|||
16447025|NCT01194830|40115459|FG001|Overall Study|Lost to Follow-up|7|||
16447026|NCT01194830|40115458|FG000|Overall Study|Withdrawal by Subject|2|||
16447027|NCT01194830|40115459|FG001|Overall Study|Withdrawal by Subject|1|||
16067983|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16067984|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16264401|NCT01597245|39453268|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264402|NCT01597245|39453269|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264403|NCT01597245|39453270|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264404|NCT01597245|39453271|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264405|NCT01597245|39453272|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264406|NCT01597245|39453273|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264407|NCT01597245|39453274|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
16264408|NCT01597245|39453254|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
16370161|NCT00663351|39839823|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
16370162|NCT00663351|39839824|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
16067985|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16067986|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16370163|NCT00663351|39839823|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
16447028|NCT01194830|40115458|FG000|Overall Study|Lack of Efficacy|1|||
16447029|NCT01194830|40115459|FG001|Overall Study|Lack of Efficacy|1|||
16067987|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16067988|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16067989|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16067990|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
16067991|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16160020|NCT00091832|39068422|FG001|Overall Study|Ineligibility Determined|0|||
16160021|NCT00091832|39068423|FG002|Overall Study|Ineligibility Determined|1|||
16160022|NCT00091832|39068424|FG003|Overall Study|Ineligibility Determined|0|||
16160023|NCT00091832|39068425|FG004|Overall Study|Ineligibility Determined|1|||
16160024|NCT00091832|39068426|FG005|Overall Study|Ineligibility Determined|0|||
16160025|NCT00091832|39068421|FG000|Overall Study|Lost to Follow-up|1|||
16160026|NCT00091832|39068422|FG001|Overall Study|Lost to Follow-up|0|||
16160027|NCT00091832|39068423|FG002|Overall Study|Lost to Follow-up|3|||
16160028|NCT00091832|39068424|FG003|Overall Study|Lost to Follow-up|3|||
16160029|NCT00091832|39068425|FG004|Overall Study|Lost to Follow-up|2|||
16160030|NCT00091832|39068426|FG005|Overall Study|Lost to Follow-up|1|||
16160031|NCT00091832|39068421|FG000|Overall Study|Noncompliance|0|||
16160032|NCT00091832|39068422|FG001|Overall Study|Noncompliance|1|||
16160033|NCT00091832|39068423|FG002|Overall Study|Noncompliance|0|||
16160034|NCT00091832|39068424|FG003|Overall Study|Noncompliance|0|||
16160035|NCT00091832|39068425|FG004|Overall Study|Noncompliance|0|||
16160036|NCT00091832|39068426|FG005|Overall Study|Noncompliance|0|||
16160037|NCT00091832|39068421|FG000|Overall Study|Other|0|||
16264409|NCT01597245|39453255|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264410|NCT01597245|39453256|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264411|NCT01597245|39453257|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
16264412|NCT01597245|39453258|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264413|NCT01597245|39453259|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264414|NCT01597245|39453260|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264415|NCT01597245|39453261|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264416|NCT01597245|39453262|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264417|NCT01597245|39453263|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264418|NCT01597245|39453264|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264419|NCT01597245|39453265|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264420|NCT01597245|39453266|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264421|NCT01597245|39453267|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264422|NCT01597245|39453268|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264423|NCT01597245|39453269|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16160038|NCT00091832|39068422|FG001|Overall Study|Other|1|||
16160039|NCT00091832|39068423|FG002|Overall Study|Other|2|||
16160040|NCT00091832|39068424|FG003|Overall Study|Other|0|||
16160041|NCT00091832|39068425|FG004|Overall Study|Other|0|||
16160042|NCT00091832|39068426|FG005|Overall Study|Other|0|||
16160043|NCT00091832|39068421|FG000|Overall Study|Protocol Violation|0|||
16160044|NCT00091832|39068422|FG001|Overall Study|Protocol Violation|0|||
16160045|NCT00091832|39068423|FG002|Overall Study|Protocol Violation|1|||
16160046|NCT00091832|39068424|FG003|Overall Study|Protocol Violation|0|||
16160047|NCT00091832|39068425|FG004|Overall Study|Protocol Violation|0|||
16160048|NCT00091832|39068426|FG005|Overall Study|Protocol Violation|1|||
16160049|NCT02302963|39068428|FG000|Overall Study|Withdrawal by Subject|2|||
16160050|NCT02302963|39068429|FG001|Overall Study|Withdrawal by Subject|1|||
16160051|NCT02302963|39068428|FG000|Overall Study|Steroid injection|0|||
16160052|NCT02302963|39068429|FG001|Overall Study|Steroid injection|1|||
16160053|NCT02302963|39068428|FG000|Overall Study|Physician Decision|1|||
16160054|NCT02302963|39068429|FG001|Overall Study|Physician Decision|0|||
16160055|NCT00356278|39068430|FG000|Overall Study|Withdrawal by Subject|25|||
16160056|NCT00356278|39068431|FG001|Overall Study|Withdrawal by Subject|15|||
16160057|NCT00356278|39068432|FG002|Overall Study|Withdrawal by Subject|19|||
16160058|NCT00516737|39068433|FG000|Overall Study|Lost to Follow-up|2|||
16160059|NCT00516737|39068434|FG001|Overall Study|Lost to Follow-up|0|||
16160060|NCT00516737|39068433|FG000|Overall Study|Physician Decision|0|||
16160061|NCT00516737|39068434|FG001|Overall Study|Physician Decision|1|||
16160062|NCT00516737|39068433|FG000|Overall Study|Withdrawal by Subject|0|||
16160063|NCT00516737|39068434|FG001|Overall Study|Withdrawal by Subject|1|||
16160064|NCT00516737|39068433|FG000|Overall Study|Lack of Qualifying Event|9|||
16160065|NCT00516737|39068434|FG001|Overall Study|Lack of Qualifying Event|6|||
16160066|NCT04667117|39068439|FG000|Investigational Period|Lost to Follow-up|0|||
16160067|NCT04667117|39068440|FG001|Investigational Period|Lost to Follow-up|0|||
16160068|NCT04667117|39068441|FG002|Investigational Period|Lost to Follow-up|1|||
16160069|NCT04667117|39068439|FG000|Investigational Period|Protocol Deviation|0|||
16160070|NCT04667117|39068440|FG001|Investigational Period|Protocol Deviation|1|||
16160071|NCT04667117|39068441|FG002|Investigational Period|Protocol Deviation|0|||
16160072|NCT04667117|39068439|FG000|Extension Period|Lost to Follow-up|1|||
16160073|NCT04667117|39068440|FG001|Extension Period|Lost to Follow-up|0|||
16160074|NCT04667117|39068441|FG002|Extension Period|Lost to Follow-up|0|||
16160075|NCT04418765|39068442|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
16160076|NCT04418765|39068443|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
16160077|NCT04418765|39068444|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
16160078|NCT04418765|39068442|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
16160079|NCT04418765|39068443|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
16160080|NCT04418765|39068444|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
16160081|NCT04418765|39068442|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
16160082|NCT04418765|39068443|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
16160083|NCT04418765|39068444|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
16160084|NCT04418765|39068442|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
16160085|NCT04418765|39068443|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
16160086|NCT04418765|39068444|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
16160087|NCT04418765|39068442|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
16160088|NCT04418765|39068443|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
16160089|NCT04418765|39068444|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
16160090|NCT04418765|39068442|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
16160091|NCT04418765|39068443|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
16160092|NCT04418765|39068444|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
16160093|NCT04418765|39068442|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
16160094|NCT04418765|39068443|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
16160095|NCT04418765|39068444|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
16160096|NCT04418765|39068442|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
16160097|NCT04418765|39068443|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
16160098|NCT04418765|39068444|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
16160099|NCT04418765|39068442|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
16160100|NCT04418765|39068443|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
16160101|NCT04418765|39068444|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
16160102|NCT04418765|39068442|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
16160103|NCT04418765|39068443|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
16160104|NCT04418765|39068444|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
16160105|NCT04418765|39068442|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
16160106|NCT04418765|39068443|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
16160107|NCT04418765|39068444|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
16160108|NCT04418765|39068442|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
16160109|NCT04418765|39068443|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
16160110|NCT04418765|39068444|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
16160111|NCT04418765|39068442|FG000|Extension Period (48 Weeks)|Other than specified|0|||
16160112|NCT04418765|39068443|FG001|Extension Period (48 Weeks)|Other than specified|5|||
16160113|NCT04418765|39068444|FG002|Extension Period (48 Weeks)|Other than specified|2|||
16160114|NCT00903929|39068445|FG000|Overall Study|Withdrawal by Subject|0|||
16160115|NCT00903929|39068446|FG001|Overall Study|Withdrawal by Subject|0|||
16160116|NCT00903929|39068447|FG002|Overall Study|Withdrawal by Subject|1|||
16160117|NCT00903929|39068448|FG003|Overall Study|Withdrawal by Subject|2|||
16160118|NCT00903929|39068445|FG000|Overall Study|Adverse Event|0|||
16160119|NCT00903929|39068446|FG001|Overall Study|Adverse Event|0|||
16160120|NCT00903929|39068447|FG002|Overall Study|Adverse Event|0|||
16160121|NCT00903929|39068448|FG003|Overall Study|Adverse Event|1|||
16160122|NCT00603915|39068449|FG000|Overall Study|Physician Decision|1|||
16160123|NCT02926950|39068450|FG000|Overall Study|Adverse Event|4|||
16160124|NCT02926950|39068451|FG001|Overall Study|Adverse Event|6|||
16160125|NCT02926950|39068450|FG000|Overall Study|At the participant's own request|21|||
16160126|NCT02926950|39068451|FG001|Overall Study|At the participant's own request|25|||
16160127|NCT02926950|39068450|FG000|Overall Study|Reason not Specified|17|||
16160128|NCT02926950|39068451|FG001|Overall Study|Reason not Specified|9|||
16160129|NCT02926950|39068450|FG000|Overall Study|Lost to Follow-up|7|||
16160130|NCT02926950|39068451|FG001|Overall Study|Lost to Follow-up|8|||
16160131|NCT00993031|39068454|FG000|Overall Study|Death|0|||
16160132|NCT00993031|39068455|FG001|Overall Study|Death|1|||
16160133|NCT00993031|39068454|FG000|Overall Study|Physician Decision|0|||
16160134|NCT00993031|39068455|FG001|Overall Study|Physician Decision|2|||
16160135|NCT00993031|39068454|FG000|Overall Study|Withdrawal by Subject|3|||
16160136|NCT00993031|39068455|FG001|Overall Study|Withdrawal by Subject|3|||
16160137|NCT00993031|39068454|FG000|Overall Study|Lost to Follow-up|19|||
16160138|NCT00993031|39068455|FG001|Overall Study|Lost to Follow-up|13|||
16160139|NCT00704964|39068459|FG000|Overall Study|Not completed on time|328|||
16160140|NCT01496885|39068460|FG000|Overall Study|Lost to Follow-up|13|||
16160141|NCT01496885|39068460|FG000|Overall Study|Withdrawal by Subject|7|||
16160142|NCT01496885|39068460|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
16160143|NCT01496885|39068460|FG000|Overall Study|Death|1|||
16160144|NCT01668654|39068461|FG000|Overall Study|Study Closed/Terminated|3|||
16160145|NCT01668654|39068461|FG000|Overall Study|Withdrawal by Subject|1|||
16160146|NCT00946309|39068464|FG000|Overall Study|Protocol Violation|1|||
16160147|NCT00946309|39068465|FG001|Overall Study|Protocol Violation|0|||
16160148|NCT00946309|39068464|FG000|Overall Study|Lost to Follow-up|0|||
16160149|NCT00946309|39068465|FG001|Overall Study|Lost to Follow-up|1|||
16160150|NCT00946309|39068464|FG000|Overall Study|Procedure cancelled/discontinued|0|||
16160151|NCT00946309|39068465|FG001|Overall Study|Procedure cancelled/discontinued|3|||
16370164|NCT00663351|39839824|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
16370165|NCT00663351|39839823|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
16370166|NCT00663351|39839824|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
16370167|NCT00663351|39839823|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
16370168|NCT00663351|39839824|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
16370169|NCT00663351|39839823|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
16370170|NCT00663351|39839824|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
16370171|NCT00086307|39839825|FG000|Overall Study|Lack of Efficacy|1|||
16370172|NCT00086307|39839826|FG001|Overall Study|Lack of Efficacy|1|||
16370173|NCT00086307|39839827|FG002|Overall Study|Lack of Efficacy|2|||
16370174|NCT00086307|39839825|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
16370175|NCT00086307|39839826|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
16370176|NCT00086307|39839827|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
16370177|NCT00086307|39839825|FG000|Overall Study|Nausea and headaches|0|||
16370178|NCT00086307|39839826|FG001|Overall Study|Nausea and headaches|0|||
16370179|NCT00086307|39839827|FG002|Overall Study|Nausea and headaches|1|||
16370180|NCT00086307|39839825|FG000|Overall Study|Constipation and sleepiness|0|||
16370181|NCT00086307|39839826|FG001|Overall Study|Constipation and sleepiness|0|||
16370182|NCT00086307|39839827|FG002|Overall Study|Constipation and sleepiness|1|||
16370183|NCT00086307|39839825|FG000|Overall Study|Suicidal ideation|0|||
16370184|NCT00086307|39839826|FG001|Overall Study|Suicidal ideation|0|||
16370185|NCT00086307|39839827|FG002|Overall Study|Suicidal ideation|1|||
16370186|NCT00086307|39839825|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
16370187|NCT00086307|39839826|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
16370188|NCT00086307|39839827|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
16370189|NCT00086307|39839825|FG000|Overall Study|Withdrawal by Subject|0|||
16370190|NCT00086307|39839826|FG001|Overall Study|Withdrawal by Subject|0|||
16370191|NCT00086307|39839827|FG002|Overall Study|Withdrawal by Subject|2|||
16370192|NCT00710554|39839828|FG000|Overall Study|Adverse Event|24|||
16447030|NCT01194830|40115458|FG000|Overall Study|Non-compliance issues|4|||
16447031|NCT01194830|40115459|FG001|Overall Study|Non-compliance issues|4|||
16447032|NCT01194830|40115458|FG000|Overall Study|Other Reason|12|||
16447033|NCT01194830|40115459|FG001|Overall Study|Other Reason|8|||
16447034|NCT00391586|40115460|FG000|Overall Study|Progressive disease|13|||
16447035|NCT00391586|40115460|FG000|Overall Study|Adverse Event|5|||
16447036|NCT00391586|40115460|FG000|Overall Study|Physician Decision|2|||
16447037|NCT00391586|40115460|FG000|Overall Study|Death|4|||
16447038|NCT01193244|40115462|FG000|Overall Study|Withdrawal by Subject|79|||
16447039|NCT01193244|40115463|FG001|Overall Study|Withdrawal by Subject|97|||
16447040|NCT01193244|40115462|FG000|Overall Study|Other|303|||
16447041|NCT01193244|40115463|FG001|Overall Study|Other|278|||
16447042|NCT01193244|40115462|FG000|Overall Study|Lost to Follow-up|6|||
16447043|NCT01193244|40115463|FG001|Overall Study|Lost to Follow-up|15|||
16447044|NCT03096288|40115464|FG000|Overall Study|Withdrawal by Subject|0|||
16447045|NCT03096288|40115465|FG001|Overall Study|Withdrawal by Subject|1|||
16447046|NCT03096288|40115466|FG002|Overall Study|Withdrawal by Subject|0|||
16447047|NCT03096288|40115467|FG003|Overall Study|Withdrawal by Subject|1|||
16447048|NCT03085095|40115468|FG000|Overall Study|Adverse Event|23|||
16447049|NCT03085095|40115469|FG001|Overall Study|Adverse Event|8|||
16447050|NCT03085095|40115468|FG000|Overall Study|Protocol Violation|0|||
16067992|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16067993|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16067994|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16067995|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
16067996|NCT03982199|38739549|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16067997|NCT03982199|38739550|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16067998|NCT03982199|38739551|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16067999|NCT03982199|38739552|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16068000|NCT03982199|38739553|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16068001|NCT03982199|38739554|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
16068002|NCT03982199|38739555|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16068003|NCT03982199|38739556|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
16068004|NCT03982199|38739557|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
16068005|NCT03982199|38739558|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16068006|NCT03982199|38739559|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16068007|NCT03982199|38739560|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16068008|NCT03982199|38739561|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16370193|NCT00710554|39839829|FG001|Overall Study|Adverse Event|7|||
16447051|NCT03085095|40115469|FG001|Overall Study|Protocol Violation|1|||
16447052|NCT03085095|40115468|FG000|Overall Study|Lost to Follow-up|2|||
16447053|NCT03085095|40115469|FG001|Overall Study|Lost to Follow-up|1|||
16264424|NCT01597245|39453270|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264425|NCT01597245|39453271|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264426|NCT01597245|39453272|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16264427|NCT01597245|39453273|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16447054|NCT03085095|40115468|FG000|Overall Study|Withdrawal by Subject|17|||
16447055|NCT03085095|40115469|FG001|Overall Study|Withdrawal by Subject|6|||
16447056|NCT03085095|40115468|FG000|Overall Study|Physician Decision|9|||
16447057|NCT03085095|40115469|FG001|Overall Study|Physician Decision|3|||
16447058|NCT03085095|40115468|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
16447059|NCT03085095|40115469|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
16447060|NCT03085095|40115468|FG000|Overall Study|Did not Receive Study Drug|2|||
16447061|NCT03085095|40115469|FG001|Overall Study|Did not Receive Study Drug|2|||
16447062|NCT03085095|40115468|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
16447063|NCT03085095|40115469|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
16447064|NCT01838694|40115470|FG000|Overall Study|Adverse Event|0|||
16447065|NCT01838694|40115471|FG001|Overall Study|Adverse Event|1|||
16447066|NCT00751296|40115472|FG000|Overall Study|Adverse Event|2|||
16447067|NCT01462370|40118449|FG000|Overall Study|Lack of Qualifying Event|1|||
16447068|NCT01462370|40118450|FG001|Overall Study|Lack of Qualifying Event|1|||
16068009|NCT03982199|38739562|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
16068010|NCT03982199|38739549|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
16068011|NCT03982199|38739550|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
16068012|NCT03982199|38739551|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
16068013|NCT03982199|38739552|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
16068014|NCT03982199|38739553|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
16068015|NCT03982199|38739554|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
16068016|NCT03982199|38739555|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
16068017|NCT03982199|38739556|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
16068018|NCT03982199|38739557|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
16068019|NCT03982199|38739558|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
16068020|NCT03982199|38739559|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
16068021|NCT03982199|38739560|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
16068022|NCT03982199|38739561|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
16068023|NCT03982199|38739562|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
16068024|NCT03982199|38739549|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068025|NCT03982199|38739550|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068026|NCT03982199|38739551|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068027|NCT03982199|38739552|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068028|NCT03982199|38739553|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068029|NCT03982199|38739554|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068030|NCT03982199|38739555|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068031|NCT03982199|38739556|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068032|NCT03982199|38739557|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068033|NCT03982199|38739558|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
16068034|NCT03982199|38739559|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068035|NCT03982199|38739560|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068036|NCT03982199|38739561|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068037|NCT03982199|38739562|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
16068038|NCT03982199|38739549|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068039|NCT03982199|38739550|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068040|NCT03982199|38739551|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068041|NCT03982199|38739552|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068042|NCT03982199|38739553|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068043|NCT03982199|38739554|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068044|NCT03982199|38739555|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068045|NCT03982199|38739556|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068046|NCT03982199|38739557|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068047|NCT03982199|38739558|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068048|NCT03982199|38739559|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068049|NCT03982199|38739560|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16068050|NCT03982199|38739561|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
16264428|NCT01597245|39453274|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
16447069|NCT01462370|40118449|FG000|Overall Study|Physician Decision|0|||
16447070|NCT01462370|40118450|FG001|Overall Study|Physician Decision|1|||
16447071|NCT01462370|40118449|FG000|Overall Study|Withdrawal by Subject|0|||
16160152|NCT02720094|39068466|FG000|Overall Study|Scheduled exit visit/end of study|2|||
16160153|NCT02720094|39068467|FG001|Overall Study|Scheduled exit visit/end of study|1|||
16160154|NCT02720094|39068466|FG000|Overall Study|Death|4|||
16160155|NCT02720094|39068467|FG001|Overall Study|Death|7|||
16160156|NCT02720094|39068466|FG000|Overall Study|Withdrawal by Subject|55|||
16160157|NCT02720094|39068467|FG001|Overall Study|Withdrawal by Subject|56|||
16160158|NCT02720094|39068466|FG000|Overall Study|Lost to Follow-up|2|||
16160159|NCT02720094|39068467|FG001|Overall Study|Lost to Follow-up|7|||
16160160|NCT02720094|39068466|FG000|Overall Study|Physician Decision|1|||
16160161|NCT02720094|39068467|FG001|Overall Study|Physician Decision|3|||
16160162|NCT02720094|39068466|FG000|Overall Study|Inappropriate enrollment|1|||
16160163|NCT02720094|39068467|FG001|Overall Study|Inappropriate enrollment|3|||
16160164|NCT02720094|39068466|FG000|Overall Study|Ongoing|2210|||
16160165|NCT02720094|39068467|FG001|Overall Study|Ongoing|2203|||
16160166|NCT02720094|39068466|FG000|Overall Study|Relocation|1|||
16160167|NCT02720094|39068467|FG001|Overall Study|Relocation|1|||
16160168|NCT01262365|39068468|FG000|Overall Study|Lack of Efficacy|35|||
16160169|NCT01262365|39068469|FG001|Overall Study|Lack of Efficacy|30|||
16160170|NCT01262365|39068470|FG002|Overall Study|Lack of Efficacy|47|||
16160171|NCT01262365|39068468|FG000|Overall Study|Protocol Violation|3|||
16160172|NCT01262365|39068469|FG001|Overall Study|Protocol Violation|1|||
16160173|NCT01262365|39068470|FG002|Overall Study|Protocol Violation|1|||
16160174|NCT01262365|39068468|FG000|Overall Study|Lost to Follow-up|3|||
16160175|NCT01262365|39068469|FG001|Overall Study|Lost to Follow-up|7|||
16160176|NCT01262365|39068470|FG002|Overall Study|Lost to Follow-up|6|||
16160177|NCT01262365|39068468|FG000|Overall Study|Withdrawal by Subject|17|||
16160178|NCT01262365|39068469|FG001|Overall Study|Withdrawal by Subject|22|||
16160179|NCT01262365|39068470|FG002|Overall Study|Withdrawal by Subject|22|||
16160180|NCT01262365|39068468|FG000|Overall Study|Death|1|||
16160181|NCT01262365|39068469|FG001|Overall Study|Death|2|||
16160182|NCT01262365|39068470|FG002|Overall Study|Death|1|||
16370194|NCT00710554|39839828|FG000|Overall Study|Withdrawal by Subject|7|||
16370195|NCT00710554|39839829|FG001|Overall Study|Withdrawal by Subject|3|||
16447072|NCT01462370|40118450|FG001|Overall Study|Withdrawal by Subject|3|||
16447073|NCT03044106|40118453|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
16447074|NCT03044106|40118454|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
16447075|NCT04226742|40118455|FG000|Overall Study|Lost to Follow-up|16|||
16370196|NCT00710554|39839828|FG000|Overall Study|Lost to Follow-up|7|||
16370197|NCT00710554|39839829|FG001|Overall Study|Lost to Follow-up|1|||
16370198|NCT00710554|39839828|FG000|Overall Study|Lack of Efficacy|11|||
16370199|NCT00710554|39839829|FG001|Overall Study|Lack of Efficacy|12|||
16370200|NCT00710554|39839828|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
16370201|NCT00710554|39839829|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
16370202|NCT01166945|39839830|FG000|Randomized|diagnosed with Group A strep|4|||
16447076|NCT04226742|40118456|FG001|Overall Study|Lost to Follow-up|13|||
16447077|NCT04226742|40118455|FG000|Overall Study|Withdrawal by Subject|5|||
16447078|NCT04226742|40118456|FG001|Overall Study|Withdrawal by Subject|3|||
16447079|NCT01198977|40118457|FG000|Overall Study|Lost to Follow-up|1|||
16447080|NCT01198977|40118458|FG001|Overall Study|Lost to Follow-up|0|||
16068051|NCT03982199|38739562|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
16068052|NCT03982199|38739549|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068053|NCT03982199|38739550|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068054|NCT03982199|38739551|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068055|NCT03982199|38739552|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068056|NCT03982199|38739553|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068057|NCT03982199|38739554|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068058|NCT03982199|38739555|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068059|NCT03982199|38739556|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068060|NCT03982199|38739557|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068061|NCT03982199|38739558|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068062|NCT03982199|38739559|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
16160183|NCT01262365|39068468|FG000|Overall Study|Adverse Event|26|||
16447081|NCT02509026|40118459|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
16447082|NCT02509026|40118459|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
16160184|NCT01262365|39068469|FG001|Overall Study|Adverse Event|16|||
16160185|NCT01262365|39068470|FG002|Overall Study|Adverse Event|11|||
16160186|NCT01262365|39068468|FG000|Overall Study|sponsor decision|1|||
16160187|NCT01262365|39068469|FG001|Overall Study|sponsor decision|1|||
16160188|NCT01262365|39068470|FG002|Overall Study|sponsor decision|0|||
16160189|NCT01262365|39068468|FG000|Overall Study|Randomization error|1|||
16160190|NCT01262365|39068469|FG001|Overall Study|Randomization error|0|||
16160191|NCT01262365|39068470|FG002|Overall Study|Randomization error|2|||
16370203|NCT01166945|39839831|FG001|Randomized|diagnosed with Group A strep|4|||
16370204|NCT01166945|39839830|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
16447083|NCT02509026|40118459|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
16447084|NCT02509026|40118459|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
16447085|NCT02509026|40118459|FG000|Induction Period (24 Weeks)|Other|2|||
16447086|NCT02509026|40118459|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
16447087|NCT02509026|40118459|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
16447088|NCT02509026|40118459|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
16447089|NCT02509026|40118459|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
16447090|NCT02509026|40118459|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
16447091|NCT02509026|40118459|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
16447092|NCT02509026|40118459|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
16068063|NCT03982199|38739560|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
16068064|NCT03982199|38739561|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
16068065|NCT03982199|38739562|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
16068066|NCT03982199|38739549|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068067|NCT03982199|38739550|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068068|NCT03982199|38739551|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068069|NCT03982199|38739552|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068070|NCT03982199|38739553|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16370205|NCT01166945|39839831|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
16370206|NCT01166945|39839830|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
16370207|NCT01166945|39839831|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
16370208|NCT01166945|39839830|FG000|Day 30|Lost to Follow-up|4|||
16447093|NCT02509026|40118459|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
16447094|NCT01298648|40118463|FG000|Overall Study|Withdrawal by Subject|2|||
16447095|NCT01298648|40118463|FG000|Overall Study|Lost to Follow-up|21|||
16447096|NCT00446849|40118464|FG000|Acute Phase|Lack of Efficacy|64|||
16447097|NCT00446849|40118464|FG000|Acute Phase|Protocol Violation|10|||
16447098|NCT00446849|40118464|FG000|Acute Phase|Consent withdrawn|4|||
16447099|NCT00446849|40118464|FG000|Acute Phase|Lost to Follow-up|2|||
16447100|NCT00446849|40118464|FG000|Acute Phase|Physician Decision|1|||
16447101|NCT00446849|40118464|FG000|Acute Phase|noncompliance|1|||
16447102|NCT00446849|40118464|FG000|Maintenance Phase|Lack of Efficacy|40|||
16447103|NCT00446849|40118464|FG000|Maintenance Phase|Protocol Violation|7|||
16447104|NCT00446849|40118464|FG000|Maintenance Phase|Adverse Event|6|||
16447105|NCT00446849|40118464|FG000|Maintenance Phase|Consent withdrawn|5|||
16447106|NCT00446849|40118464|FG000|Maintenance Phase|Lost to Follow-up|3|||
16447107|NCT00446849|40118464|FG000|Maintenance Phase|Pregnancy|1|||
16447108|NCT00446849|40118464|FG000|Maintenance Phase|noncompliance|2|||
16447109|NCT00446849|40118464|FG000|Maintenance Phase|prohibited medication use|2|||
16447110|NCT00446849|40118464|FG000|Maintenance Phase|antibiotic use|1|||
16447111|NCT00446849|40118464|FG000|Maintenance Phase|study closure|1|||
16447112|NCT00446849|40118464|FG000|Maintenance Phase|hydrocodone use|1|||
16447113|NCT00446849|40118464|FG000|Maintenance Phase|concomitant medication use|1|||
16447114|NCT00198822|40118472|FG000|Overall Study|Lost to Follow-up|14|||
16447115|NCT00198822|40118473|FG001|Overall Study|Lost to Follow-up|20|||
16447116|NCT00198822|40118474|FG002|Overall Study|Lost to Follow-up|21|||
16447117|NCT01709084|40118480|FG000|Overall Study|Lost to Follow-up|4|||
16447118|NCT01709084|40118481|FG001|Overall Study|Lost to Follow-up|7|||
16447119|NCT01709084|40118480|FG000|Overall Study|Withdrawal by Subject|2|||
16264429|NCT01597245|39453254|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
16370209|NCT01166945|39839831|FG001|Day 30|Lost to Follow-up|3|||
16370210|NCT00710970|39839836|FG000|Overall Study|Never took drug|3|||
16370211|NCT01943825|39839837|FG000|Overall Study|Lost to Follow-up|9|||
16370212|NCT01943825|39839838|FG001|Overall Study|Lost to Follow-up|3|||
16370213|NCT01943825|39839839|FG002|Overall Study|Lost to Follow-up|12|||
16370214|NCT01943825|39839840|FG003|Overall Study|Lost to Follow-up|8|||
16370215|NCT01943825|39839837|FG000|Overall Study|Withdrawal by Subject|1|||
16370216|NCT01943825|39839838|FG001|Overall Study|Withdrawal by Subject|0|||
16370217|NCT01943825|39839839|FG002|Overall Study|Withdrawal by Subject|3|||
16370218|NCT01943825|39839840|FG003|Overall Study|Withdrawal by Subject|2|||
16370219|NCT01943825|39839837|FG000|Overall Study|Other than specified above|0|||
16370220|NCT01943825|39839838|FG001|Overall Study|Other than specified above|1|||
16370221|NCT01943825|39839839|FG002|Overall Study|Other than specified above|0|||
16370222|NCT01943825|39839840|FG003|Overall Study|Other than specified above|1|||
16370223|NCT02413346|39839841|FG000|Overall Study|Adverse Event|6|||
16370224|NCT02413346|39839842|FG001|Overall Study|Adverse Event|6|||
16370225|NCT02413346|39839841|FG000|Overall Study|Withdrawal by Subject|30|||
16370226|NCT02413346|39839842|FG001|Overall Study|Withdrawal by Subject|40|||
16370227|NCT02413346|39839841|FG000|Overall Study|Lost to Follow-up|17|||
16447120|NCT01709084|40118481|FG001|Overall Study|Withdrawal by Subject|2|||
16370228|NCT02413346|39839842|FG001|Overall Study|Lost to Follow-up|21|||
16447121|NCT01709084|40118480|FG000|Overall Study|Adverse Event|5|||
16447122|NCT01709084|40118481|FG001|Overall Study|Adverse Event|0|||
16447123|NCT01709084|40118480|FG000|Overall Study|Other|5|||
16447124|NCT01709084|40118481|FG001|Overall Study|Other|3|||
16447125|NCT01709084|40118480|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
16447126|NCT01709084|40118481|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
16160192|NCT01262365|39068468|FG000|Overall Study|Non-compliance|1|||
16160193|NCT01262365|39068469|FG001|Overall Study|Non-compliance|0|||
16160194|NCT01262365|39068470|FG002|Overall Study|Non-compliance|2|||
16160195|NCT01262365|39068468|FG000|Overall Study|Suspected pregnancy|1|||
16160196|NCT01262365|39068469|FG001|Overall Study|Suspected pregnancy|0|||
16160197|NCT01262365|39068470|FG002|Overall Study|Suspected pregnancy|0|||
16160198|NCT01262365|39068468|FG000|Overall Study|Patient pregnant|1|||
16160199|NCT01262365|39068469|FG001|Overall Study|Patient pregnant|0|||
16160200|NCT01262365|39068470|FG002|Overall Study|Patient pregnant|1|||
16160201|NCT01262365|39068468|FG000|Overall Study|Toxicity related to study drug|0|||
16160202|NCT01262365|39068469|FG001|Overall Study|Toxicity related to study drug|1|||
16160203|NCT01262365|39068470|FG002|Overall Study|Toxicity related to study drug|0|||
16160204|NCT01262365|39068468|FG000|Overall Study|Cannot tolerate the protocol|0|||
16160205|NCT01262365|39068469|FG001|Overall Study|Cannot tolerate the protocol|1|||
16160206|NCT01262365|39068470|FG002|Overall Study|Cannot tolerate the protocol|0|||
16160207|NCT01262365|39068468|FG000|Overall Study|Patient unavailable|0|||
16160208|NCT01262365|39068469|FG001|Overall Study|Patient unavailable|0|||
16160209|NCT01262365|39068470|FG002|Overall Study|Patient unavailable|1|||
16160210|NCT00506883|39068475|FG000|Overall Study|Lost to Follow-up|1|||
16160211|NCT00506883|39068476|FG001|Overall Study|Lost to Follow-up|1|||
16160212|NCT00506883|39068477|FG002|Overall Study|Lost to Follow-up|1|||
16160213|NCT00506883|39068475|FG000|Overall Study|Withdrawal by Subject|1|||
16160214|NCT00506883|39068476|FG001|Overall Study|Withdrawal by Subject|0|||
16160215|NCT00506883|39068477|FG002|Overall Study|Withdrawal by Subject|1|||
16160216|NCT00506883|39068475|FG000|Overall Study|Lack of Efficacy|0|||
16160217|NCT00506883|39068476|FG001|Overall Study|Lack of Efficacy|1|||
16160218|NCT00506883|39068477|FG002|Overall Study|Lack of Efficacy|1|||
16160219|NCT00506883|39068475|FG000|Overall Study|Other|5|||
16160220|NCT00506883|39068476|FG001|Overall Study|Other|1|||
16160221|NCT00506883|39068477|FG002|Overall Study|Other|1|||
16160222|NCT00676715|39068478|FG000|Overall Study|Withdrawal by Subject|7|||
16160223|NCT00676715|39068479|FG001|Overall Study|Withdrawal by Subject|9|||
16160224|NCT00676715|39068480|FG002|Overall Study|Withdrawal by Subject|10|||
16160225|NCT00676715|39068481|FG003|Overall Study|Withdrawal by Subject|10|||
16160226|NCT00676715|39068478|FG000|Overall Study|Other|2|||
16160227|NCT00676715|39068479|FG001|Overall Study|Other|6|||
16160228|NCT00676715|39068480|FG002|Overall Study|Other|4|||
16160229|NCT00676715|39068481|FG003|Overall Study|Other|3|||
16160230|NCT00676715|39068478|FG000|Overall Study|Lost to Follow-up|1|||
16160231|NCT00676715|39068479|FG001|Overall Study|Lost to Follow-up|1|||
16160232|NCT00676715|39068480|FG002|Overall Study|Lost to Follow-up|7|||
16160233|NCT00676715|39068481|FG003|Overall Study|Lost to Follow-up|3|||
16160234|NCT00676715|39068478|FG000|Overall Study|Death|1|||
16160235|NCT00676715|39068479|FG001|Overall Study|Death|1|||
16160236|NCT00676715|39068480|FG002|Overall Study|Death|1|||
16160237|NCT00676715|39068481|FG003|Overall Study|Death|0|||
16160238|NCT00676715|39068478|FG000|Overall Study|Adverse Event|0|||
16370229|NCT02413346|39839841|FG000|Overall Study|Protocol Violation|2|||
16370230|NCT02413346|39839842|FG001|Overall Study|Protocol Violation|0|||
16370231|NCT02413346|39839841|FG000|Overall Study|Other Miscellaneous Reasons|4|||
16370232|NCT02413346|39839842|FG001|Overall Study|Other Miscellaneous Reasons|3|||
16370233|NCT00376506|39839843|FG000|Overall Study|Death|0|||
16370234|NCT00376506|39839844|FG001|Overall Study|Death|2|||
16370235|NCT01698008|39839847|FG000|Overall Study|Withdrawal by Subject|1|||
16370236|NCT01698008|39839848|FG001|Overall Study|Withdrawal by Subject|2|||
16370237|NCT01127061|39839849|FG000|Overall Study|Lost to Follow-up|7|||
16370238|NCT01127061|39839850|FG001|Overall Study|Lost to Follow-up|10|||
16370239|NCT01127061|39839849|FG000|Overall Study|Physician Decision|3|||
16370240|NCT01127061|39839850|FG001|Overall Study|Physician Decision|3|||
16370241|NCT01421134|39839851|FG000|Overall Study|Adverse Event|3|||
16370242|NCT01421134|39839852|FG001|Overall Study|Adverse Event|5|||
16370243|NCT01421134|39839851|FG000|Overall Study|Lack of Efficacy|2|||
16370244|NCT01421134|39839852|FG001|Overall Study|Lack of Efficacy|4|||
16370245|NCT01421134|39839851|FG000|Overall Study|Protocol Violation|0|||
16370246|NCT01421134|39839852|FG001|Overall Study|Protocol Violation|3|||
16370247|NCT01421134|39839851|FG000|Overall Study|Withdrawal by Subject|1|||
16160239|NCT00676715|39068479|FG001|Overall Study|Adverse Event|1|||
16160240|NCT00676715|39068480|FG002|Overall Study|Adverse Event|2|||
16160241|NCT00676715|39068481|FG003|Overall Study|Adverse Event|0|||
16370248|NCT01421134|39839852|FG001|Overall Study|Withdrawal by Subject|1|||
16370249|NCT01421134|39839851|FG000|Overall Study|Administrative|0|||
16370250|NCT01421134|39839852|FG001|Overall Study|Administrative|1|||
16370251|NCT01421134|39839851|FG000|Overall Study|Lost to Follow-up|1|||
16160242|NCT00676715|39068478|FG000|Overall Study|Participants Ongoing|29|||
16160243|NCT00676715|39068479|FG001|Overall Study|Participants Ongoing|29|||
16160244|NCT00676715|39068480|FG002|Overall Study|Participants Ongoing|17|||
16160245|NCT00676715|39068481|FG003|Overall Study|Participants Ongoing|24|||
16160246|NCT02921971|39068482|FG000|Overall Study|Adverse Event|1|||
16160247|NCT02921971|39068483|FG001|Overall Study|Adverse Event|2|||
16370252|NCT01421134|39839852|FG001|Overall Study|Lost to Follow-up|1|||
16068071|NCT03982199|38739554|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068072|NCT03982199|38739555|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068073|NCT03982199|38739556|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068074|NCT03982199|38739557|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16160248|NCT02921971|39068482|FG000|Overall Study|Lack of Efficacy|3|||
16160249|NCT02921971|39068483|FG001|Overall Study|Lack of Efficacy|1|||
16447127|NCT01709084|40118480|FG000|Overall Study|Not Treated|0|||
16447128|NCT01709084|40118481|FG001|Overall Study|Not Treated|2|||
16447129|NCT02608684|40118484|FG000|Overall Study|Physician Decision|2|||
16160250|NCT02921971|39068482|FG000|Overall Study|Other than specified above|2|||
16160251|NCT02921971|39068483|FG001|Overall Study|Other than specified above|1|||
16160252|NCT01135498|39068484|FG000|Overall Study|Adverse Event|20|||
16160253|NCT01135498|39068484|FG000|Overall Study|Progressive disease|38|||
16160254|NCT01135498|39068484|FG000|Overall Study|Investigator judgement|25|||
16160255|NCT01135498|39068484|FG000|Overall Study|Withdrawal by Subject|4|||
16160256|NCT01135498|39068484|FG000|Overall Study|Death|1|||
16160257|NCT01135498|39068484|FG000|Overall Study|Ongoing at time of analysis|2|||
16160258|NCT02356562|39068485|FG000|Overall Study|Withdrawal by Subject|0|||
16160259|NCT02356562|39068486|FG001|Overall Study|Withdrawal by Subject|1|||
16160260|NCT02356562|39068485|FG000|Overall Study|Re-entered treatment in a previous study|1|||
16160261|NCT02356562|39068486|FG001|Overall Study|Re-entered treatment in a previous study|0|||
16160262|NCT02356562|39068485|FG000|Overall Study|site closure|1|||
16160263|NCT02356562|39068486|FG001|Overall Study|site closure|0|||
16160264|NCT01097863|39068489|FG000|Overall Study|Discomfort|1|||
16160265|NCT01097863|39068490|FG001|Overall Study|Discomfort|0|||
16160266|NCT01097863|39068491|FG002|Overall Study|Discomfort|1|||
16160267|NCT01097863|39068489|FG000|Overall Study|Did not return for final visit|0|||
16370253|NCT01131585|39839856|FG000|Overall Study|Adverse Event|0|||
16068075|NCT03982199|38739558|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068076|NCT03982199|38739559|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068077|NCT03982199|38739560|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068078|NCT03982199|38739561|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
16068079|NCT03982199|38739562|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
16068080|NCT03982199|38739549|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068081|NCT03982199|38739550|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068082|NCT03982199|38739551|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068083|NCT03982199|38739552|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068084|NCT03982199|38739553|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068085|NCT03982199|38739554|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068086|NCT03982199|38739555|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068087|NCT03982199|38739556|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068088|NCT03982199|38739557|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068089|NCT03982199|38739558|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068090|NCT03982199|38739559|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068091|NCT03982199|38739560|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
16068092|NCT03982199|38739561|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
16068093|NCT03982199|38739562|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
16068094|NCT03982199|38739549|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068095|NCT03982199|38739550|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068096|NCT03982199|38739551|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068097|NCT03982199|38739552|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068098|NCT03982199|38739553|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068099|NCT03982199|38739554|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068100|NCT03982199|38739555|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068101|NCT03982199|38739556|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068102|NCT03982199|38739557|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068103|NCT03982199|38739558|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068104|NCT03982199|38739559|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068105|NCT03982199|38739560|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068106|NCT03982199|38739561|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
16068107|NCT03982199|38739562|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
16068108|NCT04555044|38739565|FG000|Overall Study|Adverse Event|0|||
16068109|NCT04555044|38739566|FG001|Overall Study|Adverse Event|1|||
16068110|NCT01124162|38739567|FG000|First Intervention|Adverse Event|2|||
16068111|NCT01124162|38739568|FG001|First Intervention|Adverse Event|0|||
16068112|NCT01124162|38739567|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16068113|NCT01124162|38739568|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16160268|NCT01097863|39068490|FG001|Overall Study|Did not return for final visit|0|||
16160269|NCT01097863|39068491|FG002|Overall Study|Did not return for final visit|1|||
16447130|NCT02608684|40118484|FG000|Overall Study|Withdrawal by Subject|1|||
16264430|NCT01597245|39453255|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
16264431|NCT01597245|39453256|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
16264432|NCT01597245|39453257|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264433|NCT01597245|39453258|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264434|NCT01597245|39453259|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16447131|NCT00891904|40118493|FG000|Overall Study|Death|1|||
16160270|NCT00412750|39068492|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16160271|NCT00412750|39068493|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16160272|NCT00412750|39068494|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16160273|NCT00412750|39068492|FG000|Overall Study|Administrative problems|21|||
16160274|NCT00412750|39068493|FG001|Overall Study|Administrative problems|17|||
16160275|NCT00412750|39068494|FG002|Overall Study|Administrative problems|14|||
16160276|NCT00412750|39068492|FG000|Overall Study|Adverse Event|8|||
16160277|NCT00412750|39068493|FG001|Overall Study|Adverse Event|3|||
16160278|NCT00412750|39068494|FG002|Overall Study|Adverse Event|3|||
16160279|NCT00412750|39068492|FG000|Overall Study|Lost to Follow-up|1|||
16160280|NCT00412750|39068493|FG001|Overall Study|Lost to Follow-up|0|||
16160281|NCT00412750|39068494|FG002|Overall Study|Lost to Follow-up|1|||
16160282|NCT00412750|39068492|FG000|Overall Study|Withdrawal by Subject|0|||
16160283|NCT00412750|39068493|FG001|Overall Study|Withdrawal by Subject|1|||
16160284|NCT00412750|39068494|FG002|Overall Study|Withdrawal by Subject|2|||
16160285|NCT00412750|39068492|FG000|Overall Study|Lack of Efficacy|0|||
16160286|NCT00412750|39068493|FG001|Overall Study|Lack of Efficacy|0|||
16160287|NCT00412750|39068494|FG002|Overall Study|Lack of Efficacy|3|||
16160288|NCT00391222|39068496|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
16160289|NCT00391222|39068497|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
16160290|NCT00391222|39068498|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
16160291|NCT00391222|39068499|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
16160292|NCT00391222|39068496|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
16160293|NCT00391222|39068497|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
16160294|NCT00391222|39068498|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
16160295|NCT00391222|39068499|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
16160296|NCT00391222|39068496|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
16160297|NCT00391222|39068497|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
16160298|NCT00391222|39068498|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
16160299|NCT00391222|39068499|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
16160300|NCT00391222|39068496|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
16160301|NCT00391222|39068497|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
16160302|NCT00391222|39068498|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
16160303|NCT00391222|39068499|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
16160304|NCT00391222|39068496|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
16160305|NCT00391222|39068497|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
16160306|NCT00391222|39068498|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
16160307|NCT00391222|39068499|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
16160308|NCT00391222|39068496|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
16160309|NCT00391222|39068497|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
16160310|NCT00391222|39068498|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
16160311|NCT00391222|39068499|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
16160312|NCT00391222|39068496|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
16160313|NCT00391222|39068497|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
16160314|NCT00391222|39068498|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
16160315|NCT00391222|39068499|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
16160316|NCT00391222|39068496|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
16160317|NCT00391222|39068497|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
16160318|NCT00391222|39068498|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
16160319|NCT00391222|39068499|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
16160320|NCT00391222|39068496|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
16160321|NCT00391222|39068497|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
16160322|NCT00391222|39068498|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
16160323|NCT00391222|39068499|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
16160324|NCT00391222|39068496|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
16160325|NCT00391222|39068497|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
16160326|NCT00391222|39068498|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
16160327|NCT00391222|39068499|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
16160328|NCT00391222|39068496|FG000|Period III (Double-Blind Treatment)|Other|6|||
16160329|NCT00391222|39068497|FG001|Period III (Double-Blind Treatment)|Other|1|||
16160330|NCT00391222|39068498|FG002|Period III (Double-Blind Treatment)|Other|6|||
16160331|NCT00391222|39068499|FG003|Period III (Double-Blind Treatment)|Other|0|||
16160332|NCT00783094|39068500|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
16447132|NCT00891904|40118493|FG000|Overall Study|Adverse Event|1|||
16447133|NCT02004093|40118496|FG000|Overall Study|Death|2|||
16447134|NCT02004093|40118497|FG001|Overall Study|Death|1|||
16447135|NCT02004093|40118496|FG000|Overall Study|Lack of Efficacy|66|||
16447136|NCT02004093|40118497|FG001|Overall Study|Lack of Efficacy|62|||
16447137|NCT02004093|40118496|FG000|Overall Study|Protocol Violation|0|||
16447138|NCT02004093|40118497|FG001|Overall Study|Protocol Violation|1|||
16447139|NCT02004093|40118496|FG000|Overall Study|Lost to Follow-up|0|||
16447140|NCT02004093|40118497|FG001|Overall Study|Lost to Follow-up|1|||
16447141|NCT02004093|40118496|FG000|Overall Study|Withdrawal by Subject|3|||
16447142|NCT02004093|40118497|FG001|Overall Study|Withdrawal by Subject|7|||
16447143|NCT02004093|40118496|FG000|Overall Study|Other|3|||
16447144|NCT02004093|40118497|FG001|Overall Study|Other|1|||
16447145|NCT04032093|40118498|FG000|Overall Study|Lost to Follow-up|7|||
16447146|NCT04032093|40118499|FG001|Overall Study|Lost to Follow-up|7|||
16447147|NCT04032093|40118500|FG002|Overall Study|Lost to Follow-up|6|||
16447148|NCT04032093|40118501|FG003|Overall Study|Lost to Follow-up|10|||
16447149|NCT04032093|40118502|FG004|Overall Study|Lost to Follow-up|13|||
16447150|NCT04032093|40118503|FG005|Overall Study|Lost to Follow-up|7|||
16068114|NCT01097655|38739570|FG000|Overall Study|Withdrawal by Subject|1|||
16068115|NCT01097655|38739570|FG000|Overall Study|Subject Documented Twice|1|||
16068116|NCT01097655|38739570|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
16068117|NCT01763047|38739573|FG000|Period 1|Test Article Not Available|4|||
16068118|NCT01763047|38739574|FG001|Period 1|Test Article Not Available|1|||
16068119|NCT01763047|38739573|FG000|Period 1|Protocol Violation|4|||
16370254|NCT01131585|39839857|FG001|Overall Study|Adverse Event|2|||
16370255|NCT01131585|39839856|FG000|Overall Study|Abnormal laboratory value|1|||
16370256|NCT01131585|39839857|FG001|Overall Study|Abnormal laboratory value|0|||
16370257|NCT01131585|39839856|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16370258|NCT01131585|39839857|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
16370259|NCT01131585|39839856|FG000|Overall Study|Protocol Violation|2|||
16370260|NCT01131585|39839857|FG001|Overall Study|Protocol Violation|1|||
16068120|NCT01763047|38739574|FG001|Period 1|Protocol Violation|4|||
16068121|NCT01763047|38739573|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
16068122|NCT01763047|38739574|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
16068123|NCT01763047|38739573|FG000|Period 1|Adverse Event|0|||
16068124|NCT01763047|38739574|FG001|Period 1|Adverse Event|1|||
16068125|NCT01763047|38739573|FG000|Period 1|Unsatisfactory Visual Response|0|||
16068126|NCT01763047|38739574|FG001|Period 1|Unsatisfactory Visual Response|3|||
16068127|NCT01763047|38739573|FG000|Period 1|Lens Power Not Available|0|||
16068128|NCT01763047|38739574|FG001|Period 1|Lens Power Not Available|1|||
16068129|NCT01763047|38739573|FG000|Period 1|Study Site office Closed|0|||
16068130|NCT01763047|38739574|FG001|Period 1|Study Site office Closed|1|||
16068131|NCT01763047|38739573|FG000|Period 2|Lens Discomfort|1|||
16068132|NCT01763047|38739574|FG001|Period 2|Lens Discomfort|0|||
16068133|NCT01763047|38739573|FG000|Period 2|No longer meets Eligibility Criteria|1|||
16068134|NCT01763047|38739574|FG001|Period 2|No longer meets Eligibility Criteria|0|||
16068135|NCT01763047|38739573|FG000|Period 2|Study Site office Closed|1|||
16068136|NCT01763047|38739574|FG001|Period 2|Study Site office Closed|1|||
16068137|NCT01763047|38739573|FG000|Period 2|Unsatisfactory Visual Response|1|||
16068138|NCT01763047|38739574|FG001|Period 2|Unsatisfactory Visual Response|1|||
16068139|NCT01763047|38739573|FG000|Period 2|Protocol Violation|0|||
16068140|NCT01763047|38739574|FG001|Period 2|Protocol Violation|2|||
16068141|NCT01763047|38739573|FG000|Period 2|Unsatisfactory lens Fitting|0|||
16068142|NCT01763047|38739574|FG001|Period 2|Unsatisfactory lens Fitting|1|||
16068143|NCT00079937|38739575|FG000|Overall Study|Adverse Event|2|||
16068144|NCT00079937|38739576|FG001|Overall Study|Adverse Event|1|||
16068145|NCT00079937|38739575|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16068146|NCT00079937|38739576|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16068147|NCT00079937|38739575|FG000|Overall Study|Subject no longer requires study drug|3|||
16068148|NCT00079937|38739576|FG001|Overall Study|Subject no longer requires study drug|0|||
16068149|NCT00079937|38739575|FG000|Overall Study|Protocol Violation|8|||
16068150|NCT00079937|38739576|FG001|Overall Study|Protocol Violation|6|||
16068151|NCT00079937|38739575|FG000|Overall Study|Withdrawal by Subject|21|||
16068152|NCT00079937|38739576|FG001|Overall Study|Withdrawal by Subject|7|||
16068153|NCT00079937|38739575|FG000|Overall Study|Lost to Follow-up|12|||
16370261|NCT01131585|39839856|FG000|Overall Study|Withdrawal by Subject|3|||
16447151|NCT04032093|40118504|FG006|Overall Study|Lost to Follow-up|7|||
16068154|NCT00079937|38739576|FG001|Overall Study|Lost to Follow-up|5|||
16068155|NCT00079937|38739575|FG000|Overall Study|Administrative problems|22|||
16068156|NCT00079937|38739576|FG001|Overall Study|Administrative problems|11|||
16068157|NCT04759131|38739581|FG000|Overall Study|Investigator's discretion|1|||
16068158|NCT04759131|38739582|FG001|Overall Study|Investigator's discretion|0|||
16068159|NCT04759131|38739581|FG000|Overall Study|Subject withdrawal|1|||
16447152|NCT04032093|40118505|FG007|Overall Study|Lost to Follow-up|5|||
16447153|NCT04032093|40118506|FG008|Overall Study|Lost to Follow-up|9|||
16447154|NCT04032093|40118507|FG009|Overall Study|Lost to Follow-up|12|||
16447155|NCT04032093|40118498|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
16160333|NCT00783094|39068501|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
16160334|NCT00783094|39068502|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
16160335|NCT00783094|39068500|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
16370262|NCT01131585|39839857|FG001|Overall Study|Withdrawal by Subject|3|||
16370263|NCT01131585|39839856|FG000|Overall Study|Lost to Follow-up|0|||
16160336|NCT00783094|39068501|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
16160337|NCT00783094|39068502|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
16370264|NCT01131585|39839857|FG001|Overall Study|Lost to Follow-up|1|||
16370265|NCT01131585|39839856|FG000|Overall Study|Administrative problems|1|||
16370266|NCT01131585|39839857|FG001|Overall Study|Administrative problems|1|||
16370267|NCT01131585|39839856|FG000|Overall Study|Study termination|78|||
16370268|NCT01131585|39839857|FG001|Overall Study|Study termination|32|||
16370269|NCT00973973|39839858|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
16370270|NCT00973973|39839859|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
16370271|NCT00973973|39839858|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
16370272|NCT00973973|39839859|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
16370273|NCT00973973|39839858|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
16370274|NCT00973973|39839859|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
16370275|NCT00973973|39839858|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
16370276|NCT00973973|39839859|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
16370277|NCT00973973|39839858|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
16370278|NCT00973973|39839859|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
16370279|NCT00973973|39839858|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
16370280|NCT00973973|39839859|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
16370281|NCT00973973|39839858|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
16370282|NCT00973973|39839859|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
16370283|NCT00973973|39839858|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
16370284|NCT00973973|39839859|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
16370285|NCT00973973|39839858|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
16370286|NCT00973973|39839859|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
16370287|NCT00973973|39839858|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
16370288|NCT00973973|39839859|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
16370289|NCT00973973|39839858|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
16370290|NCT00973973|39839859|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
16370291|NCT00973973|39839858|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
16370292|NCT00973973|39839859|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
16370293|NCT05161936|39839860|FG000|Overall Study|Study terminated by Sponsor|1|||
16370294|NCT05161936|39839861|FG001|Overall Study|Study terminated by Sponsor|0|||
16370295|NCT05161936|39839862|FG002|Overall Study|Study terminated by Sponsor|0|||
16370296|NCT05161936|39839860|FG000|Overall Study|Withdrawal by Subject|0|||
16370297|NCT05161936|39839861|FG001|Overall Study|Withdrawal by Subject|0|||
16370298|NCT05161936|39839862|FG002|Overall Study|Withdrawal by Subject|1|||
16370299|NCT01301001|39839863|FG000|First Intervention|Lost to Follow-up|4|||
16370300|NCT01301001|39839864|FG001|First Intervention|Lost to Follow-up|4|||
16370301|NCT01301001|39839863|FG000|First Intervention|Withdrawal by Subject|1|||
16370302|NCT01301001|39839864|FG001|First Intervention|Withdrawal by Subject|4|||
16370303|NCT01301001|39839863|FG000|First Intervention|Adverse Event|5|||
16370304|NCT01301001|39839864|FG001|First Intervention|Adverse Event|0|||
16447156|NCT04032093|40118499|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
16068160|NCT04759131|38739582|FG001|Overall Study|Subject withdrawal|0|||
16068161|NCT02735915|38739583|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
16068162|NCT02735915|38739583|FG000|Overall Study|Withdrawal following SAE|2|||
16068163|NCT02735915|38739583|FG000|Overall Study|Withdrawal by Subject|1|||
16068164|NCT01876043|38739584|FG000|Overall Study|Death|1|||
16068165|NCT01876043|38739584|FG000|Overall Study|Withdrawal by Subject|1|||
16068166|NCT01027871|38739585|FG000|Overall Study|Physician Decision|1|||
16068167|NCT01027871|38739586|FG001|Overall Study|Physician Decision|5|||
16068168|NCT01027871|38739587|FG002|Overall Study|Physician Decision|0|||
16160338|NCT00783094|39068500|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
16160339|NCT00783094|39068501|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
16160340|NCT00783094|39068502|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
16160341|NCT00783094|39068500|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
16160342|NCT00783094|39068501|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
16370305|NCT01301001|39839863|FG000|First Intervention|Protocol Violation|0|||
16370306|NCT01301001|39839864|FG001|First Intervention|Protocol Violation|1|||
16370307|NCT01301001|39839863|FG000|Second Intervention|Adverse Event|2|||
16370308|NCT01301001|39839864|FG001|Second Intervention|Adverse Event|0|||
16370309|NCT01301001|39839863|FG000|Second Intervention|Withdrawal by Subject|2|||
16447157|NCT04032093|40118500|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
16447158|NCT04032093|40118501|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
16447159|NCT04032093|40118502|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
16447160|NCT04032093|40118503|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
16447161|NCT04032093|40118504|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
16447162|NCT04032093|40118505|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
16447163|NCT04032093|40118506|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
16447164|NCT04032093|40118507|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
16447165|NCT04032093|40118498|FG000|Overall Study|Other|1|||
16447166|NCT04032093|40118499|FG001|Overall Study|Other|0|||
16447167|NCT04032093|40118500|FG002|Overall Study|Other|0|||
16447168|NCT04032093|40118501|FG003|Overall Study|Other|1|||
16447169|NCT04032093|40118502|FG004|Overall Study|Other|1|||
16447170|NCT04032093|40118503|FG005|Overall Study|Other|0|||
16447171|NCT04032093|40118504|FG006|Overall Study|Other|0|||
16447172|NCT04032093|40118505|FG007|Overall Study|Other|0|||
16447173|NCT04032093|40118506|FG008|Overall Study|Other|0|||
16447174|NCT04032093|40118507|FG009|Overall Study|Other|1|||
16447175|NCT04032093|40118498|FG000|Overall Study|Withdrawal by Subject|1|||
16447176|NCT04032093|40118499|FG001|Overall Study|Withdrawal by Subject|3|||
16447177|NCT04032093|40118500|FG002|Overall Study|Withdrawal by Subject|2|||
16447178|NCT04032093|40118501|FG003|Overall Study|Withdrawal by Subject|2|||
16447179|NCT04032093|40118502|FG004|Overall Study|Withdrawal by Subject|3|||
16447180|NCT04032093|40118503|FG005|Overall Study|Withdrawal by Subject|0|||
16447181|NCT04032093|40118504|FG006|Overall Study|Withdrawal by Subject|0|||
16447182|NCT04032093|40118505|FG007|Overall Study|Withdrawal by Subject|0|||
16447183|NCT04032093|40118506|FG008|Overall Study|Withdrawal by Subject|0|||
16447184|NCT04032093|40118507|FG009|Overall Study|Withdrawal by Subject|0|||
16447185|NCT04032093|40118498|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16447186|NCT04032093|40118499|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16447187|NCT04032093|40118500|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16447188|NCT04032093|40118501|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
16447189|NCT04032093|40118502|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
16447190|NCT04032093|40118503|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
16447191|NCT04032093|40118504|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
16447192|NCT04032093|40118505|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
16447193|NCT04032093|40118506|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
16447194|NCT04032093|40118507|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
16447195|NCT04032093|40118498|FG000|Overall Study|Adverse Event|0|||
16447196|NCT04032093|40118499|FG001|Overall Study|Adverse Event|0|||
16447197|NCT04032093|40118500|FG002|Overall Study|Adverse Event|0|||
16447198|NCT04032093|40118501|FG003|Overall Study|Adverse Event|0|||
16447199|NCT04032093|40118502|FG004|Overall Study|Adverse Event|0|||
16447200|NCT04032093|40118503|FG005|Overall Study|Adverse Event|0|||
16447201|NCT04032093|40118504|FG006|Overall Study|Adverse Event|0|||
16447202|NCT04032093|40118505|FG007|Overall Study|Adverse Event|0|||
16447203|NCT04032093|40118506|FG008|Overall Study|Adverse Event|0|||
16447204|NCT04032093|40118507|FG009|Overall Study|Adverse Event|1|||
16447205|NCT04032093|40118498|FG000|Overall Study|Physician Decision|0|||
16447206|NCT04032093|40118499|FG001|Overall Study|Physician Decision|0|||
16447207|NCT04032093|40118500|FG002|Overall Study|Physician Decision|0|||
16447208|NCT04032093|40118501|FG003|Overall Study|Physician Decision|0|||
16447209|NCT04032093|40118502|FG004|Overall Study|Physician Decision|0|||
16447210|NCT04032093|40118503|FG005|Overall Study|Physician Decision|1|||
16447211|NCT04032093|40118504|FG006|Overall Study|Physician Decision|0|||
16447212|NCT04032093|40118505|FG007|Overall Study|Physician Decision|0|||
16447213|NCT04032093|40118506|FG008|Overall Study|Physician Decision|0|||
16447214|NCT04032093|40118507|FG009|Overall Study|Physician Decision|0|||
16447215|NCT02668653|40118512|FG000|Overall Study|Refractory disease|41|||
16447216|NCT02668653|40118513|FG001|Overall Study|Refractory disease|70|||
16447217|NCT02668653|40118512|FG000|Overall Study|Relapse|44|||
16447218|NCT02668653|40118513|FG001|Overall Study|Relapse|65|||
16447219|NCT02668653|40118512|FG000|Overall Study|Adverse Event|58|||
16447220|NCT02668653|40118513|FG001|Overall Study|Adverse Event|23|||
16447221|NCT02668653|40118512|FG000|Overall Study|Subject decision to stop study drug|25|||
16447222|NCT02668653|40118513|FG001|Overall Study|Subject decision to stop study drug|23|||
16447223|NCT02668653|40118512|FG000|Overall Study|Other reasons not specified|16|||
16447224|NCT02668653|40118513|FG001|Overall Study|Other reasons not specified|11|||
16447225|NCT02668653|40118512|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
16447226|NCT02668653|40118513|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
16447227|NCT02668653|40118512|FG000|Overall Study|Investigator decision|10|||
16447228|NCT02668653|40118513|FG001|Overall Study|Investigator decision|7|||
16068169|NCT01027871|38739585|FG000|Overall Study|Protocol Violation|0|||
16447229|NCT02668653|40118512|FG000|Overall Study|Failure to meet continuation criteria|5|||
16447230|NCT02668653|40118513|FG001|Overall Study|Failure to meet continuation criteria|12|||
16447231|NCT02668653|40118512|FG000|Overall Study|Lost to Follow-up|1|||
16447232|NCT02668653|40118513|FG001|Overall Study|Lost to Follow-up|0|||
16447233|NCT02668653|40118512|FG000|Overall Study|Pregnancy|0|||
16160343|NCT00783094|39068502|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
16160344|NCT00783094|39068500|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
16160345|NCT00783094|39068501|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
16160346|NCT00783094|39068502|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
16160347|NCT00783094|39068500|FG000|Open-Label Extension Period|Adverse Event|12|||
16160348|NCT00783094|39068501|FG001|Open-Label Extension Period|Adverse Event|7|||
16160349|NCT00783094|39068502|FG002|Open-Label Extension Period|Adverse Event|16|||
16160350|NCT00783094|39068500|FG000|Open-Label Extension Period|Death|0|||
16160351|NCT00783094|39068501|FG001|Open-Label Extension Period|Death|0|||
16160352|NCT00783094|39068502|FG002|Open-Label Extension Period|Death|1|||
16160353|NCT00783094|39068500|FG000|Open-Label Extension Period|Protocol Violation|4|||
16160354|NCT00783094|39068501|FG001|Open-Label Extension Period|Protocol Violation|5|||
16160355|NCT00783094|39068502|FG002|Open-Label Extension Period|Protocol Violation|7|||
16160356|NCT00783094|39068500|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
16264435|NCT01597245|39453260|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16447234|NCT02668653|40118513|FG001|Overall Study|Pregnancy|1|||
16447235|NCT02668653|40118512|FG000|Overall Study|Death|0|||
16447236|NCT02668653|40118513|FG001|Overall Study|Death|1|||
16447237|NCT01658436|40118514|FG000|Overall Study|Adverse Event|6|||
16447238|NCT01658436|40118515|FG001|Overall Study|Adverse Event|5|||
16447239|NCT01658436|40118514|FG000|Overall Study|Physician Decision|1|||
16447240|NCT01658436|40118515|FG001|Overall Study|Physician Decision|0|||
16447241|NCT01658436|40118514|FG000|Overall Study|Progressive disease|12|||
16447242|NCT01658436|40118515|FG001|Overall Study|Progressive disease|4|||
16447243|NCT01658436|40118514|FG000|Overall Study|Study terminated by sponsor|0|||
16447244|NCT01658436|40118515|FG001|Overall Study|Study terminated by sponsor|1|||
16447245|NCT01658436|40118514|FG000|Overall Study|Subject/guardian decision|0|||
16447246|NCT01658436|40118515|FG001|Overall Study|Subject/guardian decision|1|||
16447247|NCT01658436|40118514|FG000|Overall Study|Death|1|||
16447248|NCT01658436|40118515|FG001|Overall Study|Death|0|||
16447249|NCT03841604|40118516|FG000|Overall Study|Withdrawal by Subject|3|||
16447250|NCT03841604|40118517|FG001|Overall Study|Withdrawal by Subject|1|||
16447251|NCT03841604|40118516|FG000|Overall Study|Adverse Event|4|||
16447252|NCT03841604|40118517|FG001|Overall Study|Adverse Event|2|||
16447253|NCT03841604|40118516|FG000|Overall Study|Physician Decision|1|||
16447254|NCT03841604|40118517|FG001|Overall Study|Physician Decision|0|||
16447255|NCT01353898|40118518|FG000|Overall Study|Study site terminated|0|||
16447256|NCT01353898|40118519|FG001|Overall Study|Study site terminated|0|||
16447257|NCT01353898|40118520|FG002|Overall Study|Study site terminated|0|||
16447258|NCT01353898|40118521|FG003|Overall Study|Study site terminated|0|||
16447259|NCT01353898|40118522|FG004|Overall Study|Study site terminated|0|||
16447260|NCT01353898|40118523|FG005|Overall Study|Study site terminated|1|||
16447261|NCT00313014|40118524|FG000|Overall Study|Withdrawal by Subject|11|||
16447262|NCT00313014|40118525|FG001|Overall Study|Withdrawal by Subject|7|||
16447263|NCT00313014|40118526|FG002|Overall Study|Withdrawal by Subject|5|||
16447264|NCT00313014|40118524|FG000|Overall Study|Adverse Event|14|||
16447265|NCT00313014|40118525|FG001|Overall Study|Adverse Event|29|||
16447266|NCT00313014|40118526|FG002|Overall Study|Adverse Event|16|||
16447267|NCT00313014|40118524|FG000|Overall Study|Lost to Follow-up|7|||
16447268|NCT00313014|40118525|FG001|Overall Study|Lost to Follow-up|6|||
16068170|NCT01027871|38739586|FG001|Overall Study|Protocol Violation|2|||
16068171|NCT01027871|38739587|FG002|Overall Study|Protocol Violation|2|||
16068172|NCT01027871|38739585|FG000|Overall Study|Withdrawal by Subject|1|||
16068173|NCT01027871|38739586|FG001|Overall Study|Withdrawal by Subject|2|||
16068174|NCT01027871|38739587|FG002|Overall Study|Withdrawal by Subject|2|||
16068175|NCT01027871|38739585|FG000|Overall Study|Adverse Event|0|||
16068176|NCT01027871|38739586|FG001|Overall Study|Adverse Event|2|||
16068177|NCT01027871|38739587|FG002|Overall Study|Adverse Event|2|||
16068178|NCT01027871|38739585|FG000|Overall Study|Sponsor Decision|0|||
16068179|NCT01027871|38739586|FG001|Overall Study|Sponsor Decision|2|||
16068180|NCT01027871|38739587|FG002|Overall Study|Sponsor Decision|0|||
16068181|NCT01027871|38739585|FG000|Overall Study|Discontinued Prior to Treatment|0|||
16068182|NCT01027871|38739586|FG001|Overall Study|Discontinued Prior to Treatment|0|||
16068183|NCT01027871|38739587|FG002|Overall Study|Discontinued Prior to Treatment|1|||
16068184|NCT01174550|38739590|FG000|Overall Study|Death|75|||
16068185|NCT01174550|38739591|FG001|Overall Study|Death|74|||
16068186|NCT01174550|38739590|FG000|Overall Study|Lost to Follow-up|652|||
16068187|NCT01174550|38739591|FG001|Overall Study|Lost to Follow-up|510|||
16068188|NCT01174550|38739590|FG000|Overall Study|Withdrawal by Subject|543|||
16068189|NCT01174550|38739591|FG001|Overall Study|Withdrawal by Subject|289|||
16068190|NCT03404843|38739593|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
16447269|NCT00313014|40118526|FG002|Overall Study|Lost to Follow-up|10|||
16447270|NCT00313014|40118524|FG000|Overall Study|Administrative|9|||
16447271|NCT00313014|40118525|FG001|Overall Study|Administrative|6|||
16447272|NCT00313014|40118526|FG002|Overall Study|Administrative|14|||
16068191|NCT03404843|38739594|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
16068192|NCT01460381|38739595|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
16160357|NCT00783094|39068501|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
16160358|NCT00783094|39068502|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
16160359|NCT00783094|39068500|FG000|Open-Label Extension Period|Physician Decision|4|||
16160360|NCT00783094|39068501|FG001|Open-Label Extension Period|Physician Decision|2|||
16160361|NCT00783094|39068502|FG002|Open-Label Extension Period|Physician Decision|3|||
16160362|NCT00783094|39068500|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
16160363|NCT00783094|39068501|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
16160364|NCT00783094|39068502|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
16160365|NCT01870739|39068505|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
16160366|NCT01870739|39068506|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
16160367|NCT01870739|39068505|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
16160368|NCT01870739|39068506|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
16160369|NCT01870739|39068505|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
16160370|NCT01870739|39068506|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
16160371|NCT01870739|39068505|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
16160372|NCT01870739|39068506|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
16160373|NCT01870739|39068505|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
16160374|NCT01870739|39068506|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
16160375|NCT01870739|39068505|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
16160376|NCT01870739|39068506|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
16160377|NCT01870739|39068505|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
16160378|NCT01870739|39068506|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
16160379|NCT01965262|39068507|FG000|Second Intervention (7 Days)|Discontinued|0|||
16160380|NCT01965262|39068508|FG001|Second Intervention (7 Days)|Discontinued|1|||
16160381|NCT01965262|39068507|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
16160382|NCT01965262|39068508|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
16160383|NCT01965262|39068507|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
16160384|NCT01965262|39068508|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
16160385|NCT02526550|39068510|FG000|Overall Study|Lost to Follow-up|1|||
16160386|NCT00477165|39068511|FG000|Overall Study|Adverse Event|7|||
16160387|NCT00477165|39068512|FG001|Overall Study|Adverse Event|2|||
16160388|NCT04428424|39068513|FG000|Overall Study|Does not meet entrance criteria|132|||
16160389|NCT04428424|39068513|FG000|Overall Study|Lost to Follow-up|115|||
16160390|NCT03686397|39068525|FG000|Overall Study|Lack of Efficacy|3|||
16160391|NCT03686397|39068526|FG001|Overall Study|Lack of Efficacy|5|||
16160392|NCT03686397|39068525|FG000|Overall Study|Adverse Event|0|||
16160393|NCT03686397|39068526|FG001|Overall Study|Adverse Event|1|||
16160394|NCT03686397|39068525|FG000|Overall Study|Protocol Violation|0|||
16160395|NCT03686397|39068526|FG001|Overall Study|Protocol Violation|1|||
16160396|NCT03686397|39068525|FG000|Overall Study|Withdrawal by Subject|0|||
16160397|NCT03686397|39068526|FG001|Overall Study|Withdrawal by Subject|1|||
16160398|NCT03686397|39068525|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
16160399|NCT03686397|39068526|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
16160400|NCT04562090|39068527|FG000|Overall Study|Withdrawal by Subject|3|||
16160401|NCT04562090|39068528|FG001|Overall Study|Withdrawal by Subject|4|||
16160402|NCT04562090|39068527|FG000|Overall Study|Protocol Violation|2|||
16160403|NCT04562090|39068528|FG001|Overall Study|Protocol Violation|0|||
16160404|NCT04562090|39068527|FG000|Overall Study|Lack of Efficacy|0|||
16447273|NCT00313014|40118524|FG000|Overall Study|Lack of Efficacy|52|||
16447274|NCT00313014|40118525|FG001|Overall Study|Lack of Efficacy|25|||
16447275|NCT00313014|40118526|FG002|Overall Study|Lack of Efficacy|16|||
16447276|NCT01654302|40118527|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
16447277|NCT01654302|40118528|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
16447278|NCT02675634|40118529|FG000|Test Period 1|Adverse Event|0|||
16447279|NCT02675634|40118530|FG001|Test Period 1|Adverse Event|1|||
16447280|NCT02675634|40118531|FG002|Test Period 1|Adverse Event|0|||
16447281|NCT02675634|40118532|FG003|Test Period 1|Adverse Event|1|||
16447282|NCT02675634|40118533|FG004|Test Period 1|Adverse Event|0|||
16447283|NCT02675634|40118534|FG005|Test Period 1|Adverse Event|0|||
16447284|NCT02675634|40118529|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
16447285|NCT02675634|40118530|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
16447286|NCT02675634|40118531|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
16447287|NCT02675634|40118532|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
16447288|NCT02675634|40118533|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
16447289|NCT02675634|40118534|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
16447290|NCT02675634|40118529|FG000|Test Period 2|Lack of Efficacy|1|||
16447291|NCT02675634|40118530|FG001|Test Period 2|Lack of Efficacy|0|||
16447292|NCT02675634|40118531|FG002|Test Period 2|Lack of Efficacy|0|||
16447293|NCT02675634|40118532|FG003|Test Period 2|Lack of Efficacy|0|||
16160405|NCT04562090|39068528|FG001|Overall Study|Lack of Efficacy|1|||
16160406|NCT04562090|39068527|FG000|Overall Study|Adverse Event|1|||
16160407|NCT04562090|39068528|FG001|Overall Study|Adverse Event|4|||
16160408|NCT04562090|39068527|FG000|Overall Study|Miscellaneous|0|||
16447294|NCT02675634|40118533|FG004|Test Period 2|Lack of Efficacy|0|||
16370310|NCT01301001|39839864|FG001|Second Intervention|Withdrawal by Subject|0|||
16370311|NCT00326495|39839865|FG000|Overall Study|Switched to alternative treatment|1|||
16370312|NCT00326495|39839865|FG000|Overall Study|Disease progression before treatment|1|||
16370313|NCT00326495|39839865|FG000|Overall Study|Refused further treatment|2|||
16370314|NCT00326495|39839865|FG000|Overall Study|Subject off study before assessment|1|||
16370315|NCT01873833|39839868|FG000|Overall Study|Withdrawal by Subject|1|||
16370316|NCT01968785|39839869|FG000|Overall Study|Withdrawal by Subject|1|||
16370317|NCT01968785|39839870|FG001|Overall Study|Withdrawal by Subject|0|||
16370318|NCT01489358|39839871|FG000|Overall Study|Lost to Follow-up|0|||
16370319|NCT01489358|39839872|FG001|Overall Study|Lost to Follow-up|0|||
16370320|NCT01489358|39839873|FG002|Overall Study|Lost to Follow-up|2|||
16370321|NCT01121575|39839878|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
16370322|NCT01121575|39839879|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
16370323|NCT01121575|39839880|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
16370324|NCT01121575|39839881|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
16370325|NCT01121575|39839882|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
16370326|NCT01121575|39839883|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
16370327|NCT01121575|39839878|FG000|Overall Study|Unspecified Reasons|8|||
16370328|NCT01121575|39839879|FG001|Overall Study|Unspecified Reasons|6|||
16370329|NCT01121575|39839880|FG002|Overall Study|Unspecified Reasons|7|||
16370330|NCT01121575|39839881|FG003|Overall Study|Unspecified Reasons|5|||
16370331|NCT01121575|39839882|FG004|Overall Study|Unspecified Reasons|13|||
16370332|NCT01121575|39839883|FG005|Overall Study|Unspecified Reasons|10|||
16370333|NCT01121575|39839878|FG000|Overall Study|Death|6|||
16370334|NCT01121575|39839879|FG001|Overall Study|Death|0|||
16370335|NCT01121575|39839880|FG002|Overall Study|Death|0|||
16370336|NCT01121575|39839881|FG003|Overall Study|Death|1|||
16370337|NCT01121575|39839882|FG004|Overall Study|Death|7|||
16370338|NCT01121575|39839883|FG005|Overall Study|Death|1|||
16370339|NCT03336866|39839884|FG000|Overall Study|Lost to Follow-up|2|||
16370340|NCT03336866|39839885|FG001|Overall Study|Lost to Follow-up|0|||
16370341|NCT03336866|39839886|FG002|Overall Study|Lost to Follow-up|3|||
16370342|NCT03336866|39839884|FG000|Overall Study|Withdrawal by Subject|1|||
16370343|NCT03336866|39839885|FG001|Overall Study|Withdrawal by Subject|1|||
16370344|NCT03336866|39839886|FG002|Overall Study|Withdrawal by Subject|0|||
16370345|NCT03336866|39839884|FG000|Overall Study|Noncompliance with clinic house rules|0|||
16370346|NCT03336866|39839885|FG001|Overall Study|Noncompliance with clinic house rules|0|||
16370347|NCT03336866|39839886|FG002|Overall Study|Noncompliance with clinic house rules|1|||
16370348|NCT01717859|39839887|FG000|Overall Study|Adverse Event|5|||
16370349|NCT01717859|39839887|FG000|Overall Study|Moved out of state|1|||
16370350|NCT01717859|39839887|FG000|Overall Study|Patient concerned about mental health|1|||
16370351|NCT01717859|39839887|FG000|Overall Study|Lost to Follow-up|1|||
16370352|NCT01717859|39839887|FG000|Overall Study|Withdrawal by Subject|2|||
16370353|NCT01108055|39839888|FG000|Overall Study|Ineligible|11|||
16370354|NCT01108055|39839888|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
16370355|NCT00397930|39839889|FG000|Overall Study|Personal reasons|14|||
16370356|NCT00397930|39839890|FG001|Overall Study|Personal reasons|8|||
16370357|NCT00397930|39839889|FG000|Overall Study|Other medical|9|||
16370358|NCT00397930|39839890|FG001|Overall Study|Other medical|4|||
16370359|NCT00397930|39839889|FG000|Overall Study|Unknown reasons|9|||
16370360|NCT00397930|39839890|FG001|Overall Study|Unknown reasons|14|||
16370361|NCT00397930|39839889|FG000|Overall Study|Noncompliant|3|||
16370362|NCT00397930|39839890|FG001|Overall Study|Noncompliant|2|||
16370363|NCT00397930|39839889|FG000|Overall Study|Too time-consuming|2|||
16370364|NCT00397930|39839890|FG001|Overall Study|Too time-consuming|9|||
16068193|NCT01460381|38739596|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
16068194|NCT03415022|38739597|FG000|Overall Study|Withdrawal by Subject|1|||
16068195|NCT03415022|38739598|FG001|Overall Study|Withdrawal by Subject|2|||
16068196|NCT03415022|38739597|FG000|Overall Study|COVID-19 Suspension|2|||
16068197|NCT03415022|38739598|FG001|Overall Study|COVID-19 Suspension|3|||
16068198|NCT03415022|38739597|FG000|Overall Study|Lost to Follow-up|2|||
16068199|NCT03415022|38739598|FG001|Overall Study|Lost to Follow-up|0|||
16160409|NCT04562090|39068528|FG001|Overall Study|Miscellaneous|3|||
16370365|NCT00397930|39839889|FG000|Overall Study|Started own yoga program|1|||
16370366|NCT00397930|39839890|FG001|Overall Study|Started own yoga program|1|||
16370367|NCT00397930|39839889|FG000|Overall Study|Did not want to be in control group|0|||
16370368|NCT00397930|39839890|FG001|Overall Study|Did not want to be in control group|1|||
16370369|NCT00397930|39839889|FG000|Overall Study|Withdrawal by Subject|0|||
16370370|NCT00397930|39839890|FG001|Overall Study|Withdrawal by Subject|8|||
16370371|NCT00397930|39839889|FG000|Overall Study|Missing data|0|||
16370372|NCT00397930|39839890|FG001|Overall Study|Missing data|4|||
16370373|NCT01814332|39839891|FG000|Overall Study|Adverse Event|8|||
16068200|NCT01456780|38739599|FG000|Overall Study|Lost to Follow-up|3|||
16068201|NCT01456780|38739600|FG001|Overall Study|Lost to Follow-up|3|||
16068202|NCT01456780|38739601|FG002|Overall Study|Lost to Follow-up|0|||
16068203|NCT03303105|38739602|FG000|Overall Study|Adverse Event|0|||
16068204|NCT03303105|38739603|FG001|Overall Study|Adverse Event|2|||
16447295|NCT02675634|40118534|FG005|Test Period 2|Lack of Efficacy|0|||
16447296|NCT02675634|40118529|FG000|Test Period 2|Adverse Event|0|||
16447297|NCT02675634|40118530|FG001|Test Period 2|Adverse Event|0|||
16447298|NCT02675634|40118531|FG002|Test Period 2|Adverse Event|0|||
16447299|NCT02675634|40118532|FG003|Test Period 2|Adverse Event|0|||
16447300|NCT02675634|40118533|FG004|Test Period 2|Adverse Event|0|||
16447301|NCT02675634|40118534|FG005|Test Period 2|Adverse Event|1|||
16447302|NCT01337960|40118535|FG000|Overall Study|Lost to Follow-up|1|||
16447303|NCT01337960|40118536|FG001|Overall Study|Lost to Follow-up|0|||
16447304|NCT01337960|40118537|FG002|Overall Study|Lost to Follow-up|0|||
16447305|NCT01337960|40118535|FG000|Overall Study|Withdrawal by Subject|1|||
16447306|NCT01337960|40118536|FG001|Overall Study|Withdrawal by Subject|0|||
16447307|NCT01337960|40118537|FG002|Overall Study|Withdrawal by Subject|0|||
16447308|NCT02195518|40118545|FG000|Overall Study|Adverse Event|1|||
16447309|NCT02195518|40118545|FG000|Overall Study|Protocol Violation|4|||
16447310|NCT02195518|40118545|FG000|Overall Study|Pregnancy|2|||
16447311|NCT02195518|40118545|FG000|Overall Study|Withdrawal by Subject|1|||
16447312|NCT02195518|40118545|FG000|Overall Study|Lost to Follow-up|1|||
16447313|NCT02461134|40118546|FG000|Overall Study|Adverse Event|1|||
16447314|NCT04596267|40118547|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
16447315|NCT04596267|40118548|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
16447316|NCT04596267|40118547|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
16447317|NCT04596267|40118548|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
16447318|NCT02556177|40118549|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
16447319|NCT02556177|40118550|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
16447320|NCT03399552|40118551|FG000|Overall Study|No evidence of disease|1|||
16447321|NCT03399552|40118551|FG000|Overall Study|Unevaluable|1|||
16447322|NCT02624986|40118552|FG000|Overall Study|Death|0|||
16447323|NCT02624986|40118553|FG001|Overall Study|Death|1|||
16447324|NCT02624986|40118554|FG002|Overall Study|Death|2|||
16447325|NCT02624986|40118555|FG003|Overall Study|Death|2|||
16447326|NCT02624986|40118556|FG004|Overall Study|Death|2|||
16447327|NCT02624986|40118557|FG005|Overall Study|Death|0|||
16068205|NCT03303105|38739602|FG000|Overall Study|Lack of Efficacy|1|||
16068206|NCT03303105|38739603|FG001|Overall Study|Lack of Efficacy|0|||
16068207|NCT03303105|38739602|FG000|Overall Study|Protocol Violation|1|||
16068208|NCT03303105|38739603|FG001|Overall Study|Protocol Violation|0|||
16068209|NCT03303105|38739602|FG000|Overall Study|Withdrawal by Subject|0|||
16068210|NCT03303105|38739603|FG001|Overall Study|Withdrawal by Subject|2|||
16068211|NCT02824432|38739604|FG000|Overall Study|Major Protocol Deviation|1|||
16068212|NCT02824432|38739605|FG001|Overall Study|Major Protocol Deviation|0|||
16068213|NCT00477412|38739606|FG000|Overall Study|Death|0|||
16068214|NCT00477412|38739607|FG001|Overall Study|Death|0|||
16068215|NCT00477412|38739608|FG002|Overall Study|Death|0|||
16068216|NCT00477412|38739609|FG003|Overall Study|Death|4|||
16068217|NCT00477412|38739606|FG000|Overall Study|Lost to Follow-up|0|||
16068218|NCT00477412|38739607|FG001|Overall Study|Lost to Follow-up|0|||
16068219|NCT00477412|38739608|FG002|Overall Study|Lost to Follow-up|0|||
16068220|NCT00477412|38739609|FG003|Overall Study|Lost to Follow-up|1|||
16068221|NCT00477412|38739606|FG000|Overall Study|Withdrawal by Subject|0|||
16068222|NCT00477412|38739607|FG001|Overall Study|Withdrawal by Subject|0|||
16068223|NCT00477412|38739608|FG002|Overall Study|Withdrawal by Subject|0|||
16068224|NCT00477412|38739609|FG003|Overall Study|Withdrawal by Subject|2|||
16068225|NCT00477412|38739606|FG000|Overall Study|Second Malignancy|0|||
16068226|NCT00477412|38739607|FG001|Overall Study|Second Malignancy|0|||
16068227|NCT00477412|38739608|FG002|Overall Study|Second Malignancy|0|||
16068228|NCT00477412|38739609|FG003|Overall Study|Second Malignancy|1|||
16447328|NCT02624986|40118558|FG006|Overall Study|Death|0|||
16447329|NCT02624986|40118559|FG007|Overall Study|Death|1|||
16447330|NCT02624986|40118552|FG000|Overall Study|Study Terminated by Sponsor|1|||
16447331|NCT02624986|40118553|FG001|Overall Study|Study Terminated by Sponsor|1|||
16447332|NCT02624986|40118554|FG002|Overall Study|Study Terminated by Sponsor|0|||
16068229|NCT00477412|38739606|FG000|Overall Study|Adverse Event|1|||
16068230|NCT00477412|38739607|FG001|Overall Study|Adverse Event|0|||
16068231|NCT00477412|38739608|FG002|Overall Study|Adverse Event|1|||
16068232|NCT00477412|38739609|FG003|Overall Study|Adverse Event|0|||
16068233|NCT05074498|38739612|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
16068234|NCT05074498|38739613|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
16068235|NCT05074498|38739614|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
16068236|NCT05074498|38739615|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
16068237|NCT05074498|38739616|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
16068238|NCT05074498|38739617|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
16068239|NCT05074498|38739612|FG000|Part 1 (Upto Day 104)|Other|1|||
16068240|NCT05074498|38739613|FG001|Part 1 (Upto Day 104)|Other|0|||
16068241|NCT05074498|38739614|FG002|Part 1 (Upto Day 104)|Other|0|||
16068242|NCT05074498|38739615|FG003|Part 1 (Upto Day 104)|Other|0|||
16068243|NCT05074498|38739616|FG004|Part 1 (Upto Day 104)|Other|0|||
16447333|NCT02624986|40118555|FG003|Overall Study|Study Terminated by Sponsor|1|||
16447334|NCT02624986|40118556|FG004|Overall Study|Study Terminated by Sponsor|2|||
16447335|NCT02624986|40118557|FG005|Overall Study|Study Terminated by Sponsor|2|||
16447336|NCT02624986|40118558|FG006|Overall Study|Study Terminated by Sponsor|4|||
16447337|NCT02624986|40118559|FG007|Overall Study|Study Terminated by Sponsor|3|||
16447338|NCT02624986|40118552|FG000|Overall Study|Progressive Disease|0|||
16447339|NCT02624986|40118553|FG001|Overall Study|Progressive Disease|1|||
16447340|NCT02624986|40118554|FG002|Overall Study|Progressive Disease|0|||
16447341|NCT02624986|40118555|FG003|Overall Study|Progressive Disease|0|||
16447342|NCT02624986|40118556|FG004|Overall Study|Progressive Disease|0|||
16447343|NCT02624986|40118557|FG005|Overall Study|Progressive Disease|0|||
16447344|NCT02624986|40118558|FG006|Overall Study|Progressive Disease|0|||
16447345|NCT02624986|40118559|FG007|Overall Study|Progressive Disease|0|||
16447346|NCT02624986|40118552|FG000|Overall Study|Protocol Violation|1|||
16447347|NCT02624986|40118553|FG001|Overall Study|Protocol Violation|0|||
16447348|NCT02624986|40118554|FG002|Overall Study|Protocol Violation|0|||
16447349|NCT02624986|40118555|FG003|Overall Study|Protocol Violation|0|||
16447350|NCT02624986|40118556|FG004|Overall Study|Protocol Violation|0|||
16447351|NCT02624986|40118557|FG005|Overall Study|Protocol Violation|0|||
16447352|NCT02624986|40118558|FG006|Overall Study|Protocol Violation|0|||
16447353|NCT02624986|40118559|FG007|Overall Study|Protocol Violation|0|||
16447354|NCT02624986|40118552|FG000|Overall Study|Withdrawal by Subject|0|||
16447355|NCT02624986|40118553|FG001|Overall Study|Withdrawal by Subject|0|||
16447356|NCT02624986|40118554|FG002|Overall Study|Withdrawal by Subject|0|||
16160410|NCT01046877|39068529|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
16160411|NCT01046877|39068529|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
16160412|NCT01445951|39068530|FG000|Overall Study|Adverse Event|16|||
16160413|NCT01445951|39068531|FG001|Overall Study|Adverse Event|9|||
16160414|NCT01445951|39068532|FG002|Overall Study|Adverse Event|0|||
16160415|NCT01445951|39068530|FG000|Overall Study|Protocol Violation|2|||
16160416|NCT01445951|39068531|FG001|Overall Study|Protocol Violation|2|||
16160417|NCT01445951|39068532|FG002|Overall Study|Protocol Violation|2|||
16160418|NCT01445951|39068530|FG000|Overall Study|Withdrawal by Subject|21|||
16160419|NCT01445951|39068531|FG001|Overall Study|Withdrawal by Subject|16|||
16160420|NCT01445951|39068532|FG002|Overall Study|Withdrawal by Subject|8|||
16160421|NCT01445951|39068530|FG000|Overall Study|Physician Decision|3|||
16160422|NCT01445951|39068531|FG001|Overall Study|Physician Decision|1|||
16160423|NCT01445951|39068532|FG002|Overall Study|Physician Decision|0|||
16160424|NCT01445951|39068530|FG000|Overall Study|Lost to Follow-up|1|||
16160425|NCT01445951|39068531|FG001|Overall Study|Lost to Follow-up|2|||
16160426|NCT01445951|39068532|FG002|Overall Study|Lost to Follow-up|4|||
16160427|NCT01445951|39068530|FG000|Overall Study|Pregnancy|0|||
16160428|NCT01445951|39068531|FG001|Overall Study|Pregnancy|1|||
16160429|NCT01445951|39068532|FG002|Overall Study|Pregnancy|4|||
16160430|NCT01445951|39068530|FG000|Overall Study|Death|0|||
16160431|NCT01445951|39068531|FG001|Overall Study|Death|0|||
16160432|NCT01445951|39068532|FG002|Overall Study|Death|1|||
16160433|NCT01445951|39068530|FG000|Overall Study|Non-compliance with study drug|1|||
16160434|NCT01445951|39068531|FG001|Overall Study|Non-compliance with study drug|2|||
16160435|NCT01445951|39068532|FG002|Overall Study|Non-compliance with study drug|0|||
16160436|NCT01445951|39068530|FG000|Overall Study|Non-compliance with protocol|0|||
16160437|NCT01445951|39068531|FG001|Overall Study|Non-compliance with protocol|1|||
16160438|NCT01445951|39068532|FG002|Overall Study|Non-compliance with protocol|0|||
16160439|NCT01445951|39068530|FG000|Overall Study|Sponsor decision - subject travel|0|||
16160440|NCT01445951|39068531|FG001|Overall Study|Sponsor decision - subject travel|1|||
16160441|NCT01445951|39068532|FG002|Overall Study|Sponsor decision - subject travel|0|||
16160442|NCT01445951|39068530|FG000|Overall Study|Cough|0|||
16160443|NCT01445951|39068531|FG001|Overall Study|Cough|1|||
16160444|NCT01445951|39068532|FG002|Overall Study|Cough|0|||
16160445|NCT02164981|39068533|FG000|Started|Withdrawal by Subject|2|||
16160446|NCT02164981|39068534|FG001|Started|Withdrawal by Subject|1|||
16160447|NCT02164981|39068535|FG002|Started|Withdrawal by Subject|0|||
16160448|NCT02164981|39068533|FG000|Started|Protocol Violation|2|||
16160449|NCT02164981|39068534|FG001|Started|Protocol Violation|0|||
16160450|NCT02164981|39068535|FG002|Started|Protocol Violation|0|||
16370374|NCT01814332|39839892|FG001|Overall Study|Adverse Event|3|||
16447357|NCT02624986|40118555|FG003|Overall Study|Withdrawal by Subject|0|||
16068244|NCT05074498|38739617|FG005|Part 1 (Upto Day 104)|Other|0|||
16160451|NCT02164981|39068533|FG000|Started|Adverse Event|1|||
16160452|NCT02164981|39068534|FG001|Started|Adverse Event|2|||
16160453|NCT02164981|39068535|FG002|Started|Adverse Event|0|||
16160454|NCT02164981|39068533|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
16160455|NCT02164981|39068534|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
16160456|NCT02164981|39068535|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
16160457|NCT02164981|39068533|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
16160458|NCT02164981|39068534|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
16447358|NCT02624986|40118556|FG004|Overall Study|Withdrawal by Subject|0|||
16447359|NCT02624986|40118557|FG005|Overall Study|Withdrawal by Subject|0|||
16447360|NCT02624986|40118558|FG006|Overall Study|Withdrawal by Subject|0|||
16160459|NCT02164981|39068535|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
16160460|NCT02164981|39068533|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
16160461|NCT02164981|39068534|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
16160462|NCT02164981|39068535|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
16160463|NCT02111993|39068549|FG000|Overall Study|Physician Decision|5|||
16160464|NCT02111993|39068550|FG001|Overall Study|Physician Decision|4|||
16160465|NCT00781456|39068551|FG000|Overall Study|Adverse Event|3|||
16160466|NCT00781456|39068552|FG001|Overall Study|Adverse Event|3|||
16447361|NCT02624986|40118559|FG007|Overall Study|Withdrawal by Subject|1|||
16447362|NCT03962504|40118562|FG000|Overall Study|Other|11|||
16447363|NCT03962504|40118563|FG001|Overall Study|Other|32|||
16447364|NCT02904954|40118566|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
16447365|NCT02904954|40118567|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
16447366|NCT02904954|40118566|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
16447367|NCT02904954|40118567|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
16447368|NCT02904954|40118566|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
16447369|NCT02904954|40118567|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
16447370|NCT02904954|40118566|FG000|Adjuvant Durvalumab|Recurrence|2|||
16447371|NCT02904954|40118567|FG001|Adjuvant Durvalumab|Recurrence|0|||
16447372|NCT02904954|40118566|FG000|Adjuvant Durvalumab|Adverse Event|2|||
16447373|NCT02904954|40118567|FG001|Adjuvant Durvalumab|Adverse Event|6|||
16447374|NCT02904954|40118566|FG000|Adjuvant Durvalumab|Participant wishes|12|||
16447375|NCT02904954|40118567|FG001|Adjuvant Durvalumab|Participant wishes|7|||
16447376|NCT02904954|40118566|FG000|Adjuvant Durvalumab|Physician Decision|2|||
16447377|NCT02904954|40118567|FG001|Adjuvant Durvalumab|Physician Decision|1|||
16447378|NCT02904954|40118566|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
16447379|NCT02904954|40118567|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
16447380|NCT02904954|40118566|FG000|Adjuvant Durvalumab|Death|0|||
16447381|NCT02904954|40118567|FG001|Adjuvant Durvalumab|Death|1|||
16160467|NCT00781456|39068551|FG000|Overall Study|Withdrawal by Subject|3|||
16160468|NCT00781456|39068552|FG001|Overall Study|Withdrawal by Subject|5|||
16160469|NCT00781456|39068551|FG000|Overall Study|Protocol Violation|4|||
16160470|NCT00781456|39068552|FG001|Overall Study|Protocol Violation|1|||
16160471|NCT00781456|39068551|FG000|Overall Study|Noncompliance With Protocol|1|||
16160472|NCT00781456|39068552|FG001|Overall Study|Noncompliance With Protocol|1|||
16160473|NCT00781456|39068551|FG000|Overall Study|Lost to Follow-up|10|||
16160474|NCT00781456|39068552|FG001|Overall Study|Lost to Follow-up|5|||
16160475|NCT00781456|39068551|FG000|Overall Study|Other Reason, Unknown|0|||
16370375|NCT01814332|39839891|FG000|Overall Study|Withdrawal by Subject|3|||
16370376|NCT01814332|39839892|FG001|Overall Study|Withdrawal by Subject|8|||
16370377|NCT01814332|39839891|FG000|Overall Study|Protocol Violation|0|||
16370378|NCT01814332|39839892|FG001|Overall Study|Protocol Violation|4|||
16370379|NCT01814332|39839891|FG000|Overall Study|Lost to Follow-up|5|||
16370380|NCT01814332|39839892|FG001|Overall Study|Lost to Follow-up|1|||
16370381|NCT01623752|39839894|FG000|Phase 1 (78 Weeks)|No Data|249|||
16370382|NCT01623752|39839895|FG001|Phase 1 (78 Weeks)|No Data|66|||
16370383|NCT01623752|39839896|FG002|Phase 1 (78 Weeks)|No Data|2|||
16370384|NCT01623752|39839894|FG000|Phase 1 (78 Weeks)|Other|33|||
16370385|NCT01623752|39839895|FG001|Phase 1 (78 Weeks)|Other|20|||
16370386|NCT01623752|39839896|FG002|Phase 1 (78 Weeks)|Other|0|||
16370387|NCT01623752|39839894|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
16370388|NCT01623752|39839895|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
16370389|NCT01623752|39839896|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
16370390|NCT01623752|39839894|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
16370391|NCT01623752|39839895|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
16370392|NCT01623752|39839896|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
16370393|NCT01623752|39839894|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
16370394|NCT01623752|39839895|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
16370395|NCT01623752|39839896|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
16370396|NCT01623752|39839894|FG000|Phase 2 (78 Weeks)|Other|5|||
16370397|NCT01623752|39839895|FG001|Phase 2 (78 Weeks)|Other|1|||
16370398|NCT01623752|39839896|FG002|Phase 2 (78 Weeks)|Other|0|||
16370399|NCT01623752|39839894|FG000|Phase 2 (78 Weeks)|No Data|43|||
16370400|NCT01623752|39839895|FG001|Phase 2 (78 Weeks)|No Data|11|||
16370401|NCT01623752|39839896|FG002|Phase 2 (78 Weeks)|No Data|0|||
16370402|NCT01623752|39839894|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
16370403|NCT01623752|39839895|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
16370404|NCT01623752|39839896|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
16447382|NCT02904954|40118566|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
16160476|NCT00781456|39068552|FG001|Overall Study|Other Reason, Unknown|1|||
16160477|NCT01823679|39068554|FG000|Overall Study|Death|1|||
16160478|NCT00326898|39068557|FG000|Overall Study|Disease progression|52|||
16160479|NCT00326898|39068558|FG001|Overall Study|Disease progression|54|||
16370405|NCT01472835|39839899|FG000|Overall Study|Lost to Follow-up|2|||
16370406|NCT01472835|39839900|FG001|Overall Study|Lost to Follow-up|0|||
16370407|NCT01666652|39839901|FG000|Overall Study|Serious Adverse Event|0|||
16370408|NCT01666652|39839902|FG001|Overall Study|Serious Adverse Event|0|||
16370409|NCT01666652|39839903|FG002|Overall Study|Serious Adverse Event|0|||
16370410|NCT01666652|39839904|FG003|Overall Study|Serious Adverse Event|1|||
16370411|NCT01666652|39839905|FG004|Overall Study|Serious Adverse Event|0|||
16447383|NCT02904954|40118567|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
16447384|NCT01213472|40118568|FG000|Overall Study|Recurrence/Progressive disease|25|||
16447385|NCT01213472|40118568|FG000|Overall Study|Withdrawal by Subject|1|||
16447386|NCT01213472|40118568|FG000|Overall Study|Physician Decision|1|||
16447387|NCT03829228|40118572|FG000|Overall Study|Protocol Violation|1|||
16447388|NCT01910298|40118573|FG000|Overall Study|Adverse Event|1|||
16447389|NCT01910298|40118574|FG001|Overall Study|Adverse Event|0|||
16447390|NCT01910298|40118573|FG000|Overall Study|Withdrawal by Subject|2|||
16160480|NCT00326898|39068559|FG002|Overall Study|Disease progression|102|||
16160481|NCT00326898|39068557|FG000|Overall Study|Adverse Event|124|||
16447391|NCT01910298|40118574|FG001|Overall Study|Withdrawal by Subject|7|||
16447392|NCT01910298|40118573|FG000|Overall Study|Protocol Deviation|0|||
16068245|NCT05074498|38739612|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
16068246|NCT05074498|38739613|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
16068247|NCT05074498|38739614|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
16068248|NCT05074498|38739615|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
16068249|NCT05074498|38739616|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
16160482|NCT00326898|39068558|FG001|Overall Study|Adverse Event|128|||
16160483|NCT00326898|39068559|FG002|Overall Study|Adverse Event|33|||
16160484|NCT00326898|39068557|FG000|Overall Study|Death|2|||
16160485|NCT00326898|39068558|FG001|Overall Study|Death|0|||
16160486|NCT00326898|39068559|FG002|Overall Study|Death|0|||
16160487|NCT00326898|39068557|FG000|Overall Study|Withdrawal by Subject|134|||
16160488|NCT00326898|39068558|FG001|Overall Study|Withdrawal by Subject|128|||
16160489|NCT00326898|39068559|FG002|Overall Study|Withdrawal by Subject|32|||
16160490|NCT00326898|39068557|FG000|Overall Study|Alternative therapy|1|||
16160491|NCT00326898|39068558|FG001|Overall Study|Alternative therapy|0|||
16160492|NCT00326898|39068559|FG002|Overall Study|Alternative therapy|0|||
16160493|NCT00326898|39068557|FG000|Overall Study|Other complicating disease|5|||
16160494|NCT00326898|39068558|FG001|Overall Study|Other complicating disease|5|||
16160495|NCT00326898|39068559|FG002|Overall Study|Other complicating disease|4|||
16160496|NCT00326898|39068557|FG000|Overall Study|Other/Missing/Unknown|33|||
16160497|NCT00326898|39068558|FG001|Overall Study|Other/Missing/Unknown|28|||
16160498|NCT00326898|39068559|FG002|Overall Study|Other/Missing/Unknown|32|||
16160499|NCT00371865|39068560|FG000|Overall Study|Lack of Efficacy|0|||
16370412|NCT01666652|39839901|FG000|Overall Study|Withdrawal by Subject|0|||
16370413|NCT01666652|39839902|FG001|Overall Study|Withdrawal by Subject|0|||
16370414|NCT01666652|39839903|FG002|Overall Study|Withdrawal by Subject|0|||
16370415|NCT01666652|39839904|FG003|Overall Study|Withdrawal by Subject|0|||
16370416|NCT01666652|39839905|FG004|Overall Study|Withdrawal by Subject|1|||
16370417|NCT01666652|39839901|FG000|Overall Study|Moved from study area|1|||
16370418|NCT01666652|39839902|FG001|Overall Study|Moved from study area|0|||
16370419|NCT01666652|39839903|FG002|Overall Study|Moved from study area|0|||
16370420|NCT01666652|39839904|FG003|Overall Study|Moved from study area|2|||
16370421|NCT01666652|39839905|FG004|Overall Study|Moved from study area|0|||
16370422|NCT01666652|39839901|FG000|Overall Study|Lost to Follow-up|1|||
16370423|NCT01666652|39839902|FG001|Overall Study|Lost to Follow-up|1|||
16370424|NCT01666652|39839903|FG002|Overall Study|Lost to Follow-up|1|||
16370425|NCT01666652|39839904|FG003|Overall Study|Lost to Follow-up|1|||
16370426|NCT01666652|39839905|FG004|Overall Study|Lost to Follow-up|0|||
16370427|NCT02346370|39839908|FG000|Overall Study|Not treated|1|||
16370428|NCT02346370|39839909|FG001|Overall Study|Not treated|0|||
16370429|NCT02346370|39839910|FG002|Overall Study|Not treated|0|||
16370430|NCT02346370|39839908|FG000|Overall Study|Withdrawal of consent|1|||
16370431|NCT02346370|39839909|FG001|Overall Study|Withdrawal of consent|0|||
16370432|NCT02346370|39839910|FG002|Overall Study|Withdrawal of consent|0|||
16370433|NCT02346370|39839908|FG000|Overall Study|Death|1|||
16370434|NCT02346370|39839909|FG001|Overall Study|Death|3|||
16370435|NCT02346370|39839910|FG002|Overall Study|Death|1|||
16370436|NCT02346370|39839908|FG000|Overall Study|Sponsor discontinued study|5|||
16370437|NCT02346370|39839909|FG001|Overall Study|Sponsor discontinued study|0|||
16370438|NCT02346370|39839910|FG002|Overall Study|Sponsor discontinued study|2|||
16370439|NCT02346370|39839908|FG000|Overall Study|Radiologic progression|0|||
16370440|NCT02346370|39839909|FG001|Overall Study|Radiologic progression|0|||
16447393|NCT01910298|40118574|FG001|Overall Study|Protocol Deviation|5|||
16068250|NCT05074498|38739617|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
16068251|NCT05074498|38739612|FG000|Part 2 (Upto Day 104)|Death|0|||
16160500|NCT00371865|39068561|FG001|Overall Study|Lack of Efficacy|2|||
16160501|NCT00371865|39068560|FG000|Overall Study|Protocol Violation|3|||
16160502|NCT00371865|39068561|FG001|Overall Study|Protocol Violation|2|||
16160503|NCT00371865|39068560|FG000|Overall Study|Withdrawal by Subject|12|||
16370441|NCT02346370|39839910|FG002|Overall Study|Radiologic progression|1|||
16370442|NCT02346370|39839908|FG000|Overall Study|Physician Decision|0|||
16370443|NCT02346370|39839909|FG001|Overall Study|Physician Decision|1|||
16370444|NCT02346370|39839910|FG002|Overall Study|Physician Decision|0|||
16447394|NCT01910298|40118573|FG000|Overall Study|Lost to Follow-up|1|||
16447395|NCT01910298|40118574|FG001|Overall Study|Lost to Follow-up|1|||
16447396|NCT01910298|40118573|FG000|Overall Study|Study Terminated by Sponsor|1|||
16068252|NCT05074498|38739613|FG001|Part 2 (Upto Day 104)|Death|0|||
16068253|NCT05074498|38739614|FG002|Part 2 (Upto Day 104)|Death|0|||
16068254|NCT05074498|38739615|FG003|Part 2 (Upto Day 104)|Death|0|||
16068255|NCT05074498|38739616|FG004|Part 2 (Upto Day 104)|Death|1|||
16068256|NCT05074498|38739617|FG005|Part 2 (Upto Day 104)|Death|0|||
16068257|NCT05074498|38739612|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
16068258|NCT05074498|38739613|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
16068259|NCT05074498|38739614|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
16068260|NCT05074498|38739615|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
16068261|NCT05074498|38739616|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
16068262|NCT05074498|38739617|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
16370445|NCT02541903|39843384|FG000|Overall Study|Death|1|||
16370446|NCT04167462|39843385|FG000|Overall Study|Other reasons|3|||
16370447|NCT04167462|39843386|FG001|Overall Study|Other reasons|2|||
16370448|NCT04167462|39843385|FG000|Overall Study|Withdrawal by Subject|6|||
16370449|NCT04167462|39843386|FG001|Overall Study|Withdrawal by Subject|7|||
16370450|NCT04167462|39843385|FG000|Overall Study|Adverse Event|4|||
16370451|NCT04167462|39843386|FG001|Overall Study|Adverse Event|0|||
16370452|NCT04167462|39843385|FG000|Overall Study|Pregnancy|1|||
16370453|NCT04167462|39843386|FG001|Overall Study|Pregnancy|0|||
16370454|NCT04167462|39843385|FG000|Overall Study|Lack of Efficacy|0|||
16370455|NCT04167462|39843386|FG001|Overall Study|Lack of Efficacy|1|||
16370456|NCT01879852|39843387|FG000|Overall Study|Withdrawal by Subject|2|||
16370457|NCT01879852|39843388|FG001|Overall Study|Withdrawal by Subject|0|||
16370458|NCT02406612|39843391|FG000|Overall Study|Screening Failure|3|||
16370459|NCT02406612|39843392|FG001|Overall Study|Screening Failure|0|||
16370460|NCT02406612|39843391|FG000|Overall Study|Intra-procedural Exclusion|1|||
16370461|NCT02406612|39843392|FG001|Overall Study|Intra-procedural Exclusion|3|||
16370462|NCT02406612|39843391|FG000|Overall Study|Guidewire Failure|0|||
16370463|NCT02406612|39843392|FG001|Overall Study|Guidewire Failure|1|||
16370464|NCT00585169|39843394|FG000|Overall Study|Withdrawal by Subject|1|||
16370465|NCT04495478|39843395|FG000|Overall Study|Withdrawal by Subject|0|||
16068263|NCT05074498|38739612|FG000|Part 2 (Upto Day 104)|Other|0|||
16068264|NCT05074498|38739613|FG001|Part 2 (Upto Day 104)|Other|0|||
16068265|NCT05074498|38739614|FG002|Part 2 (Upto Day 104)|Other|0|||
16068266|NCT05074498|38739615|FG003|Part 2 (Upto Day 104)|Other|0|||
16068267|NCT05074498|38739616|FG004|Part 2 (Upto Day 104)|Other|1|||
16068268|NCT05074498|38739617|FG005|Part 2 (Upto Day 104)|Other|0|||
16068269|NCT01872611|38739624|FG000|Overall Study|Adverse Event|3|||
16370466|NCT04495478|39843396|FG001|Overall Study|Withdrawal by Subject|0|||
16370467|NCT04495478|39843397|FG002|Overall Study|Withdrawal by Subject|0|||
16370468|NCT04495478|39843398|FG003|Overall Study|Withdrawal by Subject|1|||
16370469|NCT04495478|39843399|FG004|Overall Study|Withdrawal by Subject|0|||
16370470|NCT04495478|39843400|FG005|Overall Study|Withdrawal by Subject|0|||
16370471|NCT04495478|39843401|FG006|Overall Study|Withdrawal by Subject|0|||
16370472|NCT04495478|39843395|FG000|Overall Study|Physician Decision|0|||
16370473|NCT04495478|39843396|FG001|Overall Study|Physician Decision|1|||
16370474|NCT04495478|39843397|FG002|Overall Study|Physician Decision|0|||
16370475|NCT04495478|39843398|FG003|Overall Study|Physician Decision|0|||
16370476|NCT04495478|39843399|FG004|Overall Study|Physician Decision|1|||
16370477|NCT04495478|39843400|FG005|Overall Study|Physician Decision|0|||
16370478|NCT04495478|39843401|FG006|Overall Study|Physician Decision|0|||
16370479|NCT02739828|39843406|FG000|Overall Study|Adverse Event|1|||
16370480|NCT02739828|39843406|FG000|Overall Study|Lost to Follow-up|4|||
16370481|NCT04359680|39843407|FG000|Overall Study|Withdrawal by Subject|29|||
16370482|NCT04359680|39843408|FG001|Overall Study|Withdrawal by Subject|24|||
16370483|NCT04359680|39843407|FG000|Overall Study|Adverse Event|6|||
16068270|NCT01872611|38739625|FG001|Overall Study|Adverse Event|1|||
16068271|NCT01872611|38739624|FG000|Overall Study|Adverse Event, prior to treatment|0|||
16068272|NCT01872611|38739625|FG001|Overall Study|Adverse Event, prior to treatment|1|||
16068273|NCT01872611|38739624|FG000|Overall Study|Death|0|||
16068274|NCT01872611|38739625|FG001|Overall Study|Death|1|||
16160504|NCT00371865|39068561|FG001|Overall Study|Withdrawal by Subject|10|||
16160505|NCT03002155|39068562|FG000|Overall Study|Lost to Follow-up|1|||
16160506|NCT03002155|39068563|FG001|Overall Study|Lost to Follow-up|2|||
16160507|NCT03002155|39068562|FG000|Overall Study|Withdrawal by Subject|1|||
16160508|NCT03002155|39068563|FG001|Overall Study|Withdrawal by Subject|0|||
16160509|NCT03002155|39068562|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
16160510|NCT03002155|39068563|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
16160511|NCT00511355|39068564|FG000|Overall Study|Adverse Event|4|||
16160512|NCT00511355|39068565|FG001|Overall Study|Adverse Event|4|||
16160513|NCT00511355|39068564|FG000|Overall Study|Pregnancy Wish|1|||
16160514|NCT00511355|39068565|FG001|Overall Study|Pregnancy Wish|0|||
16160515|NCT00511355|39068564|FG000|Overall Study|Lost to Follow-up|2|||
16160516|NCT00511355|39068565|FG001|Overall Study|Lost to Follow-up|1|||
16160517|NCT00511355|39068564|FG000|Overall Study|Other Reason|0|||
16160518|NCT00511355|39068565|FG001|Overall Study|Other Reason|1|||
16447397|NCT01910298|40118574|FG001|Overall Study|Study Terminated by Sponsor|17|||
16447398|NCT01910298|40118573|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16447399|NCT01910298|40118574|FG001|Overall Study|Other Miscellaneous Reasons|2|||
16447400|NCT04393454|40118577|FG000|Overall Study|Death|1|||
16447401|NCT04393454|40118577|FG000|Overall Study|Lost to Follow-up|1|||
16447402|NCT04119414|40118579|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
16447403|NCT00632229|40118583|FG000|Overall Study|Adverse Event|6|||
16447404|NCT00632229|40118584|FG001|Overall Study|Adverse Event|0|||
16447405|NCT00632229|40118583|FG000|Overall Study|Lost to Follow-up|0|||
16447406|NCT00632229|40118584|FG001|Overall Study|Lost to Follow-up|3|||
16068275|NCT01872611|38739624|FG000|Overall Study|Death, prior to treatment|0|||
16068276|NCT01872611|38739625|FG001|Overall Study|Death, prior to treatment|1|||
16068277|NCT01872611|38739624|FG000|Overall Study|Lost to Follow-up|8|||
16068278|NCT01872611|38739625|FG001|Overall Study|Lost to Follow-up|1|||
16068279|NCT01872611|38739624|FG000|Overall Study|Physician Decision|1|||
16068280|NCT01872611|38739625|FG001|Overall Study|Physician Decision|0|||
16068281|NCT01872611|38739624|FG000|Overall Study|Withdrawal by Subject|6|||
16068282|NCT01872611|38739625|FG001|Overall Study|Withdrawal by Subject|1|||
16068283|NCT01872611|38739624|FG000|Overall Study|Reason not provided|6|||
16068284|NCT01872611|38739625|FG001|Overall Study|Reason not provided|6|||
16068285|NCT01329328|38739626|FG000|Overall Study|Withdrawal by Subject|2|||
16068286|NCT01329328|38739627|FG001|Overall Study|Withdrawal by Subject|4|||
16068287|NCT01329328|38739628|FG002|Overall Study|Withdrawal by Subject|3|||
16068288|NCT02469064|38739629|FG000|Overall Study|Request not to receive intervention.|1|||
16068289|NCT02469064|38739630|FG001|Overall Study|Request not to receive intervention.|3|||
16068290|NCT00916006|38739631|FG000|Overall Study|Adverse Event|1|||
16068291|NCT00916006|38739632|FG001|Overall Study|Adverse Event|1|||
16068292|NCT00916006|38739631|FG000|Overall Study|Withdrawal by Subject|2|||
16068293|NCT00916006|38739632|FG001|Overall Study|Withdrawal by Subject|5|||
16068294|NCT00916006|38739631|FG000|Overall Study|Protocol Violation|0|||
16068295|NCT00916006|38739632|FG001|Overall Study|Protocol Violation|1|||
16068296|NCT01687270|38739633|FG000|Overall Study|Lack of Efficacy|11|||
16068297|NCT01687270|38739633|FG000|Overall Study|Lost to Follow-up|1|||
16068298|NCT00049517|38739634|FG000|Induction|Disease progression|0|||
16068299|NCT00049517|38739635|FG001|Induction|Disease progression|0|||
16068300|NCT00049517|38739636|FG002|Induction|Disease progression|0|||
16068301|NCT00049517|38739637|FG003|Induction|Disease progression|0|||
16068302|NCT00049517|38739638|FG004|Induction|Disease progression|18|||
16068303|NCT00049517|38739639|FG005|Induction|Disease progression|11|||
16068304|NCT00049517|38739634|FG000|Induction|Adverse Event|0|||
16068305|NCT00049517|38739635|FG001|Induction|Adverse Event|0|||
16068306|NCT00049517|38739636|FG002|Induction|Adverse Event|0|||
16068307|NCT00049517|38739637|FG003|Induction|Adverse Event|0|||
16068308|NCT00049517|38739638|FG004|Induction|Adverse Event|5|||
16068309|NCT00049517|38739639|FG005|Induction|Adverse Event|7|||
16068310|NCT00049517|38739634|FG000|Induction|Death|0|||
16068311|NCT00049517|38739635|FG001|Induction|Death|0|||
16068312|NCT00049517|38739636|FG002|Induction|Death|0|||
16068313|NCT00049517|38739637|FG003|Induction|Death|0|||
16068314|NCT00049517|38739638|FG004|Induction|Death|9|||
16068315|NCT00049517|38739639|FG005|Induction|Death|6|||
16068316|NCT00049517|38739634|FG000|Induction|Withdrawal by Subject|0|||
16068317|NCT00049517|38739635|FG001|Induction|Withdrawal by Subject|0|||
16068318|NCT00049517|38739636|FG002|Induction|Withdrawal by Subject|0|||
16068319|NCT00049517|38739637|FG003|Induction|Withdrawal by Subject|0|||
16068320|NCT00049517|38739638|FG004|Induction|Withdrawal by Subject|1|||
16068321|NCT00049517|38739639|FG005|Induction|Withdrawal by Subject|3|||
16068322|NCT00049517|38739634|FG000|Induction|Alternative therapy|0|||
16068323|NCT00049517|38739635|FG001|Induction|Alternative therapy|0|||
16068324|NCT00049517|38739636|FG002|Induction|Alternative therapy|0|||
16068325|NCT00049517|38739637|FG003|Induction|Alternative therapy|0|||
16068326|NCT00049517|38739638|FG004|Induction|Alternative therapy|2|||
16068327|NCT00049517|38739639|FG005|Induction|Alternative therapy|2|||
16068328|NCT00049517|38739634|FG000|Induction|Other complicating disease|0|||
16068329|NCT00049517|38739635|FG001|Induction|Other complicating disease|0|||
16447407|NCT00632229|40118583|FG000|Overall Study|Lack of Efficacy|0|||
16447408|NCT00632229|40118584|FG001|Overall Study|Lack of Efficacy|2|||
16447409|NCT00632229|40118583|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
16447410|NCT00632229|40118584|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
16068330|NCT00049517|38739636|FG002|Induction|Other complicating disease|0|||
16068331|NCT00049517|38739637|FG003|Induction|Other complicating disease|0|||
16068332|NCT00049517|38739638|FG004|Induction|Other complicating disease|3|||
16068333|NCT00049517|38739639|FG005|Induction|Other complicating disease|0|||
16068334|NCT00049517|38739634|FG000|Induction|Reasons not reported|0|||
16068335|NCT00049517|38739635|FG001|Induction|Reasons not reported|0|||
16068336|NCT00049517|38739636|FG002|Induction|Reasons not reported|0|||
16068337|NCT00049517|38739637|FG003|Induction|Reasons not reported|0|||
16068338|NCT00049517|38739638|FG004|Induction|Reasons not reported|22|||
16068339|NCT00049517|38739639|FG005|Induction|Reasons not reported|25|||
16068340|NCT00049517|38739634|FG000|Conditioning/Transplant|Disease progression|14|||
16264436|NCT01597245|39453261|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264437|NCT01597245|39453262|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264438|NCT01597245|39453263|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264439|NCT01597245|39453264|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264440|NCT01597245|39453265|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264441|NCT01597245|39453266|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264442|NCT01597245|39453267|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264443|NCT01597245|39453268|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264444|NCT01597245|39453269|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264445|NCT01597245|39453270|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264446|NCT01597245|39453271|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264447|NCT01597245|39453272|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264448|NCT01597245|39453273|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264449|NCT01597245|39453274|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
16264450|NCT01597245|39453254|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264451|NCT01597245|39453255|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264452|NCT01597245|39453256|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264453|NCT01597245|39453257|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264454|NCT01597245|39453258|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264455|NCT01597245|39453259|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
16264456|NCT01597245|39453260|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
16264457|NCT01597245|39453261|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264458|NCT01597245|39453262|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264459|NCT01597245|39453263|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264460|NCT01597245|39453264|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264461|NCT01597245|39453265|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264462|NCT01597245|39453266|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264463|NCT01597245|39453267|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264464|NCT01597245|39453268|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264465|NCT01597245|39453269|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264466|NCT01597245|39453270|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264467|NCT01597245|39453271|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264468|NCT01597245|39453272|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264469|NCT01597245|39453273|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264470|NCT01597245|39453274|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
16264471|NCT01597245|39453254|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264472|NCT01597245|39453255|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264473|NCT01597245|39453256|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264474|NCT01597245|39453257|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264475|NCT01597245|39453258|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
16264476|NCT01597245|39453259|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
16264477|NCT01597245|39453260|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
16264478|NCT01597245|39453261|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
16264479|NCT01597245|39453262|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264480|NCT01597245|39453263|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
16264481|NCT01597245|39453264|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264482|NCT01597245|39453265|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264483|NCT01597245|39453266|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264484|NCT01597245|39453267|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264485|NCT01597245|39453268|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264486|NCT01597245|39453269|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264487|NCT01597245|39453270|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264488|NCT01597245|39453271|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264489|NCT01597245|39453272|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264490|NCT01597245|39453273|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264491|NCT01597245|39453274|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
16264492|NCT01597245|39453254|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264493|NCT01597245|39453255|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264494|NCT01597245|39453256|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264495|NCT01597245|39453257|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264496|NCT01597245|39453258|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264497|NCT01597245|39453259|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
16264498|NCT01597245|39453260|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264499|NCT01597245|39453261|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264500|NCT01597245|39453262|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
16370484|NCT04359680|39843408|FG001|Overall Study|Adverse Event|2|||
16160519|NCT00511355|39068564|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
16160520|NCT00511355|39068565|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
16160521|NCT00511355|39068564|FG000|Overall Study|Withdrawal of informed consent|0|||
16160522|NCT00511355|39068565|FG001|Overall Study|Withdrawal of informed consent|1|||
16160523|NCT00511355|39068564|FG000|Overall Study|Other reason pre-treatment|0|||
16160524|NCT00511355|39068565|FG001|Overall Study|Other reason pre-treatment|1|||
16160525|NCT02740478|39068566|FG000|Overall Study|Withdrawal by Subject|1|||
16160526|NCT03984305|39068567|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
16160527|NCT03984305|39068568|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
16068341|NCT00049517|38739635|FG001|Conditioning/Transplant|Disease progression|6|||
16068342|NCT00049517|38739636|FG002|Conditioning/Transplant|Disease progression|10|||
16068343|NCT00049517|38739637|FG003|Conditioning/Transplant|Disease progression|6|||
16068344|NCT00049517|38739638|FG004|Conditioning/Transplant|Disease progression|0|||
16068345|NCT00049517|38739639|FG005|Conditioning/Transplant|Disease progression|0|||
16068346|NCT00049517|38739634|FG000|Conditioning/Transplant|Adverse Event|2|||
16068347|NCT00049517|38739635|FG001|Conditioning/Transplant|Adverse Event|1|||
16068348|NCT00049517|38739636|FG002|Conditioning/Transplant|Adverse Event|4|||
16068349|NCT00049517|38739637|FG003|Conditioning/Transplant|Adverse Event|8|||
16068350|NCT00049517|38739638|FG004|Conditioning/Transplant|Adverse Event|0|||
16068351|NCT00049517|38739639|FG005|Conditioning/Transplant|Adverse Event|0|||
16068352|NCT00049517|38739634|FG000|Conditioning/Transplant|Death|1|||
16068353|NCT00049517|38739635|FG001|Conditioning/Transplant|Death|0|||
16068354|NCT00049517|38739636|FG002|Conditioning/Transplant|Death|0|||
16370485|NCT04359680|39843407|FG000|Overall Study|Lost to Follow-up|56|||
16370486|NCT04359680|39843408|FG001|Overall Study|Lost to Follow-up|59|||
16370487|NCT04359680|39843407|FG000|Overall Study|Protocol Violation|3|||
16370488|NCT04359680|39843408|FG001|Overall Study|Protocol Violation|5|||
16370489|NCT04359680|39843407|FG000|Overall Study|Physician Decision|1|||
16370490|NCT04359680|39843408|FG001|Overall Study|Physician Decision|1|||
16370491|NCT04359680|39843407|FG000|Overall Study|Sponsor Decision|0|||
16370492|NCT04359680|39843408|FG001|Overall Study|Sponsor Decision|1|||
16370493|NCT02391584|39843409|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
16370494|NCT02391584|39843410|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
16370495|NCT02391584|39843409|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
16370496|NCT02391584|39843410|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
16370497|NCT02391584|39843409|FG000|3 Month|Lost to Follow-up|1|||
16370498|NCT02391584|39843410|FG001|3 Month|Lost to Follow-up|0|||
16370499|NCT02391584|39843409|FG000|6 Month|Withdrawal by Subject|1|||
16370500|NCT02391584|39843410|FG001|6 Month|Withdrawal by Subject|0|||
16447411|NCT02201953|40118585|FG000|Overall Study|Randomized but Never Treated|1|||
16447412|NCT02201953|40118586|FG001|Overall Study|Randomized but Never Treated|5|||
16447413|NCT02201953|40118585|FG000|Overall Study|Lack of Efficacy|9|||
16447414|NCT02201953|40118586|FG001|Overall Study|Lack of Efficacy|30|||
16447415|NCT02201953|40118585|FG000|Overall Study|Lost to Follow-up|8|||
16447416|NCT02201953|40118586|FG001|Overall Study|Lost to Follow-up|8|||
16447417|NCT02201953|40118585|FG000|Overall Study|Withdrew Consent|2|||
16447418|NCT02201953|40118586|FG001|Overall Study|Withdrew Consent|5|||
16447419|NCT02201953|40118585|FG000|Overall Study|Adverse Event|0|||
16447420|NCT02201953|40118586|FG001|Overall Study|Adverse Event|5|||
16447421|NCT02201953|40118585|FG000|Overall Study|Death|0|||
16160528|NCT03984305|39068567|FG000|Overall Study|Withdrawal by Subject|3|||
16160529|NCT03984305|39068568|FG001|Overall Study|Withdrawal by Subject|3|||
16160530|NCT03984305|39068567|FG000|Overall Study|Lost to Follow-up|1|||
16160531|NCT03984305|39068568|FG001|Overall Study|Lost to Follow-up|0|||
16447422|NCT02201953|40118586|FG001|Overall Study|Death|3|||
16447423|NCT03038100|40118589|FG000|Overall Study|Death|289|||
16447424|NCT03038100|40118590|FG001|Overall Study|Death|272|||
16447425|NCT03038100|40118589|FG000|Overall Study|Lost to Follow-up|9|||
16068355|NCT00049517|38739637|FG003|Conditioning/Transplant|Death|2|||
16068356|NCT00049517|38739638|FG004|Conditioning/Transplant|Death|0|||
16068357|NCT00049517|38739639|FG005|Conditioning/Transplant|Death|0|||
16068358|NCT00049517|38739634|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
16068359|NCT00049517|38739635|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
16068360|NCT00049517|38739636|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
16068361|NCT00049517|38739637|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
16068362|NCT00049517|38739638|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
16068363|NCT00049517|38739639|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
16160532|NCT05779072|39068570|FG000|Overall Study|Lost to Follow-up|0|||
16160533|NCT05779072|39068571|FG001|Overall Study|Lost to Follow-up|1|||
16160534|NCT05779072|39068570|FG000|Overall Study|Withdrawal by Subject|1|||
16370501|NCT02391584|39843409|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
16447426|NCT03038100|40118590|FG001|Overall Study|Lost to Follow-up|10|||
16447427|NCT03038100|40118589|FG000|Overall Study|Protocol Deviation|1|||
16447428|NCT03038100|40118590|FG001|Overall Study|Protocol Deviation|4|||
16447429|NCT03038100|40118589|FG000|Overall Study|Withdrawal by Subject|45|||
16447430|NCT03038100|40118590|FG001|Overall Study|Withdrawal by Subject|51|||
16068364|NCT00049517|38739634|FG000|Conditioning/Transplant|Alternative therapy|4|||
16068365|NCT00049517|38739635|FG001|Conditioning/Transplant|Alternative therapy|4|||
16068366|NCT00049517|38739636|FG002|Conditioning/Transplant|Alternative therapy|2|||
16068367|NCT00049517|38739637|FG003|Conditioning/Transplant|Alternative therapy|1|||
16068368|NCT00049517|38739638|FG004|Conditioning/Transplant|Alternative therapy|1|||
16068369|NCT00049517|38739639|FG005|Conditioning/Transplant|Alternative therapy|0|||
16068370|NCT00049517|38739634|FG000|Conditioning/Transplant|Other complicating disease|2|||
16068371|NCT00049517|38739635|FG001|Conditioning/Transplant|Other complicating disease|0|||
16068372|NCT00049517|38739636|FG002|Conditioning/Transplant|Other complicating disease|0|||
16068373|NCT00049517|38739637|FG003|Conditioning/Transplant|Other complicating disease|4|||
16068374|NCT00049517|38739638|FG004|Conditioning/Transplant|Other complicating disease|0|||
16068375|NCT00049517|38739639|FG005|Conditioning/Transplant|Other complicating disease|1|||
16068376|NCT00049517|38739634|FG000|Conditioning/Transplant|Reasons not reported|25|||
16068377|NCT00049517|38739635|FG001|Conditioning/Transplant|Reasons not reported|31|||
16068378|NCT00049517|38739636|FG002|Conditioning/Transplant|Reasons not reported|18|||
16068379|NCT00049517|38739637|FG003|Conditioning/Transplant|Reasons not reported|15|||
16068380|NCT00049517|38739638|FG004|Conditioning/Transplant|Reasons not reported|5|||
16068381|NCT00049517|38739639|FG005|Conditioning/Transplant|Reasons not reported|5|||
16068382|NCT02040844|38739642|FG000|Overall Study|Adverse Event|0|||
16068383|NCT02040844|38739643|FG001|Overall Study|Adverse Event|0|||
16160535|NCT05779072|39068571|FG001|Overall Study|Withdrawal by Subject|5|||
16160536|NCT00272038|39068580|FG000|Overall Study|withdrew before they received 2 cycles|7|||
16160537|NCT02307370|39068583|FG000|Overall Study|Death|5|||
16160538|NCT02307370|39068583|FG000|Overall Study|Lost to Follow-up|1|||
16160539|NCT02307370|39068583|FG000|Overall Study|Withdrawal by Subject|1|||
16370502|NCT02391584|39843410|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
16370503|NCT02175758|39843413|FG000|Treatment Phase|Lost to Follow-up|0|||
16370504|NCT02175758|39843414|FG001|Treatment Phase|Lost to Follow-up|1|||
16370505|NCT02175758|39843415|FG002|Treatment Phase|Lost to Follow-up|0|||
16370506|NCT02175758|39843416|FG003|Treatment Phase|Lost to Follow-up|0|||
16370507|NCT02175758|39843417|FG004|Treatment Phase|Lost to Follow-up|0|||
16370508|NCT02175758|39843418|FG005|Treatment Phase|Lost to Follow-up|0|||
16370509|NCT02175758|39843413|FG000|Treatment Phase|Adverse Event|0|||
16370510|NCT02175758|39843414|FG001|Treatment Phase|Adverse Event|0|||
16370511|NCT02175758|39843415|FG002|Treatment Phase|Adverse Event|0|||
16370512|NCT02175758|39843416|FG003|Treatment Phase|Adverse Event|0|||
16370513|NCT02175758|39843417|FG004|Treatment Phase|Adverse Event|1|||
16370514|NCT02175758|39843418|FG005|Treatment Phase|Adverse Event|0|||
16370515|NCT01712074|39843419|FG000|Placebo Run-in Period|Adverse Event|2|||
16370516|NCT01712074|39843420|FG001|Placebo Run-in Period|Adverse Event|0|||
16370517|NCT01712074|39843421|FG002|Placebo Run-in Period|Adverse Event|0|||
16370518|NCT01712074|39843419|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
16370519|NCT01712074|39843420|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
16370520|NCT01712074|39843421|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
16370521|NCT01712074|39843419|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
16370522|NCT01712074|39843420|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
16370523|NCT01712074|39843421|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
16370524|NCT01712074|39843419|FG000|Placebo Run-in Period|Other|1|||
16370525|NCT01712074|39843420|FG001|Placebo Run-in Period|Other|0|||
16370526|NCT01712074|39843421|FG002|Placebo Run-in Period|Other|0|||
16370527|NCT01712074|39843419|FG000|Placebo Run-in Period|No longer willing to participate|1|||
16370528|NCT01712074|39843420|FG001|Placebo Run-in Period|No longer willing to participate|0|||
16447431|NCT03038100|40118589|FG000|Overall Study|Study Terminated By Sponsor|305|||
16160540|NCT02307370|39068583|FG000|Overall Study|Declined Addendum ICF|6|||
16160541|NCT02307370|39068583|FG000|Overall Study|No response during telephone contact|5|||
16160542|NCT02307370|39068583|FG000|Overall Study|Protocol Violation|1|||
16264501|NCT01597245|39453263|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264502|NCT01597245|39453264|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
16264503|NCT01597245|39453265|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
16264504|NCT01597245|39453266|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
16264505|NCT01597245|39453267|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264506|NCT01597245|39453268|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264507|NCT01597245|39453269|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264508|NCT01597245|39453270|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264509|NCT01597245|39453271|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264510|NCT01597245|39453272|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16264511|NCT01597245|39453273|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16370529|NCT01712074|39843421|FG002|Placebo Run-in Period|No longer willing to participate|0|||
16370530|NCT01712074|39843419|FG000|Double Blind Period|Adverse Event|0|||
16370531|NCT01712074|39843420|FG001|Double Blind Period|Adverse Event|2|||
16370532|NCT01712074|39843421|FG002|Double Blind Period|Adverse Event|1|||
16447432|NCT03038100|40118590|FG001|Overall Study|Study Terminated By Sponsor|311|||
16370533|NCT01712074|39843419|FG000|Double Blind Period|No longer willing to participate|0|||
16370534|NCT01712074|39843420|FG001|Double Blind Period|No longer willing to participate|2|||
16370535|NCT01712074|39843421|FG002|Double Blind Period|No longer willing to participate|4|||
16370536|NCT01712074|39843419|FG000|Double Blind Period|Death|0|||
16370537|NCT01712074|39843420|FG001|Double Blind Period|Death|1|||
16370538|NCT01712074|39843421|FG002|Double Blind Period|Death|0|||
16370539|NCT01712074|39843419|FG000|Double Blind Period|Lost to Follow-up|0|||
16370540|NCT01712074|39843420|FG001|Double Blind Period|Lost to Follow-up|2|||
16370541|NCT01712074|39843421|FG002|Double Blind Period|Lost to Follow-up|1|||
16370542|NCT01712074|39843419|FG000|Double Blind Period|Other|0|||
16370543|NCT01712074|39843420|FG001|Double Blind Period|Other|4|||
16068384|NCT02040844|38739644|FG002|Overall Study|Adverse Event|1|||
16160543|NCT00772629|39068585|FG000|Overall Study|Subject was not vaccinated|1|||
16160544|NCT00772629|39068586|FG001|Overall Study|Subject was not vaccinated|0|||
16160545|NCT02317562|39068588|FG000|Overall Study|Physician Decision|1|||
16160546|NCT02317562|39068588|FG000|Overall Study|early termination of the study|8|||
16160547|NCT02317562|39068588|FG000|Overall Study|Lack of Efficacy|4|||
16160548|NCT02317562|39068588|FG000|Overall Study|Withdrawal by Subject|1|||
16160549|NCT03847987|39068590|FG000|Overall Study|Lost to Follow-up|1|||
16160550|NCT03847987|39068591|FG001|Overall Study|Lost to Follow-up|0|||
16160551|NCT03847987|39068590|FG000|Overall Study|Adverse Event|2|||
16160552|NCT03847987|39068591|FG001|Overall Study|Adverse Event|0|||
16160553|NCT02340663|39068592|FG000|Overall Study|Lost to Follow-up|1|||
16160554|NCT02340663|39068593|FG001|Overall Study|Lost to Follow-up|0|||
16160555|NCT02340663|39068592|FG000|Overall Study|Protocol Violation|1|||
16160556|NCT02340663|39068593|FG001|Overall Study|Protocol Violation|0|||
16160557|NCT02340663|39068592|FG000|Overall Study|Withdrawal by Subject|3|||
16160558|NCT02340663|39068593|FG001|Overall Study|Withdrawal by Subject|1|||
16160559|NCT02362503|39068594|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
16160560|NCT02362503|39068595|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
16160561|NCT02362503|39068596|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
16160562|NCT02362503|39068594|FG000|Double-blind Period-Up to 8 Days|Death|1|||
16160563|NCT02362503|39068595|FG001|Double-blind Period-Up to 8 Days|Death|0|||
16160564|NCT02362503|39068596|FG002|Double-blind Period-Up to 8 Days|Death|0|||
16160565|NCT02362503|39068594|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
16068385|NCT02040844|38739642|FG000|Overall Study|Withdrawal by Subject|16|||
16068386|NCT02040844|38739643|FG001|Overall Study|Withdrawal by Subject|22|||
16068387|NCT02040844|38739644|FG002|Overall Study|Withdrawal by Subject|25|||
16160566|NCT02362503|39068595|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
16160567|NCT02362503|39068596|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
16160568|NCT02362503|39068594|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
16160569|NCT02362503|39068595|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
16160570|NCT02362503|39068596|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
16160571|NCT02362503|39068594|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
16160572|NCT02362503|39068595|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
16160573|NCT02362503|39068596|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
16160574|NCT02362503|39068594|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
16160575|NCT02362503|39068595|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
16160576|NCT02362503|39068596|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
16160577|NCT02362503|39068594|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
16160578|NCT02362503|39068595|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
16160579|NCT02362503|39068596|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
16160580|NCT02362503|39068594|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
16160581|NCT02362503|39068595|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
16160582|NCT02362503|39068596|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
16370544|NCT01712074|39843421|FG002|Double Blind Period|Other|1|||
16370545|NCT01712074|39843419|FG000|Double Blind Period|Protocol Violation|0|||
16068388|NCT02040844|38739642|FG000|Overall Study|Lost to Follow-up|12|||
16068389|NCT02040844|38739643|FG001|Overall Study|Lost to Follow-up|9|||
16068390|NCT02040844|38739644|FG002|Overall Study|Lost to Follow-up|13|||
16068391|NCT02040844|38739642|FG000|Overall Study|Missing|13|||
16068392|NCT02040844|38739643|FG001|Overall Study|Missing|3|||
16068393|NCT02040844|38739644|FG002|Overall Study|Missing|2|||
16068394|NCT02040844|38739642|FG000|Overall Study|Non-specified|8|||
16068395|NCT02040844|38739643|FG001|Overall Study|Non-specified|2|||
16068396|NCT02040844|38739644|FG002|Overall Study|Non-specified|5|||
16068397|NCT02040844|38739642|FG000|Overall Study|Concomitant medication|1|||
16370546|NCT01712074|39843420|FG001|Double Blind Period|Protocol Violation|0|||
16370547|NCT01712074|39843421|FG002|Double Blind Period|Protocol Violation|1|||
16160583|NCT02362503|39068594|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
16160584|NCT02362503|39068595|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
16160585|NCT02362503|39068596|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
16160586|NCT02362503|39068594|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
16370548|NCT01712074|39843419|FG000|Double Blind Period|No longer met eligibility criteria|0|||
16370549|NCT01712074|39843420|FG001|Double Blind Period|No longer met eligibility criteria|3|||
16370550|NCT01712074|39843421|FG002|Double Blind Period|No longer met eligibility criteria|0|||
16370551|NCT03378635|39843422|FG000|Overall Study|Adverse Event|1|||
16370552|NCT03378635|39843423|FG001|Overall Study|Adverse Event|0|||
16370553|NCT03378635|39843424|FG002|Overall Study|Adverse Event|0|||
16370554|NCT03378635|39843422|FG000|Overall Study|Withdrawal by Subject|1|||
16370555|NCT03378635|39843423|FG001|Overall Study|Withdrawal by Subject|0|||
16370556|NCT03378635|39843424|FG002|Overall Study|Withdrawal by Subject|0|||
16370557|NCT02134028|39843425|FG000|Overall Study|Lack of Efficacy|1|||
16370558|NCT02134028|39843426|FG001|Overall Study|Lack of Efficacy|0|||
16370559|NCT02134028|39843427|FG002|Overall Study|Lack of Efficacy|3|||
16370560|NCT02134028|39843428|FG003|Overall Study|Lack of Efficacy|2|||
16370561|NCT02134028|39843429|FG004|Overall Study|Lack of Efficacy|1|||
16370562|NCT02134028|39843430|FG005|Overall Study|Lack of Efficacy|2|||
16370563|NCT02134028|39843431|FG006|Overall Study|Lack of Efficacy|1|||
16370564|NCT02134028|39843432|FG007|Overall Study|Lack of Efficacy|0|||
16370565|NCT02134028|39843425|FG000|Overall Study|Poor compliance to protocol|1|||
16370566|NCT02134028|39843426|FG001|Overall Study|Poor compliance to protocol|1|||
16370567|NCT02134028|39843427|FG002|Overall Study|Poor compliance to protocol|3|||
16370568|NCT02134028|39843428|FG003|Overall Study|Poor compliance to protocol|7|||
16370569|NCT02134028|39843429|FG004|Overall Study|Poor compliance to protocol|1|||
16068398|NCT02040844|38739643|FG001|Overall Study|Concomitant medication|3|||
16068399|NCT02040844|38739644|FG002|Overall Study|Concomitant medication|1|||
16370570|NCT02134028|39843430|FG005|Overall Study|Poor compliance to protocol|1|||
16370571|NCT02134028|39843431|FG006|Overall Study|Poor compliance to protocol|0|||
16160587|NCT02362503|39068595|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
16160588|NCT02362503|39068596|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
16068400|NCT00828945|38739645|FG000|Overall Study|Death|4|||
16068401|NCT00828945|38739645|FG000|Overall Study|Participant was missing|1|||
16068402|NCT00828945|38739645|FG000|Overall Study|Other|36|||
16068403|NCT02179918|38739648|FG000|Overall Study|Death|0|||
16068404|NCT02179918|38739649|FG001|Overall Study|Death|0|||
16068405|NCT02179918|38739650|FG002|Overall Study|Death|0|||
16068406|NCT02179918|38739651|FG003|Overall Study|Death|1|||
16068407|NCT02179918|38739652|FG004|Overall Study|Death|0|||
16068408|NCT02179918|38739648|FG000|Overall Study|Lost to Follow-up|0|||
16068409|NCT02179918|38739649|FG001|Overall Study|Lost to Follow-up|0|||
16068410|NCT02179918|38739650|FG002|Overall Study|Lost to Follow-up|1|||
16068411|NCT02179918|38739651|FG003|Overall Study|Lost to Follow-up|0|||
16068412|NCT02179918|38739652|FG004|Overall Study|Lost to Follow-up|0|||
16068413|NCT02179918|38739648|FG000|Overall Study|Progressive Disease|4|||
16068414|NCT02179918|38739649|FG001|Overall Study|Progressive Disease|1|||
16068415|NCT02179918|38739650|FG002|Overall Study|Progressive Disease|1|||
16068416|NCT02179918|38739651|FG003|Overall Study|Progressive Disease|2|||
16160589|NCT02362503|39068594|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
16160590|NCT02362503|39068595|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
16160591|NCT02362503|39068596|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
16160592|NCT02362503|39068594|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
16160593|NCT02362503|39068595|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
16160594|NCT02362503|39068596|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
16160595|NCT02362503|39068594|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
16160596|NCT02362503|39068595|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
16160597|NCT02362503|39068596|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
16264512|NCT01597245|39453274|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
16370572|NCT02134028|39843432|FG007|Overall Study|Poor compliance to protocol|0|||
16370573|NCT02134028|39843425|FG000|Overall Study|Other unspecified|4|||
16068417|NCT02179918|38739652|FG004|Overall Study|Progressive Disease|6|||
16068418|NCT02179918|38739648|FG000|Overall Study|Other|0|||
16068419|NCT02179918|38739649|FG001|Overall Study|Other|1|||
16068420|NCT02179918|38739650|FG002|Overall Study|Other|0|||
16447433|NCT03038100|40118589|FG000|Overall Study|Physician Decision|1|||
16447434|NCT03038100|40118590|FG001|Overall Study|Physician Decision|3|||
16447435|NCT02007096|40118592|FG000|Overall Study|medication not available|2|||
16447436|NCT02007096|40118593|FG001|Overall Study|medication not available|0|||
16447437|NCT02007096|40118592|FG000|Overall Study|did not inject saline|0|||
16068421|NCT02179918|38739651|FG003|Overall Study|Other|0|||
16068422|NCT02179918|38739652|FG004|Overall Study|Other|1|||
16264513|NCT01597245|39453254|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16370574|NCT02134028|39843426|FG001|Overall Study|Other unspecified|22|||
16447438|NCT02007096|40118593|FG001|Overall Study|did not inject saline|3|||
16447439|NCT02007096|40118592|FG000|Overall Study|did not follow postoperative protocol|8|||
16447440|NCT02007096|40118593|FG001|Overall Study|did not follow postoperative protocol|11|||
16068423|NCT02179918|38739648|FG000|Overall Study|Subject refused further follow-up|0|||
16068424|NCT02179918|38739649|FG001|Overall Study|Subject refused further follow-up|1|||
16068425|NCT02179918|38739650|FG002|Overall Study|Subject refused further follow-up|0|||
16068426|NCT02179918|38739651|FG003|Overall Study|Subject refused further follow-up|0|||
16370575|NCT02134028|39843427|FG002|Overall Study|Other unspecified|33|||
16370576|NCT02134028|39843428|FG003|Overall Study|Other unspecified|64|||
16370577|NCT02134028|39843429|FG004|Overall Study|Other unspecified|8|||
16370578|NCT02134028|39843430|FG005|Overall Study|Other unspecified|6|||
16370579|NCT02134028|39843431|FG006|Overall Study|Other unspecified|2|||
16370580|NCT02134028|39843432|FG007|Overall Study|Other unspecified|1|||
16370581|NCT02134028|39843425|FG000|Overall Study|Adverse Event|3|||
16370582|NCT02134028|39843426|FG001|Overall Study|Adverse Event|19|||
16370583|NCT02134028|39843427|FG002|Overall Study|Adverse Event|13|||
16370584|NCT02134028|39843428|FG003|Overall Study|Adverse Event|32|||
16370585|NCT02134028|39843429|FG004|Overall Study|Adverse Event|4|||
16370586|NCT02134028|39843430|FG005|Overall Study|Adverse Event|5|||
16370587|NCT02134028|39843431|FG006|Overall Study|Adverse Event|1|||
16370588|NCT02134028|39843432|FG007|Overall Study|Adverse Event|2|||
16370589|NCT04341662|39843435|FG000|Overall Study|Did not have source-verified blood loss data|423|||
16370590|NCT04341662|39843436|FG001|Overall Study|Did not have source-verified blood loss data|514|||
16370591|NCT01178411|39843437|FG000|Overall Study|Adverse Event|5|||
16370592|NCT01178411|39843437|FG000|Overall Study|Withdrawal by Subject|4|||
16370593|NCT01178411|39843437|FG000|Overall Study|Protocol Violation|1|||
16370594|NCT01178411|39843437|FG000|Overall Study|Progressive disease per RECIST|32|||
16370595|NCT01178411|39843437|FG000|Overall Study|Progressive disease per clinician|9|||
16370596|NCT01178411|39843437|FG000|Overall Study|Physician Decision|6|||
16370597|NCT01178411|39843437|FG000|Overall Study|Death|1|||
16370598|NCT01178411|39843437|FG000|Overall Study|No reason provided|1|||
16370599|NCT01178411|39843437|FG000|Overall Study|Drug manufacturing ended|1|||
16370600|NCT00090402|39843441|FG000|Overall Study|Death|1|||
16370601|NCT00090402|39843442|FG001|Overall Study|Death|1|||
16370602|NCT00090402|39843443|FG002|Overall Study|Death|0|||
16370603|NCT00090402|39843441|FG000|Overall Study|subject moved|0|||
16370604|NCT00090402|39843442|FG001|Overall Study|subject moved|1|||
16160598|NCT02362503|39068594|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
16160599|NCT02362503|39068595|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
16160600|NCT02362503|39068596|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
16160601|NCT01777581|39072171|FG000|Overall Study|Lost to Follow-up|1|||
16160602|NCT01777581|39072172|FG001|Overall Study|Lost to Follow-up|1|||
16370605|NCT00090402|39843443|FG002|Overall Study|subject moved|0|||
16370606|NCT00090402|39843441|FG000|Overall Study|stopped taking study medication|1|||
16160603|NCT01777581|39072171|FG000|Overall Study|Adverse Event|2|||
16160604|NCT01777581|39072172|FG001|Overall Study|Adverse Event|0|||
16160605|NCT01777581|39072171|FG000|Overall Study|Lack of Efficacy|0|||
16160606|NCT01777581|39072172|FG001|Overall Study|Lack of Efficacy|1|||
16160607|NCT00209339|39072173|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
16160608|NCT00209339|39072173|FG000|At 12 Months Follow-up|Death|1|||
16160609|NCT00209339|39072173|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
16160610|NCT00209339|39072173|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
16160611|NCT00209339|39072173|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
16160612|NCT00209339|39072173|FG000|At 24 Months Follow-up|Death|1|||
16160613|NCT00209339|39072173|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
16160614|NCT00209339|39072173|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
16160615|NCT00209339|39072173|FG000|At 4 Years Follow-up|Death|1|||
16160616|NCT00209339|39072173|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
16160617|NCT00209339|39072173|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
16160618|NCT00209339|39072173|FG000|At 5 Years Follow-up|Death|1|||
16160619|NCT02475655|39072174|FG000|Overall Study|Lost to Follow-up|0|||
16160620|NCT02475655|39072175|FG001|Overall Study|Lost to Follow-up|1|||
16370607|NCT00090402|39843442|FG001|Overall Study|stopped taking study medication|0|||
16370608|NCT00090402|39843443|FG002|Overall Study|stopped taking study medication|1|||
16370609|NCT02533674|39843444|FG000|Dose Level I|Progressive disease|1|||
16370610|NCT02533674|39843445|FG001|Dose Level I|Progressive disease|0|||
16160621|NCT01920711|39072176|FG000|Overall Study|Death|347|||
16160622|NCT01920711|39072177|FG001|Overall Study|Death|356|||
16160623|NCT01920711|39072176|FG000|Overall Study|Lost to Follow-up|13|||
16160624|NCT01920711|39072177|FG001|Overall Study|Lost to Follow-up|14|||
16370611|NCT02533674|39843446|FG002|Dose Level I|Progressive disease|0|||
16370612|NCT02533674|39843447|FG003|Dose Level I|Progressive disease|0|||
16370613|NCT02533674|39843448|FG004|Dose Level I|Progressive disease|0|||
16370614|NCT02533674|39843449|FG005|Dose Level I|Progressive disease|0|||
16160625|NCT01920711|39072176|FG000|Overall Study|Withdrawal by Subject|4|||
16160626|NCT01920711|39072177|FG001|Overall Study|Withdrawal by Subject|3|||
16160627|NCT02296242|39072178|FG000|Overall Study|Death|1|||
16160628|NCT02296242|39072179|FG001|Overall Study|Death|1|||
16160629|NCT02296242|39072180|FG002|Overall Study|Death|1|||
16264514|NCT01597245|39453255|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16370615|NCT02533674|39843450|FG006|Dose Level I|Progressive disease|0|||
16160630|NCT02296242|39072181|FG003|Overall Study|Death|1|||
16370616|NCT02533674|39843451|FG007|Dose Level I|Progressive disease|0|||
16160631|NCT02296242|39072182|FG004|Overall Study|Death|1|||
16160632|NCT02296242|39072178|FG000|Overall Study|Withdrawal by Subject|0|||
16160633|NCT02296242|39072179|FG001|Overall Study|Withdrawal by Subject|0|||
16160634|NCT02296242|39072180|FG002|Overall Study|Withdrawal by Subject|1|||
16160635|NCT02296242|39072181|FG003|Overall Study|Withdrawal by Subject|1|||
16160636|NCT02296242|39072182|FG004|Overall Study|Withdrawal by Subject|3|||
16160637|NCT02296242|39072178|FG000|Overall Study|Disease Progression|1|||
16160638|NCT02296242|39072179|FG001|Overall Study|Disease Progression|3|||
16160639|NCT02296242|39072180|FG002|Overall Study|Disease Progression|2|||
16160640|NCT02296242|39072181|FG003|Overall Study|Disease Progression|8|||
16160641|NCT02296242|39072182|FG004|Overall Study|Disease Progression|11|||
16160642|NCT02296242|39072178|FG000|Overall Study|Unacceptable Toxicity|0|||
16160643|NCT02296242|39072179|FG001|Overall Study|Unacceptable Toxicity|0|||
16160644|NCT02296242|39072180|FG002|Overall Study|Unacceptable Toxicity|0|||
16160645|NCT02296242|39072181|FG003|Overall Study|Unacceptable Toxicity|0|||
16160646|NCT02296242|39072182|FG004|Overall Study|Unacceptable Toxicity|1|||
16160647|NCT02296242|39072178|FG000|Overall Study|Patient Condition Changed|0|||
16160648|NCT02296242|39072179|FG001|Overall Study|Patient Condition Changed|0|||
16160649|NCT02296242|39072180|FG002|Overall Study|Patient Condition Changed|2|||
16160650|NCT02296242|39072181|FG003|Overall Study|Patient Condition Changed|0|||
16160651|NCT02296242|39072182|FG004|Overall Study|Patient Condition Changed|1|||
16160652|NCT02296242|39072178|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
16160653|NCT02296242|39072179|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
16160654|NCT02296242|39072180|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
16160655|NCT02296242|39072181|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
16160656|NCT02296242|39072182|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
16160657|NCT02296242|39072178|FG000|Overall Study|Lost to Follow-up|1|||
16160658|NCT02296242|39072179|FG001|Overall Study|Lost to Follow-up|0|||
16160659|NCT02296242|39072180|FG002|Overall Study|Lost to Follow-up|0|||
16160660|NCT02296242|39072181|FG003|Overall Study|Lost to Follow-up|0|||
16160661|NCT02296242|39072182|FG004|Overall Study|Lost to Follow-up|0|||
16160662|NCT02296242|39072178|FG000|Overall Study|Need for Hydroxyurea|2|||
16160663|NCT02296242|39072179|FG001|Overall Study|Need for Hydroxyurea|0|||
16160664|NCT02296242|39072180|FG002|Overall Study|Need for Hydroxyurea|0|||
16160665|NCT02296242|39072181|FG003|Overall Study|Need for Hydroxyurea|0|||
16160666|NCT02296242|39072182|FG004|Overall Study|Need for Hydroxyurea|0|||
16160667|NCT02296242|39072178|FG000|Overall Study|Screened for Other Protocol|0|||
16160668|NCT02296242|39072179|FG001|Overall Study|Screened for Other Protocol|1|||
16160669|NCT02296242|39072180|FG002|Overall Study|Screened for Other Protocol|0|||
16160670|NCT02296242|39072181|FG003|Overall Study|Screened for Other Protocol|0|||
16160671|NCT02296242|39072182|FG004|Overall Study|Screened for Other Protocol|0|||
16160672|NCT02296242|39072178|FG000|Overall Study|Physician Decision|0|||
16160673|NCT02296242|39072179|FG001|Overall Study|Physician Decision|1|||
16160674|NCT02296242|39072180|FG002|Overall Study|Physician Decision|0|||
16160675|NCT02296242|39072181|FG003|Overall Study|Physician Decision|1|||
16160676|NCT02296242|39072182|FG004|Overall Study|Physician Decision|0|||
16160677|NCT02296242|39072178|FG000|Overall Study|Alternative Treatment|0|||
16160678|NCT02296242|39072179|FG001|Overall Study|Alternative Treatment|0|||
16160679|NCT02296242|39072180|FG002|Overall Study|Alternative Treatment|0|||
16160680|NCT02296242|39072181|FG003|Overall Study|Alternative Treatment|1|||
16160681|NCT02296242|39072182|FG004|Overall Study|Alternative Treatment|0|||
16160682|NCT02296242|39072178|FG000|Overall Study|Adverse Event|0|||
16160683|NCT02296242|39072179|FG001|Overall Study|Adverse Event|0|||
16160684|NCT02296242|39072180|FG002|Overall Study|Adverse Event|0|||
16160685|NCT02296242|39072181|FG003|Overall Study|Adverse Event|1|||
16160686|NCT02296242|39072182|FG004|Overall Study|Adverse Event|0|||
16160687|NCT02296242|39072178|FG000|Overall Study|Lack of Efficacy|0|||
16160688|NCT02296242|39072179|FG001|Overall Study|Lack of Efficacy|0|||
16160689|NCT02296242|39072180|FG002|Overall Study|Lack of Efficacy|0|||
16160690|NCT02296242|39072181|FG003|Overall Study|Lack of Efficacy|0|||
16160691|NCT02296242|39072182|FG004|Overall Study|Lack of Efficacy|3|||
16160692|NCT00705783|39072185|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
16160693|NCT00705783|39072186|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
16160694|NCT00705783|39072187|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
16160695|NCT00705783|39072185|FG000|Conversion Phase|Lost to Follow-up|13|||
16160696|NCT00705783|39072186|FG001|Conversion Phase|Lost to Follow-up|0|||
16160697|NCT00705783|39072187|FG002|Conversion Phase|Lost to Follow-up|0|||
16160698|NCT00705783|39072185|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
16160699|NCT00705783|39072186|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
16160700|NCT00705783|39072187|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
16160701|NCT00705783|39072185|FG000|Conversion Phase|Withdrawn by Investigator|4|||
16160702|NCT00705783|39072186|FG001|Conversion Phase|Withdrawn by Investigator|0|||
16160703|NCT00705783|39072187|FG002|Conversion Phase|Withdrawn by Investigator|0|||
16160704|NCT00705783|39072185|FG000|Conversion Phase|Withdrew Consent|24|||
16160705|NCT00705783|39072186|FG001|Conversion Phase|Withdrew Consent|0|||
16264515|NCT01597245|39453256|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16264516|NCT01597245|39453257|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16370617|NCT02533674|39843444|FG000|Dose Level I|Withdrawal by Subject|1|||
16370618|NCT02533674|39843445|FG001|Dose Level I|Withdrawal by Subject|0|||
16160706|NCT00705783|39072187|FG002|Conversion Phase|Withdrew Consent|0|||
16160707|NCT00705783|39072185|FG000|Conversion Phase|Protocol Deviation|2|||
16160708|NCT00705783|39072186|FG001|Conversion Phase|Protocol Deviation|0|||
16370619|NCT02533674|39843446|FG002|Dose Level I|Withdrawal by Subject|0|||
16370620|NCT02533674|39843447|FG003|Dose Level I|Withdrawal by Subject|0|||
16370621|NCT02533674|39843448|FG004|Dose Level I|Withdrawal by Subject|0|||
16160709|NCT00705783|39072187|FG002|Conversion Phase|Protocol Deviation|0|||
16160710|NCT00705783|39072185|FG000|Conversion Phase|Adverse Event|11|||
16160711|NCT00705783|39072186|FG001|Conversion Phase|Adverse Event|0|||
16160712|NCT00705783|39072187|FG002|Conversion Phase|Adverse Event|0|||
16160713|NCT00705783|39072185|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
16160714|NCT00705783|39072186|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
16160715|NCT00705783|39072187|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
16160716|NCT00705783|39072185|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
16160717|NCT00705783|39072186|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
16160718|NCT00705783|39072187|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
16160719|NCT00705783|39072185|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
16160720|NCT00705783|39072186|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
16160721|NCT00705783|39072187|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
16160722|NCT00705783|39072185|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
16160723|NCT00705783|39072186|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
16160724|NCT00705783|39072187|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
16160725|NCT00705783|39072185|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
16160726|NCT00705783|39072186|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
16160727|NCT00705783|39072187|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
16160728|NCT00705783|39072185|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
16160729|NCT00705783|39072186|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
16160730|NCT00705783|39072187|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
16160731|NCT00705783|39072185|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
16160732|NCT00705783|39072186|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
16160733|NCT00705783|39072187|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
16160734|NCT00705783|39072185|FG000|Oral Stabilization Phase|Adverse Event|14|||
16160735|NCT00705783|39072186|FG001|Oral Stabilization Phase|Adverse Event|0|||
16160736|NCT00705783|39072187|FG002|Oral Stabilization Phase|Adverse Event|0|||
16160737|NCT00705783|39072185|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
16160738|NCT00705783|39072186|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
16160739|NCT00705783|39072187|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
16160740|NCT00705783|39072185|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
16160741|NCT00705783|39072186|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
16160742|NCT00705783|39072187|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
16160743|NCT00705783|39072185|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
16160744|NCT00705783|39072186|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
16160745|NCT00705783|39072187|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
16160746|NCT00705783|39072185|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
16160747|NCT00705783|39072186|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
16160748|NCT00705783|39072187|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
16160749|NCT00705783|39072185|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
16370622|NCT02533674|39843449|FG005|Dose Level I|Withdrawal by Subject|0|||
16370623|NCT02533674|39843450|FG006|Dose Level I|Withdrawal by Subject|0|||
16370624|NCT02533674|39843451|FG007|Dose Level I|Withdrawal by Subject|0|||
16370625|NCT02533674|39843444|FG000|Dose Level I|Physician Decision|1|||
16370626|NCT02533674|39843445|FG001|Dose Level I|Physician Decision|0|||
16370627|NCT02533674|39843446|FG002|Dose Level I|Physician Decision|0|||
16370628|NCT02533674|39843447|FG003|Dose Level I|Physician Decision|0|||
16370629|NCT02533674|39843448|FG004|Dose Level I|Physician Decision|0|||
16370630|NCT02533674|39843449|FG005|Dose Level I|Physician Decision|0|||
16370631|NCT02533674|39843450|FG006|Dose Level I|Physician Decision|0|||
16370632|NCT02533674|39843451|FG007|Dose Level I|Physician Decision|0|||
16370633|NCT02533674|39843444|FG000|Dose Level I|Death|1|||
16370634|NCT02533674|39843445|FG001|Dose Level I|Death|0|||
16370635|NCT02533674|39843446|FG002|Dose Level I|Death|0|||
16370636|NCT02533674|39843447|FG003|Dose Level I|Death|0|||
16370637|NCT02533674|39843448|FG004|Dose Level I|Death|0|||
16370638|NCT02533674|39843449|FG005|Dose Level I|Death|0|||
16447441|NCT02007096|40118592|FG000|Overall Study|converted to open surgery|1|||
16447442|NCT02007096|40118593|FG001|Overall Study|converted to open surgery|1|||
16160750|NCT00705783|39072186|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
16160751|NCT00705783|39072187|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
16370639|NCT02533674|39843450|FG006|Dose Level I|Death|0|||
16370640|NCT02533674|39843451|FG007|Dose Level I|Death|0|||
16370641|NCT02533674|39843444|FG000|Dose Level I|Never Treated|1|||
16160752|NCT00705783|39072185|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
16160753|NCT00705783|39072186|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
16160754|NCT00705783|39072187|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
16160755|NCT00705783|39072185|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
16160756|NCT00705783|39072186|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
16160757|NCT00705783|39072187|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
16160758|NCT00705783|39072185|FG000|Depot Stabilization Phase|Adverse Event|17|||
16160759|NCT00705783|39072186|FG001|Depot Stabilization Phase|Adverse Event|0|||
16160760|NCT00705783|39072187|FG002|Depot Stabilization Phase|Adverse Event|0|||
16160761|NCT00705783|39072185|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
16160762|NCT00705783|39072186|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
16160763|NCT00705783|39072187|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
16160764|NCT00705783|39072185|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
16160765|NCT00705783|39072186|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
16160766|NCT00705783|39072187|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
16160767|NCT00705783|39072185|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
16160768|NCT00705783|39072186|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
16160769|NCT00705783|39072187|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
16160770|NCT00705783|39072185|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
16160771|NCT00705783|39072186|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
16160772|NCT00705783|39072187|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
16160773|NCT00705783|39072185|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
16160774|NCT00705783|39072186|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
16160775|NCT00705783|39072187|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
16160776|NCT00705783|39072185|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
16160777|NCT00705783|39072186|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
16160778|NCT00705783|39072187|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
16160779|NCT00705783|39072185|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
16160780|NCT00705783|39072186|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
16160781|NCT00705783|39072187|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
16160782|NCT00705783|39072185|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
16160783|NCT00705783|39072186|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
16068427|NCT02179918|38739652|FG004|Overall Study|Subject refused further follow-up|1|||
16068428|NCT00320489|38739653|FG000|Overall Study|Adverse Event|26|||
16068429|NCT00320489|38739654|FG001|Overall Study|Adverse Event|25|||
16068430|NCT00320489|38739653|FG000|Overall Study|Clinical Relapse|26|||
16068431|NCT00320489|38739654|FG001|Overall Study|Clinical Relapse|20|||
16068432|NCT00320489|38739653|FG000|Overall Study|Death|0|||
16068433|NCT00320489|38739654|FG001|Overall Study|Death|2|||
16068434|NCT00320489|38739653|FG000|Overall Study|Entry Criteria Exclusion|2|||
16068435|NCT00320489|38739654|FG001|Overall Study|Entry Criteria Exclusion|4|||
16068436|NCT00320489|38739653|FG000|Overall Study|Lack of Efficacy|16|||
16068437|NCT00320489|38739654|FG001|Overall Study|Lack of Efficacy|7|||
16068438|NCT00320489|38739653|FG000|Overall Study|Lost to Follow-up|21|||
16068439|NCT00320489|38739654|FG001|Overall Study|Lost to Follow-up|22|||
16068440|NCT00320489|38739653|FG000|Overall Study|Physician Decision|8|||
16068441|NCT00320489|38739654|FG001|Overall Study|Physician Decision|8|||
16068442|NCT00320489|38739653|FG000|Overall Study|Protocol Violation|4|||
16068443|NCT00320489|38739654|FG001|Overall Study|Protocol Violation|4|||
16068444|NCT00320489|38739653|FG000|Overall Study|Sponsor Decision|3|||
16068445|NCT00320489|38739654|FG001|Overall Study|Sponsor Decision|3|||
16068446|NCT00320489|38739653|FG000|Overall Study|Withdrawal by Subject|39|||
16068447|NCT00320489|38739654|FG001|Overall Study|Withdrawal by Subject|41|||
16068448|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
16068449|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
16068450|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
16068451|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
16068452|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Adverse Event|198|||
16068453|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Adverse Event|0|||
16068454|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Adverse Event|0|||
16068455|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Adverse Event|0|||
16068456|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Death|62|||
16068457|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Death|0|||
16068458|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Death|0|||
16068459|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Death|0|||
16068460|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
16068461|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
16068462|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
16068463|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
16068464|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Complicating disease|13|||
16068465|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Complicating disease|0|||
16068466|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Complicating disease|0|||
16068467|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Complicating disease|0|||
16068468|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
16068469|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
16068470|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
16068471|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
16068472|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
16068473|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
16068474|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
16068475|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
16068476|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Non-compliance|4|||
16068477|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Non-compliance|0|||
16068478|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Non-compliance|0|||
16068479|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Non-compliance|0|||
16068480|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Pain|4|||
16068481|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Pain|0|||
16160784|NCT00705783|39072187|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
16160785|NCT00705783|39072185|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
16160786|NCT00705783|39072186|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
16160787|NCT00705783|39072187|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
16160788|NCT00705783|39072185|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
16160789|NCT00705783|39072186|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
16160790|NCT00705783|39072187|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
16160791|NCT00705783|39072185|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
16160792|NCT00705783|39072186|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
16160793|NCT00705783|39072187|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
16160794|NCT02634580|39072188|FG000|Double-blind Treatment Period|Subject Request|1|||
16160795|NCT02634580|39072189|FG001|Double-blind Treatment Period|Subject Request|0|||
16160796|NCT02634580|39072190|FG002|Double-blind Treatment Period|Subject Request|1|||
16160797|NCT02634580|39072191|FG003|Double-blind Treatment Period|Subject Request|1|||
16160798|NCT02634580|39072188|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
16160799|NCT02634580|39072189|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
16160800|NCT02634580|39072190|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
16160801|NCT02634580|39072191|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
16160802|NCT04004221|39072192|FG000|Overall Study|Death|89|||
16160803|NCT04004221|39072192|FG000|Overall Study|Withdrawal by Subject|5|||
16160804|NCT04004221|39072192|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
16160805|NCT04004221|39072192|FG000|Overall Study|Sponsor Decision|9|||
16160806|NCT04004221|39072192|FG000|Overall Study|Participant refused to enter LTE|1|||
16160807|NCT02469090|39072196|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
16160808|NCT02469090|39072197|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
16160809|NCT02469090|39072198|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
16160810|NCT02469090|39072196|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
16160811|NCT02469090|39072197|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
16160812|NCT02469090|39072198|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
16160813|NCT02469090|39072196|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
16160814|NCT02469090|39072197|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
16160815|NCT02469090|39072198|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
16160816|NCT02469090|39072196|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
16160817|NCT02469090|39072197|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
16160818|NCT02469090|39072198|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
16160819|NCT02469090|39072196|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
16160820|NCT02469090|39072197|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
16160821|NCT02469090|39072198|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
16160822|NCT02469090|39072196|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
16160823|NCT02469090|39072197|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
16160824|NCT02469090|39072198|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
16160825|NCT02469090|39072196|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
16160826|NCT02469090|39072197|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
16160827|NCT02469090|39072198|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
16160828|NCT02469090|39072196|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
16160829|NCT02469090|39072197|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
16068482|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Pain|0|||
16068483|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Pain|0|||
16068484|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
16068485|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
16068486|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
16160830|NCT02469090|39072198|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
16160831|NCT00494091|39072202|FG000|Overall Study|Death|5|||
16160832|NCT00494091|39072203|FG001|Overall Study|Death|54|||
16264517|NCT01597245|39453258|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
16160833|NCT00494091|39072202|FG000|Overall Study|Lost to Follow-up|0|||
16160834|NCT00494091|39072203|FG001|Overall Study|Lost to Follow-up|4|||
16160835|NCT00494091|39072202|FG000|Overall Study|Other|1|||
16160836|NCT00494091|39072203|FG001|Overall Study|Other|11|||
16160837|NCT00494091|39072202|FG000|Overall Study|Withdrawal by Subject|0|||
16160838|NCT00494091|39072203|FG001|Overall Study|Withdrawal by Subject|7|||
16160839|NCT03261531|39072206|FG000|Overall Study|Withdrawal by Subject|4|||
16160840|NCT02867995|39072209|FG000|Overall Study|Withdrawal by Subject|0|||
16160841|NCT02867995|39072210|FG001|Overall Study|Withdrawal by Subject|1|||
16160842|NCT02867995|39072209|FG000|Overall Study|Lost to Follow-up|0|||
16160843|NCT02867995|39072210|FG001|Overall Study|Lost to Follow-up|2|||
16160844|NCT01029366|39072214|FG000|Overall Study|Withdrawal by Subject|1|||
16160845|NCT01029366|39072215|FG001|Overall Study|Withdrawal by Subject|0|||
16160846|NCT01029366|39072214|FG000|Overall Study|Death|1|||
16160847|NCT01029366|39072215|FG001|Overall Study|Death|1|||
16160848|NCT01029366|39072214|FG000|Overall Study|disease progression|2|||
16160849|NCT01029366|39072215|FG001|Overall Study|disease progression|0|||
16160850|NCT01029366|39072214|FG000|Overall Study|manufacturing failure|0|||
16160851|NCT01029366|39072215|FG001|Overall Study|manufacturing failure|1|||
16160852|NCT05098041|39072218|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
16160853|NCT01430442|39072219|FG000|Overall Study|Subject Withdrew Consent|3|||
16160854|NCT01430442|39072220|FG001|Overall Study|Subject Withdrew Consent|0|||
16160855|NCT01430442|39072221|FG002|Overall Study|Subject Withdrew Consent|1|||
16160856|NCT01430442|39072222|FG003|Overall Study|Subject Withdrew Consent|0|||
16160857|NCT01430442|39072223|FG004|Overall Study|Subject Withdrew Consent|2|||
16160858|NCT01430442|39072224|FG005|Overall Study|Subject Withdrew Consent|1|||
16160859|NCT01430442|39072225|FG006|Overall Study|Subject Withdrew Consent|5|||
16160860|NCT01430442|39072226|FG007|Overall Study|Subject Withdrew Consent|2|||
16160861|NCT01430442|39072219|FG000|Overall Study|Lost to Follow-up|2|||
16160862|NCT01430442|39072220|FG001|Overall Study|Lost to Follow-up|0|||
16160863|NCT01430442|39072221|FG002|Overall Study|Lost to Follow-up|1|||
16160864|NCT01430442|39072222|FG003|Overall Study|Lost to Follow-up|2|||
16160865|NCT01430442|39072223|FG004|Overall Study|Lost to Follow-up|2|||
16160866|NCT01430442|39072224|FG005|Overall Study|Lost to Follow-up|1|||
16160867|NCT01430442|39072225|FG006|Overall Study|Lost to Follow-up|5|||
16160868|NCT01430442|39072226|FG007|Overall Study|Lost to Follow-up|1|||
16160869|NCT01430442|39072219|FG000|Overall Study|Pregnancy|1|||
16160870|NCT01430442|39072220|FG001|Overall Study|Pregnancy|0|||
16160871|NCT01430442|39072221|FG002|Overall Study|Pregnancy|0|||
16160872|NCT01430442|39072222|FG003|Overall Study|Pregnancy|0|||
16160873|NCT01430442|39072223|FG004|Overall Study|Pregnancy|0|||
16160874|NCT01430442|39072224|FG005|Overall Study|Pregnancy|1|||
16160875|NCT01430442|39072225|FG006|Overall Study|Pregnancy|0|||
16160876|NCT01430442|39072226|FG007|Overall Study|Pregnancy|0|||
16160877|NCT01430442|39072219|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
16160878|NCT01430442|39072220|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
16068487|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
16068488|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Hospice care|1|||
16068489|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Hospice care|0|||
16068490|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Hospice care|0|||
16068491|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Hospice care|0|||
16068492|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Physician Decision|1|||
16068493|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Physician Decision|0|||
16068494|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Physician Decision|0|||
16068495|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Physician Decision|0|||
16068496|NCT01107626|38739655|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
16068497|NCT01107626|38739656|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
16068498|NCT01107626|38739657|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
16068499|NCT01107626|38739658|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
16068500|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
16160879|NCT01430442|39072221|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
16160880|NCT01430442|39072222|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
16160881|NCT01430442|39072223|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
16160882|NCT01430442|39072224|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
16160883|NCT01430442|39072225|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
16160884|NCT01430442|39072226|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
16160885|NCT00700180|39072227|FG000|Overall Study|Death|99|||
16160886|NCT00700180|39072228|FG001|Overall Study|Death|114|||
16160887|NCT00700180|39072227|FG000|Overall Study|Alive on treatment|5|||
16160888|NCT00700180|39072228|FG001|Overall Study|Alive on treatment|3|||
16160889|NCT00700180|39072227|FG000|Overall Study|Alive in follow-up|46|||
16160890|NCT00700180|39072228|FG001|Overall Study|Alive in follow-up|27|||
16160891|NCT00700180|39072227|FG000|Overall Study|Lost to Follow-up|4|||
16160892|NCT00700180|39072228|FG001|Overall Study|Lost to Follow-up|5|||
16160893|NCT04429061|39072229|FG000|Overall Study|Lost to Follow-up|62|||
16160894|NCT04429061|39072230|FG001|Overall Study|Lost to Follow-up|87|||
16370642|NCT02533674|39843445|FG001|Dose Level I|Never Treated|0|||
16160895|NCT04429061|39072229|FG000|Overall Study|Withdrawal by Subject|3|||
16447443|NCT02007096|40118592|FG000|Overall Study|no mesh placed|0|||
16447444|NCT02007096|40118593|FG001|Overall Study|no mesh placed|1|||
16447445|NCT01458392|40118594|FG000|Overall Study|Death|2|||
16447446|NCT01458392|40118595|FG001|Overall Study|Death|11|||
16447447|NCT01458392|40118596|FG002|Overall Study|Death|22|||
16447448|NCT01458392|40118594|FG000|Overall Study|At the discretion of the sponsor|0|||
16370643|NCT02533674|39843446|FG002|Dose Level I|Never Treated|0|||
16370644|NCT02533674|39843447|FG003|Dose Level I|Never Treated|0|||
16370645|NCT02533674|39843448|FG004|Dose Level I|Never Treated|0|||
16370646|NCT02533674|39843449|FG005|Dose Level I|Never Treated|0|||
16370647|NCT02533674|39843450|FG006|Dose Level I|Never Treated|0|||
16370648|NCT02533674|39843451|FG007|Dose Level I|Never Treated|0|||
16370649|NCT02533674|39843444|FG000|Dose Level II|Progressive disease|0|||
16370650|NCT02533674|39843445|FG001|Dose Level II|Progressive disease|3|||
16370651|NCT02533674|39843446|FG002|Dose Level II|Progressive disease|0|||
16370652|NCT02533674|39843447|FG003|Dose Level II|Progressive disease|0|||
16370653|NCT02533674|39843448|FG004|Dose Level II|Progressive disease|0|||
16370654|NCT02533674|39843449|FG005|Dose Level II|Progressive disease|0|||
16370655|NCT02533674|39843450|FG006|Dose Level II|Progressive disease|0|||
16370656|NCT02533674|39843451|FG007|Dose Level II|Progressive disease|0|||
16370657|NCT02533674|39843444|FG000|Dose Level II|Withdrawal by Subject|0|||
16447449|NCT01458392|40118595|FG001|Overall Study|At the discretion of the sponsor|2|||
16447450|NCT01458392|40118596|FG002|Overall Study|At the discretion of the sponsor|7|||
16447451|NCT01458392|40118594|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
16447452|NCT01458392|40118595|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
16370658|NCT02533674|39843445|FG001|Dose Level II|Withdrawal by Subject|1|||
16370659|NCT02533674|39843446|FG002|Dose Level II|Withdrawal by Subject|0|||
16370660|NCT02533674|39843447|FG003|Dose Level II|Withdrawal by Subject|0|||
16370661|NCT02533674|39843448|FG004|Dose Level II|Withdrawal by Subject|0|||
16370662|NCT02533674|39843449|FG005|Dose Level II|Withdrawal by Subject|0|||
16370663|NCT02533674|39843450|FG006|Dose Level II|Withdrawal by Subject|0|||
16370664|NCT02533674|39843451|FG007|Dose Level II|Withdrawal by Subject|0|||
16370665|NCT02533674|39843444|FG000|Dose Level II|Treatment-related AE|0|||
16370666|NCT02533674|39843445|FG001|Dose Level II|Treatment-related AE|1|||
16370667|NCT02533674|39843446|FG002|Dose Level II|Treatment-related AE|0|||
16370668|NCT02533674|39843447|FG003|Dose Level II|Treatment-related AE|0|||
16370669|NCT02533674|39843448|FG004|Dose Level II|Treatment-related AE|0|||
16447453|NCT01458392|40118596|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
16447454|NCT01074502|40118597|FG000|Overall Study|Withdrawal by Subject|1|||
16447455|NCT01708902|40118600|FG000|Overall Study|Adverse Event|3|||
16447456|NCT01708902|40118601|FG001|Overall Study|Adverse Event|4|||
16447457|NCT01708902|40118602|FG002|Overall Study|Adverse Event|9|||
16447458|NCT01708902|40118603|FG003|Overall Study|Adverse Event|2|||
16447459|NCT01708902|40118604|FG004|Overall Study|Adverse Event|7|||
16447460|NCT01708902|40118605|FG005|Overall Study|Adverse Event|3|||
16447461|NCT01708902|40118606|FG006|Overall Study|Adverse Event|5|||
16447462|NCT01708902|40118600|FG000|Overall Study|Lack of Efficacy|3|||
16447463|NCT01708902|40118601|FG001|Overall Study|Lack of Efficacy|1|||
16447464|NCT01708902|40118602|FG002|Overall Study|Lack of Efficacy|0|||
16447465|NCT01708902|40118603|FG003|Overall Study|Lack of Efficacy|0|||
16447466|NCT01708902|40118604|FG004|Overall Study|Lack of Efficacy|0|||
16447467|NCT01708902|40118605|FG005|Overall Study|Lack of Efficacy|1|||
16160896|NCT04429061|39072230|FG001|Overall Study|Withdrawal by Subject|4|||
16160897|NCT01106846|39072232|FG000|Overall Study|Change in surgical procedure|0|||
16160898|NCT01106846|39072233|FG001|Overall Study|Change in surgical procedure|1|||
16160899|NCT01292057|39072234|FG000|Overall Study|Protocol Violation|1|||
16160900|NCT01292057|39072235|FG001|Overall Study|Protocol Violation|1|||
16160901|NCT01292057|39072234|FG000|Overall Study|Lost to Follow-up|1|||
16160902|NCT01292057|39072235|FG001|Overall Study|Lost to Follow-up|1|||
16160903|NCT00586495|39072237|FG000|Treatment Period|Adverse Event|11|||
16160904|NCT00586495|39072237|FG000|Treatment Period|Death|1|||
16160905|NCT00586495|39072237|FG000|Treatment Period|Protocol Violation|1|||
16370670|NCT02533674|39843449|FG005|Dose Level II|Treatment-related AE|0|||
16447468|NCT01708902|40118606|FG006|Overall Study|Lack of Efficacy|0|||
16447469|NCT01708902|40118600|FG000|Overall Study|Non compliance with protocol|0|||
16447470|NCT01708902|40118601|FG001|Overall Study|Non compliance with protocol|2|||
16447471|NCT01708902|40118602|FG002|Overall Study|Non compliance with protocol|1|||
16447472|NCT01708902|40118603|FG003|Overall Study|Non compliance with protocol|3|||
16447473|NCT01708902|40118604|FG004|Overall Study|Non compliance with protocol|0|||
16447474|NCT01708902|40118605|FG005|Overall Study|Non compliance with protocol|0|||
16160906|NCT00586495|39072237|FG000|Treatment Period|Withdrawal by Subject|1|||
16370671|NCT02533674|39843450|FG006|Dose Level II|Treatment-related AE|0|||
16370672|NCT02533674|39843451|FG007|Dose Level II|Treatment-related AE|0|||
16370673|NCT02533674|39843444|FG000|Dose Level II|Physician Decision|0|||
16370674|NCT02533674|39843445|FG001|Dose Level II|Physician Decision|1|||
16264518|NCT01597245|39453259|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
16264519|NCT01597245|39453260|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
16264520|NCT01597245|39453261|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
16447475|NCT01708902|40118606|FG006|Overall Study|Non compliance with protocol|0|||
16447476|NCT01708902|40118600|FG000|Overall Study|Lost to Follow-up|2|||
16447477|NCT01708902|40118601|FG001|Overall Study|Lost to Follow-up|1|||
16447478|NCT01708902|40118602|FG002|Overall Study|Lost to Follow-up|2|||
16447479|NCT01708902|40118603|FG003|Overall Study|Lost to Follow-up|2|||
16447480|NCT01708902|40118604|FG004|Overall Study|Lost to Follow-up|0|||
16370675|NCT02533674|39843446|FG002|Dose Level II|Physician Decision|0|||
16370676|NCT02533674|39843447|FG003|Dose Level II|Physician Decision|0|||
16370677|NCT02533674|39843448|FG004|Dose Level II|Physician Decision|0|||
16370678|NCT02533674|39843449|FG005|Dose Level II|Physician Decision|0|||
16370679|NCT02533674|39843450|FG006|Dose Level II|Physician Decision|0|||
16370680|NCT02533674|39843451|FG007|Dose Level II|Physician Decision|0|||
16370681|NCT02533674|39843444|FG000|Dose Level II|Non-treatment-related AE|0|||
16370682|NCT02533674|39843445|FG001|Dose Level II|Non-treatment-related AE|1|||
16370683|NCT02533674|39843446|FG002|Dose Level II|Non-treatment-related AE|0|||
16447481|NCT01708902|40118605|FG005|Overall Study|Lost to Follow-up|0|||
16447482|NCT01708902|40118606|FG006|Overall Study|Lost to Follow-up|1|||
16447483|NCT01708902|40118600|FG000|Overall Study|Refused to continue trial medication|8|||
16264521|NCT01597245|39453262|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
16264522|NCT01597245|39453263|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
16264523|NCT01597245|39453264|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
16264524|NCT01597245|39453265|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
16264525|NCT01597245|39453266|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
16370684|NCT02533674|39843447|FG003|Dose Level II|Non-treatment-related AE|0|||
16370685|NCT02533674|39843448|FG004|Dose Level II|Non-treatment-related AE|0|||
16447484|NCT01708902|40118601|FG001|Overall Study|Refused to continue trial medication|0|||
16447485|NCT01708902|40118602|FG002|Overall Study|Refused to continue trial medication|4|||
16447486|NCT01708902|40118603|FG003|Overall Study|Refused to continue trial medication|2|||
16447487|NCT01708902|40118604|FG004|Overall Study|Refused to continue trial medication|8|||
16447488|NCT01708902|40118605|FG005|Overall Study|Refused to continue trial medication|1|||
16447489|NCT01708902|40118606|FG006|Overall Study|Refused to continue trial medication|1|||
16447490|NCT01708902|40118600|FG000|Overall Study|Other Reason|1|||
16447491|NCT01708902|40118601|FG001|Overall Study|Other Reason|0|||
16447492|NCT01708902|40118602|FG002|Overall Study|Other Reason|1|||
16447493|NCT01708902|40118603|FG003|Overall Study|Other Reason|1|||
16447494|NCT01708902|40118604|FG004|Overall Study|Other Reason|1|||
16447495|NCT01708902|40118605|FG005|Overall Study|Other Reason|2|||
16447496|NCT01708902|40118606|FG006|Overall Study|Other Reason|0|||
16068501|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
16068502|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
16068503|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
16068504|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
16068505|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
16068506|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
16068507|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
16068508|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Death|0|||
16068509|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Death|8|||
16068510|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Death|2|||
16068511|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Death|13|||
16068512|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
16068513|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
16068514|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
16068515|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
16068516|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
16068517|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
16068518|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
16068519|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
16068520|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
16068521|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
16068522|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
16068523|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
16370686|NCT02533674|39843449|FG005|Dose Level II|Non-treatment-related AE|0|||
16447497|NCT01772316|40118607|FG000|Overall Study|Serious adverse event|1|||
16447498|NCT01772316|40118607|FG000|Overall Study|Inform consent withdrawn|1|||
16447499|NCT01772316|40118607|FG000|Overall Study|Withdrawn by sponsor decision|5|||
16447500|NCT01812252|40118608|FG000|Overall Study|Persistent Disease|1|||
16447501|NCT01812252|40118609|FG001|Overall Study|Persistent Disease|0|||
16447502|NCT01812252|40118608|FG000|Overall Study|Not transplanted|11|||
16068524|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
16370687|NCT02533674|39843450|FG006|Dose Level II|Non-treatment-related AE|0|||
16068525|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
16068526|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
16068527|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
16068528|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
16068529|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
16068530|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
16068531|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
16068532|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
16068533|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
16068534|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
16068535|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
16068536|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
16068537|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
16068538|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
16068539|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
16068540|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
16068541|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
16068542|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
16160907|NCT00586495|39072237|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
16160908|NCT00586495|39072237|FG000|Treatment Period|Switch to commercial drug|10|||
16160909|NCT00586495|39072237|FG000|Follow-up|Death|40|||
16160910|NCT00586495|39072237|FG000|Follow-up|Lost to Follow-up|1|||
16160911|NCT00586495|39072237|FG000|Follow-up|Withdrawal by Subject|4|||
16160912|NCT00586495|39072237|FG000|Follow-up|Protocol driven decision point|37|||
16160913|NCT00586495|39072237|FG000|Follow-up|Switch to commercial drug|10|||
16160914|NCT04557384|39072238|FG000|Overall Study|Study Terminated by Sponsor|1|||
16160915|NCT04557384|39072238|FG000|Overall Study|Death|1|||
16160916|NCT02452762|39072239|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
16160917|NCT02452762|39072240|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
16160918|NCT02452762|39072239|FG000|Overall Study|Withdrawal by Subject|1|||
16160919|NCT02452762|39072240|FG001|Overall Study|Withdrawal by Subject|0|||
16160920|NCT00464178|39072241|FG000|Overall Study|Protocol Violation|1|||
16160921|NCT00464178|39072241|FG000|Overall Study|Withdrawal by Subject|1|||
16160922|NCT02793232|39072245|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
16160923|NCT02793232|39072246|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
16160924|NCT02793232|39072247|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
16160925|NCT02793232|39072248|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
16160926|NCT02793232|39072249|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
16160927|NCT02793232|39072250|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
16160928|NCT02793232|39072251|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
16160929|NCT02793232|39072252|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
16160930|NCT02793232|39072253|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
16160931|NCT00848354|39072254|FG000|Phase 1|Adverse Event|5|||
16160932|NCT00848354|39072255|FG001|Phase 1|Adverse Event|4|||
16160933|NCT00848354|39072254|FG000|Phase 1|Discontinuation of study by sponsor|2|||
16160934|NCT00848354|39072255|FG001|Phase 1|Discontinuation of study by sponsor|1|||
16160935|NCT00848354|39072254|FG000|Phase 1|Failed to return|0|||
16160936|NCT00848354|39072255|FG001|Phase 1|Failed to return|1|||
16160937|NCT00848354|39072254|FG000|Phase 1|Lost to Follow-up|1|||
16160938|NCT00848354|39072255|FG001|Phase 1|Lost to Follow-up|1|||
16160939|NCT00848354|39072254|FG000|Phase 1|Unspecified Reason|1|||
16160940|NCT00848354|39072255|FG001|Phase 1|Unspecified Reason|1|||
16160941|NCT00848354|39072254|FG000|Phase 1|Protocol Violation|1|||
16160942|NCT00848354|39072255|FG001|Phase 1|Protocol Violation|1|||
16160943|NCT00848354|39072254|FG000|Phase 1|Withdrawal by Subject|2|||
16160944|NCT00848354|39072255|FG001|Phase 1|Withdrawal by Subject|4|||
16160945|NCT00848354|39072254|FG000|Phase 1|Lack of Efficacy|0|||
16160946|NCT00848354|39072255|FG001|Phase 1|Lack of Efficacy|1|||
16160947|NCT00848354|39072254|FG000|Phase 2 Year 1|Adverse Event|7|||
16160948|NCT00848354|39072255|FG001|Phase 2 Year 1|Adverse Event|2|||
16160949|NCT00848354|39072254|FG000|Phase 2 Year 1|Death|1|||
16447503|NCT01812252|40118609|FG001|Overall Study|Not transplanted|11|||
16447504|NCT01812252|40118608|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
16068543|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
16160950|NCT00848354|39072255|FG001|Phase 2 Year 1|Death|0|||
16160951|NCT00848354|39072254|FG000|Phase 2 Year 1|Failed to Return|1|||
16160952|NCT00848354|39072255|FG001|Phase 2 Year 1|Failed to Return|1|||
16160953|NCT00848354|39072254|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
16160954|NCT00848354|39072255|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
16160955|NCT00848354|39072254|FG000|Phase 2 Year 1|Unspecified Reason|3|||
16160956|NCT00848354|39072255|FG001|Phase 2 Year 1|Unspecified Reason|0|||
16264526|NCT01597245|39453267|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16160957|NCT00848354|39072254|FG000|Phase 2 Year 1|Protocol Violation|4|||
16160958|NCT00848354|39072255|FG001|Phase 2 Year 1|Protocol Violation|1|||
16160959|NCT00848354|39072254|FG000|Phase 2 Year 1|Subject Request|1|||
16160960|NCT00848354|39072255|FG001|Phase 2 Year 1|Subject Request|2|||
16160961|NCT00848354|39072254|FG000|Phase 2 Year 2|Adverse Event|12|||
16160962|NCT00848354|39072255|FG001|Phase 2 Year 2|Adverse Event|2|||
16447505|NCT01812252|40118609|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
16447506|NCT01812252|40118608|FG000|Overall Study|Withdrawal by Subject|1|||
16447507|NCT01812252|40118609|FG001|Overall Study|Withdrawal by Subject|1|||
16447508|NCT01812252|40118608|FG000|Overall Study|Screen Failure|1|||
16447509|NCT01812252|40118609|FG001|Overall Study|Screen Failure|0|||
16447510|NCT05021978|40118616|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
16160963|NCT00848354|39072254|FG000|Phase 2 Year 2|Death|2|||
16160964|NCT00848354|39072255|FG001|Phase 2 Year 2|Death|0|||
16160965|NCT00848354|39072254|FG000|Phase 2 Year 2|Failed to return|3|||
16160966|NCT00848354|39072255|FG001|Phase 2 Year 2|Failed to return|0|||
16160967|NCT00848354|39072254|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
16160968|NCT00848354|39072255|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
16160969|NCT00848354|39072254|FG000|Phase 2 Year 2|Unspecified Reason|1|||
16160970|NCT00848354|39072255|FG001|Phase 2 Year 2|Unspecified Reason|0|||
16160971|NCT00848354|39072254|FG000|Phase 2 Year 2|Protocol Violation|1|||
16160972|NCT00848354|39072255|FG001|Phase 2 Year 2|Protocol Violation|1|||
16160973|NCT00848354|39072254|FG000|Phase 2 Year 2|Subject Request|1|||
16160974|NCT00848354|39072255|FG001|Phase 2 Year 2|Subject Request|1|||
16160975|NCT00848354|39072254|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
16160976|NCT00848354|39072255|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
16160977|NCT05019131|39072259|FG000|Overall Study|Lost to Follow-up|0|||
16160978|NCT05019131|39072260|FG001|Overall Study|Lost to Follow-up|3|||
16160979|NCT01641939|39072263|FG000|Overall Study|Death|90|||
16160980|NCT01641939|39072264|FG001|Overall Study|Death|187|||
16160981|NCT01641939|39072265|FG002|Overall Study|Death|61|||
16160982|NCT01641939|39072263|FG000|Overall Study|Lost to Follow-up|3|||
16447511|NCT05021978|40118617|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
16160983|NCT01641939|39072264|FG001|Overall Study|Lost to Follow-up|2|||
16160984|NCT01641939|39072265|FG002|Overall Study|Lost to Follow-up|1|||
16160985|NCT01641939|39072263|FG000|Overall Study|Withdrawal by Subject|14|||
16160986|NCT01641939|39072264|FG001|Overall Study|Withdrawal by Subject|11|||
16160987|NCT01641939|39072265|FG002|Overall Study|Withdrawal by Subject|5|||
16160988|NCT01641939|39072263|FG000|Overall Study|Study Terminated by Sponsor|10|||
16160989|NCT01641939|39072264|FG001|Overall Study|Study Terminated by Sponsor|28|||
16160990|NCT01641939|39072265|FG002|Overall Study|Study Terminated by Sponsor|3|||
16160991|NCT01441063|39072266|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
16160992|NCT01441063|39072266|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
16160993|NCT03403205|39072267|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
16160994|NCT03403205|39072268|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
16160995|NCT03403205|39072269|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
16264527|NCT01597245|39453268|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16264528|NCT01597245|39453269|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16264529|NCT01597245|39453270|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16264530|NCT01597245|39453271|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16264531|NCT01597245|39453272|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16264532|NCT01597245|39453273|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16264533|NCT01597245|39453274|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
16264534|NCT01597245|39453254|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16447512|NCT05021978|40118618|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
16160996|NCT03403205|39072270|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
16264535|NCT01597245|39453255|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264536|NCT01597245|39453256|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264537|NCT01597245|39453257|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264538|NCT01597245|39453258|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
16264539|NCT01597245|39453259|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
16264540|NCT01597245|39453260|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
16264541|NCT01597245|39453261|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16370688|NCT02533674|39843451|FG007|Dose Level II|Non-treatment-related AE|0|||
16447513|NCT05021978|40118619|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
16160997|NCT03403205|39072271|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
16160998|NCT03403205|39072272|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
16160999|NCT03403205|39072267|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
16161000|NCT03403205|39072268|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
16161001|NCT03403205|39072269|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
16161002|NCT03403205|39072270|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
16264542|NCT01597245|39453262|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
16264543|NCT01597245|39453263|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
16264544|NCT01597245|39453264|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
16264545|NCT01597245|39453265|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
16264546|NCT01597245|39453266|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
16264547|NCT01597245|39453267|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264548|NCT01597245|39453268|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264549|NCT01597245|39453269|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264550|NCT01597245|39453270|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264551|NCT01597245|39453271|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264552|NCT01597245|39453272|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264553|NCT01597245|39453273|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264554|NCT01597245|39453274|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
16264555|NCT01597245|39453254|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264556|NCT01597245|39453255|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264557|NCT01597245|39453256|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264558|NCT01597245|39453257|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264559|NCT01597245|39453258|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
16264560|NCT01597245|39453259|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264561|NCT01597245|39453260|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264562|NCT01597245|39453261|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264563|NCT01597245|39453262|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
16264564|NCT01597245|39453263|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
16264565|NCT01597245|39453264|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
16264566|NCT01597245|39453265|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264567|NCT01597245|39453266|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
16264568|NCT01597245|39453267|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264569|NCT01597245|39453268|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16068544|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
16068545|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
16068546|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
16068547|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
16068548|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
16068549|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
16068550|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
16068551|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
16068552|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Pain|0|||
16068553|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Pain|0|||
16068554|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Pain|0|||
16068555|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Pain|1|||
16068556|NCT01107626|38739655|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
16264570|NCT01597245|39453269|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264571|NCT01597245|39453270|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264572|NCT01597245|39453271|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264573|NCT01597245|39453272|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264574|NCT01597245|39453273|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264575|NCT01597245|39453274|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
16264576|NCT01597245|39453254|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264577|NCT01597245|39453255|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264578|NCT01597245|39453256|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264579|NCT01597245|39453257|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264580|NCT01597245|39453258|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
16264581|NCT01597245|39453259|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
16264582|NCT01597245|39453260|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
16264583|NCT01597245|39453261|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264584|NCT01597245|39453262|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
16264585|NCT01597245|39453263|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
16264586|NCT01597245|39453264|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
16264587|NCT01597245|39453265|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
16264588|NCT01597245|39453266|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
16264589|NCT01597245|39453267|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16447514|NCT05021978|40118616|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
16068557|NCT01107626|38739656|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
16068558|NCT01107626|38739657|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
16068559|NCT01107626|38739658|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
16068560|NCT02206685|38742600|FG000|Overall Study|Surgery cancelled/changed|2|||
16068561|NCT02206685|38742601|FG001|Overall Study|Surgery cancelled/changed|3|||
16068562|NCT02206685|38742600|FG000|Overall Study|Withdrawal by Subject|1|||
16068563|NCT02206685|38742601|FG001|Overall Study|Withdrawal by Subject|2|||
16068564|NCT02206685|38742600|FG000|Overall Study|Protocol Violation|2|||
16068565|NCT02206685|38742601|FG001|Overall Study|Protocol Violation|2|||
16068566|NCT03302156|38742602|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
16264590|NCT01597245|39453268|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16370689|NCT02533674|39843444|FG000|Dose Level III|Progressive disease|0|||
16370690|NCT02533674|39843445|FG001|Dose Level III|Progressive disease|0|||
16264591|NCT01597245|39453269|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264592|NCT01597245|39453270|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264593|NCT01597245|39453271|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264594|NCT01597245|39453272|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264595|NCT01597245|39453273|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264596|NCT01597245|39453274|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
16264597|NCT01597245|39453254|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264598|NCT01597245|39453255|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264599|NCT01597245|39453256|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264600|NCT01597245|39453257|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264601|NCT01597245|39453258|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264602|NCT01597245|39453259|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
16264603|NCT01597245|39453260|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264604|NCT01597245|39453261|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264605|NCT01597245|39453262|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
16264606|NCT01597245|39453263|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
16264607|NCT01597245|39453264|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
16264608|NCT01597245|39453265|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
16264609|NCT01597245|39453266|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264610|NCT01597245|39453267|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264611|NCT01597245|39453268|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264612|NCT01597245|39453269|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264613|NCT01597245|39453270|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264614|NCT01597245|39453271|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264615|NCT01597245|39453272|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264616|NCT01597245|39453273|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264617|NCT01597245|39453274|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
16264618|NCT01597245|39453254|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264619|NCT01597245|39453255|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264620|NCT01597245|39453256|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264621|NCT01597245|39453257|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264622|NCT01597245|39453258|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264623|NCT01597245|39453259|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264624|NCT01597245|39453260|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264625|NCT01597245|39453261|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264626|NCT01597245|39453262|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264627|NCT01597245|39453263|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16370691|NCT02533674|39843446|FG002|Dose Level III|Progressive disease|2|||
16370692|NCT02533674|39843447|FG003|Dose Level III|Progressive disease|0|||
16370693|NCT02533674|39843448|FG004|Dose Level III|Progressive disease|0|||
16370694|NCT02533674|39843449|FG005|Dose Level III|Progressive disease|0|||
16370695|NCT02533674|39843450|FG006|Dose Level III|Progressive disease|0|||
16370696|NCT02533674|39843451|FG007|Dose Level III|Progressive disease|0|||
16370697|NCT02533674|39843444|FG000|Dose Level III|Withdrawal by Subject|0|||
16370698|NCT02533674|39843445|FG001|Dose Level III|Withdrawal by Subject|0|||
16370699|NCT02533674|39843446|FG002|Dose Level III|Withdrawal by Subject|1|||
16370700|NCT02533674|39843447|FG003|Dose Level III|Withdrawal by Subject|0|||
16370701|NCT02533674|39843448|FG004|Dose Level III|Withdrawal by Subject|0|||
16370702|NCT02533674|39843449|FG005|Dose Level III|Withdrawal by Subject|0|||
16370703|NCT02533674|39843450|FG006|Dose Level III|Withdrawal by Subject|0|||
16370704|NCT02533674|39843451|FG007|Dose Level III|Withdrawal by Subject|0|||
16370705|NCT02533674|39843444|FG000|Dose Level III|Treatment-related AE|0|||
16370706|NCT02533674|39843445|FG001|Dose Level III|Treatment-related AE|0|||
16370707|NCT02533674|39843446|FG002|Dose Level III|Treatment-related AE|1|||
16370708|NCT02533674|39843447|FG003|Dose Level III|Treatment-related AE|0|||
16068567|NCT03302156|38742603|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
16264628|NCT01597245|39453264|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
16264629|NCT01597245|39453265|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264630|NCT01597245|39453266|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264631|NCT01597245|39453267|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264632|NCT01597245|39453268|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264633|NCT01597245|39453269|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264634|NCT01597245|39453270|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264635|NCT01597245|39453271|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264636|NCT01597245|39453272|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264637|NCT01597245|39453273|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264638|NCT01597245|39453274|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
16264639|NCT01597245|39453254|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264640|NCT01597245|39453255|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264641|NCT01597245|39453256|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264642|NCT01597245|39453257|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264643|NCT01597245|39453258|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264644|NCT01597245|39453259|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264645|NCT01597245|39453260|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16370709|NCT02533674|39843448|FG004|Dose Level III|Treatment-related AE|0|||
16068568|NCT03302156|38742604|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
16264646|NCT01597245|39453261|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264647|NCT01597245|39453262|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264648|NCT01597245|39453263|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264649|NCT01597245|39453264|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264650|NCT01597245|39453265|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264651|NCT01597245|39453266|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264652|NCT01597245|39453267|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
16264653|NCT01597245|39453268|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
16264654|NCT01597245|39453269|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
16264655|NCT01597245|39453270|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264656|NCT01597245|39453271|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264657|NCT01597245|39453272|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264658|NCT01597245|39453273|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16370710|NCT02533674|39843449|FG005|Dose Level III|Treatment-related AE|0|||
16370711|NCT02533674|39843450|FG006|Dose Level III|Treatment-related AE|0|||
16370712|NCT02533674|39843451|FG007|Dose Level III|Treatment-related AE|0|||
16068569|NCT03264456|38742605|FG000|Overall Study|Withdrawal by Subject|3|||
16068570|NCT03264456|38742605|FG000|Overall Study|Lost to Follow-up|1|||
16068571|NCT03782727|38742606|FG000|Overall Study|Lost to Follow-up|32|||
16068572|NCT01599325|38742607|FG000|Primary Parent Phase|Adverse Event|5|||
16068573|NCT01599325|38742607|FG000|Primary Parent Phase|Disease Progression|7|||
16068574|NCT01599325|38742607|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
16068575|NCT01599325|38742607|FG000|Primary Parent Phase|Death|13|||
16068576|NCT01599325|38742607|FG000|Primary Parent Phase|Protocol Violation|1|||
16068577|NCT01599325|38742607|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
16068578|NCT01599325|38742607|FG000|Primary Parent Phase|Other|2|||
16068579|NCT01599325|38742607|FG000|Extension Phase|Study Closure|1|||
16068580|NCT01599325|38742607|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
16068581|NCT01599325|38742607|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
16068582|NCT01599325|38742607|FG000|Extension Phase|Disease Progression|1|||
16068583|NCT01599325|38742607|FG000|Extension Phase|Withdrawal by Subject|8|||
16068584|NCT01333514|38742608|FG000|Overall Study|Withdrawal by Subject|1|||
16068585|NCT01333514|38742609|FG001|Overall Study|Withdrawal by Subject|0|||
16068586|NCT03568162|38742610|FG000|Overall Study|Adverse Event|0|||
16068587|NCT03568162|38742611|FG001|Overall Study|Adverse Event|1|||
16068588|NCT03568162|38742612|FG002|Overall Study|Adverse Event|2|||
16068589|NCT03568162|38742613|FG003|Overall Study|Adverse Event|0|||
16068590|NCT03568162|38742614|FG004|Overall Study|Adverse Event|0|||
16068591|NCT03568162|38742615|FG005|Overall Study|Adverse Event|1|||
16068592|NCT03568162|38742610|FG000|Overall Study|Death|0|||
16068593|NCT03568162|38742611|FG001|Overall Study|Death|0|||
16068594|NCT03568162|38742612|FG002|Overall Study|Death|0|||
16370713|NCT02533674|39843444|FG000|Dose Level IV|Progressive disease|0|||
16370714|NCT02533674|39843445|FG001|Dose Level IV|Progressive disease|0|||
16068595|NCT03568162|38742613|FG003|Overall Study|Death|0|||
16068596|NCT03568162|38742614|FG004|Overall Study|Death|1|||
16068597|NCT03568162|38742615|FG005|Overall Study|Death|0|||
16068598|NCT03568162|38742610|FG000|Overall Study|Lost to Follow-up|3|||
16068599|NCT03568162|38742611|FG001|Overall Study|Lost to Follow-up|2|||
16068600|NCT03568162|38742612|FG002|Overall Study|Lost to Follow-up|4|||
16068601|NCT03568162|38742613|FG003|Overall Study|Lost to Follow-up|2|||
16068602|NCT03568162|38742614|FG004|Overall Study|Lost to Follow-up|3|||
16264659|NCT01597245|39453274|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
16264660|NCT01597245|39453254|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264661|NCT01597245|39453255|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264662|NCT01597245|39453256|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264663|NCT01597245|39453257|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264664|NCT01597245|39453258|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264665|NCT01597245|39453259|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264666|NCT01597245|39453260|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264667|NCT01597245|39453261|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264668|NCT01597245|39453262|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264669|NCT01597245|39453263|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264670|NCT01597245|39453264|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264671|NCT01597245|39453265|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264672|NCT01597245|39453266|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264673|NCT01597245|39453267|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
16264674|NCT01597245|39453268|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
16264675|NCT01597245|39453269|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
16264676|NCT01597245|39453270|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264677|NCT01597245|39453271|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16370715|NCT02533674|39843446|FG002|Dose Level IV|Progressive disease|0|||
16370716|NCT02533674|39843447|FG003|Dose Level IV|Progressive disease|3|||
16370717|NCT02533674|39843448|FG004|Dose Level IV|Progressive disease|0|||
16370718|NCT02533674|39843449|FG005|Dose Level IV|Progressive disease|0|||
16370719|NCT02533674|39843450|FG006|Dose Level IV|Progressive disease|0|||
16370720|NCT02533674|39843451|FG007|Dose Level IV|Progressive disease|0|||
16370721|NCT02533674|39843444|FG000|Dose Level IV|Withdrawal by Subject|0|||
16370722|NCT02533674|39843445|FG001|Dose Level IV|Withdrawal by Subject|0|||
16370723|NCT02533674|39843446|FG002|Dose Level IV|Withdrawal by Subject|0|||
16370724|NCT02533674|39843447|FG003|Dose Level IV|Withdrawal by Subject|1|||
16370725|NCT02533674|39843448|FG004|Dose Level IV|Withdrawal by Subject|0|||
16370726|NCT02533674|39843449|FG005|Dose Level IV|Withdrawal by Subject|0|||
16370727|NCT02533674|39843450|FG006|Dose Level IV|Withdrawal by Subject|0|||
16370728|NCT02533674|39843451|FG007|Dose Level IV|Withdrawal by Subject|0|||
16370729|NCT02533674|39843444|FG000|Dose Level IV|Physician Decision|0|||
16370730|NCT02533674|39843445|FG001|Dose Level IV|Physician Decision|0|||
16447515|NCT05021978|40118617|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
16447516|NCT05021978|40118618|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
16447517|NCT05021978|40118619|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
16447518|NCT01958164|40118622|FG000|Overall Study|Adverse Event|0|||
16447519|NCT01958164|40118623|FG001|Overall Study|Adverse Event|2|||
16447520|NCT01958164|40118622|FG000|Overall Study|Lost to Follow-up|2|||
16447521|NCT01958164|40118623|FG001|Overall Study|Lost to Follow-up|3|||
16447522|NCT02396199|40118624|FG000|Overall Study|Lost to Follow-up|1|||
16447523|NCT02396199|40118624|FG000|Overall Study|Death|4|||
16447524|NCT02177032|40118626|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
16447525|NCT02177032|40118627|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
16447526|NCT02177032|40118628|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
16447527|NCT02177032|40118629|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
16447528|NCT02177032|40118626|FG000|Overall Study|Lost to Follow-up|0|||
16447529|NCT02177032|40118627|FG001|Overall Study|Lost to Follow-up|2|||
16447530|NCT02177032|40118628|FG002|Overall Study|Lost to Follow-up|0|||
16447531|NCT02177032|40118629|FG003|Overall Study|Lost to Follow-up|0|||
16447532|NCT02177032|40118626|FG000|Overall Study|OTHER|2|||
16447533|NCT02177032|40118627|FG001|Overall Study|OTHER|0|||
16447534|NCT02177032|40118628|FG002|Overall Study|OTHER|1|||
16447535|NCT02177032|40118629|FG003|Overall Study|OTHER|0|||
16447536|NCT02177032|40118626|FG000|Overall Study|Withdrawal by Subject|1|||
16447537|NCT02177032|40118627|FG001|Overall Study|Withdrawal by Subject|0|||
16068603|NCT03568162|38742615|FG005|Overall Study|Lost to Follow-up|2|||
16068604|NCT03568162|38742610|FG000|Overall Study|Physician Decision|0|||
16068605|NCT03568162|38742611|FG001|Overall Study|Physician Decision|1|||
16068606|NCT03568162|38742612|FG002|Overall Study|Physician Decision|1|||
16068607|NCT03568162|38742613|FG003|Overall Study|Physician Decision|0|||
16068608|NCT03568162|38742614|FG004|Overall Study|Physician Decision|1|||
16068609|NCT03568162|38742615|FG005|Overall Study|Physician Decision|0|||
16068610|NCT03568162|38742610|FG000|Overall Study|Pregnancy|0|||
16068611|NCT03568162|38742611|FG001|Overall Study|Pregnancy|0|||
16447538|NCT02177032|40118628|FG002|Overall Study|Withdrawal by Subject|1|||
16447539|NCT02177032|40118629|FG003|Overall Study|Withdrawal by Subject|0|||
16447540|NCT00473564|40118631|FG000|Overall Study|robot surgery aborted in OR|23|||
16447541|NCT03131570|40118639|FG000|Overall Study|Adverse Event|1|||
16068612|NCT03568162|38742612|FG002|Overall Study|Pregnancy|0|||
16068613|NCT03568162|38742613|FG003|Overall Study|Pregnancy|1|||
16264678|NCT01597245|39453272|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16447542|NCT03131570|40118640|FG001|Overall Study|Adverse Event|0|||
16447543|NCT01527370|40118643|FG000|Overall Study|Withdrawal by Subject|4|||
16447544|NCT01527370|40118643|FG000|Overall Study|Physician Decision|1|||
16447545|NCT01527370|40118643|FG000|Overall Study|Death|1|||
16447546|NCT03822117|40118645|FG000|Overall Study|Death|18|||
16447547|NCT03822117|40118646|FG001|Overall Study|Death|17|||
16447548|NCT03822117|40118647|FG002|Overall Study|Death|12|||
16447549|NCT03822117|40118648|FG003|Overall Study|Death|4|||
16447550|NCT03822117|40118645|FG000|Overall Study|Lost to Follow-up|1|||
16447551|NCT03822117|40118646|FG001|Overall Study|Lost to Follow-up|2|||
16447552|NCT03822117|40118647|FG002|Overall Study|Lost to Follow-up|3|||
16447553|NCT03822117|40118648|FG003|Overall Study|Lost to Follow-up|0|||
16447554|NCT03822117|40118645|FG000|Overall Study|Study Terminated by Sponsor|25|||
16447555|NCT03822117|40118646|FG001|Overall Study|Study Terminated by Sponsor|11|||
16447556|NCT03822117|40118647|FG002|Overall Study|Study Terminated by Sponsor|6|||
16447557|NCT03822117|40118648|FG003|Overall Study|Study Terminated by Sponsor|0|||
16447558|NCT03822117|40118645|FG000|Overall Study|Withdrawal by Subject|4|||
16447559|NCT03822117|40118646|FG001|Overall Study|Withdrawal by Subject|0|||
16447560|NCT03822117|40118647|FG002|Overall Study|Withdrawal by Subject|3|||
16447561|NCT03822117|40118648|FG003|Overall Study|Withdrawal by Subject|0|||
16447562|NCT03822117|40118645|FG000|Overall Study|Disease Progression|1|||
16370731|NCT02533674|39843446|FG002|Dose Level IV|Physician Decision|0|||
16370732|NCT02533674|39843447|FG003|Dose Level IV|Physician Decision|1|||
16370733|NCT02533674|39843448|FG004|Dose Level IV|Physician Decision|0|||
16370734|NCT02533674|39843449|FG005|Dose Level IV|Physician Decision|0|||
16370735|NCT02533674|39843450|FG006|Dose Level IV|Physician Decision|0|||
16447563|NCT03822117|40118646|FG001|Overall Study|Disease Progression|2|||
16447564|NCT03822117|40118647|FG002|Overall Study|Disease Progression|1|||
16068614|NCT03568162|38742614|FG004|Overall Study|Pregnancy|0|||
16068615|NCT03568162|38742615|FG005|Overall Study|Pregnancy|0|||
16068616|NCT03568162|38742610|FG000|Overall Study|Protocol Violation|1|||
16068617|NCT03568162|38742611|FG001|Overall Study|Protocol Violation|0|||
16370736|NCT02533674|39843451|FG007|Dose Level IV|Physician Decision|0|||
16370737|NCT02533674|39843444|FG000|Dose Level V|Progressive disease|0|||
16370738|NCT02533674|39843445|FG001|Dose Level V|Progressive disease|0|||
16370739|NCT02533674|39843446|FG002|Dose Level V|Progressive disease|0|||
16370740|NCT02533674|39843447|FG003|Dose Level V|Progressive disease|0|||
16370741|NCT02533674|39843448|FG004|Dose Level V|Progressive disease|3|||
16370742|NCT02533674|39843449|FG005|Dose Level V|Progressive disease|0|||
16370743|NCT02533674|39843450|FG006|Dose Level V|Progressive disease|0|||
16370744|NCT02533674|39843451|FG007|Dose Level V|Progressive disease|0|||
16370745|NCT02533674|39843444|FG000|Dose Level V|Withdrawal by Subject|0|||
16370746|NCT02533674|39843445|FG001|Dose Level V|Withdrawal by Subject|0|||
16370747|NCT02533674|39843446|FG002|Dose Level V|Withdrawal by Subject|0|||
16370748|NCT02533674|39843447|FG003|Dose Level V|Withdrawal by Subject|0|||
16370749|NCT02533674|39843448|FG004|Dose Level V|Withdrawal by Subject|1|||
16370750|NCT02533674|39843449|FG005|Dose Level V|Withdrawal by Subject|0|||
16370751|NCT02533674|39843450|FG006|Dose Level V|Withdrawal by Subject|0|||
16370752|NCT02533674|39843451|FG007|Dose Level V|Withdrawal by Subject|0|||
16370753|NCT02533674|39843444|FG000|Dose Level V|Physician Decision|0|||
16370754|NCT02533674|39843445|FG001|Dose Level V|Physician Decision|0|||
16370755|NCT02533674|39843446|FG002|Dose Level V|Physician Decision|0|||
16370756|NCT02533674|39843447|FG003|Dose Level V|Physician Decision|0|||
16370757|NCT02533674|39843448|FG004|Dose Level V|Physician Decision|1|||
16370758|NCT02533674|39843449|FG005|Dose Level V|Physician Decision|0|||
16068618|NCT03568162|38742612|FG002|Overall Study|Protocol Violation|1|||
16068619|NCT03568162|38742613|FG003|Overall Study|Protocol Violation|1|||
16068620|NCT03568162|38742614|FG004|Overall Study|Protocol Violation|1|||
16370759|NCT02533674|39843450|FG006|Dose Level V|Physician Decision|0|||
16370760|NCT02533674|39843451|FG007|Dose Level V|Physician Decision|0|||
16370761|NCT02533674|39843444|FG000|Dose Level VI|Progressive disease|0|||
16068621|NCT03568162|38742615|FG005|Overall Study|Protocol Violation|1|||
16068622|NCT03568162|38742610|FG000|Overall Study|Withdrawal by Subject|15|||
16068623|NCT03568162|38742611|FG001|Overall Study|Withdrawal by Subject|15|||
16068624|NCT03568162|38742612|FG002|Overall Study|Withdrawal by Subject|26|||
16068625|NCT03568162|38742613|FG003|Overall Study|Withdrawal by Subject|22|||
16068626|NCT03568162|38742614|FG004|Overall Study|Withdrawal by Subject|6|||
16068627|NCT03568162|38742615|FG005|Overall Study|Withdrawal by Subject|9|||
16068628|NCT03568162|38742610|FG000|Overall Study|Others|3|||
16264679|NCT01597245|39453273|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16370762|NCT02533674|39843445|FG001|Dose Level VI|Progressive disease|0|||
16370763|NCT02533674|39843446|FG002|Dose Level VI|Progressive disease|0|||
16447565|NCT03822117|40118648|FG003|Overall Study|Disease Progression|0|||
16447566|NCT03822117|40118645|FG000|Overall Study|Never Returned to Hospital|0|||
16068629|NCT03568162|38742611|FG001|Overall Study|Others|4|||
16370764|NCT02533674|39843447|FG003|Dose Level VI|Progressive disease|0|||
16370765|NCT02533674|39843448|FG004|Dose Level VI|Progressive disease|0|||
16370766|NCT02533674|39843449|FG005|Dose Level VI|Progressive disease|7|||
16447567|NCT03822117|40118646|FG001|Overall Study|Never Returned to Hospital|0|||
16447568|NCT03822117|40118647|FG002|Overall Study|Never Returned to Hospital|1|||
16264680|NCT01597245|39453274|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
16264681|NCT01597245|39453254|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264682|NCT01597245|39453255|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264683|NCT01597245|39453256|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264684|NCT01597245|39453257|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264685|NCT01597245|39453258|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264686|NCT01597245|39453259|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264687|NCT01597245|39453260|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264688|NCT01597245|39453261|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264689|NCT01597245|39453262|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264690|NCT01597245|39453263|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264691|NCT01597245|39453264|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16370767|NCT02533674|39843450|FG006|Dose Level VI|Progressive disease|0|||
16370768|NCT02533674|39843451|FG007|Dose Level VI|Progressive disease|0|||
16370769|NCT02533674|39843444|FG000|Dose Level VI|Withdrawal by Subject|0|||
16370770|NCT02533674|39843445|FG001|Dose Level VI|Withdrawal by Subject|0|||
16370771|NCT02533674|39843446|FG002|Dose Level VI|Withdrawal by Subject|0|||
16370772|NCT02533674|39843447|FG003|Dose Level VI|Withdrawal by Subject|0|||
16370773|NCT02533674|39843448|FG004|Dose Level VI|Withdrawal by Subject|0|||
16370774|NCT02533674|39843449|FG005|Dose Level VI|Withdrawal by Subject|1|||
16370775|NCT02533674|39843450|FG006|Dose Level VI|Withdrawal by Subject|0|||
16370776|NCT02533674|39843451|FG007|Dose Level VI|Withdrawal by Subject|0|||
16370777|NCT02533674|39843444|FG000|Dose Level VI|Treatment-related AE|0|||
16370778|NCT02533674|39843445|FG001|Dose Level VI|Treatment-related AE|0|||
16370779|NCT02533674|39843446|FG002|Dose Level VI|Treatment-related AE|0|||
16370780|NCT02533674|39843447|FG003|Dose Level VI|Treatment-related AE|0|||
16370781|NCT02533674|39843448|FG004|Dose Level VI|Treatment-related AE|0|||
16370782|NCT02533674|39843449|FG005|Dose Level VI|Treatment-related AE|1|||
16370783|NCT02533674|39843450|FG006|Dose Level VI|Treatment-related AE|0|||
16370784|NCT02533674|39843451|FG007|Dose Level VI|Treatment-related AE|0|||
16370785|NCT02533674|39843444|FG000|Dose Level VII|Progressive disease|0|||
16370786|NCT02533674|39843445|FG001|Dose Level VII|Progressive disease|0|||
16370787|NCT02533674|39843446|FG002|Dose Level VII|Progressive disease|0|||
16370788|NCT02533674|39843447|FG003|Dose Level VII|Progressive disease|0|||
16370789|NCT02533674|39843448|FG004|Dose Level VII|Progressive disease|0|||
16370790|NCT02533674|39843449|FG005|Dose Level VII|Progressive disease|0|||
16370791|NCT02533674|39843450|FG006|Dose Level VII|Progressive disease|10|||
16370792|NCT02533674|39843451|FG007|Dose Level VII|Progressive disease|0|||
16370793|NCT02533674|39843444|FG000|Dose Level VII|Withdrawal by Subject|0|||
16370794|NCT02533674|39843445|FG001|Dose Level VII|Withdrawal by Subject|0|||
16370795|NCT02533674|39843446|FG002|Dose Level VII|Withdrawal by Subject|0|||
16370796|NCT02533674|39843447|FG003|Dose Level VII|Withdrawal by Subject|0|||
16370797|NCT02533674|39843448|FG004|Dose Level VII|Withdrawal by Subject|0|||
16370798|NCT02533674|39843449|FG005|Dose Level VII|Withdrawal by Subject|0|||
16370799|NCT02533674|39843450|FG006|Dose Level VII|Withdrawal by Subject|3|||
16370800|NCT02533674|39843451|FG007|Dose Level VII|Withdrawal by Subject|0|||
16370801|NCT02533674|39843444|FG000|Dose Level VII|Treatment-related AE|0|||
16370802|NCT02533674|39843445|FG001|Dose Level VII|Treatment-related AE|0|||
16370803|NCT02533674|39843446|FG002|Dose Level VII|Treatment-related AE|0|||
16370804|NCT02533674|39843447|FG003|Dose Level VII|Treatment-related AE|0|||
16370805|NCT02533674|39843448|FG004|Dose Level VII|Treatment-related AE|0|||
16370806|NCT02533674|39843449|FG005|Dose Level VII|Treatment-related AE|0|||
16370807|NCT02533674|39843450|FG006|Dose Level VII|Treatment-related AE|1|||
16370808|NCT02533674|39843451|FG007|Dose Level VII|Treatment-related AE|0|||
16370809|NCT02533674|39843444|FG000|Dose Level VII|Death|0|||
16370810|NCT02533674|39843445|FG001|Dose Level VII|Death|0|||
16370811|NCT02533674|39843446|FG002|Dose Level VII|Death|0|||
16370812|NCT02533674|39843447|FG003|Dose Level VII|Death|0|||
16370813|NCT02533674|39843448|FG004|Dose Level VII|Death|0|||
16370814|NCT02533674|39843449|FG005|Dose Level VII|Death|0|||
16370815|NCT02533674|39843450|FG006|Dose Level VII|Death|2|||
16370816|NCT02533674|39843451|FG007|Dose Level VII|Death|0|||
16370817|NCT02533674|39843444|FG000|Dose Level VIII|Progressive disease|0|||
16370818|NCT02533674|39843445|FG001|Dose Level VIII|Progressive disease|0|||
16068630|NCT03568162|38742612|FG002|Overall Study|Others|1|||
16068631|NCT03568162|38742613|FG003|Overall Study|Others|4|||
16068632|NCT03568162|38742614|FG004|Overall Study|Others|2|||
16370819|NCT02533674|39843446|FG002|Dose Level VIII|Progressive disease|0|||
16370820|NCT02533674|39843447|FG003|Dose Level VIII|Progressive disease|0|||
16370821|NCT02533674|39843448|FG004|Dose Level VIII|Progressive disease|0|||
16370822|NCT02533674|39843449|FG005|Dose Level VIII|Progressive disease|0|||
16370823|NCT02533674|39843450|FG006|Dose Level VIII|Progressive disease|0|||
16370824|NCT02533674|39843451|FG007|Dose Level VIII|Progressive disease|3|||
16068633|NCT03568162|38742615|FG005|Overall Study|Others|1|||
16370825|NCT02533674|39843444|FG000|Dose Level VIII|Withdrawal by Subject|0|||
16370826|NCT02533674|39843445|FG001|Dose Level VIII|Withdrawal by Subject|0|||
16370827|NCT02533674|39843446|FG002|Dose Level VIII|Withdrawal by Subject|0|||
16370828|NCT02533674|39843447|FG003|Dose Level VIII|Withdrawal by Subject|0|||
16370829|NCT02533674|39843448|FG004|Dose Level VIII|Withdrawal by Subject|0|||
16370830|NCT02533674|39843449|FG005|Dose Level VIII|Withdrawal by Subject|0|||
16370831|NCT02533674|39843450|FG006|Dose Level VIII|Withdrawal by Subject|0|||
16370832|NCT02533674|39843451|FG007|Dose Level VIII|Withdrawal by Subject|1|||
16370833|NCT02533674|39843444|FG000|Dose Level VIII|Treatment-related AE|0|||
16370834|NCT02533674|39843445|FG001|Dose Level VIII|Treatment-related AE|0|||
16370835|NCT02533674|39843446|FG002|Dose Level VIII|Treatment-related AE|0|||
16370836|NCT02533674|39843447|FG003|Dose Level VIII|Treatment-related AE|0|||
16370837|NCT02533674|39843448|FG004|Dose Level VIII|Treatment-related AE|0|||
16370838|NCT02533674|39843449|FG005|Dose Level VIII|Treatment-related AE|0|||
16370839|NCT02533674|39843450|FG006|Dose Level VIII|Treatment-related AE|0|||
16370840|NCT02533674|39843451|FG007|Dose Level VIII|Treatment-related AE|1|||
16370841|NCT02533674|39843444|FG000|Dose Level VIII|Never treated|0|||
16370842|NCT02533674|39843445|FG001|Dose Level VIII|Never treated|0|||
16370843|NCT02533674|39843446|FG002|Dose Level VIII|Never treated|0|||
16370844|NCT02533674|39843447|FG003|Dose Level VIII|Never treated|0|||
16370845|NCT02533674|39843448|FG004|Dose Level VIII|Never treated|0|||
16370846|NCT02533674|39843449|FG005|Dose Level VIII|Never treated|0|||
16370847|NCT02533674|39843450|FG006|Dose Level VIII|Never treated|0|||
16370848|NCT02533674|39843451|FG007|Dose Level VIII|Never treated|1|||
16370849|NCT02939781|39843452|FG000|Overall Study|Protocol Violation|8|||
16370850|NCT02939781|39843452|FG000|Overall Study|Withdrawal by Subject|1|||
16370851|NCT03436420|39843453|FG000|Overall Study|Lack of Efficacy|3|||
16370852|NCT02665455|39843454|FG000|Overall Study|Withdrawal by Subject|6|||
16370853|NCT02665455|39843454|FG000|Overall Study|Lost to Follow-up|1|||
16370854|NCT02665455|39843454|FG000|Overall Study|Adverse Event|1|||
16370855|NCT02665455|39843454|FG000|Overall Study|Protocol Violation|1|||
16370856|NCT00098293|39843455|FG000|Double-blind (DB) Phase|Adverse Event|14|||
16370857|NCT00098293|39843456|FG001|Double-blind (DB) Phase|Adverse Event|27|||
16370858|NCT00098293|39843457|FG002|Double-blind (DB) Phase|Adverse Event|60|||
16370859|NCT00098293|39843458|FG003|Double-blind (DB) Phase|Adverse Event|0|||
16370860|NCT00098293|39843459|FG004|Double-blind (DB) Phase|Adverse Event|0|||
16370861|NCT00098293|39843455|FG000|Double-blind (DB) Phase|Pregnancy|0|||
16370862|NCT00098293|39843456|FG001|Double-blind (DB) Phase|Pregnancy|7|||
16068634|NCT00545844|38742619|FG000|Overall Study|Lost to Follow-up|9|||
16264692|NCT01597245|39453265|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16370863|NCT00098293|39843457|FG002|Double-blind (DB) Phase|Pregnancy|9|||
16370864|NCT00098293|39843458|FG003|Double-blind (DB) Phase|Pregnancy|0|||
16447569|NCT03822117|40118648|FG003|Overall Study|Never Returned to Hospital|0|||
16447570|NCT01598532|40118650|FG000|Overall Study|Lost to Follow-up|3|||
16447571|NCT01598532|40118650|FG000|Overall Study|Did not meet inclusion criteria|8|||
16447572|NCT01815918|40118651|FG000|Overall Study|Patient samples not analyzable|3|||
16447573|NCT01815918|40118652|FG001|Overall Study|Patient samples not analyzable|4|||
16447574|NCT01815918|40118651|FG000|Overall Study|Lack of Efficacy|15|||
16447575|NCT01815918|40118652|FG001|Overall Study|Lack of Efficacy|15|||
16447576|NCT00910650|40118655|FG000|Overall Study|Death|2|||
16447577|NCT00812708|40118656|FG000|Overall Study|Device could not be implanted|2|||
16447578|NCT00812708|40118656|FG000|Overall Study|Lack of medical insurance|1|||
16447579|NCT00812708|40118656|FG000|Overall Study|Switched to another study|1|||
16447580|NCT00812708|40118656|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
16447581|NCT00812708|40118656|FG000|Overall Study|Signed consent but later withdrew|3|||
16447582|NCT00248625|40118657|FG000|Overall Study|Withdrawal by Subject|0|||
16447583|NCT00248625|40118658|FG001|Overall Study|Withdrawal by Subject|2|||
16447584|NCT03077412|40118666|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
16447585|NCT03077412|40118667|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
16447586|NCT03077412|40118668|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
16447587|NCT03077412|40118666|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
16447588|NCT03077412|40118667|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
16447589|NCT03077412|40118668|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
16447590|NCT03077412|40118666|FG000|Overall Study|Adverse Event|1|||
16447591|NCT03077412|40118667|FG001|Overall Study|Adverse Event|2|||
16447592|NCT03077412|40118668|FG002|Overall Study|Adverse Event|2|||
16447593|NCT03077412|40118666|FG000|Overall Study|Investigator's Discretion|0|||
16447594|NCT03077412|40118667|FG001|Overall Study|Investigator's Discretion|1|||
16447595|NCT03077412|40118668|FG002|Overall Study|Investigator's Discretion|1|||
16447596|NCT03077412|40118666|FG000|Overall Study|Withdrew Consent|0|||
16264693|NCT01597245|39453266|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16370865|NCT00098293|39843459|FG004|Double-blind (DB) Phase|Pregnancy|0|||
16370866|NCT00098293|39843455|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
16370867|NCT00098293|39843456|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
16370868|NCT00098293|39843457|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
16370869|NCT00098293|39843458|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
16370870|NCT00098293|39843459|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
16370871|NCT00098293|39843455|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
16370872|NCT00098293|39843456|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
16370873|NCT00098293|39843457|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
16370874|NCT00098293|39843458|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
16370875|NCT00098293|39843459|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
16370876|NCT00098293|39843455|FG000|Double-blind (DB) Phase|Death|1|||
16370877|NCT00098293|39843456|FG001|Double-blind (DB) Phase|Death|2|||
16370878|NCT00098293|39843457|FG002|Double-blind (DB) Phase|Death|2|||
16370879|NCT00098293|39843458|FG003|Double-blind (DB) Phase|Death|0|||
16370880|NCT00098293|39843459|FG004|Double-blind (DB) Phase|Death|0|||
16370881|NCT00098293|39843455|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
16370882|NCT00098293|39843456|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
16068635|NCT00545844|38742619|FG000|Overall Study|Protocol Violation|1|||
16068636|NCT00545844|38742619|FG000|Overall Study|Withdrawal by Subject|2|||
16068637|NCT01516892|38742620|FG000|Overall Study|Adverse Event|25|||
16068638|NCT01516892|38742620|FG000|Overall Study|Lack of Efficacy|35|||
16068639|NCT01516892|38742620|FG000|Overall Study|Pregnancy|5|||
16068640|NCT01516892|38742620|FG000|Overall Study|Lost to Follow-up|82|||
16068641|NCT01516892|38742620|FG000|Overall Study|Subject Withdrew Consent|92|||
16068642|NCT01516892|38742620|FG000|Overall Study|Protocol Violation|60|||
16068643|NCT01516892|38742620|FG000|Overall Study|Other Miscellaneous Reasons|43|||
16068644|NCT01516892|38742620|FG000|Overall Study|Missing|1|||
16068645|NCT01928940|38742621|FG000|Overall Study|Adverse Event|0|||
16068646|NCT01928940|38742622|FG001|Overall Study|Adverse Event|1|||
16068647|NCT01280591|38742623|FG000|Overall Study|Withdrawal by Subject|0|||
16068648|NCT01280591|38742624|FG001|Overall Study|Withdrawal by Subject|0|||
16068649|NCT01280591|38742625|FG002|Overall Study|Withdrawal by Subject|0|||
16447597|NCT03077412|40118667|FG001|Overall Study|Withdrew Consent|2|||
16447598|NCT03077412|40118668|FG002|Overall Study|Withdrew Consent|0|||
16447599|NCT04030143|40118669|FG000|Overall Study|Adverse Event|5|||
16447600|NCT04030143|40118670|FG001|Overall Study|Adverse Event|10|||
16447601|NCT04030143|40118669|FG000|Overall Study|Lost to Follow-up|3|||
16068650|NCT01280591|38742626|FG003|Overall Study|Withdrawal by Subject|2|||
16068651|NCT01280591|38742623|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
16068652|NCT01280591|38742624|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
16068653|NCT01280591|38742625|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
16068654|NCT01280591|38742626|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
16068655|NCT02929108|38742631|FG000|Overall Study|Hospice patient death|100|||
16068656|NCT02929108|38742632|FG001|Overall Study|Hospice patient death|64|||
16068657|NCT02929108|38742633|FG002|Overall Study|Hospice patient death|28|||
16068658|NCT02929108|38742634|FG003|Overall Study|Hospice patient death|46|||
16068659|NCT02929108|38742635|FG004|Overall Study|Hospice patient death|55|||
16068660|NCT02929108|38742636|FG005|Overall Study|Hospice patient death|28|||
16068661|NCT02929108|38742637|FG006|Overall Study|Hospice patient death|78|||
16447602|NCT04030143|40118670|FG001|Overall Study|Lost to Follow-up|7|||
16447603|NCT04030143|40118669|FG000|Overall Study|Protocol Deviation|2|||
16447604|NCT04030143|40118670|FG001|Overall Study|Protocol Deviation|2|||
16068662|NCT00580801|38742638|FG000|Overall Study|Physician Decision|1|||
16068663|NCT00580801|38742639|FG001|Overall Study|Physician Decision|0|||
16068664|NCT00580801|38742640|FG002|Overall Study|Physician Decision|0|||
16068665|NCT00580801|38742638|FG000|Overall Study|Adverse Event|2|||
16068666|NCT00580801|38742639|FG001|Overall Study|Adverse Event|0|||
16068667|NCT00580801|38742640|FG002|Overall Study|Adverse Event|0|||
16068668|NCT00580801|38742638|FG000|Overall Study|Lost to Follow-up|2|||
16068669|NCT00580801|38742639|FG001|Overall Study|Lost to Follow-up|0|||
16068670|NCT00580801|38742640|FG002|Overall Study|Lost to Follow-up|0|||
16068671|NCT00580801|38742638|FG000|Overall Study|Reached a virologic endpoint|0|||
16370883|NCT00098293|39843457|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
16370884|NCT00098293|39843458|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
16370885|NCT00098293|39843459|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
16447605|NCT04030143|40118669|FG000|Overall Study|Withdrawal by Subject|16|||
16447606|NCT04030143|40118670|FG001|Overall Study|Withdrawal by Subject|18|||
16447607|NCT04030143|40118669|FG000|Overall Study|Physician Decision|1|||
16068672|NCT00580801|38742639|FG001|Overall Study|Reached a virologic endpoint|1|||
16447608|NCT04030143|40118670|FG001|Overall Study|Physician Decision|1|||
16068673|NCT00580801|38742640|FG002|Overall Study|Reached a virologic endpoint|2|||
16068674|NCT00580801|38742638|FG000|Overall Study|Participant non-compliant|0|||
16068675|NCT00580801|38742639|FG001|Overall Study|Participant non-compliant|0|||
16068676|NCT00580801|38742640|FG002|Overall Study|Participant non-compliant|1|||
16370886|NCT00098293|39843455|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
16068677|NCT00580801|38742638|FG000|Overall Study|Travel|1|||
16068678|NCT00580801|38742639|FG001|Overall Study|Travel|0|||
16370887|NCT00098293|39843456|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
16447609|NCT04030143|40118669|FG000|Overall Study|Due to Covid-19|2|||
16370888|NCT00098293|39843457|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
16370889|NCT00098293|39843458|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
16370890|NCT00098293|39843459|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
16370891|NCT00098293|39843455|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
16370892|NCT00098293|39843456|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
16370893|NCT00098293|39843457|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
16370894|NCT00098293|39843458|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
16370895|NCT00098293|39843459|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
16370896|NCT00098293|39843455|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
16370897|NCT00098293|39843456|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
16370898|NCT00098293|39843457|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
16370899|NCT00098293|39843458|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
16370900|NCT00098293|39843459|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
16370901|NCT00098293|39843455|FG000|Open-label (OL) Phase|Adverse Event|0|||
16370902|NCT00098293|39843456|FG001|Open-label (OL) Phase|Adverse Event|3|||
16370903|NCT00098293|39843457|FG002|Open-label (OL) Phase|Adverse Event|7|||
16370904|NCT00098293|39843458|FG003|Open-label (OL) Phase|Adverse Event|6|||
16370905|NCT00098293|39843459|FG004|Open-label (OL) Phase|Adverse Event|0|||
16370906|NCT00098293|39843455|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
16370907|NCT00098293|39843456|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
16370908|NCT00098293|39843457|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
16370909|NCT00098293|39843458|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
16370910|NCT00098293|39843459|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
16370911|NCT00098293|39843455|FG000|Open-label (OL) Phase|Pregnancy|0|||
16370912|NCT00098293|39843456|FG001|Open-label (OL) Phase|Pregnancy|1|||
16370913|NCT00098293|39843457|FG002|Open-label (OL) Phase|Pregnancy|0|||
16370914|NCT00098293|39843458|FG003|Open-label (OL) Phase|Pregnancy|3|||
16370915|NCT00098293|39843459|FG004|Open-label (OL) Phase|Pregnancy|0|||
16370916|NCT00098293|39843455|FG000|Open-label (OL) Phase|Protocol Violation|0|||
16370917|NCT00098293|39843456|FG001|Open-label (OL) Phase|Protocol Violation|6|||
16370918|NCT00098293|39843457|FG002|Open-label (OL) Phase|Protocol Violation|13|||
16370919|NCT00098293|39843458|FG003|Open-label (OL) Phase|Protocol Violation|16|||
16370920|NCT00098293|39843459|FG004|Open-label (OL) Phase|Protocol Violation|0|||
16370921|NCT00098293|39843455|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
16370922|NCT00098293|39843456|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
16370923|NCT00098293|39843457|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
16447610|NCT04030143|40118670|FG001|Overall Study|Due to Covid-19|3|||
16447611|NCT04030143|40118669|FG000|Overall Study|Not Due to Covid-19|1|||
16447612|NCT04030143|40118670|FG001|Overall Study|Not Due to Covid-19|1|||
16447613|NCT00999804|40118671|FG000|Overall Study|Lack of Efficacy|9|||
16447614|NCT00999804|40118672|FG001|Overall Study|Lack of Efficacy|2|||
16447615|NCT00999804|40118671|FG000|Overall Study|Adverse Event|4|||
16447616|NCT00999804|40118672|FG001|Overall Study|Adverse Event|3|||
16447617|NCT00999804|40118671|FG000|Overall Study|Withdrawal by Subject|4|||
16447618|NCT00999804|40118672|FG001|Overall Study|Withdrawal by Subject|0|||
16447619|NCT00999804|40118671|FG000|Overall Study|Death|1|||
16447620|NCT00999804|40118672|FG001|Overall Study|Death|0|||
16447621|NCT00999804|40118671|FG000|Overall Study|Ineligible|3|||
16447622|NCT00999804|40118672|FG001|Overall Study|Ineligible|0|||
16447623|NCT01281124|40118673|FG000|Overall Study|Death|1|||
16447624|NCT02351856|40118674|FG000|Overall Study|Adverse Event|2|||
16447625|NCT02351856|40118674|FG000|Overall Study|Physician Decision|5|||
16447626|NCT02351856|40118674|FG000|Overall Study|Study terminated by sponsor|1|||
16447627|NCT00566696|40118675|FG000|Overall Study|Met Exclusion Criteria|2|||
16447628|NCT00566696|40118675|FG000|Overall Study|Muromonab not available|1|||
16068679|NCT00580801|38742640|FG002|Overall Study|Travel|0|||
16370924|NCT00098293|39843458|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
16370925|NCT00098293|39843459|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
16370926|NCT00098293|39843455|FG000|Open-label (OL) Phase|Death|0|||
16370927|NCT00098293|39843456|FG001|Open-label (OL) Phase|Death|2|||
16370928|NCT00098293|39843457|FG002|Open-label (OL) Phase|Death|3|||
16370929|NCT00098293|39843458|FG003|Open-label (OL) Phase|Death|0|||
16370930|NCT00098293|39843459|FG004|Open-label (OL) Phase|Death|0|||
16370931|NCT00098293|39843455|FG000|Supplemental Phase (SP)|Death|0|||
16370932|NCT00098293|39843456|FG001|Supplemental Phase (SP)|Death|0|||
16447629|NCT00566696|40118675|FG000|Overall Study|Health Status Change|1|||
16447630|NCT00566696|40118675|FG000|Overall Study|Physician Decision|1|||
16447631|NCT00566696|40118675|FG000|Overall Study|Non-Patient Donors|37|||
16068680|NCT02351180|38742641|FG000|Overall Study|Withdrawal by Subject|1|||
16370933|NCT00098293|39843457|FG002|Supplemental Phase (SP)|Death|0|||
16370934|NCT00098293|39843458|FG003|Supplemental Phase (SP)|Death|0|||
16370935|NCT00098293|39843459|FG004|Supplemental Phase (SP)|Death|1|||
16370936|NCT00098293|39843455|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
16370937|NCT00098293|39843456|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
16370938|NCT00098293|39843457|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
16447632|NCT01782378|40118676|FG000|First Series|Lost to Follow-up|7|||
16370939|NCT00098293|39843458|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
16370940|NCT00098293|39843459|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
16370941|NCT00098293|39843455|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
16370942|NCT00098293|39843456|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
16370943|NCT00098293|39843457|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
16370944|NCT00098293|39843458|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
16370945|NCT00098293|39843459|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
16370946|NCT00098293|39843455|FG000|Supplemental Phase (SP)|Other|0|||
16370947|NCT00098293|39843456|FG001|Supplemental Phase (SP)|Other|0|||
16370948|NCT00098293|39843457|FG002|Supplemental Phase (SP)|Other|0|||
16068681|NCT02351180|38742642|FG001|Overall Study|Withdrawal by Subject|0|||
16068682|NCT03523091|38742643|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
16447633|NCT01782378|40118677|FG001|First Series|Lost to Follow-up|8|||
16447634|NCT01782378|40118676|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
16447635|NCT01782378|40118677|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
16447636|NCT01782378|40118676|FG000|Second Series|Lost to Follow-up|8|||
16447637|NCT01782378|40118677|FG001|Second Series|Lost to Follow-up|7|||
16447638|NCT01782378|40118676|FG000|Second Series|Did not choose to complete S2 Optional|18|||
16447639|NCT01782378|40118677|FG001|Second Series|Did not choose to complete S2 Optional|0|||
16447640|NCT02435992|40118710|FG000|Overall Study|non compliance with protocol|2|||
16447641|NCT02435992|40118711|FG001|Overall Study|non compliance with protocol|0|||
16447642|NCT02435992|40118712|FG002|Overall Study|non compliance with protocol|1|||
16447643|NCT02435992|40118713|FG003|Overall Study|non compliance with protocol|0|||
16447644|NCT02435992|40118714|FG004|Overall Study|non compliance with protocol|0|||
16447645|NCT02435992|40118710|FG000|Overall Study|Adverse Event|11|||
16447646|NCT02435992|40118711|FG001|Overall Study|Adverse Event|6|||
16068683|NCT03523091|38742644|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
16068684|NCT03523091|38742643|FG000|Overall Study|Withdrawal by Subject|0|||
16068685|NCT03523091|38742644|FG001|Overall Study|Withdrawal by Subject|3|||
16068686|NCT03523091|38742643|FG000|Overall Study|Increase Botox dose|0|||
16068687|NCT03523091|38742644|FG001|Overall Study|Increase Botox dose|1|||
16068688|NCT02236559|38742647|FG000|Overall Study|Met Exclusion|3|||
16068689|NCT02236559|38742648|FG001|Overall Study|Met Exclusion|6|||
16447647|NCT02435992|40118712|FG002|Overall Study|Adverse Event|12|||
16447648|NCT02435992|40118713|FG003|Overall Study|Adverse Event|0|||
16068690|NCT02236559|38742647|FG000|Overall Study|Did not Meet Inclusion|3|||
16068691|NCT02236559|38742648|FG001|Overall Study|Did not Meet Inclusion|3|||
16068692|NCT02236559|38742647|FG000|Overall Study|Subject Did Not Consent|4|||
16068693|NCT02236559|38742648|FG001|Overall Study|Subject Did Not Consent|2|||
16068694|NCT02236559|38742647|FG000|Overall Study|Physician Decision|1|||
16068695|NCT02236559|38742648|FG001|Overall Study|Physician Decision|1|||
16068696|NCT02236559|38742647|FG000|Overall Study|Withdrawal by Subject|1|||
16068697|NCT02236559|38742648|FG001|Overall Study|Withdrawal by Subject|0|||
16068698|NCT01264718|38742649|FG000|Overall Study|Lost to Follow-up|3|||
16068699|NCT01264718|38742650|FG001|Overall Study|Lost to Follow-up|2|||
16068700|NCT01264718|38742649|FG000|Overall Study|Withdrawal by Subject|9|||
16068701|NCT01264718|38742650|FG001|Overall Study|Withdrawal by Subject|15|||
16068702|NCT01264718|38742649|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
16068703|NCT01264718|38742650|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
16068704|NCT04109118|38742651|FG000|Overall Study|Lost to Follow-up|3|||
16068705|NCT01178762|38742656|FG000|Overall Study|Lost to Follow-up|15|||
16068706|NCT01080131|38742657|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
16068707|NCT01080131|38742658|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
16068708|NCT01080131|38742657|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
16068709|NCT01080131|38742658|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
16068710|NCT01080131|38742657|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
16068711|NCT01080131|38742658|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
16068712|NCT01080131|38742657|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
16068713|NCT01080131|38742658|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
16068714|NCT01080131|38742657|FG000|Core Study (0- 12 Weeks)|Death|1|||
16068715|NCT01080131|38742658|FG001|Core Study (0- 12 Weeks)|Death|0|||
16068716|NCT01080131|38742657|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
16068717|NCT01080131|38742658|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
16068718|NCT01080131|38742657|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
16068719|NCT01080131|38742658|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
16068720|NCT01080131|38742657|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
16068721|NCT01080131|38742658|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
16068722|NCT01080131|38742657|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
16370949|NCT00098293|39843458|FG003|Supplemental Phase (SP)|Other|0|||
16447649|NCT02435992|40118714|FG004|Overall Study|Adverse Event|0|||
16447650|NCT02435992|40118710|FG000|Overall Study|Lack of Efficacy|4|||
16447651|NCT02435992|40118711|FG001|Overall Study|Lack of Efficacy|10|||
16370950|NCT00098293|39843459|FG004|Supplemental Phase (SP)|Other|22|||
16447652|NCT02435992|40118712|FG002|Overall Study|Lack of Efficacy|9|||
16068723|NCT01080131|38742658|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
16068724|NCT01080131|38742657|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
16068725|NCT01080131|38742658|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
16068726|NCT01080131|38742657|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
16068727|NCT01080131|38742658|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
16068728|NCT01080131|38742657|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
16068729|NCT01080131|38742658|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
16447653|NCT02435992|40118713|FG003|Overall Study|Lack of Efficacy|0|||
16447654|NCT02435992|40118714|FG004|Overall Study|Lack of Efficacy|0|||
16447655|NCT02435992|40118710|FG000|Overall Study|Withdrawal by Subject|10|||
16447656|NCT02435992|40118711|FG001|Overall Study|Withdrawal by Subject|8|||
16068730|NCT01080131|38742657|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
16068731|NCT01080131|38742658|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
16068732|NCT02930343|38742659|FG000|Overall Study|Lost to Follow-up|9|||
16068733|NCT02930343|38742660|FG001|Overall Study|Lost to Follow-up|7|||
16068734|NCT01450943|38742661|FG000|Overall Study|Screen failure, loss to follow-up|2|||
16068735|NCT01450943|38742662|FG001|Overall Study|Screen failure, loss to follow-up|7|||
16068736|NCT01450943|38742663|FG002|Overall Study|Screen failure, loss to follow-up|6|||
16264694|NCT01597245|39453267|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264695|NCT01597245|39453268|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
16264696|NCT01597245|39453269|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
16264697|NCT01597245|39453270|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264698|NCT01597245|39453271|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16068737|NCT00587288|38742666|FG000|Overall Study|Adverse Event|0|||
16068738|NCT00587288|38742667|FG001|Overall Study|Adverse Event|1|||
16068739|NCT00587288|38742666|FG000|Overall Study|Lack of Efficacy|2|||
16068740|NCT00587288|38742667|FG001|Overall Study|Lack of Efficacy|8|||
16068741|NCT00587288|38742666|FG000|Overall Study|Protocol Violation|1|||
16068742|NCT00587288|38742667|FG001|Overall Study|Protocol Violation|0|||
16068743|NCT02380742|38742668|FG000|Overall Study|Withdrawal by Subject|1|||
16068744|NCT02380742|38742669|FG001|Overall Study|Withdrawal by Subject|0|||
16068745|NCT00906282|38742674|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
16264699|NCT01597245|39453272|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264700|NCT01597245|39453273|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264701|NCT01597245|39453274|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
16264702|NCT01597245|39453254|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264703|NCT01597245|39453255|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264704|NCT01597245|39453256|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16370951|NCT04345601|39843461|FG000|Overall Study|Death|0|||
16370952|NCT04345601|39843462|FG001|Overall Study|Death|3|||
16370953|NCT04345601|39843463|FG002|Overall Study|Death|2|||
16370954|NCT04345601|39843461|FG000|Overall Study|Lost to Follow-up|0|||
16370955|NCT04345601|39843462|FG001|Overall Study|Lost to Follow-up|0|||
16370956|NCT04345601|39843463|FG002|Overall Study|Lost to Follow-up|2|||
16370957|NCT00756314|39843464|FG000|Overall Study|Lost to Follow-up|2|||
16370958|NCT00756314|39843465|FG001|Overall Study|Lost to Follow-up|59|||
16370959|NCT03364686|39843467|FG000|Overall Study|Physician Decision|2|||
16370960|NCT01093885|39843468|FG000|Overall Study|Adverse Event|4|||
16370961|NCT01093885|39843468|FG000|Overall Study|Lost to Follow-up|1|||
16370962|NCT01986751|39843469|FG000|Overall Study|improperly consented|10|||
16370963|NCT01986751|39843470|FG001|Overall Study|improperly consented|2|||
16370964|NCT02453191|39843471|FG000|Overall Study|Withdrawal by Subject|1|||
16370965|NCT00724503|39843472|FG000|Overall Study|Lost to Follow-up|4|||
16370966|NCT00724503|39843473|FG001|Overall Study|Lost to Follow-up|8|||
16370967|NCT00724503|39843472|FG000|Overall Study|Withdrawal by Subject|11|||
16370968|NCT00724503|39843473|FG001|Overall Study|Withdrawal by Subject|23|||
16370969|NCT00724503|39843472|FG000|Overall Study|Death|190|||
16370970|NCT00724503|39843473|FG001|Overall Study|Death|182|||
16370971|NCT00724503|39843472|FG000|Overall Study|Adverse Event|1|||
16370972|NCT00724503|39843473|FG001|Overall Study|Adverse Event|0|||
16447657|NCT02435992|40118712|FG002|Overall Study|Withdrawal by Subject|20|||
16447658|NCT02435992|40118713|FG003|Overall Study|Withdrawal by Subject|0|||
16447659|NCT02435992|40118714|FG004|Overall Study|Withdrawal by Subject|0|||
16447660|NCT02435992|40118710|FG000|Overall Study|Other Reason|1|||
16447661|NCT02435992|40118711|FG001|Overall Study|Other Reason|0|||
16447662|NCT02435992|40118712|FG002|Overall Study|Other Reason|0|||
16068746|NCT00906282|38742674|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
16370973|NCT00724503|39843472|FG000|Overall Study|Not otherwise specified|4|||
16370974|NCT00724503|39843473|FG001|Overall Study|Not otherwise specified|7|||
16447663|NCT02435992|40118713|FG003|Overall Study|Other Reason|0|||
16068747|NCT00906282|38742674|FG000|Preoperative Chemotherapy|Progressive disease|6|||
16068748|NCT00906282|38742674|FG000|Preoperative Chemotherapy|Toxicity|1|||
16068749|NCT03124108|38742677|FG000|Overall Study|Adverse Event|0|||
16370975|NCT02205359|39843474|FG000|Overall Study|Death|293|||
16370976|NCT02205359|39843475|FG001|Overall Study|Death|327|||
16370977|NCT02205359|39843474|FG000|Overall Study|Lost to Follow-up|182|||
16370978|NCT02205359|39843475|FG001|Overall Study|Lost to Follow-up|162|||
16370979|NCT02205359|39843474|FG000|Overall Study|Physician Decision|51|||
16370980|NCT02205359|39843475|FG001|Overall Study|Physician Decision|53|||
16370981|NCT02205359|39843474|FG000|Overall Study|Withdrawal by Subject|167|||
16370982|NCT02205359|39843475|FG001|Overall Study|Withdrawal by Subject|169|||
16370983|NCT02082483|39843476|FG000|Overall Study|Lost to Follow-up|1|||
16370984|NCT02082483|39843477|FG001|Overall Study|Lost to Follow-up|1|||
16370985|NCT02082483|39843476|FG000|Overall Study|Withdrawal by Subject|2|||
16370986|NCT02082483|39843477|FG001|Overall Study|Withdrawal by Subject|1|||
16370987|NCT02082483|39843476|FG000|Overall Study|Physician Decision|1|||
16370988|NCT02082483|39843477|FG001|Overall Study|Physician Decision|1|||
16370989|NCT02082483|39843476|FG000|Overall Study|Death|2|||
16370990|NCT02082483|39843477|FG001|Overall Study|Death|3|||
16370991|NCT01186419|39843478|FG000|Overall Study|Withdrawal by Subject|5|||
16370992|NCT01186419|39843479|FG001|Overall Study|Withdrawal by Subject|3|||
16370993|NCT01186419|39843478|FG000|Overall Study|Adverse Event|1|||
16370994|NCT01186419|39843479|FG001|Overall Study|Adverse Event|2|||
16370995|NCT01186419|39843478|FG000|Overall Study|Physician Decision|0|||
16370996|NCT01186419|39843479|FG001|Overall Study|Physician Decision|3|||
16370997|NCT01186419|39843478|FG000|Overall Study|Other|1|||
16370998|NCT01186419|39843479|FG001|Overall Study|Other|1|||
16370999|NCT00923702|39843480|FG000|Overall Study|Ongoing enrollment|0|||
16371000|NCT00923702|39843481|FG001|Overall Study|Ongoing enrollment|0|||
16371001|NCT00923702|39843482|FG002|Overall Study|Ongoing enrollment|0|||
16371002|NCT00923702|39843483|FG003|Overall Study|Ongoing enrollment|0|||
16371003|NCT00923702|39843484|FG004|Overall Study|Ongoing enrollment|354|||
16371004|NCT01896986|39843485|FG000|Overall Study|samples lost|14|||
16371005|NCT01896986|39843486|FG001|Overall Study|samples lost|23|||
16371006|NCT01570192|39843489|FG000|Overall Study|no qualifying organism|6|||
16371007|NCT01570192|39843490|FG001|Overall Study|no qualifying organism|12|||
16371008|NCT01570192|39843489|FG000|Overall Study|changed to palliative care|1|||
16371009|NCT01570192|39843490|FG001|Overall Study|changed to palliative care|0|||
16371010|NCT01570192|39843489|FG000|Overall Study|Physician Decision|0|||
16068750|NCT03124108|38742678|FG001|Overall Study|Adverse Event|1|||
16068751|NCT03124108|38742679|FG002|Overall Study|Adverse Event|0|||
16068752|NCT00777556|38742680|FG000|Overall Study|Inappropriate self-selection|34|||
16068753|NCT00777556|38742680|FG000|Overall Study|Dispensed but did not use product|12|||
16068754|NCT00777556|38742680|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
16068755|NCT00975806|38742683|FG000|Overall Study|Adverse Event|2|||
16068756|NCT00975806|38742684|FG001|Overall Study|Adverse Event|1|||
16068757|NCT00975806|38742685|FG002|Overall Study|Adverse Event|2|||
16068758|NCT00975806|38742683|FG000|Overall Study|Disease Progression|1|||
16068759|NCT00975806|38742684|FG001|Overall Study|Disease Progression|5|||
16068760|NCT00975806|38742685|FG002|Overall Study|Disease Progression|1|||
16068761|NCT00975806|38742683|FG000|Overall Study|Withdrawal by Subject|1|||
16068762|NCT00975806|38742684|FG001|Overall Study|Withdrawal by Subject|0|||
16068763|NCT00975806|38742685|FG002|Overall Study|Withdrawal by Subject|0|||
16068764|NCT00975806|38742683|FG000|Overall Study|Death|0|||
16068765|NCT00975806|38742684|FG001|Overall Study|Death|1|||
16068766|NCT00975806|38742685|FG002|Overall Study|Death|0|||
16068767|NCT00975806|38742683|FG000|Overall Study|Physician decision and disease related|1|||
16068768|NCT00975806|38742684|FG001|Overall Study|Physician decision and disease related|0|||
16068769|NCT00975806|38742685|FG002|Overall Study|Physician decision and disease related|1|||
16068770|NCT00354029|38742687|FG000|Overall Study|Protocol Violation|4|||
16068771|NCT00354029|38742688|FG001|Overall Study|Protocol Violation|2|||
16068772|NCT01414166|38742689|FG000|Overall Study|Adverse Event|10|||
16068773|NCT01414166|38742690|FG001|Overall Study|Adverse Event|2|||
16068774|NCT01414166|38742689|FG000|Overall Study|Lost to Follow-up|4|||
16068775|NCT01414166|38742690|FG001|Overall Study|Lost to Follow-up|1|||
16068776|NCT01414166|38742689|FG000|Overall Study|Non-compliance with study drug|2|||
16068777|NCT01414166|38742690|FG001|Overall Study|Non-compliance with study drug|0|||
16068778|NCT01414166|38742689|FG000|Overall Study|Physician Decision|2|||
16068779|NCT01414166|38742690|FG001|Overall Study|Physician Decision|0|||
16068780|NCT01414166|38742689|FG000|Overall Study|Protocol Violation|2|||
16068781|NCT01414166|38742690|FG001|Overall Study|Protocol Violation|0|||
16068782|NCT01414166|38742689|FG000|Overall Study|Study terminated by Sponsor|68|||
16068783|NCT01414166|38742690|FG001|Overall Study|Study terminated by Sponsor|75|||
16068784|NCT01414166|38742689|FG000|Overall Study|Withdrawal by Subject|3|||
16371011|NCT01570192|39843490|FG001|Overall Study|Physician Decision|1|||
16371012|NCT01520714|39843491|FG000|Overall Study|Protocol Violation|0|||
16068785|NCT01414166|38742690|FG001|Overall Study|Withdrawal by Subject|5|||
16371013|NCT01520714|39843492|FG001|Overall Study|Protocol Violation|3|||
16371014|NCT01520714|39843491|FG000|Overall Study|Adverse Event|0|||
16371015|NCT01520714|39843492|FG001|Overall Study|Adverse Event|2|||
16371016|NCT01520714|39843491|FG000|Overall Study|Lack of Efficacy|0|||
16371017|NCT01520714|39843492|FG001|Overall Study|Lack of Efficacy|1|||
16371018|NCT02545127|39843495|FG000|Overall Study|Lost to Follow-up|1|||
16264705|NCT01597245|39453257|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264706|NCT01597245|39453258|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264707|NCT01597245|39453259|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264708|NCT01597245|39453260|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264709|NCT01597245|39453261|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264710|NCT01597245|39453262|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264711|NCT01597245|39453263|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264712|NCT01597245|39453264|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264713|NCT01597245|39453265|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264714|NCT01597245|39453266|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264715|NCT01597245|39453267|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264716|NCT01597245|39453268|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
16264717|NCT01597245|39453269|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
16264718|NCT01597245|39453270|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264719|NCT01597245|39453271|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264720|NCT01597245|39453272|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264721|NCT01597245|39453273|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264722|NCT01597245|39453274|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
16264723|NCT01597245|39453254|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264724|NCT01597245|39453255|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264725|NCT01597245|39453256|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264726|NCT01597245|39453257|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264727|NCT01597245|39453258|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264728|NCT01597245|39453259|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264729|NCT01597245|39453260|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264730|NCT01597245|39453261|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16068786|NCT01311713|38742691|FG000|Overall Study|Death|0|||
16068787|NCT01311713|38742692|FG001|Overall Study|Death|0|||
16068788|NCT01311713|38742693|FG002|Overall Study|Death|1|||
16068789|NCT01311713|38742694|FG003|Overall Study|Death|1|||
16068790|NCT01311713|38742695|FG004|Overall Study|Death|0|||
16068791|NCT01311713|38742696|FG005|Overall Study|Death|1|||
16264731|NCT01597245|39453262|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264732|NCT01597245|39453263|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16447664|NCT02435992|40118714|FG004|Overall Study|Other Reason|0|||
16447665|NCT02435992|40118710|FG000|Overall Study|Physician Decision|0|||
16447666|NCT02435992|40118711|FG001|Overall Study|Physician Decision|0|||
16447667|NCT02435992|40118712|FG002|Overall Study|Physician Decision|1|||
16447668|NCT02435992|40118713|FG003|Overall Study|Physician Decision|0|||
16447669|NCT02435992|40118714|FG004|Overall Study|Physician Decision|0|||
16447670|NCT03137381|40118716|FG000|Overall Study|Adverse Event|3|||
16447671|NCT03137381|40118717|FG001|Overall Study|Adverse Event|0|||
16447672|NCT03137381|40118718|FG002|Overall Study|Adverse Event|2|||
16447673|NCT03137381|40118719|FG003|Overall Study|Adverse Event|0|||
16447674|NCT03137381|40118716|FG000|Overall Study|Lost to Follow-up|2|||
16447675|NCT03137381|40118717|FG001|Overall Study|Lost to Follow-up|1|||
16447676|NCT03137381|40118718|FG002|Overall Study|Lost to Follow-up|1|||
16068792|NCT01311713|38742697|FG006|Overall Study|Death|0|||
16068793|NCT01311713|38742691|FG000|Overall Study|Adverse Event|0|||
16068794|NCT01311713|38742692|FG001|Overall Study|Adverse Event|1|||
16068795|NCT01311713|38742693|FG002|Overall Study|Adverse Event|0|||
16068796|NCT01311713|38742694|FG003|Overall Study|Adverse Event|2|||
16068797|NCT01311713|38742695|FG004|Overall Study|Adverse Event|0|||
16068798|NCT01311713|38742696|FG005|Overall Study|Adverse Event|0|||
16447677|NCT03137381|40118719|FG003|Overall Study|Lost to Follow-up|0|||
16447678|NCT03137381|40118716|FG000|Overall Study|Protocol deviation|1|||
16447679|NCT03137381|40118717|FG001|Overall Study|Protocol deviation|1|||
16447680|NCT03137381|40118718|FG002|Overall Study|Protocol deviation|0|||
16447681|NCT03137381|40118719|FG003|Overall Study|Protocol deviation|1|||
16447682|NCT03137381|40118716|FG000|Overall Study|Withdrawal by Investigator|0|||
16447683|NCT03137381|40118717|FG001|Overall Study|Withdrawal by Investigator|1|||
16447684|NCT03137381|40118718|FG002|Overall Study|Withdrawal by Investigator|1|||
16447685|NCT03137381|40118719|FG003|Overall Study|Withdrawal by Investigator|0|||
16447686|NCT03137381|40118716|FG000|Overall Study|Withdrawal by Subject|3|||
16447687|NCT03137381|40118717|FG001|Overall Study|Withdrawal by Subject|4|||
16447688|NCT03137381|40118718|FG002|Overall Study|Withdrawal by Subject|3|||
16447689|NCT03137381|40118719|FG003|Overall Study|Withdrawal by Subject|0|||
16068799|NCT01311713|38742697|FG006|Overall Study|Adverse Event|2|||
16068800|NCT01311713|38742691|FG000|Overall Study|Withdrawal by Subject|0|||
16447690|NCT03137381|40118716|FG000|Overall Study|Pregnancy|0|||
16068801|NCT01311713|38742692|FG001|Overall Study|Withdrawal by Subject|1|||
16068802|NCT01311713|38742693|FG002|Overall Study|Withdrawal by Subject|1|||
16447691|NCT03137381|40118717|FG001|Overall Study|Pregnancy|0|||
16447692|NCT03137381|40118718|FG002|Overall Study|Pregnancy|1|||
16068803|NCT01311713|38742694|FG003|Overall Study|Withdrawal by Subject|0|||
16371019|NCT02545127|39843496|FG001|Overall Study|Lost to Follow-up|0|||
16371020|NCT02547987|39843497|FG000|Overall Study|Withdrawal by Subject|1|||
16371021|NCT02547987|39843497|FG000|Overall Study|Adverse Event|2|||
16371022|NCT00964678|39843498|FG000|Overall Study|Physician Decision|4|||
16371023|NCT00303628|39843505|FG000|Overall Study|Disease progression|0|||
16371024|NCT00303628|39843506|FG001|Overall Study|Disease progression|1|||
16371025|NCT00303628|39843505|FG000|Overall Study|Adverse Event|26|||
16371026|NCT00303628|39843506|FG001|Overall Study|Adverse Event|36|||
16371027|NCT00303628|39843505|FG000|Overall Study|Death|0|||
16371028|NCT00303628|39843506|FG001|Overall Study|Death|1|||
16371029|NCT00303628|39843505|FG000|Overall Study|Withdrawal by Subject|11|||
16371030|NCT00303628|39843506|FG001|Overall Study|Withdrawal by Subject|20|||
16371031|NCT00303628|39843505|FG000|Overall Study|Alternative therapy|2|||
16371032|NCT00303628|39843506|FG001|Overall Study|Alternative therapy|0|||
16371033|NCT00303628|39843505|FG000|Overall Study|Other complicating disease|0|||
16371034|NCT00303628|39843506|FG001|Overall Study|Other complicating disease|1|||
16371035|NCT00303628|39843505|FG000|Overall Study|Not start protocol therapy|3|||
16371036|NCT00303628|39843506|FG001|Overall Study|Not start protocol therapy|5|||
16371037|NCT00303628|39843505|FG000|Overall Study|Other|8|||
16371038|NCT00303628|39843506|FG001|Overall Study|Other|9|||
16371039|NCT03412890|39843508|FG000|Overall Study|Adverse Event|5|||
16371040|NCT03412890|39843509|FG001|Overall Study|Adverse Event|5|||
16371041|NCT03412890|39843510|FG002|Overall Study|Adverse Event|9|||
16371042|NCT03412890|39843508|FG000|Overall Study|Protocol deviation|2|||
16371043|NCT03412890|39843509|FG001|Overall Study|Protocol deviation|1|||
16447693|NCT03137381|40118719|FG003|Overall Study|Pregnancy|0|||
16447694|NCT01747876|40118720|FG000|Overall Study|Adverse Event|1|||
16447695|NCT01747876|40118721|FG001|Overall Study|Adverse Event|0|||
16447696|NCT01747876|40118722|FG002|Overall Study|Adverse Event|2|||
16447697|NCT01747876|40118720|FG000|Overall Study|Withdrawal by Subject|0|||
16447698|NCT01747876|40118721|FG001|Overall Study|Withdrawal by Subject|1|||
16447699|NCT01747876|40118722|FG002|Overall Study|Withdrawal by Subject|1|||
16447700|NCT01747876|40118720|FG000|Overall Study|Disease progression|4|||
16447701|NCT01747876|40118721|FG001|Overall Study|Disease progression|13|||
16447702|NCT01747876|40118722|FG002|Overall Study|Disease progression|8|||
16447703|NCT01747876|40118720|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
16447704|NCT01747876|40118721|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
16447705|NCT01747876|40118722|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
16447706|NCT01120964|40118730|FG000|Overall Study|Did not receive full treatment|1|||
16447707|NCT01120964|40118731|FG001|Overall Study|Did not receive full treatment|0|||
16447708|NCT04551963|40118732|FG000|Overall Study|Physician Decision|1|||
16447709|NCT04551963|40118733|FG001|Overall Study|Physician Decision|1|||
16447710|NCT04551963|40118732|FG000|Overall Study|Death|1|||
16447711|NCT04551963|40118733|FG001|Overall Study|Death|0|||
16447712|NCT03682770|40118740|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
16447713|NCT03682770|40118741|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
16447714|NCT03682770|40118742|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
16447715|NCT03682770|40118743|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
16371044|NCT03412890|39843510|FG002|Overall Study|Protocol deviation|2|||
16371045|NCT03412890|39843508|FG000|Overall Study|Lost to Follow-up|7|||
16371046|NCT03412890|39843509|FG001|Overall Study|Lost to Follow-up|10|||
16371047|NCT03412890|39843510|FG002|Overall Study|Lost to Follow-up|10|||
16371048|NCT03412890|39843508|FG000|Overall Study|Withdrawal by Subject|9|||
16371049|NCT03412890|39843509|FG001|Overall Study|Withdrawal by Subject|12|||
16371050|NCT03412890|39843510|FG002|Overall Study|Withdrawal by Subject|11|||
16371051|NCT03412890|39843508|FG000|Overall Study|Lack of Efficacy|2|||
16371052|NCT03412890|39843509|FG001|Overall Study|Lack of Efficacy|7|||
16371053|NCT03412890|39843510|FG002|Overall Study|Lack of Efficacy|5|||
16371054|NCT03412890|39843508|FG000|Overall Study|Other|5|||
16068804|NCT01311713|38742695|FG004|Overall Study|Withdrawal by Subject|0|||
16371055|NCT03412890|39843509|FG001|Overall Study|Other|6|||
16371056|NCT03412890|39843510|FG002|Overall Study|Other|5|||
16068805|NCT01311713|38742696|FG005|Overall Study|Withdrawal by Subject|1|||
16371057|NCT03412890|39843508|FG000|Overall Study|Participants who did not receive any study drug|0|||
16371058|NCT03412890|39843509|FG001|Overall Study|Participants who did not receive any study drug|1|||
16371059|NCT03412890|39843510|FG002|Overall Study|Participants who did not receive any study drug|0|||
16371060|NCT00215553|39843511|FG000|Overall Study|Adverse Event|0|||
16371061|NCT00215553|39843512|FG001|Overall Study|Adverse Event|1|||
16371062|NCT00215553|39843513|FG002|Overall Study|Adverse Event|2|||
16371063|NCT00215553|39843514|FG003|Overall Study|Adverse Event|1|||
16447716|NCT03682770|40118744|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
16371064|NCT00215553|39843515|FG004|Overall Study|Adverse Event|2|||
16371065|NCT00215553|39843516|FG005|Overall Study|Adverse Event|6|||
16371066|NCT00215553|39843517|FG006|Overall Study|Adverse Event|0|||
16371067|NCT03312907|39843518|FG000|Overall Study|Adverse Event|1|||
16371068|NCT03312907|39843519|FG001|Overall Study|Adverse Event|6|||
16068806|NCT01311713|38742697|FG006|Overall Study|Withdrawal by Subject|2|||
16068807|NCT01311713|38742691|FG000|Overall Study|Disease progression|3|||
16068808|NCT01311713|38742692|FG001|Overall Study|Disease progression|4|||
16068809|NCT01311713|38742693|FG002|Overall Study|Disease progression|3|||
16068810|NCT01311713|38742694|FG003|Overall Study|Disease progression|2|||
16068811|NCT01311713|38742695|FG004|Overall Study|Disease progression|4|||
16068812|NCT01311713|38742696|FG005|Overall Study|Disease progression|4|||
16068813|NCT01311713|38742697|FG006|Overall Study|Disease progression|5|||
16068814|NCT01311713|38742691|FG000|Overall Study|Lost to Follow-up|0|||
16068815|NCT01311713|38742692|FG001|Overall Study|Lost to Follow-up|0|||
16068816|NCT01311713|38742693|FG002|Overall Study|Lost to Follow-up|1|||
16068817|NCT01311713|38742694|FG003|Overall Study|Lost to Follow-up|0|||
16068818|NCT01311713|38742695|FG004|Overall Study|Lost to Follow-up|0|||
16068819|NCT01311713|38742696|FG005|Overall Study|Lost to Follow-up|0|||
16068820|NCT01311713|38742697|FG006|Overall Study|Lost to Follow-up|0|||
16068821|NCT01311713|38742691|FG000|Overall Study|Stopped taking study medication|0|||
16068822|NCT01311713|38742692|FG001|Overall Study|Stopped taking study medication|0|||
16068823|NCT01311713|38742693|FG002|Overall Study|Stopped taking study medication|0|||
16068824|NCT01311713|38742694|FG003|Overall Study|Stopped taking study medication|1|||
16068825|NCT01311713|38742695|FG004|Overall Study|Stopped taking study medication|1|||
16068826|NCT01311713|38742696|FG005|Overall Study|Stopped taking study medication|0|||
16068827|NCT01311713|38742697|FG006|Overall Study|Stopped taking study medication|0|||
16068828|NCT01311713|38742691|FG000|Overall Study|Enrolled but not treated|0|||
16068829|NCT01311713|38742692|FG001|Overall Study|Enrolled but not treated|0|||
16068830|NCT01311713|38742693|FG002|Overall Study|Enrolled but not treated|1|||
16068831|NCT01311713|38742694|FG003|Overall Study|Enrolled but not treated|0|||
16068832|NCT01311713|38742695|FG004|Overall Study|Enrolled but not treated|0|||
16068833|NCT01311713|38742696|FG005|Overall Study|Enrolled but not treated|0|||
16371069|NCT03312907|39843520|FG002|Overall Study|Adverse Event|1|||
16371070|NCT03312907|39843518|FG000|Overall Study|Protocol Violation|2|||
16371071|NCT03312907|39843519|FG001|Overall Study|Protocol Violation|3|||
16371072|NCT03312907|39843520|FG002|Overall Study|Protocol Violation|4|||
16371073|NCT03312907|39843518|FG000|Overall Study|Lost to Follow-up|2|||
16371074|NCT03312907|39843519|FG001|Overall Study|Lost to Follow-up|3|||
16371075|NCT03312907|39843520|FG002|Overall Study|Lost to Follow-up|2|||
16371076|NCT03312907|39843518|FG000|Overall Study|Physician Decision|3|||
16371077|NCT03312907|39843519|FG001|Overall Study|Physician Decision|4|||
16371078|NCT03312907|39843520|FG002|Overall Study|Physician Decision|2|||
16371079|NCT03312907|39843518|FG000|Overall Study|Withdrawal by Subject|9|||
16371080|NCT03312907|39843519|FG001|Overall Study|Withdrawal by Subject|14|||
16371081|NCT03312907|39843520|FG002|Overall Study|Withdrawal by Subject|10|||
16371082|NCT04807400|39843521|FG000|Overall Study|Adverse Event|2|||
16371083|NCT04807400|39843522|FG001|Overall Study|Adverse Event|3|||
16371084|NCT04807400|39843523|FG002|Overall Study|Adverse Event|3|||
16371085|NCT04807400|39843521|FG000|Overall Study|Death|2|||
16371086|NCT04807400|39843522|FG001|Overall Study|Death|0|||
16371087|NCT04807400|39843523|FG002|Overall Study|Death|0|||
16371088|NCT04807400|39843521|FG000|Overall Study|Lost to Follow-up|8|||
16371089|NCT04807400|39843522|FG001|Overall Study|Lost to Follow-up|6|||
16371090|NCT04807400|39843523|FG002|Overall Study|Lost to Follow-up|6|||
16371091|NCT04807400|39843521|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16371092|NCT04807400|39843522|FG001|Overall Study|Non-Compliance With Study Drug|4|||
16371093|NCT04807400|39843523|FG002|Overall Study|Non-Compliance With Study Drug|1|||
16371094|NCT04807400|39843521|FG000|Overall Study|Participant Decision|20|||
16371095|NCT04807400|39843522|FG001|Overall Study|Participant Decision|19|||
16371096|NCT04807400|39843523|FG002|Overall Study|Participant Decision|26|||
16371097|NCT04807400|39843521|FG000|Overall Study|Physician Decision|0|||
16371098|NCT04807400|39843522|FG001|Overall Study|Physician Decision|1|||
16371099|NCT04807400|39843523|FG002|Overall Study|Physician Decision|0|||
16371100|NCT04807400|39843521|FG000|Overall Study|Protocol Violation|4|||
16371101|NCT04807400|39843522|FG001|Overall Study|Protocol Violation|3|||
16371102|NCT04807400|39843523|FG002|Overall Study|Protocol Violation|7|||
16371103|NCT04807400|39843521|FG000|Overall Study|Withdrawal by Subject|13|||
16371104|NCT04807400|39843522|FG001|Overall Study|Withdrawal by Subject|9|||
16371105|NCT04807400|39843523|FG002|Overall Study|Withdrawal by Subject|20|||
16371106|NCT04807400|39843521|FG000|Overall Study|Mis-randomized|1|||
16371107|NCT04807400|39843522|FG001|Overall Study|Mis-randomized|0|||
16371108|NCT04807400|39843523|FG002|Overall Study|Mis-randomized|0|||
16371109|NCT00128492|39843524|FG000|Overall Study|AE unrelated to study|2|||
16371110|NCT00128492|39843525|FG001|Overall Study|AE unrelated to study|9|||
16371111|NCT00128492|39843524|FG000|Overall Study|Study drug intolerance (AE)|2|||
16068834|NCT01311713|38742697|FG006|Overall Study|Enrolled but not treated|0|||
16068835|NCT01311713|38742691|FG000|Overall Study|Other than specified|0|||
16371112|NCT00128492|39843525|FG001|Overall Study|Study drug intolerance (AE)|8|||
16371113|NCT00128492|39843524|FG000|Overall Study|AE related to study|1|||
16371114|NCT00128492|39843525|FG001|Overall Study|AE related to study|4|||
16371115|NCT00128492|39843524|FG000|Overall Study|Death|1|||
16371116|NCT00128492|39843525|FG001|Overall Study|Death|0|||
16161003|NCT03403205|39072271|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
16161004|NCT03403205|39072272|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
16161005|NCT03403205|39072267|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
16161006|NCT03403205|39072268|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
16161007|NCT03403205|39072269|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
16161008|NCT03403205|39072270|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
16161009|NCT03403205|39072271|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
16161010|NCT03403205|39072272|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
16161011|NCT03403205|39072267|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
16161012|NCT03403205|39072268|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
16161013|NCT03403205|39072269|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
16161014|NCT03403205|39072270|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
16161015|NCT03403205|39072271|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
16161016|NCT03403205|39072272|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
16161017|NCT03403205|39072267|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
16161018|NCT03403205|39072268|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
16161019|NCT03403205|39072269|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
16161020|NCT03403205|39072270|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
16161021|NCT03403205|39072271|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
16161022|NCT03403205|39072272|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
16264733|NCT01597245|39453264|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264734|NCT01597245|39453265|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264735|NCT01597245|39453266|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264736|NCT01597245|39453267|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
16264737|NCT01597245|39453268|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
16264738|NCT01597245|39453269|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
16161023|NCT03403205|39072267|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
16161024|NCT03403205|39072268|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
16161025|NCT03403205|39072269|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
16264739|NCT01597245|39453270|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264740|NCT01597245|39453271|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264741|NCT01597245|39453272|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264742|NCT01597245|39453273|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264743|NCT01597245|39453274|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
16264744|NCT01597245|39453254|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264745|NCT01597245|39453255|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264746|NCT01597245|39453256|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264747|NCT01597245|39453257|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264748|NCT01597245|39453258|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264749|NCT01597245|39453259|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264750|NCT01597245|39453260|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264751|NCT01597245|39453261|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264752|NCT01597245|39453262|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264753|NCT01597245|39453263|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264754|NCT01597245|39453264|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264755|NCT01597245|39453265|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264756|NCT01597245|39453266|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264757|NCT01597245|39453267|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264758|NCT01597245|39453268|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
16264759|NCT01597245|39453269|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
16264760|NCT01597245|39453270|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264761|NCT01597245|39453271|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264762|NCT01597245|39453272|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264763|NCT01597245|39453273|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
16264764|NCT01597245|39453274|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
16371117|NCT00128492|39843524|FG000|Overall Study|Lost to Follow-up|1|||
16371118|NCT00128492|39843525|FG001|Overall Study|Lost to Follow-up|5|||
16371119|NCT00128492|39843524|FG000|Overall Study|Noncompliance|0|||
16371120|NCT00128492|39843525|FG001|Overall Study|Noncompliance|5|||
16371121|NCT00128492|39843524|FG000|Overall Study|Personal or administrative|10|||
16371122|NCT00128492|39843525|FG001|Overall Study|Personal or administrative|22|||
16371123|NCT00128492|39843524|FG000|Overall Study|Withdrawal by Subject|3|||
16371124|NCT00128492|39843525|FG001|Overall Study|Withdrawal by Subject|5|||
16371125|NCT00128492|39843524|FG000|Overall Study|Pregnancy|0|||
16371126|NCT00128492|39843525|FG001|Overall Study|Pregnancy|1|||
16371127|NCT00862277|39843526|FG000|Overall Study|Protocol Violation|1|||
16371128|NCT00862277|39843527|FG001|Overall Study|Protocol Violation|2|||
16371129|NCT00862277|39843528|FG002|Overall Study|Protocol Violation|5|||
16371130|NCT02400580|39843529|FG000|Overall Study|Withdrawal by Subject|1|||
16161026|NCT03403205|39072270|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
16161027|NCT03403205|39072271|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
16161028|NCT03403205|39072272|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
16161029|NCT03403205|39072267|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
16161030|NCT03403205|39072268|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
16161031|NCT03403205|39072269|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
16161032|NCT03403205|39072270|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
16161033|NCT03403205|39072271|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
16161034|NCT03403205|39072272|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
16161035|NCT03403205|39072267|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
16068836|NCT01311713|38742692|FG001|Overall Study|Other than specified|1|||
16068837|NCT01311713|38742693|FG002|Overall Study|Other than specified|2|||
16447717|NCT03682770|40118745|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
16447718|NCT03682770|40118746|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
16447719|NCT03682770|40118740|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
16447720|NCT03682770|40118741|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
16447721|NCT03682770|40118742|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
16447722|NCT03682770|40118743|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
16447723|NCT03682770|40118744|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
16447724|NCT03682770|40118745|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
16447725|NCT03682770|40118746|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
16447726|NCT03682770|40118740|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
16161036|NCT03403205|39072268|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
16161037|NCT03403205|39072269|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
16161038|NCT03403205|39072270|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
16161039|NCT03403205|39072271|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
16161040|NCT03403205|39072272|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
16161041|NCT03403205|39072267|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
16161042|NCT03403205|39072268|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
16161043|NCT03403205|39072269|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
16161044|NCT03403205|39072270|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
16161045|NCT03403205|39072271|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
16161046|NCT03403205|39072272|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
16161047|NCT03403205|39072267|FG000|Extension Period (Up to 60 Months)|Death|1|||
16161048|NCT03403205|39072268|FG001|Extension Period (Up to 60 Months)|Death|0|||
16161049|NCT03403205|39072269|FG002|Extension Period (Up to 60 Months)|Death|0|||
16161050|NCT03403205|39072270|FG003|Extension Period (Up to 60 Months)|Death|0|||
16161051|NCT03403205|39072271|FG004|Extension Period (Up to 60 Months)|Death|0|||
16161052|NCT03403205|39072272|FG005|Extension Period (Up to 60 Months)|Death|0|||
16161053|NCT03403205|39072267|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
16447727|NCT03682770|40118741|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
16447728|NCT03682770|40118742|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
16447729|NCT03682770|40118743|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
16447730|NCT03682770|40118744|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
16068838|NCT01311713|38742694|FG003|Overall Study|Other than specified|0|||
16068839|NCT01311713|38742695|FG004|Overall Study|Other than specified|0|||
16068840|NCT01311713|38742696|FG005|Overall Study|Other than specified|0|||
16068841|NCT01311713|38742697|FG006|Overall Study|Other than specified|0|||
16068842|NCT01744691|38742698|FG000|Overall Study|Progressive Disease|18|||
16068843|NCT01744691|38742698|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
16068844|NCT01744691|38742698|FG000|Overall Study|Withdrawal of consent for treatment|3|||
16068845|NCT01744691|38742698|FG000|Overall Study|Physician Decision|4|||
16068846|NCT03586544|38742699|FG000|First Intervention|Adverse Event|0|||
16068847|NCT03586544|38742700|FG001|First Intervention|Adverse Event|1|||
16068848|NCT03586544|38742699|FG000|Second Intervention|Withdrawal by Subject|0|||
16068849|NCT03586544|38742700|FG001|Second Intervention|Withdrawal by Subject|1|||
16068850|NCT00567879|38742704|FG000|Overall Study|Adverse Event|2|||
16068851|NCT00567879|38742705|FG001|Overall Study|Adverse Event|0|||
16068852|NCT00567879|38742706|FG002|Overall Study|Adverse Event|1|||
16068853|NCT00567879|38742707|FG003|Overall Study|Adverse Event|0|||
16068854|NCT00567879|38742708|FG004|Overall Study|Adverse Event|1|||
16068855|NCT00567879|38742709|FG005|Overall Study|Adverse Event|0|||
16068856|NCT00567879|38742704|FG000|Overall Study|Abnormal test procedure(s)|0|||
16068857|NCT00567879|38742705|FG001|Overall Study|Abnormal test procedure(s)|0|||
16068858|NCT00567879|38742706|FG002|Overall Study|Abnormal test procedure(s)|1|||
16068859|NCT00567879|38742707|FG003|Overall Study|Abnormal test procedure(s)|0|||
16068860|NCT00567879|38742708|FG004|Overall Study|Abnormal test procedure(s)|0|||
16161054|NCT03403205|39072268|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
16161055|NCT03403205|39072269|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
16161056|NCT03403205|39072270|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
16161057|NCT03403205|39072271|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
16161058|NCT03403205|39072272|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
16161059|NCT03403205|39072267|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
16161060|NCT03403205|39072268|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
16161061|NCT03403205|39072269|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
16161062|NCT03403205|39072270|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
16161063|NCT03403205|39072271|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
16161064|NCT03403205|39072272|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
16161065|NCT03403205|39072267|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
16161066|NCT03403205|39072268|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
16161067|NCT03403205|39072269|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
16161068|NCT03403205|39072270|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
16161069|NCT03403205|39072271|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
16161070|NCT03403205|39072272|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
16161071|NCT03403205|39072267|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
16161072|NCT03403205|39072268|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
16161073|NCT03403205|39072269|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
16161074|NCT03403205|39072270|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
16161075|NCT03403205|39072271|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
16161076|NCT03403205|39072272|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
16161077|NCT03403205|39072267|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
16161078|NCT03403205|39072268|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
16161079|NCT03403205|39072269|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
16161080|NCT03403205|39072270|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
16161081|NCT03403205|39072271|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
16161082|NCT03403205|39072272|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
16161083|NCT03403205|39072267|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
16264765|NCT01597245|39453254|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264766|NCT01597245|39453255|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264767|NCT01597245|39453256|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264768|NCT01597245|39453257|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16068861|NCT00567879|38742709|FG005|Overall Study|Abnormal test procedure(s)|0|||
16068862|NCT00567879|38742704|FG000|Overall Study|Withdrawal by Subject|0|||
16068863|NCT00567879|38742705|FG001|Overall Study|Withdrawal by Subject|0|||
16068864|NCT00567879|38742706|FG002|Overall Study|Withdrawal by Subject|3|||
16068865|NCT00567879|38742707|FG003|Overall Study|Withdrawal by Subject|1|||
16068866|NCT00567879|38742708|FG004|Overall Study|Withdrawal by Subject|0|||
16068867|NCT00567879|38742709|FG005|Overall Study|Withdrawal by Subject|0|||
16068868|NCT00567879|38742704|FG000|Overall Study|New cancer therapy|0|||
16068869|NCT00567879|38742705|FG001|Overall Study|New cancer therapy|0|||
16068870|NCT00567879|38742706|FG002|Overall Study|New cancer therapy|1|||
16068871|NCT00567879|38742707|FG003|Overall Study|New cancer therapy|0|||
16068872|NCT00567879|38742708|FG004|Overall Study|New cancer therapy|0|||
16068873|NCT00567879|38742709|FG005|Overall Study|New cancer therapy|0|||
16068874|NCT00567879|38742704|FG000|Overall Study|Disease progression|5|||
16068875|NCT00567879|38742705|FG001|Overall Study|Disease progression|7|||
16068876|NCT00567879|38742706|FG002|Overall Study|Disease progression|15|||
16068877|NCT00567879|38742707|FG003|Overall Study|Disease progression|5|||
16068878|NCT00567879|38742708|FG004|Overall Study|Disease progression|11|||
16068879|NCT00567879|38742709|FG005|Overall Study|Disease progression|3|||
16068880|NCT02289560|38742713|FG000|Overall Study|Lost to Follow-up|6|||
16068881|NCT02289560|38742713|FG000|Overall Study|Alternative Treatment|4|||
16068882|NCT02289560|38742713|FG000|Overall Study|Inadequate Treatment|2|||
16068883|NCT02289560|38742713|FG000|Overall Study|Withdrawal by Subject|23|||
16068884|NCT01007149|38742716|FG000|Overall Study|Administrative problems|0|||
16068885|NCT01007149|38742717|FG001|Overall Study|Administrative problems|1|||
16068886|NCT00389519|38742718|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
16068887|NCT00389519|38742719|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
16068888|NCT00389519|38742720|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
16068889|NCT00389519|38742721|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
16068890|NCT00389519|38742718|FG000|Placebo Run-In|Withdrawal by Subject|19|||
16068891|NCT00389519|38742719|FG001|Placebo Run-In|Withdrawal by Subject|0|||
16068892|NCT00389519|38742720|FG002|Placebo Run-In|Withdrawal by Subject|0|||
16068893|NCT00389519|38742721|FG003|Placebo Run-In|Withdrawal by Subject|0|||
16068894|NCT00389519|38742718|FG000|Placebo Run-In|Reason not specified|40|||
16068895|NCT00389519|38742719|FG001|Placebo Run-In|Reason not specified|0|||
16161084|NCT03403205|39072268|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
16068896|NCT00389519|38742720|FG002|Placebo Run-In|Reason not specified|0|||
16068897|NCT00389519|38742721|FG003|Placebo Run-In|Reason not specified|0|||
16068898|NCT00389519|38742718|FG000|Randomized|Did not receive study drug|2|||
16068899|NCT00389519|38742719|FG001|Randomized|Did not receive study drug|0|||
16068900|NCT00389519|38742720|FG002|Randomized|Did not receive study drug|0|||
16068901|NCT00389519|38742721|FG003|Randomized|Did not receive study drug|0|||
16068902|NCT00389519|38742718|FG000|Treated|Adverse Event|1|||
16264769|NCT01597245|39453258|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264770|NCT01597245|39453259|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264771|NCT01597245|39453260|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264772|NCT01597245|39453261|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264773|NCT01597245|39453262|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264774|NCT01597245|39453263|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264775|NCT01597245|39453264|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264776|NCT01597245|39453265|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264777|NCT01597245|39453266|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264778|NCT01597245|39453267|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264779|NCT01597245|39453268|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
16264780|NCT01597245|39453269|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
16264781|NCT01597245|39453270|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264782|NCT01597245|39453271|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264783|NCT01597245|39453272|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264784|NCT01597245|39453273|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264785|NCT01597245|39453274|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
16264786|NCT01597245|39453254|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264787|NCT01597245|39453255|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264788|NCT01597245|39453256|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264789|NCT01597245|39453257|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264790|NCT01597245|39453258|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264791|NCT01597245|39453259|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264792|NCT01597245|39453260|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264793|NCT01597245|39453261|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264794|NCT01597245|39453262|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264795|NCT01597245|39453263|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264796|NCT01597245|39453264|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264797|NCT01597245|39453265|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264798|NCT01597245|39453266|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264799|NCT01597245|39453267|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264800|NCT01597245|39453268|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
16264801|NCT01597245|39453269|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
16264802|NCT01597245|39453270|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264803|NCT01597245|39453271|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264804|NCT01597245|39453272|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264805|NCT01597245|39453273|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264806|NCT01597245|39453274|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
16264807|NCT01597245|39453254|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264808|NCT01597245|39453255|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264809|NCT01597245|39453256|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264810|NCT01597245|39453257|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264811|NCT01597245|39453258|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264812|NCT01597245|39453259|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264813|NCT01597245|39453260|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264814|NCT01597245|39453261|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264815|NCT01597245|39453262|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264816|NCT01597245|39453263|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16068903|NCT00389519|38742719|FG001|Treated|Adverse Event|0|||
16068904|NCT00389519|38742720|FG002|Treated|Adverse Event|0|||
16068905|NCT00389519|38742721|FG003|Treated|Adverse Event|2|||
16068906|NCT00389519|38742718|FG000|Treated|Reason not specified|1|||
16068907|NCT00389519|38742719|FG001|Treated|Reason not specified|1|||
16068908|NCT00389519|38742720|FG002|Treated|Reason not specified|0|||
16068909|NCT00389519|38742721|FG003|Treated|Reason not specified|2|||
16068910|NCT00864682|38742722|FG000|Overall Study|Protocol Violation|2|||
16068911|NCT00864682|38742723|FG001|Overall Study|Protocol Violation|1|||
16068912|NCT00864682|38742724|FG002|Overall Study|Protocol Violation|2|||
16068913|NCT04044664|38742731|FG000|Stage 1|Adverse Event|3|||
16068914|NCT04044664|38742732|FG001|Stage 1|Adverse Event|3|||
16068915|NCT04044664|38742733|FG002|Stage 1|Adverse Event|1|||
16068916|NCT04044664|38742731|FG000|Stage 1|Lost to Follow-up|3|||
16068917|NCT04044664|38742732|FG001|Stage 1|Lost to Follow-up|2|||
16068918|NCT04044664|38742733|FG002|Stage 1|Lost to Follow-up|2|||
16068919|NCT04044664|38742731|FG000|Stage 1|Withdrawal by Subject|9|||
16068920|NCT04044664|38742732|FG001|Stage 1|Withdrawal by Subject|1|||
16068921|NCT04044664|38742733|FG002|Stage 1|Withdrawal by Subject|0|||
16068922|NCT04044664|38742731|FG000|Stage 1|noncompliance, personal reason|2|||
16068923|NCT04044664|38742732|FG001|Stage 1|noncompliance, personal reason|0|||
16068924|NCT04044664|38742733|FG002|Stage 1|noncompliance, personal reason|0|||
16068925|NCT04044664|38742731|FG000|Stage 1|randomization error|0|||
16068926|NCT04044664|38742732|FG001|Stage 1|randomization error|1|||
16161085|NCT03403205|39072269|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
16161086|NCT03403205|39072270|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
16161087|NCT03403205|39072271|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
16161088|NCT03403205|39072272|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
16161089|NCT02508194|39072273|FG000|Overall Study|Death|5|||
16161090|NCT02508194|39072274|FG001|Overall Study|Death|3|||
16161091|NCT02508194|39072273|FG000|Overall Study|Lost to Follow-up|25|||
16161092|NCT02508194|39072274|FG001|Overall Study|Lost to Follow-up|18|||
16161093|NCT02508194|39072273|FG000|Overall Study|Withdrawal by Subject|20|||
16161094|NCT02508194|39072274|FG001|Overall Study|Withdrawal by Subject|18|||
16161095|NCT02508194|39072273|FG000|Overall Study|Error in Randomization|1|||
16161096|NCT02508194|39072274|FG001|Overall Study|Error in Randomization|3|||
16161097|NCT02508194|39072273|FG000|Overall Study|Principal Investigator Decision|1|||
16161098|NCT02508194|39072274|FG001|Overall Study|Principal Investigator Decision|2|||
16161099|NCT03806127|39072275|FG000|Overall Study|Withdrawal by Subject|4|||
16161100|NCT03806127|39072276|FG001|Overall Study|Withdrawal by Subject|5|||
16161101|NCT03806127|39072275|FG000|Overall Study|Protocol Violation|3|||
16161102|NCT03806127|39072276|FG001|Overall Study|Protocol Violation|1|||
16161103|NCT03806127|39072275|FG000|Overall Study|Adverse Event|3|||
16161104|NCT03806127|39072276|FG001|Overall Study|Adverse Event|0|||
16161105|NCT03806127|39072275|FG000|Overall Study|Unable to Complete Procedures|0|||
16161106|NCT03806127|39072276|FG001|Overall Study|Unable to Complete Procedures|1|||
16161107|NCT03806127|39072275|FG000|Overall Study|Pregnancy|0|||
16161108|NCT03806127|39072276|FG001|Overall Study|Pregnancy|1|||
16161109|NCT03806127|39072275|FG000|Overall Study|Lost to Follow-up|5|||
16161110|NCT03806127|39072276|FG001|Overall Study|Lost to Follow-up|1|||
16161111|NCT03806127|39072275|FG000|Overall Study|Physician Decision|1|||
16161112|NCT03806127|39072276|FG001|Overall Study|Physician Decision|1|||
16161113|NCT03806127|39072275|FG000|Overall Study|Could Not Come Due to Covid|1|||
16161114|NCT03806127|39072276|FG001|Overall Study|Could Not Come Due to Covid|0|||
16161115|NCT03806127|39072275|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
16161116|NCT03806127|39072276|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
16161117|NCT03806127|39072275|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
16161118|NCT03806127|39072276|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
16161119|NCT03806127|39072275|FG000|Overall Study|Covid 19 Restrictions|2|||
16161120|NCT03806127|39072276|FG001|Overall Study|Covid 19 Restrictions|0|||
16161121|NCT03806127|39072275|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
16161122|NCT03806127|39072276|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
16161123|NCT03806127|39072275|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
16161124|NCT03806127|39072276|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
16161125|NCT03634800|39072282|FG000|Overall Study|Adverse Event|1|||
16161126|NCT03634800|39072282|FG000|Overall Study|Disease Progression|4|||
16161127|NCT03634800|39072282|FG000|Overall Study|Withdrawal by Subject|1|||
16161128|NCT02787850|39072283|FG000|Overall Study|Withdrawal by Subject|0|||
16161129|NCT02787850|39072284|FG001|Overall Study|Withdrawal by Subject|1|||
16161130|NCT01400451|39072287|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
16161131|NCT01400451|39072288|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
16161132|NCT01400451|39072289|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
16161133|NCT01400451|39072287|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
16161134|NCT01400451|39072288|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
16161135|NCT01400451|39072289|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
16161136|NCT01400451|39072287|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
16161137|NCT01400451|39072288|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
16161138|NCT01400451|39072289|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
16161139|NCT01400451|39072287|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
16161140|NCT01400451|39072288|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
16161141|NCT01400451|39072289|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
16161142|NCT01400451|39072287|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
16161143|NCT01400451|39072288|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
16161144|NCT01400451|39072289|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
16161145|NCT01324232|39072290|FG000|Overall Study|Protocol Violation|0|||
16161146|NCT01324232|39072291|FG001|Overall Study|Protocol Violation|0|||
16161147|NCT01324232|39072292|FG002|Overall Study|Protocol Violation|0|||
16068927|NCT04044664|38742733|FG002|Stage 1|randomization error|0|||
16161148|NCT01324232|39072293|FG003|Overall Study|Protocol Violation|2|||
16161149|NCT01324232|39072290|FG000|Overall Study|Missing|0|||
16161150|NCT01324232|39072291|FG001|Overall Study|Missing|0|||
16161151|NCT01324232|39072292|FG002|Overall Study|Missing|1|||
16161152|NCT01324232|39072293|FG003|Overall Study|Missing|0|||
16161153|NCT01324232|39072290|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
16161154|NCT01324232|39072291|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
16161155|NCT01324232|39072292|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
16161156|NCT01324232|39072293|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
16161157|NCT01324232|39072290|FG000|Overall Study|Lack of Efficacy|2|||
16161158|NCT01324232|39072291|FG001|Overall Study|Lack of Efficacy|1|||
16161159|NCT01324232|39072292|FG002|Overall Study|Lack of Efficacy|2|||
16161160|NCT01324232|39072293|FG003|Overall Study|Lack of Efficacy|2|||
16161161|NCT01324232|39072290|FG000|Overall Study|Participant Refused Medication|0|||
16161162|NCT01324232|39072291|FG001|Overall Study|Participant Refused Medication|1|||
16161163|NCT01324232|39072292|FG002|Overall Study|Participant Refused Medication|0|||
16161164|NCT01324232|39072293|FG003|Overall Study|Participant Refused Medication|0|||
16161165|NCT01324232|39072290|FG000|Overall Study|Intercurrent illness|0|||
16161166|NCT01324232|39072291|FG001|Overall Study|Intercurrent illness|0|||
16161167|NCT01324232|39072292|FG002|Overall Study|Intercurrent illness|0|||
16161168|NCT01324232|39072293|FG003|Overall Study|Intercurrent illness|1|||
16161169|NCT01324232|39072290|FG000|Overall Study|Adverse Event|2|||
16161170|NCT01324232|39072291|FG001|Overall Study|Adverse Event|5|||
16161171|NCT01324232|39072292|FG002|Overall Study|Adverse Event|6|||
16161172|NCT01324232|39072293|FG003|Overall Study|Adverse Event|6|||
16161173|NCT01324232|39072290|FG000|Overall Study|Withdrawal by Subject|0|||
16161174|NCT01324232|39072291|FG001|Overall Study|Withdrawal by Subject|3|||
16161175|NCT01324232|39072292|FG002|Overall Study|Withdrawal by Subject|4|||
16161176|NCT01324232|39072293|FG003|Overall Study|Withdrawal by Subject|0|||
16161177|NCT01324232|39072290|FG000|Overall Study|Lost to Follow-up|1|||
16161178|NCT01324232|39072291|FG001|Overall Study|Lost to Follow-up|0|||
16161179|NCT01324232|39072292|FG002|Overall Study|Lost to Follow-up|0|||
16161180|NCT01324232|39072293|FG003|Overall Study|Lost to Follow-up|0|||
16161181|NCT00354601|39072296|FG000|Overall Study|Protocol Violation|1|||
16447731|NCT03682770|40118745|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
16447732|NCT03682770|40118746|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
16447733|NCT03682770|40118740|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
16447734|NCT03682770|40118741|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
16447735|NCT03682770|40118742|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
16447736|NCT03682770|40118743|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
16447737|NCT03682770|40118744|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
16447738|NCT03682770|40118745|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
16447739|NCT03682770|40118746|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
16447740|NCT03682770|40118740|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
16447741|NCT03682770|40118741|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
16447742|NCT03682770|40118742|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
16447743|NCT03682770|40118743|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
16447744|NCT03682770|40118744|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
16447745|NCT03682770|40118745|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
16447746|NCT03682770|40118746|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
16447747|NCT03682770|40118740|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
16447748|NCT03682770|40118741|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
16447749|NCT03682770|40118742|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
16447750|NCT03682770|40118743|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
16068928|NCT04044664|38742731|FG000|Stage 2|Adverse Event|2|||
16068929|NCT04044664|38742732|FG001|Stage 2|Adverse Event|0|||
16068930|NCT04044664|38742733|FG002|Stage 2|Adverse Event|0|||
16068931|NCT04044664|38742731|FG000|Stage 2|Lost to Follow-up|3|||
16068932|NCT04044664|38742732|FG001|Stage 2|Lost to Follow-up|2|||
16068933|NCT04044664|38742733|FG002|Stage 2|Lost to Follow-up|1|||
16068934|NCT04044664|38742731|FG000|Stage 2|Withdrawal by Subject|3|||
16068935|NCT04044664|38742732|FG001|Stage 2|Withdrawal by Subject|0|||
16068936|NCT04044664|38742733|FG002|Stage 2|Withdrawal by Subject|0|||
16161182|NCT00354601|39072296|FG000|Overall Study|progression|1|||
16068937|NCT04044664|38742731|FG000|Stage 2|protocol deviation|1|||
16068938|NCT04044664|38742732|FG001|Stage 2|protocol deviation|0|||
16161183|NCT02432235|39072298|FG000|Overall Study|Death|1|||
16161184|NCT02432235|39072299|FG001|Overall Study|Death|1|||
16161185|NCT02432235|39072300|FG002|Overall Study|Death|2|||
16161186|NCT02432235|39072301|FG003|Overall Study|Death|2|||
16161187|NCT02432235|39072302|FG004|Overall Study|Death|1|||
16161188|NCT02432235|39072303|FG005|Overall Study|Death|3|||
16161189|NCT02432235|39072304|FG006|Overall Study|Death|11|||
16161190|NCT02432235|39072305|FG007|Overall Study|Death|15|||
16068939|NCT04044664|38742733|FG002|Stage 2|protocol deviation|0|||
16068940|NCT04335591|38742734|FG000|Overall Study|Adverse Event|5|||
16068941|NCT04335591|38742735|FG001|Overall Study|Adverse Event|2|||
16068942|NCT04335591|38742736|FG002|Overall Study|Adverse Event|3|||
16068943|NCT04335591|38742737|FG003|Overall Study|Adverse Event|2|||
16068944|NCT04335591|38742734|FG000|Overall Study|Protocol Violation|1|||
16068945|NCT04335591|38742735|FG001|Overall Study|Protocol Violation|0|||
16068946|NCT04335591|38742736|FG002|Overall Study|Protocol Violation|0|||
16068947|NCT04335591|38742737|FG003|Overall Study|Protocol Violation|0|||
16068948|NCT04335591|38742734|FG000|Overall Study|Withdrawal by Subject|8|||
16068949|NCT04335591|38742735|FG001|Overall Study|Withdrawal by Subject|4|||
16068950|NCT04335591|38742736|FG002|Overall Study|Withdrawal by Subject|4|||
16068951|NCT04335591|38742737|FG003|Overall Study|Withdrawal by Subject|5|||
16068952|NCT04335591|38742734|FG000|Overall Study|Subject planning pregnancy|0|||
16068953|NCT04335591|38742735|FG001|Overall Study|Subject planning pregnancy|1|||
16068954|NCT04335591|38742736|FG002|Overall Study|Subject planning pregnancy|0|||
16068955|NCT04335591|38742737|FG003|Overall Study|Subject planning pregnancy|0|||
16068956|NCT04335591|38742734|FG000|Overall Study|Ukrainian Russian war conflict|4|||
16068957|NCT04335591|38742735|FG001|Overall Study|Ukrainian Russian war conflict|5|||
16068958|NCT04335591|38742736|FG002|Overall Study|Ukrainian Russian war conflict|2|||
16068959|NCT04335591|38742737|FG003|Overall Study|Ukrainian Russian war conflict|0|||
16068960|NCT00762463|38742738|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
16068961|NCT00762463|38742739|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
16161191|NCT02432235|39072306|FG008|Overall Study|Death|15|||
16161192|NCT02432235|39072307|FG009|Overall Study|Death|3|||
16161193|NCT02432235|39072308|FG010|Overall Study|Death|1|||
16161194|NCT02432235|39072309|FG011|Overall Study|Death|0|||
16264817|NCT01597245|39453264|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264818|NCT01597245|39453265|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16068962|NCT00762463|38742740|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
16068963|NCT00762463|38742741|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
16068964|NCT00762463|38742738|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
16068965|NCT00762463|38742739|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
16068966|NCT00762463|38742740|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
16068967|NCT00762463|38742741|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
16068968|NCT00762463|38742738|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
16068969|NCT00762463|38742739|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
16068970|NCT00762463|38742740|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
16068971|NCT00762463|38742741|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
16068972|NCT00762463|38742738|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
16068973|NCT00762463|38742739|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
16068974|NCT00762463|38742740|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
16068975|NCT00762463|38742741|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
16068976|NCT00762463|38742738|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
16068977|NCT00762463|38742739|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
16068978|NCT00762463|38742740|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
16068979|NCT00762463|38742741|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
16068980|NCT00762463|38742738|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
16068981|NCT00762463|38742739|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
16068982|NCT00762463|38742740|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
16068983|NCT00762463|38742741|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
16068984|NCT00762463|38742738|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
16068985|NCT00762463|38742739|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
16068986|NCT00762463|38742740|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
16068987|NCT00762463|38742741|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
16068988|NCT00762463|38742738|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
16068989|NCT00762463|38742739|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
16068990|NCT00762463|38742740|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
16068991|NCT00762463|38742741|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
16068992|NCT03861767|38742742|FG000|Overall Study|Withdrawal by Subject|2|||
16068993|NCT03861767|38742743|FG001|Overall Study|Withdrawal by Subject|1|||
16068994|NCT03861767|38742744|FG002|Overall Study|Withdrawal by Subject|0|||
16068995|NCT03861767|38742745|FG003|Overall Study|Withdrawal by Subject|5|||
16068996|NCT03861767|38742746|FG004|Overall Study|Withdrawal by Subject|2|||
16068997|NCT03861767|38742747|FG005|Overall Study|Withdrawal by Subject|1|||
16068998|NCT03861767|38742748|FG006|Overall Study|Withdrawal by Subject|3|||
16068999|NCT03861767|38742749|FG007|Overall Study|Withdrawal by Subject|1|||
16069000|NCT03861767|38742750|FG008|Overall Study|Withdrawal by Subject|0|||
16264819|NCT01597245|39453266|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16069001|NCT03861767|38742751|FG009|Overall Study|Withdrawal by Subject|5|||
16069002|NCT01605136|38742752|FG000|Study Period|Withdrawal by Subject|2|||
16069003|NCT01605136|38742753|FG001|Study Period|Withdrawal by Subject|0|||
16069004|NCT01605136|38742752|FG000|Study Period|Physician Decision|1|||
16069005|NCT01605136|38742753|FG001|Study Period|Physician Decision|1|||
16069006|NCT01605136|38742752|FG000|Study Period|Lost to Follow-up|0|||
16069007|NCT01605136|38742753|FG001|Study Period|Lost to Follow-up|2|||
16069008|NCT01605136|38742752|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
16161195|NCT02432235|39072298|FG000|Overall Study|Withdrawal by Subject|0|||
16161196|NCT02432235|39072299|FG001|Overall Study|Withdrawal by Subject|1|||
16161197|NCT02432235|39072300|FG002|Overall Study|Withdrawal by Subject|0|||
16161198|NCT02432235|39072301|FG003|Overall Study|Withdrawal by Subject|0|||
16161199|NCT02432235|39072302|FG004|Overall Study|Withdrawal by Subject|0|||
16161200|NCT02432235|39072303|FG005|Overall Study|Withdrawal by Subject|2|||
16161201|NCT02432235|39072304|FG006|Overall Study|Withdrawal by Subject|5|||
16161202|NCT02432235|39072305|FG007|Overall Study|Withdrawal by Subject|3|||
16161203|NCT02432235|39072306|FG008|Overall Study|Withdrawal by Subject|1|||
16161204|NCT02432235|39072307|FG009|Overall Study|Withdrawal by Subject|0|||
16161205|NCT02432235|39072308|FG010|Overall Study|Withdrawal by Subject|0|||
16161206|NCT02432235|39072309|FG011|Overall Study|Withdrawal by Subject|0|||
16161207|NCT02432235|39072298|FG000|Overall Study|Lost to Follow-up|0|||
16161208|NCT02432235|39072299|FG001|Overall Study|Lost to Follow-up|0|||
16161209|NCT02432235|39072300|FG002|Overall Study|Lost to Follow-up|0|||
16161210|NCT02432235|39072301|FG003|Overall Study|Lost to Follow-up|0|||
16161211|NCT02432235|39072302|FG004|Overall Study|Lost to Follow-up|0|||
16161212|NCT02432235|39072303|FG005|Overall Study|Lost to Follow-up|1|||
16161213|NCT02432235|39072304|FG006|Overall Study|Lost to Follow-up|0|||
16161214|NCT02432235|39072305|FG007|Overall Study|Lost to Follow-up|0|||
16161215|NCT02432235|39072306|FG008|Overall Study|Lost to Follow-up|1|||
16161216|NCT02432235|39072307|FG009|Overall Study|Lost to Follow-up|0|||
16371131|NCT02400580|39843530|FG001|Overall Study|Withdrawal by Subject|1|||
16371132|NCT02400580|39843529|FG000|Overall Study|Adverse Event|1|||
16371133|NCT02400580|39843530|FG001|Overall Study|Adverse Event|0|||
16371134|NCT00401830|39843531|FG000|Overall Study|Adverse Event|10|||
16371135|NCT00401830|39843532|FG001|Overall Study|Adverse Event|18|||
16069009|NCT01605136|38742753|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
16069010|NCT01537133|38742760|FG000|Overall Study|Withdrawal by Subject|2|||
16069011|NCT01537133|38742761|FG001|Overall Study|Withdrawal by Subject|0|||
16069012|NCT01537133|38742762|FG002|Overall Study|Withdrawal by Subject|0|||
16069013|NCT01537133|38742763|FG003|Overall Study|Withdrawal by Subject|0|||
16069014|NCT01537133|38742760|FG000|Overall Study|Lost to Follow-up|1|||
16069015|NCT01537133|38742761|FG001|Overall Study|Lost to Follow-up|0|||
16069016|NCT01537133|38742762|FG002|Overall Study|Lost to Follow-up|0|||
16069017|NCT01537133|38742763|FG003|Overall Study|Lost to Follow-up|0|||
16069018|NCT00926393|38742764|FG000|Overall Study|Withdrawal by Subject|1|||
16069019|NCT00926393|38742765|FG001|Overall Study|Withdrawal by Subject|2|||
16069020|NCT00926393|38742764|FG000|Overall Study|Adverse Event|1|||
16069021|NCT00926393|38742765|FG001|Overall Study|Adverse Event|1|||
16069022|NCT02155829|38742766|FG000|Overall Study|Adverse Event|1|||
16069023|NCT02155829|38742767|FG001|Overall Study|Adverse Event|0|||
16371136|NCT00401830|39843531|FG000|Overall Study|Lack of Efficacy|11|||
16371137|NCT00401830|39843532|FG001|Overall Study|Lack of Efficacy|5|||
16371138|NCT00401830|39843531|FG000|Overall Study|Withdrawal by Subject|4|||
16371139|NCT00401830|39843532|FG001|Overall Study|Withdrawal by Subject|3|||
16371140|NCT00401830|39843531|FG000|Overall Study|Protocol Violation|3|||
16371141|NCT00401830|39843532|FG001|Overall Study|Protocol Violation|3|||
16371142|NCT00401830|39843531|FG000|Overall Study|Non-compliance with drug study|1|||
16371143|NCT00401830|39843532|FG001|Overall Study|Non-compliance with drug study|0|||
16371144|NCT00401830|39843531|FG000|Overall Study|Lost to Follow-up|1|||
16371145|NCT00401830|39843532|FG001|Overall Study|Lost to Follow-up|3|||
16371146|NCT00401830|39843531|FG000|Overall Study|Other: Personal / Family problems|1|||
16371147|NCT00401830|39843532|FG001|Overall Study|Other: Personal / Family problems|0|||
16371148|NCT00245570|39843534|FG000|Washout Between Periods III and IV|Adverse Event|0|||
16371149|NCT00245570|39843535|FG001|Washout Between Periods III and IV|Adverse Event|1|||
16371150|NCT00245570|39843536|FG002|Washout Between Periods III and IV|Adverse Event|0|||
16371151|NCT00245570|39843537|FG003|Washout Between Periods III and IV|Adverse Event|0|||
16069024|NCT02155829|38742766|FG000|Overall Study|Withdrawal by Subject|3|||
16161217|NCT02432235|39072308|FG010|Overall Study|Lost to Follow-up|0|||
16161218|NCT02432235|39072309|FG011|Overall Study|Lost to Follow-up|0|||
16161219|NCT02432235|39072298|FG000|Overall Study|Miscellaneous|0|||
16161220|NCT02432235|39072299|FG001|Overall Study|Miscellaneous|0|||
16371152|NCT00245570|39843538|FG004|Washout Between Periods III and IV|Adverse Event|0|||
16161221|NCT02432235|39072300|FG002|Overall Study|Miscellaneous|0|||
16161222|NCT02432235|39072301|FG003|Overall Study|Miscellaneous|0|||
16161223|NCT02432235|39072302|FG004|Overall Study|Miscellaneous|1|||
16069025|NCT02155829|38742767|FG001|Overall Study|Withdrawal by Subject|3|||
16371153|NCT00245570|39843539|FG005|Washout Between Periods III and IV|Adverse Event|0|||
16069026|NCT02155829|38742766|FG000|Overall Study|Protocol Violation|2|||
16069027|NCT02155829|38742767|FG001|Overall Study|Protocol Violation|0|||
16069028|NCT00256243|38742768|FG000|Overall Study|Lost to Follow-up|2|||
16069029|NCT00256243|38742768|FG000|Overall Study|Death|7|||
16069030|NCT00256243|38742768|FG000|Overall Study|Not treated|1|||
16069031|NCT01249092|38742770|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
16069032|NCT01249092|38742770|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
16069033|NCT02949271|38742771|FG000|Overall Study|Lack of Efficacy|5|||
16069034|NCT02949271|38742772|FG001|Overall Study|Lack of Efficacy|4|||
16069035|NCT02949271|38742771|FG000|Overall Study|Lost to Follow-up|3|||
16069036|NCT02949271|38742772|FG001|Overall Study|Lost to Follow-up|6|||
16161224|NCT02432235|39072303|FG005|Overall Study|Miscellaneous|6|||
16161225|NCT02432235|39072304|FG006|Overall Study|Miscellaneous|2|||
16371154|NCT00452400|39843542|FG000|Overall Study|Adverse Event|1|||
16371155|NCT00452400|39843543|FG001|Overall Study|Adverse Event|1|||
16371156|NCT00452400|39843544|FG002|Overall Study|Adverse Event|5|||
16371157|NCT00452400|39843545|FG003|Overall Study|Adverse Event|0|||
16371158|NCT00452400|39843546|FG004|Overall Study|Adverse Event|2|||
16371159|NCT00452400|39843542|FG000|Overall Study|Protocol Violation|0|||
16371160|NCT00452400|39843543|FG001|Overall Study|Protocol Violation|0|||
16371161|NCT00452400|39843544|FG002|Overall Study|Protocol Violation|1|||
16371162|NCT00452400|39843545|FG003|Overall Study|Protocol Violation|0|||
16371163|NCT00452400|39843546|FG004|Overall Study|Protocol Violation|0|||
16371164|NCT00452400|39843542|FG000|Overall Study|Lost to Follow-up|1|||
16371165|NCT00452400|39843543|FG001|Overall Study|Lost to Follow-up|0|||
16371166|NCT00452400|39843544|FG002|Overall Study|Lost to Follow-up|0|||
16371167|NCT00452400|39843545|FG003|Overall Study|Lost to Follow-up|0|||
16371168|NCT00452400|39843546|FG004|Overall Study|Lost to Follow-up|0|||
16371169|NCT00452400|39843542|FG000|Overall Study|Withdrawal by Subject|1|||
16371170|NCT00452400|39843543|FG001|Overall Study|Withdrawal by Subject|0|||
16371171|NCT00452400|39843544|FG002|Overall Study|Withdrawal by Subject|1|||
16371172|NCT00452400|39843545|FG003|Overall Study|Withdrawal by Subject|0|||
16371173|NCT00452400|39843546|FG004|Overall Study|Withdrawal by Subject|0|||
16371174|NCT00452400|39843542|FG000|Overall Study|Lack of Efficacy|2|||
16371175|NCT00452400|39843543|FG001|Overall Study|Lack of Efficacy|0|||
16371176|NCT00452400|39843544|FG002|Overall Study|Lack of Efficacy|0|||
16371177|NCT00452400|39843545|FG003|Overall Study|Lack of Efficacy|0|||
16371178|NCT00452400|39843546|FG004|Overall Study|Lack of Efficacy|0|||
16371179|NCT00452400|39843542|FG000|Overall Study|Other reasons not listed above|0|||
16371180|NCT00452400|39843543|FG001|Overall Study|Other reasons not listed above|0|||
16371181|NCT00452400|39843544|FG002|Overall Study|Other reasons not listed above|0|||
16371182|NCT00452400|39843545|FG003|Overall Study|Other reasons not listed above|1|||
16371183|NCT00452400|39843546|FG004|Overall Study|Other reasons not listed above|1|||
16371184|NCT02294019|39843550|FG000|Overall Study|Adverse Event|2|||
16371185|NCT02294019|39843550|FG000|Overall Study|Protocol Violation|68|||
16371186|NCT02294019|39843550|FG000|Overall Study|Lost to Follow-up|31|||
16371187|NCT02294019|39843550|FG000|Overall Study|Other|1|||
16371188|NCT02294019|39843550|FG000|Overall Study|Withdrawal by Subject|1|||
16371189|NCT03439514|39843553|FG000|Double-Blind Treatment Period|Other|4|||
16371190|NCT03439514|39843554|FG001|Double-Blind Treatment Period|Other|1|||
16371191|NCT03439514|39843553|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
16069037|NCT02949271|38742771|FG000|Overall Study|Physician Decision|5|||
16161226|NCT02432235|39072305|FG007|Overall Study|Miscellaneous|2|||
16161227|NCT02432235|39072306|FG008|Overall Study|Miscellaneous|4|||
16161228|NCT02432235|39072307|FG009|Overall Study|Miscellaneous|0|||
16161229|NCT02432235|39072308|FG010|Overall Study|Miscellaneous|0|||
16161230|NCT02432235|39072309|FG011|Overall Study|Miscellaneous|1|||
16161231|NCT00493038|39072310|FG000|Treatment|Adverse Event|8|||
16161232|NCT00493038|39072311|FG001|Treatment|Adverse Event|4|||
16161233|NCT00493038|39072310|FG000|Treatment|Lost to Follow-up|5|||
16161234|NCT00493038|39072311|FG001|Treatment|Lost to Follow-up|3|||
16161235|NCT00493038|39072310|FG000|Treatment|Withdrawal by Subject|11|||
16161236|NCT00493038|39072311|FG001|Treatment|Withdrawal by Subject|12|||
16161237|NCT00493038|39072310|FG000|Treatment|Other|0|||
16161238|NCT00493038|39072311|FG001|Treatment|Other|1|||
16371192|NCT03439514|39843554|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
16371193|NCT03439514|39843553|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
16371194|NCT03439514|39843554|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
16371195|NCT03439514|39843553|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
16371196|NCT03439514|39843554|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
16069038|NCT02949271|38742772|FG001|Overall Study|Physician Decision|5|||
16161239|NCT00493038|39072310|FG000|Follow-up|Lost to Follow-up|1|||
16161240|NCT00493038|39072311|FG001|Follow-up|Lost to Follow-up|0|||
16161241|NCT01623271|39072312|FG000|Overall Study|Withdrawal by Subject|2|||
16161242|NCT03733392|39072315|FG000|Overall Study|Withdrawal by Subject|11|||
16161243|NCT03733392|39072316|FG001|Overall Study|Withdrawal by Subject|1|||
16371197|NCT03439514|39843553|FG000|Double-Blind Treatment Period|Death|1|||
16371198|NCT03439514|39843554|FG001|Double-Blind Treatment Period|Death|2|||
16161244|NCT03733392|39072315|FG000|Overall Study|Death|1|||
16161245|NCT03733392|39072316|FG001|Overall Study|Death|0|||
16161246|NCT03733392|39072315|FG000|Overall Study|Lost to Follow-up|5|||
16161247|NCT03733392|39072316|FG001|Overall Study|Lost to Follow-up|0|||
16161248|NCT03733392|39072315|FG000|Overall Study|Protocol Violation|0|||
16161249|NCT03733392|39072316|FG001|Overall Study|Protocol Violation|1|||
16161250|NCT03733392|39072315|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
16161251|NCT03733392|39072316|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
16161252|NCT03733392|39072315|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
16161253|NCT03733392|39072316|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
16161254|NCT03733392|39072315|FG000|Overall Study|Patient Non-Compliance|2|||
16161255|NCT03733392|39072316|FG001|Overall Study|Patient Non-Compliance|1|||
16161256|NCT03733392|39072315|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
16161257|NCT03733392|39072316|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
16161258|NCT03733392|39072315|FG000|Overall Study|Withdrawal prior to procedure|5|||
16161259|NCT03733392|39072316|FG001|Overall Study|Withdrawal prior to procedure|2|||
16161260|NCT00847912|39072317|FG000|Overall Study|Protocol Violation|6|||
16161261|NCT00847912|39072318|FG001|Overall Study|Protocol Violation|7|||
16161262|NCT00847912|39072317|FG000|Overall Study|Withdrawal by Subject|3|||
16161263|NCT00847912|39072318|FG001|Overall Study|Withdrawal by Subject|6|||
16161264|NCT01084551|39072319|FG000|Overall Study|Adverse Event|2|||
16161265|NCT01084551|39072320|FG001|Overall Study|Adverse Event|9|||
16161266|NCT01084551|39072321|FG002|Overall Study|Adverse Event|4|||
16161267|NCT01084551|39072319|FG000|Overall Study|Lack of Efficacy|2|||
16161268|NCT01084551|39072320|FG001|Overall Study|Lack of Efficacy|0|||
16371199|NCT03309605|39843556|FG000|Overall Study|Adverse Event|0|||
16371200|NCT03309605|39843557|FG001|Overall Study|Adverse Event|0|||
16371201|NCT03309605|39843558|FG002|Overall Study|Adverse Event|0|||
16371202|NCT03309605|39843559|FG003|Overall Study|Adverse Event|1|||
16069039|NCT02949271|38742771|FG000|Overall Study|Protocol Violation|6|||
16069040|NCT02949271|38742772|FG001|Overall Study|Protocol Violation|3|||
16069041|NCT02949271|38742771|FG000|Overall Study|Withdrawal by Subject|1|||
16069042|NCT02949271|38742772|FG001|Overall Study|Withdrawal by Subject|0|||
16069043|NCT02949271|38742771|FG000|Overall Study|Delivered prior to intervention|7|||
16069044|NCT02949271|38742772|FG001|Overall Study|Delivered prior to intervention|9|||
16069045|NCT02949271|38742771|FG000|Overall Study|Outside the window for cervical dilation|2|||
16069046|NCT02949271|38742772|FG001|Overall Study|Outside the window for cervical dilation|3|||
16069047|NCT03736785|38742779|FG000|Overall Study|Adverse Event|1|||
16371203|NCT03309605|39843560|FG004|Overall Study|Adverse Event|0|||
16371204|NCT03309605|39843561|FG005|Overall Study|Adverse Event|0|||
16371205|NCT03309605|39843562|FG006|Overall Study|Adverse Event|2|||
16371206|NCT03309605|39843563|FG007|Overall Study|Adverse Event|1|||
16069048|NCT03736785|38742780|FG001|Overall Study|Adverse Event|1|||
16069049|NCT03736785|38742781|FG002|Overall Study|Adverse Event|1|||
16069050|NCT03736785|38742779|FG000|Overall Study|Death|1|||
16069051|NCT03736785|38742780|FG001|Overall Study|Death|0|||
16069052|NCT03736785|38742781|FG002|Overall Study|Death|1|||
16069053|NCT03736785|38742779|FG000|Overall Study|Lost to Follow-up|0|||
16069054|NCT03736785|38742780|FG001|Overall Study|Lost to Follow-up|2|||
16069055|NCT03736785|38742781|FG002|Overall Study|Lost to Follow-up|3|||
16069056|NCT03736785|38742779|FG000|Overall Study|Non compliance with study drug|1|||
16069057|NCT03736785|38742780|FG001|Overall Study|Non compliance with study drug|1|||
16069058|NCT03736785|38742781|FG002|Overall Study|Non compliance with study drug|0|||
16069059|NCT03736785|38742779|FG000|Overall Study|Physician Decision|0|||
16069060|NCT03736785|38742780|FG001|Overall Study|Physician Decision|1|||
16069061|NCT03736785|38742781|FG002|Overall Study|Physician Decision|1|||
16069062|NCT03736785|38742779|FG000|Overall Study|Protocol Violation|1|||
16069063|NCT03736785|38742780|FG001|Overall Study|Protocol Violation|4|||
16069064|NCT03736785|38742781|FG002|Overall Study|Protocol Violation|3|||
16069065|NCT03736785|38742779|FG000|Overall Study|Sponsor Decision|1|||
16069066|NCT03736785|38742780|FG001|Overall Study|Sponsor Decision|0|||
16069067|NCT03736785|38742781|FG002|Overall Study|Sponsor Decision|0|||
16069068|NCT03736785|38742779|FG000|Overall Study|Unknown/Missing data|3|||
16069069|NCT03736785|38742780|FG001|Overall Study|Unknown/Missing data|2|||
16069070|NCT03736785|38742781|FG002|Overall Study|Unknown/Missing data|1|||
16069071|NCT03736785|38742779|FG000|Overall Study|Withdrawal by Subject|9|||
16161269|NCT01084551|39072321|FG002|Overall Study|Lack of Efficacy|1|||
16161270|NCT01084551|39072319|FG000|Overall Study|Withdrawal by Subject|2|||
16161271|NCT01084551|39072320|FG001|Overall Study|Withdrawal by Subject|1|||
16371207|NCT03309605|39843556|FG000|Overall Study|Withdrawal by Subject|0|||
16371208|NCT03309605|39843557|FG001|Overall Study|Withdrawal by Subject|0|||
16371209|NCT03309605|39843558|FG002|Overall Study|Withdrawal by Subject|0|||
16447751|NCT03682770|40118744|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
16069072|NCT03736785|38742780|FG001|Overall Study|Withdrawal by Subject|6|||
16069073|NCT03736785|38742781|FG002|Overall Study|Withdrawal by Subject|4|||
16069074|NCT02689349|38742782|FG000|Overall Study|Not implanted|4|||
16069075|NCT02689349|38742783|FG001|Overall Study|Not implanted|0|||
16069076|NCT02689349|38742782|FG000|Overall Study|Withdrawal by Subject|9|||
16069077|NCT02689349|38742783|FG001|Overall Study|Withdrawal by Subject|0|||
16069078|NCT02781584|38742784|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
16069079|NCT02781584|38742785|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
16069080|NCT02781584|38742786|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
16069081|NCT02781584|38742787|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
16069082|NCT02781584|38742788|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
16371210|NCT03309605|39843559|FG003|Overall Study|Withdrawal by Subject|0|||
16371211|NCT03309605|39843560|FG004|Overall Study|Withdrawal by Subject|1|||
16371212|NCT03309605|39843561|FG005|Overall Study|Withdrawal by Subject|0|||
16161272|NCT01084551|39072321|FG002|Overall Study|Withdrawal by Subject|0|||
16161273|NCT01084551|39072319|FG000|Overall Study|Protocol Violation|2|||
16161274|NCT01084551|39072320|FG001|Overall Study|Protocol Violation|4|||
16161275|NCT01084551|39072321|FG002|Overall Study|Protocol Violation|0|||
16161276|NCT01084551|39072319|FG000|Overall Study|Lost to Follow-up|0|||
16161277|NCT01084551|39072320|FG001|Overall Study|Lost to Follow-up|0|||
16161278|NCT01084551|39072321|FG002|Overall Study|Lost to Follow-up|3|||
16161279|NCT01084551|39072319|FG000|Overall Study|Physician Decision|1|||
16161280|NCT01084551|39072320|FG001|Overall Study|Physician Decision|0|||
16069083|NCT02781584|38742789|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
16069084|NCT02781584|38742790|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
16069085|NCT02781584|38742791|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
16069086|NCT02781584|38742792|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
16069087|NCT02781584|38742793|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
16069088|NCT02781584|38742794|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
16069089|NCT02781584|38742795|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
16069090|NCT02781584|38742796|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
16069091|NCT02781584|38742784|FG000|Pre-treatment Phase|Adverse Event|0|||
16069092|NCT02781584|38742785|FG001|Pre-treatment Phase|Adverse Event|0|||
16069093|NCT02781584|38742786|FG002|Pre-treatment Phase|Adverse Event|0|||
16069094|NCT02781584|38742787|FG003|Pre-treatment Phase|Adverse Event|0|||
16069095|NCT02781584|38742788|FG004|Pre-treatment Phase|Adverse Event|0|||
16069096|NCT02781584|38742789|FG005|Pre-treatment Phase|Adverse Event|0|||
16069097|NCT02781584|38742790|FG006|Pre-treatment Phase|Adverse Event|0|||
16161281|NCT01084551|39072321|FG002|Overall Study|Physician Decision|0|||
16161282|NCT00493870|39072322|FG000|Overall Study|Lost to Follow-up|12|||
16161283|NCT00493870|39072323|FG001|Overall Study|Lost to Follow-up|15|||
16161284|NCT01564862|39072325|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
16161285|NCT01564862|39072326|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
16161286|NCT01564862|39072327|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
16161287|NCT01564862|39072325|FG000|Overall Study|Major Protocol Deviation|3|||
16161288|NCT01564862|39072326|FG001|Overall Study|Major Protocol Deviation|3|||
16161289|NCT01564862|39072327|FG002|Overall Study|Major Protocol Deviation|4|||
16161290|NCT01564862|39072325|FG000|Overall Study|Lost to Follow-up|10|||
16161291|NCT01564862|39072326|FG001|Overall Study|Lost to Follow-up|8|||
16161292|NCT01564862|39072327|FG002|Overall Study|Lost to Follow-up|6|||
16161293|NCT01564862|39072325|FG000|Overall Study|Voluntary Withdrawal|9|||
16161294|NCT01564862|39072326|FG001|Overall Study|Voluntary Withdrawal|6|||
16161295|NCT01564862|39072327|FG002|Overall Study|Voluntary Withdrawal|8|||
16161296|NCT01564862|39072325|FG000|Overall Study|Lack of Efficacy|1|||
16161297|NCT01564862|39072326|FG001|Overall Study|Lack of Efficacy|5|||
16161298|NCT01564862|39072327|FG002|Overall Study|Lack of Efficacy|6|||
16161299|NCT01564862|39072325|FG000|Overall Study|Other reason(s)|1|||
16161300|NCT01564862|39072326|FG001|Overall Study|Other reason(s)|0|||
16161301|NCT01564862|39072327|FG002|Overall Study|Other reason(s)|0|||
16161302|NCT04849780|39072336|FG000|Period 1|Covid-19 Related|1|||
16161303|NCT04849780|39072337|FG001|Period 1|Covid-19 Related|0|||
16161304|NCT04849780|39072336|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
16161305|NCT04849780|39072337|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
16161306|NCT04849780|39072336|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
16161307|NCT04849780|39072337|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
16161308|NCT02319044|39072338|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
16161309|NCT02319044|39072339|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
16161310|NCT02319044|39072340|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
16161311|NCT02319044|39072338|FG000|Overall Study|Withdrawal by Subject|3|||
16069098|NCT02781584|38742791|FG007|Pre-treatment Phase|Adverse Event|0|||
16161312|NCT02319044|39072339|FG001|Overall Study|Withdrawal by Subject|3|||
16264820|NCT01597245|39453267|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16069099|NCT02781584|38742792|FG008|Pre-treatment Phase|Adverse Event|0|||
16161313|NCT02319044|39072340|FG002|Overall Study|Withdrawal by Subject|6|||
16161314|NCT02319044|39072338|FG000|Overall Study|Condition under investigation worsened|100|||
16161315|NCT02319044|39072339|FG001|Overall Study|Condition under investigation worsened|50|||
16161316|NCT02319044|39072340|FG002|Overall Study|Condition under investigation worsened|46|||
16161317|NCT02319044|39072338|FG000|Overall Study|Adverse Event|17|||
16371213|NCT03309605|39843562|FG006|Overall Study|Withdrawal by Subject|1|||
16371214|NCT03309605|39843563|FG007|Overall Study|Withdrawal by Subject|1|||
16371215|NCT00422461|39843564|FG000|Overall Study|Adverse Event|1|||
16371216|NCT00422461|39843565|FG001|Overall Study|Adverse Event|2|||
16371217|NCT00422461|39843566|FG002|Overall Study|Adverse Event|1|||
16371218|NCT00422461|39843567|FG003|Overall Study|Adverse Event|1|||
16371219|NCT00422461|39843564|FG000|Overall Study|Other|0|||
16161318|NCT02319044|39072339|FG001|Overall Study|Adverse Event|2|||
16161319|NCT02319044|39072340|FG002|Overall Study|Adverse Event|8|||
16161320|NCT02319044|39072338|FG000|Overall Study|Study specific discontinuation criteria|2|||
16161321|NCT02319044|39072339|FG001|Overall Study|Study specific discontinuation criteria|2|||
16161322|NCT02319044|39072340|FG002|Overall Study|Study specific discontinuation criteria|1|||
16161323|NCT02319044|39072338|FG000|Overall Study|Not treated|0|||
16161324|NCT02319044|39072339|FG001|Overall Study|Not treated|2|||
16161325|NCT02319044|39072340|FG002|Overall Study|Not treated|2|||
16161326|NCT00796315|39072346|FG000|Overall Study|Protocol Violation|0|||
16161327|NCT00796315|39072347|FG001|Overall Study|Protocol Violation|1|||
16161328|NCT00796315|39072348|FG002|Overall Study|Protocol Violation|0|||
16161329|NCT03605680|39072351|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
16161330|NCT03605680|39072352|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
16161331|NCT03605680|39072353|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
16161332|NCT03605680|39072354|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
16069100|NCT02781584|38742793|FG009|Pre-treatment Phase|Adverse Event|0|||
16069101|NCT02781584|38742794|FG010|Pre-treatment Phase|Adverse Event|0|||
16069102|NCT02781584|38742795|FG011|Pre-treatment Phase|Adverse Event|1|||
16069103|NCT02781584|38742796|FG012|Pre-treatment Phase|Adverse Event|0|||
16069104|NCT02781584|38742784|FG000|Treatment Phase|Withdrew Consent|0|||
16069105|NCT02781584|38742785|FG001|Treatment Phase|Withdrew Consent|0|||
16069106|NCT02781584|38742786|FG002|Treatment Phase|Withdrew Consent|0|||
16069107|NCT02781584|38742787|FG003|Treatment Phase|Withdrew Consent|0|||
16069108|NCT02781584|38742788|FG004|Treatment Phase|Withdrew Consent|0|||
16069109|NCT02781584|38742789|FG005|Treatment Phase|Withdrew Consent|1|||
16069110|NCT02781584|38742790|FG006|Treatment Phase|Withdrew Consent|0|||
16069111|NCT02781584|38742791|FG007|Treatment Phase|Withdrew Consent|0|||
16069112|NCT02781584|38742792|FG008|Treatment Phase|Withdrew Consent|0|||
16069113|NCT02781584|38742793|FG009|Treatment Phase|Withdrew Consent|0|||
16069114|NCT02781584|38742794|FG010|Treatment Phase|Withdrew Consent|1|||
16069115|NCT02781584|38742795|FG011|Treatment Phase|Withdrew Consent|2|||
16069116|NCT02781584|38742796|FG012|Treatment Phase|Withdrew Consent|0|||
16069117|NCT02781584|38742784|FG000|Treatment Phase|Adverse Event|0|||
16069118|NCT02781584|38742785|FG001|Treatment Phase|Adverse Event|0|||
16069119|NCT02781584|38742786|FG002|Treatment Phase|Adverse Event|0|||
16069120|NCT02781584|38742787|FG003|Treatment Phase|Adverse Event|0|||
16069121|NCT02781584|38742788|FG004|Treatment Phase|Adverse Event|0|||
16069122|NCT02781584|38742789|FG005|Treatment Phase|Adverse Event|0|||
16069123|NCT02781584|38742790|FG006|Treatment Phase|Adverse Event|0|||
16069124|NCT02781584|38742791|FG007|Treatment Phase|Adverse Event|1|||
16069125|NCT02781584|38742792|FG008|Treatment Phase|Adverse Event|0|||
16069126|NCT02781584|38742793|FG009|Treatment Phase|Adverse Event|0|||
16069127|NCT02781584|38742794|FG010|Treatment Phase|Adverse Event|0|||
16069128|NCT02781584|38742795|FG011|Treatment Phase|Adverse Event|0|||
16069129|NCT02781584|38742796|FG012|Treatment Phase|Adverse Event|0|||
16069130|NCT03396913|38742797|FG000|Overall Study|Lost to Follow-up|0|||
16069131|NCT03396913|38742798|FG001|Overall Study|Lost to Follow-up|6|||
16069132|NCT03256344|38742799|FG000|Overall Study|Death|6|||
16069133|NCT03256344|38742800|FG001|Overall Study|Death|22|||
16069134|NCT03256344|38742799|FG000|Overall Study|Withdrawal by Subject|3|||
16069135|NCT03256344|38742800|FG001|Overall Study|Withdrawal by Subject|3|||
16069136|NCT03256344|38742799|FG000|Overall Study|Sponsor Decision|1|||
16069137|NCT03256344|38742800|FG001|Overall Study|Sponsor Decision|0|||
16069138|NCT02974010|38742801|FG000|Overall Study|Lost to Follow-up|3|||
16069139|NCT02974010|38742802|FG001|Overall Study|Lost to Follow-up|1|||
16069140|NCT02974010|38742803|FG002|Overall Study|Lost to Follow-up|0|||
16069141|NCT02974010|38742804|FG003|Overall Study|Lost to Follow-up|0|||
16069142|NCT02974010|38742801|FG000|Overall Study|Withdrawal by Subject|2|||
16069143|NCT02974010|38742802|FG001|Overall Study|Withdrawal by Subject|1|||
16069144|NCT02974010|38742803|FG002|Overall Study|Withdrawal by Subject|0|||
16069145|NCT02974010|38742804|FG003|Overall Study|Withdrawal by Subject|0|||
16161333|NCT03605680|39072351|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
16161334|NCT03605680|39072352|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
16161335|NCT03605680|39072353|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
16371220|NCT00422461|39843565|FG001|Overall Study|Other|0|||
16371221|NCT00422461|39843566|FG002|Overall Study|Other|0|||
16371222|NCT00422461|39843567|FG003|Overall Study|Other|2|||
16069146|NCT02974010|38742801|FG000|Overall Study|Adverse Event|0|||
16069147|NCT02974010|38742802|FG001|Overall Study|Adverse Event|1|||
16069148|NCT02974010|38742803|FG002|Overall Study|Adverse Event|0|||
16069149|NCT02974010|38742804|FG003|Overall Study|Adverse Event|0|||
16371223|NCT00422461|39843564|FG000|Overall Study|Participants no longer willing to participate in study|1|||
16371224|NCT00422461|39843565|FG001|Overall Study|Participants no longer willing to participate in study|0|||
16371225|NCT00422461|39843566|FG002|Overall Study|Participants no longer willing to participate in study|0|||
16371226|NCT00422461|39843567|FG003|Overall Study|Participants no longer willing to participate in study|0|||
16371227|NCT00422461|39843564|FG000|Overall Study|Randomized but not treated|1|||
16371228|NCT00422461|39843565|FG001|Overall Study|Randomized but not treated|1|||
16371229|NCT00422461|39843566|FG002|Overall Study|Randomized but not treated|0|||
16371230|NCT00422461|39843567|FG003|Overall Study|Randomized but not treated|0|||
16371231|NCT00960856|39843571|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
16371232|NCT00960856|39843572|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
16371233|NCT00960856|39843573|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
16371234|NCT00960856|39843574|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
16371235|NCT00960856|39843571|FG000|Washout Period of 7 Days|Adverse Event|0|||
16447752|NCT03682770|40118745|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
16447753|NCT03682770|40118746|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
16371236|NCT00960856|39843572|FG001|Washout Period of 7 Days|Adverse Event|0|||
16371237|NCT00960856|39843573|FG002|Washout Period of 7 Days|Adverse Event|1|||
16371238|NCT00960856|39843574|FG003|Washout Period of 7 Days|Adverse Event|0|||
16371239|NCT03164356|39843578|FG000|Overall Study|Lost to Follow-up|1|||
16371240|NCT03164356|39843579|FG001|Overall Study|Lost to Follow-up|1|||
16371241|NCT03164356|39843580|FG002|Overall Study|Lost to Follow-up|2|||
16371242|NCT03164356|39843581|FG003|Overall Study|Lost to Follow-up|1|||
16371243|NCT03164356|39843578|FG000|Overall Study|Physician Decision|0|||
16371244|NCT03164356|39843579|FG001|Overall Study|Physician Decision|0|||
16371245|NCT03164356|39843580|FG002|Overall Study|Physician Decision|3|||
16371246|NCT03164356|39843581|FG003|Overall Study|Physician Decision|0|||
16371247|NCT03164356|39843578|FG000|Overall Study|Protocol Violation|2|||
16371248|NCT03164356|39843579|FG001|Overall Study|Protocol Violation|1|||
16371249|NCT03164356|39843580|FG002|Overall Study|Protocol Violation|0|||
16371250|NCT03164356|39843581|FG003|Overall Study|Protocol Violation|0|||
16371251|NCT03164356|39843578|FG000|Overall Study|Withdrawal by Subject|1|||
16371252|NCT03164356|39843579|FG001|Overall Study|Withdrawal by Subject|0|||
16371253|NCT03164356|39843580|FG002|Overall Study|Withdrawal by Subject|0|||
16371254|NCT03164356|39843581|FG003|Overall Study|Withdrawal by Subject|0|||
16371255|NCT03164356|39843578|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
16371256|NCT03164356|39843579|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
16371257|NCT03164356|39843580|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
16371258|NCT03164356|39843581|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
16371259|NCT03164356|39843578|FG000|Overall Study|Subject Incarcerated|0|||
16371260|NCT03164356|39843579|FG001|Overall Study|Subject Incarcerated|1|||
16371261|NCT03164356|39843580|FG002|Overall Study|Subject Incarcerated|0|||
16371262|NCT03164356|39843581|FG003|Overall Study|Subject Incarcerated|0|||
16371263|NCT03164356|39843578|FG000|Overall Study|Prosthetist unable to participate|0|||
16371264|NCT03164356|39843579|FG001|Overall Study|Prosthetist unable to participate|2|||
16371265|NCT03164356|39843580|FG002|Overall Study|Prosthetist unable to participate|1|||
16371266|NCT03164356|39843581|FG003|Overall Study|Prosthetist unable to participate|0|||
16371267|NCT03158311|39843585|FG000|Overall Study|Subject/Guardian Decision|10|||
16371268|NCT03158311|39843586|FG001|Overall Study|Subject/Guardian Decision|6|||
16371269|NCT03158311|39843587|FG002|Overall Study|Subject/Guardian Decision|11|||
16371270|NCT03158311|39843585|FG000|Overall Study|Adverse Event|5|||
16371271|NCT03158311|39843586|FG001|Overall Study|Adverse Event|3|||
16371272|NCT03158311|39843587|FG002|Overall Study|Adverse Event|3|||
16371273|NCT03158311|39843585|FG000|Overall Study|Techinical Problems|3|||
16371274|NCT03158311|39843586|FG001|Overall Study|Techinical Problems|1|||
16371275|NCT03158311|39843587|FG002|Overall Study|Techinical Problems|5|||
16371276|NCT03158311|39843585|FG000|Overall Study|Physician Decision|2|||
16371277|NCT03158311|39843586|FG001|Overall Study|Physician Decision|3|||
16371278|NCT03158311|39843587|FG002|Overall Study|Physician Decision|7|||
16371279|NCT03158311|39843585|FG000|Overall Study|Lost to Follow-up|1|||
16371280|NCT03158311|39843586|FG001|Overall Study|Lost to Follow-up|1|||
16371281|NCT03158311|39843587|FG002|Overall Study|Lost to Follow-up|1|||
16371282|NCT03158311|39843585|FG000|Overall Study|Sponsor decision|1|||
16371283|NCT03158311|39843586|FG001|Overall Study|Sponsor decision|0|||
16371284|NCT03158311|39843587|FG002|Overall Study|Sponsor decision|0|||
16371285|NCT03158311|39843585|FG000|Overall Study|Pregnancy|0|||
16371286|NCT03158311|39843586|FG001|Overall Study|Pregnancy|2|||
16371287|NCT03158311|39843587|FG002|Overall Study|Pregnancy|0|||
16371288|NCT03158311|39843585|FG000|Overall Study|Randomized in error|0|||
16371289|NCT03158311|39843586|FG001|Overall Study|Randomized in error|0|||
16371290|NCT03158311|39843587|FG002|Overall Study|Randomized in error|1|||
16371291|NCT03019588|39843600|FG000|Overall Study|Death|44|||
16371292|NCT03019588|39843601|FG001|Overall Study|Death|46|||
16371293|NCT03019588|39843600|FG000|Overall Study|Study terminated by Sponsor|3|||
16371294|NCT03019588|39843601|FG001|Overall Study|Study terminated by Sponsor|1|||
16371295|NCT00501085|39843602|FG000|Overall Study|Lost to Follow-up|195|||
16447754|NCT03682770|40118740|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
16371296|NCT00501085|39843602|FG000|Overall Study|Withdrawal by Subject|34|||
16371297|NCT00501085|39843602|FG000|Overall Study|Subject Decision|1|||
16371298|NCT00501085|39843602|FG000|Overall Study|Revision Surgery|7|||
16371299|NCT00501085|39843602|FG000|Overall Study|Explantation Surgery|26|||
16371300|NCT00501085|39843602|FG000|Overall Study|Adverse Event|4|||
16371301|NCT00501085|39843602|FG000|Overall Study|Non-Compliance|24|||
16371302|NCT00501085|39843602|FG000|Overall Study|Study closed by sponsor|109|||
16371303|NCT00501085|39843602|FG000|Overall Study|Other loss to follow-up|32|||
16371304|NCT04969263|39843604|FG000|Overall Study|Death|1|||
16371305|NCT04969263|39843604|FG000|Overall Study|Lost to Follow-up|2|||
16371306|NCT04969263|39843604|FG000|Overall Study|Withdrawal by Subject|5|||
16371307|NCT04969263|39843604|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
16371308|NCT00871000|39843605|FG000|Overall Study|Withdrawal by Subject|1|||
16371309|NCT00871000|39843606|FG001|Overall Study|Withdrawal by Subject|0|||
16371310|NCT00182637|39843607|FG000|Overall Study|Adverse Event|2|||
16371311|NCT00182637|39843607|FG000|Overall Study|Disease Progression|1|||
16371312|NCT00924651|39843608|FG000|Overall Study|Chemo started too soon|2|||
16371313|NCT00924651|39843609|FG001|Overall Study|Chemo started too soon|3|||
16371314|NCT00924651|39843608|FG000|Overall Study|No Reason|3|||
16371315|NCT00924651|39843609|FG001|Overall Study|No Reason|7|||
16371316|NCT00924651|39843608|FG000|Overall Study|Overwhelmed|6|||
16069150|NCT02974010|38742801|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
16069151|NCT02974010|38742802|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
16069152|NCT02974010|38742803|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
16069153|NCT02974010|38742804|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
16069154|NCT02974010|38742801|FG000|Overall Study|Lack of Efficacy|0|||
16069155|NCT02974010|38742802|FG001|Overall Study|Lack of Efficacy|0|||
16069156|NCT02974010|38742803|FG002|Overall Study|Lack of Efficacy|1|||
16069157|NCT02974010|38742804|FG003|Overall Study|Lack of Efficacy|0|||
16069158|NCT01123083|38742805|FG000|Overall Study|Investigator recommendation|1|||
16069159|NCT01123083|38742806|FG001|Overall Study|Investigator recommendation|1|||
16069160|NCT01123083|38742805|FG000|Overall Study|Administrative reasons|0|||
16069161|NCT01123083|38742806|FG001|Overall Study|Administrative reasons|4|||
16069162|NCT01123083|38742805|FG000|Overall Study|Lost to Follow-up|2|||
16069163|NCT01123083|38742806|FG001|Overall Study|Lost to Follow-up|6|||
16069164|NCT01123083|38742805|FG000|Overall Study|Adverse Event|1|||
16069165|NCT01123083|38742806|FG001|Overall Study|Adverse Event|0|||
16069166|NCT01123083|38742805|FG000|Overall Study|Withdrew for another reason not covered|0|||
16069167|NCT01123083|38742806|FG001|Overall Study|Withdrew for another reason not covered|1|||
16069168|NCT01123083|38742805|FG000|Overall Study|Participant/legal representative request|7|||
16069169|NCT01123083|38742806|FG001|Overall Study|Participant/legal representative request|3|||
16069170|NCT00723294|38742809|FG000|Overall Study|Lobular histology|2|||
16069171|NCT00723294|38742809|FG000|Overall Study|>25% intraductal component|1|||
16069172|NCT00723294|38742809|FG000|Overall Study|No MRI tumor enhancement|1|||
16069173|NCT00723294|38742809|FG000|Overall Study|1.0-Tesla MRI|1|||
16069174|NCT00723294|38742809|FG000|Overall Study|No cryoabalation|2|||
16069175|NCT00723294|38742809|FG000|Overall Study|Did not undergo surgery|1|||
16069176|NCT00723294|38742809|FG000|Overall Study|Treated prior to registration|1|||
16069177|NCT00723294|38742809|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
16069178|NCT00723294|38742809|FG000|Overall Study|Benign lesion|1|||
16069179|NCT00723294|38742809|FG000|Overall Study|Withdrawal by Subject|1|||
16069180|NCT00723294|38742809|FG000|Overall Study|No treatment due to probe failure|1|||
16069181|NCT00038103|38742810|FG000|Overall Study|Adverse Event|5|||
16069182|NCT00038103|38742811|FG001|Overall Study|Adverse Event|6|||
16069183|NCT00038103|38742810|FG000|Overall Study|Lack of Efficacy|48|||
16069184|NCT00038103|38742811|FG001|Overall Study|Lack of Efficacy|41|||
16069185|NCT00038103|38742810|FG000|Overall Study|Withdrawal by Subject|0|||
16069186|NCT00038103|38742811|FG001|Overall Study|Withdrawal by Subject|3|||
16069187|NCT00038103|38742810|FG000|Overall Study|Lost to Follow-up|0|||
16069188|NCT00038103|38742811|FG001|Overall Study|Lost to Follow-up|3|||
16069189|NCT00038103|38742810|FG000|Overall Study|Protocol Violation|0|||
16069190|NCT00038103|38742811|FG001|Overall Study|Protocol Violation|2|||
16069191|NCT00038103|38742810|FG000|Overall Study|Sponsor Decision|0|||
16069192|NCT00038103|38742811|FG001|Overall Study|Sponsor Decision|1|||
16069193|NCT00038103|38742810|FG000|Overall Study|Randomized/never treated|2|||
16069194|NCT00038103|38742811|FG001|Overall Study|Randomized/never treated|0|||
16069195|NCT00771667|38742814|FG000|Induction Phase|Adverse Event|5|||
16069196|NCT00771667|38742815|FG001|Induction Phase|Adverse Event|2|||
16069197|NCT00771667|38742816|FG002|Induction Phase|Adverse Event|4|||
16161336|NCT03605680|39072354|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
16069198|NCT00771667|38742817|FG003|Induction Phase|Adverse Event|1|||
16371317|NCT00924651|39843609|FG001|Overall Study|Overwhelmed|6|||
16069199|NCT00771667|38742818|FG004|Induction Phase|Adverse Event|0|||
16069200|NCT00771667|38742819|FG005|Induction Phase|Adverse Event|0|||
16069201|NCT00771667|38742820|FG006|Induction Phase|Adverse Event|0|||
16371318|NCT00924651|39843608|FG000|Overall Study|Noncompliant|1|||
16371319|NCT00924651|39843609|FG001|Overall Study|Noncompliant|4|||
16371320|NCT00924651|39843608|FG000|Overall Study|Medical|1|||
16371321|NCT00924651|39843609|FG001|Overall Study|Medical|3|||
16371322|NCT00924651|39843608|FG000|Overall Study|Changed Mind|10|||
16371323|NCT00924651|39843609|FG001|Overall Study|Changed Mind|1|||
16371324|NCT00924651|39843608|FG000|Overall Study|Incomplete Form|2|||
16371325|NCT00924651|39843609|FG001|Overall Study|Incomplete Form|1|||
16371326|NCT01028053|39843610|FG000|Overall Study|Screen Failure|113|||
16371327|NCT01028053|39843610|FG000|Overall Study|Patient Request|11|||
16371328|NCT01028053|39843610|FG000|Overall Study|Protocol Violation|1|||
16371329|NCT01028053|39843610|FG000|Overall Study|Physician Decision|2|||
16371330|NCT01028053|39843610|FG000|Overall Study|Technical Problem|1|||
16371331|NCT01028053|39843610|FG000|Overall Study|Terminated by Sponsor|1|||
16371332|NCT01028053|39843610|FG000|Overall Study|Various reasons|4|||
16371333|NCT02821000|39843611|FG000|Overall Study|Death|89|||
16371334|NCT02821000|39843611|FG000|Overall Study|Sponsor Decision|12|||
16371335|NCT02821000|39843611|FG000|Overall Study|Withdrawal by Subject|2|||
16371336|NCT02489773|39843615|FG000|Overall Study|Lost to Follow-up|4|||
16371337|NCT02489773|39843616|FG001|Overall Study|Lost to Follow-up|1|||
16371338|NCT02489773|39843615|FG000|Overall Study|Physician Decision|1|||
16371339|NCT02489773|39843616|FG001|Overall Study|Physician Decision|0|||
16371340|NCT02489773|39843615|FG000|Overall Study|Withdrawal by Subject|1|||
16371341|NCT02489773|39843616|FG001|Overall Study|Withdrawal by Subject|0|||
16371342|NCT02489773|39843615|FG000|Overall Study|Leave the country or the state|1|||
16371343|NCT02489773|39843616|FG001|Overall Study|Leave the country or the state|1|||
16371344|NCT00758043|39843619|FG000|Overall Study|Adverse Event|1|||
16371345|NCT00758043|39843620|FG001|Overall Study|Adverse Event|20|||
16371346|NCT00758043|39843621|FG002|Overall Study|Adverse Event|12|||
16371347|NCT00758043|39843622|FG003|Overall Study|Adverse Event|62|||
16371348|NCT00758043|39843619|FG000|Overall Study|Lack of Efficacy|0|||
16371349|NCT00758043|39843620|FG001|Overall Study|Lack of Efficacy|6|||
16371350|NCT00758043|39843621|FG002|Overall Study|Lack of Efficacy|18|||
16371351|NCT00758043|39843622|FG003|Overall Study|Lack of Efficacy|12|||
16371352|NCT00758043|39843619|FG000|Overall Study|Refused Further Treatment|0|||
16371353|NCT00758043|39843620|FG001|Overall Study|Refused Further Treatment|11|||
16371354|NCT00758043|39843621|FG002|Overall Study|Refused Further Treatment|5|||
16371355|NCT00758043|39843622|FG003|Overall Study|Refused Further Treatment|8|||
16371356|NCT00758043|39843619|FG000|Overall Study|Lost to Follow-up|0|||
16371357|NCT00758043|39843620|FG001|Overall Study|Lost to Follow-up|2|||
16371358|NCT00758043|39843621|FG002|Overall Study|Lost to Follow-up|2|||
16371359|NCT00758043|39843622|FG003|Overall Study|Lost to Follow-up|5|||
16371360|NCT00758043|39843619|FG000|Overall Study|Withdrawal by Subject|0|||
16371361|NCT00758043|39843620|FG001|Overall Study|Withdrawal by Subject|1|||
16371362|NCT00758043|39843621|FG002|Overall Study|Withdrawal by Subject|1|||
16371363|NCT00758043|39843622|FG003|Overall Study|Withdrawal by Subject|4|||
16371364|NCT00758043|39843619|FG000|Overall Study|Required Prohibited Medication|0|||
16371365|NCT00758043|39843620|FG001|Overall Study|Required Prohibited Medication|0|||
16371366|NCT00758043|39843621|FG002|Overall Study|Required Prohibited Medication|1|||
16371367|NCT00758043|39843622|FG003|Overall Study|Required Prohibited Medication|3|||
16371368|NCT00758043|39843619|FG000|Overall Study|Non-Compliant With study Drug|0|||
16371369|NCT00758043|39843620|FG001|Overall Study|Non-Compliant With study Drug|0|||
16371370|NCT00758043|39843621|FG002|Overall Study|Non-Compliant With study Drug|0|||
16371371|NCT00758043|39843622|FG003|Overall Study|Non-Compliant With study Drug|1|||
16371372|NCT00758043|39843619|FG000|Overall Study|Other Reasons|0|||
16371373|NCT00758043|39843620|FG001|Overall Study|Other Reasons|1|||
16371374|NCT00758043|39843621|FG002|Overall Study|Other Reasons|0|||
16371375|NCT00758043|39843622|FG003|Overall Study|Other Reasons|5|||
16447755|NCT03682770|40118741|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
16447756|NCT03682770|40118742|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
16447757|NCT03682770|40118743|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
16447758|NCT03682770|40118744|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
16447759|NCT03682770|40118745|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
16447760|NCT03682770|40118746|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
16447761|NCT03682770|40118740|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
16447762|NCT03682770|40118741|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
16447763|NCT03682770|40118742|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
16447764|NCT03682770|40118743|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
16447765|NCT03682770|40118744|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
16447766|NCT03682770|40118745|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
16447767|NCT03682770|40118746|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
16447768|NCT03682770|40118740|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
16447769|NCT03682770|40118741|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
16447770|NCT03682770|40118742|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
16371376|NCT01016015|39843623|FG000|Overall Study|Not Treated|3|||
16371377|NCT01016015|39843623|FG000|Overall Study|Withdrawal by Subject|1|||
16161337|NCT03605680|39072351|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
16161338|NCT03605680|39072352|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
16161339|NCT03605680|39072353|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
16371378|NCT01016015|39843623|FG000|Overall Study|Adverse Event|15|||
16371379|NCT01060111|39843624|FG000|Overall Study|Adverse Event|9|||
16161340|NCT03605680|39072354|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
16161341|NCT03605680|39072351|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
16161342|NCT03605680|39072352|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
16161343|NCT03605680|39072353|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
16161344|NCT03605680|39072354|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
16161345|NCT03605680|39072351|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
16161346|NCT03605680|39072352|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
16161347|NCT03605680|39072353|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
16161348|NCT03605680|39072354|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
16161349|NCT03605680|39072351|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
16161350|NCT03605680|39072352|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
16161351|NCT03605680|39072353|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
16161352|NCT03605680|39072354|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
16161353|NCT03605680|39072351|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
16161354|NCT03605680|39072352|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
16161355|NCT03605680|39072353|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
16161356|NCT03605680|39072354|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
16161357|NCT03605680|39072351|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
16161358|NCT03605680|39072352|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
16161359|NCT03605680|39072353|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
16161360|NCT03605680|39072354|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
16161361|NCT03605680|39072351|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
16161362|NCT03605680|39072352|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
16161363|NCT03605680|39072353|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
16161364|NCT03605680|39072354|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
16264821|NCT01597245|39453268|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
16264822|NCT01597245|39453269|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
16264823|NCT01597245|39453270|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264824|NCT01597245|39453271|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264825|NCT01597245|39453272|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264826|NCT01597245|39453273|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264827|NCT01597245|39453274|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
16264828|NCT01597245|39453254|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264829|NCT01597245|39453255|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264830|NCT01597245|39453256|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264831|NCT01597245|39453257|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264832|NCT01597245|39453258|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264833|NCT01597245|39453259|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264834|NCT01597245|39453260|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264835|NCT01597245|39453261|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264836|NCT01597245|39453262|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264837|NCT01597245|39453263|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264838|NCT01597245|39453264|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264839|NCT01597245|39453265|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264840|NCT01597245|39453266|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264841|NCT01597245|39453267|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
16264842|NCT01597245|39453268|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264843|NCT01597245|39453269|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264844|NCT01597245|39453270|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264845|NCT01597245|39453271|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264846|NCT01597245|39453272|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264847|NCT01597245|39453273|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264848|NCT01597245|39453274|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
16264849|NCT01597245|39453254|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16264850|NCT01597245|39453255|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16264851|NCT01597245|39453256|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16264852|NCT01597245|39453257|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16264853|NCT01597245|39453258|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16264854|NCT01597245|39453259|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16371380|NCT01060111|39843625|FG001|Overall Study|Adverse Event|5|||
16371381|NCT01060111|39843626|FG002|Overall Study|Adverse Event|18|||
16371382|NCT01060111|39843624|FG000|Overall Study|Lack of Efficacy|2|||
16371383|NCT01060111|39843625|FG001|Overall Study|Lack of Efficacy|1|||
16371384|NCT01060111|39843626|FG002|Overall Study|Lack of Efficacy|0|||
16371385|NCT01060111|39843624|FG000|Overall Study|Inappropriate participant|5|||
16371386|NCT01060111|39843625|FG001|Overall Study|Inappropriate participant|4|||
16371387|NCT01060111|39843626|FG002|Overall Study|Inappropriate participant|5|||
16371388|NCT01060111|39843624|FG000|Overall Study|Participants' evasion for hospital visit|0|||
16371389|NCT01060111|39843625|FG001|Overall Study|Participants' evasion for hospital visit|3|||
16371390|NCT01060111|39843626|FG002|Overall Study|Participants' evasion for hospital visit|2|||
16371391|NCT01060111|39843624|FG000|Overall Study|Participants' non-cooperation|8|||
16371392|NCT01060111|39843625|FG001|Overall Study|Participants' non-cooperation|6|||
16371393|NCT01060111|39843626|FG002|Overall Study|Participants' non-cooperation|6|||
16371394|NCT01060111|39843624|FG000|Overall Study|Adverse event and insufficient effect|0|||
16371395|NCT01060111|39843625|FG001|Overall Study|Adverse event and insufficient effect|1|||
16371396|NCT01060111|39843626|FG002|Overall Study|Adverse event and insufficient effect|0|||
16371397|NCT01060111|39843624|FG000|Overall Study|Participants' non-cooperation|1|||
16371398|NCT01060111|39843625|FG001|Overall Study|Participants' non-cooperation|0|||
16371399|NCT01060111|39843626|FG002|Overall Study|Participants' non-cooperation|0|||
16371400|NCT01060111|39843624|FG000|Overall Study|Other|2|||
16371401|NCT01060111|39843625|FG001|Overall Study|Other|3|||
16371402|NCT01060111|39843626|FG002|Overall Study|Other|4|||
16371403|NCT00309244|39843632|FG000|Overall Study|Adverse Event|29|||
16371404|NCT00309244|39843633|FG001|Overall Study|Adverse Event|12|||
16371405|NCT00309244|39843632|FG000|Overall Study|Lost to Follow-up|6|||
16371406|NCT00309244|39843633|FG001|Overall Study|Lost to Follow-up|22|||
16371407|NCT00309244|39843632|FG000|Overall Study|Physician Decision|5|||
16371408|NCT00309244|39843633|FG001|Overall Study|Physician Decision|8|||
16371409|NCT00309244|39843632|FG000|Overall Study|Protocol Violation|6|||
16371410|NCT00309244|39843633|FG001|Overall Study|Protocol Violation|3|||
16371411|NCT00309244|39843632|FG000|Overall Study|Withdrawal by Subject|50|||
16371412|NCT00309244|39843633|FG001|Overall Study|Withdrawal by Subject|32|||
16371413|NCT00309244|39843632|FG000|Overall Study|Various|7|||
16371414|NCT00309244|39843633|FG001|Overall Study|Various|7|||
16371415|NCT00309244|39843632|FG000|Overall Study|Randomized but not dosed|11|||
16371416|NCT00309244|39843633|FG001|Overall Study|Randomized but not dosed|12|||
16371417|NCT00309244|39843632|FG000|Overall Study|Death|4|||
16371418|NCT00309244|39843633|FG001|Overall Study|Death|1|||
16371419|NCT01696214|39843636|FG000|Overall Study|Lost to Follow-up|1|||
16371420|NCT01696214|39843637|FG001|Overall Study|Lost to Follow-up|0|||
16371421|NCT01696214|39843638|FG002|Overall Study|Lost to Follow-up|0|||
16371422|NCT01696214|39843639|FG003|Overall Study|Lost to Follow-up|0|||
16371423|NCT03528577|39843652|FG000|Sequence 1|Failed Spirometry|1|||
16371424|NCT03528577|39843652|FG000|Sequence 1|Restricted medication|1|||
16371425|NCT03528577|39843652|FG000|Sequence 2|Adverse Event|1|||
16371426|NCT03528577|39843652|FG000|Sequence 2|Withdrawal by Subject|1|||
16371427|NCT03528577|39843652|FG000|Sequence 2|Failed Spirometry|1|||
16371428|NCT03528577|39843652|FG000|Sequence 3|Failed Spirometry|1|||
16371429|NCT03528577|39843652|FG000|Sequence 4|Failed Spirometry|2|||
16371430|NCT03528577|39843652|FG000|Sequence 4|Adverse Event|1|||
16371431|NCT00899847|39843653|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
16371432|NCT02460380|39843654|FG000|Overall Study|Withdrawal by Subject|10|||
16371433|NCT02460380|39843655|FG001|Overall Study|Withdrawal by Subject|5|||
16371434|NCT00474968|39843668|FG000|Overall Study|Withdrawal by Subject|8|||
16371435|NCT00474968|39843669|FG001|Overall Study|Withdrawal by Subject|7|||
16371436|NCT00474968|39843668|FG000|Overall Study|Protocol Violation|9|||
16371437|NCT00474968|39843669|FG001|Overall Study|Protocol Violation|8|||
16371438|NCT00474968|39843668|FG000|Overall Study|Sample not collected|1|||
16371439|NCT00474968|39843669|FG001|Overall Study|Sample not collected|1|||
16371440|NCT01691482|39843670|FG000|Treatment Period 2|Adverse Event|0|||
16371441|NCT01691482|39843671|FG001|Treatment Period 2|Adverse Event|1|||
16371442|NCT01691482|39843670|FG000|Treatment Period 2|Protocol Violation|1|||
16371443|NCT01691482|39843671|FG001|Treatment Period 2|Protocol Violation|1|||
16371444|NCT03055221|39843672|FG000|Overall Study|Adverse Event|2|||
16371445|NCT03055221|39843672|FG000|Overall Study|Withdrawal by Subject|4|||
16371446|NCT03055221|39843672|FG000|Overall Study|Death|6|||
16371447|NCT03055221|39843672|FG000|Overall Study|Physician Decision|1|||
16371448|NCT03055221|39843672|FG000|Overall Study|Study terminated by Sponsor|3|||
16371449|NCT03055221|39843672|FG000|Overall Study|Lost to Follow-up|4|||
16371450|NCT04090749|39843673|FG000|Open Label Pilot|Lost to Follow-up|1|||
16371451|NCT04090749|39843674|FG001|Open Label Pilot|Lost to Follow-up|0|||
16371452|NCT04090749|39843675|FG002|Open Label Pilot|Lost to Follow-up|0|||
16371453|NCT04090749|39843673|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
16371454|NCT04090749|39843674|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
16371455|NCT04090749|39843675|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
16371456|NCT04090749|39843673|FG000|Pilot Trial|Lost to Follow-up|0|||
16371457|NCT04090749|39843674|FG001|Pilot Trial|Lost to Follow-up|1|||
16371458|NCT04090749|39843675|FG002|Pilot Trial|Lost to Follow-up|1|||
16371459|NCT03072875|39843690|FG000|Overall Study|Lost to Follow-up|1|||
16371460|NCT01543503|39843691|FG000|Overall Study|Lost to Follow-up|32|||
16371461|NCT01543503|39843692|FG001|Overall Study|Lost to Follow-up|36|||
16371462|NCT01543503|39843691|FG000|Overall Study|Adverse Event|9|||
16371463|NCT01543503|39843692|FG001|Overall Study|Adverse Event|13|||
16371464|NCT01543503|39843691|FG000|Overall Study|Lack of Efficacy|4|||
16371465|NCT01543503|39843692|FG001|Overall Study|Lack of Efficacy|16|||
16371466|NCT01543503|39843691|FG000|Overall Study|Participant withdrew informed consent|8|||
16371467|NCT01543503|39843692|FG001|Overall Study|Participant withdrew informed consent|10|||
16371468|NCT01543503|39843691|FG000|Overall Study|Change of jobs|0|||
16371469|NCT01543503|39843692|FG001|Overall Study|Change of jobs|1|||
16371470|NCT01543503|39843691|FG000|Overall Study|Intolerance to the biologic treatment|0|||
16371471|NCT01543503|39843692|FG001|Overall Study|Intolerance to the biologic treatment|1|||
16371472|NCT01543503|39843691|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
16371473|NCT01543503|39843692|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
16371474|NCT01543503|39843691|FG000|Overall Study|Participant did not complete last visit|0|||
16371475|NCT01543503|39843692|FG001|Overall Study|Participant did not complete last visit|2|||
16371476|NCT01543503|39843691|FG000|Overall Study|Refused to continue treatment|7|||
16371477|NCT01543503|39843692|FG001|Overall Study|Refused to continue treatment|0|||
16371478|NCT01543503|39843691|FG000|Overall Study|Incorrect medication received|1|||
16371479|NCT01543503|39843692|FG001|Overall Study|Incorrect medication received|0|||
16069202|NCT00771667|38742821|FG007|Induction Phase|Adverse Event|0|||
16069203|NCT00771667|38742822|FG008|Induction Phase|Adverse Event|0|||
16069204|NCT00771667|38742823|FG009|Induction Phase|Adverse Event|0|||
16069205|NCT00771667|38742814|FG000|Induction Phase|Lack of Efficacy|9|||
16069206|NCT00771667|38742815|FG001|Induction Phase|Lack of Efficacy|2|||
16069207|NCT00771667|38742816|FG002|Induction Phase|Lack of Efficacy|4|||
16069208|NCT00771667|38742817|FG003|Induction Phase|Lack of Efficacy|3|||
16069209|NCT00771667|38742818|FG004|Induction Phase|Lack of Efficacy|0|||
16069210|NCT00771667|38742819|FG005|Induction Phase|Lack of Efficacy|0|||
16069211|NCT00771667|38742820|FG006|Induction Phase|Lack of Efficacy|0|||
16371480|NCT01543503|39843691|FG000|Overall Study|Participant moved to another city|2|||
16371481|NCT01543503|39843692|FG001|Overall Study|Participant moved to another city|0|||
16371482|NCT01543503|39843691|FG000|Overall Study|Participant will not return for visits|0|||
16371483|NCT01543503|39843692|FG001|Overall Study|Participant will not return for visits|2|||
16371484|NCT01543503|39843691|FG000|Overall Study|Participant transferred to another city|1|||
16371485|NCT01543503|39843692|FG001|Overall Study|Participant transferred to another city|0|||
16371486|NCT01543503|39843691|FG000|Overall Study|Participant moved to Scotland|1|||
16371487|NCT01543503|39843692|FG001|Overall Study|Participant moved to Scotland|0|||
16371488|NCT01543503|39843691|FG000|Overall Study|Participant decision to stop treatment|1|||
16371489|NCT01543503|39843692|FG001|Overall Study|Participant decision to stop treatment|0|||
16371490|NCT01543503|39843691|FG000|Overall Study|Investigator did not wish to participate|1|||
16371491|NCT01543503|39843692|FG001|Overall Study|Investigator did not wish to participate|1|||
16371492|NCT01543503|39843691|FG000|Overall Study|Participant recruited after closing date|0|||
16371493|NCT01543503|39843692|FG001|Overall Study|Participant recruited after closing date|1|||
16371494|NCT01543503|39843691|FG000|Overall Study|Site stopped participation|5|||
16371495|NCT01543503|39843692|FG001|Overall Study|Site stopped participation|1|||
16069212|NCT00771667|38742821|FG007|Induction Phase|Lack of Efficacy|0|||
16069213|NCT00771667|38742822|FG008|Induction Phase|Lack of Efficacy|0|||
16371496|NCT01543503|39843691|FG000|Overall Study|Participant did not attend a visit|1|||
16371497|NCT01543503|39843692|FG001|Overall Study|Participant did not attend a visit|0|||
16371498|NCT01543503|39843691|FG000|Overall Study|Moved to other rheumatologic site|0|||
16371499|NCT01543503|39843692|FG001|Overall Study|Moved to other rheumatologic site|1|||
16371500|NCT01543503|39843691|FG000|Overall Study|Participant consented to another study|0|||
16371501|NCT01543503|39843692|FG001|Overall Study|Participant consented to another study|2|||
16371502|NCT01543503|39843691|FG000|Overall Study|Participant went to United States|1|||
16371503|NCT01543503|39843692|FG001|Overall Study|Participant went to United States|0|||
16371504|NCT01543503|39843691|FG000|Overall Study|Screen failure|1|||
16371505|NCT01543503|39843692|FG001|Overall Study|Screen failure|0|||
16371506|NCT01720602|39843693|FG000|Overall Study|Adverse Event|3|||
16371507|NCT01720602|39843693|FG000|Overall Study|Progressive disease on therapy|2|||
16371508|NCT00366535|39843697|FG000|First Phase: 12 Weeks|Adverse Event|1|||
16371509|NCT00366535|39843698|FG001|First Phase: 12 Weeks|Adverse Event|3|||
16371510|NCT00366535|39843697|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
16371511|NCT00366535|39843698|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
16371512|NCT00366535|39843697|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
16371513|NCT00366535|39843698|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
16371514|NCT00366535|39843697|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
16371515|NCT00366535|39843698|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
16069214|NCT00771667|38742823|FG009|Induction Phase|Lack of Efficacy|0|||
16069215|NCT00771667|38742814|FG000|Induction Phase|Lost to Follow-up|1|||
16371516|NCT01750281|39843699|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
16371517|NCT01750281|39843700|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
16371518|NCT01750281|39843701|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
16371519|NCT01750281|39843699|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
16371520|NCT01750281|39843700|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
16371521|NCT01750281|39843701|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
16371522|NCT01750281|39843699|FG000|Overall Study|Did not receive treatment|0|||
16371523|NCT01750281|39843700|FG001|Overall Study|Did not receive treatment|1|||
16371524|NCT01750281|39843701|FG002|Overall Study|Did not receive treatment|0|||
16371525|NCT01402700|39843702|FG000|Overall Study|Death|3|||
16371526|NCT01402700|39843702|FG000|Overall Study|Withdrawal by Subject|3|||
16371527|NCT01402700|39843702|FG000|Overall Study|Missed Visit|1|||
16371528|NCT02151604|39846501|FG000|Overall Study|Lost to Follow-up|3|||
16371529|NCT02151604|39846501|FG000|Overall Study|Withdrawal by Subject|2|||
16371530|NCT02151604|39846501|FG000|Overall Study|Physician Decision|3|||
16371531|NCT02151604|39846501|FG000|Overall Study|Death|1|||
16371532|NCT00212355|39846502|FG000|Overall Study|Adverse Event|1|||
16371533|NCT00212355|39846502|FG000|Overall Study|Withdrawal by Subject|1|||
16371534|NCT00212355|39846502|FG000|Overall Study|A change of address|1|||
16371535|NCT00003474|39846503|FG000|Overall Study|Not Evaluable|14|||
16371536|NCT03425188|39846505|FG000|Overall Study|Withdrawal by Subject|1|||
16371537|NCT01560988|39846506|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
16371538|NCT01560988|39846507|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
16371539|NCT01560988|39846506|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
16371540|NCT01560988|39846507|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
16371541|NCT01560988|39846506|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
16371542|NCT01560988|39846507|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
16371543|NCT01927861|39846511|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
16371544|NCT01927861|39846512|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
16371545|NCT01927861|39846511|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
16371546|NCT01927861|39846512|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
16371547|NCT02493855|39846516|FG000|Overall Study|Non-compliance|1|||
16371548|NCT02493855|39846517|FG001|Overall Study|Non-compliance|0|||
16371549|NCT02493855|39846518|FG002|Overall Study|Non-compliance|0|||
16371550|NCT02493855|39846516|FG000|Overall Study|Adverse Event|0|||
16371551|NCT02493855|39846517|FG001|Overall Study|Adverse Event|1|||
16371552|NCT02493855|39846518|FG002|Overall Study|Adverse Event|0|||
16371553|NCT02493855|39846516|FG000|Overall Study|Withdrawal by Subject|1|||
16371554|NCT02493855|39846517|FG001|Overall Study|Withdrawal by Subject|0|||
16371555|NCT02493855|39846518|FG002|Overall Study|Withdrawal by Subject|0|||
16371556|NCT02959892|39846522|FG000|Overall Study|PET tracer synthesis failure|1|||
16371557|NCT02959892|39846523|FG001|Overall Study|PET tracer synthesis failure|0|||
16371558|NCT02959892|39846522|FG000|Overall Study|Study termination|0|||
16371559|NCT02959892|39846523|FG001|Overall Study|Study termination|1|||
16371560|NCT02872142|39846525|FG000|Overall Study|Adverse Event|2|||
16371561|NCT02872142|39846525|FG000|Overall Study|Death|1|||
16371562|NCT02872142|39846525|FG000|Overall Study|Participant Decision|3|||
16371563|NCT02184442|39846527|FG000|Overall Study|Death|61|||
16371564|NCT02184442|39846528|FG001|Overall Study|Death|65|||
16371565|NCT02184442|39846527|FG000|Overall Study|Withdrawal by Subject|3|||
16371566|NCT02184442|39846528|FG001|Overall Study|Withdrawal by Subject|11|||
16371567|NCT02186171|39846529|FG000|Overall Study|Withdrawal by Subject|1|||
16371568|NCT02186171|39846530|FG001|Overall Study|Withdrawal by Subject|9|||
16371569|NCT02186171|39846529|FG000|Overall Study|Lost to Follow-up|2|||
16371570|NCT02186171|39846530|FG001|Overall Study|Lost to Follow-up|2|||
16371571|NCT02186171|39846529|FG000|Overall Study|Death|1|||
16371572|NCT02186171|39846530|FG001|Overall Study|Death|2|||
16371573|NCT02186171|39846529|FG000|Overall Study|Protocol-specified Criteria|0|||
16371574|NCT02186171|39846530|FG001|Overall Study|Protocol-specified Criteria|2|||
16371575|NCT01618708|39846531|FG000|Overall Study|Adverse Event|10|||
16371576|NCT01618708|39846532|FG001|Overall Study|Adverse Event|10|||
16371577|NCT01618708|39846531|FG000|Overall Study|Lost to Follow-up|3|||
16371578|NCT01618708|39846532|FG001|Overall Study|Lost to Follow-up|3|||
16371579|NCT01618708|39846531|FG000|Overall Study|Withdrawal by Subject|17|||
16371580|NCT01618708|39846532|FG001|Overall Study|Withdrawal by Subject|22|||
16371581|NCT01618708|39846531|FG000|Overall Study|Lack of Efficacy|8|||
16371582|NCT01618708|39846532|FG001|Overall Study|Lack of Efficacy|8|||
16371583|NCT01618708|39846531|FG000|Overall Study|Technical problems|2|||
16371584|NCT01618708|39846532|FG001|Overall Study|Technical problems|0|||
16371585|NCT01618708|39846531|FG000|Overall Study|Other than specified above|1|||
16371586|NCT01618708|39846532|FG001|Overall Study|Other than specified above|1|||
16371587|NCT01618708|39846531|FG000|Overall Study|Randomized but not treated|3|||
16371588|NCT01618708|39846532|FG001|Overall Study|Randomized but not treated|2|||
16447771|NCT03682770|40118743|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
16371589|NCT02636283|39846533|FG000|Overall Study|Adverse Event|2|||
16371590|NCT02636283|39846534|FG001|Overall Study|Adverse Event|0|||
16371591|NCT02636283|39846533|FG000|Overall Study|Trial Terminated Prematurely|0|||
16371592|NCT02636283|39846534|FG001|Overall Study|Trial Terminated Prematurely|3|||
16371593|NCT00806026|39846537|FG000|Overall Study|Death|0|||
16371594|NCT00806026|39846538|FG001|Overall Study|Death|0|||
16371595|NCT00806026|39846539|FG002|Overall Study|Death|0|||
16371596|NCT00806026|39846540|FG003|Overall Study|Death|1|||
16371597|NCT00806026|39846541|FG004|Overall Study|Death|0|||
16371598|NCT00806026|39846542|FG005|Overall Study|Death|0|||
16371599|NCT00806026|39846537|FG000|Overall Study|Did not meet entrance criteria|4|||
16371600|NCT00806026|39846538|FG001|Overall Study|Did not meet entrance criteria|1|||
16371601|NCT00806026|39846539|FG002|Overall Study|Did not meet entrance criteria|2|||
16371602|NCT00806026|39846540|FG003|Overall Study|Did not meet entrance criteria|1|||
16069216|NCT00771667|38742815|FG001|Induction Phase|Lost to Follow-up|0|||
16069217|NCT00771667|38742816|FG002|Induction Phase|Lost to Follow-up|1|||
16069218|NCT00771667|38742817|FG003|Induction Phase|Lost to Follow-up|0|||
16371603|NCT00806026|39846541|FG004|Overall Study|Did not meet entrance criteria|0|||
16371604|NCT00806026|39846542|FG005|Overall Study|Did not meet entrance criteria|0|||
16371605|NCT00806026|39846537|FG000|Overall Study|Lack of Efficacy|5|||
16371606|NCT00806026|39846538|FG001|Overall Study|Lack of Efficacy|18|||
16371607|NCT00806026|39846539|FG002|Overall Study|Lack of Efficacy|13|||
16371608|NCT00806026|39846540|FG003|Overall Study|Lack of Efficacy|4|||
16371609|NCT00806026|39846541|FG004|Overall Study|Lack of Efficacy|8|||
16371610|NCT00806026|39846542|FG005|Overall Study|Lack of Efficacy|7|||
16371611|NCT00806026|39846537|FG000|Overall Study|Lost to Follow-up|8|||
16371612|NCT00806026|39846538|FG001|Overall Study|Lost to Follow-up|15|||
16371613|NCT00806026|39846539|FG002|Overall Study|Lost to Follow-up|8|||
16371614|NCT00806026|39846540|FG003|Overall Study|Lost to Follow-up|2|||
16371615|NCT00806026|39846541|FG004|Overall Study|Lost to Follow-up|6|||
16371616|NCT00806026|39846542|FG005|Overall Study|Lost to Follow-up|6|||
16371617|NCT00806026|39846537|FG000|Overall Study|Withdrawal by Subject|14|||
16371618|NCT00806026|39846538|FG001|Overall Study|Withdrawal by Subject|17|||
16371619|NCT00806026|39846539|FG002|Overall Study|Withdrawal by Subject|9|||
16371620|NCT00806026|39846540|FG003|Overall Study|Withdrawal by Subject|2|||
16447772|NCT03682770|40118744|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
16447773|NCT03682770|40118745|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
16447774|NCT03682770|40118746|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
16447775|NCT03682770|40118740|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
16447776|NCT03682770|40118741|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
16447777|NCT03682770|40118742|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
16447778|NCT03682770|40118743|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
16447779|NCT03682770|40118744|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
16447780|NCT03682770|40118745|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
16447781|NCT03682770|40118746|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
16447782|NCT03682770|40118740|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
16447783|NCT03682770|40118741|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
16447784|NCT03682770|40118742|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
16447785|NCT03682770|40118743|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
16447786|NCT03682770|40118744|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
16447787|NCT03682770|40118745|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
16447788|NCT03682770|40118746|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
16447789|NCT03682770|40118740|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
16447790|NCT03682770|40118741|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
16447791|NCT03682770|40118742|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
16447792|NCT03682770|40118743|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
16447793|NCT03682770|40118744|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
16447794|NCT03682770|40118745|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
16447795|NCT03682770|40118746|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
16447796|NCT03879772|40118747|FG000|Overall Study|Adverse Event|2|||
16447797|NCT03879772|40118748|FG001|Overall Study|Adverse Event|2|||
16447798|NCT03879772|40118749|FG002|Overall Study|Adverse Event|3|||
16447799|NCT03879772|40118750|FG003|Overall Study|Adverse Event|4|||
16447800|NCT03879772|40118751|FG004|Overall Study|Adverse Event|3|||
16447801|NCT03879772|40118747|FG000|Overall Study|Treatment Failure|1|||
16447802|NCT03879772|40118748|FG001|Overall Study|Treatment Failure|0|||
16447803|NCT03879772|40118749|FG002|Overall Study|Treatment Failure|0|||
16447804|NCT03879772|40118750|FG003|Overall Study|Treatment Failure|2|||
16447805|NCT03879772|40118751|FG004|Overall Study|Treatment Failure|1|||
16371621|NCT00806026|39846541|FG004|Overall Study|Withdrawal by Subject|5|||
16371622|NCT00806026|39846542|FG005|Overall Study|Withdrawal by Subject|3|||
16371623|NCT00806026|39846537|FG000|Overall Study|Other|3|||
16371624|NCT00806026|39846538|FG001|Overall Study|Other|6|||
16371625|NCT00806026|39846539|FG002|Overall Study|Other|8|||
16371626|NCT00806026|39846540|FG003|Overall Study|Other|2|||
16371627|NCT00806026|39846541|FG004|Overall Study|Other|0|||
16161365|NCT03605680|39072351|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
16161366|NCT03605680|39072352|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
16161367|NCT03605680|39072353|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
16161368|NCT03605680|39072354|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
16371628|NCT00806026|39846542|FG005|Overall Study|Other|4|||
16371629|NCT00806026|39846537|FG000|Overall Study|Protocol Violation|6|||
16161369|NCT03605680|39072351|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
16161370|NCT03605680|39072352|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
16161371|NCT03605680|39072353|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
16161372|NCT03605680|39072354|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
16161373|NCT03605680|39072351|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
16161374|NCT03605680|39072352|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
16161375|NCT03605680|39072353|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
16161376|NCT03605680|39072354|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
16161377|NCT03605680|39072351|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
16161378|NCT03605680|39072352|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
16161379|NCT03605680|39072353|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
16161380|NCT03605680|39072354|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
16161381|NCT03605680|39072351|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
16161382|NCT03605680|39072352|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
16161383|NCT03605680|39072353|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
16161384|NCT03605680|39072354|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
16161385|NCT03605680|39072351|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
16161386|NCT03605680|39072352|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
16161387|NCT03605680|39072353|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
16161388|NCT03605680|39072354|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
16161389|NCT03605680|39072351|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
16371630|NCT00806026|39846538|FG001|Overall Study|Protocol Violation|9|||
16371631|NCT00806026|39846539|FG002|Overall Study|Protocol Violation|9|||
16371632|NCT00806026|39846540|FG003|Overall Study|Protocol Violation|0|||
16069219|NCT00771667|38742818|FG004|Induction Phase|Lost to Follow-up|0|||
16069220|NCT00771667|38742819|FG005|Induction Phase|Lost to Follow-up|0|||
16069221|NCT00771667|38742820|FG006|Induction Phase|Lost to Follow-up|0|||
16069222|NCT00771667|38742821|FG007|Induction Phase|Lost to Follow-up|0|||
16069223|NCT00771667|38742822|FG008|Induction Phase|Lost to Follow-up|0|||
16069224|NCT00771667|38742823|FG009|Induction Phase|Lost to Follow-up|0|||
16069225|NCT00771667|38742814|FG000|Induction Phase|Other|4|||
16069226|NCT00771667|38742815|FG001|Induction Phase|Other|6|||
16069227|NCT00771667|38742816|FG002|Induction Phase|Other|3|||
16069228|NCT00771667|38742817|FG003|Induction Phase|Other|4|||
16069229|NCT00771667|38742818|FG004|Induction Phase|Other|0|||
16069230|NCT00771667|38742819|FG005|Induction Phase|Other|0|||
16069231|NCT00771667|38742820|FG006|Induction Phase|Other|0|||
16069232|NCT00771667|38742821|FG007|Induction Phase|Other|0|||
16069233|NCT00771667|38742822|FG008|Induction Phase|Other|0|||
16371633|NCT00806026|39846541|FG004|Overall Study|Protocol Violation|2|||
16371634|NCT00806026|39846542|FG005|Overall Study|Protocol Violation|3|||
16371635|NCT00806026|39846537|FG000|Overall Study|Adverse Event|52|||
16371636|NCT00806026|39846538|FG001|Overall Study|Adverse Event|35|||
16371637|NCT00806026|39846539|FG002|Overall Study|Adverse Event|44|||
16371638|NCT00806026|39846540|FG003|Overall Study|Adverse Event|17|||
16371639|NCT00806026|39846541|FG004|Overall Study|Adverse Event|9|||
16371640|NCT00806026|39846542|FG005|Overall Study|Adverse Event|9|||
16371641|NCT00471107|39846543|FG000|Overall Study|Technical problems/data loss|3|||
16371642|NCT00471107|39846544|FG001|Overall Study|Technical problems/data loss|1|||
16371643|NCT00471107|39846545|FG002|Overall Study|Technical problems/data loss|3|||
16371644|NCT00689052|39846549|FG000|Overall Study|Adverse Event|4|||
16371645|NCT00689052|39846550|FG001|Overall Study|Adverse Event|6|||
16371646|NCT00689052|39846549|FG000|Overall Study|Protocol Violation|1|||
16371647|NCT00689052|39846550|FG001|Overall Study|Protocol Violation|0|||
16371648|NCT00689052|39846549|FG000|Overall Study|Lost to Follow-up|2|||
16371649|NCT00689052|39846550|FG001|Overall Study|Lost to Follow-up|0|||
16371650|NCT00689052|39846549|FG000|Overall Study|Withdrawal by Subject|2|||
16371651|NCT00689052|39846550|FG001|Overall Study|Withdrawal by Subject|0|||
16371652|NCT00689052|39846549|FG000|Overall Study|Early termination of the trial|22|||
16371653|NCT00689052|39846550|FG001|Overall Study|Early termination of the trial|24|||
16069234|NCT00771667|38742823|FG009|Induction Phase|Other|0|||
16069235|NCT00771667|38742814|FG000|Maintenance Phase|Adverse Event|0|||
16069236|NCT00771667|38742815|FG001|Maintenance Phase|Adverse Event|0|||
16069237|NCT00771667|38742816|FG002|Maintenance Phase|Adverse Event|0|||
16069238|NCT00771667|38742817|FG003|Maintenance Phase|Adverse Event|0|||
16069239|NCT00771667|38742818|FG004|Maintenance Phase|Adverse Event|1|||
16069240|NCT00771667|38742819|FG005|Maintenance Phase|Adverse Event|3|||
16161390|NCT03605680|39072352|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
16161391|NCT03605680|39072353|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
16161392|NCT03605680|39072354|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
16161393|NCT03605680|39072351|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
16161394|NCT03605680|39072352|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
16161395|NCT03605680|39072353|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
16161396|NCT03605680|39072354|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
16161397|NCT03605680|39072351|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
16161398|NCT03605680|39072352|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
16161399|NCT03605680|39072353|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
16161400|NCT03605680|39072354|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
16161401|NCT03605680|39072351|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
16161402|NCT03605680|39072352|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
16161403|NCT03605680|39072353|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
16069241|NCT00771667|38742820|FG006|Maintenance Phase|Adverse Event|5|||
16069242|NCT00771667|38742821|FG007|Maintenance Phase|Adverse Event|1|||
16069243|NCT00771667|38742822|FG008|Maintenance Phase|Adverse Event|8|||
16069244|NCT00771667|38742823|FG009|Maintenance Phase|Adverse Event|7|||
16069245|NCT00771667|38742814|FG000|Maintenance Phase|Lack of Efficacy|0|||
16069246|NCT00771667|38742815|FG001|Maintenance Phase|Lack of Efficacy|0|||
16069247|NCT00771667|38742816|FG002|Maintenance Phase|Lack of Efficacy|0|||
16069248|NCT00771667|38742817|FG003|Maintenance Phase|Lack of Efficacy|0|||
16069249|NCT00771667|38742818|FG004|Maintenance Phase|Lack of Efficacy|1|||
16069250|NCT00771667|38742819|FG005|Maintenance Phase|Lack of Efficacy|3|||
16161404|NCT03605680|39072354|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
16161405|NCT02894840|39072355|FG000|Overall Study|Lost to Follow-up|1|||
16161406|NCT02894840|39072356|FG001|Overall Study|Lost to Follow-up|0|||
16161407|NCT02894840|39072357|FG002|Overall Study|Lost to Follow-up|3|||
16161408|NCT02894840|39072358|FG003|Overall Study|Lost to Follow-up|0|||
16161409|NCT01632566|39072359|FG000|Overall Study|Withdrawal by Subject|0|||
16161410|NCT01632566|39072360|FG001|Overall Study|Withdrawal by Subject|1|||
16161411|NCT01632566|39072361|FG002|Overall Study|Withdrawal by Subject|0|||
16161412|NCT01632566|39072362|FG003|Overall Study|Withdrawal by Subject|0|||
16161413|NCT01632566|39072363|FG004|Overall Study|Withdrawal by Subject|0|||
16161414|NCT01632566|39072359|FG000|Overall Study|Sponsor Decision|0|||
16069251|NCT00771667|38742820|FG006|Maintenance Phase|Lack of Efficacy|3|||
16069252|NCT00771667|38742821|FG007|Maintenance Phase|Lack of Efficacy|2|||
16069253|NCT00771667|38742822|FG008|Maintenance Phase|Lack of Efficacy|11|||
16069254|NCT00771667|38742823|FG009|Maintenance Phase|Lack of Efficacy|7|||
16069255|NCT00771667|38742814|FG000|Maintenance Phase|Other|0|||
16069256|NCT00771667|38742815|FG001|Maintenance Phase|Other|0|||
16069257|NCT00771667|38742816|FG002|Maintenance Phase|Other|0|||
16069258|NCT00771667|38742817|FG003|Maintenance Phase|Other|0|||
16069259|NCT00771667|38742818|FG004|Maintenance Phase|Other|0|||
16069260|NCT00771667|38742819|FG005|Maintenance Phase|Other|1|||
16069261|NCT00771667|38742820|FG006|Maintenance Phase|Other|2|||
16069262|NCT00771667|38742821|FG007|Maintenance Phase|Other|2|||
16069263|NCT00771667|38742822|FG008|Maintenance Phase|Other|3|||
16069264|NCT00771667|38742823|FG009|Maintenance Phase|Other|3|||
16069265|NCT02333630|38742824|FG000|Overall Study|Lost to Follow-up|5|||
16069266|NCT02333630|38742825|FG001|Overall Study|Lost to Follow-up|2|||
16069267|NCT00711646|38742831|FG000|Overall Study|Adverse Event|6|||
16069268|NCT00711646|38742832|FG001|Overall Study|Adverse Event|1|||
16069269|NCT00711646|38742831|FG000|Overall Study|Withdrawal by Subject|4|||
16069270|NCT00711646|38742832|FG001|Overall Study|Withdrawal by Subject|0|||
16069271|NCT00711646|38742831|FG000|Overall Study|Protocol Violation|0|||
16069272|NCT00711646|38742832|FG001|Overall Study|Protocol Violation|1|||
16069273|NCT00711646|38742831|FG000|Overall Study|Lost to Follow-up|1|||
16069274|NCT00711646|38742832|FG001|Overall Study|Lost to Follow-up|0|||
16069275|NCT00711646|38742831|FG000|Overall Study|administrative decision|0|||
16069276|NCT00711646|38742832|FG001|Overall Study|administrative decision|1|||
16161415|NCT01632566|39072360|FG001|Overall Study|Sponsor Decision|2|||
16161416|NCT01632566|39072361|FG002|Overall Study|Sponsor Decision|9|||
16161417|NCT01632566|39072362|FG003|Overall Study|Sponsor Decision|2|||
16161418|NCT01632566|39072363|FG004|Overall Study|Sponsor Decision|2|||
16447806|NCT03879772|40118747|FG000|Overall Study|Lost to Follow-up|0|||
16069277|NCT00711646|38742831|FG000|Overall Study|patient non-compliance|1|||
16069278|NCT00711646|38742832|FG001|Overall Study|patient non-compliance|0|||
16069279|NCT03120676|38742833|FG000|Overall Study|Not treated|1|||
16069280|NCT01120275|38742834|FG000|Overall Study|Adverse Event|3|||
16069281|NCT01120275|38742834|FG000|Overall Study|Progression|27|||
16069282|NCT01120275|38742834|FG000|Overall Study|Ineligible|3|||
16069283|NCT01120275|38742834|FG000|Overall Study|Withdrawal by Subject|1|||
16069284|NCT01120275|38742834|FG000|Overall Study|Refusal|1|||
16069285|NCT01120275|38742834|FG000|Overall Study|Not specific|1|||
16161419|NCT01609842|39072364|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
16161420|NCT01609842|39072365|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
16161421|NCT00763321|39072371|FG000|Open-label Period|Adverse Event|24|||
16161422|NCT00763321|39072372|FG001|Open-label Period|Adverse Event|0|||
16161423|NCT00763321|39072373|FG002|Open-label Period|Adverse Event|0|||
16161424|NCT00763321|39072371|FG000|Open-label Period|Lost to Follow-up|14|||
16161425|NCT00763321|39072372|FG001|Open-label Period|Lost to Follow-up|0|||
16161426|NCT00763321|39072373|FG002|Open-label Period|Lost to Follow-up|0|||
16161427|NCT00763321|39072371|FG000|Open-label Period|Withdrawal by Subject|7|||
16161428|NCT00763321|39072372|FG001|Open-label Period|Withdrawal by Subject|0|||
16161429|NCT00763321|39072373|FG002|Open-label Period|Withdrawal by Subject|0|||
16161430|NCT00763321|39072371|FG000|Open-label Period|Subject noncompliant|7|||
16161431|NCT00763321|39072372|FG001|Open-label Period|Subject noncompliant|0|||
16161432|NCT00763321|39072373|FG002|Open-label Period|Subject noncompliant|0|||
16161433|NCT00763321|39072371|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
16161434|NCT00763321|39072372|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
16161435|NCT00763321|39072373|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
16161436|NCT00763321|39072371|FG000|Open-label Period|Lack of Efficacy|2|||
16161437|NCT00763321|39072372|FG001|Open-label Period|Lack of Efficacy|0|||
16161438|NCT00763321|39072373|FG002|Open-label Period|Lack of Efficacy|0|||
16161439|NCT00763321|39072371|FG000|Open-label Period|Other|4|||
16161440|NCT00763321|39072372|FG001|Open-label Period|Other|0|||
16161441|NCT00763321|39072373|FG002|Open-label Period|Other|0|||
16161442|NCT00763321|39072371|FG000|Double-blind Period|Lack of Efficacy|0|||
16161443|NCT00763321|39072372|FG001|Double-blind Period|Lack of Efficacy|9|||
16161444|NCT00763321|39072373|FG002|Double-blind Period|Lack of Efficacy|17|||
16161445|NCT00763321|39072371|FG000|Double-blind Period|Adverse Event|0|||
16161446|NCT00763321|39072372|FG001|Double-blind Period|Adverse Event|4|||
16161447|NCT00763321|39072373|FG002|Double-blind Period|Adverse Event|4|||
16161448|NCT00763321|39072371|FG000|Double-blind Period|Lost to Follow-up|0|||
16161449|NCT00763321|39072372|FG001|Double-blind Period|Lost to Follow-up|4|||
16161450|NCT00763321|39072373|FG002|Double-blind Period|Lost to Follow-up|2|||
16161451|NCT00763321|39072371|FG000|Double-blind Period|Withdrawal by Subject|0|||
16161452|NCT00763321|39072372|FG001|Double-blind Period|Withdrawal by Subject|2|||
16161453|NCT00763321|39072373|FG002|Double-blind Period|Withdrawal by Subject|3|||
16161454|NCT00763321|39072371|FG000|Double-blind Period|Other|0|||
16161455|NCT00763321|39072372|FG001|Double-blind Period|Other|2|||
16161456|NCT00763321|39072373|FG002|Double-blind Period|Other|3|||
16161457|NCT02437162|39072374|FG000|Overall Study|Protocol Violation|0|||
16161458|NCT02437162|39072375|FG001|Overall Study|Protocol Violation|1|||
16161459|NCT02437162|39072376|FG002|Overall Study|Protocol Violation|0|||
16161460|NCT02437162|39072374|FG000|Overall Study|Randomized but not treated|0|||
16069286|NCT00946192|38742835|FG000|Overall Study|Lost to Follow-up|6|||
16069287|NCT00946192|38742836|FG001|Overall Study|Lost to Follow-up|11|||
16069288|NCT00946192|38742837|FG002|Overall Study|Lost to Follow-up|9|||
16069289|NCT00946192|38742835|FG000|Overall Study|Withdrawal by Subject|10|||
16069290|NCT00946192|38742836|FG001|Overall Study|Withdrawal by Subject|7|||
16069291|NCT00946192|38742837|FG002|Overall Study|Withdrawal by Subject|3|||
16069292|NCT00946192|38742835|FG000|Overall Study|Did not start medication|2|||
16069293|NCT00946192|38742836|FG001|Overall Study|Did not start medication|0|||
16069294|NCT00946192|38742837|FG002|Overall Study|Did not start medication|0|||
16069295|NCT01710514|38742838|FG000|Overall Study|Adverse Event|6|||
16069296|NCT01710514|38742839|FG001|Overall Study|Adverse Event|7|||
16069297|NCT01710514|38742838|FG000|Overall Study|Withdrawal by Subject|1|||
16069298|NCT01710514|38742839|FG001|Overall Study|Withdrawal by Subject|0|||
16069299|NCT02577523|38742840|FG000|Overall Study|Adverse Event|1|||
16069300|NCT02577523|38742841|FG001|Overall Study|Adverse Event|1|||
16069301|NCT02577523|38742840|FG000|Overall Study|Lack of Efficacy|1|||
16069302|NCT02577523|38742841|FG001|Overall Study|Lack of Efficacy|1|||
16069303|NCT02577523|38742840|FG000|Overall Study|Withdrawal by Subject|1|||
16069304|NCT02577523|38742841|FG001|Overall Study|Withdrawal by Subject|0|||
16069305|NCT02954055|38742850|FG000|Overall Study|Did not initiate therapy|6|||
16069306|NCT02954055|38742851|FG001|Overall Study|Did not initiate therapy|1|||
16069307|NCT05298111|38742854|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
16069308|NCT05298111|38742855|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
16069309|NCT02223793|38742858|FG000|Overall Study|Lost to Follow-up|10|||
16069310|NCT02223793|38742859|FG001|Overall Study|Lost to Follow-up|1|||
16069311|NCT02223793|38742860|FG002|Overall Study|Lost to Follow-up|2|||
16069312|NCT02223793|38742858|FG000|Overall Study|Withdrawal by Subject|3|||
16069313|NCT02223793|38742859|FG001|Overall Study|Withdrawal by Subject|2|||
16069314|NCT02223793|38742860|FG002|Overall Study|Withdrawal by Subject|3|||
16161461|NCT02437162|39072375|FG001|Overall Study|Randomized but not treated|0|||
16161462|NCT02437162|39072376|FG002|Overall Study|Randomized but not treated|1|||
16161463|NCT02437162|39072374|FG000|Overall Study|Study discontinued by Sponsor|93|||
16161464|NCT02437162|39072375|FG001|Overall Study|Study discontinued by Sponsor|98|||
16161465|NCT02437162|39072376|FG002|Overall Study|Study discontinued by Sponsor|97|||
16447807|NCT03879772|40118748|FG001|Overall Study|Lost to Follow-up|0|||
16069315|NCT02223793|38742858|FG000|Overall Study|Moved/studycenter unable to participate|4|||
16069316|NCT02223793|38742859|FG001|Overall Study|Moved/studycenter unable to participate|6|||
16069317|NCT02223793|38742860|FG002|Overall Study|Moved/studycenter unable to participate|8|||
16069318|NCT01348087|38742861|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
16069319|NCT01348087|38742861|FG000|Overall Study|Administrative problems|79|||
16069320|NCT01348087|38742861|FG000|Overall Study|protocol deviation|1|||
16069321|NCT01348087|38742861|FG000|Overall Study|Lost to Follow-up|1|||
16069322|NCT01348087|38742861|FG000|Overall Study|Subject withdrew consent|7|||
16069323|NCT01348087|38742861|FG000|Overall Study|Adverse Event|25|||
16069324|NCT00631917|38742862|FG000|Overall Study|Adverse Event|34|||
16069325|NCT00631917|38742863|FG001|Overall Study|Adverse Event|45|||
16069326|NCT00631917|38742862|FG000|Overall Study|Abnormal laboratory value(s)|2|||
16069327|NCT00631917|38742863|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16069328|NCT00631917|38742862|FG000|Overall Study|Abnormal test procedure result(s)|3|||
16069329|NCT00631917|38742863|FG001|Overall Study|Abnormal test procedure result(s)|2|||
16069330|NCT00631917|38742862|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
16069331|NCT00631917|38742863|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
16069332|NCT00631917|38742862|FG000|Overall Study|No longer required study drug|0|||
16069333|NCT00631917|38742863|FG001|Overall Study|No longer required study drug|1|||
16069334|NCT00631917|38742862|FG000|Overall Study|Protocol deviation|6|||
16069335|NCT00631917|38742863|FG001|Overall Study|Protocol deviation|5|||
16069336|NCT00631917|38742862|FG000|Overall Study|Subject withdrew consent|25|||
16069337|NCT00631917|38742863|FG001|Overall Study|Subject withdrew consent|33|||
16069338|NCT00631917|38742862|FG000|Overall Study|Lost to Follow-up|7|||
16069339|NCT00631917|38742863|FG001|Overall Study|Lost to Follow-up|7|||
16069340|NCT00631917|38742862|FG000|Overall Study|Administrative problems|2|||
16069341|NCT00631917|38742863|FG001|Overall Study|Administrative problems|0|||
16069342|NCT00631917|38742862|FG000|Overall Study|Death|1|||
16069343|NCT00631917|38742863|FG001|Overall Study|Death|0|||
16069344|NCT00631475|38742864|FG000|Overall Study|Death|18|||
16069345|NCT00631475|38742864|FG000|Overall Study|Adverse Event|14|||
16069346|NCT00631475|38742864|FG000|Overall Study|Withdrew consent|5|||
16069347|NCT00631475|38742864|FG000|Overall Study|Preparation for lung transplant|8|||
16069348|NCT02334306|38742870|FG000|Double-blind Period|Adverse Event|0|||
16069349|NCT02334306|38742871|FG001|Double-blind Period|Adverse Event|1|||
16069350|NCT02334306|38742870|FG000|Double-blind Period|Withdrawal by Subject|1|||
16069351|NCT02334306|38742871|FG001|Double-blind Period|Withdrawal by Subject|1|||
16069352|NCT00768066|38742874|FG000|Overall Study|Did not receive study product injection.|3|||
16069353|NCT00768066|38742875|FG001|Overall Study|Did not receive study product injection.|3|||
16069354|NCT00768066|38742876|FG002|Overall Study|Did not receive study product injection.|0|||
16069355|NCT04088188|38742877|FG000|Overall Study|Withdrawal by Subject|2|||
16069356|NCT04088188|38742878|FG001|Overall Study|Withdrawal by Subject|0|||
16069357|NCT04088188|38742877|FG000|Overall Study|Adverse Event|2|||
16069358|NCT04088188|38742878|FG001|Overall Study|Adverse Event|0|||
16069359|NCT00603447|38742879|FG000|Overall Study|Adverse Event|0|||
16069360|NCT00603447|38742880|FG001|Overall Study|Adverse Event|1|||
16069361|NCT00603447|38742881|FG002|Overall Study|Adverse Event|1|||
16069362|NCT00603447|38742882|FG003|Overall Study|Adverse Event|2|||
16069363|NCT00603447|38742883|FG004|Overall Study|Adverse Event|1|||
16069364|NCT00603447|38742884|FG005|Overall Study|Adverse Event|2|||
16069365|NCT00603447|38742885|FG006|Overall Study|Adverse Event|10|||
16069366|NCT00603447|38742879|FG000|Overall Study|Other|0|||
16069367|NCT00603447|38742880|FG001|Overall Study|Other|0|||
16069368|NCT00603447|38742881|FG002|Overall Study|Other|1|||
16069369|NCT00603447|38742882|FG003|Overall Study|Other|0|||
16069370|NCT00603447|38742883|FG004|Overall Study|Other|3|||
16069371|NCT00603447|38742884|FG005|Overall Study|Other|0|||
16069372|NCT00603447|38742885|FG006|Overall Study|Other|13|||
16069373|NCT00603447|38742879|FG000|Overall Study|Withdrew Consent|0|||
16069374|NCT00603447|38742880|FG001|Overall Study|Withdrew Consent|2|||
16069375|NCT00603447|38742881|FG002|Overall Study|Withdrew Consent|0|||
16069376|NCT00603447|38742882|FG003|Overall Study|Withdrew Consent|0|||
16069377|NCT00603447|38742883|FG004|Overall Study|Withdrew Consent|1|||
16069378|NCT00603447|38742884|FG005|Overall Study|Withdrew Consent|0|||
16069379|NCT00603447|38742885|FG006|Overall Study|Withdrew Consent|1|||
16069380|NCT00567164|38742887|FG000|Overall Study|Withdrawal by Subject|171|||
16069381|NCT00567164|38742888|FG001|Overall Study|Withdrawal by Subject|21|||
16069382|NCT00567164|38742889|FG002|Overall Study|Withdrawal by Subject|17|||
16069383|NCT00567164|38742887|FG000|Overall Study|Protocol Violation|23|||
16069384|NCT00567164|38742888|FG001|Overall Study|Protocol Violation|4|||
16069385|NCT00567164|38742889|FG002|Overall Study|Protocol Violation|2|||
16069386|NCT00567164|38742887|FG000|Overall Study|Adverse Event|92|||
16069387|NCT00567164|38742888|FG001|Overall Study|Adverse Event|13|||
16069388|NCT00567164|38742889|FG002|Overall Study|Adverse Event|9|||
16069389|NCT00567164|38742887|FG000|Overall Study|Death|0|||
16069390|NCT00567164|38742888|FG001|Overall Study|Death|0|||
16069391|NCT00567164|38742889|FG002|Overall Study|Death|1|||
16069392|NCT00567164|38742887|FG000|Overall Study|Lost to Follow-up|202|||
16069393|NCT00567164|38742888|FG001|Overall Study|Lost to Follow-up|23|||
16069394|NCT00567164|38742889|FG002|Overall Study|Lost to Follow-up|21|||
16069395|NCT00567164|38742887|FG000|Overall Study|Pregnancy|20|||
16069396|NCT00567164|38742888|FG001|Overall Study|Pregnancy|4|||
16069397|NCT00567164|38742889|FG002|Overall Study|Pregnancy|6|||
16069398|NCT00567164|38742887|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
16069399|NCT00567164|38742888|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
16447808|NCT03879772|40118749|FG002|Overall Study|Lost to Follow-up|0|||
16447809|NCT03879772|40118750|FG003|Overall Study|Lost to Follow-up|0|||
16447810|NCT03879772|40118751|FG004|Overall Study|Lost to Follow-up|1|||
16447811|NCT03879772|40118747|FG000|Overall Study|Withdrawal by Subject|0|||
16447812|NCT03879772|40118748|FG001|Overall Study|Withdrawal by Subject|1|||
16069400|NCT00567164|38742889|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
16069401|NCT00567164|38742887|FG000|Overall Study|Missing|1|||
16069402|NCT00567164|38742888|FG001|Overall Study|Missing|0|||
16069403|NCT00567164|38742889|FG002|Overall Study|Missing|0|||
16069404|NCT03441984|38742890|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069405|NCT03441984|38742891|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069406|NCT03441984|38742892|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
16069407|NCT03441984|38742893|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069408|NCT03441984|38742894|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069409|NCT03441984|38742895|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069410|NCT03441984|38742896|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069411|NCT03441984|38742897|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069412|NCT03441984|38742898|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069413|NCT03441984|38742899|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069414|NCT03441984|38742900|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069415|NCT03441984|38742901|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
16069416|NCT01419717|38742905|FG000|Overall Study|Protocol-specified Criteria|62|||
16069417|NCT01419717|38742905|FG000|Overall Study|Adverse Event|19|||
16069418|NCT01419717|38742905|FG000|Overall Study|Death|17|||
16069419|NCT01419717|38742905|FG000|Overall Study|Withdrawal by Subject|10|||
16069420|NCT01419717|38742905|FG000|Overall Study|Disease Progression|9|||
16069421|NCT01419717|38742905|FG000|Overall Study|Other|4|||
16069422|NCT01419717|38742905|FG000|Overall Study|Lost to Follow-up|2|||
16069423|NCT01419717|38742905|FG000|Overall Study|Administrative Decision|1|||
16069424|NCT01419717|38742905|FG000|Overall Study|Noncompliance|1|||
16069425|NCT01651949|38742909|FG000|Overall Study|Unknown status|4|||
16069426|NCT01651949|38742910|FG001|Overall Study|Unknown status|4|||
16069427|NCT01651949|38742911|FG002|Overall Study|Unknown status|0|||
16069428|NCT01651949|38742909|FG000|Overall Study|Lost to Follow-up|30|||
16069429|NCT01651949|38742910|FG001|Overall Study|Lost to Follow-up|56|||
16069430|NCT01651949|38742911|FG002|Overall Study|Lost to Follow-up|20|||
16069431|NCT01651949|38742909|FG000|Overall Study|Protocol Violation|0|||
16069432|NCT01651949|38742910|FG001|Overall Study|Protocol Violation|2|||
16069433|NCT01651949|38742911|FG002|Overall Study|Protocol Violation|1|||
16069434|NCT01651949|38742909|FG000|Overall Study|Physician Decision|0|||
16069435|NCT01651949|38742910|FG001|Overall Study|Physician Decision|2|||
16069436|NCT01651949|38742911|FG002|Overall Study|Physician Decision|0|||
16069437|NCT01651949|38742909|FG000|Overall Study|Adverse Event|0|||
16069438|NCT01651949|38742910|FG001|Overall Study|Adverse Event|2|||
16069439|NCT01651949|38742911|FG002|Overall Study|Adverse Event|1|||
16069440|NCT01651949|38742909|FG000|Overall Study|Screen failure|2|||
16069441|NCT01651949|38742910|FG001|Overall Study|Screen failure|2|||
16069442|NCT01651949|38742911|FG002|Overall Study|Screen failure|0|||
16069443|NCT01651949|38742909|FG000|Overall Study|Withdrawal by Subject|17|||
16161466|NCT02437162|39072374|FG000|Overall Study|Withdrawal by Subject|13|||
16161467|NCT02437162|39072375|FG001|Overall Study|Withdrawal by Subject|7|||
16447813|NCT03879772|40118749|FG002|Overall Study|Withdrawal by Subject|3|||
16447814|NCT03879772|40118750|FG003|Overall Study|Withdrawal by Subject|1|||
16447815|NCT03879772|40118751|FG004|Overall Study|Withdrawal by Subject|1|||
16069444|NCT01651949|38742910|FG001|Overall Study|Withdrawal by Subject|18|||
16069445|NCT01651949|38742911|FG002|Overall Study|Withdrawal by Subject|9|||
16069446|NCT01155869|38742912|FG000|Overall Study|Lost to Follow-up|3|||
16069447|NCT01155869|38742913|FG001|Overall Study|Lost to Follow-up|1|||
16069448|NCT00748969|38742914|FG000|Overall Study|Withdrawal by Subject|1|||
16069449|NCT00748969|38742915|FG001|Overall Study|Withdrawal by Subject|0|||
16069450|NCT00748969|38742914|FG000|Overall Study|Withdrawal by Subject|0|||
16069451|NCT00748969|38742915|FG001|Overall Study|Withdrawal by Subject|1|||
16161468|NCT02437162|39072376|FG002|Overall Study|Withdrawal by Subject|9|||
16161469|NCT02437162|39072374|FG000|Overall Study|Adverse Event|0|||
16161470|NCT02437162|39072375|FG001|Overall Study|Adverse Event|1|||
16161471|NCT02437162|39072376|FG002|Overall Study|Adverse Event|0|||
16161472|NCT02437162|39072374|FG000|Overall Study|Lost to Follow-up|1|||
16447816|NCT03879772|40118747|FG000|Overall Study|Protocol Violation|0|||
16069452|NCT01806714|38745572|FG000|Overall Study|No functioning phone number|200|||
16069453|NCT01806714|38745573|FG001|Overall Study|No functioning phone number|170|||
16069454|NCT00424762|38745574|FG000|Overall Study|Withdrawal by Subject|18|||
16069455|NCT00424762|38745575|FG001|Overall Study|Withdrawal by Subject|19|||
16069456|NCT00424762|38745574|FG000|Overall Study|Lost to Follow-up|2|||
16069457|NCT00424762|38745575|FG001|Overall Study|Lost to Follow-up|3|||
16069458|NCT04511650|38745576|FG000|Overall Study|Lost to Follow-up|1|||
16069459|NCT04511650|38745577|FG001|Overall Study|Lost to Follow-up|0|||
16069460|NCT04511650|38745578|FG002|Overall Study|Lost to Follow-up|0|||
16069461|NCT04511650|38745576|FG000|Overall Study|Withdrawal by Subject|1|||
16069462|NCT04511650|38745577|FG001|Overall Study|Withdrawal by Subject|0|||
16069463|NCT04511650|38745578|FG002|Overall Study|Withdrawal by Subject|0|||
16069464|NCT04511650|38745576|FG000|Overall Study|reason not provided|0|||
16069465|NCT04511650|38745577|FG001|Overall Study|reason not provided|0|||
16069466|NCT04511650|38745578|FG002|Overall Study|reason not provided|1|||
16069467|NCT04511650|38745576|FG000|Overall Study|Death|1|||
16069468|NCT04511650|38745577|FG001|Overall Study|Death|1|||
16069469|NCT04511650|38745578|FG002|Overall Study|Death|1|||
16069470|NCT04454567|38745579|FG000|Overall Study|Study Terminated by Sponsor|1|||
16069471|NCT04454567|38745580|FG001|Overall Study|Study Terminated by Sponsor|1|||
16069472|NCT02701361|38745583|FG000|Overall Study|Lost to Follow-up|5|||
16069473|NCT02701361|38745584|FG001|Overall Study|Lost to Follow-up|2|||
16069474|NCT02701361|38745585|FG002|Overall Study|Lost to Follow-up|1|||
16069475|NCT02701361|38745583|FG000|Overall Study|Withdrawal by Subject|4|||
16069476|NCT02701361|38745584|FG001|Overall Study|Withdrawal by Subject|0|||
16069477|NCT02701361|38745585|FG002|Overall Study|Withdrawal by Subject|0|||
16069478|NCT02701361|38745583|FG000|Overall Study|timed out in rehab center|0|||
16069479|NCT02701361|38745584|FG001|Overall Study|timed out in rehab center|1|||
16069480|NCT02701361|38745585|FG002|Overall Study|timed out in rehab center|0|||
16069481|NCT02701361|38745583|FG000|Overall Study|incarceration|0|||
16069482|NCT02701361|38745584|FG001|Overall Study|incarceration|0|||
16069483|NCT02701361|38745585|FG002|Overall Study|incarceration|1|||
16069484|NCT00886613|38745586|FG000|Overall Study|Protocol deviation (Part B)|1|||
16069485|NCT00886613|38745587|FG001|Overall Study|Protocol deviation (Part B)|0|||
16069486|NCT00886613|38745588|FG002|Overall Study|Protocol deviation (Part B)|0|||
16069487|NCT00886613|38745586|FG000|Overall Study|Lost to follow-up (Part B)|1|||
16069488|NCT00886613|38745587|FG001|Overall Study|Lost to follow-up (Part B)|0|||
16069489|NCT00886613|38745588|FG002|Overall Study|Lost to follow-up (Part B)|1|||
16069490|NCT00886613|38745586|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
16069491|NCT00886613|38745587|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
16069492|NCT00886613|38745588|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
16069493|NCT02968004|38745589|FG000|Overall Study|Adverse Event|1|||
16069494|NCT02968004|38745590|FG001|Overall Study|Adverse Event|0|||
16069495|NCT02968004|38745589|FG000|Overall Study|Withdrawal by Subject|0|||
16069496|NCT02968004|38745590|FG001|Overall Study|Withdrawal by Subject|1|||
16069497|NCT02680756|38745591|FG000|Overall Study|Adverse Event|10|||
16069498|NCT02680756|38745592|FG001|Overall Study|Adverse Event|2|||
16069499|NCT02680756|38745591|FG000|Overall Study|Lost to Follow-up|7|||
16069500|NCT02680756|38745592|FG001|Overall Study|Lost to Follow-up|6|||
16069501|NCT02680756|38745591|FG000|Overall Study|Withdrawal by Subject|5|||
16069502|NCT02680756|38745592|FG001|Overall Study|Withdrawal by Subject|5|||
16069503|NCT02680756|38745591|FG000|Overall Study|Physician Decision|4|||
16069504|NCT02680756|38745592|FG001|Overall Study|Physician Decision|1|||
16069505|NCT02680756|38745591|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
16069506|NCT02680756|38745592|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
16161473|NCT02437162|39072375|FG001|Overall Study|Lost to Follow-up|0|||
16371654|NCT00784927|39846551|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
16371655|NCT00784927|39846551|FG000|Overall Study|Protocol Violation|1|||
16371656|NCT00784927|39846551|FG000|Overall Study|Ineligible|1|||
16069507|NCT02680756|38745591|FG000|Overall Study|Blood transfusion for any reason|0|||
16069508|NCT02680756|38745592|FG001|Overall Study|Blood transfusion for any reason|1|||
16069509|NCT02680756|38745591|FG000|Overall Study|Death|1|||
16069510|NCT02680756|38745592|FG001|Overall Study|Death|0|||
16069511|NCT02680756|38745591|FG000|Overall Study|Protocol Violation|1|||
16069512|NCT02680756|38745592|FG001|Overall Study|Protocol Violation|0|||
16069513|NCT02680756|38745591|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
16069514|NCT02680756|38745592|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
16069515|NCT02680756|38745591|FG000|Overall Study|None of above or not recorded|3|||
16069516|NCT02680756|38745592|FG001|Overall Study|None of above or not recorded|2|||
16069517|NCT01191788|38745594|FG000|Overall Study|Lost to Follow-up|21|||
16069518|NCT01191788|38745595|FG001|Overall Study|Lost to Follow-up|22|||
16069519|NCT03545984|38745596|FG000|Overall Study|CSF cases not present during rotation|11|||
16069520|NCT03545984|38745597|FG001|Overall Study|CSF cases not present during rotation|9|||
16069521|NCT00151996|38745598|FG000|Overall Study|Adverse Event|3|||
16069522|NCT00151996|38745599|FG001|Overall Study|Adverse Event|2|||
16069523|NCT00151996|38745598|FG000|Overall Study|Withdrawal by Subject|1|||
16069524|NCT00151996|38745599|FG001|Overall Study|Withdrawal by Subject|1|||
16069525|NCT00151996|38745598|FG000|Overall Study|Protocol Violation|1|||
16069526|NCT00151996|38745599|FG001|Overall Study|Protocol Violation|2|||
16069527|NCT00151996|38745598|FG000|Overall Study|Sponsor's decision|0|||
16447817|NCT03879772|40118748|FG001|Overall Study|Protocol Violation|0|||
16447818|NCT03879772|40118749|FG002|Overall Study|Protocol Violation|3|||
16447819|NCT03879772|40118750|FG003|Overall Study|Protocol Violation|1|||
16447820|NCT03879772|40118751|FG004|Overall Study|Protocol Violation|2|||
16447821|NCT03879772|40118747|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
16447822|NCT03879772|40118748|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
16447823|NCT03879772|40118749|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
16447824|NCT03879772|40118750|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
16447825|NCT03879772|40118751|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
16447826|NCT00687193|40118755|FG000|Overall Study|Adverse Event|0|||
16447827|NCT00687193|40118756|FG001|Overall Study|Adverse Event|1|||
16447828|NCT00687193|40118757|FG002|Overall Study|Adverse Event|2|||
16447829|NCT00687193|40118758|FG003|Overall Study|Adverse Event|3|||
16447830|NCT00687193|40118759|FG004|Overall Study|Adverse Event|0|||
16447831|NCT00687193|40118760|FG005|Overall Study|Adverse Event|2|||
16447832|NCT00687193|40118755|FG000|Overall Study|Lack of Efficacy|1|||
16447833|NCT00687193|40118756|FG001|Overall Study|Lack of Efficacy|1|||
16447834|NCT00687193|40118757|FG002|Overall Study|Lack of Efficacy|0|||
16447835|NCT00687193|40118758|FG003|Overall Study|Lack of Efficacy|0|||
16447836|NCT00687193|40118759|FG004|Overall Study|Lack of Efficacy|0|||
16447837|NCT00687193|40118760|FG005|Overall Study|Lack of Efficacy|2|||
16447838|NCT00687193|40118755|FG000|Overall Study|Protocol Violation|1|||
16447839|NCT00687193|40118756|FG001|Overall Study|Protocol Violation|2|||
16447840|NCT00687193|40118757|FG002|Overall Study|Protocol Violation|0|||
16447841|NCT00687193|40118758|FG003|Overall Study|Protocol Violation|1|||
16447842|NCT00687193|40118759|FG004|Overall Study|Protocol Violation|2|||
16447843|NCT00687193|40118760|FG005|Overall Study|Protocol Violation|0|||
16447844|NCT02383576|40118761|FG000|Overall Study|Death|53|||
16447845|NCT02383576|40118762|FG001|Overall Study|Death|33|||
16447846|NCT02383576|40118761|FG000|Overall Study|Lost to Follow-up|7|||
16447847|NCT02383576|40118762|FG001|Overall Study|Lost to Follow-up|1|||
16447848|NCT02383576|40118761|FG000|Overall Study|Withdrew Consent|1|||
16447849|NCT02383576|40118762|FG001|Overall Study|Withdrew Consent|6|||
16447850|NCT02383576|40118761|FG000|Overall Study|Investigator's Decision|0|||
16447851|NCT02383576|40118762|FG001|Overall Study|Investigator's Decision|1|||
16447852|NCT02383576|40118761|FG000|Overall Study|Administrative/Other|2|||
16447853|NCT02383576|40118762|FG001|Overall Study|Administrative/Other|4|||
16447854|NCT03304626|40118763|FG000|Overall Study|Adverse Event|1|||
16447855|NCT03304626|40118764|FG001|Overall Study|Adverse Event|0|||
16447856|NCT03304626|40118763|FG000|Overall Study|Lack of Efficacy|1|||
16447857|NCT03304626|40118764|FG001|Overall Study|Lack of Efficacy|1|||
16447858|NCT01411891|40118765|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
16447859|NCT01411891|40118766|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
16447860|NCT03367793|40118767|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
16447861|NCT03367793|40118768|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
16447862|NCT03367793|40118769|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
16447863|NCT03367793|40118770|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
16447864|NCT03367793|40118771|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
16447865|NCT03367793|40118772|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
16447866|NCT04682366|40118773|FG000|Overall Study|Lost to Follow-up|1|||
16447867|NCT04682366|40118774|FG001|Overall Study|Lost to Follow-up|1|||
16447868|NCT00674817|40122043|FG000|Period 1|Withdrawal by Subject|2|||
16447869|NCT00674817|40122043|FG000|Period 1|Protocol Violation|1|||
16447870|NCT00674817|40122043|FG000|Period 3|Adverse Event|1|||
16447871|NCT00674817|40122043|FG000|Period 3|Protocol Violation|1|||
16447872|NCT00674817|40122043|FG000|Period 4|Adverse Event|1|||
16069528|NCT00151996|38745599|FG001|Overall Study|Sponsor's decision|2|||
16069529|NCT01768676|38745600|FG000|Overall Study|Adverse Event|3|||
16069530|NCT01768676|38745601|FG001|Overall Study|Adverse Event|3|||
16069531|NCT01768676|38745600|FG000|Overall Study|Lost to Follow-up|13|||
16069532|NCT01768676|38745601|FG001|Overall Study|Lost to Follow-up|16|||
16069533|NCT01768676|38745600|FG000|Overall Study|Protocol Violation|1|||
16069534|NCT01768676|38745601|FG001|Overall Study|Protocol Violation|1|||
16447873|NCT02506244|40122045|FG000|Overall Study|Did not undergo active monitoring|458|||
16447874|NCT02506244|40122046|FG001|Overall Study|Did not undergo active monitoring|459|||
16447875|NCT02506244|40122047|FG002|Overall Study|Did not undergo active monitoring|0|||
16447876|NCT01472289|40122048|FG000|Overall Study|Death|2|||
16447877|NCT02976038|40122053|FG000|Overall Study|Physician Decision|22|||
16447878|NCT02976038|40122053|FG000|Overall Study|Withdrawal by Subject|3|||
16447879|NCT02976038|40122053|FG000|Overall Study|Lost to Follow-up|2|||
16069535|NCT01768676|38745600|FG000|Overall Study|Physician Decision|4|||
16447880|NCT02976038|40122053|FG000|Overall Study|Adverse Event|1|||
16447881|NCT01701674|40122054|FG000|Overall Study|Unable to safely complete treatment|1|||
16447882|NCT00628108|40122055|FG000|Overall Study|Adverse Event|0|||
16447883|NCT00628108|40122056|FG001|Overall Study|Adverse Event|3|||
16447884|NCT00628108|40122055|FG000|Overall Study|Withdrawal by Subject|1|||
16447885|NCT00628108|40122056|FG001|Overall Study|Withdrawal by Subject|0|||
16447886|NCT00321620|40122057|FG000|Overall Study|Death|269|||
16447887|NCT00321620|40122058|FG001|Overall Study|Death|294|||
16447888|NCT00321620|40122057|FG000|Overall Study|Withdrawal by Subject|164|||
16069536|NCT01768676|38745601|FG001|Overall Study|Physician Decision|1|||
16069537|NCT01768676|38745600|FG000|Overall Study|Withdrawal by Subject|3|||
16069538|NCT01768676|38745601|FG001|Overall Study|Withdrawal by Subject|10|||
16069539|NCT03386929|38745605|FG000|Overall Study|Death|0|||
16069540|NCT03386929|38745606|FG001|Overall Study|Death|0|||
16069541|NCT03386929|38745607|FG002|Overall Study|Death|1|||
16069542|NCT03386929|38745605|FG000|Overall Study|Withdrawal by Subject|0|||
16069543|NCT03386929|38745606|FG001|Overall Study|Withdrawal by Subject|1|||
16069544|NCT03386929|38745607|FG002|Overall Study|Withdrawal by Subject|0|||
16069545|NCT03386929|38745605|FG000|Overall Study|Physician Decision|0|||
16069546|NCT03386929|38745606|FG001|Overall Study|Physician Decision|0|||
16069547|NCT03386929|38745607|FG002|Overall Study|Physician Decision|1|||
16069548|NCT03386929|38745605|FG000|Overall Study|Progression|4|||
16069549|NCT03386929|38745606|FG001|Overall Study|Progression|4|||
16069550|NCT03386929|38745607|FG002|Overall Study|Progression|0|||
16069551|NCT03386929|38745605|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
16069552|NCT03386929|38745606|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
16069553|NCT03386929|38745607|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
16069554|NCT03386929|38745605|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
16069555|NCT03386929|38745606|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
16069556|NCT03386929|38745607|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
16069557|NCT01405924|38745608|FG000|Overall Study|Protocol Violation|8|||
16069558|NCT01405924|38745608|FG000|Overall Study|Missing/Incomplete Data|2|||
16069559|NCT01191086|38745617|FG000|Overall Study|Adverse Event|20|||
16069560|NCT01191086|38745617|FG000|Overall Study|Lack of Efficacy|10|||
16371657|NCT03211858|39846553|FG000|Overall Study|Adverse Event|8|||
16371658|NCT03211858|39846554|FG001|Overall Study|Adverse Event|6|||
16371659|NCT03211858|39846553|FG000|Overall Study|Lack of Efficacy|0|||
16371660|NCT03211858|39846554|FG001|Overall Study|Lack of Efficacy|4|||
16371661|NCT03211858|39846553|FG000|Overall Study|Poor compliance to protocol|6|||
16371662|NCT03211858|39846554|FG001|Overall Study|Poor compliance to protocol|2|||
16371663|NCT03211858|39846553|FG000|Overall Study|Non-serious Hypoglycemia|1|||
16371664|NCT03211858|39846554|FG001|Overall Study|Non-serious Hypoglycemia|0|||
16371665|NCT03211858|39846553|FG000|Overall Study|Other than specified above|22|||
16371666|NCT03211858|39846554|FG001|Overall Study|Other than specified above|21|||
16371667|NCT02061592|39846555|FG000|Period 1|Withdrawal by Subject|1|||
16069561|NCT01191086|38745617|FG000|Overall Study|Lost to Follow-up|4|||
16069562|NCT01191086|38745617|FG000|Overall Study|Physician Decision|2|||
16069563|NCT01191086|38745617|FG000|Overall Study|Withdrawal by Subject|24|||
16069564|NCT01191086|38745617|FG000|Overall Study|Discontinuation criterion met|1|||
16069565|NCT01191086|38745617|FG000|Overall Study|Other|1|||
16069566|NCT03721016|38745619|FG000|Overall Study|Adverse Event|0|||
16069567|NCT03721016|38745620|FG001|Overall Study|Adverse Event|1|||
16069568|NCT03721016|38745621|FG002|Overall Study|Adverse Event|1|||
16069569|NCT03721016|38745619|FG000|Overall Study|Withdrawal by Subject|8|||
16069570|NCT03721016|38745620|FG001|Overall Study|Withdrawal by Subject|16|||
16069571|NCT03721016|38745621|FG002|Overall Study|Withdrawal by Subject|13|||
16069572|NCT03721016|38745619|FG000|Overall Study|Lost to Follow-up|4|||
16069573|NCT03721016|38745620|FG001|Overall Study|Lost to Follow-up|6|||
16069574|NCT03721016|38745621|FG002|Overall Study|Lost to Follow-up|5|||
16069575|NCT03721016|38745619|FG000|Overall Study|Physician Decision|0|||
16069576|NCT03721016|38745620|FG001|Overall Study|Physician Decision|1|||
16069577|NCT03721016|38745621|FG002|Overall Study|Physician Decision|2|||
16069578|NCT03721016|38745619|FG000|Overall Study|Protocol Violation|0|||
16069579|NCT03721016|38745620|FG001|Overall Study|Protocol Violation|1|||
16264855|NCT01597245|39453260|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16371668|NCT02061592|39846556|FG001|Period 1|Withdrawal by Subject|0|||
16371669|NCT02061592|39846555|FG000|Period 1|Protocol Violation|1|||
16371670|NCT02061592|39846556|FG001|Period 1|Protocol Violation|0|||
16069580|NCT03721016|38745621|FG002|Overall Study|Protocol Violation|0|||
16069581|NCT03721016|38745619|FG000|Overall Study|Site terminated by sponsor|3|||
16069582|NCT03721016|38745620|FG001|Overall Study|Site terminated by sponsor|7|||
16069583|NCT03721016|38745621|FG002|Overall Study|Site terminated by sponsor|6|||
16069584|NCT03721016|38745619|FG000|Overall Study|Subject exited early due to COVID-19|1|||
16069585|NCT03721016|38745620|FG001|Overall Study|Subject exited early due to COVID-19|0|||
16069586|NCT03721016|38745621|FG002|Overall Study|Subject exited early due to COVID-19|0|||
16069587|NCT00831792|38745628|FG000|Overall Study|Not Eligible|3|||
16069588|NCT00831792|38745628|FG000|Overall Study|Adverse Event|1|||
16069589|NCT00831792|38745628|FG000|Overall Study|Death|1|||
16069590|NCT00831792|38745628|FG000|Overall Study|Lack of Efficacy|1|||
16447889|NCT00321620|40122058|FG001|Overall Study|Withdrawal by Subject|147|||
16069591|NCT01494662|38745629|FG000|Overall Study|Withdrawal by Subject|0|||
16069592|NCT01494662|38745630|FG001|Overall Study|Withdrawal by Subject|0|||
16069593|NCT01494662|38745631|FG002|Overall Study|Withdrawal by Subject|1|||
16069594|NCT01494662|38745632|FG003|Overall Study|Withdrawal by Subject|0|||
16069595|NCT01494662|38745633|FG004|Overall Study|Withdrawal by Subject|0|||
16371671|NCT02061592|39846555|FG000|Period 2|Lost to Follow-up|0|||
16371672|NCT02061592|39846556|FG001|Period 2|Lost to Follow-up|1|||
16371673|NCT01778985|39846557|FG000|Overall Study|Lost to Follow-up|1|||
16161474|NCT02437162|39072376|FG002|Overall Study|Lost to Follow-up|1|||
16161475|NCT02437162|39072374|FG000|Overall Study|Death|0|||
16161476|NCT02437162|39072375|FG001|Overall Study|Death|1|||
16161477|NCT02437162|39072376|FG002|Overall Study|Death|0|||
16161478|NCT02437162|39072374|FG000|Overall Study|Other|0|||
16161479|NCT02437162|39072375|FG001|Overall Study|Other|0|||
16161480|NCT02437162|39072376|FG002|Overall Study|Other|1|||
16161481|NCT01877083|39072377|FG000|Treatment Phase|Disease Progression|10|||
16371674|NCT01778985|39846558|FG001|Overall Study|Lost to Follow-up|0|||
16371675|NCT01778985|39846557|FG000|Overall Study|Physician Decision|2|||
16371676|NCT01778985|39846558|FG001|Overall Study|Physician Decision|2|||
16371677|NCT01778985|39846557|FG000|Overall Study|Protocol Violation|4|||
16371678|NCT01778985|39846558|FG001|Overall Study|Protocol Violation|1|||
16371679|NCT01471574|39846559|FG000|Treatment Period|Lack of Efficacy|12|||
16371680|NCT01471574|39846560|FG001|Treatment Period|Lack of Efficacy|4|||
16371681|NCT01471574|39846561|FG002|Treatment Period|Lack of Efficacy|14|||
16371682|NCT01471574|39846562|FG003|Treatment Period|Lack of Efficacy|1|||
16371683|NCT01471574|39846559|FG000|Treatment Period|Adverse Event|7|||
16371684|NCT01471574|39846560|FG001|Treatment Period|Adverse Event|3|||
16371685|NCT01471574|39846561|FG002|Treatment Period|Adverse Event|6|||
16371686|NCT01471574|39846562|FG003|Treatment Period|Adverse Event|1|||
16371687|NCT01471574|39846559|FG000|Treatment Period|Withdrawal by Subject|5|||
16371688|NCT01471574|39846560|FG001|Treatment Period|Withdrawal by Subject|1|||
16371689|NCT01471574|39846561|FG002|Treatment Period|Withdrawal by Subject|1|||
16371690|NCT01471574|39846562|FG003|Treatment Period|Withdrawal by Subject|0|||
16371691|NCT01471574|39846559|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
16371692|NCT01471574|39846560|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
16371693|NCT01471574|39846561|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
16371694|NCT01471574|39846562|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
16069596|NCT01494662|38745634|FG005|Overall Study|Withdrawal by Subject|0|||
16069597|NCT01494662|38745635|FG006|Overall Study|Withdrawal by Subject|0|||
16069598|NCT01494662|38745629|FG000|Overall Study|Physician Decision|0|||
16069599|NCT01494662|38745630|FG001|Overall Study|Physician Decision|0|||
16069600|NCT01494662|38745631|FG002|Overall Study|Physician Decision|1|||
16069601|NCT01494662|38745632|FG003|Overall Study|Physician Decision|0|||
16069602|NCT01494662|38745633|FG004|Overall Study|Physician Decision|0|||
16069603|NCT01494662|38745634|FG005|Overall Study|Physician Decision|0|||
16069604|NCT01494662|38745635|FG006|Overall Study|Physician Decision|0|||
16069605|NCT01823341|38745636|FG000|Overall Study|Failed run-in|7|||
16069606|NCT01823341|38745636|FG000|Overall Study|Withdrawal by Subject|7|||
16069607|NCT01823341|38745636|FG000|Overall Study|Adverse Event|1|||
16069608|NCT03034915|38745639|FG000|Overall Study|Adverse Event|29|||
16161482|NCT01877083|39072377|FG000|Treatment Phase|Clinical Progression|1|||
16161483|NCT01877083|39072377|FG000|Treatment Phase|Adverse Event|6|||
16161484|NCT01877083|39072377|FG000|Treatment Phase|Withdrawal by Subject|2|||
16161485|NCT01877083|39072377|FG000|Treatment Phase|Lost to Follow-up|1|||
16161486|NCT01877083|39072377|FG000|Extension Phase|Disease Progression|3|||
16161487|NCT01877083|39072377|FG000|Extension Phase|Adverse Event|2|||
16161488|NCT02615990|39072382|FG000|Overall Study|study terminated|1|||
16161489|NCT02615990|39072383|FG001|Overall Study|study terminated|1|||
16161490|NCT02387580|39072384|FG000|Overall Study|Withdrawal by Subject|0|||
16161491|NCT02387580|39072385|FG001|Overall Study|Withdrawal by Subject|0|||
16161492|NCT02387580|39072386|FG002|Overall Study|Withdrawal by Subject|0|||
16161493|NCT02387580|39072387|FG003|Overall Study|Withdrawal by Subject|1|||
16161494|NCT02387580|39072388|FG004|Overall Study|Withdrawal by Subject|0|||
16161495|NCT02387580|39072389|FG005|Overall Study|Withdrawal by Subject|0|||
16371695|NCT01471574|39846559|FG000|Treatment Period|Lost to Follow-up|1|||
16069609|NCT03034915|38745640|FG001|Overall Study|Adverse Event|32|||
16069610|NCT03034915|38745641|FG002|Overall Study|Adverse Event|22|||
16161496|NCT03434977|39072390|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
16161497|NCT03434977|39072391|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
16161498|NCT00978029|39072392|FG000|Overall Study|Adverse Event|1|||
16371696|NCT01471574|39846560|FG001|Treatment Period|Lost to Follow-up|2|||
16371697|NCT01471574|39846561|FG002|Treatment Period|Lost to Follow-up|2|||
16371698|NCT01471574|39846562|FG003|Treatment Period|Lost to Follow-up|0|||
16371699|NCT01471574|39846559|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
16371700|NCT01471574|39846560|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
16069611|NCT03034915|38745639|FG000|Overall Study|Lost to Follow-up|5|||
16069612|NCT03034915|38745640|FG001|Overall Study|Lost to Follow-up|13|||
16069613|NCT03034915|38745641|FG002|Overall Study|Lost to Follow-up|3|||
16069614|NCT03034915|38745639|FG000|Overall Study|Withdrawal by Subject|29|||
16069615|NCT03034915|38745640|FG001|Overall Study|Withdrawal by Subject|46|||
16069616|NCT03034915|38745641|FG002|Overall Study|Withdrawal by Subject|41|||
16069617|NCT03034915|38745639|FG000|Overall Study|Protocol Deviation|2|||
16069618|NCT03034915|38745640|FG001|Overall Study|Protocol Deviation|14|||
16069619|NCT03034915|38745641|FG002|Overall Study|Protocol Deviation|7|||
16069620|NCT03034915|38745639|FG000|Overall Study|Lack of Efficacy|8|||
16069621|NCT03034915|38745640|FG001|Overall Study|Lack of Efficacy|16|||
16069622|NCT03034915|38745641|FG002|Overall Study|Lack of Efficacy|18|||
16069623|NCT03034915|38745639|FG000|Overall Study|Site closed|2|||
16069624|NCT03034915|38745640|FG001|Overall Study|Site closed|2|||
16371701|NCT01471574|39846561|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
16069625|NCT03034915|38745641|FG002|Overall Study|Site closed|4|||
16069626|NCT03034915|38745639|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
16069627|NCT03034915|38745640|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
16069628|NCT03034915|38745641|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
16069629|NCT03034915|38745639|FG000|Overall Study|Physician Decision|1|||
16069630|NCT03034915|38745640|FG001|Overall Study|Physician Decision|5|||
16069631|NCT03034915|38745641|FG002|Overall Study|Physician Decision|2|||
16069632|NCT03278028|38745642|FG000|Overall Study|Lost to Follow-up|1|||
16069633|NCT03278028|38745643|FG001|Overall Study|Lost to Follow-up|0|||
16069634|NCT03278028|38745642|FG000|Overall Study|Withdrawal by Subject|3|||
16069635|NCT03278028|38745643|FG001|Overall Study|Withdrawal by Subject|1|||
16069636|NCT03278028|38745642|FG000|Overall Study|Pregnancy|0|||
16069637|NCT03278028|38745643|FG001|Overall Study|Pregnancy|1|||
16069638|NCT00946114|38745644|FG000|Overall Study|Death|5|||
16069639|NCT00946114|38745645|FG001|Overall Study|Death|2|||
16069640|NCT00946114|38745644|FG000|Overall Study|Other|1|||
16069641|NCT00946114|38745645|FG001|Overall Study|Other|0|||
16069642|NCT00946114|38745644|FG000|Overall Study|Withdrawal by Subject|2|||
16069643|NCT00946114|38745645|FG001|Overall Study|Withdrawal by Subject|0|||
16069644|NCT01175707|38745646|FG000|Overall Study|Adverse Event|4|||
16069645|NCT01175707|38745647|FG001|Overall Study|Adverse Event|6|||
16069646|NCT03538054|38745652|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
16069647|NCT03538054|38745652|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
16264856|NCT01597245|39453261|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16371702|NCT01471574|39846562|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
16371703|NCT01471574|39846559|FG000|Treatment Period|Other|1|||
16371704|NCT01471574|39846560|FG001|Treatment Period|Other|0|||
16371705|NCT01471574|39846561|FG002|Treatment Period|Other|0|||
16371706|NCT01471574|39846562|FG003|Treatment Period|Other|0|||
16371707|NCT01471574|39846559|FG000|Follow-up Period|Withdrawal by Subject|3|||
16371708|NCT01471574|39846560|FG001|Follow-up Period|Withdrawal by Subject|0|||
16371709|NCT01471574|39846561|FG002|Follow-up Period|Withdrawal by Subject|3|||
16371710|NCT01471574|39846562|FG003|Follow-up Period|Withdrawal by Subject|1|||
16371711|NCT01471574|39846559|FG000|Follow-up Period|Lost to Follow-up|4|||
16371712|NCT01471574|39846560|FG001|Follow-up Period|Lost to Follow-up|1|||
16371713|NCT01471574|39846561|FG002|Follow-up Period|Lost to Follow-up|3|||
16371714|NCT01471574|39846562|FG003|Follow-up Period|Lost to Follow-up|2|||
16371715|NCT01471574|39846559|FG000|Follow-up Period|Death|0|||
16371716|NCT01471574|39846560|FG001|Follow-up Period|Death|0|||
16371717|NCT01471574|39846561|FG002|Follow-up Period|Death|1|||
16371718|NCT01471574|39846562|FG003|Follow-up Period|Death|0|||
16371719|NCT01471574|39846559|FG000|Follow-up Period|Follow-up no longer required|0|||
16371720|NCT01471574|39846560|FG001|Follow-up Period|Follow-up no longer required|1|||
16371721|NCT01471574|39846561|FG002|Follow-up Period|Follow-up no longer required|0|||
16371722|NCT01471574|39846562|FG003|Follow-up Period|Follow-up no longer required|0|||
16371723|NCT00927082|39846563|FG000|Overall Study|Lost to Follow-up|9|||
16371724|NCT00927082|39846564|FG001|Overall Study|Lost to Follow-up|8|||
16371725|NCT00927082|39846565|FG002|Overall Study|Lost to Follow-up|12|||
16371726|NCT00927082|39846566|FG003|Overall Study|Lost to Follow-up|16|||
16371727|NCT00927082|39846563|FG000|Overall Study|Withdrawal by Subject|3|||
16371728|NCT00927082|39846564|FG001|Overall Study|Withdrawal by Subject|2|||
16371729|NCT00927082|39846565|FG002|Overall Study|Withdrawal by Subject|7|||
16371730|NCT00927082|39846566|FG003|Overall Study|Withdrawal by Subject|2|||
16371731|NCT00927082|39846563|FG000|Overall Study|Death|0|||
16069648|NCT03538054|38745652|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
16069649|NCT03254394|38745656|FG000|Overall Study|Withdrawal by Subject|0|||
16069650|NCT03254394|38745657|FG001|Overall Study|Withdrawal by Subject|2|||
16069651|NCT00357396|38745658|FG000|Overall Study|Adverse Event|1|||
16069652|NCT00357396|38745659|FG001|Overall Study|Adverse Event|0|||
16371732|NCT00927082|39846564|FG001|Overall Study|Death|0|||
16371733|NCT00927082|39846565|FG002|Overall Study|Death|1|||
16371734|NCT00927082|39846566|FG003|Overall Study|Death|0|||
16371735|NCT00927082|39846563|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
16371736|NCT00927082|39846564|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
16371737|NCT00927082|39846565|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
16371738|NCT00927082|39846566|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
16447890|NCT00321620|40122057|FG000|Overall Study|Disease progression|113|||
16447891|NCT00321620|40122058|FG001|Overall Study|Disease progression|117|||
16447892|NCT00321620|40122057|FG000|Overall Study|Adverse Event|43|||
16447893|NCT00321620|40122058|FG001|Overall Study|Adverse Event|56|||
16447894|NCT00321620|40122057|FG000|Overall Study|Lost to Follow-up|13|||
16447895|NCT00321620|40122058|FG001|Overall Study|Lost to Follow-up|9|||
16447896|NCT00321620|40122057|FG000|Overall Study|Physician Decision|4|||
16447897|NCT00321620|40122058|FG001|Overall Study|Physician Decision|1|||
16447898|NCT00321620|40122057|FG000|Overall Study|Noncompliance|14|||
16447899|NCT00321620|40122058|FG001|Overall Study|Noncompliance|7|||
16447900|NCT00321620|40122057|FG000|Overall Study|Protocol deviation|4|||
16447901|NCT00321620|40122058|FG001|Overall Study|Protocol deviation|3|||
16447902|NCT00321620|40122057|FG000|Overall Study|Ineligibility determined|2|||
16447903|NCT00321620|40122058|FG001|Overall Study|Ineligibility determined|3|||
16447904|NCT00321620|40122057|FG000|Overall Study|Participant request|75|||
16447905|NCT00321620|40122058|FG001|Overall Study|Participant request|52|||
16447906|NCT00321620|40122057|FG000|Overall Study|Other|42|||
16447907|NCT00321620|40122058|FG001|Overall Study|Other|33|||
16447908|NCT04161157|40122059|FG000|Overall Study|Lost to Follow-up|4|||
16447909|NCT04161157|40122059|FG000|Overall Study|Death|3|||
16447910|NCT04161157|40122059|FG000|Overall Study|Ineligible|2|||
16447911|NCT04161157|40122059|FG000|Overall Study|Withdrawal by Subject|4|||
16447912|NCT00929695|40122060|FG000|Overall Study|Death|2|||
16447913|NCT00929695|40122061|FG001|Overall Study|Death|1|||
16447914|NCT00929695|40122060|FG000|Overall Study|Withdrawal by Subject|0|||
16447915|NCT00929695|40122061|FG001|Overall Study|Withdrawal by Subject|2|||
16447916|NCT00929695|40122060|FG000|Overall Study|discharge home|4|||
16447917|NCT00929695|40122061|FG001|Overall Study|discharge home|3|||
16447918|NCT00929695|40122060|FG000|Overall Study|incorrect stratification|2|||
16447919|NCT00929695|40122061|FG001|Overall Study|incorrect stratification|0|||
16447920|NCT02492763|40122068|FG000|Overall Study|Withdrawal by Subject|0|||
16447921|NCT02492763|40122069|FG001|Overall Study|Withdrawal by Subject|2|||
16447922|NCT02492763|40122070|FG002|Overall Study|Withdrawal by Subject|1|||
16447923|NCT02492763|40122071|FG003|Overall Study|Withdrawal by Subject|0|||
16447924|NCT02492763|40122068|FG000|Overall Study|Adverse Event|3|||
16447925|NCT02492763|40122069|FG001|Overall Study|Adverse Event|1|||
16447926|NCT02492763|40122070|FG002|Overall Study|Adverse Event|1|||
16447927|NCT02492763|40122071|FG003|Overall Study|Adverse Event|2|||
16447928|NCT02492763|40122068|FG000|Overall Study|Death|0|||
16447929|NCT02492763|40122069|FG001|Overall Study|Death|0|||
16447930|NCT02492763|40122070|FG002|Overall Study|Death|1|||
16447931|NCT02492763|40122071|FG003|Overall Study|Death|0|||
16447932|NCT02492763|40122068|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
16447933|NCT02492763|40122069|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
16447934|NCT02492763|40122070|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
16447935|NCT02492763|40122071|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
16447936|NCT02492763|40122068|FG000|Overall Study|Lost to Follow-up|0|||
16447937|NCT02492763|40122069|FG001|Overall Study|Lost to Follow-up|0|||
16447938|NCT02492763|40122070|FG002|Overall Study|Lost to Follow-up|1|||
16447939|NCT02492763|40122071|FG003|Overall Study|Lost to Follow-up|0|||
16447940|NCT02492763|40122068|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16069653|NCT01786564|38745660|FG000|Overall Study|Lost to Follow-up|47|||
16069654|NCT01786564|38745660|FG000|Overall Study|Ineligible|17|||
16069655|NCT04860258|38745669|FG000|Overall Study|Withdrawal by Subject|0|||
16069656|NCT04860258|38745670|FG001|Overall Study|Withdrawal by Subject|0|||
16069657|NCT04860258|38745671|FG002|Overall Study|Withdrawal by Subject|4|||
16069658|NCT04860258|38745672|FG003|Overall Study|Withdrawal by Subject|1|||
16069659|NCT04860258|38745673|FG004|Overall Study|Withdrawal by Subject|4|||
16069660|NCT04860258|38745674|FG005|Overall Study|Withdrawal by Subject|1|||
16069661|NCT04860258|38745675|FG006|Overall Study|Withdrawal by Subject|0|||
16069662|NCT02994654|38745676|FG000|Overall Study|Lost to Follow-up|1|||
16069663|NCT01913340|38745686|FG000|Overall Study|Death|2|||
16069664|NCT01913340|38745687|FG001|Overall Study|Death|5|||
16069665|NCT01913340|38745686|FG000|Overall Study|Lost to Follow-up|1|||
16069666|NCT01913340|38745687|FG001|Overall Study|Lost to Follow-up|1|||
16161499|NCT00978029|39072393|FG001|Overall Study|Adverse Event|2|||
16447941|NCT02492763|40122069|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16447942|NCT02492763|40122070|FG002|Overall Study|Non-Compliance With Study Drug|0|||
16447943|NCT02492763|40122071|FG003|Overall Study|Non-Compliance With Study Drug|0|||
16447944|NCT02492763|40122068|FG000|Overall Study|Screen Failure|0|||
16447945|NCT02492763|40122069|FG001|Overall Study|Screen Failure|0|||
16447946|NCT02492763|40122070|FG002|Overall Study|Screen Failure|0|||
16447947|NCT02492763|40122071|FG003|Overall Study|Screen Failure|1|||
16447948|NCT02492763|40122068|FG000|Overall Study|Study Terminated by Sponsor|13|||
16447949|NCT02492763|40122069|FG001|Overall Study|Study Terminated by Sponsor|10|||
16447950|NCT02492763|40122070|FG002|Overall Study|Study Terminated by Sponsor|6|||
16447951|NCT02492763|40122071|FG003|Overall Study|Study Terminated by Sponsor|10|||
16447952|NCT02083354|40122072|FG000|Overall Study|Withdrawal by Subject|9|||
16447953|NCT02083354|40122072|FG000|Overall Study|Lost to Follow-up|1|||
16069667|NCT02046616|38745688|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
16069668|NCT02046616|38745688|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
16371739|NCT01953354|39846567|FG000|Overall Study|Withdrawal by Subject|0|||
16371740|NCT01953354|39846568|FG001|Overall Study|Withdrawal by Subject|1|||
16371741|NCT01953354|39846567|FG000|Overall Study|Decision of Sponsor|0|||
16371742|NCT01953354|39846568|FG001|Overall Study|Decision of Sponsor|1|||
16371743|NCT01953354|39846567|FG000|Overall Study|Disease Exacerbation|1|||
16371744|NCT01953354|39846568|FG001|Overall Study|Disease Exacerbation|0|||
16371745|NCT01716559|39846570|FG000|Overall Study|Adverse Event|11|||
16371746|NCT01716559|39846570|FG000|Overall Study|Death|21|||
16371747|NCT01716559|39846570|FG000|Overall Study|Withdrawal by Subject|4|||
16371748|NCT01716559|39846570|FG000|Overall Study|Other withdrawal reason|75|||
16371749|NCT01096186|39846571|FG000|Overall Study|Adverse Event|16|||
16371750|NCT01096186|39846571|FG000|Overall Study|Death|4|||
16371751|NCT01096186|39846571|FG000|Overall Study|Lack of Efficacy|4|||
16371752|NCT01096186|39846571|FG000|Overall Study|Lost to Follow-up|2|||
16371753|NCT01096186|39846571|FG000|Overall Study|Withdrawal by Subject|22|||
16371754|NCT01096186|39846571|FG000|Overall Study|Physician Decision|1|||
16371755|NCT01096186|39846571|FG000|Overall Study|Noncompliance with study drug|1|||
16371756|NCT03718000|39846572|FG000|Overall Study|Relocation|2|||
16371757|NCT03718000|39846573|FG001|Overall Study|Relocation|4|||
16371758|NCT03718000|39846572|FG000|Overall Study|Pregnancy|0|||
16371759|NCT03718000|39846573|FG001|Overall Study|Pregnancy|1|||
16371760|NCT01283386|39846575|FG000|Overall Study|Death|2|||
16371761|NCT01283386|39846576|FG001|Overall Study|Death|0|||
16371762|NCT01283386|39846575|FG000|Overall Study|Withdrawal by Subject|2|||
16371763|NCT01283386|39846576|FG001|Overall Study|Withdrawal by Subject|1|||
16371764|NCT01283386|39846575|FG000|Overall Study|Relapse of underlying disease|1|||
16371765|NCT01283386|39846576|FG001|Overall Study|Relapse of underlying disease|3|||
16371766|NCT01283386|39846575|FG000|Overall Study|Progression of underlying disease|2|||
16371767|NCT01283386|39846576|FG001|Overall Study|Progression of underlying disease|7|||
16371768|NCT01283386|39846575|FG000|Overall Study|Reason not specified|1|||
16371769|NCT01283386|39846576|FG001|Overall Study|Reason not specified|0|||
16371770|NCT01283386|39846575|FG000|Overall Study|Protocol Violation|0|||
16371771|NCT01283386|39846576|FG001|Overall Study|Protocol Violation|1|||
16371772|NCT01862029|39846577|FG000|Overall Study|Physician Decision|1|||
16371773|NCT01018953|39846580|FG000|Overall Study|Adverse Event|2|||
16371774|NCT01018953|39846580|FG000|Overall Study|Withdrawal by Subject|1|||
16371775|NCT01018953|39846580|FG000|Overall Study|Study termination by sponsor|5|||
16371776|NCT04625972|39846581|FG000|Overall Study|Death|3|||
16371777|NCT04625972|39846582|FG001|Overall Study|Death|2|||
16371778|NCT04625972|39846581|FG000|Overall Study|Lost to Follow-up|82|||
16371779|NCT04625972|39846582|FG001|Overall Study|Lost to Follow-up|38|||
16371780|NCT04625972|39846581|FG000|Overall Study|Physician Decision|2|||
16371781|NCT04625972|39846582|FG001|Overall Study|Physician Decision|0|||
16371782|NCT04625972|39846581|FG000|Overall Study|Protocol Violation|0|||
16371783|NCT04625972|39846582|FG001|Overall Study|Protocol Violation|1|||
16371784|NCT04625972|39846581|FG000|Overall Study|Withdrawal by Subject|37|||
16371785|NCT04625972|39846582|FG001|Overall Study|Withdrawal by Subject|24|||
16371786|NCT04625972|39846581|FG000|Overall Study|Not specified elsewhere|8|||
16371787|NCT04625972|39846582|FG001|Overall Study|Not specified elsewhere|6|||
16371788|NCT02829957|39846583|FG000|Overall Study|Lost to Follow-up|2|||
16069669|NCT02046616|38745688|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
16069670|NCT02046616|38745688|FG000|24-Week Treatment Period|Physician Decision|3|||
16069671|NCT02046616|38745688|FG000|24-Week Treatment Period|Other|1|||
16069672|NCT02046616|38745688|FG000|8-Week FU Period|Lost to Follow-up|1|||
16069673|NCT03425539|38745689|FG000|Overall Study|Randomized but not treated|0|||
16069674|NCT03425539|38745690|FG001|Overall Study|Randomized but not treated|1|||
16069675|NCT03425539|38745689|FG000|Overall Study|Adverse Event|2|||
16069676|NCT03425539|38745690|FG001|Overall Study|Adverse Event|2|||
16069677|NCT03425539|38745689|FG000|Overall Study|Withdrawal by Subject|3|||
16069678|NCT03425539|38745690|FG001|Overall Study|Withdrawal by Subject|0|||
16447954|NCT02083354|40122072|FG000|Overall Study|Adverse Event|3|||
16069679|NCT03425539|38745689|FG000|Overall Study|Lost to Follow-up|0|||
16069680|NCT03425539|38745690|FG001|Overall Study|Lost to Follow-up|1|||
16371789|NCT02829957|39846584|FG001|Overall Study|Lost to Follow-up|1|||
16371790|NCT00183391|39846587|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
16371791|NCT00183391|39846588|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
16371792|NCT00183391|39846587|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
16371793|NCT00183391|39846588|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
16371794|NCT02965976|39846589|FG000|Overall Study|Withdrawal by Subject|2|||
16371795|NCT02965976|39846590|FG001|Overall Study|Withdrawal by Subject|0|||
16371796|NCT01441414|39846591|FG000|Overall Study|Participant died|9|||
16371797|NCT01441414|39846591|FG000|Overall Study|Other reasons|3|||
16371798|NCT01441414|39846591|FG000|Overall Study|Study terminated by sponsor|2|||
16371799|NCT01441414|39846591|FG000|Overall Study|Subject refused further follow-up|1|||
16371800|NCT00225758|39846593|FG000|Overall Study|Adverse Event|4|||
16447955|NCT02083354|40122072|FG000|Overall Study|Disease progression|46|||
16371801|NCT03437733|39846594|FG000|Overall Study|Eligibility criteria not met|0|||
16371802|NCT03437733|39846595|FG001|Overall Study|Eligibility criteria not met|3|||
16371803|NCT01684033|39846596|FG000|Period 1, First 30 Days|Adverse Event|1|||
16371804|NCT01684033|39846597|FG001|Period 1, First 30 Days|Adverse Event|1|||
16371805|NCT01684033|39846596|FG000|Period 1, First 30 Days|Noncompliance|1|||
16371806|NCT01684033|39846597|FG001|Period 1, First 30 Days|Noncompliance|0|||
16371807|NCT01684033|39846596|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
16371808|NCT01684033|39846597|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
16371809|NCT01684033|39846596|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
16371810|NCT01684033|39846597|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
16371811|NCT01684033|39846596|FG000|Period 2, Second 30 Days|Adverse Event|1|||
16371812|NCT01684033|39846597|FG001|Period 2, Second 30 Days|Adverse Event|0|||
16371813|NCT02568254|39846598|FG000|Period 2|Adverse Event|0|||
16371814|NCT02568254|39846599|FG001|Period 2|Adverse Event|0|||
16371815|NCT02568254|39846600|FG002|Period 2|Adverse Event|1|||
16371816|NCT02568254|39846601|FG003|Period 2|Adverse Event|0|||
16371817|NCT02568254|39846602|FG004|Period 2|Adverse Event|0|||
16371818|NCT02568254|39846603|FG005|Period 2|Adverse Event|0|||
16371819|NCT02568254|39846598|FG000|Period 3|Unstatisfactory Lens fitting|0|||
16371820|NCT02568254|39846599|FG001|Period 3|Unstatisfactory Lens fitting|0|||
16371821|NCT02568254|39846600|FG002|Period 3|Unstatisfactory Lens fitting|0|||
16371822|NCT02568254|39846601|FG003|Period 3|Unstatisfactory Lens fitting|0|||
16371823|NCT02568254|39846602|FG004|Period 3|Unstatisfactory Lens fitting|1|||
16371824|NCT02568254|39846603|FG005|Period 3|Unstatisfactory Lens fitting|0|||
16371825|NCT03020888|39846604|FG000|Overall Study|Physician Decision|4|||
16371826|NCT03020888|39846604|FG000|Overall Study|Withdrawal by Subject|6|||
16371827|NCT03020888|39846604|FG000|Overall Study|Insurance coverage|2|||
16371828|NCT03020888|39846604|FG000|Overall Study|Lost to Follow-up|1|||
16371829|NCT00176254|39846610|FG000|Overall Study|Lost to Follow-up|1|||
16371830|NCT01428128|39846621|FG000|Overall Study|Withdrawal by Subject|4|||
16371831|NCT01428128|39846621|FG000|Overall Study|Screen failure by p53|10|||
16371832|NCT01428128|39846621|FG000|Overall Study|Received Neulasta in one cycle|2|||
16371833|NCT01428128|39846621|FG000|Overall Study|Adverse Event|1|||
16371834|NCT01379937|39846622|FG000|Overall Study|Protocol Violation|0|||
16371835|NCT01379937|39846623|FG001|Overall Study|Protocol Violation|0|||
16371836|NCT01379937|39846624|FG002|Overall Study|Protocol Violation|0|||
16371837|NCT01379937|39846625|FG003|Overall Study|Protocol Violation|1|||
16371838|NCT01379937|39846622|FG000|Overall Study|Consent withdrawal|0|||
16371839|NCT01379937|39846623|FG001|Overall Study|Consent withdrawal|1|||
16371840|NCT01379937|39846624|FG002|Overall Study|Consent withdrawal|0|||
16371841|NCT01379937|39846625|FG003|Overall Study|Consent withdrawal|0|||
16371842|NCT01379937|39846622|FG000|Overall Study|Lost to Follow-up|1|||
16069681|NCT03518112|38745692|FG000|Overall Study|Withdrawal by Subject|1|||
16069682|NCT03140176|38745695|FG000|Overall Study|Reason missing|23|||
16069683|NCT03140176|38745695|FG000|Overall Study|Death|33|||
16069684|NCT03140176|38745695|FG000|Overall Study|Disease progression|1|||
16069685|NCT03140176|38745695|FG000|Overall Study|Physician Decision|1|||
16069686|NCT03140176|38745695|FG000|Overall Study|Withdrawal by Subject|1|||
16069687|NCT03140176|38745695|FG000|Overall Study|Lost to Follow-up|15|||
16069688|NCT00425503|38745696|FG000|Overall Study|Adverse Event|2|||
16069689|NCT00425503|38745696|FG000|Overall Study|Protocol Violation|1|||
16069690|NCT01306331|38745705|FG000|Overall Study|Adverse Event|28|||
16069691|NCT01306331|38745706|FG001|Overall Study|Adverse Event|25|||
16069692|NCT01306331|38745705|FG000|Overall Study|Lost to Follow-up|321|||
16069693|NCT01306331|38745706|FG001|Overall Study|Lost to Follow-up|323|||
16069694|NCT01306331|38745705|FG000|Overall Study|Physician Decision|26|||
16069695|NCT01306331|38745706|FG001|Overall Study|Physician Decision|22|||
16069696|NCT01306331|38745705|FG000|Overall Study|Pregnancy|136|||
16069697|NCT01306331|38745706|FG001|Overall Study|Pregnancy|151|||
16069698|NCT01306331|38745705|FG000|Overall Study|Protocol Violation|154|||
16069699|NCT01306331|38745706|FG001|Overall Study|Protocol Violation|124|||
16069700|NCT01306331|38745705|FG000|Overall Study|Withdrawal by Subject|163|||
16069701|NCT01306331|38745706|FG001|Overall Study|Withdrawal by Subject|152|||
16069702|NCT01306331|38745705|FG000|Overall Study|Not sexually active|29|||
16069703|NCT01306331|38745706|FG001|Overall Study|Not sexually active|28|||
16161500|NCT00978029|39072394|FG002|Overall Study|Adverse Event|5|||
16161501|NCT00978029|39072392|FG000|Overall Study|Withdrawal by Subject|0|||
16371843|NCT01379937|39846623|FG001|Overall Study|Lost to Follow-up|2|||
16371844|NCT01379937|39846624|FG002|Overall Study|Lost to Follow-up|2|||
16371845|NCT01379937|39846625|FG003|Overall Study|Lost to Follow-up|0|||
16371846|NCT03681093|39846626|FG000|Overall Study|Subject decision|0|||
16371847|NCT03681093|39846627|FG001|Overall Study|Subject decision|2|||
16371848|NCT03681093|39846628|FG002|Overall Study|Subject decision|1|||
16371849|NCT01429623|39846630|FG000|Overall Study|Death|1|||
16371850|NCT01429623|39846631|FG001|Overall Study|Death|0|||
16371851|NCT01429623|39846630|FG000|Overall Study|Adverse Event|7|||
16371852|NCT01429623|39846631|FG001|Overall Study|Adverse Event|14|||
16069704|NCT01306331|38745705|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
16069705|NCT01306331|38745706|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
16069706|NCT01306331|38745705|FG000|Overall Study|Other|34|||
16069707|NCT01306331|38745706|FG001|Overall Study|Other|32|||
16069708|NCT01090024|38745707|FG000|Period 1|Met exclusion criteria|0|||
16069709|NCT01090024|38745708|FG001|Period 1|Met exclusion criteria|0|||
16069710|NCT01090024|38745709|FG002|Period 1|Met exclusion criteria|0|||
16069711|NCT01090024|38745710|FG003|Period 1|Met exclusion criteria|0|||
16069712|NCT01090024|38745711|FG004|Period 1|Met exclusion criteria|0|||
16069713|NCT01090024|38745712|FG005|Period 1|Met exclusion criteria|0|||
16069714|NCT01090024|38745713|FG006|Period 1|Met exclusion criteria|0|||
16069715|NCT01090024|38745714|FG007|Period 1|Met exclusion criteria|0|||
16069716|NCT01090024|38745715|FG008|Period 1|Met exclusion criteria|0|||
16069717|NCT01090024|38745716|FG009|Period 1|Met exclusion criteria|0|||
16069718|NCT01090024|38745717|FG010|Period 1|Met exclusion criteria|0|||
16069719|NCT01090024|38745718|FG011|Period 1|Met exclusion criteria|0|||
16069720|NCT01090024|38745719|FG012|Period 1|Met exclusion criteria|0|||
16069721|NCT01090024|38745720|FG013|Period 1|Met exclusion criteria|0|||
16069722|NCT01090024|38745721|FG014|Period 1|Met exclusion criteria|1|||
16069723|NCT01090024|38745722|FG015|Period 1|Met exclusion criteria|0|||
16069724|NCT01090024|38745723|FG016|Period 1|Met exclusion criteria|0|||
16069725|NCT01090024|38745724|FG017|Period 1|Met exclusion criteria|0|||
16069726|NCT01090024|38745707|FG000|Period 1|Adverse Event|0|||
16069727|NCT01090024|38745708|FG001|Period 1|Adverse Event|0|||
16069728|NCT01090024|38745709|FG002|Period 1|Adverse Event|0|||
16069729|NCT01090024|38745710|FG003|Period 1|Adverse Event|0|||
16069730|NCT01090024|38745711|FG004|Period 1|Adverse Event|0|||
16069731|NCT01090024|38745712|FG005|Period 1|Adverse Event|0|||
16069732|NCT01090024|38745713|FG006|Period 1|Adverse Event|0|||
16069733|NCT01090024|38745714|FG007|Period 1|Adverse Event|0|||
16069734|NCT01090024|38745715|FG008|Period 1|Adverse Event|0|||
16069735|NCT01090024|38745716|FG009|Period 1|Adverse Event|1|||
16069736|NCT01090024|38745717|FG010|Period 1|Adverse Event|0|||
16069737|NCT01090024|38745718|FG011|Period 1|Adverse Event|1|||
16069738|NCT01090024|38745719|FG012|Period 1|Adverse Event|0|||
16069739|NCT01090024|38745720|FG013|Period 1|Adverse Event|0|||
16069740|NCT01090024|38745721|FG014|Period 1|Adverse Event|0|||
16069741|NCT01090024|38745722|FG015|Period 1|Adverse Event|0|||
16069742|NCT01090024|38745723|FG016|Period 1|Adverse Event|0|||
16069743|NCT01090024|38745724|FG017|Period 1|Adverse Event|1|||
16069744|NCT01090024|38745707|FG000|Period 1|Withdrawal by Subject|0|||
16069745|NCT01090024|38745708|FG001|Period 1|Withdrawal by Subject|0|||
16161502|NCT00978029|39072393|FG001|Overall Study|Withdrawal by Subject|0|||
16161503|NCT00978029|39072394|FG002|Overall Study|Withdrawal by Subject|1|||
16161504|NCT00978029|39072392|FG000|Overall Study|Protocol Violation|0|||
16069746|NCT01090024|38745709|FG002|Period 1|Withdrawal by Subject|0|||
16069747|NCT01090024|38745710|FG003|Period 1|Withdrawal by Subject|1|||
16069748|NCT01090024|38745711|FG004|Period 1|Withdrawal by Subject|0|||
16069749|NCT01090024|38745712|FG005|Period 1|Withdrawal by Subject|0|||
16069750|NCT01090024|38745713|FG006|Period 1|Withdrawal by Subject|0|||
16069751|NCT01090024|38745714|FG007|Period 1|Withdrawal by Subject|0|||
16069752|NCT01090024|38745715|FG008|Period 1|Withdrawal by Subject|0|||
16069753|NCT01090024|38745716|FG009|Period 1|Withdrawal by Subject|0|||
16069754|NCT01090024|38745717|FG010|Period 1|Withdrawal by Subject|0|||
16069755|NCT01090024|38745718|FG011|Period 1|Withdrawal by Subject|0|||
16069756|NCT01090024|38745719|FG012|Period 1|Withdrawal by Subject|0|||
16069757|NCT01090024|38745720|FG013|Period 1|Withdrawal by Subject|0|||
16069758|NCT01090024|38745721|FG014|Period 1|Withdrawal by Subject|0|||
16069759|NCT01090024|38745722|FG015|Period 1|Withdrawal by Subject|0|||
16069760|NCT01090024|38745723|FG016|Period 1|Withdrawal by Subject|0|||
16069761|NCT01090024|38745724|FG017|Period 1|Withdrawal by Subject|0|||
16069762|NCT01090024|38745707|FG000|Period 1|Lost to Follow-up|0|||
16161505|NCT00978029|39072393|FG001|Overall Study|Protocol Violation|1|||
16161506|NCT00978029|39072394|FG002|Overall Study|Protocol Violation|0|||
16161507|NCT03713944|39072395|FG000|Study Treatment|Patient non-compliance|1|||
16161508|NCT03713944|39072395|FG000|Study Treatment|Alternative Cancer Therapy|3|||
16161509|NCT03713944|39072395|FG000|Study Treatment|Disease Progression|18|||
16161510|NCT03713944|39072395|FG000|Study Treatment|AE/Side Effects/Complications|2|||
16161511|NCT03713944|39072395|FG000|Study Treatment|Death|2|||
16161512|NCT03713944|39072395|FG000|Study Treatment|Withdrawal by Subject|1|||
16161513|NCT03713944|39072395|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
16161514|NCT03713944|39072395|FG000|Study Treatment|Symptomatic Deterioration|2|||
16161515|NCT03713944|39072395|FG000|Follow up|Withdrawal by Subject|2|||
16161516|NCT03713944|39072395|FG000|Follow up|Death|11|||
16161517|NCT03713944|39072395|FG000|Follow up|Study Terminated|3|||
16069763|NCT01090024|38745708|FG001|Period 1|Lost to Follow-up|1|||
16069764|NCT01090024|38745709|FG002|Period 1|Lost to Follow-up|0|||
16069765|NCT01090024|38745710|FG003|Period 1|Lost to Follow-up|0|||
16069766|NCT01090024|38745711|FG004|Period 1|Lost to Follow-up|0|||
16069767|NCT01090024|38745712|FG005|Period 1|Lost to Follow-up|0|||
16069768|NCT01090024|38745713|FG006|Period 1|Lost to Follow-up|0|||
16069769|NCT01090024|38745714|FG007|Period 1|Lost to Follow-up|0|||
16069770|NCT01090024|38745715|FG008|Period 1|Lost to Follow-up|0|||
16069771|NCT01090024|38745716|FG009|Period 1|Lost to Follow-up|0|||
16371853|NCT01429623|39846630|FG000|Overall Study|Withdrawal by Subject|19|||
16371854|NCT01429623|39846631|FG001|Overall Study|Withdrawal by Subject|13|||
16371855|NCT01429623|39846630|FG000|Overall Study|Physician Decision|2|||
16371856|NCT01429623|39846631|FG001|Overall Study|Physician Decision|3|||
16371857|NCT01429623|39846630|FG000|Overall Study|Protocol Violation|3|||
16371858|NCT01429623|39846631|FG001|Overall Study|Protocol Violation|2|||
16371859|NCT01429623|39846630|FG000|Overall Study|Assorted|1|||
16371860|NCT01429623|39846631|FG001|Overall Study|Assorted|2|||
16371861|NCT01429623|39846630|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
16371862|NCT01429623|39846631|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
16371863|NCT01429623|39846630|FG000|Overall Study|No post baseline data|4|||
16371864|NCT01429623|39846631|FG001|Overall Study|No post baseline data|4|||
16371865|NCT03197935|39846640|FG000|Overall Study|Death due to any cause|26|||
16371866|NCT03197935|39846641|FG001|Overall Study|Death due to any cause|15|||
16371867|NCT03197935|39846640|FG000|Overall Study|Lost to Follow-up|3|||
16371868|NCT03197935|39846641|FG001|Overall Study|Lost to Follow-up|5|||
16371869|NCT03197935|39846640|FG000|Overall Study|Physician Decision|2|||
16371870|NCT03197935|39846641|FG001|Overall Study|Physician Decision|1|||
16371871|NCT03197935|39846640|FG000|Overall Study|Withdrawal by Subject|16|||
16371872|NCT03197935|39846641|FG001|Overall Study|Withdrawal by Subject|8|||
16371873|NCT00736476|39846642|FG000|Overall Study|Adverse Event|1|||
16371874|NCT00736476|39846643|FG001|Overall Study|Adverse Event|0|||
16371875|NCT03178942|39846648|FG000|Overall Study|Withdrawal by Subject|2|||
16371876|NCT03178942|39846649|FG001|Overall Study|Withdrawal by Subject|0|||
16371877|NCT03178942|39846648|FG000|Overall Study|Lost to Follow-up|1|||
16371878|NCT03178942|39846649|FG001|Overall Study|Lost to Follow-up|2|||
16371879|NCT00560404|39846650|FG000|Overall Study|Adverse Event|2|||
16371880|NCT00560404|39846651|FG001|Overall Study|Adverse Event|3|||
16371881|NCT00560404|39846650|FG000|Overall Study|Death|3|||
16371882|NCT00560404|39846651|FG001|Overall Study|Death|3|||
16371883|NCT00560404|39846650|FG000|Overall Study|Protocol Violation|12|||
16371884|NCT00560404|39846651|FG001|Overall Study|Protocol Violation|7|||
16371885|NCT00560404|39846650|FG000|Overall Study|Administrative Reasons|1|||
16371886|NCT00560404|39846651|FG001|Overall Study|Administrative Reasons|1|||
16371887|NCT00560404|39846650|FG000|Overall Study|Withdrew Consent|4|||
16371888|NCT00560404|39846651|FG001|Overall Study|Withdrew Consent|0|||
16371889|NCT00560404|39846650|FG000|Overall Study|Failure to return|1|||
16371890|NCT00560404|39846651|FG001|Overall Study|Failure to return|2|||
16371891|NCT00560404|39846650|FG000|Overall Study|Other withdrawal reason|13|||
16371892|NCT00560404|39846651|FG001|Overall Study|Other withdrawal reason|5|||
16447956|NCT02083354|40122072|FG000|Overall Study|Study closed/terminated|5|||
16447957|NCT03557034|40122073|FG000|Overall Study|Withdrawal by Subject|1|||
16371893|NCT00414609|39846652|FG000|Core Study|Adverse Event|9|||
16371894|NCT00414609|39846653|FG001|Core Study|Adverse Event|11|||
16371895|NCT00414609|39846654|FG002|Core Study|Adverse Event|0|||
16371896|NCT00414609|39846652|FG000|Core Study|Abnormal laboratory values|0|||
16371897|NCT00414609|39846653|FG001|Core Study|Abnormal laboratory values|1|||
16371898|NCT00414609|39846654|FG002|Core Study|Abnormal laboratory values|0|||
16371899|NCT00414609|39846652|FG000|Core Study|Abnormal test procedure results|1|||
16371900|NCT00414609|39846653|FG001|Core Study|Abnormal test procedure results|1|||
16371901|NCT00414609|39846654|FG002|Core Study|Abnormal test procedure results|0|||
16371902|NCT00414609|39846652|FG000|Core Study|Protocol deviation|0|||
16371903|NCT00414609|39846653|FG001|Core Study|Protocol deviation|1|||
16371904|NCT00414609|39846654|FG002|Core Study|Protocol deviation|0|||
16371905|NCT00414609|39846652|FG000|Core Study|Patient withdrew consent|10|||
16371906|NCT00414609|39846653|FG001|Core Study|Patient withdrew consent|11|||
16371907|NCT00414609|39846654|FG002|Core Study|Patient withdrew consent|0|||
16447958|NCT03557034|40122074|FG001|Overall Study|Withdrawal by Subject|0|||
16447959|NCT02377817|40122075|FG000|Overall Study|Transportation/childcare barriers.|2|||
16447960|NCT02377817|40122076|FG001|Overall Study|Transportation/childcare barriers.|0|||
16069772|NCT01090024|38745717|FG010|Period 1|Lost to Follow-up|0|||
16371908|NCT00414609|39846652|FG000|Core Study|Lost to Follow-up|7|||
16371909|NCT00414609|39846653|FG001|Core Study|Lost to Follow-up|4|||
16371910|NCT00414609|39846654|FG002|Core Study|Lost to Follow-up|0|||
16371911|NCT00414609|39846652|FG000|Core Study|Administrative problems|0|||
16371912|NCT00414609|39846653|FG001|Core Study|Administrative problems|2|||
16371913|NCT00414609|39846654|FG002|Core Study|Administrative problems|0|||
16371914|NCT00414609|39846652|FG000|Core Study|Death|7|||
16371915|NCT00414609|39846653|FG001|Core Study|Death|14|||
16371916|NCT00414609|39846654|FG002|Core Study|Death|0|||
16371917|NCT00414609|39846652|FG000|Extension Study|Adverse Event|0|||
16371918|NCT00414609|39846653|FG001|Extension Study|Adverse Event|0|||
16371919|NCT00414609|39846654|FG002|Extension Study|Adverse Event|14|||
16371920|NCT00414609|39846652|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
16371921|NCT00414609|39846653|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
16371922|NCT00414609|39846654|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
16371923|NCT00414609|39846652|FG000|Extension Study|Withdrawal by Subject|0|||
16447961|NCT02377817|40122075|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
16371924|NCT00414609|39846653|FG001|Extension Study|Withdrawal by Subject|0|||
16371925|NCT00414609|39846654|FG002|Extension Study|Withdrawal by Subject|13|||
16069773|NCT01090024|38745718|FG011|Period 1|Lost to Follow-up|0|||
16069774|NCT01090024|38745719|FG012|Period 1|Lost to Follow-up|0|||
16069775|NCT01090024|38745720|FG013|Period 1|Lost to Follow-up|0|||
16069776|NCT01090024|38745721|FG014|Period 1|Lost to Follow-up|0|||
16161518|NCT03804684|39072396|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
16069777|NCT01090024|38745722|FG015|Period 1|Lost to Follow-up|0|||
16069778|NCT01090024|38745723|FG016|Period 1|Lost to Follow-up|0|||
16069779|NCT01090024|38745724|FG017|Period 1|Lost to Follow-up|0|||
16069780|NCT01090024|38745707|FG000|Period 2|Lost to Follow-up|0|||
16069781|NCT01090024|38745708|FG001|Period 2|Lost to Follow-up|0|||
16069782|NCT01090024|38745709|FG002|Period 2|Lost to Follow-up|0|||
16069783|NCT01090024|38745710|FG003|Period 2|Lost to Follow-up|1|||
16069784|NCT01090024|38745711|FG004|Period 2|Lost to Follow-up|0|||
16069785|NCT01090024|38745712|FG005|Period 2|Lost to Follow-up|0|||
16069786|NCT01090024|38745713|FG006|Period 2|Lost to Follow-up|0|||
16069787|NCT01090024|38745714|FG007|Period 2|Lost to Follow-up|0|||
16069788|NCT01090024|38745715|FG008|Period 2|Lost to Follow-up|0|||
16161519|NCT03804684|39072397|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
16069789|NCT01090024|38745716|FG009|Period 2|Lost to Follow-up|0|||
16069790|NCT01090024|38745717|FG010|Period 2|Lost to Follow-up|0|||
16069791|NCT01090024|38745718|FG011|Period 2|Lost to Follow-up|0|||
16069792|NCT01090024|38745719|FG012|Period 2|Lost to Follow-up|0|||
16069793|NCT01090024|38745720|FG013|Period 2|Lost to Follow-up|0|||
16069794|NCT01090024|38745721|FG014|Period 2|Lost to Follow-up|0|||
16069795|NCT01090024|38745722|FG015|Period 2|Lost to Follow-up|0|||
16069796|NCT01090024|38745723|FG016|Period 2|Lost to Follow-up|0|||
16069797|NCT01090024|38745724|FG017|Period 2|Lost to Follow-up|0|||
16069798|NCT01090024|38745707|FG000|Period 2|Adverse Event|1|||
16069799|NCT01090024|38745708|FG001|Period 2|Adverse Event|0|||
16069800|NCT01090024|38745709|FG002|Period 2|Adverse Event|0|||
16069801|NCT01090024|38745710|FG003|Period 2|Adverse Event|0|||
16069802|NCT01090024|38745711|FG004|Period 2|Adverse Event|0|||
16069803|NCT01090024|38745712|FG005|Period 2|Adverse Event|0|||
16069804|NCT01090024|38745713|FG006|Period 2|Adverse Event|0|||
16069805|NCT01090024|38745714|FG007|Period 2|Adverse Event|0|||
16069806|NCT01090024|38745715|FG008|Period 2|Adverse Event|0|||
16069807|NCT01090024|38745716|FG009|Period 2|Adverse Event|0|||
16069808|NCT01090024|38745717|FG010|Period 2|Adverse Event|0|||
16069809|NCT01090024|38745718|FG011|Period 2|Adverse Event|0|||
16069810|NCT01090024|38745719|FG012|Period 2|Adverse Event|0|||
16069811|NCT01090024|38745720|FG013|Period 2|Adverse Event|0|||
16069812|NCT01090024|38745721|FG014|Period 2|Adverse Event|0|||
16069813|NCT01090024|38745722|FG015|Period 2|Adverse Event|0|||
16069814|NCT01090024|38745723|FG016|Period 2|Adverse Event|0|||
16069815|NCT01090024|38745724|FG017|Period 2|Adverse Event|0|||
16161520|NCT03757988|39072398|FG000|Overall Study|Withdrawal by Subject|1|||
16161521|NCT01637142|39072399|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
16161522|NCT00661531|39072401|FG000|Overall Study|Withdrawal by Subject|3|||
16161523|NCT05594173|39072402|FG000|Overall Study|Adverse Event|1|||
16069816|NCT01090024|38745707|FG000|Period 3|Withdrawal by Subject|0|||
16069817|NCT01090024|38745708|FG001|Period 3|Withdrawal by Subject|0|||
16069818|NCT01090024|38745709|FG002|Period 3|Withdrawal by Subject|0|||
16069819|NCT01090024|38745710|FG003|Period 3|Withdrawal by Subject|0|||
16069820|NCT01090024|38745711|FG004|Period 3|Withdrawal by Subject|0|||
16069821|NCT01090024|38745712|FG005|Period 3|Withdrawal by Subject|0|||
16069822|NCT01090024|38745713|FG006|Period 3|Withdrawal by Subject|0|||
16069823|NCT01090024|38745714|FG007|Period 3|Withdrawal by Subject|0|||
16069824|NCT01090024|38745715|FG008|Period 3|Withdrawal by Subject|0|||
16069825|NCT01090024|38745716|FG009|Period 3|Withdrawal by Subject|0|||
16069826|NCT01090024|38745717|FG010|Period 3|Withdrawal by Subject|0|||
16069827|NCT01090024|38745718|FG011|Period 3|Withdrawal by Subject|0|||
16069828|NCT01090024|38745719|FG012|Period 3|Withdrawal by Subject|0|||
16069829|NCT01090024|38745720|FG013|Period 3|Withdrawal by Subject|0|||
16069830|NCT01090024|38745721|FG014|Period 3|Withdrawal by Subject|0|||
16069831|NCT01090024|38745722|FG015|Period 3|Withdrawal by Subject|1|||
16069832|NCT01090024|38745723|FG016|Period 3|Withdrawal by Subject|0|||
16069833|NCT01090024|38745724|FG017|Period 3|Withdrawal by Subject|0|||
16069834|NCT01090024|38745707|FG000|Period 3|Protocol Violation|0|||
16069835|NCT01090024|38745708|FG001|Period 3|Protocol Violation|0|||
16069836|NCT01090024|38745709|FG002|Period 3|Protocol Violation|0|||
16161524|NCT05594173|39072402|FG000|Overall Study|COVID-19 Pandemic|2|||
16371926|NCT00414609|39846652|FG000|Extension Study|Lost to Follow-up|0|||
16069837|NCT01090024|38745710|FG003|Period 3|Protocol Violation|0|||
16069838|NCT01090024|38745711|FG004|Period 3|Protocol Violation|0|||
16069839|NCT01090024|38745712|FG005|Period 3|Protocol Violation|0|||
16069840|NCT01090024|38745713|FG006|Period 3|Protocol Violation|0|||
16069841|NCT01090024|38745714|FG007|Period 3|Protocol Violation|0|||
16069842|NCT01090024|38745715|FG008|Period 3|Protocol Violation|1|||
16069843|NCT01090024|38745716|FG009|Period 3|Protocol Violation|0|||
16069844|NCT01090024|38745717|FG010|Period 3|Protocol Violation|0|||
16069845|NCT01090024|38745718|FG011|Period 3|Protocol Violation|0|||
16069846|NCT01090024|38745719|FG012|Period 3|Protocol Violation|0|||
16069847|NCT01090024|38745720|FG013|Period 3|Protocol Violation|0|||
16069848|NCT01090024|38745721|FG014|Period 3|Protocol Violation|0|||
16069849|NCT01090024|38745722|FG015|Period 3|Protocol Violation|0|||
16069850|NCT01090024|38745723|FG016|Period 3|Protocol Violation|0|||
16069851|NCT01090024|38745724|FG017|Period 3|Protocol Violation|0|||
16069852|NCT01090024|38745707|FG000|Period 3|Adverse Event|0|||
16069853|NCT01090024|38745708|FG001|Period 3|Adverse Event|0|||
16069854|NCT01090024|38745709|FG002|Period 3|Adverse Event|0|||
16069855|NCT01090024|38745710|FG003|Period 3|Adverse Event|0|||
16069856|NCT01090024|38745711|FG004|Period 3|Adverse Event|0|||
16069857|NCT01090024|38745712|FG005|Period 3|Adverse Event|1|||
16069858|NCT01090024|38745713|FG006|Period 3|Adverse Event|0|||
16069859|NCT01090024|38745714|FG007|Period 3|Adverse Event|0|||
16069860|NCT01090024|38745715|FG008|Period 3|Adverse Event|0|||
16069861|NCT01090024|38745716|FG009|Period 3|Adverse Event|0|||
16069862|NCT01090024|38745717|FG010|Period 3|Adverse Event|0|||
16069863|NCT01090024|38745718|FG011|Period 3|Adverse Event|0|||
16069864|NCT01090024|38745719|FG012|Period 3|Adverse Event|0|||
16069865|NCT01090024|38745720|FG013|Period 3|Adverse Event|0|||
16069866|NCT01090024|38745721|FG014|Period 3|Adverse Event|0|||
16069867|NCT01090024|38745722|FG015|Period 3|Adverse Event|0|||
16069868|NCT01090024|38745723|FG016|Period 3|Adverse Event|0|||
16069869|NCT01090024|38745724|FG017|Period 3|Adverse Event|0|||
16371927|NCT00414609|39846653|FG001|Extension Study|Lost to Follow-up|0|||
16371928|NCT00414609|39846654|FG002|Extension Study|Lost to Follow-up|10|||
16371929|NCT00414609|39846652|FG000|Extension Study|Administrative problems|0|||
16371930|NCT00414609|39846653|FG001|Extension Study|Administrative problems|0|||
16371931|NCT00414609|39846654|FG002|Extension Study|Administrative problems|1|||
16371932|NCT00414609|39846652|FG000|Extension Study|Death|0|||
16371933|NCT00414609|39846653|FG001|Extension Study|Death|0|||
16371934|NCT00414609|39846654|FG002|Extension Study|Death|17|||
16371935|NCT01797185|39846655|FG000|Overall Study|Adverse Event|5|||
16371936|NCT01797185|39846656|FG001|Overall Study|Adverse Event|15|||
16371937|NCT01797185|39846657|FG002|Overall Study|Adverse Event|6|||
16371938|NCT01797185|39846655|FG000|Overall Study|Withdrawal by Subject|6|||
16371939|NCT01797185|39846656|FG001|Overall Study|Withdrawal by Subject|9|||
16371940|NCT01797185|39846657|FG002|Overall Study|Withdrawal by Subject|5|||
16371941|NCT01797185|39846655|FG000|Overall Study|Site terminated|8|||
16371942|NCT01797185|39846656|FG001|Overall Study|Site terminated|4|||
16069870|NCT02962674|38745728|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
16069871|NCT00957658|38745729|FG000|Overall Study|Death|1|||
16069872|NCT00957658|38745729|FG000|Overall Study|Lost to Follow-up|4|||
16069873|NCT00957658|38745729|FG000|Overall Study|Withdrawal by Subject|12|||
16069874|NCT00957658|38745729|FG000|Overall Study|Revision|1|||
16069875|NCT00957658|38745729|FG000|Overall Study|Incomplete 2 yr data|28|||
16069876|NCT00957658|38745729|FG000|Overall Study|Site termination|10|||
16069877|NCT00957658|38745729|FG000|Overall Study|unwilling/unable to return|2|||
16069878|NCT00957658|38745729|FG000|Overall Study|surgery cancelled|2|||
16069879|NCT00957658|38745729|FG000|Overall Study|Protocol Violation|5|||
16069880|NCT00954707|38745730|FG000|Overall Study|Death|34|||
16069881|NCT00954707|38745730|FG000|Overall Study|Withdrawal by Subject|100|||
16069882|NCT00954707|38745730|FG000|Overall Study|Lost to Follow-up|33|||
16069883|NCT01704846|38745731|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16069884|NCT01704846|38745732|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16069885|NCT00837616|38745733|FG000|Overall Study|Withdrawal by Subject|0|||
16371943|NCT01797185|39846657|FG002|Overall Study|Site terminated|0|||
16371944|NCT01797185|39846655|FG000|Overall Study|Lost to Follow-up|2|||
16371945|NCT01797185|39846656|FG001|Overall Study|Lost to Follow-up|6|||
16371946|NCT01797185|39846657|FG002|Overall Study|Lost to Follow-up|1|||
16371947|NCT01797185|39846655|FG000|Overall Study|Withdrawn per sponsor|5|||
16371948|NCT01797185|39846656|FG001|Overall Study|Withdrawn per sponsor|0|||
16371949|NCT01797185|39846657|FG002|Overall Study|Withdrawn per sponsor|0|||
16069886|NCT00837616|38745734|FG001|Overall Study|Withdrawal by Subject|1|||
16069887|NCT00470626|38745735|FG000|Overall Study|Lost to Follow-up|10|||
16069888|NCT00470626|38745735|FG000|Overall Study|Withdrawal by Subject|7|||
16069889|NCT01769391|38745739|FG000|Overall Study|Death|10|||
16371950|NCT01797185|39846655|FG000|Overall Study|Physician Decision|1|||
16371951|NCT01797185|39846656|FG001|Overall Study|Physician Decision|3|||
16371952|NCT01797185|39846657|FG002|Overall Study|Physician Decision|0|||
16371953|NCT01797185|39846655|FG000|Overall Study|Protocol Violation|1|||
16371954|NCT01797185|39846656|FG001|Overall Study|Protocol Violation|1|||
16371955|NCT01797185|39846657|FG002|Overall Study|Protocol Violation|0|||
16371956|NCT01152385|39846658|FG000|Overall Study|Withdrawal by Subject|3|||
16371957|NCT01152385|39846659|FG001|Overall Study|Withdrawal by Subject|1|||
16371958|NCT01152385|39846660|FG002|Overall Study|Withdrawal by Subject|1|||
16371959|NCT01152385|39846661|FG003|Overall Study|Withdrawal by Subject|1|||
16069890|NCT01769391|38745740|FG001|Overall Study|Death|1|||
16069891|NCT01769391|38745739|FG000|Overall Study|Adverse Event|0|||
16371960|NCT01152385|39846658|FG000|Overall Study|Protocol Violation|0|||
16371961|NCT01152385|39846659|FG001|Overall Study|Protocol Violation|0|||
16371962|NCT01152385|39846660|FG002|Overall Study|Protocol Violation|0|||
16371963|NCT01152385|39846661|FG003|Overall Study|Protocol Violation|1|||
16371964|NCT01152385|39846658|FG000|Overall Study|Adverse Event|1|||
16371965|NCT01152385|39846659|FG001|Overall Study|Adverse Event|1|||
16371966|NCT01152385|39846660|FG002|Overall Study|Adverse Event|0|||
16371967|NCT01152385|39846661|FG003|Overall Study|Adverse Event|0|||
16371968|NCT01152385|39846658|FG000|Overall Study|Study-specific withdrawal criteria|1|||
16371969|NCT01152385|39846659|FG001|Overall Study|Study-specific withdrawal criteria|1|||
16371970|NCT01152385|39846660|FG002|Overall Study|Study-specific withdrawal criteria|2|||
16371971|NCT01152385|39846661|FG003|Overall Study|Study-specific withdrawal criteria|0|||
16371972|NCT01152385|39846658|FG000|Overall Study|Other|4|||
16371973|NCT01152385|39846659|FG001|Overall Study|Other|3|||
16371974|NCT01152385|39846660|FG002|Overall Study|Other|2|||
16371975|NCT01152385|39846661|FG003|Overall Study|Other|3|||
16371976|NCT02958527|39846662|FG000|Overall Study|Not collected CRFs|12|||
16371977|NCT02441114|39846667|FG000|Washout2|Withdrawal by Subject|4|||
16371978|NCT05059080|39846668|FG000|Overall Study|Withdrawal by Subject|3|||
16371979|NCT05059080|39846668|FG000|Overall Study|Study Terminated by Sponsor|64|||
16371980|NCT00507507|39846669|FG000|Treatment Period|Lost to Follow-up|0|||
16371981|NCT00507507|39846670|FG001|Treatment Period|Lost to Follow-up|2|||
16371982|NCT00507507|39846669|FG000|Treatment Period|Physician Decision|4|||
16371983|NCT00507507|39846670|FG001|Treatment Period|Physician Decision|1|||
16371984|NCT00507507|39846669|FG000|Treatment Period|Protocol Violation|1|||
16371985|NCT00507507|39846670|FG001|Treatment Period|Protocol Violation|2|||
16371986|NCT00507507|39846669|FG000|Treatment Period|Adverse Event|1|||
16371987|NCT00507507|39846670|FG001|Treatment Period|Adverse Event|1|||
16371988|NCT00507507|39846669|FG000|Treatment Period|Withdrawal by Subject|46|||
16371989|NCT00507507|39846670|FG001|Treatment Period|Withdrawal by Subject|47|||
16371990|NCT00507507|39846669|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
16371991|NCT00507507|39846670|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
16371992|NCT00507507|39846669|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
16371993|NCT00507507|39846670|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
16371994|NCT00507507|39846669|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
16371995|NCT00507507|39846670|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
16371996|NCT03983109|39846671|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
16371997|NCT03983109|39846672|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
16371998|NCT00676689|39846673|FG000|Overall Study|Screen Failure|2|||
16371999|NCT00676689|39846673|FG000|Overall Study|Death|2|||
16372000|NCT00676689|39846673|FG000|Overall Study|Lost to Follow-up|4|||
16372001|NCT00676689|39846673|FG000|Overall Study|Physician Decision|1|||
16372002|NCT00676689|39846673|FG000|Overall Study|Withdrawal by Subject|3|||
16372003|NCT00676689|39846673|FG000|Overall Study|Continuing FU|49|||
16372004|NCT02639559|39846674|FG000|Overall Study|Mobilization failure|0|||
16372005|NCT02639559|39846675|FG001|Overall Study|Mobilization failure|3|||
16372006|NCT02639559|39846674|FG000|Overall Study|Issues with vascular acess|1|||
16372007|NCT02639559|39846675|FG001|Overall Study|Issues with vascular acess|0|||
16372008|NCT03462563|39846680|FG000|Overall Study|Death|1|||
16372009|NCT03462563|39846681|FG001|Overall Study|Death|1|||
16069892|NCT01769391|38745740|FG001|Overall Study|Adverse Event|3|||
16069893|NCT01769391|38745739|FG000|Overall Study|Progressive Disease|1|||
16069894|NCT01769391|38745740|FG001|Overall Study|Progressive Disease|2|||
16069895|NCT01769391|38745739|FG000|Overall Study|Withdrawal by Subject|4|||
16069896|NCT01769391|38745740|FG001|Overall Study|Withdrawal by Subject|3|||
16069897|NCT01769391|38745739|FG000|Overall Study|Investigator Decision|2|||
16069898|NCT01769391|38745740|FG001|Overall Study|Investigator Decision|0|||
16069899|NCT02534896|38745741|FG000|Overall Study|Adverse Event|2|||
16069900|NCT02534896|38745742|FG001|Overall Study|Adverse Event|1|||
16069901|NCT02534896|38745743|FG002|Overall Study|Adverse Event|1|||
16069902|NCT02534896|38745741|FG000|Overall Study|Insufficient therapeutic response|2|||
16069903|NCT02534896|38745742|FG001|Overall Study|Insufficient therapeutic response|0|||
16069904|NCT02534896|38745743|FG002|Overall Study|Insufficient therapeutic response|0|||
16069905|NCT04565249|38745744|FG000|Overall Study|Death|0|||
16372010|NCT03462563|39846680|FG000|Overall Study|Termination of study|2|||
16372011|NCT03462563|39846681|FG001|Overall Study|Termination of study|1|||
16372012|NCT03462563|39846680|FG000|Overall Study|Adverse Event|1|||
16372013|NCT03462563|39846681|FG001|Overall Study|Adverse Event|3|||
16372014|NCT03462563|39846680|FG000|Overall Study|Unspecified reason|10|||
16372015|NCT03462563|39846681|FG001|Overall Study|Unspecified reason|12|||
16372016|NCT03462563|39846680|FG000|Overall Study|Physician Decision|1|||
16372017|NCT03462563|39846681|FG001|Overall Study|Physician Decision|0|||
16372018|NCT00520572|39846689|FG000|Overall Study|Adverse Event|9|||
16372019|NCT00520572|39846690|FG001|Overall Study|Adverse Event|3|||
16372020|NCT00520572|39846691|FG002|Overall Study|Adverse Event|6|||
16372021|NCT00520572|39846692|FG003|Overall Study|Adverse Event|9|||
16372022|NCT00520572|39846693|FG004|Overall Study|Adverse Event|7|||
16372023|NCT00520572|39846694|FG005|Overall Study|Adverse Event|2|||
16372024|NCT00520572|39846689|FG000|Overall Study|Withdrawal by Subject|0|||
16372025|NCT00520572|39846690|FG001|Overall Study|Withdrawal by Subject|9|||
16372026|NCT00520572|39846691|FG002|Overall Study|Withdrawal by Subject|5|||
16372027|NCT00520572|39846692|FG003|Overall Study|Withdrawal by Subject|2|||
16372028|NCT00520572|39846693|FG004|Overall Study|Withdrawal by Subject|2|||
16372029|NCT00520572|39846694|FG005|Overall Study|Withdrawal by Subject|0|||
16372030|NCT00520572|39846689|FG000|Overall Study|Protocol Violation|0|||
16372031|NCT00520572|39846690|FG001|Overall Study|Protocol Violation|0|||
16372032|NCT00520572|39846691|FG002|Overall Study|Protocol Violation|1|||
16372033|NCT00520572|39846692|FG003|Overall Study|Protocol Violation|0|||
16372034|NCT00520572|39846693|FG004|Overall Study|Protocol Violation|0|||
16372035|NCT00520572|39846694|FG005|Overall Study|Protocol Violation|0|||
16372036|NCT00520572|39846689|FG000|Overall Study|Lack of Efficacy|1|||
16372037|NCT00520572|39846690|FG001|Overall Study|Lack of Efficacy|1|||
16372038|NCT00520572|39846691|FG002|Overall Study|Lack of Efficacy|1|||
16372039|NCT00520572|39846692|FG003|Overall Study|Lack of Efficacy|2|||
16372040|NCT00520572|39846693|FG004|Overall Study|Lack of Efficacy|1|||
16372041|NCT00520572|39846694|FG005|Overall Study|Lack of Efficacy|0|||
16372042|NCT00520572|39846689|FG000|Overall Study|Lost to Follow-up|0|||
16372043|NCT00520572|39846690|FG001|Overall Study|Lost to Follow-up|0|||
16372044|NCT00520572|39846691|FG002|Overall Study|Lost to Follow-up|0|||
16372045|NCT00520572|39846692|FG003|Overall Study|Lost to Follow-up|0|||
16372046|NCT00520572|39846693|FG004|Overall Study|Lost to Follow-up|1|||
16372047|NCT00520572|39846694|FG005|Overall Study|Lost to Follow-up|0|||
16372048|NCT00520572|39846689|FG000|Overall Study|Incorrect enrollment|1|||
16372049|NCT00520572|39846690|FG001|Overall Study|Incorrect enrollment|0|||
16372050|NCT00520572|39846691|FG002|Overall Study|Incorrect enrollment|1|||
16372051|NCT00520572|39846692|FG003|Overall Study|Incorrect enrollment|0|||
16372052|NCT00520572|39846693|FG004|Overall Study|Incorrect enrollment|1|||
16372053|NCT00520572|39846694|FG005|Overall Study|Incorrect enrollment|0|||
16372054|NCT00520572|39846689|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
16372055|NCT00520572|39846690|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
16372056|NCT00520572|39846691|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
16372057|NCT00520572|39846692|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
16069906|NCT04565249|38745745|FG001|Overall Study|Death|0|||
16069907|NCT04565249|38745746|FG002|Overall Study|Death|0|||
16069908|NCT04565249|38745747|FG003|Overall Study|Death|1|||
16069909|NCT00554801|38745748|FG000|Overall Study|left area before completion|5|||
16069910|NCT00554801|38745749|FG001|Overall Study|left area before completion|0|||
16069911|NCT00554801|38745748|FG000|Overall Study|Withdrawal by Subject|14|||
16069912|NCT00554801|38745749|FG001|Overall Study|Withdrawal by Subject|0|||
16069913|NCT01144182|38745750|FG000|Overall Study|Death|5|||
16069914|NCT01144182|38745751|FG001|Overall Study|Death|6|||
16069915|NCT01144182|38745750|FG000|Overall Study|Withdrawal by Subject|3|||
16069916|NCT01144182|38745751|FG001|Overall Study|Withdrawal by Subject|6|||
16069917|NCT01144182|38745750|FG000|Overall Study|Lost to Follow-up|9|||
16069918|NCT01144182|38745751|FG001|Overall Study|Lost to Follow-up|9|||
16069919|NCT00961636|38745754|FG000|Overall Study|Adverse Event|35|||
16069920|NCT00961636|38745755|FG001|Overall Study|Adverse Event|54|||
16069921|NCT00961636|38745756|FG002|Overall Study|Adverse Event|13|||
16069922|NCT00961636|38745754|FG000|Overall Study|Flushing Symptoms|29|||
16069923|NCT00961636|38745755|FG001|Overall Study|Flushing Symptoms|46|||
16069924|NCT00961636|38745756|FG002|Overall Study|Flushing Symptoms|3|||
16372058|NCT00520572|39846693|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
16372059|NCT00520572|39846694|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
16372060|NCT00520572|39846689|FG000|Overall Study|Long break in taking Medication|0|||
16372061|NCT00520572|39846690|FG001|Overall Study|Long break in taking Medication|0|||
16372062|NCT00520572|39846691|FG002|Overall Study|Long break in taking Medication|0|||
16372063|NCT00520572|39846692|FG003|Overall Study|Long break in taking Medication|1|||
16372064|NCT00520572|39846693|FG004|Overall Study|Long break in taking Medication|0|||
16372065|NCT00520572|39846694|FG005|Overall Study|Long break in taking Medication|0|||
16069925|NCT00961636|38745754|FG000|Overall Study|Lost to Follow-up|2|||
16069926|NCT00961636|38745755|FG001|Overall Study|Lost to Follow-up|3|||
16069927|NCT00961636|38745756|FG002|Overall Study|Lost to Follow-up|1|||
16069928|NCT00961636|38745754|FG000|Overall Study|Physician Decision|3|||
16069929|NCT00961636|38745755|FG001|Overall Study|Physician Decision|1|||
16161525|NCT02721355|39072411|FG000|Overall Study|Lost to Follow-up|6|||
16372066|NCT00520572|39846689|FG000|Overall Study|Did not receive Treatment|1|||
16372067|NCT00520572|39846690|FG001|Overall Study|Did not receive Treatment|0|||
16372068|NCT00520572|39846691|FG002|Overall Study|Did not receive Treatment|1|||
16372069|NCT00520572|39846692|FG003|Overall Study|Did not receive Treatment|0|||
16372070|NCT00520572|39846693|FG004|Overall Study|Did not receive Treatment|0|||
16372071|NCT00520572|39846694|FG005|Overall Study|Did not receive Treatment|0|||
16372072|NCT00812097|39846695|FG000|Overall Study|Death|3|||
16372073|NCT00812097|39846696|FG001|Overall Study|Death|10|||
16372074|NCT00812097|39846697|FG002|Overall Study|Death|3|||
16372075|NCT00812097|39846698|FG003|Overall Study|Death|3|||
16069930|NCT00961636|38745756|FG002|Overall Study|Physician Decision|1|||
16069931|NCT00961636|38745754|FG000|Overall Study|Protocol Violation|9|||
16069932|NCT00961636|38745755|FG001|Overall Study|Protocol Violation|5|||
16069933|NCT00961636|38745756|FG002|Overall Study|Protocol Violation|1|||
16069934|NCT00961636|38745754|FG000|Overall Study|Withdrawal by Subject|29|||
16069935|NCT00961636|38745755|FG001|Overall Study|Withdrawal by Subject|22|||
16069936|NCT00961636|38745756|FG002|Overall Study|Withdrawal by Subject|13|||
16069937|NCT00109967|38745757|FG000|Overall Study|Cancel Prior to Treatment|2|||
16069938|NCT00109967|38745758|FG001|Overall Study|Cancel Prior to Treatment|0|||
16069939|NCT00109967|38745757|FG000|Overall Study|Adverse Event|12|||
16069940|NCT00109967|38745758|FG001|Overall Study|Adverse Event|1|||
16069941|NCT00109967|38745757|FG000|Overall Study|Withdrawal by Subject|5|||
16069942|NCT00109967|38745758|FG001|Overall Study|Withdrawal by Subject|0|||
16161526|NCT02721355|39072412|FG001|Overall Study|Lost to Follow-up|1|||
16161527|NCT02161562|39072417|FG000|Overall Study|Withdrawal by Subject|5|||
16161528|NCT02161562|39072418|FG001|Overall Study|Withdrawal by Subject|8|||
16161529|NCT02161562|39072417|FG000|Overall Study|Protocol Violation|9|||
16161530|NCT02161562|39072418|FG001|Overall Study|Protocol Violation|4|||
16161531|NCT02161562|39072417|FG000|Overall Study|Pregnancy|1|||
16161532|NCT02161562|39072418|FG001|Overall Study|Pregnancy|2|||
16161533|NCT02161562|39072417|FG000|Overall Study|Lost to Follow-up|3|||
16161534|NCT02161562|39072418|FG001|Overall Study|Lost to Follow-up|1|||
16161535|NCT02161562|39072417|FG000|Overall Study|Lack of Efficacy|4|||
16161536|NCT02161562|39072418|FG001|Overall Study|Lack of Efficacy|1|||
16161537|NCT02161562|39072417|FG000|Overall Study|Adverse Event|1|||
16069943|NCT00109967|38745757|FG000|Overall Study|Physician Decision|1|||
16069944|NCT00109967|38745758|FG001|Overall Study|Physician Decision|3|||
16069945|NCT00109967|38745757|FG000|Overall Study|Death|0|||
16069946|NCT00109967|38745758|FG001|Overall Study|Death|2|||
16069947|NCT00367055|38745773|FG000|Overall Study|Adverse Event|6|||
16069948|NCT00367055|38745774|FG001|Overall Study|Adverse Event|3|||
16069949|NCT00367055|38745773|FG000|Overall Study|Patient's Willing|3|||
16069950|NCT00367055|38745774|FG001|Overall Study|Patient's Willing|2|||
16069951|NCT00367055|38745773|FG000|Overall Study|Lack of Efficacy|1|||
16069952|NCT00367055|38745774|FG001|Overall Study|Lack of Efficacy|2|||
16069953|NCT00367055|38745773|FG000|Overall Study|Lost to Follow-up|1|||
16069954|NCT00367055|38745774|FG001|Overall Study|Lost to Follow-up|1|||
16069955|NCT00367055|38745773|FG000|Overall Study|Protocol Violation|0|||
16069956|NCT00367055|38745774|FG001|Overall Study|Protocol Violation|1|||
16069957|NCT00367055|38745773|FG000|Overall Study|Stopping Criterion Met|0|||
16069958|NCT00367055|38745774|FG001|Overall Study|Stopping Criterion Met|1|||
16069959|NCT00367055|38745773|FG000|Overall Study|Participant Living too Far from Hospital|0|||
16069960|NCT00367055|38745774|FG001|Overall Study|Participant Living too Far from Hospital|1|||
16069961|NCT03781804|38745776|FG000|Overall Study|Adverse Event|2|||
16069962|NCT03781804|38745777|FG001|Overall Study|Adverse Event|2|||
16069963|NCT03781804|38745778|FG002|Overall Study|Adverse Event|3|||
16069964|NCT03781804|38745776|FG000|Overall Study|Lost to Follow-up|1|||
16069965|NCT03781804|38745777|FG001|Overall Study|Lost to Follow-up|1|||
16069966|NCT03781804|38745778|FG002|Overall Study|Lost to Follow-up|2|||
16069967|NCT03781804|38745776|FG000|Overall Study|Lack of Efficacy|4|||
16069968|NCT03781804|38745777|FG001|Overall Study|Lack of Efficacy|2|||
16069969|NCT03781804|38745778|FG002|Overall Study|Lack of Efficacy|9|||
16069970|NCT03781804|38745776|FG000|Overall Study|Protocol Violation|0|||
16069971|NCT03781804|38745777|FG001|Overall Study|Protocol Violation|0|||
16069972|NCT03781804|38745778|FG002|Overall Study|Protocol Violation|1|||
16069973|NCT03781804|38745776|FG000|Overall Study|Withdrawal by Subject|0|||
16069974|NCT03781804|38745777|FG001|Overall Study|Withdrawal by Subject|1|||
16069975|NCT03781804|38745778|FG002|Overall Study|Withdrawal by Subject|1|||
16069976|NCT03781804|38745776|FG000|Overall Study|Reason not provided|2|||
16069977|NCT03781804|38745777|FG001|Overall Study|Reason not provided|2|||
16069978|NCT03781804|38745778|FG002|Overall Study|Reason not provided|0|||
16069979|NCT02430532|38745779|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
16069980|NCT02430532|38745780|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
16069981|NCT02430532|38745779|FG000|Overall Study|Consent Withdrawn|0|||
16069982|NCT02430532|38745780|FG001|Overall Study|Consent Withdrawn|2|||
16069983|NCT02430532|38745779|FG000|Overall Study|Adverse Event|0|||
16069984|NCT02430532|38745780|FG001|Overall Study|Adverse Event|1|||
16069985|NCT03603717|38745781|FG000|Overall Study|Lost to Follow-up|20|||
16069986|NCT03603717|38745782|FG001|Overall Study|Lost to Follow-up|20|||
16069987|NCT03603717|38745781|FG000|Overall Study|Withdrawal by Subject|16|||
16069988|NCT03603717|38745782|FG001|Overall Study|Withdrawal by Subject|10|||
16161538|NCT02161562|39072418|FG001|Overall Study|Adverse Event|1|||
16161539|NCT02161562|39072417|FG000|Overall Study|Participant moved back to home country|1|||
16372076|NCT00812097|39846695|FG000|Overall Study|Withdrawal by Subject|14|||
16069989|NCT04084769|38745789|FG000|Overall Study|Protocol Violation|1|||
16069990|NCT04084769|38745790|FG001|Overall Study|Protocol Violation|3|||
16069991|NCT04084769|38745791|FG002|Overall Study|Protocol Violation|0|||
16069992|NCT04084769|38745792|FG003|Overall Study|Protocol Violation|1|||
16069993|NCT04084769|38745789|FG000|Overall Study|Withdrawal by Subject|0|||
16069994|NCT04084769|38745790|FG001|Overall Study|Withdrawal by Subject|1|||
16069995|NCT04084769|38745791|FG002|Overall Study|Withdrawal by Subject|0|||
16069996|NCT04084769|38745792|FG003|Overall Study|Withdrawal by Subject|0|||
16069997|NCT04084769|38745789|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16069998|NCT04084769|38745790|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16069999|NCT04084769|38745791|FG002|Overall Study|Withdrawal by parent/guardian|0|||
16070000|NCT04084769|38745792|FG003|Overall Study|Withdrawal by parent/guardian|1|||
16070001|NCT04084769|38745789|FG000|Overall Study|Lost to Follow-up|2|||
16070002|NCT04084769|38745790|FG001|Overall Study|Lost to Follow-up|0|||
16070003|NCT04084769|38745791|FG002|Overall Study|Lost to Follow-up|0|||
16070004|NCT04084769|38745792|FG003|Overall Study|Lost to Follow-up|0|||
16070005|NCT01751724|38745793|FG000|Overall Study|extubated bef.start assigned treatment|1|||
16070006|NCT01751724|38745794|FG001|Overall Study|extubated bef.start assigned treatment|0|||
16070007|NCT01751724|38745793|FG000|Overall Study|withdrawn by parent|0|||
16070008|NCT01751724|38745794|FG001|Overall Study|withdrawn by parent|2|||
16070009|NCT00686517|38745795|FG000|Treatment|Serious Adverse Event|1|||
16070010|NCT00686517|38745796|FG001|Treatment|Serious Adverse Event|2|||
16070011|NCT00686517|38745797|FG002|Treatment|Serious Adverse Event|1|||
16070012|NCT00686517|38745795|FG000|Treatment|Adverse Event|2|||
16070013|NCT00686517|38745796|FG001|Treatment|Adverse Event|0|||
16070014|NCT00686517|38745797|FG002|Treatment|Adverse Event|0|||
16070015|NCT00686517|38745795|FG000|Treatment|Poor Protocol Compliance|1|||
16070016|NCT00686517|38745796|FG001|Treatment|Poor Protocol Compliance|0|||
16070017|NCT00686517|38745797|FG002|Treatment|Poor Protocol Compliance|0|||
16070018|NCT00686517|38745795|FG000|Treatment|Protocol Violation|2|||
16070019|NCT00686517|38745796|FG001|Treatment|Protocol Violation|1|||
16070020|NCT00686517|38745797|FG002|Treatment|Protocol Violation|0|||
16070021|NCT00536380|38745800|FG000|Overall Study|Adverse Event|0|||
16070022|NCT00536380|38745801|FG001|Overall Study|Adverse Event|2|||
16070023|NCT00536380|38745802|FG002|Overall Study|Adverse Event|2|||
16070024|NCT00536380|38745800|FG000|Overall Study|Lost to Follow-up|0|||
16070025|NCT00536380|38745801|FG001|Overall Study|Lost to Follow-up|0|||
16070026|NCT00536380|38745802|FG002|Overall Study|Lost to Follow-up|1|||
16070027|NCT00536380|38745800|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
16070028|NCT00536380|38745801|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
16070029|NCT00536380|38745802|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
16070030|NCT00536380|38745800|FG000|Overall Study|Withdrawal related to study drug|7|||
16070031|NCT00536380|38745801|FG001|Overall Study|Withdrawal related to study drug|5|||
16070032|NCT00536380|38745802|FG002|Overall Study|Withdrawal related to study drug|2|||
16070033|NCT00536380|38745800|FG000|Overall Study|Noncompliance with protocol|3|||
16070034|NCT00536380|38745801|FG001|Overall Study|Noncompliance with protocol|2|||
16070035|NCT00536380|38745802|FG002|Overall Study|Noncompliance with protocol|2|||
16070036|NCT00536380|38745800|FG000|Overall Study|Did not meet protocol eligibility|0|||
16070037|NCT00536380|38745801|FG001|Overall Study|Did not meet protocol eligibility|0|||
16070038|NCT00536380|38745802|FG002|Overall Study|Did not meet protocol eligibility|1|||
16070039|NCT00536380|38745800|FG000|Overall Study|Administrative|0|||
16070040|NCT00536380|38745801|FG001|Overall Study|Administrative|0|||
16070041|NCT00536380|38745802|FG002|Overall Study|Administrative|1|||
16070042|NCT01362491|38745803|FG000|Overall Study|Ineligible|1|||
16070043|NCT01362491|38745804|FG001|Overall Study|Ineligible|0|||
16070044|NCT01362491|38745805|FG002|Overall Study|Ineligible|0|||
16070045|NCT03681691|38745806|FG000|Overall Study|COVID|1|||
16070046|NCT03681691|38745807|FG001|Overall Study|COVID|0|||
16070047|NCT03681691|38745806|FG000|Overall Study|prolonged bleeding|1|||
16070048|NCT03681691|38745807|FG001|Overall Study|prolonged bleeding|0|||
16070049|NCT03681691|38745806|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
16070050|NCT03681691|38745807|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
16070051|NCT01664104|38745808|FG000|Overall Study|Adverse Event|6|||
16070052|NCT01664104|38745808|FG000|Overall Study|Lack of Efficacy|2|||
16070053|NCT01664104|38745808|FG000|Overall Study|Withdrawal by Subject|1|||
16070054|NCT01664104|38745808|FG000|Overall Study|Lost to Follow-up|4|||
16070055|NCT01664104|38745808|FG000|Overall Study|Other|1|||
16264857|NCT01597245|39453262|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16070056|NCT01664104|38745808|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
16070057|NCT03586167|38745809|FG000|Overall Study|Other|1|||
16070058|NCT03586167|38745810|FG001|Overall Study|Other|0|||
16070059|NCT00984282|38745811|FG000|Double Blind Treatment|Adverse Event|40|||
16070060|NCT00984282|38745812|FG001|Double Blind Treatment|Adverse Event|6|||
16070061|NCT00984282|38745811|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
16070062|NCT00984282|38745812|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
16070063|NCT00984282|38745811|FG000|Double Blind Treatment|Physician Decision|1|||
16070064|NCT00984282|38745812|FG001|Double Blind Treatment|Physician Decision|2|||
16070065|NCT00984282|38745811|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
16070066|NCT00984282|38745812|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
16070067|NCT00984282|38745811|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
16264858|NCT01597245|39453263|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16070068|NCT00984282|38745812|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
16070069|NCT00984282|38745811|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
16070070|NCT00984282|38745812|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
16070071|NCT00984282|38745811|FG000|Double Blind Treatment|Lost to Follow-up|3|||
16070072|NCT00984282|38745812|FG001|Double Blind Treatment|Lost to Follow-up|0|||
16070073|NCT00984282|38745811|FG000|Double Blind Treatment|Death|8|||
16070074|NCT00984282|38745812|FG001|Double Blind Treatment|Death|4|||
16070075|NCT00984282|38745811|FG000|Double Blind Treatment|Not treated|0|||
16070076|NCT00984282|38745812|FG001|Double Blind Treatment|Not treated|1|||
16070077|NCT00984282|38745811|FG000|Double Blind Treatment|Switched to commercial drug|6|||
16070078|NCT00984282|38745812|FG001|Double Blind Treatment|Switched to commercial drug|1|||
16070079|NCT00984282|38745811|FG000|Double Blind Treatment|protocol driven decision point|1|||
16070080|NCT00984282|38745812|FG001|Double Blind Treatment|protocol driven decision point|1|||
16070081|NCT00984282|38745811|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
16070082|NCT00984282|38745812|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
16070083|NCT00984282|38745811|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
16070084|NCT00984282|38745812|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
16070085|NCT00984282|38745811|FG000|Open-label Treatment|Adverse Event|20|||
16070086|NCT00984282|38745812|FG001|Open-label Treatment|Adverse Event|30|||
16070087|NCT00984282|38745811|FG000|Open-label Treatment|Withdrawal by Subject|6|||
16070088|NCT00984282|38745812|FG001|Open-label Treatment|Withdrawal by Subject|21|||
16070089|NCT00984282|38745811|FG000|Open-label Treatment|Death|7|||
16070090|NCT00984282|38745812|FG001|Open-label Treatment|Death|15|||
16070091|NCT00984282|38745811|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
16070092|NCT00984282|38745812|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
16070093|NCT00984282|38745811|FG000|Open-label Treatment|Lost to Follow-up|1|||
16070094|NCT00984282|38745812|FG001|Open-label Treatment|Lost to Follow-up|1|||
16070095|NCT00984282|38745811|FG000|Open-label Treatment|Patient convenience|1|||
16070096|NCT00984282|38745812|FG001|Open-label Treatment|Patient convenience|0|||
16070097|NCT00984282|38745811|FG000|Open-label Treatment|Non-compliant with study medication|1|||
16070098|NCT00984282|38745812|FG001|Open-label Treatment|Non-compliant with study medication|0|||
16372077|NCT00812097|39846696|FG001|Overall Study|Withdrawal by Subject|12|||
16372078|NCT00812097|39846697|FG002|Overall Study|Withdrawal by Subject|8|||
16372079|NCT00812097|39846698|FG003|Overall Study|Withdrawal by Subject|2|||
16372080|NCT00812097|39846695|FG000|Overall Study|Lost to Follow-up|90|||
16372081|NCT00812097|39846696|FG001|Overall Study|Lost to Follow-up|14|||
16372082|NCT00812097|39846697|FG002|Overall Study|Lost to Follow-up|17|||
16372083|NCT00812097|39846698|FG003|Overall Study|Lost to Follow-up|5|||
16372084|NCT00812097|39846695|FG000|Overall Study|Explantation of study device(s)|27|||
16070099|NCT00984282|38745811|FG000|Open-label Treatment|Target lesion removed|0|||
16070100|NCT00984282|38745812|FG001|Open-label Treatment|Target lesion removed|1|||
16070101|NCT00984282|38745811|FG000|Open-label Treatment|Protocol driven decision point|1|||
16070102|NCT00984282|38745812|FG001|Open-label Treatment|Protocol driven decision point|1|||
16070103|NCT00984282|38745811|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
16070104|NCT00984282|38745812|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
16070105|NCT00984282|38745811|FG000|Open-label Treatment|Switched to commercial drug|6|||
16070106|NCT00984282|38745812|FG001|Open-label Treatment|Switched to commercial drug|7|||
16070107|NCT00984282|38745811|FG000|Open-label Treatment|Physician Decision|1|||
16070108|NCT00984282|38745812|FG001|Open-label Treatment|Physician Decision|0|||
16070109|NCT00984282|38745811|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
16070110|NCT00984282|38745812|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
16070111|NCT00984282|38745811|FG000|Long Term Follow-up|Death|27|||
16070112|NCT00984282|38745812|FG001|Long Term Follow-up|Death|68|||
16070113|NCT00984282|38745811|FG000|Long Term Follow-up|Lost to Follow-up|3|||
16070114|NCT00984282|38745812|FG001|Long Term Follow-up|Lost to Follow-up|6|||
16070115|NCT00984282|38745811|FG000|Long Term Follow-up|Protocol driven decision point|25|||
16070116|NCT00984282|38745812|FG001|Long Term Follow-up|Protocol driven decision point|26|||
16070117|NCT00984282|38745811|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
16070118|NCT00984282|38745812|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
16070119|NCT00984282|38745811|FG000|Long Term Follow-up|Switched to commercial drug|4|||
16070120|NCT00984282|38745812|FG001|Long Term Follow-up|Switched to commercial drug|2|||
16070121|NCT00984282|38745811|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
16070122|NCT00984282|38745812|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
16070123|NCT02943993|38745813|FG000|Overall Study|Withdrawal by Subject|52|||
16070124|NCT02943993|38745813|FG000|Overall Study|Transfer to another institution|6|||
16372085|NCT00812097|39846696|FG001|Overall Study|Explantation of study device(s)|29|||
16372086|NCT00812097|39846697|FG002|Overall Study|Explantation of study device(s)|14|||
16372087|NCT00812097|39846698|FG003|Overall Study|Explantation of study device(s)|20|||
16372088|NCT00812097|39846695|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
16372089|NCT00812097|39846696|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
16372090|NCT00812097|39846697|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
16372091|NCT00812097|39846698|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
16372092|NCT01297244|39846699|FG000|Overall Study|Progressive disease|22|||
16372093|NCT01297244|39846700|FG001|Overall Study|Progressive disease|3|||
16372094|NCT01297244|39846699|FG000|Overall Study|Adverse Event|9|||
16372095|NCT01297244|39846700|FG001|Overall Study|Adverse Event|1|||
16372096|NCT01297244|39846699|FG000|Overall Study|Death|1|||
16372097|NCT01297244|39846700|FG001|Overall Study|Death|1|||
16372098|NCT01297244|39846699|FG000|Overall Study|Clinical progression|1|||
16070125|NCT02943993|38745813|FG000|Overall Study|Lost to Follow-up|135|||
16070126|NCT02943993|38745813|FG000|Overall Study|Death|98|||
16372099|NCT01297244|39846700|FG001|Overall Study|Clinical progression|1|||
16372100|NCT01297244|39846699|FG000|Overall Study|Withdrawal by Subject|2|||
16372101|NCT01297244|39846700|FG001|Overall Study|Withdrawal by Subject|0|||
16372102|NCT03753542|39846701|FG000|Overall Study|Lost to Follow-up|9|||
16372103|NCT03753542|39846702|FG001|Overall Study|Lost to Follow-up|14|||
16372104|NCT01795937|39846703|FG000|Overall Study|Withdrawal by Subject|1|||
16372105|NCT01795937|39846704|FG001|Overall Study|Withdrawal by Subject|0|||
16372106|NCT01795937|39846705|FG002|Overall Study|Withdrawal by Subject|0|||
16372107|NCT01795937|39846703|FG000|Overall Study|Physician Decision|0|||
16372108|NCT01795937|39846704|FG001|Overall Study|Physician Decision|1|||
16372109|NCT01795937|39846705|FG002|Overall Study|Physician Decision|0|||
16372110|NCT03018938|39846706|FG000|Overall Study|Death|0|||
16372111|NCT03018938|39846707|FG001|Overall Study|Death|1|||
16372112|NCT03018938|39846706|FG000|Overall Study|Lost to Follow-up|21|||
16372113|NCT03018938|39846707|FG001|Overall Study|Lost to Follow-up|32|||
16372114|NCT03018938|39846706|FG000|Overall Study|Withdrawal by Subject|38|||
16372115|NCT03018938|39846707|FG001|Overall Study|Withdrawal by Subject|45|||
16372116|NCT03018938|39846706|FG000|Overall Study|Physician Decision|3|||
16372117|NCT03018938|39846707|FG001|Overall Study|Physician Decision|2|||
16372118|NCT03018938|39846706|FG000|Overall Study|Sponsor Decision|0|||
16372119|NCT03018938|39846707|FG001|Overall Study|Sponsor Decision|1|||
16372120|NCT03018938|39846706|FG000|Overall Study|Screen failure-After randomization|4|||
16372121|NCT03018938|39846707|FG001|Overall Study|Screen failure-After randomization|2|||
16372122|NCT03018938|39846706|FG000|Overall Study|Not recorded|0|||
16372123|NCT03018938|39846707|FG001|Overall Study|Not recorded|2|||
16372124|NCT02056288|39846710|FG000|In-Hospital Data|Surgery cancelled|1|||
16372125|NCT02056288|39846711|FG001|In-Hospital Data|Surgery cancelled|0|||
16372126|NCT02056288|39846710|FG000|In-Hospital Data|Protocol Violation|3|||
16372127|NCT02056288|39846711|FG001|In-Hospital Data|Protocol Violation|0|||
16372128|NCT02056288|39846710|FG000|In-Hospital Data|Physician Decision|1|||
16372129|NCT02056288|39846711|FG001|In-Hospital Data|Physician Decision|0|||
16372130|NCT02056288|39846710|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
16372131|NCT02056288|39846711|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
16372132|NCT00620035|39846712|FG000|Overall Study|Adverse Event|106|||
16372133|NCT00620035|39846712|FG000|Overall Study|Withdrawal of Informed Consent|1|||
16372134|NCT00620035|39846712|FG000|Overall Study|Other Reason|38|||
16372135|NCT01158404|39846713|FG000|Overall Study|Withdrawal by Subject|0|||
16372136|NCT01158404|39846714|FG001|Overall Study|Withdrawal by Subject|1|||
16372137|NCT01158404|39846715|FG002|Overall Study|Withdrawal by Subject|0|||
16372138|NCT01158404|39846716|FG003|Overall Study|Withdrawal by Subject|0|||
16372139|NCT01158404|39846717|FG004|Overall Study|Withdrawal by Subject|3|||
16372140|NCT01158404|39846718|FG005|Overall Study|Withdrawal by Subject|1|||
16372141|NCT01158404|39846719|FG006|Overall Study|Withdrawal by Subject|0|||
16372142|NCT01158404|39846720|FG007|Overall Study|Withdrawal by Subject|1|||
16372143|NCT01158404|39846713|FG000|Overall Study|Physician Decision|0|||
16372144|NCT01158404|39846714|FG001|Overall Study|Physician Decision|0|||
16372145|NCT01158404|39846715|FG002|Overall Study|Physician Decision|0|||
16372146|NCT01158404|39846716|FG003|Overall Study|Physician Decision|0|||
16372147|NCT01158404|39846717|FG004|Overall Study|Physician Decision|0|||
16372148|NCT01158404|39846718|FG005|Overall Study|Physician Decision|0|||
16372149|NCT01158404|39846719|FG006|Overall Study|Physician Decision|0|||
16372150|NCT01158404|39846720|FG007|Overall Study|Physician Decision|1|||
16372151|NCT01158404|39846713|FG000|Overall Study|Progressive Disease|0|||
16372152|NCT01158404|39846714|FG001|Overall Study|Progressive Disease|0|||
16372153|NCT01158404|39846715|FG002|Overall Study|Progressive Disease|0|||
16372154|NCT01158404|39846716|FG003|Overall Study|Progressive Disease|0|||
16372155|NCT01158404|39846717|FG004|Overall Study|Progressive Disease|0|||
16372156|NCT01158404|39846718|FG005|Overall Study|Progressive Disease|0|||
16070127|NCT02943993|38745813|FG000|Overall Study|Other reason for premature termination|32|||
16372157|NCT01158404|39846719|FG006|Overall Study|Progressive Disease|1|||
16372158|NCT01158404|39846720|FG007|Overall Study|Progressive Disease|0|||
16372159|NCT02528305|39846721|FG000|Overall Study|Withdrawal by Subject|1|||
16372160|NCT02528305|39846721|FG000|Overall Study|Adverse Event|1|||
16372161|NCT02528305|39846721|FG000|Overall Study|Physician Decision|1|||
16372162|NCT01316900|39846722|FG000|Overall Study|Adverse Event|10|||
16372163|NCT01316900|39846723|FG001|Overall Study|Adverse Event|10|||
16372164|NCT01316900|39846724|FG002|Overall Study|Adverse Event|15|||
16372165|NCT01316900|39846725|FG003|Overall Study|Adverse Event|9|||
16372166|NCT01316900|39846722|FG000|Overall Study|Lack of Efficacy|17|||
16372167|NCT01316900|39846723|FG001|Overall Study|Lack of Efficacy|9|||
16372168|NCT01316900|39846724|FG002|Overall Study|Lack of Efficacy|5|||
16372169|NCT01316900|39846725|FG003|Overall Study|Lack of Efficacy|7|||
16372170|NCT01316900|39846722|FG000|Overall Study|Protocol Violation|7|||
16372171|NCT01316900|39846723|FG001|Overall Study|Protocol Violation|1|||
16372172|NCT01316900|39846724|FG002|Overall Study|Protocol Violation|4|||
16372173|NCT01316900|39846725|FG003|Overall Study|Protocol Violation|0|||
16372174|NCT01316900|39846722|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
16372175|NCT01316900|39846723|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
16372176|NCT01316900|39846724|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
16372177|NCT01316900|39846725|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
16372178|NCT01316900|39846722|FG000|Overall Study|Lost to Follow-up|1|||
16372179|NCT01316900|39846723|FG001|Overall Study|Lost to Follow-up|0|||
16372180|NCT01316900|39846724|FG002|Overall Study|Lost to Follow-up|1|||
16372181|NCT01316900|39846725|FG003|Overall Study|Lost to Follow-up|1|||
16372182|NCT01316900|39846722|FG000|Overall Study|Withdrawal by Subject|7|||
16372183|NCT01316900|39846723|FG001|Overall Study|Withdrawal by Subject|8|||
16372184|NCT01316900|39846724|FG002|Overall Study|Withdrawal by Subject|6|||
16372185|NCT01316900|39846725|FG003|Overall Study|Withdrawal by Subject|9|||
16372186|NCT01370642|39846729|FG000|Overall Study|Adverse Event|2|||
16372187|NCT01370642|39846730|FG001|Overall Study|Adverse Event|1|||
16372188|NCT01370642|39846731|FG002|Overall Study|Adverse Event|1|||
16372189|NCT01370642|39846729|FG000|Overall Study|Detectable HCV RNA|0|||
16372190|NCT01370642|39846730|FG001|Overall Study|Detectable HCV RNA|0|||
16372191|NCT01370642|39846731|FG002|Overall Study|Detectable HCV RNA|22|||
16372192|NCT01370642|39846729|FG000|Overall Study|Lost to Follow-up|0|||
16372193|NCT01370642|39846730|FG001|Overall Study|Lost to Follow-up|0|||
16372194|NCT01370642|39846731|FG002|Overall Study|Lost to Follow-up|1|||
16372195|NCT01370642|39846729|FG000|Overall Study|Physician Decision|4|||
16372196|NCT01370642|39846730|FG001|Overall Study|Physician Decision|1|||
16372197|NCT01370642|39846731|FG002|Overall Study|Physician Decision|2|||
16070128|NCT02943993|38745813|FG000|Overall Study|Missing reason for termination|7|||
16070129|NCT00290732|38745814|FG000|Overall Study|Inability to instill drug intraductally.|0|||
16070130|NCT00290732|38745815|FG001|Overall Study|Inability to instill drug intraductally.|1|||
16070131|NCT00290732|38745816|FG002|Overall Study|Inability to instill drug intraductally.|1|||
16070132|NCT00290732|38745817|FG003|Overall Study|Inability to instill drug intraductally.|0|||
16070133|NCT00290732|38745818|FG004|Overall Study|Inability to instill drug intraductally.|0|||
16070134|NCT03395353|38745819|FG000|Overall Study|Adverse Event|20|||
16070135|NCT03395353|38745819|FG000|Overall Study|Protocol Violation|1|||
16070136|NCT03395353|38745819|FG000|Overall Study|Lack of Efficacy|3|||
16070137|NCT03395353|38745819|FG000|Overall Study|Withdrawal by Subject|24|||
16070138|NCT03395353|38745819|FG000|Overall Study|Discontinued visit|1|||
16070139|NCT03395353|38745819|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
16070140|NCT03395353|38745819|FG000|Overall Study|Physician Decision|4|||
16070141|NCT03395353|38745819|FG000|Overall Study|Early termination of overall study|33|||
16070142|NCT01152190|38745821|FG000|Overall Study|Adverse Event|2|||
16070143|NCT01152190|38745822|FG001|Overall Study|Adverse Event|4|||
16070144|NCT01152190|38745821|FG000|Overall Study|Death|1|||
16070145|NCT01152190|38745822|FG001|Overall Study|Death|0|||
16070146|NCT01152190|38745821|FG000|Overall Study|Protocol Violation|1|||
16070147|NCT01152190|38745822|FG001|Overall Study|Protocol Violation|1|||
16372198|NCT01370642|39846729|FG000|Overall Study|Withdrawal by Subject|2|||
16372199|NCT01370642|39846730|FG001|Overall Study|Withdrawal by Subject|4|||
16372200|NCT01370642|39846731|FG002|Overall Study|Withdrawal by Subject|3|||
16372201|NCT00195429|39846734|FG000|Overall Study|Adverse Event|2|||
16372202|NCT00195429|39846735|FG001|Overall Study|Adverse Event|4|||
16372203|NCT00195429|39846734|FG000|Overall Study|Lack of Efficacy|2|||
16372204|NCT00195429|39846735|FG001|Overall Study|Lack of Efficacy|1|||
16372205|NCT00195429|39846734|FG000|Overall Study|Lost to Follow-up|1|||
16372206|NCT00195429|39846735|FG001|Overall Study|Lost to Follow-up|0|||
16372207|NCT03518203|39846736|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
16372208|NCT03518203|39846736|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
16372209|NCT04027946|39846742|FG000|Overall Study|Screen failures|3|||
16372210|NCT01694771|39846745|FG000|Overall Study|Adverse Event|18|||
16372211|NCT01694771|39846746|FG001|Overall Study|Adverse Event|16|||
16372212|NCT01694771|39846745|FG000|Overall Study|Lack of Efficacy|1|||
16372213|NCT01694771|39846746|FG001|Overall Study|Lack of Efficacy|0|||
16372214|NCT01694771|39846745|FG000|Overall Study|Non compliance protocol|7|||
16372215|NCT01694771|39846746|FG001|Overall Study|Non compliance protocol|6|||
16372216|NCT01694771|39846745|FG000|Overall Study|Lost to Follow-up|2|||
16372217|NCT01694771|39846746|FG001|Overall Study|Lost to Follow-up|3|||
16372218|NCT01694771|39846745|FG000|Overall Study|Consent withdrawn|7|||
16372219|NCT01694771|39846746|FG001|Overall Study|Consent withdrawn|9|||
16372220|NCT01694771|39846745|FG000|Overall Study|Other reasons|5|||
16161540|NCT02161562|39072418|FG001|Overall Study|Participant moved back to home country|0|||
16372221|NCT01694771|39846746|FG001|Overall Study|Other reasons|6|||
16070148|NCT01152190|38745821|FG000|Overall Study|Withdrawal by Subject|1|||
16070149|NCT01152190|38745822|FG001|Overall Study|Withdrawal by Subject|3|||
16070150|NCT03467724|38745826|FG000|Overall Study|Lost to Follow-up|5|||
16070151|NCT03467724|38745826|FG000|Overall Study|Withdrawal by Subject|1|||
16070152|NCT03467724|38745826|FG000|Overall Study|Protocol Violation|1|||
16070153|NCT03467724|38745826|FG000|Overall Study|Adverse Event|1|||
16070154|NCT02390557|38749640|FG000|Wave 2|Survey non-respondent|72|||
16070155|NCT02390557|38749641|FG001|Wave 2|Survey non-respondent|41|||
16070156|NCT02390557|38749642|FG002|Wave 2|Survey non-respondent|23|||
16070157|NCT00465985|38749643|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
16070158|NCT00465985|38749644|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
16070159|NCT00465985|38749643|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
16070160|NCT00465985|38749644|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
16070161|NCT00465985|38749643|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
16070162|NCT00465985|38749644|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
16070163|NCT00465985|38749643|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
16070164|NCT00465985|38749644|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
16070165|NCT01792830|38749645|FG000|Overall Study|Withdrawal by Subject|22|||
16070166|NCT01792830|38749646|FG001|Overall Study|Withdrawal by Subject|0|||
16070167|NCT01792830|38749647|FG002|Overall Study|Withdrawal by Subject|0|||
16070168|NCT01792830|38749648|FG003|Overall Study|Withdrawal by Subject|2|||
16070169|NCT01792830|38749649|FG004|Overall Study|Withdrawal by Subject|1|||
16070170|NCT01792830|38749650|FG005|Overall Study|Withdrawal by Subject|1|||
16070171|NCT01792830|38749651|FG006|Overall Study|Withdrawal by Subject|1|||
16070172|NCT01792830|38749652|FG007|Overall Study|Withdrawal by Subject|1|||
16070173|NCT01792830|38749653|FG008|Overall Study|Withdrawal by Subject|7|||
16070174|NCT01792830|38749654|FG009|Overall Study|Withdrawal by Subject|0|||
16070175|NCT01792830|38749655|FG010|Overall Study|Withdrawal by Subject|2|||
16070176|NCT01792830|38749645|FG000|Overall Study|Death|3|||
16070177|NCT01792830|38749646|FG001|Overall Study|Death|0|||
16070178|NCT01792830|38749647|FG002|Overall Study|Death|0|||
16070179|NCT01792830|38749648|FG003|Overall Study|Death|1|||
16070180|NCT01792830|38749649|FG004|Overall Study|Death|0|||
16070181|NCT01792830|38749650|FG005|Overall Study|Death|0|||
16070182|NCT01792830|38749651|FG006|Overall Study|Death|1|||
16070183|NCT01792830|38749652|FG007|Overall Study|Death|0|||
16070184|NCT01792830|38749653|FG008|Overall Study|Death|1|||
16070185|NCT01792830|38749654|FG009|Overall Study|Death|0|||
16070186|NCT01792830|38749655|FG010|Overall Study|Death|1|||
16070187|NCT01792830|38749645|FG000|Overall Study|Adverse Event|0|||
16372222|NCT00896233|39846747|FG000|Overall Study|Claustrophobia during MRI|1|||
16372223|NCT01835431|39846750|FG000|Overall Study|Adverse Event|1|||
16372224|NCT01835431|39846751|FG001|Overall Study|Adverse Event|0|||
16372225|NCT01835431|39846750|FG000|Overall Study|other|0|||
16372226|NCT01835431|39846751|FG001|Overall Study|other|2|||
16372227|NCT01835431|39846750|FG000|Overall Study|Withdrawal by Subject|6|||
16372228|NCT01835431|39846751|FG001|Overall Study|Withdrawal by Subject|10|||
16372229|NCT01835431|39846750|FG000|Overall Study|Protocol Violation|1|||
16372230|NCT01835431|39846751|FG001|Overall Study|Protocol Violation|0|||
16372231|NCT02571244|39846752|FG000|Overall Study|Lost to Follow-up|0|||
16372232|NCT02571244|39846753|FG001|Overall Study|Lost to Follow-up|1|||
16372233|NCT02571244|39846752|FG000|Overall Study|Unable to reach out post discharge|3|||
16372234|NCT02571244|39846753|FG001|Overall Study|Unable to reach out post discharge|0|||
16372235|NCT00032487|39846754|FG000|Overall Study|Withdrawal by Subject|67|||
16372236|NCT00032487|39846755|FG001|Overall Study|Withdrawal by Subject|43|||
16372237|NCT00032487|39846754|FG000|Overall Study|Adverse Event|3|||
16372238|NCT00032487|39846755|FG001|Overall Study|Adverse Event|7|||
16372239|NCT00032487|39846754|FG000|Overall Study|Lost to Follow-up|57|||
16372240|NCT00032487|39846755|FG001|Overall Study|Lost to Follow-up|58|||
16372241|NCT00032487|39846754|FG000|Overall Study|Had other reason|12|||
16372242|NCT00032487|39846755|FG001|Overall Study|Had other reason|12|||
16372243|NCT01061710|39846758|FG000|Overall Study|Protocol Violation|14|||
16372244|NCT03446573|39846765|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
16372245|NCT03446573|39846766|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
16372246|NCT03446573|39846765|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
16372247|NCT03446573|39846766|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
16372248|NCT03446573|39846765|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
16372249|NCT03446573|39846766|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
16070188|NCT01792830|38749646|FG001|Overall Study|Adverse Event|0|||
16070189|NCT01792830|38749647|FG002|Overall Study|Adverse Event|0|||
16070190|NCT01792830|38749648|FG003|Overall Study|Adverse Event|0|||
16070191|NCT01792830|38749649|FG004|Overall Study|Adverse Event|0|||
16070192|NCT01792830|38749650|FG005|Overall Study|Adverse Event|0|||
16070193|NCT01792830|38749651|FG006|Overall Study|Adverse Event|0|||
16070194|NCT01792830|38749652|FG007|Overall Study|Adverse Event|0|||
16161541|NCT02161562|39072417|FG000|Overall Study|Withdrew due to being out of the country|1|||
16161542|NCT02161562|39072418|FG001|Overall Study|Withdrew due to being out of the country|0|||
16070195|NCT01792830|38749653|FG008|Overall Study|Adverse Event|1|||
16070196|NCT01792830|38749654|FG009|Overall Study|Adverse Event|0|||
16070197|NCT01792830|38749655|FG010|Overall Study|Adverse Event|0|||
16070198|NCT01720446|38749656|FG000|Overall Study|Lost to Follow-up|12|||
16070199|NCT01720446|38749657|FG001|Overall Study|Lost to Follow-up|6|||
16070200|NCT01720446|38749658|FG002|Overall Study|Lost to Follow-up|16|||
16070201|NCT01720446|38749659|FG003|Overall Study|Lost to Follow-up|16|||
16070202|NCT01720446|38749656|FG000|Overall Study|Withdrawal by Subject|2|||
16070203|NCT01720446|38749657|FG001|Overall Study|Withdrawal by Subject|5|||
16070204|NCT01720446|38749658|FG002|Overall Study|Withdrawal by Subject|4|||
16070205|NCT01720446|38749659|FG003|Overall Study|Withdrawal by Subject|4|||
16070206|NCT00530335|38749660|FG000|Overall Study|Adverse Event|3|||
16070207|NCT00530335|38749660|FG000|Overall Study|Protocol Violation|1|||
16070208|NCT00530335|38749660|FG000|Overall Study|Withdrawal by Subject|1|||
16070209|NCT00530335|38749660|FG000|Overall Study|Physician Decision|1|||
16070210|NCT00094809|38749661|FG000|Overall Study|Protocol deviation|2|||
16070211|NCT00094809|38749662|FG001|Overall Study|Protocol deviation|2|||
16070212|NCT00094809|38749661|FG000|Overall Study|Noncompliance|1|||
16070213|NCT00094809|38749662|FG001|Overall Study|Noncompliance|0|||
16070214|NCT00094809|38749661|FG000|Overall Study|Adverse Event|3|||
16070215|NCT00094809|38749662|FG001|Overall Study|Adverse Event|1|||
16070216|NCT00094809|38749661|FG000|Overall Study|Withdrawal by Subject|8|||
16070217|NCT00094809|38749662|FG001|Overall Study|Withdrawal by Subject|9|||
16070218|NCT00094809|38749661|FG000|Overall Study|Disease progression|3|||
16070219|NCT00094809|38749662|FG001|Overall Study|Disease progression|3|||
16070220|NCT00094809|38749661|FG000|Overall Study|Physician Decision|3|||
16070221|NCT00094809|38749662|FG001|Overall Study|Physician Decision|5|||
16070222|NCT00094809|38749661|FG000|Overall Study|Lost to Follow-up|6|||
16070223|NCT00094809|38749662|FG001|Overall Study|Lost to Follow-up|6|||
16070224|NCT00094809|38749661|FG000|Overall Study|Death|19|||
16070225|NCT00094809|38749662|FG001|Overall Study|Death|25|||
16070226|NCT00094809|38749661|FG000|Overall Study|Protocol-specified criteria|1|||
16070227|NCT00094809|38749662|FG001|Overall Study|Protocol-specified criteria|1|||
16070228|NCT00094809|38749661|FG000|Overall Study|Other|2|||
16070229|NCT00094809|38749662|FG001|Overall Study|Other|4|||
16070230|NCT00094809|38749661|FG000|Overall Study|Informed consent signed after treatment|1|||
16070231|NCT00094809|38749662|FG001|Overall Study|Informed consent signed after treatment|0|||
16070232|NCT00094809|38749661|FG000|Overall Study|Study drug not received|2|||
16070233|NCT00094809|38749662|FG001|Overall Study|Study drug not received|8|||
16070234|NCT00094809|38749661|FG000|Overall Study|Other|1|||
16070235|NCT00094809|38749662|FG001|Overall Study|Other|1|||
16070236|NCT02030028|38749663|FG000|Overall Study|Withdrawal by Subject|4|||
16070237|NCT02030028|38749663|FG000|Overall Study|lack of transportation|1|||
16070238|NCT03784963|38749664|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
16070239|NCT03784963|38749665|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
16070240|NCT03784963|38749666|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
16070241|NCT03784963|38749667|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
16070242|NCT01833832|38749668|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
16070243|NCT03601507|38749669|FG000|Overall Study|Adverse Event|1|||
16070244|NCT01190150|38749670|FG000|First Treatment|Withdrawal by Subject|1|||
16070245|NCT01190150|38749671|FG001|First Treatment|Withdrawal by Subject|0|||
16070246|NCT01190150|38749670|FG000|Washout|Withdrawal by Subject|0|||
16070247|NCT01190150|38749671|FG001|Washout|Withdrawal by Subject|1|||
16070248|NCT01190150|38749670|FG000|Washout|Difficulty in adherence|0|||
16070249|NCT01190150|38749671|FG001|Washout|Difficulty in adherence|1|||
16070250|NCT02750709|38749675|FG000|Treatment Period 1|Adverse Event|0|||
16070251|NCT02750709|38749676|FG001|Treatment Period 1|Adverse Event|0|||
16070252|NCT02750709|38749677|FG002|Treatment Period 1|Adverse Event|0|||
16070253|NCT02750709|38749678|FG003|Treatment Period 1|Adverse Event|0|||
16070254|NCT02750709|38749679|FG004|Treatment Period 1|Adverse Event|0|||
16070255|NCT02750709|38749680|FG005|Treatment Period 1|Adverse Event|1|||
16070256|NCT00404079|38749683|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
16161543|NCT02161562|39072417|FG000|Overall Study|Participant moved out of province|1|||
16161544|NCT02161562|39072418|FG001|Overall Study|Participant moved out of province|0|||
16070257|NCT00404079|38749684|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
16070258|NCT01585038|38749685|FG000|Overall Study|Adverse Event|2|||
16070259|NCT01585038|38749686|FG001|Overall Study|Adverse Event|2|||
16070260|NCT01499134|38749689|FG000|Overall Study|Withdrawal by Subject|0|||
16070261|NCT01499134|38749690|FG001|Overall Study|Withdrawal by Subject|1|||
16070262|NCT00964366|38749691|FG000|Overall Study|Did not qualify at Day 1|1|||
16070263|NCT00964366|38749692|FG001|Overall Study|Did not qualify at Day 1|0|||
16070264|NCT00964366|38749691|FG000|Overall Study|Withdrawal by Subject|0|||
16161545|NCT01273064|39072421|FG000|Overall Study|Adverse Event|5|||
16447962|NCT02377817|40122076|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
16447963|NCT02504151|40122079|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
16447964|NCT02504151|40122080|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
16447965|NCT02504151|40122079|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
16447966|NCT02504151|40122080|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
16447967|NCT02504151|40122079|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
16447968|NCT02504151|40122080|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
16447969|NCT02504151|40122079|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
16070265|NCT00964366|38749692|FG001|Overall Study|Withdrawal by Subject|1|||
16070266|NCT01831791|38749694|FG000|Overall Study|Withdrawal by Subject|10|||
16070267|NCT00542386|38749695|FG000|Overall Study|Adverse Event|1|||
16070268|NCT00542386|38749696|FG001|Overall Study|Adverse Event|7|||
16070269|NCT00542386|38749697|FG002|Overall Study|Adverse Event|7|||
16070270|NCT00542386|38749698|FG003|Overall Study|Adverse Event|8|||
16070271|NCT00542386|38749699|FG004|Overall Study|Adverse Event|13|||
16070272|NCT00542386|38749700|FG005|Overall Study|Adverse Event|4|||
16070273|NCT00542386|38749695|FG000|Overall Study|Death|0|||
16070274|NCT00542386|38749696|FG001|Overall Study|Death|0|||
16070275|NCT00542386|38749697|FG002|Overall Study|Death|1|||
16372250|NCT03446573|39846765|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
16372251|NCT03446573|39846766|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
16372252|NCT03446573|39846765|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
16372253|NCT03446573|39846766|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
16372254|NCT03446573|39846765|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
16372255|NCT03446573|39846766|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
16372256|NCT03446573|39846765|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
16372257|NCT03446573|39846766|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
16372258|NCT03446573|39846765|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
16372259|NCT03446573|39846766|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
16372260|NCT03446573|39846765|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
16372261|NCT03446573|39846766|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
16372262|NCT03446573|39846765|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
16372263|NCT03446573|39846766|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
16372264|NCT03446573|39846765|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
16372265|NCT03446573|39846766|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
16372266|NCT03446573|39846765|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
16372267|NCT03446573|39846766|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
16372268|NCT03446573|39846765|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
16372269|NCT03446573|39846766|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
16372270|NCT00395512|39846767|FG000|Overall Study|Adverse Event|3|||
16372271|NCT00395512|39846768|FG001|Overall Study|Adverse Event|8|||
16372272|NCT00395512|39846769|FG002|Overall Study|Adverse Event|6|||
16372273|NCT00395512|39846770|FG003|Overall Study|Adverse Event|6|||
16372274|NCT00395512|39846767|FG000|Overall Study|Protocol Violation|2|||
16372275|NCT00395512|39846768|FG001|Overall Study|Protocol Violation|3|||
16372276|NCT00395512|39846769|FG002|Overall Study|Protocol Violation|6|||
16372277|NCT00395512|39846770|FG003|Overall Study|Protocol Violation|7|||
16372278|NCT00395512|39846767|FG000|Overall Study|Lost to Follow-up|2|||
16372279|NCT00395512|39846768|FG001|Overall Study|Lost to Follow-up|6|||
16372280|NCT00395512|39846769|FG002|Overall Study|Lost to Follow-up|5|||
16372281|NCT00395512|39846770|FG003|Overall Study|Lost to Follow-up|5|||
16372282|NCT00395512|39846767|FG000|Overall Study|Withdrawal by Subject|6|||
16372283|NCT00395512|39846768|FG001|Overall Study|Withdrawal by Subject|5|||
16372284|NCT00395512|39846769|FG002|Overall Study|Withdrawal by Subject|5|||
16372285|NCT00395512|39846770|FG003|Overall Study|Withdrawal by Subject|12|||
16372286|NCT00395512|39846767|FG000|Overall Study|Physician Decision|6|||
16372287|NCT00395512|39846768|FG001|Overall Study|Physician Decision|4|||
16372288|NCT00395512|39846769|FG002|Overall Study|Physician Decision|2|||
16372289|NCT00395512|39846770|FG003|Overall Study|Physician Decision|2|||
16372290|NCT00395512|39846767|FG000|Overall Study|Other|1|||
16372291|NCT00395512|39846768|FG001|Overall Study|Other|1|||
16372292|NCT00395512|39846769|FG002|Overall Study|Other|0|||
16372293|NCT00395512|39846770|FG003|Overall Study|Other|0|||
16372294|NCT00395512|39846767|FG000|Overall Study|Hyperglycemic Rescue|18|||
16372295|NCT00395512|39846768|FG001|Overall Study|Hyperglycemic Rescue|10|||
16372296|NCT00395512|39846769|FG002|Overall Study|Hyperglycemic Rescue|4|||
16372297|NCT00395512|39846770|FG003|Overall Study|Hyperglycemic Rescue|6|||
16372298|NCT02004275|39849568|FG000|Phase 1|Ineligible|0|||
16372299|NCT02004275|39849569|FG001|Phase 1|Ineligible|0|||
16372300|NCT02004275|39849570|FG002|Phase 1|Ineligible|0|||
16372301|NCT02004275|39849571|FG003|Phase 1|Ineligible|1|||
16447970|NCT02504151|40122080|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
16447971|NCT02215252|40122087|FG000|Overall Study|Adverse Event|1|||
16447972|NCT02215252|40122088|FG001|Overall Study|Adverse Event|5|||
16447973|NCT02215252|40122089|FG002|Overall Study|Adverse Event|2|||
16447974|NCT02215252|40122087|FG000|Overall Study|Lost to Follow-up|0|||
16447975|NCT02215252|40122088|FG001|Overall Study|Lost to Follow-up|0|||
16447976|NCT02215252|40122089|FG002|Overall Study|Lost to Follow-up|1|||
16447977|NCT02215252|40122087|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
16447978|NCT02215252|40122088|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
16447979|NCT02215252|40122089|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
16447980|NCT02215252|40122087|FG000|Overall Study|Protocol Violation|0|||
16447981|NCT02215252|40122088|FG001|Overall Study|Protocol Violation|1|||
16447982|NCT02215252|40122089|FG002|Overall Study|Protocol Violation|0|||
16447983|NCT02215252|40122087|FG000|Overall Study|Withdrawal by Subject|1|||
16447984|NCT02215252|40122088|FG001|Overall Study|Withdrawal by Subject|0|||
16447985|NCT02215252|40122089|FG002|Overall Study|Withdrawal by Subject|0|||
16447986|NCT02215252|40122087|FG000|Overall Study|Other|0|||
16070276|NCT00542386|38749698|FG003|Overall Study|Death|2|||
16070277|NCT00542386|38749699|FG004|Overall Study|Death|1|||
16070278|NCT00542386|38749700|FG005|Overall Study|Death|2|||
16070279|NCT00542386|38749695|FG000|Overall Study|Lack of Efficacy|32|||
16070280|NCT00542386|38749696|FG001|Overall Study|Lack of Efficacy|12|||
16070281|NCT00542386|38749697|FG002|Overall Study|Lack of Efficacy|10|||
16070282|NCT00542386|38749698|FG003|Overall Study|Lack of Efficacy|13|||
16070283|NCT00542386|38749699|FG004|Overall Study|Lack of Efficacy|7|||
16070284|NCT00542386|38749700|FG005|Overall Study|Lack of Efficacy|31|||
16447987|NCT02215252|40122088|FG001|Overall Study|Other|1|||
16447988|NCT02215252|40122089|FG002|Overall Study|Other|1|||
16447989|NCT00124943|40122090|FG000|Phase II|Adverse Event|0|||
16447990|NCT00124943|40122091|FG001|Phase II|Adverse Event|2|||
16447991|NCT00124943|40122092|FG002|Phase II|Adverse Event|0|||
16447992|NCT00124943|40122093|FG003|Phase II|Adverse Event|1|||
16447993|NCT00124943|40122090|FG000|Phase II|Protocol Violation|0|||
16447994|NCT00124943|40122091|FG001|Phase II|Protocol Violation|0|||
16447995|NCT00124943|40122092|FG002|Phase II|Protocol Violation|0|||
16447996|NCT00124943|40122093|FG003|Phase II|Protocol Violation|1|||
16447997|NCT00124943|40122090|FG000|Phase II|Lost to Follow-up|0|||
16447998|NCT00124943|40122091|FG001|Phase II|Lost to Follow-up|0|||
16447999|NCT00124943|40122092|FG002|Phase II|Lost to Follow-up|0|||
16448000|NCT00124943|40122093|FG003|Phase II|Lost to Follow-up|1|||
16448001|NCT00124943|40122090|FG000|Phase II|Withdrawal by Subject|0|||
16448002|NCT00124943|40122091|FG001|Phase II|Withdrawal by Subject|0|||
16448003|NCT00124943|40122092|FG002|Phase II|Withdrawal by Subject|0|||
16448004|NCT00124943|40122093|FG003|Phase II|Withdrawal by Subject|2|||
16448005|NCT01936870|40122096|FG000|Overall Study|No Visit After Treatment|176|||
16448006|NCT01936870|40122096|FG000|Overall Study|Protocol Violation|12|||
16448007|NCT01936870|40122096|FG000|Overall Study|No Drug Administration|1|||
16448008|NCT00936715|40122097|FG000|Overall Study|Investigators Discretion|1|||
16448009|NCT00936715|40122097|FG000|Overall Study|Protocol Violation|1|||
16448010|NCT00936715|40122097|FG000|Overall Study|Safety or Tolerability Reasons|4|||
16448011|NCT01519921|40122098|FG000|Overall Study|Adverse Event|10|||
16448012|NCT01519921|40122099|FG001|Overall Study|Adverse Event|9|||
16448013|NCT01519921|40122098|FG000|Overall Study|Lack of Efficacy|4|||
16448014|NCT01519921|40122099|FG001|Overall Study|Lack of Efficacy|3|||
16448015|NCT01519921|40122098|FG000|Overall Study|Withdrawal by Subject|3|||
16448016|NCT01519921|40122099|FG001|Overall Study|Withdrawal by Subject|0|||
16448017|NCT01519921|40122098|FG000|Overall Study|Lost to Follow-up|2|||
16448018|NCT01519921|40122099|FG001|Overall Study|Lost to Follow-up|1|||
16448019|NCT01519921|40122098|FG000|Overall Study|Treatment refusal|2|||
16448020|NCT01519921|40122099|FG001|Overall Study|Treatment refusal|1|||
16448021|NCT01519921|40122098|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
16448022|NCT01519921|40122099|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
16448023|NCT00369265|40122101|FG000|Overall Study|Study terminated|4|||
16448024|NCT00369265|40122102|FG001|Overall Study|Study terminated|7|||
16448025|NCT03337477|40122103|FG000|Overall Study|not categorized into the listed ones|11|||
16070285|NCT00542386|38749695|FG000|Overall Study|Physician Decision|1|||
16070286|NCT00542386|38749696|FG001|Overall Study|Physician Decision|0|||
16070287|NCT00542386|38749697|FG002|Overall Study|Physician Decision|0|||
16070288|NCT00542386|38749698|FG003|Overall Study|Physician Decision|1|||
16070289|NCT00542386|38749699|FG004|Overall Study|Physician Decision|0|||
16448026|NCT03337477|40122104|FG001|Overall Study|not categorized into the listed ones|9|||
16448027|NCT03337477|40122103|FG000|Overall Study|Withdrawal by Subject|0|||
16448028|NCT03337477|40122104|FG001|Overall Study|Withdrawal by Subject|1|||
16448029|NCT03337477|40122103|FG000|Overall Study|Death|0|||
16448030|NCT03337477|40122104|FG001|Overall Study|Death|1|||
16448031|NCT03337477|40122103|FG000|Overall Study|Lost to Follow-up|0|||
16448032|NCT03337477|40122104|FG001|Overall Study|Lost to Follow-up|2|||
16448033|NCT02113982|40122105|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
16448034|NCT02113982|40122106|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
16448035|NCT02113982|40122107|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
16448036|NCT02113982|40122108|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
16448037|NCT02113982|40122109|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
16448038|NCT02113982|40122110|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
16448039|NCT02113982|40122111|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
16448040|NCT02113982|40122112|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
16448041|NCT02113982|40122113|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
16448042|NCT02113982|40122114|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
16448043|NCT02113982|40122115|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
16448044|NCT02113982|40122116|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
16448045|NCT02113982|40122117|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
16448046|NCT02113982|40122118|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
16448047|NCT02113982|40122105|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
16448048|NCT02113982|40122106|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
16448049|NCT02113982|40122107|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
16448050|NCT02113982|40122108|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
16448051|NCT02113982|40122109|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
16448052|NCT02113982|40122110|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
16448053|NCT02113982|40122111|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
16448054|NCT02113982|40122112|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
16448055|NCT02113982|40122113|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
16448056|NCT02113982|40122114|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
16448057|NCT02113982|40122115|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
16448058|NCT02113982|40122116|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
16448059|NCT02113982|40122117|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
16448060|NCT02113982|40122118|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
16448061|NCT02113982|40122105|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448062|NCT02113982|40122106|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448063|NCT02113982|40122107|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448064|NCT02113982|40122108|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448065|NCT02113982|40122109|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448066|NCT02113982|40122110|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448067|NCT02113982|40122111|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
16448068|NCT02113982|40122112|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448069|NCT02113982|40122113|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448070|NCT02113982|40122114|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448071|NCT02113982|40122115|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448072|NCT02113982|40122116|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16070290|NCT00542386|38749700|FG005|Overall Study|Physician Decision|0|||
16070291|NCT00542386|38749695|FG000|Overall Study|Protocol Violation|0|||
16070292|NCT00542386|38749696|FG001|Overall Study|Protocol Violation|0|||
16070293|NCT00542386|38749697|FG002|Overall Study|Protocol Violation|1|||
16070294|NCT00542386|38749698|FG003|Overall Study|Protocol Violation|0|||
16070295|NCT00542386|38749699|FG004|Overall Study|Protocol Violation|0|||
16070296|NCT00542386|38749700|FG005|Overall Study|Protocol Violation|4|||
16070297|NCT00542386|38749695|FG000|Overall Study|Withdrawal by Subject|5|||
16070298|NCT00542386|38749696|FG001|Overall Study|Withdrawal by Subject|8|||
16070299|NCT00542386|38749697|FG002|Overall Study|Withdrawal by Subject|10|||
16070300|NCT00542386|38749698|FG003|Overall Study|Withdrawal by Subject|11|||
16070301|NCT00542386|38749699|FG004|Overall Study|Withdrawal by Subject|15|||
16070302|NCT00542386|38749700|FG005|Overall Study|Withdrawal by Subject|7|||
16070303|NCT00542386|38749695|FG000|Overall Study|Other Reasons|4|||
16448073|NCT02113982|40122117|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448074|NCT02113982|40122118|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
16448075|NCT02113982|40122105|FG000|Stage 1: Dose Escalation|Transplant|0|||
16448076|NCT02113982|40122106|FG001|Stage 1: Dose Escalation|Transplant|1|||
16448077|NCT02113982|40122107|FG002|Stage 1: Dose Escalation|Transplant|0|||
16448078|NCT02113982|40122108|FG003|Stage 1: Dose Escalation|Transplant|0|||
16448079|NCT02113982|40122109|FG004|Stage 1: Dose Escalation|Transplant|0|||
16448080|NCT02113982|40122110|FG005|Stage 1: Dose Escalation|Transplant|1|||
16448081|NCT02113982|40122111|FG006|Stage 1: Dose Escalation|Transplant|0|||
16448082|NCT02113982|40122112|FG007|Stage 1: Dose Escalation|Transplant|0|||
16448083|NCT02113982|40122113|FG008|Stage 1: Dose Escalation|Transplant|0|||
16448084|NCT02113982|40122114|FG009|Stage 1: Dose Escalation|Transplant|0|||
16070304|NCT00542386|38749696|FG001|Overall Study|Other Reasons|1|||
16070305|NCT00542386|38749697|FG002|Overall Study|Other Reasons|4|||
16070306|NCT00542386|38749698|FG003|Overall Study|Other Reasons|3|||
16070307|NCT00542386|38749699|FG004|Overall Study|Other Reasons|4|||
16070308|NCT00542386|38749700|FG005|Overall Study|Other Reasons|2|||
16070309|NCT01167426|38749701|FG000|Overall Study|Lost to Follow-up|6|||
16448085|NCT02113982|40122115|FG010|Stage 1: Dose Escalation|Transplant|0|||
16448086|NCT02113982|40122116|FG011|Stage 1: Dose Escalation|Transplant|0|||
16448087|NCT02113982|40122117|FG012|Stage 1: Dose Escalation|Transplant|0|||
16448088|NCT02113982|40122118|FG013|Stage 1: Dose Escalation|Transplant|0|||
16448089|NCT02113982|40122105|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
16448090|NCT02113982|40122106|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
16448091|NCT02113982|40122107|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
16448092|NCT02113982|40122108|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
16448093|NCT02113982|40122109|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
16448094|NCT02113982|40122110|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
16448095|NCT02113982|40122111|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
16448096|NCT02113982|40122112|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
16448097|NCT02113982|40122113|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
16448098|NCT02113982|40122114|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
16448099|NCT02113982|40122115|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
16448100|NCT02113982|40122116|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
16448101|NCT02113982|40122117|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
16448102|NCT02113982|40122118|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
16448103|NCT02113982|40122105|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
16448104|NCT02113982|40122106|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
16448105|NCT02113982|40122107|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
16448106|NCT02113982|40122108|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
16448107|NCT02113982|40122109|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
16448108|NCT02113982|40122110|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
16448109|NCT02113982|40122111|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
16448110|NCT02113982|40122112|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
16448111|NCT02113982|40122113|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
16448112|NCT02113982|40122114|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
16448113|NCT02113982|40122115|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
16448114|NCT02113982|40122116|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
16448115|NCT02113982|40122117|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
16448116|NCT02113982|40122118|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
16448117|NCT02113982|40122105|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
16448118|NCT02113982|40122106|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
16448119|NCT02113982|40122107|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
16448120|NCT02113982|40122108|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
16448121|NCT02113982|40122109|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
16448122|NCT02113982|40122110|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
16448123|NCT02113982|40122111|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
16448124|NCT02113982|40122112|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
16448125|NCT02113982|40122113|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
16448126|NCT02113982|40122114|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
16448127|NCT02113982|40122115|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
16448128|NCT02113982|40122116|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
16448129|NCT02113982|40122117|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
16448130|NCT02113982|40122118|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
16448131|NCT02113982|40122105|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
16448132|NCT02113982|40122106|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
16448133|NCT02113982|40122107|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
16448134|NCT02113982|40122108|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
16448135|NCT02113982|40122109|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
16448136|NCT02113982|40122110|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
16448137|NCT02113982|40122111|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
16448138|NCT02113982|40122112|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
16448139|NCT02113982|40122113|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
16070310|NCT01167426|38749701|FG000|Overall Study|Protocol Violation|1|||
16070311|NCT01167426|38749701|FG000|Overall Study|Withdrawal by Subject|2|||
16070312|NCT01167426|38749701|FG000|Overall Study|Sponsor Decision|1|||
16070313|NCT03635567|38749704|FG000|Overall Study|Lost to Follow-up|0|||
16448140|NCT02113982|40122114|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
16448141|NCT02113982|40122115|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
16448142|NCT02113982|40122116|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
16070314|NCT03635567|38749705|FG001|Overall Study|Lost to Follow-up|2|||
16070315|NCT03635567|38749704|FG000|Overall Study|Withdrawal by Subject|9|||
16070316|NCT03635567|38749705|FG001|Overall Study|Withdrawal by Subject|10|||
16070317|NCT03635567|38749704|FG000|Overall Study|Ongoing in Study|125|||
16070318|NCT03635567|38749705|FG001|Overall Study|Ongoing in Study|76|||
16070319|NCT03635567|38749704|FG000|Overall Study|Death|174|||
16070320|NCT03635567|38749705|FG001|Overall Study|Death|221|||
16070321|NCT03357341|38749709|FG000|Overall Study|Withdrawal by Subject|3|||
16448143|NCT02113982|40122117|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
16448144|NCT02113982|40122118|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
16448145|NCT02113982|40122105|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448146|NCT02113982|40122106|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448147|NCT02113982|40122107|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448148|NCT02113982|40122108|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448149|NCT02113982|40122109|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448150|NCT02113982|40122110|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448151|NCT02113982|40122111|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448152|NCT02113982|40122112|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
16161546|NCT01273064|39072422|FG001|Overall Study|Adverse Event|1|||
16161547|NCT01273064|39072423|FG002|Overall Study|Adverse Event|3|||
16161548|NCT01273064|39072424|FG003|Overall Study|Adverse Event|2|||
16161549|NCT01273064|39072425|FG004|Overall Study|Adverse Event|1|||
16161550|NCT01273064|39072421|FG000|Overall Study|Withdrawal by Subject|4|||
16161551|NCT01273064|39072422|FG001|Overall Study|Withdrawal by Subject|2|||
16161552|NCT01273064|39072423|FG002|Overall Study|Withdrawal by Subject|2|||
16161553|NCT01273064|39072424|FG003|Overall Study|Withdrawal by Subject|2|||
16161554|NCT01273064|39072425|FG004|Overall Study|Withdrawal by Subject|0|||
16161555|NCT01273064|39072421|FG000|Overall Study|Study Termination|13|||
16161556|NCT01273064|39072422|FG001|Overall Study|Study Termination|27|||
16070322|NCT03357341|38749710|FG001|Overall Study|Withdrawal by Subject|6|||
16070323|NCT03357341|38749709|FG000|Overall Study|Lost to Follow-up|4|||
16070324|NCT03357341|38749710|FG001|Overall Study|Lost to Follow-up|5|||
16070325|NCT03357341|38749709|FG000|Overall Study|Death|0|||
16070326|NCT03357341|38749710|FG001|Overall Study|Death|1|||
16070327|NCT04842604|38749712|FG000|Overall Study|Death|1|||
16070328|NCT04842604|38749713|FG001|Overall Study|Death|0|||
16070329|NCT04842604|38749712|FG000|Overall Study|Other|4|||
16070330|NCT04842604|38749713|FG001|Overall Study|Other|4|||
16070331|NCT04842604|38749712|FG000|Overall Study|Randomized but not treated|1|||
16070332|NCT04842604|38749713|FG001|Overall Study|Randomized but not treated|0|||
16070333|NCT00957229|38749714|FG000|Study Start|Adverse Event|0|||
16070334|NCT00957229|38749715|FG001|Study Start|Adverse Event|3|||
16070335|NCT00957229|38749714|FG000|Study Start|Disease Progression|1|||
16070336|NCT00957229|38749715|FG001|Study Start|Disease Progression|0|||
16070337|NCT00957229|38749714|FG000|Reallocated to or Continued Vismodegib|Death|1|||
16070338|NCT00957229|38749715|FG001|Reallocated to or Continued Vismodegib|Death|1|||
16070339|NCT00957229|38749714|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
16070340|NCT00957229|38749715|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
16070341|NCT01119950|38749720|FG000|Overall Study|Adverse Event|25|||
16070342|NCT01119950|38749720|FG000|Overall Study|Withdrawal by Subject|9|||
16070343|NCT01119950|38749720|FG000|Overall Study|Protocol Violation|5|||
16070344|NCT01119950|38749720|FG000|Overall Study|Lost to Follow-up|4|||
16070345|NCT01119950|38749720|FG000|Overall Study|Administrative|2|||
16070346|NCT01119950|38749720|FG000|Overall Study|Abnormal lab value|1|||
16070347|NCT01119950|38749720|FG000|Overall Study|Death|1|||
16070348|NCT04012853|38749721|FG000|Overall Study|Withdrawal by Subject|1|||
16070349|NCT04012853|38749722|FG001|Overall Study|Withdrawal by Subject|1|||
16070350|NCT04012853|38749721|FG000|Overall Study|Protocol Violation|1|||
16070351|NCT04012853|38749722|FG001|Overall Study|Protocol Violation|0|||
16070352|NCT04012853|38749721|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
16161557|NCT01273064|39072423|FG002|Overall Study|Study Termination|26|||
16161558|NCT01273064|39072424|FG003|Overall Study|Study Termination|16|||
16161559|NCT01273064|39072425|FG004|Overall Study|Study Termination|8|||
16161560|NCT01273064|39072421|FG000|Overall Study|Lost to Follow-up|1|||
16161561|NCT01273064|39072422|FG001|Overall Study|Lost to Follow-up|0|||
16161562|NCT01273064|39072423|FG002|Overall Study|Lost to Follow-up|0|||
16161563|NCT01273064|39072424|FG003|Overall Study|Lost to Follow-up|0|||
16161564|NCT01273064|39072425|FG004|Overall Study|Lost to Follow-up|0|||
16161565|NCT01273064|39072421|FG000|Overall Study|Physician Decision|0|||
16161566|NCT01273064|39072422|FG001|Overall Study|Physician Decision|0|||
16161567|NCT01273064|39072423|FG002|Overall Study|Physician Decision|0|||
16161568|NCT01273064|39072424|FG003|Overall Study|Physician Decision|0|||
16161569|NCT01273064|39072425|FG004|Overall Study|Physician Decision|1|||
16161570|NCT01849874|39072426|FG000|Overall Study|Death|89|||
16161571|NCT01849874|39072427|FG001|Overall Study|Death|42|||
16161572|NCT01849874|39072426|FG000|Overall Study|Withdrawal by Subject|17|||
16161573|NCT01849874|39072427|FG001|Overall Study|Withdrawal by Subject|16|||
16161574|NCT01849874|39072426|FG000|Overall Study|Lost to Follow-up|3|||
16161575|NCT01849874|39072427|FG001|Overall Study|Lost to Follow-up|2|||
16161576|NCT01849874|39072426|FG000|Overall Study|Study Termination By Sponsor|93|||
16161577|NCT01849874|39072427|FG001|Overall Study|Study Termination By Sponsor|48|||
16161578|NCT01849874|39072426|FG000|Overall Study|Completed as per protocol amendment 6|3|||
16161579|NCT01849874|39072427|FG001|Overall Study|Completed as per protocol amendment 6|0|||
16161580|NCT01849874|39072426|FG000|Overall Study|Physician Decision|7|||
16161581|NCT01849874|39072427|FG001|Overall Study|Physician Decision|1|||
16161582|NCT01849874|39072426|FG000|Overall Study|Other|16|||
16161583|NCT01849874|39072427|FG001|Overall Study|Other|4|||
16070353|NCT04012853|38749722|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
16070354|NCT01156116|38749731|FG000|Overall Study|Withdrawal by Subject|3|||
16070355|NCT01156116|38749732|FG001|Overall Study|Withdrawal by Subject|1|||
16161584|NCT02361216|39072428|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
16161585|NCT02361216|39072429|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
16161586|NCT02361216|39072428|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
16161587|NCT02361216|39072429|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
16161588|NCT02361216|39072428|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
16372302|NCT02004275|39849572|FG004|Phase 1|Ineligible|1|||
16070356|NCT01156116|38749731|FG000|Overall Study|CPAP intolerance|2|||
16070357|NCT01156116|38749732|FG001|Overall Study|CPAP intolerance|0|||
16070358|NCT02486588|38749733|FG000|Overall Study|Randomized in error- ineligible|738|||
16070359|NCT02486588|38749734|FG001|Overall Study|Randomized in error- ineligible|750|||
16070360|NCT02486588|38749735|FG002|Overall Study|Randomized in error- ineligible|755|||
16161589|NCT02361216|39072429|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
16161590|NCT02361216|39072428|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
16161591|NCT02361216|39072429|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
16161592|NCT02361216|39072428|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
16161593|NCT02361216|39072429|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
16161594|NCT02361216|39072428|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
16161595|NCT02361216|39072429|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
16161596|NCT01582308|39072430|FG000|Period 1|Withdrawal by Subject|0|||
16161597|NCT01582308|39072431|FG001|Period 1|Withdrawal by Subject|0|||
16161598|NCT01582308|39072432|FG002|Period 1|Withdrawal by Subject|0|||
16070361|NCT02486588|38749736|FG003|Overall Study|Randomized in error- ineligible|738|||
16070362|NCT02486588|38749737|FG004|Overall Study|Randomized in error- ineligible|746|||
16070363|NCT02486588|38749738|FG005|Overall Study|Randomized in error- ineligible|746|||
16070364|NCT01570751|38749739|FG000|Period A (16 Weeks)|Protocol Violation|1|||
16070365|NCT01570751|38749740|FG001|Period A (16 Weeks)|Protocol Violation|1|||
16070366|NCT01570751|38749739|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
16070367|NCT01570751|38749740|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
16070368|NCT01570751|38749739|FG000|Period A (16 Weeks)|Unclassified|2|||
16070369|NCT01570751|38749740|FG001|Period A (16 Weeks)|Unclassified|3|||
16070370|NCT01570751|38749739|FG000|Period B (16 Weeks)|Adverse Event|1|||
16070371|NCT01570751|38749740|FG001|Period B (16 Weeks)|Adverse Event|0|||
16070372|NCT01570751|38749739|FG000|Period B (16 Weeks)|Protocol Violation|0|||
16070373|NCT01570751|38749740|FG001|Period B (16 Weeks)|Protocol Violation|1|||
16070374|NCT03098030|38749748|FG000|Overall Study|Death|10|||
16070375|NCT03098030|38749749|FG001|Overall Study|Death|156|||
16070376|NCT03098030|38749750|FG002|Overall Study|Death|156|||
16070377|NCT03098030|38749751|FG003|Overall Study|Death|82|||
16070378|NCT03098030|38749748|FG000|Overall Study|Withdrawal by Subject|0|||
16070379|NCT03098030|38749749|FG001|Overall Study|Withdrawal by Subject|7|||
16070380|NCT03098030|38749750|FG002|Overall Study|Withdrawal by Subject|8|||
16070381|NCT03098030|38749751|FG003|Overall Study|Withdrawal by Subject|2|||
16070382|NCT03098030|38749748|FG000|Overall Study|Lost to Follow-up|0|||
16070383|NCT03098030|38749749|FG001|Overall Study|Lost to Follow-up|0|||
16070384|NCT03098030|38749750|FG002|Overall Study|Lost to Follow-up|2|||
16070385|NCT03098030|38749751|FG003|Overall Study|Lost to Follow-up|1|||
16070386|NCT04880733|38749752|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
16070387|NCT04880733|38749753|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
16070388|NCT04880733|38749754|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
16070389|NCT04880733|38749752|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
16070390|NCT04880733|38749753|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
16070391|NCT04880733|38749754|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
16070392|NCT04880733|38749752|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
16070393|NCT04880733|38749753|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
16070394|NCT04880733|38749754|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
16070395|NCT04880733|38749752|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
16070396|NCT04880733|38749753|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
16070397|NCT04880733|38749754|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
16070398|NCT04880733|38749752|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
16070399|NCT04880733|38749753|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
16070400|NCT04880733|38749754|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
16070401|NCT00208767|38749760|FG000|Overall Study|Adverse Event|9|||
16070402|NCT00208767|38749761|FG001|Overall Study|Adverse Event|1|||
16070403|NCT00208767|38749760|FG000|Overall Study|Withdrawal by Subject|14|||
16070404|NCT00208767|38749761|FG001|Overall Study|Withdrawal by Subject|3|||
16070405|NCT00208767|38749760|FG000|Overall Study|Death|1|||
16070406|NCT00208767|38749761|FG001|Overall Study|Death|0|||
16070407|NCT00208767|38749760|FG000|Overall Study|Lost to Follow-up|3|||
16070408|NCT00208767|38749761|FG001|Overall Study|Lost to Follow-up|3|||
16070409|NCT04107805|38749782|FG000|Overall Study|Adverse Event|0|||
16070410|NCT04107805|38749783|FG001|Overall Study|Adverse Event|0|||
16070411|NCT04107805|38749784|FG002|Overall Study|Adverse Event|0|||
16070412|NCT04107805|38749785|FG003|Overall Study|Adverse Event|1|||
16070413|NCT04107805|38749786|FG004|Overall Study|Adverse Event|0|||
16070414|NCT04107805|38749787|FG005|Overall Study|Adverse Event|1|||
16070415|NCT04107805|38749788|FG006|Overall Study|Adverse Event|0|||
16070416|NCT04107805|38749789|FG007|Overall Study|Adverse Event|0|||
16161599|NCT01582308|39072433|FG003|Period 1|Withdrawal by Subject|0|||
16161600|NCT01582308|39072434|FG004|Period 1|Withdrawal by Subject|0|||
16070417|NCT04107805|38749790|FG008|Overall Study|Adverse Event|1|||
16070418|NCT00678795|38749791|FG000|Overall Study|Adverse Event|7|||
16070419|NCT00678795|38749792|FG001|Overall Study|Adverse Event|3|||
16070420|NCT00678795|38749791|FG000|Overall Study|Withdrawal by Subject|3|||
16070421|NCT00678795|38749792|FG001|Overall Study|Withdrawal by Subject|0|||
16070422|NCT00678795|38749791|FG000|Overall Study|Protocol Violation|0|||
16264859|NCT01597245|39453264|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16070423|NCT00678795|38749792|FG001|Overall Study|Protocol Violation|1|||
16070424|NCT00678795|38749791|FG000|Overall Study|Lost to Follow-up|0|||
16070425|NCT00678795|38749792|FG001|Overall Study|Lost to Follow-up|1|||
16070426|NCT00678795|38749791|FG000|Overall Study|Lack of Efficacy|1|||
16070427|NCT00678795|38749792|FG001|Overall Study|Lack of Efficacy|1|||
16070428|NCT01803646|38749793|FG000|Overall Study|Protocol Violation|1|||
16070429|NCT01803646|38749794|FG001|Overall Study|Protocol Violation|0|||
16070430|NCT01803646|38749793|FG000|Overall Study|Adverse Event|1|||
16070431|NCT01803646|38749794|FG001|Overall Study|Adverse Event|1|||
16070432|NCT01803646|38749793|FG000|Overall Study|Withdrawal by Subject|9|||
16070433|NCT01803646|38749794|FG001|Overall Study|Withdrawal by Subject|6|||
16070434|NCT01803646|38749793|FG000|Overall Study|Randomization error|1|||
16070435|NCT01803646|38749794|FG001|Overall Study|Randomization error|2|||
16070436|NCT01803646|38749793|FG000|Overall Study|Lost to Follow-up|5|||
16070437|NCT01803646|38749794|FG001|Overall Study|Lost to Follow-up|1|||
16070438|NCT04588480|38749795|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
16070439|NCT04588480|38749796|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
16070440|NCT04588480|38749797|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
16070441|NCT04588480|38749795|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
16070442|NCT04588480|38749796|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
16070443|NCT04588480|38749797|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
16070444|NCT00941031|38749799|FG000|Induction Period|Lack of Efficacy|2|||
16070445|NCT00941031|38749800|FG001|Induction Period|Lack of Efficacy|1|||
16070446|NCT00941031|38749801|FG002|Induction Period|Lack of Efficacy|0|||
16070447|NCT00941031|38749802|FG003|Induction Period|Lack of Efficacy|5|||
16070448|NCT00941031|38749803|FG004|Induction Period|Lack of Efficacy|0|||
16070449|NCT00941031|38749804|FG005|Induction Period|Lack of Efficacy|0|||
16070450|NCT00941031|38749805|FG006|Induction Period|Lack of Efficacy|0|||
16070451|NCT00941031|38749799|FG000|Induction Period|Withdrawal by Subject|1|||
16070452|NCT00941031|38749800|FG001|Induction Period|Withdrawal by Subject|2|||
16070453|NCT00941031|38749801|FG002|Induction Period|Withdrawal by Subject|2|||
16070454|NCT00941031|38749802|FG003|Induction Period|Withdrawal by Subject|2|||
16070455|NCT00941031|38749803|FG004|Induction Period|Withdrawal by Subject|0|||
16070456|NCT00941031|38749804|FG005|Induction Period|Withdrawal by Subject|0|||
16070457|NCT00941031|38749805|FG006|Induction Period|Withdrawal by Subject|0|||
16070458|NCT00941031|38749799|FG000|Induction Period|Adminstative Problems|1|||
16070459|NCT00941031|38749800|FG001|Induction Period|Adminstative Problems|1|||
16070460|NCT00941031|38749801|FG002|Induction Period|Adminstative Problems|1|||
16070461|NCT00941031|38749802|FG003|Induction Period|Adminstative Problems|0|||
16070462|NCT00941031|38749803|FG004|Induction Period|Adminstative Problems|0|||
16070463|NCT00941031|38749804|FG005|Induction Period|Adminstative Problems|0|||
16070464|NCT00941031|38749805|FG006|Induction Period|Adminstative Problems|0|||
16070465|NCT00941031|38749799|FG000|Induction Period|Adverse Event|1|||
16070466|NCT00941031|38749800|FG001|Induction Period|Adverse Event|0|||
16070467|NCT00941031|38749801|FG002|Induction Period|Adverse Event|3|||
16070468|NCT00941031|38749802|FG003|Induction Period|Adverse Event|2|||
16070469|NCT00941031|38749803|FG004|Induction Period|Adverse Event|0|||
16070470|NCT00941031|38749804|FG005|Induction Period|Adverse Event|0|||
16070471|NCT00941031|38749805|FG006|Induction Period|Adverse Event|0|||
16264860|NCT01597245|39453265|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16264861|NCT01597245|39453266|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16264862|NCT01597245|39453267|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16264863|NCT01597245|39453268|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16264864|NCT01597245|39453269|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
16264865|NCT01597245|39453270|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
16264866|NCT01597245|39453271|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
16264867|NCT01597245|39453272|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
16264868|NCT01597245|39453273|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
16070472|NCT00941031|38749799|FG000|Maintenance Period|Withdrawal by Subject|0|||
16070473|NCT00941031|38749800|FG001|Maintenance Period|Withdrawal by Subject|0|||
16070474|NCT00941031|38749801|FG002|Maintenance Period|Withdrawal by Subject|0|||
16070475|NCT00941031|38749802|FG003|Maintenance Period|Withdrawal by Subject|0|||
16070476|NCT00941031|38749803|FG004|Maintenance Period|Withdrawal by Subject|6|||
16070477|NCT00941031|38749804|FG005|Maintenance Period|Withdrawal by Subject|2|||
16070478|NCT00941031|38749805|FG006|Maintenance Period|Withdrawal by Subject|13|||
16070479|NCT00941031|38749799|FG000|Maintenance Period|Administrative Problems|0|||
16070480|NCT00941031|38749800|FG001|Maintenance Period|Administrative Problems|0|||
16264869|NCT01597245|39453274|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
16070481|NCT00941031|38749801|FG002|Maintenance Period|Administrative Problems|0|||
16070482|NCT00941031|38749802|FG003|Maintenance Period|Administrative Problems|0|||
16070483|NCT00941031|38749803|FG004|Maintenance Period|Administrative Problems|1|||
16070484|NCT00941031|38749804|FG005|Maintenance Period|Administrative Problems|0|||
16070485|NCT00941031|38749805|FG006|Maintenance Period|Administrative Problems|1|||
16264870|NCT01597245|39453254|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264871|NCT01597245|39453255|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264872|NCT01597245|39453256|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264873|NCT01597245|39453257|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16070486|NCT00941031|38749799|FG000|Maintenance Period|Protocol Violation|0|||
16070487|NCT00941031|38749800|FG001|Maintenance Period|Protocol Violation|0|||
16070488|NCT00941031|38749801|FG002|Maintenance Period|Protocol Violation|0|||
16070489|NCT00941031|38749802|FG003|Maintenance Period|Protocol Violation|0|||
16070490|NCT00941031|38749803|FG004|Maintenance Period|Protocol Violation|0|||
16070491|NCT00941031|38749804|FG005|Maintenance Period|Protocol Violation|0|||
16070492|NCT00941031|38749805|FG006|Maintenance Period|Protocol Violation|1|||
16070493|NCT00941031|38749799|FG000|Maintenance Period|Adverse Event|0|||
16070494|NCT00941031|38749800|FG001|Maintenance Period|Adverse Event|0|||
16070495|NCT00941031|38749801|FG002|Maintenance Period|Adverse Event|0|||
16070496|NCT00941031|38749802|FG003|Maintenance Period|Adverse Event|0|||
16070497|NCT00941031|38749803|FG004|Maintenance Period|Adverse Event|0|||
16070498|NCT00941031|38749804|FG005|Maintenance Period|Adverse Event|2|||
16070499|NCT00941031|38749805|FG006|Maintenance Period|Adverse Event|8|||
16070500|NCT00941031|38749799|FG000|Maintenance Period|Lost to Follow-up|0|||
16070501|NCT00941031|38749800|FG001|Maintenance Period|Lost to Follow-up|0|||
16070502|NCT00941031|38749801|FG002|Maintenance Period|Lost to Follow-up|0|||
16070503|NCT00941031|38749802|FG003|Maintenance Period|Lost to Follow-up|0|||
16070504|NCT00941031|38749803|FG004|Maintenance Period|Lost to Follow-up|2|||
16070505|NCT00941031|38749804|FG005|Maintenance Period|Lost to Follow-up|2|||
16070506|NCT00941031|38749805|FG006|Maintenance Period|Lost to Follow-up|7|||
16070507|NCT00941031|38749799|FG000|Maintenance Period|Lack of Efficacy|0|||
16070508|NCT00941031|38749800|FG001|Maintenance Period|Lack of Efficacy|0|||
16070509|NCT00941031|38749801|FG002|Maintenance Period|Lack of Efficacy|0|||
16070510|NCT00941031|38749802|FG003|Maintenance Period|Lack of Efficacy|0|||
16070511|NCT00941031|38749803|FG004|Maintenance Period|Lack of Efficacy|0|||
16070512|NCT00941031|38749804|FG005|Maintenance Period|Lack of Efficacy|0|||
16070513|NCT00941031|38749805|FG006|Maintenance Period|Lack of Efficacy|13|||
16070514|NCT00408928|38749808|FG000|Overall Study|Withdrawal by Subject|1|||
16070515|NCT00408928|38749808|FG000|Overall Study|Death|1|||
16070516|NCT00408928|38749808|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
16070517|NCT01972152|38749809|FG000|First Treatment Visit|Lost to Follow-up|0|||
16070518|NCT01972152|38749810|FG001|First Treatment Visit|Lost to Follow-up|1|||
16070519|NCT01972152|38749811|FG002|First Treatment Visit|Lost to Follow-up|0|||
16070520|NCT01972152|38749812|FG003|First Treatment Visit|Lost to Follow-up|0|||
16070521|NCT01972152|38749813|FG004|First Treatment Visit|Lost to Follow-up|0|||
16070522|NCT01972152|38749814|FG005|First Treatment Visit|Lost to Follow-up|0|||
16070523|NCT01972152|38749809|FG000|Second Treatment Visit|Protocol Violation|0|||
16070524|NCT01972152|38749810|FG001|Second Treatment Visit|Protocol Violation|1|||
16070525|NCT01972152|38749811|FG002|Second Treatment Visit|Protocol Violation|0|||
16070526|NCT01972152|38749812|FG003|Second Treatment Visit|Protocol Violation|0|||
16070527|NCT01972152|38749813|FG004|Second Treatment Visit|Protocol Violation|0|||
16264874|NCT01597245|39453258|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264875|NCT01597245|39453259|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264876|NCT01597245|39453260|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264877|NCT01597245|39453261|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264878|NCT01597245|39453262|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264879|NCT01597245|39453263|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264880|NCT01597245|39453264|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264881|NCT01597245|39453265|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264882|NCT01597245|39453266|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264883|NCT01597245|39453267|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264884|NCT01597245|39453268|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264885|NCT01597245|39453269|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16372303|NCT02004275|39849573|FG005|Phase 1|Ineligible|0|||
16372304|NCT02004275|39849568|FG000|Phase 1|Protocol Violation|0|||
16070528|NCT01972152|38749814|FG005|Second Treatment Visit|Protocol Violation|0|||
16070529|NCT01648140|38749815|FG000|Overall Study|Physician Decision|1|||
16070530|NCT01648140|38749816|FG001|Overall Study|Physician Decision|0|||
16070531|NCT01648140|38749817|FG002|Overall Study|Physician Decision|0|||
16070532|NCT01648140|38749818|FG003|Overall Study|Physician Decision|0|||
16070533|NCT01648140|38749815|FG000|Overall Study|Lack of Efficacy|4|||
16070534|NCT01648140|38749816|FG001|Overall Study|Lack of Efficacy|7|||
16070535|NCT01648140|38749817|FG002|Overall Study|Lack of Efficacy|1|||
16161601|NCT01582308|39072435|FG005|Period 1|Withdrawal by Subject|0|||
16161602|NCT01582308|39072436|FG006|Period 1|Withdrawal by Subject|1|||
16161603|NCT01582308|39072437|FG007|Period 1|Withdrawal by Subject|0|||
16161604|NCT01582308|39072438|FG008|Period 1|Withdrawal by Subject|0|||
16161605|NCT01582308|39072439|FG009|Period 1|Withdrawal by Subject|0|||
16161606|NCT01582308|39072430|FG000|10-day Washout Following Period 1|Physician Decision|0|||
16161607|NCT01582308|39072431|FG001|10-day Washout Following Period 1|Physician Decision|0|||
16161608|NCT01582308|39072432|FG002|10-day Washout Following Period 1|Physician Decision|0|||
16161609|NCT01582308|39072433|FG003|10-day Washout Following Period 1|Physician Decision|0|||
16161610|NCT01582308|39072434|FG004|10-day Washout Following Period 1|Physician Decision|1|||
16161611|NCT01582308|39072435|FG005|10-day Washout Following Period 1|Physician Decision|0|||
16161612|NCT01582308|39072436|FG006|10-day Washout Following Period 1|Physician Decision|0|||
16161613|NCT01582308|39072437|FG007|10-day Washout Following Period 1|Physician Decision|0|||
16161614|NCT01582308|39072438|FG008|10-day Washout Following Period 1|Physician Decision|0|||
16161615|NCT01582308|39072439|FG009|10-day Washout Following Period 1|Physician Decision|0|||
16161616|NCT01582308|39072430|FG000|Period 4|Physician Decision|1|||
16161617|NCT01582308|39072431|FG001|Period 4|Physician Decision|0|||
16161618|NCT01582308|39072432|FG002|Period 4|Physician Decision|0|||
16161619|NCT01582308|39072433|FG003|Period 4|Physician Decision|0|||
16161620|NCT01582308|39072434|FG004|Period 4|Physician Decision|0|||
16372305|NCT02004275|39849569|FG001|Phase 1|Protocol Violation|0|||
16372306|NCT02004275|39849570|FG002|Phase 1|Protocol Violation|0|||
16372307|NCT02004275|39849571|FG003|Phase 1|Protocol Violation|1|||
16372308|NCT02004275|39849572|FG004|Phase 1|Protocol Violation|0|||
16372309|NCT02004275|39849573|FG005|Phase 1|Protocol Violation|5|||
16372310|NCT02004275|39849568|FG000|Phase 2 Part 1|Ineligible|6|||
16372311|NCT02004275|39849569|FG001|Phase 2 Part 1|Ineligible|9|||
16372312|NCT02004275|39849570|FG002|Phase 2 Part 1|Ineligible|0|||
16372313|NCT02004275|39849571|FG003|Phase 2 Part 1|Ineligible|0|||
16372314|NCT02004275|39849572|FG004|Phase 2 Part 1|Ineligible|0|||
16372315|NCT02004275|39849573|FG005|Phase 2 Part 1|Ineligible|0|||
16372316|NCT02004275|39849568|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
16372317|NCT02004275|39849569|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
16372318|NCT02004275|39849570|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
16372319|NCT02004275|39849571|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
16372320|NCT02004275|39849572|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
16372321|NCT02004275|39849573|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
16372322|NCT01654250|39849574|FG000|Overall Study|Lost to Follow-up|1|||
16372323|NCT01654250|39849575|FG001|Overall Study|Lost to Follow-up|0|||
16372324|NCT00394472|39849580|FG000|Overall Study|Protocol Violation|1|||
16372325|NCT00394472|39849581|FG001|Overall Study|Protocol Violation|3|||
16372326|NCT00394472|39849580|FG000|Overall Study|incorrect enrolment|4|||
16372327|NCT00394472|39849581|FG001|Overall Study|incorrect enrolment|2|||
16372328|NCT00394472|39849580|FG000|Overall Study|Adverse Event|4|||
16372329|NCT00394472|39849581|FG001|Overall Study|Adverse Event|2|||
16372330|NCT00394472|39849580|FG000|Overall Study|Withdrawal by Subject|0|||
16372331|NCT00394472|39849581|FG001|Overall Study|Withdrawal by Subject|2|||
16372332|NCT00394472|39849580|FG000|Overall Study|Physician Decision|0|||
16372333|NCT00394472|39849581|FG001|Overall Study|Physician Decision|1|||
16372334|NCT00394472|39849580|FG000|Overall Study|Lost to Follow-up|0|||
16372335|NCT00394472|39849581|FG001|Overall Study|Lost to Follow-up|1|||
16372336|NCT00562861|39849582|FG000|Overall Study|Adverse Event|1|||
16372337|NCT00562861|39849583|FG001|Overall Study|Adverse Event|1|||
16372338|NCT00562861|39849582|FG000|Overall Study|Lack of Efficacy|5|||
16372339|NCT00562861|39849583|FG001|Overall Study|Lack of Efficacy|5|||
16372340|NCT00562861|39849582|FG000|Overall Study|noncompliance, moved|7|||
16372341|NCT00562861|39849583|FG001|Overall Study|noncompliance, moved|2|||
16372342|NCT00562861|39849582|FG000|Overall Study|Lost to Follow-up|7|||
16372343|NCT00562861|39849583|FG001|Overall Study|Lost to Follow-up|3|||
16372344|NCT05085405|39849586|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
16372345|NCT05085405|39849587|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
16372346|NCT05085405|39849588|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
16372347|NCT05085405|39849589|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
16070536|NCT01648140|38749818|FG003|Overall Study|Lack of Efficacy|0|||
16070537|NCT01648140|38749815|FG000|Overall Study|Adverse Event|3|||
16070538|NCT01648140|38749816|FG001|Overall Study|Adverse Event|1|||
16070539|NCT01648140|38749817|FG002|Overall Study|Adverse Event|2|||
16070540|NCT01648140|38749818|FG003|Overall Study|Adverse Event|0|||
16070541|NCT01648140|38749815|FG000|Overall Study|Withdrawal by Subject|2|||
16070542|NCT01648140|38749816|FG001|Overall Study|Withdrawal by Subject|3|||
16070543|NCT01648140|38749817|FG002|Overall Study|Withdrawal by Subject|3|||
16070544|NCT01648140|38749818|FG003|Overall Study|Withdrawal by Subject|2|||
16070545|NCT01648140|38749815|FG000|Overall Study|Lost to Follow-up|2|||
16070546|NCT01648140|38749816|FG001|Overall Study|Lost to Follow-up|1|||
16372348|NCT05085405|39849590|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
16264886|NCT01597245|39453270|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
16264887|NCT01597245|39453271|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
16161621|NCT01582308|39072435|FG005|Period 4|Physician Decision|1|||
16161622|NCT01582308|39072436|FG006|Period 4|Physician Decision|0|||
16161623|NCT01582308|39072437|FG007|Period 4|Physician Decision|0|||
16161624|NCT01582308|39072438|FG008|Period 4|Physician Decision|0|||
16161625|NCT01582308|39072439|FG009|Period 4|Physician Decision|1|||
16161626|NCT00293579|39072440|FG000|Overall Study|Withdrawal by Subject|1|||
16161627|NCT02447848|39072441|FG000|Overall Study|Patient discharged|3|||
16161628|NCT02447848|39072441|FG000|Overall Study|Lack of Efficacy|4|||
16161629|NCT02447848|39072441|FG000|Overall Study|Withdrawal by Subject|4|||
16161630|NCT04016311|39072444|FG000|Overall Study|Withdrawal by Subject|1|||
16161631|NCT04016311|39072445|FG001|Overall Study|Withdrawal by Subject|0|||
16161632|NCT03298022|39072446|FG000|Overall Study|Lack of Efficacy|4|||
16161633|NCT03298022|39072446|FG000|Overall Study|Withdrawal by Subject|7|||
16161634|NCT03298022|39072446|FG000|Overall Study|Adverse Event|1|||
16161635|NCT03298022|39072446|FG000|Overall Study|disease relapse|1|||
16161636|NCT00191451|39072447|FG000|Overall Study|Withdrawal by Subject|2|||
16161637|NCT00191451|39072448|FG001|Overall Study|Withdrawal by Subject|3|||
16161638|NCT00191451|39072449|FG002|Overall Study|Withdrawal by Subject|5|||
16161639|NCT00191451|39072447|FG000|Overall Study|Physician Decision|2|||
16161640|NCT00191451|39072448|FG001|Overall Study|Physician Decision|9|||
16161641|NCT00191451|39072449|FG002|Overall Study|Physician Decision|6|||
16161642|NCT00191451|39072447|FG000|Overall Study|Sponsor Decision|1|||
16161643|NCT00191451|39072448|FG001|Overall Study|Sponsor Decision|0|||
16161644|NCT00191451|39072449|FG002|Overall Study|Sponsor Decision|0|||
16161645|NCT00191451|39072447|FG000|Overall Study|Ineligible|0|||
16161646|NCT00191451|39072448|FG001|Overall Study|Ineligible|1|||
16161647|NCT00191451|39072449|FG002|Overall Study|Ineligible|0|||
16161648|NCT00191451|39072447|FG000|Overall Study|Reason Not Specified|2|||
16161649|NCT00191451|39072448|FG001|Overall Study|Reason Not Specified|1|||
16161650|NCT00191451|39072449|FG002|Overall Study|Reason Not Specified|3|||
16161651|NCT03718143|39072450|FG000|Overall Study|Death|1|||
16161652|NCT03718143|39072451|FG001|Overall Study|Death|0|||
16161653|NCT03718143|39072452|FG002|Overall Study|Death|0|||
16161654|NCT03718143|39072450|FG000|Overall Study|Progression of Disease|1|||
16161655|NCT03718143|39072451|FG001|Overall Study|Progression of Disease|0|||
16161656|NCT03718143|39072452|FG002|Overall Study|Progression of Disease|0|||
16161657|NCT03718143|39072450|FG000|Overall Study|Withdrawal of Informed Consent|1|||
16161658|NCT03718143|39072451|FG001|Overall Study|Withdrawal of Informed Consent|2|||
16161659|NCT03718143|39072452|FG002|Overall Study|Withdrawal of Informed Consent|1|||
16161660|NCT04607733|39072461|FG000|Overall Study|Lost to Follow-up|1|||
16161661|NCT04607733|39072462|FG001|Overall Study|Lost to Follow-up|0|||
16161662|NCT04607733|39072463|FG002|Overall Study|Lost to Follow-up|0|||
16161663|NCT04607733|39072464|FG003|Overall Study|Lost to Follow-up|1|||
16161664|NCT04607733|39072465|FG004|Overall Study|Lost to Follow-up|1|||
16161665|NCT04607733|39072466|FG005|Overall Study|Lost to Follow-up|0|||
16161666|NCT04607733|39072461|FG000|Overall Study|Withdrawal by Subject|0|||
16161667|NCT04607733|39072462|FG001|Overall Study|Withdrawal by Subject|0|||
16161668|NCT04607733|39072463|FG002|Overall Study|Withdrawal by Subject|0|||
16161669|NCT04607733|39072464|FG003|Overall Study|Withdrawal by Subject|0|||
16161670|NCT04607733|39072465|FG004|Overall Study|Withdrawal by Subject|1|||
16161671|NCT04607733|39072466|FG005|Overall Study|Withdrawal by Subject|0|||
16161672|NCT01100944|39072467|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
16161673|NCT01100944|39072468|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
16161674|NCT01100944|39072469|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
16161675|NCT01100944|39072467|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
16161676|NCT01100944|39072468|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
16161677|NCT01100944|39072469|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
16161678|NCT01100944|39072467|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
16161679|NCT01100944|39072468|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
16161680|NCT01100944|39072469|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
16161681|NCT01100944|39072467|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
16161682|NCT01100944|39072468|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
16161683|NCT01100944|39072469|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
16161684|NCT00818259|39072470|FG000|Part I|Withdrawal by Subject|1|||
16161685|NCT00818259|39072471|FG001|Part I|Withdrawal by Subject|0|||
16161686|NCT00818259|39072472|FG002|Part I|Withdrawal by Subject|0|||
16161687|NCT00818259|39072473|FG003|Part I|Withdrawal by Subject|0|||
16161688|NCT00818259|39072474|FG004|Part I|Withdrawal by Subject|0|||
16161689|NCT00818259|39072475|FG005|Part I|Withdrawal by Subject|0|||
16161690|NCT00818259|39072476|FG006|Part I|Withdrawal by Subject|0|||
16161691|NCT00818259|39072477|FG007|Part I|Withdrawal by Subject|0|||
16161692|NCT00818259|39072478|FG008|Part I|Withdrawal by Subject|0|||
16161693|NCT00818259|39072470|FG000|Part II|Physician Decision|0|||
16161694|NCT00818259|39072471|FG001|Part II|Physician Decision|0|||
16161695|NCT00818259|39072472|FG002|Part II|Physician Decision|1|||
16161696|NCT00818259|39072473|FG003|Part II|Physician Decision|0|||
16161697|NCT00818259|39072474|FG004|Part II|Physician Decision|0|||
16161698|NCT00818259|39072475|FG005|Part II|Physician Decision|0|||
16161699|NCT00818259|39072476|FG006|Part II|Physician Decision|0|||
16161700|NCT00818259|39072477|FG007|Part II|Physician Decision|0|||
16372349|NCT05085405|39849591|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
16372350|NCT05085405|39849586|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
16372351|NCT05085405|39849587|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
16070547|NCT01648140|38749817|FG002|Overall Study|Lost to Follow-up|2|||
16070548|NCT01648140|38749818|FG003|Overall Study|Lost to Follow-up|0|||
16070549|NCT01565928|38749819|FG000|Overall Study|Adverse Event|3|||
16070550|NCT01565928|38749819|FG000|Overall Study|Other|3|||
16070551|NCT01565928|38749819|FG000|Overall Study|Progressive Disease|13|||
16070552|NCT01565928|38749819|FG000|Overall Study|Withdrawal by Subject|1|||
16070553|NCT01565928|38749819|FG000|Overall Study|Death|2|||
16070554|NCT00487578|38749821|FG000|Overall Study|Adverse Event|1|||
16070555|NCT00487578|38749822|FG001|Overall Study|Adverse Event|2|||
16372352|NCT05085405|39849588|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
16372353|NCT05085405|39849589|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
16372354|NCT05085405|39849590|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
16372355|NCT05085405|39849591|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
16372356|NCT04432298|39849592|FG000|Overall Study|Other than specified|1|||
16372357|NCT04432298|39849593|FG001|Overall Study|Other than specified|0|||
16372358|NCT04432298|39849592|FG000|Overall Study|Lost to Follow-up|0|||
16372359|NCT04432298|39849593|FG001|Overall Study|Lost to Follow-up|1|||
16372360|NCT04432298|39849592|FG000|Overall Study|Death|3|||
16372361|NCT04432298|39849593|FG001|Overall Study|Death|2|||
16372362|NCT04432298|39849592|FG000|Overall Study|Withdrawal by Subject|2|||
16372363|NCT04432298|39849593|FG001|Overall Study|Withdrawal by Subject|0|||
16372364|NCT04204902|39849594|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
16372365|NCT04204902|39849595|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
16372366|NCT02830087|39849596|FG000|Overall Study|No study staff to follow-up patients|4|||
16372367|NCT02830087|39849597|FG001|Overall Study|No study staff to follow-up patients|4|||
16372368|NCT02830087|39849598|FG002|Overall Study|No study staff to follow-up patients|4|||
16372369|NCT02830087|39849599|FG003|Overall Study|No study staff to follow-up patients|3|||
16372370|NCT02830087|39849600|FG004|Overall Study|No study staff to follow-up patients|3|||
16372371|NCT02830087|39849601|FG005|Overall Study|No study staff to follow-up patients|3|||
16372372|NCT01433978|39849602|FG000|Core Study|Adverse Event, Non-Fatal|0|||
16372373|NCT01433978|39849603|FG001|Core Study|Adverse Event, Non-Fatal|1|||
16372374|NCT01433978|39849604|FG002|Core Study|Adverse Event, Non-Fatal|0|||
16372375|NCT01433978|39849602|FG000|Core Study|Lack of Efficacy|5|||
16372376|NCT01433978|39849603|FG001|Core Study|Lack of Efficacy|1|||
16372377|NCT01433978|39849604|FG002|Core Study|Lack of Efficacy|0|||
16372378|NCT01433978|39849602|FG000|Core Study|Study Terminated by Sponsor|6|||
16372379|NCT01433978|39849603|FG001|Core Study|Study Terminated by Sponsor|9|||
16372380|NCT01433978|39849604|FG002|Core Study|Study Terminated by Sponsor|0|||
16372381|NCT01433978|39849602|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
16372382|NCT01433978|39849603|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
16372383|NCT01433978|39849604|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
16372384|NCT01433978|39849602|FG000|Extension Phase|Lack of Efficacy|0|||
16372385|NCT01433978|39849603|FG001|Extension Phase|Lack of Efficacy|0|||
16372386|NCT01433978|39849604|FG002|Extension Phase|Lack of Efficacy|1|||
16372387|NCT01433978|39849602|FG000|Extension Phase|Study Terminated by Sponsor|0|||
16372388|NCT01433978|39849603|FG001|Extension Phase|Study Terminated by Sponsor|0|||
16372389|NCT01433978|39849604|FG002|Extension Phase|Study Terminated by Sponsor|4|||
16372390|NCT00800384|39849607|FG000|Overall Study|Withdrawal by Subject|24|||
16372391|NCT00800384|39849608|FG001|Overall Study|Withdrawal by Subject|17|||
16372392|NCT00800384|39849607|FG000|Overall Study|Lost to Follow-up|17|||
16372393|NCT00800384|39849608|FG001|Overall Study|Lost to Follow-up|26|||
16161701|NCT00818259|39072478|FG008|Part II|Physician Decision|0|||
16161702|NCT00818259|39072470|FG000|Part II|Lack of Efficacy|0|||
16161703|NCT00818259|39072471|FG001|Part II|Lack of Efficacy|0|||
16161704|NCT00818259|39072472|FG002|Part II|Lack of Efficacy|0|||
16372394|NCT03548415|39849609|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
16372395|NCT03548415|39849610|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
16372396|NCT03548415|39849611|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
16448153|NCT02113982|40122113|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448154|NCT02113982|40122114|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
16070556|NCT00487578|38749821|FG000|Overall Study|Lack of Efficacy|0|||
16161705|NCT00818259|39072473|FG003|Part II|Lack of Efficacy|1|||
16161706|NCT00818259|39072474|FG004|Part II|Lack of Efficacy|0|||
16070557|NCT00487578|38749822|FG001|Overall Study|Lack of Efficacy|1|||
16161707|NCT00818259|39072475|FG005|Part II|Lack of Efficacy|0|||
16372397|NCT03548415|39849612|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
16372398|NCT03548415|39849613|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
16372399|NCT01716156|39849619|FG000|Overall Study|Protocol Violation|1|||
16372400|NCT01716156|39849620|FG001|Overall Study|Protocol Violation|0|||
16372401|NCT01716156|39849621|FG002|Overall Study|Protocol Violation|0|||
16372402|NCT01716156|39849619|FG000|Overall Study|Withdrawal by Subject|0|||
16372403|NCT01716156|39849620|FG001|Overall Study|Withdrawal by Subject|1|||
16372404|NCT01716156|39849621|FG002|Overall Study|Withdrawal by Subject|2|||
16372405|NCT01716156|39849619|FG000|Overall Study|Lost to Follow-up|1|||
16372406|NCT01716156|39849620|FG001|Overall Study|Lost to Follow-up|0|||
16372407|NCT01716156|39849621|FG002|Overall Study|Lost to Follow-up|0|||
16372408|NCT01089543|39849626|FG000|Overall Study|Withdrawal by Subject|2|||
16372409|NCT01089543|39849627|FG001|Overall Study|Withdrawal by Subject|3|||
16372410|NCT01089543|39849628|FG002|Overall Study|Withdrawal by Subject|3|||
16372411|NCT01089543|39849629|FG003|Overall Study|Withdrawal by Subject|1|||
16372412|NCT01089543|39849626|FG000|Overall Study|Physician Decision|1|||
16372413|NCT01089543|39849627|FG001|Overall Study|Physician Decision|0|||
16372414|NCT01089543|39849628|FG002|Overall Study|Physician Decision|0|||
16372415|NCT01089543|39849629|FG003|Overall Study|Physician Decision|1|||
16372416|NCT01089543|39849626|FG000|Overall Study|Adverse Event|0|||
16372417|NCT01089543|39849627|FG001|Overall Study|Adverse Event|1|||
16372418|NCT01089543|39849628|FG002|Overall Study|Adverse Event|0|||
16372419|NCT01089543|39849629|FG003|Overall Study|Adverse Event|0|||
16372420|NCT01412983|39849630|FG000|1st Period|Ineligible|0|||
16372421|NCT01412983|39849631|FG001|1st Period|Ineligible|1|||
16372422|NCT01412983|39849630|FG000|1st Period|Positive slit lamp finding|0|||
16372423|NCT01412983|39849631|FG001|1st Period|Positive slit lamp finding|1|||
16372424|NCT01412983|39849630|FG000|1st Period|Unacceptable lens movement|0|||
16372425|NCT01412983|39849631|FG001|1st Period|Unacceptable lens movement|1|||
16372426|NCT01412983|39849630|FG000|1st Period|Inability to maintain wear|0|||
16372427|NCT01412983|39849631|FG001|1st Period|Inability to maintain wear|1|||
16372428|NCT01658735|39849632|FG000|Overall Study|Lack of Efficacy|1|||
16372429|NCT01658735|39849633|FG001|Overall Study|Lack of Efficacy|0|||
16448155|NCT02113982|40122115|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
16448156|NCT02113982|40122116|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448157|NCT02113982|40122117|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448158|NCT02113982|40122118|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
16448159|NCT02113982|40122105|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16448160|NCT02113982|40122106|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16448161|NCT02113982|40122107|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16448162|NCT02113982|40122108|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16448163|NCT02113982|40122109|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16448164|NCT02113982|40122110|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16448165|NCT02113982|40122111|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16070558|NCT00487578|38749821|FG000|Overall Study|Lost to Follow-up|0|||
16070559|NCT00487578|38749822|FG001|Overall Study|Lost to Follow-up|1|||
16070560|NCT00309452|38749823|FG000|Overall Study|Withdrawal by Subject|3|||
16070561|NCT00309452|38749824|FG001|Overall Study|Withdrawal by Subject|0|||
16070562|NCT00938340|38749825|FG000|Overall Study|Withdrawal by Subject|3|||
16448166|NCT02113982|40122112|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
16448167|NCT02113982|40122113|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16448168|NCT02113982|40122114|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
16448169|NCT02113982|40122115|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16448170|NCT02113982|40122116|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16448171|NCT02113982|40122117|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16448172|NCT02113982|40122118|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
16070563|NCT00938340|38749825|FG000|Overall Study|Protocol Violation|1|||
16070564|NCT00938340|38749825|FG000|Overall Study|Adverse Event|1|||
16070565|NCT00139737|38749826|FG000|Overall Study|Withdrawal by Subject|190|||
16070566|NCT00139737|38749826|FG000|Overall Study|Adverse Event|58|||
16070567|NCT00139737|38749826|FG000|Overall Study|Lack of Efficacy|40|||
16161708|NCT00818259|39072476|FG006|Part II|Lack of Efficacy|0|||
16372430|NCT01658735|39849634|FG002|Overall Study|Lack of Efficacy|1|||
16372431|NCT01658735|39849632|FG000|Overall Study|Lost to Follow-up|1|||
16372432|NCT01658735|39849633|FG001|Overall Study|Lost to Follow-up|1|||
16372433|NCT01658735|39849634|FG002|Overall Study|Lost to Follow-up|0|||
16372434|NCT01658735|39849632|FG000|Overall Study|Protocol Violation|0|||
16372435|NCT01658735|39849633|FG001|Overall Study|Protocol Violation|1|||
16372436|NCT01658735|39849634|FG002|Overall Study|Protocol Violation|0|||
16448173|NCT02113982|40122105|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16070568|NCT00139737|38749826|FG000|Overall Study|Lost to Follow-up|8|||
16070569|NCT00139737|38749826|FG000|Overall Study|Death|3|||
16372437|NCT01658735|39849632|FG000|Overall Study|Withdrawal by Subject|3|||
16372438|NCT01658735|39849633|FG001|Overall Study|Withdrawal by Subject|5|||
16372439|NCT01658735|39849634|FG002|Overall Study|Withdrawal by Subject|3|||
16448174|NCT02113982|40122106|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16448175|NCT02113982|40122107|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16448176|NCT02113982|40122108|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16448177|NCT02113982|40122109|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16448178|NCT02113982|40122110|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16070570|NCT00139737|38749826|FG000|Overall Study|Laboratory Abnormality|2|||
16070571|NCT00139737|38749826|FG000|Overall Study|Protocol Violation|18|||
16070572|NCT00139737|38749826|FG000|Overall Study|Withdrew During Screening Phase|8|||
16070573|NCT00139737|38749826|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
16070574|NCT00139737|38749826|FG000|Overall Study|Screened, Not Treated|13|||
16070575|NCT02357784|38749827|FG000|Overall Study|Withdrawal by Subject|1|||
16070576|NCT00387465|38749831|FG000|Overall Study|Withdrawal by Subject|0|||
16070577|NCT00387465|38749832|FG001|Overall Study|Withdrawal by Subject|1|||
16070578|NCT00387465|38749833|FG002|Overall Study|Withdrawal by Subject|0|||
16070579|NCT00605033|38749838|FG000|Overall Study|Adverse Event|2|||
16070580|NCT00605033|38749839|FG001|Overall Study|Adverse Event|2|||
16070581|NCT00605033|38749838|FG000|Overall Study|Lost to Follow-up|1|||
16070582|NCT00605033|38749839|FG001|Overall Study|Lost to Follow-up|1|||
16070583|NCT00605033|38749838|FG000|Overall Study|Withdrawal by Subject|3|||
16070584|NCT00605033|38749839|FG001|Overall Study|Withdrawal by Subject|4|||
16070585|NCT00605033|38749838|FG000|Overall Study|Protocol Violation|1|||
16070586|NCT00605033|38749839|FG001|Overall Study|Protocol Violation|1|||
16070587|NCT00771849|38749842|FG000|Overall Study|Lost to Follow-up|1|||
16070588|NCT00771849|38749843|FG001|Overall Study|Lost to Follow-up|2|||
16070589|NCT00771849|38749842|FG000|Overall Study|Withdrawal by Subject|1|||
16070590|NCT00771849|38749843|FG001|Overall Study|Withdrawal by Subject|1|||
16070591|NCT00771849|38749842|FG000|Overall Study|Not vaccinated|0|||
16070592|NCT00771849|38749843|FG001|Overall Study|Not vaccinated|1|||
16070593|NCT03055767|38749844|FG000|Open-Label Period|Lost to Follow-up|0|||
16070594|NCT03055767|38749845|FG001|Open-Label Period|Lost to Follow-up|0|||
16070595|NCT03055767|38749846|FG002|Open-Label Period|Lost to Follow-up|2|||
16070596|NCT03055767|38749847|FG003|Open-Label Period|Lost to Follow-up|0|||
16070597|NCT03055767|38749844|FG000|Open-Label Period|Withdrawal by Subject|0|||
16070598|NCT03055767|38749845|FG001|Open-Label Period|Withdrawal by Subject|0|||
16070599|NCT03055767|38749846|FG002|Open-Label Period|Withdrawal by Subject|0|||
16070600|NCT03055767|38749847|FG003|Open-Label Period|Withdrawal by Subject|1|||
16070601|NCT03939819|38749848|FG000|Overall Study|Death|2|||
16070602|NCT03939819|38749849|FG001|Overall Study|Death|0|||
16070603|NCT01451814|38749851|FG000|Overall Study|Withdrawal by Subject|1|||
16070604|NCT01451814|38749852|FG001|Overall Study|Withdrawal by Subject|1|||
16070605|NCT01451814|38749851|FG000|Overall Study|Lost to Follow-up|5|||
16070606|NCT01451814|38749852|FG001|Overall Study|Lost to Follow-up|4|||
16070607|NCT01137292|38749854|FG000|Overall Study|Death|30|||
16070608|NCT01137292|38749854|FG000|Overall Study|Adverse Event|3|||
16070609|NCT01137292|38749854|FG000|Overall Study|Lack of Efficacy|13|||
16070610|NCT01137292|38749854|FG000|Overall Study|Lost to Follow-up|1|||
16070611|NCT01137292|38749854|FG000|Overall Study|Other|7|||
16070612|NCT03823911|38749857|FG000|Overall Study|Lost to Follow-up|1|||
16070613|NCT03823911|38749858|FG001|Overall Study|Lost to Follow-up|5|||
16070614|NCT03823911|38749859|FG002|Overall Study|Lost to Follow-up|2|||
16070615|NCT03823911|38749857|FG000|Overall Study|Did not meet eligibility criteria|13|||
16070616|NCT03823911|38749858|FG001|Overall Study|Did not meet eligibility criteria|7|||
16070617|NCT03823911|38749859|FG002|Overall Study|Did not meet eligibility criteria|4|||
16070618|NCT03823911|38749857|FG000|Overall Study|Death|0|||
16070619|NCT03823911|38749858|FG001|Overall Study|Death|1|||
16070620|NCT03823911|38749859|FG002|Overall Study|Death|0|||
16070621|NCT02993471|38749861|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
16070622|NCT02993471|38749861|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
16070623|NCT03613129|38749862|FG000|Pre-treatment Assessment|Protocol Violation|2|||
16070624|NCT03613129|38749863|FG001|Pre-treatment Assessment|Protocol Violation|0|||
16070625|NCT03613129|38749864|FG002|Pre-treatment Assessment|Protocol Violation|0|||
16070626|NCT03613129|38749865|FG003|Pre-treatment Assessment|Protocol Violation|0|||
16070627|NCT03613129|38749866|FG004|Pre-treatment Assessment|Protocol Violation|0|||
16070628|NCT03613129|38749862|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
16070629|NCT03613129|38749863|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
16070630|NCT03613129|38749864|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
16070631|NCT03613129|38749865|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
16070632|NCT03613129|38749866|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
16070633|NCT01616654|38749867|FG000|Overall Study|Lack of Efficacy|1|||
16070634|NCT01616654|38749868|FG001|Overall Study|Lack of Efficacy|0|||
16070635|NCT01616654|38749869|FG002|Overall Study|Lack of Efficacy|0|||
16070636|NCT01616654|38749870|FG003|Overall Study|Lack of Efficacy|0|||
16070637|NCT01616654|38749871|FG004|Overall Study|Lack of Efficacy|1|||
16070638|NCT01616654|38749867|FG000|Overall Study|Adverse Event|0|||
16264888|NCT01597245|39453272|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
16070639|NCT01616654|38749868|FG001|Overall Study|Adverse Event|1|||
16070640|NCT01616654|38749869|FG002|Overall Study|Adverse Event|2|||
16070641|NCT01616654|38749870|FG003|Overall Study|Adverse Event|1|||
16070642|NCT01616654|38749871|FG004|Overall Study|Adverse Event|0|||
16070643|NCT01616654|38749867|FG000|Overall Study|Withdrawal by Subject|2|||
16070644|NCT01616654|38749868|FG001|Overall Study|Withdrawal by Subject|2|||
16070645|NCT01616654|38749869|FG002|Overall Study|Withdrawal by Subject|3|||
16070646|NCT01616654|38749870|FG003|Overall Study|Withdrawal by Subject|1|||
16070647|NCT01616654|38749871|FG004|Overall Study|Withdrawal by Subject|5|||
16070648|NCT01616654|38749867|FG000|Overall Study|Protocol Violation|0|||
16070649|NCT01616654|38749868|FG001|Overall Study|Protocol Violation|5|||
16070650|NCT01616654|38749869|FG002|Overall Study|Protocol Violation|2|||
16070651|NCT01616654|38749870|FG003|Overall Study|Protocol Violation|4|||
16070652|NCT01616654|38749871|FG004|Overall Study|Protocol Violation|4|||
16070653|NCT01616654|38749867|FG000|Overall Study|Lost to Follow-up|1|||
16070654|NCT01616654|38749868|FG001|Overall Study|Lost to Follow-up|0|||
16070655|NCT01616654|38749869|FG002|Overall Study|Lost to Follow-up|3|||
16070656|NCT01616654|38749870|FG003|Overall Study|Lost to Follow-up|2|||
16070657|NCT01616654|38749871|FG004|Overall Study|Lost to Follow-up|1|||
16070658|NCT01616654|38749867|FG000|Overall Study|Pregnancy|1|||
16070659|NCT01616654|38749868|FG001|Overall Study|Pregnancy|0|||
16070660|NCT01616654|38749869|FG002|Overall Study|Pregnancy|0|||
16070661|NCT01616654|38749870|FG003|Overall Study|Pregnancy|0|||
16070662|NCT01616654|38749871|FG004|Overall Study|Pregnancy|1|||
16070663|NCT02107014|38749872|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
16070664|NCT01981356|38749876|FG000|Overall Study|Lost to Follow-up|4|||
16070665|NCT01981356|38749877|FG001|Overall Study|Lost to Follow-up|1|||
16070666|NCT01981356|38749876|FG000|Overall Study|Withdrawal by Subject|1|||
16070667|NCT01981356|38749877|FG001|Overall Study|Withdrawal by Subject|1|||
16372440|NCT02037984|39849635|FG000|Overall Study|Lack of Efficacy|0|||
16372441|NCT02037984|39849636|FG001|Overall Study|Lack of Efficacy|0|||
16372442|NCT02037984|39849637|FG002|Overall Study|Lack of Efficacy|3|||
16372443|NCT02037984|39849638|FG003|Overall Study|Lack of Efficacy|10|||
16372444|NCT02037984|39849639|FG004|Overall Study|Lack of Efficacy|2|||
16372445|NCT02037984|39849640|FG005|Overall Study|Lack of Efficacy|2|||
16372446|NCT02037984|39849641|FG006|Overall Study|Lack of Efficacy|4|||
16372447|NCT02037984|39849642|FG007|Overall Study|Lack of Efficacy|3|||
16372448|NCT02037984|39849635|FG000|Overall Study|Lost to Follow-up|1|||
16372449|NCT02037984|39849636|FG001|Overall Study|Lost to Follow-up|0|||
16372450|NCT02037984|39849637|FG002|Overall Study|Lost to Follow-up|3|||
16372451|NCT02037984|39849638|FG003|Overall Study|Lost to Follow-up|5|||
16372452|NCT02037984|39849639|FG004|Overall Study|Lost to Follow-up|2|||
16372453|NCT02037984|39849640|FG005|Overall Study|Lost to Follow-up|2|||
16372454|NCT02037984|39849641|FG006|Overall Study|Lost to Follow-up|2|||
16372455|NCT02037984|39849642|FG007|Overall Study|Lost to Follow-up|4|||
16372456|NCT02037984|39849635|FG000|Overall Study|Physician Decision|0|||
16372457|NCT02037984|39849636|FG001|Overall Study|Physician Decision|0|||
16372458|NCT02037984|39849637|FG002|Overall Study|Physician Decision|0|||
16372459|NCT02037984|39849638|FG003|Overall Study|Physician Decision|0|||
16372460|NCT02037984|39849639|FG004|Overall Study|Physician Decision|0|||
16372461|NCT02037984|39849640|FG005|Overall Study|Physician Decision|0|||
16372462|NCT02037984|39849641|FG006|Overall Study|Physician Decision|1|||
16372463|NCT02037984|39849642|FG007|Overall Study|Physician Decision|0|||
16372464|NCT02037984|39849635|FG000|Overall Study|Protocol Violation|0|||
16372465|NCT02037984|39849636|FG001|Overall Study|Protocol Violation|0|||
16372466|NCT02037984|39849637|FG002|Overall Study|Protocol Violation|0|||
16372467|NCT02037984|39849638|FG003|Overall Study|Protocol Violation|0|||
16372468|NCT02037984|39849639|FG004|Overall Study|Protocol Violation|0|||
16372469|NCT02037984|39849640|FG005|Overall Study|Protocol Violation|1|||
16372470|NCT02037984|39849641|FG006|Overall Study|Protocol Violation|2|||
16372471|NCT02037984|39849642|FG007|Overall Study|Protocol Violation|0|||
16372472|NCT02037984|39849635|FG000|Overall Study|Technical Problems|0|||
16372473|NCT02037984|39849636|FG001|Overall Study|Technical Problems|0|||
16372474|NCT02037984|39849637|FG002|Overall Study|Technical Problems|3|||
16372475|NCT02037984|39849638|FG003|Overall Study|Technical Problems|3|||
16372476|NCT02037984|39849639|FG004|Overall Study|Technical Problems|2|||
16372477|NCT02037984|39849640|FG005|Overall Study|Technical Problems|3|||
16372478|NCT02037984|39849641|FG006|Overall Study|Technical Problems|4|||
16372479|NCT02037984|39849642|FG007|Overall Study|Technical Problems|2|||
16372480|NCT02037984|39849635|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16372481|NCT02037984|39849636|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
16372482|NCT02037984|39849637|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
16372483|NCT02037984|39849638|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
16070668|NCT01981356|38749876|FG000|Overall Study|Protocol Violation|2|||
16070669|NCT01981356|38749877|FG001|Overall Study|Protocol Violation|0|||
16070670|NCT01670019|38749884|FG000|Overall Study|Adverse Event|3|||
16070671|NCT01670019|38749885|FG001|Overall Study|Adverse Event|0|||
16372484|NCT02037984|39849639|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
16372485|NCT02037984|39849640|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
16070672|NCT01670019|38749884|FG000|Overall Study|Withdrawal by Subject|6|||
16070673|NCT01670019|38749885|FG001|Overall Study|Withdrawal by Subject|0|||
16372486|NCT02037984|39849641|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
16372487|NCT02037984|39849642|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
16372488|NCT02037984|39849635|FG000|Overall Study|Withdrawal by Subject|0|||
16372489|NCT02037984|39849636|FG001|Overall Study|Withdrawal by Subject|0|||
16372490|NCT02037984|39849637|FG002|Overall Study|Withdrawal by Subject|0|||
16372491|NCT02037984|39849638|FG003|Overall Study|Withdrawal by Subject|1|||
16372492|NCT02037984|39849639|FG004|Overall Study|Withdrawal by Subject|1|||
16372493|NCT02037984|39849640|FG005|Overall Study|Withdrawal by Subject|3|||
16372494|NCT02037984|39849641|FG006|Overall Study|Withdrawal by Subject|0|||
16372495|NCT02037984|39849642|FG007|Overall Study|Withdrawal by Subject|1|||
16372496|NCT02383173|39849643|FG000|Overall Study|Palliative Care Team withdrew|0|||
16372497|NCT02383173|39849644|FG001|Overall Study|Palliative Care Team withdrew|2|||
16372498|NCT00974233|39849645|FG000|Induction Chemoimmunotherapy|Death|2|||
16372499|NCT00974233|39849645|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
16372500|NCT00974233|39849645|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
16372501|NCT00974233|39849645|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
16372502|NCT00974233|39849645|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
16372503|NCT00974233|39849645|FG000|Maintenance Lenalidomide|Adverse Event|8|||
16372504|NCT02181621|39849647|FG000|Overall Study|Adverse Event|1|||
16372505|NCT02181621|39849648|FG001|Overall Study|Adverse Event|0|||
16372506|NCT02181621|39849647|FG000|Overall Study|Previously Enrolled|0|||
16372507|NCT02181621|39849648|FG001|Overall Study|Previously Enrolled|1|||
16372508|NCT02181621|39849647|FG000|Overall Study|Enrollment Hold|1|||
16372509|NCT02181621|39849648|FG001|Overall Study|Enrollment Hold|1|||
16372510|NCT01160744|39849651|FG000|Overall Study|Withdrawal by Subject|11|||
16372511|NCT01160744|39849652|FG001|Overall Study|Withdrawal by Subject|5|||
16372512|NCT01160744|39849653|FG002|Overall Study|Withdrawal by Subject|6|||
16372513|NCT01160744|39849654|FG003|Overall Study|Withdrawal by Subject|4|||
16372514|NCT01160744|39849651|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
16372515|NCT01160744|39849652|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
16372516|NCT01160744|39849653|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
16372517|NCT01160744|39849654|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
16448179|NCT02113982|40122111|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16448180|NCT02113982|40122112|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
16448181|NCT02113982|40122113|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16448182|NCT02113982|40122114|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16448183|NCT02113982|40122115|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16448184|NCT02113982|40122116|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16448185|NCT02113982|40122117|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16448186|NCT02113982|40122118|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
16070674|NCT03107611|38749886|FG000|Overall Study|Adverse Event|1|||
16070675|NCT03107611|38749887|FG001|Overall Study|Adverse Event|0|||
16070676|NCT03107611|38749888|FG002|Overall Study|Adverse Event|2|||
16070677|NCT03107611|38749886|FG000|Overall Study|Lost to Follow-up|3|||
16070678|NCT03107611|38749887|FG001|Overall Study|Lost to Follow-up|3|||
16448187|NCT02113982|40122105|FG000|Stage 2: Cohort Expansion|Transplant|0|||
16448188|NCT02113982|40122106|FG001|Stage 2: Cohort Expansion|Transplant|0|||
16448189|NCT02113982|40122107|FG002|Stage 2: Cohort Expansion|Transplant|0|||
16448190|NCT02113982|40122108|FG003|Stage 2: Cohort Expansion|Transplant|0|||
16448191|NCT02113982|40122109|FG004|Stage 2: Cohort Expansion|Transplant|0|||
16448192|NCT02113982|40122110|FG005|Stage 2: Cohort Expansion|Transplant|0|||
16070679|NCT03107611|38749888|FG002|Overall Study|Lost to Follow-up|3|||
16070680|NCT03107611|38749886|FG000|Overall Study|Protocol Violation|0|||
16070681|NCT03107611|38749887|FG001|Overall Study|Protocol Violation|0|||
16070682|NCT03107611|38749888|FG002|Overall Study|Protocol Violation|1|||
16070683|NCT03107611|38749886|FG000|Overall Study|Withdrawal by Subject|1|||
16070684|NCT03107611|38749887|FG001|Overall Study|Withdrawal by Subject|0|||
16070685|NCT03107611|38749888|FG002|Overall Study|Withdrawal by Subject|1|||
16070686|NCT03107611|38749886|FG000|Overall Study|Worsening signs/symptoms|2|||
16070687|NCT03107611|38749887|FG001|Overall Study|Worsening signs/symptoms|1|||
16070688|NCT03107611|38749888|FG002|Overall Study|Worsening signs/symptoms|2|||
16372518|NCT02916433|39849658|FG000|Overall Study|Withdrawal by Subject|1|||
16372519|NCT02916433|39849659|FG001|Overall Study|Withdrawal by Subject|0|||
16372520|NCT02916433|39849658|FG000|Overall Study|Physician Decision|1|||
16372521|NCT02916433|39849659|FG001|Overall Study|Physician Decision|0|||
16372522|NCT00655746|39849660|FG000|Overall Study|Withdrawal by Subject|1|||
16372523|NCT00145327|39849664|FG000|Overall Study|Withdrawal by Subject|77|||
16070689|NCT02013037|38749889|FG000|Overall Study|Death|6|||
16372524|NCT00145327|39849665|FG001|Overall Study|Withdrawal by Subject|72|||
16372525|NCT00145327|39849666|FG002|Overall Study|Withdrawal by Subject|164|||
16372526|NCT00145327|39849664|FG000|Overall Study|Death|26|||
16372527|NCT00145327|39849665|FG001|Overall Study|Death|18|||
16372528|NCT00145327|39849666|FG002|Overall Study|Death|30|||
16372529|NCT00145327|39849664|FG000|Overall Study|Adverse Event|14|||
16372530|NCT00145327|39849665|FG001|Overall Study|Adverse Event|11|||
16448193|NCT02113982|40122111|FG006|Stage 2: Cohort Expansion|Transplant|0|||
16448194|NCT02113982|40122112|FG007|Stage 2: Cohort Expansion|Transplant|0|||
16448195|NCT02113982|40122113|FG008|Stage 2: Cohort Expansion|Transplant|0|||
16448196|NCT02113982|40122114|FG009|Stage 2: Cohort Expansion|Transplant|4|||
16448197|NCT02113982|40122115|FG010|Stage 2: Cohort Expansion|Transplant|2|||
16448198|NCT02113982|40122116|FG011|Stage 2: Cohort Expansion|Transplant|0|||
16448199|NCT02113982|40122117|FG012|Stage 2: Cohort Expansion|Transplant|0|||
16448200|NCT02113982|40122118|FG013|Stage 2: Cohort Expansion|Transplant|0|||
16448201|NCT02113982|40122105|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
16448202|NCT02113982|40122106|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
16448203|NCT02113982|40122107|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
16448204|NCT02113982|40122108|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
16448205|NCT02113982|40122109|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
16448206|NCT02113982|40122110|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
16448207|NCT02113982|40122111|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
16448208|NCT02113982|40122112|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
16448209|NCT02113982|40122113|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
16448210|NCT02113982|40122114|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
16448211|NCT02113982|40122115|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
16070690|NCT02013037|38749889|FG000|Overall Study|Withdrawal by Subject|1|||
16070691|NCT02013037|38749889|FG000|Overall Study|Awaiting Transplantation|7|||
16070692|NCT02013037|38749889|FG000|Overall Study|Transplanted without DSA|2|||
16372531|NCT00145327|39849666|FG002|Overall Study|Adverse Event|22|||
16372532|NCT00145327|39849664|FG000|Overall Study|Lost to Follow-up|9|||
16372533|NCT00145327|39849665|FG001|Overall Study|Lost to Follow-up|14|||
16372534|NCT00145327|39849666|FG002|Overall Study|Lost to Follow-up|14|||
16372535|NCT00145327|39849664|FG000|Overall Study|Administrative problems|12|||
16372536|NCT00145327|39849665|FG001|Overall Study|Administrative problems|9|||
16372537|NCT00145327|39849666|FG002|Overall Study|Administrative problems|13|||
16372538|NCT00145327|39849664|FG000|Overall Study|Protocol Violation|2|||
16372539|NCT00145327|39849665|FG001|Overall Study|Protocol Violation|0|||
16372540|NCT00145327|39849666|FG002|Overall Study|Protocol Violation|2|||
16372541|NCT00145327|39849664|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16372542|NCT00145327|39849665|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16372543|NCT00145327|39849666|FG002|Overall Study|Abnormal laboratory value(s)|2|||
16372544|NCT00145327|39849664|FG000|Overall Study|Missing - not stated|1|||
16372545|NCT00145327|39849665|FG001|Overall Study|Missing - not stated|0|||
16372546|NCT00145327|39849666|FG002|Overall Study|Missing - not stated|1|||
16372547|NCT02769481|39849667|FG000|Overall Study|Protocol Violation|1|||
16372548|NCT02769481|39849668|FG001|Overall Study|Protocol Violation|0|||
16372549|NCT02769481|39849667|FG000|Overall Study|Adverse Event|3|||
16372550|NCT02769481|39849668|FG001|Overall Study|Adverse Event|6|||
16372551|NCT02769481|39849667|FG000|Overall Study|Entry Criteria Not Met|1|||
16372552|NCT02769481|39849668|FG001|Overall Study|Entry Criteria Not Met|2|||
16372553|NCT02769481|39849667|FG000|Overall Study|Withdrawal by Subject|14|||
16372554|NCT02769481|39849668|FG001|Overall Study|Withdrawal by Subject|16|||
16372555|NCT02769481|39849667|FG000|Overall Study|Lost to Follow-up|9|||
16372556|NCT02769481|39849668|FG001|Overall Study|Lost to Follow-up|9|||
16372557|NCT02769481|39849667|FG000|Overall Study|Physician Decision|0|||
16372558|NCT02769481|39849668|FG001|Overall Study|Physician Decision|1|||
16372559|NCT02769481|39849667|FG000|Overall Study|Terminated by Sponsor|1|||
16372560|NCT02769481|39849668|FG001|Overall Study|Terminated by Sponsor|0|||
16372561|NCT02769481|39849667|FG000|Overall Study|Death|0|||
16372562|NCT02769481|39849668|FG001|Overall Study|Death|1|||
16372563|NCT02769481|39849667|FG000|Overall Study|Undefined|4|||
16372564|NCT02769481|39849668|FG001|Overall Study|Undefined|1|||
16372565|NCT02569242|39849669|FG000|Overall Study|Death|1|||
16372566|NCT02569242|39849670|FG001|Overall Study|Death|0|||
16372567|NCT02569242|39849669|FG000|Overall Study|Withdrawal by Subject|0|||
16372568|NCT02569242|39849670|FG001|Overall Study|Withdrawal by Subject|1|||
16372569|NCT03931785|39849671|FG000|Overall Study|Lost to Follow-up|4|||
16372570|NCT03931785|39849672|FG001|Overall Study|Lost to Follow-up|1|||
16372571|NCT03931785|39849673|FG002|Overall Study|Lost to Follow-up|4|||
16070693|NCT02359435|38749890|FG000|Overall Study|Lost to Follow-up|4|||
16070694|NCT02359435|38749891|FG001|Overall Study|Lost to Follow-up|4|||
16070695|NCT01977612|38749892|FG000|Overall Study|Lost to Follow-up|1|||
16070696|NCT01977612|38749893|FG001|Overall Study|Lost to Follow-up|1|||
16070697|NCT02282527|38749894|FG000|Overall Study|Lost to Follow-up|0|||
16070698|NCT02282527|38749895|FG001|Overall Study|Lost to Follow-up|1|||
16070699|NCT02282527|38749894|FG000|Overall Study|Lack of home health aid|1|||
16372572|NCT03931785|39849674|FG003|Overall Study|Lost to Follow-up|3|||
16372573|NCT03931785|39849671|FG000|Overall Study|Adverse Event|1|||
16372574|NCT03931785|39849672|FG001|Overall Study|Adverse Event|0|||
16372575|NCT03931785|39849673|FG002|Overall Study|Adverse Event|3|||
16372576|NCT03931785|39849674|FG003|Overall Study|Adverse Event|4|||
16372577|NCT03931785|39849671|FG000|Overall Study|Protocol Violation|0|||
16448212|NCT02113982|40122116|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
16448213|NCT02113982|40122117|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
16161709|NCT00818259|39072477|FG007|Part II|Lack of Efficacy|0|||
16161710|NCT00818259|39072478|FG008|Part II|Lack of Efficacy|0|||
16161711|NCT00818259|39072470|FG000|Part II|Not Treated|0|||
16161712|NCT00818259|39072471|FG001|Part II|Not Treated|0|||
16161713|NCT00818259|39072472|FG002|Part II|Not Treated|0|||
16161714|NCT00818259|39072473|FG003|Part II|Not Treated|1|||
16161715|NCT00818259|39072474|FG004|Part II|Not Treated|0|||
16161716|NCT00818259|39072475|FG005|Part II|Not Treated|0|||
16161717|NCT00818259|39072476|FG006|Part II|Not Treated|0|||
16161718|NCT00818259|39072477|FG007|Part II|Not Treated|0|||
16161719|NCT00818259|39072478|FG008|Part II|Not Treated|0|||
16161720|NCT00818259|39072470|FG000|Part IV|Physician Decision|0|||
16161721|NCT00818259|39072471|FG001|Part IV|Physician Decision|0|||
16161722|NCT00818259|39072472|FG002|Part IV|Physician Decision|0|||
16070700|NCT02282527|38749895|FG001|Overall Study|Lack of home health aid|0|||
16070701|NCT01729819|38749896|FG000|Overall Study|Adverse Event|2|||
16070702|NCT01729819|38749897|FG001|Overall Study|Adverse Event|4|||
16070703|NCT01729819|38749896|FG000|Overall Study|Lack of Efficacy|1|||
16070704|NCT01729819|38749897|FG001|Overall Study|Lack of Efficacy|0|||
16070705|NCT01729819|38749896|FG000|Overall Study|Lost to Follow-up|2|||
16070706|NCT01729819|38749897|FG001|Overall Study|Lost to Follow-up|0|||
16070707|NCT01729819|38749896|FG000|Overall Study|Other reason|1|||
16070708|NCT01729819|38749897|FG001|Overall Study|Other reason|0|||
16070709|NCT01729819|38749896|FG000|Overall Study|Protocol Violation|0|||
16070710|NCT01729819|38749897|FG001|Overall Study|Protocol Violation|1|||
16070711|NCT01729819|38749896|FG000|Overall Study|Withdrawal by Subject|0|||
16070712|NCT01729819|38749897|FG001|Overall Study|Withdrawal by Subject|2|||
16070713|NCT00853827|38749904|FG000|Single Blind Period (1 Week)|Other|4|||
16070714|NCT00853827|38749905|FG001|Single Blind Period (1 Week)|Other|0|||
16070715|NCT00853827|38749904|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
16070716|NCT00853827|38749905|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
16070717|NCT00853827|38749904|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
16070718|NCT00853827|38749905|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
16070719|NCT00853827|38749904|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
16070720|NCT00853827|38749905|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
16070721|NCT00853827|38749904|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
16070722|NCT00853827|38749905|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
16070723|NCT00853827|38749904|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
16070724|NCT00853827|38749905|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
16070725|NCT00853827|38749904|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
16070726|NCT00853827|38749905|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
16070727|NCT00853827|38749904|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
16070728|NCT00853827|38749905|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
16070729|NCT00853827|38749904|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
16070730|NCT00853827|38749905|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
16070731|NCT00853827|38749904|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
16070732|NCT00853827|38749905|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
16070733|NCT00853827|38749904|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
16070734|NCT00853827|38749905|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
16070735|NCT00853827|38749904|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
16070736|NCT00853827|38749905|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
16070737|NCT00853827|38749904|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
16070738|NCT00853827|38749905|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
16070739|NCT00853827|38749904|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
16070740|NCT00853827|38749905|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
16070741|NCT00853827|38749904|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
16070742|NCT00853827|38749905|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
16070743|NCT00853827|38749904|FG000|Double Blind Period (103 Weeks)|Death|1|||
16070744|NCT00853827|38749905|FG001|Double Blind Period (103 Weeks)|Death|6|||
16070745|NCT00364286|38749912|FG000|Overall Study|Withdrawal by Subject|1|||
16070746|NCT00364286|38749912|FG000|Overall Study|Adverse Event|2|||
16070747|NCT01145885|38749920|FG000|Overall Study|Progressive Disease|7|||
16070748|NCT01211665|38749921|FG000|Overall Study|Withdrawal by Subject|1|||
16161723|NCT00818259|39072473|FG003|Part IV|Physician Decision|0|||
16161724|NCT00818259|39072474|FG004|Part IV|Physician Decision|0|||
16161725|NCT00818259|39072475|FG005|Part IV|Physician Decision|1|||
16161726|NCT00818259|39072476|FG006|Part IV|Physician Decision|0|||
16372578|NCT03931785|39849672|FG001|Overall Study|Protocol Violation|1|||
16372579|NCT03931785|39849673|FG002|Overall Study|Protocol Violation|0|||
16070749|NCT01211665|38749922|FG001|Overall Study|Withdrawal by Subject|0|||
16070750|NCT01211665|38749921|FG000|Overall Study|Death|1|||
16070751|NCT01211665|38749922|FG001|Overall Study|Death|0|||
16161727|NCT00818259|39072477|FG007|Part IV|Physician Decision|0|||
16161728|NCT00818259|39072478|FG008|Part IV|Physician Decision|0|||
16161729|NCT00818259|39072470|FG000|Part V|Adverse Event|0|||
16372580|NCT03931785|39849674|FG003|Overall Study|Protocol Violation|0|||
16372581|NCT03931785|39849671|FG000|Overall Study|Noncompliance With Study drug|0|||
16372582|NCT03931785|39849672|FG001|Overall Study|Noncompliance With Study drug|1|||
16372583|NCT03931785|39849673|FG002|Overall Study|Noncompliance With Study drug|0|||
16372584|NCT03931785|39849674|FG003|Overall Study|Noncompliance With Study drug|0|||
16372585|NCT03931785|39849671|FG000|Overall Study|Other Not specified|0|||
16372586|NCT03931785|39849672|FG001|Overall Study|Other Not specified|2|||
16372587|NCT03931785|39849673|FG002|Overall Study|Other Not specified|2|||
16372588|NCT03931785|39849674|FG003|Overall Study|Other Not specified|2|||
16372589|NCT03931785|39849671|FG000|Overall Study|Withdrawal by Subject|0|||
16372590|NCT03931785|39849672|FG001|Overall Study|Withdrawal by Subject|2|||
16372591|NCT03931785|39849673|FG002|Overall Study|Withdrawal by Subject|4|||
16372592|NCT03931785|39849674|FG003|Overall Study|Withdrawal by Subject|1|||
16372593|NCT03931785|39849671|FG000|Overall Study|Pregnancy|0|||
16372594|NCT03931785|39849672|FG001|Overall Study|Pregnancy|0|||
16372595|NCT03931785|39849673|FG002|Overall Study|Pregnancy|0|||
16372596|NCT03931785|39849674|FG003|Overall Study|Pregnancy|1|||
16372597|NCT03315689|39849675|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
16372598|NCT03315689|39849676|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
16372599|NCT03315689|39849675|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
16372600|NCT03315689|39849676|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
16372601|NCT03315689|39849675|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
16372602|NCT03315689|39849676|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
16372603|NCT04621786|39849677|FG000|Overall Study|Lost to Follow-up|9|||
16372604|NCT04621786|39849677|FG000|Overall Study|Protocol Violation|3|||
16372605|NCT03888482|39849678|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
16372606|NCT03888482|39849679|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
16372607|NCT03888482|39849678|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
16372608|NCT03888482|39849679|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
16372609|NCT00803049|39849681|FG000|Overall Study|Adverse Event|21|||
16372610|NCT00803049|39849682|FG001|Overall Study|Adverse Event|33|||
16372611|NCT00803049|39849683|FG002|Overall Study|Adverse Event|13|||
16372612|NCT00803049|39849684|FG003|Overall Study|Adverse Event|27|||
16372613|NCT00803049|39849681|FG000|Overall Study|Lack of Efficacy|10|||
16372614|NCT00803049|39849682|FG001|Overall Study|Lack of Efficacy|19|||
16372615|NCT00803049|39849683|FG002|Overall Study|Lack of Efficacy|6|||
16372616|NCT00803049|39849684|FG003|Overall Study|Lack of Efficacy|13|||
16372617|NCT00803049|39849681|FG000|Overall Study|Lost to Follow-up|0|||
16372618|NCT00803049|39849682|FG001|Overall Study|Lost to Follow-up|2|||
16372619|NCT00803049|39849683|FG002|Overall Study|Lost to Follow-up|0|||
16372620|NCT00803049|39849684|FG003|Overall Study|Lost to Follow-up|3|||
16372621|NCT00803049|39849681|FG000|Overall Study|Death|2|||
16372622|NCT00803049|39849682|FG001|Overall Study|Death|1|||
16372623|NCT00803049|39849683|FG002|Overall Study|Death|0|||
16372624|NCT00803049|39849684|FG003|Overall Study|Death|2|||
16372625|NCT00803049|39849681|FG000|Overall Study|Progressive Disease|6|||
16372626|NCT00803049|39849682|FG001|Overall Study|Progressive Disease|10|||
16372627|NCT00803049|39849683|FG002|Overall Study|Progressive Disease|6|||
16070752|NCT00290706|38749927|FG000|Overall Study|Withdrawal by Subject|2|||
16070753|NCT00290706|38749928|FG001|Overall Study|Withdrawal by Subject|0|||
16070754|NCT00290706|38749929|FG002|Overall Study|Withdrawal by Subject|0|||
16070755|NCT00290706|38749930|FG003|Overall Study|Withdrawal by Subject|0|||
16070756|NCT00290706|38749927|FG000|Overall Study|Progressive Disease|3|||
16070757|NCT00290706|38749928|FG001|Overall Study|Progressive Disease|5|||
16070758|NCT00290706|38749929|FG002|Overall Study|Progressive Disease|4|||
16070759|NCT00290706|38749930|FG003|Overall Study|Progressive Disease|10|||
16070760|NCT00290706|38749927|FG000|Overall Study|Adverse Event|0|||
16070761|NCT00290706|38749928|FG001|Overall Study|Adverse Event|1|||
16070762|NCT00290706|38749929|FG002|Overall Study|Adverse Event|2|||
16070763|NCT00290706|38749930|FG003|Overall Study|Adverse Event|0|||
16070764|NCT00290706|38749927|FG000|Overall Study|Receive auto transplant or radiation|0|||
16070765|NCT00290706|38749928|FG001|Overall Study|Receive auto transplant or radiation|0|||
16070766|NCT00290706|38749929|FG002|Overall Study|Receive auto transplant or radiation|0|||
16070767|NCT00290706|38749930|FG003|Overall Study|Receive auto transplant or radiation|1|||
16070768|NCT00290706|38749927|FG000|Overall Study|Physician Decision|0|||
16070769|NCT00290706|38749928|FG001|Overall Study|Physician Decision|0|||
16070770|NCT00290706|38749929|FG002|Overall Study|Physician Decision|0|||
16070771|NCT00290706|38749930|FG003|Overall Study|Physician Decision|1|||
16372628|NCT00803049|39849684|FG003|Overall Study|Progressive Disease|6|||
16372629|NCT00803049|39849681|FG000|Overall Study|Withdrawal by Subject|19|||
16372630|NCT00803049|39849682|FG001|Overall Study|Withdrawal by Subject|43|||
16372631|NCT00803049|39849683|FG002|Overall Study|Withdrawal by Subject|16|||
16372632|NCT00803049|39849684|FG003|Overall Study|Withdrawal by Subject|44|||
16372633|NCT00803049|39849681|FG000|Overall Study|Protocol Violation|0|||
16070772|NCT01981954|38749935|FG000|Titration Period|Protocol Deviation|1|||
16070773|NCT01981954|38749935|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
16264889|NCT01597245|39453273|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
16070774|NCT04310579|38749936|FG000|Overall Study|Adverse Event|0|||
16070775|NCT04310579|38749937|FG001|Overall Study|Adverse Event|0|||
16372634|NCT00803049|39849682|FG001|Overall Study|Protocol Violation|1|||
16372635|NCT00803049|39849683|FG002|Overall Study|Protocol Violation|1|||
16372636|NCT00803049|39849684|FG003|Overall Study|Protocol Violation|0|||
16372637|NCT00803049|39849681|FG000|Overall Study|Randomized and Not Treated|0|||
16372638|NCT00803049|39849682|FG001|Overall Study|Randomized and Not Treated|0|||
16372639|NCT00803049|39849683|FG002|Overall Study|Randomized and Not Treated|0|||
16372640|NCT00803049|39849684|FG003|Overall Study|Randomized and Not Treated|2|||
16372641|NCT00803049|39849681|FG000|Overall Study|Other than Specified Above|3|||
16372642|NCT00803049|39849682|FG001|Overall Study|Other than Specified Above|9|||
16372643|NCT00803049|39849683|FG002|Overall Study|Other than Specified Above|2|||
16372644|NCT00803049|39849684|FG003|Overall Study|Other than Specified Above|5|||
16372645|NCT00985192|39849689|FG000|Overall Study|Withdrawal by Subject|1|||
16161730|NCT00818259|39072471|FG001|Part V|Adverse Event|0|||
16161731|NCT00818259|39072472|FG002|Part V|Adverse Event|0|||
16161732|NCT00818259|39072473|FG003|Part V|Adverse Event|0|||
16161733|NCT00818259|39072474|FG004|Part V|Adverse Event|0|||
16161734|NCT00818259|39072475|FG005|Part V|Adverse Event|0|||
16161735|NCT00818259|39072476|FG006|Part V|Adverse Event|0|||
16161736|NCT00818259|39072477|FG007|Part V|Adverse Event|1|||
16372646|NCT00985192|39849689|FG000|Overall Study|Disease Progression|1|||
16372647|NCT00985192|39849689|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
16372648|NCT00965094|39849690|FG000|Overall Study|Adverse Event|5|||
16372649|NCT00965094|39849691|FG001|Overall Study|Adverse Event|0|||
16372650|NCT00965094|39849690|FG000|Overall Study|Lost to Follow-up|0|||
16372651|NCT00965094|39849691|FG001|Overall Study|Lost to Follow-up|1|||
16372652|NCT01392495|39849692|FG000|Overall Study|Death|3|||
16372653|NCT01392495|39849692|FG000|Overall Study|Administrative problems|8|||
16372654|NCT01392495|39849692|FG000|Overall Study|Withdrawal by Subject|2|||
16070776|NCT04310579|38749938|FG002|Overall Study|Adverse Event|0|||
16070777|NCT04310579|38749939|FG003|Overall Study|Adverse Event|0|||
16070778|NCT04310579|38749940|FG004|Overall Study|Adverse Event|0|||
16070779|NCT04310579|38749941|FG005|Overall Study|Adverse Event|0|||
16070780|NCT04310579|38749942|FG006|Overall Study|Adverse Event|2|||
16070781|NCT04310579|38749943|FG007|Overall Study|Adverse Event|0|||
16070782|NCT04310579|38749944|FG008|Overall Study|Adverse Event|1|||
16070783|NCT04310579|38749945|FG009|Overall Study|Adverse Event|1|||
16070784|NCT04310579|38749946|FG010|Overall Study|Adverse Event|0|||
16070785|NCT04310579|38749936|FG000|Overall Study|Withdrawal by Subject|0|||
16070786|NCT04310579|38749937|FG001|Overall Study|Withdrawal by Subject|0|||
16070787|NCT04310579|38749938|FG002|Overall Study|Withdrawal by Subject|0|||
16070788|NCT04310579|38749939|FG003|Overall Study|Withdrawal by Subject|0|||
16070789|NCT04310579|38749940|FG004|Overall Study|Withdrawal by Subject|0|||
16070790|NCT04310579|38749941|FG005|Overall Study|Withdrawal by Subject|1|||
16070791|NCT04310579|38749942|FG006|Overall Study|Withdrawal by Subject|0|||
16070792|NCT04310579|38749943|FG007|Overall Study|Withdrawal by Subject|0|||
16070793|NCT04310579|38749944|FG008|Overall Study|Withdrawal by Subject|0|||
16070794|NCT04310579|38749945|FG009|Overall Study|Withdrawal by Subject|0|||
16070795|NCT04310579|38749946|FG010|Overall Study|Withdrawal by Subject|0|||
16372655|NCT01392495|39849692|FG000|Overall Study|Adverse Event|3|||
16372656|NCT00799864|39849695|FG000|Overall Study|Participant reached a virologic endpoint|9|||
16372657|NCT00799864|39849696|FG001|Overall Study|Participant reached a virologic endpoint|2|||
16372658|NCT00799864|39849697|FG002|Overall Study|Participant reached a virologic endpoint|2|||
16372659|NCT00799864|39849698|FG003|Overall Study|Participant reached a virologic endpoint|0|||
16372660|NCT00799864|39849699|FG004|Overall Study|Participant reached a virologic endpoint|0|||
16372661|NCT00799864|39849695|FG000|Overall Study|Other|2|||
16372662|NCT00799864|39849696|FG001|Overall Study|Other|1|||
16372663|NCT00799864|39849697|FG002|Overall Study|Other|0|||
16372664|NCT00799864|39849698|FG003|Overall Study|Other|0|||
16372665|NCT00799864|39849699|FG004|Overall Study|Other|0|||
16372666|NCT03467945|39849700|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16372667|NCT03467945|39849701|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16372668|NCT03467945|39849702|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16372669|NCT03467945|39849703|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16372670|NCT03467945|39849700|FG000|Treatment Period 3|Withdrawal by Subject|1|||
16070796|NCT04310579|38749936|FG000|Overall Study|Positive COVID-19 test|0|||
16161737|NCT00818259|39072478|FG008|Part V|Adverse Event|0|||
16161738|NCT01557166|39072479|FG000|Overall Study|Adverse Event|20|||
16161739|NCT01557166|39072480|FG001|Overall Study|Adverse Event|6|||
16372671|NCT03467945|39849701|FG001|Treatment Period 3|Withdrawal by Subject|0|||
16372672|NCT03467945|39849702|FG002|Treatment Period 3|Withdrawal by Subject|2|||
16372673|NCT03467945|39849703|FG003|Treatment Period 3|Withdrawal by Subject|1|||
16070797|NCT04310579|38749937|FG001|Overall Study|Positive COVID-19 test|0|||
16161740|NCT01557166|39072479|FG000|Overall Study|Lack of Efficacy|2|||
16161741|NCT01557166|39072480|FG001|Overall Study|Lack of Efficacy|1|||
16161742|NCT01557166|39072479|FG000|Overall Study|Protocol Violation|8|||
16372674|NCT02301429|39849706|FG000|Overall Study|not acceptable vascular anatomy|3|||
16372675|NCT04560309|39849707|FG000|Overall Study|Meet drop out criteria|1|||
16372676|NCT04560309|39849708|FG001|Overall Study|Meet drop out criteria|1|||
16070798|NCT04310579|38749938|FG002|Overall Study|Positive COVID-19 test|0|||
16070799|NCT04310579|38749939|FG003|Overall Study|Positive COVID-19 test|0|||
16070800|NCT04310579|38749940|FG004|Overall Study|Positive COVID-19 test|0|||
16070801|NCT04310579|38749941|FG005|Overall Study|Positive COVID-19 test|0|||
16070802|NCT04310579|38749942|FG006|Overall Study|Positive COVID-19 test|0|||
16070803|NCT04310579|38749943|FG007|Overall Study|Positive COVID-19 test|0|||
16070804|NCT04310579|38749944|FG008|Overall Study|Positive COVID-19 test|0|||
16070805|NCT04310579|38749945|FG009|Overall Study|Positive COVID-19 test|0|||
16070806|NCT04310579|38749946|FG010|Overall Study|Positive COVID-19 test|1|||
16070807|NCT03834493|38749947|FG000|Overall Study|Participants Ongoing|311|||
16070808|NCT03834493|38749948|FG001|Overall Study|Participants Ongoing|324|||
16070809|NCT03834493|38749947|FG000|Overall Study|Withdrawal by Subject|20|||
16070810|NCT03834493|38749948|FG001|Overall Study|Withdrawal by Subject|17|||
16070811|NCT03834493|38749947|FG000|Overall Study|Physician Decision|1|||
16070812|NCT03834493|38749948|FG001|Overall Study|Physician Decision|0|||
16070813|NCT03834493|38749947|FG000|Overall Study|Death|289|||
16070814|NCT03834493|38749948|FG001|Overall Study|Death|282|||
16070815|NCT01695317|38749949|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
16070816|NCT01695317|38749950|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
16070817|NCT01695317|38749949|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
16070818|NCT01695317|38749950|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
16070819|NCT02512042|38749951|FG000|Overall Study|Adverse Event|0|||
16070820|NCT02512042|38749952|FG001|Overall Study|Adverse Event|4|||
16070821|NCT02512042|38749951|FG000|Overall Study|Withdrawal by Subject|6|||
16070822|NCT02512042|38749952|FG001|Overall Study|Withdrawal by Subject|6|||
16070823|NCT02512042|38749951|FG000|Overall Study|Non-compliance with study drug|1|||
16070824|NCT02512042|38749952|FG001|Overall Study|Non-compliance with study drug|2|||
16070825|NCT02512042|38749951|FG000|Overall Study|Lost to Follow-up|5|||
16070826|NCT02512042|38749952|FG001|Overall Study|Lost to Follow-up|2|||
16070827|NCT02512042|38749951|FG000|Overall Study|Other|11|||
16070828|NCT02512042|38749952|FG001|Overall Study|Other|11|||
16070829|NCT01352507|38749953|FG000|Treatment Period 1|Adverse Event|3|||
16070830|NCT01352507|38749954|FG001|Treatment Period 1|Adverse Event|0|||
16070831|NCT01352507|38749953|FG000|Treatment Period 1|Lost to Follow-up|3|||
16070832|NCT01352507|38749954|FG001|Treatment Period 1|Lost to Follow-up|4|||
16070833|NCT01352507|38749953|FG000|Treatment Period 1|Withdrawal by Subject|7|||
16070834|NCT01352507|38749954|FG001|Treatment Period 1|Withdrawal by Subject|5|||
16070835|NCT01352507|38749953|FG000|Treatment Period 1|Physician Decision|1|||
16070836|NCT01352507|38749954|FG001|Treatment Period 1|Physician Decision|0|||
16070837|NCT01352507|38749953|FG000|Washout Period|Withdrawal by Subject|0|||
16070838|NCT01352507|38749954|FG001|Washout Period|Withdrawal by Subject|1|||
16070839|NCT01352507|38749953|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
16070840|NCT01352507|38749954|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
16070841|NCT01352507|38749953|FG000|Treatment Period 2|Withdrawal by Subject|4|||
16070842|NCT01352507|38749954|FG001|Treatment Period 2|Withdrawal by Subject|3|||
16070843|NCT01352507|38749953|FG000|Treatment Period 2|Lack of Efficacy|1|||
16070844|NCT01352507|38749954|FG001|Treatment Period 2|Lack of Efficacy|0|||
16070845|NCT01385176|38749955|FG000|Randomization Phase|Death|1|||
16070846|NCT01385176|38749956|FG001|Randomization Phase|Death|2|||
16070847|NCT01385176|38749955|FG000|6-18 Month All VNS Active|Death|1|||
16070848|NCT01385176|38749956|FG001|6-18 Month All VNS Active|Death|2|||
16070849|NCT01385176|38749955|FG000|6-18 Month All VNS Active|Physician Decision|0|||
16070850|NCT01385176|38749956|FG001|6-18 Month All VNS Active|Physician Decision|1|||
16070851|NCT01385176|38749955|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
16070852|NCT01385176|38749956|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
16070853|NCT01385176|38749955|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
16070854|NCT01385176|38749956|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
16070855|NCT00502593|38749957|FG000|Overall Study|Withdrawn unspecified reason|1|||
16070856|NCT00502593|38749958|FG001|Overall Study|Withdrawn unspecified reason|1|||
16070857|NCT00502593|38749959|FG002|Overall Study|Withdrawn unspecified reason|3|||
16070858|NCT00502593|38749960|FG003|Overall Study|Withdrawn unspecified reason|1|||
16070859|NCT00502593|38749961|FG004|Overall Study|Withdrawn unspecified reason|2|||
16070860|NCT00502593|38749962|FG005|Overall Study|Withdrawn unspecified reason|0|||
16070861|NCT00502593|38749963|FG006|Overall Study|Withdrawn unspecified reason|2|||
16070862|NCT00502593|38749964|FG007|Overall Study|Withdrawn unspecified reason|0|||
16070863|NCT00502593|38749965|FG008|Overall Study|Withdrawn unspecified reason|0|||
16070864|NCT00502593|38749966|FG009|Overall Study|Withdrawn unspecified reason|0|||
16264890|NCT01597245|39453274|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
16264891|NCT01597245|39453254|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264892|NCT01597245|39453255|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16070865|NCT00502593|38749967|FG010|Overall Study|Withdrawn unspecified reason|0|||
16070866|NCT00502593|38749968|FG011|Overall Study|Withdrawn unspecified reason|0|||
16372677|NCT01769443|39849710|FG000|Overall Study|Study closure|1|||
16372678|NCT01769443|39849711|FG001|Overall Study|Study closure|0|||
16372679|NCT01451203|39849719|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
16372680|NCT01451203|39849720|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
16372681|NCT01451203|39849719|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
16070867|NCT00502593|38749957|FG000|Overall Study|Withdrawal by Subject|0|||
16070868|NCT00502593|38749958|FG001|Overall Study|Withdrawal by Subject|0|||
16070869|NCT00502593|38749959|FG002|Overall Study|Withdrawal by Subject|6|||
16070870|NCT00502593|38749960|FG003|Overall Study|Withdrawal by Subject|2|||
16070871|NCT00502593|38749961|FG004|Overall Study|Withdrawal by Subject|2|||
16070872|NCT00502593|38749962|FG005|Overall Study|Withdrawal by Subject|0|||
16264893|NCT01597245|39453256|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264894|NCT01597245|39453257|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264895|NCT01597245|39453258|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264896|NCT01597245|39453259|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264897|NCT01597245|39453260|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264898|NCT01597245|39453261|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264899|NCT01597245|39453262|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264900|NCT01597245|39453263|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264901|NCT01597245|39453264|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264902|NCT01597245|39453265|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264903|NCT01597245|39453266|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264904|NCT01597245|39453267|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264905|NCT01597245|39453268|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264906|NCT01597245|39453269|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264907|NCT01597245|39453270|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
16264908|NCT01597245|39453271|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264909|NCT01597245|39453272|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
16264910|NCT01597245|39453273|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
16264911|NCT01597245|39453274|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
16264912|NCT01597245|39453254|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264913|NCT01597245|39453255|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264914|NCT01597245|39453256|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264915|NCT01597245|39453257|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264916|NCT01597245|39453258|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264917|NCT01597245|39453259|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264918|NCT01597245|39453260|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264919|NCT01597245|39453261|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264920|NCT01597245|39453262|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264921|NCT01597245|39453263|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264922|NCT01597245|39453264|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264923|NCT01597245|39453265|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264924|NCT01597245|39453266|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264925|NCT01597245|39453267|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264926|NCT01597245|39453268|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264927|NCT01597245|39453269|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264928|NCT01597245|39453270|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264929|NCT01597245|39453271|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
16264930|NCT01597245|39453272|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
16264931|NCT01597245|39453273|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
16264932|NCT01597245|39453274|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
16264933|NCT01597245|39453254|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264934|NCT01597245|39453255|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264935|NCT01597245|39453256|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264936|NCT01597245|39453257|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264937|NCT01597245|39453258|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264938|NCT01597245|39453259|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264939|NCT01597245|39453260|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264940|NCT01597245|39453261|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264941|NCT01597245|39453262|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264942|NCT01597245|39453263|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264943|NCT01597245|39453264|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264944|NCT01597245|39453265|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264945|NCT01597245|39453266|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16372682|NCT01451203|39849720|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
16070873|NCT00502593|38749963|FG006|Overall Study|Withdrawal by Subject|3|||
16070874|NCT00502593|38749964|FG007|Overall Study|Withdrawal by Subject|0|||
16070875|NCT00502593|38749965|FG008|Overall Study|Withdrawal by Subject|3|||
16070876|NCT00502593|38749966|FG009|Overall Study|Withdrawal by Subject|0|||
16070877|NCT00502593|38749967|FG010|Overall Study|Withdrawal by Subject|1|||
16070878|NCT00502593|38749968|FG011|Overall Study|Withdrawal by Subject|0|||
16070879|NCT00502593|38749957|FG000|Overall Study|Lost to Follow-up|2|||
16070880|NCT00502593|38749958|FG001|Overall Study|Lost to Follow-up|1|||
16070881|NCT00502593|38749959|FG002|Overall Study|Lost to Follow-up|1|||
16070882|NCT00502593|38749960|FG003|Overall Study|Lost to Follow-up|1|||
16070883|NCT00502593|38749961|FG004|Overall Study|Lost to Follow-up|0|||
16070884|NCT00502593|38749962|FG005|Overall Study|Lost to Follow-up|0|||
16070885|NCT00502593|38749963|FG006|Overall Study|Lost to Follow-up|0|||
16070886|NCT00502593|38749964|FG007|Overall Study|Lost to Follow-up|0|||
16070887|NCT00502593|38749965|FG008|Overall Study|Lost to Follow-up|3|||
16070888|NCT00502593|38749966|FG009|Overall Study|Lost to Follow-up|0|||
16070889|NCT00502593|38749967|FG010|Overall Study|Lost to Follow-up|1|||
16070890|NCT00502593|38749968|FG011|Overall Study|Lost to Follow-up|0|||
16070891|NCT04173572|38749969|FG000|Overall Study|Withdrawal by Subject|1|||
16070892|NCT04173572|38749970|FG001|Overall Study|Withdrawal by Subject|5|||
16070893|NCT04173572|38749969|FG000|Overall Study|Lost to Follow-up|3|||
16070894|NCT04173572|38749970|FG001|Overall Study|Lost to Follow-up|1|||
16070895|NCT03710564|38749971|FG000|Overall Study|Study Terminated by Sponsor|104|||
16070896|NCT03710564|38749972|FG001|Overall Study|Study Terminated by Sponsor|55|||
16070897|NCT03710564|38749971|FG000|Overall Study|Withdrawal by Subject|57|||
16070898|NCT03710564|38749972|FG001|Overall Study|Withdrawal by Subject|25|||
16070899|NCT03710564|38749971|FG000|Overall Study|Death|10|||
16070900|NCT03710564|38749972|FG001|Overall Study|Death|4|||
16070901|NCT03710564|38749971|FG000|Overall Study|Lost to Follow-up|5|||
16070902|NCT03710564|38749972|FG001|Overall Study|Lost to Follow-up|4|||
16070903|NCT03710564|38749971|FG000|Overall Study|Protocol Violation|3|||
16070904|NCT03710564|38749972|FG001|Overall Study|Protocol Violation|2|||
16070905|NCT03710564|38749971|FG000|Overall Study|Adverse Event|3|||
16070906|NCT03710564|38749972|FG001|Overall Study|Adverse Event|0|||
16070907|NCT03710564|38749971|FG000|Overall Study|Physician Decision|2|||
16070908|NCT03710564|38749972|FG001|Overall Study|Physician Decision|3|||
16070909|NCT03761784|38749973|FG000|Overall Study|Adverse Event|4|||
16070910|NCT03761784|38749974|FG001|Overall Study|Adverse Event|0|||
16070911|NCT03761784|38749973|FG000|Overall Study|Lost to Follow-up|10|||
16070912|NCT03761784|38749974|FG001|Overall Study|Lost to Follow-up|7|||
16070913|NCT03761784|38749973|FG000|Overall Study|Pregnancy|1|||
16070914|NCT03761784|38749974|FG001|Overall Study|Pregnancy|0|||
16070915|NCT03761784|38749973|FG000|Overall Study|Protocol Violation|2|||
16070916|NCT03761784|38749974|FG001|Overall Study|Protocol Violation|0|||
16070917|NCT03761784|38749973|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
16070918|NCT03761784|38749974|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
16070919|NCT03761784|38749973|FG000|Overall Study|Withdrawal by Subject|9|||
16070920|NCT03761784|38749974|FG001|Overall Study|Withdrawal by Subject|4|||
16070921|NCT03761784|38749973|FG000|Overall Study|Physician Decision|1|||
16070922|NCT03761784|38749974|FG001|Overall Study|Physician Decision|0|||
16070923|NCT03761784|38749973|FG000|Overall Study|Other Than Specified|1|||
16070924|NCT03761784|38749974|FG001|Overall Study|Other Than Specified|0|||
16070925|NCT01726023|38749978|FG000|Overall Study|Death|1|||
16070926|NCT01726023|38749979|FG001|Overall Study|Death|1|||
16070927|NCT01726023|38749978|FG000|Overall Study|Lost to Follow-up|5|||
16070928|NCT01726023|38749979|FG001|Overall Study|Lost to Follow-up|10|||
16070929|NCT01726023|38749978|FG000|Overall Study|Other Eligibility criteria|7|||
16070930|NCT01726023|38749979|FG001|Overall Study|Other Eligibility criteria|7|||
16070931|NCT01726023|38749978|FG000|Overall Study|Withdrawal by Subject|16|||
16070932|NCT01726023|38749979|FG001|Overall Study|Withdrawal by Subject|8|||
16070933|NCT01466881|38749980|FG000|Overall Study|Ineligible|5|||
16264946|NCT01597245|39453267|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16070934|NCT01466881|38749980|FG000|Overall Study|Adverse Event|6|||
16070935|NCT01466881|38749980|FG000|Overall Study|Progression/relapse|20|||
16070936|NCT01466881|38749980|FG000|Overall Study|Death|4|||
16070937|NCT01466881|38749980|FG000|Overall Study|Other reason not protocol specified|5|||
16070938|NCT03537651|38749983|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
16070939|NCT03537651|38749983|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
16070940|NCT03537651|38749983|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
16070941|NCT03537651|38749983|FG000|Part A (Up to 96 Weeks)|Other|1|||
16070942|NCT03537651|38749983|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
16070943|NCT03537651|38749983|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
16070944|NCT03537651|38749983|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
16070945|NCT03537651|38749983|FG000|Part B (Up to 192 Weeks)|Other|1|||
16070946|NCT03621761|38749988|FG000|Overall Study|Lost to Follow-up|1|||
16070947|NCT03621761|38749989|FG001|Overall Study|Lost to Follow-up|1|||
16070948|NCT03621761|38749990|FG002|Overall Study|Lost to Follow-up|2|||
16070949|NCT03621761|38749988|FG000|Overall Study|Withdrawal by Subject|2|||
16070950|NCT03621761|38749989|FG001|Overall Study|Withdrawal by Subject|1|||
16070951|NCT03621761|38749990|FG002|Overall Study|Withdrawal by Subject|1|||
16070952|NCT03621761|38749988|FG000|Overall Study|Became Ineligible|0|||
16070953|NCT03621761|38749989|FG001|Overall Study|Became Ineligible|2|||
16070954|NCT03621761|38749990|FG002|Overall Study|Became Ineligible|0|||
16070955|NCT00930813|38749991|FG000|Overall Study|Death|4|||
16070956|NCT00930813|38749992|FG001|Overall Study|Death|5|||
16070957|NCT00930813|38749991|FG000|Overall Study|Withdrawal by Subject|2|||
16070958|NCT00930813|38749992|FG001|Overall Study|Withdrawal by Subject|5|||
16070959|NCT00930813|38749991|FG000|Overall Study|Lost to Follow-up|2|||
16070960|NCT00930813|38749992|FG001|Overall Study|Lost to Follow-up|4|||
16070961|NCT01549652|38749993|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
16070962|NCT01549652|38749994|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
16070963|NCT01549652|38749995|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
16070964|NCT01549652|38749996|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
16070965|NCT01549652|38749993|FG000|Overall Study|Study Drug Titration Failure|5|||
16070966|NCT01549652|38749994|FG001|Overall Study|Study Drug Titration Failure|6|||
16070967|NCT01549652|38749995|FG002|Overall Study|Study Drug Titration Failure|0|||
16070968|NCT01549652|38749996|FG003|Overall Study|Study Drug Titration Failure|0|||
16070969|NCT01549652|38749993|FG000|Overall Study|Withdrawal Effect|0|||
16070970|NCT01549652|38749994|FG001|Overall Study|Withdrawal Effect|2|||
16070971|NCT01549652|38749995|FG002|Overall Study|Withdrawal Effect|0|||
16070972|NCT01549652|38749996|FG003|Overall Study|Withdrawal Effect|0|||
16070973|NCT01549652|38749993|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
16070974|NCT01549652|38749994|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
16070975|NCT01549652|38749995|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
16070976|NCT01549652|38749996|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
16070977|NCT01549652|38749993|FG000|Overall Study|Problem with Infusion|1|||
16070978|NCT01549652|38749994|FG001|Overall Study|Problem with Infusion|0|||
16070979|NCT01549652|38749995|FG002|Overall Study|Problem with Infusion|0|||
16070980|NCT01549652|38749996|FG003|Overall Study|Problem with Infusion|0|||
16070981|NCT01549652|38749993|FG000|Overall Study|Titration Non-Compliance|1|||
16070982|NCT01549652|38749994|FG001|Overall Study|Titration Non-Compliance|3|||
16070983|NCT01549652|38749995|FG002|Overall Study|Titration Non-Compliance|4|||
16070984|NCT01549652|38749996|FG003|Overall Study|Titration Non-Compliance|5|||
16070985|NCT01549652|38749993|FG000|Overall Study|Titration Side Effects|0|||
16070986|NCT01549652|38749994|FG001|Overall Study|Titration Side Effects|0|||
16070987|NCT01549652|38749995|FG002|Overall Study|Titration Side Effects|6|||
16070988|NCT01549652|38749996|FG003|Overall Study|Titration Side Effects|3|||
16070989|NCT01549652|38749993|FG000|Overall Study|Withdrawal by Subject|0|||
16070990|NCT01549652|38749994|FG001|Overall Study|Withdrawal by Subject|0|||
16070991|NCT01549652|38749995|FG002|Overall Study|Withdrawal by Subject|5|||
16070992|NCT01549652|38749996|FG003|Overall Study|Withdrawal by Subject|3|||
16070993|NCT00920686|38749997|FG000|Overall Study|Lost to Follow-up|2|||
16070994|NCT00920686|38749998|FG001|Overall Study|Lost to Follow-up|3|||
16070995|NCT00920686|38749999|FG002|Overall Study|Lost to Follow-up|1|||
16070996|NCT00920686|38749997|FG000|Overall Study|Study drug dosing criteria not met|17|||
16070997|NCT00920686|38749998|FG001|Overall Study|Study drug dosing criteria not met|19|||
16070998|NCT00920686|38749999|FG002|Overall Study|Study drug dosing criteria not met|12|||
16070999|NCT02049866|38753086|FG000|Overall Study|Withdrawal by Subject|1|||
16071000|NCT00943605|38753087|FG000|Overall Study|Study termination|30|||
16071001|NCT00943605|38753088|FG001|Overall Study|Study termination|30|||
16071002|NCT02317016|38753090|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
16071003|NCT02317016|38753090|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
16071004|NCT02317016|38753090|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
16071005|NCT02317016|38753090|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
16071006|NCT02317016|38753090|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
16071007|NCT02317016|38753090|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
16071008|NCT02317016|38753090|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
16071009|NCT01876511|38753091|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
16071010|NCT01876511|38753092|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
16071011|NCT01876511|38753093|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
16071012|NCT01876511|38753091|FG000|Overall Study|Death (unrelated)|3|||
16071013|NCT01876511|38753092|FG001|Overall Study|Death (unrelated)|0|||
16071014|NCT01876511|38753093|FG002|Overall Study|Death (unrelated)|2|||
16071015|NCT01876511|38753091|FG000|Overall Study|Drug-related Toxicity|5|||
16071016|NCT01876511|38753092|FG001|Overall Study|Drug-related Toxicity|1|||
16071017|NCT01876511|38753093|FG002|Overall Study|Drug-related Toxicity|6|||
16071018|NCT01876511|38753091|FG000|Overall Study|Patient Decision|3|||
16071019|NCT01876511|38753092|FG001|Overall Study|Patient Decision|0|||
16071020|NCT01876511|38753093|FG002|Overall Study|Patient Decision|6|||
16071021|NCT01876511|38753091|FG000|Overall Study|Physician Decision|1|||
16071022|NCT01876511|38753092|FG001|Overall Study|Physician Decision|0|||
16071023|NCT01876511|38753093|FG002|Overall Study|Physician Decision|1|||
16071024|NCT03942042|38753094|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
16071025|NCT03942042|38753095|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
16071026|NCT03942042|38753094|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
16071027|NCT03942042|38753095|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
16071028|NCT02482233|38753100|FG000|Overall Study|Lost to Follow-up|1|||
16071029|NCT02482233|38753101|FG001|Overall Study|Lost to Follow-up|1|||
16071030|NCT01697319|38753102|FG000|Primary Phase|Withdrawal by Subject|1|||
16372683|NCT01451203|39849719|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
16372684|NCT01451203|39849720|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
16071031|NCT01697319|38753102|FG000|Extension Phase|Terminated by Sponsor|15|||
16071032|NCT02736799|38753103|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
16071033|NCT02736799|38753104|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
16071034|NCT02736799|38753105|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
16071035|NCT02736799|38753106|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
16071036|NCT01908634|38753107|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
16071037|NCT01908634|38753107|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
16071038|NCT03006341|38753108|FG000|Overall Study|Not linked in the EMR|25069|||
16071039|NCT03006341|38753109|FG001|Overall Study|Not linked in the EMR|67505|||
16071040|NCT03006341|38753110|FG002|Overall Study|Not linked in the EMR|30993|||
16071041|NCT03006341|38753111|FG003|Overall Study|Not linked in the EMR|10685|||
16071042|NCT02595398|38753112|FG000|Overall Study|Non-compliance|1|||
16071043|NCT02595398|38753113|FG001|Overall Study|Non-compliance|0|||
16071044|NCT02595398|38753112|FG000|Overall Study|Withdrawal by Subject|2|||
16071045|NCT02595398|38753113|FG001|Overall Study|Withdrawal by Subject|1|||
16071046|NCT02595398|38753112|FG000|Overall Study|Lost to Follow-up|1|||
16071047|NCT02595398|38753113|FG001|Overall Study|Lost to Follow-up|0|||
16071048|NCT00506519|38753114|FG000|Overall Study|Death|4|||
16071049|NCT00506519|38753115|FG001|Overall Study|Death|6|||
16071050|NCT00506519|38753116|FG002|Overall Study|Death|0|||
16071051|NCT00506519|38753114|FG000|Overall Study|Adverse Event|1|||
16071052|NCT00506519|38753115|FG001|Overall Study|Adverse Event|0|||
16071053|NCT00506519|38753116|FG002|Overall Study|Adverse Event|0|||
16071054|NCT04163458|38753117|FG000|Overall Study|Protocol Deviation|7|||
16071055|NCT04163458|38753118|FG001|Overall Study|Protocol Deviation|13|||
16071056|NCT04163458|38753117|FG000|Overall Study|Adverse Event|5|||
16071057|NCT04163458|38753118|FG001|Overall Study|Adverse Event|8|||
16071058|NCT04163458|38753117|FG000|Overall Study|Due to COVID-19 pandemic|4|||
16372685|NCT01451203|39849719|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
16372686|NCT01451203|39849720|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
16372687|NCT01451203|39849719|FG000|Double-blind Treatment Period|Adverse Event|6|||
16372688|NCT01451203|39849720|FG001|Double-blind Treatment Period|Adverse Event|9|||
16372689|NCT01451203|39849719|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
16372690|NCT01451203|39849720|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
16071059|NCT04163458|38753118|FG001|Overall Study|Due to COVID-19 pandemic|2|||
16071060|NCT04163458|38753117|FG000|Overall Study|Participant withdrew consent|2|||
16071061|NCT04163458|38753118|FG001|Overall Study|Participant withdrew consent|3|||
16071062|NCT04163458|38753117|FG000|Overall Study|Randomization failure|2|||
16071063|NCT04163458|38753118|FG001|Overall Study|Randomization failure|2|||
16071064|NCT04163458|38753117|FG000|Overall Study|Other|4|||
16071065|NCT04163458|38753118|FG001|Overall Study|Other|2|||
16071066|NCT00817635|38753121|FG000|Overall Study|Adverse Event|1|||
16071067|NCT00817635|38753122|FG001|Overall Study|Adverse Event|0|||
16071068|NCT00817635|38753123|FG002|Overall Study|Adverse Event|0|||
16071069|NCT00817635|38753124|FG003|Overall Study|Adverse Event|1|||
16071070|NCT00817635|38753125|FG004|Overall Study|Adverse Event|1|||
16071071|NCT00817635|38753121|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
16071072|NCT00817635|38753122|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
16071073|NCT00817635|38753123|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
16071074|NCT00817635|38753124|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
16071075|NCT00817635|38753125|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
16071076|NCT00817635|38753121|FG000|Overall Study|Withdrawal by Subject|2|||
16071077|NCT00817635|38753122|FG001|Overall Study|Withdrawal by Subject|1|||
16071078|NCT00817635|38753123|FG002|Overall Study|Withdrawal by Subject|0|||
16071079|NCT00817635|38753124|FG003|Overall Study|Withdrawal by Subject|1|||
16071080|NCT00817635|38753125|FG004|Overall Study|Withdrawal by Subject|2|||
16071081|NCT00817635|38753121|FG000|Overall Study|Lost to Follow-up|0|||
16071082|NCT00817635|38753122|FG001|Overall Study|Lost to Follow-up|1|||
16071083|NCT00817635|38753123|FG002|Overall Study|Lost to Follow-up|0|||
16071084|NCT00817635|38753124|FG003|Overall Study|Lost to Follow-up|1|||
16071085|NCT00817635|38753125|FG004|Overall Study|Lost to Follow-up|0|||
16071086|NCT00817635|38753121|FG000|Overall Study|Administrative Problems|0|||
16071087|NCT00817635|38753122|FG001|Overall Study|Administrative Problems|0|||
16071088|NCT00817635|38753123|FG002|Overall Study|Administrative Problems|0|||
16071089|NCT00817635|38753124|FG003|Overall Study|Administrative Problems|0|||
16071090|NCT00817635|38753125|FG004|Overall Study|Administrative Problems|1|||
16071091|NCT00817635|38753121|FG000|Overall Study|Protocol Violation|5|||
16071092|NCT00817635|38753122|FG001|Overall Study|Protocol Violation|1|||
16071093|NCT00817635|38753123|FG002|Overall Study|Protocol Violation|3|||
16071094|NCT00817635|38753124|FG003|Overall Study|Protocol Violation|2|||
16071095|NCT00817635|38753125|FG004|Overall Study|Protocol Violation|3|||
16071096|NCT01393119|38753128|FG000|Overall Study|Adverse Event|1|||
16071097|NCT01393119|38753129|FG001|Overall Study|Adverse Event|1|||
16071098|NCT01393119|38753130|FG002|Overall Study|Adverse Event|0|||
16071099|NCT01393119|38753131|FG003|Overall Study|Adverse Event|1|||
16071100|NCT01393119|38753128|FG000|Overall Study|Withdrawal by Subject|0|||
16071101|NCT01393119|38753129|FG001|Overall Study|Withdrawal by Subject|1|||
16071102|NCT01393119|38753130|FG002|Overall Study|Withdrawal by Subject|1|||
16071103|NCT01393119|38753131|FG003|Overall Study|Withdrawal by Subject|0|||
16071104|NCT01393119|38753128|FG000|Overall Study|Lack of Efficacy|1|||
16071105|NCT01393119|38753129|FG001|Overall Study|Lack of Efficacy|0|||
16071106|NCT01393119|38753130|FG002|Overall Study|Lack of Efficacy|2|||
16071107|NCT01393119|38753131|FG003|Overall Study|Lack of Efficacy|1|||
16071108|NCT01393119|38753128|FG000|Overall Study|Protocol Violation|0|||
16071109|NCT01393119|38753129|FG001|Overall Study|Protocol Violation|0|||
16071110|NCT01393119|38753130|FG002|Overall Study|Protocol Violation|1|||
16071111|NCT01393119|38753131|FG003|Overall Study|Protocol Violation|0|||
16071112|NCT01393119|38753128|FG000|Overall Study|Death|0|||
16448214|NCT02113982|40122118|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
16448215|NCT02113982|40122105|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
16448216|NCT02113982|40122106|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
16448217|NCT02113982|40122107|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
16448218|NCT02113982|40122108|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
16448219|NCT02113982|40122109|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
16448220|NCT02113982|40122110|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
16448221|NCT02113982|40122111|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
16448222|NCT02113982|40122112|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
16448223|NCT02113982|40122113|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
16448224|NCT02113982|40122114|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
16448225|NCT02113982|40122115|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
16448226|NCT02113982|40122116|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
16448227|NCT02113982|40122117|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
16448228|NCT02113982|40122118|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
16448229|NCT02113982|40122105|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
16071113|NCT01393119|38753129|FG001|Overall Study|Death|0|||
16071114|NCT01393119|38753130|FG002|Overall Study|Death|0|||
16071115|NCT01393119|38753131|FG003|Overall Study|Death|1|||
16448230|NCT02113982|40122106|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
16448231|NCT02113982|40122107|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
16448232|NCT02113982|40122108|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
16448233|NCT02113982|40122109|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
16448234|NCT02113982|40122110|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
16448235|NCT02113982|40122111|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
16448236|NCT02113982|40122112|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
16448237|NCT02113982|40122113|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
16071116|NCT01393119|38753128|FG000|Overall Study|Randomized but Not treated|1|||
16161743|NCT01557166|39072480|FG001|Overall Study|Protocol Violation|5|||
16071117|NCT01393119|38753129|FG001|Overall Study|Randomized but Not treated|0|||
16071118|NCT01393119|38753130|FG002|Overall Study|Randomized but Not treated|1|||
16071119|NCT01393119|38753131|FG003|Overall Study|Randomized but Not treated|1|||
16161744|NCT01557166|39072479|FG000|Overall Study|Withdrawn consent|12|||
16071120|NCT01393119|38753128|FG000|Overall Study|Sponsor Termination of Study|11|||
16071121|NCT01393119|38753129|FG001|Overall Study|Sponsor Termination of Study|12|||
16071122|NCT01393119|38753130|FG002|Overall Study|Sponsor Termination of Study|9|||
16071123|NCT01393119|38753131|FG003|Overall Study|Sponsor Termination of Study|12|||
16071124|NCT02987543|38753134|FG000|Overall Study|Ongoing study at data cut off|49|||
16071125|NCT02987543|38753135|FG001|Overall Study|Ongoing study at data cut off|21|||
16071126|NCT02987543|38753136|FG002|Overall Study|Ongoing study at data cut off|19|||
16071127|NCT02987543|38753137|FG003|Overall Study|Ongoing study at data cut off|12|||
16264947|NCT01597245|39453268|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16071128|NCT02987543|38753134|FG000|Overall Study|Death|88|||
16071129|NCT02987543|38753135|FG001|Overall Study|Death|54|||
16071130|NCT02987543|38753136|FG002|Overall Study|Death|67|||
16071131|NCT02987543|38753137|FG003|Overall Study|Death|28|||
16161745|NCT01557166|39072480|FG001|Overall Study|Withdrawn consent|20|||
16448238|NCT02113982|40122114|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
16448239|NCT02113982|40122115|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
16448240|NCT02113982|40122116|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
16448241|NCT02113982|40122117|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
16071132|NCT02987543|38753134|FG000|Overall Study|Lost to Follow-up|3|||
16071133|NCT02987543|38753135|FG001|Overall Study|Lost to Follow-up|0|||
16071134|NCT02987543|38753136|FG002|Overall Study|Lost to Follow-up|1|||
16071135|NCT02987543|38753137|FG003|Overall Study|Lost to Follow-up|0|||
16071136|NCT02987543|38753134|FG000|Overall Study|Screen failure|0|||
16071137|NCT02987543|38753135|FG001|Overall Study|Screen failure|0|||
16071138|NCT02987543|38753136|FG002|Overall Study|Screen failure|0|||
16071139|NCT02987543|38753137|FG003|Overall Study|Screen failure|1|||
16071140|NCT02987543|38753134|FG000|Overall Study|Withdrawal by Subject|21|||
16071141|NCT02987543|38753135|FG001|Overall Study|Withdrawal by Subject|7|||
16071142|NCT02987543|38753136|FG002|Overall Study|Withdrawal by Subject|7|||
16071143|NCT02987543|38753137|FG003|Overall Study|Withdrawal by Subject|6|||
16071144|NCT02987543|38753134|FG000|Overall Study|Study terminated by sponsor|1|||
16071145|NCT02987543|38753135|FG001|Overall Study|Study terminated by sponsor|0|||
16071146|NCT02987543|38753136|FG002|Overall Study|Study terminated by sponsor|0|||
16071147|NCT02987543|38753137|FG003|Overall Study|Study terminated by sponsor|0|||
16372691|NCT01451203|39849719|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
16372692|NCT01451203|39849720|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
16372693|NCT01451203|39849719|FG000|Double-blind Treatment Period|Investigator decision|2|||
16372694|NCT01451203|39849720|FG001|Double-blind Treatment Period|Investigator decision|0|||
16071148|NCT02987543|38753134|FG000|Overall Study|Investigator decision|0|||
16071149|NCT02987543|38753135|FG001|Overall Study|Investigator decision|1|||
16071150|NCT02987543|38753136|FG002|Overall Study|Investigator decision|0|||
16071151|NCT02987543|38753137|FG003|Overall Study|Investigator decision|0|||
16071152|NCT02987543|38753134|FG000|Overall Study|Disease progression|0|||
16071153|NCT02987543|38753135|FG001|Overall Study|Disease progression|0|||
16071154|NCT02987543|38753136|FG002|Overall Study|Disease progression|0|||
16071155|NCT02987543|38753137|FG003|Overall Study|Disease progression|1|||
16071156|NCT00315055|38753138|FG000|Overall Study|Protocol Violation|2|||
16071157|NCT00315055|38753139|FG001|Overall Study|Protocol Violation|4|||
16071158|NCT00315055|38753138|FG000|Overall Study|Lost to Follow-up|1|||
16071159|NCT00315055|38753139|FG001|Overall Study|Lost to Follow-up|1|||
16071160|NCT00486759|38753140|FG000|Treatment|Adverse event/intercurrent illness|86|||
16071161|NCT00486759|38753141|FG001|Treatment|Adverse event/intercurrent illness|39|||
16071162|NCT00486759|38753140|FG000|Treatment|Insufficient therapeutic response|37|||
16071163|NCT00486759|38753141|FG001|Treatment|Insufficient therapeutic response|39|||
16071164|NCT00486759|38753140|FG000|Treatment|Death|17|||
16071165|NCT00486759|38753141|FG001|Treatment|Death|10|||
16071166|NCT00486759|38753140|FG000|Treatment|Withdrew consent|15|||
16071167|NCT00486759|38753141|FG001|Treatment|Withdrew consent|12|||
16071168|NCT00486759|38753140|FG000|Treatment|Administrative/reason not specified|17|||
16071169|NCT00486759|38753141|FG001|Treatment|Administrative/reason not specified|21|||
16264948|NCT01597245|39453269|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16372695|NCT01451203|39849719|FG000|Post-treatment Period|Consent withdrawn|2|||
16372696|NCT01451203|39849720|FG001|Post-treatment Period|Consent withdrawn|4|||
16372697|NCT01451203|39849719|FG000|Post-treatment Period|Lack of Efficacy|12|||
16372698|NCT01451203|39849720|FG001|Post-treatment Period|Lack of Efficacy|28|||
16448242|NCT02113982|40122118|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
16448243|NCT02113982|40122105|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448244|NCT02113982|40122106|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448245|NCT02113982|40122107|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448246|NCT02113982|40122108|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448247|NCT02113982|40122109|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448248|NCT02113982|40122110|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448249|NCT02113982|40122111|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448250|NCT02113982|40122112|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448251|NCT02113982|40122113|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448252|NCT02113982|40122114|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
16071170|NCT00486759|38753140|FG000|Treatment|Refused treatment|10|||
16071171|NCT00486759|38753141|FG001|Treatment|Refused treatment|7|||
16071172|NCT00486759|38753140|FG000|Treatment|Violation of selection criteria at entry|3|||
16071173|NCT00486759|38753141|FG001|Treatment|Violation of selection criteria at entry|3|||
16264949|NCT01597245|39453270|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
16264950|NCT01597245|39453271|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264951|NCT01597245|39453272|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
16264952|NCT01597245|39453273|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
16264953|NCT01597245|39453274|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
16264954|NCT01597245|39453254|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264955|NCT01597245|39453255|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264956|NCT01597245|39453256|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16448253|NCT02113982|40122115|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
16071174|NCT00486759|38753140|FG000|Treatment|Other protocol violation|1|||
16448254|NCT02113982|40122116|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
16448255|NCT02113982|40122117|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448256|NCT02113982|40122118|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
16448257|NCT02113982|40122105|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448258|NCT02113982|40122106|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448259|NCT02113982|40122107|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448260|NCT02113982|40122108|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448261|NCT02113982|40122109|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448262|NCT02113982|40122110|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448263|NCT02113982|40122111|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448264|NCT02113982|40122112|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448265|NCT02113982|40122113|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448266|NCT02113982|40122114|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448267|NCT02113982|40122115|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448268|NCT02113982|40122116|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
16448269|NCT02113982|40122117|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16071175|NCT00486759|38753141|FG001|Treatment|Other protocol violation|5|||
16071176|NCT00486759|38753140|FG000|Treatment|Failure to return|1|||
16071177|NCT00486759|38753141|FG001|Treatment|Failure to return|1|||
16071178|NCT00486759|38753140|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
16071179|NCT00486759|38753141|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
16071180|NCT00486759|38753140|FG000|Safety Follow-up|Death|40|||
16071181|NCT00486759|38753141|FG001|Safety Follow-up|Death|29|||
16071182|NCT00486759|38753140|FG000|Safety Follow-up|Withdrew consent|32|||
16071183|NCT00486759|38753141|FG001|Safety Follow-up|Withdrew consent|23|||
16071184|NCT00486759|38753140|FG000|Safety Follow-up|Failure to return|9|||
16071185|NCT00486759|38753141|FG001|Safety Follow-up|Failure to return|6|||
16071186|NCT00486759|38753140|FG000|Safety Follow-up|Administrative/not specified|8|||
16071187|NCT00486759|38753141|FG001|Safety Follow-up|Administrative/not specified|6|||
16071188|NCT00486759|38753140|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
16071189|NCT00486759|38753141|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
16071190|NCT00486759|38753140|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
16071191|NCT00486759|38753141|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
16071192|NCT00377455|38753142|FG000|Overall Study|Withdrawal by Subject|1|||
16071193|NCT01838200|38753145|FG000|Overall Study|Adverse Event|0|||
16071194|NCT01838200|38753146|FG001|Overall Study|Adverse Event|2|||
16071195|NCT01838200|38753145|FG000|Overall Study|Progressive disease|3|||
16071196|NCT01838200|38753146|FG001|Overall Study|Progressive disease|0|||
16071197|NCT00927823|38753153|FG000|Continuous Dosing Period|Death|0|||
16071198|NCT00927823|38753154|FG001|Continuous Dosing Period|Death|0|||
16071199|NCT00927823|38753155|FG002|Continuous Dosing Period|Death|6|||
16071200|NCT00927823|38753156|FG003|Continuous Dosing Period|Death|0|||
16071201|NCT00927823|38753153|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
16372699|NCT01451203|39849719|FG000|Post-treatment Period|Adverse Event|0|||
16372700|NCT01451203|39849720|FG001|Post-treatment Period|Adverse Event|1|||
16372701|NCT01451203|39849719|FG000|Post-treatment Period|Investigator decision|0|||
16372702|NCT01451203|39849720|FG001|Post-treatment Period|Investigator decision|1|||
16372703|NCT04233580|39849721|FG000|Overall Study|Adverse Event|3|||
16372704|NCT04233580|39849722|FG001|Overall Study|Adverse Event|3|||
16372705|NCT04233580|39849721|FG000|Overall Study|Withdrawal by Subject|2|||
16372706|NCT04233580|39849722|FG001|Overall Study|Withdrawal by Subject|1|||
16372707|NCT04605588|39849723|FG000|Overall Study|Withdrawal by Subject|1|||
16372708|NCT04605588|39849724|FG001|Overall Study|Withdrawal by Subject|0|||
16372709|NCT01503515|39849727|FG000|Overall Study|Adverse Event|4|||
16372710|NCT01503515|39849728|FG001|Overall Study|Adverse Event|5|||
16372711|NCT01503515|39849727|FG000|Overall Study|Death|0|||
16372712|NCT01503515|39849728|FG001|Overall Study|Death|1|||
16372713|NCT01503515|39849727|FG000|Overall Study|Physician Decision|14|||
16372714|NCT01503515|39849728|FG001|Overall Study|Physician Decision|23|||
16372715|NCT01503515|39849727|FG000|Overall Study|Withdrawal by Subject|0|||
16372716|NCT01503515|39849728|FG001|Overall Study|Withdrawal by Subject|1|||
16372717|NCT01503515|39849727|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
16372718|NCT01503515|39849728|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
16372719|NCT01503515|39849727|FG000|Overall Study|Ineligible|1|||
16372720|NCT01503515|39849728|FG001|Overall Study|Ineligible|1|||
16372721|NCT00567112|39849729|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
16372722|NCT00567112|39849730|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
16372723|NCT00567112|39849731|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
16372724|NCT00567112|39849729|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
16372725|NCT00567112|39849730|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
16372726|NCT00567112|39849731|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
16372727|NCT00567112|39849729|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
16372728|NCT00567112|39849730|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
16448270|NCT02113982|40122118|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
16448271|NCT02113982|40122105|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
16448272|NCT02113982|40122106|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
16448273|NCT02113982|40122107|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
16448274|NCT02113982|40122108|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
16448275|NCT02113982|40122109|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
16448276|NCT02113982|40122110|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
16448277|NCT02113982|40122111|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
16448278|NCT02113982|40122112|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
16448279|NCT02113982|40122113|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
16448280|NCT02113982|40122114|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
16448281|NCT02113982|40122115|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
16448282|NCT02113982|40122116|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
16448283|NCT02113982|40122117|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
16071202|NCT00927823|38753154|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
16071203|NCT00927823|38753155|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
16071204|NCT00927823|38753156|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
16071205|NCT00927823|38753153|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
16264957|NCT01597245|39453257|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16372729|NCT00567112|39849731|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
16372730|NCT01336972|39849732|FG000|Overall Study|Adverse Event|1|||
16372731|NCT01336972|39849733|FG001|Overall Study|Adverse Event|1|||
16372732|NCT01336972|39849734|FG002|Overall Study|Adverse Event|0|||
16372733|NCT02366130|39849735|FG000|Overall Study|Withdrawal by Subject|3|||
16372734|NCT02366130|39849735|FG000|Overall Study|Ineligible|6|||
16372735|NCT00289900|39849739|FG000|Overall Study|Adverse Event|28|||
16372736|NCT00289900|39849740|FG001|Overall Study|Adverse Event|40|||
16372737|NCT00289900|39849741|FG002|Overall Study|Adverse Event|13|||
16372738|NCT00289900|39849742|FG003|Overall Study|Adverse Event|19|||
16372739|NCT00289900|39849743|FG004|Overall Study|Adverse Event|20|||
16372740|NCT00289900|39849744|FG005|Overall Study|Adverse Event|33|||
16372741|NCT00289900|39849739|FG000|Overall Study|Lost to Follow-up|7|||
16448284|NCT02113982|40122118|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
16448285|NCT02113982|40122105|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448286|NCT02113982|40122106|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448287|NCT02113982|40122107|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448288|NCT02113982|40122108|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448289|NCT02113982|40122109|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448290|NCT02113982|40122110|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448291|NCT02113982|40122111|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448292|NCT02113982|40122112|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448293|NCT02113982|40122113|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448294|NCT02113982|40122114|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448295|NCT02113982|40122115|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448296|NCT02113982|40122116|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448297|NCT02113982|40122117|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
16448298|NCT02113982|40122118|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
16448299|NCT02113982|40122105|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448300|NCT02113982|40122106|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448301|NCT02113982|40122107|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448302|NCT02113982|40122108|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448303|NCT02113982|40122109|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448304|NCT02113982|40122110|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448305|NCT02113982|40122111|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448306|NCT02113982|40122112|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448307|NCT02113982|40122113|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448308|NCT02113982|40122114|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448309|NCT02113982|40122115|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16071206|NCT00927823|38753154|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
16264958|NCT01597245|39453258|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264959|NCT01597245|39453259|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264960|NCT01597245|39453260|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264961|NCT01597245|39453261|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264962|NCT01597245|39453262|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264963|NCT01597245|39453263|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264964|NCT01597245|39453264|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264965|NCT01597245|39453265|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264966|NCT01597245|39453266|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16372742|NCT00289900|39849740|FG001|Overall Study|Lost to Follow-up|7|||
16372743|NCT00289900|39849741|FG002|Overall Study|Lost to Follow-up|8|||
16372744|NCT00289900|39849742|FG003|Overall Study|Lost to Follow-up|8|||
16448310|NCT02113982|40122116|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
16448311|NCT02113982|40122117|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
16448312|NCT02113982|40122118|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
16448313|NCT02113982|40122105|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448314|NCT02113982|40122106|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16372745|NCT00289900|39849743|FG004|Overall Study|Lost to Follow-up|4|||
16372746|NCT00289900|39849744|FG005|Overall Study|Lost to Follow-up|8|||
16372747|NCT00289900|39849739|FG000|Overall Study|Participant had flushing|18|||
16372748|NCT00289900|39849740|FG001|Overall Study|Participant had flushing|42|||
16372749|NCT00289900|39849741|FG002|Overall Study|Participant had flushing|1|||
16372750|NCT00289900|39849742|FG003|Overall Study|Participant had flushing|2|||
16372751|NCT00289900|39849743|FG004|Overall Study|Participant had flushing|0|||
16372752|NCT00289900|39849744|FG005|Overall Study|Participant had flushing|4|||
16372753|NCT00289900|39849739|FG000|Overall Study|Other|0|||
16372754|NCT00289900|39849740|FG001|Overall Study|Other|0|||
16372755|NCT00289900|39849741|FG002|Overall Study|Other|0|||
16372756|NCT00289900|39849742|FG003|Overall Study|Other|5|||
16372757|NCT00289900|39849743|FG004|Overall Study|Other|1|||
16372758|NCT00289900|39849744|FG005|Overall Study|Other|0|||
16372759|NCT00289900|39849739|FG000|Overall Study|Participant moved|1|||
16372760|NCT00289900|39849740|FG001|Overall Study|Participant moved|0|||
16372761|NCT00289900|39849741|FG002|Overall Study|Participant moved|0|||
16372762|NCT00289900|39849742|FG003|Overall Study|Participant moved|1|||
16372763|NCT00289900|39849743|FG004|Overall Study|Participant moved|1|||
16372764|NCT00289900|39849744|FG005|Overall Study|Participant moved|1|||
16372765|NCT00289900|39849739|FG000|Overall Study|Withdrawal by Subject|10|||
16372766|NCT00289900|39849740|FG001|Overall Study|Withdrawal by Subject|21|||
16372767|NCT00289900|39849741|FG002|Overall Study|Withdrawal by Subject|8|||
16448315|NCT02113982|40122107|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448316|NCT02113982|40122108|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448317|NCT02113982|40122109|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448318|NCT02113982|40122110|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448319|NCT02113982|40122111|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448320|NCT02113982|40122112|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448321|NCT02113982|40122113|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448322|NCT02113982|40122114|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448323|NCT02113982|40122115|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448324|NCT02113982|40122116|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
16448325|NCT02113982|40122117|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
16448326|NCT02113982|40122118|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
16448327|NCT02113982|40122105|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448328|NCT02113982|40122106|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448329|NCT02113982|40122107|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448330|NCT02113982|40122108|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448331|NCT02113982|40122109|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448332|NCT02113982|40122110|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448333|NCT02113982|40122111|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448334|NCT02113982|40122112|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448335|NCT02113982|40122113|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448336|NCT02113982|40122114|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448337|NCT02113982|40122115|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448338|NCT02113982|40122116|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
16448339|NCT02113982|40122117|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
16448340|NCT02113982|40122118|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
16448341|NCT02113982|40122105|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448342|NCT02113982|40122106|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16071207|NCT00927823|38753155|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
16071208|NCT00927823|38753156|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
16071209|NCT00927823|38753153|FG000|Continuous Dosing Period|Other|1|||
16448343|NCT02113982|40122107|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448344|NCT02113982|40122108|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448345|NCT02113982|40122109|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448346|NCT02113982|40122110|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448347|NCT02113982|40122111|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448348|NCT02113982|40122112|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448349|NCT02113982|40122113|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16071210|NCT00927823|38753154|FG001|Continuous Dosing Period|Other|2|||
16372768|NCT00289900|39849742|FG003|Overall Study|Withdrawal by Subject|18|||
16372769|NCT00289900|39849743|FG004|Overall Study|Withdrawal by Subject|12|||
16372770|NCT00289900|39849744|FG005|Overall Study|Withdrawal by Subject|11|||
16372771|NCT00289900|39849739|FG000|Overall Study|Protocol Violation|3|||
16372772|NCT00289900|39849740|FG001|Overall Study|Protocol Violation|9|||
16372773|NCT00289900|39849741|FG002|Overall Study|Protocol Violation|2|||
16372774|NCT00289900|39849742|FG003|Overall Study|Protocol Violation|6|||
16071211|NCT00927823|38753155|FG002|Continuous Dosing Period|Other|9|||
16071212|NCT00927823|38753156|FG003|Continuous Dosing Period|Other|3|||
16071213|NCT01185522|38753157|FG000|Overall Study|Lack of Efficacy|28|||
16071214|NCT01185522|38753157|FG000|Overall Study|Lost to Follow-up|19|||
16071215|NCT01185522|38753157|FG000|Overall Study|Withdrawal by Subject|10|||
16071216|NCT01185522|38753157|FG000|Overall Study|Poor tolerance|39|||
16071217|NCT01185522|38753157|FG000|Overall Study|Other reasons|12|||
16071218|NCT02918968|38753160|FG000|1st Line AAT|Progressive disease|9|||
16071219|NCT02918968|38753161|FG001|1st Line AAT|Progressive disease|4|||
16071220|NCT02918968|38753160|FG000|1st Line AAT|Adverse Event|12|||
16071221|NCT02918968|38753161|FG001|1st Line AAT|Adverse Event|3|||
16071222|NCT02918968|38753160|FG000|1st Line AAT|Physician Decision|4|||
16071223|NCT02918968|38753161|FG001|1st Line AAT|Physician Decision|2|||
16071224|NCT02918968|38753160|FG000|1st Line AAT|Withdrawal by Subject|2|||
16071225|NCT02918968|38753161|FG001|1st Line AAT|Withdrawal by Subject|1|||
16071226|NCT02918968|38753160|FG000|1st Line AAT|Lost to Follow-up|0|||
16071227|NCT02918968|38753161|FG001|1st Line AAT|Lost to Follow-up|1|||
16071228|NCT02918968|38753160|FG000|1st Line AAT|Death|1|||
16071229|NCT02918968|38753161|FG001|1st Line AAT|Death|0|||
16071230|NCT02918968|38753160|FG000|1st Line AAT|Miscellaneous|1|||
16071231|NCT02918968|38753161|FG001|1st Line AAT|Miscellaneous|0|||
16071232|NCT02918968|38753160|FG000|2nd Line AAT|Progressive disease|21|||
16071233|NCT02918968|38753161|FG001|2nd Line AAT|Progressive disease|3|||
16071234|NCT02918968|38753160|FG000|2nd Line AAT|Adverse Event|2|||
16071235|NCT02918968|38753161|FG001|2nd Line AAT|Adverse Event|5|||
16071236|NCT02918968|38753160|FG000|2nd Line AAT|Physician Decision|0|||
16071237|NCT02918968|38753161|FG001|2nd Line AAT|Physician Decision|1|||
16071238|NCT02918968|38753160|FG000|2nd Line AAT|Withdrawal by Subject|2|||
16071239|NCT02918968|38753161|FG001|2nd Line AAT|Withdrawal by Subject|2|||
16071240|NCT02918968|38753160|FG000|2nd Line AAT|Death|0|||
16071241|NCT02918968|38753161|FG001|2nd Line AAT|Death|1|||
16071242|NCT00880906|38753162|FG000|Overall Study|Lost to Follow-up|0|||
16071243|NCT00880906|38753163|FG001|Overall Study|Lost to Follow-up|1|||
16071244|NCT00880906|38753162|FG000|Overall Study|Did not meet criteria following patholog|12|||
16071245|NCT00880906|38753163|FG001|Overall Study|Did not meet criteria following patholog|6|||
16071246|NCT00197015|38753166|FG000|Overall Study|Adverse Event|3|||
16071247|NCT00197015|38753167|FG001|Overall Study|Adverse Event|0|||
16071248|NCT00197015|38753168|FG002|Overall Study|Adverse Event|1|||
16071249|NCT00197015|38753166|FG000|Overall Study|Protocol Violation|0|||
16071250|NCT00197015|38753167|FG001|Overall Study|Protocol Violation|3|||
16071251|NCT00197015|38753168|FG002|Overall Study|Protocol Violation|3|||
16071252|NCT00197015|38753166|FG000|Overall Study|Withdrawal by Subject|17|||
16071253|NCT00197015|38753167|FG001|Overall Study|Withdrawal by Subject|37|||
16071254|NCT00197015|38753168|FG002|Overall Study|Withdrawal by Subject|34|||
16071255|NCT00197015|38753166|FG000|Overall Study|Lost to Follow-up|28|||
16071256|NCT00197015|38753167|FG001|Overall Study|Lost to Follow-up|46|||
16071257|NCT00197015|38753168|FG002|Overall Study|Lost to Follow-up|37|||
16071258|NCT00197015|38753166|FG000|Overall Study|Other|2|||
16071259|NCT00197015|38753167|FG001|Overall Study|Other|3|||
16071260|NCT00197015|38753168|FG002|Overall Study|Other|2|||
16071261|NCT01810263|38753169|FG000|Overall Study|Lost to Follow-up|8|||
16071262|NCT01810263|38753170|FG001|Overall Study|Lost to Follow-up|7|||
16071263|NCT00603538|38753171|FG000|Overall Study|Adverse Event|0|||
16071264|NCT00603538|38753172|FG001|Overall Study|Adverse Event|4|||
16071265|NCT00603538|38753173|FG002|Overall Study|Adverse Event|2|||
16071266|NCT00603538|38753171|FG000|Overall Study|Objective progression or relapse|3|||
16071267|NCT00603538|38753172|FG001|Overall Study|Objective progression or relapse|0|||
16071268|NCT00603538|38753173|FG002|Overall Study|Objective progression or relapse|0|||
16071269|NCT01183780|38753174|FG000|Overall Study|Withdrawal by Subject|25|||
16071270|NCT01183780|38753175|FG001|Overall Study|Withdrawal by Subject|14|||
16071271|NCT01183780|38753174|FG000|Overall Study|Lost to Follow-up|6|||
16071272|NCT01183780|38753175|FG001|Overall Study|Lost to Follow-up|11|||
16071273|NCT00299702|38753176|FG000|Overall Study|Death|1|||
16071274|NCT00299702|38753177|FG001|Overall Study|Death|0|||
16071275|NCT00299702|38753176|FG000|Overall Study|Adverse Event|0|||
16071276|NCT00299702|38753177|FG001|Overall Study|Adverse Event|4|||
16071277|NCT00299702|38753176|FG000|Overall Study|Lost to Follow-up|18|||
16071278|NCT00299702|38753177|FG001|Overall Study|Lost to Follow-up|10|||
16071279|NCT00299702|38753176|FG000|Overall Study|Withdrawal by Subject|25|||
16071280|NCT00299702|38753177|FG001|Overall Study|Withdrawal by Subject|23|||
16071281|NCT00299702|38753176|FG000|Overall Study|Pregnancy|0|||
16071282|NCT00299702|38753177|FG001|Overall Study|Pregnancy|1|||
16071283|NCT00299702|38753176|FG000|Overall Study|Insufficient Response|4|||
16071284|NCT00299702|38753177|FG001|Overall Study|Insufficient Response|3|||
16071285|NCT00299702|38753176|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
16071286|NCT00299702|38753177|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
16071287|NCT00464672|38753178|FG000|Overall Study|withdrawal of consent|0|||
16071288|NCT00464672|38753179|FG001|Overall Study|withdrawal of consent|0|||
16071289|NCT00464672|38753180|FG002|Overall Study|withdrawal of consent|0|||
16372775|NCT00289900|39849743|FG004|Overall Study|Protocol Violation|7|||
16372776|NCT00289900|39849744|FG005|Overall Study|Protocol Violation|4|||
16372777|NCT00289900|39849739|FG000|Overall Study|site terminated|1|||
16372778|NCT00289900|39849740|FG001|Overall Study|site terminated|0|||
16372779|NCT00289900|39849741|FG002|Overall Study|site terminated|1|||
16372780|NCT00289900|39849742|FG003|Overall Study|site terminated|0|||
16372781|NCT00289900|39849743|FG004|Overall Study|site terminated|0|||
16372782|NCT00289900|39849744|FG005|Overall Study|site terminated|0|||
16372783|NCT00289900|39849739|FG000|Overall Study|Not treated|0|||
16372784|NCT00289900|39849740|FG001|Overall Study|Not treated|1|||
16372785|NCT00289900|39849741|FG002|Overall Study|Not treated|0|||
16372786|NCT00289900|39849742|FG003|Overall Study|Not treated|0|||
16372787|NCT00289900|39849743|FG004|Overall Study|Not treated|0|||
16372788|NCT00289900|39849744|FG005|Overall Study|Not treated|0|||
16372789|NCT03174275|39849753|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
16372790|NCT03174275|39849753|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
16372791|NCT03174275|39849753|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
16372792|NCT03174275|39849753|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
16372793|NCT03174275|39849753|FG000|Adjuvant Chemotherapy|Progression|1|||
16372794|NCT03174275|39849753|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
16372795|NCT03174275|39849753|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
16372796|NCT03174275|39849753|FG000|Adjuvant Durvalumab|Progression|1|||
16372797|NCT03174275|39849753|FG000|Adjuvant Durvalumab|Adverse Event|3|||
16372798|NCT03174275|39849753|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
16372799|NCT03174275|39849753|FG000|Adjuvant Radiotherapy|Progression|1|||
16372800|NCT03174275|39849753|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
16372801|NCT04091438|39849754|FG000|Treatment Period 1 (1 Day)|Other|1|||
16372802|NCT04091438|39849755|FG001|Treatment Period 1 (1 Day)|Other|0|||
16372803|NCT04091438|39849754|FG000|Washout Period (1 Day)|Protocol deviation|0|||
16372804|NCT04091438|39849755|FG001|Washout Period (1 Day)|Protocol deviation|1|||
16372805|NCT04091438|39849754|FG000|Washout Period (1 Day)|Other|0|||
16372806|NCT04091438|39849755|FG001|Washout Period (1 Day)|Other|1|||
16372807|NCT03253627|39849757|FG000|Overall Study|Lost to Follow-up|1|||
16372808|NCT03253627|39849758|FG001|Overall Study|Lost to Follow-up|2|||
16372809|NCT03253627|39849757|FG000|Overall Study|Withdrawal by Subject|0|||
16372810|NCT03253627|39849758|FG001|Overall Study|Withdrawal by Subject|2|||
16372811|NCT03253627|39849757|FG000|Overall Study|Inability to complete MRI|1|||
16372812|NCT03253627|39849758|FG001|Overall Study|Inability to complete MRI|0|||
16372813|NCT04648241|39849759|FG000|Overall Study|Lost to Follow-up|1|||
16372814|NCT04648241|39849760|FG001|Overall Study|Lost to Follow-up|0|||
16372815|NCT00776997|39849761|FG000|Overall Study|Adverse Event|2|||
16372816|NCT03016403|39849762|FG000|Baseline|Death|5|||
16372817|NCT03016403|39849763|FG001|Baseline|Death|8|||
16372818|NCT03016403|39849764|FG002|Baseline|Death|1|||
16372819|NCT03016403|39849765|FG003|Baseline|Death|0|||
16372820|NCT03016403|39849762|FG000|Baseline|Withdrawal by Subject|2|||
16372821|NCT03016403|39849763|FG001|Baseline|Withdrawal by Subject|8|||
16372822|NCT03016403|39849764|FG002|Baseline|Withdrawal by Subject|4|||
16372823|NCT03016403|39849765|FG003|Baseline|Withdrawal by Subject|10|||
16372824|NCT03016403|39849762|FG000|Baseline|Lost to Follow-up|9|||
16372825|NCT03016403|39849763|FG001|Baseline|Lost to Follow-up|11|||
16372826|NCT03016403|39849764|FG002|Baseline|Lost to Follow-up|6|||
16372827|NCT03016403|39849765|FG003|Baseline|Lost to Follow-up|24|||
16372828|NCT03016403|39849762|FG000|6-week Follow-up|Death|1|||
16372829|NCT03016403|39849763|FG001|6-week Follow-up|Death|4|||
16372830|NCT03016403|39849764|FG002|6-week Follow-up|Death|0|||
16372831|NCT03016403|39849765|FG003|6-week Follow-up|Death|0|||
16372832|NCT03016403|39849762|FG000|6-week Follow-up|Lost to Follow-up|2|||
16372833|NCT03016403|39849763|FG001|6-week Follow-up|Lost to Follow-up|7|||
16372834|NCT03016403|39849764|FG002|6-week Follow-up|Lost to Follow-up|4|||
16372835|NCT03016403|39849765|FG003|6-week Follow-up|Lost to Follow-up|8|||
16372836|NCT03016403|39849762|FG000|6-week Follow-up|Withdrawal by Subject|0|||
16372837|NCT03016403|39849763|FG001|6-week Follow-up|Withdrawal by Subject|2|||
16372838|NCT03016403|39849764|FG002|6-week Follow-up|Withdrawal by Subject|0|||
16372839|NCT03016403|39849765|FG003|6-week Follow-up|Withdrawal by Subject|1|||
16372840|NCT03016403|39849762|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
16372841|NCT03016403|39849763|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
16372842|NCT03016403|39849764|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
16372843|NCT03016403|39849765|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
16372844|NCT03016403|39849762|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
16372845|NCT03016403|39849763|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
16372846|NCT03016403|39849764|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
16372847|NCT03016403|39849765|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
16372848|NCT03016403|39849762|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
16372849|NCT03016403|39849763|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
16372850|NCT03016403|39849764|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
16372851|NCT03016403|39849765|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
16071290|NCT00464672|38753181|FG003|Overall Study|withdrawal of consent|1|||
16071291|NCT00464672|38753182|FG004|Overall Study|withdrawal of consent|9|||
16071292|NCT00464672|38753183|FG005|Overall Study|withdrawal of consent|4|||
16071293|NCT00464672|38753178|FG000|Overall Study|Lost to Follow-up|25|||
16071294|NCT00464672|38753179|FG001|Overall Study|Lost to Follow-up|10|||
16071295|NCT00464672|38753180|FG002|Overall Study|Lost to Follow-up|0|||
16372852|NCT03511066|39849768|FG000|Overall Study|Withdrawal by Subject|1|||
16372853|NCT03511066|39849769|FG001|Overall Study|Withdrawal by Subject|2|||
16372854|NCT03511066|39849770|FG002|Overall Study|Withdrawal by Subject|3|||
16372855|NCT03511066|39849768|FG000|Overall Study|Lost to Follow-up|2|||
16372856|NCT03511066|39849769|FG001|Overall Study|Lost to Follow-up|3|||
16372857|NCT03511066|39849770|FG002|Overall Study|Lost to Follow-up|0|||
16372858|NCT00723944|39849787|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
16372859|NCT00723944|39849788|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
16372860|NCT00723944|39849787|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
16372861|NCT00723944|39849788|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
16372862|NCT00723944|39849787|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
16372863|NCT00723944|39849788|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
16372864|NCT00452530|39849793|FG000|Overall Study|Death|1|||
16372865|NCT00452530|39849794|FG001|Overall Study|Death|0|||
16372866|NCT00452530|39849793|FG000|Overall Study|Adverse Event|40|||
16372867|NCT00452530|39849794|FG001|Overall Study|Adverse Event|44|||
16372868|NCT00452530|39849793|FG000|Overall Study|Withdrawal by Subject|68|||
16372869|NCT00452530|39849794|FG001|Overall Study|Withdrawal by Subject|57|||
16372870|NCT00452530|39849793|FG000|Overall Study|Lost to Follow-up|1|||
16372871|NCT00452530|39849794|FG001|Overall Study|Lost to Follow-up|0|||
16372872|NCT00452530|39849793|FG000|Overall Study|Poor compliance/noncompliance|1|||
16372873|NCT00452530|39849794|FG001|Overall Study|Poor compliance/noncompliance|2|||
16372874|NCT00452530|39849793|FG000|Overall Study|No longer met study criteria|18|||
16372875|NCT00452530|39849794|FG001|Overall Study|No longer met study criteria|22|||
16372876|NCT00452530|39849793|FG000|Overall Study|Other|7|||
16372877|NCT00452530|39849794|FG001|Overall Study|Other|11|||
16372878|NCT01502072|39849795|FG000|Overall Study|Withdrawal by Subject|1|||
16372879|NCT01502072|39849796|FG001|Overall Study|Withdrawal by Subject|0|||
16372880|NCT01502072|39849797|FG002|Overall Study|Withdrawal by Subject|0|||
16372881|NCT01502072|39849795|FG000|Overall Study|Death|0|||
16372882|NCT01502072|39849796|FG001|Overall Study|Death|1|||
16372883|NCT01502072|39849797|FG002|Overall Study|Death|0|||
16372884|NCT01703221|39849798|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
16372885|NCT01703221|39849799|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
16372886|NCT01703221|39849800|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
16372887|NCT01703221|39849798|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
16372888|NCT01703221|39849799|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
16372889|NCT01703221|39849800|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
16071296|NCT00464672|38753181|FG003|Overall Study|Lost to Follow-up|0|||
16071297|NCT00464672|38753182|FG004|Overall Study|Lost to Follow-up|1|||
16071298|NCT00464672|38753183|FG005|Overall Study|Lost to Follow-up|0|||
16071299|NCT01193153|38753184|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
16071300|NCT01193153|38753185|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
16071301|NCT01193153|38753184|FG000|Open-label Lead in Period|Pregnancy|1|||
16071302|NCT01193153|38753185|FG001|Open-label Lead in Period|Pregnancy|0|||
16071303|NCT01193153|38753184|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
16071304|NCT01193153|38753185|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
16071305|NCT01193153|38753184|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
16071306|NCT01193153|38753185|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
16071307|NCT01193153|38753184|FG000|Open-label Lead in Period|Other|14|||
16071308|NCT01193153|38753185|FG001|Open-label Lead in Period|Other|0|||
16071309|NCT01193153|38753184|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
16071310|NCT01193153|38753185|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
16071311|NCT01193153|38753184|FG000|Open-label Lead in Period|Adverse Event|41|||
16071312|NCT01193153|38753185|FG001|Open-label Lead in Period|Adverse Event|0|||
16071313|NCT01193153|38753184|FG000|Open-label Lead in Period|Death|1|||
16071314|NCT01193153|38753185|FG001|Open-label Lead in Period|Death|0|||
16071315|NCT01193153|38753184|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
16071316|NCT01193153|38753185|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
16071317|NCT01193153|38753184|FG000|Open-label Stabilization Period|Adverse Event|9|||
16372890|NCT01703221|39849798|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
16372891|NCT01703221|39849799|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16372892|NCT01703221|39849800|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
16372893|NCT01703221|39849798|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
16372894|NCT01703221|39849799|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
16372895|NCT01703221|39849800|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
16071318|NCT01193153|38753185|FG001|Open-label Stabilization Period|Adverse Event|0|||
16372896|NCT01703221|39849798|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16372897|NCT01703221|39849799|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
16071319|NCT01193153|38753184|FG000|Open-label Stabilization Period|Death|2|||
16071320|NCT01193153|38753185|FG001|Open-label Stabilization Period|Death|0|||
16071321|NCT01193153|38753184|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
16448350|NCT02113982|40122114|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448351|NCT02113982|40122115|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448352|NCT02113982|40122116|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448353|NCT02113982|40122117|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
16448354|NCT02113982|40122118|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
16448355|NCT02113982|40122105|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448356|NCT02113982|40122106|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448357|NCT02113982|40122107|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448358|NCT02113982|40122108|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448359|NCT02113982|40122109|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448360|NCT02113982|40122110|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448361|NCT02113982|40122111|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448362|NCT02113982|40122112|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448363|NCT02113982|40122113|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16372898|NCT01703221|39849800|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
16372899|NCT01703221|39849798|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
16372900|NCT01703221|39849799|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
16372901|NCT01703221|39849800|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
16372902|NCT01703221|39849798|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
16372903|NCT01703221|39849799|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
16372904|NCT01703221|39849800|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
16372905|NCT01703221|39849798|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
16372906|NCT01703221|39849799|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
16372907|NCT01703221|39849800|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
16372908|NCT04821245|39849801|FG000|Overall Study|Withdrawal by Subject|3|||
16372909|NCT04821245|39849801|FG000|Overall Study|Physician Decision|1|||
16372910|NCT04821245|39849801|FG000|Overall Study|Protocol Violation|5|||
16372911|NCT01783015|39849802|FG000|Blinded Treatment|Adverse Event|0|||
16372912|NCT01783015|39849803|FG001|Blinded Treatment|Adverse Event|1|||
16372913|NCT01783015|39849804|FG002|Blinded Treatment|Adverse Event|0|||
16372914|NCT01783015|39849802|FG000|Blinded Treatment|Protocol Violation|0|||
16372915|NCT01783015|39849803|FG001|Blinded Treatment|Protocol Violation|1|||
16372916|NCT01783015|39849804|FG002|Blinded Treatment|Protocol Violation|0|||
16448364|NCT02113982|40122114|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448365|NCT02113982|40122115|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448366|NCT02113982|40122116|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448367|NCT02113982|40122117|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
16448368|NCT02113982|40122118|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
16448369|NCT02113982|40122105|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448370|NCT02113982|40122106|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16071322|NCT01193153|38753185|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
16071323|NCT01193153|38753184|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
16071324|NCT01193153|38753185|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
16071325|NCT01193153|38753184|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
16071326|NCT01193153|38753185|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
16071327|NCT01193153|38753184|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
16071328|NCT01193153|38753185|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
16071329|NCT01193153|38753184|FG000|Open-label Stabilization Period|Other|8|||
16071330|NCT01193153|38753185|FG001|Open-label Stabilization Period|Other|0|||
16071331|NCT01193153|38753184|FG000|Double Blind Relapse Prevention Period|Other|2|||
16071332|NCT01193153|38753185|FG001|Double Blind Relapse Prevention Period|Other|3|||
16071333|NCT01193153|38753184|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
16071334|NCT01193153|38753185|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
16071335|NCT01193153|38753184|FG000|Double Blind Relapse Prevention Period|Death|2|||
16071336|NCT01193153|38753185|FG001|Double Blind Relapse Prevention Period|Death|0|||
16071337|NCT01193153|38753184|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
16071338|NCT01193153|38753185|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
16071339|NCT01193153|38753184|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
16071340|NCT01193153|38753185|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
16071341|NCT01193153|38753184|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
16071342|NCT01193153|38753185|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
16071343|NCT01193153|38753184|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
16071344|NCT01193153|38753185|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
16071345|NCT01193153|38753184|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
16071346|NCT01193153|38753185|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
16372917|NCT01783015|39849802|FG000|Blinded Treatment|Withdrawal by Subject|0|||
16448371|NCT02113982|40122107|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448372|NCT02113982|40122108|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448373|NCT02113982|40122109|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448374|NCT02113982|40122110|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448375|NCT02113982|40122111|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448376|NCT02113982|40122112|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448377|NCT02113982|40122113|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448378|NCT02113982|40122114|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448379|NCT02113982|40122115|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448380|NCT02113982|40122116|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448381|NCT02113982|40122117|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
16448382|NCT02113982|40122118|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
16448383|NCT02170077|40122119|FG000|Overall Study|Withdrawal by Subject|3|||
16448384|NCT02170077|40122120|FG001|Overall Study|Withdrawal by Subject|4|||
16448385|NCT02170077|40122121|FG002|Overall Study|Withdrawal by Subject|2|||
16448386|NCT02170077|40122119|FG000|Overall Study|Adverse Event|4|||
16448387|NCT02170077|40122120|FG001|Overall Study|Adverse Event|4|||
16448388|NCT02170077|40122121|FG002|Overall Study|Adverse Event|4|||
16448389|NCT02170077|40122119|FG000|Overall Study|Lost to Follow-up|0|||
16448390|NCT02170077|40122120|FG001|Overall Study|Lost to Follow-up|1|||
16448391|NCT02170077|40122121|FG002|Overall Study|Lost to Follow-up|0|||
16448392|NCT02170077|40122119|FG000|Overall Study|Exclusion criteria|2|||
16448393|NCT02170077|40122120|FG001|Overall Study|Exclusion criteria|2|||
16448394|NCT02170077|40122121|FG002|Overall Study|Exclusion criteria|5|||
16448395|NCT02170077|40122119|FG000|Overall Study|Exacerbation of seizures|0|||
16448396|NCT02170077|40122120|FG001|Overall Study|Exacerbation of seizures|2|||
16448397|NCT02170077|40122121|FG002|Overall Study|Exacerbation of seizures|1|||
16448398|NCT02851615|40122122|FG000|Overall Study|Cognitive Issue|1|||
16448399|NCT02851615|40122123|FG001|Overall Study|Cognitive Issue|0|||
16448400|NCT02851615|40122122|FG000|Overall Study|Lost to Follow-up|0|||
16448401|NCT02851615|40122123|FG001|Overall Study|Lost to Follow-up|4|||
16448402|NCT00408317|40122127|FG000|First Intervention Period|Adverse Event|0|||
16448403|NCT00408317|40122128|FG001|First Intervention Period|Adverse Event|1|||
16448404|NCT00408317|40122127|FG000|Second Intervention Period|Adverse Event|2|||
16448405|NCT00408317|40122128|FG001|Second Intervention Period|Adverse Event|0|||
16448406|NCT00408317|40122127|FG000|Second Intervention Period|Protocol Violation|0|||
16448407|NCT00408317|40122128|FG001|Second Intervention Period|Protocol Violation|1|||
16448408|NCT00408317|40122127|FG000|Second Intervention Period|Withdrawal of consent|0|||
16448409|NCT00408317|40122128|FG001|Second Intervention Period|Withdrawal of consent|1|||
16448410|NCT02952820|40122131|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
16448411|NCT02952820|40122132|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
16448412|NCT02952820|40122133|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
16448413|NCT02952820|40122131|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
16448414|NCT02952820|40122132|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
16448415|NCT02952820|40122133|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
16448416|NCT02952820|40122131|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
16448417|NCT02952820|40122132|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
16448418|NCT02952820|40122133|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
16448419|NCT02952820|40122131|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
16448420|NCT02952820|40122132|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
16448421|NCT02952820|40122133|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
16448422|NCT02952820|40122131|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
16448423|NCT02952820|40122132|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
16448424|NCT02952820|40122133|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
16448425|NCT02952820|40122131|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
16448426|NCT02952820|40122132|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
16071347|NCT01956669|38753186|FG000|Overall Study|Disease Progression|12|||
16071348|NCT01956669|38753187|FG001|Overall Study|Disease Progression|7|||
16071349|NCT01956669|38753188|FG002|Overall Study|Disease Progression|7|||
16071350|NCT01956669|38753189|FG003|Overall Study|Disease Progression|8|||
16071351|NCT01956669|38753190|FG004|Overall Study|Disease Progression|4|||
16071352|NCT01956669|38753191|FG005|Overall Study|Disease Progression|3|||
16071353|NCT01956669|38753192|FG006|Overall Study|Disease Progression|5|||
16071354|NCT01956669|38753186|FG000|Overall Study|Adverse Event|0|||
16448427|NCT02952820|40122133|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
16448428|NCT02952820|40122131|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
16448429|NCT02952820|40122132|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
16071355|NCT01956669|38753187|FG001|Overall Study|Adverse Event|2|||
16071356|NCT01956669|38753188|FG002|Overall Study|Adverse Event|2|||
16071357|NCT01956669|38753189|FG003|Overall Study|Adverse Event|1|||
16071358|NCT01956669|38753190|FG004|Overall Study|Adverse Event|0|||
16071359|NCT01956669|38753191|FG005|Overall Study|Adverse Event|0|||
16071360|NCT01956669|38753192|FG006|Overall Study|Adverse Event|0|||
16071361|NCT01956669|38753186|FG000|Overall Study|Physician Decision|0|||
16071362|NCT01956669|38753187|FG001|Overall Study|Physician Decision|2|||
16071363|NCT01956669|38753188|FG002|Overall Study|Physician Decision|0|||
16071364|NCT01956669|38753189|FG003|Overall Study|Physician Decision|0|||
16071365|NCT01956669|38753190|FG004|Overall Study|Physician Decision|0|||
16071366|NCT01956669|38753191|FG005|Overall Study|Physician Decision|1|||
16071367|NCT01956669|38753192|FG006|Overall Study|Physician Decision|0|||
16071368|NCT01956669|38753186|FG000|Overall Study|Withdrawal by Subject|0|||
16071369|NCT01956669|38753187|FG001|Overall Study|Withdrawal by Subject|0|||
16071370|NCT01956669|38753188|FG002|Overall Study|Withdrawal by Subject|1|||
16071371|NCT01956669|38753189|FG003|Overall Study|Withdrawal by Subject|1|||
16071372|NCT01956669|38753190|FG004|Overall Study|Withdrawal by Subject|0|||
16071373|NCT01956669|38753191|FG005|Overall Study|Withdrawal by Subject|0|||
16071374|NCT01956669|38753192|FG006|Overall Study|Withdrawal by Subject|1|||
16071375|NCT03125382|38753197|FG000|Randomization|screening failure|1|||
16071376|NCT03125382|38753198|FG001|Randomization|screening failure|4|||
16071377|NCT03125382|38753199|FG002|Randomization|screening failure|2|||
16071378|NCT03125382|38753200|FG003|Randomization|screening failure|0|||
16071379|NCT03125382|38753197|FG000|Follow-up|Death|1|||
16071380|NCT03125382|38753198|FG001|Follow-up|Death|2|||
16071381|NCT03125382|38753199|FG002|Follow-up|Death|1|||
16071382|NCT03125382|38753200|FG003|Follow-up|Death|2|||
16071383|NCT03125382|38753197|FG000|Follow-up|Lost to Follow-up|1|||
16071384|NCT03125382|38753198|FG001|Follow-up|Lost to Follow-up|4|||
16071385|NCT03125382|38753199|FG002|Follow-up|Lost to Follow-up|3|||
16071386|NCT03125382|38753200|FG003|Follow-up|Lost to Follow-up|1|||
16071387|NCT02503202|38753201|FG000|Base Study: Up to Month 6|Death|1|||
16071388|NCT02503202|38753202|FG001|Base Study: Up to Month 6|Death|1|||
16071389|NCT02503202|38753203|FG002|Base Study: Up to Month 6|Death|0|||
16071390|NCT02503202|38753204|FG003|Base Study: Up to Month 6|Death|0|||
16071391|NCT02503202|38753205|FG004|Base Study: Up to Month 6|Death|0|||
16071392|NCT02503202|38753201|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
16071393|NCT02503202|38753202|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
16071394|NCT02503202|38753203|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
16071395|NCT02503202|38753204|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
16071396|NCT02503202|38753205|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
16071397|NCT02503202|38753201|FG000|Base Study: Up to Month 6|Physician Decision|0|||
16071398|NCT02503202|38753202|FG001|Base Study: Up to Month 6|Physician Decision|0|||
16071399|NCT02503202|38753203|FG002|Base Study: Up to Month 6|Physician Decision|0|||
16071400|NCT02503202|38753204|FG003|Base Study: Up to Month 6|Physician Decision|0|||
16071401|NCT02503202|38753205|FG004|Base Study: Up to Month 6|Physician Decision|1|||
16071402|NCT02503202|38753201|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
16071403|NCT02503202|38753202|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
16071404|NCT02503202|38753203|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
16071405|NCT02503202|38753204|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
16071406|NCT02503202|38753205|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
16071407|NCT02503202|38753201|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
16071408|NCT02503202|38753202|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
16071409|NCT02503202|38753203|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
16071410|NCT02503202|38753204|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
16071411|NCT02503202|38753205|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
16071412|NCT02503202|38753201|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
16071413|NCT02503202|38753202|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
16071414|NCT02503202|38753203|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
16071415|NCT02503202|38753204|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
16071416|NCT02503202|38753205|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
16071417|NCT02503202|38753201|FG000|Extension: Month 6 to 24|Death|1|||
16071418|NCT02503202|38753202|FG001|Extension: Month 6 to 24|Death|0|||
16071419|NCT02503202|38753203|FG002|Extension: Month 6 to 24|Death|0|||
16071420|NCT02503202|38753204|FG003|Extension: Month 6 to 24|Death|0|||
16071421|NCT02503202|38753205|FG004|Extension: Month 6 to 24|Death|0|||
16071422|NCT02503202|38753201|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
16071423|NCT02503202|38753202|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
16071424|NCT02503202|38753203|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
16071425|NCT02503202|38753204|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
16071426|NCT02503202|38753205|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
16071427|NCT02503202|38753201|FG000|Extension: Month 6 to 24|Physician Decision|1|||
16071428|NCT02503202|38753202|FG001|Extension: Month 6 to 24|Physician Decision|0|||
16071429|NCT02503202|38753203|FG002|Extension: Month 6 to 24|Physician Decision|1|||
16071430|NCT02503202|38753204|FG003|Extension: Month 6 to 24|Physician Decision|3|||
16071431|NCT02503202|38753205|FG004|Extension: Month 6 to 24|Physician Decision|0|||
16071432|NCT02503202|38753201|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
16448430|NCT02952820|40122133|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
16448431|NCT02952820|40122131|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
16448432|NCT02952820|40122132|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
16448433|NCT02952820|40122133|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
16448434|NCT02952820|40122131|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
16448435|NCT02952820|40122132|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
16448436|NCT02952820|40122133|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
16448437|NCT02952820|40122131|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
16448438|NCT02952820|40122132|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
16448439|NCT02952820|40122133|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
16448440|NCT02952820|40122131|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
16448441|NCT02952820|40122132|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
16448442|NCT02952820|40122133|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
16448443|NCT02952820|40122131|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
16448444|NCT02952820|40122132|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
16448445|NCT02952820|40122133|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
16448446|NCT02952820|40122131|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
16448447|NCT02952820|40122132|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
16448448|NCT02952820|40122133|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
16448449|NCT02952820|40122131|FG000|Active Treatment Period (6 Months)|Not treated|0|||
16448450|NCT02952820|40122132|FG001|Active Treatment Period (6 Months)|Not treated|0|||
16448451|NCT02952820|40122133|FG002|Active Treatment Period (6 Months)|Not treated|1|||
16448452|NCT01352793|40122135|FG000|Overall Study|Lost to Follow-up|289|||
16448453|NCT01352793|40122136|FG001|Overall Study|Lost to Follow-up|125|||
16448454|NCT01352793|40122135|FG000|Overall Study|Withdrawal by Subject|120|||
16448455|NCT01352793|40122136|FG001|Overall Study|Withdrawal by Subject|55|||
16448456|NCT01352793|40122135|FG000|Overall Study|Protocol Violation|44|||
16448457|NCT01352793|40122136|FG001|Overall Study|Protocol Violation|23|||
16448458|NCT01352793|40122135|FG000|Overall Study|Adverse Event|44|||
16448459|NCT01352793|40122136|FG001|Overall Study|Adverse Event|10|||
16448460|NCT01352793|40122135|FG000|Overall Study|Physician Decision|1|||
16448461|NCT01352793|40122136|FG001|Overall Study|Physician Decision|0|||
16448462|NCT01352793|40122135|FG000|Overall Study|Pregnancy|26|||
16448463|NCT01352793|40122136|FG001|Overall Study|Pregnancy|8|||
16448464|NCT01352793|40122135|FG000|Overall Study|Other|25|||
16448465|NCT01352793|40122136|FG001|Overall Study|Other|7|||
16448466|NCT01352793|40122135|FG000|Overall Study|Medication error|2|||
16071433|NCT02503202|38753202|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
16071434|NCT02503202|38753203|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
16071435|NCT02503202|38753204|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
16071436|NCT02503202|38753205|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
16071437|NCT02784704|38753207|FG000|Overall Study|Adverse Event|4|||
16071438|NCT02784704|38753208|FG001|Overall Study|Adverse Event|2|||
16071439|NCT02784704|38753207|FG000|Overall Study|Lost to Follow-up|6|||
16071440|NCT02784704|38753208|FG001|Overall Study|Lost to Follow-up|4|||
16071441|NCT02784704|38753207|FG000|Overall Study|Withdrawal by Subject|1|||
16071442|NCT02784704|38753208|FG001|Overall Study|Withdrawal by Subject|3|||
16071443|NCT02784704|38753207|FG000|Overall Study|Subject Non Compliance|2|||
16071444|NCT02784704|38753208|FG001|Overall Study|Subject Non Compliance|0|||
16071445|NCT00763282|38753209|FG000|Overall Study|Withdrawal by Subject|6|||
16071446|NCT00763282|38753210|FG001|Overall Study|Withdrawal by Subject|5|||
16071447|NCT00763282|38753209|FG000|Overall Study|Death|4|||
16071448|NCT00763282|38753210|FG001|Overall Study|Death|3|||
16071449|NCT00763282|38753209|FG000|Overall Study|Lost to Follow-up|22|||
16071450|NCT00763282|38753210|FG001|Overall Study|Lost to Follow-up|26|||
16071451|NCT02131324|38753211|FG000|Overall Study|Withdrawal by Subject|1|||
16071452|NCT02131324|38753212|FG001|Overall Study|Withdrawal by Subject|2|||
16071453|NCT02131324|38753211|FG000|Overall Study|Lost to Follow-up|1|||
16071454|NCT02131324|38753212|FG001|Overall Study|Lost to Follow-up|1|||
16071455|NCT00547118|38753213|FG000|Overall Study|Did not qualify prior to starting drug|1|||
16071456|NCT00547118|38753214|FG001|Overall Study|Did not qualify prior to starting drug|1|||
16071457|NCT00547118|38753213|FG000|Overall Study|Study suspended|7|||
16071458|NCT00547118|38753214|FG001|Overall Study|Study suspended|8|||
16071459|NCT03418324|38753215|FG000|Overall Study|Death|0|||
16071460|NCT03418324|38753216|FG001|Overall Study|Death|1|||
16071461|NCT03418324|38753215|FG000|Overall Study|Physician Decision|1|||
16071462|NCT03418324|38753216|FG001|Overall Study|Physician Decision|1|||
16071463|NCT01801930|38753217|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
16071464|NCT01801930|38753218|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
16071465|NCT01801930|38753219|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
16161746|NCT01557166|39072479|FG000|Overall Study|Target dose not tolerated|1|||
16448467|NCT01352793|40122136|FG001|Overall Study|Medication error|2|||
16448468|NCT01352793|40122135|FG000|Overall Study|Death|1|||
16448469|NCT01352793|40122136|FG001|Overall Study|Death|0|||
16448470|NCT01352793|40122135|FG000|Overall Study|Randomized but not vaccinated|8|||
16448471|NCT01352793|40122136|FG001|Overall Study|Randomized but not vaccinated|0|||
16448472|NCT01352793|40122135|FG000|Overall Study|No longer meets eligibility criteria|25|||
16448473|NCT01352793|40122136|FG001|Overall Study|No longer meets eligibility criteria|15|||
16448474|NCT01488890|40122138|FG000|Overall Study|Serious adverse event|2|||
16448475|NCT01488890|40122139|FG001|Overall Study|Serious adverse event|0|||
16448476|NCT01488890|40122140|FG002|Overall Study|Serious adverse event|0|||
16448477|NCT01488890|40122141|FG003|Overall Study|Serious adverse event|0|||
16448478|NCT01488890|40122138|FG000|Overall Study|Protocol Violation|3|||
16448479|NCT01488890|40122139|FG001|Overall Study|Protocol Violation|0|||
16448480|NCT01488890|40122140|FG002|Overall Study|Protocol Violation|4|||
16071466|NCT01801930|38753220|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
16071467|NCT01801930|38753217|FG000|Overall Study|DLT occurs|0|||
16071468|NCT01801930|38753218|FG001|Overall Study|DLT occurs|1|||
16071469|NCT01801930|38753219|FG002|Overall Study|DLT occurs|0|||
16071470|NCT01801930|38753220|FG003|Overall Study|DLT occurs|0|||
16071471|NCT01689519|38753221|FG000|Intent to Treat|Death|157|||
16071472|NCT01689519|38753222|FG001|Intent to Treat|Death|167|||
16071473|NCT01689519|38753221|FG000|Intent to Treat|Lost to Follow-up|4|||
16071474|NCT01689519|38753222|FG001|Intent to Treat|Lost to Follow-up|8|||
16071475|NCT01689519|38753221|FG000|Intent to Treat|Other|2|||
16071476|NCT01689519|38753222|FG001|Intent to Treat|Other|4|||
16071477|NCT01689519|38753221|FG000|Intent to Treat|Physician Decision|4|||
16071478|NCT01689519|38753222|FG001|Intent to Treat|Physician Decision|1|||
16071479|NCT01689519|38753221|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
16071480|NCT01689519|38753222|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
16071481|NCT01689519|38753221|FG000|Intent to Treat|Withdrawal by Subject|21|||
16071482|NCT01689519|38753222|FG001|Intent to Treat|Withdrawal by Subject|20|||
16071483|NCT01689519|38753221|FG000|Safety Population|Death|158|||
16071484|NCT01689519|38753222|FG001|Safety Population|Death|165|||
16071485|NCT01689519|38753221|FG000|Safety Population|Lost to Follow-up|4|||
16071486|NCT01689519|38753222|FG001|Safety Population|Lost to Follow-up|8|||
16071487|NCT01689519|38753221|FG000|Safety Population|Other|2|||
16071488|NCT01689519|38753222|FG001|Safety Population|Other|4|||
16071489|NCT01689519|38753221|FG000|Safety Population|Physician Decision|4|||
16071490|NCT01689519|38753222|FG001|Safety Population|Physician Decision|1|||
16071491|NCT01689519|38753221|FG000|Safety Population|Study Terminated By Sponsor|60|||
16071492|NCT01689519|38753222|FG001|Safety Population|Study Terminated By Sponsor|47|||
16071493|NCT01689519|38753221|FG000|Safety Population|Withdrawal by Subject|20|||
16071494|NCT01689519|38753222|FG001|Safety Population|Withdrawal by Subject|20|||
16071495|NCT03068468|38753228|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
16071496|NCT03068468|38753229|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
16071497|NCT03068468|38753230|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
16071498|NCT03068468|38753231|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
16071499|NCT03068468|38753228|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
16071500|NCT03068468|38753229|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
16071501|NCT03068468|38753230|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
16071502|NCT03068468|38753231|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
16071503|NCT03068468|38753228|FG000|Placebo-Controlled Period|Adverse Event|16|||
16071504|NCT03068468|38753229|FG001|Placebo-Controlled Period|Adverse Event|21|||
16071505|NCT03068468|38753230|FG002|Placebo-Controlled Period|Adverse Event|0|||
16071506|NCT03068468|38753231|FG003|Placebo-Controlled Period|Adverse Event|0|||
16071507|NCT03068468|38753228|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
16071508|NCT03068468|38753229|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
16071509|NCT03068468|38753230|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
16071510|NCT03068468|38753231|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
16071511|NCT03068468|38753228|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
16071512|NCT03068468|38753229|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
16071513|NCT03068468|38753230|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16071514|NCT03068468|38753231|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
16071515|NCT03068468|38753228|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
16071516|NCT03068468|38753229|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
16071517|NCT03068468|38753230|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
16071518|NCT03068468|38753231|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
16071519|NCT03068468|38753228|FG000|Placebo-Controlled Period|Death|0|||
16071520|NCT03068468|38753229|FG001|Placebo-Controlled Period|Death|1|||
16071521|NCT03068468|38753230|FG002|Placebo-Controlled Period|Death|0|||
16071522|NCT03068468|38753231|FG003|Placebo-Controlled Period|Death|0|||
16071523|NCT03068468|38753228|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
16071524|NCT03068468|38753229|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
16071525|NCT03068468|38753230|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
16448481|NCT01488890|40122141|FG003|Overall Study|Protocol Violation|0|||
16448482|NCT01488890|40122138|FG000|Overall Study|Lost to Follow-up|13|||
16448483|NCT01488890|40122139|FG001|Overall Study|Lost to Follow-up|10|||
16448484|NCT01488890|40122140|FG002|Overall Study|Lost to Follow-up|20|||
16071526|NCT03068468|38753231|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
16071527|NCT03068468|38753228|FG000|Open-Label Extension Period|Adverse Event|0|||
16071528|NCT03068468|38753229|FG001|Open-Label Extension Period|Adverse Event|0|||
16071529|NCT03068468|38753230|FG002|Open-Label Extension Period|Adverse Event|13|||
16071530|NCT03068468|38753231|FG003|Open-Label Extension Period|Adverse Event|17|||
16071531|NCT03068468|38753228|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
16071532|NCT03068468|38753229|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
16448485|NCT01488890|40122141|FG003|Overall Study|Lost to Follow-up|3|||
16448486|NCT01488890|40122138|FG000|Overall Study|Withdrawal by Subject|14|||
16448487|NCT01488890|40122139|FG001|Overall Study|Withdrawal by Subject|10|||
16448488|NCT01488890|40122140|FG002|Overall Study|Withdrawal by Subject|11|||
16448489|NCT01488890|40122141|FG003|Overall Study|Withdrawal by Subject|2|||
16448490|NCT03697252|40122142|FG000|Overall Study|Adverse Event|3|||
16448491|NCT03697252|40122143|FG001|Overall Study|Adverse Event|2|||
16448492|NCT03697252|40122142|FG000|Overall Study|Withdrawal by Subject|14|||
16448493|NCT03697252|40122143|FG001|Overall Study|Withdrawal by Subject|14|||
16448494|NCT03697252|40122142|FG000|Overall Study|Lost to Follow-up|0|||
16448495|NCT03697252|40122143|FG001|Overall Study|Lost to Follow-up|1|||
16448496|NCT03697252|40122142|FG000|Overall Study|Physician Decision|1|||
16448497|NCT03697252|40122143|FG001|Overall Study|Physician Decision|1|||
16448498|NCT03697252|40122142|FG000|Overall Study|Other|0|||
16448499|NCT03697252|40122143|FG001|Overall Study|Other|1|||
16448500|NCT00907335|40122144|FG000|Overall Study|Withdrawal by Subject|2|||
16448501|NCT00907335|40122145|FG001|Overall Study|Withdrawal by Subject|0|||
16448502|NCT00907335|40122144|FG000|Overall Study|Adverse Event|4|||
16448503|NCT00907335|40122145|FG001|Overall Study|Adverse Event|1|||
16448504|NCT00907335|40122144|FG000|Overall Study|Lost to Follow-up|2|||
16448505|NCT00907335|40122145|FG001|Overall Study|Lost to Follow-up|0|||
16448506|NCT00998296|40122146|FG000|Overall Study|Progressive disease|0|||
16448507|NCT00998296|40122147|FG001|Overall Study|Progressive disease|1|||
16448508|NCT00998296|40122148|FG002|Overall Study|Progressive disease|0|||
16448509|NCT00998296|40122149|FG003|Overall Study|Progressive disease|0|||
16448510|NCT00998296|40122150|FG004|Overall Study|Progressive disease|0|||
16448511|NCT00998296|40122151|FG005|Overall Study|Progressive disease|0|||
16448512|NCT00998296|40122152|FG006|Overall Study|Progressive disease|1|||
16448513|NCT00998296|40122153|FG007|Overall Study|Progressive disease|0|||
16448514|NCT00998296|40122154|FG008|Overall Study|Progressive disease|0|||
16448515|NCT00998296|40122155|FG009|Overall Study|Progressive disease|14|||
16448516|NCT00998296|40122156|FG010|Overall Study|Progressive disease|5|||
16448517|NCT00998296|40122146|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
16448518|NCT00998296|40122147|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
16448519|NCT00998296|40122148|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
16448520|NCT00998296|40122149|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
16448521|NCT00998296|40122150|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
16448522|NCT00998296|40122151|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
16448523|NCT00998296|40122152|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
16448524|NCT00998296|40122153|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
16448525|NCT00998296|40122154|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
16448526|NCT00998296|40122155|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
16448527|NCT00998296|40122156|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
16448528|NCT00998296|40122146|FG000|Overall Study|Other adverse event|0|||
16448529|NCT00998296|40122147|FG001|Overall Study|Other adverse event|0|||
16448530|NCT00998296|40122148|FG002|Overall Study|Other adverse event|0|||
16448531|NCT00998296|40122149|FG003|Overall Study|Other adverse event|0|||
16448532|NCT00998296|40122150|FG004|Overall Study|Other adverse event|1|||
16448533|NCT00998296|40122151|FG005|Overall Study|Other adverse event|0|||
16448534|NCT00998296|40122152|FG006|Overall Study|Other adverse event|0|||
16448535|NCT00998296|40122153|FG007|Overall Study|Other adverse event|0|||
16448536|NCT00998296|40122154|FG008|Overall Study|Other adverse event|0|||
16448537|NCT00998296|40122155|FG009|Overall Study|Other adverse event|1|||
16448538|NCT00998296|40122156|FG010|Overall Study|Other adverse event|2|||
16448539|NCT00998296|40122146|FG000|Overall Study|Refused to continue taking trial med.|0|||
16448540|NCT00998296|40122147|FG001|Overall Study|Refused to continue taking trial med.|0|||
16448541|NCT00998296|40122148|FG002|Overall Study|Refused to continue taking trial med.|0|||
16448542|NCT00998296|40122149|FG003|Overall Study|Refused to continue taking trial med.|0|||
16071533|NCT03068468|38753230|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
16071534|NCT03068468|38753231|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
16448543|NCT00998296|40122150|FG004|Overall Study|Refused to continue taking trial med.|0|||
16448544|NCT00998296|40122151|FG005|Overall Study|Refused to continue taking trial med.|0|||
16448545|NCT00998296|40122152|FG006|Overall Study|Refused to continue taking trial med.|0|||
16448546|NCT00998296|40122153|FG007|Overall Study|Refused to continue taking trial med.|0|||
16448547|NCT00998296|40122154|FG008|Overall Study|Refused to continue taking trial med.|0|||
16448548|NCT00998296|40122155|FG009|Overall Study|Refused to continue taking trial med.|2|||
16448549|NCT00998296|40122156|FG010|Overall Study|Refused to continue taking trial med.|0|||
16448550|NCT00998296|40122146|FG000|Overall Study|Reason other than those specified above|0|||
16448551|NCT00998296|40122147|FG001|Overall Study|Reason other than those specified above|0|||
16448552|NCT00998296|40122148|FG002|Overall Study|Reason other than those specified above|0|||
16448553|NCT00998296|40122149|FG003|Overall Study|Reason other than those specified above|0|||
16448554|NCT00998296|40122150|FG004|Overall Study|Reason other than those specified above|0|||
16448555|NCT00998296|40122151|FG005|Overall Study|Reason other than those specified above|0|||
16448556|NCT00998296|40122152|FG006|Overall Study|Reason other than those specified above|0|||
16448557|NCT00998296|40122153|FG007|Overall Study|Reason other than those specified above|0|||
16448558|NCT00998296|40122154|FG008|Overall Study|Reason other than those specified above|0|||
16448559|NCT00998296|40122155|FG009|Overall Study|Reason other than those specified above|1|||
16448560|NCT00998296|40122156|FG010|Overall Study|Reason other than those specified above|0|||
16448561|NCT01760733|40122167|FG000|Waiting List|Death|18|||
16448562|NCT01760733|40122167|FG000|Waiting List|Removed from waiting list|41|||
16448563|NCT01760733|40122167|FG000|Waiting List|Not received a transplant yet|13|||
16448564|NCT01760733|40122167|FG000|Transplanted|Not reached 10 years post transplant|184|||
16448565|NCT01760733|40122167|FG000|Transplanted|Death|26|||
16448566|NCT01760733|40122167|FG000|Transplanted|Graft loss|7|||
16448567|NCT03387085|40122175|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
16448568|NCT00803569|40122176|FG000|Overall Study|Progressive Disease|3|||
16448569|NCT00803569|40122176|FG000|Overall Study|Noncompliance|1|||
16448570|NCT04476797|40122179|FG000|Overall Study|Withdrawal by Subject|1|||
16448571|NCT04476797|40122180|FG001|Overall Study|Withdrawal by Subject|0|||
16448572|NCT04476797|40122181|FG002|Overall Study|Withdrawal by Subject|0|||
16448573|NCT04476797|40122179|FG000|Overall Study|Death|0|||
16448574|NCT04476797|40122180|FG001|Overall Study|Death|1|||
16448575|NCT04476797|40122181|FG002|Overall Study|Death|2|||
16448576|NCT04476797|40122179|FG000|Overall Study|Sponsor Terminated Study|0|||
16448577|NCT04476797|40122180|FG001|Overall Study|Sponsor Terminated Study|18|||
16448578|NCT04476797|40122181|FG002|Overall Study|Sponsor Terminated Study|17|||
16448579|NCT01442103|40122182|FG000|Overall Study|Lost to Follow-up|2|||
16448580|NCT01021020|40122183|FG000|Period I|Protocol Violation|1|||
16448581|NCT01021020|40122183|FG000|Period I|Withdrawal by Subject|1|||
16448582|NCT01021020|40122183|FG000|14 Day Washout Period A|Physician Decision|1|||
16448583|NCT03895840|40122184|FG000|Overall Study|Withdrawal by Subject|21|||
16448584|NCT00975780|40122185|FG000|Follow Up|Death|88|||
16448585|NCT00975780|40122186|FG001|Follow Up|Death|122|||
16448586|NCT00975780|40122185|FG000|Follow Up|Facility Withdrawal|7|||
16448587|NCT00975780|40122186|FG001|Follow Up|Facility Withdrawal|23|||
16448588|NCT00975780|40122185|FG000|Follow Up|Discharged from Facility|7|||
16448589|NCT00975780|40122186|FG001|Follow Up|Discharged from Facility|12|||
16448590|NCT00953056|40122190|FG000|Overall Study|Withdrew Consent|0|||
16448591|NCT00953056|40122191|FG001|Overall Study|Withdrew Consent|0|||
16448592|NCT00953056|40122192|FG002|Overall Study|Withdrew Consent|0|||
16448593|NCT00953056|40122193|FG003|Overall Study|Withdrew Consent|0|||
16448594|NCT00953056|40122194|FG004|Overall Study|Withdrew Consent|2|||
16448595|NCT00953056|40122195|FG005|Overall Study|Withdrew Consent|3|||
16448596|NCT00953056|40122190|FG000|Overall Study|Serious Adverse Event|0|||
16448597|NCT00953056|40122191|FG001|Overall Study|Serious Adverse Event|0|||
16448598|NCT00953056|40122192|FG002|Overall Study|Serious Adverse Event|0|||
16448599|NCT00953056|40122193|FG003|Overall Study|Serious Adverse Event|0|||
16448600|NCT00953056|40122194|FG004|Overall Study|Serious Adverse Event|0|||
16448601|NCT00953056|40122195|FG005|Overall Study|Serious Adverse Event|1|||
16448602|NCT02581410|40122196|FG000|Vaccination Phase|Adverse Event|2|||
16448603|NCT02581410|40122197|FG001|Vaccination Phase|Adverse Event|1|||
16448604|NCT02581410|40122196|FG000|Vaccination Phase|Withdrawal by Subject|0|||
16448605|NCT02581410|40122197|FG001|Vaccination Phase|Withdrawal by Subject|1|||
16448606|NCT02581410|40122196|FG000|Vaccination Phase|Migrated/moved from study area|0|||
16448607|NCT02581410|40122197|FG001|Vaccination Phase|Migrated/moved from study area|1|||
16448608|NCT02581410|40122196|FG000|End of Study Phase|Adverse Event|4|||
16448609|NCT02581410|40122197|FG001|End of Study Phase|Adverse Event|3|||
16448610|NCT02581410|40122196|FG000|End of Study Phase|Withdrawal by Subject|1|||
16448611|NCT02581410|40122197|FG001|End of Study Phase|Withdrawal by Subject|2|||
16448612|NCT02581410|40122196|FG000|End of Study Phase|Migrated/moved from study area|0|||
16448613|NCT02581410|40122197|FG001|End of Study Phase|Migrated/moved from study area|3|||
16448614|NCT02581410|40122196|FG000|End of Study Phase|Lost to Follow-up|0|||
16448615|NCT02581410|40122197|FG001|End of Study Phase|Lost to Follow-up|2|||
16448616|NCT02581410|40122196|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
16448617|NCT02581410|40122197|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
16448618|NCT04322526|40122198|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
16264967|NCT01597245|39453267|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16448619|NCT04322526|40122199|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
16448620|NCT04322526|40122198|FG000|Washout (1 Week)|Lost to Follow-up|1|||
16448621|NCT04322526|40122199|FG001|Washout (1 Week)|Lost to Follow-up|2|||
16448622|NCT01077076|40122200|FG000|First Intervention|Withdrawal by Subject|1|||
16448623|NCT01077076|40122201|FG001|First Intervention|Withdrawal by Subject|0|||
16448624|NCT01077076|40122202|FG002|First Intervention|Withdrawal by Subject|0|||
16448625|NCT01077076|40122203|FG003|First Intervention|Withdrawal by Subject|0|||
16448626|NCT01077076|40122204|FG004|First Intervention|Withdrawal by Subject|0|||
16448627|NCT01077076|40122205|FG005|First Intervention|Withdrawal by Subject|0|||
16448628|NCT01077076|40122200|FG000|Third Intervention|Death in the participant's family|0|||
16448629|NCT01077076|40122201|FG001|Third Intervention|Death in the participant's family|0|||
16448630|NCT01077076|40122202|FG002|Third Intervention|Death in the participant's family|0|||
16448631|NCT01077076|40122203|FG003|Third Intervention|Death in the participant's family|0|||
16448632|NCT01077076|40122204|FG004|Third Intervention|Death in the participant's family|0|||
16448633|NCT01077076|40122205|FG005|Third Intervention|Death in the participant's family|1|||
16448634|NCT02873377|40122210|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
16448635|NCT02873377|40122211|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
16448636|NCT02873377|40122210|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
16448637|NCT02873377|40122211|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
16448638|NCT02919995|40122212|FG000|Overall Study|Adverse Event|0|||
16448639|NCT02919995|40122213|FG001|Overall Study|Adverse Event|0|||
16448640|NCT02919995|40122214|FG002|Overall Study|Adverse Event|0|||
16448641|NCT02919995|40122215|FG003|Overall Study|Adverse Event|0|||
16448642|NCT02919995|40122216|FG004|Overall Study|Adverse Event|0|||
16448643|NCT02919995|40122217|FG005|Overall Study|Adverse Event|1|||
16448644|NCT00067002|40122219|FG000|Overall Study|Early Death|1|||
16448645|NCT00067002|40122220|FG001|Overall Study|Early Death|2|||
16448646|NCT00067002|40122219|FG000|Overall Study|Delayed|1|||
16448647|NCT00067002|40122220|FG001|Overall Study|Delayed|1|||
16448648|NCT00067002|40122219|FG000|Overall Study|Graft Failure|5|||
16448649|NCT00067002|40122220|FG001|Overall Study|Graft Failure|6|||
16448650|NCT00716417|40122221|FG000|Overall Study|Adverse Event|0|||
16448651|NCT00716417|40122222|FG001|Overall Study|Adverse Event|0|||
16448652|NCT00716417|40122223|FG002|Overall Study|Adverse Event|2|||
16448653|NCT00716417|40122224|FG003|Overall Study|Adverse Event|1|||
16448654|NCT00716417|40122225|FG004|Overall Study|Adverse Event|0|||
16448655|NCT00716417|40122226|FG005|Overall Study|Adverse Event|0|||
16448656|NCT00716417|40122227|FG006|Overall Study|Adverse Event|3|||
16448657|NCT00716417|40122228|FG007|Overall Study|Adverse Event|1|||
16448658|NCT00716417|40122229|FG008|Overall Study|Adverse Event|0|||
16448659|NCT00716417|40122230|FG009|Overall Study|Adverse Event|3|||
16448660|NCT00716417|40122221|FG000|Overall Study|Withdrawal by Subject|0|||
16448661|NCT00716417|40122222|FG001|Overall Study|Withdrawal by Subject|1|||
16448662|NCT00716417|40122223|FG002|Overall Study|Withdrawal by Subject|0|||
16448663|NCT00716417|40122224|FG003|Overall Study|Withdrawal by Subject|2|||
16448664|NCT00716417|40122225|FG004|Overall Study|Withdrawal by Subject|0|||
16448665|NCT00716417|40122226|FG005|Overall Study|Withdrawal by Subject|0|||
16448666|NCT00716417|40122227|FG006|Overall Study|Withdrawal by Subject|1|||
16448667|NCT00716417|40122228|FG007|Overall Study|Withdrawal by Subject|0|||
16448668|NCT00716417|40122229|FG008|Overall Study|Withdrawal by Subject|0|||
16448669|NCT00716417|40122230|FG009|Overall Study|Withdrawal by Subject|0|||
16448670|NCT00716417|40122221|FG000|Overall Study|Progressive disease|3|||
16448671|NCT00716417|40122222|FG001|Overall Study|Progressive disease|5|||
16448672|NCT00716417|40122223|FG002|Overall Study|Progressive disease|3|||
16448673|NCT00716417|40122224|FG003|Overall Study|Progressive disease|8|||
16448674|NCT00716417|40122225|FG004|Overall Study|Progressive disease|0|||
16448675|NCT00716417|40122226|FG005|Overall Study|Progressive disease|3|||
16448676|NCT00716417|40122227|FG006|Overall Study|Progressive disease|3|||
16448677|NCT00716417|40122228|FG007|Overall Study|Progressive disease|1|||
16448678|NCT00716417|40122229|FG008|Overall Study|Progressive disease|5|||
16448679|NCT00716417|40122230|FG009|Overall Study|Progressive disease|0|||
16448680|NCT00716417|40122221|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
16448681|NCT00716417|40122222|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
16448682|NCT00716417|40122223|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
16448683|NCT00716417|40122224|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
16448684|NCT00716417|40122225|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
16448685|NCT00716417|40122226|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
16448686|NCT00716417|40122227|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
16448687|NCT00716417|40122228|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
16448688|NCT00716417|40122229|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
16448689|NCT00716417|40122230|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
16448690|NCT00716417|40122221|FG000|Overall Study|On patient request due to toxicities|0|||
16448691|NCT00716417|40122222|FG001|Overall Study|On patient request due to toxicities|0|||
16448692|NCT00716417|40122223|FG002|Overall Study|On patient request due to toxicities|0|||
16448693|NCT00716417|40122224|FG003|Overall Study|On patient request due to toxicities|0|||
16448694|NCT00716417|40122225|FG004|Overall Study|On patient request due to toxicities|0|||
16448695|NCT00716417|40122226|FG005|Overall Study|On patient request due to toxicities|0|||
16448696|NCT00716417|40122227|FG006|Overall Study|On patient request due to toxicities|0|||
16448697|NCT00716417|40122228|FG007|Overall Study|On patient request due to toxicities|1|||
16448698|NCT00716417|40122229|FG008|Overall Study|On patient request due to toxicities|0|||
16448699|NCT00716417|40122230|FG009|Overall Study|On patient request due to toxicities|0|||
16448700|NCT04960202|40122231|FG000|Overall Study|Other|12|||
16448701|NCT04960202|40122232|FG001|Overall Study|Other|10|||
16448702|NCT04960202|40122231|FG000|Overall Study|Withdrawal by Subject|43|||
16448703|NCT04960202|40122232|FG001|Overall Study|Withdrawal by Subject|45|||
16448704|NCT04960202|40122231|FG000|Overall Study|Lost to Follow-up|20|||
16448705|NCT04960202|40122232|FG001|Overall Study|Lost to Follow-up|17|||
16448706|NCT04960202|40122231|FG000|Overall Study|Death|0|||
16448707|NCT04960202|40122232|FG001|Overall Study|Death|15|||
16448708|NCT02592798|40122233|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
16071535|NCT03068468|38753228|FG000|Open-Label Extension Period|Death|0|||
16448709|NCT02592798|40122234|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
16448710|NCT02592798|40122233|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
16448711|NCT02592798|40122234|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
16448712|NCT02592798|40122233|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
16448713|NCT02592798|40122234|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
16448714|NCT02592798|40122233|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
16448715|NCT02592798|40122234|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
16448716|NCT02592798|40122233|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
16448717|NCT02592798|40122234|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
16448718|NCT02592798|40122233|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
16448719|NCT02592798|40122234|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
16448720|NCT02592798|40122233|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
16071536|NCT03068468|38753229|FG001|Open-Label Extension Period|Death|0|||
16071537|NCT03068468|38753230|FG002|Open-Label Extension Period|Death|0|||
16071538|NCT03068468|38753231|FG003|Open-Label Extension Period|Death|1|||
16071539|NCT03068468|38753228|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
16071540|NCT03068468|38753229|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
16071541|NCT03068468|38753230|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
16071542|NCT03068468|38753231|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
16071543|NCT03068468|38753228|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
16071544|NCT03068468|38753229|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
16071545|NCT03068468|38753230|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
16071546|NCT03068468|38753231|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
16071547|NCT03068468|38753228|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
16071548|NCT03068468|38753229|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
16071549|NCT03068468|38753230|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
16071550|NCT03068468|38753231|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
16071551|NCT03068468|38753228|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
16071552|NCT03068468|38753229|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
16071553|NCT03068468|38753230|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
16071554|NCT03068468|38753231|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
16071555|NCT03068468|38753228|FG000|Open-Label Extension Period|Reason not Specified|0|||
16071556|NCT03068468|38753229|FG001|Open-Label Extension Period|Reason not Specified|0|||
16071557|NCT03068468|38753230|FG002|Open-Label Extension Period|Reason not Specified|1|||
16071558|NCT03068468|38753231|FG003|Open-Label Extension Period|Reason not Specified|4|||
16071559|NCT01050569|38753232|FG000|Overall Study|Lost to Follow-up|20|||
16071560|NCT01050569|38753233|FG001|Overall Study|Lost to Follow-up|14|||
16071561|NCT01050569|38753234|FG002|Overall Study|Lost to Follow-up|16|||
16071562|NCT01050569|38753232|FG000|Overall Study|Withdrawal by Subject|9|||
16071563|NCT01050569|38753233|FG001|Overall Study|Withdrawal by Subject|3|||
16071564|NCT01050569|38753234|FG002|Overall Study|Withdrawal by Subject|11|||
16071565|NCT01050569|38753232|FG000|Overall Study|Lack of Efficacy|5|||
16071566|NCT01050569|38753233|FG001|Overall Study|Lack of Efficacy|4|||
16071567|NCT01050569|38753234|FG002|Overall Study|Lack of Efficacy|3|||
16071568|NCT01050569|38753232|FG000|Overall Study|Adverse Event|1|||
16071569|NCT01050569|38753233|FG001|Overall Study|Adverse Event|0|||
16071570|NCT01050569|38753234|FG002|Overall Study|Adverse Event|0|||
16071571|NCT01050569|38753232|FG000|Overall Study|Physician Decision|3|||
16071572|NCT01050569|38753233|FG001|Overall Study|Physician Decision|3|||
16071573|NCT01050569|38753234|FG002|Overall Study|Physician Decision|3|||
16071574|NCT00741988|38753235|FG000|Overall Study|Adverse Event|2|||
16071575|NCT00741988|38753236|FG001|Overall Study|Adverse Event|4|||
16071576|NCT00741988|38753235|FG000|Overall Study|Lack of Efficacy|2|||
16071577|NCT00741988|38753236|FG001|Overall Study|Lack of Efficacy|0|||
16071578|NCT00269399|38753237|FG000|Overall Study|Lack of Efficacy|27|||
16071579|NCT00269399|38753238|FG001|Overall Study|Lack of Efficacy|10|||
16071580|NCT00269399|38753237|FG000|Overall Study|Adverse Event|10|||
16071581|NCT00269399|38753238|FG001|Overall Study|Adverse Event|4|||
16071582|NCT00269399|38753237|FG000|Overall Study|Withdrawal by Subject|2|||
16071583|NCT00269399|38753238|FG001|Overall Study|Withdrawal by Subject|5|||
16071584|NCT00269399|38753237|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
16448721|NCT02592798|40122234|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
16448722|NCT02592798|40122233|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
16448723|NCT02592798|40122234|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
16448724|NCT02592798|40122233|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
16448725|NCT02592798|40122234|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
16448726|NCT02592798|40122233|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
16161747|NCT01557166|39072480|FG001|Overall Study|Target dose not tolerated|0|||
16161748|NCT01557166|39072479|FG000|Overall Study|Psychiatric disorder|1|||
16161749|NCT01557166|39072480|FG001|Overall Study|Psychiatric disorder|0|||
16071585|NCT00269399|38753238|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
16071586|NCT00269399|38753237|FG000|Overall Study|Other|0|||
16071587|NCT00269399|38753238|FG001|Overall Study|Other|4|||
16071588|NCT00269399|38753237|FG000|Overall Study|Development of exclusion criteria|0|||
16071589|NCT00269399|38753238|FG001|Overall Study|Development of exclusion criteria|1|||
16071590|NCT03184558|38753239|FG000|Overall Study|Withdrawal by Subject|2|||
16071591|NCT03184558|38753239|FG000|Overall Study|Death|16|||
16071592|NCT03184558|38753239|FG000|Overall Study|Lost to Follow-up|2|||
16071593|NCT03184558|38753239|FG000|Overall Study|Other|9|||
16071594|NCT03478696|38753240|FG000|Overall Study|Adverse Event|1|||
16071595|NCT03478696|38753241|FG001|Overall Study|Adverse Event|5|||
16071596|NCT03478696|38753240|FG000|Overall Study|Lost to Follow-up|1|||
16071597|NCT03478696|38753241|FG001|Overall Study|Lost to Follow-up|0|||
16071598|NCT03478696|38753240|FG000|Overall Study|Physician Decision|6|||
16161750|NCT01557166|39072479|FG000|Overall Study|Unclassified|2|||
16161751|NCT01557166|39072480|FG001|Overall Study|Unclassified|5|||
16071599|NCT03478696|38753241|FG001|Overall Study|Physician Decision|3|||
16071600|NCT03478696|38753240|FG000|Overall Study|Withdrawal by Subject|9|||
16071601|NCT03478696|38753241|FG001|Overall Study|Withdrawal by Subject|4|||
16071602|NCT04072822|38753242|FG000|Treatment|Adverse Event|9|||
16071603|NCT04072822|38753243|FG001|Treatment|Adverse Event|5|||
16071604|NCT04072822|38753242|FG000|Treatment|Met Stopping Criteria|13|||
16161752|NCT02513329|39072485|FG000|Overall Study|Lost to Follow-up|5|||
16161753|NCT02513329|39072486|FG001|Overall Study|Lost to Follow-up|2|||
16161754|NCT03694925|39072487|FG000|Overall Study|Inadequate laboratory testing|0|||
16161755|NCT03694925|39072488|FG001|Overall Study|Inadequate laboratory testing|3|||
16161756|NCT03694925|39072489|FG002|Overall Study|Inadequate laboratory testing|0|||
16161757|NCT03107793|39072493|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
16161758|NCT03107793|39072494|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
16264968|NCT01597245|39453268|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264969|NCT01597245|39453269|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264970|NCT01597245|39453270|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
16264971|NCT01597245|39453271|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264972|NCT01597245|39453272|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
16264973|NCT01597245|39453273|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
16264974|NCT01597245|39453274|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
16372918|NCT01783015|39849803|FG001|Blinded Treatment|Withdrawal by Subject|1|||
16448727|NCT02592798|40122234|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
16448728|NCT02592798|40122233|FG000|Transition From DB2 to OLE|Other reasons|1|||
16448729|NCT02592798|40122234|FG001|Transition From DB2 to OLE|Other reasons|0|||
16448730|NCT02592798|40122233|FG000|Open Label Period (OLE)|Other reasons|0|||
16448731|NCT02592798|40122234|FG001|Open Label Period (OLE)|Other reasons|2|||
16448732|NCT02592798|40122233|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
16071605|NCT04072822|38753243|FG001|Treatment|Met Stopping Criteria|24|||
16071606|NCT04072822|38753242|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
16071607|NCT04072822|38753243|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
16161759|NCT03107793|39072495|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
16161760|NCT03107793|39072496|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
16264975|NCT01597245|39453254|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16372919|NCT01783015|39849804|FG002|Blinded Treatment|Withdrawal by Subject|0|||
16372920|NCT01783015|39849802|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
16372921|NCT01783015|39849803|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
16372922|NCT01783015|39849804|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
16372923|NCT01783015|39849802|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
16372924|NCT01783015|39849803|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
16372925|NCT01783015|39849804|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
16372926|NCT00500110|39849805|FG000|Overall Study|Withdrawal by Subject|3|||
16372927|NCT02044458|39849807|FG000|Overall Study|Protocol Violation|3|||
16372928|NCT02044458|39849808|FG001|Overall Study|Protocol Violation|8|||
16372929|NCT00609973|39849810|FG000|Overall Study|Adverse Event|2|||
16372930|NCT00609973|39849811|FG001|Overall Study|Adverse Event|1|||
16372931|NCT00609973|39849810|FG000|Overall Study|Protocol Violation|4|||
16372932|NCT00609973|39849811|FG001|Overall Study|Protocol Violation|3|||
16372933|NCT00609973|39849810|FG000|Overall Study|Lost to Follow-up|2|||
16264976|NCT01597245|39453255|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264977|NCT01597245|39453256|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264978|NCT01597245|39453257|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264979|NCT01597245|39453258|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16071608|NCT04072822|38753242|FG000|Treatment|Withdrawal by Subject|0|||
16071609|NCT04072822|38753243|FG001|Treatment|Withdrawal by Subject|2|||
16264980|NCT01597245|39453259|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16372934|NCT00609973|39849811|FG001|Overall Study|Lost to Follow-up|1|||
16071610|NCT04072822|38753242|FG000|Treatment|Death|0|||
16071611|NCT04072822|38753243|FG001|Treatment|Death|2|||
16071612|NCT04072822|38753242|FG000|Treatment|Lost to Follow-up|11|||
16071613|NCT04072822|38753243|FG001|Treatment|Lost to Follow-up|3|||
16071614|NCT04072822|38753242|FG000|Treatment|Physician Decision|1|||
16071615|NCT04072822|38753243|FG001|Treatment|Physician Decision|0|||
16071616|NCT04072822|38753242|FG000|Treatment|Other|7|||
16071617|NCT04072822|38753243|FG001|Treatment|Other|9|||
16071618|NCT04072822|38753242|FG000|Follow-up|Withdrawal by Subject|1|||
16071619|NCT04072822|38753243|FG001|Follow-up|Withdrawal by Subject|0|||
16071620|NCT04072822|38753242|FG000|Follow-up|Lost to Follow-up|5|||
16071621|NCT04072822|38753243|FG001|Follow-up|Lost to Follow-up|4|||
16071622|NCT00814346|38753246|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
16071623|NCT00814346|38753247|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
16071624|NCT00814346|38753246|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
16071625|NCT00814346|38753247|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
16071626|NCT00814346|38753246|FG000|Open Phase (17 Months)|Adverse Event|5|||
16071627|NCT00814346|38753247|FG001|Open Phase (17 Months)|Adverse Event|0|||
16071628|NCT00814346|38753246|FG000|Open Phase (17 Months)|Consent|2|||
16071629|NCT00814346|38753247|FG001|Open Phase (17 Months)|Consent|0|||
16071630|NCT00814346|38753246|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
16071631|NCT00814346|38753247|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
16071632|NCT00814346|38753246|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
16071633|NCT00814346|38753247|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
16071634|NCT04849416|38753248|FG000|Overall Study|Ongoing Treatment|12|||
16071635|NCT04849416|38753249|FG001|Overall Study|Ongoing Treatment|5|||
16071636|NCT04849416|38753250|FG002|Overall Study|Ongoing Treatment|3|||
16071637|NCT04849416|38753248|FG000|Overall Study|On Post-Treatment Follow-up|8|||
16071638|NCT04849416|38753249|FG001|Overall Study|On Post-Treatment Follow-up|9|||
16071639|NCT04849416|38753250|FG002|Overall Study|On Post-Treatment Follow-up|10|||
16071640|NCT04849416|38753248|FG000|Overall Study|Withdrawal by Subject|0|||
16071641|NCT04849416|38753249|FG001|Overall Study|Withdrawal by Subject|0|||
16071642|NCT04849416|38753250|FG002|Overall Study|Withdrawal by Subject|1|||
16071643|NCT04849416|38753248|FG000|Overall Study|Lost to Follow-up|1|||
16071644|NCT04849416|38753249|FG001|Overall Study|Lost to Follow-up|0|||
16071645|NCT04849416|38753250|FG002|Overall Study|Lost to Follow-up|0|||
16071646|NCT01460290|38753254|FG000|Overall Study|Adverse Event|3|||
16071647|NCT01460290|38753254|FG000|Overall Study|Elevated liver function|1|||
16071648|NCT02106442|38753255|FG000|Overall Study|Case Report Forms Uncollected|7|||
16071649|NCT02106442|38753255|FG000|Overall Study|Protocol Deviation|30|||
16071650|NCT01460342|38753256|FG000|Overall Study|Adverse Event|5|||
16071651|NCT01460342|38753257|FG001|Overall Study|Adverse Event|4|||
16071652|NCT01460342|38753256|FG000|Overall Study|Lost to Follow-up|1|||
16071653|NCT01460342|38753257|FG001|Overall Study|Lost to Follow-up|2|||
16071654|NCT01460342|38753256|FG000|Overall Study|Protocol Violation|0|||
16071655|NCT01460342|38753257|FG001|Overall Study|Protocol Violation|1|||
16071656|NCT01460342|38753256|FG000|Overall Study|Withdrawal by Subject|3|||
16071657|NCT01460342|38753257|FG001|Overall Study|Withdrawal by Subject|4|||
16071658|NCT01460342|38753256|FG000|Overall Study|Physician Decision|1|||
16071659|NCT01460342|38753257|FG001|Overall Study|Physician Decision|3|||
16071660|NCT01460342|38753256|FG000|Overall Study|Lack of Efficacy|1|||
16071661|NCT01460342|38753257|FG001|Overall Study|Lack of Efficacy|0|||
16071662|NCT03396835|38753264|FG000|Overall Study|Withdrawn prior to completion|1|||
16071663|NCT03396835|38753264|FG000|Overall Study|Did not meet criteria for data analysis|1|||
16071664|NCT01149681|38753265|FG000|Overall Study|Withdrawal by Subject|7|||
16071665|NCT01149681|38753265|FG000|Overall Study|Progressive disease|1|||
16071666|NCT01149681|38753265|FG000|Overall Study|Physician Decision|2|||
16071667|NCT01149681|38753265|FG000|Overall Study|adverse events nonrelated study drug|2|||
16071668|NCT04439799|38753266|FG000|Overall Study|Lost to Follow-up|6|||
16071669|NCT04439799|38753267|FG001|Overall Study|Lost to Follow-up|6|||
16071670|NCT04439799|38753266|FG000|Overall Study|Withdrawal by Subject|2|||
16071671|NCT04439799|38753267|FG001|Overall Study|Withdrawal by Subject|6|||
16071672|NCT04439799|38753266|FG000|Overall Study|Adverse Event|2|||
16071673|NCT04439799|38753267|FG001|Overall Study|Adverse Event|5|||
16071674|NCT03635112|38753268|FG000|Overall Study|Adverse Event|5|||
16071675|NCT03635112|38753269|FG001|Overall Study|Adverse Event|9|||
16071676|NCT03635112|38753270|FG002|Overall Study|Adverse Event|14|||
16071677|NCT03635112|38753268|FG000|Overall Study|Lost to Follow-up|1|||
16071678|NCT03635112|38753269|FG001|Overall Study|Lost to Follow-up|0|||
16264981|NCT01597245|39453260|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264982|NCT01597245|39453261|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264983|NCT01597245|39453262|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16071679|NCT03635112|38753270|FG002|Overall Study|Lost to Follow-up|1|||
16071680|NCT03635112|38753268|FG000|Overall Study|Physician Decision|5|||
16071681|NCT03635112|38753269|FG001|Overall Study|Physician Decision|7|||
16071682|NCT03635112|38753270|FG002|Overall Study|Physician Decision|5|||
16071683|NCT03635112|38753268|FG000|Overall Study|Protocol Violation|0|||
16071684|NCT03635112|38753269|FG001|Overall Study|Protocol Violation|0|||
16071685|NCT03635112|38753270|FG002|Overall Study|Protocol Violation|1|||
16071686|NCT03635112|38753268|FG000|Overall Study|Study Terminated by Sponsor|11|||
16071687|NCT03635112|38753269|FG001|Overall Study|Study Terminated by Sponsor|17|||
16071688|NCT03635112|38753270|FG002|Overall Study|Study Terminated by Sponsor|21|||
16071689|NCT03635112|38753268|FG000|Overall Study|Withdrawal by Subject|4|||
16071690|NCT03635112|38753269|FG001|Overall Study|Withdrawal by Subject|9|||
16071691|NCT03635112|38753270|FG002|Overall Study|Withdrawal by Subject|7|||
16071692|NCT03635112|38753268|FG000|Overall Study|Miscellaneous|0|||
16071693|NCT03635112|38753269|FG001|Overall Study|Miscellaneous|0|||
16071694|NCT03635112|38753270|FG002|Overall Study|Miscellaneous|1|||
16071695|NCT00586339|38753271|FG000|Overall Study|Withdrawal by Subject|1|||
16071696|NCT00586339|38753272|FG001|Overall Study|Withdrawal by Subject|3|||
16071697|NCT00586339|38753273|FG002|Overall Study|Withdrawal by Subject|1|||
16071698|NCT00586339|38753271|FG000|Overall Study|Migrated/moved from study area|3|||
16071699|NCT00586339|38753272|FG001|Overall Study|Migrated/moved from study area|2|||
16071700|NCT00586339|38753273|FG002|Overall Study|Migrated/moved from study area|4|||
16071701|NCT00586339|38753271|FG000|Overall Study|Lost to Follow-up|3|||
16071702|NCT00586339|38753272|FG001|Overall Study|Lost to Follow-up|2|||
16071703|NCT00586339|38753273|FG002|Overall Study|Lost to Follow-up|1|||
16071704|NCT02261467|38753274|FG000|Overall Study|Enrolled in Error|1|||
16071705|NCT02261467|38753275|FG001|Overall Study|Enrolled in Error|0|||
16071706|NCT02261467|38753274|FG000|Overall Study|Protocol Violation|0|||
16071707|NCT02261467|38753275|FG001|Overall Study|Protocol Violation|1|||
16071708|NCT02261467|38753274|FG000|Overall Study|Personal Reasons|17|||
16071709|NCT02261467|38753275|FG001|Overall Study|Personal Reasons|22|||
16071710|NCT02261467|38753274|FG000|Overall Study|Lost to Follow-up|2|||
16071711|NCT02261467|38753275|FG001|Overall Study|Lost to Follow-up|13|||
16071712|NCT02261467|38753274|FG000|Overall Study|Adverse Event|1|||
16071713|NCT02261467|38753275|FG001|Overall Study|Adverse Event|1|||
16071714|NCT01186848|38753277|FG000|Overall Study|Lost to Follow-up|4|||
16071715|NCT01186848|38753277|FG000|Overall Study|Withdrawal by Subject|2|||
16071716|NCT01186848|38753277|FG000|Overall Study|Adverse Event|2|||
16071717|NCT03532178|38753281|FG000|First Period|Withdrawal by Subject|1|||
16071718|NCT03532178|38753282|FG001|First Period|Withdrawal by Subject|3|||
16071719|NCT03532178|38753281|FG000|First Period|technical issues in data collection Technical issues|0|||
16071720|NCT03532178|38753282|FG001|First Period|technical issues in data collection Technical issues|1|||
16071721|NCT03532178|38753281|FG000|Second Period|Withdrawal by Subject|1|||
16071722|NCT03532178|38753282|FG001|Second Period|Withdrawal by Subject|1|||
16071723|NCT03532178|38753281|FG000|Second Period|Technical issues|0|||
16071724|NCT03532178|38753282|FG001|Second Period|Technical issues|1|||
16071725|NCT02163915|38753283|FG000|Overall Study|Withdrawal by Subject|2|||
16071726|NCT02163915|38753284|FG001|Overall Study|Withdrawal by Subject|0|||
16071727|NCT02163915|38753285|FG002|Overall Study|Withdrawal by Subject|2|||
16071728|NCT02163915|38753286|FG003|Overall Study|Withdrawal by Subject|2|||
16071729|NCT02163915|38753287|FG004|Overall Study|Withdrawal by Subject|2|||
16071730|NCT02163915|38753283|FG000|Overall Study|Study termination|1|||
16071731|NCT02163915|38753284|FG001|Overall Study|Study termination|0|||
16071732|NCT02163915|38753285|FG002|Overall Study|Study termination|0|||
16071733|NCT02163915|38753286|FG003|Overall Study|Study termination|0|||
16071734|NCT02163915|38753287|FG004|Overall Study|Study termination|2|||
16071735|NCT02163915|38753283|FG000|Overall Study|Physician Decision|0|||
16071736|NCT02163915|38753284|FG001|Overall Study|Physician Decision|0|||
16071737|NCT02163915|38753285|FG002|Overall Study|Physician Decision|0|||
16071738|NCT02163915|38753286|FG003|Overall Study|Physician Decision|1|||
16071739|NCT02163915|38753287|FG004|Overall Study|Physician Decision|0|||
16071740|NCT03265210|38753290|FG000|Overall Study|Withdrawal by Subject|7|||
16071741|NCT03265210|38753291|FG001|Overall Study|Withdrawal by Subject|9|||
16071742|NCT03265210|38753290|FG000|Overall Study|Lost to Follow-up|2|||
16071743|NCT03265210|38753291|FG001|Overall Study|Lost to Follow-up|0|||
16071744|NCT03265210|38753290|FG000|Overall Study|Physician Decision|2|||
16071745|NCT03265210|38753291|FG001|Overall Study|Physician Decision|0|||
16071746|NCT03265210|38753290|FG000|Overall Study|Adverse Event|1|||
16071747|NCT03265210|38753291|FG001|Overall Study|Adverse Event|0|||
16071748|NCT04176458|38753292|FG000|Overall Study|Covid 19|4|||
16071749|NCT00305695|38753293|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
16071750|NCT00305695|38753294|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
16071751|NCT00305695|38753293|FG000|Overall Study|Did not have baseline scan|1|||
16071752|NCT00305695|38753294|FG001|Overall Study|Did not have baseline scan|1|||
16071753|NCT02072226|38753295|FG000|Overall Study|Lost to Follow-up|11|||
16071754|NCT02072226|38753296|FG001|Overall Study|Lost to Follow-up|7|||
16071755|NCT02072226|38753295|FG000|Overall Study|Patient Non-compliance|2|||
16071756|NCT02072226|38753296|FG001|Overall Study|Patient Non-compliance|3|||
16071757|NCT02072226|38753295|FG000|Overall Study|Death|1|||
16071758|NCT02072226|38753296|FG001|Overall Study|Death|0|||
16071759|NCT02072226|38753295|FG000|Overall Study|Patient Withdrawal of Consent|1|||
16071760|NCT02072226|38753296|FG001|Overall Study|Patient Withdrawal of Consent|0|||
16071761|NCT02488980|38753297|FG000|Overall Study|Protocol Violation|2|||
16071762|NCT02488980|38753298|FG001|Overall Study|Protocol Violation|2|||
16071763|NCT02488980|38753299|FG002|Overall Study|Protocol Violation|2|||
16071764|NCT00891618|38753304|FG000|Overall Study|Withdrawal by Subject|1|||
16071765|NCT01140048|38753305|FG000|Overall Study|Physician Decision|1|||
16071766|NCT01140048|38753305|FG000|Overall Study|Withdrawal by Subject|13|||
16071767|NCT01140048|38753305|FG000|Overall Study|Lost to Follow-up|31|||
16071768|NCT01227707|38753306|FG000|Overall Study|Adverse Event|10|||
16071769|NCT01227707|38753306|FG000|Overall Study|Progression of disease|3|||
16071770|NCT01227707|38753306|FG000|Overall Study|Withdrawal by Subject|1|||
16071771|NCT01227707|38753306|FG000|Overall Study|Patient non-compliance|3|||
16071772|NCT01227707|38753306|FG000|Overall Study|Medical decision|6|||
16071773|NCT01227707|38753306|FG000|Overall Study|Death|1|||
16071774|NCT01134562|38753307|FG000|Overall Study|Adverse Event|0|||
16071775|NCT01134562|38753308|FG001|Overall Study|Adverse Event|1|||
16071776|NCT01134562|38753309|FG002|Overall Study|Adverse Event|0|||
16071777|NCT01134562|38753310|FG003|Overall Study|Adverse Event|0|||
16071778|NCT01134562|38753311|FG004|Overall Study|Adverse Event|0|||
16071779|NCT00619645|38753312|FG000|Overall Study|Adverse Event|1|||
16071780|NCT01988233|38753313|FG000|Overall Study|Lost to Follow-up|64|||
16071781|NCT01988233|38753314|FG001|Overall Study|Lost to Follow-up|51|||
16071782|NCT02517307|38753315|FG000|Overall Study|Withdrawal by Subject|1|||
16071783|NCT02517307|38753316|FG001|Overall Study|Withdrawal by Subject|0|||
16071784|NCT02517307|38753317|FG002|Overall Study|Withdrawal by Subject|1|||
16071785|NCT02517307|38753318|FG003|Overall Study|Withdrawal by Subject|0|||
16071786|NCT02517307|38753315|FG000|Overall Study|Protocol Violation|0|||
16071787|NCT02517307|38753316|FG001|Overall Study|Protocol Violation|0|||
16071788|NCT02517307|38753317|FG002|Overall Study|Protocol Violation|1|||
16071789|NCT02517307|38753318|FG003|Overall Study|Protocol Violation|1|||
16071790|NCT02839330|38753320|FG000|Overall Study|Adverse Event|0|||
16071791|NCT02839330|38753321|FG001|Overall Study|Adverse Event|1|||
16071792|NCT02839330|38753322|FG002|Overall Study|Adverse Event|2|||
16071793|NCT02839330|38753323|FG003|Overall Study|Adverse Event|2|||
16071794|NCT02839330|38753320|FG000|Overall Study|Death|4|||
16071795|NCT02839330|38753321|FG001|Overall Study|Death|6|||
16071796|NCT02839330|38753322|FG002|Overall Study|Death|1|||
16071797|NCT02839330|38753323|FG003|Overall Study|Death|1|||
16071798|NCT02839330|38753320|FG000|Overall Study|Withdrawal by Subject|27|||
16071799|NCT02839330|38753321|FG001|Overall Study|Withdrawal by Subject|19|||
16071800|NCT02839330|38753322|FG002|Overall Study|Withdrawal by Subject|11|||
16071801|NCT02839330|38753323|FG003|Overall Study|Withdrawal by Subject|13|||
16071802|NCT02839330|38753320|FG000|Overall Study|Lost to Follow-up|22|||
16071803|NCT02839330|38753321|FG001|Overall Study|Lost to Follow-up|27|||
16071804|NCT02839330|38753322|FG002|Overall Study|Lost to Follow-up|29|||
16071805|NCT02839330|38753323|FG003|Overall Study|Lost to Follow-up|25|||
16071806|NCT02839330|38753320|FG000|Overall Study|Administrative Reason|0|||
16071807|NCT02839330|38753321|FG001|Overall Study|Administrative Reason|0|||
16071808|NCT02839330|38753322|FG002|Overall Study|Administrative Reason|0|||
16071809|NCT02839330|38753323|FG003|Overall Study|Administrative Reason|1|||
16071810|NCT02839330|38753320|FG000|Overall Study|Protocol Violation|1|||
16071811|NCT02839330|38753321|FG001|Overall Study|Protocol Violation|2|||
16071812|NCT02839330|38753322|FG002|Overall Study|Protocol Violation|2|||
16071813|NCT02839330|38753323|FG003|Overall Study|Protocol Violation|3|||
16071814|NCT02839330|38753320|FG000|Overall Study|Other reason, not specified|4|||
16071815|NCT02839330|38753321|FG001|Overall Study|Other reason, not specified|3|||
16071816|NCT02839330|38753322|FG002|Overall Study|Other reason, not specified|3|||
16071817|NCT02839330|38753323|FG003|Overall Study|Other reason, not specified|6|||
16071818|NCT04347954|38753326|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
16071819|NCT04347954|38753327|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
16071820|NCT04347954|38753328|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
16071821|NCT04347954|38753326|FG000|Overall Study|Lost to Follow-up|0|||
16071822|NCT04347954|38753327|FG001|Overall Study|Lost to Follow-up|1|||
16071823|NCT04347954|38753328|FG002|Overall Study|Lost to Follow-up|0|||
16071824|NCT03525119|38753329|FG000|Overall Study|Adverse Event|0|||
16071825|NCT03525119|38753330|FG001|Overall Study|Adverse Event|1|||
16071826|NCT03525119|38753331|FG002|Overall Study|Adverse Event|0|||
16071827|NCT03525119|38753329|FG000|Overall Study|Lost to Follow-up|32|||
16071828|NCT03525119|38753330|FG001|Overall Study|Lost to Follow-up|33|||
16071829|NCT03525119|38753331|FG002|Overall Study|Lost to Follow-up|37|||
16071830|NCT03525119|38753329|FG000|Overall Study|Withdrawal by Subject|5|||
16071831|NCT03525119|38753330|FG001|Overall Study|Withdrawal by Subject|4|||
16071832|NCT03525119|38753331|FG002|Overall Study|Withdrawal by Subject|2|||
16071833|NCT03525119|38753329|FG000|Overall Study|Reason not Specified|2|||
16071834|NCT03525119|38753330|FG001|Overall Study|Reason not Specified|1|||
16071835|NCT03525119|38753331|FG002|Overall Study|Reason not Specified|2|||
16071836|NCT03525119|38753329|FG000|Overall Study|Randomized but not Vaccinated|1|||
16071837|NCT03525119|38753330|FG001|Overall Study|Randomized but not Vaccinated|0|||
16448733|NCT02592798|40122234|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
16448734|NCT02592798|40122233|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
16448735|NCT02592798|40122234|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
16448736|NCT02592798|40122233|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
16448737|NCT02592798|40122234|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
16448738|NCT02592798|40122233|FG000|Open Label Period (OLE)|Adverse Event|0|||
16448739|NCT02592798|40122234|FG001|Open Label Period (OLE)|Adverse Event|1|||
16448740|NCT01941186|40122235|FG000|Follow-up|Lost to Follow-up|1|||
16448741|NCT01941186|40122236|FG001|Follow-up|Lost to Follow-up|0|||
16448742|NCT04730271|40122237|FG000|Overall Study|Adverse Event|0|||
16448743|NCT04730271|40122238|FG001|Overall Study|Adverse Event|2|||
16448744|NCT04730271|40122237|FG000|Overall Study|Withdrawal by Subject|1|||
16448745|NCT04730271|40122238|FG001|Overall Study|Withdrawal by Subject|1|||
16071838|NCT03525119|38753331|FG002|Overall Study|Randomized but not Vaccinated|2|||
16071839|NCT01048788|38753332|FG000|Overall Study|Adverse Event|5|||
16071840|NCT01048788|38753333|FG001|Overall Study|Adverse Event|1|||
16071841|NCT01048788|38753334|FG002|Overall Study|Adverse Event|1|||
16071842|NCT01048788|38753332|FG000|Overall Study|Lack of Efficacy|0|||
16071843|NCT01048788|38753333|FG001|Overall Study|Lack of Efficacy|0|||
16071844|NCT01048788|38753334|FG002|Overall Study|Lack of Efficacy|1|||
16071845|NCT01048788|38753332|FG000|Overall Study|Withdrawal by Subject|0|||
16071846|NCT01048788|38753333|FG001|Overall Study|Withdrawal by Subject|1|||
16071847|NCT01048788|38753334|FG002|Overall Study|Withdrawal by Subject|0|||
16071848|NCT03768206|38753335|FG000|Overall Study|Lost to Follow-up|2|||
16071849|NCT03768206|38753336|FG001|Overall Study|Lost to Follow-up|1|||
16071850|NCT03768206|38753335|FG000|Overall Study|Withdrawal by Subject|0|||
16071851|NCT03768206|38753336|FG001|Overall Study|Withdrawal by Subject|1|||
16071852|NCT00591838|38753342|FG000|Overall Study|Withdrawal by Subject|0|||
16071853|NCT00591838|38753343|FG001|Overall Study|Withdrawal by Subject|0|||
16071854|NCT00591838|38753344|FG002|Overall Study|Withdrawal by Subject|0|||
16071855|NCT00591838|38753345|FG003|Overall Study|Withdrawal by Subject|1|||
16071856|NCT00591838|38753346|FG004|Overall Study|Withdrawal by Subject|0|||
16071857|NCT01076335|38753347|FG000|Overall Study|Withdrawal by Subject|3|||
16071858|NCT01076335|38753347|FG000|Overall Study|Withdrawal without treatment|1|||
16071859|NCT01268891|38753348|FG000|Overall Study|Adverse Event|3|||
16071860|NCT01268891|38753349|FG001|Overall Study|Adverse Event|7|||
16071861|NCT01268891|38753348|FG000|Overall Study|Lack of Efficacy|1|||
16071862|NCT01268891|38753349|FG001|Overall Study|Lack of Efficacy|0|||
16071863|NCT01268891|38753348|FG000|Overall Study|Withdrawal of Consent|3|||
16071864|NCT01268891|38753349|FG001|Overall Study|Withdrawal of Consent|1|||
16071865|NCT01268891|38753348|FG000|Overall Study|Administrative or other reason(s)|1|||
16071866|NCT01268891|38753349|FG001|Overall Study|Administrative or other reason(s)|0|||
16071867|NCT00337818|38753350|FG000|Overall Study|Lost to Follow-up|289|||
16071868|NCT00337818|38753351|FG001|Overall Study|Lost to Follow-up|91|||
16071869|NCT00337818|38753352|FG002|Overall Study|Lost to Follow-up|107|||
16071870|NCT02174562|38753353|FG000|Overall Study|Withdrawal by Subject|7|||
16071871|NCT02174562|38753354|FG001|Overall Study|Withdrawal by Subject|2|||
16071872|NCT02174562|38753353|FG000|Overall Study|Death|2|||
16071873|NCT02174562|38753354|FG001|Overall Study|Death|0|||
16071874|NCT02174562|38753353|FG000|Overall Study|Lost to Follow-up|0|||
16071875|NCT02174562|38753354|FG001|Overall Study|Lost to Follow-up|3|||
16071876|NCT01196988|38753355|FG000|Overall Study|Adverse Event|1|||
16071877|NCT01196988|38753356|FG001|Overall Study|Adverse Event|2|||
16372935|NCT00609973|39849810|FG000|Overall Study|Withdrawal by Subject|0|||
16372936|NCT00609973|39849811|FG001|Overall Study|Withdrawal by Subject|1|||
16372937|NCT01346709|39849812|FG000|Overall Study|Protocol Violation|35|||
16372938|NCT01346709|39849812|FG000|Overall Study|Lost to Follow-up|31|||
16372939|NCT01346709|39849812|FG000|Overall Study|Missing data in candidate risk factor|285|||
16372940|NCT01229111|39849813|FG000|Overall Study|Death|1|||
16372941|NCT02255279|39849814|FG000|Overall Study|Lost to Follow-up|2|||
16372942|NCT02255279|39849815|FG001|Overall Study|Lost to Follow-up|2|||
16372943|NCT02255279|39849814|FG000|Overall Study|Protocol Violation|0|||
16372944|NCT02255279|39849815|FG001|Overall Study|Protocol Violation|1|||
16372945|NCT02255279|39849814|FG000|Overall Study|Withdrawal by Subject|3|||
16372946|NCT02255279|39849815|FG001|Overall Study|Withdrawal by Subject|6|||
16372947|NCT03156621|39849822|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
16372948|NCT03156621|39849823|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
16372949|NCT03156621|39849822|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
16448746|NCT04730271|40122237|FG000|Overall Study|Protocol Violation|7|||
16448747|NCT04730271|40122238|FG001|Overall Study|Protocol Violation|13|||
16071878|NCT01196988|38753357|FG002|Overall Study|Adverse Event|0|||
16071879|NCT01196988|38753358|FG003|Overall Study|Adverse Event|0|||
16071880|NCT01196988|38753355|FG000|Overall Study|Withdrawal by Subject|5|||
16071881|NCT01196988|38753356|FG001|Overall Study|Withdrawal by Subject|1|||
16071882|NCT01196988|38753357|FG002|Overall Study|Withdrawal by Subject|4|||
16071883|NCT01196988|38753358|FG003|Overall Study|Withdrawal by Subject|0|||
16071884|NCT01196988|38753355|FG000|Overall Study|Lost to Follow-up|16|||
16071885|NCT01196988|38753356|FG001|Overall Study|Lost to Follow-up|29|||
16071886|NCT01196988|38753357|FG002|Overall Study|Lost to Follow-up|21|||
16071887|NCT01196988|38753358|FG003|Overall Study|Lost to Follow-up|1|||
16071888|NCT01196988|38753355|FG000|Overall Study|Other|2|||
16071889|NCT01196988|38753356|FG001|Overall Study|Other|0|||
16071890|NCT01196988|38753357|FG002|Overall Study|Other|0|||
16071891|NCT01196988|38753358|FG003|Overall Study|Other|0|||
16071892|NCT01235949|38753359|FG000|Primary Phase|Migrated/moved from study area|1|||
16071893|NCT01235949|38753360|FG001|Primary Phase|Migrated/moved from study area|1|||
16071894|NCT01235949|38753361|FG002|Primary Phase|Migrated/moved from study area|0|||
16071895|NCT01235949|38753362|FG003|Primary Phase|Migrated/moved from study area|0|||
16071896|NCT01235949|38753363|FG004|Primary Phase|Migrated/moved from study area|1|||
16071897|NCT01235949|38753364|FG005|Primary Phase|Migrated/moved from study area|2|||
16071898|NCT01235949|38753365|FG006|Primary Phase|Migrated/moved from study area|0|||
16071899|NCT01235949|38753366|FG007|Primary Phase|Migrated/moved from study area|0|||
16071900|NCT01235949|38753367|FG008|Primary Phase|Migrated/moved from study area|0|||
16071901|NCT01235949|38753368|FG009|Primary Phase|Migrated/moved from study area|0|||
16071902|NCT01235949|38753369|FG010|Primary Phase|Migrated/moved from study area|0|||
16071903|NCT01235949|38753370|FG011|Primary Phase|Migrated/moved from study area|0|||
16071904|NCT01235949|38753371|FG012|Primary Phase|Migrated/moved from study area|0|||
16071905|NCT01235949|38753372|FG013|Primary Phase|Migrated/moved from study area|0|||
16071906|NCT01235949|38753373|FG014|Primary Phase|Migrated/moved from study area|0|||
16448748|NCT04730271|40122237|FG000|Overall Study|Lost to Follow-up|3|||
16448749|NCT04730271|40122238|FG001|Overall Study|Lost to Follow-up|3|||
16448750|NCT04730271|40122237|FG000|Overall Study|Death|1|||
16448751|NCT04730271|40122238|FG001|Overall Study|Death|0|||
16448752|NCT02699749|40122239|FG000|Overall Study|Other|0|||
16448753|NCT02699749|40122240|FG001|Overall Study|Other|0|||
16448754|NCT02699749|40122241|FG002|Overall Study|Other|2|||
16448755|NCT02699749|40122242|FG003|Overall Study|Other|0|||
16448756|NCT02699749|40122243|FG004|Overall Study|Other|0|||
16448757|NCT02699749|40122244|FG005|Overall Study|Other|1|||
16448758|NCT02699749|40122245|FG006|Overall Study|Other|1|||
16448759|NCT02699749|40122246|FG007|Overall Study|Other|0|||
16448760|NCT02699749|40122247|FG008|Overall Study|Other|0|||
16448761|NCT02699749|40122248|FG009|Overall Study|Other|0|||
16448762|NCT02699749|40122249|FG010|Overall Study|Other|1|||
16448763|NCT02699749|40122250|FG011|Overall Study|Other|0|||
16448764|NCT02699749|40122251|FG012|Overall Study|Other|0|||
16448765|NCT02699749|40122252|FG013|Overall Study|Other|0|||
16448766|NCT02699749|40122239|FG000|Overall Study|Progressive Disease|3|||
16448767|NCT02699749|40122240|FG001|Overall Study|Progressive Disease|3|||
16448768|NCT02699749|40122241|FG002|Overall Study|Progressive Disease|14|||
16448769|NCT02699749|40122242|FG003|Overall Study|Progressive Disease|3|||
16448770|NCT02699749|40122243|FG004|Overall Study|Progressive Disease|3|||
16448771|NCT02699749|40122244|FG005|Overall Study|Progressive Disease|7|||
16448772|NCT02699749|40122245|FG006|Overall Study|Progressive Disease|5|||
16448773|NCT02699749|40122246|FG007|Overall Study|Progressive Disease|5|||
16448774|NCT02699749|40122247|FG008|Overall Study|Progressive Disease|6|||
16448775|NCT02699749|40122248|FG009|Overall Study|Progressive Disease|6|||
16448776|NCT02699749|40122249|FG010|Overall Study|Progressive Disease|5|||
16448777|NCT02699749|40122250|FG011|Overall Study|Progressive Disease|4|||
16448778|NCT02699749|40122251|FG012|Overall Study|Progressive Disease|3|||
16448779|NCT02699749|40122252|FG013|Overall Study|Progressive Disease|5|||
16448780|NCT02699749|40122239|FG000|Overall Study|Death|0|||
16448781|NCT02699749|40122240|FG001|Overall Study|Death|0|||
16448782|NCT02699749|40122241|FG002|Overall Study|Death|0|||
16448783|NCT02699749|40122242|FG003|Overall Study|Death|0|||
16448784|NCT02699749|40122243|FG004|Overall Study|Death|0|||
16448785|NCT02699749|40122244|FG005|Overall Study|Death|0|||
16071907|NCT01235949|38753374|FG015|Primary Phase|Migrated/moved from study area|0|||
16071908|NCT01235949|38753375|FG016|Primary Phase|Migrated/moved from study area|0|||
16071909|NCT01235949|38753376|FG017|Primary Phase|Migrated/moved from study area|0|||
16071910|NCT01235949|38753359|FG000|Primary Phase|Adverse Event|0|||
16071911|NCT01235949|38753360|FG001|Primary Phase|Adverse Event|0|||
16448786|NCT02699749|40122245|FG006|Overall Study|Death|0|||
16448787|NCT02699749|40122246|FG007|Overall Study|Death|0|||
16448788|NCT02699749|40122247|FG008|Overall Study|Death|0|||
16448789|NCT02699749|40122248|FG009|Overall Study|Death|0|||
16448790|NCT02699749|40122249|FG010|Overall Study|Death|0|||
16448791|NCT02699749|40122250|FG011|Overall Study|Death|0|||
16448792|NCT02699749|40122251|FG012|Overall Study|Death|0|||
16448793|NCT02699749|40122252|FG013|Overall Study|Death|1|||
16448794|NCT02699749|40122239|FG000|Overall Study|Lost to Follow-up|0|||
16071912|NCT01235949|38753361|FG002|Primary Phase|Adverse Event|0|||
16071913|NCT01235949|38753362|FG003|Primary Phase|Adverse Event|1|||
16071914|NCT01235949|38753363|FG004|Primary Phase|Adverse Event|0|||
16071915|NCT01235949|38753364|FG005|Primary Phase|Adverse Event|0|||
16071916|NCT01235949|38753365|FG006|Primary Phase|Adverse Event|0|||
16071917|NCT01235949|38753366|FG007|Primary Phase|Adverse Event|0|||
16071918|NCT01235949|38753367|FG008|Primary Phase|Adverse Event|0|||
16071919|NCT01235949|38753368|FG009|Primary Phase|Adverse Event|0|||
16071920|NCT01235949|38753369|FG010|Primary Phase|Adverse Event|0|||
16071921|NCT01235949|38753370|FG011|Primary Phase|Adverse Event|0|||
16071922|NCT01235949|38753371|FG012|Primary Phase|Adverse Event|0|||
16071923|NCT01235949|38753372|FG013|Primary Phase|Adverse Event|0|||
16071924|NCT01235949|38753373|FG014|Primary Phase|Adverse Event|0|||
16071925|NCT01235949|38753374|FG015|Primary Phase|Adverse Event|0|||
16071926|NCT01235949|38753375|FG016|Primary Phase|Adverse Event|0|||
16071927|NCT01235949|38753376|FG017|Primary Phase|Adverse Event|0|||
16071928|NCT01235949|38753359|FG000|Primary Phase|Withdrawal by Subject|3|||
16071929|NCT01235949|38753360|FG001|Primary Phase|Withdrawal by Subject|2|||
16071930|NCT01235949|38753361|FG002|Primary Phase|Withdrawal by Subject|2|||
16071931|NCT01235949|38753362|FG003|Primary Phase|Withdrawal by Subject|0|||
16071932|NCT01235949|38753363|FG004|Primary Phase|Withdrawal by Subject|0|||
16071933|NCT01235949|38753364|FG005|Primary Phase|Withdrawal by Subject|3|||
16071934|NCT01235949|38753365|FG006|Primary Phase|Withdrawal by Subject|0|||
16071935|NCT01235949|38753366|FG007|Primary Phase|Withdrawal by Subject|0|||
16071936|NCT01235949|38753367|FG008|Primary Phase|Withdrawal by Subject|0|||
16071937|NCT01235949|38753368|FG009|Primary Phase|Withdrawal by Subject|0|||
16071938|NCT01235949|38753369|FG010|Primary Phase|Withdrawal by Subject|0|||
16071939|NCT01235949|38753370|FG011|Primary Phase|Withdrawal by Subject|0|||
16071940|NCT01235949|38753371|FG012|Primary Phase|Withdrawal by Subject|0|||
16071941|NCT01235949|38753372|FG013|Primary Phase|Withdrawal by Subject|0|||
16071942|NCT01235949|38753373|FG014|Primary Phase|Withdrawal by Subject|0|||
16071943|NCT01235949|38753374|FG015|Primary Phase|Withdrawal by Subject|0|||
16071944|NCT01235949|38753375|FG016|Primary Phase|Withdrawal by Subject|0|||
16071945|NCT01235949|38753376|FG017|Primary Phase|Withdrawal by Subject|0|||
16071946|NCT01235949|38753359|FG000|Primary Phase|Lost to Follow-up|0|||
16071947|NCT01235949|38753360|FG001|Primary Phase|Lost to Follow-up|0|||
16071948|NCT01235949|38753361|FG002|Primary Phase|Lost to Follow-up|1|||
16071949|NCT01235949|38753362|FG003|Primary Phase|Lost to Follow-up|1|||
16071950|NCT01235949|38753363|FG004|Primary Phase|Lost to Follow-up|0|||
16071951|NCT01235949|38753364|FG005|Primary Phase|Lost to Follow-up|2|||
16071952|NCT01235949|38753365|FG006|Primary Phase|Lost to Follow-up|0|||
16071953|NCT01235949|38753366|FG007|Primary Phase|Lost to Follow-up|0|||
16071954|NCT01235949|38753367|FG008|Primary Phase|Lost to Follow-up|0|||
16071955|NCT01235949|38753368|FG009|Primary Phase|Lost to Follow-up|0|||
16071956|NCT01235949|38753369|FG010|Primary Phase|Lost to Follow-up|0|||
16071957|NCT01235949|38753370|FG011|Primary Phase|Lost to Follow-up|0|||
16071958|NCT01235949|38753371|FG012|Primary Phase|Lost to Follow-up|0|||
16071959|NCT01235949|38753372|FG013|Primary Phase|Lost to Follow-up|0|||
16071960|NCT01235949|38753373|FG014|Primary Phase|Lost to Follow-up|0|||
16071961|NCT01235949|38753374|FG015|Primary Phase|Lost to Follow-up|0|||
16071962|NCT01235949|38753375|FG016|Primary Phase|Lost to Follow-up|0|||
16071963|NCT01235949|38753376|FG017|Primary Phase|Lost to Follow-up|0|||
16071964|NCT01235949|38753359|FG000|Booster Phase|Migrated/moved from study area|0|||
16071965|NCT01235949|38753360|FG001|Booster Phase|Migrated/moved from study area|0|||
16071966|NCT01235949|38753361|FG002|Booster Phase|Migrated/moved from study area|0|||
16071967|NCT01235949|38753362|FG003|Booster Phase|Migrated/moved from study area|0|||
16071968|NCT01235949|38753363|FG004|Booster Phase|Migrated/moved from study area|0|||
16071969|NCT01235949|38753364|FG005|Booster Phase|Migrated/moved from study area|0|||
16071970|NCT01235949|38753365|FG006|Booster Phase|Migrated/moved from study area|0|||
16071971|NCT01235949|38753366|FG007|Booster Phase|Migrated/moved from study area|0|||
16071972|NCT01235949|38753367|FG008|Booster Phase|Migrated/moved from study area|0|||
16071973|NCT01235949|38753368|FG009|Booster Phase|Migrated/moved from study area|0|||
16071974|NCT01235949|38753369|FG010|Booster Phase|Migrated/moved from study area|0|||
16071975|NCT01235949|38753370|FG011|Booster Phase|Migrated/moved from study area|1|||
16071976|NCT01235949|38753371|FG012|Booster Phase|Migrated/moved from study area|1|||
16071977|NCT01235949|38753372|FG013|Booster Phase|Migrated/moved from study area|0|||
16071978|NCT01235949|38753373|FG014|Booster Phase|Migrated/moved from study area|0|||
16071979|NCT01235949|38753374|FG015|Booster Phase|Migrated/moved from study area|0|||
16071980|NCT01235949|38753375|FG016|Booster Phase|Migrated/moved from study area|0|||
16071981|NCT01235949|38753376|FG017|Booster Phase|Migrated/moved from study area|1|||
16071982|NCT01235949|38753359|FG000|Booster Phase|Adverse Event|0|||
16071983|NCT01235949|38753360|FG001|Booster Phase|Adverse Event|0|||
16071984|NCT01235949|38753361|FG002|Booster Phase|Adverse Event|0|||
16071985|NCT01235949|38753362|FG003|Booster Phase|Adverse Event|0|||
16071986|NCT01235949|38753363|FG004|Booster Phase|Adverse Event|0|||
16071987|NCT01235949|38753364|FG005|Booster Phase|Adverse Event|0|||
16372950|NCT03156621|39849823|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
16071988|NCT01235949|38753365|FG006|Booster Phase|Adverse Event|0|||
16071989|NCT01235949|38753366|FG007|Booster Phase|Adverse Event|0|||
16071990|NCT01235949|38753367|FG008|Booster Phase|Adverse Event|0|||
16071991|NCT01235949|38753368|FG009|Booster Phase|Adverse Event|0|||
16071992|NCT01235949|38753369|FG010|Booster Phase|Adverse Event|0|||
16071993|NCT01235949|38753370|FG011|Booster Phase|Adverse Event|0|||
16071994|NCT01235949|38753371|FG012|Booster Phase|Adverse Event|0|||
16071995|NCT01235949|38753372|FG013|Booster Phase|Adverse Event|0|||
16071996|NCT01235949|38753373|FG014|Booster Phase|Adverse Event|0|||
16071997|NCT01235949|38753374|FG015|Booster Phase|Adverse Event|1|||
16071998|NCT01235949|38753375|FG016|Booster Phase|Adverse Event|0|||
16071999|NCT01235949|38753376|FG017|Booster Phase|Adverse Event|0|||
16072000|NCT01235949|38753359|FG000|Booster Phase|Withdrawal by Subject|0|||
16072001|NCT01235949|38753360|FG001|Booster Phase|Withdrawal by Subject|0|||
16072002|NCT01235949|38753361|FG002|Booster Phase|Withdrawal by Subject|0|||
16072003|NCT01235949|38753362|FG003|Booster Phase|Withdrawal by Subject|0|||
16072004|NCT01235949|38753363|FG004|Booster Phase|Withdrawal by Subject|0|||
16072005|NCT01235949|38753364|FG005|Booster Phase|Withdrawal by Subject|0|||
16072006|NCT01235949|38753365|FG006|Booster Phase|Withdrawal by Subject|0|||
16072007|NCT01235949|38753366|FG007|Booster Phase|Withdrawal by Subject|1|||
16072008|NCT01235949|38753367|FG008|Booster Phase|Withdrawal by Subject|1|||
16072009|NCT01235949|38753368|FG009|Booster Phase|Withdrawal by Subject|0|||
16072010|NCT01235949|38753369|FG010|Booster Phase|Withdrawal by Subject|1|||
16072011|NCT01235949|38753370|FG011|Booster Phase|Withdrawal by Subject|1|||
16072012|NCT01235949|38753371|FG012|Booster Phase|Withdrawal by Subject|2|||
16072013|NCT01235949|38753372|FG013|Booster Phase|Withdrawal by Subject|0|||
16072014|NCT01235949|38753373|FG014|Booster Phase|Withdrawal by Subject|2|||
16072015|NCT01235949|38753374|FG015|Booster Phase|Withdrawal by Subject|0|||
16072016|NCT01235949|38753375|FG016|Booster Phase|Withdrawal by Subject|0|||
16072017|NCT01235949|38753376|FG017|Booster Phase|Withdrawal by Subject|0|||
16072018|NCT01235949|38753359|FG000|Booster Phase|Lost to Follow-up|0|||
16072019|NCT01235949|38753360|FG001|Booster Phase|Lost to Follow-up|0|||
16072020|NCT01235949|38753361|FG002|Booster Phase|Lost to Follow-up|0|||
16072021|NCT01235949|38753362|FG003|Booster Phase|Lost to Follow-up|0|||
16072022|NCT01235949|38753363|FG004|Booster Phase|Lost to Follow-up|0|||
16072023|NCT01235949|38753364|FG005|Booster Phase|Lost to Follow-up|0|||
16072024|NCT01235949|38753365|FG006|Booster Phase|Lost to Follow-up|0|||
16072025|NCT01235949|38753366|FG007|Booster Phase|Lost to Follow-up|0|||
16072026|NCT01235949|38753367|FG008|Booster Phase|Lost to Follow-up|1|||
16072027|NCT01235949|38753368|FG009|Booster Phase|Lost to Follow-up|1|||
16072028|NCT01235949|38753369|FG010|Booster Phase|Lost to Follow-up|1|||
16072029|NCT01235949|38753370|FG011|Booster Phase|Lost to Follow-up|1|||
16072030|NCT01235949|38753371|FG012|Booster Phase|Lost to Follow-up|0|||
16072031|NCT01235949|38753372|FG013|Booster Phase|Lost to Follow-up|0|||
16072032|NCT01235949|38753373|FG014|Booster Phase|Lost to Follow-up|0|||
16072033|NCT01235949|38753374|FG015|Booster Phase|Lost to Follow-up|0|||
16072034|NCT01235949|38753375|FG016|Booster Phase|Lost to Follow-up|0|||
16072035|NCT01235949|38753376|FG017|Booster Phase|Lost to Follow-up|1|||
16072036|NCT01368406|38753377|FG000|Overall Study|Lost to Follow-up|8|||
16072037|NCT01368406|38753378|FG001|Overall Study|Lost to Follow-up|4|||
16072038|NCT01368406|38753377|FG000|Overall Study|Withdrawal by Subject|8|||
16072039|NCT01368406|38753378|FG001|Overall Study|Withdrawal by Subject|4|||
16072040|NCT01368406|38753377|FG000|Overall Study|relapse of the disease|3|||
16072041|NCT01368406|38753378|FG001|Overall Study|relapse of the disease|2|||
16072042|NCT01368406|38753377|FG000|Overall Study|started working|2|||
16072043|NCT01368406|38753378|FG001|Overall Study|started working|3|||
16072044|NCT00197236|38753381|FG000|Overall Study|Adverse Event|1|||
16072045|NCT00197236|38753382|FG001|Overall Study|Adverse Event|0|||
16072046|NCT00197236|38753383|FG002|Overall Study|Adverse Event|1|||
16072047|NCT00197236|38753381|FG000|Overall Study|Lost to Follow-up|5|||
16072048|NCT00197236|38753382|FG001|Overall Study|Lost to Follow-up|14|||
16072049|NCT00197236|38753383|FG002|Overall Study|Lost to Follow-up|6|||
16072050|NCT00197236|38753381|FG000|Overall Study|Protocol Violation|0|||
16072051|NCT00197236|38753382|FG001|Overall Study|Protocol Violation|0|||
16072052|NCT00197236|38753383|FG002|Overall Study|Protocol Violation|1|||
16372951|NCT00231465|39849824|FG000|Overall Study|Completed only one cycle|1|||
16072053|NCT00197236|38753381|FG000|Overall Study|Withdrawal by Subject|7|||
16072054|NCT00197236|38753382|FG001|Overall Study|Withdrawal by Subject|3|||
16072055|NCT00197236|38753383|FG002|Overall Study|Withdrawal by Subject|11|||
16372952|NCT00231465|39849824|FG000|Overall Study|Did not have follow up CT scans|1|||
16072056|NCT00197236|38753381|FG000|Overall Study|Study drug/medication expiration|1|||
16072057|NCT00197236|38753382|FG001|Overall Study|Study drug/medication expiration|0|||
16072058|NCT00197236|38753383|FG002|Overall Study|Study drug/medication expiration|3|||
16072059|NCT00197236|38753381|FG000|Overall Study|Returned out of specified time window|0|||
16072060|NCT00197236|38753382|FG001|Overall Study|Returned out of specified time window|0|||
16072061|NCT00197236|38753383|FG002|Overall Study|Returned out of specified time window|1|||
16072062|NCT00217672|38753386|FG000|Allocation|Ineligible|2|||
16072063|NCT00217672|38753387|FG001|Allocation|Ineligible|0|||
16072064|NCT00217672|38753386|FG000|Treatment|disease progression|33|||
16072065|NCT00217672|38753387|FG001|Treatment|disease progression|4|||
16072066|NCT00217672|38753386|FG000|Treatment|Adverse Event|18|||
16072067|NCT00217672|38753387|FG001|Treatment|Adverse Event|2|||
16072068|NCT00217672|38753386|FG000|Treatment|reqd treatment not permitted by protocol|6|||
16072069|NCT00217672|38753387|FG001|Treatment|reqd treatment not permitted by protocol|0|||
16072070|NCT00217672|38753386|FG000|Treatment|Physician Decision|6|||
16072071|NCT00217672|38753387|FG001|Treatment|Physician Decision|0|||
16072072|NCT00217672|38753386|FG000|Treatment|insurance issues|1|||
16072073|NCT00217672|38753387|FG001|Treatment|insurance issues|1|||
16072074|NCT00217672|38753386|FG000|Treatment|Death|2|||
16072075|NCT00217672|38753387|FG001|Treatment|Death|0|||
16072076|NCT00217672|38753386|FG000|Treatment|secondary malignancy|1|||
16072077|NCT00217672|38753387|FG001|Treatment|secondary malignancy|0|||
16072078|NCT00217672|38753386|FG000|Follow-up|Withdrawal by Subject|4|||
16072079|NCT00217672|38753387|FG001|Follow-up|Withdrawal by Subject|0|||
16072080|NCT00217672|38753386|FG000|Follow-up|Lost to Follow-up|1|||
16072081|NCT00217672|38753387|FG001|Follow-up|Lost to Follow-up|0|||
16072082|NCT00854906|38756162|FG000|Overall Study|One person had no ocular history|1|||
16072083|NCT03181958|38756167|FG000|Overall Study|Lost to Follow-up|17|||
16072084|NCT03181958|38756168|FG001|Overall Study|Lost to Follow-up|21|||
16072085|NCT03181958|38756169|FG002|Overall Study|Lost to Follow-up|15|||
16072086|NCT00612586|38756172|FG000|Overall Study|Adverse Event|6|||
16072087|NCT00612586|38756173|FG001|Overall Study|Adverse Event|2|||
16072088|NCT00612586|38756172|FG000|Overall Study|Death|1|||
16072089|NCT00612586|38756173|FG001|Overall Study|Death|0|||
16072090|NCT00612586|38756172|FG000|Overall Study|Entry Criteria Not Met|0|||
16072091|NCT00612586|38756173|FG001|Overall Study|Entry Criteria Not Met|2|||
16072092|NCT00612586|38756172|FG000|Overall Study|Withdrawal by Subject|7|||
16072093|NCT00612586|38756173|FG001|Overall Study|Withdrawal by Subject|9|||
16072094|NCT00612586|38756172|FG000|Overall Study|Physician Decision|1|||
16072095|NCT00612586|38756173|FG001|Overall Study|Physician Decision|2|||
16072096|NCT00612586|38756172|FG000|Overall Study|Sponsor Decision|1|||
16072097|NCT00612586|38756173|FG001|Overall Study|Sponsor Decision|1|||
16072098|NCT00612586|38756172|FG000|Overall Study|Progressive Disease|26|||
16072099|NCT00612586|38756173|FG001|Overall Study|Progressive Disease|24|||
16072100|NCT00612586|38756172|FG000|Overall Study|Randomized and Not Treated|1|||
16072101|NCT00612586|38756173|FG001|Overall Study|Randomized and Not Treated|1|||
16072102|NCT00157014|38756176|FG000|Overall Study|Death|4|||
16072103|NCT00157014|38756177|FG001|Overall Study|Death|2|||
16072104|NCT00157014|38756178|FG002|Overall Study|Death|1|||
16072105|NCT00157014|38756179|FG003|Overall Study|Death|1|||
16072106|NCT00157014|38756176|FG000|Overall Study|Physician Decision|0|||
16072107|NCT00157014|38756177|FG001|Overall Study|Physician Decision|1|||
16072108|NCT00157014|38756178|FG002|Overall Study|Physician Decision|0|||
16072109|NCT00157014|38756179|FG003|Overall Study|Physician Decision|0|||
16072110|NCT00157014|38756176|FG000|Overall Study|Medications withdrawn on family request|0|||
16072111|NCT00157014|38756177|FG001|Overall Study|Medications withdrawn on family request|1|||
16072112|NCT00157014|38756178|FG002|Overall Study|Medications withdrawn on family request|0|||
16072113|NCT00157014|38756179|FG003|Overall Study|Medications withdrawn on family request|0|||
16072114|NCT00157014|38756176|FG000|Overall Study|Patient withdrawn by investigator|1|||
16072115|NCT00157014|38756177|FG001|Overall Study|Patient withdrawn by investigator|0|||
16072116|NCT00157014|38756178|FG002|Overall Study|Patient withdrawn by investigator|0|||
16072117|NCT00157014|38756179|FG003|Overall Study|Patient withdrawn by investigator|0|||
16072118|NCT00157014|38756176|FG000|Overall Study|Patient unable to return in nursing home|1|||
16072119|NCT00157014|38756177|FG001|Overall Study|Patient unable to return in nursing home|0|||
16072120|NCT00157014|38756178|FG002|Overall Study|Patient unable to return in nursing home|0|||
16072121|NCT00157014|38756179|FG003|Overall Study|Patient unable to return in nursing home|0|||
16072122|NCT00157014|38756176|FG000|Overall Study|Patient would not receive transplant|0|||
16072123|NCT00157014|38756177|FG001|Overall Study|Patient would not receive transplant|1|||
16072124|NCT00157014|38756178|FG002|Overall Study|Patient would not receive transplant|0|||
16072125|NCT00157014|38756179|FG003|Overall Study|Patient would not receive transplant|0|||
16072126|NCT00157014|38756176|FG000|Overall Study|Withdrawal by Subject|1|||
16072127|NCT00157014|38756177|FG001|Overall Study|Withdrawal by Subject|0|||
16072128|NCT00157014|38756178|FG002|Overall Study|Withdrawal by Subject|0|||
16072129|NCT00157014|38756179|FG003|Overall Study|Withdrawal by Subject|0|||
16072130|NCT02057718|38756183|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
16072131|NCT02057718|38756184|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
16072132|NCT02057718|38756183|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
16072133|NCT02057718|38756184|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
16072134|NCT02057718|38756183|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
16072135|NCT02057718|38756184|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
16072136|NCT02057718|38756183|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
16072137|NCT02057718|38756184|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
16372953|NCT01454063|39849825|FG000|Randomized|Adverse Event|1|||
16072138|NCT02057718|38756183|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
16072139|NCT02057718|38756184|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
16072140|NCT02057718|38756183|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
16072141|NCT02057718|38756184|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
16072142|NCT02057718|38756183|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
16072143|NCT02057718|38756184|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
16072144|NCT02057718|38756183|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
16072145|NCT02057718|38756184|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
16072146|NCT02057718|38756183|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
16072147|NCT02057718|38756184|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
16072148|NCT02057718|38756183|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
16072149|NCT02057718|38756184|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
16072150|NCT02057718|38756183|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
16072151|NCT02057718|38756184|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
16072152|NCT00597519|38756191|FG000|Overall Study|Death|1|||
16072153|NCT00258895|38756193|FG000|Overall Study|Lost to Follow-up|3|||
16072154|NCT00258895|38756194|FG001|Overall Study|Lost to Follow-up|1|||
16072155|NCT00258895|38756193|FG000|Overall Study|Protocol Violation|6|||
16072156|NCT00258895|38756194|FG001|Overall Study|Protocol Violation|2|||
16072157|NCT00258895|38756193|FG000|Overall Study|Withdrawal by Subject|1|||
16072158|NCT00258895|38756194|FG001|Overall Study|Withdrawal by Subject|0|||
16072159|NCT00244855|38756196|FG000|Overall Study|Withdrawal by Subject|0|||
16072160|NCT00244855|38756197|FG001|Overall Study|Withdrawal by Subject|1|||
16072161|NCT02918071|38756198|FG000|Overall Study|Withdrawal by Subject|2|||
16072162|NCT02918071|38756198|FG000|Overall Study|Lost to Follow-up|1|||
16072163|NCT00117988|38756200|FG000|Overall Study|Death|3|||
16072164|NCT00117988|38756200|FG000|Overall Study|Adverse Event|1|||
16072165|NCT01546155|38756202|FG000|Overall Study|could not tolerate long scan duration|3|||
16072166|NCT00909363|38756203|FG000|Overall Study|Withdrawal by Subject|1|||
16072167|NCT00909363|38756204|FG001|Overall Study|Withdrawal by Subject|0|||
16072168|NCT00909363|38756205|FG002|Overall Study|Withdrawal by Subject|0|||
16072169|NCT00909363|38756203|FG000|Overall Study|Lack of Efficacy|1|||
16072170|NCT00909363|38756204|FG001|Overall Study|Lack of Efficacy|0|||
16072171|NCT00909363|38756205|FG002|Overall Study|Lack of Efficacy|0|||
16072172|NCT01131494|38756207|FG000|Overall Study|Withdrawal by Subject|2|||
16072173|NCT03061474|38756212|FG000|Overall Study|Adverse Event|2|||
16072174|NCT03061474|38756213|FG001|Overall Study|Adverse Event|0|||
16072175|NCT03061474|38756212|FG000|Overall Study|Safety Risk|0|||
16072176|NCT03061474|38756213|FG001|Overall Study|Safety Risk|1|||
16072177|NCT03061474|38756212|FG000|Overall Study|Participant unwilling or unable to participate|0|||
16072178|NCT03061474|38756213|FG001|Overall Study|Participant unwilling or unable to participate|2|||
16072179|NCT03061474|38756212|FG000|Overall Study|Lost to Follow-up|0|||
16072180|NCT03061474|38756213|FG001|Overall Study|Lost to Follow-up|1|||
16072181|NCT03913130|38756214|FG000|Overall Study|Sponsor Decision|1|||
16072182|NCT02888080|38756220|FG000|Overall Study|Subject / Guardian decision|1|||
16072183|NCT02888080|38756221|FG001|Overall Study|Subject / Guardian decision|3|||
16072184|NCT02888080|38756220|FG000|Overall Study|New Therapy for study indication|1|||
16072185|NCT02888080|38756221|FG001|Overall Study|New Therapy for study indication|0|||
16072186|NCT02888080|38756220|FG000|Overall Study|Lack of Efficacy|0|||
16072187|NCT02888080|38756221|FG001|Overall Study|Lack of Efficacy|1|||
16072188|NCT02888080|38756220|FG000|Overall Study|Adverse Event|0|||
16072189|NCT02888080|38756221|FG001|Overall Study|Adverse Event|1|||
16072190|NCT05019729|38756222|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
16072191|NCT05019729|38756223|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
16072192|NCT05019729|38756224|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
16072193|NCT05019729|38756225|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
16072194|NCT05019729|38756226|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
16072195|NCT05019729|38756227|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
16072196|NCT03691428|38756228|FG000|Overall Study|Withdrawal by Subject|6|||
16072197|NCT03691428|38756229|FG001|Overall Study|Withdrawal by Subject|8|||
16072198|NCT01924767|38756239|FG000|Overall Study|Adverse Event|1|||
16072199|NCT01924767|38756240|FG001|Overall Study|Adverse Event|0|||
16072200|NCT01924767|38756241|FG002|Overall Study|Adverse Event|1|||
16072201|NCT01924767|38756242|FG003|Overall Study|Adverse Event|0|||
16072202|NCT01924767|38756243|FG004|Overall Study|Adverse Event|0|||
16072203|NCT03255018|38756244|FG000|Overall Study|Death on study|0|||
16072204|NCT03255018|38756245|FG001|Overall Study|Death on study|5|||
16072205|NCT03255018|38756244|FG000|Overall Study|Withdrawal by Subject|0|||
16072206|NCT03255018|38756245|FG001|Overall Study|Withdrawal by Subject|2|||
16372954|NCT01454063|39849826|FG001|Randomized|Adverse Event|1|||
16372955|NCT01454063|39849825|FG000|Randomized|Protocol Violation|0|||
16072207|NCT02982213|38756248|FG000|Overall Study|Did not complete follow up questionnaire|5|||
16072208|NCT02982213|38756249|FG001|Overall Study|Did not complete follow up questionnaire|1|||
16072209|NCT03121950|38756250|FG000|Overall Study|Withdrawal by Subject|11|||
16072210|NCT03121950|38756251|FG001|Overall Study|Withdrawal by Subject|2|||
16072211|NCT05046132|38756252|FG000|Overall Study|Adverse Event|4|||
16072212|NCT05046132|38756253|FG001|Overall Study|Adverse Event|0|||
16072213|NCT05046132|38756254|FG002|Overall Study|Adverse Event|0|||
16072214|NCT05046132|38756252|FG000|Overall Study|Withdrawal by Subject|3|||
16072215|NCT05046132|38756253|FG001|Overall Study|Withdrawal by Subject|0|||
16072216|NCT05046132|38756254|FG002|Overall Study|Withdrawal by Subject|0|||
16072217|NCT05046132|38756252|FG000|Overall Study|Positive Covid19 Result.|0|||
16072218|NCT05046132|38756253|FG001|Overall Study|Positive Covid19 Result.|1|||
16072219|NCT05046132|38756254|FG002|Overall Study|Positive Covid19 Result.|0|||
16072220|NCT01591616|38756255|FG000|Overall Study|Withdrawal by Subject|1|||
16072221|NCT00688519|38756256|FG000|Overall Study|Adverse Event|2|||
16072222|NCT00688519|38756257|FG001|Overall Study|Adverse Event|3|||
16072223|NCT00688519|38756256|FG000|Overall Study|Lost to Follow-up|3|||
16072224|NCT00688519|38756257|FG001|Overall Study|Lost to Follow-up|3|||
16072225|NCT00688519|38756256|FG000|Overall Study|Lack of Efficacy|3|||
16072226|NCT00688519|38756257|FG001|Overall Study|Lack of Efficacy|1|||
16072227|NCT00688519|38756256|FG000|Overall Study|Withdrawal by Subject|7|||
16072228|NCT00688519|38756257|FG001|Overall Study|Withdrawal by Subject|6|||
16072229|NCT00688519|38756256|FG000|Overall Study|Prohibited medication|1|||
16072230|NCT00688519|38756257|FG001|Overall Study|Prohibited medication|0|||
16072231|NCT00688519|38756256|FG000|Overall Study|Non-compliance|0|||
16072232|NCT00688519|38756257|FG001|Overall Study|Non-compliance|1|||
16072233|NCT00688519|38756256|FG000|Overall Study|Subject moved out of state|1|||
16072234|NCT00688519|38756257|FG001|Overall Study|Subject moved out of state|0|||
16072235|NCT00688519|38756256|FG000|Overall Study|Investigator decision|1|||
16072236|NCT00688519|38756257|FG001|Overall Study|Investigator decision|0|||
16072237|NCT00688519|38756256|FG000|Overall Study|Subject moved out of area|1|||
16072238|NCT00688519|38756257|FG001|Overall Study|Subject moved out of area|0|||
16072239|NCT00688519|38756256|FG000|Overall Study|Pregnancy|0|||
16072240|NCT00688519|38756257|FG001|Overall Study|Pregnancy|1|||
16072241|NCT03441360|38756261|FG000|Overall Study|Radiological disease progression|5|||
16072242|NCT03441360|38756262|FG001|Overall Study|Radiological disease progression|6|||
16072243|NCT03441360|38756263|FG002|Overall Study|Radiological disease progression|4|||
16072244|NCT03441360|38756261|FG000|Overall Study|Clinical disease progression|2|||
16072245|NCT03441360|38756262|FG001|Overall Study|Clinical disease progression|2|||
16072246|NCT03441360|38756263|FG002|Overall Study|Clinical disease progression|0|||
16072247|NCT03441360|38756261|FG000|Overall Study|Adverse Event|1|||
16072248|NCT03441360|38756262|FG001|Overall Study|Adverse Event|0|||
16072249|NCT03441360|38756263|FG002|Overall Study|Adverse Event|1|||
16072250|NCT00628862|38756264|FG000|Overall Study|Adverse Event|6|||
16072251|NCT00628862|38756265|FG001|Overall Study|Adverse Event|8|||
16072252|NCT00628862|38756266|FG002|Overall Study|Adverse Event|10|||
16072253|NCT00628862|38756264|FG000|Overall Study|Withdrawal by Subject|4|||
16072254|NCT00628862|38756265|FG001|Overall Study|Withdrawal by Subject|6|||
16072255|NCT00628862|38756266|FG002|Overall Study|Withdrawal by Subject|11|||
16072256|NCT00628862|38756264|FG000|Overall Study|Lost to Follow-up|0|||
16072257|NCT00628862|38756265|FG001|Overall Study|Lost to Follow-up|2|||
16072258|NCT00628862|38756266|FG002|Overall Study|Lost to Follow-up|1|||
16072259|NCT00628862|38756264|FG000|Overall Study|Protocol Violation|1|||
16072260|NCT00628862|38756265|FG001|Overall Study|Protocol Violation|0|||
16072261|NCT00628862|38756266|FG002|Overall Study|Protocol Violation|0|||
16072262|NCT00628862|38756264|FG000|Overall Study|COPD Exacerbation|0|||
16072263|NCT00628862|38756265|FG001|Overall Study|COPD Exacerbation|1|||
16072264|NCT00628862|38756266|FG002|Overall Study|COPD Exacerbation|0|||
16072265|NCT00158054|38756267|FG000|Overall Study|Refused to continue|3|||
16072266|NCT00158054|38756268|FG001|Overall Study|Refused to continue|0|||
16072267|NCT00158054|38756267|FG000|Overall Study|Unavailable for follow up|7|||
16072268|NCT00158054|38756268|FG001|Overall Study|Unavailable for follow up|3|||
16072269|NCT05179837|38756269|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
16072270|NCT05179837|38756269|FG000|Overall Study|Device malfunctioned|1|||
16072271|NCT05179837|38756269|FG000|Overall Study|Image quality too low|2|||
16072272|NCT00762606|38756270|FG000|Overall Study|Lost to Follow-up|18|||
16072273|NCT00762606|38756271|FG001|Overall Study|Lost to Follow-up|13|||
16072274|NCT02674750|38756274|FG000|Overall Study|Death|4|||
16072275|NCT02674750|38756275|FG001|Overall Study|Death|5|||
16072276|NCT02674750|38756276|FG002|Overall Study|Death|8|||
16072277|NCT02674750|38756274|FG000|Overall Study|Lost to Follow-up|0|||
16072278|NCT02674750|38756275|FG001|Overall Study|Lost to Follow-up|8|||
16072279|NCT02674750|38756276|FG002|Overall Study|Lost to Follow-up|0|||
16072280|NCT02674750|38756274|FG000|Overall Study|Lack of Efficacy|1|||
16072281|NCT02674750|38756275|FG001|Overall Study|Lack of Efficacy|17|||
16072282|NCT02674750|38756276|FG002|Overall Study|Lack of Efficacy|3|||
16072283|NCT02674750|38756274|FG000|Overall Study|Withdrawal by Subject|0|||
16072284|NCT02674750|38756275|FG001|Overall Study|Withdrawal by Subject|7|||
16072285|NCT02674750|38756276|FG002|Overall Study|Withdrawal by Subject|1|||
16072286|NCT02674750|38756274|FG000|Overall Study|Other|0|||
16072287|NCT02674750|38756275|FG001|Overall Study|Other|8|||
16072288|NCT02674750|38756276|FG002|Overall Study|Other|0|||
16072289|NCT01713530|38756277|FG000|Overall Study|Adverse Event|0|||
16072290|NCT01713530|38756278|FG001|Overall Study|Adverse Event|5|||
16072291|NCT01713530|38756277|FG000|Overall Study|Withdrawal criteria|21|||
16072292|NCT01713530|38756278|FG001|Overall Study|Withdrawal criteria|12|||
16072293|NCT01713530|38756277|FG000|Overall Study|Unclassified|4|||
16072294|NCT01713530|38756278|FG001|Overall Study|Unclassified|2|||
16072295|NCT00919763|38756279|FG000|Overall Study|Adverse Event|7|||
16072296|NCT00919763|38756280|FG001|Overall Study|Adverse Event|1|||
16072297|NCT00919763|38756279|FG000|Overall Study|Lost to Follow-up|1|||
16072298|NCT00919763|38756280|FG001|Overall Study|Lost to Follow-up|0|||
16072299|NCT00919763|38756279|FG000|Overall Study|Protocol Violation|1|||
16072300|NCT00919763|38756280|FG001|Overall Study|Protocol Violation|1|||
16072301|NCT00919763|38756279|FG000|Overall Study|Withdrawal by Subject|3|||
16072302|NCT00919763|38756280|FG001|Overall Study|Withdrawal by Subject|1|||
16072303|NCT00919763|38756279|FG000|Overall Study|Non-compliance|0|||
16072304|NCT00919763|38756280|FG001|Overall Study|Non-compliance|1|||
16072305|NCT01596504|38756281|FG000|Overall Study|Participant's Private Reason|0|||
16072306|NCT01596504|38756282|FG001|Overall Study|Participant's Private Reason|1|||
16072307|NCT01596504|38756283|FG002|Overall Study|Participant's Private Reason|0|||
16072308|NCT01596504|38756281|FG000|Overall Study|Adverse Event|1|||
16072309|NCT01596504|38756282|FG001|Overall Study|Adverse Event|2|||
16072310|NCT01596504|38756283|FG002|Overall Study|Adverse Event|1|||
16072311|NCT01596504|38756281|FG000|Overall Study|Withdrawal by Subject|1|||
16072312|NCT01596504|38756282|FG001|Overall Study|Withdrawal by Subject|0|||
16072313|NCT01596504|38756283|FG002|Overall Study|Withdrawal by Subject|0|||
16072314|NCT00906035|38756286|FG000|Overall Study|Withdrawal by Subject|2|||
16072315|NCT00906035|38756287|FG001|Overall Study|Withdrawal by Subject|3|||
16072316|NCT00906035|38756288|FG002|Overall Study|Withdrawal by Subject|0|||
16072317|NCT02459899|38756294|FG000|Overall Study|Adverse Event|1|||
16072318|NCT02459899|38756295|FG001|Overall Study|Adverse Event|1|||
16072319|NCT02459899|38756296|FG002|Overall Study|Adverse Event|0|||
16072320|NCT02459899|38756297|FG003|Overall Study|Adverse Event|0|||
16072321|NCT02459899|38756294|FG000|Overall Study|Lost to Follow-up|1|||
16072322|NCT02459899|38756295|FG001|Overall Study|Lost to Follow-up|2|||
16072323|NCT02459899|38756296|FG002|Overall Study|Lost to Follow-up|0|||
16072324|NCT02459899|38756297|FG003|Overall Study|Lost to Follow-up|1|||
16072325|NCT02459899|38756294|FG000|Overall Study|Non-compliance with the treatment|0|||
16072326|NCT02459899|38756295|FG001|Overall Study|Non-compliance with the treatment|0|||
16072327|NCT02459899|38756296|FG002|Overall Study|Non-compliance with the treatment|0|||
16072328|NCT02459899|38756297|FG003|Overall Study|Non-compliance with the treatment|1|||
16072329|NCT02459899|38756294|FG000|Overall Study|Withdrawal by Subject|1|||
16072330|NCT02459899|38756295|FG001|Overall Study|Withdrawal by Subject|3|||
16072331|NCT02459899|38756296|FG002|Overall Study|Withdrawal by Subject|0|||
16072332|NCT02459899|38756297|FG003|Overall Study|Withdrawal by Subject|0|||
16072333|NCT04379713|38756298|FG000|Overall Study|Adverse Event|2|||
16072334|NCT04379713|38756299|FG001|Overall Study|Adverse Event|0|||
16072335|NCT04379713|38756298|FG000|Overall Study|Physician Decision|2|||
16072336|NCT04379713|38756299|FG001|Overall Study|Physician Decision|1|||
16072337|NCT04379713|38756298|FG000|Overall Study|Protocol Violation|11|||
16072338|NCT04379713|38756299|FG001|Overall Study|Protocol Violation|6|||
16072339|NCT04379713|38756298|FG000|Overall Study|No longer met eligibility criteria|14|||
16072340|NCT04379713|38756299|FG001|Overall Study|No longer met eligibility criteria|11|||
16072341|NCT04379713|38756298|FG000|Overall Study|Withdrawal by parent/guardian|36|||
16072342|NCT04379713|38756299|FG001|Overall Study|Withdrawal by parent/guardian|15|||
16072343|NCT04379713|38756298|FG000|Overall Study|Lost to Follow-up|31|||
16072344|NCT04379713|38756299|FG001|Overall Study|Lost to Follow-up|21|||
16072345|NCT03179787|38756300|FG000|Overall Study|Lost to Follow-up|15|||
16072346|NCT03179787|38756300|FG000|Overall Study|Case report failures|2|||
16072347|NCT03179787|38756300|FG000|Overall Study|Treatment not administered|1|||
16072348|NCT02751580|38756301|FG000|Overall Study|Lost to Follow-up|4|||
16072349|NCT02751580|38756301|FG000|Overall Study|Death|2|||
16072350|NCT03635424|38756305|FG000|Overall Study|Adverse Event|1|||
16072351|NCT03635424|38756305|FG000|Overall Study|Death|1|||
16072352|NCT03635424|38756305|FG000|Overall Study|Device not implanted|1|||
16072353|NCT04304534|38756307|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
16072354|NCT04304534|38756308|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
16072355|NCT04304534|38756309|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
16072356|NCT04304534|38756310|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
16072357|NCT04304534|38756307|FG000|Overall Study|Non-Compliance with study drug|0|||
16072358|NCT04304534|38756308|FG001|Overall Study|Non-Compliance with study drug|1|||
16072359|NCT04304534|38756309|FG002|Overall Study|Non-Compliance with study drug|1|||
16072360|NCT04304534|38756310|FG003|Overall Study|Non-Compliance with study drug|1|||
16072361|NCT04304534|38756307|FG000|Overall Study|Lost to Follow-up|0|||
16072362|NCT04304534|38756308|FG001|Overall Study|Lost to Follow-up|1|||
16072363|NCT04304534|38756309|FG002|Overall Study|Lost to Follow-up|2|||
16072364|NCT04304534|38756310|FG003|Overall Study|Lost to Follow-up|3|||
16072365|NCT04304534|38756307|FG000|Overall Study|Unspecific|4|||
16072366|NCT04304534|38756308|FG001|Overall Study|Unspecific|2|||
16072367|NCT04304534|38756309|FG002|Overall Study|Unspecific|2|||
16072368|NCT04304534|38756310|FG003|Overall Study|Unspecific|2|||
16072369|NCT04304534|38756307|FG000|Overall Study|Technical Problems|2|||
16072370|NCT04304534|38756308|FG001|Overall Study|Technical Problems|2|||
16072371|NCT04304534|38756309|FG002|Overall Study|Technical Problems|3|||
16072372|NCT04304534|38756310|FG003|Overall Study|Technical Problems|4|||
16072373|NCT04304534|38756307|FG000|Overall Study|Death|7|||
16072374|NCT04304534|38756308|FG001|Overall Study|Death|2|||
16072375|NCT04304534|38756309|FG002|Overall Study|Death|4|||
16072376|NCT04304534|38756310|FG003|Overall Study|Death|3|||
16072377|NCT04304534|38756307|FG000|Overall Study|Withdrawal by Subject|7|||
16072378|NCT04304534|38756308|FG001|Overall Study|Withdrawal by Subject|2|||
16072379|NCT04304534|38756309|FG002|Overall Study|Withdrawal by Subject|7|||
16072380|NCT04304534|38756310|FG003|Overall Study|Withdrawal by Subject|4|||
16072381|NCT04304534|38756307|FG000|Overall Study|Physician Decision|4|||
16072382|NCT04304534|38756308|FG001|Overall Study|Physician Decision|9|||
16072383|NCT04304534|38756309|FG002|Overall Study|Physician Decision|9|||
16072384|NCT04304534|38756310|FG003|Overall Study|Physician Decision|5|||
16072385|NCT04304534|38756307|FG000|Overall Study|Subject Decision|34|||
16072386|NCT04304534|38756308|FG001|Overall Study|Subject Decision|25|||
16072387|NCT04304534|38756309|FG002|Overall Study|Subject Decision|25|||
16072388|NCT04304534|38756310|FG003|Overall Study|Subject Decision|26|||
16072389|NCT04304534|38756307|FG000|Overall Study|Adverse Event|35|||
16072390|NCT04304534|38756308|FG001|Overall Study|Adverse Event|40|||
16072391|NCT04304534|38756309|FG002|Overall Study|Adverse Event|39|||
16072392|NCT04304534|38756310|FG003|Overall Study|Adverse Event|44|||
16072393|NCT00845832|38756317|FG000|Treatment Period|Adverse Event|0|||
16072394|NCT00845832|38756318|FG001|Treatment Period|Adverse Event|2|||
16072395|NCT00845832|38756319|FG002|Treatment Period|Adverse Event|0|||
16072396|NCT00845832|38756317|FG000|Treatment Period|Protocol Violation|1|||
16072397|NCT00845832|38756318|FG001|Treatment Period|Protocol Violation|1|||
16072398|NCT00845832|38756319|FG002|Treatment Period|Protocol Violation|0|||
16072399|NCT00845832|38756317|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
16072400|NCT00845832|38756318|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
16072401|NCT00845832|38756319|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
16072402|NCT00845832|38756317|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
16072403|NCT00845832|38756318|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
16072404|NCT00845832|38756319|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
16072405|NCT00130637|38756323|FG000|Overall Study|Adverse Event|2|||
16072406|NCT00130637|38756323|FG000|Overall Study|Withdrawal by Subject|1|||
16072407|NCT00530842|38756324|FG000|Overall Study|Adverse Event|10|||
16072408|NCT00530842|38756325|FG001|Overall Study|Adverse Event|6|||
16072409|NCT00530842|38756324|FG000|Overall Study|Lack of Efficacy|2|||
16072410|NCT00530842|38756325|FG001|Overall Study|Lack of Efficacy|1|||
16072411|NCT00530842|38756324|FG000|Overall Study|Lost to Follow-up|0|||
16072412|NCT00530842|38756325|FG001|Overall Study|Lost to Follow-up|4|||
16072413|NCT00530842|38756324|FG000|Overall Study|Protocol Violation|3|||
16072414|NCT00530842|38756325|FG001|Overall Study|Protocol Violation|2|||
16072415|NCT00530842|38756324|FG000|Overall Study|Withdrawal by Subject|4|||
16072416|NCT00530842|38756325|FG001|Overall Study|Withdrawal by Subject|5|||
16072417|NCT00530842|38756324|FG000|Overall Study|Individual different reasons|4|||
16072418|NCT00530842|38756325|FG001|Overall Study|Individual different reasons|3|||
16072419|NCT00530842|38756324|FG000|Period 1|Adverse Event|7|||
16072420|NCT00530842|38756325|FG001|Period 1|Adverse Event|3|||
16072421|NCT00530842|38756324|FG000|Period 1|Lack of Efficacy|1|||
16072422|NCT00530842|38756325|FG001|Period 1|Lack of Efficacy|1|||
16072423|NCT00530842|38756324|FG000|Period 1|Protocol Violation|2|||
16072424|NCT00530842|38756325|FG001|Period 1|Protocol Violation|1|||
16072425|NCT00530842|38756324|FG000|Period 1|Withdrawal by Subject|2|||
16072426|NCT00530842|38756325|FG001|Period 1|Withdrawal by Subject|3|||
16072427|NCT00530842|38756324|FG000|Period 1|Individual different reasons|2|||
16072428|NCT00530842|38756325|FG001|Period 1|Individual different reasons|3|||
16072429|NCT00530842|38756324|FG000|Period 2|Adverse Event|3|||
16072430|NCT00530842|38756325|FG001|Period 2|Adverse Event|3|||
16072431|NCT00530842|38756324|FG000|Period 2|Lack of Efficacy|1|||
16072432|NCT00530842|38756325|FG001|Period 2|Lack of Efficacy|0|||
16072433|NCT00530842|38756324|FG000|Period 2|Lost to Follow-up|0|||
16072434|NCT00530842|38756325|FG001|Period 2|Lost to Follow-up|4|||
16072435|NCT00530842|38756324|FG000|Period 2|Protocol Violation|1|||
16072436|NCT00530842|38756325|FG001|Period 2|Protocol Violation|0|||
16072437|NCT00530842|38756324|FG000|Period 2|Withdrawal by Subject|1|||
16072438|NCT00530842|38756325|FG001|Period 2|Withdrawal by Subject|2|||
16072439|NCT00530842|38756324|FG000|Period 2|Individual different reasons|2|||
16072440|NCT00530842|38756325|FG001|Period 2|Individual different reasons|0|||
16072441|NCT01510912|38756328|FG000|Overall Study|Adverse Event|99|||
16072442|NCT01510912|38756328|FG000|Overall Study|Lack of Efficacy|12|||
16072443|NCT01510912|38756328|FG000|Overall Study|Non-compliance with trial drug|23|||
16072444|NCT01510912|38756328|FG000|Overall Study|Withdrawal by Subject|49|||
16072445|NCT01510912|38756328|FG000|Overall Study|Physician Decision|1|||
16072446|NCT01510912|38756328|FG000|Overall Study|Protocol Violation|27|||
16072447|NCT01510912|38756328|FG000|Overall Study|Lost to Follow-up|26|||
16072448|NCT01510912|38756328|FG000|Overall Study|Other, including joint replacement|5|||
16072449|NCT00758602|38756336|FG000|Overall Study|Adverse Event|11|||
16072450|NCT00758602|38756337|FG001|Overall Study|Adverse Event|10|||
16072451|NCT00758602|38756336|FG000|Overall Study|Lost to Follow-up|4|||
16072452|NCT00758602|38756337|FG001|Overall Study|Lost to Follow-up|3|||
16072453|NCT00758602|38756336|FG000|Overall Study|Withdrawal by Subject|1|||
16072454|NCT00758602|38756337|FG001|Overall Study|Withdrawal by Subject|3|||
16072455|NCT00758602|38756336|FG000|Overall Study|Protocol Violation|0|||
16072456|NCT00758602|38756337|FG001|Overall Study|Protocol Violation|2|||
16072457|NCT00758602|38756336|FG000|Overall Study|Death|0|||
16072458|NCT00758602|38756337|FG001|Overall Study|Death|1|||
16072459|NCT00758602|38756336|FG000|Overall Study|Reason not specified|3|||
16072460|NCT00758602|38756337|FG001|Overall Study|Reason not specified|3|||
16072461|NCT06351371|38756338|FG000|Overall Study|Mutation Status Not Confirmed|9|||
16072462|NCT06351371|38756338|FG000|Overall Study|Ineligible|1|||
16072463|NCT06351371|38756338|FG000|Overall Study|Adverse Event|4|||
16072464|NCT06351371|38756338|FG000|Overall Study|Death|1|||
16072465|NCT06351371|38756338|FG000|Overall Study|Disease progression|14|||
16072466|NCT06351371|38756338|FG000|Overall Study|Withdrawal by Subject|3|||
16072467|NCT06351371|38756338|FG000|Overall Study|Physician Decision|3|||
16072468|NCT01070888|38756339|FG000|First Intervention (14 Days)|Adverse Event|0|||
16072469|NCT01070888|38756340|FG001|First Intervention (14 Days)|Adverse Event|1|||
16072470|NCT01070888|38756339|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
16072471|NCT01070888|38756340|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
16072472|NCT01070888|38756339|FG000|Washout (14 Days)|Physician Decision|1|||
16072473|NCT01070888|38756340|FG001|Washout (14 Days)|Physician Decision|0|||
16072474|NCT03235349|38756341|FG000|Overall Study|Adverse Event|1|||
16072475|NCT03235349|38756341|FG000|Overall Study|Other|1|||
16072476|NCT02263508|38756342|FG000|Overall Study|Withdrawal by Subject|1|||
16072477|NCT02263508|38756343|FG001|Overall Study|Withdrawal by Subject|23|||
16072478|NCT02263508|38756344|FG002|Overall Study|Withdrawal by Subject|17|||
16072479|NCT02263508|38756342|FG000|Overall Study|Sponsor Decision|12|||
16072480|NCT02263508|38756343|FG001|Overall Study|Sponsor Decision|165|||
16072481|NCT02263508|38756344|FG002|Overall Study|Sponsor Decision|182|||
16072482|NCT02263508|38756342|FG000|Overall Study|Lost to Follow-up|2|||
16072483|NCT02263508|38756343|FG001|Overall Study|Lost to Follow-up|7|||
16072484|NCT02263508|38756344|FG002|Overall Study|Lost to Follow-up|7|||
16072485|NCT02263508|38756342|FG000|Overall Study|Death|6|||
16072486|NCT02263508|38756343|FG001|Overall Study|Death|151|||
16072487|NCT02263508|38756344|FG002|Overall Study|Death|140|||
16072488|NCT03781336|38756345|FG000|Overall Study|Withdrawal by Subject|2|||
16072489|NCT03781336|38756346|FG001|Overall Study|Withdrawal by Subject|2|||
16072490|NCT01370694|38756348|FG000|Overall Study|Switched to rituximab|4|||
16072491|NCT01370694|38756348|FG000|Overall Study|Progressive disease|2|||
16072492|NCT00573833|38756349|FG000|Overall Study|Not Treated|2|||
16072493|NCT00608907|38756350|FG000|Overall Study|Adverse Event|6|||
16072494|NCT00608907|38756351|FG001|Overall Study|Adverse Event|0|||
16072495|NCT00608907|38756352|FG002|Overall Study|Adverse Event|1|||
16072496|NCT00608907|38756350|FG000|Overall Study|Death|1|||
16072497|NCT00608907|38756351|FG001|Overall Study|Death|0|||
16072498|NCT00608907|38756352|FG002|Overall Study|Death|0|||
16072499|NCT00608907|38756350|FG000|Overall Study|Withdrawal by Subject|4|||
16072500|NCT00608907|38756351|FG001|Overall Study|Withdrawal by Subject|0|||
16072501|NCT00608907|38756352|FG002|Overall Study|Withdrawal by Subject|0|||
16072502|NCT00608907|38756350|FG000|Overall Study|Progressive Disease|1|||
16072503|NCT00608907|38756351|FG001|Overall Study|Progressive Disease|0|||
16072504|NCT00608907|38756352|FG002|Overall Study|Progressive Disease|0|||
16072505|NCT01025843|38756355|FG000|Washout 4|Withdrawal by Subject|0|||
16072506|NCT01025843|38756356|FG001|Washout 4|Withdrawal by Subject|0|||
16072507|NCT01025843|38756357|FG002|Washout 4|Withdrawal by Subject|1|||
16072508|NCT01025843|38756358|FG003|Washout 4|Withdrawal by Subject|1|||
16072509|NCT01025843|38756359|FG004|Washout 4|Withdrawal by Subject|0|||
16072510|NCT01025843|38756360|FG005|Washout 4|Withdrawal by Subject|0|||
16072511|NCT01025843|38756361|FG006|Washout 4|Withdrawal by Subject|0|||
16072512|NCT01025843|38756362|FG007|Washout 4|Withdrawal by Subject|0|||
16072513|NCT01025843|38756363|FG008|Washout 4|Withdrawal by Subject|0|||
16072514|NCT01025843|38756364|FG009|Washout 4|Withdrawal by Subject|0|||
16072515|NCT01063036|38756365|FG000|Participants Treated With Study Drug|Adverse Event|1|||
16072516|NCT01063036|38756365|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
16072517|NCT01063036|38756365|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
16072518|NCT01063036|38756365|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
16072519|NCT01063036|38756365|FG000|Participants Treated With Study Drug|Pregnancy|1|||
16072520|NCT01063036|38756365|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
16072521|NCT01063036|38756365|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
16072522|NCT01063036|38756365|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
16072523|NCT01649791|38756372|FG000|Overall Study|Disease Progression|2|||
16072524|NCT01649791|38756372|FG000|Overall Study|Adverse Event|1|||
16448795|NCT02699749|40122240|FG001|Overall Study|Lost to Follow-up|0|||
16448796|NCT02699749|40122241|FG002|Overall Study|Lost to Follow-up|0|||
16448797|NCT02699749|40122242|FG003|Overall Study|Lost to Follow-up|0|||
16448798|NCT02699749|40122243|FG004|Overall Study|Lost to Follow-up|0|||
16448799|NCT02699749|40122244|FG005|Overall Study|Lost to Follow-up|1|||
16448800|NCT02699749|40122245|FG006|Overall Study|Lost to Follow-up|0|||
16448801|NCT02699749|40122246|FG007|Overall Study|Lost to Follow-up|1|||
16264984|NCT01597245|39453263|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16072525|NCT02715258|38756376|FG000|Overall Study|Withdrawal by Subject|6|||
16072526|NCT02715258|38756377|FG001|Overall Study|Withdrawal by Subject|1|||
16072527|NCT02715258|38756376|FG000|Overall Study|Lost to Follow-up|7|||
16072528|NCT02715258|38756377|FG001|Overall Study|Lost to Follow-up|1|||
16072529|NCT02715258|38756376|FG000|Overall Study|Terminated by Sponsor|0|||
16072530|NCT02715258|38756377|FG001|Overall Study|Terminated by Sponsor|1|||
16072531|NCT02715258|38756376|FG000|Overall Study|Death|0|||
16264985|NCT01597245|39453264|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264986|NCT01597245|39453265|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264987|NCT01597245|39453266|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264988|NCT01597245|39453267|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264989|NCT01597245|39453268|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264990|NCT01597245|39453269|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264991|NCT01597245|39453270|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
16264992|NCT01597245|39453271|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264993|NCT01597245|39453272|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264994|NCT01597245|39453273|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
16264995|NCT01597245|39453274|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
16264996|NCT01597245|39453254|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16264997|NCT01597245|39453255|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16264998|NCT01597245|39453256|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16264999|NCT01597245|39453257|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265000|NCT01597245|39453258|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265001|NCT01597245|39453259|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265002|NCT01597245|39453260|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265003|NCT01597245|39453261|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265004|NCT01597245|39453262|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265005|NCT01597245|39453263|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265006|NCT01597245|39453264|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265007|NCT01597245|39453265|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265008|NCT01597245|39453266|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265009|NCT01597245|39453267|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265010|NCT01597245|39453268|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265011|NCT01597245|39453269|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265012|NCT01597245|39453270|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
16265013|NCT01597245|39453271|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265014|NCT01597245|39453272|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16265015|NCT01597245|39453273|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
16448802|NCT02699749|40122247|FG008|Overall Study|Lost to Follow-up|0|||
16448803|NCT02699749|40122248|FG009|Overall Study|Lost to Follow-up|0|||
16448804|NCT02699749|40122249|FG010|Overall Study|Lost to Follow-up|0|||
16448805|NCT02699749|40122250|FG011|Overall Study|Lost to Follow-up|0|||
16448806|NCT02699749|40122251|FG012|Overall Study|Lost to Follow-up|0|||
16448807|NCT02699749|40122252|FG013|Overall Study|Lost to Follow-up|0|||
16448808|NCT00760617|40122255|FG000|Overall Study|Adverse Event|5|||
16448809|NCT00760617|40122256|FG001|Overall Study|Adverse Event|2|||
16448810|NCT00760617|40122257|FG002|Overall Study|Adverse Event|0|||
16448811|NCT00760617|40122255|FG000|Overall Study|Lost to Follow-up|0|||
16448812|NCT00760617|40122256|FG001|Overall Study|Lost to Follow-up|0|||
16448813|NCT00760617|40122257|FG002|Overall Study|Lost to Follow-up|5|||
16448814|NCT03133793|40122258|FG000|Overall Study|Withdrawal by Subject|0|||
16448815|NCT03133793|40122259|FG001|Overall Study|Withdrawal by Subject|4|||
16448816|NCT03133793|40122260|FG002|Overall Study|Withdrawal by Subject|2|||
16448817|NCT03133793|40122261|FG003|Overall Study|Withdrawal by Subject|4|||
16448818|NCT03133793|40122258|FG000|Overall Study|Lost to Follow-up|1|||
16448819|NCT03133793|40122259|FG001|Overall Study|Lost to Follow-up|0|||
16448820|NCT03133793|40122260|FG002|Overall Study|Lost to Follow-up|2|||
16072532|NCT02715258|38756377|FG001|Overall Study|Death|1|||
16072533|NCT02715258|38756376|FG000|Overall Study|Subject non-compliant|1|||
16072534|NCT02715258|38756377|FG001|Overall Study|Subject non-compliant|1|||
16072535|NCT02715258|38756376|FG000|Overall Study|GCP violation|2|||
16072536|NCT02715258|38756377|FG001|Overall Study|GCP violation|1|||
16072537|NCT00646451|38756379|FG000|Overall Study|Adverse Event|3|||
16072538|NCT00646451|38756380|FG001|Overall Study|Adverse Event|0|||
16072539|NCT00646451|38756379|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
16072540|NCT00646451|38756380|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
16072541|NCT00878722|38756381|FG000|Overall Study|Progressive disease|3|||
16072542|NCT00878722|38756382|FG001|Overall Study|Progressive disease|3|||
16072543|NCT00878722|38756383|FG002|Overall Study|Progressive disease|3|||
16072544|NCT00878722|38756384|FG003|Overall Study|Progressive disease|7|||
16072545|NCT00878722|38756385|FG004|Overall Study|Progressive disease|7|||
16072546|NCT00878722|38756386|FG005|Overall Study|Progressive disease|1|||
16072547|NCT00878722|38756387|FG006|Overall Study|Progressive disease|4|||
16072548|NCT00878722|38756388|FG007|Overall Study|Progressive disease|3|||
16072549|NCT00878722|38756381|FG000|Overall Study|Death|0|||
16072550|NCT00878722|38756382|FG001|Overall Study|Death|0|||
16072551|NCT00878722|38756383|FG002|Overall Study|Death|0|||
16072552|NCT00878722|38756384|FG003|Overall Study|Death|1|||
16072553|NCT00878722|38756385|FG004|Overall Study|Death|0|||
16072554|NCT00878722|38756386|FG005|Overall Study|Death|1|||
16072555|NCT00878722|38756387|FG006|Overall Study|Death|0|||
16072556|NCT00878722|38756388|FG007|Overall Study|Death|2|||
16072557|NCT00878722|38756381|FG000|Overall Study|Adverse Event|0|||
16072558|NCT00878722|38756382|FG001|Overall Study|Adverse Event|0|||
16072559|NCT00878722|38756383|FG002|Overall Study|Adverse Event|0|||
16072560|NCT00878722|38756384|FG003|Overall Study|Adverse Event|0|||
16072561|NCT00878722|38756385|FG004|Overall Study|Adverse Event|0|||
16161761|NCT03107793|39072497|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
16161762|NCT03107793|39072493|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
16161763|NCT03107793|39072494|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
16161764|NCT03107793|39072495|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
16161765|NCT03107793|39072496|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
16161766|NCT03107793|39072497|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
16161767|NCT03107793|39072493|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
16161768|NCT03107793|39072494|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
16161769|NCT03107793|39072495|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
16161770|NCT03107793|39072496|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
16161771|NCT03107793|39072497|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
16161772|NCT03107793|39072493|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
16161773|NCT03107793|39072494|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16161774|NCT03107793|39072495|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16161775|NCT03107793|39072496|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16161776|NCT03107793|39072497|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
16161777|NCT03107793|39072493|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
16161778|NCT03107793|39072494|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
16161779|NCT03107793|39072495|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
16161780|NCT03107793|39072496|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
16161781|NCT03107793|39072497|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
16161782|NCT03107793|39072493|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
16161783|NCT03107793|39072494|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
16161784|NCT03107793|39072495|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
16161785|NCT03107793|39072496|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
16161786|NCT03107793|39072497|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
16161787|NCT03107793|39072493|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
16161788|NCT03107793|39072494|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
16161789|NCT03107793|39072495|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
16161790|NCT03107793|39072496|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
16161791|NCT03107793|39072497|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
16161792|NCT03107793|39072493|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
16161793|NCT03107793|39072494|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
16161794|NCT03107793|39072495|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
16161795|NCT03107793|39072496|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
16161796|NCT03107793|39072497|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
16161797|NCT03107793|39072493|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
16161798|NCT03107793|39072494|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
16161799|NCT03107793|39072495|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
16161800|NCT03107793|39072496|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
16072562|NCT00878722|38756386|FG005|Overall Study|Adverse Event|0|||
16072563|NCT00878722|38756387|FG006|Overall Study|Adverse Event|2|||
16161801|NCT03107793|39072497|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
16072564|NCT00878722|38756388|FG007|Overall Study|Adverse Event|0|||
16161802|NCT03107793|39072493|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
16161803|NCT03107793|39072494|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
16161804|NCT03107793|39072495|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
16161805|NCT03107793|39072496|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
16161806|NCT03107793|39072497|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
16161807|NCT03107793|39072493|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16448821|NCT03133793|40122261|FG003|Overall Study|Lost to Follow-up|0|||
16448822|NCT03133793|40122258|FG000|Overall Study|Death|0|||
16448823|NCT03133793|40122259|FG001|Overall Study|Death|0|||
16448824|NCT03133793|40122260|FG002|Overall Study|Death|0|||
16448825|NCT03133793|40122261|FG003|Overall Study|Death|1|||
16448826|NCT00755183|40122267|FG000|Overall Study|Adverse Event|5|||
16448827|NCT00755183|40122268|FG001|Overall Study|Adverse Event|2|||
16448828|NCT00755183|40122267|FG000|Overall Study|Protocol Violation|0|||
16448829|NCT00755183|40122268|FG001|Overall Study|Protocol Violation|1|||
16448830|NCT00755183|40122267|FG000|Overall Study|Withdrawal by Subject|0|||
16448831|NCT00755183|40122268|FG001|Overall Study|Withdrawal by Subject|2|||
16448832|NCT00755183|40122267|FG000|Overall Study|Administrative|2|||
16448833|NCT00755183|40122268|FG001|Overall Study|Administrative|1|||
16448834|NCT00003475|40122269|FG000|Overall Study|Not evaluable|13|||
16448835|NCT00400946|40122273|FG000|Overall Study|Ineligible|0|||
16448836|NCT00400946|40122274|FG001|Overall Study|Ineligible|0|||
16448837|NCT00400946|40122275|FG002|Overall Study|Ineligible|0|||
16448838|NCT00400946|40122276|FG003|Overall Study|Ineligible|5|||
16448839|NCT00400946|40122277|FG004|Overall Study|Ineligible|1|||
16448840|NCT00400946|40122273|FG000|Overall Study|Induction Failure|0|||
16448841|NCT00400946|40122274|FG001|Overall Study|Induction Failure|0|||
16448842|NCT00400946|40122275|FG002|Overall Study|Induction Failure|0|||
16448843|NCT00400946|40122276|FG003|Overall Study|Induction Failure|11|||
16448844|NCT00400946|40122277|FG004|Overall Study|Induction Failure|8|||
16448845|NCT00400946|40122273|FG000|Overall Study|Induction Death|0|||
16448846|NCT00400946|40122274|FG001|Overall Study|Induction Death|0|||
16448847|NCT00400946|40122275|FG002|Overall Study|Induction Death|0|||
16448848|NCT00400946|40122276|FG003|Overall Study|Induction Death|13|||
16448849|NCT00400946|40122277|FG004|Overall Study|Induction Death|3|||
16448850|NCT00400946|40122273|FG000|Overall Study|Lost to Follow-up|1|||
16448851|NCT00400946|40122274|FG001|Overall Study|Lost to Follow-up|1|||
16448852|NCT00400946|40122275|FG002|Overall Study|Lost to Follow-up|0|||
16448853|NCT00400946|40122276|FG003|Overall Study|Lost to Follow-up|0|||
16448854|NCT00400946|40122277|FG004|Overall Study|Lost to Follow-up|1|||
16448855|NCT00400946|40122273|FG000|Overall Study|Remission Death|1|||
16448856|NCT00400946|40122274|FG001|Overall Study|Remission Death|1|||
16448857|NCT00400946|40122275|FG002|Overall Study|Remission Death|0|||
16448858|NCT00400946|40122276|FG003|Overall Study|Remission Death|0|||
16448859|NCT00400946|40122277|FG004|Overall Study|Remission Death|1|||
16448860|NCT00400946|40122273|FG000|Overall Study|Relapse|9|||
16448861|NCT00400946|40122274|FG001|Overall Study|Relapse|2|||
16448862|NCT00400946|40122275|FG002|Overall Study|Relapse|1|||
16448863|NCT00400946|40122276|FG003|Overall Study|Relapse|1|||
16448864|NCT00400946|40122277|FG004|Overall Study|Relapse|5|||
16448865|NCT00400946|40122273|FG000|Overall Study|Transplant in CR1|0|||
16448866|NCT00400946|40122274|FG001|Overall Study|Transplant in CR1|0|||
16448867|NCT00400946|40122275|FG002|Overall Study|Transplant in CR1|0|||
16448868|NCT00400946|40122276|FG003|Overall Study|Transplant in CR1|10|||
16448869|NCT00400946|40122277|FG004|Overall Study|Transplant in CR1|1|||
16448870|NCT00400946|40122273|FG000|Overall Study|Withdrawal by Subject|2|||
16448871|NCT00400946|40122274|FG001|Overall Study|Withdrawal by Subject|5|||
16448872|NCT00400946|40122275|FG002|Overall Study|Withdrawal by Subject|1|||
16448873|NCT00400946|40122276|FG003|Overall Study|Withdrawal by Subject|5|||
16448874|NCT00400946|40122277|FG004|Overall Study|Withdrawal by Subject|8|||
16448875|NCT00400946|40122273|FG000|Overall Study|Clinical|1|||
16448876|NCT00400946|40122274|FG001|Overall Study|Clinical|2|||
16448877|NCT00400946|40122275|FG002|Overall Study|Clinical|0|||
16448878|NCT00400946|40122276|FG003|Overall Study|Clinical|2|||
16448879|NCT00400946|40122277|FG004|Overall Study|Clinical|9|||
16448880|NCT00400946|40122273|FG000|Overall Study|Other|0|||
16448881|NCT00400946|40122274|FG001|Overall Study|Other|0|||
16448882|NCT00400946|40122275|FG002|Overall Study|Other|0|||
16448883|NCT00400946|40122276|FG003|Overall Study|Other|0|||
16448884|NCT00400946|40122277|FG004|Overall Study|Other|1|||
16448885|NCT02558296|40122279|FG000|Completed the Study Through Week 24|Adverse Event|9|||
16448886|NCT02558296|40122280|FG001|Completed the Study Through Week 24|Adverse Event|3|||
16448887|NCT02558296|40122279|FG000|Completed the Study Through Week 24|Death|7|||
16448888|NCT02558296|40122280|FG001|Completed the Study Through Week 24|Death|7|||
16448889|NCT02558296|40122279|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
16448890|NCT02558296|40122280|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
16448891|NCT02558296|40122279|FG000|Completed the Study Through Week 24|Physician Decision|1|||
16448892|NCT02558296|40122280|FG001|Completed the Study Through Week 24|Physician Decision|0|||
16448893|NCT02558296|40122279|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
16161808|NCT03107793|39072494|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
16161809|NCT03107793|39072495|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16161810|NCT03107793|39072496|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16161811|NCT03107793|39072497|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
16161812|NCT03107793|39072493|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
16161813|NCT03107793|39072494|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
16161814|NCT03107793|39072495|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
16161815|NCT03107793|39072496|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
16161816|NCT03107793|39072497|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
16161817|NCT03107793|39072493|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
16161818|NCT03107793|39072494|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
16161819|NCT03107793|39072495|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
16161820|NCT03107793|39072496|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
16161821|NCT03107793|39072497|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
16161822|NCT03107793|39072493|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
16161823|NCT03107793|39072494|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
16161824|NCT03107793|39072495|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
16161825|NCT03107793|39072496|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
16161826|NCT03107793|39072497|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
16161827|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
16161828|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
16161829|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
16161830|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
16161831|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
16161832|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
16161833|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
16161834|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
16161835|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
16161836|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
16161837|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
16448894|NCT02558296|40122280|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
16448895|NCT02558296|40122279|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
16448896|NCT02558296|40122280|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
16448897|NCT02558296|40122279|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
16448898|NCT02558296|40122280|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
16448899|NCT02558296|40122279|FG000|Completed the Study|Adverse Event|14|||
16448900|NCT02558296|40122280|FG001|Completed the Study|Adverse Event|5|||
16448901|NCT02558296|40122279|FG000|Completed the Study|Death|39|||
16448902|NCT02558296|40122280|FG001|Completed the Study|Death|25|||
16448903|NCT02558296|40122279|FG000|Completed the Study|Lost to Follow-up|31|||
16448904|NCT02558296|40122280|FG001|Completed the Study|Lost to Follow-up|23|||
16448905|NCT02558296|40122279|FG000|Completed the Study|Physician Decision|6|||
16448906|NCT02558296|40122280|FG001|Completed the Study|Physician Decision|0|||
16448907|NCT02558296|40122279|FG000|Completed the Study|Protocol Violation|2|||
16448908|NCT02558296|40122280|FG001|Completed the Study|Protocol Violation|1|||
16448909|NCT02558296|40122279|FG000|Completed the Study|Withdrawal by Subject|53|||
16448910|NCT02558296|40122280|FG001|Completed the Study|Withdrawal by Subject|31|||
16448911|NCT02558296|40122279|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
16448912|NCT02558296|40122280|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
16448913|NCT01759446|40122283|FG000|Overall Study|Protocol Violation|1|||
16448914|NCT01759446|40122284|FG001|Overall Study|Protocol Violation|0|||
16448915|NCT01759446|40122285|FG002|Overall Study|Protocol Violation|1|||
16448916|NCT01759446|40122286|FG003|Overall Study|Protocol Violation|0|||
16448917|NCT01759446|40122287|FG004|Overall Study|Protocol Violation|0|||
16448918|NCT01759446|40122283|FG000|Overall Study|Withdrawal by Subject|0|||
16448919|NCT01759446|40122284|FG001|Overall Study|Withdrawal by Subject|1|||
16448920|NCT01759446|40122285|FG002|Overall Study|Withdrawal by Subject|0|||
16448921|NCT01759446|40122286|FG003|Overall Study|Withdrawal by Subject|1|||
16448922|NCT01759446|40122287|FG004|Overall Study|Withdrawal by Subject|0|||
16448923|NCT00853307|40122291|FG000|Overall Study|Adverse Event|1|||
16448924|NCT00853307|40122292|FG001|Overall Study|Adverse Event|2|||
16448925|NCT00853307|40122291|FG000|Overall Study|Withdrawal by Subject|1|||
16448926|NCT00853307|40122292|FG001|Overall Study|Withdrawal by Subject|2|||
16448927|NCT00853307|40122291|FG000|Overall Study|Reason Not Specified|0|||
16448928|NCT00853307|40122292|FG001|Overall Study|Reason Not Specified|1|||
16448929|NCT05101122|40122293|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
16448930|NCT05101122|40122293|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
16448931|NCT05101122|40122293|FG000|AD313 80/5|Withdrawal by Subject|1|||
16161838|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
16448932|NCT05101122|40122293|FG000|AD313 80/10|Physician Decision|1|||
16448933|NCT02454517|40122296|FG000|Overall Study|Withdrawal by Subject|3|||
16448934|NCT02454517|40122297|FG001|Overall Study|Withdrawal by Subject|0|||
16448935|NCT02454517|40122296|FG000|Overall Study|Lost to Follow-up|4|||
16448936|NCT02454517|40122297|FG001|Overall Study|Lost to Follow-up|7|||
16448937|NCT02454517|40122296|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
16448938|NCT02454517|40122297|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
16448939|NCT01635153|40122298|FG000|Overall Study|Lost to Follow-up|40|||
16448940|NCT01635153|40122299|FG001|Overall Study|Lost to Follow-up|43|||
16448941|NCT02131259|40122303|FG000|Overall Study|Progressive disease|751|||
16448942|NCT02131259|40122303|FG000|Overall Study|Adverse Event|341|||
16448943|NCT02131259|40122303|FG000|Overall Study|Lost to Follow-up|7|||
16448944|NCT02131259|40122303|FG000|Overall Study|Relocation|32|||
16448945|NCT02131259|40122303|FG000|Overall Study|Other|63|||
16448946|NCT02131259|40122303|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
16448947|NCT02131259|40122303|FG000|Overall Study|Progressive disease/relocation|1|||
16448948|NCT02131259|40122303|FG000|Overall Study|Progressive disease/other|2|||
16448949|NCT02131259|40122303|FG000|Overall Study|AE/lost to follow-up|1|||
16448950|NCT02131259|40122303|FG000|Overall Study|AE/other|1|||
16448951|NCT02131259|40122303|FG000|Overall Study|Progressive disease/AE/other|1|||
16072565|NCT00878722|38756381|FG000|Overall Study|Withdrawal by Subject|0|||
16161839|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
16161840|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
16448952|NCT02131259|40122303|FG000|Overall Study|Missing|3|||
16448953|NCT01177397|40122304|FG000|Overall Study|Protocol Violation|0|||
16448954|NCT01177397|40122305|FG001|Overall Study|Protocol Violation|0|||
16448955|NCT01177397|40122306|FG002|Overall Study|Protocol Violation|0|||
16448956|NCT01177397|40122307|FG003|Overall Study|Protocol Violation|0|||
16448957|NCT01177397|40122308|FG004|Overall Study|Protocol Violation|0|||
16448958|NCT01177397|40122309|FG005|Overall Study|Protocol Violation|1|||
16072566|NCT00878722|38756382|FG001|Overall Study|Withdrawal by Subject|0|||
16072567|NCT00878722|38756383|FG002|Overall Study|Withdrawal by Subject|0|||
16072568|NCT00878722|38756384|FG003|Overall Study|Withdrawal by Subject|0|||
16072569|NCT00878722|38756385|FG004|Overall Study|Withdrawal by Subject|0|||
16072570|NCT00878722|38756386|FG005|Overall Study|Withdrawal by Subject|0|||
16072571|NCT00878722|38756387|FG006|Overall Study|Withdrawal by Subject|0|||
16072572|NCT00878722|38756388|FG007|Overall Study|Withdrawal by Subject|2|||
16072573|NCT00878722|38756381|FG000|Overall Study|Relapse|0|||
16072574|NCT00878722|38756382|FG001|Overall Study|Relapse|0|||
16072575|NCT00878722|38756383|FG002|Overall Study|Relapse|0|||
16072576|NCT00878722|38756384|FG003|Overall Study|Relapse|1|||
16072577|NCT00878722|38756385|FG004|Overall Study|Relapse|0|||
16072578|NCT00878722|38756386|FG005|Overall Study|Relapse|0|||
16072579|NCT00878722|38756387|FG006|Overall Study|Relapse|0|||
16072580|NCT00878722|38756388|FG007|Overall Study|Relapse|0|||
16072581|NCT01909336|38756392|FG000|Overall Study|Lost to Follow-up|4|||
16072582|NCT01909336|38756393|FG001|Overall Study|Lost to Follow-up|2|||
16072583|NCT01909336|38756394|FG002|Overall Study|Lost to Follow-up|2|||
16072584|NCT01909336|38756392|FG000|Overall Study|Physician Decision|0|||
16072585|NCT01909336|38756393|FG001|Overall Study|Physician Decision|1|||
16072586|NCT01909336|38756394|FG002|Overall Study|Physician Decision|1|||
16072587|NCT01390402|38756399|FG000|Overall Study|Death|1|||
16072588|NCT01390402|38756399|FG000|Overall Study|Disease Progression|4|||
16072589|NCT04644237|38756400|FG000|Overall Study|Death|3|||
16072590|NCT04644237|38756401|FG001|Overall Study|Death|2|||
16072591|NCT04644237|38756400|FG000|Overall Study|Adverse Event|15|||
16072592|NCT04644237|38756401|FG001|Overall Study|Adverse Event|12|||
16072593|NCT04644237|38756400|FG000|Overall Study|Progressive Disease|47|||
16072594|NCT04644237|38756401|FG001|Overall Study|Progressive Disease|19|||
16072595|NCT04644237|38756400|FG000|Overall Study|Clinical Progression|4|||
16072596|NCT04644237|38756401|FG001|Overall Study|Clinical Progression|1|||
16072597|NCT04644237|38756400|FG000|Overall Study|Withdrawal by Subject|1|||
16072598|NCT04644237|38756401|FG001|Overall Study|Withdrawal by Subject|2|||
16072599|NCT04644237|38756400|FG000|Overall Study|Physician Decision|3|||
16072600|NCT04644237|38756401|FG001|Overall Study|Physician Decision|0|||
16072601|NCT04644237|38756400|FG000|Overall Study|Other|1|||
16072602|NCT04644237|38756401|FG001|Overall Study|Other|0|||
16072603|NCT04644237|38756400|FG000|Overall Study|Randomized but not Treated|1|||
16072604|NCT04644237|38756401|FG001|Overall Study|Randomized but not Treated|0|||
16072605|NCT03987451|38756403|FG000|Overall Study|Lost to Follow-up|1|||
16072606|NCT03987451|38756404|FG001|Overall Study|Lost to Follow-up|0|||
16072607|NCT03987451|38756403|FG000|Overall Study|Withdrawal by Subject|1|||
16072608|NCT03987451|38756404|FG001|Overall Study|Withdrawal by Subject|1|||
16072609|NCT01254019|38756409|FG000|Overall Study|Adverse Event|0|||
16072610|NCT01254019|38756410|FG001|Overall Study|Adverse Event|2|||
16072611|NCT01254019|38756409|FG000|Overall Study|Protocol Violation|1|||
16072612|NCT01254019|38756410|FG001|Overall Study|Protocol Violation|0|||
16072613|NCT01254019|38756409|FG000|Overall Study|Withdrawal by Subject|0|||
16448959|NCT01177397|40122310|FG006|Overall Study|Protocol Violation|0|||
16448960|NCT01177397|40122311|FG007|Overall Study|Protocol Violation|0|||
16448961|NCT01177397|40122312|FG008|Overall Study|Protocol Violation|0|||
16448962|NCT01177397|40122313|FG009|Overall Study|Protocol Violation|0|||
16448963|NCT01177397|40122314|FG010|Overall Study|Protocol Violation|0|||
16448964|NCT01177397|40122315|FG011|Overall Study|Protocol Violation|0|||
16448965|NCT01177397|40122304|FG000|Overall Study|Lost to Follow-up|0|||
16448966|NCT01177397|40122305|FG001|Overall Study|Lost to Follow-up|0|||
16448967|NCT01177397|40122306|FG002|Overall Study|Lost to Follow-up|0|||
16448968|NCT01177397|40122307|FG003|Overall Study|Lost to Follow-up|0|||
16448969|NCT01177397|40122308|FG004|Overall Study|Lost to Follow-up|1|||
16448970|NCT01177397|40122309|FG005|Overall Study|Lost to Follow-up|0|||
16448971|NCT01177397|40122310|FG006|Overall Study|Lost to Follow-up|0|||
16448972|NCT01177397|40122311|FG007|Overall Study|Lost to Follow-up|2|||
16448973|NCT01177397|40122312|FG008|Overall Study|Lost to Follow-up|0|||
16448974|NCT01177397|40122313|FG009|Overall Study|Lost to Follow-up|0|||
16448975|NCT01177397|40122314|FG010|Overall Study|Lost to Follow-up|0|||
16448976|NCT01177397|40122315|FG011|Overall Study|Lost to Follow-up|0|||
16448977|NCT01177397|40122304|FG000|Overall Study|Death|0|||
16448978|NCT01177397|40122305|FG001|Overall Study|Death|0|||
16448979|NCT01177397|40122306|FG002|Overall Study|Death|1|||
16448980|NCT01177397|40122307|FG003|Overall Study|Death|1|||
16448981|NCT01177397|40122308|FG004|Overall Study|Death|0|||
16448982|NCT01177397|40122309|FG005|Overall Study|Death|0|||
16448983|NCT01177397|40122310|FG006|Overall Study|Death|0|||
16448984|NCT01177397|40122311|FG007|Overall Study|Death|5|||
16448985|NCT01177397|40122312|FG008|Overall Study|Death|2|||
16448986|NCT01177397|40122313|FG009|Overall Study|Death|1|||
16448987|NCT01177397|40122314|FG010|Overall Study|Death|0|||
16448988|NCT01177397|40122315|FG011|Overall Study|Death|0|||
16448989|NCT01177397|40122304|FG000|Overall Study|Withdrawal by Subject|0|||
16448990|NCT01177397|40122305|FG001|Overall Study|Withdrawal by Subject|0|||
16448991|NCT01177397|40122306|FG002|Overall Study|Withdrawal by Subject|1|||
16448992|NCT01177397|40122307|FG003|Overall Study|Withdrawal by Subject|1|||
16448993|NCT01177397|40122308|FG004|Overall Study|Withdrawal by Subject|1|||
16448994|NCT01177397|40122309|FG005|Overall Study|Withdrawal by Subject|2|||
16448995|NCT01177397|40122310|FG006|Overall Study|Withdrawal by Subject|0|||
16448996|NCT01177397|40122311|FG007|Overall Study|Withdrawal by Subject|5|||
16448997|NCT01177397|40122312|FG008|Overall Study|Withdrawal by Subject|9|||
16448998|NCT01177397|40122313|FG009|Overall Study|Withdrawal by Subject|1|||
16448999|NCT01177397|40122314|FG010|Overall Study|Withdrawal by Subject|1|||
16449000|NCT01177397|40122315|FG011|Overall Study|Withdrawal by Subject|0|||
16449001|NCT01177397|40122304|FG000|Overall Study|Adverse Event|0|||
16449002|NCT01177397|40122305|FG001|Overall Study|Adverse Event|0|||
16449003|NCT01177397|40122306|FG002|Overall Study|Adverse Event|1|||
16449004|NCT01177397|40122307|FG003|Overall Study|Adverse Event|2|||
16449005|NCT01177397|40122308|FG004|Overall Study|Adverse Event|0|||
16449006|NCT01177397|40122309|FG005|Overall Study|Adverse Event|12|||
16449007|NCT01177397|40122310|FG006|Overall Study|Adverse Event|1|||
16449008|NCT01177397|40122311|FG007|Overall Study|Adverse Event|14|||
16449009|NCT01177397|40122312|FG008|Overall Study|Adverse Event|8|||
16449010|NCT01177397|40122313|FG009|Overall Study|Adverse Event|6|||
16449011|NCT01177397|40122314|FG010|Overall Study|Adverse Event|3|||
16449012|NCT01177397|40122315|FG011|Overall Study|Adverse Event|7|||
16449013|NCT01177397|40122304|FG000|Overall Study|Disease progression|1|||
16449014|NCT01177397|40122305|FG001|Overall Study|Disease progression|2|||
16449015|NCT01177397|40122306|FG002|Overall Study|Disease progression|5|||
16449016|NCT01177397|40122307|FG003|Overall Study|Disease progression|5|||
16449017|NCT01177397|40122308|FG004|Overall Study|Disease progression|4|||
16449018|NCT01177397|40122309|FG005|Overall Study|Disease progression|10|||
16449019|NCT01177397|40122310|FG006|Overall Study|Disease progression|10|||
16449020|NCT01177397|40122311|FG007|Overall Study|Disease progression|21|||
16449021|NCT01177397|40122312|FG008|Overall Study|Disease progression|18|||
16449022|NCT01177397|40122313|FG009|Overall Study|Disease progression|12|||
16449023|NCT01177397|40122314|FG010|Overall Study|Disease progression|10|||
16449024|NCT01177397|40122315|FG011|Overall Study|Disease progression|8|||
16449025|NCT01177397|40122304|FG000|Overall Study|Other reasons|0|||
16449026|NCT01177397|40122305|FG001|Overall Study|Other reasons|0|||
16449027|NCT01177397|40122306|FG002|Overall Study|Other reasons|1|||
16449028|NCT01177397|40122307|FG003|Overall Study|Other reasons|0|||
16449029|NCT01177397|40122308|FG004|Overall Study|Other reasons|1|||
16449030|NCT01177397|40122309|FG005|Overall Study|Other reasons|1|||
16449031|NCT01177397|40122310|FG006|Overall Study|Other reasons|2|||
16449032|NCT01177397|40122311|FG007|Overall Study|Other reasons|6|||
16449033|NCT01177397|40122312|FG008|Overall Study|Other reasons|10|||
16449034|NCT01177397|40122313|FG009|Overall Study|Other reasons|8|||
16449035|NCT01177397|40122314|FG010|Overall Study|Other reasons|0|||
16449036|NCT01177397|40122315|FG011|Overall Study|Other reasons|2|||
16449037|NCT01599637|40122317|FG000|Overall Study|administrative problems|0|||
16449038|NCT01599637|40122318|FG001|Overall Study|administrative problems|2|||
16449039|NCT01599637|40122319|FG002|Overall Study|administrative problems|0|||
16161841|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
16161842|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Death|0|||
16161843|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Death|0|||
16161844|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Death|0|||
16161845|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Death|0|||
16161846|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Death|1|||
16161847|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
16161848|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
16161849|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
16161850|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
16161851|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
16161852|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
16161853|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
16161854|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
16161855|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
16161856|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
16161857|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
16161858|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
16161859|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
16161860|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
16161861|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
16161862|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
16161863|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
16161864|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
16161865|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
16161866|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
16161867|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
16161868|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
16161869|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
16161870|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
16161871|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
16161872|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Other|0|||
16161873|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Other|0|||
16161874|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Other|0|||
16161875|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Other|1|||
16161876|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Other|3|||
16161877|NCT03107793|39072493|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
16161878|NCT03107793|39072494|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
16161879|NCT03107793|39072495|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
16161880|NCT03107793|39072496|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
16161881|NCT03107793|39072497|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
16161882|NCT02217566|39072501|FG000|Overall Study|Lost to Follow-up|2|||
16161883|NCT02217566|39072501|FG000|Overall Study|Death|3|||
16161884|NCT02217566|39072501|FG000|Overall Study|Early study termination|6|||
16161885|NCT03891901|39072502|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
16161886|NCT03891901|39072503|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
16161887|NCT03891901|39072504|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
16161888|NCT03891901|39072505|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
16161889|NCT03891901|39072506|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
16161890|NCT03891901|39072507|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
16161891|NCT03891901|39072508|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
16161892|NCT03891901|39072509|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
16161893|NCT03891901|39072510|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
16161894|NCT03891901|39072502|FG000|Overall Study|Adverse Event|2|||
16161895|NCT03891901|39072503|FG001|Overall Study|Adverse Event|2|||
16161896|NCT03891901|39072504|FG002|Overall Study|Adverse Event|0|||
16161897|NCT03891901|39072505|FG003|Overall Study|Adverse Event|0|||
16161898|NCT03891901|39072506|FG004|Overall Study|Adverse Event|0|||
16161899|NCT03891901|39072507|FG005|Overall Study|Adverse Event|0|||
16161900|NCT03891901|39072508|FG006|Overall Study|Adverse Event|0|||
16161901|NCT03891901|39072509|FG007|Overall Study|Adverse Event|0|||
16161902|NCT03891901|39072510|FG008|Overall Study|Adverse Event|0|||
16161903|NCT03891901|39072502|FG000|Overall Study|Poor venous access|1|||
16161904|NCT03891901|39072503|FG001|Overall Study|Poor venous access|0|||
16161905|NCT03891901|39072504|FG002|Overall Study|Poor venous access|0|||
16161906|NCT03891901|39072505|FG003|Overall Study|Poor venous access|0|||
16161907|NCT03891901|39072506|FG004|Overall Study|Poor venous access|0|||
16161908|NCT03891901|39072507|FG005|Overall Study|Poor venous access|0|||
16161909|NCT03891901|39072508|FG006|Overall Study|Poor venous access|0|||
16161910|NCT03891901|39072509|FG007|Overall Study|Poor venous access|0|||
16161911|NCT03891901|39072510|FG008|Overall Study|Poor venous access|0|||
16161912|NCT03891901|39072502|FG000|Overall Study|Withdrawal by Subject|0|||
16161913|NCT03891901|39072503|FG001|Overall Study|Withdrawal by Subject|2|||
16161914|NCT03891901|39072504|FG002|Overall Study|Withdrawal by Subject|0|||
16161915|NCT03891901|39072505|FG003|Overall Study|Withdrawal by Subject|0|||
16161916|NCT03891901|39072506|FG004|Overall Study|Withdrawal by Subject|0|||
16161917|NCT03891901|39072507|FG005|Overall Study|Withdrawal by Subject|0|||
16161918|NCT03891901|39072508|FG006|Overall Study|Withdrawal by Subject|0|||
16161919|NCT03891901|39072509|FG007|Overall Study|Withdrawal by Subject|0|||
16161920|NCT03891901|39072510|FG008|Overall Study|Withdrawal by Subject|0|||
16161921|NCT02543528|39072515|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
16161922|NCT02543528|39072516|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
16161923|NCT02543528|39072517|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
16161924|NCT02543528|39072518|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
16161925|NCT02543528|39072519|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
16161926|NCT02543528|39072515|FG000|Adaptation Period|Lens Handling Difficultes|0|||
16161927|NCT02543528|39072516|FG001|Adaptation Period|Lens Handling Difficultes|0|||
16161928|NCT02543528|39072517|FG002|Adaptation Period|Lens Handling Difficultes|0|||
16161929|NCT02543528|39072518|FG003|Adaptation Period|Lens Handling Difficultes|0|||
16161930|NCT02543528|39072519|FG004|Adaptation Period|Lens Handling Difficultes|8|||
16161931|NCT02543528|39072515|FG000|Adaptation Period|Lost to Follow-up|0|||
16161932|NCT02543528|39072516|FG001|Adaptation Period|Lost to Follow-up|0|||
16161933|NCT02543528|39072517|FG002|Adaptation Period|Lost to Follow-up|0|||
16161934|NCT02543528|39072518|FG003|Adaptation Period|Lost to Follow-up|0|||
16161935|NCT02543528|39072519|FG004|Adaptation Period|Lost to Follow-up|14|||
16161936|NCT02543528|39072515|FG000|Adaptation Period|Adverse Event|0|||
16161937|NCT02543528|39072516|FG001|Adaptation Period|Adverse Event|0|||
16161938|NCT02543528|39072517|FG002|Adaptation Period|Adverse Event|0|||
16161939|NCT02543528|39072518|FG003|Adaptation Period|Adverse Event|0|||
16161940|NCT02543528|39072519|FG004|Adaptation Period|Adverse Event|2|||
16161941|NCT02543528|39072515|FG000|Extended Wear Period|Adverse Event|17|||
16161942|NCT02543528|39072516|FG001|Extended Wear Period|Adverse Event|11|||
16161943|NCT02543528|39072517|FG002|Extended Wear Period|Adverse Event|16|||
16161944|NCT02543528|39072518|FG003|Extended Wear Period|Adverse Event|3|||
16161945|NCT02543528|39072519|FG004|Extended Wear Period|Adverse Event|0|||
16161946|NCT02543528|39072515|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
16161947|NCT02543528|39072516|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
16161948|NCT02543528|39072517|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
16161949|NCT02543528|39072518|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
16161950|NCT02543528|39072519|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
16161951|NCT02543528|39072515|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
16161952|NCT02543528|39072516|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
16161953|NCT02543528|39072517|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
16161954|NCT02543528|39072518|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
16161955|NCT02543528|39072519|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
16161956|NCT02543528|39072515|FG000|Extended Wear Period|Lost to Follow-up|0|||
16161957|NCT02543528|39072516|FG001|Extended Wear Period|Lost to Follow-up|1|||
16161958|NCT02543528|39072517|FG002|Extended Wear Period|Lost to Follow-up|2|||
16161959|NCT02543528|39072518|FG003|Extended Wear Period|Lost to Follow-up|1|||
16161960|NCT02543528|39072519|FG004|Extended Wear Period|Lost to Follow-up|0|||
16161961|NCT02543528|39072515|FG000|Extended Wear Period|Withdrawal by Subject|10|||
16161962|NCT02543528|39072516|FG001|Extended Wear Period|Withdrawal by Subject|9|||
16161963|NCT02543528|39072517|FG002|Extended Wear Period|Withdrawal by Subject|4|||
16161964|NCT02543528|39072518|FG003|Extended Wear Period|Withdrawal by Subject|5|||
16161965|NCT02543528|39072519|FG004|Extended Wear Period|Withdrawal by Subject|0|||
16161966|NCT02275338|39072520|FG000|Overall Study|Adverse Event|15|||
16161967|NCT02275338|39072520|FG000|Overall Study|Lack of Efficacy|3|||
16161968|NCT02275338|39072520|FG000|Overall Study|Withdrawal by Subject|4|||
16161969|NCT02275338|39072520|FG000|Overall Study|Disease progression (death)|1|||
16161970|NCT02275338|39072520|FG000|Overall Study|Ineligible to start Phase 2|4|||
16161971|NCT02275338|39072520|FG000|Overall Study|Reason not specified|5|||
16161972|NCT02275338|39072520|FG000|Overall Study|Does not meet entry criteria|1|||
16161973|NCT00643994|39076603|FG000|Overall Study|Death|24|||
16161974|NCT00643994|39076603|FG000|Overall Study|Lost to Follow-up|72|||
16161975|NCT03175549|39076604|FG000|Overall Study|Lost to Follow-up|2|||
16161976|NCT03175549|39076605|FG001|Overall Study|Lost to Follow-up|2|||
16161977|NCT03175549|39076604|FG000|Overall Study|Medication non-compliance|2|||
16161978|NCT03175549|39076605|FG001|Overall Study|Medication non-compliance|2|||
16161979|NCT02792842|39076606|FG000|Overall Study|Adverse Event|4|||
16161980|NCT02792842|39076607|FG001|Overall Study|Adverse Event|2|||
16161981|NCT02792842|39076608|FG002|Overall Study|Adverse Event|3|||
16449040|NCT01599637|40122317|FG000|Overall Study|Adverse Event|1|||
16449041|NCT01599637|40122318|FG001|Overall Study|Adverse Event|0|||
16449042|NCT01599637|40122319|FG002|Overall Study|Adverse Event|0|||
16449043|NCT02633020|40122320|FG000|Overall Study|Adverse Event|1|||
16449044|NCT02633020|40122321|FG001|Overall Study|Adverse Event|0|||
16449045|NCT00068692|40122322|FG000|Step 1: Registration|Disese progression/relapse|5|||
16449046|NCT00068692|40122323|FG001|Step 1: Registration|Disese progression/relapse|0|||
16449047|NCT00068692|40122324|FG002|Step 1: Registration|Disese progression/relapse|0|||
16449048|NCT00068692|40122325|FG003|Step 1: Registration|Disese progression/relapse|0|||
16449049|NCT00068692|40122326|FG004|Step 1: Registration|Disese progression/relapse|0|||
16449050|NCT00068692|40122327|FG005|Step 1: Registration|Disese progression/relapse|0|||
16449051|NCT00068692|40122328|FG006|Step 1: Registration|Disese progression/relapse|0|||
16449052|NCT00068692|40122329|FG007|Step 1: Registration|Disese progression/relapse|0|||
16449053|NCT00068692|40122322|FG000|Step 1: Registration|Adverse Event|7|||
16449054|NCT00068692|40122323|FG001|Step 1: Registration|Adverse Event|0|||
16449055|NCT00068692|40122324|FG002|Step 1: Registration|Adverse Event|0|||
16449056|NCT00068692|40122325|FG003|Step 1: Registration|Adverse Event|0|||
16449057|NCT00068692|40122326|FG004|Step 1: Registration|Adverse Event|0|||
16449058|NCT00068692|40122327|FG005|Step 1: Registration|Adverse Event|0|||
16449059|NCT00068692|40122328|FG006|Step 1: Registration|Adverse Event|0|||
16449060|NCT00068692|40122329|FG007|Step 1: Registration|Adverse Event|0|||
16449061|NCT00068692|40122322|FG000|Step 1: Registration|Death|1|||
16449062|NCT00068692|40122323|FG001|Step 1: Registration|Death|0|||
16449063|NCT00068692|40122324|FG002|Step 1: Registration|Death|0|||
16449064|NCT00068692|40122325|FG003|Step 1: Registration|Death|0|||
16449065|NCT00068692|40122326|FG004|Step 1: Registration|Death|0|||
16449066|NCT00068692|40122327|FG005|Step 1: Registration|Death|0|||
16449067|NCT00068692|40122328|FG006|Step 1: Registration|Death|0|||
16449068|NCT00068692|40122329|FG007|Step 1: Registration|Death|0|||
16449069|NCT00068692|40122322|FG000|Step 1: Registration|Withdrawal by Subject|11|||
16449070|NCT00068692|40122323|FG001|Step 1: Registration|Withdrawal by Subject|0|||
16449071|NCT00068692|40122324|FG002|Step 1: Registration|Withdrawal by Subject|0|||
16449072|NCT00068692|40122325|FG003|Step 1: Registration|Withdrawal by Subject|0|||
16449073|NCT00068692|40122326|FG004|Step 1: Registration|Withdrawal by Subject|0|||
16449074|NCT00068692|40122327|FG005|Step 1: Registration|Withdrawal by Subject|0|||
16449075|NCT00068692|40122328|FG006|Step 1: Registration|Withdrawal by Subject|0|||
16449076|NCT00068692|40122329|FG007|Step 1: Registration|Withdrawal by Subject|0|||
16449077|NCT00068692|40122322|FG000|Step 1: Registration|Alternative therapy|2|||
16449078|NCT00068692|40122323|FG001|Step 1: Registration|Alternative therapy|0|||
16449079|NCT00068692|40122324|FG002|Step 1: Registration|Alternative therapy|0|||
16449080|NCT00068692|40122325|FG003|Step 1: Registration|Alternative therapy|0|||
16449081|NCT00068692|40122326|FG004|Step 1: Registration|Alternative therapy|0|||
16449082|NCT00068692|40122327|FG005|Step 1: Registration|Alternative therapy|0|||
16449083|NCT00068692|40122328|FG006|Step 1: Registration|Alternative therapy|0|||
16449084|NCT00068692|40122329|FG007|Step 1: Registration|Alternative therapy|0|||
16449085|NCT00068692|40122322|FG000|Step 1: Registration|Complicating disease|2|||
16449086|NCT00068692|40122323|FG001|Step 1: Registration|Complicating disease|0|||
16449087|NCT00068692|40122324|FG002|Step 1: Registration|Complicating disease|0|||
16449088|NCT00068692|40122325|FG003|Step 1: Registration|Complicating disease|0|||
16449089|NCT00068692|40122326|FG004|Step 1: Registration|Complicating disease|0|||
16449090|NCT00068692|40122327|FG005|Step 1: Registration|Complicating disease|0|||
16449091|NCT00068692|40122328|FG006|Step 1: Registration|Complicating disease|0|||
16449092|NCT00068692|40122329|FG007|Step 1: Registration|Complicating disease|0|||
16449093|NCT00068692|40122322|FG000|Step 1: Registration|Protocol Violation|1|||
16449094|NCT00068692|40122323|FG001|Step 1: Registration|Protocol Violation|0|||
16449095|NCT00068692|40122324|FG002|Step 1: Registration|Protocol Violation|0|||
16449096|NCT00068692|40122325|FG003|Step 1: Registration|Protocol Violation|0|||
16449097|NCT00068692|40122326|FG004|Step 1: Registration|Protocol Violation|0|||
16449098|NCT00068692|40122327|FG005|Step 1: Registration|Protocol Violation|0|||
16449099|NCT00068692|40122328|FG006|Step 1: Registration|Protocol Violation|0|||
16449100|NCT00068692|40122329|FG007|Step 1: Registration|Protocol Violation|0|||
16449101|NCT00068692|40122322|FG000|Step 1: Registration|Not eligible|6|||
16449102|NCT00068692|40122323|FG001|Step 1: Registration|Not eligible|0|||
16449103|NCT00068692|40122324|FG002|Step 1: Registration|Not eligible|0|||
16449104|NCT00068692|40122325|FG003|Step 1: Registration|Not eligible|0|||
16449105|NCT00068692|40122326|FG004|Step 1: Registration|Not eligible|0|||
16449106|NCT00068692|40122327|FG005|Step 1: Registration|Not eligible|0|||
16449107|NCT00068692|40122328|FG006|Step 1: Registration|Not eligible|0|||
16449108|NCT00068692|40122329|FG007|Step 1: Registration|Not eligible|0|||
16449109|NCT00068692|40122322|FG000|Step 1: Registration|Other|2|||
16449110|NCT00068692|40122323|FG001|Step 1: Registration|Other|0|||
16449111|NCT00068692|40122324|FG002|Step 1: Registration|Other|0|||
16161982|NCT02792842|39076606|FG000|Overall Study|Withdrawal by Subject|0|||
16161983|NCT02792842|39076607|FG001|Overall Study|Withdrawal by Subject|1|||
16449112|NCT00068692|40122325|FG003|Step 1: Registration|Other|0|||
16449113|NCT00068692|40122326|FG004|Step 1: Registration|Other|0|||
16161984|NCT02792842|39076608|FG002|Overall Study|Withdrawal by Subject|2|||
16161985|NCT02792842|39076606|FG000|Overall Study|Lost to Follow-up|0|||
16161986|NCT02792842|39076607|FG001|Overall Study|Lost to Follow-up|0|||
16161987|NCT02792842|39076608|FG002|Overall Study|Lost to Follow-up|1|||
16161988|NCT02792842|39076606|FG000|Overall Study|Schedule delay|0|||
16161989|NCT02792842|39076607|FG001|Overall Study|Schedule delay|1|||
16161990|NCT02792842|39076608|FG002|Overall Study|Schedule delay|1|||
16161991|NCT03682120|39076609|FG000|Overall Study|Lost to Follow-up|11|||
16161992|NCT03682120|39076610|FG001|Overall Study|Lost to Follow-up|4|||
16161993|NCT03682120|39076611|FG002|Overall Study|Lost to Follow-up|5|||
16161994|NCT03682120|39076612|FG003|Overall Study|Lost to Follow-up|2|||
16161995|NCT03682120|39076609|FG000|Overall Study|Physician Decision|1|||
16161996|NCT03682120|39076610|FG001|Overall Study|Physician Decision|0|||
16161997|NCT03682120|39076611|FG002|Overall Study|Physician Decision|0|||
16161998|NCT03682120|39076612|FG003|Overall Study|Physician Decision|0|||
16161999|NCT03682120|39076609|FG000|Overall Study|Withdrawal by Subject|1|||
16162000|NCT03682120|39076610|FG001|Overall Study|Withdrawal by Subject|2|||
16162001|NCT03682120|39076611|FG002|Overall Study|Withdrawal by Subject|3|||
16162002|NCT03682120|39076612|FG003|Overall Study|Withdrawal by Subject|0|||
16162003|NCT03682120|39076609|FG000|Overall Study|Death|0|||
16162004|NCT03682120|39076610|FG001|Overall Study|Death|1|||
16162005|NCT03682120|39076611|FG002|Overall Study|Death|0|||
16162006|NCT03682120|39076612|FG003|Overall Study|Death|0|||
16162007|NCT03682120|39076609|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
16162008|NCT03682120|39076610|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
16162009|NCT03682120|39076611|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
16162010|NCT03682120|39076612|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
16162011|NCT02285114|39076615|FG000|Overall Study|Investigator's Discretion|0|||
16162012|NCT02285114|39076616|FG001|Overall Study|Investigator's Discretion|2|||
16162013|NCT02285114|39076617|FG002|Overall Study|Investigator's Discretion|0|||
16162014|NCT02285114|39076615|FG000|Overall Study|Withdrew Consent|0|||
16162015|NCT02285114|39076616|FG001|Overall Study|Withdrew Consent|0|||
16162016|NCT02285114|39076617|FG002|Overall Study|Withdrew Consent|1|||
16162017|NCT02285114|39076615|FG000|Overall Study|Enrolled but not treated|1|||
16162018|NCT02285114|39076616|FG001|Overall Study|Enrolled but not treated|0|||
16162019|NCT02285114|39076617|FG002|Overall Study|Enrolled but not treated|0|||
16162020|NCT02285114|39076615|FG000|Overall Study|Still on study|21|||
16162021|NCT02285114|39076616|FG001|Overall Study|Still on study|5|||
16162022|NCT02285114|39076617|FG002|Overall Study|Still on study|2|||
16162023|NCT01182428|39076618|FG000|Overall Study|Physician Decision|1|||
16162024|NCT01182428|39076619|FG001|Overall Study|Physician Decision|0|||
16449114|NCT00068692|40122327|FG005|Step 1: Registration|Other|0|||
16449115|NCT00068692|40122328|FG006|Step 1: Registration|Other|0|||
16449116|NCT00068692|40122329|FG007|Step 1: Registration|Other|0|||
16449117|NCT00068692|40122322|FG000|Step 1: Registration|Not start protocol therapy|3|||
16449118|NCT00068692|40122323|FG001|Step 1: Registration|Not start protocol therapy|0|||
16449119|NCT00068692|40122324|FG002|Step 1: Registration|Not start protocol therapy|0|||
16449120|NCT00068692|40122325|FG003|Step 1: Registration|Not start protocol therapy|0|||
16449121|NCT00068692|40122326|FG004|Step 1: Registration|Not start protocol therapy|0|||
16449122|NCT00068692|40122327|FG005|Step 1: Registration|Not start protocol therapy|0|||
16449123|NCT00068692|40122328|FG006|Step 1: Registration|Not start protocol therapy|0|||
16449124|NCT00068692|40122329|FG007|Step 1: Registration|Not start protocol therapy|0|||
16449125|NCT00068692|40122322|FG000|Step 1: Registration|Registered but not randomized|0|||
16449126|NCT00068692|40122323|FG001|Step 1: Registration|Registered but not randomized|1|||
16449127|NCT00068692|40122324|FG002|Step 1: Registration|Registered but not randomized|0|||
16449128|NCT00068692|40122325|FG003|Step 1: Registration|Registered but not randomized|0|||
16449129|NCT00068692|40122326|FG004|Step 1: Registration|Registered but not randomized|0|||
16449130|NCT00068692|40122327|FG005|Step 1: Registration|Registered but not randomized|0|||
16449131|NCT00068692|40122328|FG006|Step 1: Registration|Registered but not randomized|0|||
16449132|NCT00068692|40122329|FG007|Step 1: Registration|Registered but not randomized|0|||
16449133|NCT00068692|40122322|FG000|Step 2: Randomization|Disesae progression/replase|0|||
16449134|NCT00068692|40122323|FG001|Step 2: Randomization|Disesae progression/replase|0|||
16449135|NCT00068692|40122324|FG002|Step 2: Randomization|Disesae progression/replase|1|||
16449136|NCT00068692|40122325|FG003|Step 2: Randomization|Disesae progression/replase|1|||
16162025|NCT01182428|39076618|FG000|Overall Study|Lost to Follow-up|9|||
16162026|NCT01182428|39076619|FG001|Overall Study|Lost to Follow-up|1|||
16449137|NCT00068692|40122326|FG004|Step 2: Randomization|Disesae progression/replase|0|||
16449138|NCT00068692|40122327|FG005|Step 2: Randomization|Disesae progression/replase|0|||
16449139|NCT00068692|40122328|FG006|Step 2: Randomization|Disesae progression/replase|0|||
16449140|NCT00068692|40122329|FG007|Step 2: Randomization|Disesae progression/replase|0|||
16162027|NCT01182428|39076618|FG000|Overall Study|Withdrawal by Subject|1|||
16162028|NCT01182428|39076619|FG001|Overall Study|Withdrawal by Subject|0|||
16162029|NCT00763009|39076620|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
16162030|NCT00911989|39076621|FG000|Overall Study|Adverse Event|1|||
16162031|NCT00527605|39076623|FG000|Overall Study|Adverse Event|3|||
16162032|NCT00527605|39076624|FG001|Overall Study|Adverse Event|0|||
16162033|NCT00527605|39076623|FG000|Overall Study|Withdrawal by Subject|3|||
16162034|NCT00527605|39076624|FG001|Overall Study|Withdrawal by Subject|7|||
16162035|NCT00527605|39076623|FG000|Overall Study|Lost to Follow-up|6|||
16162036|NCT00527605|39076624|FG001|Overall Study|Lost to Follow-up|2|||
16162037|NCT00527605|39076623|FG000|Overall Study|Protocol Violation|1|||
16162038|NCT00527605|39076624|FG001|Overall Study|Protocol Violation|2|||
16162039|NCT00256295|39076633|FG000|Overall Study|Withdrawal by Subject|3|||
16162040|NCT00256295|39076633|FG000|Overall Study|Death|1|||
16162041|NCT00626093|39076636|FG000|Overall Study|Lost to Follow-up|5|||
16162042|NCT00626093|39076636|FG000|Overall Study|Death|1|||
16162043|NCT00626093|39076636|FG000|Overall Study|Physician Decision|4|||
16162044|NCT00626093|39076636|FG000|Overall Study|Withdrawal by Subject|6|||
16162045|NCT00626093|39076636|FG000|Overall Study|Protocol Violation|1|||
16162046|NCT00626093|39076636|FG000|Overall Study|One of the required devices not implante|6|||
16162047|NCT00323557|39076637|FG000|Overall Study|Physician Decision|1|||
16162048|NCT00323557|39076638|FG001|Overall Study|Physician Decision|0|||
16162049|NCT02902120|39076639|FG000|Overall Study|Lack of Efficacy|1|||
16162050|NCT01928381|39076640|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
16162051|NCT01928381|39076641|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16162052|NCT01928381|39076642|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16162053|NCT01928381|39076643|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16162054|NCT01928381|39076644|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16162055|NCT01928381|39076645|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16162056|NCT01928381|39076646|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
16162057|NCT01928381|39076640|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
16162058|NCT01928381|39076641|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
16162059|NCT01928381|39076642|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
16162060|NCT01928381|39076643|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
16162061|NCT01928381|39076644|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
16162062|NCT01928381|39076645|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
16162063|NCT01928381|39076646|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
16162064|NCT01928381|39076640|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
16162065|NCT01928381|39076641|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
16162066|NCT01928381|39076642|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
16162067|NCT01928381|39076643|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
16162068|NCT01928381|39076644|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
16162069|NCT01928381|39076645|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
16162070|NCT01928381|39076646|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
16162071|NCT01928381|39076640|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
16162072|NCT01928381|39076641|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
16162073|NCT01928381|39076642|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
16162074|NCT01928381|39076643|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
16162075|NCT01928381|39076644|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
16162076|NCT01928381|39076645|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
16162077|NCT01928381|39076646|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
16162078|NCT01928381|39076640|FG000|Part 1 - Pain Training|Protocol Violation|1|||
16162079|NCT01928381|39076641|FG001|Part 1 - Pain Training|Protocol Violation|0|||
16162080|NCT01928381|39076642|FG002|Part 1 - Pain Training|Protocol Violation|0|||
16162081|NCT01928381|39076643|FG003|Part 1 - Pain Training|Protocol Violation|0|||
16162082|NCT01928381|39076644|FG004|Part 1 - Pain Training|Protocol Violation|0|||
16162083|NCT01928381|39076645|FG005|Part 1 - Pain Training|Protocol Violation|0|||
16162084|NCT01928381|39076646|FG006|Part 1 - Pain Training|Protocol Violation|0|||
16162085|NCT01928381|39076640|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
16162086|NCT01928381|39076641|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16162087|NCT01928381|39076642|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16162088|NCT01928381|39076643|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16162089|NCT01928381|39076644|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16162090|NCT01928381|39076645|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16162091|NCT01928381|39076646|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
16162092|NCT01928381|39076640|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
16162093|NCT01928381|39076641|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16162094|NCT01928381|39076642|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16162095|NCT01928381|39076643|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16162096|NCT01928381|39076644|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16162097|NCT01928381|39076645|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16162098|NCT01928381|39076646|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
16162099|NCT01928381|39076640|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
16162100|NCT01928381|39076641|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16162101|NCT01928381|39076642|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16162102|NCT01928381|39076643|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16162103|NCT01928381|39076644|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16162104|NCT01928381|39076645|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16162105|NCT01928381|39076646|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
16162106|NCT01928381|39076640|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
16162107|NCT01928381|39076641|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16162108|NCT01928381|39076642|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16162109|NCT01928381|39076643|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16162110|NCT01928381|39076644|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16162111|NCT01928381|39076645|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16162112|NCT01928381|39076646|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
16162113|NCT01928381|39076640|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
16162114|NCT01928381|39076641|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
16162115|NCT01928381|39076642|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
16162116|NCT01928381|39076643|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
16162117|NCT01928381|39076644|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
16162118|NCT01928381|39076645|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
16162119|NCT01928381|39076646|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
16162120|NCT01928381|39076640|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16162121|NCT01928381|39076641|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16162122|NCT01928381|39076642|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
16162123|NCT01928381|39076643|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16162124|NCT01928381|39076644|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16162125|NCT01928381|39076645|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16162126|NCT01928381|39076646|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
16162127|NCT01928381|39076640|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
16162128|NCT01928381|39076641|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
16162129|NCT01928381|39076642|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
16162130|NCT01928381|39076643|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
16162131|NCT01928381|39076644|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
16162132|NCT01928381|39076645|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
16162133|NCT01928381|39076646|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
16162134|NCT01928381|39076640|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
16162135|NCT01928381|39076641|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
16162136|NCT01928381|39076642|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
16162137|NCT01928381|39076643|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
16162138|NCT01928381|39076644|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
16162139|NCT01928381|39076645|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
16162140|NCT01928381|39076646|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
16162141|NCT01928381|39076640|FG000|Washout First Intervention|Protocol Violation|0|||
16162142|NCT01928381|39076641|FG001|Washout First Intervention|Protocol Violation|0|||
16162143|NCT01928381|39076642|FG002|Washout First Intervention|Protocol Violation|0|||
16162144|NCT01928381|39076643|FG003|Washout First Intervention|Protocol Violation|0|||
16162145|NCT01928381|39076644|FG004|Washout First Intervention|Protocol Violation|1|||
16162146|NCT01928381|39076645|FG005|Washout First Intervention|Protocol Violation|0|||
16162147|NCT01928381|39076646|FG006|Washout First Intervention|Protocol Violation|0|||
16162148|NCT01928381|39076640|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
16162149|NCT01928381|39076641|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
16162150|NCT01928381|39076642|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
16162151|NCT01928381|39076643|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
16162152|NCT01928381|39076644|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
16162153|NCT01928381|39076645|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
16449141|NCT00068692|40122322|FG000|Step 2: Randomization|Adverse Event|0|||
16449142|NCT00068692|40122323|FG001|Step 2: Randomization|Adverse Event|0|||
16449143|NCT00068692|40122324|FG002|Step 2: Randomization|Adverse Event|4|||
16449144|NCT00068692|40122325|FG003|Step 2: Randomization|Adverse Event|2|||
16449145|NCT00068692|40122326|FG004|Step 2: Randomization|Adverse Event|2|||
16449146|NCT00068692|40122327|FG005|Step 2: Randomization|Adverse Event|3|||
16449147|NCT00068692|40122328|FG006|Step 2: Randomization|Adverse Event|4|||
16449148|NCT00068692|40122329|FG007|Step 2: Randomization|Adverse Event|4|||
16449149|NCT00068692|40122322|FG000|Step 2: Randomization|Death|0|||
16449150|NCT00068692|40122323|FG001|Step 2: Randomization|Death|0|||
16449151|NCT00068692|40122324|FG002|Step 2: Randomization|Death|0|||
16449152|NCT00068692|40122325|FG003|Step 2: Randomization|Death|0|||
16449153|NCT00068692|40122326|FG004|Step 2: Randomization|Death|1|||
16449154|NCT00068692|40122327|FG005|Step 2: Randomization|Death|0|||
16449155|NCT00068692|40122328|FG006|Step 2: Randomization|Death|0|||
16449156|NCT00068692|40122329|FG007|Step 2: Randomization|Death|1|||
16449157|NCT00068692|40122322|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
16449158|NCT00068692|40122323|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
16449159|NCT00068692|40122324|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
16449160|NCT00068692|40122325|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
16449161|NCT00068692|40122326|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
16449162|NCT00068692|40122327|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
16449163|NCT00068692|40122328|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
16449164|NCT00068692|40122329|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
16162154|NCT01928381|39076646|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
16162155|NCT01928381|39076640|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
16162156|NCT01928381|39076641|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
16162157|NCT01928381|39076642|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
16162158|NCT01928381|39076643|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
16162159|NCT01928381|39076644|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
16162160|NCT01928381|39076645|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
16162161|NCT01928381|39076646|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
16162162|NCT01512264|39076647|FG000|Overall Study|Lost to Follow-up|0|||
16162163|NCT01512264|39076648|FG001|Overall Study|Lost to Follow-up|0|||
16162164|NCT01512264|39076649|FG002|Overall Study|Lost to Follow-up|0|||
16162165|NCT01512264|39076650|FG003|Overall Study|Lost to Follow-up|1|||
16162166|NCT04506294|39076656|FG000|Overall Study|Lost to Follow-up|70|||
16162167|NCT04506294|39076657|FG001|Overall Study|Lost to Follow-up|20|||
16162168|NCT04506294|39076656|FG000|Overall Study|Withdrawal by Subject|16|||
16162169|NCT04506294|39076657|FG001|Overall Study|Withdrawal by Subject|2|||
16162170|NCT03920670|39076660|FG000|Overall Study|Protocol Violation|2|||
16162171|NCT03920670|39076661|FG001|Overall Study|Protocol Violation|2|||
16162172|NCT03920670|39076660|FG000|Overall Study|Adverse Event|1|||
16162173|NCT03920670|39076661|FG001|Overall Study|Adverse Event|0|||
16162174|NCT00803179|39076662|FG000|Overall Study|Lost to Follow-up|3|||
16162175|NCT00684515|39076665|FG000|Overall Study|Adverse Event|3|||
16162176|NCT00684515|39076666|FG001|Overall Study|Adverse Event|3|||
16162177|NCT00684515|39076667|FG002|Overall Study|Adverse Event|1|||
16162178|NCT00684515|39076665|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
16162179|NCT00684515|39076666|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
16162180|NCT00684515|39076667|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
16162181|NCT03870555|39076668|FG000|Period 3 (2 Days)|Adverse Event|1|||
16162182|NCT03870555|39076669|FG001|Period 3 (2 Days)|Adverse Event|0|||
16162183|NCT03870555|39076670|FG002|Period 3 (2 Days)|Adverse Event|0|||
16162184|NCT00883337|39076672|FG000|Core Treatment Period|Adverse Event|9|||
16162185|NCT00883337|39076673|FG001|Core Treatment Period|Adverse Event|12|||
16162186|NCT00883337|39076674|FG002|Core Treatment Period|Adverse Event|22|||
16162187|NCT00883337|39076672|FG000|Core Treatment Period|Lack of Efficacy|7|||
16162188|NCT00883337|39076673|FG001|Core Treatment Period|Lack of Efficacy|4|||
16162189|NCT00883337|39076674|FG002|Core Treatment Period|Lack of Efficacy|2|||
16162190|NCT00883337|39076672|FG000|Core Treatment Period|Lost to Follow-up|1|||
16162191|NCT00883337|39076673|FG001|Core Treatment Period|Lost to Follow-up|1|||
16162192|NCT00883337|39076674|FG002|Core Treatment Period|Lost to Follow-up|0|||
16162193|NCT00883337|39076672|FG000|Core Treatment Period|Withdrawal by Subject|2|||
16162194|NCT00883337|39076673|FG001|Core Treatment Period|Withdrawal by Subject|2|||
16162195|NCT00883337|39076674|FG002|Core Treatment Period|Withdrawal by Subject|6|||
16162196|NCT00883337|39076672|FG000|Core Treatment Period|Wish to be pregnant|1|||
16162197|NCT00883337|39076673|FG001|Core Treatment Period|Wish to be pregnant|2|||
16162198|NCT00883337|39076674|FG002|Core Treatment Period|Wish to be pregnant|1|||
16162199|NCT00883337|39076672|FG000|Core Treatment Period|Poor compliance to protocol|0|||
16162200|NCT00883337|39076673|FG001|Core Treatment Period|Poor compliance to protocol|0|||
16162201|NCT00883337|39076674|FG002|Core Treatment Period|Poor compliance to protocol|1|||
16162202|NCT00883337|39076672|FG000|Core Treatment Period|Other than above|0|||
16162203|NCT00883337|39076673|FG001|Core Treatment Period|Other than above|1|||
16162204|NCT00883337|39076674|FG002|Core Treatment Period|Other than above|1|||
16162205|NCT00883337|39076672|FG000|Extension Treatment Period|Adverse Event|8|||
16162206|NCT00883337|39076673|FG001|Extension Treatment Period|Adverse Event|5|||
16162207|NCT00883337|39076674|FG002|Extension Treatment Period|Adverse Event|5|||
16162208|NCT00883337|39076672|FG000|Extension Treatment Period|Lack of Efficacy|8|||
16449165|NCT00068692|40122322|FG000|Step 2: Randomization|alternative therapy|0|||
16162209|NCT00883337|39076673|FG001|Extension Treatment Period|Lack of Efficacy|8|||
16162210|NCT00883337|39076674|FG002|Extension Treatment Period|Lack of Efficacy|8|||
16162211|NCT00883337|39076672|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
16265016|NCT01597245|39453274|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
16162212|NCT00883337|39076673|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
16162213|NCT00883337|39076674|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
16162214|NCT00883337|39076672|FG000|Extension Treatment Period|Lost to Follow-up|1|||
16162215|NCT00883337|39076673|FG001|Extension Treatment Period|Lost to Follow-up|0|||
16162216|NCT00883337|39076674|FG002|Extension Treatment Period|Lost to Follow-up|0|||
16162217|NCT00883337|39076672|FG000|Extension Treatment Period|Other than above|10|||
16162218|NCT00883337|39076673|FG001|Extension Treatment Period|Other than above|9|||
16162219|NCT00883337|39076674|FG002|Extension Treatment Period|Other than above|5|||
16162220|NCT00044512|39076675|FG000|Follow Up|Lost to Follow-up|2|||
16162221|NCT00577993|39076676|FG000|Overall Study|Adverse Event|1|||
16162222|NCT00577993|39076677|FG001|Overall Study|Adverse Event|0|||
16162223|NCT00577993|39076678|FG002|Overall Study|Adverse Event|0|||
16162224|NCT00577993|39076676|FG000|Overall Study|Death|0|||
16162225|NCT00577993|39076677|FG001|Overall Study|Death|1|||
16162226|NCT00577993|39076678|FG002|Overall Study|Death|1|||
16162227|NCT00577993|39076676|FG000|Overall Study|Lack of Efficacy|0|||
16162228|NCT00577993|39076677|FG001|Overall Study|Lack of Efficacy|1|||
16162229|NCT00577993|39076678|FG002|Overall Study|Lack of Efficacy|0|||
16162230|NCT00577993|39076676|FG000|Overall Study|Protocol Violation|2|||
16162231|NCT00577993|39076677|FG001|Overall Study|Protocol Violation|3|||
16162232|NCT00577993|39076678|FG002|Overall Study|Protocol Violation|0|||
16162233|NCT00577993|39076676|FG000|Overall Study|Withdrawal by Subject|1|||
16162234|NCT00577993|39076677|FG001|Overall Study|Withdrawal by Subject|0|||
16162235|NCT00577993|39076678|FG002|Overall Study|Withdrawal by Subject|2|||
16162236|NCT00577993|39076676|FG000|Overall Study|Conversion|2|||
16162237|NCT00577993|39076677|FG001|Overall Study|Conversion|5|||
16162238|NCT00577993|39076678|FG002|Overall Study|Conversion|0|||
16162239|NCT00577993|39076676|FG000|Overall Study|Uninsured|1|||
16162240|NCT00577993|39076677|FG001|Overall Study|Uninsured|0|||
16162241|NCT00577993|39076678|FG002|Overall Study|Uninsured|0|||
16162242|NCT03118297|39076690|FG000|Overall Study|Lost to Follow-up|0|||
16162243|NCT03118297|39076691|FG001|Overall Study|Lost to Follow-up|2|||
16162244|NCT02435849|39076694|FG000|Overall Study|Death|23|||
16162245|NCT02435849|39076695|FG001|Overall Study|Death|0|||
16162246|NCT02435849|39076694|FG000|Overall Study|Lack of Efficacy|10|||
16162247|NCT02435849|39076695|FG001|Overall Study|Lack of Efficacy|0|||
16162248|NCT02435849|39076694|FG000|Overall Study|New therapy for study indication|8|||
16162249|NCT02435849|39076695|FG001|Overall Study|New therapy for study indication|0|||
16162250|NCT02435849|39076694|FG000|Overall Study|Subject/guardian decision|5|||
16162251|NCT02435849|39076695|FG001|Overall Study|Subject/guardian decision|1|||
16162252|NCT02435849|39076694|FG000|Overall Study|Lost to Follow-up|1|||
16162253|NCT02435849|39076695|FG001|Overall Study|Lost to Follow-up|0|||
16162254|NCT02435849|39076694|FG000|Overall Study|Physician Decision|1|||
16162255|NCT02435849|39076695|FG001|Overall Study|Physician Decision|0|||
16162256|NCT00328627|39076696|FG000|Overall Study|Hyperglycemic Rescue|41|||
16162257|NCT00328627|39076697|FG001|Overall Study|Hyperglycemic Rescue|18|||
16162258|NCT00328627|39076698|FG002|Overall Study|Hyperglycemic Rescue|16|||
16162259|NCT00328627|39076699|FG003|Overall Study|Hyperglycemic Rescue|13|||
16162260|NCT00328627|39076700|FG004|Overall Study|Hyperglycemic Rescue|6|||
16162261|NCT00328627|39076701|FG005|Overall Study|Hyperglycemic Rescue|5|||
16162262|NCT00328627|39076702|FG006|Overall Study|Hyperglycemic Rescue|19|||
16162263|NCT00328627|39076703|FG007|Overall Study|Hyperglycemic Rescue|6|||
16162264|NCT00328627|39076704|FG008|Overall Study|Hyperglycemic Rescue|6|||
16162265|NCT00328627|39076705|FG009|Overall Study|Hyperglycemic Rescue|11|||
16162266|NCT00328627|39076706|FG010|Overall Study|Hyperglycemic Rescue|3|||
16162267|NCT00328627|39076707|FG011|Overall Study|Hyperglycemic Rescue|2|||
16162268|NCT00328627|39076696|FG000|Overall Study|Adverse Event|3|||
16162269|NCT00328627|39076697|FG001|Overall Study|Adverse Event|1|||
16162270|NCT00328627|39076698|FG002|Overall Study|Adverse Event|2|||
16162271|NCT00328627|39076699|FG003|Overall Study|Adverse Event|3|||
16162272|NCT00328627|39076700|FG004|Overall Study|Adverse Event|1|||
16162273|NCT00328627|39076701|FG005|Overall Study|Adverse Event|2|||
16162274|NCT00328627|39076702|FG006|Overall Study|Adverse Event|1|||
16162275|NCT00328627|39076703|FG007|Overall Study|Adverse Event|2|||
16162276|NCT00328627|39076704|FG008|Overall Study|Adverse Event|0|||
16162277|NCT00328627|39076705|FG009|Overall Study|Adverse Event|7|||
16162278|NCT00328627|39076706|FG010|Overall Study|Adverse Event|5|||
16162279|NCT00328627|39076707|FG011|Overall Study|Adverse Event|4|||
16162280|NCT00328627|39076696|FG000|Overall Study|Protocol Violation|2|||
16162281|NCT00328627|39076697|FG001|Overall Study|Protocol Violation|2|||
16162282|NCT00328627|39076698|FG002|Overall Study|Protocol Violation|2|||
16162283|NCT00328627|39076699|FG003|Overall Study|Protocol Violation|8|||
16162284|NCT00328627|39076700|FG004|Overall Study|Protocol Violation|5|||
16162285|NCT00328627|39076701|FG005|Overall Study|Protocol Violation|5|||
16162286|NCT00328627|39076702|FG006|Overall Study|Protocol Violation|6|||
16162287|NCT00328627|39076703|FG007|Overall Study|Protocol Violation|2|||
16162288|NCT00328627|39076704|FG008|Overall Study|Protocol Violation|1|||
16449166|NCT00068692|40122323|FG001|Step 2: Randomization|alternative therapy|0|||
16449167|NCT00068692|40122324|FG002|Step 2: Randomization|alternative therapy|0|||
16162289|NCT00328627|39076705|FG009|Overall Study|Protocol Violation|4|||
16162290|NCT00328627|39076706|FG010|Overall Study|Protocol Violation|6|||
16162291|NCT00328627|39076707|FG011|Overall Study|Protocol Violation|2|||
16162292|NCT00328627|39076696|FG000|Overall Study|Lost to Follow-up|4|||
16162293|NCT00328627|39076697|FG001|Overall Study|Lost to Follow-up|2|||
16162294|NCT00328627|39076698|FG002|Overall Study|Lost to Follow-up|2|||
16162295|NCT00328627|39076699|FG003|Overall Study|Lost to Follow-up|4|||
16162296|NCT00328627|39076700|FG004|Overall Study|Lost to Follow-up|0|||
16162297|NCT00328627|39076701|FG005|Overall Study|Lost to Follow-up|2|||
16162298|NCT00328627|39076702|FG006|Overall Study|Lost to Follow-up|3|||
16162299|NCT00328627|39076703|FG007|Overall Study|Lost to Follow-up|0|||
16162300|NCT00328627|39076704|FG008|Overall Study|Lost to Follow-up|3|||
16162301|NCT00328627|39076705|FG009|Overall Study|Lost to Follow-up|2|||
16162302|NCT00328627|39076706|FG010|Overall Study|Lost to Follow-up|0|||
16162303|NCT00328627|39076707|FG011|Overall Study|Lost to Follow-up|1|||
16162304|NCT00328627|39076696|FG000|Overall Study|Withdrawal by Subject|5|||
16162305|NCT00328627|39076697|FG001|Overall Study|Withdrawal by Subject|4|||
16162306|NCT00328627|39076698|FG002|Overall Study|Withdrawal by Subject|5|||
16162307|NCT00328627|39076699|FG003|Overall Study|Withdrawal by Subject|6|||
16162308|NCT00328627|39076700|FG004|Overall Study|Withdrawal by Subject|2|||
16162309|NCT00328627|39076701|FG005|Overall Study|Withdrawal by Subject|5|||
16162310|NCT00328627|39076702|FG006|Overall Study|Withdrawal by Subject|4|||
16162311|NCT00328627|39076703|FG007|Overall Study|Withdrawal by Subject|4|||
16162312|NCT00328627|39076704|FG008|Overall Study|Withdrawal by Subject|4|||
16162313|NCT00328627|39076705|FG009|Overall Study|Withdrawal by Subject|5|||
16162314|NCT00328627|39076706|FG010|Overall Study|Withdrawal by Subject|2|||
16162315|NCT00328627|39076707|FG011|Overall Study|Withdrawal by Subject|7|||
16162316|NCT00328627|39076696|FG000|Overall Study|Pregnancy|0|||
16162317|NCT00328627|39076697|FG001|Overall Study|Pregnancy|1|||
16162318|NCT00328627|39076698|FG002|Overall Study|Pregnancy|0|||
16162319|NCT00328627|39076699|FG003|Overall Study|Pregnancy|0|||
16162320|NCT00328627|39076700|FG004|Overall Study|Pregnancy|0|||
16162321|NCT00328627|39076701|FG005|Overall Study|Pregnancy|0|||
16162322|NCT00328627|39076702|FG006|Overall Study|Pregnancy|0|||
16162323|NCT00328627|39076703|FG007|Overall Study|Pregnancy|0|||
16162324|NCT00328627|39076704|FG008|Overall Study|Pregnancy|0|||
16162325|NCT00328627|39076705|FG009|Overall Study|Pregnancy|0|||
16162326|NCT00328627|39076706|FG010|Overall Study|Pregnancy|0|||
16162327|NCT00328627|39076707|FG011|Overall Study|Pregnancy|0|||
16162328|NCT00328627|39076696|FG000|Overall Study|Physician Decision|4|||
16162329|NCT00328627|39076697|FG001|Overall Study|Physician Decision|3|||
16162330|NCT00328627|39076698|FG002|Overall Study|Physician Decision|1|||
16162331|NCT00328627|39076699|FG003|Overall Study|Physician Decision|2|||
16162332|NCT00328627|39076700|FG004|Overall Study|Physician Decision|1|||
16162333|NCT00328627|39076701|FG005|Overall Study|Physician Decision|1|||
16162334|NCT00328627|39076702|FG006|Overall Study|Physician Decision|1|||
16162335|NCT00328627|39076703|FG007|Overall Study|Physician Decision|0|||
16162336|NCT00328627|39076704|FG008|Overall Study|Physician Decision|3|||
16162337|NCT00328627|39076705|FG009|Overall Study|Physician Decision|2|||
16162338|NCT00328627|39076706|FG010|Overall Study|Physician Decision|1|||
16162339|NCT00328627|39076707|FG011|Overall Study|Physician Decision|0|||
16162340|NCT00328627|39076696|FG000|Overall Study|Other|0|||
16162341|NCT00328627|39076697|FG001|Overall Study|Other|0|||
16162342|NCT00328627|39076698|FG002|Overall Study|Other|0|||
16162343|NCT00328627|39076699|FG003|Overall Study|Other|1|||
16162344|NCT00328627|39076700|FG004|Overall Study|Other|0|||
16162345|NCT00328627|39076701|FG005|Overall Study|Other|0|||
16162346|NCT00328627|39076702|FG006|Overall Study|Other|1|||
16162347|NCT00328627|39076703|FG007|Overall Study|Other|0|||
16162348|NCT00328627|39076704|FG008|Overall Study|Other|0|||
16162349|NCT00328627|39076705|FG009|Overall Study|Other|1|||
16162350|NCT00328627|39076706|FG010|Overall Study|Other|1|||
16162351|NCT00328627|39076707|FG011|Overall Study|Other|0|||
16162352|NCT02049944|39076710|FG000|Overall Study|Protocol Violation|2|||
16162353|NCT03603652|39076711|FG000|Overall Study|Death|2|||
16162354|NCT01731678|39076714|FG000|Overall Study|Withdrawal by Subject|3|||
16162355|NCT01731678|39076714|FG000|Overall Study|Did not meet inclusion criteria|1|||
16162356|NCT01731678|39076714|FG000|Overall Study|RMT too high, making TMS difficult|3|||
16162357|NCT02322710|39076718|FG000|Overall Study|No efficacy assessment post-baseline|0|||
16162358|NCT02322710|39076719|FG001|Overall Study|No efficacy assessment post-baseline|1|||
16162359|NCT02322710|39076718|FG000|Overall Study|Protocol Violation|20|||
16162360|NCT02322710|39076719|FG001|Overall Study|Protocol Violation|25|||
16162361|NCT00413959|39076720|FG000|Overall Study|Pt had only one cycle.|1|||
16162362|NCT00763139|39076724|FG000|Overall Study|Adverse Event|4|||
16162363|NCT00763139|39076725|FG001|Overall Study|Adverse Event|2|||
16162364|NCT00763139|39076724|FG000|Overall Study|Withdrawal by Subject|0|||
16162365|NCT00763139|39076725|FG001|Overall Study|Withdrawal by Subject|1|||
16162366|NCT00763139|39076724|FG000|Overall Study|med change not allowed by protocol|1|||
16162367|NCT00763139|39076725|FG001|Overall Study|med change not allowed by protocol|0|||
16162368|NCT01017952|39076726|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
16162369|NCT01017952|39076727|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16265017|NCT01597245|39453254|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16162370|NCT01017952|39076728|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16162371|NCT01017952|39076729|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16162372|NCT01017952|39076730|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
16372956|NCT01454063|39849826|FG001|Randomized|Protocol Violation|1|||
16162373|NCT01017952|39076726|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
16162374|NCT01017952|39076727|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
16162375|NCT01017952|39076728|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
16162376|NCT01017952|39076729|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
16162377|NCT01017952|39076730|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
16162378|NCT01017952|39076726|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
16162379|NCT01017952|39076727|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
16162380|NCT01017952|39076728|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
16162381|NCT01017952|39076729|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
16162382|NCT01017952|39076730|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
16162383|NCT01017952|39076726|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
16162384|NCT01017952|39076727|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16162385|NCT01017952|39076728|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16162386|NCT01017952|39076729|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16162387|NCT01017952|39076730|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
16162388|NCT01017952|39076726|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
16162389|NCT01017952|39076727|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
16162390|NCT01017952|39076728|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
16162391|NCT01017952|39076729|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
16162392|NCT01017952|39076730|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
16162393|NCT01017952|39076726|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
16162394|NCT01017952|39076727|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16162395|NCT01017952|39076728|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16162396|NCT01017952|39076729|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16162397|NCT01017952|39076730|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
16162398|NCT01017952|39076726|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
16162399|NCT01017952|39076727|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
16162400|NCT01017952|39076728|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
16162401|NCT01017952|39076729|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
16162402|NCT01017952|39076730|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
16162403|NCT01017952|39076726|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16449168|NCT00068692|40122325|FG003|Step 2: Randomization|alternative therapy|1|||
16449169|NCT00068692|40122326|FG004|Step 2: Randomization|alternative therapy|1|||
16449170|NCT00068692|40122327|FG005|Step 2: Randomization|alternative therapy|0|||
16449171|NCT00068692|40122328|FG006|Step 2: Randomization|alternative therapy|0|||
16449172|NCT00068692|40122329|FG007|Step 2: Randomization|alternative therapy|0|||
16449173|NCT00068692|40122322|FG000|Step 2: Randomization|Physician Decision|0|||
16449174|NCT00068692|40122323|FG001|Step 2: Randomization|Physician Decision|0|||
16449175|NCT00068692|40122324|FG002|Step 2: Randomization|Physician Decision|0|||
16449176|NCT00068692|40122325|FG003|Step 2: Randomization|Physician Decision|1|||
16449177|NCT00068692|40122326|FG004|Step 2: Randomization|Physician Decision|1|||
16449178|NCT00068692|40122327|FG005|Step 2: Randomization|Physician Decision|0|||
16449179|NCT00068692|40122328|FG006|Step 2: Randomization|Physician Decision|0|||
16449180|NCT00068692|40122329|FG007|Step 2: Randomization|Physician Decision|0|||
16449181|NCT00068692|40122322|FG000|Step 2: Randomization|Other|0|||
16449182|NCT00068692|40122323|FG001|Step 2: Randomization|Other|0|||
16449183|NCT00068692|40122324|FG002|Step 2: Randomization|Other|0|||
16449184|NCT00068692|40122325|FG003|Step 2: Randomization|Other|1|||
16449185|NCT00068692|40122326|FG004|Step 2: Randomization|Other|0|||
16449186|NCT00068692|40122327|FG005|Step 2: Randomization|Other|1|||
16449187|NCT00068692|40122328|FG006|Step 2: Randomization|Other|0|||
16449188|NCT00068692|40122329|FG007|Step 2: Randomization|Other|0|||
16449189|NCT00068692|40122322|FG000|Step 2: Randomization|never start protocol therapy|0|||
16449190|NCT00068692|40122323|FG001|Step 2: Randomization|never start protocol therapy|0|||
16449191|NCT00068692|40122324|FG002|Step 2: Randomization|never start protocol therapy|1|||
16449192|NCT00068692|40122325|FG003|Step 2: Randomization|never start protocol therapy|0|||
16449193|NCT00068692|40122326|FG004|Step 2: Randomization|never start protocol therapy|1|||
16449194|NCT00068692|40122327|FG005|Step 2: Randomization|never start protocol therapy|0|||
16449195|NCT00068692|40122328|FG006|Step 2: Randomization|never start protocol therapy|0|||
16449196|NCT00068692|40122329|FG007|Step 2: Randomization|never start protocol therapy|0|||
16449197|NCT00914316|40122334|FG000|Phase 1|Physician Decision|4|||
16449198|NCT00914316|40122335|FG001|Phase 1|Physician Decision|0|||
16449199|NCT00914316|40122336|FG002|Phase 1|Physician Decision|1|||
16449200|NCT00914316|40122337|FG003|Phase 1|Physician Decision|2|||
16449201|NCT00914316|40122334|FG000|Phase 1|Withdrawal by Subject|0|||
16449202|NCT00914316|40122335|FG001|Phase 1|Withdrawal by Subject|2|||
16449203|NCT00914316|40122336|FG002|Phase 1|Withdrawal by Subject|4|||
16449204|NCT00914316|40122337|FG003|Phase 1|Withdrawal by Subject|0|||
16449205|NCT00914316|40122334|FG000|Phase 1|Adverse Event|1|||
16449206|NCT00914316|40122335|FG001|Phase 1|Adverse Event|0|||
16449207|NCT00914316|40122336|FG002|Phase 1|Adverse Event|0|||
16449208|NCT00914316|40122337|FG003|Phase 1|Adverse Event|0|||
16449209|NCT00914316|40122334|FG000|Phase 2|Withdrawal by Subject|1|||
16449210|NCT00914316|40122335|FG001|Phase 2|Withdrawal by Subject|0|||
16449211|NCT00914316|40122336|FG002|Phase 2|Withdrawal by Subject|1|||
16449212|NCT00914316|40122337|FG003|Phase 2|Withdrawal by Subject|0|||
16449213|NCT01088048|40125732|FG000|Overall Study|Adverse Event|7|||
16449214|NCT01088048|40125733|FG001|Overall Study|Adverse Event|9|||
16449215|NCT01088048|40125734|FG002|Overall Study|Adverse Event|7|||
16449216|NCT01088048|40125735|FG003|Overall Study|Adverse Event|5|||
16449217|NCT01088048|40125736|FG004|Overall Study|Adverse Event|6|||
16449218|NCT01088048|40125737|FG005|Overall Study|Adverse Event|3|||
16449219|NCT01088048|40125738|FG006|Overall Study|Adverse Event|3|||
16449220|NCT01088048|40125739|FG007|Overall Study|Adverse Event|0|||
16449221|NCT01088048|40125740|FG008|Overall Study|Adverse Event|2|||
16449222|NCT01088048|40125741|FG009|Overall Study|Adverse Event|2|||
16449223|NCT01088048|40125732|FG000|Overall Study|Withdrew Consent|1|||
16449224|NCT01088048|40125733|FG001|Overall Study|Withdrew Consent|1|||
16449225|NCT01088048|40125734|FG002|Overall Study|Withdrew Consent|1|||
16449226|NCT01088048|40125735|FG003|Overall Study|Withdrew Consent|1|||
16449227|NCT01088048|40125736|FG004|Overall Study|Withdrew Consent|2|||
16449228|NCT01088048|40125737|FG005|Overall Study|Withdrew Consent|1|||
16449229|NCT01088048|40125738|FG006|Overall Study|Withdrew Consent|0|||
16449230|NCT01088048|40125739|FG007|Overall Study|Withdrew Consent|2|||
16449231|NCT01088048|40125740|FG008|Overall Study|Withdrew Consent|2|||
16449232|NCT01088048|40125741|FG009|Overall Study|Withdrew Consent|1|||
16449233|NCT01088048|40125732|FG000|Overall Study|Concomitant Medication Prohibited|1|||
16449234|NCT01088048|40125733|FG001|Overall Study|Concomitant Medication Prohibited|0|||
16449235|NCT01088048|40125734|FG002|Overall Study|Concomitant Medication Prohibited|0|||
16449236|NCT01088048|40125735|FG003|Overall Study|Concomitant Medication Prohibited|0|||
16449237|NCT01088048|40125736|FG004|Overall Study|Concomitant Medication Prohibited|0|||
16449238|NCT01088048|40125737|FG005|Overall Study|Concomitant Medication Prohibited|0|||
16449239|NCT01088048|40125738|FG006|Overall Study|Concomitant Medication Prohibited|0|||
16449240|NCT01088048|40125739|FG007|Overall Study|Concomitant Medication Prohibited|0|||
16449241|NCT01088048|40125740|FG008|Overall Study|Concomitant Medication Prohibited|0|||
16449242|NCT01088048|40125741|FG009|Overall Study|Concomitant Medication Prohibited|0|||
16449243|NCT01088048|40125732|FG000|Overall Study|Investigator Request|2|||
16449244|NCT01088048|40125733|FG001|Overall Study|Investigator Request|2|||
16449245|NCT01088048|40125734|FG002|Overall Study|Investigator Request|0|||
16449246|NCT01088048|40125735|FG003|Overall Study|Investigator Request|0|||
16449247|NCT01088048|40125736|FG004|Overall Study|Investigator Request|3|||
16449248|NCT01088048|40125737|FG005|Overall Study|Investigator Request|1|||
16449249|NCT01088048|40125738|FG006|Overall Study|Investigator Request|1|||
16449250|NCT01088048|40125739|FG007|Overall Study|Investigator Request|0|||
16449251|NCT01088048|40125740|FG008|Overall Study|Investigator Request|0|||
16449252|NCT01088048|40125741|FG009|Overall Study|Investigator Request|0|||
16449253|NCT01088048|40125732|FG000|Overall Study|Patient Non-compliance|0|||
16449254|NCT01088048|40125733|FG001|Overall Study|Patient Non-compliance|1|||
16449255|NCT01088048|40125734|FG002|Overall Study|Patient Non-compliance|0|||
16449256|NCT01088048|40125735|FG003|Overall Study|Patient Non-compliance|0|||
16449257|NCT01088048|40125736|FG004|Overall Study|Patient Non-compliance|0|||
16449258|NCT01088048|40125737|FG005|Overall Study|Patient Non-compliance|0|||
16449259|NCT01088048|40125738|FG006|Overall Study|Patient Non-compliance|0|||
16449260|NCT01088048|40125739|FG007|Overall Study|Patient Non-compliance|0|||
16449261|NCT01088048|40125740|FG008|Overall Study|Patient Non-compliance|0|||
16449262|NCT01088048|40125741|FG009|Overall Study|Patient Non-compliance|0|||
16449263|NCT01088048|40125732|FG000|Overall Study|Disease Progression|7|||
16449264|NCT01088048|40125733|FG001|Overall Study|Disease Progression|4|||
16449265|NCT01088048|40125734|FG002|Overall Study|Disease Progression|3|||
16449266|NCT01088048|40125735|FG003|Overall Study|Disease Progression|5|||
16449267|NCT01088048|40125736|FG004|Overall Study|Disease Progression|3|||
16449268|NCT01088048|40125737|FG005|Overall Study|Disease Progression|3|||
16449269|NCT01088048|40125738|FG006|Overall Study|Disease Progression|2|||
16449270|NCT01088048|40125739|FG007|Overall Study|Disease Progression|1|||
16449271|NCT01088048|40125740|FG008|Overall Study|Disease Progression|0|||
16449272|NCT01088048|40125741|FG009|Overall Study|Disease Progression|0|||
16449273|NCT01088048|40125732|FG000|Overall Study|Death|1|||
16449274|NCT01088048|40125733|FG001|Overall Study|Death|5|||
16449275|NCT01088048|40125734|FG002|Overall Study|Death|3|||
16449276|NCT01088048|40125735|FG003|Overall Study|Death|3|||
16449277|NCT01088048|40125736|FG004|Overall Study|Death|1|||
16449278|NCT01088048|40125737|FG005|Overall Study|Death|3|||
16449279|NCT01088048|40125738|FG006|Overall Study|Death|0|||
16449280|NCT01088048|40125739|FG007|Overall Study|Death|0|||
16449281|NCT01088048|40125740|FG008|Overall Study|Death|3|||
16449282|NCT01088048|40125741|FG009|Overall Study|Death|1|||
16449283|NCT01088048|40125732|FG000|Overall Study|Other|3|||
16449284|NCT01088048|40125733|FG001|Overall Study|Other|5|||
16449285|NCT01088048|40125734|FG002|Overall Study|Other|0|||
16449286|NCT01088048|40125735|FG003|Overall Study|Other|0|||
16449287|NCT01088048|40125736|FG004|Overall Study|Other|2|||
16449288|NCT01088048|40125737|FG005|Overall Study|Other|0|||
16449289|NCT01088048|40125738|FG006|Overall Study|Other|0|||
16449290|NCT01088048|40125739|FG007|Overall Study|Other|2|||
16449291|NCT01088048|40125740|FG008|Overall Study|Other|0|||
16449292|NCT01088048|40125741|FG009|Overall Study|Other|0|||
16449293|NCT02560558|40125744|FG000|Overall Study|Adverse Event|1|||
16449294|NCT02560558|40125745|FG001|Overall Study|Adverse Event|0|||
16449295|NCT02560558|40125744|FG000|Overall Study|Death|0|||
16449296|NCT02560558|40125745|FG001|Overall Study|Death|2|||
16449297|NCT02560558|40125744|FG000|Overall Study|Lost to Follow-up|0|||
16449298|NCT02560558|40125745|FG001|Overall Study|Lost to Follow-up|4|||
16449299|NCT02560558|40125744|FG000|Overall Study|Protocol Violation|3|||
16449300|NCT02560558|40125745|FG001|Overall Study|Protocol Violation|0|||
16449301|NCT02560558|40125744|FG000|Overall Study|Withdrawal by Subject|3|||
16449302|NCT02560558|40125745|FG001|Overall Study|Withdrawal by Subject|0|||
16449303|NCT02565108|40125746|FG000|Overall Study|Adverse Event|1|||
16449304|NCT02565108|40125747|FG001|Overall Study|Adverse Event|0|||
16449305|NCT02565108|40125746|FG000|Overall Study|Withdrew Consent|1|||
16449306|NCT02565108|40125747|FG001|Overall Study|Withdrew Consent|0|||
16449307|NCT05097963|40125748|FG000|Overall Study|Protocol Violation|13|||
16449308|NCT05097963|40125748|FG000|Overall Study|Withdrawal by Subject|21|||
16449309|NCT03216226|40125749|FG000|Overall Study|Adverse Event|3|||
16449310|NCT03216226|40125750|FG001|Overall Study|Adverse Event|0|||
16449311|NCT03216226|40125749|FG000|Overall Study|Protocol Violation|1|||
16449312|NCT03216226|40125750|FG001|Overall Study|Protocol Violation|3|||
16449313|NCT03216226|40125749|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
16449314|NCT03216226|40125750|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
16449315|NCT03216226|40125749|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
16449316|NCT03216226|40125750|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
16449317|NCT03216226|40125749|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
16449318|NCT03216226|40125750|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
16449319|NCT00912808|40125753|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
16449320|NCT00912808|40125754|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
16449321|NCT00912808|40125753|FG000|Washout|Withdrawal by Subject|0|||
16449322|NCT00912808|40125754|FG001|Washout|Withdrawal by Subject|1|||
16449323|NCT00912808|40125753|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
16449324|NCT00912808|40125754|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
16449325|NCT00912808|40125753|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
16449326|NCT00912808|40125754|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
16449327|NCT02625909|40125755|FG000|Overall Study|Death|2|||
16449328|NCT02625909|40125756|FG001|Overall Study|Death|0|||
16449329|NCT02625909|40125755|FG000|Overall Study|Lost to Follow-up|3|||
16449330|NCT02625909|40125756|FG001|Overall Study|Lost to Follow-up|5|||
16162404|NCT01017952|39076727|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
16162405|NCT01017952|39076728|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
16162406|NCT01017952|39076729|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
16162407|NCT01017952|39076730|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
16162408|NCT01017952|39076726|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
16162409|NCT01017952|39076727|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
16162410|NCT01017952|39076728|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
16162411|NCT01017952|39076729|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
16162412|NCT01017952|39076730|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
16162413|NCT01017952|39076726|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
16162414|NCT01017952|39076727|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
16162415|NCT01017952|39076728|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
16162416|NCT01017952|39076729|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
16162417|NCT01017952|39076730|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
16162418|NCT01017952|39076726|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
16162419|NCT01017952|39076727|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
16162420|NCT01017952|39076728|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
16162421|NCT01017952|39076729|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
16162422|NCT01017952|39076730|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
16162423|NCT01017952|39076726|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16162424|NCT01017952|39076727|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
16162425|NCT01017952|39076728|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
16162426|NCT01017952|39076729|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16162427|NCT01017952|39076730|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
16162428|NCT01017952|39076726|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16162429|NCT01017952|39076727|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
16162430|NCT01017952|39076728|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
16162431|NCT01017952|39076729|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
16162432|NCT01017952|39076730|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
16162433|NCT01017952|39076726|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
16162434|NCT01017952|39076727|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
16449331|NCT02625909|40125755|FG000|Overall Study|Lack of Efficacy|9|||
16449332|NCT02625909|40125756|FG001|Overall Study|Lack of Efficacy|2|||
16162435|NCT01017952|39076728|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
16162436|NCT01017952|39076729|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
16162437|NCT01017952|39076730|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
16162438|NCT00725075|39076731|FG000|Overall Study|Use of Excluded Medication|0|||
16449333|NCT02625909|40125755|FG000|Overall Study|Reinfection|3|||
16449334|NCT02625909|40125756|FG001|Overall Study|Reinfection|2|||
16449335|NCT00774566|40125757|FG000|Overall Study|Protocol Violation|18|||
16449336|NCT00774566|40125758|FG001|Overall Study|Protocol Violation|15|||
16449337|NCT01208207|40125759|FG000|Part I|Adverse Event|19|||
16449338|NCT01208207|40125760|FG001|Part I|Adverse Event|2|||
16449339|NCT01208207|40125761|FG002|Part I|Adverse Event|6|||
16449340|NCT01208207|40125762|FG003|Part I|Adverse Event|0|||
16162439|NCT00725075|39076732|FG001|Overall Study|Use of Excluded Medication|1|||
16162440|NCT00725075|39076733|FG002|Overall Study|Use of Excluded Medication|0|||
16162441|NCT00725075|39076731|FG000|Overall Study|Protocol Violation|0|||
16162442|NCT00725075|39076732|FG001|Overall Study|Protocol Violation|0|||
16162443|NCT00725075|39076733|FG002|Overall Study|Protocol Violation|1|||
16162444|NCT00725075|39076731|FG000|Overall Study|Lost to Follow-up|1|||
16162445|NCT00725075|39076732|FG001|Overall Study|Lost to Follow-up|0|||
16162446|NCT00725075|39076733|FG002|Overall Study|Lost to Follow-up|0|||
16162447|NCT00725075|39076731|FG000|Overall Study|Withdrawal by Subject|4|||
16162448|NCT00725075|39076732|FG001|Overall Study|Withdrawal by Subject|5|||
16162449|NCT00725075|39076733|FG002|Overall Study|Withdrawal by Subject|4|||
16162450|NCT00725075|39076731|FG000|Overall Study|Adverse Event|2|||
16162451|NCT00725075|39076732|FG001|Overall Study|Adverse Event|1|||
16162452|NCT00725075|39076733|FG002|Overall Study|Adverse Event|1|||
16449341|NCT01208207|40125763|FG004|Part I|Adverse Event|0|||
16449342|NCT01208207|40125764|FG005|Part I|Adverse Event|0|||
16449343|NCT01208207|40125765|FG006|Part I|Adverse Event|0|||
16449344|NCT01208207|40125759|FG000|Part I|Lack of Efficacy|21|||
16449345|NCT01208207|40125760|FG001|Part I|Lack of Efficacy|3|||
16449346|NCT01208207|40125761|FG002|Part I|Lack of Efficacy|2|||
16449347|NCT01208207|40125762|FG003|Part I|Lack of Efficacy|0|||
16449348|NCT01208207|40125763|FG004|Part I|Lack of Efficacy|0|||
16449349|NCT01208207|40125764|FG005|Part I|Lack of Efficacy|0|||
16449350|NCT01208207|40125765|FG006|Part I|Lack of Efficacy|0|||
16449351|NCT01208207|40125759|FG000|Part I|Lost to Follow-up|6|||
16449352|NCT01208207|40125760|FG001|Part I|Lost to Follow-up|1|||
16449353|NCT01208207|40125761|FG002|Part I|Lost to Follow-up|0|||
16449354|NCT01208207|40125762|FG003|Part I|Lost to Follow-up|0|||
16449355|NCT01208207|40125763|FG004|Part I|Lost to Follow-up|0|||
16449356|NCT01208207|40125764|FG005|Part I|Lost to Follow-up|0|||
16449357|NCT01208207|40125765|FG006|Part I|Lost to Follow-up|0|||
16449358|NCT01208207|40125759|FG000|Part I|Non-Compliance With Study Drug|1|||
16449359|NCT01208207|40125760|FG001|Part I|Non-Compliance With Study Drug|0|||
16449360|NCT01208207|40125761|FG002|Part I|Non-Compliance With Study Drug|1|||
16449361|NCT01208207|40125762|FG003|Part I|Non-Compliance With Study Drug|0|||
16449362|NCT01208207|40125763|FG004|Part I|Non-Compliance With Study Drug|0|||
16449363|NCT01208207|40125764|FG005|Part I|Non-Compliance With Study Drug|0|||
16449364|NCT01208207|40125765|FG006|Part I|Non-Compliance With Study Drug|0|||
16449365|NCT01208207|40125759|FG000|Part I|Physician Decision|0|||
16449366|NCT01208207|40125760|FG001|Part I|Physician Decision|1|||
16449367|NCT01208207|40125761|FG002|Part I|Physician Decision|0|||
16162453|NCT00725075|39076731|FG000|Overall Study|Worsening of Disease|2|||
16162454|NCT00725075|39076732|FG001|Overall Study|Worsening of Disease|1|||
16162455|NCT00725075|39076733|FG002|Overall Study|Worsening of Disease|2|||
16162456|NCT00725075|39076731|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
16162457|NCT00725075|39076732|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
16162458|NCT00725075|39076733|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
16162459|NCT00725075|39076731|FG000|Overall Study|Other|1|||
16162460|NCT00725075|39076732|FG001|Overall Study|Other|0|||
16162461|NCT00725075|39076733|FG002|Overall Study|Other|0|||
16162462|NCT01353703|39076734|FG000|Overall Study|Migrated/moved from study area|1|||
16162463|NCT01353703|39076735|FG001|Overall Study|Migrated/moved from study area|0|||
16162464|NCT02867761|39076741|FG000|Overall Study|Participant withdrawn by investigator|0|||
16449368|NCT01208207|40125762|FG003|Part I|Physician Decision|0|||
16449369|NCT01208207|40125763|FG004|Part I|Physician Decision|0|||
16449370|NCT01208207|40125764|FG005|Part I|Physician Decision|0|||
16449371|NCT01208207|40125765|FG006|Part I|Physician Decision|0|||
16449372|NCT01208207|40125759|FG000|Part I|Progressive Disease|1|||
16449373|NCT01208207|40125760|FG001|Part I|Progressive Disease|0|||
16162465|NCT02867761|39076742|FG001|Overall Study|Participant withdrawn by investigator|1|||
16162466|NCT02867761|39076741|FG000|Overall Study|Lost to Follow-up|25|||
16162467|NCT02867761|39076742|FG001|Overall Study|Lost to Follow-up|18|||
16162468|NCT02867761|39076741|FG000|Overall Study|Unable to complete protocol|3|||
16162469|NCT02867761|39076742|FG001|Overall Study|Unable to complete protocol|7|||
16162470|NCT01298492|39076748|FG000|Overall Study|Death|2|||
16162471|NCT01298492|39076748|FG000|Overall Study|Insufficient Clinical Response|22|||
16162472|NCT01298492|39076748|FG000|Overall Study|Lost to Follow-up|12|||
16162473|NCT01298492|39076748|FG000|Overall Study|Withdrawal by Subject|47|||
16162474|NCT01298492|39076748|FG000|Overall Study|Other (Unspecified)|7|||
16162475|NCT01298492|39076748|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
16162476|NCT01298492|39076748|FG000|Overall Study|Protocol Violation|2|||
16162477|NCT01298492|39076748|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
16162478|NCT01298492|39076748|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
16162479|NCT01639833|39076751|FG000|Overall Study|Death|4|||
16449374|NCT01208207|40125761|FG002|Part I|Progressive Disease|0|||
16449375|NCT01208207|40125762|FG003|Part I|Progressive Disease|0|||
16449376|NCT01208207|40125763|FG004|Part I|Progressive Disease|0|||
16449377|NCT01208207|40125764|FG005|Part I|Progressive Disease|0|||
16449378|NCT01208207|40125765|FG006|Part I|Progressive Disease|0|||
16449379|NCT01208207|40125759|FG000|Part I|Protocol Violation|8|||
16449380|NCT01208207|40125760|FG001|Part I|Protocol Violation|0|||
16449381|NCT01208207|40125761|FG002|Part I|Protocol Violation|2|||
16449382|NCT01208207|40125762|FG003|Part I|Protocol Violation|0|||
16449383|NCT01208207|40125763|FG004|Part I|Protocol Violation|0|||
16449384|NCT01208207|40125764|FG005|Part I|Protocol Violation|0|||
16449385|NCT01208207|40125765|FG006|Part I|Protocol Violation|0|||
16449386|NCT01208207|40125759|FG000|Part I|Withdrawal by Subject|14|||
16449387|NCT01208207|40125760|FG001|Part I|Withdrawal by Subject|4|||
16449388|NCT01208207|40125761|FG002|Part I|Withdrawal by Subject|4|||
16449389|NCT01208207|40125762|FG003|Part I|Withdrawal by Subject|0|||
16449390|NCT01208207|40125763|FG004|Part I|Withdrawal by Subject|0|||
16449391|NCT01208207|40125764|FG005|Part I|Withdrawal by Subject|0|||
16449392|NCT01208207|40125765|FG006|Part I|Withdrawal by Subject|0|||
16449393|NCT01208207|40125759|FG000|Part II|Withdrawal by Subject|0|||
16449394|NCT01208207|40125760|FG001|Part II|Withdrawal by Subject|0|||
16449395|NCT01208207|40125761|FG002|Part II|Withdrawal by Subject|0|||
16449396|NCT01208207|40125762|FG003|Part II|Withdrawal by Subject|10|||
16449397|NCT01208207|40125763|FG004|Part II|Withdrawal by Subject|9|||
16449398|NCT01208207|40125764|FG005|Part II|Withdrawal by Subject|3|||
16449399|NCT01208207|40125765|FG006|Part II|Withdrawal by Subject|5|||
16449400|NCT01208207|40125759|FG000|Part II|Adverse Event|0|||
16449401|NCT01208207|40125760|FG001|Part II|Adverse Event|0|||
16449402|NCT01208207|40125761|FG002|Part II|Adverse Event|0|||
16449403|NCT01208207|40125762|FG003|Part II|Adverse Event|5|||
16449404|NCT01208207|40125763|FG004|Part II|Adverse Event|9|||
16449405|NCT01208207|40125764|FG005|Part II|Adverse Event|4|||
16449406|NCT01208207|40125765|FG006|Part II|Adverse Event|2|||
16449407|NCT01208207|40125759|FG000|Part II|Lack of Efficacy|0|||
16449408|NCT01208207|40125760|FG001|Part II|Lack of Efficacy|0|||
16449409|NCT01208207|40125761|FG002|Part II|Lack of Efficacy|0|||
16449410|NCT01208207|40125762|FG003|Part II|Lack of Efficacy|6|||
16449411|NCT01208207|40125763|FG004|Part II|Lack of Efficacy|4|||
16449412|NCT01208207|40125764|FG005|Part II|Lack of Efficacy|3|||
16449413|NCT01208207|40125765|FG006|Part II|Lack of Efficacy|3|||
16449414|NCT01208207|40125759|FG000|Part II|Lost to Follow-up|0|||
16449415|NCT01208207|40125760|FG001|Part II|Lost to Follow-up|0|||
16449416|NCT01208207|40125761|FG002|Part II|Lost to Follow-up|0|||
16449417|NCT01208207|40125762|FG003|Part II|Lost to Follow-up|4|||
16449418|NCT01208207|40125763|FG004|Part II|Lost to Follow-up|0|||
16449419|NCT01208207|40125764|FG005|Part II|Lost to Follow-up|2|||
16449420|NCT01208207|40125765|FG006|Part II|Lost to Follow-up|1|||
16449421|NCT01208207|40125759|FG000|Part II|Non-Compliance With Study Drug|0|||
16449422|NCT01208207|40125760|FG001|Part II|Non-Compliance With Study Drug|0|||
16449423|NCT01208207|40125761|FG002|Part II|Non-Compliance With Study Drug|0|||
16449424|NCT01208207|40125762|FG003|Part II|Non-Compliance With Study Drug|4|||
16449425|NCT01208207|40125763|FG004|Part II|Non-Compliance With Study Drug|1|||
16449426|NCT01208207|40125764|FG005|Part II|Non-Compliance With Study Drug|1|||
16449427|NCT01208207|40125765|FG006|Part II|Non-Compliance With Study Drug|0|||
16449428|NCT01208207|40125759|FG000|Part II|Physician Decision|0|||
16449429|NCT01208207|40125760|FG001|Part II|Physician Decision|0|||
16162480|NCT01639833|39076752|FG001|Overall Study|Death|2|||
16162481|NCT01639833|39076751|FG000|Overall Study|Withdrawal by Subject|2|||
16162482|NCT01639833|39076752|FG001|Overall Study|Withdrawal by Subject|2|||
16449430|NCT01208207|40125761|FG002|Part II|Physician Decision|0|||
16449431|NCT01208207|40125762|FG003|Part II|Physician Decision|1|||
16449432|NCT01208207|40125763|FG004|Part II|Physician Decision|0|||
16449433|NCT01208207|40125764|FG005|Part II|Physician Decision|2|||
16449434|NCT01208207|40125765|FG006|Part II|Physician Decision|0|||
16449435|NCT01208207|40125759|FG000|Part II|Protocol Violation|0|||
16449436|NCT01208207|40125760|FG001|Part II|Protocol Violation|0|||
16449437|NCT01208207|40125761|FG002|Part II|Protocol Violation|0|||
16162483|NCT01848145|39076753|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
16162484|NCT01848145|39076753|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
16162485|NCT01848145|39076753|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
16162486|NCT01848145|39076753|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
16162487|NCT01848145|39076753|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
16449438|NCT01208207|40125762|FG003|Part II|Protocol Violation|1|||
16449439|NCT01208207|40125763|FG004|Part II|Protocol Violation|0|||
16449440|NCT01208207|40125764|FG005|Part II|Protocol Violation|0|||
16449441|NCT01208207|40125765|FG006|Part II|Protocol Violation|0|||
16449442|NCT01208207|40125759|FG000|Part II|Technical Problems|0|||
16449443|NCT01208207|40125760|FG001|Part II|Technical Problems|0|||
16449444|NCT01208207|40125761|FG002|Part II|Technical Problems|0|||
16449445|NCT01208207|40125762|FG003|Part II|Technical Problems|1|||
16449446|NCT01208207|40125763|FG004|Part II|Technical Problems|0|||
16162488|NCT01848145|39076753|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
16162489|NCT01848145|39076753|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
16162490|NCT03345472|39076754|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
16162491|NCT03345472|39076754|FG000|Implant to 3 Months|Physician Decision|1|||
16162492|NCT03345472|39076754|FG000|Implant to 3 Months|Adverse Event|1|||
16162493|NCT03345472|39076754|FG000|3 Months to 12 Months|Physician Decision|3|||
16162494|NCT03345472|39076754|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
16162495|NCT03345472|39076754|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
16162496|NCT03345472|39076754|FG000|3 Months to 12 Months|Adverse Event|1|||
16162497|NCT03345472|39076754|FG000|3 Months to 12 Months|Death|1|||
16162498|NCT01765673|39076755|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
16162499|NCT00130832|39076763|FG000|Overall Study|Adverse Event|1|||
16162500|NCT00130832|39076764|FG001|Overall Study|Adverse Event|1|||
16162501|NCT00130832|39076763|FG000|Overall Study|Lost to Follow-up|1|||
16162502|NCT00130832|39076764|FG001|Overall Study|Lost to Follow-up|2|||
16162503|NCT00130832|39076763|FG000|Overall Study|Protocol Violation|6|||
16162504|NCT00130832|39076764|FG001|Overall Study|Protocol Violation|8|||
16162505|NCT00130832|39076763|FG000|Overall Study|Withdrawal by Subject|6|||
16162506|NCT00130832|39076764|FG001|Overall Study|Withdrawal by Subject|1|||
16162507|NCT00130832|39076763|FG000|Overall Study|Moved|2|||
16162508|NCT00130832|39076764|FG001|Overall Study|Moved|2|||
16162509|NCT00130832|39076763|FG000|Overall Study|Other|0|||
16162510|NCT00130832|39076764|FG001|Overall Study|Other|3|||
16162511|NCT03742037|39076765|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
16162512|NCT03742037|39076766|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
16162513|NCT03742037|39076767|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
16162514|NCT03742037|39076768|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
16162515|NCT03742037|39076769|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
16162516|NCT03742037|39076770|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
16162517|NCT03742037|39076771|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
16162518|NCT03742037|39076765|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
16162519|NCT03742037|39076766|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
16162520|NCT03742037|39076767|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
16162521|NCT03742037|39076768|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
16162522|NCT03742037|39076769|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
16162523|NCT03742037|39076770|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
16162524|NCT03742037|39076771|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
16162525|NCT03742037|39076765|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
16162526|NCT03742037|39076766|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
16162527|NCT03742037|39076767|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
16162528|NCT03742037|39076768|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
16162529|NCT03742037|39076769|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
16162530|NCT03742037|39076770|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
16162531|NCT03742037|39076771|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
16162532|NCT03742037|39076765|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
16449447|NCT01208207|40125764|FG005|Part II|Technical Problems|1|||
16449448|NCT01208207|40125765|FG006|Part II|Technical Problems|0|||
16449449|NCT02362282|40125766|FG000|Overall Study|Withdrawal by Subject|1|||
16449450|NCT02362282|40125767|FG001|Overall Study|Withdrawal by Subject|0|||
16449451|NCT02948634|40125768|FG000|Overall Study|Lack of efficacy and study suspended|10|||
16449452|NCT02948634|40125769|FG001|Overall Study|Lack of efficacy and study suspended|2|||
16162533|NCT03742037|39076766|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
16449453|NCT01165216|40125771|FG000|Overall Study|Adverse Event|6|||
16162534|NCT03742037|39076767|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
16162535|NCT03742037|39076768|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
16162536|NCT03742037|39076769|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
16449454|NCT01165216|40125772|FG001|Overall Study|Adverse Event|3|||
16449455|NCT01165216|40125771|FG000|Overall Study|Withdrawal by Subject|1|||
16449456|NCT01165216|40125772|FG001|Overall Study|Withdrawal by Subject|1|||
16449457|NCT01165216|40125771|FG000|Overall Study|Disease progression|1|||
16449458|NCT01165216|40125772|FG001|Overall Study|Disease progression|3|||
16449459|NCT01668589|40125773|FG000|Overall Study|Lost to Follow-up|29|||
16449460|NCT01668589|40125774|FG001|Overall Study|Lost to Follow-up|37|||
16449461|NCT01668589|40125775|FG002|Overall Study|Lost to Follow-up|15|||
16449462|NCT01668589|40125776|FG003|Overall Study|Lost to Follow-up|5|||
16449463|NCT01668589|40125773|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
16449464|NCT01668589|40125774|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
16449465|NCT01668589|40125775|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
16449466|NCT01668589|40125776|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
16449467|NCT01668589|40125773|FG000|Overall Study|Death|12|||
16449468|NCT01668589|40125774|FG001|Overall Study|Death|3|||
16449469|NCT01668589|40125775|FG002|Overall Study|Death|2|||
16162537|NCT03742037|39076770|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
16162538|NCT03742037|39076771|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
16162539|NCT03742037|39076765|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
16162540|NCT03742037|39076766|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
16162541|NCT03742037|39076767|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
16162542|NCT03742037|39076768|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
16162543|NCT03742037|39076769|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
16162544|NCT03742037|39076770|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
16162545|NCT03742037|39076771|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
16162546|NCT03742037|39076765|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
16265018|NCT01597245|39453255|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265019|NCT01597245|39453256|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265020|NCT01597245|39453257|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265021|NCT01597245|39453258|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265022|NCT01597245|39453259|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265023|NCT01597245|39453260|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265024|NCT01597245|39453261|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265025|NCT01597245|39453262|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265026|NCT01597245|39453263|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265027|NCT01597245|39453264|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265028|NCT01597245|39453265|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265029|NCT01597245|39453266|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265030|NCT01597245|39453267|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265031|NCT01597245|39453268|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265032|NCT01597245|39453269|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16162547|NCT03742037|39076766|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
16162548|NCT03742037|39076767|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
16162549|NCT03742037|39076768|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
16162550|NCT03742037|39076769|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
16162551|NCT03742037|39076770|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
16162552|NCT03742037|39076771|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
16162553|NCT03742037|39076765|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
16162554|NCT03742037|39076766|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
16265033|NCT01597245|39453270|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265034|NCT01597245|39453271|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265035|NCT01597245|39453272|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265036|NCT01597245|39453273|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
16265037|NCT01597245|39453274|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
16265038|NCT02714062|39453275|FG000|Overall Study|Adverse Event|0|||
16162555|NCT03742037|39076767|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
16162556|NCT03742037|39076768|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
16162557|NCT03742037|39076769|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
16162558|NCT03742037|39076770|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
16162559|NCT03742037|39076771|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
16162560|NCT03742037|39076765|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
16162561|NCT03742037|39076766|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
16162562|NCT03742037|39076767|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
16449470|NCT01668589|40125776|FG003|Overall Study|Death|11|||
16449471|NCT01668589|40125773|FG000|Overall Study|Other|44|||
16265039|NCT02714062|39453276|FG001|Overall Study|Adverse Event|0|||
16449472|NCT01668589|40125774|FG001|Overall Study|Other|10|||
16449473|NCT01668589|40125775|FG002|Overall Study|Other|7|||
16449474|NCT01668589|40125776|FG003|Overall Study|Other|15|||
16449475|NCT03023397|40125777|FG000|Run-In|Failed screening allergen challenge|1|||
16265040|NCT02714062|39453277|FG002|Overall Study|Adverse Event|2|||
16265041|NCT02714062|39453275|FG000|Overall Study|Withdrawal by Subject|1|||
16265042|NCT02714062|39453276|FG001|Overall Study|Withdrawal by Subject|0|||
16265043|NCT02714062|39453277|FG002|Overall Study|Withdrawal by Subject|1|||
16265044|NCT02714062|39453275|FG000|Overall Study|Protocol Violation|0|||
16265045|NCT02714062|39453276|FG001|Overall Study|Protocol Violation|1|||
16265046|NCT02714062|39453277|FG002|Overall Study|Protocol Violation|0|||
16265047|NCT00420238|39453278|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
16265048|NCT00420238|39453279|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
16265049|NCT00420238|39453278|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
16265050|NCT00420238|39453279|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
16265051|NCT00420238|39453278|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
16265052|NCT00420238|39453279|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
16265053|NCT00420238|39453278|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
16265054|NCT00420238|39453279|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
16265055|NCT00420238|39453278|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
16265056|NCT00420238|39453279|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
16162563|NCT03742037|39076768|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
16162564|NCT03742037|39076769|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
16162565|NCT03742037|39076770|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
16162566|NCT03742037|39076771|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
16162567|NCT03742037|39076765|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
16162568|NCT03742037|39076766|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
16162569|NCT03742037|39076767|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
16162570|NCT03742037|39076768|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
16162571|NCT03742037|39076769|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
16162572|NCT03742037|39076770|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
16162573|NCT03742037|39076771|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
16162574|NCT03742037|39076765|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
16162575|NCT03742037|39076766|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
16162576|NCT03742037|39076767|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
16162577|NCT03742037|39076768|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
16162578|NCT03742037|39076769|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
16162579|NCT03742037|39076770|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
16162580|NCT03742037|39076771|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
16162581|NCT03742037|39076765|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
16162582|NCT03742037|39076766|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
16162583|NCT03742037|39076767|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
16162584|NCT03742037|39076768|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
16162585|NCT03742037|39076769|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
16162586|NCT03742037|39076770|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
16162587|NCT03742037|39076771|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
16162588|NCT03742037|39076765|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
16162589|NCT03742037|39076766|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
16162590|NCT03742037|39076767|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
16162591|NCT03742037|39076768|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
16162592|NCT03742037|39076769|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
16162593|NCT03742037|39076770|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
16162594|NCT03742037|39076771|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
16162595|NCT03742037|39076765|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
16162596|NCT03742037|39076766|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
16162597|NCT03742037|39076767|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
16162598|NCT03742037|39076768|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
16162599|NCT03742037|39076769|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
16162600|NCT03742037|39076770|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
16162601|NCT03742037|39076771|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
16162602|NCT03742037|39076765|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
16162603|NCT03742037|39076766|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
16162604|NCT03742037|39076767|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
16265057|NCT00420238|39453278|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
16265058|NCT00420238|39453279|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
16265059|NCT00147498|39453280|FG000|Overall Study|Adverse Event|1|||
16265060|NCT00147498|39453281|FG001|Overall Study|Adverse Event|6|||
16265061|NCT00147498|39453282|FG002|Overall Study|Adverse Event|7|||
16265062|NCT00147498|39453283|FG003|Overall Study|Adverse Event|3|||
16265063|NCT00147498|39453280|FG000|Overall Study|Lack of Efficacy|1|||
16265064|NCT00147498|39453281|FG001|Overall Study|Lack of Efficacy|1|||
16449476|NCT03023397|40125778|FG001|Run-In|Failed screening allergen challenge|0|||
16449477|NCT03023397|40125779|FG002|Run-In|Failed screening allergen challenge|0|||
16449478|NCT03023397|40125777|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
16449479|NCT03023397|40125778|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
16449480|NCT03023397|40125779|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
16449481|NCT02161016|40125782|FG000|Overall Study|withdrawn by IRB|1|||
16162605|NCT03742037|39076768|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
16162606|NCT03742037|39076769|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
16162607|NCT03742037|39076770|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
16162608|NCT03742037|39076771|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
16162609|NCT03742037|39076765|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
16162610|NCT03742037|39076766|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
16162611|NCT03742037|39076767|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
16162612|NCT03742037|39076768|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
16162613|NCT03742037|39076769|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
16162614|NCT03742037|39076770|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
16162615|NCT03742037|39076771|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
16162616|NCT03683394|39076782|FG000|Overall Study|Withdrawal by Subject|4|||
16162617|NCT03683394|39076783|FG001|Overall Study|Withdrawal by Subject|8|||
16162618|NCT03683394|39076782|FG000|Overall Study|Lost to Follow-up|7|||
16162619|NCT03683394|39076783|FG001|Overall Study|Lost to Follow-up|0|||
16162620|NCT03683394|39076782|FG000|Overall Study|Death|3|||
16162621|NCT03683394|39076783|FG001|Overall Study|Death|1|||
16162622|NCT01580397|39076784|FG000|Overall Study|Lack of Efficacy|14|||
16162623|NCT00343512|39076785|FG000|Overall Study|Withdrawal by Subject|2|||
16162624|NCT01554579|39076786|FG000|Overall Study|Adverse Event|6|||
16162625|NCT01554579|39076787|FG001|Overall Study|Adverse Event|25|||
16162626|NCT01554579|39076786|FG000|Overall Study|Lack of Efficacy|2|||
16162627|NCT01554579|39076787|FG001|Overall Study|Lack of Efficacy|1|||
16162628|NCT01554579|39076786|FG000|Overall Study|Withdrawal by Subject|2|||
16162629|NCT01554579|39076787|FG001|Overall Study|Withdrawal by Subject|1|||
16162630|NCT01467492|39076788|FG000|Overall Study|Withdrawal by Subject|6|||
16162631|NCT01467492|39076789|FG001|Overall Study|Withdrawal by Subject|4|||
16162632|NCT01467492|39076788|FG000|Overall Study|Study Terminated by Sponsor|6|||
16162633|NCT01467492|39076789|FG001|Overall Study|Study Terminated by Sponsor|4|||
16162634|NCT01467492|39076788|FG000|Overall Study|Adverse Event|4|||
16162635|NCT01467492|39076789|FG001|Overall Study|Adverse Event|3|||
16162636|NCT01467492|39076788|FG000|Overall Study|Lost to Follow-up|3|||
16162637|NCT01467492|39076789|FG001|Overall Study|Lost to Follow-up|2|||
16162638|NCT01467492|39076788|FG000|Overall Study|Undefined|2|||
16162639|NCT01467492|39076789|FG001|Overall Study|Undefined|0|||
16162640|NCT01467492|39076788|FG000|Overall Study|Enrolled But Not Treated|1|||
16162641|NCT01467492|39076789|FG001|Overall Study|Enrolled But Not Treated|0|||
16162642|NCT01171820|39076790|FG000|Overall Study|Death|3|||
16162643|NCT01171820|39076791|FG001|Overall Study|Death|3|||
16162644|NCT01171820|39076790|FG000|Overall Study|Lost to Follow-up|0|||
16162645|NCT01171820|39076791|FG001|Overall Study|Lost to Follow-up|1|||
16162646|NCT01171820|39076790|FG000|Overall Study|Withdrawal by Subject|2|||
16162647|NCT01171820|39076791|FG001|Overall Study|Withdrawal by Subject|0|||
16162648|NCT01171820|39076790|FG000|Overall Study|Physician Decision|0|||
16162649|NCT01171820|39076791|FG001|Overall Study|Physician Decision|1|||
16162650|NCT01171820|39076790|FG000|Overall Study|1-Year Missed Visit|1|||
16162651|NCT01171820|39076791|FG001|Overall Study|1-Year Missed Visit|1|||
16162652|NCT02167945|39076794|FG000|Overall Study|Adverse Event|16|||
16162653|NCT02167945|39076794|FG000|Overall Study|Withdrew Consent|42|||
16162654|NCT02167945|39076794|FG000|Overall Study|Lost to Follow-up|122|||
16162655|NCT02167945|39076794|FG000|Overall Study|COVID-19 logistical restrictions|6|||
16162656|NCT02167945|39076794|FG000|Overall Study|Other, not specified|63|||
16162657|NCT00573794|39076797|FG000|Overall Study|Adverse Event|81|||
16162658|NCT00573794|39076797|FG000|Overall Study|Withdrew Consent|90|||
16162659|NCT00573794|39076797|FG000|Overall Study|Lost to Follow-up|13|||
16162660|NCT00573794|39076797|FG000|Overall Study|Protocol Violation|6|||
16162661|NCT00573794|39076797|FG000|Overall Study|Lack of Efficacy|94|||
16162662|NCT00573794|39076797|FG000|Overall Study|Other|46|||
16162663|NCT02450578|39076798|FG000|Overall Study|ECG abnormality so not treated|1|||
16162664|NCT02450578|39076799|FG001|Overall Study|ECG abnormality so not treated|0|||
16162665|NCT02450578|39076800|FG002|Overall Study|ECG abnormality so not treated|0|||
16162666|NCT02450578|39076801|FG003|Overall Study|ECG abnormality so not treated|0|||
16162667|NCT00217087|39076802|FG000|Overall Study|decided to have esophagectomy|1|||
16162668|NCT00217087|39076803|FG001|Overall Study|decided to have esophagectomy|2|||
16265065|NCT00147498|39453282|FG002|Overall Study|Lack of Efficacy|1|||
16265066|NCT00147498|39453283|FG003|Overall Study|Lack of Efficacy|8|||
16265067|NCT00147498|39453280|FG000|Overall Study|Laboratory abnormality|0|||
16265068|NCT00147498|39453281|FG001|Overall Study|Laboratory abnormality|0|||
16265069|NCT00147498|39453282|FG002|Overall Study|Laboratory abnormality|2|||
16265070|NCT00147498|39453283|FG003|Overall Study|Laboratory abnormality|0|||
16265071|NCT00147498|39453280|FG000|Overall Study|Participant defaulted|0|||
16265072|NCT00147498|39453281|FG001|Overall Study|Participant defaulted|1|||
16265073|NCT00147498|39453282|FG002|Overall Study|Participant defaulted|4|||
16265074|NCT00147498|39453283|FG003|Overall Study|Participant defaulted|3|||
16265075|NCT00147498|39453280|FG000|Overall Study|Other|1|||
16265076|NCT00147498|39453281|FG001|Overall Study|Other|1|||
16265077|NCT00147498|39453282|FG002|Overall Study|Other|3|||
16265078|NCT00147498|39453283|FG003|Overall Study|Other|3|||
16265079|NCT03084471|39453286|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
16265080|NCT03084471|39453286|FG000|Overall Study|Condition under investigation worsened|84|||
16162669|NCT00217087|39076802|FG000|Overall Study|completed less than 12 months return|10|||
16162670|NCT00217087|39076803|FG001|Overall Study|completed less than 12 months return|18|||
16162671|NCT01192347|39076806|FG000|Overall Study|Death|3|||
16162672|NCT01192347|39076806|FG000|Overall Study|Lost to Follow-up|3|||
16162673|NCT01192347|39076806|FG000|Overall Study|Withdrawal by Subject|1|||
16162674|NCT01192347|39076806|FG000|Overall Study|Adverse Event|1|||
16162675|NCT01192347|39076806|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
16162676|NCT01192347|39076806|FG000|Overall Study|Patient seen in different hospital|1|||
16162677|NCT01192347|39076806|FG000|Overall Study|Patient not visiting hospital regularly|1|||
16162678|NCT01192347|39076806|FG000|Overall Study|Patient did not show up for visits|1|||
16162679|NCT00865020|39076807|FG000|Overall Study|Withdrawal by Subject|22|||
16162680|NCT00865020|39076808|FG001|Overall Study|Withdrawal by Subject|16|||
16162681|NCT00865020|39076807|FG000|Overall Study|Adverse Event|9|||
16162682|NCT00865020|39076808|FG001|Overall Study|Adverse Event|14|||
16162683|NCT00865020|39076807|FG000|Overall Study|Abnormal test procedure result(s)|6|||
16162684|NCT00865020|39076808|FG001|Overall Study|Abnormal test procedure result(s)|8|||
16162685|NCT00865020|39076807|FG000|Overall Study|Lost to Follow-up|6|||
16162686|NCT00865020|39076808|FG001|Overall Study|Lost to Follow-up|4|||
16162687|NCT00865020|39076807|FG000|Overall Study|Protocol deviation|4|||
16162688|NCT00865020|39076808|FG001|Overall Study|Protocol deviation|1|||
16162689|NCT00865020|39076807|FG000|Overall Study|Administrative problems|0|||
16162690|NCT00865020|39076808|FG001|Overall Study|Administrative problems|2|||
16162691|NCT00865020|39076807|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16162692|NCT00865020|39076808|FG001|Overall Study|Abnormal laboratory value(s)|1|||
16162693|NCT00865020|39076807|FG000|Overall Study|Death|0|||
16162694|NCT00865020|39076808|FG001|Overall Study|Death|1|||
16162695|NCT00865020|39076807|FG000|Overall Study|Randomized but discontinued|2|||
16162696|NCT00865020|39076808|FG001|Overall Study|Randomized but discontinued|4|||
16162697|NCT01145066|39076809|FG000|Overall Study|To resume NSAIDs|2|||
16162698|NCT01145066|39076810|FG001|Overall Study|To resume NSAIDs|2|||
16162699|NCT01145066|39076811|FG002|Overall Study|To resume NSAIDs|1|||
16162700|NCT01145066|39076809|FG000|Overall Study|Non-related surgery|0|||
16162701|NCT01145066|39076810|FG001|Overall Study|Non-related surgery|0|||
16449482|NCT00702221|40125783|FG000|Overall Study|Adverse Event|4|||
16449483|NCT00702221|40125784|FG001|Overall Study|Adverse Event|3|||
16449484|NCT03349034|40125785|FG000|Overall Study|catheters dislodged during transport|2|||
16449485|NCT03349034|40125786|FG001|Overall Study|catheters dislodged during transport|0|||
16449486|NCT03349034|40125785|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
16449487|NCT03349034|40125786|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
16449488|NCT03349034|40125785|FG000|Overall Study|soft tissue flap used|1|||
16449489|NCT03349034|40125786|FG001|Overall Study|soft tissue flap used|0|||
16449490|NCT03349034|40125785|FG000|Overall Study|Other|0|||
16449491|NCT03349034|40125786|FG001|Overall Study|Other|1|||
16449492|NCT03739203|40125787|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
16449493|NCT03739203|40125788|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
16449494|NCT03739203|40125789|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
16449495|NCT03739203|40125787|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
16449496|NCT03739203|40125788|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
16449497|NCT03739203|40125789|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
16449498|NCT03739203|40125787|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
16449499|NCT03739203|40125788|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
16162702|NCT01145066|39076811|FG002|Overall Study|Non-related surgery|1|||
16162703|NCT01145066|39076809|FG000|Overall Study|Withdrawal by Subject|0|||
16162704|NCT01145066|39076810|FG001|Overall Study|Withdrawal by Subject|0|||
16265081|NCT03084471|39453286|FG000|Overall Study|Lack of therapeutic response|2|||
16265082|NCT03084471|39453286|FG000|Overall Study|Protocol Violation|1|||
16265083|NCT03084471|39453286|FG000|Overall Study|Adverse Event|73|||
16265084|NCT03084471|39453286|FG000|Overall Study|Withdrawal by Subject|12|||
16449500|NCT03739203|40125789|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
16449501|NCT03739203|40125787|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
16449502|NCT03739203|40125788|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
16162705|NCT01145066|39076811|FG002|Overall Study|Withdrawal by Subject|2|||
16162706|NCT01145066|39076809|FG000|Overall Study|To start new med|1|||
16162707|NCT01145066|39076810|FG001|Overall Study|To start new med|0|||
16162708|NCT01145066|39076811|FG002|Overall Study|To start new med|0|||
16162709|NCT01145066|39076809|FG000|Overall Study|problems swallowing capsule|1|||
16162710|NCT01145066|39076810|FG001|Overall Study|problems swallowing capsule|0|||
16162711|NCT01145066|39076811|FG002|Overall Study|problems swallowing capsule|0|||
16162712|NCT01145066|39076809|FG000|Overall Study|Abdominal discomfort|0|||
16162713|NCT01145066|39076810|FG001|Overall Study|Abdominal discomfort|1|||
16162714|NCT01145066|39076811|FG002|Overall Study|Abdominal discomfort|0|||
16162715|NCT01145066|39076809|FG000|Overall Study|Low platelet count|0|||
16162716|NCT01145066|39076810|FG001|Overall Study|Low platelet count|1|||
16162717|NCT01145066|39076811|FG002|Overall Study|Low platelet count|0|||
16162718|NCT03213366|39076812|FG000|Overall Study|Lost to Follow-up|9|||
16162719|NCT03213366|39076813|FG001|Overall Study|Lost to Follow-up|4|||
16162720|NCT01656434|39076814|FG000|Overall Study|Adverse Event|199|||
16162721|NCT01656434|39076815|FG001|Overall Study|Adverse Event|63|||
16162722|NCT01656434|39076814|FG000|Overall Study|Enrollment terminated at trial site|2|||
16162723|NCT01656434|39076815|FG001|Overall Study|Enrollment terminated at trial site|0|||
16162724|NCT01656434|39076814|FG000|Overall Study|Lost to Follow-up|309|||
16162725|NCT01656434|39076815|FG001|Overall Study|Lost to Follow-up|76|||
16162726|NCT01656434|39076814|FG000|Overall Study|Site discontinued study participation|24|||
16162727|NCT01656434|39076815|FG001|Overall Study|Site discontinued study participation|9|||
16162728|NCT01656434|39076814|FG000|Overall Study|Screen failure|2|||
16449503|NCT03739203|40125789|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
16162729|NCT01656434|39076815|FG001|Overall Study|Screen failure|0|||
16162730|NCT01656434|39076814|FG000|Overall Study|Protocol Violation|7|||
16162731|NCT01656434|39076815|FG001|Overall Study|Protocol Violation|0|||
16162732|NCT01656434|39076814|FG000|Overall Study|Pregnancy wish|18|||
16162733|NCT01656434|39076815|FG001|Overall Study|Pregnancy wish|6|||
16162734|NCT01656434|39076814|FG000|Overall Study|Pregnancy|45|||
16162735|NCT01656434|39076815|FG001|Overall Study|Pregnancy|10|||
16162736|NCT01656434|39076814|FG000|Overall Study|Physician Decision|7|||
16162737|NCT01656434|39076815|FG001|Overall Study|Physician Decision|2|||
16162738|NCT01656434|39076814|FG000|Overall Study|Non-compliance with study drug|48|||
16162739|NCT01656434|39076815|FG001|Overall Study|Non-compliance with study drug|9|||
16162740|NCT01656434|39076814|FG000|Overall Study|Study terminated by sponsor|1501|||
16162741|NCT01656434|39076815|FG001|Overall Study|Study terminated by sponsor|348|||
16162742|NCT01656434|39076814|FG000|Overall Study|Participant discontinued; drug related|13|||
16162743|NCT01656434|39076815|FG001|Overall Study|Participant discontinued; drug related|4|||
16162744|NCT01656434|39076814|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
16162745|NCT01656434|39076815|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
16162746|NCT01656434|39076814|FG000|Overall Study|Non-compliance with protocol|39|||
16162747|NCT01656434|39076815|FG001|Overall Study|Non-compliance with protocol|15|||
16449504|NCT03739203|40125787|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
16449505|NCT03739203|40125788|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
16449506|NCT03739203|40125789|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
16449507|NCT03739203|40125787|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
16449508|NCT03739203|40125788|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
16449509|NCT03739203|40125789|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
16449510|NCT03739203|40125787|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
16449511|NCT03739203|40125788|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
16449512|NCT03739203|40125789|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
16449513|NCT03739203|40125787|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
16449514|NCT03739203|40125788|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
16449515|NCT03739203|40125789|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
16449516|NCT03739203|40125787|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
16449517|NCT03739203|40125788|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
16449518|NCT03739203|40125789|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
16449519|NCT03739203|40125787|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
16449520|NCT03739203|40125788|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
16449521|NCT03739203|40125789|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
16162748|NCT01656434|39076814|FG000|Overall Study|Participant moved|40|||
16162749|NCT01656434|39076815|FG001|Overall Study|Participant moved|12|||
16449522|NCT03739203|40125787|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
16449523|NCT03739203|40125788|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
16162750|NCT01656434|39076814|FG000|Overall Study|Participant withdrew consent|28|||
16162751|NCT01656434|39076815|FG001|Overall Study|Participant withdrew consent|9|||
16162752|NCT01656434|39076814|FG000|Overall Study|Withdrawal by Subject|64|||
16162753|NCT01656434|39076815|FG001|Overall Study|Withdrawal by Subject|7|||
16162754|NCT04316585|39076816|FG000|Overall Study|Adverse Event|2|||
16162755|NCT04316585|39076817|FG001|Overall Study|Adverse Event|1|||
16162756|NCT04316585|39076816|FG000|Overall Study|Lost to Follow-up|1|||
16162757|NCT04316585|39076817|FG001|Overall Study|Lost to Follow-up|0|||
16162758|NCT04316585|39076816|FG000|Overall Study|Withdrawal by Subject|2|||
16162759|NCT04316585|39076817|FG001|Overall Study|Withdrawal by Subject|3|||
16162760|NCT04316585|39076816|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
16162761|NCT04316585|39076817|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
16162762|NCT04316585|39076816|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
16162763|NCT04316585|39076817|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
16162764|NCT01235962|39076819|FG000|Overall Study|Withdrawal by Subject|20|||
16449524|NCT03739203|40125789|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
16449525|NCT00753506|40125790|FG000|Overall Study|Withdrawal by Subject|4|||
16449526|NCT00753506|40125791|FG001|Overall Study|Withdrawal by Subject|1|||
16449527|NCT00753506|40125790|FG000|Overall Study|Lost to Follow-up|2|||
16449528|NCT00753506|40125791|FG001|Overall Study|Lost to Follow-up|0|||
16449529|NCT00753506|40125790|FG000|Overall Study|Other reason|1|||
16449530|NCT00753506|40125791|FG001|Overall Study|Other reason|1|||
16162765|NCT01235962|39076820|FG001|Overall Study|Withdrawal by Subject|19|||
16162766|NCT01235962|39076821|FG002|Overall Study|Withdrawal by Subject|62|||
16162767|NCT01235962|39076822|FG003|Overall Study|Withdrawal by Subject|49|||
16162768|NCT01235962|39076819|FG000|Overall Study|Lost to Follow-up|21|||
16162769|NCT01235962|39076820|FG001|Overall Study|Lost to Follow-up|16|||
16162770|NCT01235962|39076821|FG002|Overall Study|Lost to Follow-up|47|||
16162771|NCT01235962|39076822|FG003|Overall Study|Lost to Follow-up|32|||
16162772|NCT01235962|39076819|FG000|Overall Study|Physician Decision|5|||
16162773|NCT01235962|39076820|FG001|Overall Study|Physician Decision|0|||
16162774|NCT01235962|39076821|FG002|Overall Study|Physician Decision|9|||
16162775|NCT01235962|39076822|FG003|Overall Study|Physician Decision|5|||
16162776|NCT01465659|39076823|FG000|Completed 1 Cycle of Treatment|Death|0|||
16162777|NCT01465659|39076824|FG001|Completed 1 Cycle of Treatment|Death|1|||
16162778|NCT01465659|39076825|FG002|Completed 1 Cycle of Treatment|Death|0|||
16162779|NCT01465659|39076826|FG003|Completed 1 Cycle of Treatment|Death|0|||
16162780|NCT01465659|39076823|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
16162781|NCT01465659|39076824|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
16162782|NCT01465659|39076825|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
16162783|NCT01465659|39076826|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
16162784|NCT01465659|39076823|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
16162785|NCT01465659|39076824|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
16162786|NCT01465659|39076825|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
16162787|NCT01465659|39076826|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
16162788|NCT01465659|39076823|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
16162789|NCT01465659|39076824|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
16162790|NCT01465659|39076825|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
16162791|NCT01465659|39076826|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
16162792|NCT01465659|39076823|FG000|Completed Follow for 1 Year|Death|6|||
16162793|NCT01465659|39076824|FG001|Completed Follow for 1 Year|Death|3|||
16162794|NCT01465659|39076825|FG002|Completed Follow for 1 Year|Death|2|||
16162795|NCT01465659|39076826|FG003|Completed Follow for 1 Year|Death|4|||
16162796|NCT05162066|39076827|FG000|Overall Study|Adverse Event|1|||
16162797|NCT05162066|39076828|FG001|Overall Study|Adverse Event|0|||
16162798|NCT05162066|39076829|FG002|Overall Study|Adverse Event|0|||
16162799|NCT05162066|39076827|FG000|Overall Study|Perceived lack of efficacy|1|||
16162800|NCT05162066|39076828|FG001|Overall Study|Perceived lack of efficacy|0|||
16449531|NCT01287741|40125792|FG000|Overall Study|Withdrawal by Subject|35|||
16449532|NCT01287741|40125793|FG001|Overall Study|Withdrawal by Subject|38|||
16449533|NCT01287741|40125792|FG000|Overall Study|Protocol Violation|2|||
16449534|NCT01287741|40125793|FG001|Overall Study|Protocol Violation|0|||
16449535|NCT01287741|40125792|FG000|Overall Study|Physician Decision|15|||
16449536|NCT01287741|40125793|FG001|Overall Study|Physician Decision|23|||
16449537|NCT01287741|40125792|FG000|Overall Study|Non-compliance|8|||
16449538|NCT01287741|40125793|FG001|Overall Study|Non-compliance|6|||
16449539|NCT01287741|40125792|FG000|Overall Study|Lost to Follow-up|10|||
16449540|NCT01287741|40125793|FG001|Overall Study|Lost to Follow-up|8|||
16449541|NCT01287741|40125792|FG000|Overall Study|Death|32|||
16162801|NCT05162066|39076829|FG002|Overall Study|Perceived lack of efficacy|0|||
16265085|NCT03084471|39453286|FG000|Overall Study|Disease relapse|181|||
16449542|NCT01287741|40125793|FG001|Overall Study|Death|44|||
16449543|NCT01287741|40125792|FG000|Overall Study|Adverse Event|4|||
16449544|NCT01287741|40125793|FG001|Overall Study|Adverse Event|6|||
16449545|NCT01287741|40125792|FG000|Overall Study|Study terminated by Sponsor|307|||
16449546|NCT01287741|40125793|FG001|Overall Study|Study terminated by Sponsor|315|||
16449547|NCT01287741|40125792|FG000|Overall Study|Progressive disease|190|||
16449548|NCT01287741|40125793|FG001|Overall Study|Progressive disease|166|||
16162802|NCT01363986|39076831|FG000|Overall Study|Disease progression|1|||
16162803|NCT01078805|39076832|FG000|Overall Study|Clinically significant abnormal lab|5|||
16162804|NCT01078805|39076832|FG000|Overall Study|Death|134|||
16162805|NCT01078805|39076832|FG000|Overall Study|Lost to Follow-up|676|||
16162806|NCT01078805|39076832|FG000|Overall Study|Physician Decision|169|||
16162807|NCT01078805|39076832|FG000|Overall Study|Serious adverse event|26|||
16162808|NCT01078805|39076832|FG000|Overall Study|Sponsor decision|46|||
16162809|NCT01078805|39076832|FG000|Overall Study|Withdrawal by Subject|739|||
16162810|NCT01078805|39076832|FG000|Overall Study|Other|173|||
16162811|NCT01078805|39076832|FG000|Overall Study|Didn't take study drug|82|||
16162812|NCT00428597|39076833|FG000|Overall Study|Randomized but not treated|3|||
16162813|NCT00428597|39076834|FG001|Overall Study|Randomized but not treated|3|||
16162814|NCT00428597|39076833|FG000|Overall Study|Objective Progression or Relapse|19|||
16162815|NCT00428597|39076834|FG001|Overall Study|Objective Progression or Relapse|47|||
16162816|NCT00428597|39076833|FG000|Overall Study|Study Terminated by Sponsor|41|||
16162817|NCT00428597|39076834|FG001|Overall Study|Study Terminated by Sponsor|16|||
16162818|NCT00428597|39076833|FG000|Overall Study|Adverse Event|15|||
16372957|NCT00292370|39849827|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
16372958|NCT00292370|39849828|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
16372959|NCT00292370|39849829|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
16372960|NCT00292370|39849827|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
16372961|NCT00292370|39849828|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
16372962|NCT00292370|39849829|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
16372963|NCT00292370|39849827|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
16372964|NCT00292370|39849828|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
16372965|NCT00292370|39849829|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
16372966|NCT00292370|39849827|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
16372967|NCT00292370|39849828|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
16372968|NCT00292370|39849829|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
16372969|NCT00292370|39849827|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
16372970|NCT00292370|39849828|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
16372971|NCT00292370|39849829|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
16372972|NCT00292370|39849827|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
16372973|NCT00292370|39849828|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
16372974|NCT00292370|39849829|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
16372975|NCT04832971|39849831|FG000|Overall Study|Death|1|||
16372976|NCT04832971|39849832|FG001|Overall Study|Death|0|||
16372977|NCT04832971|39849833|FG002|Overall Study|Death|0|||
16372978|NCT04832971|39849834|FG003|Overall Study|Death|0|||
16372979|NCT04832971|39849831|FG000|Overall Study|Lost to Follow-up|1|||
16372980|NCT04832971|39849832|FG001|Overall Study|Lost to Follow-up|1|||
16372981|NCT04832971|39849833|FG002|Overall Study|Lost to Follow-up|1|||
16372982|NCT04832971|39849834|FG003|Overall Study|Lost to Follow-up|0|||
16372983|NCT04832971|39849831|FG000|Overall Study|Withdrawal by Subject|1|||
16372984|NCT04832971|39849832|FG001|Overall Study|Withdrawal by Subject|3|||
16372985|NCT04832971|39849833|FG002|Overall Study|Withdrawal by Subject|2|||
16372986|NCT04832971|39849834|FG003|Overall Study|Withdrawal by Subject|2|||
16372987|NCT04832971|39849831|FG000|Overall Study|Other, Not Specified|0|||
16372988|NCT04832971|39849832|FG001|Overall Study|Other, Not Specified|0|||
16372989|NCT04832971|39849833|FG002|Overall Study|Other, Not Specified|1|||
16372990|NCT04832971|39849834|FG003|Overall Study|Other, Not Specified|0|||
16372991|NCT01230814|39849836|FG000|Overall Study|Lost to Follow-up|11|||
16372992|NCT01230814|39849837|FG001|Overall Study|Lost to Follow-up|3|||
16372993|NCT01230814|39849836|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
16372994|NCT01230814|39849837|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
16372995|NCT05427916|39849838|FG000|Overall Study|Adverse Event|3|||
16372996|NCT05427916|39849839|FG001|Overall Study|Adverse Event|0|||
16372997|NCT05427916|39849838|FG000|Overall Study|Lack of Efficacy|6|||
16372998|NCT05427916|39849839|FG001|Overall Study|Lack of Efficacy|0|||
16372999|NCT05427916|39849838|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
16373000|NCT05427916|39849839|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
16373001|NCT03338023|39849843|FG000|Overall Study|Withdrawal by Subject|3|||
16373002|NCT03338023|39849844|FG001|Overall Study|Withdrawal by Subject|4|||
16162819|NCT00428597|39076834|FG001|Overall Study|Adverse Event|7|||
16162820|NCT00428597|39076833|FG000|Overall Study|Global Deterioration of Health Status|1|||
16162821|NCT00428597|39076834|FG001|Overall Study|Global Deterioration of Health Status|5|||
16373003|NCT03338023|39849843|FG000|Overall Study|Protocol Violation|3|||
16373004|NCT03338023|39849844|FG001|Overall Study|Protocol Violation|3|||
16373005|NCT03338023|39849843|FG000|Overall Study|Lost to Follow-up|2|||
16373006|NCT03338023|39849844|FG001|Overall Study|Lost to Follow-up|1|||
16373007|NCT03338023|39849843|FG000|Overall Study|Physician Decision|1|||
16373008|NCT03338023|39849844|FG001|Overall Study|Physician Decision|2|||
16373009|NCT02595437|39849845|FG000|Triferic Via IV|Withdrawal by Subject|1|||
16373010|NCT04621760|39849846|FG000|Overall Study|Lost to Follow-up|2|||
16373011|NCT04621760|39849847|FG001|Overall Study|Lost to Follow-up|4|||
16373012|NCT04621760|39849846|FG000|Overall Study|Withdrawal by Subject|1|||
16373013|NCT04621760|39849847|FG001|Overall Study|Withdrawal by Subject|0|||
16373014|NCT02605967|39849852|FG000|Overall Study|subject / guardian decision|1|||
16373015|NCT02605967|39849853|FG001|Overall Study|subject / guardian decision|2|||
16373016|NCT02605967|39849852|FG000|Overall Study|Physician Decision|10|||
16373017|NCT02605967|39849853|FG001|Overall Study|Physician Decision|1|||
16373018|NCT02605967|39849852|FG000|Overall Study|Death|4|||
16373019|NCT02605967|39849853|FG001|Overall Study|Death|2|||
16373020|NCT02605967|39849852|FG000|Overall Study|Adverse Event|1|||
16162822|NCT00428597|39076833|FG000|Overall Study|Protocol Violation|2|||
16162823|NCT00428597|39076834|FG001|Overall Study|Protocol Violation|1|||
16162824|NCT00428597|39076833|FG000|Overall Study|Withdrawal by Subject|2|||
16162825|NCT00428597|39076834|FG001|Overall Study|Withdrawal by Subject|1|||
16162826|NCT00428597|39076833|FG000|Overall Study|Other|1|||
16162827|NCT00428597|39076834|FG001|Overall Study|Other|1|||
16162828|NCT00428597|39076833|FG000|Overall Study|Lost to Follow-up|0|||
16162829|NCT00428597|39076834|FG001|Overall Study|Lost to Follow-up|1|||
16162830|NCT00428597|39076833|FG000|Overall Study|Pregnancy|1|||
16162831|NCT00428597|39076834|FG001|Overall Study|Pregnancy|0|||
16162832|NCT00428597|39076833|FG000|Overall Study|Death|1|||
16162833|NCT00428597|39076834|FG001|Overall Study|Death|3|||
16162834|NCT01031446|39076835|FG000|Overall Study|Disease Progression|38|||
16162835|NCT01031446|39076835|FG000|Overall Study|Adverse Event|9|||
16162836|NCT01031446|39076835|FG000|Overall Study|Physician Decision|4|||
16162837|NCT01031446|39076835|FG000|Overall Study|Withdrawal by Subject|3|||
16162838|NCT01031446|39076835|FG000|Overall Study|Still on treatment|1|||
16162839|NCT00074958|39076841|FG000|Overall Study|Adverse Event|1|||
16162840|NCT03538743|39076842|FG000|Overall Study|Adverse Event|0|||
16162841|NCT03538743|39076843|FG001|Overall Study|Adverse Event|0|||
16162842|NCT03538743|39076844|FG002|Overall Study|Adverse Event|1|||
16162843|NCT03538743|39076845|FG003|Overall Study|Adverse Event|1|||
16162844|NCT03538743|39076846|FG004|Overall Study|Adverse Event|0|||
16162845|NCT03538743|39076847|FG005|Overall Study|Adverse Event|0|||
16162846|NCT03538743|39076848|FG006|Overall Study|Adverse Event|0|||
16162847|NCT03538743|39076849|FG007|Overall Study|Adverse Event|0|||
16162848|NCT03538743|39076850|FG008|Overall Study|Adverse Event|0|||
16162849|NCT03538743|39076842|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
16162850|NCT03538743|39076843|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
16162851|NCT03538743|39076844|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
16162852|NCT03538743|39076845|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
16162853|NCT03538743|39076846|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
16162854|NCT03538743|39076847|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
16162855|NCT03538743|39076848|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
16449549|NCT01287741|40125792|FG000|Overall Study|Reason not specified|23|||
16449550|NCT01287741|40125793|FG001|Overall Study|Reason not specified|9|||
16449551|NCT03181932|40125801|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
16449552|NCT03181932|40125802|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
16449553|NCT03181932|40125801|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
16449554|NCT03181932|40125802|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
16449555|NCT03181932|40125801|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
16449556|NCT03181932|40125802|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
16449557|NCT03181932|40125801|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
16449558|NCT03181932|40125802|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
16373021|NCT02605967|39849853|FG001|Overall Study|Adverse Event|0|||
16162856|NCT03538743|39076849|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
16162857|NCT03538743|39076850|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
16162858|NCT03538743|39076842|FG000|Overall Study|Withdrawal by Subject|0|||
16162859|NCT03538743|39076843|FG001|Overall Study|Withdrawal by Subject|0|||
16162860|NCT03538743|39076844|FG002|Overall Study|Withdrawal by Subject|0|||
16162861|NCT03538743|39076845|FG003|Overall Study|Withdrawal by Subject|1|||
16162862|NCT03538743|39076846|FG004|Overall Study|Withdrawal by Subject|0|||
16162863|NCT03538743|39076847|FG005|Overall Study|Withdrawal by Subject|0|||
16449559|NCT03181932|40125801|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
16449560|NCT03181932|40125802|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
16162864|NCT03538743|39076848|FG006|Overall Study|Withdrawal by Subject|0|||
16162865|NCT03538743|39076849|FG007|Overall Study|Withdrawal by Subject|0|||
16162866|NCT03538743|39076850|FG008|Overall Study|Withdrawal by Subject|0|||
16162867|NCT01408147|39076863|FG000|Overall Study|Withdrawal by Subject|0|||
16162868|NCT01408147|39076864|FG001|Overall Study|Withdrawal by Subject|1|||
16162869|NCT03446885|39076867|FG000|Overall Study|Lost to Follow-up|1|||
16162870|NCT03446885|39076868|FG001|Overall Study|Lost to Follow-up|0|||
16373022|NCT02605967|39849852|FG000|Overall Study|progressive disease|66|||
16373023|NCT02605967|39849853|FG001|Overall Study|progressive disease|35|||
16373024|NCT00147537|39849854|FG000|Phase 1b|Death|0|||
16373025|NCT00147537|39849855|FG001|Phase 1b|Death|1|||
16162871|NCT03446885|39076867|FG000|Overall Study|Did not complete entire visit|1|||
16162872|NCT03446885|39076868|FG001|Overall Study|Did not complete entire visit|0|||
16162873|NCT01445769|39079920|FG000|Overall Study|Consent Withdrawn|2|||
16162874|NCT01445769|39079920|FG000|Overall Study|Disease Progression|1|||
16162875|NCT01445769|39079920|FG000|Overall Study|Lost to Follow-up|5|||
16162876|NCT03847610|39079921|FG000|Overall Study|Withdrawal by Subject|1|||
16162877|NCT01986062|39079922|FG000|Overall Study|Lost to Follow-up|1|||
16449561|NCT03181932|40125801|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
16449562|NCT03181932|40125802|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
16449563|NCT03181932|40125801|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
16449564|NCT03181932|40125802|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
16449565|NCT03181932|40125801|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
16449566|NCT03181932|40125802|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
16449567|NCT03181932|40125801|FG000|Period 2 (Open-label Period)|Reason missing|2|||
16449568|NCT03181932|40125802|FG001|Period 2 (Open-label Period)|Reason missing|0|||
16449569|NCT01417377|40125803|FG000|Overall Study|Lost to Follow-up|12|||
16449570|NCT01417377|40125803|FG000|Overall Study|Enrolled, but not treated|1|||
16265086|NCT03084471|39453286|FG000|Overall Study|Subjective disease progression|359|||
16265087|NCT03084471|39453286|FG000|Overall Study|Other (as recorded)|33|||
16265088|NCT03084471|39453286|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
16265089|NCT00453362|39453287|FG000|Overall Study|Adverse Event|5|||
16265090|NCT00453362|39453287|FG000|Overall Study|Death|7|||
16265091|NCT00453362|39453287|FG000|Overall Study|Physician Decision|2|||
16265092|NCT00453362|39453287|FG000|Overall Study|Withdrawal by Subject|3|||
16265093|NCT00453362|39453287|FG000|Overall Study|Progression of disease|56|||
16449571|NCT01967940|40125807|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
16449572|NCT01967940|40125808|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
16449573|NCT01967940|40125809|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
16449574|NCT01967940|40125810|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
16449575|NCT01967940|40125807|FG000|Part 2|Adverse Event|0|||
16449576|NCT01967940|40125808|FG001|Part 2|Adverse Event|0|||
16449577|NCT01967940|40125809|FG002|Part 2|Adverse Event|0|||
16449578|NCT01967940|40125810|FG003|Part 2|Adverse Event|1|||
16449579|NCT01967940|40125807|FG000|Part 2|Unknown Reason|0|||
16449580|NCT01967940|40125808|FG001|Part 2|Unknown Reason|0|||
16449581|NCT01967940|40125809|FG002|Part 2|Unknown Reason|0|||
16449582|NCT01967940|40125810|FG003|Part 2|Unknown Reason|1|||
16449583|NCT04198714|40125814|FG000|Overall Study|Physician Decision|0|||
16449584|NCT04198714|40125815|FG001|Overall Study|Physician Decision|1|||
16449585|NCT03125395|40125816|FG000|Overall Study|Adverse Event|2|||
16449586|NCT03125395|40125816|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
16449587|NCT03125395|40125816|FG000|Overall Study|Physician Decision|2|||
16449588|NCT03125395|40125816|FG000|Overall Study|Commercial drug is available|5|||
16449589|NCT02367833|40125819|FG000|Overall Study|Withdrawal by Subject|1|||
16449590|NCT02367833|40125820|FG001|Overall Study|Withdrawal by Subject|1|||
16449591|NCT02367833|40125821|FG002|Overall Study|Withdrawal by Subject|0|||
16449592|NCT01077050|40125822|FG000|Overall Study|Subjects signed ICF could not be located|1|||
16449593|NCT01077050|40125822|FG000|Overall Study|Screen failure|8|||
16449594|NCT01092546|40125823|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
16449595|NCT00478023|40125824|FG000|Overall Study|Adverse Event|11|||
16449596|NCT00478023|40125825|FG001|Overall Study|Adverse Event|7|||
16162878|NCT01986062|39079923|FG001|Overall Study|Lost to Follow-up|0|||
16162879|NCT01986062|39079922|FG000|Overall Study|Withdrawal by Subject|0|||
16162880|NCT01986062|39079923|FG001|Overall Study|Withdrawal by Subject|1|||
16162881|NCT00529958|39079926|FG000|2-Year Follow-up|Lost to Follow-up|1|||
16162882|NCT00529958|39079927|FG001|2-Year Follow-up|Lost to Follow-up|2|||
16162883|NCT00529958|39079928|FG002|2-Year Follow-up|Lost to Follow-up|2|||
16162884|NCT00529958|39079926|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
16162885|NCT00529958|39079927|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
16162886|NCT00529958|39079928|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
16162887|NCT00529958|39079926|FG000|5-Year Follow-up|Lost to Follow-up|2|||
16162888|NCT00529958|39079927|FG001|5-Year Follow-up|Lost to Follow-up|3|||
16162889|NCT00529958|39079928|FG002|5-Year Follow-up|Lost to Follow-up|1|||
16162890|NCT00529958|39079926|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
16449597|NCT00478023|40125826|FG002|Overall Study|Adverse Event|8|||
16449598|NCT00478023|40125827|FG003|Overall Study|Adverse Event|14|||
16449599|NCT00478023|40125828|FG004|Overall Study|Adverse Event|6|||
16449600|NCT00478023|40125824|FG000|Overall Study|Death|1|||
16449601|NCT00478023|40125825|FG001|Overall Study|Death|0|||
16162891|NCT00529958|39079927|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
16162892|NCT00529958|39079928|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
16162893|NCT00647556|39079929|FG000|Overall Study|Adverse Event|0|||
16162894|NCT00647556|39079930|FG001|Overall Study|Adverse Event|1|||
16162895|NCT00647556|39079929|FG000|Overall Study|Lost to Follow-up|1|||
16265094|NCT00453362|39453287|FG000|Overall Study|Screening Failure|14|||
16265095|NCT03122535|39453288|FG000|Overall Study|Lost to Follow-up|68|||
16449602|NCT00478023|40125826|FG002|Overall Study|Death|0|||
16162896|NCT00647556|39079930|FG001|Overall Study|Lost to Follow-up|0|||
16162897|NCT00647556|39079929|FG000|Overall Study|Protocol Violation|0|||
16162898|NCT00647556|39079930|FG001|Overall Study|Protocol Violation|1|||
16162899|NCT00647556|39079929|FG000|Overall Study|Withdrawal by Subject|1|||
16162900|NCT00647556|39079930|FG001|Overall Study|Withdrawal by Subject|0|||
16162901|NCT00647556|39079929|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
16162902|NCT00647556|39079930|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
16162903|NCT00400400|39079931|FG000|Overall Study|Adverse Event|9|||
16162904|NCT00400400|39079932|FG001|Overall Study|Adverse Event|8|||
16162905|NCT00400400|39079931|FG000|Overall Study|Protocol Violation|2|||
16162906|NCT00400400|39079932|FG001|Overall Study|Protocol Violation|0|||
16162907|NCT00400400|39079931|FG000|Overall Study|Withdrawal by Subject|1|||
16162908|NCT00400400|39079932|FG001|Overall Study|Withdrawal by Subject|3|||
16162909|NCT00400400|39079931|FG000|Overall Study|Administrative Problem|1|||
16162910|NCT00400400|39079932|FG001|Overall Study|Administrative Problem|0|||
16162911|NCT00400400|39079931|FG000|Overall Study|Lost to Follow-up|0|||
16162912|NCT00400400|39079932|FG001|Overall Study|Lost to Follow-up|1|||
16162913|NCT00400400|39079931|FG000|Overall Study|Did not receive study drug|1|||
16162914|NCT00400400|39079932|FG001|Overall Study|Did not receive study drug|3|||
16162915|NCT02062658|39079933|FG000|Overall Study|Withdrawal by Subject|1|||
16162916|NCT02062658|39079933|FG000|Overall Study|Lack of Efficacy|1|||
16162917|NCT03434379|39079934|FG000|Global Period|Lost to Follow-up|3|||
16162918|NCT03434379|39079935|FG001|Global Period|Lost to Follow-up|6|||
16162919|NCT03434379|39079936|FG002|Global Period|Lost to Follow-up|0|||
16162920|NCT03434379|39079937|FG003|Global Period|Lost to Follow-up|0|||
16162921|NCT03434379|39079934|FG000|Global Period|Death|115|||
16162922|NCT03434379|39079935|FG001|Global Period|Death|228|||
16162923|NCT03434379|39079936|FG002|Global Period|Death|0|||
16162924|NCT03434379|39079937|FG003|Global Period|Death|0|||
16162925|NCT03434379|39079934|FG000|Global Period|Withdrawal by Subject|20|||
16162926|NCT03434379|39079935|FG001|Global Period|Withdrawal by Subject|21|||
16162927|NCT03434379|39079936|FG002|Global Period|Withdrawal by Subject|0|||
16162928|NCT03434379|39079937|FG003|Global Period|Withdrawal by Subject|0|||
16162929|NCT03434379|39079934|FG000|Global Period|Reason Unspecified|0|||
16162930|NCT03434379|39079935|FG001|Global Period|Reason Unspecified|1|||
16162931|NCT03434379|39079936|FG002|Global Period|Reason Unspecified|0|||
16162932|NCT03434379|39079937|FG003|Global Period|Reason Unspecified|0|||
16162933|NCT03434379|39079934|FG000|Global Period|Study Ended by Sponsor|26|||
16162934|NCT03434379|39079935|FG001|Global Period|Study Ended by Sponsor|80|||
16162935|NCT03434379|39079936|FG002|Global Period|Study Ended by Sponsor|0|||
16162936|NCT03434379|39079937|FG003|Global Period|Study Ended by Sponsor|0|||
16162937|NCT03434379|39079934|FG000|Global Period|Physician Decision|1|||
16162938|NCT03434379|39079935|FG001|Global Period|Physician Decision|0|||
16162939|NCT03434379|39079936|FG002|Global Period|Physician Decision|0|||
16162940|NCT03434379|39079937|FG003|Global Period|Physician Decision|0|||
16162941|NCT03434379|39079934|FG000|China Extension Period|Lost to Follow-up|0|||
16162942|NCT03434379|39079935|FG001|China Extension Period|Lost to Follow-up|0|||
16162943|NCT03434379|39079936|FG002|China Extension Period|Lost to Follow-up|2|||
16162944|NCT03434379|39079937|FG003|China Extension Period|Lost to Follow-up|3|||
16162945|NCT03434379|39079934|FG000|China Extension Period|Death|0|||
16162946|NCT03434379|39079935|FG001|China Extension Period|Death|0|||
16162947|NCT03434379|39079936|FG002|China Extension Period|Death|46|||
16162948|NCT03434379|39079937|FG003|China Extension Period|Death|88|||
16162949|NCT03434379|39079934|FG000|China Extension Period|Withdrawal by Subject|0|||
16162950|NCT03434379|39079935|FG001|China Extension Period|Withdrawal by Subject|0|||
16162951|NCT03434379|39079936|FG002|China Extension Period|Withdrawal by Subject|8|||
16162952|NCT03434379|39079937|FG003|China Extension Period|Withdrawal by Subject|6|||
16162953|NCT03434379|39079934|FG000|China Extension Period|Study Ended by Sponsor|0|||
16162954|NCT03434379|39079935|FG001|China Extension Period|Study Ended by Sponsor|0|||
16162955|NCT03434379|39079936|FG002|China Extension Period|Study Ended by Sponsor|5|||
16162956|NCT03434379|39079937|FG003|China Extension Period|Study Ended by Sponsor|36|||
16162957|NCT02404103|39079938|FG000|Overall Study|Adverse Event|1|||
16162958|NCT02404103|39079939|FG001|Overall Study|Adverse Event|0|||
16162959|NCT02404103|39079938|FG000|Overall Study|Lost to Follow-up|3|||
16162960|NCT02404103|39079939|FG001|Overall Study|Lost to Follow-up|3|||
16162961|NCT00482014|39079940|FG000|Overall Study|Withdrawal by Subject|1|||
16162962|NCT00482014|39079941|FG001|Overall Study|Withdrawal by Subject|2|||
16162963|NCT00482014|39079942|FG002|Overall Study|Withdrawal by Subject|3|||
16162964|NCT00482014|39079943|FG003|Overall Study|Withdrawal by Subject|4|||
16449603|NCT00478023|40125827|FG003|Overall Study|Death|0|||
16162965|NCT00482014|39079940|FG000|Overall Study|Adverse Event|3|||
16162966|NCT00482014|39079941|FG001|Overall Study|Adverse Event|0|||
16162967|NCT00482014|39079942|FG002|Overall Study|Adverse Event|2|||
16162968|NCT00482014|39079943|FG003|Overall Study|Adverse Event|8|||
16162969|NCT00482014|39079940|FG000|Overall Study|Death|1|||
16162970|NCT00482014|39079941|FG001|Overall Study|Death|2|||
16162971|NCT00482014|39079942|FG002|Overall Study|Death|1|||
16162972|NCT00482014|39079943|FG003|Overall Study|Death|4|||
16449604|NCT00478023|40125828|FG004|Overall Study|Death|0|||
16449605|NCT00478023|40125824|FG000|Overall Study|Lack of Efficacy|11|||
16449606|NCT00478023|40125825|FG001|Overall Study|Lack of Efficacy|10|||
16449607|NCT00478023|40125826|FG002|Overall Study|Lack of Efficacy|4|||
16449608|NCT00478023|40125827|FG003|Overall Study|Lack of Efficacy|5|||
16449609|NCT00478023|40125828|FG004|Overall Study|Lack of Efficacy|41|||
16449610|NCT00478023|40125824|FG000|Overall Study|Lost to Follow-up|3|||
16449611|NCT00478023|40125825|FG001|Overall Study|Lost to Follow-up|1|||
16449612|NCT00478023|40125826|FG002|Overall Study|Lost to Follow-up|1|||
16449613|NCT00478023|40125827|FG003|Overall Study|Lost to Follow-up|1|||
16449614|NCT00478023|40125828|FG004|Overall Study|Lost to Follow-up|0|||
16162973|NCT00482014|39079940|FG000|Overall Study|Lack of Efficacy|1|||
16162974|NCT00482014|39079941|FG001|Overall Study|Lack of Efficacy|0|||
16162975|NCT00482014|39079942|FG002|Overall Study|Lack of Efficacy|4|||
16162976|NCT00482014|39079943|FG003|Overall Study|Lack of Efficacy|6|||
16162977|NCT00482014|39079940|FG000|Overall Study|Sponsor Decision|1|||
16162978|NCT00482014|39079941|FG001|Overall Study|Sponsor Decision|2|||
16162979|NCT00482014|39079942|FG002|Overall Study|Sponsor Decision|1|||
16162980|NCT00482014|39079943|FG003|Overall Study|Sponsor Decision|1|||
16162981|NCT00379795|39079944|FG000|Overall Study|Death|31|||
16162982|NCT00379795|39079945|FG001|Overall Study|Death|8|||
16162983|NCT00379795|39079946|FG002|Overall Study|Death|6|||
16162984|NCT00379795|39079947|FG003|Overall Study|Death|4|||
16162985|NCT00379795|39079948|FG004|Overall Study|Death|7|||
16162986|NCT00379795|39079944|FG000|Overall Study|Adverse Event|17|||
16162987|NCT00379795|39079945|FG001|Overall Study|Adverse Event|3|||
16162988|NCT00379795|39079946|FG002|Overall Study|Adverse Event|3|||
16162989|NCT00379795|39079947|FG003|Overall Study|Adverse Event|1|||
16162990|NCT00379795|39079948|FG004|Overall Study|Adverse Event|4|||
16162991|NCT00379795|39079944|FG000|Overall Study|Lost to Follow-up|8|||
16162992|NCT00379795|39079945|FG001|Overall Study|Lost to Follow-up|1|||
16162993|NCT00379795|39079946|FG002|Overall Study|Lost to Follow-up|2|||
16162994|NCT00379795|39079947|FG003|Overall Study|Lost to Follow-up|1|||
16162995|NCT00379795|39079948|FG004|Overall Study|Lost to Follow-up|4|||
16162996|NCT00379795|39079944|FG000|Overall Study|Physician Decision|25|||
16162997|NCT00379795|39079945|FG001|Overall Study|Physician Decision|0|||
16162998|NCT00379795|39079946|FG002|Overall Study|Physician Decision|2|||
16162999|NCT00379795|39079947|FG003|Overall Study|Physician Decision|2|||
16163000|NCT00379795|39079948|FG004|Overall Study|Physician Decision|2|||
16163001|NCT00379795|39079944|FG000|Overall Study|Withdrawal by Subject|94|||
16163002|NCT00379795|39079945|FG001|Overall Study|Withdrawal by Subject|11|||
16163003|NCT00379795|39079946|FG002|Overall Study|Withdrawal by Subject|19|||
16163004|NCT00379795|39079947|FG003|Overall Study|Withdrawal by Subject|7|||
16163005|NCT00379795|39079948|FG004|Overall Study|Withdrawal by Subject|14|||
16163006|NCT00379795|39079944|FG000|Overall Study|Subject non-compliance|7|||
16163007|NCT00379795|39079945|FG001|Overall Study|Subject non-compliance|2|||
16163008|NCT00379795|39079946|FG002|Overall Study|Subject non-compliance|0|||
16163009|NCT00379795|39079947|FG003|Overall Study|Subject non-compliance|0|||
16163010|NCT00379795|39079948|FG004|Overall Study|Subject non-compliance|1|||
16449615|NCT00478023|40125824|FG000|Overall Study|Withdrawal by Subject|2|||
16449616|NCT00478023|40125825|FG001|Overall Study|Withdrawal by Subject|3|||
16449617|NCT00478023|40125826|FG002|Overall Study|Withdrawal by Subject|2|||
16449618|NCT00478023|40125827|FG003|Overall Study|Withdrawal by Subject|4|||
16449619|NCT00478023|40125828|FG004|Overall Study|Withdrawal by Subject|5|||
16449620|NCT00478023|40125824|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
16449621|NCT00478023|40125825|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
16449622|NCT00478023|40125826|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
16449623|NCT00478023|40125827|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
16163011|NCT00379795|39079944|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
16163012|NCT00379795|39079945|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
16449624|NCT00478023|40125828|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
16449625|NCT05660577|40125829|FG000|Overall Study|Discontinued|9|||
16449626|NCT03857867|40125830|FG000|Overall Study|Physician Decision|1|||
16449627|NCT01750229|40125831|FG000|Randomized Crossover Phase|Adverse Event|1|||
16449628|NCT01750229|40125831|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
16449629|NCT01750229|40125831|FG000|Long-term Follow-up Phase|Adverse Event|2|||
16449630|NCT01750229|40125831|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
16163013|NCT00379795|39079946|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
16163014|NCT00379795|39079947|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
16163015|NCT00379795|39079948|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
16163016|NCT00379795|39079944|FG000|Overall Study|Subjects condition mandated intervention|34|||
16163017|NCT00379795|39079945|FG001|Overall Study|Subjects condition mandated intervention|9|||
16163018|NCT00379795|39079946|FG002|Overall Study|Subjects condition mandated intervention|7|||
16163019|NCT00379795|39079947|FG003|Overall Study|Subjects condition mandated intervention|5|||
16163020|NCT00379795|39079948|FG004|Overall Study|Subjects condition mandated intervention|7|||
16449631|NCT03472885|40125832|FG000|24-Week Treatment Period|Adverse Event|1|||
16449632|NCT02900378|40125833|FG000|Randomization (Visit 2)|Adverse Event|14|||
16449633|NCT02900378|40125834|FG001|Randomization (Visit 2)|Adverse Event|11|||
16449634|NCT02900378|40125833|FG000|Randomization (Visit 2)|Death|1|||
16449635|NCT02900378|40125834|FG001|Randomization (Visit 2)|Death|4|||
16449636|NCT02900378|40125833|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
16449637|NCT02900378|40125834|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
16449638|NCT02900378|40125833|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
16449639|NCT02900378|40125834|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
16449640|NCT02900378|40125833|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
16449641|NCT02900378|40125834|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
16449642|NCT02900378|40125833|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
16163021|NCT00379795|39079944|FG000|Overall Study|Sponsor's decision|257|||
16163022|NCT00379795|39079945|FG001|Overall Study|Sponsor's decision|17|||
16163023|NCT00379795|39079946|FG002|Overall Study|Sponsor's decision|54|||
16163024|NCT00379795|39079947|FG003|Overall Study|Sponsor's decision|47|||
16163025|NCT00379795|39079948|FG004|Overall Study|Sponsor's decision|10|||
16163026|NCT02363478|39079949|FG000|Overall Study|Lost to Follow-up|4|||
16163027|NCT02363478|39079949|FG000|Overall Study|Adverse Event|4|||
16163028|NCT00854828|39079950|FG000|Overall Study|Death|1|||
16163029|NCT00854828|39079951|FG001|Overall Study|Death|0|||
16163030|NCT00854828|39079952|FG002|Overall Study|Death|0|||
16163031|NCT00854828|39079953|FG003|Overall Study|Death|0|||
16163032|NCT00854828|39079950|FG000|Overall Study|Withdrawal by Subject|1|||
16163033|NCT00854828|39079951|FG001|Overall Study|Withdrawal by Subject|1|||
16163034|NCT00854828|39079952|FG002|Overall Study|Withdrawal by Subject|0|||
16163035|NCT00854828|39079953|FG003|Overall Study|Withdrawal by Subject|9|||
16163036|NCT00854828|39079950|FG000|Overall Study|Missed 24mo visit|1|||
16163037|NCT00854828|39079951|FG001|Overall Study|Missed 24mo visit|1|||
16163038|NCT00854828|39079952|FG002|Overall Study|Missed 24mo visit|8|||
16163039|NCT00854828|39079953|FG003|Overall Study|Missed 24mo visit|8|||
16163040|NCT01459614|39079954|FG000|Overall Study|Adverse Event|1|||
16163041|NCT01459614|39079955|FG001|Overall Study|Adverse Event|0|||
16163042|NCT04041284|39079958|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
16163043|NCT04041284|39079959|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
16163044|NCT04041284|39079958|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
16163045|NCT04041284|39079959|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
16163046|NCT04041284|39079958|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
16163047|NCT04041284|39079959|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
16163048|NCT04041284|39079958|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
16163049|NCT04041284|39079959|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
16163050|NCT04041284|39079958|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
16163051|NCT04041284|39079959|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
16163052|NCT04041284|39079958|FG000|DB Phase (12 Weeks)|Other than specified|1|||
16163053|NCT04041284|39079959|FG001|DB Phase (12 Weeks)|Other than specified|0|||
16163054|NCT04041284|39079958|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
16163055|NCT04041284|39079959|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
16163056|NCT04041284|39079958|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
16163057|NCT04041284|39079959|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
16163058|NCT04041284|39079958|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
16163059|NCT04041284|39079959|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
16163060|NCT04041284|39079958|FG000|OL Phase (12 Weeks)|Other than specified|6|||
16163061|NCT04041284|39079959|FG001|OL Phase (12 Weeks)|Other than specified|2|||
16163062|NCT03093155|39079960|FG000|Overall Study|Not Eligible|1|||
16163063|NCT03093155|39079961|FG001|Overall Study|Not Eligible|0|||
16163064|NCT03093155|39079960|FG000|Overall Study|Withdrawal by Subject|0|||
16163065|NCT03093155|39079961|FG001|Overall Study|Withdrawal by Subject|1|||
16163066|NCT00454779|39079962|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
16163067|NCT00454779|39079963|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
16163068|NCT00454779|39079962|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
16163069|NCT00454779|39079963|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
16163070|NCT00454779|39079962|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
16163071|NCT00454779|39079963|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
16449643|NCT02900378|40125834|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
16163072|NCT00454779|39079962|FG000|First-line Treatment Phase|Protocol Violation|0|||
16163073|NCT00454779|39079963|FG001|First-line Treatment Phase|Protocol Violation|1|||
16163074|NCT00454779|39079962|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
16163075|NCT00454779|39079963|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
16163076|NCT00454779|39079962|FG000|First-line Treatment Phase|Ongoing|1|||
16163077|NCT00454779|39079963|FG001|First-line Treatment Phase|Ongoing|0|||
16163078|NCT00454779|39079962|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
16163079|NCT00454779|39079963|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
16163080|NCT00454779|39079962|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
16163081|NCT00454779|39079963|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
16163082|NCT00454779|39079962|FG000|Second-line Treatment Phase|Ongoing|0|||
16163083|NCT00454779|39079963|FG001|Second-line Treatment Phase|Ongoing|1|||
16449644|NCT02900378|40125833|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
16449645|NCT02900378|40125834|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
16449646|NCT01273519|40125835|FG000|Overall Study|Adverse Event|3|||
16449647|NCT01273519|40125836|FG001|Overall Study|Adverse Event|0|||
16449648|NCT01273519|40125837|FG002|Overall Study|Adverse Event|0|||
16449649|NCT01273519|40125835|FG000|Overall Study|Lost to Follow-up|2|||
16449650|NCT01273519|40125836|FG001|Overall Study|Lost to Follow-up|1|||
16449651|NCT01273519|40125837|FG002|Overall Study|Lost to Follow-up|3|||
16449652|NCT01273519|40125835|FG000|Overall Study|Lack of Efficacy|8|||
16449653|NCT01273519|40125836|FG001|Overall Study|Lack of Efficacy|3|||
16449654|NCT01273519|40125837|FG002|Overall Study|Lack of Efficacy|4|||
16449655|NCT01273519|40125835|FG000|Overall Study|Other|6|||
16449656|NCT01273519|40125836|FG001|Overall Study|Other|1|||
16449657|NCT01273519|40125837|FG002|Overall Study|Other|1|||
16449658|NCT02839200|40125838|FG000|Overall Study|Withdrawal by Subject|2|||
16449659|NCT02839200|40125839|FG001|Overall Study|Withdrawal by Subject|0|||
16449660|NCT02839200|40125840|FG002|Overall Study|Withdrawal by Subject|1|||
16449661|NCT02839200|40125841|FG003|Overall Study|Withdrawal by Subject|0|||
16449662|NCT02839200|40125842|FG004|Overall Study|Withdrawal by Subject|0|||
16449663|NCT02839200|40125843|FG005|Overall Study|Withdrawal by Subject|1|||
16449664|NCT02839200|40125838|FG000|Overall Study|Lost to Follow-up|2|||
16449665|NCT02839200|40125839|FG001|Overall Study|Lost to Follow-up|0|||
16449666|NCT02839200|40125840|FG002|Overall Study|Lost to Follow-up|0|||
16449667|NCT02839200|40125841|FG003|Overall Study|Lost to Follow-up|0|||
16449668|NCT02839200|40125842|FG004|Overall Study|Lost to Follow-up|1|||
16449669|NCT02839200|40125843|FG005|Overall Study|Lost to Follow-up|0|||
16449670|NCT02839200|40125838|FG000|Overall Study|Adverse Event|0|||
16449671|NCT02839200|40125839|FG001|Overall Study|Adverse Event|0|||
16449672|NCT02839200|40125840|FG002|Overall Study|Adverse Event|0|||
16449673|NCT02839200|40125841|FG003|Overall Study|Adverse Event|0|||
16449674|NCT02839200|40125842|FG004|Overall Study|Adverse Event|1|||
16449675|NCT02839200|40125843|FG005|Overall Study|Adverse Event|0|||
16449676|NCT02839200|40125838|FG000|Overall Study|Randomized in error|0|||
16449677|NCT02839200|40125839|FG001|Overall Study|Randomized in error|1|||
16449678|NCT02839200|40125840|FG002|Overall Study|Randomized in error|0|||
16449679|NCT02839200|40125841|FG003|Overall Study|Randomized in error|0|||
16449680|NCT02839200|40125842|FG004|Overall Study|Randomized in error|0|||
16449681|NCT02839200|40125843|FG005|Overall Study|Randomized in error|0|||
16449682|NCT02395081|40125844|FG000|Overall Study|Withdrawal by Subject|1|||
16449683|NCT02395081|40125845|FG001|Overall Study|Withdrawal by Subject|1|||
16449684|NCT02395081|40125846|FG002|Overall Study|Withdrawal by Subject|0|||
16449685|NCT02395081|40125844|FG000|Overall Study|Moved where blood couldn't be collected|4|||
16449686|NCT02395081|40125845|FG001|Overall Study|Moved where blood couldn't be collected|1|||
16449687|NCT02395081|40125846|FG002|Overall Study|Moved where blood couldn't be collected|3|||
16449688|NCT02395081|40125844|FG000|Overall Study|Fetal Loss|2|||
16449689|NCT02395081|40125845|FG001|Overall Study|Fetal Loss|3|||
16449690|NCT02395081|40125846|FG002|Overall Study|Fetal Loss|1|||
16449691|NCT04139018|40125847|FG000|Overall Study|Screen fail|1|||
16449692|NCT04139018|40125848|FG001|Overall Study|Screen fail|0|||
16449693|NCT04139018|40125847|FG000|Overall Study|Withdrawal by Subject|2|||
16449694|NCT04139018|40125848|FG001|Overall Study|Withdrawal by Subject|0|||
16449695|NCT04139018|40125847|FG000|Overall Study|Lost to Follow-up|0|||
16449696|NCT04139018|40125848|FG001|Overall Study|Lost to Follow-up|1|||
16449697|NCT00106704|40125849|FG000|Overall Study|Adverse Event|10|||
16449698|NCT00106704|40125850|FG001|Overall Study|Adverse Event|7|||
16449699|NCT00106704|40125849|FG000|Overall Study|Death|2|||
16163084|NCT01072344|39079964|FG000|Overall Study|Relasped-reached end point|7|||
16163085|NCT01072344|39079965|FG001|Overall Study|Relasped-reached end point|12|||
16163086|NCT01072344|39079964|FG000|Overall Study|Protocol Violation|1|||
16163087|NCT01072344|39079965|FG001|Overall Study|Protocol Violation|2|||
16163088|NCT01072344|39079964|FG000|Overall Study|Lost to Follow-up|3|||
16163089|NCT01072344|39079965|FG001|Overall Study|Lost to Follow-up|4|||
16163090|NCT00364689|39079966|FG000|Overall Study|Lost to Follow-up|1|||
16163091|NCT03064841|39079967|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
16449700|NCT00106704|40125850|FG001|Overall Study|Death|1|||
16449701|NCT00106704|40125849|FG000|Overall Study|Lack of Efficacy|67|||
16449702|NCT00106704|40125850|FG001|Overall Study|Lack of Efficacy|69|||
16449703|NCT00106704|40125849|FG000|Overall Study|Lost to Follow-up|7|||
16449704|NCT00106704|40125850|FG001|Overall Study|Lost to Follow-up|3|||
16449705|NCT00106704|40125849|FG000|Overall Study|Pregnancy|1|||
16449706|NCT00106704|40125850|FG001|Overall Study|Pregnancy|0|||
16449707|NCT00106704|40125849|FG000|Overall Study|Protocol Violation|4|||
16449708|NCT00106704|40125850|FG001|Overall Study|Protocol Violation|7|||
16163092|NCT03064841|39079967|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
16163093|NCT03064841|39079967|FG000|Overall Study|Screen failure|2|||
16449709|NCT00106704|40125849|FG000|Overall Study|Withdrawal by Subject|14|||
16449710|NCT00106704|40125850|FG001|Overall Study|Withdrawal by Subject|21|||
16163094|NCT01163786|39079976|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
16449711|NCT00106704|40125849|FG000|Overall Study|Patient moved|1|||
16163095|NCT01163786|39079976|FG000|Treatment With Bortezomib|Adverse Event|2|||
16163096|NCT01163786|39079976|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
16163097|NCT04428411|39079984|FG000|Overall Study|Lost to Follow-up|114|||
16163098|NCT00684957|39079987|FG000|Overall Study|Withdrawal by Subject|1|||
16163099|NCT00684957|39079988|FG001|Overall Study|Withdrawal by Subject|1|||
16163100|NCT00684957|39079987|FG000|Overall Study|Lost to Follow-up|1|||
16163101|NCT00684957|39079988|FG001|Overall Study|Lost to Follow-up|0|||
16163102|NCT00500682|39079989|FG000|Overall Study|Adverse Event|37|||
16163103|NCT00500682|39079990|FG001|Overall Study|Adverse Event|29|||
16163104|NCT00500682|39079989|FG000|Overall Study|Death|25|||
16163105|NCT00500682|39079990|FG001|Overall Study|Death|16|||
16163106|NCT00500682|39079989|FG000|Overall Study|Lost to Follow-up|11|||
16265096|NCT03122535|39453289|FG001|Overall Study|Lost to Follow-up|68|||
16265097|NCT03122535|39453288|FG000|Overall Study|Physician Decision|3|||
16265098|NCT03122535|39453289|FG001|Overall Study|Physician Decision|3|||
16265099|NCT03122535|39453288|FG000|Overall Study|Withdrawal by Subject|2|||
16265100|NCT03122535|39453289|FG001|Overall Study|Withdrawal by Subject|2|||
16265101|NCT02017223|39453292|FG000|Overall Study|Algorithm problems|2|||
16265102|NCT00777023|39453295|FG000|Overall Study|Adverse Event|15|||
16265103|NCT00777023|39453296|FG001|Overall Study|Adverse Event|21|||
16265104|NCT00777023|39453297|FG002|Overall Study|Adverse Event|8|||
16265105|NCT00777023|39453295|FG000|Overall Study|Lack of Efficacy|1|||
16265106|NCT00777023|39453296|FG001|Overall Study|Lack of Efficacy|0|||
16265107|NCT00777023|39453297|FG002|Overall Study|Lack of Efficacy|14|||
16265108|NCT00777023|39453295|FG000|Overall Study|Protocol Violation|2|||
16265109|NCT00777023|39453296|FG001|Overall Study|Protocol Violation|1|||
16265110|NCT00777023|39453297|FG002|Overall Study|Protocol Violation|1|||
16265111|NCT00777023|39453295|FG000|Overall Study|Lost to Follow-up|2|||
16265112|NCT00777023|39453296|FG001|Overall Study|Lost to Follow-up|3|||
16265113|NCT00777023|39453297|FG002|Overall Study|Lost to Follow-up|3|||
16265114|NCT00777023|39453295|FG000|Overall Study|Death|0|||
16265115|NCT00777023|39453296|FG001|Overall Study|Death|1|||
16265116|NCT00777023|39453297|FG002|Overall Study|Death|0|||
16265117|NCT00777023|39453295|FG000|Overall Study|Withdrawal by Subject|7|||
16265118|NCT00777023|39453296|FG001|Overall Study|Withdrawal by Subject|7|||
16265119|NCT00777023|39453297|FG002|Overall Study|Withdrawal by Subject|8|||
16265120|NCT00777023|39453295|FG000|Overall Study|Missing data|1|||
16265121|NCT00777023|39453296|FG001|Overall Study|Missing data|1|||
16265122|NCT00777023|39453297|FG002|Overall Study|Missing data|0|||
16265123|NCT00777023|39453295|FG000|Overall Study|Reasons not specified|4|||
16265124|NCT00777023|39453296|FG001|Overall Study|Reasons not specified|4|||
16265125|NCT00777023|39453297|FG002|Overall Study|Reasons not specified|2|||
16265126|NCT00777023|39453295|FG000|Overall Study|Last dose date unknown|3|||
16373026|NCT00147537|39849856|FG002|Phase 1b|Death|2|||
16373027|NCT00147537|39849857|FG003|Phase 1b|Death|1|||
16373028|NCT00147537|39849858|FG004|Phase 1b|Death|2|||
16373029|NCT00147537|39849859|FG005|Phase 1b|Death|2|||
16373030|NCT00147537|39849860|FG006|Phase 1b|Death|1|||
16373031|NCT00147537|39849861|FG007|Phase 1b|Death|3|||
16373032|NCT00147537|39849862|FG008|Phase 1b|Death|9|||
16373033|NCT00147537|39849863|FG009|Phase 1b|Death|0|||
16373034|NCT00147537|39849864|FG010|Phase 1b|Death|0|||
16373035|NCT00147537|39849854|FG000|Phase 1b|Lost to Follow-up|2|||
16373036|NCT00147537|39849855|FG001|Phase 1b|Lost to Follow-up|1|||
16373037|NCT00147537|39849856|FG002|Phase 1b|Lost to Follow-up|0|||
16373038|NCT00147537|39849857|FG003|Phase 1b|Lost to Follow-up|0|||
16373039|NCT00147537|39849858|FG004|Phase 1b|Lost to Follow-up|0|||
16373040|NCT00147537|39849859|FG005|Phase 1b|Lost to Follow-up|0|||
16373041|NCT00147537|39849860|FG006|Phase 1b|Lost to Follow-up|2|||
16373042|NCT00147537|39849861|FG007|Phase 1b|Lost to Follow-up|0|||
16373043|NCT00147537|39849862|FG008|Phase 1b|Lost to Follow-up|1|||
16373044|NCT00147537|39849863|FG009|Phase 1b|Lost to Follow-up|0|||
16373045|NCT00147537|39849864|FG010|Phase 1b|Lost to Follow-up|0|||
16373046|NCT00147537|39849854|FG000|Phase 1b|Other|0|||
16373047|NCT00147537|39849855|FG001|Phase 1b|Other|0|||
16373048|NCT00147537|39849856|FG002|Phase 1b|Other|2|||
16449712|NCT00106704|40125850|FG001|Overall Study|Patient moved|0|||
16163107|NCT00500682|39079990|FG001|Overall Study|Lost to Follow-up|11|||
16163108|NCT00500682|39079989|FG000|Overall Study|Physician Decision|6|||
16265127|NCT00777023|39453296|FG001|Overall Study|Last dose date unknown|3|||
16265128|NCT00777023|39453297|FG002|Overall Study|Last dose date unknown|1|||
16265129|NCT01802320|39453298|FG000|Overall Study|Death|1|||
16265130|NCT01802320|39453298|FG000|Overall Study|Withdrawal by Subject|1|||
16265131|NCT00415363|39453299|FG000|Overall Study|Withdrawal by Subject|4|||
16265132|NCT00415363|39453300|FG001|Overall Study|Withdrawal by Subject|4|||
16265133|NCT00415363|39453299|FG000|Overall Study|Adverse Event|4|||
16373049|NCT00147537|39849857|FG003|Phase 1b|Other|1|||
16373050|NCT00147537|39849858|FG004|Phase 1b|Other|1|||
16373051|NCT00147537|39849859|FG005|Phase 1b|Other|1|||
16373052|NCT00147537|39849860|FG006|Phase 1b|Other|14|||
16373053|NCT00147537|39849861|FG007|Phase 1b|Other|4|||
16373054|NCT00147537|39849862|FG008|Phase 1b|Other|4|||
16373055|NCT00147537|39849863|FG009|Phase 1b|Other|0|||
16449713|NCT00106704|40125849|FG000|Overall Study|Site terminated|0|||
16449714|NCT00106704|40125850|FG001|Overall Study|Site terminated|1|||
16449715|NCT00106704|40125849|FG000|Overall Study|Planned major surgery|1|||
16449716|NCT00106704|40125850|FG001|Overall Study|Planned major surgery|0|||
16449717|NCT00106704|40125849|FG000|Overall Study|Patient Received Glycemic Medication|22|||
16449718|NCT00106704|40125850|FG001|Overall Study|Patient Received Glycemic Medication|41|||
16449719|NCT00106704|40125849|FG000|Overall Study|Unable to re-enter US|1|||
16449720|NCT00106704|40125850|FG001|Overall Study|Unable to re-enter US|0|||
16449721|NCT00106704|40125849|FG000|Overall Study|Laboratory test|1|||
16449722|NCT00106704|40125850|FG001|Overall Study|Laboratory test|1|||
16449723|NCT03388164|40125851|FG000|Overall Study|Withdrawal by Subject|3|||
16449724|NCT03388164|40125852|FG001|Overall Study|Withdrawal by Subject|1|||
16449725|NCT04639258|40125853|FG000|Overall Study|Screen failure|5|||
16449726|NCT04639258|40125853|FG000|Overall Study|Physician Decision|2|||
16449727|NCT04639258|40125853|FG000|Overall Study|Early study termination|3|||
16449728|NCT04639258|40125853|FG000|Overall Study|Withdrawal by Subject|1|||
16449729|NCT02531802|40125855|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
16449730|NCT02531802|40125856|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
16449731|NCT02531802|40125857|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
16449732|NCT02531802|40125858|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
16449733|NCT02531802|40125859|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
16449734|NCT02531802|40125860|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
16449735|NCT02531802|40125861|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
16449736|NCT02531802|40125862|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
16449737|NCT02531802|40125863|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
16449738|NCT02531802|40125864|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
16449739|NCT02531802|40125865|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
16449740|NCT02531802|40125866|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
16449741|NCT02531802|40125867|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
16449742|NCT02531802|40125868|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
16449743|NCT02531802|40125869|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
16449744|NCT02531802|40125870|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
16449745|NCT02531802|40125871|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
16449746|NCT02531802|40125872|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
16163109|NCT00500682|39079990|FG001|Overall Study|Physician Decision|10|||
16163110|NCT00500682|39079989|FG000|Overall Study|Pregnancy|2|||
16163111|NCT00500682|39079990|FG001|Overall Study|Pregnancy|0|||
16163112|NCT00500682|39079989|FG000|Overall Study|Protocol Violation|1|||
16163113|NCT00500682|39079990|FG001|Overall Study|Protocol Violation|3|||
16163114|NCT00500682|39079989|FG000|Overall Study|Withdrawal by Subject|80|||
16163115|NCT00500682|39079990|FG001|Overall Study|Withdrawal by Subject|74|||
16163116|NCT00500682|39079989|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
16163117|NCT00500682|39079990|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
16163118|NCT01665807|39079993|FG000|Overall Study|Withdrawal by Subject|2|||
16163119|NCT01665807|39079994|FG001|Overall Study|Withdrawal by Subject|0|||
16163120|NCT01665807|39079995|FG002|Overall Study|Withdrawal by Subject|1|||
16163121|NCT01422239|39080000|FG000|Overall Study|Lost to Follow-up|4|||
16163122|NCT01422239|39080001|FG001|Overall Study|Lost to Follow-up|3|||
16163123|NCT02058147|39080006|FG000|Overall Study|Randomized but not treated|0|||
16163124|NCT02058147|39080007|FG001|Overall Study|Randomized but not treated|0|||
16163125|NCT02058147|39080008|FG002|Overall Study|Randomized but not treated|1|||
16163126|NCT02058147|39080006|FG000|Overall Study|Adverse Event|12|||
16163127|NCT02058147|39080007|FG001|Overall Study|Adverse Event|9|||
16163128|NCT02058147|39080008|FG002|Overall Study|Adverse Event|21|||
16163129|NCT02058147|39080006|FG000|Overall Study|Lack of Efficacy|1|||
16163130|NCT02058147|39080007|FG001|Overall Study|Lack of Efficacy|0|||
16163131|NCT02058147|39080008|FG002|Overall Study|Lack of Efficacy|3|||
16163132|NCT02058147|39080006|FG000|Overall Study|Poor compliance to protocol|8|||
16163133|NCT02058147|39080007|FG001|Overall Study|Poor compliance to protocol|9|||
16163134|NCT02058147|39080008|FG002|Overall Study|Poor compliance to protocol|4|||
16163135|NCT02058147|39080006|FG000|Overall Study|Other than specified|8|||
16163136|NCT02058147|39080007|FG001|Overall Study|Other than specified|9|||
16449747|NCT02531802|40125873|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
16449748|NCT02531802|40125874|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
16449749|NCT02531802|40125875|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
16163137|NCT02058147|39080008|FG002|Overall Study|Other than specified|0|||
16163138|NCT02445586|39080011|FG000|Overall Study|Death|14|||
16163139|NCT02445586|39080011|FG000|Overall Study|Withdrawal by Subject|13|||
16265134|NCT00415363|39453300|FG001|Overall Study|Adverse Event|4|||
16163140|NCT02445586|39080011|FG000|Overall Study|Disease Progression|10|||
16163141|NCT02445586|39080011|FG000|Overall Study|Protocol Violation|1|||
16163142|NCT02445586|39080011|FG000|Overall Study|Medical Condition|1|||
16163143|NCT01482910|39080014|FG000|Overall Study|Adverse Event|6|||
16163144|NCT01482910|39080015|FG001|Overall Study|Adverse Event|5|||
16163145|NCT01482910|39080014|FG000|Overall Study|Lost to Follow-up|0|||
16163146|NCT01482910|39080015|FG001|Overall Study|Lost to Follow-up|1|||
16163147|NCT01482910|39080014|FG000|Overall Study|Protocol Violation|1|||
16163148|NCT01482910|39080015|FG001|Overall Study|Protocol Violation|1|||
16163149|NCT01482910|39080014|FG000|Overall Study|Withdrawal by Subject|7|||
16163150|NCT01482910|39080015|FG001|Overall Study|Withdrawal by Subject|2|||
16163151|NCT01482910|39080014|FG000|Overall Study|Death|1|||
16163152|NCT01482910|39080015|FG001|Overall Study|Death|0|||
16163153|NCT00996203|39080017|FG000|Overall Study|Adverse Event|3|||
16163154|NCT00996203|39080017|FG000|Overall Study|Lost to Follow-up|1|||
16163155|NCT00996203|39080017|FG000|Overall Study|Lack of Efficacy|1|||
16163156|NCT00996203|39080017|FG000|Overall Study|Protocol Violation|2|||
16163157|NCT00706030|39080018|FG000|Overall Study|Disease Progression|4|||
16163158|NCT00706030|39080019|FG001|Overall Study|Disease Progression|6|||
16163159|NCT00706030|39080020|FG002|Overall Study|Disease Progression|46|||
16163160|NCT00706030|39080021|FG003|Overall Study|Disease Progression|12|||
16163161|NCT00706030|39080018|FG000|Overall Study|Adverse Event|1|||
16163162|NCT00706030|39080019|FG001|Overall Study|Adverse Event|0|||
16163163|NCT00706030|39080020|FG002|Overall Study|Adverse Event|4|||
16163164|NCT00706030|39080021|FG003|Overall Study|Adverse Event|2|||
16163165|NCT00706030|39080018|FG000|Overall Study|Withdrawal by Subject|1|||
16163166|NCT00706030|39080019|FG001|Overall Study|Withdrawal by Subject|0|||
16163167|NCT00706030|39080020|FG002|Overall Study|Withdrawal by Subject|2|||
16163168|NCT00706030|39080021|FG003|Overall Study|Withdrawal by Subject|0|||
16163169|NCT00706030|39080018|FG000|Overall Study|Physician Decision|0|||
16163170|NCT00706030|39080019|FG001|Overall Study|Physician Decision|0|||
16163171|NCT00706030|39080020|FG002|Overall Study|Physician Decision|2|||
16163172|NCT00706030|39080021|FG003|Overall Study|Physician Decision|0|||
16163173|NCT00706030|39080018|FG000|Overall Study|Not recorded|0|||
16163174|NCT00706030|39080019|FG001|Overall Study|Not recorded|0|||
16163175|NCT00706030|39080020|FG002|Overall Study|Not recorded|2|||
16163176|NCT00706030|39080021|FG003|Overall Study|Not recorded|0|||
16163177|NCT00706030|39080018|FG000|Overall Study|Protocol Violation|0|||
16163178|NCT00706030|39080019|FG001|Overall Study|Protocol Violation|0|||
16163179|NCT00706030|39080020|FG002|Overall Study|Protocol Violation|1|||
16163180|NCT00706030|39080021|FG003|Overall Study|Protocol Violation|1|||
16163181|NCT00706030|39080018|FG000|Overall Study|Failed to return|0|||
16163182|NCT00706030|39080019|FG001|Overall Study|Failed to return|0|||
16265135|NCT00415363|39453299|FG000|Overall Study|Lost to Follow-up|2|||
16265136|NCT00415363|39453300|FG001|Overall Study|Lost to Follow-up|1|||
16449750|NCT02531802|40125855|FG000|Received Vaccination 2|Physician Decision|0|||
16449751|NCT02531802|40125856|FG001|Received Vaccination 2|Physician Decision|0|||
16449752|NCT02531802|40125857|FG002|Received Vaccination 2|Physician Decision|0|||
16449753|NCT02531802|40125858|FG003|Received Vaccination 2|Physician Decision|0|||
16449754|NCT02531802|40125859|FG004|Received Vaccination 2|Physician Decision|0|||
16449755|NCT02531802|40125860|FG005|Received Vaccination 2|Physician Decision|1|||
16449756|NCT02531802|40125861|FG006|Received Vaccination 2|Physician Decision|0|||
16449757|NCT02531802|40125862|FG007|Received Vaccination 2|Physician Decision|0|||
16449758|NCT02531802|40125863|FG008|Received Vaccination 2|Physician Decision|0|||
16449759|NCT02531802|40125864|FG009|Received Vaccination 2|Physician Decision|2|||
16449760|NCT02531802|40125865|FG010|Received Vaccination 2|Physician Decision|0|||
16449761|NCT02531802|40125866|FG011|Received Vaccination 2|Physician Decision|0|||
16449762|NCT02531802|40125867|FG012|Received Vaccination 2|Physician Decision|0|||
16449763|NCT02531802|40125868|FG013|Received Vaccination 2|Physician Decision|1|||
16449764|NCT02531802|40125869|FG014|Received Vaccination 2|Physician Decision|0|||
16449765|NCT02531802|40125870|FG015|Received Vaccination 2|Physician Decision|0|||
16449766|NCT02531802|40125871|FG016|Received Vaccination 2|Physician Decision|0|||
16449767|NCT02531802|40125872|FG017|Received Vaccination 2|Physician Decision|1|||
16449768|NCT02531802|40125873|FG018|Received Vaccination 2|Physician Decision|0|||
16449769|NCT02531802|40125874|FG019|Received Vaccination 2|Physician Decision|0|||
16449770|NCT02531802|40125875|FG020|Received Vaccination 2|Physician Decision|0|||
16449771|NCT02531802|40125855|FG000|Received Vaccination 2|Adverse Event|0|||
16163183|NCT00706030|39080020|FG002|Overall Study|Failed to return|1|||
16163184|NCT00706030|39080021|FG003|Overall Study|Failed to return|0|||
16163185|NCT00706030|39080018|FG000|Overall Study|Symptomatic Deterioration|0|||
16163186|NCT00706030|39080019|FG001|Overall Study|Symptomatic Deterioration|0|||
16163187|NCT00706030|39080020|FG002|Overall Study|Symptomatic Deterioration|1|||
16163188|NCT00706030|39080021|FG003|Overall Study|Symptomatic Deterioration|0|||
16163189|NCT00706030|39080018|FG000|Overall Study|No treatment received|0|||
16163190|NCT00706030|39080019|FG001|Overall Study|No treatment received|0|||
16449772|NCT02531802|40125856|FG001|Received Vaccination 2|Adverse Event|0|||
16163191|NCT00706030|39080020|FG002|Overall Study|No treatment received|0|||
16163192|NCT00706030|39080021|FG003|Overall Study|No treatment received|1|||
16163193|NCT00706030|39080018|FG000|Overall Study|Death|0|||
16163194|NCT00706030|39080019|FG001|Overall Study|Death|0|||
16265137|NCT00415363|39453299|FG000|Overall Study|Physician Decision|3|||
16449773|NCT02531802|40125857|FG002|Received Vaccination 2|Adverse Event|0|||
16449774|NCT02531802|40125858|FG003|Received Vaccination 2|Adverse Event|0|||
16449775|NCT02531802|40125859|FG004|Received Vaccination 2|Adverse Event|0|||
16449776|NCT02531802|40125860|FG005|Received Vaccination 2|Adverse Event|2|||
16449777|NCT02531802|40125861|FG006|Received Vaccination 2|Adverse Event|0|||
16449778|NCT02531802|40125862|FG007|Received Vaccination 2|Adverse Event|0|||
16449779|NCT02531802|40125863|FG008|Received Vaccination 2|Adverse Event|0|||
16449780|NCT02531802|40125864|FG009|Received Vaccination 2|Adverse Event|0|||
16449781|NCT02531802|40125865|FG010|Received Vaccination 2|Adverse Event|0|||
16449782|NCT02531802|40125866|FG011|Received Vaccination 2|Adverse Event|0|||
16449783|NCT02531802|40125867|FG012|Received Vaccination 2|Adverse Event|0|||
16449784|NCT02531802|40125868|FG013|Received Vaccination 2|Adverse Event|0|||
16449785|NCT02531802|40125869|FG014|Received Vaccination 2|Adverse Event|0|||
16449786|NCT02531802|40125870|FG015|Received Vaccination 2|Adverse Event|0|||
16449787|NCT02531802|40125871|FG016|Received Vaccination 2|Adverse Event|0|||
16449788|NCT02531802|40125872|FG017|Received Vaccination 2|Adverse Event|2|||
16449789|NCT02531802|40125873|FG018|Received Vaccination 2|Adverse Event|1|||
16449790|NCT02531802|40125874|FG019|Received Vaccination 2|Adverse Event|0|||
16449791|NCT02531802|40125875|FG020|Received Vaccination 2|Adverse Event|1|||
16449792|NCT02531802|40125855|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
16449793|NCT02531802|40125856|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
16449794|NCT02531802|40125857|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
16449795|NCT02531802|40125858|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
16449796|NCT02531802|40125859|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
16449797|NCT02531802|40125860|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
16449798|NCT02531802|40125861|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
16449799|NCT02531802|40125862|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
16449800|NCT02531802|40125863|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
16449801|NCT02531802|40125864|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
16449802|NCT02531802|40125865|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
16449803|NCT02531802|40125866|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
16449804|NCT02531802|40125867|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
16449805|NCT02531802|40125868|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
16449806|NCT02531802|40125869|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
16449807|NCT02531802|40125870|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
16449808|NCT02531802|40125871|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
16449809|NCT02531802|40125872|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
16449810|NCT02531802|40125873|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
16449811|NCT02531802|40125874|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
16449812|NCT02531802|40125875|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
16449813|NCT01929317|40125876|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
16449814|NCT01929317|40125877|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
16449815|NCT01929317|40125876|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
16449816|NCT01929317|40125877|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
16449817|NCT01929317|40125876|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
16449818|NCT01929317|40125877|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
16449819|NCT01929317|40125876|FG000|Long-term Phase|Adverse Event|5|||
16449820|NCT01929317|40125877|FG001|Long-term Phase|Adverse Event|1|||
16449821|NCT01929317|40125876|FG000|Long-term Phase|Physician Decision|3|||
16449822|NCT01929317|40125877|FG001|Long-term Phase|Physician Decision|0|||
16449823|NCT01929317|40125876|FG000|Long-term Phase|Withdrawal by Subject|4|||
16449824|NCT01929317|40125877|FG001|Long-term Phase|Withdrawal by Subject|0|||
16449825|NCT01929317|40125876|FG000|Long-term Phase|Protocol Violation|1|||
16449826|NCT01929317|40125877|FG001|Long-term Phase|Protocol Violation|0|||
16449827|NCT01929317|40125876|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
16449828|NCT01929317|40125877|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
16449829|NCT01929317|40125876|FG000|Long-term Phase|Study Closed/Terminated|5|||
16449830|NCT01929317|40125877|FG001|Long-term Phase|Study Closed/Terminated|3|||
16449831|NCT03694353|40125878|FG000|Overall Study|Withdrawal by Subject|1|||
16449832|NCT03694353|40125878|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
16449833|NCT01108185|40125881|FG000|Overall Study|Non-compliance|15|||
16265138|NCT00415363|39453300|FG001|Overall Study|Physician Decision|1|||
16449834|NCT01108185|40125881|FG000|Overall Study|Lost to Follow-up|12|||
16449835|NCT01987453|40125882|FG000|Overall Study|Death|0|||
16449836|NCT01987453|40125883|FG001|Overall Study|Death|0|||
16449837|NCT01987453|40125884|FG002|Overall Study|Death|1|||
16449838|NCT01987453|40125882|FG000|Overall Study|Lack of Efficacy|1|||
16449839|NCT01987453|40125883|FG001|Overall Study|Lack of Efficacy|12|||
16449840|NCT01987453|40125884|FG002|Overall Study|Lack of Efficacy|0|||
16449841|NCT04292899|40125885|FG000|Overall Study|Death|21|||
16449842|NCT04292899|40125886|FG001|Overall Study|Death|28|||
16163195|NCT00706030|39080020|FG002|Overall Study|Death|1|||
16163196|NCT00706030|39080021|FG003|Overall Study|Death|0|||
16163197|NCT00634569|39080022|FG000|Overall Study|Withdrawal by Subject|0|||
16163198|NCT00634569|39080023|FG001|Overall Study|Withdrawal by Subject|4|||
16163199|NCT00634569|39080022|FG000|Overall Study|Physician Decision|0|||
16163200|NCT00634569|39080023|FG001|Overall Study|Physician Decision|1|||
16163201|NCT03902080|39080030|FG000|Overall Study|Adverse Event|17|||
16163202|NCT03902080|39080031|FG001|Overall Study|Adverse Event|15|||
16163203|NCT03902080|39080030|FG000|Overall Study|Withdrawal by Subject|28|||
16163204|NCT03902080|39080031|FG001|Overall Study|Withdrawal by Subject|35|||
16163205|NCT03902080|39080030|FG000|Overall Study|Lost to Follow-up|6|||
16163206|NCT03902080|39080031|FG001|Overall Study|Lost to Follow-up|7|||
16163207|NCT03902080|39080030|FG000|Overall Study|Other|3|||
16163208|NCT03902080|39080031|FG001|Overall Study|Other|5|||
16163209|NCT03902080|39080030|FG000|Overall Study|Non compliance|4|||
16163210|NCT03902080|39080031|FG001|Overall Study|Non compliance|3|||
16163211|NCT03902080|39080030|FG000|Overall Study|Physician Decision|5|||
16163212|NCT03902080|39080031|FG001|Overall Study|Physician Decision|1|||
16163213|NCT03902080|39080030|FG000|Overall Study|Protocol Violation|3|||
16163214|NCT03902080|39080031|FG001|Overall Study|Protocol Violation|3|||
16163215|NCT03902080|39080030|FG000|Overall Study|Lack of Efficacy|1|||
16163216|NCT03902080|39080031|FG001|Overall Study|Lack of Efficacy|3|||
16163217|NCT03902080|39080030|FG000|Overall Study|Withdrawn prior to dosing|0|||
16163218|NCT03902080|39080031|FG001|Overall Study|Withdrawn prior to dosing|1|||
16163219|NCT00332709|39080040|FG000|Overall Study|Adverse Event|11|||
16163220|NCT00332709|39080041|FG001|Overall Study|Adverse Event|14|||
16163221|NCT00332709|39080040|FG000|Overall Study|Withdrawal by Subject|2|||
16163222|NCT00332709|39080041|FG001|Overall Study|Withdrawal by Subject|3|||
16163223|NCT00332709|39080040|FG000|Overall Study|Lost to Follow-up|2|||
16163224|NCT00332709|39080041|FG001|Overall Study|Lost to Follow-up|0|||
16163225|NCT00332709|39080040|FG000|Overall Study|Administrative Problems|0|||
16163226|NCT00332709|39080041|FG001|Overall Study|Administrative Problems|3|||
16163227|NCT00332709|39080040|FG000|Overall Study|Abnormal test procedure result|1|||
16449843|NCT04292899|40125887|FG002|Overall Study|Death|188|||
16449844|NCT04292899|40125888|FG003|Overall Study|Death|371|||
16449845|NCT04292899|40125885|FG000|Overall Study|Lost to Follow-up|8|||
16449846|NCT04292899|40125886|FG001|Overall Study|Lost to Follow-up|4|||
16449847|NCT04292899|40125887|FG002|Overall Study|Lost to Follow-up|22|||
16449848|NCT04292899|40125888|FG003|Overall Study|Lost to Follow-up|235|||
16449849|NCT04292899|40125885|FG000|Overall Study|Withdrew consent|1|||
16449850|NCT04292899|40125886|FG001|Overall Study|Withdrew consent|0|||
16449851|NCT04292899|40125887|FG002|Overall Study|Withdrew consent|11|||
16449852|NCT04292899|40125888|FG003|Overall Study|Withdrew consent|32|||
16449853|NCT04292899|40125885|FG000|Overall Study|Adverse Event|2|||
16449854|NCT04292899|40125886|FG001|Overall Study|Adverse Event|1|||
16449855|NCT04292899|40125887|FG002|Overall Study|Adverse Event|2|||
16449856|NCT04292899|40125888|FG003|Overall Study|Adverse Event|2|||
16449857|NCT04292899|40125885|FG000|Overall Study|Investigator's Discretion|0|||
16449858|NCT04292899|40125886|FG001|Overall Study|Investigator's Discretion|0|||
16449859|NCT04292899|40125887|FG002|Overall Study|Investigator's Discretion|0|||
16163228|NCT00332709|39080041|FG001|Overall Study|Abnormal test procedure result|0|||
16163229|NCT02154425|39080044|FG000|Screening Period|Adverse Event|1|||
16449860|NCT04292899|40125888|FG003|Overall Study|Investigator's Discretion|3|||
16449861|NCT04292899|40125885|FG000|Overall Study|Non-compliance With Study Drug|0|||
16449862|NCT04292899|40125886|FG001|Overall Study|Non-compliance With Study Drug|0|||
16449863|NCT04292899|40125887|FG002|Overall Study|Non-compliance With Study Drug|0|||
16449864|NCT04292899|40125888|FG003|Overall Study|Non-compliance With Study Drug|1|||
16449865|NCT04292899|40125885|FG000|Overall Study|Protocol Violation|0|||
16449866|NCT04292899|40125886|FG001|Overall Study|Protocol Violation|0|||
16449867|NCT04292899|40125887|FG002|Overall Study|Protocol Violation|0|||
16449868|NCT04292899|40125888|FG003|Overall Study|Protocol Violation|1|||
16449869|NCT01166282|40125893|FG000|Open-label Period|Adverse Event|0|||
16449870|NCT01166282|40125894|FG001|Open-label Period|Adverse Event|0|||
16449871|NCT01166282|40125895|FG002|Open-label Period|Adverse Event|6|||
16163230|NCT01931059|39080045|FG000|Day 1|Pregnancy|0|||
16163231|NCT01931059|39080046|FG001|Day 1|Pregnancy|1|||
16163232|NCT01931059|39080045|FG000|Day3|Lost to Follow-up|1|||
16449872|NCT01166282|40125893|FG000|Open-label Period|Withdrawal by Subject|0|||
16449873|NCT01166282|40125894|FG001|Open-label Period|Withdrawal by Subject|0|||
16449874|NCT01166282|40125895|FG002|Open-label Period|Withdrawal by Subject|4|||
16163233|NCT01931059|39080046|FG001|Day3|Lost to Follow-up|0|||
16163234|NCT00713219|39080047|FG000|Overall Study|Death|1|||
16163235|NCT00713219|39080047|FG000|Overall Study|Protocol Violation|1|||
16163236|NCT00454805|39080048|FG000|Overall Study|Withdrawal by Subject|9|||
16163237|NCT00454805|39080049|FG001|Overall Study|Withdrawal by Subject|2|||
16449875|NCT01166282|40125893|FG000|Open-label Period|Lack of Efficacy|0|||
16449876|NCT01166282|40125894|FG001|Open-label Period|Lack of Efficacy|0|||
16449877|NCT01166282|40125895|FG002|Open-label Period|Lack of Efficacy|2|||
16163238|NCT00454805|39080048|FG000|Overall Study|Death|0|||
16163239|NCT00454805|39080049|FG001|Overall Study|Death|2|||
16163240|NCT00454805|39080048|FG000|Overall Study|Disease progression|16|||
16449878|NCT01166282|40125893|FG000|Open-label Period|Remission|0|||
16449879|NCT01166282|40125894|FG001|Open-label Period|Remission|0|||
16449880|NCT01166282|40125895|FG002|Open-label Period|Remission|4|||
16449881|NCT01166282|40125893|FG000|Open-label Period|Irregular Compliance|0|||
16265139|NCT00415363|39453299|FG000|Overall Study|Death|16|||
16265140|NCT00415363|39453300|FG001|Overall Study|Death|12|||
16265141|NCT00415363|39453299|FG000|Overall Study|Progressive disease|26|||
16449882|NCT01166282|40125894|FG001|Open-label Period|Irregular Compliance|0|||
16449883|NCT01166282|40125895|FG002|Open-label Period|Irregular Compliance|1|||
16449884|NCT01584440|40125896|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
16449885|NCT01584440|40125897|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
16449886|NCT01584440|40125898|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
16449887|NCT01584440|40125899|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
16449888|NCT01584440|40125900|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
16449889|NCT01584440|40125896|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
16449890|NCT01584440|40125897|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
16449891|NCT01584440|40125898|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
16449892|NCT01584440|40125899|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
16163241|NCT00454805|39080049|FG001|Overall Study|Disease progression|19|||
16163242|NCT00454805|39080048|FG000|Overall Study|In order to begin radiotherapy|1|||
16163243|NCT00454805|39080049|FG001|Overall Study|In order to begin radiotherapy|0|||
16163244|NCT00560755|39080054|FG000|Overall Study|Protocol Violation|15|||
16163245|NCT00560755|39080054|FG000|Overall Study|Withdrawal by Subject|26|||
16163246|NCT00560755|39080054|FG000|Overall Study|Lost to Follow-up|9|||
16163247|NCT00560755|39080054|FG000|Overall Study|Adverse Event|8|||
16449893|NCT01584440|40125900|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
16449894|NCT01584440|40125896|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
16449895|NCT01584440|40125897|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
16449896|NCT01584440|40125898|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
16449897|NCT01584440|40125899|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
16449898|NCT01584440|40125900|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
16449899|NCT01584440|40125896|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
16449900|NCT01584440|40125897|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
16449901|NCT01584440|40125898|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
16449902|NCT01584440|40125899|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
16449903|NCT01584440|40125900|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
16449904|NCT01584440|40125896|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
16449905|NCT01584440|40125897|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
16449906|NCT01584440|40125898|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
16449907|NCT01584440|40125899|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
16449908|NCT01584440|40125900|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
16449909|NCT01584440|40125896|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
16449910|NCT01584440|40125897|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
16449911|NCT01584440|40125898|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
16449912|NCT01584440|40125899|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
16449913|NCT01584440|40125900|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
16449914|NCT01584440|40125896|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
16449915|NCT01584440|40125897|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
16449916|NCT01584440|40125898|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
16449917|NCT01584440|40125899|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
16449918|NCT01584440|40125900|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
16449919|NCT01584440|40125896|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
16449920|NCT01584440|40125897|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
16449921|NCT01584440|40125898|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
16449922|NCT01584440|40125899|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
16449923|NCT01584440|40125900|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
16449924|NCT01584440|40125896|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
16449925|NCT01584440|40125897|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
16163248|NCT00560755|39080054|FG000|Overall Study|Physician Decision|2|||
16163249|NCT00608985|39080059|FG000|Overall Study|Adverse Event|2|||
16163250|NCT00608985|39080060|FG001|Overall Study|Adverse Event|7|||
16265142|NCT00415363|39453300|FG001|Overall Study|Progressive disease|32|||
16449926|NCT01584440|40125898|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
16163251|NCT00608985|39080061|FG002|Overall Study|Adverse Event|4|||
16449927|NCT01584440|40125899|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
16449928|NCT01584440|40125900|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
16449929|NCT01780974|40125901|FG000|Overall Study|Death|1|||
16449930|NCT01780974|40125902|FG001|Overall Study|Death|0|||
16449931|NCT01780974|40125901|FG000|Overall Study|Adverse Event|1|||
16449932|NCT01780974|40125902|FG001|Overall Study|Adverse Event|3|||
16163252|NCT00608985|39080062|FG003|Overall Study|Adverse Event|6|||
16163253|NCT00608985|39080059|FG000|Overall Study|Administrative/Other|7|||
16265143|NCT01471353|39453301|FG000|Overall Study|remain on study|3|||
16265144|NCT03966365|39453302|FG000|Overall Study|Protocol Violation|1|||
16449933|NCT00577889|40125904|FG000|Overall Study|Withdrawal by Subject|1|||
16449934|NCT00577889|40125905|FG001|Overall Study|Withdrawal by Subject|0|||
16449935|NCT00577889|40125906|FG002|Overall Study|Withdrawal by Subject|0|||
16449936|NCT02346721|40125907|FG000|Overall Study|Withdrew Consent|3|||
16449937|NCT02346721|40125907|FG000|Overall Study|Lack of Efficacy|1|||
16449938|NCT03819114|40125909|FG000|Overall Study|Protocol Violation|0|||
16449939|NCT03819114|40125910|FG001|Overall Study|Protocol Violation|1|||
16449940|NCT03819114|40125911|FG002|Overall Study|Protocol Violation|1|||
16163254|NCT00608985|39080060|FG001|Overall Study|Administrative/Other|4|||
16163255|NCT00608985|39080061|FG002|Overall Study|Administrative/Other|1|||
16163256|NCT00608985|39080062|FG003|Overall Study|Administrative/Other|2|||
16163257|NCT00608985|39080059|FG000|Overall Study|Withdrawal of Consent|5|||
16163258|NCT00608985|39080060|FG001|Overall Study|Withdrawal of Consent|1|||
16163259|NCT00608985|39080061|FG002|Overall Study|Withdrawal of Consent|1|||
16163260|NCT00608985|39080062|FG003|Overall Study|Withdrawal of Consent|1|||
16163261|NCT00608985|39080059|FG000|Overall Study|Lost to Follow-up|2|||
16163262|NCT00608985|39080060|FG001|Overall Study|Lost to Follow-up|1|||
16163263|NCT00608985|39080061|FG002|Overall Study|Lost to Follow-up|0|||
16163264|NCT00608985|39080062|FG003|Overall Study|Lost to Follow-up|0|||
16163265|NCT02918019|39080063|FG000|Overall Study|Death|0|||
16163266|NCT02918019|39080064|FG001|Overall Study|Death|0|||
16163267|NCT02918019|39080065|FG002|Overall Study|Death|1|||
16163268|NCT02918019|39080066|FG003|Overall Study|Death|0|||
16449941|NCT03819114|40125912|FG003|Overall Study|Protocol Violation|0|||
16449942|NCT03819114|40125909|FG000|Overall Study|Lost to Follow-up|0|||
16449943|NCT03819114|40125910|FG001|Overall Study|Lost to Follow-up|0|||
16449944|NCT03819114|40125911|FG002|Overall Study|Lost to Follow-up|1|||
16449945|NCT03819114|40125912|FG003|Overall Study|Lost to Follow-up|0|||
16449946|NCT01456039|40125913|FG000|Phase 1 (First Step)|Disease Progression|1|||
16449947|NCT01456039|40125914|FG001|Phase 1 (First Step)|Disease Progression|1|||
16449948|NCT01456039|40125915|FG002|Phase 1 (First Step)|Disease Progression|0|||
16449949|NCT01456039|40125913|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
16449950|NCT01456039|40125914|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
16449951|NCT01456039|40125915|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
16449952|NCT01456039|40125913|FG000|Phase 1 (First Step)|Adverse Event|0|||
16449953|NCT01456039|40125914|FG001|Phase 1 (First Step)|Adverse Event|3|||
16449954|NCT01456039|40125915|FG002|Phase 1 (First Step)|Adverse Event|0|||
16449955|NCT01456039|40125913|FG000|Phase 1 (First Step)|Other|0|||
16449956|NCT01456039|40125914|FG001|Phase 1 (First Step)|Other|1|||
16449957|NCT01456039|40125915|FG002|Phase 1 (First Step)|Other|0|||
16449958|NCT01456039|40125913|FG000|Phase 2 (Second Step)|Disease Progression|0|||
16449959|NCT01456039|40125914|FG001|Phase 2 (Second Step)|Disease Progression|0|||
16449960|NCT01456039|40125915|FG002|Phase 2 (Second Step)|Disease Progression|17|||
16449961|NCT01456039|40125913|FG000|Phase 2 (Second Step)|Adverse Event|0|||
16449962|NCT01456039|40125914|FG001|Phase 2 (Second Step)|Adverse Event|0|||
16449963|NCT01456039|40125915|FG002|Phase 2 (Second Step)|Adverse Event|10|||
16449964|NCT01456039|40125913|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
16449965|NCT01456039|40125914|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
16449966|NCT01456039|40125915|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
16449967|NCT01456039|40125913|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
16449968|NCT01456039|40125914|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
16449969|NCT01456039|40125915|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
16449970|NCT01456039|40125913|FG000|Phase 2 (Second Step)|Other|0|||
16449971|NCT01456039|40125914|FG001|Phase 2 (Second Step)|Other|0|||
16449972|NCT01456039|40125915|FG002|Phase 2 (Second Step)|Other|1|||
16449973|NCT00942604|40125916|FG000|Overall Study|Protocol Violation|1|||
16449974|NCT00942604|40125917|FG001|Overall Study|Protocol Violation|1|||
16449975|NCT00942604|40125916|FG000|Overall Study|Adverse Event|0|||
16449976|NCT00942604|40125917|FG001|Overall Study|Adverse Event|1|||
16449977|NCT00942604|40125916|FG000|Overall Study|Withdrawal by Subject|0|||
16449978|NCT00942604|40125917|FG001|Overall Study|Withdrawal by Subject|1|||
16449979|NCT00942604|40125916|FG000|Overall Study|Patient relocation|1|||
16449980|NCT00942604|40125917|FG001|Overall Study|Patient relocation|1|||
16449981|NCT03041181|40125921|FG000|Overall Study|Disease Progression|1|||
16449982|NCT03041181|40125922|FG001|Overall Study|Disease Progression|2|||
16449983|NCT00665652|40125923|FG000|Overall Study|Adverse Event|4|||
16449984|NCT00665652|40125923|FG000|Overall Study|Death|1|||
16449985|NCT00665652|40125923|FG000|Overall Study|No longer met inclusion criteria.|1|||
16163269|NCT02918019|39080063|FG000|Overall Study|Lost to Follow-up|1|||
16163270|NCT02918019|39080064|FG001|Overall Study|Lost to Follow-up|1|||
16163271|NCT02918019|39080065|FG002|Overall Study|Lost to Follow-up|0|||
16449986|NCT02633306|40125924|FG000|Overall Study|Withdrawal by Subject|3|||
16449987|NCT03131219|40125925|FG000|Initial Evaluation Period|Adverse Event|2|||
16449988|NCT03131219|40125926|FG001|Initial Evaluation Period|Adverse Event|0|||
16449989|NCT03131219|40125925|FG000|Initial Evaluation Period|Protocol Violation|1|||
16163272|NCT02918019|39080066|FG003|Overall Study|Lost to Follow-up|1|||
16449990|NCT03131219|40125926|FG001|Initial Evaluation Period|Protocol Violation|0|||
16449991|NCT03131219|40125925|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
16449992|NCT03131219|40125926|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
16449993|NCT03131219|40125925|FG000|Initial Evaluation Period|Physician Decision|1|||
16449994|NCT03131219|40125926|FG001|Initial Evaluation Period|Physician Decision|0|||
16449995|NCT03131219|40125925|FG000|Extension Period|Physician Decision|1|||
16449996|NCT03131219|40125926|FG001|Extension Period|Physician Decision|0|||
16449997|NCT02999672|40125927|FG000|Overall Study|Death|0|||
16449998|NCT02999672|40125928|FG001|Overall Study|Death|1|||
16449999|NCT02999672|40125927|FG000|Overall Study|Study Terminated by Sponsor|0|||
16450000|NCT02999672|40125928|FG001|Overall Study|Study Terminated by Sponsor|1|||
16450001|NCT02999672|40125927|FG000|Overall Study|Progressive Disease|9|||
16450002|NCT02999672|40125928|FG001|Overall Study|Progressive Disease|5|||
16450003|NCT02999672|40125927|FG000|Overall Study|Adverse Event|4|||
16450004|NCT02999672|40125928|FG001|Overall Study|Adverse Event|0|||
16450005|NCT02873702|40125933|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
16450006|NCT02873702|40125934|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
16450007|NCT02873702|40125935|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
16450008|NCT02873702|40125936|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
16450009|NCT02873702|40125933|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
16450010|NCT02873702|40125934|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
16450011|NCT02873702|40125935|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
16450012|NCT02873702|40125936|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
16450013|NCT02873702|40125933|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
16450014|NCT02873702|40125934|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
16450015|NCT02873702|40125935|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
16450016|NCT02873702|40125936|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
16450017|NCT02873702|40125933|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
16450018|NCT02873702|40125934|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
16450019|NCT02873702|40125935|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
16450020|NCT02873702|40125936|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
16450021|NCT02873702|40125933|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
16450022|NCT02873702|40125934|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
16450023|NCT02873702|40125935|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
16450024|NCT02873702|40125936|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
16450025|NCT04953728|40125938|FG000|Overall Study|Withdrawal by Subject|3|||
16450026|NCT04953728|40125938|FG000|Overall Study|Physician Decision|1|||
16450027|NCT01780506|40125941|FG000|Double-Blind Phase|Randomized but not Treated|3|||
16163273|NCT02918019|39080063|FG000|Overall Study|Principal investigator request|0|||
16163274|NCT02918019|39080064|FG001|Overall Study|Principal investigator request|0|||
16163275|NCT02918019|39080065|FG002|Overall Study|Principal investigator request|0|||
16163276|NCT02918019|39080066|FG003|Overall Study|Principal investigator request|1|||
16163277|NCT02918019|39080063|FG000|Overall Study|Physician Decision|1|||
16163278|NCT02918019|39080064|FG001|Overall Study|Physician Decision|3|||
16163279|NCT02918019|39080065|FG002|Overall Study|Physician Decision|2|||
16163280|NCT02918019|39080066|FG003|Overall Study|Physician Decision|0|||
16163281|NCT02918019|39080063|FG000|Overall Study|Protocol deviation|1|||
16163282|NCT02918019|39080064|FG001|Overall Study|Protocol deviation|1|||
16163283|NCT02918019|39080065|FG002|Overall Study|Protocol deviation|0|||
16163284|NCT02918019|39080066|FG003|Overall Study|Protocol deviation|2|||
16450028|NCT01780506|40125942|FG001|Double-Blind Phase|Randomized but not Treated|2|||
16450029|NCT01780506|40125941|FG000|Double-Blind Phase|Adverse Event|4|||
16450030|NCT01780506|40125942|FG001|Double-Blind Phase|Adverse Event|14|||
16450031|NCT01780506|40125941|FG000|Double-Blind Phase|Death|1|||
16450032|NCT01780506|40125942|FG001|Double-Blind Phase|Death|2|||
16450033|NCT01780506|40125941|FG000|Double-Blind Phase|Pregnancy|2|||
16163285|NCT02918019|39080063|FG000|Overall Study|Withdrawal by Subject|3|||
16163286|NCT02918019|39080064|FG001|Overall Study|Withdrawal by Subject|4|||
16163287|NCT02918019|39080065|FG002|Overall Study|Withdrawal by Subject|6|||
16163288|NCT02918019|39080066|FG003|Overall Study|Withdrawal by Subject|4|||
16163289|NCT02918019|39080063|FG000|Overall Study|Adverse Event|0|||
16163290|NCT02918019|39080064|FG001|Overall Study|Adverse Event|1|||
16163291|NCT02918019|39080065|FG002|Overall Study|Adverse Event|0|||
16163292|NCT02918019|39080066|FG003|Overall Study|Adverse Event|1|||
16450034|NCT01780506|40125942|FG001|Double-Blind Phase|Pregnancy|1|||
16450035|NCT01780506|40125941|FG000|Double-Blind Phase|Lack of Efficacy|1|||
16450036|NCT01780506|40125942|FG001|Double-Blind Phase|Lack of Efficacy|1|||
16450037|NCT01780506|40125941|FG000|Double-Blind Phase|Investigator's Discretion|5|||
16450038|NCT01780506|40125942|FG001|Double-Blind Phase|Investigator's Discretion|2|||
16450039|NCT01780506|40125941|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
16450040|NCT01780506|40125942|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
16163293|NCT00584870|39080067|FG000|Overall Study|Adverse Event|4|||
16163294|NCT00584870|39080068|FG001|Overall Study|Adverse Event|3|||
16163295|NCT00584870|39080069|FG002|Overall Study|Adverse Event|2|||
16163296|NCT00584870|39080067|FG000|Overall Study|Lost to Follow-up|4|||
16163297|NCT00584870|39080068|FG001|Overall Study|Lost to Follow-up|1|||
16450041|NCT01780506|40125941|FG000|Double-Blind Phase|Protocol Violation|4|||
16450042|NCT01780506|40125942|FG001|Double-Blind Phase|Protocol Violation|3|||
16450043|NCT01780506|40125941|FG000|Double-Blind Phase|Withdrew Consent|23|||
16450044|NCT01780506|40125942|FG001|Double-Blind Phase|Withdrew Consent|24|||
16450045|NCT01780506|40125941|FG000|Double-Blind Phase|Lost to Follow-up|23|||
16450046|NCT01780506|40125942|FG001|Double-Blind Phase|Lost to Follow-up|26|||
16450047|NCT01780506|40125941|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
16450048|NCT01780506|40125942|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
16450049|NCT00714870|40125948|FG000|Overall Study|Lost to Follow-up|22|||
16450050|NCT00714870|40125949|FG001|Overall Study|Lost to Follow-up|5|||
16450051|NCT00714870|40125948|FG000|Overall Study|patient unable to come b/c back pain|1|||
16450052|NCT00714870|40125949|FG001|Overall Study|patient unable to come b/c back pain|0|||
16450053|NCT00714870|40125948|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
16450054|NCT00714870|40125949|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
16450055|NCT01774721|40125951|FG000|Overall Study|Death|133|||
16450056|NCT01774721|40125952|FG001|Overall Study|Death|152|||
16450057|NCT01774721|40125951|FG000|Overall Study|Withdrawal by Subject|20|||
16450058|NCT01774721|40125952|FG001|Overall Study|Withdrawal by Subject|14|||
16450059|NCT01774721|40125951|FG000|Overall Study|Lost to Follow-up|6|||
16450060|NCT01774721|40125952|FG001|Overall Study|Lost to Follow-up|7|||
16450061|NCT01774721|40125951|FG000|Overall Study|Did not meet eligibility criteria|0|||
16450062|NCT01774721|40125952|FG001|Overall Study|Did not meet eligibility criteria|3|||
16450063|NCT01774721|40125951|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
16450064|NCT01774721|40125952|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
16450065|NCT01774721|40125951|FG000|Overall Study|Study terminated by sponsor|5|||
16450066|NCT01774721|40125952|FG001|Overall Study|Study terminated by sponsor|0|||
16450067|NCT01774721|40125951|FG000|Overall Study|Disease progression|5|||
16450068|NCT01774721|40125952|FG001|Overall Study|Disease progression|0|||
16450069|NCT01702311|40125954|FG000|Overall Study|Withdrawal by Subject|3|||
16450070|NCT01702311|40125955|FG001|Overall Study|Withdrawal by Subject|2|||
16450071|NCT01702311|40125954|FG000|Overall Study|Discharge less than 24 hours|10|||
16450072|NCT01702311|40125955|FG001|Overall Study|Discharge less than 24 hours|7|||
16450073|NCT01702311|40125954|FG000|Overall Study|Physician Decision|3|||
16450074|NCT01702311|40125955|FG001|Overall Study|Physician Decision|4|||
16450075|NCT00357006|40125956|FG000|Overall Study|Lost to Follow-up|1|||
16450076|NCT00357006|40125957|FG001|Overall Study|Lost to Follow-up|2|||
16450077|NCT00357006|40125958|FG002|Overall Study|Lost to Follow-up|1|||
16450078|NCT00357006|40125956|FG000|Overall Study|Withdrawal by Subject|1|||
16450079|NCT00357006|40125957|FG001|Overall Study|Withdrawal by Subject|3|||
16450080|NCT00357006|40125958|FG002|Overall Study|Withdrawal by Subject|2|||
16450081|NCT02453321|40125959|FG000|Overall Study|Weakness|1|||
16450082|NCT02453321|40125960|FG001|Overall Study|Weakness|1|||
16450083|NCT02453321|40125961|FG002|Overall Study|Weakness|2|||
16450084|NCT02453321|40125959|FG000|Overall Study|Deep Venous Thrombosis|0|||
16450085|NCT02453321|40125960|FG001|Overall Study|Deep Venous Thrombosis|1|||
16450086|NCT02453321|40125961|FG002|Overall Study|Deep Venous Thrombosis|0|||
16450087|NCT00834093|40125964|FG000|Overall Study|Progressive Disease|3|||
16450088|NCT00834093|40125964|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
16450089|NCT04597632|40125965|FG000|Overall Study|Withdrawal by Subject|10|||
16450090|NCT04597632|40125965|FG000|Overall Study|Lost to Follow-up|1|||
16450091|NCT04597632|40125965|FG000|Overall Study|Death|1|||
16450092|NCT04597632|40125965|FG000|Overall Study|Adverse Event|5|||
16450093|NCT00888134|40125966|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
16450094|NCT00888134|40125966|FG000|Follow-up|being followed for long-term survival|1|||
16450095|NCT01578486|40125983|FG000|Overall Study|Physician Decision|3|||
16450096|NCT01578486|40125983|FG000|Overall Study|Withdrawal by Subject|2|||
16450097|NCT03863080|40125984|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
16450098|NCT03863080|40125985|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
16450099|NCT03863080|40125986|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
16450100|NCT03863080|40125987|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
16450101|NCT03863080|40125984|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
16450102|NCT03863080|40125985|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
16450103|NCT03863080|40125986|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
16450104|NCT03863080|40125987|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
16450105|NCT03863080|40125984|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
16450106|NCT03863080|40125985|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
16450107|NCT03863080|40125986|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
16450108|NCT03863080|40125987|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
16450109|NCT00865566|40125988|FG000|Overall Study|Death|1|||
16450110|NCT00865566|40125989|FG001|Overall Study|Death|11|||
16450111|NCT00865566|40125988|FG000|Overall Study|Lost to Follow-up|314|||
16450112|NCT00865566|40125989|FG001|Overall Study|Lost to Follow-up|315|||
16163298|NCT00584870|39080069|FG002|Overall Study|Lost to Follow-up|1|||
16450113|NCT00865566|40125988|FG000|Overall Study|Withdrawal by Subject|45|||
16450114|NCT00865566|40125989|FG001|Overall Study|Withdrawal by Subject|65|||
16450115|NCT00865566|40125988|FG000|Overall Study|Physician Decision|0|||
16450116|NCT00865566|40125989|FG001|Overall Study|Physician Decision|1|||
16450117|NCT00865566|40125988|FG000|Overall Study|Participant relocated|78|||
16450118|NCT00865566|40125989|FG001|Overall Study|Participant relocated|107|||
16450119|NCT00865566|40125988|FG000|Overall Study|Participant unable to adhere|27|||
16450120|NCT00865566|40125989|FG001|Overall Study|Participant unable to adhere|42|||
16450121|NCT00865566|40125988|FG000|Overall Study|Other; N=245 due to early study closure|154|||
16450122|NCT00865566|40125989|FG001|Overall Study|Other; N=245 due to early study closure|139|||
16450123|NCT00865566|40125988|FG000|Overall Study|HIV infection|5|||
16450124|NCT00865566|40125989|FG001|Overall Study|HIV infection|7|||
16450125|NCT03486834|40125990|FG000|Overall Study|Withdrawal by Subject|46|||
16450126|NCT03486834|40125991|FG001|Overall Study|Withdrawal by Subject|46|||
16450127|NCT03486834|40125992|FG002|Overall Study|Withdrawal by Subject|52|||
16450128|NCT03486834|40125990|FG000|Overall Study|Adverse Event|8|||
16450129|NCT03486834|40125991|FG001|Overall Study|Adverse Event|7|||
16450130|NCT03486834|40125992|FG002|Overall Study|Adverse Event|0|||
16450131|NCT03486834|40125990|FG000|Overall Study|Lost to Follow-up|41|||
16450132|NCT03486834|40125991|FG001|Overall Study|Lost to Follow-up|24|||
16450133|NCT03486834|40125992|FG002|Overall Study|Lost to Follow-up|39|||
16450134|NCT03486834|40125990|FG000|Overall Study|Non-compliance with Study Drug|2|||
16450135|NCT03486834|40125991|FG001|Overall Study|Non-compliance with Study Drug|2|||
16450136|NCT03486834|40125992|FG002|Overall Study|Non-compliance with Study Drug|0|||
16450137|NCT03486834|40125990|FG000|Overall Study|Physician Decision|5|||
16450138|NCT03486834|40125991|FG001|Overall Study|Physician Decision|2|||
16450139|NCT03486834|40125992|FG002|Overall Study|Physician Decision|3|||
16450140|NCT03486834|40125990|FG000|Overall Study|Pregnancy|10|||
16450141|NCT03486834|40125991|FG001|Overall Study|Pregnancy|12|||
16450142|NCT03486834|40125992|FG002|Overall Study|Pregnancy|12|||
16450143|NCT03486834|40125990|FG000|Overall Study|Protocol Deviation|2|||
16450144|NCT03486834|40125991|FG001|Overall Study|Protocol Deviation|3|||
16450145|NCT03486834|40125992|FG002|Overall Study|Protocol Deviation|3|||
16450146|NCT03486834|40125990|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
16450147|NCT03486834|40125991|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
16450148|NCT03486834|40125992|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
16450149|NCT03486834|40125990|FG000|Overall Study|Randomized but not treated|4|||
16450150|NCT03486834|40125991|FG001|Overall Study|Randomized but not treated|4|||
16450151|NCT03486834|40125992|FG002|Overall Study|Randomized but not treated|1|||
16450152|NCT03614156|40125993|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
16450153|NCT03614156|40125994|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
16450154|NCT03614156|40125995|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
16450155|NCT03614156|40125996|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
16450156|NCT03614156|40125993|FG000|Open-Label Treatment Period|Adverse Event|7|||
16450157|NCT03614156|40125994|FG001|Open-Label Treatment Period|Adverse Event|0|||
16450158|NCT03614156|40125995|FG002|Open-Label Treatment Period|Adverse Event|0|||
16450159|NCT03614156|40125996|FG003|Open-Label Treatment Period|Adverse Event|0|||
16450160|NCT03614156|40125993|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
16450161|NCT03614156|40125994|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
16450162|NCT03614156|40125995|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
16450163|NCT03614156|40125996|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
16450164|NCT03614156|40125993|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
16450165|NCT03614156|40125994|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
16450166|NCT03614156|40125995|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
16450167|NCT03614156|40125996|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
16450168|NCT03614156|40125993|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
16450169|NCT03614156|40125994|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
16450170|NCT03614156|40125995|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
16450171|NCT03614156|40125996|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
16450172|NCT03614156|40125993|FG000|Open-Label Treatment Period|Protocol Violation|2|||
16450173|NCT03614156|40125994|FG001|Open-Label Treatment Period|Protocol Violation|0|||
16450174|NCT03614156|40125995|FG002|Open-Label Treatment Period|Protocol Violation|0|||
16450175|NCT03614156|40125996|FG003|Open-Label Treatment Period|Protocol Violation|0|||
16450176|NCT03614156|40125993|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
16450177|NCT03614156|40125994|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
16450178|NCT03614156|40125995|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
16450179|NCT03614156|40125996|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
16450180|NCT03614156|40125993|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
16450181|NCT03614156|40125994|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
16450182|NCT03614156|40125995|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
16450183|NCT03614156|40125996|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
16450184|NCT03614156|40125993|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
16450185|NCT03614156|40125994|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
16450186|NCT03614156|40125995|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
16450187|NCT03614156|40125996|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
16450188|NCT03614156|40125993|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
16163299|NCT00584870|39080067|FG000|Overall Study|Lack of Efficacy|7|||
16163300|NCT00584870|39080068|FG001|Overall Study|Lack of Efficacy|14|||
16163301|NCT00584870|39080069|FG002|Overall Study|Lack of Efficacy|8|||
16163302|NCT00584870|39080067|FG000|Overall Study|Withdrawal by Subject|10|||
16163303|NCT00584870|39080068|FG001|Overall Study|Withdrawal by Subject|5|||
16163304|NCT00584870|39080069|FG002|Overall Study|Withdrawal by Subject|3|||
16163305|NCT00584870|39080067|FG000|Overall Study|Protocol Violation|1|||
16163306|NCT00584870|39080068|FG001|Overall Study|Protocol Violation|1|||
16163307|NCT00584870|39080069|FG002|Overall Study|Protocol Violation|2|||
16163308|NCT00584870|39080067|FG000|Overall Study|Did not met entrance criteria|1|||
16163309|NCT00584870|39080068|FG001|Overall Study|Did not met entrance criteria|0|||
16163310|NCT00584870|39080069|FG002|Overall Study|Did not met entrance criteria|0|||
16163311|NCT00584870|39080067|FG000|Overall Study|Other|2|||
16163312|NCT00584870|39080068|FG001|Overall Study|Other|0|||
16163313|NCT00584870|39080069|FG002|Overall Study|Other|0|||
16450189|NCT03614156|40125994|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
16450190|NCT03614156|40125995|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
16450191|NCT03614156|40125996|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
16450192|NCT03614156|40125993|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16450193|NCT03614156|40125994|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
16450194|NCT03614156|40125995|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
16450195|NCT03614156|40125996|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
16450196|NCT03614156|40125993|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
16450197|NCT03614156|40125994|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
16450198|NCT03614156|40125995|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
16450199|NCT03614156|40125996|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
16450200|NCT03614156|40125993|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
16450201|NCT03614156|40125994|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
16450202|NCT03614156|40125995|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
16450203|NCT03614156|40125996|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
16450204|NCT03614156|40125993|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
16450205|NCT03614156|40125994|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
16450206|NCT03614156|40125995|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
16450207|NCT03614156|40125996|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
16450208|NCT03614156|40125993|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
16450209|NCT03614156|40125994|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
16450210|NCT03614156|40125995|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
16450211|NCT03614156|40125996|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
16450212|NCT03614156|40125993|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
16450213|NCT03614156|40125994|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
16450214|NCT03614156|40125995|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
16450215|NCT03614156|40125996|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
16450216|NCT03614156|40125993|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
16450217|NCT03614156|40125994|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
16450218|NCT03614156|40125995|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
16450219|NCT03614156|40125996|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
16450220|NCT00930046|40125997|FG000|Overall Study|Wound catheter malfunctioned|1|||
16450221|NCT00930046|40125998|FG001|Overall Study|Wound catheter malfunctioned|2|||
16450222|NCT00853567|40125999|FG000|Overall Study|Study prematurely terminated|71|||
16450223|NCT03847896|40126002|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
16450224|NCT03847896|40126003|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
16450225|NCT03847896|40126004|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
16450226|NCT03847896|40126005|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
16450227|NCT03847896|40126006|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
16450228|NCT03847896|40126002|FG000|Overall Study|Withdrawal by Subject|2|||
16450229|NCT03847896|40126003|FG001|Overall Study|Withdrawal by Subject|10|||
16450230|NCT03847896|40126004|FG002|Overall Study|Withdrawal by Subject|5|||
16450231|NCT03847896|40126005|FG003|Overall Study|Withdrawal by Subject|9|||
16450232|NCT03847896|40126006|FG004|Overall Study|Withdrawal by Subject|8|||
16450233|NCT03847896|40126002|FG000|Overall Study|Withdrawal by parent/guardian|0|||
16163314|NCT00584870|39080067|FG000|Overall Study|Randomized but not treated|0|||
16163315|NCT00584870|39080068|FG001|Overall Study|Randomized but not treated|1|||
16163316|NCT00584870|39080069|FG002|Overall Study|Randomized but not treated|2|||
16163317|NCT01142726|39080070|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
16450234|NCT03847896|40126003|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16450235|NCT03847896|40126004|FG002|Overall Study|Withdrawal by parent/guardian|1|||
16450236|NCT03847896|40126005|FG003|Overall Study|Withdrawal by parent/guardian|0|||
16450237|NCT03847896|40126006|FG004|Overall Study|Withdrawal by parent/guardian|0|||
16450238|NCT03847896|40126002|FG000|Overall Study|Adverse Event|2|||
16450239|NCT03847896|40126003|FG001|Overall Study|Adverse Event|1|||
16450240|NCT03847896|40126004|FG002|Overall Study|Adverse Event|3|||
16450241|NCT03847896|40126005|FG003|Overall Study|Adverse Event|2|||
16450242|NCT03847896|40126006|FG004|Overall Study|Adverse Event|4|||
16450243|NCT03847896|40126002|FG000|Overall Study|A severe exacerbation event|0|||
16450244|NCT03847896|40126003|FG001|Overall Study|A severe exacerbation event|0|||
16450245|NCT03847896|40126004|FG002|Overall Study|A severe exacerbation event|0|||
16450246|NCT03847896|40126005|FG003|Overall Study|A severe exacerbation event|0|||
16450247|NCT03847896|40126006|FG004|Overall Study|A severe exacerbation event|3|||
16450248|NCT03847896|40126002|FG000|Overall Study|Protocol Violation|0|||
16450249|NCT03847896|40126003|FG001|Overall Study|Protocol Violation|2|||
16450250|NCT03847896|40126004|FG002|Overall Study|Protocol Violation|1|||
16450251|NCT03847896|40126005|FG003|Overall Study|Protocol Violation|0|||
16450252|NCT03847896|40126006|FG004|Overall Study|Protocol Violation|2|||
16450253|NCT03847896|40126002|FG000|Overall Study|Lost to Follow-up|0|||
16450254|NCT03847896|40126003|FG001|Overall Study|Lost to Follow-up|0|||
16450255|NCT03847896|40126004|FG002|Overall Study|Lost to Follow-up|0|||
16450256|NCT03847896|40126005|FG003|Overall Study|Lost to Follow-up|1|||
16450257|NCT03847896|40126006|FG004|Overall Study|Lost to Follow-up|0|||
16450258|NCT03847896|40126002|FG000|Overall Study|Condition under investigation worsened|0|||
16450259|NCT03847896|40126003|FG001|Overall Study|Condition under investigation worsened|0|||
16450260|NCT03847896|40126004|FG002|Overall Study|Condition under investigation worsened|0|||
16450261|NCT03847896|40126005|FG003|Overall Study|Condition under investigation worsened|1|||
16450262|NCT03847896|40126006|FG004|Overall Study|Condition under investigation worsened|1|||
16450263|NCT03847896|40126002|FG000|Overall Study|Lack of Efficacy|0|||
16450264|NCT03847896|40126003|FG001|Overall Study|Lack of Efficacy|0|||
16450265|NCT03847896|40126004|FG002|Overall Study|Lack of Efficacy|0|||
16450266|NCT03847896|40126005|FG003|Overall Study|Lack of Efficacy|2|||
16450267|NCT03847896|40126006|FG004|Overall Study|Lack of Efficacy|2|||
16450268|NCT03847896|40126002|FG000|Overall Study|Other reasons|3|||
16450269|NCT03847896|40126003|FG001|Overall Study|Other reasons|3|||
16450270|NCT03847896|40126004|FG002|Overall Study|Other reasons|1|||
16450271|NCT03847896|40126005|FG003|Overall Study|Other reasons|2|||
16450272|NCT03847896|40126006|FG004|Overall Study|Other reasons|1|||
16450273|NCT01134055|40126007|FG000|Overall Study|Adverse Event|5|||
16450274|NCT01134055|40126008|FG001|Overall Study|Adverse Event|2|||
16450275|NCT01134055|40126009|FG002|Overall Study|Adverse Event|2|||
16450276|NCT01134055|40126010|FG003|Overall Study|Adverse Event|2|||
16450277|NCT01134055|40126011|FG004|Overall Study|Adverse Event|5|||
16450278|NCT01134055|40126012|FG005|Overall Study|Adverse Event|7|||
16450279|NCT01134055|40126013|FG006|Overall Study|Adverse Event|2|||
16265145|NCT03966365|39453303|FG001|Overall Study|Protocol Violation|0|||
16265146|NCT00640562|39453308|FG000|Overall Study|Adverse Event|8|||
16265147|NCT00640562|39453309|FG001|Overall Study|Adverse Event|5|||
16265148|NCT00640562|39453308|FG000|Overall Study|Lack of Efficacy|1|||
16265149|NCT00640562|39453309|FG001|Overall Study|Lack of Efficacy|4|||
16265150|NCT00640562|39453308|FG000|Overall Study|Protocol Violation|2|||
16450280|NCT01134055|40126007|FG000|Overall Study|Lost to Follow-up|0|||
16450281|NCT01134055|40126008|FG001|Overall Study|Lost to Follow-up|1|||
16450282|NCT01134055|40126009|FG002|Overall Study|Lost to Follow-up|0|||
16450283|NCT01134055|40126010|FG003|Overall Study|Lost to Follow-up|1|||
16450284|NCT01134055|40126011|FG004|Overall Study|Lost to Follow-up|0|||
16450285|NCT01134055|40126012|FG005|Overall Study|Lost to Follow-up|0|||
16450286|NCT01134055|40126013|FG006|Overall Study|Lost to Follow-up|0|||
16450287|NCT01134055|40126007|FG000|Overall Study|Withdrawal by Subject|3|||
16450288|NCT01134055|40126008|FG001|Overall Study|Withdrawal by Subject|3|||
16450289|NCT01134055|40126009|FG002|Overall Study|Withdrawal by Subject|1|||
16450290|NCT01134055|40126010|FG003|Overall Study|Withdrawal by Subject|2|||
16450291|NCT01134055|40126011|FG004|Overall Study|Withdrawal by Subject|0|||
16450292|NCT01134055|40126012|FG005|Overall Study|Withdrawal by Subject|0|||
16450293|NCT01134055|40126013|FG006|Overall Study|Withdrawal by Subject|8|||
16450294|NCT01134055|40126007|FG000|Overall Study|Protocol Violation|0|||
16450295|NCT01134055|40126008|FG001|Overall Study|Protocol Violation|0|||
16450296|NCT01134055|40126009|FG002|Overall Study|Protocol Violation|0|||
16450297|NCT01134055|40126010|FG003|Overall Study|Protocol Violation|1|||
16450298|NCT01134055|40126011|FG004|Overall Study|Protocol Violation|1|||
16450299|NCT01134055|40126012|FG005|Overall Study|Protocol Violation|0|||
16450300|NCT01134055|40126013|FG006|Overall Study|Protocol Violation|0|||
16450301|NCT01134055|40126007|FG000|Overall Study|Physician Decision|0|||
16265151|NCT00640562|39453309|FG001|Overall Study|Protocol Violation|4|||
16450302|NCT01134055|40126008|FG001|Overall Study|Physician Decision|0|||
16450303|NCT01134055|40126009|FG002|Overall Study|Physician Decision|0|||
16450304|NCT01134055|40126010|FG003|Overall Study|Physician Decision|0|||
16450305|NCT01134055|40126011|FG004|Overall Study|Physician Decision|0|||
16450306|NCT01134055|40126012|FG005|Overall Study|Physician Decision|0|||
16450307|NCT01134055|40126013|FG006|Overall Study|Physician Decision|1|||
16450308|NCT01112917|40126016|FG000|Overall Study|Death|2|||
16450309|NCT01112917|40126017|FG001|Overall Study|Death|11|||
16450310|NCT01112917|40126016|FG000|Overall Study|Lost to Follow-up|1|||
16450311|NCT01112917|40126017|FG001|Overall Study|Lost to Follow-up|1|||
16450312|NCT01112917|40126016|FG000|Overall Study|Withdrawal by Subject|1|||
16450313|NCT01112917|40126017|FG001|Overall Study|Withdrawal by Subject|3|||
16450314|NCT01112917|40126016|FG000|Overall Study|Unable to Convert Filter|3|||
16450315|NCT01112917|40126017|FG001|Overall Study|Unable to Convert Filter|0|||
16450316|NCT02963506|40126023|FG000|Double-Blind Period|Adverse Event|0|||
16450317|NCT02963506|40126024|FG001|Double-Blind Period|Adverse Event|0|||
16450318|NCT02963506|40126025|FG002|Double-Blind Period|Adverse Event|1|||
16450319|NCT02963506|40126026|FG003|Double-Blind Period|Adverse Event|0|||
16450320|NCT02963506|40126027|FG004|Double-Blind Period|Adverse Event|0|||
16450321|NCT02963506|40126028|FG005|Double-Blind Period|Adverse Event|0|||
16450322|NCT02963506|40126029|FG006|Double-Blind Period|Adverse Event|0|||
16450323|NCT02963506|40126030|FG007|Double-Blind Period|Adverse Event|0|||
16450324|NCT02963506|40126031|FG008|Double-Blind Period|Adverse Event|0|||
16450325|NCT02963506|40126032|FG009|Double-Blind Period|Adverse Event|0|||
16450326|NCT02963506|40126033|FG010|Double-Blind Period|Adverse Event|0|||
16450327|NCT02963506|40126034|FG011|Double-Blind Period|Adverse Event|0|||
16450328|NCT02963506|40126035|FG012|Double-Blind Period|Adverse Event|0|||
16450329|NCT02963506|40126023|FG000|Double-Blind Period|Death|0|||
16450330|NCT02963506|40126024|FG001|Double-Blind Period|Death|0|||
16450331|NCT02963506|40126025|FG002|Double-Blind Period|Death|0|||
16450332|NCT02963506|40126026|FG003|Double-Blind Period|Death|1|||
16450333|NCT02963506|40126027|FG004|Double-Blind Period|Death|0|||
16450334|NCT02963506|40126028|FG005|Double-Blind Period|Death|0|||
16450335|NCT02963506|40126029|FG006|Double-Blind Period|Death|0|||
16450336|NCT02963506|40126030|FG007|Double-Blind Period|Death|0|||
16450337|NCT02963506|40126031|FG008|Double-Blind Period|Death|0|||
16450338|NCT02963506|40126032|FG009|Double-Blind Period|Death|0|||
16450339|NCT02963506|40126033|FG010|Double-Blind Period|Death|0|||
16450340|NCT02963506|40126034|FG011|Double-Blind Period|Death|0|||
16450341|NCT02963506|40126035|FG012|Double-Blind Period|Death|0|||
16450342|NCT02963506|40126023|FG000|Double-Blind Period|Lost to Follow-up|0|||
16450343|NCT02963506|40126024|FG001|Double-Blind Period|Lost to Follow-up|1|||
16450344|NCT02963506|40126025|FG002|Double-Blind Period|Lost to Follow-up|0|||
16450345|NCT02963506|40126026|FG003|Double-Blind Period|Lost to Follow-up|0|||
16450346|NCT02963506|40126027|FG004|Double-Blind Period|Lost to Follow-up|0|||
16450347|NCT02963506|40126028|FG005|Double-Blind Period|Lost to Follow-up|0|||
16450348|NCT02963506|40126029|FG006|Double-Blind Period|Lost to Follow-up|0|||
16450349|NCT02963506|40126030|FG007|Double-Blind Period|Lost to Follow-up|0|||
16450350|NCT02963506|40126031|FG008|Double-Blind Period|Lost to Follow-up|0|||
16450351|NCT02963506|40126032|FG009|Double-Blind Period|Lost to Follow-up|0|||
16450352|NCT02963506|40126033|FG010|Double-Blind Period|Lost to Follow-up|0|||
16450353|NCT02963506|40126034|FG011|Double-Blind Period|Lost to Follow-up|0|||
16450354|NCT02963506|40126035|FG012|Double-Blind Period|Lost to Follow-up|0|||
16450355|NCT02963506|40126023|FG000|Double-Blind Period|Withdrawal by Subject|0|||
16450356|NCT02963506|40126024|FG001|Double-Blind Period|Withdrawal by Subject|0|||
16450357|NCT02963506|40126025|FG002|Double-Blind Period|Withdrawal by Subject|1|||
16450358|NCT02963506|40126026|FG003|Double-Blind Period|Withdrawal by Subject|1|||
16450359|NCT02963506|40126027|FG004|Double-Blind Period|Withdrawal by Subject|0|||
16450360|NCT02963506|40126028|FG005|Double-Blind Period|Withdrawal by Subject|0|||
16450361|NCT02963506|40126029|FG006|Double-Blind Period|Withdrawal by Subject|0|||
16450362|NCT02963506|40126030|FG007|Double-Blind Period|Withdrawal by Subject|0|||
16450363|NCT02963506|40126031|FG008|Double-Blind Period|Withdrawal by Subject|0|||
16163318|NCT01142726|39080071|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
16163319|NCT01142726|39080072|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
16450364|NCT02963506|40126032|FG009|Double-Blind Period|Withdrawal by Subject|0|||
16450365|NCT02963506|40126033|FG010|Double-Blind Period|Withdrawal by Subject|0|||
16450366|NCT02963506|40126034|FG011|Double-Blind Period|Withdrawal by Subject|0|||
16450367|NCT02963506|40126035|FG012|Double-Blind Period|Withdrawal by Subject|0|||
16450368|NCT02963506|40126023|FG000|Double-Blind Period|No compliance|0|||
16450369|NCT02963506|40126024|FG001|Double-Blind Period|No compliance|1|||
16450370|NCT02963506|40126025|FG002|Double-Blind Period|No compliance|0|||
16450371|NCT02963506|40126026|FG003|Double-Blind Period|No compliance|0|||
16450372|NCT02963506|40126027|FG004|Double-Blind Period|No compliance|0|||
16450373|NCT02963506|40126028|FG005|Double-Blind Period|No compliance|0|||
16450374|NCT02963506|40126029|FG006|Double-Blind Period|No compliance|0|||
16450375|NCT02963506|40126030|FG007|Double-Blind Period|No compliance|0|||
16450376|NCT02963506|40126031|FG008|Double-Blind Period|No compliance|0|||
16450377|NCT02963506|40126032|FG009|Double-Blind Period|No compliance|0|||
16450378|NCT02963506|40126033|FG010|Double-Blind Period|No compliance|0|||
16450379|NCT02963506|40126034|FG011|Double-Blind Period|No compliance|0|||
16450380|NCT02963506|40126035|FG012|Double-Blind Period|No compliance|0|||
16450381|NCT02963506|40126023|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450382|NCT02963506|40126024|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
16450383|NCT02963506|40126025|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450384|NCT02963506|40126026|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450385|NCT02963506|40126027|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450386|NCT02963506|40126028|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450387|NCT02963506|40126029|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450388|NCT02963506|40126030|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450389|NCT02963506|40126031|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450390|NCT02963506|40126032|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450391|NCT02963506|40126033|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450392|NCT02963506|40126034|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450393|NCT02963506|40126035|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
16450394|NCT02963506|40126023|FG000|Dose-Blind Period|Adverse Event|0|||
16450395|NCT02963506|40126024|FG001|Dose-Blind Period|Adverse Event|0|||
16450396|NCT02963506|40126025|FG002|Dose-Blind Period|Adverse Event|0|||
16450397|NCT02963506|40126026|FG003|Dose-Blind Period|Adverse Event|0|||
16450398|NCT02963506|40126027|FG004|Dose-Blind Period|Adverse Event|0|||
16450399|NCT02963506|40126028|FG005|Dose-Blind Period|Adverse Event|1|||
16450400|NCT02963506|40126029|FG006|Dose-Blind Period|Adverse Event|3|||
16450401|NCT02963506|40126030|FG007|Dose-Blind Period|Adverse Event|2|||
16450402|NCT02963506|40126031|FG008|Dose-Blind Period|Adverse Event|2|||
16450403|NCT02963506|40126032|FG009|Dose-Blind Period|Adverse Event|2|||
16450404|NCT02963506|40126033|FG010|Dose-Blind Period|Adverse Event|1|||
16450405|NCT02963506|40126034|FG011|Dose-Blind Period|Adverse Event|1|||
16450406|NCT02963506|40126035|FG012|Dose-Blind Period|Adverse Event|6|||
16450407|NCT02963506|40126023|FG000|Dose-Blind Period|Lack of Efficacy|0|||
16450408|NCT02963506|40126024|FG001|Dose-Blind Period|Lack of Efficacy|0|||
16450409|NCT02963506|40126025|FG002|Dose-Blind Period|Lack of Efficacy|0|||
16450410|NCT02963506|40126026|FG003|Dose-Blind Period|Lack of Efficacy|0|||
16450411|NCT02963506|40126027|FG004|Dose-Blind Period|Lack of Efficacy|0|||
16450412|NCT02963506|40126028|FG005|Dose-Blind Period|Lack of Efficacy|0|||
16450413|NCT02963506|40126029|FG006|Dose-Blind Period|Lack of Efficacy|0|||
16450414|NCT02963506|40126030|FG007|Dose-Blind Period|Lack of Efficacy|1|||
16450415|NCT02963506|40126031|FG008|Dose-Blind Period|Lack of Efficacy|0|||
16450416|NCT02963506|40126032|FG009|Dose-Blind Period|Lack of Efficacy|1|||
16450417|NCT02963506|40126033|FG010|Dose-Blind Period|Lack of Efficacy|0|||
16450418|NCT02963506|40126034|FG011|Dose-Blind Period|Lack of Efficacy|0|||
16450419|NCT02963506|40126035|FG012|Dose-Blind Period|Lack of Efficacy|0|||
16450420|NCT02963506|40126023|FG000|Dose-Blind Period|Lost to Follow-up|0|||
16450421|NCT02963506|40126024|FG001|Dose-Blind Period|Lost to Follow-up|0|||
16450422|NCT02963506|40126025|FG002|Dose-Blind Period|Lost to Follow-up|0|||
16450423|NCT02963506|40126026|FG003|Dose-Blind Period|Lost to Follow-up|0|||
16450424|NCT02963506|40126027|FG004|Dose-Blind Period|Lost to Follow-up|0|||
16450425|NCT02963506|40126028|FG005|Dose-Blind Period|Lost to Follow-up|1|||
16450426|NCT02963506|40126029|FG006|Dose-Blind Period|Lost to Follow-up|0|||
16450427|NCT02963506|40126030|FG007|Dose-Blind Period|Lost to Follow-up|0|||
16450428|NCT02963506|40126031|FG008|Dose-Blind Period|Lost to Follow-up|1|||
16450429|NCT02963506|40126032|FG009|Dose-Blind Period|Lost to Follow-up|0|||
16450430|NCT02963506|40126033|FG010|Dose-Blind Period|Lost to Follow-up|0|||
16450431|NCT02963506|40126034|FG011|Dose-Blind Period|Lost to Follow-up|1|||
16450432|NCT02963506|40126035|FG012|Dose-Blind Period|Lost to Follow-up|0|||
16450433|NCT02963506|40126023|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
16450434|NCT02963506|40126024|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
16450435|NCT02963506|40126025|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
16450436|NCT02963506|40126026|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
16450437|NCT02963506|40126027|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
16450438|NCT02963506|40126028|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
16450439|NCT02963506|40126029|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
16450440|NCT02963506|40126030|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
16450441|NCT02963506|40126031|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
16450442|NCT02963506|40126032|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
16450443|NCT02963506|40126033|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
16450444|NCT02963506|40126034|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
16450445|NCT02963506|40126035|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
16450446|NCT02963506|40126023|FG000|Dose-Blind Period|Sponsor decision|0|||
16450447|NCT02963506|40126024|FG001|Dose-Blind Period|Sponsor decision|0|||
16072614|NCT01254019|38756410|FG001|Overall Study|Withdrawal by Subject|2|||
16450448|NCT02963506|40126025|FG002|Dose-Blind Period|Sponsor decision|0|||
16450449|NCT02963506|40126026|FG003|Dose-Blind Period|Sponsor decision|0|||
16450450|NCT02963506|40126027|FG004|Dose-Blind Period|Sponsor decision|0|||
16450451|NCT02963506|40126028|FG005|Dose-Blind Period|Sponsor decision|1|||
16450452|NCT02963506|40126029|FG006|Dose-Blind Period|Sponsor decision|0|||
16450453|NCT02963506|40126030|FG007|Dose-Blind Period|Sponsor decision|0|||
16450454|NCT02963506|40126031|FG008|Dose-Blind Period|Sponsor decision|0|||
16450455|NCT02963506|40126032|FG009|Dose-Blind Period|Sponsor decision|0|||
16450456|NCT02963506|40126033|FG010|Dose-Blind Period|Sponsor decision|0|||
16450457|NCT02963506|40126034|FG011|Dose-Blind Period|Sponsor decision|0|||
16450458|NCT02963506|40126035|FG012|Dose-Blind Period|Sponsor decision|0|||
16450459|NCT02963506|40126023|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450460|NCT02963506|40126024|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450461|NCT02963506|40126025|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450462|NCT02963506|40126026|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450463|NCT02963506|40126027|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450464|NCT02963506|40126028|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450465|NCT02963506|40126029|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450466|NCT02963506|40126030|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450467|NCT02963506|40126031|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450468|NCT02963506|40126032|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450469|NCT02963506|40126033|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450470|NCT02963506|40126034|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
16450471|NCT02963506|40126035|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
16450472|NCT00482053|40126036|FG000|Inter-treatment Period|Disease progression|1|||
16450473|NCT01055197|40126040|FG000|Overall Study|Protocol Violation|7|||
16450474|NCT01055197|40126041|FG001|Overall Study|Protocol Violation|2|||
16450475|NCT01055197|40126040|FG000|Overall Study|Withdrawal by Subject|2|||
16450476|NCT01055197|40126041|FG001|Overall Study|Withdrawal by Subject|0|||
16450477|NCT02766023|40126042|FG000|Overall Study|Lost to Follow-up|23|||
16450478|NCT02766023|40126043|FG001|Overall Study|Lost to Follow-up|11|||
16450479|NCT02766023|40126042|FG000|Overall Study|Pregnancy|1|||
16450480|NCT02766023|40126043|FG001|Overall Study|Pregnancy|0|||
16450481|NCT02766023|40126042|FG000|Overall Study|Adverse Event|1|||
16450482|NCT02766023|40126043|FG001|Overall Study|Adverse Event|0|||
16450483|NCT02766023|40126042|FG000|Overall Study|Withdrawal by Subject|4|||
16450484|NCT02766023|40126043|FG001|Overall Study|Withdrawal by Subject|5|||
16373056|NCT00147537|39849864|FG010|Phase 1b|Other|0|||
16373057|NCT00147537|39849854|FG000|Phase 1b|Withdrawal by Subject|0|||
16373058|NCT00147537|39849855|FG001|Phase 1b|Withdrawal by Subject|0|||
16373059|NCT00147537|39849856|FG002|Phase 1b|Withdrawal by Subject|0|||
16373060|NCT00147537|39849857|FG003|Phase 1b|Withdrawal by Subject|0|||
16373061|NCT00147537|39849858|FG004|Phase 1b|Withdrawal by Subject|0|||
16373062|NCT00147537|39849859|FG005|Phase 1b|Withdrawal by Subject|0|||
16373063|NCT00147537|39849860|FG006|Phase 1b|Withdrawal by Subject|0|||
16373064|NCT00147537|39849861|FG007|Phase 1b|Withdrawal by Subject|0|||
16373065|NCT00147537|39849862|FG008|Phase 1b|Withdrawal by Subject|2|||
16373066|NCT00147537|39849863|FG009|Phase 1b|Withdrawal by Subject|0|||
16373067|NCT00147537|39849864|FG010|Phase 1b|Withdrawal by Subject|0|||
16373068|NCT00147537|39849854|FG000|Phase 1b|Randomized but not treated|0|||
16373069|NCT00147537|39849855|FG001|Phase 1b|Randomized but not treated|0|||
16373070|NCT00147537|39849856|FG002|Phase 1b|Randomized but not treated|0|||
16373071|NCT00147537|39849857|FG003|Phase 1b|Randomized but not treated|0|||
16373072|NCT00147537|39849858|FG004|Phase 1b|Randomized but not treated|0|||
16373073|NCT00147537|39849859|FG005|Phase 1b|Randomized but not treated|0|||
16373074|NCT00147537|39849860|FG006|Phase 1b|Randomized but not treated|1|||
16373075|NCT00147537|39849861|FG007|Phase 1b|Randomized but not treated|0|||
16373076|NCT00147537|39849862|FG008|Phase 1b|Randomized but not treated|1|||
16373077|NCT00147537|39849863|FG009|Phase 1b|Randomized but not treated|0|||
16373078|NCT00147537|39849864|FG010|Phase 1b|Randomized but not treated|0|||
16373079|NCT00147537|39849854|FG000|Phase 2|Death|0|||
16373080|NCT00147537|39849855|FG001|Phase 2|Death|0|||
16373081|NCT00147537|39849856|FG002|Phase 2|Death|0|||
16373082|NCT00147537|39849857|FG003|Phase 2|Death|0|||
16373083|NCT00147537|39849858|FG004|Phase 2|Death|0|||
16373084|NCT00147537|39849859|FG005|Phase 2|Death|0|||
16373085|NCT00147537|39849860|FG006|Phase 2|Death|0|||
16373086|NCT00147537|39849861|FG007|Phase 2|Death|0|||
16373087|NCT00147537|39849862|FG008|Phase 2|Death|0|||
16373088|NCT00147537|39849863|FG009|Phase 2|Death|85|||
16373089|NCT00147537|39849864|FG010|Phase 2|Death|31|||
16373090|NCT00147537|39849854|FG000|Phase 2|Lost to Follow-up|0|||
16373091|NCT00147537|39849855|FG001|Phase 2|Lost to Follow-up|0|||
16373092|NCT00147537|39849856|FG002|Phase 2|Lost to Follow-up|0|||
16373093|NCT00147537|39849857|FG003|Phase 2|Lost to Follow-up|0|||
16373094|NCT00147537|39849858|FG004|Phase 2|Lost to Follow-up|0|||
16450485|NCT02766023|40126042|FG000|Overall Study|Physician Decision|1|||
16450486|NCT02766023|40126043|FG001|Overall Study|Physician Decision|0|||
16450487|NCT02766023|40126042|FG000|Overall Study|Not Eligible at Enrollment|0|||
16450488|NCT02766023|40126043|FG001|Overall Study|Not Eligible at Enrollment|1|||
16450489|NCT03312634|40126044|FG000|Overall Study|Adverse Event|11|||
16450490|NCT03312634|40126045|FG001|Overall Study|Adverse Event|0|||
16450491|NCT03312634|40126044|FG000|Overall Study|Sponsor request|2|||
16450492|NCT03312634|40126045|FG001|Overall Study|Sponsor request|0|||
16450493|NCT03312634|40126044|FG000|Overall Study|Withdrawal by Subject|31|||
16450494|NCT03312634|40126045|FG001|Overall Study|Withdrawal by Subject|9|||
16450495|NCT03312634|40126044|FG000|Overall Study|Enrolled in an interventional study|0|||
16450496|NCT03312634|40126045|FG001|Overall Study|Enrolled in an interventional study|52|||
16450497|NCT03312634|40126044|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
16450498|NCT03312634|40126045|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
16450499|NCT03312634|40126044|FG000|Overall Study|Death|0|||
16450500|NCT03312634|40126045|FG001|Overall Study|Death|1|||
16450501|NCT03312634|40126044|FG000|Overall Study|Non-compliance|0|||
16450502|NCT03312634|40126045|FG001|Overall Study|Non-compliance|2|||
16450503|NCT03312634|40126044|FG000|Overall Study|Lost to Follow-up|0|||
16450504|NCT03312634|40126045|FG001|Overall Study|Lost to Follow-up|1|||
16450505|NCT03312634|40126044|FG000|Overall Study|Enrolled into non-interventional study|0|||
16450506|NCT03312634|40126045|FG001|Overall Study|Enrolled into non-interventional study|5|||
16450507|NCT03312634|40126044|FG000|Overall Study|Worsening clinical condition|0|||
16450508|NCT03312634|40126045|FG001|Overall Study|Worsening clinical condition|1|||
16450509|NCT03312634|40126044|FG000|Overall Study|Participant did not want to travel|0|||
16450510|NCT03312634|40126045|FG001|Overall Study|Participant did not want to travel|1|||
16450511|NCT03312634|40126044|FG000|Overall Study|Physician Decision|1|||
16450512|NCT03312634|40126045|FG001|Overall Study|Physician Decision|0|||
16450513|NCT03312634|40126044|FG000|Overall Study|Other|13|||
16450514|NCT03312634|40126045|FG001|Overall Study|Other|0|||
16450515|NCT04237116|40126046|FG000|Overall Study|Adverse Event|0|||
16450516|NCT04237116|40126047|FG001|Overall Study|Adverse Event|1|||
16450517|NCT04237116|40126046|FG000|Overall Study|Study terminated by Sponsor|4|||
16450518|NCT04237116|40126047|FG001|Overall Study|Study terminated by Sponsor|1|||
16450519|NCT00043979|40129953|FG000|Period 1|recipient with progressive disease|7|||
16450520|NCT00043979|40129954|FG001|Period 1|recipient with progressive disease|4|||
16450521|NCT00043979|40129955|FG002|Period 1|recipient with progressive disease|3|||
16450522|NCT03818321|40129956|FG000|Overall Study|Withdrawal by Subject|1|||
16450523|NCT03818321|40129957|FG001|Overall Study|Withdrawal by Subject|2|||
16450524|NCT00275509|40129962|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
16450525|NCT00275509|40129963|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
16450526|NCT03763877|40129964|FG000|Overall Study|Withdrawal by Subject|3|||
16450527|NCT03763877|40129965|FG001|Overall Study|Withdrawal by Subject|1|||
16450528|NCT03763877|40129966|FG002|Overall Study|Withdrawal by Subject|3|||
16450529|NCT03763877|40129967|FG003|Overall Study|Withdrawal by Subject|4|||
16450530|NCT03763877|40129964|FG000|Overall Study|Adverse Event|1|||
16450531|NCT03763877|40129965|FG001|Overall Study|Adverse Event|1|||
16450532|NCT03763877|40129966|FG002|Overall Study|Adverse Event|3|||
16450533|NCT03763877|40129967|FG003|Overall Study|Adverse Event|1|||
16450534|NCT03763877|40129964|FG000|Overall Study|Protocol Violation|1|||
16450535|NCT03763877|40129965|FG001|Overall Study|Protocol Violation|1|||
16450536|NCT03763877|40129966|FG002|Overall Study|Protocol Violation|0|||
16450537|NCT03763877|40129967|FG003|Overall Study|Protocol Violation|0|||
16450538|NCT03763877|40129964|FG000|Overall Study|Lost to Follow-up|0|||
16450539|NCT03763877|40129965|FG001|Overall Study|Lost to Follow-up|1|||
16450540|NCT03763877|40129966|FG002|Overall Study|Lost to Follow-up|1|||
16450541|NCT03763877|40129967|FG003|Overall Study|Lost to Follow-up|0|||
16450542|NCT01931566|40129970|FG000|Overall Study|Randomized But Not Treated|6|||
16450543|NCT01931566|40129971|FG001|Overall Study|Randomized But Not Treated|9|||
16450544|NCT01931566|40129972|FG002|Overall Study|Randomized But Not Treated|14|||
16450545|NCT01931566|40129970|FG000|Overall Study|Adverse Event|37|||
16450546|NCT01931566|40129971|FG001|Overall Study|Adverse Event|167|||
16450547|NCT01931566|40129972|FG002|Overall Study|Adverse Event|132|||
16450548|NCT01931566|40129970|FG000|Overall Study|Major Protocol Deviation|5|||
16450549|NCT01931566|40129971|FG001|Overall Study|Major Protocol Deviation|14|||
16450550|NCT01931566|40129972|FG002|Overall Study|Major Protocol Deviation|21|||
16450551|NCT01931566|40129970|FG000|Overall Study|Lost to Follow-up|3|||
16450552|NCT01931566|40129971|FG001|Overall Study|Lost to Follow-up|26|||
16450553|NCT01931566|40129972|FG002|Overall Study|Lost to Follow-up|23|||
16450554|NCT01931566|40129970|FG000|Overall Study|Voluntary Withdrawal|78|||
16450555|NCT01931566|40129971|FG001|Overall Study|Voluntary Withdrawal|245|||
16450556|NCT01931566|40129972|FG002|Overall Study|Voluntary Withdrawal|225|||
16450557|NCT01931566|40129970|FG000|Overall Study|Study Termination|289|||
16450558|NCT01931566|40129971|FG001|Overall Study|Study Termination|968|||
16450559|NCT01931566|40129972|FG002|Overall Study|Study Termination|1037|||
16450560|NCT01931566|40129970|FG000|Overall Study|Reason Not Specified|11|||
16450561|NCT01931566|40129971|FG001|Overall Study|Reason Not Specified|47|||
16450562|NCT01931566|40129972|FG002|Overall Study|Reason Not Specified|53|||
16450563|NCT01931566|40129970|FG000|Overall Study|Missing|0|||
16450564|NCT01931566|40129971|FG001|Overall Study|Missing|0|||
16450565|NCT01931566|40129972|FG002|Overall Study|Missing|1|||
16450566|NCT03104400|40129982|FG000|Overall Study|Adverse Event|5|||
16450567|NCT03104400|40129983|FG001|Overall Study|Adverse Event|7|||
16450568|NCT03104400|40129984|FG002|Overall Study|Adverse Event|11|||
16450569|NCT03104400|40129985|FG003|Overall Study|Adverse Event|9|||
16450570|NCT03104400|40129986|FG004|Overall Study|Adverse Event|21|||
16450571|NCT03104400|40129982|FG000|Overall Study|Withdrawal by Subject|17|||
16450572|NCT03104400|40129983|FG001|Overall Study|Withdrawal by Subject|19|||
16450573|NCT03104400|40129984|FG002|Overall Study|Withdrawal by Subject|29|||
16450574|NCT03104400|40129985|FG003|Overall Study|Withdrawal by Subject|25|||
16163320|NCT01142726|39080070|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
16163321|NCT01142726|39080071|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
16163322|NCT01142726|39080072|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
16163323|NCT01142726|39080070|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
16163324|NCT01142726|39080071|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
16163325|NCT01142726|39080072|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
16163326|NCT01142726|39080070|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
16163327|NCT01142726|39080071|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
16163328|NCT01142726|39080072|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
16163329|NCT01142726|39080070|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
16163330|NCT01142726|39080071|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
16163331|NCT01142726|39080072|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
16373095|NCT00147537|39849859|FG005|Phase 2|Lost to Follow-up|0|||
16163332|NCT01142726|39080070|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
16163333|NCT01142726|39080071|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
16163334|NCT01142726|39080072|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
16163335|NCT01142726|39080070|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
16163336|NCT01142726|39080071|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
16163337|NCT01142726|39080072|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
16163338|NCT01142726|39080070|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
16163339|NCT01142726|39080071|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
16163340|NCT01142726|39080072|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
16163341|NCT01142726|39080070|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
16163342|NCT01142726|39080071|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
16163343|NCT01142726|39080072|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
16163344|NCT01142726|39080070|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
16163345|NCT01142726|39080071|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
16163346|NCT01142726|39080072|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
16163347|NCT01142726|39080070|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
16163348|NCT01142726|39080071|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
16163349|NCT01142726|39080072|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
16163350|NCT01142726|39080070|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
16163351|NCT01142726|39080071|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
16163352|NCT01142726|39080072|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
16163353|NCT01142726|39080070|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
16373096|NCT00147537|39849860|FG006|Phase 2|Lost to Follow-up|0|||
16373097|NCT00147537|39849861|FG007|Phase 2|Lost to Follow-up|0|||
16373098|NCT00147537|39849862|FG008|Phase 2|Lost to Follow-up|0|||
16373099|NCT00147537|39849863|FG009|Phase 2|Lost to Follow-up|12|||
16373100|NCT00147537|39849864|FG010|Phase 2|Lost to Follow-up|4|||
16373101|NCT00147537|39849854|FG000|Phase 2|Other|0|||
16373102|NCT00147537|39849855|FG001|Phase 2|Other|0|||
16373103|NCT00147537|39849856|FG002|Phase 2|Other|0|||
16373104|NCT00147537|39849857|FG003|Phase 2|Other|0|||
16373105|NCT00147537|39849858|FG004|Phase 2|Other|0|||
16373106|NCT00147537|39849859|FG005|Phase 2|Other|0|||
16373107|NCT00147537|39849860|FG006|Phase 2|Other|0|||
16373108|NCT00147537|39849861|FG007|Phase 2|Other|0|||
16373109|NCT00147537|39849862|FG008|Phase 2|Other|0|||
16373110|NCT00147537|39849863|FG009|Phase 2|Other|47|||
16373111|NCT00147537|39849864|FG010|Phase 2|Other|12|||
16373112|NCT00147537|39849854|FG000|Phase 2|Withdrawal by Subject|0|||
16373113|NCT00147537|39849855|FG001|Phase 2|Withdrawal by Subject|0|||
16373114|NCT00147537|39849856|FG002|Phase 2|Withdrawal by Subject|0|||
16373115|NCT00147537|39849857|FG003|Phase 2|Withdrawal by Subject|0|||
16373116|NCT00147537|39849858|FG004|Phase 2|Withdrawal by Subject|0|||
16373117|NCT00147537|39849859|FG005|Phase 2|Withdrawal by Subject|0|||
16373118|NCT00147537|39849860|FG006|Phase 2|Withdrawal by Subject|0|||
16373119|NCT00147537|39849861|FG007|Phase 2|Withdrawal by Subject|0|||
16373120|NCT00147537|39849862|FG008|Phase 2|Withdrawal by Subject|0|||
16373121|NCT00147537|39849863|FG009|Phase 2|Withdrawal by Subject|16|||
16373122|NCT00147537|39849864|FG010|Phase 2|Withdrawal by Subject|4|||
16373123|NCT00147537|39849854|FG000|Phase 2|Randomized but not treated|0|||
16373124|NCT00147537|39849855|FG001|Phase 2|Randomized but not treated|0|||
16373125|NCT00147537|39849856|FG002|Phase 2|Randomized but not treated|0|||
16373126|NCT00147537|39849857|FG003|Phase 2|Randomized but not treated|0|||
16373127|NCT00147537|39849858|FG004|Phase 2|Randomized but not treated|0|||
16373128|NCT00147537|39849859|FG005|Phase 2|Randomized but not treated|0|||
16373129|NCT00147537|39849860|FG006|Phase 2|Randomized but not treated|0|||
16373130|NCT00147537|39849861|FG007|Phase 2|Randomized but not treated|0|||
16163354|NCT01142726|39080071|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
16163355|NCT01142726|39080072|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
16163356|NCT01142726|39080070|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
16163357|NCT01142726|39080071|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
16163358|NCT01142726|39080072|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
16163359|NCT01142726|39080070|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
16163360|NCT01142726|39080071|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
16163361|NCT01142726|39080072|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
16163362|NCT01142726|39080070|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
16163363|NCT01142726|39080071|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
16163364|NCT01142726|39080072|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
16163365|NCT01239160|39080073|FG000|Overall Study|Lost to Follow-up|3|||
16163366|NCT01239160|39080074|FG001|Overall Study|Lost to Follow-up|5|||
16163367|NCT01239160|39080075|FG002|Overall Study|Lost to Follow-up|0|||
16163368|NCT01239160|39080073|FG000|Overall Study|Withdrawal by Subject|17|||
16163369|NCT01239160|39080074|FG001|Overall Study|Withdrawal by Subject|6|||
16163370|NCT01239160|39080075|FG002|Overall Study|Withdrawal by Subject|2|||
16163371|NCT01239160|39080073|FG000|Overall Study|Physician Decision|5|||
16163372|NCT01239160|39080074|FG001|Overall Study|Physician Decision|7|||
16163373|NCT01239160|39080075|FG002|Overall Study|Physician Decision|2|||
16163374|NCT01239160|39080073|FG000|Overall Study|Early Termination Due to Study Closure|0|||
16163375|NCT01239160|39080074|FG001|Overall Study|Early Termination Due to Study Closure|1|||
16163376|NCT01239160|39080075|FG002|Overall Study|Early Termination Due to Study Closure|6|||
16163377|NCT01613326|39080076|FG000|Overall Study|Adverse Event|7|||
16163378|NCT01613326|39080077|FG001|Overall Study|Adverse Event|5|||
16163379|NCT01613326|39080076|FG000|Overall Study|Withdrawal by Subject|3|||
16163380|NCT01613326|39080077|FG001|Overall Study|Withdrawal by Subject|4|||
16163381|NCT01613326|39080076|FG000|Overall Study|Abnormal test procedure result(s)|2|||
16163382|NCT01613326|39080077|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16163383|NCT01613326|39080076|FG000|Overall Study|inability to use device|1|||
16163384|NCT01613326|39080077|FG001|Overall Study|inability to use device|0|||
16163385|NCT01613326|39080076|FG000|Overall Study|Lack of Efficacy|0|||
16163386|NCT01613326|39080077|FG001|Overall Study|Lack of Efficacy|1|||
16163387|NCT01613326|39080076|FG000|Overall Study|Lost to Follow-up|0|||
16163388|NCT01613326|39080077|FG001|Overall Study|Lost to Follow-up|1|||
16163389|NCT01613326|39080076|FG000|Overall Study|Administrative|0|||
16163390|NCT01613326|39080077|FG001|Overall Study|Administrative|2|||
16163391|NCT01613326|39080076|FG000|Overall Study|Protocol Violation|0|||
16163392|NCT01613326|39080077|FG001|Overall Study|Protocol Violation|1|||
16163393|NCT04640766|39080078|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
16163394|NCT02499029|39080083|FG000|Overall Study|Lost to Follow-up|2|||
16163395|NCT02499029|39080084|FG001|Overall Study|Lost to Follow-up|2|||
16163396|NCT02499029|39080083|FG000|Overall Study|Physician Decision|2|||
16163397|NCT02499029|39080084|FG001|Overall Study|Physician Decision|1|||
16163398|NCT02499029|39080083|FG000|Overall Study|Death|1|||
16163399|NCT02499029|39080084|FG001|Overall Study|Death|0|||
16163400|NCT01960855|39080087|FG000|Overall Study|Subject noncompliant|1|||
16373131|NCT00147537|39849862|FG008|Phase 2|Randomized but not treated|0|||
16373132|NCT00147537|39849863|FG009|Phase 2|Randomized but not treated|1|||
16373133|NCT00147537|39849864|FG010|Phase 2|Randomized but not treated|1|||
16373134|NCT00236197|39849867|FG000|Overall Study|Withdrawal by Subject|3|||
16373135|NCT00236197|39849868|FG001|Overall Study|Withdrawal by Subject|2|||
16373136|NCT00236197|39849867|FG000|Overall Study|Lost to Follow-up|1|||
16373137|NCT00236197|39849868|FG001|Overall Study|Lost to Follow-up|5|||
16373138|NCT00236197|39849867|FG000|Overall Study|Protocol Violation|0|||
16373139|NCT00236197|39849868|FG001|Overall Study|Protocol Violation|3|||
16373140|NCT00236197|39849867|FG000|Overall Study|Medication non-compliance|1|||
16373141|NCT00236197|39849868|FG001|Overall Study|Medication non-compliance|2|||
16373142|NCT00236197|39849867|FG000|Overall Study|Other|0|||
16373143|NCT00236197|39849868|FG001|Overall Study|Other|2|||
16373144|NCT02451007|39849869|FG000|Overall Study|Withdrawal by Subject|4|||
16163401|NCT01960855|39080088|FG001|Overall Study|Subject noncompliant|0|||
16163402|NCT01960855|39080089|FG002|Overall Study|Subject noncompliant|0|||
16163403|NCT01960855|39080090|FG003|Overall Study|Subject noncompliant|0|||
16163404|NCT01960855|39080091|FG004|Overall Study|Subject noncompliant|0|||
16163405|NCT01960855|39080087|FG000|Overall Study|Adverse Event|2|||
16163406|NCT01960855|39080088|FG001|Overall Study|Adverse Event|0|||
16163407|NCT01960855|39080089|FG002|Overall Study|Adverse Event|6|||
16163408|NCT01960855|39080090|FG003|Overall Study|Adverse Event|2|||
16163409|NCT01960855|39080091|FG004|Overall Study|Adverse Event|2|||
16163410|NCT01960855|39080087|FG000|Overall Study|Lack of Efficacy|1|||
16163411|NCT01960855|39080088|FG001|Overall Study|Lack of Efficacy|1|||
16373145|NCT02451007|39849869|FG000|Overall Study|Adverse Event|1|||
16373146|NCT02451007|39849869|FG000|Overall Study|Disease Progression|2|||
16373147|NCT01630811|39849870|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
16163412|NCT01960855|39080089|FG002|Overall Study|Lack of Efficacy|0|||
16163413|NCT01960855|39080090|FG003|Overall Study|Lack of Efficacy|0|||
16373148|NCT01630811|39849871|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
16373149|NCT01539525|39849872|FG000|Overall Study|Lost to Follow-up|19|||
16373150|NCT01539525|39849873|FG001|Overall Study|Lost to Follow-up|12|||
16373151|NCT01539525|39849874|FG002|Overall Study|Lost to Follow-up|11|||
16373152|NCT01539525|39849872|FG000|Overall Study|Withdrawal by Subject|0|||
16373153|NCT01539525|39849873|FG001|Overall Study|Withdrawal by Subject|3|||
16373154|NCT01539525|39849874|FG002|Overall Study|Withdrawal by Subject|2|||
16373155|NCT01539525|39849872|FG000|Overall Study|Protocol Violation|1|||
16373156|NCT01539525|39849873|FG001|Overall Study|Protocol Violation|1|||
16373157|NCT01539525|39849874|FG002|Overall Study|Protocol Violation|4|||
16373158|NCT00537082|39849875|FG000|Overall Study|Adverse Event|6|||
16373159|NCT00537082|39849876|FG001|Overall Study|Adverse Event|6|||
16373160|NCT00537082|39849877|FG002|Overall Study|Adverse Event|3|||
16373161|NCT00537082|39849875|FG000|Overall Study|Protocol Violation|0|||
16373162|NCT00537082|39849876|FG001|Overall Study|Protocol Violation|2|||
16450575|NCT03104400|40129986|FG004|Overall Study|Withdrawal by Subject|24|||
16450576|NCT03104400|40129982|FG000|Overall Study|Lost to Follow-up|4|||
16163414|NCT01960855|39080091|FG004|Overall Study|Lack of Efficacy|0|||
16163415|NCT01960855|39080087|FG000|Overall Study|Other|2|||
16373163|NCT00537082|39849877|FG002|Overall Study|Protocol Violation|1|||
16450577|NCT03104400|40129983|FG001|Overall Study|Lost to Follow-up|1|||
16450578|NCT03104400|40129984|FG002|Overall Study|Lost to Follow-up|4|||
16450579|NCT03104400|40129985|FG003|Overall Study|Lost to Follow-up|8|||
16450580|NCT03104400|40129986|FG004|Overall Study|Lost to Follow-up|7|||
16450581|NCT03104400|40129982|FG000|Overall Study|Lack of Efficacy|6|||
16450582|NCT03104400|40129983|FG001|Overall Study|Lack of Efficacy|3|||
16450583|NCT03104400|40129984|FG002|Overall Study|Lack of Efficacy|8|||
16450584|NCT03104400|40129985|FG003|Overall Study|Lack of Efficacy|2|||
16450585|NCT03104400|40129986|FG004|Overall Study|Lack of Efficacy|1|||
16450586|NCT03104400|40129982|FG000|Overall Study|COVID Logistical Restrictions|0|||
16450587|NCT03104400|40129983|FG001|Overall Study|COVID Logistical Restrictions|0|||
16450588|NCT03104400|40129984|FG002|Overall Study|COVID Logistical Restrictions|0|||
16450589|NCT03104400|40129985|FG003|Overall Study|COVID Logistical Restrictions|1|||
16450590|NCT03104400|40129986|FG004|Overall Study|COVID Logistical Restrictions|0|||
16450591|NCT03104400|40129982|FG000|Overall Study|Other|2|||
16450592|NCT03104400|40129983|FG001|Overall Study|Other|3|||
16450593|NCT03104400|40129984|FG002|Overall Study|Other|7|||
16450594|NCT03104400|40129985|FG003|Overall Study|Other|6|||
16450595|NCT03104400|40129986|FG004|Overall Study|Other|4|||
16450596|NCT03104400|40129982|FG000|Overall Study|Other|0|||
16450597|NCT03104400|40129983|FG001|Overall Study|Other|1|||
16450598|NCT03104400|40129984|FG002|Overall Study|Other|0|||
16450599|NCT03104400|40129985|FG003|Overall Study|Other|0|||
16450600|NCT03104400|40129986|FG004|Overall Study|Other|0|||
16450601|NCT02085161|40129991|FG000|Overall Study|Not Treated|1|||
16450602|NCT02085161|40129992|FG001|Overall Study|Not Treated|0|||
16450603|NCT02085161|40129993|FG002|Overall Study|Not Treated|0|||
16450604|NCT02085161|40129994|FG003|Overall Study|Not Treated|0|||
16450605|NCT02085161|40129991|FG000|Overall Study|Adverse Event|8|||
16450606|NCT02085161|40129992|FG001|Overall Study|Adverse Event|5|||
16450607|NCT02085161|40129993|FG002|Overall Study|Adverse Event|4|||
16450608|NCT02085161|40129994|FG003|Overall Study|Adverse Event|5|||
16450609|NCT02085161|40129991|FG000|Overall Study|Protocol Violation|0|||
16450610|NCT02085161|40129992|FG001|Overall Study|Protocol Violation|1|||
16450611|NCT02085161|40129993|FG002|Overall Study|Protocol Violation|0|||
16450612|NCT02085161|40129994|FG003|Overall Study|Protocol Violation|1|||
16373164|NCT00537082|39849875|FG000|Overall Study|Lack of Efficacy|0|||
16373165|NCT00537082|39849876|FG001|Overall Study|Lack of Efficacy|0|||
16373166|NCT00537082|39849877|FG002|Overall Study|Lack of Efficacy|2|||
16450613|NCT02085161|40129991|FG000|Overall Study|Withdrawal by Subject|2|||
16450614|NCT02085161|40129992|FG001|Overall Study|Withdrawal by Subject|4|||
16450615|NCT02085161|40129993|FG002|Overall Study|Withdrawal by Subject|0|||
16450616|NCT02085161|40129994|FG003|Overall Study|Withdrawal by Subject|3|||
16450617|NCT02085161|40129991|FG000|Overall Study|Other Reason|1|||
16450618|NCT02085161|40129992|FG001|Overall Study|Other Reason|0|||
16450619|NCT02085161|40129993|FG002|Overall Study|Other Reason|1|||
16450620|NCT02085161|40129994|FG003|Overall Study|Other Reason|1|||
16450621|NCT01598506|40129995|FG000|Overall Study|Withdrawal by Subject|2|||
16163416|NCT01960855|39080088|FG001|Overall Study|Other|1|||
16163417|NCT01960855|39080089|FG002|Overall Study|Other|1|||
16163418|NCT01960855|39080090|FG003|Overall Study|Other|1|||
16163419|NCT01960855|39080091|FG004|Overall Study|Other|0|||
16163420|NCT01960855|39080087|FG000|Overall Study|Consent withdrawn by subject|3|||
16163421|NCT01960855|39080088|FG001|Overall Study|Consent withdrawn by subject|1|||
16163422|NCT01960855|39080089|FG002|Overall Study|Consent withdrawn by subject|2|||
16163423|NCT01960855|39080090|FG003|Overall Study|Consent withdrawn by subject|1|||
16163424|NCT01960855|39080091|FG004|Overall Study|Consent withdrawn by subject|1|||
16163425|NCT01960855|39080087|FG000|Overall Study|Lost to Follow-up|2|||
16450622|NCT00048074|40130004|FG000|Overall Study|Adverse Event|46|||
16450623|NCT00048074|40130005|FG001|Overall Study|Adverse Event|41|||
16450624|NCT00048074|40130006|FG002|Overall Study|Adverse Event|53|||
16450625|NCT00048074|40130004|FG000|Overall Study|Death|3|||
16450626|NCT00048074|40130005|FG001|Overall Study|Death|3|||
16450627|NCT00048074|40130006|FG002|Overall Study|Death|2|||
16450628|NCT00048074|40130004|FG000|Overall Study|Lost to Follow-up|2|||
16450629|NCT00048074|40130005|FG001|Overall Study|Lost to Follow-up|6|||
16450630|NCT00048074|40130006|FG002|Overall Study|Lost to Follow-up|6|||
16450631|NCT00048074|40130004|FG000|Overall Study|Withdrawal by Subject|28|||
16450632|NCT00048074|40130005|FG001|Overall Study|Withdrawal by Subject|30|||
16450633|NCT00048074|40130006|FG002|Overall Study|Withdrawal by Subject|35|||
16450634|NCT00048074|40130004|FG000|Overall Study|Protocol Violation|1|||
16450635|NCT00048074|40130005|FG001|Overall Study|Protocol Violation|3|||
16450636|NCT00048074|40130006|FG002|Overall Study|Protocol Violation|0|||
16450637|NCT00048074|40130004|FG000|Overall Study|Study participation was terminated|0|||
16450638|NCT00048074|40130005|FG001|Overall Study|Study participation was terminated|1|||
16450639|NCT00048074|40130006|FG002|Overall Study|Study participation was terminated|0|||
16450640|NCT00048074|40130004|FG000|Overall Study|Husband ill|0|||
16450641|NCT00048074|40130005|FG001|Overall Study|Husband ill|1|||
16450642|NCT00048074|40130006|FG002|Overall Study|Husband ill|0|||
16450643|NCT00048074|40130004|FG000|Overall Study|Poor compliance|0|||
16450644|NCT00048074|40130005|FG001|Overall Study|Poor compliance|1|||
16450645|NCT00048074|40130006|FG002|Overall Study|Poor compliance|0|||
16450646|NCT00048074|40130004|FG000|Overall Study|Out of station|0|||
16450647|NCT00048074|40130005|FG001|Overall Study|Out of station|1|||
16450648|NCT00048074|40130006|FG002|Overall Study|Out of station|1|||
16450649|NCT00048074|40130004|FG000|Overall Study|Social reasons|1|||
16450650|NCT00048074|40130005|FG001|Overall Study|Social reasons|0|||
16450651|NCT00048074|40130006|FG002|Overall Study|Social reasons|0|||
16450652|NCT03860259|40130007|FG000|Overall Study|Lost to Follow-up|5|||
16450653|NCT03860259|40130008|FG001|Overall Study|Lost to Follow-up|5|||
16450654|NCT03860259|40130007|FG000|Overall Study|Protocol Violation|1|||
16450655|NCT03860259|40130008|FG001|Overall Study|Protocol Violation|0|||
16450656|NCT00325897|40130015|FG000|Overall Study|Lost to Follow-up|12|||
16450657|NCT00325897|40130016|FG001|Overall Study|Lost to Follow-up|13|||
16450658|NCT01216189|40130019|FG000|Overall Study|Lost to Follow-up|21|||
16450659|NCT01216189|40130020|FG001|Overall Study|Lost to Follow-up|3|||
16450660|NCT01216189|40130019|FG000|Overall Study|Death|4|||
16450661|NCT01216189|40130020|FG001|Overall Study|Death|2|||
16450662|NCT00297258|40130021|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
16450663|NCT00297258|40130021|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
16450664|NCT00297258|40130021|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
16450665|NCT00297258|40130021|FG000|Overall Study|Intercurrent Illness|3|||
16450666|NCT00297258|40130021|FG000|Overall Study|Intercurrent Death|2|||
16450667|NCT00297258|40130021|FG000|Overall Study|Deteriorization of General Condition|1|||
16450668|NCT00297258|40130021|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
16450669|NCT00297258|40130021|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
16450670|NCT00297258|40130021|FG000|Overall Study|Switch to Commercial Treatment|1|||
16450671|NCT00297258|40130021|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
16450672|NCT00035932|40130024|FG000|Overall Study|Adverse Event|10|||
16450673|NCT00035932|40130025|FG001|Overall Study|Adverse Event|9|||
16450674|NCT00035932|40130026|FG002|Overall Study|Adverse Event|9|||
16450675|NCT00035932|40130024|FG000|Overall Study|Death|0|||
16450676|NCT00035932|40130025|FG001|Overall Study|Death|0|||
16450677|NCT00035932|40130026|FG002|Overall Study|Death|1|||
16450678|NCT00035932|40130024|FG000|Overall Study|Disease Progression / Relapse|1|||
16450679|NCT00035932|40130025|FG001|Overall Study|Disease Progression / Relapse|1|||
16450680|NCT00035932|40130026|FG002|Overall Study|Disease Progression / Relapse|0|||
16450681|NCT00035932|40130024|FG000|Overall Study|Lost to Follow-up|4|||
16450682|NCT00035932|40130025|FG001|Overall Study|Lost to Follow-up|4|||
16450683|NCT00035932|40130026|FG002|Overall Study|Lost to Follow-up|3|||
16450684|NCT00035932|40130024|FG000|Overall Study|Noncompliance|6|||
16450685|NCT00035932|40130025|FG001|Overall Study|Noncompliance|7|||
16450686|NCT00035932|40130026|FG002|Overall Study|Noncompliance|6|||
16450687|NCT00035932|40130024|FG000|Overall Study|Protocol Violation While on Study|0|||
16450688|NCT00035932|40130025|FG001|Overall Study|Protocol Violation While on Study|1|||
16450689|NCT00035932|40130026|FG002|Overall Study|Protocol Violation While on Study|2|||
16450690|NCT00035932|40130024|FG000|Overall Study|Withdrawal by Subject|1|||
16163426|NCT01960855|39080088|FG001|Overall Study|Lost to Follow-up|1|||
16163427|NCT01960855|39080089|FG002|Overall Study|Lost to Follow-up|0|||
16450691|NCT00035932|40130025|FG001|Overall Study|Withdrawal by Subject|5|||
16450692|NCT00035932|40130026|FG002|Overall Study|Withdrawal by Subject|0|||
16450693|NCT00035932|40130024|FG000|Overall Study|Study Termination by Sponsor|1|||
16450694|NCT00035932|40130025|FG001|Overall Study|Study Termination by Sponsor|0|||
16450695|NCT00035932|40130026|FG002|Overall Study|Study Termination by Sponsor|0|||
16450696|NCT00035932|40130024|FG000|Overall Study|Lack of Efficacy|33|||
16450697|NCT00035932|40130025|FG001|Overall Study|Lack of Efficacy|33|||
16450698|NCT00035932|40130026|FG002|Overall Study|Lack of Efficacy|28|||
16450699|NCT01263197|40130029|FG000|First Intervention (Period 1)|Adverse Event|0|||
16450700|NCT01263197|40130030|FG001|First Intervention (Period 1)|Adverse Event|0|||
16450701|NCT01263197|40130031|FG002|First Intervention (Period 1)|Adverse Event|0|||
16450702|NCT01263197|40130032|FG003|First Intervention (Period 1)|Adverse Event|0|||
16450703|NCT01263197|40130033|FG004|First Intervention (Period 1)|Adverse Event|0|||
16450704|NCT01263197|40130034|FG005|First Intervention (Period 1)|Adverse Event|1|||
16450705|NCT01263197|40130029|FG000|Washout Period 1|Protocol Violation|0|||
16450706|NCT01263197|40130030|FG001|Washout Period 1|Protocol Violation|0|||
16450707|NCT01263197|40130031|FG002|Washout Period 1|Protocol Violation|0|||
16450708|NCT01263197|40130032|FG003|Washout Period 1|Protocol Violation|0|||
16450709|NCT01263197|40130033|FG004|Washout Period 1|Protocol Violation|1|||
16450710|NCT01263197|40130034|FG005|Washout Period 1|Protocol Violation|0|||
16450711|NCT01263197|40130029|FG000|Washout Period 2|Physician Decision|0|||
16450712|NCT01263197|40130030|FG001|Washout Period 2|Physician Decision|0|||
16450713|NCT01263197|40130031|FG002|Washout Period 2|Physician Decision|0|||
16450714|NCT01263197|40130032|FG003|Washout Period 2|Physician Decision|0|||
16450715|NCT01263197|40130033|FG004|Washout Period 2|Physician Decision|0|||
16450716|NCT01263197|40130034|FG005|Washout Period 2|Physician Decision|1|||
16450717|NCT01263197|40130029|FG000|Washout Period 2|Protocol Violation|0|||
16450718|NCT01263197|40130030|FG001|Washout Period 2|Protocol Violation|0|||
16450719|NCT01263197|40130031|FG002|Washout Period 2|Protocol Violation|0|||
16450720|NCT01263197|40130032|FG003|Washout Period 2|Protocol Violation|1|||
16450721|NCT01263197|40130033|FG004|Washout Period 2|Protocol Violation|0|||
16450722|NCT01263197|40130034|FG005|Washout Period 2|Protocol Violation|0|||
16450723|NCT01263197|40130029|FG000|Third Intervention (Period 3)|Adverse Event|0|||
16450724|NCT01263197|40130030|FG001|Third Intervention (Period 3)|Adverse Event|1|||
16450725|NCT01263197|40130031|FG002|Third Intervention (Period 3)|Adverse Event|0|||
16450726|NCT01263197|40130032|FG003|Third Intervention (Period 3)|Adverse Event|0|||
16450727|NCT01263197|40130033|FG004|Third Intervention (Period 3)|Adverse Event|0|||
16450728|NCT01263197|40130034|FG005|Third Intervention (Period 3)|Adverse Event|0|||
16450729|NCT00472030|40130037|FG000|Overall Study|Physician Decision|1|||
16450730|NCT00472030|40130038|FG001|Overall Study|Physician Decision|0|||
16450731|NCT02350478|40130039|FG000|Overall Study|Lost to Follow-up|5|||
16450732|NCT02350478|40130040|FG001|Overall Study|Lost to Follow-up|1|||
16450733|NCT02817464|40130043|FG000|Overall Study|Lost to Follow-up|1|||
16373167|NCT00537082|39849875|FG000|Overall Study|Withdrawal by Subject|0|||
16373168|NCT00537082|39849876|FG001|Overall Study|Withdrawal by Subject|1|||
16373169|NCT00537082|39849877|FG002|Overall Study|Withdrawal by Subject|0|||
16373170|NCT00537082|39849875|FG000|Overall Study|Discontinued before initiating treatment|3|||
16373171|NCT00537082|39849876|FG001|Overall Study|Discontinued before initiating treatment|0|||
16373172|NCT00537082|39849877|FG002|Overall Study|Discontinued before initiating treatment|0|||
16373173|NCT03760666|39849883|FG000|Overall Study|Adverse Event|2|||
16373174|NCT03760666|39849884|FG001|Overall Study|Adverse Event|4|||
16373175|NCT03760666|39849885|FG002|Overall Study|Adverse Event|1|||
16373176|NCT03760666|39849883|FG000|Overall Study|AML Disease Progression|3|||
16373177|NCT03760666|39849884|FG001|Overall Study|AML Disease Progression|3|||
16373178|NCT03760666|39849885|FG002|Overall Study|AML Disease Progression|0|||
16373179|NCT03760666|39849883|FG000|Overall Study|Physician Decision|0|||
16373180|NCT03760666|39849884|FG001|Overall Study|Physician Decision|3|||
16373181|NCT03760666|39849885|FG002|Overall Study|Physician Decision|0|||
16373182|NCT03760666|39849883|FG000|Overall Study|Withdrawal by Subject|0|||
16373183|NCT03760666|39849884|FG001|Overall Study|Withdrawal by Subject|1|||
16373184|NCT03760666|39849885|FG002|Overall Study|Withdrawal by Subject|0|||
16373185|NCT02539394|39849894|FG000|Overall Study|Protocol Violation|1|||
16373186|NCT02539394|39849895|FG001|Overall Study|Protocol Violation|3|||
16373187|NCT02539394|39849894|FG000|Overall Study|Lost to Follow-up|1|||
16373188|NCT02539394|39849895|FG001|Overall Study|Lost to Follow-up|2|||
16373189|NCT02539394|39849894|FG000|Overall Study|Incomplete dataset|6|||
16373190|NCT02539394|39849895|FG001|Overall Study|Incomplete dataset|6|||
16373191|NCT02802865|39849896|FG000|Overall Study|Pregnancy|1|||
16373192|NCT02802865|39849897|FG001|Overall Study|Pregnancy|1|||
16373193|NCT02802865|39849896|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
16373194|NCT02802865|39849897|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
16373195|NCT00595075|39849898|FG000|Overall Study|Withdrawal by Subject|1|||
16373196|NCT00595075|39849899|FG001|Overall Study|Withdrawal by Subject|0|||
16373197|NCT01682720|39853112|FG000|Overall Study|Randomized but Not Treated|0|||
16450734|NCT02817464|40130044|FG001|Overall Study|Lost to Follow-up|0|||
16450735|NCT02817464|40130043|FG000|Overall Study|Discontinued early due to personal decision|1|||
16072615|NCT03520920|38756411|FG000|Overall Study|Death|13|||
16373198|NCT01682720|39853113|FG001|Overall Study|Randomized but Not Treated|1|||
16373199|NCT01682720|39853114|FG002|Overall Study|Randomized but Not Treated|1|||
16373200|NCT01682720|39853115|FG003|Overall Study|Randomized but Not Treated|0|||
16373201|NCT01682720|39853112|FG000|Overall Study|Terminated by Sponsor|83|||
16373202|NCT01682720|39853113|FG001|Overall Study|Terminated by Sponsor|0|||
16450736|NCT02817464|40130044|FG001|Overall Study|Discontinued early due to personal decision|1|||
16450737|NCT00380367|40130049|FG000|Overall Study|Lost to Follow-up|1|||
16450738|NCT00380367|40130049|FG000|Overall Study|Withdrawal by Subject|1|||
16450739|NCT00892099|40130053|FG000|Overall Study|Death|1|||
16450740|NCT00892099|40130054|FG001|Overall Study|Death|0|||
16450741|NCT00892099|40130055|FG002|Overall Study|Death|1|||
16450742|NCT00892099|40130053|FG000|Overall Study|Adverse Event|1|||
16450743|NCT00892099|40130054|FG001|Overall Study|Adverse Event|0|||
16450744|NCT00892099|40130055|FG002|Overall Study|Adverse Event|0|||
16450745|NCT00892099|40130053|FG000|Overall Study|replocated|1|||
16450746|NCT00892099|40130054|FG001|Overall Study|replocated|0|||
16450747|NCT00892099|40130055|FG002|Overall Study|replocated|2|||
16450748|NCT00892099|40130053|FG000|Overall Study|Prolonged hospitalization|1|||
16450749|NCT00892099|40130054|FG001|Overall Study|Prolonged hospitalization|0|||
16450750|NCT00892099|40130055|FG002|Overall Study|Prolonged hospitalization|1|||
16450751|NCT00892099|40130053|FG000|Overall Study|no further details|1|||
16450752|NCT00892099|40130054|FG001|Overall Study|no further details|0|||
16450753|NCT00892099|40130055|FG002|Overall Study|no further details|1|||
16450754|NCT00892099|40130053|FG000|Overall Study|kidney function recovered|0|||
16450755|NCT00892099|40130054|FG001|Overall Study|kidney function recovered|1|||
16450756|NCT00892099|40130055|FG002|Overall Study|kidney function recovered|0|||
16450757|NCT00892099|40130053|FG000|Overall Study|investigator decision|0|||
16450758|NCT00892099|40130054|FG001|Overall Study|investigator decision|0|||
16450759|NCT00892099|40130055|FG002|Overall Study|investigator decision|1|||
16450760|NCT00892099|40130053|FG000|Overall Study|Lost to Follow-up|0|||
16450761|NCT00892099|40130054|FG001|Overall Study|Lost to Follow-up|0|||
16450762|NCT00892099|40130055|FG002|Overall Study|Lost to Follow-up|1|||
16450763|NCT00248040|40130059|FG000|Overall Study|transplantectomy|2|||
16450764|NCT00248040|40130060|FG001|Overall Study|transplantectomy|1|||
16450765|NCT00248040|40130061|FG002|Overall Study|transplantectomy|3|||
16450766|NCT00248040|40130059|FG000|Overall Study|transplant cancelled post treat start|1|||
16450767|NCT00248040|40130060|FG001|Overall Study|transplant cancelled post treat start|0|||
16450768|NCT00248040|40130061|FG002|Overall Study|transplant cancelled post treat start|0|||
16450769|NCT00248040|40130059|FG000|Overall Study|Death|0|||
16450770|NCT00248040|40130060|FG001|Overall Study|Death|0|||
16450771|NCT00248040|40130061|FG002|Overall Study|Death|1|||
16450772|NCT00611026|40130063|FG000|Randomized to Double-blind Treatment|Not treated|2|||
16450773|NCT00611026|40130064|FG001|Randomized to Double-blind Treatment|Not treated|1|||
16450774|NCT00611026|40130065|FG002|Randomized to Double-blind Treatment|Not treated|3|||
16450775|NCT00611026|40130063|FG000|Double-blind Treatment Period|Death|1|||
16450776|NCT00611026|40130064|FG001|Double-blind Treatment Period|Death|0|||
16450777|NCT00611026|40130065|FG002|Double-blind Treatment Period|Death|0|||
16450778|NCT00611026|40130063|FG000|Double-blind Treatment Period|Adverse Event|9|||
16450779|NCT00611026|40130064|FG001|Double-blind Treatment Period|Adverse Event|28|||
16450780|NCT00611026|40130065|FG002|Double-blind Treatment Period|Adverse Event|46|||
16450781|NCT00611026|40130063|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
16450782|NCT00611026|40130064|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
16450783|NCT00611026|40130065|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
16450784|NCT00611026|40130063|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
16450785|NCT00611026|40130064|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
16450786|NCT00611026|40130065|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
16450787|NCT00611026|40130063|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
16450788|NCT00611026|40130064|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
16450789|NCT00611026|40130065|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
16450790|NCT00611026|40130063|FG000|Double-blind Treatment Period|Other|13|||
16450791|NCT00611026|40130064|FG001|Double-blind Treatment Period|Other|20|||
16450792|NCT00611026|40130065|FG002|Double-blind Treatment Period|Other|18|||
16450793|NCT02578706|40130066|FG000|Overall Study|Withdrawal by Subject|1|||
16450794|NCT02578706|40130067|FG001|Overall Study|Withdrawal by Subject|0|||
16450795|NCT02578706|40130068|FG002|Overall Study|Withdrawal by Subject|0|||
16450796|NCT02578706|40130066|FG000|Overall Study|Lost to Follow-up|0|||
16450797|NCT02578706|40130067|FG001|Overall Study|Lost to Follow-up|4|||
16450798|NCT02578706|40130068|FG002|Overall Study|Lost to Follow-up|0|||
16450799|NCT02578706|40130066|FG000|Overall Study|Physician Decision|0|||
16450800|NCT02578706|40130067|FG001|Overall Study|Physician Decision|1|||
16450801|NCT02578706|40130068|FG002|Overall Study|Physician Decision|0|||
16450802|NCT04396639|40130070|FG000|Overall Study|Withdrawal by Subject|1|||
16450803|NCT04396639|40130070|FG000|Overall Study|Other|1|||
16450804|NCT00737672|40130074|FG000|Overall Study|Graft Abandonment|48|||
16450805|NCT00737672|40130075|FG001|Overall Study|Graft Abandonment|56|||
16450806|NCT00737672|40130074|FG000|Overall Study|Death|23|||
16450807|NCT00737672|40130075|FG001|Overall Study|Death|22|||
16450808|NCT00737672|40130074|FG000|Overall Study|Withdrawal by Subject|1|||
16450809|NCT00737672|40130075|FG001|Overall Study|Withdrawal by Subject|2|||
16450810|NCT00737672|40130074|FG000|Overall Study|Lost to Follow-up|1|||
16450811|NCT00737672|40130075|FG001|Overall Study|Lost to Follow-up|0|||
16450812|NCT00737672|40130074|FG000|Overall Study|Miscellaneous|7|||
16450813|NCT00737672|40130075|FG001|Overall Study|Miscellaneous|1|||
16450814|NCT00737672|40130074|FG000|Overall Study|Physician Decision|0|||
16450815|NCT00737672|40130075|FG001|Overall Study|Physician Decision|2|||
16450816|NCT01995838|40130077|FG000|Overall Study|Lost to Follow-up|0|||
16450817|NCT01995838|40130078|FG001|Overall Study|Lost to Follow-up|1|||
16450818|NCT01995838|40130079|FG002|Overall Study|Lost to Follow-up|0|||
16450819|NCT01995838|40130080|FG003|Overall Study|Lost to Follow-up|0|||
16450820|NCT01995838|40130081|FG004|Overall Study|Lost to Follow-up|0|||
16450821|NCT01995838|40130082|FG005|Overall Study|Lost to Follow-up|0|||
16450822|NCT01995838|40130083|FG006|Overall Study|Lost to Follow-up|1|||
16450823|NCT01995838|40130077|FG000|Overall Study|Participant choice|2|||
16450824|NCT01995838|40130078|FG001|Overall Study|Participant choice|0|||
16450825|NCT01995838|40130079|FG002|Overall Study|Participant choice|0|||
16450826|NCT01995838|40130080|FG003|Overall Study|Participant choice|0|||
16450827|NCT01995838|40130081|FG004|Overall Study|Participant choice|0|||
16450828|NCT01995838|40130082|FG005|Overall Study|Participant choice|1|||
16450829|NCT01995838|40130083|FG006|Overall Study|Participant choice|1|||
16450830|NCT01995838|40130077|FG000|Overall Study|Adverse Event|0|||
16450831|NCT01995838|40130078|FG001|Overall Study|Adverse Event|0|||
16450832|NCT01995838|40130079|FG002|Overall Study|Adverse Event|0|||
16450833|NCT01995838|40130080|FG003|Overall Study|Adverse Event|0|||
16450834|NCT01995838|40130081|FG004|Overall Study|Adverse Event|0|||
16450835|NCT01995838|40130082|FG005|Overall Study|Adverse Event|0|||
16450836|NCT01995838|40130083|FG006|Overall Study|Adverse Event|1|||
16450837|NCT01995838|40130077|FG000|Overall Study|Withdrawal by Subject|0|||
16450838|NCT01995838|40130078|FG001|Overall Study|Withdrawal by Subject|0|||
16450839|NCT01995838|40130079|FG002|Overall Study|Withdrawal by Subject|0|||
16450840|NCT01995838|40130080|FG003|Overall Study|Withdrawal by Subject|0|||
16450841|NCT01995838|40130081|FG004|Overall Study|Withdrawal by Subject|1|||
16450842|NCT01995838|40130082|FG005|Overall Study|Withdrawal by Subject|0|||
16450843|NCT01995838|40130083|FG006|Overall Study|Withdrawal by Subject|0|||
16450844|NCT01995838|40130077|FG000|Overall Study|Other|3|||
16450845|NCT01995838|40130078|FG001|Overall Study|Other|1|||
16450846|NCT01995838|40130079|FG002|Overall Study|Other|0|||
16450847|NCT01995838|40130080|FG003|Overall Study|Other|2|||
16450848|NCT01995838|40130081|FG004|Overall Study|Other|1|||
16450849|NCT01995838|40130082|FG005|Overall Study|Other|1|||
16450850|NCT01995838|40130083|FG006|Overall Study|Other|2|||
16450851|NCT00950859|40130091|FG000|Overall Study|Adverse Event|3|||
16450852|NCT00950859|40130092|FG001|Overall Study|Adverse Event|3|||
16450853|NCT00950859|40130091|FG000|Overall Study|Insufficient Viral Load Response|12|||
16450854|NCT00950859|40130092|FG001|Overall Study|Insufficient Viral Load Response|3|||
16450855|NCT00950859|40130091|FG000|Overall Study|Protocol Violation|1|||
16450856|NCT00950859|40130092|FG001|Overall Study|Protocol Violation|1|||
16450857|NCT00950859|40130091|FG000|Overall Study|Lost to Follow-up|0|||
16450858|NCT00950859|40130092|FG001|Overall Study|Lost to Follow-up|3|||
16450859|NCT03554486|40130093|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
16450860|NCT03554486|40130094|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
16450861|NCT03554486|40130095|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
16450862|NCT03554486|40130093|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
16450863|NCT03554486|40130094|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
16450864|NCT03554486|40130095|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
16450865|NCT03554486|40130093|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
16450866|NCT03554486|40130094|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
16450867|NCT03554486|40130095|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
16450868|NCT01286480|40130097|FG000|Overall Study|Withdrawal by Subject|5|||
16450869|NCT01286480|40130098|FG001|Overall Study|Withdrawal by Subject|3|||
16450870|NCT00976560|40130099|FG000|Overall Study|Adverse Event|5|||
16450871|NCT00976560|40130100|FG001|Overall Study|Adverse Event|5|||
16450872|NCT00976560|40130099|FG000|Overall Study|Lack of Efficacy|3|||
16450873|NCT00976560|40130100|FG001|Overall Study|Lack of Efficacy|5|||
16450874|NCT00976560|40130099|FG000|Overall Study|Protocol Violation|1|||
16450875|NCT00976560|40130100|FG001|Overall Study|Protocol Violation|0|||
16450876|NCT00976560|40130099|FG000|Overall Study|Lost to Follow-up|1|||
16450877|NCT00976560|40130100|FG001|Overall Study|Lost to Follow-up|0|||
16450878|NCT00976560|40130099|FG000|Overall Study|Physician Decision|2|||
16450879|NCT00976560|40130100|FG001|Overall Study|Physician Decision|0|||
16450880|NCT00976560|40130099|FG000|Overall Study|Withdrawal by Subject|2|||
16450881|NCT00976560|40130100|FG001|Overall Study|Withdrawal by Subject|3|||
16450882|NCT00432172|40130102|FG000|Overall Study|Physician Decision|0|||
16450883|NCT00432172|40130103|FG001|Overall Study|Physician Decision|0|||
16450884|NCT00432172|40130104|FG002|Overall Study|Physician Decision|2|||
16450885|NCT00432172|40130105|FG003|Overall Study|Physician Decision|0|||
16450886|NCT00432172|40130102|FG000|Overall Study|Adverse Event|4|||
16450887|NCT00432172|40130103|FG001|Overall Study|Adverse Event|2|||
16450888|NCT00432172|40130104|FG002|Overall Study|Adverse Event|4|||
16450889|NCT00432172|40130105|FG003|Overall Study|Adverse Event|3|||
16450890|NCT00432172|40130102|FG000|Overall Study|Disease progression|0|||
16450891|NCT00432172|40130103|FG001|Overall Study|Disease progression|2|||
16450892|NCT00432172|40130104|FG002|Overall Study|Disease progression|5|||
16450893|NCT00432172|40130105|FG003|Overall Study|Disease progression|1|||
16450894|NCT00432172|40130102|FG000|Overall Study|Withdrawal by Subject|0|||
16450895|NCT00432172|40130103|FG001|Overall Study|Withdrawal by Subject|1|||
16450896|NCT00432172|40130104|FG002|Overall Study|Withdrawal by Subject|0|||
16450897|NCT00432172|40130105|FG003|Overall Study|Withdrawal by Subject|2|||
16450898|NCT00432172|40130102|FG000|Overall Study|No treatment received|2|||
16450899|NCT00432172|40130103|FG001|Overall Study|No treatment received|2|||
16450900|NCT00432172|40130104|FG002|Overall Study|No treatment received|0|||
16450901|NCT00432172|40130105|FG003|Overall Study|No treatment received|1|||
16450902|NCT01716234|40130108|FG000|Overall Study|Protocol Violation|0|||
16450903|NCT01716234|40130109|FG001|Overall Study|Protocol Violation|0|||
16450904|NCT01716234|40130110|FG002|Overall Study|Protocol Violation|0|||
16450905|NCT01716234|40130111|FG003|Overall Study|Protocol Violation|1|||
16450906|NCT01716234|40130112|FG004|Overall Study|Protocol Violation|1|||
16450907|NCT01716234|40130113|FG005|Overall Study|Protocol Violation|1|||
16450908|NCT01716234|40130114|FG006|Overall Study|Protocol Violation|0|||
16450909|NCT01716234|40130108|FG000|Overall Study|Lack of Efficacy|0|||
16450910|NCT01716234|40130109|FG001|Overall Study|Lack of Efficacy|0|||
16450911|NCT01716234|40130110|FG002|Overall Study|Lack of Efficacy|0|||
16450912|NCT01716234|40130111|FG003|Overall Study|Lack of Efficacy|1|||
16450913|NCT01716234|40130112|FG004|Overall Study|Lack of Efficacy|0|||
16450914|NCT01716234|40130113|FG005|Overall Study|Lack of Efficacy|0|||
16450915|NCT01716234|40130114|FG006|Overall Study|Lack of Efficacy|0|||
16450916|NCT01716234|40130108|FG000|Overall Study|Did not meet protocol eligibility|0|||
16450917|NCT01716234|40130109|FG001|Overall Study|Did not meet protocol eligibility|0|||
16450918|NCT01716234|40130110|FG002|Overall Study|Did not meet protocol eligibility|1|||
16450919|NCT01716234|40130111|FG003|Overall Study|Did not meet protocol eligibility|0|||
16450920|NCT01716234|40130112|FG004|Overall Study|Did not meet protocol eligibility|0|||
16450921|NCT01716234|40130113|FG005|Overall Study|Did not meet protocol eligibility|4|||
16450922|NCT01716234|40130114|FG006|Overall Study|Did not meet protocol eligibility|0|||
16450923|NCT01716234|40130108|FG000|Overall Study|Adverse Event|7|||
16450924|NCT01716234|40130109|FG001|Overall Study|Adverse Event|10|||
16450925|NCT01716234|40130110|FG002|Overall Study|Adverse Event|2|||
16450926|NCT01716234|40130111|FG003|Overall Study|Adverse Event|8|||
16450927|NCT01716234|40130112|FG004|Overall Study|Adverse Event|3|||
16450928|NCT01716234|40130113|FG005|Overall Study|Adverse Event|6|||
16450929|NCT01716234|40130114|FG006|Overall Study|Adverse Event|0|||
16450930|NCT01716234|40130108|FG000|Overall Study|Withdrawal by Subject|3|||
16450931|NCT01716234|40130109|FG001|Overall Study|Withdrawal by Subject|0|||
16450932|NCT01716234|40130110|FG002|Overall Study|Withdrawal by Subject|2|||
16450933|NCT01716234|40130111|FG003|Overall Study|Withdrawal by Subject|2|||
16450934|NCT01716234|40130112|FG004|Overall Study|Withdrawal by Subject|1|||
16450935|NCT01716234|40130113|FG005|Overall Study|Withdrawal by Subject|3|||
16450936|NCT01716234|40130114|FG006|Overall Study|Withdrawal by Subject|0|||
16450937|NCT03774576|40130122|FG000|Period 2|Adverse Event|1|||
16450938|NCT04287517|40130123|FG000|Overall Study|Withdrawal by Subject|1|||
16450939|NCT04287517|40130124|FG001|Overall Study|Withdrawal by Subject|1|||
16450940|NCT02395471|40130125|FG000|Overall Study|Lost to Follow-up|2|||
16450941|NCT02395471|40130126|FG001|Overall Study|Lost to Follow-up|0|||
16450942|NCT02395471|40130125|FG000|Overall Study|Withdrawal by Subject|2|||
16450943|NCT02395471|40130126|FG001|Overall Study|Withdrawal by Subject|1|||
16450944|NCT02395471|40130125|FG000|Overall Study|Physician Decision|1|||
16450945|NCT02395471|40130126|FG001|Overall Study|Physician Decision|0|||
16450946|NCT02395471|40130125|FG000|Overall Study|Protocol Violation|0|||
16450947|NCT02395471|40130126|FG001|Overall Study|Protocol Violation|1|||
16450948|NCT02395471|40130125|FG000|Overall Study|Failure to swollow sponge twice|1|||
16450949|NCT02395471|40130126|FG001|Overall Study|Failure to swollow sponge twice|0|||
16450950|NCT02395471|40130125|FG000|Overall Study|Patient did not return for procedure|0|||
16450951|NCT02395471|40130126|FG001|Overall Study|Patient did not return for procedure|1|||
16450952|NCT02395471|40130125|FG000|Overall Study|Subject not eligible|1|||
16450953|NCT02395471|40130126|FG001|Overall Study|Subject not eligible|0|||
16450954|NCT01391546|40130127|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
16450955|NCT01391546|40130128|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
16450956|NCT02533453|40130129|FG000|Overall Study|Adverse Event|6|||
16450957|NCT02533453|40130129|FG000|Overall Study|Protocol Violation|1|||
16450958|NCT02533453|40130129|FG000|Overall Study|Withdrawal by Subject|2|||
16450959|NCT02105961|40130130|FG000|Overall Study|Adverse Event|18|||
16450960|NCT02105961|40130131|FG001|Overall Study|Adverse Event|7|||
16450961|NCT02105961|40130132|FG002|Overall Study|Adverse Event|13|||
16450962|NCT02105961|40130130|FG000|Overall Study|Lack of Efficacy|3|||
16450963|NCT02105961|40130131|FG001|Overall Study|Lack of Efficacy|0|||
16450964|NCT02105961|40130132|FG002|Overall Study|Lack of Efficacy|3|||
16450965|NCT02105961|40130130|FG000|Overall Study|Lost to Follow-up|2|||
16450966|NCT02105961|40130131|FG001|Overall Study|Lost to Follow-up|0|||
16450967|NCT02105961|40130132|FG002|Overall Study|Lost to Follow-up|1|||
16450968|NCT02105961|40130130|FG000|Overall Study|Physician Decision|3|||
16450969|NCT02105961|40130131|FG001|Overall Study|Physician Decision|3|||
16450970|NCT02105961|40130132|FG002|Overall Study|Physician Decision|2|||
16450971|NCT02105961|40130130|FG000|Overall Study|Withdrawal by Subject|15|||
16450972|NCT02105961|40130131|FG001|Overall Study|Withdrawal by Subject|7|||
16450973|NCT02105961|40130132|FG002|Overall Study|Withdrawal by Subject|11|||
16450974|NCT01544335|40130135|FG000|Overall Study|Lost to Follow-up|27|||
16450975|NCT01544335|40130135|FG000|Overall Study|Death|4|||
16450976|NCT01544335|40130135|FG000|Overall Study|Disease progression|3|||
16450977|NCT01544335|40130135|FG000|Overall Study|Baseline Measurements not Available|19|||
16450978|NCT02745119|40130136|FG000|Overall Study|Adverse Event|1|||
16450979|NCT02745119|40130137|FG001|Overall Study|Adverse Event|0|||
16450980|NCT02745119|40130138|FG002|Overall Study|Adverse Event|1|||
16450981|NCT02745119|40130139|FG003|Overall Study|Adverse Event|3|||
16450982|NCT02745119|40130136|FG000|Overall Study|Death|3|||
16450983|NCT02745119|40130137|FG001|Overall Study|Death|3|||
16450984|NCT02745119|40130138|FG002|Overall Study|Death|0|||
16450985|NCT02745119|40130139|FG003|Overall Study|Death|4|||
16450986|NCT02745119|40130136|FG000|Overall Study|Lost to Follow-up|0|||
16450987|NCT02745119|40130137|FG001|Overall Study|Lost to Follow-up|0|||
16450988|NCT02745119|40130138|FG002|Overall Study|Lost to Follow-up|0|||
16450989|NCT02745119|40130139|FG003|Overall Study|Lost to Follow-up|1|||
16450990|NCT02745119|40130136|FG000|Overall Study|Protocol Deviation|0|||
16450991|NCT02745119|40130137|FG001|Overall Study|Protocol Deviation|0|||
16450992|NCT02745119|40130138|FG002|Overall Study|Protocol Deviation|0|||
16450993|NCT02745119|40130139|FG003|Overall Study|Protocol Deviation|1|||
16450994|NCT02745119|40130136|FG000|Overall Study|Withdrawal by Subject|7|||
16450995|NCT02745119|40130137|FG001|Overall Study|Withdrawal by Subject|15|||
16450996|NCT02745119|40130138|FG002|Overall Study|Withdrawal by Subject|8|||
16450997|NCT02745119|40130139|FG003|Overall Study|Withdrawal by Subject|14|||
16450998|NCT02745119|40130136|FG000|Overall Study|Study Terminated by Sponsor|134|||
16450999|NCT02745119|40130137|FG001|Overall Study|Study Terminated by Sponsor|252|||
16451000|NCT02745119|40130138|FG002|Overall Study|Study Terminated by Sponsor|135|||
16451001|NCT02745119|40130139|FG003|Overall Study|Study Terminated by Sponsor|251|||
16451002|NCT02745119|40130136|FG000|Overall Study|Physician Decision|0|||
16451003|NCT02745119|40130137|FG001|Overall Study|Physician Decision|2|||
16451004|NCT02745119|40130138|FG002|Overall Study|Physician Decision|2|||
16451005|NCT02745119|40130139|FG003|Overall Study|Physician Decision|2|||
16451006|NCT02745119|40130136|FG000|Overall Study|Reason Not Specified|0|||
16451007|NCT02745119|40130137|FG001|Overall Study|Reason Not Specified|2|||
16451008|NCT02745119|40130138|FG002|Overall Study|Reason Not Specified|0|||
16451009|NCT02745119|40130139|FG003|Overall Study|Reason Not Specified|1|||
16451010|NCT02157883|40130141|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
16451011|NCT02157883|40130141|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
16451012|NCT02157883|40130141|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
16451013|NCT02157883|40130141|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
16451014|NCT02157883|40130141|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
16451015|NCT01470326|40130142|FG000|Overall Study|Protocol Violation|32|||
16451016|NCT01470326|40130142|FG000|Overall Study|No Drug Administration Information|2|||
16451017|NCT01470326|40130142|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
16451018|NCT02667119|40130144|FG000|Overall Study|Lost to Follow-up|3|||
16451019|NCT02667119|40130145|FG001|Overall Study|Lost to Follow-up|0|||
16451020|NCT01064947|40130146|FG000|Overall Study|negative culture|41|||
16451021|NCT00525161|40130147|FG000|Overall Study|Adverse Event|1|||
16451022|NCT00560352|40130148|FG000|Overall Study|Adverse event unrelated to study drug|2|||
16451023|NCT00560352|40130149|FG001|Overall Study|Adverse event unrelated to study drug|1|||
16451024|NCT00560352|40130150|FG002|Overall Study|Adverse event unrelated to study drug|1|||
16451025|NCT00560352|40130148|FG000|Overall Study|Study drug toxicity|3|||
16451026|NCT00560352|40130149|FG001|Overall Study|Study drug toxicity|0|||
16451027|NCT00560352|40130150|FG002|Overall Study|Study drug toxicity|1|||
16451028|NCT00560352|40130148|FG000|Overall Study|Disease progression|0|||
16451029|NCT00560352|40130149|FG001|Overall Study|Disease progression|1|||
16451030|NCT00560352|40130150|FG002|Overall Study|Disease progression|1|||
16451031|NCT00560352|40130148|FG000|Overall Study|Withdrawal by Subject|1|||
16451032|NCT00560352|40130149|FG001|Overall Study|Withdrawal by Subject|1|||
16451033|NCT00560352|40130150|FG002|Overall Study|Withdrawal by Subject|1|||
16451034|NCT00560352|40130148|FG000|Overall Study|Maximum clinical benefit|1|||
16451035|NCT00560352|40130149|FG001|Overall Study|Maximum clinical benefit|0|||
16451036|NCT00560352|40130150|FG002|Overall Study|Maximum clinical benefit|0|||
16451037|NCT00060840|40130153|FG000|Overall Study|Change in surgical plan|2|||
16451038|NCT00060840|40130154|FG001|Overall Study|Change in surgical plan|6|||
16451039|NCT00060840|40130153|FG000|Overall Study|Death|0|||
16451040|NCT00060840|40130154|FG001|Overall Study|Death|1|||
16451041|NCT00060840|40130153|FG000|Overall Study|Withdrawal by Subject|0|||
16451042|NCT00060840|40130154|FG001|Overall Study|Withdrawal by Subject|1|||
16451043|NCT00060840|40130153|FG000|Overall Study|Subinvestigator unavailable|0|||
16451044|NCT00060840|40130154|FG001|Overall Study|Subinvestigator unavailable|1|||
16451045|NCT00060840|40130153|FG000|Overall Study|Physician Decision|1|||
16451046|NCT00060840|40130154|FG001|Overall Study|Physician Decision|0|||
16451047|NCT00060840|40130153|FG000|Overall Study|Other|1|||
16451048|NCT00060840|40130154|FG001|Overall Study|Other|0|||
16451049|NCT04085289|40130155|FG000|Overall Study|Withdrawal by Subject|0|||
16451050|NCT04085289|40130156|FG001|Overall Study|Withdrawal by Subject|0|||
16451051|NCT04085289|40130157|FG002|Overall Study|Withdrawal by Subject|1|||
16451052|NCT01459497|40130158|FG000|Overall Study|Inability to meet trial constraints.|1|||
16451053|NCT01459497|40130159|FG001|Overall Study|Inability to meet trial constraints.|0|||
16451054|NCT01459497|40130158|FG000|Overall Study|Physician Decision|1|||
16451055|NCT01459497|40130159|FG001|Overall Study|Physician Decision|1|||
16451056|NCT01459497|40130158|FG000|Overall Study|Hospitalization.|0|||
16451057|NCT01459497|40130159|FG001|Overall Study|Hospitalization.|3|||
16451058|NCT01459497|40130158|FG000|Overall Study|Disease progression.|0|||
16451059|NCT01459497|40130159|FG001|Overall Study|Disease progression.|1|||
16451060|NCT00981058|40130160|FG000|Overall Study|Adverse Event|1|||
16451061|NCT00981058|40130161|FG001|Overall Study|Adverse Event|1|||
16451062|NCT00981058|40130160|FG000|Overall Study|Progressive Disease|61|||
16451063|NCT00981058|40130161|FG001|Overall Study|Progressive Disease|49|||
16451064|NCT00981058|40130160|FG000|Overall Study|Lost to Follow-up|16|||
16451065|NCT00981058|40130161|FG001|Overall Study|Lost to Follow-up|15|||
16451066|NCT00981058|40130160|FG000|Overall Study|New Anticancer Therapy|6|||
16451067|NCT00981058|40130161|FG001|Overall Study|New Anticancer Therapy|6|||
16451068|NCT00981058|40130160|FG000|Overall Study|Noncompliance|1|||
16451069|NCT00981058|40130161|FG001|Overall Study|Noncompliance|0|||
16451070|NCT00981058|40130160|FG000|Overall Study|Radiologist Error|0|||
16451071|NCT00981058|40130161|FG001|Overall Study|Radiologist Error|1|||
16451072|NCT00981058|40130160|FG000|Overall Study|Randomization Error|1|||
16451073|NCT00981058|40130161|FG001|Overall Study|Randomization Error|2|||
16451074|NCT00981058|40130160|FG000|Overall Study|Withdrawal by Subject|25|||
16451075|NCT00981058|40130161|FG001|Overall Study|Withdrawal by Subject|23|||
16451076|NCT00981058|40130160|FG000|Overall Study|On study treatment at conclusion|9|||
16451077|NCT00981058|40130161|FG001|Overall Study|On study treatment at conclusion|0|||
16451078|NCT03056690|40130171|FG000|Overall Study|Adverse Event|3|||
16451079|NCT03056690|40130172|FG001|Overall Study|Adverse Event|2|||
16451080|NCT03056690|40130171|FG000|Overall Study|Lack of Efficacy|1|||
16451081|NCT03056690|40130172|FG001|Overall Study|Lack of Efficacy|2|||
16451082|NCT03056690|40130171|FG000|Overall Study|Lost to Follow-up|3|||
16451083|NCT03056690|40130172|FG001|Overall Study|Lost to Follow-up|2|||
16451084|NCT03056690|40130171|FG000|Overall Study|Protocol Violation|2|||
16451085|NCT03056690|40130172|FG001|Overall Study|Protocol Violation|2|||
16451086|NCT03056690|40130171|FG000|Overall Study|Withdrawal by Subject|3|||
16451087|NCT03056690|40130172|FG001|Overall Study|Withdrawal by Subject|6|||
16451088|NCT03056690|40130171|FG000|Overall Study|Non-compliance with Study Drug|1|||
16451089|NCT03056690|40130172|FG001|Overall Study|Non-compliance with Study Drug|0|||
16373203|NCT01682720|39853114|FG002|Overall Study|Terminated by Sponsor|0|||
16373204|NCT01682720|39853115|FG003|Overall Study|Terminated by Sponsor|0|||
16373205|NCT01682720|39853112|FG000|Overall Study|Efficacy Failure|0|||
16373206|NCT01682720|39853113|FG001|Overall Study|Efficacy Failure|3|||
16373207|NCT01682720|39853114|FG002|Overall Study|Efficacy Failure|3|||
16373208|NCT01682720|39853115|FG003|Overall Study|Efficacy Failure|30|||
16373209|NCT01682720|39853112|FG000|Overall Study|Lost to Follow-up|1|||
16373210|NCT01682720|39853113|FG001|Overall Study|Lost to Follow-up|1|||
16373211|NCT01682720|39853114|FG002|Overall Study|Lost to Follow-up|0|||
16373212|NCT01682720|39853115|FG003|Overall Study|Lost to Follow-up|6|||
16373213|NCT01682720|39853112|FG000|Overall Study|Subject Withdrew Consent|0|||
16373214|NCT01682720|39853113|FG001|Overall Study|Subject Withdrew Consent|0|||
16373215|NCT01682720|39853114|FG002|Overall Study|Subject Withdrew Consent|2|||
16373216|NCT01682720|39853115|FG003|Overall Study|Subject Withdrew Consent|2|||
16373217|NCT01682720|39853112|FG000|Overall Study|Adverse Event|1|||
16373218|NCT01682720|39853113|FG001|Overall Study|Adverse Event|0|||
16373219|NCT01682720|39853114|FG002|Overall Study|Adverse Event|1|||
16373220|NCT01682720|39853115|FG003|Overall Study|Adverse Event|1|||
16373221|NCT01964560|39853116|FG000|Overall Study|Adverse Event|23|||
16373222|NCT01964560|39853116|FG000|Overall Study|Lack of Efficacy|46|||
16451090|NCT03056690|40130171|FG000|Overall Study|Miscellaneous|1|||
16373223|NCT01964560|39853116|FG000|Overall Study|Protocol deviation|2|||
16373224|NCT01964560|39853116|FG000|Overall Study|Lost to Follow-up|4|||
16373225|NCT01964560|39853116|FG000|Overall Study|Withdrawal by Subject|64|||
16373226|NCT01964560|39853116|FG000|Overall Study|Surgery-hemispherotomy|1|||
16373227|NCT01964560|39853116|FG000|Overall Study|Surgery|1|||
16373228|NCT01964560|39853116|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
16373229|NCT01964560|39853116|FG000|Overall Study|Patient and Investigator choice|1|||
16373230|NCT01964560|39853116|FG000|Overall Study|Patient was prescribed CBD|1|||
16451091|NCT03056690|40130172|FG001|Overall Study|Miscellaneous|2|||
16451092|NCT00354432|40130173|FG000|Overall Study|Adverse Event|3|||
16451093|NCT00354432|40130174|FG001|Overall Study|Adverse Event|1|||
16451094|NCT00354432|40130175|FG002|Overall Study|Adverse Event|5|||
16451095|NCT00354432|40130176|FG003|Overall Study|Adverse Event|5|||
16163428|NCT01960855|39080090|FG003|Overall Study|Lost to Follow-up|0|||
16163429|NCT01960855|39080091|FG004|Overall Study|Lost to Follow-up|2|||
16163430|NCT02706730|39080092|FG000|Overall Study|Adverse Event|3|||
16163431|NCT02706730|39080092|FG000|Overall Study|Lack of Efficacy|5|||
16163432|NCT02706730|39080092|FG000|Overall Study|Withdrawal by Subject|11|||
16163433|NCT02706730|39080092|FG000|Overall Study|Study Terminated by Sponsor|11|||
16163434|NCT02706730|39080092|FG000|Overall Study|Subject chose not to receive injection|3|||
16163435|NCT00939692|39080093|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
16163436|NCT00939692|39080094|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
16163437|NCT00939692|39080093|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
16265152|NCT00640562|39453308|FG000|Overall Study|Withdrawal by Subject|6|||
16265153|NCT00640562|39453309|FG001|Overall Study|Withdrawal by Subject|10|||
16265154|NCT00640562|39453308|FG000|Overall Study|Known risperidone intolerance|0|||
16265155|NCT00640562|39453309|FG001|Overall Study|Known risperidone intolerance|1|||
16265156|NCT00640562|39453308|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
16265157|NCT00640562|39453309|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
16265158|NCT00640562|39453308|FG000|Overall Study|Low study drug dose|0|||
16265159|NCT00640562|39453309|FG001|Overall Study|Low study drug dose|1|||
16451096|NCT00354432|40130173|FG000|Overall Study|Off/Toxicity|3|||
16451097|NCT00354432|40130174|FG001|Overall Study|Off/Toxicity|7|||
16451098|NCT00354432|40130175|FG002|Overall Study|Off/Toxicity|5|||
16163438|NCT00939692|39080094|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
16163439|NCT02026063|39080095|FG000|Overall Study|Physician Decision|0|||
16163440|NCT02026063|39080096|FG001|Overall Study|Physician Decision|10|||
16163441|NCT02026063|39080095|FG000|Overall Study|Noncompliance with Study Drug|1|||
16163442|NCT02026063|39080096|FG001|Overall Study|Noncompliance with Study Drug|1|||
16163443|NCT02026063|39080095|FG000|Overall Study|Withdrawal of Consent|1|||
16163444|NCT02026063|39080096|FG001|Overall Study|Withdrawal of Consent|6|||
16163445|NCT02026063|39080095|FG000|Overall Study|Adverse Event|5|||
16163446|NCT02026063|39080096|FG001|Overall Study|Adverse Event|20|||
16451099|NCT00354432|40130176|FG003|Overall Study|Off/Toxicity|5|||
16451100|NCT02500797|40130179|FG000|Overall Study|Cancel (rapid disease progression)|0|||
16451101|NCT02500797|40130180|FG001|Overall Study|Cancel (rapid disease progression)|0|||
16163447|NCT02026063|39080095|FG000|Overall Study|Lack of Efficacy|0|||
16163448|NCT02026063|39080096|FG001|Overall Study|Lack of Efficacy|4|||
16163449|NCT02026063|39080095|FG000|Overall Study|Lost to Follow-up|0|||
16163450|NCT02026063|39080096|FG001|Overall Study|Lost to Follow-up|1|||
16163451|NCT02026063|39080095|FG000|Overall Study|Reason not Specified|2|||
16163452|NCT02026063|39080096|FG001|Overall Study|Reason not Specified|7|||
16163453|NCT00820755|39080097|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
16163454|NCT00820755|39080098|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
16163455|NCT00820755|39080099|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
16163456|NCT00820755|39080097|FG000|Period 1: Combination Therapy Phase|Death|28|||
16163457|NCT00820755|39080098|FG001|Period 1: Combination Therapy Phase|Death|0|||
16163458|NCT00820755|39080099|FG002|Period 1: Combination Therapy Phase|Death|0|||
16163459|NCT00820755|39080097|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
16163460|NCT00820755|39080098|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
16451102|NCT02500797|40130181|FG002|Overall Study|Cancel (rapid disease progression)|0|||
16451103|NCT02500797|40130182|FG003|Overall Study|Cancel (rapid disease progression)|0|||
16451104|NCT02500797|40130183|FG004|Overall Study|Cancel (rapid disease progression)|1|||
16451105|NCT02500797|40130184|FG005|Overall Study|Cancel (rapid disease progression)|1|||
16163461|NCT00820755|39080099|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
16163462|NCT00820755|39080097|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
16163463|NCT00820755|39080098|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
16163464|NCT00820755|39080099|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
16163465|NCT00820755|39080097|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
16163466|NCT00820755|39080098|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
16163467|NCT00820755|39080099|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
16163468|NCT00820755|39080097|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
16163469|NCT00820755|39080098|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
16163470|NCT00820755|39080099|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
16163471|NCT00820755|39080097|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
16163472|NCT00820755|39080098|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
16265160|NCT00640562|39453308|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
16265161|NCT00640562|39453309|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
16451106|NCT02500797|40130185|FG006|Overall Study|Cancel (rapid disease progression)|0|||
16451107|NCT02500797|40130186|FG007|Overall Study|Cancel (rapid disease progression)|0|||
16451108|NCT02500797|40130179|FG000|Overall Study|Withdrawal by Subject|1|||
16451109|NCT02500797|40130180|FG001|Overall Study|Withdrawal by Subject|0|||
16451110|NCT02500797|40130181|FG002|Overall Study|Withdrawal by Subject|0|||
16451111|NCT02500797|40130182|FG003|Overall Study|Withdrawal by Subject|0|||
16451112|NCT02500797|40130183|FG004|Overall Study|Withdrawal by Subject|0|||
16163473|NCT00820755|39080099|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
16163474|NCT00820755|39080097|FG000|Period 1: Combination Therapy Phase|Other|11|||
16163475|NCT00820755|39080098|FG001|Period 1: Combination Therapy Phase|Other|0|||
16163476|NCT00820755|39080099|FG002|Period 1: Combination Therapy Phase|Other|0|||
16163477|NCT00820755|39080097|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
16163478|NCT00820755|39080098|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
16163479|NCT00820755|39080099|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
16163480|NCT00927368|39080101|FG000|Overall Study|enrollment in another study|1|||
16163481|NCT00927368|39080102|FG001|Overall Study|enrollment in another study|1|||
16163482|NCT00927368|39080103|FG002|Overall Study|enrollment in another study|2|||
16163483|NCT00927368|39080101|FG000|Overall Study|Lost to Follow-up|4|||
16163484|NCT00927368|39080102|FG001|Overall Study|Lost to Follow-up|0|||
16163485|NCT00927368|39080103|FG002|Overall Study|Lost to Follow-up|0|||
16163486|NCT00927368|39080101|FG000|Overall Study|equipment failure|1|||
16163487|NCT00927368|39080102|FG001|Overall Study|equipment failure|0|||
16163488|NCT00927368|39080103|FG002|Overall Study|equipment failure|0|||
16163489|NCT00927368|39080101|FG000|Overall Study|ineligible post randomization|0|||
16265162|NCT03935880|39453310|FG000|Overall Study|Lost to Follow-up|0|||
16265163|NCT03935880|39453311|FG001|Overall Study|Lost to Follow-up|1|||
16265164|NCT03620747|39453312|FG000|Overall Study|Participant decision|7|||
16265165|NCT03620747|39453312|FG000|Overall Study|Adverse Event|6|||
16451113|NCT02500797|40130184|FG005|Overall Study|Withdrawal by Subject|0|||
16451114|NCT02500797|40130185|FG006|Overall Study|Withdrawal by Subject|0|||
16451115|NCT02500797|40130186|FG007|Overall Study|Withdrawal by Subject|0|||
16451116|NCT00960999|40130187|FG000|Overall Study|Withdrawal by Subject|1|||
16451117|NCT00960999|40130188|FG001|Overall Study|Withdrawal by Subject|0|||
16451118|NCT00960999|40130187|FG000|Overall Study|Protocol Violation|5|||
16451119|NCT00960999|40130188|FG001|Overall Study|Protocol Violation|2|||
16451120|NCT00960999|40130187|FG000|Overall Study|RT dose constraints not met|2|||
16451121|NCT00960999|40130188|FG001|Overall Study|RT dose constraints not met|0|||
16451122|NCT02761330|40130194|FG000|Treatment Week 1|Withdrawal by Subject|0|||
16451123|NCT02761330|40130195|FG001|Treatment Week 1|Withdrawal by Subject|0|||
16451124|NCT02761330|40130196|FG002|Treatment Week 1|Withdrawal by Subject|0|||
16451125|NCT02761330|40130197|FG003|Treatment Week 1|Withdrawal by Subject|1|||
16451126|NCT02761330|40130198|FG004|Treatment Week 1|Withdrawal by Subject|0|||
16163490|NCT00927368|39080102|FG001|Overall Study|ineligible post randomization|3|||
16163491|NCT00927368|39080103|FG002|Overall Study|ineligible post randomization|1|||
16451127|NCT02761330|40130199|FG005|Treatment Week 1|Withdrawal by Subject|1|||
16451128|NCT01388335|40130202|FG000|Period 1|Progressive Disease|1|||
16451129|NCT01388335|40130202|FG000|Period 2|Progressive Disease|2|||
16451130|NCT01388335|40130202|FG000|Period 2|Sponsor Decision|1|||
16451131|NCT01388335|40130202|FG000|Safety Extension|Progressive Disease|7|||
16451132|NCT01523756|40130203|FG000|Baseline Period|Adverse Event|0|||
16451133|NCT01523756|40130204|FG001|Baseline Period|Adverse Event|1|||
16451134|NCT01523756|40130203|FG000|Test Period 1|Adverse Event|1|||
16451135|NCT01523756|40130204|FG001|Test Period 1|Adverse Event|0|||
16451136|NCT01523756|40130203|FG000|Test Period 2|Withdrawal by Subject|0|||
16451137|NCT01523756|40130204|FG001|Test Period 2|Withdrawal by Subject|1|||
16451138|NCT01120717|40130205|FG000|Overall Study|Withdrawal by Subject|11|||
16451139|NCT01120717|40130206|FG001|Overall Study|Withdrawal by Subject|6|||
16451140|NCT01120717|40130205|FG000|Overall Study|Adverse Event|10|||
16451141|NCT01120717|40130206|FG001|Overall Study|Adverse Event|6|||
16451142|NCT01120717|40130205|FG000|Overall Study|Protocol Deviation|2|||
16451143|NCT01120717|40130206|FG001|Overall Study|Protocol Deviation|5|||
16451144|NCT01120717|40130205|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16451145|NCT01120717|40130206|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
16451146|NCT01120717|40130205|FG000|Overall Study|Lost to Follow-up|2|||
16451147|NCT01120717|40130206|FG001|Overall Study|Lost to Follow-up|3|||
16451148|NCT01120717|40130205|FG000|Overall Study|Death|3|||
16163492|NCT00927368|39080101|FG000|Overall Study|cancellation of surgery|0|||
16163493|NCT00927368|39080102|FG001|Overall Study|cancellation of surgery|1|||
16163494|NCT00927368|39080103|FG002|Overall Study|cancellation of surgery|2|||
16163495|NCT01847885|39080104|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
16163496|NCT01847885|39080105|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
16163497|NCT01847885|39080106|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
16163498|NCT01847885|39080104|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
16163499|NCT01847885|39080105|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
16163500|NCT01847885|39080106|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
16163501|NCT01847885|39080104|FG000|Initial Enrollment (Consented)|Screen failure|39|||
16163502|NCT01847885|39080105|FG001|Initial Enrollment (Consented)|Screen failure|0|||
16163503|NCT01847885|39080106|FG002|Initial Enrollment (Consented)|Screen failure|0|||
16265166|NCT03620747|39453312|FG000|Overall Study|Lack of Efficacy|1|||
16451149|NCT01120717|40130206|FG001|Overall Study|Death|1|||
16451150|NCT01120717|40130205|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
16451151|NCT01120717|40130206|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
16163504|NCT01847885|39080104|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
16163505|NCT01847885|39080105|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
16163506|NCT01847885|39080106|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
16163507|NCT01847885|39080104|FG000|Randomization|Protocol Violation|0|||
16163508|NCT01847885|39080105|FG001|Randomization|Protocol Violation|1|||
16163509|NCT01847885|39080106|FG002|Randomization|Protocol Violation|0|||
16163510|NCT01847885|39080104|FG000|Randomization|Withdrawal by Subject|0|||
16163511|NCT01847885|39080105|FG001|Randomization|Withdrawal by Subject|0|||
16163512|NCT01847885|39080106|FG002|Randomization|Withdrawal by Subject|2|||
16163513|NCT01847885|39080104|FG000|Randomization|Screen Failure|0|||
16163514|NCT01847885|39080105|FG001|Randomization|Screen Failure|3|||
16163515|NCT01847885|39080106|FG002|Randomization|Screen Failure|0|||
16163516|NCT00382993|39080107|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
16163517|NCT00382993|39080108|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
16163518|NCT00382993|39080107|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
16163519|NCT00382993|39080108|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
16163520|NCT00382993|39080107|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
16163521|NCT00382993|39080108|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
16163522|NCT00382993|39080107|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
16163523|NCT00382993|39080108|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
16163524|NCT00382993|39080107|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
16163525|NCT00382993|39080108|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
16163526|NCT00382993|39080107|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
16163527|NCT00382993|39080108|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
16163528|NCT00382993|39080107|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
16163529|NCT00382993|39080108|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
16163530|NCT00382993|39080107|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
16163531|NCT00382993|39080108|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
16163532|NCT00382993|39080107|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
16163533|NCT00382993|39080108|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
16265167|NCT03620747|39453312|FG000|Overall Study|Poor compliance to protocol|2|||
16265168|NCT03620747|39453312|FG000|Overall Study|Other-unspecified|3|||
16265169|NCT00316186|39453313|FG000|Overall Study|Adverse Event|6|||
16265170|NCT00316186|39453313|FG000|Overall Study|Disease Progression|4|||
16451152|NCT01249261|40130209|FG000|Overall Study|Withdrawal by Subject|1|||
16451153|NCT01249261|40130210|FG001|Overall Study|Withdrawal by Subject|0|||
16451154|NCT02872935|40130215|FG000|Overall Study|Other|0|||
16451155|NCT02872935|40130216|FG001|Overall Study|Other|1|||
16451156|NCT00499083|40130217|FG000|Overall Study|Not evaluable|3|||
16451157|NCT03212144|40130218|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
16451158|NCT03212144|40130219|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
16451159|NCT03212144|40130218|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
16451160|NCT03212144|40130219|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
16265171|NCT00316186|39453313|FG000|Overall Study|Lost to Follow-up|1|||
16265172|NCT00316186|39453313|FG000|Overall Study|Other|1|||
16265173|NCT01279486|39453318|FG000|Overall Study|Lost to Follow-up|1|||
16265174|NCT01204294|39453319|FG000|Overall Study|Adverse Event|2|||
16265175|NCT01204294|39453320|FG001|Overall Study|Adverse Event|6|||
16265176|NCT01204294|39453321|FG002|Overall Study|Adverse Event|0|||
16265177|NCT01204294|39453322|FG003|Overall Study|Adverse Event|7|||
16451161|NCT01147874|40130223|FG000|Overall Study|Adverse Event|5|||
16451162|NCT01147874|40130223|FG000|Overall Study|Investigator's Request|1|||
16451163|NCT01147874|40130223|FG000|Overall Study|Lost to Follow-up|25|||
16451164|NCT01147874|40130223|FG000|Overall Study|Other|5|||
16451165|NCT01147874|40130223|FG000|Overall Study|Protocol Violation|5|||
16451166|NCT01147874|40130223|FG000|Overall Study|Sponsor's Decision|2|||
16451167|NCT01147874|40130223|FG000|Overall Study|Withdrawal by Subject|24|||
16451168|NCT00286468|40130224|FG000|Overall Study|Hyperglycemic Rescue|28|||
16451169|NCT00286468|40130225|FG001|Overall Study|Hyperglycemic Rescue|30|||
16451170|NCT00286468|40130226|FG002|Overall Study|Hyperglycemic Rescue|31|||
16451171|NCT00286468|40130224|FG000|Overall Study|Adverse Event|2|||
16451172|NCT00286468|40130225|FG001|Overall Study|Adverse Event|6|||
16451173|NCT00286468|40130226|FG002|Overall Study|Adverse Event|4|||
16451174|NCT00286468|40130224|FG000|Overall Study|Protocol Violation|0|||
16451175|NCT00286468|40130225|FG001|Overall Study|Protocol Violation|3|||
16451176|NCT00286468|40130226|FG002|Overall Study|Protocol Violation|1|||
16451177|NCT00286468|40130224|FG000|Overall Study|Lost to Follow-up|1|||
16163534|NCT00382993|39080107|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
16163535|NCT00382993|39080108|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
16163536|NCT02675075|39080110|FG000|Overall Study|Lost to Follow-up|3|||
16265178|NCT01204294|39453323|FG004|Overall Study|Adverse Event|1|||
16265179|NCT01204294|39453324|FG005|Overall Study|Adverse Event|4|||
16265180|NCT01204294|39453325|FG006|Overall Study|Adverse Event|0|||
16163537|NCT02675075|39080111|FG001|Overall Study|Lost to Follow-up|0|||
16451178|NCT00286468|40130225|FG001|Overall Study|Lost to Follow-up|1|||
16451179|NCT00286468|40130226|FG002|Overall Study|Lost to Follow-up|2|||
16451180|NCT00286468|40130224|FG000|Overall Study|Withdrawal by Subject|3|||
16451181|NCT00286468|40130225|FG001|Overall Study|Withdrawal by Subject|8|||
16451182|NCT00286468|40130226|FG002|Overall Study|Withdrawal by Subject|11|||
16451183|NCT00286468|40130224|FG000|Overall Study|Physician Decision|3|||
16451184|NCT00286468|40130225|FG001|Overall Study|Physician Decision|2|||
16451185|NCT00286468|40130226|FG002|Overall Study|Physician Decision|1|||
16163538|NCT03783442|39080112|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
16163539|NCT03783442|39080113|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
16163540|NCT03783442|39080112|FG000|Overall Study|Death|196|||
16163541|NCT03783442|39080113|FG001|Overall Study|Death|226|||
16163542|NCT03783442|39080112|FG000|Overall Study|Withdrawal by Subject|14|||
16163543|NCT03783442|39080113|FG001|Overall Study|Withdrawal by Subject|17|||
16163544|NCT03783442|39080112|FG000|Overall Study|Lost to Follow-up|2|||
16163545|NCT03783442|39080113|FG001|Overall Study|Lost to Follow-up|3|||
16163546|NCT00440726|39080114|FG000|Phase 1|Dose-Limiting Toxicity|0|||
16163547|NCT00440726|39080115|FG001|Phase 1|Dose-Limiting Toxicity|1|||
16163548|NCT00440726|39080116|FG002|Phase 1|Dose-Limiting Toxicity|0|||
16163549|NCT00440726|39080114|FG000|Phase 1|Physician Decision|1|||
16163550|NCT00440726|39080115|FG001|Phase 1|Physician Decision|0|||
16163551|NCT00440726|39080116|FG002|Phase 1|Physician Decision|0|||
16163552|NCT00440726|39080114|FG000|Phase 2|Death|0|||
16163553|NCT00440726|39080115|FG001|Phase 2|Death|0|||
16163554|NCT00440726|39080116|FG002|Phase 2|Death|1|||
16163555|NCT00440726|39080114|FG000|Phase 2|Adverse Event|0|||
16163556|NCT00440726|39080115|FG001|Phase 2|Adverse Event|0|||
16163557|NCT00440726|39080116|FG002|Phase 2|Adverse Event|1|||
16163558|NCT01671280|39080123|FG000|Overall Study|Withdrawal by Subject|2|||
16163559|NCT04312009|39080124|FG000|Overall Study|Withdrawal by Subject|2|||
16163560|NCT04312009|39080125|FG001|Overall Study|Withdrawal by Subject|1|||
16265181|NCT01204294|39453319|FG000|Overall Study|Protocol Violation|1|||
16265182|NCT01204294|39453320|FG001|Overall Study|Protocol Violation|0|||
16265183|NCT01204294|39453321|FG002|Overall Study|Protocol Violation|2|||
16265184|NCT01204294|39453322|FG003|Overall Study|Protocol Violation|1|||
16265185|NCT01204294|39453323|FG004|Overall Study|Protocol Violation|0|||
16265186|NCT01204294|39453324|FG005|Overall Study|Protocol Violation|0|||
16265187|NCT01204294|39453325|FG006|Overall Study|Protocol Violation|0|||
16265188|NCT01204294|39453319|FG000|Overall Study|Withdrawal by Subject|0|||
16265189|NCT01204294|39453320|FG001|Overall Study|Withdrawal by Subject|2|||
16265190|NCT01204294|39453321|FG002|Overall Study|Withdrawal by Subject|2|||
16265191|NCT01204294|39453322|FG003|Overall Study|Withdrawal by Subject|1|||
16265192|NCT01204294|39453323|FG004|Overall Study|Withdrawal by Subject|1|||
16265193|NCT01204294|39453324|FG005|Overall Study|Withdrawal by Subject|1|||
16265194|NCT01204294|39453325|FG006|Overall Study|Withdrawal by Subject|2|||
16265195|NCT01204294|39453319|FG000|Overall Study|Lack of Efficacy|0|||
16265196|NCT01204294|39453320|FG001|Overall Study|Lack of Efficacy|0|||
16265197|NCT01204294|39453321|FG002|Overall Study|Lack of Efficacy|0|||
16265198|NCT01204294|39453322|FG003|Overall Study|Lack of Efficacy|2|||
16265199|NCT01204294|39453323|FG004|Overall Study|Lack of Efficacy|0|||
16265200|NCT01204294|39453324|FG005|Overall Study|Lack of Efficacy|0|||
16265201|NCT01204294|39453325|FG006|Overall Study|Lack of Efficacy|0|||
16265202|NCT01204294|39453319|FG000|Overall Study|Other (house moving)|0|||
16265203|NCT01204294|39453320|FG001|Overall Study|Other (house moving)|0|||
16265204|NCT01204294|39453321|FG002|Overall Study|Other (house moving)|1|||
16451186|NCT03345784|40130227|FG000|Overall Study|Withdrawal by Subject|2|||
16451187|NCT03345784|40130228|FG001|Overall Study|Withdrawal by Subject|1|||
16451188|NCT00071058|40130239|FG000|Overall Study|brain tumor-removed from study|1|||
16163561|NCT01405053|39080126|FG000|Overall Study|Adverse Event|3|||
16163562|NCT01405053|39080127|FG001|Overall Study|Adverse Event|0|||
16163563|NCT01405053|39080126|FG000|Overall Study|Lost to Follow-up|0|||
16163564|NCT01405053|39080127|FG001|Overall Study|Lost to Follow-up|1|||
16163565|NCT01405053|39080126|FG000|Overall Study|Participant choice|2|||
16163566|NCT01405053|39080127|FG001|Overall Study|Participant choice|1|||
16163567|NCT01405053|39080126|FG000|Overall Study|Inadequate therapeutic effect|2|||
16163568|NCT01405053|39080127|FG001|Overall Study|Inadequate therapeutic effect|1|||
16163569|NCT01405053|39080126|FG000|Overall Study|Withdrawal by Subject|3|||
16163570|NCT01405053|39080127|FG001|Overall Study|Withdrawal by Subject|4|||
16163571|NCT01405053|39080126|FG000|Overall Study|Other|0|||
16163572|NCT01405053|39080127|FG001|Overall Study|Other|1|||
16163573|NCT00130286|39080128|FG000|Overall Study|Withdrawal by Subject|0|||
16163574|NCT00130286|39080129|FG001|Overall Study|Withdrawal by Subject|1|||
16265205|NCT01204294|39453322|FG003|Overall Study|Other (house moving)|0|||
16265206|NCT01204294|39453323|FG004|Overall Study|Other (house moving)|0|||
16265207|NCT01204294|39453324|FG005|Overall Study|Other (house moving)|0|||
16265208|NCT01204294|39453325|FG006|Overall Study|Other (house moving)|0|||
16265209|NCT01519661|39453326|FG000|Overall Study|Protocol deviation|6|||
16265210|NCT01519661|39453326|FG000|Overall Study|Lost to Follow-up|3|||
16265211|NCT01519661|39453326|FG000|Overall Study|Withdrawal by Subject|17|||
16265212|NCT01519661|39453326|FG000|Overall Study|Lack of Efficacy|6|||
16265213|NCT01519661|39453326|FG000|Overall Study|Adverse Event|29|||
16265214|NCT03104374|39453327|FG000|Overall Study|Adverse Event|7|||
16265215|NCT03104374|39453328|FG001|Overall Study|Adverse Event|6|||
16265216|NCT03104374|39453329|FG002|Overall Study|Adverse Event|12|||
16265217|NCT03104374|39453330|FG003|Overall Study|Adverse Event|15|||
16265218|NCT03104374|39453327|FG000|Overall Study|Withdrawal by Subject|18|||
16265219|NCT03104374|39453328|FG001|Overall Study|Withdrawal by Subject|10|||
16265220|NCT03104374|39453329|FG002|Overall Study|Withdrawal by Subject|10|||
16265221|NCT03104374|39453330|FG003|Overall Study|Withdrawal by Subject|17|||
16265222|NCT03104374|39453327|FG000|Overall Study|Lost to Follow-up|4|||
16265223|NCT03104374|39453328|FG001|Overall Study|Lost to Follow-up|4|||
16265224|NCT03104374|39453329|FG002|Overall Study|Lost to Follow-up|6|||
16265225|NCT03104374|39453330|FG003|Overall Study|Lost to Follow-up|8|||
16265226|NCT03104374|39453327|FG000|Overall Study|Lack of Efficacy|6|||
16265227|NCT03104374|39453328|FG001|Overall Study|Lack of Efficacy|7|||
16265228|NCT03104374|39453329|FG002|Overall Study|Lack of Efficacy|12|||
16265229|NCT03104374|39453330|FG003|Overall Study|Lack of Efficacy|6|||
16163575|NCT00130286|39080130|FG002|Overall Study|Withdrawal by Subject|2|||
16163576|NCT00130286|39080131|FG003|Overall Study|Withdrawal by Subject|2|||
16265230|NCT03104374|39453327|FG000|Overall Study|Other|2|||
16265231|NCT03104374|39453328|FG001|Overall Study|Other|2|||
16265232|NCT03104374|39453329|FG002|Overall Study|Other|4|||
16265233|NCT03104374|39453330|FG003|Overall Study|Other|7|||
16265234|NCT02308163|39453334|FG000|Overall Study|Not fulfill eligible criteria|1|||
16265235|NCT02308163|39453335|FG001|Overall Study|Not fulfill eligible criteria|2|||
16265236|NCT02308163|39453336|FG002|Overall Study|Not fulfill eligible criteria|0|||
16265237|NCT02308163|39453337|FG003|Overall Study|Not fulfill eligible criteria|1|||
16265238|NCT02308163|39453338|FG004|Overall Study|Not fulfill eligible criteria|1|||
16265239|NCT02308163|39453334|FG000|Overall Study|Adverse Event|9|||
16265240|NCT02308163|39453335|FG001|Overall Study|Adverse Event|5|||
16265241|NCT02308163|39453336|FG002|Overall Study|Adverse Event|2|||
16265242|NCT02308163|39453337|FG003|Overall Study|Adverse Event|2|||
16265243|NCT02308163|39453338|FG004|Overall Study|Adverse Event|11|||
16265244|NCT02308163|39453334|FG000|Overall Study|Lack of Efficacy|11|||
16265245|NCT02308163|39453335|FG001|Overall Study|Lack of Efficacy|3|||
16265246|NCT02308163|39453336|FG002|Overall Study|Lack of Efficacy|8|||
16265247|NCT02308163|39453337|FG003|Overall Study|Lack of Efficacy|4|||
16163577|NCT00130286|39080128|FG000|Overall Study|Adverse Event|0|||
16163578|NCT00130286|39080129|FG001|Overall Study|Adverse Event|0|||
16163579|NCT00130286|39080130|FG002|Overall Study|Adverse Event|2|||
16163580|NCT00130286|39080131|FG003|Overall Study|Adverse Event|0|||
16163581|NCT00130286|39080128|FG000|Overall Study|Missing lab specimens|0|||
16163582|NCT00130286|39080129|FG001|Overall Study|Missing lab specimens|2|||
16163583|NCT00130286|39080130|FG002|Overall Study|Missing lab specimens|0|||
16163584|NCT00130286|39080131|FG003|Overall Study|Missing lab specimens|0|||
16163585|NCT02532855|39080132|FG000|Overall Study|Lost to Follow-up|4|||
16163586|NCT02532855|39080133|FG001|Overall Study|Lost to Follow-up|3|||
16163587|NCT02532855|39080132|FG000|Overall Study|Withdrawal by Subject|4|||
16163588|NCT02532855|39080133|FG001|Overall Study|Withdrawal by Subject|8|||
16163589|NCT01972074|39080134|FG000|Overall Study|Adverse Event|4|||
16163590|NCT01972074|39080135|FG001|Overall Study|Adverse Event|1|||
16163591|NCT01972074|39080136|FG002|Overall Study|Adverse Event|0|||
16163592|NCT01972074|39080134|FG000|Overall Study|Lack of Efficacy|1|||
16163593|NCT01972074|39080135|FG001|Overall Study|Lack of Efficacy|1|||
16163594|NCT01972074|39080136|FG002|Overall Study|Lack of Efficacy|0|||
16163595|NCT01972074|39080134|FG000|Overall Study|Lost to Follow-up|0|||
16163596|NCT01972074|39080135|FG001|Overall Study|Lost to Follow-up|1|||
16163597|NCT01972074|39080136|FG002|Overall Study|Lost to Follow-up|1|||
16163598|NCT01972074|39080134|FG000|Overall Study|Withdrawal by Subject|1|||
16163599|NCT01972074|39080135|FG001|Overall Study|Withdrawal by Subject|1|||
16163600|NCT01972074|39080136|FG002|Overall Study|Withdrawal by Subject|1|||
16163601|NCT01972074|39080134|FG000|Overall Study|Scanner Unavailable|0|||
16163602|NCT01972074|39080135|FG001|Overall Study|Scanner Unavailable|0|||
16163603|NCT01972074|39080136|FG002|Overall Study|Scanner Unavailable|1|||
16163604|NCT01463098|39080141|FG000|Part A (11 Days)|Participant Choice|2|||
16163605|NCT01463098|39080142|FG001|Part A (11 Days)|Participant Choice|0|||
16163606|NCT01463098|39080143|FG002|Part A (11 Days)|Participant Choice|0|||
16163607|NCT01463098|39080144|FG003|Part A (11 Days)|Participant Choice|0|||
16265248|NCT02308163|39453338|FG004|Overall Study|Lack of Efficacy|6|||
16265249|NCT02308163|39453334|FG000|Overall Study|Withdrawal of consent|2|||
16265250|NCT02308163|39453335|FG001|Overall Study|Withdrawal of consent|3|||
16265251|NCT02308163|39453336|FG002|Overall Study|Withdrawal of consent|0|||
16265252|NCT02308163|39453337|FG003|Overall Study|Withdrawal of consent|2|||
16265253|NCT02308163|39453338|FG004|Overall Study|Withdrawal of consent|6|||
16265254|NCT02308163|39453334|FG000|Overall Study|Protocol Violation|3|||
16265255|NCT02308163|39453335|FG001|Overall Study|Protocol Violation|3|||
16265256|NCT02308163|39453336|FG002|Overall Study|Protocol Violation|3|||
16265257|NCT02308163|39453337|FG003|Overall Study|Protocol Violation|2|||
16265258|NCT02308163|39453338|FG004|Overall Study|Protocol Violation|5|||
16265259|NCT02308163|39453334|FG000|Overall Study|Lab data met discontinuation criteria|3|||
16265260|NCT02308163|39453335|FG001|Overall Study|Lab data met discontinuation criteria|0|||
16265261|NCT02308163|39453336|FG002|Overall Study|Lab data met discontinuation criteria|0|||
16451189|NCT00753649|40130243|FG000|Overall Study|Migrated/moved from study area|1|||
16451190|NCT00753649|40130244|FG001|Overall Study|Migrated/moved from study area|0|||
16451191|NCT00753649|40130243|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
16451192|NCT00753649|40130244|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
16451193|NCT00753649|40130243|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
16451194|NCT00753649|40130244|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
16451195|NCT00753649|40130243|FG000|Overall Study|Protocol Violation|2|||
16451196|NCT00753649|40130244|FG001|Overall Study|Protocol Violation|0|||
16451197|NCT01157234|40130248|FG000|Overall Study|Withdrawal by Subject|1|||
16451198|NCT01157234|40130249|FG001|Overall Study|Withdrawal by Subject|0|||
16163608|NCT01463098|39080145|FG004|Part A (11 Days)|Participant Choice|0|||
16163609|NCT01463098|39080146|FG005|Part A (11 Days)|Participant Choice|0|||
16163610|NCT01463098|39080147|FG006|Part A (11 Days)|Participant Choice|0|||
16163611|NCT01463098|39080148|FG007|Part A (11 Days)|Participant Choice|0|||
16163612|NCT01463098|39080149|FG008|Part A (11 Days)|Participant Choice|1|||
16163613|NCT01463098|39080150|FG009|Part A (11 Days)|Participant Choice|0|||
16163614|NCT01463098|39080151|FG010|Part A (11 Days)|Participant Choice|0|||
16163615|NCT01463098|39080152|FG011|Part A (11 Days)|Participant Choice|0|||
16163616|NCT01463098|39080153|FG012|Part A (11 Days)|Participant Choice|0|||
16163617|NCT01463098|39080154|FG013|Part A (11 Days)|Participant Choice|0|||
16163618|NCT01463098|39080141|FG000|Part A (11 Days)|Lost to Follow-up|0|||
16163619|NCT01463098|39080142|FG001|Part A (11 Days)|Lost to Follow-up|0|||
16163620|NCT01463098|39080143|FG002|Part A (11 Days)|Lost to Follow-up|0|||
16163621|NCT01463098|39080144|FG003|Part A (11 Days)|Lost to Follow-up|0|||
16163622|NCT01463098|39080145|FG004|Part A (11 Days)|Lost to Follow-up|1|||
16163623|NCT01463098|39080146|FG005|Part A (11 Days)|Lost to Follow-up|0|||
16163624|NCT01463098|39080147|FG006|Part A (11 Days)|Lost to Follow-up|0|||
16163625|NCT01463098|39080148|FG007|Part A (11 Days)|Lost to Follow-up|0|||
16163626|NCT01463098|39080149|FG008|Part A (11 Days)|Lost to Follow-up|0|||
16163627|NCT01463098|39080150|FG009|Part A (11 Days)|Lost to Follow-up|0|||
16163628|NCT01463098|39080151|FG010|Part A (11 Days)|Lost to Follow-up|0|||
16163629|NCT01463098|39080152|FG011|Part A (11 Days)|Lost to Follow-up|0|||
16163630|NCT01463098|39080153|FG012|Part A (11 Days)|Lost to Follow-up|0|||
16163631|NCT01463098|39080154|FG013|Part A (11 Days)|Lost to Follow-up|0|||
16163632|NCT01463098|39080141|FG000|Part B (11 Days)|Participant Choice|0|||
16163633|NCT01463098|39080142|FG001|Part B (11 Days)|Participant Choice|0|||
16265262|NCT02308163|39453337|FG003|Overall Study|Lab data met discontinuation criteria|2|||
16265263|NCT02308163|39453338|FG004|Overall Study|Lab data met discontinuation criteria|0|||
16265264|NCT02308163|39453334|FG000|Overall Study|Miscellaneous|2|||
16265265|NCT02308163|39453335|FG001|Overall Study|Miscellaneous|2|||
16265266|NCT02308163|39453336|FG002|Overall Study|Miscellaneous|1|||
16265267|NCT02308163|39453337|FG003|Overall Study|Miscellaneous|0|||
16265268|NCT02308163|39453338|FG004|Overall Study|Miscellaneous|5|||
16265269|NCT02655679|39453339|FG000|Overall Study|Adverse Event|0|||
16265270|NCT02655679|39453340|FG001|Overall Study|Adverse Event|1|||
16265271|NCT02655679|39453341|FG002|Overall Study|Adverse Event|0|||
16265272|NCT02655679|39453342|FG003|Overall Study|Adverse Event|0|||
16265273|NCT02655679|39453343|FG004|Overall Study|Adverse Event|0|||
16265274|NCT02655679|39453339|FG000|Overall Study|Withdrawal by Subject|1|||
16265275|NCT02655679|39453340|FG001|Overall Study|Withdrawal by Subject|1|||
16265276|NCT02655679|39453341|FG002|Overall Study|Withdrawal by Subject|0|||
16265277|NCT02655679|39453342|FG003|Overall Study|Withdrawal by Subject|3|||
16451199|NCT02357368|40130250|FG000|Overall Study|Lost to Follow-up|0|||
16163634|NCT01463098|39080143|FG002|Part B (11 Days)|Participant Choice|0|||
16163635|NCT01463098|39080144|FG003|Part B (11 Days)|Participant Choice|0|||
16163636|NCT01463098|39080145|FG004|Part B (11 Days)|Participant Choice|0|||
16163637|NCT01463098|39080146|FG005|Part B (11 Days)|Participant Choice|0|||
16163638|NCT01463098|39080147|FG006|Part B (11 Days)|Participant Choice|0|||
16163639|NCT01463098|39080148|FG007|Part B (11 Days)|Participant Choice|0|||
16163640|NCT01463098|39080149|FG008|Part B (11 Days)|Participant Choice|0|||
16163641|NCT01463098|39080150|FG009|Part B (11 Days)|Participant Choice|0|||
16163642|NCT01463098|39080151|FG010|Part B (11 Days)|Participant Choice|0|||
16163643|NCT01463098|39080152|FG011|Part B (11 Days)|Participant Choice|1|||
16163644|NCT01463098|39080153|FG012|Part B (11 Days)|Participant Choice|0|||
16163645|NCT01463098|39080154|FG013|Part B (11 Days)|Participant Choice|0|||
16265278|NCT02655679|39453343|FG004|Overall Study|Withdrawal by Subject|1|||
16265279|NCT02655679|39453339|FG000|Overall Study|Inability to Comply with the Protocol|1|||
16265280|NCT02655679|39453340|FG001|Overall Study|Inability to Comply with the Protocol|0|||
16265281|NCT02655679|39453341|FG002|Overall Study|Inability to Comply with the Protocol|0|||
16163646|NCT00419380|39080178|FG000|Overall Study|Lack of Efficacy|1|||
16163647|NCT00419380|39080179|FG001|Overall Study|Lack of Efficacy|7|||
16163648|NCT00419380|39080178|FG000|Overall Study|Physician Decision|0|||
16163649|NCT00419380|39080179|FG001|Overall Study|Physician Decision|1|||
16163650|NCT00419380|39080178|FG000|Overall Study|Lost to Follow-up|0|||
16163651|NCT00419380|39080179|FG001|Overall Study|Lost to Follow-up|1|||
16163652|NCT00419380|39080178|FG000|Overall Study|Withdrawal by Subject|0|||
16163653|NCT00419380|39080179|FG001|Overall Study|Withdrawal by Subject|1|||
16163654|NCT01791855|39080180|FG000|Overall Study|Adverse Event|0|||
16163655|NCT01791855|39080181|FG001|Overall Study|Adverse Event|0|||
16163656|NCT01791855|39080182|FG002|Overall Study|Adverse Event|0|||
16163657|NCT01791855|39080183|FG003|Overall Study|Adverse Event|1|||
16163658|NCT01791855|39080180|FG000|Overall Study|Randomized, not treated|0|||
16163659|NCT01791855|39080181|FG001|Overall Study|Randomized, not treated|1|||
16163660|NCT01791855|39080182|FG002|Overall Study|Randomized, not treated|0|||
16163661|NCT01791855|39080183|FG003|Overall Study|Randomized, not treated|0|||
16163662|NCT02154087|39080184|FG000|Overall Study|Study Termination|1|||
16163663|NCT00662792|39080187|FG000|Period 1|Personal Reasons|0|||
16163664|NCT00662792|39080188|FG001|Period 1|Personal Reasons|0|||
16163665|NCT00662792|39080189|FG002|Period 1|Personal Reasons|1|||
16163666|NCT00662792|39080190|FG003|Period 1|Personal Reasons|0|||
16163667|NCT00662792|39080187|FG000|Period 1|Refused continuing medication|0|||
16451200|NCT02357368|40130251|FG001|Overall Study|Lost to Follow-up|0|||
16451201|NCT02357368|40130252|FG002|Overall Study|Lost to Follow-up|0|||
16451202|NCT02357368|40130253|FG003|Overall Study|Lost to Follow-up|1|||
16451203|NCT02357368|40130250|FG000|Overall Study|Pregnancy|3|||
16451204|NCT02357368|40130251|FG001|Overall Study|Pregnancy|2|||
16451205|NCT02357368|40130252|FG002|Overall Study|Pregnancy|0|||
16451206|NCT02357368|40130253|FG003|Overall Study|Pregnancy|0|||
16451207|NCT02357368|40130250|FG000|Overall Study|Withdrawal by Subject|3|||
16451208|NCT02357368|40130251|FG001|Overall Study|Withdrawal by Subject|1|||
16163668|NCT00662792|39080188|FG001|Period 1|Refused continuing medication|1|||
16163669|NCT00662792|39080189|FG002|Period 1|Refused continuing medication|1|||
16163670|NCT00662792|39080190|FG003|Period 1|Refused continuing medication|0|||
16163671|NCT00662792|39080187|FG000|Period 1|Lost to Follow-up|1|||
16163672|NCT00662792|39080188|FG001|Period 1|Lost to Follow-up|0|||
16163673|NCT00662792|39080189|FG002|Period 1|Lost to Follow-up|0|||
16163674|NCT00662792|39080190|FG003|Period 1|Lost to Follow-up|0|||
16451209|NCT02357368|40130252|FG002|Overall Study|Withdrawal by Subject|1|||
16163675|NCT00662792|39080187|FG000|Period 1|Other adverse event (AE)|0|||
16163676|NCT00662792|39080188|FG001|Period 1|Other adverse event (AE)|2|||
16163677|NCT00662792|39080189|FG002|Period 1|Other adverse event (AE)|0|||
16163678|NCT00662792|39080190|FG003|Period 1|Other adverse event (AE)|0|||
16163679|NCT00662792|39080187|FG000|Period 1|Worsening of disease under study (AE)|1|||
16163680|NCT00662792|39080188|FG001|Period 1|Worsening of disease under study (AE)|3|||
16163681|NCT00662792|39080189|FG002|Period 1|Worsening of disease under study (AE)|2|||
16163682|NCT00662792|39080190|FG003|Period 1|Worsening of disease under study (AE)|0|||
16163683|NCT00662792|39080187|FG000|Period 1|Not treated|0|||
16163684|NCT00662792|39080188|FG001|Period 1|Not treated|1|||
16163685|NCT00662792|39080189|FG002|Period 1|Not treated|0|||
16163686|NCT00662792|39080190|FG003|Period 1|Not treated|0|||
16163687|NCT00662792|39080187|FG000|Period 2|Worsening of disease under study|1|||
16163688|NCT00662792|39080188|FG001|Period 2|Worsening of disease under study|0|||
16163689|NCT00662792|39080189|FG002|Period 2|Worsening of disease under study|0|||
16163690|NCT00662792|39080190|FG003|Period 2|Worsening of disease under study|3|||
16163691|NCT00662792|39080187|FG000|Period 3|Refused continuing medication|1|||
16163692|NCT00662792|39080188|FG001|Period 3|Refused continuing medication|0|||
16163693|NCT00662792|39080189|FG002|Period 3|Refused continuing medication|1|||
16163694|NCT00662792|39080190|FG003|Period 3|Refused continuing medication|0|||
16163695|NCT00662792|39080187|FG000|Period 3|Other adverse event (AE)|0|||
16163696|NCT00662792|39080188|FG001|Period 3|Other adverse event (AE)|0|||
16163697|NCT00662792|39080189|FG002|Period 3|Other adverse event (AE)|1|||
16163698|NCT00662792|39080190|FG003|Period 3|Other adverse event (AE)|1|||
16163699|NCT00662792|39080187|FG000|Period 4|Refused continuing medication|0|||
16163700|NCT00662792|39080188|FG001|Period 4|Refused continuing medication|1|||
16163701|NCT00662792|39080189|FG002|Period 4|Refused continuing medication|0|||
16163702|NCT00662792|39080190|FG003|Period 4|Refused continuing medication|0|||
16163703|NCT00662792|39080187|FG000|Period 4|Other adverse event (AE)|1|||
16163704|NCT00662792|39080188|FG001|Period 4|Other adverse event (AE)|0|||
16163705|NCT00662792|39080189|FG002|Period 4|Other adverse event (AE)|0|||
16163706|NCT00662792|39080190|FG003|Period 4|Other adverse event (AE)|0|||
16163707|NCT00662792|39080187|FG000|Period 4|Worsening of disease under study (AE)|0|||
16163708|NCT00662792|39080188|FG001|Period 4|Worsening of disease under study (AE)|0|||
16163709|NCT00662792|39080189|FG002|Period 4|Worsening of disease under study (AE)|0|||
16163710|NCT00662792|39080190|FG003|Period 4|Worsening of disease under study (AE)|1|||
16163711|NCT02883244|39080191|FG000|Overall Study|Lost to Follow-up|0|||
16451210|NCT02357368|40130253|FG003|Overall Study|Withdrawal by Subject|2|||
16451211|NCT01143246|40130256|FG000|Overall Study|Adverse Event|24|||
16451212|NCT01143246|40130257|FG001|Overall Study|Adverse Event|28|||
16163712|NCT02883244|39080192|FG001|Overall Study|Lost to Follow-up|1|||
16163713|NCT03705793|39080196|FG000|Overall Study|Lost to Follow-up|3|||
16163714|NCT03705793|39080197|FG001|Overall Study|Lost to Follow-up|4|||
16163715|NCT03705793|39080196|FG000|Overall Study|Withdrawal by Subject|2|||
16163716|NCT03705793|39080197|FG001|Overall Study|Withdrawal by Subject|1|||
16163717|NCT02024971|39080198|FG000|Overall Study|Data Not Available|30|||
16163718|NCT02024971|39080198|FG000|Overall Study|Lost to Follow-up|6|||
16163719|NCT00768898|39080199|FG000|Overall Study|Unrelated injury|1|||
16163720|NCT00768898|39080199|FG000|Overall Study|Headache|1|||
16163721|NCT00352105|39080200|FG000|Overall Study|Death|5|||
16163722|NCT00352105|39080200|FG000|Overall Study|Withdrawal by Subject|5|||
16163723|NCT00352105|39080200|FG000|Overall Study|Lack of Efficacy|9|||
16163724|NCT00352105|39080200|FG000|Overall Study|Adverse Event|19|||
16163725|NCT00352105|39080200|FG000|Overall Study|Protocol Violation|2|||
16163726|NCT03222349|39080201|FG000|Overall Study|Treatment B not done|5|||
16163727|NCT03222349|39080202|FG001|Overall Study|Treatment B not done|0|||
16163728|NCT03222349|39080201|FG000|Overall Study|Lost to Follow-up|1|||
16163729|NCT03222349|39080202|FG001|Overall Study|Lost to Follow-up|2|||
16163730|NCT03222349|39080201|FG000|Overall Study|Withdrawal by Subject|1|||
16163731|NCT03222349|39080202|FG001|Overall Study|Withdrawal by Subject|0|||
16163732|NCT03222349|39080201|FG000|Overall Study|Treatment A not done|0|||
16163733|NCT03222349|39080202|FG001|Overall Study|Treatment A not done|5|||
16163734|NCT03222349|39080201|FG000|Overall Study|Study terminated by sponsor|1|||
16163735|NCT03222349|39080202|FG001|Overall Study|Study terminated by sponsor|0|||
16163736|NCT03555266|39080207|FG000|Overall Study|Protocol Violation|6|||
16163737|NCT03555266|39080208|FG001|Overall Study|Protocol Violation|4|||
16163738|NCT04067518|39080209|FG000|Overall Study|Adverse Event|1|||
16163739|NCT04067518|39080210|FG001|Overall Study|Adverse Event|3|||
16163740|NCT04067518|39080209|FG000|Overall Study|Screen failures|0|||
16163741|NCT04067518|39080210|FG001|Overall Study|Screen failures|1|||
16163742|NCT04067518|39080209|FG000|Overall Study|Enrolled but not treated|0|||
16163743|NCT04067518|39080210|FG001|Overall Study|Enrolled but not treated|1|||
16163744|NCT00197054|39080215|FG000|Overall Study|Withdrawal by Subject|9|||
16163745|NCT00197054|39080216|FG001|Overall Study|Withdrawal by Subject|3|||
16163746|NCT00197054|39080217|FG002|Overall Study|Withdrawal by Subject|3|||
16163747|NCT00197054|39080215|FG000|Overall Study|Moved from area|7|||
16451213|NCT01143246|40130256|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
16163748|NCT00197054|39080216|FG001|Overall Study|Moved from area|14|||
16163749|NCT00197054|39080217|FG002|Overall Study|Moved from area|9|||
16163750|NCT00197054|39080215|FG000|Overall Study|Lost to Follow-up|1|||
16163751|NCT00197054|39080216|FG001|Overall Study|Lost to Follow-up|4|||
16163752|NCT00197054|39080217|FG002|Overall Study|Lost to Follow-up|0|||
16163753|NCT01282229|39080218|FG000|Overall Study|Protocol Violation|2|||
16163754|NCT01042600|39080219|FG000|Overall Study|Ineligible|1|||
16163755|NCT01042600|39080220|FG001|Overall Study|Ineligible|0|||
16265282|NCT02655679|39453342|FG003|Overall Study|Inability to Comply with the Protocol|0|||
16265283|NCT02655679|39453343|FG004|Overall Study|Inability to Comply with the Protocol|0|||
16265284|NCT02655679|39453339|FG000|Overall Study|Lost to Follow-up|0|||
16265285|NCT02655679|39453340|FG001|Overall Study|Lost to Follow-up|1|||
16265286|NCT02655679|39453341|FG002|Overall Study|Lost to Follow-up|1|||
16265287|NCT02655679|39453342|FG003|Overall Study|Lost to Follow-up|1|||
16265288|NCT02655679|39453343|FG004|Overall Study|Lost to Follow-up|0|||
16265289|NCT02655679|39453339|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16265290|NCT02655679|39453340|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16265291|NCT02655679|39453341|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16265292|NCT02655679|39453342|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16163756|NCT02527707|39080225|FG000|Overall Study|Adverse Event|1|||
16163757|NCT02527707|39080225|FG000|Overall Study|Adverse Event|1|||
16163758|NCT02979431|39080226|FG000|Overall Study|Parent/guardian withdrew consent|2|||
16163759|NCT02979431|39080227|FG001|Overall Study|Parent/guardian withdrew consent|1|||
16163760|NCT02979431|39080228|FG002|Overall Study|Parent/guardian withdrew consent|1|||
16265293|NCT02655679|39453343|FG004|Overall Study|Other Miscellaneous Reasons|0|||
16265294|NCT01954394|39453344|FG000|Overall Study|Enrolled but not treated|1|||
16265295|NCT01954394|39453345|FG001|Overall Study|Enrolled but not treated|0|||
16265296|NCT01954394|39453344|FG000|Overall Study|Adverse Event|10|||
16265297|NCT01954394|39453345|FG001|Overall Study|Adverse Event|23|||
16163761|NCT02979431|39080229|FG003|Overall Study|Parent/guardian withdrew consent|1|||
16163762|NCT02979431|39080226|FG000|Overall Study|Randomized but received no study drug|1|||
16163763|NCT02979431|39080227|FG001|Overall Study|Randomized but received no study drug|1|||
16163764|NCT02979431|39080228|FG002|Overall Study|Randomized but received no study drug|0|||
16163765|NCT02979431|39080229|FG003|Overall Study|Randomized but received no study drug|0|||
16163766|NCT02979431|39080226|FG000|Overall Study|Adverse Event|0|||
16163767|NCT02979431|39080227|FG001|Overall Study|Adverse Event|0|||
16163768|NCT02979431|39080228|FG002|Overall Study|Adverse Event|1|||
16265298|NCT01954394|39453344|FG000|Overall Study|Poor compliance to protocol|7|||
16265299|NCT01954394|39453345|FG001|Overall Study|Poor compliance to protocol|7|||
16265300|NCT01954394|39453344|FG000|Overall Study|Participant Moved|0|||
16265301|NCT01954394|39453345|FG001|Overall Study|Participant Moved|4|||
16265302|NCT01954394|39453344|FG000|Overall Study|Related to Study Drug administration|2|||
16163769|NCT02979431|39080229|FG003|Overall Study|Adverse Event|0|||
16163770|NCT02979431|39080226|FG000|Overall Study|Subject left country after Day14|1|||
16163771|NCT02979431|39080227|FG001|Overall Study|Subject left country after Day14|0|||
16163772|NCT02979431|39080228|FG002|Overall Study|Subject left country after Day14|0|||
16163773|NCT02979431|39080229|FG003|Overall Study|Subject left country after Day14|0|||
16163774|NCT01818297|39080230|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
16163775|NCT01818297|39080231|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
16163776|NCT01818297|39080230|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
16163777|NCT01818297|39080231|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
16163778|NCT01818297|39080230|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
16163779|NCT01818297|39080231|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
16163780|NCT00930059|39080232|FG000|Overall Study|Death|1|||
16163781|NCT00930059|39080233|FG001|Overall Study|Death|0|||
16163782|NCT00930059|39080232|FG000|Overall Study|Did not meet entrance criteria|1|||
16163783|NCT00930059|39080233|FG001|Overall Study|Did not meet entrance criteria|1|||
16163784|NCT00930059|39080232|FG000|Overall Study|Withdrawal by Subject|3|||
16163785|NCT00930059|39080233|FG001|Overall Study|Withdrawal by Subject|4|||
16163786|NCT00930059|39080232|FG000|Overall Study|Other|1|||
16163787|NCT00930059|39080233|FG001|Overall Study|Other|0|||
16163788|NCT00930059|39080232|FG000|Overall Study|1 site terminated by sponsor|1|||
16163789|NCT00930059|39080233|FG001|Overall Study|1 site terminated by sponsor|1|||
16163790|NCT00930059|39080232|FG000|Overall Study|Adverse Event|1|||
16163791|NCT00930059|39080233|FG001|Overall Study|Adverse Event|6|||
16163792|NCT04162210|39080234|FG000|Overall Study|Lost to Follow-up|4|||
16265303|NCT01954394|39453345|FG001|Overall Study|Related to Study Drug administration|2|||
16265304|NCT01954394|39453344|FG000|Overall Study|Other than specified above|10|||
16265305|NCT01954394|39453345|FG001|Overall Study|Other than specified above|21|||
16265306|NCT00251979|39453352|FG000|Overall Study|Protocol Violation|3|||
16265307|NCT00251979|39453353|FG001|Overall Study|Protocol Violation|5|||
16265308|NCT00251979|39453352|FG000|Overall Study|Adverse Event|11|||
16265309|NCT00251979|39453353|FG001|Overall Study|Adverse Event|17|||
16265310|NCT00251979|39453352|FG000|Overall Study|Withdrawal by Subject|13|||
16265311|NCT00251979|39453353|FG001|Overall Study|Withdrawal by Subject|7|||
16265312|NCT00251979|39453352|FG000|Overall Study|Lost to Follow-up|8|||
16265313|NCT00251979|39453353|FG001|Overall Study|Lost to Follow-up|6|||
16265314|NCT00251979|39453352|FG000|Overall Study|Death|3|||
16265315|NCT00251979|39453353|FG001|Overall Study|Death|5|||
16265316|NCT03290781|39453354|FG000|Overall Study|Adverse Event|5|||
16265317|NCT03290781|39453355|FG001|Overall Study|Adverse Event|7|||
16265318|NCT03290781|39453356|FG002|Overall Study|Adverse Event|4|||
16265319|NCT03290781|39453357|FG003|Overall Study|Adverse Event|1|||
16265320|NCT03290781|39453358|FG004|Overall Study|Adverse Event|0|||
16265321|NCT03290781|39453359|FG005|Overall Study|Adverse Event|0|||
16265322|NCT03290781|39453360|FG006|Overall Study|Adverse Event|0|||
16265323|NCT03290781|39453354|FG000|Overall Study|Death|0|||
16265324|NCT03290781|39453355|FG001|Overall Study|Death|0|||
16265325|NCT03290781|39453356|FG002|Overall Study|Death|1|||
16265326|NCT03290781|39453357|FG003|Overall Study|Death|0|||
16265327|NCT03290781|39453358|FG004|Overall Study|Death|1|||
16265328|NCT03290781|39453359|FG005|Overall Study|Death|0|||
16265329|NCT03290781|39453360|FG006|Overall Study|Death|0|||
16265330|NCT03290781|39453354|FG000|Overall Study|Withdrawal by Subject|6|||
16265331|NCT03290781|39453355|FG001|Overall Study|Withdrawal by Subject|5|||
16265332|NCT03290781|39453356|FG002|Overall Study|Withdrawal by Subject|9|||
16265333|NCT03290781|39453357|FG003|Overall Study|Withdrawal by Subject|10|||
16265334|NCT03290781|39453358|FG004|Overall Study|Withdrawal by Subject|1|||
16265335|NCT03290781|39453359|FG005|Overall Study|Withdrawal by Subject|2|||
16265336|NCT03290781|39453360|FG006|Overall Study|Withdrawal by Subject|0|||
16265337|NCT03290781|39453354|FG000|Overall Study|Physician Decision|0|||
16265338|NCT03290781|39453355|FG001|Overall Study|Physician Decision|1|||
16265339|NCT03290781|39453356|FG002|Overall Study|Physician Decision|0|||
16265340|NCT03290781|39453357|FG003|Overall Study|Physician Decision|0|||
16163793|NCT04162210|39080235|FG001|Overall Study|Lost to Follow-up|1|||
16265341|NCT03290781|39453358|FG004|Overall Study|Physician Decision|0|||
16163794|NCT04162210|39080234|FG000|Overall Study|Withdrawal by Subject|17|||
16163795|NCT04162210|39080235|FG001|Overall Study|Withdrawal by Subject|9|||
16265342|NCT03290781|39453359|FG005|Overall Study|Physician Decision|0|||
16265343|NCT03290781|39453360|FG006|Overall Study|Physician Decision|0|||
16265344|NCT03290781|39453354|FG000|Overall Study|Site Terminated by Sponsor|1|||
16265345|NCT03290781|39453355|FG001|Overall Study|Site Terminated by Sponsor|0|||
16265346|NCT03290781|39453356|FG002|Overall Study|Site Terminated by Sponsor|2|||
16265347|NCT03290781|39453357|FG003|Overall Study|Site Terminated by Sponsor|1|||
16265348|NCT03290781|39453358|FG004|Overall Study|Site Terminated by Sponsor|0|||
16265349|NCT03290781|39453359|FG005|Overall Study|Site Terminated by Sponsor|0|||
16265350|NCT03290781|39453360|FG006|Overall Study|Site Terminated by Sponsor|0|||
16163796|NCT04162210|39080234|FG000|Overall Study|Ongoing|113|||
16163797|NCT04162210|39080235|FG001|Overall Study|Ongoing|59|||
16163798|NCT03595280|39080236|FG000|Overall Study|Lost to Follow-up|6|||
16163799|NCT03595280|39080237|FG001|Overall Study|Lost to Follow-up|9|||
16163800|NCT03595280|39080238|FG002|Overall Study|Lost to Follow-up|15|||
16163801|NCT00756938|39080239|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
16163802|NCT00756938|39080240|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
16163803|NCT00756938|39080241|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
16163804|NCT00756938|39080242|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
16163805|NCT00756938|39080239|FG000|12-week Base Study|Protocol Violation|0|||
16163806|NCT00756938|39080240|FG001|12-week Base Study|Protocol Violation|0|||
16163807|NCT00756938|39080241|FG002|12-week Base Study|Protocol Violation|1|||
16373231|NCT01964560|39853116|FG000|Overall Study|Participant moved to another country|1|||
16373232|NCT01129284|39853117|FG000|Overall Study|Adverse Event|2|||
16373233|NCT01129284|39853118|FG001|Overall Study|Adverse Event|0|||
16163808|NCT00756938|39080242|FG003|12-week Base Study|Protocol Violation|0|||
16163809|NCT00756938|39080239|FG000|12-week Base Study|Lost to Follow-up|1|||
16163810|NCT00756938|39080240|FG001|12-week Base Study|Lost to Follow-up|0|||
16163811|NCT00756938|39080241|FG002|12-week Base Study|Lost to Follow-up|0|||
16163812|NCT00756938|39080242|FG003|12-week Base Study|Lost to Follow-up|0|||
16163813|NCT00756938|39080239|FG000|Optional Extension|Lack of Efficacy|0|||
16163814|NCT00756938|39080240|FG001|Optional Extension|Lack of Efficacy|0|||
16163815|NCT00756938|39080241|FG002|Optional Extension|Lack of Efficacy|0|||
16163816|NCT00756938|39080242|FG003|Optional Extension|Lack of Efficacy|1|||
16163817|NCT00756938|39080239|FG000|Optional Extension|End of Study|0|||
16163818|NCT00756938|39080240|FG001|Optional Extension|End of Study|0|||
16163819|NCT00756938|39080241|FG002|Optional Extension|End of Study|0|||
16163820|NCT00756938|39080242|FG003|Optional Extension|End of Study|11|||
16163821|NCT00756938|39080239|FG000|Optional Extension|Protocol-specific criteria met|0|||
16163822|NCT00756938|39080240|FG001|Optional Extension|Protocol-specific criteria met|0|||
16163823|NCT00756938|39080241|FG002|Optional Extension|Protocol-specific criteria met|0|||
16163824|NCT00756938|39080242|FG003|Optional Extension|Protocol-specific criteria met|9|||
16163825|NCT00756938|39080239|FG000|Optional Extension|Physician Decision|0|||
16163826|NCT00756938|39080240|FG001|Optional Extension|Physician Decision|0|||
16163827|NCT00756938|39080241|FG002|Optional Extension|Physician Decision|0|||
16163828|NCT00756938|39080242|FG003|Optional Extension|Physician Decision|3|||
16163829|NCT00756938|39080239|FG000|Optional Extension|Lost to Follow-up|0|||
16163830|NCT00756938|39080240|FG001|Optional Extension|Lost to Follow-up|0|||
16163831|NCT00756938|39080241|FG002|Optional Extension|Lost to Follow-up|0|||
16163832|NCT00756938|39080242|FG003|Optional Extension|Lost to Follow-up|1|||
16163833|NCT00756938|39080239|FG000|Optional Extension|Protocol Violation|0|||
16163834|NCT00756938|39080240|FG001|Optional Extension|Protocol Violation|0|||
16163835|NCT00756938|39080241|FG002|Optional Extension|Protocol Violation|0|||
16163836|NCT00756938|39080242|FG003|Optional Extension|Protocol Violation|1|||
16163837|NCT00756938|39080239|FG000|Optional Extension|Withdrawal by Subject|0|||
16163838|NCT00756938|39080240|FG001|Optional Extension|Withdrawal by Subject|0|||
16163839|NCT00756938|39080241|FG002|Optional Extension|Withdrawal by Subject|0|||
16163840|NCT00756938|39080242|FG003|Optional Extension|Withdrawal by Subject|10|||
16163841|NCT00756938|39080239|FG000|Optional Extension|Adverse Event|0|||
16163842|NCT00756938|39080240|FG001|Optional Extension|Adverse Event|0|||
16163843|NCT00756938|39080241|FG002|Optional Extension|Adverse Event|0|||
16163844|NCT00756938|39080242|FG003|Optional Extension|Adverse Event|1|||
16163845|NCT04823949|39080243|FG000|Overall Study|Withdrawal by Subject|0|||
16163846|NCT04823949|39080244|FG001|Overall Study|Withdrawal by Subject|4|||
16163847|NCT04823949|39080243|FG000|Overall Study|Physician Decision|0|||
16163848|NCT04823949|39080244|FG001|Overall Study|Physician Decision|1|||
16163849|NCT00087646|39083659|FG000|Overall Study|Adverse Event|37|||
16163850|NCT00087646|39083660|FG001|Overall Study|Adverse Event|6|||
16163851|NCT00087646|39083661|FG002|Overall Study|Adverse Event|18|||
16163852|NCT00087646|39083662|FG003|Overall Study|Adverse Event|20|||
16163853|NCT00087646|39083659|FG000|Overall Study|Death|0|||
16163854|NCT00087646|39083660|FG001|Overall Study|Death|1|||
16163855|NCT00087646|39083661|FG002|Overall Study|Death|0|||
16163856|NCT00087646|39083662|FG003|Overall Study|Death|0|||
16163857|NCT00087646|39083659|FG000|Overall Study|Withdrawal by Subject|6|||
16163858|NCT00087646|39083660|FG001|Overall Study|Withdrawal by Subject|1|||
16163859|NCT00087646|39083661|FG002|Overall Study|Withdrawal by Subject|2|||
16373234|NCT01129284|39853119|FG002|Overall Study|Adverse Event|1|||
16163860|NCT00087646|39083662|FG003|Overall Study|Withdrawal by Subject|2|||
16163861|NCT00087646|39083659|FG000|Overall Study|Insufficient therapeutic response|64|||
16163862|NCT00087646|39083660|FG001|Overall Study|Insufficient therapeutic response|24|||
16163863|NCT00087646|39083661|FG002|Overall Study|Insufficient therapeutic response|38|||
16163864|NCT00087646|39083662|FG003|Overall Study|Insufficient therapeutic response|51|||
16163865|NCT00087646|39083659|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
16163866|NCT00087646|39083660|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
16163867|NCT00087646|39083661|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
16163868|NCT00087646|39083662|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
16163869|NCT00087646|39083659|FG000|Overall Study|Failure to Return|5|||
16163870|NCT00087646|39083660|FG001|Overall Study|Failure to Return|2|||
16163871|NCT00087646|39083661|FG002|Overall Study|Failure to Return|2|||
16163872|NCT00087646|39083662|FG003|Overall Study|Failure to Return|3|||
16163873|NCT00087646|39083659|FG000|Overall Study|Administrative/Other|6|||
16163874|NCT00087646|39083660|FG001|Overall Study|Administrative/Other|1|||
16163875|NCT00087646|39083661|FG002|Overall Study|Administrative/Other|1|||
16163876|NCT00087646|39083662|FG003|Overall Study|Administrative/Other|2|||
16163877|NCT00087646|39083659|FG000|Overall Study|Other Protocol Violation|3|||
16163878|NCT00087646|39083660|FG001|Overall Study|Other Protocol Violation|1|||
16163879|NCT00087646|39083661|FG002|Overall Study|Other Protocol Violation|0|||
16163880|NCT00087646|39083662|FG003|Overall Study|Other Protocol Violation|0|||
16163881|NCT00087646|39083659|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
16163882|NCT00087646|39083660|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
16163883|NCT00087646|39083661|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
16163884|NCT00087646|39083662|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
16163885|NCT04684420|39083663|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
16163886|NCT04684420|39083664|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
16163887|NCT04684420|39083665|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
16163888|NCT04684420|39083666|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
16163889|NCT04684420|39083663|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
16163890|NCT04684420|39083664|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
16163891|NCT04684420|39083665|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
16163892|NCT04684420|39083666|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
16163893|NCT01699087|39083668|FG000|Overall Study|Lost to Follow-up|7|||
16163894|NCT01699087|39083668|FG000|Overall Study|Screen failure (prior to treatment)|15|||
16163895|NCT01699087|39083668|FG000|Overall Study|Unable to make future visits|2|||
16163896|NCT01688050|39083669|FG000|Overall Study|Death|7|||
16163897|NCT01688050|39083669|FG000|Overall Study|Conversion to open repair|1|||
16163898|NCT01688050|39083669|FG000|Overall Study|Lost to Follow-up|13|||
16163899|NCT01688050|39083669|FG000|Overall Study|Withdrawal by Subject|10|||
16451214|NCT01143246|40130257|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
16451215|NCT01143246|40130256|FG000|Overall Study|Lost to Follow-up|0|||
16451216|NCT01143246|40130257|FG001|Overall Study|Lost to Follow-up|1|||
16451217|NCT01143246|40130256|FG000|Overall Study|Death|16|||
16451218|NCT01143246|40130257|FG001|Overall Study|Death|15|||
16451219|NCT01143246|40130256|FG000|Overall Study|Reason not Specified|3|||
16451220|NCT01143246|40130257|FG001|Overall Study|Reason not Specified|5|||
16451221|NCT01976741|40130260|FG000|Overall Study|Withdrawal by Subject|1|||
16451222|NCT01976741|40130261|FG001|Overall Study|Withdrawal by Subject|0|||
16451223|NCT01976741|40130262|FG002|Overall Study|Withdrawal by Subject|1|||
16451224|NCT01976741|40130263|FG003|Overall Study|Withdrawal by Subject|1|||
16451225|NCT01976741|40130264|FG004|Overall Study|Withdrawal by Subject|0|||
16451226|NCT01976741|40130265|FG005|Overall Study|Withdrawal by Subject|0|||
16451227|NCT01976741|40130266|FG006|Overall Study|Withdrawal by Subject|1|||
16451228|NCT01976741|40130267|FG007|Overall Study|Withdrawal by Subject|4|||
16451229|NCT01976741|40130268|FG008|Overall Study|Withdrawal by Subject|0|||
16451230|NCT01976741|40130269|FG009|Overall Study|Withdrawal by Subject|0|||
16163900|NCT01761266|39083670|FG000|Overall Study|Death|415|||
16163901|NCT01761266|39083671|FG001|Overall Study|Death|402|||
16163902|NCT01761266|39083670|FG000|Overall Study|Lost to Follow-up|8|||
16163903|NCT01761266|39083671|FG001|Overall Study|Lost to Follow-up|12|||
16163904|NCT01761266|39083670|FG000|Overall Study|Withdrawal by Subject|14|||
16163905|NCT01761266|39083671|FG001|Overall Study|Withdrawal by Subject|10|||
16163906|NCT01761266|39083670|FG000|Overall Study|Sponsor Decision|41|||
16163907|NCT01761266|39083671|FG001|Overall Study|Sponsor Decision|52|||
16163908|NCT03619213|39083672|FG000|Overall Study|Lost to Follow-up|2|||
16163909|NCT03619213|39083673|FG001|Overall Study|Lost to Follow-up|1|||
16163910|NCT03619213|39083672|FG000|Overall Study|Withdrawal by Subject|8|||
16163911|NCT03619213|39083673|FG001|Overall Study|Withdrawal by Subject|10|||
16163912|NCT01506882|39083674|FG000|Overall Study|Lack of Efficacy|4|||
16451231|NCT01976741|40130260|FG000|Overall Study|Adverse Event|0|||
16451232|NCT01976741|40130261|FG001|Overall Study|Adverse Event|0|||
16451233|NCT01976741|40130262|FG002|Overall Study|Adverse Event|2|||
16072616|NCT03520920|38756412|FG001|Overall Study|Death|1|||
16163913|NCT01506882|39083675|FG001|Overall Study|Lack of Efficacy|3|||
16163914|NCT01506882|39083674|FG000|Overall Study|Lost to Follow-up|1|||
16163915|NCT01506882|39083675|FG001|Overall Study|Lost to Follow-up|0|||
16163916|NCT01506882|39083674|FG000|Overall Study|Withdrawal by Subject|9|||
16163917|NCT01506882|39083675|FG001|Overall Study|Withdrawal by Subject|3|||
16163918|NCT01506882|39083674|FG000|Overall Study|SAE, non-fatal|2|||
16163919|NCT01506882|39083675|FG001|Overall Study|SAE, non-fatal|0|||
16451234|NCT01976741|40130263|FG003|Overall Study|Adverse Event|0|||
16451235|NCT01976741|40130264|FG004|Overall Study|Adverse Event|0|||
16451236|NCT01976741|40130265|FG005|Overall Study|Adverse Event|0|||
16451237|NCT01976741|40130266|FG006|Overall Study|Adverse Event|3|||
16451238|NCT01976741|40130267|FG007|Overall Study|Adverse Event|8|||
16451239|NCT01976741|40130268|FG008|Overall Study|Adverse Event|1|||
16451240|NCT01976741|40130269|FG009|Overall Study|Adverse Event|4|||
16451241|NCT03179319|40130270|FG000|Overall Study|Lost to Follow-up|6|||
16451242|NCT03179319|40130271|FG001|Overall Study|Lost to Follow-up|0|||
16451243|NCT02055118|40130272|FG000|Overall Study|Withdrawal by Subject|0|||
16451244|NCT02055118|40130273|FG001|Overall Study|Withdrawal by Subject|2|||
16451245|NCT02055118|40130274|FG002|Overall Study|Withdrawal by Subject|0|||
16451246|NCT01039376|40130275|FG000|Overall Study|Lost to Follow-up|5|||
16265351|NCT03290781|39453354|FG000|Overall Study|Lost to Follow-up|0|||
16373235|NCT00887588|39853123|FG000|Core Period|Death|1|||
16373236|NCT00887588|39853124|FG001|Core Period|Death|1|||
16373237|NCT00887588|39853123|FG000|Core Period|Lost to Follow-up|3|||
16373238|NCT00887588|39853124|FG001|Core Period|Lost to Follow-up|1|||
16373239|NCT00887588|39853123|FG000|Core Period|Withdrawal by Subject|6|||
16373240|NCT00887588|39853124|FG001|Core Period|Withdrawal by Subject|8|||
16373241|NCT00887588|39853123|FG000|Core Period|Adverse Event|9|||
16373242|NCT00887588|39853124|FG001|Core Period|Adverse Event|11|||
16373243|NCT00887588|39853123|FG000|Extension Period|Adverse Event|4|||
16373244|NCT00887588|39853124|FG001|Extension Period|Adverse Event|4|||
16373245|NCT00887588|39853123|FG000|Extension Period|Death|0|||
16373246|NCT00887588|39853124|FG001|Extension Period|Death|1|||
16373247|NCT00887588|39853123|FG000|Extension Period|Protocol deviation|1|||
16373248|NCT00887588|39853124|FG001|Extension Period|Protocol deviation|0|||
16373249|NCT00887588|39853123|FG000|Extension Period|Lost to Follow-up|1|||
16373250|NCT00887588|39853124|FG001|Extension Period|Lost to Follow-up|0|||
16373251|NCT04102111|39853125|FG000|Overall Study|Withdrawal by Subject|2|||
16373252|NCT04102111|39853126|FG001|Overall Study|Withdrawal by Subject|3|||
16373253|NCT04102111|39853125|FG000|Overall Study|Adverse Event|1|||
16373254|NCT04102111|39853126|FG001|Overall Study|Adverse Event|1|||
16373255|NCT04102111|39853125|FG000|Overall Study|Study terminated by sponsor|1|||
16373256|NCT04102111|39853126|FG001|Overall Study|Study terminated by sponsor|3|||
16373257|NCT03302936|39853127|FG000|Overall Study|Protocol Violation|3|||
16373258|NCT03302936|39853128|FG001|Overall Study|Protocol Violation|4|||
16373259|NCT01550965|39853129|FG000|Overall Study|Adverse Event|26|||
16373260|NCT01550965|39853129|FG000|Overall Study|Withdrawal by Subject|10|||
16373261|NCT01550965|39853129|FG000|Overall Study|Lost to Follow-up|2|||
16373262|NCT01550965|39853129|FG000|Overall Study|Lack of Efficacy|59|||
16373263|NCT01550965|39853129|FG000|Overall Study|Other|13|||
16373264|NCT04829214|39853132|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
16373265|NCT04829214|39853133|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
16373266|NCT04829214|39853132|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
16373267|NCT04829214|39853133|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
16373268|NCT03280615|39853134|FG000|Overall Study|Lost to Follow-up|1|||
16373269|NCT03280615|39853135|FG001|Overall Study|Lost to Follow-up|2|||
16373270|NCT03280615|39853134|FG000|Overall Study|Adverse Event|1|||
16373271|NCT03280615|39853135|FG001|Overall Study|Adverse Event|1|||
16373272|NCT03280615|39853134|FG000|Overall Study|Withdrawal by Subject|2|||
16373273|NCT03280615|39853135|FG001|Overall Study|Withdrawal by Subject|2|||
16373274|NCT00063999|39853136|FG000|Overall Study|Withdrawal by Subject|1|||
16373275|NCT00063999|39853137|FG001|Overall Study|Withdrawal by Subject|0|||
16373276|NCT00063999|39853136|FG000|Overall Study|Ineligible|44|||
16373277|NCT00063999|39853137|FG001|Overall Study|Ineligible|24|||
16373278|NCT02514746|39853140|FG000|Overall Study|Chronically Ill|1|||
16373279|NCT02514746|39853141|FG001|Overall Study|Chronically Ill|2|||
16373280|NCT02514746|39853140|FG000|Overall Study|Physician Decision|4|||
16373281|NCT02514746|39853141|FG001|Overall Study|Physician Decision|2|||
16373282|NCT02514746|39853140|FG000|Overall Study|Withdrawal by Subject|12|||
16373283|NCT02514746|39853141|FG001|Overall Study|Withdrawal by Subject|10|||
16373284|NCT02514746|39853140|FG000|Overall Study|Other|5|||
16373285|NCT02514746|39853141|FG001|Overall Study|Other|1|||
16373286|NCT01044459|39853144|FG000|Overall Study|Withdrawal by Subject|21|||
16373287|NCT01044459|39853145|FG001|Overall Study|Withdrawal by Subject|28|||
16373288|NCT01044459|39853144|FG000|Overall Study|Terminated by Sponsor|22|||
16373289|NCT01044459|39853145|FG001|Overall Study|Terminated by Sponsor|21|||
16373290|NCT01044459|39853144|FG000|Overall Study|Adverse Event|22|||
16373291|NCT01044459|39853145|FG001|Overall Study|Adverse Event|20|||
16373292|NCT01044459|39853144|FG000|Overall Study|Lack of Efficacy|23|||
16373293|NCT01044459|39853145|FG001|Overall Study|Lack of Efficacy|12|||
16373294|NCT01044459|39853144|FG000|Overall Study|Protocol Violation|11|||
16373295|NCT01044459|39853145|FG001|Overall Study|Protocol Violation|16|||
16373296|NCT01044459|39853144|FG000|Overall Study|Other Reason|7|||
16373297|NCT01044459|39853145|FG001|Overall Study|Other Reason|14|||
16373298|NCT01044459|39853144|FG000|Overall Study|COPD exacerbation|9|||
16373299|NCT01044459|39853145|FG001|Overall Study|COPD exacerbation|8|||
16373300|NCT01044459|39853144|FG000|Overall Study|Lost to Follow-up|18|||
16373301|NCT01044459|39853145|FG001|Overall Study|Lost to Follow-up|12|||
16373302|NCT01773889|39853146|FG000|Overall Study|lack of funding|2|||
16451247|NCT01039376|40130276|FG001|Overall Study|Lost to Follow-up|12|||
16451248|NCT01039376|40130275|FG000|Overall Study|Physician Decision|15|||
16451249|NCT01039376|40130276|FG001|Overall Study|Physician Decision|10|||
16451250|NCT01039376|40130275|FG000|Overall Study|Withdrawal by Subject|20|||
16451251|NCT01039376|40130276|FG001|Overall Study|Withdrawal by Subject|32|||
16451252|NCT01039376|40130275|FG000|Overall Study|Study terminated by Sponsor|90|||
16451253|NCT01039376|40130276|FG001|Overall Study|Study terminated by Sponsor|72|||
16451254|NCT05024032|40130278|FG000|Overall Study|Withdrawal by Subject|0|||
16451255|NCT05024032|40130279|FG001|Overall Study|Withdrawal by Subject|3|||
16451256|NCT05024032|40130280|FG002|Overall Study|Withdrawal by Subject|4|||
16451257|NCT05024032|40130278|FG000|Overall Study|Adverse Event|0|||
16451258|NCT05024032|40130279|FG001|Overall Study|Adverse Event|1|||
16451259|NCT05024032|40130280|FG002|Overall Study|Adverse Event|0|||
16451260|NCT05024032|40130278|FG000|Overall Study|Protocol Deviation|1|||
16451261|NCT05024032|40130279|FG001|Overall Study|Protocol Deviation|0|||
16451262|NCT05024032|40130280|FG002|Overall Study|Protocol Deviation|0|||
16451263|NCT00196313|40130281|FG000|Overall Study|Protocol Violation|2|||
16451264|NCT00196313|40130282|FG001|Overall Study|Protocol Violation|3|||
16451265|NCT00196313|40130281|FG000|Overall Study|Withdrawal by Subject|3|||
16451266|NCT00196313|40130282|FG001|Overall Study|Withdrawal by Subject|1|||
16451267|NCT00196313|40130281|FG000|Overall Study|Adverse Event|3|||
16451268|NCT00196313|40130282|FG001|Overall Study|Adverse Event|1|||
16451269|NCT00196313|40130281|FG000|Overall Study|Subject Pregnant|1|||
16451270|NCT00196313|40130282|FG001|Overall Study|Subject Pregnant|1|||
16451271|NCT00196313|40130281|FG000|Overall Study|Lost to Follow-up|2|||
16451272|NCT00196313|40130282|FG001|Overall Study|Lost to Follow-up|2|||
16451273|NCT00815659|40130283|FG000|Overall Study|Adverse Event|9|||
16451274|NCT00815659|40130283|FG000|Overall Study|Withdrawal by Subject|9|||
16451275|NCT00815659|40130283|FG000|Overall Study|Lost to Follow-up|4|||
16451276|NCT00815659|40130283|FG000|Overall Study|Protocol Violation|1|||
16451277|NCT02577718|40130284|FG000|Overall Study|Death|6|||
16451278|NCT02577718|40130284|FG000|Overall Study|Withdrawal by Subject|2|||
16451279|NCT02840461|40130285|FG000|Overall Study|Adverse Event|1|||
16451280|NCT02840461|40130286|FG001|Overall Study|Adverse Event|5|||
16451281|NCT02840461|40130287|FG002|Overall Study|Adverse Event|3|||
16451282|NCT02840461|40130285|FG000|Overall Study|Lost to Follow-up|10|||
16451283|NCT02840461|40130286|FG001|Overall Study|Lost to Follow-up|7|||
16451284|NCT02840461|40130287|FG002|Overall Study|Lost to Follow-up|6|||
16451285|NCT02840461|40130285|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
16451286|NCT02840461|40130286|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
16451287|NCT02840461|40130287|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
16451288|NCT02840461|40130285|FG000|Overall Study|Protocol Violation|2|||
16451289|NCT02840461|40130286|FG001|Overall Study|Protocol Violation|3|||
16451290|NCT02840461|40130287|FG002|Overall Study|Protocol Violation|1|||
16451291|NCT02840461|40130285|FG000|Overall Study|Withdrawal by Subject|10|||
16451292|NCT02840461|40130286|FG001|Overall Study|Withdrawal by Subject|6|||
16451293|NCT02840461|40130287|FG002|Overall Study|Withdrawal by Subject|2|||
16451294|NCT02840461|40130285|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
16451295|NCT02840461|40130286|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
16451296|NCT02840461|40130287|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
16451297|NCT04555616|40130290|FG000|Overall Study|Death|1|||
16451298|NCT04555616|40130291|FG001|Overall Study|Death|0|||
16451299|NCT04555616|40130292|FG002|Overall Study|Death|1|||
16451300|NCT04555616|40130290|FG000|Overall Study|Withdrawal by Subject|2|||
16072617|NCT03520920|38756413|FG002|Overall Study|Death|0|||
16072618|NCT03520920|38756411|FG000|Overall Study|Withdrawal by Subject|2|||
16072619|NCT03520920|38756412|FG001|Overall Study|Withdrawal by Subject|1|||
16072620|NCT03520920|38756413|FG002|Overall Study|Withdrawal by Subject|0|||
16163920|NCT01506882|39083674|FG000|Overall Study|AE, non-serious non-fatal|3|||
16163921|NCT01506882|39083675|FG001|Overall Study|AE, non-serious non-fatal|1|||
16163922|NCT01506882|39083674|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
16451301|NCT04555616|40130291|FG001|Overall Study|Withdrawal by Subject|1|||
16451302|NCT04555616|40130292|FG002|Overall Study|Withdrawal by Subject|0|||
16451303|NCT03040336|40130293|FG000|Overall Study|Death|1|||
16451304|NCT03040336|40130294|FG001|Overall Study|Death|0|||
16451305|NCT03040336|40130293|FG000|Overall Study|Withdrawal by Subject|2|||
16451306|NCT03040336|40130294|FG001|Overall Study|Withdrawal by Subject|3|||
16072621|NCT03520920|38756411|FG000|Overall Study|Study Terminated by the Sponsor|5|||
16072622|NCT03520920|38756412|FG001|Overall Study|Study Terminated by the Sponsor|14|||
16072623|NCT03520920|38756413|FG002|Overall Study|Study Terminated by the Sponsor|5|||
16072624|NCT00371566|38756414|FG000|Treatment Phase|Withdrawal by Subject|0|||
16451307|NCT02015637|40130295|FG000|Overall Study|Lost to Follow-up|3|||
16451308|NCT02015637|40130296|FG001|Overall Study|Lost to Follow-up|5|||
16451309|NCT02015637|40130295|FG000|Overall Study|Adverse Event|3|||
16451310|NCT02015637|40130296|FG001|Overall Study|Adverse Event|0|||
16451311|NCT02015637|40130295|FG000|Overall Study|Did not take study drug|2|||
16451312|NCT02015637|40130296|FG001|Overall Study|Did not take study drug|0|||
16451313|NCT00414596|40130297|FG000|Overall Study|Protocol Violation|2|||
16451314|NCT02136069|40130298|FG000|Overall Study|UC flare-up|1|||
16451315|NCT02136069|40130299|FG001|Overall Study|UC flare-up|0|||
16163923|NCT01506882|39083675|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
16163924|NCT01506882|39083674|FG000|Overall Study|Other Reason|2|||
16163925|NCT01506882|39083675|FG001|Overall Study|Other Reason|0|||
16163926|NCT01662440|39083678|FG000|Overall Study|Adverse Event|1|||
16163927|NCT01662440|39083679|FG001|Overall Study|Adverse Event|0|||
16163928|NCT01662440|39083680|FG002|Overall Study|Adverse Event|0|||
16163929|NCT01662440|39083681|FG003|Overall Study|Adverse Event|1|||
16163930|NCT01662440|39083678|FG000|Overall Study|Death|0|||
16163931|NCT01662440|39083679|FG001|Overall Study|Death|1|||
16163932|NCT01662440|39083680|FG002|Overall Study|Death|0|||
16163933|NCT01662440|39083681|FG003|Overall Study|Death|0|||
16163934|NCT01662440|39083678|FG000|Overall Study|Lost to Follow-up|2|||
16163935|NCT01662440|39083679|FG001|Overall Study|Lost to Follow-up|2|||
16163936|NCT01662440|39083680|FG002|Overall Study|Lost to Follow-up|4|||
16163937|NCT01662440|39083681|FG003|Overall Study|Lost to Follow-up|1|||
16163938|NCT01662440|39083678|FG000|Overall Study|Subject moved to another country.|0|||
16163939|NCT01662440|39083679|FG001|Overall Study|Subject moved to another country.|1|||
16163940|NCT01662440|39083680|FG002|Overall Study|Subject moved to another country.|0|||
16163941|NCT01662440|39083681|FG003|Overall Study|Subject moved to another country.|0|||
16163942|NCT01662440|39083678|FG000|Overall Study|Protocol Violation|1|||
16163943|NCT01662440|39083679|FG001|Overall Study|Protocol Violation|0|||
16163944|NCT01662440|39083680|FG002|Overall Study|Protocol Violation|0|||
16163945|NCT01662440|39083681|FG003|Overall Study|Protocol Violation|0|||
16163946|NCT01662440|39083678|FG000|Overall Study|Withdrawal by Subject|5|||
16163947|NCT01662440|39083679|FG001|Overall Study|Withdrawal by Subject|2|||
16163948|NCT01662440|39083680|FG002|Overall Study|Withdrawal by Subject|2|||
16163949|NCT01662440|39083681|FG003|Overall Study|Withdrawal by Subject|2|||
16163950|NCT02429856|39083682|FG000|Overall Study|Death|12|||
16163951|NCT02429856|39083683|FG001|Overall Study|Death|13|||
16163952|NCT02429856|39083682|FG000|Overall Study|Lost to Follow-up|6|||
16163953|NCT02429856|39083683|FG001|Overall Study|Lost to Follow-up|5|||
16163954|NCT02429856|39083682|FG000|Overall Study|Withdrawal by Subject|1|||
16163955|NCT02429856|39083683|FG001|Overall Study|Withdrawal by Subject|1|||
16163956|NCT03969875|39083684|FG000|Overall Study|did not receive allocated intervention|3|||
16163957|NCT03969875|39083685|FG001|Overall Study|did not receive allocated intervention|3|||
16163958|NCT03969875|39083686|FG002|Overall Study|did not receive allocated intervention|4|||
16163959|NCT03969875|39083684|FG000|Overall Study|Protocol Violation|4|||
16163960|NCT03969875|39083685|FG001|Overall Study|Protocol Violation|2|||
16163961|NCT03969875|39083686|FG002|Overall Study|Protocol Violation|2|||
16163962|NCT01194440|39083687|FG000|Baseline (First Dose)|Reason not specified|4|||
16163963|NCT01194440|39083687|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
16163964|NCT01194440|39083687|FG000|Baseline (First Dose)|Change in therapy|1|||
16163965|NCT01194440|39083687|FG000|Baseline (First Dose)|Adverse Event|1|||
16265352|NCT03290781|39453355|FG001|Overall Study|Lost to Follow-up|0|||
16265353|NCT03290781|39453356|FG002|Overall Study|Lost to Follow-up|0|||
16265354|NCT03290781|39453357|FG003|Overall Study|Lost to Follow-up|1|||
16451316|NCT02136069|40130298|FG000|Overall Study|Adverse Event|6|||
16451317|NCT02136069|40130299|FG001|Overall Study|Adverse Event|8|||
16451318|NCT02136069|40130298|FG000|Overall Study|Death|0|||
16451319|NCT02136069|40130299|FG001|Overall Study|Death|1|||
16451320|NCT02136069|40130298|FG000|Overall Study|Lack of Efficacy|10|||
16451321|NCT02136069|40130299|FG001|Overall Study|Lack of Efficacy|4|||
16451322|NCT02136069|40130298|FG000|Overall Study|Lost to Follow-up|1|||
16451323|NCT02136069|40130299|FG001|Overall Study|Lost to Follow-up|0|||
16451324|NCT02136069|40130298|FG000|Overall Study|Non-Compliance|1|||
16451325|NCT02136069|40130299|FG001|Overall Study|Non-Compliance|0|||
16451326|NCT02136069|40130298|FG000|Overall Study|Physician Decision|5|||
16451327|NCT02136069|40130299|FG001|Overall Study|Physician Decision|4|||
16451328|NCT02136069|40130298|FG000|Overall Study|Withdrawal by Subject|10|||
16451329|NCT02136069|40130299|FG001|Overall Study|Withdrawal by Subject|11|||
16451330|NCT02249832|40130300|FG000|Overall Study|Withdrawal by Subject|3|||
16451331|NCT02249832|40130300|FG000|Overall Study|Lost to Follow-up|10|||
16451332|NCT01188343|40130301|FG000|Overall Study|Not vaccinated|0|||
16265355|NCT03290781|39453358|FG004|Overall Study|Lost to Follow-up|0|||
16265356|NCT03290781|39453359|FG005|Overall Study|Lost to Follow-up|0|||
16265357|NCT03290781|39453360|FG006|Overall Study|Lost to Follow-up|0|||
16265358|NCT03290781|39453354|FG000|Overall Study|Protocol Deviation|2|||
16451333|NCT01188343|40130302|FG001|Overall Study|Not vaccinated|2|||
16163966|NCT01194440|39083687|FG000|6-months (2nd Dose)|Change in therapy|4|||
16163967|NCT00896532|39083688|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163968|NCT00896532|39083689|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16265359|NCT03290781|39453355|FG001|Overall Study|Protocol Deviation|0|||
16265360|NCT03290781|39453356|FG002|Overall Study|Protocol Deviation|0|||
16265361|NCT03290781|39453357|FG003|Overall Study|Protocol Deviation|1|||
16451334|NCT01188343|40130303|FG002|Overall Study|Not vaccinated|1|||
16451335|NCT01188343|40130301|FG000|Overall Study|Withdrawal by Subject|1|||
16451336|NCT01188343|40130302|FG001|Overall Study|Withdrawal by Subject|24|||
16451337|NCT01188343|40130303|FG002|Overall Study|Withdrawal by Subject|0|||
16451338|NCT01342211|40130304|FG000|Overall Study|Lost to Follow-up|0|||
16451339|NCT01342211|40130305|FG001|Overall Study|Lost to Follow-up|0|||
16451340|NCT01342211|40130306|FG002|Overall Study|Lost to Follow-up|0|||
16451341|NCT01342211|40130307|FG003|Overall Study|Lost to Follow-up|1|||
16451342|NCT01342211|40130308|FG004|Overall Study|Lost to Follow-up|0|||
16451343|NCT01342211|40130304|FG000|Overall Study|Adverse Event|0|||
16451344|NCT01342211|40130305|FG001|Overall Study|Adverse Event|0|||
16451345|NCT01342211|40130306|FG002|Overall Study|Adverse Event|0|||
16451346|NCT01342211|40130307|FG003|Overall Study|Adverse Event|0|||
16451347|NCT01342211|40130308|FG004|Overall Study|Adverse Event|1|||
16451348|NCT01342211|40130304|FG000|Overall Study|Withdrawal by Subject|0|||
16451349|NCT01342211|40130305|FG001|Overall Study|Withdrawal by Subject|0|||
16451350|NCT01342211|40130306|FG002|Overall Study|Withdrawal by Subject|0|||
16451351|NCT01342211|40130307|FG003|Overall Study|Withdrawal by Subject|1|||
16451352|NCT01342211|40130308|FG004|Overall Study|Withdrawal by Subject|0|||
16451353|NCT01342211|40130304|FG000|Overall Study|Randomized, but not Treated|0|||
16451354|NCT01342211|40130305|FG001|Overall Study|Randomized, but not Treated|2|||
16451355|NCT01342211|40130306|FG002|Overall Study|Randomized, but not Treated|0|||
16451356|NCT01342211|40130307|FG003|Overall Study|Randomized, but not Treated|0|||
16451357|NCT01342211|40130308|FG004|Overall Study|Randomized, but not Treated|1|||
16451358|NCT01605799|40130323|FG000|Overall Study|Withdrawal by Subject|2|||
16451359|NCT01605799|40130324|FG001|Overall Study|Withdrawal by Subject|1|||
16451360|NCT04004988|40130325|FG000|Period 1|Physician Decision|2|||
16451361|NCT04004988|40130326|FG001|Period 1|Physician Decision|0|||
16451362|NCT04004988|40130325|FG000|Period 1|Withdrawal by Subject|0|||
16451363|NCT04004988|40130326|FG001|Period 1|Withdrawal by Subject|1|||
16451364|NCT04004988|40130325|FG000|Period 1|Adverse Event|1|||
16265362|NCT03290781|39453358|FG004|Overall Study|Protocol Deviation|0|||
16373303|NCT01475825|39853147|FG000|Overall Study|Adverse Event|41|||
16373304|NCT01475825|39853148|FG001|Overall Study|Adverse Event|15|||
16373305|NCT01475825|39853149|FG002|Overall Study|Adverse Event|27|||
16373306|NCT01475825|39853150|FG003|Overall Study|Adverse Event|11|||
16373307|NCT01475825|39853147|FG000|Overall Study|Death|1|||
16373308|NCT01475825|39853148|FG001|Overall Study|Death|0|||
16373309|NCT01475825|39853149|FG002|Overall Study|Death|1|||
16373310|NCT01475825|39853150|FG003|Overall Study|Death|0|||
16373311|NCT01475825|39853147|FG000|Overall Study|Lack of Efficacy|0|||
16373312|NCT01475825|39853148|FG001|Overall Study|Lack of Efficacy|0|||
16373313|NCT01475825|39853149|FG002|Overall Study|Lack of Efficacy|1|||
16373314|NCT01475825|39853150|FG003|Overall Study|Lack of Efficacy|0|||
16373315|NCT01475825|39853147|FG000|Overall Study|Lost to Follow-up|0|||
16373316|NCT01475825|39853148|FG001|Overall Study|Lost to Follow-up|0|||
16373317|NCT01475825|39853149|FG002|Overall Study|Lost to Follow-up|3|||
16373318|NCT01475825|39853150|FG003|Overall Study|Lost to Follow-up|1|||
16373319|NCT01475825|39853147|FG000|Overall Study|Non-compliance with Study Drug|1|||
16373320|NCT01475825|39853148|FG001|Overall Study|Non-compliance with Study Drug|2|||
16373321|NCT01475825|39853149|FG002|Overall Study|Non-compliance with Study Drug|4|||
16373322|NCT01475825|39853150|FG003|Overall Study|Non-compliance with Study Drug|0|||
16373323|NCT01475825|39853147|FG000|Overall Study|Other: Not available|0|||
16373324|NCT01475825|39853148|FG001|Overall Study|Other: Not available|0|||
16373325|NCT01475825|39853149|FG002|Overall Study|Other: Not available|2|||
16373326|NCT01475825|39853150|FG003|Overall Study|Other: Not available|0|||
16373327|NCT01475825|39853147|FG000|Overall Study|Protocol Violation|1|||
16373328|NCT01475825|39853148|FG001|Overall Study|Protocol Violation|0|||
16373329|NCT01475825|39853149|FG002|Overall Study|Protocol Violation|0|||
16373330|NCT01475825|39853150|FG003|Overall Study|Protocol Violation|0|||
16373331|NCT01475825|39853147|FG000|Overall Study|Physician Decision|0|||
16373332|NCT01475825|39853148|FG001|Overall Study|Physician Decision|1|||
16373333|NCT01475825|39853149|FG002|Overall Study|Physician Decision|0|||
16373334|NCT01475825|39853150|FG003|Overall Study|Physician Decision|0|||
16373335|NCT01475825|39853147|FG000|Overall Study|Withdrawal by Subject|8|||
16373336|NCT01475825|39853148|FG001|Overall Study|Withdrawal by Subject|3|||
16373337|NCT01475825|39853149|FG002|Overall Study|Withdrawal by Subject|11|||
16373338|NCT01475825|39853150|FG003|Overall Study|Withdrawal by Subject|7|||
16373339|NCT01475825|39853147|FG000|Overall Study|Did not enter OLC|15|||
16373340|NCT01475825|39853148|FG001|Overall Study|Did not enter OLC|11|||
16373341|NCT01475825|39853149|FG002|Overall Study|Did not enter OLC|15|||
16373342|NCT01475825|39853150|FG003|Overall Study|Did not enter OLC|11|||
16373343|NCT03180138|39853153|FG000|Overall Study|Mobile-phone could not be verified|2|||
16373344|NCT03180138|39853154|FG001|Overall Study|Mobile-phone could not be verified|13|||
16373345|NCT03180138|39853155|FG002|Overall Study|Mobile-phone could not be verified|15|||
16373346|NCT03180138|39853153|FG000|Overall Study|No prior immunization records|17|||
16373347|NCT03180138|39853154|FG001|Overall Study|No prior immunization records|0|||
16373348|NCT03180138|39853155|FG002|Overall Study|No prior immunization records|6|||
16451365|NCT04004988|40130326|FG001|Period 1|Adverse Event|2|||
16451366|NCT02304367|40130327|FG000|Overall Study|Lack of Response to Bruosumab|1|||
16451367|NCT02304367|40130327|FG000|Overall Study|Sponsor Decision|3|||
16451368|NCT02304367|40130327|FG000|Overall Study|Death|2|||
16451369|NCT02304367|40130327|FG000|Overall Study|Physician Decision|1|||
16451370|NCT02304367|40130327|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
16451371|NCT00759941|40130328|FG000|Overall Study|Use of medication|1|||
16451372|NCT00759941|40130329|FG001|Overall Study|Use of medication|0|||
16451373|NCT00759941|40130328|FG000|Overall Study|Adverse Event|1|||
16265363|NCT03290781|39453359|FG005|Overall Study|Protocol Deviation|0|||
16451374|NCT00759941|40130329|FG001|Overall Study|Adverse Event|0|||
16451375|NCT00759941|40130328|FG000|Overall Study|Exited in error by site|1|||
16451376|NCT00759941|40130329|FG001|Overall Study|Exited in error by site|1|||
16451377|NCT01587924|40130330|FG000|Overall Study|Adverse Event|0|||
16451378|NCT01587924|40130331|FG001|Overall Study|Adverse Event|2|||
16451379|NCT01587924|40130332|FG002|Overall Study|Adverse Event|0|||
16451380|NCT01587924|40130333|FG003|Overall Study|Adverse Event|0|||
16451381|NCT01587924|40130330|FG000|Overall Study|Protocol Violation|2|||
16451382|NCT01587924|40130331|FG001|Overall Study|Protocol Violation|1|||
16451383|NCT01587924|40130332|FG002|Overall Study|Protocol Violation|2|||
16451384|NCT01587924|40130333|FG003|Overall Study|Protocol Violation|1|||
16451385|NCT01587924|40130330|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
16265364|NCT03290781|39453360|FG006|Overall Study|Protocol Deviation|0|||
16265365|NCT03290781|39453354|FG000|Overall Study|Disease Relapse|32|||
16265366|NCT03290781|39453355|FG001|Overall Study|Disease Relapse|5|||
16265367|NCT03290781|39453356|FG002|Overall Study|Disease Relapse|38|||
16265368|NCT03290781|39453357|FG003|Overall Study|Disease Relapse|7|||
16451386|NCT01587924|40130331|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
16451387|NCT01587924|40130332|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
16451388|NCT01587924|40130333|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
16451389|NCT01587924|40130330|FG000|Overall Study|Withdrawal by Subject|0|||
16451390|NCT01587924|40130331|FG001|Overall Study|Withdrawal by Subject|1|||
16451391|NCT01587924|40130332|FG002|Overall Study|Withdrawal by Subject|1|||
16451392|NCT01587924|40130333|FG003|Overall Study|Withdrawal by Subject|0|||
16451393|NCT01189032|40130334|FG000|Overall Study|Adverse Event|1|||
16451394|NCT01189032|40130335|FG001|Overall Study|Adverse Event|3|||
16451395|NCT01189032|40130336|FG002|Overall Study|Adverse Event|4|||
16451396|NCT01189032|40130334|FG000|Overall Study|Lack of Efficacy|2|||
16265369|NCT03290781|39453358|FG004|Overall Study|Disease Relapse|3|||
16265370|NCT03290781|39453359|FG005|Overall Study|Disease Relapse|1|||
16265371|NCT03290781|39453360|FG006|Overall Study|Disease Relapse|4|||
16265372|NCT03290781|39453354|FG000|Overall Study|Other|3|||
16265373|NCT03290781|39453355|FG001|Overall Study|Other|0|||
16265374|NCT03290781|39453356|FG002|Overall Study|Other|2|||
16265375|NCT03290781|39453357|FG003|Overall Study|Other|2|||
16373349|NCT03180138|39853153|FG000|Overall Study|Found to be >24 mon after randomization|3|||
16373350|NCT03180138|39853154|FG001|Overall Study|Found to be >24 mon after randomization|0|||
16373351|NCT03180138|39853155|FG002|Overall Study|Found to be >24 mon after randomization|3|||
16373352|NCT02369159|39853156|FG000|Overall Study|Adverse Event|0|||
16373353|NCT02369159|39853157|FG001|Overall Study|Adverse Event|1|||
16373354|NCT02369159|39853156|FG000|Overall Study|Lost to Follow-up|1|||
16373355|NCT02369159|39853157|FG001|Overall Study|Lost to Follow-up|1|||
16373356|NCT02369159|39853156|FG000|Overall Study|Withdrawal by Subject|7|||
16373357|NCT02369159|39853157|FG001|Overall Study|Withdrawal by Subject|0|||
16373358|NCT01653262|39853163|FG000|Overall Study|Lack of Efficacy|1|||
16373359|NCT01653262|39853163|FG000|Overall Study|SAE, non-fatal|1|||
16373360|NCT01653262|39853163|FG000|Overall Study|AE, non-serious non-fatal|1|||
16373361|NCT00682435|39853164|FG000|Overall Study|Insufficient data|5|||
16373362|NCT00682435|39853164|FG000|Overall Study|Erroneously enrolled twice|2|||
16373363|NCT00052715|39853167|FG000|Overall Study|wrong histology|1|||
16373364|NCT02123511|39853168|FG000|Overall Study|Cancelled treatment|1|||
16373365|NCT02123511|39853169|FG001|Overall Study|Cancelled treatment|0|||
16373366|NCT02123511|39853168|FG000|Overall Study|Incomplete data|1|||
16373367|NCT02123511|39853169|FG001|Overall Study|Incomplete data|3|||
16373368|NCT02123511|39853168|FG000|Overall Study|Ineligible|0|||
16373369|NCT02123511|39853169|FG001|Overall Study|Ineligible|1|||
16373370|NCT01292473|39853170|FG000|Overall Study|Adverse Event|1|||
16373371|NCT01292473|39853171|FG001|Overall Study|Adverse Event|0|||
16373372|NCT01292473|39853172|FG002|Overall Study|Adverse Event|1|||
16373373|NCT01292473|39853173|FG003|Overall Study|Adverse Event|1|||
16373374|NCT01292473|39853170|FG000|Overall Study|Lost to Follow-up|1|||
16373375|NCT01292473|39853171|FG001|Overall Study|Lost to Follow-up|1|||
16373376|NCT01292473|39853172|FG002|Overall Study|Lost to Follow-up|2|||
16373377|NCT01292473|39853173|FG003|Overall Study|Lost to Follow-up|2|||
16373378|NCT01292473|39853170|FG000|Overall Study|Withdrawal by Subject|3|||
16373379|NCT01292473|39853171|FG001|Overall Study|Withdrawal by Subject|4|||
16373380|NCT01292473|39853172|FG002|Overall Study|Withdrawal by Subject|3|||
16373381|NCT01292473|39853173|FG003|Overall Study|Withdrawal by Subject|3|||
16451397|NCT01189032|40130335|FG001|Overall Study|Lack of Efficacy|3|||
16451398|NCT01189032|40130336|FG002|Overall Study|Lack of Efficacy|0|||
16451399|NCT01189032|40130334|FG000|Overall Study|Withdrawal by Subject|1|||
16451400|NCT01189032|40130335|FG001|Overall Study|Withdrawal by Subject|0|||
16451401|NCT01189032|40130336|FG002|Overall Study|Withdrawal by Subject|1|||
16163969|NCT00896532|39083690|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163970|NCT00896532|39083691|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
16163971|NCT00896532|39083692|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16265376|NCT03290781|39453358|FG004|Overall Study|Other|0|||
16265377|NCT03290781|39453359|FG005|Overall Study|Other|0|||
16265378|NCT03290781|39453360|FG006|Overall Study|Other|0|||
16265379|NCT03233724|39453361|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
16265380|NCT03233724|39453362|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
16265381|NCT03233724|39453363|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
16265382|NCT03233724|39453364|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
16265383|NCT03233724|39453365|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
16265384|NCT03233724|39453361|FG000|Phase I Dose Escalation|Best interest of participant|1|||
16265385|NCT03233724|39453362|FG001|Phase I Dose Escalation|Best interest of participant|1|||
16265386|NCT03233724|39453363|FG002|Phase I Dose Escalation|Best interest of participant|1|||
16265387|NCT03233724|39453364|FG003|Phase I Dose Escalation|Best interest of participant|0|||
16265388|NCT03233724|39453365|FG004|Phase I Dose Escalation|Best interest of participant|0|||
16265389|NCT03233724|39453361|FG000|Phase I Dose Escalation|Physician Decision|0|||
16451402|NCT01189032|40130334|FG000|Overall Study|Protocol Violation|1|||
16163972|NCT00896532|39083693|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
16163973|NCT00896532|39083694|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163974|NCT00896532|39083695|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163975|NCT00896532|39083696|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163976|NCT00896532|39083697|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16451403|NCT01189032|40130335|FG001|Overall Study|Protocol Violation|1|||
16451404|NCT01189032|40130336|FG002|Overall Study|Protocol Violation|1|||
16451405|NCT03252925|40133370|FG000|Overall Study|Withdrawal by Subject|1|||
16451406|NCT03252925|40133371|FG001|Overall Study|Withdrawal by Subject|0|||
16451407|NCT03252925|40133370|FG000|Overall Study|Protocol Violation|6|||
16451408|NCT03252925|40133371|FG001|Overall Study|Protocol Violation|0|||
16451409|NCT03252925|40133370|FG000|Overall Study|Adverse Event|1|||
16451410|NCT03252925|40133371|FG001|Overall Study|Adverse Event|0|||
16451411|NCT03252925|40133370|FG000|Overall Study|Lost to Follow-up|6|||
16451412|NCT03252925|40133371|FG001|Overall Study|Lost to Follow-up|6|||
16451413|NCT02224560|40133372|FG000|Overall Study|Protocol Deviation|1|||
16451414|NCT02224560|40133373|FG001|Overall Study|Protocol Deviation|0|||
16451415|NCT02224560|40133374|FG002|Overall Study|Protocol Deviation|0|||
16451416|NCT02224560|40133372|FG000|Overall Study|Withdrawal by Subject|2|||
16451417|NCT02224560|40133373|FG001|Overall Study|Withdrawal by Subject|0|||
16451418|NCT02224560|40133374|FG002|Overall Study|Withdrawal by Subject|1|||
16451419|NCT02224560|40133372|FG000|Overall Study|Met Withdrawal Criteria|1|||
16451420|NCT02224560|40133373|FG001|Overall Study|Met Withdrawal Criteria|0|||
16451421|NCT02224560|40133374|FG002|Overall Study|Met Withdrawal Criteria|0|||
16451422|NCT02224560|40133372|FG000|Overall Study|Adverse Event|4|||
16451423|NCT02224560|40133373|FG001|Overall Study|Adverse Event|1|||
16451424|NCT02224560|40133374|FG002|Overall Study|Adverse Event|1|||
16451425|NCT02224560|40133372|FG000|Overall Study|Withdrawn by Investigator|1|||
16451426|NCT02224560|40133373|FG001|Overall Study|Withdrawn by Investigator|1|||
16451427|NCT02224560|40133374|FG002|Overall Study|Withdrawn by Investigator|0|||
16451428|NCT04080167|40133375|FG000|Overall Study|Lost to Follow-up-Patients|7|||
16451429|NCT04080167|40133376|FG001|Overall Study|Lost to Follow-up-Patients|14|||
16451430|NCT04080167|40133377|FG002|Overall Study|Lost to Follow-up-Patients|0|||
16451431|NCT04080167|40133375|FG000|Overall Study|Lost to Follow-up-Providers|2|||
16451432|NCT04080167|40133376|FG001|Overall Study|Lost to Follow-up-Providers|2|||
16451433|NCT04080167|40133377|FG002|Overall Study|Lost to Follow-up-Providers|0|||
16451434|NCT04080167|40133375|FG000|Overall Study|Withdrawal by Subject|1|||
16451435|NCT04080167|40133376|FG001|Overall Study|Withdrawal by Subject|2|||
16451436|NCT04080167|40133377|FG002|Overall Study|Withdrawal by Subject|0|||
16451437|NCT04080167|40133375|FG000|Overall Study|Withdrawal by Provider|0|||
16451438|NCT04080167|40133376|FG001|Overall Study|Withdrawal by Provider|0|||
16451439|NCT04080167|40133377|FG002|Overall Study|Withdrawal by Provider|4|||
16451440|NCT04080167|40133375|FG000|Overall Study|Death-Patient|2|||
16451441|NCT04080167|40133376|FG001|Overall Study|Death-Patient|1|||
16451442|NCT04080167|40133377|FG002|Overall Study|Death-Patient|0|||
16451443|NCT04080167|40133375|FG000|Overall Study|Hydroxyurea New Starts|0|||
16072625|NCT00371566|38756415|FG001|Treatment Phase|Withdrawal by Subject|1|||
16072626|NCT00371566|38756414|FG000|Treatment Phase|Adverse Event|0|||
16451444|NCT04080167|40133376|FG001|Overall Study|Hydroxyurea New Starts|0|||
16072627|NCT00371566|38756415|FG001|Treatment Phase|Adverse Event|1|||
16451445|NCT04080167|40133377|FG002|Overall Study|Hydroxyurea New Starts|1|||
16451446|NCT04080167|40133375|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
16163977|NCT00896532|39083698|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163978|NCT00896532|39083699|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163979|NCT00896532|39083700|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163980|NCT00896532|39083701|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163981|NCT00896532|39083702|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163982|NCT00896532|39083703|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163983|NCT00896532|39083704|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163984|NCT00896532|39083705|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163985|NCT00896532|39083706|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163986|NCT00896532|39083707|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163987|NCT00896532|39083708|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163988|NCT00896532|39083709|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163989|NCT00896532|39083710|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
16163990|NCT00896532|39083688|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
16163991|NCT00896532|39083689|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
16163992|NCT00896532|39083690|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
16163993|NCT00896532|39083691|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
16163994|NCT00896532|39083692|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
16163995|NCT00896532|39083693|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
16163996|NCT00896532|39083694|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
16163997|NCT00896532|39083695|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16163998|NCT00896532|39083696|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16163999|NCT00896532|39083697|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164000|NCT00896532|39083698|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164001|NCT00896532|39083699|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164002|NCT00896532|39083700|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164003|NCT00896532|39083701|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164004|NCT00896532|39083702|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164005|NCT00896532|39083703|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164006|NCT00896532|39083704|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164007|NCT00896532|39083705|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164008|NCT00896532|39083706|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164009|NCT00896532|39083707|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164010|NCT00896532|39083708|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164011|NCT00896532|39083709|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16451447|NCT04080167|40133376|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
16451448|NCT04080167|40133377|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
16451449|NCT00148317|40133379|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
16451450|NCT00148317|40133379|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
16451451|NCT00148317|40133379|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
16451452|NCT00346697|40133380|FG000|Overall Study|Lost to Follow-up|0|||
16164012|NCT00896532|39083710|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
16164013|NCT00896532|39083688|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
16164014|NCT00896532|39083689|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
16164015|NCT00896532|39083690|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
16164016|NCT00896532|39083691|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
16164017|NCT00896532|39083692|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
16164018|NCT00896532|39083693|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
16164019|NCT00896532|39083694|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
16164020|NCT00896532|39083695|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
16164021|NCT00896532|39083696|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164022|NCT00896532|39083697|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164023|NCT00896532|39083698|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164024|NCT00896532|39083699|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164025|NCT00896532|39083700|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16265390|NCT03233724|39453362|FG001|Phase I Dose Escalation|Physician Decision|0|||
16265391|NCT03233724|39453363|FG002|Phase I Dose Escalation|Physician Decision|1|||
16265392|NCT03233724|39453364|FG003|Phase I Dose Escalation|Physician Decision|0|||
16451453|NCT00346697|40133381|FG001|Overall Study|Lost to Follow-up|1|||
16451454|NCT02284243|40133382|FG000|Overall Study|Lack of Efficacy|3|||
16451455|NCT02284243|40133383|FG001|Overall Study|Lack of Efficacy|3|||
16451456|NCT02284243|40133382|FG000|Overall Study|Adverse Event|1|||
16451457|NCT02284243|40133383|FG001|Overall Study|Adverse Event|0|||
16451458|NCT04154189|40133393|FG000|Overall Study|Withdrawal by Subject|4|||
16072628|NCT00371566|38756414|FG000|Treatment Phase|Protocol Violation|0|||
16451459|NCT04154189|40133394|FG001|Overall Study|Withdrawal by Subject|6|||
16451460|NCT04154189|40133393|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
16451461|NCT04154189|40133394|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
16451462|NCT04154189|40133393|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
16451463|NCT04154189|40133394|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
16451464|NCT04154189|40133393|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
16451465|NCT04154189|40133394|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
16451466|NCT04154189|40133393|FG000|Overall Study|Death|25|||
16451467|NCT04154189|40133394|FG001|Overall Study|Death|25|||
16451468|NCT00118417|40133395|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
16451469|NCT00118417|40133396|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
16451470|NCT00118417|40133395|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
16451471|NCT00118417|40133396|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
16451472|NCT00118417|40133395|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
16451473|NCT00118417|40133396|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
16451474|NCT00118417|40133395|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
16451475|NCT00118417|40133396|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
16451476|NCT00118417|40133395|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
16451477|NCT00118417|40133396|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
16451478|NCT01209689|40133399|FG000|Overall Study|Insufficient Therapeutic Response|7|||
16451479|NCT01209689|40133400|FG001|Overall Study|Insufficient Therapeutic Response|2|||
16451480|NCT01209689|40133399|FG000|Overall Study|Refused Treatment|8|||
16451481|NCT01209689|40133400|FG001|Overall Study|Refused Treatment|3|||
16451482|NCT01209689|40133399|FG000|Overall Study|Adverse Event|4|||
16451483|NCT01209689|40133400|FG001|Overall Study|Adverse Event|0|||
16451484|NCT01209689|40133399|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
16451485|NCT01209689|40133400|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
16451486|NCT01209689|40133399|FG000|Overall Study|Failure to Return|3|||
16451487|NCT01209689|40133400|FG001|Overall Study|Failure to Return|0|||
16451488|NCT01209689|40133399|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
16451489|NCT01209689|40133400|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
16451490|NCT03524118|40133401|FG000|Overall Study|Lost to Follow-up|0|||
16451491|NCT03524118|40133402|FG001|Overall Study|Lost to Follow-up|0|||
16451492|NCT03524118|40133403|FG002|Overall Study|Lost to Follow-up|0|||
16451493|NCT03524118|40133404|FG003|Overall Study|Lost to Follow-up|0|||
16451494|NCT03524118|40133405|FG004|Overall Study|Lost to Follow-up|1|||
16451495|NCT03524118|40133406|FG005|Overall Study|Lost to Follow-up|0|||
16451496|NCT03524118|40133401|FG000|Overall Study|Other|0|||
16451497|NCT03524118|40133402|FG001|Overall Study|Other|1|||
16451498|NCT03524118|40133403|FG002|Overall Study|Other|0|||
16451499|NCT03524118|40133404|FG003|Overall Study|Other|0|||
16451500|NCT03524118|40133405|FG004|Overall Study|Other|1|||
16451501|NCT03524118|40133406|FG005|Overall Study|Other|1|||
16451502|NCT03524118|40133401|FG000|Overall Study|Physician Decision|0|||
16451503|NCT03524118|40133402|FG001|Overall Study|Physician Decision|0|||
16451504|NCT03524118|40133403|FG002|Overall Study|Physician Decision|0|||
16451505|NCT03524118|40133404|FG003|Overall Study|Physician Decision|0|||
16451506|NCT03524118|40133405|FG004|Overall Study|Physician Decision|1|||
16451507|NCT03524118|40133406|FG005|Overall Study|Physician Decision|0|||
16451508|NCT03524118|40133401|FG000|Overall Study|Protocol Violation|0|||
16451509|NCT03524118|40133402|FG001|Overall Study|Protocol Violation|0|||
16451510|NCT03524118|40133403|FG002|Overall Study|Protocol Violation|1|||
16451511|NCT03524118|40133404|FG003|Overall Study|Protocol Violation|0|||
16451512|NCT03524118|40133405|FG004|Overall Study|Protocol Violation|1|||
16451513|NCT03524118|40133406|FG005|Overall Study|Protocol Violation|0|||
16451514|NCT03524118|40133401|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16451515|NCT03524118|40133402|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16451516|NCT03524118|40133403|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16451517|NCT03524118|40133404|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
16451518|NCT03524118|40133405|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
16451519|NCT03524118|40133406|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
16451520|NCT02281383|40133407|FG000|Overall Study|Progressive Disease|1|||
16451521|NCT02281383|40133407|FG000|Overall Study|Withdrawal by Subject|6|||
16451522|NCT02281383|40133407|FG000|Overall Study|Protocol Violation|2|||
16072629|NCT00371566|38756415|FG001|Treatment Phase|Protocol Violation|1|||
16265393|NCT03233724|39453365|FG004|Phase I Dose Escalation|Physician Decision|0|||
16451523|NCT02281383|40133407|FG000|Overall Study|Death|1|||
16451524|NCT02281383|40133407|FG000|Overall Study|Adverse Event|2|||
16451525|NCT02892448|40133409|FG000|Overall Study|Screening failure|2|||
16451526|NCT02892448|40133410|FG001|Overall Study|Screening failure|2|||
16451527|NCT02892448|40133411|FG002|Overall Study|Screening failure|1|||
16451528|NCT03710161|40133413|FG000|Overall Study|Study halted due to COVID pandemic|3|||
16451529|NCT03710161|40133414|FG001|Overall Study|Study halted due to COVID pandemic|2|||
16451530|NCT02167139|40133415|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
16451531|NCT02167139|40133416|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
16164026|NCT00896532|39083701|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164027|NCT00896532|39083702|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164028|NCT00896532|39083703|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164029|NCT00896532|39083704|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164030|NCT00896532|39083705|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164031|NCT00896532|39083706|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164032|NCT00896532|39083707|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164033|NCT00896532|39083708|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164034|NCT00896532|39083709|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164035|NCT00896532|39083710|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
16164036|NCT00896532|39083688|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164037|NCT00896532|39083689|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164038|NCT00896532|39083690|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
16164039|NCT00896532|39083691|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164040|NCT00896532|39083692|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
16164041|NCT00896532|39083693|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164042|NCT00896532|39083694|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164043|NCT00896532|39083695|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164044|NCT00896532|39083696|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164045|NCT00896532|39083697|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164046|NCT00896532|39083698|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164047|NCT00896532|39083699|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164048|NCT00896532|39083700|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164049|NCT00896532|39083701|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164050|NCT00896532|39083702|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164051|NCT00896532|39083703|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164052|NCT00896532|39083704|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164053|NCT00896532|39083705|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164054|NCT00896532|39083706|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164055|NCT00896532|39083707|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164056|NCT00896532|39083708|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164057|NCT00896532|39083709|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164058|NCT00896532|39083710|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
16164059|NCT00896532|39083688|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
16164060|NCT00896532|39083689|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164061|NCT00896532|39083690|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164062|NCT00896532|39083691|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
16164063|NCT00896532|39083692|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164064|NCT00896532|39083693|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164065|NCT00896532|39083694|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164066|NCT00896532|39083695|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164067|NCT00896532|39083696|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164068|NCT00896532|39083697|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164069|NCT00896532|39083698|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16451532|NCT02167139|40133417|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
16451533|NCT02167139|40133418|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
16451534|NCT02167139|40133415|FG000|Randomised, Double-blind|Adverse Event|2|||
16451535|NCT02167139|40133416|FG001|Randomised, Double-blind|Adverse Event|9|||
16451536|NCT02167139|40133417|FG002|Randomised, Double-blind|Adverse Event|0|||
16451537|NCT02167139|40133418|FG003|Randomised, Double-blind|Adverse Event|0|||
16451538|NCT02167139|40133415|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
16451539|NCT02167139|40133416|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
16451540|NCT02167139|40133417|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
16451541|NCT02167139|40133418|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
16451542|NCT02167139|40133415|FG000|Randomised, Double-blind|Other|3|||
16451543|NCT02167139|40133416|FG001|Randomised, Double-blind|Other|0|||
16451544|NCT02167139|40133417|FG002|Randomised, Double-blind|Other|0|||
16164070|NCT00896532|39083699|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164071|NCT00896532|39083700|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164072|NCT00896532|39083701|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164073|NCT00896532|39083702|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164074|NCT00896532|39083703|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164075|NCT00896532|39083704|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164076|NCT00896532|39083705|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164077|NCT00896532|39083706|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164078|NCT00896532|39083707|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164079|NCT00896532|39083708|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164080|NCT00896532|39083709|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164081|NCT00896532|39083710|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
16164082|NCT00896532|39083688|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164083|NCT00896532|39083689|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164084|NCT00896532|39083690|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
16164085|NCT00896532|39083691|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164086|NCT00896532|39083692|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16451545|NCT02167139|40133418|FG003|Randomised, Double-blind|Other|0|||
16451546|NCT02167139|40133415|FG000|Transition-extension|Adverse Event|2|||
16451547|NCT02167139|40133416|FG001|Transition-extension|Adverse Event|0|||
16451548|NCT02167139|40133417|FG002|Transition-extension|Adverse Event|2|||
16164087|NCT00896532|39083693|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164088|NCT00896532|39083694|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164089|NCT00896532|39083695|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164090|NCT00896532|39083696|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164091|NCT00896532|39083697|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16451549|NCT02167139|40133418|FG003|Transition-extension|Adverse Event|3|||
16451550|NCT02167139|40133415|FG000|Transition-extension|Withdrawal by Subject|2|||
16451551|NCT02167139|40133416|FG001|Transition-extension|Withdrawal by Subject|0|||
16451552|NCT02167139|40133417|FG002|Transition-extension|Withdrawal by Subject|4|||
16451553|NCT02167139|40133418|FG003|Transition-extension|Withdrawal by Subject|1|||
16451554|NCT02167139|40133415|FG000|Transition-extension|Lack of Efficacy|0|||
16164092|NCT00896532|39083698|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164093|NCT00896532|39083699|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164094|NCT00896532|39083700|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164095|NCT00896532|39083701|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164096|NCT00896532|39083702|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164097|NCT00896532|39083703|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164098|NCT00896532|39083704|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164099|NCT00896532|39083705|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164100|NCT00896532|39083706|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164101|NCT00896532|39083707|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164102|NCT00896532|39083708|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164103|NCT00896532|39083709|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164104|NCT00896532|39083710|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
16164105|NCT00896532|39083688|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164106|NCT00896532|39083689|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164107|NCT00896532|39083690|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
16164108|NCT00896532|39083691|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164109|NCT00896532|39083692|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164110|NCT00896532|39083693|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164111|NCT00896532|39083694|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164112|NCT00896532|39083695|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164113|NCT00896532|39083696|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164114|NCT00896532|39083697|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164115|NCT00896532|39083698|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164116|NCT00896532|39083699|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164117|NCT00896532|39083700|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164118|NCT00896532|39083701|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164119|NCT00896532|39083702|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164120|NCT00896532|39083703|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164121|NCT00896532|39083704|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164122|NCT00896532|39083705|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164123|NCT00896532|39083706|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164124|NCT00896532|39083707|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164125|NCT00896532|39083708|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164126|NCT00896532|39083709|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16164127|NCT00896532|39083710|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
16451555|NCT02167139|40133416|FG001|Transition-extension|Lack of Efficacy|0|||
16072630|NCT00371566|38756414|FG000|Chemoradiation Phase|Physician Decision|2|||
16072631|NCT00371566|38756415|FG001|Chemoradiation Phase|Physician Decision|0|||
16072632|NCT00371566|38756414|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
16072633|NCT00371566|38756415|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
16072634|NCT00371566|38756414|FG000|Chemoradiation Phase|Non compliant|0|||
16072635|NCT00371566|38756415|FG001|Chemoradiation Phase|Non compliant|1|||
16451556|NCT02167139|40133417|FG002|Transition-extension|Lack of Efficacy|1|||
16451557|NCT02167139|40133418|FG003|Transition-extension|Lack of Efficacy|1|||
16451558|NCT02167139|40133415|FG000|Transition-extension|Other|1|||
16451559|NCT02167139|40133416|FG001|Transition-extension|Other|0|||
16451560|NCT02167139|40133417|FG002|Transition-extension|Other|1|||
16451561|NCT02167139|40133418|FG003|Transition-extension|Other|0|||
16451562|NCT02167139|40133415|FG000|Transition-extension|Lost to Follow-up|1|||
16451563|NCT02167139|40133416|FG001|Transition-extension|Lost to Follow-up|0|||
16451564|NCT02167139|40133417|FG002|Transition-extension|Lost to Follow-up|0|||
16451565|NCT02167139|40133418|FG003|Transition-extension|Lost to Follow-up|0|||
16451566|NCT01063283|40133421|FG000|Cycle 1|Adverse Event|2|||
16451567|NCT01063283|40133422|FG001|Cycle 1|Adverse Event|0|||
16451568|NCT01063283|40133423|FG002|Cycle 1|Adverse Event|0|||
16451569|NCT01063283|40133421|FG000|Cycle 1|Technical failure in data collection|1|||
16451570|NCT01063283|40133422|FG001|Cycle 1|Technical failure in data collection|0|||
16451571|NCT01063283|40133423|FG002|Cycle 1|Technical failure in data collection|0|||
16451572|NCT01967576|40133433|FG000|Overall Study|Withdrawal by Subject|3|||
16451573|NCT01967576|40133433|FG000|Overall Study|Progressed/Removed from treatment|1|||
16451574|NCT01967576|40133433|FG000|Overall Study|Study closing at site|1|||
16451575|NCT01967576|40133433|FG000|Overall Study|Adverse Event|1|||
16451576|NCT01967576|40133433|FG000|Overall Study|Refused further treatment|1|||
16451577|NCT00719472|40133439|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
16451578|NCT00719472|40133439|FG000|Enrolled in Study|Subject decision to withdraw|8|||
16451579|NCT00719472|40133439|FG000|Enrolled in Study|Various Reasons|17|||
16451580|NCT00719472|40133439|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
16451581|NCT00719472|40133439|FG000|Received Cycle 1 Treatment|Death|5|||
16451582|NCT00719472|40133439|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
16451583|NCT00719472|40133439|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
16451584|NCT00719472|40133439|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
16451585|NCT00719472|40133439|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
16451586|NCT00719472|40133439|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
16451587|NCT00719472|40133439|FG000|Received Cycle 2 Treatment|Death|6|||
16451588|NCT00719472|40133439|FG000|Received Cycle 2 Treatment|Disease progression|3|||
16451589|NCT00719472|40133439|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
16451590|NCT00719472|40133439|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
16451591|NCT00719472|40133439|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
16451592|NCT00719472|40133439|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
16451593|NCT01317277|40133440|FG000|Overall Study|Lost to Follow-up|3|||
16451594|NCT01317277|40133441|FG001|Overall Study|Lost to Follow-up|1|||
16451595|NCT01317277|40133440|FG000|Overall Study|Lost MEMS|1|||
16451596|NCT01317277|40133441|FG001|Overall Study|Lost MEMS|1|||
16451597|NCT01317277|40133440|FG000|Overall Study|Unable to comply with intervention|1|||
16451598|NCT01317277|40133441|FG001|Overall Study|Unable to comply with intervention|0|||
16451599|NCT01317277|40133440|FG000|Overall Study|Withdrawal by Subject|1|||
16451600|NCT01317277|40133441|FG001|Overall Study|Withdrawal by Subject|0|||
16451601|NCT01317277|40133440|FG000|Overall Study|Adverse Event|1|||
16451602|NCT01317277|40133441|FG001|Overall Study|Adverse Event|0|||
16451603|NCT04040933|40133447|FG000|Overall Study|Protocol Violation|1|||
16451604|NCT04040933|40133447|FG000|Overall Study|Withdrawal by Subject|2|||
16451605|NCT01621802|40133448|FG000|Overall Study|Protocol Violation|0|||
16451606|NCT01621802|40133449|FG001|Overall Study|Protocol Violation|0|||
16451607|NCT01621802|40133450|FG002|Overall Study|Protocol Violation|0|||
16451608|NCT01621802|40133451|FG003|Overall Study|Protocol Violation|0|||
16451609|NCT01621802|40133452|FG004|Overall Study|Protocol Violation|0|||
16451610|NCT01621802|40133453|FG005|Overall Study|Protocol Violation|1|||
16451611|NCT01621802|40133448|FG000|Overall Study|Withdrawal by Subject|8|||
16451612|NCT01621802|40133449|FG001|Overall Study|Withdrawal by Subject|4|||
16451613|NCT01621802|40133450|FG002|Overall Study|Withdrawal by Subject|4|||
16451614|NCT01621802|40133451|FG003|Overall Study|Withdrawal by Subject|2|||
16451615|NCT01621802|40133452|FG004|Overall Study|Withdrawal by Subject|2|||
16451616|NCT01621802|40133453|FG005|Overall Study|Withdrawal by Subject|0|||
16451617|NCT01621802|40133448|FG000|Overall Study|Migrated/moved from study area|0|||
16451618|NCT01621802|40133449|FG001|Overall Study|Migrated/moved from study area|0|||
16451619|NCT01621802|40133450|FG002|Overall Study|Migrated/moved from study area|2|||
16451620|NCT01621802|40133451|FG003|Overall Study|Migrated/moved from study area|0|||
16451621|NCT01621802|40133452|FG004|Overall Study|Migrated/moved from study area|1|||
16164128|NCT00896532|39083688|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164129|NCT00896532|39083689|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16373382|NCT01292473|39853170|FG000|Overall Study|Physician Decision|0|||
16451622|NCT01621802|40133453|FG005|Overall Study|Migrated/moved from study area|0|||
16451623|NCT01621802|40133448|FG000|Overall Study|Others|3|||
16451624|NCT01621802|40133449|FG001|Overall Study|Others|3|||
16451625|NCT01621802|40133450|FG002|Overall Study|Others|3|||
16451626|NCT01621802|40133451|FG003|Overall Study|Others|2|||
16451627|NCT01621802|40133452|FG004|Overall Study|Others|1|||
16451628|NCT01621802|40133453|FG005|Overall Study|Others|0|||
16451629|NCT01621802|40133448|FG000|Overall Study|Lost to Follow-up|36|||
16451630|NCT01621802|40133449|FG001|Overall Study|Lost to Follow-up|16|||
16451631|NCT01621802|40133450|FG002|Overall Study|Lost to Follow-up|24|||
16451632|NCT01621802|40133451|FG003|Overall Study|Lost to Follow-up|7|||
16451633|NCT01621802|40133452|FG004|Overall Study|Lost to Follow-up|31|||
16451634|NCT01621802|40133453|FG005|Overall Study|Lost to Follow-up|11|||
16451635|NCT03848832|40133454|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
16451636|NCT03848832|40133455|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
16451637|NCT03848832|40133456|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
16451638|NCT03848832|40133454|FG000|Overall Study|Withdrawal by Subject|0|||
16451639|NCT03848832|40133455|FG001|Overall Study|Withdrawal by Subject|0|||
16451640|NCT03848832|40133456|FG002|Overall Study|Withdrawal by Subject|1|||
16451641|NCT03848832|40133454|FG000|Overall Study|Withdrawal (Covid-19)|0|||
16451642|NCT03848832|40133455|FG001|Overall Study|Withdrawal (Covid-19)|2|||
16451643|NCT03848832|40133456|FG002|Overall Study|Withdrawal (Covid-19)|0|||
16451644|NCT03848832|40133454|FG000|Overall Study|Physician Decision|2|||
16451645|NCT03848832|40133455|FG001|Overall Study|Physician Decision|1|||
16451646|NCT03848832|40133456|FG002|Overall Study|Physician Decision|3|||
16451647|NCT03848832|40133454|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
16451648|NCT03848832|40133455|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
16451649|NCT03848832|40133456|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
16451650|NCT03848832|40133454|FG000|Overall Study|Adverse Event|1|||
16451651|NCT03848832|40133455|FG001|Overall Study|Adverse Event|0|||
16451652|NCT03848832|40133456|FG002|Overall Study|Adverse Event|0|||
16451653|NCT01310075|40133459|FG000|Overall Study|Lost to Follow-up|1|||
16451654|NCT01310075|40133460|FG001|Overall Study|Lost to Follow-up|0|||
16451655|NCT01310075|40133459|FG000|Overall Study|Physician Decision|10|||
16451656|NCT01310075|40133460|FG001|Overall Study|Physician Decision|7|||
16451657|NCT01310075|40133459|FG000|Overall Study|Protocol Violation|2|||
16373383|NCT01292473|39853171|FG001|Overall Study|Physician Decision|1|||
16373384|NCT01292473|39853172|FG002|Overall Study|Physician Decision|0|||
16373385|NCT01292473|39853173|FG003|Overall Study|Physician Decision|0|||
16373386|NCT01292473|39853170|FG000|Overall Study|Disease Progression|0|||
16373387|NCT01292473|39853171|FG001|Overall Study|Disease Progression|1|||
16373388|NCT01292473|39853172|FG002|Overall Study|Disease Progression|3|||
16373389|NCT01292473|39853173|FG003|Overall Study|Disease Progression|6|||
16373390|NCT01348490|39853174|FG000|Overall Study|Death|1|||
16373391|NCT01348490|39853174|FG000|Overall Study|Adverse Event|3|||
16373392|NCT01348490|39853174|FG000|Overall Study|Consent withdrawn|7|||
16373393|NCT01348490|39853174|FG000|Overall Study|Disease progression|3|||
16373394|NCT01348490|39853174|FG000|Overall Study|Lost to Follow-up|1|||
16373395|NCT01348490|39853174|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
16373396|NCT01348490|39853174|FG000|Overall Study|Other Unspecified|8|||
16373397|NCT04189588|39853175|FG000|Overall Study|Death|0|||
16373398|NCT04189588|39853176|FG001|Overall Study|Death|1|||
16373399|NCT04189588|39853175|FG000|Overall Study|Lost to Follow-up|0|||
16373400|NCT04189588|39853176|FG001|Overall Study|Lost to Follow-up|1|||
16373401|NCT01117350|39853177|FG000|Comparative Period|Not Treated|5|||
16373402|NCT01117350|39853178|FG001|Comparative Period|Not Treated|8|||
16373403|NCT01117350|39853177|FG000|Comparative Period|Adverse Event|6|||
16373404|NCT01117350|39853178|FG001|Comparative Period|Adverse Event|33|||
16373405|NCT01117350|39853177|FG000|Comparative Period|Lost to Follow-up|11|||
16373406|NCT01117350|39853178|FG001|Comparative Period|Lost to Follow-up|7|||
16373407|NCT01117350|39853177|FG000|Comparative Period|Withdrawal by Subject|9|||
16373408|NCT01117350|39853178|FG001|Comparative Period|Withdrawal by Subject|13|||
16373409|NCT01117350|39853177|FG000|Comparative Period|Protocol Violation|8|||
16373410|NCT01117350|39853178|FG001|Comparative Period|Protocol Violation|12|||
16373411|NCT01117350|39853177|FG000|Comparative Period|Lack of Efficacy|1|||
16373412|NCT01117350|39853178|FG001|Comparative Period|Lack of Efficacy|0|||
16373413|NCT01117350|39853177|FG000|Comparative Period|Physician Decision|0|||
16373414|NCT01117350|39853178|FG001|Comparative Period|Physician Decision|1|||
16373415|NCT01117350|39853177|FG000|Comparative Period|Move to another city/country|2|||
16373416|NCT01117350|39853178|FG001|Comparative Period|Move to another city/country|1|||
16373417|NCT01117350|39853177|FG000|Extension Period|Not included in extension, not treated|0|||
16373418|NCT01117350|39853178|FG001|Extension Period|Not included in extension, not treated|50|||
16373419|NCT01117350|39853177|FG000|Extension Period|Adverse Event|0|||
16373420|NCT01117350|39853178|FG001|Extension Period|Adverse Event|2|||
16373421|NCT01117350|39853177|FG000|Extension Period|Protocol Violation|0|||
16373422|NCT01117350|39853178|FG001|Extension Period|Protocol Violation|2|||
16373423|NCT01117350|39853177|FG000|Extension Period|Lost to Follow-up|0|||
16451658|NCT01310075|40133460|FG001|Overall Study|Protocol Violation|2|||
16451659|NCT01310075|40133459|FG000|Overall Study|Withdrawal by Subject|1|||
16451660|NCT01310075|40133460|FG001|Overall Study|Withdrawal by Subject|1|||
16451661|NCT00686686|40133461|FG000|Overall Study|Non-compliance|1|||
16451662|NCT00686686|40133461|FG000|Overall Study|Adverse Event|2|||
16451663|NCT00686686|40133461|FG000|Overall Study|Lost to Follow-up|3|||
16451664|NCT02754440|40133462|FG000|Overall Study|Protocol Violation|3|||
16451665|NCT02754440|40133463|FG001|Overall Study|Protocol Violation|2|||
16164130|NCT00896532|39083690|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16451666|NCT02754440|40133464|FG002|Overall Study|Protocol Violation|2|||
16451667|NCT02754440|40133465|FG003|Overall Study|Protocol Violation|6|||
16451668|NCT02754440|40133462|FG000|Overall Study|Adverse Event|3|||
16451669|NCT02754440|40133463|FG001|Overall Study|Adverse Event|1|||
16451670|NCT02754440|40133464|FG002|Overall Study|Adverse Event|0|||
16451671|NCT02754440|40133465|FG003|Overall Study|Adverse Event|9|||
16451672|NCT02754440|40133462|FG000|Overall Study|Withdrawal by Subject|0|||
16164131|NCT00896532|39083691|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
16164132|NCT00896532|39083692|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164133|NCT00896532|39083693|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16373424|NCT01117350|39853178|FG001|Extension Period|Lost to Follow-up|2|||
16373425|NCT01117350|39853177|FG000|Extension Period|Withdrawal by Subject|0|||
16373426|NCT01117350|39853178|FG001|Extension Period|Withdrawal by Subject|3|||
16373427|NCT01117350|39853177|FG000|Extension Period|Lack of Efficacy|0|||
16373428|NCT01117350|39853178|FG001|Extension Period|Lack of Efficacy|2|||
16373429|NCT01117350|39853177|FG000|Extension Period|Inclusion criteria not respected|0|||
16373430|NCT01117350|39853178|FG001|Extension Period|Inclusion criteria not respected|1|||
16373431|NCT01117350|39853177|FG000|Extension Period|Prohibited medication|0|||
16373432|NCT01117350|39853178|FG001|Extension Period|Prohibited medication|1|||
16373433|NCT00300495|39853182|FG000|Overall Study|Protocol Violation|4|||
16373434|NCT00300495|39853183|FG001|Overall Study|Protocol Violation|1|||
16373435|NCT01803737|39853186|FG000|Overall Study|Lack of Time|1|||
16373436|NCT01803737|39853187|FG001|Overall Study|Lack of Time|0|||
16373437|NCT01803737|39853186|FG000|Overall Study|Medical Reason|0|||
16373438|NCT01803737|39853187|FG001|Overall Study|Medical Reason|1|||
16373439|NCT01803737|39853186|FG000|Overall Study|Lost to Follow-up|0|||
16373440|NCT01803737|39853187|FG001|Overall Study|Lost to Follow-up|2|||
16373441|NCT00504556|39853188|FG000|Overall Study|Adverse Event|11|||
16373442|NCT00504556|39853189|FG001|Overall Study|Adverse Event|11|||
16373443|NCT00504556|39853190|FG002|Overall Study|Adverse Event|14|||
16373444|NCT00504556|39853191|FG003|Overall Study|Adverse Event|13|||
16373445|NCT00504556|39853192|FG004|Overall Study|Adverse Event|5|||
16373446|NCT00504556|39853188|FG000|Overall Study|Death|3|||
16373447|NCT00504556|39853189|FG001|Overall Study|Death|3|||
16373448|NCT00504556|39853190|FG002|Overall Study|Death|1|||
16373449|NCT00504556|39853191|FG003|Overall Study|Death|0|||
16373450|NCT00504556|39853192|FG004|Overall Study|Death|2|||
16373451|NCT00504556|39853188|FG000|Overall Study|Protocol Violation|1|||
16373452|NCT00504556|39853189|FG001|Overall Study|Protocol Violation|3|||
16373453|NCT00504556|39853190|FG002|Overall Study|Protocol Violation|2|||
16373454|NCT00504556|39853191|FG003|Overall Study|Protocol Violation|1|||
16373455|NCT00504556|39853192|FG004|Overall Study|Protocol Violation|2|||
16373456|NCT00504556|39853188|FG000|Overall Study|Lost to Follow-up|0|||
16373457|NCT00504556|39853189|FG001|Overall Study|Lost to Follow-up|0|||
16373458|NCT00504556|39853190|FG002|Overall Study|Lost to Follow-up|1|||
16373459|NCT00504556|39853191|FG003|Overall Study|Lost to Follow-up|1|||
16373460|NCT00504556|39853192|FG004|Overall Study|Lost to Follow-up|1|||
16373461|NCT00504556|39853188|FG000|Overall Study|Withdrawal by Subject|16|||
16373462|NCT00504556|39853189|FG001|Overall Study|Withdrawal by Subject|16|||
16373463|NCT00504556|39853190|FG002|Overall Study|Withdrawal by Subject|7|||
16373464|NCT00504556|39853191|FG003|Overall Study|Withdrawal by Subject|8|||
16373465|NCT00504556|39853192|FG004|Overall Study|Withdrawal by Subject|12|||
16373466|NCT00504556|39853188|FG000|Overall Study|administrative reasons|0|||
16373467|NCT00504556|39853189|FG001|Overall Study|administrative reasons|2|||
16373468|NCT00504556|39853190|FG002|Overall Study|administrative reasons|2|||
16373469|NCT00504556|39853191|FG003|Overall Study|administrative reasons|1|||
16373470|NCT00504556|39853192|FG004|Overall Study|administrative reasons|2|||
16373471|NCT00504556|39853188|FG000|Overall Study|did not meet entry criteria|2|||
16373472|NCT00504556|39853189|FG001|Overall Study|did not meet entry criteria|0|||
16373473|NCT00504556|39853190|FG002|Overall Study|did not meet entry criteria|1|||
16373474|NCT00504556|39853191|FG003|Overall Study|did not meet entry criteria|1|||
16373475|NCT00504556|39853192|FG004|Overall Study|did not meet entry criteria|0|||
16373476|NCT00504556|39853188|FG000|Overall Study|data monitor committee decision|0|||
16373477|NCT00504556|39853189|FG001|Overall Study|data monitor committee decision|0|||
16373478|NCT00504556|39853190|FG002|Overall Study|data monitor committee decision|0|||
16373479|NCT00504556|39853191|FG003|Overall Study|data monitor committee decision|100|||
16373480|NCT00504556|39853192|FG004|Overall Study|data monitor committee decision|0|||
16373481|NCT00504556|39853188|FG000|Overall Study|Other|2|||
16373482|NCT00504556|39853189|FG001|Overall Study|Other|2|||
16373483|NCT00504556|39853190|FG002|Overall Study|Other|2|||
16373484|NCT00504556|39853191|FG003|Overall Study|Other|3|||
16373485|NCT00504556|39853192|FG004|Overall Study|Other|0|||
16451673|NCT02754440|40133463|FG001|Overall Study|Withdrawal by Subject|0|||
16451674|NCT02754440|40133464|FG002|Overall Study|Withdrawal by Subject|0|||
16451675|NCT02754440|40133465|FG003|Overall Study|Withdrawal by Subject|1|||
16451676|NCT02754440|40133462|FG000|Overall Study|Equipment failure|0|||
16451677|NCT02754440|40133463|FG001|Overall Study|Equipment failure|5|||
16451678|NCT02754440|40133464|FG002|Overall Study|Equipment failure|5|||
16451679|NCT02754440|40133465|FG003|Overall Study|Equipment failure|7|||
16451680|NCT02754440|40133462|FG000|Overall Study|Subject issues not resulting in AE|0|||
16451681|NCT02754440|40133463|FG001|Overall Study|Subject issues not resulting in AE|0|||
16451682|NCT02754440|40133464|FG002|Overall Study|Subject issues not resulting in AE|0|||
16451683|NCT02754440|40133465|FG003|Overall Study|Subject issues not resulting in AE|12|||
16451684|NCT01327482|40133466|FG000|Overall Study|Adverse Event|1|||
16451685|NCT01244893|40133467|FG000|Baseline|Protocol Violation|0|||
16451686|NCT01244893|40133468|FG001|Baseline|Protocol Violation|1|||
16451687|NCT01244893|40133467|FG000|1-Week Follow Up|Lost to Follow-up|1|||
16451688|NCT01244893|40133468|FG001|1-Week Follow Up|Lost to Follow-up|0|||
16451689|NCT00993967|40133469|FG000|Overall Study|Adverse Event|8|||
16451690|NCT00993967|40133469|FG000|Overall Study|Death|1|||
16451691|NCT00993967|40133469|FG000|Overall Study|Lost to Follow-up|14|||
16451692|NCT00993967|40133469|FG000|Overall Study|Withdrawal by Subject|36|||
16451693|NCT00993967|40133469|FG000|Overall Study|Protocol Violation|2|||
16451694|NCT00473382|40133470|FG000|Core Study|Adverse Event|3|||
16451695|NCT00473382|40133471|FG001|Core Study|Adverse Event|1|||
16451696|NCT00473382|40133472|FG002|Core Study|Adverse Event|1|||
16451697|NCT00473382|40133470|FG000|Core Study|Death|3|||
16451698|NCT00473382|40133471|FG001|Core Study|Death|5|||
16451699|NCT00473382|40133472|FG002|Core Study|Death|10|||
16451700|NCT00473382|40133470|FG000|Core Study|Lost to Follow-up|3|||
16451701|NCT00473382|40133471|FG001|Core Study|Lost to Follow-up|3|||
16451702|NCT00473382|40133472|FG002|Core Study|Lost to Follow-up|3|||
16451703|NCT00473382|40133470|FG000|Core Study|Physician Decision|1|||
16451704|NCT00473382|40133471|FG001|Core Study|Physician Decision|2|||
16451705|NCT00473382|40133472|FG002|Core Study|Physician Decision|2|||
16451706|NCT00473382|40133470|FG000|Core Study|Subject non-compliance|5|||
16451707|NCT00473382|40133471|FG001|Core Study|Subject non-compliance|2|||
16451708|NCT00473382|40133472|FG002|Core Study|Subject non-compliance|1|||
16451709|NCT00473382|40133470|FG000|Core Study|Subject needed other treatment|1|||
16451710|NCT00473382|40133471|FG001|Core Study|Subject needed other treatment|3|||
16451711|NCT00473382|40133472|FG002|Core Study|Subject needed other treatment|2|||
16451712|NCT00473382|40133470|FG000|Core Study|Subject's decision|12|||
16451713|NCT00473382|40133471|FG001|Core Study|Subject's decision|11|||
16451714|NCT00473382|40133472|FG002|Core Study|Subject's decision|10|||
16451715|NCT00473382|40133470|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
16451716|NCT00473382|40133471|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
16451717|NCT00473382|40133472|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
16451718|NCT00473382|40133470|FG000|Open-label Extension Through Month 48|Death|1|||
16451719|NCT00473382|40133471|FG001|Open-label Extension Through Month 48|Death|3|||
16451720|NCT00473382|40133472|FG002|Open-label Extension Through Month 48|Death|3|||
16451721|NCT00473382|40133470|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
16451722|NCT00473382|40133471|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
16451723|NCT00473382|40133472|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
16451724|NCT00473382|40133470|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
16451725|NCT00473382|40133471|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
16451726|NCT00473382|40133472|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
16451727|NCT00473382|40133470|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
16451728|NCT00473382|40133471|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
16451729|NCT00473382|40133472|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
16451730|NCT00473382|40133470|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
16451731|NCT00473382|40133471|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
16451732|NCT00473382|40133472|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
16451733|NCT00473382|40133470|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
16451734|NCT00473382|40133471|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
16451735|NCT00473382|40133472|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
16451736|NCT00473382|40133470|FG000|Open-label Extension Through Month 60|Death|1|||
16451737|NCT00473382|40133471|FG001|Open-label Extension Through Month 60|Death|7|||
16451738|NCT00473382|40133472|FG002|Open-label Extension Through Month 60|Death|4|||
16451739|NCT00473382|40133470|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
16451740|NCT00473382|40133471|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
16451741|NCT00473382|40133472|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
16451742|NCT00473382|40133470|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
16451743|NCT00473382|40133471|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
16451744|NCT00473382|40133472|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
16451745|NCT00473382|40133470|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
16451746|NCT00473382|40133471|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
16373486|NCT00504556|39853188|FG000|Overall Study|not in safety analysis set|0|||
16373487|NCT00504556|39853189|FG001|Overall Study|not in safety analysis set|1|||
16373488|NCT00504556|39853190|FG002|Overall Study|not in safety analysis set|1|||
16373489|NCT00504556|39853191|FG003|Overall Study|not in safety analysis set|0|||
16373490|NCT00504556|39853192|FG004|Overall Study|not in safety analysis set|1|||
16373491|NCT01472185|39853193|FG000|Overall Study|Randomized but Not Treated|0|||
16373492|NCT01472185|39853194|FG001|Overall Study|Randomized but Not Treated|1|||
16373493|NCT01472185|39853193|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
16373494|NCT01472185|39853194|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
16373495|NCT01472185|39853193|FG000|Overall Study|Hyperglycemia|5|||
16373496|NCT01472185|39853194|FG001|Overall Study|Hyperglycemia|2|||
16373497|NCT01472185|39853193|FG000|Overall Study|Investigator's Discretion|3|||
16373498|NCT01472185|39853194|FG001|Overall Study|Investigator's Discretion|1|||
16373499|NCT01472185|39853193|FG000|Overall Study|Lost to Follow-up|4|||
16373500|NCT01472185|39853194|FG001|Overall Study|Lost to Follow-up|1|||
16373501|NCT01472185|39853193|FG000|Overall Study|Protocol Violation|5|||
16373502|NCT01472185|39853194|FG001|Overall Study|Protocol Violation|1|||
16373503|NCT01472185|39853193|FG000|Overall Study|Subject Noncompliance|8|||
16373504|NCT01472185|39853194|FG001|Overall Study|Subject Noncompliance|15|||
16373505|NCT01472185|39853193|FG000|Overall Study|Subject Withdrew Consent|6|||
16373506|NCT01472185|39853194|FG001|Overall Study|Subject Withdrew Consent|3|||
16373507|NCT00655356|39853195|FG000|Overall Study|Withdrawal by Subject|3|||
16373508|NCT00655356|39853196|FG001|Overall Study|Withdrawal by Subject|4|||
16373509|NCT00655356|39853195|FG000|Overall Study|Sponsor Request|10|||
16373510|NCT00655356|39853196|FG001|Overall Study|Sponsor Request|4|||
16373511|NCT00655356|39853195|FG000|Overall Study|Adverse Event|1|||
16373512|NCT00655356|39853196|FG001|Overall Study|Adverse Event|1|||
16373513|NCT00655356|39853195|FG000|Overall Study|Protocol Violation|2|||
16373514|NCT00655356|39853196|FG001|Overall Study|Protocol Violation|1|||
16373515|NCT00655356|39853195|FG000|Overall Study|Other Reason|1|||
16373516|NCT00655356|39853196|FG001|Overall Study|Other Reason|0|||
16373517|NCT04008069|39853197|FG000|Open-Label Period|Adverse Event|1|||
16373518|NCT04008069|39853198|FG001|Open-Label Period|Adverse Event|0|||
16373519|NCT04008069|39853199|FG002|Open-Label Period|Adverse Event|0|||
16373520|NCT04008069|39853197|FG000|Open-Label Period|Lack of Efficacy|4|||
16373521|NCT04008069|39853198|FG001|Open-Label Period|Lack of Efficacy|0|||
16373522|NCT04008069|39853199|FG002|Open-Label Period|Lack of Efficacy|0|||
16373523|NCT04008069|39853197|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
16373524|NCT04008069|39853198|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
16373525|NCT04008069|39853199|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
16373526|NCT04008069|39853197|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
16373527|NCT04008069|39853198|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
16373528|NCT04008069|39853199|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
16373529|NCT00669331|39853200|FG000|Randomisation to First Dose|Adverse Event|1|||
16373530|NCT00669331|39853201|FG001|Randomisation to First Dose|Adverse Event|0|||
16373531|NCT00669331|39853200|FG000|Randomisation to First Dose|Protocol Violation|1|||
16373532|NCT00669331|39853201|FG001|Randomisation to First Dose|Protocol Violation|0|||
16373533|NCT00669331|39853200|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
16373534|NCT00669331|39853201|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
16373535|NCT00669331|39853200|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
16373536|NCT00669331|39853201|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
16373537|NCT00669331|39853200|FG000|Randomisation to First Dose|Death|1|||
16373538|NCT00669331|39853201|FG001|Randomisation to First Dose|Death|0|||
16373539|NCT00669331|39853200|FG000|Randomisation to First Dose|Sponsor decision|0|||
16373540|NCT00669331|39853201|FG001|Randomisation to First Dose|Sponsor decision|1|||
16373541|NCT00669331|39853200|FG000|Randomisation to First Dose|Randomised in error|3|||
16373542|NCT00669331|39853201|FG001|Randomisation to First Dose|Randomised in error|10|||
16373543|NCT00669331|39853200|FG000|Blinded Treatment Period|Adverse Event|16|||
16373544|NCT00669331|39853201|FG001|Blinded Treatment Period|Adverse Event|10|||
16373545|NCT00669331|39853200|FG000|Blinded Treatment Period|Protocol Violation|1|||
16373546|NCT00669331|39853201|FG001|Blinded Treatment Period|Protocol Violation|1|||
16164134|NCT00896532|39083694|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164135|NCT00896532|39083695|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164136|NCT00896532|39083696|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164137|NCT00896532|39083697|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164138|NCT00896532|39083698|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164139|NCT00896532|39083699|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164140|NCT00896532|39083700|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164141|NCT00896532|39083701|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16373547|NCT00669331|39853200|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
16373548|NCT00669331|39853201|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
16373549|NCT00669331|39853200|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
16451747|NCT00473382|40133472|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
16451748|NCT00473382|40133470|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
16451749|NCT00473382|40133471|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
16451750|NCT00473382|40133472|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
16451751|NCT00728689|40133473|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
16451752|NCT00728689|40133474|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
16451753|NCT01413204|40133479|FG000|Overall Study|Adverse Event|1|||
16451754|NCT01413204|40133480|FG001|Overall Study|Adverse Event|2|||
16451755|NCT01413204|40133481|FG002|Overall Study|Adverse Event|2|||
16451756|NCT01413204|40133479|FG000|Overall Study|Physician Decision|3|||
16451757|NCT01413204|40133480|FG001|Overall Study|Physician Decision|0|||
16451758|NCT01413204|40133481|FG002|Overall Study|Physician Decision|2|||
16451759|NCT01413204|40133479|FG000|Overall Study|Withdrawal by Subject|1|||
16451760|NCT01413204|40133480|FG001|Overall Study|Withdrawal by Subject|4|||
16451761|NCT01413204|40133481|FG002|Overall Study|Withdrawal by Subject|4|||
16451762|NCT01413204|40133479|FG000|Overall Study|Clearly not eligible for the study|0|||
16451763|NCT01413204|40133480|FG001|Overall Study|Clearly not eligible for the study|0|||
16451764|NCT01413204|40133481|FG002|Overall Study|Clearly not eligible for the study|1|||
16451765|NCT01413204|40133479|FG000|Overall Study|Fasting plasma glucose level increased|1|||
16451766|NCT01413204|40133480|FG001|Overall Study|Fasting plasma glucose level increased|0|||
16451767|NCT01413204|40133481|FG002|Overall Study|Fasting plasma glucose level increased|10|||
16451768|NCT01054885|40133482|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
16451769|NCT01054885|40133483|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16451770|NCT01054885|40133484|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16451771|NCT01054885|40133485|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16451772|NCT01054885|40133486|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16451773|NCT01054885|40133487|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16451774|NCT01054885|40133488|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
16451775|NCT01054885|40133482|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
16451776|NCT01054885|40133483|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
16451777|NCT01054885|40133484|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
16451778|NCT01054885|40133485|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
16451779|NCT01054885|40133486|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
16164142|NCT00896532|39083702|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164143|NCT00896532|39083703|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164144|NCT00896532|39083704|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164145|NCT00896532|39083705|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164146|NCT00896532|39083706|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164147|NCT00896532|39083707|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164148|NCT00896532|39083708|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164149|NCT00896532|39083709|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164150|NCT00896532|39083710|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
16164151|NCT00896532|39083688|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164152|NCT00896532|39083689|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
16164153|NCT00896532|39083690|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164154|NCT00896532|39083691|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
16164155|NCT00896532|39083692|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
16164156|NCT00896532|39083693|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164157|NCT00896532|39083694|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164158|NCT00896532|39083695|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164159|NCT00896532|39083696|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164160|NCT00896532|39083697|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164161|NCT00896532|39083698|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164162|NCT00896532|39083699|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164163|NCT00896532|39083700|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164164|NCT00896532|39083701|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164165|NCT00896532|39083702|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164166|NCT00896532|39083703|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164167|NCT00896532|39083704|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164168|NCT00896532|39083705|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164169|NCT00896532|39083706|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164170|NCT00896532|39083707|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164171|NCT00896532|39083708|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164172|NCT00896532|39083709|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164173|NCT00896532|39083710|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
16164174|NCT00896532|39083688|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164175|NCT00896532|39083689|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164176|NCT00896532|39083690|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164177|NCT00896532|39083691|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164178|NCT00896532|39083692|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164179|NCT00896532|39083693|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164180|NCT00896532|39083694|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164181|NCT00896532|39083695|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164182|NCT00896532|39083696|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
16164183|NCT00896532|39083697|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164184|NCT00896532|39083698|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164185|NCT00896532|39083699|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16373550|NCT00669331|39853201|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
16373551|NCT00669331|39853200|FG000|Blinded Treatment Period|Death|0|||
16373552|NCT00669331|39853201|FG001|Blinded Treatment Period|Death|2|||
16451780|NCT01054885|40133487|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
16451781|NCT01054885|40133488|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
16451782|NCT01054885|40133482|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
16451783|NCT01054885|40133483|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16451784|NCT01054885|40133484|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16451785|NCT01054885|40133485|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16451786|NCT01054885|40133486|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16451787|NCT01054885|40133487|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16451788|NCT01054885|40133488|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
16451789|NCT01054885|40133482|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
16451790|NCT01054885|40133483|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16451791|NCT01054885|40133484|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16451792|NCT01054885|40133485|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16451793|NCT01054885|40133486|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16451794|NCT01054885|40133487|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16451795|NCT01054885|40133488|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
16451796|NCT01054885|40133482|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
16451797|NCT01054885|40133483|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
16451798|NCT01054885|40133484|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
16451799|NCT01054885|40133485|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
16451800|NCT01054885|40133486|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
16451801|NCT01054885|40133487|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
16451802|NCT01054885|40133488|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
16451803|NCT01054885|40133482|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
16373553|NCT00669331|39853200|FG000|Blinded Treatment Period|Physician Decision|3|||
16373554|NCT00669331|39853201|FG001|Blinded Treatment Period|Physician Decision|3|||
16373555|NCT00669331|39853200|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
16373556|NCT00669331|39853201|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
16373557|NCT05425732|39853204|FG000|Overall Study|Death|4|||
16373558|NCT05425732|39853205|FG001|Overall Study|Death|2|||
16373559|NCT05425732|39853206|FG002|Overall Study|Death|0|||
16373560|NCT05425732|39853207|FG003|Overall Study|Death|0|||
16373561|NCT05425732|39853204|FG000|Overall Study|Lost to Follow-up|10|||
16373562|NCT05425732|39853205|FG001|Overall Study|Lost to Follow-up|15|||
16373563|NCT05425732|39853206|FG002|Overall Study|Lost to Follow-up|5|||
16373564|NCT05425732|39853207|FG003|Overall Study|Lost to Follow-up|3|||
16373565|NCT05425732|39853204|FG000|Overall Study|Physician Decision|0|||
16373566|NCT05425732|39853205|FG001|Overall Study|Physician Decision|2|||
16373567|NCT05425732|39853206|FG002|Overall Study|Physician Decision|0|||
16373568|NCT05425732|39853207|FG003|Overall Study|Physician Decision|0|||
16373569|NCT05425732|39853204|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
16373570|NCT05425732|39853205|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
16373571|NCT05425732|39853206|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16373572|NCT05425732|39853207|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16373573|NCT05425732|39853204|FG000|Overall Study|Withdrawal by Subject|4|||
16373574|NCT05425732|39853205|FG001|Overall Study|Withdrawal by Subject|8|||
16373575|NCT05425732|39853206|FG002|Overall Study|Withdrawal by Subject|1|||
16373576|NCT05425732|39853207|FG003|Overall Study|Withdrawal by Subject|1|||
16373577|NCT05425732|39853204|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
16373578|NCT05425732|39853205|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
16373579|NCT05425732|39853206|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
16373580|NCT05425732|39853207|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
16373581|NCT00281580|39853208|FG000|Overall Study|Adverse Event|2|||
16373582|NCT00281580|39853209|FG001|Overall Study|Adverse Event|0|||
16451804|NCT01054885|40133483|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16451805|NCT01054885|40133484|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16451806|NCT01054885|40133485|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16451807|NCT01054885|40133486|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16164186|NCT00896532|39083700|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16265394|NCT03233724|39453361|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
16265395|NCT03233724|39453362|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
16265396|NCT03233724|39453363|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
16265397|NCT03233724|39453364|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
16265398|NCT03233724|39453365|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
16265399|NCT04605094|39453368|FG000|Overall Study|Adverse Event|2|||
16265400|NCT04605094|39453369|FG001|Overall Study|Adverse Event|2|||
16265401|NCT04605094|39453368|FG000|Overall Study|Lost to Follow-up|1|||
16265402|NCT04605094|39453369|FG001|Overall Study|Lost to Follow-up|4|||
16373583|NCT00281580|39853210|FG002|Overall Study|Adverse Event|2|||
16373584|NCT00281580|39853211|FG003|Overall Study|Adverse Event|4|||
16373585|NCT00281580|39853212|FG004|Overall Study|Adverse Event|1|||
16373586|NCT00281580|39853213|FG005|Overall Study|Adverse Event|0|||
16373587|NCT00281580|39853214|FG006|Overall Study|Adverse Event|1|||
16373588|NCT00281580|39853215|FG007|Overall Study|Adverse Event|0|||
16373589|NCT00281580|39853216|FG008|Overall Study|Adverse Event|1|||
16373590|NCT00281580|39853217|FG009|Overall Study|Adverse Event|6|||
16373591|NCT00281580|39853218|FG010|Overall Study|Adverse Event|0|||
16373592|NCT00281580|39853219|FG011|Overall Study|Adverse Event|5|||
16373593|NCT00281580|39853220|FG012|Overall Study|Adverse Event|8|||
16373594|NCT00281580|39853221|FG013|Overall Study|Adverse Event|2|||
16373595|NCT00281580|39853222|FG014|Overall Study|Adverse Event|3|||
16373596|NCT00281580|39853223|FG015|Overall Study|Adverse Event|3|||
16373597|NCT00281580|39853208|FG000|Overall Study|Protocol Violation|0|||
16373598|NCT00281580|39853209|FG001|Overall Study|Protocol Violation|0|||
16373599|NCT00281580|39853210|FG002|Overall Study|Protocol Violation|1|||
16373600|NCT00281580|39853211|FG003|Overall Study|Protocol Violation|1|||
16373601|NCT00281580|39853212|FG004|Overall Study|Protocol Violation|0|||
16373602|NCT00281580|39853213|FG005|Overall Study|Protocol Violation|0|||
16373603|NCT00281580|39853214|FG006|Overall Study|Protocol Violation|1|||
16373604|NCT00281580|39853215|FG007|Overall Study|Protocol Violation|0|||
16373605|NCT00281580|39853216|FG008|Overall Study|Protocol Violation|2|||
16373606|NCT00281580|39853217|FG009|Overall Study|Protocol Violation|0|||
16373607|NCT00281580|39853218|FG010|Overall Study|Protocol Violation|1|||
16373608|NCT00281580|39853219|FG011|Overall Study|Protocol Violation|2|||
16373609|NCT00281580|39853220|FG012|Overall Study|Protocol Violation|0|||
16373610|NCT00281580|39853221|FG013|Overall Study|Protocol Violation|1|||
16373611|NCT00281580|39853222|FG014|Overall Study|Protocol Violation|1|||
16373612|NCT00281580|39853223|FG015|Overall Study|Protocol Violation|3|||
16373613|NCT00281580|39853208|FG000|Overall Study|Withdrawal by Subject|3|||
16373614|NCT00281580|39853209|FG001|Overall Study|Withdrawal by Subject|0|||
16373615|NCT00281580|39853210|FG002|Overall Study|Withdrawal by Subject|1|||
16373616|NCT00281580|39853211|FG003|Overall Study|Withdrawal by Subject|1|||
16373617|NCT00281580|39853212|FG004|Overall Study|Withdrawal by Subject|1|||
16373618|NCT00281580|39853213|FG005|Overall Study|Withdrawal by Subject|2|||
16373619|NCT00281580|39853214|FG006|Overall Study|Withdrawal by Subject|2|||
16373620|NCT00281580|39853215|FG007|Overall Study|Withdrawal by Subject|0|||
16373621|NCT00281580|39853216|FG008|Overall Study|Withdrawal by Subject|1|||
16373622|NCT00281580|39853217|FG009|Overall Study|Withdrawal by Subject|4|||
16373623|NCT00281580|39853218|FG010|Overall Study|Withdrawal by Subject|1|||
16373624|NCT00281580|39853219|FG011|Overall Study|Withdrawal by Subject|1|||
16373625|NCT00281580|39853220|FG012|Overall Study|Withdrawal by Subject|2|||
16373626|NCT00281580|39853221|FG013|Overall Study|Withdrawal by Subject|2|||
16373627|NCT00281580|39853222|FG014|Overall Study|Withdrawal by Subject|1|||
16373628|NCT00281580|39853223|FG015|Overall Study|Withdrawal by Subject|5|||
16373629|NCT00281580|39853208|FG000|Overall Study|Lack of Efficacy|2|||
16373630|NCT00281580|39853209|FG001|Overall Study|Lack of Efficacy|1|||
16373631|NCT00281580|39853210|FG002|Overall Study|Lack of Efficacy|1|||
16373632|NCT00281580|39853211|FG003|Overall Study|Lack of Efficacy|6|||
16373633|NCT00281580|39853212|FG004|Overall Study|Lack of Efficacy|2|||
16373634|NCT00281580|39853213|FG005|Overall Study|Lack of Efficacy|0|||
16373635|NCT00281580|39853214|FG006|Overall Study|Lack of Efficacy|0|||
16373636|NCT00281580|39853215|FG007|Overall Study|Lack of Efficacy|0|||
16373637|NCT00281580|39853216|FG008|Overall Study|Lack of Efficacy|0|||
16373638|NCT00281580|39853217|FG009|Overall Study|Lack of Efficacy|0|||
16373639|NCT00281580|39853218|FG010|Overall Study|Lack of Efficacy|0|||
16164187|NCT00896532|39083701|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16265403|NCT04605094|39453368|FG000|Overall Study|Physician Decision|2|||
16373640|NCT00281580|39853219|FG011|Overall Study|Lack of Efficacy|1|||
16265404|NCT04605094|39453369|FG001|Overall Study|Physician Decision|2|||
16373641|NCT00281580|39853220|FG012|Overall Study|Lack of Efficacy|0|||
16373642|NCT00281580|39853221|FG013|Overall Study|Lack of Efficacy|2|||
16265405|NCT04605094|39453368|FG000|Overall Study|Study terminated by Sponsor|31|||
16265406|NCT04605094|39453369|FG001|Overall Study|Study terminated by Sponsor|33|||
16265407|NCT04605094|39453368|FG000|Overall Study|Withdrawal by Subject|22|||
16265408|NCT04605094|39453369|FG001|Overall Study|Withdrawal by Subject|19|||
16265409|NCT04605094|39453368|FG000|Overall Study|Other|1|||
16265410|NCT04605094|39453369|FG001|Overall Study|Other|1|||
16265411|NCT03203447|39453376|FG000|Overall Study|Withdrawal by Subject|2|||
16265412|NCT03203447|39453377|FG001|Overall Study|Withdrawal by Subject|1|||
16265413|NCT03203447|39453376|FG000|Overall Study|Lost to Follow-up|1|||
16265414|NCT03203447|39453377|FG001|Overall Study|Lost to Follow-up|10|||
16265415|NCT03203447|39453376|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
16265416|NCT03203447|39453377|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
16265417|NCT03161405|39453381|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
16265418|NCT01848938|39453385|FG000|Overall Study|Lost to Follow-up|1|||
16265419|NCT01848938|39453386|FG001|Overall Study|Lost to Follow-up|1|||
16265420|NCT02558491|39453387|FG000|First Invention|Withdrawal by Subject|3|||
16451808|NCT01054885|40133487|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16451809|NCT01054885|40133488|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
16451810|NCT01054885|40133482|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
16451811|NCT01054885|40133483|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
16451812|NCT01054885|40133484|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
16451813|NCT01054885|40133485|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
16164188|NCT00896532|39083702|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164189|NCT00896532|39083703|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164190|NCT00896532|39083704|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164191|NCT00896532|39083705|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164192|NCT00896532|39083706|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164193|NCT00896532|39083707|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164194|NCT00896532|39083708|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164195|NCT00896532|39083709|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164196|NCT00896532|39083710|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
16164197|NCT00896532|39083688|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164198|NCT00896532|39083689|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164199|NCT00896532|39083690|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164200|NCT00896532|39083691|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164201|NCT00896532|39083692|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164202|NCT00896532|39083693|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164203|NCT00896532|39083694|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164204|NCT00896532|39083695|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164205|NCT00896532|39083696|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164206|NCT00896532|39083697|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164207|NCT00896532|39083698|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164208|NCT00896532|39083699|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164209|NCT00896532|39083700|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
16164210|NCT00896532|39083701|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164211|NCT00896532|39083702|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164212|NCT00896532|39083703|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164213|NCT00896532|39083704|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164214|NCT00896532|39083705|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164215|NCT00896532|39083706|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164216|NCT00896532|39083707|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164217|NCT00896532|39083708|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164218|NCT00896532|39083709|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164219|NCT00896532|39083710|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
16164220|NCT00896532|39083688|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164221|NCT00896532|39083689|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164222|NCT00896532|39083690|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164223|NCT00896532|39083691|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164224|NCT00896532|39083692|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164225|NCT00896532|39083693|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164226|NCT00896532|39083694|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164227|NCT00896532|39083695|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164228|NCT00896532|39083696|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164229|NCT00896532|39083697|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164230|NCT00896532|39083698|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
16265421|NCT02558491|39453388|FG001|First Invention|Withdrawal by Subject|1|||
16265422|NCT02558491|39453387|FG000|First Invention|Data collection issues|1|||
16164231|NCT00896532|39083699|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164232|NCT00896532|39083700|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
16164233|NCT00896532|39083701|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164234|NCT00896532|39083702|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164235|NCT00896532|39083703|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164236|NCT00896532|39083704|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164237|NCT00896532|39083705|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164238|NCT00896532|39083706|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164239|NCT00896532|39083707|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164240|NCT00896532|39083708|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164241|NCT00896532|39083709|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164242|NCT00896532|39083710|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
16164243|NCT00896532|39083688|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164244|NCT00896532|39083689|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164245|NCT00896532|39083690|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16265423|NCT02558491|39453388|FG001|First Invention|Data collection issues|0|||
16265424|NCT02558491|39453387|FG000|First Invention|Stopping criteria|0|||
16265425|NCT02558491|39453388|FG001|First Invention|Stopping criteria|1|||
16265426|NCT02558491|39453387|FG000|First Invention|Changed parameters during trial|1|||
16265427|NCT02558491|39453388|FG001|First Invention|Changed parameters during trial|0|||
16265428|NCT02558491|39453387|FG000|Second Intervention|Withdrawal by Subject|1|||
16265429|NCT02558491|39453388|FG001|Second Intervention|Withdrawal by Subject|0|||
16265430|NCT02558491|39453387|FG000|Second Intervention|Stopping Criteria|1|||
16265431|NCT02558491|39453388|FG001|Second Intervention|Stopping Criteria|0|||
16164246|NCT00896532|39083691|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164247|NCT00896532|39083692|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164248|NCT00896532|39083693|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164249|NCT00896532|39083694|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164250|NCT00896532|39083695|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164251|NCT00896532|39083696|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164252|NCT00896532|39083697|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164253|NCT00896532|39083698|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164254|NCT00896532|39083699|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164255|NCT00896532|39083700|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
16164256|NCT00896532|39083701|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
16265432|NCT02659150|39453389|FG000|Subject Enrollment|Physician Decision|3|||
16265433|NCT02659150|39453389|FG000|Subject Enrollment|Withdrawal by Subject|2|||
16265434|NCT02659150|39453389|FG000|Baseline Imaging|Withdrawal by Subject|1|||
16265435|NCT02659150|39453389|FG000|Baseline Imaging|Physician Decision|1|||
16265436|NCT02659150|39453389|FG000|Study Drug Dosing|Adverse Event|1|||
16265437|NCT00834795|39453390|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
16265438|NCT00834795|39453391|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
16265439|NCT00834795|39453390|FG000|Second Intervention|Adverse Event|1|||
16265440|NCT00834795|39453391|FG001|Second Intervention|Adverse Event|0|||
16265441|NCT04032977|39453393|FG000|Overall Study|Withdrawal by Subject|6|||
16265442|NCT04032977|39453394|FG001|Overall Study|Withdrawal by Subject|1|||
16265443|NCT04032977|39453393|FG000|Overall Study|Lost to Follow-up|2|||
16265444|NCT04032977|39453394|FG001|Overall Study|Lost to Follow-up|7|||
16265445|NCT04032977|39453393|FG000|Overall Study|Pregnancy|1|||
16265446|NCT04032977|39453394|FG001|Overall Study|Pregnancy|0|||
16265447|NCT03450057|39453395|FG000|Overall Study|Death|17|||
16265448|NCT03450057|39453395|FG000|Overall Study|ICF withdrawal|4|||
16265449|NCT03450057|39453395|FG000|Overall Study|Lost to Follow-up|2|||
16265450|NCT00633594|39453396|FG000|Overall Study|Adverse Event|0|||
16265451|NCT00633594|39453397|FG001|Overall Study|Adverse Event|4|||
16265452|NCT00633594|39453398|FG002|Overall Study|Adverse Event|7|||
16265453|NCT00633594|39453396|FG000|Overall Study|Death|0|||
16265454|NCT00633594|39453397|FG001|Overall Study|Death|1|||
16265455|NCT00633594|39453398|FG002|Overall Study|Death|2|||
16265456|NCT00633594|39453396|FG000|Overall Study|Disease Progression|0|||
16265457|NCT00633594|39453397|FG001|Overall Study|Disease Progression|0|||
16265458|NCT00633594|39453398|FG002|Overall Study|Disease Progression|1|||
16265459|NCT01030133|39453399|FG000|Overall Study|failed to experience pain at level 7/10|2|||
16265460|NCT01030133|39453400|FG001|Overall Study|failed to experience pain at level 7/10|2|||
16265461|NCT02624050|39456582|FG000|Overall Study|Physician Decision|4|||
16265462|NCT02624050|39456583|FG001|Overall Study|Physician Decision|0|||
16265463|NCT02624050|39456582|FG000|Overall Study|Protocol Violation|2|||
16265464|NCT02624050|39456583|FG001|Overall Study|Protocol Violation|0|||
16265465|NCT01038856|39456584|FG000|Overall Study|Adverse Event|2|||
16265466|NCT04827394|39456585|FG000|Overall Study|Physician Decision|0|||
16265467|NCT04827394|39456586|FG001|Overall Study|Physician Decision|2|||
16265468|NCT00849901|39456588|FG000|Acute Treatment Phase|Adverse Event|9|||
16164257|NCT00896532|39083702|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164258|NCT00896532|39083703|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164259|NCT00896532|39083704|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164260|NCT00896532|39083705|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164261|NCT00896532|39083706|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164262|NCT00896532|39083707|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164263|NCT00896532|39083708|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164264|NCT00896532|39083709|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164265|NCT00896532|39083710|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
16164266|NCT00896532|39083688|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
16164267|NCT00896532|39083689|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
16164268|NCT00896532|39083690|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
16164269|NCT00896532|39083691|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
16164270|NCT00896532|39083692|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
16164271|NCT00896532|39083693|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
16164272|NCT00896532|39083694|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
16164273|NCT00896532|39083695|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
16164274|NCT00896532|39083696|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
16164275|NCT00896532|39083697|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
16164276|NCT00896532|39083698|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
16164277|NCT00896532|39083699|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
16164278|NCT00896532|39083700|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
16164279|NCT00896532|39083701|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
16164280|NCT00896532|39083702|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
16164281|NCT00896532|39083703|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
16164282|NCT00896532|39083704|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
16164283|NCT00896532|39083705|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
16164284|NCT00896532|39083706|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
16164285|NCT00896532|39083707|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
16164286|NCT00896532|39083708|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
16164287|NCT00896532|39083709|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
16164288|NCT00896532|39083710|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
16164289|NCT00896532|39083688|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164290|NCT00896532|39083689|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164291|NCT00896532|39083690|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164292|NCT00896532|39083691|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164293|NCT00896532|39083692|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164294|NCT00896532|39083693|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164295|NCT00896532|39083694|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164296|NCT00896532|39083695|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164297|NCT00896532|39083696|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164298|NCT00896532|39083697|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164299|NCT00896532|39083698|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164300|NCT00896532|39083699|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164301|NCT00896532|39083700|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164302|NCT00896532|39083701|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164303|NCT00896532|39083702|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164304|NCT00896532|39083703|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
16164305|NCT00896532|39083704|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
16164306|NCT00896532|39083705|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164307|NCT00896532|39083706|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164308|NCT00896532|39083707|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164309|NCT00896532|39083708|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164310|NCT00896532|39083709|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164311|NCT00896532|39083710|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
16164312|NCT00896532|39083688|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164313|NCT00896532|39083689|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164314|NCT00896532|39083690|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164315|NCT00896532|39083691|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164316|NCT00896532|39083692|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164317|NCT00896532|39083693|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164318|NCT00896532|39083694|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164319|NCT00896532|39083695|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164320|NCT00896532|39083696|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16373643|NCT00281580|39853222|FG014|Overall Study|Lack of Efficacy|1|||
16451814|NCT01054885|40133486|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
16164321|NCT00896532|39083697|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164322|NCT00896532|39083698|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164323|NCT00896532|39083699|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164324|NCT00896532|39083700|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164325|NCT00896532|39083701|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164326|NCT00896532|39083702|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164327|NCT00896532|39083703|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
16164328|NCT00896532|39083704|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
16164329|NCT00896532|39083705|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
16164330|NCT00896532|39083706|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164331|NCT00896532|39083707|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16373644|NCT00281580|39853223|FG015|Overall Study|Lack of Efficacy|0|||
16373645|NCT00281580|39853208|FG000|Overall Study|Lost to Follow-up|0|||
16373646|NCT00281580|39853209|FG001|Overall Study|Lost to Follow-up|0|||
16373647|NCT00281580|39853210|FG002|Overall Study|Lost to Follow-up|0|||
16373648|NCT00281580|39853211|FG003|Overall Study|Lost to Follow-up|3|||
16373649|NCT00281580|39853212|FG004|Overall Study|Lost to Follow-up|0|||
16373650|NCT00281580|39853213|FG005|Overall Study|Lost to Follow-up|1|||
16373651|NCT00281580|39853214|FG006|Overall Study|Lost to Follow-up|0|||
16373652|NCT00281580|39853215|FG007|Overall Study|Lost to Follow-up|1|||
16373653|NCT00281580|39853216|FG008|Overall Study|Lost to Follow-up|2|||
16373654|NCT00281580|39853217|FG009|Overall Study|Lost to Follow-up|1|||
16373655|NCT00281580|39853218|FG010|Overall Study|Lost to Follow-up|1|||
16373656|NCT00281580|39853219|FG011|Overall Study|Lost to Follow-up|0|||
16373657|NCT00281580|39853220|FG012|Overall Study|Lost to Follow-up|1|||
16373658|NCT00281580|39853221|FG013|Overall Study|Lost to Follow-up|0|||
16373659|NCT00281580|39853222|FG014|Overall Study|Lost to Follow-up|0|||
16373660|NCT00281580|39853223|FG015|Overall Study|Lost to Follow-up|0|||
16373661|NCT00281580|39853208|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
16373662|NCT00281580|39853209|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
16373663|NCT00281580|39853210|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
16373664|NCT00281580|39853211|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
16373665|NCT00281580|39853212|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
16373666|NCT00281580|39853213|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
16373667|NCT00281580|39853214|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
16373668|NCT00281580|39853215|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
16373669|NCT00281580|39853216|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
16373670|NCT00281580|39853217|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
16373671|NCT00281580|39853218|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
16373672|NCT00281580|39853219|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
16373673|NCT00281580|39853220|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
16373674|NCT00281580|39853221|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
16373675|NCT00281580|39853222|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
16373676|NCT00281580|39853223|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
16373677|NCT00762788|39853224|FG000|Overall Study|Lost to Follow-up|26|||
16373678|NCT00762788|39853225|FG001|Overall Study|Lost to Follow-up|37|||
16373679|NCT00762788|39853226|FG002|Overall Study|Lost to Follow-up|21|||
16373680|NCT00762788|39853227|FG003|Overall Study|Lost to Follow-up|26|||
16373681|NCT00762788|39853228|FG004|Overall Study|Lost to Follow-up|13|||
16373682|NCT00762788|39853229|FG005|Overall Study|Lost to Follow-up|21|||
16373683|NCT02143778|39853232|FG000|Overall Study|Withdrawal by Subject|2|||
16373684|NCT02143778|39853232|FG000|Overall Study|Device malfunction|1|||
16164332|NCT00896532|39083708|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16373685|NCT04439357|39853233|FG000|Overall Study|Disease Progression|4|||
16373686|NCT04105725|39853234|FG000|Primary Intervention|Lost to Follow-up|0|||
16373687|NCT04105725|39853235|FG001|Primary Intervention|Lost to Follow-up|2|||
16373688|NCT04105725|39853234|FG000|Primary Intervention|Withdrawal by Subject|0|||
16373689|NCT04105725|39853235|FG001|Primary Intervention|Withdrawal by Subject|1|||
16373690|NCT02070380|39853236|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
16373691|NCT02070380|39853237|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
16373692|NCT02070380|39853238|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
16373693|NCT02070380|39853239|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
16373694|NCT02070380|39853236|FG000|Second Injection|Image sets missing or technically inadeq|0|||
16373695|NCT02070380|39853237|FG001|Second Injection|Image sets missing or technically inadeq|1|||
16373696|NCT02070380|39853238|FG002|Second Injection|Image sets missing or technically inadeq|0|||
16451815|NCT01054885|40133487|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
16164333|NCT00896532|39083709|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164334|NCT00896532|39083710|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
16164335|NCT00896532|39083688|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164336|NCT00896532|39083689|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164337|NCT00896532|39083690|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164338|NCT00896532|39083691|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164339|NCT00896532|39083692|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16265469|NCT00849901|39456589|FG001|Acute Treatment Phase|Adverse Event|1|||
16265470|NCT00849901|39456590|FG002|Acute Treatment Phase|Adverse Event|3|||
16265471|NCT00849901|39456588|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
16265472|NCT00849901|39456589|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
16265473|NCT00849901|39456590|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
16265474|NCT00849901|39456588|FG000|Acute Treatment Phase|Protocol Violation|0|||
16265475|NCT00849901|39456589|FG001|Acute Treatment Phase|Protocol Violation|2|||
16265476|NCT00849901|39456590|FG002|Acute Treatment Phase|Protocol Violation|1|||
16265477|NCT00849901|39456588|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
16265478|NCT00849901|39456589|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
16265479|NCT00849901|39456590|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
16265480|NCT00849901|39456588|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
16265481|NCT00849901|39456589|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
16265482|NCT00849901|39456590|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
16265483|NCT00849901|39456588|FG000|Acute Treatment Phase|Physician Decision|1|||
16265484|NCT00849901|39456589|FG001|Acute Treatment Phase|Physician Decision|1|||
16265485|NCT00849901|39456590|FG002|Acute Treatment Phase|Physician Decision|1|||
16265486|NCT00849901|39456588|FG000|Acute Treatment Phase|Sponsor Decision|1|||
16265487|NCT00849901|39456589|FG001|Acute Treatment Phase|Sponsor Decision|0|||
16265488|NCT00849901|39456590|FG002|Acute Treatment Phase|Sponsor Decision|0|||
16265489|NCT00849901|39456588|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
16265490|NCT00849901|39456589|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
16265491|NCT00849901|39456590|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
16265492|NCT00849901|39456588|FG000|Extension Phase|Adverse Event|2|||
16265493|NCT00849901|39456589|FG001|Extension Phase|Adverse Event|8|||
16373697|NCT02070380|39853239|FG003|Second Injection|Image sets missing or technically inadeq|0|||
16373698|NCT02070380|39853236|FG000|Second Injection|Protocol Violation|0|||
16373699|NCT02070380|39853237|FG001|Second Injection|Protocol Violation|1|||
16373700|NCT02070380|39853238|FG002|Second Injection|Protocol Violation|1|||
16373701|NCT02070380|39853239|FG003|Second Injection|Protocol Violation|5|||
16373702|NCT00819832|39853240|FG000|Overall Study|Sponsor Termination of Study|3|||
16373703|NCT00819832|39853241|FG001|Overall Study|Sponsor Termination of Study|0|||
16373704|NCT00819832|39853242|FG002|Overall Study|Sponsor Termination of Study|0|||
16373705|NCT00819832|39853243|FG003|Overall Study|Sponsor Termination of Study|0|||
16373706|NCT00819832|39853244|FG004|Overall Study|Sponsor Termination of Study|0|||
16373707|NCT00819832|39853245|FG005|Overall Study|Sponsor Termination of Study|0|||
16373708|NCT01903720|39853249|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
16373709|NCT01903720|39853249|FG000|Overall Study|Adverse Event|1|||
16373710|NCT01903720|39853249|FG000|Overall Study|Rescinding of informed consent|2|||
16373711|NCT01903720|39853249|FG000|Overall Study|Lost to Follow-up|2|||
16373712|NCT01903720|39853249|FG000|Overall Study|Treatment with alternative drug|1|||
16373713|NCT00504231|39853250|FG000|Overall Study|Discrepant chart documentation re route|0|||
16373714|NCT00504231|39853251|FG001|Overall Study|Discrepant chart documentation re route|0|||
16373715|NCT00504231|39853252|FG002|Overall Study|Discrepant chart documentation re route|1|||
16373716|NCT00504231|39853253|FG003|Overall Study|Discrepant chart documentation re route|0|||
16373717|NCT00754559|39853254|FG000|Overall Study|Adverse Event|15|||
16373718|NCT00754559|39853254|FG000|Overall Study|Protocol Violation|11|||
16373719|NCT00754559|39853254|FG000|Overall Study|Lack of Efficacy|10|||
16373720|NCT00754559|39853254|FG000|Overall Study|Lost to Follow-up|2|||
16373721|NCT00754559|39853254|FG000|Overall Study|Administrative reason|1|||
16373722|NCT00754559|39853254|FG000|Overall Study|Other|5|||
16373723|NCT00754559|39853254|FG000|Overall Study|Withdrawal by Subject|3|||
16373724|NCT00825175|39853255|FG000|Overall Study|Withdrawal by Subject|0|||
16373725|NCT00825175|39853256|FG001|Overall Study|Withdrawal by Subject|5|||
16373726|NCT01065766|39853259|FG000|Overall Study|Assessed before the contracted date|1|||
16373727|NCT01065766|39853259|FG000|Overall Study|Contraindication to administration|6|||
16373728|NCT01065766|39853259|FG000|Overall Study|Violated dosage/administration|25|||
16373729|NCT01657500|39853260|FG000|Overall Study|set impropperly matched|3|||
16373730|NCT01657500|39853261|FG001|Overall Study|set impropperly matched|3|||
16373731|NCT01657500|39853260|FG000|Overall Study|Lost to Follow-up|2|||
16373732|NCT01657500|39853261|FG001|Overall Study|Lost to Follow-up|2|||
16373733|NCT03073109|39853266|FG000|Overall Study|Adverse Event|0|||
16373734|NCT03073109|39853267|FG001|Overall Study|Adverse Event|1|||
16373735|NCT03073109|39853266|FG000|Overall Study|Other|2|||
16373736|NCT03073109|39853267|FG001|Overall Study|Other|0|||
16373737|NCT03073109|39853266|FG000|Overall Study|Lost to Follow-up|8|||
16373738|NCT03073109|39853267|FG001|Overall Study|Lost to Follow-up|1|||
16373739|NCT00983957|39853271|FG000|Overall Study|Adverse Event|1|||
16373740|NCT00983957|39853271|FG000|Overall Study|Personal Reasons|1|||
16373741|NCT00621322|39853274|FG000|Overall Study|Lost to Follow-up|0|||
16451816|NCT01054885|40133488|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
16451817|NCT01054885|40133482|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16451818|NCT01054885|40133483|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16451819|NCT01054885|40133484|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
16451820|NCT01054885|40133485|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
16451821|NCT01054885|40133486|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16164340|NCT00896532|39083693|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164341|NCT00896532|39083694|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16265494|NCT00849901|39456590|FG002|Extension Phase|Adverse Event|4|||
16373742|NCT00621322|39853275|FG001|Overall Study|Lost to Follow-up|0|||
16373743|NCT00621322|39853276|FG002|Overall Study|Lost to Follow-up|0|||
16373744|NCT00621322|39853277|FG003|Overall Study|Lost to Follow-up|0|||
16373745|NCT00621322|39853278|FG004|Overall Study|Lost to Follow-up|1|||
16373746|NCT00621322|39853279|FG005|Overall Study|Lost to Follow-up|0|||
16373747|NCT00621322|39853274|FG000|Overall Study|Physician Decision|0|||
16373748|NCT00621322|39853275|FG001|Overall Study|Physician Decision|0|||
16373749|NCT00621322|39853276|FG002|Overall Study|Physician Decision|1|||
16373750|NCT00621322|39853277|FG003|Overall Study|Physician Decision|1|||
16373751|NCT00621322|39853278|FG004|Overall Study|Physician Decision|0|||
16373752|NCT00621322|39853279|FG005|Overall Study|Physician Decision|0|||
16164342|NCT00896532|39083695|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164343|NCT00896532|39083696|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164344|NCT00896532|39083697|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164345|NCT00896532|39083698|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164346|NCT00896532|39083699|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164347|NCT00896532|39083700|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164348|NCT00896532|39083701|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164349|NCT00896532|39083702|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164350|NCT00896532|39083703|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164351|NCT00896532|39083704|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
16164352|NCT00896532|39083705|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16265495|NCT00849901|39456588|FG000|Extension Phase|Lost to Follow-up|3|||
16265496|NCT00849901|39456589|FG001|Extension Phase|Lost to Follow-up|0|||
16265497|NCT00849901|39456590|FG002|Extension Phase|Lost to Follow-up|1|||
16265498|NCT00849901|39456588|FG000|Extension Phase|Protocol Violation|2|||
16265499|NCT00849901|39456589|FG001|Extension Phase|Protocol Violation|2|||
16265500|NCT00849901|39456590|FG002|Extension Phase|Protocol Violation|4|||
16265501|NCT00849901|39456588|FG000|Extension Phase|Withdrawal by Subject|7|||
16265502|NCT00849901|39456589|FG001|Extension Phase|Withdrawal by Subject|6|||
16265503|NCT00849901|39456590|FG002|Extension Phase|Withdrawal by Subject|3|||
16265504|NCT00849901|39456588|FG000|Extension Phase|Parent or Caregiver Decision|10|||
16265505|NCT00849901|39456589|FG001|Extension Phase|Parent or Caregiver Decision|4|||
16265506|NCT00849901|39456590|FG002|Extension Phase|Parent or Caregiver Decision|4|||
16265507|NCT00849901|39456588|FG000|Extension Phase|Physician Decision|1|||
16265508|NCT00849901|39456589|FG001|Extension Phase|Physician Decision|2|||
16265509|NCT00849901|39456590|FG002|Extension Phase|Physician Decision|0|||
16265510|NCT00849901|39456588|FG000|Extension Phase|Lack of Efficacy|2|||
16265511|NCT00849901|39456589|FG001|Extension Phase|Lack of Efficacy|4|||
16265512|NCT00849901|39456590|FG002|Extension Phase|Lack of Efficacy|1|||
16265513|NCT04633564|39456597|FG000|Period 1|Adverse Event|28|||
16265514|NCT04633564|39456598|FG001|Period 1|Adverse Event|19|||
16265515|NCT04633564|39456597|FG000|Period 1|Death|8|||
16265516|NCT04633564|39456598|FG001|Period 1|Death|7|||
16265517|NCT04633564|39456597|FG000|Period 1|Lost to Follow-up|3|||
16265518|NCT04633564|39456598|FG001|Period 1|Lost to Follow-up|5|||
16265519|NCT04633564|39456597|FG000|Period 1|Physician Decision|4|||
16265520|NCT04633564|39456598|FG001|Period 1|Physician Decision|12|||
16265521|NCT04633564|39456597|FG000|Period 1|Protocol Violation|0|||
16265522|NCT04633564|39456598|FG001|Period 1|Protocol Violation|1|||
16265523|NCT04633564|39456597|FG000|Period 1|Withdrawal by Subject|10|||
16265524|NCT04633564|39456598|FG001|Period 1|Withdrawal by Subject|8|||
16265525|NCT04633564|39456597|FG000|Period 1|Progressive disease|47|||
16265526|NCT04633564|39456598|FG001|Period 1|Progressive disease|51|||
16265527|NCT04633564|39456597|FG000|Period 1|Terminated by Sponsor|8|||
16373753|NCT00621322|39853274|FG000|Overall Study|Withdrawal by Subject|0|||
16265528|NCT04633564|39456598|FG001|Period 1|Terminated by Sponsor|6|||
16265529|NCT04633564|39456597|FG000|Period 2|Adverse Event|3|||
16265530|NCT04633564|39456598|FG001|Period 2|Adverse Event|4|||
16265531|NCT04633564|39456597|FG000|Period 2|Death|0|||
16265532|NCT04633564|39456598|FG001|Period 2|Death|2|||
16265533|NCT04633564|39456597|FG000|Period 2|Lost to Follow-up|0|||
16265534|NCT04633564|39456598|FG001|Period 2|Lost to Follow-up|1|||
16265535|NCT04633564|39456597|FG000|Period 2|Physician Decision|2|||
16265536|NCT04633564|39456598|FG001|Period 2|Physician Decision|4|||
16265537|NCT04633564|39456597|FG000|Period 2|Withdrawal by Subject|5|||
16373754|NCT00621322|39853275|FG001|Overall Study|Withdrawal by Subject|0|||
16451822|NCT01054885|40133487|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
16451823|NCT01054885|40133488|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
16451824|NCT01054885|40133482|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
16451825|NCT01054885|40133483|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
16451826|NCT01054885|40133484|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
16451827|NCT01054885|40133485|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
16451828|NCT01054885|40133486|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
16451829|NCT01054885|40133487|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
16451830|NCT01054885|40133488|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
16451831|NCT01054885|40133482|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
16451832|NCT01054885|40133483|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
16451833|NCT01054885|40133484|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
16451834|NCT01054885|40133485|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
16451835|NCT01054885|40133486|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
16451836|NCT01054885|40133487|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
16451837|NCT01054885|40133488|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
16451838|NCT01054885|40133482|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
16451839|NCT01054885|40133483|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
16451840|NCT01054885|40133484|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
16451841|NCT01054885|40133485|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
16451842|NCT01054885|40133486|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
16451843|NCT01054885|40133487|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
16451844|NCT01054885|40133488|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
16451845|NCT01054885|40133482|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
16451846|NCT01054885|40133483|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
16451847|NCT01054885|40133484|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
16451848|NCT01054885|40133485|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
16451849|NCT01054885|40133486|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
16451850|NCT01054885|40133487|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
16451851|NCT01054885|40133488|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
16451852|NCT01054885|40133482|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16451853|NCT01054885|40133483|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
16451854|NCT01054885|40133484|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
16451855|NCT01054885|40133485|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16451856|NCT01054885|40133486|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
16451857|NCT01054885|40133487|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
16451858|NCT01054885|40133488|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
16451859|NCT01054885|40133482|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
16451860|NCT01054885|40133483|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
16451861|NCT01054885|40133484|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
16451862|NCT01054885|40133485|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
16451863|NCT01054885|40133486|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
16451864|NCT01054885|40133487|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
16451865|NCT01054885|40133488|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
16451866|NCT01054885|40133482|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
16451867|NCT01054885|40133483|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
16451868|NCT01054885|40133484|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
16451869|NCT01054885|40133485|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
16451870|NCT01054885|40133486|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
16451871|NCT01054885|40133487|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
16451872|NCT01054885|40133488|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
16451873|NCT04540913|40133489|FG000|Overall Study|Withdrawal by Subject|14|||
16451874|NCT04540913|40133490|FG001|Overall Study|Withdrawal by Subject|3|||
16451875|NCT00711191|40133491|FG000|Overall Study|Adverse Event|1|||
16451876|NCT00711191|40133492|FG001|Overall Study|Adverse Event|1|||
16451877|NCT00711191|40133493|FG002|Overall Study|Adverse Event|2|||
16451878|NCT00711191|40133491|FG000|Overall Study|Objective progression or relapse|2|||
16451879|NCT00711191|40133492|FG001|Overall Study|Objective progression or relapse|3|||
16451880|NCT00711191|40133493|FG002|Overall Study|Objective progression or relapse|7|||
16451881|NCT00711191|40133491|FG000|Overall Study|Withdrawal by Subject|0|||
16451882|NCT00711191|40133492|FG001|Overall Study|Withdrawal by Subject|1|||
16451883|NCT00711191|40133493|FG002|Overall Study|Withdrawal by Subject|3|||
16164353|NCT00896532|39083706|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16451884|NCT00357552|40133496|FG000|Screening|Did not meet eligibility criteria|84|||
16451885|NCT00357552|40133496|FG000|Weeks 0 to 24|Death|1|||
16451886|NCT00357552|40133496|FG000|Weeks 24 to 104|Death|3|||
16451887|NCT00357552|40133496|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
16451888|NCT01657019|40133498|FG000|Overall Study|Withdrawal by Subject|65|||
16451889|NCT01657019|40133498|FG000|Overall Study|Adverse Event|55|||
16164354|NCT00896532|39083707|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164355|NCT00896532|39083708|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164356|NCT00896532|39083709|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164357|NCT00896532|39083710|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
16164358|NCT00896532|39083688|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
16164359|NCT00896532|39083689|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
16164360|NCT00896532|39083690|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
16164361|NCT00896532|39083691|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
16164362|NCT00896532|39083692|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
16164363|NCT00896532|39083693|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
16164364|NCT00896532|39083694|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
16265538|NCT04633564|39456598|FG001|Period 2|Withdrawal by Subject|1|||
16265539|NCT04633564|39456597|FG000|Period 2|Progressive Disease|74|||
16265540|NCT04633564|39456598|FG001|Period 2|Progressive Disease|82|||
16265541|NCT04633564|39456597|FG000|Period 2|Terminated by Sponsor|9|||
16265542|NCT04633564|39456598|FG001|Period 2|Terminated by Sponsor|3|||
16265543|NCT00124618|39456599|FG000|Overall Study|Ineligible|1|||
16265544|NCT01873586|39456601|FG000|Overall Study|Lost to Follow-up|3|||
16265545|NCT04123548|39456602|FG000|Overall Study|Withdrawal by Subject|1|||
16265546|NCT04123548|39456602|FG000|Overall Study|Lost to Follow-up|8|||
16265547|NCT04123548|39456602|FG000|Overall Study|Death|4|||
16265548|NCT04123548|39456602|FG000|Overall Study|Reason Not Specified|1|||
16265549|NCT03273153|39456603|FG000|Overall Study|Adverse Event|1|||
16373755|NCT00621322|39853276|FG002|Overall Study|Withdrawal by Subject|0|||
16373756|NCT00621322|39853277|FG003|Overall Study|Withdrawal by Subject|1|||
16373757|NCT00621322|39853278|FG004|Overall Study|Withdrawal by Subject|0|||
16373758|NCT00621322|39853279|FG005|Overall Study|Withdrawal by Subject|2|||
16373759|NCT00621322|39853274|FG000|Overall Study|Migrated/moved from study area|1|||
16373760|NCT00621322|39853275|FG001|Overall Study|Migrated/moved from study area|0|||
16373761|NCT00621322|39853276|FG002|Overall Study|Migrated/moved from study area|1|||
16373762|NCT00621322|39853277|FG003|Overall Study|Migrated/moved from study area|1|||
16373763|NCT00621322|39853278|FG004|Overall Study|Migrated/moved from study area|0|||
16373764|NCT00621322|39853279|FG005|Overall Study|Migrated/moved from study area|2|||
16373765|NCT03954938|39853283|FG000|Overall Study|Withdrawal by Subject|2|||
16373766|NCT03954938|39853283|FG000|Overall Study|Adverse Event|1|||
16373767|NCT03566550|39853286|FG000|Overall Study|Withdrawal by Subject|0|||
16373768|NCT03566550|39853287|FG001|Overall Study|Withdrawal by Subject|1|||
16373769|NCT02642679|39853288|FG000|Overall Study|Withdrawal by Subject|1|||
16373770|NCT02642679|39853288|FG000|Overall Study|Physician Decision|1|||
16373771|NCT02642679|39853288|FG000|Overall Study|Physician Decision|1|||
16373772|NCT04186806|39853289|FG000|Period 1: 7 Days|Adverse Event|1|||
16373773|NCT04186806|39853290|FG001|Period 1: 7 Days|Adverse Event|0|||
16373774|NCT01478087|39853291|FG000|Overall Study|due to sponsor closing study|1|||
16373775|NCT01663987|39853293|FG000|Overall Study|Adverse Event|7|||
16373776|NCT01663987|39853294|FG001|Overall Study|Adverse Event|2|||
16373777|NCT01663987|39853293|FG000|Overall Study|Lost to Follow-up|1|||
16373778|NCT01663987|39853294|FG001|Overall Study|Lost to Follow-up|1|||
16373779|NCT01663987|39853293|FG000|Overall Study|Withdrawal by Subject|2|||
16373780|NCT01663987|39853294|FG001|Overall Study|Withdrawal by Subject|3|||
16373781|NCT01663987|39853293|FG000|Overall Study|Other reason not defined above|3|||
16373782|NCT01663987|39853294|FG001|Overall Study|Other reason not defined above|0|||
16373783|NCT00160615|39853301|FG000|Overall Study|Adverse Event|5|||
16373784|NCT00160615|39853302|FG001|Overall Study|Adverse Event|12|||
16373785|NCT00160615|39853301|FG000|Overall Study|Withdrawal by Subject|0|||
16373786|NCT00160615|39853302|FG001|Overall Study|Withdrawal by Subject|2|||
16373787|NCT00160615|39853301|FG000|Overall Study|Lack of Efficacy|11|||
16373788|NCT00160615|39853302|FG001|Overall Study|Lack of Efficacy|23|||
16373789|NCT00160615|39853301|FG000|Overall Study|Patient decision|1|||
16265550|NCT03273153|39456604|FG001|Overall Study|Adverse Event|2|||
16265551|NCT03273153|39456603|FG000|Overall Study|Missing|0|||
16373790|NCT00160615|39853302|FG001|Overall Study|Patient decision|2|||
16451890|NCT01657019|40133498|FG000|Overall Study|Lost to Follow-up|48|||
16373791|NCT00160615|39853301|FG000|Overall Study|Investigator decision|1|||
16164365|NCT00896532|39083695|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
16265552|NCT03273153|39456604|FG001|Overall Study|Missing|2|||
16373792|NCT00160615|39853302|FG001|Overall Study|Investigator decision|1|||
16451891|NCT01657019|40133498|FG000|Overall Study|Protocol Violation|6|||
16451892|NCT01657019|40133498|FG000|Overall Study|Lack of Efficacy|3|||
16451893|NCT01657019|40133498|FG000|Overall Study|Other|58|||
16373793|NCT00160615|39853301|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
16265553|NCT03273153|39456603|FG000|Overall Study|Other|3|||
16265554|NCT03273153|39456604|FG001|Overall Study|Other|2|||
16265555|NCT03273153|39456603|FG000|Overall Study|Symptomatic Deterioration|0|||
16265556|NCT03273153|39456604|FG001|Overall Study|Symptomatic Deterioration|1|||
16265557|NCT03273153|39456603|FG000|Overall Study|Progressive Disease|6|||
16265558|NCT03273153|39456604|FG001|Overall Study|Progressive Disease|5|||
16265559|NCT03273153|39456603|FG000|Overall Study|Physician Decision|1|||
16265560|NCT03273153|39456604|FG001|Overall Study|Physician Decision|3|||
16265561|NCT03273153|39456603|FG000|Overall Study|Study Terminated by Sponsor|112|||
16265562|NCT03273153|39456604|FG001|Overall Study|Study Terminated by Sponsor|102|||
16265563|NCT03273153|39456603|FG000|Overall Study|Withdrawal by Subject|26|||
16265564|NCT03273153|39456604|FG001|Overall Study|Withdrawal by Subject|25|||
16265565|NCT03273153|39456603|FG000|Overall Study|Protocol Deviation|3|||
16265566|NCT03273153|39456604|FG001|Overall Study|Protocol Deviation|0|||
16265567|NCT03273153|39456603|FG000|Overall Study|Lost to Follow-up|6|||
16265568|NCT03273153|39456604|FG001|Overall Study|Lost to Follow-up|11|||
16265569|NCT03273153|39456603|FG000|Overall Study|Death|66|||
16265570|NCT03273153|39456604|FG001|Overall Study|Death|69|||
16265571|NCT01370317|39456607|FG000|Overall Study|Participant withdrew consent|1|||
16265572|NCT01370317|39456608|FG001|Overall Study|Participant withdrew consent|0|||
16265573|NCT01370317|39456607|FG000|Overall Study|Protocol deviation|0|||
16265574|NCT01370317|39456608|FG001|Overall Study|Protocol deviation|1|||
16265575|NCT02632344|39456609|FG000|Overall Study|Adverse Event|3|||
16265576|NCT02632344|39456609|FG000|Overall Study|Lack of Efficacy|3|||
16265577|NCT02632344|39456609|FG000|Overall Study|Withdrawal by Subject|2|||
16265578|NCT01577381|39456610|FG000|Overall Study|Discontinued|2|||
16265579|NCT01577381|39456611|FG001|Overall Study|Discontinued|1|||
16265580|NCT01577381|39456612|FG002|Overall Study|Discontinued|2|||
16265581|NCT01577381|39456613|FG003|Overall Study|Discontinued|2|||
16265582|NCT01577381|39456610|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
16265583|NCT01577381|39456611|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
16265584|NCT01577381|39456612|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
16265585|NCT01577381|39456613|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
16265586|NCT03100344|39456614|FG000|Overall Study|Adverse Event|0|||
16265587|NCT03100344|39456615|FG001|Overall Study|Adverse Event|3|||
16373794|NCT00160615|39853302|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
16373795|NCT00160615|39853301|FG000|Overall Study|Switch to surgical treatment|0|||
16373796|NCT00160615|39853302|FG001|Overall Study|Switch to surgical treatment|2|||
16164366|NCT00896532|39083696|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
16164367|NCT00896532|39083697|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
16164368|NCT00896532|39083698|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
16164369|NCT00896532|39083699|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
16164370|NCT00896532|39083700|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
16164371|NCT00896532|39083701|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
16164372|NCT00896532|39083702|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
16164373|NCT00896532|39083703|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
16164374|NCT00896532|39083704|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
16164375|NCT00896532|39083705|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
16164376|NCT00896532|39083706|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
16164377|NCT00896532|39083707|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
16164378|NCT00896532|39083708|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
16164379|NCT00896532|39083709|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
16164380|NCT00896532|39083710|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
16164381|NCT00896532|39083688|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164382|NCT00896532|39083689|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16373797|NCT00160615|39853301|FG000|Overall Study|Non-compliance was suspected|0|||
16373798|NCT00160615|39853302|FG001|Overall Study|Non-compliance was suspected|1|||
16373799|NCT00160615|39853301|FG000|Overall Study|Poor compliance|0|||
16373800|NCT00160615|39853302|FG001|Overall Study|Poor compliance|1|||
16373801|NCT01423084|39853303|FG000|Overall Study|Adverse Event|0|||
16373802|NCT01423084|39853304|FG001|Overall Study|Adverse Event|1|||
16373803|NCT01423084|39853303|FG000|Overall Study|Withdrawal by Subject|2|||
16373804|NCT01423084|39853304|FG001|Overall Study|Withdrawal by Subject|3|||
16373805|NCT02191397|39853305|FG000|Overall Study|Adverse Event|28|||
16373806|NCT02191397|39853306|FG001|Overall Study|Adverse Event|17|||
16373807|NCT02191397|39853305|FG000|Overall Study|Lack of Efficacy|10|||
16373808|NCT02191397|39853306|FG001|Overall Study|Lack of Efficacy|5|||
16373809|NCT02191397|39853305|FG000|Overall Study|Protocol Violation|0|||
16451894|NCT00223080|40133501|FG000|Overall Study|Withdrawal by Subject|253|||
16265588|NCT03100344|39456616|FG002|Overall Study|Adverse Event|2|||
16265589|NCT03100344|39456617|FG003|Overall Study|Adverse Event|3|||
16265590|NCT03100344|39456614|FG000|Overall Study|Lack of Efficacy|2|||
16265591|NCT03100344|39456615|FG001|Overall Study|Lack of Efficacy|0|||
16265592|NCT03100344|39456616|FG002|Overall Study|Lack of Efficacy|0|||
16265593|NCT03100344|39456617|FG003|Overall Study|Lack of Efficacy|0|||
16265594|NCT03100344|39456614|FG000|Overall Study|Protocol Violation|1|||
16451895|NCT00223080|40133502|FG001|Overall Study|Withdrawal by Subject|232|||
16451896|NCT00223080|40133501|FG000|Overall Study|Required contraindicated med|0|||
16451897|NCT00223080|40133502|FG001|Overall Study|Required contraindicated med|1|||
16451898|NCT00223080|40133501|FG000|Overall Study|Non-compliant|7|||
16451899|NCT00223080|40133502|FG001|Overall Study|Non-compliant|7|||
16451900|NCT00223080|40133501|FG000|Overall Study|Moved from study area|37|||
16451901|NCT00223080|40133502|FG001|Overall Study|Moved from study area|47|||
16451902|NCT00223080|40133501|FG000|Overall Study|Lost to Follow-up|259|||
16451903|NCT00223080|40133502|FG001|Overall Study|Lost to Follow-up|284|||
16451904|NCT00223080|40133501|FG000|Overall Study|Death|85|||
16451905|NCT00223080|40133502|FG001|Overall Study|Death|74|||
16451906|NCT00223080|40133501|FG000|Overall Study|Other|14|||
16451907|NCT00223080|40133502|FG001|Overall Study|Other|11|||
16451908|NCT00223080|40133501|FG000|Overall Study|Reason not provided|141|||
16451909|NCT00223080|40133502|FG001|Overall Study|Reason not provided|140|||
16451910|NCT00223080|40133501|FG000|Overall Study|Adverse Event|0|||
16451911|NCT00223080|40133502|FG001|Overall Study|Adverse Event|1|||
16451912|NCT02637037|40133503|FG000|Overall Study|Positive drug screen at admission|1|||
16451913|NCT02637037|40133504|FG001|Overall Study|Positive drug screen at admission|0|||
16451914|NCT02637037|40133503|FG000|Overall Study|Withdrawal by Subject|2|||
16451915|NCT02637037|40133504|FG001|Overall Study|Withdrawal by Subject|1|||
16451916|NCT02637037|40133503|FG000|Overall Study|Adverse Event|1|||
16451917|NCT02637037|40133504|FG001|Overall Study|Adverse Event|0|||
16265595|NCT03100344|39456615|FG001|Overall Study|Protocol Violation|0|||
16265596|NCT03100344|39456616|FG002|Overall Study|Protocol Violation|0|||
16265597|NCT03100344|39456617|FG003|Overall Study|Protocol Violation|0|||
16265598|NCT03100344|39456614|FG000|Overall Study|Withdrawal by Subject|10|||
16451918|NCT03565497|40133509|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
16451919|NCT03565497|40133510|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
16451920|NCT03565497|40133511|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
16451921|NCT03565497|40133509|FG000|Overall Study|Lost to Follow-up|1|||
16451922|NCT03565497|40133510|FG001|Overall Study|Lost to Follow-up|1|||
16451923|NCT03565497|40133511|FG002|Overall Study|Lost to Follow-up|2|||
16451924|NCT03565497|40133509|FG000|Overall Study|Withdrawal by Subject|1|||
16451925|NCT03565497|40133510|FG001|Overall Study|Withdrawal by Subject|1|||
16451926|NCT03565497|40133511|FG002|Overall Study|Withdrawal by Subject|1|||
16451927|NCT01583296|40133520|FG000|Overall Study|Withdrawal by Subject|11|||
16451928|NCT01583296|40133521|FG001|Overall Study|Withdrawal by Subject|10|||
16451929|NCT01265537|40133522|FG000|Overall Study|Adverse Event|2|||
16451930|NCT01265537|40133523|FG001|Overall Study|Adverse Event|1|||
16451931|NCT01265537|40133522|FG000|Overall Study|Physician Decision|0|||
16451932|NCT01265537|40133523|FG001|Overall Study|Physician Decision|1|||
16451933|NCT01094119|40133527|FG000|Overall Study|Lack of Efficacy|2|||
16451934|NCT01094119|40133528|FG001|Overall Study|Lack of Efficacy|4|||
16451935|NCT01296672|40133529|FG000|Overall Study|Lost to Follow-up|73|||
16451936|NCT01296672|40133530|FG001|Overall Study|Lost to Follow-up|18|||
16451937|NCT02035267|40133534|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
16451938|NCT02035267|40133535|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
16451939|NCT02035267|40133536|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
16451940|NCT02035267|40133537|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
16451941|NCT02035267|40133534|FG000|Overall Study|Adverse Event|0|||
16451942|NCT02035267|40133535|FG001|Overall Study|Adverse Event|0|||
16451943|NCT02035267|40133536|FG002|Overall Study|Adverse Event|1|||
16451944|NCT02035267|40133537|FG003|Overall Study|Adverse Event|0|||
16451945|NCT02035267|40133534|FG000|Overall Study|Lost to Follow-up|0|||
16451946|NCT02035267|40133535|FG001|Overall Study|Lost to Follow-up|0|||
16451947|NCT02035267|40133536|FG002|Overall Study|Lost to Follow-up|0|||
16451948|NCT02035267|40133537|FG003|Overall Study|Lost to Follow-up|1|||
16451949|NCT02035267|40133534|FG000|Overall Study|Other unspecified|0|||
16451950|NCT02035267|40133535|FG001|Overall Study|Other unspecified|1|||
16451951|NCT02035267|40133536|FG002|Overall Study|Other unspecified|0|||
16451952|NCT02035267|40133537|FG003|Overall Study|Other unspecified|0|||
16265599|NCT03100344|39456615|FG001|Overall Study|Withdrawal by Subject|7|||
16451953|NCT00889720|40133538|FG000|Overall Study|Withdrawal by Subject|4|||
16451954|NCT00889720|40133538|FG000|Overall Study|Other|4|||
16451955|NCT00658359|40133539|FG000|Overall Study|Death|3|||
16451956|NCT00658359|40133540|FG001|Overall Study|Death|1|||
16451957|NCT00658359|40133541|FG002|Overall Study|Death|2|||
16451958|NCT00658359|40133539|FG000|Overall Study|Adverse Event|13|||
16451959|NCT00658359|40133540|FG001|Overall Study|Adverse Event|6|||
16451960|NCT00658359|40133541|FG002|Overall Study|Adverse Event|9|||
16451961|NCT00658359|40133539|FG000|Overall Study|Protocol Violation|1|||
16451962|NCT00658359|40133540|FG001|Overall Study|Protocol Violation|0|||
16451963|NCT00658359|40133541|FG002|Overall Study|Protocol Violation|0|||
16451964|NCT00658359|40133539|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
16451965|NCT00658359|40133540|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
16451966|NCT00658359|40133541|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
16265600|NCT03100344|39456616|FG002|Overall Study|Withdrawal by Subject|4|||
16451967|NCT00658359|40133539|FG000|Overall Study|Withdrawal by Subject|7|||
16451968|NCT00658359|40133540|FG001|Overall Study|Withdrawal by Subject|4|||
16451969|NCT00658359|40133541|FG002|Overall Study|Withdrawal by Subject|2|||
16451970|NCT00658359|40133539|FG000|Overall Study|Lost to Follow-up|2|||
16451971|NCT00658359|40133540|FG001|Overall Study|Lost to Follow-up|2|||
16451972|NCT00658359|40133541|FG002|Overall Study|Lost to Follow-up|4|||
16451973|NCT00658359|40133539|FG000|Overall Study|Lack of Efficacy|0|||
16451974|NCT00658359|40133540|FG001|Overall Study|Lack of Efficacy|1|||
16451975|NCT00658359|40133541|FG002|Overall Study|Lack of Efficacy|0|||
16451976|NCT02834793|40133542|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
16451977|NCT02834793|40133543|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
16451978|NCT02834793|40133544|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
16451979|NCT02834793|40133545|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
16164383|NCT00896532|39083690|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164384|NCT00896532|39083691|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164385|NCT00896532|39083692|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16265601|NCT03100344|39456617|FG003|Overall Study|Withdrawal by Subject|8|||
16265602|NCT03100344|39456614|FG000|Overall Study|Lost to Follow-up|1|||
16265603|NCT03100344|39456615|FG001|Overall Study|Lost to Follow-up|1|||
16265604|NCT03100344|39456616|FG002|Overall Study|Lost to Follow-up|1|||
16265605|NCT03100344|39456617|FG003|Overall Study|Lost to Follow-up|1|||
16265606|NCT01926119|39456618|FG000|Overall Study|Withdrawal by Subject|1|||
16265607|NCT00185458|39456619|FG000|Contraception Phase|Adverse Event|37|||
16265608|NCT00185458|39456619|FG000|Contraception Phase|Lost to Follow-up|10|||
16265609|NCT00185458|39456619|FG000|Contraception Phase|Protocol Violation|2|||
16265610|NCT00185458|39456619|FG000|Contraception Phase|Physician Decision|2|||
16265611|NCT00185458|39456619|FG000|Contraception Phase|Withdrawal by Subject|7|||
16265612|NCT00185458|39456619|FG000|HRT Phase|Adverse Event|18|||
16265613|NCT00185458|39456619|FG000|HRT Phase|Lost to Follow-up|4|||
16265614|NCT00185458|39456619|FG000|HRT Phase|Protocol Violation|2|||
16265615|NCT00185458|39456619|FG000|HRT Phase|Withdrawal by Subject|3|||
16265616|NCT02682784|39456623|FG000|Overall Study|Withdrawal by Subject|0|||
16265617|NCT02682784|39456624|FG001|Overall Study|Withdrawal by Subject|2|||
16265618|NCT02682784|39456625|FG002|Overall Study|Withdrawal by Subject|1|||
16265619|NCT02682784|39456626|FG003|Overall Study|Withdrawal by Subject|2|||
16265620|NCT02682784|39456623|FG000|Overall Study|Physician Decision|1|||
16265621|NCT02682784|39456624|FG001|Overall Study|Physician Decision|0|||
16265622|NCT02682784|39456625|FG002|Overall Study|Physician Decision|1|||
16265623|NCT02682784|39456626|FG003|Overall Study|Physician Decision|1|||
16164386|NCT00896532|39083693|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164387|NCT00896532|39083694|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16265624|NCT00574847|39456627|FG000|Overall Study|Adverse Event|2|||
16265625|NCT00574847|39456628|FG001|Overall Study|Adverse Event|0|||
16265626|NCT00574847|39456627|FG000|Overall Study|Death|1|||
16265627|NCT00574847|39456628|FG001|Overall Study|Death|0|||
16265628|NCT00574847|39456627|FG000|Overall Study|Withdrawal by Subject|2|||
16265629|NCT00574847|39456628|FG001|Overall Study|Withdrawal by Subject|2|||
16265630|NCT00574847|39456627|FG000|Overall Study|Physician Decision|1|||
16265631|NCT00574847|39456628|FG001|Overall Study|Physician Decision|0|||
16265632|NCT00574847|39456627|FG000|Overall Study|Did not receive medication (declined)|2|||
16265633|NCT00574847|39456628|FG001|Overall Study|Did not receive medication (declined)|5|||
16265634|NCT00851877|39456641|FG000|Phase I-1|Death|1|||
16265635|NCT00851877|39456642|FG001|Phase I-1|Death|0|||
16265636|NCT00851877|39456643|FG002|Phase I-1|Death|0|||
16265637|NCT00851877|39456641|FG000|Phase II|Withdrawal by Subject|0|||
16265638|NCT00851877|39456642|FG001|Phase II|Withdrawal by Subject|0|||
16265639|NCT00851877|39456643|FG002|Phase II|Withdrawal by Subject|3|||
16265640|NCT03804983|39456644|FG000|Overall Study|Adverse Event|0|||
16373810|NCT02191397|39853306|FG001|Overall Study|Protocol Violation|3|||
16164388|NCT00896532|39083695|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164389|NCT00896532|39083696|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16373811|NCT02191397|39853305|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
16373812|NCT02191397|39853306|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
16373813|NCT02191397|39853305|FG000|Overall Study|Lost to Follow-up|10|||
16373814|NCT02191397|39853306|FG001|Overall Study|Lost to Follow-up|11|||
16373815|NCT02191397|39853305|FG000|Overall Study|Physician Decision|8|||
16373816|NCT02191397|39853306|FG001|Overall Study|Physician Decision|3|||
16373817|NCT02191397|39853305|FG000|Overall Study|Withdrawal by Subject|22|||
16373818|NCT02191397|39853306|FG001|Overall Study|Withdrawal by Subject|27|||
16373819|NCT00421733|39853307|FG000|Overall Study|Adverse Event|4|||
16373820|NCT00421733|39853308|FG001|Overall Study|Adverse Event|9|||
16451980|NCT02834793|40133542|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
16451981|NCT02834793|40133543|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
16451982|NCT02834793|40133544|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
16265641|NCT03804983|39456645|FG001|Overall Study|Adverse Event|1|||
16265642|NCT03804983|39456644|FG000|Overall Study|Family Obligation|1|||
16265643|NCT03804983|39456645|FG001|Overall Study|Family Obligation|0|||
16265644|NCT00604162|39456650|FG000|Overall Study|Physician Decision|3|||
16265645|NCT00604162|39456650|FG000|Overall Study|Withdrawal by Subject|1|||
16265646|NCT00096447|39456651|FG000|Overall Study|Never treated|1|||
16265647|NCT00396279|39456653|FG000|Overall Study|Ongoing in study|26|||
16164390|NCT00896532|39083697|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164391|NCT00896532|39083698|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164392|NCT00896532|39083699|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164393|NCT00896532|39083700|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164394|NCT00896532|39083701|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164395|NCT00896532|39083702|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16265648|NCT00396279|39456653|FG000|Overall Study|Disease progression|2|||
16265649|NCT00396279|39456653|FG000|Overall Study|Withdrawal by Subject|1|||
16265650|NCT00396279|39456653|FG000|Overall Study|Physician Decision|1|||
16265651|NCT00433147|39456655|FG000|Overall Study|Adverse Event|0|||
16265652|NCT00433147|39456656|FG001|Overall Study|Adverse Event|1|||
16265653|NCT00433147|39456657|FG002|Overall Study|Adverse Event|0|||
16265654|NCT00433147|39456658|FG003|Overall Study|Adverse Event|0|||
16265655|NCT04533594|39456659|FG000|Overall Study|Death|26|||
16265656|NCT02601560|39456660|FG000|Overall Study|Other|0|||
16265657|NCT02601560|39456661|FG001|Overall Study|Other|0|||
16265658|NCT02601560|39456662|FG002|Overall Study|Other|0|||
16265659|NCT02601560|39456663|FG003|Overall Study|Other|0|||
16265660|NCT02601560|39456664|FG004|Overall Study|Other|0|||
16265661|NCT02601560|39456665|FG005|Overall Study|Other|0|||
16265662|NCT02601560|39456666|FG006|Overall Study|Other|1|||
16265663|NCT02601560|39456667|FG007|Overall Study|Other|0|||
16265664|NCT01248247|39456668|FG000|Overall Study|Adverse Event|2|||
16265665|NCT01248247|39456669|FG001|Overall Study|Adverse Event|4|||
16265666|NCT01248247|39456670|FG002|Overall Study|Adverse Event|4|||
16265667|NCT01248247|39456671|FG003|Overall Study|Adverse Event|2|||
16265668|NCT01248247|39456668|FG000|Overall Study|Death|0|||
16265669|NCT01248247|39456669|FG001|Overall Study|Death|1|||
16265670|NCT01248247|39456670|FG002|Overall Study|Death|4|||
16265671|NCT01248247|39456671|FG003|Overall Study|Death|7|||
16265672|NCT01248247|39456668|FG000|Overall Study|Lost to Follow-up|0|||
16265673|NCT01248247|39456669|FG001|Overall Study|Lost to Follow-up|1|||
16265674|NCT01248247|39456670|FG002|Overall Study|Lost to Follow-up|1|||
16265675|NCT01248247|39456671|FG003|Overall Study|Lost to Follow-up|0|||
16265676|NCT01248247|39456668|FG000|Overall Study|Alternative treatment|0|||
16265677|NCT01248247|39456669|FG001|Overall Study|Alternative treatment|1|||
16265678|NCT01248247|39456670|FG002|Overall Study|Alternative treatment|0|||
16265679|NCT01248247|39456671|FG003|Overall Study|Alternative treatment|0|||
16265680|NCT01248247|39456668|FG000|Overall Study|Other|2|||
16265681|NCT01248247|39456669|FG001|Overall Study|Other|8|||
16265682|NCT01248247|39456670|FG002|Overall Study|Other|8|||
16265683|NCT01248247|39456671|FG003|Overall Study|Other|5|||
16265684|NCT01248247|39456668|FG000|Overall Study|Progression|18|||
16265685|NCT01248247|39456669|FG001|Overall Study|Progression|27|||
16265686|NCT01248247|39456670|FG002|Overall Study|Progression|56|||
16265687|NCT01248247|39456671|FG003|Overall Study|Progression|44|||
16265688|NCT01248247|39456668|FG000|Overall Study|Refuse further treatment|0|||
16265689|NCT01248247|39456669|FG001|Overall Study|Refuse further treatment|0|||
16265690|NCT01248247|39456670|FG002|Overall Study|Refuse further treatment|1|||
16265691|NCT01248247|39456671|FG003|Overall Study|Refuse further treatment|2|||
16265692|NCT01248247|39456668|FG000|Overall Study|Complicating disease|0|||
16265693|NCT01248247|39456669|FG001|Overall Study|Complicating disease|0|||
16265694|NCT01248247|39456670|FG002|Overall Study|Complicating disease|1|||
16265695|NCT01248247|39456671|FG003|Overall Study|Complicating disease|1|||
16265696|NCT01745120|39456672|FG000|Overall Study|Investigator decision|1|||
16265697|NCT01745120|39456673|FG001|Overall Study|Investigator decision|0|||
16265698|NCT00824291|39456676|FG000|Overall Study|Adverse Event|15|||
16265699|NCT00824291|39456677|FG001|Overall Study|Adverse Event|6|||
16265700|NCT00824291|39456676|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
16451983|NCT02834793|40133545|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
16164396|NCT00896532|39083703|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16265701|NCT00824291|39456677|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
16265702|NCT00824291|39456676|FG000|Overall Study|Lost to Follow-up|11|||
16265703|NCT00824291|39456677|FG001|Overall Study|Lost to Follow-up|9|||
16265704|NCT00824291|39456676|FG000|Overall Study|Non-compliance|1|||
16265705|NCT00824291|39456677|FG001|Overall Study|Non-compliance|1|||
16265706|NCT00824291|39456676|FG000|Overall Study|Protocol Violation|4|||
16265707|NCT00824291|39456677|FG001|Overall Study|Protocol Violation|1|||
16265708|NCT00824291|39456676|FG000|Overall Study|Withdrawal by Subject|14|||
16265709|NCT00824291|39456677|FG001|Overall Study|Withdrawal by Subject|8|||
16265710|NCT00824291|39456676|FG000|Overall Study|Lack of Efficacy|7|||
16265711|NCT00824291|39456677|FG001|Overall Study|Lack of Efficacy|8|||
16265712|NCT00824291|39456676|FG000|Overall Study|Participant on prohibited medication|1|||
16265713|NCT00824291|39456677|FG001|Overall Study|Participant on prohibited medication|0|||
16265714|NCT02865850|39456680|FG000|Overall Study|Death|15|||
16265715|NCT02865850|39456681|FG001|Overall Study|Death|19|||
16265716|NCT02865850|39456680|FG000|Overall Study|Withdrawal by Subject|3|||
16265717|NCT02865850|39456681|FG001|Overall Study|Withdrawal by Subject|2|||
16265718|NCT02865850|39456680|FG000|Overall Study|Lost to Follow-up|3|||
16265719|NCT02865850|39456681|FG001|Overall Study|Lost to Follow-up|2|||
16265720|NCT04400890|39456682|FG000|Overall Study|Withdrawal by Subject|3|||
16265721|NCT04400890|39456683|FG001|Overall Study|Withdrawal by Subject|2|||
16265722|NCT00309985|39456684|FG000|Overall Study|Disease progression|12|||
16265723|NCT00309985|39456685|FG001|Overall Study|Disease progression|0|||
16265724|NCT00309985|39456684|FG000|Overall Study|Adverse Event|30|||
16265725|NCT00309985|39456685|FG001|Overall Study|Adverse Event|0|||
16265726|NCT00309985|39456684|FG000|Overall Study|Death|2|||
16265727|NCT00309985|39456685|FG001|Overall Study|Death|0|||
16265728|NCT00309985|39456684|FG000|Overall Study|Withdrawal by Subject|5|||
16265729|NCT00309985|39456685|FG001|Overall Study|Withdrawal by Subject|1|||
16265730|NCT00309985|39456684|FG000|Overall Study|Physician Decision|3|||
16265731|NCT00309985|39456685|FG001|Overall Study|Physician Decision|0|||
16265732|NCT00309985|39456684|FG000|Overall Study|Never started treatment|7|||
16265733|NCT00309985|39456685|FG001|Overall Study|Never started treatment|0|||
16265734|NCT00309985|39456684|FG000|Overall Study|Complicating disease|1|||
16265735|NCT00309985|39456685|FG001|Overall Study|Complicating disease|0|||
16265736|NCT00309985|39456684|FG000|Overall Study|Non-compliance|1|||
16265737|NCT00309985|39456685|FG001|Overall Study|Non-compliance|0|||
16265738|NCT00309985|39456684|FG000|Overall Study|Chemotherapy discontinued only|1|||
16265739|NCT00309985|39456685|FG001|Overall Study|Chemotherapy discontinued only|0|||
16265740|NCT00909610|39456686|FG000|Period: First Intervention|Adverse Event|0|||
16265741|NCT00909610|39456687|FG001|Period: First Intervention|Adverse Event|1|||
16265742|NCT00909610|39456686|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
16265743|NCT00909610|39456687|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
16265744|NCT00909610|39456686|FG000|Period: Second Intervention|Adverse Event|1|||
16265745|NCT00909610|39456687|FG001|Period: Second Intervention|Adverse Event|0|||
16265746|NCT03381274|39456689|FG000|Overall Study|Death|2|||
16265747|NCT03381274|39456690|FG001|Overall Study|Death|9|||
16265748|NCT03381274|39456691|FG002|Overall Study|Death|3|||
16265749|NCT03381274|39456692|FG003|Overall Study|Death|2|||
16265750|NCT03381274|39456693|FG004|Overall Study|Death|3|||
16265751|NCT03381274|39456689|FG000|Overall Study|Lost to Follow-up|0|||
16265752|NCT03381274|39456690|FG001|Overall Study|Lost to Follow-up|0|||
16265753|NCT03381274|39456691|FG002|Overall Study|Lost to Follow-up|0|||
16265754|NCT03381274|39456692|FG003|Overall Study|Lost to Follow-up|1|||
16265755|NCT03381274|39456693|FG004|Overall Study|Lost to Follow-up|0|||
16265756|NCT03381274|39456689|FG000|Overall Study|Withdrawal by Subject|2|||
16265757|NCT03381274|39456690|FG001|Overall Study|Withdrawal by Subject|1|||
16265758|NCT03381274|39456691|FG002|Overall Study|Withdrawal by Subject|3|||
16265759|NCT03381274|39456692|FG003|Overall Study|Withdrawal by Subject|1|||
16265760|NCT03381274|39456693|FG004|Overall Study|Withdrawal by Subject|0|||
16265761|NCT03381274|39456689|FG000|Overall Study|Other|1|||
16265762|NCT03381274|39456690|FG001|Overall Study|Other|11|||
16265763|NCT03381274|39456691|FG002|Overall Study|Other|0|||
16265764|NCT03381274|39456692|FG003|Overall Study|Other|2|||
16265765|NCT03381274|39456693|FG004|Overall Study|Other|2|||
16265766|NCT02159183|39456696|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
16265767|NCT02159183|39456697|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
16265768|NCT02159183|39456696|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
16265769|NCT02159183|39456697|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
16265770|NCT02159183|39456696|FG000|Analysis After the 36 Months Follow-up|Death|0|||
16265771|NCT02159183|39456697|FG001|Analysis After the 36 Months Follow-up|Death|1|||
16265772|NCT02159183|39456696|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
16265773|NCT02159183|39456697|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
16265774|NCT02159183|39456696|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
16265775|NCT02159183|39456697|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
16265776|NCT02178787|39456698|FG000|Overall Study|Lost to Follow-up|1|||
16265777|NCT02178787|39456699|FG001|Overall Study|Lost to Follow-up|0|||
16265778|NCT02178787|39456698|FG000|Overall Study|Withdrawal by Subject|0|||
16265779|NCT02178787|39456699|FG001|Overall Study|Withdrawal by Subject|2|||
16265780|NCT02178787|39456698|FG000|Overall Study|No TCD window|3|||
16265781|NCT02178787|39456699|FG001|Overall Study|No TCD window|7|||
16265782|NCT02178787|39456698|FG000|Overall Study|Physician Decision|1|||
16265783|NCT02178787|39456699|FG001|Overall Study|Physician Decision|0|||
16265784|NCT01882647|39456700|FG000|Overall Study|Lost to Follow-up|2|||
16265785|NCT01882647|39456701|FG001|Overall Study|Lost to Follow-up|2|||
16265786|NCT01882647|39456700|FG000|Overall Study|Withdrawal by Subject|0|||
16265787|NCT01882647|39456701|FG001|Overall Study|Withdrawal by Subject|4|||
16265788|NCT01686477|39456708|FG000|Feeding Intervention|Death|1|||
16265789|NCT01686477|39456709|FG001|Feeding Intervention|Death|0|||
16265790|NCT01686477|39456710|FG002|Feeding Intervention|Death|1|||
16265791|NCT01686477|39456708|FG000|Feeding Intervention|Withdrawal by Subject|0|||
16265792|NCT01686477|39456709|FG001|Feeding Intervention|Withdrawal by Subject|6|||
16265793|NCT01686477|39456710|FG002|Feeding Intervention|Withdrawal by Subject|0|||
16265794|NCT01686477|39456708|FG000|Feeding Intervention|Physician Decision|1|||
16265795|NCT01686477|39456709|FG001|Feeding Intervention|Physician Decision|2|||
16265796|NCT01686477|39456710|FG002|Feeding Intervention|Physician Decision|0|||
16265797|NCT01686477|39456708|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
16265798|NCT01686477|39456709|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
16265799|NCT01686477|39456710|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
16265800|NCT01686477|39456708|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
16265801|NCT01686477|39456709|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
16265802|NCT01686477|39456710|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
16265803|NCT01686477|39456708|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
16265804|NCT01686477|39456709|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
16265805|NCT01686477|39456710|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
16265806|NCT01686477|39456708|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
16265807|NCT01686477|39456709|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
16265808|NCT01686477|39456710|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
16265809|NCT01686477|39456708|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
16265810|NCT01686477|39456709|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
16265811|NCT01686477|39456710|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
16265812|NCT01686477|39456708|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
16265813|NCT01686477|39456709|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
16265814|NCT01686477|39456710|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
16265815|NCT01686477|39456708|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
16265816|NCT01686477|39456709|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
16265817|NCT01686477|39456710|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
16265818|NCT03165994|39456711|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
16265819|NCT03165994|39456711|FG000|Overall Study|Death|2|||
16265820|NCT03165994|39456711|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
16265821|NCT03165994|39456711|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
16265822|NCT03165994|39456711|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
16265823|NCT03165994|39456711|FG000|Overall Study|Miscellaneous|1|||
16265824|NCT02642653|39456712|FG000|Overall Study|Adverse Event|2|||
16265825|NCT02642653|39456713|FG001|Overall Study|Adverse Event|0|||
16265826|NCT02822235|39456714|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
16265827|NCT02822235|39456715|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
16265828|NCT02822235|39456714|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
16265829|NCT02822235|39456715|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
16265830|NCT02822235|39456714|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
16265831|NCT02822235|39456715|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
16265832|NCT02822235|39456714|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
16265833|NCT02822235|39456715|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
16265834|NCT02822235|39456714|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
16265835|NCT02822235|39456715|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
16265836|NCT02822235|39456714|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
16265837|NCT02822235|39456715|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
16265838|NCT00829790|39456716|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
16265839|NCT00829790|39456717|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
16265840|NCT03249454|39456718|FG000|Overall Study|Withdrawal by Subject|0|||
16265841|NCT03249454|39456719|FG001|Overall Study|Withdrawal by Subject|0|||
16265842|NCT03249454|39456720|FG002|Overall Study|Withdrawal by Subject|0|||
16265843|NCT03249454|39456721|FG003|Overall Study|Withdrawal by Subject|0|||
16265844|NCT03249454|39456722|FG004|Overall Study|Withdrawal by Subject|0|||
16265845|NCT03249454|39456723|FG005|Overall Study|Withdrawal by Subject|0|||
16265846|NCT03249454|39456724|FG006|Overall Study|Withdrawal by Subject|0|||
16265847|NCT03249454|39456725|FG007|Overall Study|Withdrawal by Subject|0|||
16373821|NCT00421733|39853309|FG002|Overall Study|Adverse Event|2|||
16373822|NCT00421733|39853307|FG000|Overall Study|Lost to Follow-up|1|||
16373823|NCT00421733|39853308|FG001|Overall Study|Lost to Follow-up|2|||
16373824|NCT00421733|39853309|FG002|Overall Study|Lost to Follow-up|4|||
16373825|NCT00421733|39853307|FG000|Overall Study|Withdrawal by Subject|1|||
16265848|NCT03249454|39456726|FG008|Overall Study|Withdrawal by Subject|0|||
16265849|NCT03249454|39456727|FG009|Overall Study|Withdrawal by Subject|1|||
16265850|NCT03249454|39456728|FG010|Overall Study|Withdrawal by Subject|1|||
16265851|NCT01507051|39456732|FG000|Overall Study|Withdrawal by Subject|1|||
16265852|NCT01507051|39456733|FG001|Overall Study|Withdrawal by Subject|3|||
16373826|NCT00421733|39853308|FG001|Overall Study|Withdrawal by Subject|2|||
16265853|NCT01507051|39456734|FG002|Overall Study|Withdrawal by Subject|1|||
16265854|NCT01507051|39456735|FG003|Overall Study|Withdrawal by Subject|6|||
16265855|NCT01507051|39456732|FG000|Overall Study|Physician Decision|0|||
16265856|NCT01507051|39456733|FG001|Overall Study|Physician Decision|0|||
16265857|NCT01507051|39456734|FG002|Overall Study|Physician Decision|0|||
16265858|NCT01507051|39456735|FG003|Overall Study|Physician Decision|1|||
16265859|NCT01507051|39456732|FG000|Overall Study|Adverse Event|1|||
16265860|NCT01507051|39456733|FG001|Overall Study|Adverse Event|0|||
16265861|NCT01507051|39456734|FG002|Overall Study|Adverse Event|0|||
16265862|NCT01507051|39456735|FG003|Overall Study|Adverse Event|0|||
16265863|NCT03600376|39456738|FG000|Overall Study|Adverse Event|1|||
16265864|NCT03600376|39456739|FG001|Overall Study|Adverse Event|1|||
16265865|NCT03600376|39456738|FG000|Overall Study|Transferred to other facility|1|||
16265866|NCT03600376|39456739|FG001|Overall Study|Transferred to other facility|0|||
16265867|NCT03600376|39456738|FG000|Overall Study|Investigator Decision|0|||
16265868|NCT03600376|39456739|FG001|Overall Study|Investigator Decision|4|||
16265869|NCT03600376|39456738|FG000|Overall Study|Determined to be ineligible for study|0|||
16265870|NCT03600376|39456739|FG001|Overall Study|Determined to be ineligible for study|1|||
16265871|NCT00418561|39456740|FG000|Overall Study|Participant's (guardian's) decision|0|||
16265872|NCT00418561|39456741|FG001|Overall Study|Participant's (guardian's) decision|1|||
16265873|NCT00418561|39456742|FG002|Overall Study|Participant's (guardian's) decision|0|||
16373827|NCT00421733|39853309|FG002|Overall Study|Withdrawal by Subject|7|||
16373828|NCT00421733|39853307|FG000|Overall Study|Death|0|||
16373829|NCT00421733|39853308|FG001|Overall Study|Death|3|||
16373830|NCT00421733|39853309|FG002|Overall Study|Death|0|||
16373831|NCT00421733|39853307|FG000|Overall Study|Required dialysis|1|||
16373832|NCT00421733|39853308|FG001|Overall Study|Required dialysis|0|||
16373833|NCT00421733|39853309|FG002|Overall Study|Required dialysis|0|||
16373834|NCT00421733|39853307|FG000|Overall Study|Administrative|2|||
16373835|NCT00421733|39853308|FG001|Overall Study|Administrative|0|||
16373836|NCT00421733|39853309|FG002|Overall Study|Administrative|0|||
16373837|NCT00421733|39853307|FG000|Overall Study|Did not satisfy entry criteria|1|||
16373838|NCT00421733|39853308|FG001|Overall Study|Did not satisfy entry criteria|3|||
16373839|NCT00421733|39853309|FG002|Overall Study|Did not satisfy entry criteria|2|||
16373840|NCT00421733|39853307|FG000|Overall Study|Sponsor request|1|||
16373841|NCT00421733|39853308|FG001|Overall Study|Sponsor request|0|||
16373842|NCT00421733|39853309|FG002|Overall Study|Sponsor request|3|||
16373843|NCT00421733|39853307|FG000|Overall Study|Protocol deviation|4|||
16373844|NCT00421733|39853308|FG001|Overall Study|Protocol deviation|7|||
16373845|NCT00421733|39853309|FG002|Overall Study|Protocol deviation|2|||
16373846|NCT03632720|39853310|FG000|Overall Study|Adverse Event|2|||
16373847|NCT03632720|39853311|FG001|Overall Study|Adverse Event|0|||
16373848|NCT03632720|39853312|FG002|Overall Study|Adverse Event|0|||
16373849|NCT03632720|39853310|FG000|Overall Study|Lost to Follow-up|0|||
16373850|NCT03632720|39853311|FG001|Overall Study|Lost to Follow-up|1|||
16373851|NCT03632720|39853312|FG002|Overall Study|Lost to Follow-up|0|||
16373852|NCT03632720|39853310|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
16373853|NCT03632720|39853311|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
16373854|NCT03632720|39853312|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
16373855|NCT03632720|39853310|FG000|Overall Study|Screen failure|0|||
16373856|NCT03632720|39853311|FG001|Overall Study|Screen failure|1|||
16373857|NCT03632720|39853312|FG002|Overall Study|Screen failure|0|||
16373858|NCT01623154|39853313|FG000|Overall Study|Did not drink Pranactin Citric|4|||
16373859|NCT02503865|39853314|FG000|Overall Study|Moved out of area|1|||
16373860|NCT02503865|39853315|FG001|Overall Study|Moved out of area|8|||
16373861|NCT02503865|39853316|FG002|Overall Study|Moved out of area|0|||
16373862|NCT02503865|39853314|FG000|Overall Study|Refused treatment|4|||
16373863|NCT02503865|39853315|FG001|Overall Study|Refused treatment|39|||
16373864|NCT02503865|39853316|FG002|Overall Study|Refused treatment|2|||
16373865|NCT00866775|39853317|FG000|Overall Study|Adverse Event|5|||
16373866|NCT00866775|39853318|FG001|Overall Study|Adverse Event|19|||
16373867|NCT00866775|39853317|FG000|Overall Study|Death|1|||
16373868|NCT00866775|39853318|FG001|Overall Study|Death|0|||
16373869|NCT00866775|39853317|FG000|Overall Study|Lost to Follow-up|0|||
16373870|NCT00866775|39853318|FG001|Overall Study|Lost to Follow-up|4|||
16373871|NCT00866775|39853317|FG000|Overall Study|Physician Decision|0|||
16373872|NCT00866775|39853318|FG001|Overall Study|Physician Decision|3|||
16373873|NCT00866775|39853317|FG000|Overall Study|Protocol Violation|3|||
16265874|NCT01056484|39456743|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
16265875|NCT01056484|39456744|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
16265876|NCT01056484|39456743|FG000|Randomized Controlled Trial|Physician Decision|1|||
16373874|NCT00866775|39853318|FG001|Overall Study|Protocol Violation|4|||
16373875|NCT00866775|39853317|FG000|Overall Study|Withdrawal by Subject|4|||
16373876|NCT00866775|39853318|FG001|Overall Study|Withdrawal by Subject|4|||
16265877|NCT01056484|39456744|FG001|Randomized Controlled Trial|Physician Decision|0|||
16373877|NCT00866775|39853317|FG000|Overall Study|met exit criteria|23|||
16373878|NCT00866775|39853318|FG001|Overall Study|met exit criteria|17|||
16373879|NCT00866775|39853317|FG000|Overall Study|discontinued due to communication error|0|||
16373880|NCT00866775|39853318|FG001|Overall Study|discontinued due to communication error|1|||
16373881|NCT00421408|39853319|FG000|Overall Study|Lost to Follow-up|30|||
16373882|NCT00421408|39853320|FG001|Overall Study|Lost to Follow-up|20|||
16373883|NCT00421408|39853319|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
16373884|NCT00421408|39853320|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
16373885|NCT03061214|39853321|FG000|Overall Study|Withdrawal by Subject|21|||
16373886|NCT03061214|39853322|FG001|Overall Study|Withdrawal by Subject|26|||
16373887|NCT03061214|39853323|FG002|Overall Study|Withdrawal by Subject|9|||
16373888|NCT03061214|39853321|FG000|Overall Study|Lost to Follow-up|3|||
16373889|NCT03061214|39853322|FG001|Overall Study|Lost to Follow-up|1|||
16373890|NCT03061214|39853323|FG002|Overall Study|Lost to Follow-up|1|||
16373891|NCT03061214|39853321|FG000|Overall Study|Death|1|||
16373892|NCT03061214|39853322|FG001|Overall Study|Death|1|||
16373893|NCT03061214|39853323|FG002|Overall Study|Death|0|||
16373894|NCT01796470|39853324|FG000|Overall Study|Adverse Event|4|||
16373895|NCT01796470|39853325|FG001|Overall Study|Adverse Event|2|||
16373896|NCT01796470|39853326|FG002|Overall Study|Adverse Event|2|||
16373897|NCT01796470|39853327|FG003|Overall Study|Adverse Event|1|||
16373898|NCT01796470|39853328|FG004|Overall Study|Adverse Event|3|||
16373899|NCT01796470|39853324|FG000|Overall Study|Death|2|||
16373900|NCT01796470|39853325|FG001|Overall Study|Death|0|||
16373901|NCT01796470|39853326|FG002|Overall Study|Death|0|||
16373902|NCT01796470|39853327|FG003|Overall Study|Death|0|||
16373903|NCT01796470|39853328|FG004|Overall Study|Death|1|||
16373904|NCT01796470|39853324|FG000|Overall Study|Initiated New Therapy|9|||
16373905|NCT01796470|39853325|FG001|Overall Study|Initiated New Therapy|0|||
16373906|NCT01796470|39853326|FG002|Overall Study|Initiated New Therapy|0|||
16451984|NCT02834793|40133542|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
16451985|NCT02834793|40133543|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
16451986|NCT02834793|40133544|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
16451987|NCT02834793|40133545|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
16451988|NCT02834793|40133542|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
16451989|NCT02834793|40133543|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
16451990|NCT02834793|40133544|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
16451991|NCT02834793|40133545|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
16451992|NCT02834793|40133542|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
16451993|NCT02834793|40133543|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
16451994|NCT02834793|40133544|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
16451995|NCT02834793|40133545|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
16373907|NCT01796470|39853327|FG003|Overall Study|Initiated New Therapy|0|||
16373908|NCT01796470|39853328|FG004|Overall Study|Initiated New Therapy|2|||
16373909|NCT01796470|39853324|FG000|Overall Study|Lost to Follow-up|0|||
16373910|NCT01796470|39853325|FG001|Overall Study|Lost to Follow-up|1|||
16373911|NCT01796470|39853326|FG002|Overall Study|Lost to Follow-up|0|||
16373912|NCT01796470|39853327|FG003|Overall Study|Lost to Follow-up|0|||
16373913|NCT01796470|39853328|FG004|Overall Study|Lost to Follow-up|0|||
16373914|NCT01796470|39853324|FG000|Overall Study|Physician Decision|5|||
16373915|NCT01796470|39853325|FG001|Overall Study|Physician Decision|4|||
16373916|NCT01796470|39853326|FG002|Overall Study|Physician Decision|1|||
16373917|NCT01796470|39853327|FG003|Overall Study|Physician Decision|0|||
16373918|NCT01796470|39853328|FG004|Overall Study|Physician Decision|1|||
16373919|NCT01796470|39853324|FG000|Overall Study|Progressive Disease|7|||
16373920|NCT01796470|39853325|FG001|Overall Study|Progressive Disease|7|||
16373921|NCT01796470|39853326|FG002|Overall Study|Progressive Disease|3|||
16373922|NCT01796470|39853327|FG003|Overall Study|Progressive Disease|2|||
16451996|NCT02834793|40133542|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
16164397|NCT00896532|39083704|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
16164398|NCT00896532|39083705|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164399|NCT00896532|39083706|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164400|NCT00896532|39083707|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164401|NCT00896532|39083708|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164402|NCT00896532|39083709|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164403|NCT00896532|39083710|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
16164404|NCT00896532|39083688|FG000|Months 48-72: Follow-on Phase|Death|0|||
16164405|NCT00896532|39083689|FG001|Months 48-72: Follow-on Phase|Death|0|||
16164406|NCT00896532|39083690|FG002|Months 48-72: Follow-on Phase|Death|0|||
16164407|NCT00896532|39083691|FG003|Months 48-72: Follow-on Phase|Death|0|||
16164408|NCT00896532|39083692|FG004|Months 48-72: Follow-on Phase|Death|0|||
16164409|NCT00896532|39083693|FG005|Months 48-72: Follow-on Phase|Death|0|||
16164410|NCT00896532|39083694|FG006|Months 48-72: Follow-on Phase|Death|0|||
16373923|NCT01796470|39853328|FG004|Overall Study|Progressive Disease|0|||
16373924|NCT01796470|39853324|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
16373925|NCT01796470|39853325|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
16373926|NCT01796470|39853326|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
16373927|NCT01796470|39853327|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
16373928|NCT01796470|39853328|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
16373929|NCT01796470|39853324|FG000|Overall Study|Withdrawal by Subject|7|||
16373930|NCT01796470|39853325|FG001|Overall Study|Withdrawal by Subject|0|||
16373931|NCT01796470|39853326|FG002|Overall Study|Withdrawal by Subject|0|||
16373932|NCT01796470|39853327|FG003|Overall Study|Withdrawal by Subject|0|||
16373933|NCT01796470|39853328|FG004|Overall Study|Withdrawal by Subject|1|||
16373934|NCT00348374|39853329|FG000|Overall Study|Adverse Event|1|||
16373935|NCT00348374|39853330|FG001|Overall Study|Adverse Event|4|||
16373936|NCT00348374|39853329|FG000|Overall Study|Lost to Follow-up|1|||
16373937|NCT00348374|39853330|FG001|Overall Study|Lost to Follow-up|3|||
16373938|NCT00348374|39853329|FG000|Overall Study|Withdrawal by Subject|5|||
16373939|NCT00348374|39853330|FG001|Overall Study|Withdrawal by Subject|5|||
16373940|NCT00348374|39853329|FG000|Overall Study|Other|11|||
16373941|NCT00348374|39853330|FG001|Overall Study|Other|12|||
16373942|NCT00348374|39853329|FG000|Overall Study|ongoing at date of cutoff|1|||
16373943|NCT00348374|39853330|FG001|Overall Study|ongoing at date of cutoff|1|||
16373944|NCT00348374|39853329|FG000|Overall Study|randomized but did not receive treatment|0|||
16164411|NCT00896532|39083695|FG007|Months 48-72: Follow-on Phase|Death|0|||
16164412|NCT00896532|39083696|FG008|Months 48-72: Follow-on Phase|Death|0|||
16164413|NCT00896532|39083697|FG009|Months 48-72: Follow-on Phase|Death|0|||
16164414|NCT00896532|39083698|FG010|Months 48-72: Follow-on Phase|Death|0|||
16164415|NCT00896532|39083699|FG011|Months 48-72: Follow-on Phase|Death|0|||
16164416|NCT00896532|39083700|FG012|Months 48-72: Follow-on Phase|Death|0|||
16164417|NCT00896532|39083701|FG013|Months 48-72: Follow-on Phase|Death|0|||
16164418|NCT00896532|39083702|FG014|Months 48-72: Follow-on Phase|Death|0|||
16164419|NCT00896532|39083703|FG015|Months 48-72: Follow-on Phase|Death|0|||
16164420|NCT00896532|39083704|FG016|Months 48-72: Follow-on Phase|Death|0|||
16164421|NCT00896532|39083705|FG017|Months 48-72: Follow-on Phase|Death|0|||
16164422|NCT00896532|39083706|FG018|Months 48-72: Follow-on Phase|Death|1|||
16164423|NCT00896532|39083707|FG019|Months 48-72: Follow-on Phase|Death|0|||
16164424|NCT00896532|39083708|FG020|Months 48-72: Follow-on Phase|Death|0|||
16164425|NCT00896532|39083709|FG021|Months 48-72: Follow-on Phase|Death|0|||
16164426|NCT00896532|39083710|FG022|Months 48-72: Follow-on Phase|Death|0|||
16164427|NCT00896532|39083688|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164428|NCT00896532|39083689|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164429|NCT00896532|39083690|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164430|NCT00896532|39083691|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164431|NCT00896532|39083692|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164432|NCT00896532|39083693|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164433|NCT00896532|39083694|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164434|NCT00896532|39083695|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164435|NCT00896532|39083696|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164436|NCT00896532|39083697|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164437|NCT00896532|39083698|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164438|NCT00896532|39083699|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164439|NCT00896532|39083700|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164440|NCT00896532|39083701|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164441|NCT00896532|39083702|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164442|NCT00896532|39083703|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164443|NCT00896532|39083704|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164444|NCT00896532|39083705|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164445|NCT00896532|39083706|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164446|NCT00896532|39083707|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164447|NCT00896532|39083708|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164448|NCT00896532|39083709|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
16373945|NCT00348374|39853330|FG001|Overall Study|randomized but did not receive treatment|7|||
16451997|NCT02834793|40133543|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
16451998|NCT02834793|40133544|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
16451999|NCT02834793|40133545|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
16452000|NCT02834793|40133542|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
16452001|NCT02834793|40133543|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
16452002|NCT02834793|40133544|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
16452003|NCT02834793|40133545|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
16164449|NCT00896532|39083710|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
16164450|NCT00896532|39083688|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164451|NCT00896532|39083689|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16373946|NCT01786109|39853331|FG000|Overall Study|fail manometry barostat tube placement|1|||
16452004|NCT02834793|40133542|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
16373947|NCT01786109|39853332|FG001|Overall Study|fail manometry barostat tube placement|0|||
16373948|NCT01786109|39853333|FG002|Overall Study|fail manometry barostat tube placement|0|||
16373949|NCT01786109|39853331|FG000|Overall Study|unrelated illness|0|||
16373950|NCT01786109|39853332|FG001|Overall Study|unrelated illness|0|||
16373951|NCT01786109|39853333|FG002|Overall Study|unrelated illness|1|||
16373952|NCT01786109|39853331|FG000|Overall Study|adverse effects colon preparation|0|||
16373953|NCT01786109|39853332|FG001|Overall Study|adverse effects colon preparation|0|||
16373954|NCT01786109|39853333|FG002|Overall Study|adverse effects colon preparation|1|||
16373955|NCT00263562|39853334|FG000|Overall Study|Protocol Violation|3|||
16373956|NCT00263562|39853335|FG001|Overall Study|Protocol Violation|0|||
16373957|NCT01852214|39853338|FG000|Period 1|Adverse Event|1|||
16373958|NCT01852214|39853339|FG001|Period 1|Adverse Event|2|||
16373959|NCT01852214|39853338|FG000|Period 1|Withdrawal by Subject|0|||
16373960|NCT01852214|39853339|FG001|Period 1|Withdrawal by Subject|1|||
16373961|NCT01852214|39853338|FG000|Washout Period|Withdrawal by Subject|0|||
16373962|NCT01852214|39853339|FG001|Washout Period|Withdrawal by Subject|1|||
16373963|NCT00203242|39853342|FG000|Overall Study|Lost to Follow-up|1|||
16373964|NCT00553475|39853343|FG000|Overall Study|Adverse Event|7|||
16373965|NCT00553475|39853344|FG001|Overall Study|Adverse Event|17|||
16373966|NCT00553475|39853345|FG002|Overall Study|Adverse Event|13|||
16373967|NCT00553475|39853343|FG000|Overall Study|Lack of Efficacy|7|||
16373968|NCT00553475|39853344|FG001|Overall Study|Lack of Efficacy|1|||
16373969|NCT00553475|39853345|FG002|Overall Study|Lack of Efficacy|0|||
16373970|NCT00553475|39853343|FG000|Overall Study|Withdrawal by Subject|1|||
16373971|NCT00553475|39853344|FG001|Overall Study|Withdrawal by Subject|1|||
16373972|NCT00553475|39853345|FG002|Overall Study|Withdrawal by Subject|0|||
16373973|NCT00553475|39853343|FG000|Overall Study|Physician Decision|1|||
16373974|NCT00553475|39853344|FG001|Overall Study|Physician Decision|0|||
16373975|NCT00553475|39853345|FG002|Overall Study|Physician Decision|0|||
16373976|NCT00553475|39853343|FG000|Overall Study|Due to moving|0|||
16373977|NCT00553475|39853344|FG001|Overall Study|Due to moving|1|||
16373978|NCT00553475|39853345|FG002|Overall Study|Due to moving|0|||
16373979|NCT03335566|39853352|FG000|Overall Study|Adverse Event|0|||
16373980|NCT03335566|39853353|FG001|Overall Study|Adverse Event|1|||
16373981|NCT03335566|39853352|FG000|Overall Study|Lost to Follow-up|1|||
16373982|NCT03335566|39853353|FG001|Overall Study|Lost to Follow-up|0|||
16373983|NCT03335566|39853352|FG000|Overall Study|Technical Problems|1|||
16373984|NCT03335566|39853353|FG001|Overall Study|Technical Problems|0|||
16373985|NCT03335566|39853352|FG000|Overall Study|Protocol Violation|1|||
16373986|NCT03335566|39853353|FG001|Overall Study|Protocol Violation|0|||
16373987|NCT03335566|39853352|FG000|Overall Study|Other than specified above|1|||
16373988|NCT03335566|39853353|FG001|Overall Study|Other than specified above|2|||
16373989|NCT00362609|39853354|FG000|Overall Study|Withdrawal by Subject|0|||
16373990|NCT00362609|39853355|FG001|Overall Study|Withdrawal by Subject|1|||
16373991|NCT00362609|39853354|FG000|Overall Study|Protocol Violation|0|||
16373992|NCT00362609|39853355|FG001|Overall Study|Protocol Violation|1|||
16373993|NCT02904265|39853358|FG000|Overall Study|Physician Decision|1|||
16373994|NCT02904265|39853359|FG001|Overall Study|Physician Decision|2|||
16373995|NCT00124657|39853360|FG000|Overall Study|Toxicity|0|||
16373996|NCT00124657|39853361|FG001|Overall Study|Toxicity|0|||
16373997|NCT00124657|39853362|FG002|Overall Study|Toxicity|1|||
16373998|NCT00124657|39853360|FG000|Overall Study|Non-compliance|1|||
16373999|NCT00124657|39853361|FG001|Overall Study|Non-compliance|0|||
16374000|NCT00124657|39853362|FG002|Overall Study|Non-compliance|4|||
16374001|NCT00124657|39853360|FG000|Overall Study|Progressive disease|14|||
16374002|NCT00124657|39853361|FG001|Overall Study|Progressive disease|5|||
16452005|NCT02834793|40133543|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
16452006|NCT02834793|40133544|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
16452007|NCT02834793|40133545|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
16452008|NCT02834793|40133542|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
16452009|NCT02834793|40133543|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
16452010|NCT02834793|40133544|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
16452011|NCT02834793|40133545|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
16452012|NCT02834793|40133542|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
16452013|NCT02834793|40133543|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
16452014|NCT02834793|40133544|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
16452015|NCT02834793|40133545|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
16164452|NCT00896532|39083690|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164453|NCT00896532|39083691|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16374003|NCT00124657|39853362|FG002|Overall Study|Progressive disease|27|||
16374004|NCT00124657|39853360|FG000|Overall Study|Intercurrent illness|1|||
16374005|NCT00124657|39853361|FG001|Overall Study|Intercurrent illness|0|||
16374006|NCT00124657|39853362|FG002|Overall Study|Intercurrent illness|0|||
16452016|NCT02834793|40133542|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
16452017|NCT02834793|40133543|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
16374007|NCT00266032|39853363|FG000|Treatment|Adverse Event|42|||
16374008|NCT00266032|39853364|FG001|Treatment|Adverse Event|26|||
16452018|NCT02834793|40133544|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
16452019|NCT02834793|40133545|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
16452020|NCT02834793|40133542|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
16452021|NCT02834793|40133543|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
16452022|NCT02834793|40133544|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
16452023|NCT02834793|40133545|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
16452024|NCT02834793|40133542|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
16452025|NCT02834793|40133543|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
16452026|NCT02834793|40133544|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
16452027|NCT02834793|40133545|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
16452028|NCT02834793|40133542|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
16452029|NCT02834793|40133543|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
16452030|NCT02834793|40133544|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
16452031|NCT02834793|40133545|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
16452032|NCT02834793|40133542|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
16452033|NCT02834793|40133543|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
16452034|NCT02834793|40133544|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
16452035|NCT02834793|40133545|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
16452036|NCT00670306|40133546|FG000|Overall Study|Adverse Event|8|||
16452037|NCT00670306|40133546|FG000|Overall Study|Lack of Efficacy|10|||
16452038|NCT00670306|40133546|FG000|Overall Study|Withdrawal by Subject|9|||
16452039|NCT00670306|40133546|FG000|Overall Study|Physician Decision|1|||
16452040|NCT00670306|40133546|FG000|Overall Study|Lost to Follow-up|8|||
16452041|NCT00670306|40133546|FG000|Overall Study|incl/excl criterias did not meet|19|||
16452042|NCT03530124|40133547|FG000|Overall Study|Withdrawal by Subject|0|||
16452043|NCT03530124|40133548|FG001|Overall Study|Withdrawal by Subject|1|||
16452044|NCT03530124|40133547|FG000|Overall Study|Protocol Violation|1|||
16452045|NCT03530124|40133548|FG001|Overall Study|Protocol Violation|0|||
16452046|NCT03530124|40133547|FG000|Overall Study|Discharged prior to study completion|1|||
16452047|NCT03530124|40133548|FG001|Overall Study|Discharged prior to study completion|0|||
16452048|NCT00467753|40133551|FG000|Overall Study|Lost to Follow-up|1|||
16452049|NCT00467753|40133552|FG001|Overall Study|Lost to Follow-up|2|||
16452050|NCT00467753|40133551|FG000|Overall Study|Adverse Event|2|||
16452051|NCT00467753|40133552|FG001|Overall Study|Adverse Event|0|||
16452052|NCT00670748|40133553|FG000|Overall Study|Death during treatment|1|||
16452053|NCT00670748|40133554|FG001|Overall Study|Death during treatment|1|||
16452054|NCT00670748|40133555|FG002|Overall Study|Death during treatment|1|||
16452055|NCT00670748|40133556|FG003|Overall Study|Death during treatment|0|||
16452056|NCT00670748|40133553|FG000|Overall Study|Not off study|2|||
16452057|NCT00670748|40133554|FG001|Overall Study|Not off study|1|||
16452058|NCT00670748|40133555|FG002|Overall Study|Not off study|1|||
16452059|NCT00670748|40133556|FG003|Overall Study|Not off study|1|||
16452060|NCT04041414|40133557|FG000|Overall Study|Lost to Follow-up|1|||
16452061|NCT04041414|40133558|FG001|Overall Study|Lost to Follow-up|2|||
16452062|NCT00705016|40133559|FG000|Overall Study|Adverse Event|6|||
16452063|NCT00705016|40133560|FG001|Overall Study|Adverse Event|11|||
16452064|NCT00705016|40133561|FG002|Overall Study|Adverse Event|10|||
16452065|NCT00705016|40133559|FG000|Overall Study|Death|5|||
16265878|NCT01056484|39456743|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
16265879|NCT01056484|39456744|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
16265880|NCT02647944|39456747|FG000|Overall Study|Withdrawal by Subject|0|||
16265881|NCT02647944|39456748|FG001|Overall Study|Withdrawal by Subject|3|||
16265882|NCT02647944|39456747|FG000|Overall Study|Adverse Event|2|||
16265883|NCT02647944|39456748|FG001|Overall Study|Adverse Event|0|||
16265884|NCT02335658|39456749|FG000|Overall Study|Adverse Event|18|||
16452066|NCT00705016|40133560|FG001|Overall Study|Death|7|||
16452067|NCT00705016|40133561|FG002|Overall Study|Death|5|||
16452068|NCT00705016|40133559|FG000|Overall Study|Protocol Violation|0|||
16452069|NCT00705016|40133560|FG001|Overall Study|Protocol Violation|1|||
16452070|NCT00705016|40133561|FG002|Overall Study|Protocol Violation|1|||
16452071|NCT00705016|40133559|FG000|Overall Study|Withdrawal by Subject|4|||
16452072|NCT00705016|40133560|FG001|Overall Study|Withdrawal by Subject|3|||
16452073|NCT00705016|40133561|FG002|Overall Study|Withdrawal by Subject|2|||
16452074|NCT00705016|40133559|FG000|Overall Study|Progressive Disease|33|||
16452075|NCT00705016|40133560|FG001|Overall Study|Progressive Disease|29|||
16452076|NCT00705016|40133561|FG002|Overall Study|Progressive Disease|33|||
16452077|NCT00705016|40133559|FG000|Overall Study|Symptomatic Deterioration|3|||
16452078|NCT00705016|40133560|FG001|Overall Study|Symptomatic Deterioration|1|||
16452079|NCT00705016|40133561|FG002|Overall Study|Symptomatic Deterioration|1|||
16452080|NCT00705016|40133559|FG000|Overall Study|Other|9|||
16452081|NCT00705016|40133560|FG001|Overall Study|Other|6|||
16452082|NCT00705016|40133561|FG002|Overall Study|Other|6|||
16265885|NCT02335658|39456750|FG001|Overall Study|Adverse Event|12|||
16452083|NCT00882557|40133565|FG000|Overall Study|Withdrawal by Subject|1|||
16452084|NCT00882557|40133566|FG001|Overall Study|Withdrawal by Subject|0|||
16452085|NCT00882557|40133565|FG000|Overall Study|Trouble with Vein Access|1|||
16164454|NCT00896532|39083692|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16374009|NCT00266032|39853365|FG002|Treatment|Adverse Event|10|||
16374010|NCT00266032|39853363|FG000|Treatment|Lost to Follow-up|19|||
16374011|NCT00266032|39853364|FG001|Treatment|Lost to Follow-up|4|||
16374012|NCT00266032|39853365|FG002|Treatment|Lost to Follow-up|2|||
16374013|NCT00266032|39853363|FG000|Treatment|Pregnancy|3|||
16374014|NCT00266032|39853364|FG001|Treatment|Pregnancy|2|||
16374015|NCT00266032|39853365|FG002|Treatment|Pregnancy|2|||
16374016|NCT00266032|39853363|FG000|Treatment|Protocol Violation|6|||
16374017|NCT00266032|39853364|FG001|Treatment|Protocol Violation|14|||
16374018|NCT00266032|39853365|FG002|Treatment|Protocol Violation|13|||
16374019|NCT00266032|39853363|FG000|Treatment|Withdrawal by Subject|28|||
16374020|NCT00266032|39853364|FG001|Treatment|Withdrawal by Subject|13|||
16374021|NCT00266032|39853365|FG002|Treatment|Withdrawal by Subject|12|||
16374022|NCT00266032|39853363|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
16374023|NCT00266032|39853364|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
16374024|NCT00266032|39853365|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
16374025|NCT00266032|39853363|FG000|Open-label Safety Extension|Adverse Event|5|||
16374026|NCT00266032|39853364|FG001|Open-label Safety Extension|Adverse Event|0|||
16374027|NCT00266032|39853365|FG002|Open-label Safety Extension|Adverse Event|4|||
16374028|NCT00266032|39853363|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
16374029|NCT00266032|39853364|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
16374030|NCT00266032|39853365|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
16374031|NCT00266032|39853363|FG000|Open-label Safety Extension|Pregnancy|4|||
16374032|NCT00266032|39853364|FG001|Open-label Safety Extension|Pregnancy|1|||
16374033|NCT00266032|39853365|FG002|Open-label Safety Extension|Pregnancy|2|||
16374034|NCT00266032|39853363|FG000|Open-label Safety Extension|Protocol Violation|1|||
16374035|NCT00266032|39853364|FG001|Open-label Safety Extension|Protocol Violation|3|||
16374036|NCT00266032|39853365|FG002|Open-label Safety Extension|Protocol Violation|2|||
16374037|NCT00266032|39853363|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
16374038|NCT00266032|39853364|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
16374039|NCT00266032|39853365|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
16374040|NCT00266032|39853363|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
16374041|NCT00266032|39853364|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
16374042|NCT00266032|39853365|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
16374043|NCT01936974|39853366|FG000|Overall Study|Physician Decision|2|||
16374044|NCT01936974|39853367|FG001|Overall Study|Physician Decision|5|||
16374045|NCT02766478|39853372|FG000|Overall Study|Withdrawal by Subject|1|||
16374046|NCT02766478|39853373|FG001|Overall Study|Withdrawal by Subject|1|||
16374047|NCT02536339|39853376|FG000|Overall Study|Death|20|||
16374048|NCT02536339|39853376|FG000|Overall Study|Withdrawal by Subject|3|||
16374049|NCT02536339|39853376|FG000|Overall Study|Lost to Follow-up|2|||
16374050|NCT02536339|39853376|FG000|Overall Study|Treatment discontinued|2|||
16374051|NCT02536339|39853376|FG000|Overall Study|Physician Decision|1|||
16374052|NCT00004228|39853377|FG000|Overall Study|Adverse Event|0|||
16374053|NCT00004228|39853378|FG001|Overall Study|Adverse Event|1|||
16374054|NCT00004228|39853379|FG002|Overall Study|Adverse Event|0|||
16374055|NCT00004228|39853380|FG003|Overall Study|Adverse Event|0|||
16374056|NCT00004228|39853381|FG004|Overall Study|Adverse Event|1|||
16374057|NCT00004228|39853382|FG005|Overall Study|Adverse Event|0|||
16374058|NCT00004228|39853383|FG006|Overall Study|Adverse Event|0|||
16374059|NCT00004228|39853377|FG000|Overall Study|Death|0|||
16374060|NCT00004228|39853378|FG001|Overall Study|Death|1|||
16374061|NCT00004228|39853379|FG002|Overall Study|Death|2|||
16374062|NCT00004228|39853380|FG003|Overall Study|Death|0|||
16374063|NCT00004228|39853381|FG004|Overall Study|Death|1|||
16374064|NCT00004228|39853382|FG005|Overall Study|Death|0|||
16374065|NCT00004228|39853383|FG006|Overall Study|Death|0|||
16374066|NCT00004228|39853377|FG000|Overall Study|Lack of Efficacy|1|||
16374067|NCT00004228|39853378|FG001|Overall Study|Lack of Efficacy|6|||
16374068|NCT00004228|39853379|FG002|Overall Study|Lack of Efficacy|5|||
16374069|NCT00004228|39853380|FG003|Overall Study|Lack of Efficacy|3|||
16374070|NCT00004228|39853381|FG004|Overall Study|Lack of Efficacy|9|||
16374071|NCT00004228|39853382|FG005|Overall Study|Lack of Efficacy|8|||
16374072|NCT00004228|39853383|FG006|Overall Study|Lack of Efficacy|4|||
16374073|NCT00004228|39853377|FG000|Overall Study|Lost to Follow-up|0|||
16374074|NCT00004228|39853378|FG001|Overall Study|Lost to Follow-up|0|||
16374075|NCT00004228|39853379|FG002|Overall Study|Lost to Follow-up|1|||
16374076|NCT00004228|39853380|FG003|Overall Study|Lost to Follow-up|0|||
16374077|NCT00004228|39853381|FG004|Overall Study|Lost to Follow-up|0|||
16374078|NCT00004228|39853382|FG005|Overall Study|Lost to Follow-up|0|||
16374079|NCT00004228|39853383|FG006|Overall Study|Lost to Follow-up|0|||
16374080|NCT00004228|39853377|FG000|Overall Study|Physician Decision|1|||
16374081|NCT00004228|39853378|FG001|Overall Study|Physician Decision|0|||
16374082|NCT00004228|39853379|FG002|Overall Study|Physician Decision|3|||
16374083|NCT00004228|39853380|FG003|Overall Study|Physician Decision|2|||
16374084|NCT00004228|39853381|FG004|Overall Study|Physician Decision|1|||
16452086|NCT00882557|40133566|FG001|Overall Study|Trouble with Vein Access|0|||
16452087|NCT00882557|40133565|FG000|Overall Study|Randomized Not Treated|0|||
16452088|NCT00882557|40133566|FG001|Overall Study|Randomized Not Treated|1|||
16452089|NCT01339052|40133567|FG000|Overall Study|Disease progression|13|||
16452090|NCT01339052|40133568|FG001|Overall Study|Disease progression|46|||
16452091|NCT01339052|40133567|FG000|Overall Study|Adverse Event|1|||
16452092|NCT01339052|40133568|FG001|Overall Study|Adverse Event|1|||
16452093|NCT01339052|40133567|FG000|Overall Study|Withdrawal by Subject|0|||
16452094|NCT01339052|40133568|FG001|Overall Study|Withdrawal by Subject|3|||
16452095|NCT01339052|40133567|FG000|Overall Study|Physician Decision|1|||
16164455|NCT00896532|39083693|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16452096|NCT01339052|40133568|FG001|Overall Study|Physician Decision|0|||
16452097|NCT01076361|40133571|FG000|Overall Study|22 leads were excluded from analysis|21|||
16452098|NCT03196349|40133572|FG000|Overall Study|Did not receive study drug|0|||
16452099|NCT03196349|40133573|FG001|Overall Study|Did not receive study drug|1|||
16452100|NCT03196349|40133574|FG002|Overall Study|Did not receive study drug|2|||
16452101|NCT03196349|40133572|FG000|Overall Study|No data entered|2|||
16452102|NCT03196349|40133573|FG001|Overall Study|No data entered|4|||
16452103|NCT03196349|40133574|FG002|Overall Study|No data entered|0|||
16452104|NCT03196349|40133572|FG000|Overall Study|Study Terminated early|15|||
16452105|NCT03196349|40133573|FG001|Overall Study|Study Terminated early|9|||
16452106|NCT03196349|40133574|FG002|Overall Study|Study Terminated early|11|||
16452107|NCT00622440|40133575|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
16452108|NCT00622440|40133576|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
16452109|NCT00622440|40133575|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
16452110|NCT00622440|40133576|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
16452111|NCT00622440|40133575|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
16452112|NCT00622440|40133576|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
16452113|NCT00622440|40133575|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
16452114|NCT00622440|40133576|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
16452115|NCT02725788|40133577|FG000|Overall Study|Lost to Follow-up|1|||
16452116|NCT02725788|40133578|FG001|Overall Study|Lost to Follow-up|1|||
16452117|NCT02725788|40133577|FG000|Overall Study|Protocol Violation|0|||
16452118|NCT02725788|40133578|FG001|Overall Study|Protocol Violation|1|||
16452119|NCT02991040|40133579|FG000|Overall Study|Withdrawal by Subject|2|||
16452120|NCT02991040|40133579|FG000|Overall Study|Lost to Follow-up|2|||
16452121|NCT00241839|40133585|FG000|Overall Study|Withdrawal by Subject|18|||
16164456|NCT00896532|39083694|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164457|NCT00896532|39083695|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164458|NCT00896532|39083696|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164459|NCT00896532|39083697|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164460|NCT00896532|39083698|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164461|NCT00896532|39083699|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16265886|NCT02335658|39456749|FG000|Overall Study|Lack of Efficacy|4|||
16265887|NCT02335658|39456750|FG001|Overall Study|Lack of Efficacy|5|||
16265888|NCT02335658|39456749|FG000|Overall Study|Pregnancy|1|||
16265889|NCT02335658|39456750|FG001|Overall Study|Pregnancy|0|||
16265890|NCT02335658|39456749|FG000|Overall Study|Withdrawal by Subject|13|||
16265891|NCT02335658|39456750|FG001|Overall Study|Withdrawal by Subject|21|||
16265892|NCT02335658|39456749|FG000|Overall Study|non-compliance|2|||
16265893|NCT02335658|39456750|FG001|Overall Study|non-compliance|3|||
16265894|NCT02335658|39456749|FG000|Overall Study|other reason|2|||
16265895|NCT02335658|39456750|FG001|Overall Study|other reason|3|||
16265896|NCT01757392|39456751|FG000|Overall Study|Withdrawal by Subject|1|||
16265897|NCT01757392|39456751|FG000|Overall Study|Screen Fail|3|||
16265898|NCT03956862|39456752|FG000|Overall Study|Lost to Follow-up|1|||
16265899|NCT03956862|39456753|FG001|Overall Study|Lost to Follow-up|1|||
16265900|NCT03956862|39456752|FG000|Overall Study|Withdrawal by Subject|1|||
16265901|NCT03956862|39456753|FG001|Overall Study|Withdrawal by Subject|1|||
16265902|NCT02152163|39456754|FG000|Overall Study|Physician Decision|12|||
16265903|NCT02152163|39456755|FG001|Overall Study|Physician Decision|13|||
16265904|NCT00859430|39456759|FG000|First Intervention|Withdrawal by Subject|0|||
16265905|NCT00859430|39456760|FG001|First Intervention|Withdrawal by Subject|1|||
16265906|NCT00985439|39456762|FG000|Overall Study|Adverse Event|0|||
16265907|NCT00985439|39456763|FG001|Overall Study|Adverse Event|0|||
16265908|NCT00985439|39456764|FG002|Overall Study|Adverse Event|1|||
16265909|NCT00985439|39456765|FG003|Overall Study|Adverse Event|0|||
16164462|NCT00896532|39083700|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16265910|NCT00837486|39456766|FG000|Blinded-treatment Phase|Physician Decision|1|||
16265911|NCT00837486|39456767|FG001|Blinded-treatment Phase|Physician Decision|0|||
16265912|NCT00837486|39456766|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
16265913|NCT00837486|39456767|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
16452122|NCT00241839|40133586|FG001|Overall Study|Withdrawal by Subject|17|||
16452123|NCT00241839|40133585|FG000|Overall Study|Adverse Event|1|||
16452124|NCT00241839|40133586|FG001|Overall Study|Adverse Event|1|||
16452125|NCT02819804|40133587|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
16452126|NCT00828204|40133588|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
16452127|NCT00828204|40133589|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
16452128|NCT00828204|40133588|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
16452129|NCT00828204|40133589|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
16452130|NCT00828204|40133588|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
16452131|NCT00828204|40133589|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
16452132|NCT00828204|40133588|FG000|Main Study: After Study Restart|Adverse Event|0|||
16452133|NCT00828204|40133589|FG001|Main Study: After Study Restart|Adverse Event|2|||
16452134|NCT00828204|40133588|FG000|Main Study: After Study Restart|Noncompliance|0|||
16452135|NCT00828204|40133589|FG001|Main Study: After Study Restart|Noncompliance|1|||
16452136|NCT00828204|40133588|FG000|Extension Study|Lost to Follow-up|0|||
16452137|NCT00828204|40133589|FG001|Extension Study|Lost to Follow-up|1|||
16452138|NCT00828204|40133588|FG000|Extension Study|Physician Decision|0|||
16452139|NCT00828204|40133589|FG001|Extension Study|Physician Decision|2|||
16452140|NCT00521404|40133591|FG000|Overall Study|Adverse Event|13|||
16452141|NCT00521404|40133591|FG000|Overall Study|Disease Progression|33|||
16452142|NCT00521404|40133591|FG000|Overall Study|Investigator decision|5|||
16452143|NCT00521404|40133591|FG000|Overall Study|Withdrawal of consent|3|||
16452144|NCT00521404|40133591|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
16452145|NCT00521404|40133591|FG000|Overall Study|Other|7|||
16452146|NCT01012440|40133592|FG000|Overall Study|Withdrawal by Subject|2|||
16452147|NCT01383356|40133593|FG000|Period 1|Adverse Event|5|||
16452148|NCT01383356|40133594|FG001|Period 1|Adverse Event|3|||
16452149|NCT01383356|40133593|FG000|Period 1|Non-compliance|3|||
16452150|NCT01383356|40133594|FG001|Period 1|Non-compliance|0|||
16452151|NCT01383356|40133593|FG000|Period 1|Out of Range Mid-study-Test|0|||
16452152|NCT01383356|40133594|FG001|Period 1|Out of Range Mid-study-Test|1|||
16452153|NCT01383356|40133593|FG000|Period 1|Personal|0|||
16452154|NCT01383356|40133594|FG001|Period 1|Personal|2|||
16452155|NCT00616759|40133595|FG000|Overall Study|Physician Decision|2|||
16452156|NCT00616759|40133596|FG001|Overall Study|Physician Decision|0|||
16452157|NCT00616759|40133595|FG000|Overall Study|Withdrawal by Subject|1|||
16452158|NCT00616759|40133596|FG001|Overall Study|Withdrawal by Subject|2|||
16452159|NCT01039519|40133597|FG000|Treatment|Progressive disease|20|||
16452160|NCT01039519|40133597|FG000|Treatment|Treatment failure|2|||
16452161|NCT01039519|40133597|FG000|Treatment|Adverse Event|3|||
16452162|NCT01039519|40133597|FG000|Treatment|Physician Decision|2|||
16452163|NCT01039519|40133597|FG000|Survival Follow-up|Death|23|||
16452164|NCT01039519|40133597|FG000|Survival Follow-up|Sponsor decision|4|||
16452165|NCT01192191|40133598|FG000|Overall Study|Adverse Event|7|||
16452166|NCT01192191|40133599|FG001|Overall Study|Adverse Event|12|||
16452167|NCT01192191|40133598|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
16452168|NCT01192191|40133599|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
16452169|NCT01192191|40133598|FG000|Overall Study|Lost to Follow-up|0|||
16452170|NCT01192191|40133599|FG001|Overall Study|Lost to Follow-up|1|||
16452171|NCT01192191|40133598|FG000|Overall Study|Withdrawal by Subject|1|||
16452172|NCT01192191|40133599|FG001|Overall Study|Withdrawal by Subject|6|||
16452173|NCT00345358|40133600|FG000|Primary Vaccination Phase|Other|0|||
16164463|NCT00896532|39083701|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164464|NCT00896532|39083702|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16452174|NCT00345358|40133601|FG001|Primary Vaccination Phase|Other|1|||
16452175|NCT00345358|40133602|FG002|Primary Vaccination Phase|Other|1|||
16452176|NCT00345358|40133603|FG003|Primary Vaccination Phase|Other|0|||
16452177|NCT00345358|40133600|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
16164465|NCT00896532|39083703|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16265914|NCT00837486|39456766|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
16265915|NCT00837486|39456767|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
16452178|NCT00345358|40133601|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
16452179|NCT00345358|40133602|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
16452180|NCT00345358|40133603|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
16452181|NCT00345358|40133600|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
16265916|NCT00837486|39456766|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
16452182|NCT00345358|40133601|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
16452183|NCT00345358|40133602|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
16452184|NCT00345358|40133603|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
16452185|NCT00345358|40133600|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
16452186|NCT00345358|40133601|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
16452187|NCT00345358|40133602|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
16452188|NCT00345358|40133603|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
16265917|NCT00837486|39456767|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
16164466|NCT00896532|39083704|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16452189|NCT00345358|40133600|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
16452190|NCT00345358|40133601|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
16452191|NCT00345358|40133602|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
16452192|NCT00345358|40133603|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
16452193|NCT00345358|40133600|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
16452194|NCT00345358|40133601|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
16452195|NCT00345358|40133602|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
16452196|NCT00345358|40133603|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
16452197|NCT01075685|40133604|FG000|Overall Study|Protocol Violation|9|||
16452198|NCT01075685|40133605|FG001|Overall Study|Protocol Violation|1|||
16452199|NCT01075685|40133604|FG000|Overall Study|Withdrawal by Subject|20|||
16452200|NCT01075685|40133605|FG001|Overall Study|Withdrawal by Subject|5|||
16452201|NCT01075685|40133604|FG000|Overall Study|Lost to Follow-up|563|||
16452202|NCT01075685|40133605|FG001|Overall Study|Lost to Follow-up|220|||
16452203|NCT03052426|40133608|FG000|Overall Study|Withdrawal by Subject|0|||
16452204|NCT03052426|40133609|FG001|Overall Study|Withdrawal by Subject|1|||
16452205|NCT03052426|40133610|FG002|Overall Study|Withdrawal by Subject|0|||
16452206|NCT03052426|40133608|FG000|Overall Study|Lost to Follow-up|2|||
16452207|NCT03052426|40133609|FG001|Overall Study|Lost to Follow-up|0|||
16452208|NCT03052426|40133610|FG002|Overall Study|Lost to Follow-up|1|||
16452209|NCT00885534|40133613|FG000|Overall Study|Patient deemed ineligible|1|||
16452210|NCT00363480|40133614|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
16452211|NCT00363480|40133614|FG000|Overall Study|Adverse Event|4|||
16452212|NCT00363480|40133614|FG000|Overall Study|Lost to Follow-up|5|||
16452213|NCT00363480|40133614|FG000|Overall Study|Withdrawal by Subject|5|||
16452214|NCT00363480|40133614|FG000|Overall Study|Non-compliance of subject|1|||
16452215|NCT00363480|40133614|FG000|Overall Study|Participant discontinued on its own|1|||
16452216|NCT04421027|40133615|FG000|Treatment Period|Adverse Event|5|||
16452217|NCT04421027|40133616|FG001|Treatment Period|Adverse Event|3|||
16452218|NCT04421027|40133617|FG002|Treatment Period|Adverse Event|0|||
16452219|NCT04421027|40133618|FG003|Treatment Period|Adverse Event|0|||
16452220|NCT04421027|40133615|FG000|Treatment Period|Death|98|||
16452221|NCT04421027|40133616|FG001|Treatment Period|Death|61|||
16452222|NCT04421027|40133617|FG002|Treatment Period|Death|0|||
16452223|NCT04421027|40133618|FG003|Treatment Period|Death|0|||
16452224|NCT04421027|40133615|FG000|Treatment Period|Lost to Follow-up|22|||
16452225|NCT04421027|40133616|FG001|Treatment Period|Lost to Follow-up|20|||
16452226|NCT04421027|40133617|FG002|Treatment Period|Lost to Follow-up|0|||
16452227|NCT04421027|40133618|FG003|Treatment Period|Lost to Follow-up|0|||
16452228|NCT04421027|40133615|FG000|Treatment Period|Other-Unknown|15|||
16452229|NCT04421027|40133616|FG001|Treatment Period|Other-Unknown|9|||
16452230|NCT04421027|40133617|FG002|Treatment Period|Other-Unknown|0|||
16452231|NCT04421027|40133618|FG003|Treatment Period|Other-Unknown|0|||
16452232|NCT04421027|40133615|FG000|Treatment Period|Physician Decision|1|||
16452233|NCT04421027|40133616|FG001|Treatment Period|Physician Decision|1|||
16452234|NCT04421027|40133617|FG002|Treatment Period|Physician Decision|0|||
16452235|NCT04421027|40133618|FG003|Treatment Period|Physician Decision|0|||
16452236|NCT04421027|40133615|FG000|Treatment Period|Withdrawal by Subject|7|||
16452237|NCT04421027|40133616|FG001|Treatment Period|Withdrawal by Subject|12|||
16452238|NCT04421027|40133617|FG002|Treatment Period|Withdrawal by Subject|0|||
16452239|NCT04421027|40133618|FG003|Treatment Period|Withdrawal by Subject|0|||
16452240|NCT04421027|40133615|FG000|Treatment Period|Randomized Not Dosed|9|||
16452241|NCT04421027|40133616|FG001|Treatment Period|Randomized Not Dosed|14|||
16452242|NCT04421027|40133617|FG002|Treatment Period|Randomized Not Dosed|0|||
16452243|NCT04421027|40133618|FG003|Treatment Period|Randomized Not Dosed|0|||
16452244|NCT04421027|40133615|FG000|Follow-Up Period|Adverse Event|0|||
16452245|NCT04421027|40133616|FG001|Follow-Up Period|Adverse Event|0|||
16452246|NCT04421027|40133617|FG002|Follow-Up Period|Adverse Event|0|||
16452247|NCT04421027|40133618|FG003|Follow-Up Period|Adverse Event|3|||
16452248|NCT04421027|40133615|FG000|Follow-Up Period|Death|0|||
16452249|NCT04421027|40133616|FG001|Follow-Up Period|Death|0|||
16452250|NCT04421027|40133617|FG002|Follow-Up Period|Death|16|||
16452251|NCT04421027|40133618|FG003|Follow-Up Period|Death|17|||
16452252|NCT04421027|40133615|FG000|Follow-Up Period|Lost to Follow-up|0|||
16452253|NCT04421027|40133616|FG001|Follow-Up Period|Lost to Follow-up|0|||
16452254|NCT04421027|40133617|FG002|Follow-Up Period|Lost to Follow-up|7|||
16452255|NCT04421027|40133618|FG003|Follow-Up Period|Lost to Follow-up|7|||
16452256|NCT04421027|40133615|FG000|Follow-Up Period|Protocol Deviation|0|||
16452257|NCT04421027|40133616|FG001|Follow-Up Period|Protocol Deviation|0|||
16452258|NCT04421027|40133617|FG002|Follow-Up Period|Protocol Deviation|1|||
16452259|NCT04421027|40133618|FG003|Follow-Up Period|Protocol Deviation|0|||
16452260|NCT04421027|40133615|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
16452261|NCT04421027|40133616|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
16452262|NCT04421027|40133617|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
16452263|NCT04421027|40133618|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
16452264|NCT04421027|40133615|FG000|Follow-Up Period|Left message, participant did not call back|0|||
16452265|NCT04421027|40133616|FG001|Follow-Up Period|Left message, participant did not call back|0|||
16452266|NCT04421027|40133617|FG002|Follow-Up Period|Left message, participant did not call back|0|||
16452267|NCT04421027|40133618|FG003|Follow-Up Period|Left message, participant did not call back|1|||
16452268|NCT04421027|40133615|FG000|Follow-Up Period|Participant died|0|||
16452269|NCT04421027|40133616|FG001|Follow-Up Period|Participant died|0|||
16452270|NCT04421027|40133617|FG002|Follow-Up Period|Participant died|0|||
16452271|NCT04421027|40133618|FG003|Follow-Up Period|Participant died|1|||
16452272|NCT04421027|40133615|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
16452273|NCT04421027|40133616|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
16374085|NCT00004228|39853382|FG005|Overall Study|Physician Decision|1|||
16374086|NCT00004228|39853383|FG006|Overall Study|Physician Decision|1|||
16374087|NCT00004228|39853377|FG000|Overall Study|Protocol Violation|0|||
16374088|NCT00004228|39853378|FG001|Overall Study|Protocol Violation|5|||
16374089|NCT00004228|39853379|FG002|Overall Study|Protocol Violation|2|||
16374090|NCT00004228|39853380|FG003|Overall Study|Protocol Violation|1|||
16374091|NCT00004228|39853381|FG004|Overall Study|Protocol Violation|1|||
16374092|NCT00004228|39853382|FG005|Overall Study|Protocol Violation|2|||
16374093|NCT00004228|39853383|FG006|Overall Study|Protocol Violation|0|||
16374094|NCT00004228|39853377|FG000|Overall Study|Withdrawal by Subject|3|||
16374095|NCT00004228|39853378|FG001|Overall Study|Withdrawal by Subject|0|||
16374096|NCT00004228|39853379|FG002|Overall Study|Withdrawal by Subject|1|||
16374097|NCT00004228|39853380|FG003|Overall Study|Withdrawal by Subject|0|||
16374098|NCT00004228|39853381|FG004|Overall Study|Withdrawal by Subject|2|||
16374099|NCT00004228|39853382|FG005|Overall Study|Withdrawal by Subject|1|||
16374100|NCT00004228|39853383|FG006|Overall Study|Withdrawal by Subject|2|||
16374101|NCT00004228|39853377|FG000|Overall Study|Other|0|||
16374102|NCT00004228|39853378|FG001|Overall Study|Other|0|||
16374103|NCT00004228|39853379|FG002|Overall Study|Other|1|||
16374104|NCT00004228|39853380|FG003|Overall Study|Other|0|||
16374105|NCT00004228|39853381|FG004|Overall Study|Other|0|||
16374106|NCT00004228|39853382|FG005|Overall Study|Other|0|||
16374107|NCT00004228|39853383|FG006|Overall Study|Other|0|||
16374108|NCT00004228|39853377|FG000|Overall Study|ineligible|4|||
16374109|NCT00004228|39853378|FG001|Overall Study|ineligible|2|||
16374110|NCT00004228|39853379|FG002|Overall Study|ineligible|4|||
16374111|NCT00004228|39853380|FG003|Overall Study|ineligible|1|||
16374112|NCT00004228|39853381|FG004|Overall Study|ineligible|1|||
16374113|NCT00004228|39853382|FG005|Overall Study|ineligible|2|||
16374114|NCT00004228|39853383|FG006|Overall Study|ineligible|5|||
16374115|NCT01184118|39853384|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
16374116|NCT01184118|39853384|FG000|Overall Study|No physiologic confirmation of asthma|8|||
16374117|NCT01184118|39853384|FG000|Overall Study|FEV1 <60% predicted|2|||
16374118|NCT01184118|39853384|FG000|Overall Study|Exclusionary medical condition|2|||
16374119|NCT01184118|39853384|FG000|Overall Study|Withdrawal by Subject|5|||
16374120|NCT03438656|39853391|FG000|Overall Study|Lost to Follow-up|2|||
16452274|NCT04421027|40133617|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
16452275|NCT04421027|40133618|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
16452276|NCT03809104|40133619|FG000|Overall Study|Withdrawal by Subject|3|||
16452277|NCT00802945|40133620|FG000|Overall Study|Death|27|||
16452278|NCT00802945|40133621|FG001|Overall Study|Death|23|||
16452279|NCT00802945|40133620|FG000|Overall Study|Terminated by sponsor|8|||
16452280|NCT00802945|40133621|FG001|Overall Study|Terminated by sponsor|12|||
16452281|NCT00372593|40133625|FG000|Overall Study|Adverse Event|43|||
16452282|NCT00372593|40133626|FG001|Overall Study|Adverse Event|45|||
16452283|NCT00372593|40133627|FG002|Overall Study|Adverse Event|0|||
16452284|NCT00372593|40133625|FG000|Overall Study|Death|16|||
16452285|NCT00372593|40133626|FG001|Overall Study|Death|20|||
16452286|NCT00372593|40133627|FG002|Overall Study|Death|1|||
16452287|NCT00372593|40133625|FG000|Overall Study|Lack of Efficacy|82|||
16452288|NCT00372593|40133626|FG001|Overall Study|Lack of Efficacy|71|||
16452289|NCT00372593|40133627|FG002|Overall Study|Lack of Efficacy|2|||
16452290|NCT00372593|40133625|FG000|Overall Study|Lost to Follow-up|1|||
16452291|NCT00372593|40133626|FG001|Overall Study|Lost to Follow-up|0|||
16452292|NCT00372593|40133627|FG002|Overall Study|Lost to Follow-up|0|||
16452293|NCT00372593|40133625|FG000|Overall Study|Physician Decision|42|||
16452294|NCT00372593|40133626|FG001|Overall Study|Physician Decision|41|||
16452295|NCT00372593|40133627|FG002|Overall Study|Physician Decision|0|||
16452296|NCT00372593|40133625|FG000|Overall Study|Ineligible|20|||
16452297|NCT00372593|40133626|FG001|Overall Study|Ineligible|21|||
16452298|NCT00372593|40133627|FG002|Overall Study|Ineligible|1|||
16452299|NCT00790842|40133629|FG000|Dose Level 1|Adverse Event|1|||
16452300|NCT00790842|40133630|FG001|Dose Level 1|Adverse Event|0|||
16452301|NCT00790842|40133631|FG002|Dose Level 1|Adverse Event|0|||
16452302|NCT00790842|40133632|FG003|Dose Level 1|Adverse Event|2|||
16452303|NCT00790842|40133633|FG004|Dose Level 1|Adverse Event|0|||
16452304|NCT00790842|40133634|FG005|Dose Level 1|Adverse Event|0|||
16452305|NCT00790842|40133635|FG006|Dose Level 1|Adverse Event|0|||
16452306|NCT00790842|40133636|FG007|Dose Level 1|Adverse Event|1|||
16452307|NCT00790842|40133637|FG008|Dose Level 1|Adverse Event|0|||
16452308|NCT00790842|40133638|FG009|Dose Level 1|Adverse Event|0|||
16452309|NCT00790842|40133639|FG010|Dose Level 1|Adverse Event|0|||
16452310|NCT00790842|40133629|FG000|Dose Level 1|Physician Decision|1|||
16452311|NCT00790842|40133630|FG001|Dose Level 1|Physician Decision|0|||
16452312|NCT00790842|40133631|FG002|Dose Level 1|Physician Decision|0|||
16452313|NCT00790842|40133632|FG003|Dose Level 1|Physician Decision|0|||
16452314|NCT00790842|40133633|FG004|Dose Level 1|Physician Decision|0|||
16452315|NCT00790842|40133634|FG005|Dose Level 1|Physician Decision|0|||
16452316|NCT00790842|40133635|FG006|Dose Level 1|Physician Decision|0|||
16452317|NCT00790842|40133636|FG007|Dose Level 1|Physician Decision|1|||
16452318|NCT00790842|40133637|FG008|Dose Level 1|Physician Decision|0|||
16452319|NCT00790842|40133638|FG009|Dose Level 1|Physician Decision|0|||
16452320|NCT00790842|40133639|FG010|Dose Level 1|Physician Decision|0|||
16452321|NCT00790842|40133629|FG000|Dose Level 1|Withdrawal by Subject|1|||
16452322|NCT00790842|40133630|FG001|Dose Level 1|Withdrawal by Subject|0|||
16452323|NCT00790842|40133631|FG002|Dose Level 1|Withdrawal by Subject|0|||
16452324|NCT00790842|40133632|FG003|Dose Level 1|Withdrawal by Subject|0|||
16452325|NCT00790842|40133633|FG004|Dose Level 1|Withdrawal by Subject|0|||
16452326|NCT00790842|40133634|FG005|Dose Level 1|Withdrawal by Subject|0|||
16452327|NCT00790842|40133635|FG006|Dose Level 1|Withdrawal by Subject|0|||
16452328|NCT00790842|40133636|FG007|Dose Level 1|Withdrawal by Subject|0|||
16452329|NCT00790842|40133637|FG008|Dose Level 1|Withdrawal by Subject|0|||
16452330|NCT00790842|40133638|FG009|Dose Level 1|Withdrawal by Subject|0|||
16452331|NCT00790842|40133639|FG010|Dose Level 1|Withdrawal by Subject|0|||
16452332|NCT00790842|40133629|FG000|Dose Level 2|Death|0|||
16452333|NCT00790842|40133630|FG001|Dose Level 2|Death|1|||
16452334|NCT00790842|40133631|FG002|Dose Level 2|Death|0|||
16164467|NCT00896532|39083705|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164468|NCT00896532|39083706|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164469|NCT00896532|39083707|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164470|NCT00896532|39083708|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164471|NCT00896532|39083709|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
16164472|NCT00896532|39083710|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
16164473|NCT02397473|39083711|FG000|Treatment Phase|Adverse Event|1|||
16164474|NCT02397473|39083712|FG001|Treatment Phase|Adverse Event|2|||
16164475|NCT02397473|39083711|FG000|Treatment Phase|Lack of Efficacy|8|||
16164476|NCT02397473|39083712|FG001|Treatment Phase|Lack of Efficacy|1|||
16164477|NCT02397473|39083711|FG000|Treatment Phase|Lost to Follow-up|1|||
16164478|NCT02397473|39083712|FG001|Treatment Phase|Lost to Follow-up|0|||
16164479|NCT02397473|39083711|FG000|Treatment Phase|Withdrawal by Subject|2|||
16164480|NCT02397473|39083712|FG001|Treatment Phase|Withdrawal by Subject|1|||
16164481|NCT02397473|39083711|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
16164482|NCT02397473|39083712|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
16164483|NCT02397473|39083711|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
16164484|NCT02397473|39083712|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
16164485|NCT02397473|39083711|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
16164486|NCT02397473|39083712|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
16164487|NCT02397473|39083711|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
16164488|NCT02397473|39083712|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
16164489|NCT02397473|39083711|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
16164490|NCT02397473|39083712|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
16164491|NCT01995071|39083713|FG000|Overall Study|Adverse Event|0|||
16164492|NCT01995071|39083714|FG001|Overall Study|Adverse Event|0|||
16164493|NCT01995071|39083715|FG002|Overall Study|Adverse Event|0|||
16164494|NCT01995071|39083716|FG003|Overall Study|Adverse Event|0|||
16164495|NCT01995071|39083717|FG004|Overall Study|Adverse Event|0|||
16164496|NCT01995071|39083718|FG005|Overall Study|Adverse Event|0|||
16164497|NCT01995071|39083719|FG006|Overall Study|Adverse Event|1|||
16164498|NCT01995071|39083720|FG007|Overall Study|Adverse Event|0|||
16164499|NCT01995071|39083721|FG008|Overall Study|Adverse Event|0|||
16164500|NCT01995071|39083722|FG009|Overall Study|Adverse Event|0|||
16164501|NCT01995071|39083723|FG010|Overall Study|Adverse Event|0|||
16164502|NCT01995071|39083724|FG011|Overall Study|Adverse Event|0|||
16164503|NCT01995071|39083713|FG000|Overall Study|Moved|0|||
16164504|NCT01995071|39083714|FG001|Overall Study|Moved|0|||
16452335|NCT00790842|40133632|FG003|Dose Level 2|Death|0|||
16452336|NCT00790842|40133633|FG004|Dose Level 2|Death|1|||
16452337|NCT00790842|40133634|FG005|Dose Level 2|Death|0|||
16452338|NCT00790842|40133635|FG006|Dose Level 2|Death|0|||
16452339|NCT00790842|40133636|FG007|Dose Level 2|Death|0|||
16164505|NCT01995071|39083715|FG002|Overall Study|Moved|1|||
16164506|NCT01995071|39083716|FG003|Overall Study|Moved|0|||
16164507|NCT01995071|39083717|FG004|Overall Study|Moved|1|||
16164508|NCT01995071|39083718|FG005|Overall Study|Moved|0|||
16164509|NCT01995071|39083719|FG006|Overall Study|Moved|0|||
16452340|NCT00790842|40133637|FG008|Dose Level 2|Death|0|||
16452341|NCT00790842|40133638|FG009|Dose Level 2|Death|0|||
16452342|NCT00790842|40133639|FG010|Dose Level 2|Death|0|||
16452343|NCT00790842|40133629|FG000|Dose Level 2|Physician Decision|0|||
16452344|NCT00790842|40133630|FG001|Dose Level 2|Physician Decision|1|||
16452345|NCT00790842|40133631|FG002|Dose Level 2|Physician Decision|0|||
16452346|NCT00790842|40133632|FG003|Dose Level 2|Physician Decision|0|||
16452347|NCT00790842|40133633|FG004|Dose Level 2|Physician Decision|0|||
16452348|NCT00790842|40133634|FG005|Dose Level 2|Physician Decision|0|||
16452349|NCT00790842|40133635|FG006|Dose Level 2|Physician Decision|0|||
16452350|NCT00790842|40133636|FG007|Dose Level 2|Physician Decision|0|||
16452351|NCT00790842|40133637|FG008|Dose Level 2|Physician Decision|0|||
16452352|NCT00790842|40133638|FG009|Dose Level 2|Physician Decision|0|||
16452353|NCT00790842|40133639|FG010|Dose Level 2|Physician Decision|0|||
16452354|NCT00790842|40133629|FG000|Dose Level 2|Withdrawal by Subject|0|||
16452355|NCT00790842|40133630|FG001|Dose Level 2|Withdrawal by Subject|1|||
16452356|NCT00790842|40133631|FG002|Dose Level 2|Withdrawal by Subject|0|||
16452357|NCT00790842|40133632|FG003|Dose Level 2|Withdrawal by Subject|0|||
16452358|NCT00790842|40133633|FG004|Dose Level 2|Withdrawal by Subject|0|||
16452359|NCT00790842|40133634|FG005|Dose Level 2|Withdrawal by Subject|0|||
16452360|NCT00790842|40133635|FG006|Dose Level 2|Withdrawal by Subject|0|||
16452361|NCT00790842|40133636|FG007|Dose Level 2|Withdrawal by Subject|0|||
16452362|NCT00790842|40133637|FG008|Dose Level 2|Withdrawal by Subject|0|||
16452363|NCT00790842|40133638|FG009|Dose Level 2|Withdrawal by Subject|0|||
16452364|NCT00790842|40133639|FG010|Dose Level 2|Withdrawal by Subject|0|||
16452365|NCT00790842|40133629|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
16452366|NCT00790842|40133630|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
16452367|NCT00790842|40133631|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
16452368|NCT00790842|40133632|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
16452369|NCT00790842|40133633|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
16452370|NCT00790842|40133634|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
16452371|NCT00790842|40133635|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
16452372|NCT00790842|40133636|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
16452373|NCT00790842|40133637|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
16452374|NCT00790842|40133638|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
16452375|NCT00790842|40133639|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
16452376|NCT00790842|40133629|FG000|Dose Level 3|Adverse Event|0|||
16452377|NCT00790842|40133630|FG001|Dose Level 3|Adverse Event|0|||
16452378|NCT00790842|40133631|FG002|Dose Level 3|Adverse Event|1|||
16452379|NCT00790842|40133632|FG003|Dose Level 3|Adverse Event|0|||
16452380|NCT00790842|40133633|FG004|Dose Level 3|Adverse Event|0|||
16452381|NCT00790842|40133634|FG005|Dose Level 3|Adverse Event|0|||
16452382|NCT00790842|40133635|FG006|Dose Level 3|Adverse Event|0|||
16452383|NCT00790842|40133636|FG007|Dose Level 3|Adverse Event|0|||
16265918|NCT00549718|39456768|FG000|Overall Study|Insufficient clinical response|20|||
16452384|NCT00790842|40133637|FG008|Dose Level 3|Adverse Event|0|||
16452385|NCT00790842|40133638|FG009|Dose Level 3|Adverse Event|0|||
16452386|NCT00790842|40133639|FG010|Dose Level 3|Adverse Event|0|||
16452387|NCT00790842|40133629|FG000|Dose Level 3|Withdrawal by Subject|0|||
16452388|NCT00790842|40133630|FG001|Dose Level 3|Withdrawal by Subject|0|||
16452389|NCT00790842|40133631|FG002|Dose Level 3|Withdrawal by Subject|3|||
16452390|NCT00790842|40133632|FG003|Dose Level 3|Withdrawal by Subject|0|||
16452391|NCT00790842|40133633|FG004|Dose Level 3|Withdrawal by Subject|0|||
16452392|NCT00790842|40133634|FG005|Dose Level 3|Withdrawal by Subject|0|||
16452393|NCT00790842|40133635|FG006|Dose Level 3|Withdrawal by Subject|0|||
16452394|NCT00790842|40133636|FG007|Dose Level 3|Withdrawal by Subject|0|||
16452395|NCT00790842|40133637|FG008|Dose Level 3|Withdrawal by Subject|0|||
16452396|NCT00790842|40133638|FG009|Dose Level 3|Withdrawal by Subject|2|||
16452397|NCT00790842|40133639|FG010|Dose Level 3|Withdrawal by Subject|0|||
16452398|NCT00790842|40133629|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
16452399|NCT00790842|40133630|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
16452400|NCT00790842|40133631|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
16452401|NCT00790842|40133632|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
16452402|NCT00790842|40133633|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
16452403|NCT00790842|40133634|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
16452404|NCT00790842|40133635|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
16452405|NCT00790842|40133636|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
16452406|NCT00790842|40133637|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
16452407|NCT00790842|40133638|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
16452408|NCT00790842|40133639|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
16452409|NCT00790842|40133629|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
16452410|NCT00790842|40133630|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
16452411|NCT00790842|40133631|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
16452412|NCT00790842|40133632|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
16452413|NCT00790842|40133633|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
16452414|NCT00790842|40133634|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
16452415|NCT00790842|40133635|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
16452416|NCT00790842|40133636|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
16452417|NCT00790842|40133637|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
16452418|NCT00790842|40133638|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
16452419|NCT00790842|40133639|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
16452420|NCT00790842|40133629|FG000|Dose Level 4|Adverse Event|0|||
16452421|NCT00790842|40133630|FG001|Dose Level 4|Adverse Event|0|||
16452422|NCT00790842|40133631|FG002|Dose Level 4|Adverse Event|0|||
16452423|NCT00790842|40133632|FG003|Dose Level 4|Adverse Event|0|||
16452424|NCT00790842|40133633|FG004|Dose Level 4|Adverse Event|0|||
16452425|NCT00790842|40133634|FG005|Dose Level 4|Adverse Event|0|||
16452426|NCT00790842|40133635|FG006|Dose Level 4|Adverse Event|1|||
16452427|NCT00790842|40133636|FG007|Dose Level 4|Adverse Event|0|||
16452428|NCT00790842|40133637|FG008|Dose Level 4|Adverse Event|0|||
16452429|NCT00790842|40133638|FG009|Dose Level 4|Adverse Event|0|||
16452430|NCT00790842|40133639|FG010|Dose Level 4|Adverse Event|0|||
16452431|NCT00790842|40133629|FG000|Dose Level 4|Physician Decision|0|||
16452432|NCT00790842|40133630|FG001|Dose Level 4|Physician Decision|0|||
16452433|NCT00790842|40133631|FG002|Dose Level 4|Physician Decision|0|||
16452434|NCT00790842|40133632|FG003|Dose Level 4|Physician Decision|0|||
16452435|NCT00790842|40133633|FG004|Dose Level 4|Physician Decision|0|||
16452436|NCT00790842|40133634|FG005|Dose Level 4|Physician Decision|0|||
16452437|NCT00790842|40133635|FG006|Dose Level 4|Physician Decision|1|||
16452438|NCT00790842|40133636|FG007|Dose Level 4|Physician Decision|0|||
16452439|NCT00790842|40133637|FG008|Dose Level 4|Physician Decision|0|||
16452440|NCT00790842|40133638|FG009|Dose Level 4|Physician Decision|0|||
16452441|NCT00790842|40133639|FG010|Dose Level 4|Physician Decision|1|||
16452442|NCT00790842|40133629|FG000|Dose Level 4|Withdrawal by Subject|0|||
16452443|NCT00790842|40133630|FG001|Dose Level 4|Withdrawal by Subject|0|||
16452444|NCT00790842|40133631|FG002|Dose Level 4|Withdrawal by Subject|0|||
16452445|NCT00790842|40133632|FG003|Dose Level 4|Withdrawal by Subject|0|||
16452446|NCT00790842|40133633|FG004|Dose Level 4|Withdrawal by Subject|0|||
16452447|NCT00790842|40133634|FG005|Dose Level 4|Withdrawal by Subject|0|||
16452448|NCT00790842|40133635|FG006|Dose Level 4|Withdrawal by Subject|0|||
16452449|NCT00790842|40133636|FG007|Dose Level 4|Withdrawal by Subject|0|||
16452450|NCT00790842|40133637|FG008|Dose Level 4|Withdrawal by Subject|0|||
16452451|NCT00790842|40133638|FG009|Dose Level 4|Withdrawal by Subject|0|||
16452452|NCT00790842|40133639|FG010|Dose Level 4|Withdrawal by Subject|1|||
16452453|NCT00790842|40133629|FG000|Expansion Cohort|Adverse Event|0|||
16452454|NCT00790842|40133630|FG001|Expansion Cohort|Adverse Event|0|||
16452455|NCT00790842|40133631|FG002|Expansion Cohort|Adverse Event|0|||
16452456|NCT00790842|40133632|FG003|Expansion Cohort|Adverse Event|0|||
16452457|NCT00790842|40133633|FG004|Expansion Cohort|Adverse Event|0|||
16452458|NCT00790842|40133634|FG005|Expansion Cohort|Adverse Event|0|||
16452459|NCT00790842|40133635|FG006|Expansion Cohort|Adverse Event|1|||
16452460|NCT00790842|40133636|FG007|Expansion Cohort|Adverse Event|0|||
16452461|NCT00790842|40133637|FG008|Expansion Cohort|Adverse Event|0|||
16452462|NCT00790842|40133638|FG009|Expansion Cohort|Adverse Event|0|||
16452463|NCT00790842|40133639|FG010|Expansion Cohort|Adverse Event|0|||
16452464|NCT00790842|40133629|FG000|Expansion Cohort|Death|0|||
16452465|NCT00790842|40133630|FG001|Expansion Cohort|Death|0|||
16452466|NCT00790842|40133631|FG002|Expansion Cohort|Death|2|||
16452467|NCT00790842|40133632|FG003|Expansion Cohort|Death|0|||
16452468|NCT00790842|40133633|FG004|Expansion Cohort|Death|0|||
16452469|NCT00790842|40133634|FG005|Expansion Cohort|Death|0|||
16452470|NCT00790842|40133635|FG006|Expansion Cohort|Death|0|||
16452471|NCT00790842|40133636|FG007|Expansion Cohort|Death|0|||
16452472|NCT00790842|40133637|FG008|Expansion Cohort|Death|0|||
16452473|NCT00790842|40133638|FG009|Expansion Cohort|Death|0|||
16452474|NCT00790842|40133639|FG010|Expansion Cohort|Death|0|||
16452475|NCT00790842|40133629|FG000|Expansion Cohort|Physician Decision|0|||
16452476|NCT00790842|40133630|FG001|Expansion Cohort|Physician Decision|0|||
16452477|NCT00790842|40133631|FG002|Expansion Cohort|Physician Decision|1|||
16452478|NCT00790842|40133632|FG003|Expansion Cohort|Physician Decision|0|||
16452479|NCT00790842|40133633|FG004|Expansion Cohort|Physician Decision|0|||
16452480|NCT00790842|40133634|FG005|Expansion Cohort|Physician Decision|0|||
16452481|NCT00790842|40133635|FG006|Expansion Cohort|Physician Decision|0|||
16452482|NCT00790842|40133636|FG007|Expansion Cohort|Physician Decision|0|||
16452483|NCT00790842|40133637|FG008|Expansion Cohort|Physician Decision|0|||
16452484|NCT00790842|40133638|FG009|Expansion Cohort|Physician Decision|0|||
16452485|NCT00790842|40133639|FG010|Expansion Cohort|Physician Decision|0|||
16452486|NCT00790842|40133629|FG000|Expansion Cohort|Withdrawal by Subject|0|||
16452487|NCT00790842|40133630|FG001|Expansion Cohort|Withdrawal by Subject|0|||
16452488|NCT00790842|40133631|FG002|Expansion Cohort|Withdrawal by Subject|3|||
16452489|NCT00790842|40133632|FG003|Expansion Cohort|Withdrawal by Subject|0|||
16452490|NCT00790842|40133633|FG004|Expansion Cohort|Withdrawal by Subject|0|||
16452491|NCT00790842|40133634|FG005|Expansion Cohort|Withdrawal by Subject|0|||
16452492|NCT00790842|40133635|FG006|Expansion Cohort|Withdrawal by Subject|0|||
16452493|NCT00790842|40133636|FG007|Expansion Cohort|Withdrawal by Subject|0|||
16452494|NCT00790842|40133637|FG008|Expansion Cohort|Withdrawal by Subject|0|||
16452495|NCT00790842|40133638|FG009|Expansion Cohort|Withdrawal by Subject|0|||
16452496|NCT00790842|40133639|FG010|Expansion Cohort|Withdrawal by Subject|0|||
16452497|NCT00790842|40133629|FG000|Expansion Cohort|Study Closure|0|||
16265919|NCT00549718|39456769|FG001|Overall Study|Insufficient clinical response|7|||
16265920|NCT00549718|39456770|FG002|Overall Study|Insufficient clinical response|18|||
16265921|NCT00549718|39456771|FG003|Overall Study|Insufficient clinical response|32|||
16265922|NCT00549718|39456768|FG000|Overall Study|Adverse Event|6|||
16265923|NCT00549718|39456769|FG001|Overall Study|Adverse Event|8|||
16265924|NCT00549718|39456770|FG002|Overall Study|Adverse Event|7|||
16265925|NCT00549718|39456771|FG003|Overall Study|Adverse Event|3|||
16265926|NCT00549718|39456768|FG000|Overall Study|Lost to Follow-up|4|||
16265927|NCT00549718|39456769|FG001|Overall Study|Lost to Follow-up|2|||
16265928|NCT00549718|39456770|FG002|Overall Study|Lost to Follow-up|0|||
16265929|NCT00549718|39456771|FG003|Overall Study|Lost to Follow-up|6|||
16265930|NCT00549718|39456768|FG000|Overall Study|Withdrawal by Subject|9|||
16452498|NCT00790842|40133630|FG001|Expansion Cohort|Study Closure|0|||
16452499|NCT00790842|40133631|FG002|Expansion Cohort|Study Closure|1|||
16452500|NCT00790842|40133632|FG003|Expansion Cohort|Study Closure|0|||
16452501|NCT00790842|40133633|FG004|Expansion Cohort|Study Closure|0|||
16452502|NCT00790842|40133634|FG005|Expansion Cohort|Study Closure|0|||
16452503|NCT00790842|40133635|FG006|Expansion Cohort|Study Closure|0|||
16452504|NCT00790842|40133636|FG007|Expansion Cohort|Study Closure|0|||
16452505|NCT00790842|40133637|FG008|Expansion Cohort|Study Closure|0|||
16452506|NCT00790842|40133638|FG009|Expansion Cohort|Study Closure|0|||
16452507|NCT00790842|40133639|FG010|Expansion Cohort|Study Closure|0|||
16452508|NCT01626872|40133640|FG000|Overall Study|Physician Decision|13|||
16452509|NCT01626872|40133641|FG001|Overall Study|Physician Decision|9|||
16452510|NCT01626872|40133642|FG002|Overall Study|Physician Decision|6|||
16452511|NCT01626872|40133640|FG000|Overall Study|Withdrawal by Subject|19|||
16452512|NCT01626872|40133641|FG001|Overall Study|Withdrawal by Subject|27|||
16452513|NCT01626872|40133642|FG002|Overall Study|Withdrawal by Subject|8|||
16452514|NCT01626872|40133640|FG000|Overall Study|Adverse Event (including Death)|20|||
16452515|NCT01626872|40133641|FG001|Overall Study|Adverse Event (including Death)|28|||
16452516|NCT01626872|40133642|FG002|Overall Study|Adverse Event (including Death)|8|||
16452517|NCT01626872|40133640|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
16452518|NCT01626872|40133641|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
16452519|NCT01626872|40133642|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
16452520|NCT02175030|40133644|FG000|Overall Study|Failed screen after consent|7|||
16452521|NCT02175030|40133645|FG001|Overall Study|Failed screen after consent|6|||
16452522|NCT02175030|40133644|FG000|Overall Study|Failed IUD Insertion|20|||
16452523|NCT02175030|40133645|FG001|Overall Study|Failed IUD Insertion|21|||
16452524|NCT02175030|40133644|FG000|Overall Study|Physician Decision|1|||
16452525|NCT02175030|40133645|FG001|Overall Study|Physician Decision|1|||
16452526|NCT02175030|40133644|FG000|Overall Study|Lost to Follow-up|6|||
16452527|NCT02175030|40133645|FG001|Overall Study|Lost to Follow-up|6|||
16452528|NCT02175030|40133644|FG000|Overall Study|Withdrawal by Subject|1|||
16452529|NCT02175030|40133645|FG001|Overall Study|Withdrawal by Subject|4|||
16452530|NCT02453711|40133646|FG000|Overall Study|Withdrawal by Subject|5|||
16452531|NCT02453711|40133647|FG001|Overall Study|Withdrawal by Subject|4|||
16452532|NCT02453711|40133648|FG002|Overall Study|Withdrawal by Subject|6|||
16452533|NCT02453711|40133649|FG003|Overall Study|Withdrawal by Subject|4|||
16452534|NCT02453711|40133650|FG004|Overall Study|Withdrawal by Subject|1|||
16452535|NCT02453711|40133651|FG005|Overall Study|Withdrawal by Subject|1|||
16452536|NCT02453711|40133652|FG006|Overall Study|Withdrawal by Subject|0|||
16452537|NCT02453711|40133653|FG007|Overall Study|Withdrawal by Subject|1|||
16452538|NCT02453711|40133654|FG008|Overall Study|Withdrawal by Subject|7|||
16452539|NCT02453711|40133646|FG000|Overall Study|Lost to Follow-up|5|||
16452540|NCT02453711|40133647|FG001|Overall Study|Lost to Follow-up|3|||
16452541|NCT02453711|40133648|FG002|Overall Study|Lost to Follow-up|2|||
16452542|NCT02453711|40133649|FG003|Overall Study|Lost to Follow-up|3|||
16452543|NCT02453711|40133650|FG004|Overall Study|Lost to Follow-up|1|||
16452544|NCT02453711|40133651|FG005|Overall Study|Lost to Follow-up|5|||
16452545|NCT02453711|40133652|FG006|Overall Study|Lost to Follow-up|2|||
16452546|NCT02453711|40133653|FG007|Overall Study|Lost to Follow-up|6|||
16164510|NCT01995071|39083720|FG007|Overall Study|Moved|0|||
16164511|NCT01995071|39083721|FG008|Overall Study|Moved|0|||
16164512|NCT01995071|39083722|FG009|Overall Study|Moved|0|||
16164513|NCT01995071|39083723|FG010|Overall Study|Moved|1|||
16164514|NCT01995071|39083724|FG011|Overall Study|Moved|0|||
16164515|NCT01995071|39083713|FG000|Overall Study|Lost to Follow-up|1|||
16164516|NCT01995071|39083714|FG001|Overall Study|Lost to Follow-up|0|||
16265931|NCT00549718|39456769|FG001|Overall Study|Withdrawal by Subject|18|||
16265932|NCT00549718|39456770|FG002|Overall Study|Withdrawal by Subject|12|||
16452547|NCT02453711|40133654|FG008|Overall Study|Lost to Follow-up|6|||
16164517|NCT01995071|39083715|FG002|Overall Study|Lost to Follow-up|0|||
16164518|NCT01995071|39083716|FG003|Overall Study|Lost to Follow-up|0|||
16265933|NCT00549718|39456771|FG003|Overall Study|Withdrawal by Subject|13|||
16452548|NCT02453711|40133646|FG000|Overall Study|Death|0|||
16452549|NCT02453711|40133647|FG001|Overall Study|Death|0|||
16452550|NCT02453711|40133648|FG002|Overall Study|Death|0|||
16452551|NCT02453711|40133649|FG003|Overall Study|Death|0|||
16452552|NCT02453711|40133650|FG004|Overall Study|Death|0|||
16452553|NCT02453711|40133651|FG005|Overall Study|Death|0|||
16452554|NCT02453711|40133652|FG006|Overall Study|Death|1|||
16452555|NCT02453711|40133653|FG007|Overall Study|Death|0|||
16452556|NCT02453711|40133654|FG008|Overall Study|Death|0|||
16452557|NCT02453711|40133646|FG000|Overall Study|Unclassified|1|||
16452558|NCT02453711|40133647|FG001|Overall Study|Unclassified|0|||
16452559|NCT02453711|40133648|FG002|Overall Study|Unclassified|1|||
16452560|NCT02453711|40133649|FG003|Overall Study|Unclassified|0|||
16452561|NCT02453711|40133650|FG004|Overall Study|Unclassified|0|||
16452562|NCT02453711|40133651|FG005|Overall Study|Unclassified|0|||
16452563|NCT02453711|40133652|FG006|Overall Study|Unclassified|0|||
16452564|NCT02453711|40133653|FG007|Overall Study|Unclassified|0|||
16452565|NCT02453711|40133654|FG008|Overall Study|Unclassified|0|||
16452566|NCT01524796|40133657|FG000|Overall Study|Adverse Event|13|||
16452567|NCT01524796|40133657|FG000|Overall Study|Lack of Efficacy|3|||
16452568|NCT01524796|40133657|FG000|Overall Study|Lost to Follow-up|1|||
16452569|NCT01524796|40133657|FG000|Overall Study|The price|1|||
16452570|NCT01524796|40133657|FG000|Overall Study|Withdrawal by Subject|4|||
16452571|NCT01524796|40133657|FG000|Overall Study|Move|1|||
16452572|NCT01524796|40133657|FG000|Overall Study|Deterioration of pains|1|||
16452573|NCT01524796|40133657|FG000|Overall Study|Gall stone surgery|1|||
16452574|NCT01524796|40133657|FG000|Overall Study|Nervous about confidentiality|1|||
16452575|NCT01524796|40133657|FG000|Overall Study|Switch to carbamazapine|1|||
16452576|NCT01524796|40133657|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
16452577|NCT02721966|40133659|FG000|Overall Study|Protocol Violation|1|||
16452578|NCT02721966|40133660|FG001|Overall Study|Protocol Violation|0|||
16452579|NCT02721966|40133661|FG002|Overall Study|Protocol Violation|0|||
16164519|NCT01995071|39083717|FG004|Overall Study|Lost to Follow-up|0|||
16164520|NCT01995071|39083718|FG005|Overall Study|Lost to Follow-up|0|||
16164521|NCT01995071|39083719|FG006|Overall Study|Lost to Follow-up|0|||
16164522|NCT01995071|39083720|FG007|Overall Study|Lost to Follow-up|1|||
16164523|NCT01995071|39083721|FG008|Overall Study|Lost to Follow-up|1|||
16164524|NCT01995071|39083722|FG009|Overall Study|Lost to Follow-up|0|||
16164525|NCT01995071|39083723|FG010|Overall Study|Lost to Follow-up|0|||
16164526|NCT01995071|39083724|FG011|Overall Study|Lost to Follow-up|0|||
16265934|NCT00549718|39456768|FG000|Overall Study|Administrative|2|||
16265935|NCT00549718|39456769|FG001|Overall Study|Administrative|2|||
16265936|NCT00549718|39456770|FG002|Overall Study|Administrative|2|||
16265937|NCT00549718|39456771|FG003|Overall Study|Administrative|1|||
16265938|NCT00830206|39456772|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
16265939|NCT00830206|39456773|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
16265940|NCT02151981|39456774|FG000|Overall Study|Death|184|||
16265941|NCT02151981|39456775|FG001|Overall Study|Death|88|||
16265942|NCT02151981|39456774|FG000|Overall Study|Lost to Follow-up|7|||
16265943|NCT02151981|39456775|FG001|Overall Study|Lost to Follow-up|1|||
16265944|NCT02151981|39456774|FG000|Overall Study|Withdrawal by Subject|27|||
16265945|NCT02151981|39456775|FG001|Overall Study|Withdrawal by Subject|21|||
16265946|NCT02151981|39456774|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
16265947|NCT02151981|39456775|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
16265948|NCT02151981|39456774|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16265949|NCT02151981|39456775|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
16265950|NCT02151981|39456774|FG000|Overall Study|Patient had no clinical benefit|1|||
16164527|NCT01995071|39083713|FG000|Overall Study|Incarcerated|0|||
16164528|NCT01995071|39083714|FG001|Overall Study|Incarcerated|0|||
16164529|NCT01995071|39083715|FG002|Overall Study|Incarcerated|0|||
16164530|NCT01995071|39083716|FG003|Overall Study|Incarcerated|0|||
16164531|NCT01995071|39083717|FG004|Overall Study|Incarcerated|0|||
16164532|NCT01995071|39083718|FG005|Overall Study|Incarcerated|0|||
16164533|NCT01995071|39083719|FG006|Overall Study|Incarcerated|0|||
16164534|NCT01995071|39083720|FG007|Overall Study|Incarcerated|1|||
16164535|NCT01995071|39083721|FG008|Overall Study|Incarcerated|0|||
16265951|NCT02151981|39456775|FG001|Overall Study|Patient had no clinical benefit|0|||
16265952|NCT02151981|39456774|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
16265953|NCT02151981|39456775|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
16265954|NCT02151981|39456774|FG000|Overall Study|Study terminated|0|||
16265955|NCT02151981|39456775|FG001|Overall Study|Study terminated|1|||
16452580|NCT02721966|40133662|FG003|Overall Study|Protocol Violation|0|||
16452581|NCT02721966|40133663|FG004|Overall Study|Protocol Violation|0|||
16452582|NCT02721966|40133659|FG000|Overall Study|Withdrawal by Subject|9|||
16452583|NCT02721966|40133660|FG001|Overall Study|Withdrawal by Subject|2|||
16452584|NCT02721966|40133661|FG002|Overall Study|Withdrawal by Subject|3|||
16452585|NCT02721966|40133662|FG003|Overall Study|Withdrawal by Subject|7|||
16452586|NCT02721966|40133663|FG004|Overall Study|Withdrawal by Subject|0|||
16452587|NCT02721966|40133659|FG000|Overall Study|Adverse Event|4|||
16452588|NCT02721966|40133660|FG001|Overall Study|Adverse Event|4|||
16265956|NCT06195579|39456777|FG000|Overall Study|Withdrawal by Subject|1|||
16265957|NCT01348789|39456779|FG000|Overall Study|Protocol Violation|2|||
16265958|NCT01348789|39456779|FG000|Overall Study|Withdrawal by Subject|2|||
16265959|NCT03872128|39456780|FG000|Overall Study|Dropped out before treatment|1|||
16265960|NCT03872128|39456781|FG001|Overall Study|Dropped out before treatment|0|||
16265961|NCT03872128|39456782|FG002|Overall Study|Dropped out before treatment|4|||
16265962|NCT03872128|39456780|FG000|Overall Study|Lost to Follow-up|2|||
16265963|NCT03872128|39456781|FG001|Overall Study|Lost to Follow-up|5|||
16265964|NCT03872128|39456782|FG002|Overall Study|Lost to Follow-up|8|||
16265965|NCT01663233|39456787|FG000|Overall Study|Withdrawal by Subject|3|||
16164536|NCT01995071|39083722|FG009|Overall Study|Incarcerated|0|||
16164537|NCT01995071|39083723|FG010|Overall Study|Incarcerated|0|||
16164538|NCT01995071|39083724|FG011|Overall Study|Incarcerated|0|||
16164539|NCT03033745|39083726|FG000|Overall Study|Protocol Violation|0|||
16164540|NCT03033745|39083727|FG001|Overall Study|Protocol Violation|0|||
16164541|NCT03033745|39083728|FG002|Overall Study|Protocol Violation|1|||
16164542|NCT03033745|39083726|FG000|Overall Study|Adverse Event|1|||
16164543|NCT03033745|39083727|FG001|Overall Study|Adverse Event|0|||
16265966|NCT01663233|39456788|FG001|Overall Study|Withdrawal by Subject|2|||
16265967|NCT01663233|39456787|FG000|Overall Study|Protocol Deviation|1|||
16265968|NCT01663233|39456788|FG001|Overall Study|Protocol Deviation|4|||
16265969|NCT01663233|39456787|FG000|Overall Study|Lost to Follow-up|0|||
16265970|NCT01663233|39456788|FG001|Overall Study|Lost to Follow-up|1|||
16265971|NCT01474551|39456789|FG000|Overall Study|Death|1|||
16265972|NCT00113386|39456790|FG000|Overall Study|Withdrawal by Subject|1|||
16265973|NCT00113386|39456791|FG001|Overall Study|Withdrawal by Subject|0|||
16265974|NCT00113386|39456790|FG000|Overall Study|Physician Decision|0|||
16265975|NCT00113386|39456791|FG001|Overall Study|Physician Decision|1|||
16265976|NCT00113386|39456790|FG000|Overall Study|Toxicity|3|||
16265977|NCT00113386|39456791|FG001|Overall Study|Toxicity|0|||
16265978|NCT00113386|39456790|FG000|Overall Study|Ineligible|1|||
16164544|NCT03033745|39083728|FG002|Overall Study|Adverse Event|1|||
16164545|NCT03033745|39083726|FG000|Overall Study|Withdrawal by Subject|0|||
16164546|NCT03033745|39083727|FG001|Overall Study|Withdrawal by Subject|1|||
16164547|NCT03033745|39083728|FG002|Overall Study|Withdrawal by Subject|0|||
16265979|NCT00113386|39456791|FG001|Overall Study|Ineligible|2|||
16265980|NCT00113386|39456790|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
16265981|NCT00113386|39456791|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
16452589|NCT02721966|40133661|FG002|Overall Study|Adverse Event|3|||
16452590|NCT02721966|40133662|FG003|Overall Study|Adverse Event|0|||
16452591|NCT02721966|40133663|FG004|Overall Study|Adverse Event|0|||
16452592|NCT02721966|40133659|FG000|Overall Study|Death|1|||
16452593|NCT02721966|40133660|FG001|Overall Study|Death|0|||
16452594|NCT02721966|40133661|FG002|Overall Study|Death|0|||
16452595|NCT02721966|40133662|FG003|Overall Study|Death|0|||
16452596|NCT02721966|40133663|FG004|Overall Study|Death|0|||
16452597|NCT02721966|40133659|FG000|Overall Study|Lack of Efficacy|7|||
16452598|NCT02721966|40133660|FG001|Overall Study|Lack of Efficacy|4|||
16452599|NCT02721966|40133661|FG002|Overall Study|Lack of Efficacy|0|||
16452600|NCT02721966|40133662|FG003|Overall Study|Lack of Efficacy|0|||
16452601|NCT02721966|40133663|FG004|Overall Study|Lack of Efficacy|0|||
16452602|NCT02721966|40133659|FG000|Overall Study|Lost to Follow-up|0|||
16452603|NCT02721966|40133660|FG001|Overall Study|Lost to Follow-up|0|||
16452604|NCT02721966|40133661|FG002|Overall Study|Lost to Follow-up|3|||
16452605|NCT02721966|40133662|FG003|Overall Study|Lost to Follow-up|0|||
16452606|NCT02721966|40133663|FG004|Overall Study|Lost to Follow-up|0|||
16452607|NCT02721966|40133659|FG000|Overall Study|Physician Decision|1|||
16452608|NCT02721966|40133660|FG001|Overall Study|Physician Decision|1|||
16452609|NCT02721966|40133661|FG002|Overall Study|Physician Decision|0|||
16452610|NCT02721966|40133662|FG003|Overall Study|Physician Decision|0|||
16452611|NCT02721966|40133663|FG004|Overall Study|Physician Decision|0|||
16452612|NCT02721966|40133659|FG000|Overall Study|Pregnancy|1|||
16452613|NCT02721966|40133660|FG001|Overall Study|Pregnancy|0|||
16452614|NCT02721966|40133661|FG002|Overall Study|Pregnancy|0|||
16452615|NCT02721966|40133662|FG003|Overall Study|Pregnancy|0|||
16164548|NCT01756274|39083732|FG000|Overall Study|Protocol Violation|2|||
16164549|NCT01756274|39083732|FG000|Overall Study|Laboratory error|1|||
16164550|NCT03609619|39083733|FG000|Overall Study|Adverse Event|1|||
16265982|NCT02392000|39456792|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
16265983|NCT02392000|39456792|FG000|Overall Study|Withdrawal by Subject|1|||
16265984|NCT02392000|39456792|FG000|Overall Study|Lost to Follow-up|8|||
16452616|NCT02721966|40133663|FG004|Overall Study|Pregnancy|0|||
16452617|NCT02721966|40133659|FG000|Overall Study|Did not continue to period 2|5|||
16452618|NCT02721966|40133660|FG001|Overall Study|Did not continue to period 2|12|||
16452619|NCT02721966|40133661|FG002|Overall Study|Did not continue to period 2|0|||
16452620|NCT02721966|40133662|FG003|Overall Study|Did not continue to period 2|0|||
16452621|NCT02721966|40133663|FG004|Overall Study|Did not continue to period 2|5|||
16452622|NCT00295880|40133664|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
16452623|NCT00295880|40133664|FG000|Overall Study|Unit randomization did not occur|1|||
16164551|NCT03609619|39083734|FG001|Overall Study|Adverse Event|0|||
16164552|NCT03609619|39083733|FG000|Overall Study|Lack of Efficacy|1|||
16164553|NCT03609619|39083734|FG001|Overall Study|Lack of Efficacy|2|||
16164554|NCT03609619|39083733|FG000|Overall Study|Protocol Violation|5|||
16164555|NCT03609619|39083734|FG001|Overall Study|Protocol Violation|0|||
16164556|NCT03609619|39083733|FG000|Overall Study|Withdrawal by Subject|2|||
16164557|NCT03609619|39083734|FG001|Overall Study|Withdrawal by Subject|3|||
16164558|NCT03609619|39083733|FG000|Overall Study|Lost to Follow-up|1|||
16164559|NCT03609619|39083734|FG001|Overall Study|Lost to Follow-up|1|||
16164560|NCT03575104|39083737|FG000|Overall Study|Adverse Event|4|||
16164561|NCT03575104|39083738|FG001|Overall Study|Adverse Event|3|||
16164562|NCT03575104|39083739|FG002|Overall Study|Adverse Event|4|||
16164563|NCT03575104|39083737|FG000|Overall Study|Withdrawal by Subject|13|||
16164564|NCT03575104|39083738|FG001|Overall Study|Withdrawal by Subject|16|||
16164565|NCT03575104|39083739|FG002|Overall Study|Withdrawal by Subject|11|||
16164566|NCT03575104|39083737|FG000|Overall Study|Other reasons|6|||
16164567|NCT03575104|39083738|FG001|Overall Study|Other reasons|8|||
16164568|NCT03575104|39083739|FG002|Overall Study|Other reasons|6|||
16164569|NCT03575104|39083737|FG000|Overall Study|Lost to Follow-up|1|||
16265985|NCT02956460|39456795|FG000|Lens 1|Lost to Follow-up|1|||
16265986|NCT02956460|39456796|FG001|Lens 1|Lost to Follow-up|0|||
16265987|NCT00436163|39456797|FG000|Overall Study|Lost to Follow-up|2|||
16265988|NCT00436163|39456797|FG000|Overall Study|Adverse Event|1|||
16265989|NCT03503318|39456798|FG000|Overall Study|Death|1|||
16265990|NCT03503318|39456799|FG001|Overall Study|Death|0|||
16265991|NCT03503318|39456800|FG002|Overall Study|Death|4|||
16265992|NCT03503318|39456798|FG000|Overall Study|Adverse Event|3|||
16265993|NCT03503318|39456799|FG001|Overall Study|Adverse Event|4|||
16265994|NCT03503318|39456800|FG002|Overall Study|Adverse Event|2|||
16265995|NCT03503318|39456798|FG000|Overall Study|Withdrawal by Subject|12|||
16265996|NCT03503318|39456799|FG001|Overall Study|Withdrawal by Subject|17|||
16265997|NCT03503318|39456800|FG002|Overall Study|Withdrawal by Subject|16|||
16265998|NCT03503318|39456798|FG000|Overall Study|Protocol Violation|5|||
16265999|NCT03503318|39456799|FG001|Overall Study|Protocol Violation|0|||
16266000|NCT03503318|39456800|FG002|Overall Study|Protocol Violation|3|||
16266001|NCT03503318|39456798|FG000|Overall Study|Lost to Follow-up|17|||
16266002|NCT03503318|39456799|FG001|Overall Study|Lost to Follow-up|15|||
16164570|NCT03575104|39083738|FG001|Overall Study|Lost to Follow-up|2|||
16164571|NCT03575104|39083739|FG002|Overall Study|Lost to Follow-up|1|||
16164572|NCT04957290|39083740|FG000|Overall Study|Progressive disease|3|||
16164573|NCT04957290|39083741|FG001|Overall Study|Progressive disease|3|||
16164574|NCT04957290|39083742|FG002|Overall Study|Progressive disease|2|||
16164575|NCT04957290|39083743|FG003|Overall Study|Progressive disease|0|||
16164576|NCT04957290|39083744|FG004|Overall Study|Progressive disease|0|||
16164577|NCT04957290|39083745|FG005|Overall Study|Progressive disease|0|||
16164578|NCT04957290|39083740|FG000|Overall Study|Withdrawal by Subject|1|||
16164579|NCT04957290|39083741|FG001|Overall Study|Withdrawal by Subject|0|||
16164580|NCT04957290|39083742|FG002|Overall Study|Withdrawal by Subject|1|||
16164581|NCT04957290|39083743|FG003|Overall Study|Withdrawal by Subject|0|||
16164582|NCT04957290|39083744|FG004|Overall Study|Withdrawal by Subject|0|||
16164583|NCT04957290|39083745|FG005|Overall Study|Withdrawal by Subject|0|||
16164584|NCT04957290|39083740|FG000|Overall Study|Death|0|||
16164585|NCT04957290|39083741|FG001|Overall Study|Death|2|||
16164586|NCT04957290|39083742|FG002|Overall Study|Death|1|||
16164587|NCT04957290|39083743|FG003|Overall Study|Death|0|||
16164588|NCT04957290|39083744|FG004|Overall Study|Death|0|||
16164589|NCT04957290|39083745|FG005|Overall Study|Death|0|||
16164590|NCT04957290|39083740|FG000|Overall Study|non compliance with study drug|0|||
16164591|NCT04957290|39083741|FG001|Overall Study|non compliance with study drug|1|||
16164592|NCT04957290|39083742|FG002|Overall Study|non compliance with study drug|0|||
16164593|NCT04957290|39083743|FG003|Overall Study|non compliance with study drug|0|||
16164594|NCT04957290|39083744|FG004|Overall Study|non compliance with study drug|0|||
16164595|NCT04957290|39083745|FG005|Overall Study|non compliance with study drug|0|||
16164596|NCT04957290|39083740|FG000|Overall Study|none specified.|0|||
16164597|NCT04957290|39083741|FG001|Overall Study|none specified.|1|||
16164598|NCT04957290|39083742|FG002|Overall Study|none specified.|2|||
16164599|NCT04957290|39083743|FG003|Overall Study|none specified.|0|||
16164600|NCT04957290|39083744|FG004|Overall Study|none specified.|0|||
16164601|NCT04957290|39083745|FG005|Overall Study|none specified.|0|||
16266003|NCT03503318|39456800|FG002|Overall Study|Lost to Follow-up|12|||
16266004|NCT03503318|39456798|FG000|Overall Study|Other than specified|1|||
16266005|NCT03503318|39456799|FG001|Overall Study|Other than specified|3|||
16164602|NCT04957290|39083740|FG000|Overall Study|unacceptable toxicity|0|||
16164603|NCT04957290|39083741|FG001|Overall Study|unacceptable toxicity|0|||
16164604|NCT04957290|39083742|FG002|Overall Study|unacceptable toxicity|1|||
16164605|NCT04957290|39083743|FG003|Overall Study|unacceptable toxicity|0|||
16164606|NCT04957290|39083744|FG004|Overall Study|unacceptable toxicity|0|||
16164607|NCT04957290|39083745|FG005|Overall Study|unacceptable toxicity|0|||
16164608|NCT04957290|39083740|FG000|Overall Study|Adverse Event|0|||
16164609|NCT04957290|39083741|FG001|Overall Study|Adverse Event|0|||
16164610|NCT04957290|39083742|FG002|Overall Study|Adverse Event|1|||
16164611|NCT04957290|39083743|FG003|Overall Study|Adverse Event|0|||
16164612|NCT04957290|39083744|FG004|Overall Study|Adverse Event|0|||
16164613|NCT04957290|39083745|FG005|Overall Study|Adverse Event|0|||
16164614|NCT04957290|39083740|FG000|Overall Study|study terminated by sponsor|0|||
16164615|NCT04957290|39083741|FG001|Overall Study|study terminated by sponsor|0|||
16164616|NCT04957290|39083742|FG002|Overall Study|study terminated by sponsor|2|||
16164617|NCT04957290|39083743|FG003|Overall Study|study terminated by sponsor|0|||
16164618|NCT04957290|39083744|FG004|Overall Study|study terminated by sponsor|0|||
16164619|NCT04957290|39083745|FG005|Overall Study|study terminated by sponsor|0|||
16164620|NCT02149810|39083746|FG000|Overall Study|Physician Decision|1|||
16164621|NCT02149810|39083747|FG001|Overall Study|Physician Decision|2|||
16164622|NCT02149810|39083746|FG000|Overall Study|Lost to Follow-up|2|||
16164623|NCT02149810|39083747|FG001|Overall Study|Lost to Follow-up|1|||
16164624|NCT02149810|39083746|FG000|Overall Study|Withdrawal by Subject|5|||
16164625|NCT02149810|39083747|FG001|Overall Study|Withdrawal by Subject|1|||
16164626|NCT00331409|39083748|FG000|Overall Study|Lack of Efficacy|4|||
16164627|NCT01014585|39083750|FG000|Overall Study|Adverse Event|0|||
16164628|NCT01014585|39083751|FG001|Overall Study|Adverse Event|2|||
16164629|NCT01014585|39083752|FG002|Overall Study|Adverse Event|0|||
16164630|NCT01014585|39083753|FG003|Overall Study|Adverse Event|3|||
16452624|NCT03436290|40133667|FG000|Overall Study|Post-randomization Exclusion|1|||
16452625|NCT03436290|40133668|FG001|Overall Study|Post-randomization Exclusion|0|||
16452626|NCT03436290|40133667|FG000|Overall Study|Death|6|||
16452627|NCT03436290|40133668|FG001|Overall Study|Death|0|||
16452628|NCT03436290|40133667|FG000|Overall Study|Withdrawal by Subject|4|||
16452629|NCT03436290|40133668|FG001|Overall Study|Withdrawal by Subject|0|||
16452630|NCT03436290|40133667|FG000|Overall Study|Protocol Violation|30|||
16452631|NCT03436290|40133668|FG001|Overall Study|Protocol Violation|0|||
16452632|NCT02640508|40137260|FG000|Overall Study|Death|19|||
16452633|NCT02640508|40137260|FG000|Overall Study|Withdrawal by Subject|8|||
16452634|NCT02640508|40137260|FG000|Overall Study|Physician Decision|1|||
16452635|NCT02640508|40137260|FG000|Overall Study|Lost to Follow-up|1|||
16452636|NCT04233216|40137261|FG000|Overall Study|Lost to Follow-up|0|||
16452637|NCT04233216|40137262|FG001|Overall Study|Lost to Follow-up|0|||
16452638|NCT04233216|40137263|FG002|Overall Study|Lost to Follow-up|2|||
16452639|NCT04233216|40137264|FG003|Overall Study|Lost to Follow-up|0|||
16452640|NCT04233216|40137261|FG000|Overall Study|Physician Decision|0|||
16452641|NCT04233216|40137262|FG001|Overall Study|Physician Decision|1|||
16452642|NCT04233216|40137263|FG002|Overall Study|Physician Decision|0|||
16452643|NCT04233216|40137264|FG003|Overall Study|Physician Decision|0|||
16452644|NCT04233216|40137261|FG000|Overall Study|Withdrawal by Subject|0|||
16452645|NCT04233216|40137262|FG001|Overall Study|Withdrawal by Subject|1|||
16452646|NCT04233216|40137263|FG002|Overall Study|Withdrawal by Subject|1|||
16452647|NCT04233216|40137264|FG003|Overall Study|Withdrawal by Subject|0|||
16452648|NCT04233216|40137261|FG000|Overall Study|Ongoing participation in study|7|||
16452649|NCT04233216|40137262|FG001|Overall Study|Ongoing participation in study|12|||
16452650|NCT04233216|40137263|FG002|Overall Study|Ongoing participation in study|4|||
16452651|NCT04233216|40137264|FG003|Overall Study|Ongoing participation in study|7|||
16452652|NCT00865280|40137268|FG000|Overall Study|Withdrawal by Subject|4|||
16452653|NCT00865280|40137269|FG001|Overall Study|Withdrawal by Subject|1|||
16452654|NCT00865280|40137268|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
16452655|NCT00865280|40137269|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
16452656|NCT00865280|40137268|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
16452657|NCT00865280|40137269|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
16452658|NCT00865280|40137268|FG000|Overall Study|Exclusion Condition|1|||
16452659|NCT00865280|40137269|FG001|Overall Study|Exclusion Condition|0|||
16452660|NCT00865280|40137268|FG000|Overall Study|Adverse Event|0|||
16452661|NCT00865280|40137269|FG001|Overall Study|Adverse Event|1|||
16452662|NCT01746901|40137270|FG000|Naloxone Challenge Phase|Adverse Event|2|||
16452663|NCT01746901|40137271|FG001|Naloxone Challenge Phase|Adverse Event|0|||
16452664|NCT01746901|40137272|FG002|Naloxone Challenge Phase|Adverse Event|0|||
16452665|NCT01746901|40137273|FG003|Naloxone Challenge Phase|Adverse Event|0|||
16164631|NCT01014585|39083750|FG000|Overall Study|Withdrawal by Subject|2|||
16164632|NCT01014585|39083751|FG001|Overall Study|Withdrawal by Subject|0|||
16164633|NCT01014585|39083752|FG002|Overall Study|Withdrawal by Subject|1|||
16164634|NCT01014585|39083753|FG003|Overall Study|Withdrawal by Subject|3|||
16452666|NCT01746901|40137274|FG004|Naloxone Challenge Phase|Adverse Event|0|||
16452667|NCT01746901|40137275|FG005|Naloxone Challenge Phase|Adverse Event|0|||
16452668|NCT01746901|40137276|FG006|Naloxone Challenge Phase|Adverse Event|0|||
16452669|NCT01746901|40137277|FG007|Naloxone Challenge Phase|Adverse Event|0|||
16452670|NCT01746901|40137278|FG008|Naloxone Challenge Phase|Adverse Event|0|||
16452671|NCT01746901|40137270|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
16452672|NCT01746901|40137271|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16452673|NCT01746901|40137272|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16452674|NCT01746901|40137273|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16452675|NCT01746901|40137274|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16452676|NCT01746901|40137275|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16452677|NCT01746901|40137276|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16452678|NCT01746901|40137277|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16452679|NCT01746901|40137278|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
16452680|NCT01746901|40137270|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16452681|NCT01746901|40137271|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
16452682|NCT01746901|40137272|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16452683|NCT01746901|40137273|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16452684|NCT01746901|40137274|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16452685|NCT01746901|40137275|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16452686|NCT01746901|40137276|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16452687|NCT01746901|40137277|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16452688|NCT01746901|40137278|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
16452689|NCT01746901|40137270|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16452690|NCT01746901|40137271|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
16164635|NCT01014585|39083750|FG000|Overall Study|Lost to Follow-up|0|||
16164636|NCT01014585|39083751|FG001|Overall Study|Lost to Follow-up|0|||
16164637|NCT01014585|39083752|FG002|Overall Study|Lost to Follow-up|0|||
16164638|NCT01014585|39083753|FG003|Overall Study|Lost to Follow-up|2|||
16164639|NCT01014585|39083750|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
16164640|NCT01014585|39083751|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
16164641|NCT01014585|39083752|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
16164642|NCT01014585|39083753|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
16164643|NCT02574637|39083754|FG000|Double-blind Period|Adverse Event|1|||
16164644|NCT02574637|39083755|FG001|Double-blind Period|Adverse Event|0|||
16164645|NCT02574637|39083756|FG002|Double-blind Period|Adverse Event|0|||
16164646|NCT02574637|39083757|FG003|Double-blind Period|Adverse Event|0|||
16164647|NCT02574637|39083758|FG004|Double-blind Period|Adverse Event|0|||
16164648|NCT02574637|39083759|FG005|Double-blind Period|Adverse Event|0|||
16164649|NCT02574637|39083760|FG006|Double-blind Period|Adverse Event|0|||
16164650|NCT02574637|39083761|FG007|Double-blind Period|Adverse Event|0|||
16164651|NCT02574637|39083762|FG008|Double-blind Period|Adverse Event|0|||
16164652|NCT02574637|39083763|FG009|Double-blind Period|Adverse Event|0|||
16164653|NCT02574637|39083754|FG000|Double-blind Period|Lack of Efficacy|0|||
16164654|NCT02574637|39083755|FG001|Double-blind Period|Lack of Efficacy|0|||
16164655|NCT02574637|39083756|FG002|Double-blind Period|Lack of Efficacy|2|||
16164656|NCT02574637|39083757|FG003|Double-blind Period|Lack of Efficacy|0|||
16164657|NCT02574637|39083758|FG004|Double-blind Period|Lack of Efficacy|0|||
16164658|NCT02574637|39083759|FG005|Double-blind Period|Lack of Efficacy|0|||
16164659|NCT02574637|39083760|FG006|Double-blind Period|Lack of Efficacy|0|||
16164660|NCT02574637|39083761|FG007|Double-blind Period|Lack of Efficacy|0|||
16164661|NCT02574637|39083762|FG008|Double-blind Period|Lack of Efficacy|0|||
16164662|NCT02574637|39083763|FG009|Double-blind Period|Lack of Efficacy|0|||
16164663|NCT02574637|39083754|FG000|Double-blind Period|Protocol Deviation|1|||
16266006|NCT03503318|39456800|FG002|Overall Study|Other than specified|3|||
16266007|NCT01855750|39456806|FG000|Overall Study|Death|78|||
16266008|NCT01855750|39456807|FG001|Overall Study|Death|78|||
16266009|NCT01855750|39456806|FG000|Overall Study|Lost to Follow-up|9|||
16266010|NCT01855750|39456807|FG001|Overall Study|Lost to Follow-up|23|||
16266011|NCT01855750|39456806|FG000|Overall Study|Withdrawal by Subject|35|||
16266012|NCT01855750|39456807|FG001|Overall Study|Withdrawal by Subject|28|||
16266013|NCT01855750|39456806|FG000|Overall Study|Sponsor ends the study|297|||
16266014|NCT01855750|39456807|FG001|Overall Study|Sponsor ends the study|290|||
16266015|NCT02601625|39456808|FG000|Overall Study|Lost to Follow-up|0|||
16266016|NCT02601625|39456809|FG001|Overall Study|Lost to Follow-up|0|||
16266017|NCT02601625|39456810|FG002|Overall Study|Lost to Follow-up|1|||
16266018|NCT02601625|39456811|FG003|Overall Study|Lost to Follow-up|1|||
16266019|NCT00794963|39456814|FG000|Overall Study|Withdrawal by Subject|1|||
16266020|NCT00794963|39456815|FG001|Overall Study|Withdrawal by Subject|4|||
16266021|NCT03965091|39456819|FG000|Overall Study|Adverse Event|0|||
16266022|NCT03965091|39456820|FG001|Overall Study|Adverse Event|2|||
16266023|NCT03965091|39456821|FG002|Overall Study|Adverse Event|3|||
16266024|NCT03965091|39456819|FG000|Overall Study|Withdrawal by Subject|11|||
16452691|NCT01746901|40137272|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
16164664|NCT02574637|39083755|FG001|Double-blind Period|Protocol Deviation|0|||
16164665|NCT02574637|39083756|FG002|Double-blind Period|Protocol Deviation|0|||
16164666|NCT02574637|39083757|FG003|Double-blind Period|Protocol Deviation|0|||
16266025|NCT03965091|39456820|FG001|Overall Study|Withdrawal by Subject|3|||
16266026|NCT03965091|39456821|FG002|Overall Study|Withdrawal by Subject|5|||
16266027|NCT03965091|39456819|FG000|Overall Study|Non-compliance with study drug|0|||
16266028|NCT03965091|39456820|FG001|Overall Study|Non-compliance with study drug|0|||
16452692|NCT01746901|40137273|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16452693|NCT01746901|40137274|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16452694|NCT01746901|40137275|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16452695|NCT01746901|40137276|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16452696|NCT01746901|40137277|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16452697|NCT01746901|40137278|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
16452698|NCT01746901|40137270|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16452699|NCT01746901|40137271|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
16452700|NCT01746901|40137272|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
16452701|NCT01746901|40137273|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16452702|NCT01746901|40137274|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16452703|NCT01746901|40137275|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16452704|NCT01746901|40137276|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16452705|NCT01746901|40137277|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16452706|NCT01746901|40137278|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
16452707|NCT01746901|40137270|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16452708|NCT01746901|40137271|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
16452709|NCT01746901|40137272|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
16452710|NCT01746901|40137273|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16452711|NCT01746901|40137274|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16452712|NCT01746901|40137275|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16452713|NCT01746901|40137276|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16452714|NCT01746901|40137277|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16452715|NCT01746901|40137278|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
16452716|NCT01746901|40137270|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
16452717|NCT01746901|40137271|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
16452718|NCT01746901|40137272|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
16452719|NCT01746901|40137273|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
16452720|NCT01746901|40137274|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
16452721|NCT01746901|40137275|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
16266029|NCT03965091|39456821|FG002|Overall Study|Non-compliance with study drug|1|||
16266030|NCT03965091|39456819|FG000|Overall Study|Lost to Follow-up|1|||
16452722|NCT01746901|40137276|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
16452723|NCT01746901|40137277|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
16452724|NCT01746901|40137278|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
16452725|NCT01746901|40137270|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16452726|NCT01746901|40137271|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16452727|NCT01746901|40137272|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16452728|NCT01746901|40137273|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16452729|NCT01746901|40137274|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16452730|NCT01746901|40137275|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16452731|NCT01746901|40137276|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16452732|NCT01746901|40137277|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
16452733|NCT01746901|40137278|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
16452734|NCT01746901|40137270|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
16452735|NCT01746901|40137271|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
16452736|NCT01746901|40137272|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
16452737|NCT01746901|40137273|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
16452738|NCT01746901|40137274|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
16164667|NCT02574637|39083758|FG004|Double-blind Period|Protocol Deviation|0|||
16164668|NCT02574637|39083759|FG005|Double-blind Period|Protocol Deviation|0|||
16164669|NCT02574637|39083760|FG006|Double-blind Period|Protocol Deviation|0|||
16164670|NCT02574637|39083761|FG007|Double-blind Period|Protocol Deviation|0|||
16266031|NCT03965091|39456820|FG001|Overall Study|Lost to Follow-up|1|||
16266032|NCT03965091|39456821|FG002|Overall Study|Lost to Follow-up|1|||
16266033|NCT03965091|39456819|FG000|Overall Study|Lack of Efficacy|2|||
16266034|NCT03965091|39456820|FG001|Overall Study|Lack of Efficacy|0|||
16266035|NCT03965091|39456821|FG002|Overall Study|Lack of Efficacy|0|||
16266036|NCT03965091|39456819|FG000|Overall Study|Other than specified|9|||
16266037|NCT03965091|39456820|FG001|Overall Study|Other than specified|11|||
16266038|NCT03965091|39456821|FG002|Overall Study|Other than specified|8|||
16266039|NCT02057458|39456822|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
16164671|NCT02574637|39083762|FG008|Double-blind Period|Protocol Deviation|0|||
16164672|NCT02574637|39083763|FG009|Double-blind Period|Protocol Deviation|0|||
16266040|NCT02057458|39456823|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
16266041|NCT02057458|39456824|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
16266042|NCT02057458|39456822|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
16452739|NCT01746901|40137275|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
16452740|NCT01746901|40137276|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
16452741|NCT01746901|40137277|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
16452742|NCT01746901|40137278|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
16452743|NCT01746901|40137270|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16452744|NCT01746901|40137271|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16452745|NCT01746901|40137272|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16452746|NCT01746901|40137273|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
16452747|NCT01746901|40137274|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16452748|NCT01746901|40137275|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16452749|NCT01746901|40137276|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16452750|NCT01746901|40137277|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16452751|NCT01746901|40137278|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
16452752|NCT01746901|40137270|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16452753|NCT01746901|40137271|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16452754|NCT01746901|40137272|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16452755|NCT01746901|40137273|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16452756|NCT01746901|40137274|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16452757|NCT01746901|40137275|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
16452758|NCT01746901|40137276|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16452759|NCT01746901|40137277|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
16452760|NCT01746901|40137278|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
16452761|NCT01746901|40137270|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16452762|NCT01746901|40137271|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16452763|NCT01746901|40137272|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16452764|NCT01746901|40137273|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16452765|NCT01746901|40137274|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16452766|NCT01746901|40137275|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16452767|NCT01746901|40137276|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
16452768|NCT01746901|40137277|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
16452769|NCT01746901|40137278|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
16452770|NCT01215097|40137279|FG000|Overall Study|Adverse Event|1|||
16452771|NCT01215097|40137280|FG001|Overall Study|Adverse Event|3|||
16452772|NCT01215097|40137279|FG000|Overall Study|Protocol Violation|0|||
16452773|NCT01215097|40137280|FG001|Overall Study|Protocol Violation|2|||
16452774|NCT01215097|40137279|FG000|Overall Study|Lost to Follow-up|2|||
16452775|NCT01215097|40137280|FG001|Overall Study|Lost to Follow-up|0|||
16452776|NCT01215097|40137279|FG000|Overall Study|Withdrawal by Subject|6|||
16452777|NCT01215097|40137280|FG001|Overall Study|Withdrawal by Subject|3|||
16452778|NCT01215097|40137279|FG000|Overall Study|Lack of Efficacy|0|||
16452779|NCT01215097|40137280|FG001|Overall Study|Lack of Efficacy|3|||
16452780|NCT01215097|40137279|FG000|Overall Study|patient's refusal to come|2|||
16452781|NCT01215097|40137280|FG001|Overall Study|patient's refusal to come|2|||
16452782|NCT01215097|40137279|FG000|Overall Study|patient's private reason|1|||
16452783|NCT01215097|40137280|FG001|Overall Study|patient's private reason|1|||
16452784|NCT03070964|40137285|FG000|Overall Study|Progressive disease|8|||
16452785|NCT03070964|40137285|FG000|Overall Study|Treatment-unrelated adverse event|2|||
16452786|NCT03070964|40137285|FG000|Overall Study|Never treated|1|||
16452787|NCT03070964|40137285|FG000|Overall Study|Physician Decision|1|||
16452788|NCT03070964|40137285|FG000|Overall Study|Withdrawal by Subject|1|||
16164673|NCT02574637|39083754|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
16164674|NCT02574637|39083755|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
16452789|NCT03070964|40137285|FG000|Overall Study|Adverse Event|1|||
16452790|NCT01716052|40137288|FG000|Overall Study|Withdrawal of funding|1|||
16452791|NCT01716052|40137289|FG001|Overall Study|Withdrawal of funding|1|||
16452792|NCT01554241|40137290|FG000|Overall Study|Death|3|||
16452793|NCT01554241|40137291|FG001|Overall Study|Death|1|||
16452794|NCT01554241|40137292|FG002|Overall Study|Death|1|||
16452795|NCT01554241|40137293|FG003|Overall Study|Death|0|||
16452796|NCT01554241|40137290|FG000|Overall Study|protocol specified renal stone|0|||
16452797|NCT01554241|40137291|FG001|Overall Study|protocol specified renal stone|0|||
16452798|NCT01554241|40137292|FG002|Overall Study|protocol specified renal stone|0|||
16452799|NCT01554241|40137293|FG003|Overall Study|protocol specified renal stone|1|||
16452800|NCT01554241|40137290|FG000|Overall Study|protocol specified change in eGFR|0|||
16452801|NCT01554241|40137291|FG001|Overall Study|protocol specified change in eGFR|0|||
16452802|NCT01554241|40137292|FG002|Overall Study|protocol specified change in eGFR|1|||
16452803|NCT01554241|40137293|FG003|Overall Study|protocol specified change in eGFR|0|||
16452804|NCT01554241|40137290|FG000|Overall Study|Withdrawal by Subject|0|||
16452805|NCT01554241|40137291|FG001|Overall Study|Withdrawal by Subject|0|||
16452806|NCT01554241|40137292|FG002|Overall Study|Withdrawal by Subject|2|||
16452807|NCT01554241|40137293|FG003|Overall Study|Withdrawal by Subject|0|||
16452808|NCT01903811|40137309|FG000|Overall Study|No measurable disease|1|||
16452809|NCT01903811|40137310|FG001|Overall Study|No measurable disease|1|||
16452810|NCT01903811|40137309|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
16452811|NCT01903811|40137310|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
16452812|NCT01903811|40137309|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
16452813|NCT01903811|40137310|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
16452814|NCT01903811|40137309|FG000|Overall Study|Withdrawal by Subject|0|||
16452815|NCT01903811|40137310|FG001|Overall Study|Withdrawal by Subject|1|||
16452816|NCT01869764|40137311|FG000|Overall Study|Withdrawal by Subject|0|||
16452817|NCT01869764|40137312|FG001|Overall Study|Withdrawal by Subject|2|||
16452818|NCT02504216|40137313|FG000|Overall Study|Lost to Follow-up|3|||
16452819|NCT02504216|40137314|FG001|Overall Study|Lost to Follow-up|3|||
16452820|NCT02504216|40137313|FG000|Overall Study|Withdrawal by Subject|8|||
16452821|NCT02504216|40137314|FG001|Overall Study|Withdrawal by Subject|12|||
16452822|NCT03436082|40137315|FG000|Overall Study|Did not undergo procedure|1|||
16452823|NCT03436082|40137316|FG001|Overall Study|Did not undergo procedure|0|||
16452824|NCT05343624|40137319|FG000|Overall Study|Chart review not completed|1|||
16164675|NCT02574637|39083756|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
16164676|NCT02574637|39083757|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
16164677|NCT02574637|39083758|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
16164678|NCT02574637|39083759|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
16164679|NCT02574637|39083760|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
16164680|NCT02574637|39083761|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
16164681|NCT02574637|39083762|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
16164682|NCT02574637|39083763|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
16164683|NCT02574637|39083754|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
16164684|NCT02574637|39083755|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
16164685|NCT02574637|39083756|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
16164686|NCT02574637|39083757|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
16164687|NCT02574637|39083758|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
16164688|NCT02574637|39083759|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
16164689|NCT02574637|39083760|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
16164690|NCT02574637|39083761|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
16164691|NCT02574637|39083762|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
16164692|NCT02574637|39083763|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
16164693|NCT02574637|39083754|FG000|Double-blind Period|Reason Not Specified|0|||
16164694|NCT02574637|39083755|FG001|Double-blind Period|Reason Not Specified|0|||
16164695|NCT02574637|39083756|FG002|Double-blind Period|Reason Not Specified|0|||
16164696|NCT02574637|39083757|FG003|Double-blind Period|Reason Not Specified|1|||
16164697|NCT02574637|39083758|FG004|Double-blind Period|Reason Not Specified|0|||
16266043|NCT02057458|39456823|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
16266044|NCT02057458|39456824|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
16266045|NCT02057458|39456822|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
16266046|NCT02057458|39456823|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
16266047|NCT02057458|39456824|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
16266048|NCT01319383|39456825|FG000|Overall Study|No ex vivo or in vivo response|4|||
16266049|NCT01319383|39456826|FG001|Overall Study|No ex vivo or in vivo response|0|||
16266050|NCT01319383|39456825|FG000|Overall Study|Physician Decision|3|||
16266051|NCT01319383|39456826|FG001|Overall Study|Physician Decision|0|||
16266052|NCT01319383|39456825|FG000|Overall Study|Lack of Efficacy|5|||
16266053|NCT01319383|39456826|FG001|Overall Study|Lack of Efficacy|9|||
16266054|NCT01319383|39456825|FG000|Overall Study|No in vivo response to interval doses|0|||
16266055|NCT01319383|39456826|FG001|Overall Study|No in vivo response to interval doses|1|||
16266056|NCT00245063|39456831|FG000|Overall Study|Adverse Event|6|||
16266057|NCT00245063|39456832|FG001|Overall Study|Adverse Event|5|||
16266058|NCT00245063|39456831|FG000|Overall Study|Death|1|||
16266059|NCT00245063|39456832|FG001|Overall Study|Death|0|||
16266060|NCT01173692|39456833|FG000|Overall Study|Adverse Event|1|||
16266061|NCT01173692|39456834|FG001|Overall Study|Adverse Event|2|||
16266062|NCT01173692|39456833|FG000|Overall Study|Withdrawal by Subject|1|||
16266063|NCT01173692|39456834|FG001|Overall Study|Withdrawal by Subject|3|||
16266064|NCT03987191|39456835|FG000|Overall Study|COVID-19 related research disruption|0|||
16266065|NCT03987191|39456836|FG001|Overall Study|COVID-19 related research disruption|2|||
16452825|NCT00811018|40137320|FG000|Overall Study|Additional Chronic Treatment|31|||
16452826|NCT00811018|40137320|FG000|Overall Study|Adverse Event|79|||
16452827|NCT00811018|40137320|FG000|Overall Study|Death|147|||
16452828|NCT00811018|40137320|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
16164698|NCT02574637|39083759|FG005|Double-blind Period|Reason Not Specified|0|||
16164699|NCT02574637|39083760|FG006|Double-blind Period|Reason Not Specified|0|||
16266066|NCT02158663|39456839|FG000|Overall Study|Withdrawal by Subject|5|||
16452829|NCT00811018|40137320|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
16452830|NCT00811018|40137320|FG000|Overall Study|Investigator Decision|57|||
16164700|NCT02574637|39083761|FG007|Double-blind Period|Reason Not Specified|0|||
16266067|NCT02158663|39456840|FG001|Overall Study|Withdrawal by Subject|4|||
16452831|NCT00811018|40137320|FG000|Overall Study|Lost to Follow-up|19|||
16164701|NCT02574637|39083762|FG008|Double-blind Period|Reason Not Specified|0|||
16164702|NCT02574637|39083763|FG009|Double-blind Period|Reason Not Specified|0|||
16164703|NCT02574637|39083754|FG000|Open-label (OL) Period|Adverse Event|0|||
16164704|NCT02574637|39083755|FG001|Open-label (OL) Period|Adverse Event|0|||
16164705|NCT02574637|39083756|FG002|Open-label (OL) Period|Adverse Event|0|||
16164706|NCT02574637|39083757|FG003|Open-label (OL) Period|Adverse Event|0|||
16164707|NCT02574637|39083758|FG004|Open-label (OL) Period|Adverse Event|0|||
16164708|NCT02574637|39083759|FG005|Open-label (OL) Period|Adverse Event|0|||
16164709|NCT02574637|39083760|FG006|Open-label (OL) Period|Adverse Event|0|||
16164710|NCT02574637|39083761|FG007|Open-label (OL) Period|Adverse Event|0|||
16164711|NCT02574637|39083762|FG008|Open-label (OL) Period|Adverse Event|1|||
16164712|NCT02574637|39083763|FG009|Open-label (OL) Period|Adverse Event|0|||
16164713|NCT02574637|39083754|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
16164714|NCT02574637|39083755|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
16164715|NCT02574637|39083756|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
16164716|NCT02574637|39083757|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
16164717|NCT02574637|39083758|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
16164718|NCT02574637|39083759|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
16164719|NCT02574637|39083760|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
16164720|NCT02574637|39083761|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
16164721|NCT02574637|39083762|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
16266068|NCT03435081|39456843|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
16266069|NCT03435081|39456844|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
16266070|NCT03435081|39456845|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
16266071|NCT03435081|39456843|FG000|Week 0 to Week 16|Adverse Event|2|||
16266072|NCT03435081|39456844|FG001|Week 0 to Week 16|Adverse Event|2|||
16266073|NCT03435081|39456845|FG002|Week 0 to Week 16|Adverse Event|2|||
16266074|NCT03435081|39456843|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
16266075|NCT03435081|39456844|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
16266076|NCT03435081|39456845|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
16266077|NCT03435081|39456843|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
16266078|NCT03435081|39456844|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
16266079|NCT03435081|39456845|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
16266080|NCT03435081|39456843|FG000|Week 0 to Week 16|Pregnancy|1|||
16266081|NCT03435081|39456844|FG001|Week 0 to Week 16|Pregnancy|0|||
16266082|NCT03435081|39456845|FG002|Week 0 to Week 16|Pregnancy|0|||
16266083|NCT03435081|39456843|FG000|Week 0 to Week 16|Non-compliance|1|||
16266084|NCT03435081|39456844|FG001|Week 0 to Week 16|Non-compliance|0|||
16266085|NCT03435081|39456845|FG002|Week 0 to Week 16|Non-compliance|2|||
16266086|NCT03435081|39456843|FG000|Week 0 to Week 16|Inadequate Response|0|||
16266087|NCT03435081|39456844|FG001|Week 0 to Week 16|Inadequate Response|1|||
16266088|NCT03435081|39456845|FG002|Week 0 to Week 16|Inadequate Response|0|||
16266089|NCT03435081|39456843|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
16452832|NCT00811018|40137320|FG000|Overall Study|Pregnancy|6|||
16452833|NCT00811018|40137320|FG000|Overall Study|Sponsor Decision|450|||
16452834|NCT00811018|40137320|FG000|Overall Study|Withdrawal by Subject|70|||
16452835|NCT00811018|40137320|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
16452836|NCT00811018|40137320|FG000|Overall Study|Other|26|||
16452837|NCT00943618|40137321|FG000|Overall Study|Lost to Follow-up|38|||
16452838|NCT00943618|40137322|FG001|Overall Study|Lost to Follow-up|48|||
16452839|NCT00943618|40137323|FG002|Overall Study|Lost to Follow-up|20|||
16452840|NCT00943618|40137321|FG000|Overall Study|Discontinued Medication|17|||
16452841|NCT00943618|40137322|FG001|Overall Study|Discontinued Medication|29|||
16452842|NCT00943618|40137323|FG002|Overall Study|Discontinued Medication|11|||
16452843|NCT01229267|40137328|FG000|Overall Study|Adverse Event|4|||
16452844|NCT01229267|40137329|FG001|Overall Study|Adverse Event|6|||
16452845|NCT01229267|40137330|FG002|Overall Study|Adverse Event|3|||
16452846|NCT01229267|40137331|FG003|Overall Study|Adverse Event|2|||
16452847|NCT01229267|40137332|FG004|Overall Study|Adverse Event|10|||
16452848|NCT01229267|40137328|FG000|Overall Study|Death|40|||
16164722|NCT02574637|39083763|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
16164723|NCT02574637|39083754|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16266090|NCT03435081|39456844|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
16266091|NCT03435081|39456845|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
16266092|NCT03435081|39456843|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
16266093|NCT03435081|39456844|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
16452849|NCT01229267|40137329|FG001|Overall Study|Death|37|||
16452850|NCT01229267|40137330|FG002|Overall Study|Death|35|||
16452851|NCT01229267|40137331|FG003|Overall Study|Death|13|||
16164724|NCT02574637|39083755|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16452852|NCT01229267|40137332|FG004|Overall Study|Death|103|||
16164725|NCT02574637|39083756|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16452853|NCT01229267|40137328|FG000|Overall Study|Withdrawal by Subject|23|||
16072636|NCT00371566|38756414|FG000|Chemoradiation Phase|Progressive Disease|1|||
16452854|NCT01229267|40137329|FG001|Overall Study|Withdrawal by Subject|22|||
16452855|NCT01229267|40137330|FG002|Overall Study|Withdrawal by Subject|32|||
16452856|NCT01229267|40137331|FG003|Overall Study|Withdrawal by Subject|14|||
16452857|NCT01229267|40137332|FG004|Overall Study|Withdrawal by Subject|59|||
16452858|NCT01229267|40137328|FG000|Overall Study|Protocol Violation|0|||
16452859|NCT01229267|40137329|FG001|Overall Study|Protocol Violation|1|||
16452860|NCT01229267|40137330|FG002|Overall Study|Protocol Violation|0|||
16452861|NCT01229267|40137331|FG003|Overall Study|Protocol Violation|0|||
16452862|NCT01229267|40137332|FG004|Overall Study|Protocol Violation|0|||
16452863|NCT01229267|40137328|FG000|Overall Study|Progressive disease|0|||
16452864|NCT01229267|40137329|FG001|Overall Study|Progressive disease|0|||
16452865|NCT01229267|40137330|FG002|Overall Study|Progressive disease|0|||
16452866|NCT01229267|40137331|FG003|Overall Study|Progressive disease|0|||
16452867|NCT01229267|40137332|FG004|Overall Study|Progressive disease|1|||
16452868|NCT01229267|40137328|FG000|Overall Study|Physician Decision|8|||
16452869|NCT01229267|40137329|FG001|Overall Study|Physician Decision|11|||
16452870|NCT01229267|40137330|FG002|Overall Study|Physician Decision|8|||
16452871|NCT01229267|40137331|FG003|Overall Study|Physician Decision|3|||
16452872|NCT01229267|40137332|FG004|Overall Study|Physician Decision|25|||
16452873|NCT01229267|40137328|FG000|Overall Study|Lost to Follow-up|6|||
16452874|NCT01229267|40137329|FG001|Overall Study|Lost to Follow-up|5|||
16452875|NCT01229267|40137330|FG002|Overall Study|Lost to Follow-up|8|||
16452876|NCT01229267|40137331|FG003|Overall Study|Lost to Follow-up|3|||
16452877|NCT01229267|40137332|FG004|Overall Study|Lost to Follow-up|22|||
16452878|NCT01255436|40137333|FG000|Overall Study|Lost to Follow-up|178|||
16452879|NCT01255436|40137334|FG001|Overall Study|Lost to Follow-up|191|||
16452880|NCT01255436|40137333|FG000|Overall Study|Death, stroke, or MI|4|||
16452881|NCT01255436|40137334|FG001|Overall Study|Death, stroke, or MI|3|||
16452882|NCT00557856|40137335|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
16452883|NCT00557856|40137336|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
16452884|NCT00557856|40137337|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
16452885|NCT00557856|40137338|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
16452886|NCT00557856|40137339|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
16452887|NCT00557856|40137340|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
16452888|NCT00557856|40137341|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
16452889|NCT00557856|40137342|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
16452890|NCT00557856|40137343|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
16452891|NCT00557856|40137335|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
16452892|NCT00557856|40137336|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
16452893|NCT00557856|40137337|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
16452894|NCT00557856|40137338|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
16452895|NCT00557856|40137339|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
16452896|NCT00557856|40137340|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
16452897|NCT00557856|40137341|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
16452898|NCT00557856|40137342|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
16452899|NCT00557856|40137343|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
16452900|NCT00557856|40137335|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
16452901|NCT00557856|40137336|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
16452902|NCT00557856|40137337|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
16452903|NCT00557856|40137338|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
16452904|NCT00557856|40137339|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
16452905|NCT00557856|40137340|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
16452906|NCT00557856|40137341|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
16452907|NCT00557856|40137342|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
16452908|NCT00557856|40137343|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
16452909|NCT00557856|40137335|FG000|Part 1: Dose Escalation Phase|Other|0|||
16452910|NCT00557856|40137336|FG001|Part 1: Dose Escalation Phase|Other|0|||
16452911|NCT00557856|40137337|FG002|Part 1: Dose Escalation Phase|Other|1|||
16452912|NCT00557856|40137338|FG003|Part 1: Dose Escalation Phase|Other|1|||
16452913|NCT00557856|40137339|FG004|Part 1: Dose Escalation Phase|Other|0|||
16452914|NCT00557856|40137340|FG005|Part 1: Dose Escalation Phase|Other|0|||
16452915|NCT00557856|40137341|FG006|Part 1: Dose Escalation Phase|Other|0|||
16452916|NCT00557856|40137342|FG007|Part 1: Dose Escalation Phase|Other|1|||
16452917|NCT00557856|40137343|FG008|Part 1: Dose Escalation Phase|Other|0|||
16452918|NCT00557856|40137335|FG000|Part 1: Dose Escalation Phase|Death|0|||
16452919|NCT00557856|40137336|FG001|Part 1: Dose Escalation Phase|Death|0|||
16452920|NCT00557856|40137337|FG002|Part 1: Dose Escalation Phase|Death|0|||
16452921|NCT00557856|40137338|FG003|Part 1: Dose Escalation Phase|Death|0|||
16452922|NCT00557856|40137339|FG004|Part 1: Dose Escalation Phase|Death|0|||
16452923|NCT00557856|40137340|FG005|Part 1: Dose Escalation Phase|Death|1|||
16452924|NCT00557856|40137341|FG006|Part 1: Dose Escalation Phase|Death|0|||
16164726|NCT02574637|39083757|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16452925|NCT00557856|40137342|FG007|Part 1: Dose Escalation Phase|Death|0|||
16452926|NCT00557856|40137343|FG008|Part 1: Dose Escalation Phase|Death|0|||
16452927|NCT00557856|40137335|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
16452928|NCT00557856|40137336|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
16452929|NCT00557856|40137337|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
16452930|NCT00557856|40137338|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
16452931|NCT00557856|40137339|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
16452932|NCT00557856|40137340|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
16452933|NCT00557856|40137341|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
16452934|NCT00557856|40137342|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
16452935|NCT00557856|40137343|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
16452936|NCT00557856|40137335|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
16452937|NCT00557856|40137336|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
16452938|NCT00557856|40137337|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
16452939|NCT00557856|40137338|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
16452940|NCT00557856|40137339|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
16452941|NCT00557856|40137340|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
16452942|NCT00557856|40137341|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
16452943|NCT00557856|40137342|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
16452944|NCT00557856|40137343|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
16452945|NCT00557856|40137335|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
16452946|NCT00557856|40137336|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
16452947|NCT00557856|40137337|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
16452948|NCT00557856|40137338|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
16452949|NCT00557856|40137339|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
16452950|NCT00557856|40137340|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
16452951|NCT00557856|40137341|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
16452952|NCT00557856|40137342|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
16452953|NCT00557856|40137343|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
16452954|NCT00557856|40137335|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
16452955|NCT00557856|40137336|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
16452956|NCT00557856|40137337|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
16452957|NCT00557856|40137338|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
16452958|NCT00557856|40137339|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
16452959|NCT00557856|40137340|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
16452960|NCT00557856|40137341|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
16452961|NCT00557856|40137342|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
16452962|NCT00557856|40137343|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
16452963|NCT00557856|40137335|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
16452964|NCT00557856|40137336|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
16452965|NCT00557856|40137337|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
16452966|NCT00557856|40137338|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
16452967|NCT00557856|40137339|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
16452968|NCT00557856|40137340|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
16452969|NCT00557856|40137341|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
16452970|NCT00557856|40137342|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
16452971|NCT00557856|40137343|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
16452972|NCT00557856|40137335|FG000|Part 2: Exploratory Phase|Other|0|||
16452973|NCT00557856|40137336|FG001|Part 2: Exploratory Phase|Other|0|||
16452974|NCT00557856|40137337|FG002|Part 2: Exploratory Phase|Other|0|||
16452975|NCT00557856|40137338|FG003|Part 2: Exploratory Phase|Other|0|||
16452976|NCT00557856|40137339|FG004|Part 2: Exploratory Phase|Other|0|||
16452977|NCT00557856|40137340|FG005|Part 2: Exploratory Phase|Other|0|||
16452978|NCT00557856|40137341|FG006|Part 2: Exploratory Phase|Other|0|||
16452979|NCT00557856|40137342|FG007|Part 2: Exploratory Phase|Other|0|||
16452980|NCT00557856|40137343|FG008|Part 2: Exploratory Phase|Other|1|||
16452981|NCT00557856|40137335|FG000|Part 2: Exploratory Phase|Death|0|||
16452982|NCT00557856|40137336|FG001|Part 2: Exploratory Phase|Death|0|||
16452983|NCT00557856|40137337|FG002|Part 2: Exploratory Phase|Death|0|||
16452984|NCT00557856|40137338|FG003|Part 2: Exploratory Phase|Death|0|||
16452985|NCT00557856|40137339|FG004|Part 2: Exploratory Phase|Death|0|||
16452986|NCT00557856|40137340|FG005|Part 2: Exploratory Phase|Death|0|||
16452987|NCT00557856|40137341|FG006|Part 2: Exploratory Phase|Death|0|||
16452988|NCT00557856|40137342|FG007|Part 2: Exploratory Phase|Death|0|||
16452989|NCT00557856|40137343|FG008|Part 2: Exploratory Phase|Death|2|||
16452990|NCT00557856|40137335|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
16164727|NCT02574637|39083758|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16452991|NCT00557856|40137336|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
16452992|NCT00557856|40137337|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
16452993|NCT00557856|40137338|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
16452994|NCT00557856|40137339|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
16452995|NCT00557856|40137340|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
16452996|NCT00557856|40137341|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
16452997|NCT00557856|40137342|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
16452998|NCT00557856|40137343|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
16452999|NCT00114517|40137345|FG000|Overall Study|Adverse Event|6|||
16453000|NCT00114517|40137346|FG001|Overall Study|Adverse Event|1|||
16453001|NCT00114517|40137347|FG002|Overall Study|Adverse Event|6|||
16453002|NCT00114517|40137348|FG003|Overall Study|Adverse Event|3|||
16453003|NCT00114517|40137345|FG000|Overall Study|Lost to Follow-up|2|||
16453004|NCT00114517|40137346|FG001|Overall Study|Lost to Follow-up|2|||
16453005|NCT00114517|40137347|FG002|Overall Study|Lost to Follow-up|2|||
16453006|NCT00114517|40137348|FG003|Overall Study|Lost to Follow-up|1|||
16453007|NCT00114517|40137345|FG000|Overall Study|Too busy|3|||
16453008|NCT00114517|40137346|FG001|Overall Study|Too busy|1|||
16453009|NCT00114517|40137347|FG002|Overall Study|Too busy|1|||
16453010|NCT00114517|40137348|FG003|Overall Study|Too busy|2|||
16453011|NCT00114517|40137345|FG000|Overall Study|Moved from area|0|||
16453012|NCT00114517|40137346|FG001|Overall Study|Moved from area|3|||
16453013|NCT00114517|40137347|FG002|Overall Study|Moved from area|2|||
16453014|NCT00114517|40137348|FG003|Overall Study|Moved from area|1|||
16453015|NCT00114517|40137345|FG000|Overall Study|Did not want estradiol|1|||
16453016|NCT00114517|40137346|FG001|Overall Study|Did not want estradiol|1|||
16453017|NCT00114517|40137347|FG002|Overall Study|Did not want estradiol|0|||
16453018|NCT00114517|40137348|FG003|Overall Study|Did not want estradiol|0|||
16453019|NCT00114517|40137345|FG000|Overall Study|Armed-services duty|0|||
16453020|NCT00114517|40137346|FG001|Overall Study|Armed-services duty|1|||
16453021|NCT00114517|40137347|FG002|Overall Study|Armed-services duty|0|||
16453022|NCT00114517|40137348|FG003|Overall Study|Armed-services duty|1|||
16453023|NCT00114517|40137345|FG000|Overall Study|Competing family issue|0|||
16453024|NCT00114517|40137346|FG001|Overall Study|Competing family issue|1|||
16453025|NCT00114517|40137347|FG002|Overall Study|Competing family issue|0|||
16453026|NCT00114517|40137348|FG003|Overall Study|Competing family issue|1|||
16453027|NCT00114517|40137345|FG000|Overall Study|Physician Decision|0|||
16453028|NCT00114517|40137346|FG001|Overall Study|Physician Decision|1|||
16453029|NCT00114517|40137347|FG002|Overall Study|Physician Decision|0|||
16453030|NCT00114517|40137348|FG003|Overall Study|Physician Decision|0|||
16453031|NCT00114517|40137345|FG000|Overall Study|Lost interest|0|||
16453032|NCT00114517|40137346|FG001|Overall Study|Lost interest|0|||
16453033|NCT00114517|40137347|FG002|Overall Study|Lost interest|1|||
16453034|NCT00114517|40137348|FG003|Overall Study|Lost interest|0|||
16453035|NCT00114517|40137345|FG000|Overall Study|Weight increase|0|||
16453036|NCT00114517|40137346|FG001|Overall Study|Weight increase|0|||
16453037|NCT00114517|40137347|FG002|Overall Study|Weight increase|1|||
16453038|NCT00114517|40137348|FG003|Overall Study|Weight increase|0|||
16453039|NCT00114517|40137345|FG000|Overall Study|Concern about blood clots|0|||
16453040|NCT00114517|40137346|FG001|Overall Study|Concern about blood clots|0|||
16453041|NCT00114517|40137347|FG002|Overall Study|Concern about blood clots|1|||
16453042|NCT00114517|40137348|FG003|Overall Study|Concern about blood clots|0|||
16453043|NCT00114517|40137345|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
16453044|NCT00114517|40137346|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
16453045|NCT00114517|40137347|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
16453046|NCT00114517|40137348|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
16453047|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
16453048|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
16453049|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Adverse Event|31|||
16453050|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Adverse Event|21|||
16453051|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
16453052|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
16453053|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
16453054|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
16453055|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
16453056|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
16453057|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
16453058|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
16453059|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Administrative problems|3|||
16453060|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Administrative problems|3|||
16453061|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Death|5|||
16453062|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Death|8|||
16453063|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Disease progression|139|||
16453064|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Disease progression|119|||
16453065|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
16453066|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
16453067|NCT00785785|40137351|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
16453068|NCT00785785|40137352|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
16453069|NCT00785785|40137351|FG000|Optional Extension Phase|Adverse Event|4|||
16453070|NCT00785785|40137352|FG001|Optional Extension Phase|Adverse Event|5|||
16453071|NCT00785785|40137351|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
16453072|NCT00785785|40137352|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
16453073|NCT00785785|40137351|FG000|Optional Extension Phase|Lost to Follow-up|1|||
16453074|NCT00785785|40137352|FG001|Optional Extension Phase|Lost to Follow-up|0|||
16453075|NCT00785785|40137351|FG000|Optional Extension Phase|Administrative problems|2|||
16453076|NCT00785785|40137352|FG001|Optional Extension Phase|Administrative problems|0|||
16453077|NCT00785785|40137351|FG000|Optional Extension Phase|Death|1|||
16453078|NCT00785785|40137352|FG001|Optional Extension Phase|Death|5|||
16453079|NCT00785785|40137351|FG000|Optional Extension Phase|Disease progression|22|||
16453080|NCT00785785|40137352|FG001|Optional Extension Phase|Disease progression|70|||
16453081|NCT00785785|40137351|FG000|Optional Extension Phase|Protocol deviation|0|||
16453082|NCT00785785|40137352|FG001|Optional Extension Phase|Protocol deviation|2|||
16453083|NCT00785785|40137351|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
16453084|NCT00785785|40137352|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
16453085|NCT00123422|40137353|FG000|Overall Study|Physician Decision|2|||
16453086|NCT00123422|40137354|FG001|Overall Study|Physician Decision|2|||
16453087|NCT00123422|40137355|FG002|Overall Study|Physician Decision|6|||
16453088|NCT00123422|40137353|FG000|Overall Study|Withdrawal by Subject|1|||
16453089|NCT00123422|40137354|FG001|Overall Study|Withdrawal by Subject|2|||
16453090|NCT00123422|40137355|FG002|Overall Study|Withdrawal by Subject|2|||
16453091|NCT00123422|40137353|FG000|Overall Study|Lost to Follow-up|1|||
16453092|NCT00123422|40137354|FG001|Overall Study|Lost to Follow-up|2|||
16453093|NCT00123422|40137355|FG002|Overall Study|Lost to Follow-up|2|||
16453094|NCT04294680|40137356|FG000|Overall Study|Withdrawal by Subject|2|||
16453095|NCT04294680|40137357|FG001|Overall Study|Withdrawal by Subject|1|||
16453096|NCT04294680|40137356|FG000|Overall Study|Follow-up visits completed outside of window|1|||
16453097|NCT04294680|40137357|FG001|Overall Study|Follow-up visits completed outside of window|0|||
16453098|NCT02779556|40137368|FG000|Baseline|Partial baseline interview completed|1|||
16453099|NCT02779556|40137369|FG001|Baseline|Partial baseline interview completed|0|||
16453100|NCT02779556|40137368|FG000|3 Months|Lost to Follow-up|40|||
16453101|NCT02779556|40137369|FG001|3 Months|Lost to Follow-up|29|||
16453102|NCT02779556|40137368|FG000|3 Months|Missed 3 month clinic visit|27|||
16453103|NCT02779556|40137369|FG001|3 Months|Missed 3 month clinic visit|19|||
16453104|NCT02779556|40137368|FG000|6 Month|Lost to Follow-up|33|||
16453105|NCT02779556|40137369|FG001|6 Month|Lost to Follow-up|39|||
16453106|NCT02779556|40137368|FG000|6 Month HbA1c|No value collected during window|69|||
16453107|NCT02779556|40137369|FG001|6 Month HbA1c|No value collected during window|50|||
16453108|NCT02779556|40137368|FG000|12 Month HbA1c|No value collected during window|138|||
16453109|NCT02779556|40137369|FG001|12 Month HbA1c|No value collected during window|102|||
16453110|NCT00080899|40137370|FG000|Overall Study|Adverse Event|1|||
16453111|NCT02194985|40137371|FG000|Overall Study|Adverse Event|1|||
16164728|NCT02574637|39083759|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
16164729|NCT02574637|39083760|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
16266094|NCT03435081|39456845|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
16453112|NCT02194985|40137371|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
16453113|NCT02194985|40137371|FG000|Overall Study|Physician Decision|4|||
16453114|NCT02194985|40137371|FG000|Overall Study|Lost to Follow-up|1|||
16453115|NCT02194985|40137371|FG000|Overall Study|Withdrawal by Subject|2|||
16453116|NCT00602472|40137373|FG000|Overall Study|Adverse Event|5|||
16453117|NCT00602472|40137374|FG001|Overall Study|Adverse Event|23|||
16453118|NCT00602472|40137373|FG000|Overall Study|Protocol Violation|4|||
16453119|NCT00602472|40137374|FG001|Overall Study|Protocol Violation|19|||
16453120|NCT00602472|40137373|FG000|Overall Study|Withdrawal by Subject|8|||
16453121|NCT00602472|40137374|FG001|Overall Study|Withdrawal by Subject|14|||
16453122|NCT00602472|40137373|FG000|Overall Study|Other incl. lack of efficacy|4|||
16453123|NCT00602472|40137374|FG001|Overall Study|Other incl. lack of efficacy|2|||
16453124|NCT02722304|40137375|FG000|Overall Study|Study Terminated by Sponsor|1|||
16453125|NCT02722304|40137376|FG001|Overall Study|Study Terminated by Sponsor|0|||
16453126|NCT02722304|40137377|FG002|Overall Study|Study Terminated by Sponsor|2|||
16453127|NCT02722304|40137378|FG003|Overall Study|Study Terminated by Sponsor|1|||
16453128|NCT02722304|40137379|FG004|Overall Study|Study Terminated by Sponsor|1|||
16453129|NCT02722304|40137375|FG000|Overall Study|Other|0|||
16453130|NCT02722304|40137376|FG001|Overall Study|Other|0|||
16453131|NCT02722304|40137377|FG002|Overall Study|Other|0|||
16453132|NCT02722304|40137378|FG003|Overall Study|Other|1|||
16453133|NCT02722304|40137379|FG004|Overall Study|Other|1|||
16453134|NCT02427464|40137380|FG000|Overall Study|Adverse Event|6|||
16266095|NCT03435081|39456843|FG000|Week 16 to Week 104|Adverse Event|1|||
16453135|NCT02427464|40137381|FG001|Overall Study|Adverse Event|1|||
16453136|NCT02427464|40137380|FG000|Overall Study|Lost to Follow-up|16|||
16453137|NCT02427464|40137381|FG001|Overall Study|Lost to Follow-up|5|||
16453138|NCT02427464|40137380|FG000|Overall Study|Physician Decision|2|||
16453139|NCT02427464|40137381|FG001|Overall Study|Physician Decision|0|||
16453140|NCT02427464|40137380|FG000|Overall Study|Withdrawal by Subject|10|||
16453141|NCT02427464|40137381|FG001|Overall Study|Withdrawal by Subject|8|||
16453142|NCT02427464|40137380|FG000|Overall Study|Noncompliance|16|||
16453143|NCT02427464|40137381|FG001|Overall Study|Noncompliance|10|||
16453144|NCT03116152|40137382|FG000|Overall Study|Disease Progression|49|||
16453145|NCT03116152|40137383|FG001|Overall Study|Disease Progression|47|||
16453146|NCT03116152|40137382|FG000|Overall Study|Death|5|||
16453147|NCT03116152|40137383|FG001|Overall Study|Death|2|||
16453148|NCT03116152|40137382|FG000|Overall Study|Adverse Event|21|||
16453149|NCT03116152|40137383|FG001|Overall Study|Adverse Event|7|||
16453150|NCT03116152|40137382|FG000|Overall Study|Protocol Violation|2|||
16453151|NCT03116152|40137383|FG001|Overall Study|Protocol Violation|2|||
16453152|NCT03116152|40137382|FG000|Overall Study|Withdrawal by Subject|0|||
16453153|NCT03116152|40137383|FG001|Overall Study|Withdrawal by Subject|1|||
16453154|NCT03116152|40137382|FG000|Overall Study|Physician Decision|3|||
16453155|NCT03116152|40137383|FG001|Overall Study|Physician Decision|2|||
16453156|NCT03116152|40137382|FG000|Overall Study|other|11|||
16453157|NCT03116152|40137383|FG001|Overall Study|other|34|||
16453158|NCT01818752|40137384|FG000|Overall Study|Adverse Event|64|||
16453159|NCT01818752|40137385|FG001|Overall Study|Adverse Event|74|||
16453160|NCT01818752|40137384|FG000|Overall Study|Death|14|||
16453161|NCT01818752|40137385|FG001|Overall Study|Death|18|||
16453162|NCT01818752|40137384|FG000|Overall Study|Non-compliance|16|||
16453163|NCT01818752|40137385|FG001|Overall Study|Non-compliance|20|||
16453164|NCT01818752|40137384|FG000|Overall Study|Withdrawal by Subject|15|||
16453165|NCT01818752|40137385|FG001|Overall Study|Withdrawal by Subject|14|||
16453166|NCT01818752|40137384|FG000|Overall Study|Physician Decision|9|||
16453167|NCT01818752|40137385|FG001|Overall Study|Physician Decision|8|||
16453168|NCT01818752|40137384|FG000|Overall Study|Disease Progression|54|||
16453169|NCT01818752|40137385|FG001|Overall Study|Disease Progression|48|||
16453170|NCT01818752|40137384|FG000|Overall Study|Other|7|||
16453171|NCT01818752|40137385|FG001|Overall Study|Other|8|||
16453172|NCT01818752|40137384|FG000|Overall Study|Continuing Treatment|1|||
16453173|NCT01818752|40137385|FG001|Overall Study|Continuing Treatment|4|||
16453174|NCT01818752|40137384|FG000|Overall Study|Randomized but not Dosed|7|||
16453175|NCT01818752|40137385|FG001|Overall Study|Randomized but not Dosed|4|||
16453176|NCT02000440|40137386|FG000|Overall Study|Adverse Event|3|||
16453177|NCT02000440|40137386|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
16453178|NCT02280408|40137387|FG000|Overall Study|Lost to Follow-up|0|||
16453179|NCT02280408|40137388|FG001|Overall Study|Lost to Follow-up|2|||
16453180|NCT02280408|40137389|FG002|Overall Study|Lost to Follow-up|0|||
16453181|NCT02280408|40137390|FG003|Overall Study|Lost to Follow-up|0|||
16453182|NCT00787267|40137391|FG000|Overall Study|Screen failure/Ineligible|10|||
16453183|NCT00787267|40137391|FG000|Overall Study|No Reason Provided|1|||
16453184|NCT00787267|40137391|FG000|Overall Study|Withdrawal by Subject|1|||
16453185|NCT03584789|40137397|FG000|Overall Study|refused EHR permission|19|||
16453186|NCT03584789|40137398|FG001|Overall Study|refused EHR permission|28|||
16453187|NCT03584789|40137399|FG002|Overall Study|refused EHR permission|23|||
16453188|NCT03584789|40137397|FG000|Overall Study|patients tied to a provider who retired|0|||
16453189|NCT03584789|40137398|FG001|Overall Study|patients tied to a provider who retired|0|||
16453190|NCT03584789|40137399|FG002|Overall Study|patients tied to a provider who retired|3|||
16453191|NCT01254422|40137402|FG000|Overall Study|Protocol Violation|1|||
16453192|NCT01254422|40137403|FG001|Overall Study|Protocol Violation|0|||
16453193|NCT01254422|40137402|FG000|Overall Study|Adverse Event|1|||
16453194|NCT01254422|40137403|FG001|Overall Study|Adverse Event|0|||
16453195|NCT01254422|40137402|FG000|Overall Study|Serious adverse event|0|||
16453196|NCT01254422|40137403|FG001|Overall Study|Serious adverse event|1|||
16453197|NCT01254422|40137402|FG000|Overall Study|Lost to Follow-up|1|||
16453198|NCT01254422|40137403|FG001|Overall Study|Lost to Follow-up|0|||
16453199|NCT01763996|40137404|FG000|Treatment Period 2|Adverse Event|0|||
16453200|NCT01763996|40137405|FG001|Treatment Period 2|Adverse Event|1|||
16453201|NCT04816669|40137406|FG000|Part 1|Adverse Event|1|||
16453202|NCT04816669|40137407|FG001|Part 1|Adverse Event|1|||
16453203|NCT04816669|40137408|FG002|Part 1|Adverse Event|0|||
16453204|NCT04816669|40137409|FG003|Part 1|Adverse Event|0|||
16453205|NCT04816669|40137406|FG000|Part 1|Lost to Follow-up|2|||
16453206|NCT04816669|40137407|FG001|Part 1|Lost to Follow-up|2|||
16453207|NCT04816669|40137408|FG002|Part 1|Lost to Follow-up|0|||
16453208|NCT04816669|40137409|FG003|Part 1|Lost to Follow-up|0|||
16453209|NCT04816669|40137406|FG000|Part 1|Protocol Violation|0|||
16453210|NCT04816669|40137407|FG001|Part 1|Protocol Violation|1|||
16453211|NCT04816669|40137408|FG002|Part 1|Protocol Violation|0|||
16453212|NCT04816669|40137409|FG003|Part 1|Protocol Violation|0|||
16453213|NCT04816669|40137406|FG000|Part 1|Withdrawal by Subject|1|||
16453214|NCT04816669|40137407|FG001|Part 1|Withdrawal by Subject|2|||
16453215|NCT04816669|40137408|FG002|Part 1|Withdrawal by Subject|0|||
16453216|NCT04816669|40137409|FG003|Part 1|Withdrawal by Subject|0|||
16453217|NCT04816669|40137406|FG000|Part 2|Other|0|||
16453218|NCT04816669|40137407|FG001|Part 2|Other|0|||
16453219|NCT04816669|40137408|FG002|Part 2|Other|1|||
16453220|NCT04816669|40137409|FG003|Part 2|Other|0|||
16453221|NCT04816669|40137406|FG000|Part 2|Withdrawal by Subject|0|||
16453222|NCT04816669|40137407|FG001|Part 2|Withdrawal by Subject|0|||
16453223|NCT04816669|40137408|FG002|Part 2|Withdrawal by Subject|0|||
16453224|NCT04816669|40137409|FG003|Part 2|Withdrawal by Subject|1|||
16453225|NCT04816669|40137406|FG000|Part 2|Lost to Follow-up|0|||
16453226|NCT04816669|40137407|FG001|Part 2|Lost to Follow-up|0|||
16453227|NCT04816669|40137408|FG002|Part 2|Lost to Follow-up|1|||
16453228|NCT04816669|40137409|FG003|Part 2|Lost to Follow-up|0|||
16453229|NCT03038880|40137411|FG000|Overall Study|Death|1|||
16453230|NCT03038880|40137412|FG001|Overall Study|Death|2|||
16453231|NCT03038880|40137413|FG002|Overall Study|Death|0|||
16453232|NCT03038880|40137411|FG000|Overall Study|Physician Decision|2|||
16453233|NCT03038880|40137412|FG001|Overall Study|Physician Decision|1|||
16453234|NCT03038880|40137413|FG002|Overall Study|Physician Decision|0|||
16453235|NCT00845897|40137414|FG000|Overall Study|Lost to Follow-up|1|||
16453236|NCT00845897|40137415|FG001|Overall Study|Lost to Follow-up|1|||
16453237|NCT00845897|40137416|FG002|Overall Study|Lost to Follow-up|0|||
16453238|NCT00845897|40137414|FG000|Overall Study|Withdrawal by Subject|0|||
16453239|NCT00845897|40137415|FG001|Overall Study|Withdrawal by Subject|3|||
16453240|NCT00845897|40137416|FG002|Overall Study|Withdrawal by Subject|2|||
16453241|NCT00845897|40137414|FG000|Overall Study|Ulcer did not heal|1|||
16453242|NCT00845897|40137415|FG001|Overall Study|Ulcer did not heal|0|||
16453243|NCT00845897|40137416|FG002|Overall Study|Ulcer did not heal|1|||
16453244|NCT00845897|40137414|FG000|Overall Study|Too ill to participate|0|||
16453245|NCT00845897|40137415|FG001|Overall Study|Too ill to participate|1|||
16453246|NCT00845897|40137416|FG002|Overall Study|Too ill to participate|0|||
16453247|NCT02447003|40137417|FG000|Overall Study|Other|0|||
16453248|NCT02447003|40137418|FG001|Overall Study|Other|4|||
16453249|NCT02447003|40137417|FG000|Overall Study|Site discontinued|0|||
16453250|NCT02447003|40137418|FG001|Overall Study|Site discontinued|2|||
16453251|NCT02447003|40137417|FG000|Overall Study|Physician Decision|0|||
16453252|NCT02447003|40137418|FG001|Overall Study|Physician Decision|1|||
16453253|NCT02447003|40137417|FG000|Overall Study|Withdrawal by Subject|4|||
16453254|NCT02447003|40137418|FG001|Overall Study|Withdrawal by Subject|3|||
16453255|NCT02447003|40137417|FG000|Overall Study|Sponsor Decision|6|||
16453256|NCT02447003|40137418|FG001|Overall Study|Sponsor Decision|11|||
16453257|NCT02447003|40137417|FG000|Overall Study|Progressive Disease|1|||
16453258|NCT02447003|40137418|FG001|Overall Study|Progressive Disease|0|||
16453259|NCT02447003|40137417|FG000|Overall Study|Lost to Follow-up|5|||
16453260|NCT02447003|40137418|FG001|Overall Study|Lost to Follow-up|0|||
16453261|NCT02447003|40137417|FG000|Overall Study|Death|154|||
16453262|NCT02447003|40137418|FG001|Overall Study|Death|63|||
16453263|NCT00494676|40137419|FG000|Allocation|Withdrawal by Subject|2|||
16453264|NCT00494676|40137420|FG001|Allocation|Withdrawal by Subject|4|||
16453265|NCT00494676|40137419|FG000|First Intervention|Withdrawal by Subject|1|||
16453266|NCT00494676|40137420|FG001|First Intervention|Withdrawal by Subject|3|||
16453267|NCT00494676|40137419|FG000|Second Intervention|Withdrawal by Subject|1|||
16453268|NCT00494676|40137420|FG001|Second Intervention|Withdrawal by Subject|1|||
16453269|NCT01421719|40137421|FG000|Overall Study|Withdrawal by Subject|4|||
16453270|NCT01083771|40137424|FG000|Overall Study|non-compliant|2|||
16453271|NCT01083771|40137424|FG000|Overall Study|Withdrawal by Subject|3|||
16453272|NCT01047553|40137425|FG000|Overall Study|Adverse Event|10|||
16453273|NCT01047553|40137426|FG001|Overall Study|Adverse Event|5|||
16453274|NCT01047553|40137425|FG000|Overall Study|Withdrawal by Subject|4|||
16453275|NCT01047553|40137426|FG001|Overall Study|Withdrawal by Subject|2|||
16453276|NCT01047553|40137425|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
16453277|NCT01047553|40137426|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
16453278|NCT01047553|40137425|FG000|Overall Study|Lost to Follow-up|1|||
16453279|NCT01047553|40137426|FG001|Overall Study|Lost to Follow-up|0|||
16164730|NCT02574637|39083761|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
16164731|NCT02574637|39083762|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
16453280|NCT01047553|40137425|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
16453281|NCT01047553|40137426|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
16453282|NCT01047553|40137425|FG000|Overall Study|PI's decision|0|||
16453283|NCT01047553|40137426|FG001|Overall Study|PI's decision|1|||
16453284|NCT00423917|40137432|FG000|Overall Study|Cancel|2|||
16453285|NCT00423917|40137432|FG000|Overall Study|Ineligible|1|||
16453286|NCT04413617|40137433|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
16453287|NCT04413617|40137434|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
16453288|NCT04413617|40137435|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
16453289|NCT04413617|40137436|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
16453290|NCT04413617|40137437|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
16453291|NCT04413617|40137433|FG000|Overall Study|Protocol Violation|0|||
16453292|NCT04413617|40137434|FG001|Overall Study|Protocol Violation|1|||
16453293|NCT04413617|40137435|FG002|Overall Study|Protocol Violation|0|||
16266096|NCT03435081|39456844|FG001|Week 16 to Week 104|Adverse Event|0|||
16164732|NCT02574637|39083763|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
16164733|NCT03099707|39083767|FG000|Overall Study|Withdrawal by Subject|0|||
16164734|NCT03099707|39083768|FG001|Overall Study|Withdrawal by Subject|3|||
16164735|NCT03099707|39083767|FG000|Overall Study|Lost to Follow-up|0|||
16164736|NCT03099707|39083768|FG001|Overall Study|Lost to Follow-up|1|||
16164737|NCT03543410|39083771|FG000|Overall Study|Adverse Event|10|||
16164738|NCT03543410|39083772|FG001|Overall Study|Adverse Event|8|||
16164739|NCT03543410|39083773|FG002|Overall Study|Adverse Event|2|||
16164740|NCT03543410|39083771|FG000|Overall Study|Lack of Efficacy|0|||
16164741|NCT03543410|39083772|FG001|Overall Study|Lack of Efficacy|1|||
16453294|NCT04413617|40137436|FG003|Overall Study|Protocol Violation|0|||
16453295|NCT04413617|40137437|FG004|Overall Study|Protocol Violation|1|||
16453296|NCT04413617|40137433|FG000|Overall Study|Lack of Efficacy|2|||
16453297|NCT04413617|40137434|FG001|Overall Study|Lack of Efficacy|0|||
16453298|NCT04413617|40137435|FG002|Overall Study|Lack of Efficacy|2|||
16453299|NCT04413617|40137436|FG003|Overall Study|Lack of Efficacy|1|||
16453300|NCT04413617|40137437|FG004|Overall Study|Lack of Efficacy|0|||
16453301|NCT04413617|40137433|FG000|Overall Study|Withdrawal by Subject|3|||
16453302|NCT04413617|40137434|FG001|Overall Study|Withdrawal by Subject|4|||
16453303|NCT04413617|40137435|FG002|Overall Study|Withdrawal by Subject|2|||
16453304|NCT04413617|40137436|FG003|Overall Study|Withdrawal by Subject|5|||
16453305|NCT04413617|40137437|FG004|Overall Study|Withdrawal by Subject|3|||
16453306|NCT04413617|40137433|FG000|Overall Study|Death|1|||
16453307|NCT04413617|40137434|FG001|Overall Study|Death|0|||
16453308|NCT04413617|40137435|FG002|Overall Study|Death|0|||
16453309|NCT04413617|40137436|FG003|Overall Study|Death|0|||
16453310|NCT04413617|40137437|FG004|Overall Study|Death|0|||
16453311|NCT04413617|40137433|FG000|Overall Study|Adverse Event|1|||
16453312|NCT04413617|40137434|FG001|Overall Study|Adverse Event|0|||
16453313|NCT04413617|40137435|FG002|Overall Study|Adverse Event|0|||
16453314|NCT04413617|40137436|FG003|Overall Study|Adverse Event|1|||
16453315|NCT04413617|40137437|FG004|Overall Study|Adverse Event|1|||
16453316|NCT04413617|40137433|FG000|Overall Study|COVID-19|0|||
16453317|NCT04413617|40137434|FG001|Overall Study|COVID-19|1|||
16453318|NCT04413617|40137435|FG002|Overall Study|COVID-19|0|||
16453319|NCT04413617|40137436|FG003|Overall Study|COVID-19|0|||
16453320|NCT04413617|40137437|FG004|Overall Study|COVID-19|0|||
16453321|NCT04200352|40137438|FG000|Overall Study|Death|1|||
16453322|NCT04200352|40137438|FG000|Overall Study|Adverse Event|6|||
16453323|NCT04200352|40137438|FG000|Overall Study|Withdrawal by parent/guardian|6|||
16453324|NCT04200352|40137438|FG000|Overall Study|Lack of Efficacy|1|||
16453325|NCT04200352|40137438|FG000|Overall Study|Other than specified|6|||
16453326|NCT01821118|40137445|FG000|Overall Study|Death|0|||
16453327|NCT01821118|40137446|FG001|Overall Study|Death|1|||
16453328|NCT01528969|40137447|FG000|Overall Study|absent from the school at baseline|2|||
16453329|NCT01528969|40137448|FG001|Overall Study|absent from the school at baseline|0|||
16453330|NCT03714672|40137449|FG000|Overall Study|Adverse Event|0|||
16453331|NCT03714672|40137450|FG001|Overall Study|Adverse Event|0|||
16453332|NCT03714672|40137451|FG002|Overall Study|Adverse Event|3|||
16453333|NCT03714672|40137452|FG003|Overall Study|Adverse Event|0|||
16453334|NCT03714672|40137449|FG000|Overall Study|Physician Decision|0|||
16453335|NCT03714672|40137450|FG001|Overall Study|Physician Decision|1|||
16453336|NCT03714672|40137451|FG002|Overall Study|Physician Decision|0|||
16453337|NCT03714672|40137452|FG003|Overall Study|Physician Decision|0|||
16453338|NCT03714672|40137449|FG000|Overall Study|Other Reason|1|||
16453339|NCT03714672|40137450|FG001|Overall Study|Other Reason|2|||
16453340|NCT03714672|40137451|FG002|Overall Study|Other Reason|1|||
16453341|NCT03714672|40137452|FG003|Overall Study|Other Reason|1|||
16453342|NCT03714672|40137449|FG000|Overall Study|Lost to Follow-up|1|||
16453343|NCT03714672|40137450|FG001|Overall Study|Lost to Follow-up|1|||
16453344|NCT03714672|40137451|FG002|Overall Study|Lost to Follow-up|0|||
16453345|NCT03714672|40137452|FG003|Overall Study|Lost to Follow-up|0|||
16453346|NCT02536963|40137457|FG000|Overall Study|Withdrawal by Subject|18|||
16453347|NCT00996333|40137460|FG000|Overall Study|Screen failure|1|||
16453348|NCT00996333|40137460|FG000|Overall Study|Withdrawal by Subject|1|||
16453349|NCT00996333|40137460|FG000|Overall Study|Death|4|||
16453350|NCT00996333|40137460|FG000|Overall Study|Adverse Event|1|||
16453351|NCT00996333|40137460|FG000|Overall Study|Physician Decision|1|||
16453352|NCT00996333|40137460|FG000|Overall Study|Other|5|||
16453353|NCT02561832|40137463|FG000|Overall Study|Withdrawal by Subject|1|||
16453354|NCT02561832|40137464|FG001|Overall Study|Withdrawal by Subject|1|||
16453355|NCT02561832|40137463|FG000|Overall Study|Adverse Event|3|||
16453356|NCT02561832|40137464|FG001|Overall Study|Adverse Event|0|||
16453357|NCT02561832|40137463|FG000|Overall Study|Disease progression|3|||
16453358|NCT02561832|40137464|FG001|Overall Study|Disease progression|3|||
16164742|NCT03543410|39083773|FG002|Overall Study|Lack of Efficacy|0|||
16164743|NCT03543410|39083771|FG000|Overall Study|Lost to Follow-up|0|||
16453359|NCT00433004|40137465|FG000|Overall Study|Lost to Follow-up|5|||
16453360|NCT00433004|40137466|FG001|Overall Study|Lost to Follow-up|7|||
16453361|NCT01474239|40137467|FG000|Overall Study|Disease Progression|37|||
16453362|NCT01474239|40137468|FG001|Overall Study|Disease Progression|25|||
16453363|NCT01474239|40137467|FG000|Overall Study|Adverse Event|12|||
16453364|NCT01474239|40137468|FG001|Overall Study|Adverse Event|3|||
16453365|NCT01474239|40137467|FG000|Overall Study|Withdrawal by Subject|1|||
16453366|NCT01474239|40137468|FG001|Overall Study|Withdrawal by Subject|2|||
16453367|NCT01474239|40137467|FG000|Overall Study|Death|1|||
16453368|NCT01474239|40137468|FG001|Overall Study|Death|1|||
16453369|NCT01474239|40137467|FG000|Overall Study|Clinical Disease Progression|7|||
16453370|NCT01474239|40137468|FG001|Overall Study|Clinical Disease Progression|1|||
16453371|NCT01474239|40137467|FG000|Overall Study|Withdrawal for Economic Reason|1|||
16453372|NCT01474239|40137468|FG001|Overall Study|Withdrawal for Economic Reason|0|||
16453373|NCT01185080|40137469|FG000|Overall Study|Adverse Event|1|||
16453374|NCT01185080|40137470|FG001|Overall Study|Adverse Event|1|||
16453375|NCT01185080|40137471|FG002|Overall Study|Adverse Event|0|||
16453376|NCT01185080|40137469|FG000|Overall Study|Personal reasons|0|||
16453377|NCT01185080|40137470|FG001|Overall Study|Personal reasons|0|||
16453378|NCT01185080|40137471|FG002|Overall Study|Personal reasons|1|||
16453379|NCT02541604|40137472|FG000|Overall Study|Death|6|||
16453380|NCT02541604|40137473|FG001|Overall Study|Death|5|||
16453381|NCT02541604|40137474|FG002|Overall Study|Death|7|||
16453382|NCT02541604|40137475|FG003|Overall Study|Death|2|||
16453383|NCT02541604|40137476|FG004|Overall Study|Death|9|||
16453384|NCT02541604|40137477|FG005|Overall Study|Death|8|||
16453385|NCT02541604|40137478|FG006|Overall Study|Death|9|||
16453386|NCT02541604|40137479|FG007|Overall Study|Death|9|||
16453387|NCT02541604|40137480|FG008|Overall Study|Death|3|||
16453388|NCT02541604|40137481|FG009|Overall Study|Death|4|||
16453389|NCT02541604|40137482|FG010|Overall Study|Death|2|||
16453390|NCT02541604|40137483|FG011|Overall Study|Death|3|||
16453391|NCT02541604|40137472|FG000|Overall Study|Lost to Follow-up|2|||
16453392|NCT02541604|40137473|FG001|Overall Study|Lost to Follow-up|0|||
16453393|NCT02541604|40137474|FG002|Overall Study|Lost to Follow-up|1|||
16453394|NCT02541604|40137475|FG003|Overall Study|Lost to Follow-up|0|||
16453395|NCT02541604|40137476|FG004|Overall Study|Lost to Follow-up|0|||
16453396|NCT02541604|40137477|FG005|Overall Study|Lost to Follow-up|1|||
16453397|NCT02541604|40137478|FG006|Overall Study|Lost to Follow-up|1|||
16453398|NCT02541604|40137479|FG007|Overall Study|Lost to Follow-up|0|||
16453399|NCT02541604|40137480|FG008|Overall Study|Lost to Follow-up|0|||
16453400|NCT02541604|40137481|FG009|Overall Study|Lost to Follow-up|0|||
16453401|NCT02541604|40137482|FG010|Overall Study|Lost to Follow-up|0|||
16453402|NCT02541604|40137483|FG011|Overall Study|Lost to Follow-up|0|||
16453403|NCT02541604|40137472|FG000|Overall Study|Withdrawal by Subject|2|||
16453404|NCT02541604|40137473|FG001|Overall Study|Withdrawal by Subject|0|||
16453405|NCT02541604|40137474|FG002|Overall Study|Withdrawal by Subject|1|||
16453406|NCT02541604|40137475|FG003|Overall Study|Withdrawal by Subject|0|||
16453407|NCT02541604|40137476|FG004|Overall Study|Withdrawal by Subject|1|||
16453408|NCT02541604|40137477|FG005|Overall Study|Withdrawal by Subject|1|||
16453409|NCT02541604|40137478|FG006|Overall Study|Withdrawal by Subject|0|||
16453410|NCT02541604|40137479|FG007|Overall Study|Withdrawal by Subject|0|||
16453411|NCT02541604|40137480|FG008|Overall Study|Withdrawal by Subject|1|||
16453412|NCT02541604|40137481|FG009|Overall Study|Withdrawal by Subject|0|||
16453413|NCT02541604|40137482|FG010|Overall Study|Withdrawal by Subject|0|||
16453414|NCT02541604|40137483|FG011|Overall Study|Withdrawal by Subject|0|||
16453415|NCT02541604|40137472|FG000|Overall Study|Study Terminated by Sponsor|1|||
16453416|NCT02541604|40137473|FG001|Overall Study|Study Terminated by Sponsor|4|||
16453417|NCT02541604|40137474|FG002|Overall Study|Study Terminated by Sponsor|2|||
16453418|NCT02541604|40137475|FG003|Overall Study|Study Terminated by Sponsor|1|||
16453419|NCT02541604|40137476|FG004|Overall Study|Study Terminated by Sponsor|0|||
16453420|NCT02541604|40137477|FG005|Overall Study|Study Terminated by Sponsor|0|||
16453421|NCT02541604|40137478|FG006|Overall Study|Study Terminated by Sponsor|0|||
16453422|NCT02541604|40137479|FG007|Overall Study|Study Terminated by Sponsor|0|||
16453423|NCT02541604|40137480|FG008|Overall Study|Study Terminated by Sponsor|0|||
16453424|NCT02541604|40137481|FG009|Overall Study|Study Terminated by Sponsor|0|||
16453425|NCT02541604|40137482|FG010|Overall Study|Study Terminated by Sponsor|0|||
16453426|NCT02541604|40137483|FG011|Overall Study|Study Terminated by Sponsor|0|||
16453427|NCT02541604|40137472|FG000|Overall Study|Medical condition may jeopardize safety|0|||
16453428|NCT02541604|40137473|FG001|Overall Study|Medical condition may jeopardize safety|0|||
16453429|NCT02541604|40137474|FG002|Overall Study|Medical condition may jeopardize safety|0|||
16453430|NCT02541604|40137475|FG003|Overall Study|Medical condition may jeopardize safety|0|||
16453431|NCT02541604|40137476|FG004|Overall Study|Medical condition may jeopardize safety|0|||
16453432|NCT02541604|40137477|FG005|Overall Study|Medical condition may jeopardize safety|0|||
16453433|NCT02541604|40137478|FG006|Overall Study|Medical condition may jeopardize safety|0|||
16453434|NCT02541604|40137479|FG007|Overall Study|Medical condition may jeopardize safety|1|||
16453435|NCT02541604|40137480|FG008|Overall Study|Medical condition may jeopardize safety|0|||
16453436|NCT02541604|40137481|FG009|Overall Study|Medical condition may jeopardize safety|0|||
16453437|NCT02541604|40137482|FG010|Overall Study|Medical condition may jeopardize safety|0|||
16453438|NCT02541604|40137483|FG011|Overall Study|Medical condition may jeopardize safety|0|||
16453439|NCT02668393|40137484|FG000|Overall Study|Progressive disease|6|||
16453440|NCT02668393|40137485|FG001|Overall Study|Progressive disease|3|||
16453441|NCT02668393|40137484|FG000|Overall Study|Adverse Event|0|||
16453442|NCT02668393|40137485|FG001|Overall Study|Adverse Event|2|||
16453443|NCT02668393|40137484|FG000|Overall Study|Withdrawal from the trial|0|||
16453444|NCT02668393|40137485|FG001|Overall Study|Withdrawal from the trial|1|||
16453445|NCT02668393|40137484|FG000|Overall Study|Lack of benefit and side effects|1|||
16453446|NCT02668393|40137485|FG001|Overall Study|Lack of benefit and side effects|0|||
16453447|NCT01379508|40137488|FG000|Treatment to Week 104|Adverse Event|2|||
16453448|NCT01379508|40137489|FG001|Treatment to Week 104|Adverse Event|0|||
16453449|NCT01379508|40137490|FG002|Treatment to Week 104|Adverse Event|5|||
16453450|NCT01379508|40137491|FG003|Treatment to Week 104|Adverse Event|0|||
16453451|NCT01379508|40137488|FG000|Treatment to Week 104|Abnormal lab value|1|||
16453452|NCT01379508|40137489|FG001|Treatment to Week 104|Abnormal lab value|0|||
16453453|NCT01379508|40137490|FG002|Treatment to Week 104|Abnormal lab value|0|||
16453454|NCT01379508|40137491|FG003|Treatment to Week 104|Abnormal lab value|0|||
16453455|NCT01379508|40137488|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
16453456|NCT01379508|40137489|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
16453457|NCT01379508|40137490|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
16453458|NCT01379508|40137491|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
16453459|NCT01379508|40137488|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
16453460|NCT01379508|40137489|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
16453461|NCT01379508|40137490|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
16453462|NCT01379508|40137491|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
16453463|NCT01379508|40137488|FG000|Treatment to Week 104|Lost to Follow-up|5|||
16453464|NCT01379508|40137489|FG001|Treatment to Week 104|Lost to Follow-up|0|||
16453465|NCT01379508|40137490|FG002|Treatment to Week 104|Lost to Follow-up|3|||
16453466|NCT01379508|40137491|FG003|Treatment to Week 104|Lost to Follow-up|0|||
16453467|NCT01379508|40137488|FG000|Treatment to Week 104|Administrative problems|3|||
16453468|NCT01379508|40137489|FG001|Treatment to Week 104|Administrative problems|1|||
16453469|NCT01379508|40137490|FG002|Treatment to Week 104|Administrative problems|0|||
16453470|NCT01379508|40137491|FG003|Treatment to Week 104|Administrative problems|0|||
16453471|NCT01379508|40137488|FG000|Treatment to Week 104|Protocol Violation|1|||
16453472|NCT01379508|40137489|FG001|Treatment to Week 104|Protocol Violation|1|||
16453473|NCT01379508|40137490|FG002|Treatment to Week 104|Protocol Violation|1|||
16453474|NCT01379508|40137491|FG003|Treatment to Week 104|Protocol Violation|0|||
16453475|NCT01379508|40137488|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
16453476|NCT01379508|40137489|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
16453477|NCT01379508|40137490|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
16453478|NCT01379508|40137491|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
16453479|NCT01379508|40137488|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
16453480|NCT01379508|40137489|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
16453481|NCT01379508|40137490|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
16453482|NCT01379508|40137491|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
16453483|NCT01379508|40137488|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
16453484|NCT01379508|40137489|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
16453485|NCT01379508|40137490|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
16453486|NCT01379508|40137491|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
16453487|NCT01379508|40137488|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
16453488|NCT01379508|40137489|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
16453489|NCT01379508|40137490|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
16453490|NCT01379508|40137491|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
16453491|NCT02858362|40137492|FG000|Overall Study|Protocol Violation|0|||
16453492|NCT02858362|40137493|FG001|Overall Study|Protocol Violation|1|||
16453493|NCT02858362|40137494|FG002|Overall Study|Protocol Violation|0|||
16453494|NCT02858362|40137492|FG000|Overall Study|Withdrawal by Subject|1|||
16453495|NCT02858362|40137493|FG001|Overall Study|Withdrawal by Subject|0|||
16453496|NCT02858362|40137494|FG002|Overall Study|Withdrawal by Subject|0|||
16453497|NCT02858362|40137492|FG000|Overall Study|Early Study Termination|0|||
16453498|NCT02858362|40137493|FG001|Overall Study|Early Study Termination|0|||
16453499|NCT02858362|40137494|FG002|Overall Study|Early Study Termination|3|||
16453500|NCT02858362|40137492|FG000|Overall Study|Lost to Follow-up|1|||
16453501|NCT02858362|40137493|FG001|Overall Study|Lost to Follow-up|0|||
16453502|NCT02858362|40137494|FG002|Overall Study|Lost to Follow-up|0|||
16453503|NCT01711216|40137498|FG000|Overall Study|Adverse Event|4|||
16453504|NCT01711216|40137498|FG000|Overall Study|Pregnancy|56|||
16453505|NCT01711216|40137498|FG000|Overall Study|Withdrawal by Subject|6|||
16453506|NCT01711216|40137498|FG000|Overall Study|Lost to Follow-up|46|||
16453507|NCT01711216|40137498|FG000|Overall Study|variety of other minor reasons|83|||
16453508|NCT01711216|40137498|FG000|Overall Study|no reason specified|22|||
16453509|NCT00470275|40137499|FG000|Overall Study|Death|1|||
16453510|NCT00470275|40137499|FG000|Overall Study|Lack of Efficacy|7|||
16453511|NCT00470275|40137499|FG000|Overall Study|Withdrawal by Subject|2|||
16453512|NCT00220636|40137500|FG000|Overall Study|Withdrawal by Subject|4|||
16453513|NCT00934362|40137501|FG000|Overall Study|Adverse Event|1|||
16453514|NCT00934362|40137502|FG001|Overall Study|Adverse Event|0|||
16453515|NCT02282605|40137503|FG000|Overall Study|negative SA result on Day -1|3|||
16453516|NCT02282605|40137504|FG001|Overall Study|negative SA result on Day -1|0|||
16453517|NCT02282605|40137505|FG002|Overall Study|negative SA result on Day -1|0|||
16453518|NCT03967444|40137508|FG000|Overall Study|Lost to Follow-up|1|||
16453519|NCT03967444|40137509|FG001|Overall Study|Lost to Follow-up|2|||
16453520|NCT01867671|40137512|FG000|Overall Study|Adverse Event|5|||
16453521|NCT01867671|40137513|FG001|Overall Study|Adverse Event|3|||
16453522|NCT01867671|40137512|FG000|Overall Study|Anaphylaxis|0|||
16453523|NCT01867671|40137513|FG001|Overall Study|Anaphylaxis|1|||
16453524|NCT01867671|40137512|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
16453525|NCT01867671|40137513|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
16453526|NCT01867671|40137512|FG000|Overall Study|Lost to Follow-up|0|||
16453527|NCT01867671|40137513|FG001|Overall Study|Lost to Follow-up|1|||
16453528|NCT01867671|40137512|FG000|Overall Study|Non-compliance with Study Drug|1|||
16453529|NCT01867671|40137513|FG001|Overall Study|Non-compliance with Study Drug|2|||
16453530|NCT01867671|40137512|FG000|Overall Study|Withdrawal by Subject|21|||
16453531|NCT01867671|40137513|FG001|Overall Study|Withdrawal by Subject|21|||
16453532|NCT00439517|40137514|FG000|Overall Study|Subject on treatment|1|||
16453533|NCT00439517|40137515|FG001|Overall Study|Subject on treatment|0|||
16453534|NCT00439517|40137514|FG000|Overall Study|Subject in survival follow-up|1|||
16453535|NCT00439517|40137515|FG001|Overall Study|Subject in survival follow-up|0|||
16453536|NCT00334113|40137519|FG000|Overall Study|Lost to Follow-up|2|||
16453537|NCT00334113|40137520|FG001|Overall Study|Lost to Follow-up|2|||
16453538|NCT00334113|40137519|FG000|Overall Study|Withdrawal by Subject|0|||
16453539|NCT00334113|40137520|FG001|Overall Study|Withdrawal by Subject|1|||
16453540|NCT00526071|40137522|FG000|Overall Study|Adverse Event|1|||
16453541|NCT00526071|40137522|FG000|Overall Study|Withdrawal by Subject|1|||
16072637|NCT00371566|38756415|FG001|Chemoradiation Phase|Progressive Disease|1|||
16072638|NCT00371566|38756414|FG000|Chemoradiation Phase|Death|2|||
16072639|NCT00371566|38756415|FG001|Chemoradiation Phase|Death|0|||
16072640|NCT00371566|38756414|FG000|Follow Up Phase|Death|0|||
16072641|NCT00371566|38756415|FG001|Follow Up Phase|Death|5|||
16072642|NCT00371566|38756414|FG000|Follow Up Phase|Disease progression|1|||
16072643|NCT00371566|38756415|FG001|Follow Up Phase|Disease progression|0|||
16072644|NCT00371566|38756414|FG000|Follow Up Phase|Withdrawal by Subject|0|||
16072645|NCT00371566|38756415|FG001|Follow Up Phase|Withdrawal by Subject|1|||
16072646|NCT00371566|38756414|FG000|Follow Up Phase|Physician Decision|1|||
16072647|NCT00371566|38756415|FG001|Follow Up Phase|Physician Decision|1|||
16072648|NCT00371566|38756414|FG000|Follow Up Phase|Lost to Follow-up|1|||
16072649|NCT00371566|38756415|FG001|Follow Up Phase|Lost to Follow-up|0|||
16072650|NCT01467700|38756418|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
16072651|NCT01467700|38756419|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
16072652|NCT01467700|38756420|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
16072653|NCT01467700|38756421|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
16072654|NCT01467700|38756418|FG000|Overall Study|Major Protocol Deviation|3|||
16072655|NCT01467700|38756419|FG001|Overall Study|Major Protocol Deviation|3|||
16072656|NCT01467700|38756420|FG002|Overall Study|Major Protocol Deviation|2|||
16072657|NCT01467700|38756421|FG003|Overall Study|Major Protocol Deviation|3|||
16072658|NCT01467700|38756418|FG000|Overall Study|Lost to Follow-up|6|||
16164744|NCT03543410|39083772|FG001|Overall Study|Lost to Follow-up|1|||
16164745|NCT03543410|39083773|FG002|Overall Study|Lost to Follow-up|0|||
16164746|NCT03543410|39083771|FG000|Overall Study|Withdrawal by Subject|5|||
16164747|NCT03543410|39083772|FG001|Overall Study|Withdrawal by Subject|2|||
16164748|NCT03543410|39083773|FG002|Overall Study|Withdrawal by Subject|8|||
16164749|NCT03543410|39083771|FG000|Overall Study|Protocol Violation|0|||
16164750|NCT03543410|39083772|FG001|Overall Study|Protocol Violation|1|||
16164751|NCT03543410|39083773|FG002|Overall Study|Protocol Violation|0|||
16164752|NCT03543410|39083771|FG000|Overall Study|Due to COVID-19|4|||
16164753|NCT03543410|39083772|FG001|Overall Study|Due to COVID-19|0|||
16164754|NCT03543410|39083773|FG002|Overall Study|Due to COVID-19|2|||
16164755|NCT03543410|39083771|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
16164756|NCT03543410|39083772|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
16164757|NCT03543410|39083773|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
16164758|NCT03543410|39083771|FG000|Overall Study|Not Due to COVID-19|2|||
16164759|NCT03543410|39083772|FG001|Overall Study|Not Due to COVID-19|0|||
16164760|NCT03543410|39083773|FG002|Overall Study|Not Due to COVID-19|1|||
16164761|NCT00648167|39083776|FG000|Overall Study|Adverse Event|6|||
16453542|NCT00526071|40137522|FG000|Overall Study|Lack of Response to Study Drug|4|||
16453543|NCT02597478|40137528|FG000|Overall Study|Withdrawal by Subject|2|||
16453544|NCT02597478|40137529|FG001|Overall Study|Withdrawal by Subject|0|||
16072659|NCT01467700|38756419|FG001|Overall Study|Lost to Follow-up|5|||
16164762|NCT00648167|39083776|FG000|Overall Study|unable to swallow tablets|1|||
16164763|NCT02411747|39083777|FG000|Overall Study|Withdrawal by Subject|1|||
16164764|NCT02411747|39083778|FG001|Overall Study|Withdrawal by Subject|0|||
16164765|NCT02411747|39083777|FG000|Overall Study|Protocol Violation|2|||
16164766|NCT02411747|39083778|FG001|Overall Study|Protocol Violation|4|||
16164767|NCT04682405|39083779|FG000|Overall Study|Adverse Event|0|||
16164768|NCT04682405|39083780|FG001|Overall Study|Adverse Event|1|||
16164769|NCT02908880|39083781|FG000|Overall Study|Lost to Follow-up|4|||
16164770|NCT02908880|39083781|FG000|Overall Study|Explantation of the device|1|||
16164771|NCT02908880|39083781|FG000|Overall Study|Withdrawal by Subject|17|||
16164772|NCT02908880|39083781|FG000|Overall Study|Death|5|||
16164773|NCT01790503|39083782|FG000|Overall Study|Adverse Event|1|||
16164774|NCT01790503|39083783|FG001|Overall Study|Adverse Event|0|||
16164775|NCT01790503|39083784|FG002|Overall Study|Adverse Event|0|||
16164776|NCT01790503|39083785|FG003|Overall Study|Adverse Event|0|||
16164777|NCT01790503|39083786|FG004|Overall Study|Adverse Event|0|||
16164778|NCT01790503|39083787|FG005|Overall Study|Adverse Event|2|||
16164779|NCT01790503|39083788|FG006|Overall Study|Adverse Event|0|||
16164780|NCT01790503|39083789|FG007|Overall Study|Adverse Event|0|||
16164781|NCT01790503|39083790|FG008|Overall Study|Adverse Event|2|||
16164782|NCT01790503|39083791|FG009|Overall Study|Adverse Event|4|||
16164783|NCT01790503|39083792|FG010|Overall Study|Adverse Event|7|||
16164784|NCT01790503|39083782|FG000|Overall Study|Withdrawal by Subject|0|||
16164785|NCT01790503|39083783|FG001|Overall Study|Withdrawal by Subject|0|||
16453545|NCT02597478|40137528|FG000|Overall Study|Change of opioid dose|1|||
16453546|NCT02597478|40137529|FG001|Overall Study|Change of opioid dose|0|||
16453547|NCT02597478|40137528|FG000|Overall Study|Insufficient exertional dyspnea|0|||
16453548|NCT02597478|40137529|FG001|Overall Study|Insufficient exertional dyspnea|1|||
16453549|NCT01663103|40137530|FG000|Overall Study|Withdrawal by Subject|1|||
16453550|NCT01663103|40137531|FG001|Overall Study|Withdrawal by Subject|2|||
16453551|NCT01663103|40137530|FG000|Overall Study|Adverse Event|1|||
16453552|NCT01663103|40137531|FG001|Overall Study|Adverse Event|0|||
16453553|NCT01663103|40137530|FG000|Overall Study|dog bite|1|||
16453554|NCT01663103|40137531|FG001|Overall Study|dog bite|0|||
16453555|NCT01677377|40137533|FG000|Overall Study|Protocol Violation|1|||
16453556|NCT01677377|40137534|FG001|Overall Study|Protocol Violation|0|||
16453557|NCT01677377|40137535|FG002|Overall Study|Protocol Violation|0|||
16453558|NCT01677377|40137533|FG000|Overall Study|Lost to Follow-up|0|||
16453559|NCT01677377|40137534|FG001|Overall Study|Lost to Follow-up|1|||
16453560|NCT01677377|40137535|FG002|Overall Study|Lost to Follow-up|1|||
16453561|NCT01677377|40137533|FG000|Overall Study|Withdrawal by Subject|0|||
16453562|NCT01677377|40137534|FG001|Overall Study|Withdrawal by Subject|0|||
16453563|NCT01677377|40137535|FG002|Overall Study|Withdrawal by Subject|3|||
16453564|NCT01677377|40137533|FG000|Overall Study|Lack of Efficacy|0|||
16453565|NCT01677377|40137534|FG001|Overall Study|Lack of Efficacy|0|||
16453566|NCT01677377|40137535|FG002|Overall Study|Lack of Efficacy|1|||
16453567|NCT01677377|40137533|FG000|Overall Study|Pregnancy|0|||
16453568|NCT01677377|40137534|FG001|Overall Study|Pregnancy|0|||
16453569|NCT01677377|40137535|FG002|Overall Study|Pregnancy|1|||
16453570|NCT00807001|40137537|FG000|Overall Study|Non-compliance|0|||
16453571|NCT00807001|40137538|FG001|Overall Study|Non-compliance|1|||
16453572|NCT00807001|40137539|FG002|Overall Study|Non-compliance|0|||
16453573|NCT00807001|40137540|FG003|Overall Study|Non-compliance|0|||
16453574|NCT00807001|40137541|FG004|Overall Study|Non-compliance|0|||
16453575|NCT03339219|40137544|FG000|Overall Study|Death|12|||
16453576|NCT03339219|40137544|FG000|Overall Study|Site Terminated by Sponsor|22|||
16453577|NCT03339219|40137544|FG000|Overall Study|Withdrawal by Subject|1|||
16453578|NCT02792829|40137545|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
16453579|NCT02792829|40137546|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
16453580|NCT02792829|40137547|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
16453581|NCT02792829|40137548|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
16453582|NCT02792829|40137549|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
16453583|NCT02792829|40137550|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
16453584|NCT02792829|40137551|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
16453585|NCT02792829|40137552|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
16453586|NCT02792829|40137545|FG000|Treatment Period 2|Adverse Event|0|||
16453587|NCT02792829|40137546|FG001|Treatment Period 2|Adverse Event|0|||
16164786|NCT01790503|39083784|FG002|Overall Study|Withdrawal by Subject|1|||
16164787|NCT01790503|39083785|FG003|Overall Study|Withdrawal by Subject|1|||
16164788|NCT01790503|39083786|FG004|Overall Study|Withdrawal by Subject|1|||
16453588|NCT02792829|40137547|FG002|Treatment Period 2|Adverse Event|0|||
16453589|NCT02792829|40137548|FG003|Treatment Period 2|Adverse Event|0|||
16453590|NCT02792829|40137549|FG004|Treatment Period 2|Adverse Event|1|||
16453591|NCT02792829|40137550|FG005|Treatment Period 2|Adverse Event|0|||
16453592|NCT02792829|40137551|FG006|Treatment Period 2|Adverse Event|1|||
16453593|NCT02792829|40137552|FG007|Treatment Period 2|Adverse Event|1|||
16453594|NCT02792829|40137545|FG000|Treatment Period 2|Use of proscribed medications|0|||
16453595|NCT02792829|40137546|FG001|Treatment Period 2|Use of proscribed medications|0|||
16453596|NCT02792829|40137547|FG002|Treatment Period 2|Use of proscribed medications|0|||
16453597|NCT02792829|40137548|FG003|Treatment Period 2|Use of proscribed medications|0|||
16453598|NCT02792829|40137549|FG004|Treatment Period 2|Use of proscribed medications|0|||
16453599|NCT02792829|40137550|FG005|Treatment Period 2|Use of proscribed medications|0|||
16453600|NCT02792829|40137551|FG006|Treatment Period 2|Use of proscribed medications|0|||
16453601|NCT02792829|40137552|FG007|Treatment Period 2|Use of proscribed medications|1|||
16453602|NCT01671319|40137553|FG000|Overall Study|Withdrawal by Subject|1|||
16453603|NCT01696188|40137554|FG000|Overall Study|Protocol Violation|1|||
16453604|NCT01696188|40137555|FG001|Overall Study|Protocol Violation|1|||
16453605|NCT01656408|40137556|FG000|Overall Study|Adverse Event|0|||
16453606|NCT01656408|40137557|FG001|Overall Study|Adverse Event|0|||
16453607|NCT01656408|40137558|FG002|Overall Study|Adverse Event|1|||
16453608|NCT01656408|40137559|FG003|Overall Study|Adverse Event|0|||
16453609|NCT01656408|40137560|FG004|Overall Study|Adverse Event|0|||
16453610|NCT01656408|40137561|FG005|Overall Study|Adverse Event|1|||
16453611|NCT01656408|40137562|FG006|Overall Study|Adverse Event|1|||
16453612|NCT01656408|40137563|FG007|Overall Study|Adverse Event|0|||
16453613|NCT01656408|40137564|FG008|Overall Study|Adverse Event|1|||
16453614|NCT01656408|40137565|FG009|Overall Study|Adverse Event|0|||
16453615|NCT01656408|40137556|FG000|Overall Study|Physician Decision|1|||
16453616|NCT01656408|40137557|FG001|Overall Study|Physician Decision|0|||
16453617|NCT01656408|40137558|FG002|Overall Study|Physician Decision|1|||
16453618|NCT01656408|40137559|FG003|Overall Study|Physician Decision|0|||
16453619|NCT01656408|40137560|FG004|Overall Study|Physician Decision|1|||
16453620|NCT01656408|40137561|FG005|Overall Study|Physician Decision|1|||
16453621|NCT01656408|40137562|FG006|Overall Study|Physician Decision|0|||
16453622|NCT01656408|40137563|FG007|Overall Study|Physician Decision|1|||
16453623|NCT01656408|40137564|FG008|Overall Study|Physician Decision|1|||
16453624|NCT01656408|40137565|FG009|Overall Study|Physician Decision|3|||
16453625|NCT00477386|40137566|FG000|Overall Study|Adverse Event|4|||
16453626|NCT00477386|40137567|FG001|Overall Study|Adverse Event|8|||
16453627|NCT00477386|40137566|FG000|Overall Study|Disease progression, relapse|3|||
16453628|NCT00477386|40137567|FG001|Overall Study|Disease progression, relapse|4|||
16453629|NCT00477386|40137566|FG000|Overall Study|Disease progression, refractory|1|||
16453630|NCT00477386|40137567|FG001|Overall Study|Disease progression, refractory|3|||
16453631|NCT00477386|40137566|FG000|Overall Study|Other|1|||
16453632|NCT00477386|40137567|FG001|Overall Study|Other|2|||
16453633|NCT00477386|40137566|FG000|Overall Study|Physician Decision|1|||
16453634|NCT00477386|40137567|FG001|Overall Study|Physician Decision|0|||
16453635|NCT00477386|40137566|FG000|Overall Study|Withdrawal by Subject|1|||
16453636|NCT00477386|40137567|FG001|Overall Study|Withdrawal by Subject|0|||
16453637|NCT03599089|40137568|FG000|Overall Study|Lost to Follow-up|1|||
16453638|NCT03599089|40137569|FG001|Overall Study|Lost to Follow-up|0|||
16453639|NCT03599089|40137570|FG002|Overall Study|Lost to Follow-up|0|||
16164789|NCT01790503|39083787|FG005|Overall Study|Withdrawal by Subject|2|||
16164790|NCT01790503|39083788|FG006|Overall Study|Withdrawal by Subject|1|||
16164791|NCT01790503|39083789|FG007|Overall Study|Withdrawal by Subject|0|||
16164792|NCT01790503|39083790|FG008|Overall Study|Withdrawal by Subject|0|||
16164793|NCT01790503|39083791|FG009|Overall Study|Withdrawal by Subject|0|||
16164794|NCT01790503|39083792|FG010|Overall Study|Withdrawal by Subject|1|||
16164795|NCT01790503|39083782|FG000|Overall Study|Disease progression|2|||
16164796|NCT01790503|39083783|FG001|Overall Study|Disease progression|1|||
16164797|NCT01790503|39083784|FG002|Overall Study|Disease progression|0|||
16164798|NCT01790503|39083785|FG003|Overall Study|Disease progression|1|||
16164799|NCT01790503|39083786|FG004|Overall Study|Disease progression|2|||
16164800|NCT01790503|39083787|FG005|Overall Study|Disease progression|1|||
16266097|NCT03435081|39456845|FG002|Week 16 to Week 104|Adverse Event|2|||
16266098|NCT03435081|39456843|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
16266099|NCT03435081|39456844|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
16266100|NCT03435081|39456845|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
16266101|NCT03435081|39456843|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
16266102|NCT03435081|39456844|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
16266103|NCT03435081|39456845|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
16266104|NCT03435081|39456843|FG000|Week 16 to Week 104|Non--Compliance|0|||
16266105|NCT03435081|39456844|FG001|Week 16 to Week 104|Non--Compliance|0|||
16266106|NCT03435081|39456845|FG002|Week 16 to Week 104|Non--Compliance|1|||
16453640|NCT03599089|40137571|FG003|Overall Study|Lost to Follow-up|0|||
16453641|NCT03599089|40137568|FG000|Overall Study|Withdrawal by Subject|2|||
16164801|NCT01790503|39083788|FG006|Overall Study|Disease progression|0|||
16266107|NCT00579345|39456846|FG000|Overall Study|Withdrawal by Subject|2|||
16453642|NCT03599089|40137569|FG001|Overall Study|Withdrawal by Subject|1|||
16453643|NCT03599089|40137570|FG002|Overall Study|Withdrawal by Subject|0|||
16453644|NCT03599089|40137571|FG003|Overall Study|Withdrawal by Subject|0|||
16453645|NCT03599089|40137568|FG000|Overall Study|Lack of Efficacy|0|||
16453646|NCT03599089|40137569|FG001|Overall Study|Lack of Efficacy|0|||
16453647|NCT03599089|40137570|FG002|Overall Study|Lack of Efficacy|1|||
16453648|NCT03599089|40137571|FG003|Overall Study|Lack of Efficacy|2|||
16453649|NCT03534180|40137572|FG000|Overall Study|Withdrawal by Subject|1|||
16453650|NCT01509053|40137573|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
16453651|NCT01509053|40137573|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
16266108|NCT00579345|39456847|FG001|Overall Study|Withdrawal by Subject|0|||
16266109|NCT00579345|39456848|FG002|Overall Study|Withdrawal by Subject|0|||
16266110|NCT00579345|39456849|FG003|Overall Study|Withdrawal by Subject|0|||
16164802|NCT01790503|39083789|FG007|Overall Study|Disease progression|1|||
16164803|NCT01790503|39083790|FG008|Overall Study|Disease progression|0|||
16164804|NCT01790503|39083791|FG009|Overall Study|Disease progression|17|||
16164805|NCT01790503|39083792|FG010|Overall Study|Disease progression|7|||
16164806|NCT01790503|39083782|FG000|Overall Study|Protocol Violation|0|||
16164807|NCT01790503|39083783|FG001|Overall Study|Protocol Violation|0|||
16164808|NCT01790503|39083784|FG002|Overall Study|Protocol Violation|0|||
16164809|NCT01790503|39083785|FG003|Overall Study|Protocol Violation|0|||
16164810|NCT01790503|39083786|FG004|Overall Study|Protocol Violation|0|||
16164811|NCT01790503|39083787|FG005|Overall Study|Protocol Violation|0|||
16266111|NCT00579345|39456850|FG004|Overall Study|Withdrawal by Subject|0|||
16266112|NCT00579345|39456851|FG005|Overall Study|Withdrawal by Subject|0|||
16164812|NCT01790503|39083788|FG006|Overall Study|Protocol Violation|0|||
16164813|NCT01790503|39083789|FG007|Overall Study|Protocol Violation|0|||
16164814|NCT01790503|39083790|FG008|Overall Study|Protocol Violation|0|||
16164815|NCT01790503|39083791|FG009|Overall Study|Protocol Violation|1|||
16164816|NCT01790503|39083792|FG010|Overall Study|Protocol Violation|0|||
16164817|NCT01790503|39083782|FG000|Overall Study|Physician Decision|0|||
16164818|NCT01790503|39083783|FG001|Overall Study|Physician Decision|0|||
16164819|NCT01790503|39083784|FG002|Overall Study|Physician Decision|0|||
16164820|NCT01790503|39083785|FG003|Overall Study|Physician Decision|0|||
16164821|NCT01790503|39083786|FG004|Overall Study|Physician Decision|0|||
16164822|NCT01790503|39083787|FG005|Overall Study|Physician Decision|0|||
16164823|NCT01790503|39083788|FG006|Overall Study|Physician Decision|0|||
16164824|NCT01790503|39083789|FG007|Overall Study|Physician Decision|0|||
16164825|NCT01790503|39083790|FG008|Overall Study|Physician Decision|0|||
16164826|NCT01790503|39083791|FG009|Overall Study|Physician Decision|1|||
16164827|NCT01790503|39083792|FG010|Overall Study|Physician Decision|1|||
16164828|NCT01790503|39083782|FG000|Overall Study|Death|0|||
16164829|NCT01790503|39083783|FG001|Overall Study|Death|0|||
16266113|NCT00579345|39456852|FG006|Overall Study|Withdrawal by Subject|0|||
16266114|NCT00579345|39456853|FG007|Overall Study|Withdrawal by Subject|1|||
16266115|NCT00579345|39456846|FG000|Overall Study|Lost to Follow-up|1|||
16266116|NCT00579345|39456847|FG001|Overall Study|Lost to Follow-up|0|||
16266117|NCT00579345|39456848|FG002|Overall Study|Lost to Follow-up|0|||
16266118|NCT00579345|39456849|FG003|Overall Study|Lost to Follow-up|0|||
16266119|NCT00579345|39456850|FG004|Overall Study|Lost to Follow-up|0|||
16453652|NCT01509053|40137573|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
16453653|NCT01509053|40137573|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
16164830|NCT01790503|39083784|FG002|Overall Study|Death|0|||
16164831|NCT01790503|39083785|FG003|Overall Study|Death|0|||
16453654|NCT01509053|40137573|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
16266120|NCT00579345|39456851|FG005|Overall Study|Lost to Follow-up|0|||
16453655|NCT01509053|40137573|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
16453656|NCT03698591|40137574|FG000|Overall Study|Withdrawal by Subject|2|||
16453657|NCT03698591|40137575|FG001|Overall Study|Withdrawal by Subject|2|||
16453658|NCT03698591|40137574|FG000|Overall Study|Failed drug screen|1|||
16453659|NCT03698591|40137575|FG001|Overall Study|Failed drug screen|1|||
16453660|NCT03698591|40137574|FG000|Overall Study|Failed health screen|0|||
16453661|NCT03698591|40137575|FG001|Overall Study|Failed health screen|1|||
16453662|NCT03698591|40137574|FG000|Overall Study|Ineligible for financial compensation|1|||
16453663|NCT03698591|40137575|FG001|Overall Study|Ineligible for financial compensation|0|||
16453664|NCT03698591|40137574|FG000|Overall Study|Equipment Error|1|||
16453665|NCT03698591|40137575|FG001|Overall Study|Equipment Error|0|||
16453666|NCT03698591|40137574|FG000|Overall Study|Could not establish TMS dosage|0|||
16453667|NCT03698591|40137575|FG001|Overall Study|Could not establish TMS dosage|1|||
16453668|NCT00641667|40137580|FG000|Overall Study|Withdrawal by Subject|1|||
16453669|NCT00641667|40137580|FG000|Overall Study|Adverse Event|1|||
16453670|NCT00641667|40137580|FG000|Overall Study|Physician Decision|1|||
16453671|NCT00641667|40137580|FG000|Overall Study|Worsening of underlying disease|3|||
16453672|NCT03544333|40137581|FG000|Overall Study|Withdrawal by Subject|1|||
16453673|NCT03544333|40137582|FG001|Overall Study|Withdrawal by Subject|0|||
16453674|NCT01262989|40137583|FG000|Period 1|Lost to Follow-up|1|||
16453675|NCT01262989|40137584|FG001|Period 1|Lost to Follow-up|1|||
16453676|NCT01262989|40137583|FG000|Period 1|Intercurrent disease|0|||
16453677|NCT01262989|40137584|FG001|Period 1|Intercurrent disease|1|||
16453678|NCT01262989|40137583|FG000|Period 1|Positive answer for exclusion criteria|0|||
16453679|NCT01262989|40137584|FG001|Period 1|Positive answer for exclusion criteria|1|||
16164832|NCT01790503|39083786|FG004|Overall Study|Death|0|||
16164833|NCT01790503|39083787|FG005|Overall Study|Death|0|||
16164834|NCT01790503|39083788|FG006|Overall Study|Death|0|||
16453680|NCT01262989|40137583|FG000|Period 2|Intercurrent disease|0|||
16453681|NCT01262989|40137584|FG001|Period 2|Intercurrent disease|1|||
16164835|NCT01790503|39083789|FG007|Overall Study|Death|0|||
16164836|NCT01790503|39083790|FG008|Overall Study|Death|0|||
16453682|NCT01276054|40137589|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
16453683|NCT01276054|40137590|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
16453684|NCT03158285|40141422|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
16453685|NCT03158285|40141423|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
16453686|NCT03158285|40141424|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
16453687|NCT03158285|40141422|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
16164837|NCT01790503|39083791|FG009|Overall Study|Death|1|||
16164838|NCT01790503|39083792|FG010|Overall Study|Death|0|||
16164839|NCT01790503|39083782|FG000|Overall Study|Non Compliance|0|||
16164840|NCT01790503|39083783|FG001|Overall Study|Non Compliance|0|||
16164841|NCT01790503|39083784|FG002|Overall Study|Non Compliance|0|||
16164842|NCT01790503|39083785|FG003|Overall Study|Non Compliance|0|||
16164843|NCT01790503|39083786|FG004|Overall Study|Non Compliance|1|||
16164844|NCT01790503|39083787|FG005|Overall Study|Non Compliance|0|||
16164845|NCT01790503|39083788|FG006|Overall Study|Non Compliance|0|||
16164846|NCT01790503|39083789|FG007|Overall Study|Non Compliance|0|||
16164847|NCT01790503|39083790|FG008|Overall Study|Non Compliance|0|||
16164848|NCT01790503|39083791|FG009|Overall Study|Non Compliance|0|||
16164849|NCT01790503|39083792|FG010|Overall Study|Non Compliance|0|||
16164850|NCT01790503|39083782|FG000|Overall Study|Other|0|||
16266121|NCT00579345|39456852|FG006|Overall Study|Lost to Follow-up|0|||
16266122|NCT00579345|39456853|FG007|Overall Study|Lost to Follow-up|0|||
16266123|NCT00579345|39456846|FG000|Overall Study|Adverse Event|0|||
16266124|NCT00579345|39456847|FG001|Overall Study|Adverse Event|0|||
16164851|NCT01790503|39083783|FG001|Overall Study|Other|0|||
16164852|NCT01790503|39083784|FG002|Overall Study|Other|0|||
16164853|NCT01790503|39083785|FG003|Overall Study|Other|0|||
16164854|NCT01790503|39083786|FG004|Overall Study|Other|1|||
16164855|NCT01790503|39083787|FG005|Overall Study|Other|0|||
16164856|NCT01790503|39083788|FG006|Overall Study|Other|0|||
16266125|NCT00579345|39456848|FG002|Overall Study|Adverse Event|1|||
16266126|NCT00579345|39456849|FG003|Overall Study|Adverse Event|0|||
16164857|NCT01790503|39083789|FG007|Overall Study|Other|0|||
16164858|NCT01790503|39083790|FG008|Overall Study|Other|1|||
16164859|NCT01790503|39083791|FG009|Overall Study|Other|2|||
16164860|NCT01790503|39083792|FG010|Overall Study|Other|0|||
16164861|NCT00491179|39083793|FG000|Overall Study|Adverse Event|5|||
16164862|NCT00491179|39083794|FG001|Overall Study|Adverse Event|1|||
16164863|NCT00491179|39083793|FG000|Overall Study|Withdrawal by Subject|2|||
16164864|NCT00491179|39083794|FG001|Overall Study|Withdrawal by Subject|1|||
16164865|NCT01015833|39083795|FG000|Overall Study|Death|1|||
16164866|NCT01015833|39083796|FG001|Overall Study|Death|0|||
16164867|NCT01015833|39083795|FG000|Overall Study|Withdrawal by Subject|3|||
16266127|NCT00579345|39456850|FG004|Overall Study|Adverse Event|0|||
16266128|NCT00579345|39456851|FG005|Overall Study|Adverse Event|0|||
16266129|NCT00579345|39456852|FG006|Overall Study|Adverse Event|0|||
16266130|NCT00579345|39456853|FG007|Overall Study|Adverse Event|0|||
16266131|NCT00579345|39456846|FG000|Overall Study|Protocol Violation|1|||
16266132|NCT00579345|39456847|FG001|Overall Study|Protocol Violation|0|||
16266133|NCT00579345|39456848|FG002|Overall Study|Protocol Violation|0|||
16266134|NCT00579345|39456849|FG003|Overall Study|Protocol Violation|0|||
16266135|NCT00579345|39456850|FG004|Overall Study|Protocol Violation|0|||
16266136|NCT00579345|39456851|FG005|Overall Study|Protocol Violation|0|||
16266137|NCT00579345|39456852|FG006|Overall Study|Protocol Violation|0|||
16266138|NCT00579345|39456853|FG007|Overall Study|Protocol Violation|1|||
16266139|NCT00579345|39456846|FG000|Overall Study|Death|1|||
16453688|NCT03158285|40141423|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
16453689|NCT03158285|40141424|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
16453690|NCT03158285|40141422|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
16453691|NCT03158285|40141423|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
16453692|NCT03158285|40141424|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
16453693|NCT03158285|40141422|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
16453694|NCT03158285|40141423|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
16453695|NCT03158285|40141424|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
16453696|NCT03158285|40141422|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
16453697|NCT03158285|40141423|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
16453698|NCT03158285|40141424|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
16453699|NCT03158285|40141422|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
16164868|NCT01015833|39083796|FG001|Overall Study|Withdrawal by Subject|2|||
16164869|NCT01015833|39083795|FG000|Overall Study|Adverse Event|0|||
16164870|NCT01015833|39083796|FG001|Overall Study|Adverse Event|1|||
16164871|NCT01015833|39083795|FG000|Overall Study|Physician Decision|2|||
16164872|NCT01015833|39083796|FG001|Overall Study|Physician Decision|0|||
16164873|NCT01015833|39083795|FG000|Overall Study|Symptomatic deterioration|0|||
16164874|NCT01015833|39083796|FG001|Overall Study|Symptomatic deterioration|1|||
16164875|NCT01015833|39083795|FG000|Overall Study|Other|5|||
16266140|NCT00579345|39456847|FG001|Overall Study|Death|1|||
16266141|NCT00579345|39456848|FG002|Overall Study|Death|1|||
16266142|NCT00579345|39456849|FG003|Overall Study|Death|1|||
16266143|NCT00579345|39456850|FG004|Overall Study|Death|0|||
16266144|NCT00579345|39456851|FG005|Overall Study|Death|0|||
16266145|NCT00579345|39456852|FG006|Overall Study|Death|0|||
16266146|NCT00579345|39456853|FG007|Overall Study|Death|0|||
16266147|NCT02736721|39456854|FG000|Overall Study|Adverse Event|8|||
16453700|NCT03158285|40141423|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
16453701|NCT03158285|40141424|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
16453702|NCT03158285|40141422|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
16453703|NCT03158285|40141423|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
16453704|NCT03158285|40141424|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
16453705|NCT03158285|40141422|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
16453706|NCT03158285|40141423|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
16453707|NCT03158285|40141424|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
16164876|NCT01015833|39083796|FG001|Overall Study|Other|1|||
16164877|NCT01015833|39083795|FG000|Overall Study|Motor Vehicle Accidents|1|||
16164878|NCT01015833|39083796|FG001|Overall Study|Motor Vehicle Accidents|0|||
16164879|NCT01015833|39083795|FG000|Overall Study|Did not start treatment|1|||
16164880|NCT01015833|39083796|FG001|Overall Study|Did not start treatment|0|||
16164881|NCT02292771|39083797|FG000|Overall Study|Withdrawal by Subject|2|||
16164882|NCT02292771|39083798|FG001|Overall Study|Withdrawal by Subject|1|||
16164883|NCT02292771|39083797|FG000|Overall Study|Lost to Follow-up|2|||
16164884|NCT02292771|39083798|FG001|Overall Study|Lost to Follow-up|1|||
16164885|NCT01469000|39083799|FG000|Overall Study|Withdrawal by Subject|16|||
16164886|NCT01469000|39083800|FG001|Overall Study|Withdrawal by Subject|3|||
16164887|NCT01469000|39083799|FG000|Overall Study|Sponsor Decision|4|||
16164888|NCT01469000|39083800|FG001|Overall Study|Sponsor Decision|1|||
16164889|NCT00132041|39083801|FG000|Baseline|Ineligible|6|||
16164890|NCT00132041|39083801|FG000|3 Months Post Ablation|Transplant|1|||
16164891|NCT00132041|39083801|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
16164892|NCT00132041|39083801|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
16164893|NCT00132041|39083801|FG000|6 Months Post Ablation|Death|2|||
16164894|NCT00132041|39083801|FG000|6 Months Post Ablation|Transplant|6|||
16164895|NCT00132041|39083801|FG000|9 Months Post Ablation|Death|1|||
16164896|NCT00132041|39083801|FG000|9 Months Post Ablation|Transplant|1|||
16164897|NCT00132041|39083801|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
16164898|NCT00132041|39083801|FG000|12 Months Post Ablation|Death|1|||
16164899|NCT00132041|39083801|FG000|12 Months Post Ablation|Transplant|1|||
16164900|NCT00132041|39083801|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
16164901|NCT00132041|39083801|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
16164902|NCT00132041|39083801|FG000|15 Months Post Ablation|Death|1|||
16164903|NCT00132041|39083801|FG000|15 Months Post Ablation|Transplant|5|||
16164904|NCT00132041|39083801|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
16164905|NCT00132041|39083801|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
16164906|NCT00132041|39083801|FG000|18 Months Post Ablation|Transplant|1|||
16164907|NCT00132041|39083801|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
16164908|NCT00132041|39083801|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
16164909|NCT00675597|39083806|FG000|Overall Study|Withdrawal by Subject|3|||
16164910|NCT00631137|39083808|FG000|Overall Study|Withdrawal by Subject|1|||
16164911|NCT00631137|39083809|FG001|Overall Study|Withdrawal by Subject|0|||
16164912|NCT01551693|39083812|FG000|Overall Study|Disease Progression|1|||
16164913|NCT01551693|39083813|FG001|Overall Study|Disease Progression|0|||
16164914|NCT01551693|39083812|FG000|Overall Study|Adverse Event|0|||
16164915|NCT01551693|39083813|FG001|Overall Study|Adverse Event|1|||
16164916|NCT01551693|39083812|FG000|Overall Study|Withdrawal by Subject|0|||
16164917|NCT01551693|39083813|FG001|Overall Study|Withdrawal by Subject|1|||
16164918|NCT02723201|39083816|FG000|Second Intervention Period|Protocol Violation|1|||
16164919|NCT02723201|39083817|FG001|Second Intervention Period|Protocol Violation|0|||
16164920|NCT02723201|39083818|FG002|Second Intervention Period|Protocol Violation|0|||
16164921|NCT02723201|39083816|FG000|Second Intervention Period|Adverse Event|1|||
16164922|NCT02723201|39083817|FG001|Second Intervention Period|Adverse Event|0|||
16164923|NCT02723201|39083818|FG002|Second Intervention Period|Adverse Event|0|||
16164924|NCT00687362|39083819|FG000|Overall Study|Protocol Violation|2|||
16164925|NCT00687362|39083819|FG000|Overall Study|Withdrawal by Subject|1|||
16164926|NCT00848120|39083823|FG000|Overall Study|Adverse Event|1|||
16164927|NCT03167073|39083824|FG000|Overall Study|Stillbirth|1|||
16164928|NCT03167073|39083825|FG001|Overall Study|Stillbirth|0|||
16164929|NCT02863809|39083826|FG000|Overall Study|Adverse Event|8|||
16164930|NCT02863809|39083827|FG001|Overall Study|Adverse Event|8|||
16164931|NCT02863809|39083826|FG000|Overall Study|Withdrawal by Subject|0|||
16164932|NCT02863809|39083827|FG001|Overall Study|Withdrawal by Subject|1|||
16164933|NCT02863809|39083826|FG000|Overall Study|Lost to Follow-up|1|||
16164934|NCT02863809|39083827|FG001|Overall Study|Lost to Follow-up|1|||
16164935|NCT02863809|39083826|FG000|Overall Study|Death|1|||
16164936|NCT02863809|39083827|FG001|Overall Study|Death|0|||
16164937|NCT02004873|39083828|FG000|Overall Study|Implant unsuccessful|6|||
16164938|NCT02004873|39083828|FG000|Overall Study|Awaiting 6-month visit|390|||
16164939|NCT02004873|39083828|FG000|Overall Study|Missed 6-month visit|4|||
16164940|NCT02004873|39083828|FG000|Overall Study|Death|23|||
16164941|NCT02004873|39083828|FG000|Overall Study|Withdrawal by Subject|1|||
16164942|NCT01879410|39083831|FG000|Overall Study|Adverse Event|9|||
16164943|NCT01879410|39083832|FG001|Overall Study|Adverse Event|14|||
16164944|NCT01879410|39083831|FG000|Overall Study|Lack of Efficacy|4|||
16164945|NCT01879410|39083832|FG001|Overall Study|Lack of Efficacy|6|||
16164946|NCT01879410|39083831|FG000|Overall Study|Protocol Violation|1|||
16164947|NCT01879410|39083832|FG001|Overall Study|Protocol Violation|7|||
16164948|NCT01879410|39083831|FG000|Overall Study|Lost to Follow-up|2|||
16164949|NCT01879410|39083832|FG001|Overall Study|Lost to Follow-up|1|||
16164950|NCT01879410|39083831|FG000|Overall Study|Withdrawal by Subject|7|||
16164951|NCT01879410|39083832|FG001|Overall Study|Withdrawal by Subject|8|||
16266148|NCT02736721|39456854|FG000|Overall Study|Lost to Follow-up|3|||
16266149|NCT02736721|39456854|FG000|Overall Study|Other|5|||
16453708|NCT03158285|40141422|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
16164952|NCT01879410|39083831|FG000|Overall Study|Randomised in Error|1|||
16164953|NCT01879410|39083832|FG001|Overall Study|Randomised in Error|2|||
16164954|NCT01592760|39083835|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
16164955|NCT01592760|39083836|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
16164956|NCT01592760|39083837|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
16164957|NCT00578643|39083838|FG000|Overall Study|Death|1|||
16164958|NCT00578643|39083838|FG000|Overall Study|Lost to Follow-up|1|||
16164959|NCT05099640|39083839|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
16164960|NCT05099640|39083840|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
16164961|NCT05099640|39083841|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
16164962|NCT05099640|39083839|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
16164963|NCT05099640|39083840|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
16164964|NCT05099640|39083841|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
16164965|NCT05099640|39083839|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
16164966|NCT05099640|39083840|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
16164967|NCT05099640|39083841|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
16164968|NCT05099640|39083839|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
16164969|NCT05099640|39083840|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
16164970|NCT05099640|39083841|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
16164971|NCT05099640|39083839|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
16164972|NCT05099640|39083840|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
16164973|NCT05099640|39083841|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
16266150|NCT02963259|39456856|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
16266151|NCT02963259|39456856|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
16266152|NCT02963259|39456856|FG000|Overall Study|Death|1|||
16453709|NCT03158285|40141423|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
16453710|NCT03158285|40141424|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
16453711|NCT03158285|40141422|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
16453712|NCT03158285|40141423|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
16453713|NCT03158285|40141424|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
16453714|NCT03158285|40141422|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
16453715|NCT03158285|40141423|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
16453716|NCT03158285|40141424|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
16164974|NCT05099640|39083839|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
16164975|NCT05099640|39083840|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
16164976|NCT05099640|39083841|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
16266153|NCT02963259|39456856|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
16266154|NCT03597256|39456857|FG000|Overall Study|Lost to Follow-up|3|||
16266155|NCT03597256|39456858|FG001|Overall Study|Lost to Follow-up|1|||
16266156|NCT03597256|39456857|FG000|Overall Study|Withdrawal by Subject|0|||
16266157|NCT03597256|39456858|FG001|Overall Study|Withdrawal by Subject|1|||
16266158|NCT03597256|39456857|FG000|Overall Study|Could not return for treatment|0|||
16266159|NCT03597256|39456858|FG001|Overall Study|Could not return for treatment|1|||
16266160|NCT03597256|39456857|FG000|Overall Study|Moved from location|0|||
16266161|NCT03597256|39456858|FG001|Overall Study|Moved from location|1|||
16266162|NCT03597256|39456857|FG000|Overall Study|Not accepted the treatment|0|||
16266163|NCT03597256|39456858|FG001|Overall Study|Not accepted the treatment|1|||
16164977|NCT01528787|39083842|FG000|Overall Study|Withdrawal by Subject|0|||
16266164|NCT01725529|39456859|FG000|Overall Study|Adverse Event|1|||
16266165|NCT01725529|39456860|FG001|Overall Study|Adverse Event|0|||
16164978|NCT01528787|39083843|FG001|Overall Study|Withdrawal by Subject|0|||
16164979|NCT01528787|39083844|FG002|Overall Study|Withdrawal by Subject|0|||
16164980|NCT01528787|39083845|FG003|Overall Study|Withdrawal by Subject|1|||
16453717|NCT03158285|40141422|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
16453718|NCT03158285|40141423|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
16453719|NCT03158285|40141424|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
16453720|NCT03158285|40141422|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
16164981|NCT01528787|39083842|FG000|Overall Study|Family Emergency|0|||
16164982|NCT01528787|39083843|FG001|Overall Study|Family Emergency|0|||
16164983|NCT01528787|39083844|FG002|Overall Study|Family Emergency|1|||
16164984|NCT01528787|39083845|FG003|Overall Study|Family Emergency|0|||
16164985|NCT01176916|39083846|FG000|Overall Study|Adverse Event|61|||
16164986|NCT01176916|39083846|FG000|Overall Study|Death|1|||
16164987|NCT01176916|39083846|FG000|Overall Study|Lost to Follow-up|15|||
16164988|NCT01176916|39083846|FG000|Overall Study|Objective progression or relapse|17|||
16164989|NCT01176916|39083846|FG000|Overall Study|Protocol Violation|24|||
16164990|NCT01176916|39083846|FG000|Overall Study|Withdrawal by Subject|37|||
16164991|NCT01176916|39083846|FG000|Overall Study|Other|6|||
16453721|NCT03158285|40141423|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
16453722|NCT03158285|40141424|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
16453723|NCT03158285|40141422|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
16453724|NCT03158285|40141423|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
16453725|NCT03158285|40141424|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
16453726|NCT03158285|40141422|FG000|Active Treatment Period: Week 52-100|Death|1|||
16453727|NCT03158285|40141423|FG001|Active Treatment Period: Week 52-100|Death|0|||
16453728|NCT03158285|40141424|FG002|Active Treatment Period: Week 52-100|Death|0|||
16453729|NCT03158285|40141422|FG000|Active Treatment Period: Week 52-100|Other|4|||
16453730|NCT03158285|40141423|FG001|Active Treatment Period: Week 52-100|Other|1|||
16453731|NCT03158285|40141424|FG002|Active Treatment Period: Week 52-100|Other|0|||
16453732|NCT00888940|40141426|FG000|Overall Study|Adverse Event|12|||
16453733|NCT00888940|40141427|FG001|Overall Study|Adverse Event|3|||
16453734|NCT00888940|40141426|FG000|Overall Study|Lost to Follow-up|5|||
16453735|NCT00888940|40141427|FG001|Overall Study|Lost to Follow-up|5|||
16453736|NCT00888940|40141426|FG000|Overall Study|Randomized Not Treated|11|||
16453737|NCT00888940|40141427|FG001|Overall Study|Randomized Not Treated|13|||
16453738|NCT00862082|40141428|FG000|Overall Study|Sponsor decision to terminate the study|5|||
16453739|NCT00862082|40141429|FG001|Overall Study|Sponsor decision to terminate the study|0|||
16453740|NCT00862082|40141428|FG000|Overall Study|Withdrawal by Subject|0|||
16453741|NCT00862082|40141429|FG001|Overall Study|Withdrawal by Subject|1|||
16453742|NCT00594815|40141430|FG000|Overall Study|Never Treated|3|||
16453743|NCT00594815|40141430|FG000|Overall Study|Withdrawal by Subject|2|||
16453744|NCT00594815|40141430|FG000|Overall Study|Toxicity|4|||
16453745|NCT01106248|40141431|FG000|Overall Study|Adverse Event|1|||
16453746|NCT01106248|40141431|FG000|Overall Study|Administrative|2|||
16453747|NCT04646044|40141432|FG000|Overall Study|Lost to Follow-up|0|||
16453748|NCT04646044|40141433|FG001|Overall Study|Lost to Follow-up|0|||
16453749|NCT04646044|40141434|FG002|Overall Study|Lost to Follow-up|1|||
16453750|NCT04646044|40141435|FG003|Overall Study|Lost to Follow-up|0|||
16453751|NCT04646044|40141432|FG000|Overall Study|Withdrawal by Subject|0|||
16453752|NCT04646044|40141433|FG001|Overall Study|Withdrawal by Subject|1|||
16453753|NCT04646044|40141434|FG002|Overall Study|Withdrawal by Subject|0|||
16453754|NCT04646044|40141435|FG003|Overall Study|Withdrawal by Subject|0|||
16453755|NCT01096589|40141436|FG000|Overall Study|Adverse Event|2|||
16453756|NCT01096589|40141437|FG001|Overall Study|Adverse Event|1|||
16453757|NCT01096589|40141438|FG002|Overall Study|Adverse Event|2|||
16453758|NCT01096589|40141439|FG003|Overall Study|Adverse Event|1|||
16453759|NCT01096589|40141436|FG000|Overall Study|Withdrawal by Subject|2|||
16453760|NCT01096589|40141437|FG001|Overall Study|Withdrawal by Subject|1|||
16453761|NCT01096589|40141438|FG002|Overall Study|Withdrawal by Subject|1|||
16453762|NCT01096589|40141439|FG003|Overall Study|Withdrawal by Subject|1|||
16453763|NCT01096589|40141436|FG000|Overall Study|Compliance with protocol|0|||
16453764|NCT01096589|40141437|FG001|Overall Study|Compliance with protocol|0|||
16453765|NCT01096589|40141438|FG002|Overall Study|Compliance with protocol|1|||
16164992|NCT01176916|39083846|FG000|Overall Study|Withdrawal prior to Treatment|6|||
16164993|NCT00272987|39083847|FG000|Overall Study|Adverse Event|1|||
16164994|NCT00272987|39083848|FG001|Overall Study|Adverse Event|0|||
16164995|NCT00272987|39083849|FG002|Overall Study|Adverse Event|0|||
16164996|NCT00272987|39083847|FG000|Overall Study|Lost to Follow-up|3|||
16453766|NCT01096589|40141439|FG003|Overall Study|Compliance with protocol|0|||
16453767|NCT01096589|40141436|FG000|Overall Study|found treatment exhausting|0|||
16453768|NCT01096589|40141437|FG001|Overall Study|found treatment exhausting|0|||
16453769|NCT01096589|40141438|FG002|Overall Study|found treatment exhausting|0|||
16453770|NCT01096589|40141439|FG003|Overall Study|found treatment exhausting|1|||
16453771|NCT01033448|40141440|FG000|Overall Study|Withdrawal by Subject|4|||
16453772|NCT01033448|40141440|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
16453773|NCT01033448|40141440|FG000|Overall Study|Lost to Follow-up|3|||
16072660|NCT01467700|38756420|FG002|Overall Study|Lost to Follow-up|2|||
16164997|NCT00272987|39083848|FG001|Overall Study|Lost to Follow-up|1|||
16164998|NCT00272987|39083849|FG002|Overall Study|Lost to Follow-up|1|||
16164999|NCT00272987|39083847|FG000|Overall Study|Withdrawal by Subject|1|||
16165000|NCT00272987|39083848|FG001|Overall Study|Withdrawal by Subject|0|||
16165001|NCT00272987|39083849|FG002|Overall Study|Withdrawal by Subject|3|||
16165002|NCT00272987|39083847|FG000|Overall Study|Sponsor Terminated study|0|||
16165003|NCT00272987|39083848|FG001|Overall Study|Sponsor Terminated study|1|||
16165004|NCT00272987|39083849|FG002|Overall Study|Sponsor Terminated study|1|||
16165005|NCT00272987|39083847|FG000|Overall Study|Disease progression|1|||
16165006|NCT00272987|39083848|FG001|Overall Study|Disease progression|1|||
16165007|NCT00272987|39083849|FG002|Overall Study|Disease progression|2|||
16165008|NCT00272987|39083847|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
16165009|NCT00272987|39083848|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
16165010|NCT00272987|39083849|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
16165011|NCT00272987|39083847|FG000|Overall Study|Death|1|||
16165012|NCT00272987|39083848|FG001|Overall Study|Death|0|||
16165013|NCT00272987|39083849|FG002|Overall Study|Death|0|||
16165014|NCT00880256|39083850|FG000|Overall Study|Lost to Follow-up|28|||
16165015|NCT02908100|39083860|FG000|Overall Study|Adverse Event|7|||
16165016|NCT02908100|39083861|FG001|Overall Study|Adverse Event|6|||
16165017|NCT02908100|39083862|FG002|Overall Study|Adverse Event|9|||
16165018|NCT02908100|39083860|FG000|Overall Study|Death|2|||
16165019|NCT02908100|39083861|FG001|Overall Study|Death|0|||
16165020|NCT02908100|39083862|FG002|Overall Study|Death|0|||
16165021|NCT02908100|39083860|FG000|Overall Study|Lack of Efficacy|2|||
16165022|NCT02908100|39083861|FG001|Overall Study|Lack of Efficacy|3|||
16165023|NCT02908100|39083862|FG002|Overall Study|Lack of Efficacy|3|||
16165024|NCT02908100|39083860|FG000|Overall Study|Lost to Follow-up|0|||
16165025|NCT02908100|39083861|FG001|Overall Study|Lost to Follow-up|1|||
16165026|NCT02908100|39083862|FG002|Overall Study|Lost to Follow-up|2|||
16165027|NCT02908100|39083860|FG000|Overall Study|Non-Compliance With Study Drug|1|||
16165028|NCT02908100|39083861|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16165029|NCT02908100|39083862|FG002|Overall Study|Non-Compliance With Study Drug|2|||
16165030|NCT02908100|39083860|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
16165031|NCT02908100|39083861|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
16165032|NCT02908100|39083862|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
16165033|NCT02908100|39083860|FG000|Overall Study|Physician Decision|0|||
16165034|NCT02908100|39083861|FG001|Overall Study|Physician Decision|1|||
16165035|NCT02908100|39083862|FG002|Overall Study|Physician Decision|0|||
16165036|NCT02908100|39083860|FG000|Overall Study|Pregnancy|1|||
16165037|NCT02908100|39083861|FG001|Overall Study|Pregnancy|2|||
16165038|NCT02908100|39083862|FG002|Overall Study|Pregnancy|0|||
16165039|NCT02908100|39083860|FG000|Overall Study|Withdrawal by Subject|8|||
16165040|NCT02908100|39083861|FG001|Overall Study|Withdrawal by Subject|7|||
16165041|NCT02908100|39083862|FG002|Overall Study|Withdrawal by Subject|5|||
16165042|NCT02908100|39083860|FG000|Overall Study|Randomised in Error|1|||
16165043|NCT02908100|39083861|FG001|Overall Study|Randomised in Error|0|||
16165044|NCT02908100|39083862|FG002|Overall Study|Randomised in Error|0|||
16165045|NCT05048719|39083866|FG000|Overall Study|Withdrawal by Subject|2|||
16165046|NCT05048719|39083867|FG001|Overall Study|Withdrawal by Subject|1|||
16165047|NCT05048719|39083868|FG002|Overall Study|Withdrawal by Subject|3|||
16453774|NCT01033448|40141440|FG000|Overall Study|Withdrew due to other reasons|3|||
16453775|NCT01033448|40141440|FG000|Overall Study|Unknown disposition|1|||
16453776|NCT02970942|40141441|FG000|Overall Study|Death|0|||
16453777|NCT02970942|40141442|FG001|Overall Study|Death|1|||
16453778|NCT02970942|40141443|FG002|Overall Study|Death|0|||
16453779|NCT02970942|40141444|FG003|Overall Study|Death|0|||
16453780|NCT02970942|40141441|FG000|Overall Study|Lost to Follow-up|1|||
16453781|NCT02970942|40141442|FG001|Overall Study|Lost to Follow-up|0|||
16453782|NCT02970942|40141443|FG002|Overall Study|Lost to Follow-up|2|||
16453783|NCT02970942|40141444|FG003|Overall Study|Lost to Follow-up|1|||
16453784|NCT02970942|40141441|FG000|Overall Study|Withdrawal by Subject|3|||
16453785|NCT02970942|40141442|FG001|Overall Study|Withdrawal by Subject|5|||
16453786|NCT02970942|40141443|FG002|Overall Study|Withdrawal by Subject|3|||
16453787|NCT02970942|40141444|FG003|Overall Study|Withdrawal by Subject|2|||
16453788|NCT02998268|40141445|FG000|Overall Study|Adverse Event|0|||
16453789|NCT02998268|40141446|FG001|Overall Study|Adverse Event|2|||
16453790|NCT02998268|40141445|FG000|Overall Study|Withdrawal by Subject|0|||
16453791|NCT02998268|40141446|FG001|Overall Study|Withdrawal by Subject|1|||
16453792|NCT01006291|40141447|FG000|Overall Study|Adverse Event|2|||
16453793|NCT01006291|40141448|FG001|Overall Study|Adverse Event|1|||
16453794|NCT01006291|40141449|FG002|Overall Study|Adverse Event|2|||
16453795|NCT01006291|40141447|FG000|Overall Study|Lack of Efficacy|2|||
16453796|NCT01006291|40141448|FG001|Overall Study|Lack of Efficacy|2|||
16453797|NCT01006291|40141449|FG002|Overall Study|Lack of Efficacy|1|||
16453798|NCT01006291|40141447|FG000|Overall Study|Protocol Violation|3|||
16453799|NCT01006291|40141448|FG001|Overall Study|Protocol Violation|3|||
16453800|NCT01006291|40141449|FG002|Overall Study|Protocol Violation|3|||
16453801|NCT01006291|40141447|FG000|Overall Study|Withdrawal criteria|5|||
16165048|NCT05048719|39083869|FG003|Overall Study|Withdrawal by Subject|1|||
16165049|NCT05048719|39083870|FG004|Overall Study|Withdrawal by Subject|0|||
16165050|NCT05048719|39083871|FG005|Overall Study|Withdrawal by Subject|2|||
16165051|NCT05048719|39083872|FG006|Overall Study|Withdrawal by Subject|1|||
16165052|NCT05048719|39083873|FG007|Overall Study|Withdrawal by Subject|1|||
16165053|NCT05048719|39083874|FG008|Overall Study|Withdrawal by Subject|0|||
16165054|NCT05048719|39083866|FG000|Overall Study|Death|1|||
16165055|NCT05048719|39083867|FG001|Overall Study|Death|0|||
16165056|NCT05048719|39083868|FG002|Overall Study|Death|0|||
16165057|NCT05048719|39083869|FG003|Overall Study|Death|0|||
16165058|NCT05048719|39083870|FG004|Overall Study|Death|0|||
16165059|NCT05048719|39083871|FG005|Overall Study|Death|0|||
16165060|NCT05048719|39083872|FG006|Overall Study|Death|0|||
16165061|NCT05048719|39083873|FG007|Overall Study|Death|0|||
16165062|NCT05048719|39083874|FG008|Overall Study|Death|0|||
16165063|NCT05048719|39083866|FG000|Overall Study|Adverse Event|0|||
16165064|NCT05048719|39083867|FG001|Overall Study|Adverse Event|1|||
16165065|NCT05048719|39083868|FG002|Overall Study|Adverse Event|2|||
16165066|NCT05048719|39083869|FG003|Overall Study|Adverse Event|0|||
16165067|NCT05048719|39083870|FG004|Overall Study|Adverse Event|1|||
16165068|NCT05048719|39083871|FG005|Overall Study|Adverse Event|0|||
16165069|NCT05048719|39083872|FG006|Overall Study|Adverse Event|0|||
16165070|NCT05048719|39083873|FG007|Overall Study|Adverse Event|0|||
16165071|NCT05048719|39083874|FG008|Overall Study|Adverse Event|0|||
16165072|NCT05048719|39083866|FG000|Overall Study|Lost to Follow-up|0|||
16165073|NCT05048719|39083867|FG001|Overall Study|Lost to Follow-up|0|||
16165074|NCT05048719|39083868|FG002|Overall Study|Lost to Follow-up|1|||
16165075|NCT05048719|39083869|FG003|Overall Study|Lost to Follow-up|3|||
16165076|NCT05048719|39083870|FG004|Overall Study|Lost to Follow-up|1|||
16165077|NCT05048719|39083871|FG005|Overall Study|Lost to Follow-up|1|||
16165078|NCT05048719|39083872|FG006|Overall Study|Lost to Follow-up|1|||
16165079|NCT05048719|39083873|FG007|Overall Study|Lost to Follow-up|1|||
16165080|NCT05048719|39083874|FG008|Overall Study|Lost to Follow-up|0|||
16165081|NCT05048719|39083866|FG000|Overall Study|Physician Decision|0|||
16165082|NCT05048719|39083867|FG001|Overall Study|Physician Decision|0|||
16453802|NCT01006291|40141448|FG001|Overall Study|Withdrawal criteria|4|||
16453803|NCT01006291|40141449|FG002|Overall Study|Withdrawal criteria|4|||
16453804|NCT01006291|40141447|FG000|Overall Study|Other|14|||
16453805|NCT01006291|40141448|FG001|Overall Study|Other|14|||
16453806|NCT01006291|40141449|FG002|Overall Study|Other|17|||
16453807|NCT00329797|40141450|FG000|Overall Study|Protocol Violation|1|||
16453808|NCT00329797|40141451|FG001|Overall Study|Protocol Violation|0|||
16453809|NCT00329797|40141450|FG000|Overall Study|Withdrawal by Subject|6|||
16453810|NCT00329797|40141451|FG001|Overall Study|Withdrawal by Subject|6|||
16453811|NCT02656693|40141452|FG000|Overall Study|Pregnancy|1|||
16453812|NCT02656693|40141453|FG001|Overall Study|Pregnancy|1|||
16453813|NCT02656693|40141454|FG002|Overall Study|Pregnancy|1|||
16453814|NCT02656693|40141452|FG000|Overall Study|Bariatric surgery|0|||
16453815|NCT02656693|40141453|FG001|Overall Study|Bariatric surgery|1|||
16453816|NCT02656693|40141454|FG002|Overall Study|Bariatric surgery|2|||
16453817|NCT03527732|40141458|FG000|Overall Study|Lost to Follow-up|21|||
16453818|NCT03527732|40141459|FG001|Overall Study|Lost to Follow-up|23|||
16453819|NCT03527732|40141460|FG002|Overall Study|Lost to Follow-up|80|||
16453820|NCT03527732|40141461|FG003|Overall Study|Lost to Follow-up|62|||
16453821|NCT03527732|40141462|FG004|Overall Study|Lost to Follow-up|12|||
16453822|NCT03527732|40141463|FG005|Overall Study|Lost to Follow-up|20|||
16453823|NCT00829504|40141464|FG000|First Intervention|Adverse Event|1|||
16453824|NCT00829504|40141465|FG001|First Intervention|Adverse Event|0|||
16453825|NCT00829504|40141464|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16453826|NCT00829504|40141465|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16453827|NCT00829504|40141464|FG000|Second Intervention|Physician Decision|1|||
16453828|NCT00829504|40141465|FG001|Second Intervention|Physician Decision|0|||
16453829|NCT00775190|40141466|FG000|Overall Study|Lost to Follow-up|2|||
16453830|NCT00775190|40141467|FG001|Overall Study|Lost to Follow-up|3|||
16165083|NCT05048719|39083868|FG002|Overall Study|Physician Decision|0|||
16165084|NCT05048719|39083869|FG003|Overall Study|Physician Decision|0|||
16165085|NCT05048719|39083870|FG004|Overall Study|Physician Decision|0|||
16165086|NCT05048719|39083871|FG005|Overall Study|Physician Decision|0|||
16453831|NCT00775190|40141466|FG000|Overall Study|Withdrawal by Subject|1|||
16453832|NCT00775190|40141467|FG001|Overall Study|Withdrawal by Subject|2|||
16453833|NCT00775190|40141466|FG000|Overall Study|Protocol Violation|1|||
16453834|NCT00775190|40141467|FG001|Overall Study|Protocol Violation|0|||
16165087|NCT05048719|39083872|FG006|Overall Study|Physician Decision|0|||
16165088|NCT05048719|39083873|FG007|Overall Study|Physician Decision|1|||
16165089|NCT05048719|39083874|FG008|Overall Study|Physician Decision|1|||
16165090|NCT05048719|39083866|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
16453835|NCT02252939|40141468|FG000|Overall Study|Lost to Follow-up|3|||
16453836|NCT00243269|40141469|FG000|Overall Study|Protocol Violation|2|||
16453837|NCT00243269|40141470|FG001|Overall Study|Protocol Violation|1|||
16165091|NCT05048719|39083867|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
16266166|NCT01725529|39456861|FG002|Overall Study|Adverse Event|0|||
16453838|NCT00243269|40141471|FG002|Overall Study|Protocol Violation|0|||
16453839|NCT00243269|40141472|FG003|Overall Study|Protocol Violation|1|||
16453840|NCT00243269|40141469|FG000|Overall Study|Lost to Follow-up|1|||
16165092|NCT05048719|39083868|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
16165093|NCT05048719|39083869|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
16165094|NCT05048719|39083870|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
16165095|NCT05048719|39083871|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
16266167|NCT01725529|39456859|FG000|Overall Study|Lost to Follow-up|2|||
16266168|NCT01725529|39456860|FG001|Overall Study|Lost to Follow-up|1|||
16266169|NCT01725529|39456861|FG002|Overall Study|Lost to Follow-up|1|||
16453841|NCT00243269|40141470|FG001|Overall Study|Lost to Follow-up|0|||
16453842|NCT00243269|40141471|FG002|Overall Study|Lost to Follow-up|1|||
16453843|NCT00243269|40141472|FG003|Overall Study|Lost to Follow-up|3|||
16453844|NCT03894813|40141475|FG000|Overall Study|Adverse Event|1|||
16453845|NCT03894813|40141476|FG001|Overall Study|Adverse Event|1|||
16453846|NCT03894813|40141475|FG000|Overall Study|Lack of Efficacy|3|||
16453847|NCT03894813|40141476|FG001|Overall Study|Lack of Efficacy|3|||
16453848|NCT03894813|40141475|FG000|Overall Study|Lost to Follow-up|1|||
16453849|NCT03894813|40141476|FG001|Overall Study|Lost to Follow-up|0|||
16453850|NCT03894813|40141475|FG000|Overall Study|Pregnancy|2|||
16453851|NCT03894813|40141476|FG001|Overall Study|Pregnancy|1|||
16453852|NCT03894813|40141475|FG000|Overall Study|Protocol Violation|3|||
16453853|NCT03894813|40141476|FG001|Overall Study|Protocol Violation|7|||
16453854|NCT03894813|40141475|FG000|Overall Study|Withdrawal by Subject|1|||
16453855|NCT03894813|40141476|FG001|Overall Study|Withdrawal by Subject|3|||
16453856|NCT03894813|40141475|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
16453857|NCT03894813|40141476|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
16453858|NCT03237286|40141477|FG000|Overall Study|Withdrawal by Subject|1|||
16453859|NCT03237286|40141478|FG001|Overall Study|Withdrawal by Subject|0|||
16453860|NCT03237286|40141479|FG002|Overall Study|Withdrawal by Subject|2|||
16453861|NCT03237286|40141477|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
16453862|NCT03237286|40141478|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
16453863|NCT03237286|40141479|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
16453864|NCT00392769|40141480|FG000|Overall Study|Clinical Deterioration|9|||
16453865|NCT00392769|40141480|FG000|Overall Study|Adverse Event|1|||
16453866|NCT03773796|40141481|FG000|Overall Study|Adverse Event|1|||
16453867|NCT03773796|40141481|FG000|Overall Study|Withdrawal by Subject|1|||
16453868|NCT03773796|40141481|FG000|Overall Study|Lack of Efficacy|1|||
16453869|NCT02259088|40141482|FG000|Overall Study|Adverse Event|6|||
16453870|NCT02259088|40141483|FG001|Overall Study|Adverse Event|4|||
16453871|NCT02259088|40141482|FG000|Overall Study|Lost to Follow-up|2|||
16453872|NCT02259088|40141483|FG001|Overall Study|Lost to Follow-up|0|||
16453873|NCT02259088|40141482|FG000|Overall Study|Death|2|||
16453874|NCT02259088|40141483|FG001|Overall Study|Death|0|||
16453875|NCT02259088|40141482|FG000|Overall Study|Physician Decision|5|||
16453876|NCT02259088|40141483|FG001|Overall Study|Physician Decision|2|||
16453877|NCT02259088|40141482|FG000|Overall Study|Protocol deviation|5|||
16453878|NCT02259088|40141483|FG001|Overall Study|Protocol deviation|0|||
16453879|NCT02259088|40141482|FG000|Overall Study|Subject/guardian decision|8|||
16266170|NCT01725529|39456859|FG000|Overall Study|Protocol Violation|0|||
16266171|NCT01725529|39456860|FG001|Overall Study|Protocol Violation|1|||
16266172|NCT01725529|39456861|FG002|Overall Study|Protocol Violation|1|||
16266173|NCT01725529|39456859|FG000|Overall Study|Withdrawal by Subject|12|||
16266174|NCT01725529|39456860|FG001|Overall Study|Withdrawal by Subject|14|||
16266175|NCT01725529|39456861|FG002|Overall Study|Withdrawal by Subject|8|||
16266176|NCT00272779|39456865|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
16266177|NCT00272779|39456866|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
16266178|NCT00272779|39456865|FG000|Baseline Through Week 48|Death before Week 48|4|||
16266179|NCT00272779|39456866|FG001|Baseline Through Week 48|Death before Week 48|4|||
16266180|NCT00272779|39456865|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
16266181|NCT00272779|39456866|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
16266182|NCT00272779|39456865|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
16266183|NCT00272779|39456866|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
16266184|NCT00272779|39456865|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
16266185|NCT00272779|39456866|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
16453880|NCT02259088|40141483|FG001|Overall Study|Subject/guardian decision|8|||
16453881|NCT00939393|40141486|FG000|Overall Study|Withdrawal by Subject|1|||
16453882|NCT00939393|40141487|FG001|Overall Study|Withdrawal by Subject|0|||
16453883|NCT00939393|40141486|FG000|Overall Study|Lost to Follow-up|3|||
16453884|NCT00939393|40141487|FG001|Overall Study|Lost to Follow-up|0|||
16453885|NCT00599339|40141490|FG000|Overall Study|Adverse Event|79|||
16453886|NCT00599339|40141490|FG000|Overall Study|Withdrawal by Subject|137|||
16453887|NCT00599339|40141490|FG000|Overall Study|Other Reason|179|||
16453888|NCT00599339|40141490|FG000|Overall Study|Lost to Follow-up|221|||
16165096|NCT05048719|39083872|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
16165097|NCT05048719|39083873|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
16165098|NCT05048719|39083874|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
16165099|NCT05048719|39083866|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
16165100|NCT05048719|39083867|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
16165101|NCT05048719|39083868|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
16173409|NCT01607892|39111206|FG001|Overall Study|Investigator discretion|4|||
16453889|NCT00599339|40141490|FG000|Overall Study|No valid data consent|36|||
16453890|NCT00599339|40141490|FG000|Overall Study|Study Termination Status Unknown|12|||
16453891|NCT04463069|40141491|FG000|Overall Study|Withdrawal by Subject|2|||
16453892|NCT04463069|40141492|FG001|Overall Study|Withdrawal by Subject|10|||
16453893|NCT04463069|40141491|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
16453894|NCT04463069|40141492|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
16453895|NCT02425943|40141493|FG000|Overall Study|Adverse Event|3|||
16453896|NCT02425943|40141494|FG001|Overall Study|Adverse Event|1|||
16453897|NCT02425943|40141493|FG000|Overall Study|Lost to Follow-up|59|||
16453898|NCT02425943|40141494|FG001|Overall Study|Lost to Follow-up|37|||
16453899|NCT02425943|40141493|FG000|Overall Study|Protocol Violation|4|||
16453900|NCT02425943|40141494|FG001|Overall Study|Protocol Violation|1|||
16453901|NCT02425943|40141493|FG000|Overall Study|Withdrawal by Subject|64|||
16453902|NCT02425943|40141494|FG001|Overall Study|Withdrawal by Subject|31|||
16453903|NCT02425943|40141493|FG000|Overall Study|Other|6|||
16453904|NCT02425943|40141494|FG001|Overall Study|Other|0|||
16453905|NCT00441116|40141510|FG000|Overall Study|Adverse Event|1|||
16453906|NCT00441116|40141511|FG001|Overall Study|Adverse Event|1|||
16453907|NCT00441116|40141510|FG000|Overall Study|Withdrawal by Subject|1|||
16453908|NCT00441116|40141511|FG001|Overall Study|Withdrawal by Subject|0|||
16453909|NCT00441116|40141510|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
16453910|NCT00441116|40141511|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
16453911|NCT00990704|40141512|FG000|Overall Study|Adverse Event|1|||
16453912|NCT00990704|40141513|FG001|Overall Study|Adverse Event|1|||
16453913|NCT00990704|40141512|FG000|Overall Study|Physician Decision|0|||
16453914|NCT00990704|40141513|FG001|Overall Study|Physician Decision|1|||
16453915|NCT00125164|40141514|FG000|Overall Study|Adverse Event|0|||
16453916|NCT00125164|40141515|FG001|Overall Study|Adverse Event|0|||
16453917|NCT00125164|40141516|FG002|Overall Study|Adverse Event|2|||
16453918|NCT00125164|40141517|FG003|Overall Study|Adverse Event|4|||
16453919|NCT00125164|40141514|FG000|Overall Study|Lost to Follow-up|0|||
16453920|NCT00125164|40141515|FG001|Overall Study|Lost to Follow-up|0|||
16453921|NCT00125164|40141516|FG002|Overall Study|Lost to Follow-up|1|||
16453922|NCT00125164|40141517|FG003|Overall Study|Lost to Follow-up|1|||
16453923|NCT00125164|40141514|FG000|Overall Study|Withdrawal by Subject|2|||
16453924|NCT00125164|40141515|FG001|Overall Study|Withdrawal by Subject|0|||
16453925|NCT00125164|40141516|FG002|Overall Study|Withdrawal by Subject|1|||
16453926|NCT00125164|40141517|FG003|Overall Study|Withdrawal by Subject|1|||
16453927|NCT02269267|40141518|FG000|Overall Study|Death|5|||
16453928|NCT03583385|40141519|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16453929|NCT03583385|40141520|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16453930|NCT03583385|40141519|FG000|Treatment Period 2|Adverse Event|1|||
16453931|NCT03583385|40141520|FG001|Treatment Period 2|Adverse Event|0|||
16453932|NCT02736578|40141521|FG000|Overall Study|Adverse Event|1|||
16453933|NCT02736578|40141522|FG001|Overall Study|Adverse Event|0|||
16453934|NCT00750438|40141525|FG000|Overall Study|Protocol Violation|4|||
16453935|NCT00750438|40141526|FG001|Overall Study|Protocol Violation|1|||
16453936|NCT00750438|40141525|FG000|Overall Study|Physician Decision|2|||
16453937|NCT00750438|40141526|FG001|Overall Study|Physician Decision|2|||
16453938|NCT00750438|40141525|FG000|Overall Study|Withdrawal by Subject|1|||
16453939|NCT00750438|40141526|FG001|Overall Study|Withdrawal by Subject|1|||
16453940|NCT02023697|40141527|FG000|Treatment Period|Radiological progression|13|||
16453941|NCT02023697|40141528|FG001|Treatment Period|Radiological progression|17|||
16453942|NCT02023697|40141529|FG002|Treatment Period|Radiological progression|26|||
16453943|NCT02023697|40141527|FG000|Treatment Period|Never Treated|5|||
16453944|NCT02023697|40141528|FG001|Treatment Period|Never Treated|6|||
16453945|NCT02023697|40141529|FG002|Treatment Period|Never Treated|10|||
16453946|NCT02023697|40141527|FG000|Treatment Period|Adverse Event|13|||
16453947|NCT02023697|40141528|FG001|Treatment Period|Adverse Event|25|||
16453948|NCT02023697|40141529|FG002|Treatment Period|Adverse Event|23|||
16453949|NCT02023697|40141527|FG000|Treatment Period|Logistical difficulties|1|||
16453950|NCT02023697|40141528|FG001|Treatment Period|Logistical difficulties|1|||
16453951|NCT02023697|40141529|FG002|Treatment Period|Logistical difficulties|1|||
16453952|NCT02023697|40141527|FG000|Treatment Period|Clinical progression|10|||
16453953|NCT02023697|40141528|FG001|Treatment Period|Clinical progression|8|||
16453954|NCT02023697|40141529|FG002|Treatment Period|Clinical progression|28|||
16453955|NCT02023697|40141527|FG000|Treatment Period|Withdrawal by Subject|4|||
16453956|NCT02023697|40141528|FG001|Treatment Period|Withdrawal by Subject|5|||
16453957|NCT02023697|40141529|FG002|Treatment Period|Withdrawal by Subject|13|||
16453958|NCT02023697|40141527|FG000|Treatment Period|Safety outcome reached|0|||
16453959|NCT02023697|40141528|FG001|Treatment Period|Safety outcome reached|1|||
16453960|NCT02023697|40141529|FG002|Treatment Period|Safety outcome reached|0|||
16453961|NCT02023697|40141527|FG000|Treatment Period|Physician Decision|0|||
16453962|NCT02023697|40141528|FG001|Treatment Period|Physician Decision|0|||
16453963|NCT02023697|40141529|FG002|Treatment Period|Physician Decision|1|||
16453964|NCT02023697|40141527|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
16453965|NCT02023697|40141528|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
16453966|NCT02023697|40141529|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
16453967|NCT02023697|40141527|FG000|Active Follow-up Period|Lost to Follow-up|1|||
16453968|NCT02023697|40141528|FG001|Active Follow-up Period|Lost to Follow-up|1|||
16453969|NCT02023697|40141529|FG002|Active Follow-up Period|Lost to Follow-up|1|||
16453970|NCT02023697|40141527|FG000|Active Follow-up Period|Deterioration of general condition|1|||
16453971|NCT02023697|40141528|FG001|Active Follow-up Period|Deterioration of general condition|1|||
16453972|NCT02023697|40141529|FG002|Active Follow-up Period|Deterioration of general condition|1|||
16453973|NCT02023697|40141527|FG000|Active Follow-up Period|Other unspecified|2|||
16453974|NCT02023697|40141528|FG001|Active Follow-up Period|Other unspecified|0|||
16453975|NCT02023697|40141529|FG002|Active Follow-up Period|Other unspecified|1|||
16453976|NCT02023697|40141527|FG000|Active Follow-up Period|Clinical progression|0|||
16453977|NCT02023697|40141528|FG001|Active Follow-up Period|Clinical progression|2|||
16453978|NCT02023697|40141529|FG002|Active Follow-up Period|Clinical progression|1|||
16453979|NCT02023697|40141527|FG000|Active Follow-up Period|Radiological progression|0|||
16453980|NCT02023697|40141528|FG001|Active Follow-up Period|Radiological progression|0|||
16453981|NCT02023697|40141529|FG002|Active Follow-up Period|Radiological progression|1|||
16453982|NCT02023697|40141527|FG000|Active Follow-up Period|Death|83|||
16453983|NCT02023697|40141528|FG001|Active Follow-up Period|Death|82|||
16453984|NCT02023697|40141529|FG002|Active Follow-up Period|Death|87|||
16453985|NCT02023697|40141527|FG000|Long-term Follow-up Period|Death|9|||
16453986|NCT02023697|40141528|FG001|Long-term Follow-up Period|Death|6|||
16453987|NCT02023697|40141529|FG002|Long-term Follow-up Period|Death|4|||
16453988|NCT02023697|40141527|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
16453989|NCT02023697|40141528|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
16453990|NCT02023697|40141529|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
16453991|NCT02023697|40141527|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
16453992|NCT02023697|40141528|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
16453993|NCT02023697|40141529|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
16453994|NCT02023697|40141527|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
16453995|NCT02023697|40141528|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
16453996|NCT02023697|40141529|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
16453997|NCT02023697|40141527|FG000|Long-term Follow-up Period|Technical problems|0|||
16453998|NCT02023697|40141528|FG001|Long-term Follow-up Period|Technical problems|0|||
16453999|NCT02023697|40141529|FG002|Long-term Follow-up Period|Technical problems|1|||
16454000|NCT02023697|40141527|FG000|Long-term Follow-up Period|Other unspecified|6|||
16454001|NCT02023697|40141528|FG001|Long-term Follow-up Period|Other unspecified|3|||
16454002|NCT02023697|40141529|FG002|Long-term Follow-up Period|Other unspecified|5|||
16454003|NCT00960570|40141530|FG000|21 Day Washout Period|Adverse Event|1|||
16454004|NCT00960570|40141530|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
16454005|NCT00960570|40141530|FG000|1 Day Period Between Dosing|Adverse Event|2|||
16454006|NCT00960570|40141530|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
16454007|NCT02238080|40141531|FG000|Overall Study|Death|13|||
16454008|NCT02238080|40141531|FG000|Overall Study|Treatment interrupted|6|||
16454009|NCT02238080|40141531|FG000|Overall Study|Withdrawal by Subject|2|||
16454010|NCT02238080|40141531|FG000|Overall Study|Other|4|||
16454011|NCT00202878|40141532|FG000|Overall Study|Death|964|||
16454012|NCT00202878|40141533|FG001|Overall Study|Death|968|||
16454013|NCT00202878|40141532|FG000|Overall Study|Only Vital Status Known|357|||
16454014|NCT00202878|40141533|FG001|Overall Study|Only Vital Status Known|356|||
16454015|NCT00202878|40141532|FG000|Overall Study|Lost to Follow-up|44|||
16454016|NCT00202878|40141533|FG001|Overall Study|Lost to Follow-up|49|||
16454017|NCT00202878|40141532|FG000|Overall Study|Site Closure|39|||
16454018|NCT00202878|40141533|FG001|Overall Study|Site Closure|36|||
16454019|NCT00202878|40141532|FG000|Overall Study|Withdrawal by Subject|795|||
16454020|NCT00202878|40141533|FG001|Overall Study|Withdrawal by Subject|808|||
16454021|NCT02223858|40141534|FG000|Overall Study|Death|1|||
16454022|NCT02223858|40141535|FG001|Overall Study|Death|1|||
16454023|NCT02223858|40141534|FG000|Overall Study|Lost to Follow-up|6|||
16454024|NCT02223858|40141535|FG001|Overall Study|Lost to Follow-up|11|||
16454025|NCT02223858|40141534|FG000|Overall Study|Withdrawal by Subject|8|||
16454026|NCT02223858|40141535|FG001|Overall Study|Withdrawal by Subject|5|||
16454027|NCT02223858|40141534|FG000|Overall Study|Refused|9|||
16454028|NCT02223858|40141535|FG001|Overall Study|Refused|9|||
16454029|NCT00122980|40141536|FG000|Overall Study|Death|0|||
16454030|NCT00122980|40141537|FG001|Overall Study|Death|1|||
16454031|NCT00122980|40141536|FG000|Overall Study|Physician Decision|2|||
16454032|NCT00122980|40141537|FG001|Overall Study|Physician Decision|0|||
16454033|NCT00122980|40141536|FG000|Overall Study|Protocol Violation|5|||
16454034|NCT00122980|40141537|FG001|Overall Study|Protocol Violation|1|||
16454035|NCT00122980|40141536|FG000|Overall Study|Withdrawal by Subject|2|||
16454036|NCT00122980|40141537|FG001|Overall Study|Withdrawal by Subject|3|||
16454037|NCT00122980|40141536|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
16454038|NCT00122980|40141537|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
16454039|NCT00122980|40141536|FG000|Overall Study|Study termination|27|||
16454040|NCT00122980|40141537|FG001|Overall Study|Study termination|35|||
16454041|NCT01802073|40141540|FG000|Overall Study|Lost to Follow-up|0|||
16454042|NCT01802073|40141541|FG001|Overall Study|Lost to Follow-up|1|||
16454043|NCT01802073|40141540|FG000|Overall Study|Non-compliant|4|||
16454044|NCT01802073|40141541|FG001|Overall Study|Non-compliant|2|||
16454045|NCT01802073|40141540|FG000|Overall Study|Withdrawal by Subject|1|||
16454046|NCT01802073|40141541|FG001|Overall Study|Withdrawal by Subject|1|||
16454047|NCT01802073|40141540|FG000|Overall Study|Physician Decision|0|||
16454048|NCT01802073|40141541|FG001|Overall Study|Physician Decision|7|||
16454049|NCT01938716|40141558|FG000|Overall Study|Physician Decision|2|||
16454050|NCT01938716|40141558|FG000|Overall Study|Withdrawal by Subject|2|||
16454051|NCT00948441|40141564|FG000|Overall Study|no longer meet inclusion criteria|1|||
16454052|NCT00948441|40141565|FG001|Overall Study|no longer meet inclusion criteria|4|||
16454053|NCT01235741|40141566|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
16454054|NCT01235741|40141567|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
16454055|NCT01235741|40141568|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
16454056|NCT01235741|40141566|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
16454057|NCT01235741|40141567|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
16454058|NCT01235741|40141568|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
16454059|NCT01235741|40141566|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
16454060|NCT01235741|40141567|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
16454061|NCT01235741|40141568|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
16454062|NCT01235741|40141566|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
16454063|NCT01235741|40141567|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
16454064|NCT01235741|40141568|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
16454065|NCT01235741|40141566|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
16454066|NCT01235741|40141567|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
16454067|NCT01235741|40141568|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
16454068|NCT01235741|40141566|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
16454069|NCT01235741|40141567|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
16454070|NCT01235741|40141568|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
16454071|NCT01235741|40141566|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
16454072|NCT01235741|40141567|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
16454073|NCT01235741|40141568|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
16454074|NCT01235741|40141566|FG000|Randomized to Treatment|Adverse Event|0|||
16454075|NCT01235741|40141567|FG001|Randomized to Treatment|Adverse Event|1|||
16454076|NCT01235741|40141568|FG002|Randomized to Treatment|Adverse Event|1|||
16454077|NCT01235741|40141566|FG000|Randomized to Treatment|Sponsor terminated study|0|||
16454078|NCT01235741|40141567|FG001|Randomized to Treatment|Sponsor terminated study|35|||
16454079|NCT01235741|40141568|FG002|Randomized to Treatment|Sponsor terminated study|34|||
16454080|NCT01235741|40141566|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
16454081|NCT01235741|40141567|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
16454082|NCT01235741|40141568|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
16454083|NCT01235741|40141566|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
16454084|NCT01235741|40141567|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
16454085|NCT01235741|40141568|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
16454086|NCT01235741|40141566|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
16454087|NCT01235741|40141567|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
16454088|NCT01235741|40141568|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
16454089|NCT01376804|40141573|FG000|Treatment Period|Withdrawal by Subject|1|||
16454090|NCT01376804|40141573|FG000|Treatment Period|Adverse Event|6|||
16454091|NCT01376804|40141573|FG000|Treatment Period|Patient did not receive study drug|1|||
16454092|NCT02876601|40141574|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
16454093|NCT02876601|40141575|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
16454094|NCT02876601|40141576|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
16454095|NCT02876601|40141577|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
16454096|NCT01330108|40141578|FG000|Overall Study|Withdrawal by Subject|4|||
16454097|NCT03671148|40141579|FG000|Overall Study|Adverse Event|3|||
16454098|NCT03671148|40141580|FG001|Overall Study|Adverse Event|2|||
16454099|NCT03671148|40141579|FG000|Overall Study|Withdrawal by Subject|8|||
16454100|NCT03671148|40141580|FG001|Overall Study|Withdrawal by Subject|2|||
16454101|NCT03671148|40141579|FG000|Overall Study|Lost to Follow-up|1|||
16454102|NCT03671148|40141580|FG001|Overall Study|Lost to Follow-up|2|||
16454103|NCT03671148|40141579|FG000|Overall Study|Lack of Efficacy|7|||
16454104|NCT03671148|40141580|FG001|Overall Study|Lack of Efficacy|2|||
16454105|NCT03671148|40141579|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
16454106|NCT03671148|40141580|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
16454107|NCT03671148|40141579|FG000|Overall Study|Other|1|||
16454108|NCT03671148|40141580|FG001|Overall Study|Other|0|||
16454109|NCT03671148|40141579|FG000|Overall Study|Incomplete Randomization Visit|1|||
16454110|NCT03671148|40141580|FG001|Overall Study|Incomplete Randomization Visit|0|||
16454111|NCT00131248|40141583|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
16454112|NCT00131248|40141584|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
16454113|NCT01950013|40141585|FG000|Overall Study|Withdrawal by Subject|0|||
16454114|NCT01950013|40141586|FG001|Overall Study|Withdrawal by Subject|2|||
16454115|NCT01950013|40141587|FG002|Overall Study|Withdrawal by Subject|0|||
16454116|NCT00808080|40141588|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
16454117|NCT00643162|40141589|FG000|Overall Study|Withdrawal by Subject|1|||
16454118|NCT00643162|40141590|FG001|Overall Study|Withdrawal by Subject|1|||
16454119|NCT03048578|40141591|FG000|Overall Study|Withdrawal by Subject|5|||
16454120|NCT03048578|40141592|FG001|Overall Study|Withdrawal by Subject|6|||
16454121|NCT03048578|40141591|FG000|Overall Study|Lost to Follow-up|22|||
16454122|NCT03048578|40141592|FG001|Overall Study|Lost to Follow-up|10|||
16454123|NCT03048578|40141591|FG000|Overall Study|Adverse Event|1|||
16454124|NCT03048578|40141592|FG001|Overall Study|Adverse Event|2|||
16454125|NCT03048578|40141591|FG000|Overall Study|Terminated|3|||
16454126|NCT03048578|40141592|FG001|Overall Study|Terminated|2|||
16454127|NCT02379637|40141593|FG000|Overall Study|Protocol Violation|0|||
16454128|NCT02379637|40141594|FG001|Overall Study|Protocol Violation|1|||
16454129|NCT02379637|40141593|FG000|Overall Study|Adverse Event|1|||
16454130|NCT02379637|40141594|FG001|Overall Study|Adverse Event|0|||
16454131|NCT02379637|40141593|FG000|Overall Study|Withdrawal by Subject|1|||
16454132|NCT02379637|40141594|FG001|Overall Study|Withdrawal by Subject|0|||
16454133|NCT02461758|40141595|FG000|Overall Study|Lost to Follow-up|0|||
16454134|NCT02461758|40141596|FG001|Overall Study|Lost to Follow-up|1|||
16454135|NCT02461758|40141597|FG002|Overall Study|Lost to Follow-up|1|||
16454136|NCT02461758|40141598|FG003|Overall Study|Lost to Follow-up|0|||
16454137|NCT03083873|40141599|FG000|Overall Study|Death|6|||
16454138|NCT03083873|40141600|FG001|Overall Study|Death|15|||
16454139|NCT03083873|40141601|FG002|Overall Study|Death|13|||
16454140|NCT03083873|40141602|FG003|Overall Study|Death|9|||
16454141|NCT03083873|40141603|FG004|Overall Study|Death|0|||
16454142|NCT03083873|40141599|FG000|Overall Study|Sponsor Terminated Study|0|||
16454143|NCT03083873|40141600|FG001|Overall Study|Sponsor Terminated Study|1|||
16454144|NCT03083873|40141601|FG002|Overall Study|Sponsor Terminated Study|2|||
16454145|NCT03083873|40141602|FG003|Overall Study|Sponsor Terminated Study|3|||
16454146|NCT03083873|40141603|FG004|Overall Study|Sponsor Terminated Study|0|||
16454147|NCT03083873|40141599|FG000|Overall Study|Lost to Follow-up|0|||
16454148|NCT03083873|40141600|FG001|Overall Study|Lost to Follow-up|1|||
16454149|NCT03083873|40141601|FG002|Overall Study|Lost to Follow-up|1|||
16454150|NCT03083873|40141602|FG003|Overall Study|Lost to Follow-up|0|||
16454151|NCT03083873|40141603|FG004|Overall Study|Lost to Follow-up|0|||
16454152|NCT03083873|40141599|FG000|Overall Study|Withdrawal by Subject|2|||
16454153|NCT03083873|40141600|FG001|Overall Study|Withdrawal by Subject|0|||
16454154|NCT03083873|40141601|FG002|Overall Study|Withdrawal by Subject|0|||
16165102|NCT05048719|39083869|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
16165103|NCT05048719|39083870|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
16165104|NCT05048719|39083871|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
16165105|NCT05048719|39083872|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
16165106|NCT05048719|39083873|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
16165107|NCT05048719|39083874|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
16165108|NCT05048719|39083866|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
16165109|NCT05048719|39083867|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
16165110|NCT05048719|39083868|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
16165111|NCT05048719|39083869|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
16165112|NCT05048719|39083870|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
16165113|NCT05048719|39083871|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
16454155|NCT03083873|40141602|FG003|Overall Study|Withdrawal by Subject|0|||
16454156|NCT03083873|40141603|FG004|Overall Study|Withdrawal by Subject|0|||
16454157|NCT03083873|40141599|FG000|Overall Study|Did Not Receive TIL|2|||
16454158|NCT03083873|40141600|FG001|Overall Study|Did Not Receive TIL|5|||
16454159|NCT03083873|40141601|FG002|Overall Study|Did Not Receive TIL|3|||
16454160|NCT03083873|40141602|FG003|Overall Study|Did Not Receive TIL|1|||
16454161|NCT03083873|40141603|FG004|Overall Study|Did Not Receive TIL|0|||
16454162|NCT03083990|40141604|FG000|Overall Study|Adverse Event|1|||
16454163|NCT03083990|40141605|FG001|Overall Study|Adverse Event|0|||
16454164|NCT02399163|40141608|FG000|Overall Study|Adverse Event|2|||
16454165|NCT02399163|40141608|FG000|Overall Study|Protocol Deviation|2|||
16454166|NCT02399163|40141608|FG000|Overall Study|Withdrawal by Participant|5|||
16454167|NCT01071798|40141609|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
16454168|NCT01071798|40141609|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
16454169|NCT01071798|40141609|FG000|Participants Who Received One Cycle|Patient requirement|20|||
16454170|NCT01071798|40141609|FG000|Participants Who Received One Cycle|Death|5|||
16454171|NCT01071798|40141609|FG000|Participants Who Received One Cycle|Change of therapy|6|||
16454172|NCT01071798|40141609|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
16454173|NCT01071798|40141609|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
16454174|NCT01071798|40141609|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
16454175|NCT01071798|40141609|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
16454176|NCT01071798|40141609|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
16454177|NCT00387790|40141610|FG000|Overall Study|Adverse Event|5|||
16454178|NCT00387790|40141610|FG000|Overall Study|Lack of Efficacy|2|||
16454179|NCT00387790|40141610|FG000|Overall Study|Physician Decision|2|||
16454180|NCT00387790|40141610|FG000|Overall Study|Withdrawal by Subject|3|||
16454181|NCT00387790|40141610|FG000|Overall Study|Ineligible for study|2|||
16454182|NCT02283762|40141611|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
16454183|NCT02283762|40141612|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
16454184|NCT02283762|40141611|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
16454185|NCT02283762|40141612|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
16454186|NCT02283762|40141611|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
16454187|NCT02283762|40141612|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
16454188|NCT02283762|40141611|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
16454189|NCT02283762|40141612|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
16454190|NCT02283762|40141611|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
16454191|NCT02283762|40141612|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
16454192|NCT02283762|40141611|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
16454193|NCT02283762|40141612|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
16454194|NCT02283762|40141611|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
16454195|NCT02283762|40141612|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
16454196|NCT02283762|40141611|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
16454197|NCT02283762|40141612|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
16454198|NCT02283762|40141611|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
16454199|NCT02283762|40141612|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
16454200|NCT02283762|40141611|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
16454201|NCT02283762|40141612|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
16454202|NCT02283762|40141611|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
16454203|NCT02283762|40141612|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
16454204|NCT02283762|40141611|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
16454205|NCT02283762|40141612|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
16454206|NCT00843284|40141616|FG000|Overall Study|Adverse Event|39|||
16454207|NCT00843284|40141616|FG000|Overall Study|Lack of Efficacy|5|||
16454208|NCT00843284|40141616|FG000|Overall Study|Lost to Follow-up|11|||
16454209|NCT00843284|40141616|FG000|Overall Study|Other|10|||
16454210|NCT00843284|40141616|FG000|Overall Study|Withdrawal by Subject|4|||
16454211|NCT00843284|40141616|FG000|Overall Study|Death|3|||
16454212|NCT00993148|40141617|FG000|Overall Study|Lost to Follow-up|2|||
16454213|NCT00993148|40141617|FG000|Overall Study|never initiated treatment|1|||
16454214|NCT00871975|40141618|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
16454215|NCT00871975|40141618|FG000|Overall Study|Catheters could not be inserted|1|||
16454216|NCT00871975|40141618|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
16454217|NCT00871975|40141618|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
16454218|NCT00750152|40141619|FG000|Overall Study|Adverse Event|2|||
16454219|NCT00750152|40141620|FG001|Overall Study|Adverse Event|1|||
16454220|NCT00750152|40141619|FG000|Overall Study|Lost to Follow-up|8|||
16454221|NCT00750152|40141620|FG001|Overall Study|Lost to Follow-up|13|||
16454222|NCT00750152|40141619|FG000|Overall Study|Withdrawal by Subject|3|||
16454223|NCT00750152|40141620|FG001|Overall Study|Withdrawal by Subject|3|||
16454224|NCT00750152|40141619|FG000|Overall Study|Physician Decision|1|||
16454225|NCT00750152|40141620|FG001|Overall Study|Physician Decision|1|||
16165114|NCT05048719|39083872|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
16165115|NCT05048719|39083873|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
16454226|NCT00750152|40141619|FG000|Overall Study|Non-compliance|0|||
16454227|NCT00750152|40141620|FG001|Overall Study|Non-compliance|1|||
16454228|NCT00750152|40141619|FG000|Overall Study|Termination by sponsor|1|||
16454229|NCT00750152|40141620|FG001|Overall Study|Termination by sponsor|0|||
16454230|NCT00750152|40141619|FG000|Overall Study|Other|7|||
16165116|NCT05048719|39083874|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
16266186|NCT00272779|39456865|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
16165117|NCT05048719|39083866|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
16165118|NCT05048719|39083867|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
16165119|NCT05048719|39083868|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
16165120|NCT05048719|39083869|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
16165121|NCT05048719|39083870|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
16165122|NCT05048719|39083871|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
16165123|NCT05048719|39083872|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
16454231|NCT00750152|40141620|FG001|Overall Study|Other|8|||
16454232|NCT01788215|40141625|FG000|Overall Study|Withdrawal by Subject|0|||
16454233|NCT01788215|40141626|FG001|Overall Study|Withdrawal by Subject|1|||
16454234|NCT01788215|40141625|FG000|Overall Study|Lost to Follow-up|2|||
16454235|NCT01788215|40141626|FG001|Overall Study|Lost to Follow-up|0|||
16454236|NCT01519869|40141627|FG000|Overall Study|Lost to Follow-up|1|||
16454237|NCT00452361|40141641|FG000|Overall Study|Adverse Event|8|||
16454238|NCT00452361|40141642|FG001|Overall Study|Adverse Event|0|||
16454239|NCT00452361|40141641|FG000|Overall Study|Withdrawal by Subject|0|||
16165124|NCT05048719|39083873|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
16165125|NCT05048719|39083874|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
16165126|NCT05048719|39083866|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
16165127|NCT05048719|39083867|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
16165128|NCT05048719|39083868|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
16165129|NCT05048719|39083869|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
16165130|NCT05048719|39083870|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
16165131|NCT05048719|39083871|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
16165132|NCT05048719|39083872|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
16165133|NCT05048719|39083873|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
16165134|NCT05048719|39083874|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
16165135|NCT01827384|39083877|FG000|Overall Study|Switched to alternative treatment|0|||
16165136|NCT01827384|39083878|FG001|Overall Study|Switched to alternative treatment|0|||
16165137|NCT01827384|39083879|FG002|Overall Study|Switched to alternative treatment|0|||
16165138|NCT01827384|39083880|FG003|Overall Study|Switched to alternative treatment|0|||
16165139|NCT01827384|39083881|FG004|Overall Study|Switched to alternative treatment|0|||
16165140|NCT01827384|39083882|FG005|Overall Study|Switched to alternative treatment|0|||
16165141|NCT01827384|39083883|FG006|Overall Study|Switched to alternative treatment|0|||
16165142|NCT01827384|39083884|FG007|Overall Study|Switched to alternative treatment|0|||
16165143|NCT01827384|39083885|FG008|Overall Study|Switched to alternative treatment|0|||
16165144|NCT01827384|39083886|FG009|Overall Study|Switched to alternative treatment|0|||
16165145|NCT01827384|39083887|FG010|Overall Study|Switched to alternative treatment|0|||
16165146|NCT01827384|39083888|FG011|Overall Study|Switched to alternative treatment|0|||
16165147|NCT01827384|39083889|FG012|Overall Study|Switched to alternative treatment|0|||
16165148|NCT01827384|39083890|FG013|Overall Study|Switched to alternative treatment|2|||
16165149|NCT01827384|39083877|FG000|Overall Study|Disease progression before treatment|0|||
16165150|NCT01827384|39083878|FG001|Overall Study|Disease progression before treatment|0|||
16165151|NCT01827384|39083879|FG002|Overall Study|Disease progression before treatment|0|||
16165152|NCT01827384|39083880|FG003|Overall Study|Disease progression before treatment|0|||
16165153|NCT01827384|39083881|FG004|Overall Study|Disease progression before treatment|0|||
16165154|NCT01827384|39083882|FG005|Overall Study|Disease progression before treatment|0|||
16165155|NCT01827384|39083883|FG006|Overall Study|Disease progression before treatment|0|||
16165156|NCT01827384|39083884|FG007|Overall Study|Disease progression before treatment|0|||
16165157|NCT01827384|39083885|FG008|Overall Study|Disease progression before treatment|0|||
16165158|NCT01827384|39083886|FG009|Overall Study|Disease progression before treatment|0|||
16165159|NCT01827384|39083887|FG010|Overall Study|Disease progression before treatment|0|||
16165160|NCT01827384|39083888|FG011|Overall Study|Disease progression before treatment|0|||
16165161|NCT01827384|39083889|FG012|Overall Study|Disease progression before treatment|0|||
16165162|NCT01827384|39083890|FG013|Overall Study|Disease progression before treatment|4|||
16165163|NCT01827384|39083877|FG000|Overall Study|Ineligible|0|||
16165164|NCT01827384|39083878|FG001|Overall Study|Ineligible|0|||
16165165|NCT01827384|39083879|FG002|Overall Study|Ineligible|0|||
16165166|NCT01827384|39083880|FG003|Overall Study|Ineligible|0|||
16165167|NCT01827384|39083881|FG004|Overall Study|Ineligible|0|||
16165168|NCT01827384|39083882|FG005|Overall Study|Ineligible|0|||
16165169|NCT01827384|39083883|FG006|Overall Study|Ineligible|0|||
16165170|NCT01827384|39083884|FG007|Overall Study|Ineligible|0|||
16165171|NCT01827384|39083885|FG008|Overall Study|Ineligible|0|||
16165172|NCT01827384|39083886|FG009|Overall Study|Ineligible|0|||
16454240|NCT00452361|40141642|FG001|Overall Study|Withdrawal by Subject|1|||
16454241|NCT00452361|40141641|FG000|Overall Study|Premature termination|13|||
16454242|NCT00452361|40141642|FG001|Overall Study|Premature termination|9|||
16454243|NCT01590888|40141643|FG000|Overall Study|Adverse Event|3|||
16454244|NCT01590888|40141644|FG001|Overall Study|Adverse Event|0|||
16454245|NCT01590888|40141645|FG002|Overall Study|Adverse Event|1|||
16454246|NCT01590888|40141643|FG000|Overall Study|Lost to Follow-up|1|||
16454247|NCT01590888|40141644|FG001|Overall Study|Lost to Follow-up|0|||
16454248|NCT01590888|40141645|FG002|Overall Study|Lost to Follow-up|0|||
16454249|NCT04195893|40141646|FG000|Second Intervention|Withdrawal by Subject|1|||
16454250|NCT04195893|40141647|FG001|Second Intervention|Withdrawal by Subject|0|||
16454251|NCT01146795|40141648|FG000|Overall Study|Withdrawal by Subject|4|||
16454252|NCT01146795|40141648|FG000|Overall Study|Adverse Event|6|||
16454253|NCT01146795|40141648|FG000|Overall Study|Still in treatment at study closure|10|||
16454254|NCT01011309|40141654|FG000|Overall Study|Adverse Event|2|||
16454255|NCT01011309|40141655|FG001|Overall Study|Adverse Event|1|||
16454256|NCT01011309|40141656|FG002|Overall Study|Adverse Event|2|||
16454257|NCT01011309|40141654|FG000|Overall Study|Lack of Efficacy|0|||
16454258|NCT01011309|40141655|FG001|Overall Study|Lack of Efficacy|1|||
16454259|NCT01011309|40141656|FG002|Overall Study|Lack of Efficacy|0|||
16454260|NCT01011309|40141654|FG000|Overall Study|Protocol Violation|0|||
16454261|NCT01011309|40141655|FG001|Overall Study|Protocol Violation|1|||
16454262|NCT01011309|40141656|FG002|Overall Study|Protocol Violation|3|||
16454263|NCT00312195|40141661|FG000|Overall Study|Adverse Event|4|||
16454264|NCT00312195|40141662|FG001|Overall Study|Adverse Event|6|||
16454265|NCT00312195|40141661|FG000|Overall Study|Lost to Follow-up|1|||
16454266|NCT00312195|40141662|FG001|Overall Study|Lost to Follow-up|0|||
16454267|NCT00312195|40141661|FG000|Overall Study|Protocol Violation|1|||
16454268|NCT00312195|40141662|FG001|Overall Study|Protocol Violation|0|||
16454269|NCT01181986|40141663|FG000|Phase 1|Lost to Follow-up|0|||
16454270|NCT01181986|40141664|FG001|Phase 1|Lost to Follow-up|1|||
16454271|NCT01181986|40141665|FG002|Phase 1|Lost to Follow-up|1|||
16454272|NCT01181986|40141663|FG000|Phase 1|Adverse Event|0|||
16454273|NCT01181986|40141664|FG001|Phase 1|Adverse Event|0|||
16454274|NCT01181986|40141665|FG002|Phase 1|Adverse Event|1|||
16454275|NCT01181986|40141663|FG000|Phase 1|Protocol Violation|1|||
16454276|NCT01181986|40141664|FG001|Phase 1|Protocol Violation|0|||
16454277|NCT01181986|40141665|FG002|Phase 1|Protocol Violation|0|||
16454278|NCT01181986|40141663|FG000|Phase 2|Adverse Event|0|||
16454279|NCT01181986|40141664|FG001|Phase 2|Adverse Event|3|||
16454280|NCT01181986|40141665|FG002|Phase 2|Adverse Event|0|||
16454281|NCT01181986|40141663|FG000|Phase 2|Medical condition|0|||
16454282|NCT01181986|40141664|FG001|Phase 2|Medical condition|1|||
16454283|NCT01181986|40141665|FG002|Phase 2|Medical condition|0|||
16454284|NCT00095940|40141666|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
16454285|NCT00095940|40141667|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
16454286|NCT00095940|40141668|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
16454287|NCT00095940|40141669|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
16454288|NCT00095940|40141670|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
16454289|NCT00095940|40141671|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
16454290|NCT00095940|40141672|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
16454291|NCT00095940|40141673|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
16454292|NCT00095940|40141674|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
16454293|NCT00095940|40141666|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
16454294|NCT00095940|40141667|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
16454295|NCT00095940|40141668|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
16454296|NCT00095940|40141669|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
16454297|NCT00095940|40141670|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
16454298|NCT00095940|40141671|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
16454299|NCT00095940|40141672|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
16454300|NCT00095940|40141673|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
16454301|NCT00095940|40141674|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
16454302|NCT00095940|40141666|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
16454303|NCT00095940|40141667|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
16454304|NCT00095940|40141668|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
16454305|NCT00095940|40141669|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
16454306|NCT00095940|40141670|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
16454307|NCT00095940|40141671|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
16454308|NCT00095940|40141672|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
16454309|NCT00095940|40141673|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
16454310|NCT00095940|40141674|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
16454311|NCT03085797|40141676|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
16454312|NCT03085797|40141677|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
16454313|NCT03085797|40141676|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
16454314|NCT03085797|40141677|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
16454315|NCT03085797|40141676|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
16454316|NCT03085797|40141677|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
16454317|NCT04343235|40141683|FG000|Overall Study|Lost to Follow-up|3|||
16454318|NCT04343235|40141684|FG001|Overall Study|Lost to Follow-up|2|||
16454319|NCT00357903|40141687|FG000|Overall Study|Adverse Event|87|||
16454320|NCT00357903|40141688|FG001|Overall Study|Adverse Event|4|||
16454321|NCT00357903|40141687|FG000|Overall Study|Death|33|||
16454322|NCT00357903|40141688|FG001|Overall Study|Death|0|||
16454323|NCT00357903|40141687|FG000|Overall Study|Lost to Follow-up|23|||
16454324|NCT00357903|40141688|FG001|Overall Study|Lost to Follow-up|4|||
16454325|NCT00357903|40141687|FG000|Overall Study|Physician Decision|39|||
16454326|NCT00357903|40141688|FG001|Overall Study|Physician Decision|5|||
16454327|NCT00357903|40141687|FG000|Overall Study|Withdrawal by Subject|57|||
16454328|NCT00357903|40141688|FG001|Overall Study|Withdrawal by Subject|7|||
16454329|NCT00357903|40141687|FG000|Overall Study|Completed month 12 only|0|||
16454330|NCT00357903|40141688|FG001|Overall Study|Completed month 12 only|1|||
16454331|NCT00357903|40141687|FG000|Overall Study|Protocol issues|14|||
16454332|NCT00357903|40141688|FG001|Overall Study|Protocol issues|3|||
16454333|NCT00357903|40141687|FG000|Overall Study|Response status|61|||
16454334|NCT00357903|40141688|FG001|Overall Study|Response status|9|||
16454335|NCT00357903|40141687|FG000|Overall Study|Other|49|||
16454336|NCT00357903|40141688|FG001|Overall Study|Other|10|||
16454337|NCT00393861|40141689|FG000|Overall Study|Adverse Event|2|||
16454338|NCT00393861|40141689|FG000|Overall Study|Disease Progression|24|||
16454339|NCT00541385|40141690|FG000|Overall Study|Adverse Event|6|||
16454340|NCT00541385|40141691|FG001|Overall Study|Adverse Event|3|||
16454341|NCT00541385|40141690|FG000|Overall Study|Withdrawal by Subject|2|||
16454342|NCT00541385|40141691|FG001|Overall Study|Withdrawal by Subject|2|||
16454343|NCT00541385|40141690|FG000|Overall Study|Lost to Follow-up|6|||
16454344|NCT00541385|40141691|FG001|Overall Study|Lost to Follow-up|1|||
16454345|NCT00541385|40141690|FG000|Overall Study|Parasite reappearance/malaria|67|||
16454346|NCT00541385|40141691|FG001|Overall Study|Parasite reappearance/malaria|32|||
16454347|NCT00214201|40141692|FG000|Overall Study|Withdrawal by Subject|2|||
16454348|NCT00214201|40141693|FG001|Overall Study|Withdrawal by Subject|0|||
16454349|NCT00214201|40141692|FG000|Overall Study|Death|0|||
16454350|NCT00214201|40141693|FG001|Overall Study|Death|2|||
16454351|NCT02067676|40141701|FG000|Overall Study|Withdrawal by Subject|1|||
16454352|NCT02067676|40141702|FG001|Overall Study|Withdrawal by Subject|0|||
16454353|NCT02067676|40141703|FG002|Overall Study|Withdrawal by Subject|0|||
16454354|NCT02067676|40141704|FG003|Overall Study|Withdrawal by Subject|0|||
16454355|NCT02067676|40141705|FG004|Overall Study|Withdrawal by Subject|0|||
16454356|NCT02067676|40141706|FG005|Overall Study|Withdrawal by Subject|0|||
16454357|NCT01516034|40141707|FG000|Overall Study|Physician Decision|1|||
16454358|NCT01516034|40141707|FG000|Overall Study|Lack of Efficacy|7|||
16454359|NCT01399372|40141710|FG000|Overall Study|Protocol Violation|3|||
16454360|NCT01399372|40141711|FG001|Overall Study|Protocol Violation|1|||
16454361|NCT00661427|40144579|FG000|Overall Study|Adverse Event|5|||
16454362|NCT00661427|40144580|FG001|Overall Study|Adverse Event|5|||
16454363|NCT00661427|40144579|FG000|Overall Study|Patient not treated|0|||
16454364|NCT00661427|40144580|FG001|Overall Study|Patient not treated|2|||
16454365|NCT02563067|40144581|FG000|Overall Study|Subject/guardian decision|14|||
16454366|NCT02563067|40144582|FG001|Overall Study|Subject/guardian decision|20|||
16454367|NCT02563067|40144583|FG002|Overall Study|Subject/guardian decision|16|||
16454368|NCT02563067|40144581|FG000|Overall Study|Physician Decision|0|||
16454369|NCT02563067|40144582|FG001|Overall Study|Physician Decision|1|||
16454370|NCT02563067|40144583|FG002|Overall Study|Physician Decision|3|||
16454371|NCT02563067|40144581|FG000|Overall Study|Lost to Follow-up|1|||
16454372|NCT02563067|40144582|FG001|Overall Study|Lost to Follow-up|2|||
16454373|NCT02563067|40144583|FG002|Overall Study|Lost to Follow-up|0|||
16454374|NCT02563067|40144581|FG000|Overall Study|Technical problems|0|||
16454375|NCT02563067|40144582|FG001|Overall Study|Technical problems|1|||
16454376|NCT02563067|40144583|FG002|Overall Study|Technical problems|0|||
16454377|NCT02563067|40144581|FG000|Overall Study|Lack of Efficacy|1|||
16454378|NCT02563067|40144582|FG001|Overall Study|Lack of Efficacy|0|||
16266187|NCT00272779|39456866|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
16266188|NCT00272779|39456865|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
16454379|NCT02563067|40144583|FG002|Overall Study|Lack of Efficacy|0|||
16454380|NCT02563067|40144581|FG000|Overall Study|Death|0|||
16454381|NCT02563067|40144582|FG001|Overall Study|Death|1|||
16454382|NCT02563067|40144583|FG002|Overall Study|Death|1|||
16454383|NCT02563067|40144581|FG000|Overall Study|Adverse Event|2|||
16454384|NCT02563067|40144582|FG001|Overall Study|Adverse Event|1|||
16454385|NCT02563067|40144583|FG002|Overall Study|Adverse Event|0|||
16454386|NCT02563067|40144581|FG000|Overall Study|Death post Treatment/safety period|1|||
16454387|NCT02563067|40144582|FG001|Overall Study|Death post Treatment/safety period|0|||
16454388|NCT02563067|40144583|FG002|Overall Study|Death post Treatment/safety period|0|||
16454389|NCT00419952|40144584|FG000|Overall Study|Adverse Event|8|||
16454390|NCT00419952|40144585|FG001|Overall Study|Adverse Event|10|||
16454391|NCT00419952|40144584|FG000|Overall Study|Withdrawal by Subject|44|||
16454392|NCT00419952|40144585|FG001|Overall Study|Withdrawal by Subject|43|||
16454393|NCT00419952|40144584|FG000|Overall Study|Lost to Follow-up|43|||
16454394|NCT00419952|40144585|FG001|Overall Study|Lost to Follow-up|34|||
16454395|NCT00419952|40144584|FG000|Overall Study|Protocol Violation|32|||
16454396|NCT00419952|40144585|FG001|Overall Study|Protocol Violation|24|||
16454397|NCT00419952|40144584|FG000|Overall Study|Pregnancy|4|||
16454398|NCT00419952|40144585|FG001|Overall Study|Pregnancy|2|||
16454399|NCT00419952|40144584|FG000|Overall Study|Physician Decision|1|||
16454400|NCT00419952|40144585|FG001|Overall Study|Physician Decision|3|||
16165173|NCT01827384|39083887|FG010|Overall Study|Ineligible|0|||
16165174|NCT01827384|39083888|FG011|Overall Study|Ineligible|0|||
16165175|NCT01827384|39083889|FG012|Overall Study|Ineligible|0|||
16165176|NCT01827384|39083890|FG013|Overall Study|Ineligible|19|||
16165177|NCT01827384|39083877|FG000|Overall Study|Participant died before treatment|0|||
16165178|NCT01827384|39083878|FG001|Overall Study|Participant died before treatment|0|||
16165179|NCT01827384|39083879|FG002|Overall Study|Participant died before treatment|0|||
16165180|NCT01827384|39083880|FG003|Overall Study|Participant died before treatment|0|||
16165181|NCT01827384|39083881|FG004|Overall Study|Participant died before treatment|0|||
16165182|NCT01827384|39083882|FG005|Overall Study|Participant died before treatment|0|||
16165183|NCT01827384|39083883|FG006|Overall Study|Participant died before treatment|0|||
16165184|NCT01827384|39083884|FG007|Overall Study|Participant died before treatment|0|||
16165185|NCT01827384|39083885|FG008|Overall Study|Participant died before treatment|0|||
16165186|NCT01827384|39083886|FG009|Overall Study|Participant died before treatment|0|||
16165187|NCT01827384|39083887|FG010|Overall Study|Participant died before treatment|0|||
16165188|NCT01827384|39083888|FG011|Overall Study|Participant died before treatment|0|||
16165189|NCT01827384|39083889|FG012|Overall Study|Participant died before treatment|0|||
16165190|NCT01827384|39083890|FG013|Overall Study|Participant died before treatment|5|||
16165191|NCT01827384|39083877|FG000|Overall Study|Insufficient tumor cells|0|||
16165192|NCT01827384|39083878|FG001|Overall Study|Insufficient tumor cells|0|||
16165193|NCT01827384|39083879|FG002|Overall Study|Insufficient tumor cells|0|||
16165194|NCT01827384|39083880|FG003|Overall Study|Insufficient tumor cells|0|||
16165195|NCT01827384|39083881|FG004|Overall Study|Insufficient tumor cells|0|||
16165196|NCT01827384|39083882|FG005|Overall Study|Insufficient tumor cells|0|||
16165197|NCT01827384|39083883|FG006|Overall Study|Insufficient tumor cells|0|||
16165198|NCT01827384|39083884|FG007|Overall Study|Insufficient tumor cells|0|||
16165199|NCT01827384|39083885|FG008|Overall Study|Insufficient tumor cells|0|||
16454401|NCT00419952|40144584|FG000|Overall Study|Incorrectly enrolled|10|||
16454402|NCT00419952|40144585|FG001|Overall Study|Incorrectly enrolled|3|||
16454403|NCT00419952|40144584|FG000|Overall Study|Intake of prohibited medication|2|||
16454404|NCT00419952|40144585|FG001|Overall Study|Intake of prohibited medication|2|||
16454405|NCT00419952|40144584|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
16454406|NCT00419952|40144585|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
16454407|NCT00419952|40144584|FG000|Overall Study|Diary or medication non-compliance|2|||
16454408|NCT00419952|40144585|FG001|Overall Study|Diary or medication non-compliance|4|||
16454409|NCT00419952|40144584|FG000|Overall Study|Abnormal ECG|1|||
16454410|NCT00419952|40144585|FG001|Overall Study|Abnormal ECG|0|||
16454411|NCT01623050|40144587|FG000|Overall Study|Lost to Follow-up|9|||
16454412|NCT00396253|40144590|FG000|Overall Study|Protocol Violation|1|||
16454413|NCT00396253|40144590|FG000|Overall Study|Withdrawal by Subject|7|||
16454414|NCT00396253|40144590|FG000|Overall Study|Death|3|||
16454415|NCT00396253|40144590|FG000|Overall Study|Physician Decision|1|||
16454416|NCT00396253|40144590|FG000|Overall Study|Change in eligibility status|1|||
16454417|NCT01092117|40144593|FG000|Index Procedure to 1 Month|Death|1|||
16454418|NCT01092117|40144593|FG000|1 Month|Death|1|||
16454419|NCT01092117|40144593|FG000|1 Month|Withdrawal by Subject|1|||
16454420|NCT01092117|40144593|FG000|1 Month|Lost to Follow-up|1|||
16454421|NCT01092117|40144593|FG000|6 Months|Death|2|||
16454422|NCT01092117|40144593|FG000|6 Months|Withdrawal by Subject|3|||
16454423|NCT01092117|40144593|FG000|12 Month|Death|11|||
16454424|NCT01092117|40144593|FG000|12 Month|Withdrawal by Subject|2|||
16454425|NCT01092117|40144593|FG000|12 Month|Lost to Follow-up|1|||
16454426|NCT01092117|40144593|FG000|Year 2|Death|5|||
16454427|NCT01092117|40144593|FG000|Year 2|Withdrawal by Subject|4|||
16454428|NCT01092117|40144593|FG000|Year 2|Lost to Follow-up|1|||
16454429|NCT01092117|40144593|FG000|Year 3|Death|7|||
16454430|NCT01092117|40144593|FG000|Year 3|Withdrawal by Subject|9|||
16454431|NCT01092117|40144593|FG000|Year 3|Lost to Follow-up|3|||
16454432|NCT01092117|40144593|FG000|Year 4|Death|8|||
16454433|NCT01092117|40144593|FG000|Year 4|Withdrawal by Subject|4|||
16454434|NCT01092117|40144593|FG000|Year 4|Lost to Follow-up|4|||
16454435|NCT00606593|40144601|FG000|Overall Study|Adverse Event|0|||
16454436|NCT00606593|40144602|FG001|Overall Study|Adverse Event|0|||
16454437|NCT00606593|40144603|FG002|Overall Study|Adverse Event|0|||
16454438|NCT00606593|40144604|FG003|Overall Study|Adverse Event|1|||
16454439|NCT00606593|40144605|FG004|Overall Study|Adverse Event|1|||
16454440|NCT00606593|40144606|FG005|Overall Study|Adverse Event|0|||
16454441|NCT00606593|40144607|FG006|Overall Study|Adverse Event|1|||
16454442|NCT00606593|40144608|FG007|Overall Study|Adverse Event|2|||
16454443|NCT00606593|40144609|FG008|Overall Study|Adverse Event|1|||
16454444|NCT00606593|40144610|FG009|Overall Study|Adverse Event|0|||
16454445|NCT00606593|40144601|FG000|Overall Study|Withdrawal of consent|1|||
16454446|NCT00606593|40144602|FG001|Overall Study|Withdrawal of consent|0|||
16454447|NCT00606593|40144603|FG002|Overall Study|Withdrawal of consent|1|||
16454448|NCT00606593|40144604|FG003|Overall Study|Withdrawal of consent|0|||
16454449|NCT00606593|40144605|FG004|Overall Study|Withdrawal of consent|0|||
16454450|NCT00606593|40144606|FG005|Overall Study|Withdrawal of consent|0|||
16454451|NCT00606593|40144607|FG006|Overall Study|Withdrawal of consent|0|||
16454452|NCT00606593|40144608|FG007|Overall Study|Withdrawal of consent|0|||
16454453|NCT00606593|40144609|FG008|Overall Study|Withdrawal of consent|0|||
16454454|NCT00606593|40144610|FG009|Overall Study|Withdrawal of consent|0|||
16454455|NCT00606593|40144601|FG000|Overall Study|Administrative/Other|0|||
16454456|NCT00606593|40144602|FG001|Overall Study|Administrative/Other|0|||
16454457|NCT00606593|40144603|FG002|Overall Study|Administrative/Other|1|||
16454458|NCT00606593|40144604|FG003|Overall Study|Administrative/Other|0|||
16454459|NCT00606593|40144605|FG004|Overall Study|Administrative/Other|0|||
16454460|NCT00606593|40144606|FG005|Overall Study|Administrative/Other|0|||
16454461|NCT00606593|40144607|FG006|Overall Study|Administrative/Other|0|||
16454462|NCT00606593|40144608|FG007|Overall Study|Administrative/Other|0|||
16454463|NCT00606593|40144609|FG008|Overall Study|Administrative/Other|0|||
16165200|NCT01827384|39083886|FG009|Overall Study|Insufficient tumor cells|0|||
16454464|NCT00606593|40144610|FG009|Overall Study|Administrative/Other|0|||
16454465|NCT01738477|40144611|FG000|Overall Study|Lost to Follow-up|1|||
16165201|NCT01827384|39083887|FG010|Overall Study|Insufficient tumor cells|0|||
16165202|NCT01827384|39083888|FG011|Overall Study|Insufficient tumor cells|0|||
16165203|NCT01827384|39083889|FG012|Overall Study|Insufficient tumor cells|0|||
16165204|NCT01827384|39083890|FG013|Overall Study|Insufficient tumor cells|13|||
16165205|NCT01827384|39083877|FG000|Overall Study|No actionable mutation|0|||
16165206|NCT01827384|39083878|FG001|Overall Study|No actionable mutation|0|||
16165207|NCT01827384|39083879|FG002|Overall Study|No actionable mutation|0|||
16165208|NCT01827384|39083880|FG003|Overall Study|No actionable mutation|0|||
16165209|NCT01827384|39083881|FG004|Overall Study|No actionable mutation|0|||
16165210|NCT01827384|39083882|FG005|Overall Study|No actionable mutation|0|||
16165211|NCT01827384|39083883|FG006|Overall Study|No actionable mutation|0|||
16165212|NCT01827384|39083884|FG007|Overall Study|No actionable mutation|0|||
16165213|NCT01827384|39083885|FG008|Overall Study|No actionable mutation|0|||
16165214|NCT01827384|39083886|FG009|Overall Study|No actionable mutation|0|||
16165215|NCT01827384|39083887|FG010|Overall Study|No actionable mutation|0|||
16165216|NCT01827384|39083888|FG011|Overall Study|No actionable mutation|0|||
16165217|NCT01827384|39083889|FG012|Overall Study|No actionable mutation|0|||
16165218|NCT01827384|39083890|FG013|Overall Study|No actionable mutation|73|||
16165219|NCT01827384|39083877|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
16165220|NCT01827384|39083878|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
16165221|NCT01827384|39083879|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
16165222|NCT01827384|39083880|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
16454466|NCT01738477|40144612|FG001|Overall Study|Lost to Follow-up|4|||
16454467|NCT01301027|40144613|FG000|Overall Study|Physician Decision|2|||
16165223|NCT01827384|39083881|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
16165224|NCT01827384|39083882|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
16165225|NCT01827384|39083883|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
16454468|NCT01301027|40144614|FG001|Overall Study|Physician Decision|0|||
16454469|NCT01301027|40144613|FG000|Overall Study|Withdrawal by Subject|2|||
16454470|NCT01301027|40144614|FG001|Overall Study|Withdrawal by Subject|3|||
16266189|NCT00272779|39456866|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
16454471|NCT01301027|40144613|FG000|Overall Study|Adverse Event|0|||
16454472|NCT01301027|40144614|FG001|Overall Study|Adverse Event|2|||
16454473|NCT01301027|40144613|FG000|Overall Study|Fracture|1|||
16454474|NCT01301027|40144614|FG001|Overall Study|Fracture|3|||
16454475|NCT01301027|40144613|FG000|Overall Study|Transplant|0|||
16454476|NCT01301027|40144614|FG001|Overall Study|Transplant|2|||
16454477|NCT01301027|40144613|FG000|Overall Study|Volume Overload|3|||
16072661|NCT01467700|38756421|FG003|Overall Study|Lost to Follow-up|3|||
16454478|NCT01301027|40144614|FG001|Overall Study|Volume Overload|0|||
16454479|NCT03052400|40144615|FG000|Overall Study|Lost to Follow-up|1|||
16454480|NCT03052400|40144616|FG001|Overall Study|Lost to Follow-up|0|||
16454481|NCT03052400|40144615|FG000|Overall Study|Withdrawal by Subject|0|||
16454482|NCT03052400|40144616|FG001|Overall Study|Withdrawal by Subject|1|||
16454483|NCT00502203|40144623|FG000|Overall Study|Inevaluable|1|||
16454484|NCT03805659|40144624|FG000|Overall Study|Withdrawal by Subject|0|||
16454485|NCT03805659|40144625|FG001|Overall Study|Withdrawal by Subject|1|||
16454486|NCT01396057|40144628|FG000|Overall Study|Adverse Event|2|||
16454487|NCT01396057|40144629|FG001|Overall Study|Adverse Event|6|||
16454488|NCT01396057|40144628|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16454489|NCT01396057|40144629|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
16454490|NCT01396057|40144628|FG000|Overall Study|Protocol deviation|4|||
16165226|NCT01827384|39083884|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
16165227|NCT01827384|39083885|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
16165228|NCT01827384|39083886|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
16165229|NCT01827384|39083887|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
16165230|NCT01827384|39083888|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
16165231|NCT01827384|39083889|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
16454491|NCT01396057|40144629|FG001|Overall Study|Protocol deviation|4|||
16454492|NCT01396057|40144628|FG000|Overall Study|Consent withdrawn|3|||
16165232|NCT01827384|39083890|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
16165233|NCT02982954|39083896|FG000|Overall Study|Death|55|||
16165234|NCT02982954|39083897|FG001|Overall Study|Death|29|||
16165235|NCT02982954|39083898|FG002|Overall Study|Death|15|||
16266190|NCT00272779|39456865|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
16266191|NCT00272779|39456866|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
16165236|NCT02982954|39083899|FG003|Overall Study|Death|20|||
16165237|NCT02982954|39083896|FG000|Overall Study|Lost to Follow-up|2|||
16165238|NCT02982954|39083897|FG001|Overall Study|Lost to Follow-up|1|||
16165239|NCT02982954|39083898|FG002|Overall Study|Lost to Follow-up|0|||
16165240|NCT02982954|39083899|FG003|Overall Study|Lost to Follow-up|0|||
16165241|NCT02982954|39083896|FG000|Overall Study|Participant withdrew consent|7|||
16165242|NCT02982954|39083897|FG001|Overall Study|Participant withdrew consent|5|||
16165243|NCT02982954|39083898|FG002|Overall Study|Participant withdrew consent|1|||
16165244|NCT02982954|39083899|FG003|Overall Study|Participant withdrew consent|1|||
16165245|NCT02982954|39083896|FG000|Overall Study|Other reasons|42|||
16165246|NCT02982954|39083897|FG001|Overall Study|Other reasons|17|||
16165247|NCT02982954|39083898|FG002|Overall Study|Other reasons|12|||
16165248|NCT02982954|39083899|FG003|Overall Study|Other reasons|3|||
16165249|NCT02982954|39083896|FG000|Overall Study|Premature site closure|0|||
16165250|NCT02982954|39083897|FG001|Overall Study|Premature site closure|0|||
16165251|NCT02982954|39083898|FG002|Overall Study|Premature site closure|0|||
16165252|NCT02982954|39083899|FG003|Overall Study|Premature site closure|1|||
16165253|NCT03604445|39083901|FG000|Overall Study|Death|0|||
16165254|NCT03604445|39083902|FG001|Overall Study|Death|0|||
16165255|NCT03604445|39083903|FG002|Overall Study|Death|0|||
16165256|NCT03604445|39083904|FG003|Overall Study|Death|0|||
16165257|NCT03604445|39083905|FG004|Overall Study|Death|0|||
16165258|NCT03604445|39083906|FG005|Overall Study|Death|0|||
16165259|NCT03604445|39083907|FG006|Overall Study|Death|0|||
16165260|NCT03604445|39083908|FG007|Overall Study|Death|0|||
16165261|NCT03604445|39083909|FG008|Overall Study|Death|1|||
16165262|NCT03604445|39083901|FG000|Overall Study|Withdrawal by Subject|0|||
16165263|NCT03604445|39083902|FG001|Overall Study|Withdrawal by Subject|0|||
16165264|NCT03604445|39083903|FG002|Overall Study|Withdrawal by Subject|0|||
16165265|NCT03604445|39083904|FG003|Overall Study|Withdrawal by Subject|0|||
16165266|NCT03604445|39083905|FG004|Overall Study|Withdrawal by Subject|0|||
16165267|NCT03604445|39083906|FG005|Overall Study|Withdrawal by Subject|0|||
16165268|NCT03604445|39083907|FG006|Overall Study|Withdrawal by Subject|1|||
16165269|NCT03604445|39083908|FG007|Overall Study|Withdrawal by Subject|0|||
16165270|NCT03604445|39083909|FG008|Overall Study|Withdrawal by Subject|0|||
16165271|NCT03604445|39083901|FG000|Overall Study|Missing visit|0|||
16165272|NCT03604445|39083902|FG001|Overall Study|Missing visit|0|||
16165273|NCT03604445|39083903|FG002|Overall Study|Missing visit|0|||
16266192|NCT00272779|39456865|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
16266193|NCT00272779|39456866|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
16266194|NCT00272779|39456865|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
16266195|NCT00272779|39456866|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
16266196|NCT00272779|39456865|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
16266197|NCT00272779|39456866|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
16266198|NCT00272779|39456865|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
16266199|NCT00272779|39456866|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
16266200|NCT00272779|39456865|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
16266201|NCT00272779|39456866|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
16266202|NCT00272779|39456865|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
16266203|NCT00272779|39456866|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
16266204|NCT00272779|39456865|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
16454493|NCT01396057|40144629|FG001|Overall Study|Consent withdrawn|2|||
16454494|NCT02474069|40144630|FG000|Selection Phase (SP)|Adverse Event|8|||
16454495|NCT02474069|40144631|FG001|Selection Phase (SP)|Adverse Event|0|||
16454496|NCT02474069|40144632|FG002|Selection Phase (SP)|Adverse Event|0|||
16165274|NCT03604445|39083904|FG003|Overall Study|Missing visit|0|||
16454497|NCT02474069|40144630|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
16165275|NCT03604445|39083905|FG004|Overall Study|Missing visit|0|||
16165276|NCT03604445|39083906|FG005|Overall Study|Missing visit|1|||
16454498|NCT02474069|40144631|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
16454499|NCT02474069|40144632|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
16454500|NCT02474069|40144630|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
16454501|NCT02474069|40144631|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
16454502|NCT02474069|40144632|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
16454503|NCT02474069|40144630|FG000|Selection Phase (SP)|Physician Decision|1|||
16454504|NCT02474069|40144631|FG001|Selection Phase (SP)|Physician Decision|0|||
16454505|NCT02474069|40144632|FG002|Selection Phase (SP)|Physician Decision|0|||
16454506|NCT02474069|40144630|FG000|Selection Phase (SP)|Protocol Violation|1|||
16454507|NCT02474069|40144631|FG001|Selection Phase (SP)|Protocol Violation|0|||
16454508|NCT02474069|40144632|FG002|Selection Phase (SP)|Protocol Violation|0|||
16454509|NCT02474069|40144630|FG000|Selection Phase (SP)|No longer requires treatment|1|||
16454510|NCT02474069|40144631|FG001|Selection Phase (SP)|No longer requires treatment|0|||
16454511|NCT02474069|40144632|FG002|Selection Phase (SP)|No longer requires treatment|0|||
16454512|NCT02474069|40144630|FG000|Selection Phase (SP)|Technical Problem|1|||
16454513|NCT02474069|40144631|FG001|Selection Phase (SP)|Technical Problem|0|||
16165277|NCT03604445|39083907|FG006|Overall Study|Missing visit|0|||
16165278|NCT03604445|39083908|FG007|Overall Study|Missing visit|1|||
16165279|NCT03604445|39083909|FG008|Overall Study|Missing visit|0|||
16165280|NCT03604445|39083901|FG000|Overall Study|Adverse Event|0|||
16165281|NCT03604445|39083902|FG001|Overall Study|Adverse Event|0|||
16165282|NCT03604445|39083903|FG002|Overall Study|Adverse Event|0|||
16165283|NCT03604445|39083904|FG003|Overall Study|Adverse Event|1|||
16454514|NCT02474069|40144632|FG002|Selection Phase (SP)|Technical Problem|0|||
16454515|NCT02474069|40144630|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
16454516|NCT02474069|40144631|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
16454517|NCT02474069|40144632|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
16454518|NCT02474069|40144630|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
16454519|NCT02474069|40144631|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
16454520|NCT02474069|40144632|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
16454521|NCT02474069|40144630|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
16454522|NCT02474069|40144631|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
16454523|NCT02474069|40144632|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
16454524|NCT02474069|40144630|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
16454525|NCT02474069|40144631|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
16454526|NCT02474069|40144632|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
16165284|NCT03604445|39083905|FG004|Overall Study|Adverse Event|0|||
16165285|NCT03604445|39083906|FG005|Overall Study|Adverse Event|0|||
16165286|NCT03604445|39083907|FG006|Overall Study|Adverse Event|0|||
16165287|NCT03604445|39083908|FG007|Overall Study|Adverse Event|0|||
16165288|NCT03604445|39083909|FG008|Overall Study|Adverse Event|1|||
16165289|NCT02307682|39083910|FG000|Overall Study|Adverse Event|9|||
16165290|NCT02307682|39083911|FG001|Overall Study|Adverse Event|8|||
16165291|NCT02307682|39083912|FG002|Overall Study|Adverse Event|12|||
16165292|NCT02307682|39083910|FG000|Overall Study|Lack of Efficacy|1|||
16165293|NCT02307682|39083911|FG001|Overall Study|Lack of Efficacy|0|||
16165294|NCT02307682|39083912|FG002|Overall Study|Lack of Efficacy|1|||
16165295|NCT02307682|39083910|FG000|Overall Study|Physician Decision|2|||
16165296|NCT02307682|39083911|FG001|Overall Study|Physician Decision|2|||
16165297|NCT02307682|39083912|FG002|Overall Study|Physician Decision|8|||
16165298|NCT02307682|39083910|FG000|Overall Study|Progressive Disease|1|||
16165299|NCT02307682|39083911|FG001|Overall Study|Progressive Disease|0|||
16165300|NCT02307682|39083912|FG002|Overall Study|Progressive Disease|0|||
16165301|NCT02307682|39083910|FG000|Overall Study|Withdrawal by Subject|26|||
16165302|NCT02307682|39083911|FG001|Overall Study|Withdrawal by Subject|34|||
16165303|NCT02307682|39083912|FG002|Overall Study|Withdrawal by Subject|23|||
16165304|NCT02307682|39083910|FG000|Overall Study|Death|9|||
16165305|NCT02307682|39083911|FG001|Overall Study|Death|7|||
16165306|NCT02307682|39083912|FG002|Overall Study|Death|12|||
16165307|NCT02307682|39083910|FG000|Overall Study|Lost to Follow-up|1|||
16165308|NCT02307682|39083911|FG001|Overall Study|Lost to Follow-up|5|||
16165309|NCT02307682|39083912|FG002|Overall Study|Lost to Follow-up|6|||
16165310|NCT02307682|39083910|FG000|Overall Study|Protocol Deviation|0|||
16165311|NCT02307682|39083911|FG001|Overall Study|Protocol Deviation|0|||
16454527|NCT02474069|40144630|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
16454528|NCT02474069|40144631|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
16165312|NCT02307682|39083912|FG002|Overall Study|Protocol Deviation|2|||
16165313|NCT02307682|39083910|FG000|Overall Study|Other|1|||
16165314|NCT02307682|39083911|FG001|Overall Study|Other|1|||
16165315|NCT02307682|39083912|FG002|Overall Study|Other|0|||
16165316|NCT03739528|39083913|FG000|Overall Study|Not treated|8|||
16165317|NCT03739528|39083914|FG001|Overall Study|Not treated|12|||
16165318|NCT03739528|39083913|FG000|Overall Study|Treatment and study discontinued|6|||
16165319|NCT03739528|39083914|FG001|Overall Study|Treatment and study discontinued|2|||
16165320|NCT03739528|39083913|FG000|Overall Study|Treatment discontinued + study completed|1|||
16165321|NCT03739528|39083914|FG001|Overall Study|Treatment discontinued + study completed|3|||
16165322|NCT01318122|39083922|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16165323|NCT01318122|39083923|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
16165324|NCT01318122|39083924|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
16165325|NCT01318122|39083925|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
16165326|NCT01318122|39083922|FG000|Enrolled - Long-Term Extension Study|Other|1|||
16165327|NCT01318122|39083923|FG001|Enrolled - Long-Term Extension Study|Other|0|||
16165328|NCT01318122|39083924|FG002|Enrolled - Long-Term Extension Study|Other|0|||
16165329|NCT01318122|39083925|FG003|Enrolled - Long-Term Extension Study|Other|0|||
16165330|NCT01318122|39083922|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
16165331|NCT01318122|39083923|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
16165332|NCT01318122|39083924|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
16165333|NCT01318122|39083925|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
16165334|NCT01318122|39083922|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
16165335|NCT01318122|39083923|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16165336|NCT01318122|39083924|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16165337|NCT01318122|39083925|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
16165338|NCT01318122|39083922|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
16165339|NCT01318122|39083923|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
16165340|NCT01318122|39083924|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
16165341|NCT01318122|39083925|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
16165342|NCT01318122|39083922|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
16165343|NCT01318122|39083923|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
16165344|NCT01318122|39083924|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
16165345|NCT01318122|39083925|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
16165346|NCT01360645|39083926|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
16165347|NCT01360645|39083927|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
16165348|NCT01360645|39083928|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
16165349|NCT01360645|39083929|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
16165350|NCT01360645|39083926|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
16165351|NCT01360645|39083927|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
16165352|NCT01360645|39083928|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
16165353|NCT01360645|39083929|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
16165354|NCT01360645|39083926|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
16165355|NCT01360645|39083927|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
16165356|NCT01360645|39083928|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
16165357|NCT01360645|39083929|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
16165358|NCT01360645|39083926|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
16165359|NCT01360645|39083927|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
16165360|NCT01360645|39083928|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
16165361|NCT01360645|39083929|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
16165362|NCT01360645|39083926|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
16165363|NCT01360645|39083927|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
16165364|NCT01360645|39083928|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
16165365|NCT01360645|39083929|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
16165366|NCT01360645|39083926|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
16165367|NCT01360645|39083927|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
16165368|NCT01360645|39083928|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
16165369|NCT01360645|39083929|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
16165370|NCT01360645|39083926|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
16165371|NCT01360645|39083927|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
16165372|NCT01360645|39083928|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
16165373|NCT01360645|39083929|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
16165374|NCT01360645|39083926|FG000|Phase B (6 Weeks)|Adverse Event|0|||
16165375|NCT01360645|39083927|FG001|Phase B (6 Weeks)|Adverse Event|6|||
16165376|NCT01360645|39083928|FG002|Phase B (6 Weeks)|Adverse Event|0|||
16165377|NCT01360645|39083929|FG003|Phase B (6 Weeks)|Adverse Event|0|||
16165378|NCT01360645|39083926|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
16165379|NCT01360645|39083927|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
16165380|NCT01360645|39083928|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
16165381|NCT01360645|39083929|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
16165382|NCT01360645|39083926|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
16165383|NCT01360645|39083927|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
16165384|NCT01360645|39083928|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
16165385|NCT01360645|39083929|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
16165386|NCT01360645|39083926|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
16165387|NCT01360645|39083927|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
16165388|NCT01360645|39083928|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
16165389|NCT01360645|39083929|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
16165390|NCT01360645|39083926|FG000|Phase A+|Lost to Follow-up|0|||
16165391|NCT01360645|39083927|FG001|Phase A+|Lost to Follow-up|0|||
16165392|NCT01360645|39083928|FG002|Phase A+|Lost to Follow-up|0|||
16165393|NCT01360645|39083929|FG003|Phase A+|Lost to Follow-up|7|||
16165394|NCT01360645|39083926|FG000|Phase A+|Adverse Event|0|||
16165395|NCT01360645|39083927|FG001|Phase A+|Adverse Event|0|||
16165396|NCT01360645|39083928|FG002|Phase A+|Adverse Event|0|||
16165397|NCT01360645|39083929|FG003|Phase A+|Adverse Event|2|||
16165398|NCT01360645|39083926|FG000|Phase A+|Met Withdrawal Criteria|0|||
16165399|NCT01360645|39083927|FG001|Phase A+|Met Withdrawal Criteria|0|||
16165400|NCT01360645|39083928|FG002|Phase A+|Met Withdrawal Criteria|0|||
16165401|NCT01360645|39083929|FG003|Phase A+|Met Withdrawal Criteria|4|||
16165402|NCT01360645|39083926|FG000|Phase A+|Physician Decision|0|||
16165403|NCT01360645|39083927|FG001|Phase A+|Physician Decision|0|||
16165404|NCT01360645|39083928|FG002|Phase A+|Physician Decision|0|||
16165405|NCT01360645|39083929|FG003|Phase A+|Physician Decision|2|||
16165406|NCT01360645|39083926|FG000|Phase A+|Withdrawal by Subject|0|||
16165407|NCT01360645|39083927|FG001|Phase A+|Withdrawal by Subject|0|||
16165408|NCT01360645|39083928|FG002|Phase A+|Withdrawal by Subject|0|||
16165409|NCT01360645|39083929|FG003|Phase A+|Withdrawal by Subject|5|||
16165410|NCT01360645|39083926|FG000|Phase A+|Protocol Deviation|0|||
16165411|NCT01360645|39083927|FG001|Phase A+|Protocol Deviation|0|||
16165412|NCT01360645|39083928|FG002|Phase A+|Protocol Deviation|0|||
16165413|NCT01360645|39083929|FG003|Phase A+|Protocol Deviation|4|||
16165414|NCT02111564|39083935|FG000|Overall Study|Death|109|||
16165415|NCT02111564|39083936|FG001|Overall Study|Death|120|||
16165416|NCT02111564|39083935|FG000|Overall Study|Lost to Follow-up|2|||
16165417|NCT02111564|39083936|FG001|Overall Study|Lost to Follow-up|3|||
16165418|NCT02111564|39083935|FG000|Overall Study|Withdrawal by Subject|20|||
16165419|NCT02111564|39083936|FG001|Overall Study|Withdrawal by Subject|20|||
16165420|NCT00481065|39083939|FG000|Overall Study|Adverse event or death|1|||
16165421|NCT00481065|39083940|FG001|Overall Study|Adverse event or death|1|||
16165422|NCT00481065|39083941|FG002|Overall Study|Adverse event or death|3|||
16165423|NCT00481065|39083942|FG003|Overall Study|Adverse event or death|0|||
16165424|NCT00481065|39083943|FG004|Overall Study|Adverse event or death|2|||
16165425|NCT00481065|39083944|FG005|Overall Study|Adverse event or death|0|||
16165426|NCT00481065|39083945|FG006|Overall Study|Adverse event or death|1|||
16165427|NCT00481065|39083946|FG007|Overall Study|Adverse event or death|1|||
16165428|NCT00481065|39083939|FG000|Overall Study|Withdrawal by Subject|11|||
16165429|NCT00481065|39083940|FG001|Overall Study|Withdrawal by Subject|12|||
16165430|NCT00481065|39083941|FG002|Overall Study|Withdrawal by Subject|7|||
16165431|NCT00481065|39083942|FG003|Overall Study|Withdrawal by Subject|11|||
16165432|NCT00481065|39083943|FG004|Overall Study|Withdrawal by Subject|13|||
16165433|NCT00481065|39083944|FG005|Overall Study|Withdrawal by Subject|12|||
16165434|NCT00481065|39083945|FG006|Overall Study|Withdrawal by Subject|9|||
16165435|NCT00481065|39083946|FG007|Overall Study|Withdrawal by Subject|10|||
16165436|NCT00481065|39083939|FG000|Overall Study|Lost to Follow-up|4|||
16165437|NCT00481065|39083940|FG001|Overall Study|Lost to Follow-up|2|||
16165438|NCT00481065|39083941|FG002|Overall Study|Lost to Follow-up|4|||
16165439|NCT00481065|39083942|FG003|Overall Study|Lost to Follow-up|3|||
16165440|NCT00481065|39083943|FG004|Overall Study|Lost to Follow-up|3|||
16165441|NCT00481065|39083944|FG005|Overall Study|Lost to Follow-up|3|||
16165442|NCT00481065|39083945|FG006|Overall Study|Lost to Follow-up|2|||
16165443|NCT00481065|39083946|FG007|Overall Study|Lost to Follow-up|5|||
16165444|NCT00481065|39083939|FG000|Overall Study|Inappropriate enrollment|4|||
16165445|NCT00481065|39083940|FG001|Overall Study|Inappropriate enrollment|0|||
16165446|NCT00481065|39083941|FG002|Overall Study|Inappropriate enrollment|2|||
16165447|NCT00481065|39083942|FG003|Overall Study|Inappropriate enrollment|0|||
16165448|NCT00481065|39083943|FG004|Overall Study|Inappropriate enrollment|2|||
16165449|NCT00481065|39083944|FG005|Overall Study|Inappropriate enrollment|1|||
16165450|NCT00481065|39083945|FG006|Overall Study|Inappropriate enrollment|0|||
16266205|NCT00272779|39456866|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
16165451|NCT00481065|39083946|FG007|Overall Study|Inappropriate enrollment|1|||
16165452|NCT00481065|39083939|FG000|Overall Study|Administrative reason|0|||
16165453|NCT00481065|39083940|FG001|Overall Study|Administrative reason|0|||
16165454|NCT00481065|39083941|FG002|Overall Study|Administrative reason|0|||
16165455|NCT00481065|39083942|FG003|Overall Study|Administrative reason|0|||
16165456|NCT00481065|39083943|FG004|Overall Study|Administrative reason|0|||
16165457|NCT00481065|39083944|FG005|Overall Study|Administrative reason|2|||
16165458|NCT00481065|39083945|FG006|Overall Study|Administrative reason|1|||
16165459|NCT00481065|39083946|FG007|Overall Study|Administrative reason|0|||
16165460|NCT00481065|39083939|FG000|Overall Study|Protocol Violation|2|||
16165461|NCT00481065|39083940|FG001|Overall Study|Protocol Violation|1|||
16165462|NCT00481065|39083941|FG002|Overall Study|Protocol Violation|1|||
16165463|NCT00481065|39083942|FG003|Overall Study|Protocol Violation|1|||
16165464|NCT00481065|39083943|FG004|Overall Study|Protocol Violation|2|||
16165465|NCT00481065|39083944|FG005|Overall Study|Protocol Violation|6|||
16165466|NCT00481065|39083945|FG006|Overall Study|Protocol Violation|3|||
16165467|NCT00481065|39083946|FG007|Overall Study|Protocol Violation|2|||
16165468|NCT00481065|39083939|FG000|Overall Study|Unable to classify|0|||
16165469|NCT00481065|39083940|FG001|Overall Study|Unable to classify|1|||
16165470|NCT00481065|39083941|FG002|Overall Study|Unable to classify|2|||
16454529|NCT02474069|40144632|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
16454530|NCT02474069|40144630|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
16454531|NCT02474069|40144631|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
16454532|NCT02474069|40144632|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
16454533|NCT03710083|40144633|FG000|Overall Study|Withdrawal by Subject|2|||
16454534|NCT03710083|40144633|FG000|Overall Study|Unsuccessful Procedure|1|||
16454535|NCT01253577|40144634|FG000|Overall Study|Lost to Follow-up|3|||
16454536|NCT01243242|40144635|FG000|Overall Study|Adverse Event|1|||
16454537|NCT01243242|40144636|FG001|Overall Study|Adverse Event|1|||
16454538|NCT01243242|40144635|FG000|Overall Study|Withdrawal by Subject|1|||
16454539|NCT01243242|40144636|FG001|Overall Study|Withdrawal by Subject|1|||
16454540|NCT01243242|40144635|FG000|Overall Study|Physician Decision|0|||
16454541|NCT01243242|40144636|FG001|Overall Study|Physician Decision|1|||
16454542|NCT01243242|40144635|FG000|Overall Study|sponsor decision|0|||
16454543|NCT01243242|40144636|FG001|Overall Study|sponsor decision|1|||
16454544|NCT01243242|40144635|FG000|Overall Study|non compliance|1|||
16454545|NCT01243242|40144636|FG001|Overall Study|non compliance|0|||
16454546|NCT02228980|40144637|FG000|Overall Study|Adverse Event|14|||
16454547|NCT02228980|40144638|FG001|Overall Study|Adverse Event|0|||
16454548|NCT02228980|40144639|FG002|Overall Study|Adverse Event|0|||
16454549|NCT02228980|40144640|FG003|Overall Study|Adverse Event|0|||
16454550|NCT02228980|40144637|FG000|Overall Study|Protocol Violation|7|||
16454551|NCT02228980|40144638|FG001|Overall Study|Protocol Violation|0|||
16454552|NCT02228980|40144639|FG002|Overall Study|Protocol Violation|0|||
16454553|NCT02228980|40144640|FG003|Overall Study|Protocol Violation|0|||
16454554|NCT02228980|40144637|FG000|Overall Study|Withdrawal by Subject|3|||
16454555|NCT02228980|40144638|FG001|Overall Study|Withdrawal by Subject|3|||
16454556|NCT02228980|40144639|FG002|Overall Study|Withdrawal by Subject|2|||
16454557|NCT02228980|40144640|FG003|Overall Study|Withdrawal by Subject|3|||
16454558|NCT03636893|40144641|FG000|Overall Study|Death|0|||
16454559|NCT03636893|40144642|FG001|Overall Study|Death|1|||
16454560|NCT03636893|40144641|FG000|Overall Study|Protocol Violation|0|||
16454561|NCT03636893|40144642|FG001|Overall Study|Protocol Violation|3|||
16454562|NCT03636893|40144641|FG000|Overall Study|Withdrawal by Subject|1|||
16165471|NCT00481065|39083942|FG003|Overall Study|Unable to classify|0|||
16165472|NCT00481065|39083943|FG004|Overall Study|Unable to classify|1|||
16165473|NCT00481065|39083944|FG005|Overall Study|Unable to classify|0|||
16165474|NCT00481065|39083945|FG006|Overall Study|Unable to classify|0|||
16165475|NCT00481065|39083946|FG007|Overall Study|Unable to classify|0|||
16165476|NCT00542997|39083947|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
16165477|NCT00542997|39083947|FG000|Wash in / Wash Out Period|Adverse Event|3|||
16165478|NCT00542997|39083947|FG000|Efficacy Period|Adverse Event|3|||
16165479|NCT03686969|39083948|FG000|Overall Study|Study terminated|1|||
16165480|NCT03686969|39083949|FG001|Overall Study|Study terminated|0|||
16165481|NCT02751931|39083950|FG000|Overall Study|Adverse Event|3|||
16165482|NCT02751931|39083951|FG001|Overall Study|Adverse Event|0|||
16165483|NCT02751931|39083950|FG000|Overall Study|Other: Miscelleneous|10|||
16165484|NCT02751931|39083951|FG001|Overall Study|Other: Miscelleneous|8|||
16454563|NCT03636893|40144642|FG001|Overall Study|Withdrawal by Subject|2|||
16454564|NCT03636893|40144641|FG000|Overall Study|Refusal to surgery|4|||
16454565|NCT03636893|40144642|FG001|Overall Study|Refusal to surgery|3|||
16454566|NCT03636893|40144641|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
16454567|NCT03636893|40144642|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
16454568|NCT03636893|40144641|FG000|Overall Study|Adverse Event|1|||
16454569|NCT03636893|40144642|FG001|Overall Study|Adverse Event|1|||
16165485|NCT01565980|39083954|FG000|Overall Study|Death|1|||
16165486|NCT01565980|39083955|FG001|Overall Study|Death|0|||
16165487|NCT01565980|39083954|FG000|Overall Study|Lost to Follow-up|1|||
16165488|NCT01565980|39083955|FG001|Overall Study|Lost to Follow-up|0|||
16165489|NCT01565980|39083954|FG000|Overall Study|health complications|1|||
16454570|NCT05366738|40144643|FG000|Overall Study|Adverse Event|0|||
16454571|NCT05366738|40144644|FG001|Overall Study|Adverse Event|1|||
16454572|NCT05366738|40144645|FG002|Overall Study|Adverse Event|0|||
16454573|NCT01026324|40144646|FG000|Follow up/Survival|Withdrawal by Subject|1|||
16454574|NCT01026324|40144647|FG001|Follow up/Survival|Withdrawal by Subject|0|||
16454575|NCT01026324|40144648|FG002|Follow up/Survival|Withdrawal by Subject|0|||
16454576|NCT00942994|40144652|FG000|Overall Study|Adverse Event|7|||
16454577|NCT00942994|40144653|FG001|Overall Study|Adverse Event|4|||
16454578|NCT00942994|40144652|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16454579|NCT00942994|40144653|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16454580|NCT00942994|40144652|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16454581|NCT00942994|40144653|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
16454582|NCT00942994|40144652|FG000|Overall Study|Patient withdrew consent|5|||
16454583|NCT00942994|40144653|FG001|Overall Study|Patient withdrew consent|8|||
16454584|NCT00942994|40144652|FG000|Overall Study|Lost to Follow-up|1|||
16454585|NCT00942994|40144653|FG001|Overall Study|Lost to Follow-up|4|||
16454586|NCT00942994|40144652|FG000|Overall Study|Protocol deviation|1|||
16454587|NCT00942994|40144653|FG001|Overall Study|Protocol deviation|2|||
16454588|NCT00441064|40144654|FG000|Overall Study|Adverse Event|1|||
16454589|NCT00441064|40144655|FG001|Overall Study|Adverse Event|0|||
16454590|NCT00441064|40144654|FG000|Overall Study|Abnormal laboratory values|0|||
16454591|NCT00441064|40144655|FG001|Overall Study|Abnormal laboratory values|2|||
16454592|NCT00441064|40144654|FG000|Overall Study|Abnormal test procedure results|0|||
16454593|NCT00441064|40144655|FG001|Overall Study|Abnormal test procedure results|1|||
16454594|NCT00441064|40144654|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16454595|NCT00441064|40144655|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16454596|NCT00441064|40144654|FG000|Overall Study|Protocol Deviation|3|||
16454597|NCT00441064|40144655|FG001|Overall Study|Protocol Deviation|2|||
16454598|NCT00441064|40144654|FG000|Overall Study|Patient withdrew consent|5|||
16454599|NCT00441064|40144655|FG001|Overall Study|Patient withdrew consent|2|||
16454600|NCT03023813|40144656|FG000|Overall Study|Lost to Follow-up|1|||
16454601|NCT03023813|40144657|FG001|Overall Study|Lost to Follow-up|2|||
16454602|NCT03023813|40144658|FG002|Overall Study|Lost to Follow-up|0|||
16454603|NCT03214666|40144659|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
16454604|NCT03214666|40144660|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
16454605|NCT03214666|40144661|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
16454606|NCT03214666|40144662|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
16454607|NCT03214666|40144663|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
16454608|NCT03214666|40144664|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
16454609|NCT00463567|40144665|FG000|Overall Study|Adverse Event|29|||
16454610|NCT00463567|40144666|FG001|Overall Study|Adverse Event|26|||
16454611|NCT00463567|40144667|FG002|Overall Study|Adverse Event|17|||
16454612|NCT00463567|40144668|FG003|Overall Study|Adverse Event|46|||
16454613|NCT00463567|40144669|FG004|Overall Study|Adverse Event|10|||
16454614|NCT00463567|40144670|FG005|Overall Study|Adverse Event|10|||
16454615|NCT00463567|40144671|FG006|Overall Study|Adverse Event|4|||
16454616|NCT00463567|40144665|FG000|Overall Study|Withdrawal by Subject|29|||
16266206|NCT00272779|39456865|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
16266207|NCT00272779|39456866|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
16266208|NCT00272779|39456865|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
16266209|NCT00272779|39456866|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
16266210|NCT00272779|39456865|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
16266211|NCT00272779|39456866|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
16266212|NCT00272779|39456865|FG000|Baseline Through Week 48|Continuing treatment|385|||
16266213|NCT00272779|39456866|FG001|Baseline Through Week 48|Continuing treatment|368|||
16266214|NCT00272779|39456865|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
16266215|NCT00272779|39456866|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
16266216|NCT00272779|39456865|FG000|Baseline Through Week 48|Never treated|2|||
16266217|NCT00272779|39456866|FG001|Baseline Through Week 48|Never treated|3|||
16266218|NCT00272779|39456865|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
16266219|NCT00272779|39456866|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
16266220|NCT00272779|39456865|FG000|Baseline Through Week 96|Death before Week 96|6|||
16266221|NCT00272779|39456866|FG001|Baseline Through Week 96|Death before Week 96|5|||
16266222|NCT00272779|39456865|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
16266223|NCT00272779|39456866|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
16266224|NCT00272779|39456865|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
16266225|NCT00272779|39456866|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
16454617|NCT00463567|40144666|FG001|Overall Study|Withdrawal by Subject|22|||
16454618|NCT00463567|40144667|FG002|Overall Study|Withdrawal by Subject|20|||
16454619|NCT00463567|40144668|FG003|Overall Study|Withdrawal by Subject|37|||
16454620|NCT00463567|40144669|FG004|Overall Study|Withdrawal by Subject|6|||
16454621|NCT00463567|40144670|FG005|Overall Study|Withdrawal by Subject|5|||
16454622|NCT00463567|40144671|FG006|Overall Study|Withdrawal by Subject|1|||
16454623|NCT00463567|40144665|FG000|Overall Study|Protocol Deviation|13|||
16454624|NCT00463567|40144666|FG001|Overall Study|Protocol Deviation|9|||
16454625|NCT00463567|40144667|FG002|Overall Study|Protocol Deviation|14|||
16266226|NCT00272779|39456865|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
16266227|NCT00272779|39456866|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
16266228|NCT00272779|39456865|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
16454626|NCT00463567|40144668|FG003|Overall Study|Protocol Deviation|11|||
16454627|NCT00463567|40144669|FG004|Overall Study|Protocol Deviation|1|||
16454628|NCT00463567|40144670|FG005|Overall Study|Protocol Deviation|1|||
16454629|NCT00463567|40144671|FG006|Overall Study|Protocol Deviation|2|||
16454630|NCT00463567|40144665|FG000|Overall Study|Lost to Follow-up|12|||
16454631|NCT00463567|40144666|FG001|Overall Study|Lost to Follow-up|6|||
16454632|NCT00463567|40144667|FG002|Overall Study|Lost to Follow-up|13|||
16266229|NCT00272779|39456866|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
16266230|NCT00272779|39456865|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
16266231|NCT00272779|39456866|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
16266232|NCT00272779|39456865|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
16266233|NCT00272779|39456866|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
16266234|NCT00272779|39456865|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
16266235|NCT00272779|39456866|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
16266236|NCT00272779|39456865|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
16266237|NCT00272779|39456866|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
16266238|NCT00272779|39456865|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
16266239|NCT00272779|39456866|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
16266240|NCT00272779|39456865|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
16266241|NCT00272779|39456866|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
16266242|NCT00272779|39456865|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
16266243|NCT00272779|39456866|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
16266244|NCT00272779|39456865|FG000|Baseline Through Week 96|Never treated|2|||
16266245|NCT00272779|39456866|FG001|Baseline Through Week 96|Never treated|3|||
16266246|NCT00272779|39456865|FG000|Baseline Through Week 96|Continuing on treatment|61|||
16266247|NCT00272779|39456866|FG001|Baseline Through Week 96|Continuing on treatment|38|||
16266248|NCT01171963|39456871|FG000|Overall Study|Adverse Event|10|||
16266249|NCT01171963|39456872|FG001|Overall Study|Adverse Event|15|||
16266250|NCT01171963|39456871|FG000|Overall Study|Lost to Follow-up|23|||
16266251|NCT01171963|39456872|FG001|Overall Study|Lost to Follow-up|24|||
16266252|NCT01171963|39456871|FG000|Overall Study|Other - diarrhoea|1|||
16266253|NCT01171963|39456872|FG001|Overall Study|Other - diarrhoea|0|||
16266254|NCT01171963|39456871|FG000|Overall Study|Withdrawal by Subject|114|||
16266255|NCT01171963|39456872|FG001|Overall Study|Withdrawal by Subject|129|||
16266256|NCT04408794|39456873|FG000|Overall Study|Adverse Event|43|||
16266257|NCT04408794|39456873|FG000|Overall Study|Infrequent study drug usage|43|||
16266258|NCT04408794|39456873|FG000|Overall Study|Lack of Efficacy|61|||
16266259|NCT04408794|39456873|FG000|Overall Study|Lost to Follow-up|33|||
16266260|NCT04408794|39456873|FG000|Overall Study|Non-compliance|6|||
16266261|NCT04408794|39456873|FG000|Overall Study|Physician Decision|1|||
16266262|NCT04408794|39456873|FG000|Overall Study|Pregnancy|6|||
16266263|NCT04408794|39456873|FG000|Overall Study|Protocol Deviation|9|||
16266264|NCT04408794|39456873|FG000|Overall Study|Sheehan-STS Result|1|||
16266265|NCT04408794|39456873|FG000|Overall Study|Withdrawal by Subject|57|||
16266266|NCT04408794|39456873|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
16266267|NCT04408794|39456873|FG000|Overall Study|Never Treated Migraine|5|||
16266268|NCT02880761|39456875|FG000|Overall Study|Death|6|||
16266269|NCT02880761|39456876|FG001|Overall Study|Death|8|||
16266270|NCT02880761|39456875|FG000|Overall Study|Withdrawal by Subject|3|||
16266271|NCT02880761|39456876|FG001|Overall Study|Withdrawal by Subject|6|||
16266272|NCT02880761|39456875|FG000|Overall Study|Protocol Violation|4|||
16266273|NCT02880761|39456876|FG001|Overall Study|Protocol Violation|3|||
16266274|NCT02880761|39456875|FG000|Overall Study|Lost to Follow-up|3|||
16266275|NCT02880761|39456876|FG001|Overall Study|Lost to Follow-up|4|||
16266276|NCT00834756|39456877|FG000|First Intervention|Adverse Event|1|||
16266277|NCT00834756|39456878|FG001|First Intervention|Adverse Event|0|||
16266278|NCT00834756|39456877|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
16266279|NCT00834756|39456878|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
16266280|NCT01929863|39456879|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
16266281|NCT01929863|39456880|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
16266282|NCT01929863|39456879|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
16266283|NCT01929863|39456880|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
16266284|NCT01929863|39456879|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
16266285|NCT01929863|39456880|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
16266286|NCT03792477|39459279|FG000|Overall Study|Adverse Event|0|||
16266287|NCT03792477|39459280|FG001|Overall Study|Adverse Event|0|||
16266288|NCT03792477|39459281|FG002|Overall Study|Adverse Event|0|||
16266289|NCT03792477|39459282|FG003|Overall Study|Adverse Event|1|||
16266290|NCT03792477|39459283|FG004|Overall Study|Adverse Event|0|||
16266291|NCT03792477|39459279|FG000|Overall Study|Lost to Follow-up|0|||
16266292|NCT03792477|39459280|FG001|Overall Study|Lost to Follow-up|0|||
16266293|NCT03792477|39459281|FG002|Overall Study|Lost to Follow-up|2|||
16266294|NCT03792477|39459282|FG003|Overall Study|Lost to Follow-up|0|||
16266295|NCT03792477|39459283|FG004|Overall Study|Lost to Follow-up|0|||
16266296|NCT03792477|39459279|FG000|Overall Study|Other|0|||
16266297|NCT03792477|39459280|FG001|Overall Study|Other|0|||
16266298|NCT03792477|39459281|FG002|Overall Study|Other|0|||
16266299|NCT03792477|39459282|FG003|Overall Study|Other|0|||
16266300|NCT03792477|39459283|FG004|Overall Study|Other|1|||
16266301|NCT00731783|39459284|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
16266302|NCT00731783|39459285|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
16266303|NCT00731783|39459284|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
16266304|NCT00731783|39459285|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
16266305|NCT00731783|39459284|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
16266306|NCT00731783|39459285|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
16266307|NCT00731783|39459284|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
16266308|NCT00731783|39459285|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
16266309|NCT03803774|39459286|FG000|Dose Escalation|Withdrawal by Subject|0|||
16266310|NCT03803774|39459287|FG001|Dose Escalation|Withdrawal by Subject|0|||
16266311|NCT03803774|39459288|FG002|Dose Escalation|Withdrawal by Subject|0|||
16266312|NCT03803774|39459289|FG003|Dose Escalation|Withdrawal by Subject|1|||
16266313|NCT03803774|39459290|FG004|Dose Escalation|Withdrawal by Subject|0|||
16266314|NCT04179032|39459293|FG000|Part B (Up to Week 52)|Adverse Event|1|||
16266315|NCT04179032|39459293|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
16266316|NCT04179032|39459293|FG000|Access Extension Phase|Ongoing|11|||
16266317|NCT04022954|39459296|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
16266318|NCT04022954|39459296|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
16266319|NCT04022954|39459296|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
16266320|NCT03769025|39459299|FG000|Overall Study|Withdrawal by Subject|1|||
16266321|NCT03769025|39459300|FG001|Overall Study|Withdrawal by Subject|1|||
16266322|NCT03769025|39459299|FG000|Overall Study|Lost to Follow-up|4|||
16266323|NCT03769025|39459300|FG001|Overall Study|Lost to Follow-up|3|||
16266324|NCT00244764|39459304|FG000|Overall Study|Adverse Event|37|||
16266325|NCT00244764|39459304|FG000|Overall Study|Lost to Follow-up|23|||
16266326|NCT00244764|39459304|FG000|Overall Study|Withdrawal by Subject|12|||
16266327|NCT00244764|39459304|FG000|Overall Study|Disease Progression|13|||
16266328|NCT00244764|39459304|FG000|Overall Study|Protocol Violation|2|||
16266329|NCT00244764|39459304|FG000|Overall Study|Death|1|||
16266330|NCT00244764|39459304|FG000|Overall Study|Off Study Medication for >21 Days|1|||
16266331|NCT00244764|39459304|FG000|Overall Study|Declining Performance Status|1|||
16266332|NCT00244764|39459304|FG000|Overall Study|Participant was Hospitalized until Death|1|||
16266333|NCT00244764|39459304|FG000|Overall Study|Primary Investigator Discretion|2|||
16266334|NCT00244764|39459304|FG000|Overall Study|Sponsor Terminated Study|2|||
16266335|NCT00244764|39459304|FG000|Overall Study|Developed Secondary Malignancy|1|||
16266336|NCT03285594|39459307|FG000|Overall Study|At the Participant's Own Request|10|||
16266337|NCT03285594|39459308|FG001|Overall Study|At the Participant's Own Request|5|||
16266338|NCT03285594|39459309|FG002|Overall Study|At the Participant's Own Request|21|||
16266339|NCT03285594|39459307|FG000|Overall Study|Adverse Event|2|||
16266340|NCT03285594|39459308|FG001|Overall Study|Adverse Event|2|||
16266341|NCT03285594|39459309|FG002|Overall Study|Adverse Event|6|||
16266342|NCT03285594|39459307|FG000|Overall Study|Poor Compliance to Protocol|0|||
16266343|NCT03285594|39459308|FG001|Overall Study|Poor Compliance to Protocol|0|||
16266344|NCT03285594|39459309|FG002|Overall Study|Poor Compliance to Protocol|1|||
16266345|NCT03285594|39459307|FG000|Overall Study|Lost to Follow-up|0|||
16266346|NCT03285594|39459308|FG001|Overall Study|Lost to Follow-up|0|||
16266347|NCT03285594|39459309|FG002|Overall Study|Lost to Follow-up|1|||
16266348|NCT03285594|39459307|FG000|Overall Study|Reason Not Specified|3|||
16266349|NCT03285594|39459308|FG001|Overall Study|Reason Not Specified|4|||
16266350|NCT03285594|39459309|FG002|Overall Study|Reason Not Specified|8|||
16266351|NCT03204539|39459311|FG000|Overall Study|Loss of funding|0|||
16266352|NCT03204539|39459312|FG001|Overall Study|Loss of funding|1|||
16266353|NCT01940341|39459315|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
16266354|NCT01940341|39459316|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
16454633|NCT00463567|40144668|FG003|Overall Study|Lost to Follow-up|8|||
16454634|NCT00463567|40144669|FG004|Overall Study|Lost to Follow-up|1|||
16454635|NCT00463567|40144670|FG005|Overall Study|Lost to Follow-up|1|||
16454636|NCT00463567|40144671|FG006|Overall Study|Lost to Follow-up|1|||
16454637|NCT00463567|40144665|FG000|Overall Study|Administrative problems|5|||
16454638|NCT00463567|40144666|FG001|Overall Study|Administrative problems|3|||
16454639|NCT00463567|40144667|FG002|Overall Study|Administrative problems|6|||
16454640|NCT00463567|40144668|FG003|Overall Study|Administrative problems|9|||
16454641|NCT00463567|40144669|FG004|Overall Study|Administrative problems|3|||
16454642|NCT00463567|40144670|FG005|Overall Study|Administrative problems|2|||
16454643|NCT00463567|40144671|FG006|Overall Study|Administrative problems|2|||
16454644|NCT00463567|40144665|FG000|Overall Study|Lack of Efficacy|4|||
16454645|NCT00463567|40144666|FG001|Overall Study|Lack of Efficacy|9|||
16454646|NCT00463567|40144667|FG002|Overall Study|Lack of Efficacy|9|||
16454647|NCT00463567|40144668|FG003|Overall Study|Lack of Efficacy|17|||
16454648|NCT00463567|40144669|FG004|Overall Study|Lack of Efficacy|1|||
16454649|NCT00463567|40144670|FG005|Overall Study|Lack of Efficacy|0|||
16454650|NCT00463567|40144671|FG006|Overall Study|Lack of Efficacy|1|||
16454651|NCT00463567|40144665|FG000|Overall Study|Abnormal lab value(s)|1|||
16454652|NCT00463567|40144666|FG001|Overall Study|Abnormal lab value(s)|1|||
16454653|NCT00463567|40144667|FG002|Overall Study|Abnormal lab value(s)|2|||
16266355|NCT01940341|39459317|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
16266356|NCT01940341|39459318|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
16454654|NCT00463567|40144668|FG003|Overall Study|Abnormal lab value(s)|1|||
16266357|NCT01940341|39459315|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
16266358|NCT01940341|39459316|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
16266359|NCT01940341|39459317|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
16266360|NCT01940341|39459318|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
16266361|NCT01940341|39459315|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
16266362|NCT01940341|39459316|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
16266363|NCT01940341|39459317|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
16266364|NCT01940341|39459318|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
16266365|NCT01940341|39459315|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
16266366|NCT01940341|39459316|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
16266367|NCT01940341|39459317|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
16266368|NCT01940341|39459318|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
16266369|NCT01940341|39459315|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
16266370|NCT01940341|39459316|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
16266371|NCT01940341|39459317|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
16266372|NCT01940341|39459318|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
16266373|NCT01940341|39459315|FG000|Period 1: Double-blind Phase|Death|0|||
16266374|NCT01940341|39459316|FG001|Period 1: Double-blind Phase|Death|1|||
16266375|NCT01940341|39459317|FG002|Period 1: Double-blind Phase|Death|0|||
16266376|NCT01940341|39459318|FG003|Period 1: Double-blind Phase|Death|0|||
16266377|NCT01940341|39459315|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
16266378|NCT01940341|39459316|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
16266379|NCT01940341|39459317|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
16266380|NCT01940341|39459318|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
16266381|NCT01940341|39459315|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
16266382|NCT01940341|39459316|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
16266383|NCT01940341|39459317|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
16266384|NCT01940341|39459318|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
16266385|NCT01940341|39459315|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
16266386|NCT01940341|39459316|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
16266387|NCT01940341|39459317|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
16266388|NCT01940341|39459318|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
16266389|NCT01940341|39459315|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
16266390|NCT01940341|39459316|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
16266391|NCT01940341|39459317|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
16266392|NCT01940341|39459318|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
16266393|NCT01940341|39459315|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
16266394|NCT01940341|39459316|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
16266395|NCT01940341|39459317|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
16266396|NCT01940341|39459318|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
16266397|NCT01940341|39459315|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
16266398|NCT01940341|39459316|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
16266399|NCT01940341|39459317|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
16266400|NCT01940341|39459318|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
16266401|NCT01940341|39459315|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
16266402|NCT01940341|39459316|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
16266403|NCT01940341|39459317|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
16266404|NCT01940341|39459318|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
16266405|NCT01940341|39459315|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
16266406|NCT01940341|39459316|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
16266407|NCT01940341|39459317|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
16266408|NCT01940341|39459318|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
16266409|NCT01940341|39459315|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
16266410|NCT01940341|39459316|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
16266411|NCT01940341|39459317|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
16266412|NCT01940341|39459318|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
16266413|NCT01940341|39459315|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
16266414|NCT01940341|39459316|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
16266415|NCT01940341|39459317|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
16266416|NCT01940341|39459318|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
16266417|NCT01940341|39459315|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
16266418|NCT01940341|39459316|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
16266419|NCT01940341|39459317|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
16454655|NCT00463567|40144669|FG004|Overall Study|Abnormal lab value(s)|1|||
16266420|NCT01940341|39459318|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
16266421|NCT01940341|39459315|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
16266422|NCT01940341|39459316|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
16266423|NCT01940341|39459317|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
16266424|NCT01940341|39459318|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
16266425|NCT01940341|39459315|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
16266426|NCT01940341|39459316|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
16266427|NCT01940341|39459317|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
16165490|NCT01565980|39083955|FG001|Overall Study|health complications|1|||
16165491|NCT01565980|39083954|FG000|Overall Study|stopped medical treatment|1|||
16165492|NCT01565980|39083955|FG001|Overall Study|stopped medical treatment|0|||
16165493|NCT01565980|39083954|FG000|Overall Study|Withdrawal by Subject|0|||
16165494|NCT01565980|39083955|FG001|Overall Study|Withdrawal by Subject|3|||
16165495|NCT00666926|39083956|FG000|Overall Study|Adverse Event|0|||
16165496|NCT00666926|39083957|FG001|Overall Study|Adverse Event|0|||
16165497|NCT00666926|39083958|FG002|Overall Study|Adverse Event|0|||
16165498|NCT00666926|39083959|FG003|Overall Study|Adverse Event|0|||
16165499|NCT00666926|39083960|FG004|Overall Study|Adverse Event|0|||
16165500|NCT00666926|39083961|FG005|Overall Study|Adverse Event|0|||
16165501|NCT00666926|39083962|FG006|Overall Study|Adverse Event|0|||
16165502|NCT00666926|39083963|FG007|Overall Study|Adverse Event|0|||
16165503|NCT00666926|39083964|FG008|Overall Study|Adverse Event|0|||
16165504|NCT00666926|39083965|FG009|Overall Study|Adverse Event|2|||
16165505|NCT00666926|39083966|FG010|Overall Study|Adverse Event|2|||
16165506|NCT00666926|39083967|FG011|Overall Study|Adverse Event|2|||
16165507|NCT00666926|39083968|FG012|Overall Study|Adverse Event|0|||
16165508|NCT00666926|39083969|FG013|Overall Study|Adverse Event|1|||
16165509|NCT00666926|39083970|FG014|Overall Study|Adverse Event|0|||
16165510|NCT00666926|39083971|FG015|Overall Study|Adverse Event|0|||
16165511|NCT00666926|39083956|FG000|Overall Study|Laboratory abnormality|0|||
16165512|NCT00666926|39083957|FG001|Overall Study|Laboratory abnormality|0|||
16165513|NCT00666926|39083958|FG002|Overall Study|Laboratory abnormality|0|||
16165514|NCT00666926|39083959|FG003|Overall Study|Laboratory abnormality|0|||
16165515|NCT00666926|39083960|FG004|Overall Study|Laboratory abnormality|0|||
16165516|NCT00666926|39083961|FG005|Overall Study|Laboratory abnormality|0|||
16165517|NCT00666926|39083962|FG006|Overall Study|Laboratory abnormality|0|||
16165518|NCT00666926|39083963|FG007|Overall Study|Laboratory abnormality|0|||
16165519|NCT00666926|39083964|FG008|Overall Study|Laboratory abnormality|0|||
16165520|NCT00666926|39083965|FG009|Overall Study|Laboratory abnormality|0|||
16165521|NCT00666926|39083966|FG010|Overall Study|Laboratory abnormality|1|||
16165522|NCT00666926|39083967|FG011|Overall Study|Laboratory abnormality|0|||
16165523|NCT00666926|39083968|FG012|Overall Study|Laboratory abnormality|0|||
16165524|NCT00666926|39083969|FG013|Overall Study|Laboratory abnormality|0|||
16165525|NCT00666926|39083970|FG014|Overall Study|Laboratory abnormality|0|||
16165526|NCT00666926|39083971|FG015|Overall Study|Laboratory abnormality|1|||
16165527|NCT00666926|39083956|FG000|Overall Study|Lack of Efficacy|0|||
16165528|NCT00666926|39083957|FG001|Overall Study|Lack of Efficacy|0|||
16165529|NCT00666926|39083958|FG002|Overall Study|Lack of Efficacy|0|||
16165530|NCT00666926|39083959|FG003|Overall Study|Lack of Efficacy|0|||
16165531|NCT00666926|39083960|FG004|Overall Study|Lack of Efficacy|0|||
16165532|NCT00666926|39083961|FG005|Overall Study|Lack of Efficacy|1|||
16165533|NCT00666926|39083962|FG006|Overall Study|Lack of Efficacy|0|||
16165534|NCT00666926|39083963|FG007|Overall Study|Lack of Efficacy|0|||
16165535|NCT00666926|39083964|FG008|Overall Study|Lack of Efficacy|0|||
16165536|NCT00666926|39083965|FG009|Overall Study|Lack of Efficacy|0|||
16165537|NCT00666926|39083966|FG010|Overall Study|Lack of Efficacy|0|||
16165538|NCT00666926|39083967|FG011|Overall Study|Lack of Efficacy|1|||
16165539|NCT00666926|39083968|FG012|Overall Study|Lack of Efficacy|0|||
16165540|NCT00666926|39083969|FG013|Overall Study|Lack of Efficacy|0|||
16165541|NCT00666926|39083970|FG014|Overall Study|Lack of Efficacy|0|||
16165542|NCT00666926|39083971|FG015|Overall Study|Lack of Efficacy|0|||
16165543|NCT00666926|39083956|FG000|Overall Study|Lost to Follow-up|0|||
16165544|NCT00666926|39083957|FG001|Overall Study|Lost to Follow-up|0|||
16165545|NCT00666926|39083958|FG002|Overall Study|Lost to Follow-up|0|||
16165546|NCT00666926|39083959|FG003|Overall Study|Lost to Follow-up|1|||
16165547|NCT00666926|39083960|FG004|Overall Study|Lost to Follow-up|0|||
16165548|NCT00666926|39083961|FG005|Overall Study|Lost to Follow-up|0|||
16165549|NCT00666926|39083962|FG006|Overall Study|Lost to Follow-up|0|||
16165550|NCT00666926|39083963|FG007|Overall Study|Lost to Follow-up|0|||
16165551|NCT00666926|39083964|FG008|Overall Study|Lost to Follow-up|0|||
16165552|NCT00666926|39083965|FG009|Overall Study|Lost to Follow-up|0|||
16165553|NCT00666926|39083966|FG010|Overall Study|Lost to Follow-up|0|||
16165554|NCT00666926|39083967|FG011|Overall Study|Lost to Follow-up|0|||
16165555|NCT00666926|39083968|FG012|Overall Study|Lost to Follow-up|0|||
16165556|NCT00666926|39083969|FG013|Overall Study|Lost to Follow-up|0|||
16165557|NCT00666926|39083970|FG014|Overall Study|Lost to Follow-up|0|||
16165558|NCT00666926|39083971|FG015|Overall Study|Lost to Follow-up|0|||
16165559|NCT00666926|39083956|FG000|Overall Study|Other|2|||
16165560|NCT00666926|39083957|FG001|Overall Study|Other|4|||
16165561|NCT00666926|39083958|FG002|Overall Study|Other|3|||
16165562|NCT00666926|39083959|FG003|Overall Study|Other|3|||
16165563|NCT00666926|39083960|FG004|Overall Study|Other|3|||
16165564|NCT00666926|39083961|FG005|Overall Study|Other|3|||
16165565|NCT00666926|39083962|FG006|Overall Study|Other|4|||
16165566|NCT00666926|39083963|FG007|Overall Study|Other|0|||
16165567|NCT00666926|39083964|FG008|Overall Study|Other|3|||
16165568|NCT00666926|39083965|FG009|Overall Study|Other|5|||
16165569|NCT00666926|39083966|FG010|Overall Study|Other|3|||
16165570|NCT00666926|39083967|FG011|Overall Study|Other|26|||
16165571|NCT00666926|39083968|FG012|Overall Study|Other|3|||
16165572|NCT00666926|39083969|FG013|Overall Study|Other|2|||
16165573|NCT00666926|39083970|FG014|Overall Study|Other|4|||
16165574|NCT00666926|39083971|FG015|Overall Study|Other|4|||
16165575|NCT00666926|39083956|FG000|Overall Study|Withdrawal by Subject|0|||
16165576|NCT00666926|39083957|FG001|Overall Study|Withdrawal by Subject|0|||
16165577|NCT00666926|39083958|FG002|Overall Study|Withdrawal by Subject|0|||
16165578|NCT00666926|39083959|FG003|Overall Study|Withdrawal by Subject|0|||
16165579|NCT00666926|39083960|FG004|Overall Study|Withdrawal by Subject|0|||
16165580|NCT00666926|39083961|FG005|Overall Study|Withdrawal by Subject|0|||
16165581|NCT00666926|39083962|FG006|Overall Study|Withdrawal by Subject|0|||
16165582|NCT00666926|39083963|FG007|Overall Study|Withdrawal by Subject|1|||
16165583|NCT00666926|39083964|FG008|Overall Study|Withdrawal by Subject|0|||
16165584|NCT00666926|39083965|FG009|Overall Study|Withdrawal by Subject|3|||
16165585|NCT00666926|39083966|FG010|Overall Study|Withdrawal by Subject|0|||
16165586|NCT00666926|39083967|FG011|Overall Study|Withdrawal by Subject|3|||
16165587|NCT00666926|39083968|FG012|Overall Study|Withdrawal by Subject|0|||
16165588|NCT00666926|39083969|FG013|Overall Study|Withdrawal by Subject|1|||
16165589|NCT00666926|39083970|FG014|Overall Study|Withdrawal by Subject|3|||
16165590|NCT00666926|39083971|FG015|Overall Study|Withdrawal by Subject|3|||
16165591|NCT00666926|39083956|FG000|Overall Study|Death|0|||
16165592|NCT00666926|39083957|FG001|Overall Study|Death|0|||
16165593|NCT00666926|39083958|FG002|Overall Study|Death|0|||
16165594|NCT00666926|39083959|FG003|Overall Study|Death|0|||
16165595|NCT00666926|39083960|FG004|Overall Study|Death|0|||
16165596|NCT00666926|39083961|FG005|Overall Study|Death|0|||
16165597|NCT00666926|39083962|FG006|Overall Study|Death|0|||
16165598|NCT00666926|39083963|FG007|Overall Study|Death|0|||
16165599|NCT00666926|39083964|FG008|Overall Study|Death|0|||
16165600|NCT00666926|39083965|FG009|Overall Study|Death|0|||
16165601|NCT00666926|39083966|FG010|Overall Study|Death|0|||
16165602|NCT00666926|39083967|FG011|Overall Study|Death|1|||
16165603|NCT00666926|39083968|FG012|Overall Study|Death|0|||
16165604|NCT00666926|39083969|FG013|Overall Study|Death|0|||
16165605|NCT00666926|39083970|FG014|Overall Study|Death|0|||
16165606|NCT00666926|39083971|FG015|Overall Study|Death|0|||
16165607|NCT03980938|39083972|FG000|Treatment Period 1|Study Terminated|1|||
16165608|NCT03980938|39083973|FG001|Treatment Period 1|Study Terminated|1|||
16165609|NCT03980938|39083972|FG000|Treatment Period 2|Study Terminated|2|||
16165610|NCT03980938|39083973|FG001|Treatment Period 2|Study Terminated|2|||
16165611|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
16165612|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
16165613|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
16165614|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
16165615|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
16165616|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
16165617|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
16266428|NCT01940341|39459318|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
16266429|NCT02075463|39459319|FG000|Overall Study|Adverse Event|3|||
16266430|NCT02075463|39459319|FG000|Overall Study|Par. reached stopping criteria|4|||
16266431|NCT02075463|39459319|FG000|Overall Study|Withdrawal by Subject|1|||
16266432|NCT02760927|39459326|FG000|Overall Study|Tube Slippage from Device|1|||
16266433|NCT01948258|39459327|FG000|Overall Study|Pregnancy|41|||
16266434|NCT01948258|39459327|FG000|Overall Study|Did not complete by cut-off date|35|||
16266435|NCT01948258|39459327|FG000|Overall Study|Lost to Follow-up|27|||
16266436|NCT01948258|39459327|FG000|Overall Study|Withdrawal by SPD|8|||
16165618|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
16165619|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
16266437|NCT01948258|39459327|FG000|Overall Study|Withdrawal by Subject|6|||
16165620|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
16165621|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
16165622|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
16165623|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
16266438|NCT01948258|39459327|FG000|Overall Study|Health Care Professional|43|||
16266439|NCT01948258|39459327|FG000|Overall Study|Removed from statistical analysis|2|||
16266440|NCT02588339|39459328|FG000|Overall Study|Withdrawal by Subject|1|||
16266441|NCT02588339|39459328|FG000|Overall Study|GVHD Progression prior to treatment|2|||
16266442|NCT00840203|39459333|FG000|First Intervention|Protocol Violation|1|||
16266443|NCT00840203|39459334|FG001|First Intervention|Protocol Violation|1|||
16266444|NCT00840203|39459333|FG000|Washout|Protocol Violation|1|||
16266445|NCT00840203|39459334|FG001|Washout|Protocol Violation|0|||
16266446|NCT02378935|39459335|FG000|Overall Study|Lack of Efficacy|10|||
16266447|NCT02378935|39459336|FG001|Overall Study|Lack of Efficacy|0|||
16266448|NCT02378935|39459337|FG002|Overall Study|Lack of Efficacy|2|||
16266449|NCT02378935|39459338|FG003|Overall Study|Lack of Efficacy|6|||
16266450|NCT02378935|39459339|FG004|Overall Study|Lack of Efficacy|0|||
16266451|NCT02378935|39459340|FG005|Overall Study|Lack of Efficacy|0|||
16266452|NCT02378935|39459341|FG006|Overall Study|Lack of Efficacy|0|||
16266453|NCT02378935|39459335|FG000|Overall Study|Death|0|||
16266454|NCT02378935|39459336|FG001|Overall Study|Death|0|||
16266455|NCT02378935|39459337|FG002|Overall Study|Death|1|||
16266456|NCT02378935|39459338|FG003|Overall Study|Death|0|||
16266457|NCT02378935|39459339|FG004|Overall Study|Death|0|||
16266458|NCT02378935|39459340|FG005|Overall Study|Death|0|||
16266459|NCT02378935|39459341|FG006|Overall Study|Death|0|||
16266460|NCT01466166|39459344|FG000|Overall Study|Death|1|||
16266461|NCT01466166|39459344|FG000|Overall Study|Lost to Follow-up|7|||
16266462|NCT01466166|39459344|FG000|Overall Study|Infusion Reaction (IR)|27|||
16266463|NCT01466166|39459344|FG000|Overall Study|Adverse Event (Other than IR)|11|||
16266464|NCT01466166|39459344|FG000|Overall Study|Elevated Serum Uric Acid|78|||
16266465|NCT01466166|39459344|FG000|Overall Study|Withdrawal by Subject|13|||
16266466|NCT01466166|39459344|FG000|Overall Study|Sponsor Decision|4|||
16266467|NCT01466166|39459344|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
16266468|NCT01466166|39459344|FG000|Overall Study|Other|20|||
16266469|NCT03447353|39459350|FG000|Overall Study|Failure at Screening Visit|2|||
16266470|NCT03447353|39459350|FG000|Overall Study|Lost to Follow-up|4|||
16266471|NCT03447353|39459350|FG000|Overall Study|Scheduling Conflicts|3|||
16266472|NCT03447353|39459350|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
16266473|NCT01527006|39459355|FG000|Core Study|Adverse Event|0|||
16266474|NCT01527006|39459356|FG001|Core Study|Adverse Event|2|||
16266475|NCT01527006|39459355|FG000|Core Study|Lost to Follow-up|0|||
16266476|NCT01527006|39459356|FG001|Core Study|Lost to Follow-up|1|||
16266477|NCT01527006|39459355|FG000|Core Study|Subject Choice|1|||
16266478|NCT01527006|39459356|FG001|Core Study|Subject Choice|0|||
16266479|NCT01527006|39459355|FG000|Core Study|Inadequate Therapeutic Effect|1|||
16266480|NCT01527006|39459356|FG001|Core Study|Inadequate Therapeutic Effect|0|||
16266481|NCT01527006|39459355|FG000|Core Study|Withdrawal by Subject|0|||
16266482|NCT01527006|39459356|FG001|Core Study|Withdrawal by Subject|1|||
16266483|NCT01527006|39459355|FG000|Core Study|Other|0|||
16266484|NCT01527006|39459356|FG001|Core Study|Other|2|||
16266485|NCT01527006|39459355|FG000|Extension Phase|Adverse Event|4|||
16266486|NCT01527006|39459356|FG001|Extension Phase|Adverse Event|2|||
16266487|NCT01527006|39459355|FG000|Extension Phase|Lost to Follow-up|0|||
16266488|NCT01527006|39459356|FG001|Extension Phase|Lost to Follow-up|1|||
16266489|NCT01527006|39459355|FG000|Extension Phase|Subject Choice|1|||
16266490|NCT01527006|39459356|FG001|Extension Phase|Subject Choice|1|||
16266491|NCT01527006|39459355|FG000|Extension Phase|Inadequate therapeutic effect|1|||
16266492|NCT01527006|39459356|FG001|Extension Phase|Inadequate therapeutic effect|1|||
16266493|NCT01527006|39459355|FG000|Extension Phase|Other|0|||
16266494|NCT01527006|39459356|FG001|Extension Phase|Other|3|||
16266495|NCT03138967|39459358|FG000|Overall Study|Death|0|||
16266496|NCT03138967|39459359|FG001|Overall Study|Death|1|||
16266497|NCT03138967|39459358|FG000|Overall Study|Physician Decision|1|||
16266498|NCT03138967|39459359|FG001|Overall Study|Physician Decision|3|||
16266499|NCT03238781|39459360|FG000|Overall Study|Adverse Event|1|||
16266500|NCT03238781|39459361|FG001|Overall Study|Adverse Event|1|||
16266501|NCT03238781|39459362|FG002|Overall Study|Adverse Event|2|||
16266502|NCT03238781|39459360|FG000|Overall Study|Lost to Follow-up|2|||
16454656|NCT00463567|40144670|FG005|Overall Study|Abnormal lab value(s)|0|||
16266503|NCT03238781|39459361|FG001|Overall Study|Lost to Follow-up|1|||
16266504|NCT03238781|39459362|FG002|Overall Study|Lost to Follow-up|2|||
16266505|NCT03238781|39459360|FG000|Overall Study|Withdrawal by Subject|23|||
16266506|NCT03238781|39459361|FG001|Overall Study|Withdrawal by Subject|14|||
16266507|NCT03238781|39459362|FG002|Overall Study|Withdrawal by Subject|16|||
16266508|NCT03238781|39459360|FG000|Overall Study|Decision by sponsor|0|||
16266509|NCT03238781|39459361|FG001|Overall Study|Decision by sponsor|1|||
16266510|NCT03238781|39459362|FG002|Overall Study|Decision by sponsor|0|||
16266511|NCT02157974|39459363|FG000|Overall Study|Withdrawal by Subject|0|||
16266512|NCT02157974|39459364|FG001|Overall Study|Withdrawal by Subject|1|||
16266513|NCT02157974|39459365|FG002|Overall Study|Withdrawal by Subject|0|||
16266514|NCT02157974|39459366|FG003|Overall Study|Withdrawal by Subject|0|||
16266515|NCT02157974|39459367|FG004|Overall Study|Withdrawal by Subject|0|||
16266516|NCT02157974|39459363|FG000|Overall Study|Screen Failure|0|||
16266517|NCT02157974|39459364|FG001|Overall Study|Screen Failure|1|||
16266518|NCT02157974|39459365|FG002|Overall Study|Screen Failure|0|||
16266519|NCT02157974|39459366|FG003|Overall Study|Screen Failure|0|||
16266520|NCT02157974|39459367|FG004|Overall Study|Screen Failure|0|||
16266521|NCT02157974|39459363|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
16266522|NCT02157974|39459364|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
16266523|NCT02157974|39459365|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
16266524|NCT02157974|39459366|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
16266525|NCT02157974|39459367|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
16266526|NCT00906399|39459370|FG000|Year 1|Randomized But Not Treated|0|||
16266527|NCT00906399|39459371|FG001|Year 1|Randomized But Not Treated|1|||
16266528|NCT00906399|39459372|FG002|Year 1|Randomized But Not Treated|3|||
16266529|NCT00906399|39459373|FG003|Year 1|Randomized But Not Treated|0|||
16266530|NCT00906399|39459374|FG004|Year 1|Randomized But Not Treated|0|||
16266531|NCT00906399|39459375|FG005|Year 1|Randomized But Not Treated|0|||
16266532|NCT00906399|39459376|FG006|Year 1|Randomized But Not Treated|0|||
16266533|NCT00906399|39459370|FG000|Year 1|Adverse Event|4|||
16266534|NCT00906399|39459371|FG001|Year 1|Adverse Event|22|||
16266535|NCT00906399|39459372|FG002|Year 1|Adverse Event|24|||
16266536|NCT00906399|39459373|FG003|Year 1|Adverse Event|0|||
16266537|NCT00906399|39459374|FG004|Year 1|Adverse Event|0|||
16266538|NCT00906399|39459375|FG005|Year 1|Adverse Event|0|||
16266539|NCT00906399|39459376|FG006|Year 1|Adverse Event|0|||
16266540|NCT00906399|39459370|FG000|Year 1|Lost to Follow-up|4|||
16266541|NCT00906399|39459371|FG001|Year 1|Lost to Follow-up|4|||
16266542|NCT00906399|39459372|FG002|Year 1|Lost to Follow-up|2|||
16266543|NCT00906399|39459373|FG003|Year 1|Lost to Follow-up|0|||
16266544|NCT00906399|39459374|FG004|Year 1|Lost to Follow-up|0|||
16266545|NCT00906399|39459375|FG005|Year 1|Lost to Follow-up|0|||
16266546|NCT00906399|39459376|FG006|Year 1|Lost to Follow-up|0|||
16266547|NCT00906399|39459370|FG000|Year 1|Withdrawal by Subject|30|||
16266548|NCT00906399|39459371|FG001|Year 1|Withdrawal by Subject|32|||
16266549|NCT00906399|39459372|FG002|Year 1|Withdrawal by Subject|36|||
16266550|NCT00906399|39459373|FG003|Year 1|Withdrawal by Subject|0|||
16266551|NCT00906399|39459374|FG004|Year 1|Withdrawal by Subject|0|||
16266552|NCT00906399|39459375|FG005|Year 1|Withdrawal by Subject|0|||
16266553|NCT00906399|39459376|FG006|Year 1|Withdrawal by Subject|0|||
16266554|NCT00906399|39459370|FG000|Year 1|Physician Decision|0|||
16266555|NCT00906399|39459371|FG001|Year 1|Physician Decision|1|||
16266556|NCT00906399|39459372|FG002|Year 1|Physician Decision|3|||
16266557|NCT00906399|39459373|FG003|Year 1|Physician Decision|0|||
16266558|NCT00906399|39459374|FG004|Year 1|Physician Decision|0|||
16266559|NCT00906399|39459375|FG005|Year 1|Physician Decision|0|||
16266560|NCT00906399|39459376|FG006|Year 1|Physician Decision|0|||
16266561|NCT00906399|39459370|FG000|Year 1|Death|2|||
16266562|NCT00906399|39459371|FG001|Year 1|Death|1|||
16266563|NCT00906399|39459372|FG002|Year 1|Death|1|||
16266564|NCT00906399|39459373|FG003|Year 1|Death|0|||
16266565|NCT00906399|39459374|FG004|Year 1|Death|0|||
16266566|NCT00906399|39459375|FG005|Year 1|Death|0|||
16266567|NCT00906399|39459376|FG006|Year 1|Death|0|||
16266568|NCT00906399|39459370|FG000|Year 1|Other|4|||
16266569|NCT00906399|39459371|FG001|Year 1|Other|2|||
16266570|NCT00906399|39459372|FG002|Year 1|Other|7|||
16266571|NCT00906399|39459373|FG003|Year 1|Other|0|||
16266572|NCT00906399|39459374|FG004|Year 1|Other|0|||
16266573|NCT00906399|39459375|FG005|Year 1|Other|0|||
16266574|NCT00906399|39459376|FG006|Year 1|Other|0|||
16266575|NCT00906399|39459370|FG000|Year 2|Adverse Event|0|||
16072662|NCT01467700|38756418|FG000|Overall Study|Voluntary Withdrawal|5|||
16072663|NCT01467700|38756419|FG001|Overall Study|Voluntary Withdrawal|7|||
16072664|NCT01467700|38756420|FG002|Overall Study|Voluntary Withdrawal|6|||
16072665|NCT01467700|38756421|FG003|Overall Study|Voluntary Withdrawal|2|||
16072666|NCT01467700|38756418|FG000|Overall Study|Study Termination|6|||
16072667|NCT01467700|38756419|FG001|Overall Study|Study Termination|5|||
16072668|NCT01467700|38756420|FG002|Overall Study|Study Termination|10|||
16072669|NCT01467700|38756421|FG003|Overall Study|Study Termination|7|||
16266576|NCT00906399|39459371|FG001|Year 2|Adverse Event|0|||
16266577|NCT00906399|39459372|FG002|Year 2|Adverse Event|0|||
16266578|NCT00906399|39459373|FG003|Year 2|Adverse Event|9|||
16266579|NCT00906399|39459374|FG004|Year 2|Adverse Event|8|||
16266580|NCT00906399|39459375|FG005|Year 2|Adverse Event|11|||
16266581|NCT00906399|39459376|FG006|Year 2|Adverse Event|6|||
16266582|NCT00906399|39459370|FG000|Year 2|Lost to Follow-up|0|||
16266583|NCT00906399|39459371|FG001|Year 2|Lost to Follow-up|0|||
16266584|NCT00906399|39459372|FG002|Year 2|Lost to Follow-up|0|||
16266585|NCT00906399|39459373|FG003|Year 2|Lost to Follow-up|1|||
16266586|NCT00906399|39459374|FG004|Year 2|Lost to Follow-up|4|||
16266587|NCT00906399|39459375|FG005|Year 2|Lost to Follow-up|2|||
16266588|NCT00906399|39459376|FG006|Year 2|Lost to Follow-up|4|||
16266589|NCT00906399|39459370|FG000|Year 2|Withdrawal by Subject|0|||
16266590|NCT00906399|39459371|FG001|Year 2|Withdrawal by Subject|0|||
16266591|NCT00906399|39459372|FG002|Year 2|Withdrawal by Subject|0|||
16266592|NCT00906399|39459373|FG003|Year 2|Withdrawal by Subject|17|||
16266593|NCT00906399|39459374|FG004|Year 2|Withdrawal by Subject|18|||
16266594|NCT00906399|39459375|FG005|Year 2|Withdrawal by Subject|27|||
16266595|NCT00906399|39459376|FG006|Year 2|Withdrawal by Subject|13|||
16266596|NCT00906399|39459370|FG000|Year 2|Physician Decision|0|||
16266597|NCT00906399|39459371|FG001|Year 2|Physician Decision|0|||
16266598|NCT00906399|39459372|FG002|Year 2|Physician Decision|0|||
16266599|NCT00906399|39459373|FG003|Year 2|Physician Decision|0|||
16266600|NCT00906399|39459374|FG004|Year 2|Physician Decision|2|||
16165624|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
16165625|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
16165626|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
16165627|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
16165628|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
16165629|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
16165630|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
16165631|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
16165632|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
16165633|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
16165634|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
16165635|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Death|2|||
16165636|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Death|1|||
16165637|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Death|2|||
16165638|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Graft loss|0|||
16165639|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Graft loss|2|||
16165640|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Graft loss|0|||
16165641|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
16165642|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
16165643|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
16165644|NCT01114529|39083974|FG000|Completed Study Medication at Month 24|Missing|2|||
16165645|NCT01114529|39083975|FG001|Completed Study Medication at Month 24|Missing|0|||
16165646|NCT01114529|39083976|FG002|Completed Study Medication at Month 24|Missing|0|||
16165647|NCT01114529|39083974|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
16165648|NCT01114529|39083975|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
16165649|NCT01114529|39083976|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
16165650|NCT01114529|39083974|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
16165651|NCT01114529|39083975|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
16165652|NCT01114529|39083976|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
16165653|NCT01114529|39083974|FG000|Completed Study Phase at Month 24|Death|8|||
16165654|NCT01114529|39083975|FG001|Completed Study Phase at Month 24|Death|5|||
16165655|NCT01114529|39083976|FG002|Completed Study Phase at Month 24|Death|4|||
16165656|NCT01114529|39083974|FG000|Completed Study Phase at Month 24|Other|2|||
16165657|NCT01114529|39083975|FG001|Completed Study Phase at Month 24|Other|0|||
16165658|NCT01114529|39083976|FG002|Completed Study Phase at Month 24|Other|0|||
16165659|NCT01114529|39083974|FG000|Completed Study Phase at Month 24|Missing|2|||
16165660|NCT01114529|39083975|FG001|Completed Study Phase at Month 24|Missing|0|||
16165661|NCT01114529|39083976|FG002|Completed Study Phase at Month 24|Missing|0|||
16165662|NCT03370770|39083977|FG000|Overall Study|Patient was followed in another hospital center|1|||
16165663|NCT03370770|39083977|FG000|Overall Study|Progressive Disease|98|||
16165664|NCT03370770|39083977|FG000|Overall Study|Adverse Event|2|||
16165665|NCT03370770|39083977|FG000|Overall Study|Death|5|||
16165666|NCT02769624|39083982|FG000|Overall Study|Lost to Follow-up|0|||
16165667|NCT02769624|39083983|FG001|Overall Study|Lost to Follow-up|1|||
16165668|NCT00094757|39083984|FG000|Overall Study|Adverse Event|11|||
16165669|NCT00094757|39083985|FG001|Overall Study|Adverse Event|9|||
16165670|NCT00094757|39083986|FG002|Overall Study|Adverse Event|6|||
16165671|NCT00094757|39083984|FG000|Overall Study|Lack of Efficacy|11|||
16165672|NCT00094757|39083985|FG001|Overall Study|Lack of Efficacy|15|||
16165673|NCT00094757|39083986|FG002|Overall Study|Lack of Efficacy|8|||
16165674|NCT00094757|39083984|FG000|Overall Study|Lost to Follow-up|3|||
16165675|NCT00094757|39083985|FG001|Overall Study|Lost to Follow-up|5|||
16165676|NCT00094757|39083986|FG002|Overall Study|Lost to Follow-up|6|||
16165677|NCT00094757|39083984|FG000|Overall Study|Patient Moved|2|||
16165678|NCT00094757|39083985|FG001|Overall Study|Patient Moved|1|||
16266601|NCT00906399|39459375|FG005|Year 2|Physician Decision|6|||
16266602|NCT00906399|39459376|FG006|Year 2|Physician Decision|3|||
16266603|NCT00906399|39459370|FG000|Year 2|Death|0|||
16266604|NCT00906399|39459371|FG001|Year 2|Death|0|||
16165679|NCT00094757|39083986|FG002|Overall Study|Patient Moved|1|||
16165680|NCT00094757|39083984|FG000|Overall Study|Protocol Violation|8|||
16165681|NCT00094757|39083985|FG001|Overall Study|Protocol Violation|5|||
16165682|NCT00094757|39083986|FG002|Overall Study|Protocol Violation|3|||
16165683|NCT00094757|39083984|FG000|Overall Study|Withdrawal by Subject|14|||
16266605|NCT00906399|39459372|FG002|Year 2|Death|0|||
16266606|NCT00906399|39459373|FG003|Year 2|Death|1|||
16266607|NCT00906399|39459374|FG004|Year 2|Death|0|||
16266608|NCT00906399|39459375|FG005|Year 2|Death|0|||
16266609|NCT00906399|39459376|FG006|Year 2|Death|3|||
16165684|NCT00094757|39083985|FG001|Overall Study|Withdrawal by Subject|21|||
16165685|NCT00094757|39083986|FG002|Overall Study|Withdrawal by Subject|5|||
16165686|NCT00094757|39083984|FG000|Overall Study|Other|3|||
16165687|NCT00094757|39083985|FG001|Overall Study|Other|3|||
16165688|NCT00094757|39083986|FG002|Overall Study|Other|1|||
16165689|NCT00094757|39083984|FG000|Overall Study|Protocol specified discontinuation|1|||
16165690|NCT00094757|39083985|FG001|Overall Study|Protocol specified discontinuation|3|||
16165691|NCT00094757|39083986|FG002|Overall Study|Protocol specified discontinuation|0|||
16165692|NCT00132730|39083988|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
16165693|NCT00132730|39083989|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
16165694|NCT00132730|39083990|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
16165695|NCT00132730|39083991|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
16165696|NCT00132730|39083992|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
16165697|NCT00132730|39083993|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
16165698|NCT00132730|39083988|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
16165699|NCT00132730|39083989|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
16165700|NCT00132730|39083990|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
16165701|NCT00132730|39083991|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
16165702|NCT00132730|39083992|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
16165703|NCT00132730|39083993|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
16165704|NCT00132730|39083988|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
16165705|NCT00132730|39083989|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
16165706|NCT00132730|39083990|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
16165707|NCT00132730|39083991|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
16165708|NCT00132730|39083992|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
16165709|NCT00132730|39083993|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
16165710|NCT00132730|39083988|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
16165711|NCT00132730|39083989|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
16165712|NCT00132730|39083990|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
16165713|NCT00132730|39083991|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
16165714|NCT00132730|39083992|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
16165715|NCT00132730|39083993|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
16165716|NCT00132730|39083988|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
16165717|NCT00132730|39083989|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
16165718|NCT00132730|39083990|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
16165719|NCT00132730|39083991|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
16165720|NCT00132730|39083992|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
16165721|NCT00132730|39083993|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
16165722|NCT00132730|39083988|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
16165723|NCT00132730|39083989|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
16165724|NCT00132730|39083990|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
16165725|NCT00132730|39083991|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
16165726|NCT00132730|39083992|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
16165727|NCT00132730|39083993|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
16165728|NCT00132730|39083988|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
16165729|NCT00132730|39083989|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
16165730|NCT00132730|39083990|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
16165731|NCT00132730|39083991|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
16165732|NCT00132730|39083992|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
16165733|NCT00132730|39083993|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
16165734|NCT00132730|39083988|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
16165735|NCT00132730|39083989|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
16165736|NCT00132730|39083990|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
16165737|NCT00132730|39083991|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
16165738|NCT00132730|39083992|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
16165739|NCT00132730|39083993|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
16165740|NCT00132730|39083988|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
16165741|NCT00132730|39083989|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
16165742|NCT00132730|39083990|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
16165743|NCT00132730|39083991|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
16165744|NCT00132730|39083992|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
16165745|NCT00132730|39083993|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
16165746|NCT00132730|39083988|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
16266610|NCT00906399|39459370|FG000|Year 2|Other|0|||
16165747|NCT00132730|39083989|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
16165748|NCT00132730|39083990|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
16165749|NCT00132730|39083991|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
16165750|NCT00132730|39083992|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
16165751|NCT00132730|39083993|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
16165752|NCT00132730|39083988|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
16165753|NCT00132730|39083989|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
16165754|NCT00132730|39083990|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
16165755|NCT00132730|39083991|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
16165756|NCT00132730|39083992|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
16165757|NCT00132730|39083993|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
16165758|NCT00132730|39083988|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
16165759|NCT00132730|39083989|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
16165760|NCT00132730|39083990|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
16165761|NCT00132730|39083991|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
16165762|NCT00132730|39083992|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
16165763|NCT00132730|39083993|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
16165764|NCT00090545|39083994|FG000|Overall Study|Disease progression on study|21|||
16165765|NCT00090545|39083995|FG001|Overall Study|Disease progression on study|17|||
16454657|NCT00463567|40144671|FG006|Overall Study|Abnormal lab value(s)|0|||
16454658|NCT00463567|40144665|FG000|Overall Study|Abnormal test procedure result(s)|1|||
16454659|NCT00463567|40144666|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16454660|NCT00463567|40144667|FG002|Overall Study|Abnormal test procedure result(s)|6|||
16165766|NCT00090545|39083994|FG000|Overall Study|Refused further treatment|1|||
16165767|NCT00090545|39083995|FG001|Overall Study|Refused further treatment|4|||
16165768|NCT00090545|39083994|FG000|Overall Study|Death|0|||
16165769|NCT00090545|39083995|FG001|Overall Study|Death|1|||
16165770|NCT00090545|39083994|FG000|Overall Study|Adverse Event|0|||
16165771|NCT00090545|39083995|FG001|Overall Study|Adverse Event|2|||
16165772|NCT03094195|39083997|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
16165773|NCT03094195|39083998|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
16165774|NCT03094195|39083999|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
16165775|NCT03094195|39084000|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
16165776|NCT03094195|39084001|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
16165777|NCT03094195|39084002|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
16165778|NCT03094195|39084003|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
16165779|NCT03094195|39084004|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
16165780|NCT03094195|39083997|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
16165781|NCT03094195|39083998|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
16165782|NCT03094195|39083999|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
16165783|NCT03094195|39084000|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
16165784|NCT03094195|39084001|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
16165785|NCT03094195|39084002|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
16165786|NCT03094195|39084003|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
16165787|NCT03094195|39084004|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
16165788|NCT03094195|39083997|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
16165789|NCT03094195|39083998|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
16165790|NCT03094195|39083999|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
16165791|NCT03094195|39084000|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
16165792|NCT03094195|39084001|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
16165793|NCT03094195|39084002|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
16165794|NCT03094195|39084003|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
16165795|NCT03094195|39084004|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
16165796|NCT03094195|39083997|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
16165797|NCT03094195|39083998|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
16165798|NCT03094195|39083999|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
16165799|NCT03094195|39084000|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
16165800|NCT03094195|39084001|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
16165801|NCT03094195|39084002|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
16165802|NCT03094195|39084003|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
16165803|NCT03094195|39084004|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
16165804|NCT00257010|39084005|FG000|Overall Study|Lack of Efficacy|11|||
16165805|NCT00257010|39084005|FG000|Overall Study|Lost to Follow-up|53|||
16165806|NCT00257010|39084005|FG000|Overall Study|Withdrawal by Subject|34|||
16165807|NCT00257010|39084005|FG000|Overall Study|Adverse Event|10|||
16165808|NCT00257010|39084005|FG000|Overall Study|various|11|||
16454661|NCT00463567|40144668|FG003|Overall Study|Abnormal test procedure result(s)|2|||
16165809|NCT00257010|39084005|FG000|Overall Study|no headache reported|9|||
16165810|NCT01178138|39087413|FG000|Overall Study|Lost to Follow-up|8|||
16165811|NCT01178138|39087413|FG000|Overall Study|Withdrawal by Subject|7|||
16165812|NCT01178138|39087413|FG000|Overall Study|Physician Decision|8|||
16165813|NCT00769119|39087414|FG000|Overall Study|Voluntary discontinuation|0|||
16165814|NCT00769119|39087415|FG001|Overall Study|Voluntary discontinuation|2|||
16165815|NCT00769119|39087414|FG000|Overall Study|Adverse Event|1|||
16165816|NCT00769119|39087415|FG001|Overall Study|Adverse Event|1|||
16165817|NCT00769119|39087414|FG000|Overall Study|Disallowed medication|1|||
16165818|NCT00769119|39087415|FG001|Overall Study|Disallowed medication|0|||
16165819|NCT02817087|39087416|FG000|Overall Study|Withdrawal by Subject|2|||
16165820|NCT02817087|39087417|FG001|Overall Study|Withdrawal by Subject|0|||
16165821|NCT02239263|39087418|FG000|Overall Study|Protocol Violation|6|||
16165822|NCT02554929|39087424|FG000|Overall Study|Lost to Follow-up|4|||
16165823|NCT02554929|39087425|FG001|Overall Study|Lost to Follow-up|4|||
16165824|NCT02554929|39087424|FG000|Overall Study|Withdrawal by Subject|2|||
16165825|NCT02554929|39087425|FG001|Overall Study|Withdrawal by Subject|8|||
16165826|NCT02814565|39087426|FG000|Overall Study|Lack of Efficacy|0|||
16165827|NCT02814565|39087427|FG001|Overall Study|Lack of Efficacy|1|||
16165828|NCT02814565|39087426|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
16165829|NCT02814565|39087427|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
16165830|NCT03433781|39087428|FG000|Overall Study|Progression of Disease|1|||
16165831|NCT03433781|39087429|FG001|Overall Study|Progression of Disease|0|||
16165832|NCT03433781|39087430|FG002|Overall Study|Progression of Disease|0|||
16165833|NCT03433781|39087428|FG000|Overall Study|Physician Decision|0|||
16165834|NCT03433781|39087429|FG001|Overall Study|Physician Decision|1|||
16165835|NCT03433781|39087430|FG002|Overall Study|Physician Decision|0|||
16165836|NCT00821678|39087434|FG000|Overall Study|Withdrawal by Subject|8|||
16165837|NCT00821678|39087435|FG001|Overall Study|Withdrawal by Subject|0|||
16454662|NCT00463567|40144669|FG004|Overall Study|Abnormal test procedure result(s)|0|||
16454663|NCT00463567|40144670|FG005|Overall Study|Abnormal test procedure result(s)|2|||
16266611|NCT00906399|39459371|FG001|Year 2|Other|0|||
16266612|NCT00906399|39459372|FG002|Year 2|Other|0|||
16266613|NCT00906399|39459373|FG003|Year 2|Other|2|||
16266614|NCT00906399|39459374|FG004|Year 2|Other|3|||
16266615|NCT00906399|39459375|FG005|Year 2|Other|1|||
16266616|NCT00906399|39459376|FG006|Year 2|Other|0|||
16266617|NCT00112463|39459380|FG000|Overall Study|Physician Decision|1|||
16266618|NCT00112463|39459380|FG000|Overall Study|Progression|30|||
16266619|NCT00112463|39459380|FG000|Overall Study|Second Primary|1|||
16266620|NCT00112463|39459380|FG000|Overall Study|Toxicity|3|||
16266621|NCT00112463|39459380|FG000|Overall Study|Withdrawal by Subject|2|||
16266622|NCT00112463|39459380|FG000|Overall Study|Never started treatment|2|||
16266623|NCT02849457|39459381|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
16266624|NCT02849457|39459382|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
16266625|NCT02849457|39459383|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
16266626|NCT02849457|39459384|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
16266627|NCT00834522|39459385|FG000|Washout|Adverse Event|1|||
16266628|NCT00834522|39459386|FG001|Washout|Adverse Event|0|||
16266629|NCT00834522|39459385|FG000|Washout|Withdrawal by Subject|2|||
16266630|NCT00834522|39459386|FG001|Washout|Withdrawal by Subject|1|||
16266631|NCT00834743|39459387|FG000|Second Intervention|Withdrawal by Subject|1|||
16266632|NCT00834743|39459388|FG001|Second Intervention|Withdrawal by Subject|0|||
16266633|NCT00875524|39459392|FG000|Overall Study|Serious adverse event|0|||
16266634|NCT00875524|39459393|FG001|Overall Study|Serious adverse event|1|||
16266635|NCT00875524|39459392|FG000|Overall Study|Protocol Violation|4|||
16266636|NCT00875524|39459393|FG001|Overall Study|Protocol Violation|0|||
16266637|NCT00875524|39459392|FG000|Overall Study|Lost to Follow-up|1|||
16454664|NCT00463567|40144671|FG006|Overall Study|Abnormal test procedure result(s)|0|||
16454665|NCT00463567|40144665|FG000|Overall Study|Death|1|||
16454666|NCT00463567|40144666|FG001|Overall Study|Death|0|||
16165838|NCT00821678|39087434|FG000|Overall Study|Lost to Follow-up|13|||
16165839|NCT00821678|39087435|FG001|Overall Study|Lost to Follow-up|12|||
16165840|NCT00821678|39087434|FG000|Overall Study|Death|0|||
16165841|NCT00821678|39087435|FG001|Overall Study|Death|2|||
16165842|NCT01439945|39087436|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
16165843|NCT01439945|39087437|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
16165844|NCT01439945|39087438|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
16165845|NCT01439945|39087439|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
16165846|NCT01439945|39087436|FG000|Double-Blind Treatment Phase|Ineligible|1|||
16266638|NCT00875524|39459393|FG001|Overall Study|Lost to Follow-up|0|||
16266639|NCT00875524|39459392|FG000|Overall Study|Withdrawal by Subject|3|||
16454667|NCT00463567|40144667|FG002|Overall Study|Death|2|||
16454668|NCT00463567|40144668|FG003|Overall Study|Death|0|||
16454669|NCT00463567|40144669|FG004|Overall Study|Death|0|||
16165847|NCT01439945|39087437|FG001|Double-Blind Treatment Phase|Ineligible|2|||
16165848|NCT01439945|39087438|FG002|Double-Blind Treatment Phase|Ineligible|0|||
16165849|NCT01439945|39087439|FG003|Double-Blind Treatment Phase|Ineligible|1|||
16165850|NCT00686647|39087444|FG000|Overall Study|Lost to Follow-up|1|||
16165851|NCT00686647|39087444|FG000|Overall Study|Death|1|||
16165852|NCT02354703|39087445|FG000|Overall Study|Withdrawal by Subject|1|||
16165853|NCT02354703|39087446|FG001|Overall Study|Withdrawal by Subject|1|||
16165854|NCT02354703|39087447|FG002|Overall Study|Withdrawal by Subject|1|||
16165855|NCT02354703|39087448|FG003|Overall Study|Withdrawal by Subject|1|||
16165856|NCT02354703|39087445|FG000|Overall Study|Lost to Follow-up|2|||
16165857|NCT02354703|39087446|FG001|Overall Study|Lost to Follow-up|7|||
16165858|NCT02354703|39087447|FG002|Overall Study|Lost to Follow-up|9|||
16165859|NCT02354703|39087448|FG003|Overall Study|Lost to Follow-up|2|||
16165860|NCT02354703|39087445|FG000|Overall Study|Adverse Event|0|||
16165861|NCT02354703|39087446|FG001|Overall Study|Adverse Event|0|||
16165862|NCT02354703|39087447|FG002|Overall Study|Adverse Event|1|||
16165863|NCT02354703|39087448|FG003|Overall Study|Adverse Event|0|||
16165864|NCT02597062|39087458|FG000|Overall Study|Ineligible|1|||
16165865|NCT01225562|39087459|FG000|Overall Study|Withdrawal by Subject|52|||
16165866|NCT01225562|39087460|FG001|Overall Study|Withdrawal by Subject|50|||
16165867|NCT01225562|39087461|FG002|Overall Study|Withdrawal by Subject|52|||
16165868|NCT01225562|39087459|FG000|Overall Study|Lost to Follow-up|3|||
16165869|NCT01225562|39087460|FG001|Overall Study|Lost to Follow-up|6|||
16165870|NCT01225562|39087461|FG002|Overall Study|Lost to Follow-up|1|||
16165871|NCT04002310|39087462|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
16165872|NCT04002310|39087463|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
16165873|NCT04002310|39087464|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
16165874|NCT04002310|39087465|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
16165875|NCT04002310|39087466|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
16165876|NCT01813890|39087471|FG000|Overall Study|Adverse Event|0|||
16165877|NCT01813890|39087472|FG001|Overall Study|Adverse Event|3|||
16165878|NCT01813890|39087473|FG002|Overall Study|Adverse Event|4|||
16165879|NCT01813890|39087471|FG000|Overall Study|Lack of Efficacy|9|||
16165880|NCT01813890|39087472|FG001|Overall Study|Lack of Efficacy|1|||
16165881|NCT01813890|39087473|FG002|Overall Study|Lack of Efficacy|2|||
16165882|NCT01622569|39087474|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
16165883|NCT01622569|39087475|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
16165884|NCT01622569|39087476|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
16165885|NCT01622569|39087477|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
16165886|NCT01622569|39087474|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
16165887|NCT01622569|39087475|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
16165888|NCT01622569|39087476|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
16165889|NCT01622569|39087477|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
16165890|NCT01622569|39087474|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
16165891|NCT01622569|39087475|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
16165892|NCT01622569|39087476|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
16165893|NCT01622569|39087477|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
16165894|NCT01622569|39087474|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
16165895|NCT01622569|39087475|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
16165896|NCT01622569|39087476|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
16165897|NCT01622569|39087477|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
16165898|NCT01622569|39087474|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
16165899|NCT01622569|39087475|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
16165900|NCT01622569|39087476|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
16165901|NCT01622569|39087477|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
16165902|NCT01622569|39087474|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
16165903|NCT01622569|39087475|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
16165904|NCT01622569|39087476|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
16165905|NCT01622569|39087477|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
16165906|NCT01622569|39087474|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
16165907|NCT01622569|39087475|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
16165908|NCT01622569|39087476|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
16165909|NCT01622569|39087477|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
16165910|NCT01622569|39087474|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16165911|NCT01622569|39087475|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16165912|NCT01622569|39087476|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
16165913|NCT01622569|39087477|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
16165914|NCT00463476|39087478|FG000|Overall Study|Withdrawal by Subject|1|||
16165915|NCT00463476|39087479|FG001|Overall Study|Withdrawal by Subject|2|||
16454670|NCT00463567|40144670|FG005|Overall Study|Death|0|||
16454671|NCT00463567|40144671|FG006|Overall Study|Death|0|||
16165916|NCT00463476|39087478|FG000|Overall Study|Lost to Follow-up|1|||
16165917|NCT00463476|39087479|FG001|Overall Study|Lost to Follow-up|1|||
16165918|NCT01097629|39087484|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
16165919|NCT01097629|39087485|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
16165920|NCT01097629|39087486|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
16165921|NCT01097629|39087487|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16266640|NCT00875524|39459393|FG001|Overall Study|Withdrawal by Subject|5|||
16266641|NCT00905606|39459394|FG000|Period 1|Adverse Event|0|||
16266642|NCT00905606|39459395|FG001|Period 1|Adverse Event|1|||
16266643|NCT00905606|39459394|FG000|Washout|Withdrawal by Subject|1|||
16266644|NCT00905606|39459395|FG001|Washout|Withdrawal by Subject|0|||
16266645|NCT00207090|39459396|FG000|Overall Study|Study drug toxicity|3|||
16266646|NCT00207090|39459396|FG000|Overall Study|Chest wall mass larger|1|||
16266647|NCT00207090|39459396|FG000|Overall Study|Disease progression/relapse|2|||
16266648|NCT00207090|39459396|FG000|Overall Study|Physician Decision|1|||
16266649|NCT01316055|39459397|FG000|Overall Study|Lost to Follow-up|1|||
16266650|NCT01316055|39459398|FG001|Overall Study|Lost to Follow-up|0|||
16266651|NCT01316055|39459399|FG002|Overall Study|Lost to Follow-up|0|||
16266652|NCT00834418|39459400|FG000|Overall Study|Adverse Event|0|||
16266653|NCT00834418|39459401|FG001|Overall Study|Adverse Event|2|||
16266654|NCT03635320|39459406|FG000|Overall Study|not implanted the device|1|||
16266655|NCT03635320|39459407|FG001|Overall Study|not implanted the device|2|||
16266656|NCT03635320|39459406|FG000|Overall Study|Withdrawal by Subject|11|||
16454672|NCT00947882|40144672|FG000|Overall Study|Adverse Event|0|||
16454673|NCT00947882|40144673|FG001|Overall Study|Adverse Event|1|||
16266657|NCT03635320|39459407|FG001|Overall Study|Withdrawal by Subject|6|||
16266658|NCT00829673|39459408|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16266659|NCT00829673|39459409|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16266660|NCT00395694|39459410|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
16266661|NCT00395694|39459411|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
16266662|NCT00395694|39459410|FG000|Continuation Phase|Adverse Event|1|||
16266663|NCT00395694|39459411|FG001|Continuation Phase|Adverse Event|0|||
16266664|NCT00395694|39459410|FG000|Continuation Phase|Lack of Efficacy|12|||
16266665|NCT00395694|39459411|FG001|Continuation Phase|Lack of Efficacy|11|||
16266666|NCT00395694|39459410|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
16266667|NCT00395694|39459411|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
16266668|NCT00395694|39459410|FG000|Continuation Phase|Poor Compliance|1|||
16454674|NCT00947882|40144674|FG002|Overall Study|Adverse Event|4|||
16454675|NCT00947882|40144675|FG003|Overall Study|Adverse Event|4|||
16454676|NCT00947882|40144672|FG000|Overall Study|Withdrawal by Subject|2|||
16454677|NCT00947882|40144673|FG001|Overall Study|Withdrawal by Subject|0|||
16454678|NCT00947882|40144674|FG002|Overall Study|Withdrawal by Subject|8|||
16454679|NCT00947882|40144675|FG003|Overall Study|Withdrawal by Subject|2|||
16454680|NCT00947882|40144672|FG000|Overall Study|Protocol Violation|0|||
16454681|NCT00947882|40144673|FG001|Overall Study|Protocol Violation|0|||
16454682|NCT00947882|40144674|FG002|Overall Study|Protocol Violation|1|||
16454683|NCT00947882|40144675|FG003|Overall Study|Protocol Violation|0|||
16454684|NCT00947882|40144672|FG000|Overall Study|Lost to Follow-up|0|||
16454685|NCT00947882|40144673|FG001|Overall Study|Lost to Follow-up|2|||
16454686|NCT00947882|40144674|FG002|Overall Study|Lost to Follow-up|1|||
16454687|NCT00947882|40144675|FG003|Overall Study|Lost to Follow-up|0|||
16454688|NCT00947882|40144672|FG000|Overall Study|Other/Unknown|10|||
16454689|NCT00947882|40144673|FG001|Overall Study|Other/Unknown|13|||
16454690|NCT00947882|40144674|FG002|Overall Study|Other/Unknown|3|||
16454691|NCT00947882|40144675|FG003|Overall Study|Other/Unknown|6|||
16454692|NCT00947882|40144672|FG000|Overall Study|Trial Terminated by Sponsor|62|||
16454693|NCT00947882|40144673|FG001|Overall Study|Trial Terminated by Sponsor|61|||
16454694|NCT00947882|40144674|FG002|Overall Study|Trial Terminated by Sponsor|62|||
16454695|NCT00947882|40144675|FG003|Overall Study|Trial Terminated by Sponsor|70|||
16454696|NCT04270370|40144676|FG000|Overall Study|Lost to Follow-up|1|||
16454697|NCT04270370|40144677|FG001|Overall Study|Lost to Follow-up|0|||
16454698|NCT04270370|40144678|FG002|Overall Study|Lost to Follow-up|0|||
16454699|NCT04270370|40144679|FG003|Overall Study|Lost to Follow-up|0|||
16454700|NCT04270370|40144680|FG004|Overall Study|Lost to Follow-up|0|||
16454701|NCT04270370|40144681|FG005|Overall Study|Lost to Follow-up|0|||
16454702|NCT04270370|40144682|FG006|Overall Study|Lost to Follow-up|0|||
16165922|NCT01097629|39087488|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16165923|NCT01097629|39087489|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16266669|NCT00395694|39459411|FG001|Continuation Phase|Poor Compliance|0|||
16266670|NCT00395694|39459410|FG000|Continuation Phase|Withdrawal by Subject|0|||
16454703|NCT04270370|40144683|FG007|Overall Study|Lost to Follow-up|0|||
16266671|NCT00395694|39459411|FG001|Continuation Phase|Withdrawal by Subject|2|||
16454704|NCT04270370|40144684|FG008|Overall Study|Lost to Follow-up|1|||
16454705|NCT04270370|40144685|FG009|Overall Study|Lost to Follow-up|0|||
16454706|NCT04270370|40144686|FG010|Overall Study|Lost to Follow-up|0|||
16454707|NCT04270370|40144687|FG011|Overall Study|Lost to Follow-up|0|||
16454708|NCT01587898|40144688|FG000|Overall Study|Adverse Event|1|||
16454709|NCT01587898|40144689|FG001|Overall Study|Adverse Event|1|||
16454710|NCT01587898|40144690|FG002|Overall Study|Adverse Event|0|||
16454711|NCT01587898|40144691|FG003|Overall Study|Adverse Event|0|||
16454712|NCT01587898|40144688|FG000|Overall Study|Protocol Violation|0|||
16454713|NCT01587898|40144689|FG001|Overall Study|Protocol Violation|2|||
16454714|NCT01587898|40144690|FG002|Overall Study|Protocol Violation|1|||
16454715|NCT01587898|40144691|FG003|Overall Study|Protocol Violation|1|||
16454716|NCT01587898|40144688|FG000|Overall Study|Lost to Follow-up|0|||
16454717|NCT01587898|40144689|FG001|Overall Study|Lost to Follow-up|0|||
16454718|NCT01587898|40144690|FG002|Overall Study|Lost to Follow-up|0|||
16454719|NCT01587898|40144691|FG003|Overall Study|Lost to Follow-up|1|||
16454720|NCT01587898|40144688|FG000|Overall Study|Withdrawal by Subject|2|||
16454721|NCT01587898|40144689|FG001|Overall Study|Withdrawal by Subject|1|||
16454722|NCT01587898|40144690|FG002|Overall Study|Withdrawal by Subject|0|||
16454723|NCT01587898|40144691|FG003|Overall Study|Withdrawal by Subject|0|||
16454724|NCT01587898|40144688|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
16454725|NCT01587898|40144689|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
16454726|NCT01587898|40144690|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
16454727|NCT01587898|40144691|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
16454728|NCT00488683|40144694|FG000|Overall Study|Withdrawal by Subject|1|||
16266672|NCT03733444|39459412|FG000|Overall Study|Adverse Event|8|||
16454729|NCT00488683|40144695|FG001|Overall Study|Withdrawal by Subject|2|||
16454730|NCT00488683|40144696|FG002|Overall Study|Withdrawal by Subject|2|||
16454731|NCT00488683|40144694|FG000|Overall Study|Lost to Follow-up|5|||
16454732|NCT00488683|40144695|FG001|Overall Study|Lost to Follow-up|3|||
16454733|NCT00488683|40144696|FG002|Overall Study|Lost to Follow-up|0|||
16454734|NCT00488683|40144694|FG000|Overall Study|Protocol Violation|5|||
16454735|NCT00488683|40144695|FG001|Overall Study|Protocol Violation|1|||
16454736|NCT00488683|40144696|FG002|Overall Study|Protocol Violation|0|||
16454737|NCT00488683|40144694|FG000|Overall Study|Unable to Classify|1|||
16454738|NCT00488683|40144695|FG001|Overall Study|Unable to Classify|0|||
16454739|NCT00488683|40144696|FG002|Overall Study|Unable to Classify|0|||
16454740|NCT00476229|40144697|FG000|Overall Study|Progressive shortness of breath|1|||
16454741|NCT00555061|40144698|FG000|Overall Study|Adverse Event|3|||
16454742|NCT00555061|40144698|FG000|Overall Study|Protocol Violation|1|||
16454743|NCT00555061|40144698|FG000|Overall Study|Lost to Follow-up|2|||
16454744|NCT00555061|40144698|FG000|Overall Study|Withdrawal by Subject|2|||
16454745|NCT00555061|40144698|FG000|Overall Study|Participant enrolled, but never treated|1|||
16266673|NCT03733444|39459413|FG001|Overall Study|Adverse Event|10|||
16266674|NCT03733444|39459414|FG002|Overall Study|Adverse Event|5|||
16266675|NCT03733444|39459412|FG000|Overall Study|Death|20|||
16266676|NCT03733444|39459413|FG001|Overall Study|Death|19|||
16266677|NCT03733444|39459414|FG002|Overall Study|Death|11|||
16266678|NCT03733444|39459412|FG000|Overall Study|Lost to Follow-up|3|||
16266679|NCT03733444|39459413|FG001|Overall Study|Lost to Follow-up|0|||
16266680|NCT03733444|39459414|FG002|Overall Study|Lost to Follow-up|1|||
16266681|NCT03733444|39459412|FG000|Overall Study|Lack of Efficacy|0|||
16266682|NCT03733444|39459413|FG001|Overall Study|Lack of Efficacy|1|||
16266683|NCT03733444|39459414|FG002|Overall Study|Lack of Efficacy|1|||
16266684|NCT03733444|39459412|FG000|Overall Study|Physician Decision|2|||
16266685|NCT03733444|39459413|FG001|Overall Study|Physician Decision|1|||
16266686|NCT03733444|39459414|FG002|Overall Study|Physician Decision|0|||
16266687|NCT03733444|39459412|FG000|Overall Study|Protocol Violation|2|||
16266688|NCT03733444|39459413|FG001|Overall Study|Protocol Violation|1|||
16266689|NCT03733444|39459414|FG002|Overall Study|Protocol Violation|0|||
16266690|NCT03733444|39459412|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
16266691|NCT03733444|39459413|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
16266692|NCT03733444|39459414|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
16266693|NCT03733444|39459412|FG000|Overall Study|Study Terminated by Sponsor|203|||
16266694|NCT03733444|39459413|FG001|Overall Study|Study Terminated by Sponsor|209|||
16266695|NCT03733444|39459414|FG002|Overall Study|Study Terminated by Sponsor|221|||
16266696|NCT03733444|39459412|FG000|Overall Study|Withdrawal by Subject|19|||
16266697|NCT03733444|39459413|FG001|Overall Study|Withdrawal by Subject|18|||
16266698|NCT03733444|39459414|FG002|Overall Study|Withdrawal by Subject|16|||
16266699|NCT03733444|39459412|FG000|Overall Study|Miscellaneous|1|||
16266700|NCT03733444|39459413|FG001|Overall Study|Miscellaneous|0|||
16266701|NCT03733444|39459414|FG002|Overall Study|Miscellaneous|1|||
16266702|NCT03733444|39459412|FG000|Overall Study|Not Treated|1|||
16266703|NCT03733444|39459413|FG001|Overall Study|Not Treated|2|||
16266704|NCT03733444|39459414|FG002|Overall Study|Not Treated|1|||
16454746|NCT04455815|40144699|FG000|Randomisation Phase|Adverse Event|1|||
16454747|NCT04455815|40144700|FG001|Randomisation Phase|Adverse Event|0|||
16454748|NCT04455815|40144699|FG000|Treatment Phase|Adverse Event|0|||
16454749|NCT04455815|40144700|FG001|Treatment Phase|Adverse Event|1|||
16454750|NCT04455815|40144699|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
16454751|NCT04455815|40144700|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
16266705|NCT03406156|39459415|FG000|Overall Study|Death|9|||
16266706|NCT03406156|39459416|FG001|Overall Study|Death|3|||
16165924|NCT01097629|39087490|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16165925|NCT01097629|39087491|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
16266707|NCT03406156|39459415|FG000|Overall Study|Withdrawal by Subject|1|||
16266708|NCT03406156|39459416|FG001|Overall Study|Withdrawal by Subject|2|||
16266709|NCT03406156|39459415|FG000|Overall Study|COVID-19 infection|1|||
16266710|NCT03406156|39459416|FG001|Overall Study|COVID-19 infection|0|||
16266711|NCT03406156|39459415|FG000|Overall Study|Non-compliance with study procedures|1|||
16266712|NCT03406156|39459416|FG001|Overall Study|Non-compliance with study procedures|1|||
16266713|NCT03406156|39459415|FG000|Overall Study|Lost to Follow-up|0|||
16266714|NCT03406156|39459416|FG001|Overall Study|Lost to Follow-up|2|||
16266715|NCT03406156|39459415|FG000|Overall Study|Other, not specified|72|||
16266716|NCT03406156|39459416|FG001|Overall Study|Other, not specified|28|||
16266717|NCT01963728|39459417|FG000|Overall Study|Study terminated early|0|||
16165926|NCT01097629|39087484|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
16165927|NCT01097629|39087485|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
16165928|NCT01097629|39087486|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
16165929|NCT01097629|39087487|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16165930|NCT01097629|39087488|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16165931|NCT01097629|39087489|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16165932|NCT01097629|39087490|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16165933|NCT01097629|39087491|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
16165934|NCT01097629|39087484|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
16165935|NCT01097629|39087485|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
16165936|NCT01097629|39087486|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
16165937|NCT01097629|39087487|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16165938|NCT01097629|39087488|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16165939|NCT01097629|39087489|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16165940|NCT01097629|39087490|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16165941|NCT01097629|39087491|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
16165942|NCT01097629|39087484|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
16165943|NCT01097629|39087485|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
16165944|NCT01097629|39087486|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
16165945|NCT01097629|39087487|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16165946|NCT01097629|39087488|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16165947|NCT01097629|39087489|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16165948|NCT01097629|39087490|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16165949|NCT01097629|39087491|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
16165950|NCT01097629|39087484|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
16165951|NCT01097629|39087485|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
16165952|NCT01097629|39087486|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
16165953|NCT01097629|39087487|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16165954|NCT01097629|39087488|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16165955|NCT01097629|39087489|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16165956|NCT01097629|39087490|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16165957|NCT01097629|39087491|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
16165958|NCT01097629|39087484|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
16165959|NCT01097629|39087485|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
16165960|NCT01097629|39087486|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16165961|NCT01097629|39087487|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16165962|NCT01097629|39087488|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16165963|NCT01097629|39087489|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16165964|NCT01097629|39087490|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16165965|NCT01097629|39087491|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
16165966|NCT01097629|39087484|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
16165967|NCT01097629|39087485|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
16165968|NCT01097629|39087486|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
16165969|NCT01097629|39087487|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16165970|NCT01097629|39087488|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16165971|NCT01097629|39087489|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16165972|NCT01097629|39087490|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16165973|NCT01097629|39087491|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
16165974|NCT01097629|39087484|FG000|DB RO Phase|Withdrawal by Subject|0|||
16165975|NCT01097629|39087485|FG001|DB RO Phase|Withdrawal by Subject|0|||
16165976|NCT01097629|39087486|FG002|DB RO Phase|Withdrawal by Subject|0|||
16165977|NCT01097629|39087487|FG003|DB RO Phase|Withdrawal by Subject|0|||
16266718|NCT01963728|39459418|FG001|Overall Study|Study terminated early|1|||
16165978|NCT01097629|39087488|FG004|DB RO Phase|Withdrawal by Subject|0|||
16165979|NCT01097629|39087489|FG005|DB RO Phase|Withdrawal by Subject|0|||
16165980|NCT01097629|39087490|FG006|DB RO Phase|Withdrawal by Subject|0|||
16165981|NCT01097629|39087491|FG007|DB RO Phase|Withdrawal by Subject|1|||
16165982|NCT01097629|39087484|FG000|DB RO Phase|Protocol Violation|0|||
16165983|NCT01097629|39087485|FG001|DB RO Phase|Protocol Violation|0|||
16165984|NCT01097629|39087486|FG002|DB RO Phase|Protocol Violation|0|||
16165985|NCT01097629|39087487|FG003|DB RO Phase|Protocol Violation|1|||
16165986|NCT01097629|39087488|FG004|DB RO Phase|Protocol Violation|0|||
16165987|NCT01097629|39087489|FG005|DB RO Phase|Protocol Violation|1|||
16165988|NCT01097629|39087490|FG006|DB RO Phase|Protocol Violation|1|||
16266719|NCT00834873|39459422|FG000|First Intervention|Adverse Event|0|||
16266720|NCT00834873|39459423|FG001|First Intervention|Adverse Event|1|||
16266721|NCT04442503|39459424|FG000|Overall Study|Adverse Event|1|||
16266722|NCT04442503|39459425|FG001|Overall Study|Adverse Event|1|||
16266723|NCT04442503|39459424|FG000|Overall Study|Lost to Follow-up|8|||
16266724|NCT04442503|39459425|FG001|Overall Study|Lost to Follow-up|6|||
16266725|NCT04442503|39459424|FG000|Overall Study|Physician Decision|0|||
16266726|NCT04442503|39459425|FG001|Overall Study|Physician Decision|2|||
16266727|NCT04442503|39459424|FG000|Overall Study|Withdrawal by Subject|3|||
16266728|NCT04442503|39459425|FG001|Overall Study|Withdrawal by Subject|4|||
16266729|NCT04442503|39459424|FG000|Overall Study|Reason not Specified|0|||
16266730|NCT04442503|39459425|FG001|Overall Study|Reason not Specified|1|||
16266731|NCT04442503|39459424|FG000|Overall Study|Randomized but not Treated|3|||
16266732|NCT04442503|39459425|FG001|Overall Study|Randomized but not Treated|1|||
16266733|NCT00910663|39459434|FG000|Period 1|Withdrawal by Subject|0|||
16266734|NCT00910663|39459435|FG001|Period 1|Withdrawal by Subject|1|||
16266735|NCT03719040|39459437|FG000|Overall Study|Withdrawal by Subject|177|||
16266736|NCT03719040|39459437|FG000|Overall Study|Lost to Follow-up|26|||
16266737|NCT01528696|39459441|FG000|Overall Study|See detailed description|18|||
16266738|NCT01528696|39459442|FG001|Overall Study|See detailed description|19|||
16266739|NCT01149473|39459443|FG000|First Intervention|Adverse Event|1|||
16266740|NCT01149473|39459444|FG001|First Intervention|Adverse Event|1|||
16266741|NCT01149473|39459443|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16266742|NCT01149473|39459444|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
16266743|NCT01701063|39459445|FG000|Overall Study|Lost to Follow-up|0|||
16266744|NCT01701063|39459446|FG001|Overall Study|Lost to Follow-up|1|||
16266745|NCT01701063|39459447|FG002|Overall Study|Lost to Follow-up|0|||
16266746|NCT01701063|39459445|FG000|Overall Study|Withdrawal by Subject|0|||
16266747|NCT01701063|39459446|FG001|Overall Study|Withdrawal by Subject|0|||
16266748|NCT01701063|39459447|FG002|Overall Study|Withdrawal by Subject|1|||
16266749|NCT01701063|39459445|FG000|Overall Study|Other|0|||
16266750|NCT01701063|39459446|FG001|Overall Study|Other|0|||
16266751|NCT01701063|39459447|FG002|Overall Study|Other|1|||
16266752|NCT03663179|39459448|FG000|Overall Study|Withdrawal by Subject|2|||
16266753|NCT03663179|39459449|FG001|Overall Study|Withdrawal by Subject|0|||
16266754|NCT03663179|39459448|FG000|Overall Study|Lost to Follow-up|1|||
16266755|NCT03663179|39459449|FG001|Overall Study|Lost to Follow-up|1|||
16266756|NCT03663179|39459448|FG000|Overall Study|Revealed exclusionary condition|1|||
16266757|NCT03663179|39459449|FG001|Overall Study|Revealed exclusionary condition|0|||
16266758|NCT05327491|39459451|FG000|Periods 1 & 2|Miscellaneous|0|||
16266759|NCT05327491|39459452|FG001|Periods 1 & 2|Miscellaneous|1|||
16266760|NCT05327491|39459453|FG002|Periods 1 & 2|Miscellaneous|0|||
16266761|NCT05327491|39459454|FG003|Periods 1 & 2|Miscellaneous|0|||
16266762|NCT05327491|39459451|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
16266763|NCT05327491|39459452|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
16266764|NCT05327491|39459453|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
16266765|NCT05327491|39459454|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
16266766|NCT00833937|39459455|FG000|Washout|Withdrawal by Subject|1|||
16266767|NCT00833937|39459456|FG001|Washout|Withdrawal by Subject|0|||
16266768|NCT01249651|39459457|FG000|Overall Study|Withdrawal by Subject|4|||
16266769|NCT01249651|39459457|FG000|Overall Study|Adverse Event|1|||
16266770|NCT01249651|39459457|FG000|Overall Study|Protocol Violation|1|||
16266771|NCT01249651|39459457|FG000|Overall Study|Sponsor Decision|1|||
16266772|NCT04239872|39459458|FG000|Overall Study|Lost to Follow-up|0|||
16266773|NCT04239872|39459459|FG001|Overall Study|Lost to Follow-up|1|||
16266774|NCT00679081|39459460|FG000|Overall Study|Lost to Follow-up|1|||
16266775|NCT02334722|39459461|FG000|Overall Study|Lost to Follow-up|4|||
16266776|NCT02334722|39459462|FG001|Overall Study|Lost to Follow-up|0|||
16266777|NCT02334722|39459461|FG000|Overall Study|6 week questionnaire not completed|2|||
16266778|NCT02334722|39459462|FG001|Overall Study|6 week questionnaire not completed|0|||
16266779|NCT02334722|39459461|FG000|Overall Study|Unable to obtain medication|1|||
16266780|NCT02334722|39459462|FG001|Overall Study|Unable to obtain medication|1|||
16266781|NCT02334722|39459461|FG000|Overall Study|Withdrawal by Subject|0|||
16266782|NCT02334722|39459462|FG001|Overall Study|Withdrawal by Subject|3|||
16072670|NCT01467700|38756418|FG000|Overall Study|Pregnancy|0|||
16165989|NCT01097629|39087491|FG007|DB RO Phase|Protocol Violation|0|||
16165990|NCT01097629|39087484|FG000|DB RO Phase|Lost to Follow-up|0|||
16266783|NCT02334722|39459461|FG000|Overall Study|Adverse Event|0|||
16266784|NCT02334722|39459462|FG001|Overall Study|Adverse Event|2|||
16266785|NCT02334722|39459461|FG000|Overall Study|Physician Decision|0|||
16266786|NCT02334722|39459462|FG001|Overall Study|Physician Decision|1|||
16266787|NCT00835263|39459463|FG000|Second Intervention|Adverse Event|1|||
16266788|NCT00835263|39459464|FG001|Second Intervention|Adverse Event|0|||
16266789|NCT00835666|39459466|FG000|Washout|Protocol Violation|1|||
16266790|NCT00835666|39459467|FG001|Washout|Protocol Violation|0|||
16266791|NCT00835666|39459466|FG000|Washout|Withdrawal by Subject|1|||
16266792|NCT00835666|39459467|FG001|Washout|Withdrawal by Subject|0|||
16266793|NCT02362464|39459468|FG000|Overall Study|Switched to alternative therapy|1|||
16266794|NCT02362464|39459468|FG000|Overall Study|Refused further treatment|1|||
16266795|NCT02362464|39459468|FG000|Overall Study|Physician Decision|4|||
16266796|NCT04774380|39459470|FG000|Overall Study|Patients ongoing study at data cut-off|75|||
16266797|NCT02819518|39459475|FG000|Overall Study|Death|9|||
16266798|NCT02819518|39459476|FG001|Overall Study|Death|11|||
16266799|NCT02819518|39459477|FG002|Overall Study|Death|9|||
16266800|NCT02819518|39459478|FG003|Overall Study|Death|447|||
16266801|NCT02819518|39459479|FG004|Overall Study|Death|233|||
16266802|NCT02819518|39459475|FG000|Overall Study|Withdrawal by Subject|0|||
16266803|NCT02819518|39459476|FG001|Overall Study|Withdrawal by Subject|0|||
16266804|NCT02819518|39459477|FG002|Overall Study|Withdrawal by Subject|0|||
16266805|NCT02819518|39459478|FG003|Overall Study|Withdrawal by Subject|21|||
16266806|NCT02819518|39459479|FG004|Overall Study|Withdrawal by Subject|6|||
16266807|NCT02819518|39459475|FG000|Overall Study|Ongoing in Study|2|||
16266808|NCT02819518|39459476|FG001|Overall Study|Ongoing in Study|3|||
16266809|NCT02819518|39459477|FG002|Overall Study|Ongoing in Study|1|||
16266810|NCT02819518|39459478|FG003|Overall Study|Ongoing in Study|98|||
16266811|NCT02819518|39459479|FG004|Overall Study|Ongoing in Study|42|||
16266812|NCT03214952|39459489|FG000|Overall Study|Protocol Deviation|45|||
16266813|NCT03214952|39459489|FG000|Overall Study|Case Report Forms Uncollected|13|||
16266814|NCT00123734|39459490|FG000|Overall Study|Death|3|||
16266815|NCT00123734|39459490|FG000|Overall Study|Lost to Follow-up|3|||
16266816|NCT00123734|39459490|FG000|Overall Study|Dropout|1|||
16266817|NCT00123734|39459490|FG000|Overall Study|Withdrawal by Subject|1|||
16266818|NCT00461786|39459493|FG000|Overall Study|Entry Criteria Not Met|2|||
16266819|NCT00461786|39459493|FG000|Overall Study|Inevaluable (Never Treated)|1|||
16266820|NCT01867658|39459494|FG000|Overall Study|Withdrawal by Subject|6|||
16266821|NCT01867658|39459494|FG000|Overall Study|Death|2|||
16266822|NCT01867658|39459494|FG000|Overall Study|Subject could not be contacted|1|||
16165991|NCT01097629|39087485|FG001|DB RO Phase|Lost to Follow-up|0|||
16165992|NCT01097629|39087486|FG002|DB RO Phase|Lost to Follow-up|0|||
16165993|NCT01097629|39087487|FG003|DB RO Phase|Lost to Follow-up|0|||
16165994|NCT01097629|39087488|FG004|DB RO Phase|Lost to Follow-up|0|||
16165995|NCT01097629|39087489|FG005|DB RO Phase|Lost to Follow-up|0|||
16165996|NCT01097629|39087490|FG006|DB RO Phase|Lost to Follow-up|2|||
16165997|NCT01097629|39087491|FG007|DB RO Phase|Lost to Follow-up|0|||
16165998|NCT01824979|39087492|FG000|Overall Study|Withdrawal by Subject|5|||
16165999|NCT01824979|39087493|FG001|Overall Study|Withdrawal by Subject|0|||
16166000|NCT01824979|39087492|FG000|Overall Study|Physician Decision|2|||
16166001|NCT01824979|39087493|FG001|Overall Study|Physician Decision|0|||
16166002|NCT01824979|39087492|FG000|Overall Study|Protocol Violation|6|||
16166003|NCT01824979|39087493|FG001|Overall Study|Protocol Violation|13|||
16166004|NCT04303000|39087494|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
16166005|NCT04303000|39087495|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
16166006|NCT04303000|39087496|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
16166007|NCT01046695|39087499|FG000|Overall Study|Subject had a pacemaker|0|||
16166008|NCT01046695|39087500|FG001|Overall Study|Subject had a pacemaker|1|||
16166009|NCT01046695|39087499|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
16166010|NCT01046695|39087500|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
16166011|NCT00630331|39087504|FG000|Overall Study|Death|2|||
16166012|NCT00630331|39087505|FG001|Overall Study|Death|1|||
16166013|NCT00630331|39087506|FG002|Overall Study|Death|1|||
16166014|NCT00630331|39087504|FG000|Overall Study|Adverse Event|1|||
16166015|NCT00630331|39087505|FG001|Overall Study|Adverse Event|0|||
16166016|NCT00630331|39087506|FG002|Overall Study|Adverse Event|0|||
16166017|NCT00630331|39087504|FG000|Overall Study|Withdrawal by Subject|12|||
16166018|NCT00630331|39087505|FG001|Overall Study|Withdrawal by Subject|7|||
16166019|NCT00630331|39087506|FG002|Overall Study|Withdrawal by Subject|5|||
16166020|NCT00630331|39087504|FG000|Overall Study|Lost to Follow-up|175|||
16166021|NCT00630331|39087505|FG001|Overall Study|Lost to Follow-up|143|||
16166022|NCT00630331|39087506|FG002|Overall Study|Lost to Follow-up|170|||
16166023|NCT00630331|39087504|FG000|Overall Study|Inappropriate enrollment|3|||
16166024|NCT00630331|39087505|FG001|Overall Study|Inappropriate enrollment|6|||
16166025|NCT00630331|39087506|FG002|Overall Study|Inappropriate enrollment|3|||
16166026|NCT00630331|39087504|FG000|Overall Study|Unable to classify|9|||
16166027|NCT00630331|39087505|FG001|Overall Study|Unable to classify|4|||
16166028|NCT00630331|39087506|FG002|Overall Study|Unable to classify|3|||
16266823|NCT01370083|39459497|FG000|Overall Study|Lost to Follow-up|2|||
16266824|NCT01370083|39459498|FG001|Overall Study|Lost to Follow-up|0|||
16266825|NCT01370083|39459497|FG000|Overall Study|Adverse Event|0|||
16266826|NCT01370083|39459498|FG001|Overall Study|Adverse Event|1|||
16266827|NCT03098394|39459499|FG000|Overall Study|Pregnancy|0|||
16266828|NCT03098394|39459500|FG001|Overall Study|Pregnancy|1|||
16266829|NCT01442155|39459501|FG000|Overall Study|Complete remission|35|||
16266830|NCT01442155|39459501|FG000|Overall Study|Recurrence|26|||
16266831|NCT01442155|39459501|FG000|Overall Study|Adverse Event|2|||
16266832|NCT01442155|39459501|FG000|Overall Study|Lost to Follow-up|2|||
16266833|NCT03107091|39459502|FG000|Overall Study|Physician Decision|1|||
16266834|NCT02186821|39459503|FG000|Overall Study|Adverse Event|9|||
16266835|NCT02186821|39459503|FG000|Overall Study|Death|2|||
16266836|NCT02186821|39459503|FG000|Overall Study|Disease progression|32|||
16266837|NCT02186821|39459503|FG000|Overall Study|Protocol Violation|1|||
16266838|NCT02186821|39459503|FG000|Overall Study|Physician Decision|1|||
16266839|NCT02186821|39459503|FG000|Overall Study|Study terminated by sponsor|2|||
16266840|NCT00850174|39459506|FG000|Washout: One Week|Withdrawal by Subject|0|||
16266841|NCT00850174|39459507|FG001|Washout: One Week|Withdrawal by Subject|2|||
16266842|NCT00850174|39459506|FG000|Second Intervention|Withdrawal by Subject|1|||
16266843|NCT00850174|39459507|FG001|Second Intervention|Withdrawal by Subject|0|||
16266844|NCT01566721|39459508|FG000|Treatment Period|Withdrawal by Subject|35|||
16266845|NCT01566721|39459509|FG001|Treatment Period|Withdrawal by Subject|9|||
16266846|NCT01566721|39459508|FG000|Treatment Period|Disease Progression/Recurrence|37|||
16266847|NCT01566721|39459509|FG001|Treatment Period|Disease Progression/Recurrence|13|||
16266848|NCT01566721|39459508|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
16266849|NCT01566721|39459509|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
16266850|NCT01566721|39459508|FG000|Treatment Period|Other|13|||
16266851|NCT01566721|39459509|FG001|Treatment Period|Other|2|||
16266852|NCT01566721|39459508|FG000|Treatment Period|Lack of Compliance|5|||
16266853|NCT01566721|39459509|FG001|Treatment Period|Lack of Compliance|1|||
16266854|NCT01566721|39459508|FG000|Treatment Period|Adverse Event|100|||
16266855|NCT01566721|39459509|FG001|Treatment Period|Adverse Event|30|||
16266856|NCT01566721|39459508|FG000|Treatment Period|Pregnancy|1|||
16266857|NCT01566721|39459509|FG001|Treatment Period|Pregnancy|0|||
16266858|NCT01566721|39459508|FG000|Safety Follow-up|Physician Decision|6|||
16266859|NCT01566721|39459509|FG001|Safety Follow-up|Physician Decision|4|||
16266860|NCT01566721|39459508|FG000|Safety Follow-up|Lost to Follow-up|101|||
16266861|NCT01566721|39459509|FG001|Safety Follow-up|Lost to Follow-up|48|||
16266862|NCT01566721|39459508|FG000|Safety Follow-up|Withdrawal by Subject|155|||
16266863|NCT01566721|39459509|FG001|Safety Follow-up|Withdrawal by Subject|49|||
16266864|NCT01566721|39459508|FG000|Safety Follow-up|Death|28|||
16266865|NCT01566721|39459509|FG001|Safety Follow-up|Death|4|||
16266866|NCT01566721|39459508|FG000|Safety Follow-up|Non-compliance|7|||
16266867|NCT01566721|39459509|FG001|Safety Follow-up|Non-compliance|3|||
16266868|NCT01566721|39459508|FG000|Safety Follow-up|Protocol Violation|7|||
16266869|NCT01566721|39459509|FG001|Safety Follow-up|Protocol Violation|0|||
16266870|NCT01566721|39459508|FG000|Safety Follow-up|Site closure|2|||
16266871|NCT01566721|39459509|FG001|Safety Follow-up|Site closure|3|||
16266872|NCT01566721|39459508|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
16266873|NCT01566721|39459509|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
16266874|NCT01566721|39459508|FG000|Safety Follow-up|Missing|7|||
16266875|NCT01566721|39459509|FG001|Safety Follow-up|Missing|2|||
16266876|NCT01566721|39459508|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
16266877|NCT01566721|39459509|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
16266878|NCT01566721|39459508|FG000|Safety Follow-up|Sponsor decision|1|||
16266879|NCT01566721|39459509|FG001|Safety Follow-up|Sponsor decision|0|||
16266880|NCT01566721|39459508|FG000|Safety Follow-up|Adverse Event|8|||
16266881|NCT01566721|39459509|FG001|Safety Follow-up|Adverse Event|4|||
16266882|NCT03325881|39459510|FG000|Overall Study|Protocol Violation|0|||
16266883|NCT03325881|39459511|FG001|Overall Study|Protocol Violation|1|||
16266884|NCT03325881|39459510|FG000|Overall Study|Withdrawal by Subject|0|||
16266885|NCT03325881|39459511|FG001|Overall Study|Withdrawal by Subject|2|||
16266886|NCT03325881|39459510|FG000|Overall Study|Lack of Efficacy|2|||
16266887|NCT03325881|39459511|FG001|Overall Study|Lack of Efficacy|0|||
16266888|NCT03325881|39459510|FG000|Overall Study|Not treated|1|||
16266889|NCT03325881|39459511|FG001|Overall Study|Not treated|0|||
16266890|NCT04278560|39459512|FG000|Overall Study|Adverse Event|1|||
16266891|NCT04278560|39459513|FG001|Overall Study|Adverse Event|2|||
16266892|NCT04278560|39459512|FG000|Overall Study|Withdrawal by Subject|0|||
16266893|NCT04278560|39459513|FG001|Overall Study|Withdrawal by Subject|1|||
16266894|NCT00838630|39459516|FG000|First Intervention|Adverse Event|1|||
16266895|NCT00838630|39459517|FG001|First Intervention|Adverse Event|0|||
16266896|NCT00838630|39459516|FG000|Washout: 7 Days|Protocol Violation|1|||
16266897|NCT00838630|39459517|FG001|Washout: 7 Days|Protocol Violation|0|||
16266898|NCT02545283|39462946|FG000|Overall Study|Lost to Follow-up|2|||
16266899|NCT02545283|39462947|FG001|Overall Study|Lost to Follow-up|4|||
16266900|NCT02545283|39462946|FG000|Overall Study|Withdrawal by Subject|5|||
16266901|NCT02545283|39462947|FG001|Overall Study|Withdrawal by Subject|9|||
16266902|NCT02545283|39462946|FG000|Overall Study|Death|109|||
16266903|NCT02545283|39462947|FG001|Overall Study|Death|211|||
16266904|NCT02545283|39462946|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
16266905|NCT02545283|39462947|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
16266906|NCT02545283|39462946|FG000|Overall Study|Study Terminated By Sponsor|33|||
16266907|NCT02545283|39462947|FG001|Overall Study|Study Terminated By Sponsor|71|||
16266908|NCT01168856|39462953|FG000|Overall Study|Lost to Follow-up|4|||
16266909|NCT01168856|39462954|FG001|Overall Study|Lost to Follow-up|34|||
16266910|NCT01168856|39462953|FG000|Overall Study|Withdrawal by Subject|6|||
16266911|NCT01168856|39462954|FG001|Overall Study|Withdrawal by Subject|8|||
16266912|NCT01168856|39462953|FG000|Overall Study|Physician Decision|2|||
16266913|NCT01168856|39462954|FG001|Overall Study|Physician Decision|1|||
16266914|NCT01168856|39462953|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
16266915|NCT01168856|39462954|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
16266916|NCT01168856|39462953|FG000|Overall Study|Participant received anti-HCV treatment|1|||
16266917|NCT01168856|39462954|FG001|Overall Study|Participant received anti-HCV treatment|0|||
16266918|NCT01168856|39462953|FG000|Overall Study|Death|0|||
16266919|NCT01168856|39462954|FG001|Overall Study|Death|2|||
16266920|NCT01168856|39462953|FG000|Overall Study|Other|1|||
16266921|NCT01168856|39462954|FG001|Overall Study|Other|291|||
16266922|NCT01168856|39462953|FG000|Overall Study|Protocol Violation|4|||
16266923|NCT01168856|39462954|FG001|Overall Study|Protocol Violation|6|||
16266924|NCT02842853|39462955|FG000|Overall Study|Non-compliance with the protocol|3|||
16266925|NCT02842853|39462956|FG001|Overall Study|Non-compliance with the protocol|7|||
16266926|NCT02842853|39462957|FG002|Overall Study|Non-compliance with the protocol|2|||
16266927|NCT02842853|39462958|FG003|Overall Study|Non-compliance with the protocol|5|||
16266928|NCT02842853|39462955|FG000|Overall Study|Subject met exclusion criteria|0|||
16266929|NCT02842853|39462956|FG001|Overall Study|Subject met exclusion criteria|1|||
16266930|NCT02842853|39462957|FG002|Overall Study|Subject met exclusion criteria|0|||
16266931|NCT02842853|39462958|FG003|Overall Study|Subject met exclusion criteria|0|||
16266932|NCT02842853|39462955|FG000|Overall Study|Withdrawal by Subject|11|||
16266933|NCT02842853|39462956|FG001|Overall Study|Withdrawal by Subject|13|||
16266934|NCT02842853|39462957|FG002|Overall Study|Withdrawal by Subject|9|||
16266935|NCT02842853|39462958|FG003|Overall Study|Withdrawal by Subject|8|||
16266936|NCT02842853|39462955|FG000|Overall Study|Lost to Follow-up|9|||
16266937|NCT02842853|39462956|FG001|Overall Study|Lost to Follow-up|13|||
16266938|NCT02842853|39462957|FG002|Overall Study|Lost to Follow-up|10|||
16266939|NCT02842853|39462958|FG003|Overall Study|Lost to Follow-up|11|||
16266940|NCT00294047|39462959|FG000|Month 48|Adverse Event|28|||
16266941|NCT00294047|39462960|FG001|Month 48|Adverse Event|13|||
16266942|NCT00294047|39462959|FG000|Month 48|Protocol Violation|4|||
16266943|NCT00294047|39462960|FG001|Month 48|Protocol Violation|4|||
16266944|NCT00294047|39462959|FG000|Month 48|Withdrawal by Subject|111|||
16266945|NCT00294047|39462960|FG001|Month 48|Withdrawal by Subject|115|||
16266946|NCT00294047|39462959|FG000|Month 48|Lost to Follow-up|272|||
16266947|NCT00294047|39462960|FG001|Month 48|Lost to Follow-up|287|||
16266948|NCT00294047|39462959|FG000|Month 48|Other|10|||
16266949|NCT00294047|39462960|FG001|Month 48|Other|14|||
16266950|NCT00294047|39462959|FG000|Month 84|Adverse Event|4|||
16266951|NCT00294047|39462960|FG001|Month 84|Adverse Event|2|||
16266952|NCT00294047|39462959|FG000|Month 84|Protocol Violation|1|||
16266953|NCT00294047|39462960|FG001|Month 84|Protocol Violation|1|||
16266954|NCT00294047|39462959|FG000|Month 84|Withdrawal by Subject|33|||
16266955|NCT00294047|39462960|FG001|Month 84|Withdrawal by Subject|31|||
16266956|NCT00294047|39462959|FG000|Month 84|Lost to Follow-up|187|||
16266957|NCT00294047|39462960|FG001|Month 84|Lost to Follow-up|190|||
16266958|NCT00294047|39462959|FG000|Month 84|Absent Cervix|2|||
16266959|NCT00294047|39462960|FG001|Month 84|Absent Cervix|0|||
16266960|NCT00294047|39462959|FG000|Month 84|Work related reasons|4|||
16266961|NCT00294047|39462960|FG001|Month 84|Work related reasons|2|||
16266962|NCT00294047|39462959|FG000|Month 84|Center closed, subject did not transfer|1|||
16266963|NCT00294047|39462960|FG001|Month 84|Center closed, subject did not transfer|0|||
16266964|NCT00294047|39462959|FG000|Month 84|Family problems|2|||
16266965|NCT00294047|39462960|FG001|Month 84|Family problems|2|||
16266966|NCT00294047|39462959|FG000|Month 84|Lack of time|3|||
16266967|NCT00294047|39462960|FG001|Month 84|Lack of time|1|||
16266968|NCT00294047|39462959|FG000|Month 84|Personal reason|2|||
16266969|NCT00294047|39462960|FG001|Month 84|Personal reason|4|||
16266970|NCT00294047|39462959|FG000|Month 84|Subject does not want male physician|1|||
16454752|NCT04455815|40144699|FG000|Treatment Phase|Withdrawal by Subject|1|||
16454753|NCT04455815|40144700|FG001|Treatment Phase|Withdrawal by Subject|1|||
16266971|NCT00294047|39462960|FG001|Month 84|Subject does not want male physician|0|||
16266972|NCT00294047|39462959|FG000|Month 84|Transport reimbursement delayed|0|||
16266973|NCT00294047|39462960|FG001|Month 84|Transport reimbursement delayed|1|||
16266974|NCT00294047|39462959|FG000|Month 84|Unable to reach study site|1|||
16266975|NCT00294047|39462960|FG001|Month 84|Unable to reach study site|0|||
16266976|NCT00294047|39462959|FG000|Month 84|Under investigation locally|1|||
16266977|NCT00294047|39462960|FG001|Month 84|Under investigation locally|0|||
16266978|NCT00294047|39462959|FG000|Month 84|Visit missed|0|||
16266979|NCT00294047|39462960|FG001|Month 84|Visit missed|1|||
16266980|NCT00294047|39462959|FG000|Month 84|No consent for Month 84 Follow-up|731|||
16266981|NCT00294047|39462960|FG001|Month 84|No consent for Month 84 Follow-up|754|||
16266982|NCT00835991|39462961|FG000|First Intervention|Adverse Event|0|||
16266983|NCT00835991|39462962|FG001|First Intervention|Adverse Event|1|||
16266984|NCT00835991|39462961|FG000|Washout|Protocol Violation|0|||
16266985|NCT00835991|39462962|FG001|Washout|Protocol Violation|2|||
16266986|NCT00835991|39462961|FG000|Washout|Withdrawal by Subject|3|||
16266987|NCT00835991|39462962|FG001|Washout|Withdrawal by Subject|1|||
16266988|NCT02088554|39462963|FG000|Overall Study|Exited before procedure|130|||
16266989|NCT02088554|39462963|FG000|Overall Study|Attempted but not implanted|31|||
16266990|NCT02088554|39462963|FG000|Overall Study|Implant not attempted|19|||
16266991|NCT02088554|39462963|FG000|Overall Study|Pending next visit|532|||
16266992|NCT02088554|39462963|FG000|Overall Study|Death|170|||
16266993|NCT02088554|39462963|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
16266994|NCT02088554|39462963|FG000|Overall Study|Lost to Follow-up|23|||
16266995|NCT02088554|39462963|FG000|Overall Study|Explanted|32|||
16266996|NCT02088554|39462963|FG000|Overall Study|Any other reason not covered by previous categories|11|||
16266997|NCT03343535|39462964|FG000|Overall Study|Lost to Follow-up|1|||
16266998|NCT03343535|39462964|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
16266999|NCT03343535|39462964|FG000|Overall Study|Death|12|||
16267000|NCT01101022|39462965|FG000|Overall Study|Adverse Event|6|||
16267001|NCT01101022|39462966|FG001|Overall Study|Adverse Event|2|||
16267002|NCT01101022|39462965|FG000|Overall Study|Protocol Violation|4|||
16267003|NCT01101022|39462966|FG001|Overall Study|Protocol Violation|3|||
16267004|NCT01101022|39462965|FG000|Overall Study|Withdrawal by Subject|3|||
16267005|NCT01101022|39462966|FG001|Overall Study|Withdrawal by Subject|8|||
16267006|NCT01101022|39462965|FG000|Overall Study|Lost to Follow-up|1|||
16267007|NCT01101022|39462966|FG001|Overall Study|Lost to Follow-up|4|||
16267008|NCT01101022|39462965|FG000|Overall Study|Lack of Efficacy|0|||
16267009|NCT01101022|39462966|FG001|Overall Study|Lack of Efficacy|7|||
16267010|NCT01101022|39462965|FG000|Overall Study|Sponsor decision|1|||
16267011|NCT01101022|39462966|FG001|Overall Study|Sponsor decision|1|||
16267012|NCT01101022|39462965|FG000|Overall Study|Non-compliance|1|||
16267013|NCT01101022|39462966|FG001|Overall Study|Non-compliance|0|||
16267014|NCT01101022|39462965|FG000|Overall Study|Work schedule|1|||
16267015|NCT01101022|39462966|FG001|Overall Study|Work schedule|1|||
16267016|NCT01101022|39462965|FG000|Overall Study|Vacation|0|||
16267017|NCT01101022|39462966|FG001|Overall Study|Vacation|1|||
16267018|NCT00747565|39462971|FG000|Overall Study|Withdrawal by Subject|10|||
16267019|NCT00747565|39462972|FG001|Overall Study|Withdrawal by Subject|6|||
16267020|NCT00747565|39462971|FG000|Overall Study|Lost to Follow-up|4|||
16267021|NCT00747565|39462972|FG001|Overall Study|Lost to Follow-up|1|||
16267022|NCT02269657|39462976|FG000|Overall Study|Protocol Violation|3|||
16267023|NCT04263649|39462977|FG000|Overall Study|Adverse Event|53|||
16267024|NCT04263649|39462977|FG000|Overall Study|Lost to Follow-up|3|||
16267025|NCT04263649|39462977|FG000|Overall Study|Death|29|||
16267026|NCT04263649|39462977|FG000|Overall Study|Device deficiency|19|||
16267027|NCT04263649|39462977|FG000|Overall Study|other reasons|11|||
16267028|NCT04089735|39462980|FG000|Overall Study|Adverse Event|1|||
16267029|NCT04089735|39462981|FG001|Overall Study|Adverse Event|0|||
16267030|NCT04089735|39462982|FG002|Overall Study|Adverse Event|1|||
16267031|NCT04089735|39462983|FG003|Overall Study|Adverse Event|1|||
16267032|NCT04089735|39462984|FG004|Overall Study|Adverse Event|0|||
16267033|NCT04089735|39462985|FG005|Overall Study|Adverse Event|0|||
16267034|NCT04089735|39462980|FG000|Overall Study|Physician Decision|0|||
16454754|NCT00796419|40144701|FG000|Overall Study|Death|0|||
16454755|NCT00796419|40144702|FG001|Overall Study|Death|1|||
16454756|NCT01419197|40144705|FG000|Overall Study|Death|247|||
16454757|NCT01419197|40144706|FG001|Overall Study|Death|122|||
16454758|NCT01419197|40144705|FG000|Overall Study|Physician Decision|4|||
16454759|NCT01419197|40144706|FG001|Overall Study|Physician Decision|4|||
16454760|NCT01419197|40144705|FG000|Overall Study|Non-compliance|3|||
16454761|NCT01419197|40144706|FG001|Overall Study|Non-compliance|1|||
16454762|NCT01419197|40144705|FG000|Overall Study|Withdrawal by Subject|33|||
16267035|NCT04089735|39462981|FG001|Overall Study|Physician Decision|3|||
16267036|NCT04089735|39462982|FG002|Overall Study|Physician Decision|0|||
16267037|NCT04089735|39462983|FG003|Overall Study|Physician Decision|0|||
16267038|NCT04089735|39462984|FG004|Overall Study|Physician Decision|0|||
16267039|NCT04089735|39462985|FG005|Overall Study|Physician Decision|0|||
16267040|NCT04089735|39462980|FG000|Overall Study|Withdrawal by Subject|0|||
16267041|NCT04089735|39462981|FG001|Overall Study|Withdrawal by Subject|0|||
16267042|NCT04089735|39462982|FG002|Overall Study|Withdrawal by Subject|1|||
16267043|NCT04089735|39462983|FG003|Overall Study|Withdrawal by Subject|0|||
16267044|NCT04089735|39462984|FG004|Overall Study|Withdrawal by Subject|0|||
16267045|NCT04089735|39462985|FG005|Overall Study|Withdrawal by Subject|0|||
16267046|NCT04089735|39462980|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
16454763|NCT01419197|40144706|FG001|Overall Study|Withdrawal by Subject|32|||
16166029|NCT00630331|39087504|FG000|Overall Study|Protocol Violation|4|||
16166030|NCT00630331|39087505|FG001|Overall Study|Protocol Violation|5|||
16166031|NCT00630331|39087506|FG002|Overall Study|Protocol Violation|6|||
16166032|NCT01670994|39087507|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
16166033|NCT01670994|39087508|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
16166034|NCT01670994|39087507|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
16166035|NCT01670994|39087508|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
16166036|NCT01670994|39087507|FG000|Overall Study|Patient experienced DLT|0|||
16166037|NCT01670994|39087508|FG001|Overall Study|Patient experienced DLT|1|||
16166038|NCT03905863|39087510|FG000|Overall Study|Adverse Event|2|||
16166039|NCT03905863|39087511|FG001|Overall Study|Adverse Event|4|||
16166040|NCT03905863|39087510|FG000|Overall Study|Withdrawal by Subject|2|||
16166041|NCT03905863|39087511|FG001|Overall Study|Withdrawal by Subject|2|||
16166042|NCT03905863|39087510|FG000|Overall Study|Physician Decision|0|||
16166043|NCT03905863|39087511|FG001|Overall Study|Physician Decision|3|||
16166044|NCT03905863|39087510|FG000|Overall Study|Lost to Follow-up|1|||
16166045|NCT03905863|39087511|FG001|Overall Study|Lost to Follow-up|0|||
16166046|NCT03905863|39087510|FG000|Overall Study|Protocol Violation|0|||
16166047|NCT03905863|39087511|FG001|Overall Study|Protocol Violation|2|||
16166048|NCT03905863|39087510|FG000|Overall Study|Death|0|||
16166049|NCT03905863|39087511|FG001|Overall Study|Death|1|||
16166050|NCT02631200|39087512|FG000|First Period|Death|1|||
16166051|NCT02631200|39087513|FG001|First Period|Death|2|||
16166052|NCT02631200|39087512|FG000|First Period|Patient ill-health|2|||
16166053|NCT02631200|39087513|FG001|First Period|Patient ill-health|4|||
16166054|NCT02631200|39087512|FG000|First Period|Withdrawal by Subject|4|||
16166055|NCT02631200|39087513|FG001|First Period|Withdrawal by Subject|1|||
16166056|NCT02631200|39087512|FG000|Deferred Period|Death|0|||
16166057|NCT02631200|39087513|FG001|Deferred Period|Death|1|||
16166058|NCT02631200|39087512|FG000|Deferred Period|Received kidney transplant|0|||
16166059|NCT02631200|39087513|FG001|Deferred Period|Received kidney transplant|1|||
16166060|NCT02631200|39087512|FG000|Deferred Period|Withdrawal by Subject|0|||
16166061|NCT02631200|39087513|FG001|Deferred Period|Withdrawal by Subject|2|||
16166062|NCT02631200|39087512|FG000|Deferred Period|Lost to Follow-up|0|||
16166063|NCT02631200|39087513|FG001|Deferred Period|Lost to Follow-up|1|||
16166064|NCT01486199|39087514|FG000|Two Year Period Between Study Days|Physician Decision|1|||
16166065|NCT01486199|39087515|FG001|Two Year Period Between Study Days|Physician Decision|0|||
16166066|NCT02152345|39087517|FG000|Overall Study|Case Cancellations|2|||
16166067|NCT02152345|39087518|FG001|Overall Study|Case Cancellations|4|||
16166068|NCT02152345|39087517|FG000|Overall Study|Withdrawal by Subject|2|||
16166069|NCT02152345|39087518|FG001|Overall Study|Withdrawal by Subject|1|||
16166070|NCT01752023|39087521|FG000|Overall Study|Physician Decision|2|||
16166071|NCT01752023|39087522|FG001|Overall Study|Physician Decision|1|||
16166072|NCT00741819|39087526|FG000|Overall Study|Adverse Event|3|||
16166073|NCT00741819|39087526|FG000|Overall Study|Withdrawal by Subject|3|||
16166074|NCT00741819|39087526|FG000|Overall Study|Death|1|||
16166075|NCT00741819|39087526|FG000|Overall Study|Disease progression|1|||
16166076|NCT01627860|39087527|FG000|Overall Study|Adverse Event|9|||
16166077|NCT01627860|39087528|FG001|Overall Study|Adverse Event|4|||
16166078|NCT01627860|39087527|FG000|Overall Study|Withdrawal by Subject|2|||
16166079|NCT01627860|39087528|FG001|Overall Study|Withdrawal by Subject|1|||
16166080|NCT01627860|39087527|FG000|Overall Study|Seizure frequency doubled|0|||
16166081|NCT01627860|39087528|FG001|Overall Study|Seizure frequency doubled|1|||
16166082|NCT01627860|39087527|FG000|Overall Study|Protocol Violation|1|||
16166083|NCT01627860|39087528|FG001|Overall Study|Protocol Violation|0|||
16166084|NCT02419508|39087532|FG000|Overall Study|Adverse Event|9|||
16166085|NCT02419508|39087533|FG001|Overall Study|Adverse Event|3|||
16166086|NCT02419508|39087532|FG000|Overall Study|Withdrawal by Subject|1|||
16166087|NCT02419508|39087533|FG001|Overall Study|Withdrawal by Subject|0|||
16166088|NCT02419508|39087532|FG000|Overall Study|Other - Reason not specified|0|||
16166089|NCT02419508|39087533|FG001|Overall Study|Other - Reason not specified|1|||
16166090|NCT01652287|39087536|FG000|Overall Study|Withdrawal by Subject|2|||
16166091|NCT01652287|39087537|FG001|Overall Study|Withdrawal by Subject|0|||
16166092|NCT00112905|39087538|FG000|Overall Study|Adverse Event|4|||
16166093|NCT00112905|39087538|FG000|Overall Study|Death|1|||
16166094|NCT00112905|39087538|FG000|Overall Study|Ineligibility|5|||
16166095|NCT00112905|39087538|FG000|Overall Study|Alternative treatment|1|||
16166096|NCT00112905|39087538|FG000|Overall Study|performance status was deteiorating|1|||
16166097|NCT04276207|39087544|FG000|Period 1|Withdrawal by Subject|0|||
16166098|NCT04276207|39087545|FG001|Period 1|Withdrawal by Subject|1|||
16166099|NCT01254669|39087550|FG000|Overall Study|Withdrawal by Subject|0|||
16166100|NCT01254669|39087551|FG001|Overall Study|Withdrawal by Subject|1|||
16267047|NCT04089735|39462981|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
16166101|NCT01254669|39087550|FG000|Overall Study|time constraint|2|||
16166102|NCT01254669|39087551|FG001|Overall Study|time constraint|2|||
16166103|NCT01254669|39087550|FG000|Overall Study|called to clinic during intervention|1|||
16166104|NCT01254669|39087551|FG001|Overall Study|called to clinic during intervention|1|||
16166105|NCT01262976|39087552|FG000|Up to Month 2|Serious Adverse Event|0|||
16166106|NCT01262976|39087553|FG001|Up to Month 2|Serious Adverse Event|0|||
16166107|NCT01262976|39087554|FG002|Up to Month 2|Serious Adverse Event|1|||
16166108|NCT01262976|39087555|FG003|Up to Month 2|Serious Adverse Event|0|||
16166109|NCT01262976|39087556|FG004|Up to Month 2|Serious Adverse Event|0|||
16166110|NCT01262976|39087557|FG005|Up to Month 2|Serious Adverse Event|0|||
16166111|NCT01262976|39087552|FG000|Up to Month 2|Withdrawal by Subject|1|||
16166112|NCT01262976|39087553|FG001|Up to Month 2|Withdrawal by Subject|0|||
16166113|NCT01262976|39087554|FG002|Up to Month 2|Withdrawal by Subject|0|||
16166114|NCT01262976|39087555|FG003|Up to Month 2|Withdrawal by Subject|0|||
16166115|NCT01262976|39087556|FG004|Up to Month 2|Withdrawal by Subject|0|||
16166116|NCT01262976|39087557|FG005|Up to Month 2|Withdrawal by Subject|0|||
16166117|NCT01262976|39087552|FG000|Up to Month 2|Migrated/moved from study area|0|||
16166118|NCT01262976|39087553|FG001|Up to Month 2|Migrated/moved from study area|1|||
16166119|NCT01262976|39087554|FG002|Up to Month 2|Migrated/moved from study area|0|||
16166120|NCT01262976|39087555|FG003|Up to Month 2|Migrated/moved from study area|0|||
16166121|NCT01262976|39087556|FG004|Up to Month 2|Migrated/moved from study area|1|||
16166122|NCT01262976|39087557|FG005|Up to Month 2|Migrated/moved from study area|1|||
16166123|NCT01262976|39087552|FG000|Up to Month 2|Lost to Follow-up|1|||
16166124|NCT01262976|39087553|FG001|Up to Month 2|Lost to Follow-up|0|||
16166125|NCT01262976|39087554|FG002|Up to Month 2|Lost to Follow-up|0|||
16166126|NCT01262976|39087555|FG003|Up to Month 2|Lost to Follow-up|1|||
16166127|NCT01262976|39087556|FG004|Up to Month 2|Lost to Follow-up|1|||
16166128|NCT01262976|39087557|FG005|Up to Month 2|Lost to Follow-up|1|||
16166129|NCT01262976|39087552|FG000|Up to Month 2|Other|1|||
16166130|NCT01262976|39087553|FG001|Up to Month 2|Other|0|||
16166131|NCT01262976|39087554|FG002|Up to Month 2|Other|0|||
16454764|NCT01419197|40144705|FG000|Overall Study|Study Completed by Sponsor|103|||
16454765|NCT01419197|40144706|FG001|Overall Study|Study Completed by Sponsor|34|||
16454766|NCT01419197|40144705|FG000|Overall Study|Reason Not Specified|0|||
16454767|NCT01419197|40144706|FG001|Overall Study|Reason Not Specified|1|||
16454768|NCT01419197|40144705|FG000|Overall Study|Lost to Follow-up|14|||
16454769|NCT01419197|40144706|FG001|Overall Study|Lost to Follow-up|4|||
16454770|NCT02147561|40144713|FG000|Overall Study|Lost to Follow-up|3|||
16454771|NCT02147561|40144713|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
16454772|NCT00515619|40144718|FG000|Overall Study|Adverse Event|34|||
16454773|NCT00515619|40144718|FG000|Overall Study|Lack of Efficacy|92|||
16454774|NCT00515619|40144718|FG000|Overall Study|Withdrawal by Subject|66|||
16454775|NCT00515619|40144718|FG000|Overall Study|Protocol Violation|3|||
16454776|NCT00515619|40144718|FG000|Overall Study|Lost to Follow-up|4|||
16454777|NCT00515619|40144718|FG000|Overall Study|Unsatisfactory compliance|6|||
16454778|NCT00515619|40144718|FG000|Overall Study|Other: Site discontinuing trials|2|||
16454779|NCT00515619|40144718|FG000|Overall Study|Other: Subject cannot attend visits|2|||
16454780|NCT00515619|40144718|FG000|Overall Study|Other: Subject required surgery|1|||
16454781|NCT00515619|40144718|FG000|Overall Study|Other: Subject moved to another country|1|||
16454782|NCT00515619|40144718|FG000|Overall Study|Other: Investigator decision|1|||
16454783|NCT00515619|40144718|FG000|Overall Study|Other: Subject became pregnant|1|||
16454784|NCT00515619|40144718|FG000|Overall Study|Other: Request from sponsor|1|||
16454785|NCT00515619|40144718|FG000|Overall Study|Other: Drug available on license|1|||
16454786|NCT00515619|40144718|FG000|Overall Study|Other: Subject interested in other AED|1|||
16454787|NCT00635219|40144719|FG000|Overall Study|Adverse Event|12|||
16454788|NCT00635219|40144720|FG001|Overall Study|Adverse Event|10|||
16454789|NCT00635219|40144721|FG002|Overall Study|Adverse Event|18|||
16454790|NCT00635219|40144722|FG003|Overall Study|Adverse Event|15|||
16454791|NCT00635219|40144723|FG004|Overall Study|Adverse Event|19|||
16454792|NCT00635219|40144719|FG000|Overall Study|Lack of Efficacy|5|||
16454793|NCT00635219|40144720|FG001|Overall Study|Lack of Efficacy|6|||
16454794|NCT00635219|40144721|FG002|Overall Study|Lack of Efficacy|3|||
16454795|NCT00635219|40144722|FG003|Overall Study|Lack of Efficacy|4|||
16454796|NCT00635219|40144723|FG004|Overall Study|Lack of Efficacy|6|||
16454797|NCT00635219|40144719|FG000|Overall Study|Non-compliance With Study Product|0|||
16454798|NCT00635219|40144720|FG001|Overall Study|Non-compliance With Study Product|0|||
16454799|NCT00635219|40144721|FG002|Overall Study|Non-compliance With Study Product|0|||
16454800|NCT00635219|40144722|FG003|Overall Study|Non-compliance With Study Product|2|||
16454801|NCT00635219|40144723|FG004|Overall Study|Non-compliance With Study Product|1|||
16454802|NCT00635219|40144719|FG000|Overall Study|Protocol Violation|0|||
16166132|NCT01262976|39087555|FG003|Up to Month 2|Other|1|||
16166133|NCT01262976|39087556|FG004|Up to Month 2|Other|0|||
16267048|NCT04089735|39462982|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
16454803|NCT00635219|40144720|FG001|Overall Study|Protocol Violation|2|||
16454804|NCT00635219|40144721|FG002|Overall Study|Protocol Violation|3|||
16454805|NCT00635219|40144722|FG003|Overall Study|Protocol Violation|2|||
16166134|NCT01262976|39087557|FG005|Up to Month 2|Other|2|||
16166135|NCT01262976|39087552|FG000|Up to Month 7|Serious Adverse Event|0|||
16166136|NCT01262976|39087553|FG001|Up to Month 7|Serious Adverse Event|0|||
16454806|NCT00635219|40144723|FG004|Overall Study|Protocol Violation|4|||
16454807|NCT00635219|40144719|FG000|Overall Study|Withdrawal of Consent|8|||
16454808|NCT00635219|40144720|FG001|Overall Study|Withdrawal of Consent|6|||
16454809|NCT00635219|40144721|FG002|Overall Study|Withdrawal of Consent|8|||
16454810|NCT00635219|40144722|FG003|Overall Study|Withdrawal of Consent|11|||
16454811|NCT00635219|40144723|FG004|Overall Study|Withdrawal of Consent|8|||
16454812|NCT00635219|40144719|FG000|Overall Study|Lost to Follow-up|0|||
16454813|NCT00635219|40144720|FG001|Overall Study|Lost to Follow-up|0|||
16454814|NCT00635219|40144721|FG002|Overall Study|Lost to Follow-up|2|||
16454815|NCT00635219|40144722|FG003|Overall Study|Lost to Follow-up|0|||
16454816|NCT00635219|40144723|FG004|Overall Study|Lost to Follow-up|3|||
16454817|NCT00635219|40144719|FG000|Overall Study|Administrative or Other Reasons|0|||
16454818|NCT00635219|40144720|FG001|Overall Study|Administrative or Other Reasons|1|||
16454819|NCT00635219|40144721|FG002|Overall Study|Administrative or Other Reasons|1|||
16454820|NCT00635219|40144722|FG003|Overall Study|Administrative or Other Reasons|0|||
16454821|NCT00635219|40144723|FG004|Overall Study|Administrative or Other Reasons|1|||
16454822|NCT00831493|40144724|FG000|Overall Study|Intractable nausea and vomiting|1|||
16454823|NCT02709538|40144726|FG000|Overall Study|Adverse Event|13|||
16454824|NCT02709538|40144727|FG001|Overall Study|Adverse Event|2|||
16454825|NCT02709538|40144728|FG002|Overall Study|Adverse Event|3|||
16454826|NCT02709538|40144726|FG000|Overall Study|Lack of Efficacy|1|||
16454827|NCT02709538|40144727|FG001|Overall Study|Lack of Efficacy|0|||
16454828|NCT02709538|40144728|FG002|Overall Study|Lack of Efficacy|0|||
16454829|NCT02709538|40144726|FG000|Overall Study|Lost to Follow-up|24|||
16454830|NCT02709538|40144727|FG001|Overall Study|Lost to Follow-up|8|||
16454831|NCT02709538|40144728|FG002|Overall Study|Lost to Follow-up|4|||
16454832|NCT02709538|40144726|FG000|Overall Study|Physician Decision|1|||
16454833|NCT02709538|40144727|FG001|Overall Study|Physician Decision|0|||
16454834|NCT02709538|40144728|FG002|Overall Study|Physician Decision|0|||
16454835|NCT02709538|40144726|FG000|Overall Study|Withdrawal by Subject|40|||
16454836|NCT02709538|40144727|FG001|Overall Study|Withdrawal by Subject|7|||
16454837|NCT02709538|40144728|FG002|Overall Study|Withdrawal by Subject|4|||
16454838|NCT02709538|40144726|FG000|Overall Study|Non-compliance with study procedures|5|||
16454839|NCT02709538|40144727|FG001|Overall Study|Non-compliance with study procedures|0|||
16454840|NCT02709538|40144728|FG002|Overall Study|Non-compliance with study procedures|0|||
16454841|NCT02709538|40144726|FG000|Overall Study|Non-compliance with study drug|2|||
16454842|NCT02709538|40144727|FG001|Overall Study|Non-compliance with study drug|0|||
16454843|NCT02709538|40144728|FG002|Overall Study|Non-compliance with study drug|0|||
16454844|NCT02709538|40144726|FG000|Overall Study|Protocol deviation|10|||
16454845|NCT02709538|40144727|FG001|Overall Study|Protocol deviation|4|||
16454846|NCT02709538|40144728|FG002|Overall Study|Protocol deviation|4|||
16454847|NCT02709538|40144726|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
16454848|NCT02709538|40144727|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
16454849|NCT02709538|40144728|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
16454850|NCT02709538|40144726|FG000|Overall Study|Other|16|||
16454851|NCT02709538|40144727|FG001|Overall Study|Other|7|||
16454852|NCT02709538|40144728|FG002|Overall Study|Other|5|||
16454853|NCT03110770|40144730|FG000|Overall Study|Death|1|||
16454854|NCT03110770|40144731|FG001|Overall Study|Death|0|||
16454855|NCT03110770|40144732|FG002|Overall Study|Death|0|||
16454856|NCT03110770|40144733|FG003|Overall Study|Death|1|||
16454857|NCT03110770|40144734|FG004|Overall Study|Death|0|||
16454858|NCT03110770|40144730|FG000|Overall Study|Enrolled but did not receive product|0|||
16454859|NCT03110770|40144731|FG001|Overall Study|Enrolled but did not receive product|0|||
16454860|NCT03110770|40144732|FG002|Overall Study|Enrolled but did not receive product|0|||
16454861|NCT03110770|40144733|FG003|Overall Study|Enrolled but did not receive product|8|||
16454862|NCT03110770|40144734|FG004|Overall Study|Enrolled but did not receive product|7|||
16454863|NCT03110770|40144730|FG000|Overall Study|Lost to Follow-up|0|||
16454864|NCT03110770|40144731|FG001|Overall Study|Lost to Follow-up|0|||
16454865|NCT03110770|40144732|FG002|Overall Study|Lost to Follow-up|0|||
16454866|NCT03110770|40144733|FG003|Overall Study|Lost to Follow-up|53|||
16454867|NCT03110770|40144734|FG004|Overall Study|Lost to Follow-up|45|||
16454868|NCT03110770|40144730|FG000|Overall Study|Investigator Decision|0|||
16454869|NCT03110770|40144731|FG001|Overall Study|Investigator Decision|0|||
16454870|NCT03110770|40144732|FG002|Overall Study|Investigator Decision|0|||
16454871|NCT03110770|40144733|FG003|Overall Study|Investigator Decision|5|||
16454872|NCT03110770|40144734|FG004|Overall Study|Investigator Decision|3|||
16454873|NCT03110770|40144730|FG000|Overall Study|Withdrawal by Subject|0|||
16454874|NCT03110770|40144731|FG001|Overall Study|Withdrawal by Subject|0|||
16454875|NCT03110770|40144732|FG002|Overall Study|Withdrawal by Subject|0|||
16454876|NCT03110770|40144733|FG003|Overall Study|Withdrawal by Subject|24|||
16454877|NCT03110770|40144734|FG004|Overall Study|Withdrawal by Subject|24|||
16454878|NCT03110770|40144730|FG000|Overall Study|Moved from area|5|||
16454879|NCT03110770|40144731|FG001|Overall Study|Moved from area|0|||
16454880|NCT03110770|40144732|FG002|Overall Study|Moved from area|2|||
16454881|NCT03110770|40144733|FG003|Overall Study|Moved from area|42|||
16454882|NCT03110770|40144734|FG004|Overall Study|Moved from area|43|||
16454883|NCT03110770|40144730|FG000|Overall Study|Illness/Injury unrelated to product|0|||
16454884|NCT03110770|40144731|FG001|Overall Study|Illness/Injury unrelated to product|0|||
16454885|NCT03110770|40144732|FG002|Overall Study|Illness/Injury unrelated to product|0|||
16454886|NCT03110770|40144733|FG003|Overall Study|Illness/Injury unrelated to product|0|||
16454887|NCT03110770|40144734|FG004|Overall Study|Illness/Injury unrelated to product|1|||
16454888|NCT00479687|40144737|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
16454889|NCT00479687|40144738|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
16454890|NCT00479687|40144739|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
16454891|NCT00479687|40144737|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
16454892|NCT00479687|40144738|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
16454893|NCT00479687|40144739|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
16454894|NCT00479687|40144737|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
16454895|NCT00479687|40144738|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
16454896|NCT00479687|40144739|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
16454897|NCT00479687|40144737|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
16454898|NCT00479687|40144738|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
16454899|NCT00479687|40144739|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
16454900|NCT00479687|40144737|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
16454901|NCT00479687|40144738|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
16454902|NCT00479687|40144739|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
16454903|NCT00479687|40144737|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
16454904|NCT00479687|40144738|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
16454905|NCT00479687|40144739|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
16454906|NCT00479687|40144737|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
16454907|NCT00479687|40144738|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
16454908|NCT00479687|40144739|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
16454909|NCT00479687|40144737|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
16454910|NCT00479687|40144738|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
16454911|NCT00479687|40144739|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
16454912|NCT00479687|40144737|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
16454913|NCT00479687|40144738|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
16454914|NCT00479687|40144739|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
16454915|NCT00804908|40144740|FG000|Overall Study|Other|115|||
16454916|NCT00804908|40144741|FG001|Overall Study|Other|116|||
16454917|NCT00804908|40144742|FG002|Overall Study|Other|114|||
16454918|NCT03783078|40144743|FG000|Overall Study|Participants Ongoing|29|||
16454919|NCT03783078|40144743|FG000|Overall Study|Death|26|||
16454920|NCT01354899|40144752|FG000|Overall Study|discharge from the hospital|2|||
16454921|NCT01354899|40144752|FG000|Overall Study|Protocol Violation|1|||
16454922|NCT02864862|40144753|FG000|Overall Study|Lost to Follow-up|1|||
16454923|NCT02864862|40144754|FG001|Overall Study|Lost to Follow-up|0|||
16267049|NCT04089735|39462983|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
16267050|NCT04089735|39462984|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
16267051|NCT04089735|39462985|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
16267052|NCT01788423|39462993|FG000|Overall Study|See Comments in Completed (above)|0|||
16267053|NCT01788423|39462994|FG001|Overall Study|See Comments in Completed (above)|4|||
16267054|NCT01788423|39462995|FG002|Overall Study|See Comments in Completed (above)|5|||
16267055|NCT01376167|39462997|FG000|Overall Study|Lost to Follow-up|2|||
16267056|NCT01376167|39462998|FG001|Overall Study|Lost to Follow-up|4|||
16267057|NCT01376167|39462999|FG002|Overall Study|Lost to Follow-up|2|||
16267058|NCT01376167|39462997|FG000|Overall Study|Physician Decision|1|||
16267059|NCT01376167|39462998|FG001|Overall Study|Physician Decision|1|||
16267060|NCT01376167|39462999|FG002|Overall Study|Physician Decision|0|||
16267061|NCT01376167|39462997|FG000|Overall Study|Withdrawal by Subject|1|||
16267062|NCT01376167|39462998|FG001|Overall Study|Withdrawal by Subject|5|||
16267063|NCT01376167|39462999|FG002|Overall Study|Withdrawal by Subject|4|||
16267064|NCT01634139|39463000|FG000|Overall Study|Non compliant with protocol|1|||
16267065|NCT01634139|39463001|FG001|Overall Study|Non compliant with protocol|0|||
16267066|NCT01634139|39463002|FG002|Overall Study|Non compliant with protocol|0|||
16267067|NCT01634139|39463000|FG000|Overall Study|Consent withdrawn not due to AE|4|||
16267068|NCT01634139|39463001|FG001|Overall Study|Consent withdrawn not due to AE|3|||
16267069|NCT01634139|39463002|FG002|Overall Study|Consent withdrawn not due to AE|2|||
16267070|NCT01634139|39463000|FG000|Overall Study|Other|4|||
16267071|NCT01634139|39463001|FG001|Overall Study|Other|0|||
16267072|NCT01634139|39463002|FG002|Overall Study|Other|3|||
16267073|NCT01634139|39463000|FG000|Overall Study|Lost to Follow-up|0|||
16454924|NCT02864862|40144755|FG002|Overall Study|Lost to Follow-up|1|||
16454925|NCT02864862|40144753|FG000|Overall Study|Protocol Violation|0|||
16454926|NCT02864862|40144754|FG001|Overall Study|Protocol Violation|0|||
16267074|NCT01634139|39463001|FG001|Overall Study|Lost to Follow-up|2|||
16267075|NCT01634139|39463002|FG002|Overall Study|Lost to Follow-up|0|||
16267076|NCT01634139|39463000|FG000|Overall Study|Not treated|1|||
16267077|NCT01634139|39463001|FG001|Overall Study|Not treated|1|||
16267078|NCT01634139|39463002|FG002|Overall Study|Not treated|0|||
16267079|NCT00840073|39463003|FG000|Second Intervention|Missed 72 hour blood draw|1|||
16267080|NCT00840073|39463004|FG001|Second Intervention|Missed 72 hour blood draw|1|||
16267081|NCT00420303|39463008|FG000|Overall Study|Serious Adverse Event|1|||
16267082|NCT00420303|39463009|FG001|Overall Study|Serious Adverse Event|0|||
16267083|NCT00420303|39463008|FG000|Overall Study|Lack of Efficacy|0|||
16267084|NCT00420303|39463009|FG001|Overall Study|Lack of Efficacy|3|||
16267085|NCT00420303|39463008|FG000|Overall Study|Physician Decision|0|||
16267086|NCT00420303|39463009|FG001|Overall Study|Physician Decision|1|||
16267087|NCT00859521|39463010|FG000|Washout|Withdrawal by Subject|0|||
16267088|NCT00859521|39463011|FG001|Washout|Withdrawal by Subject|1|||
16267089|NCT00440518|39463012|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
16267090|NCT00440518|39463013|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
16267091|NCT00440518|39463014|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
16267092|NCT00440518|39463012|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
16267093|NCT00440518|39463013|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
16267094|NCT00440518|39463014|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
16267095|NCT00440518|39463012|FG000|Randomized /Titration Period|Protocol Deviation|1|||
16267096|NCT00440518|39463013|FG001|Randomized /Titration Period|Protocol Deviation|0|||
16267097|NCT00440518|39463014|FG002|Randomized /Titration Period|Protocol Deviation|0|||
16267098|NCT00440518|39463012|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
16267099|NCT00440518|39463013|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
16267100|NCT00440518|39463014|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
16267101|NCT00440518|39463012|FG000|Randomized /Titration Period|Other|1|||
16267102|NCT00440518|39463013|FG001|Randomized /Titration Period|Other|0|||
16267103|NCT00440518|39463014|FG002|Randomized /Titration Period|Other|0|||
16267104|NCT00440518|39463012|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
16267105|NCT00440518|39463013|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
16267106|NCT00440518|39463014|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
16267107|NCT00440518|39463012|FG000|Randomized /Titration Period|Adverse Event|2|||
16267108|NCT00440518|39463013|FG001|Randomized /Titration Period|Adverse Event|3|||
16267109|NCT00440518|39463014|FG002|Randomized /Titration Period|Adverse Event|0|||
16267110|NCT00440518|39463012|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
16267111|NCT00440518|39463013|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
16267112|NCT00440518|39463014|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
16267113|NCT00440518|39463012|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
16267114|NCT00440518|39463013|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
16267115|NCT00440518|39463014|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
16267116|NCT00440518|39463012|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
16267117|NCT00440518|39463013|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
16267118|NCT00440518|39463014|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
16267119|NCT00440518|39463012|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
16267120|NCT00440518|39463013|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
16267121|NCT00440518|39463014|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
16267122|NCT00440518|39463012|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
16267123|NCT00440518|39463013|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
16267124|NCT00440518|39463014|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
16267125|NCT00440518|39463012|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
16267126|NCT00440518|39463013|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
16267127|NCT00440518|39463014|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
16267128|NCT02106156|39463015|FG000|Overall Study|Patient Died|19|||
16267129|NCT02106156|39463016|FG001|Overall Study|Patient Died|0|||
16267130|NCT02106156|39463017|FG002|Overall Study|Patient Died|0|||
16267131|NCT02106156|39463015|FG000|Overall Study|Lack of Tolerability|305|||
16267132|NCT02106156|39463016|FG001|Overall Study|Lack of Tolerability|3|||
16267133|NCT02106156|39463017|FG002|Overall Study|Lack of Tolerability|0|||
16267134|NCT02106156|39463015|FG000|Overall Study|Lack of Virological Response|1044|||
16267135|NCT02106156|39463016|FG001|Overall Study|Lack of Virological Response|8|||
16267136|NCT02106156|39463017|FG002|Overall Study|Lack of Virological Response|0|||
16454927|NCT02864862|40144755|FG002|Overall Study|Protocol Violation|1|||
16267137|NCT02106156|39463015|FG000|Overall Study|Concomitant Disease|74|||
16267138|NCT02106156|39463016|FG001|Overall Study|Concomitant Disease|2|||
16267139|NCT02106156|39463017|FG002|Overall Study|Concomitant Disease|0|||
16267140|NCT02106156|39463015|FG000|Overall Study|Lack of Compliance|211|||
16267141|NCT02106156|39463016|FG001|Overall Study|Lack of Compliance|7|||
16267142|NCT02106156|39463017|FG002|Overall Study|Lack of Compliance|0|||
16267143|NCT02106156|39463015|FG000|Overall Study|Patients Request|307|||
16454928|NCT03695367|40144756|FG000|Overall Study|Missed the Day 28 visit.|1|||
16267144|NCT02106156|39463016|FG001|Overall Study|Patients Request|9|||
16267145|NCT02106156|39463017|FG002|Overall Study|Patients Request|0|||
16267146|NCT02106156|39463015|FG000|Overall Study|Lost to Follow-up|451|||
16267147|NCT02106156|39463016|FG001|Overall Study|Lost to Follow-up|8|||
16267148|NCT02106156|39463017|FG002|Overall Study|Lost to Follow-up|0|||
16267149|NCT02106156|39463015|FG000|Overall Study|Unplanned Event|82|||
16267150|NCT02106156|39463016|FG001|Overall Study|Unplanned Event|2|||
16267151|NCT02106156|39463017|FG002|Overall Study|Unplanned Event|0|||
16267152|NCT02106156|39463015|FG000|Overall Study|Change of Laboratory Parameter|10|||
16267153|NCT02106156|39463016|FG001|Overall Study|Change of Laboratory Parameter|0|||
16267154|NCT02106156|39463017|FG002|Overall Study|Change of Laboratory Parameter|0|||
16267155|NCT02106156|39463015|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
16267156|NCT02106156|39463016|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
16267157|NCT02106156|39463017|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
16267158|NCT02106156|39463015|FG000|Overall Study|Relocation/Change of Physician|40|||
16267159|NCT02106156|39463016|FG001|Overall Study|Relocation/Change of Physician|1|||
16267160|NCT02106156|39463017|FG002|Overall Study|Relocation/Change of Physician|0|||
16267161|NCT00811655|39463025|FG000|Overall Study|Physician Decision|1|||
16267162|NCT00059332|39463027|FG000|Overall Study|Withdrawal by Subject|2|||
16267163|NCT00059332|39463028|FG001|Overall Study|Withdrawal by Subject|1|||
16267164|NCT00059332|39463027|FG000|Overall Study|Lost to Follow-up|1|||
16267165|NCT00059332|39463028|FG001|Overall Study|Lost to Follow-up|1|||
16267166|NCT00835575|39463036|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
16267167|NCT00835575|39463037|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
16267168|NCT00443651|39463038|FG000|Overall Study|Death|1|||
16267169|NCT00443651|39463039|FG001|Overall Study|Death|5|||
16267170|NCT00443651|39463038|FG000|Overall Study|Adverse Event|5|||
16267171|NCT00443651|39463039|FG001|Overall Study|Adverse Event|6|||
16267172|NCT00443651|39463038|FG000|Overall Study|Lost to Follow-up|18|||
16267173|NCT00443651|39463039|FG001|Overall Study|Lost to Follow-up|12|||
16267174|NCT00443651|39463038|FG000|Overall Study|Patient's/Guardian's Decision|58|||
16267175|NCT00443651|39463039|FG001|Overall Study|Patient's/Guardian's Decision|30|||
16267176|NCT00443651|39463038|FG000|Overall Study|Physician Decision|13|||
16267177|NCT00443651|39463039|FG001|Overall Study|Physician Decision|4|||
16267178|NCT00443651|39463038|FG000|Overall Study|Pregnancy|0|||
16267179|NCT00443651|39463039|FG001|Overall Study|Pregnancy|1|||
16267180|NCT00606281|39463042|FG000|Overall Study|Adverse Event|11|||
16267181|NCT00606281|39463043|FG001|Overall Study|Adverse Event|12|||
16267182|NCT00606281|39463042|FG000|Overall Study|Death|1|||
16267183|NCT00606281|39463043|FG001|Overall Study|Death|0|||
16267184|NCT00606281|39463042|FG000|Overall Study|Lack of Efficacy|28|||
16267185|NCT00606281|39463043|FG001|Overall Study|Lack of Efficacy|35|||
16267186|NCT00606281|39463042|FG000|Overall Study|Physician Decision|0|||
16267187|NCT00606281|39463043|FG001|Overall Study|Physician Decision|1|||
16267188|NCT00606281|39463042|FG000|Overall Study|Protocol Violation|3|||
16267189|NCT00606281|39463043|FG001|Overall Study|Protocol Violation|3|||
16267190|NCT00606281|39463042|FG000|Overall Study|Withdrawal by Subject|11|||
16267191|NCT00606281|39463043|FG001|Overall Study|Withdrawal by Subject|13|||
16267192|NCT00606281|39463042|FG000|Overall Study|Progression to depressive phase|1|||
16267193|NCT00606281|39463043|FG001|Overall Study|Progression to depressive phase|1|||
16454929|NCT03695367|40144757|FG001|Overall Study|Missed the Day 28 visit.|0|||
16454930|NCT03695367|40144756|FG000|Overall Study|Lost to Follow-up|0|||
16454931|NCT03695367|40144757|FG001|Overall Study|Lost to Follow-up|1|||
16454932|NCT03695367|40144756|FG000|Overall Study|Withdrawal by Subject|0|||
16454933|NCT03695367|40144757|FG001|Overall Study|Withdrawal by Subject|1|||
16454934|NCT03695367|40144756|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
16454935|NCT03695367|40144757|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
16454936|NCT02318706|40144758|FG000|Double-blind Phase|Adverse Event|7|||
16454937|NCT02318706|40144759|FG001|Double-blind Phase|Adverse Event|4|||
16267194|NCT00606281|39463042|FG000|Overall Study|Change of residence or other commitments|1|||
16267195|NCT00606281|39463043|FG001|Overall Study|Change of residence or other commitments|1|||
16267196|NCT01975948|39463044|FG000|Overall Study|Withdrawal by Subject|17|||
16267197|NCT01975948|39463045|FG001|Overall Study|Withdrawal by Subject|21|||
16267198|NCT01975948|39463046|FG002|Overall Study|Withdrawal by Subject|7|||
16267199|NCT01975948|39463047|FG003|Overall Study|Withdrawal by Subject|6|||
16267200|NCT03446768|39463048|FG000|Overall Study|Withdrawal by Subject|0|||
16267201|NCT03446768|39463049|FG001|Overall Study|Withdrawal by Subject|1|||
16267202|NCT00841698|39463050|FG000|First Intervention|Withdrawal by Subject|1|||
16454938|NCT02318706|40144760|FG002|Double-blind Phase|Adverse Event|3|||
16454939|NCT02318706|40144761|FG003|Double-blind Phase|Adverse Event|10|||
16454940|NCT02318706|40144762|FG004|Double-blind Phase|Adverse Event|0|||
16454941|NCT02318706|40144758|FG000|Double-blind Phase|Lost to Follow-up|1|||
16454942|NCT02318706|40144759|FG001|Double-blind Phase|Lost to Follow-up|0|||
16454943|NCT02318706|40144760|FG002|Double-blind Phase|Lost to Follow-up|0|||
16454944|NCT02318706|40144761|FG003|Double-blind Phase|Lost to Follow-up|0|||
16454945|NCT02318706|40144762|FG004|Double-blind Phase|Lost to Follow-up|0|||
16267203|NCT00841698|39463051|FG001|First Intervention|Withdrawal by Subject|0|||
16267204|NCT00152451|39463052|FG000|Overall Study|Adverse Event|4|||
16267205|NCT03106415|39463053|FG000|Phase 1|Withdrawal by Subject|1|||
16267206|NCT03106415|39463054|FG001|Phase 1|Withdrawal by Subject|0|||
16267207|NCT03106415|39463055|FG002|Phase 1|Withdrawal by Subject|0|||
16267208|NCT03106415|39463053|FG000|Phase 1|Adverse Event|1|||
16267209|NCT03106415|39463054|FG001|Phase 1|Adverse Event|1|||
16267210|NCT03106415|39463055|FG002|Phase 1|Adverse Event|0|||
16267211|NCT03106415|39463053|FG000|Phase 1|Protocol Violation|0|||
16267212|NCT03106415|39463054|FG001|Phase 1|Protocol Violation|1|||
16267213|NCT03106415|39463055|FG002|Phase 1|Protocol Violation|0|||
16267214|NCT00073307|39463063|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
16267215|NCT00073307|39463064|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
16267216|NCT00073307|39463065|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
16267217|NCT00073307|39463063|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
16267218|NCT00073307|39463064|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
16267219|NCT00073307|39463065|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
16267220|NCT00073307|39463063|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
16267221|NCT00073307|39463064|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
16267222|NCT00073307|39463065|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
16267223|NCT00073307|39463063|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
16267224|NCT00073307|39463064|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
16267225|NCT00073307|39463065|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
16267226|NCT00073307|39463063|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
16267227|NCT00073307|39463064|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
16267228|NCT00073307|39463065|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
16267229|NCT00073307|39463063|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
16267230|NCT00073307|39463064|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
16267231|NCT00073307|39463065|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
16267232|NCT00073307|39463063|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
16267233|NCT00073307|39463064|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
16267234|NCT00073307|39463065|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
16267235|NCT00073307|39463063|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
16267236|NCT00073307|39463064|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
16267237|NCT00073307|39463065|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
16267238|NCT00073307|39463063|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
16267239|NCT00073307|39463064|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
16267240|NCT00073307|39463065|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
16267241|NCT00073307|39463063|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
16267242|NCT00073307|39463064|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
16267243|NCT00073307|39463065|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
16267244|NCT00073307|39463063|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
16267245|NCT00073307|39463064|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
16267246|NCT00073307|39463065|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
16267247|NCT00073307|39463063|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
16267248|NCT00073307|39463064|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
16267249|NCT00073307|39463065|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
16267250|NCT00073307|39463063|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
16267251|NCT00073307|39463064|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
16267252|NCT00073307|39463065|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
16267253|NCT00073307|39463063|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
16267254|NCT00073307|39463064|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
16267255|NCT00073307|39463065|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
16267256|NCT00073307|39463063|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
16267257|NCT00073307|39463064|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
16267258|NCT00073307|39463065|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
16267259|NCT00073307|39463063|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
16267260|NCT00073307|39463064|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
16267261|NCT00073307|39463065|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
16267262|NCT00073307|39463063|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
16267263|NCT00073307|39463064|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
16267264|NCT00073307|39463065|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
16454946|NCT02318706|40144758|FG000|Double-blind Phase|Protocol Violation|4|||
16267265|NCT00073307|39463063|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
16454947|NCT02318706|40144759|FG001|Double-blind Phase|Protocol Violation|2|||
16454948|NCT02318706|40144760|FG002|Double-blind Phase|Protocol Violation|4|||
16454949|NCT02318706|40144761|FG003|Double-blind Phase|Protocol Violation|3|||
16454950|NCT02318706|40144762|FG004|Double-blind Phase|Protocol Violation|0|||
16454951|NCT02318706|40144758|FG000|Double-blind Phase|Withdrawal by Subject|9|||
16454952|NCT02318706|40144759|FG001|Double-blind Phase|Withdrawal by Subject|5|||
16454953|NCT02318706|40144760|FG002|Double-blind Phase|Withdrawal by Subject|7|||
16454954|NCT02318706|40144761|FG003|Double-blind Phase|Withdrawal by Subject|10|||
16454955|NCT02318706|40144762|FG004|Double-blind Phase|Withdrawal by Subject|0|||
16454956|NCT02318706|40144758|FG000|Double-blind Phase|Other|4|||
16454957|NCT02318706|40144759|FG001|Double-blind Phase|Other|1|||
16454958|NCT02318706|40144760|FG002|Double-blind Phase|Other|2|||
16454959|NCT02318706|40144761|FG003|Double-blind Phase|Other|1|||
16454960|NCT02318706|40144762|FG004|Double-blind Phase|Other|0|||
16454961|NCT02318706|40144758|FG000|Double-blind Phase|Death|0|||
16454962|NCT02318706|40144759|FG001|Double-blind Phase|Death|0|||
16454963|NCT02318706|40144760|FG002|Double-blind Phase|Death|2|||
16454964|NCT02318706|40144761|FG003|Double-blind Phase|Death|0|||
16454965|NCT02318706|40144762|FG004|Double-blind Phase|Death|0|||
16166137|NCT01262976|39087554|FG002|Up to Month 7|Serious Adverse Event|2|||
16166138|NCT01262976|39087555|FG003|Up to Month 7|Serious Adverse Event|0|||
16166139|NCT01262976|39087556|FG004|Up to Month 7|Serious Adverse Event|0|||
16166140|NCT01262976|39087557|FG005|Up to Month 7|Serious Adverse Event|0|||
16166141|NCT01262976|39087552|FG000|Up to Month 7|Withdrawal by Subject|1|||
16166142|NCT01262976|39087553|FG001|Up to Month 7|Withdrawal by Subject|0|||
16166143|NCT01262976|39087554|FG002|Up to Month 7|Withdrawal by Subject|0|||
16166144|NCT01262976|39087555|FG003|Up to Month 7|Withdrawal by Subject|0|||
16166145|NCT01262976|39087556|FG004|Up to Month 7|Withdrawal by Subject|0|||
16166146|NCT01262976|39087557|FG005|Up to Month 7|Withdrawal by Subject|0|||
16166147|NCT01262976|39087552|FG000|Up to Month 7|Migrated/moved from study area|0|||
16166148|NCT01262976|39087553|FG001|Up to Month 7|Migrated/moved from study area|0|||
16166149|NCT01262976|39087554|FG002|Up to Month 7|Migrated/moved from study area|1|||
16166150|NCT01262976|39087555|FG003|Up to Month 7|Migrated/moved from study area|3|||
16166151|NCT01262976|39087556|FG004|Up to Month 7|Migrated/moved from study area|1|||
16166152|NCT01262976|39087557|FG005|Up to Month 7|Migrated/moved from study area|1|||
16166153|NCT01262976|39087552|FG000|Up to Month 7|Lost to Follow-up|1|||
16166154|NCT01262976|39087553|FG001|Up to Month 7|Lost to Follow-up|0|||
16166155|NCT01262976|39087554|FG002|Up to Month 7|Lost to Follow-up|1|||
16166156|NCT01262976|39087555|FG003|Up to Month 7|Lost to Follow-up|3|||
16166157|NCT01262976|39087556|FG004|Up to Month 7|Lost to Follow-up|1|||
16166158|NCT01262976|39087557|FG005|Up to Month 7|Lost to Follow-up|3|||
16166159|NCT01262976|39087552|FG000|Up to Month 7|Other|3|||
16166160|NCT01262976|39087553|FG001|Up to Month 7|Other|0|||
16166161|NCT01262976|39087554|FG002|Up to Month 7|Other|2|||
16166162|NCT01262976|39087555|FG003|Up to Month 7|Other|0|||
16166163|NCT01262976|39087556|FG004|Up to Month 7|Other|0|||
16166164|NCT01262976|39087557|FG005|Up to Month 7|Other|0|||
16166165|NCT01262976|39087552|FG000|Up to Year 1|Serious Adverse Event|0|||
16166166|NCT01262976|39087553|FG001|Up to Year 1|Serious Adverse Event|0|||
16166167|NCT01262976|39087554|FG002|Up to Year 1|Serious Adverse Event|2|||
16166168|NCT01262976|39087555|FG003|Up to Year 1|Serious Adverse Event|0|||
16166169|NCT01262976|39087556|FG004|Up to Year 1|Serious Adverse Event|0|||
16166170|NCT01262976|39087557|FG005|Up to Year 1|Serious Adverse Event|0|||
16166171|NCT01262976|39087552|FG000|Up to Year 1|Withdrawal by Subject|1|||
16166172|NCT01262976|39087553|FG001|Up to Year 1|Withdrawal by Subject|0|||
16166173|NCT01262976|39087554|FG002|Up to Year 1|Withdrawal by Subject|0|||
16166174|NCT01262976|39087555|FG003|Up to Year 1|Withdrawal by Subject|0|||
16166175|NCT01262976|39087556|FG004|Up to Year 1|Withdrawal by Subject|0|||
16166176|NCT01262976|39087557|FG005|Up to Year 1|Withdrawal by Subject|0|||
16166177|NCT01262976|39087552|FG000|Up to Year 1|Migrated/moved from study area|1|||
16166178|NCT01262976|39087553|FG001|Up to Year 1|Migrated/moved from study area|0|||
16166179|NCT01262976|39087554|FG002|Up to Year 1|Migrated/moved from study area|0|||
16166180|NCT01262976|39087555|FG003|Up to Year 1|Migrated/moved from study area|3|||
16166181|NCT01262976|39087556|FG004|Up to Year 1|Migrated/moved from study area|3|||
16166182|NCT01262976|39087557|FG005|Up to Year 1|Migrated/moved from study area|2|||
16166183|NCT01262976|39087552|FG000|Up to Year 1|Lost to Follow-up|4|||
16166184|NCT01262976|39087553|FG001|Up to Year 1|Lost to Follow-up|0|||
16166185|NCT01262976|39087554|FG002|Up to Year 1|Lost to Follow-up|0|||
16166186|NCT01262976|39087555|FG003|Up to Year 1|Lost to Follow-up|1|||
16166187|NCT01262976|39087556|FG004|Up to Year 1|Lost to Follow-up|6|||
16166188|NCT01262976|39087557|FG005|Up to Year 1|Lost to Follow-up|5|||
16166189|NCT01262976|39087552|FG000|Up to Year 1|Other|3|||
16166190|NCT01262976|39087553|FG001|Up to Year 1|Other|1|||
16166191|NCT01262976|39087554|FG002|Up to Year 1|Other|0|||
16454966|NCT02318706|40144758|FG000|Open-label Extension Phase|Adverse Event|0|||
16454967|NCT02318706|40144759|FG001|Open-label Extension Phase|Adverse Event|0|||
16454968|NCT02318706|40144760|FG002|Open-label Extension Phase|Adverse Event|0|||
16454969|NCT02318706|40144761|FG003|Open-label Extension Phase|Adverse Event|0|||
16454970|NCT02318706|40144762|FG004|Open-label Extension Phase|Adverse Event|21|||
16267266|NCT00073307|39463064|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
16267267|NCT00073307|39463065|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
16267268|NCT00073307|39463063|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
16267269|NCT00073307|39463064|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
16267270|NCT00073307|39463065|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
16267271|NCT04572633|39463066|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
16267272|NCT00834340|39463067|FG000|Washout|Adverse Event|1|||
16267273|NCT00834340|39463068|FG001|Washout|Adverse Event|0|||
16267274|NCT00834340|39463067|FG000|Washout|Withdrawal by Subject|1|||
16267275|NCT00834340|39463068|FG001|Washout|Withdrawal by Subject|0|||
16267276|NCT03276754|39463072|FG000|Overall Study|Withdrawal of informed consent|4|||
16267277|NCT03276754|39463072|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
16267278|NCT03276754|39463072|FG000|Overall Study|Lost to Follow-up|27|||
16267279|NCT03276754|39463072|FG000|Overall Study|No data reported at Month 24|31|||
16267280|NCT03276754|39463072|FG000|Overall Study|Death|39|||
16267281|NCT00829530|39463073|FG000|First Intervention|Adverse Event|0|||
16267282|NCT00829530|39463074|FG001|First Intervention|Adverse Event|1|||
16267283|NCT00829530|39463073|FG000|First Intervention|Intolerance to Venopuncture|0|||
16267284|NCT00829530|39463074|FG001|First Intervention|Intolerance to Venopuncture|1|||
16267285|NCT00829530|39463073|FG000|Second Intervention|Intolerance to Venopuncture|1|||
16267286|NCT00829530|39463074|FG001|Second Intervention|Intolerance to Venopuncture|0|||
16267287|NCT03114891|39463075|FG000|First Treatment Round|Lost to Follow-up|0|||
16267288|NCT03114891|39463076|FG001|First Treatment Round|Lost to Follow-up|1|||
16267289|NCT03114891|39463077|FG002|First Treatment Round|Lost to Follow-up|1|||
16267290|NCT03114891|39463078|FG003|First Treatment Round|Lost to Follow-up|0|||
16267291|NCT03114891|39463075|FG000|First Treatment Round|Withdrawal by Subject|0|||
16267292|NCT03114891|39463076|FG001|First Treatment Round|Withdrawal by Subject|2|||
16267293|NCT03114891|39463077|FG002|First Treatment Round|Withdrawal by Subject|0|||
16267294|NCT03114891|39463078|FG003|First Treatment Round|Withdrawal by Subject|1|||
16267295|NCT03114891|39463075|FG000|3 Week Break|Lost to Follow-up|1|||
16267296|NCT03114891|39463076|FG001|3 Week Break|Lost to Follow-up|0|||
16267297|NCT03114891|39463077|FG002|3 Week Break|Lost to Follow-up|0|||
16267298|NCT03114891|39463078|FG003|3 Week Break|Lost to Follow-up|1|||
16267299|NCT03114891|39463075|FG000|3 Week Break|Withdrawal by Subject|0|||
16267300|NCT03114891|39463076|FG001|3 Week Break|Withdrawal by Subject|1|||
16267301|NCT03114891|39463077|FG002|3 Week Break|Withdrawal by Subject|0|||
16267302|NCT03114891|39463078|FG003|3 Week Break|Withdrawal by Subject|0|||
16267303|NCT03114891|39463075|FG000|Second Treatment Round|Lost to Follow-up|1|||
16267304|NCT03114891|39463076|FG001|Second Treatment Round|Lost to Follow-up|0|||
16267305|NCT03114891|39463077|FG002|Second Treatment Round|Lost to Follow-up|0|||
16267306|NCT03114891|39463078|FG003|Second Treatment Round|Lost to Follow-up|0|||
16267307|NCT03114891|39463075|FG000|Second Treatment Round|Physician Decision|1|||
16267308|NCT03114891|39463076|FG001|Second Treatment Round|Physician Decision|0|||
16267309|NCT03114891|39463077|FG002|Second Treatment Round|Physician Decision|0|||
16267310|NCT03114891|39463078|FG003|Second Treatment Round|Physician Decision|0|||
16267311|NCT02554890|39463082|FG000|Double-blind|Adverse Event|45|||
16267312|NCT02554890|39463083|FG001|Double-blind|Adverse Event|51|||
16267313|NCT02554890|39463082|FG000|Double-blind|Death|6|||
16267314|NCT02554890|39463083|FG001|Double-blind|Death|4|||
16267315|NCT02554890|39463082|FG000|Double-blind|Protocol Violation|1|||
16267316|NCT02554890|39463083|FG001|Double-blind|Protocol Violation|1|||
16267317|NCT02554890|39463082|FG000|Double-blind|Physician Decision|4|||
16267318|NCT02554890|39463083|FG001|Double-blind|Physician Decision|3|||
16267319|NCT02554890|39463082|FG000|Double-blind|Subject/Guardian decision|21|||
16267320|NCT02554890|39463083|FG001|Double-blind|Subject/Guardian decision|16|||
16267321|NCT02554890|39463082|FG000|Double-blind|Lost to Follow-up|7|||
16267322|NCT02554890|39463083|FG001|Double-blind|Lost to Follow-up|5|||
16267323|NCT02554890|39463082|FG000|Double-blind|Technical problems|1|||
16267324|NCT02554890|39463083|FG001|Double-blind|Technical problems|0|||
16267325|NCT02554890|39463082|FG000|Double-blind|Withdrawal by Subject|5|||
16267326|NCT02554890|39463083|FG001|Double-blind|Withdrawal by Subject|6|||
16267327|NCT02554890|39463082|FG000|Double-blind|Noncompliance with study treatment|6|||
16267328|NCT02554890|39463083|FG001|Double-blind|Noncompliance with study treatment|5|||
16267329|NCT02554890|39463082|FG000|Open-label|Adverse Event|0|||
16267330|NCT02554890|39463083|FG001|Open-label|Adverse Event|30|||
16267331|NCT02554890|39463082|FG000|Open-label|Death|0|||
16267332|NCT02554890|39463083|FG001|Open-label|Death|1|||
16267333|NCT02554890|39463082|FG000|Open-label|Physician Decision|0|||
16267334|NCT02554890|39463083|FG001|Open-label|Physician Decision|1|||
16267335|NCT02554890|39463082|FG000|Open-label|Subject/Guardian decision|0|||
16267336|NCT02554890|39463083|FG001|Open-label|Subject/Guardian decision|11|||
16267337|NCT02554890|39463082|FG000|Open-label|Lost to Follow-up|0|||
16454971|NCT02318706|40144758|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
16267338|NCT02554890|39463083|FG001|Open-label|Lost to Follow-up|7|||
16267339|NCT02554890|39463082|FG000|Open-label|Technical problems|0|||
16267340|NCT02554890|39463083|FG001|Open-label|Technical problems|1|||
16267341|NCT02554890|39463082|FG000|Open-label|Withdrawal by Subject|0|||
16267342|NCT02554890|39463083|FG001|Open-label|Withdrawal by Subject|1|||
16267343|NCT01124175|39463084|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
16267344|NCT01124175|39463085|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
16267345|NCT00836472|39463086|FG000|Washout|Adverse Event|1|||
16267346|NCT00836472|39463087|FG001|Washout|Adverse Event|2|||
16267347|NCT00836472|39463086|FG000|Washout|Withdrawal by Subject|1|||
16267348|NCT00836472|39463087|FG001|Washout|Withdrawal by Subject|1|||
16267349|NCT01237054|39463088|FG000|Overall Study|imaging 10C0096|1|||
16267350|NCT05093205|39463091|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
16267351|NCT05093205|39463092|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
16267352|NCT05093205|39463093|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
16267353|NCT05093205|39463094|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
16267354|NCT05093205|39463095|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
16267355|NCT05093205|39463096|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
16267356|NCT05093205|39463097|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
16267357|NCT05093205|39463098|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
16267358|NCT05093205|39463099|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
16267359|NCT05093205|39463100|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
16267360|NCT05093205|39463101|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
16267361|NCT05093205|39463102|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
16267362|NCT05093205|39463103|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
16267363|NCT05093205|39463091|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267364|NCT05093205|39463092|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267365|NCT05093205|39463093|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
16267366|NCT05093205|39463094|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267367|NCT05093205|39463095|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267368|NCT05093205|39463096|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267369|NCT05093205|39463097|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267370|NCT05093205|39463098|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267371|NCT05093205|39463099|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267372|NCT05093205|39463100|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267373|NCT05093205|39463101|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267374|NCT05093205|39463102|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267375|NCT05093205|39463103|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
16267376|NCT05093205|39463091|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
16267377|NCT05093205|39463092|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
16267378|NCT05093205|39463093|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
16267379|NCT05093205|39463094|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
16267380|NCT05093205|39463095|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
16267381|NCT05093205|39463096|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
16267382|NCT05093205|39463097|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
16267383|NCT05093205|39463098|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
16267384|NCT05093205|39463099|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
16267385|NCT05093205|39463100|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
16267386|NCT05093205|39463101|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
16267387|NCT05093205|39463102|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
16267388|NCT05093205|39463103|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
16267389|NCT05093205|39463091|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
16267390|NCT05093205|39463092|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
16267391|NCT05093205|39463093|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
16267392|NCT05093205|39463094|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
16267393|NCT05093205|39463095|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
16267394|NCT05093205|39463096|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
16267395|NCT05093205|39463097|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
16267396|NCT05093205|39463098|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
16267397|NCT05093205|39463099|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
16267398|NCT05093205|39463100|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
16267399|NCT05093205|39463101|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
16267400|NCT05093205|39463102|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
16267401|NCT05093205|39463103|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
16267402|NCT05093205|39463091|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
16267403|NCT05093205|39463092|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
16267404|NCT05093205|39463093|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
16267405|NCT05093205|39463094|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
16267406|NCT05093205|39463095|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
16267407|NCT05093205|39463096|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
16267408|NCT05093205|39463097|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
16267409|NCT05093205|39463098|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
16267410|NCT05093205|39463099|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
16267411|NCT05093205|39463100|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
16267412|NCT05093205|39463101|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
16267413|NCT05093205|39463102|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
16267414|NCT05093205|39463103|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
16267415|NCT05093205|39463091|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
16267416|NCT05093205|39463092|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
16267417|NCT05093205|39463093|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
16267418|NCT05093205|39463094|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
16267419|NCT05093205|39463095|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
16267420|NCT05093205|39463096|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
16267421|NCT05093205|39463097|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
16267422|NCT05093205|39463098|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
16267423|NCT05093205|39463099|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
16267424|NCT05093205|39463100|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
16267425|NCT05093205|39463101|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
16267426|NCT05093205|39463102|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
16267427|NCT05093205|39463103|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
16267428|NCT05093205|39463091|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
16267429|NCT05093205|39463092|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
16267430|NCT05093205|39463093|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
16267431|NCT05093205|39463094|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
16267432|NCT05093205|39463095|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
16267433|NCT05093205|39463096|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
16267434|NCT05093205|39463097|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
16267435|NCT05093205|39463098|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
16267436|NCT05093205|39463099|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
16267437|NCT05093205|39463100|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
16267438|NCT05093205|39463101|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
16267439|NCT05093205|39463102|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
16267440|NCT05093205|39463103|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
16267441|NCT05093205|39463091|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
16267442|NCT05093205|39463092|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
16267443|NCT05093205|39463093|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
16267444|NCT05093205|39463094|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
16267445|NCT05093205|39463095|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
16267446|NCT05093205|39463096|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
16267447|NCT05093205|39463097|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
16267448|NCT05093205|39463098|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
16267449|NCT05093205|39463099|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
16267450|NCT05093205|39463100|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
16267451|NCT05093205|39463101|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
16267452|NCT05093205|39463102|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
16267453|NCT05093205|39463103|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
16267454|NCT05093205|39463091|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267455|NCT05093205|39463092|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267456|NCT05093205|39463093|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267457|NCT05093205|39463094|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267458|NCT05093205|39463095|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267459|NCT05093205|39463096|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267460|NCT05093205|39463097|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267461|NCT05093205|39463098|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267462|NCT05093205|39463099|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267463|NCT05093205|39463100|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
16267464|NCT05093205|39463101|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267465|NCT05093205|39463102|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267466|NCT05093205|39463103|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
16267467|NCT05093205|39463091|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
16267468|NCT05093205|39463092|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
16267469|NCT05093205|39463093|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
16267470|NCT05093205|39463094|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
16267471|NCT05093205|39463095|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
16267472|NCT05093205|39463096|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
16267473|NCT05093205|39463097|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
16267474|NCT05093205|39463098|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
16267475|NCT05093205|39463099|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
16267476|NCT05093205|39463100|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
16267477|NCT05093205|39463101|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
16267478|NCT05093205|39463102|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
16267479|NCT05093205|39463103|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
16267480|NCT05093205|39463091|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267481|NCT05093205|39463092|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267482|NCT05093205|39463093|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267483|NCT05093205|39463094|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267484|NCT05093205|39463095|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267485|NCT05093205|39463096|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267486|NCT05093205|39463097|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267487|NCT05093205|39463098|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267488|NCT05093205|39463099|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267489|NCT05093205|39463100|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267490|NCT05093205|39463101|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
16267491|NCT05093205|39463102|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267492|NCT05093205|39463103|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
16267493|NCT05093205|39463091|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267494|NCT05093205|39463092|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267495|NCT05093205|39463093|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267496|NCT05093205|39463094|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267497|NCT05093205|39463095|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267498|NCT05093205|39463096|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267499|NCT05093205|39463097|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267500|NCT05093205|39463098|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267501|NCT05093205|39463099|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267502|NCT05093205|39463100|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267503|NCT05093205|39463101|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267504|NCT05093205|39463102|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
16267505|NCT05093205|39463103|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
16267506|NCT05093205|39463091|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
16267507|NCT05093205|39463092|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
16267508|NCT05093205|39463093|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
16267509|NCT05093205|39463094|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
16267510|NCT05093205|39463095|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
16267511|NCT05093205|39463096|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
16267512|NCT05093205|39463097|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
16267513|NCT05093205|39463098|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
16267514|NCT05093205|39463099|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
16267515|NCT05093205|39463100|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
16267516|NCT05093205|39463101|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
16267517|NCT05093205|39463102|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
16267518|NCT05093205|39463103|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
16267519|NCT05093205|39463091|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267520|NCT05093205|39463092|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267521|NCT05093205|39463093|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267522|NCT05093205|39463094|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267523|NCT05093205|39463095|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267524|NCT05093205|39463096|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267525|NCT05093205|39463097|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267526|NCT05093205|39463098|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267527|NCT05093205|39463099|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267528|NCT05093205|39463100|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267529|NCT05093205|39463101|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267530|NCT05093205|39463102|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
16267531|NCT05093205|39463103|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
16267532|NCT00620074|39463104|FG000|Overall Study|Adverse Event|1|||
16267533|NCT01564394|39463122|FG000|Overall Study|Withdrawal by Subject|6|||
16267534|NCT01564394|39463123|FG001|Overall Study|Withdrawal by Subject|10|||
16267535|NCT02699463|39463124|FG000|Overall Study|Lost to Follow-up|11|||
16267536|NCT02699463|39463125|FG001|Overall Study|Lost to Follow-up|8|||
16267537|NCT02699463|39463124|FG000|Overall Study|Withdrawal by Subject|4|||
16267538|NCT02699463|39463125|FG001|Overall Study|Withdrawal by Subject|1|||
16267539|NCT01537887|39463127|FG000|Period 1|Physician Decision|0|||
16267540|NCT01537887|39463128|FG001|Period 1|Physician Decision|0|||
16267541|NCT01537887|39463129|FG002|Period 1|Physician Decision|0|||
16454972|NCT02318706|40144759|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
16454973|NCT02318706|40144760|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
16454974|NCT02318706|40144761|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
16454975|NCT02318706|40144762|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
16454976|NCT02318706|40144758|FG000|Open-label Extension Phase|Death|0|||
16454977|NCT02318706|40144759|FG001|Open-label Extension Phase|Death|0|||
16454978|NCT02318706|40144760|FG002|Open-label Extension Phase|Death|0|||
16454979|NCT02318706|40144761|FG003|Open-label Extension Phase|Death|0|||
16454980|NCT02318706|40144762|FG004|Open-label Extension Phase|Death|1|||
16267542|NCT01537887|39463130|FG003|Period 1|Physician Decision|0|||
16267543|NCT01537887|39463131|FG004|Period 1|Physician Decision|1|||
16267544|NCT01537887|39463132|FG005|Period 1|Physician Decision|1|||
16267545|NCT01537887|39463127|FG000|Period 1|Did not receive treatment|0|||
16267546|NCT01537887|39463128|FG001|Period 1|Did not receive treatment|0|||
16267547|NCT01537887|39463129|FG002|Period 1|Did not receive treatment|1|||
16267548|NCT01537887|39463130|FG003|Period 1|Did not receive treatment|0|||
16267549|NCT01537887|39463131|FG004|Period 1|Did not receive treatment|0|||
16267550|NCT01537887|39463132|FG005|Period 1|Did not receive treatment|0|||
16267551|NCT01537887|39463127|FG000|Period 2|Withdrawal by Subject|0|||
16267552|NCT01537887|39463128|FG001|Period 2|Withdrawal by Subject|1|||
16267553|NCT01537887|39463129|FG002|Period 2|Withdrawal by Subject|0|||
16267554|NCT01537887|39463130|FG003|Period 2|Withdrawal by Subject|0|||
16267555|NCT01537887|39463131|FG004|Period 2|Withdrawal by Subject|0|||
16267556|NCT01537887|39463132|FG005|Period 2|Withdrawal by Subject|0|||
16267557|NCT01537887|39463127|FG000|Period 3|Adverse Event|0|||
16267558|NCT01537887|39463128|FG001|Period 3|Adverse Event|0|||
16267559|NCT01537887|39463129|FG002|Period 3|Adverse Event|1|||
16267560|NCT01537887|39463130|FG003|Period 3|Adverse Event|0|||
16267561|NCT01537887|39463131|FG004|Period 3|Adverse Event|0|||
16267562|NCT01537887|39463132|FG005|Period 3|Adverse Event|0|||
16267563|NCT01537887|39463127|FG000|Period 3|Withdrawal by Subject|0|||
16267564|NCT01537887|39463128|FG001|Period 3|Withdrawal by Subject|1|||
16267565|NCT01537887|39463129|FG002|Period 3|Withdrawal by Subject|0|||
16267566|NCT01537887|39463130|FG003|Period 3|Withdrawal by Subject|0|||
16267567|NCT01537887|39463131|FG004|Period 3|Withdrawal by Subject|0|||
16267568|NCT01537887|39463132|FG005|Period 3|Withdrawal by Subject|0|||
16267569|NCT00835081|39463133|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
16267570|NCT00835081|39463134|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
16267571|NCT02286739|39463138|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
16267572|NCT02286739|39463139|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
16267573|NCT02286739|39463138|FG000|Overall Study|No Verasense type documented|0|||
16267574|NCT02286739|39463139|FG001|Overall Study|No Verasense type documented|23|||
16267575|NCT02286739|39463138|FG000|Overall Study|Adverse Event|1|||
16267576|NCT02286739|39463139|FG001|Overall Study|Adverse Event|2|||
16267577|NCT02286739|39463138|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
16267578|NCT02286739|39463139|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
16267579|NCT02576938|39463140|FG000|Overall Study|Adverse Event|5|||
16267580|NCT02576938|39463141|FG001|Overall Study|Adverse Event|3|||
16267581|NCT02576938|39463142|FG002|Overall Study|Adverse Event|6|||
16267582|NCT02576938|39463140|FG000|Overall Study|Protocol Violation|1|||
16267583|NCT02576938|39463141|FG001|Overall Study|Protocol Violation|1|||
16267584|NCT02576938|39463142|FG002|Overall Study|Protocol Violation|1|||
16267585|NCT02576938|39463140|FG000|Overall Study|Withdrawal by Subject|3|||
16267586|NCT02576938|39463141|FG001|Overall Study|Withdrawal by Subject|2|||
16267587|NCT02576938|39463142|FG002|Overall Study|Withdrawal by Subject|4|||
16267588|NCT02576938|39463140|FG000|Overall Study|Lack of Efficacy|9|||
16267589|NCT02576938|39463141|FG001|Overall Study|Lack of Efficacy|4|||
16267590|NCT02576938|39463142|FG002|Overall Study|Lack of Efficacy|0|||
16267591|NCT02576938|39463140|FG000|Overall Study|Lost to Follow-up|2|||
16267592|NCT02576938|39463141|FG001|Overall Study|Lost to Follow-up|0|||
16267593|NCT02576938|39463142|FG002|Overall Study|Lost to Follow-up|1|||
16267594|NCT02576938|39463140|FG000|Overall Study|Physician Decision|0|||
16267595|NCT02576938|39463141|FG001|Overall Study|Physician Decision|1|||
16267596|NCT02576938|39463142|FG002|Overall Study|Physician Decision|0|||
16267597|NCT02576938|39463140|FG000|Overall Study|Met Exclusion Criteria|0|||
16267598|NCT02576938|39463141|FG001|Overall Study|Met Exclusion Criteria|1|||
16267599|NCT02576938|39463142|FG002|Overall Study|Met Exclusion Criteria|0|||
16267600|NCT02615249|39463143|FG000|Overall Study|Withdrawal by Subject|1|||
16267601|NCT04025021|39463144|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
16267602|NCT04025021|39463145|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
16267603|NCT00838279|39463146|FG000|Washout|Protocol Violation|1|||
16267604|NCT00838279|39463147|FG001|Washout|Protocol Violation|0|||
16267605|NCT00838279|39463146|FG000|Washout|Withdrawal by Subject|0|||
16267606|NCT00838279|39463147|FG001|Washout|Withdrawal by Subject|1|||
16267607|NCT02635750|39463148|FG000|Part 1, Period 2|Adverse Event|1|||
16267608|NCT02635750|39463149|FG001|Part 1, Period 2|Adverse Event|0|||
16267609|NCT02635750|39463150|FG002|Part 1, Period 2|Adverse Event|0|||
16267610|NCT01247701|39463151|FG000|Overall Study|Death|2|||
16267611|NCT01247701|39463151|FG000|Overall Study|Relapsed|8|||
16267612|NCT00682461|39463153|FG000|Overall Study|Adverse Event|5|||
16454981|NCT02318706|40144758|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
16454982|NCT02318706|40144759|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
16454983|NCT02318706|40144760|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
16454984|NCT02318706|40144761|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
16454985|NCT02318706|40144762|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
16454986|NCT01523366|40144765|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16454987|NCT01523366|40144766|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16454988|NCT01523366|40144765|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
16454989|NCT01523366|40144766|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
16454990|NCT05300763|40144769|FG000|Overall Study|Adverse Event|0|||
16454991|NCT05300763|40144770|FG001|Overall Study|Adverse Event|1|||
16454992|NCT05300763|40144769|FG000|Overall Study|Major Protocol Deviation|1|||
16454993|NCT05300763|40144770|FG001|Overall Study|Major Protocol Deviation|0|||
16267613|NCT00682461|39463154|FG001|Overall Study|Adverse Event|7|||
16267614|NCT00682461|39463153|FG000|Overall Study|Lost to Follow-up|8|||
16267615|NCT00682461|39463154|FG001|Overall Study|Lost to Follow-up|5|||
16267616|NCT00682461|39463153|FG000|Overall Study|Withdrawal by Subject|12|||
16267617|NCT00682461|39463154|FG001|Overall Study|Withdrawal by Subject|19|||
16267618|NCT00841659|39463161|FG000|Washout: 2 Weeks|Protocol Violation|1|||
16267619|NCT00841659|39463162|FG001|Washout: 2 Weeks|Protocol Violation|0|||
16267620|NCT00804856|39463163|FG000|Overall Study|Progressive Disease|3|||
16267621|NCT00804856|39463164|FG001|Overall Study|Progressive Disease|2|||
16267622|NCT00804856|39463165|FG002|Overall Study|Progressive Disease|4|||
16267623|NCT00804856|39463166|FG003|Overall Study|Progressive Disease|6|||
16267624|NCT00804856|39463167|FG004|Overall Study|Progressive Disease|4|||
16267625|NCT00804856|39463168|FG005|Overall Study|Progressive Disease|1|||
16267626|NCT00804856|39463169|FG006|Overall Study|Progressive Disease|8|||
16267627|NCT00804856|39463170|FG007|Overall Study|Progressive Disease|2|||
16267628|NCT00804856|39463171|FG008|Overall Study|Progressive Disease|4|||
16267629|NCT00804856|39463172|FG009|Overall Study|Progressive Disease|5|||
16267630|NCT00804856|39463173|FG010|Overall Study|Progressive Disease|12|||
16267631|NCT00804856|39463174|FG011|Overall Study|Progressive Disease|2|||
16267632|NCT00804856|39463175|FG012|Overall Study|Progressive Disease|2|||
16267633|NCT00804856|39463176|FG013|Overall Study|Progressive Disease|26|||
16267634|NCT00804856|39463177|FG014|Overall Study|Progressive Disease|20|||
16267635|NCT00804856|39463163|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267636|NCT00804856|39463164|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267637|NCT00804856|39463165|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267638|NCT00804856|39463166|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267639|NCT00804856|39463167|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
16267640|NCT00804856|39463168|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267641|NCT00804856|39463169|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267642|NCT00804856|39463170|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267643|NCT00804856|39463171|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267644|NCT00804856|39463172|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267645|NCT00804856|39463173|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267646|NCT00804856|39463174|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267647|NCT00804856|39463175|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267648|NCT00804856|39463176|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16267649|NCT00804856|39463177|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
16267650|NCT00804856|39463163|FG000|Overall Study|Other Adverse Event|1|||
16267651|NCT00804856|39463164|FG001|Overall Study|Other Adverse Event|1|||
16267652|NCT00804856|39463165|FG002|Overall Study|Other Adverse Event|1|||
16267653|NCT00804856|39463166|FG003|Overall Study|Other Adverse Event|2|||
16267654|NCT00804856|39463167|FG004|Overall Study|Other Adverse Event|2|||
16267655|NCT00804856|39463168|FG005|Overall Study|Other Adverse Event|1|||
16267656|NCT00804856|39463169|FG006|Overall Study|Other Adverse Event|3|||
16267657|NCT00804856|39463170|FG007|Overall Study|Other Adverse Event|0|||
16267658|NCT00804856|39463171|FG008|Overall Study|Other Adverse Event|0|||
16267659|NCT00804856|39463172|FG009|Overall Study|Other Adverse Event|1|||
16267660|NCT00804856|39463173|FG010|Overall Study|Other Adverse Event|5|||
16267661|NCT00804856|39463174|FG011|Overall Study|Other Adverse Event|2|||
16267662|NCT00804856|39463175|FG012|Overall Study|Other Adverse Event|0|||
16267663|NCT00804856|39463176|FG013|Overall Study|Other Adverse Event|6|||
16267664|NCT00804856|39463177|FG014|Overall Study|Other Adverse Event|13|||
16267665|NCT00804856|39463163|FG000|Overall Study|Non compliance with protocol|0|||
16267666|NCT00804856|39463164|FG001|Overall Study|Non compliance with protocol|0|||
16267667|NCT00804856|39463165|FG002|Overall Study|Non compliance with protocol|0|||
16267668|NCT00804856|39463166|FG003|Overall Study|Non compliance with protocol|0|||
16267669|NCT00804856|39463167|FG004|Overall Study|Non compliance with protocol|0|||
16267670|NCT00804856|39463168|FG005|Overall Study|Non compliance with protocol|0|||
16267671|NCT00804856|39463169|FG006|Overall Study|Non compliance with protocol|0|||
16267672|NCT00804856|39463170|FG007|Overall Study|Non compliance with protocol|0|||
16267673|NCT00804856|39463171|FG008|Overall Study|Non compliance with protocol|0|||
16267674|NCT00804856|39463172|FG009|Overall Study|Non compliance with protocol|0|||
16267675|NCT00804856|39463173|FG010|Overall Study|Non compliance with protocol|0|||
16267676|NCT00804856|39463174|FG011|Overall Study|Non compliance with protocol|0|||
16267677|NCT00804856|39463175|FG012|Overall Study|Non compliance with protocol|0|||
16267678|NCT00804856|39463176|FG013|Overall Study|Non compliance with protocol|2|||
16267679|NCT00804856|39463177|FG014|Overall Study|Non compliance with protocol|0|||
16267680|NCT00804856|39463163|FG000|Overall Study|Refused to continue medication|0|||
16267681|NCT00804856|39463164|FG001|Overall Study|Refused to continue medication|0|||
16267682|NCT00804856|39463165|FG002|Overall Study|Refused to continue medication|0|||
16267683|NCT00804856|39463166|FG003|Overall Study|Refused to continue medication|1|||
16267684|NCT00804856|39463167|FG004|Overall Study|Refused to continue medication|1|||
16267685|NCT00804856|39463168|FG005|Overall Study|Refused to continue medication|0|||
16267686|NCT00804856|39463169|FG006|Overall Study|Refused to continue medication|0|||
16267687|NCT00804856|39463170|FG007|Overall Study|Refused to continue medication|0|||
16267688|NCT00804856|39463171|FG008|Overall Study|Refused to continue medication|0|||
16267689|NCT00804856|39463172|FG009|Overall Study|Refused to continue medication|0|||
16267690|NCT00804856|39463173|FG010|Overall Study|Refused to continue medication|3|||
16267691|NCT00804856|39463174|FG011|Overall Study|Refused to continue medication|0|||
16267692|NCT00804856|39463175|FG012|Overall Study|Refused to continue medication|1|||
16267693|NCT00804856|39463176|FG013|Overall Study|Refused to continue medication|1|||
16267694|NCT00804856|39463177|FG014|Overall Study|Refused to continue medication|5|||
16267695|NCT00804856|39463163|FG000|Overall Study|Other reason than listed above|0|||
16267696|NCT00804856|39463164|FG001|Overall Study|Other reason than listed above|0|||
16267697|NCT00804856|39463165|FG002|Overall Study|Other reason than listed above|0|||
16267698|NCT00804856|39463166|FG003|Overall Study|Other reason than listed above|0|||
16267699|NCT00804856|39463167|FG004|Overall Study|Other reason than listed above|0|||
16267700|NCT00804856|39463168|FG005|Overall Study|Other reason than listed above|1|||
16267701|NCT00804856|39463169|FG006|Overall Study|Other reason than listed above|0|||
16267702|NCT00804856|39463170|FG007|Overall Study|Other reason than listed above|0|||
16267703|NCT00804856|39463171|FG008|Overall Study|Other reason than listed above|1|||
16267704|NCT00804856|39463172|FG009|Overall Study|Other reason than listed above|0|||
16267705|NCT00804856|39463173|FG010|Overall Study|Other reason than listed above|3|||
16267706|NCT00804856|39463174|FG011|Overall Study|Other reason than listed above|1|||
16267707|NCT00804856|39463175|FG012|Overall Study|Other reason than listed above|1|||
16267708|NCT00804856|39463176|FG013|Overall Study|Other reason than listed above|10|||
16267709|NCT00804856|39463177|FG014|Overall Study|Other reason than listed above|3|||
16267710|NCT01340495|39463180|FG000|Overall Study|Withdrawal by Subject|1|||
16267711|NCT05214560|39463181|FG000|Overall Study|Screening Failure|1|||
16267712|NCT05214560|39463181|FG000|Overall Study|Physician Decision|4|||
16267713|NCT05214560|39463181|FG000|Overall Study|Withdrawal by Subject|1|||
16267714|NCT05214560|39463181|FG000|Overall Study|Lost to Follow-up|2|||
16267715|NCT05214560|39463181|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
16267716|NCT05214560|39463181|FG000|Overall Study|Study physician not available for the anesthesia|3|||
16267717|NCT05214560|39463181|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
16267718|NCT05214560|39463181|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
16267719|NCT05214560|39463181|FG000|Overall Study|Surgery not performed|3|||
16267720|NCT03769896|39463184|FG000|Open-label Phase|Lack of Efficacy|5|||
16454994|NCT05300763|40144769|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
16454995|NCT05300763|40144770|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
16454996|NCT03091348|40144771|FG000|Overall Study|Lost to Follow-up|2|||
16454997|NCT03091348|40144772|FG001|Overall Study|Lost to Follow-up|1|||
16454998|NCT02238067|40144777|FG000|Overall Study|Not completed survey at Month 6|45|||
16454999|NCT02660983|40144780|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
16455000|NCT02660983|40144781|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
16455001|NCT02660983|40144780|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
16455002|NCT02660983|40144781|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
16455003|NCT02660983|40144780|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
16455004|NCT02660983|40144781|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
16455005|NCT02660983|40144780|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
16455006|NCT02660983|40144781|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
16455007|NCT02660983|40144780|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
16455008|NCT02660983|40144781|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
16455009|NCT02660983|40144780|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
16455010|NCT02660983|40144781|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
16455011|NCT02660983|40144780|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
16455012|NCT02660983|40144781|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
16455013|NCT00899431|40144782|FG000|Overall Study|Physician Decision|1|||
16455014|NCT00899431|40144783|FG001|Overall Study|Physician Decision|0|||
16455015|NCT00899431|40144784|FG002|Overall Study|Physician Decision|0|||
16455016|NCT00092443|40144785|FG000|Overall Study|Adverse Event|9|||
16455017|NCT00092443|40144786|FG001|Overall Study|Adverse Event|13|||
16455018|NCT00092443|40144785|FG000|Overall Study|Lost to Follow-up|7|||
16455019|NCT00092443|40144786|FG001|Overall Study|Lost to Follow-up|3|||
16455020|NCT00092443|40144785|FG000|Overall Study|Protocol Violation|11|||
16455021|NCT00092443|40144786|FG001|Overall Study|Protocol Violation|9|||
16455022|NCT00092443|40144785|FG000|Overall Study|Withdrawal by Subject|9|||
16455023|NCT00092443|40144786|FG001|Overall Study|Withdrawal by Subject|11|||
16455024|NCT00092443|40144785|FG000|Overall Study|Moved|5|||
16267721|NCT03769896|39463185|FG001|Open-label Phase|Lack of Efficacy|0|||
16267722|NCT03769896|39463184|FG000|Open-label Phase|Adverse Event|3|||
16455025|NCT00092443|40144786|FG001|Overall Study|Moved|5|||
16455026|NCT00092443|40144785|FG000|Overall Study|Other|17|||
16455027|NCT00092443|40144786|FG001|Overall Study|Other|13|||
16455028|NCT01297491|40144787|FG000|Overall Study|Adverse Event|11|||
16455029|NCT01297491|40144788|FG001|Overall Study|Adverse Event|6|||
16455030|NCT01297491|40144787|FG000|Overall Study|Physician Decision|3|||
16455031|NCT01297491|40144788|FG001|Overall Study|Physician Decision|2|||
16455032|NCT01297491|40144787|FG000|Overall Study|Progressive disease|11|||
16455033|NCT01297491|40144788|FG001|Overall Study|Progressive disease|20|||
16455034|NCT01297491|40144787|FG000|Overall Study|Patient/Guardian decision|3|||
16455035|NCT01297491|40144788|FG001|Overall Study|Patient/Guardian decision|4|||
16455036|NCT01297491|40144787|FG000|Overall Study|Death|2|||
16455037|NCT01297491|40144788|FG001|Overall Study|Death|1|||
16455038|NCT00545272|40144789|FG000|Overall Study|Protocol deviation|0|||
16455039|NCT00545272|40144790|FG001|Overall Study|Protocol deviation|1|||
16455040|NCT00545272|40144791|FG002|Overall Study|Protocol deviation|0|||
16455041|NCT00545272|40144792|FG003|Overall Study|Protocol deviation|1|||
16455042|NCT00545272|40144793|FG004|Overall Study|Protocol deviation|0|||
16455043|NCT00545272|40144794|FG005|Overall Study|Protocol deviation|1|||
16455044|NCT00545272|40144789|FG000|Overall Study|Adverse Event|0|||
16455045|NCT00545272|40144790|FG001|Overall Study|Adverse Event|0|||
16455046|NCT00545272|40144791|FG002|Overall Study|Adverse Event|1|||
16455047|NCT00545272|40144792|FG003|Overall Study|Adverse Event|0|||
16455048|NCT00545272|40144793|FG004|Overall Study|Adverse Event|0|||
16455049|NCT00545272|40144794|FG005|Overall Study|Adverse Event|1|||
16455050|NCT00545272|40144789|FG000|Overall Study|Abnormal laboratory value(s)|0|||
16166192|NCT01262976|39087555|FG003|Up to Year 1|Other|0|||
16455051|NCT00545272|40144790|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16455052|NCT00545272|40144791|FG002|Overall Study|Abnormal laboratory value(s)|0|||
16455053|NCT00545272|40144792|FG003|Overall Study|Abnormal laboratory value(s)|0|||
16455054|NCT00545272|40144793|FG004|Overall Study|Abnormal laboratory value(s)|0|||
16455055|NCT00545272|40144794|FG005|Overall Study|Abnormal laboratory value(s)|1|||
16455056|NCT00545272|40144789|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16455057|NCT00545272|40144790|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16455058|NCT00545272|40144791|FG002|Overall Study|Abnormal test procedure result(s)|0|||
16455059|NCT00545272|40144792|FG003|Overall Study|Abnormal test procedure result(s)|0|||
16455060|NCT00545272|40144793|FG004|Overall Study|Abnormal test procedure result(s)|1|||
16455061|NCT00545272|40144794|FG005|Overall Study|Abnormal test procedure result(s)|0|||
16455062|NCT00545272|40144789|FG000|Overall Study|Lost to Follow-up|0|||
16455063|NCT00545272|40144790|FG001|Overall Study|Lost to Follow-up|0|||
16455064|NCT00545272|40144791|FG002|Overall Study|Lost to Follow-up|0|||
16455065|NCT00545272|40144792|FG003|Overall Study|Lost to Follow-up|0|||
16455066|NCT00545272|40144793|FG004|Overall Study|Lost to Follow-up|1|||
16455067|NCT00545272|40144794|FG005|Overall Study|Lost to Follow-up|0|||
16455068|NCT00068419|40144797|FG000|Overall Study|Adverse Event|3|||
16455069|NCT00068419|40144797|FG000|Overall Study|Lack of Efficacy|24|||
16455070|NCT00068419|40144797|FG000|Overall Study|Lost to Follow-up|1|||
16455071|NCT00068419|40144797|FG000|Overall Study|Physician Decision|7|||
16455072|NCT00068419|40144797|FG000|Overall Study|Withdrawal by Subject|14|||
16455073|NCT00068419|40144797|FG000|Overall Study|Ineligible|11|||
16455074|NCT04173494|40144801|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
16455075|NCT04173494|40144802|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
16455076|NCT04173494|40144801|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
16455077|NCT04173494|40144802|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
16455078|NCT04173494|40144801|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
16455079|NCT04173494|40144802|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
16455080|NCT04173494|40144801|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
16166193|NCT01262976|39087556|FG004|Up to Year 1|Other|2|||
16166194|NCT01262976|39087557|FG005|Up to Year 1|Other|1|||
16166195|NCT01262976|39087552|FG000|Up to Year 1|Subjects with unknown completion status|0|||
16166196|NCT01262976|39087553|FG001|Up to Year 1|Subjects with unknown completion status|0|||
16166197|NCT01262976|39087554|FG002|Up to Year 1|Subjects with unknown completion status|1|||
16166198|NCT01262976|39087555|FG003|Up to Year 1|Subjects with unknown completion status|0|||
16166199|NCT01262976|39087556|FG004|Up to Year 1|Subjects with unknown completion status|0|||
16166200|NCT01262976|39087557|FG005|Up to Year 1|Subjects with unknown completion status|1|||
16166201|NCT01262976|39087552|FG000|Up to Year 2|Serious Adverse Event|0|||
16166202|NCT01262976|39087553|FG001|Up to Year 2|Serious Adverse Event|0|||
16166203|NCT01262976|39087554|FG002|Up to Year 2|Serious Adverse Event|2|||
16166204|NCT01262976|39087555|FG003|Up to Year 2|Serious Adverse Event|0|||
16166205|NCT01262976|39087556|FG004|Up to Year 2|Serious Adverse Event|0|||
16166206|NCT01262976|39087557|FG005|Up to Year 2|Serious Adverse Event|0|||
16455081|NCT04173494|40144802|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
16455082|NCT04173494|40144801|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
16455083|NCT04173494|40144802|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
16455084|NCT04173494|40144801|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
16455085|NCT04173494|40144802|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
16455086|NCT04173494|40144801|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
16455087|NCT04173494|40144802|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
16455088|NCT04173494|40144801|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
16455089|NCT04173494|40144802|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
16166207|NCT01262976|39087552|FG000|Up to Year 2|Withdrawal by Subject|1|||
16166208|NCT01262976|39087553|FG001|Up to Year 2|Withdrawal by Subject|0|||
16166209|NCT01262976|39087554|FG002|Up to Year 2|Withdrawal by Subject|0|||
16166210|NCT01262976|39087555|FG003|Up to Year 2|Withdrawal by Subject|0|||
16166211|NCT01262976|39087556|FG004|Up to Year 2|Withdrawal by Subject|0|||
16166212|NCT01262976|39087557|FG005|Up to Year 2|Withdrawal by Subject|0|||
16166213|NCT01262976|39087552|FG000|Up to Year 2|Migrated/moved from study area|0|||
16166214|NCT01262976|39087553|FG001|Up to Year 2|Migrated/moved from study area|0|||
16166215|NCT01262976|39087554|FG002|Up to Year 2|Migrated/moved from study area|0|||
16166216|NCT01262976|39087555|FG003|Up to Year 2|Migrated/moved from study area|2|||
16166217|NCT01262976|39087556|FG004|Up to Year 2|Migrated/moved from study area|1|||
16166218|NCT01262976|39087557|FG005|Up to Year 2|Migrated/moved from study area|2|||
16166219|NCT01262976|39087552|FG000|Up to Year 2|Lost to Follow-up|1|||
16166220|NCT01262976|39087553|FG001|Up to Year 2|Lost to Follow-up|1|||
16166221|NCT01262976|39087554|FG002|Up to Year 2|Lost to Follow-up|2|||
16166222|NCT01262976|39087555|FG003|Up to Year 2|Lost to Follow-up|2|||
16166223|NCT01262976|39087556|FG004|Up to Year 2|Lost to Follow-up|3|||
16166224|NCT01262976|39087557|FG005|Up to Year 2|Lost to Follow-up|3|||
16166225|NCT01262976|39087552|FG000|Up to Year 2|Subjects with unknown completion status|0|||
16166226|NCT01262976|39087553|FG001|Up to Year 2|Subjects with unknown completion status|0|||
16166227|NCT01262976|39087554|FG002|Up to Year 2|Subjects with unknown completion status|1|||
16166228|NCT01262976|39087555|FG003|Up to Year 2|Subjects with unknown completion status|0|||
16166229|NCT01262976|39087556|FG004|Up to Year 2|Subjects with unknown completion status|0|||
16166230|NCT01262976|39087557|FG005|Up to Year 2|Subjects with unknown completion status|0|||
16166231|NCT01262976|39087552|FG000|Up to Year 2|Other|3|||
16166232|NCT01262976|39087553|FG001|Up to Year 2|Other|0|||
16166233|NCT01262976|39087554|FG002|Up to Year 2|Other|0|||
16166234|NCT01262976|39087555|FG003|Up to Year 2|Other|0|||
16455090|NCT04173494|40144801|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
16455091|NCT04173494|40144802|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
16455092|NCT04173494|40144801|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
16455093|NCT04173494|40144802|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
16455094|NCT04173494|40144801|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
16455095|NCT04173494|40144802|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
16455096|NCT04173494|40144801|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
16455097|NCT04173494|40144802|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
16455098|NCT04173494|40144801|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
16455099|NCT04173494|40144802|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
16455100|NCT04173494|40144801|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
16455101|NCT04173494|40144802|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
16455102|NCT04173494|40144801|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
16455103|NCT04173494|40144802|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
16455104|NCT04173494|40144801|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
16455105|NCT04173494|40144802|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
16455106|NCT02803580|40144803|FG000|Overall Study|Death|13|||
16455107|NCT02803580|40144803|FG000|Overall Study|Lost to Follow-up|19|||
16455108|NCT02803580|40144803|FG000|Overall Study|Withdrawal by Subject|3|||
16455109|NCT02803580|40144803|FG000|Overall Study|Inclusion in clinical trial|1|||
16455110|NCT04629066|40144808|FG000|Overall Study|Lost to Follow-up|3|||
16455111|NCT04629066|40144809|FG001|Overall Study|Lost to Follow-up|2|||
16455112|NCT00867815|40144812|FG000|Overall Study|Lost to Follow-up|1|||
16455113|NCT00796978|40144813|FG000|Overall Study|Cardiac adverse event|5|||
16455114|NCT00796978|40144813|FG000|Overall Study|Adverse Event|4|||
16455115|NCT00796978|40144813|FG000|Overall Study|Withdrawal by Subject|3|||
16455116|NCT04075734|40144814|FG000|Overall Study|Lost to Follow-up|1|||
16455117|NCT04075734|40144815|FG001|Overall Study|Lost to Follow-up|1|||
16455118|NCT04075734|40144816|FG002|Overall Study|Lost to Follow-up|0|||
16455119|NCT04075734|40144814|FG000|Overall Study|Withdrawal by Subject|3|||
16455120|NCT04075734|40144815|FG001|Overall Study|Withdrawal by Subject|0|||
16455121|NCT04075734|40144816|FG002|Overall Study|Withdrawal by Subject|0|||
16455122|NCT00233064|40144817|FG000|Overall Study|Lost to Follow-up|7|||
16455123|NCT00233064|40144818|FG001|Overall Study|Lost to Follow-up|7|||
16455124|NCT00233064|40144817|FG000|Overall Study|Withdrawal by Subject|5|||
16455125|NCT00233064|40144818|FG001|Overall Study|Withdrawal by Subject|3|||
16455126|NCT00233064|40144817|FG000|Overall Study|Death|0|||
16166235|NCT01262976|39087556|FG004|Up to Year 2|Other|0|||
16455127|NCT00233064|40144818|FG001|Overall Study|Death|1|||
16166236|NCT01262976|39087557|FG005|Up to Year 2|Other|0|||
16166237|NCT01262976|39087552|FG000|Up to Year 3|Serious Adverse Event|0|||
16166238|NCT01262976|39087553|FG001|Up to Year 3|Serious Adverse Event|0|||
16455128|NCT00233064|40144817|FG000|Overall Study|Relocation|0|||
16455129|NCT00233064|40144818|FG001|Overall Study|Relocation|1|||
16455130|NCT00233064|40144817|FG000|Overall Study|Protocol Violation|1|||
16455131|NCT00233064|40144818|FG001|Overall Study|Protocol Violation|0|||
16455132|NCT00233064|40144817|FG000|Overall Study|Moved to Dom. Republic|1|||
16455133|NCT00233064|40144818|FG001|Overall Study|Moved to Dom. Republic|0|||
16455134|NCT03120351|40144820|FG000|Overall Study|Physician Decision|1|||
16455135|NCT03120351|40144821|FG001|Overall Study|Physician Decision|1|||
16455136|NCT02598583|40144824|FG000|Extension Period|Withdrawal by Subject|1|||
16455137|NCT02598583|40144825|FG001|Extension Period|Withdrawal by Subject|0|||
16455138|NCT02978781|40144826|FG000|Part A|Adverse Event|1|||
16455139|NCT02978781|40144827|FG001|Part A|Adverse Event|1|||
16455140|NCT02978781|40144828|FG002|Part A|Adverse Event|0|||
16455141|NCT02978781|40144829|FG003|Part A|Adverse Event|0|||
16455142|NCT02978781|40144830|FG004|Part A|Adverse Event|0|||
16455143|NCT02978781|40144826|FG000|Part A|Withdrawal by Subject|0|||
16455144|NCT02978781|40144827|FG001|Part A|Withdrawal by Subject|1|||
16455145|NCT02978781|40144828|FG002|Part A|Withdrawal by Subject|0|||
16455146|NCT02978781|40144829|FG003|Part A|Withdrawal by Subject|0|||
16455147|NCT02978781|40144830|FG004|Part A|Withdrawal by Subject|0|||
16455148|NCT02978781|40144826|FG000|Part B|Withdrawal by Subject|0|||
16455149|NCT02978781|40144827|FG001|Part B|Withdrawal by Subject|0|||
16455150|NCT02978781|40144828|FG002|Part B|Withdrawal by Subject|0|||
16455151|NCT02978781|40144829|FG003|Part B|Withdrawal by Subject|1|||
16455152|NCT02978781|40144830|FG004|Part B|Withdrawal by Subject|0|||
16455153|NCT02978781|40144826|FG000|Part C|Adverse Event|0|||
16455154|NCT02978781|40144827|FG001|Part C|Adverse Event|0|||
16455155|NCT02978781|40144828|FG002|Part C|Adverse Event|0|||
16455156|NCT02978781|40144829|FG003|Part C|Adverse Event|0|||
16455157|NCT02978781|40144830|FG004|Part C|Adverse Event|2|||
16455158|NCT02978781|40144826|FG000|Part C|Withdrawal by Subject|0|||
16455159|NCT02978781|40144827|FG001|Part C|Withdrawal by Subject|0|||
16455160|NCT02978781|40144828|FG002|Part C|Withdrawal by Subject|0|||
16455161|NCT02978781|40144829|FG003|Part C|Withdrawal by Subject|0|||
16455162|NCT02978781|40144830|FG004|Part C|Withdrawal by Subject|1|||
16455163|NCT02978781|40144826|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
16455164|NCT02978781|40144827|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
16455165|NCT02978781|40144828|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
16455166|NCT02978781|40144829|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
16455167|NCT02978781|40144830|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
16455168|NCT02141204|40144833|FG000|Overall Study|Lost to Follow-up|2|||
16455169|NCT02141204|40144834|FG001|Overall Study|Lost to Follow-up|1|||
16455170|NCT02141204|40144833|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
16455171|NCT02141204|40144834|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
16455172|NCT02141204|40144833|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
16455173|NCT02141204|40144834|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
16455174|NCT02141204|40144833|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
16455175|NCT02141204|40144834|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
16455176|NCT02447302|40144843|FG000|Overall Study|Physician Decision|1|||
16455177|NCT02447302|40144844|FG001|Overall Study|Physician Decision|0|||
16455178|NCT02447302|40144845|FG002|Overall Study|Physician Decision|0|||
16455179|NCT02447302|40144843|FG000|Overall Study|Adverse Event|4|||
16455180|NCT02447302|40144844|FG001|Overall Study|Adverse Event|3|||
16455181|NCT02447302|40144845|FG002|Overall Study|Adverse Event|0|||
16455182|NCT02447302|40144843|FG000|Overall Study|Withdrawal by Subject|0|||
16455183|NCT02447302|40144844|FG001|Overall Study|Withdrawal by Subject|1|||
16455184|NCT02447302|40144845|FG002|Overall Study|Withdrawal by Subject|5|||
16455185|NCT02447302|40144843|FG000|Overall Study|Sponsor Decision|0|||
16455186|NCT02447302|40144844|FG001|Overall Study|Sponsor Decision|0|||
16455187|NCT02447302|40144845|FG002|Overall Study|Sponsor Decision|1|||
16455188|NCT00775593|40144846|FG000|Overall Study|Unmet eligibility criteria|6|||
16455189|NCT00775593|40144846|FG000|Overall Study|Death|1|||
16455190|NCT04380519|40144847|FG000|Overall Study|Withdrawal by Subject|4|||
16455191|NCT04380519|40144848|FG001|Overall Study|Withdrawal by Subject|0|||
16455192|NCT04380519|40144849|FG002|Overall Study|Withdrawal by Subject|1|||
16455193|NCT04380519|40144847|FG000|Overall Study|Death|14|||
16455194|NCT04380519|40144848|FG001|Overall Study|Death|9|||
16455195|NCT04380519|40144849|FG002|Overall Study|Death|6|||
16455196|NCT04380519|40144847|FG000|Overall Study|Adverse Event|0|||
16455197|NCT04380519|40144848|FG001|Overall Study|Adverse Event|1|||
16455198|NCT04380519|40144849|FG002|Overall Study|Adverse Event|0|||
16455199|NCT04380519|40144847|FG000|Overall Study|relatives' decision|0|||
16455200|NCT04380519|40144848|FG001|Overall Study|relatives' decision|1|||
16455201|NCT04380519|40144849|FG002|Overall Study|relatives' decision|0|||
16455202|NCT02302339|40144856|FG000|Overall Study|Lost to Follow-up|1|||
16455203|NCT02302339|40144857|FG001|Overall Study|Lost to Follow-up|0|||
16455204|NCT02302339|40144858|FG002|Overall Study|Lost to Follow-up|0|||
16455205|NCT02302339|40144859|FG003|Overall Study|Lost to Follow-up|0|||
16455206|NCT02302339|40144856|FG000|Overall Study|Withdrawal by Subject|0|||
16455207|NCT02302339|40144857|FG001|Overall Study|Withdrawal by Subject|2|||
16455208|NCT02302339|40144858|FG002|Overall Study|Withdrawal by Subject|1|||
16455209|NCT02302339|40144859|FG003|Overall Study|Withdrawal by Subject|0|||
16455210|NCT01262820|40144860|FG000|Overall Study|Adverse Event|5|||
16455211|NCT01262820|40144860|FG000|Overall Study|Lack of Efficacy|9|||
16455212|NCT01262820|40144860|FG000|Overall Study|Drug held for 21+ days|1|||
16455213|NCT03224819|40144863|FG000|Overall Study|Withdrawal by Subject|0|||
16455214|NCT03224819|40144864|FG001|Overall Study|Withdrawal by Subject|0|||
16455215|NCT03224819|40144865|FG002|Overall Study|Withdrawal by Subject|0|||
16455216|NCT03224819|40144866|FG003|Overall Study|Withdrawal by Subject|0|||
16455217|NCT03224819|40144867|FG004|Overall Study|Withdrawal by Subject|0|||
16455218|NCT03224819|40144868|FG005|Overall Study|Withdrawal by Subject|0|||
16455219|NCT03224819|40144869|FG006|Overall Study|Withdrawal by Subject|0|||
16455220|NCT03224819|40144870|FG007|Overall Study|Withdrawal by Subject|0|||
16455221|NCT03224819|40144871|FG008|Overall Study|Withdrawal by Subject|0|||
16455222|NCT03224819|40144872|FG009|Overall Study|Withdrawal by Subject|0|||
16455223|NCT03224819|40144873|FG010|Overall Study|Withdrawal by Subject|0|||
16455224|NCT03224819|40144874|FG011|Overall Study|Withdrawal by Subject|0|||
16455225|NCT03224819|40144875|FG012|Overall Study|Withdrawal by Subject|1|||
16455226|NCT03224819|40144876|FG013|Overall Study|Withdrawal by Subject|0|||
16455227|NCT03224819|40144863|FG000|Overall Study|Sponsor Decision|0|||
16455228|NCT03224819|40144864|FG001|Overall Study|Sponsor Decision|0|||
16455229|NCT03224819|40144865|FG002|Overall Study|Sponsor Decision|0|||
16455230|NCT03224819|40144866|FG003|Overall Study|Sponsor Decision|1|||
16455231|NCT03224819|40144867|FG004|Overall Study|Sponsor Decision|1|||
16455232|NCT03224819|40144868|FG005|Overall Study|Sponsor Decision|2|||
16455233|NCT03224819|40144869|FG006|Overall Study|Sponsor Decision|1|||
16455234|NCT03224819|40144870|FG007|Overall Study|Sponsor Decision|1|||
16455235|NCT03224819|40144871|FG008|Overall Study|Sponsor Decision|1|||
16455236|NCT03224819|40144872|FG009|Overall Study|Sponsor Decision|2|||
16455237|NCT03224819|40144873|FG010|Overall Study|Sponsor Decision|1|||
16455238|NCT03224819|40144874|FG011|Overall Study|Sponsor Decision|1|||
16455239|NCT03224819|40144875|FG012|Overall Study|Sponsor Decision|1|||
16455240|NCT03224819|40144876|FG013|Overall Study|Sponsor Decision|0|||
16455241|NCT03224819|40144863|FG000|Overall Study|Lost to Follow-up|0|||
16455242|NCT03224819|40144864|FG001|Overall Study|Lost to Follow-up|0|||
16455243|NCT03224819|40144865|FG002|Overall Study|Lost to Follow-up|0|||
16455244|NCT03224819|40144866|FG003|Overall Study|Lost to Follow-up|0|||
16455245|NCT03224819|40144867|FG004|Overall Study|Lost to Follow-up|0|||
16455246|NCT03224819|40144868|FG005|Overall Study|Lost to Follow-up|0|||
16455247|NCT03224819|40144869|FG006|Overall Study|Lost to Follow-up|0|||
16455248|NCT03224819|40144870|FG007|Overall Study|Lost to Follow-up|0|||
16455249|NCT03224819|40144871|FG008|Overall Study|Lost to Follow-up|1|||
16455250|NCT03224819|40144872|FG009|Overall Study|Lost to Follow-up|0|||
16455251|NCT03224819|40144873|FG010|Overall Study|Lost to Follow-up|0|||
16455252|NCT03224819|40144874|FG011|Overall Study|Lost to Follow-up|0|||
16455253|NCT03224819|40144875|FG012|Overall Study|Lost to Follow-up|0|||
16455254|NCT03224819|40144876|FG013|Overall Study|Lost to Follow-up|0|||
16455255|NCT03224819|40144863|FG000|Overall Study|Death|0|||
16455256|NCT03224819|40144864|FG001|Overall Study|Death|1|||
16455257|NCT03224819|40144865|FG002|Overall Study|Death|0|||
16455258|NCT03224819|40144866|FG003|Overall Study|Death|0|||
16455259|NCT03224819|40144867|FG004|Overall Study|Death|0|||
16455260|NCT03224819|40144868|FG005|Overall Study|Death|0|||
16455261|NCT03224819|40144869|FG006|Overall Study|Death|0|||
16455262|NCT03224819|40144870|FG007|Overall Study|Death|1|||
16455263|NCT03224819|40144871|FG008|Overall Study|Death|0|||
16455264|NCT03224819|40144872|FG009|Overall Study|Death|0|||
16455265|NCT03224819|40144873|FG010|Overall Study|Death|0|||
16455266|NCT03224819|40144874|FG011|Overall Study|Death|1|||
16455267|NCT03224819|40144875|FG012|Overall Study|Death|0|||
16455268|NCT03224819|40144876|FG013|Overall Study|Death|0|||
16455269|NCT01191762|40148065|FG000|Overall Study|Adverse Event|1|||
16455270|NCT01191762|40148066|FG001|Overall Study|Adverse Event|0|||
16455271|NCT01616693|40148078|FG000|Evaluated for Safety|Physician Decision|1|||
16455272|NCT01616693|40148079|FG001|Evaluated for Safety|Physician Decision|0|||
16455273|NCT01616693|40148080|FG002|Evaluated for Safety|Physician Decision|1|||
16455274|NCT01616693|40148081|FG003|Evaluated for Safety|Physician Decision|0|||
16455275|NCT01616693|40148078|FG000|Received Both Vaccines|Adverse Event|2|||
16455276|NCT01616693|40148079|FG001|Received Both Vaccines|Adverse Event|0|||
16455277|NCT01616693|40148080|FG002|Received Both Vaccines|Adverse Event|0|||
16455278|NCT01616693|40148081|FG003|Received Both Vaccines|Adverse Event|0|||
16455279|NCT01616693|40148078|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
16455280|NCT01616693|40148079|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
16455281|NCT01616693|40148080|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
16455282|NCT01616693|40148081|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
16455283|NCT01616693|40148078|FG000|Received Both Vaccines|Lost to Follow-up|4|||
16455284|NCT01616693|40148079|FG001|Received Both Vaccines|Lost to Follow-up|3|||
16455285|NCT01616693|40148080|FG002|Received Both Vaccines|Lost to Follow-up|4|||
16455286|NCT01616693|40148081|FG003|Received Both Vaccines|Lost to Follow-up|4|||
16455287|NCT01616693|40148078|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
16455288|NCT01616693|40148079|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
16455289|NCT01616693|40148080|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
16455290|NCT01616693|40148081|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
16455291|NCT00640224|40148082|FG000|Overall Study|Lost to Follow-up|5|||
16455292|NCT00640224|40148083|FG001|Overall Study|Lost to Follow-up|2|||
16455293|NCT00640224|40148084|FG002|Overall Study|Lost to Follow-up|0|||
16455294|NCT00640224|40148085|FG003|Overall Study|Lost to Follow-up|0|||
16455295|NCT00640224|40148082|FG000|Overall Study|Withdrawal by Subject|1|||
16455296|NCT00640224|40148083|FG001|Overall Study|Withdrawal by Subject|0|||
16455297|NCT00640224|40148084|FG002|Overall Study|Withdrawal by Subject|0|||
16455298|NCT00640224|40148085|FG003|Overall Study|Withdrawal by Subject|0|||
16455299|NCT00640224|40148082|FG000|Overall Study|Headaches|0|||
16455300|NCT00640224|40148083|FG001|Overall Study|Headaches|1|||
16166239|NCT01262976|39087554|FG002|Up to Year 3|Serious Adverse Event|2|||
16166240|NCT01262976|39087555|FG003|Up to Year 3|Serious Adverse Event|0|||
16166241|NCT01262976|39087556|FG004|Up to Year 3|Serious Adverse Event|0|||
16166242|NCT01262976|39087557|FG005|Up to Year 3|Serious Adverse Event|0|||
16166243|NCT01262976|39087552|FG000|Up to Year 3|Withdrawal by Subject|1|||
16166244|NCT01262976|39087553|FG001|Up to Year 3|Withdrawal by Subject|0|||
16166245|NCT01262976|39087554|FG002|Up to Year 3|Withdrawal by Subject|0|||
16267723|NCT03769896|39463185|FG001|Open-label Phase|Adverse Event|0|||
16267724|NCT03769896|39463184|FG000|Open-label Phase|Withdrawal by Subject|1|||
16267725|NCT03769896|39463185|FG001|Open-label Phase|Withdrawal by Subject|0|||
16267726|NCT02311361|39463192|FG000|Overall Study|Did not receive treatment|0|||
16267727|NCT02311361|39463193|FG001|Overall Study|Did not receive treatment|1|||
16267728|NCT02311361|39463194|FG002|Overall Study|Did not receive treatment|0|||
16267729|NCT02311361|39463195|FG003|Overall Study|Did not receive treatment|1|||
16267730|NCT01900691|39463198|FG000|Overall Study|Death|7|||
16267731|NCT01900691|39463198|FG000|Overall Study|Lost to Follow-up|4|||
16267732|NCT01900691|39463198|FG000|Overall Study|Study Device Not Placed|3|||
16267733|NCT01900691|39463198|FG000|Overall Study|Non study stent placed|2|||
16267734|NCT01900691|39463198|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
16267735|NCT01900691|39463198|FG000|Overall Study|Complete stent migration through digestive tract|1|||
16267736|NCT00316277|39463201|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
16267737|NCT00316277|39463202|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
16267738|NCT00316277|39463201|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
16267739|NCT00316277|39463202|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
16267740|NCT00316277|39463201|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
16267741|NCT00316277|39463202|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
16267742|NCT00316277|39463201|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
16267743|NCT00316277|39463202|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
16267744|NCT00316277|39463201|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
16267745|NCT00316277|39463202|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
16267746|NCT03522675|39463203|FG000|Overall Study|Screen fail|1|||
16267747|NCT03522675|39463203|FG000|Overall Study|Non-reactive to histamine|1|||
16267748|NCT04573881|39463204|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
16267749|NCT01218867|39463207|FG000|Overall Study|Death during treatment|0|||
16267750|NCT01218867|39463208|FG001|Overall Study|Death during treatment|0|||
16267751|NCT01218867|39463209|FG002|Overall Study|Death during treatment|0|||
16267752|NCT01218867|39463210|FG003|Overall Study|Death during treatment|0|||
16267753|NCT01218867|39463211|FG004|Overall Study|Death during treatment|0|||
16267754|NCT01218867|39463212|FG005|Overall Study|Death during treatment|0|||
16267755|NCT01218867|39463213|FG006|Overall Study|Death during treatment|1|||
16267756|NCT01218867|39463214|FG007|Overall Study|Death during treatment|0|||
16267757|NCT01218867|39463215|FG008|Overall Study|Death during treatment|0|||
16267758|NCT01218867|39463216|FG009|Overall Study|Death during treatment|0|||
16267759|NCT01218867|39463217|FG010|Overall Study|Death during treatment|0|||
16267760|NCT02476994|39463221|FG000|Overall Study|Based on feedback from FDA|1|||
16267761|NCT02476994|39463222|FG001|Overall Study|Based on feedback from FDA|0|||
16267762|NCT05133180|39463223|FG000|Overall Study|Withdrawal of consent|1|||
16267763|NCT05133180|39463224|FG001|Overall Study|Withdrawal of consent|1|||
16267764|NCT05133180|39463223|FG000|Overall Study|Lost to Follow-up|1|||
16267765|NCT05133180|39463224|FG001|Overall Study|Lost to Follow-up|1|||
16267766|NCT05133180|39463223|FG000|Overall Study|Documented disease progression|0|||
16267767|NCT05133180|39463224|FG001|Overall Study|Documented disease progression|1|||
16267768|NCT02213263|39463225|FG000|Overall Study|Insufficient clinical response|4|||
16267769|NCT02213263|39463226|FG001|Overall Study|Insufficient clinical response|3|||
16267770|NCT02213263|39463225|FG000|Overall Study|Lost to Follow-up|0|||
16267771|NCT02213263|39463226|FG001|Overall Study|Lost to Follow-up|1|||
16267772|NCT02213263|39463225|FG000|Overall Study|No longer willing to participate|3|||
16267773|NCT02213263|39463226|FG001|Overall Study|No longer willing to participate|4|||
16267774|NCT02213263|39463225|FG000|Overall Study|Progressive disease|20|||
16267775|NCT02213263|39463226|FG001|Overall Study|Progressive disease|14|||
16267776|NCT02213263|39463225|FG000|Overall Study|Protocol Violation|0|||
16267777|NCT02213263|39463226|FG001|Overall Study|Protocol Violation|1|||
16267778|NCT02213263|39463225|FG000|Overall Study|Adverse Event|1|||
16455301|NCT00640224|40148084|FG002|Overall Study|Headaches|0|||
16267779|NCT02213263|39463226|FG001|Overall Study|Adverse Event|3|||
16267780|NCT01838681|39463227|FG000|Period A|Adverse Event|39|||
16267781|NCT01838681|39463228|FG001|Period A|Adverse Event|0|||
16267782|NCT01838681|39463229|FG002|Period A|Adverse Event|0|||
16267783|NCT01838681|39463230|FG003|Period A|Adverse Event|0|||
16267784|NCT01838681|39463227|FG000|Period A|Lack of Efficacy|21|||
16267785|NCT01838681|39463228|FG001|Period A|Lack of Efficacy|0|||
16267786|NCT01838681|39463229|FG002|Period A|Lack of Efficacy|0|||
16267787|NCT01838681|39463230|FG003|Period A|Lack of Efficacy|0|||
16267788|NCT01838681|39463227|FG000|Period A|Early response|148|||
16267789|NCT01838681|39463228|FG001|Period A|Early response|0|||
16267790|NCT01838681|39463229|FG002|Period A|Early response|0|||
16267791|NCT01838681|39463230|FG003|Period A|Early response|0|||
16267792|NCT01838681|39463227|FG000|Period A|Withdrawal by Subject|70|||
16267793|NCT01838681|39463228|FG001|Period A|Withdrawal by Subject|0|||
16267794|NCT01838681|39463229|FG002|Period A|Withdrawal by Subject|0|||
16267795|NCT01838681|39463230|FG003|Period A|Withdrawal by Subject|0|||
16267796|NCT01838681|39463227|FG000|Period A|Protocol Violation|16|||
16267797|NCT01838681|39463228|FG001|Period A|Protocol Violation|0|||
16267798|NCT01838681|39463229|FG002|Period A|Protocol Violation|0|||
16267799|NCT01838681|39463230|FG003|Period A|Protocol Violation|0|||
16267800|NCT01838681|39463227|FG000|Period A|Non-compliance with IMP|6|||
16267801|NCT01838681|39463228|FG001|Period A|Non-compliance with IMP|0|||
16267802|NCT01838681|39463229|FG002|Period A|Non-compliance with IMP|0|||
16267803|NCT01838681|39463230|FG003|Period A|Non-compliance with IMP|0|||
16267804|NCT01838681|39463227|FG000|Period A|Lost to Follow-up|4|||
16267805|NCT01838681|39463228|FG001|Period A|Lost to Follow-up|0|||
16455302|NCT00640224|40148085|FG003|Overall Study|Headaches|0|||
16166246|NCT01262976|39087555|FG003|Up to Year 3|Withdrawal by Subject|0|||
16166247|NCT01262976|39087556|FG004|Up to Year 3|Withdrawal by Subject|0|||
16166248|NCT01262976|39087557|FG005|Up to Year 3|Withdrawal by Subject|0|||
16166249|NCT01262976|39087552|FG000|Up to Year 3|Migrated/moved from study area|0|||
16166250|NCT01262976|39087553|FG001|Up to Year 3|Migrated/moved from study area|0|||
16166251|NCT01262976|39087554|FG002|Up to Year 3|Migrated/moved from study area|0|||
16166252|NCT01262976|39087555|FG003|Up to Year 3|Migrated/moved from study area|2|||
16166253|NCT01262976|39087556|FG004|Up to Year 3|Migrated/moved from study area|1|||
16166254|NCT01262976|39087557|FG005|Up to Year 3|Migrated/moved from study area|1|||
16166255|NCT01262976|39087552|FG000|Up to Year 3|Lost to Follow-up|2|||
16166256|NCT01262976|39087553|FG001|Up to Year 3|Lost to Follow-up|2|||
16166257|NCT01262976|39087554|FG002|Up to Year 3|Lost to Follow-up|4|||
16166258|NCT01262976|39087555|FG003|Up to Year 3|Lost to Follow-up|3|||
16166259|NCT01262976|39087556|FG004|Up to Year 3|Lost to Follow-up|1|||
16166260|NCT01262976|39087557|FG005|Up to Year 3|Lost to Follow-up|3|||
16166261|NCT01262976|39087552|FG000|Up to Year 3|Subjects with unknown completion status|0|||
16166262|NCT01262976|39087553|FG001|Up to Year 3|Subjects with unknown completion status|0|||
16166263|NCT01262976|39087554|FG002|Up to Year 3|Subjects with unknown completion status|1|||
16166264|NCT01262976|39087555|FG003|Up to Year 3|Subjects with unknown completion status|0|||
16166265|NCT01262976|39087556|FG004|Up to Year 3|Subjects with unknown completion status|0|||
16166266|NCT01262976|39087557|FG005|Up to Year 3|Subjects with unknown completion status|0|||
16166267|NCT01262976|39087552|FG000|Up to Year 3|Other|3|||
16166268|NCT01262976|39087553|FG001|Up to Year 3|Other|0|||
16166269|NCT01262976|39087554|FG002|Up to Year 3|Other|0|||
16166270|NCT01262976|39087555|FG003|Up to Year 3|Other|0|||
16166271|NCT01262976|39087556|FG004|Up to Year 3|Other|0|||
16166272|NCT01262976|39087557|FG005|Up to Year 3|Other|0|||
16166273|NCT03653390|39087558|FG000|Overall Study|Lost to Follow-up|12|||
16166274|NCT03653390|39087559|FG001|Overall Study|Lost to Follow-up|8|||
16166275|NCT03653390|39087560|FG002|Overall Study|Lost to Follow-up|7|||
16166276|NCT03653390|39087558|FG000|Overall Study|Withdrawal by Subject|6|||
16166277|NCT03653390|39087559|FG001|Overall Study|Withdrawal by Subject|1|||
16166278|NCT03653390|39087560|FG002|Overall Study|Withdrawal by Subject|1|||
16166279|NCT03653390|39087558|FG000|Overall Study|Death|1|||
16166280|NCT03653390|39087559|FG001|Overall Study|Death|0|||
16166281|NCT03653390|39087560|FG002|Overall Study|Death|0|||
16166282|NCT03653390|39087558|FG000|Overall Study|Paper Survey Lost|1|||
16166283|NCT03653390|39087559|FG001|Overall Study|Paper Survey Lost|0|||
16166284|NCT03653390|39087560|FG002|Overall Study|Paper Survey Lost|0|||
16166285|NCT02083380|39087561|FG000|Overall Study|Lack of Efficacy|68|||
16166286|NCT02083380|39087562|FG001|Overall Study|Lack of Efficacy|79|||
16166287|NCT02083380|39087563|FG002|Overall Study|Lack of Efficacy|64|||
16267806|NCT01838681|39463229|FG002|Period A|Lost to Follow-up|0|||
16267807|NCT01838681|39463230|FG003|Period A|Lost to Follow-up|0|||
16267808|NCT01838681|39463227|FG000|Period A|Withdrawal before treatment|4|||
16267809|NCT01838681|39463228|FG001|Period A|Withdrawal before treatment|0|||
16455303|NCT01798849|40148099|FG000|Overall Study|Physician Decision|0|||
16166288|NCT02083380|39087561|FG000|Overall Study|Withdrawal by Subject|9|||
16166289|NCT02083380|39087562|FG001|Overall Study|Withdrawal by Subject|3|||
16166290|NCT02083380|39087563|FG002|Overall Study|Withdrawal by Subject|7|||
16166291|NCT02083380|39087561|FG000|Overall Study|Physician Decision|1|||
16166292|NCT02083380|39087562|FG001|Overall Study|Physician Decision|6|||
16267810|NCT01838681|39463229|FG002|Period A|Withdrawal before treatment|0|||
16267811|NCT01838681|39463230|FG003|Period A|Withdrawal before treatment|0|||
16267812|NCT01838681|39463227|FG000|Period A|Administrative or other reasons|17|||
16267813|NCT01838681|39463228|FG001|Period A|Administrative or other reasons|0|||
16267814|NCT01838681|39463229|FG002|Period A|Administrative or other reasons|0|||
16267815|NCT01838681|39463230|FG003|Period A|Administrative or other reasons|0|||
16267816|NCT01838681|39463227|FG000|Period B/A+|Adverse Event|0|||
16267817|NCT01838681|39463228|FG001|Period B/A+|Adverse Event|13|||
16267818|NCT01838681|39463229|FG002|Period B/A+|Adverse Event|27|||
16267819|NCT01838681|39463230|FG003|Period B/A+|Adverse Event|16|||
16267820|NCT01838681|39463227|FG000|Period B/A+|Lack of Efficacy|0|||
16267821|NCT01838681|39463228|FG001|Period B/A+|Lack of Efficacy|9|||
16267822|NCT01838681|39463229|FG002|Period B/A+|Lack of Efficacy|11|||
16267823|NCT01838681|39463230|FG003|Period B/A+|Lack of Efficacy|6|||
16267824|NCT01838681|39463227|FG000|Period B/A+|Withdrawal by Subject|0|||
16267825|NCT01838681|39463228|FG001|Period B/A+|Withdrawal by Subject|28|||
16267826|NCT01838681|39463229|FG002|Period B/A+|Withdrawal by Subject|35|||
16267827|NCT01838681|39463230|FG003|Period B/A+|Withdrawal by Subject|47|||
16267828|NCT01838681|39463227|FG000|Period B/A+|Protocol Violation|0|||
16267829|NCT01838681|39463228|FG001|Period B/A+|Protocol Violation|1|||
16267830|NCT01838681|39463229|FG002|Period B/A+|Protocol Violation|4|||
16267831|NCT01838681|39463230|FG003|Period B/A+|Protocol Violation|6|||
16267832|NCT01838681|39463227|FG000|Period B/A+|Non-compliance with IMP|0|||
16267833|NCT01838681|39463228|FG001|Period B/A+|Non-compliance with IMP|2|||
16267834|NCT01838681|39463229|FG002|Period B/A+|Non-compliance with IMP|3|||
16267835|NCT01838681|39463230|FG003|Period B/A+|Non-compliance with IMP|3|||
16267836|NCT01838681|39463227|FG000|Period B/A+|Lost to Follow-up|0|||
16267837|NCT01838681|39463228|FG001|Period B/A+|Lost to Follow-up|2|||
16267838|NCT01838681|39463229|FG002|Period B/A+|Lost to Follow-up|5|||
16267839|NCT01838681|39463230|FG003|Period B/A+|Lost to Follow-up|11|||
16267840|NCT01838681|39463227|FG000|Period B/A+|Withdrawal before treatment|0|||
16267841|NCT01838681|39463228|FG001|Period B/A+|Withdrawal before treatment|1|||
16267842|NCT01838681|39463229|FG002|Period B/A+|Withdrawal before treatment|0|||
16267843|NCT01838681|39463230|FG003|Period B/A+|Withdrawal before treatment|0|||
16267844|NCT01838681|39463227|FG000|Period B/A+|Administrative or other reasons|0|||
16267845|NCT01838681|39463228|FG001|Period B/A+|Administrative or other reasons|6|||
16267846|NCT01838681|39463229|FG002|Period B/A+|Administrative or other reasons|10|||
16267847|NCT01838681|39463230|FG003|Period B/A+|Administrative or other reasons|28|||
16267848|NCT05652140|39463236|FG000|Overall Study|Lost to Follow-up|7|||
16267849|NCT05652140|39463237|FG001|Overall Study|Lost to Follow-up|16|||
16267850|NCT05652140|39463238|FG002|Overall Study|Lost to Follow-up|22|||
16267851|NCT05652140|39463239|FG003|Overall Study|Lost to Follow-up|31|||
16267852|NCT00835536|39463244|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
16267853|NCT00835536|39463245|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
16267854|NCT00834717|39463246|FG000|First Intervention|Adverse Event|1|||
16267855|NCT00834717|39463247|FG001|First Intervention|Adverse Event|0|||
16267856|NCT00834717|39463246|FG000|First Intervention|Withdrawal by Subject|0|||
16267857|NCT00834717|39463247|FG001|First Intervention|Withdrawal by Subject|1|||
16267858|NCT02149420|39463250|FG000|Core Study|Administrative problems|0|||
16267859|NCT02149420|39463251|FG001|Core Study|Administrative problems|1|||
16267860|NCT02149420|39463252|FG002|Core Study|Administrative problems|2|||
16267861|NCT02149420|39463250|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
16267862|NCT02149420|39463251|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
16267863|NCT02149420|39463252|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
16267864|NCT00672984|39463253|FG000|First Intervention|Adverse Event|5|||
16267865|NCT00672984|39463254|FG001|First Intervention|Adverse Event|0|||
16267866|NCT00672984|39463255|FG002|First Intervention|Adverse Event|0|||
16267867|NCT00672984|39463253|FG000|First Intervention|Withdrawal by Subject|1|||
16267868|NCT00672984|39463254|FG001|First Intervention|Withdrawal by Subject|2|||
16267869|NCT00672984|39463255|FG002|First Intervention|Withdrawal by Subject|2|||
16267870|NCT00672984|39463253|FG000|First Intervention|Sponsor decision|3|||
16267871|NCT00672984|39463254|FG001|First Intervention|Sponsor decision|0|||
16267872|NCT00672984|39463255|FG002|First Intervention|Sponsor decision|0|||
16267873|NCT00672984|39463253|FG000|Second Intervention|Non-compliance with facility policies|0|||
16267874|NCT00672984|39463254|FG001|Second Intervention|Non-compliance with facility policies|2|||
16267875|NCT00672984|39463255|FG002|Second Intervention|Non-compliance with facility policies|0|||
16267876|NCT00672984|39463253|FG000|Second Intervention|Withdrawal by Subject|0|||
16267877|NCT00672984|39463254|FG001|Second Intervention|Withdrawal by Subject|3|||
16267878|NCT00672984|39463255|FG002|Second Intervention|Withdrawal by Subject|0|||
16267879|NCT00672984|39463253|FG000|Second Intervention|Protocol Violation|0|||
16267880|NCT00672984|39463254|FG001|Second Intervention|Protocol Violation|1|||
16166293|NCT02083380|39087563|FG002|Overall Study|Physician Decision|3|||
16166294|NCT02083380|39087561|FG000|Overall Study|Adverse Event|0|||
16072671|NCT01467700|38756419|FG001|Overall Study|Pregnancy|1|||
16267881|NCT00672984|39463255|FG002|Second Intervention|Protocol Violation|1|||
16267882|NCT00672984|39463253|FG000|Third Intervention|Adverse Event|1|||
16267883|NCT00672984|39463254|FG001|Third Intervention|Adverse Event|0|||
16267884|NCT00672984|39463255|FG002|Third Intervention|Adverse Event|1|||
16267885|NCT02718326|39463257|FG000|Overall Study|Adverse Event|4|||
16267886|NCT02718326|39463258|FG001|Overall Study|Adverse Event|9|||
16267887|NCT02718326|39463259|FG002|Overall Study|Adverse Event|0|||
16267888|NCT02718326|39463257|FG000|Overall Study|Death|8|||
16267889|NCT02718326|39463258|FG001|Overall Study|Death|1|||
16267890|NCT02718326|39463259|FG002|Overall Study|Death|2|||
16267891|NCT02718326|39463257|FG000|Overall Study|Withdrawal by Subject|4|||
16267892|NCT02718326|39463258|FG001|Overall Study|Withdrawal by Subject|9|||
16267893|NCT02718326|39463259|FG002|Overall Study|Withdrawal by Subject|6|||
16267894|NCT02718326|39463257|FG000|Overall Study|Lost to Follow-up|18|||
16267895|NCT02718326|39463258|FG001|Overall Study|Lost to Follow-up|5|||
16267896|NCT02718326|39463259|FG002|Overall Study|Lost to Follow-up|14|||
16267897|NCT02718326|39463257|FG000|Overall Study|Protocol Deviation|1|||
16267898|NCT02718326|39463258|FG001|Overall Study|Protocol Deviation|0|||
16267899|NCT02718326|39463259|FG002|Overall Study|Protocol Deviation|0|||
16267900|NCT02718326|39463257|FG000|Overall Study|Pregnancy|1|||
16267901|NCT02718326|39463258|FG001|Overall Study|Pregnancy|0|||
16267902|NCT02718326|39463259|FG002|Overall Study|Pregnancy|0|||
16267903|NCT01289262|39463272|FG000|Overall Study|Lost to Follow-up|29|||
16267904|NCT01289262|39463273|FG001|Overall Study|Lost to Follow-up|16|||
16267905|NCT01289262|39463272|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
16267906|NCT01289262|39463273|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
16267907|NCT03499873|39463274|FG000|Overall Study|Withdrawal by Subject|4|||
16267908|NCT03499873|39463275|FG001|Overall Study|Withdrawal by Subject|6|||
16267909|NCT03499873|39463276|FG002|Overall Study|Withdrawal by Subject|1|||
16267910|NCT03499873|39463274|FG000|Overall Study|Subjects condition worsened|0|||
16267911|NCT03499873|39463275|FG001|Overall Study|Subjects condition worsened|3|||
16267912|NCT03499873|39463276|FG002|Overall Study|Subjects condition worsened|11|||
16267913|NCT03499873|39463274|FG000|Overall Study|Adverse Event|8|||
16267914|NCT03499873|39463275|FG001|Overall Study|Adverse Event|3|||
16267915|NCT03499873|39463276|FG002|Overall Study|Adverse Event|6|||
16267916|NCT03499873|39463274|FG000|Overall Study|Physician Decision|1|||
16267917|NCT03499873|39463275|FG001|Overall Study|Physician Decision|0|||
16267918|NCT03499873|39463276|FG002|Overall Study|Physician Decision|0|||
16267919|NCT03499873|39463274|FG000|Overall Study|Administrative reasons|0|||
16267920|NCT03499873|39463275|FG001|Overall Study|Administrative reasons|1|||
16267921|NCT03499873|39463276|FG002|Overall Study|Administrative reasons|0|||
16267922|NCT03499873|39463274|FG000|Overall Study|Concomitant therapy|5|||
16267923|NCT03499873|39463275|FG001|Overall Study|Concomitant therapy|4|||
16267924|NCT03499873|39463276|FG002|Overall Study|Concomitant therapy|7|||
16267925|NCT03499873|39463274|FG000|Overall Study|Miscellaneous|1|||
16455304|NCT01798849|40148100|FG001|Overall Study|Physician Decision|0|||
16455305|NCT01798849|40148101|FG002|Overall Study|Physician Decision|1|||
16455306|NCT00275340|40148102|FG000|Overall Study|Lost to Follow-up|2|||
16455307|NCT00275340|40148103|FG001|Overall Study|Lost to Follow-up|4|||
16455308|NCT01727024|40148105|FG000|Period 1|Lost to Follow-up|1|||
16166295|NCT02083380|39087562|FG001|Overall Study|Adverse Event|0|||
16166296|NCT02083380|39087563|FG002|Overall Study|Adverse Event|1|||
16166297|NCT02083380|39087561|FG000|Overall Study|Lost to Follow-up|5|||
16166298|NCT02083380|39087562|FG001|Overall Study|Lost to Follow-up|3|||
16166299|NCT02083380|39087563|FG002|Overall Study|Lost to Follow-up|3|||
16166300|NCT02083380|39087561|FG000|Overall Study|Other|8|||
16166301|NCT02083380|39087562|FG001|Overall Study|Other|4|||
16166302|NCT02083380|39087563|FG002|Overall Study|Other|6|||
16166303|NCT02292212|39087564|FG000|ViE Phase|Withdrawal by Subject|1|||
16166304|NCT02292212|39087564|FG000|ViE Phase|Protocol Violation|2|||
16166305|NCT01929135|39087565|FG000|Overall Study|Lost to Follow-up|1|||
16166306|NCT01929135|39087566|FG001|Overall Study|Lost to Follow-up|1|||
16166307|NCT01737931|39087567|FG000|Overall Study|Withdrawal by Subject|0|||
16166308|NCT01737931|39087568|FG001|Overall Study|Withdrawal by Subject|1|||
16166309|NCT01737931|39087569|FG002|Overall Study|Withdrawal by Subject|1|||
16166310|NCT01737931|39087567|FG000|Overall Study|Physician Decision|0|||
16166311|NCT01737931|39087568|FG001|Overall Study|Physician Decision|1|||
16166312|NCT01737931|39087569|FG002|Overall Study|Physician Decision|0|||
16166313|NCT00559507|39087570|FG000|Overall Study|Not treated, patient ineligible|3|||
16166314|NCT01407926|39087574|FG000|Overall Study|Lost to Follow-up|55|||
16166315|NCT00624520|39087585|FG000|Overall Study|Withdrawal by Subject|12|||
16455309|NCT01727024|40148106|FG001|Period 1|Lost to Follow-up|1|||
16455310|NCT01727024|40148105|FG000|Period 1|Withdrawal by Subject|2|||
16166316|NCT00624520|39087586|FG001|Overall Study|Withdrawal by Subject|7|||
16166317|NCT00624520|39087585|FG000|Overall Study|Death|0|||
16166318|NCT00624520|39087586|FG001|Overall Study|Death|1|||
16166319|NCT00598975|39087589|FG000|Overall Study|Adverse Event|1|||
16267926|NCT03499873|39463275|FG001|Overall Study|Miscellaneous|2|||
16267927|NCT03499873|39463276|FG002|Overall Study|Miscellaneous|2|||
16267928|NCT03499873|39463274|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
16267929|NCT03499873|39463275|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
16455311|NCT01727024|40148106|FG001|Period 1|Withdrawal by Subject|3|||
16166320|NCT00598975|39087590|FG001|Overall Study|Adverse Event|1|||
16166321|NCT00598975|39087589|FG000|Overall Study|Brain metastases|1|||
16166322|NCT00598975|39087590|FG001|Overall Study|Brain metastases|0|||
16166323|NCT00598975|39087589|FG000|Overall Study|Withdrawal by Subject|1|||
16166324|NCT00598975|39087590|FG001|Overall Study|Withdrawal by Subject|1|||
16166325|NCT00598975|39087589|FG000|Overall Study|Withdrawal of consent|0|||
16166326|NCT00598975|39087590|FG001|Overall Study|Withdrawal of consent|1|||
16166327|NCT00598975|39087589|FG000|Overall Study|Disease progression|8|||
16166328|NCT00598975|39087590|FG001|Overall Study|Disease progression|3|||
16166329|NCT00598975|39087589|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
16166330|NCT00598975|39087590|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
16166331|NCT00699907|39087591|FG000|Overall Study|Withdrawal by Subject|2|||
16166332|NCT00699907|39087592|FG001|Overall Study|Withdrawal by Subject|1|||
16166333|NCT00699907|39087593|FG002|Overall Study|Withdrawal by Subject|0|||
16267930|NCT03499873|39463276|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
16267931|NCT00107991|39463279|FG000|Eligibility Assessment|Disease not severe enough|7|||
16267932|NCT00107991|39463279|FG000|Eligibility Assessment|Unwilling to participate|7|||
16267933|NCT00107991|39463279|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
16267934|NCT00107991|39463279|FG000|Eligibility Assessment|Abnormal labs|2|||
16267935|NCT00107991|39463279|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
16267936|NCT00107991|39463279|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
16267937|NCT00107991|39463279|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
16267938|NCT00107991|39463279|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
16267939|NCT00107991|39463279|FG000|12 Week Treatment Period|Adverse Event|1|||
16267940|NCT00107991|39463279|FG000|12 Week Treatment Period|Protocol Violation|1|||
16267941|NCT00107991|39463279|FG000|12 Week Treatment Period|Incarcerated|1|||
16267942|NCT00107991|39463279|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
16267943|NCT03199963|39463280|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
16267944|NCT03199963|39463281|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
16267945|NCT03199963|39463280|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
16267946|NCT03199963|39463281|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
16267947|NCT03199963|39463280|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
16267948|NCT03199963|39463281|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
16267949|NCT03199963|39463280|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
16267950|NCT03199963|39463281|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
16267951|NCT03199963|39463280|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
16267952|NCT03199963|39463281|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
16267953|NCT03199963|39463280|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
16267954|NCT03199963|39463281|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
16267955|NCT00840632|39463286|FG000|First Intervention|Withdrawal by Subject|0|||
16267956|NCT00840632|39463287|FG001|First Intervention|Withdrawal by Subject|1|||
16267957|NCT00840632|39463286|FG000|Washout|Withdrawal by Subject|1|||
16267958|NCT00840632|39463287|FG001|Washout|Withdrawal by Subject|1|||
16267959|NCT04631562|39463290|FG000|Overall Study|Withdrawal by Subject|0|||
16267960|NCT04631562|39463291|FG001|Overall Study|Withdrawal by Subject|0|||
16267961|NCT04631562|39463292|FG002|Overall Study|Withdrawal by Subject|0|||
16267962|NCT04631562|39463293|FG003|Overall Study|Withdrawal by Subject|0|||
16455312|NCT04027608|40148108|FG000|Overall Study|Withdrawal by Subject|13|||
16166334|NCT00699907|39087591|FG000|Overall Study|No usable sample|0|||
16166335|NCT00699907|39087592|FG001|Overall Study|No usable sample|9|||
16166336|NCT00699907|39087593|FG002|Overall Study|No usable sample|8|||
16166337|NCT01276236|39087594|FG000|Overall Study|Lack of Efficacy|2|||
16166338|NCT01276236|39087594|FG000|Overall Study|Withdrawal by Subject|4|||
16166339|NCT02799069|39087596|FG000|Overall Study|Adverse Event|0|||
16166340|NCT02799069|39087597|FG001|Overall Study|Adverse Event|2|||
16166341|NCT02799069|39087598|FG002|Overall Study|Adverse Event|2|||
16166342|NCT02799069|39087596|FG000|Overall Study|Lack of Efficacy|2|||
16166343|NCT02799069|39087597|FG001|Overall Study|Lack of Efficacy|0|||
16166344|NCT02799069|39087598|FG002|Overall Study|Lack of Efficacy|0|||
16166345|NCT02799069|39087596|FG000|Overall Study|Lost to Follow-up|1|||
16166346|NCT02799069|39087597|FG001|Overall Study|Lost to Follow-up|1|||
16166347|NCT02799069|39087598|FG002|Overall Study|Lost to Follow-up|0|||
16166348|NCT02799069|39087596|FG000|Overall Study|Withdrawal by Subject|4|||
16166349|NCT02799069|39087597|FG001|Overall Study|Withdrawal by Subject|4|||
16166350|NCT02799069|39087598|FG002|Overall Study|Withdrawal by Subject|3|||
16166351|NCT02799069|39087596|FG000|Overall Study|Protocol Violation|1|||
16267963|NCT04631562|39463294|FG004|Overall Study|Withdrawal by Subject|0|||
16267964|NCT04631562|39463295|FG005|Overall Study|Withdrawal by Subject|0|||
16166352|NCT02799069|39087597|FG001|Overall Study|Protocol Violation|0|||
16166353|NCT02799069|39087598|FG002|Overall Study|Protocol Violation|2|||
16166354|NCT02624492|39087600|FG000|Overall Study|Adverse Event|2|||
16166355|NCT02624492|39087601|FG001|Overall Study|Adverse Event|2|||
16166356|NCT02624492|39087602|FG002|Overall Study|Adverse Event|2|||
16166357|NCT02624492|39087600|FG000|Overall Study|Progressive disease|0|||
16166358|NCT02624492|39087601|FG001|Overall Study|Progressive disease|2|||
16166359|NCT02624492|39087602|FG002|Overall Study|Progressive disease|3|||
16166360|NCT02211261|39087603|FG000|Overall Study|Withdrawal by Subject|0|||
16166361|NCT02211261|39087604|FG001|Overall Study|Withdrawal by Subject|0|||
16166362|NCT02211261|39087605|FG002|Overall Study|Withdrawal by Subject|1|||
16166363|NCT02211261|39087606|FG003|Overall Study|Withdrawal by Subject|0|||
16166364|NCT02211261|39087607|FG004|Overall Study|Withdrawal by Subject|2|||
16166365|NCT02211261|39087608|FG005|Overall Study|Withdrawal by Subject|0|||
16455313|NCT04027608|40148109|FG001|Overall Study|Withdrawal by Subject|2|||
16455314|NCT04027608|40148108|FG000|Overall Study|Protocol Violation|2|||
16455315|NCT04027608|40148109|FG001|Overall Study|Protocol Violation|1|||
16455316|NCT04027608|40148108|FG000|Overall Study|Physician Decision|1|||
16455317|NCT04027608|40148109|FG001|Overall Study|Physician Decision|0|||
16455318|NCT04027608|40148108|FG000|Overall Study|Lost to Follow-up|20|||
16455319|NCT04027608|40148109|FG001|Overall Study|Lost to Follow-up|4|||
16455320|NCT01432730|40148110|FG000|Period 1|Adverse Event|2|||
16455321|NCT01432730|40148111|FG001|Period 1|Adverse Event|0|||
16455322|NCT01432730|40148110|FG000|Period 2|Adverse Event|0|||
16455323|NCT01432730|40148111|FG001|Period 2|Adverse Event|4|||
16455324|NCT01469377|40148112|FG000|Overall Study|Protocol Deviation|7|||
16455325|NCT01469377|40148113|FG001|Overall Study|Protocol Deviation|10|||
16455326|NCT01469377|40148114|FG002|Overall Study|Protocol Deviation|10|||
16455327|NCT01469377|40148112|FG000|Overall Study|Lost to Follow-up|3|||
16166366|NCT02211261|39087609|FG006|Overall Study|Withdrawal by Subject|0|||
16166367|NCT02211261|39087610|FG007|Overall Study|Withdrawal by Subject|0|||
16166368|NCT02211261|39087611|FG008|Overall Study|Withdrawal by Subject|0|||
16166369|NCT02211261|39087612|FG009|Overall Study|Withdrawal by Subject|0|||
16166370|NCT02211261|39087613|FG010|Overall Study|Withdrawal by Subject|0|||
16166371|NCT02211261|39087603|FG000|Overall Study|Other|0|||
16166372|NCT02211261|39087604|FG001|Overall Study|Other|0|||
16166373|NCT02211261|39087605|FG002|Overall Study|Other|0|||
16166374|NCT02211261|39087606|FG003|Overall Study|Other|0|||
16166375|NCT02211261|39087607|FG004|Overall Study|Other|0|||
16166376|NCT02211261|39087608|FG005|Overall Study|Other|1|||
16166377|NCT02211261|39087609|FG006|Overall Study|Other|0|||
16166378|NCT02211261|39087610|FG007|Overall Study|Other|0|||
16166379|NCT02211261|39087611|FG008|Overall Study|Other|0|||
16166380|NCT02211261|39087612|FG009|Overall Study|Other|2|||
16166381|NCT02211261|39087613|FG010|Overall Study|Other|0|||
16166382|NCT02211261|39087603|FG000|Overall Study|Lost to Follow-up|0|||
16166383|NCT02211261|39087604|FG001|Overall Study|Lost to Follow-up|0|||
16166384|NCT02211261|39087605|FG002|Overall Study|Lost to Follow-up|0|||
16166385|NCT02211261|39087606|FG003|Overall Study|Lost to Follow-up|0|||
16166386|NCT02211261|39087607|FG004|Overall Study|Lost to Follow-up|0|||
16166387|NCT02211261|39087608|FG005|Overall Study|Lost to Follow-up|0|||
16166388|NCT02211261|39087609|FG006|Overall Study|Lost to Follow-up|0|||
16166389|NCT02211261|39087610|FG007|Overall Study|Lost to Follow-up|1|||
16166390|NCT02211261|39087611|FG008|Overall Study|Lost to Follow-up|0|||
16166391|NCT02211261|39087612|FG009|Overall Study|Lost to Follow-up|0|||
16166392|NCT02211261|39087613|FG010|Overall Study|Lost to Follow-up|0|||
16166393|NCT00070941|39087614|FG000|Overall Study|Adverse Event|10|||
16166394|NCT00070941|39087615|FG001|Overall Study|Adverse Event|8|||
16166395|NCT00070941|39087616|FG002|Overall Study|Adverse Event|4|||
16166396|NCT02796755|39087622|FG000|Overall Study|Adverse Event|2|||
16166397|NCT02796755|39087623|FG001|Overall Study|Adverse Event|0|||
16166398|NCT00441545|39087624|FG000|First Intervention|Adverse Event|6|||
16267965|NCT04631562|39463296|FG006|Overall Study|Withdrawal by Subject|0|||
16267966|NCT04631562|39463297|FG007|Overall Study|Withdrawal by Subject|1|||
16267967|NCT04631562|39463298|FG008|Overall Study|Withdrawal by Subject|0|||
16267968|NCT04631562|39463290|FG000|Overall Study|Other|0|||
16267969|NCT04631562|39463291|FG001|Overall Study|Other|0|||
16267970|NCT04631562|39463292|FG002|Overall Study|Other|0|||
16267971|NCT04631562|39463293|FG003|Overall Study|Other|0|||
16267972|NCT04631562|39463294|FG004|Overall Study|Other|0|||
16267973|NCT04631562|39463295|FG005|Overall Study|Other|0|||
16267974|NCT04631562|39463296|FG006|Overall Study|Other|0|||
16166399|NCT00441545|39087625|FG001|First Intervention|Adverse Event|5|||
16166400|NCT00441545|39087624|FG000|First Intervention|Protocol Violation|2|||
16267975|NCT04631562|39463297|FG007|Overall Study|Other|0|||
16267976|NCT04631562|39463298|FG008|Overall Study|Other|1|||
16455328|NCT01469377|40148113|FG001|Overall Study|Lost to Follow-up|2|||
16166401|NCT00441545|39087625|FG001|First Intervention|Protocol Violation|2|||
16166402|NCT00441545|39087624|FG000|First Intervention|Withdrawal by Subject|3|||
16166403|NCT00441545|39087625|FG001|First Intervention|Withdrawal by Subject|3|||
16166404|NCT00441545|39087624|FG000|First Intervention|Kidney transplant|1|||
16166405|NCT00441545|39087625|FG001|First Intervention|Kidney transplant|1|||
16267977|NCT04631562|39463290|FG000|Overall Study|Lost to Follow-up|0|||
16455329|NCT01469377|40148114|FG002|Overall Study|Lost to Follow-up|5|||
16166406|NCT00441545|39087624|FG000|First Intervention|Lack of Efficacy|2|||
16166407|NCT00441545|39087625|FG001|First Intervention|Lack of Efficacy|0|||
16166408|NCT00441545|39087624|FG000|First Intervention|Subject exceeded safety criteria|0|||
16166409|NCT00441545|39087625|FG001|First Intervention|Subject exceeded safety criteria|1|||
16166410|NCT00441545|39087624|FG000|First Intervention|Subject met an exclusionary criteria|1|||
16166411|NCT00441545|39087625|FG001|First Intervention|Subject met an exclusionary criteria|0|||
16166412|NCT00441545|39087624|FG000|First Intervention|Extended hospitalization|1|||
16166413|NCT00441545|39087625|FG001|First Intervention|Extended hospitalization|0|||
16166414|NCT00441545|39087624|FG000|First Intervention|Site error|1|||
16166415|NCT00441545|39087625|FG001|First Intervention|Site error|0|||
16166416|NCT00441545|39087624|FG000|First Intervention|Sponsor's request|1|||
16166417|NCT00441545|39087625|FG001|First Intervention|Sponsor's request|0|||
16166418|NCT00441545|39087624|FG000|Second Intervention|Adverse Event|5|||
16166419|NCT00441545|39087625|FG001|Second Intervention|Adverse Event|2|||
16166420|NCT00441545|39087624|FG000|Second Intervention|Protocol Violation|4|||
16166421|NCT00441545|39087625|FG001|Second Intervention|Protocol Violation|1|||
16455330|NCT01469377|40148112|FG000|Overall Study|Withdrawal of Consent|12|||
16455331|NCT01469377|40148113|FG001|Overall Study|Withdrawal of Consent|14|||
16455332|NCT01469377|40148114|FG002|Overall Study|Withdrawal of Consent|15|||
16455333|NCT01469377|40148112|FG000|Overall Study|Adverse Event|8|||
16455334|NCT01469377|40148113|FG001|Overall Study|Adverse Event|18|||
16455335|NCT01469377|40148114|FG002|Overall Study|Adverse Event|36|||
16455336|NCT01469377|40148112|FG000|Overall Study|Insufficient Therapeutic Response|3|||
16455337|NCT01469377|40148113|FG001|Overall Study|Insufficient Therapeutic Response|4|||
16455338|NCT01469377|40148114|FG002|Overall Study|Insufficient Therapeutic Response|0|||
16455339|NCT01469377|40148112|FG000|Overall Study|Other Miscellaneous Reasons|2|||
16455340|NCT01469377|40148113|FG001|Overall Study|Other Miscellaneous Reasons|0|||
16455341|NCT01469377|40148114|FG002|Overall Study|Other Miscellaneous Reasons|0|||
16455342|NCT01738646|40148117|FG000|Overall Study|Still Receiving Treatment|2|||
16455343|NCT02930018|40148118|FG000|Overall Study|Lost to Follow-up|1|||
16455344|NCT02930018|40148119|FG001|Overall Study|Lost to Follow-up|1|||
16455345|NCT02930018|40148118|FG000|Overall Study|Withdrawal by Subject|5|||
16455346|NCT02930018|40148119|FG001|Overall Study|Withdrawal by Subject|2|||
16455347|NCT02537015|40148122|FG000|Overall Study|Adverse Event|3|||
16455348|NCT02537015|40148122|FG000|Overall Study|Withdrawal by Subject|2|||
16455349|NCT02537015|40148122|FG000|Overall Study|Other Miscellaneous Reasons|1|||
16455350|NCT00806819|40148123|FG000|Overall Study|progressive disease (modified RECIST )|217|||
16455351|NCT00806819|40148124|FG001|Overall Study|progressive disease (modified RECIST )|216|||
16455352|NCT00806819|40148123|FG000|Overall Study|Worsening or AE of underlying disease|18|||
16455353|NCT00806819|40148124|FG001|Overall Study|Worsening or AE of underlying disease|25|||
16455354|NCT00806819|40148123|FG000|Overall Study|Other AE|38|||
16166422|NCT00441545|39087624|FG000|Second Intervention|Withdrawal by Subject|1|||
16166423|NCT00441545|39087625|FG001|Second Intervention|Withdrawal by Subject|1|||
16166424|NCT00441545|39087624|FG000|Second Intervention|Kidney Transplant|1|||
16166425|NCT00441545|39087625|FG001|Second Intervention|Kidney Transplant|1|||
16166426|NCT00441545|39087624|FG000|Second Intervention|Lack of Efficacy|0|||
16166427|NCT00441545|39087625|FG001|Second Intervention|Lack of Efficacy|1|||
16166428|NCT00441545|39087624|FG000|Second Intervention|Subject exceeded safety criteria|1|||
16166429|NCT00441545|39087625|FG001|Second Intervention|Subject exceeded safety criteria|0|||
16455355|NCT00806819|40148124|FG001|Overall Study|Other AE|40|||
16455356|NCT00806819|40148123|FG000|Overall Study|Protocol Violation|9|||
16455357|NCT00806819|40148124|FG001|Overall Study|Protocol Violation|4|||
16455358|NCT00806819|40148123|FG000|Overall Study|Lost to Follow-up|1|||
16455359|NCT00806819|40148124|FG001|Overall Study|Lost to Follow-up|0|||
16455360|NCT00806819|40148123|FG000|Overall Study|Withdrawal by Subject|32|||
16455361|NCT00806819|40148124|FG001|Overall Study|Withdrawal by Subject|29|||
16166430|NCT00441545|39087624|FG000|Second Intervention|Subject moved|0|||
16166431|NCT00441545|39087625|FG001|Second Intervention|Subject moved|1|||
16166432|NCT03183128|39087648|FG000|Overall Study|Adverse Event|1|||
16166433|NCT03183128|39087649|FG001|Overall Study|Adverse Event|2|||
16166434|NCT03183128|39087648|FG000|Overall Study|Withdrawal by Subject|1|||
16166435|NCT03183128|39087649|FG001|Overall Study|Withdrawal by Subject|8|||
16267978|NCT04631562|39463291|FG001|Overall Study|Lost to Follow-up|0|||
16267979|NCT04631562|39463292|FG002|Overall Study|Lost to Follow-up|0|||
16267980|NCT04631562|39463293|FG003|Overall Study|Lost to Follow-up|1|||
16267981|NCT04631562|39463294|FG004|Overall Study|Lost to Follow-up|0|||
16267982|NCT04631562|39463295|FG005|Overall Study|Lost to Follow-up|0|||
16267983|NCT04631562|39463296|FG006|Overall Study|Lost to Follow-up|0|||
16267984|NCT04631562|39463297|FG007|Overall Study|Lost to Follow-up|0|||
16267985|NCT04631562|39463298|FG008|Overall Study|Lost to Follow-up|0|||
16267986|NCT04631562|39463290|FG000|Overall Study|Adverse Event|0|||
16267987|NCT04631562|39463291|FG001|Overall Study|Adverse Event|0|||
16455362|NCT00806819|40148123|FG000|Overall Study|Not treated|6|||
16455363|NCT00806819|40148124|FG001|Overall Study|Not treated|3|||
16455364|NCT00806819|40148123|FG000|Overall Study|Reasons other than stated above|25|||
16166436|NCT03183128|39087648|FG000|Overall Study|Protocol Violation|2|||
16455365|NCT00806819|40148124|FG001|Overall Study|Reasons other than stated above|41|||
16455366|NCT01781299|40148133|FG000|Overall Study|Withdrawal by Subject|0|||
16455367|NCT01781299|40148134|FG001|Overall Study|Withdrawal by Subject|1|||
16455368|NCT02948088|40148135|FG000|Overall Study|Lost to Follow-up|8|||
16455369|NCT02948088|40148135|FG000|Overall Study|Death|1|||
16455370|NCT02948088|40148135|FG000|Overall Study|Withdrawal by Subject|4|||
16455371|NCT02948088|40148135|FG000|Overall Study|Other|2|||
16455372|NCT04248491|40148136|FG000|Overall Study|Lost to Follow-up|1|||
16455373|NCT04248491|40148137|FG001|Overall Study|Lost to Follow-up|0|||
16455374|NCT01474018|40148146|FG000|Overall Study|Lost to Follow-up|0|||
16267988|NCT04631562|39463292|FG002|Overall Study|Adverse Event|0|||
16267989|NCT04631562|39463293|FG003|Overall Study|Adverse Event|0|||
16267990|NCT04631562|39463294|FG004|Overall Study|Adverse Event|0|||
16267991|NCT04631562|39463295|FG005|Overall Study|Adverse Event|0|||
16267992|NCT04631562|39463296|FG006|Overall Study|Adverse Event|1|||
16267993|NCT04631562|39463297|FG007|Overall Study|Adverse Event|0|||
16267994|NCT04631562|39463298|FG008|Overall Study|Adverse Event|0|||
16267995|NCT00905346|39467525|FG000|Period 1|Withdrawal by Subject|1|||
16267996|NCT00905346|39467526|FG001|Period 1|Withdrawal by Subject|0|||
16267997|NCT00088829|39467531|FG000|Overall Study|PI left institution and study was close|22|||
16267998|NCT00830258|39467532|FG000|First Intervention|Adverse Event|1|||
16267999|NCT00830258|39467533|FG001|First Intervention|Adverse Event|0|||
16268000|NCT00830258|39467532|FG000|Washout: 7 Days|Protocol Violation|1|||
16268001|NCT00830258|39467533|FG001|Washout: 7 Days|Protocol Violation|0|||
16268002|NCT02640235|39467536|FG000|Overall Study|Withdrawal by Subject|7|||
16268003|NCT02640235|39467537|FG001|Overall Study|Withdrawal by Subject|6|||
16268004|NCT02640235|39467536|FG000|Overall Study|Lost to Follow-up|4|||
16268005|NCT02640235|39467537|FG001|Overall Study|Lost to Follow-up|3|||
16268006|NCT02640235|39467536|FG000|Overall Study|Death|2|||
16268007|NCT02640235|39467537|FG001|Overall Study|Death|3|||
16268008|NCT02640235|39467536|FG000|Overall Study|Other|1|||
16268009|NCT02640235|39467537|FG001|Overall Study|Other|2|||
16268010|NCT04994535|39467542|FG000|Overall Study|Lost to Follow-up|7|||
16268011|NCT04994535|39467543|FG001|Overall Study|Lost to Follow-up|7|||
16268012|NCT04994535|39467542|FG000|Overall Study|Withdrawal by Subject|10|||
16268013|NCT04994535|39467543|FG001|Overall Study|Withdrawal by Subject|7|||
16268014|NCT04994535|39467542|FG000|Overall Study|Other|1|||
16268015|NCT04994535|39467543|FG001|Overall Study|Other|1|||
16268016|NCT04078022|39467546|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
16268017|NCT04078022|39467547|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
16268018|NCT04466111|39467552|FG000|Prior to Trial Phase|Physician Decision|1|||
16268019|NCT01735994|39467556|FG000|Overall Study|Withdrawal by Subject|6|||
16268020|NCT01735994|39467557|FG001|Overall Study|Withdrawal by Subject|4|||
16268021|NCT01735994|39467556|FG000|Overall Study|Injury|2|||
16268022|NCT01735994|39467557|FG001|Overall Study|Injury|0|||
16268023|NCT01735994|39467556|FG000|Overall Study|Kicked off team|5|||
16268024|NCT01735994|39467557|FG001|Overall Study|Kicked off team|0|||
16268025|NCT01735994|39467556|FG000|Overall Study|Lost to Follow-up|50|||
16268026|NCT01735994|39467557|FG001|Overall Study|Lost to Follow-up|62|||
16268035|NCT00835705|39467565|FG000|First Intervention|Difficulty with vein|1|||
16268036|NCT00835705|39467566|FG001|First Intervention|Difficulty with vein|0|||
16268037|NCT00835705|39467565|FG000|Second Intervention|Difficulty with vein|1|||
16268038|NCT00835705|39467566|FG001|Second Intervention|Difficulty with vein|0|||
16268039|NCT00624286|39467569|FG000|Overall Study|Protocol Deviation|7|||
16268040|NCT00624286|39467570|FG001|Overall Study|Protocol Deviation|9|||
16455375|NCT01474018|40148147|FG001|Overall Study|Lost to Follow-up|1|||
16455376|NCT01474018|40148146|FG000|Overall Study|Withdrawal by Subject|0|||
16455377|NCT01474018|40148147|FG001|Overall Study|Withdrawal by Subject|2|||
16268041|NCT00624286|39467569|FG000|Overall Study|Adverse Event|6|||
16268042|NCT00624286|39467570|FG001|Overall Study|Adverse Event|3|||
16268043|NCT00624286|39467569|FG000|Overall Study|Withdrawal by Subject|5|||
16268044|NCT00624286|39467570|FG001|Overall Study|Withdrawal by Subject|4|||
16268045|NCT00624286|39467569|FG000|Overall Study|Lost to Follow-up|3|||
16268046|NCT00624286|39467570|FG001|Overall Study|Lost to Follow-up|2|||
16268047|NCT00624286|39467569|FG000|Overall Study|Administrative problems|3|||
16268048|NCT00624286|39467570|FG001|Overall Study|Administrative problems|0|||
16268049|NCT00624286|39467569|FG000|Overall Study|Lack of Efficacy|1|||
16268050|NCT00624286|39467570|FG001|Overall Study|Lack of Efficacy|6|||
16268051|NCT00624286|39467569|FG000|Overall Study|Not stated|0|||
16268052|NCT00624286|39467570|FG001|Overall Study|Not stated|1|||
16455378|NCT01456897|40148148|FG000|Overall Study|Adverse Event|19|||
16268053|NCT00624286|39467569|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16268054|NCT00624286|39467570|FG001|Overall Study|Abnormal test procedure result(s)|1|||
16268055|NCT00624286|39467569|FG000|Overall Study|Death|0|||
16268056|NCT00624286|39467570|FG001|Overall Study|Death|1|||
16268057|NCT00841542|39467571|FG000|Period 1|Adverse Event|1|||
16268058|NCT00841542|39467572|FG001|Period 1|Adverse Event|0|||
16268059|NCT01020474|39467575|FG000|Overall Study|Adverse Event|4|||
16268060|NCT01020474|39467576|FG001|Overall Study|Adverse Event|4|||
16268061|NCT01020474|39467575|FG000|Overall Study|Protocol Violation|0|||
16268062|NCT01020474|39467576|FG001|Overall Study|Protocol Violation|2|||
16268063|NCT01020474|39467575|FG000|Overall Study|Withdrawal by Subject|5|||
16268064|NCT01020474|39467576|FG001|Overall Study|Withdrawal by Subject|7|||
16268065|NCT01020474|39467575|FG000|Overall Study|Other Reasons|1|||
16268066|NCT01020474|39467576|FG001|Overall Study|Other Reasons|1|||
16268067|NCT01020474|39467575|FG000|Overall Study|Insufficient Clinical Response|0|||
16268068|NCT01020474|39467576|FG001|Overall Study|Insufficient Clinical Response|3|||
16268069|NCT04223791|39467578|FG000|Overall Study|Lost to Follow-up|0|||
16268070|NCT04223791|39467579|FG001|Overall Study|Lost to Follow-up|4|||
16268071|NCT04223791|39467578|FG000|Overall Study|Physician Decision|5|||
16268072|NCT04223791|39467579|FG001|Overall Study|Physician Decision|1|||
16268073|NCT04223791|39467578|FG000|Overall Study|Protocol Violation|1|||
16268074|NCT04223791|39467579|FG001|Overall Study|Protocol Violation|1|||
16268075|NCT04223791|39467578|FG000|Overall Study|Withdrawal by Subject|10|||
16268076|NCT04223791|39467579|FG001|Overall Study|Withdrawal by Subject|12|||
16268077|NCT04223791|39467578|FG000|Overall Study|Pregnancy|1|||
16268078|NCT04223791|39467579|FG001|Overall Study|Pregnancy|1|||
16268079|NCT04223791|39467578|FG000|Overall Study|Ongoing in Study|305|||
16268080|NCT04223791|39467579|FG001|Overall Study|Ongoing in Study|302|||
16268081|NCT00728754|39467585|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
16268082|NCT00728754|39467586|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
16268083|NCT00728754|39467585|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
16268084|NCT00728754|39467586|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
16268085|NCT00728754|39467585|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
16268086|NCT00728754|39467586|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
16268087|NCT00819169|39467591|FG000|Overall Study|Withdrawal by Subject|2|||
16268088|NCT00819169|39467592|FG001|Overall Study|Withdrawal by Subject|0|||
16268089|NCT00819169|39467593|FG002|Overall Study|Withdrawal by Subject|0|||
16268090|NCT00819169|39467594|FG003|Overall Study|Withdrawal by Subject|1|||
16268091|NCT00819169|39467595|FG004|Overall Study|Withdrawal by Subject|1|||
16268092|NCT00819169|39467596|FG005|Overall Study|Withdrawal by Subject|1|||
16268093|NCT00819169|39467597|FG006|Overall Study|Withdrawal by Subject|5|||
16268094|NCT00819169|39467598|FG007|Overall Study|Withdrawal by Subject|1|||
16268095|NCT00819169|39467599|FG008|Overall Study|Withdrawal by Subject|4|||
16268096|NCT00819169|39467591|FG000|Overall Study|Lost to Follow-up|0|||
16268097|NCT00819169|39467592|FG001|Overall Study|Lost to Follow-up|2|||
16268098|NCT00819169|39467593|FG002|Overall Study|Lost to Follow-up|0|||
16268099|NCT00819169|39467594|FG003|Overall Study|Lost to Follow-up|1|||
16268100|NCT00819169|39467595|FG004|Overall Study|Lost to Follow-up|0|||
16268101|NCT00819169|39467596|FG005|Overall Study|Lost to Follow-up|6|||
16268102|NCT00819169|39467597|FG006|Overall Study|Lost to Follow-up|2|||
16268103|NCT00819169|39467598|FG007|Overall Study|Lost to Follow-up|2|||
16268104|NCT00819169|39467599|FG008|Overall Study|Lost to Follow-up|1|||
16268105|NCT00819169|39467591|FG000|Overall Study|Death|1|||
16268106|NCT00819169|39467592|FG001|Overall Study|Death|1|||
16268107|NCT00819169|39467593|FG002|Overall Study|Death|3|||
16268108|NCT00819169|39467594|FG003|Overall Study|Death|8|||
16268109|NCT00819169|39467595|FG004|Overall Study|Death|5|||
16268110|NCT00819169|39467596|FG005|Overall Study|Death|7|||
16268111|NCT00819169|39467597|FG006|Overall Study|Death|9|||
16268112|NCT00819169|39467598|FG007|Overall Study|Death|4|||
16268113|NCT00819169|39467599|FG008|Overall Study|Death|7|||
16268114|NCT00819169|39467591|FG000|Overall Study|Ineligibility determined|0|||
16268115|NCT00819169|39467592|FG001|Overall Study|Ineligibility determined|0|||
16268116|NCT00819169|39467593|FG002|Overall Study|Ineligibility determined|0|||
16268117|NCT00819169|39467594|FG003|Overall Study|Ineligibility determined|2|||
16268118|NCT00819169|39467595|FG004|Overall Study|Ineligibility determined|0|||
16268119|NCT00819169|39467596|FG005|Overall Study|Ineligibility determined|0|||
16268120|NCT00819169|39467597|FG006|Overall Study|Ineligibility determined|0|||
16268121|NCT00819169|39467598|FG007|Overall Study|Ineligibility determined|0|||
16268122|NCT00819169|39467599|FG008|Overall Study|Ineligibility determined|1|||
16268123|NCT00819169|39467591|FG000|Overall Study|Adverse Event|0|||
16268124|NCT00819169|39467592|FG001|Overall Study|Adverse Event|0|||
16268125|NCT00819169|39467593|FG002|Overall Study|Adverse Event|0|||
16268126|NCT00819169|39467594|FG003|Overall Study|Adverse Event|0|||
16268127|NCT00819169|39467595|FG004|Overall Study|Adverse Event|1|||
16268128|NCT00819169|39467596|FG005|Overall Study|Adverse Event|0|||
16268129|NCT00819169|39467597|FG006|Overall Study|Adverse Event|0|||
16268130|NCT00819169|39467598|FG007|Overall Study|Adverse Event|0|||
16455379|NCT01456897|40148149|FG001|Overall Study|Adverse Event|22|||
16268131|NCT00819169|39467599|FG008|Overall Study|Adverse Event|0|||
16268132|NCT00819169|39467591|FG000|Overall Study|Administrative Decision|0|||
16268133|NCT00819169|39467592|FG001|Overall Study|Administrative Decision|0|||
16268134|NCT00819169|39467593|FG002|Overall Study|Administrative Decision|0|||
16268135|NCT00819169|39467594|FG003|Overall Study|Administrative Decision|0|||
16268136|NCT00819169|39467595|FG004|Overall Study|Administrative Decision|1|||
16268137|NCT00819169|39467596|FG005|Overall Study|Administrative Decision|2|||
16268138|NCT00819169|39467597|FG006|Overall Study|Administrative Decision|0|||
16268139|NCT00819169|39467598|FG007|Overall Study|Administrative Decision|2|||
16268140|NCT00819169|39467599|FG008|Overall Study|Administrative Decision|0|||
16268141|NCT02704091|39467600|FG000|Overall Study|Adverse Event|4|||
16268142|NCT02704091|39467601|FG001|Overall Study|Adverse Event|3|||
16268143|NCT02704091|39467600|FG000|Overall Study|Protocol Violation|5|||
16268144|NCT02704091|39467601|FG001|Overall Study|Protocol Violation|3|||
16268145|NCT02704091|39467600|FG000|Overall Study|Consent withdrawn|4|||
16268146|NCT02704091|39467601|FG001|Overall Study|Consent withdrawn|4|||
16268147|NCT02704091|39467600|FG000|Overall Study|Lost to Follow-up|13|||
16268148|NCT02704091|39467601|FG001|Overall Study|Lost to Follow-up|5|||
16268149|NCT02704091|39467600|FG000|Overall Study|Other|2|||
16268150|NCT02704091|39467601|FG001|Overall Study|Other|8|||
16268151|NCT02011945|39467602|FG000|Overall Study|Participant requested to Discontinue|0|||
16268152|NCT02011945|39467603|FG001|Overall Study|Participant requested to Discontinue|1|||
16268153|NCT02011945|39467604|FG002|Overall Study|Participant requested to Discontinue|1|||
16268154|NCT02011945|39467602|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
16268155|NCT02011945|39467603|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
16268156|NCT02011945|39467604|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
16268157|NCT02011945|39467602|FG000|Overall Study|Study Drug Toxicity|0|||
16268158|NCT02011945|39467603|FG001|Overall Study|Study Drug Toxicity|0|||
16268159|NCT02011945|39467604|FG002|Overall Study|Study Drug Toxicity|1|||
16268160|NCT02011945|39467602|FG000|Overall Study|Treatment Failure|0|||
16268161|NCT02011945|39467603|FG001|Overall Study|Treatment Failure|7|||
16268162|NCT02011945|39467604|FG002|Overall Study|Treatment Failure|6|||
16268163|NCT02011945|39467602|FG000|Overall Study|No Longer Meets Study Criteria|1|||
16268164|NCT02011945|39467603|FG001|Overall Study|No Longer Meets Study Criteria|0|||
16268165|NCT02011945|39467604|FG002|Overall Study|No Longer Meets Study Criteria|0|||
16268166|NCT02011945|39467602|FG000|Overall Study|Proceeded to stem cell transplant|0|||
16268167|NCT02011945|39467603|FG001|Overall Study|Proceeded to stem cell transplant|0|||
16268168|NCT02011945|39467604|FG002|Overall Study|Proceeded to stem cell transplant|1|||
16268169|NCT02011945|39467602|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
16268170|NCT02011945|39467603|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
16268171|NCT02011945|39467604|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
16268172|NCT04852978|39467606|FG000|Overall Study|Physician Decision|0|||
16268173|NCT04852978|39467607|FG001|Overall Study|Physician Decision|1|||
16268174|NCT04852978|39467608|FG002|Overall Study|Physician Decision|0|||
16268175|NCT04852978|39467609|FG003|Overall Study|Physician Decision|0|||
16268176|NCT04852978|39467610|FG004|Overall Study|Physician Decision|0|||
16268177|NCT04852978|39467611|FG005|Overall Study|Physician Decision|0|||
16268178|NCT04852978|39467612|FG006|Overall Study|Physician Decision|0|||
16268179|NCT04852978|39467613|FG007|Overall Study|Physician Decision|2|||
16268180|NCT04852978|39467614|FG008|Overall Study|Physician Decision|0|||
16268181|NCT04852978|39467606|FG000|Overall Study|Sponsor request|0|||
16268182|NCT04852978|39467607|FG001|Overall Study|Sponsor request|0|||
16268183|NCT04852978|39467608|FG002|Overall Study|Sponsor request|1|||
16268184|NCT04852978|39467609|FG003|Overall Study|Sponsor request|0|||
16268185|NCT04852978|39467610|FG004|Overall Study|Sponsor request|0|||
16268186|NCT04852978|39467611|FG005|Overall Study|Sponsor request|0|||
16268187|NCT04852978|39467612|FG006|Overall Study|Sponsor request|0|||
16268188|NCT04852978|39467613|FG007|Overall Study|Sponsor request|0|||
16268189|NCT04852978|39467614|FG008|Overall Study|Sponsor request|0|||
16268190|NCT04852978|39467606|FG000|Overall Study|Death|0|||
16268191|NCT04852978|39467607|FG001|Overall Study|Death|0|||
16268192|NCT04852978|39467608|FG002|Overall Study|Death|0|||
16268193|NCT04852978|39467609|FG003|Overall Study|Death|0|||
16268194|NCT04852978|39467610|FG004|Overall Study|Death|0|||
16268195|NCT04852978|39467611|FG005|Overall Study|Death|0|||
16268196|NCT04852978|39467612|FG006|Overall Study|Death|1|||
16268197|NCT04852978|39467613|FG007|Overall Study|Death|0|||
16268198|NCT04852978|39467614|FG008|Overall Study|Death|0|||
16268199|NCT04852978|39467606|FG000|Overall Study|Lost to Follow-up|3|||
16455380|NCT01456897|40148148|FG000|Overall Study|Protocol Violation|3|||
16455381|NCT01456897|40148149|FG001|Overall Study|Protocol Violation|4|||
16268200|NCT04852978|39467607|FG001|Overall Study|Lost to Follow-up|2|||
16268201|NCT04852978|39467608|FG002|Overall Study|Lost to Follow-up|2|||
16268202|NCT04852978|39467609|FG003|Overall Study|Lost to Follow-up|0|||
16268203|NCT04852978|39467610|FG004|Overall Study|Lost to Follow-up|2|||
16268204|NCT04852978|39467611|FG005|Overall Study|Lost to Follow-up|4|||
16268205|NCT04852978|39467612|FG006|Overall Study|Lost to Follow-up|1|||
16268206|NCT04852978|39467613|FG007|Overall Study|Lost to Follow-up|2|||
16268207|NCT04852978|39467614|FG008|Overall Study|Lost to Follow-up|2|||
16268208|NCT04852978|39467606|FG000|Overall Study|Withdrawal by Subject|4|||
16268209|NCT04852978|39467607|FG001|Overall Study|Withdrawal by Subject|2|||
16268210|NCT04852978|39467608|FG002|Overall Study|Withdrawal by Subject|2|||
16268211|NCT04852978|39467609|FG003|Overall Study|Withdrawal by Subject|1|||
16268212|NCT04852978|39467610|FG004|Overall Study|Withdrawal by Subject|5|||
16268213|NCT04852978|39467611|FG005|Overall Study|Withdrawal by Subject|3|||
16268214|NCT04852978|39467612|FG006|Overall Study|Withdrawal by Subject|2|||
16268215|NCT04852978|39467613|FG007|Overall Study|Withdrawal by Subject|2|||
16072672|NCT01467700|38756420|FG002|Overall Study|Pregnancy|1|||
16072673|NCT01467700|38756421|FG003|Overall Study|Pregnancy|0|||
16072674|NCT01467700|38756418|FG000|Overall Study|Lack of Efficacy|2|||
16072675|NCT01467700|38756419|FG001|Overall Study|Lack of Efficacy|0|||
16072676|NCT01467700|38756420|FG002|Overall Study|Lack of Efficacy|2|||
16072677|NCT01467700|38756421|FG003|Overall Study|Lack of Efficacy|1|||
16072678|NCT01467700|38756418|FG000|Overall Study|Reason not Specified|1|||
16072679|NCT01467700|38756419|FG001|Overall Study|Reason not Specified|3|||
16072680|NCT01467700|38756420|FG002|Overall Study|Reason not Specified|2|||
16072681|NCT01467700|38756421|FG003|Overall Study|Reason not Specified|8|||
16072682|NCT02248480|38759134|FG000|Overall Study|Lack of Efficacy|4|||
16072683|NCT02248480|38759135|FG001|Overall Study|Lack of Efficacy|6|||
16072684|NCT02248480|38759134|FG000|Overall Study|Adverse Event|11|||
16072685|NCT02248480|38759135|FG001|Overall Study|Adverse Event|2|||
16072686|NCT02248480|38759134|FG000|Overall Study|Withdrawal by Subject|2|||
16072687|NCT02248480|38759135|FG001|Overall Study|Withdrawal by Subject|4|||
16072688|NCT02248480|38759134|FG000|Overall Study|Entry Criteria Not Met|0|||
16072689|NCT02248480|38759135|FG001|Overall Study|Entry Criteria Not Met|1|||
16072690|NCT02248480|38759134|FG000|Overall Study|Other:Physician Decision|0|||
16072691|NCT02248480|38759135|FG001|Overall Study|Other:Physician Decision|1|||
16072692|NCT00801983|38759136|FG000|Period 1|Lost to Follow-up|2|||
16268216|NCT04852978|39467614|FG008|Overall Study|Withdrawal by Subject|1|||
16268217|NCT01827163|39467615|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
16268218|NCT01827163|39467615|FG000|Overall Study|Adverse Event|9|||
16268219|NCT00813592|39467619|FG000|Overall Study|Disease assessment was not completed per|2|||
16268220|NCT04236596|39467620|FG000|Overall Study|Withdrawal by Subject|1|||
16268221|NCT04236596|39467620|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
16268222|NCT04236596|39467620|FG000|Overall Study|Participants did not receive implant at all|4|||
16268223|NCT04887415|39467621|FG000|Overall Study|Lost to Follow-up|2|||
16268224|NCT01087502|39467622|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
16268225|NCT01087502|39467623|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
16268226|NCT01087502|39467622|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
16268227|NCT01087502|39467623|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
16268228|NCT01087502|39467622|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
16268229|NCT01087502|39467623|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
16268230|NCT01087502|39467622|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
16268231|NCT01087502|39467623|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
16268232|NCT01087502|39467622|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
16268233|NCT01087502|39467623|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
16268234|NCT01087502|39467622|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
16268235|NCT01087502|39467623|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
16268236|NCT01087502|39467622|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
16268237|NCT01087502|39467623|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
16268238|NCT01087502|39467622|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
16268239|NCT01087502|39467623|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
16268240|NCT01087502|39467622|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
16268241|NCT01087502|39467623|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
16268242|NCT01087502|39467622|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
16268243|NCT01087502|39467623|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
16268244|NCT01087502|39467622|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
16268245|NCT01087502|39467623|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
16268246|NCT01087502|39467622|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
16268247|NCT01087502|39467623|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
16268248|NCT01116739|39467624|FG000|Overall Study|Child had 2 years of HS|110|||
16268249|NCT01116739|39467625|FG001|Overall Study|Child had 2 years of HS|128|||
16268250|NCT01116739|39467624|FG000|Overall Study|Withdrawal by Subject|6|||
16268251|NCT01116739|39467625|FG001|Overall Study|Withdrawal by Subject|0|||
16268252|NCT01116739|39467624|FG000|Overall Study|child too young|2|||
16268253|NCT01116739|39467625|FG001|Overall Study|child too young|6|||
16268254|NCT01116739|39467624|FG000|Overall Study|child not enrolled in head start|10|||
16268255|NCT01116739|39467625|FG001|Overall Study|child not enrolled in head start|2|||
16268256|NCT01116739|39467624|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
16072693|NCT00801983|38759137|FG001|Period 1|Lost to Follow-up|0|||
16072694|NCT00801983|38759136|FG000|Period 1|Withdrawal by Subject|2|||
16268257|NCT01116739|39467625|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
16268258|NCT03605342|39467628|FG000|Overall Study|Withdrawal by Subject|9|||
16268259|NCT03605342|39467629|FG001|Overall Study|Withdrawal by Subject|7|||
16268260|NCT03605342|39467628|FG000|Overall Study|Lost to Follow-up|1|||
16268261|NCT03605342|39467629|FG001|Overall Study|Lost to Follow-up|1|||
16268262|NCT05239195|39467630|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
16268263|NCT05239195|39467631|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
16268264|NCT01863745|39467632|FG000|Overall Study|Disease Progression|9|||
16268265|NCT01863745|39467632|FG000|Overall Study|Adverse Event|2|||
16268266|NCT01863745|39467632|FG000|Overall Study|Death|1|||
16268267|NCT01863745|39467632|FG000|Overall Study|Withdrawal by Subject|1|||
16268268|NCT03966911|39467633|FG000|Overall Study|Adverse Event|1|||
16268269|NCT03966911|39467634|FG001|Overall Study|Adverse Event|1|||
16268270|NCT03966911|39467633|FG000|Overall Study|Withdrawal by Subject|8|||
16268271|NCT03966911|39467634|FG001|Overall Study|Withdrawal by Subject|2|||
16268272|NCT03966911|39467633|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
16268273|NCT03966911|39467634|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
16268274|NCT02671435|39467637|FG000|Overall Study|Death|1|||
16268275|NCT02671435|39467638|FG001|Overall Study|Death|3|||
16268276|NCT02671435|39467639|FG002|Overall Study|Death|0|||
16268277|NCT02671435|39467640|FG003|Overall Study|Death|16|||
16268278|NCT02671435|39467641|FG004|Overall Study|Death|14|||
16268279|NCT02671435|39467642|FG005|Overall Study|Death|29|||
16268280|NCT02671435|39467643|FG006|Overall Study|Death|34|||
16268281|NCT02671435|39467644|FG007|Overall Study|Death|28|||
16268282|NCT02671435|39467645|FG008|Overall Study|Death|19|||
16268283|NCT02671435|39467646|FG009|Overall Study|Death|10|||
16268284|NCT02671435|39467647|FG010|Overall Study|Death|8|||
16268285|NCT02671435|39467648|FG011|Overall Study|Death|29|||
16268286|NCT02671435|39467649|FG012|Overall Study|Death|29|||
16268287|NCT02671435|39467650|FG013|Overall Study|Death|29|||
16268288|NCT02671435|39467651|FG014|Overall Study|Death|27|||
16268289|NCT02671435|39467637|FG000|Overall Study|Lost to Follow-up|0|||
16268290|NCT02671435|39467638|FG001|Overall Study|Lost to Follow-up|0|||
16268291|NCT02671435|39467639|FG002|Overall Study|Lost to Follow-up|1|||
16268292|NCT02671435|39467640|FG003|Overall Study|Lost to Follow-up|0|||
16268293|NCT02671435|39467641|FG004|Overall Study|Lost to Follow-up|1|||
16268294|NCT02671435|39467642|FG005|Overall Study|Lost to Follow-up|1|||
16268295|NCT02671435|39467643|FG006|Overall Study|Lost to Follow-up|2|||
16268296|NCT02671435|39467644|FG007|Overall Study|Lost to Follow-up|2|||
16268297|NCT02671435|39467645|FG008|Overall Study|Lost to Follow-up|0|||
16268298|NCT02671435|39467646|FG009|Overall Study|Lost to Follow-up|2|||
16268299|NCT02671435|39467647|FG010|Overall Study|Lost to Follow-up|0|||
16268300|NCT02671435|39467648|FG011|Overall Study|Lost to Follow-up|3|||
16268301|NCT02671435|39467649|FG012|Overall Study|Lost to Follow-up|3|||
16268302|NCT02671435|39467650|FG013|Overall Study|Lost to Follow-up|2|||
16268303|NCT02671435|39467651|FG014|Overall Study|Lost to Follow-up|0|||
16268304|NCT02671435|39467637|FG000|Overall Study|Withdrawal by Subject|2|||
16268305|NCT02671435|39467638|FG001|Overall Study|Withdrawal by Subject|0|||
16268306|NCT02671435|39467639|FG002|Overall Study|Withdrawal by Subject|2|||
16268307|NCT02671435|39467640|FG003|Overall Study|Withdrawal by Subject|2|||
16268308|NCT02671435|39467641|FG004|Overall Study|Withdrawal by Subject|2|||
16268309|NCT02671435|39467642|FG005|Overall Study|Withdrawal by Subject|7|||
16268310|NCT02671435|39467643|FG006|Overall Study|Withdrawal by Subject|2|||
16268311|NCT02671435|39467644|FG007|Overall Study|Withdrawal by Subject|7|||
16268312|NCT02671435|39467645|FG008|Overall Study|Withdrawal by Subject|1|||
16268313|NCT02671435|39467646|FG009|Overall Study|Withdrawal by Subject|1|||
16268314|NCT02671435|39467647|FG010|Overall Study|Withdrawal by Subject|2|||
16268315|NCT02671435|39467648|FG011|Overall Study|Withdrawal by Subject|4|||
16268316|NCT02671435|39467649|FG012|Overall Study|Withdrawal by Subject|4|||
16268317|NCT02671435|39467650|FG013|Overall Study|Withdrawal by Subject|4|||
16268318|NCT02671435|39467651|FG014|Overall Study|Withdrawal by Subject|2|||
16268319|NCT02671435|39467637|FG000|Overall Study|Un-specified|0|||
16268320|NCT02671435|39467638|FG001|Overall Study|Un-specified|0|||
16268321|NCT02671435|39467639|FG002|Overall Study|Un-specified|0|||
16268322|NCT02671435|39467640|FG003|Overall Study|Un-specified|0|||
16268323|NCT02671435|39467641|FG004|Overall Study|Un-specified|1|||
16268324|NCT02671435|39467642|FG005|Overall Study|Un-specified|3|||
16268325|NCT02671435|39467643|FG006|Overall Study|Un-specified|2|||
16268326|NCT02671435|39467644|FG007|Overall Study|Un-specified|3|||
16268327|NCT02671435|39467645|FG008|Overall Study|Un-specified|0|||
16268328|NCT02671435|39467646|FG009|Overall Study|Un-specified|5|||
16268329|NCT02671435|39467647|FG010|Overall Study|Un-specified|8|||
16268330|NCT02671435|39467648|FG011|Overall Study|Un-specified|4|||
16268331|NCT02671435|39467649|FG012|Overall Study|Un-specified|5|||
16268332|NCT02671435|39467650|FG013|Overall Study|Un-specified|9|||
16268333|NCT02671435|39467651|FG014|Overall Study|Un-specified|8|||
16268334|NCT00989950|39467652|FG000|Randomized Phase|Protocol Violation|1|||
16268335|NCT00989950|39467653|FG001|Randomized Phase|Protocol Violation|0|||
16268336|NCT00989950|39467654|FG002|Randomized Phase|Protocol Violation|0|||
16268337|NCT00989950|39467655|FG003|Randomized Phase|Protocol Violation|0|||
16268338|NCT00989950|39467652|FG000|Randomized Phase|Adverse Event|0|||
16268339|NCT00989950|39467653|FG001|Randomized Phase|Adverse Event|1|||
16268340|NCT00989950|39467654|FG002|Randomized Phase|Adverse Event|0|||
16268341|NCT00989950|39467655|FG003|Randomized Phase|Adverse Event|0|||
16268342|NCT04281472|39467660|FG000|Stage A|Lack of Efficacy|8|||
16268343|NCT04281472|39467661|FG001|Stage A|Lack of Efficacy|0|||
16268344|NCT04281472|39467662|FG002|Stage A|Lack of Efficacy|0|||
16268345|NCT04281472|39467660|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
16268346|NCT04281472|39467661|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
16268347|NCT04281472|39467662|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
16268348|NCT04281472|39467660|FG000|Stage A|Adverse Event|20|||
16268349|NCT04281472|39467661|FG001|Stage A|Adverse Event|0|||
16268350|NCT04281472|39467662|FG002|Stage A|Adverse Event|0|||
16268351|NCT04281472|39467660|FG000|Stage A|Death|1|||
16268352|NCT04281472|39467661|FG001|Stage A|Death|0|||
16268353|NCT04281472|39467662|FG002|Stage A|Death|0|||
16268354|NCT04281472|39467660|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
16268355|NCT04281472|39467661|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
16268356|NCT04281472|39467662|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
16268357|NCT04281472|39467660|FG000|Stage A|Lost to Follow-up|2|||
16268358|NCT04281472|39467661|FG001|Stage A|Lost to Follow-up|0|||
16268359|NCT04281472|39467662|FG002|Stage A|Lost to Follow-up|0|||
16268360|NCT04281472|39467660|FG000|Stage A|Non-compliance with study drug|1|||
16268361|NCT04281472|39467661|FG001|Stage A|Non-compliance with study drug|0|||
16268362|NCT04281472|39467662|FG002|Stage A|Non-compliance with study drug|0|||
16268363|NCT04281472|39467660|FG000|Stage A|Physician Decision|1|||
16268364|NCT04281472|39467661|FG001|Stage A|Physician Decision|0|||
16268365|NCT04281472|39467662|FG002|Stage A|Physician Decision|0|||
16268366|NCT04281472|39467660|FG000|Stage A|Prohibited medications|2|||
16268367|NCT04281472|39467661|FG001|Stage A|Prohibited medications|0|||
16268368|NCT04281472|39467662|FG002|Stage A|Prohibited medications|0|||
16268369|NCT04281472|39467660|FG000|Stage A|Withdrawal by Subject|11|||
16268370|NCT04281472|39467661|FG001|Stage A|Withdrawal by Subject|0|||
16268371|NCT04281472|39467662|FG002|Stage A|Withdrawal by Subject|0|||
16268372|NCT04281472|39467660|FG000|Stage A|Other|5|||
16268373|NCT04281472|39467661|FG001|Stage A|Other|0|||
16268374|NCT04281472|39467662|FG002|Stage A|Other|0|||
16268375|NCT04281472|39467660|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
16268376|NCT04281472|39467661|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
16268377|NCT04281472|39467662|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
16268378|NCT04281472|39467660|FG000|Stage B|Adverse Event|0|||
16268379|NCT04281472|39467661|FG001|Stage B|Adverse Event|3|||
16268380|NCT04281472|39467662|FG002|Stage B|Adverse Event|0|||
16268381|NCT04281472|39467660|FG000|Stage B|Death|0|||
16268382|NCT04281472|39467661|FG001|Stage B|Death|0|||
16268383|NCT04281472|39467662|FG002|Stage B|Death|1|||
16268384|NCT04281472|39467660|FG000|Stage B|Lack of Efficacy|0|||
16268385|NCT04281472|39467661|FG001|Stage B|Lack of Efficacy|0|||
16268386|NCT04281472|39467662|FG002|Stage B|Lack of Efficacy|1|||
16268387|NCT04281472|39467660|FG000|Stage B|Lost to Follow-up|0|||
16268388|NCT04281472|39467661|FG001|Stage B|Lost to Follow-up|0|||
16268389|NCT04281472|39467662|FG002|Stage B|Lost to Follow-up|2|||
16268390|NCT04281472|39467660|FG000|Stage B|Prohibited medications|0|||
16268391|NCT04281472|39467661|FG001|Stage B|Prohibited medications|2|||
16268392|NCT04281472|39467662|FG002|Stage B|Prohibited medications|1|||
16268393|NCT04281472|39467660|FG000|Stage B|Protocol Violation|0|||
16268394|NCT04281472|39467661|FG001|Stage B|Protocol Violation|1|||
16268395|NCT04281472|39467662|FG002|Stage B|Protocol Violation|1|||
16268396|NCT04281472|39467660|FG000|Stage B|Sponsor decision|0|||
16268397|NCT04281472|39467661|FG001|Stage B|Sponsor decision|0|||
16072695|NCT00801983|38759137|FG001|Period 1|Withdrawal by Subject|8|||
16268398|NCT04281472|39467662|FG002|Stage B|Sponsor decision|1|||
16268399|NCT04281472|39467660|FG000|Stage B|Withdrawal by Subject|0|||
16268400|NCT04281472|39467661|FG001|Stage B|Withdrawal by Subject|3|||
16268401|NCT04281472|39467662|FG002|Stage B|Withdrawal by Subject|3|||
16268402|NCT04281472|39467660|FG000|Stage B|Other|0|||
16268403|NCT04281472|39467661|FG001|Stage B|Other|3|||
16268404|NCT04281472|39467662|FG002|Stage B|Other|0|||
16268405|NCT00840411|39467663|FG000|First Intervention|Adverse Event|1|||
16268406|NCT00840411|39467664|FG001|First Intervention|Adverse Event|0|||
16268407|NCT00840411|39467663|FG000|Washout|Withdrawal by Subject|1|||
16268408|NCT00840411|39467664|FG001|Washout|Withdrawal by Subject|0|||
16268409|NCT03259165|39467665|FG000|Overall Study|COVID 19 pandemic|1|||
16268410|NCT03259165|39467666|FG001|Overall Study|COVID 19 pandemic|1|||
16268411|NCT02025010|39467670|FG000|Overall Study|Symptomatic or radiographic progression|36|||
16268412|NCT02025010|39467670|FG000|Overall Study|Adverse Event|6|||
16268413|NCT02025010|39467670|FG000|Overall Study|Physician Decision|7|||
16268414|NCT02025010|39467670|FG000|Overall Study|Withdrawal by Subject|3|||
16268415|NCT02025010|39467670|FG000|Overall Study|Intercurrent illness|3|||
16268416|NCT02025010|39467670|FG000|Overall Study|Patients still on treatment|3|||
16268417|NCT02025010|39467670|FG000|Overall Study|Never initiate the treatment|2|||
16268418|NCT00571064|39467673|FG000|Overall Study|Adverse Event|13|||
16268419|NCT00571064|39467673|FG000|Overall Study|Protocol Violation|4|||
16268420|NCT00571064|39467673|FG000|Overall Study|Withdrawal by Subject|2|||
16268421|NCT00571064|39467673|FG000|Overall Study|Other|2|||
16268422|NCT00834067|39467676|FG000|Washout of 21 Days|Protocol Violation|0|||
16268423|NCT00834067|39467677|FG001|Washout of 21 Days|Protocol Violation|1|||
16268424|NCT01693523|39467678|FG000|Overall Study|Adverse Event|2|||
16268425|NCT01693523|39467679|FG001|Overall Study|Adverse Event|1|||
16268426|NCT01693523|39467680|FG002|Overall Study|Adverse Event|0|||
16268427|NCT01693523|39467678|FG000|Overall Study|Death|0|||
16268428|NCT01693523|39467679|FG001|Overall Study|Death|1|||
16268429|NCT01693523|39467680|FG002|Overall Study|Death|1|||
16268430|NCT01693523|39467678|FG000|Overall Study|Lost to Follow-up|0|||
16268431|NCT01693523|39467679|FG001|Overall Study|Lost to Follow-up|0|||
16268432|NCT01693523|39467680|FG002|Overall Study|Lost to Follow-up|4|||
16268433|NCT01693523|39467678|FG000|Overall Study|Physician Decision|0|||
16268434|NCT01693523|39467679|FG001|Overall Study|Physician Decision|0|||
16268435|NCT01693523|39467680|FG002|Overall Study|Physician Decision|1|||
16268436|NCT01693523|39467678|FG000|Overall Study|Withdrawal by Subject|1|||
16268437|NCT01693523|39467679|FG001|Overall Study|Withdrawal by Subject|2|||
16268438|NCT01693523|39467680|FG002|Overall Study|Withdrawal by Subject|2|||
16268439|NCT01693523|39467678|FG000|Overall Study|Lack of compliance study medication|1|||
16268440|NCT01693523|39467679|FG001|Overall Study|Lack of compliance study medication|2|||
16268441|NCT01693523|39467680|FG002|Overall Study|Lack of compliance study medication|0|||
16268442|NCT01693523|39467678|FG000|Overall Study|Chemotherapy was held|1|||
16268443|NCT01693523|39467679|FG001|Overall Study|Chemotherapy was held|2|||
16268444|NCT01693523|39467680|FG002|Overall Study|Chemotherapy was held|0|||
16268445|NCT01250912|39467690|FG000|Overall Study|Lost to Follow-up|1|||
16455382|NCT01456897|40148148|FG000|Overall Study|Physician Decision|5|||
16166437|NCT03183128|39087649|FG001|Overall Study|Protocol Violation|0|||
16166438|NCT03183128|39087648|FG000|Overall Study|Lack of Efficacy|4|||
16166439|NCT03183128|39087649|FG001|Overall Study|Lack of Efficacy|27|||
16166440|NCT03183128|39087648|FG000|Overall Study|Lost to Follow-up|1|||
16166441|NCT03183128|39087649|FG001|Overall Study|Lost to Follow-up|0|||
16166442|NCT03183128|39087648|FG000|Overall Study|Death|2|||
16166443|NCT03183128|39087649|FG001|Overall Study|Death|0|||
16166444|NCT03183128|39087648|FG000|Overall Study|Physician Decision|1|||
16166445|NCT03183128|39087649|FG001|Overall Study|Physician Decision|0|||
16166446|NCT04451330|39087650|FG000|Overall Study|Adverse Event|1|||
16166447|NCT04451330|39087651|FG001|Overall Study|Adverse Event|2|||
16166448|NCT04451330|39087650|FG000|Overall Study|Lost to Follow-up|5|||
16166449|NCT04451330|39087651|FG001|Overall Study|Lost to Follow-up|0|||
16166450|NCT04451330|39087650|FG000|Overall Study|Withdrawal by Subject|3|||
16166451|NCT04451330|39087651|FG001|Overall Study|Withdrawal by Subject|1|||
16166452|NCT04451330|39087650|FG000|Overall Study|Withdrawal by parent/guardian|1|||
16455383|NCT01456897|40148149|FG001|Overall Study|Physician Decision|3|||
16455384|NCT01456897|40148148|FG000|Overall Study|Withdrawal by Subject|44|||
16455385|NCT01456897|40148149|FG001|Overall Study|Withdrawal by Subject|17|||
16455386|NCT01456897|40148148|FG000|Overall Study|Lack of Efficacy|4|||
16455387|NCT01456897|40148149|FG001|Overall Study|Lack of Efficacy|11|||
16455388|NCT02105662|40148150|FG000|Overall Study|Lost to Follow-up|5|||
16455389|NCT02105662|40148150|FG000|Overall Study|Withdrawal by Subject|1|||
16455390|NCT00823615|40148152|FG000|Period 2|Lost to Follow-up|2|||
16455391|NCT00823615|40148153|FG001|Period 2|Lost to Follow-up|0|||
16166453|NCT04451330|39087651|FG001|Overall Study|Withdrawal by parent/guardian|0|||
16166454|NCT04451330|39087650|FG000|Overall Study|Other than specified|0|||
16166455|NCT04451330|39087651|FG001|Overall Study|Other than specified|1|||
16166456|NCT02549339|39087652|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
16166457|NCT02549339|39087653|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
16166458|NCT02549339|39087652|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
16166459|NCT02549339|39087653|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
16166460|NCT02549339|39087652|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
16455392|NCT00823615|40148152|FG000|Period 2|Time/Job Conflict|1|||
16166461|NCT02549339|39087653|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
16268446|NCT00561015|39467692|FG000|Overall Study|Adverse Event|0|||
16268447|NCT00561015|39467693|FG001|Overall Study|Adverse Event|0|||
16268448|NCT00561015|39467694|FG002|Overall Study|Adverse Event|0|||
16268449|NCT00561015|39467695|FG003|Overall Study|Adverse Event|0|||
16268450|NCT00561015|39467696|FG004|Overall Study|Adverse Event|1|||
16268451|NCT00561015|39467697|FG005|Overall Study|Adverse Event|0|||
16268452|NCT00561015|39467692|FG000|Overall Study|Lost to Follow-up|2|||
16268453|NCT00561015|39467693|FG001|Overall Study|Lost to Follow-up|0|||
16455393|NCT00823615|40148153|FG001|Period 2|Time/Job Conflict|2|||
16166462|NCT02549339|39087652|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
16455394|NCT02644109|40148154|FG000|Overall Study|Adverse Event|0|||
16166463|NCT02549339|39087653|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
16166464|NCT02549339|39087652|FG000|12-month Follow-up|Lack of Efficacy|0|||
16166465|NCT02549339|39087653|FG001|12-month Follow-up|Lack of Efficacy|2|||
16268454|NCT00561015|39467694|FG002|Overall Study|Lost to Follow-up|0|||
16268455|NCT00561015|39467695|FG003|Overall Study|Lost to Follow-up|1|||
16268456|NCT00561015|39467696|FG004|Overall Study|Lost to Follow-up|0|||
16268457|NCT00561015|39467697|FG005|Overall Study|Lost to Follow-up|3|||
16268458|NCT00561015|39467692|FG000|Overall Study|Participant non-compliance|2|||
16268459|NCT00561015|39467693|FG001|Overall Study|Participant non-compliance|0|||
16166466|NCT02549339|39087652|FG000|12-month Follow-up|Withdrawal by Subject|8|||
16166467|NCT02549339|39087653|FG001|12-month Follow-up|Withdrawal by Subject|3|||
16166468|NCT02549339|39087652|FG000|12-month Follow-up|Lost to Follow-up|1|||
16166469|NCT02549339|39087653|FG001|12-month Follow-up|Lost to Follow-up|3|||
16166470|NCT02549339|39087652|FG000|12-month Follow-up|Other|0|||
16268460|NCT00561015|39467694|FG002|Overall Study|Participant non-compliance|0|||
16268461|NCT00561015|39467695|FG003|Overall Study|Participant non-compliance|0|||
16268462|NCT00561015|39467696|FG004|Overall Study|Participant non-compliance|0|||
16268463|NCT00561015|39467697|FG005|Overall Study|Participant non-compliance|0|||
16268464|NCT00177164|39467698|FG000|Overall Study|Protocol Violation|0|||
16268465|NCT00177164|39467699|FG001|Overall Study|Protocol Violation|7|||
16268466|NCT00177164|39467698|FG000|Overall Study|Lost to Follow-up|4|||
16268467|NCT00177164|39467699|FG001|Overall Study|Lost to Follow-up|5|||
16268468|NCT00177164|39467698|FG000|Overall Study|increase in alcohol and drug use|1|||
16268469|NCT00177164|39467699|FG001|Overall Study|increase in alcohol and drug use|2|||
16268470|NCT00177164|39467698|FG000|Overall Study|Adverse Event|1|||
16268471|NCT00177164|39467699|FG001|Overall Study|Adverse Event|0|||
16268472|NCT00177164|39467698|FG000|Overall Study|discharge from hospital|1|||
16268473|NCT00177164|39467699|FG001|Overall Study|discharge from hospital|0|||
16268474|NCT00177164|39467698|FG000|Overall Study|Lack of Efficacy|2|||
16268475|NCT00177164|39467699|FG001|Overall Study|Lack of Efficacy|1|||
16268476|NCT00177164|39467698|FG000|Overall Study|Pregnancy|0|||
16268477|NCT00177164|39467699|FG001|Overall Study|Pregnancy|1|||
16268478|NCT04079296|39467700|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
16268479|NCT04079296|39467701|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
16268480|NCT04079296|39467702|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
16268481|NCT04079296|39467703|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
16268482|NCT04079296|39467704|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
16268483|NCT04079296|39467700|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
16268484|NCT04079296|39467701|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
16268485|NCT04079296|39467702|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
16268486|NCT04079296|39467703|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
16268487|NCT04079296|39467704|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
16268488|NCT04079296|39467700|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
16268489|NCT04079296|39467701|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
16268490|NCT04079296|39467702|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
16268491|NCT04079296|39467703|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
16268492|NCT04079296|39467704|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
16268493|NCT04079296|39467700|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
16268494|NCT04079296|39467701|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
16268495|NCT04079296|39467702|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
16268496|NCT04079296|39467703|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
16268497|NCT04079296|39467704|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
16268498|NCT04079296|39467700|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
16268499|NCT04079296|39467701|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
16268500|NCT04079296|39467702|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
16268501|NCT04079296|39467703|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
16166471|NCT02549339|39087653|FG001|12-month Follow-up|Other|3|||
16166472|NCT00661271|39087654|FG000|Overall Study|Lost to Follow-up|28|||
16166473|NCT00661271|39087655|FG001|Overall Study|Lost to Follow-up|25|||
16166474|NCT00956943|39087656|FG000|Overall Study|Lost to Follow-up|9|||
16268502|NCT04079296|39467704|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
16268503|NCT04079296|39467700|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
16268504|NCT04079296|39467701|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
16268505|NCT04079296|39467702|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
16268506|NCT04079296|39467703|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
16166475|NCT00956943|39087657|FG001|Overall Study|Lost to Follow-up|10|||
16268507|NCT04079296|39467704|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
16268508|NCT04079296|39467700|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
16268509|NCT04079296|39467701|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
16268510|NCT04079296|39467702|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
16268511|NCT04079296|39467703|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
16268512|NCT04079296|39467704|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
16268513|NCT04079296|39467700|FG000|Dose Expansion Phase (168 Days)|Death|0|||
16455395|NCT02644109|40148155|FG001|Overall Study|Adverse Event|4|||
16455396|NCT00534599|40148164|FG000|Overall Study|Adverse Event|25|||
16455397|NCT00534599|40148165|FG001|Overall Study|Adverse Event|4|||
16455398|NCT00534599|40148164|FG000|Overall Study|Incorrect enrollment|2|||
16455399|NCT00534599|40148165|FG001|Overall Study|Incorrect enrollment|1|||
16455400|NCT00534599|40148164|FG000|Overall Study|Mis-randomization|2|||
16455401|NCT00534599|40148165|FG001|Overall Study|Mis-randomization|2|||
16455402|NCT00534599|40148164|FG000|Overall Study|Developed study-specific d/c criteria|5|||
16455403|NCT00534599|40148165|FG001|Overall Study|Developed study-specific d/c criteria|0|||
16455404|NCT00534599|40148164|FG000|Overall Study|Lack of Efficacy|0|||
16455405|NCT00534599|40148165|FG001|Overall Study|Lack of Efficacy|1|||
16455406|NCT00534599|40148164|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
16455407|NCT00534599|40148165|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
16455408|NCT00534599|40148164|FG000|Overall Study|Protocol Violation|1|||
16455409|NCT00534599|40148165|FG001|Overall Study|Protocol Violation|3|||
16455410|NCT00534599|40148164|FG000|Overall Study|Lost to Follow-up|11|||
16455411|NCT00534599|40148165|FG001|Overall Study|Lost to Follow-up|14|||
16455412|NCT00534599|40148164|FG000|Overall Study|Withdrawal by Subject|4|||
16166476|NCT01497262|39087660|FG000|Overall Study|Abnormal Lab Values|4|||
16166477|NCT01497262|39087660|FG000|Overall Study|Abnormal Test Procedure Result|1|||
16166478|NCT01497262|39087660|FG000|Overall Study|Physician Decision|1|||
16166479|NCT01497262|39087660|FG000|Overall Study|Withdrawal by Subject|2|||
16166480|NCT01497262|39087660|FG000|Overall Study|Adverse Event|2|||
16166481|NCT01497262|39087660|FG000|Overall Study|Protocol Violation|1|||
16166482|NCT05020899|39087661|FG000|8 Week Follow-up|Lost to Follow-up|3|||
16166483|NCT05020899|39087662|FG001|8 Week Follow-up|Lost to Follow-up|6|||
16166484|NCT05020899|39087661|FG000|12 Week Follow-up|Lost to Follow-up|1|||
16166485|NCT05020899|39087662|FG001|12 Week Follow-up|Lost to Follow-up|0|||
16166486|NCT05020899|39087661|FG000|12 Week Follow-up|Death|0|||
16166487|NCT05020899|39087662|FG001|12 Week Follow-up|Death|1|||
16166488|NCT00234039|39087663|FG000|Overall Study|Adverse Event|2|||
16166489|NCT00234039|39087663|FG000|Overall Study|Progression/relapse|34|||
16166490|NCT00234039|39087663|FG000|Overall Study|Other - Not Protocol Specified|3|||
16166491|NCT00234039|39087663|FG000|Overall Study|Ineligible|9|||
16166492|NCT00234039|39087663|FG000|Overall Study|No Protocol Treatment Received|2|||
16166493|NCT03687502|39087666|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
16166494|NCT03687502|39087666|FG000|Overall Study|Lumason not available|1|||
16166495|NCT00395967|39087668|FG000|Treatment Period|Failed Mobilization|1|||
16166496|NCT00395967|39087668|FG000|Follow-up Period|Death|1|||
16166497|NCT00395967|39087668|FG000|Follow-up Period|Lost to Follow-up|1|||
16166498|NCT01885000|39087669|FG000|Overall Study|Adverse Event|1|||
16166499|NCT01885000|39087670|FG001|Overall Study|Adverse Event|0|||
16166500|NCT01885000|39087669|FG000|Overall Study|Withdrawal by Subject|1|||
16166501|NCT01885000|39087670|FG001|Overall Study|Withdrawal by Subject|1|||
16166502|NCT01885000|39087669|FG000|Overall Study|Protocol Violation|0|||
16166503|NCT01885000|39087670|FG001|Overall Study|Protocol Violation|1|||
16166504|NCT01001702|39087671|FG000|Overall Study|Lost to Follow-up|7|||
16166505|NCT01001702|39087671|FG000|Overall Study|Adverse Event|7|||
16166506|NCT01001702|39087671|FG000|Overall Study|Sponsor Discontinued Study|4|||
16166507|NCT01001702|39087671|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
16166508|NCT01001702|39087671|FG000|Overall Study|Investigator withdrew Subject|10|||
16166509|NCT01001702|39087671|FG000|Overall Study|Withdrawal by Subject|19|||
16166510|NCT01001702|39087671|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
16166511|NCT01725750|39087672|FG000|Overall Study|Adverse Event|1|||
16166512|NCT01725750|39087673|FG001|Overall Study|Adverse Event|0|||
16166513|NCT01725750|39087672|FG000|Overall Study|Lost to Follow-up|1|||
16166514|NCT01725750|39087673|FG001|Overall Study|Lost to Follow-up|1|||
16166515|NCT01725750|39087672|FG000|Overall Study|Withdrawal by Subject|0|||
16166516|NCT01725750|39087673|FG001|Overall Study|Withdrawal by Subject|9|||
16166517|NCT02183519|39087686|FG000|Overall Study|computer error|3|||
16166518|NCT02183519|39087687|FG001|Overall Study|computer error|0|||
16166519|NCT02183519|39087686|FG000|Overall Study|Did not respond to cough inducter|0|||
16166520|NCT02183519|39087687|FG001|Overall Study|Did not respond to cough inducter|3|||
16166521|NCT01959165|39087688|FG000|Overall Study|Adverse Event|0|||
16166522|NCT01959165|39087689|FG001|Overall Study|Adverse Event|0|||
16166523|NCT01959165|39087690|FG002|Overall Study|Adverse Event|0|||
16166524|NCT01959165|39087691|FG003|Overall Study|Adverse Event|1|||
16166525|NCT01959165|39087688|FG000|Overall Study|Lack of Efficacy|1|||
16166526|NCT01959165|39087689|FG001|Overall Study|Lack of Efficacy|0|||
16166527|NCT01959165|39087690|FG002|Overall Study|Lack of Efficacy|0|||
16166528|NCT01959165|39087691|FG003|Overall Study|Lack of Efficacy|0|||
16166529|NCT01959165|39087688|FG000|Overall Study|overdose|0|||
16455413|NCT00534599|40148165|FG001|Overall Study|Withdrawal by Subject|6|||
16455414|NCT00534599|40148164|FG000|Overall Study|Other|7|||
16166530|NCT01959165|39087689|FG001|Overall Study|overdose|0|||
16166531|NCT01959165|39087690|FG002|Overall Study|overdose|0|||
16455415|NCT00534599|40148165|FG001|Overall Study|Other|0|||
16455416|NCT02704143|40148168|FG000|Overall Study|disease progression|10|||
16455417|NCT00711477|40148169|FG000|Overall Study|Adverse Event|3|||
16455418|NCT00711477|40148170|FG001|Overall Study|Adverse Event|1|||
16455419|NCT00711477|40148169|FG000|Overall Study|Lost to Follow-up|0|||
16455420|NCT00711477|40148170|FG001|Overall Study|Lost to Follow-up|1|||
16455421|NCT00711477|40148169|FG000|Overall Study|Noncompliance|0|||
16455422|NCT00711477|40148170|FG001|Overall Study|Noncompliance|1|||
16455423|NCT02565784|40148171|FG000|First Treatment|Adverse Event|1|||
16455424|NCT02565784|40148171|FG000|First Treatment|Withdrawal by Subject|1|||
16455425|NCT02565784|40148171|FG000|Second Treatment|Withdrawal by Subject|2|||
16455426|NCT03198507|40148172|FG000|Overall Study|Withdrawal by Subject|1|||
16268514|NCT04079296|39467701|FG001|Dose Expansion Phase (168 Days)|Death|0|||
16268515|NCT04079296|39467702|FG002|Dose Expansion Phase (168 Days)|Death|0|||
16268516|NCT04079296|39467703|FG003|Dose Expansion Phase (168 Days)|Death|1|||
16268517|NCT04079296|39467704|FG004|Dose Expansion Phase (168 Days)|Death|0|||
16268518|NCT04594252|39467712|FG000|Overall Study|Adverse Event|0|||
16268519|NCT04594252|39467713|FG001|Overall Study|Adverse Event|2|||
16268520|NCT04035187|39467716|FG000|Overall Study|Withdrawal by Subject|2|||
16268521|NCT04035187|39467717|FG001|Overall Study|Withdrawal by Subject|1|||
16268522|NCT04035187|39467718|FG002|Overall Study|Withdrawal by Subject|0|||
16268523|NCT04035187|39467719|FG003|Overall Study|Withdrawal by Subject|0|||
16268524|NCT04035187|39467716|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
16268525|NCT04035187|39467717|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
16268526|NCT04035187|39467718|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
16268527|NCT04035187|39467719|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
16268528|NCT03256695|39467720|FG000|Overall Study|Adverse Event|8|||
16268529|NCT03256695|39467720|FG000|Overall Study|Death|2|||
16455427|NCT03198507|40148173|FG001|Overall Study|Withdrawal by Subject|0|||
16455428|NCT02722499|40148177|FG000|Overall Study|Lost to Follow-up|2|||
16455429|NCT02722499|40148178|FG001|Overall Study|Lost to Follow-up|0|||
16455430|NCT02722499|40148179|FG002|Overall Study|Lost to Follow-up|1|||
16455431|NCT01182844|40148180|FG000|Overall Study|Withdrawal by Subject|0|||
16455432|NCT01182844|40148181|FG001|Overall Study|Withdrawal by Subject|2|||
16455433|NCT00481091|40148182|FG000|Overall Study|Withdrawal by Subject|0|||
16455434|NCT00481091|40148183|FG001|Overall Study|Withdrawal by Subject|1|||
16455435|NCT00481091|40148184|FG002|Overall Study|Withdrawal by Subject|1|||
16455436|NCT00481091|40148185|FG003|Overall Study|Withdrawal by Subject|0|||
16455437|NCT00481091|40148186|FG004|Overall Study|Withdrawal by Subject|0|||
16455438|NCT00481091|40148187|FG005|Overall Study|Withdrawal by Subject|0|||
16455439|NCT00481091|40148188|FG006|Overall Study|Withdrawal by Subject|0|||
16455440|NCT00481091|40148189|FG007|Overall Study|Withdrawal by Subject|0|||
16455441|NCT00481091|40148190|FG008|Overall Study|Withdrawal by Subject|1|||
16455442|NCT00481091|40148191|FG009|Overall Study|Withdrawal by Subject|6|||
16455443|NCT00481091|40148182|FG000|Overall Study|Other, Not Specified|0|||
16455444|NCT00481091|40148183|FG001|Overall Study|Other, Not Specified|1|||
16455445|NCT00481091|40148184|FG002|Overall Study|Other, Not Specified|1|||
16455446|NCT00481091|40148185|FG003|Overall Study|Other, Not Specified|0|||
16455447|NCT00481091|40148186|FG004|Overall Study|Other, Not Specified|0|||
16455448|NCT00481091|40148187|FG005|Overall Study|Other, Not Specified|1|||
16455449|NCT00481091|40148188|FG006|Overall Study|Other, Not Specified|0|||
16455450|NCT00481091|40148189|FG007|Overall Study|Other, Not Specified|0|||
16268530|NCT03256695|39467720|FG000|Overall Study|Withdrawal by Subject|14|||
16268531|NCT03256695|39467720|FG000|Overall Study|Non-compliance with study drug|1|||
16268532|NCT03256695|39467720|FG000|Overall Study|Lost to Follow-up|3|||
16268533|NCT03256695|39467720|FG000|Overall Study|Lack of Efficacy|3|||
16268534|NCT03256695|39467720|FG000|Overall Study|Protocol Violation|5|||
16268535|NCT03256695|39467720|FG000|Overall Study|Other than specified|3|||
16268536|NCT02028715|39467721|FG000|Overall Study|Adverse Event|2|||
16268537|NCT02028715|39467722|FG001|Overall Study|Adverse Event|2|||
16268538|NCT02028715|39467721|FG000|Overall Study|Physician Decision|1|||
16268539|NCT02028715|39467722|FG001|Overall Study|Physician Decision|0|||
16268540|NCT02028715|39467721|FG000|Overall Study|Did not complete satisfaction surveys|2|||
16268541|NCT02028715|39467722|FG001|Overall Study|Did not complete satisfaction surveys|2|||
16268542|NCT01647828|39467725|FG000|Overall Study|Death|3|||
16455451|NCT00481091|40148190|FG008|Overall Study|Other, Not Specified|0|||
16455452|NCT00481091|40148191|FG009|Overall Study|Other, Not Specified|4|||
16455453|NCT00481091|40148182|FG000|Overall Study|Adverse Event|1|||
16455454|NCT00481091|40148183|FG001|Overall Study|Adverse Event|2|||
16455455|NCT00481091|40148184|FG002|Overall Study|Adverse Event|0|||
16268543|NCT01647828|39467726|FG001|Overall Study|Death|4|||
16268544|NCT01647828|39467727|FG002|Overall Study|Death|4|||
16268545|NCT01647828|39467728|FG003|Overall Study|Death|5|||
16268546|NCT01647828|39467729|FG004|Overall Study|Death|6|||
16455456|NCT00481091|40148185|FG003|Overall Study|Adverse Event|1|||
16455457|NCT00481091|40148186|FG004|Overall Study|Adverse Event|1|||
16455458|NCT00481091|40148187|FG005|Overall Study|Adverse Event|1|||
16268547|NCT01647828|39467730|FG005|Overall Study|Death|3|||
16268548|NCT01647828|39467731|FG006|Overall Study|Death|10|||
16268549|NCT01647828|39467732|FG007|Overall Study|Death|60|||
16268550|NCT01647828|39467733|FG008|Overall Study|Death|71|||
16268551|NCT01647828|39467725|FG000|Overall Study|Withdrawal by Subject|2|||
16268552|NCT01647828|39467726|FG001|Overall Study|Withdrawal by Subject|0|||
16455459|NCT00481091|40148188|FG006|Overall Study|Adverse Event|2|||
16455460|NCT00481091|40148189|FG007|Overall Study|Adverse Event|1|||
16455461|NCT00481091|40148190|FG008|Overall Study|Adverse Event|1|||
16455462|NCT00481091|40148191|FG009|Overall Study|Adverse Event|6|||
16455463|NCT00481091|40148182|FG000|Overall Study|Progressive disease clinical|0|||
16268553|NCT01647828|39467727|FG002|Overall Study|Withdrawal by Subject|0|||
16268554|NCT01647828|39467728|FG003|Overall Study|Withdrawal by Subject|1|||
16268555|NCT01647828|39467729|FG004|Overall Study|Withdrawal by Subject|0|||
16268556|NCT01647828|39467730|FG005|Overall Study|Withdrawal by Subject|0|||
16268557|NCT01647828|39467731|FG006|Overall Study|Withdrawal by Subject|1|||
16268558|NCT01647828|39467732|FG007|Overall Study|Withdrawal by Subject|0|||
16455464|NCT00481091|40148183|FG001|Overall Study|Progressive disease clinical|0|||
16455465|NCT00481091|40148184|FG002|Overall Study|Progressive disease clinical|0|||
16455466|NCT00481091|40148185|FG003|Overall Study|Progressive disease clinical|0|||
16455467|NCT00481091|40148186|FG004|Overall Study|Progressive disease clinical|0|||
16455468|NCT00481091|40148187|FG005|Overall Study|Progressive disease clinical|0|||
16455469|NCT00481091|40148188|FG006|Overall Study|Progressive disease clinical|0|||
16455470|NCT00481091|40148189|FG007|Overall Study|Progressive disease clinical|0|||
16455471|NCT00481091|40148190|FG008|Overall Study|Progressive disease clinical|1|||
16455472|NCT00481091|40148191|FG009|Overall Study|Progressive disease clinical|7|||
16455473|NCT00481091|40148182|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
16455474|NCT00481091|40148183|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
16455475|NCT00481091|40148184|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
16455476|NCT00481091|40148185|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
16455477|NCT00481091|40148186|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
16455478|NCT00481091|40148187|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
16455479|NCT00481091|40148188|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
16455480|NCT00481091|40148189|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
16455481|NCT00481091|40148190|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
16455482|NCT00481091|40148191|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
16455483|NCT00481091|40148182|FG000|Overall Study|Progressive disease other|1|||
16455484|NCT00481091|40148183|FG001|Overall Study|Progressive disease other|1|||
16455485|NCT00481091|40148184|FG002|Overall Study|Progressive disease other|0|||
16455486|NCT00481091|40148185|FG003|Overall Study|Progressive disease other|1|||
16455487|NCT00481091|40148186|FG004|Overall Study|Progressive disease other|1|||
16455488|NCT00481091|40148187|FG005|Overall Study|Progressive disease other|1|||
16455489|NCT00481091|40148188|FG006|Overall Study|Progressive disease other|0|||
16166532|NCT01959165|39087691|FG003|Overall Study|overdose|1|||
16268559|NCT01647828|39467733|FG008|Overall Study|Withdrawal by Subject|2|||
16268560|NCT01647828|39467725|FG000|Overall Study|Study terminated by Sponsor|0|||
16268561|NCT01647828|39467726|FG001|Overall Study|Study terminated by Sponsor|0|||
16268562|NCT01647828|39467727|FG002|Overall Study|Study terminated by Sponsor|0|||
16268563|NCT01647828|39467728|FG003|Overall Study|Study terminated by Sponsor|0|||
16268564|NCT01647828|39467729|FG004|Overall Study|Study terminated by Sponsor|0|||
16268565|NCT01647828|39467730|FG005|Overall Study|Study terminated by Sponsor|0|||
16268566|NCT01647828|39467731|FG006|Overall Study|Study terminated by Sponsor|1|||
16268567|NCT01647828|39467732|FG007|Overall Study|Study terminated by Sponsor|26|||
16268568|NCT01647828|39467733|FG008|Overall Study|Study terminated by Sponsor|16|||
16268569|NCT01647828|39467725|FG000|Overall Study|Lost to Follow-up|0|||
16268570|NCT01647828|39467726|FG001|Overall Study|Lost to Follow-up|0|||
16268571|NCT01647828|39467727|FG002|Overall Study|Lost to Follow-up|0|||
16268572|NCT01647828|39467728|FG003|Overall Study|Lost to Follow-up|0|||
16268573|NCT01647828|39467729|FG004|Overall Study|Lost to Follow-up|0|||
16268574|NCT01647828|39467730|FG005|Overall Study|Lost to Follow-up|0|||
16268575|NCT01647828|39467731|FG006|Overall Study|Lost to Follow-up|0|||
16268576|NCT01647828|39467732|FG007|Overall Study|Lost to Follow-up|2|||
16268577|NCT01647828|39467733|FG008|Overall Study|Lost to Follow-up|0|||
16268578|NCT04608188|39467736|FG000|Overall Study|Withdrawal by Subject|4|||
16455490|NCT00481091|40148189|FG007|Overall Study|Progressive disease other|2|||
16455491|NCT00481091|40148190|FG008|Overall Study|Progressive disease other|0|||
16455492|NCT00481091|40148191|FG009|Overall Study|Progressive disease other|0|||
16268579|NCT04608188|39467737|FG001|Overall Study|Withdrawal by Subject|8|||
16268580|NCT00829764|39467738|FG000|First Intervention|Adverse Event|1|||
16268581|NCT00829764|39467739|FG001|First Intervention|Adverse Event|0|||
16268582|NCT00829764|39467738|FG000|First Intervention|Withdrawal by Subject|1|||
16268583|NCT00829764|39467739|FG001|First Intervention|Withdrawal by Subject|1|||
16268584|NCT00829452|39467742|FG000|First Intervention|Withdrawal by Subject|0|||
16268585|NCT00829452|39467743|FG001|First Intervention|Withdrawal by Subject|1|||
16268586|NCT00829452|39467742|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
16268587|NCT00829452|39467743|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
16268588|NCT00829452|39467742|FG000|Second Intervention|Physician Decision|0|||
16268589|NCT00829452|39467743|FG001|Second Intervention|Physician Decision|1|||
16268590|NCT05752721|39467744|FG000|Overall Study|Lost to Follow-up|22|||
16268591|NCT05752721|39467745|FG001|Overall Study|Lost to Follow-up|20|||
16268592|NCT05752721|39467744|FG000|Overall Study|Withdrawal by Subject|15|||
16268593|NCT05752721|39467745|FG001|Overall Study|Withdrawal by Subject|12|||
16268594|NCT00834444|39467748|FG000|First Intervention|Adverse Event|1|||
16268595|NCT00834444|39467749|FG001|First Intervention|Adverse Event|0|||
16268596|NCT00834444|39467748|FG000|First Intervention|Intolerance to Venopuncture|0|||
16268597|NCT00834444|39467749|FG001|First Intervention|Intolerance to Venopuncture|1|||
16268598|NCT00834444|39467748|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
16268599|NCT00834444|39467749|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
16268600|NCT00834444|39467748|FG000|Second Intervention|Adverse Event|1|||
16268601|NCT00834444|39467749|FG001|Second Intervention|Adverse Event|0|||
16268602|NCT02974621|39467752|FG000|Overall Study|Didn't receive study treatment|1|||
16268603|NCT02974621|39467753|FG001|Overall Study|Didn't receive study treatment|10|||
16268604|NCT00665925|39467754|FG000|Overall Study|Lack of Efficacy|10|||
16268605|NCT00665925|39467755|FG001|Overall Study|Lack of Efficacy|8|||
16268606|NCT00665925|39467756|FG002|Overall Study|Lack of Efficacy|9|||
16268607|NCT00665925|39467757|FG003|Overall Study|Lack of Efficacy|8|||
16268608|NCT00665925|39467754|FG000|Overall Study|Lost to Follow-up|1|||
16268609|NCT00665925|39467755|FG001|Overall Study|Lost to Follow-up|2|||
16268610|NCT00665925|39467756|FG002|Overall Study|Lost to Follow-up|2|||
16268611|NCT00665925|39467757|FG003|Overall Study|Lost to Follow-up|2|||
16268612|NCT00665925|39467754|FG000|Overall Study|Withdrawal by Subject|2|||
16268613|NCT00665925|39467755|FG001|Overall Study|Withdrawal by Subject|2|||
16268614|NCT00665925|39467756|FG002|Overall Study|Withdrawal by Subject|3|||
16166533|NCT01959165|39087688|FG000|Overall Study|Welfare recipient|0|||
16166534|NCT01959165|39087689|FG001|Overall Study|Welfare recipient|1|||
16166535|NCT01959165|39087690|FG002|Overall Study|Welfare recipient|0|||
16268615|NCT00665925|39467757|FG003|Overall Study|Withdrawal by Subject|2|||
16268616|NCT00665925|39467754|FG000|Overall Study|Physician Decision|0|||
16268617|NCT00665925|39467755|FG001|Overall Study|Physician Decision|0|||
16268618|NCT00665925|39467756|FG002|Overall Study|Physician Decision|1|||
16268619|NCT00665925|39467757|FG003|Overall Study|Physician Decision|2|||
16268620|NCT00665925|39467754|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
16268621|NCT00665925|39467755|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
16268622|NCT00665925|39467756|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
16268623|NCT00665925|39467757|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
16268624|NCT00665925|39467754|FG000|Overall Study|Adverse Event|1|||
16268625|NCT00665925|39467755|FG001|Overall Study|Adverse Event|5|||
16268626|NCT00665925|39467756|FG002|Overall Study|Adverse Event|10|||
16268627|NCT00665925|39467757|FG003|Overall Study|Adverse Event|5|||
16268628|NCT00665925|39467754|FG000|Overall Study|Enrolled by mistake|0|||
16268629|NCT00665925|39467755|FG001|Overall Study|Enrolled by mistake|0|||
16268630|NCT00665925|39467756|FG002|Overall Study|Enrolled by mistake|0|||
16268631|NCT00665925|39467757|FG003|Overall Study|Enrolled by mistake|1|||
16268632|NCT00665925|39467754|FG000|Overall Study|Due to exclusion criteria|1|||
16268633|NCT00665925|39467755|FG001|Overall Study|Due to exclusion criteria|0|||
16268634|NCT00665925|39467756|FG002|Overall Study|Due to exclusion criteria|0|||
16268635|NCT00665925|39467757|FG003|Overall Study|Due to exclusion criteria|0|||
16268636|NCT03874715|39467758|FG000|Overall Study|Adverse Event|2|||
16268637|NCT03874715|39467759|FG001|Overall Study|Adverse Event|0|||
16268638|NCT03874715|39467758|FG000|Overall Study|Poor compliance to protocol|5|||
16268639|NCT03874715|39467759|FG001|Overall Study|Poor compliance to protocol|1|||
16268640|NCT03874715|39467758|FG000|Overall Study|Withdrawal by Subject|1|||
16268641|NCT03874715|39467759|FG001|Overall Study|Withdrawal by Subject|0|||
16268642|NCT03874715|39467758|FG000|Overall Study|Other-unspecified|1|||
16268643|NCT03874715|39467759|FG001|Overall Study|Other-unspecified|0|||
16166536|NCT01959165|39087691|FG003|Overall Study|Welfare recipient|0|||
16166537|NCT02847598|39087693|FG000|Overall Study|Adverse Event|0|||
16268644|NCT00669162|39467760|FG000|Overall Study|Withdrawal by Subject|1|||
16268645|NCT01015625|39467761|FG000|Overall Study|Lost to Follow-up|3|||
16268646|NCT01015625|39467762|FG001|Overall Study|Lost to Follow-up|1|||
16268647|NCT01015625|39467761|FG000|Overall Study|Withdrawal by Subject|2|||
16268648|NCT01015625|39467762|FG001|Overall Study|Withdrawal by Subject|3|||
16268649|NCT01015625|39467761|FG000|Overall Study|Physician Decision|2|||
16268650|NCT01015625|39467762|FG001|Overall Study|Physician Decision|0|||
16166538|NCT02847598|39087694|FG001|Overall Study|Adverse Event|0|||
16166539|NCT02847598|39087695|FG002|Overall Study|Adverse Event|0|||
16268651|NCT01015625|39467761|FG000|Overall Study|Death|30|||
16268652|NCT01015625|39467762|FG001|Overall Study|Death|22|||
16268653|NCT00881751|39467763|FG000|Overall Study|Physician Decision|0|||
16268654|NCT00881751|39467764|FG001|Overall Study|Physician Decision|1|||
16268655|NCT00881751|39467763|FG000|Overall Study|Adverse Event|0|||
16268656|NCT00881751|39467764|FG001|Overall Study|Adverse Event|2|||
16268657|NCT00881751|39467763|FG000|Overall Study|Withdrawal by Subject|0|||
16268658|NCT00881751|39467764|FG001|Overall Study|Withdrawal by Subject|2|||
16268659|NCT02625974|39467765|FG000|Part 1|Lost to Follow-up|9|||
16268660|NCT02625974|39467766|FG001|Part 1|Lost to Follow-up|3|||
16268661|NCT02625974|39467765|FG000|Part 2|Lost to Follow-up|4|||
16268662|NCT02625974|39467766|FG001|Part 2|Lost to Follow-up|6|||
16268663|NCT02625974|39467765|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
16268664|NCT02625974|39467766|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
16268665|NCT04345653|39467769|FG000|Overall Study|Withdrawal by Subject|2|||
16268666|NCT00829309|39467770|FG000|Washout: 7 Days|Protocol Violation|1|||
16268667|NCT00829309|39467771|FG001|Washout: 7 Days|Protocol Violation|0|||
16268668|NCT00772603|39467772|FG000|Overall Study|Withdrawal by Subject|11|||
16268669|NCT00772603|39467773|FG001|Overall Study|Withdrawal by Subject|10|||
16268670|NCT00772603|39467774|FG002|Overall Study|Withdrawal by Subject|6|||
16268671|NCT00772603|39467772|FG000|Overall Study|Adverse Event|37|||
16268672|NCT00772603|39467773|FG001|Overall Study|Adverse Event|18|||
16268673|NCT00772603|39467774|FG002|Overall Study|Adverse Event|10|||
16268674|NCT00772603|39467772|FG000|Overall Study|Subject Non-compliance|1|||
16268675|NCT00772603|39467773|FG001|Overall Study|Subject Non-compliance|6|||
16268676|NCT00772603|39467774|FG002|Overall Study|Subject Non-compliance|4|||
16268677|NCT00772603|39467772|FG000|Overall Study|Protocol Violation|0|||
16268678|NCT00772603|39467773|FG001|Overall Study|Protocol Violation|1|||
16268679|NCT00772603|39467774|FG002|Overall Study|Protocol Violation|1|||
16268680|NCT00772603|39467772|FG000|Overall Study|Lost to Follow-up|1|||
16268681|NCT00772603|39467773|FG001|Overall Study|Lost to Follow-up|5|||
16268682|NCT00772603|39467774|FG002|Overall Study|Lost to Follow-up|2|||
16268683|NCT00772603|39467772|FG000|Overall Study|Physician Decision|0|||
16268684|NCT00772603|39467773|FG001|Overall Study|Physician Decision|0|||
16268685|NCT00772603|39467774|FG002|Overall Study|Physician Decision|1|||
16268686|NCT00772603|39467772|FG000|Overall Study|Other|2|||
16268687|NCT00772603|39467773|FG001|Overall Study|Other|0|||
16268688|NCT00772603|39467774|FG002|Overall Study|Other|2|||
16268689|NCT00373256|39467775|FG000|Overall Study|Adverse Event (AE)|1|||
16268690|NCT00373256|39467776|FG001|Overall Study|Adverse Event (AE)|5|||
16268691|NCT00373256|39467775|FG000|Overall Study|Lost to Follow-up|2|||
16268692|NCT00373256|39467776|FG001|Overall Study|Lost to Follow-up|1|||
16268693|NCT00373256|39467775|FG000|Overall Study|Death|9|||
16268694|NCT00373256|39467776|FG001|Overall Study|Death|8|||
16268695|NCT00373256|39467775|FG000|Overall Study|Objective Progression or Relapse|111|||
16268696|NCT00373256|39467776|FG001|Overall Study|Objective Progression or Relapse|104|||
16268697|NCT00373256|39467775|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
16268698|NCT00373256|39467776|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
16268699|NCT00373256|39467775|FG000|Overall Study|Other|73|||
16268700|NCT00373256|39467776|FG001|Overall Study|Other|107|||
16268701|NCT00373256|39467775|FG000|Overall Study|Protocol Violation|0|||
16268702|NCT00373256|39467776|FG001|Overall Study|Protocol Violation|2|||
16268703|NCT00373256|39467775|FG000|Overall Study|Study Terminated by Sponsor|41|||
16268704|NCT00373256|39467776|FG001|Overall Study|Study Terminated by Sponsor|13|||
16268705|NCT00354159|39467782|FG000|Randomized Study Period|Withdrawal by Subject|5|||
16268706|NCT00354159|39467783|FG001|Randomized Study Period|Withdrawal by Subject|3|||
16268707|NCT00354159|39467782|FG000|Randomized Study Period|Physician Decision|6|||
16268708|NCT00354159|39467783|FG001|Randomized Study Period|Physician Decision|10|||
16268709|NCT00354159|39467782|FG000|Randomized Study Period|Lost to Follow-up|4|||
16268710|NCT00354159|39467783|FG001|Randomized Study Period|Lost to Follow-up|0|||
16455493|NCT00481091|40148182|FG000|Overall Study|No reason given|0|||
16455494|NCT00481091|40148183|FG001|Overall Study|No reason given|0|||
16455495|NCT00481091|40148184|FG002|Overall Study|No reason given|1|||
16455496|NCT00481091|40148185|FG003|Overall Study|No reason given|1|||
16455497|NCT00481091|40148186|FG004|Overall Study|No reason given|1|||
16455498|NCT00481091|40148187|FG005|Overall Study|No reason given|0|||
16455499|NCT00481091|40148188|FG006|Overall Study|No reason given|1|||
16455500|NCT00481091|40148189|FG007|Overall Study|No reason given|1|||
16268711|NCT00354159|39467782|FG000|Randomized Study Period|Death|7|||
16268712|NCT00354159|39467783|FG001|Randomized Study Period|Death|9|||
16268713|NCT00354159|39467782|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
16268714|NCT00354159|39467783|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
16268715|NCT00354159|39467782|FG000|Long-term Follow-up|Physician Decision|127|||
16268716|NCT00354159|39467783|FG001|Long-term Follow-up|Physician Decision|122|||
16268717|NCT00354159|39467782|FG000|Long-term Follow-up|Lost to Follow-up|1|||
16268718|NCT00354159|39467783|FG001|Long-term Follow-up|Lost to Follow-up|0|||
16268719|NCT00354159|39467782|FG000|Long-term Follow-up|Death|14|||
16268720|NCT00354159|39467783|FG001|Long-term Follow-up|Death|11|||
16268721|NCT00354159|39467782|FG000|Long-term Follow-up|Study Closed|29|||
16268722|NCT00354159|39467783|FG001|Long-term Follow-up|Study Closed|34|||
16268723|NCT01650194|39467784|FG000|Overall Study|Progressive Disease (PD)|35|||
16268724|NCT01650194|39467784|FG000|Overall Study|Withdrawal by Subject|2|||
16455501|NCT00481091|40148190|FG008|Overall Study|No reason given|1|||
16268725|NCT01650194|39467784|FG000|Overall Study|Miscellaneous|10|||
16268726|NCT00418145|39467785|FG000|Overall Study|study terminated|6|||
16268727|NCT01149057|39467786|FG000|Overall Study|Lack of Efficacy|16|||
16268728|NCT01149057|39467786|FG000|Overall Study|Adverse Event|13|||
16268729|NCT01149057|39467786|FG000|Overall Study|Withdrawal by Subject|9|||
16268730|NCT01149057|39467786|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
16268731|NCT01149057|39467786|FG000|Overall Study|B Cell Depletion|4|||
16268732|NCT01149057|39467786|FG000|Overall Study|Participant Non-Compliance|2|||
16268733|NCT01149057|39467786|FG000|Overall Study|Lost to Follow-up|1|||
16268734|NCT01149057|39467786|FG000|Overall Study|High Parathyroid Hormone Value|1|||
16268735|NCT01149057|39467786|FG000|Overall Study|Other|6|||
16268736|NCT00469417|39467789|FG000|Overall Study|Treatment failure all lesions|18|||
16268737|NCT00469417|39467790|FG001|Overall Study|Treatment failure all lesions|11|||
16268738|NCT00469417|39467789|FG000|Overall Study|Consent withdrawn|1|||
16268739|NCT00469417|39467790|FG001|Overall Study|Consent withdrawn|1|||
16268740|NCT00469417|39467789|FG000|Overall Study|Adverse Event|8|||
16268741|NCT00469417|39467790|FG001|Overall Study|Adverse Event|2|||
16268742|NCT00469417|39467789|FG000|Overall Study|Lost to Follow-up|1|||
16268743|NCT00469417|39467790|FG001|Overall Study|Lost to Follow-up|2|||
16268744|NCT00469417|39467789|FG000|Overall Study|Intercurrent disease|0|||
16268745|NCT00469417|39467790|FG001|Overall Study|Intercurrent disease|1|||
16268746|NCT00469417|39467789|FG000|Overall Study|Randomized but not treated|2|||
16268747|NCT00469417|39467790|FG001|Overall Study|Randomized but not treated|0|||
16268748|NCT01188681|39467794|FG000|Overall Study|bladder cancer|0|||
16268749|NCT01188681|39467795|FG001|Overall Study|bladder cancer|0|||
16268750|NCT01188681|39467796|FG002|Overall Study|bladder cancer|1|||
16268751|NCT01188681|39467797|FG003|Overall Study|bladder cancer|0|||
16268752|NCT01188681|39467794|FG000|Overall Study|Withdrawal by Subject|0|||
16268753|NCT01188681|39467795|FG001|Overall Study|Withdrawal by Subject|0|||
16268754|NCT01188681|39467796|FG002|Overall Study|Withdrawal by Subject|0|||
16268755|NCT01188681|39467797|FG003|Overall Study|Withdrawal by Subject|1|||
16268756|NCT01642277|39467798|FG000|Overall Study|Adverse Event|10|||
16268757|NCT01642277|39467799|FG001|Overall Study|Adverse Event|0|||
16268758|NCT01642277|39467798|FG000|Overall Study|Physician Decision|2|||
16268759|NCT01642277|39467799|FG001|Overall Study|Physician Decision|0|||
16268760|NCT01642277|39467798|FG000|Overall Study|Protocol Violation|1|||
16268761|NCT01642277|39467799|FG001|Overall Study|Protocol Violation|0|||
16268762|NCT01642277|39467798|FG000|Overall Study|Withdrawal by Subject|11|||
16268763|NCT01642277|39467799|FG001|Overall Study|Withdrawal by Subject|0|||
16268764|NCT00881569|39467800|FG000|Overall Study|Disease progression|1|||
16268765|NCT00881569|39467801|FG001|Overall Study|Disease progression|1|||
16268766|NCT02875392|39467806|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
16268767|NCT02875392|39467807|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
16268768|NCT01895335|39467808|FG000|Overall Study|Adverse Event|106|||
16268769|NCT01895335|39467808|FG000|Overall Study|Lack of Efficacy|53|||
16268770|NCT01895335|39467808|FG000|Overall Study|Poor Compliance to Protocol|11|||
16268771|NCT01895335|39467808|FG000|Overall Study|Included But Not treated|1|||
16268772|NCT01895335|39467808|FG000|Overall Study|Other than Specified Above|44|||
16268773|NCT00984022|39467811|FG000|Overall Study|Lost to Follow-up|10|||
16268774|NCT00984022|39467812|FG001|Overall Study|Lost to Follow-up|14|||
16268775|NCT02267187|39467813|FG000|Overall Study|Physician Decision|2|||
16268776|NCT02267187|39467813|FG000|Overall Study|Screen fail|3|||
16268777|NCT00009945|39467814|FG000|Overall Study|no follow up data|7|||
16268778|NCT00009945|39467815|FG001|Overall Study|no follow up data|5|||
16268779|NCT02055547|39467816|FG000|Overall Study|Protocol Violation|0|||
16268780|NCT02055547|39467817|FG001|Overall Study|Protocol Violation|0|||
16268781|NCT02055547|39467818|FG002|Overall Study|Protocol Violation|1|||
16268782|NCT02055547|39467819|FG003|Overall Study|Protocol Violation|0|||
16268783|NCT02055547|39467820|FG004|Overall Study|Protocol Violation|0|||
16268784|NCT02055547|39467821|FG005|Overall Study|Protocol Violation|0|||
16268785|NCT02055547|39467822|FG006|Overall Study|Protocol Violation|1|||
16268786|NCT02055547|39467823|FG007|Overall Study|Protocol Violation|0|||
16268787|NCT02055547|39467824|FG008|Overall Study|Protocol Violation|0|||
16268788|NCT02055547|39467825|FG009|Overall Study|Protocol Violation|0|||
16268789|NCT02055547|39467826|FG010|Overall Study|Protocol Violation|0|||
16268790|NCT02055547|39467827|FG011|Overall Study|Protocol Violation|0|||
16268791|NCT02055547|39467828|FG012|Overall Study|Protocol Violation|0|||
16268792|NCT02055547|39467829|FG013|Overall Study|Protocol Violation|0|||
16268793|NCT02055547|39467830|FG014|Overall Study|Protocol Violation|0|||
16268794|NCT02055547|39467831|FG015|Overall Study|Protocol Violation|0|||
16268795|NCT02055547|39467832|FG016|Overall Study|Protocol Violation|0|||
16268796|NCT02055547|39467833|FG017|Overall Study|Protocol Violation|0|||
16268797|NCT02055547|39467834|FG018|Overall Study|Protocol Violation|0|||
16268798|NCT02055547|39467816|FG000|Overall Study|Physician Decision|0|||
16268799|NCT02055547|39467817|FG001|Overall Study|Physician Decision|1|||
16268800|NCT02055547|39467818|FG002|Overall Study|Physician Decision|1|||
16268801|NCT02055547|39467819|FG003|Overall Study|Physician Decision|0|||
16268802|NCT02055547|39467820|FG004|Overall Study|Physician Decision|1|||
16268803|NCT02055547|39467821|FG005|Overall Study|Physician Decision|0|||
16455502|NCT00481091|40148191|FG009|Overall Study|No reason given|4|||
16455503|NCT01068600|40148192|FG000|Overall Study|Withdrawal by Subject|5|||
16455504|NCT01068600|40148193|FG001|Overall Study|Withdrawal by Subject|6|||
16455505|NCT01068600|40148192|FG000|Overall Study|Adverse Event|3|||
16455506|NCT01068600|40148193|FG001|Overall Study|Adverse Event|3|||
16455507|NCT01068600|40148192|FG000|Overall Study|Abnormal laboratory value(s)|1|||
16455508|NCT01068600|40148193|FG001|Overall Study|Abnormal laboratory value(s)|0|||
16455509|NCT01068600|40148192|FG000|Overall Study|Lost to Follow-up|1|||
16455510|NCT01068600|40148193|FG001|Overall Study|Lost to Follow-up|2|||
16455511|NCT01068600|40148192|FG000|Overall Study|Protocol deviation|1|||
16455512|NCT01068600|40148193|FG001|Overall Study|Protocol deviation|1|||
16268804|NCT02055547|39467822|FG006|Overall Study|Physician Decision|0|||
16268805|NCT02055547|39467823|FG007|Overall Study|Physician Decision|0|||
16268806|NCT02055547|39467824|FG008|Overall Study|Physician Decision|0|||
16268807|NCT02055547|39467825|FG009|Overall Study|Physician Decision|1|||
16268808|NCT02055547|39467826|FG010|Overall Study|Physician Decision|1|||
16268809|NCT02055547|39467827|FG011|Overall Study|Physician Decision|0|||
16268810|NCT02055547|39467828|FG012|Overall Study|Physician Decision|0|||
16268811|NCT02055547|39467829|FG013|Overall Study|Physician Decision|0|||
16268812|NCT02055547|39467830|FG014|Overall Study|Physician Decision|0|||
16268813|NCT02055547|39467831|FG015|Overall Study|Physician Decision|0|||
16268814|NCT02055547|39467832|FG016|Overall Study|Physician Decision|0|||
16268815|NCT02055547|39467833|FG017|Overall Study|Physician Decision|0|||
16268816|NCT02055547|39467834|FG018|Overall Study|Physician Decision|0|||
16268817|NCT02055547|39467816|FG000|Overall Study|Adverse Event|0|||
16268818|NCT02055547|39467817|FG001|Overall Study|Adverse Event|0|||
16268819|NCT02055547|39467818|FG002|Overall Study|Adverse Event|0|||
16268820|NCT02055547|39467819|FG003|Overall Study|Adverse Event|0|||
16268821|NCT02055547|39467820|FG004|Overall Study|Adverse Event|0|||
16268822|NCT02055547|39467821|FG005|Overall Study|Adverse Event|0|||
16268823|NCT02055547|39467822|FG006|Overall Study|Adverse Event|1|||
16268824|NCT02055547|39467823|FG007|Overall Study|Adverse Event|0|||
16268825|NCT02055547|39467824|FG008|Overall Study|Adverse Event|1|||
16455513|NCT01068600|40148192|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16455514|NCT01068600|40148193|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
16455515|NCT01068600|40148192|FG000|Overall Study|Administrative problems|0|||
16455516|NCT01068600|40148193|FG001|Overall Study|Administrative problems|1|||
16455517|NCT00832624|40148197|FG000|Overall Study|Study Terminated|10|||
16455518|NCT00790088|40148198|FG000|Overall Study|Protocol Violation|11|||
16455519|NCT00790088|40148198|FG000|Overall Study|Withdrawal by Subject|17|||
16455520|NCT00790088|40148198|FG000|Overall Study|Lost to Follow-up|7|||
16455521|NCT00790088|40148198|FG000|Overall Study|Physician Decision|4|||
16455522|NCT02404025|40148199|FG000|Overall Study|Adverse Event|1|||
16455523|NCT02404025|40148199|FG000|Overall Study|Lack of Efficacy|3|||
16455524|NCT01864603|40148202|FG000|Stage 2|DSMB design modification|86056|||
16455525|NCT01864603|40148203|FG001|Stage 2|DSMB design modification|92558|||
16455526|NCT02855541|40148204|FG000|Overall Study|Change in health status|2|||
16455527|NCT02855541|40148204|FG000|Overall Study|Withdrawal by Subject|2|||
16455528|NCT01358721|40148205|FG000|Overall Study|Withdrawal by Subject|0|||
16455529|NCT01358721|40148206|FG001|Overall Study|Withdrawal by Subject|0|||
16455530|NCT01358721|40148207|FG002|Overall Study|Withdrawal by Subject|0|||
16455531|NCT01358721|40148208|FG003|Overall Study|Withdrawal by Subject|1|||
16455532|NCT01358721|40148205|FG000|Overall Study|Death|0|||
16455533|NCT01358721|40148206|FG001|Overall Study|Death|2|||
16455534|NCT01358721|40148207|FG002|Overall Study|Death|0|||
16455535|NCT01358721|40148208|FG003|Overall Study|Death|0|||
16455536|NCT01358721|40148205|FG000|Overall Study|Study Drug Toxicity|1|||
16455537|NCT01358721|40148206|FG001|Overall Study|Study Drug Toxicity|3|||
16455538|NCT01358721|40148207|FG002|Overall Study|Study Drug Toxicity|4|||
16455539|NCT01358721|40148208|FG003|Overall Study|Study Drug Toxicity|5|||
16455540|NCT01358721|40148205|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
16455541|NCT01358721|40148206|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
16455542|NCT01358721|40148207|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
16455543|NCT01358721|40148208|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
16455544|NCT01358721|40148205|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
16455545|NCT01358721|40148206|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
16455546|NCT01358721|40148207|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
16455547|NCT01358721|40148208|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
16455548|NCT01358721|40148205|FG000|Overall Study|Adverse Event related to study drug|1|||
16455549|NCT01358721|40148206|FG001|Overall Study|Adverse Event related to study drug|0|||
16268826|NCT02055547|39467825|FG009|Overall Study|Adverse Event|0|||
16268827|NCT02055547|39467826|FG010|Overall Study|Adverse Event|0|||
16268828|NCT02055547|39467827|FG011|Overall Study|Adverse Event|0|||
16268829|NCT02055547|39467828|FG012|Overall Study|Adverse Event|0|||
16268830|NCT02055547|39467829|FG013|Overall Study|Adverse Event|0|||
16268831|NCT02055547|39467830|FG014|Overall Study|Adverse Event|0|||
16268832|NCT02055547|39467831|FG015|Overall Study|Adverse Event|0|||
16268833|NCT02055547|39467832|FG016|Overall Study|Adverse Event|0|||
16268834|NCT02055547|39467833|FG017|Overall Study|Adverse Event|0|||
16268835|NCT02055547|39467834|FG018|Overall Study|Adverse Event|0|||
16268836|NCT02055547|39467816|FG000|Overall Study|Withdrawal by Subject|0|||
16268837|NCT02055547|39467817|FG001|Overall Study|Withdrawal by Subject|0|||
16268838|NCT02055547|39467818|FG002|Overall Study|Withdrawal by Subject|0|||
16268839|NCT02055547|39467819|FG003|Overall Study|Withdrawal by Subject|0|||
16268840|NCT02055547|39467820|FG004|Overall Study|Withdrawal by Subject|0|||
16268841|NCT02055547|39467821|FG005|Overall Study|Withdrawal by Subject|1|||
16268842|NCT02055547|39467822|FG006|Overall Study|Withdrawal by Subject|0|||
16268843|NCT02055547|39467823|FG007|Overall Study|Withdrawal by Subject|0|||
16268844|NCT02055547|39467824|FG008|Overall Study|Withdrawal by Subject|1|||
16268845|NCT02055547|39467825|FG009|Overall Study|Withdrawal by Subject|0|||
16268846|NCT02055547|39467826|FG010|Overall Study|Withdrawal by Subject|0|||
16268847|NCT02055547|39467827|FG011|Overall Study|Withdrawal by Subject|0|||
16268848|NCT02055547|39467828|FG012|Overall Study|Withdrawal by Subject|0|||
16268849|NCT02055547|39467829|FG013|Overall Study|Withdrawal by Subject|1|||
16268850|NCT02055547|39467830|FG014|Overall Study|Withdrawal by Subject|0|||
16268851|NCT02055547|39467831|FG015|Overall Study|Withdrawal by Subject|1|||
16268852|NCT02055547|39467832|FG016|Overall Study|Withdrawal by Subject|0|||
16268853|NCT02055547|39467833|FG017|Overall Study|Withdrawal by Subject|0|||
16268854|NCT02055547|39467834|FG018|Overall Study|Withdrawal by Subject|0|||
16268855|NCT02055547|39467816|FG000|Overall Study|Lost to Follow-up|0|||
16268856|NCT02055547|39467817|FG001|Overall Study|Lost to Follow-up|0|||
16268857|NCT02055547|39467818|FG002|Overall Study|Lost to Follow-up|1|||
16268858|NCT02055547|39467819|FG003|Overall Study|Lost to Follow-up|0|||
16268859|NCT02055547|39467820|FG004|Overall Study|Lost to Follow-up|0|||
16268860|NCT02055547|39467821|FG005|Overall Study|Lost to Follow-up|0|||
16268861|NCT02055547|39467822|FG006|Overall Study|Lost to Follow-up|0|||
16268862|NCT02055547|39467823|FG007|Overall Study|Lost to Follow-up|0|||
16268863|NCT02055547|39467824|FG008|Overall Study|Lost to Follow-up|0|||
16268864|NCT02055547|39467825|FG009|Overall Study|Lost to Follow-up|0|||
16166540|NCT02847598|39087696|FG003|Overall Study|Adverse Event|0|||
16268865|NCT02055547|39467826|FG010|Overall Study|Lost to Follow-up|0|||
16166541|NCT02847598|39087697|FG004|Overall Study|Adverse Event|0|||
16166542|NCT02847598|39087698|FG005|Overall Study|Adverse Event|0|||
16166543|NCT02847598|39087699|FG006|Overall Study|Adverse Event|0|||
16166544|NCT02847598|39087700|FG007|Overall Study|Adverse Event|1|||
16166545|NCT02847598|39087693|FG000|Overall Study|Consent withdrawn|2|||
16166546|NCT02847598|39087694|FG001|Overall Study|Consent withdrawn|0|||
16166547|NCT02847598|39087695|FG002|Overall Study|Consent withdrawn|0|||
16166548|NCT02847598|39087696|FG003|Overall Study|Consent withdrawn|4|||
16166549|NCT02847598|39087697|FG004|Overall Study|Consent withdrawn|3|||
16166550|NCT02847598|39087698|FG005|Overall Study|Consent withdrawn|2|||
16166551|NCT02847598|39087699|FG006|Overall Study|Consent withdrawn|1|||
16166552|NCT02847598|39087700|FG007|Overall Study|Consent withdrawn|3|||
16166553|NCT02847598|39087693|FG000|Overall Study|Death|3|||
16166554|NCT02847598|39087694|FG001|Overall Study|Death|0|||
16166555|NCT02847598|39087695|FG002|Overall Study|Death|0|||
16166556|NCT02847598|39087696|FG003|Overall Study|Death|0|||
16166557|NCT02847598|39087697|FG004|Overall Study|Death|0|||
16166558|NCT02847598|39087698|FG005|Overall Study|Death|0|||
16166559|NCT02847598|39087699|FG006|Overall Study|Death|0|||
16166560|NCT02847598|39087700|FG007|Overall Study|Death|0|||
16166561|NCT02847598|39087693|FG000|Overall Study|Lost to Follow-up|0|||
16166562|NCT02847598|39087694|FG001|Overall Study|Lost to Follow-up|0|||
16166563|NCT02847598|39087695|FG002|Overall Study|Lost to Follow-up|0|||
16166564|NCT02847598|39087696|FG003|Overall Study|Lost to Follow-up|0|||
16166565|NCT02847598|39087697|FG004|Overall Study|Lost to Follow-up|0|||
16166566|NCT02847598|39087698|FG005|Overall Study|Lost to Follow-up|1|||
16166567|NCT02847598|39087699|FG006|Overall Study|Lost to Follow-up|1|||
16166568|NCT02847598|39087700|FG007|Overall Study|Lost to Follow-up|0|||
16166569|NCT00382967|39087704|FG000|Overall Study|Protocol Violation|1|||
16166570|NCT00382967|39087705|FG001|Overall Study|Protocol Violation|1|||
16268866|NCT02055547|39467827|FG011|Overall Study|Lost to Follow-up|0|||
16268867|NCT02055547|39467828|FG012|Overall Study|Lost to Follow-up|0|||
16268868|NCT02055547|39467829|FG013|Overall Study|Lost to Follow-up|0|||
16268869|NCT02055547|39467830|FG014|Overall Study|Lost to Follow-up|0|||
16268870|NCT02055547|39467831|FG015|Overall Study|Lost to Follow-up|0|||
16268871|NCT02055547|39467832|FG016|Overall Study|Lost to Follow-up|0|||
16268872|NCT02055547|39467833|FG017|Overall Study|Lost to Follow-up|0|||
16268873|NCT02055547|39467834|FG018|Overall Study|Lost to Follow-up|0|||
16268874|NCT00840879|39467839|FG000|Second Intervention|Withdrawal by Subject|1|||
16455550|NCT01358721|40148207|FG002|Overall Study|Adverse Event related to study drug|0|||
16166571|NCT03158220|39087706|FG000|Overall Study|Screen Failure|0|||
16166572|NCT03158220|39087707|FG001|Overall Study|Screen Failure|1|||
16166573|NCT03158220|39087706|FG000|Overall Study|Withdrawal by Subject|8|||
16166574|NCT03158220|39087707|FG001|Overall Study|Withdrawal by Subject|9|||
16166575|NCT03158220|39087706|FG000|Overall Study|Status unknown|0|||
16268875|NCT00840879|39467840|FG001|Second Intervention|Withdrawal by Subject|0|||
16166576|NCT03158220|39087707|FG001|Overall Study|Status unknown|1|||
16166577|NCT03158220|39087706|FG000|Overall Study|Lost to Follow-up|8|||
16166578|NCT03158220|39087707|FG001|Overall Study|Lost to Follow-up|5|||
16166579|NCT03158220|39087706|FG000|Overall Study|Physician Decision|1|||
16166580|NCT03158220|39087707|FG001|Overall Study|Physician Decision|0|||
16166581|NCT03588741|39087709|FG000|Overall Study|Withdrawal by Subject|1|||
16166582|NCT01987908|39087713|FG000|Placebo Lead-in Period|Adverse Event|2|||
16166583|NCT01987908|39087714|FG001|Placebo Lead-in Period|Adverse Event|0|||
16166584|NCT01987908|39087715|FG002|Placebo Lead-in Period|Adverse Event|0|||
16166585|NCT01987908|39087713|FG000|Placebo Lead-in Period|Physician Decision|2|||
16166586|NCT01987908|39087714|FG001|Placebo Lead-in Period|Physician Decision|0|||
16166587|NCT01987908|39087715|FG002|Placebo Lead-in Period|Physician Decision|0|||
16455551|NCT01358721|40148208|FG003|Overall Study|Adverse Event related to study drug|1|||
16455552|NCT01358721|40148205|FG000|Overall Study|Disease Progression|19|||
16455553|NCT01358721|40148206|FG001|Overall Study|Disease Progression|15|||
16455554|NCT01358721|40148207|FG002|Overall Study|Disease Progression|17|||
16455555|NCT01358721|40148208|FG003|Overall Study|Disease Progression|15|||
16455556|NCT01358721|40148205|FG000|Overall Study|Out of State/Unmet Criteria|0|||
16166588|NCT01987908|39087713|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
16166589|NCT01987908|39087714|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
16166590|NCT01987908|39087715|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
16166591|NCT01987908|39087713|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
16166592|NCT01987908|39087714|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
16166593|NCT01987908|39087715|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
16166594|NCT01987908|39087713|FG000|Treatment Period|Adverse Event|0|||
16166595|NCT01987908|39087714|FG001|Treatment Period|Adverse Event|1|||
16166596|NCT01987908|39087715|FG002|Treatment Period|Adverse Event|1|||
16166597|NCT01987908|39087713|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
16166598|NCT01987908|39087714|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
16166599|NCT01987908|39087715|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
16268876|NCT03531827|39467843|FG000|Overall Study|Adverse Event|2|||
16268877|NCT03531827|39467844|FG001|Overall Study|Adverse Event|0|||
16268878|NCT03531827|39467843|FG000|Overall Study|Progressive disease|1|||
16268879|NCT03531827|39467844|FG001|Overall Study|Progressive disease|0|||
16268880|NCT00942968|39467847|FG000|Overall Study|Adverse Event|60|||
16268881|NCT00942968|39467847|FG000|Overall Study|Death|76|||
16268882|NCT00942968|39467847|FG000|Overall Study|Protocol Violation|9|||
16268883|NCT00942968|39467847|FG000|Overall Study|Lost to Follow-up|4|||
16268884|NCT00942968|39467847|FG000|Overall Study|Withdrawal by Subject|44|||
16166600|NCT01987908|39087713|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
16166601|NCT01987908|39087714|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
16166602|NCT01987908|39087715|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
16166603|NCT01602341|39087720|FG000|Overall Study|Adverse Event|0|||
16166604|NCT01602341|39087721|FG001|Overall Study|Adverse Event|1|||
16166605|NCT02090855|39087722|FG000|Overall Study|no evaluable Standard of Truth results|2|||
16166606|NCT02324270|39087725|FG000|Overall Study|Withdrawal by Subject|0|||
16166607|NCT02324270|39087726|FG001|Overall Study|Withdrawal by Subject|1|||
16166608|NCT02324270|39087727|FG002|Overall Study|Withdrawal by Subject|0|||
16166609|NCT02324270|39087725|FG000|Overall Study|Lost to Follow-up|4|||
16166610|NCT02324270|39087726|FG001|Overall Study|Lost to Follow-up|3|||
16166611|NCT02324270|39087727|FG002|Overall Study|Lost to Follow-up|4|||
16166612|NCT02324270|39087725|FG000|Overall Study|Protocol Violation|0|||
16166613|NCT02324270|39087726|FG001|Overall Study|Protocol Violation|1|||
16166614|NCT02324270|39087727|FG002|Overall Study|Protocol Violation|1|||
16166615|NCT02324270|39087725|FG000|Overall Study|Non Compliance with Study Drug|1|||
16166616|NCT02324270|39087726|FG001|Overall Study|Non Compliance with Study Drug|2|||
16166617|NCT02324270|39087727|FG002|Overall Study|Non Compliance with Study Drug|0|||
16166618|NCT01231555|39087728|FG000|Overall Study|Study terminated|8|||
16166619|NCT01231555|39087729|FG001|Overall Study|Study terminated|5|||
16166620|NCT01231555|39087730|FG002|Overall Study|Study terminated|8|||
16166621|NCT01231555|39087728|FG000|Overall Study|Withdrawal by Subject|0|||
16268885|NCT00942968|39467847|FG000|Overall Study|Sponsor request|5|||
16268886|NCT00942968|39467847|FG000|Overall Study|Physician Decision|11|||
16268887|NCT00942968|39467847|FG000|Overall Study|Progression of disease|12|||
16268888|NCT00942968|39467847|FG000|Overall Study|Inferior vena cava filter placement|4|||
16455557|NCT01358721|40148206|FG001|Overall Study|Out of State/Unmet Criteria|0|||
16166622|NCT01231555|39087729|FG001|Overall Study|Withdrawal by Subject|2|||
16166623|NCT01231555|39087730|FG002|Overall Study|Withdrawal by Subject|0|||
16166624|NCT01284114|39087731|FG000|Overall Study|viral infection|1|||
16166625|NCT01284114|39087731|FG000|Overall Study|From the results of ALLTITUDE study|1|||
16166626|NCT01284114|39087731|FG000|Overall Study|Symptomatic hypotension|1|||
16166627|NCT01284114|39087731|FG000|Overall Study|dizziness|1|||
16166628|NCT02078219|39087744|FG000|Overall Study|Other|2|||
16166629|NCT02078219|39087745|FG001|Overall Study|Other|2|||
16268889|NCT00942968|39467847|FG000|Overall Study|Pulmonary embolism (PE)|1|||
16268890|NCT00942968|39467847|FG000|Overall Study|Participant required pancreatic biopsy|1|||
16166630|NCT02078219|39087746|FG002|Overall Study|Other|3|||
16166631|NCT02078219|39087747|FG003|Overall Study|Other|0|||
16166632|NCT02078219|39087748|FG004|Overall Study|Other|1|||
16166633|NCT02078219|39087744|FG000|Overall Study|Withdrawal by Subject|0|||
16166634|NCT02078219|39087745|FG001|Overall Study|Withdrawal by Subject|1|||
16166635|NCT02078219|39087746|FG002|Overall Study|Withdrawal by Subject|0|||
16166636|NCT02078219|39087747|FG003|Overall Study|Withdrawal by Subject|1|||
16166637|NCT02078219|39087748|FG004|Overall Study|Withdrawal by Subject|1|||
16268891|NCT00942968|39467847|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
16268892|NCT01440803|39467848|FG000|Overall Study|Met study stopping rule|2|||
16455558|NCT01358721|40148207|FG002|Overall Study|Out of State/Unmet Criteria|1|||
16455559|NCT01358721|40148208|FG003|Overall Study|Out of State/Unmet Criteria|0|||
16455560|NCT01761240|40148209|FG000|Overall Study|Progressive disease:radiology assessment|3|||
16455561|NCT01761240|40148210|FG001|Overall Study|Progressive disease:radiology assessment|3|||
16455562|NCT01761240|40148211|FG002|Overall Study|Progressive disease:radiology assessment|0|||
16455563|NCT01761240|40148212|FG003|Overall Study|Progressive disease:radiology assessment|0|||
16455564|NCT01761240|40148213|FG004|Overall Study|Progressive disease:radiology assessment|0|||
16455565|NCT01761240|40148209|FG000|Overall Study|Progressive disease:clinical assessment|0|||
16455566|NCT01761240|40148210|FG001|Overall Study|Progressive disease:clinical assessment|0|||
16455567|NCT01761240|40148211|FG002|Overall Study|Progressive disease:clinical assessment|3|||
16455568|NCT01761240|40148212|FG003|Overall Study|Progressive disease:clinical assessment|1|||
16455569|NCT01761240|40148213|FG004|Overall Study|Progressive disease:clinical assessment|0|||
16455570|NCT01761240|40148209|FG000|Overall Study|Withdrawal by Subject|0|||
16455571|NCT01761240|40148210|FG001|Overall Study|Withdrawal by Subject|0|||
16455572|NCT01761240|40148211|FG002|Overall Study|Withdrawal by Subject|0|||
16455573|NCT01761240|40148212|FG003|Overall Study|Withdrawal by Subject|3|||
16455574|NCT01761240|40148213|FG004|Overall Study|Withdrawal by Subject|1|||
16455575|NCT01761240|40148209|FG000|Overall Study|Adverse Event|0|||
16455576|NCT01761240|40148210|FG001|Overall Study|Adverse Event|0|||
16455577|NCT01761240|40148211|FG002|Overall Study|Adverse Event|0|||
16455578|NCT01761240|40148212|FG003|Overall Study|Adverse Event|1|||
16455579|NCT01761240|40148213|FG004|Overall Study|Adverse Event|6|||
16455580|NCT01761240|40148209|FG000|Overall Study|Death|0|||
16455581|NCT01761240|40148210|FG001|Overall Study|Death|1|||
16455582|NCT01761240|40148211|FG002|Overall Study|Death|1|||
16455583|NCT01761240|40148212|FG003|Overall Study|Death|2|||
16455584|NCT01761240|40148213|FG004|Overall Study|Death|1|||
16455585|NCT01761240|40148209|FG000|Overall Study|Non-compliance|0|||
16455586|NCT01761240|40148210|FG001|Overall Study|Non-compliance|0|||
16455587|NCT01761240|40148211|FG002|Overall Study|Non-compliance|1|||
16268893|NCT01440803|39467849|FG001|Overall Study|Met study stopping rule|1|||
16268894|NCT01440803|39467848|FG000|Overall Study|Lost to Follow-up|0|||
16268895|NCT01440803|39467849|FG001|Overall Study|Lost to Follow-up|2|||
16268896|NCT01440803|39467848|FG000|Overall Study|Withdrawal by Subject|0|||
16268897|NCT01440803|39467849|FG001|Overall Study|Withdrawal by Subject|1|||
16268898|NCT04238754|39467850|FG000|Washout - 1 Week|Lost to Follow-up|1|||
16268899|NCT04238754|39467851|FG001|Washout - 1 Week|Lost to Follow-up|0|||
16268900|NCT01421277|39467852|FG000|Overall Study|Lack of qualifying event|0|||
16268901|NCT01421277|39467853|FG001|Overall Study|Lack of qualifying event|61|||
16268902|NCT01421277|39467852|FG000|Overall Study|Incomplete baseline data|0|||
16268903|NCT01421277|39467853|FG001|Overall Study|Incomplete baseline data|31|||
16268904|NCT02061280|39467855|FG000|Overall Study|Protocol Violation|12|||
16268905|NCT02061280|39467856|FG001|Overall Study|Protocol Violation|8|||
16268906|NCT02061280|39467855|FG000|Overall Study|moved out of state|0|||
16268907|NCT02061280|39467856|FG001|Overall Study|moved out of state|1|||
16268908|NCT02061280|39467855|FG000|Overall Study|Withdrawal by Subject|1|||
16268909|NCT02061280|39467856|FG001|Overall Study|Withdrawal by Subject|2|||
16268910|NCT02061280|39467855|FG000|Overall Study|Lost to Follow-up|5|||
16268911|NCT02061280|39467856|FG001|Overall Study|Lost to Follow-up|1|||
16268912|NCT01702987|39467860|FG000|Overall Study|Withdrawal by Subject|1|||
16268913|NCT01702987|39467861|FG001|Overall Study|Withdrawal by Subject|0|||
16268914|NCT00712959|39467862|FG000|Overall Study|Protocol Violation|3|||
16455588|NCT01761240|40148212|FG003|Overall Study|Non-compliance|0|||
16455589|NCT01761240|40148213|FG004|Overall Study|Non-compliance|0|||
16455590|NCT01305577|40148214|FG000|Overall Study|Adverse Event|2|||
16072696|NCT00801983|38759136|FG000|Period 2|Withdrawal by Subject|2|||
16166638|NCT02078219|39087744|FG000|Overall Study|Protocol Violation|0|||
16166639|NCT02078219|39087745|FG001|Overall Study|Protocol Violation|0|||
16166640|NCT02078219|39087746|FG002|Overall Study|Protocol Violation|0|||
16268915|NCT00712959|39467863|FG001|Overall Study|Protocol Violation|1|||
16268916|NCT00712959|39467862|FG000|Overall Study|Lost to Follow-up|13|||
16268917|NCT00712959|39467863|FG001|Overall Study|Lost to Follow-up|2|||
16268918|NCT00712959|39467862|FG000|Overall Study|Withdrawal by Subject|3|||
16455591|NCT01305577|40148215|FG001|Overall Study|Adverse Event|2|||
16455592|NCT01305577|40148216|FG002|Overall Study|Adverse Event|1|||
16455593|NCT01305577|40148214|FG000|Overall Study|Withdrawal by Subject|7|||
16268919|NCT00712959|39467863|FG001|Overall Study|Withdrawal by Subject|0|||
16268920|NCT00723710|39467864|FG000|Overall Study|Disease progression|48|||
16268921|NCT00723710|39467864|FG000|Overall Study|Adverse Event|88|||
16268922|NCT00723710|39467864|FG000|Overall Study|Withdrawal by Subject|36|||
16268923|NCT00723710|39467864|FG000|Overall Study|Physician Decision|2|||
16268924|NCT01602380|39467865|FG000|Overall Study|Death|147|||
16268925|NCT01602380|39467866|FG001|Overall Study|Death|145|||
16268926|NCT01602380|39467865|FG000|Overall Study|Withdrawal by Subject|39|||
16268927|NCT01602380|39467866|FG001|Overall Study|Withdrawal by Subject|41|||
16268928|NCT01602380|39467865|FG000|Overall Study|Lost to Follow-up|15|||
16268929|NCT01602380|39467866|FG001|Overall Study|Lost to Follow-up|12|||
16268930|NCT01602380|39467865|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
16268931|NCT01602380|39467866|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
16268932|NCT01602380|39467865|FG000|Overall Study|Other|2|||
16268933|NCT01602380|39467866|FG001|Overall Study|Other|0|||
16268934|NCT01049334|39467867|FG000|Overall Study|Withdrawal by Subject|5|||
16268935|NCT01049334|39467868|FG001|Overall Study|Withdrawal by Subject|3|||
16268936|NCT01049334|39467867|FG000|Overall Study|Adverse Event|2|||
16268937|NCT01049334|39467868|FG001|Overall Study|Adverse Event|3|||
16268938|NCT01049334|39467867|FG000|Overall Study|Physician Decision|2|||
16268939|NCT01049334|39467868|FG001|Overall Study|Physician Decision|0|||
16268940|NCT01049334|39467867|FG000|Overall Study|Protocol Violation|0|||
16268941|NCT01049334|39467868|FG001|Overall Study|Protocol Violation|1|||
16268942|NCT00745420|39467871|FG000|Overall Study|Ineligible|1|||
16268943|NCT03913377|39467875|FG000|Period 1|Test Article no longer available|0|||
16268944|NCT03913377|39467876|FG001|Period 1|Test Article no longer available|1|||
16268945|NCT03913377|39467877|FG002|Period 1|Test Article no longer available|0|||
16268946|NCT03913377|39467875|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
16268947|NCT03913377|39467876|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
16268948|NCT03913377|39467877|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
16268949|NCT03669861|39470942|FG000|Overall Study|Disease Flare|5|||
16268950|NCT03669861|39470942|FG000|Overall Study|Lack of Efficacy|2|||
16268951|NCT02676973|39470943|FG000|Overall Study|Withdrawal by Subject|9|||
16268952|NCT02676973|39470944|FG001|Overall Study|Withdrawal by Subject|8|||
16268953|NCT02676973|39470945|FG002|Overall Study|Withdrawal by Subject|11|||
16268954|NCT02676973|39470943|FG000|Overall Study|Lost to Follow-up|8|||
16268955|NCT02676973|39470944|FG001|Overall Study|Lost to Follow-up|12|||
16268956|NCT02676973|39470945|FG002|Overall Study|Lost to Follow-up|8|||
16268957|NCT02676973|39470943|FG000|Overall Study|Death|2|||
16268958|NCT02676973|39470944|FG001|Overall Study|Death|1|||
16268959|NCT02676973|39470945|FG002|Overall Study|Death|5|||
16268960|NCT00462345|39470951|FG000|Overall Study|Withdrawal by Subject|2|||
16268961|NCT00462345|39470951|FG000|Overall Study|Did not complete second course|1|||
16268962|NCT00835796|39470952|FG000|First Intervention|Withdrawal by Subject|0|||
16268963|NCT00835796|39470953|FG001|First Intervention|Withdrawal by Subject|1|||
16268964|NCT00985751|39470954|FG000|Overall Study|Adverse Event|0|||
16268965|NCT00985751|39470955|FG001|Overall Study|Adverse Event|0|||
16268966|NCT00985751|39470956|FG002|Overall Study|Adverse Event|0|||
16268967|NCT00985751|39470957|FG003|Overall Study|Adverse Event|0|||
16268968|NCT00985751|39470958|FG004|Overall Study|Adverse Event|1|||
16268969|NCT00645853|39470963|FG000|Overall Study|Adverse Event|18|||
16268970|NCT00645853|39470964|FG001|Overall Study|Adverse Event|7|||
16268971|NCT00645853|39470963|FG000|Overall Study|AZ study closure in Hungary|60|||
16268972|NCT00645853|39470964|FG001|Overall Study|AZ study closure in Hungary|40|||
16268973|NCT00645853|39470963|FG000|Overall Study|Withdrawal by Subject|5|||
16268974|NCT00645853|39470964|FG001|Overall Study|Withdrawal by Subject|2|||
16268975|NCT00645853|39470963|FG000|Overall Study|Protocol Violation|0|||
16268976|NCT00645853|39470964|FG001|Overall Study|Protocol Violation|2|||
16268977|NCT00645853|39470963|FG000|Overall Study|Discontinuation criteria|2|||
16268978|NCT00645853|39470964|FG001|Overall Study|Discontinuation criteria|2|||
16455594|NCT01305577|40148215|FG001|Overall Study|Withdrawal by Subject|5|||
16455595|NCT01305577|40148216|FG002|Overall Study|Withdrawal by Subject|6|||
16455596|NCT01305577|40148214|FG000|Overall Study|Lost to Follow-up|4|||
16268979|NCT00645853|39470963|FG000|Overall Study|recall of ICF, planned operation, death|7|||
16268980|NCT00645853|39470964|FG001|Overall Study|recall of ICF, planned operation, death|4|||
16268981|NCT04278417|39470965|FG000|Overall Study|Withdrawal by Subject|13|||
16268982|NCT04278417|39470966|FG001|Overall Study|Withdrawal by Subject|12|||
16268983|NCT04278417|39470965|FG000|Overall Study|Progressive disease|0|||
16268984|NCT04278417|39470966|FG001|Overall Study|Progressive disease|1|||
16268985|NCT04278417|39470965|FG000|Overall Study|Physician Decision|2|||
16268986|NCT04278417|39470966|FG001|Overall Study|Physician Decision|1|||
16268987|NCT04278417|39470965|FG000|Overall Study|Lost to Follow-up|7|||
16268988|NCT04278417|39470966|FG001|Overall Study|Lost to Follow-up|8|||
16268989|NCT04278417|39470965|FG000|Overall Study|Death|6|||
16268990|NCT04278417|39470966|FG001|Overall Study|Death|3|||
16268991|NCT04278417|39470965|FG000|Overall Study|Adverse Event|2|||
16268992|NCT04278417|39470966|FG001|Overall Study|Adverse Event|4|||
16268993|NCT04278417|39470965|FG000|Overall Study|Ongoing, did not complete Week 54|31|||
16268994|NCT04278417|39470966|FG001|Overall Study|Ongoing, did not complete Week 54|27|||
16268995|NCT03637764|39470967|FG000|Overall Study|Adverse Event|2|||
16268996|NCT03637764|39470968|FG001|Overall Study|Adverse Event|0|||
16268997|NCT03637764|39470969|FG002|Overall Study|Adverse Event|0|||
16268998|NCT03637764|39470970|FG003|Overall Study|Adverse Event|1|||
16268999|NCT03637764|39470967|FG000|Overall Study|Progressive Disease|23|||
16269000|NCT03637764|39470968|FG001|Overall Study|Progressive Disease|23|||
16269001|NCT03637764|39470969|FG002|Overall Study|Progressive Disease|18|||
16269002|NCT03637764|39470970|FG003|Overall Study|Progressive Disease|31|||
16269003|NCT03637764|39470967|FG000|Overall Study|Withdrawal by Subject|1|||
16269004|NCT03637764|39470968|FG001|Overall Study|Withdrawal by Subject|3|||
16269005|NCT03637764|39470969|FG002|Overall Study|Withdrawal by Subject|0|||
16269006|NCT03637764|39470970|FG003|Overall Study|Withdrawal by Subject|1|||
16269007|NCT01911676|39470975|FG000|Period 1 of Study|Withdrawal by Subject|4|||
16269008|NCT01911676|39470976|FG001|Period 1 of Study|Withdrawal by Subject|2|||
16269009|NCT01911676|39470977|FG002|Period 1 of Study|Withdrawal by Subject|1|||
16269010|NCT01911676|39470978|FG003|Period 1 of Study|Withdrawal by Subject|2|||
16269011|NCT01911676|39470975|FG000|Period 1 of Study|Physician Decision|2|||
16269012|NCT01911676|39470976|FG001|Period 1 of Study|Physician Decision|0|||
16269013|NCT01911676|39470977|FG002|Period 1 of Study|Physician Decision|0|||
16269014|NCT01911676|39470978|FG003|Period 1 of Study|Physician Decision|1|||
16269015|NCT01911676|39470975|FG000|Period 2 of Study|Physician Decision|2|||
16269016|NCT01911676|39470976|FG001|Period 2 of Study|Physician Decision|0|||
16269017|NCT01911676|39470977|FG002|Period 2 of Study|Physician Decision|0|||
16269018|NCT01911676|39470978|FG003|Period 2 of Study|Physician Decision|1|||
16269019|NCT01911676|39470975|FG000|Period 2 of Study|Lost to Follow-up|0|||
16269020|NCT01911676|39470976|FG001|Period 2 of Study|Lost to Follow-up|0|||
16269021|NCT01911676|39470977|FG002|Period 2 of Study|Lost to Follow-up|0|||
16269022|NCT01911676|39470978|FG003|Period 2 of Study|Lost to Follow-up|1|||
16269023|NCT03158727|39470979|FG000|Overall Study|Withdrawal by Subject|2|||
16269024|NCT03158727|39470980|FG001|Overall Study|Withdrawal by Subject|6|||
16269025|NCT03158727|39470979|FG000|Overall Study|Death|11|||
16269026|NCT03158727|39470980|FG001|Overall Study|Death|12|||
16269027|NCT03158727|39470979|FG000|Overall Study|Lost to Follow-up|1|||
16269028|NCT03158727|39470980|FG001|Overall Study|Lost to Follow-up|0|||
16269029|NCT03158727|39470979|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
16269030|NCT03158727|39470980|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
16269031|NCT03158727|39470979|FG000|Overall Study|Visit 11 not done by mistake|0|||
16269032|NCT03158727|39470980|FG001|Overall Study|Visit 11 not done by mistake|1|||
16269033|NCT03158727|39470979|FG000|Overall Study|Enrolled, not treated|1|||
16269034|NCT03158727|39470980|FG001|Overall Study|Enrolled, not treated|0|||
16269035|NCT03808376|39470982|FG000|Overall Study|Withdrawal by Subject|10|||
16269036|NCT03599193|39470983|FG000|Overall Study|Adverse Event|0|||
16269037|NCT03599193|39470984|FG001|Overall Study|Adverse Event|2|||
16269038|NCT03599193|39470983|FG000|Overall Study|Withdrawal by Subject|1|||
16269039|NCT03599193|39470984|FG001|Overall Study|Withdrawal by Subject|0|||
16269040|NCT03599193|39470983|FG000|Overall Study|Protocol Violation|1|||
16269041|NCT03599193|39470984|FG001|Overall Study|Protocol Violation|0|||
16269042|NCT03599193|39470983|FG000|Overall Study|Lost to Follow-up|0|||
16269043|NCT03599193|39470984|FG001|Overall Study|Lost to Follow-up|1|||
16269044|NCT03248128|39470985|FG000|Overall Study|Lost to Follow-up|1|||
16269045|NCT03248128|39470986|FG001|Overall Study|Lost to Follow-up|0|||
16269046|NCT03248128|39470985|FG000|Overall Study|Withdrawal by Subject|16|||
16166641|NCT02078219|39087747|FG003|Overall Study|Protocol Violation|1|||
16269047|NCT03248128|39470986|FG001|Overall Study|Withdrawal by Subject|14|||
16269048|NCT03248128|39470985|FG000|Overall Study|Site Closed|4|||
16269049|NCT03248128|39470986|FG001|Overall Study|Site Closed|3|||
16269050|NCT03248128|39470985|FG000|Overall Study|Randomized, but did not receive treatment|1|||
16269051|NCT03248128|39470986|FG001|Overall Study|Randomized, but did not receive treatment|3|||
16269052|NCT02902211|39470993|FG000|First Three Months|Withdrawal by Subject|7|||
16269053|NCT02902211|39470994|FG001|First Three Months|Withdrawal by Subject|3|||
16269054|NCT00834249|39470995|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
16269055|NCT00834249|39470996|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
16269056|NCT00834249|39470995|FG000|Second Intervention|Adverse Event|1|||
16269057|NCT00834249|39470996|FG001|Second Intervention|Adverse Event|0|||
16269058|NCT00545792|39470997|FG000|Overall Study|Withdrawal by Subject|1|||
16269059|NCT00840216|39470998|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
16269060|NCT00840216|39470999|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
16455597|NCT01305577|40148215|FG001|Overall Study|Lost to Follow-up|3|||
16269061|NCT00909753|39471000|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
16269062|NCT00909753|39471001|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
16269063|NCT00909753|39471000|FG000|Period: Second Intervention|Protocol Violation|1|||
16269064|NCT00909753|39471001|FG001|Period: Second Intervention|Protocol Violation|0|||
16269065|NCT00957021|39471006|FG000|Overall Study|Death|5|||
16269066|NCT00957021|39471006|FG000|Overall Study|Lost to Follow-up|8|||
16269067|NCT00957021|39471006|FG000|Overall Study|Withdrawal by Subject|34|||
16269068|NCT00957021|39471006|FG000|Overall Study|No 2 yr ROM data|35|||
16269069|NCT00957021|39471006|FG000|Overall Study|Revised study component by 2 yr visit|8|||
16269070|NCT00957021|39471006|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
16269071|NCT00957021|39471006|FG000|Overall Study|Surgery Cancelled|9|||
16269072|NCT00957021|39471006|FG000|Overall Study|Termination due to language issue|2|||
16269073|NCT01750294|39471007|FG000|Overall Study|Withdrawal by Subject|1|||
16269074|NCT01750294|39471007|FG000|Overall Study|Safety Endpoint|1|||
16269075|NCT03818581|39471008|FG000|Overall Study|Adverse Event|1|||
16269076|NCT03818581|39471009|FG001|Overall Study|Adverse Event|0|||
16269077|NCT03818581|39471010|FG002|Overall Study|Adverse Event|0|||
16269078|NCT03818581|39471011|FG003|Overall Study|Adverse Event|0|||
16269079|NCT03818581|39471012|FG004|Overall Study|Adverse Event|0|||
16269080|NCT03818581|39471008|FG000|Overall Study|Covid-19|2|||
16455598|NCT01305577|40148216|FG002|Overall Study|Lost to Follow-up|2|||
16455599|NCT01305577|40148214|FG000|Overall Study|Protocol Deviation|0|||
16455600|NCT01305577|40148215|FG001|Overall Study|Protocol Deviation|1|||
16455601|NCT01305577|40148216|FG002|Overall Study|Protocol Deviation|1|||
16455602|NCT01105767|40148217|FG000|Overall Study|Lost to Follow-up|1160|||
16455603|NCT01105767|40148218|FG001|Overall Study|Lost to Follow-up|1614|||
16455604|NCT01105767|40148219|FG002|Overall Study|Lost to Follow-up|1184|||
16455605|NCT02405442|40148220|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
16455606|NCT02405442|40148221|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
16166642|NCT02078219|39087748|FG004|Overall Study|Protocol Violation|0|||
16166643|NCT02078219|39087744|FG000|Overall Study|Death|0|||
16166644|NCT02078219|39087745|FG001|Overall Study|Death|0|||
16166645|NCT02078219|39087746|FG002|Overall Study|Death|0|||
16455607|NCT02405442|40148222|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
16455608|NCT02405442|40148223|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
16455609|NCT02405442|40148220|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
16455610|NCT02405442|40148221|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
16455611|NCT02405442|40148222|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
16455612|NCT02405442|40148223|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
16455613|NCT02405442|40148220|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
16455614|NCT02405442|40148221|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
16455615|NCT02405442|40148222|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
16455616|NCT02405442|40148223|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
16455617|NCT02405442|40148220|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
16455618|NCT02405442|40148221|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
16455619|NCT02405442|40148222|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
16455620|NCT02405442|40148223|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
16455621|NCT02405442|40148220|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
16455622|NCT02405442|40148221|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
16455623|NCT02405442|40148222|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
16455624|NCT02405442|40148223|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
16455625|NCT02405442|40148220|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
16455626|NCT02405442|40148221|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
16455627|NCT02405442|40148222|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
16455628|NCT02405442|40148223|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
16455629|NCT02405442|40148220|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
16455630|NCT02405442|40148221|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
16455631|NCT02405442|40148222|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
16455632|NCT02405442|40148223|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
16455633|NCT02405442|40148220|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
16455634|NCT02405442|40148221|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
16455635|NCT02405442|40148222|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
16455636|NCT02405442|40148223|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
16455637|NCT02405442|40148220|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
16455638|NCT02405442|40148221|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
16455639|NCT02405442|40148222|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
16455640|NCT02405442|40148223|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
16269081|NCT03818581|39471009|FG001|Overall Study|Covid-19|0|||
16269082|NCT03818581|39471010|FG002|Overall Study|Covid-19|0|||
16455641|NCT02405442|40148220|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
16455642|NCT02405442|40148221|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
16455643|NCT02405442|40148222|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
16455644|NCT02405442|40148223|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
16455645|NCT02405442|40148220|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
16166646|NCT02078219|39087747|FG003|Overall Study|Death|1|||
16166647|NCT02078219|39087748|FG004|Overall Study|Death|0|||
16269083|NCT03818581|39471011|FG003|Overall Study|Covid-19|0|||
16269084|NCT03818581|39471012|FG004|Overall Study|Covid-19|1|||
16455646|NCT02405442|40148221|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
16455647|NCT02405442|40148222|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
16455648|NCT02405442|40148223|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
16455649|NCT02405442|40148220|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
16455650|NCT02405442|40148221|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
16455651|NCT02405442|40148222|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
16455652|NCT02405442|40148223|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
16455653|NCT02405442|40148220|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
16455654|NCT02405442|40148221|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
16455655|NCT02405442|40148222|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
16455656|NCT02405442|40148223|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
16455657|NCT02405442|40148220|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
16455658|NCT02405442|40148221|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
16455659|NCT02405442|40148222|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
16455660|NCT02405442|40148223|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
16455661|NCT00539864|40148225|FG000|Overall Study|Lost to Follow-up|0|||
16455662|NCT00539864|40148226|FG001|Overall Study|Lost to Follow-up|1|||
16455663|NCT00539864|40148225|FG000|Overall Study|Withdrawal by Subject|1|||
16455664|NCT00539864|40148226|FG001|Overall Study|Withdrawal by Subject|1|||
16455665|NCT00485134|40148230|FG000|Overall Study|Lost to Follow-up|1|||
16455666|NCT00485134|40148231|FG001|Overall Study|Lost to Follow-up|0|||
16455667|NCT00485134|40148232|FG002|Overall Study|Lost to Follow-up|0|||
16455668|NCT00485134|40148233|FG003|Overall Study|Lost to Follow-up|0|||
16455669|NCT00485134|40148234|FG004|Overall Study|Lost to Follow-up|0|||
16166648|NCT02078219|39087744|FG000|Overall Study|Adverse Event|1|||
16166649|NCT02078219|39087745|FG001|Overall Study|Adverse Event|1|||
16166650|NCT02078219|39087746|FG002|Overall Study|Adverse Event|3|||
16166651|NCT02078219|39087747|FG003|Overall Study|Adverse Event|1|||
16166652|NCT02078219|39087748|FG004|Overall Study|Adverse Event|0|||
16455670|NCT00485134|40148235|FG005|Overall Study|Lost to Follow-up|0|||
16455671|NCT00485134|40148236|FG006|Overall Study|Lost to Follow-up|0|||
16455672|NCT00485134|40148237|FG007|Overall Study|Lost to Follow-up|0|||
16455673|NCT00485134|40148230|FG000|Overall Study|Withdrawal by Subject|0|||
16455674|NCT00485134|40148231|FG001|Overall Study|Withdrawal by Subject|1|||
16455675|NCT00485134|40148232|FG002|Overall Study|Withdrawal by Subject|0|||
16455676|NCT00485134|40148233|FG003|Overall Study|Withdrawal by Subject|0|||
16455677|NCT00485134|40148234|FG004|Overall Study|Withdrawal by Subject|0|||
16455678|NCT00485134|40148235|FG005|Overall Study|Withdrawal by Subject|0|||
16455679|NCT00485134|40148236|FG006|Overall Study|Withdrawal by Subject|0|||
16455680|NCT00485134|40148237|FG007|Overall Study|Withdrawal by Subject|0|||
16455681|NCT00485134|40148230|FG000|Overall Study|Change in health status|0|||
16455682|NCT00485134|40148231|FG001|Overall Study|Change in health status|1|||
16455683|NCT00485134|40148232|FG002|Overall Study|Change in health status|2|||
16455684|NCT00485134|40148233|FG003|Overall Study|Change in health status|1|||
16455685|NCT00485134|40148234|FG004|Overall Study|Change in health status|0|||
16455686|NCT00485134|40148235|FG005|Overall Study|Change in health status|1|||
16455687|NCT00485134|40148236|FG006|Overall Study|Change in health status|0|||
16455688|NCT00485134|40148237|FG007|Overall Study|Change in health status|0|||
16455689|NCT00485134|40148230|FG000|Overall Study|Withdrew for adverse event|0|||
16455690|NCT00485134|40148231|FG001|Overall Study|Withdrew for adverse event|0|||
16455691|NCT00485134|40148232|FG002|Overall Study|Withdrew for adverse event|1|||
16455692|NCT00485134|40148233|FG003|Overall Study|Withdrew for adverse event|0|||
16455693|NCT00485134|40148234|FG004|Overall Study|Withdrew for adverse event|0|||
16455694|NCT00485134|40148235|FG005|Overall Study|Withdrew for adverse event|0|||
16455695|NCT00485134|40148236|FG006|Overall Study|Withdrew for adverse event|0|||
16455696|NCT00485134|40148237|FG007|Overall Study|Withdrew for adverse event|0|||
16455697|NCT00485134|40148230|FG000|Overall Study|Positive drug test|0|||
16455698|NCT00485134|40148231|FG001|Overall Study|Positive drug test|0|||
16455699|NCT00485134|40148232|FG002|Overall Study|Positive drug test|0|||
16455700|NCT00485134|40148233|FG003|Overall Study|Positive drug test|0|||
16455701|NCT00485134|40148234|FG004|Overall Study|Positive drug test|2|||
16455702|NCT00485134|40148235|FG005|Overall Study|Positive drug test|1|||
16455703|NCT00485134|40148236|FG006|Overall Study|Positive drug test|0|||
16455704|NCT00485134|40148237|FG007|Overall Study|Positive drug test|0|||
16455705|NCT00485134|40148230|FG000|Overall Study|Non-compliance|0|||
16455706|NCT00485134|40148231|FG001|Overall Study|Non-compliance|0|||
16455707|NCT00485134|40148232|FG002|Overall Study|Non-compliance|0|||
16455708|NCT00485134|40148233|FG003|Overall Study|Non-compliance|0|||
16455709|NCT00485134|40148234|FG004|Overall Study|Non-compliance|1|||
16455710|NCT00485134|40148235|FG005|Overall Study|Non-compliance|2|||
16455711|NCT00485134|40148236|FG006|Overall Study|Non-compliance|2|||
16455712|NCT00485134|40148237|FG007|Overall Study|Non-compliance|0|||
16166653|NCT00927563|39087751|FG000|Overall Study|Lost to Follow-up|1|||
16455713|NCT00485134|40148230|FG000|Overall Study|Unable to comply with study schedule|0|||
16455714|NCT00485134|40148231|FG001|Overall Study|Unable to comply with study schedule|0|||
16269085|NCT03818581|39471008|FG000|Overall Study|Withdrawal by Subject|0|||
16269086|NCT03818581|39471009|FG001|Overall Study|Withdrawal by Subject|0|||
16269087|NCT03818581|39471010|FG002|Overall Study|Withdrawal by Subject|0|||
16269088|NCT03818581|39471011|FG003|Overall Study|Withdrawal by Subject|0|||
16269089|NCT03818581|39471012|FG004|Overall Study|Withdrawal by Subject|1|||
16269090|NCT03818581|39471008|FG000|Overall Study|No longer met study criteria|0|||
16269091|NCT03818581|39471009|FG001|Overall Study|No longer met study criteria|0|||
16269092|NCT03818581|39471010|FG002|Overall Study|No longer met study criteria|0|||
16269093|NCT03818581|39471011|FG003|Overall Study|No longer met study criteria|0|||
16269094|NCT03818581|39471012|FG004|Overall Study|No longer met study criteria|1|||
16269095|NCT05098743|39471013|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
16269096|NCT05098743|39471014|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
16269097|NCT05098743|39471013|FG000|Overall Study|Lost to Follow-up|1|||
16269098|NCT05098743|39471014|FG001|Overall Study|Lost to Follow-up|2|||
16269099|NCT01808651|39471015|FG000|Study Period 1|Lost to Follow-up|1|||
16269100|NCT01808651|39471016|FG001|Study Period 1|Lost to Follow-up|3|||
16269101|NCT01808651|39471017|FG002|Study Period 1|Lost to Follow-up|0|||
16269102|NCT01808651|39471015|FG000|Study Period 1|Protocol Violation|1|||
16269103|NCT01808651|39471016|FG001|Study Period 1|Protocol Violation|0|||
16269104|NCT01808651|39471017|FG002|Study Period 1|Protocol Violation|1|||
16269105|NCT01808651|39471015|FG000|Study Period 1|Physician Decision|3|||
16269106|NCT01808651|39471016|FG001|Study Period 1|Physician Decision|2|||
16269107|NCT01808651|39471017|FG002|Study Period 1|Physician Decision|0|||
16269108|NCT01808651|39471015|FG000|Study Period 1|Lack of Efficacy|2|||
16269109|NCT01808651|39471016|FG001|Study Period 1|Lack of Efficacy|1|||
16269110|NCT01808651|39471017|FG002|Study Period 1|Lack of Efficacy|0|||
16269111|NCT01808651|39471015|FG000|Study Period 1|Adverse Event|10|||
16269112|NCT01808651|39471016|FG001|Study Period 1|Adverse Event|4|||
16269113|NCT01808651|39471017|FG002|Study Period 1|Adverse Event|1|||
16269114|NCT01808651|39471015|FG000|Study Period 1|Participant Decision|9|||
16269115|NCT01808651|39471016|FG001|Study Period 1|Participant Decision|7|||
16269116|NCT01808651|39471017|FG002|Study Period 1|Participant Decision|3|||
16269117|NCT01660243|39471020|FG000|Overall Study|Adverse Event|1|||
16269118|NCT01660243|39471021|FG001|Overall Study|Adverse Event|0|||
16269119|NCT01660243|39471022|FG002|Overall Study|Adverse Event|1|||
16269120|NCT01660243|39471023|FG003|Overall Study|Adverse Event|0|||
16269121|NCT01660243|39471020|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
16269122|NCT01660243|39471021|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
16269123|NCT01660243|39471022|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
16269124|NCT01660243|39471023|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
16269125|NCT01660243|39471020|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
16269126|NCT01660243|39471021|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
16269127|NCT01660243|39471022|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
16269128|NCT01660243|39471023|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
16269129|NCT01660243|39471020|FG000|Overall Study|Randomization error|0|||
16269130|NCT01660243|39471021|FG001|Overall Study|Randomization error|0|||
16269131|NCT01660243|39471022|FG002|Overall Study|Randomization error|0|||
16269132|NCT01660243|39471023|FG003|Overall Study|Randomization error|1|||
16269133|NCT01943435|39471024|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
16269134|NCT01943435|39471025|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
16269135|NCT01943435|39471026|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
16269136|NCT01943435|39471024|FG000|Intervention Period|Withdrawal by Subject|3|||
16269137|NCT01943435|39471025|FG001|Intervention Period|Withdrawal by Subject|3|||
16269138|NCT01943435|39471026|FG002|Intervention Period|Withdrawal by Subject|4|||
16269139|NCT01943435|39471024|FG000|2 Month Follow up|Lost to Follow-up|2|||
16269140|NCT01943435|39471025|FG001|2 Month Follow up|Lost to Follow-up|3|||
16269141|NCT01943435|39471026|FG002|2 Month Follow up|Lost to Follow-up|0|||
16269142|NCT01943435|39471024|FG000|6 Month Follow up|Lost to Follow-up|12|||
16269143|NCT01943435|39471025|FG001|6 Month Follow up|Lost to Follow-up|7|||
16269144|NCT01943435|39471026|FG002|6 Month Follow up|Lost to Follow-up|15|||
16269145|NCT01075282|39471027|FG000|Overall Study|Withdrawal by Subject|11|||
16269146|NCT01075282|39471028|FG001|Overall Study|Withdrawal by Subject|7|||
16269147|NCT01075282|39471029|FG002|Overall Study|Withdrawal by Subject|11|||
16269148|NCT01075282|39471027|FG000|Overall Study|Adverse Event|9|||
16269149|NCT01075282|39471028|FG001|Overall Study|Adverse Event|8|||
16269150|NCT01075282|39471029|FG002|Overall Study|Adverse Event|5|||
16269151|NCT01075282|39471027|FG000|Overall Study|Entry Criteria Not Met|3|||
16269152|NCT01075282|39471028|FG001|Overall Study|Entry Criteria Not Met|2|||
16455715|NCT00485134|40148232|FG002|Overall Study|Unable to comply with study schedule|0|||
16455716|NCT00485134|40148233|FG003|Overall Study|Unable to comply with study schedule|0|||
16455717|NCT00485134|40148234|FG004|Overall Study|Unable to comply with study schedule|0|||
16455718|NCT00485134|40148235|FG005|Overall Study|Unable to comply with study schedule|0|||
16455719|NCT00485134|40148236|FG006|Overall Study|Unable to comply with study schedule|0|||
16455720|NCT00485134|40148237|FG007|Overall Study|Unable to comply with study schedule|1|||
16455721|NCT00485134|40148230|FG000|Overall Study|Pregnancy|0|||
16455722|NCT00485134|40148231|FG001|Overall Study|Pregnancy|0|||
16455723|NCT00485134|40148232|FG002|Overall Study|Pregnancy|0|||
16455724|NCT00485134|40148233|FG003|Overall Study|Pregnancy|0|||
16455725|NCT00485134|40148234|FG004|Overall Study|Pregnancy|0|||
16455726|NCT00485134|40148235|FG005|Overall Study|Pregnancy|0|||
16455727|NCT00485134|40148236|FG006|Overall Study|Pregnancy|1|||
16455728|NCT00485134|40148237|FG007|Overall Study|Pregnancy|0|||
16455729|NCT02054104|40148238|FG000|Overall Study|Did not want to continue due to college classes|1|||
16455730|NCT02054104|40148239|FG001|Overall Study|Did not want to continue due to college classes|0|||
16455731|NCT02054104|40148238|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
16455732|NCT02054104|40148239|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
16455733|NCT02054104|40148238|FG000|Overall Study|No evidence of immunologic response|2|||
16455734|NCT02054104|40148239|FG001|Overall Study|No evidence of immunologic response|2|||
16455735|NCT02054104|40148238|FG000|Overall Study|Disease Progression On Study|4|||
16455736|NCT02054104|40148239|FG001|Overall Study|Disease Progression On Study|5|||
16455737|NCT02054104|40148238|FG000|Overall Study|Diagnosis of lymphoma|0|||
16455738|NCT02054104|40148239|FG001|Overall Study|Diagnosis of lymphoma|1|||
16455739|NCT02054104|40148238|FG000|Overall Study|Inconclusive response|0|||
16455740|NCT02054104|40148239|FG001|Overall Study|Inconclusive response|1|||
16455741|NCT02331277|40148242|FG000|Overall Study|Withdrawal by Subject|1|||
16455742|NCT02331277|40148243|FG001|Overall Study|Withdrawal by Subject|0|||
16455743|NCT02888119|40148244|FG000|Overall Study|Lost to Follow-up|5|||
16455744|NCT02888119|40148245|FG001|Overall Study|Lost to Follow-up|4|||
16455745|NCT02888119|40148246|FG002|Overall Study|Lost to Follow-up|0|||
16455746|NCT02207088|40148247|FG000|Overall Study|Adverse Event|2|||
16455747|NCT01837823|40148252|FG000|Overall Study|Lost to Follow-up|6|||
16455748|NCT01290796|40148255|FG000|Overall Study|Lost to Follow-up|21|||
16455749|NCT01290796|40148255|FG000|Overall Study|Withdrawal by Subject|4|||
16455750|NCT01290796|40148255|FG000|Overall Study|Physician Decision|2|||
16455751|NCT01290796|40148255|FG000|Overall Study|Secondary Surgical Intervention|2|||
16455752|NCT01290796|40148255|FG000|Overall Study|Withdrawal by Sponsor|1|||
16455753|NCT00724867|40148259|FG000|Overall Study|Adverse Event|25|||
16455754|NCT00724867|40148259|FG000|Overall Study|Lack of Efficacy|14|||
16455755|NCT00724867|40148259|FG000|Overall Study|Lost to Follow-up|12|||
16455756|NCT00724867|40148259|FG000|Overall Study|Non-compliance with study drug|6|||
16455757|NCT00724867|40148259|FG000|Overall Study|Physician Decision|17|||
16455758|NCT00724867|40148259|FG000|Overall Study|Protocol Violation|1|||
16455759|NCT00724867|40148259|FG000|Overall Study|Withdrawal by Subject|31|||
16455760|NCT00724867|40148259|FG000|Overall Study|Sponsor decision to end study|14|||
16455761|NCT00724867|40148259|FG000|Overall Study|Subject incarcerated|1|||
16455762|NCT00724867|40148259|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
16455763|NCT00724867|40148259|FG000|Overall Study|Subject moved out of state|1|||
16455764|NCT00724867|40148259|FG000|Overall Study|Elected to exit due to site closure|2|||
16455765|NCT00530504|40148260|FG000|Overall Study|Death|54|||
16455766|NCT00530504|40148260|FG000|Overall Study|Lost to Follow-up|26|||
16455767|NCT00530504|40148260|FG000|Overall Study|Withdrawal by Subject|39|||
16455768|NCT00530504|40148260|FG000|Overall Study|Exited study due to other reasons|33|||
16455769|NCT00706342|40148261|FG000|Overall Study|Adverse Event|3|||
16455770|NCT00706342|40148261|FG000|Overall Study|Not responding to treatment|2|||
16455771|NCT00706342|40148261|FG000|Overall Study|Withdrawn due to failure to respond|1|||
16455772|NCT00706342|40148261|FG000|Overall Study|Death|1|||
16455773|NCT00706342|40148261|FG000|Overall Study|Withdrew from the study on his own.|1|||
16455774|NCT00706342|40148261|FG000|Overall Study|Investigator discretion|2|||
16455775|NCT00706342|40148261|FG000|Overall Study|Non-responder Week 12|1|||
16455776|NCT00706342|40148261|FG000|Overall Study|Ongoing|6|||
16455777|NCT00706342|40148261|FG000|Overall Study|WIthdrawal of consent|1|||
16455778|NCT02636361|40148262|FG000|Period 4|Physician Decision|0|||
16455779|NCT02636361|40148263|FG001|Period 4|Physician Decision|0|||
16455780|NCT02636361|40148264|FG002|Period 4|Physician Decision|0|||
16455781|NCT02636361|40148265|FG003|Period 4|Physician Decision|1|||
16455782|NCT02636361|40148266|FG004|Period 4|Physician Decision|0|||
16455783|NCT01104311|40148267|FG000|Overall Study|Withdrawal by Subject|6|||
16455784|NCT01104311|40148268|FG001|Overall Study|Withdrawal by Subject|6|||
16455785|NCT01104311|40148267|FG000|Overall Study|Protocol Violation|0|||
16455786|NCT01104311|40148268|FG001|Overall Study|Protocol Violation|1|||
16455787|NCT01104311|40148267|FG000|Overall Study|Physician Decision|2|||
16455788|NCT01104311|40148268|FG001|Overall Study|Physician Decision|2|||
16455789|NCT01104311|40148267|FG000|Overall Study|low compliance|1|||
16455790|NCT01104311|40148268|FG001|Overall Study|low compliance|1|||
16455791|NCT01104311|40148267|FG000|Overall Study|Adverse Event|1|||
16455792|NCT01104311|40148268|FG001|Overall Study|Adverse Event|2|||
16455793|NCT03983317|40148269|FG000|Overall Study|Physician Decision|5|||
16455794|NCT01175083|40148271|FG000|Primary Epoch|Withdrawal by Subject|0|||
16455795|NCT01175083|40148272|FG001|Primary Epoch|Withdrawal by Subject|0|||
16455796|NCT01175083|40148273|FG002|Primary Epoch|Withdrawal by Subject|0|||
16455797|NCT01175083|40148274|FG003|Primary Epoch|Withdrawal by Subject|0|||
16455798|NCT01175083|40148275|FG004|Primary Epoch|Withdrawal by Subject|0|||
16455799|NCT01175083|40148276|FG005|Primary Epoch|Withdrawal by Subject|2|||
16455800|NCT01175083|40148271|FG000|Primary Epoch|Lost to Follow-up|0|||
16455801|NCT01175083|40148272|FG001|Primary Epoch|Lost to Follow-up|0|||
16455802|NCT01175083|40148273|FG002|Primary Epoch|Lost to Follow-up|0|||
16455803|NCT01175083|40148274|FG003|Primary Epoch|Lost to Follow-up|0|||
16455804|NCT01175083|40148275|FG004|Primary Epoch|Lost to Follow-up|0|||
16455805|NCT01175083|40148276|FG005|Primary Epoch|Lost to Follow-up|1|||
16455806|NCT01175083|40148271|FG000|Booster Epoch|Death|0|||
16455807|NCT01175083|40148272|FG001|Booster Epoch|Death|0|||
16455808|NCT01175083|40148273|FG002|Booster Epoch|Death|1|||
16455809|NCT01175083|40148274|FG003|Booster Epoch|Death|0|||
16455810|NCT01175083|40148275|FG004|Booster Epoch|Death|0|||
16455811|NCT01175083|40148276|FG005|Booster Epoch|Death|0|||
16455812|NCT01175083|40148271|FG000|Booster Epoch|Withdrawal by Subject|0|||
16455813|NCT01175083|40148272|FG001|Booster Epoch|Withdrawal by Subject|0|||
16455814|NCT01175083|40148273|FG002|Booster Epoch|Withdrawal by Subject|0|||
16455815|NCT01175083|40148274|FG003|Booster Epoch|Withdrawal by Subject|1|||
16455816|NCT01175083|40148275|FG004|Booster Epoch|Withdrawal by Subject|0|||
16455817|NCT01175083|40148276|FG005|Booster Epoch|Withdrawal by Subject|0|||
16455818|NCT00104520|40148277|FG000|Overall Study|Unrelated adverse event|34|||
16455819|NCT00104520|40148278|FG001|Overall Study|Unrelated adverse event|47|||
16455820|NCT00104520|40148277|FG000|Overall Study|Study drug intolerance|0|||
16455821|NCT00104520|40148278|FG001|Overall Study|Study drug intolerance|1|||
16455822|NCT00104520|40148277|FG000|Overall Study|Related adverse event|13|||
16455823|NCT00104520|40148278|FG001|Overall Study|Related adverse event|15|||
16455824|NCT00104520|40148277|FG000|Overall Study|Lost to Follow-up|1|||
16455825|NCT00104520|40148278|FG001|Overall Study|Lost to Follow-up|0|||
16455826|NCT00104520|40148277|FG000|Overall Study|Noncompliance|0|||
16455827|NCT00104520|40148278|FG001|Overall Study|Noncompliance|2|||
16455828|NCT00104520|40148277|FG000|Overall Study|Personal/administrative|1|||
16455829|NCT00104520|40148278|FG001|Overall Study|Personal/administrative|1|||
16455830|NCT00104520|40148277|FG000|Overall Study|Other|1|||
16455831|NCT00104520|40148278|FG001|Overall Study|Other|5|||
16455832|NCT00436345|40148279|FG000|Overall Study|ICU resident beyond follow-up period|3|||
16455833|NCT00436345|40148280|FG001|Overall Study|ICU resident beyond follow-up period|0|||
16455834|NCT01733680|40148281|FG000|Overall Study|Withdrawal by Subject|0|||
16455835|NCT01733680|40148282|FG001|Overall Study|Withdrawal by Subject|1|||
16455836|NCT02395172|40148285|FG000|Overall Study|Participants randomized but not treated|3|||
16455837|NCT02395172|40148286|FG001|Overall Study|Participants randomized but not treated|31|||
16455838|NCT00145119|40148287|FG000|Overall Study|Death|45|||
16455839|NCT05334212|40148288|FG000|Overall Study|Study terminated prematurely|7|||
16455840|NCT00777153|40148289|FG000|Overall Study|Lost to Follow-up|1|||
16455841|NCT00777153|40148290|FG001|Overall Study|Lost to Follow-up|1|||
16455842|NCT00777153|40148291|FG002|Overall Study|Lost to Follow-up|0|||
16455843|NCT00777153|40148289|FG000|Overall Study|Death|85|||
16455844|NCT00777153|40148290|FG001|Overall Study|Death|73|||
16455845|NCT00777153|40148291|FG002|Overall Study|Death|33|||
16455846|NCT00777153|40148289|FG000|Overall Study|Withdrawal by Subject|3|||
16455847|NCT00777153|40148290|FG001|Overall Study|Withdrawal by Subject|4|||
16455848|NCT00777153|40148291|FG002|Overall Study|Withdrawal by Subject|3|||
16455849|NCT00777153|40148289|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
16455850|NCT00777153|40148290|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
16455851|NCT00777153|40148291|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
16455852|NCT02934503|40148292|FG000|Overall Study|progression of disease|3|||
16455853|NCT02934503|40148292|FG000|Overall Study|Withdrawal by Subject|1|||
16455854|NCT00771953|40148295|FG000|Overall Study|Adverse Event|5|||
16455855|NCT00771953|40148296|FG001|Overall Study|Adverse Event|3|||
16455856|NCT00771953|40148295|FG000|Overall Study|Death|2|||
16455857|NCT00771953|40148296|FG001|Overall Study|Death|2|||
16455858|NCT00771953|40148295|FG000|Overall Study|Progression before active Tx|1|||
16455859|NCT00771953|40148296|FG001|Overall Study|Progression before active Tx|2|||
16455860|NCT00771953|40148295|FG000|Overall Study|Sponsor decision|1|||
16455861|NCT00771953|40148296|FG001|Overall Study|Sponsor decision|0|||
16455862|NCT00771953|40148295|FG000|Overall Study|Other complicating disease|1|||
16455863|NCT00771953|40148296|FG001|Overall Study|Other complicating disease|0|||
16455864|NCT00771953|40148295|FG000|Overall Study|Withdrawal by Subject|0|||
16455865|NCT00771953|40148296|FG001|Overall Study|Withdrawal by Subject|3|||
16455866|NCT01160822|40148297|FG000|Overall Study|Adverse Event|0|||
16455867|NCT01160822|40148298|FG001|Overall Study|Adverse Event|0|||
16455868|NCT01160822|40148299|FG002|Overall Study|Adverse Event|0|||
16455869|NCT01160822|40148300|FG003|Overall Study|Adverse Event|0|||
16455870|NCT01160822|40148301|FG004|Overall Study|Adverse Event|1|||
16455871|NCT01160822|40148302|FG005|Overall Study|Adverse Event|2|||
16455872|NCT01160822|40148303|FG006|Overall Study|Adverse Event|5|||
16455873|NCT01160822|40148297|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16455874|NCT01160822|40148298|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16455875|NCT01160822|40148299|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
16455876|NCT01160822|40148300|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
16455877|NCT01160822|40148301|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
16455878|NCT01160822|40148302|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
16455879|NCT01160822|40148303|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
16455880|NCT01160822|40148297|FG000|Overall Study|Withdrawal by Subject|0|||
16455881|NCT01160822|40148298|FG001|Overall Study|Withdrawal by Subject|0|||
16455882|NCT01160822|40148299|FG002|Overall Study|Withdrawal by Subject|0|||
16455883|NCT01160822|40148300|FG003|Overall Study|Withdrawal by Subject|0|||
16455884|NCT01160822|40148301|FG004|Overall Study|Withdrawal by Subject|0|||
16455885|NCT01160822|40148302|FG005|Overall Study|Withdrawal by Subject|0|||
16455886|NCT01160822|40148303|FG006|Overall Study|Withdrawal by Subject|1|||
16455887|NCT01160822|40148297|FG000|Overall Study|Lost to Follow-up|0|||
16455888|NCT01160822|40148298|FG001|Overall Study|Lost to Follow-up|0|||
16455889|NCT01160822|40148299|FG002|Overall Study|Lost to Follow-up|0|||
16455890|NCT01160822|40148300|FG003|Overall Study|Lost to Follow-up|0|||
16455891|NCT01160822|40148301|FG004|Overall Study|Lost to Follow-up|1|||
16455892|NCT01160822|40148302|FG005|Overall Study|Lost to Follow-up|0|||
16455893|NCT01160822|40148303|FG006|Overall Study|Lost to Follow-up|0|||
16455894|NCT01160822|40148297|FG000|Overall Study|Administrative problems|0|||
16455895|NCT01160822|40148298|FG001|Overall Study|Administrative problems|0|||
16455896|NCT01160822|40148299|FG002|Overall Study|Administrative problems|0|||
16455897|NCT01160822|40148300|FG003|Overall Study|Administrative problems|0|||
16455898|NCT01160822|40148301|FG004|Overall Study|Administrative problems|1|||
16455899|NCT01160822|40148302|FG005|Overall Study|Administrative problems|0|||
16455900|NCT01160822|40148303|FG006|Overall Study|Administrative problems|0|||
16455901|NCT01160822|40148297|FG000|Overall Study|Protocol deviation|0|||
16455902|NCT01160822|40148298|FG001|Overall Study|Protocol deviation|0|||
16455903|NCT01160822|40148299|FG002|Overall Study|Protocol deviation|0|||
16455904|NCT01160822|40148300|FG003|Overall Study|Protocol deviation|0|||
16455905|NCT01160822|40148301|FG004|Overall Study|Protocol deviation|2|||
16455906|NCT01160822|40148302|FG005|Overall Study|Protocol deviation|0|||
16455907|NCT01160822|40148303|FG006|Overall Study|Protocol deviation|0|||
16455908|NCT04093024|40148309|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
16455909|NCT04093024|40148310|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
16455910|NCT04093024|40148309|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
16455911|NCT04093024|40148310|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
16455912|NCT04093024|40148309|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
16455913|NCT04093024|40148310|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
16455914|NCT04093024|40148309|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
16455915|NCT04093024|40148310|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
16455916|NCT02175199|40148319|FG000|Overall Study|Withdrawal by Subject|1|||
16455917|NCT02175199|40148320|FG001|Overall Study|Withdrawal by Subject|5|||
16455918|NCT02175199|40148319|FG000|Overall Study|Randomized in Error|1|||
16455919|NCT02175199|40148320|FG001|Overall Study|Randomized in Error|0|||
16455920|NCT02175199|40148319|FG000|Overall Study|Sponsor Decision|1|||
16455921|NCT02175199|40148320|FG001|Overall Study|Sponsor Decision|0|||
16455922|NCT00884741|40148330|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
16455923|NCT00884741|40148331|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
16455924|NCT00884741|40148332|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
16455925|NCT00884741|40148333|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
16455926|NCT00884741|40148330|FG000|Step 1 Registration: Tissue Screening|Death|3|||
16455927|NCT00884741|40148331|FG001|Step 1 Registration: Tissue Screening|Death|0|||
16455928|NCT00884741|40148332|FG002|Step 1 Registration: Tissue Screening|Death|0|||
16455929|NCT00884741|40148333|FG003|Step 1 Registration: Tissue Screening|Death|0|||
16455930|NCT00884741|40148330|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
16455931|NCT00884741|40148331|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
16455932|NCT00884741|40148332|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
16455933|NCT00884741|40148333|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
16455934|NCT00884741|40148330|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
16455935|NCT00884741|40148331|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
16455936|NCT00884741|40148332|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
16455937|NCT00884741|40148333|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
16455938|NCT00884741|40148330|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
16455939|NCT00884741|40148331|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
16455940|NCT00884741|40148332|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
16455941|NCT00884741|40148333|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
16455942|NCT00884741|40148330|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
16455943|NCT00884741|40148331|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
16455944|NCT00884741|40148332|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
16455945|NCT00884741|40148333|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
16455946|NCT00884741|40148330|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
16455947|NCT00884741|40148331|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
16455948|NCT00884741|40148332|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
16455949|NCT00884741|40148333|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
16455950|NCT00884741|40148330|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
16455951|NCT00884741|40148331|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
16455952|NCT00884741|40148332|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
16455953|NCT00884741|40148333|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
16455954|NCT00884741|40148330|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
16455955|NCT00884741|40148331|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
16455956|NCT00884741|40148332|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
16455957|NCT00884741|40148333|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
16455958|NCT00884741|40148330|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
16455959|NCT00884741|40148331|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
16455960|NCT00884741|40148332|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
16455961|NCT00884741|40148333|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
16455962|NCT00884741|40148330|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
16455963|NCT00884741|40148331|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
16455964|NCT00884741|40148332|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
16455965|NCT00884741|40148333|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
16455966|NCT00884741|40148330|FG000|Randomization|Protocol Violation|0|||
16455967|NCT00884741|40148331|FG001|Randomization|Protocol Violation|0|||
16455968|NCT00884741|40148332|FG002|Randomization|Protocol Violation|8|||
16455969|NCT00884741|40148333|FG003|Randomization|Protocol Violation|8|||
16455970|NCT01598129|40148336|FG000|Overall Study|Disease progression|6|||
16455971|NCT01598129|40148336|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
16455972|NCT01598129|40148336|FG000|Overall Study|Withdrawal by Subject|1|||
16455973|NCT00074490|40148337|FG000|Overall Study|Progressive malignancy|0|||
16455974|NCT00074490|40148338|FG001|Overall Study|Progressive malignancy|7|||
16455975|NCT00074490|40148339|FG002|Overall Study|Progressive malignancy|0|||
16455976|NCT00074490|40148340|FG003|Overall Study|Progressive malignancy|0|||
16455977|NCT00074490|40148341|FG004|Overall Study|Progressive malignancy|3|||
16455978|NCT00074490|40148342|FG005|Overall Study|Progressive malignancy|0|||
16455979|NCT04254913|40148343|FG000|Overall Study|Adverse Event|1|||
16455980|NCT00459186|40148345|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
16455981|NCT00459186|40148345|FG000|PET Imaging and Assessment|Adverse Event|3|||
16455982|NCT02657408|40148346|FG000|Overall Study|Adverse Event|3|||
16455983|NCT02657408|40148347|FG001|Overall Study|Adverse Event|7|||
16455984|NCT01915303|40148348|FG000|Core Phase|Adverse Event|7|||
16455985|NCT01915303|40148348|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
16455986|NCT01915303|40148348|FG000|Core Phase|Death|2|||
16455987|NCT01915303|40148348|FG000|Core Phase|Protocol Violation|2|||
16455988|NCT01915303|40148348|FG000|Core Phase|Abnormal lab value|1|||
16455989|NCT01915303|40148348|FG000|Core Phase|Withdrawal by Subject|1|||
16455990|NCT01915303|40148348|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
16455991|NCT01915303|40148348|FG000|Extension Phase|Withdrawal by Subject|4|||
16455992|NCT01915303|40148348|FG000|Extension Phase|Adverse Event|3|||
16455993|NCT01915303|40148348|FG000|Extension Phase|Death|1|||
16455994|NCT01915303|40148348|FG000|Extension Phase|Protocol Violation|1|||
16455995|NCT03926611|40148349|FG000|Overall Study|Adverse Event|0|||
16455996|NCT03926611|40148350|FG001|Overall Study|Adverse Event|0|||
16455997|NCT03926611|40148351|FG002|Overall Study|Adverse Event|0|||
16455998|NCT03926611|40148352|FG003|Overall Study|Adverse Event|3|||
16455999|NCT03926611|40148353|FG004|Overall Study|Adverse Event|1|||
16456000|NCT03926611|40148354|FG005|Overall Study|Adverse Event|3|||
16456001|NCT03926611|40148355|FG006|Overall Study|Adverse Event|0|||
16456002|NCT03926611|40148349|FG000|Overall Study|Lack of Efficacy|1|||
16456003|NCT03926611|40148350|FG001|Overall Study|Lack of Efficacy|2|||
16166654|NCT00927563|39087751|FG000|Overall Study|Withdrawal by Subject|1|||
16456004|NCT03926611|40148351|FG002|Overall Study|Lack of Efficacy|0|||
16456005|NCT03926611|40148352|FG003|Overall Study|Lack of Efficacy|0|||
16456006|NCT03926611|40148353|FG004|Overall Study|Lack of Efficacy|1|||
16456007|NCT03926611|40148354|FG005|Overall Study|Lack of Efficacy|0|||
16456008|NCT03926611|40148355|FG006|Overall Study|Lack of Efficacy|1|||
16456009|NCT03926611|40148349|FG000|Overall Study|Physician Decision|0|||
16456010|NCT03926611|40148350|FG001|Overall Study|Physician Decision|0|||
16456011|NCT03926611|40148351|FG002|Overall Study|Physician Decision|0|||
16456012|NCT03926611|40148352|FG003|Overall Study|Physician Decision|0|||
16456013|NCT03926611|40148353|FG004|Overall Study|Physician Decision|0|||
16456014|NCT03926611|40148354|FG005|Overall Study|Physician Decision|1|||
16456015|NCT03926611|40148355|FG006|Overall Study|Physician Decision|0|||
16456016|NCT03926611|40148349|FG000|Overall Study|Protocol Violation|1|||
16456017|NCT03926611|40148350|FG001|Overall Study|Protocol Violation|0|||
16456018|NCT03926611|40148351|FG002|Overall Study|Protocol Violation|0|||
16456019|NCT03926611|40148352|FG003|Overall Study|Protocol Violation|1|||
16456020|NCT03926611|40148353|FG004|Overall Study|Protocol Violation|1|||
16456021|NCT03926611|40148354|FG005|Overall Study|Protocol Violation|1|||
16456022|NCT03926611|40148355|FG006|Overall Study|Protocol Violation|1|||
16456023|NCT03926611|40148349|FG000|Overall Study|Technical problems|0|||
16456024|NCT03926611|40148350|FG001|Overall Study|Technical problems|0|||
16456025|NCT03926611|40148351|FG002|Overall Study|Technical problems|0|||
16456026|NCT03926611|40148352|FG003|Overall Study|Technical problems|0|||
16456027|NCT03926611|40148353|FG004|Overall Study|Technical problems|0|||
16456028|NCT03926611|40148354|FG005|Overall Study|Technical problems|1|||
16456029|NCT03926611|40148355|FG006|Overall Study|Technical problems|0|||
16456030|NCT03926611|40148349|FG000|Overall Study|Withdrawal by Subject|1|||
16456031|NCT03926611|40148350|FG001|Overall Study|Withdrawal by Subject|1|||
16456032|NCT03926611|40148351|FG002|Overall Study|Withdrawal by Subject|1|||
16456033|NCT03926611|40148352|FG003|Overall Study|Withdrawal by Subject|0|||
16456034|NCT03926611|40148353|FG004|Overall Study|Withdrawal by Subject|0|||
16456035|NCT03926611|40148354|FG005|Overall Study|Withdrawal by Subject|1|||
16456036|NCT03926611|40148355|FG006|Overall Study|Withdrawal by Subject|3|||
16456037|NCT03926611|40148349|FG000|Overall Study|Covid-19 pandemic|0|||
16456038|NCT03926611|40148350|FG001|Overall Study|Covid-19 pandemic|0|||
16456039|NCT03926611|40148351|FG002|Overall Study|Covid-19 pandemic|1|||
16456040|NCT03926611|40148352|FG003|Overall Study|Covid-19 pandemic|0|||
16456041|NCT03926611|40148353|FG004|Overall Study|Covid-19 pandemic|1|||
16456042|NCT03926611|40148354|FG005|Overall Study|Covid-19 pandemic|2|||
16456043|NCT03926611|40148355|FG006|Overall Study|Covid-19 pandemic|0|||
16456044|NCT00548184|40148356|FG000|Overall Study|Adverse Event|3|||
16456045|NCT00548184|40148356|FG000|Overall Study|took other drug|1|||
16456046|NCT00548184|40148356|FG000|Overall Study|Found Her2 negative|1|||
16456047|NCT01767142|40148357|FG000|Overall Study|Lost to Follow-up|3|||
16456048|NCT00721968|40148360|FG000|Overall Study|Lost to Follow-up|2|||
16456049|NCT00721968|40148361|FG001|Overall Study|Lost to Follow-up|0|||
16456050|NCT05083585|40148364|FG000|Overall Study|Death|1|||
16456051|NCT05083585|40148365|FG001|Overall Study|Death|1|||
16456052|NCT05083585|40148364|FG000|Overall Study|Lost to Follow-up|1|||
16456053|NCT05083585|40148365|FG001|Overall Study|Lost to Follow-up|1|||
16456054|NCT05083585|40148364|FG000|Overall Study|Withdrawal by Subject|2|||
16456055|NCT05083585|40148365|FG001|Overall Study|Withdrawal by Subject|0|||
16456056|NCT05083585|40148364|FG000|Overall Study|Randomized but not vaccinated|2|||
16456057|NCT05083585|40148365|FG001|Overall Study|Randomized but not vaccinated|0|||
16456058|NCT02791763|40148366|FG000|Overall Study|Protocol Violation|0|||
16456059|NCT02791763|40148367|FG001|Overall Study|Protocol Violation|0|||
16456060|NCT02791763|40148368|FG002|Overall Study|Protocol Violation|1|||
16456061|NCT02791763|40148366|FG000|Overall Study|Withdrawal by Subject|5|||
16456062|NCT02791763|40148367|FG001|Overall Study|Withdrawal by Subject|1|||
16456063|NCT02791763|40148368|FG002|Overall Study|Withdrawal by Subject|0|||
16456064|NCT02791763|40148366|FG000|Overall Study|Physician Decision|0|||
16456065|NCT02791763|40148367|FG001|Overall Study|Physician Decision|1|||
16456066|NCT02791763|40148368|FG002|Overall Study|Physician Decision|0|||
16456067|NCT02791763|40148366|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
16456068|NCT02791763|40148367|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
16456069|NCT02791763|40148368|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
16456070|NCT02791763|40148366|FG000|Overall Study|Cancer event|1|||
16456071|NCT02791763|40148367|FG001|Overall Study|Cancer event|3|||
16456072|NCT02791763|40148368|FG002|Overall Study|Cancer event|0|||
16456073|NCT02791763|40148366|FG000|Overall Study|Participant had renal transplant|3|||
16456074|NCT02791763|40148367|FG001|Overall Study|Participant had renal transplant|0|||
16456075|NCT02791763|40148368|FG002|Overall Study|Participant had renal transplant|0|||
16456076|NCT02791763|40148366|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
16456077|NCT02791763|40148367|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
16456078|NCT02791763|40148368|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
16456079|NCT02791763|40148366|FG000|Overall Study|Adverse Event|12|||
16456080|NCT02791763|40148367|FG001|Overall Study|Adverse Event|13|||
16166655|NCT03430986|39087752|FG000|24-week Control Period|Adverse Event|1|||
16456081|NCT02791763|40148368|FG002|Overall Study|Adverse Event|7|||
16456082|NCT01657461|40148369|FG000|Overall Study|Death|9|||
16456083|NCT01657461|40148370|FG001|Overall Study|Death|12|||
16456084|NCT01657461|40148369|FG000|Overall Study|Lost to Follow-up|0|||
16456085|NCT01657461|40148370|FG001|Overall Study|Lost to Follow-up|3|||
16456086|NCT01657461|40148369|FG000|Overall Study|Physician Decision|0|||
16166656|NCT03430986|39087753|FG001|24-week Control Period|Adverse Event|0|||
16456087|NCT01657461|40148370|FG001|Overall Study|Physician Decision|2|||
16456088|NCT01657461|40148369|FG000|Overall Study|Withdrawal by Subject|1|||
16456089|NCT01657461|40148370|FG001|Overall Study|Withdrawal by Subject|3|||
16456090|NCT02433080|40148371|FG000|Overall Study|Lost to Follow-up|1|||
16456091|NCT02433080|40148372|FG001|Overall Study|Lost to Follow-up|2|||
16456092|NCT02433080|40148371|FG000|Overall Study|Withdrawal by Subject|0|||
16456093|NCT02433080|40148372|FG001|Overall Study|Withdrawal by Subject|2|||
16456094|NCT00098813|40148373|FG000|Overall Study|Death|8|||
16456095|NCT00098813|40148373|FG000|Overall Study|Protocol Violation|1|||
16456096|NCT00098813|40148373|FG000|Overall Study|Withdrawal by Subject|7|||
16456097|NCT00098813|40148373|FG000|Overall Study|Progression of Disease|1|||
16456098|NCT00098813|40148373|FG000|Overall Study|Other complicating disease|1|||
16456099|NCT00098813|40148373|FG000|Overall Study|Reversal of RAI resistance|1|||
16456100|NCT02379091|40148383|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
16456101|NCT02379091|40148384|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
16456102|NCT02379091|40148385|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
16456103|NCT02379091|40148386|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
16456104|NCT02379091|40148383|FG000|Overall Study|Principal Investigator Discretion|0|||
16456105|NCT02379091|40148384|FG001|Overall Study|Principal Investigator Discretion|1|||
16456106|NCT02379091|40148385|FG002|Overall Study|Principal Investigator Discretion|0|||
16456107|NCT02379091|40148386|FG003|Overall Study|Principal Investigator Discretion|0|||
16456108|NCT02379091|40148383|FG000|Overall Study|Lost to Follow-up|0|||
16456109|NCT02379091|40148384|FG001|Overall Study|Lost to Follow-up|0|||
16456110|NCT02379091|40148385|FG002|Overall Study|Lost to Follow-up|0|||
16456111|NCT02379091|40148386|FG003|Overall Study|Lost to Follow-up|1|||
16456112|NCT02379091|40148383|FG000|Overall Study|Voluntary Withdrawal|2|||
16456113|NCT02379091|40148384|FG001|Overall Study|Voluntary Withdrawal|5|||
16456114|NCT02379091|40148385|FG002|Overall Study|Voluntary Withdrawal|2|||
16456115|NCT02379091|40148386|FG003|Overall Study|Voluntary Withdrawal|4|||
16456116|NCT02379091|40148383|FG000|Overall Study|Study Termination|7|||
16456117|NCT02379091|40148384|FG001|Overall Study|Study Termination|2|||
16456118|NCT02379091|40148385|FG002|Overall Study|Study Termination|5|||
16456119|NCT02379091|40148386|FG003|Overall Study|Study Termination|8|||
16456120|NCT02379091|40148383|FG000|Overall Study|Lack of Efficacy|3|||
16456121|NCT02379091|40148384|FG001|Overall Study|Lack of Efficacy|0|||
16456122|NCT02379091|40148385|FG002|Overall Study|Lack of Efficacy|0|||
16456123|NCT02379091|40148386|FG003|Overall Study|Lack of Efficacy|0|||
16456124|NCT01908803|40148389|FG000|Overall Study|Adverse Event|1|||
16456125|NCT01908803|40148390|FG001|Overall Study|Adverse Event|0|||
16456126|NCT01908803|40148389|FG000|Overall Study|Physician Decision|0|||
16456127|NCT01908803|40148390|FG001|Overall Study|Physician Decision|1|||
16456128|NCT01908803|40148389|FG000|Overall Study|Withdrawal by Subject|1|||
16456129|NCT01908803|40148390|FG001|Overall Study|Withdrawal by Subject|0|||
16456130|NCT01908803|40148389|FG000|Overall Study|Randomization Error|1|||
16456131|NCT01908803|40148390|FG001|Overall Study|Randomization Error|0|||
16456132|NCT01908803|40148389|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
16456133|NCT01908803|40148390|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
16456134|NCT01209325|40152019|FG000|Overall Study|Lost to Follow-up|24|||
16456135|NCT01209325|40152019|FG000|Overall Study|Adverse Event|1|||
16456136|NCT01209325|40152019|FG000|Overall Study|Relocated|3|||
16456137|NCT01209325|40152019|FG000|Overall Study|Refusal after starting therapy|8|||
16456138|NCT01209325|40152019|FG000|Overall Study|Protocol Violation|4|||
16456139|NCT01209325|40152019|FG000|Overall Study|Refusal prior to therapy|1|||
16456140|NCT01209325|40152019|FG000|Overall Study|Incarceration|2|||
16456141|NCT02925338|40152020|FG000|Overall Study|Death|0|||
16456142|NCT02925338|40152021|FG001|Overall Study|Death|2|||
16456143|NCT02925338|40152022|FG002|Overall Study|Death|1|||
16456144|NCT02925338|40152023|FG003|Overall Study|Death|0|||
16456145|NCT02925338|40152024|FG004|Overall Study|Death|0|||
16456146|NCT02925338|40152020|FG000|Overall Study|Lost to Follow-up|30|||
16456147|NCT02925338|40152021|FG001|Overall Study|Lost to Follow-up|10|||
16456148|NCT02925338|40152022|FG002|Overall Study|Lost to Follow-up|1|||
16456149|NCT02925338|40152023|FG003|Overall Study|Lost to Follow-up|16|||
16456150|NCT02925338|40152024|FG004|Overall Study|Lost to Follow-up|3|||
16456151|NCT02925338|40152020|FG000|Overall Study|Withdrawal by Subject|3|||
16456152|NCT02925338|40152021|FG001|Overall Study|Withdrawal by Subject|0|||
16456153|NCT02925338|40152022|FG002|Overall Study|Withdrawal by Subject|3|||
16456154|NCT02925338|40152023|FG003|Overall Study|Withdrawal by Subject|2|||
16456155|NCT02925338|40152024|FG004|Overall Study|Withdrawal by Subject|2|||
16456156|NCT02925338|40152020|FG000|Overall Study|Missing|38|||
16456157|NCT02925338|40152021|FG001|Overall Study|Missing|27|||
16456158|NCT02925338|40152022|FG002|Overall Study|Missing|0|||
16456159|NCT02925338|40152023|FG003|Overall Study|Missing|3|||
16456160|NCT02925338|40152024|FG004|Overall Study|Missing|2|||
16456161|NCT02925338|40152020|FG000|Overall Study|Participant's Decision|11|||
16456162|NCT02925338|40152021|FG001|Overall Study|Participant's Decision|7|||
16456163|NCT02925338|40152022|FG002|Overall Study|Participant's Decision|3|||
16456164|NCT02925338|40152023|FG003|Overall Study|Participant's Decision|8|||
16456165|NCT02925338|40152024|FG004|Overall Study|Participant's Decision|1|||
16456166|NCT02925338|40152020|FG000|Overall Study|Treatment Discontinuation|144|||
16456167|NCT02925338|40152021|FG001|Overall Study|Treatment Discontinuation|65|||
16456168|NCT02925338|40152022|FG002|Overall Study|Treatment Discontinuation|56|||
16456169|NCT02925338|40152023|FG003|Overall Study|Treatment Discontinuation|131|||
16456170|NCT02925338|40152024|FG004|Overall Study|Treatment Discontinuation|22|||
16456171|NCT00742235|40152029|FG000|Overall Study|Lost to Follow-up|0|||
16456172|NCT00742235|40152030|FG001|Overall Study|Lost to Follow-up|31|||
16456173|NCT03288142|40152032|FG000|Overall Study|Lost to Follow-up|22|||
16456174|NCT03288142|40152033|FG001|Overall Study|Lost to Follow-up|15|||
16456175|NCT00854113|40152038|FG000|Overall Study|Adverse Event|0|||
16456176|NCT00854113|40152039|FG001|Overall Study|Adverse Event|0|||
16456177|NCT00854113|40152040|FG002|Overall Study|Adverse Event|0|||
16456178|NCT00854113|40152041|FG003|Overall Study|Adverse Event|0|||
16456179|NCT00854113|40152042|FG004|Overall Study|Adverse Event|0|||
16456180|NCT00854113|40152043|FG005|Overall Study|Adverse Event|0|||
16456181|NCT00854113|40152044|FG006|Overall Study|Adverse Event|0|||
16456182|NCT00854113|40152045|FG007|Overall Study|Adverse Event|2|||
16456183|NCT00854113|40152046|FG008|Overall Study|Adverse Event|0|||
16456184|NCT00854113|40152047|FG009|Overall Study|Adverse Event|0|||
16166657|NCT03430986|39087752|FG000|24-week Control Period|Lost to Follow-up|2|||
16166658|NCT03430986|39087753|FG001|24-week Control Period|Lost to Follow-up|2|||
16166659|NCT03430986|39087752|FG000|24-week Control Period|Withdrawal by Participant|5|||
16166660|NCT03430986|39087753|FG001|24-week Control Period|Withdrawal by Participant|0|||
16166661|NCT03430986|39087752|FG000|24-week Control Period|Protocol Deviation|0|||
16166662|NCT03430986|39087753|FG001|24-week Control Period|Protocol Deviation|2|||
16166663|NCT03430986|39087752|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
16166664|NCT03430986|39087753|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
16166665|NCT03430986|39087752|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
16166666|NCT03430986|39087753|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
16166667|NCT02614079|39087754|FG000|Overall Study|Withdrawal by Subject|1|||
16166668|NCT00568555|39087755|FG000|Overall Study|Withdrawal by Subject|1|||
16166669|NCT00568555|39087756|FG001|Overall Study|Withdrawal by Subject|1|||
16166670|NCT02771522|39087757|FG000|Overall Study|Lost to Follow-up|3|||
16166671|NCT02771522|39087757|FG000|Overall Study|Withdrawal by Subject|2|||
16166672|NCT02771522|39087757|FG000|Overall Study|No white spot lesions|3|||
16166673|NCT01808612|39087758|FG000|Treatment Period|Adverse Event|8|||
16166674|NCT01808612|39087759|FG001|Treatment Period|Adverse Event|4|||
16166675|NCT01808612|39087760|FG002|Treatment Period|Adverse Event|3|||
16166676|NCT01808612|39087758|FG000|Treatment Period|Lost to Follow-up|2|||
16166677|NCT01808612|39087759|FG001|Treatment Period|Lost to Follow-up|2|||
16166678|NCT01808612|39087760|FG002|Treatment Period|Lost to Follow-up|1|||
16166679|NCT01808612|39087758|FG000|Treatment Period|Protocol Violation|1|||
16166680|NCT01808612|39087759|FG001|Treatment Period|Protocol Violation|0|||
16166681|NCT01808612|39087760|FG002|Treatment Period|Protocol Violation|0|||
16166682|NCT01808612|39087758|FG000|Treatment Period|Withdrawal by Subject|1|||
16166683|NCT01808612|39087759|FG001|Treatment Period|Withdrawal by Subject|0|||
16166684|NCT01808612|39087760|FG002|Treatment Period|Withdrawal by Subject|4|||
16166685|NCT01808612|39087758|FG000|Treatment Period|Physician Decision|1|||
16166686|NCT01808612|39087759|FG001|Treatment Period|Physician Decision|0|||
16166687|NCT01808612|39087760|FG002|Treatment Period|Physician Decision|4|||
16166688|NCT01808612|39087758|FG000|Treatment Period|Sponsor Decision|1|||
16166689|NCT01808612|39087759|FG001|Treatment Period|Sponsor Decision|0|||
16166690|NCT01808612|39087760|FG002|Treatment Period|Sponsor Decision|0|||
16166691|NCT01808612|39087758|FG000|Treatment Period|Lack of Efficacy|1|||
16166692|NCT01808612|39087759|FG001|Treatment Period|Lack of Efficacy|1|||
16166693|NCT01808612|39087760|FG002|Treatment Period|Lack of Efficacy|2|||
16166694|NCT01808612|39087758|FG000|Discontinuation Period|Adverse Event|1|||
16166695|NCT01808612|39087759|FG001|Discontinuation Period|Adverse Event|0|||
16166696|NCT01808612|39087760|FG002|Discontinuation Period|Adverse Event|0|||
16166697|NCT01808612|39087758|FG000|Discontinuation Period|Physician Decision|1|||
16166698|NCT01808612|39087759|FG001|Discontinuation Period|Physician Decision|0|||
16166699|NCT01808612|39087760|FG002|Discontinuation Period|Physician Decision|0|||
16166700|NCT01808612|39087758|FG000|Discontinuation Period|Lost to Follow-up|0|||
16166701|NCT01808612|39087759|FG001|Discontinuation Period|Lost to Follow-up|1|||
16456185|NCT00854113|40152048|FG010|Overall Study|Adverse Event|0|||
16456186|NCT00854113|40152038|FG000|Overall Study|Withdrawal by Subject|0|||
16166702|NCT01808612|39087760|FG002|Discontinuation Period|Lost to Follow-up|0|||
16166703|NCT04082663|39087761|FG000|Overall Study|Adverse Event|6|||
16166704|NCT04082663|39087761|FG000|Overall Study|Lost to Follow-up|1|||
16166705|NCT01327651|39087762|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
16166706|NCT01327651|39087763|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
16166707|NCT01327651|39087764|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
16166708|NCT01327651|39087765|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
16166709|NCT01327651|39087766|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
16456187|NCT00854113|40152039|FG001|Overall Study|Withdrawal by Subject|0|||
16456188|NCT00854113|40152040|FG002|Overall Study|Withdrawal by Subject|0|||
16456189|NCT00854113|40152041|FG003|Overall Study|Withdrawal by Subject|0|||
16166710|NCT01327651|39087767|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
16166711|NCT01327651|39087768|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
16166712|NCT01327651|39087769|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
16166713|NCT01327651|39087770|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
16166714|NCT01327651|39087762|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
16166715|NCT01327651|39087763|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16166716|NCT01327651|39087764|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16166717|NCT01327651|39087765|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16166718|NCT01327651|39087766|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16166719|NCT01327651|39087767|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16166720|NCT01327651|39087768|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16166721|NCT01327651|39087769|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16166722|NCT01327651|39087770|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
16166723|NCT01327651|39087762|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
16166724|NCT01327651|39087763|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
16166725|NCT01327651|39087764|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
16166726|NCT01327651|39087765|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
16166727|NCT01327651|39087766|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
16166728|NCT01327651|39087767|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
16166729|NCT01327651|39087768|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
16166730|NCT01327651|39087769|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
16166731|NCT01327651|39087770|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
16166732|NCT01327651|39087762|FG000|Post Study Follow-up|Lost to Follow-up|0|||
16166733|NCT01327651|39087763|FG001|Post Study Follow-up|Lost to Follow-up|1|||
16166734|NCT01327651|39087764|FG002|Post Study Follow-up|Lost to Follow-up|1|||
16166735|NCT01327651|39087765|FG003|Post Study Follow-up|Lost to Follow-up|0|||
16166736|NCT01327651|39087766|FG004|Post Study Follow-up|Lost to Follow-up|0|||
16166737|NCT01327651|39087767|FG005|Post Study Follow-up|Lost to Follow-up|0|||
16166738|NCT01327651|39087768|FG006|Post Study Follow-up|Lost to Follow-up|4|||
16166739|NCT01327651|39087769|FG007|Post Study Follow-up|Lost to Follow-up|1|||
16166740|NCT01327651|39087770|FG008|Post Study Follow-up|Lost to Follow-up|2|||
16166741|NCT05425563|39087773|FG000|Overall Study|Withdrawal by Subject|17|||
16166742|NCT01709331|39087776|FG000|Overall Study|Adverse Event|1|||
16166743|NCT01109940|39087777|FG000|Overall Study|Administrative problems|2|||
16166744|NCT01109940|39087778|FG001|Overall Study|Administrative problems|0|||
16166745|NCT01109940|39087779|FG002|Overall Study|Administrative problems|0|||
16166746|NCT01109940|39087780|FG003|Overall Study|Administrative problems|0|||
16166747|NCT01109940|39087777|FG000|Overall Study|Serious Adverse Event|2|||
16166748|NCT01109940|39087778|FG001|Overall Study|Serious Adverse Event|1|||
16166749|NCT01109940|39087779|FG002|Overall Study|Serious Adverse Event|0|||
16456190|NCT00854113|40152042|FG004|Overall Study|Withdrawal by Subject|0|||
16456191|NCT00854113|40152043|FG005|Overall Study|Withdrawal by Subject|0|||
16456192|NCT00854113|40152044|FG006|Overall Study|Withdrawal by Subject|0|||
16456193|NCT00854113|40152045|FG007|Overall Study|Withdrawal by Subject|1|||
16456194|NCT00854113|40152046|FG008|Overall Study|Withdrawal by Subject|1|||
16456195|NCT00854113|40152047|FG009|Overall Study|Withdrawal by Subject|0|||
16456196|NCT00854113|40152048|FG010|Overall Study|Withdrawal by Subject|0|||
16456197|NCT00531427|40152049|FG000|Overall Study|Withdrawal by Subject|7|||
16456198|NCT00531427|40152050|FG001|Overall Study|Withdrawal by Subject|13|||
16456199|NCT00531427|40152049|FG000|Overall Study|Adverse Event|44|||
16456200|NCT00531427|40152050|FG001|Overall Study|Adverse Event|30|||
16456201|NCT00531427|40152049|FG000|Overall Study|Lost to Follow-up|4|||
16456202|NCT00531427|40152050|FG001|Overall Study|Lost to Follow-up|3|||
16456203|NCT00531427|40152049|FG000|Overall Study|Lack of Efficacy|14|||
16456204|NCT00531427|40152050|FG001|Overall Study|Lack of Efficacy|39|||
16166750|NCT01109940|39087780|FG003|Overall Study|Serious Adverse Event|0|||
16166751|NCT01109940|39087777|FG000|Overall Study|Lost to Follow-up|1|||
16166752|NCT01109940|39087778|FG001|Overall Study|Lost to Follow-up|0|||
16166753|NCT01109940|39087779|FG002|Overall Study|Lost to Follow-up|0|||
16166754|NCT01109940|39087780|FG003|Overall Study|Lost to Follow-up|0|||
16166755|NCT01109940|39087777|FG000|Overall Study|Patient withdrew consent|1|||
16166756|NCT01109940|39087778|FG001|Overall Study|Patient withdrew consent|1|||
16166757|NCT01109940|39087779|FG002|Overall Study|Patient withdrew consent|0|||
16456205|NCT00531427|40152049|FG000|Overall Study|Administrative|4|||
16456206|NCT00531427|40152050|FG001|Overall Study|Administrative|9|||
16166758|NCT01109940|39087780|FG003|Overall Study|Patient withdrew consent|0|||
16166759|NCT01109940|39087777|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16166760|NCT01109940|39087778|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16269153|NCT01075282|39471029|FG002|Overall Study|Entry Criteria Not Met|0|||
16456207|NCT02106390|40152053|FG000|Overall Study|Withdrawal by Subject|15|||
16456208|NCT02106390|40152054|FG001|Overall Study|Withdrawal by Subject|16|||
16456209|NCT02106390|40152055|FG002|Overall Study|Withdrawal by Subject|15|||
16166761|NCT01109940|39087779|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
16166762|NCT01109940|39087780|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
16166763|NCT00168831|39087781|FG000|Overall Study|Adverse Event|36|||
16166764|NCT00168831|39087782|FG001|Overall Study|Adverse Event|47|||
16166765|NCT00168831|39087783|FG002|Overall Study|Adverse Event|74|||
16166766|NCT00168831|39087781|FG000|Overall Study|Lost to Follow-up|5|||
16166767|NCT00168831|39087782|FG001|Overall Study|Lost to Follow-up|6|||
16166768|NCT00168831|39087783|FG002|Overall Study|Lost to Follow-up|4|||
16166769|NCT00168831|39087781|FG000|Overall Study|Withdrawal by Subject|7|||
16166770|NCT00168831|39087782|FG001|Overall Study|Withdrawal by Subject|14|||
16166771|NCT00168831|39087783|FG002|Overall Study|Withdrawal by Subject|19|||
16166772|NCT00168831|39087781|FG000|Overall Study|Protocol Violation|6|||
16166773|NCT00168831|39087782|FG001|Overall Study|Protocol Violation|11|||
16166774|NCT00168831|39087783|FG002|Overall Study|Protocol Violation|11|||
16166775|NCT00168831|39087781|FG000|Overall Study|Other|6|||
16166776|NCT00168831|39087782|FG001|Overall Study|Other|3|||
16166777|NCT00168831|39087783|FG002|Overall Study|Other|6|||
16166778|NCT02542267|39087784|FG000|Overall Study|Withdrawal by Subject|10|||
16166779|NCT02542267|39087784|FG000|Overall Study|Physician Decision|6|||
16166780|NCT02542267|39087784|FG000|Overall Study|Lost to Follow-up|4|||
16166781|NCT02542267|39087784|FG000|Overall Study|Death|13|||
16166782|NCT02542267|39087784|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
16166783|NCT02542267|39087784|FG000|Overall Study|Other|9|||
16166784|NCT02944448|39087785|FG000|Overall Study|Adverse Event|37|||
16166785|NCT02944448|39087786|FG001|Overall Study|Adverse Event|6|||
16166786|NCT02944448|39087785|FG000|Overall Study|Lack of Efficacy|8|||
16166787|NCT02944448|39087786|FG001|Overall Study|Lack of Efficacy|5|||
16166788|NCT02944448|39087785|FG000|Overall Study|Lost to Follow-up|3|||
16166789|NCT02944448|39087786|FG001|Overall Study|Lost to Follow-up|1|||
16166790|NCT02944448|39087785|FG000|Overall Study|Protocol Violation|25|||
16166791|NCT02944448|39087786|FG001|Overall Study|Protocol Violation|7|||
16166792|NCT02944448|39087785|FG000|Overall Study|Withdrawal by Subject|14|||
16166793|NCT02944448|39087786|FG001|Overall Study|Withdrawal by Subject|4|||
16456210|NCT02106390|40152053|FG000|Overall Study|Lost to Follow-up|25|||
16456211|NCT02106390|40152054|FG001|Overall Study|Lost to Follow-up|20|||
16456212|NCT02106390|40152055|FG002|Overall Study|Lost to Follow-up|13|||
16456213|NCT02106390|40152053|FG000|Overall Study|Other: Administrative Reason|8|||
16456214|NCT02106390|40152054|FG001|Overall Study|Other: Administrative Reason|5|||
16456215|NCT02106390|40152055|FG002|Overall Study|Other: Administrative Reason|12|||
16456216|NCT02106390|40152053|FG000|Overall Study|Other: Unspecified|1|||
16456217|NCT02106390|40152054|FG001|Overall Study|Other: Unspecified|4|||
16456218|NCT02106390|40152055|FG002|Overall Study|Other: Unspecified|2|||
16456219|NCT02106390|40152053|FG000|Overall Study|Adverse Event|0|||
16456220|NCT02106390|40152054|FG001|Overall Study|Adverse Event|2|||
16456221|NCT02106390|40152055|FG002|Overall Study|Adverse Event|1|||
16456222|NCT02106390|40152053|FG000|Overall Study|Protocol Violation|0|||
16456223|NCT02106390|40152054|FG001|Overall Study|Protocol Violation|1|||
16456224|NCT02106390|40152055|FG002|Overall Study|Protocol Violation|0|||
16456225|NCT01918306|40152056|FG000|Overall Study|progresive disease|4|||
16456226|NCT01918306|40152057|FG001|Overall Study|progresive disease|0|||
16456227|NCT01918306|40152058|FG002|Overall Study|progresive disease|1|||
16456228|NCT01918306|40152059|FG003|Overall Study|progresive disease|1|||
16456229|NCT01918306|40152056|FG000|Overall Study|Withdrawal by Subject|0|||
16456230|NCT01918306|40152057|FG001|Overall Study|Withdrawal by Subject|0|||
16456231|NCT01918306|40152058|FG002|Overall Study|Withdrawal by Subject|0|||
16456232|NCT01918306|40152059|FG003|Overall Study|Withdrawal by Subject|2|||
16456233|NCT01918306|40152056|FG000|Overall Study|neutropenia|1|||
16456234|NCT01918306|40152057|FG001|Overall Study|neutropenia|0|||
16456235|NCT01918306|40152058|FG002|Overall Study|neutropenia|0|||
16456236|NCT01918306|40152059|FG003|Overall Study|neutropenia|0|||
16456237|NCT01918306|40152056|FG000|Overall Study|Lack of Efficacy|1|||
16456238|NCT01918306|40152057|FG001|Overall Study|Lack of Efficacy|0|||
16456239|NCT01918306|40152058|FG002|Overall Study|Lack of Efficacy|0|||
16456240|NCT01918306|40152059|FG003|Overall Study|Lack of Efficacy|0|||
16456241|NCT01918306|40152056|FG000|Overall Study|progress disease, crossover|0|||
16456242|NCT01918306|40152057|FG001|Overall Study|progress disease, crossover|0|||
16456243|NCT01918306|40152058|FG002|Overall Study|progress disease, crossover|1|||
16456244|NCT01918306|40152059|FG003|Overall Study|progress disease, crossover|0|||
16456245|NCT00330967|40152064|FG000|Overall Study|Withdrawal by Subject|0|||
16456246|NCT00330967|40152065|FG001|Overall Study|Withdrawal by Subject|5|||
16166794|NCT02944448|39087785|FG000|Overall Study|Sponsor did not supply drug in time|0|||
16166795|NCT02944448|39087786|FG001|Overall Study|Sponsor did not supply drug in time|1|||
16166796|NCT02944448|39087785|FG000|Overall Study|Noncompliant with dosing|1|||
16166797|NCT02944448|39087786|FG001|Overall Study|Noncompliant with dosing|0|||
16166798|NCT02944448|39087785|FG000|Overall Study|Abnormal laboratory values|1|||
16166799|NCT02944448|39087786|FG001|Overall Study|Abnormal laboratory values|0|||
16456247|NCT00330967|40152064|FG000|Overall Study|Physician Decision|0|||
16456248|NCT00330967|40152065|FG001|Overall Study|Physician Decision|9|||
16456249|NCT01467960|40152066|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
16166800|NCT03056573|39091300|FG000|Overall Study|Death|2|||
16166801|NCT03056573|39091301|FG001|Overall Study|Death|4|||
16166802|NCT03056573|39091300|FG000|Overall Study|Withdrawal by Subject|2|||
16166803|NCT03056573|39091301|FG001|Overall Study|Withdrawal by Subject|0|||
16166804|NCT03056573|39091300|FG000|Overall Study|Lost to Follow-up|1|||
16166805|NCT03056573|39091301|FG001|Overall Study|Lost to Follow-up|1|||
16166806|NCT02623335|39091304|FG000|Overall Study|Death|8|||
16166807|NCT02623335|39091305|FG001|Overall Study|Death|7|||
16166808|NCT02623335|39091304|FG000|Overall Study|Lost to Follow-up|15|||
16456250|NCT01467960|40152067|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
16456251|NCT01467960|40152068|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
16456252|NCT01467960|40152069|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
16166809|NCT02623335|39091305|FG001|Overall Study|Lost to Follow-up|23|||
16166810|NCT02623335|39091304|FG000|Overall Study|Withdrawal by Subject|2|||
16166811|NCT02623335|39091305|FG001|Overall Study|Withdrawal by Subject|5|||
16166812|NCT02623335|39091304|FG000|Overall Study|Protocol Violation|2|||
16166813|NCT02623335|39091305|FG001|Overall Study|Protocol Violation|1|||
16166814|NCT01651780|39091310|FG000|Overall Study|Physician decision: No 30-day visit|2|||
16456253|NCT01467960|40152070|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
16456254|NCT01467960|40152071|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
16456255|NCT02164461|40152072|FG000|Overall Study|Adverse Event|0|||
16456256|NCT02164461|40152073|FG001|Overall Study|Adverse Event|0|||
16456257|NCT02164461|40152074|FG002|Overall Study|Adverse Event|1|||
16456258|NCT02164461|40152072|FG000|Overall Study|Disease Progression|1|||
16456259|NCT02164461|40152073|FG001|Overall Study|Disease Progression|3|||
16456260|NCT02164461|40152074|FG002|Overall Study|Disease Progression|4|||
16456261|NCT02164461|40152072|FG000|Overall Study|Withdrawal by Subject|0|||
16456262|NCT02164461|40152073|FG001|Overall Study|Withdrawal by Subject|3|||
16456263|NCT02164461|40152074|FG002|Overall Study|Withdrawal by Subject|0|||
16456264|NCT00439738|40152077|FG000|Overall Study|Withdrawal by Subject|16|||
16456265|NCT00439738|40152078|FG001|Overall Study|Withdrawal by Subject|13|||
16456266|NCT00439738|40152077|FG000|Overall Study|Adverse Event|6|||
16456267|NCT00439738|40152078|FG001|Overall Study|Adverse Event|4|||
16456268|NCT00439738|40152077|FG000|Overall Study|Lost to Follow-up|5|||
16456269|NCT00439738|40152078|FG001|Overall Study|Lost to Follow-up|6|||
16456270|NCT00439738|40152077|FG000|Overall Study|Protocol Violation|6|||
16456271|NCT00439738|40152078|FG001|Overall Study|Protocol Violation|3|||
16456272|NCT00439738|40152077|FG000|Overall Study|Lack of Efficacy|2|||
16456273|NCT00439738|40152078|FG001|Overall Study|Lack of Efficacy|2|||
16456274|NCT00439738|40152077|FG000|Overall Study|Abnormal Lab Values|1|||
16456275|NCT00439738|40152078|FG001|Overall Study|Abnormal Lab Values|0|||
16456276|NCT01018810|40152079|FG000|Overall Study|Withdrawal by Subject|0|||
16456277|NCT01018810|40152080|FG001|Overall Study|Withdrawal by Subject|1|||
16456278|NCT01018810|40152081|FG002|Overall Study|Withdrawal by Subject|0|||
16456279|NCT01018810|40152082|FG003|Overall Study|Withdrawal by Subject|0|||
16456280|NCT01018810|40152083|FG004|Overall Study|Withdrawal by Subject|0|||
16456281|NCT01018810|40152079|FG000|Overall Study|Sponsor Decision|2|||
16456282|NCT01018810|40152080|FG001|Overall Study|Sponsor Decision|0|||
16456283|NCT01018810|40152081|FG002|Overall Study|Sponsor Decision|1|||
16456284|NCT01018810|40152082|FG003|Overall Study|Sponsor Decision|1|||
16456285|NCT01018810|40152083|FG004|Overall Study|Sponsor Decision|1|||
16456286|NCT01237899|40152084|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
16456287|NCT01237899|40152085|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
16456288|NCT01237899|40152086|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
16456289|NCT01237899|40152087|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
16456290|NCT01237899|40152088|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
16456291|NCT01237899|40152089|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
16456292|NCT01237899|40152090|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
16456293|NCT01237899|40152091|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
16456294|NCT01237899|40152092|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
16456295|NCT01237899|40152093|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
16456296|NCT01237899|40152094|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
16456297|NCT01485172|40152096|FG000|Overall Study|Adverse Event|2|||
16456298|NCT01485172|40152097|FG001|Overall Study|Adverse Event|1|||
16456299|NCT01485172|40152098|FG002|Overall Study|Adverse Event|2|||
16456300|NCT01485172|40152099|FG003|Overall Study|Adverse Event|2|||
16456301|NCT01485172|40152100|FG004|Overall Study|Adverse Event|1|||
16456302|NCT01485172|40152101|FG005|Overall Study|Adverse Event|2|||
16456303|NCT01485172|40152096|FG000|Overall Study|Lack of Efficacy|2|||
16166815|NCT01651780|39091311|FG001|Overall Study|Physician decision: No 30-day visit|1|||
16166816|NCT01651780|39091310|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
16166817|NCT01651780|39091311|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
16166818|NCT01651780|39091310|FG000|Overall Study|Withdrawal by Subject|2|||
16456304|NCT01485172|40152097|FG001|Overall Study|Lack of Efficacy|0|||
16456305|NCT01485172|40152098|FG002|Overall Study|Lack of Efficacy|0|||
16456306|NCT01485172|40152099|FG003|Overall Study|Lack of Efficacy|0|||
16456307|NCT01485172|40152100|FG004|Overall Study|Lack of Efficacy|0|||
16456308|NCT01485172|40152101|FG005|Overall Study|Lack of Efficacy|0|||
16456309|NCT01485172|40152096|FG000|Overall Study|Protocol Violation|0|||
16456310|NCT01485172|40152097|FG001|Overall Study|Protocol Violation|0|||
16456311|NCT01485172|40152098|FG002|Overall Study|Protocol Violation|4|||
16456312|NCT01485172|40152099|FG003|Overall Study|Protocol Violation|5|||
16456313|NCT01485172|40152100|FG004|Overall Study|Protocol Violation|1|||
16456314|NCT01485172|40152101|FG005|Overall Study|Protocol Violation|0|||
16456315|NCT01485172|40152096|FG000|Overall Study|Protocol defined stopping criteria|1|||
16456316|NCT01485172|40152097|FG001|Overall Study|Protocol defined stopping criteria|0|||
16166819|NCT01651780|39091311|FG001|Overall Study|Withdrawal by Subject|0|||
16166820|NCT01651780|39091310|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
16166821|NCT01651780|39091311|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16166822|NCT01651780|39091310|FG000|Overall Study|Lost to Follow-up|1|||
16166823|NCT01651780|39091311|FG001|Overall Study|Lost to Follow-up|2|||
16166824|NCT01651780|39091310|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
16166825|NCT01651780|39091311|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
16166826|NCT02425098|39091312|FG000|Overall Study|Lost to Follow-up|7|||
16166827|NCT02425098|39091313|FG001|Overall Study|Lost to Follow-up|7|||
16166828|NCT02425098|39091312|FG000|Overall Study|Withdrawal by Subject|4|||
16166829|NCT02425098|39091313|FG001|Overall Study|Withdrawal by Subject|8|||
16166830|NCT02425098|39091312|FG000|Overall Study|Pregnancy|2|||
16166831|NCT02425098|39091313|FG001|Overall Study|Pregnancy|0|||
16166832|NCT02425098|39091312|FG000|Overall Study|Reason not Specified|0|||
16166833|NCT02425098|39091313|FG001|Overall Study|Reason not Specified|1|||
16166834|NCT03118947|39091316|FG000|Overall Study|Adverse Event|7|||
16166835|NCT03118947|39091316|FG000|Overall Study|Death|3|||
16166836|NCT03118947|39091316|FG000|Overall Study|Lack of Efficacy|4|||
16166837|NCT03118947|39091316|FG000|Overall Study|Non-compliance with study drug|1|||
16166838|NCT03118947|39091316|FG000|Overall Study|Protocol Violation|2|||
16166839|NCT03118947|39091316|FG000|Overall Study|Withdrawal by Subject|3|||
16166840|NCT03118947|39091316|FG000|Overall Study|Withdrawal by caregiver|3|||
16166841|NCT03118947|39091316|FG000|Overall Study|Change in patient's living situation|4|||
16166842|NCT03118947|39091316|FG000|Overall Study|Lost to Follow-up|2|||
16166843|NCT04178772|39091319|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
16166844|NCT04178772|39091319|FG000|Overall Study|study terminated early due to COVID-19|7|||
16166845|NCT01299766|39091320|FG000|Overall Study|Death|5|||
16166846|NCT01299766|39091321|FG001|Overall Study|Death|4|||
16166847|NCT01299766|39091320|FG000|Overall Study|Withdrawal by Subject|29|||
16166848|NCT01299766|39091321|FG001|Overall Study|Withdrawal by Subject|19|||
16166849|NCT02911688|39091322|FG000|Washout|Lost to Follow-up|1|||
16166850|NCT02911688|39091323|FG001|Washout|Lost to Follow-up|1|||
16166851|NCT02911688|39091322|FG000|Washout|Withdrawal by Subject|0|||
16166852|NCT02911688|39091323|FG001|Washout|Withdrawal by Subject|1|||
16166853|NCT03624946|39091324|FG000|Overall Study|Lost to Follow-up|0|||
16166854|NCT03624946|39091325|FG001|Overall Study|Lost to Follow-up|1|||
16166855|NCT01307033|39091327|FG000|8-week Double-blind Period|Adverse Event|2|||
16166856|NCT01307033|39091328|FG001|8-week Double-blind Period|Adverse Event|0|||
16166857|NCT01307033|39091329|FG002|8-week Double-blind Period|Adverse Event|0|||
16166858|NCT01307033|39091330|FG003|8-week Double-blind Period|Adverse Event|0|||
16166859|NCT01307033|39091327|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
16166860|NCT01307033|39091328|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
16166861|NCT01307033|39091329|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
16166862|NCT01307033|39091330|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
16166863|NCT01307033|39091327|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
16166864|NCT01307033|39091328|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
16166865|NCT01307033|39091329|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
16166866|NCT01307033|39091330|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
16166867|NCT01307033|39091327|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
16166868|NCT01307033|39091328|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
16166869|NCT01307033|39091329|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
16166870|NCT01307033|39091330|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
16166871|NCT01307033|39091327|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
16166872|NCT01307033|39091328|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
16456317|NCT01485172|40152098|FG002|Overall Study|Protocol defined stopping criteria|0|||
16456318|NCT01485172|40152099|FG003|Overall Study|Protocol defined stopping criteria|0|||
16166873|NCT01307033|39091329|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
16456319|NCT01485172|40152100|FG004|Overall Study|Protocol defined stopping criteria|1|||
16166874|NCT01307033|39091330|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
16269154|NCT01075282|39471027|FG000|Overall Study|Lost to Follow-up|3|||
16166875|NCT01307033|39091327|FG000|44-week Open-label Extension|Adverse Event|0|||
16166876|NCT01307033|39091328|FG001|44-week Open-label Extension|Adverse Event|0|||
16166877|NCT01307033|39091329|FG002|44-week Open-label Extension|Adverse Event|2|||
16269155|NCT01075282|39471028|FG001|Overall Study|Lost to Follow-up|3|||
16269156|NCT01075282|39471029|FG002|Overall Study|Lost to Follow-up|3|||
16166878|NCT01307033|39091330|FG003|44-week Open-label Extension|Adverse Event|1|||
16166879|NCT01307033|39091327|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
16166880|NCT01307033|39091328|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
16166881|NCT01307033|39091329|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
16166882|NCT01307033|39091330|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
16166883|NCT01307033|39091327|FG000|44-week Open-label Extension|Physician Decision|0|||
16166884|NCT01307033|39091328|FG001|44-week Open-label Extension|Physician Decision|0|||
16166885|NCT01307033|39091329|FG002|44-week Open-label Extension|Physician Decision|1|||
16166886|NCT01307033|39091330|FG003|44-week Open-label Extension|Physician Decision|0|||
16166887|NCT01307033|39091327|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
16166888|NCT01307033|39091328|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
16166889|NCT01307033|39091329|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
16166890|NCT01307033|39091330|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
16166891|NCT01307033|39091327|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
16166892|NCT01307033|39091328|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
16166893|NCT01307033|39091329|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
16166894|NCT01307033|39091330|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
16166895|NCT01307033|39091327|FG000|44-week Open-label Extension|Death|0|||
16166896|NCT01307033|39091328|FG001|44-week Open-label Extension|Death|0|||
16166897|NCT01307033|39091329|FG002|44-week Open-label Extension|Death|0|||
16166898|NCT01307033|39091330|FG003|44-week Open-label Extension|Death|1|||
16166899|NCT01461044|39091331|FG000|Overall Study|Death|58|||
16166900|NCT01461044|39091332|FG001|Overall Study|Death|35|||
16166901|NCT01461044|39091331|FG000|Overall Study|Lost to Follow-up|12|||
16166902|NCT01461044|39091332|FG001|Overall Study|Lost to Follow-up|5|||
16166903|NCT02949128|39091333|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
16166904|NCT02949128|39091333|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
16166905|NCT02949128|39091333|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
16166906|NCT02949128|39091333|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
16166907|NCT02949128|39091333|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
16166908|NCT02949128|39091333|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
16166909|NCT02949128|39091333|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
16166910|NCT02949128|39091333|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
16456320|NCT01485172|40152101|FG005|Overall Study|Protocol defined stopping criteria|0|||
16456321|NCT01485172|40152096|FG000|Overall Study|Lost to Follow-up|0|||
16456322|NCT01485172|40152097|FG001|Overall Study|Lost to Follow-up|0|||
16456323|NCT01485172|40152098|FG002|Overall Study|Lost to Follow-up|1|||
16456324|NCT01485172|40152099|FG003|Overall Study|Lost to Follow-up|0|||
16456325|NCT01485172|40152100|FG004|Overall Study|Lost to Follow-up|0|||
16456326|NCT01485172|40152101|FG005|Overall Study|Lost to Follow-up|1|||
16456327|NCT01485172|40152096|FG000|Overall Study|Physician Decision|0|||
16456328|NCT01485172|40152097|FG001|Overall Study|Physician Decision|0|||
16456329|NCT01485172|40152098|FG002|Overall Study|Physician Decision|0|||
16456330|NCT01485172|40152099|FG003|Overall Study|Physician Decision|0|||
16456331|NCT01485172|40152100|FG004|Overall Study|Physician Decision|1|||
16456332|NCT01485172|40152101|FG005|Overall Study|Physician Decision|0|||
16456333|NCT01485172|40152096|FG000|Overall Study|Withdrawal by Subject|2|||
16456334|NCT01485172|40152097|FG001|Overall Study|Withdrawal by Subject|0|||
16456335|NCT01485172|40152098|FG002|Overall Study|Withdrawal by Subject|0|||
16456336|NCT01485172|40152099|FG003|Overall Study|Withdrawal by Subject|1|||
16456337|NCT01485172|40152100|FG004|Overall Study|Withdrawal by Subject|1|||
16456338|NCT01485172|40152101|FG005|Overall Study|Withdrawal by Subject|1|||
16456339|NCT00776919|40152102|FG000|Overall Study|Withdrawal by Subject|16|||
16456340|NCT00776919|40152103|FG001|Overall Study|Withdrawal by Subject|14|||
16456341|NCT00776919|40152104|FG002|Overall Study|Withdrawal by Subject|15|||
16456342|NCT00776919|40152105|FG003|Overall Study|Withdrawal by Subject|26|||
16456343|NCT00776919|40152102|FG000|Overall Study|Lost to Follow-up|8|||
16456344|NCT00776919|40152103|FG001|Overall Study|Lost to Follow-up|12|||
16456345|NCT00776919|40152104|FG002|Overall Study|Lost to Follow-up|11|||
16456346|NCT00776919|40152105|FG003|Overall Study|Lost to Follow-up|8|||
16456347|NCT00776919|40152102|FG000|Overall Study|Adverse Event|1|||
16456348|NCT00776919|40152103|FG001|Overall Study|Adverse Event|0|||
16456349|NCT00776919|40152104|FG002|Overall Study|Adverse Event|2|||
16456350|NCT00776919|40152105|FG003|Overall Study|Adverse Event|2|||
16456351|NCT00776919|40152102|FG000|Overall Study|Protocol Violation|1|||
16456352|NCT00776919|40152103|FG001|Overall Study|Protocol Violation|2|||
16456353|NCT00776919|40152104|FG002|Overall Study|Protocol Violation|0|||
16456354|NCT00776919|40152105|FG003|Overall Study|Protocol Violation|1|||
16456355|NCT00776919|40152102|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
16456356|NCT00776919|40152103|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
16456357|NCT00776919|40152104|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
16456358|NCT00776919|40152105|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
16456359|NCT00862641|40152108|FG000|Overall Study|Randomized, but drug not received|1|||
16456360|NCT00862641|40152109|FG001|Overall Study|Randomized, but drug not received|4|||
16456361|NCT00862641|40152110|FG002|Overall Study|Randomized, but drug not received|1|||
16456362|NCT00862641|40152111|FG003|Overall Study|Randomized, but drug not received|4|||
16456363|NCT00835211|40152112|FG000|First Intervention|Withdrawal by Subject|0|||
16456364|NCT00835211|40152113|FG001|First Intervention|Withdrawal by Subject|1|||
16456365|NCT00835211|40152112|FG000|Washout: 7 Days|Adverse Event|2|||
16456366|NCT00835211|40152113|FG001|Washout: 7 Days|Adverse Event|1|||
16456367|NCT00835211|40152112|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
16456368|NCT00835211|40152113|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
16456369|NCT04050202|40152114|FG000|Overall Study|Lost to Follow-up|2|||
16456370|NCT03304249|40152115|FG000|Overall Study|Lost to Follow-up|8|||
16456371|NCT03304249|40152116|FG001|Overall Study|Lost to Follow-up|10|||
16456372|NCT03304249|40152115|FG000|Overall Study|Withdrawal by Subject|12|||
16456373|NCT03304249|40152116|FG001|Overall Study|Withdrawal by Subject|2|||
16456374|NCT03304249|40152115|FG000|Overall Study|Moved Out of District|4|||
16456375|NCT03304249|40152116|FG001|Overall Study|Moved Out of District|2|||
16456376|NCT00859456|40152117|FG000|Overall Study|Adverse Event|3|||
16456377|NCT00859456|40152117|FG000|Overall Study|Progressive disease|2|||
16456378|NCT00859456|40152117|FG000|Overall Study|Non-compliance|3|||
16456379|NCT03181529|40152119|FG000|Overall Study|Withdrawal by Subject|1|||
16456380|NCT03181529|40152120|FG001|Overall Study|Withdrawal by Subject|1|||
16456381|NCT03181529|40152119|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
16456382|NCT03181529|40152120|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
16456383|NCT01874340|40152121|FG000|Overall Study|Study terminated by Sponsor|6|||
16456384|NCT01874340|40152122|FG001|Overall Study|Study terminated by Sponsor|8|||
16456385|NCT01874340|40152123|FG002|Overall Study|Study terminated by Sponsor|8|||
16456386|NCT01874340|40152124|FG003|Overall Study|Study terminated by Sponsor|4|||
16456387|NCT01874340|40152121|FG000|Overall Study|Withdrawal by Subject|0|||
16456388|NCT01874340|40152122|FG001|Overall Study|Withdrawal by Subject|0|||
16456389|NCT01874340|40152123|FG002|Overall Study|Withdrawal by Subject|0|||
16456390|NCT01874340|40152124|FG003|Overall Study|Withdrawal by Subject|1|||
16456391|NCT02118961|40152125|FG000|Overall Study|Withdrawal by Subject|1|||
16456392|NCT02118961|40152126|FG001|Overall Study|Withdrawal by Subject|0|||
16456393|NCT01124864|40152127|FG000|Overall Study|Follow up phase competed as per protocol|18|||
16456394|NCT01124864|40152128|FG001|Overall Study|Follow up phase competed as per protocol|22|||
16456395|NCT01124864|40152129|FG002|Overall Study|Follow up phase competed as per protocol|24|||
16456396|NCT01124864|40152130|FG003|Overall Study|Follow up phase competed as per protocol|18|||
16456397|NCT01124864|40152131|FG004|Overall Study|Follow up phase competed as per protocol|26|||
16456398|NCT01124864|40152132|FG005|Overall Study|Follow up phase competed as per protocol|2|||
16456399|NCT01124864|40152127|FG000|Overall Study|Death|6|||
16456400|NCT01124864|40152128|FG001|Overall Study|Death|9|||
16456401|NCT01124864|40152129|FG002|Overall Study|Death|6|||
16456402|NCT01124864|40152130|FG003|Overall Study|Death|2|||
16456403|NCT01124864|40152131|FG004|Overall Study|Death|1|||
16456404|NCT01124864|40152132|FG005|Overall Study|Death|0|||
16456405|NCT01124864|40152127|FG000|Overall Study|Withdrawal by Subject|2|||
16456406|NCT01124864|40152128|FG001|Overall Study|Withdrawal by Subject|3|||
16456407|NCT01124864|40152129|FG002|Overall Study|Withdrawal by Subject|4|||
16456408|NCT01124864|40152130|FG003|Overall Study|Withdrawal by Subject|0|||
16456409|NCT01124864|40152131|FG004|Overall Study|Withdrawal by Subject|2|||
16456410|NCT01124864|40152132|FG005|Overall Study|Withdrawal by Subject|1|||
16456411|NCT01124864|40152127|FG000|Overall Study|Lost to Follow-up|1|||
16456412|NCT01124864|40152128|FG001|Overall Study|Lost to Follow-up|1|||
16456413|NCT01124864|40152129|FG002|Overall Study|Lost to Follow-up|0|||
16456414|NCT01124864|40152130|FG003|Overall Study|Lost to Follow-up|1|||
16456415|NCT01124864|40152131|FG004|Overall Study|Lost to Follow-up|0|||
16456416|NCT01124864|40152132|FG005|Overall Study|Lost to Follow-up|0|||
16456417|NCT01124864|40152127|FG000|Overall Study|Protocol Violation|1|||
16456418|NCT01124864|40152128|FG001|Overall Study|Protocol Violation|0|||
16456419|NCT01124864|40152129|FG002|Overall Study|Protocol Violation|0|||
16456420|NCT01124864|40152130|FG003|Overall Study|Protocol Violation|0|||
16456421|NCT01124864|40152131|FG004|Overall Study|Protocol Violation|1|||
16456422|NCT01124864|40152132|FG005|Overall Study|Protocol Violation|0|||
16456423|NCT02446899|40152135|FG000|Overall Study|Adverse Event|4|||
16456424|NCT02446899|40152136|FG001|Overall Study|Adverse Event|7|||
16456425|NCT02446899|40152135|FG000|Overall Study|Condition Under Investigation Worsened|1|||
16456426|NCT02446899|40152136|FG001|Overall Study|Condition Under Investigation Worsened|4|||
16456427|NCT02446899|40152135|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
16456428|NCT02446899|40152136|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
16456429|NCT02446899|40152135|FG000|Overall Study|Lack of Efficacy|2|||
16456430|NCT02446899|40152136|FG001|Overall Study|Lack of Efficacy|8|||
16456431|NCT02446899|40152135|FG000|Overall Study|Lost to Follow-up|1|||
16456432|NCT02446899|40152136|FG001|Overall Study|Lost to Follow-up|3|||
16166911|NCT02949128|39091333|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
16456433|NCT02446899|40152135|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
16456434|NCT02446899|40152136|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
16456435|NCT02446899|40152135|FG000|Overall Study|Withdrawal by Subject|11|||
16456436|NCT02446899|40152136|FG001|Overall Study|Withdrawal by Subject|19|||
16456437|NCT02446899|40152135|FG000|Overall Study|Miscellaneous|5|||
16456438|NCT02446899|40152136|FG001|Overall Study|Miscellaneous|4|||
16456439|NCT02446899|40152135|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
16456440|NCT02446899|40152136|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
16456441|NCT04145219|40152137|FG000|Overall Study|Adverse Event|18|||
16456442|NCT04145219|40152138|FG001|Overall Study|Adverse Event|6|||
16456443|NCT04145219|40152137|FG000|Overall Study|Lost to Follow-up|2|||
16456444|NCT04145219|40152138|FG001|Overall Study|Lost to Follow-up|3|||
16456445|NCT04145219|40152137|FG000|Overall Study|Physician Decision|0|||
16456446|NCT04145219|40152138|FG001|Overall Study|Physician Decision|2|||
16456447|NCT04145219|40152137|FG000|Overall Study|Withdrawal by Subject|12|||
16456448|NCT04145219|40152138|FG001|Overall Study|Withdrawal by Subject|8|||
16456449|NCT04145219|40152137|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
16456450|NCT04145219|40152138|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
16456451|NCT01086358|40152139|FG000|First Intervention|Lost to Follow-up|9|||
16456452|NCT01086358|40152140|FG001|First Intervention|Lost to Follow-up|4|||
16456453|NCT01086358|40152139|FG000|First Intervention|Withdrawal by Subject|0|||
16456454|NCT01086358|40152140|FG001|First Intervention|Withdrawal by Subject|1|||
16456455|NCT01086358|40152139|FG000|Second Intervention|Lost to Follow-up|4|||
16456456|NCT01086358|40152140|FG001|Second Intervention|Lost to Follow-up|4|||
16456457|NCT02560025|40152142|FG000|Overall Study|Ineligible after consent/ registration|3|||
16456458|NCT00773838|40152143|FG000|Overall Study|Adverse Event|29|||
16456459|NCT00773838|40152143|FG000|Overall Study|Lost to Follow-up|1|||
16456460|NCT00773838|40152143|FG000|Overall Study|Physician Decision|8|||
16456461|NCT00773838|40152143|FG000|Overall Study|Progressive Disease|82|||
16456462|NCT00773838|40152143|FG000|Overall Study|Protocol Violation|2|||
16456463|NCT00773838|40152143|FG000|Overall Study|Withdrawal by Subject|21|||
16456464|NCT05297578|40152144|FG000|Overall Study|Lost to Follow-up|1|||
16456465|NCT05297578|40152145|FG001|Overall Study|Lost to Follow-up|1|||
16456466|NCT05297578|40152146|FG002|Overall Study|Lost to Follow-up|2|||
16456467|NCT05297578|40152147|FG003|Overall Study|Lost to Follow-up|1|||
16456468|NCT05297578|40152144|FG000|Overall Study|Death|0|||
16456469|NCT05297578|40152145|FG001|Overall Study|Death|1|||
16456470|NCT05297578|40152146|FG002|Overall Study|Death|0|||
16456471|NCT05297578|40152147|FG003|Overall Study|Death|0|||
16456472|NCT05297578|40152144|FG000|Overall Study|Withdrawal by Subject|0|||
16456473|NCT05297578|40152145|FG001|Overall Study|Withdrawal by Subject|0|||
16456474|NCT05297578|40152146|FG002|Overall Study|Withdrawal by Subject|1|||
16456475|NCT05297578|40152147|FG003|Overall Study|Withdrawal by Subject|0|||
16456476|NCT00578292|40152148|FG000|Overall Study|Death|1|||
16456477|NCT00578292|40152148|FG000|Overall Study|Graft failure|2|||
16456478|NCT00607373|40152149|FG000|Treatment Period|Adverse Event|0|||
16456479|NCT00607373|40152150|FG001|Treatment Period|Adverse Event|4|||
16456480|NCT00607373|40152149|FG000|Treatment Period|Physician Decision|0|||
16456481|NCT00607373|40152150|FG001|Treatment Period|Physician Decision|1|||
16456482|NCT00607373|40152149|FG000|Treatment Period|Withdrawal by Subject|0|||
16456483|NCT00607373|40152150|FG001|Treatment Period|Withdrawal by Subject|1|||
16456484|NCT00607373|40152149|FG000|Follow-up Period|Other|0|||
16456485|NCT00607373|40152150|FG001|Follow-up Period|Other|1|||
16456486|NCT00607373|40152149|FG000|Follow-up Period|Protocol Violation|0|||
16456487|NCT00607373|40152150|FG001|Follow-up Period|Protocol Violation|1|||
16456488|NCT00607373|40152149|FG000|Follow-up Period|Withdrawal by Subject|1|||
16456489|NCT00607373|40152150|FG001|Follow-up Period|Withdrawal by Subject|3|||
16456490|NCT00101452|40152153|FG000|Overall Study|Adverse Event|2|||
16456491|NCT00101452|40152154|FG001|Overall Study|Adverse Event|0|||
16456492|NCT00101452|40152155|FG002|Overall Study|Adverse Event|1|||
16456493|NCT00101452|40152153|FG000|Overall Study|Lost to Follow-up|13|||
16456494|NCT00101452|40152154|FG001|Overall Study|Lost to Follow-up|8|||
16456495|NCT00101452|40152155|FG002|Overall Study|Lost to Follow-up|14|||
16456496|NCT00101452|40152153|FG000|Overall Study|Withdrawal by Subject|10|||
16456497|NCT00101452|40152154|FG001|Overall Study|Withdrawal by Subject|14|||
16456498|NCT00101452|40152155|FG002|Overall Study|Withdrawal by Subject|9|||
16456499|NCT00101452|40152153|FG000|Overall Study|Baseline Fail|2|||
16456500|NCT00101452|40152154|FG001|Overall Study|Baseline Fail|1|||
16456501|NCT00101452|40152155|FG002|Overall Study|Baseline Fail|2|||
16456502|NCT00101452|40152153|FG000|Overall Study|Physician Decision|0|||
16456503|NCT00101452|40152154|FG001|Overall Study|Physician Decision|3|||
16456504|NCT00101452|40152155|FG002|Overall Study|Physician Decision|2|||
16456505|NCT00101452|40152153|FG000|Overall Study|Protocol Violation|2|||
16456506|NCT00101452|40152154|FG001|Overall Study|Protocol Violation|1|||
16456507|NCT00101452|40152155|FG002|Overall Study|Protocol Violation|3|||
16456508|NCT00101452|40152153|FG000|Overall Study|Other|15|||
16456509|NCT00101452|40152154|FG001|Overall Study|Other|16|||
16456510|NCT00101452|40152155|FG002|Overall Study|Other|12|||
16456511|NCT00647270|40152158|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
16456512|NCT00647270|40152159|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
16456513|NCT00647270|40152160|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
16456514|NCT00647270|40152158|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
16456515|NCT00647270|40152159|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
16456516|NCT00647270|40152160|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
16456517|NCT00647270|40152158|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
16456518|NCT00647270|40152159|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
16456519|NCT00647270|40152160|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
16456520|NCT00647270|40152158|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
16456521|NCT00647270|40152159|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
16456522|NCT00647270|40152160|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
16456523|NCT00647270|40152158|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
16456524|NCT00647270|40152159|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
16456525|NCT00647270|40152160|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
16456526|NCT00647270|40152158|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
16456527|NCT00647270|40152159|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
16456528|NCT00647270|40152160|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
16456529|NCT00647270|40152158|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
16456530|NCT00647270|40152159|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
16456531|NCT00647270|40152160|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
16456532|NCT00946985|40152164|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
16456533|NCT00946985|40152164|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
16456534|NCT00946985|40152164|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
16456535|NCT00946985|40152164|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
16456536|NCT00946985|40152164|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
16456537|NCT00946985|40152164|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
16456538|NCT00946985|40152164|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
16456539|NCT00946985|40152164|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
16456540|NCT00946985|40152164|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
16456541|NCT00314795|40152165|FG000|Overall Study|Adverse Event|8|||
16456542|NCT00314795|40152165|FG000|Overall Study|Death|4|||
16456543|NCT00314795|40152165|FG000|Overall Study|Reason not Specified|3|||
16456544|NCT00314795|40152165|FG000|Overall Study|Renal Transplant|3|||
16456545|NCT00314795|40152165|FG000|Overall Study|Participants Withdrew Consent|2|||
16456546|NCT00856518|40152166|FG000|Overall Study|Lost to Follow-up|4|||
16456547|NCT00856518|40152167|FG001|Overall Study|Lost to Follow-up|2|||
16456548|NCT00119678|40152169|FG000|Double-blind Treatment Period|Death|1|||
16456549|NCT00119678|40152170|FG001|Double-blind Treatment Period|Death|0|||
16456550|NCT00119678|40152169|FG000|Double-blind Treatment Period|Adverse Event|7|||
16456551|NCT00119678|40152170|FG001|Double-blind Treatment Period|Adverse Event|1|||
16456552|NCT00119678|40152169|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
16456553|NCT00119678|40152170|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
16456554|NCT00119678|40152169|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
16456555|NCT00119678|40152170|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
16456556|NCT00119678|40152169|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
16456557|NCT00119678|40152170|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
16456558|NCT00119678|40152169|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
16456559|NCT00119678|40152170|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
16456560|NCT00119678|40152169|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
16456561|NCT00119678|40152170|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
16456562|NCT00119678|40152169|FG000|Double-blind Treatment Period|Pregnancy|0|||
16456563|NCT00119678|40152170|FG001|Double-blind Treatment Period|Pregnancy|2|||
16456564|NCT00119678|40152169|FG000|Double-blind Treatment Period|Not treated|1|||
16456565|NCT00119678|40152170|FG001|Double-blind Treatment Period|Not treated|2|||
16456566|NCT00119678|40152169|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
16456567|NCT00119678|40152170|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
16456568|NCT00119678|40152169|FG000|Open-label Treatment Period|Death|1|||
16456569|NCT00119678|40152170|FG001|Open-label Treatment Period|Death|0|||
16456570|NCT00119678|40152169|FG000|Open-label Treatment Period|Adverse Event|3|||
16456571|NCT00119678|40152170|FG001|Open-label Treatment Period|Adverse Event|0|||
16456572|NCT00119678|40152169|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
16456573|NCT00119678|40152170|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
16456574|NCT00119678|40152169|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
16456575|NCT00119678|40152170|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
16456576|NCT00119678|40152169|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
16456577|NCT00119678|40152170|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
16456578|NCT00119678|40152169|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
16456579|NCT00119678|40152170|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
16456580|NCT00119678|40152169|FG000|Open-label Treatment Period|Pregnancy|1|||
16456581|NCT00119678|40152170|FG001|Open-label Treatment Period|Pregnancy|0|||
16456582|NCT00119678|40152169|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
16456583|NCT00119678|40152170|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
16456584|NCT02654717|40152178|FG000|Overall Study|Adverse Event|2|||
16456585|NCT02654717|40152179|FG001|Overall Study|Adverse Event|2|||
16456586|NCT02654717|40152178|FG000|Overall Study|Protocol Violation|1|||
16456587|NCT02654717|40152179|FG001|Overall Study|Protocol Violation|2|||
16456588|NCT02654717|40152178|FG000|Overall Study|Withdrawal by Subject|0|||
16456589|NCT02654717|40152179|FG001|Overall Study|Withdrawal by Subject|1|||
16456590|NCT02654717|40152178|FG000|Overall Study|Non-permitted medication|3|||
16456591|NCT02654717|40152179|FG001|Overall Study|Non-permitted medication|0|||
16456592|NCT02509117|40152180|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16456593|NCT02509117|40152181|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
16456594|NCT02509117|40152182|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16456595|NCT02509117|40152183|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16456596|NCT02509117|40152184|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16456597|NCT02509117|40152185|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16456598|NCT02509117|40152186|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16456599|NCT02509117|40152187|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16456600|NCT02509117|40152188|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16456601|NCT02509117|40152189|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
16456602|NCT02509117|40152180|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16456603|NCT02509117|40152181|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16456604|NCT02509117|40152182|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16456605|NCT02509117|40152183|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16456606|NCT02509117|40152184|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16456607|NCT02509117|40152185|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16456608|NCT02509117|40152186|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16456609|NCT02509117|40152187|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16456610|NCT02509117|40152188|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
16456611|NCT02509117|40152189|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
16456612|NCT02509117|40152180|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16456613|NCT02509117|40152181|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16456614|NCT02509117|40152182|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16456615|NCT02509117|40152183|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16456616|NCT02509117|40152184|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16456617|NCT02509117|40152185|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16456618|NCT02509117|40152186|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16456619|NCT02509117|40152187|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16456620|NCT02509117|40152188|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
16456621|NCT02509117|40152189|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
16456622|NCT00918736|40152190|FG000|Overall Study|Withdrawal by Subject|4|||
16456623|NCT00634101|40152194|FG000|Overall Study|Study Terminated|3|||
16456624|NCT00634101|40152195|FG001|Overall Study|Study Terminated|3|||
16456625|NCT00634101|40152194|FG000|Overall Study|Lost to Follow-up|2|||
16456626|NCT00634101|40152195|FG001|Overall Study|Lost to Follow-up|0|||
16456627|NCT01242813|40152198|FG000|Overall Study|Lost to Follow-up|2|||
16456628|NCT01112306|40152201|FG000|Overall Study|Death|175|||
16456629|NCT01112306|40152201|FG000|Overall Study|Lost to Follow-up|9|||
16456630|NCT01112306|40152201|FG000|Overall Study|Withdrawal by Subject|31|||
16456631|NCT01112306|40152201|FG000|Overall Study|Other|70|||
16456632|NCT02605122|40152202|FG000|Overall Study|Withdrawal by Subject|4|||
16456633|NCT02605122|40152203|FG001|Overall Study|Withdrawal by Subject|1|||
16456634|NCT02605122|40152202|FG000|Overall Study|Lost to Follow-up|1|||
16456635|NCT02605122|40152203|FG001|Overall Study|Lost to Follow-up|1|||
16456636|NCT02762370|40152206|FG000|Overall Study|Protocol Violation|1|||
16456637|NCT02762370|40152207|FG001|Overall Study|Protocol Violation|0|||
16456638|NCT01525225|40152208|FG000|Enrollment|No longer met study criteria|1|||
16456639|NCT01525225|40152208|FG000|Enrollment|Other|1|||
16456640|NCT02260180|40152209|FG000|Overall Study|Adverse Event|2|||
16456641|NCT02260180|40152210|FG001|Overall Study|Adverse Event|0|||
16456642|NCT02260180|40152211|FG002|Overall Study|Adverse Event|1|||
16456643|NCT03642132|40152212|FG000|Chemotherapy Period|Adverse Event|1|||
16456644|NCT03642132|40152213|FG001|Chemotherapy Period|Adverse Event|1|||
16456645|NCT03642132|40152214|FG002|Chemotherapy Period|Adverse Event|0|||
16456646|NCT03642132|40152212|FG000|Chemotherapy Period|Physician's decision|4|||
16072697|NCT00801983|38759137|FG001|Period 2|Withdrawal by Subject|1|||
16456647|NCT03642132|40152213|FG001|Chemotherapy Period|Physician's decision|1|||
16456648|NCT03642132|40152214|FG002|Chemotherapy Period|Physician's decision|0|||
16456649|NCT03642132|40152212|FG000|Chemotherapy Period|Progressive disease|0|||
16456650|NCT03642132|40152213|FG001|Chemotherapy Period|Progressive disease|0|||
16456651|NCT03642132|40152214|FG002|Chemotherapy Period|Progressive disease|1|||
16456652|NCT03642132|40152212|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
16456653|NCT03642132|40152213|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
16456654|NCT03642132|40152214|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
16456655|NCT03642132|40152212|FG000|Chemotherapy Period|Other|1|||
16456656|NCT03642132|40152213|FG001|Chemotherapy Period|Other|0|||
16456657|NCT03642132|40152214|FG002|Chemotherapy Period|Other|2|||
16456658|NCT03642132|40152212|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
16456659|NCT03642132|40152213|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
16456660|NCT03642132|40152214|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
16456661|NCT03642132|40152212|FG000|Maintenance Period|Adverse Event|1|||
16456662|NCT03642132|40152213|FG001|Maintenance Period|Adverse Event|2|||
16456663|NCT03642132|40152214|FG002|Maintenance Period|Adverse Event|0|||
16456664|NCT03642132|40152212|FG000|Maintenance Period|Non-compliance with study drug|0|||
16456665|NCT03642132|40152213|FG001|Maintenance Period|Non-compliance with study drug|0|||
16456666|NCT03642132|40152214|FG002|Maintenance Period|Non-compliance with study drug|1|||
16456667|NCT03642132|40152212|FG000|Maintenance Period|Physician's decision|2|||
16456668|NCT03642132|40152213|FG001|Maintenance Period|Physician's decision|2|||
16456669|NCT03642132|40152214|FG002|Maintenance Period|Physician's decision|2|||
16456670|NCT03642132|40152212|FG000|Maintenance Period|Progressive disease|9|||
16456671|NCT03642132|40152213|FG001|Maintenance Period|Progressive disease|3|||
16456672|NCT03642132|40152214|FG002|Maintenance Period|Progressive disease|6|||
16456673|NCT03642132|40152212|FG000|Maintenance Period|Other|0|||
16456674|NCT03642132|40152213|FG001|Maintenance Period|Other|0|||
16456675|NCT03642132|40152214|FG002|Maintenance Period|Other|3|||
16456676|NCT03642132|40152212|FG000|Maintenance Period|Withdrawal by Subject|1|||
16456677|NCT03642132|40152213|FG001|Maintenance Period|Withdrawal by Subject|1|||
16456678|NCT03642132|40152214|FG002|Maintenance Period|Withdrawal by Subject|2|||
16456679|NCT03642132|40152212|FG000|Follow-up Period|Other|0|||
16456680|NCT03642132|40152213|FG001|Follow-up Period|Other|0|||
16456681|NCT03642132|40152214|FG002|Follow-up Period|Other|1|||
16456682|NCT03642132|40152212|FG000|Follow-up Period|Withdrawal by Subject|1|||
16456683|NCT03642132|40152213|FG001|Follow-up Period|Withdrawal by Subject|2|||
16456684|NCT03642132|40152214|FG002|Follow-up Period|Withdrawal by Subject|0|||
16456685|NCT03642132|40152212|FG000|Follow-up Period|Study terminated by sponsor|1|||
16456686|NCT03642132|40152213|FG001|Follow-up Period|Study terminated by sponsor|0|||
16456687|NCT03642132|40152214|FG002|Follow-up Period|Study terminated by sponsor|1|||
16456688|NCT03642132|40152212|FG000|Follow-up Period|Lack of Efficacy|1|||
16456689|NCT03642132|40152213|FG001|Follow-up Period|Lack of Efficacy|0|||
16456690|NCT03642132|40152214|FG002|Follow-up Period|Lack of Efficacy|0|||
16456691|NCT03642132|40152212|FG000|Follow-up Period|Death|1|||
16456692|NCT03642132|40152213|FG001|Follow-up Period|Death|0|||
16456693|NCT03642132|40152214|FG002|Follow-up Period|Death|2|||
16456694|NCT03642132|40152212|FG000|Follow-up Period|Adverse Event|1|||
16456695|NCT03642132|40152213|FG001|Follow-up Period|Adverse Event|0|||
16456696|NCT03642132|40152214|FG002|Follow-up Period|Adverse Event|0|||
16456697|NCT01864005|40152220|FG000|Overall Study|Protocol Violation|0|||
16456698|NCT01864005|40152221|FG001|Overall Study|Protocol Violation|1|||
16456699|NCT01864005|40152220|FG000|Overall Study|Withdrawal by Subject|0|||
16456700|NCT01864005|40152221|FG001|Overall Study|Withdrawal by Subject|1|||
16456701|NCT01864005|40152220|FG000|Overall Study|Incorrect enrolment|1|||
16456702|NCT01864005|40152221|FG001|Overall Study|Incorrect enrolment|0|||
16456703|NCT01864005|40152220|FG000|Overall Study|Disease need|1|||
16456704|NCT01864005|40152221|FG001|Overall Study|Disease need|1|||
16456705|NCT01864005|40152220|FG000|Overall Study|Need GP IIb/IIIa|1|||
16456706|NCT01864005|40152221|FG001|Overall Study|Need GP IIb/IIIa|3|||
16456707|NCT01742286|40152222|FG000|Escalation Phase|Administrative problems|1|||
16456708|NCT01742286|40152223|FG001|Escalation Phase|Administrative problems|1|||
16456709|NCT01742286|40152224|FG002|Escalation Phase|Administrative problems|0|||
16456710|NCT01742286|40152225|FG003|Escalation Phase|Administrative problems|0|||
16456711|NCT01742286|40152226|FG004|Escalation Phase|Administrative problems|0|||
16456712|NCT01742286|40152227|FG005|Escalation Phase|Administrative problems|0|||
16456713|NCT01742286|40152228|FG006|Escalation Phase|Administrative problems|2|||
16456714|NCT01742286|40152222|FG000|Escalation Phase|Adverse Event|0|||
16456715|NCT01742286|40152223|FG001|Escalation Phase|Adverse Event|1|||
16456716|NCT01742286|40152224|FG002|Escalation Phase|Adverse Event|2|||
16456717|NCT01742286|40152225|FG003|Escalation Phase|Adverse Event|0|||
16456718|NCT01742286|40152226|FG004|Escalation Phase|Adverse Event|0|||
16456719|NCT01742286|40152227|FG005|Escalation Phase|Adverse Event|1|||
16456720|NCT01742286|40152228|FG006|Escalation Phase|Adverse Event|0|||
16456721|NCT01742286|40152222|FG000|Escalation Phase|Disease progression|3|||
16456722|NCT01742286|40152223|FG001|Escalation Phase|Disease progression|7|||
16456723|NCT01742286|40152224|FG002|Escalation Phase|Disease progression|4|||
16456724|NCT01742286|40152225|FG003|Escalation Phase|Disease progression|1|||
16456725|NCT01742286|40152226|FG004|Escalation Phase|Disease progression|4|||
16456726|NCT01742286|40152227|FG005|Escalation Phase|Disease progression|3|||
16456727|NCT01742286|40152228|FG006|Escalation Phase|Disease progression|2|||
16456728|NCT01742286|40152222|FG000|Escalation Phase|Death|0|||
16456729|NCT01742286|40152223|FG001|Escalation Phase|Death|0|||
16456730|NCT01742286|40152224|FG002|Escalation Phase|Death|0|||
16456731|NCT01742286|40152225|FG003|Escalation Phase|Death|0|||
16456732|NCT01742286|40152226|FG004|Escalation Phase|Death|0|||
16456733|NCT01742286|40152227|FG005|Escalation Phase|Death|1|||
16456734|NCT01742286|40152228|FG006|Escalation Phase|Death|0|||
16456735|NCT01742286|40152222|FG000|Escalation Phase|Physician Decision|0|||
16456736|NCT01742286|40152223|FG001|Escalation Phase|Physician Decision|3|||
16456737|NCT01742286|40152224|FG002|Escalation Phase|Physician Decision|0|||
16456738|NCT01742286|40152225|FG003|Escalation Phase|Physician Decision|1|||
16456739|NCT01742286|40152226|FG004|Escalation Phase|Physician Decision|0|||
16456740|NCT01742286|40152227|FG005|Escalation Phase|Physician Decision|0|||
16456741|NCT01742286|40152228|FG006|Escalation Phase|Physician Decision|2|||
16456742|NCT01742286|40152222|FG000|Escalation Phase|Subject/guardian decision|1|||
16456743|NCT01742286|40152223|FG001|Escalation Phase|Subject/guardian decision|0|||
16456744|NCT01742286|40152224|FG002|Escalation Phase|Subject/guardian decision|0|||
16456745|NCT01742286|40152225|FG003|Escalation Phase|Subject/guardian decision|0|||
16456746|NCT01742286|40152226|FG004|Escalation Phase|Subject/guardian decision|0|||
16456747|NCT01742286|40152227|FG005|Escalation Phase|Subject/guardian decision|0|||
16456748|NCT01742286|40152228|FG006|Escalation Phase|Subject/guardian decision|0|||
16456749|NCT01742286|40152222|FG000|Expansion Phase|Administrative problems|0|||
16456750|NCT01742286|40152223|FG001|Expansion Phase|Administrative problems|0|||
16456751|NCT01742286|40152224|FG002|Expansion Phase|Administrative problems|0|||
16456752|NCT01742286|40152225|FG003|Expansion Phase|Administrative problems|0|||
16456753|NCT01742286|40152226|FG004|Expansion Phase|Administrative problems|0|||
16456754|NCT01742286|40152227|FG005|Expansion Phase|Administrative problems|0|||
16456755|NCT01742286|40152228|FG006|Expansion Phase|Administrative problems|5|||
16456756|NCT01742286|40152222|FG000|Expansion Phase|Physician Decision|0|||
16456757|NCT01742286|40152223|FG001|Expansion Phase|Physician Decision|0|||
16456758|NCT01742286|40152224|FG002|Expansion Phase|Physician Decision|4|||
16456759|NCT01742286|40152225|FG003|Expansion Phase|Physician Decision|0|||
16456760|NCT01742286|40152226|FG004|Expansion Phase|Physician Decision|0|||
16456761|NCT01742286|40152227|FG005|Expansion Phase|Physician Decision|0|||
16456762|NCT01742286|40152228|FG006|Expansion Phase|Physician Decision|9|||
16456763|NCT01742286|40152222|FG000|Expansion Phase|Adverse Event|0|||
16456764|NCT01742286|40152223|FG001|Expansion Phase|Adverse Event|0|||
16456765|NCT01742286|40152224|FG002|Expansion Phase|Adverse Event|0|||
16456766|NCT01742286|40152225|FG003|Expansion Phase|Adverse Event|0|||
16456767|NCT01742286|40152226|FG004|Expansion Phase|Adverse Event|0|||
16456768|NCT01742286|40152227|FG005|Expansion Phase|Adverse Event|0|||
16456769|NCT01742286|40152228|FG006|Expansion Phase|Adverse Event|6|||
16456770|NCT01742286|40152222|FG000|Expansion Phase|Disease progression|0|||
16456771|NCT01742286|40152223|FG001|Expansion Phase|Disease progression|0|||
16456772|NCT01742286|40152224|FG002|Expansion Phase|Disease progression|3|||
16456773|NCT01742286|40152225|FG003|Expansion Phase|Disease progression|0|||
16456774|NCT01742286|40152226|FG004|Expansion Phase|Disease progression|0|||
16456775|NCT01742286|40152227|FG005|Expansion Phase|Disease progression|0|||
16456776|NCT01742286|40152228|FG006|Expansion Phase|Disease progression|15|||
16456777|NCT01742286|40152222|FG000|Expansion Phase|Withdrawal by Subject|0|||
16456778|NCT01742286|40152223|FG001|Expansion Phase|Withdrawal by Subject|0|||
16456779|NCT01742286|40152224|FG002|Expansion Phase|Withdrawal by Subject|0|||
16456780|NCT01742286|40152225|FG003|Expansion Phase|Withdrawal by Subject|0|||
16456781|NCT01742286|40152226|FG004|Expansion Phase|Withdrawal by Subject|0|||
16456782|NCT01742286|40152227|FG005|Expansion Phase|Withdrawal by Subject|0|||
16166912|NCT02949128|39091333|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
16166913|NCT01262625|39091334|FG000|Overall Study|Administrative Error|1|||
16166914|NCT01262625|39091335|FG001|Overall Study|Administrative Error|1|||
16166915|NCT01262625|39091334|FG000|Overall Study|Site Closed|1|||
16166916|NCT01262625|39091335|FG001|Overall Study|Site Closed|0|||
16166917|NCT01552681|39091336|FG000|Overall Study|Withdrawal by Subject|4|||
16166918|NCT01552681|39091337|FG001|Overall Study|Withdrawal by Subject|0|||
16166919|NCT01552681|39091336|FG000|Overall Study|Physician Decision|1|||
16166920|NCT01552681|39091337|FG001|Overall Study|Physician Decision|0|||
16166921|NCT01552681|39091336|FG000|Overall Study|Subject moved away|0|||
16166922|NCT01552681|39091337|FG001|Overall Study|Subject moved away|1|||
16166923|NCT00947531|39091340|FG000|Overall Study|Withdrawal by Subject|10|||
16166924|NCT00947531|39091341|FG001|Overall Study|Withdrawal by Subject|7|||
16166925|NCT00947531|39091340|FG000|Overall Study|Administrative Reason|0|||
16166926|NCT00947531|39091341|FG001|Overall Study|Administrative Reason|1|||
16166927|NCT00947531|39091340|FG000|Overall Study|Adverse Event|2|||
16166928|NCT00947531|39091341|FG001|Overall Study|Adverse Event|2|||
16456783|NCT01742286|40152228|FG006|Expansion Phase|Withdrawal by Subject|1|||
16166929|NCT00947531|39091340|FG000|Overall Study|Lack of Efficacy|1|||
16456784|NCT01409811|40152231|FG000|Overall Study|Insurance denial|1|||
16456785|NCT01776307|40152232|FG000|Overall Study|Not dosed|0|||
16456786|NCT01776307|40152233|FG001|Overall Study|Not dosed|0|||
16456787|NCT01776307|40152234|FG002|Overall Study|Not dosed|1|||
16456788|NCT03844945|40152237|FG000|Overall Study|Adverse Event|1|||
16456789|NCT03844945|40152238|FG001|Overall Study|Adverse Event|1|||
16456790|NCT03844945|40152239|FG002|Overall Study|Adverse Event|4|||
16456791|NCT03844945|40152240|FG003|Overall Study|Adverse Event|0|||
16456792|NCT03844945|40152237|FG000|Overall Study|Withdrawal by Subject|0|||
16456793|NCT03844945|40152238|FG001|Overall Study|Withdrawal by Subject|0|||
16456794|NCT03844945|40152239|FG002|Overall Study|Withdrawal by Subject|1|||
16456795|NCT03844945|40152240|FG003|Overall Study|Withdrawal by Subject|0|||
16456796|NCT03844945|40152237|FG000|Overall Study|Lack of Efficacy|0|||
16456797|NCT03844945|40152238|FG001|Overall Study|Lack of Efficacy|0|||
16456798|NCT03844945|40152239|FG002|Overall Study|Lack of Efficacy|0|||
16456799|NCT03844945|40152240|FG003|Overall Study|Lack of Efficacy|1|||
16456800|NCT01410357|40152241|FG000|Overall Study|Death|2|||
16456801|NCT01410357|40152242|FG001|Overall Study|Death|1|||
16456802|NCT01410357|40152241|FG000|Overall Study|Withdrawal by Subject|1|||
16456803|NCT01410357|40152242|FG001|Overall Study|Withdrawal by Subject|2|||
16456804|NCT01410357|40152241|FG000|Overall Study|Lost to Follow-up|23|||
16456805|NCT01410357|40152242|FG001|Overall Study|Lost to Follow-up|21|||
16456806|NCT01587014|40152243|FG000|Overall Study|Death|2|||
16456807|NCT01667419|40152244|FG000|Overall Study|Reason Not Specified|1|||
16456808|NCT01667419|40152245|FG001|Overall Study|Reason Not Specified|0|||
16456809|NCT01667419|40152246|FG002|Overall Study|Reason Not Specified|0|||
16456810|NCT01667419|40152247|FG003|Overall Study|Reason Not Specified|0|||
16456811|NCT01667419|40152244|FG000|Overall Study|Withdrawal by Subject|16|||
16456812|NCT01667419|40152245|FG001|Overall Study|Withdrawal by Subject|8|||
16456813|NCT01667419|40152246|FG002|Overall Study|Withdrawal by Subject|9|||
16456814|NCT01667419|40152247|FG003|Overall Study|Withdrawal by Subject|8|||
16456815|NCT01667419|40152244|FG000|Overall Study|Non-compliance|0|||
16456816|NCT01667419|40152245|FG001|Overall Study|Non-compliance|0|||
16456817|NCT01667419|40152246|FG002|Overall Study|Non-compliance|0|||
16456818|NCT01667419|40152247|FG003|Overall Study|Non-compliance|1|||
16456819|NCT01667419|40152244|FG000|Overall Study|Protocol Violation|1|||
16456820|NCT01667419|40152245|FG001|Overall Study|Protocol Violation|0|||
16456821|NCT01667419|40152246|FG002|Overall Study|Protocol Violation|0|||
16456822|NCT01667419|40152247|FG003|Overall Study|Protocol Violation|0|||
16456823|NCT01667419|40152244|FG000|Overall Study|Lost to Follow-up|7|||
16456824|NCT01667419|40152245|FG001|Overall Study|Lost to Follow-up|6|||
16456825|NCT01667419|40152246|FG002|Overall Study|Lost to Follow-up|2|||
16456826|NCT01667419|40152247|FG003|Overall Study|Lost to Follow-up|4|||
16456827|NCT01667419|40152244|FG000|Overall Study|Death|18|||
16456828|NCT01667419|40152245|FG001|Overall Study|Death|33|||
16456829|NCT01667419|40152246|FG002|Overall Study|Death|25|||
16456830|NCT01667419|40152247|FG003|Overall Study|Death|26|||
16456831|NCT03313037|40152250|FG000|Overall Study|Protocol Violation|4|||
16456832|NCT03313037|40152251|FG001|Overall Study|Protocol Violation|1|||
16456833|NCT03313037|40152250|FG000|Overall Study|Other|1|||
16456834|NCT03313037|40152251|FG001|Overall Study|Other|1|||
16456835|NCT03313037|40152250|FG000|Overall Study|Withdrawal by Subject|4|||
16456836|NCT03313037|40152251|FG001|Overall Study|Withdrawal by Subject|3|||
16456837|NCT03313037|40152250|FG000|Overall Study|No longer meets eligibility criteria|1|||
16456838|NCT03313037|40152251|FG001|Overall Study|No longer meets eligibility criteria|7|||
16456839|NCT03313037|40152250|FG000|Overall Study|Lost to Follow-up|9|||
16456840|NCT03313037|40152251|FG001|Overall Study|Lost to Follow-up|8|||
16456841|NCT03313037|40152250|FG000|Overall Study|Randomized but not treated|1|||
16456842|NCT03313037|40152251|FG001|Overall Study|Randomized but not treated|0|||
16456843|NCT01497366|40152253|FG000|Overall Study|Virologic failure|2|||
16456844|NCT01497366|40152254|FG001|Overall Study|Virologic failure|50|||
16456845|NCT01497366|40152253|FG000|Overall Study|Lost to Follow-up|11|||
16456846|NCT01497366|40152254|FG001|Overall Study|Lost to Follow-up|10|||
16456847|NCT01497366|40152253|FG000|Overall Study|Withdrawal by Subject|6|||
16456848|NCT01497366|40152254|FG001|Overall Study|Withdrawal by Subject|6|||
16456849|NCT01497366|40152253|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
16456850|NCT01497366|40152254|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
16456851|NCT01497366|40152253|FG000|Overall Study|Other|5|||
16456852|NCT01497366|40152254|FG001|Overall Study|Other|0|||
16456853|NCT01497366|40152253|FG000|Overall Study|Death|1|||
16456854|NCT01497366|40152254|FG001|Overall Study|Death|1|||
16456855|NCT01497366|40152253|FG000|Overall Study|Randomized but not treated|7|||
16456856|NCT01497366|40152254|FG001|Overall Study|Randomized but not treated|21|||
16456857|NCT01015638|40152255|FG000|Overall Study|Withdrawal by Subject|1|||
16269157|NCT01075282|39471027|FG000|Overall Study|Physician Decision|3|||
16456858|NCT01015638|40152256|FG001|Overall Study|Withdrawal by Subject|0|||
16456859|NCT00003472|40152257|FG000|Overall Study|Not evaluable|3|||
16456860|NCT03704636|40152260|FG000|Overall Study|Inadequate Venous Flow|3|||
16456861|NCT03073733|40152261|FG000|Overall Study|Lost to Follow-up|1|||
16456862|NCT03073733|40152262|FG001|Overall Study|Lost to Follow-up|0|||
16456863|NCT03073733|40152263|FG002|Overall Study|Lost to Follow-up|0|||
16456864|NCT03073733|40152261|FG000|Overall Study|Physician Decision|0|||
16456865|NCT03073733|40152262|FG001|Overall Study|Physician Decision|1|||
16456866|NCT03073733|40152263|FG002|Overall Study|Physician Decision|0|||
16456867|NCT03073733|40152261|FG000|Overall Study|Withdrawal by Subject|0|||
16456868|NCT03073733|40152262|FG001|Overall Study|Withdrawal by Subject|0|||
16456869|NCT03073733|40152263|FG002|Overall Study|Withdrawal by Subject|1|||
16456870|NCT00635999|40152265|FG000|Overall Study|Withdrawal by Subject|4|||
16456871|NCT00635999|40152266|FG001|Overall Study|Withdrawal by Subject|2|||
16456872|NCT00635999|40152267|FG002|Overall Study|Withdrawal by Subject|1|||
16456873|NCT02036970|40152268|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
16456874|NCT02036970|40152269|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
16456875|NCT02036970|40152270|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
16456876|NCT02036970|40152271|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
16456877|NCT02036970|40152272|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
16456878|NCT02036970|40152273|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
16456879|NCT02036970|40152274|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
16456880|NCT02036970|40152275|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
16456881|NCT02036970|40152276|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
16456882|NCT02036970|40152277|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
16456883|NCT02036970|40152268|FG000|Part 1: Day 1 Through Week 16|Death|0|||
16456884|NCT02036970|40152269|FG001|Part 1: Day 1 Through Week 16|Death|0|||
16456885|NCT02036970|40152270|FG002|Part 1: Day 1 Through Week 16|Death|0|||
16456886|NCT02036970|40152271|FG003|Part 1: Day 1 Through Week 16|Death|0|||
16456887|NCT02036970|40152272|FG004|Part 1: Day 1 Through Week 16|Death|0|||
16456888|NCT02036970|40152273|FG005|Part 1: Day 1 Through Week 16|Death|0|||
16456889|NCT02036970|40152274|FG006|Part 1: Day 1 Through Week 16|Death|0|||
16456890|NCT02036970|40152275|FG007|Part 1: Day 1 Through Week 16|Death|0|||
16456891|NCT02036970|40152276|FG008|Part 1: Day 1 Through Week 16|Death|1|||
16456892|NCT02036970|40152277|FG009|Part 1: Day 1 Through Week 16|Death|0|||
16456893|NCT02036970|40152268|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
16456894|NCT02036970|40152269|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16456895|NCT02036970|40152270|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
16456896|NCT02036970|40152271|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16456897|NCT02036970|40152272|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16456898|NCT02036970|40152273|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16456899|NCT02036970|40152274|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16456900|NCT02036970|40152275|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16456901|NCT02036970|40152276|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
16456902|NCT02036970|40152277|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
16456903|NCT02036970|40152268|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16456904|NCT02036970|40152269|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16456905|NCT02036970|40152270|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16456906|NCT02036970|40152271|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16456907|NCT02036970|40152272|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
16166930|NCT00947531|39091341|FG001|Overall Study|Lack of Efficacy|0|||
16166931|NCT00947531|39091340|FG000|Overall Study|Other|1|||
16166932|NCT00947531|39091341|FG001|Overall Study|Other|1|||
16166933|NCT00054132|39091342|FG000|Overall Study|Not Treated|1|||
16166934|NCT02688647|39091343|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
16166935|NCT02688647|39091344|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
16166936|NCT02688647|39091343|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
16166937|NCT02688647|39091344|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
16166938|NCT02688647|39091343|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
16166939|NCT02688647|39091344|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
16166940|NCT02688647|39091343|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
16166941|NCT02688647|39091344|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
16166942|NCT02688647|39091343|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
16166943|NCT02688647|39091344|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
16166944|NCT02688647|39091343|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
16166945|NCT02688647|39091344|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
16166946|NCT02688647|39091343|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
16166947|NCT02688647|39091344|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
16166948|NCT00110019|39091345|FG000|Overall Study|Lack of Efficacy|253|||
16456908|NCT02036970|40152273|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16456909|NCT02036970|40152274|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16456910|NCT02036970|40152275|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
16456911|NCT02036970|40152276|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
16456912|NCT02036970|40152277|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
16456913|NCT02036970|40152268|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16166949|NCT00110019|39091346|FG001|Overall Study|Lack of Efficacy|285|||
16166950|NCT00110019|39091345|FG000|Overall Study|Adverse Event|61|||
16166951|NCT00110019|39091346|FG001|Overall Study|Adverse Event|40|||
16166952|NCT00110019|39091345|FG000|Overall Study|Death|13|||
16166953|NCT00110019|39091346|FG001|Overall Study|Death|15|||
16166954|NCT00110019|39091345|FG000|Overall Study|Withdrawal by Subject|21|||
16166955|NCT00110019|39091346|FG001|Overall Study|Withdrawal by Subject|9|||
16166956|NCT00110019|39091345|FG000|Overall Study|alternative therapy|5|||
16166957|NCT00110019|39091346|FG001|Overall Study|alternative therapy|1|||
16166958|NCT00110019|39091345|FG000|Overall Study|complicating disease|1|||
16166959|NCT00110019|39091346|FG001|Overall Study|complicating disease|1|||
16166960|NCT00110019|39091345|FG000|Overall Study|symptom deterioration|13|||
16166961|NCT00110019|39091346|FG001|Overall Study|symptom deterioration|16|||
16166962|NCT00110019|39091345|FG000|Overall Study|Not start protocol therapy|17|||
16166963|NCT00110019|39091346|FG001|Overall Study|Not start protocol therapy|16|||
16166964|NCT00110019|39091345|FG000|Overall Study|other reasons|22|||
16166965|NCT00110019|39091346|FG001|Overall Study|other reasons|30|||
16166966|NCT00552110|39091353|FG000|Overall Study|Serious or Life-Threatening AE|0|||
16166967|NCT00552110|39091354|FG001|Overall Study|Serious or Life-Threatening AE|0|||
16166968|NCT00552110|39091355|FG002|Overall Study|Serious or Life-Threatening AE|1|||
16166969|NCT00552110|39091356|FG003|Overall Study|Serious or Life-Threatening AE|0|||
16166970|NCT00552110|39091357|FG004|Overall Study|Serious or Life-Threatening AE|0|||
16166971|NCT00552110|39091353|FG000|Overall Study|Lack of Efficacy|1|||
16166972|NCT00552110|39091354|FG001|Overall Study|Lack of Efficacy|0|||
16166973|NCT00552110|39091355|FG002|Overall Study|Lack of Efficacy|0|||
16166974|NCT00552110|39091356|FG003|Overall Study|Lack of Efficacy|1|||
16166975|NCT00552110|39091357|FG004|Overall Study|Lack of Efficacy|4|||
16166976|NCT00552110|39091353|FG000|Overall Study|Withdrawal by Subject|0|||
16166977|NCT00552110|39091354|FG001|Overall Study|Withdrawal by Subject|2|||
16166978|NCT00552110|39091355|FG002|Overall Study|Withdrawal by Subject|0|||
16166979|NCT00552110|39091356|FG003|Overall Study|Withdrawal by Subject|3|||
16166980|NCT00552110|39091357|FG004|Overall Study|Withdrawal by Subject|2|||
16166981|NCT00552110|39091353|FG000|Overall Study|Lost to Follow-up|0|||
16166982|NCT00552110|39091354|FG001|Overall Study|Lost to Follow-up|0|||
16166983|NCT00552110|39091355|FG002|Overall Study|Lost to Follow-up|0|||
16166984|NCT00552110|39091356|FG003|Overall Study|Lost to Follow-up|1|||
16166985|NCT00552110|39091357|FG004|Overall Study|Lost to Follow-up|1|||
16166986|NCT00552110|39091353|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
16166987|NCT00552110|39091354|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
16166988|NCT00552110|39091355|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
16166989|NCT00552110|39091356|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
16166990|NCT00552110|39091357|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
16166991|NCT00552110|39091353|FG000|Overall Study|Withdrawn per Sponsor|0|||
16166992|NCT00552110|39091354|FG001|Overall Study|Withdrawn per Sponsor|1|||
16166993|NCT00552110|39091355|FG002|Overall Study|Withdrawn per Sponsor|0|||
16166994|NCT00552110|39091356|FG003|Overall Study|Withdrawn per Sponsor|0|||
16166995|NCT00552110|39091357|FG004|Overall Study|Withdrawn per Sponsor|1|||
16166996|NCT00552110|39091353|FG000|Overall Study|Use of Prohibited Medication|1|||
16166997|NCT00552110|39091354|FG001|Overall Study|Use of Prohibited Medication|1|||
16166998|NCT00552110|39091355|FG002|Overall Study|Use of Prohibited Medication|0|||
16166999|NCT00552110|39091356|FG003|Overall Study|Use of Prohibited Medication|0|||
16167000|NCT00552110|39091357|FG004|Overall Study|Use of Prohibited Medication|0|||
16167001|NCT00552110|39091353|FG000|Overall Study|Delay of Study due to Relabeling|0|||
16167002|NCT00552110|39091354|FG001|Overall Study|Delay of Study due to Relabeling|0|||
16167003|NCT00552110|39091355|FG002|Overall Study|Delay of Study due to Relabeling|0|||
16456914|NCT02036970|40152269|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16456915|NCT02036970|40152270|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16456916|NCT02036970|40152271|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
16456917|NCT02036970|40152272|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16167004|NCT00552110|39091356|FG003|Overall Study|Delay of Study due to Relabeling|1|||
16167005|NCT00552110|39091357|FG004|Overall Study|Delay of Study due to Relabeling|0|||
16167006|NCT00552110|39091353|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
16167007|NCT00552110|39091354|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
16167008|NCT00552110|39091355|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
16167009|NCT00552110|39091356|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
16167010|NCT00552110|39091357|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
16167011|NCT00552110|39091353|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
16167012|NCT00552110|39091354|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
16167013|NCT00552110|39091355|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
16167014|NCT00552110|39091356|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
16167015|NCT00552110|39091357|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
16167016|NCT00248287|39091358|FG000|Overall Study|Adverse Event|11|||
16167017|NCT00248287|39091359|FG001|Overall Study|Adverse Event|10|||
16456918|NCT02036970|40152273|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16167018|NCT00248287|39091358|FG000|Overall Study|Death|1|||
16167019|NCT00248287|39091359|FG001|Overall Study|Death|0|||
16167020|NCT00248287|39091358|FG000|Overall Study|Lost to Follow-up|0|||
16167021|NCT00248287|39091359|FG001|Overall Study|Lost to Follow-up|1|||
16167022|NCT00248287|39091358|FG000|Overall Study|Investigator Request|4|||
16167023|NCT00248287|39091359|FG001|Overall Study|Investigator Request|3|||
16167024|NCT00248287|39091358|FG000|Overall Study|Patient Request|5|||
16167025|NCT00248287|39091359|FG001|Overall Study|Patient Request|3|||
16167026|NCT00248287|39091358|FG000|Overall Study|Other|3|||
16167027|NCT00248287|39091359|FG001|Overall Study|Other|2|||
16167028|NCT03064763|39091363|FG000|Overall Study|Lost to Follow-up|1|||
16167029|NCT03064763|39091363|FG000|Overall Study|Death|8|||
16167030|NCT02471716|39091364|FG000|Overall Study|Withdrawal by Subject|0|||
16167031|NCT02471716|39091365|FG001|Overall Study|Withdrawal by Subject|1|||
16167032|NCT02471716|39091366|FG002|Overall Study|Withdrawal by Subject|0|||
16167033|NCT02471716|39091367|FG003|Overall Study|Withdrawal by Subject|2|||
16167034|NCT02471716|39091368|FG004|Overall Study|Withdrawal by Subject|5|||
16167035|NCT02471716|39091364|FG000|Overall Study|Study Terminiated by sponsor|0|||
16167036|NCT02471716|39091365|FG001|Overall Study|Study Terminiated by sponsor|0|||
16167037|NCT02471716|39091366|FG002|Overall Study|Study Terminiated by sponsor|0|||
16456919|NCT02036970|40152274|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16456920|NCT02036970|40152275|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16456921|NCT02036970|40152276|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16456922|NCT02036970|40152277|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
16456923|NCT02036970|40152268|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
16456924|NCT02036970|40152269|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
16456925|NCT02036970|40152270|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
16456926|NCT02036970|40152271|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
16456927|NCT02036970|40152272|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
16456928|NCT02036970|40152273|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
16456929|NCT02036970|40152274|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
16456930|NCT02036970|40152275|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
16456931|NCT02036970|40152276|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
16456932|NCT02036970|40152277|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
16456933|NCT02036970|40152268|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
16456934|NCT02036970|40152269|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
16456935|NCT02036970|40152270|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
16456936|NCT02036970|40152271|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
16456937|NCT02036970|40152272|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
16456938|NCT02036970|40152273|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
16456939|NCT02036970|40152274|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
16456940|NCT02036970|40152275|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
16167038|NCT02471716|39091367|FG003|Overall Study|Study Terminiated by sponsor|1|||
16167039|NCT02471716|39091368|FG004|Overall Study|Study Terminiated by sponsor|0|||
16167040|NCT02471716|39091364|FG000|Overall Study|Lost to Follow-up|0|||
16167041|NCT02471716|39091365|FG001|Overall Study|Lost to Follow-up|0|||
16167042|NCT02471716|39091366|FG002|Overall Study|Lost to Follow-up|0|||
16167043|NCT02471716|39091367|FG003|Overall Study|Lost to Follow-up|3|||
16167044|NCT02471716|39091368|FG004|Overall Study|Lost to Follow-up|2|||
16167045|NCT02471716|39091364|FG000|Overall Study|Death|0|||
16167046|NCT02471716|39091365|FG001|Overall Study|Death|0|||
16167047|NCT02471716|39091366|FG002|Overall Study|Death|0|||
16167048|NCT02471716|39091367|FG003|Overall Study|Death|1|||
16167049|NCT02471716|39091368|FG004|Overall Study|Death|0|||
16167050|NCT02471716|39091364|FG000|Overall Study|Other|0|||
16167051|NCT02471716|39091365|FG001|Overall Study|Other|0|||
16167052|NCT02471716|39091366|FG002|Overall Study|Other|0|||
16167053|NCT02471716|39091367|FG003|Overall Study|Other|8|||
16167054|NCT02471716|39091368|FG004|Overall Study|Other|9|||
16456941|NCT02036970|40152276|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
16456942|NCT02036970|40152277|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
16456943|NCT02036970|40152268|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16456944|NCT02036970|40152269|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
16456945|NCT02036970|40152270|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
16456946|NCT02036970|40152271|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16456947|NCT02036970|40152272|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16456948|NCT02036970|40152273|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16456949|NCT02036970|40152274|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16456950|NCT02036970|40152275|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16456951|NCT02036970|40152276|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
16167055|NCT01337973|39091374|FG000|Overall Study|Lost to Follow-up|2|||
16167056|NCT01337973|39091375|FG001|Overall Study|Lost to Follow-up|4|||
16167057|NCT01337973|39091376|FG002|Overall Study|Lost to Follow-up|3|||
16167058|NCT01337973|39091374|FG000|Overall Study|Death|1|||
16167059|NCT01337973|39091375|FG001|Overall Study|Death|2|||
16167060|NCT01337973|39091376|FG002|Overall Study|Death|1|||
16167061|NCT01337973|39091374|FG000|Overall Study|Withdrawal by Subject|10|||
16167062|NCT01337973|39091375|FG001|Overall Study|Withdrawal by Subject|8|||
16167063|NCT01337973|39091376|FG002|Overall Study|Withdrawal by Subject|4|||
16167064|NCT01337973|39091374|FG000|Overall Study|missing data on primary outcome|3|||
16167065|NCT01337973|39091375|FG001|Overall Study|missing data on primary outcome|1|||
16167066|NCT01337973|39091376|FG002|Overall Study|missing data on primary outcome|3|||
16167067|NCT00546364|39091379|FG000|Overall Study|Disease progression|5|||
16167068|NCT00546364|39091380|FG001|Overall Study|Disease progression|11|||
16167069|NCT00546364|39091381|FG002|Overall Study|Disease progression|8|||
16456952|NCT02036970|40152277|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
16456953|NCT02036970|40152268|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
16456954|NCT02036970|40152269|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
16456955|NCT02036970|40152270|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
16456956|NCT02036970|40152271|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
16456957|NCT02036970|40152272|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
16456958|NCT02036970|40152273|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
16456959|NCT02036970|40152274|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
16167070|NCT00546364|39091379|FG000|Overall Study|Completed and off treatment|1|||
16167071|NCT00546364|39091380|FG001|Overall Study|Completed and off treatment|0|||
16167072|NCT00546364|39091381|FG002|Overall Study|Completed and off treatment|2|||
16167073|NCT00546364|39091379|FG000|Overall Study|Administrative reason by sponsor|1|||
16167074|NCT00546364|39091380|FG001|Overall Study|Administrative reason by sponsor|0|||
16167075|NCT00546364|39091381|FG002|Overall Study|Administrative reason by sponsor|0|||
16167076|NCT00546364|39091379|FG000|Overall Study|Poor compliance/noncompliance|0|||
16269158|NCT01075282|39471028|FG001|Overall Study|Physician Decision|3|||
16269159|NCT01075282|39471029|FG002|Overall Study|Physician Decision|3|||
16269160|NCT01075282|39471027|FG000|Overall Study|Lack of Efficacy|1|||
16269161|NCT01075282|39471028|FG001|Overall Study|Lack of Efficacy|1|||
16269162|NCT01075282|39471029|FG002|Overall Study|Lack of Efficacy|0|||
16269163|NCT01075282|39471027|FG000|Overall Study|Treatment Non-compliance|1|||
16269164|NCT01075282|39471028|FG001|Overall Study|Treatment Non-compliance|2|||
16269165|NCT01075282|39471029|FG002|Overall Study|Treatment Non-compliance|2|||
16269166|NCT01075282|39471027|FG000|Overall Study|Protocol Violation|0|||
16269167|NCT01075282|39471028|FG001|Overall Study|Protocol Violation|2|||
16269168|NCT01075282|39471029|FG002|Overall Study|Protocol Violation|1|||
16269169|NCT01075282|39471027|FG000|Overall Study|Death|0|||
16269170|NCT01075282|39471028|FG001|Overall Study|Death|1|||
16269171|NCT01075282|39471029|FG002|Overall Study|Death|2|||
16269172|NCT01117623|39471030|FG000|Overall Study|Adverse Event|0|||
16269173|NCT01117623|39471031|FG001|Overall Study|Adverse Event|2|||
16269174|NCT01117623|39471032|FG002|Overall Study|Adverse Event|4|||
16269175|NCT01117623|39471033|FG003|Overall Study|Adverse Event|0|||
16269176|NCT01117623|39471034|FG004|Overall Study|Adverse Event|2|||
16269177|NCT01117623|39471035|FG005|Overall Study|Adverse Event|0|||
16269178|NCT01117623|39471036|FG006|Overall Study|Adverse Event|0|||
16269179|NCT01117623|39471037|FG007|Overall Study|Adverse Event|2|||
16269180|NCT01117623|39471030|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
16269181|NCT01117623|39471031|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
16269182|NCT01117623|39471032|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
16269183|NCT01117623|39471033|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
16269184|NCT01117623|39471034|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
16269185|NCT01117623|39471035|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
16269186|NCT01117623|39471036|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
16269187|NCT01117623|39471037|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
16269188|NCT01117623|39471030|FG000|Overall Study|Withdrawal by Subject|0|||
16269189|NCT01117623|39471031|FG001|Overall Study|Withdrawal by Subject|0|||
16269190|NCT01117623|39471032|FG002|Overall Study|Withdrawal by Subject|2|||
16269191|NCT01117623|39471033|FG003|Overall Study|Withdrawal by Subject|0|||
16269192|NCT01117623|39471034|FG004|Overall Study|Withdrawal by Subject|0|||
16269193|NCT01117623|39471035|FG005|Overall Study|Withdrawal by Subject|1|||
16269194|NCT01117623|39471036|FG006|Overall Study|Withdrawal by Subject|1|||
16269195|NCT01117623|39471037|FG007|Overall Study|Withdrawal by Subject|1|||
16269196|NCT01117623|39471030|FG000|Overall Study|Non-compliance with study medication|0|||
16269197|NCT01117623|39471031|FG001|Overall Study|Non-compliance with study medication|0|||
16269198|NCT01117623|39471032|FG002|Overall Study|Non-compliance with study medication|0|||
16269199|NCT01117623|39471033|FG003|Overall Study|Non-compliance with study medication|0|||
16269200|NCT01117623|39471034|FG004|Overall Study|Non-compliance with study medication|0|||
16269201|NCT01117623|39471035|FG005|Overall Study|Non-compliance with study medication|0|||
16269202|NCT01117623|39471036|FG006|Overall Study|Non-compliance with study medication|0|||
16269203|NCT01117623|39471037|FG007|Overall Study|Non-compliance with study medication|1|||
16269204|NCT01117623|39471030|FG000|Overall Study|Invest. text: completed all planned txs|0|||
16456960|NCT02036970|40152275|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
16456961|NCT02036970|40152276|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
16167077|NCT00546364|39091380|FG001|Overall Study|Poor compliance/noncompliance|0|||
16456962|NCT02036970|40152277|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
16167078|NCT00546364|39091381|FG002|Overall Study|Poor compliance/noncompliance|1|||
16167079|NCT00546364|39091379|FG000|Overall Study|No longer meets study criteria|1|||
16167080|NCT00546364|39091380|FG001|Overall Study|No longer meets study criteria|1|||
16167081|NCT00546364|39091381|FG002|Overall Study|No longer meets study criteria|0|||
16167082|NCT00546364|39091379|FG000|Overall Study|Withdrawal by Subject|5|||
16167083|NCT00546364|39091380|FG001|Overall Study|Withdrawal by Subject|6|||
16167084|NCT00546364|39091381|FG002|Overall Study|Withdrawal by Subject|3|||
16167085|NCT00546364|39091379|FG000|Overall Study|Prior taxotere|1|||
16167086|NCT00546364|39091380|FG001|Overall Study|Prior taxotere|0|||
16167087|NCT00546364|39091381|FG002|Overall Study|Prior taxotere|0|||
16167088|NCT00546364|39091379|FG000|Overall Study|Mixed response|1|||
16167089|NCT00546364|39091380|FG001|Overall Study|Mixed response|0|||
16456963|NCT02100696|40152278|FG000|Induction Phase|Adverse Event|0|||
16456964|NCT02100696|40152279|FG001|Induction Phase|Adverse Event|0|||
16456965|NCT02100696|40152280|FG002|Induction Phase|Adverse Event|1|||
16456966|NCT02100696|40152281|FG003|Induction Phase|Adverse Event|0|||
16456967|NCT02100696|40152282|FG004|Induction Phase|Adverse Event|0|||
16456968|NCT02100696|40152283|FG005|Induction Phase|Adverse Event|0|||
16456969|NCT02100696|40152278|FG000|Induction Phase|Lost to Follow-up|1|||
16456970|NCT02100696|40152279|FG001|Induction Phase|Lost to Follow-up|0|||
16456971|NCT02100696|40152280|FG002|Induction Phase|Lost to Follow-up|1|||
16456972|NCT02100696|40152281|FG003|Induction Phase|Lost to Follow-up|0|||
16456973|NCT02100696|40152282|FG004|Induction Phase|Lost to Follow-up|0|||
16456974|NCT02100696|40152283|FG005|Induction Phase|Lost to Follow-up|0|||
16456975|NCT02100696|40152278|FG000|Induction Phase|Protocol Violation|0|||
16456976|NCT02100696|40152279|FG001|Induction Phase|Protocol Violation|1|||
16456977|NCT02100696|40152280|FG002|Induction Phase|Protocol Violation|1|||
16456978|NCT02100696|40152281|FG003|Induction Phase|Protocol Violation|0|||
16456979|NCT02100696|40152282|FG004|Induction Phase|Protocol Violation|0|||
16456980|NCT02100696|40152283|FG005|Induction Phase|Protocol Violation|0|||
16456981|NCT02100696|40152278|FG000|Induction Phase|Withdrawal by Subject|8|||
16456982|NCT02100696|40152279|FG001|Induction Phase|Withdrawal by Subject|2|||
16456983|NCT02100696|40152280|FG002|Induction Phase|Withdrawal by Subject|13|||
16456984|NCT02100696|40152281|FG003|Induction Phase|Withdrawal by Subject|0|||
16456985|NCT02100696|40152282|FG004|Induction Phase|Withdrawal by Subject|0|||
16456986|NCT02100696|40152283|FG005|Induction Phase|Withdrawal by Subject|0|||
16456987|NCT02100696|40152278|FG000|Induction Phase|Physician Decision|1|||
16456988|NCT02100696|40152279|FG001|Induction Phase|Physician Decision|0|||
16456989|NCT02100696|40152280|FG002|Induction Phase|Physician Decision|2|||
16456990|NCT02100696|40152281|FG003|Induction Phase|Physician Decision|0|||
16456991|NCT02100696|40152282|FG004|Induction Phase|Physician Decision|0|||
16456992|NCT02100696|40152283|FG005|Induction Phase|Physician Decision|0|||
16456993|NCT02100696|40152278|FG000|Induction Phase|Multiple Reasons|5|||
16456994|NCT02100696|40152279|FG001|Induction Phase|Multiple Reasons|2|||
16456995|NCT02100696|40152280|FG002|Induction Phase|Multiple Reasons|8|||
16456996|NCT02100696|40152281|FG003|Induction Phase|Multiple Reasons|0|||
16456997|NCT02100696|40152282|FG004|Induction Phase|Multiple Reasons|0|||
16456998|NCT02100696|40152283|FG005|Induction Phase|Multiple Reasons|0|||
16456999|NCT02100696|40152278|FG000|Maintenance Phase|Adverse Event|0|||
16457000|NCT02100696|40152279|FG001|Maintenance Phase|Adverse Event|0|||
16457001|NCT02100696|40152280|FG002|Maintenance Phase|Adverse Event|0|||
16457002|NCT02100696|40152281|FG003|Maintenance Phase|Adverse Event|0|||
16457003|NCT02100696|40152282|FG004|Maintenance Phase|Adverse Event|0|||
16457004|NCT02100696|40152283|FG005|Maintenance Phase|Adverse Event|2|||
16457005|NCT02100696|40152278|FG000|Maintenance Phase|Lost to Follow-up|0|||
16457006|NCT02100696|40152279|FG001|Maintenance Phase|Lost to Follow-up|0|||
16457007|NCT02100696|40152280|FG002|Maintenance Phase|Lost to Follow-up|0|||
16457008|NCT02100696|40152281|FG003|Maintenance Phase|Lost to Follow-up|0|||
16457009|NCT02100696|40152282|FG004|Maintenance Phase|Lost to Follow-up|1|||
16457010|NCT02100696|40152283|FG005|Maintenance Phase|Lost to Follow-up|0|||
16457011|NCT02100696|40152278|FG000|Maintenance Phase|Protocol Violation|0|||
16457012|NCT02100696|40152279|FG001|Maintenance Phase|Protocol Violation|0|||
16457013|NCT02100696|40152280|FG002|Maintenance Phase|Protocol Violation|0|||
16167090|NCT00546364|39091381|FG002|Overall Study|Mixed response|0|||
16457014|NCT02100696|40152281|FG003|Maintenance Phase|Protocol Violation|0|||
16457015|NCT02100696|40152282|FG004|Maintenance Phase|Protocol Violation|1|||
16457016|NCT02100696|40152283|FG005|Maintenance Phase|Protocol Violation|0|||
16457017|NCT02100696|40152278|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16457018|NCT02100696|40152279|FG001|Maintenance Phase|Withdrawal by Subject|0|||
16457019|NCT02100696|40152280|FG002|Maintenance Phase|Withdrawal by Subject|0|||
16457020|NCT02100696|40152281|FG003|Maintenance Phase|Withdrawal by Subject|1|||
16167091|NCT00546364|39091379|FG000|Overall Study|Palliative treatment|1|||
16167092|NCT00546364|39091380|FG001|Overall Study|Palliative treatment|0|||
16457021|NCT02100696|40152282|FG004|Maintenance Phase|Withdrawal by Subject|4|||
16457022|NCT02100696|40152283|FG005|Maintenance Phase|Withdrawal by Subject|2|||
16457023|NCT02100696|40152278|FG000|Maintenance Phase|Physician Decision|0|||
16457024|NCT02100696|40152279|FG001|Maintenance Phase|Physician Decision|0|||
16457025|NCT02100696|40152280|FG002|Maintenance Phase|Physician Decision|0|||
16457026|NCT02100696|40152281|FG003|Maintenance Phase|Physician Decision|0|||
16457027|NCT02100696|40152282|FG004|Maintenance Phase|Physician Decision|1|||
16457028|NCT02100696|40152283|FG005|Maintenance Phase|Physician Decision|0|||
16457029|NCT02100696|40152278|FG000|Maintenance Phase|Multiple Reasons|0|||
16457030|NCT02100696|40152279|FG001|Maintenance Phase|Multiple Reasons|0|||
16457031|NCT02100696|40152280|FG002|Maintenance Phase|Multiple Reasons|0|||
16457032|NCT02100696|40152281|FG003|Maintenance Phase|Multiple Reasons|0|||
16457033|NCT02100696|40152282|FG004|Maintenance Phase|Multiple Reasons|2|||
16457034|NCT02100696|40152283|FG005|Maintenance Phase|Multiple Reasons|1|||
16457035|NCT02920242|40152286|FG000|Overall Study|Withdrawal by Subject|1|||
16457036|NCT02920242|40152287|FG001|Overall Study|Withdrawal by Subject|0|||
16457037|NCT02920242|40152288|FG002|Overall Study|Withdrawal by Subject|1|||
16457038|NCT02920242|40152286|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
16457039|NCT02920242|40152287|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
16457040|NCT02920242|40152288|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
16457041|NCT00591318|40152289|FG000|Overall Study|Lack of Efficacy|2|||
16457042|NCT00591318|40152290|FG001|Overall Study|Lack of Efficacy|0|||
16167093|NCT00546364|39091381|FG002|Overall Study|Palliative treatment|1|||
16167094|NCT00546364|39091379|FG000|Overall Study|Target lesions resected|1|||
16167095|NCT00546364|39091380|FG001|Overall Study|Target lesions resected|0|||
16167096|NCT00546364|39091381|FG002|Overall Study|Target lesions resected|0|||
16167097|NCT00546364|39091379|FG000|Overall Study|Physician Decision|0|||
16167098|NCT00546364|39091380|FG001|Overall Study|Physician Decision|0|||
16167099|NCT00546364|39091381|FG002|Overall Study|Physician Decision|1|||
16457043|NCT00591318|40152289|FG000|Overall Study|Adverse Event|2|||
16457044|NCT00591318|40152290|FG001|Overall Study|Adverse Event|0|||
16457045|NCT00402740|40152291|FG000|Overall Study|Withdrawal by Subject|18|||
16457046|NCT00402740|40152291|FG000|Overall Study|Death|50|||
16457047|NCT00402740|40152291|FG000|Overall Study|Lost to Follow-up|6|||
16457048|NCT00402740|40152291|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
16457049|NCT00402740|40152291|FG000|Overall Study|Subject disposition unknown.|1|||
16457050|NCT00001213|40152292|FG000|Overall Study|Death|18|||
16457051|NCT00509145|40152295|FG000|Overall Study|Death|0|||
16457052|NCT00509145|40152296|FG001|Overall Study|Death|2|||
16457053|NCT00509145|40152295|FG000|Overall Study|Adverse Event|42|||
16457054|NCT00509145|40152296|FG001|Overall Study|Adverse Event|28|||
16457055|NCT00509145|40152295|FG000|Overall Study|Withdrawal by Subject|32|||
16457056|NCT00509145|40152296|FG001|Overall Study|Withdrawal by Subject|38|||
16457057|NCT00509145|40152295|FG000|Overall Study|Physician Decision|11|||
16457058|NCT00509145|40152296|FG001|Overall Study|Physician Decision|14|||
16167100|NCT00546364|39091379|FG000|Overall Study|Sponsor decision|0|||
16167101|NCT00546364|39091380|FG001|Overall Study|Sponsor decision|0|||
16167102|NCT00546364|39091381|FG002|Overall Study|Sponsor decision|1|||
16167103|NCT02600507|39091382|FG000|Overall Study|Adverse Event|3|||
16167104|NCT02600507|39091383|FG001|Overall Study|Adverse Event|15|||
16457059|NCT00509145|40152295|FG000|Overall Study|Protocol Violation|1|||
16457060|NCT00509145|40152296|FG001|Overall Study|Protocol Violation|6|||
16457061|NCT00509145|40152295|FG000|Overall Study|Pregnancy|3|||
16457062|NCT00509145|40152296|FG001|Overall Study|Pregnancy|8|||
16457063|NCT00509145|40152295|FG000|Overall Study|Lost to Follow-up|6|||
16457064|NCT00509145|40152296|FG001|Overall Study|Lost to Follow-up|5|||
16457065|NCT00509145|40152295|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
16457066|NCT00509145|40152296|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
16457067|NCT00509145|40152295|FG000|Overall Study|Other|6|||
16457068|NCT00509145|40152296|FG001|Overall Study|Other|6|||
16457069|NCT02604160|40152297|FG000|Overall Study|Protocol Violation|0|||
16457070|NCT02604160|40152298|FG001|Overall Study|Protocol Violation|1|||
16457071|NCT02604160|40152297|FG000|Overall Study|Physician Decision|0|||
16457072|NCT02604160|40152298|FG001|Overall Study|Physician Decision|1|||
16457073|NCT01028300|40152302|FG000|Overall Study|Study Terminated|4|||
16457074|NCT04491604|40152303|FG000|Overall Study|Withdrawal by Subject|3|||
16167105|NCT02600507|39091384|FG002|Overall Study|Adverse Event|5|||
16457075|NCT03976648|40152304|FG000|Overall Study|Adverse Event|0|||
16457076|NCT03976648|40152305|FG001|Overall Study|Adverse Event|2|||
16457077|NCT03976648|40152304|FG000|Overall Study|Study terminated by sponsor|21|||
16457078|NCT03976648|40152305|FG001|Overall Study|Study terminated by sponsor|8|||
16457079|NCT02032238|40152309|FG000|Overall Study|Lost to Follow-up|2|||
16457080|NCT02032238|40152310|FG001|Overall Study|Lost to Follow-up|0|||
16457081|NCT01561313|40152311|FG000|Overall Study|Withdrawal by Subject|1|||
16457082|NCT01561313|40152312|FG001|Overall Study|Withdrawal by Subject|0|||
16457083|NCT01561313|40152311|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
16457084|NCT01561313|40152312|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
16457085|NCT00228553|40152313|FG000|Overall Study|Adverse Event|112|||
16457086|NCT00228553|40152313|FG000|Overall Study|Lack of Efficacy|34|||
16457087|NCT00228553|40152313|FG000|Overall Study|Lost to Follow-up|67|||
16167106|NCT02600507|39091382|FG000|Overall Study|Lack of Efficacy|3|||
16457088|NCT00228553|40152313|FG000|Overall Study|Physician Decision|48|||
16457089|NCT00228553|40152313|FG000|Overall Study|Protocol Violation|6|||
16457090|NCT00228553|40152313|FG000|Overall Study|Withdrawal by Subject|115|||
16457091|NCT00228553|40152313|FG000|Overall Study|Pregnancy|2|||
16457092|NCT00228553|40152313|FG000|Overall Study|Miscellaneous|46|||
16457093|NCT00554216|40152314|FG000|Overall Study|Lost to Follow-up|92|||
16457094|NCT00554216|40152315|FG001|Overall Study|Lost to Follow-up|31|||
16457095|NCT00554216|40152316|FG002|Overall Study|Lost to Follow-up|63|||
16457096|NCT00554216|40152314|FG000|Overall Study|Adverse Event|16|||
16457097|NCT00554216|40152315|FG001|Overall Study|Adverse Event|16|||
16457098|NCT00554216|40152316|FG002|Overall Study|Adverse Event|36|||
16457099|NCT00554216|40152314|FG000|Overall Study|Withdrawal by Subject|92|||
16457100|NCT00554216|40152315|FG001|Overall Study|Withdrawal by Subject|31|||
16167107|NCT02600507|39091383|FG001|Overall Study|Lack of Efficacy|8|||
16457101|NCT00554216|40152316|FG002|Overall Study|Withdrawal by Subject|43|||
16457102|NCT00554216|40152314|FG000|Overall Study|Non compliance|10|||
16457103|NCT00554216|40152315|FG001|Overall Study|Non compliance|4|||
16457104|NCT00554216|40152316|FG002|Overall Study|Non compliance|5|||
16457105|NCT00554216|40152314|FG000|Overall Study|Pregnancy|2|||
16457106|NCT00554216|40152315|FG001|Overall Study|Pregnancy|1|||
16457107|NCT00554216|40152316|FG002|Overall Study|Pregnancy|14|||
16457108|NCT00554216|40152314|FG000|Overall Study|Restricted med|3|||
16457109|NCT00554216|40152315|FG001|Overall Study|Restricted med|1|||
16457110|NCT00554216|40152316|FG002|Overall Study|Restricted med|1|||
16457111|NCT00554216|40152314|FG000|Overall Study|Other|12|||
16457112|NCT00554216|40152315|FG001|Overall Study|Other|7|||
16457113|NCT00554216|40152316|FG002|Overall Study|Other|10|||
16457114|NCT00554216|40152314|FG000|Overall Study|Lack of Efficacy|15|||
16457115|NCT00554216|40152315|FG001|Overall Study|Lack of Efficacy|3|||
16457116|NCT00554216|40152316|FG002|Overall Study|Lack of Efficacy|0|||
16457117|NCT00256997|40152318|FG000|Overall Study|Protocol Violation|1|||
16457118|NCT00256997|40152319|FG001|Overall Study|Protocol Violation|4|||
16457119|NCT00256997|40152318|FG000|Overall Study|Lack of Efficacy|1|||
16457120|NCT00256997|40152319|FG001|Overall Study|Lack of Efficacy|4|||
16457121|NCT00256997|40152318|FG000|Overall Study|Death|2|||
16457122|NCT00256997|40152319|FG001|Overall Study|Death|0|||
16457123|NCT00256997|40152318|FG000|Overall Study|Adverse Event|4|||
16457124|NCT00256997|40152319|FG001|Overall Study|Adverse Event|0|||
16457125|NCT00256997|40152318|FG000|Overall Study|Lost to Follow-up|3|||
16457126|NCT00256997|40152319|FG001|Overall Study|Lost to Follow-up|5|||
16457127|NCT00256997|40152318|FG000|Overall Study|Withdrawal by Subject|13|||
16457128|NCT00256997|40152319|FG001|Overall Study|Withdrawal by Subject|3|||
16457129|NCT00256997|40152318|FG000|Overall Study|Started but not treated|2|||
16457130|NCT00256997|40152319|FG001|Overall Study|Started but not treated|0|||
16457131|NCT00256997|40152318|FG000|Overall Study|Other|5|||
16457132|NCT00256997|40152319|FG001|Overall Study|Other|8|||
16457133|NCT00256997|40152318|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
16457134|NCT00256997|40152319|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
16457135|NCT00256997|40152318|FG000|Overall Study|Participant Non-compliant|3|||
16457136|NCT00256997|40152319|FG001|Overall Study|Participant Non-compliant|6|||
16457137|NCT00256997|40152318|FG000|Overall Study|Investigator Withdrew Participant|2|||
16457138|NCT00256997|40152319|FG001|Overall Study|Investigator Withdrew Participant|1|||
16457139|NCT01012219|40152320|FG000|Period 1|Withdrawal by Subject|1|||
16457140|NCT01012219|40152320|FG000|Period 2|Withdrawal by Subject|1|||
16457141|NCT00146848|40152323|FG000|Pre-randomization|Death|19|||
16457142|NCT00146848|40152324|FG001|Pre-randomization|Death|0|||
16457143|NCT00146848|40152325|FG002|Pre-randomization|Death|0|||
16457144|NCT00146848|40152323|FG000|Pre-randomization|Lost to Follow-up|70|||
16457145|NCT00146848|40152324|FG001|Pre-randomization|Lost to Follow-up|0|||
16457146|NCT00146848|40152325|FG002|Pre-randomization|Lost to Follow-up|0|||
16457147|NCT00146848|40152323|FG000|Pre-randomization|Physician Decision|8|||
16457148|NCT00146848|40152324|FG001|Pre-randomization|Physician Decision|0|||
16457149|NCT00146848|40152325|FG002|Pre-randomization|Physician Decision|0|||
16457150|NCT00146848|40152323|FG000|Pre-randomization|Protocol Violation|172|||
16457151|NCT00146848|40152324|FG001|Pre-randomization|Protocol Violation|0|||
16457152|NCT00146848|40152325|FG002|Pre-randomization|Protocol Violation|0|||
16457153|NCT00146848|40152323|FG000|Pre-randomization|Withdrawal by Subject|40|||
16457154|NCT00146848|40152324|FG001|Pre-randomization|Withdrawal by Subject|0|||
16457155|NCT00146848|40152325|FG002|Pre-randomization|Withdrawal by Subject|0|||
16457156|NCT00146848|40152323|FG000|Post-randomization|Lost to Follow-up|12|||
16457157|NCT00146848|40152324|FG001|Post-randomization|Lost to Follow-up|15|||
16457158|NCT00146848|40152325|FG002|Post-randomization|Lost to Follow-up|12|||
16457159|NCT00146848|40152323|FG000|Post-randomization|Withdrawn|26|||
16457160|NCT00146848|40152324|FG001|Post-randomization|Withdrawn|32|||
16457161|NCT00146848|40152325|FG002|Post-randomization|Withdrawn|27|||
16457162|NCT02929407|40152326|FG000|Overall Study|Adverse Event|1|||
16167108|NCT02600507|39091384|FG002|Overall Study|Lack of Efficacy|5|||
16457163|NCT01396070|40152327|FG000|Overall Study|Withdrawal by Subject|2|||
16457164|NCT01396070|40152327|FG000|Overall Study|Death|2|||
16457165|NCT01396070|40152327|FG000|Overall Study|Adverse Event|8|||
16167109|NCT02600507|39091382|FG000|Overall Study|Lost to Follow-up|3|||
16167110|NCT02600507|39091383|FG001|Overall Study|Lost to Follow-up|5|||
16167111|NCT02600507|39091384|FG002|Overall Study|Lost to Follow-up|2|||
16167112|NCT02600507|39091382|FG000|Overall Study|Protocol Violation|12|||
16167113|NCT02600507|39091383|FG001|Overall Study|Protocol Violation|4|||
16167114|NCT02600507|39091384|FG002|Overall Study|Protocol Violation|4|||
16167115|NCT02600507|39091382|FG000|Overall Study|Physician Decision|1|||
16167116|NCT02600507|39091383|FG001|Overall Study|Physician Decision|0|||
16167117|NCT02600507|39091384|FG002|Overall Study|Physician Decision|1|||
16167118|NCT02600507|39091382|FG000|Overall Study|Withdrawal by Subject|7|||
16167119|NCT02600507|39091383|FG001|Overall Study|Withdrawal by Subject|11|||
16167120|NCT02600507|39091384|FG002|Overall Study|Withdrawal by Subject|7|||
16167121|NCT02600507|39091382|FG000|Overall Study|Other|0|||
16167122|NCT02600507|39091383|FG001|Overall Study|Other|1|||
16167123|NCT02600507|39091384|FG002|Overall Study|Other|1|||
16167124|NCT05655377|39091385|FG000|Overall Study|Withdrawal by Subject|2|||
16167125|NCT01583179|39091387|FG000|Overall Study|Screen failure|1|||
16167126|NCT01583179|39091388|FG001|Overall Study|Screen failure|2|||
16167127|NCT03313050|39091400|FG000|Stage 2: 12 Months|Adverse Event|0|||
16167128|NCT03313050|39091401|FG001|Stage 2: 12 Months|Adverse Event|0|||
16167129|NCT03313050|39091402|FG002|Stage 2: 12 Months|Adverse Event|0|||
16167130|NCT03313050|39091403|FG003|Stage 2: 12 Months|Adverse Event|1|||
16167131|NCT03313050|39091400|FG000|Stage 2: 12 Months|Death|0|||
16167132|NCT03313050|39091401|FG001|Stage 2: 12 Months|Death|0|||
16167133|NCT03313050|39091402|FG002|Stage 2: 12 Months|Death|3|||
16167134|NCT03313050|39091403|FG003|Stage 2: 12 Months|Death|0|||
16167135|NCT03313050|39091400|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
16167136|NCT03313050|39091401|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
16167137|NCT03313050|39091402|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
16167138|NCT03313050|39091403|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
16167139|NCT03313050|39091400|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
16167140|NCT03313050|39091401|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
16167141|NCT03313050|39091402|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
16167142|NCT03313050|39091403|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
16167143|NCT03313050|39091400|FG000|Stage 2: 12 Months|Protocol deviation|0|||
16167144|NCT03313050|39091401|FG001|Stage 2: 12 Months|Protocol deviation|0|||
16167145|NCT03313050|39091402|FG002|Stage 2: 12 Months|Protocol deviation|7|||
16167146|NCT03313050|39091403|FG003|Stage 2: 12 Months|Protocol deviation|7|||
16167147|NCT03313050|39091400|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
16167148|NCT03313050|39091401|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
16167149|NCT03313050|39091402|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
16167150|NCT03313050|39091403|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
16167151|NCT03313050|39091400|FG000|Stage 2: 12 Months|Other|0|||
16457166|NCT01396070|40152327|FG000|Overall Study|Physician Decision|3|||
16457167|NCT01396070|40152327|FG000|Overall Study|Lack of Efficacy|4|||
16457168|NCT00636363|40152328|FG000|Overall Study|Conjunctivitis|0|||
16167152|NCT03313050|39091401|FG001|Stage 2: 12 Months|Other|0|||
16167153|NCT03313050|39091402|FG002|Stage 2: 12 Months|Other|0|||
16167154|NCT03313050|39091403|FG003|Stage 2: 12 Months|Other|1|||
16167155|NCT03828487|39091410|FG000|Overall Study|Physician Decision|1|||
16457169|NCT00636363|40152329|FG001|Overall Study|Conjunctivitis|0|||
16457170|NCT00636363|40152330|FG002|Overall Study|Conjunctivitis|1|||
16457171|NCT00636363|40152328|FG000|Overall Study|Adverse Event|0|||
16457172|NCT00636363|40152329|FG001|Overall Study|Adverse Event|0|||
16457173|NCT00636363|40152330|FG002|Overall Study|Adverse Event|1|||
16457174|NCT00636363|40152328|FG000|Overall Study|Positive slit lamp finding|0|||
16457175|NCT00636363|40152329|FG001|Overall Study|Positive slit lamp finding|2|||
16457176|NCT00636363|40152330|FG002|Overall Study|Positive slit lamp finding|1|||
16457177|NCT00636363|40152328|FG000|Overall Study|Study related symptoms/complaints|8|||
16457178|NCT00636363|40152329|FG001|Overall Study|Study related symptoms/complaints|7|||
16457179|NCT00636363|40152330|FG002|Overall Study|Study related symptoms/complaints|4|||
16457180|NCT00636363|40152328|FG000|Overall Study|Met ineligibility criteria|0|||
16167156|NCT02305563|39091418|FG000|Treatment Period|Disease progression|0|||
16167157|NCT02305563|39091419|FG001|Treatment Period|Disease progression|0|||
16167158|NCT02305563|39091420|FG002|Treatment Period|Disease progression|15|||
16167159|NCT02305563|39091421|FG003|Treatment Period|Disease progression|6|||
16167160|NCT02305563|39091422|FG004|Treatment Period|Disease progression|6|||
16167161|NCT02305563|39091418|FG000|Treatment Period|Study drug toxicity|0|||
16167162|NCT02305563|39091419|FG001|Treatment Period|Study drug toxicity|0|||
16167163|NCT02305563|39091420|FG002|Treatment Period|Study drug toxicity|0|||
16167164|NCT02305563|39091421|FG003|Treatment Period|Study drug toxicity|1|||
16457181|NCT00636363|40152329|FG001|Overall Study|Met ineligibility criteria|0|||
16457182|NCT00636363|40152330|FG002|Overall Study|Met ineligibility criteria|3|||
16457183|NCT00636363|40152328|FG000|Overall Study|Missed > 1 visit|0|||
16457184|NCT00636363|40152329|FG001|Overall Study|Missed > 1 visit|1|||
16167165|NCT02305563|39091422|FG004|Treatment Period|Study drug toxicity|2|||
16167166|NCT02305563|39091418|FG000|Treatment Period|Death|0|||
16457185|NCT00636363|40152330|FG002|Overall Study|Missed > 1 visit|3|||
16457186|NCT00636363|40152328|FG000|Overall Study|Lack of motivation|1|||
16457187|NCT00636363|40152329|FG001|Overall Study|Lack of motivation|0|||
16457188|NCT00636363|40152330|FG002|Overall Study|Lack of motivation|1|||
16457189|NCT00636363|40152328|FG000|Overall Study|Protocol Violation|0|||
16457190|NCT00636363|40152329|FG001|Overall Study|Protocol Violation|3|||
16457191|NCT00636363|40152330|FG002|Overall Study|Protocol Violation|0|||
16457192|NCT00636363|40152328|FG000|Overall Study|Lost to Follow-up|3|||
16457193|NCT00636363|40152329|FG001|Overall Study|Lost to Follow-up|4|||
16457194|NCT00636363|40152330|FG002|Overall Study|Lost to Follow-up|2|||
16457195|NCT00636363|40152328|FG000|Overall Study|Withdrawal by Subject|1|||
16457196|NCT00636363|40152329|FG001|Overall Study|Withdrawal by Subject|3|||
16457197|NCT00636363|40152330|FG002|Overall Study|Withdrawal by Subject|2|||
16457198|NCT00701662|40152331|FG000|Overall Study|Lack of Efficacy|1|||
16457199|NCT00373113|40152336|FG000|Overall Study|Death|1|||
16457200|NCT00373113|40152337|FG001|Overall Study|Death|7|||
16457201|NCT00373113|40152336|FG000|Overall Study|Adverse Event|38|||
16457202|NCT00373113|40152337|FG001|Overall Study|Adverse Event|24|||
16457203|NCT00373113|40152336|FG000|Overall Study|Study terminated by sponsor|9|||
16457204|NCT00373113|40152337|FG001|Overall Study|Study terminated by sponsor|1|||
16457205|NCT00373113|40152336|FG000|Overall Study|Global deterioration of health status|10|||
16457206|NCT00373113|40152337|FG001|Overall Study|Global deterioration of health status|7|||
16457207|NCT00373113|40152336|FG000|Overall Study|Lost to Follow-up|1|||
16457208|NCT00373113|40152337|FG001|Overall Study|Lost to Follow-up|3|||
16457209|NCT00373113|40152336|FG000|Overall Study|Objective progression or relapse|150|||
16457210|NCT00373113|40152337|FG001|Overall Study|Objective progression or relapse|169|||
16457211|NCT00373113|40152336|FG000|Overall Study|Other|14|||
16457212|NCT00373113|40152337|FG001|Overall Study|Other|17|||
16457213|NCT00373113|40152336|FG000|Overall Study|Protocol Violation|5|||
16457214|NCT00373113|40152337|FG001|Overall Study|Protocol Violation|1|||
16457215|NCT00373113|40152336|FG000|Overall Study|Withdrawal by Subject|10|||
16457216|NCT00373113|40152337|FG001|Overall Study|Withdrawal by Subject|15|||
16457217|NCT02974543|40155533|FG000|Overall Study|Withdrawal by Subject|1|||
16457218|NCT02974543|40155534|FG001|Overall Study|Withdrawal by Subject|0|||
16457219|NCT01010867|40155543|FG000|Overall Study|< 50% adherence to probiotic|1|||
16457220|NCT02703337|40155548|FG000|Period One (Part A)|Withdrawal by Subject|0|||
16457221|NCT02703337|40155549|FG001|Period One (Part A)|Withdrawal by Subject|0|||
16457222|NCT02703337|40155550|FG002|Period One (Part A)|Withdrawal by Subject|0|||
16457223|NCT02703337|40155551|FG003|Period One (Part A)|Withdrawal by Subject|0|||
16457224|NCT02703337|40155552|FG004|Period One (Part A)|Withdrawal by Subject|1|||
16457225|NCT02703337|40155553|FG005|Period One (Part A)|Withdrawal by Subject|0|||
16457226|NCT02703337|40155554|FG006|Period One (Part A)|Withdrawal by Subject|0|||
16457227|NCT02703337|40155555|FG007|Period One (Part A)|Withdrawal by Subject|0|||
16457228|NCT02695420|40155556|FG000|Overall Study|Death|0|||
16457229|NCT02695420|40155557|FG001|Overall Study|Death|1|||
16457230|NCT02695420|40155558|FG002|Overall Study|Death|0|||
16457231|NCT02695420|40155559|FG003|Overall Study|Death|0|||
16457232|NCT01932437|40155560|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
16457233|NCT01932437|40155561|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
16457234|NCT01932437|40155562|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
16457235|NCT01932437|40155563|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
16457236|NCT01932437|40155564|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
16457237|NCT01932437|40155565|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
16457238|NCT01821560|40155566|FG000|Overall Study|Lost to Follow-up|5|||
16457239|NCT01821560|40155567|FG001|Overall Study|Lost to Follow-up|5|||
16457240|NCT01821560|40155566|FG000|Overall Study|Withdrawal by Subject|1|||
16457241|NCT01821560|40155567|FG001|Overall Study|Withdrawal by Subject|1|||
16457242|NCT01821560|40155566|FG000|Overall Study|Protocol Violation|0|||
16457243|NCT01821560|40155567|FG001|Overall Study|Protocol Violation|1|||
16457244|NCT00910299|40155568|FG000|Overall Study|Withdrawal by Subject|16|||
16457245|NCT00910299|40155569|FG001|Overall Study|Withdrawal by Subject|13|||
16457246|NCT00910299|40155568|FG000|Overall Study|Sponsor Decision|58|||
16457247|NCT00910299|40155569|FG001|Overall Study|Sponsor Decision|60|||
16457248|NCT00910299|40155568|FG000|Overall Study|Didn't receive any study drug|2|||
16457249|NCT00910299|40155569|FG001|Overall Study|Didn't receive any study drug|1|||
16457250|NCT01646125|40155570|FG000|Overall Study|Untreated|2|||
16457251|NCT01646125|40155571|FG001|Overall Study|Untreated|5|||
16457252|NCT01646125|40155570|FG000|Overall Study|Adverse Event|2|||
16457253|NCT01646125|40155571|FG001|Overall Study|Adverse Event|1|||
16457254|NCT01646125|40155570|FG000|Overall Study|Death|1|||
16457255|NCT01646125|40155571|FG001|Overall Study|Death|1|||
16457256|NCT01646125|40155570|FG000|Overall Study|Physician Decision|1|||
16457257|NCT01646125|40155571|FG001|Overall Study|Physician Decision|3|||
16457258|NCT01646125|40155570|FG000|Overall Study|Progressive disease|22|||
16457259|NCT01646125|40155571|FG001|Overall Study|Progressive disease|16|||
16457260|NCT01646125|40155570|FG000|Overall Study|Study terminated by sponsor|2|||
16457261|NCT01646125|40155571|FG001|Overall Study|Study terminated by sponsor|1|||
16457262|NCT01646125|40155570|FG000|Overall Study|Subject/Guardian decision|1|||
16457263|NCT01646125|40155571|FG001|Overall Study|Subject/Guardian decision|1|||
16457264|NCT03720652|40155572|FG000|Overall Study|Withdrawal by Subject|2|||
16457265|NCT03720652|40155573|FG001|Overall Study|Withdrawal by Subject|7|||
16457266|NCT03720652|40155572|FG000|Overall Study|Lost to Follow-up|0|||
16457267|NCT03720652|40155573|FG001|Overall Study|Lost to Follow-up|4|||
16457268|NCT02139592|40155582|FG000|Overall Study|Case Report Forms Uncollected|8|||
16457269|NCT03085914|40155585|FG000|Overall Study|Death|6|||
16457270|NCT03085914|40155586|FG001|Overall Study|Death|6|||
16457271|NCT03085914|40155587|FG002|Overall Study|Death|4|||
16457272|NCT03085914|40155588|FG003|Overall Study|Death|1|||
16457273|NCT03085914|40155589|FG004|Overall Study|Death|5|||
16457274|NCT03085914|40155590|FG005|Overall Study|Death|2|||
16457275|NCT03085914|40155591|FG006|Overall Study|Death|2|||
16457276|NCT03085914|40155585|FG000|Overall Study|Withdrawal by Subject|1|||
16457277|NCT03085914|40155586|FG001|Overall Study|Withdrawal by Subject|1|||
16457278|NCT03085914|40155587|FG002|Overall Study|Withdrawal by Subject|2|||
16457279|NCT03085914|40155588|FG003|Overall Study|Withdrawal by Subject|2|||
16457280|NCT03085914|40155589|FG004|Overall Study|Withdrawal by Subject|2|||
16457281|NCT03085914|40155590|FG005|Overall Study|Withdrawal by Subject|0|||
16457282|NCT03085914|40155591|FG006|Overall Study|Withdrawal by Subject|1|||
16457283|NCT03085914|40155585|FG000|Overall Study|Lost to Follow-up|0|||
16457284|NCT03085914|40155586|FG001|Overall Study|Lost to Follow-up|0|||
16457285|NCT03085914|40155587|FG002|Overall Study|Lost to Follow-up|1|||
16457286|NCT03085914|40155588|FG003|Overall Study|Lost to Follow-up|0|||
16457287|NCT03085914|40155589|FG004|Overall Study|Lost to Follow-up|0|||
16457288|NCT03085914|40155590|FG005|Overall Study|Lost to Follow-up|1|||
16457289|NCT03085914|40155591|FG006|Overall Study|Lost to Follow-up|1|||
16457290|NCT03085914|40155585|FG000|Overall Study|Reason was not specified,|2|||
16457291|NCT03085914|40155586|FG001|Overall Study|Reason was not specified,|2|||
16457292|NCT03085914|40155587|FG002|Overall Study|Reason was not specified,|2|||
16457293|NCT03085914|40155588|FG003|Overall Study|Reason was not specified,|3|||
16457294|NCT03085914|40155589|FG004|Overall Study|Reason was not specified,|3|||
16457295|NCT03085914|40155590|FG005|Overall Study|Reason was not specified,|3|||
16457296|NCT03085914|40155591|FG006|Overall Study|Reason was not specified,|6|||
16457297|NCT03085914|40155585|FG000|Overall Study|Progressive Disease|0|||
16457298|NCT03085914|40155586|FG001|Overall Study|Progressive Disease|0|||
16457299|NCT03085914|40155587|FG002|Overall Study|Progressive Disease|2|||
16457300|NCT03085914|40155588|FG003|Overall Study|Progressive Disease|2|||
16457301|NCT03085914|40155589|FG004|Overall Study|Progressive Disease|1|||
16457302|NCT03085914|40155590|FG005|Overall Study|Progressive Disease|1|||
16457303|NCT03085914|40155591|FG006|Overall Study|Progressive Disease|1|||
16457304|NCT03085914|40155585|FG000|Overall Study|Study Terminated by the Sponsor|0|||
16457305|NCT03085914|40155586|FG001|Overall Study|Study Terminated by the Sponsor|0|||
16457306|NCT03085914|40155587|FG002|Overall Study|Study Terminated by the Sponsor|0|||
16457307|NCT03085914|40155588|FG003|Overall Study|Study Terminated by the Sponsor|1|||
16457308|NCT03085914|40155589|FG004|Overall Study|Study Terminated by the Sponsor|2|||
16457309|NCT03085914|40155590|FG005|Overall Study|Study Terminated by the Sponsor|1|||
16457310|NCT03085914|40155591|FG006|Overall Study|Study Terminated by the Sponsor|0|||
16457311|NCT02273596|40155592|FG000|24-Week Treatment Period|Adverse Event|3|||
16457312|NCT02273596|40155592|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
16457313|NCT02273596|40155592|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
16457314|NCT02273596|40155592|FG000|24-Week Treatment Period|Physician Decision|1|||
16457315|NCT02273596|40155592|FG000|24-Week Treatment Period|Protocol Deviation|1|||
16457316|NCT02273596|40155592|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
16457317|NCT02273596|40155592|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
16457318|NCT02273596|40155592|FG000|Extension Period|Lost to Follow-up|1|||
16457319|NCT02273596|40155592|FG000|Extension Period|Protocol Deviation|1|||
16457320|NCT03179605|40155595|FG000|Overall Study|Withdrawal by Subject|1|||
16457321|NCT03500224|40155602|FG000|Overall Study|Withdrawal by Subject|2|||
16457322|NCT02577887|40155604|FG000|Overall Study|Death|93|||
16457323|NCT02577887|40155604|FG000|Overall Study|Protocol Violation|125|||
16457324|NCT02577887|40155604|FG000|Overall Study|Withdrawal by Subject|80|||
16457325|NCT01137604|40155605|FG000|Overall Study|Adverse Event|3|||
16457326|NCT01137604|40155606|FG001|Overall Study|Adverse Event|6|||
16457327|NCT01137604|40155607|FG002|Overall Study|Adverse Event|9|||
16457328|NCT01137604|40155608|FG003|Overall Study|Adverse Event|9|||
16457329|NCT01137604|40155605|FG000|Overall Study|Participant Choice|0|||
16457330|NCT01137604|40155606|FG001|Overall Study|Participant Choice|2|||
16457331|NCT01137604|40155607|FG002|Overall Study|Participant Choice|2|||
16457332|NCT01137604|40155608|FG003|Overall Study|Participant Choice|0|||
16457333|NCT01137604|40155605|FG000|Overall Study|Withdrawal of consent|0|||
16457334|NCT01137604|40155606|FG001|Overall Study|Withdrawal of consent|0|||
16457335|NCT01137604|40155607|FG002|Overall Study|Withdrawal of consent|0|||
16457336|NCT01137604|40155608|FG003|Overall Study|Withdrawal of consent|2|||
16457337|NCT01137604|40155605|FG000|Overall Study|Clinical progression/deterioration|1|||
16457338|NCT01137604|40155606|FG001|Overall Study|Clinical progression/deterioration|2|||
16457339|NCT01137604|40155607|FG002|Overall Study|Clinical progression/deterioration|2|||
16457340|NCT01137604|40155608|FG003|Overall Study|Clinical progression/deterioration|0|||
16457341|NCT02840799|40155609|FG000|Phase 1|Physician Decision|1|||
16457342|NCT02840799|40155610|FG001|Phase 1|Physician Decision|3|||
16457343|NCT02840799|40155609|FG000|Phase 1|Withdrawal by Subject|4|||
16457344|NCT02840799|40155610|FG001|Phase 1|Withdrawal by Subject|0|||
16457345|NCT02840799|40155609|FG000|Phase 2 (Crossover)|Adverse Event|0|||
16457346|NCT02840799|40155610|FG001|Phase 2 (Crossover)|Adverse Event|1|||
16457347|NCT02840799|40155609|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
16457348|NCT02840799|40155610|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
16457349|NCT02230670|40155611|FG000|Overall Study|Adverse Event|1|||
16457350|NCT02230670|40155612|FG001|Overall Study|Adverse Event|2|||
16457351|NCT02230670|40155611|FG000|Overall Study|Withdrawal by Subject|2|||
16457352|NCT02230670|40155612|FG001|Overall Study|Withdrawal by Subject|2|||
16457353|NCT02230670|40155611|FG000|Overall Study|Physician Decision|0|||
16457354|NCT02230670|40155612|FG001|Overall Study|Physician Decision|1|||
16457355|NCT02230670|40155611|FG000|Overall Study|Protocol Violation|0|||
16457356|NCT02230670|40155612|FG001|Overall Study|Protocol Violation|1|||
16457357|NCT02230670|40155611|FG000|Overall Study|Progression to Child-Pugh C|1|||
16457358|NCT02230670|40155612|FG001|Overall Study|Progression to Child-Pugh C|2|||
16457359|NCT03566485|40155613|FG000|Overall Study|Disease progression|5|||
16457360|NCT03566485|40155614|FG001|Overall Study|Disease progression|4|||
16457361|NCT03566485|40155613|FG000|Overall Study|Clinical progression|0|||
16457362|NCT03566485|40155614|FG001|Overall Study|Clinical progression|1|||
16457363|NCT03566485|40155613|FG000|Overall Study|Toxicity|0|||
16457364|NCT03566485|40155614|FG001|Overall Study|Toxicity|2|||
16457365|NCT01761162|40155620|FG000|Overall Study|Withdrawal by Subject|3|||
16457366|NCT03137069|40155623|FG000|Overall Study|Withdrawal by Subject|1|||
16457367|NCT03137069|40155624|FG001|Overall Study|Withdrawal by Subject|2|||
16457368|NCT03137069|40155625|FG002|Overall Study|Withdrawal by Subject|2|||
16457369|NCT03137069|40155626|FG003|Overall Study|Withdrawal by Subject|2|||
16457370|NCT03137069|40155627|FG004|Overall Study|Withdrawal by Subject|0|||
16457371|NCT03137069|40155628|FG005|Overall Study|Withdrawal by Subject|0|||
16457372|NCT03137069|40155623|FG000|Overall Study|Adverse Event|0|||
16457373|NCT03137069|40155624|FG001|Overall Study|Adverse Event|3|||
16457374|NCT03137069|40155625|FG002|Overall Study|Adverse Event|1|||
16457375|NCT03137069|40155626|FG003|Overall Study|Adverse Event|1|||
16457376|NCT03137069|40155627|FG004|Overall Study|Adverse Event|0|||
16457377|NCT03137069|40155628|FG005|Overall Study|Adverse Event|1|||
16457378|NCT03137069|40155623|FG000|Overall Study|Protocol Violation|0|||
16457379|NCT03137069|40155624|FG001|Overall Study|Protocol Violation|1|||
16457380|NCT03137069|40155625|FG002|Overall Study|Protocol Violation|0|||
16457381|NCT03137069|40155626|FG003|Overall Study|Protocol Violation|1|||
16457382|NCT03137069|40155627|FG004|Overall Study|Protocol Violation|1|||
16457383|NCT03137069|40155628|FG005|Overall Study|Protocol Violation|1|||
16457384|NCT03137069|40155623|FG000|Overall Study|Physician Decision|0|||
16457385|NCT03137069|40155624|FG001|Overall Study|Physician Decision|0|||
16457386|NCT03137069|40155625|FG002|Overall Study|Physician Decision|0|||
16457387|NCT03137069|40155626|FG003|Overall Study|Physician Decision|1|||
16457388|NCT03137069|40155627|FG004|Overall Study|Physician Decision|0|||
16457389|NCT03137069|40155628|FG005|Overall Study|Physician Decision|0|||
16457390|NCT03137069|40155623|FG000|Overall Study|Study Terminated by Sponsor|0|||
16457391|NCT03137069|40155624|FG001|Overall Study|Study Terminated by Sponsor|0|||
16457392|NCT03137069|40155625|FG002|Overall Study|Study Terminated by Sponsor|0|||
16457393|NCT03137069|40155626|FG003|Overall Study|Study Terminated by Sponsor|0|||
16457394|NCT03137069|40155627|FG004|Overall Study|Study Terminated by Sponsor|1|||
16457395|NCT03137069|40155628|FG005|Overall Study|Study Terminated by Sponsor|0|||
16457396|NCT03137069|40155623|FG000|Overall Study|Data Entry Error|0|||
16457397|NCT03137069|40155624|FG001|Overall Study|Data Entry Error|0|||
16457398|NCT03137069|40155625|FG002|Overall Study|Data Entry Error|0|||
16457399|NCT03137069|40155626|FG003|Overall Study|Data Entry Error|1|||
16457400|NCT03137069|40155627|FG004|Overall Study|Data Entry Error|0|||
16457401|NCT03137069|40155628|FG005|Overall Study|Data Entry Error|0|||
16457402|NCT04605991|40155629|FG000|Overall Study|Adverse Event|5|||
16457403|NCT04605991|40155629|FG000|Overall Study|Lack of Efficacy|1|||
16457404|NCT04605991|40155629|FG000|Overall Study|Lost to Follow-up|8|||
16457405|NCT04605991|40155629|FG000|Overall Study|Physician Decision|4|||
16457406|NCT04605991|40155629|FG000|Overall Study|Withdrawal by Subject|14|||
16457407|NCT04605991|40155629|FG000|Overall Study|Non-compliance with study|1|||
16457408|NCT01640314|40155630|FG000|Overall Study|Protocol Violation|0|||
16457409|NCT01640314|40155631|FG001|Overall Study|Protocol Violation|1|||
16457410|NCT00796991|40155634|FG000|Overall Study|Adverse Event|0|||
16457411|NCT00796991|40155635|FG001|Overall Study|Adverse Event|0|||
16457412|NCT00796991|40155636|FG002|Overall Study|Adverse Event|1|||
16457413|NCT00796991|40155634|FG000|Overall Study|Death|2|||
16457414|NCT00796991|40155635|FG001|Overall Study|Death|0|||
16457415|NCT00796991|40155636|FG002|Overall Study|Death|0|||
16457416|NCT00796991|40155634|FG000|Overall Study|Disease Progression|10|||
16457417|NCT00796991|40155635|FG001|Overall Study|Disease Progression|9|||
16457418|NCT00796991|40155636|FG002|Overall Study|Disease Progression|7|||
16457419|NCT00796991|40155634|FG000|Overall Study|Study Drug Toxicity|3|||
16457420|NCT00796991|40155635|FG001|Overall Study|Study Drug Toxicity|3|||
16457421|NCT00796991|40155636|FG002|Overall Study|Study Drug Toxicity|5|||
16457422|NCT00796991|40155634|FG000|Overall Study|Withdrawal by Subject|0|||
16167167|NCT02305563|39091419|FG001|Treatment Period|Death|0|||
16167168|NCT02305563|39091420|FG002|Treatment Period|Death|1|||
16167169|NCT02305563|39091421|FG003|Treatment Period|Death|2|||
16167170|NCT02305563|39091422|FG004|Treatment Period|Death|1|||
16457423|NCT00796991|40155635|FG001|Overall Study|Withdrawal by Subject|0|||
16457424|NCT00796991|40155636|FG002|Overall Study|Withdrawal by Subject|1|||
16457425|NCT02314637|40155637|FG000|Overall Study|Adverse Event|4|||
16457426|NCT02314637|40155638|FG001|Overall Study|Adverse Event|8|||
16457427|NCT02314637|40155637|FG000|Overall Study|Lack of Efficacy|1|||
16457428|NCT02314637|40155638|FG001|Overall Study|Lack of Efficacy|0|||
16457429|NCT02314637|40155637|FG000|Overall Study|Physician Decision|5|||
16457430|NCT02314637|40155638|FG001|Overall Study|Physician Decision|2|||
16167171|NCT02305563|39091418|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
16167172|NCT02305563|39091419|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
16167173|NCT02305563|39091420|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
16167174|NCT02305563|39091421|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
16167175|NCT02305563|39091422|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
16167176|NCT02305563|39091418|FG000|Treatment Period|Participant request to stop therapy|0|||
16167177|NCT02305563|39091419|FG001|Treatment Period|Participant request to stop therapy|2|||
16167178|NCT02305563|39091420|FG002|Treatment Period|Participant request to stop therapy|0|||
16457431|NCT02314637|40155637|FG000|Overall Study|Withdrawal by Subject|5|||
16457432|NCT02314637|40155638|FG001|Overall Study|Withdrawal by Subject|4|||
16457433|NCT02314637|40155637|FG000|Overall Study|Other Reason|1|||
16457434|NCT02314637|40155638|FG001|Overall Study|Other Reason|0|||
16457435|NCT01309282|40155639|FG000|Overall Study|Lost to Follow-up|1|||
16457436|NCT02894502|40155640|FG000|Baseline|Withdrawal by Subject|24|||
16457437|NCT02894502|40155641|FG001|Baseline|Withdrawal by Subject|31|||
16457438|NCT02894502|40155642|FG002|Baseline|Withdrawal by Subject|36|||
16457439|NCT02894502|40155640|FG000|Baseline|Death|3|||
16457440|NCT02894502|40155641|FG001|Baseline|Death|1|||
16457441|NCT02894502|40155642|FG002|Baseline|Death|9|||
16457442|NCT02894502|40155640|FG000|First Follow up|Withdrawal by Subject|32|||
16457443|NCT02894502|40155641|FG001|First Follow up|Withdrawal by Subject|29|||
16457444|NCT02894502|40155642|FG002|First Follow up|Withdrawal by Subject|37|||
16457445|NCT02894502|40155640|FG000|First Follow up|Death|2|||
16457446|NCT02894502|40155641|FG001|First Follow up|Death|2|||
16457447|NCT02894502|40155642|FG002|First Follow up|Death|3|||
16457448|NCT02894502|40155640|FG000|Second Follow up|Withdrawal by Subject|13|||
16457449|NCT02894502|40155641|FG001|Second Follow up|Withdrawal by Subject|15|||
16457450|NCT02894502|40155642|FG002|Second Follow up|Withdrawal by Subject|13|||
16457451|NCT02894502|40155640|FG000|Second Follow up|Death|2|||
16457452|NCT02894502|40155641|FG001|Second Follow up|Death|3|||
16457453|NCT02894502|40155642|FG002|Second Follow up|Death|1|||
16457454|NCT02894502|40155640|FG000|Third Follow up|Withdrawal by Subject|5|||
16457455|NCT02894502|40155641|FG001|Third Follow up|Withdrawal by Subject|6|||
16457456|NCT02894502|40155642|FG002|Third Follow up|Withdrawal by Subject|3|||
16457457|NCT02894502|40155640|FG000|Third Follow up|Death|1|||
16457458|NCT02894502|40155641|FG001|Third Follow up|Death|1|||
16457459|NCT02894502|40155642|FG002|Third Follow up|Death|0|||
16457460|NCT02365480|40155643|FG000|Overall Study|Withdrawal by Subject|2|||
16457461|NCT02365480|40155644|FG001|Overall Study|Withdrawal by Subject|0|||
16457462|NCT01124006|40155645|FG000|Overall Study|Withdrawal by Subject|2|||
16457463|NCT01124006|40155646|FG001|Overall Study|Withdrawal by Subject|2|||
16457464|NCT01124006|40155647|FG002|Overall Study|Withdrawal by Subject|0|||
16457465|NCT01124006|40155645|FG000|Overall Study|Lost to Follow-up|1|||
16457466|NCT01124006|40155646|FG001|Overall Study|Lost to Follow-up|0|||
16457467|NCT01124006|40155647|FG002|Overall Study|Lost to Follow-up|1|||
16457468|NCT01124006|40155645|FG000|Overall Study|Other|0|||
16457469|NCT01124006|40155646|FG001|Overall Study|Other|0|||
16457470|NCT01124006|40155647|FG002|Overall Study|Other|1|||
16457471|NCT04530136|40155650|FG000|Overall Study|Lost to Follow-up|2|||
16167179|NCT02305563|39091421|FG003|Treatment Period|Participant request to stop therapy|1|||
16167180|NCT02305563|39091422|FG004|Treatment Period|Participant request to stop therapy|0|||
16457472|NCT04530136|40155651|FG001|Overall Study|Lost to Follow-up|3|||
16457473|NCT04530136|40155650|FG000|Overall Study|Withdrawal by Subject|1|||
16457474|NCT04530136|40155651|FG001|Overall Study|Withdrawal by Subject|0|||
16457475|NCT04530136|40155650|FG000|Overall Study|Death|0|||
16457476|NCT04530136|40155651|FG001|Overall Study|Death|1|||
16457477|NCT04450381|40155659|FG000|Overall Study|Protocol Violation|4|||
16457478|NCT04450381|40155659|FG000|Overall Study|Wrong device setting|2|||
16457479|NCT02466659|40155661|FG000|Overall Study|Lost to Follow-up|5|||
16457480|NCT02466659|40155662|FG001|Overall Study|Lost to Follow-up|2|||
16457481|NCT00567398|40155663|FG000|Overall Study|Adverse Event|6|||
16457482|NCT00567398|40155664|FG001|Overall Study|Adverse Event|14|||
16457483|NCT00567398|40155663|FG000|Overall Study|Physician Decision|0|||
16457484|NCT00567398|40155664|FG001|Overall Study|Physician Decision|4|||
16457485|NCT00567398|40155663|FG000|Overall Study|Withdrawal by Subject|0|||
16457486|NCT00567398|40155664|FG001|Overall Study|Withdrawal by Subject|2|||
16457487|NCT00567398|40155663|FG000|Overall Study|Renal Transplantation|0|||
16457488|NCT00567398|40155664|FG001|Overall Study|Renal Transplantation|3|||
16457489|NCT00567398|40155663|FG000|Overall Study|Other|1|||
16457490|NCT00567398|40155664|FG001|Overall Study|Other|0|||
16457491|NCT01395524|40155665|FG000|Overall Study|Non-compliance with study schedule|1|||
16457492|NCT01395524|40155666|FG001|Overall Study|Non-compliance with study schedule|0|||
16457493|NCT01395524|40155667|FG002|Overall Study|Non-compliance with study schedule|1|||
16457494|NCT01395524|40155665|FG000|Overall Study|Lost to Follow-up|3|||
16457495|NCT01395524|40155666|FG001|Overall Study|Lost to Follow-up|1|||
16457496|NCT01395524|40155667|FG002|Overall Study|Lost to Follow-up|1|||
16457497|NCT01395524|40155665|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
16457498|NCT01395524|40155666|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
16457499|NCT01395524|40155667|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
16457500|NCT01395524|40155665|FG000|Overall Study|Severe noncompliance with protocol|1|||
16457501|NCT01395524|40155666|FG001|Overall Study|Severe noncompliance with protocol|0|||
16457502|NCT01395524|40155667|FG002|Overall Study|Severe noncompliance with protocol|0|||
16457503|NCT01395524|40155665|FG000|Overall Study|Adverse Event|4|||
16457504|NCT01395524|40155666|FG001|Overall Study|Adverse Event|4|||
16457505|NCT01395524|40155667|FG002|Overall Study|Adverse Event|3|||
16457506|NCT01395524|40155665|FG000|Overall Study|Death|1|||
16457507|NCT01395524|40155666|FG001|Overall Study|Death|0|||
16457508|NCT01395524|40155667|FG002|Overall Study|Death|0|||
16457509|NCT01395524|40155665|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
16457510|NCT01395524|40155666|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16457511|NCT01395524|40155667|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
16457512|NCT01395524|40155665|FG000|Overall Study|Withdrawal by Subject|4|||
16457513|NCT01395524|40155666|FG001|Overall Study|Withdrawal by Subject|8|||
16457514|NCT01395524|40155667|FG002|Overall Study|Withdrawal by Subject|8|||
16457515|NCT01395524|40155665|FG000|Overall Study|Did not receive treatment|1|||
16457516|NCT01395524|40155666|FG001|Overall Study|Did not receive treatment|1|||
16457517|NCT01395524|40155667|FG002|Overall Study|Did not receive treatment|3|||
16457518|NCT01395524|40155665|FG000|Overall Study|Subject had spinal surgery|0|||
16457519|NCT01395524|40155666|FG001|Overall Study|Subject had spinal surgery|0|||
16457520|NCT01395524|40155667|FG002|Overall Study|Subject had spinal surgery|1|||
16457521|NCT00781885|40155668|FG000|Overall Study|Physician Decision|1|||
16457522|NCT00947193|40155676|FG000|Overall Study|Lost to Follow-up|1|||
16457523|NCT00947193|40155677|FG001|Overall Study|Lost to Follow-up|0|||
16457524|NCT00947193|40155676|FG000|Overall Study|Withdrawal by Subject|1|||
16457525|NCT00947193|40155677|FG001|Overall Study|Withdrawal by Subject|0|||
16457526|NCT00947193|40155676|FG000|Overall Study|Factor VIII >1%|1|||
16457527|NCT00947193|40155677|FG001|Overall Study|Factor VIII >1%|0|||
16457528|NCT00084136|40155678|FG000|PI Comparison|Death|10|||
16457529|NCT00084136|40155679|FG001|PI Comparison|Death|9|||
16457530|NCT00084136|40155680|FG002|PI Comparison|Death|0|||
16457531|NCT00084136|40155678|FG000|PI Comparison|Lost to Follow-up|11|||
16457532|NCT00084136|40155679|FG001|PI Comparison|Lost to Follow-up|8|||
16457533|NCT00084136|40155680|FG002|PI Comparison|Lost to Follow-up|0|||
16457534|NCT00084136|40155678|FG000|PI Comparison|Withdrawal by Subject|33|||
16457535|NCT00084136|40155679|FG001|PI Comparison|Withdrawal by Subject|30|||
16457536|NCT00084136|40155680|FG002|PI Comparison|Withdrawal by Subject|0|||
16457537|NCT00084136|40155678|FG000|PI Comparison|Clinic site closed|1|||
16457538|NCT00084136|40155679|FG001|PI Comparison|Clinic site closed|0|||
16457539|NCT00084136|40155680|FG002|PI Comparison|Clinic site closed|0|||
16457540|NCT00084136|40155678|FG000|NRTI Comparison|Death|20|||
16457541|NCT00084136|40155679|FG001|NRTI Comparison|Death|0|||
16457542|NCT00084136|40155680|FG002|NRTI Comparison|Death|18|||
16457543|NCT00084136|40155678|FG000|NRTI Comparison|Lost to Follow-up|14|||
16457544|NCT00084136|40155679|FG001|NRTI Comparison|Lost to Follow-up|0|||
16457545|NCT00084136|40155680|FG002|NRTI Comparison|Lost to Follow-up|12|||
16457546|NCT00084136|40155678|FG000|NRTI Comparison|Withdrawal by Subject|54|||
16457547|NCT00084136|40155679|FG001|NRTI Comparison|Withdrawal by Subject|0|||
16457548|NCT00084136|40155680|FG002|NRTI Comparison|Withdrawal by Subject|38|||
16457549|NCT00084136|40155678|FG000|NRTI Comparison|Clinic site closed|12|||
16457550|NCT00084136|40155679|FG001|NRTI Comparison|Clinic site closed|0|||
16457551|NCT00084136|40155680|FG002|NRTI Comparison|Clinic site closed|14|||
16457552|NCT00084136|40155678|FG000|NRTI Comparison|Not reason above|1|||
16457553|NCT00084136|40155679|FG001|NRTI Comparison|Not reason above|0|||
16457554|NCT00084136|40155680|FG002|NRTI Comparison|Not reason above|0|||
16457555|NCT04493892|40155683|FG000|Overall Study|Withdrawal by Subject|15|||
16457556|NCT01499277|40155684|FG000|Overall Study|Adverse Event|3|||
16457557|NCT01499277|40155685|FG001|Overall Study|Adverse Event|6|||
16457558|NCT01499277|40155684|FG000|Overall Study|Death|3|||
16457559|NCT01499277|40155685|FG001|Overall Study|Death|2|||
16457560|NCT01499277|40155684|FG000|Overall Study|Lost to Follow-up|15|||
16457561|NCT01499277|40155685|FG001|Overall Study|Lost to Follow-up|8|||
16457562|NCT01499277|40155684|FG000|Overall Study|Protocol Violation|2|||
16457563|NCT01499277|40155685|FG001|Overall Study|Protocol Violation|3|||
16457564|NCT01499277|40155684|FG000|Overall Study|Withdrawal by Subject|16|||
16457565|NCT01499277|40155685|FG001|Overall Study|Withdrawal by Subject|6|||
16457566|NCT01499277|40155684|FG000|Overall Study|Lack of therapeutic response and other|8|||
16457567|NCT01499277|40155685|FG001|Overall Study|Lack of therapeutic response and other|7|||
16457568|NCT01311024|40155687|FG000|Overall Study|Protocol Violation|35|||
16457569|NCT01311024|40155688|FG001|Overall Study|Protocol Violation|22|||
16457570|NCT01069900|40155693|FG000|Overall Study|Technical problems|0|||
16457571|NCT01069900|40155694|FG001|Overall Study|Technical problems|1|||
16457572|NCT01069900|40155693|FG000|Overall Study|Lost to Follow-up|7|||
16457573|NCT01069900|40155694|FG001|Overall Study|Lost to Follow-up|1|||
16457574|NCT01069900|40155693|FG000|Overall Study|Withdrawal by Subject|6|||
16457575|NCT01069900|40155694|FG001|Overall Study|Withdrawal by Subject|1|||
16457576|NCT01069900|40155693|FG000|Overall Study|Protocol Violation|4|||
16457577|NCT01069900|40155694|FG001|Overall Study|Protocol Violation|1|||
16457578|NCT01069900|40155693|FG000|Overall Study|Insufficient Therapeutic effect|1|||
16457579|NCT01069900|40155694|FG001|Overall Study|Insufficient Therapeutic effect|0|||
16457580|NCT02267317|40155695|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
16457581|NCT02267317|40155696|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
16457582|NCT02267317|40155697|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
16457583|NCT02267317|40155698|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
16167181|NCT02305563|39091418|FG000|Treatment Period|Participant withdrew consent|0|||
16167182|NCT02305563|39091419|FG001|Treatment Period|Participant withdrew consent|0|||
16457584|NCT02267317|40155699|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
16457585|NCT02267317|40155700|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
16457586|NCT02267317|40155695|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
16457587|NCT02267317|40155696|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
16457588|NCT02267317|40155697|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
16457589|NCT02267317|40155698|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
16457590|NCT02267317|40155699|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
16457591|NCT02267317|40155700|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
16457592|NCT02152956|40155701|FG000|Overall Study|Adverse Event|0|||
16457593|NCT02152956|40155702|FG001|Overall Study|Adverse Event|0|||
16457594|NCT02152956|40155703|FG002|Overall Study|Adverse Event|0|||
16457595|NCT02152956|40155704|FG003|Overall Study|Adverse Event|0|||
16457596|NCT02152956|40155705|FG004|Overall Study|Adverse Event|0|||
16457597|NCT02152956|40155706|FG005|Overall Study|Adverse Event|0|||
16457598|NCT02152956|40155707|FG006|Overall Study|Adverse Event|0|||
16457599|NCT02152956|40155708|FG007|Overall Study|Adverse Event|0|||
16457600|NCT02152956|40155709|FG008|Overall Study|Adverse Event|0|||
16457601|NCT02152956|40155710|FG009|Overall Study|Adverse Event|0|||
16457602|NCT02152956|40155711|FG010|Overall Study|Adverse Event|0|||
16457603|NCT02152956|40155712|FG011|Overall Study|Adverse Event|4|||
16457604|NCT02152956|40155713|FG012|Overall Study|Adverse Event|0|||
16457605|NCT02152956|40155701|FG000|Overall Study|Death|0|||
16457606|NCT02152956|40155702|FG001|Overall Study|Death|3|||
16457607|NCT02152956|40155703|FG002|Overall Study|Death|3|||
16457608|NCT02152956|40155704|FG003|Overall Study|Death|4|||
16457609|NCT02152956|40155705|FG004|Overall Study|Death|1|||
16457610|NCT02152956|40155706|FG005|Overall Study|Death|2|||
16457611|NCT02152956|40155707|FG006|Overall Study|Death|6|||
16457612|NCT02152956|40155708|FG007|Overall Study|Death|6|||
16457613|NCT02152956|40155709|FG008|Overall Study|Death|4|||
16457614|NCT02152956|40155710|FG009|Overall Study|Death|5|||
16457615|NCT02152956|40155711|FG010|Overall Study|Death|3|||
16457616|NCT02152956|40155712|FG011|Overall Study|Death|143|||
16457617|NCT02152956|40155713|FG012|Overall Study|Death|12|||
16457618|NCT02152956|40155701|FG000|Overall Study|Lost to Follow-up|0|||
16457619|NCT02152956|40155702|FG001|Overall Study|Lost to Follow-up|1|||
16457620|NCT02152956|40155703|FG002|Overall Study|Lost to Follow-up|0|||
16457621|NCT02152956|40155704|FG003|Overall Study|Lost to Follow-up|0|||
16457622|NCT02152956|40155705|FG004|Overall Study|Lost to Follow-up|0|||
16457623|NCT02152956|40155706|FG005|Overall Study|Lost to Follow-up|0|||
16457624|NCT02152956|40155707|FG006|Overall Study|Lost to Follow-up|0|||
16457625|NCT02152956|40155708|FG007|Overall Study|Lost to Follow-up|0|||
16457626|NCT02152956|40155709|FG008|Overall Study|Lost to Follow-up|0|||
16457627|NCT02152956|40155710|FG009|Overall Study|Lost to Follow-up|0|||
16457628|NCT02152956|40155711|FG010|Overall Study|Lost to Follow-up|0|||
16457629|NCT02152956|40155712|FG011|Overall Study|Lost to Follow-up|3|||
16457630|NCT02152956|40155713|FG012|Overall Study|Lost to Follow-up|0|||
16457631|NCT02152956|40155701|FG000|Overall Study|Withdrawal by Subject|1|||
16457632|NCT02152956|40155702|FG001|Overall Study|Withdrawal by Subject|0|||
16457633|NCT02152956|40155703|FG002|Overall Study|Withdrawal by Subject|1|||
16457634|NCT02152956|40155704|FG003|Overall Study|Withdrawal by Subject|0|||
16457635|NCT02152956|40155705|FG004|Overall Study|Withdrawal by Subject|2|||
16457636|NCT02152956|40155706|FG005|Overall Study|Withdrawal by Subject|2|||
16457637|NCT02152956|40155707|FG006|Overall Study|Withdrawal by Subject|0|||
16457638|NCT02152956|40155708|FG007|Overall Study|Withdrawal by Subject|0|||
16457639|NCT02152956|40155709|FG008|Overall Study|Withdrawal by Subject|1|||
16457640|NCT02152956|40155710|FG009|Overall Study|Withdrawal by Subject|0|||
16457641|NCT02152956|40155711|FG010|Overall Study|Withdrawal by Subject|0|||
16457642|NCT02152956|40155712|FG011|Overall Study|Withdrawal by Subject|4|||
16457643|NCT02152956|40155713|FG012|Overall Study|Withdrawal by Subject|0|||
16457644|NCT02152956|40155701|FG000|Overall Study|Physician Decision|0|||
16457645|NCT02152956|40155702|FG001|Overall Study|Physician Decision|0|||
16457646|NCT02152956|40155703|FG002|Overall Study|Physician Decision|0|||
16457647|NCT02152956|40155704|FG003|Overall Study|Physician Decision|0|||
16457648|NCT02152956|40155705|FG004|Overall Study|Physician Decision|0|||
16457649|NCT02152956|40155706|FG005|Overall Study|Physician Decision|0|||
16457650|NCT02152956|40155707|FG006|Overall Study|Physician Decision|0|||
16457651|NCT02152956|40155708|FG007|Overall Study|Physician Decision|0|||
16457652|NCT02152956|40155709|FG008|Overall Study|Physician Decision|0|||
16457653|NCT02152956|40155710|FG009|Overall Study|Physician Decision|0|||
16457654|NCT02152956|40155711|FG010|Overall Study|Physician Decision|0|||
16457655|NCT02152956|40155712|FG011|Overall Study|Physician Decision|1|||
16457656|NCT02152956|40155713|FG012|Overall Study|Physician Decision|0|||
16457657|NCT02152956|40155701|FG000|Overall Study|Study terminated by sponsor|0|||
16457658|NCT02152956|40155702|FG001|Overall Study|Study terminated by sponsor|0|||
16457659|NCT02152956|40155703|FG002|Overall Study|Study terminated by sponsor|0|||
16457660|NCT02152956|40155704|FG003|Overall Study|Study terminated by sponsor|0|||
16457661|NCT02152956|40155705|FG004|Overall Study|Study terminated by sponsor|0|||
16457662|NCT02152956|40155706|FG005|Overall Study|Study terminated by sponsor|0|||
16457663|NCT02152956|40155707|FG006|Overall Study|Study terminated by sponsor|0|||
16457664|NCT02152956|40155708|FG007|Overall Study|Study terminated by sponsor|0|||
16457665|NCT02152956|40155709|FG008|Overall Study|Study terminated by sponsor|0|||
16457666|NCT02152956|40155710|FG009|Overall Study|Study terminated by sponsor|0|||
16457667|NCT02152956|40155711|FG010|Overall Study|Study terminated by sponsor|0|||
16457668|NCT02152956|40155712|FG011|Overall Study|Study terminated by sponsor|29|||
16457669|NCT02152956|40155713|FG012|Overall Study|Study terminated by sponsor|0|||
16457670|NCT02152956|40155701|FG000|Overall Study|progressive disease|0|||
16457671|NCT02152956|40155702|FG001|Overall Study|progressive disease|0|||
16457672|NCT02152956|40155703|FG002|Overall Study|progressive disease|0|||
16457673|NCT02152956|40155704|FG003|Overall Study|progressive disease|0|||
16457674|NCT02152956|40155705|FG004|Overall Study|progressive disease|0|||
16457675|NCT02152956|40155706|FG005|Overall Study|progressive disease|0|||
16457676|NCT02152956|40155707|FG006|Overall Study|progressive disease|0|||
16457677|NCT02152956|40155708|FG007|Overall Study|progressive disease|0|||
16457678|NCT02152956|40155709|FG008|Overall Study|progressive disease|1|||
16457679|NCT02152956|40155710|FG009|Overall Study|progressive disease|0|||
16457680|NCT02152956|40155711|FG010|Overall Study|progressive disease|0|||
16457681|NCT02152956|40155712|FG011|Overall Study|progressive disease|1|||
16457682|NCT02152956|40155713|FG012|Overall Study|progressive disease|0|||
16457683|NCT01765218|40155714|FG000|Overall Study|Protocol Violation|1|||
16457684|NCT01765218|40155715|FG001|Overall Study|Protocol Violation|2|||
16457685|NCT04556383|40155716|FG000|PCP|Lack of Efficacy|28|||
16457686|NCT04556383|40155717|FG001|PCP|Lack of Efficacy|23|||
16457687|NCT04556383|40155718|FG002|PCP|Lack of Efficacy|23|||
16457688|NCT04556383|40155719|FG003|PCP|Lack of Efficacy|0|||
16457689|NCT04556383|40155716|FG000|PCP|Study terminated by sponsor|15|||
16457690|NCT04556383|40155717|FG001|PCP|Study terminated by sponsor|13|||
16457691|NCT04556383|40155718|FG002|PCP|Study terminated by sponsor|16|||
16457692|NCT04556383|40155719|FG003|PCP|Study terminated by sponsor|0|||
16457693|NCT04556383|40155716|FG000|PCP|Withdrawal by Subject|8|||
16457694|NCT04556383|40155717|FG001|PCP|Withdrawal by Subject|6|||
16457695|NCT04556383|40155718|FG002|PCP|Withdrawal by Subject|6|||
16457696|NCT04556383|40155719|FG003|PCP|Withdrawal by Subject|0|||
16457697|NCT04556383|40155716|FG000|PCP|Adverse Event|1|||
16457698|NCT04556383|40155717|FG001|PCP|Adverse Event|7|||
16457699|NCT04556383|40155718|FG002|PCP|Adverse Event|7|||
16457700|NCT04556383|40155719|FG003|PCP|Adverse Event|0|||
16457701|NCT04556383|40155716|FG000|PCP|Other, Not Specified|1|||
16457702|NCT04556383|40155717|FG001|PCP|Other, Not Specified|2|||
16457703|NCT04556383|40155718|FG002|PCP|Other, Not Specified|1|||
16457704|NCT04556383|40155719|FG003|PCP|Other, Not Specified|0|||
16457705|NCT04556383|40155716|FG000|PCP|Protocol Violation|1|||
16457706|NCT04556383|40155717|FG001|PCP|Protocol Violation|0|||
16457707|NCT04556383|40155718|FG002|PCP|Protocol Violation|1|||
16457708|NCT04556383|40155719|FG003|PCP|Protocol Violation|0|||
16457709|NCT04556383|40155716|FG000|PCP|Lost to Follow-up|1|||
16457710|NCT04556383|40155717|FG001|PCP|Lost to Follow-up|0|||
16457711|NCT04556383|40155718|FG002|PCP|Lost to Follow-up|0|||
16457712|NCT04556383|40155719|FG003|PCP|Lost to Follow-up|0|||
16457713|NCT04556383|40155716|FG000|PCP|Physician Decision|0|||
16457714|NCT04556383|40155717|FG001|PCP|Physician Decision|1|||
16457715|NCT04556383|40155718|FG002|PCP|Physician Decision|0|||
16457716|NCT04556383|40155719|FG003|PCP|Physician Decision|0|||
16457717|NCT04556383|40155716|FG000|PCP|Site terminated by sponsor|0|||
16457718|NCT04556383|40155717|FG001|PCP|Site terminated by sponsor|1|||
16457719|NCT04556383|40155718|FG002|PCP|Site terminated by sponsor|0|||
16457720|NCT04556383|40155719|FG003|PCP|Site terminated by sponsor|0|||
16457721|NCT04556383|40155716|FG000|OLE|Study terminated by sponsor|0|||
16457722|NCT04556383|40155717|FG001|OLE|Study terminated by sponsor|0|||
16457723|NCT04556383|40155718|FG002|OLE|Study terminated by sponsor|0|||
16457724|NCT04556383|40155719|FG003|OLE|Study terminated by sponsor|68|||
16457725|NCT04556383|40155716|FG000|OLE|Withdrawal by Subject|0|||
16457726|NCT04556383|40155717|FG001|OLE|Withdrawal by Subject|0|||
16457727|NCT04556383|40155718|FG002|OLE|Withdrawal by Subject|0|||
16457728|NCT04556383|40155719|FG003|OLE|Withdrawal by Subject|10|||
16457729|NCT04556383|40155716|FG000|OLE|Lack of Efficacy|0|||
16457730|NCT04556383|40155717|FG001|OLE|Lack of Efficacy|0|||
16457731|NCT04556383|40155718|FG002|OLE|Lack of Efficacy|0|||
16457732|NCT04556383|40155719|FG003|OLE|Lack of Efficacy|7|||
16457733|NCT04556383|40155716|FG000|OLE|Adverse Event|0|||
16457734|NCT04556383|40155717|FG001|OLE|Adverse Event|0|||
16457735|NCT04556383|40155718|FG002|OLE|Adverse Event|0|||
16457736|NCT04556383|40155719|FG003|OLE|Adverse Event|2|||
16457737|NCT04556383|40155716|FG000|OLE|Other, Not Specified|0|||
16457738|NCT04556383|40155717|FG001|OLE|Other, Not Specified|0|||
16457739|NCT04556383|40155718|FG002|OLE|Other, Not Specified|0|||
16457740|NCT04556383|40155719|FG003|OLE|Other, Not Specified|2|||
16457741|NCT04556383|40155716|FG000|OLE|Death|0|||
16457742|NCT04556383|40155717|FG001|OLE|Death|0|||
16457743|NCT04556383|40155718|FG002|OLE|Death|0|||
16457744|NCT04556383|40155719|FG003|OLE|Death|1|||
16457745|NCT04556383|40155716|FG000|OLE|Lost to Follow-up|0|||
16457746|NCT04556383|40155717|FG001|OLE|Lost to Follow-up|0|||
16457747|NCT04556383|40155718|FG002|OLE|Lost to Follow-up|0|||
16457748|NCT04556383|40155719|FG003|OLE|Lost to Follow-up|1|||
16457749|NCT00475982|40155720|FG000|Overall Study|surgery rescheduled|7|||
16457750|NCT00475982|40155721|FG001|Overall Study|surgery rescheduled|3|||
16457751|NCT00615901|40155722|FG000|Overall Study|Withdrawal by Subject|2|||
16457752|NCT00615901|40155722|FG000|Overall Study|Adverse Event|7|||
16457753|NCT02576145|40155723|FG000|Overall Study|Adverse Event|1|||
16457754|NCT02576145|40155724|FG001|Overall Study|Adverse Event|0|||
16457755|NCT02576145|40155723|FG000|Overall Study|Withdrawal by Subject|1|||
16457756|NCT02576145|40155724|FG001|Overall Study|Withdrawal by Subject|0|||
16457757|NCT02576145|40155723|FG000|Overall Study|Acute rejection|1|||
16457758|NCT02576145|40155724|FG001|Overall Study|Acute rejection|0|||
16457759|NCT02576145|40155723|FG000|Overall Study|Tetanus Titers Decreased|0|||
16457760|NCT02576145|40155724|FG001|Overall Study|Tetanus Titers Decreased|1|||
16457761|NCT01261780|40155725|FG000|Overall Study|Withdrawal by Subject|1|||
16457762|NCT01261780|40155726|FG001|Overall Study|Withdrawal by Subject|0|||
16457763|NCT01261780|40155725|FG000|Overall Study|Event not related to subject|1|||
16457764|NCT01261780|40155726|FG001|Overall Study|Event not related to subject|2|||
16457765|NCT00744042|40155731|FG000|Overall Study|Withdrawal by Subject|1|||
16457766|NCT00145158|40155735|FG000|Overall Study|premature withdrawal|2|||
16457767|NCT00145158|40155736|FG001|Overall Study|premature withdrawal|3|||
16457768|NCT03830892|40155753|FG000|Overall Study|Physician Decision|2|||
16457769|NCT03830892|40155754|FG001|Overall Study|Physician Decision|3|||
16457770|NCT03830892|40155753|FG000|Overall Study|Study terminated due to COVID|4|||
16457771|NCT03830892|40155754|FG001|Overall Study|Study terminated due to COVID|0|||
16457772|NCT03830892|40155753|FG000|Overall Study|Protocol Violation|0|||
16457773|NCT03830892|40155754|FG001|Overall Study|Protocol Violation|1|||
16457774|NCT03830892|40155753|FG000|Overall Study|Withdrawal by Subject|0|||
16457775|NCT03830892|40155754|FG001|Overall Study|Withdrawal by Subject|2|||
16457776|NCT02878798|40155755|FG000|Overall Study|Withdrawal by Subject|5|||
16457777|NCT02878798|40155756|FG001|Overall Study|Withdrawal by Subject|4|||
16457778|NCT02878798|40155755|FG000|Overall Study|Lost to Follow-up|2|||
16457779|NCT02878798|40155756|FG001|Overall Study|Lost to Follow-up|2|||
16457780|NCT02878798|40155755|FG000|Overall Study|Protocol Violation|0|||
16457781|NCT02878798|40155756|FG001|Overall Study|Protocol Violation|1|||
16457782|NCT02527421|40155757|FG000|Overall Study|Withdrawal by Subject|1|||
16457783|NCT02527421|40155758|FG001|Overall Study|Withdrawal by Subject|0|||
16457784|NCT00530816|40155759|FG000|Overall Study|Progressive Disease|16|||
16457785|NCT00530816|40155760|FG001|Overall Study|Progressive Disease|24|||
16457786|NCT00530816|40155761|FG002|Overall Study|Progressive Disease|24|||
16457787|NCT00530816|40155759|FG000|Overall Study|Adverse Event|6|||
16457788|NCT00530816|40155760|FG001|Overall Study|Adverse Event|13|||
16457789|NCT00530816|40155761|FG002|Overall Study|Adverse Event|7|||
16457790|NCT00530816|40155759|FG000|Overall Study|Other|3|||
16457791|NCT00530816|40155760|FG001|Overall Study|Other|3|||
16457792|NCT00530816|40155761|FG002|Overall Study|Other|4|||
16457793|NCT00530816|40155759|FG000|Overall Study|Withdrawal by Subject|1|||
16457794|NCT00530816|40155760|FG001|Overall Study|Withdrawal by Subject|2|||
16457795|NCT00530816|40155761|FG002|Overall Study|Withdrawal by Subject|6|||
16457796|NCT04543279|40155764|FG000|Overall Study|Withdrawal by Subject|1|||
16457797|NCT04543279|40155765|FG001|Overall Study|Withdrawal by Subject|0|||
16457798|NCT04543279|40155764|FG000|Overall Study|Adverse Event|1|||
16457799|NCT04543279|40155765|FG001|Overall Study|Adverse Event|0|||
16457800|NCT04543279|40155764|FG000|Overall Study|Physician Decision|1|||
16457801|NCT04543279|40155765|FG001|Overall Study|Physician Decision|0|||
16457802|NCT00740857|40155767|FG000|Overall Study|Withdrawal by Subject|1|||
16457803|NCT00740857|40155768|FG001|Overall Study|Withdrawal by Subject|0|||
16457804|NCT00740857|40155769|FG002|Overall Study|Withdrawal by Subject|0|||
16457805|NCT03135119|40155770|FG000|Overall Study|Lost to Follow-up|2|||
16457806|NCT03135119|40155771|FG001|Overall Study|Lost to Follow-up|0|||
16457807|NCT03135119|40155770|FG000|Overall Study|Physician Decision|1|||
16457808|NCT03135119|40155771|FG001|Overall Study|Physician Decision|1|||
16457809|NCT03135119|40155770|FG000|Overall Study|COVID-19 Shutdown|2|||
16457810|NCT03135119|40155771|FG001|Overall Study|COVID-19 Shutdown|2|||
16457811|NCT01510769|40155772|FG000|Overall Study|Adverse Event|7|||
16457812|NCT01510769|40155773|FG001|Overall Study|Adverse Event|6|||
16457813|NCT01510769|40155774|FG002|Overall Study|Adverse Event|4|||
16457814|NCT01510769|40155772|FG000|Overall Study|Gout Flare|0|||
16457815|NCT01510769|40155773|FG001|Overall Study|Gout Flare|3|||
16457816|NCT01510769|40155774|FG002|Overall Study|Gout Flare|1|||
16457817|NCT01510769|40155772|FG000|Overall Study|Protocol Violation|11|||
16457818|NCT01510769|40155773|FG001|Overall Study|Protocol Violation|10|||
16457819|NCT01510769|40155774|FG002|Overall Study|Protocol Violation|9|||
16457820|NCT01510769|40155772|FG000|Overall Study|Lost to Follow-up|5|||
16457821|NCT01510769|40155773|FG001|Overall Study|Lost to Follow-up|1|||
16457822|NCT01510769|40155774|FG002|Overall Study|Lost to Follow-up|5|||
16457823|NCT01510769|40155772|FG000|Overall Study|Withdrawal by Subject|3|||
16457824|NCT01510769|40155773|FG001|Overall Study|Withdrawal by Subject|4|||
16457825|NCT01510769|40155774|FG002|Overall Study|Withdrawal by Subject|3|||
16457826|NCT01510769|40155772|FG000|Overall Study|Death|1|||
16457827|NCT01510769|40155773|FG001|Overall Study|Death|1|||
16457828|NCT01510769|40155774|FG002|Overall Study|Death|0|||
16457829|NCT00006289|40155775|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
16457830|NCT00006289|40155776|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
16457831|NCT00006289|40155775|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
16457832|NCT00006289|40155776|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
16457833|NCT00029146|40155777|FG000|Overall Study|Lost to Follow-up|2|||
16457834|NCT00029146|40155778|FG001|Overall Study|Lost to Follow-up|1|||
16457835|NCT00280748|40155779|FG000|Overall Study|Decline in performance|3|||
16457836|NCT00280748|40155779|FG000|Overall Study|Extra-cranial disease progression|1|||
16457837|NCT01500720|40155780|FG000|Overall Study|Randomized But Not Treated|1|||
16457838|NCT01500720|40155781|FG001|Overall Study|Randomized But Not Treated|1|||
16457839|NCT01500720|40155780|FG000|Overall Study|Other|4|||
16457840|NCT01500720|40155781|FG001|Overall Study|Other|8|||
16457841|NCT00505076|40155782|FG000|Overall Study|Adverse Event|1|||
16457842|NCT00505076|40155783|FG001|Overall Study|Adverse Event|0|||
16457843|NCT00505076|40155784|FG002|Overall Study|Adverse Event|1|||
16457844|NCT00505076|40155782|FG000|Overall Study|Protocol Violation|2|||
16457845|NCT00505076|40155783|FG001|Overall Study|Protocol Violation|1|||
16457846|NCT00505076|40155784|FG002|Overall Study|Protocol Violation|2|||
16457847|NCT00505076|40155782|FG000|Overall Study|Withdrawal by Subject|0|||
16457848|NCT00505076|40155783|FG001|Overall Study|Withdrawal by Subject|1|||
16457849|NCT00505076|40155784|FG002|Overall Study|Withdrawal by Subject|2|||
16457850|NCT01032889|40155788|FG000|Overall Study|Adverse Event|2|||
16457851|NCT01032889|40155789|FG001|Overall Study|Adverse Event|2|||
16457852|NCT01032889|40155790|FG002|Overall Study|Adverse Event|0|||
16457853|NCT01032889|40155788|FG000|Overall Study|Withdrawal of Consent|1|||
16457854|NCT01032889|40155789|FG001|Overall Study|Withdrawal of Consent|2|||
16457855|NCT01032889|40155790|FG002|Overall Study|Withdrawal of Consent|1|||
16457856|NCT01032889|40155788|FG000|Overall Study|Patient Request|0|||
16457857|NCT01032889|40155789|FG001|Overall Study|Patient Request|1|||
16457858|NCT01032889|40155790|FG002|Overall Study|Patient Request|0|||
16457859|NCT01032889|40155788|FG000|Overall Study|Lost to Follow-up|1|||
16457860|NCT01032889|40155789|FG001|Overall Study|Lost to Follow-up|1|||
16457861|NCT01032889|40155790|FG002|Overall Study|Lost to Follow-up|0|||
16457862|NCT01032889|40155788|FG000|Overall Study|Lack of Submental Fat|2|||
16457863|NCT01032889|40155789|FG001|Overall Study|Lack of Submental Fat|8|||
16457864|NCT01032889|40155790|FG002|Overall Study|Lack of Submental Fat|1|||
16457865|NCT01032889|40155788|FG000|Overall Study|Miscellaneous Reasons|2|||
16457866|NCT01032889|40155789|FG001|Overall Study|Miscellaneous Reasons|1|||
16457867|NCT01032889|40155790|FG002|Overall Study|Miscellaneous Reasons|1|||
16457868|NCT04328077|40155792|FG000|Overall Study|Lost to Follow-up|0|||
16457869|NCT04328077|40155793|FG001|Overall Study|Lost to Follow-up|1|||
16457870|NCT04328077|40155794|FG002|Overall Study|Lost to Follow-up|0|||
16072698|NCT01959412|38759138|FG000|Overall Study|Protocol deviation|1|||
16457871|NCT04328077|40155795|FG003|Overall Study|Lost to Follow-up|0|||
16457872|NCT04328077|40155792|FG000|Overall Study|Withdrawal by Subject|0|||
16457873|NCT04328077|40155793|FG001|Overall Study|Withdrawal by Subject|1|||
16457874|NCT04328077|40155794|FG002|Overall Study|Withdrawal by Subject|1|||
16457875|NCT04328077|40155795|FG003|Overall Study|Withdrawal by Subject|3|||
16457876|NCT00486291|40155796|FG000|Overall Study|Adverse Event|3|||
16457877|NCT00486291|40155797|FG001|Overall Study|Adverse Event|4|||
16457878|NCT00486291|40155796|FG000|Overall Study|Lost to Follow-up|3|||
16457879|NCT00486291|40155797|FG001|Overall Study|Lost to Follow-up|7|||
16457880|NCT00486291|40155796|FG000|Overall Study|protocol non-compliance|10|||
16457881|NCT00486291|40155797|FG001|Overall Study|protocol non-compliance|15|||
16457882|NCT00486291|40155796|FG000|Overall Study|requirement for restricted medication|0|||
16457883|NCT00486291|40155797|FG001|Overall Study|requirement for restricted medication|3|||
16457884|NCT01942733|40155800|FG000|Overall Study|Lost to Follow-up|1|||
16457885|NCT01942733|40155800|FG000|Overall Study|Non-compliance with IMP|1|||
16457886|NCT01942733|40155800|FG000|Overall Study|Administrative|1|||
16457887|NCT01159431|40155801|FG000|Overall Study|Adverse Event|1|||
16457888|NCT01159431|40155802|FG001|Overall Study|Adverse Event|2|||
16457889|NCT01159431|40155801|FG000|Overall Study|non-compliance|1|||
16457890|NCT01159431|40155802|FG001|Overall Study|non-compliance|1|||
16457891|NCT01159431|40155801|FG000|Overall Study|Lack of Efficacy|0|||
16457892|NCT01159431|40155802|FG001|Overall Study|Lack of Efficacy|3|||
16457893|NCT01994889|40155803|FG000|Overall Study|Adverse Event|5|||
16457894|NCT01994889|40155804|FG001|Overall Study|Adverse Event|12|||
16457895|NCT01994889|40155805|FG002|Overall Study|Adverse Event|11|||
16457896|NCT01994889|40155803|FG000|Overall Study|Cardiac Device Implantation|0|||
16457897|NCT01994889|40155804|FG001|Overall Study|Cardiac Device Implantation|2|||
16457898|NCT01994889|40155805|FG002|Overall Study|Cardiac Device Implantation|0|||
16457899|NCT01994889|40155803|FG000|Overall Study|Organ Transplantation|1|||
16457900|NCT01994889|40155804|FG001|Overall Study|Organ Transplantation|5|||
16457901|NCT01994889|40155805|FG002|Overall Study|Organ Transplantation|5|||
16457902|NCT01994889|40155803|FG000|Overall Study|No longer willing to participate|8|||
16457903|NCT01994889|40155804|FG001|Overall Study|No longer willing to participate|17|||
16457904|NCT01994889|40155805|FG002|Overall Study|No longer willing to participate|37|||
16457905|NCT01994889|40155803|FG000|Overall Study|Lost to Follow-up|0|||
16457906|NCT01994889|40155804|FG001|Overall Study|Lost to Follow-up|1|||
16457907|NCT01994889|40155805|FG002|Overall Study|Lost to Follow-up|0|||
16457908|NCT01994889|40155803|FG000|Overall Study|Protocol Violation|0|||
16457909|NCT01994889|40155804|FG001|Overall Study|Protocol Violation|1|||
16457910|NCT01994889|40155805|FG002|Overall Study|Protocol Violation|1|||
16457911|NCT01994889|40155803|FG000|Overall Study|Death|14|||
16457912|NCT01994889|40155804|FG001|Overall Study|Death|25|||
16457913|NCT01994889|40155805|FG002|Overall Study|Death|38|||
16457914|NCT00916929|40155813|FG000|Overall Study|Lost to Follow-up|1|||
16457915|NCT00916929|40155814|FG001|Overall Study|Lost to Follow-up|3|||
16457916|NCT00916929|40155813|FG000|Overall Study|Death|5|||
16457917|NCT00916929|40155814|FG001|Overall Study|Death|10|||
16457918|NCT00916929|40155813|FG000|Overall Study|Withdrawal by Subject|1|||
16457919|NCT00916929|40155814|FG001|Overall Study|Withdrawal by Subject|5|||
16457920|NCT00916929|40155813|FG000|Overall Study|Left ventricular epicardial lead|1|||
16457921|NCT00916929|40155814|FG001|Overall Study|Left ventricular epicardial lead|2|||
16457922|NCT00916929|40155813|FG000|Overall Study|Transferred to hospice care|1|||
16457923|NCT00916929|40155814|FG001|Overall Study|Transferred to hospice care|1|||
16457924|NCT00916929|40155813|FG000|Overall Study|System explant|1|||
16457925|NCT00916929|40155814|FG001|Overall Study|System explant|0|||
16457926|NCT00916929|40155813|FG000|Overall Study|Moved to another state|0|||
16457927|NCT00916929|40155814|FG001|Overall Study|Moved to another state|1|||
16457928|NCT00916929|40155813|FG000|Overall Study|Device unable to process impedance data|0|||
16457929|NCT00916929|40155814|FG001|Overall Study|Device unable to process impedance data|7|||
16457930|NCT00271505|40155819|FG000|Overall Study|Screen Failure|3|||
16457931|NCT00271505|40155819|FG000|Overall Study|Adverse Event|1|||
16457932|NCT00271505|40155819|FG000|Overall Study|Death|1|||
16457933|NCT00612105|40155820|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
16457934|NCT00612105|40155821|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
16457935|NCT00612105|40155820|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
16457936|NCT00612105|40155821|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
16457937|NCT00612105|40155820|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
16457938|NCT00612105|40155821|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
16457939|NCT00612105|40155820|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
16457940|NCT00612105|40155821|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
16457941|NCT00612105|40155820|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
16457942|NCT00612105|40155821|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
16457943|NCT00612105|40155820|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
16457944|NCT00612105|40155821|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
16457945|NCT00612105|40155820|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
16457946|NCT00612105|40155821|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
16457947|NCT00612105|40155820|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
16457948|NCT00612105|40155821|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
16457949|NCT00612105|40155820|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
16457950|NCT00612105|40155821|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
16457951|NCT00612105|40155820|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
16457952|NCT00612105|40155821|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
16457953|NCT00612105|40155820|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
16457954|NCT00612105|40155821|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
16457955|NCT00612105|40155820|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
16457956|NCT00612105|40155821|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
16457957|NCT02160041|40155822|FG000|Overall Study|Adverse Event|11|||
16457958|NCT02160041|40155822|FG000|Overall Study|Death|2|||
16457959|NCT02160041|40155822|FG000|Overall Study|disease progression|57|||
16457960|NCT02160041|40155822|FG000|Overall Study|Protocol Violation|1|||
16457961|NCT02160041|40155822|FG000|Overall Study|non-compliance with study|1|||
16457962|NCT02160041|40155822|FG000|Overall Study|Physician Decision|3|||
16457963|NCT02160041|40155822|FG000|Overall Study|Withdrawal by Subject|8|||
16457964|NCT02160041|40155822|FG000|Overall Study|study terminated by by sponsor|1|||
16457965|NCT00970684|40155823|FG000|Overall Study|Lack of Efficacy|5|||
16457966|NCT00970684|40155823|FG000|Overall Study|Adverse Event|4|||
16457967|NCT00970684|40155823|FG000|Overall Study|Withdrawal by Subject|1|||
16457968|NCT02102204|40155824|FG000|Overall Study|Withdrawal by Subject|137|||
16457969|NCT02102204|40155824|FG000|Overall Study|Death|92|||
16457970|NCT02102204|40155824|FG000|Overall Study|Lost to Follow-up|65|||
16457971|NCT02102204|40155824|FG000|Overall Study|Sponsor Decision|5|||
16457972|NCT02102204|40155824|FG000|Overall Study|Ongoing|5|||
16457973|NCT01433250|40155825|FG000|Overall Study|Protocol Violation|0|||
16457974|NCT01433250|40155826|FG001|Overall Study|Protocol Violation|1|||
16457975|NCT01433250|40155825|FG000|Overall Study|Withdrawal by Subject|3|||
16457976|NCT01433250|40155826|FG001|Overall Study|Withdrawal by Subject|2|||
16457977|NCT00783198|40155827|FG000|Overall Study|Adverse Event|15|||
16457978|NCT00783198|40155828|FG001|Overall Study|Adverse Event|19|||
16457979|NCT00783198|40155829|FG002|Overall Study|Adverse Event|3|||
16457980|NCT00783198|40155827|FG000|Overall Study|Lost to Follow-up|11|||
16457981|NCT00783198|40155828|FG001|Overall Study|Lost to Follow-up|1|||
16457982|NCT00783198|40155829|FG002|Overall Study|Lost to Follow-up|7|||
16457983|NCT00783198|40155827|FG000|Overall Study|Withdrawal by Subject|22|||
16457984|NCT00783198|40155828|FG001|Overall Study|Withdrawal by Subject|14|||
16457985|NCT00783198|40155829|FG002|Overall Study|Withdrawal by Subject|20|||
16457986|NCT00783198|40155827|FG000|Overall Study|Noncompliance with protocol|7|||
16457987|NCT00783198|40155828|FG001|Overall Study|Noncompliance with protocol|7|||
16457988|NCT00783198|40155829|FG002|Overall Study|Noncompliance with protocol|10|||
16457989|NCT00783198|40155827|FG000|Overall Study|Did not meet protocol eligibility|0|||
16457990|NCT00783198|40155828|FG001|Overall Study|Did not meet protocol eligibility|1|||
16457991|NCT00783198|40155829|FG002|Overall Study|Did not meet protocol eligibility|0|||
16457992|NCT00783198|40155827|FG000|Overall Study|Administrative|2|||
16457993|NCT00783198|40155828|FG001|Overall Study|Administrative|1|||
16457994|NCT00783198|40155829|FG002|Overall Study|Administrative|2|||
16457995|NCT00422513|40155830|FG000|Overall Study|Lack of Efficacy|4|||
16457996|NCT00422513|40155831|FG001|Overall Study|Lack of Efficacy|5|||
16457997|NCT00422513|40155830|FG000|Overall Study|Protocol Violation|23|||
16457998|NCT00422513|40155831|FG001|Overall Study|Protocol Violation|7|||
16457999|NCT00422513|40155830|FG000|Overall Study|Refused Treatment|4|||
16458000|NCT00422513|40155831|FG001|Overall Study|Refused Treatment|2|||
16458001|NCT00422513|40155830|FG000|Overall Study|Withdrawal by Subject|2|||
16458002|NCT00422513|40155831|FG001|Overall Study|Withdrawal by Subject|1|||
16458003|NCT00422513|40155830|FG000|Overall Study|early termination of the study|67|||
16458004|NCT00422513|40155831|FG001|Overall Study|early termination of the study|80|||
16458005|NCT00422513|40155830|FG000|Overall Study|Adverse Event|4|||
16458006|NCT00422513|40155831|FG001|Overall Study|Adverse Event|4|||
16458007|NCT00422513|40155830|FG000|Overall Study|Death|3|||
16458008|NCT00422513|40155831|FG001|Overall Study|Death|7|||
16458009|NCT00612807|40155832|FG000|Overall Study|Withdrawal by Subject|2|||
16458010|NCT00612807|40155833|FG001|Overall Study|Withdrawal by Subject|0|||
16458011|NCT02036853|40155834|FG000|Overall Study|Adverse Event|0|||
16458012|NCT02036853|40155835|FG001|Overall Study|Adverse Event|2|||
16458013|NCT02036853|40155834|FG000|Overall Study|Lack of Efficacy|0|||
16458014|NCT02036853|40155835|FG001|Overall Study|Lack of Efficacy|2|||
16458015|NCT02036853|40155834|FG000|Overall Study|Physician Decision|0|||
16458016|NCT02036853|40155835|FG001|Overall Study|Physician Decision|1|||
16458017|NCT02036853|40155834|FG000|Overall Study|Withdrawal by Subject|0|||
16458018|NCT02036853|40155835|FG001|Overall Study|Withdrawal by Subject|1|||
16458019|NCT04335136|40155836|FG000|Overall Study|Death|8|||
16458020|NCT04335136|40155837|FG001|Overall Study|Death|4|||
16458021|NCT04335136|40155836|FG000|Overall Study|Lost to Follow-up|2|||
16458022|NCT04335136|40155837|FG001|Overall Study|Lost to Follow-up|0|||
16458023|NCT04335136|40155836|FG000|Overall Study|Protocol Violation|1|||
16458024|NCT04335136|40155837|FG001|Overall Study|Protocol Violation|0|||
16458025|NCT04335136|40155836|FG000|Overall Study|Withdrawal by Subject|1|||
16458026|NCT04335136|40155837|FG001|Overall Study|Withdrawal by Subject|1|||
16458027|NCT04335136|40155836|FG000|Overall Study|Health-threatening condition|0|||
16458028|NCT04335136|40155837|FG001|Overall Study|Health-threatening condition|1|||
16458029|NCT04335136|40155836|FG000|Overall Study|Adverse Event|0|||
16458030|NCT04335136|40155837|FG001|Overall Study|Adverse Event|1|||
16458031|NCT04335136|40155836|FG000|Overall Study|Erroneously randomized|2|||
16458032|NCT04335136|40155837|FG001|Overall Study|Erroneously randomized|0|||
16458033|NCT04784442|40155838|FG000|Overall Study|Adverse Event|1|||
16458034|NCT04784442|40155839|FG001|Overall Study|Adverse Event|0|||
16458035|NCT04784442|40155840|FG002|Overall Study|Adverse Event|2|||
16458036|NCT04784442|40155841|FG003|Overall Study|Adverse Event|1|||
16458037|NCT04784442|40155838|FG000|Overall Study|Protocol Violation|1|||
16458038|NCT04784442|40155839|FG001|Overall Study|Protocol Violation|0|||
16458039|NCT04784442|40155840|FG002|Overall Study|Protocol Violation|0|||
16458040|NCT04784442|40155841|FG003|Overall Study|Protocol Violation|0|||
16458041|NCT04784442|40155838|FG000|Overall Study|Non-compliance with study drug|1|||
16458042|NCT04784442|40155839|FG001|Overall Study|Non-compliance with study drug|0|||
16458043|NCT04784442|40155840|FG002|Overall Study|Non-compliance with study drug|0|||
16458044|NCT04784442|40155841|FG003|Overall Study|Non-compliance with study drug|0|||
16458045|NCT00282347|40155842|FG000|Treatment Period|Death|2|||
16458046|NCT00282347|40155843|FG001|Treatment Period|Death|0|||
16458047|NCT00282347|40155842|FG000|Treatment Period|Lost to Follow-up|2|||
16458048|NCT00282347|40155843|FG001|Treatment Period|Lost to Follow-up|5|||
16458049|NCT00282347|40155842|FG000|Treatment Period|Withdrawal by Subject|1|||
16458050|NCT00282347|40155843|FG001|Treatment Period|Withdrawal by Subject|3|||
16458051|NCT00282347|40155842|FG000|Treatment Period|Physician Decision|0|||
16458052|NCT00282347|40155843|FG001|Treatment Period|Physician Decision|1|||
16458053|NCT00282347|40155842|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
16458054|NCT00282347|40155843|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
16458055|NCT00282347|40155842|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
16458056|NCT00282347|40155843|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
16458057|NCT00282347|40155842|FG000|Safety Follow-up Period|Physician Decision|1|||
16458058|NCT00282347|40155843|FG001|Safety Follow-up Period|Physician Decision|1|||
16458059|NCT00282347|40155842|FG000|Safety Follow-up Period|Protocol Deviation|0|||
16458060|NCT00282347|40155843|FG001|Safety Follow-up Period|Protocol Deviation|2|||
16458061|NCT00282347|40155842|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
16458062|NCT00282347|40155843|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
16458063|NCT00282347|40155842|FG000|B Cell Follow-up Period|Physician Decision|1|||
16458064|NCT00282347|40155843|FG001|B Cell Follow-up Period|Physician Decision|0|||
16458065|NCT00282347|40155842|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
16458066|NCT00282347|40155843|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
16458067|NCT01712399|40155844|FG000|Overall Study|Lost to Follow-up|1|||
16458068|NCT01712399|40155844|FG000|Overall Study|Withdrawal by Subject|39|||
16458069|NCT01712399|40155844|FG000|Overall Study|Death|1|||
16458070|NCT01712399|40155844|FG000|Overall Study|Adverse Event|11|||
16458071|NCT01712399|40155844|FG000|Overall Study|Study closure|345|||
16458072|NCT02123472|40155846|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
16458073|NCT02123472|40155847|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
16458074|NCT01590758|40155849|FG000|Overall Study|Withdrawal by Subject|0|||
16458075|NCT01590758|40155850|FG001|Overall Study|Withdrawal by Subject|3|||
16458076|NCT01590758|40155849|FG000|Overall Study|Physician Decision|1|||
16458077|NCT01590758|40155850|FG001|Overall Study|Physician Decision|2|||
16458078|NCT01590758|40155849|FG000|Overall Study|Lost to Follow-up|4|||
16458079|NCT01590758|40155850|FG001|Overall Study|Lost to Follow-up|2|||
16458080|NCT04535453|40155856|FG000|Overall Study|Death|0|||
16458081|NCT04535453|40155857|FG001|Overall Study|Death|1|||
16458082|NCT04535453|40155858|FG002|Overall Study|Death|0|||
16458083|NCT04535453|40155859|FG003|Overall Study|Death|0|||
16458084|NCT04535453|40155860|FG004|Overall Study|Death|0|||
16458085|NCT04535453|40155861|FG005|Overall Study|Death|0|||
16458086|NCT04535453|40155862|FG006|Overall Study|Death|0|||
16458087|NCT04535453|40155863|FG007|Overall Study|Death|0|||
16458088|NCT04535453|40155864|FG008|Overall Study|Death|0|||
16458089|NCT04535453|40155865|FG009|Overall Study|Death|0|||
16458090|NCT04535453|40155866|FG010|Overall Study|Death|0|||
16458091|NCT04535453|40155867|FG011|Overall Study|Death|0|||
16458092|NCT04535453|40155856|FG000|Overall Study|Lost to Follow-up|1|||
16458093|NCT04535453|40155857|FG001|Overall Study|Lost to Follow-up|1|||
16458094|NCT04535453|40155858|FG002|Overall Study|Lost to Follow-up|1|||
16458095|NCT04535453|40155859|FG003|Overall Study|Lost to Follow-up|0|||
16458096|NCT04535453|40155860|FG004|Overall Study|Lost to Follow-up|3|||
16458097|NCT04535453|40155861|FG005|Overall Study|Lost to Follow-up|1|||
16167183|NCT02305563|39091420|FG002|Treatment Period|Participant withdrew consent|1|||
16458098|NCT04535453|40155862|FG006|Overall Study|Lost to Follow-up|0|||
16458099|NCT04535453|40155863|FG007|Overall Study|Lost to Follow-up|0|||
16458100|NCT04535453|40155864|FG008|Overall Study|Lost to Follow-up|1|||
16458101|NCT04535453|40155865|FG009|Overall Study|Lost to Follow-up|1|||
16458102|NCT04535453|40155866|FG010|Overall Study|Lost to Follow-up|0|||
16458103|NCT04535453|40155867|FG011|Overall Study|Lost to Follow-up|0|||
16458104|NCT04535453|40155856|FG000|Overall Study|Physician Decision|0|||
16458105|NCT04535453|40155857|FG001|Overall Study|Physician Decision|0|||
16458106|NCT04535453|40155858|FG002|Overall Study|Physician Decision|0|||
16458107|NCT04535453|40155859|FG003|Overall Study|Physician Decision|1|||
16458108|NCT04535453|40155860|FG004|Overall Study|Physician Decision|0|||
16458109|NCT04535453|40155861|FG005|Overall Study|Physician Decision|0|||
16458110|NCT04535453|40155862|FG006|Overall Study|Physician Decision|0|||
16458111|NCT04535453|40155863|FG007|Overall Study|Physician Decision|0|||
16458112|NCT04535453|40155864|FG008|Overall Study|Physician Decision|0|||
16458113|NCT04535453|40155865|FG009|Overall Study|Physician Decision|0|||
16458114|NCT04535453|40155866|FG010|Overall Study|Physician Decision|0|||
16458115|NCT04535453|40155867|FG011|Overall Study|Physician Decision|0|||
16458116|NCT04535453|40155856|FG000|Overall Study|Withdrawal by Subject|3|||
16458117|NCT04535453|40155857|FG001|Overall Study|Withdrawal by Subject|6|||
16458118|NCT04535453|40155858|FG002|Overall Study|Withdrawal by Subject|3|||
16458119|NCT04535453|40155859|FG003|Overall Study|Withdrawal by Subject|3|||
16458120|NCT04535453|40155860|FG004|Overall Study|Withdrawal by Subject|2|||
16458121|NCT04535453|40155861|FG005|Overall Study|Withdrawal by Subject|1|||
16458122|NCT04535453|40155862|FG006|Overall Study|Withdrawal by Subject|1|||
16458123|NCT04535453|40155863|FG007|Overall Study|Withdrawal by Subject|1|||
16458124|NCT04535453|40155864|FG008|Overall Study|Withdrawal by Subject|1|||
16458125|NCT04535453|40155865|FG009|Overall Study|Withdrawal by Subject|1|||
16458126|NCT04535453|40155866|FG010|Overall Study|Withdrawal by Subject|0|||
16458127|NCT04535453|40155867|FG011|Overall Study|Withdrawal by Subject|1|||
16458128|NCT04535453|40155856|FG000|Overall Study|Other|0|||
16458129|NCT04535453|40155857|FG001|Overall Study|Other|0|||
16458130|NCT04535453|40155858|FG002|Overall Study|Other|1|||
16458131|NCT04535453|40155859|FG003|Overall Study|Other|0|||
16458132|NCT04535453|40155860|FG004|Overall Study|Other|1|||
16458133|NCT04535453|40155861|FG005|Overall Study|Other|0|||
16458134|NCT04535453|40155862|FG006|Overall Study|Other|1|||
16458135|NCT04535453|40155863|FG007|Overall Study|Other|1|||
16458136|NCT04535453|40155864|FG008|Overall Study|Other|1|||
16458137|NCT04535453|40155865|FG009|Overall Study|Other|0|||
16458138|NCT04535453|40155866|FG010|Overall Study|Other|0|||
16458139|NCT04535453|40155867|FG011|Overall Study|Other|0|||
16458140|NCT01596062|40155868|FG000|Overall Study|Adverse Event|1|||
16458141|NCT01596062|40155869|FG001|Overall Study|Adverse Event|0|||
16458142|NCT01596062|40155870|FG002|Overall Study|Adverse Event|2|||
16458143|NCT01596062|40155868|FG000|Overall Study|Lack of Efficacy|0|||
16458144|NCT01596062|40155869|FG001|Overall Study|Lack of Efficacy|0|||
16458145|NCT01596062|40155870|FG002|Overall Study|Lack of Efficacy|1|||
16458146|NCT00499590|40155873|FG000|Overall Study|Study Terminated|112|||
16458147|NCT00499590|40155874|FG001|Overall Study|Study Terminated|112|||
16458148|NCT00499590|40155875|FG002|Overall Study|Study Terminated|112|||
16458149|NCT00499590|40155873|FG000|Overall Study|Not treated|1|||
16458150|NCT00499590|40155874|FG001|Overall Study|Not treated|0|||
16458151|NCT00499590|40155875|FG002|Overall Study|Not treated|1|||
16458152|NCT01250145|40158890|FG000|Overall Study|Adverse Event|2|||
16458153|NCT01250145|40158891|FG001|Overall Study|Adverse Event|1|||
16458154|NCT01250145|40158890|FG000|Overall Study|Withdrawal by Subject|0|||
16458155|NCT01250145|40158891|FG001|Overall Study|Withdrawal by Subject|4|||
16458156|NCT03263702|40158892|FG000|Overall Study|Lost to Follow-up|2|||
16458157|NCT03263702|40158893|FG001|Overall Study|Lost to Follow-up|2|||
16458158|NCT03263702|40158892|FG000|Overall Study|Withdrawal by Subject|1|||
16458159|NCT03263702|40158893|FG001|Overall Study|Withdrawal by Subject|2|||
16458160|NCT02078960|40158897|FG000|Treatment Period|Other|0|||
16458161|NCT02078960|40158898|FG001|Treatment Period|Other|0|||
16458162|NCT02078960|40158899|FG002|Treatment Period|Other|1|||
16458163|NCT02078960|40158897|FG000|Treatment Period|Lack of Efficacy|0|||
16458164|NCT02078960|40158898|FG001|Treatment Period|Lack of Efficacy|1|||
16458165|NCT02078960|40158899|FG002|Treatment Period|Lack of Efficacy|0|||
16458166|NCT02078960|40158897|FG000|Treatment Period|Disease progression - accelerated phase|0|||
16458167|NCT02078960|40158898|FG001|Treatment Period|Disease progression - accelerated phase|1|||
16458168|NCT02078960|40158899|FG002|Treatment Period|Disease progression - accelerated phase|0|||
16458169|NCT02078960|40158897|FG000|Treatment Period|Disease progression - blast phase|1|||
16458170|NCT02078960|40158898|FG001|Treatment Period|Disease progression - blast phase|0|||
16458171|NCT02078960|40158899|FG002|Treatment Period|Disease progression - blast phase|0|||
16458172|NCT02078960|40158897|FG000|Treatment Period|Withdrawal by Subject|0|||
16458173|NCT02078960|40158898|FG001|Treatment Period|Withdrawal by Subject|1|||
16458174|NCT02078960|40158899|FG002|Treatment Period|Withdrawal by Subject|1|||
16458175|NCT02078960|40158897|FG000|Treatment Period|Adverse Event|1|||
16458176|NCT02078960|40158898|FG001|Treatment Period|Adverse Event|0|||
16458177|NCT02078960|40158899|FG002|Treatment Period|Adverse Event|0|||
16458178|NCT02078960|40158897|FG000|Treatment Period|Death|0|||
16458179|NCT02078960|40158898|FG001|Treatment Period|Death|0|||
16458180|NCT02078960|40158899|FG002|Treatment Period|Death|1|||
16458181|NCT02078960|40158897|FG000|Follow-up Period|Death|2|||
16458182|NCT02078960|40158898|FG001|Follow-up Period|Death|0|||
16458183|NCT02078960|40158899|FG002|Follow-up Period|Death|0|||
16458184|NCT02078960|40158897|FG000|Follow-up Period|Lost to Follow-up|0|||
16458185|NCT02078960|40158898|FG001|Follow-up Period|Lost to Follow-up|1|||
16458186|NCT02078960|40158899|FG002|Follow-up Period|Lost to Follow-up|0|||
16458187|NCT03148691|40158907|FG000|Overall Study|Protocol Violation|1|||
16458188|NCT03148691|40158908|FG001|Overall Study|Protocol Violation|2|||
16458189|NCT03148691|40158909|FG002|Overall Study|Protocol Violation|7|||
16458190|NCT03148691|40158907|FG000|Overall Study|Lost to Follow-up|0|||
16458191|NCT03148691|40158908|FG001|Overall Study|Lost to Follow-up|0|||
16458192|NCT03148691|40158909|FG002|Overall Study|Lost to Follow-up|1|||
16458193|NCT03148691|40158907|FG000|Overall Study|Other|1|||
16458194|NCT03148691|40158908|FG001|Overall Study|Other|0|||
16458195|NCT03148691|40158909|FG002|Overall Study|Other|0|||
16458196|NCT03148691|40158907|FG000|Overall Study|Withdrawal by Subject|1|||
16458197|NCT03148691|40158908|FG001|Overall Study|Withdrawal by Subject|0|||
16458198|NCT03148691|40158909|FG002|Overall Study|Withdrawal by Subject|0|||
16458199|NCT02720042|40158914|FG000|Overall Study|Death|3|||
16458200|NCT02720042|40158914|FG000|Overall Study|Lost to Follow-up|4|||
16458201|NCT02720042|40158914|FG000|Overall Study|Withdrawal by Subject|1|||
16458202|NCT02720042|40158914|FG000|Overall Study|Physician Decision|3|||
16458203|NCT02720042|40158914|FG000|Overall Study|Phasix Mesh explanted|1|||
16458204|NCT02720042|40158914|FG000|Overall Study|unable due to non-study-related illness|3|||
16458205|NCT00743106|40158918|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
16458206|NCT00743106|40158919|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
16458207|NCT03539549|40158920|FG000|Overall Study|Adverse Event|12|||
16458208|NCT03539549|40158920|FG000|Overall Study|Lost to Follow-up|1|||
16458209|NCT03539549|40158920|FG000|Overall Study|Death|2|||
16458210|NCT03539549|40158920|FG000|Overall Study|Progressive Disease|1|||
16458211|NCT03539549|40158920|FG000|Overall Study|Reason not Specified|1|||
16458212|NCT00943072|40158921|FG000|Overall Study|Adverse Event|0|||
16458213|NCT00943072|40158922|FG001|Overall Study|Adverse Event|3|||
16458214|NCT00943072|40158921|FG000|Overall Study|Death|0|||
16458215|NCT00943072|40158922|FG001|Overall Study|Death|2|||
16458216|NCT00943072|40158921|FG000|Overall Study|Withdrawal by Subject|3|||
16458217|NCT00943072|40158922|FG001|Overall Study|Withdrawal by Subject|1|||
16458218|NCT00943072|40158921|FG000|Overall Study|Protocol Violation|0|||
16458219|NCT00943072|40158922|FG001|Overall Study|Protocol Violation|1|||
16458220|NCT00943072|40158921|FG000|Overall Study|Lost to Follow-up|1|||
16458221|NCT00943072|40158922|FG001|Overall Study|Lost to Follow-up|2|||
16458222|NCT00943072|40158921|FG000|Overall Study|Lack of Efficacy|0|||
16458223|NCT00943072|40158922|FG001|Overall Study|Lack of Efficacy|4|||
16458224|NCT00943072|40158921|FG000|Overall Study|Other|1|||
16458225|NCT00943072|40158922|FG001|Overall Study|Other|1|||
16458226|NCT03598114|40158923|FG000|Overall Study|Staff turnover/left the program|3|||
16458227|NCT03598114|40158924|FG001|Overall Study|Staff turnover/left the program|39|||
16458228|NCT00243841|40158932|FG000|Overall Study|Physician Decision|0|||
16458229|NCT00243841|40158933|FG001|Overall Study|Physician Decision|0|||
16167184|NCT02305563|39091421|FG003|Treatment Period|Participant withdrew consent|1|||
16167185|NCT02305563|39091422|FG004|Treatment Period|Participant withdrew consent|1|||
16458230|NCT00243841|40158934|FG002|Overall Study|Physician Decision|1|||
16458231|NCT00243841|40158935|FG003|Overall Study|Physician Decision|0|||
16458232|NCT00243841|40158936|FG004|Overall Study|Physician Decision|0|||
16458233|NCT00243841|40158937|FG005|Overall Study|Physician Decision|2|||
16458234|NCT01499368|40158938|FG000|Overall Study|Did not meet I/E criteria|8|||
16458235|NCT01499368|40158939|FG001|Overall Study|Did not meet I/E criteria|4|||
16458236|NCT01499368|40158940|FG002|Overall Study|Did not meet I/E criteria|4|||
16458237|NCT01499368|40158938|FG000|Overall Study|Prohibited Concomitant medication|1|||
16458238|NCT01499368|40158939|FG001|Overall Study|Prohibited Concomitant medication|1|||
16458239|NCT01499368|40158940|FG002|Overall Study|Prohibited Concomitant medication|0|||
16458240|NCT01499368|40158938|FG000|Overall Study|Withdrawal by Subject|11|||
16458241|NCT01499368|40158939|FG001|Overall Study|Withdrawal by Subject|10|||
16458242|NCT01499368|40158940|FG002|Overall Study|Withdrawal by Subject|8|||
16458243|NCT01499368|40158938|FG000|Overall Study|Lost to Follow-up|3|||
16458244|NCT01499368|40158939|FG001|Overall Study|Lost to Follow-up|2|||
16167186|NCT02305563|39091418|FG000|Treatment Period|Maximum clinical benefit|0|||
16167187|NCT02305563|39091419|FG001|Treatment Period|Maximum clinical benefit|0|||
16167188|NCT02305563|39091420|FG002|Treatment Period|Maximum clinical benefit|0|||
16167189|NCT02305563|39091421|FG003|Treatment Period|Maximum clinical benefit|0|||
16167190|NCT02305563|39091422|FG004|Treatment Period|Maximum clinical benefit|1|||
16458245|NCT01499368|40158940|FG002|Overall Study|Lost to Follow-up|5|||
16458246|NCT01499368|40158938|FG000|Overall Study|Adverse Event|4|||
16458247|NCT01499368|40158939|FG001|Overall Study|Adverse Event|0|||
16458248|NCT01499368|40158940|FG002|Overall Study|Adverse Event|2|||
16458249|NCT01499368|40158938|FG000|Overall Study|Physician Decision|0|||
16458250|NCT01499368|40158939|FG001|Overall Study|Physician Decision|1|||
16458251|NCT01499368|40158940|FG002|Overall Study|Physician Decision|0|||
16458252|NCT01499368|40158938|FG000|Overall Study|Deviation from visit window|0|||
16458253|NCT01499368|40158939|FG001|Overall Study|Deviation from visit window|0|||
16458254|NCT01499368|40158940|FG002|Overall Study|Deviation from visit window|1|||
16458255|NCT01499368|40158938|FG000|Overall Study|Error of Prescriptions|0|||
16458256|NCT01499368|40158939|FG001|Overall Study|Error of Prescriptions|0|||
16458257|NCT01499368|40158940|FG002|Overall Study|Error of Prescriptions|1|||
16458258|NCT01388985|40158941|FG000|Overall Study|Death|0|||
16458259|NCT01388985|40158942|FG001|Overall Study|Death|1|||
16458260|NCT01388985|40158941|FG000|Overall Study|Lost to Follow-up|30|||
16458261|NCT01388985|40158942|FG001|Overall Study|Lost to Follow-up|30|||
16458262|NCT01388985|40158941|FG000|Overall Study|Withdrawal by Subject|13|||
16458263|NCT01388985|40158942|FG001|Overall Study|Withdrawal by Subject|4|||
16458264|NCT01388985|40158941|FG000|Overall Study|Subject unavailable|1|||
16458265|NCT01388985|40158942|FG001|Overall Study|Subject unavailable|1|||
16458266|NCT01388985|40158941|FG000|Overall Study|Other (no reason)|0|||
16458267|NCT01388985|40158942|FG001|Overall Study|Other (no reason)|1|||
16458268|NCT01388985|40158941|FG000|Overall Study|Error of nurse|5|||
16458269|NCT01388985|40158942|FG001|Overall Study|Error of nurse|1|||
16458270|NCT00899392|40158943|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
16458271|NCT00899392|40158944|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
16458272|NCT01148979|40158949|FG000|Overall Study|Lost to Follow-up|0|||
16458273|NCT01148979|40158950|FG001|Overall Study|Lost to Follow-up|1|||
16458274|NCT00653939|40158951|FG000|Overall Study|Adverse Event|1|||
16458275|NCT00653939|40158952|FG001|Overall Study|Adverse Event|3|||
16458276|NCT00653939|40158951|FG000|Overall Study|Withdrawal by Subject|3|||
16458277|NCT00653939|40158952|FG001|Overall Study|Withdrawal by Subject|3|||
16458278|NCT00653939|40158951|FG000|Overall Study|Physician Decision|4|||
16458279|NCT00653939|40158952|FG001|Overall Study|Physician Decision|0|||
16458280|NCT00653939|40158951|FG000|Overall Study|Disease Progression|2|||
16458281|NCT00653939|40158952|FG001|Overall Study|Disease Progression|3|||
16458282|NCT00653939|40158951|FG000|Overall Study|Other|2|||
16458283|NCT00653939|40158952|FG001|Overall Study|Other|6|||
16458284|NCT01865552|40158953|FG000|Period 1|Adverse Event|1|||
16458285|NCT01865552|40158954|FG001|Period 1|Adverse Event|0|||
16458286|NCT01865552|40158955|FG002|Period 1|Adverse Event|0|||
16458287|NCT01865552|40158956|FG003|Period 1|Adverse Event|1|||
16458288|NCT01865552|40158957|FG004|Period 1|Adverse Event|1|||
16458289|NCT01865552|40158958|FG005|Period 1|Adverse Event|1|||
16458290|NCT01865552|40158953|FG000|Period 1|Pathological lab|0|||
16458291|NCT01865552|40158954|FG001|Period 1|Pathological lab|0|||
16458292|NCT01865552|40158955|FG002|Period 1|Pathological lab|0|||
16458293|NCT01865552|40158956|FG003|Period 1|Pathological lab|0|||
16458294|NCT01865552|40158957|FG004|Period 1|Pathological lab|1|||
16458295|NCT01865552|40158958|FG005|Period 1|Pathological lab|0|||
16458296|NCT01865552|40158953|FG000|Period 1|Other|0|||
16458297|NCT01865552|40158954|FG001|Period 1|Other|0|||
16458298|NCT01865552|40158955|FG002|Period 1|Other|0|||
16458299|NCT01865552|40158956|FG003|Period 1|Other|0|||
16458300|NCT01865552|40158957|FG004|Period 1|Other|1|||
16458301|NCT01865552|40158958|FG005|Period 1|Other|0|||
16458302|NCT02184572|40158959|FG000|Overall Study|Lost to Follow-up|29|||
16458303|NCT02184572|40158960|FG001|Overall Study|Lost to Follow-up|21|||
16458304|NCT02184572|40158959|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
16458305|NCT02184572|40158960|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
16458306|NCT02184572|40158959|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
16458307|NCT02184572|40158960|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
16458308|NCT02184572|40158959|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
16458309|NCT02184572|40158960|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
16458310|NCT02184572|40158959|FG000|Overall Study|Traveling Outside The Country|1|||
16458311|NCT02184572|40158960|FG001|Overall Study|Traveling Outside The Country|0|||
16458312|NCT02184572|40158959|FG000|Overall Study|Withdrawal by Subject|14|||
16458313|NCT02184572|40158960|FG001|Overall Study|Withdrawal by Subject|9|||
16458314|NCT02255435|40158961|FG000|Overall Study|Patient's Limited Time Availability|0|||
16458315|NCT02255435|40158962|FG001|Overall Study|Patient's Limited Time Availability|0|||
16458316|NCT02255435|40158963|FG002|Overall Study|Patient's Limited Time Availability|0|||
16458317|NCT02255435|40158964|FG003|Overall Study|Patient's Limited Time Availability|0|||
16458318|NCT02255435|40158965|FG004|Overall Study|Patient's Limited Time Availability|0|||
16458319|NCT02255435|40158966|FG005|Overall Study|Patient's Limited Time Availability|0|||
16458320|NCT02255435|40158967|FG006|Overall Study|Patient's Limited Time Availability|0|||
16458321|NCT02255435|40158968|FG007|Overall Study|Patient's Limited Time Availability|1|||
16458322|NCT02255435|40158969|FG008|Overall Study|Patient's Limited Time Availability|0|||
16458323|NCT02255435|40158970|FG009|Overall Study|Patient's Limited Time Availability|0|||
16458324|NCT02255435|40158961|FG000|Overall Study|Withdrawal by Subject|0|||
16458325|NCT02255435|40158962|FG001|Overall Study|Withdrawal by Subject|0|||
16458326|NCT02255435|40158963|FG002|Overall Study|Withdrawal by Subject|0|||
16458327|NCT02255435|40158964|FG003|Overall Study|Withdrawal by Subject|0|||
16458328|NCT02255435|40158965|FG004|Overall Study|Withdrawal by Subject|0|||
16458329|NCT02255435|40158966|FG005|Overall Study|Withdrawal by Subject|0|||
16458330|NCT02255435|40158967|FG006|Overall Study|Withdrawal by Subject|0|||
16458331|NCT02255435|40158968|FG007|Overall Study|Withdrawal by Subject|0|||
16458332|NCT02255435|40158969|FG008|Overall Study|Withdrawal by Subject|1|||
16458333|NCT02255435|40158970|FG009|Overall Study|Withdrawal by Subject|4|||
16167191|NCT02305563|39091418|FG000|Treatment Period|Poor/non-compliance|0|||
16167192|NCT02305563|39091419|FG001|Treatment Period|Poor/non-compliance|0|||
16167193|NCT02305563|39091420|FG002|Treatment Period|Poor/non-compliance|0|||
16167194|NCT02305563|39091421|FG003|Treatment Period|Poor/non-compliance|0|||
16167195|NCT02305563|39091422|FG004|Treatment Period|Poor/non-compliance|1|||
16167196|NCT02305563|39091418|FG000|Treatment Period|Administrative reason by Sponsor|0|||
16167197|NCT02305563|39091419|FG001|Treatment Period|Administrative reason by Sponsor|0|||
16167198|NCT02305563|39091420|FG002|Treatment Period|Administrative reason by Sponsor|0|||
16458334|NCT02255435|40158961|FG000|Overall Study|Administrative reasons|0|||
16458335|NCT02255435|40158962|FG001|Overall Study|Administrative reasons|0|||
16458336|NCT02255435|40158963|FG002|Overall Study|Administrative reasons|0|||
16458337|NCT02255435|40158964|FG003|Overall Study|Administrative reasons|0|||
16458338|NCT02255435|40158965|FG004|Overall Study|Administrative reasons|0|||
16458339|NCT02255435|40158966|FG005|Overall Study|Administrative reasons|0|||
16458340|NCT02255435|40158967|FG006|Overall Study|Administrative reasons|0|||
16458341|NCT02255435|40158968|FG007|Overall Study|Administrative reasons|0|||
16458342|NCT02255435|40158969|FG008|Overall Study|Administrative reasons|0|||
16458343|NCT02255435|40158970|FG009|Overall Study|Administrative reasons|2|||
16458344|NCT01454778|40158971|FG000|Overall Study|Lost to Follow-up|2|||
16458345|NCT01454778|40158971|FG000|Overall Study|Death|1|||
16458346|NCT01343693|40158986|FG000|Overall Study|Lost to Follow-up|9|||
16458347|NCT01478048|40158987|FG000|Overall Study|Disease Progression|52|||
16458348|NCT01478048|40158988|FG001|Overall Study|Disease Progression|35|||
16458349|NCT01478048|40158987|FG000|Overall Study|study drug toxicity|11|||
16458350|NCT01478048|40158988|FG001|Overall Study|study drug toxicity|14|||
16458351|NCT01478048|40158987|FG000|Overall Study|Adverse Event|2|||
16458352|NCT01478048|40158988|FG001|Overall Study|Adverse Event|11|||
16458353|NCT01478048|40158987|FG000|Overall Study|subject request to discontinue treatment|3|||
16458354|NCT01478048|40158988|FG001|Overall Study|subject request to discontinue treatment|5|||
16458355|NCT01478048|40158987|FG000|Overall Study|Withdrawal by Subject|2|||
16458356|NCT01478048|40158988|FG001|Overall Study|Withdrawal by Subject|5|||
16458357|NCT01478048|40158987|FG000|Overall Study|non-specified|6|||
16458358|NCT01478048|40158988|FG001|Overall Study|non-specified|4|||
16458359|NCT01478048|40158987|FG000|Overall Study|poor/non-compliance|0|||
16167199|NCT02305563|39091421|FG003|Treatment Period|Administrative reason by Sponsor|0|||
16458360|NCT01478048|40158988|FG001|Overall Study|poor/non-compliance|1|||
16458361|NCT01478048|40158987|FG000|Overall Study|no longer meets study criteria|1|||
16458362|NCT01478048|40158988|FG001|Overall Study|no longer meets study criteria|0|||
16458363|NCT01396447|40158989|FG000|Overall Study|Did Not Receive Treatment|3|||
16167200|NCT02305563|39091422|FG004|Treatment Period|Administrative reason by Sponsor|1|||
16167201|NCT02305563|39091418|FG000|Treatment Period|other reason|2|||
16167202|NCT02305563|39091419|FG001|Treatment Period|other reason|0|||
16167203|NCT02305563|39091420|FG002|Treatment Period|other reason|2|||
16167204|NCT02305563|39091421|FG003|Treatment Period|other reason|2|||
16167205|NCT02305563|39091422|FG004|Treatment Period|other reason|1|||
16167206|NCT02305563|39091418|FG000|Treatment Period|Randomized but not treated|0|||
16167207|NCT02305563|39091419|FG001|Treatment Period|Randomized but not treated|0|||
16167208|NCT02305563|39091420|FG002|Treatment Period|Randomized but not treated|0|||
16167209|NCT02305563|39091421|FG003|Treatment Period|Randomized but not treated|0|||
16167210|NCT02305563|39091422|FG004|Treatment Period|Randomized but not treated|2|||
16167211|NCT02305563|39091418|FG000|Treatment Period|added ULO, then disease progression|0|||
16167212|NCT02305563|39091419|FG001|Treatment Period|added ULO, then disease progression|0|||
16458364|NCT01396447|40158990|FG001|Overall Study|Did Not Receive Treatment|2|||
16458365|NCT01396447|40158991|FG002|Overall Study|Did Not Receive Treatment|1|||
16458366|NCT01396447|40158992|FG003|Overall Study|Did Not Receive Treatment|0|||
16458367|NCT01396447|40158989|FG000|Overall Study|Adverse Event|15|||
16458368|NCT01396447|40158990|FG001|Overall Study|Adverse Event|12|||
16458369|NCT01396447|40158991|FG002|Overall Study|Adverse Event|12|||
16458370|NCT01396447|40158992|FG003|Overall Study|Adverse Event|17|||
16458371|NCT01396447|40158989|FG000|Overall Study|Insufficient Therapeutic Response|5|||
16458372|NCT01396447|40158990|FG001|Overall Study|Insufficient Therapeutic Response|5|||
16458373|NCT01396447|40158991|FG002|Overall Study|Insufficient Therapeutic Response|2|||
16458374|NCT01396447|40158992|FG003|Overall Study|Insufficient Therapeutic Response|4|||
16458375|NCT01396447|40158989|FG000|Overall Study|Protocol Violation|5|||
16458376|NCT01396447|40158990|FG001|Overall Study|Protocol Violation|2|||
16167213|NCT02305563|39091420|FG002|Treatment Period|added ULO, then disease progression|0|||
16458377|NCT01396447|40158991|FG002|Overall Study|Protocol Violation|3|||
16458378|NCT01396447|40158992|FG003|Overall Study|Protocol Violation|7|||
16458379|NCT01396447|40158989|FG000|Overall Study|Withdrawal of Consent|11|||
16458380|NCT01396447|40158990|FG001|Overall Study|Withdrawal of Consent|9|||
16458381|NCT01396447|40158991|FG002|Overall Study|Withdrawal of Consent|4|||
16167214|NCT02305563|39091421|FG003|Treatment Period|added ULO, then disease progression|0|||
16167215|NCT02305563|39091422|FG004|Treatment Period|added ULO, then disease progression|4|||
16458382|NCT01396447|40158992|FG003|Overall Study|Withdrawal of Consent|15|||
16458383|NCT01396447|40158989|FG000|Overall Study|Lost to Follow-up|4|||
16458384|NCT01396447|40158990|FG001|Overall Study|Lost to Follow-up|8|||
16458385|NCT01396447|40158991|FG002|Overall Study|Lost to Follow-up|7|||
16458386|NCT01396447|40158992|FG003|Overall Study|Lost to Follow-up|9|||
16458387|NCT01396447|40158989|FG000|Overall Study|Other Miscellaneous Reasons|0|||
16458388|NCT01396447|40158990|FG001|Overall Study|Other Miscellaneous Reasons|2|||
16458389|NCT01396447|40158991|FG002|Overall Study|Other Miscellaneous Reasons|1|||
16458390|NCT01396447|40158992|FG003|Overall Study|Other Miscellaneous Reasons|0|||
16458391|NCT01964755|40158993|FG000|Overall Study|Death|2|||
16458392|NCT04849559|40158999|FG000|Overall Study|Withdrawal by Subject|2|||
16458393|NCT04849559|40159000|FG001|Overall Study|Withdrawal by Subject|1|||
16458394|NCT01675167|40159001|FG000|Open-label Titration Phase|Adverse Event|81|||
16458395|NCT01675167|40159002|FG001|Open-label Titration Phase|Adverse Event|0|||
16458396|NCT01675167|40159003|FG002|Open-label Titration Phase|Adverse Event|0|||
16458397|NCT01675167|40159001|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
16458398|NCT01675167|40159002|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
16458399|NCT01675167|40159003|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
16458400|NCT01675167|40159001|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
16458401|NCT01675167|40159002|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
16458402|NCT01675167|40159003|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
16458403|NCT01675167|40159001|FG000|Open-label Titration Phase|Protocol Violation|43|||
16458404|NCT01675167|40159002|FG001|Open-label Titration Phase|Protocol Violation|0|||
16458405|NCT01675167|40159003|FG002|Open-label Titration Phase|Protocol Violation|0|||
16458406|NCT01675167|40159001|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
16458407|NCT01675167|40159002|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
16458408|NCT01675167|40159003|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
16458409|NCT01675167|40159001|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
16458410|NCT01675167|40159002|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
16458411|NCT01675167|40159003|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
16458412|NCT01675167|40159001|FG000|Open-label Titration Phase|Other|55|||
16458413|NCT01675167|40159002|FG001|Open-label Titration Phase|Other|0|||
16458414|NCT01675167|40159003|FG002|Open-label Titration Phase|Other|0|||
16458415|NCT01675167|40159001|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
16458416|NCT01675167|40159002|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
16458417|NCT01675167|40159003|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
16458418|NCT01675167|40159001|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
16458419|NCT01675167|40159002|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
16458420|NCT01675167|40159003|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
16458421|NCT01675167|40159001|FG000|Double-blind Treatment Phase|Adverse Event|0|||
16458422|NCT01675167|40159002|FG001|Double-blind Treatment Phase|Adverse Event|5|||
16458423|NCT01675167|40159003|FG002|Double-blind Treatment Phase|Adverse Event|13|||
16458424|NCT01675167|40159001|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
16458425|NCT01675167|40159002|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
16458426|NCT01675167|40159003|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
16458427|NCT01675167|40159001|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
16458428|NCT01675167|40159002|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
16458429|NCT01675167|40159003|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
16458430|NCT01675167|40159001|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
16458431|NCT01675167|40159002|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
16458432|NCT01675167|40159003|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
16458433|NCT01675167|40159001|FG000|Double-blind Treatment Phase|Other|0|||
16458434|NCT01675167|40159002|FG001|Double-blind Treatment Phase|Other|7|||
16458435|NCT01675167|40159003|FG002|Double-blind Treatment Phase|Other|5|||
16458436|NCT00335764|40159004|FG000|Overall Study|wrong histology|1|||
16458437|NCT00335764|40159005|FG001|Overall Study|wrong histology|0|||
16458438|NCT00335764|40159006|FG002|Overall Study|wrong histology|0|||
16458439|NCT00335764|40159007|FG003|Overall Study|wrong histology|0|||
16458440|NCT00335764|40159008|FG004|Overall Study|wrong histology|1|||
16458441|NCT01387542|40159009|FG000|Overall Study|Adverse Event|3|||
16458442|NCT01387542|40159009|FG000|Overall Study|Withdrawal by Subject|1|||
16458443|NCT01387542|40159009|FG000|Overall Study|Changed diagnosis|1|||
16458444|NCT01387542|40159009|FG000|Overall Study|Insufficient response|1|||
16458445|NCT01387542|40159009|FG000|Overall Study|Non-compliant|1|||
16458446|NCT01387542|40159009|FG000|Overall Study|Lost to Follow-up|1|||
16458447|NCT01731938|40159010|FG000|Preliminary Part I|Withdrawal by Subject|2|||
16458448|NCT01731938|40159011|FG001|Preliminary Part I|Withdrawal by Subject|2|||
16458449|NCT01731938|40159010|FG000|Preliminary Part I|Physician Decision|1|||
16458450|NCT01731938|40159011|FG001|Preliminary Part I|Physician Decision|0|||
16458451|NCT01731938|40159010|FG000|Preliminary Part I|Lost to Follow-up|0|||
16458452|NCT01731938|40159011|FG001|Preliminary Part I|Lost to Follow-up|3|||
16458453|NCT01731938|40159010|FG000|Preliminary Part I|Missed Week 6 visit|0|||
16458454|NCT01731938|40159011|FG001|Preliminary Part I|Missed Week 6 visit|3|||
16458455|NCT01731938|40159010|FG000|Primary Part II|Withdrawal by Subject|5|||
16458456|NCT01731938|40159011|FG001|Primary Part II|Withdrawal by Subject|4|||
16458457|NCT01731938|40159010|FG000|Primary Part II|Lost to Follow-up|4|||
16458458|NCT01731938|40159011|FG001|Primary Part II|Lost to Follow-up|5|||
16458459|NCT01731938|40159010|FG000|Primary Part II|Death|2|||
16458460|NCT01731938|40159011|FG001|Primary Part II|Death|1|||
16458461|NCT01731938|40159010|FG000|Primary Part II|Missed Week 6 visit|2|||
16458462|NCT01731938|40159011|FG001|Primary Part II|Missed Week 6 visit|3|||
16458463|NCT00834080|40159012|FG000|Overall Study|Adverse Event|7|||
16458464|NCT00834080|40159012|FG000|Overall Study|Lost to Follow-up|7|||
16458465|NCT00834080|40159012|FG000|Overall Study|Withdrawal by Subject|5|||
16458466|NCT00834080|40159012|FG000|Overall Study|Other - Pregnancy|1|||
16458467|NCT00834080|40159012|FG000|Overall Study|Other - False positive tests of the UDS|1|||
16458468|NCT00834080|40159012|FG000|Overall Study|Physician Decision|1|||
16458469|NCT00834080|40159012|FG000|Overall Study|Subject Relocated|1|||
16458470|NCT00899353|40159014|FG000|Overall Study|Adverse Event|2|||
16458471|NCT00899353|40159014|FG000|Overall Study|Lost to Follow-up|1|||
16458472|NCT00899353|40159014|FG000|Overall Study|Withdrawal by Subject|2|||
16458473|NCT01546623|40159015|FG000|Overall Study|Adverse Event|2|||
16458474|NCT01546623|40159016|FG001|Overall Study|Adverse Event|3|||
16458475|NCT01546623|40159015|FG000|Overall Study|Major Protocol Deviation|1|||
16458476|NCT01546623|40159016|FG001|Overall Study|Major Protocol Deviation|1|||
16458477|NCT01546623|40159015|FG000|Overall Study|High Prostate specific antigen|2|||
16458478|NCT01546623|40159016|FG001|Overall Study|High Prostate specific antigen|1|||
16458479|NCT01546623|40159015|FG000|Overall Study|Did Not Receive Study Drug|1|||
16458480|NCT01546623|40159016|FG001|Overall Study|Did Not Receive Study Drug|1|||
16458481|NCT01578850|40159017|FG000|Period 1|Insufficient Clinical Response|1|||
16458482|NCT01578850|40159018|FG001|Period 1|Insufficient Clinical Response|0|||
16458483|NCT01578850|40159019|FG002|Period 1|Insufficient Clinical Response|0|||
16458484|NCT01578850|40159017|FG000|Period 1|Adverse Event|11|||
16458485|NCT01578850|40159018|FG001|Period 1|Adverse Event|0|||
16458486|NCT01578850|40159019|FG002|Period 1|Adverse Event|0|||
16458487|NCT01578850|40159017|FG000|Period 1|Death|1|||
16458488|NCT01578850|40159018|FG001|Period 1|Death|0|||
16458489|NCT01578850|40159019|FG002|Period 1|Death|0|||
16458490|NCT01578850|40159017|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
16458491|NCT01578850|40159018|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
16458492|NCT01578850|40159019|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
16458493|NCT01578850|40159017|FG000|Period 1|Withdrawal by Subject|9|||
16458494|NCT01578850|40159018|FG001|Period 1|Withdrawal by Subject|0|||
16458495|NCT01578850|40159019|FG002|Period 1|Withdrawal by Subject|0|||
16458496|NCT01578850|40159017|FG000|Period 1|Study Terminated by Sponsor|3|||
16458497|NCT01578850|40159018|FG001|Period 1|Study Terminated by Sponsor|0|||
16458498|NCT01578850|40159019|FG002|Period 1|Study Terminated by Sponsor|0|||
16458499|NCT01578850|40159017|FG000|Period 2|Insufficient Clinical Response|0|||
16458500|NCT01578850|40159018|FG001|Period 2|Insufficient Clinical Response|1|||
16458501|NCT01578850|40159019|FG002|Period 2|Insufficient Clinical Response|0|||
16458502|NCT01578850|40159017|FG000|Period 2|Adverse Event|0|||
16458503|NCT01578850|40159018|FG001|Period 2|Adverse Event|3|||
16458504|NCT01578850|40159019|FG002|Period 2|Adverse Event|6|||
16458505|NCT01578850|40159017|FG000|Period 2|Lost to Follow-up|0|||
16167216|NCT02305563|39091418|FG000|Treatment Period|added ULO; then other reason|0|||
16167217|NCT02305563|39091419|FG001|Treatment Period|added ULO; then other reason|0|||
16167218|NCT02305563|39091420|FG002|Treatment Period|added ULO; then other reason|0|||
16167219|NCT02305563|39091421|FG003|Treatment Period|added ULO; then other reason|0|||
16167220|NCT02305563|39091422|FG004|Treatment Period|added ULO; then other reason|1|||
16167221|NCT02305563|39091418|FG000|Treatment Period|added ULO, then request to stop|0|||
16167222|NCT02305563|39091419|FG001|Treatment Period|added ULO, then request to stop|0|||
16167223|NCT02305563|39091420|FG002|Treatment Period|added ULO, then request to stop|0|||
16167224|NCT02305563|39091421|FG003|Treatment Period|added ULO, then request to stop|0|||
16167225|NCT02305563|39091422|FG004|Treatment Period|added ULO, then request to stop|1|||
16167226|NCT02305563|39091418|FG000|Follow-up Period|Death|0|||
16167227|NCT02305563|39091419|FG001|Follow-up Period|Death|0|||
16167228|NCT02305563|39091420|FG002|Follow-up Period|Death|5|||
16167229|NCT02305563|39091421|FG003|Follow-up Period|Death|4|||
16167230|NCT02305563|39091422|FG004|Follow-up Period|Death|7|||
16458506|NCT01578850|40159018|FG001|Period 2|Lost to Follow-up|1|||
16458507|NCT01578850|40159019|FG002|Period 2|Lost to Follow-up|2|||
16458508|NCT01578850|40159017|FG000|Period 2|Withdrawal by Subject|0|||
16458509|NCT01578850|40159018|FG001|Period 2|Withdrawal by Subject|2|||
16458510|NCT01578850|40159019|FG002|Period 2|Withdrawal by Subject|2|||
16458511|NCT01578850|40159017|FG000|Period 2|Study Terminated by Sponsor|0|||
16458512|NCT01578850|40159018|FG001|Period 2|Study Terminated by Sponsor|5|||
16458513|NCT01578850|40159019|FG002|Period 2|Study Terminated by Sponsor|4|||
16458514|NCT01578850|40159017|FG000|Period 2|Unspecified Reasons|0|||
16458515|NCT01578850|40159018|FG001|Period 2|Unspecified Reasons|1|||
16458516|NCT01578850|40159019|FG002|Period 2|Unspecified Reasons|0|||
16458517|NCT04889118|40159020|FG000|Overall Study|Death|33|||
16458518|NCT04889118|40159021|FG001|Overall Study|Death|37|||
16458519|NCT04889118|40159020|FG000|Overall Study|Ongoing in Study|31|||
16167231|NCT02305563|39091418|FG000|Follow-up Period|Participant withdrew consent|0|||
16167232|NCT02305563|39091419|FG001|Follow-up Period|Participant withdrew consent|0|||
16167233|NCT02305563|39091420|FG002|Follow-up Period|Participant withdrew consent|2|||
16167234|NCT02305563|39091421|FG003|Follow-up Period|Participant withdrew consent|1|||
16167235|NCT02305563|39091422|FG004|Follow-up Period|Participant withdrew consent|0|||
16458520|NCT04889118|40159021|FG001|Overall Study|Ongoing in Study|30|||
16458521|NCT00929643|40159024|FG000|Overall Study|Protocol Violation|2|||
16458522|NCT00539188|40159025|FG000|Overall Study|Withdrawal by Subject|1|||
16458523|NCT00539188|40159026|FG001|Overall Study|Withdrawal by Subject|0|||
16458524|NCT00539188|40159025|FG000|Overall Study|Lost to Follow-up|2|||
16458525|NCT00539188|40159026|FG001|Overall Study|Lost to Follow-up|1|||
16458526|NCT01324401|40159027|FG000|Overall Study|Withdrawn before any treatment|0|||
16458527|NCT01324401|40159028|FG001|Overall Study|Withdrawn before any treatment|3|||
16458528|NCT01324401|40159027|FG000|Overall Study|Adverse Event|1|||
16458529|NCT01324401|40159028|FG001|Overall Study|Adverse Event|3|||
16458530|NCT03037580|40159029|FG000|Overall Study|Withdrawal by Subject|3|||
16458531|NCT03037580|40159030|FG001|Overall Study|Withdrawal by Subject|0|||
16458532|NCT03037580|40159029|FG000|Overall Study|Adverse Event|1|||
16458533|NCT03037580|40159030|FG001|Overall Study|Adverse Event|0|||
16458534|NCT03037580|40159029|FG000|Overall Study|Study Terminated by Sponsor|12|||
16458535|NCT03037580|40159030|FG001|Overall Study|Study Terminated by Sponsor|15|||
16458536|NCT03037580|40159029|FG000|Overall Study|Death|0|||
16458537|NCT03037580|40159030|FG001|Overall Study|Death|1|||
16458538|NCT03241368|40159031|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
16458539|NCT03241368|40159031|FG000|Overall Study|Lost to Follow-up|1|||
16458540|NCT03241368|40159031|FG000|Overall Study|Physician Decision|6|||
16458541|NCT03241368|40159031|FG000|Overall Study|Withdrawal by Subject|6|||
16458542|NCT03241368|40159031|FG000|Overall Study|Protocol Violation|1|||
16458543|NCT03180840|40159032|FG000|Overall Study|Withdrawal by Subject|1|||
16458544|NCT00313781|40159033|FG000|Before Crossover|Death|22|||
16458545|NCT00313781|40159034|FG001|Before Crossover|Death|8|||
16458546|NCT00313781|40159035|FG002|Before Crossover|Death|0|||
16458547|NCT00313781|40159033|FG000|Before Crossover|Lost to Follow-up|0|||
16458548|NCT00313781|40159034|FG001|Before Crossover|Lost to Follow-up|3|||
16458549|NCT00313781|40159035|FG002|Before Crossover|Lost to Follow-up|0|||
16458550|NCT00313781|40159033|FG000|Before Crossover|Withdrawal by Subject|3|||
16458551|NCT00313781|40159034|FG001|Before Crossover|Withdrawal by Subject|1|||
16458552|NCT00313781|40159035|FG002|Before Crossover|Withdrawal by Subject|0|||
16458553|NCT00313781|40159033|FG000|Before Crossover|Other|45|||
16458554|NCT00313781|40159034|FG001|Before Crossover|Other|30|||
16167236|NCT02305563|39091418|FG000|Follow-up Period|other reason|0|||
16167237|NCT02305563|39091419|FG001|Follow-up Period|other reason|0|||
16167238|NCT02305563|39091420|FG002|Follow-up Period|other reason|0|||
16458555|NCT00313781|40159035|FG002|Before Crossover|Other|0|||
16458556|NCT00313781|40159033|FG000|Before Crossover|Crossover|0|||
16458557|NCT00313781|40159034|FG001|Before Crossover|Crossover|37|||
16458558|NCT00313781|40159035|FG002|Before Crossover|Crossover|0|||
16458559|NCT00313781|40159033|FG000|Before Crossover|Randomized, not treated|5|||
16458560|NCT00313781|40159034|FG001|Before Crossover|Randomized, not treated|0|||
16458561|NCT00313781|40159035|FG002|Before Crossover|Randomized, not treated|0|||
16458562|NCT00313781|40159033|FG000|After Crossover|Death|0|||
16458563|NCT00313781|40159034|FG001|After Crossover|Death|0|||
16458564|NCT00313781|40159035|FG002|After Crossover|Death|6|||
16458565|NCT00313781|40159033|FG000|After Crossover|Withdrawal by Subject|0|||
16458566|NCT00313781|40159034|FG001|After Crossover|Withdrawal by Subject|0|||
16458567|NCT00313781|40159035|FG002|After Crossover|Withdrawal by Subject|3|||
16458568|NCT00313781|40159033|FG000|After Crossover|Other|0|||
16458569|NCT00313781|40159034|FG001|After Crossover|Other|0|||
16458570|NCT00313781|40159035|FG002|After Crossover|Other|18|||
16458571|NCT02424578|40159036|FG000|Overall Study|Withdrawal by Subject|0|||
16458572|NCT02424578|40159037|FG001|Overall Study|Withdrawal by Subject|1|||
16458573|NCT00684060|40159038|FG000|Overall Study|Lost to Follow-up|1|||
16458574|NCT00684060|40159039|FG001|Overall Study|Lost to Follow-up|0|||
16458575|NCT00684060|40159038|FG000|Overall Study|New stenosis identified|1|||
16458576|NCT00684060|40159039|FG001|Overall Study|New stenosis identified|0|||
16458577|NCT00684060|40159038|FG000|Overall Study|Unable to collect MRI|1|||
16458578|NCT00684060|40159039|FG001|Overall Study|Unable to collect MRI|2|||
16458579|NCT00684060|40159038|FG000|Overall Study|Death|0|||
16458580|NCT00684060|40159039|FG001|Overall Study|Death|1|||
16458581|NCT00311584|40159040|FG000|Overall Study|Death|1|||
16458582|NCT00311584|40159041|FG001|Overall Study|Death|0|||
16458583|NCT00311584|40159040|FG000|Overall Study|Lack of Efficacy|12|||
16458584|NCT00311584|40159041|FG001|Overall Study|Lack of Efficacy|15|||
16458585|NCT00311584|40159040|FG000|Overall Study|Physician Decision|4|||
16458586|NCT00311584|40159041|FG001|Overall Study|Physician Decision|5|||
16458587|NCT00311584|40159040|FG000|Overall Study|Withdrawal by Subject|1|||
16458588|NCT00311584|40159041|FG001|Overall Study|Withdrawal by Subject|1|||
16458589|NCT00311584|40159040|FG000|Overall Study|ineligible|2|||
16167239|NCT02305563|39091421|FG003|Follow-up Period|other reason|0|||
16458590|NCT00311584|40159041|FG001|Overall Study|ineligible|2|||
16458591|NCT01519167|40159044|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
16458592|NCT01519167|40159045|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
16458593|NCT01519167|40159044|FG000|Overall Study|Adverse Event|0|||
16458594|NCT01519167|40159045|FG001|Overall Study|Adverse Event|1|||
16458595|NCT01519167|40159044|FG000|Overall Study|Lack of Efficacy|0|||
16458596|NCT01519167|40159045|FG001|Overall Study|Lack of Efficacy|1|||
16458597|NCT01519167|40159044|FG000|Overall Study|Medical condition changes&deep sedation|0|||
16458598|NCT01519167|40159045|FG001|Overall Study|Medical condition changes&deep sedation|2|||
16458599|NCT01519167|40159044|FG000|Overall Study|Physician Decision|0|||
16458600|NCT01519167|40159045|FG001|Overall Study|Physician Decision|1|||
16458601|NCT00126490|40159051|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
16458602|NCT03079102|40159052|FG000|Overall Study|Physician Decision|0|||
16458603|NCT03079102|40159053|FG001|Overall Study|Physician Decision|1|||
16458604|NCT00246740|40159054|FG000|Initial Enrollment|Death|1|||
16458605|NCT00246740|40159055|FG001|Initial Enrollment|Death|0|||
16458606|NCT00246740|40159054|FG000|Initial Enrollment|Additional surgery scheduled|0|||
16458607|NCT00246740|40159055|FG001|Initial Enrollment|Additional surgery scheduled|2|||
16458608|NCT00246740|40159054|FG000|Initial Enrollment|Surgery schedule change|4|||
16458609|NCT00246740|40159055|FG001|Initial Enrollment|Surgery schedule change|4|||
16458610|NCT00246740|40159054|FG000|Initial Enrollment|Other|1|||
16458611|NCT00246740|40159055|FG001|Initial Enrollment|Other|2|||
16458612|NCT00475306|40159056|FG000|Overall Study|Protocol Violation|1|||
16458613|NCT00475306|40159057|FG001|Overall Study|Protocol Violation|1|||
16458614|NCT00475306|40159058|FG002|Overall Study|Protocol Violation|0|||
16458615|NCT00475306|40159059|FG003|Overall Study|Protocol Violation|1|||
16458616|NCT04661579|40159062|FG000|Overall Study|Lost to Follow-up|19|||
16458617|NCT04661579|40159063|FG001|Overall Study|Lost to Follow-up|10|||
16458618|NCT04661579|40159064|FG002|Overall Study|Lost to Follow-up|2|||
16458619|NCT04661579|40159065|FG003|Overall Study|Lost to Follow-up|7|||
16458620|NCT04661579|40159066|FG004|Overall Study|Lost to Follow-up|11|||
16458621|NCT04661579|40159062|FG000|Overall Study|Physician Decision|2|||
16458622|NCT04661579|40159063|FG001|Overall Study|Physician Decision|0|||
16458623|NCT04661579|40159064|FG002|Overall Study|Physician Decision|0|||
16458624|NCT04661579|40159065|FG003|Overall Study|Physician Decision|1|||
16458625|NCT04661579|40159066|FG004|Overall Study|Physician Decision|0|||
16458626|NCT04661579|40159062|FG000|Overall Study|Withdrawal by Subject|1|||
16167240|NCT02305563|39091422|FG004|Follow-up Period|other reason|1|||
16167241|NCT02305563|39091418|FG000|Follow-up Period|Followup no longer required per protocol|3|||
16458627|NCT04661579|40159063|FG001|Overall Study|Withdrawal by Subject|4|||
16458628|NCT04661579|40159064|FG002|Overall Study|Withdrawal by Subject|0|||
16458629|NCT04661579|40159065|FG003|Overall Study|Withdrawal by Subject|2|||
16458630|NCT04661579|40159066|FG004|Overall Study|Withdrawal by Subject|0|||
16458631|NCT04661579|40159062|FG000|Overall Study|Death|1|||
16458632|NCT04661579|40159063|FG001|Overall Study|Death|0|||
16458633|NCT04661579|40159064|FG002|Overall Study|Death|0|||
16458634|NCT04661579|40159065|FG003|Overall Study|Death|0|||
16458635|NCT04661579|40159066|FG004|Overall Study|Death|0|||
16458636|NCT04661579|40159062|FG000|Overall Study|Other|1|||
16458637|NCT04661579|40159063|FG001|Overall Study|Other|2|||
16458638|NCT04661579|40159064|FG002|Overall Study|Other|1|||
16458639|NCT04661579|40159065|FG003|Overall Study|Other|1|||
16458640|NCT04661579|40159066|FG004|Overall Study|Other|1|||
16458641|NCT04661579|40159062|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
16458642|NCT04661579|40159063|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
16458643|NCT04661579|40159064|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
16458644|NCT04661579|40159065|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
16458645|NCT04661579|40159066|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
16458646|NCT01868542|40159067|FG000|Overall Study|Protocol Violation|0|||
16458647|NCT01868542|40159068|FG001|Overall Study|Protocol Violation|1|||
16458648|NCT01868542|40159067|FG000|Overall Study|Unclassified|0|||
16458649|NCT01868542|40159068|FG001|Overall Study|Unclassified|1|||
16458650|NCT03672097|40159069|FG000|Period 1|Withdrawal by Subject|2|||
16458651|NCT03672097|40159069|FG000|Period 1|Adverse Event|1|||
16458652|NCT03672097|40159069|FG000|Period 1|Did not receive treatment|1|||
16458653|NCT03672097|40159069|FG000|Period 2|Withdrawal by Subject|3|||
16458654|NCT03672097|40159069|FG000|Period 2|Other|1|||
16458655|NCT00552188|40159070|FG000|Overall Study|Adverse Event|0|||
16167242|NCT02305563|39091419|FG001|Follow-up Period|Followup no longer required per protocol|3|||
16458656|NCT00552188|40159071|FG001|Overall Study|Adverse Event|2|||
16458657|NCT00552188|40159070|FG000|Overall Study|Lost to Follow-up|2|||
16458658|NCT00552188|40159071|FG001|Overall Study|Lost to Follow-up|1|||
16458659|NCT00552188|40159070|FG000|Overall Study|Withdrawal of consent|0|||
16458660|NCT00552188|40159071|FG001|Overall Study|Withdrawal of consent|1|||
16458661|NCT00552188|40159070|FG000|Overall Study|Subject returned to home country|0|||
16458662|NCT00552188|40159071|FG001|Overall Study|Subject returned to home country|1|||
16458663|NCT01214395|40159072|FG000|Overall Study|All patients had infection|5|||
16458664|NCT01134705|40159073|FG000|Overall Study|Adverse Event|1|||
16458665|NCT01134705|40159074|FG001|Overall Study|Adverse Event|7|||
16458666|NCT01134705|40159073|FG000|Overall Study|Withdrawal by Subject|6|||
16458667|NCT01134705|40159074|FG001|Overall Study|Withdrawal by Subject|6|||
16458668|NCT01134705|40159073|FG000|Overall Study|Pregnancy|1|||
16167243|NCT02305563|39091420|FG002|Follow-up Period|Followup no longer required per protocol|4|||
16167244|NCT02305563|39091421|FG003|Follow-up Period|Followup no longer required per protocol|1|||
16167245|NCT02305563|39091422|FG004|Follow-up Period|Followup no longer required per protocol|4|||
16167246|NCT04541004|39091425|FG000|Overall Study|Adverse Event|2|||
16167247|NCT01256177|39091426|FG000|Overall Study|Withdrawal by Subject|23|||
16167248|NCT01256177|39091427|FG001|Overall Study|Withdrawal by Subject|22|||
16167249|NCT01256177|39091426|FG000|Overall Study|Lost to Follow-up|2|||
16167250|NCT01256177|39091427|FG001|Overall Study|Lost to Follow-up|2|||
16167251|NCT01256177|39091426|FG000|Overall Study|Adverse Event|8|||
16167252|NCT01256177|39091427|FG001|Overall Study|Adverse Event|9|||
16458669|NCT01134705|40159074|FG001|Overall Study|Pregnancy|0|||
16458670|NCT01134705|40159073|FG000|Overall Study|Lost to Follow-up|5|||
16458671|NCT01134705|40159074|FG001|Overall Study|Lost to Follow-up|2|||
16458672|NCT01134705|40159073|FG000|Overall Study|Protocol Violation|1|||
16458673|NCT01134705|40159074|FG001|Overall Study|Protocol Violation|1|||
16458674|NCT01134705|40159073|FG000|Overall Study|Other|1|||
16458675|NCT01134705|40159074|FG001|Overall Study|Other|6|||
16458676|NCT03087617|40159077|FG000|Overall Study|Lost to Follow-up|32|||
16458677|NCT03087617|40159078|FG001|Overall Study|Lost to Follow-up|30|||
16458678|NCT03087617|40159079|FG002|Overall Study|Lost to Follow-up|30|||
16458679|NCT03087617|40159080|FG003|Overall Study|Lost to Follow-up|39|||
16458680|NCT02039843|40159085|FG000|Randomization and Observation Period|Adverse Event|2|||
16458681|NCT02039843|40159086|FG001|Randomization and Observation Period|Adverse Event|0|||
16458682|NCT02039843|40159085|FG000|Randomization and Observation Period|Death|1|||
16458683|NCT02039843|40159086|FG001|Randomization and Observation Period|Death|0|||
16458684|NCT02039843|40159085|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
16458685|NCT02039843|40159086|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
16458686|NCT02039843|40159085|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
16458687|NCT02039843|40159086|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
16458688|NCT02039843|40159085|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
16458689|NCT02039843|40159086|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
16458690|NCT02039843|40159085|FG000|Pairing With a Study Dog|Death|1|||
16458691|NCT02039843|40159086|FG001|Pairing With a Study Dog|Death|0|||
16458692|NCT02039843|40159085|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
16458693|NCT02039843|40159086|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
16458694|NCT02039843|40159085|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
16458695|NCT02039843|40159086|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
16458696|NCT02039843|40159085|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
16458697|NCT02039843|40159086|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
16458698|NCT01206322|40159087|FG000|Overall Study|Adverse Event|0|||
16458699|NCT01206322|40159088|FG001|Overall Study|Adverse Event|0|||
16458700|NCT01206322|40159089|FG002|Overall Study|Adverse Event|0|||
16458701|NCT01206322|40159090|FG003|Overall Study|Adverse Event|1|||
16458702|NCT00324961|40159092|FG000|Overall Study|Adverse Event|5|||
16458703|NCT00324961|40159092|FG000|Overall Study|Consent Withdrawn|11|||
16458704|NCT00324961|40159092|FG000|Overall Study|Lost to Follow-up|22|||
16458705|NCT00324961|40159092|FG000|Overall Study|Protocol Violation|3|||
16458706|NCT00324961|40159092|FG000|Overall Study|Other|2|||
16167253|NCT01256177|39091426|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
16167254|NCT01256177|39091427|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
16167255|NCT01256177|39091426|FG000|Overall Study|Condition under Investigation Worsened|1|||
16458707|NCT02741518|40159094|FG000|Overall Study|Withdrawal by Subject|1|||
16458708|NCT02741518|40159095|FG001|Overall Study|Withdrawal by Subject|1|||
16458709|NCT01233232|40159096|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
16458710|NCT01233232|40159097|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
16458711|NCT01233232|40159098|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
16458712|NCT01338298|40159100|FG000|Overall Study|Withdrawal by Subject|1|||
16458713|NCT01338298|40159101|FG001|Overall Study|Withdrawal by Subject|1|||
16458714|NCT01338298|40159100|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
16458715|NCT01338298|40159101|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
16167256|NCT01256177|39091427|FG001|Overall Study|Condition under Investigation Worsened|0|||
16458716|NCT01338298|40159100|FG000|Overall Study|Administrative error|0|||
16458717|NCT01338298|40159101|FG001|Overall Study|Administrative error|1|||
16458718|NCT01338298|40159100|FG000|Overall Study|Positive symptom worsening|1|||
16458719|NCT01338298|40159101|FG001|Overall Study|Positive symptom worsening|0|||
16167257|NCT01256177|39091426|FG000|Overall Study|Lack of Efficacy|11|||
16458720|NCT01338298|40159100|FG000|Overall Study|Depressive symptoms and nausea|1|||
16458721|NCT01338298|40159101|FG001|Overall Study|Depressive symptoms and nausea|0|||
16458722|NCT01338298|40159100|FG000|Overall Study|Non-adherence|1|||
16458723|NCT01338298|40159101|FG001|Overall Study|Non-adherence|0|||
16458724|NCT03615040|40159102|FG000|Overall Study|Withdrawal by Subject|2|||
16458725|NCT03615040|40159103|FG001|Overall Study|Withdrawal by Subject|1|||
16458726|NCT03615040|40159102|FG000|Overall Study|Physician Decision|2|||
16458727|NCT03615040|40159103|FG001|Overall Study|Physician Decision|2|||
16458728|NCT03615040|40159102|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
16458729|NCT03615040|40159103|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
16458730|NCT03615040|40159102|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
16458731|NCT03615040|40159103|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
16458732|NCT03615040|40159102|FG000|Overall Study|Death|0|||
16458733|NCT03615040|40159103|FG001|Overall Study|Death|2|||
16458734|NCT03275350|40159104|FG000|Overall Study|Lost to Follow-up|4|||
16458735|NCT03275350|40159105|FG001|Overall Study|Lost to Follow-up|6|||
16458736|NCT03275350|40159104|FG000|Overall Study|Death|2|||
16458737|NCT03275350|40159105|FG001|Overall Study|Death|1|||
16458738|NCT03275350|40159104|FG000|Overall Study|Physician Decision|1|||
16458739|NCT03275350|40159105|FG001|Overall Study|Physician Decision|0|||
16458740|NCT03275350|40159104|FG000|Overall Study|Incarcerated|1|||
16458741|NCT03275350|40159105|FG001|Overall Study|Incarcerated|1|||
16458742|NCT01090323|40159106|FG000|Overall Study|Adverse Event|12|||
16458743|NCT01090323|40159107|FG001|Overall Study|Adverse Event|2|||
16458744|NCT01090323|40159106|FG000|Overall Study|Abnormal Lab Values|3|||
16458745|NCT01090323|40159107|FG001|Overall Study|Abnormal Lab Values|1|||
16458746|NCT01090323|40159106|FG000|Overall Study|Abnormal Test Procedure Results|2|||
16458747|NCT01090323|40159107|FG001|Overall Study|Abnormal Test Procedure Results|0|||
16458748|NCT01090323|40159106|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
16458749|NCT01090323|40159107|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16458750|NCT01090323|40159106|FG000|Overall Study|Condition no longer requires drug|5|||
16458751|NCT01090323|40159107|FG001|Overall Study|Condition no longer requires drug|4|||
16458752|NCT01090323|40159106|FG000|Overall Study|Protocol Violation|2|||
16458753|NCT01090323|40159107|FG001|Overall Study|Protocol Violation|1|||
16458754|NCT01090323|40159106|FG000|Overall Study|Withdrew consent|33|||
16458755|NCT01090323|40159107|FG001|Overall Study|Withdrew consent|11|||
16458756|NCT01090323|40159106|FG000|Overall Study|Lost to Follow-up|11|||
16458757|NCT01090323|40159107|FG001|Overall Study|Lost to Follow-up|6|||
16458758|NCT01090323|40159106|FG000|Overall Study|Administrative problems|6|||
16458759|NCT01090323|40159107|FG001|Overall Study|Administrative problems|4|||
16458760|NCT01090323|40159106|FG000|Overall Study|Death|1|||
16458761|NCT01090323|40159107|FG001|Overall Study|Death|2|||
16458762|NCT01090323|40159106|FG000|Overall Study|Stopped end of core|7|||
16458763|NCT01090323|40159107|FG001|Overall Study|Stopped end of core|0|||
16458764|NCT01090323|40159106|FG000|Overall Study|Stopped end of extension 1#|3|||
16458765|NCT01090323|40159107|FG001|Overall Study|Stopped end of extension 1#|1|||
16458766|NCT02874144|40159110|FG000|Overall Study|Lost to Follow-up|3|||
16458767|NCT02874144|40159111|FG001|Overall Study|Lost to Follow-up|5|||
16458768|NCT00717236|40159114|FG000|Double-Blind Period|Adverse Event|33|||
16458769|NCT00717236|40159115|FG001|Double-Blind Period|Adverse Event|6|||
16458770|NCT00717236|40159114|FG000|Double-Blind Period|Lack of Efficacy|6|||
16458771|NCT00717236|40159115|FG001|Double-Blind Period|Lack of Efficacy|6|||
16458772|NCT00717236|40159114|FG000|Double-Blind Period|Lost to Follow-up|3|||
16458773|NCT00717236|40159115|FG001|Double-Blind Period|Lost to Follow-up|5|||
16458774|NCT00717236|40159114|FG000|Double-Blind Period|Withdrawal by Subject|10|||
16458775|NCT00717236|40159115|FG001|Double-Blind Period|Withdrawal by Subject|2|||
16458776|NCT00717236|40159114|FG000|Double-Blind Period|Loss of efficacy|3|||
16458777|NCT00717236|40159115|FG001|Double-Blind Period|Loss of efficacy|0|||
16458778|NCT00717236|40159114|FG000|Double-Blind Period|Other: Death|1|||
16458779|NCT00717236|40159115|FG001|Double-Blind Period|Other: Death|0|||
16458780|NCT00717236|40159114|FG000|Double-Blind Period|Other: Pregnancy|1|||
16458781|NCT00717236|40159115|FG001|Double-Blind Period|Other: Pregnancy|0|||
16458782|NCT00717236|40159114|FG000|Double-Blind Period|Other: Protocol Violation|2|||
16458783|NCT00717236|40159115|FG001|Double-Blind Period|Other: Protocol Violation|0|||
16458784|NCT00717236|40159114|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
16458785|NCT00717236|40159115|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
16458786|NCT00717236|40159114|FG000|Double-Blind Period|Other: Site withdrew|2|||
16458787|NCT00717236|40159115|FG001|Double-Blind Period|Other: Site withdrew|0|||
16458788|NCT00717236|40159114|FG000|Double-Blind Period|Other: Screening failure|1|||
16458789|NCT00717236|40159115|FG001|Double-Blind Period|Other: Screening failure|0|||
16458790|NCT00717236|40159114|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
16072699|NCT01959412|38759139|FG001|Overall Study|Protocol deviation|1|||
16458791|NCT00717236|40159115|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
16458792|NCT00717236|40159114|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
16458793|NCT00717236|40159115|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
16458794|NCT00717236|40159114|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
16458795|NCT00717236|40159115|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
16458796|NCT00717236|40159114|FG000|Double-Blind Period|Other: History of cancer|1|||
16458797|NCT00717236|40159115|FG001|Double-Blind Period|Other: History of cancer|0|||
16458798|NCT00717236|40159114|FG000|Double-Blind Period|Other: Sponsor request|1|||
16458799|NCT00717236|40159115|FG001|Double-Blind Period|Other: Sponsor request|0|||
16458800|NCT00717236|40159114|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
16458801|NCT00717236|40159115|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
16458802|NCT00717236|40159114|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
16458803|NCT00717236|40159115|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
16458804|NCT00717236|40159114|FG000|Double-Blind Period|Other: Subject moved|1|||
16458805|NCT00717236|40159115|FG001|Double-Blind Period|Other: Subject moved|1|||
16458806|NCT00717236|40159114|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
16458807|NCT00717236|40159115|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
16167258|NCT01256177|39091427|FG001|Overall Study|Lack of Efficacy|2|||
16167259|NCT01256177|39091426|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
16167260|NCT01256177|39091427|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
16167261|NCT02613208|39091428|FG000|Overall Study|Withdrawal by Subject|1|||
16167262|NCT02613208|39091428|FG000|Overall Study|Change of address|2|||
16167263|NCT02613208|39091428|FG000|Overall Study|Physician Decision|2|||
16167264|NCT02613208|39091428|FG000|Overall Study|Lost to Follow-up|5|||
16167265|NCT02613208|39091428|FG000|Overall Study|Death|37|||
16167266|NCT00772447|39091429|FG000|Overall Study|Withdrawal by Subject|9|||
16167267|NCT00772447|39091430|FG001|Overall Study|Withdrawal by Subject|5|||
16167268|NCT00772447|39091429|FG000|Overall Study|Physician Decision|4|||
16458808|NCT00717236|40159114|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
16458809|NCT00717236|40159115|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
16458810|NCT00717236|40159114|FG000|Double-Blind Period|Other: Transportation problems|0|||
16458811|NCT00717236|40159115|FG001|Double-Blind Period|Other: Transportation problems|1|||
16458812|NCT00717236|40159114|FG000|Double-Blind Period|Other: Investigator Decision|0|||
16458813|NCT00717236|40159115|FG001|Double-Blind Period|Other: Investigator Decision|1|||
16458814|NCT00717236|40159114|FG000|Open-Label Period|Adverse Event|29|||
16458815|NCT00717236|40159115|FG001|Open-Label Period|Adverse Event|4|||
16458816|NCT00717236|40159114|FG000|Open-Label Period|Lack of Efficacy|30|||
16458817|NCT00717236|40159115|FG001|Open-Label Period|Lack of Efficacy|8|||
16458818|NCT00717236|40159114|FG000|Open-Label Period|Lost to Follow-up|28|||
16458819|NCT00717236|40159115|FG001|Open-Label Period|Lost to Follow-up|4|||
16458820|NCT00717236|40159114|FG000|Open-Label Period|Withdrawal by Subject|20|||
16458821|NCT00717236|40159115|FG001|Open-Label Period|Withdrawal by Subject|2|||
16458822|NCT00717236|40159114|FG000|Open-Label Period|Loss of Efficacy|6|||
16458823|NCT00717236|40159115|FG001|Open-Label Period|Loss of Efficacy|1|||
16458824|NCT00717236|40159114|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
16458825|NCT00717236|40159115|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
16458826|NCT00717236|40159114|FG000|Open-Label Period|Other: Lack of Compliance|1|||
16458827|NCT00717236|40159115|FG001|Open-Label Period|Other: Lack of Compliance|1|||
16458828|NCT00717236|40159114|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
16458829|NCT00717236|40159115|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
16458830|NCT00717236|40159114|FG000|Open-Label Period|Other: Moved|1|||
16458831|NCT00717236|40159115|FG001|Open-Label Period|Other: Moved|0|||
16458832|NCT00717236|40159114|FG000|Open-Label Period|Other: Investigator Decision|1|||
16458833|NCT00717236|40159115|FG001|Open-Label Period|Other: Investigator Decision|0|||
16458834|NCT00717236|40159114|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
16458835|NCT00717236|40159115|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
16458836|NCT00717236|40159114|FG000|Open-Label Period|Other: Sponsor Request|3|||
16458837|NCT00717236|40159115|FG001|Open-Label Period|Other: Sponsor Request|0|||
16458838|NCT00717236|40159114|FG000|Open-Label Period|Other: Cataract Surgery|1|||
16458839|NCT00717236|40159115|FG001|Open-Label Period|Other: Cataract Surgery|0|||
16458840|NCT00717236|40159114|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
16458841|NCT00717236|40159115|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
16458842|NCT00717236|40159114|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
16458843|NCT00717236|40159115|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
16458844|NCT00717236|40159114|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
16458845|NCT00717236|40159115|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
16458846|NCT01433289|40159116|FG000|Overall Study|Pregnancy|0|||
16458847|NCT01433289|40159117|FG001|Overall Study|Pregnancy|1|||
16458848|NCT01433289|40159118|FG002|Overall Study|Pregnancy|0|||
16458849|NCT01433289|40159119|FG003|Overall Study|Pregnancy|0|||
16458850|NCT02410343|40159120|FG000|Core Period (24 Weeks)|Adverse Event|1|||
16458851|NCT02410343|40159121|FG001|Core Period (24 Weeks)|Adverse Event|0|||
16167269|NCT00772447|39091430|FG001|Overall Study|Physician Decision|8|||
16167270|NCT00772447|39091429|FG000|Overall Study|Lost to Follow-up|2|||
16458852|NCT02410343|40159120|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
16458853|NCT02410343|40159121|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
16458854|NCT02410343|40159120|FG000|Extension Period (12 Months)|Adverse Event|1|||
16458855|NCT02410343|40159121|FG001|Extension Period (12 Months)|Adverse Event|0|||
16458856|NCT02410343|40159120|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
16458857|NCT02410343|40159121|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
16458858|NCT02520089|40159124|FG000|Overall Study|Lost to Follow-up|3|||
16458859|NCT02520089|40159125|FG001|Overall Study|Lost to Follow-up|4|||
16458860|NCT04681352|40159127|FG000|Overall Study|Lost to Follow-up|2|||
16458861|NCT04681352|40159127|FG000|Overall Study|Withdrawal by Subject|22|||
16458862|NCT03207763|40159128|FG000|Overall Study|Lost to Follow-up|1|||
16458863|NCT03207763|40159129|FG001|Overall Study|Lost to Follow-up|0|||
16458864|NCT02687191|40159132|FG000|Overall Study|Death|0|||
16458865|NCT02687191|40159133|FG001|Overall Study|Death|1|||
16458866|NCT02687191|40159134|FG002|Overall Study|Death|1|||
16458867|NCT02687191|40159135|FG003|Overall Study|Death|0|||
16458868|NCT02687191|40159136|FG004|Overall Study|Death|1|||
16458869|NCT02687191|40159137|FG005|Overall Study|Death|1|||
16458870|NCT02687191|40159132|FG000|Overall Study|Withdrawal by Subject|0|||
16458871|NCT02687191|40159133|FG001|Overall Study|Withdrawal by Subject|0|||
16458872|NCT02687191|40159134|FG002|Overall Study|Withdrawal by Subject|0|||
16458873|NCT02687191|40159135|FG003|Overall Study|Withdrawal by Subject|1|||
16458874|NCT02687191|40159136|FG004|Overall Study|Withdrawal by Subject|0|||
16458875|NCT02687191|40159137|FG005|Overall Study|Withdrawal by Subject|0|||
16458876|NCT03836001|40159138|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
16458877|NCT03836001|40159139|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
16458878|NCT03836001|40159140|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
16458879|NCT03836001|40159138|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
16458880|NCT03836001|40159139|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
16458881|NCT03836001|40159140|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
16458882|NCT03836001|40159138|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
16458883|NCT03836001|40159139|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
16458884|NCT03836001|40159140|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
16458885|NCT03836001|40159138|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
16458886|NCT03836001|40159139|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
16458887|NCT03836001|40159140|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
16458888|NCT02059291|40159142|FG000|Epoch 2|Lack of Efficacy|0|||
16458889|NCT02059291|40159143|FG001|Epoch 2|Lack of Efficacy|0|||
16458890|NCT02059291|40159144|FG002|Epoch 2|Lack of Efficacy|0|||
16458891|NCT02059291|40159145|FG003|Epoch 2|Lack of Efficacy|1|||
16458892|NCT02059291|40159146|FG004|Epoch 2|Lack of Efficacy|0|||
16458893|NCT02059291|40159147|FG005|Epoch 2|Lack of Efficacy|1|||
16458894|NCT02059291|40159148|FG006|Epoch 2|Lack of Efficacy|0|||
16458895|NCT02059291|40159149|FG007|Epoch 2|Lack of Efficacy|0|||
16458896|NCT02059291|40159150|FG008|Epoch 2|Lack of Efficacy|0|||
16458897|NCT02059291|40159151|FG009|Epoch 2|Lack of Efficacy|0|||
16458898|NCT02059291|40159152|FG010|Epoch 2|Lack of Efficacy|0|||
16458899|NCT02059291|40159153|FG011|Epoch 2|Lack of Efficacy|0|||
16458900|NCT02059291|40159154|FG012|Epoch 2|Lack of Efficacy|0|||
16458901|NCT02059291|40159155|FG013|Epoch 2|Lack of Efficacy|0|||
16458902|NCT02059291|40159156|FG014|Epoch 2|Lack of Efficacy|0|||
16458903|NCT02059291|40159157|FG015|Epoch 2|Lack of Efficacy|0|||
16458904|NCT02059291|40159158|FG016|Epoch 2|Lack of Efficacy|0|||
16458905|NCT02059291|40159159|FG017|Epoch 2|Lack of Efficacy|0|||
16458906|NCT02059291|40159160|FG018|Epoch 2|Lack of Efficacy|0|||
16458907|NCT02059291|40159161|FG019|Epoch 2|Lack of Efficacy|0|||
16458908|NCT02059291|40159162|FG020|Epoch 2|Lack of Efficacy|0|||
16458909|NCT02059291|40159163|FG021|Epoch 2|Lack of Efficacy|0|||
16458910|NCT02059291|40159164|FG022|Epoch 2|Lack of Efficacy|0|||
16458911|NCT02059291|40159165|FG023|Epoch 2|Lack of Efficacy|0|||
16458912|NCT02059291|40159166|FG024|Epoch 2|Lack of Efficacy|0|||
16167271|NCT00772447|39091430|FG001|Overall Study|Lost to Follow-up|4|||
16167272|NCT00772447|39091429|FG000|Overall Study|incorrect enrolment|3|||
16458913|NCT02059291|40159142|FG000|Epoch 2|Adverse Event|0|||
16458914|NCT02059291|40159143|FG001|Epoch 2|Adverse Event|0|||
16458915|NCT02059291|40159144|FG002|Epoch 2|Adverse Event|1|||
16458916|NCT02059291|40159145|FG003|Epoch 2|Adverse Event|1|||
16458917|NCT02059291|40159146|FG004|Epoch 2|Adverse Event|0|||
16458918|NCT02059291|40159147|FG005|Epoch 2|Adverse Event|0|||
16167273|NCT00772447|39091430|FG001|Overall Study|incorrect enrolment|4|||
16458919|NCT02059291|40159148|FG006|Epoch 2|Adverse Event|0|||
16458920|NCT02059291|40159149|FG007|Epoch 2|Adverse Event|1|||
16458921|NCT02059291|40159150|FG008|Epoch 2|Adverse Event|1|||
16458922|NCT02059291|40159151|FG009|Epoch 2|Adverse Event|0|||
16458923|NCT02059291|40159152|FG010|Epoch 2|Adverse Event|0|||
16458924|NCT02059291|40159153|FG011|Epoch 2|Adverse Event|0|||
16458925|NCT02059291|40159154|FG012|Epoch 2|Adverse Event|0|||
16458926|NCT02059291|40159155|FG013|Epoch 2|Adverse Event|0|||
16458927|NCT02059291|40159156|FG014|Epoch 2|Adverse Event|0|||
16458928|NCT02059291|40159157|FG015|Epoch 2|Adverse Event|0|||
16458929|NCT02059291|40159158|FG016|Epoch 2|Adverse Event|0|||
16458930|NCT02059291|40159159|FG017|Epoch 2|Adverse Event|0|||
16458931|NCT02059291|40159160|FG018|Epoch 2|Adverse Event|0|||
16458932|NCT02059291|40159161|FG019|Epoch 2|Adverse Event|0|||
16458933|NCT02059291|40159162|FG020|Epoch 2|Adverse Event|0|||
16458934|NCT02059291|40159163|FG021|Epoch 2|Adverse Event|0|||
16458935|NCT02059291|40159164|FG022|Epoch 2|Adverse Event|0|||
16458936|NCT02059291|40159165|FG023|Epoch 2|Adverse Event|0|||
16458937|NCT02059291|40159166|FG024|Epoch 2|Adverse Event|0|||
16458938|NCT02059291|40159142|FG000|Epoch 2|Withdrawal by Subject|0|||
16458939|NCT02059291|40159143|FG001|Epoch 2|Withdrawal by Subject|1|||
16458940|NCT02059291|40159144|FG002|Epoch 2|Withdrawal by Subject|0|||
16458941|NCT02059291|40159145|FG003|Epoch 2|Withdrawal by Subject|0|||
16458942|NCT02059291|40159146|FG004|Epoch 2|Withdrawal by Subject|0|||
16458943|NCT02059291|40159147|FG005|Epoch 2|Withdrawal by Subject|1|||
16458944|NCT02059291|40159148|FG006|Epoch 2|Withdrawal by Subject|0|||
16458945|NCT02059291|40159149|FG007|Epoch 2|Withdrawal by Subject|0|||
16458946|NCT02059291|40159150|FG008|Epoch 2|Withdrawal by Subject|1|||
16458947|NCT02059291|40159151|FG009|Epoch 2|Withdrawal by Subject|0|||
16458948|NCT02059291|40159152|FG010|Epoch 2|Withdrawal by Subject|0|||
16458949|NCT02059291|40159153|FG011|Epoch 2|Withdrawal by Subject|0|||
16458950|NCT02059291|40159154|FG012|Epoch 2|Withdrawal by Subject|0|||
16458951|NCT02059291|40159155|FG013|Epoch 2|Withdrawal by Subject|0|||
16458952|NCT02059291|40159156|FG014|Epoch 2|Withdrawal by Subject|0|||
16167274|NCT00772447|39091429|FG000|Overall Study|Protocol Violation|0|||
16167275|NCT00772447|39091430|FG001|Overall Study|Protocol Violation|1|||
16167276|NCT00772447|39091429|FG000|Overall Study|all others|2|||
16167277|NCT00772447|39091430|FG001|Overall Study|all others|2|||
16167278|NCT03372941|39091433|FG000|Overall Study|Lost to Follow-up|2|||
16167279|NCT03372941|39091434|FG001|Overall Study|Lost to Follow-up|4|||
16167280|NCT00486278|39091435|FG000|Overall Study|Adverse Event|5|||
16167281|NCT00486278|39091435|FG000|Overall Study|Withdrawal by Subject|2|||
16167282|NCT00486278|39091435|FG000|Overall Study|Physician Decision|2|||
16167283|NCT00809328|39091443|FG000|Overall Study|Lack of Efficacy|18|||
16167284|NCT00809328|39091443|FG000|Overall Study|Adverse Event|6|||
16167285|NCT00809328|39091443|FG000|Overall Study|Protocol Violation|3|||
16167286|NCT00809328|39091443|FG000|Overall Study|Withdrawal by Subject|2|||
16167287|NCT01871090|39091444|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
16167288|NCT01871090|39091445|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
16167289|NCT01871090|39091444|FG000|Overall Study|Interrogation not completed correctly|1|||
16167290|NCT01871090|39091445|FG001|Overall Study|Interrogation not completed correctly|0|||
16167291|NCT01871090|39091444|FG000|Overall Study|Subject Non-Compliance|0|||
16167292|NCT01871090|39091445|FG001|Overall Study|Subject Non-Compliance|1|||
16167293|NCT03896295|39091447|FG000|Overall Study|Adverse Event|0|||
16167294|NCT03896295|39091448|FG001|Overall Study|Adverse Event|1|||
16167295|NCT03896295|39091447|FG000|Overall Study|COVID-19|7|||
16167296|NCT03896295|39091448|FG001|Overall Study|COVID-19|29|||
16167297|NCT01957137|39091452|FG000|Randomized Portion|Adverse Event|1|||
16167298|NCT01957137|39091452|FG000|Randomized Portion|Withdrawal by Subject|1|||
16167299|NCT01126580|39091453|FG000|Overall Study|Adverse Event|14|||
16458953|NCT02059291|40159157|FG015|Epoch 2|Withdrawal by Subject|0|||
16458954|NCT02059291|40159158|FG016|Epoch 2|Withdrawal by Subject|0|||
16458955|NCT02059291|40159159|FG017|Epoch 2|Withdrawal by Subject|0|||
16458956|NCT02059291|40159160|FG018|Epoch 2|Withdrawal by Subject|0|||
16458957|NCT02059291|40159161|FG019|Epoch 2|Withdrawal by Subject|0|||
16458958|NCT02059291|40159162|FG020|Epoch 2|Withdrawal by Subject|0|||
16458959|NCT02059291|40159163|FG021|Epoch 2|Withdrawal by Subject|0|||
16458960|NCT02059291|40159164|FG022|Epoch 2|Withdrawal by Subject|0|||
16458961|NCT02059291|40159165|FG023|Epoch 2|Withdrawal by Subject|0|||
16458962|NCT02059291|40159166|FG024|Epoch 2|Withdrawal by Subject|0|||
16458963|NCT02059291|40159142|FG000|Epoch 3|Physician Decision|0|||
16458964|NCT02059291|40159143|FG001|Epoch 3|Physician Decision|0|||
16458965|NCT02059291|40159144|FG002|Epoch 3|Physician Decision|0|||
16458966|NCT02059291|40159145|FG003|Epoch 3|Physician Decision|0|||
16458967|NCT02059291|40159146|FG004|Epoch 3|Physician Decision|0|||
16458968|NCT02059291|40159147|FG005|Epoch 3|Physician Decision|0|||
16458969|NCT02059291|40159148|FG006|Epoch 3|Physician Decision|0|||
16458970|NCT02059291|40159149|FG007|Epoch 3|Physician Decision|0|||
16458971|NCT02059291|40159150|FG008|Epoch 3|Physician Decision|0|||
16458972|NCT02059291|40159151|FG009|Epoch 3|Physician Decision|0|||
16458973|NCT02059291|40159152|FG010|Epoch 3|Physician Decision|0|||
16458974|NCT02059291|40159153|FG011|Epoch 3|Physician Decision|0|||
16167300|NCT01126580|39091454|FG001|Overall Study|Adverse Event|8|||
16458975|NCT02059291|40159154|FG012|Epoch 3|Physician Decision|0|||
16458976|NCT02059291|40159155|FG013|Epoch 3|Physician Decision|1|||
16458977|NCT02059291|40159156|FG014|Epoch 3|Physician Decision|0|||
16458978|NCT02059291|40159157|FG015|Epoch 3|Physician Decision|1|||
16458979|NCT02059291|40159158|FG016|Epoch 3|Physician Decision|0|||
16458980|NCT02059291|40159159|FG017|Epoch 3|Physician Decision|0|||
16458981|NCT02059291|40159160|FG018|Epoch 3|Physician Decision|0|||
16458982|NCT02059291|40159161|FG019|Epoch 3|Physician Decision|0|||
16458983|NCT02059291|40159162|FG020|Epoch 3|Physician Decision|0|||
16072700|NCT01959412|38759140|FG002|Overall Study|Protocol deviation|0|||
16167301|NCT01126580|39091455|FG002|Overall Study|Adverse Event|12|||
16167302|NCT01126580|39091453|FG000|Overall Study|Withdrawal by Subject|11|||
16167303|NCT01126580|39091454|FG001|Overall Study|Withdrawal by Subject|19|||
16167304|NCT01126580|39091455|FG002|Overall Study|Withdrawal by Subject|14|||
16167305|NCT01126580|39091453|FG000|Overall Study|Sponsor Decision|5|||
16458984|NCT02059291|40159163|FG021|Epoch 3|Physician Decision|0|||
16458985|NCT02059291|40159164|FG022|Epoch 3|Physician Decision|0|||
16458986|NCT02059291|40159165|FG023|Epoch 3|Physician Decision|0|||
16458987|NCT02059291|40159166|FG024|Epoch 3|Physician Decision|0|||
16458988|NCT02059291|40159142|FG000|Epoch 3|Adverse Event|0|||
16458989|NCT02059291|40159143|FG001|Epoch 3|Adverse Event|0|||
16458990|NCT02059291|40159144|FG002|Epoch 3|Adverse Event|0|||
16458991|NCT02059291|40159145|FG003|Epoch 3|Adverse Event|0|||
16458992|NCT02059291|40159146|FG004|Epoch 3|Adverse Event|0|||
16458993|NCT02059291|40159147|FG005|Epoch 3|Adverse Event|0|||
16458994|NCT02059291|40159148|FG006|Epoch 3|Adverse Event|0|||
16458995|NCT02059291|40159149|FG007|Epoch 3|Adverse Event|0|||
16458996|NCT02059291|40159150|FG008|Epoch 3|Adverse Event|0|||
16458997|NCT02059291|40159151|FG009|Epoch 3|Adverse Event|0|||
16458998|NCT02059291|40159152|FG010|Epoch 3|Adverse Event|0|||
16458999|NCT02059291|40159153|FG011|Epoch 3|Adverse Event|0|||
16459000|NCT02059291|40159154|FG012|Epoch 3|Adverse Event|0|||
16459001|NCT02059291|40159155|FG013|Epoch 3|Adverse Event|0|||
16459002|NCT02059291|40159156|FG014|Epoch 3|Adverse Event|0|||
16459003|NCT02059291|40159157|FG015|Epoch 3|Adverse Event|1|||
16459004|NCT02059291|40159158|FG016|Epoch 3|Adverse Event|0|||
16459005|NCT02059291|40159159|FG017|Epoch 3|Adverse Event|0|||
16459006|NCT02059291|40159160|FG018|Epoch 3|Adverse Event|0|||
16459007|NCT02059291|40159161|FG019|Epoch 3|Adverse Event|0|||
16459008|NCT02059291|40159162|FG020|Epoch 3|Adverse Event|0|||
16459009|NCT02059291|40159163|FG021|Epoch 3|Adverse Event|0|||
16459010|NCT02059291|40159164|FG022|Epoch 3|Adverse Event|0|||
16459011|NCT02059291|40159165|FG023|Epoch 3|Adverse Event|0|||
16459012|NCT02059291|40159166|FG024|Epoch 3|Adverse Event|0|||
16459013|NCT02059291|40159142|FG000|Epoch 3|Lack of Efficacy|0|||
16459014|NCT02059291|40159143|FG001|Epoch 3|Lack of Efficacy|0|||
16459015|NCT02059291|40159144|FG002|Epoch 3|Lack of Efficacy|0|||
16459016|NCT02059291|40159145|FG003|Epoch 3|Lack of Efficacy|0|||
16459017|NCT02059291|40159146|FG004|Epoch 3|Lack of Efficacy|0|||
16459018|NCT02059291|40159147|FG005|Epoch 3|Lack of Efficacy|0|||
16459019|NCT02059291|40159148|FG006|Epoch 3|Lack of Efficacy|0|||
16459020|NCT02059291|40159149|FG007|Epoch 3|Lack of Efficacy|0|||
16459021|NCT02059291|40159150|FG008|Epoch 3|Lack of Efficacy|0|||
16459022|NCT02059291|40159151|FG009|Epoch 3|Lack of Efficacy|0|||
16459023|NCT02059291|40159152|FG010|Epoch 3|Lack of Efficacy|0|||
16167306|NCT01126580|39091454|FG001|Overall Study|Sponsor Decision|4|||
16167307|NCT01126580|39091455|FG002|Overall Study|Sponsor Decision|7|||
16167308|NCT01126580|39091453|FG000|Overall Study|Physician Decision|1|||
16167309|NCT01126580|39091454|FG001|Overall Study|Physician Decision|1|||
16167310|NCT01126580|39091455|FG002|Overall Study|Physician Decision|2|||
16167311|NCT01126580|39091453|FG000|Overall Study|Entry Criteria Not Met|1|||
16167312|NCT01126580|39091454|FG001|Overall Study|Entry Criteria Not Met|1|||
16167313|NCT01126580|39091455|FG002|Overall Study|Entry Criteria Not Met|2|||
16167314|NCT01126580|39091453|FG000|Overall Study|Lack of Efficacy|2|||
16167315|NCT01126580|39091454|FG001|Overall Study|Lack of Efficacy|3|||
16167316|NCT01126580|39091455|FG002|Overall Study|Lack of Efficacy|4|||
16167317|NCT01126580|39091453|FG000|Overall Study|Protocol Violation|0|||
16167318|NCT01126580|39091454|FG001|Overall Study|Protocol Violation|1|||
16167319|NCT01126580|39091455|FG002|Overall Study|Protocol Violation|2|||
16167320|NCT01126580|39091453|FG000|Overall Study|Lost to Follow-up|15|||
16167321|NCT01126580|39091454|FG001|Overall Study|Lost to Follow-up|13|||
16167322|NCT01126580|39091455|FG002|Overall Study|Lost to Follow-up|9|||
16167323|NCT01126580|39091453|FG000|Overall Study|Treatment Non-compliance|0|||
16167324|NCT01126580|39091454|FG001|Overall Study|Treatment Non-compliance|2|||
16459024|NCT02059291|40159153|FG011|Epoch 3|Lack of Efficacy|0|||
16459025|NCT02059291|40159154|FG012|Epoch 3|Lack of Efficacy|0|||
16459026|NCT02059291|40159155|FG013|Epoch 3|Lack of Efficacy|0|||
16459027|NCT02059291|40159156|FG014|Epoch 3|Lack of Efficacy|0|||
16459028|NCT02059291|40159157|FG015|Epoch 3|Lack of Efficacy|3|||
16459029|NCT02059291|40159158|FG016|Epoch 3|Lack of Efficacy|0|||
16459030|NCT02059291|40159159|FG017|Epoch 3|Lack of Efficacy|0|||
16459031|NCT02059291|40159160|FG018|Epoch 3|Lack of Efficacy|0|||
16459032|NCT02059291|40159161|FG019|Epoch 3|Lack of Efficacy|0|||
16459033|NCT02059291|40159162|FG020|Epoch 3|Lack of Efficacy|0|||
16459034|NCT02059291|40159163|FG021|Epoch 3|Lack of Efficacy|0|||
16459035|NCT02059291|40159164|FG022|Epoch 3|Lack of Efficacy|0|||
16459036|NCT02059291|40159165|FG023|Epoch 3|Lack of Efficacy|0|||
16459037|NCT02059291|40159166|FG024|Epoch 3|Lack of Efficacy|0|||
16459038|NCT02059291|40159142|FG000|Epoch 3|Withdrawal by Subject|0|||
16459039|NCT02059291|40159143|FG001|Epoch 3|Withdrawal by Subject|0|||
16459040|NCT02059291|40159144|FG002|Epoch 3|Withdrawal by Subject|0|||
16459041|NCT02059291|40159145|FG003|Epoch 3|Withdrawal by Subject|0|||
16167325|NCT01126580|39091455|FG002|Overall Study|Treatment Non-compliance|3|||
16167326|NCT01926626|39091456|FG000|Overall Study|Withdrawal by Subject|15|||
16459042|NCT02059291|40159146|FG004|Epoch 3|Withdrawal by Subject|0|||
16459043|NCT02059291|40159147|FG005|Epoch 3|Withdrawal by Subject|0|||
16459044|NCT02059291|40159148|FG006|Epoch 3|Withdrawal by Subject|0|||
16459045|NCT02059291|40159149|FG007|Epoch 3|Withdrawal by Subject|0|||
16459046|NCT02059291|40159150|FG008|Epoch 3|Withdrawal by Subject|0|||
16459047|NCT02059291|40159151|FG009|Epoch 3|Withdrawal by Subject|0|||
16459048|NCT02059291|40159152|FG010|Epoch 3|Withdrawal by Subject|0|||
16459049|NCT02059291|40159153|FG011|Epoch 3|Withdrawal by Subject|0|||
16459050|NCT02059291|40159154|FG012|Epoch 3|Withdrawal by Subject|0|||
16459051|NCT02059291|40159155|FG013|Epoch 3|Withdrawal by Subject|0|||
16459052|NCT02059291|40159156|FG014|Epoch 3|Withdrawal by Subject|0|||
16459053|NCT02059291|40159157|FG015|Epoch 3|Withdrawal by Subject|1|||
16459054|NCT02059291|40159158|FG016|Epoch 3|Withdrawal by Subject|0|||
16167327|NCT01926626|39091456|FG000|Overall Study|Lost to Follow-up|7|||
16167328|NCT03072160|39091458|FG000|Overall Study|Adverse Event|3|||
16167329|NCT03072160|39091459|FG001|Overall Study|Adverse Event|1|||
16167330|NCT03072160|39091458|FG000|Overall Study|Refused further treatment|6|||
16167331|NCT03072160|39091459|FG001|Overall Study|Refused further treatment|1|||
16167332|NCT03072160|39091458|FG000|Overall Study|Physician Decision|1|||
16167333|NCT03072160|39091459|FG001|Overall Study|Physician Decision|0|||
16167334|NCT03072160|39091458|FG000|Overall Study|Disease progression on study|1|||
16167335|NCT03072160|39091459|FG001|Overall Study|Disease progression on study|1|||
16459055|NCT02059291|40159159|FG017|Epoch 3|Withdrawal by Subject|0|||
16459056|NCT02059291|40159160|FG018|Epoch 3|Withdrawal by Subject|0|||
16459057|NCT02059291|40159161|FG019|Epoch 3|Withdrawal by Subject|0|||
16459058|NCT02059291|40159162|FG020|Epoch 3|Withdrawal by Subject|0|||
16459059|NCT02059291|40159163|FG021|Epoch 3|Withdrawal by Subject|0|||
16459060|NCT02059291|40159164|FG022|Epoch 3|Withdrawal by Subject|0|||
16459061|NCT02059291|40159165|FG023|Epoch 3|Withdrawal by Subject|0|||
16167336|NCT03072160|39091458|FG000|Overall Study|No contact|0|||
16167337|NCT03072160|39091459|FG001|Overall Study|No contact|1|||
16167338|NCT01882907|39091463|FG000|Overall Study|Adverse Event|3|||
16167339|NCT01882907|39091464|FG001|Overall Study|Adverse Event|1|||
16167340|NCT01882907|39091463|FG000|Overall Study|Lack of Efficacy|0|||
16167341|NCT01882907|39091464|FG001|Overall Study|Lack of Efficacy|3|||
16167342|NCT01882907|39091463|FG000|Overall Study|Lost to Follow-up|1|||
16167343|NCT01882907|39091464|FG001|Overall Study|Lost to Follow-up|4|||
16167344|NCT01882907|39091463|FG000|Overall Study|Protocol Violation|10|||
16167345|NCT01882907|39091464|FG001|Overall Study|Protocol Violation|14|||
16167346|NCT01882907|39091463|FG000|Overall Study|Withdrawal by Subject|0|||
16167347|NCT01882907|39091464|FG001|Overall Study|Withdrawal by Subject|6|||
16459062|NCT02059291|40159166|FG024|Epoch 3|Withdrawal by Subject|0|||
16459063|NCT02059291|40159142|FG000|Epoch 4|Adverse Event|0|||
16459064|NCT02059291|40159143|FG001|Epoch 4|Adverse Event|0|||
16459065|NCT02059291|40159144|FG002|Epoch 4|Adverse Event|0|||
16459066|NCT02059291|40159145|FG003|Epoch 4|Adverse Event|0|||
16459067|NCT02059291|40159146|FG004|Epoch 4|Adverse Event|0|||
16167348|NCT02789657|39091465|FG000|Overall Study|Withdrawal by Subject|2|||
16167349|NCT02789657|39091466|FG001|Overall Study|Withdrawal by Subject|0|||
16167350|NCT02789657|39091467|FG002|Overall Study|Withdrawal by Subject|0|||
16167351|NCT02789657|39091468|FG003|Overall Study|Withdrawal by Subject|0|||
16167352|NCT01671345|39091469|FG000|Overall Study|Lost to Follow-up|10|||
16167353|NCT01671345|39091470|FG001|Overall Study|Lost to Follow-up|6|||
16167354|NCT01671345|39091469|FG000|Overall Study|visit with non-participating physician|3|||
16167355|NCT01671345|39091470|FG001|Overall Study|visit with non-participating physician|3|||
16167356|NCT01451645|39091471|FG000|Overall Study|Protocol Violation|1|||
16167357|NCT01451645|39091472|FG001|Overall Study|Protocol Violation|0|||
16167358|NCT01451645|39091471|FG000|Overall Study|Adverse Event|0|||
16167359|NCT01451645|39091472|FG001|Overall Study|Adverse Event|3|||
16167360|NCT01451645|39091471|FG000|Overall Study|Withdrawal by Subject|4|||
16167361|NCT01451645|39091472|FG001|Overall Study|Withdrawal by Subject|2|||
16167362|NCT01451645|39091471|FG000|Overall Study|Lost to Follow-up|4|||
16167363|NCT01451645|39091472|FG001|Overall Study|Lost to Follow-up|3|||
16167364|NCT00860158|39091473|FG000|Overall Study|Study Terminated|1|||
16167365|NCT00167245|39091474|FG000|Overall Study|Lost to Follow-up|20|||
16167366|NCT00167245|39091475|FG001|Overall Study|Lost to Follow-up|31|||
16167367|NCT00167245|39091474|FG000|Overall Study|Withdrawal by Subject|5|||
16167368|NCT00167245|39091475|FG001|Overall Study|Withdrawal by Subject|8|||
16167369|NCT00167245|39091474|FG000|Overall Study|Incarcerated|3|||
16167370|NCT00167245|39091475|FG001|Overall Study|Incarcerated|2|||
16167371|NCT00167245|39091474|FG000|Overall Study|Drowsy|1|||
16269205|NCT01117623|39471031|FG001|Overall Study|Invest. text: completed all planned txs|0|||
16459068|NCT02059291|40159147|FG005|Epoch 4|Adverse Event|0|||
16459069|NCT02059291|40159148|FG006|Epoch 4|Adverse Event|0|||
16459070|NCT02059291|40159149|FG007|Epoch 4|Adverse Event|0|||
16459071|NCT02059291|40159150|FG008|Epoch 4|Adverse Event|0|||
16459072|NCT02059291|40159151|FG009|Epoch 4|Adverse Event|0|||
16459073|NCT02059291|40159152|FG010|Epoch 4|Adverse Event|0|||
16459074|NCT02059291|40159153|FG011|Epoch 4|Adverse Event|0|||
16459075|NCT02059291|40159154|FG012|Epoch 4|Adverse Event|0|||
16459076|NCT02059291|40159155|FG013|Epoch 4|Adverse Event|0|||
16167372|NCT00167245|39091475|FG001|Overall Study|Drowsy|0|||
16167373|NCT01679002|39091476|FG000|Overall Study|Adverse Event|1|||
16167374|NCT01679002|39091477|FG001|Overall Study|Adverse Event|1|||
16167375|NCT01679002|39091478|FG002|Overall Study|Adverse Event|0|||
16459077|NCT02059291|40159156|FG014|Epoch 4|Adverse Event|0|||
16459078|NCT02059291|40159157|FG015|Epoch 4|Adverse Event|0|||
16459079|NCT02059291|40159158|FG016|Epoch 4|Adverse Event|1|||
16459080|NCT02059291|40159159|FG017|Epoch 4|Adverse Event|0|||
16459081|NCT02059291|40159160|FG018|Epoch 4|Adverse Event|0|||
16459082|NCT02059291|40159161|FG019|Epoch 4|Adverse Event|0|||
16459083|NCT02059291|40159162|FG020|Epoch 4|Adverse Event|0|||
16459084|NCT02059291|40159163|FG021|Epoch 4|Adverse Event|0|||
16459085|NCT02059291|40159164|FG022|Epoch 4|Adverse Event|1|||
16459086|NCT02059291|40159165|FG023|Epoch 4|Adverse Event|0|||
16459087|NCT02059291|40159166|FG024|Epoch 4|Adverse Event|0|||
16459088|NCT02059291|40159142|FG000|Epoch 4|Pregnancy|0|||
16459089|NCT02059291|40159143|FG001|Epoch 4|Pregnancy|0|||
16459090|NCT02059291|40159144|FG002|Epoch 4|Pregnancy|0|||
16459091|NCT02059291|40159145|FG003|Epoch 4|Pregnancy|0|||
16459092|NCT02059291|40159146|FG004|Epoch 4|Pregnancy|0|||
16459093|NCT02059291|40159147|FG005|Epoch 4|Pregnancy|0|||
16459094|NCT02059291|40159148|FG006|Epoch 4|Pregnancy|0|||
16459095|NCT02059291|40159149|FG007|Epoch 4|Pregnancy|0|||
16459096|NCT02059291|40159150|FG008|Epoch 4|Pregnancy|0|||
16459097|NCT02059291|40159151|FG009|Epoch 4|Pregnancy|0|||
16459098|NCT02059291|40159152|FG010|Epoch 4|Pregnancy|0|||
16459099|NCT02059291|40159153|FG011|Epoch 4|Pregnancy|0|||
16459100|NCT02059291|40159154|FG012|Epoch 4|Pregnancy|0|||
16459101|NCT02059291|40159155|FG013|Epoch 4|Pregnancy|0|||
16459102|NCT02059291|40159156|FG014|Epoch 4|Pregnancy|0|||
16459103|NCT02059291|40159157|FG015|Epoch 4|Pregnancy|0|||
16459104|NCT02059291|40159158|FG016|Epoch 4|Pregnancy|1|||
16459105|NCT02059291|40159159|FG017|Epoch 4|Pregnancy|0|||
16459106|NCT02059291|40159160|FG018|Epoch 4|Pregnancy|0|||
16459107|NCT02059291|40159161|FG019|Epoch 4|Pregnancy|0|||
16167376|NCT01773421|39091479|FG000|Treatment Phase|Other|0|||
16167377|NCT01773421|39091480|FG001|Treatment Phase|Other|0|||
16459108|NCT02059291|40159162|FG020|Epoch 4|Pregnancy|0|||
16459109|NCT02059291|40159163|FG021|Epoch 4|Pregnancy|0|||
16459110|NCT02059291|40159164|FG022|Epoch 4|Pregnancy|0|||
16459111|NCT02059291|40159165|FG023|Epoch 4|Pregnancy|0|||
16459112|NCT02059291|40159166|FG024|Epoch 4|Pregnancy|0|||
16459113|NCT02059291|40159142|FG000|Epoch 4|Withdrawal by Subject|0|||
16459114|NCT02059291|40159143|FG001|Epoch 4|Withdrawal by Subject|0|||
16459115|NCT02059291|40159144|FG002|Epoch 4|Withdrawal by Subject|0|||
16459116|NCT02059291|40159145|FG003|Epoch 4|Withdrawal by Subject|0|||
16459117|NCT02059291|40159146|FG004|Epoch 4|Withdrawal by Subject|0|||
16459118|NCT02059291|40159147|FG005|Epoch 4|Withdrawal by Subject|0|||
16459119|NCT02059291|40159148|FG006|Epoch 4|Withdrawal by Subject|0|||
16459120|NCT02059291|40159149|FG007|Epoch 4|Withdrawal by Subject|0|||
16459121|NCT02059291|40159150|FG008|Epoch 4|Withdrawal by Subject|0|||
16459122|NCT02059291|40159151|FG009|Epoch 4|Withdrawal by Subject|0|||
16459123|NCT02059291|40159152|FG010|Epoch 4|Withdrawal by Subject|0|||
16459124|NCT02059291|40159153|FG011|Epoch 4|Withdrawal by Subject|0|||
16459125|NCT02059291|40159154|FG012|Epoch 4|Withdrawal by Subject|0|||
16459126|NCT02059291|40159155|FG013|Epoch 4|Withdrawal by Subject|0|||
16459127|NCT02059291|40159156|FG014|Epoch 4|Withdrawal by Subject|0|||
16459128|NCT02059291|40159157|FG015|Epoch 4|Withdrawal by Subject|0|||
16459129|NCT02059291|40159158|FG016|Epoch 4|Withdrawal by Subject|0|||
16459130|NCT02059291|40159159|FG017|Epoch 4|Withdrawal by Subject|0|||
16459131|NCT02059291|40159160|FG018|Epoch 4|Withdrawal by Subject|0|||
16459132|NCT02059291|40159161|FG019|Epoch 4|Withdrawal by Subject|0|||
16459133|NCT02059291|40159162|FG020|Epoch 4|Withdrawal by Subject|1|||
16459134|NCT02059291|40159163|FG021|Epoch 4|Withdrawal by Subject|0|||
16459135|NCT02059291|40159164|FG022|Epoch 4|Withdrawal by Subject|0|||
16459136|NCT02059291|40159165|FG023|Epoch 4|Withdrawal by Subject|0|||
16459137|NCT02059291|40159166|FG024|Epoch 4|Withdrawal by Subject|0|||
16459138|NCT02059291|40159142|FG000|Epoch 4|Lack of Efficacy|0|||
16459139|NCT02059291|40159143|FG001|Epoch 4|Lack of Efficacy|0|||
16459140|NCT02059291|40159144|FG002|Epoch 4|Lack of Efficacy|0|||
16459141|NCT02059291|40159145|FG003|Epoch 4|Lack of Efficacy|0|||
16459142|NCT02059291|40159146|FG004|Epoch 4|Lack of Efficacy|0|||
16459143|NCT02059291|40159147|FG005|Epoch 4|Lack of Efficacy|0|||
16459144|NCT02059291|40159148|FG006|Epoch 4|Lack of Efficacy|0|||
16459145|NCT02059291|40159149|FG007|Epoch 4|Lack of Efficacy|0|||
16459146|NCT02059291|40159150|FG008|Epoch 4|Lack of Efficacy|0|||
16459147|NCT02059291|40159151|FG009|Epoch 4|Lack of Efficacy|0|||
16459148|NCT02059291|40159152|FG010|Epoch 4|Lack of Efficacy|0|||
16167378|NCT01773421|39091481|FG002|Treatment Phase|Other|2|||
16459149|NCT02059291|40159153|FG011|Epoch 4|Lack of Efficacy|0|||
16459150|NCT02059291|40159154|FG012|Epoch 4|Lack of Efficacy|0|||
16459151|NCT02059291|40159155|FG013|Epoch 4|Lack of Efficacy|0|||
16459152|NCT02059291|40159156|FG014|Epoch 4|Lack of Efficacy|0|||
16459153|NCT02059291|40159157|FG015|Epoch 4|Lack of Efficacy|0|||
16459154|NCT02059291|40159158|FG016|Epoch 4|Lack of Efficacy|0|||
16459155|NCT02059291|40159159|FG017|Epoch 4|Lack of Efficacy|0|||
16459156|NCT02059291|40159160|FG018|Epoch 4|Lack of Efficacy|0|||
16459157|NCT02059291|40159161|FG019|Epoch 4|Lack of Efficacy|0|||
16459158|NCT02059291|40159162|FG020|Epoch 4|Lack of Efficacy|0|||
16459159|NCT02059291|40159163|FG021|Epoch 4|Lack of Efficacy|0|||
16459160|NCT02059291|40159164|FG022|Epoch 4|Lack of Efficacy|0|||
16459161|NCT02059291|40159165|FG023|Epoch 4|Lack of Efficacy|1|||
16459162|NCT02059291|40159166|FG024|Epoch 4|Lack of Efficacy|0|||
16459163|NCT04359901|40159167|FG000|Overall Study|Withdrawal by Subject|0|||
16459164|NCT04359901|40159168|FG001|Overall Study|Withdrawal by Subject|1|||
16459165|NCT04359901|40159167|FG000|Overall Study|Death|6|||
16459166|NCT04359901|40159168|FG001|Overall Study|Death|2|||
16459167|NCT00763698|40159169|FG000|Overall Study|Unsuccessful Implant|5|||
16459168|NCT00763698|40159169|FG000|Overall Study|Death|4|||
16167379|NCT01773421|39091482|FG003|Treatment Phase|Other|0|||
16167380|NCT01773421|39091483|FG004|Treatment Phase|Other|0|||
16459169|NCT00763698|40159169|FG000|Overall Study|Withdrawal by Subject|1|||
16459170|NCT02442804|40159170|FG000|Overall Study|Withdrawal by Subject|0|||
16459171|NCT02442804|40159171|FG001|Overall Study|Withdrawal by Subject|1|||
16459172|NCT02442804|40159170|FG000|Overall Study|Adverse Event|1|||
16459173|NCT02442804|40159171|FG001|Overall Study|Adverse Event|0|||
16167381|NCT01773421|39091484|FG005|Treatment Phase|Other|0|||
16459174|NCT03425253|40159172|FG000|Overall Study|Adverse Event|2|||
16459175|NCT03425253|40159172|FG000|Overall Study|Lost to Follow-up|3|||
16459176|NCT03425253|40159172|FG000|Overall Study|Withdrew Consent|6|||
16459177|NCT03425253|40159172|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
16167382|NCT01773421|39091485|FG006|Treatment Phase|Other|0|||
16167383|NCT01773421|39091479|FG000|Treatment Phase|Adverse Event|0|||
16167384|NCT01773421|39091480|FG001|Treatment Phase|Adverse Event|0|||
16167385|NCT01773421|39091481|FG002|Treatment Phase|Adverse Event|3|||
16167386|NCT01773421|39091482|FG003|Treatment Phase|Adverse Event|1|||
16167387|NCT01773421|39091483|FG004|Treatment Phase|Adverse Event|0|||
16459178|NCT02969655|40159175|FG000|Overall Study|Withdrawal by Subject|3|||
16459179|NCT02969655|40159176|FG001|Overall Study|Withdrawal by Subject|2|||
16459180|NCT02969655|40159175|FG000|Overall Study|Physician Decision|4|||
16459181|NCT02969655|40159176|FG001|Overall Study|Physician Decision|3|||
16459182|NCT02969655|40159175|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
16459183|NCT02969655|40159176|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
16459184|NCT02969655|40159175|FG000|Overall Study|Adverse Event|10|||
16459185|NCT02969655|40159176|FG001|Overall Study|Adverse Event|8|||
16459186|NCT01136785|40159179|FG000|Overall Study|Protocol Violation|2|||
16459187|NCT01136785|40159180|FG001|Overall Study|Protocol Violation|1|||
16459188|NCT02160899|40159181|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
16459189|NCT02160899|40159182|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
16459190|NCT02160899|40159183|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
16459191|NCT02160899|40159184|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
16459192|NCT02160899|40159185|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
16459193|NCT02160899|40159186|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
16459194|NCT00171834|40159187|FG000|Overall Study|Adverse Event|2|||
16459195|NCT00171834|40159188|FG001|Overall Study|Adverse Event|1|||
16459196|NCT00171834|40159189|FG002|Overall Study|Adverse Event|3|||
16459197|NCT00171834|40159190|FG003|Overall Study|Adverse Event|2|||
16459198|NCT00171834|40159191|FG004|Overall Study|Adverse Event|2|||
16167388|NCT01773421|39091484|FG005|Treatment Phase|Adverse Event|0|||
16167389|NCT01773421|39091485|FG006|Treatment Phase|Adverse Event|0|||
16459199|NCT00171834|40159192|FG005|Overall Study|Adverse Event|15|||
16459200|NCT00171834|40159193|FG006|Overall Study|Adverse Event|1|||
16459201|NCT00171834|40159187|FG000|Overall Study|Withdrawal by Subject|0|||
16459202|NCT00171834|40159188|FG001|Overall Study|Withdrawal by Subject|2|||
16459203|NCT00171834|40159189|FG002|Overall Study|Withdrawal by Subject|0|||
16459204|NCT00171834|40159190|FG003|Overall Study|Withdrawal by Subject|1|||
16459205|NCT00171834|40159191|FG004|Overall Study|Withdrawal by Subject|1|||
16459206|NCT00171834|40159192|FG005|Overall Study|Withdrawal by Subject|1|||
16459207|NCT00171834|40159193|FG006|Overall Study|Withdrawal by Subject|0|||
16459208|NCT00171834|40159187|FG000|Overall Study|Death from study indication|0|||
16459209|NCT00171834|40159188|FG001|Overall Study|Death from study indication|1|||
16459210|NCT00171834|40159189|FG002|Overall Study|Death from study indication|0|||
16459211|NCT00171834|40159190|FG003|Overall Study|Death from study indication|0|||
16459212|NCT00171834|40159191|FG004|Overall Study|Death from study indication|1|||
16167390|NCT01773421|39091479|FG000|Treatment Phase|Withdrawal by Subject|0|||
16167391|NCT01773421|39091480|FG001|Treatment Phase|Withdrawal by Subject|0|||
16167392|NCT01773421|39091481|FG002|Treatment Phase|Withdrawal by Subject|1|||
16167393|NCT01773421|39091482|FG003|Treatment Phase|Withdrawal by Subject|1|||
16167394|NCT01773421|39091483|FG004|Treatment Phase|Withdrawal by Subject|0|||
16459213|NCT00171834|40159192|FG005|Overall Study|Death from study indication|0|||
16459214|NCT00171834|40159193|FG006|Overall Study|Death from study indication|0|||
16459215|NCT00171834|40159187|FG000|Overall Study|Disease Progression|4|||
16459216|NCT00171834|40159188|FG001|Overall Study|Disease Progression|8|||
16459217|NCT00171834|40159189|FG002|Overall Study|Disease Progression|8|||
16459218|NCT00171834|40159190|FG003|Overall Study|Disease Progression|9|||
16459219|NCT00171834|40159191|FG004|Overall Study|Disease Progression|2|||
16459220|NCT00171834|40159192|FG005|Overall Study|Disease Progression|18|||
16459221|NCT00171834|40159193|FG006|Overall Study|Disease Progression|3|||
16459222|NCT00171834|40159187|FG000|Overall Study|Treatment Duration Completed|0|||
16459223|NCT00171834|40159188|FG001|Overall Study|Treatment Duration Completed|0|||
16167395|NCT01773421|39091484|FG005|Treatment Phase|Withdrawal by Subject|0|||
16167396|NCT01773421|39091485|FG006|Treatment Phase|Withdrawal by Subject|0|||
16167397|NCT01773421|39091479|FG000|Extension Phase|Other|0|||
16167398|NCT01773421|39091480|FG001|Extension Phase|Other|0|||
16167399|NCT01773421|39091481|FG002|Extension Phase|Other|0|||
16167400|NCT01773421|39091482|FG003|Extension Phase|Other|0|||
16167401|NCT01773421|39091483|FG004|Extension Phase|Other|1|||
16167402|NCT01773421|39091484|FG005|Extension Phase|Other|2|||
16167403|NCT01773421|39091485|FG006|Extension Phase|Other|0|||
16167404|NCT01773421|39091479|FG000|Extension Phase|Adverse Event|0|||
16167405|NCT01773421|39091480|FG001|Extension Phase|Adverse Event|0|||
16167406|NCT01773421|39091481|FG002|Extension Phase|Adverse Event|0|||
16167407|NCT01773421|39091482|FG003|Extension Phase|Adverse Event|0|||
16167408|NCT01773421|39091483|FG004|Extension Phase|Adverse Event|2|||
16167409|NCT01773421|39091484|FG005|Extension Phase|Adverse Event|0|||
16459224|NCT00171834|40159189|FG002|Overall Study|Treatment Duration Completed|1|||
16459225|NCT00171834|40159190|FG003|Overall Study|Treatment Duration Completed|0|||
16459226|NCT00171834|40159191|FG004|Overall Study|Treatment Duration Completed|2|||
16459227|NCT00171834|40159192|FG005|Overall Study|Treatment Duration Completed|1|||
16459228|NCT00171834|40159193|FG006|Overall Study|Treatment Duration Completed|0|||
16459229|NCT04881942|40159194|FG000|Overall Study|Adverse Event|0|||
16459230|NCT04881942|40159195|FG001|Overall Study|Adverse Event|0|||
16459231|NCT04881942|40159196|FG002|Overall Study|Adverse Event|0|||
16459232|NCT04881942|40159197|FG003|Overall Study|Adverse Event|0|||
16459233|NCT04881942|40159198|FG004|Overall Study|Adverse Event|1|||
16459234|NCT04881942|40159194|FG000|Overall Study|Alternates|0|||
16459235|NCT04881942|40159195|FG001|Overall Study|Alternates|0|||
16459236|NCT04881942|40159196|FG002|Overall Study|Alternates|0|||
16459237|NCT04881942|40159197|FG003|Overall Study|Alternates|0|||
16459238|NCT04881942|40159198|FG004|Overall Study|Alternates|2|||
16459239|NCT00486811|40159200|FG000|Overall Study|Adverse Event|28|||
16459240|NCT00486811|40159201|FG001|Overall Study|Adverse Event|60|||
16459241|NCT00486811|40159202|FG002|Overall Study|Adverse Event|135|||
16459242|NCT00486811|40159200|FG000|Overall Study|Lack of Efficacy|34|||
16459243|NCT00486811|40159201|FG001|Overall Study|Lack of Efficacy|14|||
16459244|NCT00486811|40159202|FG002|Overall Study|Lack of Efficacy|7|||
16459245|NCT00486811|40159200|FG000|Overall Study|Lost to Follow-up|4|||
16459246|NCT00486811|40159201|FG001|Overall Study|Lost to Follow-up|6|||
16459247|NCT00486811|40159202|FG002|Overall Study|Lost to Follow-up|4|||
16459248|NCT00486811|40159200|FG000|Overall Study|Withdrawal by Subject|33|||
16459249|NCT00486811|40159201|FG001|Overall Study|Withdrawal by Subject|44|||
16459250|NCT00486811|40159202|FG002|Overall Study|Withdrawal by Subject|58|||
16459251|NCT00486811|40159200|FG000|Overall Study|Study drug non-compliant|5|||
16459252|NCT00486811|40159201|FG001|Overall Study|Study drug non-compliant|6|||
16459253|NCT00486811|40159202|FG002|Overall Study|Study drug non-compliant|3|||
16459254|NCT00486811|40159200|FG000|Overall Study|All other|18|||
16459255|NCT00486811|40159201|FG001|Overall Study|All other|11|||
16459256|NCT00486811|40159202|FG002|Overall Study|All other|7|||
16459257|NCT01689532|40159207|FG000|Overall Study|Adverse Event|9|||
16459258|NCT01689532|40159208|FG001|Overall Study|Adverse Event|5|||
16459259|NCT01689532|40159207|FG000|Overall Study|Lack of Efficacy|2|||
16459260|NCT01689532|40159208|FG001|Overall Study|Lack of Efficacy|2|||
16459261|NCT01689532|40159207|FG000|Overall Study|Withdrawal by Subject|1|||
16459262|NCT01689532|40159208|FG001|Overall Study|Withdrawal by Subject|2|||
16459263|NCT01689532|40159207|FG000|Overall Study|Physician Decision|2|||
16459264|NCT01689532|40159208|FG001|Overall Study|Physician Decision|0|||
16459265|NCT00934440|40159211|FG000|Overall Study|Lost to Follow-up|1|||
16167410|NCT01773421|39091485|FG006|Extension Phase|Adverse Event|0|||
16167411|NCT00705263|39091492|FG000|Overall Study|Withdrawal by Subject|2|||
16167412|NCT00236080|39091493|FG000|Overall Study|Adverse Event|0|||
16167413|NCT00236080|39091494|FG001|Overall Study|Adverse Event|0|||
16269206|NCT01117623|39471032|FG002|Overall Study|Invest. text: completed all planned txs|0|||
16269207|NCT01117623|39471033|FG003|Overall Study|Invest. text: completed all planned txs|0|||
16269208|NCT01117623|39471034|FG004|Overall Study|Invest. text: completed all planned txs|0|||
16269209|NCT01117623|39471035|FG005|Overall Study|Invest. text: completed all planned txs|1|||
16269210|NCT01117623|39471036|FG006|Overall Study|Invest. text: completed all planned txs|0|||
16269211|NCT01117623|39471037|FG007|Overall Study|Invest. text: completed all planned txs|0|||
16269212|NCT00115063|39471040|FG000|Overall Study|Lost to Follow-up|98|||
16269213|NCT00115063|39471041|FG001|Overall Study|Lost to Follow-up|104|||
16269214|NCT00115063|39471040|FG000|Overall Study|Death|1|||
16269215|NCT00115063|39471041|FG001|Overall Study|Death|0|||
16269216|NCT00795821|39471042|FG000|Acute Treatment Phase|Adverse Event|23|||
16269217|NCT00795821|39471043|FG001|Acute Treatment Phase|Adverse Event|4|||
16269218|NCT00795821|39471042|FG000|Acute Treatment Phase|Death|1|||
16459266|NCT04525885|40159221|FG000|Overall Study|Screen Failure|1|||
16167414|NCT00236080|39091495|FG002|Overall Study|Adverse Event|3|||
16269219|NCT00795821|39471043|FG001|Acute Treatment Phase|Death|0|||
16167415|NCT00236080|39091496|FG003|Overall Study|Adverse Event|1|||
16459267|NCT04525885|40159222|FG001|Overall Study|Screen Failure|0|||
16459268|NCT04525885|40159223|FG002|Overall Study|Screen Failure|0|||
16459269|NCT04525885|40159221|FG000|Overall Study|Withdrawal by Subject|14|||
16459270|NCT04525885|40159222|FG001|Overall Study|Withdrawal by Subject|6|||
16459271|NCT04525885|40159223|FG002|Overall Study|Withdrawal by Subject|20|||
16459272|NCT04525885|40159221|FG000|Overall Study|Physician Decision|1|||
16459273|NCT04525885|40159222|FG001|Overall Study|Physician Decision|0|||
16459274|NCT04525885|40159223|FG002|Overall Study|Physician Decision|1|||
16459275|NCT00006409|40159225|FG000|Baseline|Protocol Violation|48|||
16459276|NCT00006409|40159226|FG001|Baseline|Protocol Violation|70|||
16459277|NCT00006409|40159227|FG002|Baseline|Protocol Violation|0|||
16459278|NCT00006409|40159228|FG003|Baseline|Protocol Violation|0|||
16459279|NCT00006409|40159229|FG004|Baseline|Protocol Violation|0|||
16459280|NCT00006409|40159230|FG005|Baseline|Protocol Violation|0|||
16459281|NCT00006409|40159225|FG000|Post-2 Year Intervention|Protocol Violation|0|||
16459282|NCT00006409|40159226|FG001|Post-2 Year Intervention|Protocol Violation|0|||
16459283|NCT00006409|40159227|FG002|Post-2 Year Intervention|Protocol Violation|251|||
16459284|NCT00006409|40159228|FG003|Post-2 Year Intervention|Protocol Violation|168|||
16459285|NCT00006409|40159229|FG004|Post-2 Year Intervention|Protocol Violation|0|||
16459286|NCT00006409|40159230|FG005|Post-2 Year Intervention|Protocol Violation|0|||
16459287|NCT00006409|40159225|FG000|Post-3 Year Intervention|Protocol Violation|0|||
16459288|NCT00006409|40159226|FG001|Post-3 Year Intervention|Protocol Violation|0|||
16459289|NCT00006409|40159227|FG002|Post-3 Year Intervention|Protocol Violation|0|||
16459290|NCT00006409|40159228|FG003|Post-3 Year Intervention|Protocol Violation|0|||
16459291|NCT00006409|40159229|FG004|Post-3 Year Intervention|Protocol Violation|62|||
16459292|NCT00006409|40159230|FG005|Post-3 Year Intervention|Protocol Violation|62|||
16459293|NCT00838513|40159232|FG000|Screening Period|Screen Failure|3|||
16459294|NCT00838513|40159232|FG000|Extension Treatment Period|Death|1|||
16459295|NCT00838513|40159232|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
16459296|NCT00336856|40161838|FG000|Overall Study|Withdrawal by Subject|3|||
16459297|NCT00336856|40161838|FG000|Overall Study|Found ineligible at time of analysis|1|||
16459298|NCT03337490|40161843|FG000|Overall Study|Withdrawal by Subject|1|||
16459299|NCT03337490|40161844|FG001|Overall Study|Withdrawal by Subject|0|||
16459300|NCT03337490|40161845|FG002|Overall Study|Withdrawal by Subject|0|||
16459301|NCT03337490|40161843|FG000|Overall Study|Lack of Efficacy|10|||
16459302|NCT03337490|40161844|FG001|Overall Study|Lack of Efficacy|12|||
16459303|NCT03337490|40161845|FG002|Overall Study|Lack of Efficacy|35|||
16459304|NCT03337490|40161843|FG000|Overall Study|Physician Decision|0|||
16459305|NCT03337490|40161844|FG001|Overall Study|Physician Decision|1|||
16459306|NCT03337490|40161845|FG002|Overall Study|Physician Decision|0|||
16459307|NCT03337490|40161843|FG000|Overall Study|Lost to Follow-up|0|||
16459308|NCT03337490|40161844|FG001|Overall Study|Lost to Follow-up|1|||
16459309|NCT03337490|40161845|FG002|Overall Study|Lost to Follow-up|0|||
16459310|NCT01523275|40161846|FG000|Overall Study|Lost to Follow-up|1|||
16459311|NCT01523275|40161847|FG001|Overall Study|Lost to Follow-up|2|||
16459312|NCT01523275|40161846|FG000|Overall Study|Withdrawal by Subject|1|||
16459313|NCT01523275|40161847|FG001|Overall Study|Withdrawal by Subject|0|||
16459314|NCT02873429|40161852|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
16459315|NCT02873429|40161853|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
16459316|NCT02873429|40161852|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
16459317|NCT02873429|40161853|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
16459318|NCT02873429|40161852|FG000|16 Weeks|Lost to Follow-up|3|||
16459319|NCT02873429|40161853|FG001|16 Weeks|Lost to Follow-up|0|||
16459320|NCT00874939|40161854|FG000|Overall Study|Study terminated|4|||
16459321|NCT01705509|40161855|FG000|Inclusion CPET|Screen Failure|5|||
16459322|NCT01705509|40161855|FG000|Inclusion CPET|Withdrawal by Subject|2|||
16459323|NCT01705509|40161855|FG000|CPET w/ Ranexa|Screen Failure|2|||
16459324|NCT04129151|40161858|FG000|Overall Study|Adverse Event|1|||
16459325|NCT04129151|40161858|FG000|Overall Study|Disease Progression|7|||
16459326|NCT04129151|40161858|FG000|Overall Study|Study closure|1|||
16459327|NCT03658876|40161859|FG000|Overall Study|Protocol Violation|3|||
16459328|NCT03658876|40161860|FG001|Overall Study|Protocol Violation|2|||
16459329|NCT03658876|40161859|FG000|Overall Study|Withdrawal by Subject|2|||
16459330|NCT03658876|40161860|FG001|Overall Study|Withdrawal by Subject|0|||
16459331|NCT03658876|40161859|FG000|Overall Study|Death|0|||
16459332|NCT03658876|40161860|FG001|Overall Study|Death|1|||
16459333|NCT03658876|40161859|FG000|Overall Study|Intercurrent illness|6|||
16459334|NCT03658876|40161860|FG001|Overall Study|Intercurrent illness|4|||
16459335|NCT03658876|40161859|FG000|Overall Study|Transplantation/other operation|1|||
16459336|NCT03658876|40161860|FG001|Overall Study|Transplantation/other operation|5|||
16459337|NCT00732940|40161866|FG000|Overall Study|Withdrawal by Subject|1|||
16459338|NCT00732940|40161867|FG001|Overall Study|Withdrawal by Subject|2|||
16459339|NCT00732940|40161866|FG000|Overall Study|Adverse Event|0|||
16459340|NCT00732940|40161867|FG001|Overall Study|Adverse Event|1|||
16459341|NCT00732940|40161866|FG000|Overall Study|Lost to Follow-up|1|||
16459342|NCT00732940|40161867|FG001|Overall Study|Lost to Follow-up|0|||
16459343|NCT00375609|40161868|FG000|Overall Study|Did not receive treatment|1|||
16459344|NCT00375609|40161869|FG001|Overall Study|Did not receive treatment|0|||
16459345|NCT00375609|40161870|FG002|Overall Study|Did not receive treatment|0|||
16459346|NCT00375609|40161868|FG000|Overall Study|Adverse Event|0|||
16459347|NCT00375609|40161869|FG001|Overall Study|Adverse Event|3|||
16459348|NCT00375609|40161870|FG002|Overall Study|Adverse Event|0|||
16459349|NCT00375609|40161868|FG000|Overall Study|Lost to Follow-up|1|||
16459350|NCT00375609|40161869|FG001|Overall Study|Lost to Follow-up|0|||
16459351|NCT00375609|40161870|FG002|Overall Study|Lost to Follow-up|0|||
16459352|NCT00375609|40161868|FG000|Overall Study|Physician Decision|0|||
16459353|NCT00375609|40161869|FG001|Overall Study|Physician Decision|0|||
16459354|NCT00375609|40161870|FG002|Overall Study|Physician Decision|1|||
16459355|NCT00375609|40161868|FG000|Overall Study|Withdrawal by Subject|1|||
16459356|NCT00375609|40161869|FG001|Overall Study|Withdrawal by Subject|4|||
16459357|NCT00375609|40161870|FG002|Overall Study|Withdrawal by Subject|0|||
16459358|NCT00375609|40161868|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
16459359|NCT00375609|40161869|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
16459360|NCT00375609|40161870|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
16459361|NCT02717832|40161872|FG000|Overall Study|Inability to place IV|3|||
16459362|NCT01024309|40161881|FG000|Overall Study|Physician Decision|4|||
16459363|NCT01024309|40161882|FG001|Overall Study|Physician Decision|0|||
16459364|NCT01024309|40161881|FG000|Overall Study|Withdrawal by Subject|4|||
16459365|NCT01024309|40161882|FG001|Overall Study|Withdrawal by Subject|4|||
16459366|NCT02881567|40161890|FG000|Overall Study|Adverse Event|1|||
16459367|NCT02881567|40161890|FG000|Overall Study|Lost to Follow-up|3|||
16459368|NCT02881567|40161890|FG000|Overall Study|Consent withdrawn|1|||
16459369|NCT02881567|40161890|FG000|Overall Study|Investigator decision|1|||
16459370|NCT02881567|40161890|FG000|Overall Study|Study terminated by sponsor|9|||
16459371|NCT02881567|40161890|FG000|Overall Study|Reason not Specified|3|||
16459372|NCT03567343|40161891|FG000|Overall Study|Lost to Follow-up|2|||
16459373|NCT03567343|40161892|FG001|Overall Study|Lost to Follow-up|1|||
16459374|NCT03567343|40161891|FG000|Overall Study|No longer eligible|2|||
16459375|NCT03567343|40161892|FG001|Overall Study|No longer eligible|1|||
16459376|NCT03567343|40161891|FG000|Overall Study|Adverse Event|1|||
16459377|NCT03567343|40161892|FG001|Overall Study|Adverse Event|0|||
16459378|NCT03567343|40161891|FG000|Overall Study|Protocol Violation|1|||
16459379|NCT03567343|40161892|FG001|Overall Study|Protocol Violation|1|||
16167416|NCT00236080|39091497|FG004|Overall Study|Adverse Event|0|||
16167417|NCT00236080|39091493|FG000|Overall Study|Lost to Follow-up|0|||
16167418|NCT00236080|39091494|FG001|Overall Study|Lost to Follow-up|1|||
16167419|NCT00236080|39091495|FG002|Overall Study|Lost to Follow-up|0|||
16167420|NCT00236080|39091496|FG003|Overall Study|Lost to Follow-up|0|||
16167421|NCT00236080|39091497|FG004|Overall Study|Lost to Follow-up|0|||
16167422|NCT00236080|39091493|FG000|Overall Study|Physician Decision|1|||
16167423|NCT00236080|39091494|FG001|Overall Study|Physician Decision|0|||
16459380|NCT02745080|40161893|FG000|Overall Study|Adverse Event|13|||
16459381|NCT02745080|40161894|FG001|Overall Study|Adverse Event|21|||
16459382|NCT02745080|40161893|FG000|Overall Study|Lack of Efficacy|11|||
16459383|NCT02745080|40161894|FG001|Overall Study|Lack of Efficacy|23|||
16459384|NCT02745080|40161893|FG000|Overall Study|Lost to Follow-up|3|||
16459385|NCT02745080|40161894|FG001|Overall Study|Lost to Follow-up|3|||
16459386|NCT02745080|40161893|FG000|Overall Study|Physician Decision|3|||
16459387|NCT02745080|40161894|FG001|Overall Study|Physician Decision|0|||
16459388|NCT02745080|40161893|FG000|Overall Study|Protocol Violation|3|||
16459389|NCT02745080|40161894|FG001|Overall Study|Protocol Violation|1|||
16459390|NCT02745080|40161893|FG000|Overall Study|Withdrawal by Subject|22|||
16459391|NCT02745080|40161894|FG001|Overall Study|Withdrawal by Subject|41|||
16459392|NCT00702715|40161897|FG000|Overall Study|Lost to Follow-up|1|||
16459393|NCT00702715|40161898|FG001|Overall Study|Lost to Follow-up|0|||
16459394|NCT02043899|40161899|FG000|Overall Study|Adverse Event|3|||
16459395|NCT02043899|40161899|FG000|Overall Study|Physician Decision|1|||
16459396|NCT02043899|40161899|FG000|Overall Study|Withdrawal by Subject|2|||
16459397|NCT02043899|40161899|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
16459398|NCT02043899|40161899|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
16459399|NCT02043899|40161899|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
16459400|NCT02043899|40161899|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
16459401|NCT02043899|40161899|FG000|Overall Study|Treatment delayed|1|||
16459402|NCT00782834|40161904|FG000|Treatment Phase|fibrous tumor not GIST|1|||
16459403|NCT03753789|40161910|FG000|Overall Study|Withdrawal by Subject|2|||
16167424|NCT00236080|39091495|FG002|Overall Study|Physician Decision|1|||
16167425|NCT00236080|39091496|FG003|Overall Study|Physician Decision|1|||
16459404|NCT01239732|40161911|FG000|Overall Study|Termination of study per protocol|667|||
16459405|NCT01239732|40161911|FG000|Overall Study|Death|226|||
16459406|NCT01239732|40161911|FG000|Overall Study|Withdrawal by Subject|87|||
16167426|NCT00236080|39091497|FG004|Overall Study|Physician Decision|1|||
16167427|NCT00236080|39091493|FG000|Overall Study|Withdrawal by Subject|1|||
16167428|NCT00236080|39091494|FG001|Overall Study|Withdrawal by Subject|0|||
16167429|NCT00236080|39091495|FG002|Overall Study|Withdrawal by Subject|0|||
16459407|NCT01239732|40161911|FG000|Overall Study|Adverse Event|6|||
16459408|NCT01239732|40161911|FG000|Overall Study|Protocol Violation|3|||
16459409|NCT01239732|40161911|FG000|Overall Study|Participant non compliance|5|||
16459410|NCT01239732|40161911|FG000|Overall Study|Study termination by sponsor|2|||
16459411|NCT01239732|40161911|FG000|Overall Study|Investigator's decision|4|||
16459412|NCT01239732|40161911|FG000|Overall Study|Treatment failure|2|||
16459413|NCT01239732|40161911|FG000|Overall Study|Other|19|||
16459414|NCT03801031|40161912|FG000|Overall Study|Lost to Follow-up|1|||
16167430|NCT00236080|39091496|FG003|Overall Study|Withdrawal by Subject|0|||
16167431|NCT00236080|39091497|FG004|Overall Study|Withdrawal by Subject|0|||
16167432|NCT00236080|39091493|FG000|Overall Study|Miscellaneous|0|||
16167433|NCT00236080|39091494|FG001|Overall Study|Miscellaneous|0|||
16167434|NCT00236080|39091495|FG002|Overall Study|Miscellaneous|1|||
16167435|NCT00236080|39091496|FG003|Overall Study|Miscellaneous|0|||
16167436|NCT00236080|39091497|FG004|Overall Study|Miscellaneous|0|||
16167437|NCT02542072|39091498|FG000|First Intervention (1 Month)|Adverse Event|1|||
16167438|NCT02542072|39091499|FG001|First Intervention (1 Month)|Adverse Event|1|||
16167439|NCT02542072|39091498|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
16459415|NCT03801031|40161913|FG001|Overall Study|Lost to Follow-up|0|||
16459416|NCT03801031|40161912|FG000|Overall Study|Unable to comply|1|||
16459417|NCT03801031|40161913|FG001|Overall Study|Unable to comply|0|||
16459418|NCT03801031|40161912|FG000|Overall Study|Withdrawal by Subject|0|||
16459419|NCT03801031|40161913|FG001|Overall Study|Withdrawal by Subject|1|||
16459420|NCT04364984|40161915|FG000|Overall Study|Death|2|||
16167440|NCT02542072|39091499|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
16167441|NCT02542072|39091498|FG000|First Intervention (1 Month)|Lens discomfort|1|||
16167442|NCT02542072|39091499|FG001|First Intervention (1 Month)|Lens discomfort|2|||
16167443|NCT02542072|39091498|FG000|First Intervention (1 Month)|Protocol Violation|1|||
16167444|NCT02542072|39091499|FG001|First Intervention (1 Month)|Protocol Violation|0|||
16167445|NCT02542072|39091498|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
16167446|NCT02542072|39091499|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
16167447|NCT02542072|39091498|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
16459421|NCT04364984|40161916|FG001|Overall Study|Death|2|||
16459422|NCT04364984|40161917|FG002|Overall Study|Death|0|||
16459423|NCT01057589|40161921|FG000|Overall Study|Disease Progression|35|||
16459424|NCT01057589|40161921|FG000|Overall Study|Adverse Event|10|||
16459425|NCT01057589|40161921|FG000|Overall Study|Physician Decision|8|||
16459426|NCT01057589|40161921|FG000|Overall Study|Withdrawal by Subject|3|||
16459427|NCT01057589|40161921|FG000|Overall Study|Sponsor Decision|1|||
16459428|NCT01057589|40161921|FG000|Overall Study|Death|8|||
16459429|NCT01057589|40161921|FG000|Overall Study|Lost to Follow-up|1|||
16459430|NCT00363545|40161922|FG000|Overall Study|Serious Adverse Event|0|||
16459431|NCT00363545|40161923|FG001|Overall Study|Serious Adverse Event|1|||
16459432|NCT00363545|40161922|FG000|Overall Study|Withdrawal by Subject|12|||
16459433|NCT00363545|40161923|FG001|Overall Study|Withdrawal by Subject|15|||
16459434|NCT00363545|40161922|FG000|Overall Study|Migrated/moved from study area|3|||
16459435|NCT00363545|40161923|FG001|Overall Study|Migrated/moved from study area|6|||
16459436|NCT00363545|40161922|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
16459437|NCT00363545|40161923|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
16459438|NCT00363545|40161922|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
16459439|NCT00363545|40161923|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
16459440|NCT00363545|40161922|FG000|Overall Study|Others|1|||
16459441|NCT00363545|40161923|FG001|Overall Study|Others|0|||
16459442|NCT03560518|40161924|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
16459443|NCT03560518|40161925|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
16459444|NCT03560518|40161926|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
16459445|NCT03560518|40161924|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
16167448|NCT02542072|39091499|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
16167449|NCT02327260|39091500|FG000|Overall Study|Lost to Follow-up|2|||
16167450|NCT02327260|39091501|FG001|Overall Study|Lost to Follow-up|3|||
16167451|NCT02327260|39091502|FG002|Overall Study|Lost to Follow-up|2|||
16167452|NCT02327260|39091500|FG000|Overall Study|invalid phone number|1|||
16167453|NCT02327260|39091501|FG001|Overall Study|invalid phone number|1|||
16167454|NCT02327260|39091502|FG002|Overall Study|invalid phone number|0|||
16167455|NCT02327260|39091500|FG000|Overall Study|non-adherence to protocol|2|||
16167456|NCT02327260|39091501|FG001|Overall Study|non-adherence to protocol|0|||
16167457|NCT02327260|39091502|FG002|Overall Study|non-adherence to protocol|0|||
16459446|NCT03560518|40161925|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
16459447|NCT03560518|40161926|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
16459448|NCT03560518|40161924|FG000|Double Blind Treatment Period|Protocol Violation|1|||
16459449|NCT03560518|40161925|FG001|Double Blind Treatment Period|Protocol Violation|2|||
16459450|NCT03560518|40161926|FG002|Double Blind Treatment Period|Protocol Violation|0|||
16459451|NCT03560518|40161924|FG000|Double Blind Treatment Period|Pregnancy|0|||
16167458|NCT02327260|39091500|FG000|Overall Study|cognitive concerns|1|||
16167459|NCT02327260|39091501|FG001|Overall Study|cognitive concerns|0|||
16167460|NCT02327260|39091502|FG002|Overall Study|cognitive concerns|0|||
16459452|NCT03560518|40161925|FG001|Double Blind Treatment Period|Pregnancy|2|||
16459453|NCT03560518|40161926|FG002|Double Blind Treatment Period|Pregnancy|0|||
16459454|NCT03560518|40161924|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
16459455|NCT03560518|40161925|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
16459456|NCT03560518|40161926|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
16459457|NCT03560518|40161924|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
16459458|NCT03560518|40161925|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
16459459|NCT03560518|40161926|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
16459460|NCT03560518|40161924|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
16459461|NCT03560518|40161925|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
16459462|NCT03560518|40161926|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
16459463|NCT03560518|40161924|FG000|Double Blind Treatment Period|Adverse Event|0|||
16459464|NCT03560518|40161925|FG001|Double Blind Treatment Period|Adverse Event|3|||
16459465|NCT03560518|40161926|FG002|Double Blind Treatment Period|Adverse Event|1|||
16459466|NCT00966875|40161927|FG000|Part A|Adverse Event|2|||
16459467|NCT00966875|40161928|FG001|Part A|Adverse Event|1|||
16167461|NCT01505894|39091503|FG000|Overall Study|Adverse Event|1|||
16167462|NCT01505894|39091504|FG001|Overall Study|Adverse Event|0|||
16167463|NCT01505894|39091505|FG002|Overall Study|Adverse Event|0|||
16167464|NCT01505894|39091506|FG003|Overall Study|Adverse Event|0|||
16167465|NCT01505894|39091507|FG004|Overall Study|Adverse Event|0|||
16167466|NCT01505894|39091508|FG005|Overall Study|Adverse Event|0|||
16167467|NCT01505894|39091509|FG006|Overall Study|Adverse Event|0|||
16167468|NCT01505894|39091510|FG007|Overall Study|Adverse Event|0|||
16167469|NCT01505894|39091511|FG008|Overall Study|Adverse Event|0|||
16167470|NCT01505894|39091503|FG000|Overall Study|Other than specified|0|||
16167471|NCT01505894|39091504|FG001|Overall Study|Other than specified|0|||
16167472|NCT01505894|39091505|FG002|Overall Study|Other than specified|0|||
16167473|NCT01505894|39091506|FG003|Overall Study|Other than specified|0|||
16167474|NCT01505894|39091507|FG004|Overall Study|Other than specified|1|||
16167475|NCT01505894|39091508|FG005|Overall Study|Other than specified|0|||
16167476|NCT01505894|39091509|FG006|Overall Study|Other than specified|0|||
16167477|NCT01505894|39091510|FG007|Overall Study|Other than specified|0|||
16167478|NCT01505894|39091511|FG008|Overall Study|Other than specified|0|||
16167479|NCT01916980|39091512|FG000|Overall Study|Adverse Event|4|||
16167480|NCT01916980|39091513|FG001|Overall Study|Adverse Event|2|||
16167481|NCT01916980|39091512|FG000|Overall Study|Lack of Efficacy|2|||
16167482|NCT01916980|39091513|FG001|Overall Study|Lack of Efficacy|2|||
16459468|NCT00966875|40161929|FG002|Part A|Adverse Event|0|||
16459469|NCT00966875|40161930|FG003|Part A|Adverse Event|1|||
16459470|NCT00966875|40161931|FG004|Part A|Adverse Event|0|||
16459471|NCT00966875|40161932|FG005|Part A|Adverse Event|1|||
16459472|NCT00966875|40161933|FG006|Part A|Adverse Event|0|||
16459473|NCT00966875|40161934|FG007|Part A|Adverse Event|3|||
16459474|NCT00966875|40161935|FG008|Part A|Adverse Event|3|||
16459475|NCT00966875|40161927|FG000|Part A|Entry Criteria|0|||
16459476|NCT00966875|40161928|FG001|Part A|Entry Criteria|0|||
16459477|NCT00966875|40161929|FG002|Part A|Entry Criteria|0|||
16459478|NCT00966875|40161930|FG003|Part A|Entry Criteria|0|||
16459479|NCT00966875|40161931|FG004|Part A|Entry Criteria|0|||
16459480|NCT00966875|40161932|FG005|Part A|Entry Criteria|2|||
16459481|NCT00966875|40161933|FG006|Part A|Entry Criteria|0|||
16459482|NCT00966875|40161934|FG007|Part A|Entry Criteria|0|||
16459483|NCT00966875|40161935|FG008|Part A|Entry Criteria|0|||
16167483|NCT01916980|39091512|FG000|Overall Study|Withdrawal by Subject|1|||
16167484|NCT01916980|39091513|FG001|Overall Study|Withdrawal by Subject|0|||
16167485|NCT00655928|39091522|FG000|Overall Study|Withdrawal by Subject|2|||
16167486|NCT00655928|39091523|FG001|Overall Study|Withdrawal by Subject|1|||
16167487|NCT00655928|39091522|FG000|Overall Study|Physician Decision|1|||
16459484|NCT00966875|40161927|FG000|Part A|Lack of Efficacy|0|||
16459485|NCT00966875|40161928|FG001|Part A|Lack of Efficacy|1|||
16459486|NCT00966875|40161929|FG002|Part A|Lack of Efficacy|0|||
16459487|NCT00966875|40161930|FG003|Part A|Lack of Efficacy|0|||
16459488|NCT00966875|40161931|FG004|Part A|Lack of Efficacy|0|||
16459489|NCT00966875|40161932|FG005|Part A|Lack of Efficacy|0|||
16459490|NCT00966875|40161933|FG006|Part A|Lack of Efficacy|4|||
16459491|NCT00966875|40161934|FG007|Part A|Lack of Efficacy|0|||
16459492|NCT00966875|40161935|FG008|Part A|Lack of Efficacy|0|||
16459493|NCT00966875|40161927|FG000|Part A|Lost to Follow-up|2|||
16459494|NCT00966875|40161928|FG001|Part A|Lost to Follow-up|0|||
16459495|NCT00966875|40161929|FG002|Part A|Lost to Follow-up|0|||
16167488|NCT00655928|39091523|FG001|Overall Study|Physician Decision|1|||
16167489|NCT02971202|39091526|FG000|Overall Study|Pregnancy|1|||
16167490|NCT02971202|39091527|FG001|Overall Study|Pregnancy|0|||
16167491|NCT02971202|39091528|FG002|Overall Study|Pregnancy|0|||
16167492|NCT02971202|39091526|FG000|Overall Study|screen fail after consent|1|||
16167493|NCT02971202|39091527|FG001|Overall Study|screen fail after consent|0|||
16167494|NCT02971202|39091528|FG002|Overall Study|screen fail after consent|1|||
16459496|NCT00966875|40161930|FG003|Part A|Lost to Follow-up|0|||
16459497|NCT00966875|40161931|FG004|Part A|Lost to Follow-up|0|||
16459498|NCT00966875|40161932|FG005|Part A|Lost to Follow-up|1|||
16459499|NCT00966875|40161933|FG006|Part A|Lost to Follow-up|0|||
16167495|NCT01116544|39091531|FG000|Overall Study|Protocol Violation|1|||
16459500|NCT00966875|40161934|FG007|Part A|Lost to Follow-up|0|||
16459501|NCT00966875|40161935|FG008|Part A|Lost to Follow-up|0|||
16459502|NCT00966875|40161927|FG000|Part A|Parent/Caregiver Decision|0|||
16459503|NCT00966875|40161928|FG001|Part A|Parent/Caregiver Decision|0|||
16459504|NCT00966875|40161929|FG002|Part A|Parent/Caregiver Decision|0|||
16459505|NCT00966875|40161930|FG003|Part A|Parent/Caregiver Decision|1|||
16459506|NCT00966875|40161931|FG004|Part A|Parent/Caregiver Decision|0|||
16167496|NCT01116544|39091532|FG001|Overall Study|Protocol Violation|0|||
16167497|NCT01116544|39091531|FG000|Overall Study|Withdrawal by Subject|1|||
16167498|NCT01116544|39091532|FG001|Overall Study|Withdrawal by Subject|1|||
16167499|NCT01988090|39091533|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
16167500|NCT01988090|39091534|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
16167501|NCT01988090|39091533|FG000|Start Treament After Randomization|Protocol Violation|0|||
16167502|NCT01988090|39091534|FG001|Start Treament After Randomization|Protocol Violation|1|||
16167503|NCT01988090|39091533|FG000|Complete Study After Start|Withdrawal by Subject|2|||
16167504|NCT01988090|39091534|FG001|Complete Study After Start|Withdrawal by Subject|0|||
16167505|NCT01988090|39091533|FG000|Complete Study After Start|Protocol Violation|1|||
16167506|NCT01988090|39091534|FG001|Complete Study After Start|Protocol Violation|1|||
16167507|NCT03472560|39091536|FG000|Overall Study|Subject transfer to continuation protocol|0|||
16459507|NCT00966875|40161932|FG005|Part A|Parent/Caregiver Decision|0|||
16459508|NCT00966875|40161933|FG006|Part A|Parent/Caregiver Decision|0|||
16459509|NCT00966875|40161934|FG007|Part A|Parent/Caregiver Decision|0|||
16167508|NCT03472560|39091537|FG001|Overall Study|Subject transfer to continuation protocol|1|||
16459510|NCT00966875|40161935|FG008|Part A|Parent/Caregiver Decision|0|||
16459511|NCT00966875|40161927|FG000|Part A|Physician Decision|0|||
16459512|NCT00966875|40161928|FG001|Part A|Physician Decision|0|||
16459513|NCT00966875|40161929|FG002|Part A|Physician Decision|0|||
16459514|NCT00966875|40161930|FG003|Part A|Physician Decision|0|||
16459515|NCT00966875|40161931|FG004|Part A|Physician Decision|1|||
16459516|NCT00966875|40161932|FG005|Part A|Physician Decision|0|||
16167509|NCT03472560|39091536|FG000|Overall Study|Withdrawal by Subject|4|||
16167510|NCT03472560|39091537|FG001|Overall Study|Withdrawal by Subject|0|||
16167511|NCT03472560|39091536|FG000|Overall Study|Progressive disease|24|||
16167512|NCT03472560|39091537|FG001|Overall Study|Progressive disease|8|||
16167513|NCT03472560|39091536|FG000|Overall Study|Physician Decision|1|||
16167514|NCT03472560|39091537|FG001|Overall Study|Physician Decision|0|||
16167515|NCT03472560|39091536|FG000|Overall Study|Death|7|||
16167516|NCT03472560|39091537|FG001|Overall Study|Death|4|||
16167517|NCT03472560|39091536|FG000|Overall Study|Adverse Event|5|||
16167518|NCT03472560|39091537|FG001|Overall Study|Adverse Event|3|||
16167519|NCT03472560|39091536|FG000|Overall Study|Global deterioration of health status|0|||
16167520|NCT03472560|39091537|FG001|Overall Study|Global deterioration of health status|4|||
16167521|NCT03308188|39091538|FG000|Overall Study|Withdrawal by Subject|0|||
16167522|NCT03308188|39091539|FG001|Overall Study|Withdrawal by Subject|3|||
16167523|NCT03308188|39091538|FG000|Overall Study|Death|0|||
16167524|NCT03308188|39091539|FG001|Overall Study|Death|1|||
16167525|NCT02546986|39091540|FG000|Treatment Period|Progressive Disease|20|||
16167526|NCT02546986|39091541|FG001|Treatment Period|Progressive Disease|22|||
16167527|NCT02546986|39091540|FG000|Treatment Period|Adverse Event|14|||
16167528|NCT02546986|39091541|FG001|Treatment Period|Adverse Event|6|||
16459517|NCT00966875|40161933|FG006|Part A|Physician Decision|1|||
16459518|NCT00966875|40161934|FG007|Part A|Physician Decision|0|||
16459519|NCT00966875|40161935|FG008|Part A|Physician Decision|2|||
16459520|NCT00966875|40161927|FG000|Part A|Sponsor Decision|0|||
16459521|NCT00966875|40161928|FG001|Part A|Sponsor Decision|0|||
16459522|NCT00966875|40161929|FG002|Part A|Sponsor Decision|1|||
16459523|NCT00966875|40161930|FG003|Part A|Sponsor Decision|0|||
16459524|NCT00966875|40161931|FG004|Part A|Sponsor Decision|1|||
16459525|NCT00966875|40161932|FG005|Part A|Sponsor Decision|0|||
16167529|NCT02546986|39091540|FG000|Treatment Period|Symptomatic Deterioration|4|||
16167530|NCT02546986|39091541|FG001|Treatment Period|Symptomatic Deterioration|3|||
16167531|NCT02546986|39091540|FG000|Treatment Period|Death|3|||
16167532|NCT02546986|39091541|FG001|Treatment Period|Death|4|||
16459526|NCT00966875|40161933|FG006|Part A|Sponsor Decision|0|||
16459527|NCT00966875|40161934|FG007|Part A|Sponsor Decision|2|||
16459528|NCT00966875|40161935|FG008|Part A|Sponsor Decision|1|||
16459529|NCT00966875|40161927|FG000|Part A|Withdrawal by Subject|2|||
16072701|NCT01959412|38759141|FG003|Overall Study|Protocol deviation|1|||
16167533|NCT02546986|39091540|FG000|Treatment Period|Physician Decision|1|||
16167534|NCT02546986|39091541|FG001|Treatment Period|Physician Decision|2|||
16167535|NCT02546986|39091540|FG000|Treatment Period|Protocol Violation|1|||
16167536|NCT02546986|39091541|FG001|Treatment Period|Protocol Violation|0|||
16459530|NCT00966875|40161928|FG001|Part A|Withdrawal by Subject|2|||
16459531|NCT00966875|40161929|FG002|Part A|Withdrawal by Subject|1|||
16459532|NCT00966875|40161930|FG003|Part A|Withdrawal by Subject|1|||
16459533|NCT00966875|40161931|FG004|Part A|Withdrawal by Subject|3|||
16459534|NCT00966875|40161932|FG005|Part A|Withdrawal by Subject|0|||
16459535|NCT00966875|40161933|FG006|Part A|Withdrawal by Subject|5|||
16167537|NCT02546986|39091540|FG000|Treatment Period|Withdrawal by Subject|1|||
16167538|NCT02546986|39091541|FG001|Treatment Period|Withdrawal by Subject|1|||
16167539|NCT02546986|39091540|FG000|Treatment Period|Non-compliance with Study Drug|0|||
16167540|NCT02546986|39091541|FG001|Treatment Period|Non-compliance with Study Drug|1|||
16167541|NCT02546986|39091540|FG000|Treatment Period|Study Terminated by Sponsor|0|||
16167542|NCT02546986|39091541|FG001|Treatment Period|Study Terminated by Sponsor|1|||
16167543|NCT02546986|39091540|FG000|Treatment Period|Miscellaneous|7|||
16167544|NCT02546986|39091541|FG001|Treatment Period|Miscellaneous|9|||
16167545|NCT02546986|39091540|FG000|Survival Follow-Up Phase|Missing Status|3|||
16167546|NCT02546986|39091541|FG001|Survival Follow-Up Phase|Missing Status|5|||
16167547|NCT02546986|39091540|FG000|Survival Follow-Up Phase|Death|18|||
16167548|NCT02546986|39091541|FG001|Survival Follow-Up Phase|Death|12|||
16167549|NCT02546986|39091540|FG000|Survival Follow-Up Phase|Alive|13|||
16167550|NCT02546986|39091541|FG001|Survival Follow-Up Phase|Alive|16|||
16167551|NCT02546986|39091540|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
16167552|NCT02546986|39091541|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
16167553|NCT01468987|39091542|FG000|Overall Study|Adverse Event|12|||
16167554|NCT01468987|39091543|FG001|Overall Study|Adverse Event|9|||
16167555|NCT01468987|39091542|FG000|Overall Study|Death|4|||
16167556|NCT01468987|39091543|FG001|Overall Study|Death|1|||
16167557|NCT01468987|39091542|FG000|Overall Study|Lost to Follow-up|10|||
16167558|NCT01468987|39091543|FG001|Overall Study|Lost to Follow-up|5|||
16167559|NCT01468987|39091542|FG000|Overall Study|Protocol Violation|8|||
16167560|NCT01468987|39091543|FG001|Overall Study|Protocol Violation|2|||
16167561|NCT01468987|39091542|FG000|Overall Study|Withdrawal by Subject|28|||
16167562|NCT01468987|39091543|FG001|Overall Study|Withdrawal by Subject|28|||
16167563|NCT01468987|39091542|FG000|Overall Study|Physician Decision|8|||
16459536|NCT00966875|40161934|FG007|Part A|Withdrawal by Subject|1|||
16459537|NCT00966875|40161935|FG008|Part A|Withdrawal by Subject|1|||
16459538|NCT00966875|40161927|FG000|Part A|Protocol Violation|0|||
16459539|NCT00966875|40161928|FG001|Part A|Protocol Violation|0|||
16459540|NCT00966875|40161929|FG002|Part A|Protocol Violation|0|||
16459541|NCT00966875|40161930|FG003|Part A|Protocol Violation|0|||
16459542|NCT00966875|40161931|FG004|Part A|Protocol Violation|0|||
16459543|NCT00966875|40161932|FG005|Part A|Protocol Violation|0|||
16459544|NCT00966875|40161933|FG006|Part A|Protocol Violation|2|||
16459545|NCT00966875|40161934|FG007|Part A|Protocol Violation|1|||
16459546|NCT00966875|40161935|FG008|Part A|Protocol Violation|1|||
16459547|NCT00966875|40161927|FG000|Part B|Adverse Event|0|||
16459548|NCT00966875|40161928|FG001|Part B|Adverse Event|1|||
16167564|NCT01468987|39091543|FG001|Overall Study|Physician Decision|15|||
16167565|NCT01468987|39091542|FG000|Overall Study|Sponsor Decision|1|||
16167566|NCT01468987|39091543|FG001|Overall Study|Sponsor Decision|0|||
16167567|NCT01728779|39091550|FG000|Overall Study|Withdrawal by Subject|1|||
16167568|NCT00330187|39091551|FG000|Overall Study|Lost to Follow-up|12|||
16167569|NCT00330187|39091552|FG001|Overall Study|Lost to Follow-up|13|||
16167570|NCT00330187|39091553|FG002|Overall Study|Lost to Follow-up|14|||
16167571|NCT00330187|39091554|FG003|Overall Study|Lost to Follow-up|10|||
16167572|NCT00330187|39091551|FG000|Overall Study|Withdrawal by Subject|8|||
16167573|NCT00330187|39091552|FG001|Overall Study|Withdrawal by Subject|5|||
16459549|NCT00966875|40161929|FG002|Part B|Adverse Event|1|||
16459550|NCT00966875|40161930|FG003|Part B|Adverse Event|0|||
16459551|NCT00966875|40161931|FG004|Part B|Adverse Event|1|||
16459552|NCT00966875|40161932|FG005|Part B|Adverse Event|0|||
16459553|NCT00966875|40161933|FG006|Part B|Adverse Event|5|||
16459554|NCT00966875|40161934|FG007|Part B|Adverse Event|2|||
16459555|NCT00966875|40161935|FG008|Part B|Adverse Event|2|||
16459556|NCT00966875|40161927|FG000|Part B|Death|0|||
16459557|NCT00966875|40161928|FG001|Part B|Death|0|||
16459558|NCT00966875|40161929|FG002|Part B|Death|1|||
16459559|NCT00966875|40161930|FG003|Part B|Death|0|||
16459560|NCT00966875|40161931|FG004|Part B|Death|0|||
16459561|NCT00966875|40161932|FG005|Part B|Death|0|||
16459562|NCT00966875|40161933|FG006|Part B|Death|0|||
16459563|NCT00966875|40161934|FG007|Part B|Death|1|||
16459564|NCT00966875|40161935|FG008|Part B|Death|0|||
16459565|NCT00966875|40161927|FG000|Part B|Lack of Efficacy|2|||
16459566|NCT00966875|40161928|FG001|Part B|Lack of Efficacy|1|||
16167574|NCT00330187|39091553|FG002|Overall Study|Withdrawal by Subject|4|||
16269220|NCT00795821|39471042|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
16167575|NCT00330187|39091554|FG003|Overall Study|Withdrawal by Subject|4|||
16167576|NCT02848833|39091557|FG000|Overall Study|subject who are duplicated|1|||
16167577|NCT02848833|39091557|FG000|Overall Study|have not taken the study drug|11|||
16167578|NCT02848833|39091557|FG000|Overall Study|follow-up failure|6|||
16167579|NCT02848833|39091557|FG000|Overall Study|Protocol Violation|119|||
16167580|NCT04439279|39091558|FG000|Overall Study|Adverse Event|7|||
16459567|NCT00966875|40161929|FG002|Part B|Lack of Efficacy|1|||
16459568|NCT00966875|40161930|FG003|Part B|Lack of Efficacy|1|||
16459569|NCT00966875|40161931|FG004|Part B|Lack of Efficacy|2|||
16459570|NCT00966875|40161932|FG005|Part B|Lack of Efficacy|3|||
16459571|NCT00966875|40161933|FG006|Part B|Lack of Efficacy|12|||
16459572|NCT00966875|40161934|FG007|Part B|Lack of Efficacy|9|||
16459573|NCT00966875|40161935|FG008|Part B|Lack of Efficacy|6|||
16459574|NCT00966875|40161927|FG000|Part B|Lost to Follow-up|0|||
16459575|NCT00966875|40161928|FG001|Part B|Lost to Follow-up|0|||
16459576|NCT00966875|40161929|FG002|Part B|Lost to Follow-up|0|||
16459577|NCT00966875|40161930|FG003|Part B|Lost to Follow-up|1|||
16459578|NCT00966875|40161931|FG004|Part B|Lost to Follow-up|0|||
16459579|NCT00966875|40161932|FG005|Part B|Lost to Follow-up|0|||
16459580|NCT00966875|40161933|FG006|Part B|Lost to Follow-up|0|||
16459581|NCT00966875|40161934|FG007|Part B|Lost to Follow-up|0|||
16459582|NCT00966875|40161935|FG008|Part B|Lost to Follow-up|1|||
16459583|NCT00966875|40161927|FG000|Part B|Physician Decision|0|||
16459584|NCT00966875|40161928|FG001|Part B|Physician Decision|0|||
16459585|NCT00966875|40161929|FG002|Part B|Physician Decision|1|||
16459586|NCT00966875|40161930|FG003|Part B|Physician Decision|0|||
16459587|NCT00966875|40161931|FG004|Part B|Physician Decision|2|||
16459588|NCT00966875|40161932|FG005|Part B|Physician Decision|1|||
16459589|NCT00966875|40161933|FG006|Part B|Physician Decision|0|||
16459590|NCT00966875|40161934|FG007|Part B|Physician Decision|0|||
16459591|NCT00966875|40161935|FG008|Part B|Physician Decision|2|||
16459592|NCT00966875|40161927|FG000|Part B|Sponsor Decision|1|||
16459593|NCT00966875|40161928|FG001|Part B|Sponsor Decision|0|||
16459594|NCT00966875|40161929|FG002|Part B|Sponsor Decision|0|||
16459595|NCT00966875|40161930|FG003|Part B|Sponsor Decision|0|||
16459596|NCT00966875|40161931|FG004|Part B|Sponsor Decision|0|||
16459597|NCT00966875|40161932|FG005|Part B|Sponsor Decision|1|||
16459598|NCT00966875|40161933|FG006|Part B|Sponsor Decision|0|||
16459599|NCT00966875|40161934|FG007|Part B|Sponsor Decision|2|||
16459600|NCT00966875|40161935|FG008|Part B|Sponsor Decision|1|||
16459601|NCT00966875|40161927|FG000|Part B|Withdrawal by Subject|2|||
16459602|NCT00966875|40161928|FG001|Part B|Withdrawal by Subject|1|||
16459603|NCT00966875|40161929|FG002|Part B|Withdrawal by Subject|2|||
16459604|NCT00966875|40161930|FG003|Part B|Withdrawal by Subject|1|||
16459605|NCT00966875|40161931|FG004|Part B|Withdrawal by Subject|2|||
16459606|NCT00966875|40161932|FG005|Part B|Withdrawal by Subject|1|||
16459607|NCT00966875|40161933|FG006|Part B|Withdrawal by Subject|4|||
16459608|NCT00966875|40161934|FG007|Part B|Withdrawal by Subject|5|||
16459609|NCT00966875|40161935|FG008|Part B|Withdrawal by Subject|5|||
16459610|NCT00966875|40161927|FG000|Part B|Entry Criteria|0|||
16459611|NCT00966875|40161928|FG001|Part B|Entry Criteria|0|||
16459612|NCT00966875|40161929|FG002|Part B|Entry Criteria|0|||
16459613|NCT00966875|40161930|FG003|Part B|Entry Criteria|0|||
16459614|NCT00966875|40161931|FG004|Part B|Entry Criteria|0|||
16459615|NCT00966875|40161932|FG005|Part B|Entry Criteria|0|||
16459616|NCT00966875|40161933|FG006|Part B|Entry Criteria|1|||
16459617|NCT00966875|40161934|FG007|Part B|Entry Criteria|0|||
16459618|NCT00966875|40161935|FG008|Part B|Entry Criteria|1|||
16459619|NCT02241889|40161940|FG000|Overall Study|device issues|0|||
16459620|NCT02241889|40161941|FG001|Overall Study|device issues|0|||
16459621|NCT02241889|40161942|FG002|Overall Study|device issues|1|||
16459622|NCT02241889|40161943|FG003|Overall Study|device issues|0|||
16459623|NCT02241889|40161944|FG004|Overall Study|device issues|0|||
16459624|NCT02241889|40161945|FG005|Overall Study|device issues|0|||
16459625|NCT02241889|40161940|FG000|Overall Study|Withdrawal by Subject|0|||
16459626|NCT02241889|40161941|FG001|Overall Study|Withdrawal by Subject|0|||
16459627|NCT02241889|40161942|FG002|Overall Study|Withdrawal by Subject|0|||
16459628|NCT02241889|40161943|FG003|Overall Study|Withdrawal by Subject|0|||
16459629|NCT02241889|40161944|FG004|Overall Study|Withdrawal by Subject|0|||
16459630|NCT02241889|40161945|FG005|Overall Study|Withdrawal by Subject|1|||
16459631|NCT00065429|40161949|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
16459632|NCT00065429|40161950|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
16459633|NCT00065429|40161951|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
16459634|NCT00065429|40161952|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
16459635|NCT00065429|40161953|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
16459636|NCT00065429|40161954|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
16459637|NCT00065429|40161955|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
16167581|NCT04439279|39091558|FG000|Overall Study|Death|4|||
16459638|NCT00065429|40161949|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
16167582|NCT04439279|39091558|FG000|Overall Study|Disease progression|17|||
16167583|NCT04439279|39091558|FG000|Overall Study|Complicating disease|3|||
16459639|NCT00065429|40161950|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
16459640|NCT00065429|40161951|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
16459641|NCT00065429|40161952|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
16459642|NCT00065429|40161953|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
16459643|NCT00065429|40161954|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
16459644|NCT00065429|40161955|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
16459645|NCT00065429|40161949|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
16459646|NCT00065429|40161950|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
16459647|NCT00065429|40161951|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
16459648|NCT00065429|40161952|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
16459649|NCT00065429|40161953|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
16459650|NCT00065429|40161954|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
16459651|NCT00065429|40161955|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
16459652|NCT00065429|40161949|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
16459653|NCT00065429|40161950|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
16459654|NCT00065429|40161951|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
16459655|NCT00065429|40161952|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
16459656|NCT00065429|40161953|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
16459657|NCT00065429|40161954|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
16459658|NCT00065429|40161955|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
16459659|NCT00065429|40161949|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
16459660|NCT00065429|40161950|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
16459661|NCT00065429|40161951|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
16167584|NCT04439279|39091558|FG000|Overall Study|Withdrawal by Subject|2|||
16459662|NCT00065429|40161952|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
16459663|NCT00065429|40161953|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
16459664|NCT00065429|40161954|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
16459665|NCT00065429|40161955|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
16459666|NCT00065429|40161949|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
16459667|NCT00065429|40161950|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
16459668|NCT00065429|40161951|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
16459669|NCT00065429|40161952|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
16459670|NCT00065429|40161953|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
16459671|NCT00065429|40161954|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
16459672|NCT00065429|40161955|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
16459673|NCT00065429|40161949|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
16459674|NCT00065429|40161950|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
16459675|NCT00065429|40161951|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
16459676|NCT00065429|40161952|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
16459677|NCT00065429|40161953|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
16459678|NCT00065429|40161954|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
16459679|NCT00065429|40161955|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
16459680|NCT01008423|40161956|FG000|Overall Study|Adverse Event|13|||
16459681|NCT01008423|40161957|FG001|Overall Study|Adverse Event|6|||
16459682|NCT01008423|40161956|FG000|Overall Study|Withdrawal by Subject|4|||
16459683|NCT01008423|40161957|FG001|Overall Study|Withdrawal by Subject|7|||
16459684|NCT01008423|40161956|FG000|Overall Study|Lost to Follow-up|0|||
16459685|NCT01008423|40161957|FG001|Overall Study|Lost to Follow-up|2|||
16459686|NCT01008423|40161956|FG000|Overall Study|Low Cortisol|0|||
16459687|NCT01008423|40161957|FG001|Overall Study|Low Cortisol|1|||
16459688|NCT01008423|40161956|FG000|Overall Study|Lack of Efficacy|0|||
16459689|NCT01008423|40161957|FG001|Overall Study|Lack of Efficacy|5|||
16459690|NCT01008423|40161956|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
16459691|NCT01008423|40161957|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
16459692|NCT01008423|40161956|FG000|Overall Study|Personal Conflict|1|||
16459693|NCT01008423|40161957|FG001|Overall Study|Personal Conflict|0|||
16459694|NCT01008423|40161956|FG000|Overall Study|Other|0|||
16459695|NCT01008423|40161957|FG001|Overall Study|Other|1|||
16459696|NCT01451437|40161964|FG000|Overall Study|Adverse Event|0|||
16167585|NCT04439279|39091558|FG000|Overall Study|Ineligible|1|||
16459697|NCT01451437|40161965|FG001|Overall Study|Adverse Event|0|||
16459698|NCT01451437|40161966|FG002|Overall Study|Adverse Event|0|||
16459699|NCT01451437|40161967|FG003|Overall Study|Adverse Event|0|||
16459700|NCT01451437|40161968|FG004|Overall Study|Adverse Event|0|||
16459701|NCT01451437|40161969|FG005|Overall Study|Adverse Event|1|||
16459702|NCT01451437|40161970|FG006|Overall Study|Adverse Event|1|||
16459703|NCT01451437|40161971|FG007|Overall Study|Adverse Event|2|||
16459704|NCT01451437|40161972|FG008|Overall Study|Adverse Event|1|||
16459705|NCT01451437|40161964|FG000|Overall Study|Physician Decision|1|||
16459706|NCT01451437|40161965|FG001|Overall Study|Physician Decision|1|||
16459707|NCT01451437|40161966|FG002|Overall Study|Physician Decision|2|||
16459708|NCT01451437|40161967|FG003|Overall Study|Physician Decision|0|||
16459709|NCT01451437|40161968|FG004|Overall Study|Physician Decision|0|||
16459710|NCT01451437|40161969|FG005|Overall Study|Physician Decision|0|||
16459711|NCT01451437|40161970|FG006|Overall Study|Physician Decision|0|||
16459712|NCT01451437|40161971|FG007|Overall Study|Physician Decision|0|||
16459713|NCT01451437|40161972|FG008|Overall Study|Physician Decision|0|||
16459714|NCT01451437|40161964|FG000|Overall Study|Disease Progression|0|||
16459715|NCT01451437|40161965|FG001|Overall Study|Disease Progression|0|||
16459716|NCT01451437|40161966|FG002|Overall Study|Disease Progression|1|||
16459717|NCT01451437|40161967|FG003|Overall Study|Disease Progression|1|||
16459718|NCT01451437|40161968|FG004|Overall Study|Disease Progression|3|||
16459719|NCT01451437|40161969|FG005|Overall Study|Disease Progression|2|||
16167586|NCT04439279|39091558|FG000|Overall Study|Treatment still ongoing|1|||
16459720|NCT01451437|40161970|FG006|Overall Study|Disease Progression|3|||
16459721|NCT01451437|40161971|FG007|Overall Study|Disease Progression|1|||
16459722|NCT01451437|40161972|FG008|Overall Study|Disease Progression|3|||
16459723|NCT01451437|40161964|FG000|Overall Study|Protocol Violation|0|||
16459724|NCT01451437|40161965|FG001|Overall Study|Protocol Violation|0|||
16459725|NCT01451437|40161966|FG002|Overall Study|Protocol Violation|0|||
16459726|NCT01451437|40161967|FG003|Overall Study|Protocol Violation|0|||
16459727|NCT01451437|40161968|FG004|Overall Study|Protocol Violation|0|||
16459728|NCT01451437|40161969|FG005|Overall Study|Protocol Violation|0|||
16459729|NCT01451437|40161970|FG006|Overall Study|Protocol Violation|1|||
16459730|NCT01451437|40161971|FG007|Overall Study|Protocol Violation|0|||
16459731|NCT01451437|40161972|FG008|Overall Study|Protocol Violation|0|||
16459732|NCT01451437|40161964|FG000|Overall Study|Withdrawal by Subject|0|||
16459733|NCT01451437|40161965|FG001|Overall Study|Withdrawal by Subject|0|||
16459734|NCT01451437|40161966|FG002|Overall Study|Withdrawal by Subject|0|||
16459735|NCT01451437|40161967|FG003|Overall Study|Withdrawal by Subject|0|||
16459736|NCT01451437|40161968|FG004|Overall Study|Withdrawal by Subject|1|||
16459737|NCT01451437|40161969|FG005|Overall Study|Withdrawal by Subject|0|||
16459738|NCT01451437|40161970|FG006|Overall Study|Withdrawal by Subject|1|||
16459739|NCT01451437|40161971|FG007|Overall Study|Withdrawal by Subject|0|||
16459740|NCT01451437|40161972|FG008|Overall Study|Withdrawal by Subject|0|||
16459741|NCT02954172|40161978|FG000|Overall Study|Protocol Violation|3|||
16459742|NCT02954172|40161979|FG001|Overall Study|Protocol Violation|0|||
16459743|NCT02954172|40161978|FG000|Overall Study|allergic reaction|2|||
16459744|NCT02954172|40161979|FG001|Overall Study|allergic reaction|1|||
16459745|NCT02954172|40161978|FG000|Overall Study|non-measurable lesions at baseline|1|||
16459746|NCT02954172|40161979|FG001|Overall Study|non-measurable lesions at baseline|2|||
16459747|NCT02051933|40161980|FG000|Overall Study|Physician Decision|0|||
16459748|NCT02051933|40161981|FG001|Overall Study|Physician Decision|1|||
16459749|NCT00109590|40161982|FG000|Overall Study|Lost to Follow-up|1|||
16459750|NCT00109590|40161983|FG001|Overall Study|Lost to Follow-up|0|||
16459751|NCT00109590|40161984|FG002|Overall Study|Lost to Follow-up|1|||
16459752|NCT00109590|40161982|FG000|Overall Study|Never Started Treatment|1|||
16459753|NCT00109590|40161983|FG001|Overall Study|Never Started Treatment|2|||
16459754|NCT00109590|40161984|FG002|Overall Study|Never Started Treatment|3|||
16459755|NCT02674204|40161985|FG000|Overall Study|Adverse Event|1|||
16459756|NCT02674204|40161986|FG001|Overall Study|Adverse Event|0|||
16459757|NCT00796523|40161987|FG000|Overall Study|Lost to Follow-up|9|||
16459758|NCT00796523|40161988|FG001|Overall Study|Lost to Follow-up|7|||
16459759|NCT00905645|40161989|FG000|Overall Study|Death (not device related)|10|||
16459760|NCT00905645|40161990|FG001|Overall Study|Death (not device related)|4|||
16459761|NCT00905645|40161991|FG002|Overall Study|Death (not device related)|15|||
16459762|NCT00905645|40161992|FG003|Overall Study|Death (not device related)|8|||
16459763|NCT00905645|40161989|FG000|Overall Study|Explantation of study device(s)|78|||
16459764|NCT00905645|40161990|FG001|Overall Study|Explantation of study device(s)|47|||
16459765|NCT00905645|40161991|FG002|Overall Study|Explantation of study device(s)|28|||
16459766|NCT00905645|40161992|FG003|Overall Study|Explantation of study device(s)|21|||
16459767|NCT00905645|40161989|FG000|Overall Study|Subject Request|41|||
16459768|NCT00905645|40161990|FG001|Overall Study|Subject Request|17|||
16459769|NCT00905645|40161991|FG002|Overall Study|Subject Request|13|||
16459770|NCT00905645|40161992|FG003|Overall Study|Subject Request|11|||
16459771|NCT00905645|40161989|FG000|Overall Study|Lost to Follow-up|299|||
16459772|NCT00905645|40161990|FG001|Overall Study|Lost to Follow-up|103|||
16459773|NCT00905645|40161991|FG002|Overall Study|Lost to Follow-up|51|||
16459774|NCT00905645|40161992|FG003|Overall Study|Lost to Follow-up|12|||
16459775|NCT02891070|40161996|FG000|Overall Study|Adverse Event|1|||
16459776|NCT02891070|40161997|FG001|Overall Study|Adverse Event|0|||
16459777|NCT02891070|40161996|FG000|Overall Study|Physician Decision|0|||
16459778|NCT02891070|40161997|FG001|Overall Study|Physician Decision|1|||
16459779|NCT02891070|40161996|FG000|Overall Study|Lost to Follow-up|4|||
16459780|NCT02891070|40161997|FG001|Overall Study|Lost to Follow-up|4|||
16459781|NCT02891070|40161996|FG000|Overall Study|Other|1|||
16459782|NCT02891070|40161997|FG001|Overall Study|Other|0|||
16459783|NCT02891070|40161996|FG000|Overall Study|Protocol Violation|0|||
16459784|NCT02891070|40161997|FG001|Overall Study|Protocol Violation|1|||
16459785|NCT02891070|40161996|FG000|Overall Study|Withdrawal by Subject|1|||
16459786|NCT02891070|40161997|FG001|Overall Study|Withdrawal by Subject|2|||
16459787|NCT02891070|40161996|FG000|Overall Study|Death|3|||
16459788|NCT02891070|40161997|FG001|Overall Study|Death|0|||
16459789|NCT02343549|40162005|FG000|Overall Study|Death|11|||
16459790|NCT02343549|40162005|FG000|Overall Study|Withdrawal by Subject|2|||
16459791|NCT04345367|40162016|FG000|Overall Study|Other|3|||
16459792|NCT04345367|40162017|FG001|Overall Study|Other|4|||
16459793|NCT04345367|40162016|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
16459794|NCT04345367|40162017|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
16459795|NCT04345367|40162016|FG000|Overall Study|Withdrawal by Subject|11|||
16459796|NCT04345367|40162017|FG001|Overall Study|Withdrawal by Subject|11|||
16459797|NCT04345367|40162016|FG000|Overall Study|Protocol Violation|4|||
16459798|NCT04345367|40162017|FG001|Overall Study|Protocol Violation|3|||
16459799|NCT04345367|40162016|FG000|Overall Study|Lost to Follow-up|2|||
16459800|NCT04345367|40162017|FG001|Overall Study|Lost to Follow-up|4|||
16459801|NCT04345367|40162016|FG000|Overall Study|Lack of Efficacy|2|||
16459802|NCT04345367|40162017|FG001|Overall Study|Lack of Efficacy|0|||
16459803|NCT04345367|40162016|FG000|Overall Study|Death|2|||
16459804|NCT04345367|40162017|FG001|Overall Study|Death|0|||
16459805|NCT04345367|40162016|FG000|Overall Study|Adverse Event|10|||
16459806|NCT04345367|40162017|FG001|Overall Study|Adverse Event|9|||
16459807|NCT01536392|40162018|FG000|Overall Study|Adverse Event|2|||
16459808|NCT01536392|40162019|FG001|Overall Study|Adverse Event|2|||
16459809|NCT01536392|40162018|FG000|Overall Study|Physician Decision|2|||
16459810|NCT01536392|40162019|FG001|Overall Study|Physician Decision|3|||
16459811|NCT01536392|40162018|FG000|Overall Study|Withdrawal by Subject|3|||
16459812|NCT01536392|40162019|FG001|Overall Study|Withdrawal by Subject|6|||
16459813|NCT01536392|40162018|FG000|Overall Study|Non Compliance|3|||
16459814|NCT01536392|40162019|FG001|Overall Study|Non Compliance|4|||
16459815|NCT01536392|40162018|FG000|Overall Study|Completed therapy early|3|||
16459816|NCT01536392|40162019|FG001|Overall Study|Completed therapy early|0|||
16459817|NCT00344487|40162022|FG000|Overall Study|immunologic failure|1|||
16459818|NCT01168219|40162025|FG000|Overall Study|off study before starting treatment|2|||
16459819|NCT01168219|40162025|FG000|Overall Study|withdrew before transplant|1|||
16459820|NCT01168219|40162025|FG000|Overall Study|ineligible due to CML|2|||
16459821|NCT01349049|40162026|FG000|Overall Study|Disease progression|3|||
16459822|NCT01349049|40162027|FG001|Overall Study|Disease progression|5|||
16459823|NCT01349049|40162028|FG002|Overall Study|Disease progression|3|||
16459824|NCT01349049|40162029|FG003|Overall Study|Disease progression|2|||
16459825|NCT01349049|40162030|FG004|Overall Study|Disease progression|2|||
16459826|NCT01349049|40162031|FG005|Overall Study|Disease progression|2|||
16459827|NCT01349049|40162032|FG006|Overall Study|Disease progression|3|||
16167587|NCT04897867|39091559|FG000|Overall Study|Withdrawal of Consent|1|||
16167588|NCT04897867|39091559|FG000|Overall Study|Pregnancy|1|||
16167589|NCT04897867|39091559|FG000|Overall Study|Lost to Follow-up|7|||
16167590|NCT04897867|39091559|FG000|Overall Study|Reason not Specified|2|||
16167591|NCT02899156|39091560|FG000|Overall Study|Death|1|||
16167592|NCT02899156|39091561|FG001|Overall Study|Death|0|||
16167593|NCT02899156|39091560|FG000|Overall Study|Physician Decision|0|||
16167594|NCT02899156|39091561|FG001|Overall Study|Physician Decision|1|||
16167595|NCT03887130|39091566|FG000|Overall Study|Progressive disease|23|||
16167596|NCT03887130|39091567|FG001|Overall Study|Progressive disease|14|||
16167597|NCT03887130|39091568|FG002|Overall Study|Progressive disease|7|||
16167598|NCT03887130|39091566|FG000|Overall Study|Protocol Violation|3|||
16459828|NCT01349049|40162033|FG007|Overall Study|Disease progression|2|||
16459829|NCT01349049|40162034|FG008|Overall Study|Disease progression|33|||
16459830|NCT01349049|40162026|FG000|Overall Study|Adverse Event|0|||
16459831|NCT01349049|40162027|FG001|Overall Study|Adverse Event|1|||
16459832|NCT01349049|40162028|FG002|Overall Study|Adverse Event|0|||
16459833|NCT01349049|40162029|FG003|Overall Study|Adverse Event|0|||
16459834|NCT01349049|40162030|FG004|Overall Study|Adverse Event|0|||
16459835|NCT01349049|40162031|FG005|Overall Study|Adverse Event|3|||
16459836|NCT01349049|40162032|FG006|Overall Study|Adverse Event|1|||
16459837|NCT01349049|40162033|FG007|Overall Study|Adverse Event|0|||
16459838|NCT01349049|40162034|FG008|Overall Study|Adverse Event|4|||
16167599|NCT03887130|39091567|FG001|Overall Study|Protocol Violation|1|||
16167600|NCT03887130|39091568|FG002|Overall Study|Protocol Violation|2|||
16459839|NCT01349049|40162026|FG000|Overall Study|Physician Decision|0|||
16459840|NCT01349049|40162027|FG001|Overall Study|Physician Decision|1|||
16459841|NCT01349049|40162028|FG002|Overall Study|Physician Decision|0|||
16459842|NCT01349049|40162029|FG003|Overall Study|Physician Decision|0|||
16459843|NCT01349049|40162030|FG004|Overall Study|Physician Decision|0|||
16459844|NCT01349049|40162031|FG005|Overall Study|Physician Decision|0|||
16459845|NCT01349049|40162032|FG006|Overall Study|Physician Decision|0|||
16459846|NCT01349049|40162033|FG007|Overall Study|Physician Decision|0|||
16459847|NCT01349049|40162034|FG008|Overall Study|Physician Decision|2|||
16459848|NCT01349049|40162026|FG000|Overall Study|Protocol Violation|0|||
16459849|NCT01349049|40162027|FG001|Overall Study|Protocol Violation|0|||
16459850|NCT01349049|40162028|FG002|Overall Study|Protocol Violation|0|||
16459851|NCT01349049|40162029|FG003|Overall Study|Protocol Violation|0|||
16459852|NCT01349049|40162030|FG004|Overall Study|Protocol Violation|0|||
16459853|NCT01349049|40162031|FG005|Overall Study|Protocol Violation|0|||
16459854|NCT01349049|40162032|FG006|Overall Study|Protocol Violation|0|||
16459855|NCT01349049|40162033|FG007|Overall Study|Protocol Violation|0|||
16459856|NCT01349049|40162034|FG008|Overall Study|Protocol Violation|1|||
16459857|NCT01349049|40162026|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
16459858|NCT01349049|40162027|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
16459859|NCT01349049|40162028|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
16459860|NCT01349049|40162029|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
16459861|NCT01349049|40162030|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
16459862|NCT01349049|40162031|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
16459863|NCT01349049|40162032|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
16459864|NCT01349049|40162033|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
16167601|NCT03887130|39091566|FG000|Overall Study|Drug related toxicity|7|||
16167602|NCT03887130|39091567|FG001|Overall Study|Drug related toxicity|7|||
16459865|NCT01349049|40162034|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
16459866|NCT01349049|40162026|FG000|Overall Study|Other|0|||
16459867|NCT01349049|40162027|FG001|Overall Study|Other|0|||
16459868|NCT01349049|40162028|FG002|Overall Study|Other|0|||
16459869|NCT01349049|40162029|FG003|Overall Study|Other|0|||
16459870|NCT01349049|40162030|FG004|Overall Study|Other|0|||
16459871|NCT01349049|40162031|FG005|Overall Study|Other|1|||
16459872|NCT01349049|40162032|FG006|Overall Study|Other|0|||
16459873|NCT01349049|40162033|FG007|Overall Study|Other|0|||
16459874|NCT01349049|40162034|FG008|Overall Study|Other|4|||
16459875|NCT01349049|40162026|FG000|Overall Study|Death|0|||
16459876|NCT01349049|40162027|FG001|Overall Study|Death|0|||
16459877|NCT01349049|40162028|FG002|Overall Study|Death|0|||
16459878|NCT01349049|40162029|FG003|Overall Study|Death|0|||
16459879|NCT01349049|40162030|FG004|Overall Study|Death|0|||
16459880|NCT01349049|40162031|FG005|Overall Study|Death|0|||
16459881|NCT01349049|40162032|FG006|Overall Study|Death|0|||
16459882|NCT01349049|40162033|FG007|Overall Study|Death|1|||
16459883|NCT01349049|40162034|FG008|Overall Study|Death|5|||
16459884|NCT01349049|40162026|FG000|Overall Study|Non-compliance|0|||
16459885|NCT01349049|40162027|FG001|Overall Study|Non-compliance|0|||
16459886|NCT01349049|40162028|FG002|Overall Study|Non-compliance|0|||
16459887|NCT01349049|40162029|FG003|Overall Study|Non-compliance|1|||
16459888|NCT01349049|40162030|FG004|Overall Study|Non-compliance|0|||
16459889|NCT01349049|40162031|FG005|Overall Study|Non-compliance|0|||
16459890|NCT01349049|40162032|FG006|Overall Study|Non-compliance|0|||
16459891|NCT01349049|40162033|FG007|Overall Study|Non-compliance|0|||
16459892|NCT01349049|40162034|FG008|Overall Study|Non-compliance|0|||
16459893|NCT01349049|40162026|FG000|Overall Study|Withdrawal by Subject|0|||
16459894|NCT01349049|40162027|FG001|Overall Study|Withdrawal by Subject|0|||
16459895|NCT01349049|40162028|FG002|Overall Study|Withdrawal by Subject|0|||
16459896|NCT01349049|40162029|FG003|Overall Study|Withdrawal by Subject|0|||
16459897|NCT01349049|40162030|FG004|Overall Study|Withdrawal by Subject|0|||
16459898|NCT01349049|40162031|FG005|Overall Study|Withdrawal by Subject|0|||
16459899|NCT01349049|40162032|FG006|Overall Study|Withdrawal by Subject|0|||
16459900|NCT01349049|40162033|FG007|Overall Study|Withdrawal by Subject|0|||
16459901|NCT01349049|40162034|FG008|Overall Study|Withdrawal by Subject|6|||
16459902|NCT00881868|40162035|FG000|Overall Study|Adverse Event|0|||
16459903|NCT00881868|40162036|FG001|Overall Study|Adverse Event|1|||
16459904|NCT00881868|40162035|FG000|Overall Study|Lost to Follow-up|2|||
16459905|NCT00881868|40162036|FG001|Overall Study|Lost to Follow-up|1|||
16459906|NCT00881868|40162035|FG000|Overall Study|Physician Decision|4|||
16459907|NCT00881868|40162036|FG001|Overall Study|Physician Decision|0|||
16459908|NCT00881868|40162035|FG000|Overall Study|Protocol Violation|2|||
16459909|NCT00881868|40162036|FG001|Overall Study|Protocol Violation|0|||
16459910|NCT01808092|40162037|FG000|Overall Study|Death|39|||
16459911|NCT01808092|40162038|FG001|Overall Study|Death|29|||
16459912|NCT01808092|40162037|FG000|Overall Study|Lost to Follow-up|3|||
16459913|NCT01808092|40162038|FG001|Overall Study|Lost to Follow-up|7|||
16459914|NCT01808092|40162037|FG000|Overall Study|Withdrawal by Subject|9|||
16459915|NCT01808092|40162038|FG001|Overall Study|Withdrawal by Subject|4|||
16459916|NCT01808092|40162037|FG000|Overall Study|Other Eligibility criteria|3|||
16459917|NCT01808092|40162038|FG001|Overall Study|Other Eligibility criteria|5|||
16459918|NCT00689117|40162039|FG000|Overall Study|Adverse Event|6|||
16459919|NCT00689117|40162040|FG001|Overall Study|Adverse Event|0|||
16459920|NCT00689117|40162041|FG002|Overall Study|Adverse Event|5|||
16459921|NCT00689117|40162042|FG003|Overall Study|Adverse Event|0|||
16459922|NCT00689117|40162039|FG000|Overall Study|Lost to Follow-up|26|||
16459923|NCT00689117|40162040|FG001|Overall Study|Lost to Follow-up|19|||
16459924|NCT00689117|40162041|FG002|Overall Study|Lost to Follow-up|17|||
16459925|NCT00689117|40162042|FG003|Overall Study|Lost to Follow-up|11|||
16459926|NCT00689117|40162039|FG000|Overall Study|Lack of Efficacy|1|||
16459927|NCT00689117|40162040|FG001|Overall Study|Lack of Efficacy|2|||
16459928|NCT00689117|40162041|FG002|Overall Study|Lack of Efficacy|2|||
16459929|NCT00689117|40162042|FG003|Overall Study|Lack of Efficacy|2|||
16459930|NCT00689117|40162039|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
16459931|NCT00689117|40162040|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
16459932|NCT00689117|40162041|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
16459933|NCT00689117|40162042|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
16459934|NCT00689117|40162039|FG000|Overall Study|Withdrawal by Subject|19|||
16459935|NCT00689117|40162040|FG001|Overall Study|Withdrawal by Subject|18|||
16459936|NCT00689117|40162041|FG002|Overall Study|Withdrawal by Subject|26|||
16459937|NCT00689117|40162042|FG003|Overall Study|Withdrawal by Subject|13|||
16459938|NCT00689117|40162039|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
16459939|NCT00689117|40162040|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
16459940|NCT00689117|40162041|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
16459941|NCT00689117|40162042|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
16459942|NCT00689117|40162039|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
16459943|NCT00689117|40162040|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
16459944|NCT00689117|40162041|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16459945|NCT00689117|40162042|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
16459946|NCT00689117|40162039|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
16459947|NCT00689117|40162040|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
16459948|NCT00689117|40162041|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
16459949|NCT00689117|40162042|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
16459950|NCT00689117|40162039|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
16459951|NCT00689117|40162040|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
16459952|NCT00689117|40162041|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
16459953|NCT00689117|40162042|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
16459954|NCT00689117|40162039|FG000|Overall Study|Use of Prohibitive Medication|2|||
16459955|NCT00689117|40162040|FG001|Overall Study|Use of Prohibitive Medication|1|||
16459956|NCT00689117|40162041|FG002|Overall Study|Use of Prohibitive Medication|3|||
16459957|NCT00689117|40162042|FG003|Overall Study|Use of Prohibitive Medication|0|||
16459958|NCT00689117|40162039|FG000|Overall Study|Pregnancy|0|||
16459959|NCT00689117|40162040|FG001|Overall Study|Pregnancy|2|||
16459960|NCT00689117|40162041|FG002|Overall Study|Pregnancy|0|||
16459961|NCT00689117|40162042|FG003|Overall Study|Pregnancy|2|||
16459962|NCT00689117|40162039|FG000|Overall Study|Incarceration|2|||
16459963|NCT00689117|40162040|FG001|Overall Study|Incarceration|0|||
16459964|NCT00689117|40162041|FG002|Overall Study|Incarceration|0|||
16459965|NCT00689117|40162042|FG003|Overall Study|Incarceration|0|||
16459966|NCT00689117|40162039|FG000|Overall Study|Fear of Birth Defects|0|||
16459967|NCT00689117|40162040|FG001|Overall Study|Fear of Birth Defects|0|||
16459968|NCT00689117|40162041|FG002|Overall Study|Fear of Birth Defects|1|||
16459969|NCT00689117|40162042|FG003|Overall Study|Fear of Birth Defects|0|||
16459970|NCT00689117|40162039|FG000|Overall Study|Transportation|1|||
16459971|NCT00689117|40162040|FG001|Overall Study|Transportation|0|||
16459972|NCT00689117|40162041|FG002|Overall Study|Transportation|0|||
16459973|NCT00689117|40162042|FG003|Overall Study|Transportation|0|||
16459974|NCT00689117|40162039|FG000|Overall Study|Patient Withdrew from Study|0|||
16459975|NCT00689117|40162040|FG001|Overall Study|Patient Withdrew from Study|0|||
16459976|NCT00689117|40162041|FG002|Overall Study|Patient Withdrew from Study|0|||
16459977|NCT00689117|40162042|FG003|Overall Study|Patient Withdrew from Study|1|||
16459978|NCT00689117|40162039|FG000|Overall Study|Personal Reason|0|||
16459979|NCT00689117|40162040|FG001|Overall Study|Personal Reason|1|||
16459980|NCT00689117|40162041|FG002|Overall Study|Personal Reason|0|||
16459981|NCT00689117|40162042|FG003|Overall Study|Personal Reason|0|||
16167603|NCT03887130|39091568|FG002|Overall Study|Drug related toxicity|13|||
16167604|NCT03887130|39091566|FG000|Overall Study|Non drug related toxicity|3|||
16167605|NCT03887130|39091567|FG001|Overall Study|Non drug related toxicity|0|||
16167606|NCT03887130|39091568|FG002|Overall Study|Non drug related toxicity|0|||
16459982|NCT00689117|40162039|FG000|Overall Study|Dispensing Error|0|||
16459983|NCT00689117|40162040|FG001|Overall Study|Dispensing Error|1|||
16459984|NCT00689117|40162041|FG002|Overall Study|Dispensing Error|0|||
16459985|NCT00689117|40162042|FG003|Overall Study|Dispensing Error|0|||
16459986|NCT02034409|40162046|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
16459987|NCT02034409|40162047|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
16459988|NCT02034409|40162046|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
16459989|NCT02034409|40162047|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
16459990|NCT02034409|40162046|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
16459991|NCT02034409|40162047|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
16459992|NCT02034409|40162046|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
16459993|NCT02034409|40162047|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
16459994|NCT02034409|40162046|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
16459995|NCT02034409|40162047|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
16459996|NCT02034409|40162046|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
16459997|NCT02034409|40162047|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
16459998|NCT00978757|40162048|FG000|Overall Study|Physician Decision|1|||
16459999|NCT00978757|40162049|FG001|Overall Study|Physician Decision|3|||
16460000|NCT00734539|40162050|FG000|Main Study|Death|33|||
16460001|NCT00734539|40162051|FG001|Main Study|Death|32|||
16460002|NCT00734539|40162050|FG000|Main Study|Physician Decision|2|||
16460003|NCT00734539|40162051|FG001|Main Study|Physician Decision|0|||
16460004|NCT00734539|40162050|FG000|Main Study|Withdrawal by Subject|1|||
16460005|NCT00734539|40162051|FG001|Main Study|Withdrawal by Subject|3|||
16460006|NCT00734539|40162050|FG000|Main Study|Enrolled in error; ineligible|1|||
16167607|NCT03887130|39091566|FG000|Overall Study|Death|2|||
16269221|NCT00795821|39471043|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
16460007|NCT00734539|40162051|FG001|Main Study|Enrolled in error; ineligible|0|||
16460008|NCT04074161|40162052|FG000|Overall Study|Withdrawal by Subject|2|||
16460009|NCT04074161|40162053|FG001|Overall Study|Withdrawal by Subject|4|||
16460010|NCT04074161|40162054|FG002|Overall Study|Withdrawal by Subject|1|||
16460011|NCT04074161|40162052|FG000|Overall Study|Lost to Follow-up|4|||
16460012|NCT04074161|40162053|FG001|Overall Study|Lost to Follow-up|5|||
16460013|NCT04074161|40162054|FG002|Overall Study|Lost to Follow-up|3|||
16460014|NCT04224688|40162058|FG000|Overall Study|Withdrawal by Subject|1|||
16460015|NCT04224688|40162059|FG001|Overall Study|Withdrawal by Subject|3|||
16460016|NCT04224688|40162058|FG000|Overall Study|Lack of Efficacy|1|||
16460017|NCT04224688|40162059|FG001|Overall Study|Lack of Efficacy|1|||
16460018|NCT04224688|40162058|FG000|Overall Study|Adverse event, not fatal|0|||
16460019|NCT04224688|40162059|FG001|Overall Study|Adverse event, not fatal|2|||
16460020|NCT04224688|40162058|FG000|Overall Study|COVID-19|0|||
16460021|NCT04224688|40162059|FG001|Overall Study|COVID-19|1|||
16460022|NCT00975689|40162061|FG000|Overall Study|Adverse Event|0|||
16460023|NCT00975689|40162062|FG001|Overall Study|Adverse Event|3|||
16460024|NCT00975689|40162061|FG000|Overall Study|Withdrawal by Subject|1|||
16460025|NCT00975689|40162062|FG001|Overall Study|Withdrawal by Subject|0|||
16460026|NCT00975689|40162061|FG000|Overall Study|Physician Decision|1|||
16460027|NCT00975689|40162062|FG001|Overall Study|Physician Decision|0|||
16460028|NCT01363349|40162063|FG000|Overall Study|Adverse Event|6|||
16460029|NCT01363349|40162064|FG001|Overall Study|Adverse Event|7|||
16460030|NCT01363349|40162063|FG000|Overall Study|Lack of Efficacy|3|||
16460031|NCT01363349|40162064|FG001|Overall Study|Lack of Efficacy|10|||
16460032|NCT01363349|40162063|FG000|Overall Study|Non compliance/Protocol deviations|2|||
16460033|NCT01363349|40162064|FG001|Overall Study|Non compliance/Protocol deviations|2|||
16460034|NCT01363349|40162063|FG000|Overall Study|Withdrawal by Subject|14|||
16460035|NCT01363349|40162064|FG001|Overall Study|Withdrawal by Subject|6|||
16460036|NCT01363349|40162063|FG000|Overall Study|Lost to Follow-up|5|||
16460037|NCT01363349|40162064|FG001|Overall Study|Lost to Follow-up|6|||
16460038|NCT01363349|40162063|FG000|Overall Study|Not reported|36|||
16167608|NCT03887130|39091567|FG001|Overall Study|Death|2|||
16167609|NCT03887130|39091568|FG002|Overall Study|Death|1|||
16167610|NCT03887130|39091566|FG000|Overall Study|Withdrawal by Subject|7|||
16167611|NCT03887130|39091567|FG001|Overall Study|Withdrawal by Subject|6|||
16167612|NCT03887130|39091568|FG002|Overall Study|Withdrawal by Subject|11|||
16167613|NCT03887130|39091566|FG000|Overall Study|other reason|6|||
16167614|NCT03887130|39091567|FG001|Overall Study|other reason|20|||
16167615|NCT03887130|39091568|FG002|Overall Study|other reason|17|||
16167616|NCT00450580|39091569|FG000|Overall Study|Adverse Event|5|||
16167617|NCT00450580|39091570|FG001|Overall Study|Adverse Event|7|||
16167618|NCT00450580|39091569|FG000|Overall Study|Lost to Follow-up|4|||
16167619|NCT00450580|39091570|FG001|Overall Study|Lost to Follow-up|5|||
16167620|NCT00450580|39091569|FG000|Overall Study|Withdrawal by Subject|2|||
16167621|NCT00450580|39091570|FG001|Overall Study|Withdrawal by Subject|2|||
16167622|NCT00450580|39091569|FG000|Overall Study|Protocol Violation|1|||
16167623|NCT00450580|39091570|FG001|Overall Study|Protocol Violation|1|||
16167624|NCT00450580|39091569|FG000|Overall Study|Protocol-defined virologic failure|1|||
16167625|NCT00450580|39091570|FG001|Overall Study|Protocol-defined virologic failure|0|||
16167626|NCT00450580|39091569|FG000|Overall Study|Could not comply with scheduled visits|1|||
16167627|NCT00450580|39091570|FG001|Overall Study|Could not comply with scheduled visits|0|||
16167628|NCT00450580|39091569|FG000|Overall Study|Patient went to Brazil|1|||
16167629|NCT00450580|39091570|FG001|Overall Study|Patient went to Brazil|0|||
16167630|NCT00450580|39091569|FG000|Overall Study|Patient could not swallow Norvir|1|||
16167631|NCT00450580|39091570|FG001|Overall Study|Patient could not swallow Norvir|0|||
16167632|NCT00450580|39091569|FG000|Overall Study|Withdrawal due to pregnancy|0|||
16167633|NCT00450580|39091570|FG001|Overall Study|Withdrawal due to pregnancy|1|||
16167634|NCT02421887|39091571|FG000|Overall Study|Lost to Follow-up|5|||
16167635|NCT02421887|39091572|FG001|Overall Study|Lost to Follow-up|0|||
16167636|NCT02421887|39091571|FG000|Overall Study|Withdrawal by Subject|8|||
16167637|NCT02421887|39091572|FG001|Overall Study|Withdrawal by Subject|5|||
16167638|NCT02421887|39091571|FG000|Overall Study|Physician Decision|2|||
16167639|NCT02421887|39091572|FG001|Overall Study|Physician Decision|4|||
16167640|NCT02421887|39091571|FG000|Overall Study|Adverse Event|2|||
16167641|NCT02421887|39091572|FG001|Overall Study|Adverse Event|0|||
16167642|NCT01724528|39091576|FG000|Overall Study|Death|3|||
16167643|NCT01724528|39091577|FG001|Overall Study|Death|0|||
16167644|NCT01724528|39091576|FG000|Overall Study|Withdrawal by Subject|0|||
16167645|NCT01724528|39091577|FG001|Overall Study|Withdrawal by Subject|2|||
16167646|NCT01724528|39091576|FG000|Overall Study|Protocol Violation|0|||
16167647|NCT01724528|39091577|FG001|Overall Study|Protocol Violation|1|||
16167648|NCT01724528|39091576|FG000|Overall Study|Patient refused to attend last visit|1|||
16460039|NCT01363349|40162064|FG001|Overall Study|Not reported|37|||
16167649|NCT01724528|39091577|FG001|Overall Study|Patient refused to attend last visit|0|||
16167650|NCT01192022|39091583|FG000|Overall Study|Withdrawal of Consent|3|||
16167651|NCT01192022|39091584|FG001|Overall Study|Withdrawal of Consent|1|||
16167652|NCT01192022|39091585|FG002|Overall Study|Withdrawal of Consent|0|||
16167653|NCT01192022|39091586|FG003|Overall Study|Withdrawal of Consent|0|||
16167654|NCT01192022|39091587|FG004|Overall Study|Withdrawal of Consent|0|||
16167655|NCT01192022|39091583|FG000|Overall Study|Lost to Follow-up|4|||
16460040|NCT01363349|40162063|FG000|Overall Study|missing|1|||
16460041|NCT01363349|40162064|FG001|Overall Study|missing|2|||
16460042|NCT02270944|40162067|FG000|Overall Study|Lost to Follow-up|9|||
16460043|NCT02270944|40162068|FG001|Overall Study|Lost to Follow-up|4|||
16167656|NCT01192022|39091584|FG001|Overall Study|Lost to Follow-up|2|||
16167657|NCT01192022|39091585|FG002|Overall Study|Lost to Follow-up|1|||
16167658|NCT01192022|39091586|FG003|Overall Study|Lost to Follow-up|1|||
16167659|NCT01192022|39091587|FG004|Overall Study|Lost to Follow-up|0|||
16167660|NCT01192022|39091583|FG000|Overall Study|Adverse Event|1|||
16167661|NCT01192022|39091584|FG001|Overall Study|Adverse Event|0|||
16167662|NCT01192022|39091585|FG002|Overall Study|Adverse Event|0|||
16167663|NCT01192022|39091586|FG003|Overall Study|Adverse Event|0|||
16167664|NCT01192022|39091587|FG004|Overall Study|Adverse Event|0|||
16167665|NCT01192022|39091583|FG000|Overall Study|Fatal Adverse Event|4|||
16167666|NCT01192022|39091584|FG001|Overall Study|Fatal Adverse Event|6|||
16167667|NCT01192022|39091585|FG002|Overall Study|Fatal Adverse Event|0|||
16167668|NCT01192022|39091586|FG003|Overall Study|Fatal Adverse Event|0|||
16167669|NCT01192022|39091587|FG004|Overall Study|Fatal Adverse Event|1|||
16167670|NCT01192022|39091583|FG000|Overall Study|Physician withdrew-patient hardship|1|||
16167671|NCT01192022|39091584|FG001|Overall Study|Physician withdrew-patient hardship|0|||
16167672|NCT01192022|39091585|FG002|Overall Study|Physician withdrew-patient hardship|0|||
16167673|NCT01192022|39091586|FG003|Overall Study|Physician withdrew-patient hardship|0|||
16460044|NCT02270944|40162067|FG000|Overall Study|Withdrawal by Subject|2|||
16460045|NCT02270944|40162068|FG001|Overall Study|Withdrawal by Subject|1|||
16460046|NCT03179202|40162071|FG000|Overall Study|Screen Failure|67|||
16460047|NCT03179202|40162071|FG000|Overall Study|Subject Lost to Follow Up|12|||
16460048|NCT03179202|40162071|FG000|Overall Study|Withdrawal by Subject|7|||
16167674|NCT01192022|39091587|FG004|Overall Study|Physician withdrew-patient hardship|0|||
16167675|NCT01192022|39091583|FG000|Overall Study|Patient too sick from chemotherapy|0|||
16167676|NCT01192022|39091584|FG001|Overall Study|Patient too sick from chemotherapy|1|||
16167677|NCT01192022|39091585|FG002|Overall Study|Patient too sick from chemotherapy|0|||
16167678|NCT01192022|39091586|FG003|Overall Study|Patient too sick from chemotherapy|0|||
16167679|NCT01192022|39091587|FG004|Overall Study|Patient too sick from chemotherapy|0|||
16167680|NCT01192022|39091583|FG000|Overall Study|Patient needed surgery|0|||
16167681|NCT01192022|39091584|FG001|Overall Study|Patient needed surgery|1|||
16460049|NCT03179202|40162071|FG000|Overall Study|Adverse Event|3|||
16460050|NCT03179202|40162071|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
16167682|NCT01192022|39091585|FG002|Overall Study|Patient needed surgery|0|||
16167683|NCT01192022|39091586|FG003|Overall Study|Patient needed surgery|0|||
16167684|NCT01192022|39091587|FG004|Overall Study|Patient needed surgery|0|||
16167685|NCT01192022|39091583|FG000|Overall Study|Parents did not allow all follow up|0|||
16167686|NCT01192022|39091584|FG001|Overall Study|Parents did not allow all follow up|0|||
16167687|NCT01192022|39091585|FG002|Overall Study|Parents did not allow all follow up|0|||
16167688|NCT01192022|39091586|FG003|Overall Study|Parents did not allow all follow up|1|||
16167689|NCT01192022|39091587|FG004|Overall Study|Parents did not allow all follow up|0|||
16167690|NCT02117687|39091588|FG000|Overall Study|Lost to Follow-up|0|||
16167691|NCT02117687|39091589|FG001|Overall Study|Lost to Follow-up|1|||
16167692|NCT02117687|39091588|FG000|Overall Study|Adverse Event|0|||
16167693|NCT02117687|39091589|FG001|Overall Study|Adverse Event|2|||
16167694|NCT02117687|39091588|FG000|Overall Study|Other Reasons|1|||
16167695|NCT02117687|39091589|FG001|Overall Study|Other Reasons|1|||
16167696|NCT01481896|39091590|FG000|Overall Study|Lost to Follow-up|12|||
16167697|NCT02009878|39091591|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
16167698|NCT02009878|39091592|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
16167699|NCT02009878|39091593|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
16167700|NCT00605085|39091594|FG000|Overall Study|Withdrawal by Subject|8|||
16167701|NCT00605085|39091595|FG001|Overall Study|Withdrawal by Subject|5|||
16167702|NCT00605085|39091594|FG000|Overall Study|Adverse Event|9|||
16167703|NCT00605085|39091595|FG001|Overall Study|Adverse Event|5|||
16167704|NCT00605085|39091594|FG000|Overall Study|Pregnancy|2|||
16167705|NCT00605085|39091595|FG001|Overall Study|Pregnancy|0|||
16167706|NCT00605085|39091594|FG000|Overall Study|Protocol Violation|3|||
16167707|NCT00605085|39091595|FG001|Overall Study|Protocol Violation|2|||
16167708|NCT00605085|39091594|FG000|Overall Study|Lost to Follow-up|10|||
16167709|NCT00605085|39091595|FG001|Overall Study|Lost to Follow-up|5|||
16167710|NCT00605085|39091594|FG000|Overall Study|administrative reasons|18|||
16167711|NCT00605085|39091595|FG001|Overall Study|administrative reasons|8|||
16167712|NCT03898063|39091597|FG000|Overall Study|Withdrawal by Subject|10|||
16167713|NCT03898063|39091598|FG001|Overall Study|Withdrawal by Subject|8|||
16167714|NCT02479802|39091599|FG000|Overall Study|Lost to Follow-up|1|||
16167715|NCT02479802|39091599|FG000|Overall Study|Adverse Event|1|||
16167716|NCT02367521|39091600|FG000|Overall Study|severe headache after intervention|2|||
16167717|NCT02367521|39091601|FG001|Overall Study|severe headache after intervention|0|||
16167718|NCT02367521|39091600|FG000|Overall Study|unable to find transportation|2|||
16167719|NCT02367521|39091601|FG001|Overall Study|unable to find transportation|0|||
16167720|NCT01925209|39091603|FG000|Treatment Epoch|Physician Decision|1|||
16167721|NCT01925209|39091604|FG001|Treatment Epoch|Physician Decision|0|||
16167722|NCT01925209|39091605|FG002|Treatment Epoch|Physician Decision|0|||
16460051|NCT03179202|40162071|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
16167723|NCT01925209|39091606|FG003|Treatment Epoch|Physician Decision|0|||
16167724|NCT01925209|39091603|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
16167725|NCT01925209|39091604|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
16167726|NCT01925209|39091605|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
16167727|NCT01925209|39091606|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
16167728|NCT01925209|39091603|FG000|Treatment Epoch|Death|1|||
16167729|NCT01925209|39091604|FG001|Treatment Epoch|Death|0|||
16167730|NCT01925209|39091605|FG002|Treatment Epoch|Death|0|||
16167731|NCT01925209|39091606|FG003|Treatment Epoch|Death|0|||
16167732|NCT01925209|39091603|FG000|Treatment Epoch|Protocol deviation|0|||
16167733|NCT01925209|39091604|FG001|Treatment Epoch|Protocol deviation|0|||
16167734|NCT01925209|39091605|FG002|Treatment Epoch|Protocol deviation|1|||
16460052|NCT01324141|40162074|FG000|Overall Study|Declined to participate before treatment started|1|||
16460053|NCT01324141|40162074|FG000|Overall Study|Disease progression on study|1|||
16460054|NCT02500056|40162075|FG000|Overall Study|Lost to Follow-up|3|||
16460055|NCT02500056|40162076|FG001|Overall Study|Lost to Follow-up|7|||
16460056|NCT02500056|40162075|FG000|Overall Study|Recurrence|1|||
16460057|NCT02500056|40162076|FG001|Overall Study|Recurrence|0|||
16460058|NCT02500056|40162075|FG000|Overall Study|Death|3|||
16167735|NCT01925209|39091606|FG003|Treatment Epoch|Protocol deviation|1|||
16167736|NCT01925209|39091603|FG000|Treatment Epoch|Withdrawal by Subject|4|||
16167737|NCT01925209|39091604|FG001|Treatment Epoch|Withdrawal by Subject|3|||
16167738|NCT01925209|39091605|FG002|Treatment Epoch|Withdrawal by Subject|3|||
16167739|NCT01925209|39091606|FG003|Treatment Epoch|Withdrawal by Subject|2|||
16167740|NCT01925209|39091603|FG000|Treatment Epoch|Adverse Event|3|||
16167741|NCT01925209|39091604|FG001|Treatment Epoch|Adverse Event|5|||
16167742|NCT01925209|39091605|FG002|Treatment Epoch|Adverse Event|3|||
16167743|NCT01925209|39091606|FG003|Treatment Epoch|Adverse Event|1|||
16167744|NCT01925209|39091603|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
16167745|NCT01925209|39091604|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
16460059|NCT02500056|40162076|FG001|Overall Study|Death|1|||
16460060|NCT02445794|40162077|FG000|Overall Study|Adverse Event|0|||
16460061|NCT02445794|40162078|FG001|Overall Study|Adverse Event|0|||
16460062|NCT02445794|40162079|FG002|Overall Study|Adverse Event|2|||
16460063|NCT02445794|40162080|FG003|Overall Study|Adverse Event|0|||
16460064|NCT03180619|40162083|FG000|Overall Study|Withdrew Consent|5|||
16460065|NCT03180619|40162084|FG001|Overall Study|Withdrew Consent|0|||
16460066|NCT03180619|40162085|FG002|Overall Study|Withdrew Consent|2|||
16460067|NCT03180619|40162083|FG000|Overall Study|Death|2|||
16460068|NCT03180619|40162084|FG001|Overall Study|Death|1|||
16460069|NCT03180619|40162085|FG002|Overall Study|Death|2|||
16460070|NCT03180619|40162083|FG000|Overall Study|Adverse Event|2|||
16460071|NCT03180619|40162084|FG001|Overall Study|Adverse Event|0|||
16460072|NCT03180619|40162085|FG002|Overall Study|Adverse Event|1|||
16460073|NCT03180619|40162083|FG000|Overall Study|Investigator's discretion|2|||
16460074|NCT03180619|40162084|FG001|Overall Study|Investigator's discretion|0|||
16460075|NCT03180619|40162085|FG002|Overall Study|Investigator's discretion|1|||
16460076|NCT00955305|40162086|FG000|Overall Study|Disease progression|39|||
16460077|NCT00955305|40162087|FG001|Overall Study|Disease progression|41|||
16460078|NCT00955305|40162086|FG000|Overall Study|Adverse Event|22|||
16167746|NCT01925209|39091605|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
16167747|NCT01925209|39091606|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
16460079|NCT00955305|40162087|FG001|Overall Study|Adverse Event|22|||
16460080|NCT00955305|40162086|FG000|Overall Study|Death|2|||
16460081|NCT00955305|40162087|FG001|Overall Study|Death|1|||
16460082|NCT00955305|40162086|FG000|Overall Study|Withdrawal by Subject|5|||
16460083|NCT00955305|40162087|FG001|Overall Study|Withdrawal by Subject|4|||
16460084|NCT00955305|40162086|FG000|Overall Study|Alternative therapy|4|||
16460085|NCT00955305|40162087|FG001|Overall Study|Alternative therapy|0|||
16460086|NCT00955305|40162086|FG000|Overall Study|Other complicating disease|2|||
16460087|NCT00955305|40162087|FG001|Overall Study|Other complicating disease|4|||
16460088|NCT00955305|40162086|FG000|Overall Study|Physician Decision|1|||
16460089|NCT00955305|40162087|FG001|Overall Study|Physician Decision|0|||
16460090|NCT00955305|40162086|FG000|Overall Study|Continued presence of residual disease|0|||
16460091|NCT00955305|40162087|FG001|Overall Study|Continued presence of residual disease|1|||
16460092|NCT00955305|40162086|FG000|Overall Study|Functional decline|2|||
16460093|NCT00955305|40162087|FG001|Overall Study|Functional decline|0|||
16460094|NCT00955305|40162086|FG000|Overall Study|Maximum response achieved|0|||
16460095|NCT00955305|40162087|FG001|Overall Study|Maximum response achieved|1|||
16460096|NCT00955305|40162086|FG000|Overall Study|Lost to Follow-up|0|||
16460097|NCT00955305|40162087|FG001|Overall Study|Lost to Follow-up|1|||
16460098|NCT00955305|40162086|FG000|Overall Study|No off-treatment reason submitted|1|||
16167748|NCT01925209|39091603|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
16167749|NCT01925209|39091604|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
16167750|NCT01925209|39091605|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
16460099|NCT00955305|40162087|FG001|Overall Study|No off-treatment reason submitted|0|||
16460100|NCT00955305|40162086|FG000|Overall Study|Never started protocol treatment|5|||
16460101|NCT00955305|40162087|FG001|Overall Study|Never started protocol treatment|5|||
16460102|NCT00955305|40162086|FG000|Overall Study|Ineligible|5|||
16460103|NCT00955305|40162087|FG001|Overall Study|Ineligible|7|||
16460104|NCT01541397|40162091|FG000|Overall Study|Study ended prior to data collection|4|||
16460105|NCT01541397|40162092|FG001|Overall Study|Study ended prior to data collection|2|||
16460106|NCT02870933|40162093|FG000|Overall Study|Death|2|||
16460107|NCT02870933|40162094|FG001|Overall Study|Death|1|||
16460108|NCT02870933|40162093|FG000|Overall Study|Withdrawal by Subject|0|||
16460109|NCT02870933|40162094|FG001|Overall Study|Withdrawal by Subject|1|||
16460110|NCT00294762|40165681|FG000|Overall Study|Did not receive study treatment|3|||
16460111|NCT00294762|40165682|FG001|Overall Study|Did not receive study treatment|3|||
16460112|NCT01958489|40165690|FG000|Period 2|Adverse Event|0|||
16460113|NCT01958489|40165691|FG001|Period 2|Adverse Event|1|||
16460114|NCT03387111|40165699|FG000|Overall Study|Progressive Disease|3|||
16460115|NCT03387111|40165699|FG000|Overall Study|Other|1|||
16460116|NCT02744040|40165700|FG000|Overall Study|Withdrawal by Subject|3|||
16460117|NCT02744040|40165701|FG001|Overall Study|Withdrawal by Subject|2|||
16460118|NCT02744040|40165702|FG002|Overall Study|Withdrawal by Subject|2|||
16460119|NCT02744040|40165700|FG000|Overall Study|Physician Decision|0|||
16460120|NCT02744040|40165701|FG001|Overall Study|Physician Decision|8|||
16460121|NCT02744040|40165702|FG002|Overall Study|Physician Decision|13|||
16460122|NCT02744040|40165700|FG000|Overall Study|Lost to Follow-up|3|||
16460123|NCT02744040|40165701|FG001|Overall Study|Lost to Follow-up|1|||
16460124|NCT02744040|40165702|FG002|Overall Study|Lost to Follow-up|7|||
16460125|NCT01014910|40165703|FG000|Overall Study|Withdrawal by Subject|0|||
16460126|NCT01014910|40165704|FG001|Overall Study|Withdrawal by Subject|2|||
16460127|NCT00638183|40165710|FG000|Overall Study|Adverse Event|23|||
16460128|NCT00638183|40165710|FG000|Overall Study|Lack of Efficacy|14|||
16460129|NCT00638183|40165710|FG000|Overall Study|Physician Decision|9|||
16460130|NCT00638183|40165710|FG000|Overall Study|Lost to Follow-up|46|||
16460131|NCT00638183|40165710|FG000|Overall Study|Other reason not defined above|27|||
16460132|NCT03887702|40165711|FG000|Overall Study|Study terminated|0|||
16460133|NCT03887702|40165712|FG001|Overall Study|Study terminated|0|||
16460134|NCT03887702|40165713|FG002|Overall Study|Study terminated|2|||
16460135|NCT03887702|40165714|FG003|Overall Study|Study terminated|2|||
16460136|NCT02872285|40165715|FG000|Overall Study|Withdrawal by Subject|2|||
16460137|NCT02872285|40165716|FG001|Overall Study|Withdrawal by Subject|0|||
16460138|NCT02872285|40165715|FG000|Overall Study|Lost to Follow-up|2|||
16460139|NCT02872285|40165716|FG001|Overall Study|Lost to Follow-up|2|||
16460140|NCT02872285|40165715|FG000|Overall Study|Discontinued due to back surgery|1|||
16460141|NCT02872285|40165716|FG001|Overall Study|Discontinued due to back surgery|0|||
16460142|NCT00139477|40165717|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
16460143|NCT00139477|40165718|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
16460144|NCT00139477|40165717|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
16460145|NCT00139477|40165718|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
16460146|NCT00139477|40165717|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
16460147|NCT00139477|40165718|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
16460148|NCT00139477|40165717|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
16460149|NCT00139477|40165718|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
16460150|NCT00139477|40165717|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
16460151|NCT00139477|40165718|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
16460152|NCT00139477|40165717|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
16460153|NCT00139477|40165718|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
16460154|NCT00139477|40165717|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
16460155|NCT00139477|40165718|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
16460156|NCT02547363|40165719|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
16460157|NCT02547363|40165720|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
16460158|NCT02547363|40165719|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
16460159|NCT02547363|40165720|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
16460160|NCT02547363|40165719|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
16460161|NCT02547363|40165720|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
16460162|NCT02547363|40165719|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
16460163|NCT02547363|40165720|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
16460164|NCT02547363|40165719|FG000|12-month Follow-up|Withdrawal by Subject|4|||
16460165|NCT02547363|40165720|FG001|12-month Follow-up|Withdrawal by Subject|3|||
16460166|NCT02547363|40165719|FG000|12-month Follow-up|Lost to Follow-up|4|||
16460167|NCT02547363|40165720|FG001|12-month Follow-up|Lost to Follow-up|1|||
16460168|NCT02547363|40165719|FG000|12-month Follow-up|Lack of Efficacy|1|||
16460169|NCT02547363|40165720|FG001|12-month Follow-up|Lack of Efficacy|1|||
16460170|NCT02547363|40165719|FG000|12-month Follow-up|Other|1|||
16460171|NCT02547363|40165720|FG001|12-month Follow-up|Other|0|||
16460172|NCT02365233|40165721|FG000|Overall Study|IRB withheld the data|1|||
16460173|NCT02365233|40165722|FG001|Overall Study|IRB withheld the data|2|||
16460174|NCT02365233|40165723|FG002|Overall Study|IRB withheld the data|2|||
16460175|NCT00003590|40165724|FG000|Overall Study|Ineligible Patient|1|||
16460176|NCT00003590|40165724|FG000|Overall Study|Adverse Event|7|||
16460177|NCT00003590|40165724|FG000|Overall Study|Withdrawal by Subject|1|||
16460178|NCT00003590|40165724|FG000|Overall Study|Lack of Efficacy|11|||
16460179|NCT00003590|40165724|FG000|Overall Study|Death|1|||
16460180|NCT00003590|40165724|FG000|Overall Study|Physician Decision|1|||
16460181|NCT01217307|40165725|FG000|Overall Study|Withdrawal by Subject|0|||
16460182|NCT01217307|40165726|FG001|Overall Study|Withdrawal by Subject|1|||
16460183|NCT02123251|40165727|FG000|Overall Study|Death|1|||
16460184|NCT02123251|40165728|FG001|Overall Study|Death|1|||
16460185|NCT02123251|40165727|FG000|Overall Study|Withdrawal by Subject|0|||
16460186|NCT02123251|40165728|FG001|Overall Study|Withdrawal by Subject|3|||
16460187|NCT02123251|40165727|FG000|Overall Study|Lost Medicaid eligibility|29|||
16460188|NCT02123251|40165728|FG001|Overall Study|Lost Medicaid eligibility|22|||
16460189|NCT02123251|40165727|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
16460190|NCT02123251|40165728|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
16167751|NCT01925209|39091606|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
16167752|NCT01925209|39091603|FG000|Follow-up|Adverse Event|1|||
16167753|NCT01925209|39091604|FG001|Follow-up|Adverse Event|4|||
16167754|NCT01925209|39091605|FG002|Follow-up|Adverse Event|0|||
16167755|NCT01925209|39091606|FG003|Follow-up|Adverse Event|1|||
16167756|NCT01925209|39091603|FG000|Follow-up|Physician Decision|0|||
16167757|NCT01925209|39091604|FG001|Follow-up|Physician Decision|0|||
16167758|NCT01925209|39091605|FG002|Follow-up|Physician Decision|1|||
16167759|NCT01925209|39091606|FG003|Follow-up|Physician Decision|0|||
16167760|NCT01925209|39091603|FG000|Follow-up|Non-compliance with study treatment|0|||
16167761|NCT01925209|39091604|FG001|Follow-up|Non-compliance with study treatment|0|||
16167762|NCT01925209|39091605|FG002|Follow-up|Non-compliance with study treatment|0|||
16167763|NCT01925209|39091606|FG003|Follow-up|Non-compliance with study treatment|1|||
16167764|NCT01925209|39091603|FG000|Follow-up|Withdrawal by Subject|0|||
16167765|NCT01925209|39091604|FG001|Follow-up|Withdrawal by Subject|2|||
16167766|NCT01925209|39091605|FG002|Follow-up|Withdrawal by Subject|0|||
16167767|NCT01925209|39091606|FG003|Follow-up|Withdrawal by Subject|2|||
16167768|NCT00110994|39091607|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
16167769|NCT00110994|39091608|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
16167770|NCT00110994|39091607|FG000|Double-blind (DB) Treatment|Death|1|||
16460191|NCT01903252|40165729|FG000|Double-Blind Induction|Adverse Event|20|||
16460192|NCT01903252|40165730|FG001|Double-Blind Induction|Adverse Event|18|||
16167771|NCT00110994|39091608|FG001|Double-blind (DB) Treatment|Death|0|||
16167772|NCT00110994|39091607|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
16167773|NCT00110994|39091608|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
16167774|NCT00110994|39091607|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
16167775|NCT00110994|39091608|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
16167776|NCT00110994|39091607|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
16460193|NCT01903252|40165731|FG002|Double-Blind Induction|Adverse Event|0|||
16460194|NCT01903252|40165732|FG003|Double-Blind Induction|Adverse Event|0|||
16460195|NCT01903252|40165733|FG004|Double-Blind Induction|Adverse Event|0|||
16460196|NCT01903252|40165734|FG005|Double-Blind Induction|Adverse Event|0|||
16460197|NCT01903252|40165729|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
16460198|NCT01903252|40165730|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
16460199|NCT01903252|40165731|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
16460200|NCT01903252|40165732|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
16460201|NCT01903252|40165733|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
16460202|NCT01903252|40165734|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
16460203|NCT01903252|40165729|FG000|Double-Blind Induction|Physician Decision|2|||
16460204|NCT01903252|40165730|FG001|Double-Blind Induction|Physician Decision|3|||
16460205|NCT01903252|40165731|FG002|Double-Blind Induction|Physician Decision|0|||
16460206|NCT01903252|40165732|FG003|Double-Blind Induction|Physician Decision|0|||
16167777|NCT00110994|39091608|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
16167778|NCT00110994|39091607|FG000|Double-blind (DB) Treatment|other reasons|2|||
16167779|NCT00110994|39091608|FG001|Double-blind (DB) Treatment|other reasons|3|||
16167780|NCT00110994|39091607|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
16460207|NCT01903252|40165733|FG004|Double-Blind Induction|Physician Decision|0|||
16460208|NCT01903252|40165734|FG005|Double-Blind Induction|Physician Decision|0|||
16460209|NCT01903252|40165729|FG000|Double-Blind Induction|non-compliance,|7|||
16460210|NCT01903252|40165730|FG001|Double-Blind Induction|non-compliance,|7|||
16460211|NCT01903252|40165731|FG002|Double-Blind Induction|non-compliance,|0|||
16460212|NCT01903252|40165732|FG003|Double-Blind Induction|non-compliance,|0|||
16460213|NCT01903252|40165733|FG004|Double-Blind Induction|non-compliance,|0|||
16460214|NCT01903252|40165734|FG005|Double-Blind Induction|non-compliance,|0|||
16460215|NCT01903252|40165729|FG000|Extended Induction, Open-Label|Adverse Event|0|||
16460216|NCT01903252|40165730|FG001|Extended Induction, Open-Label|Adverse Event|0|||
16460217|NCT01903252|40165731|FG002|Extended Induction, Open-Label|Adverse Event|17|||
16460218|NCT01903252|40165732|FG003|Extended Induction, Open-Label|Adverse Event|0|||
16460219|NCT01903252|40165733|FG004|Extended Induction, Open-Label|Adverse Event|0|||
16460220|NCT01903252|40165734|FG005|Extended Induction, Open-Label|Adverse Event|0|||
16460221|NCT01903252|40165729|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
16460222|NCT01903252|40165730|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
16460223|NCT01903252|40165731|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
16460224|NCT01903252|40165732|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
16460225|NCT01903252|40165733|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
16460226|NCT01903252|40165734|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
16460227|NCT01903252|40165729|FG000|Extended Induction, Open-Label|Physician Decision|0|||
16460228|NCT01903252|40165730|FG001|Extended Induction, Open-Label|Physician Decision|0|||
16460229|NCT01903252|40165731|FG002|Extended Induction, Open-Label|Physician Decision|1|||
16460230|NCT01903252|40165732|FG003|Extended Induction, Open-Label|Physician Decision|0|||
16460231|NCT01903252|40165733|FG004|Extended Induction, Open-Label|Physician Decision|0|||
16460232|NCT01903252|40165734|FG005|Extended Induction, Open-Label|Physician Decision|0|||
16460233|NCT01903252|40165729|FG000|Maintenance, Open-Label|Adverse Event|0|||
16460234|NCT01903252|40165730|FG001|Maintenance, Open-Label|Adverse Event|0|||
16460235|NCT01903252|40165731|FG002|Maintenance, Open-Label|Adverse Event|0|||
16460236|NCT01903252|40165732|FG003|Maintenance, Open-Label|Adverse Event|3|||
16460237|NCT01903252|40165733|FG004|Maintenance, Open-Label|Adverse Event|9|||
16167781|NCT00110994|39091608|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
16167782|NCT00110994|39091607|FG000|Active Follow-up|Other reasons|0|||
16167783|NCT00110994|39091608|FG001|Active Follow-up|Other reasons|2|||
16167784|NCT00110994|39091607|FG000|Long Term Follow-up|Death|19|||
16167785|NCT00110994|39091608|FG001|Long Term Follow-up|Death|17|||
16167786|NCT02450487|39091609|FG000|Overall Study|Lost to Follow-up|3|||
16167787|NCT02400255|39091610|FG000|Overall Study|Relapse|4|||
16167788|NCT02400255|39091611|FG001|Overall Study|Relapse|1|||
16167789|NCT02400255|39091612|FG002|Overall Study|Relapse|1|||
16167790|NCT02400255|39091613|FG003|Overall Study|Relapse|2|||
16167791|NCT02400255|39091610|FG000|Overall Study|Adverse Event|6|||
16167792|NCT02400255|39091611|FG001|Overall Study|Adverse Event|3|||
16167793|NCT02400255|39091612|FG002|Overall Study|Adverse Event|0|||
16167794|NCT02400255|39091613|FG003|Overall Study|Adverse Event|0|||
16167795|NCT02400255|39091610|FG000|Overall Study|Physician Decision|6|||
16167796|NCT02400255|39091611|FG001|Overall Study|Physician Decision|0|||
16167797|NCT02400255|39091612|FG002|Overall Study|Physician Decision|0|||
16167798|NCT02400255|39091613|FG003|Overall Study|Physician Decision|0|||
16167799|NCT02400255|39091610|FG000|Overall Study|Loss of insurance|1|||
16167800|NCT02400255|39091611|FG001|Overall Study|Loss of insurance|0|||
16167801|NCT02400255|39091612|FG002|Overall Study|Loss of insurance|0|||
16167802|NCT02400255|39091613|FG003|Overall Study|Loss of insurance|0|||
16167803|NCT01900002|39091620|FG000|Overall Study|Withdrawal by Subject|2|||
16167804|NCT01900002|39091620|FG000|Overall Study|ineligible for Y-90|4|||
16167805|NCT00189462|39095074|FG000|Overall Study|Lack of Efficacy|5|||
16167806|NCT00189462|39095075|FG001|Overall Study|Lack of Efficacy|1|||
16167807|NCT00189462|39095074|FG000|Overall Study|Lost to Follow-up|18|||
16167808|NCT00189462|39095075|FG001|Overall Study|Lost to Follow-up|20|||
16167809|NCT02497001|39095077|FG000|Overall Study|Lost to Follow-up|10|||
16167810|NCT02497001|39095078|FG001|Overall Study|Lost to Follow-up|2|||
16167811|NCT02497001|39095079|FG002|Overall Study|Lost to Follow-up|0|||
16167812|NCT02497001|39095080|FG003|Overall Study|Lost to Follow-up|2|||
16167813|NCT02497001|39095077|FG000|Overall Study|Adverse Event|28|||
16167814|NCT02497001|39095078|FG001|Overall Study|Adverse Event|30|||
16167815|NCT02497001|39095079|FG002|Overall Study|Adverse Event|11|||
16167816|NCT02497001|39095080|FG003|Overall Study|Adverse Event|11|||
16167817|NCT02497001|39095077|FG000|Overall Study|Withdrawal by Subject|14|||
16167818|NCT02497001|39095078|FG001|Overall Study|Withdrawal by Subject|37|||
16167819|NCT02497001|39095079|FG002|Overall Study|Withdrawal by Subject|19|||
16167820|NCT02497001|39095080|FG003|Overall Study|Withdrawal by Subject|15|||
16167821|NCT02497001|39095077|FG000|Overall Study|Physician Decision|5|||
16167822|NCT02497001|39095078|FG001|Overall Study|Physician Decision|11|||
16167823|NCT02497001|39095079|FG002|Overall Study|Physician Decision|5|||
16167824|NCT02497001|39095080|FG003|Overall Study|Physician Decision|1|||
16167825|NCT02497001|39095077|FG000|Overall Study|subjects that were not treated|1|||
16167826|NCT02497001|39095078|FG001|Overall Study|subjects that were not treated|2|||
16167827|NCT02497001|39095079|FG002|Overall Study|subjects that were not treated|2|||
16167828|NCT02497001|39095080|FG003|Overall Study|subjects that were not treated|1|||
16167829|NCT02497001|39095077|FG000|Overall Study|Major Protocol Deviation|3|||
16167830|NCT02497001|39095078|FG001|Overall Study|Major Protocol Deviation|4|||
16167831|NCT02497001|39095079|FG002|Overall Study|Major Protocol Deviation|4|||
16167832|NCT02497001|39095080|FG003|Overall Study|Major Protocol Deviation|4|||
16167833|NCT02497001|39095077|FG000|Overall Study|Lack of Efficacy|10|||
16167834|NCT02497001|39095078|FG001|Overall Study|Lack of Efficacy|16|||
16460238|NCT01903252|40165734|FG005|Maintenance, Open-Label|Adverse Event|14|||
16460239|NCT01903252|40165729|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
16460240|NCT01903252|40165730|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
16167835|NCT02497001|39095079|FG002|Overall Study|Lack of Efficacy|6|||
16167836|NCT02497001|39095080|FG003|Overall Study|Lack of Efficacy|6|||
16167837|NCT02497001|39095077|FG000|Overall Study|Protocol Violation|3|||
16167838|NCT02497001|39095078|FG001|Overall Study|Protocol Violation|1|||
16167839|NCT02497001|39095079|FG002|Overall Study|Protocol Violation|3|||
16167840|NCT02497001|39095080|FG003|Overall Study|Protocol Violation|1|||
16167841|NCT00559273|39095086|FG000|Correction Period (20 Weeks)|Death|3|||
16167842|NCT00559273|39095087|FG001|Correction Period (20 Weeks)|Death|4|||
16167843|NCT00559273|39095086|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
16167844|NCT00559273|39095087|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
16167845|NCT00559273|39095086|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
16167846|NCT00559273|39095087|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
16167847|NCT00559273|39095086|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
16167848|NCT00559273|39095087|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
16167849|NCT00559273|39095086|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
16167850|NCT00559273|39095087|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
16167851|NCT00559273|39095086|FG000|Evaluation Period (8 Weeks)|Death|1|||
16167852|NCT00559273|39095087|FG001|Evaluation Period (8 Weeks)|Death|3|||
16167853|NCT00559273|39095086|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
16167854|NCT00559273|39095087|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
16167855|NCT00559273|39095086|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
16460241|NCT01903252|40165731|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
16460242|NCT01903252|40165732|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
16460243|NCT01903252|40165733|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
16460244|NCT01903252|40165734|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
16460245|NCT01903252|40165729|FG000|Maintenance, Open-Label|Other|0|||
16460246|NCT01903252|40165730|FG001|Maintenance, Open-Label|Other|0|||
16460247|NCT01903252|40165731|FG002|Maintenance, Open-Label|Other|0|||
16460248|NCT01903252|40165732|FG003|Maintenance, Open-Label|Other|2|||
16460249|NCT01903252|40165733|FG004|Maintenance, Open-Label|Other|6|||
16460250|NCT01903252|40165734|FG005|Maintenance, Open-Label|Other|2|||
16460251|NCT03645434|40165735|FG000|Period 1|Adverse Event|0|||
16460252|NCT03645434|40165736|FG001|Period 1|Adverse Event|0|||
16460253|NCT03645434|40165737|FG002|Period 1|Adverse Event|0|||
16460254|NCT03645434|40165738|FG003|Period 1|Adverse Event|1|||
16167856|NCT00559273|39095087|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
16167857|NCT00559273|39095086|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
16167858|NCT00559273|39095087|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
16167859|NCT03529409|39095088|FG000|Randomized|Lost to Follow-up|0|||
16167860|NCT03529409|39095089|FG001|Randomized|Lost to Follow-up|0|||
16167861|NCT03529409|39095090|FG002|Randomized|Lost to Follow-up|4|||
16167862|NCT03529409|39095088|FG000|Randomized|Excluded|0|||
16167863|NCT03529409|39095089|FG001|Randomized|Excluded|0|||
16167864|NCT03529409|39095090|FG002|Randomized|Excluded|1|||
16167865|NCT03529409|39095088|FG000|Post-treatment Assessment|Death|1|||
16460255|NCT03645434|40165739|FG004|Period 1|Adverse Event|0|||
16460256|NCT03645434|40165740|FG005|Period 1|Adverse Event|0|||
16460257|NCT03645434|40165735|FG000|Period 1|COPD exacerbation|0|||
16460258|NCT03645434|40165736|FG001|Period 1|COPD exacerbation|0|||
16460259|NCT03645434|40165737|FG002|Period 1|COPD exacerbation|0|||
16460260|NCT03645434|40165738|FG003|Period 1|COPD exacerbation|0|||
16460261|NCT03645434|40165739|FG004|Period 1|COPD exacerbation|1|||
16460262|NCT03645434|40165740|FG005|Period 1|COPD exacerbation|0|||
16460263|NCT03113136|40165741|FG000|Overall Study|Lost to Follow-up|22|||
16460264|NCT03113136|40165742|FG001|Overall Study|Lost to Follow-up|47|||
16460265|NCT03113136|40165743|FG002|Overall Study|Lost to Follow-up|54|||
16460266|NCT03113136|40165741|FG000|Overall Study|Withdrawal by Subject|4|||
16460267|NCT03113136|40165742|FG001|Overall Study|Withdrawal by Subject|13|||
16460268|NCT03113136|40165743|FG002|Overall Study|Withdrawal by Subject|14|||
16460269|NCT03113136|40165741|FG000|Overall Study|Ineligible|0|||
16460270|NCT03113136|40165742|FG001|Overall Study|Ineligible|2|||
16460271|NCT03113136|40165743|FG002|Overall Study|Ineligible|1|||
16460272|NCT03113136|40165741|FG000|Overall Study|Study Team Decision|1|||
16460273|NCT03113136|40165742|FG001|Overall Study|Study Team Decision|4|||
16460274|NCT03113136|40165743|FG002|Overall Study|Study Team Decision|0|||
16460275|NCT01256294|40165744|FG000|Overall Study|Adverse Event|1|||
16167866|NCT03529409|39095089|FG001|Post-treatment Assessment|Death|0|||
16167867|NCT03529409|39095090|FG002|Post-treatment Assessment|Death|0|||
16167868|NCT03529409|39095088|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
16167869|NCT03529409|39095089|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
16460276|NCT01256294|40165745|FG001|Overall Study|Adverse Event|0|||
16460277|NCT01256294|40165744|FG000|Overall Study|Withdrawal by Subject|1|||
16460278|NCT01256294|40165745|FG001|Overall Study|Withdrawal by Subject|1|||
16460279|NCT01256294|40165744|FG000|Overall Study|Protocol deviation|2|||
16460280|NCT01256294|40165745|FG001|Overall Study|Protocol deviation|1|||
16460281|NCT03865381|40165746|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
16460282|NCT03865381|40165746|FG000|Overall Study|Withdrawal by Subject|2|||
16460283|NCT02756806|40165747|FG000|Overall Study|Study terminated early|5|||
16460284|NCT01431638|40165751|FG000|Overall Study|Adverse Event|1|||
16460285|NCT01431638|40165752|FG001|Overall Study|Adverse Event|3|||
16460286|NCT01431638|40165753|FG002|Overall Study|Adverse Event|1|||
16460287|NCT01431638|40165751|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
16460288|NCT01431638|40165752|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16460289|NCT01431638|40165753|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
16460290|NCT01431638|40165751|FG000|Overall Study|Participants condition no longer requires study drug|0|||
16460291|NCT01431638|40165752|FG001|Overall Study|Participants condition no longer requires study drug|1|||
16460292|NCT01431638|40165753|FG002|Overall Study|Participants condition no longer requires study drug|0|||
16460293|NCT01431638|40165751|FG000|Overall Study|Participant withdrew consent|14|||
16460294|NCT01431638|40165752|FG001|Overall Study|Participant withdrew consent|5|||
16460295|NCT01431638|40165753|FG002|Overall Study|Participant withdrew consent|8|||
16460296|NCT01431638|40165751|FG000|Overall Study|Lost to Follow-up|7|||
16460297|NCT01431638|40165752|FG001|Overall Study|Lost to Follow-up|9|||
16460298|NCT01431638|40165753|FG002|Overall Study|Lost to Follow-up|7|||
16460299|NCT01431638|40165751|FG000|Overall Study|Administrative problems|1|||
16460300|NCT01431638|40165752|FG001|Overall Study|Administrative problems|4|||
16460301|NCT01431638|40165753|FG002|Overall Study|Administrative problems|6|||
16460302|NCT01431638|40165751|FG000|Overall Study|Death|1|||
16460303|NCT01431638|40165752|FG001|Overall Study|Death|0|||
16460304|NCT01431638|40165753|FG002|Overall Study|Death|0|||
16460305|NCT01431638|40165751|FG000|Overall Study|Protocol deviation|1|||
16460306|NCT01431638|40165752|FG001|Overall Study|Protocol deviation|1|||
16460307|NCT01431638|40165753|FG002|Overall Study|Protocol deviation|4|||
16460308|NCT01431638|40165751|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
16460309|NCT01431638|40165752|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
16460310|NCT01431638|40165753|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
16460311|NCT00715910|40165754|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
16460312|NCT00715910|40165755|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
16460313|NCT00715910|40165756|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
16167870|NCT03529409|39095090|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
16167871|NCT03529409|39095088|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
16167872|NCT03529409|39095089|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
16167873|NCT03529409|39095090|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
16167874|NCT03529409|39095088|FG000|Follow-up Assessment|Death|1|||
16167875|NCT03529409|39095089|FG001|Follow-up Assessment|Death|0|||
16167876|NCT03529409|39095090|FG002|Follow-up Assessment|Death|0|||
16167877|NCT03529409|39095088|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
16167878|NCT03529409|39095089|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
16167879|NCT03529409|39095090|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
16167880|NCT02700984|39095091|FG000|Overall Study|Death|2|||
16167881|NCT02700984|39095092|FG001|Overall Study|Death|1|||
16167882|NCT02700984|39095091|FG000|Overall Study|Lost to Follow-up|2|||
16167883|NCT02700984|39095092|FG001|Overall Study|Lost to Follow-up|1|||
16167884|NCT02700984|39095091|FG000|Overall Study|Physician Decision|0|||
16167885|NCT02700984|39095092|FG001|Overall Study|Physician Decision|1|||
16460314|NCT00715910|40165757|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
16460315|NCT00715910|40165758|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
16460316|NCT00715910|40165759|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
16460317|NCT00715910|40165754|FG000|Booster and ESFU Phase|Other|0|||
16460318|NCT00715910|40165755|FG001|Booster and ESFU Phase|Other|0|||
16460319|NCT00715910|40165756|FG002|Booster and ESFU Phase|Other|0|||
16460320|NCT00715910|40165757|FG003|Booster and ESFU Phase|Other|5|||
16460321|NCT00715910|40165758|FG004|Booster and ESFU Phase|Other|1|||
16460322|NCT00715910|40165759|FG005|Booster and ESFU Phase|Other|0|||
16460323|NCT02116205|40165761|FG000|Overall Study|Withdrawal by Subject|2|||
16460324|NCT02116205|40165762|FG001|Overall Study|Withdrawal by Subject|4|||
16460325|NCT02116205|40165763|FG002|Overall Study|Withdrawal by Subject|1|||
16460326|NCT02116205|40165764|FG003|Overall Study|Withdrawal by Subject|3|||
16460327|NCT02116205|40165761|FG000|Overall Study|Lost to Follow-up|0|||
16460328|NCT02116205|40165762|FG001|Overall Study|Lost to Follow-up|2|||
16460329|NCT02116205|40165763|FG002|Overall Study|Lost to Follow-up|1|||
16460330|NCT02116205|40165764|FG003|Overall Study|Lost to Follow-up|2|||
16460331|NCT02116205|40165761|FG000|Overall Study|Physician Decision|0|||
16167886|NCT02700984|39095091|FG000|Overall Study|Withdrawal by Subject|8|||
16167887|NCT02700984|39095092|FG001|Overall Study|Withdrawal by Subject|9|||
16167888|NCT02700984|39095091|FG000|Overall Study|Reason not specified|3|||
16460332|NCT02116205|40165762|FG001|Overall Study|Physician Decision|1|||
16460333|NCT02116205|40165763|FG002|Overall Study|Physician Decision|1|||
16460334|NCT02116205|40165764|FG003|Overall Study|Physician Decision|1|||
16460335|NCT02116205|40165761|FG000|Overall Study|Exclusion criteria|0|||
16460336|NCT02116205|40165762|FG001|Overall Study|Exclusion criteria|0|||
16460337|NCT02116205|40165763|FG002|Overall Study|Exclusion criteria|1|||
16460338|NCT02116205|40165764|FG003|Overall Study|Exclusion criteria|0|||
16460339|NCT01643772|40165767|FG000|Overall Study|Protocol Violation|0|||
16460340|NCT01643772|40165768|FG001|Overall Study|Protocol Violation|0|||
16460341|NCT01643772|40165769|FG002|Overall Study|Protocol Violation|0|||
16460342|NCT01643772|40165770|FG003|Overall Study|Protocol Violation|1|||
16460343|NCT01643772|40165767|FG000|Overall Study|Adverse Event|0|||
16460344|NCT01643772|40165768|FG001|Overall Study|Adverse Event|0|||
16460345|NCT01643772|40165769|FG002|Overall Study|Adverse Event|0|||
16460346|NCT01643772|40165770|FG003|Overall Study|Adverse Event|1|||
16460347|NCT00388583|40165778|FG000|Overall Study|Protocol Violation|1|||
16460348|NCT00388583|40165779|FG001|Overall Study|Protocol Violation|0|||
16460349|NCT00388583|40165778|FG000|Overall Study|Withdrawal by Subject|3|||
16460350|NCT00388583|40165779|FG001|Overall Study|Withdrawal by Subject|3|||
16460351|NCT00388583|40165778|FG000|Overall Study|Serious Adverse Event|2|||
16460352|NCT00388583|40165779|FG001|Overall Study|Serious Adverse Event|0|||
16460353|NCT00388583|40165778|FG000|Overall Study|Did not receive vaccine|0|||
16460354|NCT00388583|40165779|FG001|Overall Study|Did not receive vaccine|1|||
16460355|NCT03860818|40165780|FG000|Overall Study|Death|144|||
16460356|NCT03860818|40165781|FG001|Overall Study|Death|195|||
16460357|NCT03860818|40165780|FG000|Overall Study|Graft Loss|32|||
16460358|NCT03860818|40165781|FG001|Overall Study|Graft Loss|45|||
16460359|NCT01883453|40165782|FG000|Overall Study|No episode of common cold|25|||
16460360|NCT01883453|40165783|FG001|Overall Study|No episode of common cold|23|||
16460361|NCT00282308|40165785|FG000|Treatment Period|Lost to Follow-up|1|||
16460362|NCT00282308|40165786|FG001|Treatment Period|Lost to Follow-up|0|||
16460363|NCT00282308|40165787|FG002|Treatment Period|Lost to Follow-up|0|||
16460364|NCT00282308|40165785|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
16460365|NCT00282308|40165786|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
16460366|NCT00282308|40165787|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
16460367|NCT00282308|40165785|FG000|Treatment Period|Adverse Event|0|||
16460368|NCT00282308|40165786|FG001|Treatment Period|Adverse Event|2|||
16460369|NCT00282308|40165787|FG002|Treatment Period|Adverse Event|0|||
16460370|NCT00282308|40165785|FG000|Treatment Period|Not Treated with Study Drug|1|||
16460371|NCT00282308|40165786|FG001|Treatment Period|Not Treated with Study Drug|0|||
16460372|NCT00282308|40165787|FG002|Treatment Period|Not Treated with Study Drug|0|||
16460373|NCT00282308|40165785|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
16460374|NCT00282308|40165786|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
16460375|NCT00282308|40165787|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
16460376|NCT00282308|40165785|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
16460377|NCT00282308|40165786|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
16460378|NCT00282308|40165787|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
16460379|NCT00282308|40165785|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
16460380|NCT00282308|40165786|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
16460381|NCT00282308|40165787|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
16460382|NCT00282308|40165785|FG000|Safety Follow-up Period|Adverse Event|0|||
16460383|NCT00282308|40165786|FG001|Safety Follow-up Period|Adverse Event|0|||
16460384|NCT00282308|40165787|FG002|Safety Follow-up Period|Adverse Event|1|||
16460385|NCT00282308|40165785|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
16460386|NCT00282308|40165786|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
16460387|NCT00282308|40165787|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
16460388|NCT00282308|40165785|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
16460389|NCT00282308|40165786|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
16460390|NCT00282308|40165787|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
16460391|NCT00282308|40165785|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
16460392|NCT00282308|40165786|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
16460393|NCT00282308|40165787|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
16460394|NCT01097005|40165790|FG000|Overall Study|Case Report Form not collected|18|||
16460395|NCT01097005|40165790|FG000|Overall Study|Subjects cannot visit the hospital|1|||
16460396|NCT01097005|40165790|FG000|Overall Study|Poor medication compliance|1|||
16460397|NCT01097005|40165790|FG000|Overall Study|No examination data available|244|||
16460398|NCT01097005|40165790|FG000|Overall Study|Deviation from exclusion criteria|37|||
16460399|NCT01097005|40165790|FG000|Overall Study|Adverse Event|14|||
16460400|NCT01097005|40165790|FG000|Overall Study|Discontinuance by complication|50|||
16167889|NCT02700984|39095092|FG001|Overall Study|Reason not specified|2|||
16460401|NCT02660138|40165791|FG000|Overall Study|Adverse Event|0|||
16460402|NCT02660138|40165792|FG001|Overall Study|Adverse Event|3|||
16460403|NCT02660138|40165793|FG002|Overall Study|Adverse Event|2|||
16460404|NCT02660138|40165791|FG000|Overall Study|Lack of Efficacy|1|||
16460405|NCT02660138|40165792|FG001|Overall Study|Lack of Efficacy|2|||
16460406|NCT02660138|40165793|FG002|Overall Study|Lack of Efficacy|1|||
16460407|NCT02660138|40165791|FG000|Overall Study|Withdrawal by Subject|7|||
16460408|NCT02660138|40165792|FG001|Overall Study|Withdrawal by Subject|6|||
16460409|NCT02660138|40165793|FG002|Overall Study|Withdrawal by Subject|6|||
16460410|NCT02660138|40165791|FG000|Overall Study|Lost to Follow-up|4|||
16460411|NCT02660138|40165792|FG001|Overall Study|Lost to Follow-up|4|||
16460412|NCT02660138|40165793|FG002|Overall Study|Lost to Follow-up|1|||
16460413|NCT02660138|40165791|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
16460414|NCT02660138|40165792|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
16460415|NCT02660138|40165793|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
16167890|NCT02605642|39095093|FG000|Overall Study|Other|11|||
16167891|NCT02605642|39095094|FG001|Overall Study|Other|1|||
16167892|NCT02605642|39095093|FG000|Overall Study|Participant non-compliance|2|||
16167893|NCT02605642|39095094|FG001|Overall Study|Participant non-compliance|4|||
16167894|NCT02605642|39095093|FG000|Overall Study|Physician Decision|10|||
16167895|NCT02605642|39095094|FG001|Overall Study|Physician Decision|0|||
16460416|NCT02660138|40165791|FG000|Overall Study|Other|1|||
16460417|NCT02660138|40165792|FG001|Overall Study|Other|1|||
16460418|NCT02660138|40165793|FG002|Overall Study|Other|0|||
16460419|NCT02660138|40165791|FG000|Overall Study|Not treated|0|||
16460420|NCT02660138|40165792|FG001|Overall Study|Not treated|1|||
16460421|NCT02660138|40165793|FG002|Overall Study|Not treated|0|||
16460422|NCT02350764|40165794|FG000|Overall Study|Adverse Event|4|||
16460423|NCT02350764|40165794|FG000|Overall Study|Death|3|||
16460424|NCT02350764|40165794|FG000|Overall Study|Physician Decision|2|||
16460425|NCT02350764|40165794|FG000|Overall Study|Withdrawal by Subject|2|||
16460426|NCT00600119|40165804|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
16460427|NCT00600119|40165805|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
16460428|NCT00600119|40165806|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
16460429|NCT00600119|40165807|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
16460430|NCT00600119|40165808|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
16460431|NCT00600119|40165809|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
16460432|NCT00600119|40165804|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16460433|NCT00600119|40165805|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
16460434|NCT00600119|40165806|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
16460435|NCT00600119|40165807|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16460436|NCT00600119|40165808|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16460437|NCT00600119|40165809|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
16460438|NCT00600119|40165804|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
16460439|NCT00600119|40165805|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
16460440|NCT00600119|40165806|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
16460441|NCT00600119|40165807|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
16460442|NCT00600119|40165808|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
16460443|NCT00600119|40165809|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
16460444|NCT00600119|40165804|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
16460445|NCT00600119|40165805|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
16460446|NCT00600119|40165806|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
16460447|NCT00600119|40165807|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
16460448|NCT00600119|40165808|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
16460449|NCT00600119|40165809|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
16460450|NCT00600119|40165804|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
16460451|NCT00600119|40165805|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
16460452|NCT00600119|40165806|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
16460453|NCT00600119|40165807|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
16460454|NCT00600119|40165808|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
16460455|NCT00600119|40165809|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
16460456|NCT00600119|40165804|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
16460457|NCT00600119|40165805|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
16167896|NCT02605642|39095093|FG000|Overall Study|Lost to Follow-up|12|||
16167897|NCT02605642|39095094|FG001|Overall Study|Lost to Follow-up|1|||
16167898|NCT02605642|39095093|FG000|Overall Study|Adverse Event|14|||
16167899|NCT02605642|39095094|FG001|Overall Study|Adverse Event|2|||
16167900|NCT02605642|39095093|FG000|Overall Study|Withdrawal by Subject|23|||
16460458|NCT00600119|40165806|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
16460459|NCT00600119|40165807|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
16460460|NCT00600119|40165808|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
16460461|NCT00600119|40165809|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
16460462|NCT00600119|40165804|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
16167901|NCT02605642|39095094|FG001|Overall Study|Withdrawal by Subject|2|||
16167902|NCT02605642|39095093|FG000|Overall Study|Lack of response|24|||
16460463|NCT00600119|40165805|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
16460464|NCT00600119|40165806|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
16460465|NCT00600119|40165807|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
16460466|NCT00600119|40165808|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
16167903|NCT02605642|39095094|FG001|Overall Study|Lack of response|11|||
16167904|NCT04698629|39095095|FG000|Overall Study|Adverse Event|1|||
16167905|NCT01409928|39095096|FG000|Overall Study|Physician Decision|12|||
16460467|NCT00600119|40165809|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
16460468|NCT00600119|40165804|FG000|Double-blind Treatment Period|Other|0|||
16460469|NCT00600119|40165805|FG001|Double-blind Treatment Period|Other|0|||
16460470|NCT00600119|40165806|FG002|Double-blind Treatment Period|Other|0|||
16460471|NCT00600119|40165807|FG003|Double-blind Treatment Period|Other|0|||
16460472|NCT00600119|40165808|FG004|Double-blind Treatment Period|Other|2|||
16460473|NCT00600119|40165809|FG005|Double-blind Treatment Period|Other|1|||
16460474|NCT00600119|40165804|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
16460475|NCT00600119|40165805|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
16460476|NCT00600119|40165806|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
16460477|NCT00600119|40165807|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
16460478|NCT00600119|40165808|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
16460479|NCT00600119|40165809|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
16460480|NCT00600119|40165804|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
16460481|NCT00600119|40165805|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
16460482|NCT00600119|40165806|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
16460483|NCT00600119|40165807|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
16460484|NCT00600119|40165808|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
16460485|NCT00600119|40165809|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
16460486|NCT00600119|40165804|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
16460487|NCT00600119|40165805|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
16460488|NCT00600119|40165806|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
16460489|NCT00600119|40165807|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
16460490|NCT00600119|40165808|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
16460491|NCT00600119|40165809|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
16460492|NCT00600119|40165804|FG000|Double-blind Treatment Period|Physician Decision|2|||
16460493|NCT00600119|40165805|FG001|Double-blind Treatment Period|Physician Decision|0|||
16460494|NCT00600119|40165806|FG002|Double-blind Treatment Period|Physician Decision|0|||
16460495|NCT00600119|40165807|FG003|Double-blind Treatment Period|Physician Decision|0|||
16460496|NCT00600119|40165808|FG004|Double-blind Treatment Period|Physician Decision|0|||
16460497|NCT00600119|40165809|FG005|Double-blind Treatment Period|Physician Decision|0|||
16460498|NCT00600119|40165804|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
16460499|NCT00600119|40165805|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
16460500|NCT00600119|40165806|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
16460501|NCT00600119|40165807|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
16460502|NCT00600119|40165808|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
16460503|NCT00600119|40165809|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
16460504|NCT00600119|40165804|FG000|Double-blind Treatment Period|Adverse Event|1|||
16460505|NCT00600119|40165805|FG001|Double-blind Treatment Period|Adverse Event|1|||
16460506|NCT00600119|40165806|FG002|Double-blind Treatment Period|Adverse Event|0|||
16460507|NCT00600119|40165807|FG003|Double-blind Treatment Period|Adverse Event|1|||
16460508|NCT00600119|40165808|FG004|Double-blind Treatment Period|Adverse Event|2|||
16460509|NCT00600119|40165809|FG005|Double-blind Treatment Period|Adverse Event|10|||
16460510|NCT00600119|40165804|FG000|Follow-up Period|Adverse Event|0|||
16460511|NCT00600119|40165805|FG001|Follow-up Period|Adverse Event|0|||
16460512|NCT00600119|40165806|FG002|Follow-up Period|Adverse Event|0|||
16460513|NCT00600119|40165807|FG003|Follow-up Period|Adverse Event|0|||
16460514|NCT00600119|40165808|FG004|Follow-up Period|Adverse Event|0|||
16460515|NCT00600119|40165809|FG005|Follow-up Period|Adverse Event|1|||
16460516|NCT00600119|40165804|FG000|Follow-up Period|Other|1|||
16460517|NCT00600119|40165805|FG001|Follow-up Period|Other|0|||
16460518|NCT00600119|40165806|FG002|Follow-up Period|Other|0|||
16460519|NCT00600119|40165807|FG003|Follow-up Period|Other|0|||
16460520|NCT00600119|40165808|FG004|Follow-up Period|Other|0|||
16460521|NCT00600119|40165809|FG005|Follow-up Period|Other|0|||
16460522|NCT00992589|40165810|FG000|Open-Label Phase|Adverse Event|4|||
16460523|NCT00992589|40165811|FG001|Open-Label Phase|Adverse Event|0|||
16460524|NCT00992589|40165812|FG002|Open-Label Phase|Adverse Event|0|||
16460525|NCT00992589|40165813|FG003|Open-Label Phase|Adverse Event|0|||
16460526|NCT00992589|40165810|FG000|Open-Label Phase|Withdrawal by Subject|20|||
16460527|NCT00992589|40165811|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16460528|NCT00992589|40165812|FG002|Open-Label Phase|Withdrawal by Subject|0|||
16460529|NCT00992589|40165813|FG003|Open-Label Phase|Withdrawal by Subject|0|||
16460530|NCT00992589|40165810|FG000|Open-Label Phase|Lost to Follow-up|1|||
16167906|NCT03663166|39095097|FG000|Overall Study|Withdrawal by Subject|1|||
16167907|NCT00828464|39095098|FG000|Overall Study|Withdrawal by Subject|1|||
16167908|NCT00654498|39095099|FG000|Overall Study|Not Treated|1|||
16167909|NCT00654498|39095100|FG001|Overall Study|Not Treated|0|||
16167910|NCT00654498|39095099|FG000|Overall Study|Adverse Event|6|||
16167911|NCT00654498|39095100|FG001|Overall Study|Adverse Event|1|||
16167912|NCT00654498|39095099|FG000|Overall Study|Protocol Violation|1|||
16167913|NCT00654498|39095100|FG001|Overall Study|Protocol Violation|1|||
16167914|NCT00654498|39095099|FG000|Overall Study|Lost to Follow-up|1|||
16167915|NCT00654498|39095100|FG001|Overall Study|Lost to Follow-up|5|||
16167916|NCT00654498|39095099|FG000|Overall Study|Withdrawal by Subject|1|||
16167917|NCT00654498|39095100|FG001|Overall Study|Withdrawal by Subject|0|||
16167918|NCT00654498|39095099|FG000|Overall Study|Other reason not defined above|4|||
16167919|NCT00654498|39095100|FG001|Overall Study|Other reason not defined above|5|||
16167920|NCT03823391|39095101|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
16167921|NCT03823391|39095102|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
16167922|NCT03823391|39095101|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
16167923|NCT03823391|39095102|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
16167924|NCT03882424|39095103|FG000|Overall Study|Lost to Follow-up|3|||
16167925|NCT03882424|39095104|FG001|Overall Study|Lost to Follow-up|0|||
16167926|NCT03882424|39095105|FG002|Overall Study|Lost to Follow-up|0|||
16167927|NCT03882424|39095103|FG000|Overall Study|schedule conflict|1|||
16167928|NCT03882424|39095104|FG001|Overall Study|schedule conflict|0|||
16167929|NCT03882424|39095105|FG002|Overall Study|schedule conflict|0|||
16167930|NCT00849667|39095109|FG000|Overall Study|Withdrawal by Subject|16|||
16167931|NCT00849667|39095110|FG001|Overall Study|Withdrawal by Subject|33|||
16167932|NCT00849667|39095111|FG002|Overall Study|Withdrawal by Subject|35|||
16167933|NCT00849667|39095109|FG000|Overall Study|Lost to Follow-up|8|||
16167934|NCT00849667|39095110|FG001|Overall Study|Lost to Follow-up|8|||
16167935|NCT00849667|39095111|FG002|Overall Study|Lost to Follow-up|8|||
16167936|NCT00849667|39095109|FG000|Overall Study|Adverse Event|1|||
16167937|NCT00849667|39095110|FG001|Overall Study|Adverse Event|2|||
16167938|NCT00849667|39095111|FG002|Overall Study|Adverse Event|0|||
16167939|NCT00849667|39095109|FG000|Overall Study|Other|18|||
16167940|NCT00849667|39095110|FG001|Overall Study|Other|19|||
16167941|NCT00849667|39095111|FG002|Overall Study|Other|18|||
16167942|NCT00849667|39095109|FG000|Overall Study|Progressive disease|119|||
16167943|NCT00849667|39095110|FG001|Overall Study|Progressive disease|100|||
16167944|NCT00849667|39095111|FG002|Overall Study|Progressive disease|112|||
16167945|NCT00849667|39095109|FG000|Overall Study|Sponsor decision|208|||
16460531|NCT00992589|40165811|FG001|Open-Label Phase|Lost to Follow-up|0|||
16167946|NCT00849667|39095110|FG001|Overall Study|Sponsor decision|204|||
16167947|NCT00849667|39095111|FG002|Overall Study|Sponsor decision|190|||
16167948|NCT00849667|39095109|FG000|Overall Study|Investigator discretion|0|||
16167949|NCT00849667|39095110|FG001|Overall Study|Investigator discretion|0|||
16167950|NCT00849667|39095111|FG002|Overall Study|Investigator discretion|1|||
16167951|NCT04269395|39095112|FG000|Overall Study|Lost to Follow-up|1|||
16167952|NCT04269395|39095113|FG001|Overall Study|Lost to Follow-up|0|||
16167953|NCT04269395|39095112|FG000|Overall Study|Study terminated by Sponsor|13|||
16167954|NCT04269395|39095113|FG001|Overall Study|Study terminated by Sponsor|10|||
16167955|NCT02663895|39095114|FG000|Overall Study|Adverse Event|3|||
16167956|NCT02663895|39095114|FG000|Overall Study|Physician Decision|2|||
16167957|NCT02663895|39095114|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
16167958|NCT02663895|39095114|FG000|Overall Study|Withdrawal by Subject|1|||
16167959|NCT00508391|39095115|FG000|First Treatment|Withdrawal by Subject|6|||
16167960|NCT00508391|39095116|FG001|First Treatment|Withdrawal by Subject|3|||
16167961|NCT00508391|39095115|FG000|Second Treatment|Withdrawal by Subject|2|||
16167962|NCT00508391|39095116|FG001|Second Treatment|Withdrawal by Subject|0|||
16167963|NCT02382133|39095117|FG000|Overall Study|Death|22|||
16167964|NCT02382133|39095117|FG000|Overall Study|transfer out of ICU|4|||
16167965|NCT02382133|39095117|FG000|Overall Study|Physician Decision|2|||
16167966|NCT02382133|39095117|FG000|Overall Study|arterial catheter loss|4|||
16167967|NCT02382133|39095117|FG000|Overall Study|pressure injury both sites|1|||
16167968|NCT01869348|39095123|FG000|Overall Study|Withdrawal by Subject|1|||
16167969|NCT01869348|39095124|FG001|Overall Study|Withdrawal by Subject|1|||
16167970|NCT01444300|39095125|FG000|Overall Study|Adverse Event|4|||
16167971|NCT01444300|39095126|FG001|Overall Study|Adverse Event|0|||
16167972|NCT02507349|39095129|FG000|Overall Study|Death|12|||
16167973|NCT02507349|39095130|FG001|Overall Study|Death|16|||
16167974|NCT02507349|39095129|FG000|Overall Study|Withdrawal by Subject|1|||
16167975|NCT02507349|39095130|FG001|Overall Study|Withdrawal by Subject|1|||
16167976|NCT02507349|39095129|FG000|Overall Study|Lost to Follow-up|174|||
16167977|NCT02507349|39095130|FG001|Overall Study|Lost to Follow-up|144|||
16167978|NCT00553462|39095131|FG000|Overall Study|Adverse Event|4|||
16167979|NCT00553462|39095131|FG000|Overall Study|Progression|4|||
16167980|NCT00553462|39095131|FG000|Overall Study|Withdrawal by Subject|5|||
16167981|NCT00553462|39095131|FG000|Overall Study|Physician Decision|1|||
16460532|NCT00992589|40165812|FG002|Open-Label Phase|Lost to Follow-up|0|||
16167982|NCT00605267|39095134|FG000|Overall Study|Adverse Event|0|||
16167983|NCT00605267|39095135|FG001|Overall Study|Adverse Event|1|||
16167984|NCT00605267|39095134|FG000|Overall Study|Lack of Efficacy|1|||
16167985|NCT00605267|39095135|FG001|Overall Study|Lack of Efficacy|5|||
16167986|NCT00605267|39095134|FG000|Overall Study|Withdrawal by Subject|2|||
16167987|NCT00605267|39095135|FG001|Overall Study|Withdrawal by Subject|3|||
16167988|NCT00802360|39095136|FG000|Overall Study|Stimulation failure|4|||
16167989|NCT00802360|39095137|FG001|Overall Study|Stimulation failure|0|||
16167990|NCT00802360|39095138|FG002|Overall Study|Stimulation failure|3|||
16167991|NCT00802360|39095139|FG003|Overall Study|Stimulation failure|3|||
16167992|NCT00802360|39095136|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
16167993|NCT00802360|39095137|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
16167994|NCT00802360|39095138|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
16167995|NCT00802360|39095139|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
16167996|NCT00802360|39095136|FG000|Overall Study|Cycle cancelled|0|||
16167997|NCT00802360|39095137|FG001|Overall Study|Cycle cancelled|1|||
16167998|NCT00802360|39095138|FG002|Overall Study|Cycle cancelled|1|||
16167999|NCT00802360|39095139|FG003|Overall Study|Cycle cancelled|1|||
16168000|NCT00802360|39095136|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
16168001|NCT00802360|39095137|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
16168002|NCT00802360|39095138|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
16168003|NCT00802360|39095139|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
16168004|NCT00802360|39095136|FG000|Overall Study|No positive serum pregnancy|17|||
16168005|NCT00802360|39095137|FG001|Overall Study|No positive serum pregnancy|20|||
16168006|NCT00802360|39095138|FG002|Overall Study|No positive serum pregnancy|14|||
16460533|NCT00992589|40165813|FG003|Open-Label Phase|Lost to Follow-up|0|||
16460534|NCT00992589|40165810|FG000|Open-Label Phase|Protocol Violation|3|||
16460535|NCT00992589|40165811|FG001|Open-Label Phase|Protocol Violation|0|||
16460536|NCT00992589|40165812|FG002|Open-Label Phase|Protocol Violation|0|||
16460537|NCT00992589|40165813|FG003|Open-Label Phase|Protocol Violation|0|||
16460538|NCT00992589|40165810|FG000|Open-Label Phase|Physician Decision|4|||
16460539|NCT00992589|40165811|FG001|Open-Label Phase|Physician Decision|0|||
16460540|NCT00992589|40165812|FG002|Open-Label Phase|Physician Decision|0|||
16460541|NCT00992589|40165813|FG003|Open-Label Phase|Physician Decision|0|||
16460542|NCT00992589|40165810|FG000|Open-Label Phase|Other|45|||
16460543|NCT00992589|40165811|FG001|Open-Label Phase|Other|0|||
16460544|NCT00992589|40165812|FG002|Open-Label Phase|Other|0|||
16460545|NCT00992589|40165813|FG003|Open-Label Phase|Other|0|||
16460546|NCT00992589|40165810|FG000|Double-Blind Phase|Adverse Event|0|||
16460547|NCT00992589|40165811|FG001|Double-Blind Phase|Adverse Event|6|||
16460548|NCT00992589|40165812|FG002|Double-Blind Phase|Adverse Event|2|||
16460549|NCT00992589|40165813|FG003|Double-Blind Phase|Adverse Event|3|||
16460550|NCT00992589|40165810|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
16460551|NCT00992589|40165811|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
16460552|NCT00992589|40165812|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
16460553|NCT00992589|40165813|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
16460554|NCT00992589|40165810|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16460555|NCT00992589|40165811|FG001|Double-Blind Phase|Lost to Follow-up|0|||
16460556|NCT00992589|40165812|FG002|Double-Blind Phase|Lost to Follow-up|0|||
16460557|NCT00992589|40165813|FG003|Double-Blind Phase|Lost to Follow-up|2|||
16460558|NCT00992589|40165810|FG000|Double-Blind Phase|Other|0|||
16460559|NCT00992589|40165811|FG001|Double-Blind Phase|Other|1|||
16460560|NCT00992589|40165812|FG002|Double-Blind Phase|Other|6|||
16168007|NCT00802360|39095139|FG003|Overall Study|No positive serum pregnancy|10|||
16168008|NCT00802360|39095136|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
16168009|NCT00802360|39095137|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
16168010|NCT00802360|39095138|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
16168011|NCT00802360|39095139|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
16168012|NCT00802360|39095136|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
16168013|NCT00802360|39095137|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
16168014|NCT00802360|39095138|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
16168015|NCT00802360|39095139|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
16168016|NCT00802360|39095136|FG000|Overall Study|Other|2|||
16460561|NCT00992589|40165813|FG003|Double-Blind Phase|Other|3|||
16460562|NCT04657666|40165814|FG000|Period 1|Withdrawal of participant consent|2|||
16460563|NCT04657666|40165815|FG001|Period 1|Withdrawal of participant consent|1|||
16460564|NCT04657666|40165814|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
16460565|NCT04657666|40165815|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
16460566|NCT04657666|40165814|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
16460567|NCT04657666|40165815|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
16460568|NCT04657666|40165814|FG000|Period 2|Other|2|||
16460569|NCT04657666|40165815|FG001|Period 2|Other|0|||
16460570|NCT04657666|40165814|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
16460571|NCT04657666|40165815|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
16460572|NCT00233454|40165816|FG000|Overall Study|Death|6|||
16460573|NCT01754402|40165819|FG000|Overall Study|Death|0|||
16460574|NCT01754402|40165820|FG001|Overall Study|Death|0|||
16460575|NCT01754402|40165821|FG002|Overall Study|Death|1|||
16168017|NCT00802360|39095137|FG001|Overall Study|Other|3|||
16460576|NCT01754402|40165819|FG000|Overall Study|Adverse Event|2|||
16168018|NCT00802360|39095138|FG002|Overall Study|Other|6|||
16168019|NCT00802360|39095139|FG003|Overall Study|Other|3|||
16460577|NCT01754402|40165820|FG001|Overall Study|Adverse Event|2|||
16460578|NCT01754402|40165821|FG002|Overall Study|Adverse Event|1|||
16460579|NCT01754402|40165819|FG000|Overall Study|Withdrawal by Subject|0|||
16460580|NCT01754402|40165820|FG001|Overall Study|Withdrawal by Subject|0|||
16460581|NCT01754402|40165821|FG002|Overall Study|Withdrawal by Subject|1|||
16460582|NCT01754402|40165819|FG000|Overall Study|Lack of Efficacy|0|||
16460583|NCT01754402|40165820|FG001|Overall Study|Lack of Efficacy|0|||
16460584|NCT01754402|40165821|FG002|Overall Study|Lack of Efficacy|1|||
16460585|NCT01755026|40165823|FG000|Overall Study|Adverse Event|1|||
16460586|NCT01755026|40165824|FG001|Overall Study|Adverse Event|0|||
16460587|NCT01755026|40165823|FG000|Overall Study|Withdrawal by Subject|1|||
16460588|NCT01755026|40165824|FG001|Overall Study|Withdrawal by Subject|1|||
16460589|NCT01149148|40165830|FG000|Overall Study|Lost to Follow-up|1|||
16460590|NCT01149148|40165831|FG001|Overall Study|Lost to Follow-up|2|||
16460591|NCT01149148|40165830|FG000|Overall Study|Death|1|||
16460592|NCT01149148|40165831|FG001|Overall Study|Death|0|||
16460593|NCT01105065|40165832|FG000|Overall Study|Adverse Event|5|||
16460594|NCT01105065|40165832|FG000|Overall Study|Technical Problems|1|||
16460595|NCT02437110|40165834|FG000|Screening|Lost to Follow-up|3|||
16460596|NCT02437110|40165834|FG000|Screening|Physician Decision|1|||
16460597|NCT02437110|40165834|FG000|ART|Adverse Event|3|||
16460598|NCT02437110|40165834|FG000|ART|Protocol Violation|3|||
16460599|NCT02437110|40165834|FG000|ART|Withdrawal by Subject|4|||
16460600|NCT02437110|40165834|FG000|ART|Lost to follow-up prior to start of intervention|1|||
16460601|NCT02437110|40165834|FG000|ART|Physician decision prior to start of intervention|2|||
16460602|NCT02437110|40165834|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
16460603|NCT02437110|40165834|FG000|Post-ART|Lost to Follow-up|3|||
16460604|NCT02437110|40165834|FG000|Post-ART|Protocol Violation|4|||
16460605|NCT02437110|40165834|FG000|Post-ART|Withdrawal by Subject|3|||
16460606|NCT01332799|40165835|FG000|Overall Study|Insufficient funding|10|||
16460607|NCT01332799|40165836|FG001|Overall Study|Insufficient funding|10|||
16460608|NCT00160667|40165837|FG000|Overall Study|Adverse Event|3|||
16460609|NCT00160667|40165838|FG001|Overall Study|Adverse Event|1|||
16460610|NCT00160667|40165839|FG002|Overall Study|Adverse Event|4|||
16168020|NCT02487108|39095146|FG000|Overall Study|Adverse Event|1|||
16460611|NCT00160667|40165837|FG000|Overall Study|Withdrawal by Subject|2|||
16460612|NCT00160667|40165838|FG001|Overall Study|Withdrawal by Subject|0|||
16460613|NCT00160667|40165839|FG002|Overall Study|Withdrawal by Subject|1|||
16460614|NCT00160667|40165837|FG000|Overall Study|Lack of Efficacy|0|||
16168021|NCT02487108|39095147|FG001|Overall Study|Adverse Event|6|||
16168022|NCT02487108|39095148|FG002|Overall Study|Adverse Event|12|||
16168023|NCT02487108|39095149|FG003|Overall Study|Adverse Event|6|||
16460615|NCT00160667|40165838|FG001|Overall Study|Lack of Efficacy|1|||
16460616|NCT00160667|40165839|FG002|Overall Study|Lack of Efficacy|0|||
16460617|NCT00160667|40165837|FG000|Overall Study|Protocol Violation|0|||
16460618|NCT00160667|40165838|FG001|Overall Study|Protocol Violation|1|||
16460619|NCT00160667|40165839|FG002|Overall Study|Protocol Violation|0|||
16460620|NCT00160667|40165837|FG000|Overall Study|Patient decision|0|||
16460621|NCT00160667|40165838|FG001|Overall Study|Patient decision|0|||
16460622|NCT00160667|40165839|FG002|Overall Study|Patient decision|1|||
16460623|NCT02880956|40165840|FG000|Overall Study|Adverse Event|3|||
16460624|NCT02880956|40165841|FG001|Overall Study|Adverse Event|6|||
16168024|NCT02487108|39095146|FG000|Overall Study|Withdrawal by Subject|8|||
16168025|NCT02487108|39095147|FG001|Overall Study|Withdrawal by Subject|5|||
16460625|NCT02880956|40165842|FG002|Overall Study|Adverse Event|5|||
16460626|NCT02880956|40165843|FG003|Overall Study|Adverse Event|4|||
16460627|NCT02880956|40165840|FG000|Overall Study|Withdrawal by Subject|9|||
16460628|NCT02880956|40165841|FG001|Overall Study|Withdrawal by Subject|4|||
16460629|NCT02880956|40165842|FG002|Overall Study|Withdrawal by Subject|6|||
16460630|NCT02880956|40165843|FG003|Overall Study|Withdrawal by Subject|11|||
16460631|NCT02880956|40165840|FG000|Overall Study|Lost to Follow-up|0|||
16460632|NCT02880956|40165841|FG001|Overall Study|Lost to Follow-up|1|||
16460633|NCT02880956|40165842|FG002|Overall Study|Lost to Follow-up|0|||
16460634|NCT02880956|40165843|FG003|Overall Study|Lost to Follow-up|0|||
16460635|NCT02880956|40165840|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
16460636|NCT02880956|40165841|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
16460637|NCT02880956|40165842|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
16460638|NCT02880956|40165843|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
16168026|NCT02487108|39095148|FG002|Overall Study|Withdrawal by Subject|5|||
16168027|NCT02487108|39095149|FG003|Overall Study|Withdrawal by Subject|0|||
16460639|NCT02880956|40165840|FG000|Overall Study|Other, Not Specified|4|||
16168028|NCT02487108|39095146|FG000|Overall Study|Non-compliance to study medication|3|||
16460640|NCT02880956|40165841|FG001|Overall Study|Other, Not Specified|2|||
16460641|NCT02880956|40165842|FG002|Overall Study|Other, Not Specified|0|||
16460642|NCT02880956|40165843|FG003|Overall Study|Other, Not Specified|3|||
16460643|NCT01675544|40165844|FG000|Overall Study|Withdrawal by Subject|2|||
16168029|NCT02487108|39095147|FG001|Overall Study|Non-compliance to study medication|2|||
16460644|NCT00759564|40165845|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
16460645|NCT00759564|40165846|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
16460646|NCT00759564|40165847|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
16460647|NCT00759564|40165848|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
16168030|NCT02487108|39095148|FG002|Overall Study|Non-compliance to study medication|5|||
16168031|NCT02487108|39095149|FG003|Overall Study|Non-compliance to study medication|4|||
16168032|NCT02487108|39095146|FG000|Overall Study|Protocol Violation|1|||
16168033|NCT02487108|39095147|FG001|Overall Study|Protocol Violation|1|||
16168034|NCT02487108|39095148|FG002|Overall Study|Protocol Violation|2|||
16168035|NCT02487108|39095149|FG003|Overall Study|Protocol Violation|0|||
16168036|NCT02487108|39095146|FG000|Overall Study|Non-compliance to study procedures|0|||
16168037|NCT02487108|39095147|FG001|Overall Study|Non-compliance to study procedures|0|||
16460648|NCT00759564|40165849|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
16460649|NCT02551991|40165850|FG000|Overall Study|Death|5|||
16460650|NCT02551991|40165851|FG001|Overall Study|Death|7|||
16460651|NCT02551991|40165852|FG002|Overall Study|Death|8|||
16460652|NCT02551991|40165853|FG003|Overall Study|Death|7|||
16460653|NCT02551991|40165854|FG004|Overall Study|Death|17|||
16460654|NCT02551991|40165850|FG000|Overall Study|Withdrawal by Subject|1|||
16460655|NCT02551991|40165851|FG001|Overall Study|Withdrawal by Subject|0|||
16460656|NCT02551991|40165852|FG002|Overall Study|Withdrawal by Subject|0|||
16168038|NCT02487108|39095148|FG002|Overall Study|Non-compliance to study procedures|0|||
16460657|NCT02551991|40165853|FG003|Overall Study|Withdrawal by Subject|0|||
16460658|NCT02551991|40165854|FG004|Overall Study|Withdrawal by Subject|2|||
16460659|NCT02551991|40165850|FG000|Overall Study|Lost to Follow-up|0|||
16460660|NCT02551991|40165851|FG001|Overall Study|Lost to Follow-up|0|||
16460661|NCT02551991|40165852|FG002|Overall Study|Lost to Follow-up|1|||
16460662|NCT02551991|40165853|FG003|Overall Study|Lost to Follow-up|0|||
16460663|NCT02551991|40165854|FG004|Overall Study|Lost to Follow-up|0|||
16460664|NCT02551991|40165850|FG000|Overall Study|Sponsor Decision|1|||
16460665|NCT02551991|40165851|FG001|Overall Study|Sponsor Decision|0|||
16460666|NCT02551991|40165852|FG002|Overall Study|Sponsor Decision|1|||
16460667|NCT02551991|40165853|FG003|Overall Study|Sponsor Decision|0|||
16460668|NCT02551991|40165854|FG004|Overall Study|Sponsor Decision|5|||
16460669|NCT02551991|40165850|FG000|Overall Study|Other|0|||
16460670|NCT02551991|40165851|FG001|Overall Study|Other|0|||
16460671|NCT02551991|40165852|FG002|Overall Study|Other|0|||
16460672|NCT02551991|40165853|FG003|Overall Study|Other|0|||
16460673|NCT02551991|40165854|FG004|Overall Study|Other|1|||
16460674|NCT00724711|40165856|FG000|Overall Study|Adverse Event|7|||
16460675|NCT00724711|40165857|FG001|Overall Study|Adverse Event|3|||
16460676|NCT00724711|40165856|FG000|Overall Study|Pregnancy|0|||
16460677|NCT00724711|40165857|FG001|Overall Study|Pregnancy|1|||
16460678|NCT00724711|40165856|FG000|Overall Study|Lack of Efficacy|0|||
16460679|NCT00724711|40165857|FG001|Overall Study|Lack of Efficacy|1|||
16460680|NCT00724711|40165856|FG000|Overall Study|Physician Decision|0|||
16460681|NCT00724711|40165857|FG001|Overall Study|Physician Decision|3|||
16460682|NCT00724711|40165856|FG000|Overall Study|Withdrawal by Subject|5|||
16460683|NCT00724711|40165857|FG001|Overall Study|Withdrawal by Subject|4|||
16460684|NCT00724711|40165856|FG000|Overall Study|Lost to Follow-up|4|||
16460685|NCT00724711|40165857|FG001|Overall Study|Lost to Follow-up|5|||
16460686|NCT00724711|40165856|FG000|Overall Study|Protocol Violation|1|||
16460687|NCT00724711|40165857|FG001|Overall Study|Protocol Violation|0|||
16460688|NCT01978938|40165858|FG000|Overall Study|Lost to Follow-up|12|||
16460689|NCT01978938|40165859|FG001|Overall Study|Lost to Follow-up|6|||
16168039|NCT02487108|39095149|FG003|Overall Study|Non-compliance to study procedures|1|||
16168040|NCT02487108|39095146|FG000|Overall Study|Other than specified|3|||
16168041|NCT02487108|39095147|FG001|Overall Study|Other than specified|2|||
16168042|NCT02487108|39095148|FG002|Overall Study|Other than specified|2|||
16168043|NCT02487108|39095149|FG003|Overall Study|Other than specified|0|||
16168044|NCT01468311|39095159|FG000|Overall Study|mobilization failure|1|||
16460690|NCT01978938|40165858|FG000|Overall Study|Withdrawal by Subject|8|||
16460691|NCT01978938|40165859|FG001|Overall Study|Withdrawal by Subject|4|||
16460692|NCT01978938|40165858|FG000|Overall Study|Adverse Event, non-fatal|2|||
16168045|NCT01468311|39095159|FG000|Overall Study|Withdrawal by Subject|1|||
16168046|NCT00486902|39095160|FG000|Overall Study|Withdrawal by Subject|1|||
16168047|NCT00486902|39095161|FG001|Overall Study|Withdrawal by Subject|2|||
16460693|NCT01978938|40165859|FG001|Overall Study|Adverse Event, non-fatal|1|||
16460694|NCT01978938|40165858|FG000|Overall Study|Participant noncompliance|1|||
16460695|NCT01978938|40165859|FG001|Overall Study|Participant noncompliance|1|||
16460696|NCT01978938|40165858|FG000|Overall Study|Did not meet inclusion criteria|0|||
16460697|NCT01978938|40165859|FG001|Overall Study|Did not meet inclusion criteria|1|||
16460698|NCT01978938|40165858|FG000|Overall Study|Previously scheduled procedure|0|||
16460699|NCT01978938|40165859|FG001|Overall Study|Previously scheduled procedure|1|||
16168048|NCT00486902|39095160|FG000|Overall Study|decision for postpartum tubal ligation|3|||
16460700|NCT01284491|40165860|FG000|Overall Study|Study termination|13|||
16460701|NCT01325337|40165862|FG000|Overall Study|Adverse Event|0|||
16460702|NCT01325337|40165863|FG001|Overall Study|Adverse Event|2|||
16460703|NCT01325337|40165864|FG002|Overall Study|Adverse Event|2|||
16460704|NCT01325337|40165865|FG003|Overall Study|Adverse Event|1|||
16460705|NCT01325337|40165866|FG004|Overall Study|Adverse Event|2|||
16460706|NCT01325337|40165862|FG000|Overall Study|Lost to Follow-up|2|||
16460707|NCT01325337|40165863|FG001|Overall Study|Lost to Follow-up|2|||
16460708|NCT01325337|40165864|FG002|Overall Study|Lost to Follow-up|2|||
16460709|NCT01325337|40165865|FG003|Overall Study|Lost to Follow-up|1|||
16460710|NCT01325337|40165866|FG004|Overall Study|Lost to Follow-up|2|||
16460711|NCT01325337|40165862|FG000|Overall Study|Personal Reasons|2|||
16460712|NCT01325337|40165863|FG001|Overall Study|Personal Reasons|5|||
16460713|NCT01325337|40165864|FG002|Overall Study|Personal Reasons|4|||
16460714|NCT01325337|40165865|FG003|Overall Study|Personal Reasons|8|||
16460715|NCT01325337|40165866|FG004|Overall Study|Personal Reasons|3|||
16460716|NCT01325337|40165862|FG000|Overall Study|Withdrawal by Subject|1|||
16460717|NCT01325337|40165863|FG001|Overall Study|Withdrawal by Subject|0|||
16460718|NCT01325337|40165864|FG002|Overall Study|Withdrawal by Subject|1|||
16460719|NCT01325337|40165865|FG003|Overall Study|Withdrawal by Subject|0|||
16460720|NCT01325337|40165866|FG004|Overall Study|Withdrawal by Subject|1|||
16460721|NCT00096356|40165867|FG000|Overall Study|Adverse Event|11|||
16460722|NCT00096356|40165868|FG001|Overall Study|Adverse Event|9|||
16460723|NCT00096356|40165867|FG000|Overall Study|Physician Decision|5|||
16460724|NCT00096356|40165868|FG001|Overall Study|Physician Decision|3|||
16460725|NCT00096356|40165867|FG000|Overall Study|Withdrawal by Subject|17|||
16460726|NCT00096356|40165868|FG001|Overall Study|Withdrawal by Subject|23|||
16460727|NCT00096356|40165867|FG000|Overall Study|Lack of Efficacy|1|||
16460728|NCT00096356|40165868|FG001|Overall Study|Lack of Efficacy|0|||
16460729|NCT00096356|40165867|FG000|Overall Study|multiple reasons|10|||
16460730|NCT00096356|40165868|FG001|Overall Study|multiple reasons|18|||
16460731|NCT00348881|40165876|FG000|Overall Study|Lost to Follow-up|12|||
16460732|NCT00348881|40165877|FG001|Overall Study|Lost to Follow-up|6|||
16460733|NCT00348881|40165876|FG000|Overall Study|Withdrawal by Subject|3|||
16460734|NCT00348881|40165877|FG001|Overall Study|Withdrawal by Subject|4|||
16460735|NCT00348881|40165876|FG000|Overall Study|Adverse Event|2|||
16460736|NCT00348881|40165877|FG001|Overall Study|Adverse Event|0|||
16460737|NCT00348881|40165876|FG000|Overall Study|Serious Adverse Event|0|||
16460738|NCT00348881|40165877|FG001|Overall Study|Serious Adverse Event|2|||
16460739|NCT00668733|40165895|FG000|Overall Study|Lost to Follow-up|2|||
16460740|NCT00668733|40165896|FG001|Overall Study|Lost to Follow-up|3|||
16460741|NCT00668733|40165895|FG000|Overall Study|Withdrawal by Subject|0|||
16460742|NCT00668733|40165896|FG001|Overall Study|Withdrawal by Subject|4|||
16460743|NCT02743611|40165899|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
16460744|NCT02743611|40165900|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
16460745|NCT02743611|40165901|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
16460746|NCT02743611|40165902|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
16460747|NCT03531632|40165903|FG000|Overall Study|Adverse Event|0|||
16460748|NCT03531632|40165904|FG001|Overall Study|Adverse Event|0|||
16460749|NCT03531632|40165905|FG002|Overall Study|Adverse Event|1|||
16460750|NCT03531632|40165903|FG000|Overall Study|Death|4|||
16460751|NCT03531632|40165904|FG001|Overall Study|Death|0|||
16460752|NCT03531632|40165905|FG002|Overall Study|Death|14|||
16460753|NCT03531632|40165903|FG000|Overall Study|Study Terminated|1|||
16460754|NCT03531632|40165904|FG001|Overall Study|Study Terminated|3|||
16460755|NCT03531632|40165905|FG002|Overall Study|Study Terminated|11|||
16460756|NCT01788358|40165906|FG000|Overall Study|Other|11|||
16460757|NCT01788358|40165906|FG000|Overall Study|Logistical difficulties|1|||
16460758|NCT01788358|40165906|FG000|Overall Study|Lost to Follow-up|5|||
16460759|NCT01788358|40165906|FG000|Overall Study|Protocol Violation|3|||
16460760|NCT01788358|40165906|FG000|Overall Study|Withdrawal by Subject|26|||
16460761|NCT01788358|40165906|FG000|Overall Study|Lack of Efficacy|1|||
16460762|NCT01788358|40165906|FG000|Overall Study|Adverse Event|51|||
16460763|NCT00499616|40165908|FG000|Overall Study|Death|1|||
16460764|NCT00499616|40165909|FG001|Overall Study|Death|5|||
16460765|NCT00499616|40165910|FG002|Overall Study|Death|3|||
16460766|NCT00499616|40165911|FG003|Overall Study|Death|1|||
16460767|NCT00499616|40165908|FG000|Overall Study|Lack of Efficacy|5|||
16460768|NCT00499616|40165909|FG001|Overall Study|Lack of Efficacy|0|||
16460769|NCT00499616|40165910|FG002|Overall Study|Lack of Efficacy|19|||
16460770|NCT00499616|40165911|FG003|Overall Study|Lack of Efficacy|0|||
16460771|NCT00499616|40165908|FG000|Overall Study|Lost to Follow-up|0|||
16460772|NCT00499616|40165909|FG001|Overall Study|Lost to Follow-up|0|||
16460773|NCT00499616|40165910|FG002|Overall Study|Lost to Follow-up|1|||
16460774|NCT00499616|40165911|FG003|Overall Study|Lost to Follow-up|0|||
16460775|NCT00499616|40165908|FG000|Overall Study|Physician Decision|6|||
16460776|NCT00499616|40165909|FG001|Overall Study|Physician Decision|16|||
16460777|NCT00499616|40165910|FG002|Overall Study|Physician Decision|9|||
16460778|NCT00499616|40165911|FG003|Overall Study|Physician Decision|0|||
16460779|NCT00499616|40165908|FG000|Overall Study|Withdrawal by Subject|1|||
16460780|NCT00499616|40165909|FG001|Overall Study|Withdrawal by Subject|0|||
16460781|NCT00499616|40165910|FG002|Overall Study|Withdrawal by Subject|1|||
16460782|NCT00499616|40165911|FG003|Overall Study|Withdrawal by Subject|0|||
16460783|NCT00499616|40165908|FG000|Overall Study|Ineligible|1|||
16460784|NCT00499616|40165909|FG001|Overall Study|Ineligible|2|||
16460785|NCT00499616|40165910|FG002|Overall Study|Ineligible|0|||
16460786|NCT00499616|40165911|FG003|Overall Study|Ineligible|15|||
16460787|NCT00499616|40165908|FG000|Overall Study|Not evaluable|0|||
16460788|NCT00499616|40165909|FG001|Overall Study|Not evaluable|0|||
16460789|NCT00499616|40165910|FG002|Overall Study|Not evaluable|0|||
16460790|NCT00499616|40165911|FG003|Overall Study|Not evaluable|41|||
16460791|NCT00499616|40165908|FG000|Overall Study|Patient/Parent Refusal|1|||
16460792|NCT00499616|40165909|FG001|Overall Study|Patient/Parent Refusal|5|||
16460793|NCT00499616|40165910|FG002|Overall Study|Patient/Parent Refusal|3|||
16460794|NCT00499616|40165911|FG003|Overall Study|Patient/Parent Refusal|0|||
16460795|NCT03316911|40165912|FG000|Overall Study|Lost to Follow-up|33|||
16460796|NCT03316911|40165913|FG001|Overall Study|Lost to Follow-up|29|||
16460797|NCT02527200|40165914|FG000|Overall Study|Withdrawal by Subject|3|||
16460798|NCT02527200|40165915|FG001|Overall Study|Withdrawal by Subject|2|||
16460799|NCT02527200|40165916|FG002|Overall Study|Withdrawal by Subject|1|||
16460800|NCT02527200|40165917|FG003|Overall Study|Withdrawal by Subject|0|||
16460801|NCT02527200|40165914|FG000|Overall Study|Unclassified|0|||
16460802|NCT02527200|40165915|FG001|Overall Study|Unclassified|1|||
16460803|NCT02527200|40165916|FG002|Overall Study|Unclassified|0|||
16460804|NCT02527200|40165917|FG003|Overall Study|Unclassified|0|||
16460805|NCT02527200|40165914|FG000|Overall Study|Lost to Follow-up|0|||
16460806|NCT02527200|40165915|FG001|Overall Study|Lost to Follow-up|0|||
16460807|NCT02527200|40165916|FG002|Overall Study|Lost to Follow-up|1|||
16460808|NCT02527200|40165917|FG003|Overall Study|Lost to Follow-up|0|||
16460809|NCT00796445|40165918|FG000|Overall Study|Protocol Violation|5|||
16460810|NCT00796445|40165919|FG001|Overall Study|Protocol Violation|3|||
16460811|NCT00796445|40165918|FG000|Overall Study|Adverse event, serious fatal|10|||
16460812|NCT00796445|40165919|FG001|Overall Study|Adverse event, serious fatal|5|||
16460813|NCT00796445|40165918|FG000|Overall Study|Adverse event, non-fatal|4|||
16460814|NCT00796445|40165919|FG001|Overall Study|Adverse event, non-fatal|0|||
16460815|NCT00796445|40165918|FG000|Overall Study|Disease progression/recurrence|537|||
16460816|NCT00796445|40165919|FG001|Overall Study|Disease progression/recurrence|268|||
16460817|NCT00796445|40165918|FG000|Overall Study|Other|10|||
16460818|NCT00796445|40165919|FG001|Overall Study|Other|7|||
16460819|NCT00796445|40165918|FG000|Overall Study|Withdrawal by Subject|18|||
16460820|NCT00796445|40165919|FG001|Overall Study|Withdrawal by Subject|9|||
16460821|NCT00796445|40165918|FG000|Overall Study|Invalid Informed Consent Form|1|||
16460822|NCT00796445|40165919|FG001|Overall Study|Invalid Informed Consent Form|0|||
16460823|NCT01589653|40165920|FG000|Overall Study|Protocol Violation|3|||
16460824|NCT01589653|40165921|FG001|Overall Study|Protocol Violation|1|||
16460825|NCT01589653|40165920|FG000|Overall Study|Withdrawal criteria|4|||
16460826|NCT01589653|40165921|FG001|Overall Study|Withdrawal criteria|7|||
16460827|NCT01589653|40165920|FG000|Overall Study|Unclassified|0|||
16460828|NCT01589653|40165921|FG001|Overall Study|Unclassified|3|||
16460829|NCT00573144|40165929|FG000|Overall Study|Withdrawal by Subject|2|||
16460830|NCT00573144|40165930|FG001|Overall Study|Withdrawal by Subject|3|||
16460831|NCT00946153|40165933|FG000|Phase 2|Adverse Event|0|||
16460832|NCT00946153|40165934|FG001|Phase 2|Adverse Event|0|||
16460833|NCT00946153|40165935|FG002|Phase 2|Adverse Event|0|||
16460834|NCT00946153|40165936|FG003|Phase 2|Adverse Event|0|||
16460835|NCT00946153|40165937|FG004|Phase 2|Adverse Event|6|||
16460836|NCT00946153|40165933|FG000|Phase 2|Need more reduction of dose|0|||
16460837|NCT00946153|40165934|FG001|Phase 2|Need more reduction of dose|0|||
16460838|NCT00946153|40165935|FG002|Phase 2|Need more reduction of dose|0|||
16460839|NCT00946153|40165936|FG003|Phase 2|Need more reduction of dose|0|||
16460840|NCT00946153|40165937|FG004|Phase 2|Need more reduction of dose|2|||
16460841|NCT00946153|40165933|FG000|Phase 2|Physician Decision|0|||
16460842|NCT00946153|40165934|FG001|Phase 2|Physician Decision|0|||
16460843|NCT00946153|40165935|FG002|Phase 2|Physician Decision|0|||
16460844|NCT00946153|40165936|FG003|Phase 2|Physician Decision|0|||
16460845|NCT00946153|40165937|FG004|Phase 2|Physician Decision|1|||
16460846|NCT00946153|40165933|FG000|Phase 2|14 days washout for recovery due to AE|0|||
16460847|NCT00946153|40165934|FG001|Phase 2|14 days washout for recovery due to AE|0|||
16460848|NCT00946153|40165935|FG002|Phase 2|14 days washout for recovery due to AE|0|||
16460849|NCT00946153|40165936|FG003|Phase 2|14 days washout for recovery due to AE|0|||
16460850|NCT00946153|40165937|FG004|Phase 2|14 days washout for recovery due to AE|4|||
16460851|NCT01087736|40165940|FG000|Overall Study|Lost to Follow-up|1|||
16460852|NCT01087736|40165941|FG001|Overall Study|Lost to Follow-up|0|||
16460853|NCT01087736|40165940|FG000|Overall Study|Death|0|||
16460854|NCT01087736|40165941|FG001|Overall Study|Death|1|||
16460855|NCT01087736|40165940|FG000|Overall Study|Withdrawal by Subject|0|||
16460856|NCT01087736|40165941|FG001|Overall Study|Withdrawal by Subject|1|||
16460857|NCT01250496|40165942|FG000|Overall Study|Study terminated|124|||
16460858|NCT01250496|40165943|FG001|Overall Study|Study terminated|124|||
16460859|NCT01601652|40165944|FG000|Overall Study|Death|1|||
16460860|NCT02529553|40165953|FG000|Overall Study|Progressive Disease|1|||
16460861|NCT02529553|40165954|FG001|Overall Study|Progressive Disease|0|||
16460862|NCT02529553|40165955|FG002|Overall Study|Progressive Disease|1|||
16460863|NCT02529553|40165956|FG003|Overall Study|Progressive Disease|3|||
16460864|NCT02529553|40165957|FG004|Overall Study|Progressive Disease|2|||
16460865|NCT02529553|40165958|FG005|Overall Study|Progressive Disease|3|||
16460866|NCT02529553|40165959|FG006|Overall Study|Progressive Disease|3|||
16460867|NCT02529553|40165960|FG007|Overall Study|Progressive Disease|5|||
16460868|NCT02529553|40165961|FG008|Overall Study|Progressive Disease|3|||
16460869|NCT02529553|40165953|FG000|Overall Study|Physician Decision|0|||
16460870|NCT02529553|40165954|FG001|Overall Study|Physician Decision|1|||
16460871|NCT02529553|40165955|FG002|Overall Study|Physician Decision|0|||
16460872|NCT02529553|40165956|FG003|Overall Study|Physician Decision|0|||
16460873|NCT02529553|40165957|FG004|Overall Study|Physician Decision|1|||
16460874|NCT02529553|40165958|FG005|Overall Study|Physician Decision|0|||
16460875|NCT02529553|40165959|FG006|Overall Study|Physician Decision|0|||
16460876|NCT02529553|40165960|FG007|Overall Study|Physician Decision|0|||
16460877|NCT02529553|40165961|FG008|Overall Study|Physician Decision|0|||
16460878|NCT02529553|40165953|FG000|Overall Study|Withdrawal by Subject|0|||
16168049|NCT00486902|39095161|FG001|Overall Study|decision for postpartum tubal ligation|1|||
16168050|NCT00486902|39095160|FG000|Overall Study|spinal anesthetic protocal violation|1|||
16168051|NCT00486902|39095161|FG001|Overall Study|spinal anesthetic protocal violation|1|||
16168052|NCT00486902|39095160|FG000|Overall Study|Did not meet inclusion criteria|1|||
16168053|NCT00486902|39095161|FG001|Overall Study|Did not meet inclusion criteria|0|||
16168054|NCT00486902|39095160|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
16460879|NCT02529553|40165954|FG001|Overall Study|Withdrawal by Subject|0|||
16460880|NCT02529553|40165955|FG002|Overall Study|Withdrawal by Subject|0|||
16460881|NCT02529553|40165956|FG003|Overall Study|Withdrawal by Subject|0|||
16460882|NCT02529553|40165957|FG004|Overall Study|Withdrawal by Subject|0|||
16460883|NCT02529553|40165958|FG005|Overall Study|Withdrawal by Subject|1|||
16460884|NCT02529553|40165959|FG006|Overall Study|Withdrawal by Subject|0|||
16460885|NCT02529553|40165960|FG007|Overall Study|Withdrawal by Subject|1|||
16460886|NCT02529553|40165961|FG008|Overall Study|Withdrawal by Subject|0|||
16460887|NCT01536067|40165962|FG000|Overall Study|Disease Progression|1|||
16460888|NCT01227018|40165963|FG000|Overall Study|Disease progression|9|||
16460889|NCT01227018|40165963|FG000|Overall Study|Toxicity|2|||
16460890|NCT01227018|40165963|FG000|Overall Study|Withdrew after beginning treatment|4|||
16460891|NCT05194579|40165967|FG000|Overall Study|Lost to Follow-up|2|||
16460892|NCT05194579|40165968|FG001|Overall Study|Lost to Follow-up|3|||
16460893|NCT05194579|40165967|FG000|Overall Study|Withdrawal by Subject|3|||
16460894|NCT05194579|40165968|FG001|Overall Study|Withdrawal by Subject|4|||
16460895|NCT05194579|40165967|FG000|Overall Study|Refused further study procedures|0|||
16460896|NCT05194579|40165968|FG001|Overall Study|Refused further study procedures|1|||
16460897|NCT05194579|40165967|FG000|Overall Study|Protocol deviation|1|||
16460898|NCT05194579|40165968|FG001|Overall Study|Protocol deviation|0|||
16460899|NCT00868517|40165973|FG000|Overall Study|Withdrawal by Subject|3|||
16460900|NCT00868517|40165974|FG001|Overall Study|Withdrawal by Subject|3|||
16460901|NCT00868517|40165975|FG002|Overall Study|Withdrawal by Subject|2|||
16460902|NCT00868517|40165973|FG000|Overall Study|Protocol Violation|1|||
16460903|NCT00868517|40165974|FG001|Overall Study|Protocol Violation|1|||
16460904|NCT00868517|40165975|FG002|Overall Study|Protocol Violation|0|||
16460905|NCT01700387|40169030|FG000|Overall Study|Withdrawal by Subject|1|||
16460906|NCT01700387|40169031|FG001|Overall Study|Withdrawal by Subject|2|||
16460907|NCT01700387|40169030|FG000|Overall Study|Adverse Event|1|||
16460908|NCT01700387|40169031|FG001|Overall Study|Adverse Event|1|||
16460909|NCT01700387|40169030|FG000|Overall Study|Lost to Follow-up|2|||
16460910|NCT01700387|40169031|FG001|Overall Study|Lost to Follow-up|1|||
16460911|NCT01282463|40169032|FG000|Overall Study|Lost to Follow-up|1|||
16460912|NCT01282463|40169033|FG001|Overall Study|Lost to Follow-up|0|||
16460913|NCT01282463|40169034|FG002|Overall Study|Lost to Follow-up|0|||
16460914|NCT01282463|40169032|FG000|Overall Study|Withdrawal by Subject|6|||
16460915|NCT01282463|40169033|FG001|Overall Study|Withdrawal by Subject|2|||
16460916|NCT01282463|40169034|FG002|Overall Study|Withdrawal by Subject|3|||
16460917|NCT01282463|40169032|FG000|Overall Study|"Never Treated Death"|0|||
16460918|NCT01282463|40169033|FG001|Overall Study|"Never Treated Death"|1|||
16460919|NCT01282463|40169034|FG002|Overall Study|"Never Treated Death"|0|||
16460920|NCT01282463|40169032|FG000|Overall Study|"Never Treated PD"|0|||
16460921|NCT01282463|40169033|FG001|Overall Study|"Never Treated PD"|1|||
16460922|NCT01282463|40169034|FG002|Overall Study|"Never Treated PD"|0|||
16460923|NCT01282463|40169032|FG000|Overall Study|Protocol Violation|0|||
16460924|NCT01282463|40169033|FG001|Overall Study|Protocol Violation|0|||
16460925|NCT01282463|40169034|FG002|Overall Study|Protocol Violation|1|||
16460926|NCT01282463|40169032|FG000|Overall Study|Physician Decision|1|||
16460927|NCT01282463|40169033|FG001|Overall Study|Physician Decision|0|||
16460928|NCT01282463|40169034|FG002|Overall Study|Physician Decision|0|||
16460929|NCT02730793|40169035|FG000|Overall Study|Physician Decision|0|||
16460930|NCT02730793|40169036|FG001|Overall Study|Physician Decision|1|||
16460931|NCT02730793|40169035|FG000|Overall Study|Withdrawal by Subject|0|||
16460932|NCT02730793|40169036|FG001|Overall Study|Withdrawal by Subject|1|||
16460933|NCT00883688|40169037|FG000|Overall Study|Ineligible|2|||
16460934|NCT00490529|40169038|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
16460935|NCT00490529|40169038|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
16460936|NCT00490529|40169038|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
16460937|NCT00490529|40169038|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
16460938|NCT00490529|40169038|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
16460939|NCT00490529|40169038|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
16460940|NCT01368562|40169039|FG000|Overall Study|Adverse Event|1|||
16460941|NCT01368562|40169039|FG000|Overall Study|Disease progression|1|||
16460942|NCT01368562|40169039|FG000|Overall Study|Lost to Follow-up|1|||
16460943|NCT01368562|40169039|FG000|Overall Study|Death|6|||
16460944|NCT01368562|40169039|FG000|Overall Study|Unresponsive to treatment|5|||
16460945|NCT01368562|40169039|FG000|Overall Study|Other|3|||
16460946|NCT01368562|40169039|FG000|Overall Study|Other than specified|2|||
16460947|NCT03320824|40169042|FG000|Overall Study|Withdrawal by Subject|8|||
16460948|NCT03320824|40169043|FG001|Overall Study|Withdrawal by Subject|1|||
16460949|NCT03320824|40169042|FG000|Overall Study|Lost to Follow-up|10|||
16460950|NCT03320824|40169043|FG001|Overall Study|Lost to Follow-up|1|||
16460951|NCT03320824|40169042|FG000|Overall Study|moved out of state|0|||
16460952|NCT03320824|40169043|FG001|Overall Study|moved out of state|1|||
16460953|NCT03320824|40169042|FG000|Overall Study|could not complete final visit|0|||
16460954|NCT03320824|40169043|FG001|Overall Study|could not complete final visit|1|||
16460955|NCT01129024|40169055|FG000|Overall Study|Physician Decision|5|||
16460956|NCT01129024|40169055|FG000|Overall Study|Study Terminated by Sponsor|8|||
16168055|NCT00486902|39095161|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
16168056|NCT00264004|39095162|FG000|Overall Study|Adverse Event|2|||
16168057|NCT00264004|39095163|FG001|Overall Study|Adverse Event|3|||
16168058|NCT00264004|39095164|FG002|Overall Study|Adverse Event|6|||
16168059|NCT00264004|39095165|FG003|Overall Study|Adverse Event|4|||
16168060|NCT00264004|39095162|FG000|Overall Study|Withdrawal by Subject|0|||
16168061|NCT00264004|39095163|FG001|Overall Study|Withdrawal by Subject|1|||
16168062|NCT00264004|39095164|FG002|Overall Study|Withdrawal by Subject|2|||
16168063|NCT00264004|39095165|FG003|Overall Study|Withdrawal by Subject|2|||
16168064|NCT00264004|39095162|FG000|Overall Study|Other|2|||
16168065|NCT00264004|39095163|FG001|Overall Study|Other|2|||
16168066|NCT00264004|39095164|FG002|Overall Study|Other|0|||
16168067|NCT00264004|39095165|FG003|Overall Study|Other|3|||
16168068|NCT00264004|39095162|FG000|Overall Study|Development study specific disc. crit.|1|||
16168069|NCT00264004|39095163|FG001|Overall Study|Development study specific disc. crit.|0|||
16168070|NCT00264004|39095164|FG002|Overall Study|Development study specific disc. crit.|1|||
16168071|NCT00264004|39095165|FG003|Overall Study|Development study specific disc. crit.|0|||
16168072|NCT00264004|39095162|FG000|Overall Study|Cond. under inv. worsened|9|||
16168073|NCT00264004|39095163|FG001|Overall Study|Cond. under inv. worsened|5|||
16168074|NCT00264004|39095164|FG002|Overall Study|Cond. under inv. worsened|3|||
16168075|NCT00264004|39095165|FG003|Overall Study|Cond. under inv. worsened|4|||
16168076|NCT00264004|39095162|FG000|Overall Study|Not treated|3|||
16168077|NCT00264004|39095163|FG001|Overall Study|Not treated|0|||
16168078|NCT00264004|39095164|FG002|Overall Study|Not treated|2|||
16168079|NCT00264004|39095165|FG003|Overall Study|Not treated|2|||
16168080|NCT02939131|39095166|FG000|Overall Study|Unable to get to clinic|6|||
16168081|NCT02939131|39095167|FG001|Overall Study|Unable to get to clinic|4|||
16168082|NCT02939131|39095166|FG000|Overall Study|Lost to Follow-up|2|||
16168083|NCT02939131|39095167|FG001|Overall Study|Lost to Follow-up|4|||
16168084|NCT02939131|39095166|FG000|Overall Study|severe debilitation|1|||
16168085|NCT02939131|39095167|FG001|Overall Study|severe debilitation|0|||
16168086|NCT02939131|39095166|FG000|Overall Study|Other|0|||
16168087|NCT02939131|39095167|FG001|Overall Study|Other|1|||
16168088|NCT02939131|39095166|FG000|Overall Study|not willing to adhere to protocol|2|||
16460957|NCT01129024|40169055|FG000|Overall Study|Withdrawal by Subject|2|||
16168089|NCT02939131|39095167|FG001|Overall Study|not willing to adhere to protocol|0|||
16460958|NCT01129024|40169055|FG000|Overall Study|Lack of Efficacy|3|||
16460959|NCT01129024|40169055|FG000|Overall Study|Needed a Platelet Transfusion|1|||
16460960|NCT01642732|40169056|FG000|Overall Study|Withdrawal by Subject|1|||
16460961|NCT02730195|40169057|FG000|Overall Study|Withdrawal by Subject|1|||
16460962|NCT01155167|40169058|FG000|Overall Study|Insufficient ultrasound data|2|||
16460963|NCT01155167|40169059|FG001|Overall Study|Insufficient ultrasound data|0|||
16460964|NCT01155167|40169058|FG000|Overall Study|Access site changed to femoral artery|1|||
16460965|NCT01155167|40169059|FG001|Overall Study|Access site changed to femoral artery|0|||
16168090|NCT02901431|39095168|FG000|PK Part|Adverse Event|0|||
16168091|NCT02901431|39095169|FG001|PK Part|Adverse Event|1|||
16168092|NCT02901431|39095170|FG002|PK Part|Adverse Event|0|||
16269222|NCT00795821|39471042|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
16168093|NCT02901431|39095171|FG003|PK Part|Adverse Event|0|||
16168094|NCT02901431|39095172|FG004|PK Part|Adverse Event|0|||
16269223|NCT00795821|39471043|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
16460966|NCT03890666|40169060|FG000|Overall Study|Withdrawal by Subject|0|||
16460967|NCT03890666|40169061|FG001|Overall Study|Withdrawal by Subject|1|||
16460968|NCT03890666|40169060|FG000|Overall Study|Protocol deviation|1|||
16460969|NCT03890666|40169061|FG001|Overall Study|Protocol deviation|4|||
16460970|NCT03890666|40169060|FG000|Overall Study|Lost to Follow-up|2|||
16460971|NCT03890666|40169061|FG001|Overall Study|Lost to Follow-up|5|||
16460972|NCT03890666|40169060|FG000|Overall Study|Other than specified|1|||
16460973|NCT03890666|40169061|FG001|Overall Study|Other than specified|8|||
16460974|NCT02208063|40169062|FG000|Overall Study|Death|3|||
16460975|NCT02208063|40169063|FG001|Overall Study|Death|5|||
16460976|NCT02208063|40169062|FG000|Overall Study|Not Specified in report|3|||
16460977|NCT02208063|40169063|FG001|Overall Study|Not Specified in report|4|||
16460978|NCT02208063|40169062|FG000|Overall Study|Withdrawal by Subject|5|||
16460979|NCT02208063|40169063|FG001|Overall Study|Withdrawal by Subject|2|||
16460980|NCT02208063|40169062|FG000|Overall Study|Lost to Follow-up|1|||
16460981|NCT02208063|40169063|FG001|Overall Study|Lost to Follow-up|0|||
16460982|NCT00635024|40169066|FG000|Overall Study|Adverse Event|1|||
16460983|NCT00444678|40169067|FG000|Overall Study|Toxicity|11|||
16460984|NCT00444678|40169067|FG000|Overall Study|Disease Progression|12|||
16460985|NCT00444678|40169067|FG000|Overall Study|Death|3|||
16460986|NCT00444678|40169067|FG000|Overall Study|Physician Decision|3|||
16460987|NCT00444678|40169067|FG000|Overall Study|Withdrawal by Subject|2|||
16460988|NCT00926029|40169068|FG000|Overall Study|Lost to Follow-up|2|||
16460989|NCT00926029|40169069|FG001|Overall Study|Lost to Follow-up|1|||
16460990|NCT00926029|40169070|FG002|Overall Study|Lost to Follow-up|1|||
16460991|NCT01350544|40169071|FG000|Overall Study|Administrative Withdrawal|0|||
16460992|NCT01350544|40169072|FG001|Overall Study|Administrative Withdrawal|1|||
16460993|NCT01350544|40169071|FG000|Overall Study|Death|1|||
16460994|NCT01350544|40169072|FG001|Overall Study|Death|2|||
16460995|NCT01350544|40169071|FG000|Overall Study|Moved out of LA County|2|||
16460996|NCT01350544|40169072|FG001|Overall Study|Moved out of LA County|2|||
16460997|NCT01350544|40169071|FG000|Overall Study|Medical Issues|1|||
16460998|NCT01350544|40169072|FG001|Overall Study|Medical Issues|1|||
16460999|NCT01350544|40169071|FG000|Overall Study|Withdrawal by Subject|0|||
16461000|NCT01350544|40169072|FG001|Overall Study|Withdrawal by Subject|1|||
16168095|NCT02901431|39095173|FG005|PK Part|Adverse Event|0|||
16168096|NCT02901431|39095174|FG006|PK Part|Adverse Event|0|||
16168097|NCT02901431|39095175|FG007|PK Part|Adverse Event|0|||
16461001|NCT01350544|40169071|FG000|Overall Study|Incarceration|1|||
16461002|NCT01350544|40169072|FG001|Overall Study|Incarceration|0|||
16461003|NCT01350544|40169071|FG000|Overall Study|Lost to Follow-up|18|||
16461004|NCT01350544|40169072|FG001|Overall Study|Lost to Follow-up|15|||
16461005|NCT01128621|40169073|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
16461006|NCT01128621|40169074|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
16461007|NCT00852371|40169075|FG000|Overall Study|Lost to Follow-up|2|||
16461008|NCT00852371|40169076|FG001|Overall Study|Lost to Follow-up|3|||
16461009|NCT00852371|40169077|FG002|Overall Study|Lost to Follow-up|4|||
16461010|NCT00852371|40169078|FG003|Overall Study|Lost to Follow-up|2|||
16461011|NCT00904033|40169080|FG000|Overall Study|Withdrawal by Subject|1|||
16461012|NCT00904033|40169081|FG001|Overall Study|Withdrawal by Subject|1|||
16461013|NCT00904033|40169082|FG002|Overall Study|Withdrawal by Subject|0|||
16461014|NCT00904033|40169083|FG003|Overall Study|Withdrawal by Subject|0|||
16461015|NCT00904033|40169080|FG000|Overall Study|Physician Decision|0|||
16461016|NCT00904033|40169081|FG001|Overall Study|Physician Decision|0|||
16461017|NCT00904033|40169082|FG002|Overall Study|Physician Decision|1|||
16461018|NCT00904033|40169083|FG003|Overall Study|Physician Decision|0|||
16461019|NCT00904033|40169080|FG000|Overall Study|Unable to obtain final blood draw|0|||
16461020|NCT00904033|40169081|FG001|Overall Study|Unable to obtain final blood draw|0|||
16461021|NCT00904033|40169082|FG002|Overall Study|Unable to obtain final blood draw|0|||
16461022|NCT00904033|40169083|FG003|Overall Study|Unable to obtain final blood draw|2|||
16461023|NCT04255394|40169086|FG000|Overall Study|Death|35|||
16461024|NCT04255394|40169087|FG001|Overall Study|Death|25|||
16461025|NCT04255394|40169086|FG000|Overall Study|Device removed|2|||
16461026|NCT04255394|40169087|FG001|Overall Study|Device removed|10|||
16461027|NCT04255394|40169086|FG000|Overall Study|Withdrawal by Subject|9|||
16461028|NCT04255394|40169087|FG001|Overall Study|Withdrawal by Subject|8|||
16461029|NCT04255394|40169086|FG000|Overall Study|Screen Failure/Not treated|12|||
16461030|NCT04255394|40169087|FG001|Overall Study|Screen Failure/Not treated|8|||
16461031|NCT04255394|40169086|FG000|Overall Study|Lost to Follow-up|123|||
16461032|NCT04255394|40169087|FG001|Overall Study|Lost to Follow-up|265|||
16461033|NCT04255394|40169086|FG000|Overall Study|Adverse Event|1|||
16461034|NCT04255394|40169087|FG001|Overall Study|Adverse Event|3|||
16461035|NCT02586506|40169088|FG000|Overall Study|Protocol Violation|6|||
16461036|NCT02586506|40169088|FG000|Overall Study|Lost to Follow-up|1|||
16461037|NCT02586506|40169088|FG000|Overall Study|Other Reason|2|||
16461038|NCT03255083|40169091|FG000|Overall Study|Clinical progression|1|||
16461039|NCT03255083|40169092|FG001|Overall Study|Clinical progression|0|||
16461040|NCT03255083|40169093|FG002|Overall Study|Clinical progression|0|||
16461041|NCT03255083|40169094|FG003|Overall Study|Clinical progression|0|||
16461042|NCT03255083|40169091|FG000|Overall Study|Adverse Event|0|||
16461043|NCT03255083|40169092|FG001|Overall Study|Adverse Event|1|||
16461044|NCT03255083|40169093|FG002|Overall Study|Adverse Event|0|||
16461045|NCT03255083|40169094|FG003|Overall Study|Adverse Event|0|||
16461046|NCT03255083|40169091|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
16461047|NCT03255083|40169092|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
16461048|NCT03255083|40169093|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
16461049|NCT03255083|40169094|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
16461050|NCT03255083|40169091|FG000|Overall Study|Withdrawal by Subject|1|||
16461051|NCT03255083|40169092|FG001|Overall Study|Withdrawal by Subject|1|||
16461052|NCT03255083|40169093|FG002|Overall Study|Withdrawal by Subject|1|||
16461053|NCT03255083|40169094|FG003|Overall Study|Withdrawal by Subject|0|||
16461054|NCT00200356|40169095|FG000|Overall Study|Lack of Efficacy|3|||
16461055|NCT00200356|40169096|FG001|Overall Study|Lack of Efficacy|3|||
16461056|NCT00200356|40169095|FG000|Overall Study|Protocol Violation|4|||
16461057|NCT00200356|40169096|FG001|Overall Study|Protocol Violation|4|||
16461058|NCT00200356|40169095|FG000|Overall Study|Nontreatment|1|||
16461059|NCT00200356|40169096|FG001|Overall Study|Nontreatment|0|||
16461060|NCT01771809|40169097|FG000|Overall Study|Adverse Event|4|||
16461061|NCT01771809|40169098|FG001|Overall Study|Adverse Event|12|||
16461062|NCT01771809|40169097|FG000|Overall Study|Protocol Violation|0|||
16461063|NCT01771809|40169098|FG001|Overall Study|Protocol Violation|1|||
16461064|NCT01771809|40169097|FG000|Overall Study|Withdrawal by Subject|34|||
16461065|NCT01771809|40169098|FG001|Overall Study|Withdrawal by Subject|42|||
16461066|NCT01771809|40169097|FG000|Overall Study|Lost to Follow-up|1|||
16461067|NCT01771809|40169098|FG001|Overall Study|Lost to Follow-up|3|||
16461068|NCT01771809|40169097|FG000|Overall Study|Other (Insufficient clinical response)|22|||
16461069|NCT01771809|40169098|FG001|Overall Study|Other (Insufficient clinical response)|20|||
16461070|NCT01771809|40169097|FG000|Overall Study|Death|1|||
16461071|NCT01771809|40169098|FG001|Overall Study|Death|0|||
16461072|NCT01771809|40169097|FG000|Overall Study|Other (other)|9|||
16461073|NCT01771809|40169098|FG001|Overall Study|Other (other)|5|||
16461074|NCT01639729|40169099|FG000|Overall Study|Withdrawal by Subject|1|||
16461075|NCT01639729|40169100|FG001|Overall Study|Withdrawal by Subject|0|||
16461076|NCT01639729|40169101|FG002|Overall Study|Withdrawal by Subject|1|||
16461077|NCT01639729|40169102|FG003|Overall Study|Withdrawal by Subject|1|||
16461078|NCT01639729|40169103|FG004|Overall Study|Withdrawal by Subject|0|||
16461079|NCT01639729|40169104|FG005|Overall Study|Withdrawal by Subject|0|||
16461080|NCT02600871|40169105|FG000|Overall Study|Lost to Follow-up|13|||
16461081|NCT02600871|40169106|FG001|Overall Study|Lost to Follow-up|10|||
16461082|NCT02156271|40169107|FG000|Overall Study|Physician Decision|4|||
16461083|NCT02156271|40169108|FG001|Overall Study|Physician Decision|3|||
16461084|NCT01022398|40169112|FG000|Overall Study|Study terminated|2|||
16461085|NCT01022398|40169113|FG001|Overall Study|Study terminated|2|||
16461086|NCT01185353|40169116|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
16461087|NCT01185353|40169117|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
16461088|NCT01185353|40169118|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
16461089|NCT01185353|40169119|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
16461090|NCT01185353|40169120|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
16461091|NCT01185353|40169121|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
16461092|NCT01185353|40169122|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
16461093|NCT01185353|40169123|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
16461094|NCT01185353|40169124|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
16461095|NCT01185353|40169125|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
16168098|NCT02901431|39095176|FG008|PK Part|Adverse Event|0|||
16168099|NCT02901431|39095177|FG009|PK Part|Adverse Event|0|||
16461096|NCT01185353|40169116|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16461097|NCT01185353|40169117|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16461098|NCT01185353|40169118|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16461099|NCT01185353|40169119|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16461100|NCT01185353|40169120|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
16461101|NCT01185353|40169121|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16168100|NCT02901431|39095178|FG010|PK Part|Adverse Event|0|||
16168101|NCT02901431|39095179|FG011|PK Part|Adverse Event|0|||
16168102|NCT02901431|39095180|FG012|PK Part|Adverse Event|0|||
16168103|NCT02901431|39095168|FG000|PK Part|Lost to Follow-up|0|||
16168104|NCT02901431|39095169|FG001|PK Part|Lost to Follow-up|0|||
16168105|NCT02901431|39095170|FG002|PK Part|Lost to Follow-up|1|||
16168106|NCT02901431|39095171|FG003|PK Part|Lost to Follow-up|0|||
16461102|NCT01185353|40169122|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16461103|NCT01185353|40169123|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16461104|NCT01185353|40169124|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16461105|NCT01185353|40169125|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
16461106|NCT01185353|40169116|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
16461107|NCT01185353|40169117|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16168107|NCT02901431|39095172|FG004|PK Part|Lost to Follow-up|0|||
16168108|NCT02901431|39095173|FG005|PK Part|Lost to Follow-up|0|||
16168109|NCT02901431|39095174|FG006|PK Part|Lost to Follow-up|0|||
16168110|NCT02901431|39095175|FG007|PK Part|Lost to Follow-up|0|||
16168111|NCT02901431|39095176|FG008|PK Part|Lost to Follow-up|0|||
16168112|NCT02901431|39095177|FG009|PK Part|Lost to Follow-up|0|||
16168113|NCT02901431|39095178|FG010|PK Part|Lost to Follow-up|0|||
16168114|NCT02901431|39095179|FG011|PK Part|Lost to Follow-up|0|||
16168115|NCT02901431|39095180|FG012|PK Part|Lost to Follow-up|0|||
16168116|NCT02901431|39095168|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
16168117|NCT02901431|39095169|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168118|NCT02901431|39095170|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168119|NCT02901431|39095171|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168120|NCT02901431|39095172|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168121|NCT02901431|39095173|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168122|NCT02901431|39095174|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168123|NCT02901431|39095175|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168124|NCT02901431|39095176|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168125|NCT02901431|39095177|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168126|NCT02901431|39095178|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168127|NCT02901431|39095179|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168128|NCT02901431|39095180|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
16168129|NCT02901431|39095168|FG000|PK Part|Pending dose confirmation|0|||
16168130|NCT02901431|39095169|FG001|PK Part|Pending dose confirmation|1|||
16168131|NCT02901431|39095170|FG002|PK Part|Pending dose confirmation|0|||
16168132|NCT02901431|39095171|FG003|PK Part|Pending dose confirmation|0|||
16168133|NCT02901431|39095172|FG004|PK Part|Pending dose confirmation|0|||
16168134|NCT02901431|39095173|FG005|PK Part|Pending dose confirmation|0|||
16168135|NCT02901431|39095174|FG006|PK Part|Pending dose confirmation|0|||
16168136|NCT02901431|39095175|FG007|PK Part|Pending dose confirmation|0|||
16168137|NCT02901431|39095176|FG008|PK Part|Pending dose confirmation|0|||
16168138|NCT02901431|39095177|FG009|PK Part|Pending dose confirmation|0|||
16168139|NCT02901431|39095178|FG010|PK Part|Pending dose confirmation|0|||
16168140|NCT02901431|39095179|FG011|PK Part|Pending dose confirmation|0|||
16168141|NCT02901431|39095180|FG012|PK Part|Pending dose confirmation|0|||
16168142|NCT02901431|39095168|FG000|PK Part|8 weeks of treatment ran out|2|||
16168143|NCT02901431|39095169|FG001|PK Part|8 weeks of treatment ran out|0|||
16168144|NCT02901431|39095170|FG002|PK Part|8 weeks of treatment ran out|0|||
16168145|NCT02901431|39095171|FG003|PK Part|8 weeks of treatment ran out|0|||
16168146|NCT02901431|39095172|FG004|PK Part|8 weeks of treatment ran out|0|||
16168147|NCT02901431|39095173|FG005|PK Part|8 weeks of treatment ran out|0|||
16168148|NCT02901431|39095174|FG006|PK Part|8 weeks of treatment ran out|0|||
16168149|NCT02901431|39095175|FG007|PK Part|8 weeks of treatment ran out|0|||
16168150|NCT02901431|39095176|FG008|PK Part|8 weeks of treatment ran out|0|||
16168151|NCT02901431|39095177|FG009|PK Part|8 weeks of treatment ran out|0|||
16168152|NCT02901431|39095178|FG010|PK Part|8 weeks of treatment ran out|0|||
16168153|NCT02901431|39095179|FG011|PK Part|8 weeks of treatment ran out|0|||
16168154|NCT02901431|39095180|FG012|PK Part|8 weeks of treatment ran out|0|||
16168155|NCT02901431|39095168|FG000|PK Part|Stopped treatment after 8 weeks|1|||
16168156|NCT02901431|39095169|FG001|PK Part|Stopped treatment after 8 weeks|0|||
16168157|NCT02901431|39095170|FG002|PK Part|Stopped treatment after 8 weeks|1|||
16168158|NCT02901431|39095171|FG003|PK Part|Stopped treatment after 8 weeks|0|||
16168159|NCT02901431|39095172|FG004|PK Part|Stopped treatment after 8 weeks|0|||
16168160|NCT02901431|39095173|FG005|PK Part|Stopped treatment after 8 weeks|0|||
16168161|NCT02901431|39095174|FG006|PK Part|Stopped treatment after 8 weeks|0|||
16168162|NCT02901431|39095175|FG007|PK Part|Stopped treatment after 8 weeks|0|||
16168163|NCT02901431|39095176|FG008|PK Part|Stopped treatment after 8 weeks|0|||
16168164|NCT02901431|39095177|FG009|PK Part|Stopped treatment after 8 weeks|0|||
16168165|NCT02901431|39095178|FG010|PK Part|Stopped treatment after 8 weeks|0|||
16168166|NCT02901431|39095179|FG011|PK Part|Stopped treatment after 8 weeks|0|||
16461108|NCT01185353|40169118|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16461109|NCT01185353|40169119|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16461110|NCT01185353|40169120|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
16461111|NCT01185353|40169121|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16461112|NCT01185353|40169122|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16461113|NCT01185353|40169123|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16461114|NCT01185353|40169124|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16461115|NCT01185353|40169125|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
16461116|NCT01185353|40169116|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16461117|NCT01185353|40169117|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16461118|NCT01185353|40169118|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
16461119|NCT01185353|40169119|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16168167|NCT02901431|39095180|FG012|PK Part|Stopped treatment after 8 weeks|0|||
16168168|NCT02901431|39095168|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
16168169|NCT02901431|39095169|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16168170|NCT02901431|39095170|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
16168171|NCT02901431|39095171|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16168172|NCT02901431|39095172|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16168173|NCT02901431|39095173|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16168174|NCT02901431|39095174|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16461120|NCT01185353|40169120|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
16461121|NCT01185353|40169121|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16461122|NCT01185353|40169122|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16461123|NCT01185353|40169123|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16461124|NCT01185353|40169124|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16461125|NCT01185353|40169125|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
16461126|NCT01185353|40169116|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16461127|NCT01185353|40169117|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16461128|NCT01185353|40169118|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16461129|NCT01185353|40169119|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16168175|NCT02901431|39095175|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16168176|NCT02901431|39095176|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16168177|NCT02901431|39095177|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16168178|NCT02901431|39095178|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16168179|NCT02901431|39095179|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16168180|NCT02901431|39095180|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
16168181|NCT02901431|39095168|FG000|PK Part|Discontinued per Sponsor|0|||
16168182|NCT02901431|39095169|FG001|PK Part|Discontinued per Sponsor|3|||
16168183|NCT02901431|39095170|FG002|PK Part|Discontinued per Sponsor|0|||
16168184|NCT02901431|39095171|FG003|PK Part|Discontinued per Sponsor|0|||
16168185|NCT02901431|39095172|FG004|PK Part|Discontinued per Sponsor|0|||
16168186|NCT02901431|39095173|FG005|PK Part|Discontinued per Sponsor|0|||
16168187|NCT02901431|39095174|FG006|PK Part|Discontinued per Sponsor|0|||
16168188|NCT02901431|39095175|FG007|PK Part|Discontinued per Sponsor|0|||
16168189|NCT02901431|39095176|FG008|PK Part|Discontinued per Sponsor|0|||
16168190|NCT02901431|39095177|FG009|PK Part|Discontinued per Sponsor|0|||
16168191|NCT02901431|39095178|FG010|PK Part|Discontinued per Sponsor|0|||
16168192|NCT02901431|39095179|FG011|PK Part|Discontinued per Sponsor|0|||
16168193|NCT02901431|39095180|FG012|PK Part|Discontinued per Sponsor|0|||
16168194|NCT02901431|39095168|FG000|PK Part|Withdrawal by Subject|1|||
16168195|NCT02901431|39095169|FG001|PK Part|Withdrawal by Subject|1|||
16168196|NCT02901431|39095170|FG002|PK Part|Withdrawal by Subject|3|||
16168197|NCT02901431|39095171|FG003|PK Part|Withdrawal by Subject|0|||
16168198|NCT02901431|39095172|FG004|PK Part|Withdrawal by Subject|0|||
16168199|NCT02901431|39095173|FG005|PK Part|Withdrawal by Subject|0|||
16168200|NCT02901431|39095174|FG006|PK Part|Withdrawal by Subject|0|||
16168201|NCT02901431|39095175|FG007|PK Part|Withdrawal by Subject|0|||
16168202|NCT02901431|39095176|FG008|PK Part|Withdrawal by Subject|0|||
16168203|NCT02901431|39095177|FG009|PK Part|Withdrawal by Subject|0|||
16168204|NCT02901431|39095178|FG010|PK Part|Withdrawal by Subject|0|||
16168205|NCT02901431|39095179|FG011|PK Part|Withdrawal by Subject|0|||
16168206|NCT02901431|39095180|FG012|PK Part|Withdrawal by Subject|0|||
16168207|NCT02901431|39095168|FG000|Main Treatment Part|Adverse Event|0|||
16168208|NCT02901431|39095169|FG001|Main Treatment Part|Adverse Event|0|||
16461130|NCT01185353|40169120|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
16461131|NCT01185353|40169121|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16461132|NCT01185353|40169122|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16461133|NCT01185353|40169123|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16461134|NCT01185353|40169124|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16461135|NCT01185353|40169125|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
16461136|NCT01185353|40169116|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
16461137|NCT01185353|40169117|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16461138|NCT01185353|40169118|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16461139|NCT01185353|40169119|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16461140|NCT01185353|40169120|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
16461141|NCT01185353|40169121|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16461142|NCT01185353|40169122|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16461143|NCT01185353|40169123|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16461144|NCT01185353|40169124|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16461145|NCT01185353|40169125|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
16461146|NCT01185353|40169116|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16461147|NCT01185353|40169117|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16461148|NCT01185353|40169118|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
16461149|NCT01185353|40169119|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16461150|NCT01185353|40169120|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16461151|NCT01185353|40169121|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
16461152|NCT01185353|40169122|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16461153|NCT01185353|40169123|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16461154|NCT01185353|40169124|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16168209|NCT02901431|39095170|FG002|Main Treatment Part|Adverse Event|0|||
16072702|NCT01959412|38759142|FG004|Overall Study|Protocol deviation|3|||
16461155|NCT01185353|40169125|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
16461156|NCT01185353|40169116|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16461157|NCT01185353|40169117|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
16461158|NCT01185353|40169118|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16461159|NCT01185353|40169119|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
16461160|NCT01185353|40169120|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16461161|NCT01185353|40169121|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16461162|NCT01185353|40169122|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16461163|NCT01185353|40169123|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16461164|NCT01185353|40169124|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16461165|NCT01185353|40169125|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
16461166|NCT01185353|40169116|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16461167|NCT01185353|40169117|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16461168|NCT01185353|40169118|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16461169|NCT01185353|40169119|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
16461170|NCT01185353|40169120|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16461171|NCT01185353|40169121|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16461172|NCT01185353|40169122|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
16461173|NCT01185353|40169123|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16461174|NCT01185353|40169124|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16461175|NCT01185353|40169125|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
16461176|NCT01185353|40169116|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16461177|NCT01185353|40169117|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16461178|NCT01185353|40169118|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
16461179|NCT01185353|40169119|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
16461180|NCT01185353|40169120|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16461181|NCT01185353|40169121|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
16461182|NCT01185353|40169122|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
16461183|NCT01185353|40169123|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16461184|NCT01185353|40169124|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16461185|NCT01185353|40169125|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
16461186|NCT01185353|40169116|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16461187|NCT01185353|40169117|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16461188|NCT01185353|40169118|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16461189|NCT01185353|40169119|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16461190|NCT01185353|40169120|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16461191|NCT01185353|40169121|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16461192|NCT01185353|40169122|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
16461193|NCT01185353|40169123|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16461194|NCT01185353|40169124|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16461195|NCT01185353|40169125|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
16461196|NCT01185353|40169116|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16461197|NCT01185353|40169117|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16461198|NCT01185353|40169118|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16461199|NCT01185353|40169119|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16461200|NCT01185353|40169120|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16461201|NCT01185353|40169121|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16461202|NCT01185353|40169122|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
16461203|NCT01185353|40169123|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
16461204|NCT01185353|40169124|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
16461205|NCT01185353|40169125|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
16461206|NCT01185353|40169116|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16461207|NCT01185353|40169117|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16461208|NCT01185353|40169118|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16168210|NCT02901431|39095171|FG003|Main Treatment Part|Adverse Event|3|||
16168211|NCT02901431|39095172|FG004|Main Treatment Part|Adverse Event|3|||
16168212|NCT02901431|39095173|FG005|Main Treatment Part|Adverse Event|4|||
16168213|NCT02901431|39095174|FG006|Main Treatment Part|Adverse Event|1|||
16168214|NCT02901431|39095175|FG007|Main Treatment Part|Adverse Event|0|||
16168215|NCT02901431|39095176|FG008|Main Treatment Part|Adverse Event|0|||
16168216|NCT02901431|39095177|FG009|Main Treatment Part|Adverse Event|0|||
16168217|NCT02901431|39095178|FG010|Main Treatment Part|Adverse Event|0|||
16168218|NCT02901431|39095179|FG011|Main Treatment Part|Adverse Event|0|||
16168219|NCT02901431|39095180|FG012|Main Treatment Part|Adverse Event|0|||
16168220|NCT02901431|39095168|FG000|Main Treatment Part|Lack of Efficacy|0|||
16168221|NCT02901431|39095169|FG001|Main Treatment Part|Lack of Efficacy|0|||
16461209|NCT01185353|40169119|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16461210|NCT01185353|40169120|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16168222|NCT02901431|39095170|FG002|Main Treatment Part|Lack of Efficacy|0|||
16461211|NCT01185353|40169121|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16461212|NCT01185353|40169122|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
16461213|NCT01185353|40169123|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
16461214|NCT01185353|40169124|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
16461215|NCT01185353|40169125|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
16461216|NCT01185353|40169116|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16461217|NCT01185353|40169117|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16461218|NCT01185353|40169118|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16461219|NCT01185353|40169119|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16461220|NCT01185353|40169120|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16461221|NCT01185353|40169121|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16461222|NCT01185353|40169122|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
16461223|NCT01185353|40169123|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
16461224|NCT01185353|40169124|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
16461225|NCT01185353|40169125|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
16461226|NCT01185353|40169116|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16461227|NCT01185353|40169117|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16461228|NCT01185353|40169118|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16461229|NCT01185353|40169119|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16461230|NCT01185353|40169120|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16461231|NCT01185353|40169121|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16461232|NCT01185353|40169122|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16461233|NCT01185353|40169123|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16461234|NCT01185353|40169124|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
16461235|NCT01185353|40169125|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
16461236|NCT01185353|40169116|FG000|Part C (Weeks 24 Through 76)|Death|0|||
16461237|NCT01185353|40169117|FG001|Part C (Weeks 24 Through 76)|Death|0|||
16461238|NCT01185353|40169118|FG002|Part C (Weeks 24 Through 76)|Death|0|||
16461239|NCT01185353|40169119|FG003|Part C (Weeks 24 Through 76)|Death|0|||
16461240|NCT01185353|40169120|FG004|Part C (Weeks 24 Through 76)|Death|0|||
16461241|NCT01185353|40169121|FG005|Part C (Weeks 24 Through 76)|Death|0|||
16461242|NCT01185353|40169122|FG006|Part C (Weeks 24 Through 76)|Death|0|||
16461243|NCT01185353|40169123|FG007|Part C (Weeks 24 Through 76)|Death|0|||
16461244|NCT01185353|40169124|FG008|Part C (Weeks 24 Through 76)|Death|0|||
16461245|NCT01185353|40169125|FG009|Part C (Weeks 24 Through 76)|Death|1|||
16461246|NCT01185353|40169116|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16461247|NCT01185353|40169117|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16461248|NCT01185353|40169118|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16461249|NCT01185353|40169119|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16461250|NCT01185353|40169120|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16461251|NCT01185353|40169121|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16461252|NCT01185353|40169122|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16461253|NCT01185353|40169123|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16461254|NCT01185353|40169124|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
16461255|NCT01185353|40169125|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
16461256|NCT01185353|40169116|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16461257|NCT01185353|40169117|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16461258|NCT01185353|40169118|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16461259|NCT01185353|40169119|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16461260|NCT01185353|40169120|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16461261|NCT01185353|40169121|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16461262|NCT01185353|40169122|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16461263|NCT01185353|40169123|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16461264|NCT01185353|40169124|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
16461265|NCT01185353|40169125|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
16461266|NCT01185353|40169116|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
16461267|NCT01185353|40169117|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
16461268|NCT01185353|40169118|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
16461269|NCT01185353|40169119|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
16461270|NCT01185353|40169120|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
16461271|NCT01185353|40169121|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
16461272|NCT01185353|40169122|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
16461273|NCT01185353|40169123|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
16461274|NCT01185353|40169124|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
16461275|NCT01185353|40169125|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
16461276|NCT01185353|40169116|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16461277|NCT01185353|40169117|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16461278|NCT01185353|40169118|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16461279|NCT01185353|40169119|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16461280|NCT01185353|40169120|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16168223|NCT02901431|39095171|FG003|Main Treatment Part|Lack of Efficacy|1|||
16168224|NCT02901431|39095172|FG004|Main Treatment Part|Lack of Efficacy|0|||
16168225|NCT02901431|39095173|FG005|Main Treatment Part|Lack of Efficacy|0|||
16168226|NCT02901431|39095174|FG006|Main Treatment Part|Lack of Efficacy|0|||
16168227|NCT02901431|39095175|FG007|Main Treatment Part|Lack of Efficacy|0|||
16168228|NCT02901431|39095176|FG008|Main Treatment Part|Lack of Efficacy|0|||
16168229|NCT02901431|39095177|FG009|Main Treatment Part|Lack of Efficacy|0|||
16168230|NCT02901431|39095178|FG010|Main Treatment Part|Lack of Efficacy|0|||
16168231|NCT02901431|39095179|FG011|Main Treatment Part|Lack of Efficacy|0|||
16168232|NCT02901431|39095180|FG012|Main Treatment Part|Lack of Efficacy|0|||
16168233|NCT02901431|39095168|FG000|Main Treatment Part|Lost to Follow-up|0|||
16168234|NCT02901431|39095169|FG001|Main Treatment Part|Lost to Follow-up|0|||
16168235|NCT02901431|39095170|FG002|Main Treatment Part|Lost to Follow-up|0|||
16168236|NCT02901431|39095171|FG003|Main Treatment Part|Lost to Follow-up|3|||
16168237|NCT02901431|39095172|FG004|Main Treatment Part|Lost to Follow-up|1|||
16168238|NCT02901431|39095173|FG005|Main Treatment Part|Lost to Follow-up|2|||
16168239|NCT02901431|39095174|FG006|Main Treatment Part|Lost to Follow-up|3|||
16168240|NCT02901431|39095175|FG007|Main Treatment Part|Lost to Follow-up|0|||
16168241|NCT02901431|39095176|FG008|Main Treatment Part|Lost to Follow-up|0|||
16168242|NCT02901431|39095177|FG009|Main Treatment Part|Lost to Follow-up|0|||
16168243|NCT02901431|39095178|FG010|Main Treatment Part|Lost to Follow-up|0|||
16168244|NCT02901431|39095179|FG011|Main Treatment Part|Lost to Follow-up|0|||
16461281|NCT01185353|40169121|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16461282|NCT01185353|40169122|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16461283|NCT01185353|40169123|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
16461284|NCT01185353|40169124|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
16461285|NCT01185353|40169125|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
16168245|NCT02901431|39095180|FG012|Main Treatment Part|Lost to Follow-up|0|||
16168246|NCT02901431|39095168|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
16168247|NCT02901431|39095169|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
16168248|NCT02901431|39095170|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
16168249|NCT02901431|39095171|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
16168250|NCT02901431|39095172|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
16168251|NCT02901431|39095173|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
16168252|NCT02901431|39095174|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
16168253|NCT02901431|39095175|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
16168254|NCT02901431|39095176|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
16168255|NCT02901431|39095177|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
16168256|NCT02901431|39095178|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
16168257|NCT02901431|39095179|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
16168258|NCT02901431|39095180|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
16168259|NCT02901431|39095168|FG000|Main Treatment Part|Physician Decision|0|||
16168260|NCT02901431|39095169|FG001|Main Treatment Part|Physician Decision|0|||
16168261|NCT02901431|39095170|FG002|Main Treatment Part|Physician Decision|0|||
16168262|NCT02901431|39095171|FG003|Main Treatment Part|Physician Decision|1|||
16168263|NCT02901431|39095172|FG004|Main Treatment Part|Physician Decision|0|||
16168264|NCT02901431|39095173|FG005|Main Treatment Part|Physician Decision|0|||
16168265|NCT02901431|39095174|FG006|Main Treatment Part|Physician Decision|1|||
16168266|NCT02901431|39095175|FG007|Main Treatment Part|Physician Decision|0|||
16168267|NCT02901431|39095176|FG008|Main Treatment Part|Physician Decision|0|||
16168268|NCT02901431|39095177|FG009|Main Treatment Part|Physician Decision|0|||
16168269|NCT02901431|39095178|FG010|Main Treatment Part|Physician Decision|0|||
16168270|NCT02901431|39095179|FG011|Main Treatment Part|Physician Decision|0|||
16168271|NCT02901431|39095180|FG012|Main Treatment Part|Physician Decision|0|||
16168272|NCT02901431|39095168|FG000|Main Treatment Part|Withdrawal by Subject|0|||
16168273|NCT02901431|39095169|FG001|Main Treatment Part|Withdrawal by Subject|0|||
16168274|NCT02901431|39095170|FG002|Main Treatment Part|Withdrawal by Subject|0|||
16168275|NCT02901431|39095171|FG003|Main Treatment Part|Withdrawal by Subject|18|||
16168276|NCT02901431|39095172|FG004|Main Treatment Part|Withdrawal by Subject|3|||
16168277|NCT02901431|39095173|FG005|Main Treatment Part|Withdrawal by Subject|5|||
16168278|NCT02901431|39095174|FG006|Main Treatment Part|Withdrawal by Subject|6|||
16168279|NCT02901431|39095175|FG007|Main Treatment Part|Withdrawal by Subject|0|||
16168280|NCT02901431|39095176|FG008|Main Treatment Part|Withdrawal by Subject|0|||
16168281|NCT02901431|39095177|FG009|Main Treatment Part|Withdrawal by Subject|0|||
16168282|NCT02901431|39095178|FG010|Main Treatment Part|Withdrawal by Subject|0|||
16168283|NCT02901431|39095179|FG011|Main Treatment Part|Withdrawal by Subject|0|||
16168284|NCT02901431|39095180|FG012|Main Treatment Part|Withdrawal by Subject|0|||
16168285|NCT02901431|39095168|FG000|Open Label Part|Adverse Event|0|||
16168286|NCT02901431|39095169|FG001|Open Label Part|Adverse Event|0|||
16168287|NCT02901431|39095170|FG002|Open Label Part|Adverse Event|0|||
16168288|NCT02901431|39095171|FG003|Open Label Part|Adverse Event|0|||
16269224|NCT00795821|39471042|FG000|Acute Treatment Phase|Physician Decision|1|||
16168289|NCT02901431|39095172|FG004|Open Label Part|Adverse Event|0|||
16168290|NCT02901431|39095173|FG005|Open Label Part|Adverse Event|0|||
16461286|NCT01185353|40169116|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16461287|NCT01185353|40169117|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16461288|NCT01185353|40169118|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16461289|NCT01185353|40169119|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16461290|NCT01185353|40169120|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16461291|NCT01185353|40169121|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16461292|NCT01185353|40169122|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
16461293|NCT01185353|40169123|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
16461294|NCT01185353|40169124|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
16461295|NCT01185353|40169125|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
16461296|NCT01185353|40169116|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16461297|NCT01185353|40169117|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16461298|NCT01185353|40169118|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16461299|NCT01185353|40169119|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16461300|NCT01185353|40169120|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16461301|NCT01185353|40169121|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16461302|NCT01185353|40169122|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16461303|NCT01185353|40169123|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
16461304|NCT01185353|40169124|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
16461305|NCT01185353|40169125|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
16461306|NCT00476008|40169126|FG000|Overall Study|Adverse Event|4|||
16461307|NCT00476008|40169127|FG001|Overall Study|Adverse Event|4|||
16461308|NCT00476008|40169126|FG000|Overall Study|Placebo concerns|2|||
16461309|NCT00476008|40169127|FG001|Overall Study|Placebo concerns|2|||
16461310|NCT00476008|40169126|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
16461311|NCT00476008|40169127|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
16461312|NCT00476008|40169126|FG000|Overall Study|Withdrawal by Subject|0|||
16461313|NCT00476008|40169127|FG001|Overall Study|Withdrawal by Subject|1|||
16461314|NCT00476008|40169126|FG000|Overall Study|Death|1|||
16461315|NCT00476008|40169127|FG001|Overall Study|Death|0|||
16461316|NCT02338232|40169128|FG000|Overall Study|Screen Failure|3|||
16461317|NCT02338232|40169128|FG000|Overall Study|Withdrawal by Subject|6|||
16461318|NCT02338232|40169128|FG000|Overall Study|Adverse Event|2|||
16461319|NCT02788279|40169131|FG000|Overall Study|Death|62|||
16461320|NCT02788279|40169132|FG001|Overall Study|Death|136|||
16461321|NCT02788279|40169133|FG002|Overall Study|Death|72|||
16461322|NCT02788279|40169131|FG000|Overall Study|Withdrawal by Subject|10|||
16461323|NCT02788279|40169132|FG001|Overall Study|Withdrawal by Subject|15|||
16461324|NCT02788279|40169133|FG002|Overall Study|Withdrawal by Subject|5|||
16461325|NCT02788279|40169131|FG000|Overall Study|Lost to Follow-up|0|||
16461326|NCT02788279|40169132|FG001|Overall Study|Lost to Follow-up|3|||
16461327|NCT02788279|40169133|FG002|Overall Study|Lost to Follow-up|2|||
16461328|NCT02788279|40169131|FG000|Overall Study|Sponsor decision|18|||
16461329|NCT02788279|40169132|FG001|Overall Study|Sponsor decision|29|||
16461330|NCT02788279|40169133|FG002|Overall Study|Sponsor decision|11|||
16461331|NCT00913458|40169134|FG000|Phase 1|Non-Responder|54|||
16461332|NCT00913458|40169135|FG001|Phase 1|Non-Responder|0|||
16461333|NCT00913458|40169136|FG002|Phase 1|Non-Responder|0|||
16461334|NCT00913458|40169137|FG003|Phase 1|Non-Responder|0|||
16461335|NCT00913458|40169138|FG004|Phase 1|Non-Responder|0|||
16461336|NCT00913458|40169139|FG005|Phase 1|Non-Responder|0|||
16461337|NCT00913458|40169140|FG006|Phase 1|Non-Responder|0|||
16461338|NCT00913458|40169134|FG000|Phase 1|Subject Request|17|||
16461339|NCT00913458|40169135|FG001|Phase 1|Subject Request|0|||
16168291|NCT02901431|39095174|FG006|Open Label Part|Adverse Event|0|||
16168292|NCT02901431|39095175|FG007|Open Label Part|Adverse Event|0|||
16168293|NCT02901431|39095176|FG008|Open Label Part|Adverse Event|4|||
16168294|NCT02901431|39095177|FG009|Open Label Part|Adverse Event|4|||
16168295|NCT02901431|39095178|FG010|Open Label Part|Adverse Event|0|||
16168296|NCT02901431|39095179|FG011|Open Label Part|Adverse Event|4|||
16168297|NCT02901431|39095180|FG012|Open Label Part|Adverse Event|1|||
16168298|NCT02901431|39095168|FG000|Open Label Part|Lost to Follow-up|0|||
16168299|NCT02901431|39095169|FG001|Open Label Part|Lost to Follow-up|0|||
16168300|NCT02901431|39095170|FG002|Open Label Part|Lost to Follow-up|0|||
16168301|NCT02901431|39095171|FG003|Open Label Part|Lost to Follow-up|0|||
16168302|NCT02901431|39095172|FG004|Open Label Part|Lost to Follow-up|0|||
16168303|NCT02901431|39095173|FG005|Open Label Part|Lost to Follow-up|0|||
16168304|NCT02901431|39095174|FG006|Open Label Part|Lost to Follow-up|0|||
16168305|NCT02901431|39095175|FG007|Open Label Part|Lost to Follow-up|0|||
16168306|NCT02901431|39095176|FG008|Open Label Part|Lost to Follow-up|2|||
16168307|NCT02901431|39095177|FG009|Open Label Part|Lost to Follow-up|2|||
16168308|NCT02901431|39095178|FG010|Open Label Part|Lost to Follow-up|1|||
16461340|NCT00913458|40169136|FG002|Phase 1|Subject Request|0|||
16461341|NCT00913458|40169137|FG003|Phase 1|Subject Request|0|||
16461342|NCT00913458|40169138|FG004|Phase 1|Subject Request|0|||
16461343|NCT00913458|40169139|FG005|Phase 1|Subject Request|0|||
16461344|NCT00913458|40169140|FG006|Phase 1|Subject Request|0|||
16461345|NCT00913458|40169134|FG000|Phase 1|Adverse Event|20|||
16461346|NCT00913458|40169135|FG001|Phase 1|Adverse Event|0|||
16461347|NCT00913458|40169136|FG002|Phase 1|Adverse Event|0|||
16461348|NCT00913458|40169137|FG003|Phase 1|Adverse Event|0|||
16461349|NCT00913458|40169138|FG004|Phase 1|Adverse Event|0|||
16461350|NCT00913458|40169139|FG005|Phase 1|Adverse Event|0|||
16461351|NCT00913458|40169140|FG006|Phase 1|Adverse Event|0|||
16461352|NCT00913458|40169134|FG000|Phase 1|Lost to Follow-up|2|||
16461353|NCT00913458|40169135|FG001|Phase 1|Lost to Follow-up|0|||
16461354|NCT00913458|40169136|FG002|Phase 1|Lost to Follow-up|0|||
16461355|NCT00913458|40169137|FG003|Phase 1|Lost to Follow-up|0|||
16461356|NCT00913458|40169138|FG004|Phase 1|Lost to Follow-up|0|||
16461357|NCT00913458|40169139|FG005|Phase 1|Lost to Follow-up|0|||
16461358|NCT00913458|40169140|FG006|Phase 1|Lost to Follow-up|0|||
16461359|NCT00913458|40169134|FG000|Phase 1|Protocol Violation|10|||
16461360|NCT00913458|40169135|FG001|Phase 1|Protocol Violation|0|||
16461361|NCT00913458|40169136|FG002|Phase 1|Protocol Violation|0|||
16461362|NCT00913458|40169137|FG003|Phase 1|Protocol Violation|0|||
16461363|NCT00913458|40169138|FG004|Phase 1|Protocol Violation|0|||
16461364|NCT00913458|40169139|FG005|Phase 1|Protocol Violation|0|||
16461365|NCT00913458|40169140|FG006|Phase 1|Protocol Violation|0|||
16461366|NCT00913458|40169134|FG000|Phase 1|Sponsor|2|||
16461367|NCT00913458|40169135|FG001|Phase 1|Sponsor|0|||
16461368|NCT00913458|40169136|FG002|Phase 1|Sponsor|0|||
16461369|NCT00913458|40169137|FG003|Phase 1|Sponsor|0|||
16461370|NCT00913458|40169138|FG004|Phase 1|Sponsor|0|||
16461371|NCT00913458|40169139|FG005|Phase 1|Sponsor|0|||
16461372|NCT00913458|40169140|FG006|Phase 1|Sponsor|0|||
16461373|NCT00913458|40169134|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
16461374|NCT00913458|40169135|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
16461375|NCT00913458|40169136|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
16461376|NCT00913458|40169137|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
16461377|NCT00913458|40169138|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
16461378|NCT00913458|40169139|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
16461379|NCT00913458|40169140|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
16461380|NCT00913458|40169134|FG000|Phase 2|Non-Responder|0|||
16461381|NCT00913458|40169135|FG001|Phase 2|Non-Responder|5|||
16461382|NCT00913458|40169136|FG002|Phase 2|Non-Responder|7|||
16461383|NCT00913458|40169137|FG003|Phase 2|Non-Responder|12|||
16461384|NCT00913458|40169138|FG004|Phase 2|Non-Responder|0|||
16461385|NCT00913458|40169139|FG005|Phase 2|Non-Responder|0|||
16461386|NCT00913458|40169140|FG006|Phase 2|Non-Responder|0|||
16461387|NCT00913458|40169134|FG000|Phase 2|Subject Request|0|||
16461388|NCT00913458|40169135|FG001|Phase 2|Subject Request|0|||
16461389|NCT00913458|40169136|FG002|Phase 2|Subject Request|1|||
16461390|NCT00913458|40169137|FG003|Phase 2|Subject Request|2|||
16461391|NCT00913458|40169138|FG004|Phase 2|Subject Request|0|||
16461392|NCT00913458|40169139|FG005|Phase 2|Subject Request|0|||
16461393|NCT00913458|40169140|FG006|Phase 2|Subject Request|0|||
16461394|NCT00913458|40169134|FG000|Phase 2|Adverse Event|0|||
16461395|NCT00913458|40169135|FG001|Phase 2|Adverse Event|3|||
16461396|NCT00913458|40169136|FG002|Phase 2|Adverse Event|0|||
16461397|NCT00913458|40169137|FG003|Phase 2|Adverse Event|1|||
16461398|NCT00913458|40169138|FG004|Phase 2|Adverse Event|0|||
16461399|NCT00913458|40169139|FG005|Phase 2|Adverse Event|0|||
16461400|NCT00913458|40169140|FG006|Phase 2|Adverse Event|0|||
16461401|NCT00913458|40169134|FG000|Phase 2|Lost to Follow-up|0|||
16461402|NCT00913458|40169135|FG001|Phase 2|Lost to Follow-up|0|||
16461403|NCT00913458|40169136|FG002|Phase 2|Lost to Follow-up|0|||
16461404|NCT00913458|40169137|FG003|Phase 2|Lost to Follow-up|1|||
16461405|NCT00913458|40169138|FG004|Phase 2|Lost to Follow-up|0|||
16461406|NCT00913458|40169139|FG005|Phase 2|Lost to Follow-up|0|||
16461407|NCT00913458|40169140|FG006|Phase 2|Lost to Follow-up|0|||
16461408|NCT00913458|40169134|FG000|Phase 2|Protocol Violation|0|||
16461409|NCT00913458|40169135|FG001|Phase 2|Protocol Violation|2|||
16461410|NCT00913458|40169136|FG002|Phase 2|Protocol Violation|0|||
16461411|NCT00913458|40169137|FG003|Phase 2|Protocol Violation|0|||
16461412|NCT00913458|40169138|FG004|Phase 2|Protocol Violation|0|||
16461413|NCT00913458|40169139|FG005|Phase 2|Protocol Violation|0|||
16461414|NCT00913458|40169140|FG006|Phase 2|Protocol Violation|0|||
16461415|NCT00913458|40169134|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
16461416|NCT00913458|40169135|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
16461417|NCT00913458|40169136|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
16461418|NCT00913458|40169137|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
16461419|NCT00913458|40169138|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
16461420|NCT00913458|40169139|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
16461421|NCT00913458|40169140|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
16461422|NCT00913458|40169134|FG000|Phase 3|Adverse Event|0|||
16461423|NCT00913458|40169135|FG001|Phase 3|Adverse Event|0|||
16461424|NCT00913458|40169136|FG002|Phase 3|Adverse Event|0|||
16461425|NCT00913458|40169137|FG003|Phase 3|Adverse Event|0|||
16461426|NCT00913458|40169138|FG004|Phase 3|Adverse Event|5|||
16461427|NCT00913458|40169139|FG005|Phase 3|Adverse Event|4|||
16461428|NCT00913458|40169140|FG006|Phase 3|Adverse Event|1|||
16461429|NCT00913458|40169134|FG000|Phase 3|Lost to Follow-up|0|||
16168309|NCT02901431|39095179|FG011|Open Label Part|Lost to Follow-up|1|||
16168310|NCT02901431|39095180|FG012|Open Label Part|Lost to Follow-up|1|||
16168311|NCT02901431|39095168|FG000|Open Label Part|Physician Decision|0|||
16168312|NCT02901431|39095169|FG001|Open Label Part|Physician Decision|0|||
16168313|NCT02901431|39095170|FG002|Open Label Part|Physician Decision|0|||
16168314|NCT02901431|39095171|FG003|Open Label Part|Physician Decision|0|||
16168315|NCT02901431|39095172|FG004|Open Label Part|Physician Decision|0|||
16168316|NCT02901431|39095173|FG005|Open Label Part|Physician Decision|0|||
16168317|NCT02901431|39095174|FG006|Open Label Part|Physician Decision|0|||
16168318|NCT02901431|39095175|FG007|Open Label Part|Physician Decision|0|||
16168319|NCT02901431|39095176|FG008|Open Label Part|Physician Decision|1|||
16168320|NCT02901431|39095177|FG009|Open Label Part|Physician Decision|1|||
16168321|NCT02901431|39095178|FG010|Open Label Part|Physician Decision|0|||
16168322|NCT02901431|39095179|FG011|Open Label Part|Physician Decision|0|||
16168323|NCT02901431|39095180|FG012|Open Label Part|Physician Decision|0|||
16168324|NCT02901431|39095168|FG000|Open Label Part|Study Terminated By Sponsor|0|||
16168325|NCT02901431|39095169|FG001|Open Label Part|Study Terminated By Sponsor|0|||
16168326|NCT02901431|39095170|FG002|Open Label Part|Study Terminated By Sponsor|0|||
16168327|NCT02901431|39095171|FG003|Open Label Part|Study Terminated By Sponsor|0|||
16168328|NCT02901431|39095172|FG004|Open Label Part|Study Terminated By Sponsor|0|||
16168329|NCT02901431|39095173|FG005|Open Label Part|Study Terminated By Sponsor|0|||
16168330|NCT02901431|39095174|FG006|Open Label Part|Study Terminated By Sponsor|0|||
16168331|NCT02901431|39095175|FG007|Open Label Part|Study Terminated By Sponsor|0|||
16168332|NCT02901431|39095176|FG008|Open Label Part|Study Terminated By Sponsor|35|||
16168333|NCT02901431|39095177|FG009|Open Label Part|Study Terminated By Sponsor|12|||
16168334|NCT02901431|39095178|FG010|Open Label Part|Study Terminated By Sponsor|21|||
16168335|NCT02901431|39095179|FG011|Open Label Part|Study Terminated By Sponsor|31|||
16168336|NCT02901431|39095180|FG012|Open Label Part|Study Terminated By Sponsor|0|||
16168337|NCT02901431|39095168|FG000|Open Label Part|Withdrawal by Subject|0|||
16168338|NCT02901431|39095169|FG001|Open Label Part|Withdrawal by Subject|0|||
16168339|NCT02901431|39095170|FG002|Open Label Part|Withdrawal by Subject|0|||
16168340|NCT02901431|39095171|FG003|Open Label Part|Withdrawal by Subject|0|||
16168341|NCT02901431|39095172|FG004|Open Label Part|Withdrawal by Subject|0|||
16168342|NCT02901431|39095173|FG005|Open Label Part|Withdrawal by Subject|0|||
16168343|NCT02901431|39095174|FG006|Open Label Part|Withdrawal by Subject|0|||
16168344|NCT02901431|39095175|FG007|Open Label Part|Withdrawal by Subject|0|||
16168345|NCT02901431|39095176|FG008|Open Label Part|Withdrawal by Subject|6|||
16168346|NCT02901431|39095177|FG009|Open Label Part|Withdrawal by Subject|5|||
16168347|NCT02901431|39095178|FG010|Open Label Part|Withdrawal by Subject|7|||
16168348|NCT02901431|39095179|FG011|Open Label Part|Withdrawal by Subject|3|||
16168349|NCT02901431|39095180|FG012|Open Label Part|Withdrawal by Subject|1|||
16168350|NCT04336163|39095183|FG000|Overall Study|Lost to Follow-up|55|||
16168351|NCT04336163|39095184|FG001|Overall Study|Lost to Follow-up|0|||
16168352|NCT00448708|39095187|FG000|Overall Study|Death|21|||
16168353|NCT00448708|39095188|FG001|Overall Study|Death|17|||
16168354|NCT00448708|39095187|FG000|Overall Study|Withdrawal by Subject|8|||
16168355|NCT00448708|39095188|FG001|Overall Study|Withdrawal by Subject|4|||
16168356|NCT00448708|39095187|FG000|Overall Study|Lost to Follow-up|6|||
16461430|NCT00913458|40169135|FG001|Phase 3|Lost to Follow-up|0|||
16461431|NCT00913458|40169136|FG002|Phase 3|Lost to Follow-up|0|||
16461432|NCT00913458|40169137|FG003|Phase 3|Lost to Follow-up|0|||
16461433|NCT00913458|40169138|FG004|Phase 3|Lost to Follow-up|2|||
16461434|NCT00913458|40169139|FG005|Phase 3|Lost to Follow-up|0|||
16461435|NCT00913458|40169140|FG006|Phase 3|Lost to Follow-up|0|||
16461436|NCT00913458|40169134|FG000|Phase 3|Non-Responder|0|||
16461437|NCT00913458|40169135|FG001|Phase 3|Non-Responder|0|||
16461438|NCT00913458|40169136|FG002|Phase 3|Non-Responder|0|||
16168357|NCT00448708|39095188|FG001|Overall Study|Lost to Follow-up|8|||
16168358|NCT00448708|39095187|FG000|Overall Study|not listed|0|||
16168359|NCT00448708|39095188|FG001|Overall Study|not listed|2|||
16168360|NCT01354028|39095190|FG000|Overall Study|Physician Decision|0|||
16168361|NCT01354028|39095191|FG001|Overall Study|Physician Decision|2|||
16168362|NCT01354028|39095190|FG000|Overall Study|Discharged before study start|2|||
16168363|NCT01354028|39095191|FG001|Overall Study|Discharged before study start|2|||
16168364|NCT01354028|39095190|FG000|Overall Study|No quiet alert state|0|||
16168365|NCT01354028|39095191|FG001|Overall Study|No quiet alert state|1|||
16461439|NCT00913458|40169137|FG003|Phase 3|Non-Responder|0|||
16461440|NCT00913458|40169138|FG004|Phase 3|Non-Responder|0|||
16168366|NCT04187092|39095192|FG000|Overall Study|Lost to Follow-up|1|||
16168367|NCT04187092|39095193|FG001|Overall Study|Lost to Follow-up|1|||
16168368|NCT04187092|39095192|FG000|Overall Study|Withdrawal by Subject|1|||
16168369|NCT04187092|39095193|FG001|Overall Study|Withdrawal by Subject|1|||
16168370|NCT04187092|39095192|FG000|Overall Study|Adverse Event|0|||
16168371|NCT04187092|39095193|FG001|Overall Study|Adverse Event|1|||
16168372|NCT00984204|39095196|FG000|Overall Study|Death|1|||
16168373|NCT00984204|39095196|FG000|Overall Study|Lost to Follow-up|4|||
16461441|NCT00913458|40169139|FG005|Phase 3|Non-Responder|1|||
16461442|NCT00913458|40169140|FG006|Phase 3|Non-Responder|3|||
16168374|NCT00984204|39095196|FG000|Overall Study|Lack of Efficacy|10|||
16168375|NCT00709956|39095198|FG000|Overall Study|Withdrawal by Subject|1|||
16168376|NCT00709956|39095199|FG001|Overall Study|Withdrawal by Subject|1|||
16168377|NCT00709956|39095198|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
16168378|NCT00709956|39095199|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
16168379|NCT04698525|39095200|FG000|Overall Study|Lost to Follow-up|1|||
16168380|NCT04698525|39095201|FG001|Overall Study|Lost to Follow-up|2|||
16168381|NCT04698525|39095200|FG000|Overall Study|Three suffered of Covid-19|2|||
16168382|NCT04698525|39095201|FG001|Overall Study|Three suffered of Covid-19|1|||
16168383|NCT04426695|39095207|FG000|Overall Study|Death|2|||
16168384|NCT04426695|39095208|FG001|Overall Study|Death|0|||
16168385|NCT04426695|39095209|FG002|Overall Study|Death|1|||
16168386|NCT04426695|39095210|FG003|Overall Study|Death|27|||
16168387|NCT04426695|39095211|FG004|Overall Study|Death|25|||
16168388|NCT04426695|39095212|FG005|Overall Study|Death|21|||
16168389|NCT04426695|39095213|FG006|Overall Study|Death|42|||
16168390|NCT04426695|39095214|FG007|Overall Study|Death|23|||
16168391|NCT04426695|39095215|FG008|Overall Study|Death|37|||
16168392|NCT04426695|39095216|FG009|Overall Study|Death|14|||
16168393|NCT04426695|39095217|FG010|Overall Study|Death|8|||
16168394|NCT04426695|39095218|FG011|Overall Study|Death|7|||
16168395|NCT04426695|39095219|FG012|Overall Study|Death|13|||
16168396|NCT04426695|39095220|FG013|Overall Study|Death|25|||
16168397|NCT04426695|39095221|FG014|Overall Study|Death|19|||
16168398|NCT04426695|39095222|FG015|Overall Study|Death|7|||
16168399|NCT04426695|39095223|FG016|Overall Study|Death|8|||
16168400|NCT04426695|39095224|FG017|Overall Study|Death|4|||
16168401|NCT04426695|39095207|FG000|Overall Study|Lost to Follow-up|2|||
16168402|NCT04426695|39095208|FG001|Overall Study|Lost to Follow-up|4|||
16168403|NCT04426695|39095209|FG002|Overall Study|Lost to Follow-up|1|||
16168404|NCT04426695|39095210|FG003|Overall Study|Lost to Follow-up|19|||
16168405|NCT04426695|39095211|FG004|Overall Study|Lost to Follow-up|10|||
16168406|NCT04426695|39095212|FG005|Overall Study|Lost to Follow-up|14|||
16168407|NCT04426695|39095213|FG006|Overall Study|Lost to Follow-up|5|||
16168408|NCT04426695|39095214|FG007|Overall Study|Lost to Follow-up|14|||
16168409|NCT04426695|39095215|FG008|Overall Study|Lost to Follow-up|10|||
16168410|NCT04426695|39095216|FG009|Overall Study|Lost to Follow-up|11|||
16168411|NCT04426695|39095217|FG010|Overall Study|Lost to Follow-up|12|||
16168412|NCT04426695|39095218|FG011|Overall Study|Lost to Follow-up|6|||
16168413|NCT04426695|39095219|FG012|Overall Study|Lost to Follow-up|2|||
16168414|NCT04426695|39095220|FG013|Overall Study|Lost to Follow-up|2|||
16168415|NCT04426695|39095221|FG014|Overall Study|Lost to Follow-up|2|||
16168416|NCT04426695|39095222|FG015|Overall Study|Lost to Follow-up|0|||
16168417|NCT04426695|39095223|FG016|Overall Study|Lost to Follow-up|0|||
16168418|NCT04426695|39095224|FG017|Overall Study|Lost to Follow-up|0|||
16168419|NCT04426695|39095207|FG000|Overall Study|Participant Decision|1|||
16168420|NCT04426695|39095208|FG001|Overall Study|Participant Decision|2|||
16168421|NCT04426695|39095209|FG002|Overall Study|Participant Decision|2|||
16168422|NCT04426695|39095210|FG003|Overall Study|Participant Decision|12|||
16168423|NCT04426695|39095211|FG004|Overall Study|Participant Decision|18|||
16168424|NCT04426695|39095212|FG005|Overall Study|Participant Decision|22|||
16168425|NCT04426695|39095213|FG006|Overall Study|Participant Decision|13|||
16168426|NCT04426695|39095214|FG007|Overall Study|Participant Decision|13|||
16168427|NCT04426695|39095215|FG008|Overall Study|Participant Decision|10|||
16168428|NCT04426695|39095216|FG009|Overall Study|Participant Decision|15|||
16168429|NCT04426695|39095217|FG010|Overall Study|Participant Decision|16|||
16168430|NCT04426695|39095218|FG011|Overall Study|Participant Decision|17|||
16461443|NCT00913458|40169134|FG000|Phase 3|Withdrawal by Subject|0|||
16461444|NCT00913458|40169135|FG001|Phase 3|Withdrawal by Subject|0|||
16461445|NCT00913458|40169136|FG002|Phase 3|Withdrawal by Subject|0|||
16461446|NCT00913458|40169137|FG003|Phase 3|Withdrawal by Subject|0|||
16461447|NCT00913458|40169138|FG004|Phase 3|Withdrawal by Subject|1|||
16461448|NCT00913458|40169139|FG005|Phase 3|Withdrawal by Subject|2|||
16168431|NCT04426695|39095219|FG012|Overall Study|Participant Decision|2|||
16168432|NCT04426695|39095220|FG013|Overall Study|Participant Decision|1|||
16168433|NCT04426695|39095221|FG014|Overall Study|Participant Decision|2|||
16168434|NCT04426695|39095222|FG015|Overall Study|Participant Decision|0|||
16168435|NCT04426695|39095223|FG016|Overall Study|Participant Decision|0|||
16168436|NCT04426695|39095224|FG017|Overall Study|Participant Decision|0|||
16168437|NCT04426695|39095207|FG000|Overall Study|Adverse Event|0|||
16168438|NCT04426695|39095208|FG001|Overall Study|Adverse Event|0|||
16168439|NCT04426695|39095209|FG002|Overall Study|Adverse Event|0|||
16168440|NCT04426695|39095210|FG003|Overall Study|Adverse Event|0|||
16168441|NCT04426695|39095211|FG004|Overall Study|Adverse Event|0|||
16168442|NCT04426695|39095212|FG005|Overall Study|Adverse Event|0|||
16168443|NCT04426695|39095213|FG006|Overall Study|Adverse Event|0|||
16168444|NCT04426695|39095214|FG007|Overall Study|Adverse Event|1|||
16168445|NCT04426695|39095215|FG008|Overall Study|Adverse Event|0|||
16168446|NCT04426695|39095216|FG009|Overall Study|Adverse Event|0|||
16168447|NCT04426695|39095217|FG010|Overall Study|Adverse Event|1|||
16461449|NCT00913458|40169140|FG006|Phase 3|Withdrawal by Subject|0|||
16461450|NCT00913458|40169134|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
16461451|NCT00913458|40169135|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
16461452|NCT00913458|40169136|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
16461453|NCT00913458|40169137|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
16461454|NCT00913458|40169138|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
16461455|NCT00913458|40169139|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
16461456|NCT00913458|40169140|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
16461457|NCT01981551|40169141|FG000|Overall Study|Refused further treatment|8|||
16461458|NCT01981551|40169141|FG000|Overall Study|Adverse Event|1|||
16461459|NCT05615935|40169142|FG000|Overall Study|Lost to Follow-up|1|||
16461460|NCT05615935|40169143|FG001|Overall Study|Lost to Follow-up|1|||
16461461|NCT01425463|40169144|FG000|Overall Study|Adverse Event|5|||
16461462|NCT01425463|40169145|FG001|Overall Study|Adverse Event|7|||
16461463|NCT01425463|40169144|FG000|Overall Study|Lack of Efficacy|1|||
16461464|NCT01425463|40169145|FG001|Overall Study|Lack of Efficacy|1|||
16461465|NCT01425463|40169144|FG000|Overall Study|Protocol Violation|2|||
16461466|NCT01425463|40169145|FG001|Overall Study|Protocol Violation|2|||
16461467|NCT01425463|40169144|FG000|Overall Study|Lost to Follow-up|5|||
16461468|NCT01425463|40169145|FG001|Overall Study|Lost to Follow-up|2|||
16461469|NCT01425463|40169144|FG000|Overall Study|Withdrawal by Subject|7|||
16461470|NCT01425463|40169145|FG001|Overall Study|Withdrawal by Subject|5|||
16461471|NCT01425463|40169144|FG000|Overall Study|Unknown Reason|4|||
16461472|NCT01425463|40169145|FG001|Overall Study|Unknown Reason|7|||
16461473|NCT04268823|40169150|FG000|Overall Study|Adverse Event|1|||
16461474|NCT04268823|40169151|FG001|Overall Study|Adverse Event|0|||
16461475|NCT04268823|40169150|FG000|Overall Study|Participant Decision|1|||
16461476|NCT04268823|40169151|FG001|Overall Study|Participant Decision|0|||
16461477|NCT02929498|40169152|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
16461478|NCT02929498|40169153|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
16461479|NCT02929498|40169154|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
16461480|NCT02929498|40169152|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
16168448|NCT04426695|39095218|FG011|Overall Study|Adverse Event|1|||
16168449|NCT04426695|39095219|FG012|Overall Study|Adverse Event|0|||
16168450|NCT04426695|39095220|FG013|Overall Study|Adverse Event|0|||
16168451|NCT04426695|39095221|FG014|Overall Study|Adverse Event|0|||
16168452|NCT04426695|39095222|FG015|Overall Study|Adverse Event|0|||
16461481|NCT02929498|40169153|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
16461482|NCT02929498|40169154|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
16461483|NCT03472547|40169155|FG000|Overall Study|Withdrawal by Subject|30|||
16461484|NCT00361634|40169156|FG000|Overall Study|Lost to Follow-up|1|||
16461485|NCT00361634|40169156|FG000|Overall Study|Withdrawal by Subject|1|||
16461486|NCT03462511|40169157|FG000|Overall Study|Withdrawal by Subject|2|||
16461487|NCT03462511|40169158|FG001|Overall Study|Withdrawal by Subject|3|||
16461488|NCT03579602|40169159|FG000|Overall Study|Subject unable to receive study drug|0|||
16461489|NCT03579602|40169160|FG001|Overall Study|Subject unable to receive study drug|2|||
16461490|NCT03579602|40169159|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
16461491|NCT03579602|40169160|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
16461492|NCT01652469|40169162|FG000|Overall Study|Withdrawal by Subject|1|||
16461493|NCT01652469|40169163|FG001|Overall Study|Withdrawal by Subject|4|||
16461494|NCT01652469|40169162|FG000|Overall Study|Lost to Follow-up|0|||
16461495|NCT01652469|40169163|FG001|Overall Study|Lost to Follow-up|2|||
16461496|NCT01101308|40169168|FG000|Period 1|Adverse Event|2|||
16461497|NCT01101308|40169169|FG001|Period 1|Adverse Event|1|||
16461498|NCT01101308|40169168|FG000|Period 1|Positive for cotinine|1|||
16461499|NCT01101308|40169169|FG001|Period 1|Positive for cotinine|0|||
16461500|NCT01989208|40169174|FG000|200 mg (7 Days)|Protocol Violation|0|||
16461501|NCT01989208|40169175|FG001|200 mg (7 Days)|Protocol Violation|1|||
16461502|NCT02116530|40169176|FG000|Overall Study|Withdrawal by Subject|1|||
16461503|NCT02116530|40169177|FG001|Overall Study|Withdrawal by Subject|2|||
16461504|NCT02116530|40169176|FG000|Overall Study|Adverse Event|4|||
16461505|NCT02116530|40169177|FG001|Overall Study|Adverse Event|0|||
16461506|NCT02116530|40169176|FG000|Overall Study|Physician Decision|1|||
16461507|NCT02116530|40169177|FG001|Overall Study|Physician Decision|0|||
16461508|NCT02116530|40169176|FG000|Overall Study|Lost to Follow-up|1|||
16461509|NCT02116530|40169177|FG001|Overall Study|Lost to Follow-up|0|||
16461510|NCT02116530|40169176|FG000|Overall Study|Other Medical Problems|2|||
16461511|NCT02116530|40169177|FG001|Overall Study|Other Medical Problems|2|||
16461512|NCT01239992|40169178|FG000|Overall Study|Withdrawal by Subject|2|||
16461513|NCT01794338|40169179|FG000|Overall Study|Death|2|||
16168453|NCT04426695|39095223|FG016|Overall Study|Adverse Event|0|||
16461514|NCT01794338|40169180|FG001|Overall Study|Death|0|||
16461515|NCT01794338|40169179|FG000|Overall Study|Lost to Follow-up|6|||
16461516|NCT01794338|40169180|FG001|Overall Study|Lost to Follow-up|9|||
16461517|NCT02081859|40169181|FG000|Overall Study|No fertilization|2|||
16461518|NCT02081859|40169182|FG001|Overall Study|No fertilization|2|||
16461519|NCT02081859|40169181|FG000|Overall Study|No sperm|1|||
16461520|NCT02081859|40169182|FG001|Overall Study|No sperm|0|||
16461521|NCT02081859|40169181|FG000|Overall Study|Unanticipated freeze all cycle|2|||
16461522|NCT02081859|40169182|FG001|Overall Study|Unanticipated freeze all cycle|6|||
16461523|NCT02081859|40169181|FG000|Overall Study|< 4 embryos|27|||
16461524|NCT02081859|40169182|FG001|Overall Study|< 4 embryos|23|||
16461525|NCT02081859|40169181|FG000|Overall Study|Other reasons|2|||
16461526|NCT02081859|40169182|FG001|Overall Study|Other reasons|0|||
16461527|NCT02434471|40169186|FG000|Overall Study|Physician Decision|9|||
16461528|NCT01369329|40169188|FG000|Overall Study|Withdrawal by Subject|8|||
16461529|NCT01369329|40169189|FG001|Overall Study|Withdrawal by Subject|6|||
16461530|NCT01369329|40169190|FG002|Overall Study|Withdrawal by Subject|10|||
16461531|NCT01369329|40169188|FG000|Overall Study|Lost to Follow-up|2|||
16461532|NCT01369329|40169189|FG001|Overall Study|Lost to Follow-up|2|||
16461533|NCT01369329|40169190|FG002|Overall Study|Lost to Follow-up|2|||
16461534|NCT01369329|40169188|FG000|Overall Study|Other|2|||
16461535|NCT01369329|40169189|FG001|Overall Study|Other|3|||
16461536|NCT01369329|40169190|FG002|Overall Study|Other|2|||
16461537|NCT03041129|40169193|FG000|Overall Study|Withdrawal by Subject|2|||
16461538|NCT03041129|40169194|FG001|Overall Study|Withdrawal by Subject|0|||
16461539|NCT03041129|40169195|FG002|Overall Study|Withdrawal by Subject|0|||
16461540|NCT03041129|40169196|FG003|Overall Study|Withdrawal by Subject|0|||
16168454|NCT04426695|39095224|FG017|Overall Study|Adverse Event|0|||
16168455|NCT04426695|39095207|FG000|Overall Study|Sponsor Request|0|||
16168456|NCT04426695|39095208|FG001|Overall Study|Sponsor Request|0|||
16168457|NCT04426695|39095209|FG002|Overall Study|Sponsor Request|0|||
16461541|NCT03060551|40169197|FG000|Overall Study|Withdrawal by Subject|1|||
16461542|NCT03060551|40169197|FG000|Overall Study|Adverse Event|1|||
16461543|NCT03499964|40169198|FG000|Overall Study|Lack of Efficacy|6|||
16461544|NCT03499964|40169199|FG001|Overall Study|Lack of Efficacy|26|||
16461545|NCT03499964|40169198|FG000|Overall Study|Adverse Event|1|||
16461546|NCT03499964|40169199|FG001|Overall Study|Adverse Event|0|||
16461547|NCT03499964|40169198|FG000|Overall Study|Death|1|||
16461548|NCT03499964|40169199|FG001|Overall Study|Death|0|||
16461549|NCT03499964|40169198|FG000|Overall Study|Withdrawal by Subject|2|||
16461550|NCT03499964|40169199|FG001|Overall Study|Withdrawal by Subject|1|||
16461551|NCT03499964|40169198|FG000|Overall Study|Lost to Follow-up|1|||
16461552|NCT03499964|40169199|FG001|Overall Study|Lost to Follow-up|0|||
16461553|NCT03595228|40169203|FG000|Overall Study|Death|2|||
16461554|NCT03595228|40169203|FG000|Overall Study|Lack of Efficacy|13|||
16461555|NCT03595228|40169203|FG000|Overall Study|Withdrawal by Subject|3|||
16461556|NCT03595228|40169203|FG000|Overall Study|Withdrawal by Sponsor|1|||
16461557|NCT01203852|40169204|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
16461558|NCT01203852|40169204|FG000|Washout 2 Weeks|Physician Decision|46|||
16461559|NCT01270802|40169205|FG000|Overall Study|Withdrawal by Subject|1|||
16461560|NCT01270802|40169206|FG001|Overall Study|Withdrawal by Subject|0|||
16461561|NCT01270802|40169205|FG000|Overall Study|Adverse Event|1|||
16461562|NCT01270802|40169206|FG001|Overall Study|Adverse Event|0|||
16461563|NCT01270802|40169205|FG000|Overall Study|Lost to Follow-up|0|||
16461564|NCT01270802|40169206|FG001|Overall Study|Lost to Follow-up|1|||
16461565|NCT01642615|40169207|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
16461566|NCT01642615|40169208|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
16461567|NCT01642615|40169209|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
16168458|NCT04426695|39095210|FG003|Overall Study|Sponsor Request|0|||
16168459|NCT04426695|39095211|FG004|Overall Study|Sponsor Request|0|||
16168460|NCT04426695|39095212|FG005|Overall Study|Sponsor Request|0|||
16168461|NCT04426695|39095213|FG006|Overall Study|Sponsor Request|1|||
16168462|NCT04426695|39095214|FG007|Overall Study|Sponsor Request|0|||
16168463|NCT04426695|39095215|FG008|Overall Study|Sponsor Request|0|||
16168464|NCT04426695|39095216|FG009|Overall Study|Sponsor Request|0|||
16168465|NCT04426695|39095217|FG010|Overall Study|Sponsor Request|0|||
16168466|NCT04426695|39095218|FG011|Overall Study|Sponsor Request|0|||
16168467|NCT04426695|39095219|FG012|Overall Study|Sponsor Request|0|||
16168468|NCT04426695|39095220|FG013|Overall Study|Sponsor Request|0|||
16168469|NCT04426695|39095221|FG014|Overall Study|Sponsor Request|0|||
16168470|NCT04426695|39095222|FG015|Overall Study|Sponsor Request|0|||
16168471|NCT04426695|39095223|FG016|Overall Study|Sponsor Request|0|||
16461568|NCT01642615|40169207|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
16461569|NCT01642615|40169208|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
16461570|NCT01642615|40169209|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
16461571|NCT01642615|40169207|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
16461572|NCT01642615|40169208|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
16461573|NCT01642615|40169209|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
16461574|NCT01642615|40169207|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
16461575|NCT01642615|40169208|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
16461576|NCT01642615|40169209|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
16168472|NCT04426695|39095224|FG017|Overall Study|Sponsor Request|0|||
16168473|NCT04426695|39095207|FG000|Overall Study|Physician Decision|0|||
16168474|NCT04426695|39095208|FG001|Overall Study|Physician Decision|0|||
16168475|NCT04426695|39095209|FG002|Overall Study|Physician Decision|0|||
16168476|NCT04426695|39095210|FG003|Overall Study|Physician Decision|0|||
16168477|NCT04426695|39095211|FG004|Overall Study|Physician Decision|0|||
16168478|NCT04426695|39095212|FG005|Overall Study|Physician Decision|0|||
16168479|NCT04426695|39095213|FG006|Overall Study|Physician Decision|0|||
16168480|NCT04426695|39095214|FG007|Overall Study|Physician Decision|0|||
16168481|NCT04426695|39095215|FG008|Overall Study|Physician Decision|0|||
16461577|NCT01642615|40169207|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
16461578|NCT01642615|40169208|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
16461579|NCT01642615|40169209|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
16461580|NCT01642615|40169207|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
16461581|NCT01642615|40169208|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
16461582|NCT01642615|40169209|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
16461583|NCT01642615|40169207|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
16461584|NCT01642615|40169208|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
16461585|NCT01642615|40169209|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
16461586|NCT01642615|40169207|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
16461587|NCT01642615|40169208|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
16461588|NCT01642615|40169209|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
16461589|NCT01642615|40169207|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
16461590|NCT01642615|40169208|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
16461591|NCT01642615|40169209|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
16461592|NCT00470834|40169212|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
16461593|NCT00470834|40169213|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
16461594|NCT00470834|40169212|FG000|Treatment Period (18 Months)|Adverse Event|7|||
16461595|NCT00470834|40169213|FG001|Treatment Period (18 Months)|Adverse Event|6|||
16461596|NCT00470834|40169212|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
16168482|NCT04426695|39095216|FG009|Overall Study|Physician Decision|1|||
16461597|NCT00470834|40169213|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
16461598|NCT00470834|40169212|FG000|Treatment Period (18 Months)|Physician Decision|4|||
16461599|NCT00470834|40169213|FG001|Treatment Period (18 Months)|Physician Decision|4|||
16461600|NCT00470834|40169212|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
16461601|NCT00470834|40169213|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
16461602|NCT00470834|40169212|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
16168483|NCT04426695|39095217|FG010|Overall Study|Physician Decision|0|||
16168484|NCT04426695|39095218|FG011|Overall Study|Physician Decision|0|||
16461603|NCT00470834|40169213|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
16461604|NCT00470834|40169212|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
16461605|NCT00470834|40169213|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
16461606|NCT00470834|40169212|FG000|Treatment Period (18 Months)|Non-compliance|1|||
16461607|NCT00470834|40169213|FG001|Treatment Period (18 Months)|Non-compliance|0|||
16461608|NCT00470834|40169212|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
16461609|NCT00470834|40169213|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
16168485|NCT04426695|39095219|FG012|Overall Study|Physician Decision|1|||
16168486|NCT04426695|39095220|FG013|Overall Study|Physician Decision|0|||
16168487|NCT04426695|39095221|FG014|Overall Study|Physician Decision|0|||
16168488|NCT04426695|39095222|FG015|Overall Study|Physician Decision|0|||
16168489|NCT04426695|39095223|FG016|Overall Study|Physician Decision|0|||
16168490|NCT04426695|39095224|FG017|Overall Study|Physician Decision|0|||
16168491|NCT04426695|39095207|FG000|Overall Study|Randomized but Never Treated|3|||
16168492|NCT04426695|39095208|FG001|Overall Study|Randomized but Never Treated|1|||
16168493|NCT04426695|39095209|FG002|Overall Study|Randomized but Never Treated|0|||
16168494|NCT04426695|39095210|FG003|Overall Study|Randomized but Never Treated|4|||
16168495|NCT04426695|39095211|FG004|Overall Study|Randomized but Never Treated|5|||
16168496|NCT04426695|39095212|FG005|Overall Study|Randomized but Never Treated|5|||
16168497|NCT04426695|39095213|FG006|Overall Study|Randomized but Never Treated|4|||
16168498|NCT04426695|39095214|FG007|Overall Study|Randomized but Never Treated|6|||
16168499|NCT04426695|39095215|FG008|Overall Study|Randomized but Never Treated|6|||
16168500|NCT04426695|39095216|FG009|Overall Study|Randomized but Never Treated|3|||
16168501|NCT04426695|39095217|FG010|Overall Study|Randomized but Never Treated|3|||
16168502|NCT04426695|39095218|FG011|Overall Study|Randomized but Never Treated|6|||
16168503|NCT04426695|39095219|FG012|Overall Study|Randomized but Never Treated|1|||
16168504|NCT04426695|39095220|FG013|Overall Study|Randomized but Never Treated|2|||
16168505|NCT04426695|39095221|FG014|Overall Study|Randomized but Never Treated|0|||
16168506|NCT04426695|39095222|FG015|Overall Study|Randomized but Never Treated|0|||
16168507|NCT04426695|39095223|FG016|Overall Study|Randomized but Never Treated|0|||
16168508|NCT04426695|39095224|FG017|Overall Study|Randomized but Never Treated|0|||
16168509|NCT01412229|39095226|FG000|Overall Study|Physician Decision|1|||
16168510|NCT00891202|39095230|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
16168511|NCT00891202|39095231|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
16168512|NCT00891202|39095232|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
16461610|NCT00470834|40169212|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
16461611|NCT00470834|40169213|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
16461612|NCT00470834|40169212|FG000|Extension Period (24 Months)|Adverse Event|3|||
16461613|NCT00470834|40169213|FG001|Extension Period (24 Months)|Adverse Event|4|||
16461614|NCT00470834|40169212|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
16461615|NCT00470834|40169213|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
16461616|NCT00470834|40169212|FG000|Extension Period (24 Months)|Physician Decision|4|||
16461617|NCT00470834|40169213|FG001|Extension Period (24 Months)|Physician Decision|3|||
16461618|NCT00470834|40169212|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
16461619|NCT00470834|40169213|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
16461620|NCT00470834|40169212|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
16461621|NCT00470834|40169213|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
16461622|NCT00470834|40169212|FG000|Extension Period (24 Months)|Non-compliance|0|||
16461623|NCT00470834|40169213|FG001|Extension Period (24 Months)|Non-compliance|1|||
16461624|NCT00470834|40169212|FG000|Extension Period (24 Months)|Disease Progression|0|||
16461625|NCT00470834|40169213|FG001|Extension Period (24 Months)|Disease Progression|1|||
16461626|NCT00337675|40169215|FG000|Overall Study|Adverse Event|10|||
16461627|NCT00337675|40169216|FG001|Overall Study|Adverse Event|9|||
16461628|NCT00337675|40169217|FG002|Overall Study|Adverse Event|19|||
16461629|NCT00337675|40169215|FG000|Overall Study|Lack of Efficacy|10|||
16461630|NCT00337675|40169216|FG001|Overall Study|Lack of Efficacy|7|||
16461631|NCT00337675|40169217|FG002|Overall Study|Lack of Efficacy|9|||
16461632|NCT00337675|40169215|FG000|Overall Study|Lost to Follow-up|22|||
16461633|NCT00337675|40169216|FG001|Overall Study|Lost to Follow-up|19|||
16461634|NCT00337675|40169217|FG002|Overall Study|Lost to Follow-up|17|||
16461635|NCT00337675|40169215|FG000|Overall Study|Physician Decision|9|||
16461636|NCT00337675|40169216|FG001|Overall Study|Physician Decision|17|||
16461637|NCT00337675|40169217|FG002|Overall Study|Physician Decision|14|||
16461638|NCT00337675|40169215|FG000|Overall Study|Protocol Violation|21|||
16461639|NCT00337675|40169216|FG001|Overall Study|Protocol Violation|24|||
16461640|NCT00337675|40169217|FG002|Overall Study|Protocol Violation|19|||
16461641|NCT00337675|40169215|FG000|Overall Study|Withdrawal by Subject|25|||
16461642|NCT00337675|40169216|FG001|Overall Study|Withdrawal by Subject|25|||
16461643|NCT00337675|40169217|FG002|Overall Study|Withdrawal by Subject|19|||
16461644|NCT00337675|40169215|FG000|Overall Study|Progressive Disease|0|||
16461645|NCT00337675|40169216|FG001|Overall Study|Progressive Disease|2|||
16461646|NCT00337675|40169217|FG002|Overall Study|Progressive Disease|0|||
16461647|NCT00337675|40169215|FG000|Overall Study|Trial Terminated|0|||
16168513|NCT00891202|39095233|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
16461648|NCT00337675|40169216|FG001|Overall Study|Trial Terminated|0|||
16461649|NCT00337675|40169217|FG002|Overall Study|Trial Terminated|2|||
16461650|NCT03319745|40169219|FG000|Overall Study|Death|1|||
16461651|NCT03319745|40169219|FG000|Overall Study|Toxicity Precluding Surgery|1|||
16461652|NCT00422084|40169220|FG000|Overall Study|Adverse Event|21|||
16461653|NCT00422084|40169221|FG001|Overall Study|Adverse Event|7|||
16461654|NCT00422084|40169220|FG000|Overall Study|Withdrawal by Subject|12|||
16461655|NCT00422084|40169221|FG001|Overall Study|Withdrawal by Subject|9|||
16461656|NCT00422084|40169220|FG000|Overall Study|Lost to Follow-up|14|||
16461657|NCT00422084|40169221|FG001|Overall Study|Lost to Follow-up|9|||
16461658|NCT00422084|40169220|FG000|Overall Study|Protocol Violation|4|||
16461659|NCT00422084|40169221|FG001|Overall Study|Protocol Violation|1|||
16461660|NCT00422084|40169220|FG000|Overall Study|Lack of Efficacy|40|||
16461661|NCT00422084|40169221|FG001|Overall Study|Lack of Efficacy|42|||
16461662|NCT00422084|40169220|FG000|Overall Study|P. vivax infection|3|||
16461663|NCT00422084|40169221|FG001|Overall Study|P. vivax infection|6|||
16461664|NCT00422084|40169220|FG000|Overall Study|Cyesis|1|||
16461665|NCT00422084|40169221|FG001|Overall Study|Cyesis|0|||
16461666|NCT00422084|40169220|FG000|Overall Study|Withdrawn from study accidentally|1|||
16461667|NCT00422084|40169221|FG001|Overall Study|Withdrawn from study accidentally|0|||
16461668|NCT00422084|40169220|FG000|Overall Study|Non-compliance|1|||
16461669|NCT00422084|40169221|FG001|Overall Study|Non-compliance|0|||
16461670|NCT00422084|40169220|FG000|Overall Study|Re-location|0|||
16461671|NCT00422084|40169221|FG001|Overall Study|Re-location|1|||
16461672|NCT00422084|40169220|FG000|Overall Study|Not defined|1|||
16461673|NCT00422084|40169221|FG001|Overall Study|Not defined|1|||
16461674|NCT01221285|40169229|FG000|Overall Study|Withdrawal by Subject|1|||
16461675|NCT00835731|40169230|FG000|Overall Study|Withdrawal by Subject|1|||
16461676|NCT00835731|40169231|FG001|Overall Study|Withdrawal by Subject|0|||
16461677|NCT00835731|40169230|FG000|Overall Study|Physician Decision|1|||
16461678|NCT00835731|40169231|FG001|Overall Study|Physician Decision|1|||
16168514|NCT00891202|39095230|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
16168515|NCT00891202|39095231|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
16461679|NCT04931888|40169232|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
16461680|NCT04931888|40169233|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
16461681|NCT04931888|40169234|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
16461682|NCT04931888|40169235|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
16461683|NCT01193257|40169236|FG000|Overall Study|Death|202|||
16461684|NCT01193257|40169237|FG001|Overall Study|Death|391|||
16461685|NCT01193257|40169236|FG000|Overall Study|Study termination by sponsor|0|||
16461686|NCT01193257|40169237|FG001|Overall Study|Study termination by sponsor|3|||
16461687|NCT01193257|40169236|FG000|Overall Study|Withdrawal by Subject|26|||
16461688|NCT01193257|40169237|FG001|Overall Study|Withdrawal by Subject|86|||
16461689|NCT01193257|40169236|FG000|Overall Study|Lost to Follow-up|2|||
16461690|NCT01193257|40169237|FG001|Overall Study|Lost to Follow-up|3|||
16461691|NCT01193257|40169236|FG000|Overall Study|Unblinded due to futility|135|||
16461692|NCT01193257|40169237|FG001|Overall Study|Unblinded due to futility|251|||
16461693|NCT01501955|40169240|FG000|Overall Study|Withdrawal by Subject|1|||
16461694|NCT01501955|40169241|FG001|Overall Study|Withdrawal by Subject|0|||
16461695|NCT01501955|40169240|FG000|Overall Study|Adverse Event|1|||
16461696|NCT01501955|40169241|FG001|Overall Study|Adverse Event|3|||
16461697|NCT00145977|40169242|FG000|Overall Study|Lack of Efficacy|0|||
16461698|NCT00145977|40169243|FG001|Overall Study|Lack of Efficacy|4|||
16461699|NCT00145977|40169242|FG000|Overall Study|Lost to Follow-up|1|||
16461700|NCT00145977|40169243|FG001|Overall Study|Lost to Follow-up|0|||
16461701|NCT00145977|40169242|FG000|Overall Study|Withdrawal by Subject|1|||
16461702|NCT00145977|40169243|FG001|Overall Study|Withdrawal by Subject|0|||
16461703|NCT01119937|40169244|FG000|Overall Study|Adverse Event|11|||
16461704|NCT01119937|40169245|FG001|Overall Study|Adverse Event|5|||
16461705|NCT01119937|40169244|FG000|Overall Study|Protocol deviation|3|||
16461706|NCT01119937|40169245|FG001|Overall Study|Protocol deviation|1|||
16461707|NCT01119937|40169244|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
16461708|NCT01119937|40169245|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
16461709|NCT01119937|40169244|FG000|Overall Study|Withdrawal by Subject|2|||
16461710|NCT01119937|40169245|FG001|Overall Study|Withdrawal by Subject|1|||
16461711|NCT02471612|40169246|FG000|Overall Study|Lost to Follow-up|2|||
16461712|NCT03077087|40169249|FG000|Overall Study|Physician Decision|2|||
16461713|NCT03189524|40169250|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
16461714|NCT03189524|40169251|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
16461715|NCT03189524|40169252|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
16461716|NCT03189524|40169250|FG000|Overall Study|Death|2|||
16461717|NCT03189524|40169251|FG001|Overall Study|Death|2|||
16461718|NCT03189524|40169252|FG002|Overall Study|Death|1|||
16461719|NCT03189524|40169250|FG000|Overall Study|Lost to Follow-up|1|||
16461720|NCT03189524|40169251|FG001|Overall Study|Lost to Follow-up|0|||
16461721|NCT03189524|40169252|FG002|Overall Study|Lost to Follow-up|8|||
16461722|NCT03189524|40169250|FG000|Overall Study|Withdrawal by Subject|1|||
16461723|NCT03189524|40169251|FG001|Overall Study|Withdrawal by Subject|1|||
16461724|NCT03189524|40169252|FG002|Overall Study|Withdrawal by Subject|3|||
16461725|NCT03189524|40169250|FG000|Overall Study|Progressive Disease|0|||
16461726|NCT03189524|40169251|FG001|Overall Study|Progressive Disease|2|||
16461727|NCT03189524|40169252|FG002|Overall Study|Progressive Disease|0|||
16461728|NCT03353740|40169256|FG000|Overall Study|Images for these participants not viable|52|||
16461729|NCT02600819|40169257|FG000|GEN Phase|Adverse Event|2|||
16461730|NCT02600819|40169258|FG001|GEN Phase|Adverse Event|0|||
16461731|NCT02600819|40169257|FG000|GEN Phase|Death|2|||
16461732|NCT02600819|40169258|FG001|GEN Phase|Death|0|||
16461733|NCT02600819|40169257|FG000|GEN Phase|Investigator's Discretion|4|||
16461734|NCT02600819|40169258|FG001|GEN Phase|Investigator's Discretion|0|||
16461735|NCT02600819|40169257|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
16461736|NCT02600819|40169258|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
16461737|NCT02600819|40169257|FG000|GEN Phase|Withdrew Consent|5|||
16461738|NCT02600819|40169258|FG001|GEN Phase|Withdrew Consent|0|||
16461739|NCT02600819|40169257|FG000|GEN Phase|Lost to Follow-up|2|||
16461740|NCT02600819|40169258|FG001|GEN Phase|Lost to Follow-up|0|||
16461741|NCT01087788|40169259|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
16461742|NCT01087788|40169260|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
16461743|NCT01087788|40169261|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
16461744|NCT01087788|40169259|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
16461745|NCT01087788|40169260|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
16461746|NCT01087788|40169261|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
16461747|NCT01087788|40169259|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
16461748|NCT01087788|40169260|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
16461749|NCT01087788|40169261|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
16461750|NCT01087788|40169259|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
16461751|NCT01087788|40169260|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
16461752|NCT01087788|40169261|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
16461753|NCT01087788|40169259|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
16461754|NCT01087788|40169260|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
16461755|NCT01087788|40169261|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
16461756|NCT01087788|40169259|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
16461757|NCT01087788|40169260|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
16461758|NCT01087788|40169261|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
16461759|NCT01087788|40169259|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
16461760|NCT01087788|40169260|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
16461761|NCT01087788|40169261|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
16461762|NCT01087788|40169259|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
16461763|NCT01087788|40169260|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
16461764|NCT01087788|40169261|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
16461765|NCT01087788|40169259|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
16461766|NCT01087788|40169260|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
16461767|NCT01087788|40169261|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
16461768|NCT01087788|40169259|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
16461769|NCT01087788|40169260|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
16461770|NCT01087788|40169261|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
16461771|NCT01087788|40169259|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
16461772|NCT01087788|40169260|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
16461773|NCT01087788|40169261|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
16461774|NCT01087788|40169259|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
16461775|NCT01087788|40169260|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
16461776|NCT01087788|40169261|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
16461777|NCT01087788|40169259|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
16461778|NCT01087788|40169260|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
16461779|NCT01087788|40169261|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
16461780|NCT01087788|40169259|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
16461781|NCT01087788|40169260|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
16461782|NCT01087788|40169261|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
16461783|NCT01087788|40169259|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
16168516|NCT00891202|39095232|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
16168517|NCT00891202|39095233|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
16168518|NCT00891202|39095230|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
16168519|NCT00891202|39095231|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
16168520|NCT00891202|39095232|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
16168521|NCT00891202|39095233|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
16168522|NCT00891202|39095230|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
16168523|NCT00891202|39095231|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
16168524|NCT00891202|39095232|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
16168525|NCT00891202|39095233|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
16168526|NCT04436276|39095234|FG000|Overall Study|Adverse Event|0|||
16168527|NCT04436276|39095235|FG001|Overall Study|Adverse Event|0|||
16168528|NCT04436276|39095236|FG002|Overall Study|Adverse Event|0|||
16168529|NCT04436276|39095237|FG003|Overall Study|Adverse Event|0|||
16168530|NCT04436276|39095238|FG004|Overall Study|Adverse Event|0|||
16168531|NCT04436276|39095239|FG005|Overall Study|Adverse Event|0|||
16168532|NCT04436276|39095240|FG006|Overall Study|Adverse Event|0|||
16168533|NCT04436276|39095241|FG007|Overall Study|Adverse Event|0|||
16168534|NCT04436276|39095242|FG008|Overall Study|Adverse Event|0|||
16168535|NCT04436276|39095243|FG009|Overall Study|Adverse Event|0|||
16461784|NCT01087788|40169260|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
16461785|NCT01087788|40169261|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
16461786|NCT01087788|40169259|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
16461787|NCT01087788|40169260|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
16461788|NCT01087788|40169261|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
16461789|NCT01087788|40169259|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
16461790|NCT01087788|40169260|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
16461791|NCT01087788|40169261|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
16461792|NCT01087788|40169259|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
16461793|NCT01087788|40169260|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
16168536|NCT04436276|39095244|FG010|Overall Study|Adverse Event|0|||
16168537|NCT04436276|39095245|FG011|Overall Study|Adverse Event|0|||
16168538|NCT04436276|39095246|FG012|Overall Study|Adverse Event|0|||
16168539|NCT04436276|39095247|FG013|Overall Study|Adverse Event|0|||
16168540|NCT04436276|39095248|FG014|Overall Study|Adverse Event|0|||
16168541|NCT04436276|39095249|FG015|Overall Study|Adverse Event|0|||
16168542|NCT04436276|39095250|FG016|Overall Study|Adverse Event|1|||
16168543|NCT04436276|39095251|FG017|Overall Study|Adverse Event|0|||
16461794|NCT01087788|40169261|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
16461795|NCT01087788|40169259|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
16461796|NCT01087788|40169260|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
16461797|NCT01087788|40169261|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
16168544|NCT04436276|39095252|FG018|Overall Study|Adverse Event|0|||
16168545|NCT04436276|39095253|FG019|Overall Study|Adverse Event|0|||
16168546|NCT04436276|39095254|FG020|Overall Study|Adverse Event|0|||
16168547|NCT04436276|39095255|FG021|Overall Study|Adverse Event|0|||
16168548|NCT04436276|39095256|FG022|Overall Study|Adverse Event|0|||
16168549|NCT04436276|39095234|FG000|Overall Study|Death|0|||
16168550|NCT04436276|39095235|FG001|Overall Study|Death|0|||
16168551|NCT04436276|39095236|FG002|Overall Study|Death|0|||
16168552|NCT04436276|39095237|FG003|Overall Study|Death|0|||
16168553|NCT04436276|39095238|FG004|Overall Study|Death|0|||
16168554|NCT04436276|39095239|FG005|Overall Study|Death|0|||
16168555|NCT04436276|39095240|FG006|Overall Study|Death|0|||
16168556|NCT04436276|39095241|FG007|Overall Study|Death|0|||
16168557|NCT04436276|39095242|FG008|Overall Study|Death|0|||
16269225|NCT00795821|39471043|FG001|Acute Treatment Phase|Physician Decision|1|||
16269226|NCT00795821|39471042|FG000|Acute Treatment Phase|Protocol Violation|1|||
16269227|NCT00795821|39471043|FG001|Acute Treatment Phase|Protocol Violation|2|||
16269228|NCT00795821|39471042|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
16269229|NCT00795821|39471043|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
16269230|NCT00795821|39471042|FG000|Long-term Extension Phase|Adverse Event|25|||
16269231|NCT00795821|39471043|FG001|Long-term Extension Phase|Adverse Event|32|||
16269232|NCT00795821|39471042|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
16269233|NCT00795821|39471043|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
16269234|NCT00795821|39471042|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
16269235|NCT00795821|39471043|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
16269236|NCT00795821|39471042|FG000|Long-term Extension Phase|Physician Decision|1|||
16269237|NCT00795821|39471043|FG001|Long-term Extension Phase|Physician Decision|2|||
16269238|NCT00795821|39471042|FG000|Long-term Extension Phase|Protocol Violation|3|||
16269239|NCT00795821|39471043|FG001|Long-term Extension Phase|Protocol Violation|5|||
16269240|NCT00795821|39471042|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
16269241|NCT00795821|39471043|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
16269242|NCT00795821|39471042|FG000|Taper Phase|Adverse Event|2|||
16269243|NCT00795821|39471043|FG001|Taper Phase|Adverse Event|0|||
16269244|NCT00795821|39471042|FG000|Taper Phase|Lost to Follow-up|1|||
16269245|NCT00795821|39471043|FG001|Taper Phase|Lost to Follow-up|0|||
16269246|NCT00795821|39471042|FG000|Taper Phase|Physician Decision|2|||
16269247|NCT00795821|39471043|FG001|Taper Phase|Physician Decision|0|||
16269248|NCT00795821|39471042|FG000|Taper Phase|Withdrawal by Subject|4|||
16269249|NCT00795821|39471043|FG001|Taper Phase|Withdrawal by Subject|0|||
16269250|NCT00418938|39471044|FG000|Overall Study|Reimbursement|1|||
16269251|NCT00418938|39471045|FG001|Overall Study|Reimbursement|0|||
16269252|NCT00418938|39471044|FG000|Overall Study|Administrative decision|3|||
16269253|NCT00418938|39471045|FG001|Overall Study|Administrative decision|3|||
16269254|NCT00418938|39471044|FG000|Overall Study|Withdrawal by Subject|16|||
16269255|NCT00418938|39471045|FG001|Overall Study|Withdrawal by Subject|15|||
16461798|NCT01087788|40169259|FG000|24-weeks Dose-blind Period|Patient moved|0|||
16461799|NCT01087788|40169260|FG001|24-weeks Dose-blind Period|Patient moved|0|||
16461800|NCT01087788|40169261|FG002|24-weeks Dose-blind Period|Patient moved|1|||
16461801|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
16461802|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
16461803|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
16461804|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
16461805|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
16461806|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
16461807|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
16461808|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
16461809|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
16168558|NCT04436276|39095243|FG009|Overall Study|Death|0|||
16168559|NCT04436276|39095244|FG010|Overall Study|Death|0|||
16168560|NCT04436276|39095245|FG011|Overall Study|Death|0|||
16168561|NCT04436276|39095246|FG012|Overall Study|Death|1|||
16168562|NCT04436276|39095247|FG013|Overall Study|Death|0|||
16168563|NCT04436276|39095248|FG014|Overall Study|Death|1|||
16168564|NCT04436276|39095249|FG015|Overall Study|Death|0|||
16269256|NCT00418938|39471044|FG000|Overall Study|Lost to Follow-up|1|||
16269257|NCT00418938|39471045|FG001|Overall Study|Lost to Follow-up|3|||
16269258|NCT00418938|39471044|FG000|Overall Study|Adverse Event|1|||
16269259|NCT00418938|39471045|FG001|Overall Study|Adverse Event|1|||
16269260|NCT00418938|39471044|FG000|Overall Study|On-going|1|||
16269261|NCT00418938|39471045|FG001|Overall Study|On-going|1|||
16168565|NCT04436276|39095250|FG016|Overall Study|Death|0|||
16168566|NCT04436276|39095251|FG017|Overall Study|Death|0|||
16168567|NCT04436276|39095252|FG018|Overall Study|Death|0|||
16168568|NCT04436276|39095253|FG019|Overall Study|Death|2|||
16168569|NCT04436276|39095254|FG020|Overall Study|Death|0|||
16269262|NCT00418938|39471044|FG000|Overall Study|Ineligibility Determined|1|||
16168570|NCT04436276|39095255|FG021|Overall Study|Death|1|||
16168571|NCT04436276|39095256|FG022|Overall Study|Death|0|||
16168572|NCT04436276|39095234|FG000|Overall Study|Lost to Follow-up|0|||
16168573|NCT04436276|39095235|FG001|Overall Study|Lost to Follow-up|2|||
16168574|NCT04436276|39095236|FG002|Overall Study|Lost to Follow-up|2|||
16168575|NCT04436276|39095237|FG003|Overall Study|Lost to Follow-up|1|||
16168576|NCT04436276|39095238|FG004|Overall Study|Lost to Follow-up|4|||
16168577|NCT04436276|39095239|FG005|Overall Study|Lost to Follow-up|1|||
16168578|NCT04436276|39095240|FG006|Overall Study|Lost to Follow-up|0|||
16168579|NCT04436276|39095241|FG007|Overall Study|Lost to Follow-up|0|||
16168580|NCT04436276|39095242|FG008|Overall Study|Lost to Follow-up|1|||
16168581|NCT04436276|39095243|FG009|Overall Study|Lost to Follow-up|0|||
16168582|NCT04436276|39095244|FG010|Overall Study|Lost to Follow-up|5|||
16168583|NCT04436276|39095245|FG011|Overall Study|Lost to Follow-up|5|||
16168584|NCT04436276|39095246|FG012|Overall Study|Lost to Follow-up|4|||
16168585|NCT04436276|39095247|FG013|Overall Study|Lost to Follow-up|1|||
16168586|NCT04436276|39095248|FG014|Overall Study|Lost to Follow-up|7|||
16168587|NCT04436276|39095249|FG015|Overall Study|Lost to Follow-up|7|||
16168588|NCT04436276|39095250|FG016|Overall Study|Lost to Follow-up|1|||
16168589|NCT04436276|39095251|FG017|Overall Study|Lost to Follow-up|0|||
16168590|NCT04436276|39095252|FG018|Overall Study|Lost to Follow-up|1|||
16168591|NCT04436276|39095253|FG019|Overall Study|Lost to Follow-up|1|||
16168592|NCT04436276|39095254|FG020|Overall Study|Lost to Follow-up|2|||
16168593|NCT04436276|39095255|FG021|Overall Study|Lost to Follow-up|1|||
16168594|NCT04436276|39095256|FG022|Overall Study|Lost to Follow-up|1|||
16168595|NCT04436276|39095234|FG000|Overall Study|Physician Decision|1|||
16168596|NCT04436276|39095235|FG001|Overall Study|Physician Decision|0|||
16168597|NCT04436276|39095236|FG002|Overall Study|Physician Decision|2|||
16168598|NCT04436276|39095237|FG003|Overall Study|Physician Decision|1|||
16168599|NCT04436276|39095238|FG004|Overall Study|Physician Decision|0|||
16168600|NCT04436276|39095239|FG005|Overall Study|Physician Decision|0|||
16168601|NCT04436276|39095240|FG006|Overall Study|Physician Decision|0|||
16168602|NCT04436276|39095241|FG007|Overall Study|Physician Decision|0|||
16168603|NCT04436276|39095242|FG008|Overall Study|Physician Decision|0|||
16168604|NCT04436276|39095243|FG009|Overall Study|Physician Decision|0|||
16168605|NCT04436276|39095244|FG010|Overall Study|Physician Decision|0|||
16168606|NCT04436276|39095245|FG011|Overall Study|Physician Decision|1|||
16168607|NCT04436276|39095246|FG012|Overall Study|Physician Decision|2|||
16168608|NCT04436276|39095247|FG013|Overall Study|Physician Decision|0|||
16461810|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
16461811|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
16461812|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
16461813|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
16461814|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
16461815|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
16461816|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
16461817|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
16461818|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
16461819|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
16461820|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
16461821|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
16461822|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
16461823|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
16461824|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
16168609|NCT04436276|39095248|FG014|Overall Study|Physician Decision|0|||
16168610|NCT04436276|39095249|FG015|Overall Study|Physician Decision|0|||
16168611|NCT04436276|39095250|FG016|Overall Study|Physician Decision|0|||
16168612|NCT04436276|39095251|FG017|Overall Study|Physician Decision|0|||
16168613|NCT04436276|39095252|FG018|Overall Study|Physician Decision|0|||
16168614|NCT04436276|39095253|FG019|Overall Study|Physician Decision|0|||
16168615|NCT04436276|39095254|FG020|Overall Study|Physician Decision|1|||
16168616|NCT04436276|39095255|FG021|Overall Study|Physician Decision|2|||
16168617|NCT04436276|39095256|FG022|Overall Study|Physician Decision|0|||
16168618|NCT04436276|39095234|FG000|Overall Study|Protocol Violation|0|||
16168619|NCT04436276|39095235|FG001|Overall Study|Protocol Violation|0|||
16168620|NCT04436276|39095236|FG002|Overall Study|Protocol Violation|0|||
16168621|NCT04436276|39095237|FG003|Overall Study|Protocol Violation|0|||
16168622|NCT04436276|39095238|FG004|Overall Study|Protocol Violation|0|||
16168623|NCT04436276|39095239|FG005|Overall Study|Protocol Violation|0|||
16168624|NCT04436276|39095240|FG006|Overall Study|Protocol Violation|0|||
16168625|NCT04436276|39095241|FG007|Overall Study|Protocol Violation|0|||
16461825|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
16461826|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
16168626|NCT04436276|39095242|FG008|Overall Study|Protocol Violation|0|||
16168627|NCT04436276|39095243|FG009|Overall Study|Protocol Violation|0|||
16168628|NCT04436276|39095244|FG010|Overall Study|Protocol Violation|0|||
16168629|NCT04436276|39095245|FG011|Overall Study|Protocol Violation|0|||
16168630|NCT04436276|39095246|FG012|Overall Study|Protocol Violation|0|||
16168631|NCT04436276|39095247|FG013|Overall Study|Protocol Violation|1|||
16168632|NCT04436276|39095248|FG014|Overall Study|Protocol Violation|0|||
16168633|NCT04436276|39095249|FG015|Overall Study|Protocol Violation|1|||
16168634|NCT04436276|39095250|FG016|Overall Study|Protocol Violation|0|||
16168635|NCT04436276|39095251|FG017|Overall Study|Protocol Violation|0|||
16168636|NCT04436276|39095252|FG018|Overall Study|Protocol Violation|0|||
16168637|NCT04436276|39095253|FG019|Overall Study|Protocol Violation|0|||
16168638|NCT04436276|39095254|FG020|Overall Study|Protocol Violation|0|||
16168639|NCT04436276|39095255|FG021|Overall Study|Protocol Violation|0|||
16168640|NCT04436276|39095256|FG022|Overall Study|Protocol Violation|0|||
16168641|NCT04436276|39095234|FG000|Overall Study|Withdrawal by Subject|25|||
16168642|NCT04436276|39095235|FG001|Overall Study|Withdrawal by Subject|22|||
16168643|NCT04436276|39095236|FG002|Overall Study|Withdrawal by Subject|24|||
16168644|NCT04436276|39095237|FG003|Overall Study|Withdrawal by Subject|23|||
16168645|NCT04436276|39095238|FG004|Overall Study|Withdrawal by Subject|14|||
16168646|NCT04436276|39095239|FG005|Overall Study|Withdrawal by Subject|0|||
16168647|NCT04436276|39095240|FG006|Overall Study|Withdrawal by Subject|0|||
16168648|NCT04436276|39095241|FG007|Overall Study|Withdrawal by Subject|1|||
16168649|NCT04436276|39095242|FG008|Overall Study|Withdrawal by Subject|0|||
16168650|NCT04436276|39095243|FG009|Overall Study|Withdrawal by Subject|1|||
16168651|NCT04436276|39095244|FG010|Overall Study|Withdrawal by Subject|17|||
16168652|NCT04436276|39095245|FG011|Overall Study|Withdrawal by Subject|7|||
16168653|NCT04436276|39095246|FG012|Overall Study|Withdrawal by Subject|10|||
16168654|NCT04436276|39095247|FG013|Overall Study|Withdrawal by Subject|6|||
16168655|NCT04436276|39095248|FG014|Overall Study|Withdrawal by Subject|20|||
16168656|NCT04436276|39095249|FG015|Overall Study|Withdrawal by Subject|6|||
16168657|NCT04436276|39095250|FG016|Overall Study|Withdrawal by Subject|11|||
16168658|NCT04436276|39095251|FG017|Overall Study|Withdrawal by Subject|4|||
16168659|NCT04436276|39095252|FG018|Overall Study|Withdrawal by Subject|14|||
16168660|NCT04436276|39095253|FG019|Overall Study|Withdrawal by Subject|24|||
16168661|NCT04436276|39095254|FG020|Overall Study|Withdrawal by Subject|24|||
16168662|NCT04436276|39095255|FG021|Overall Study|Withdrawal by Subject|16|||
16168663|NCT04436276|39095256|FG022|Overall Study|Withdrawal by Subject|14|||
16168664|NCT04436276|39095234|FG000|Overall Study|Other|3|||
16168665|NCT04436276|39095235|FG001|Overall Study|Other|2|||
16168666|NCT04436276|39095236|FG002|Overall Study|Other|5|||
16168667|NCT04436276|39095237|FG003|Overall Study|Other|9|||
16168668|NCT04436276|39095238|FG004|Overall Study|Other|23|||
16168669|NCT04436276|39095239|FG005|Overall Study|Other|1|||
16168670|NCT04436276|39095240|FG006|Overall Study|Other|0|||
16168671|NCT04436276|39095241|FG007|Overall Study|Other|0|||
16168672|NCT04436276|39095242|FG008|Overall Study|Other|0|||
16168673|NCT04436276|39095243|FG009|Overall Study|Other|0|||
16168674|NCT04436276|39095244|FG010|Overall Study|Other|3|||
16168675|NCT04436276|39095245|FG011|Overall Study|Other|1|||
16168676|NCT04436276|39095246|FG012|Overall Study|Other|1|||
16168677|NCT04436276|39095247|FG013|Overall Study|Other|2|||
16168678|NCT04436276|39095248|FG014|Overall Study|Other|3|||
16168679|NCT04436276|39095249|FG015|Overall Study|Other|0|||
16168680|NCT04436276|39095250|FG016|Overall Study|Other|0|||
16168681|NCT04436276|39095251|FG017|Overall Study|Other|6|||
16168682|NCT04436276|39095252|FG018|Overall Study|Other|1|||
16168683|NCT04436276|39095253|FG019|Overall Study|Other|0|||
16168684|NCT04436276|39095254|FG020|Overall Study|Other|2|||
16168685|NCT04436276|39095255|FG021|Overall Study|Other|2|||
16168686|NCT04436276|39095256|FG022|Overall Study|Other|60|||
16168687|NCT01961115|39095257|FG000|Overall Study|Disease Progression|1|||
16168688|NCT01961115|39095258|FG001|Overall Study|Disease Progression|0|||
16168689|NCT01961115|39095259|FG002|Overall Study|Disease Progression|3|||
16168690|NCT01961115|39095257|FG000|Overall Study|Adverse Event|1|||
16168691|NCT01961115|39095258|FG001|Overall Study|Adverse Event|0|||
16168692|NCT01961115|39095259|FG002|Overall Study|Adverse Event|1|||
16168693|NCT03336502|39095262|FG000|Overall Study|Physician Decision|0|||
16168694|NCT03336502|39095263|FG001|Overall Study|Physician Decision|1|||
16168695|NCT03336502|39095262|FG000|Overall Study|Prohibited Drugs|1|||
16168696|NCT03336502|39095263|FG001|Overall Study|Prohibited Drugs|1|||
16168697|NCT03336502|39095262|FG000|Overall Study|Death|1|||
16168698|NCT03336502|39095263|FG001|Overall Study|Death|2|||
16168699|NCT03336502|39095262|FG000|Overall Study|Adverse Event|2|||
16168700|NCT03336502|39095263|FG001|Overall Study|Adverse Event|5|||
16168701|NCT05195528|39095264|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
16168702|NCT05195528|39095265|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
16461827|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
16168703|NCT05195528|39095266|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
16168704|NCT05195528|39095267|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
16168705|NCT05195528|39095268|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
16168706|NCT05195528|39095264|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
16168707|NCT05195528|39095265|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
16168708|NCT05195528|39095266|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
16168709|NCT05195528|39095267|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16168710|NCT05195528|39095268|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
16168711|NCT05195528|39095264|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16168712|NCT05195528|39095265|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
16168713|NCT05195528|39095266|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
16168714|NCT05195528|39095267|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16168715|NCT05195528|39095268|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
16168716|NCT05195528|39095264|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
16168717|NCT05195528|39095265|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
16168718|NCT05195528|39095266|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
16168719|NCT05195528|39095267|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
16168720|NCT05195528|39095268|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
16168721|NCT05195528|39095264|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
16168722|NCT05195528|39095265|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
16168723|NCT05195528|39095266|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
16168724|NCT05195528|39095267|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
16168725|NCT05195528|39095268|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
16168726|NCT05195528|39095264|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
16168727|NCT05195528|39095265|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
16168728|NCT05195528|39095266|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
16168729|NCT05195528|39095267|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
16168730|NCT05195528|39095268|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
16168731|NCT05195528|39095264|FG000|Placebo-controlled Treatment Period|Other|0|||
16168732|NCT05195528|39095265|FG001|Placebo-controlled Treatment Period|Other|0|||
16168733|NCT05195528|39095266|FG002|Placebo-controlled Treatment Period|Other|1|||
16168734|NCT05195528|39095267|FG003|Placebo-controlled Treatment Period|Other|0|||
16168735|NCT05195528|39095268|FG004|Placebo-controlled Treatment Period|Other|0|||
16168736|NCT05195528|39095264|FG000|Extension Period|PTE or AE or SAE|0|||
16168737|NCT05195528|39095265|FG001|Extension Period|PTE or AE or SAE|4|||
16168738|NCT05195528|39095266|FG002|Extension Period|PTE or AE or SAE|5|||
16168739|NCT05195528|39095267|FG003|Extension Period|PTE or AE or SAE|4|||
16168740|NCT05195528|39095268|FG004|Extension Period|PTE or AE or SAE|4|||
16461828|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
16461829|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
16461830|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
16461831|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
16461832|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
16461833|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
16461834|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
16461835|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
16461836|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
16461837|NCT01087788|40169259|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
16461838|NCT01087788|40169260|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
16461839|NCT01087788|40169261|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
16461840|NCT04644315|40169262|FG000|Overall Study|Subject withdrawal of consent|1|||
16461841|NCT02522624|40169263|FG000|Overall Study|Technical failure|1|||
16461842|NCT02522624|40169264|FG001|Overall Study|Technical failure|0|||
16461843|NCT01317550|40169267|FG000|Overall Study|Withdrawal by Subject|1|||
16461844|NCT01317550|40169268|FG001|Overall Study|Withdrawal by Subject|0|||
16461845|NCT01317550|40169269|FG002|Overall Study|Withdrawal by Subject|0|||
16461846|NCT01317550|40169270|FG003|Overall Study|Withdrawal by Subject|0|||
16461847|NCT01317550|40169267|FG000|Overall Study|Lack of compliance study med|1|||
16461848|NCT01317550|40169268|FG001|Overall Study|Lack of compliance study med|0|||
16461849|NCT01317550|40169269|FG002|Overall Study|Lack of compliance study med|0|||
16461850|NCT01317550|40169270|FG003|Overall Study|Lack of compliance study med|0|||
16461851|NCT03254108|40169271|FG000|Overall Study|Adverse Event|0|||
16461852|NCT03254108|40169272|FG001|Overall Study|Adverse Event|2|||
16461853|NCT03254108|40169273|FG002|Overall Study|Adverse Event|0|||
16461854|NCT03254108|40169274|FG003|Overall Study|Adverse Event|1|||
16461855|NCT03254108|40169275|FG004|Overall Study|Adverse Event|1|||
16461856|NCT03254108|40169271|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
16461857|NCT03254108|40169272|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
16461858|NCT03254108|40169273|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
16461859|NCT03254108|40169274|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
16461860|NCT03254108|40169275|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
16461861|NCT00436501|40169276|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
16461862|NCT00436501|40169277|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
16461863|NCT00436501|40169276|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
16461864|NCT00436501|40169277|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
16168741|NCT05195528|39095264|FG000|Extension Period|Protocol Violation|0|||
16168742|NCT05195528|39095265|FG001|Extension Period|Protocol Violation|2|||
16168743|NCT05195528|39095266|FG002|Extension Period|Protocol Violation|1|||
16168744|NCT05195528|39095267|FG003|Extension Period|Protocol Violation|0|||
16168745|NCT05195528|39095268|FG004|Extension Period|Protocol Violation|1|||
16168746|NCT05195528|39095264|FG000|Extension Period|Lost to Follow-up|0|||
16168747|NCT05195528|39095265|FG001|Extension Period|Lost to Follow-up|6|||
16168748|NCT05195528|39095266|FG002|Extension Period|Lost to Follow-up|13|||
16168749|NCT05195528|39095267|FG003|Extension Period|Lost to Follow-up|3|||
16168750|NCT05195528|39095268|FG004|Extension Period|Lost to Follow-up|7|||
16168751|NCT05195528|39095264|FG000|Extension Period|Withdrawal by Subject|0|||
16168752|NCT05195528|39095265|FG001|Extension Period|Withdrawal by Subject|12|||
16168753|NCT05195528|39095266|FG002|Extension Period|Withdrawal by Subject|9|||
16168754|NCT05195528|39095267|FG003|Extension Period|Withdrawal by Subject|6|||
16168755|NCT05195528|39095268|FG004|Extension Period|Withdrawal by Subject|5|||
16168756|NCT05195528|39095264|FG000|Extension Period|Lack of Efficacy|0|||
16168757|NCT05195528|39095265|FG001|Extension Period|Lack of Efficacy|3|||
16168758|NCT05195528|39095266|FG002|Extension Period|Lack of Efficacy|0|||
16168759|NCT05195528|39095267|FG003|Extension Period|Lack of Efficacy|0|||
16168760|NCT05195528|39095268|FG004|Extension Period|Lack of Efficacy|2|||
16168761|NCT05195528|39095264|FG000|Extension Period|Not Treated|0|||
16168762|NCT05195528|39095265|FG001|Extension Period|Not Treated|0|||
16168763|NCT05195528|39095266|FG002|Extension Period|Not Treated|2|||
16168764|NCT05195528|39095267|FG003|Extension Period|Not Treated|3|||
16168765|NCT05195528|39095268|FG004|Extension Period|Not Treated|0|||
16168766|NCT05195528|39095264|FG000|Extension Period|Other|0|||
16168767|NCT05195528|39095265|FG001|Extension Period|Other|1|||
16168768|NCT05195528|39095266|FG002|Extension Period|Other|1|||
16168769|NCT05195528|39095267|FG003|Extension Period|Other|0|||
16168770|NCT05195528|39095268|FG004|Extension Period|Other|0|||
16168771|NCT02772757|39095272|FG000|Overall Study|Withdrawal by Subject|1|||
16168772|NCT02772757|39095273|FG001|Overall Study|Withdrawal by Subject|0|||
16168773|NCT02772757|39095274|FG002|Overall Study|Withdrawal by Subject|1|||
16168774|NCT02772757|39095272|FG000|Overall Study|Protocol Violation|0|||
16168775|NCT02772757|39095273|FG001|Overall Study|Protocol Violation|0|||
16168776|NCT02772757|39095274|FG002|Overall Study|Protocol Violation|1|||
16461865|NCT00934648|40169278|FG000|Overall Study|Failure to return|8|||
16461866|NCT00934648|40169278|FG000|Overall Study|Withdrawal by Subject|1|||
16461867|NCT00729469|40169284|FG000|Overall Study|Adverse Event|14|||
16461868|NCT00729469|40169285|FG001|Overall Study|Adverse Event|25|||
16168777|NCT02772757|39095272|FG000|Overall Study|Physician Decision|0|||
16168778|NCT02772757|39095273|FG001|Overall Study|Physician Decision|3|||
16168779|NCT02772757|39095274|FG002|Overall Study|Physician Decision|3|||
16168780|NCT01442181|39095275|FG000|Overall Study|patient refused surgery|1|||
16168781|NCT01442181|39095276|FG001|Overall Study|patient refused surgery|0|||
16168782|NCT01442181|39095275|FG000|Overall Study|no insurance for surgery|1|||
16269263|NCT00418938|39471045|FG001|Overall Study|Ineligibility Determined|0|||
16461869|NCT00729469|40169284|FG000|Overall Study|Lost to Follow-up|9|||
16461870|NCT00729469|40169285|FG001|Overall Study|Lost to Follow-up|9|||
16461871|NCT00729469|40169284|FG000|Overall Study|Protocol Violation|2|||
16461872|NCT00729469|40169285|FG001|Overall Study|Protocol Violation|1|||
16461873|NCT00729469|40169284|FG000|Overall Study|Withdrawal by Subject|19|||
16461874|NCT00729469|40169285|FG001|Overall Study|Withdrawal by Subject|8|||
16461875|NCT00729469|40169284|FG000|Overall Study|Other-Not mentioned|9|||
16461876|NCT00729469|40169285|FG001|Overall Study|Other-Not mentioned|4|||
16461877|NCT00792571|40169286|FG000|Overall Study|Death|1|||
16461878|NCT00792571|40169286|FG000|Overall Study|Adverse Event|4|||
16461879|NCT00792571|40169286|FG000|Overall Study|Withdrawal by Subject|1|||
16168783|NCT01442181|39095276|FG001|Overall Study|no insurance for surgery|0|||
16168784|NCT01442181|39095275|FG000|Overall Study|low ejection factor|0|||
16168785|NCT01442181|39095276|FG001|Overall Study|low ejection factor|1|||
16168786|NCT01442181|39095275|FG000|Overall Study|Lost to Follow-up|1|||
16168787|NCT01442181|39095276|FG001|Overall Study|Lost to Follow-up|1|||
16168788|NCT01442181|39095275|FG000|Overall Study|patient in an additional study|1|||
16168789|NCT01442181|39095276|FG001|Overall Study|patient in an additional study|0|||
16168790|NCT01442181|39095275|FG000|Overall Study|atrial fibrillation not noted|0|||
16269264|NCT01874535|39471046|FG000|Overall Study|Lost to Follow-up|10|||
16269265|NCT01874535|39471047|FG001|Overall Study|Lost to Follow-up|9|||
16461880|NCT00792571|40169286|FG000|Overall Study|Other|4|||
16461881|NCT02366091|40169287|FG000|Overall Study|Withdrawal by Subject|3|||
16461882|NCT02366091|40169288|FG001|Overall Study|Withdrawal by Subject|7|||
16461883|NCT02366091|40169289|FG002|Overall Study|Withdrawal by Subject|3|||
16461884|NCT02366091|40169290|FG003|Overall Study|Withdrawal by Subject|1|||
16168791|NCT01442181|39095276|FG001|Overall Study|atrial fibrillation not noted|1|||
16168792|NCT02522767|39095278|FG000|Double-blind|Withdrawal by Subject|8|||
16269266|NCT01874535|39471046|FG000|Overall Study|incomplete symptom resolution|45|||
16461885|NCT01252667|40169291|FG000|Overall Study|Transplant aborted post-conditioning|0|||
16461886|NCT01252667|40169292|FG001|Overall Study|Transplant aborted post-conditioning|0|||
16461887|NCT01252667|40169293|FG002|Overall Study|Transplant aborted post-conditioning|0|||
16461888|NCT01252667|40169294|FG003|Overall Study|Transplant aborted post-conditioning|0|||
16461889|NCT01252667|40169295|FG004|Overall Study|Transplant aborted post-conditioning|0|||
16461890|NCT01252667|40169296|FG005|Overall Study|Transplant aborted post-conditioning|1|||
16461891|NCT01155011|40169300|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
16461892|NCT01155011|40169301|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
16461893|NCT01155011|40169300|FG000|Baseline to 6 Months|investigator decision, moved|4|||
16461894|NCT01155011|40169301|FG001|Baseline to 6 Months|investigator decision, moved|5|||
16461895|NCT01155011|40169300|FG000|Baseline to 6 Months|Death|0|||
16461896|NCT01155011|40169301|FG001|Baseline to 6 Months|Death|1|||
16461897|NCT01155011|40169300|FG000|6 to 12 Months|Withdrawal by Subject|8|||
16461898|NCT01155011|40169301|FG001|6 to 12 Months|Withdrawal by Subject|5|||
16461899|NCT01155011|40169300|FG000|6 to 12 Months|Death|1|||
16461900|NCT01155011|40169301|FG001|6 to 12 Months|Death|5|||
16461901|NCT02082340|40169303|FG000|Overall Study|Lost to Follow-up|1|||
16461902|NCT02082340|40169304|FG001|Overall Study|Lost to Follow-up|1|||
16461903|NCT03751657|40169305|FG000|Overall Study|Physician Decision|0|||
16461904|NCT03751657|40169306|FG001|Overall Study|Physician Decision|1|||
16461905|NCT03751657|40169305|FG000|Overall Study|Withdrawal by Subject|1|||
16461906|NCT03751657|40169306|FG001|Overall Study|Withdrawal by Subject|1|||
16461907|NCT03751657|40169305|FG000|Overall Study|Lost to Follow-up|2|||
16461908|NCT03751657|40169306|FG001|Overall Study|Lost to Follow-up|1|||
16461909|NCT02431260|40169310|FG000|Overall Study|Subject Decision|0|||
16461910|NCT02431260|40169311|FG001|Overall Study|Subject Decision|1|||
16168793|NCT02522767|39095279|FG001|Double-blind|Withdrawal by Subject|11|||
16168794|NCT02522767|39095278|FG000|Double-blind|Lost to Follow-up|1|||
16168795|NCT02522767|39095279|FG001|Double-blind|Lost to Follow-up|0|||
16168796|NCT02522767|39095278|FG000|Double-blind|Adverse Event|1|||
16168797|NCT02522767|39095279|FG001|Double-blind|Adverse Event|10|||
16168798|NCT02522767|39095278|FG000|Double-blind|Protocol Violation|0|||
16168799|NCT02522767|39095279|FG001|Double-blind|Protocol Violation|1|||
16168800|NCT02522767|39095278|FG000|Double-blind|Lack of Efficacy|0|||
16168801|NCT02522767|39095279|FG001|Double-blind|Lack of Efficacy|2|||
16168802|NCT02522767|39095278|FG000|Double-blind|Protocol Deviation|1|||
16168803|NCT02522767|39095279|FG001|Double-blind|Protocol Deviation|0|||
16168804|NCT02522767|39095278|FG000|Open-label|Withdrawal by Subject|2|||
16168805|NCT02522767|39095279|FG001|Open-label|Withdrawal by Subject|3|||
16168806|NCT02522767|39095278|FG000|Open-label|Lost to Follow-up|0|||
16168807|NCT02522767|39095279|FG001|Open-label|Lost to Follow-up|1|||
16168808|NCT02522767|39095278|FG000|Open-label|Adverse Event|2|||
16168809|NCT02522767|39095279|FG001|Open-label|Adverse Event|1|||
16168810|NCT02522767|39095278|FG000|Open-label|Lack of Efficacy|1|||
16461911|NCT02431260|40169312|FG002|Overall Study|Subject Decision|1|||
16461912|NCT02431260|40169313|FG003|Overall Study|Subject Decision|0|||
16461913|NCT02431260|40169314|FG004|Overall Study|Subject Decision|0|||
16461914|NCT02431260|40169315|FG005|Overall Study|Subject Decision|0|||
16461915|NCT02431260|40169316|FG006|Overall Study|Subject Decision|0|||
16461916|NCT02431260|40169317|FG007|Overall Study|Subject Decision|0|||
16461917|NCT02431260|40169318|FG008|Overall Study|Subject Decision|1|||
16461918|NCT02431260|40169319|FG009|Overall Study|Subject Decision|1|||
16461919|NCT02431260|40169320|FG010|Overall Study|Subject Decision|0|||
16461920|NCT02431260|40169321|FG011|Overall Study|Subject Decision|1|||
16461921|NCT02431260|40169322|FG012|Overall Study|Subject Decision|0|||
16461922|NCT02431260|40169323|FG013|Overall Study|Subject Decision|0|||
16461923|NCT02431260|40169310|FG000|Overall Study|Death|4|||
16461924|NCT02431260|40169311|FG001|Overall Study|Death|4|||
16461925|NCT02431260|40169312|FG002|Overall Study|Death|3|||
16461926|NCT02431260|40169313|FG003|Overall Study|Death|4|||
16461927|NCT02431260|40169314|FG004|Overall Study|Death|2|||
16461928|NCT02431260|40169315|FG005|Overall Study|Death|2|||
16461929|NCT02431260|40169316|FG006|Overall Study|Death|3|||
16461930|NCT02431260|40169317|FG007|Overall Study|Death|1|||
16168811|NCT02522767|39095279|FG001|Open-label|Lack of Efficacy|1|||
16168812|NCT02522767|39095278|FG000|Open-label|Protocol Violation|0|||
16168813|NCT02522767|39095279|FG001|Open-label|Protocol Violation|1|||
16168814|NCT03041311|39095288|FG000|Overall Study|Death|39|||
16168815|NCT03041311|39095289|FG001|Overall Study|Death|42|||
16461931|NCT02431260|40169318|FG008|Overall Study|Death|6|||
16461932|NCT02431260|40169319|FG009|Overall Study|Death|6|||
16461933|NCT02431260|40169320|FG010|Overall Study|Death|3|||
16461934|NCT02431260|40169321|FG011|Overall Study|Death|2|||
16461935|NCT02431260|40169322|FG012|Overall Study|Death|5|||
16461936|NCT02431260|40169323|FG013|Overall Study|Death|1|||
16461937|NCT02431260|40169310|FG000|Overall Study|Lost to Follow-up|0|||
16461938|NCT02431260|40169311|FG001|Overall Study|Lost to Follow-up|0|||
16461939|NCT02431260|40169312|FG002|Overall Study|Lost to Follow-up|0|||
16168816|NCT03041311|39095288|FG000|Overall Study|Lost to Follow-up|0|||
16168817|NCT03041311|39095289|FG001|Overall Study|Lost to Follow-up|1|||
16461940|NCT02431260|40169313|FG003|Overall Study|Lost to Follow-up|0|||
16461941|NCT02431260|40169314|FG004|Overall Study|Lost to Follow-up|0|||
16461942|NCT02431260|40169315|FG005|Overall Study|Lost to Follow-up|1|||
16461943|NCT02431260|40169316|FG006|Overall Study|Lost to Follow-up|0|||
16461944|NCT02431260|40169317|FG007|Overall Study|Lost to Follow-up|0|||
16461945|NCT02431260|40169318|FG008|Overall Study|Lost to Follow-up|0|||
16461946|NCT02431260|40169319|FG009|Overall Study|Lost to Follow-up|0|||
16461947|NCT02431260|40169320|FG010|Overall Study|Lost to Follow-up|0|||
16461948|NCT02431260|40169321|FG011|Overall Study|Lost to Follow-up|0|||
16461949|NCT02431260|40169322|FG012|Overall Study|Lost to Follow-up|0|||
16461950|NCT02431260|40169323|FG013|Overall Study|Lost to Follow-up|0|||
16461951|NCT02431260|40169310|FG000|Overall Study|Study Terminated by the Sponsor|0|||
16461952|NCT02431260|40169311|FG001|Overall Study|Study Terminated by the Sponsor|0|||
16461953|NCT02431260|40169312|FG002|Overall Study|Study Terminated by the Sponsor|2|||
16461954|NCT02431260|40169313|FG003|Overall Study|Study Terminated by the Sponsor|1|||
16461955|NCT02431260|40169314|FG004|Overall Study|Study Terminated by the Sponsor|1|||
16461956|NCT02431260|40169315|FG005|Overall Study|Study Terminated by the Sponsor|0|||
16461957|NCT02431260|40169316|FG006|Overall Study|Study Terminated by the Sponsor|1|||
16461958|NCT02431260|40169317|FG007|Overall Study|Study Terminated by the Sponsor|2|||
16461959|NCT02431260|40169318|FG008|Overall Study|Study Terminated by the Sponsor|1|||
16461960|NCT02431260|40169319|FG009|Overall Study|Study Terminated by the Sponsor|1|||
16461961|NCT02431260|40169320|FG010|Overall Study|Study Terminated by the Sponsor|1|||
16461962|NCT02431260|40169321|FG011|Overall Study|Study Terminated by the Sponsor|0|||
16461963|NCT02431260|40169322|FG012|Overall Study|Study Terminated by the Sponsor|4|||
16461964|NCT02431260|40169323|FG013|Overall Study|Study Terminated by the Sponsor|0|||
16461965|NCT02431260|40169310|FG000|Overall Study|Physician Decision|0|||
16461966|NCT02431260|40169311|FG001|Overall Study|Physician Decision|0|||
16461967|NCT02431260|40169312|FG002|Overall Study|Physician Decision|0|||
16461968|NCT02431260|40169313|FG003|Overall Study|Physician Decision|0|||
16461969|NCT02431260|40169314|FG004|Overall Study|Physician Decision|0|||
16461970|NCT02431260|40169315|FG005|Overall Study|Physician Decision|1|||
16461971|NCT02431260|40169316|FG006|Overall Study|Physician Decision|0|||
16461972|NCT02431260|40169317|FG007|Overall Study|Physician Decision|0|||
16461973|NCT02431260|40169318|FG008|Overall Study|Physician Decision|0|||
16461974|NCT02431260|40169319|FG009|Overall Study|Physician Decision|0|||
16461975|NCT02431260|40169320|FG010|Overall Study|Physician Decision|0|||
16461976|NCT02431260|40169321|FG011|Overall Study|Physician Decision|0|||
16461977|NCT02431260|40169322|FG012|Overall Study|Physician Decision|0|||
16461978|NCT02431260|40169323|FG013|Overall Study|Physician Decision|0|||
16461979|NCT02431260|40169310|FG000|Overall Study|Other Unspecified|0|||
16461980|NCT02431260|40169311|FG001|Overall Study|Other Unspecified|0|||
16461981|NCT02431260|40169312|FG002|Overall Study|Other Unspecified|0|||
16461982|NCT02431260|40169313|FG003|Overall Study|Other Unspecified|0|||
16461983|NCT02431260|40169314|FG004|Overall Study|Other Unspecified|0|||
16461984|NCT02431260|40169315|FG005|Overall Study|Other Unspecified|0|||
16461985|NCT02431260|40169316|FG006|Overall Study|Other Unspecified|0|||
16461986|NCT02431260|40169317|FG007|Overall Study|Other Unspecified|0|||
16461987|NCT02431260|40169318|FG008|Overall Study|Other Unspecified|0|||
16461988|NCT02431260|40169319|FG009|Overall Study|Other Unspecified|0|||
16461989|NCT02431260|40169320|FG010|Overall Study|Other Unspecified|0|||
16461990|NCT02431260|40169321|FG011|Overall Study|Other Unspecified|1|||
16461991|NCT02431260|40169322|FG012|Overall Study|Other Unspecified|1|||
16461992|NCT02431260|40169323|FG013|Overall Study|Other Unspecified|0|||
16461993|NCT00329901|40169327|FG000|Overall Study|Withdrawal by Subject|4|||
16461994|NCT00329901|40169328|FG001|Overall Study|Withdrawal by Subject|3|||
16461995|NCT00329901|40169329|FG002|Overall Study|Withdrawal by Subject|2|||
16461996|NCT00329901|40169327|FG000|Overall Study|Lost to Follow-up|2|||
16461997|NCT00329901|40169328|FG001|Overall Study|Lost to Follow-up|0|||
16461998|NCT00329901|40169329|FG002|Overall Study|Lost to Follow-up|1|||
16461999|NCT00329901|40169327|FG000|Overall Study|Protocol Violation|1|||
16462000|NCT00329901|40169328|FG001|Overall Study|Protocol Violation|0|||
16462001|NCT00329901|40169329|FG002|Overall Study|Protocol Violation|1|||
16168818|NCT03041311|39095288|FG000|Overall Study|Withdrawal by Subject|8|||
16269267|NCT01874535|39471047|FG001|Overall Study|incomplete symptom resolution|35|||
16462002|NCT00329901|40169327|FG000|Overall Study|Unable to classify|2|||
16462003|NCT00329901|40169328|FG001|Overall Study|Unable to classify|2|||
16462004|NCT00329901|40169329|FG002|Overall Study|Unable to classify|0|||
16462005|NCT00534313|40169330|FG000|Short-term Period|Adverse Event|1|||
16462006|NCT00534313|40169331|FG001|Short-term Period|Adverse Event|2|||
16462007|NCT00534313|40169332|FG002|Short-term Period|Adverse Event|1|||
16462008|NCT00534313|40169333|FG003|Short-term Period|Adverse Event|3|||
16462009|NCT00534313|40169330|FG000|Short-term Period|Lack of Efficacy|3|||
16462010|NCT00534313|40169331|FG001|Short-term Period|Lack of Efficacy|4|||
16462011|NCT00534313|40169332|FG002|Short-term Period|Lack of Efficacy|0|||
16462012|NCT00534313|40169333|FG003|Short-term Period|Lack of Efficacy|3|||
16462013|NCT00534313|40169330|FG000|Short-term Period|Participant not meeting study criteria|0|||
16168819|NCT03041311|39095289|FG001|Overall Study|Withdrawal by Subject|5|||
16462014|NCT00534313|40169331|FG001|Short-term Period|Participant not meeting study criteria|0|||
16462015|NCT00534313|40169332|FG002|Short-term Period|Participant not meeting study criteria|0|||
16462016|NCT00534313|40169333|FG003|Short-term Period|Participant not meeting study criteria|1|||
16462017|NCT00534313|40169330|FG000|Short-term Period|Participant withdrew consent|2|||
16462018|NCT00534313|40169331|FG001|Short-term Period|Participant withdrew consent|0|||
16462019|NCT00534313|40169332|FG002|Short-term Period|Participant withdrew consent|0|||
16462020|NCT00534313|40169333|FG003|Short-term Period|Participant withdrew consent|2|||
16462021|NCT00534313|40169330|FG000|Short-term Period|Pregnancy|0|||
16462022|NCT00534313|40169331|FG001|Short-term Period|Pregnancy|0|||
16462023|NCT00534313|40169332|FG002|Short-term Period|Pregnancy|1|||
16462024|NCT00534313|40169333|FG003|Short-term Period|Pregnancy|0|||
16462025|NCT00534313|40169330|FG000|Long-term Period|Adverse Event|2|||
16462026|NCT00534313|40169331|FG001|Long-term Period|Adverse Event|1|||
16462027|NCT00534313|40169332|FG002|Long-term Period|Adverse Event|0|||
16462028|NCT00534313|40169333|FG003|Long-term Period|Adverse Event|1|||
16462029|NCT00534313|40169330|FG000|Long-term Period|Lack of Efficacy|14|||
16462030|NCT00534313|40169331|FG001|Long-term Period|Lack of Efficacy|10|||
16462031|NCT00534313|40169332|FG002|Long-term Period|Lack of Efficacy|14|||
16462032|NCT00534313|40169333|FG003|Long-term Period|Lack of Efficacy|12|||
16462033|NCT00534313|40169330|FG000|Long-term Period|Lost to Follow-up|1|||
16462034|NCT00534313|40169331|FG001|Long-term Period|Lost to Follow-up|2|||
16462035|NCT00534313|40169332|FG002|Long-term Period|Lost to Follow-up|0|||
16462036|NCT00534313|40169333|FG003|Long-term Period|Lost to Follow-up|0|||
16462037|NCT00534313|40169330|FG000|Long-term Period|Withdrawal by Subject|2|||
16462038|NCT00534313|40169331|FG001|Long-term Period|Withdrawal by Subject|2|||
16462039|NCT00534313|40169332|FG002|Long-term Period|Withdrawal by Subject|0|||
16462040|NCT00534313|40169333|FG003|Long-term Period|Withdrawal by Subject|0|||
16462041|NCT00534313|40169330|FG000|Long-term Period|No longer meets study criteria|0|||
16462042|NCT00534313|40169331|FG001|Long-term Period|No longer meets study criteria|1|||
16462043|NCT00534313|40169332|FG002|Long-term Period|No longer meets study criteria|0|||
16462044|NCT00534313|40169333|FG003|Long-term Period|No longer meets study criteria|0|||
16462045|NCT00534313|40169330|FG000|Long-term Period|Poor compliance/noncompliance|0|||
16462046|NCT00534313|40169331|FG001|Long-term Period|Poor compliance/noncompliance|1|||
16462047|NCT00534313|40169332|FG002|Long-term Period|Poor compliance/noncompliance|1|||
16462048|NCT00534313|40169333|FG003|Long-term Period|Poor compliance/noncompliance|0|||
16462049|NCT00534313|40169330|FG000|Long-term Period|Administrative reason by sponsor|17|||
16462050|NCT00534313|40169331|FG001|Long-term Period|Administrative reason by sponsor|15|||
16168820|NCT03041311|39095288|FG000|Overall Study|Sponsor Terminated Study|2|||
16168821|NCT03041311|39095289|FG001|Overall Study|Sponsor Terminated Study|4|||
16168822|NCT03041311|39095288|FG000|Overall Study|Disease Progression|3|||
16168823|NCT03041311|39095289|FG001|Overall Study|Disease Progression|1|||
16168824|NCT03041311|39095288|FG000|Overall Study|Randomized in error, did not receive drug|2|||
16168825|NCT03041311|39095289|FG001|Overall Study|Randomized in error, did not receive drug|0|||
16168826|NCT00888238|39095292|FG000|Washout Period After Period 2|Adverse Event|0|||
16168827|NCT00888238|39095293|FG001|Washout Period After Period 2|Adverse Event|0|||
16168828|NCT00888238|39095294|FG002|Washout Period After Period 2|Adverse Event|1|||
16168829|NCT03075163|39095295|FG000|Overall Study|not eligible for treatment limb|138|||
16168830|NCT03075163|39095296|FG001|Overall Study|not eligible for treatment limb|138|||
16168831|NCT02908516|39095297|FG000|Overall Study|Study Terminated|3|||
16168832|NCT02908516|39095298|FG001|Overall Study|Study Terminated|3|||
16168833|NCT03786432|39095299|FG000|Overall Study|Screen Failure after consent|1|||
16168834|NCT03786432|39095299|FG000|Overall Study|Lost to Follow-up|4|||
16168835|NCT03786432|39095299|FG000|Overall Study|did not complete 12 month CT scan|1|||
16168836|NCT01570244|39095300|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
16168837|NCT02604264|39095301|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
16168838|NCT02604264|39095302|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
16168839|NCT02597855|39095307|FG000|Overall Study|Lost to Follow-up|2|||
16462051|NCT00534313|40169332|FG002|Long-term Period|Administrative reason by sponsor|26|||
16462052|NCT00534313|40169333|FG003|Long-term Period|Administrative reason by sponsor|18|||
16462053|NCT00534313|40169330|FG000|Long-term Period|Other|1|||
16462054|NCT00534313|40169331|FG001|Long-term Period|Other|2|||
16462055|NCT00534313|40169332|FG002|Long-term Period|Other|2|||
16462056|NCT00534313|40169333|FG003|Long-term Period|Other|2|||
16462057|NCT03595618|40169334|FG000|Overall Study|Adverse Event|16|||
16462058|NCT03595618|40169335|FG001|Overall Study|Adverse Event|17|||
16462059|NCT03595618|40169336|FG002|Overall Study|Adverse Event|20|||
16462060|NCT03595618|40169337|FG003|Overall Study|Adverse Event|8|||
16462061|NCT03595618|40169334|FG000|Overall Study|Withdrawal by Subject|12|||
16462062|NCT03595618|40169335|FG001|Overall Study|Withdrawal by Subject|14|||
16168840|NCT02597855|39095308|FG001|Overall Study|Lost to Follow-up|1|||
16168841|NCT03208231|39095309|FG000|Overall Study|Death|1|||
16462063|NCT03595618|40169336|FG002|Overall Study|Withdrawal by Subject|14|||
16462064|NCT03595618|40169337|FG003|Overall Study|Withdrawal by Subject|10|||
16462065|NCT03595618|40169334|FG000|Overall Study|Lost to Follow-up|6|||
16462066|NCT03595618|40169335|FG001|Overall Study|Lost to Follow-up|4|||
16462067|NCT03595618|40169336|FG002|Overall Study|Lost to Follow-up|5|||
16462068|NCT03595618|40169337|FG003|Overall Study|Lost to Follow-up|6|||
16462069|NCT03595618|40169334|FG000|Overall Study|Protocol Violation|2|||
16462070|NCT03595618|40169335|FG001|Overall Study|Protocol Violation|0|||
16462071|NCT03595618|40169336|FG002|Overall Study|Protocol Violation|6|||
16462072|NCT03595618|40169337|FG003|Overall Study|Protocol Violation|2|||
16462073|NCT03595618|40169334|FG000|Overall Study|Physician Decision|0|||
16462074|NCT03595618|40169335|FG001|Overall Study|Physician Decision|0|||
16462075|NCT03595618|40169336|FG002|Overall Study|Physician Decision|1|||
16462076|NCT03595618|40169337|FG003|Overall Study|Physician Decision|2|||
16462077|NCT03595618|40169334|FG000|Overall Study|Miscellaneous|7|||
16462078|NCT03595618|40169335|FG001|Overall Study|Miscellaneous|5|||
16462079|NCT03595618|40169336|FG002|Overall Study|Miscellaneous|10|||
16462080|NCT03595618|40169337|FG003|Overall Study|Miscellaneous|6|||
16462081|NCT00159822|40169338|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
16462082|NCT00159822|40169338|FG000|Voriconazole Treatment Period|Adverse Event|9|||
16462083|NCT00159822|40169338|FG000|Voriconazole Treatment Period|Death|4|||
16462084|NCT00159822|40169338|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
16462085|NCT00159822|40169338|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
16462086|NCT00159822|40169338|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
16462087|NCT00159822|40169338|FG000|Post-treatment Follow-up Period|Death|1|||
16462088|NCT00159822|40169338|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
16462089|NCT00159822|40169338|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
16462090|NCT01381562|40169339|FG000|Overall Study|Adverse Event|0|||
16462091|NCT01381562|40169340|FG001|Overall Study|Adverse Event|1|||
16462092|NCT01381562|40169341|FG002|Overall Study|Adverse Event|0|||
16462093|NCT00853970|40169342|FG000|Overall Study|Withdrawal by Subject|2|||
16462094|NCT00853970|40169343|FG001|Overall Study|Withdrawal by Subject|1|||
16462095|NCT00853970|40169342|FG000|Overall Study|Cancelled surgery|4|||
16462096|NCT00853970|40169343|FG001|Overall Study|Cancelled surgery|2|||
16462097|NCT01754727|40169349|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
16462098|NCT00484185|40172315|FG000|Overall Study|Lost to Follow-up|44|||
16462099|NCT00484185|40172315|FG000|Overall Study|Other|20|||
16462100|NCT00484185|40172315|FG000|Overall Study|Randomized but not treated|5|||
16462101|NCT00484185|40172315|FG000|Overall Study|Death|2|||
16462102|NCT00798759|40172316|FG000|Overall Study|Adverse Event|3|||
16462103|NCT00798759|40172317|FG001|Overall Study|Adverse Event|3|||
16462104|NCT00798759|40172316|FG000|Overall Study|Lost to Follow-up|1|||
16462105|NCT00798759|40172317|FG001|Overall Study|Lost to Follow-up|1|||
16462106|NCT00798759|40172316|FG000|Overall Study|Protocol Violation|4|||
16462107|NCT00798759|40172317|FG001|Overall Study|Protocol Violation|8|||
16462108|NCT00798759|40172316|FG000|Overall Study|Other|0|||
16462109|NCT00798759|40172317|FG001|Overall Study|Other|1|||
16462110|NCT03206788|40172318|FG000|Overall Study|Withdrawal by Subject|0|||
16462111|NCT03206788|40172319|FG001|Overall Study|Withdrawal by Subject|1|||
16462112|NCT03206788|40172318|FG000|Overall Study|Adverse Event|0|||
16462113|NCT03206788|40172319|FG001|Overall Study|Adverse Event|1|||
16462114|NCT03206788|40172318|FG000|Overall Study|Physician Decision|0|||
16462115|NCT03206788|40172319|FG001|Overall Study|Physician Decision|1|||
16462116|NCT02545543|40172320|FG000|Overall Study|Lost to Follow-up|67|||
16462117|NCT02545543|40172321|FG001|Overall Study|Lost to Follow-up|25|||
16462118|NCT02545543|40172320|FG000|Overall Study|Physician Decision|3|||
16462119|NCT02545543|40172321|FG001|Overall Study|Physician Decision|0|||
16462120|NCT02545543|40172320|FG000|Overall Study|Withdrawal by Subject|9|||
16462121|NCT02545543|40172321|FG001|Overall Study|Withdrawal by Subject|8|||
16462122|NCT02545543|40172320|FG000|Overall Study|Noncomplaince|1|||
16462123|NCT02545543|40172321|FG001|Overall Study|Noncomplaince|0|||
16462124|NCT02545543|40172320|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
16462125|NCT02545543|40172321|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
16462126|NCT00329849|40172324|FG000|Overall Study|Withdrawal by Subject|6|||
16462127|NCT00329849|40172325|FG001|Overall Study|Withdrawal by Subject|4|||
16462128|NCT02925416|40172326|FG000|Overall Study|Adverse Event|2|||
16462129|NCT02925416|40172327|FG001|Overall Study|Adverse Event|0|||
16462130|NCT01328444|40172336|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
16168842|NCT03208231|39095310|FG001|Overall Study|Death|2|||
16462131|NCT01328444|40172337|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
16462132|NCT01328444|40172338|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
16462133|NCT01328444|40172339|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
16462134|NCT01328444|40172340|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
16462135|NCT01328444|40172341|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
16462136|NCT01328444|40172336|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
16462137|NCT01328444|40172337|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
16462138|NCT01328444|40172338|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
16462139|NCT01328444|40172339|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
16462140|NCT01328444|40172340|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
16462141|NCT01328444|40172341|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
16168843|NCT03208231|39095309|FG000|Overall Study|Moved and unable to get to clinic|1|||
16462142|NCT01328444|40172336|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
16462143|NCT01328444|40172337|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
16462144|NCT01328444|40172338|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
16462145|NCT01328444|40172339|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
16462146|NCT01328444|40172340|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
16462147|NCT01328444|40172341|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
16462148|NCT01328444|40172336|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
16462149|NCT01328444|40172337|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
16462150|NCT01328444|40172338|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
16462151|NCT01328444|40172339|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
16462152|NCT01328444|40172340|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
16462153|NCT01328444|40172341|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
16462154|NCT01328444|40172336|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
16462155|NCT01328444|40172337|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16462156|NCT01328444|40172338|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16462157|NCT01328444|40172339|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
16462158|NCT01328444|40172340|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16462159|NCT01328444|40172341|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
16462160|NCT01328444|40172336|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16462161|NCT01328444|40172337|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
16462162|NCT01328444|40172338|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
16462163|NCT01328444|40172339|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
16462164|NCT01328444|40172340|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
16462165|NCT01328444|40172341|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
16462166|NCT01328444|40172336|FG000|Washout Period (14 Days)|Adverse Event|1|||
16462167|NCT01328444|40172337|FG001|Washout Period (14 Days)|Adverse Event|1|||
16462168|NCT01328444|40172338|FG002|Washout Period (14 Days)|Adverse Event|0|||
16462169|NCT01328444|40172339|FG003|Washout Period (14 Days)|Adverse Event|1|||
16462170|NCT01328444|40172340|FG004|Washout Period (14 Days)|Adverse Event|1|||
16462171|NCT01328444|40172341|FG005|Washout Period (14 Days)|Adverse Event|2|||
16462172|NCT01328444|40172336|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
16462173|NCT01328444|40172337|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
16462174|NCT01328444|40172338|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
16462175|NCT01328444|40172339|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
16462176|NCT01328444|40172340|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
16462177|NCT01328444|40172341|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
16462178|NCT01328444|40172336|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
16462179|NCT01328444|40172337|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
16462180|NCT01328444|40172338|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
16462181|NCT01328444|40172339|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
16462182|NCT01328444|40172340|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
16462183|NCT01328444|40172341|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
16462184|NCT01328444|40172336|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
16462185|NCT01328444|40172337|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
16462186|NCT01328444|40172338|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
16462187|NCT01328444|40172339|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
16462188|NCT01328444|40172340|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
16462189|NCT01328444|40172341|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
16462190|NCT01328444|40172336|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
16462191|NCT01328444|40172337|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
16462192|NCT01328444|40172338|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
16462193|NCT01328444|40172339|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
16462194|NCT01328444|40172340|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
16462195|NCT01328444|40172341|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
16462196|NCT01328444|40172336|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
16462197|NCT01328444|40172337|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
16462198|NCT01328444|40172338|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
16462199|NCT01328444|40172339|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
16462200|NCT01328444|40172340|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
16462201|NCT01328444|40172341|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
16462202|NCT01328444|40172336|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
16462203|NCT01328444|40172337|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
16462204|NCT01328444|40172338|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
16462205|NCT01328444|40172339|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
16462206|NCT01328444|40172340|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
16462207|NCT01328444|40172341|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
16462208|NCT01328444|40172336|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
16462209|NCT01328444|40172337|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
16462210|NCT01328444|40172338|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
16462211|NCT01328444|40172339|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
16462212|NCT01328444|40172340|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
16462213|NCT01328444|40172341|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
16462214|NCT01328444|40172336|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16462215|NCT01328444|40172337|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16462216|NCT01328444|40172338|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16462217|NCT01328444|40172339|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16462218|NCT01328444|40172340|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16462219|NCT01328444|40172341|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16462220|NCT01357850|40172342|FG000|Overall Study|Lost to Follow-up|1|||
16462221|NCT01357850|40172343|FG001|Overall Study|Lost to Follow-up|0|||
16462222|NCT01357850|40172344|FG002|Overall Study|Lost to Follow-up|0|||
16462223|NCT01357850|40172345|FG003|Overall Study|Lost to Follow-up|0|||
16462224|NCT00843778|40172351|FG000|Overall Study|Adverse Event|15|||
16462225|NCT00843778|40172351|FG000|Overall Study|Lack of Efficacy|14|||
16462226|NCT00843778|40172351|FG000|Overall Study|Loss of efficacy|2|||
16462227|NCT00843778|40172351|FG000|Overall Study|Withdrawal by Subject|4|||
16462228|NCT00713310|40172358|FG000|Overall Study|Adverse Event|5|||
16462229|NCT00713310|40172359|FG001|Overall Study|Adverse Event|2|||
16462230|NCT00713310|40172358|FG000|Overall Study|Lack of Efficacy|0|||
16462231|NCT00713310|40172359|FG001|Overall Study|Lack of Efficacy|2|||
16462232|NCT00713310|40172358|FG000|Overall Study|Withdrawal by Subject|0|||
16462233|NCT00713310|40172359|FG001|Overall Study|Withdrawal by Subject|2|||
16462234|NCT02604017|40172360|FG000|Overall Study|Withdrew Consent|0|||
16462235|NCT02604017|40172361|FG001|Overall Study|Withdrew Consent|2|||
16168844|NCT03208231|39095310|FG001|Overall Study|Moved and unable to get to clinic|0|||
16168845|NCT03208231|39095309|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
16168846|NCT03208231|39095310|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
16462236|NCT02604017|40172360|FG000|Overall Study|Lost to Follow-up|5|||
16462237|NCT02604017|40172361|FG001|Overall Study|Lost to Follow-up|6|||
16462238|NCT02604017|40172360|FG000|Overall Study|Other|1|||
16462239|NCT02604017|40172361|FG001|Overall Study|Other|0|||
16462240|NCT04473235|40172365|FG000|Overall Study|Lost to Follow-up|6|||
16462241|NCT04473235|40172366|FG001|Overall Study|Lost to Follow-up|5|||
16462242|NCT04473235|40172365|FG000|Overall Study|Declined continuation|2|||
16462243|NCT04473235|40172366|FG001|Overall Study|Declined continuation|0|||
16462244|NCT04473235|40172365|FG000|Overall Study|Physician Decision|1|||
16462245|NCT04473235|40172366|FG001|Overall Study|Physician Decision|1|||
16462246|NCT04473235|40172365|FG000|Overall Study|Protocol Violation|10|||
16462247|NCT04473235|40172366|FG001|Overall Study|Protocol Violation|6|||
16462248|NCT01715857|40172369|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
16462249|NCT00588861|40172370|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
16462250|NCT00588861|40172371|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
16462251|NCT00588861|40172370|FG000|6 Months|Patients did not return for follow-up|98|||
16462252|NCT00588861|40172371|FG001|6 Months|Patients did not return for follow-up|73|||
16462253|NCT00588861|40172370|FG000|1 Year|Patients did not return for follow-up|89|||
16462254|NCT00588861|40172371|FG001|1 Year|Patients did not return for follow-up|82|||
16462255|NCT00588861|40172370|FG000|2 Years|Patients did not return for follow-up|92|||
16462256|NCT00588861|40172371|FG001|2 Years|Patients did not return for follow-up|87|||
16462257|NCT00588861|40172370|FG000|4 Years|Patients did not return for follow-up|91|||
16462258|NCT00588861|40172371|FG001|4 Years|Patients did not return for follow-up|103|||
16462259|NCT00588861|40172370|FG000|6 Years|Patients did not return for follow-up|104|||
16462260|NCT00588861|40172371|FG001|6 Years|Patients did not return for follow-up|109|||
16462261|NCT00588861|40172370|FG000|8 Years|Patients did not return for follow-up|105|||
16462262|NCT00588861|40172371|FG001|8 Years|Patients did not return for follow-up|114|||
16462263|NCT00588861|40172370|FG000|10 Years|Incomplete due to study termination|107|||
16462264|NCT00588861|40172371|FG001|10 Years|Incomplete due to study termination|114|||
16462265|NCT00321646|40172372|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
16462266|NCT00321646|40172372|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
16462267|NCT00321646|40172372|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
16462268|NCT00402233|40172373|FG000|Overall Study|Adverse Event|1|||
16462269|NCT00402233|40172374|FG001|Overall Study|Adverse Event|7|||
16168847|NCT01707992|39095311|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
16168848|NCT01707992|39095312|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
16168849|NCT01707992|39095313|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
16168850|NCT01707992|39095314|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
16168851|NCT01707992|39095315|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
16462270|NCT00402233|40172375|FG002|Overall Study|Adverse Event|9|||
16462271|NCT00402233|40172376|FG003|Overall Study|Adverse Event|9|||
16462272|NCT00402233|40172373|FG000|Overall Study|Protocol Violation|0|||
16462273|NCT00402233|40172374|FG001|Overall Study|Protocol Violation|1|||
16462274|NCT00402233|40172375|FG002|Overall Study|Protocol Violation|0|||
16462275|NCT00402233|40172376|FG003|Overall Study|Protocol Violation|0|||
16462276|NCT00402233|40172373|FG000|Overall Study|Withdrawal by Subject|2|||
16462277|NCT00402233|40172374|FG001|Overall Study|Withdrawal by Subject|1|||
16462278|NCT00402233|40172375|FG002|Overall Study|Withdrawal by Subject|2|||
16462279|NCT00402233|40172376|FG003|Overall Study|Withdrawal by Subject|2|||
16462280|NCT00402233|40172373|FG000|Overall Study|Worsening of disease under study|2|||
16462281|NCT00402233|40172374|FG001|Overall Study|Worsening of disease under study|0|||
16462282|NCT00402233|40172375|FG002|Overall Study|Worsening of disease under study|0|||
16168852|NCT01707992|39095316|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
16168853|NCT01707992|39095311|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
16462283|NCT00402233|40172376|FG003|Overall Study|Worsening of disease under study|0|||
16462284|NCT00402233|40172373|FG000|Overall Study|Worsening of other pre-existing disease|0|||
16462285|NCT00402233|40172374|FG001|Overall Study|Worsening of other pre-existing disease|1|||
16462286|NCT00402233|40172375|FG002|Overall Study|Worsening of other pre-existing disease|0|||
16462287|NCT00402233|40172376|FG003|Overall Study|Worsening of other pre-existing disease|0|||
16462288|NCT01888432|40172379|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
16462289|NCT01888432|40172380|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
16462290|NCT01888432|40172379|FG000|12-month Analysis (FAS)|Physician Decision|1|||
16462291|NCT01888432|40172380|FG001|12-month Analysis (FAS)|Physician Decision|1|||
16462292|NCT01888432|40172379|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
16462293|NCT01888432|40172380|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
16462294|NCT01888432|40172379|FG000|12-month Analysis (FAS)|Death|4|||
16462295|NCT01888432|40172380|FG001|12-month Analysis (FAS)|Death|3|||
16462296|NCT01888432|40172379|FG000|24-month Analysis (FAS)|Graft loss|0|||
16462297|NCT01888432|40172380|FG001|24-month Analysis (FAS)|Graft loss|1|||
16462298|NCT01888432|40172379|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
16462299|NCT01888432|40172380|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
16462300|NCT01888432|40172379|FG000|24-month Analysis (FAS)|Physician Decision|2|||
16462301|NCT01888432|40172380|FG001|24-month Analysis (FAS)|Physician Decision|4|||
16462302|NCT01888432|40172379|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
16462303|NCT01888432|40172380|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
16462304|NCT01888432|40172379|FG000|24-month Analysis (FAS)|Death|8|||
16462305|NCT01888432|40172380|FG001|24-month Analysis (FAS)|Death|4|||
16462306|NCT01888432|40172379|FG000|36-month Analysis (Extension)|Death|1|||
16462307|NCT01888432|40172380|FG001|36-month Analysis (Extension)|Death|0|||
16168854|NCT01707992|39095312|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
16168855|NCT01707992|39095313|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
16168856|NCT01707992|39095314|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
16168857|NCT01707992|39095315|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
16168858|NCT01707992|39095316|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
16168859|NCT01707992|39095311|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
16168860|NCT01707992|39095312|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
16168861|NCT01707992|39095313|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
16168862|NCT01707992|39095314|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
16168863|NCT01707992|39095315|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
16168864|NCT01707992|39095316|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
16168865|NCT01707992|39095311|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
16168866|NCT01707992|39095312|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
16168867|NCT01707992|39095313|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
16168868|NCT01707992|39095314|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
16168869|NCT01707992|39095315|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
16168870|NCT01707992|39095316|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
16168871|NCT01707992|39095311|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
16168872|NCT01707992|39095312|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
16168873|NCT01707992|39095313|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
16168874|NCT01707992|39095314|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
16168875|NCT01707992|39095315|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
16168876|NCT01707992|39095316|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
16168877|NCT01707992|39095311|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
16168878|NCT01707992|39095312|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
16168879|NCT01707992|39095313|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
16168880|NCT01707992|39095314|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
16168881|NCT01707992|39095315|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
16168882|NCT01707992|39095316|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
16462308|NCT02813577|40172388|FG000|Overall Study|Study terminated|4|||
16462309|NCT01699867|40172390|FG000|Overall Study|Screening Failure|3|||
16462310|NCT01659554|40172391|FG000|Overall Study|Study Termination|4|||
16462311|NCT00275821|40172392|FG000|Overall Study|Adverse Event|4|||
16462312|NCT00275821|40172393|FG001|Overall Study|Adverse Event|12|||
16462313|NCT00275821|40172394|FG002|Overall Study|Adverse Event|5|||
16462314|NCT00275821|40172392|FG000|Overall Study|Administrative problems|3|||
16168883|NCT01707992|39095311|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
16168884|NCT01707992|39095312|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
16168885|NCT01707992|39095313|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
16168886|NCT01707992|39095314|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
16168887|NCT01707992|39095315|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
16168888|NCT01707992|39095316|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
16168889|NCT01707992|39095311|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
16168890|NCT01707992|39095312|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
16168891|NCT01707992|39095313|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
16168892|NCT01707992|39095314|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
16168893|NCT01707992|39095315|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
16168894|NCT01707992|39095316|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
16168895|NCT01707992|39095311|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
16168896|NCT01707992|39095312|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
16168897|NCT01707992|39095313|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
16168898|NCT01707992|39095314|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
16168899|NCT01707992|39095315|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
16168900|NCT01707992|39095316|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
16168901|NCT01707992|39095311|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
16168902|NCT01707992|39095312|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
16168903|NCT01707992|39095313|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
16168904|NCT01707992|39095314|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
16168905|NCT01707992|39095315|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
16168906|NCT01707992|39095316|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
16168907|NCT01707992|39095311|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
16168908|NCT01707992|39095312|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
16168909|NCT01707992|39095313|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
16168910|NCT01707992|39095314|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
16168911|NCT01707992|39095315|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
16168912|NCT01707992|39095316|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
16168913|NCT01707992|39095311|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
16168914|NCT01707992|39095312|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
16168915|NCT01707992|39095313|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
16168916|NCT01707992|39095314|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
16168917|NCT01707992|39095315|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
16168918|NCT01707992|39095316|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
16168919|NCT01707992|39095311|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
16168920|NCT01707992|39095312|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
16168921|NCT01707992|39095313|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
16168922|NCT01707992|39095314|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
16168923|NCT01707992|39095315|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
16168924|NCT01707992|39095316|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
16168925|NCT01707992|39095311|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
16168926|NCT01707992|39095312|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
16168927|NCT01707992|39095313|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
16168928|NCT01707992|39095314|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
16168929|NCT01707992|39095315|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
16168930|NCT01707992|39095316|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
16168931|NCT01707992|39095311|FG000|Active Treatment Phase (24 Months)|Death|0|||
16462315|NCT00275821|40172393|FG001|Overall Study|Administrative problems|4|||
16462316|NCT00275821|40172394|FG002|Overall Study|Administrative problems|4|||
16462317|NCT00275821|40172392|FG000|Overall Study|Withdrawal by Subject|0|||
16462318|NCT00275821|40172393|FG001|Overall Study|Withdrawal by Subject|2|||
16462319|NCT00275821|40172394|FG002|Overall Study|Withdrawal by Subject|1|||
16462320|NCT00275821|40172392|FG000|Overall Study|Lost to Follow-up|0|||
16462321|NCT00275821|40172393|FG001|Overall Study|Lost to Follow-up|1|||
16462322|NCT00275821|40172394|FG002|Overall Study|Lost to Follow-up|1|||
16462323|NCT00275821|40172392|FG000|Overall Study|Death|0|||
16462324|NCT00275821|40172393|FG001|Overall Study|Death|2|||
16462325|NCT00275821|40172394|FG002|Overall Study|Death|1|||
16462326|NCT00275821|40172392|FG000|Overall Study|Lack of Efficacy|2|||
16462327|NCT00275821|40172393|FG001|Overall Study|Lack of Efficacy|1|||
16462328|NCT00275821|40172394|FG002|Overall Study|Lack of Efficacy|0|||
16462329|NCT00275821|40172392|FG000|Overall Study|Protocol Violation|5|||
16462330|NCT00275821|40172393|FG001|Overall Study|Protocol Violation|1|||
16462331|NCT00275821|40172394|FG002|Overall Study|Protocol Violation|0|||
16462332|NCT01954927|40172395|FG000|Overall Study|Withdrawal by Subject|3|||
16462333|NCT01954927|40172396|FG001|Overall Study|Withdrawal by Subject|1|||
16462334|NCT00308581|40172399|FG000|Induction Phase|Adverse Event|0|||
16462335|NCT00308581|40172400|FG001|Induction Phase|Adverse Event|0|||
16462336|NCT00308581|40172401|FG002|Induction Phase|Adverse Event|37|||
16462337|NCT00308581|40172399|FG000|Induction Phase|Lack of Efficacy|0|||
16462338|NCT00308581|40172400|FG001|Induction Phase|Lack of Efficacy|0|||
16462339|NCT00308581|40172401|FG002|Induction Phase|Lack of Efficacy|121|||
16462340|NCT00308581|40172399|FG000|Induction Phase|Withdrawal by Subject|0|||
16462341|NCT00308581|40172400|FG001|Induction Phase|Withdrawal by Subject|0|||
16462342|NCT00308581|40172401|FG002|Induction Phase|Withdrawal by Subject|5|||
16462343|NCT00308581|40172399|FG000|Induction Phase|Unknown reason|0|||
16462344|NCT00308581|40172400|FG001|Induction Phase|Unknown reason|0|||
16462345|NCT00308581|40172401|FG002|Induction Phase|Unknown reason|3|||
16462346|NCT00308581|40172399|FG000|Randomized Maintenance Phase|Adverse Event|10|||
16462347|NCT00308581|40172400|FG001|Randomized Maintenance Phase|Adverse Event|17|||
16462348|NCT00308581|40172401|FG002|Randomized Maintenance Phase|Adverse Event|0|||
16462349|NCT00308581|40172399|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
16462350|NCT00308581|40172400|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
16462351|NCT00308581|40172401|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
16462352|NCT00308581|40172399|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
16462353|NCT00308581|40172400|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
16462354|NCT00308581|40172401|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
16462355|NCT00308581|40172399|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
16462356|NCT00308581|40172400|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
16462357|NCT00308581|40172401|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
16462358|NCT00308581|40172399|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
16462359|NCT00308581|40172400|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
16462360|NCT00308581|40172401|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
16462361|NCT00308581|40172399|FG000|Randomized Maintenance Phase|Unknown reason|3|||
16462362|NCT00308581|40172400|FG001|Randomized Maintenance Phase|Unknown reason|0|||
16462363|NCT00308581|40172401|FG002|Randomized Maintenance Phase|Unknown reason|0|||
16462364|NCT00833417|40172402|FG000|Overall Study|Adverse Event|5|||
16462365|NCT00833417|40172403|FG001|Overall Study|Adverse Event|16|||
16462366|NCT00833417|40172402|FG000|Overall Study|Death|1|||
16462367|NCT00833417|40172403|FG001|Overall Study|Death|3|||
16462368|NCT00833417|40172402|FG000|Overall Study|Lost to Follow-up|1|||
16462369|NCT00833417|40172403|FG001|Overall Study|Lost to Follow-up|2|||
16462370|NCT00833417|40172402|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
16462371|NCT00833417|40172403|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
16462372|NCT00833417|40172402|FG000|Overall Study|Patient Decision to Withdraw|4|||
16462373|NCT00833417|40172403|FG001|Overall Study|Patient Decision to Withdraw|23|||
16462374|NCT00833417|40172402|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
16462375|NCT00833417|40172403|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
16462376|NCT00833417|40172402|FG000|Overall Study|Disease Progression|18|||
16462377|NCT00833417|40172403|FG001|Overall Study|Disease Progression|17|||
16462378|NCT00833417|40172402|FG000|Overall Study|Reason Not Specified|0|||
16462379|NCT00833417|40172403|FG001|Overall Study|Reason Not Specified|1|||
16462380|NCT02338882|40172406|FG000|Overall Study|Death|1|||
16462381|NCT02338882|40172407|FG001|Overall Study|Death|0|||
16462382|NCT02338882|40172406|FG000|Overall Study|Lost to Follow-up|6|||
16462383|NCT02338882|40172407|FG001|Overall Study|Lost to Follow-up|3|||
16462384|NCT03232333|40172408|FG000|Overall Study|Infection or Osteomyelitis|9|||
16462385|NCT03232333|40172408|FG000|Overall Study|Lost to Follow-up|4|||
16462386|NCT03232333|40172408|FG000|Overall Study|Withdrawal by Subject|2|||
16462387|NCT03473548|40172409|FG000|Overall Study|Did not attempt HST testing|3|||
16462388|NCT03473548|40172410|FG001|Overall Study|Did not attempt HST testing|0|||
16462389|NCT02736890|40172411|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
16462390|NCT02736890|40172412|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
16462391|NCT02736890|40172411|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
16462392|NCT02736890|40172412|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
16462393|NCT01853618|40172413|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
16462394|NCT01853618|40172414|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
16462395|NCT01853618|40172415|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
16462396|NCT01853618|40172416|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
16462397|NCT01853618|40172417|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
16462398|NCT01853618|40172413|FG000|Overall Study|Progressive disease|1|||
16462399|NCT01853618|40172414|FG001|Overall Study|Progressive disease|1|||
16462400|NCT01853618|40172415|FG002|Overall Study|Progressive disease|1|||
16462401|NCT01853618|40172416|FG003|Overall Study|Progressive disease|1|||
16462402|NCT01853618|40172417|FG004|Overall Study|Progressive disease|2|||
16462403|NCT01853618|40172413|FG000|Overall Study|Physician Decision|0|||
16462404|NCT01853618|40172414|FG001|Overall Study|Physician Decision|1|||
16462405|NCT01853618|40172415|FG002|Overall Study|Physician Decision|1|||
16462406|NCT01853618|40172416|FG003|Overall Study|Physician Decision|0|||
16462407|NCT01853618|40172417|FG004|Overall Study|Physician Decision|0|||
16462408|NCT01853618|40172413|FG000|Overall Study|Refused further treatment|0|||
16462409|NCT01853618|40172414|FG001|Overall Study|Refused further treatment|0|||
16462410|NCT01853618|40172415|FG002|Overall Study|Refused further treatment|0|||
16462411|NCT01853618|40172416|FG003|Overall Study|Refused further treatment|0|||
16462412|NCT01853618|40172417|FG004|Overall Study|Refused further treatment|1|||
16462413|NCT02142387|40172418|FG000|Overall Study|<19 years old|49|||
16462414|NCT02142387|40172419|FG001|Overall Study|<19 years old|326|||
16462415|NCT02142387|40172418|FG000|Overall Study|non-cardiac etiology|504|||
16462416|NCT02142387|40172419|FG001|Overall Study|non-cardiac etiology|3431|||
16462417|NCT02142387|40172418|FG000|Overall Study|CPR not performed|74|||
16462418|NCT02142387|40172419|FG001|Overall Study|CPR not performed|473|||
16462419|NCT02142387|40172418|FG000|Overall Study|witnessed by paramedic|139|||
16462420|NCT02142387|40172419|FG001|Overall Study|witnessed by paramedic|917|||
16462421|NCT02142387|40172418|FG000|Overall Study|incomplete data|1|||
16462422|NCT02142387|40172419|FG001|Overall Study|incomplete data|9|||
16462423|NCT02142387|40172418|FG000|Overall Study|occurred not at home|298|||
16462424|NCT02142387|40172419|FG001|Overall Study|occurred not at home|2474|||
16462425|NCT00043550|40172420|FG000|Overall Study|Withdrawal by Subject|22|||
16462426|NCT00043550|40172421|FG001|Overall Study|Withdrawal by Subject|12|||
16462427|NCT00043550|40172422|FG002|Overall Study|Withdrawal by Subject|20|||
16462428|NCT00718237|40172425|FG000|Overall Study|Adverse Event|1|||
16462429|NCT00718237|40172426|FG001|Overall Study|Adverse Event|3|||
16462430|NCT00718237|40172425|FG000|Overall Study|Lost to Follow-up|2|||
16462431|NCT00718237|40172426|FG001|Overall Study|Lost to Follow-up|2|||
16462432|NCT00718237|40172425|FG000|Overall Study|Physician Decision|1|||
16462433|NCT00718237|40172426|FG001|Overall Study|Physician Decision|0|||
16462434|NCT00718237|40172425|FG000|Overall Study|Withdrawal by Subject|9|||
16462435|NCT00718237|40172426|FG001|Overall Study|Withdrawal by Subject|10|||
16462436|NCT01146860|40172429|FG000|Overall Study|Withdrawal by Subject|0|||
16462437|NCT01146860|40172430|FG001|Overall Study|Withdrawal by Subject|1|||
16462438|NCT01106092|40172439|FG000|Overall Study|Withdrawal by Subject|0|||
16462439|NCT01106092|40172440|FG001|Overall Study|Withdrawal by Subject|0|||
16462440|NCT01106092|40172441|FG002|Overall Study|Withdrawal by Subject|0|||
16462441|NCT01106092|40172442|FG003|Overall Study|Withdrawal by Subject|1|||
16462442|NCT01236547|40172443|FG000|Overall Study|Protocol Violation|0|||
16462443|NCT01236547|40172444|FG001|Overall Study|Protocol Violation|1|||
16462444|NCT01236547|40172445|FG002|Overall Study|Protocol Violation|1|||
16462445|NCT01236547|40172446|FG003|Overall Study|Protocol Violation|6|||
16462446|NCT01236547|40172447|FG004|Overall Study|Protocol Violation|12|||
16462447|NCT02810444|40172448|FG000|Overall Study|Screen Failures|14|||
16168932|NCT01707992|39095312|FG001|Active Treatment Phase (24 Months)|Death|0|||
16168933|NCT01707992|39095313|FG002|Active Treatment Phase (24 Months)|Death|0|||
16462448|NCT02810444|40172448|FG000|Overall Study|Withdrawal by Subject|4|||
16462449|NCT02810444|40172448|FG000|Overall Study|Adverse Event|3|||
16462450|NCT04658940|40172449|FG000|Overall Study|Withdrawal by Subject|1|||
16462451|NCT00392379|40172452|FG000|Overall Study|Withdrawal by Subject|17|||
16462452|NCT00392379|40172453|FG001|Overall Study|Withdrawal by Subject|28|||
16462453|NCT00392379|40172452|FG000|Overall Study|Lost to Follow-up|4|||
16462454|NCT00392379|40172453|FG001|Overall Study|Lost to Follow-up|9|||
16462455|NCT00392379|40172452|FG000|Overall Study|Adverse Event|1|||
16462456|NCT00392379|40172453|FG001|Overall Study|Adverse Event|1|||
16462457|NCT02207946|40172461|FG000|Overall Study|Lost to Follow-up|1|||
16462458|NCT02207946|40172462|FG001|Overall Study|Lost to Follow-up|0|||
16462459|NCT02207946|40172461|FG000|Overall Study|Adverse Event|0|||
16462460|NCT02207946|40172462|FG001|Overall Study|Adverse Event|1|||
16462461|NCT02656680|40172470|FG000|Overall Study|Lost to Follow-up|0|||
16462462|NCT02656680|40172471|FG001|Overall Study|Lost to Follow-up|1|||
16462463|NCT02656680|40172472|FG002|Overall Study|Lost to Follow-up|7|||
16462464|NCT00130247|40172482|FG000|Overall Study|Pregnancy|1|||
16462465|NCT00130247|40172483|FG001|Overall Study|Pregnancy|0|||
16462466|NCT00130247|40172482|FG000|Overall Study|Post-randomization exclusion|1|||
16462467|NCT00130247|40172483|FG001|Overall Study|Post-randomization exclusion|2|||
16462468|NCT00130247|40172482|FG000|Overall Study|Not compliant with DOT|0|||
16462469|NCT00130247|40172483|FG001|Overall Study|Not compliant with DOT|2|||
16462470|NCT00958438|40172484|FG000|Overall Study|Protocol Violation|3|||
16462471|NCT00958438|40172485|FG001|Overall Study|Protocol Violation|2|||
16462472|NCT00958438|40172486|FG002|Overall Study|Protocol Violation|2|||
16168934|NCT01707992|39095314|FG003|Active Treatment Phase (24 Months)|Death|2|||
16168935|NCT01707992|39095315|FG004|Active Treatment Phase (24 Months)|Death|0|||
16168936|NCT01707992|39095316|FG005|Active Treatment Phase (24 Months)|Death|0|||
16168937|NCT01707992|39095311|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
16168938|NCT01707992|39095312|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
16462473|NCT00958438|40172484|FG000|Overall Study|Withdrawal by Subject|4|||
16462474|NCT00958438|40172485|FG001|Overall Study|Withdrawal by Subject|2|||
16462475|NCT00958438|40172486|FG002|Overall Study|Withdrawal by Subject|1|||
16462476|NCT00958438|40172484|FG000|Overall Study|Adverse Event|0|||
16462477|NCT00958438|40172485|FG001|Overall Study|Adverse Event|3|||
16462478|NCT00958438|40172486|FG002|Overall Study|Adverse Event|0|||
16462479|NCT00958438|40172484|FG000|Overall Study|Physician Decision|1|||
16462480|NCT00958438|40172485|FG001|Overall Study|Physician Decision|0|||
16462481|NCT00958438|40172486|FG002|Overall Study|Physician Decision|1|||
16462482|NCT00958438|40172484|FG000|Overall Study|Other than specified above|2|||
16462483|NCT00958438|40172485|FG001|Overall Study|Other than specified above|3|||
16462484|NCT00958438|40172486|FG002|Overall Study|Other than specified above|2|||
16462485|NCT02785770|40172487|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
16462486|NCT02785770|40172488|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
16462487|NCT02785770|40172489|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
16462488|NCT02785770|40172490|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
16462489|NCT02785770|40172487|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
16462490|NCT02785770|40172488|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
16462491|NCT02785770|40172489|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
16462492|NCT02785770|40172490|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
16462493|NCT02785770|40172487|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
16462494|NCT02785770|40172488|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
16462495|NCT02785770|40172489|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
16462496|NCT02785770|40172490|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
16462497|NCT02168387|40172492|FG000|Overall Study|Planned exubation|6|||
16462498|NCT02168387|40172493|FG001|Overall Study|Planned exubation|3|||
16462499|NCT02168387|40172492|FG000|Overall Study|Death|1|||
16462500|NCT02168387|40172493|FG001|Overall Study|Death|0|||
16462501|NCT01947855|40172496|FG000|Overall Study|Withdrawal by Subject|1|||
16462502|NCT01947855|40172497|FG001|Overall Study|Withdrawal by Subject|0|||
16462503|NCT01947855|40172498|FG002|Overall Study|Withdrawal by Subject|0|||
16462504|NCT00870584|40172499|FG000|Overall Study|Adverse Event|3|||
16462505|NCT00870584|40172500|FG001|Overall Study|Adverse Event|3|||
16462506|NCT00870584|40172499|FG000|Overall Study|Withdrawal by Subject|6|||
16462507|NCT00870584|40172500|FG001|Overall Study|Withdrawal by Subject|7|||
16462508|NCT00870584|40172499|FG000|Overall Study|Lost to Follow-up|5|||
16462509|NCT00870584|40172500|FG001|Overall Study|Lost to Follow-up|1|||
16462510|NCT00870584|40172499|FG000|Overall Study|Protocol Deviation|2|||
16462511|NCT00870584|40172500|FG001|Overall Study|Protocol Deviation|2|||
16462512|NCT01589770|40172504|FG000|Overall Study|EGFR <60ml/min|6|||
16462513|NCT01589770|40172505|FG001|Overall Study|EGFR <60ml/min|4|||
16462514|NCT01589770|40172504|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
16462515|NCT01589770|40172505|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
16462516|NCT01395784|40172506|FG000|Overall Study|Lost to Follow-up|7|||
16462517|NCT01395784|40172506|FG000|Overall Study|Withdrawal by Subject|3|||
16462518|NCT01395784|40172506|FG000|Overall Study|Physician Decision|5|||
16462519|NCT02694757|40172511|FG000|Overall Study|Lack of Efficacy|3|||
16462520|NCT01402102|40172512|FG000|Overall Study|Protocol Violation|1|||
16462521|NCT01402102|40172513|FG001|Overall Study|Protocol Violation|0|||
16462522|NCT01402102|40172512|FG000|Overall Study|Insufficiency of compliance|1|||
16462523|NCT01402102|40172513|FG001|Overall Study|Insufficiency of compliance|1|||
16462524|NCT01402102|40172512|FG000|Overall Study|Withdrawal by Subject|0|||
16462525|NCT01402102|40172513|FG001|Overall Study|Withdrawal by Subject|2|||
16462526|NCT01993836|40172524|FG000|Overall Study|Surgery Cancelled|3|||
16462527|NCT01993836|40172525|FG001|Overall Study|Surgery Cancelled|0|||
16462528|NCT01993836|40172526|FG002|Overall Study|Surgery Cancelled|0|||
16462529|NCT01993836|40172524|FG000|Overall Study|Physician Decision|2|||
16462530|NCT01993836|40172525|FG001|Overall Study|Physician Decision|1|||
16462531|NCT01993836|40172526|FG002|Overall Study|Physician Decision|0|||
16462532|NCT01993836|40172524|FG000|Overall Study|Death|0|||
16462533|NCT01993836|40172525|FG001|Overall Study|Death|2|||
16462534|NCT01993836|40172526|FG002|Overall Study|Death|0|||
16462535|NCT01993836|40172524|FG000|Overall Study|Withdrawal by Subject|12|||
16462536|NCT01993836|40172525|FG001|Overall Study|Withdrawal by Subject|10|||
16462537|NCT01993836|40172526|FG002|Overall Study|Withdrawal by Subject|5|||
16462538|NCT01806662|40172527|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
16462539|NCT01806662|40172528|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
16462540|NCT01806662|40172527|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
16462541|NCT01806662|40172528|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
16462542|NCT01806662|40172527|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
16462543|NCT01806662|40172528|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
16462544|NCT01806662|40172527|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
16462545|NCT01806662|40172528|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
16462546|NCT01143389|40172529|FG000|Overall Study|Lost to Follow-up|26|||
16462547|NCT01143389|40172530|FG001|Overall Study|Lost to Follow-up|25|||
16462548|NCT02745145|40172533|FG000|Overall Study|Adverse Event|1|||
16168939|NCT01707992|39095313|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
16168940|NCT01707992|39095314|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
16462549|NCT02745145|40172534|FG001|Overall Study|Adverse Event|0|||
16462550|NCT02745145|40172535|FG002|Overall Study|Adverse Event|0|||
16462551|NCT02745145|40172533|FG000|Overall Study|Death|0|||
16462552|NCT02745145|40172534|FG001|Overall Study|Death|1|||
16462553|NCT02745145|40172535|FG002|Overall Study|Death|0|||
16462554|NCT02745145|40172533|FG000|Overall Study|Progressive disease|0|||
16462555|NCT02745145|40172534|FG001|Overall Study|Progressive disease|0|||
16462556|NCT02745145|40172535|FG002|Overall Study|Progressive disease|1|||
16462557|NCT02745145|40172533|FG000|Overall Study|Withdrew consent|1|||
16462558|NCT02745145|40172534|FG001|Overall Study|Withdrew consent|1|||
16462559|NCT02745145|40172535|FG002|Overall Study|Withdrew consent|1|||
16462560|NCT02745145|40172533|FG000|Overall Study|Study Termination|8|||
16462561|NCT02745145|40172534|FG001|Overall Study|Study Termination|3|||
16462562|NCT02745145|40172535|FG002|Overall Study|Study Termination|7|||
16462563|NCT00917644|40172537|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
16462564|NCT00917644|40172538|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
16462565|NCT00917644|40172537|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
16462566|NCT00917644|40172538|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
16462567|NCT00917644|40172537|FG000|Period 2: Second Intervention|family emergency|1|||
16462568|NCT00917644|40172538|FG001|Period 2: Second Intervention|family emergency|0|||
16462569|NCT02536404|40172541|FG000|Overall Study|Adverse Event|5|||
16462570|NCT02536404|40172542|FG001|Overall Study|Adverse Event|0|||
16462571|NCT02536404|40172541|FG000|Overall Study|Withdrawal by Subject|4|||
16462572|NCT02536404|40172542|FG001|Overall Study|Withdrawal by Subject|1|||
16462573|NCT02536404|40172541|FG000|Overall Study|Physician Decision|10|||
16462574|NCT02536404|40172542|FG001|Overall Study|Physician Decision|0|||
16462575|NCT02536404|40172541|FG000|Overall Study|Sponsor decision|1|||
16462576|NCT02536404|40172542|FG001|Overall Study|Sponsor decision|0|||
16462577|NCT01945710|40172544|FG000|Overall Study|Progressive Disease|5|||
16462578|NCT01945710|40172545|FG001|Overall Study|Progressive Disease|4|||
16462579|NCT01945710|40172546|FG002|Overall Study|Progressive Disease|3|||
16462580|NCT01945710|40172547|FG003|Overall Study|Progressive Disease|2|||
16462581|NCT01945710|40172548|FG004|Overall Study|Progressive Disease|7|||
16462582|NCT01945710|40172549|FG005|Overall Study|Progressive Disease|3|||
16462583|NCT01945710|40172550|FG006|Overall Study|Progressive Disease|19|||
16462584|NCT01945710|40172544|FG000|Overall Study|Adverse Event|0|||
16462585|NCT01945710|40172545|FG001|Overall Study|Adverse Event|1|||
16462586|NCT01945710|40172546|FG002|Overall Study|Adverse Event|0|||
16462587|NCT01945710|40172547|FG003|Overall Study|Adverse Event|0|||
16462588|NCT01945710|40172548|FG004|Overall Study|Adverse Event|0|||
16462589|NCT01945710|40172549|FG005|Overall Study|Adverse Event|0|||
16462590|NCT01945710|40172550|FG006|Overall Study|Adverse Event|0|||
16462591|NCT01945710|40172544|FG000|Overall Study|Other|2|||
16462592|NCT01945710|40172545|FG001|Overall Study|Other|0|||
16462593|NCT01945710|40172546|FG002|Overall Study|Other|3|||
16462594|NCT01945710|40172547|FG003|Overall Study|Other|1|||
16462595|NCT01945710|40172548|FG004|Overall Study|Other|1|||
16462596|NCT01945710|40172549|FG005|Overall Study|Other|0|||
16462597|NCT01945710|40172550|FG006|Overall Study|Other|4|||
16462598|NCT01945710|40172544|FG000|Overall Study|Withdrawal by Subject|0|||
16462599|NCT01945710|40172545|FG001|Overall Study|Withdrawal by Subject|1|||
16462600|NCT01945710|40172546|FG002|Overall Study|Withdrawal by Subject|1|||
16462601|NCT01945710|40172547|FG003|Overall Study|Withdrawal by Subject|0|||
16462602|NCT01945710|40172548|FG004|Overall Study|Withdrawal by Subject|1|||
16462603|NCT01945710|40172549|FG005|Overall Study|Withdrawal by Subject|0|||
16462604|NCT01945710|40172550|FG006|Overall Study|Withdrawal by Subject|0|||
16462605|NCT01909791|40172551|FG000|Overall Study|Death|9|||
16462606|NCT01909791|40172552|FG001|Overall Study|Death|8|||
16462607|NCT01909791|40172553|FG002|Overall Study|Death|4|||
16462608|NCT01909791|40172551|FG000|Overall Study|Withdrawal by Subject|5|||
16462609|NCT01909791|40172552|FG001|Overall Study|Withdrawal by Subject|9|||
16462610|NCT01909791|40172553|FG002|Overall Study|Withdrawal by Subject|13|||
16462611|NCT01909791|40172551|FG000|Overall Study|Lost to Follow-up|5|||
16462612|NCT01909791|40172552|FG001|Overall Study|Lost to Follow-up|11|||
16462613|NCT01909791|40172553|FG002|Overall Study|Lost to Follow-up|10|||
16462614|NCT01909791|40172551|FG000|Overall Study|Missed Visit|2|||
16462615|NCT01909791|40172552|FG001|Overall Study|Missed Visit|0|||
16462616|NCT01909791|40172553|FG002|Overall Study|Missed Visit|1|||
16462617|NCT02793622|40172556|FG000|Overall Study|Lost to Follow-up|31|||
16462618|NCT02793622|40172557|FG001|Overall Study|Lost to Follow-up|19|||
16462619|NCT02793622|40172556|FG000|Overall Study|Withdrawal by Subject|21|||
16462620|NCT02793622|40172557|FG001|Overall Study|Withdrawal by Subject|17|||
16462621|NCT02793622|40172556|FG000|Overall Study|Adverse Event|0|||
16462622|NCT02793622|40172557|FG001|Overall Study|Adverse Event|1|||
16462623|NCT02793622|40172556|FG000|Overall Study|Protocol Violation|1|||
16462624|NCT02793622|40172557|FG001|Overall Study|Protocol Violation|5|||
16462625|NCT01966432|40172558|FG000|Overall Study|Lost to Follow-up|3|||
16462626|NCT01966432|40172559|FG001|Overall Study|Lost to Follow-up|2|||
16462627|NCT01966432|40172560|FG002|Overall Study|Lost to Follow-up|5|||
16462628|NCT01966432|40172558|FG000|Overall Study|Withdrawal by Subject|1|||
16462629|NCT01966432|40172559|FG001|Overall Study|Withdrawal by Subject|3|||
16462630|NCT01966432|40172560|FG002|Overall Study|Withdrawal by Subject|0|||
16462631|NCT01966432|40172558|FG000|Overall Study|Subject Incarcerated|0|||
16462632|NCT01966432|40172559|FG001|Overall Study|Subject Incarcerated|0|||
16462633|NCT01966432|40172560|FG002|Overall Study|Subject Incarcerated|1|||
16462634|NCT01966432|40172558|FG000|Overall Study|SBIRT program ended|1|||
16462635|NCT01966432|40172559|FG001|Overall Study|SBIRT program ended|8|||
16462636|NCT01966432|40172560|FG002|Overall Study|SBIRT program ended|20|||
16462637|NCT03032380|40172561|FG000|Overall Study|Adverse Event|0|||
16462638|NCT03032380|40172562|FG001|Overall Study|Adverse Event|1|||
16462639|NCT03032380|40172561|FG000|Overall Study|Lack of Efficacy|1|||
16462640|NCT03032380|40172562|FG001|Overall Study|Lack of Efficacy|0|||
16462641|NCT03032380|40172561|FG000|Overall Study|Withdrawal by Subject|2|||
16462642|NCT03032380|40172562|FG001|Overall Study|Withdrawal by Subject|3|||
16462643|NCT03032380|40172561|FG000|Overall Study|Recovery|0|||
16462644|NCT03032380|40172562|FG001|Overall Study|Recovery|1|||
16462645|NCT03032380|40172561|FG000|Overall Study|Death|39|||
16462646|NCT03032380|40172562|FG001|Overall Study|Death|34|||
16462647|NCT03032380|40172561|FG000|Overall Study|Other - Miscellaneous|0|||
16462648|NCT03032380|40172562|FG001|Overall Study|Other - Miscellaneous|1|||
16462649|NCT00045942|40172563|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
16462650|NCT00045942|40172564|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
16462651|NCT00045942|40172565|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
16462652|NCT00045942|40172566|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
16462653|NCT00045942|40172567|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
16462654|NCT00045942|40172568|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
16462655|NCT00045942|40172569|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
16462656|NCT00045942|40172570|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
16462657|NCT00045942|40172571|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
16462658|NCT00045942|40172563|FG000|PKC412A2104 (Core)|Adverse Event|5|||
16462659|NCT00045942|40172564|FG001|PKC412A2104 (Core)|Adverse Event|0|||
16462660|NCT00045942|40172565|FG002|PKC412A2104 (Core)|Adverse Event|0|||
16462661|NCT00045942|40172566|FG003|PKC412A2104 (Core)|Adverse Event|0|||
16462662|NCT00045942|40172567|FG004|PKC412A2104 (Core)|Adverse Event|0|||
16462663|NCT00045942|40172568|FG005|PKC412A2104 (Core)|Adverse Event|0|||
16462664|NCT00045942|40172569|FG006|PKC412A2104 (Core)|Adverse Event|0|||
16462665|NCT00045942|40172570|FG007|PKC412A2104 (Core)|Adverse Event|0|||
16462666|NCT00045942|40172571|FG008|PKC412A2104 (Core)|Adverse Event|0|||
16462667|NCT00045942|40172563|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
16462668|NCT00045942|40172564|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
16462669|NCT00045942|40172565|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
16462670|NCT00045942|40172566|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
16462671|NCT00045942|40172567|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
16462672|NCT00045942|40172568|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
16462673|NCT00045942|40172569|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
16462674|NCT00045942|40172570|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
16462675|NCT00045942|40172571|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
16462676|NCT00045942|40172563|FG000|PKC412A2104 (Core)|Death|1|||
16462677|NCT00045942|40172564|FG001|PKC412A2104 (Core)|Death|0|||
16462678|NCT00045942|40172565|FG002|PKC412A2104 (Core)|Death|0|||
16462679|NCT00045942|40172566|FG003|PKC412A2104 (Core)|Death|0|||
16462680|NCT00045942|40172567|FG004|PKC412A2104 (Core)|Death|0|||
16462681|NCT00045942|40172568|FG005|PKC412A2104 (Core)|Death|0|||
16462682|NCT00045942|40172569|FG006|PKC412A2104 (Core)|Death|0|||
16462683|NCT00045942|40172570|FG007|PKC412A2104 (Core)|Death|0|||
16462684|NCT00045942|40172571|FG008|PKC412A2104 (Core)|Death|0|||
16462685|NCT00045942|40172563|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
16462686|NCT00045942|40172564|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
16462687|NCT00045942|40172565|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
16462688|NCT00045942|40172566|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
16462689|NCT00045942|40172567|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
16462690|NCT00045942|40172568|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
16462691|NCT00045942|40172569|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
16462692|NCT00045942|40172570|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
16462693|NCT00045942|40172571|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
16462694|NCT00045942|40172563|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
16462695|NCT00045942|40172564|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
16462696|NCT00045942|40172565|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
16462697|NCT00045942|40172566|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
16462698|NCT00045942|40172567|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
16462699|NCT00045942|40172568|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
16462700|NCT00045942|40172569|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
16462701|NCT00045942|40172570|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
16462702|NCT00045942|40172571|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
16462703|NCT00045942|40172563|FG000|PKC412A2104E1|Lack of Efficacy|0|||
16462704|NCT00045942|40172564|FG001|PKC412A2104E1|Lack of Efficacy|11|||
16462705|NCT00045942|40172565|FG002|PKC412A2104E1|Lack of Efficacy|11|||
16462706|NCT00045942|40172566|FG003|PKC412A2104E1|Lack of Efficacy|23|||
16462707|NCT00045942|40172567|FG004|PKC412A2104E1|Lack of Efficacy|17|||
16462708|NCT00045942|40172568|FG005|PKC412A2104E1|Lack of Efficacy|0|||
16462709|NCT00045942|40172569|FG006|PKC412A2104E1|Lack of Efficacy|0|||
16462710|NCT00045942|40172570|FG007|PKC412A2104E1|Lack of Efficacy|0|||
16462711|NCT00045942|40172571|FG008|PKC412A2104E1|Lack of Efficacy|0|||
16462712|NCT00045942|40172563|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
16462713|NCT00045942|40172564|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
16462714|NCT00045942|40172565|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
16462715|NCT00045942|40172566|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
16462716|NCT00045942|40172567|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
16462717|NCT00045942|40172568|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
16462718|NCT00045942|40172569|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
16462719|NCT00045942|40172570|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
16462720|NCT00045942|40172571|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
16462721|NCT00045942|40172563|FG000|PKC412A2104E1|Adverse Event|0|||
16462722|NCT00045942|40172564|FG001|PKC412A2104E1|Adverse Event|1|||
16462723|NCT00045942|40172565|FG002|PKC412A2104E1|Adverse Event|1|||
16462724|NCT00045942|40172566|FG003|PKC412A2104E1|Adverse Event|3|||
16462725|NCT00045942|40172567|FG004|PKC412A2104E1|Adverse Event|6|||
16462726|NCT00045942|40172568|FG005|PKC412A2104E1|Adverse Event|0|||
16462727|NCT00045942|40172569|FG006|PKC412A2104E1|Adverse Event|0|||
16462728|NCT00045942|40172570|FG007|PKC412A2104E1|Adverse Event|0|||
16462729|NCT00045942|40172571|FG008|PKC412A2104E1|Adverse Event|0|||
16462730|NCT00045942|40172563|FG000|PKC412A2104E1|Death|0|||
16462731|NCT00045942|40172564|FG001|PKC412A2104E1|Death|4|||
16462732|NCT00045942|40172565|FG002|PKC412A2104E1|Death|1|||
16462733|NCT00045942|40172566|FG003|PKC412A2104E1|Death|1|||
16462734|NCT00045942|40172567|FG004|PKC412A2104E1|Death|1|||
16462735|NCT00045942|40172568|FG005|PKC412A2104E1|Death|0|||
16462736|NCT00045942|40172569|FG006|PKC412A2104E1|Death|0|||
16462737|NCT00045942|40172570|FG007|PKC412A2104E1|Death|0|||
16462738|NCT00045942|40172571|FG008|PKC412A2104E1|Death|0|||
16462739|NCT00045942|40172563|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
16462740|NCT00045942|40172564|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
16462741|NCT00045942|40172565|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
16462742|NCT00045942|40172566|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
16462743|NCT00045942|40172567|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
16462744|NCT00045942|40172568|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
16462745|NCT00045942|40172569|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
16462746|NCT00045942|40172570|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
16462747|NCT00045942|40172571|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
16462748|NCT00045942|40172563|FG000|PKC412A2104E2|Lost to Follow-up|0|||
16462749|NCT00045942|40172564|FG001|PKC412A2104E2|Lost to Follow-up|0|||
16462750|NCT00045942|40172565|FG002|PKC412A2104E2|Lost to Follow-up|0|||
16462751|NCT00045942|40172566|FG003|PKC412A2104E2|Lost to Follow-up|0|||
16462752|NCT00045942|40172567|FG004|PKC412A2104E2|Lost to Follow-up|0|||
16462753|NCT00045942|40172568|FG005|PKC412A2104E2|Lost to Follow-up|0|||
16462754|NCT00045942|40172569|FG006|PKC412A2104E2|Lost to Follow-up|0|||
16462755|NCT00045942|40172570|FG007|PKC412A2104E2|Lost to Follow-up|3|||
16462756|NCT00045942|40172571|FG008|PKC412A2104E2|Lost to Follow-up|0|||
16462757|NCT00045942|40172563|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
16462758|NCT00045942|40172564|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
16462759|NCT00045942|40172565|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
16462760|NCT00045942|40172566|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
16462761|NCT00045942|40172567|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
16462762|NCT00045942|40172568|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
16462763|NCT00045942|40172569|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
16462764|NCT00045942|40172570|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
16462765|NCT00045942|40172571|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
16462766|NCT00045942|40172563|FG000|PKC412A2104E2|Lack of Efficacy|0|||
16462767|NCT00045942|40172564|FG001|PKC412A2104E2|Lack of Efficacy|0|||
16462768|NCT00045942|40172565|FG002|PKC412A2104E2|Lack of Efficacy|0|||
16462769|NCT00045942|40172566|FG003|PKC412A2104E2|Lack of Efficacy|0|||
16462770|NCT00045942|40172567|FG004|PKC412A2104E2|Lack of Efficacy|0|||
16462771|NCT00045942|40172568|FG005|PKC412A2104E2|Lack of Efficacy|3|||
16462772|NCT00045942|40172569|FG006|PKC412A2104E2|Lack of Efficacy|2|||
16462773|NCT00045942|40172570|FG007|PKC412A2104E2|Lack of Efficacy|2|||
16462774|NCT00045942|40172571|FG008|PKC412A2104E2|Lack of Efficacy|6|||
16462775|NCT00045942|40172563|FG000|PKC412A2104E2|Adverse Event|0|||
16462776|NCT00045942|40172564|FG001|PKC412A2104E2|Adverse Event|0|||
16462777|NCT00045942|40172565|FG002|PKC412A2104E2|Adverse Event|0|||
16462778|NCT00045942|40172566|FG003|PKC412A2104E2|Adverse Event|0|||
16462779|NCT00045942|40172567|FG004|PKC412A2104E2|Adverse Event|0|||
16462780|NCT00045942|40172568|FG005|PKC412A2104E2|Adverse Event|4|||
16462781|NCT00045942|40172569|FG006|PKC412A2104E2|Adverse Event|3|||
16462782|NCT00045942|40172570|FG007|PKC412A2104E2|Adverse Event|1|||
16462783|NCT00045942|40172571|FG008|PKC412A2104E2|Adverse Event|0|||
16462784|NCT00045942|40172563|FG000|PKC412A2104E2|Death|0|||
16462785|NCT00045942|40172564|FG001|PKC412A2104E2|Death|0|||
16462786|NCT00045942|40172565|FG002|PKC412A2104E2|Death|0|||
16462787|NCT00045942|40172566|FG003|PKC412A2104E2|Death|0|||
16462788|NCT00045942|40172567|FG004|PKC412A2104E2|Death|0|||
16462789|NCT00045942|40172568|FG005|PKC412A2104E2|Death|1|||
16462790|NCT00045942|40172569|FG006|PKC412A2104E2|Death|2|||
16462791|NCT00045942|40172570|FG007|PKC412A2104E2|Death|0|||
16462792|NCT00045942|40172571|FG008|PKC412A2104E2|Death|0|||
16462793|NCT04740905|40172572|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
16462794|NCT04740905|40172573|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
16462795|NCT04740905|40172572|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
16462796|NCT04740905|40172573|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
16462797|NCT04740905|40172572|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
16462798|NCT04740905|40172573|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
16462799|NCT04740905|40172572|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
16462800|NCT04740905|40172573|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
16462801|NCT04740905|40172572|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
16462802|NCT04740905|40172573|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
16462803|NCT04740905|40172572|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
16462804|NCT04740905|40172573|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
16462805|NCT04740905|40172572|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
16462806|NCT04740905|40172573|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
16462807|NCT04740905|40172572|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
16462808|NCT04740905|40172573|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
16462809|NCT04740905|40172572|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
16462810|NCT04740905|40172573|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
16462811|NCT04740905|40172572|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
16462812|NCT04740905|40172573|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
16462813|NCT04740905|40172572|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
16462814|NCT04740905|40172573|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
16462815|NCT04740905|40172572|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
16462816|NCT04740905|40172573|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
16462817|NCT04740905|40172572|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
16462818|NCT04740905|40172573|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
16462819|NCT04740905|40172572|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
16462820|NCT04740905|40172573|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
16462821|NCT03126344|40172574|FG000|Overall Study|Lost to Follow-up|0|||
16462822|NCT03126344|40172575|FG001|Overall Study|Lost to Follow-up|0|||
16462823|NCT03126344|40172576|FG002|Overall Study|Lost to Follow-up|5|||
16462824|NCT01256190|40172583|FG000|Overall Study|Lost to Follow-up|2|||
16462825|NCT01256190|40172584|FG001|Overall Study|Lost to Follow-up|0|||
16462826|NCT03565367|40172585|FG000|Overall Study|No scan due to technical issues|4|||
16462827|NCT03565367|40172586|FG001|Overall Study|No scan due to technical issues|0|||
16462828|NCT00362180|40172592|FG000|Treated Period|Withdrawal by Subject|1|||
16462829|NCT00362180|40172593|FG001|Treated Period|Withdrawal by Subject|0|||
16462830|NCT00362180|40172594|FG002|Treated Period|Withdrawal by Subject|0|||
16462831|NCT00362180|40172595|FG003|Treated Period|Withdrawal by Subject|0|||
16462832|NCT00362180|40172596|FG004|Treated Period|Withdrawal by Subject|0|||
16462833|NCT00362180|40172597|FG005|Treated Period|Withdrawal by Subject|0|||
16462834|NCT00362180|40172598|FG006|Treated Period|Withdrawal by Subject|0|||
16462835|NCT00362180|40172599|FG007|Treated Period|Withdrawal by Subject|0|||
16462836|NCT00362180|40172600|FG008|Treated Period|Withdrawal by Subject|0|||
16462837|NCT00362180|40172592|FG000|Treated Period|Adverse Event|0|||
16462838|NCT00362180|40172593|FG001|Treated Period|Adverse Event|0|||
16462839|NCT00362180|40172594|FG002|Treated Period|Adverse Event|0|||
16462840|NCT00362180|40172595|FG003|Treated Period|Adverse Event|0|||
16462841|NCT00362180|40172596|FG004|Treated Period|Adverse Event|0|||
16462842|NCT00362180|40172597|FG005|Treated Period|Adverse Event|1|||
16462843|NCT00362180|40172598|FG006|Treated Period|Adverse Event|0|||
16462844|NCT00362180|40172599|FG007|Treated Period|Adverse Event|1|||
16462845|NCT00362180|40172600|FG008|Treated Period|Adverse Event|0|||
16462846|NCT00870103|40172601|FG000|Overall Study|Physician Decision|2|||
16462847|NCT00870103|40172601|FG000|Overall Study|Lost to Follow-up|2|||
16462848|NCT01037088|40172602|FG000|Overall Study|Withdrawal by Subject|3|||
16462849|NCT01227824|40172603|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
16462850|NCT01227824|40172604|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
16462851|NCT01227824|40172605|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
16462852|NCT01227824|40172603|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
16462853|NCT01227824|40172604|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
16462854|NCT01227824|40172605|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
16462855|NCT01227824|40172603|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
16462856|NCT01227824|40172604|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
16462857|NCT01227824|40172605|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
16462858|NCT01227824|40172603|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
16462859|NCT01227824|40172604|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
16462860|NCT01227824|40172605|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
16462861|NCT01227824|40172603|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
16462862|NCT01227824|40172604|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
16462863|NCT01227824|40172605|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
16462864|NCT01227824|40172603|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
16462865|NCT01227824|40172604|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
16462866|NCT01227824|40172605|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
16462867|NCT01227824|40172603|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
16462868|NCT01227824|40172604|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
16462869|NCT01227824|40172605|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
16462870|NCT01227824|40172603|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
16462871|NCT01227824|40172604|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
16462872|NCT01227824|40172605|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
16462873|NCT01227824|40172603|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
16462874|NCT01227824|40172604|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
16462875|NCT01227824|40172605|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
16462876|NCT01227824|40172603|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
16462877|NCT01227824|40172604|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
16462878|NCT01227824|40172605|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
16462879|NCT01227824|40172603|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
16462880|NCT01227824|40172604|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
16462881|NCT01227824|40172605|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
16462882|NCT01227824|40172603|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
16462883|NCT01227824|40172604|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
16462884|NCT01227824|40172605|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
16462885|NCT01227824|40172603|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
16462886|NCT01227824|40172604|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
16462887|NCT01227824|40172605|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
16462888|NCT01227824|40172603|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
16462889|NCT01227824|40172604|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
16462890|NCT01227824|40172605|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
16462891|NCT01227824|40172603|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
16462892|NCT01227824|40172604|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
16462893|NCT01227824|40172605|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
16462894|NCT00745849|40175373|FG000|First Intervention|Withdrawal by Subject|0|||
16168941|NCT01707992|39095315|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
16168942|NCT01707992|39095316|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
16462895|NCT00745849|40175374|FG001|First Intervention|Withdrawal by Subject|1|||
16462896|NCT00745849|40175373|FG000|First Intervention|Lost to Follow-up|1|||
16462897|NCT00745849|40175374|FG001|First Intervention|Lost to Follow-up|1|||
16462898|NCT00745849|40175373|FG000|Second Intervention|Lost to Follow-up|2|||
16462899|NCT00745849|40175374|FG001|Second Intervention|Lost to Follow-up|1|||
16462900|NCT01457352|40175380|FG000|Period 1|Adverse Event|2|||
16462901|NCT01457352|40175381|FG001|Period 1|Adverse Event|0|||
16462902|NCT01457352|40175380|FG000|Period 1|Withdrawal by Subject|2|||
16462903|NCT01457352|40175381|FG001|Period 1|Withdrawal by Subject|0|||
16462904|NCT01457352|40175380|FG000|Period 1|Physician Decision|2|||
16462905|NCT01457352|40175381|FG001|Period 1|Physician Decision|0|||
16462906|NCT01457352|40175380|FG000|Period 1|MS related disease progression|1|||
16462907|NCT01457352|40175381|FG001|Period 1|MS related disease progression|0|||
16462908|NCT01457352|40175380|FG000|Period 1|Withdrawn|1|||
16462909|NCT01457352|40175381|FG001|Period 1|Withdrawn|0|||
16168943|NCT01707992|39095311|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
16168944|NCT01707992|39095312|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
16168945|NCT01707992|39095313|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
16168946|NCT01707992|39095314|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
16168947|NCT01707992|39095315|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
16168948|NCT01707992|39095316|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
16168949|NCT01707992|39095311|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
16168950|NCT01707992|39095312|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
16168951|NCT01707992|39095313|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
16168952|NCT01707992|39095314|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
16168953|NCT01707992|39095315|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
16269268|NCT04089553|39471048|FG000|Overall Study|Death|1|||
16269269|NCT04089553|39471049|FG001|Overall Study|Death|1|||
16462910|NCT01457352|40175380|FG000|Period 1|withdrew per sponsor|1|||
16462911|NCT01457352|40175381|FG001|Period 1|withdrew per sponsor|0|||
16462912|NCT01457352|40175380|FG000|Period 1|Protocol Violation|4|||
16462913|NCT01457352|40175381|FG001|Period 1|Protocol Violation|0|||
16168954|NCT01707992|39095316|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
16168955|NCT01707992|39095311|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
16168956|NCT01707992|39095312|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
16168957|NCT01707992|39095313|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
16168958|NCT01707992|39095314|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
16168959|NCT01707992|39095315|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
16168960|NCT01707992|39095316|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
16168961|NCT01790048|39095318|FG000|Overall Study|Incorrect Age|9|||
16168962|NCT01790048|39095319|FG001|Overall Study|Incorrect Age|14|||
16168963|NCT01790048|39095318|FG000|Overall Study|data entry error|0|||
16168964|NCT01790048|39095319|FG001|Overall Study|data entry error|1|||
16168965|NCT01790048|39095318|FG000|Overall Study|Other|0|||
16168966|NCT01790048|39095319|FG001|Overall Study|Other|2|||
16462914|NCT01457352|40175380|FG000|Period 1|Did not meet eligibility criteria|3|||
16462915|NCT01457352|40175381|FG001|Period 1|Did not meet eligibility criteria|0|||
16462916|NCT01457352|40175380|FG000|Period 2|Withdrawal by Subject|23|||
16462917|NCT01457352|40175381|FG001|Period 2|Withdrawal by Subject|0|||
16462918|NCT01457352|40175380|FG000|Period 2|Adverse Event|22|||
16462919|NCT01457352|40175381|FG001|Period 2|Adverse Event|0|||
16462920|NCT01457352|40175380|FG000|Period 2|no analysis|10|||
16462921|NCT01457352|40175381|FG001|Period 2|no analysis|0|||
16462922|NCT01457352|40175380|FG000|Period 2|Lack of Efficacy|8|||
16462923|NCT01457352|40175381|FG001|Period 2|Lack of Efficacy|0|||
16462924|NCT01457352|40175380|FG000|Period 2|Protocol Violation|4|||
16462925|NCT01457352|40175381|FG001|Period 2|Protocol Violation|0|||
16462926|NCT01457352|40175380|FG000|Period 2|Sponsor's withdrawal|7|||
16462927|NCT01457352|40175381|FG001|Period 2|Sponsor's withdrawal|0|||
16462928|NCT01457352|40175380|FG000|Period 2|Lost to Follow-up|1|||
16462929|NCT01457352|40175381|FG001|Period 2|Lost to Follow-up|0|||
16462930|NCT01457352|40175380|FG000|Period 2|dose change|1|||
16462931|NCT01457352|40175381|FG001|Period 2|dose change|0|||
16462932|NCT01457352|40175380|FG000|Period 2|Physician Decision|1|||
16168967|NCT01790048|39095318|FG000|Overall Study|SAM at Enrollment|2|||
16168968|NCT01790048|39095319|FG001|Overall Study|SAM at Enrollment|0|||
16168969|NCT01790048|39095318|FG000|Overall Study|Measurement error|1|||
16168970|NCT01790048|39095319|FG001|Overall Study|Measurement error|0|||
16168971|NCT02159807|39095320|FG000|Overall Study|Adverse Event|0|||
16168972|NCT02159807|39095321|FG001|Overall Study|Adverse Event|0|||
16168973|NCT02159807|39095322|FG002|Overall Study|Adverse Event|1|||
16168974|NCT02159807|39095320|FG000|Overall Study|No CSF|1|||
16168975|NCT02159807|39095321|FG001|Overall Study|No CSF|1|||
16168976|NCT02159807|39095322|FG002|Overall Study|No CSF|1|||
16168977|NCT02159807|39095320|FG000|Overall Study|elevated blood pressure|0|||
16168978|NCT02159807|39095321|FG001|Overall Study|elevated blood pressure|0|||
16168979|NCT02159807|39095322|FG002|Overall Study|elevated blood pressure|1|||
16168980|NCT02661594|39095328|FG000|Overall Study|Protocol Violation|1|||
16168981|NCT02661594|39095329|FG001|Overall Study|Protocol Violation|0|||
16168982|NCT02661594|39095330|FG002|Overall Study|Protocol Violation|1|||
16168983|NCT02661594|39095331|FG003|Overall Study|Protocol Violation|0|||
16168984|NCT01164722|39095332|FG000|Overall Study|Adverse Event|0|||
16168985|NCT01164722|39095333|FG001|Overall Study|Adverse Event|1|||
16168986|NCT01164722|39095332|FG000|Overall Study|Withdrawal by Subject|3|||
16168987|NCT01164722|39095333|FG001|Overall Study|Withdrawal by Subject|4|||
16168988|NCT01164722|39095332|FG000|Overall Study|Lost to Follow-up|3|||
16168989|NCT01164722|39095333|FG001|Overall Study|Lost to Follow-up|6|||
16168990|NCT01164722|39095332|FG000|Overall Study|met protocol criteria for non-treatment|11|||
16168991|NCT01164722|39095333|FG001|Overall Study|met protocol criteria for non-treatment|1|||
16168992|NCT01164722|39095332|FG000|Overall Study|enrolled on other study, concomitant med|1|||
16168993|NCT01164722|39095333|FG001|Overall Study|enrolled on other study, concomitant med|3|||
16168994|NCT00556426|39095338|FG000|Overall Study|Withdrawal by Subject|3|||
16168995|NCT00556426|39095338|FG000|Overall Study|Death|6|||
16168996|NCT00544869|39095339|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
16168997|NCT00544869|39095340|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
16168998|NCT00544869|39095341|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
16168999|NCT00544869|39095339|FG000|Overall Study|Adverse Event|6|||
16169000|NCT00544869|39095340|FG001|Overall Study|Adverse Event|1|||
16169001|NCT00544869|39095341|FG002|Overall Study|Adverse Event|0|||
16169002|NCT00544869|39095339|FG000|Overall Study|Lack of Efficacy|1|||
16169003|NCT00544869|39095340|FG001|Overall Study|Lack of Efficacy|1|||
16169004|NCT00544869|39095341|FG002|Overall Study|Lack of Efficacy|0|||
16169005|NCT00544869|39095339|FG000|Overall Study|Physician Decision|2|||
16269270|NCT04089553|39471048|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
16462933|NCT01457352|40175381|FG001|Period 2|Physician Decision|0|||
16462934|NCT01457352|40175380|FG000|Period 2|Did not meet eligibility criteria|3|||
16462935|NCT01457352|40175381|FG001|Period 2|Did not meet eligibility criteria|0|||
16462936|NCT01457352|40175380|FG000|Period 3|Adverse Event|1|||
16462937|NCT01457352|40175381|FG001|Period 3|Adverse Event|1|||
16462938|NCT01457352|40175380|FG000|Period 3|Withdrawal by Subject|0|||
16462939|NCT01457352|40175381|FG001|Period 3|Withdrawal by Subject|2|||
16462940|NCT01457352|40175380|FG000|Period 3|incorrect treatment|0|||
16462941|NCT01457352|40175381|FG001|Period 3|incorrect treatment|1|||
16462942|NCT01457352|40175380|FG000|Period 3|Sponsor's withdrawal|0|||
16462943|NCT01457352|40175381|FG001|Period 3|Sponsor's withdrawal|1|||
16462944|NCT00606905|40175383|FG000|Overall Study|No Pregnancy|9|||
16462945|NCT00606905|40175384|FG001|Overall Study|No Pregnancy|6|||
16462946|NCT00606905|40175383|FG000|Overall Study|Non-Index Pregnancy|1|||
16462947|NCT00606905|40175384|FG001|Overall Study|Non-Index Pregnancy|4|||
16462948|NCT00606905|40175383|FG000|Overall Study|Withdrew|5|||
16462949|NCT00606905|40175384|FG001|Overall Study|Withdrew|5|||
16462950|NCT01579812|40175385|FG000|Overall Study|Ineligible after treatment start|40|||
16462951|NCT01579812|40175385|FG000|Overall Study|Patient choice|3|||
16462952|NCT01579812|40175385|FG000|Overall Study|Noncompliance|3|||
16462953|NCT01579812|40175385|FG000|Overall Study|Withdrawal by Subject|6|||
16462954|NCT02093351|40175389|FG000|Part A|Adverse Event|0|||
16462955|NCT02093351|40175390|FG001|Part A|Adverse Event|1|||
16462956|NCT02093351|40175391|FG002|Part A|Adverse Event|1|||
16462957|NCT02093351|40175392|FG003|Part A|Adverse Event|0|||
16462958|NCT02093351|40175389|FG000|Part A|Condition under investigation worsened|2|||
16462959|NCT02093351|40175390|FG001|Part A|Condition under investigation worsened|0|||
16462960|NCT02093351|40175391|FG002|Part A|Condition under investigation worsened|2|||
16462961|NCT02093351|40175392|FG003|Part A|Condition under investigation worsened|0|||
16462962|NCT02093351|40175389|FG000|Part A|Death|0|||
16462963|NCT02093351|40175390|FG001|Part A|Death|1|||
16462964|NCT02093351|40175391|FG002|Part A|Death|0|||
16462965|NCT02093351|40175392|FG003|Part A|Death|0|||
16462966|NCT02093351|40175389|FG000|Part B|Patient decision|0|||
16462967|NCT02093351|40175390|FG001|Part B|Patient decision|0|||
16462968|NCT02093351|40175391|FG002|Part B|Patient decision|0|||
16462969|NCT02093351|40175392|FG003|Part B|Patient decision|3|||
16462970|NCT02093351|40175389|FG000|Part B|Disease progression|0|||
16462971|NCT02093351|40175390|FG001|Part B|Disease progression|0|||
16462972|NCT02093351|40175391|FG002|Part B|Disease progression|0|||
16462973|NCT02093351|40175392|FG003|Part B|Disease progression|4|||
16462974|NCT02093351|40175389|FG000|Part B|Complete response|0|||
16462975|NCT02093351|40175390|FG001|Part B|Complete response|0|||
16462976|NCT02093351|40175391|FG002|Part B|Complete response|0|||
16462977|NCT02093351|40175392|FG003|Part B|Complete response|1|||
16462978|NCT02093351|40175389|FG000|Part B|Adverse event + disease progression|0|||
16462979|NCT02093351|40175390|FG001|Part B|Adverse event + disease progression|0|||
16462980|NCT02093351|40175391|FG002|Part B|Adverse event + disease progression|0|||
16462981|NCT02093351|40175392|FG003|Part B|Adverse event + disease progression|1|||
16462982|NCT02093351|40175389|FG000|Part B|Lack of therapeutic response|0|||
16462983|NCT02093351|40175390|FG001|Part B|Lack of therapeutic response|0|||
16462984|NCT02093351|40175391|FG002|Part B|Lack of therapeutic response|0|||
16462985|NCT02093351|40175392|FG003|Part B|Lack of therapeutic response|12|||
16462986|NCT02093351|40175389|FG000|Part B|Condition under investigation worsened|0|||
16462987|NCT02093351|40175390|FG001|Part B|Condition under investigation worsened|0|||
16462988|NCT02093351|40175391|FG002|Part B|Condition under investigation worsened|0|||
16462989|NCT02093351|40175392|FG003|Part B|Condition under investigation worsened|39|||
16462990|NCT02093351|40175389|FG000|Part B|Adverse Event|0|||
16462991|NCT02093351|40175390|FG001|Part B|Adverse Event|0|||
16462992|NCT02093351|40175391|FG002|Part B|Adverse Event|0|||
16169006|NCT00544869|39095340|FG001|Overall Study|Physician Decision|0|||
16169007|NCT00544869|39095341|FG002|Overall Study|Physician Decision|0|||
16169008|NCT00880750|39095342|FG000|First Intervention|Adverse Event|1|||
16169009|NCT00880750|39095343|FG001|First Intervention|Adverse Event|0|||
16462993|NCT02093351|40175392|FG003|Part B|Adverse Event|2|||
16462994|NCT02093351|40175389|FG000|Part B|Death|0|||
16462995|NCT02093351|40175390|FG001|Part B|Death|0|||
16462996|NCT02093351|40175391|FG002|Part B|Death|0|||
16462997|NCT02093351|40175392|FG003|Part B|Death|1|||
16462998|NCT01386970|40175393|FG000|Overall Study|Withdrawal by Subject|0|||
16462999|NCT01386970|40175394|FG001|Overall Study|Withdrawal by Subject|1|||
16463000|NCT01386970|40175393|FG000|Overall Study|Adverse Event|4|||
16463001|NCT01386970|40175394|FG001|Overall Study|Adverse Event|1|||
16463002|NCT02279407|40175395|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
16463003|NCT02279407|40175396|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
16169010|NCT00880750|39095342|FG000|First Intervention|Unable to collect urine|4|||
16463004|NCT02279407|40175397|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
16463005|NCT02279407|40175398|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
16463006|NCT02279407|40175395|FG000|Overall Study|Withdrawal by Subject|1|||
16463007|NCT02279407|40175396|FG001|Overall Study|Withdrawal by Subject|0|||
16463008|NCT02279407|40175397|FG002|Overall Study|Withdrawal by Subject|1|||
16463009|NCT02279407|40175398|FG003|Overall Study|Withdrawal by Subject|1|||
16463010|NCT02279407|40175395|FG000|Overall Study|Adverse Event|1|||
16463011|NCT02279407|40175396|FG001|Overall Study|Adverse Event|1|||
16463012|NCT02279407|40175397|FG002|Overall Study|Adverse Event|2|||
16463013|NCT02279407|40175398|FG003|Overall Study|Adverse Event|0|||
16463014|NCT01870076|40175402|FG000|Overall Study|Withdrawal by Subject|1|||
16463015|NCT01870076|40175403|FG001|Overall Study|Withdrawal by Subject|0|||
16463016|NCT01870076|40175404|FG002|Overall Study|Withdrawal by Subject|1|||
16463017|NCT01870076|40175405|FG003|Overall Study|Withdrawal by Subject|0|||
16463018|NCT03459690|40175406|FG000|Overall Study|Lost to Follow-up|0|||
16463019|NCT03459690|40175407|FG001|Overall Study|Lost to Follow-up|1|||
16463020|NCT03459690|40175406|FG000|Overall Study|Withdrawal by Subject|1|||
16463021|NCT03459690|40175407|FG001|Overall Study|Withdrawal by Subject|1|||
16463022|NCT00420641|40175408|FG000|Overall Study|Adverse Event|3|||
16463023|NCT00420641|40175409|FG001|Overall Study|Adverse Event|25|||
16463024|NCT00420641|40175410|FG002|Overall Study|Adverse Event|10|||
16463025|NCT00420641|40175408|FG000|Overall Study|Lost to Follow-up|2|||
16463026|NCT00420641|40175409|FG001|Overall Study|Lost to Follow-up|4|||
16463027|NCT00420641|40175410|FG002|Overall Study|Lost to Follow-up|2|||
16463028|NCT00420641|40175408|FG000|Overall Study|Protocol Violation|8|||
16463029|NCT00420641|40175409|FG001|Overall Study|Protocol Violation|8|||
16463030|NCT00420641|40175410|FG002|Overall Study|Protocol Violation|7|||
16463031|NCT00420641|40175408|FG000|Overall Study|Withdrawal by Subject|15|||
16463032|NCT00420641|40175409|FG001|Overall Study|Withdrawal by Subject|21|||
16463033|NCT00420641|40175410|FG002|Overall Study|Withdrawal by Subject|14|||
16463034|NCT00420641|40175408|FG000|Overall Study|Lack of Efficacy|6|||
16463035|NCT00420641|40175409|FG001|Overall Study|Lack of Efficacy|5|||
16463036|NCT00420641|40175410|FG002|Overall Study|Lack of Efficacy|4|||
16463037|NCT00420641|40175408|FG000|Overall Study|Non-compliance|7|||
16463038|NCT00420641|40175409|FG001|Overall Study|Non-compliance|5|||
16463039|NCT00420641|40175410|FG002|Overall Study|Non-compliance|4|||
16463040|NCT00420641|40175408|FG000|Overall Study|Other|4|||
16463041|NCT00420641|40175409|FG001|Overall Study|Other|4|||
16463042|NCT00420641|40175410|FG002|Overall Study|Other|3|||
16463043|NCT01330017|40175411|FG000|Overall Study|Adverse Event|0|||
16169011|NCT00880750|39095343|FG001|First Intervention|Unable to collect urine|0|||
16169012|NCT00880750|39095342|FG000|First Intervention|Non-compliance with meals|0|||
16169013|NCT00880750|39095343|FG001|First Intervention|Non-compliance with meals|1|||
16169014|NCT00880750|39095342|FG000|First Intervention|Withdrawal by Subject|2|||
16169015|NCT00880750|39095343|FG001|First Intervention|Withdrawal by Subject|0|||
16169016|NCT00880750|39095342|FG000|First Intervention|Lost to Follow-up|2|||
16169017|NCT00880750|39095343|FG001|First Intervention|Lost to Follow-up|0|||
16169018|NCT00880750|39095342|FG000|Second Intervention|Withdrawal by Subject|2|||
16169019|NCT00880750|39095343|FG001|Second Intervention|Withdrawal by Subject|2|||
16169020|NCT00880750|39095342|FG000|Second Intervention|Protocol Violation|1|||
16169021|NCT00880750|39095343|FG001|Second Intervention|Protocol Violation|0|||
16169022|NCT00880750|39095342|FG000|Second Intervention|Unable to collect urine|1|||
16169023|NCT00880750|39095343|FG001|Second Intervention|Unable to collect urine|0|||
16169024|NCT04270760|39095355|FG000|Overall Study|Withdrawal by Subject|0|||
16169025|NCT04270760|39095356|FG001|Overall Study|Withdrawal by Subject|1|||
16169026|NCT04270760|39095357|FG002|Overall Study|Withdrawal by Subject|3|||
16169027|NCT04270760|39095358|FG003|Overall Study|Withdrawal by Subject|0|||
16169028|NCT04270760|39095359|FG004|Overall Study|Withdrawal by Subject|0|||
16169029|NCT04270760|39095355|FG000|Overall Study|Lost to Follow-up|1|||
16169030|NCT04270760|39095356|FG001|Overall Study|Lost to Follow-up|2|||
16169031|NCT04270760|39095357|FG002|Overall Study|Lost to Follow-up|1|||
16169032|NCT04270760|39095358|FG003|Overall Study|Lost to Follow-up|0|||
16169033|NCT04270760|39095359|FG004|Overall Study|Lost to Follow-up|0|||
16169034|NCT04270760|39095355|FG000|Overall Study|Death|0|||
16169035|NCT04270760|39095356|FG001|Overall Study|Death|0|||
16169036|NCT04270760|39095357|FG002|Overall Study|Death|0|||
16169037|NCT04270760|39095358|FG003|Overall Study|Death|0|||
16463044|NCT01330017|40175412|FG001|Overall Study|Adverse Event|1|||
16463045|NCT01330017|40175413|FG002|Overall Study|Adverse Event|1|||
16463046|NCT01330017|40175414|FG003|Overall Study|Adverse Event|4|||
16463047|NCT01330017|40175415|FG004|Overall Study|Adverse Event|0|||
16463048|NCT01330017|40175411|FG000|Overall Study|Withdrawal by Subject|0|||
16463049|NCT01330017|40175412|FG001|Overall Study|Withdrawal by Subject|0|||
16463050|NCT01330017|40175413|FG002|Overall Study|Withdrawal by Subject|1|||
16463051|NCT01330017|40175414|FG003|Overall Study|Withdrawal by Subject|0|||
16463052|NCT01330017|40175415|FG004|Overall Study|Withdrawal by Subject|1|||
16463053|NCT01330017|40175411|FG000|Overall Study|Lost to Follow-up|0|||
16463054|NCT01330017|40175412|FG001|Overall Study|Lost to Follow-up|0|||
16463055|NCT01330017|40175413|FG002|Overall Study|Lost to Follow-up|1|||
16463056|NCT01330017|40175414|FG003|Overall Study|Lost to Follow-up|0|||
16169038|NCT04270760|39095359|FG004|Overall Study|Death|1|||
16169039|NCT00059202|39095361|FG000|Overall Study|Withdrawal by Subject|5|||
16169040|NCT00059202|39095362|FG001|Overall Study|Withdrawal by Subject|9|||
16169041|NCT00059202|39095361|FG000|Overall Study|Protocol Violation|1|||
16169042|NCT00059202|39095362|FG001|Overall Study|Protocol Violation|3|||
16463057|NCT01330017|40175415|FG004|Overall Study|Lost to Follow-up|0|||
16463058|NCT01330017|40175411|FG000|Overall Study|Protocol Violation|0|||
16169043|NCT00059202|39095361|FG000|Overall Study|drug toxicity|0|||
16169044|NCT00059202|39095362|FG001|Overall Study|drug toxicity|3|||
16169045|NCT01524991|39095364|FG000|Overall Study|Adverse Event|12|||
16169046|NCT01524991|39095364|FG000|Overall Study|Death|1|||
16169047|NCT01524991|39095364|FG000|Overall Study|Disease ProgressionDu|17|||
16169048|NCT01524991|39095364|FG000|Overall Study|Other complicating disease|1|||
16169049|NCT01524991|39095364|FG000|Overall Study|Withdrawal by Subject|2|||
16169050|NCT01524991|39095364|FG000|Overall Study|Symptomatic Deterioration|1|||
16169051|NCT00045032|39095365|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
16169052|NCT00045032|39095366|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
16169053|NCT00045032|39095367|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
16169054|NCT00045032|39095365|FG000|Overall Study|Death|22|||
16169055|NCT00045032|39095366|FG001|Overall Study|Death|24|||
16463059|NCT01330017|40175412|FG001|Overall Study|Protocol Violation|0|||
16463060|NCT01330017|40175413|FG002|Overall Study|Protocol Violation|0|||
16463061|NCT01330017|40175414|FG003|Overall Study|Protocol Violation|1|||
16463062|NCT01330017|40175415|FG004|Overall Study|Protocol Violation|0|||
16463063|NCT01330017|40175411|FG000|Overall Study|Unknown Reason|5|||
16463064|NCT01330017|40175412|FG001|Overall Study|Unknown Reason|3|||
16463065|NCT01330017|40175413|FG002|Overall Study|Unknown Reason|5|||
16463066|NCT01330017|40175414|FG003|Overall Study|Unknown Reason|7|||
16463067|NCT01330017|40175415|FG004|Overall Study|Unknown Reason|2|||
16463068|NCT01253811|40175416|FG000|Overall Study|Withdrawal criteria|1|||
16463069|NCT02325791|40175420|FG000|Overall Study|Adverse Event|0|||
16463070|NCT02325791|40175421|FG001|Overall Study|Adverse Event|1|||
16463071|NCT02325791|40175422|FG002|Overall Study|Adverse Event|1|||
16463072|NCT02325791|40175423|FG003|Overall Study|Adverse Event|0|||
16463073|NCT02325791|40175420|FG000|Overall Study|Death|0|||
16463074|NCT02325791|40175421|FG001|Overall Study|Death|3|||
16463075|NCT02325791|40175422|FG002|Overall Study|Death|0|||
16463076|NCT02325791|40175423|FG003|Overall Study|Death|1|||
16463077|NCT02325791|40175420|FG000|Overall Study|Lost to Follow-up|0|||
16463078|NCT02325791|40175421|FG001|Overall Study|Lost to Follow-up|15|||
16463079|NCT02325791|40175422|FG002|Overall Study|Lost to Follow-up|14|||
16463080|NCT02325791|40175423|FG003|Overall Study|Lost to Follow-up|9|||
16463081|NCT02325791|40175420|FG000|Overall Study|Physician Decision|0|||
16463082|NCT02325791|40175421|FG001|Overall Study|Physician Decision|1|||
16463083|NCT02325791|40175422|FG002|Overall Study|Physician Decision|1|||
16463084|NCT02325791|40175423|FG003|Overall Study|Physician Decision|0|||
16463085|NCT02325791|40175420|FG000|Overall Study|Protocol Violation|0|||
16463086|NCT02325791|40175421|FG001|Overall Study|Protocol Violation|0|||
16463087|NCT02325791|40175422|FG002|Overall Study|Protocol Violation|1|||
16463088|NCT02325791|40175423|FG003|Overall Study|Protocol Violation|0|||
16463089|NCT02325791|40175420|FG000|Overall Study|Withdrawal by Subject|0|||
16463090|NCT02325791|40175421|FG001|Overall Study|Withdrawal by Subject|5|||
16463091|NCT02325791|40175422|FG002|Overall Study|Withdrawal by Subject|8|||
16463092|NCT02325791|40175423|FG003|Overall Study|Withdrawal by Subject|16|||
16463093|NCT02122783|40175424|FG000|Overall Study|Adverse Event|0|||
16463094|NCT02122783|40175425|FG001|Overall Study|Adverse Event|1|||
16463095|NCT00561977|40175426|FG000|Overall Study|Withdrawal by Subject|0|||
16463096|NCT00561977|40175427|FG001|Overall Study|Withdrawal by Subject|2|||
16463097|NCT00561977|40175428|FG002|Overall Study|Withdrawal by Subject|1|||
16169056|NCT00045032|39095367|FG002|Overall Study|Death|17|||
16169057|NCT00045032|39095365|FG000|Overall Study|Insufficient Therapeutic Response|542|||
16169058|NCT00045032|39095366|FG001|Overall Study|Insufficient Therapeutic Response|437|||
16169059|NCT00045032|39095367|FG002|Overall Study|Insufficient Therapeutic Response|445|||
16169060|NCT00045032|39095365|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
16169061|NCT00045032|39095366|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
16169062|NCT00045032|39095367|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
16169063|NCT00045032|39095365|FG000|Overall Study|Other Protocol Violation|2|||
16169064|NCT00045032|39095366|FG001|Overall Study|Other Protocol Violation|0|||
16169065|NCT00045032|39095367|FG002|Overall Study|Other Protocol Violation|1|||
16169066|NCT00045032|39095365|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
16169067|NCT00045032|39095366|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
16169068|NCT00045032|39095367|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
16169069|NCT00045032|39095365|FG000|Overall Study|Failure to Return|57|||
16463098|NCT00561977|40175426|FG000|Overall Study|Pregnancy|0|||
16463099|NCT00561977|40175427|FG001|Overall Study|Pregnancy|1|||
16463100|NCT00561977|40175428|FG002|Overall Study|Pregnancy|1|||
16463101|NCT03821844|40175429|FG000|Overall Study|Death|37|||
16463102|NCT03821844|40175430|FG001|Overall Study|Death|31|||
16463103|NCT03821844|40175429|FG000|Overall Study|Discharged|10|||
16463104|NCT03821844|40175430|FG001|Overall Study|Discharged|14|||
16463105|NCT03821844|40175429|FG000|Overall Study|Not present in facility at followup|2|||
16463106|NCT03821844|40175430|FG001|Overall Study|Not present in facility at followup|3|||
16463107|NCT02285062|40175431|FG000|Pre-Treatment Period|Protocol Violation|0|||
16169070|NCT00045032|39095366|FG001|Overall Study|Failure to Return|62|||
16169071|NCT00045032|39095367|FG002|Overall Study|Failure to Return|61|||
16169072|NCT00045032|39095365|FG000|Overall Study|Other|93|||
16169073|NCT00045032|39095366|FG001|Overall Study|Other|84|||
16169074|NCT00045032|39095367|FG002|Overall Study|Other|105|||
16463108|NCT02285062|40175432|FG001|Pre-Treatment Period|Protocol Violation|2|||
16463109|NCT02285062|40175431|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
16463110|NCT02285062|40175432|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
16463111|NCT00952380|40175433|FG000|Overall Study|Other|0|||
16463112|NCT00952380|40175434|FG001|Overall Study|Other|0|||
16463113|NCT00952380|40175435|FG002|Overall Study|Other|0|||
16463114|NCT00952380|40175436|FG003|Overall Study|Other|0|||
16463115|NCT00952380|40175437|FG004|Overall Study|Other|1|||
16463116|NCT00952380|40175433|FG000|Overall Study|Withdrawal by Subject|0|||
16463117|NCT00952380|40175434|FG001|Overall Study|Withdrawal by Subject|0|||
16463118|NCT00952380|40175435|FG002|Overall Study|Withdrawal by Subject|1|||
16463119|NCT00952380|40175436|FG003|Overall Study|Withdrawal by Subject|0|||
16463120|NCT00952380|40175437|FG004|Overall Study|Withdrawal by Subject|2|||
16463121|NCT00952380|40175433|FG000|Overall Study|Adverse Event|0|||
16463122|NCT00952380|40175434|FG001|Overall Study|Adverse Event|1|||
16463123|NCT00952380|40175435|FG002|Overall Study|Adverse Event|0|||
16169075|NCT03064490|39095368|FG000|Overall Study|Physician Decision|5|||
16169076|NCT00531960|39095369|FG000|Overall Study|Adverse Event|5|||
16169077|NCT00531960|39095370|FG001|Overall Study|Adverse Event|4|||
16169078|NCT00531960|39095369|FG000|Overall Study|Death|3|||
16169079|NCT00531960|39095370|FG001|Overall Study|Death|2|||
16169080|NCT00531960|39095369|FG000|Overall Study|Lack of Efficacy|42|||
16169081|NCT00531960|39095370|FG001|Overall Study|Lack of Efficacy|41|||
16169082|NCT00531960|39095369|FG000|Overall Study|Violation of Selection Criteria|2|||
16463124|NCT00952380|40175436|FG003|Overall Study|Adverse Event|0|||
16463125|NCT00952380|40175437|FG004|Overall Study|Adverse Event|3|||
16463126|NCT00952380|40175433|FG000|Overall Study|Physician Decision|0|||
16463127|NCT00952380|40175434|FG001|Overall Study|Physician Decision|0|||
16463128|NCT00952380|40175435|FG002|Overall Study|Physician Decision|1|||
16463129|NCT00952380|40175436|FG003|Overall Study|Physician Decision|2|||
16463130|NCT00952380|40175437|FG004|Overall Study|Physician Decision|0|||
16463131|NCT00952380|40175433|FG000|Overall Study|Non-compliant to protocol|0|||
16463132|NCT00952380|40175434|FG001|Overall Study|Non-compliant to protocol|0|||
16463133|NCT00952380|40175435|FG002|Overall Study|Non-compliant to protocol|0|||
16169083|NCT00531960|39095370|FG001|Overall Study|Violation of Selection Criteria|0|||
16169084|NCT00531960|39095369|FG000|Overall Study|Refused Treatment|5|||
16169085|NCT00531960|39095370|FG001|Overall Study|Refused Treatment|6|||
16169086|NCT00531960|39095369|FG000|Overall Study|Other|4|||
16169087|NCT00531960|39095370|FG001|Overall Study|Other|10|||
16169088|NCT00684177|39095373|FG000|Overall Study|Adverse Event|4|||
16169089|NCT00684177|39095374|FG001|Overall Study|Adverse Event|3|||
16463134|NCT00952380|40175436|FG003|Overall Study|Non-compliant to protocol|1|||
16463135|NCT00952380|40175437|FG004|Overall Study|Non-compliant to protocol|0|||
16463136|NCT03330002|40175438|FG000|Overall Study|Lost to Follow-up|15|||
16463137|NCT03330002|40175438|FG000|Overall Study|Death|7|||
16463138|NCT01092832|40175445|FG000|Overall Study|Other|1|||
16463139|NCT01092832|40175446|FG001|Overall Study|Other|0|||
16463140|NCT00435045|40175447|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
16463141|NCT00435045|40175448|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
16463142|NCT00435045|40175447|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
16463143|NCT00435045|40175448|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
16463144|NCT00435045|40175447|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
16463145|NCT00435045|40175448|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
16463146|NCT00435045|40175447|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
16463147|NCT00435045|40175448|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
16463148|NCT00435045|40175447|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
16463149|NCT00435045|40175448|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
16463150|NCT00435045|40175447|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
16463151|NCT00435045|40175448|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
16463152|NCT00435045|40175447|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
16463153|NCT00435045|40175448|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
16463154|NCT00435045|40175447|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
16463155|NCT00435045|40175448|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
16463156|NCT00435045|40175447|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
16169090|NCT00684177|39095373|FG000|Overall Study|Lack of Efficacy|10|||
16463157|NCT00435045|40175448|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
16463158|NCT00435045|40175447|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
16463159|NCT00435045|40175448|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
16463160|NCT00435045|40175447|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
16463161|NCT00435045|40175448|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
16169091|NCT00684177|39095374|FG001|Overall Study|Lack of Efficacy|15|||
16169092|NCT00684177|39095373|FG000|Overall Study|Protocol Violation|1|||
16169093|NCT00684177|39095374|FG001|Overall Study|Protocol Violation|0|||
16169094|NCT00684177|39095373|FG000|Overall Study|Lost to Follow-up|2|||
16463162|NCT01917656|40175449|FG000|Overall Study|Adverse Event|11|||
16463163|NCT01917656|40175450|FG001|Overall Study|Adverse Event|0|||
16463164|NCT01917656|40175449|FG000|Overall Study|Withdrawal criteria|8|||
16463165|NCT01917656|40175450|FG001|Overall Study|Withdrawal criteria|14|||
16463166|NCT01917656|40175449|FG000|Overall Study|Unclassified|0|||
16463167|NCT01917656|40175450|FG001|Overall Study|Unclassified|3|||
16463168|NCT01917656|40175449|FG000|Overall Study|Withdrawal by Subject|4|||
16463169|NCT01917656|40175450|FG001|Overall Study|Withdrawal by Subject|3|||
16463170|NCT01917656|40175449|FG000|Overall Study|Lost to Follow-up|3|||
16463171|NCT01917656|40175450|FG001|Overall Study|Lost to Follow-up|4|||
16463172|NCT01049009|40175465|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
16463173|NCT01049009|40175466|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
16463174|NCT01049009|40175465|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
16463175|NCT01049009|40175466|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
16463176|NCT01049009|40175465|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
16463177|NCT01049009|40175466|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
16463178|NCT01049009|40175465|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
16463179|NCT01049009|40175466|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
16463180|NCT00995566|40175471|FG000|Overall Study|Adverse Event|2|||
16463181|NCT00995566|40175471|FG000|Overall Study|Early study termination|52|||
16463182|NCT00864916|40175472|FG000|Overall Study|Lost to Follow-up|4|||
16169095|NCT00684177|39095374|FG001|Overall Study|Lost to Follow-up|1|||
16169096|NCT00684177|39095373|FG000|Overall Study|Physician Decision|2|||
16169097|NCT00684177|39095374|FG001|Overall Study|Physician Decision|0|||
16169098|NCT00684177|39095373|FG000|Overall Study|Withdrawal by Subject|1|||
16169099|NCT00684177|39095374|FG001|Overall Study|Withdrawal by Subject|2|||
16169100|NCT00684177|39095373|FG000|Overall Study|Other|1|||
16169101|NCT00684177|39095374|FG001|Overall Study|Other|2|||
16169102|NCT00621504|39095378|FG000|Overall Study|Adverse Event|1|||
16169103|NCT00621504|39095379|FG001|Overall Study|Adverse Event|3|||
16169104|NCT00621504|39095378|FG000|Overall Study|At the request of sponsor/investigator|1|||
16169105|NCT00621504|39095379|FG001|Overall Study|At the request of sponsor/investigator|0|||
16169106|NCT00621504|39095378|FG000|Overall Study|Withdrew consent|9|||
16169107|NCT00621504|39095379|FG001|Overall Study|Withdrew consent|6|||
16169108|NCT00621504|39095378|FG000|Overall Study|Lost to Follow-up|8|||
16169109|NCT00621504|39095379|FG001|Overall Study|Lost to Follow-up|10|||
16169110|NCT00621504|39095378|FG000|Overall Study|Other|1|||
16169111|NCT00621504|39095379|FG001|Overall Study|Other|0|||
16169112|NCT00621504|39095378|FG000|Overall Study|Death|6|||
16169113|NCT00621504|39095379|FG001|Overall Study|Death|6|||
16169114|NCT00151892|39095380|FG000|Overall Study|Lack of Efficacy|50|||
16169115|NCT00151892|39095381|FG001|Overall Study|Lack of Efficacy|57|||
16169116|NCT00151892|39095380|FG000|Overall Study|Patient request|10|||
16169117|NCT00151892|39095381|FG001|Overall Study|Patient request|7|||
16169118|NCT00151892|39095380|FG000|Overall Study|Lost to Follow-up|5|||
16169119|NCT00151892|39095381|FG001|Overall Study|Lost to Follow-up|10|||
16169120|NCT00151892|39095380|FG000|Overall Study|Adverse Event|6|||
16169121|NCT00151892|39095381|FG001|Overall Study|Adverse Event|3|||
16169122|NCT00151892|39095380|FG000|Overall Study|Protocol Violation|3|||
16169123|NCT00151892|39095381|FG001|Overall Study|Protocol Violation|3|||
16169124|NCT00151892|39095380|FG000|Overall Study|Non-compliance|0|||
16169125|NCT00151892|39095381|FG001|Overall Study|Non-compliance|1|||
16169126|NCT00151892|39095380|FG000|Overall Study|Pregnancy|0|||
16169127|NCT00151892|39095381|FG001|Overall Study|Pregnancy|1|||
16169128|NCT00151892|39095380|FG000|Overall Study|Did not return for a visit|1|||
16169129|NCT00151892|39095381|FG001|Overall Study|Did not return for a visit|0|||
16169130|NCT00151892|39095380|FG000|Overall Study|Used prohibited corticosteroids|1|||
16169131|NCT00151892|39095381|FG001|Overall Study|Used prohibited corticosteroids|0|||
16169132|NCT00151892|39095380|FG000|Overall Study|Lack of study medication at center|0|||
16169133|NCT00151892|39095381|FG001|Overall Study|Lack of study medication at center|1|||
16169134|NCT01934140|39095385|FG000|Persistence Phase (Year 6-10)|Other|24|||
16169135|NCT01934140|39095386|FG001|Persistence Phase (Year 6-10)|Other|6|||
16169136|NCT01934140|39095385|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
16169137|NCT01934140|39095386|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
16463183|NCT00864916|40175473|FG001|Overall Study|Lost to Follow-up|4|||
16463184|NCT00864916|40175472|FG000|Overall Study|Protocol Violation|1|||
16463185|NCT00864916|40175473|FG001|Overall Study|Protocol Violation|0|||
16463186|NCT00864916|40175472|FG000|Overall Study|Withdrawal by Subject|1|||
16463187|NCT00864916|40175473|FG001|Overall Study|Withdrawal by Subject|0|||
16169138|NCT01934140|39095385|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
16169139|NCT01934140|39095386|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
16169140|NCT01934140|39095385|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
16169141|NCT01934140|39095386|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
16169142|NCT01934140|39095385|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
16169143|NCT01934140|39095386|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
16169144|NCT01934140|39095385|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
16169145|NCT01934140|39095386|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
16169146|NCT01934140|39095385|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
16169147|NCT01934140|39095386|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
16169148|NCT01934140|39095385|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
16169149|NCT01934140|39095386|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
16169150|NCT00159432|39095391|FG000|Overall Study|Adverse Event|1|||
16169151|NCT00159432|39095391|FG000|Overall Study|Death|1|||
16169152|NCT00159432|39095391|FG000|Overall Study|Lack of Efficacy|8|||
16463188|NCT04250077|40175477|FG000|Overall Study|Withdrawal by Subject|0|||
16463189|NCT04250077|40175478|FG001|Overall Study|Withdrawal by Subject|1|||
16463190|NCT04250077|40175479|FG002|Overall Study|Withdrawal by Subject|0|||
16463191|NCT04250077|40175477|FG000|Overall Study|Lost to Follow-up|2|||
16463192|NCT04250077|40175478|FG001|Overall Study|Lost to Follow-up|3|||
16463193|NCT04250077|40175479|FG002|Overall Study|Lost to Follow-up|0|||
16463194|NCT00492063|40175482|FG000|Overall Study|Death|0|||
16463195|NCT00492063|40175483|FG001|Overall Study|Death|0|||
16463196|NCT00492063|40175484|FG002|Overall Study|Death|1|||
16463197|NCT00492063|40175485|FG003|Overall Study|Death|2|||
16463198|NCT00492063|40175482|FG000|Overall Study|Withdrawal by Subject|4|||
16463199|NCT00492063|40175483|FG001|Overall Study|Withdrawal by Subject|3|||
16463200|NCT00492063|40175484|FG002|Overall Study|Withdrawal by Subject|5|||
16463201|NCT00492063|40175485|FG003|Overall Study|Withdrawal by Subject|4|||
16463202|NCT00492063|40175482|FG000|Overall Study|Lost to Follow-up|6|||
16463203|NCT00492063|40175483|FG001|Overall Study|Lost to Follow-up|11|||
16463204|NCT00492063|40175484|FG002|Overall Study|Lost to Follow-up|5|||
16463205|NCT00492063|40175485|FG003|Overall Study|Lost to Follow-up|3|||
16463206|NCT00492063|40175482|FG000|Overall Study|Protocol Violation|0|||
16463207|NCT00492063|40175483|FG001|Overall Study|Protocol Violation|0|||
16463208|NCT00492063|40175484|FG002|Overall Study|Protocol Violation|0|||
16463209|NCT00492063|40175485|FG003|Overall Study|Protocol Violation|1|||
16463210|NCT01306929|40175486|FG000|Overall Study|Withdrawal by Subject|23|||
16463211|NCT01306929|40175486|FG000|Overall Study|Adverse Event|21|||
16463212|NCT01306929|40175486|FG000|Overall Study|Physician Decision|13|||
16463213|NCT01306929|40175486|FG000|Overall Study|Death|8|||
16463214|NCT01306929|40175486|FG000|Overall Study|Withdrawal by parent/guardian|5|||
16463215|NCT01306929|40175486|FG000|Overall Study|Protocol Violation|3|||
16463216|NCT01306929|40175486|FG000|Overall Study|Non-compliance with study drug|2|||
16463217|NCT01306929|40175486|FG000|Overall Study|Lost to Follow-up|2|||
16463218|NCT01306929|40175486|FG000|Overall Study|Various|17|||
16463219|NCT01782469|40175487|FG000|Overall Study|Lost to Follow-up|1|||
16463220|NCT04620798|40175493|FG000|Overall Study|Lost to Follow-up|126|||
16463221|NCT04620798|40175494|FG001|Overall Study|Lost to Follow-up|138|||
16463222|NCT00075270|40175495|FG000|Overall Study|Withdrawal by Subject|28|||
16463223|NCT00075270|40175496|FG001|Overall Study|Withdrawal by Subject|21|||
16463224|NCT00075270|40175495|FG000|Overall Study|Lost to Follow-up|25|||
16463225|NCT00075270|40175496|FG001|Overall Study|Lost to Follow-up|28|||
16463226|NCT00075270|40175495|FG000|Overall Study|Protocol Violation|0|||
16463227|NCT00075270|40175496|FG001|Overall Study|Protocol Violation|2|||
16463228|NCT00075270|40175495|FG000|Overall Study|Death|198|||
16463229|NCT00075270|40175496|FG001|Overall Study|Death|215|||
16463230|NCT00075270|40175495|FG000|Overall Study|Other/Unknown|9|||
16463231|NCT00075270|40175496|FG001|Overall Study|Other/Unknown|5|||
16463232|NCT00075270|40175495|FG000|Overall Study|Missing|26|||
16463233|NCT00075270|40175496|FG001|Overall Study|Missing|13|||
16463234|NCT00727441|40175497|FG000|Overall Study|Disease Progression|11|||
16463235|NCT00727441|40175498|FG001|Overall Study|Disease Progression|14|||
16463236|NCT00727441|40175499|FG002|Overall Study|Disease Progression|17|||
16463237|NCT00727441|40175497|FG000|Overall Study|Eligibility|7|||
16463238|NCT00727441|40175498|FG001|Overall Study|Eligibility|5|||
16463239|NCT00727441|40175499|FG002|Overall Study|Eligibility|7|||
16463240|NCT00727441|40175497|FG000|Overall Study|Death|0|||
16463241|NCT00727441|40175498|FG001|Overall Study|Death|1|||
16463242|NCT00727441|40175499|FG002|Overall Study|Death|1|||
16463243|NCT00727441|40175497|FG000|Overall Study|Physician Decision|0|||
16169153|NCT02886702|39095392|FG000|Overall Study|Other|4|||
16169154|NCT02886702|39095393|FG001|Overall Study|Other|3|||
16463244|NCT00727441|40175498|FG001|Overall Study|Physician Decision|1|||
16463245|NCT00727441|40175499|FG002|Overall Study|Physician Decision|0|||
16463246|NCT00727441|40175497|FG000|Overall Study|Withdrawal by Subject|0|||
16463247|NCT00727441|40175498|FG001|Overall Study|Withdrawal by Subject|1|||
16169155|NCT02886702|39095394|FG002|Overall Study|Other|9|||
16169156|NCT02886702|39095392|FG000|Overall Study|Withdrawal by Subject|24|||
16463248|NCT00727441|40175499|FG002|Overall Study|Withdrawal by Subject|0|||
16463249|NCT01700439|40175500|FG000|Overall Study|Lost to Follow-up|47|||
16463250|NCT01700439|40175500|FG000|Overall Study|Withdrawal by Subject|183|||
16463251|NCT01700439|40175500|FG000|Overall Study|Death|186|||
16463252|NCT03254459|40175501|FG000|Overall Study|Adverse Event|7|||
16463253|NCT03254459|40175502|FG001|Overall Study|Adverse Event|20|||
16463254|NCT03254459|40175501|FG000|Overall Study|Withdrawal by Subject Consent|3|||
16463255|NCT03254459|40175502|FG001|Overall Study|Withdrawal by Subject Consent|1|||
16463256|NCT03254459|40175501|FG000|Overall Study|Lost to Follow-up|0|||
16463257|NCT03254459|40175502|FG001|Overall Study|Lost to Follow-up|1|||
16463258|NCT03254459|40175501|FG000|Overall Study|Miscellaneous|0|||
16463259|NCT03254459|40175502|FG001|Overall Study|Miscellaneous|1|||
16463260|NCT00495040|40175503|FG000|Overall Study|Withdrawal by Subject|3|||
16463261|NCT02048241|40175512|FG000|Overall Study|Withdrawal by Subject|0|||
16463262|NCT02048241|40175513|FG001|Overall Study|Withdrawal by Subject|1|||
16463263|NCT00459056|40175514|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
16463264|NCT00459056|40175515|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
16463265|NCT00274924|40175516|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
16463266|NCT00274924|40175517|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
16463267|NCT00274924|40175518|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
16463268|NCT00274924|40175516|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
16463269|NCT00274924|40175517|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
16463270|NCT00274924|40175518|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
16463271|NCT00274924|40175516|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
16463272|NCT00274924|40175517|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
16463273|NCT00274924|40175518|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
16463274|NCT00274924|40175516|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
16463275|NCT00274924|40175517|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
16463276|NCT00274924|40175518|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
16463277|NCT00274924|40175516|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
16463278|NCT00274924|40175517|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
16463279|NCT00274924|40175518|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
16463280|NCT00274924|40175516|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
16463281|NCT00274924|40175517|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
16463282|NCT00274924|40175518|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
16463283|NCT00274924|40175516|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
16169157|NCT02886702|39095393|FG001|Overall Study|Withdrawal by Subject|18|||
16169158|NCT02886702|39095394|FG002|Overall Study|Withdrawal by Subject|22|||
16169159|NCT02886702|39095392|FG000|Overall Study|Significant Worsening of Condition|0|||
16169160|NCT02886702|39095393|FG001|Overall Study|Significant Worsening of Condition|1|||
16169161|NCT02886702|39095394|FG002|Overall Study|Significant Worsening of Condition|0|||
16169162|NCT02886702|39095392|FG000|Overall Study|Protocol Violation|2|||
16169163|NCT02886702|39095393|FG001|Overall Study|Protocol Violation|2|||
16169164|NCT02886702|39095394|FG002|Overall Study|Protocol Violation|1|||
16169165|NCT02886702|39095392|FG000|Overall Study|Non-Compliance With Study Drug|0|||
16169166|NCT02886702|39095393|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16169167|NCT02886702|39095394|FG002|Overall Study|Non-Compliance With Study Drug|4|||
16169168|NCT02886702|39095392|FG000|Overall Study|Lost to Follow-up|11|||
16169169|NCT02886702|39095393|FG001|Overall Study|Lost to Follow-up|13|||
16169170|NCT02886702|39095394|FG002|Overall Study|Lost to Follow-up|8|||
16169171|NCT02886702|39095392|FG000|Overall Study|Lack of Efficacy|3|||
16169172|NCT02886702|39095393|FG001|Overall Study|Lack of Efficacy|4|||
16169173|NCT02886702|39095394|FG002|Overall Study|Lack of Efficacy|5|||
16169174|NCT02886702|39095392|FG000|Overall Study|Adverse Event|4|||
16169175|NCT02886702|39095393|FG001|Overall Study|Adverse Event|9|||
16169176|NCT02886702|39095394|FG002|Overall Study|Adverse Event|3|||
16169177|NCT02886702|39095392|FG000|Overall Study|Administrative Reasons|0|||
16169178|NCT02886702|39095393|FG001|Overall Study|Administrative Reasons|0|||
16169179|NCT02886702|39095394|FG002|Overall Study|Administrative Reasons|1|||
16169180|NCT01214044|39095395|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
16169181|NCT01214044|39095395|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
16169182|NCT01214044|39095395|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
16169183|NCT01214044|39095395|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
16169184|NCT01214044|39095395|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
16169185|NCT01214044|39095395|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
16169186|NCT00804687|39095396|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
16169187|NCT00804687|39095397|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
16169188|NCT00804687|39095398|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
16169189|NCT00804687|39095399|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
16169190|NCT00804687|39095400|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
16169191|NCT00804687|39095401|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
16169192|NCT00804687|39095396|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
16169193|NCT00804687|39095397|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
16463284|NCT00274924|40175517|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
16463285|NCT00274924|40175518|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
16463286|NCT00274924|40175516|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
16463287|NCT00274924|40175517|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
16463288|NCT00274924|40175518|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
16463289|NCT00274924|40175516|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
16463290|NCT00274924|40175517|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
16463291|NCT00274924|40175518|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
16463292|NCT00274924|40175516|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
16463293|NCT00274924|40175517|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
16463294|NCT00274924|40175518|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
16463295|NCT00274924|40175516|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
16463296|NCT00274924|40175517|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
16463297|NCT00274924|40175518|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
16463298|NCT00274924|40175516|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
16463299|NCT00274924|40175517|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
16463300|NCT00274924|40175518|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
16463301|NCT00274924|40175516|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
16463302|NCT00274924|40175517|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
16463303|NCT00274924|40175518|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
16463304|NCT02923921|40175519|FG000|Overall Study|Sponsor Decision|39|||
16463305|NCT02923921|40175520|FG001|Overall Study|Sponsor Decision|38|||
16463306|NCT02923921|40175519|FG000|Overall Study|Lost to Follow-up|1|||
16463307|NCT02923921|40175520|FG001|Overall Study|Lost to Follow-up|0|||
16463308|NCT02923921|40175519|FG000|Overall Study|Withdrawal by Subject|6|||
16463309|NCT02923921|40175520|FG001|Overall Study|Withdrawal by Subject|13|||
16463310|NCT02923921|40175519|FG000|Overall Study|Unknown, Not Collected|7|||
16463311|NCT02923921|40175520|FG001|Overall Study|Unknown, Not Collected|6|||
16463312|NCT03562767|40175521|FG000|Overall Study|Physician Decision|2|||
16463313|NCT03562767|40175522|FG001|Overall Study|Physician Decision|0|||
16463314|NCT03562767|40175523|FG002|Overall Study|Physician Decision|0|||
16463315|NCT03562767|40175521|FG000|Overall Study|Logistic Reason|1|||
16463316|NCT03562767|40175522|FG001|Overall Study|Logistic Reason|3|||
16463317|NCT03562767|40175523|FG002|Overall Study|Logistic Reason|0|||
16463318|NCT01836276|40175532|FG000|Overall Study|Lost to Follow-up|28|||
16463319|NCT01836276|40175533|FG001|Overall Study|Lost to Follow-up|51|||
16463320|NCT00505778|40175538|FG000|Overall Study|Adverse Event|2|||
16463321|NCT00505778|40175539|FG001|Overall Study|Adverse Event|7|||
16463322|NCT00505778|40175538|FG000|Overall Study|Physician Decision|8|||
16463323|NCT00505778|40175539|FG001|Overall Study|Physician Decision|14|||
16463324|NCT00505778|40175538|FG000|Overall Study|Lost to Follow-up|17|||
16463325|NCT00505778|40175539|FG001|Overall Study|Lost to Follow-up|23|||
16463326|NCT00505778|40175538|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
16463327|NCT00505778|40175539|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
16463328|NCT00505778|40175538|FG000|Overall Study|Protocol Violation|7|||
16463329|NCT00505778|40175539|FG001|Overall Study|Protocol Violation|9|||
16463330|NCT00505778|40175538|FG000|Overall Study|Withdrawal by Subject|29|||
16463331|NCT00505778|40175539|FG001|Overall Study|Withdrawal by Subject|14|||
16463332|NCT00505778|40175538|FG000|Overall Study|Relapse|65|||
16463333|NCT00505778|40175539|FG001|Overall Study|Relapse|65|||
16463334|NCT00505778|40175538|FG000|Overall Study|Took No Study Drug|2|||
16463335|NCT00505778|40175539|FG001|Overall Study|Took No Study Drug|2|||
16463336|NCT00095147|40175540|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
16463337|NCT00095147|40175541|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
16463338|NCT00095147|40175542|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
16463339|NCT00095147|40175543|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
16463340|NCT00095147|40175544|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
16463341|NCT00095147|40175540|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
16463342|NCT00095147|40175541|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
16463343|NCT00095147|40175542|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
16463344|NCT00095147|40175543|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
16463345|NCT00095147|40175544|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
16463346|NCT00095147|40175540|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
16463347|NCT00095147|40175541|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
16463348|NCT00095147|40175542|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
16463349|NCT00095147|40175543|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
16463350|NCT00095147|40175544|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
16463351|NCT00095147|40175540|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
16463352|NCT00095147|40175541|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
16463353|NCT00095147|40175542|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
16463354|NCT00095147|40175543|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
16463355|NCT00095147|40175544|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
16463356|NCT00095147|40175540|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
16463357|NCT00095147|40175541|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
16463358|NCT00095147|40175542|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
16463359|NCT00095147|40175543|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
16463360|NCT00095147|40175544|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
16463361|NCT00095147|40175540|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
16463362|NCT00095147|40175541|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
16463363|NCT00095147|40175542|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
16463364|NCT00095147|40175543|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
16463365|NCT00095147|40175544|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
16463366|NCT00095147|40175540|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
16463367|NCT00095147|40175541|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
16463368|NCT00095147|40175542|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
16463369|NCT00095147|40175543|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
16463370|NCT00095147|40175544|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
16463371|NCT00095147|40175540|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
16463372|NCT00095147|40175541|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
16463373|NCT00095147|40175542|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
16463374|NCT00095147|40175543|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
16463375|NCT00095147|40175544|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
16463376|NCT00095147|40175540|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
16463377|NCT00095147|40175541|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
16463378|NCT00095147|40175542|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
16463379|NCT00095147|40175543|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
16463380|NCT00095147|40175544|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
16463381|NCT00095147|40175540|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
16463382|NCT00095147|40175541|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
16463383|NCT00095147|40175542|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
16463384|NCT00095147|40175543|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
16463385|NCT00095147|40175544|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
16463386|NCT00095147|40175540|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
16463387|NCT00095147|40175541|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
16463388|NCT00095147|40175542|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
16463389|NCT00095147|40175543|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
16463390|NCT00095147|40175544|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
16463391|NCT00095147|40175540|FG000|Long-term Extension Period|Death|0|||
16463392|NCT00095147|40175541|FG001|Long-term Extension Period|Death|0|||
16463393|NCT00095147|40175542|FG002|Long-term Extension Period|Death|0|||
16463394|NCT00095147|40175543|FG003|Long-term Extension Period|Death|0|||
16463395|NCT00095147|40175544|FG004|Long-term Extension Period|Death|3|||
16463396|NCT00095147|40175540|FG000|Long-term Extension Period|Adverse Event|0|||
16463397|NCT00095147|40175541|FG001|Long-term Extension Period|Adverse Event|0|||
16463398|NCT00095147|40175542|FG002|Long-term Extension Period|Adverse Event|0|||
16463399|NCT00095147|40175543|FG003|Long-term Extension Period|Adverse Event|0|||
16463400|NCT00095147|40175544|FG004|Long-term Extension Period|Adverse Event|11|||
16463401|NCT00095147|40175540|FG000|Long-term Extension Period|Lack of Efficacy|0|||
16463402|NCT00095147|40175541|FG001|Long-term Extension Period|Lack of Efficacy|0|||
16463403|NCT00095147|40175542|FG002|Long-term Extension Period|Lack of Efficacy|0|||
16463404|NCT00095147|40175543|FG003|Long-term Extension Period|Lack of Efficacy|0|||
16463405|NCT00095147|40175544|FG004|Long-term Extension Period|Lack of Efficacy|9|||
16463406|NCT00095147|40175540|FG000|Long-term Extension Period|Lost to Follow-up|0|||
16463407|NCT00095147|40175541|FG001|Long-term Extension Period|Lost to Follow-up|0|||
16463408|NCT00095147|40175542|FG002|Long-term Extension Period|Lost to Follow-up|0|||
16463409|NCT00095147|40175543|FG003|Long-term Extension Period|Lost to Follow-up|0|||
16463410|NCT00095147|40175544|FG004|Long-term Extension Period|Lost to Follow-up|6|||
16463411|NCT00095147|40175540|FG000|Long-term Extension Period|Withdrawal of consent|0|||
16463412|NCT00095147|40175541|FG001|Long-term Extension Period|Withdrawal of consent|0|||
16463413|NCT00095147|40175542|FG002|Long-term Extension Period|Withdrawal of consent|0|||
16463414|NCT00095147|40175543|FG003|Long-term Extension Period|Withdrawal of consent|0|||
16463415|NCT00095147|40175544|FG004|Long-term Extension Period|Withdrawal of consent|12|||
16463416|NCT00095147|40175540|FG000|Long-term Extension Period|Pregnancy|0|||
16463417|NCT00095147|40175541|FG001|Long-term Extension Period|Pregnancy|0|||
16463418|NCT00095147|40175542|FG002|Long-term Extension Period|Pregnancy|0|||
16463419|NCT00095147|40175543|FG003|Long-term Extension Period|Pregnancy|0|||
16463420|NCT00095147|40175544|FG004|Long-term Extension Period|Pregnancy|1|||
16463421|NCT00095147|40175540|FG000|Long-term Extension Period|No longer meets study criteria|0|||
16463422|NCT00095147|40175541|FG001|Long-term Extension Period|No longer meets study criteria|0|||
16463423|NCT00095147|40175542|FG002|Long-term Extension Period|No longer meets study criteria|0|||
16463424|NCT00095147|40175543|FG003|Long-term Extension Period|No longer meets study criteria|0|||
16463425|NCT00095147|40175544|FG004|Long-term Extension Period|No longer meets study criteria|1|||
16269271|NCT04089553|39471049|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
16269272|NCT04089553|39471048|FG000|Overall Study|Withdrawal by Subject|3|||
16463426|NCT00095147|40175540|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
16463427|NCT00095147|40175541|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
16169194|NCT00804687|39095398|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
16169195|NCT00804687|39095399|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
16169196|NCT00804687|39095400|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
16169197|NCT00804687|39095401|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
16169198|NCT00804687|39095396|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
16169199|NCT00804687|39095397|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
16169200|NCT00804687|39095398|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
16169201|NCT00804687|39095399|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
16169202|NCT00804687|39095400|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
16169203|NCT00804687|39095401|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
16169204|NCT00804687|39095396|FG000|Period 5: Treatment Period|Positive drug test|1|||
16169205|NCT00804687|39095397|FG001|Period 5: Treatment Period|Positive drug test|0|||
16169206|NCT00804687|39095398|FG002|Period 5: Treatment Period|Positive drug test|0|||
16169207|NCT00804687|39095399|FG003|Period 5: Treatment Period|Positive drug test|0|||
16169208|NCT00804687|39095400|FG004|Period 5: Treatment Period|Positive drug test|0|||
16169209|NCT00804687|39095401|FG005|Period 5: Treatment Period|Positive drug test|0|||
16169210|NCT02222714|39095405|FG000|Overall Study|Death|0|||
16169211|NCT02222714|39095406|FG001|Overall Study|Death|2|||
16169212|NCT02222714|39095407|FG002|Overall Study|Death|3|||
16169213|NCT02222714|39095408|FG003|Overall Study|Death|4|||
16169214|NCT02222714|39095409|FG004|Overall Study|Death|6|||
16169215|NCT02222714|39095405|FG000|Overall Study|Withdrawal by Subject|0|||
16169216|NCT02222714|39095406|FG001|Overall Study|Withdrawal by Subject|0|||
16169217|NCT02222714|39095407|FG002|Overall Study|Withdrawal by Subject|1|||
16169218|NCT02222714|39095408|FG003|Overall Study|Withdrawal by Subject|0|||
16169219|NCT02222714|39095409|FG004|Overall Study|Withdrawal by Subject|1|||
16169220|NCT02495948|39095410|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
16169221|NCT02495948|39095411|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
16169222|NCT02495948|39095410|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
16169223|NCT02495948|39095411|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
16169224|NCT01400932|39095414|FG000|Overall Study|Adverse Event|10|||
16169225|NCT01400932|39095415|FG001|Overall Study|Adverse Event|5|||
16169226|NCT01400932|39095414|FG000|Overall Study|Lack of Efficacy|0|||
16169227|NCT01400932|39095415|FG001|Overall Study|Lack of Efficacy|3|||
16169228|NCT01400932|39095414|FG000|Overall Study|Withdrawal by Subject|2|||
16169229|NCT01400932|39095415|FG001|Overall Study|Withdrawal by Subject|6|||
16169230|NCT01400932|39095414|FG000|Overall Study|Lost to Follow-up|1|||
16169231|NCT01400932|39095415|FG001|Overall Study|Lost to Follow-up|0|||
16169232|NCT01400932|39095414|FG000|Overall Study|Protocol Deviation|0|||
16169233|NCT01400932|39095415|FG001|Overall Study|Protocol Deviation|1|||
16169234|NCT01400932|39095414|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16169235|NCT01400932|39095415|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
16169236|NCT00787787|39095416|FG000|Overall Study|Lack of Efficacy|4|||
16169237|NCT00787787|39095416|FG000|Overall Study|Adverse Event|3|||
16169238|NCT00675025|39095417|FG000|Overall Study|Study Terminated by Sponsor|38|||
16169239|NCT00675025|39095418|FG001|Overall Study|Study Terminated by Sponsor|42|||
16169240|NCT00675025|39095417|FG000|Overall Study|Adverse Event|6|||
16169241|NCT00675025|39095418|FG001|Overall Study|Adverse Event|11|||
16169242|NCT00675025|39095417|FG000|Overall Study|Lost to Follow-up|6|||
16169243|NCT00675025|39095418|FG001|Overall Study|Lost to Follow-up|4|||
16169244|NCT00675025|39095417|FG000|Overall Study|Withdrawal by Subject|4|||
16169245|NCT00675025|39095418|FG001|Overall Study|Withdrawal by Subject|6|||
16169246|NCT03480802|39095419|FG000|Overall Study|Lost to Follow-up|5|||
16169247|NCT03480802|39095420|FG001|Overall Study|Lost to Follow-up|1|||
16169248|NCT03480802|39095419|FG000|Overall Study|Withdrawal by Subject|2|||
16169249|NCT03480802|39095420|FG001|Overall Study|Withdrawal by Subject|1|||
16169250|NCT03480802|39095419|FG000|Overall Study|Relocated|0|||
16169251|NCT03480802|39095420|FG001|Overall Study|Relocated|1|||
16169252|NCT00808444|39098794|FG000|Overall Study|Withdrawal by Subject|1|||
16169253|NCT00808444|39098795|FG001|Overall Study|Withdrawal by Subject|0|||
16169254|NCT00808444|39098794|FG000|Overall Study|Lost to Follow-up|0|||
16169255|NCT00808444|39098795|FG001|Overall Study|Lost to Follow-up|1|||
16169256|NCT03160560|39098796|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
16169257|NCT03160560|39098797|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16169258|NCT03160560|39098798|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
16169259|NCT03160560|39098799|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
16169260|NCT03160560|39098796|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
16169261|NCT03160560|39098797|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
16169262|NCT03160560|39098798|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
16169263|NCT03160560|39098799|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
16169264|NCT03283085|39098800|FG000|Overall Study|Adverse Event|18|||
16169265|NCT03283085|39098801|FG001|Overall Study|Adverse Event|3|||
16169266|NCT03283085|39098802|FG002|Overall Study|Adverse Event|13|||
16169267|NCT03283085|39098803|FG003|Overall Study|Adverse Event|0|||
16463428|NCT00095147|40175542|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
16463429|NCT00095147|40175543|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
16463430|NCT00095147|40175544|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
16463431|NCT00095147|40175540|FG000|Long-term Extension Period|Leaving country|0|||
16463432|NCT00095147|40175541|FG001|Long-term Extension Period|Leaving country|0|||
16463433|NCT00095147|40175542|FG002|Long-term Extension Period|Leaving country|0|||
16463434|NCT00095147|40175543|FG003|Long-term Extension Period|Leaving country|0|||
16463435|NCT00095147|40175544|FG004|Long-term Extension Period|Leaving country|1|||
16463436|NCT03774823|40175549|FG000|Overall Study|Withdrawal by Subject|1|||
16463437|NCT03774823|40175550|FG001|Overall Study|Withdrawal by Subject|1|||
16463438|NCT05028361|40175551|FG000|Overall Study|Withdrawal by Subject|1|||
16463439|NCT05028361|40175552|FG001|Overall Study|Withdrawal by Subject|0|||
16463440|NCT00779259|40175553|FG000|Quinine Alone|Adverse Event|2|||
16463441|NCT02009384|40175554|FG000|Overall Study|Death|2|||
16463442|NCT01444092|40175555|FG000|Overall Study|Adverse Event|8|||
16463443|NCT01444092|40175555|FG000|Overall Study|Protocol Violation|1|||
16463444|NCT01444092|40175555|FG000|Overall Study|Withdrawal by Subject|1|||
16463445|NCT01444092|40175555|FG000|Overall Study|Other Eligibility criteria|7|||
16463446|NCT00167778|40175558|FG000|Overall Study|Withdrawal by Subject|1|||
16463447|NCT01820260|40175559|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463448|NCT01820260|40175560|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463449|NCT01820260|40175561|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463450|NCT01820260|40175562|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463451|NCT01820260|40175563|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463452|NCT01820260|40175564|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463453|NCT01820260|40175565|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
16463454|NCT01820260|40175566|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463455|NCT01820260|40175567|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463456|NCT01820260|40175568|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463457|NCT01820260|40175569|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463458|NCT01820260|40175570|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463459|NCT01820260|40175571|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463460|NCT01820260|40175572|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
16463461|NCT01820260|40175559|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463462|NCT01820260|40175560|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463463|NCT01820260|40175561|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463464|NCT01820260|40175562|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463465|NCT01820260|40175563|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463466|NCT01820260|40175564|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463467|NCT01820260|40175565|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463468|NCT01820260|40175566|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463469|NCT01820260|40175567|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463470|NCT01820260|40175568|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
16463471|NCT01820260|40175569|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463472|NCT01820260|40175570|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463473|NCT01820260|40175571|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463474|NCT01820260|40175572|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
16463475|NCT02364336|40175575|FG000|Overall Study|Adverse Event|0|||
16463476|NCT02364336|40175576|FG001|Overall Study|Adverse Event|1|||
16463477|NCT01328366|40175577|FG000|Overall Study|Death|1|||
16463478|NCT01328366|40175577|FG000|Overall Study|Withdrawal by Subject|2|||
16463479|NCT01328366|40175577|FG000|Overall Study|Lost to Follow-up|7|||
16463480|NCT01144299|40175582|FG000|Overall Study|Lost to Follow-up|1|||
16463481|NCT01144299|40175583|FG001|Overall Study|Lost to Follow-up|0|||
16463482|NCT01144299|40175582|FG000|Overall Study|Withdrawal by Subject|1|||
16463483|NCT01144299|40175583|FG001|Overall Study|Withdrawal by Subject|0|||
16463484|NCT03996369|40175584|FG000|Overall Study|Protocol deviation|1|||
16463485|NCT03996369|40175585|FG001|Overall Study|Protocol deviation|1|||
16463486|NCT03996369|40175584|FG000|Overall Study|Physician Decision|4|||
16463487|NCT03996369|40175585|FG001|Overall Study|Physician Decision|2|||
16169268|NCT03283085|39098804|FG004|Overall Study|Adverse Event|0|||
16169269|NCT03283085|39098805|FG005|Overall Study|Adverse Event|5|||
16169270|NCT03283085|39098800|FG000|Overall Study|Death|0|||
16463488|NCT03996369|40175584|FG000|Overall Study|Participant decision|0|||
16463489|NCT03996369|40175585|FG001|Overall Study|Participant decision|1|||
16463490|NCT03996369|40175584|FG000|Overall Study|Lack of Efficacy|4|||
16463491|NCT03996369|40175585|FG001|Overall Study|Lack of Efficacy|0|||
16463492|NCT03996369|40175584|FG000|Overall Study|Adverse Event|9|||
16463493|NCT03996369|40175585|FG001|Overall Study|Adverse Event|0|||
16463494|NCT03996369|40175584|FG000|Overall Study|Withdrawal by Subject|6|||
16169271|NCT03283085|39098801|FG001|Overall Study|Death|0|||
16169272|NCT03283085|39098802|FG002|Overall Study|Death|3|||
16169273|NCT03283085|39098803|FG003|Overall Study|Death|1|||
16169274|NCT03283085|39098804|FG004|Overall Study|Death|0|||
16169275|NCT03283085|39098805|FG005|Overall Study|Death|0|||
16169276|NCT03283085|39098800|FG000|Overall Study|Withdrawal by Subject|42|||
16169277|NCT03283085|39098801|FG001|Overall Study|Withdrawal by Subject|21|||
16169278|NCT03283085|39098802|FG002|Overall Study|Withdrawal by Subject|66|||
16169279|NCT03283085|39098803|FG003|Overall Study|Withdrawal by Subject|3|||
16169280|NCT03283085|39098804|FG004|Overall Study|Withdrawal by Subject|3|||
16169281|NCT03283085|39098805|FG005|Overall Study|Withdrawal by Subject|5|||
16169282|NCT03283085|39098800|FG000|Overall Study|Physician Decision|14|||
16169283|NCT03283085|39098801|FG001|Overall Study|Physician Decision|8|||
16169284|NCT03283085|39098802|FG002|Overall Study|Physician Decision|19|||
16463495|NCT03996369|40175585|FG001|Overall Study|Withdrawal by Subject|8|||
16463496|NCT03996369|40175584|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
16463497|NCT03996369|40175585|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
16463498|NCT03996369|40175584|FG000|Overall Study|Lost to Follow-up|0|||
16463499|NCT03996369|40175585|FG001|Overall Study|Lost to Follow-up|1|||
16463500|NCT02848729|40175586|FG000|Overall Study|Withdrawal by Subject|1|||
16463501|NCT02848729|40175587|FG001|Overall Study|Withdrawal by Subject|0|||
16463502|NCT02848729|40175586|FG000|Overall Study|Emesis|15|||
16463503|NCT02848729|40175587|FG001|Overall Study|Emesis|11|||
16463504|NCT02282293|40175598|FG000|Overall Study|Lost to Follow-up|2|||
16463505|NCT02282293|40175599|FG001|Overall Study|Lost to Follow-up|2|||
16463506|NCT02282293|40175598|FG000|Overall Study|Unable to comply with study procedures|1|||
16463507|NCT02282293|40175599|FG001|Overall Study|Unable to comply with study procedures|0|||
16463508|NCT02282293|40175598|FG000|Overall Study|Moved out of study area|0|||
16463509|NCT02282293|40175599|FG001|Overall Study|Moved out of study area|1|||
16463510|NCT01120782|40175600|FG000|Overall Study|Test article shipping error|11|||
16463511|NCT03700684|40175601|FG000|Overall Study|COVID-19|0|||
16463512|NCT03700684|40175602|FG001|Overall Study|COVID-19|0|||
16463513|NCT03700684|40175603|FG002|Overall Study|COVID-19|2|||
16463514|NCT00395343|40175604|FG000|Overall Study|Adverse Event|13|||
16463515|NCT00395343|40175605|FG001|Overall Study|Adverse Event|5|||
16463516|NCT00395343|40175604|FG000|Overall Study|Lack of Efficacy|0|||
16463517|NCT00395343|40175605|FG001|Overall Study|Lack of Efficacy|1|||
16463518|NCT00395343|40175604|FG000|Overall Study|Lost to Follow-up|4|||
16463519|NCT00395343|40175605|FG001|Overall Study|Lost to Follow-up|4|||
16463520|NCT00395343|40175604|FG000|Overall Study|Physician Decision|2|||
16463521|NCT00395343|40175605|FG001|Overall Study|Physician Decision|4|||
16463522|NCT00395343|40175604|FG000|Overall Study|Protocol Violation|6|||
16463523|NCT00395343|40175605|FG001|Overall Study|Protocol Violation|8|||
16463524|NCT00395343|40175604|FG000|Overall Study|Withdrawal by Subject|11|||
16463525|NCT00395343|40175605|FG001|Overall Study|Withdrawal by Subject|12|||
16463526|NCT00395343|40175604|FG000|Overall Study|Other|5|||
16463527|NCT00395343|40175605|FG001|Overall Study|Other|2|||
16463528|NCT00555425|40175608|FG000|Overall Study|Missed Medication > 1 wk|34|||
16463529|NCT00555425|40175609|FG001|Overall Study|Missed Medication > 1 wk|15|||
16463530|NCT00555425|40175608|FG000|Overall Study|Missed 3 physician management visits|1|||
16463531|NCT00555425|40175609|FG001|Overall Study|Missed 3 physician management visits|0|||
16463532|NCT00555425|40175608|FG000|Overall Study|Met criteria for protective transfer|16|||
16463533|NCT00555425|40175609|FG001|Overall Study|Met criteria for protective transfer|3|||
16463534|NCT00555425|40175608|FG000|Overall Study|Became pregnant and transferred care|0|||
16463535|NCT00555425|40175609|FG001|Overall Study|Became pregnant and transferred care|1|||
16463536|NCT01139008|40175610|FG000|Overall Study|Withdrawal by Subject|5|||
16463537|NCT01139008|40175610|FG000|Overall Study|Non-compliant, lost product|1|||
16463538|NCT05315908|40175611|FG000|Overall Study|Lost to Follow-up|4477|||
16463539|NCT05315908|40175612|FG001|Overall Study|Lost to Follow-up|4606|||
16463540|NCT03051620|40175613|FG000|Overall Study|Lost to Follow-up|6|||
16463541|NCT03051620|40175613|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
16463542|NCT00811642|40175614|FG000|Overall Study|Adverse Event|3|||
16463543|NCT00811642|40175614|FG000|Overall Study|Protocol Violation|1|||
16169285|NCT03283085|39098803|FG003|Overall Study|Physician Decision|0|||
16463544|NCT00811642|40175614|FG000|Overall Study|Death|2|||
16463545|NCT00811642|40175614|FG000|Overall Study|Withdrawal by Subject|7|||
16463546|NCT00811642|40175614|FG000|Overall Study|Cumulative use of antifungal agent|2|||
16463547|NCT00393510|40175619|FG000|Overall Study|Physician Decision|3|||
16463548|NCT00393510|40175620|FG001|Overall Study|Physician Decision|9|||
16463549|NCT00357760|40175621|FG000|Overall Study|Disease progression|44|||
16463550|NCT00357760|40175622|FG001|Overall Study|Disease progression|17|||
16463551|NCT00357760|40175621|FG000|Overall Study|Adverse Event|10|||
16463552|NCT00357760|40175622|FG001|Overall Study|Adverse Event|7|||
16463553|NCT00357760|40175621|FG000|Overall Study|Death|0|||
16463554|NCT00357760|40175622|FG001|Overall Study|Death|3|||
16169286|NCT03283085|39098804|FG004|Overall Study|Physician Decision|0|||
16169287|NCT03283085|39098805|FG005|Overall Study|Physician Decision|2|||
16169288|NCT03283085|39098800|FG000|Overall Study|Site Terminated by Sponsor|1|||
16169289|NCT03283085|39098801|FG001|Overall Study|Site Terminated by Sponsor|0|||
16463555|NCT00357760|40175621|FG000|Overall Study|Alternative therapy|1|||
16463556|NCT00357760|40175622|FG001|Overall Study|Alternative therapy|0|||
16463557|NCT00357760|40175621|FG000|Overall Study|Withdrawal by Subject|0|||
16463558|NCT00357760|40175622|FG001|Overall Study|Withdrawal by Subject|2|||
16463559|NCT00357760|40175621|FG000|Overall Study|Never started treatment|2|||
16463560|NCT00357760|40175622|FG001|Overall Study|Never started treatment|1|||
16463561|NCT00357760|40175621|FG000|Overall Study|Ineligible|0|||
16463562|NCT00357760|40175622|FG001|Overall Study|Ineligible|2|||
16463563|NCT00357760|40175621|FG000|Overall Study|Physician Decision|2|||
16463564|NCT00357760|40175622|FG001|Overall Study|Physician Decision|1|||
16169290|NCT03283085|39098802|FG002|Overall Study|Site Terminated by Sponsor|3|||
16169291|NCT03283085|39098803|FG003|Overall Study|Site Terminated by Sponsor|0|||
16169292|NCT03283085|39098804|FG004|Overall Study|Site Terminated by Sponsor|0|||
16169293|NCT03283085|39098805|FG005|Overall Study|Site Terminated by Sponsor|0|||
16463565|NCT00357760|40175621|FG000|Overall Study|Protocol Violation|0|||
16463566|NCT00357760|40175622|FG001|Overall Study|Protocol Violation|1|||
16463567|NCT00357760|40175621|FG000|Overall Study|To receive hospice care|0|||
16463568|NCT00357760|40175622|FG001|Overall Study|To receive hospice care|1|||
16463569|NCT03255629|40175623|FG000|Overall Study|Adverse Event|1|||
16463570|NCT03255629|40175624|FG001|Overall Study|Adverse Event|0|||
16463571|NCT03255629|40175623|FG000|Overall Study|did not experience hypoglycemia|2|||
16463572|NCT03255629|40175624|FG001|Overall Study|did not experience hypoglycemia|1|||
16463573|NCT05347147|40175627|FG000|Overall Study|Lost to Follow-up|0|||
16463574|NCT05347147|40175628|FG001|Overall Study|Lost to Follow-up|1|||
16463575|NCT05347147|40175627|FG000|Overall Study|Sponsor request|3|||
16463576|NCT05347147|40175628|FG001|Overall Study|Sponsor request|3|||
16463577|NCT05347147|40175627|FG000|Overall Study|Study termination|2|||
16463578|NCT05347147|40175628|FG001|Overall Study|Study termination|1|||
16463579|NCT00945906|40175629|FG000|Overall Study|Withdrawal by Subject|1|||
16463580|NCT00945906|40175629|FG000|Overall Study|Did not want to return for last visit|2|||
16463581|NCT00945906|40175629|FG000|Overall Study|Unable to return for last visit|2|||
16463582|NCT00945906|40175629|FG000|Overall Study|Moved to another country|2|||
16463583|NCT00910624|40175634|FG000|Treatment Phase|Adverse Event|2|||
16463584|NCT00910624|40175635|FG001|Treatment Phase|Adverse Event|6|||
16463585|NCT00910624|40175636|FG002|Treatment Phase|Adverse Event|6|||
16463586|NCT00910624|40175637|FG003|Treatment Phase|Adverse Event|0|||
16463587|NCT00910624|40175634|FG000|Treatment Phase|Treatment Failure|23|||
16463588|NCT00910624|40175635|FG001|Treatment Phase|Treatment Failure|10|||
16463589|NCT00910624|40175636|FG002|Treatment Phase|Treatment Failure|0|||
16463590|NCT00910624|40175637|FG003|Treatment Phase|Treatment Failure|0|||
16463591|NCT00910624|40175634|FG000|Treatment Phase|Lost to Follow-up|0|||
16463592|NCT00910624|40175635|FG001|Treatment Phase|Lost to Follow-up|0|||
16463593|NCT00910624|40175636|FG002|Treatment Phase|Lost to Follow-up|1|||
16463594|NCT00910624|40175637|FG003|Treatment Phase|Lost to Follow-up|0|||
16169294|NCT03283085|39098800|FG000|Overall Study|Lost to Follow-up|2|||
16169295|NCT03283085|39098801|FG001|Overall Study|Lost to Follow-up|0|||
16169296|NCT03283085|39098802|FG002|Overall Study|Lost to Follow-up|2|||
16169297|NCT03283085|39098803|FG003|Overall Study|Lost to Follow-up|0|||
16169298|NCT03283085|39098804|FG004|Overall Study|Lost to Follow-up|0|||
16169299|NCT03283085|39098805|FG005|Overall Study|Lost to Follow-up|1|||
16169300|NCT03283085|39098800|FG000|Overall Study|Pregnancy|0|||
16169301|NCT03283085|39098801|FG001|Overall Study|Pregnancy|0|||
16169302|NCT03283085|39098802|FG002|Overall Study|Pregnancy|1|||
16169303|NCT03283085|39098803|FG003|Overall Study|Pregnancy|0|||
16169304|NCT03283085|39098804|FG004|Overall Study|Pregnancy|0|||
16169305|NCT03283085|39098805|FG005|Overall Study|Pregnancy|0|||
16169306|NCT03283085|39098800|FG000|Overall Study|Lack of Efficacy|12|||
16169307|NCT03283085|39098801|FG001|Overall Study|Lack of Efficacy|6|||
16169308|NCT03283085|39098802|FG002|Overall Study|Lack of Efficacy|24|||
16169309|NCT03283085|39098803|FG003|Overall Study|Lack of Efficacy|1|||
16169310|NCT03283085|39098804|FG004|Overall Study|Lack of Efficacy|1|||
16169311|NCT03283085|39098805|FG005|Overall Study|Lack of Efficacy|0|||
16169312|NCT03283085|39098800|FG000|Overall Study|Reason not Specified|0|||
16169313|NCT03283085|39098801|FG001|Overall Study|Reason not Specified|4|||
16463595|NCT00910624|40175634|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
16463596|NCT00910624|40175635|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
16463597|NCT00910624|40175636|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
16463598|NCT00910624|40175637|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
16463599|NCT00910624|40175634|FG000|Treatment Phase|Withdrawal by Subject|2|||
16463600|NCT00910624|40175635|FG001|Treatment Phase|Withdrawal by Subject|1|||
16463601|NCT00910624|40175636|FG002|Treatment Phase|Withdrawal by Subject|0|||
16169314|NCT03283085|39098802|FG002|Overall Study|Reason not Specified|8|||
16169315|NCT03283085|39098803|FG003|Overall Study|Reason not Specified|0|||
16169316|NCT03283085|39098804|FG004|Overall Study|Reason not Specified|0|||
16169317|NCT03283085|39098805|FG005|Overall Study|Reason not Specified|1|||
16169318|NCT03822884|39098812|FG000|Overall Study|Withdrawal by Subject|0|||
16463602|NCT00910624|40175637|FG003|Treatment Phase|Withdrawal by Subject|0|||
16463603|NCT00910624|40175634|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
16169319|NCT03822884|39098813|FG001|Overall Study|Withdrawal by Subject|0|||
16169320|NCT03822884|39098814|FG002|Overall Study|Withdrawal by Subject|0|||
16169321|NCT03822884|39098815|FG003|Overall Study|Withdrawal by Subject|0|||
16169322|NCT03822884|39098816|FG004|Overall Study|Withdrawal by Subject|1|||
16169323|NCT03822884|39098817|FG005|Overall Study|Withdrawal by Subject|0|||
16169324|NCT01756456|39098818|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
16169325|NCT01756456|39098819|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
16169326|NCT01756456|39098820|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
16463604|NCT00910624|40175635|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
16463605|NCT00910624|40175636|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
16463606|NCT00910624|40175637|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
16463607|NCT00910624|40175634|FG000|Follow-Up Phase|Adverse Event|0|||
16463608|NCT00910624|40175635|FG001|Follow-Up Phase|Adverse Event|0|||
16463609|NCT00910624|40175636|FG002|Follow-Up Phase|Adverse Event|1|||
16463610|NCT00910624|40175637|FG003|Follow-Up Phase|Adverse Event|0|||
16463611|NCT00910624|40175634|FG000|Follow-Up Phase|Lost to Follow-up|3|||
16463612|NCT00910624|40175635|FG001|Follow-Up Phase|Lost to Follow-up|1|||
16463613|NCT00910624|40175636|FG002|Follow-Up Phase|Lost to Follow-up|2|||
16463614|NCT00910624|40175637|FG003|Follow-Up Phase|Lost to Follow-up|0|||
16463615|NCT00910624|40175634|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
16463616|NCT00910624|40175635|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
16463617|NCT00910624|40175636|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
16463618|NCT00910624|40175637|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
16463619|NCT00910624|40175634|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
16463620|NCT00910624|40175635|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
16463621|NCT00910624|40175636|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
16463622|NCT00910624|40175637|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
16463623|NCT00910624|40175634|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
16463624|NCT00910624|40175635|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
16463625|NCT00910624|40175636|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
16463626|NCT00910624|40175637|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
16463627|NCT00910624|40175634|FG000|Follow-Up Phase|Administrative|0|||
16463628|NCT00910624|40175635|FG001|Follow-Up Phase|Administrative|1|||
16463629|NCT00910624|40175636|FG002|Follow-Up Phase|Administrative|1|||
16463630|NCT00910624|40175637|FG003|Follow-Up Phase|Administrative|0|||
16463631|NCT02184455|40175638|FG000|Overall Study|Lost to Follow-up|1|||
16463632|NCT00097981|40175639|FG000|Overall Study|Adverse Event|31|||
16463633|NCT00097981|40175640|FG001|Overall Study|Adverse Event|44|||
16463634|NCT00097981|40175639|FG000|Overall Study|Withdrawal by Subject|10|||
16463635|NCT00097981|40175640|FG001|Overall Study|Withdrawal by Subject|8|||
16463636|NCT00097981|40175639|FG000|Overall Study|Protocol Violation|1|||
16463637|NCT00097981|40175640|FG001|Overall Study|Protocol Violation|1|||
16463638|NCT00097981|40175639|FG000|Overall Study|Death|2|||
16463639|NCT00097981|40175640|FG001|Overall Study|Death|4|||
16463640|NCT00097981|40175639|FG000|Overall Study|Physician Decision|7|||
16463641|NCT00097981|40175640|FG001|Overall Study|Physician Decision|1|||
16463642|NCT00097981|40175639|FG000|Overall Study|Disease Progression|8|||
16463643|NCT00097981|40175640|FG001|Overall Study|Disease Progression|2|||
16463644|NCT00097981|40175639|FG000|Overall Study|Transplant planned|28|||
16463645|NCT00097981|40175640|FG001|Overall Study|Transplant planned|27|||
16463646|NCT00097981|40175639|FG000|Overall Study|Other|19|||
16463647|NCT00097981|40175640|FG001|Overall Study|Other|13|||
16463648|NCT04610281|40175641|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
16463649|NCT04610281|40175642|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
16463650|NCT01095094|40175645|FG000|Overall Study|Withdrawal by Subject|1|||
16463651|NCT01095094|40175645|FG000|Overall Study|Death|1|||
16463652|NCT01095094|40175645|FG000|Overall Study|Physician Decision|1|||
16463653|NCT04585009|40175646|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
16169327|NCT01756456|39098821|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
16169328|NCT01756456|39098822|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
16169329|NCT01756456|39098823|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
16463654|NCT04585009|40175647|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16463655|NCT04585009|40175648|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16463656|NCT04585009|40175649|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16463657|NCT04585009|40175650|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16463658|NCT04585009|40175651|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16463659|NCT04585009|40175652|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16463660|NCT04585009|40175653|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16463661|NCT04585009|40175654|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16169330|NCT01756456|39098818|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
16169331|NCT01756456|39098819|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
16463662|NCT04585009|40175655|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16463663|NCT04585009|40175656|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16463664|NCT04585009|40175657|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
16463665|NCT04585009|40175646|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
16463666|NCT04585009|40175647|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16463667|NCT04585009|40175648|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16463668|NCT04585009|40175649|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16463669|NCT04585009|40175650|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16463670|NCT04585009|40175651|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16169332|NCT01756456|39098820|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
16169333|NCT01756456|39098821|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
16169334|NCT01756456|39098822|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
16169335|NCT01756456|39098823|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
16169336|NCT01756456|39098818|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
16169337|NCT01756456|39098819|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
16169338|NCT01756456|39098820|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
16169339|NCT01756456|39098821|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
16169340|NCT01756456|39098822|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
16169341|NCT01756456|39098823|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
16169342|NCT01756456|39098818|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
16169343|NCT01756456|39098819|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
16169344|NCT01756456|39098820|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
16169345|NCT01756456|39098821|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
16169346|NCT01756456|39098822|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
16169347|NCT01756456|39098823|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
16169348|NCT01756456|39098818|FG000|Treatment Period: Phase I/II|Other causes|0|||
16169349|NCT01756456|39098819|FG001|Treatment Period: Phase I/II|Other causes|0|||
16169350|NCT01756456|39098820|FG002|Treatment Period: Phase I/II|Other causes|0|||
16169351|NCT01756456|39098821|FG003|Treatment Period: Phase I/II|Other causes|1|||
16169352|NCT01756456|39098822|FG004|Treatment Period: Phase I/II|Other causes|2|||
16169353|NCT01756456|39098823|FG005|Treatment Period: Phase I/II|Other causes|2|||
16169354|NCT01756456|39098818|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
16169355|NCT01756456|39098819|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
16169356|NCT01756456|39098820|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
16169357|NCT01756456|39098821|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
16169358|NCT01756456|39098822|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
16169359|NCT01756456|39098823|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
16463671|NCT04585009|40175652|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16463672|NCT04585009|40175653|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16463673|NCT04585009|40175654|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16463674|NCT04585009|40175655|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16169360|NCT01756456|39098818|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
16169361|NCT01756456|39098819|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
16169362|NCT01756456|39098820|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
16169363|NCT01756456|39098821|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
16169364|NCT01756456|39098822|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
16169365|NCT01756456|39098823|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
16169366|NCT01756456|39098818|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
16169367|NCT01756456|39098819|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
16169368|NCT01756456|39098820|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
16169369|NCT01756456|39098821|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
16169370|NCT01756456|39098822|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
16169371|NCT01756456|39098823|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
16169372|NCT01756456|39098818|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
16169373|NCT01756456|39098819|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
16169374|NCT01756456|39098820|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
16463675|NCT04585009|40175656|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16463676|NCT04585009|40175657|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
16463677|NCT04585009|40175646|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16463678|NCT04585009|40175647|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16463679|NCT04585009|40175648|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16463680|NCT04585009|40175649|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16463681|NCT04585009|40175650|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16169375|NCT01756456|39098821|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
16169376|NCT01756456|39098822|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
16169377|NCT01756456|39098823|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
16463682|NCT04585009|40175651|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16463683|NCT04585009|40175652|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16463684|NCT04585009|40175653|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
16463685|NCT04585009|40175654|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16463686|NCT04585009|40175655|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16463687|NCT04585009|40175656|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16463688|NCT04585009|40175657|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
16463689|NCT04585009|40175646|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463690|NCT04585009|40175647|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463691|NCT04585009|40175648|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463692|NCT04585009|40175649|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463693|NCT04585009|40175650|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
16463694|NCT04585009|40175651|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463695|NCT04585009|40175652|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463696|NCT04585009|40175653|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463697|NCT04585009|40175654|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463698|NCT04585009|40175655|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463699|NCT04585009|40175656|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463700|NCT04585009|40175657|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
16463701|NCT04585009|40175646|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463702|NCT04585009|40175647|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463703|NCT04585009|40175648|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463704|NCT04585009|40175649|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463705|NCT04585009|40175650|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463706|NCT04585009|40175651|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463707|NCT04585009|40175652|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463708|NCT04585009|40175653|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463709|NCT04585009|40175654|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463710|NCT04585009|40175655|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
16463711|NCT04585009|40175656|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463712|NCT04585009|40175657|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
16463713|NCT04585009|40175646|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463714|NCT04585009|40175647|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463715|NCT04585009|40175648|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463716|NCT04585009|40175649|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463717|NCT04585009|40175650|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463718|NCT04585009|40175651|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463719|NCT04585009|40175652|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463720|NCT04585009|40175653|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463721|NCT04585009|40175654|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463722|NCT04585009|40175655|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463723|NCT04585009|40175656|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
16463724|NCT04585009|40175657|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
16463725|NCT02386189|40175659|FG000|Overall Study|Lost to Follow-up|2|||
16463726|NCT02386189|40175660|FG001|Overall Study|Lost to Follow-up|3|||
16463727|NCT02386189|40175659|FG000|Overall Study|Withdrawal by Subject|1|||
16463728|NCT02386189|40175660|FG001|Overall Study|Withdrawal by Subject|0|||
16463729|NCT02386189|40175659|FG000|Overall Study|Death|1|||
16463730|NCT02386189|40175660|FG001|Overall Study|Death|0|||
16463731|NCT03859973|40175661|FG000|Overall Study|Other reason than listed|3|||
16463732|NCT03859973|40175662|FG001|Overall Study|Other reason than listed|2|||
16463733|NCT03859973|40175661|FG000|Overall Study|COVID-19 related, not due to AE|3|||
16169378|NCT01756456|39098818|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
16169379|NCT01756456|39098819|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
16169380|NCT01756456|39098820|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
16169381|NCT01756456|39098821|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
16169382|NCT01756456|39098822|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
16169383|NCT01756456|39098823|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
16169384|NCT01756456|39098818|FG000|Follow Up Period Phase I/II|Other causes|0|||
16169385|NCT01756456|39098819|FG001|Follow Up Period Phase I/II|Other causes|0|||
16169386|NCT01756456|39098820|FG002|Follow Up Period Phase I/II|Other causes|0|||
16169387|NCT01756456|39098821|FG003|Follow Up Period Phase I/II|Other causes|1|||
16169388|NCT01756456|39098822|FG004|Follow Up Period Phase I/II|Other causes|3|||
16169389|NCT01756456|39098823|FG005|Follow Up Period Phase I/II|Other causes|5|||
16463734|NCT03859973|40175662|FG001|Overall Study|COVID-19 related, not due to AE|4|||
16463735|NCT03859973|40175661|FG000|Overall Study|Withdrawal by Subject|8|||
16463736|NCT03859973|40175662|FG001|Overall Study|Withdrawal by Subject|9|||
16169390|NCT01703000|39098824|FG000|Overall Study|Death|1|||
16169391|NCT00542191|39098830|FG000|Overall Study|Death|3|||
16169392|NCT03269344|39098831|FG000|Overall Study|Protocol Violation|4|||
16169393|NCT03269344|39098832|FG001|Overall Study|Protocol Violation|3|||
16169394|NCT01838044|39098833|FG000|Overall Study|Adverse Event|4|||
16169395|NCT01838044|39098834|FG001|Overall Study|Adverse Event|6|||
16169396|NCT01838044|39098833|FG000|Overall Study|Protocol Violation|3|||
16169397|NCT01838044|39098834|FG001|Overall Study|Protocol Violation|3|||
16169398|NCT01838044|39098833|FG000|Overall Study|Withdrawal by Subject|0|||
16169399|NCT01838044|39098834|FG001|Overall Study|Withdrawal by Subject|2|||
16169400|NCT01838044|39098833|FG000|Overall Study|Insufficient clinical response|1|||
16169401|NCT01838044|39098834|FG001|Overall Study|Insufficient clinical response|2|||
16169402|NCT01838044|39098833|FG000|Overall Study|Medication error without associated AE|0|||
16169403|NCT01838044|39098834|FG001|Overall Study|Medication error without associated AE|1|||
16169404|NCT01838044|39098833|FG000|Overall Study|Lost to Follow-up|0|||
16169405|NCT01838044|39098834|FG001|Overall Study|Lost to Follow-up|2|||
16169406|NCT00944034|39098835|FG000|Overall Study|Inappropriate enrollment|0|||
16169407|NCT00944034|39098836|FG001|Overall Study|Inappropriate enrollment|1|||
16169408|NCT00944034|39098837|FG002|Overall Study|Inappropriate enrollment|0|||
16169409|NCT00944034|39098838|FG003|Overall Study|Inappropriate enrollment|1|||
16169410|NCT00944034|39098839|FG004|Overall Study|Inappropriate enrollment|2|||
16169411|NCT00944034|39098840|FG005|Overall Study|Inappropriate enrollment|1|||
16169412|NCT00944034|39098841|FG006|Overall Study|Inappropriate enrollment|0|||
16169413|NCT00944034|39098842|FG007|Overall Study|Inappropriate enrollment|0|||
16463737|NCT03859973|40175661|FG000|Overall Study|Lost to Follow-up|2|||
16463738|NCT03859973|40175662|FG001|Overall Study|Lost to Follow-up|3|||
16463739|NCT03859973|40175661|FG000|Overall Study|Protocol Violation|1|||
16463740|NCT03859973|40175662|FG001|Overall Study|Protocol Violation|3|||
16463741|NCT03859973|40175661|FG000|Overall Study|Adverse Event|3|||
16463742|NCT03859973|40175662|FG001|Overall Study|Adverse Event|5|||
16463743|NCT00483756|40175665|FG000|Overall Study|Death|2|||
16463744|NCT00483756|40175666|FG001|Overall Study|Death|0|||
16463745|NCT00483756|40175667|FG002|Overall Study|Death|1|||
16463746|NCT00483756|40175665|FG000|Overall Study|Adverse Event|19|||
16463747|NCT00483756|40175666|FG001|Overall Study|Adverse Event|38|||
16463748|NCT00483756|40175667|FG002|Overall Study|Adverse Event|40|||
16463749|NCT00483756|40175665|FG000|Overall Study|Lack of Efficacy|1|||
16463750|NCT00483756|40175666|FG001|Overall Study|Lack of Efficacy|0|||
16463751|NCT00483756|40175667|FG002|Overall Study|Lack of Efficacy|0|||
16463752|NCT00483756|40175665|FG000|Overall Study|Lost to Follow-up|3|||
16463753|NCT00483756|40175666|FG001|Overall Study|Lost to Follow-up|1|||
16463754|NCT00483756|40175667|FG002|Overall Study|Lost to Follow-up|0|||
16463755|NCT00483756|40175665|FG000|Overall Study|Withdrawal by Subject|5|||
16463756|NCT00483756|40175666|FG001|Overall Study|Withdrawal by Subject|3|||
16463757|NCT00483756|40175667|FG002|Overall Study|Withdrawal by Subject|4|||
16463758|NCT00483756|40175665|FG000|Overall Study|Other|2|||
16463759|NCT00483756|40175666|FG001|Overall Study|Other|4|||
16463760|NCT00483756|40175667|FG002|Overall Study|Other|3|||
16463761|NCT00483756|40175665|FG000|Overall Study|Randomized, Not Treated|1|||
16463762|NCT00483756|40175666|FG001|Overall Study|Randomized, Not Treated|4|||
16463763|NCT00483756|40175667|FG002|Overall Study|Randomized, Not Treated|4|||
16463764|NCT02395302|40175668|FG000|Overall Study|Screen Failure|3|||
16463765|NCT02395302|40175668|FG000|Overall Study|Run In Failure|7|||
16463766|NCT02395302|40175668|FG000|Overall Study|Withdrawal by Subject|2|||
16463767|NCT02395302|40175668|FG000|Overall Study|Physician Decision|2|||
16463768|NCT00653432|40175669|FG000|Overall Study|Adverse Event|4|||
16463769|NCT00653432|40175670|FG001|Overall Study|Adverse Event|1|||
16463770|NCT00653432|40175669|FG000|Overall Study|Withdrawal by Subject|4|||
16463771|NCT00653432|40175670|FG001|Overall Study|Withdrawal by Subject|5|||
16463772|NCT00653432|40175669|FG000|Overall Study|Lost to Follow-up|7|||
16463773|NCT00653432|40175670|FG001|Overall Study|Lost to Follow-up|6|||
16463774|NCT00653432|40175669|FG000|Overall Study|Use/Need of Con Therapy|2|||
16463775|NCT00653432|40175670|FG001|Overall Study|Use/Need of Con Therapy|1|||
16463776|NCT00653432|40175669|FG000|Overall Study|Other - Reason Not Provided|5|||
16463777|NCT00653432|40175670|FG001|Overall Study|Other - Reason Not Provided|3|||
16463778|NCT03188042|40178495|FG000|Overall Study|Withdrawal by Subject|1|||
16463779|NCT03188042|40178496|FG001|Overall Study|Withdrawal by Subject|1|||
16463780|NCT01401959|40178502|FG000|Enrolled|Withdrawal by Subject|1|||
16463781|NCT01401959|40178503|FG001|Enrolled|Withdrawal by Subject|0|||
16463782|NCT01401959|40178504|FG002|Enrolled|Withdrawal by Subject|0|||
16463783|NCT01401959|40178502|FG000|Treated|Disease Progression|2|||
16463784|NCT01401959|40178503|FG001|Treated|Disease Progression|2|||
16463785|NCT01401959|40178504|FG002|Treated|Disease Progression|1|||
16463786|NCT01401959|40178502|FG000|Treated|Adverse Event|4|||
16463787|NCT01401959|40178503|FG001|Treated|Adverse Event|3|||
16169414|NCT00944034|39098843|FG008|Overall Study|Inappropriate enrollment|1|||
16169415|NCT00944034|39098844|FG009|Overall Study|Inappropriate enrollment|1|||
16169416|NCT00944034|39098845|FG010|Overall Study|Inappropriate enrollment|0|||
16169417|NCT00944034|39098846|FG011|Overall Study|Inappropriate enrollment|0|||
16169418|NCT00944034|39098835|FG000|Overall Study|Withdrawal by Subject|3|||
16463788|NCT01401959|40178504|FG002|Treated|Adverse Event|2|||
16463789|NCT01401959|40178502|FG000|Treated|Withdrawal by Subject|1|||
16463790|NCT01401959|40178503|FG001|Treated|Withdrawal by Subject|2|||
16463791|NCT01401959|40178504|FG002|Treated|Withdrawal by Subject|2|||
16463792|NCT01401959|40178502|FG000|Treated|Protocol Violation|0|||
16463793|NCT01401959|40178503|FG001|Treated|Protocol Violation|1|||
16463794|NCT01401959|40178504|FG002|Treated|Protocol Violation|0|||
16463795|NCT00535288|40178506|FG000|Overall Study|Adverse Event|20|||
16463796|NCT00535288|40178507|FG001|Overall Study|Adverse Event|19|||
16463797|NCT00535288|40178508|FG002|Overall Study|Adverse Event|25|||
16463798|NCT00535288|40178509|FG003|Overall Study|Adverse Event|20|||
16463799|NCT00535288|40178510|FG004|Overall Study|Adverse Event|30|||
16463800|NCT00535288|40178506|FG000|Overall Study|Lost to Follow-up|0|||
16463801|NCT00535288|40178507|FG001|Overall Study|Lost to Follow-up|3|||
16463802|NCT00535288|40178508|FG002|Overall Study|Lost to Follow-up|0|||
16463803|NCT00535288|40178509|FG003|Overall Study|Lost to Follow-up|0|||
16463804|NCT00535288|40178510|FG004|Overall Study|Lost to Follow-up|0|||
16463805|NCT00535288|40178506|FG000|Overall Study|Lack of Efficacy|26|||
16463806|NCT00535288|40178507|FG001|Overall Study|Lack of Efficacy|3|||
16463807|NCT00535288|40178508|FG002|Overall Study|Lack of Efficacy|4|||
16463808|NCT00535288|40178509|FG003|Overall Study|Lack of Efficacy|4|||
16463809|NCT00535288|40178510|FG004|Overall Study|Lack of Efficacy|7|||
16463810|NCT00535288|40178506|FG000|Overall Study|Unwilling to cooperate|6|||
16463811|NCT00535288|40178507|FG001|Overall Study|Unwilling to cooperate|6|||
16463812|NCT00535288|40178508|FG002|Overall Study|Unwilling to cooperate|3|||
16463813|NCT00535288|40178509|FG003|Overall Study|Unwilling to cooperate|3|||
16463814|NCT00535288|40178510|FG004|Overall Study|Unwilling to cooperate|4|||
16463815|NCT00535288|40178506|FG000|Overall Study|Other|2|||
16463816|NCT00535288|40178507|FG001|Overall Study|Other|1|||
16463817|NCT00535288|40178508|FG002|Overall Study|Other|1|||
16463818|NCT00535288|40178509|FG003|Overall Study|Other|2|||
16463819|NCT00535288|40178510|FG004|Overall Study|Other|1|||
16463820|NCT04987944|40178511|FG000|Overall Study|Adverse Event|0|||
16463821|NCT04987944|40178512|FG001|Overall Study|Adverse Event|1|||
16463822|NCT04987944|40178511|FG000|Overall Study|Withdrawal by Subject|0|||
16463823|NCT04987944|40178512|FG001|Overall Study|Withdrawal by Subject|1|||
16463824|NCT01122264|40178517|FG000|Overall Study|Adverse Event|6|||
16463825|NCT01122264|40178518|FG001|Overall Study|Adverse Event|5|||
16463826|NCT01122264|40178519|FG002|Overall Study|Adverse Event|7|||
16463827|NCT01122264|40178517|FG000|Overall Study|Death|1|||
16463828|NCT01122264|40178518|FG001|Overall Study|Death|0|||
16463829|NCT01122264|40178519|FG002|Overall Study|Death|0|||
16463830|NCT01122264|40178517|FG000|Overall Study|Lost to Follow-up|5|||
16463831|NCT01122264|40178518|FG001|Overall Study|Lost to Follow-up|9|||
16463832|NCT01122264|40178519|FG002|Overall Study|Lost to Follow-up|13|||
16463833|NCT01122264|40178517|FG000|Overall Study|Entry Criteria Not Met|1|||
16463834|NCT01122264|40178518|FG001|Overall Study|Entry Criteria Not Met|0|||
16463835|NCT01122264|40178519|FG002|Overall Study|Entry Criteria Not Met|0|||
16463836|NCT01122264|40178517|FG000|Overall Study|Protocol Violation|7|||
16463837|NCT01122264|40178518|FG001|Overall Study|Protocol Violation|7|||
16463838|NCT01122264|40178519|FG002|Overall Study|Protocol Violation|9|||
16463839|NCT01122264|40178517|FG000|Overall Study|Withdrawal by Subject|6|||
16463840|NCT01122264|40178518|FG001|Overall Study|Withdrawal by Subject|6|||
16463841|NCT01122264|40178519|FG002|Overall Study|Withdrawal by Subject|16|||
16463842|NCT01122264|40178517|FG000|Overall Study|Physician Decision|3|||
16463843|NCT01122264|40178518|FG001|Overall Study|Physician Decision|1|||
16463844|NCT01122264|40178519|FG002|Overall Study|Physician Decision|1|||
16463845|NCT01122264|40178517|FG000|Overall Study|Lack of Efficacy|3|||
16463846|NCT01122264|40178518|FG001|Overall Study|Lack of Efficacy|1|||
16463847|NCT01122264|40178519|FG002|Overall Study|Lack of Efficacy|1|||
16463848|NCT04839562|40178520|FG000|Overall Study|Withdrawal by Subject|0|||
16169419|NCT00944034|39098836|FG001|Overall Study|Withdrawal by Subject|2|||
16169420|NCT00944034|39098837|FG002|Overall Study|Withdrawal by Subject|6|||
16169421|NCT00944034|39098838|FG003|Overall Study|Withdrawal by Subject|2|||
16463849|NCT04839562|40178521|FG001|Overall Study|Withdrawal by Subject|1|||
16463850|NCT04839562|40178520|FG000|Overall Study|Physician Decision|0|||
16463851|NCT04839562|40178521|FG001|Overall Study|Physician Decision|1|||
16463852|NCT00927940|40178522|FG000|Overall Study|Death|1|||
16463853|NCT02683746|40178523|FG000|Overall Study|Adverse Event|3|||
16463854|NCT02683746|40178524|FG001|Overall Study|Adverse Event|2|||
16463855|NCT02683746|40178523|FG000|Overall Study|Lost to Follow-up|5|||
16463856|NCT02683746|40178524|FG001|Overall Study|Lost to Follow-up|6|||
16463857|NCT02683746|40178523|FG000|Overall Study|Withdrawal by Subject|6|||
16463858|NCT02683746|40178524|FG001|Overall Study|Withdrawal by Subject|5|||
16463859|NCT02683746|40178523|FG000|Overall Study|Physician Decision|2|||
16463860|NCT02683746|40178524|FG001|Overall Study|Physician Decision|1|||
16463861|NCT04140227|40178525|FG000|Overall Study|Withdrawal by Subject|26|||
16463862|NCT04140227|40178525|FG000|Overall Study|Lost to Follow-up|8|||
16463863|NCT04140227|40178525|FG000|Overall Study|Adverse Event|8|||
16463864|NCT04140227|40178525|FG000|Overall Study|Death|1|||
16463865|NCT04140227|40178525|FG000|Overall Study|Other|3|||
16463866|NCT04140227|40178525|FG000|Overall Study|Protocol Violation|2|||
16463867|NCT00369629|40178526|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
16463868|NCT00369629|40178527|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
16463869|NCT00369629|40178528|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
16463870|NCT00369629|40178529|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
16463871|NCT00369629|40178526|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
16463872|NCT00369629|40178527|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
16463873|NCT00369629|40178528|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
16463874|NCT00369629|40178529|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
16463875|NCT00369629|40178526|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
16463876|NCT00369629|40178527|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
16463877|NCT00369629|40178528|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
16463878|NCT00369629|40178529|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
16463879|NCT00369629|40178526|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
16463880|NCT00369629|40178527|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
16463881|NCT00369629|40178528|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
16463882|NCT00369629|40178529|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
16463883|NCT00369629|40178526|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
16463884|NCT00369629|40178527|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
16463885|NCT00369629|40178528|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
16463886|NCT00369629|40178529|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
16463887|NCT00369629|40178526|FG000|Completed 4 More Cycles|Progressive disease|2|||
16463888|NCT00369629|40178527|FG001|Completed 4 More Cycles|Progressive disease|1|||
16463889|NCT00369629|40178528|FG002|Completed 4 More Cycles|Progressive disease|2|||
16463890|NCT00369629|40178529|FG003|Completed 4 More Cycles|Progressive disease|0|||
16463891|NCT00369629|40178526|FG000|Follow up for 1 Year|Death|2|||
16463892|NCT00369629|40178527|FG001|Follow up for 1 Year|Death|1|||
16463893|NCT00369629|40178528|FG002|Follow up for 1 Year|Death|1|||
16463894|NCT00369629|40178529|FG003|Follow up for 1 Year|Death|0|||
16463895|NCT00369629|40178526|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
16463896|NCT00369629|40178527|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
16463897|NCT00369629|40178528|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
16463898|NCT00369629|40178529|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
16463899|NCT00369629|40178526|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
16463900|NCT00369629|40178527|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
16463901|NCT00369629|40178528|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
16463902|NCT00369629|40178529|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
16463903|NCT02151773|40178530|FG000|Overall Study|Protocol Deviation|64|||
16463904|NCT02361580|40178533|FG000|Overall Study|Lost to Follow-up|6|||
16463905|NCT02361580|40178534|FG001|Overall Study|Lost to Follow-up|3|||
16463906|NCT00450385|40178535|FG000|Overall Study|Death|3|||
16463907|NCT00450385|40178535|FG000|Overall Study|Protocol Violation|1|||
16463908|NCT00450385|40178535|FG000|Overall Study|Withdrawal by Subject|2|||
16463909|NCT00450385|40178535|FG000|Overall Study|Lack of Efficacy|2|||
16463910|NCT00450385|40178535|FG000|Overall Study|Adverse Event|1|||
16463911|NCT00450385|40178535|FG000|Overall Study|Physician Decision|1|||
16463912|NCT00450385|40178535|FG000|Overall Study|Other|3|||
16169422|NCT00944034|39098839|FG004|Overall Study|Withdrawal by Subject|5|||
16169423|NCT00944034|39098840|FG005|Overall Study|Withdrawal by Subject|8|||
16169424|NCT00944034|39098841|FG006|Overall Study|Withdrawal by Subject|2|||
16169425|NCT00944034|39098842|FG007|Overall Study|Withdrawal by Subject|2|||
16169426|NCT00944034|39098843|FG008|Overall Study|Withdrawal by Subject|3|||
16169427|NCT00944034|39098844|FG009|Overall Study|Withdrawal by Subject|4|||
16169428|NCT00944034|39098845|FG010|Overall Study|Withdrawal by Subject|0|||
16169429|NCT00944034|39098846|FG011|Overall Study|Withdrawal by Subject|4|||
16169430|NCT00944034|39098835|FG000|Overall Study|Lost to Follow-up|0|||
16169431|NCT00944034|39098836|FG001|Overall Study|Lost to Follow-up|4|||
16169432|NCT00944034|39098837|FG002|Overall Study|Lost to Follow-up|2|||
16169433|NCT00944034|39098838|FG003|Overall Study|Lost to Follow-up|0|||
16169434|NCT00944034|39098839|FG004|Overall Study|Lost to Follow-up|5|||
16463913|NCT01715129|40178536|FG000|Overall Study|Adverse Event, fatal|1|||
16463914|NCT01715129|40178536|FG000|Overall Study|Lack of Efficacy|3|||
16169435|NCT00944034|39098840|FG005|Overall Study|Lost to Follow-up|7|||
16463915|NCT01715129|40178536|FG000|Overall Study|Protocol Violation|1|||
16463916|NCT01715129|40178536|FG000|Overall Study|Consent Withdrawn|2|||
16463917|NCT01715129|40178536|FG000|Overall Study|Lost to Follow-up|1|||
16463918|NCT01715129|40178536|FG000|Overall Study|Other|1|||
16463919|NCT00053898|40178537|FG000|Overall Study|No follow-up data from any source|9|||
16463920|NCT00053898|40178538|FG001|Overall Study|No follow-up data from any source|12|||
16169436|NCT00944034|39098841|FG006|Overall Study|Lost to Follow-up|0|||
16169437|NCT00944034|39098842|FG007|Overall Study|Lost to Follow-up|1|||
16169438|NCT00944034|39098843|FG008|Overall Study|Lost to Follow-up|5|||
16169439|NCT00944034|39098844|FG009|Overall Study|Lost to Follow-up|1|||
16463921|NCT00053898|40178537|FG000|Overall Study|Follow-up from telephone contact only|5|||
16463922|NCT00053898|40178538|FG001|Overall Study|Follow-up from telephone contact only|1|||
16463923|NCT02282345|40178539|FG000|Overall Study|Progression|0|||
16463924|NCT02282345|40178540|FG001|Overall Study|Progression|1|||
16463925|NCT00710762|40178541|FG000|Overall Study|Progressive disease|27|||
16463926|NCT00710762|40178542|FG001|Overall Study|Progressive disease|30|||
16463927|NCT00710762|40178541|FG000|Overall Study|Adverse Event other disease worsening|2|||
16463928|NCT00710762|40178542|FG001|Overall Study|Adverse Event other disease worsening|1|||
16463929|NCT00710762|40178541|FG000|Overall Study|Other Adverse Event|7|||
16463930|NCT00710762|40178542|FG001|Overall Study|Other Adverse Event|7|||
16463931|NCT00710762|40178541|FG000|Overall Study|Lost to Follow-up|1|||
16463932|NCT00710762|40178542|FG001|Overall Study|Lost to Follow-up|0|||
16463933|NCT00710762|40178541|FG000|Overall Study|Reason other than listed above|2|||
16463934|NCT00710762|40178542|FG001|Overall Study|Reason other than listed above|2|||
16463935|NCT01073462|40178543|FG000|Overall Study|Death|14|||
16463936|NCT01073462|40178543|FG000|Overall Study|Kidney transplant|10|||
16463937|NCT01073462|40178543|FG000|Overall Study|Low parathyroid hormone levels|8|||
16463938|NCT01073462|40178543|FG000|Overall Study|Serious adverse event|2|||
16463939|NCT01073462|40178543|FG000|Overall Study|Lost to Follow-up|7|||
16463940|NCT01289782|40178544|FG000|Overall Study|Lost to Follow-up|14|||
16463941|NCT01289782|40178545|FG001|Overall Study|Lost to Follow-up|7|||
16463942|NCT01289782|40178544|FG000|Overall Study|Protocol Violation|1|||
16463943|NCT01289782|40178545|FG001|Overall Study|Protocol Violation|1|||
16463944|NCT01289782|40178544|FG000|Overall Study|Withdrawal by Subject|8|||
16463945|NCT01289782|40178545|FG001|Overall Study|Withdrawal by Subject|2|||
16463946|NCT01289782|40178544|FG000|Overall Study|Sponsor's Decision|1|||
16463947|NCT01289782|40178545|FG001|Overall Study|Sponsor's Decision|0|||
16463948|NCT01289782|40178544|FG000|Overall Study|Reason not specified|1|||
16463949|NCT01289782|40178545|FG001|Overall Study|Reason not specified|2|||
16463950|NCT03709576|40178546|FG000|Overall Study|progression prior to enrollment|1|||
16463951|NCT03011892|40178549|FG000|Double Blind (DB) Period|Adverse Event|0|||
16463952|NCT03011892|40178550|FG001|Double Blind (DB) Period|Adverse Event|1|||
16463953|NCT03011892|40178551|FG002|Double Blind (DB) Period|Adverse Event|1|||
16463954|NCT03011892|40178552|FG003|Double Blind (DB) Period|Adverse Event|0|||
16463955|NCT03011892|40178553|FG004|Double Blind (DB) Period|Adverse Event|0|||
16463956|NCT03011892|40178554|FG005|Double Blind (DB) Period|Adverse Event|0|||
16463957|NCT03011892|40178555|FG006|Double Blind (DB) Period|Adverse Event|0|||
16463958|NCT03011892|40178556|FG007|Double Blind (DB) Period|Adverse Event|0|||
16463959|NCT03011892|40178557|FG008|Double Blind (DB) Period|Adverse Event|0|||
16463960|NCT03011892|40178558|FG009|Double Blind (DB) Period|Adverse Event|0|||
16463961|NCT03011892|40178559|FG010|Double Blind (DB) Period|Adverse Event|0|||
16463962|NCT03011892|40178560|FG011|Double Blind (DB) Period|Adverse Event|0|||
16463963|NCT03011892|40178549|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
16169440|NCT00944034|39098845|FG010|Overall Study|Lost to Follow-up|1|||
16169441|NCT00944034|39098846|FG011|Overall Study|Lost to Follow-up|0|||
16169442|NCT00944034|39098835|FG000|Overall Study|Death|0|||
16169443|NCT00944034|39098836|FG001|Overall Study|Death|0|||
16169444|NCT00944034|39098837|FG002|Overall Study|Death|1|||
16169445|NCT00944034|39098838|FG003|Overall Study|Death|0|||
16169446|NCT00944034|39098839|FG004|Overall Study|Death|0|||
16169447|NCT00944034|39098840|FG005|Overall Study|Death|0|||
16169448|NCT00944034|39098841|FG006|Overall Study|Death|0|||
16169449|NCT00944034|39098842|FG007|Overall Study|Death|0|||
16169450|NCT00944034|39098843|FG008|Overall Study|Death|0|||
16169451|NCT00944034|39098844|FG009|Overall Study|Death|0|||
16169452|NCT00944034|39098845|FG010|Overall Study|Death|0|||
16169453|NCT00944034|39098846|FG011|Overall Study|Death|0|||
16169454|NCT00944034|39098835|FG000|Overall Study|Protocol Violation|2|||
16169455|NCT00944034|39098836|FG001|Overall Study|Protocol Violation|0|||
16169456|NCT00944034|39098837|FG002|Overall Study|Protocol Violation|0|||
16169457|NCT00944034|39098838|FG003|Overall Study|Protocol Violation|1|||
16463964|NCT03011892|40178550|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
16463965|NCT03011892|40178551|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
16463966|NCT03011892|40178552|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
16463967|NCT03011892|40178553|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
16463968|NCT03011892|40178554|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
16463969|NCT03011892|40178555|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
16463970|NCT03011892|40178556|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
16463971|NCT03011892|40178557|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
16463972|NCT03011892|40178558|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
16463973|NCT03011892|40178559|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
16169458|NCT00944034|39098839|FG004|Overall Study|Protocol Violation|2|||
16169459|NCT00944034|39098840|FG005|Overall Study|Protocol Violation|3|||
16169460|NCT00944034|39098841|FG006|Overall Study|Protocol Violation|0|||
16169461|NCT00944034|39098842|FG007|Overall Study|Protocol Violation|1|||
16169462|NCT00944034|39098843|FG008|Overall Study|Protocol Violation|1|||
16169463|NCT00944034|39098844|FG009|Overall Study|Protocol Violation|4|||
16169464|NCT00944034|39098845|FG010|Overall Study|Protocol Violation|0|||
16169465|NCT00944034|39098846|FG011|Overall Study|Protocol Violation|0|||
16463974|NCT03011892|40178560|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
16463975|NCT03011892|40178549|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
16463976|NCT03011892|40178550|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
16463977|NCT03011892|40178551|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
16463978|NCT03011892|40178552|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
16463979|NCT03011892|40178553|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
16463980|NCT03011892|40178554|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
16463981|NCT03011892|40178555|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
16463982|NCT03011892|40178556|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
16463983|NCT03011892|40178557|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
16463984|NCT03011892|40178558|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
16463985|NCT03011892|40178559|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
16463986|NCT03011892|40178560|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
16463987|NCT03011892|40178549|FG000|Double Blind (DB) Period|Other|1|||
16463988|NCT03011892|40178550|FG001|Double Blind (DB) Period|Other|1|||
16463989|NCT03011892|40178551|FG002|Double Blind (DB) Period|Other|1|||
16463990|NCT03011892|40178552|FG003|Double Blind (DB) Period|Other|0|||
16463991|NCT03011892|40178553|FG004|Double Blind (DB) Period|Other|1|||
16463992|NCT03011892|40178554|FG005|Double Blind (DB) Period|Other|0|||
16463993|NCT03011892|40178555|FG006|Double Blind (DB) Period|Other|0|||
16463994|NCT03011892|40178556|FG007|Double Blind (DB) Period|Other|0|||
16463995|NCT03011892|40178557|FG008|Double Blind (DB) Period|Other|0|||
16463996|NCT03011892|40178558|FG009|Double Blind (DB) Period|Other|0|||
16463997|NCT03011892|40178559|FG010|Double Blind (DB) Period|Other|0|||
16463998|NCT03011892|40178560|FG011|Double Blind (DB) Period|Other|0|||
16463999|NCT03011892|40178549|FG000|Double Blind (DB) Period|Physician Decision|1|||
16464000|NCT03011892|40178550|FG001|Double Blind (DB) Period|Physician Decision|0|||
16464001|NCT03011892|40178551|FG002|Double Blind (DB) Period|Physician Decision|1|||
16464002|NCT03011892|40178552|FG003|Double Blind (DB) Period|Physician Decision|0|||
16464003|NCT03011892|40178553|FG004|Double Blind (DB) Period|Physician Decision|0|||
16464004|NCT03011892|40178554|FG005|Double Blind (DB) Period|Physician Decision|0|||
16464005|NCT03011892|40178555|FG006|Double Blind (DB) Period|Physician Decision|0|||
16464006|NCT03011892|40178556|FG007|Double Blind (DB) Period|Physician Decision|0|||
16464007|NCT03011892|40178557|FG008|Double Blind (DB) Period|Physician Decision|0|||
16464008|NCT03011892|40178558|FG009|Double Blind (DB) Period|Physician Decision|0|||
16464009|NCT03011892|40178559|FG010|Double Blind (DB) Period|Physician Decision|0|||
16464010|NCT03011892|40178560|FG011|Double Blind (DB) Period|Physician Decision|0|||
16464011|NCT03011892|40178549|FG000|Double Blind (DB) Period|Pregnancy|0|||
16464012|NCT03011892|40178550|FG001|Double Blind (DB) Period|Pregnancy|0|||
16464013|NCT03011892|40178551|FG002|Double Blind (DB) Period|Pregnancy|0|||
16464014|NCT03011892|40178552|FG003|Double Blind (DB) Period|Pregnancy|0|||
16464015|NCT03011892|40178553|FG004|Double Blind (DB) Period|Pregnancy|1|||
16464016|NCT03011892|40178554|FG005|Double Blind (DB) Period|Pregnancy|0|||
16464017|NCT03011892|40178555|FG006|Double Blind (DB) Period|Pregnancy|0|||
16464018|NCT03011892|40178556|FG007|Double Blind (DB) Period|Pregnancy|0|||
16464019|NCT03011892|40178557|FG008|Double Blind (DB) Period|Pregnancy|0|||
16464020|NCT03011892|40178558|FG009|Double Blind (DB) Period|Pregnancy|0|||
16464021|NCT03011892|40178559|FG010|Double Blind (DB) Period|Pregnancy|0|||
16464022|NCT03011892|40178560|FG011|Double Blind (DB) Period|Pregnancy|0|||
16464023|NCT03011892|40178549|FG000|Double Blind (DB) Period|Protocol Violation|1|||
16464024|NCT03011892|40178550|FG001|Double Blind (DB) Period|Protocol Violation|0|||
16464025|NCT03011892|40178551|FG002|Double Blind (DB) Period|Protocol Violation|0|||
16464026|NCT03011892|40178552|FG003|Double Blind (DB) Period|Protocol Violation|0|||
16169466|NCT00944034|39098835|FG000|Overall Study|Unable to classify|0|||
16169467|NCT00944034|39098836|FG001|Overall Study|Unable to classify|0|||
16169468|NCT00944034|39098837|FG002|Overall Study|Unable to classify|0|||
16169469|NCT00944034|39098838|FG003|Overall Study|Unable to classify|0|||
16169470|NCT00944034|39098839|FG004|Overall Study|Unable to classify|0|||
16169471|NCT00944034|39098840|FG005|Overall Study|Unable to classify|1|||
16169472|NCT00944034|39098841|FG006|Overall Study|Unable to classify|1|||
16169473|NCT00944034|39098842|FG007|Overall Study|Unable to classify|1|||
16169474|NCT00944034|39098843|FG008|Overall Study|Unable to classify|0|||
16169475|NCT00944034|39098844|FG009|Overall Study|Unable to classify|0|||
16464027|NCT03011892|40178553|FG004|Double Blind (DB) Period|Protocol Violation|0|||
16464028|NCT03011892|40178554|FG005|Double Blind (DB) Period|Protocol Violation|0|||
16464029|NCT03011892|40178555|FG006|Double Blind (DB) Period|Protocol Violation|0|||
16464030|NCT03011892|40178556|FG007|Double Blind (DB) Period|Protocol Violation|0|||
16464031|NCT03011892|40178557|FG008|Double Blind (DB) Period|Protocol Violation|0|||
16464032|NCT03011892|40178558|FG009|Double Blind (DB) Period|Protocol Violation|0|||
16464033|NCT03011892|40178559|FG010|Double Blind (DB) Period|Protocol Violation|0|||
16169476|NCT00944034|39098845|FG010|Overall Study|Unable to classify|0|||
16169477|NCT00944034|39098846|FG011|Overall Study|Unable to classify|0|||
16169478|NCT00944034|39098835|FG000|Overall Study|Administrative reason|0|||
16169479|NCT00944034|39098836|FG001|Overall Study|Administrative reason|0|||
16169480|NCT00944034|39098837|FG002|Overall Study|Administrative reason|0|||
16169481|NCT00944034|39098838|FG003|Overall Study|Administrative reason|0|||
16169482|NCT00944034|39098839|FG004|Overall Study|Administrative reason|0|||
16169483|NCT00944034|39098840|FG005|Overall Study|Administrative reason|0|||
16169484|NCT00944034|39098841|FG006|Overall Study|Administrative reason|1|||
16169485|NCT00944034|39098842|FG007|Overall Study|Administrative reason|0|||
16169486|NCT00944034|39098843|FG008|Overall Study|Administrative reason|0|||
16169487|NCT00944034|39098844|FG009|Overall Study|Administrative reason|0|||
16169488|NCT00944034|39098845|FG010|Overall Study|Administrative reason|0|||
16169489|NCT00944034|39098846|FG011|Overall Study|Administrative reason|0|||
16169490|NCT02959814|39098851|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
16169491|NCT02959814|39098851|FG000|Overall Study|Excluded based on anatomical criteria|2|||
16169492|NCT02959814|39098851|FG000|Overall Study|Protocol Violation|7|||
16169493|NCT02959814|39098851|FG000|Overall Study|FFR not measured|2|||
16169494|NCT02959814|39098851|FG000|Overall Study|In-procedure QFR not computed|6|||
16169495|NCT02959814|39098851|FG000|Overall Study|Excluded by FFR core-lab|24|||
16169496|NCT03029832|39098856|FG000|Overall Study|Safety Follow-Up Completed|2|||
16169497|NCT03029832|39098857|FG001|Overall Study|Safety Follow-Up Completed|0|||
16169498|NCT03029832|39098856|FG000|Overall Study|Death due to Disease Progression|1|||
16169499|NCT03029832|39098857|FG001|Overall Study|Death due to Disease Progression|0|||
16169500|NCT03029832|39098856|FG000|Overall Study|Study Terminated By Sponsor|1|||
16169501|NCT03029832|39098857|FG001|Overall Study|Study Terminated By Sponsor|1|||
16169502|NCT00434967|39098858|FG000|Overall Study|Adverse Event|2|||
16169503|NCT00434967|39098859|FG001|Overall Study|Adverse Event|4|||
16169504|NCT00434967|39098860|FG002|Overall Study|Adverse Event|3|||
16169505|NCT00434967|39098861|FG003|Overall Study|Adverse Event|3|||
16169506|NCT00434967|39098858|FG000|Overall Study|Lost to Follow-up|0|||
16169507|NCT00434967|39098859|FG001|Overall Study|Lost to Follow-up|0|||
16169508|NCT00434967|39098860|FG002|Overall Study|Lost to Follow-up|1|||
16169509|NCT00434967|39098861|FG003|Overall Study|Lost to Follow-up|0|||
16169510|NCT00434967|39098858|FG000|Overall Study|Withdrawal by Subject|2|||
16169511|NCT00434967|39098859|FG001|Overall Study|Withdrawal by Subject|2|||
16169512|NCT00434967|39098860|FG002|Overall Study|Withdrawal by Subject|4|||
16169513|NCT00434967|39098861|FG003|Overall Study|Withdrawal by Subject|6|||
16169514|NCT00434967|39098858|FG000|Overall Study|Randomized in error|0|||
16169515|NCT00434967|39098859|FG001|Overall Study|Randomized in error|0|||
16169516|NCT00434967|39098860|FG002|Overall Study|Randomized in error|0|||
16169517|NCT00434967|39098861|FG003|Overall Study|Randomized in error|1|||
16169518|NCT00434967|39098858|FG000|Overall Study|Protocol Violation|0|||
16169519|NCT00434967|39098859|FG001|Overall Study|Protocol Violation|1|||
16169520|NCT00434967|39098860|FG002|Overall Study|Protocol Violation|0|||
16169521|NCT00434967|39098861|FG003|Overall Study|Protocol Violation|1|||
16169522|NCT00434967|39098858|FG000|Overall Study|Physician Decision|1|||
16169523|NCT00434967|39098859|FG001|Overall Study|Physician Decision|1|||
16169524|NCT00434967|39098860|FG002|Overall Study|Physician Decision|1|||
16169525|NCT00434967|39098861|FG003|Overall Study|Physician Decision|0|||
16169526|NCT00434967|39098858|FG000|Overall Study|Patient Disposition Challenges|2|||
16169527|NCT00434967|39098859|FG001|Overall Study|Patient Disposition Challenges|0|||
16169528|NCT00434967|39098860|FG002|Overall Study|Patient Disposition Challenges|0|||
16169529|NCT00434967|39098861|FG003|Overall Study|Patient Disposition Challenges|3|||
16169530|NCT01552057|39098862|FG000|Overall Study|Adverse Event|14|||
16169531|NCT01552057|39098863|FG001|Overall Study|Adverse Event|15|||
16169532|NCT01552057|39098862|FG000|Overall Study|Lack of Efficacy|8|||
16169533|NCT01552057|39098863|FG001|Overall Study|Lack of Efficacy|23|||
16169534|NCT01552057|39098862|FG000|Overall Study|Withdrawal by Subject|5|||
16169535|NCT01552057|39098863|FG001|Overall Study|Withdrawal by Subject|8|||
16169536|NCT01552057|39098862|FG000|Overall Study|Entry Criteria Not Met|2|||
16169537|NCT01552057|39098863|FG001|Overall Study|Entry Criteria Not Met|2|||
16169538|NCT01552057|39098862|FG000|Overall Study|Physician Decision|1|||
16169539|NCT01552057|39098863|FG001|Overall Study|Physician Decision|0|||
16169540|NCT01299727|39098864|FG000|Overall Study|Withdrawal by Subject|1|||
16169541|NCT01299727|39098865|FG001|Overall Study|Withdrawal by Subject|0|||
16169542|NCT01299727|39098866|FG002|Overall Study|Withdrawal by Subject|0|||
16169543|NCT01299727|39098864|FG000|Overall Study|Adverse Event|0|||
16169544|NCT01299727|39098865|FG001|Overall Study|Adverse Event|0|||
16169545|NCT01299727|39098866|FG002|Overall Study|Adverse Event|1|||
16169546|NCT01299727|39098864|FG000|Overall Study|Completed the Treatment Period|3|||
16169547|NCT01299727|39098865|FG001|Overall Study|Completed the Treatment Period|4|||
16169548|NCT01299727|39098866|FG002|Overall Study|Completed the Treatment Period|3|||
16169549|NCT03838484|39098867|FG000|Overall Study|Lost to Follow-up|0|||
16169550|NCT03838484|39098868|FG001|Overall Study|Lost to Follow-up|1|||
16169551|NCT03838484|39098869|FG002|Overall Study|Lost to Follow-up|0|||
16169552|NCT03838484|39098870|FG003|Overall Study|Lost to Follow-up|0|||
16169553|NCT03192904|39098872|FG000|Overall Study|Physician Decision|3|||
16169554|NCT03192904|39098873|FG001|Overall Study|Physician Decision|1|||
16169555|NCT03192904|39098872|FG000|Overall Study|Lost to Follow-up|0|||
16464034|NCT03011892|40178560|FG011|Double Blind (DB) Period|Protocol Violation|0|||
16464035|NCT03011892|40178549|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
16464036|NCT03011892|40178550|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
16464037|NCT03011892|40178551|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
16464038|NCT03011892|40178552|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
16464039|NCT03011892|40178553|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
16464040|NCT03011892|40178554|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
16464041|NCT03011892|40178555|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
16464042|NCT03011892|40178556|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
16464043|NCT03011892|40178557|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
16464044|NCT03011892|40178558|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
16464045|NCT03011892|40178559|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
16464046|NCT03011892|40178560|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
16464047|NCT03011892|40178549|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
16464048|NCT03011892|40178550|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
16464049|NCT03011892|40178551|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
16464050|NCT03011892|40178552|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
16464051|NCT03011892|40178553|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
16464052|NCT03011892|40178554|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
16464053|NCT03011892|40178555|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
16464054|NCT03011892|40178556|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
16464055|NCT03011892|40178557|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
16464056|NCT03011892|40178558|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
16464057|NCT03011892|40178559|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
16464058|NCT03011892|40178560|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
16464059|NCT03011892|40178549|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
16464060|NCT03011892|40178550|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
16464061|NCT03011892|40178551|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
16464062|NCT03011892|40178552|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
16464063|NCT03011892|40178553|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
16464064|NCT03011892|40178554|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
16464065|NCT03011892|40178555|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
16464066|NCT03011892|40178556|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
16464067|NCT03011892|40178557|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
16464068|NCT03011892|40178558|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
16464069|NCT03011892|40178559|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
16464070|NCT03011892|40178560|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
16464071|NCT03011892|40178549|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
16464072|NCT03011892|40178550|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
16464073|NCT03011892|40178551|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
16464074|NCT03011892|40178552|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
16464075|NCT03011892|40178553|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
16464076|NCT03011892|40178554|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
16464077|NCT03011892|40178555|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
16464078|NCT03011892|40178556|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
16464079|NCT03011892|40178557|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
16464080|NCT03011892|40178558|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
16464081|NCT03011892|40178559|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
16464082|NCT03011892|40178560|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
16464083|NCT03011892|40178549|FG000|Open Label (OL) Period|Reason not specified|0|||
16464084|NCT03011892|40178550|FG001|Open Label (OL) Period|Reason not specified|0|||
16464085|NCT03011892|40178551|FG002|Open Label (OL) Period|Reason not specified|0|||
16464086|NCT03011892|40178552|FG003|Open Label (OL) Period|Reason not specified|0|||
16464087|NCT03011892|40178553|FG004|Open Label (OL) Period|Reason not specified|0|||
16464088|NCT03011892|40178554|FG005|Open Label (OL) Period|Reason not specified|0|||
16464089|NCT03011892|40178555|FG006|Open Label (OL) Period|Reason not specified|0|||
16464090|NCT03011892|40178556|FG007|Open Label (OL) Period|Reason not specified|1|||
16464091|NCT03011892|40178557|FG008|Open Label (OL) Period|Reason not specified|0|||
16464092|NCT03011892|40178558|FG009|Open Label (OL) Period|Reason not specified|0|||
16464093|NCT03011892|40178559|FG010|Open Label (OL) Period|Reason not specified|0|||
16464094|NCT03011892|40178560|FG011|Open Label (OL) Period|Reason not specified|0|||
16464095|NCT01569464|40178561|FG000|Overall Study|Adverse Event|4|||
16464096|NCT01569464|40178562|FG001|Overall Study|Adverse Event|0|||
16464097|NCT01569464|40178561|FG000|Overall Study|Lack of Efficacy|1|||
16464098|NCT01569464|40178562|FG001|Overall Study|Lack of Efficacy|0|||
16464099|NCT01569464|40178561|FG000|Overall Study|Protocol Violation|1|||
16464100|NCT01569464|40178562|FG001|Overall Study|Protocol Violation|0|||
16464101|NCT01569464|40178561|FG000|Overall Study|Lost to Follow-up|2|||
16464102|NCT01569464|40178562|FG001|Overall Study|Lost to Follow-up|3|||
16464103|NCT01569464|40178561|FG000|Overall Study|Withdrawal by Subject|1|||
16464104|NCT01569464|40178562|FG001|Overall Study|Withdrawal by Subject|1|||
16169556|NCT03192904|39098873|FG001|Overall Study|Lost to Follow-up|1|||
16169557|NCT03770403|39098875|FG000|Overall Study|Adverse Event|8|||
16169558|NCT03770403|39098875|FG000|Overall Study|Death|5|||
16169559|NCT03770403|39098875|FG000|Overall Study|Physician Decision|1|||
16169560|NCT03770403|39098875|FG000|Overall Study|Sponsor decision|1|||
16169561|NCT03770403|39098875|FG000|Overall Study|Study terminated by Sponsor|1|||
16169562|NCT03770403|39098875|FG000|Overall Study|Withdrawal by Subject|13|||
16169563|NCT03770403|39098875|FG000|Overall Study|Other|88|||
16169564|NCT00200850|39098876|FG000|Overall Study|relocation|1|||
16169565|NCT00200850|39098877|FG001|Overall Study|relocation|0|||
16169566|NCT00200850|39098878|FG002|Overall Study|relocation|1|||
16169567|NCT00200850|39098876|FG000|Overall Study|too busy|1|||
16169568|NCT00200850|39098877|FG001|Overall Study|too busy|0|||
16169569|NCT00200850|39098878|FG002|Overall Study|too busy|0|||
16169570|NCT00200850|39098876|FG000|Overall Study|Pregnancy|0|||
16169571|NCT00200850|39098877|FG001|Overall Study|Pregnancy|0|||
16169572|NCT00200850|39098878|FG002|Overall Study|Pregnancy|1|||
16169573|NCT00200850|39098876|FG000|Overall Study|Poor adherence|0|||
16169574|NCT00200850|39098877|FG001|Overall Study|Poor adherence|0|||
16169575|NCT00200850|39098878|FG002|Overall Study|Poor adherence|1|||
16169576|NCT00200850|39098876|FG000|Overall Study|optic neuritis|0|||
16169577|NCT00200850|39098877|FG001|Overall Study|optic neuritis|0|||
16169578|NCT00200850|39098878|FG002|Overall Study|optic neuritis|1|||
16169579|NCT00200850|39098876|FG000|Overall Study|Adverse Event|1|||
16169580|NCT00200850|39098877|FG001|Overall Study|Adverse Event|1|||
16169581|NCT00200850|39098878|FG002|Overall Study|Adverse Event|2|||
16169582|NCT00805740|39098879|FG000|Overall Study|Death|7|||
16169583|NCT00805740|39098880|FG001|Overall Study|Death|4|||
16169584|NCT00805740|39098879|FG000|Overall Study|Withdrawal by Subject|1|||
16169585|NCT00805740|39098880|FG001|Overall Study|Withdrawal by Subject|0|||
16169586|NCT00805740|39098879|FG000|Overall Study|Lost to Follow-up|1|||
16169587|NCT00805740|39098880|FG001|Overall Study|Lost to Follow-up|0|||
16169588|NCT00805740|39098879|FG000|Overall Study|Randomized, but not treated|2|||
16169589|NCT00805740|39098880|FG001|Overall Study|Randomized, but not treated|0|||
16169590|NCT01777763|39098883|FG000|Overall Study|Adverse Event|2|||
16169591|NCT01777763|39098884|FG001|Overall Study|Adverse Event|32|||
16169592|NCT01777763|39098883|FG000|Overall Study|Protocol Violation|1|||
16169593|NCT01777763|39098884|FG001|Overall Study|Protocol Violation|7|||
16169594|NCT01777763|39098883|FG000|Overall Study|Withdrawal by Subject|0|||
16169595|NCT01777763|39098884|FG001|Overall Study|Withdrawal by Subject|2|||
16169596|NCT01777763|39098883|FG000|Overall Study|Treatment Failure|1|||
16169597|NCT01777763|39098884|FG001|Overall Study|Treatment Failure|6|||
16169598|NCT01940484|39098889|FG000|Overall Study|Withdrawal by Subject|3|||
16169599|NCT01940484|39098889|FG000|Overall Study|Underwent transplantation|4|||
16169600|NCT01940484|39098889|FG000|Overall Study|Death|2|||
16169601|NCT01940484|39098889|FG000|Overall Study|Adverse Event|1|||
16169602|NCT01412957|39098892|FG000|Overall Study|Withdrawal by Subject|6|||
16169603|NCT01412957|39098893|FG001|Overall Study|Withdrawal by Subject|22|||
16169604|NCT01412957|39098892|FG000|Overall Study|Lost to Follow-up|7|||
16169605|NCT01412957|39098893|FG001|Overall Study|Lost to Follow-up|2|||
16169606|NCT01412957|39098892|FG000|Overall Study|Death|136|||
16169607|NCT01412957|39098893|FG001|Overall Study|Death|133|||
16169608|NCT02690194|39098894|FG000|Overall Study|Withdrawal by Subject|1|||
16169609|NCT02690194|39098895|FG001|Overall Study|Withdrawal by Subject|4|||
16169610|NCT02690194|39098896|FG002|Overall Study|Withdrawal by Subject|0|||
16169611|NCT03049449|39098900|FG000|Overall Study|Did not receive treatment.|0|||
16169612|NCT03049449|39098901|FG001|Overall Study|Did not receive treatment.|0|||
16169613|NCT03049449|39098902|FG002|Overall Study|Did not receive treatment.|0|||
16169614|NCT03049449|39098903|FG003|Overall Study|Did not receive treatment.|0|||
16169615|NCT03049449|39098904|FG004|Overall Study|Did not receive treatment.|0|||
16169616|NCT03049449|39098905|FG005|Overall Study|Did not receive treatment.|0|||
16169617|NCT03049449|39098906|FG006|Overall Study|Did not receive treatment.|0|||
16169618|NCT03049449|39098907|FG007|Overall Study|Did not receive treatment.|0|||
16169619|NCT03049449|39098908|FG008|Overall Study|Did not receive treatment.|1|||
16169620|NCT03049449|39098909|FG009|Overall Study|Did not receive treatment.|0|||
16169621|NCT03049449|39098900|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
16169622|NCT03049449|39098901|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
16169623|NCT03049449|39098902|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
16169624|NCT03049449|39098903|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
16169625|NCT03049449|39098904|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
16169626|NCT03049449|39098905|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
16169627|NCT03049449|39098906|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
16169628|NCT03049449|39098907|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
16169629|NCT03049449|39098908|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
16169630|NCT03049449|39098909|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
16169631|NCT03049449|39098900|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16169632|NCT03049449|39098901|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16169633|NCT03049449|39098902|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16169634|NCT03049449|39098903|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16169635|NCT03049449|39098904|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16169636|NCT03049449|39098905|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16169637|NCT03049449|39098906|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16169638|NCT03049449|39098907|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
16169639|NCT03049449|39098908|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
16169640|NCT03049449|39098909|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
16169641|NCT00454207|39098914|FG000|Overall Study|Adverse Event|3|||
16169642|NCT00454207|39098915|FG001|Overall Study|Adverse Event|1|||
16169643|NCT00454207|39098914|FG000|Overall Study|Lack of Efficacy|1|||
16169644|NCT00454207|39098915|FG001|Overall Study|Lack of Efficacy|0|||
16169645|NCT00454207|39098914|FG000|Overall Study|Protocol Violation|0|||
16169646|NCT00454207|39098915|FG001|Overall Study|Protocol Violation|1|||
16169647|NCT00179959|39098916|FG000|Overall Study|Lost to Follow-up|3|||
16169648|NCT00179959|39098917|FG001|Overall Study|Lost to Follow-up|1|||
16169649|NCT00179959|39098916|FG000|Overall Study|Withdrawal by Subject|3|||
16169650|NCT00179959|39098917|FG001|Overall Study|Withdrawal by Subject|2|||
16169651|NCT00600171|39098918|FG000|Overall Study|Adverse Event|0|||
16169652|NCT00600171|39098919|FG001|Overall Study|Adverse Event|1|||
16169653|NCT00600171|39098920|FG002|Overall Study|Adverse Event|0|||
16169654|NCT00600171|39098921|FG003|Overall Study|Adverse Event|0|||
16169655|NCT00600171|39098922|FG004|Overall Study|Adverse Event|1|||
16169656|NCT00600171|39098923|FG005|Overall Study|Adverse Event|0|||
16169657|NCT00600171|39098918|FG000|Overall Study|Lack of Efficacy|9|||
16169658|NCT00600171|39098919|FG001|Overall Study|Lack of Efficacy|12|||
16169659|NCT00600171|39098920|FG002|Overall Study|Lack of Efficacy|3|||
16169660|NCT00600171|39098921|FG003|Overall Study|Lack of Efficacy|5|||
16169661|NCT00600171|39098922|FG004|Overall Study|Lack of Efficacy|4|||
16169662|NCT00600171|39098923|FG005|Overall Study|Lack of Efficacy|0|||
16169663|NCT00600171|39098918|FG000|Overall Study|Protocol Violation|1|||
16169664|NCT00600171|39098919|FG001|Overall Study|Protocol Violation|2|||
16169665|NCT00600171|39098920|FG002|Overall Study|Protocol Violation|0|||
16169666|NCT00600171|39098921|FG003|Overall Study|Protocol Violation|1|||
16169667|NCT00600171|39098922|FG004|Overall Study|Protocol Violation|0|||
16169668|NCT00600171|39098923|FG005|Overall Study|Protocol Violation|0|||
16169669|NCT00600171|39098918|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
16169670|NCT00600171|39098919|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
16169671|NCT00600171|39098920|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
16169672|NCT00600171|39098921|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
16169673|NCT00600171|39098922|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
16169674|NCT00600171|39098923|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
16169675|NCT00600171|39098918|FG000|Overall Study|Withdrawal by Subject|3|||
16169676|NCT00600171|39098919|FG001|Overall Study|Withdrawal by Subject|0|||
16169677|NCT00600171|39098920|FG002|Overall Study|Withdrawal by Subject|0|||
16169678|NCT00600171|39098921|FG003|Overall Study|Withdrawal by Subject|1|||
16169679|NCT00600171|39098922|FG004|Overall Study|Withdrawal by Subject|1|||
16169680|NCT00600171|39098923|FG005|Overall Study|Withdrawal by Subject|1|||
16169681|NCT00600171|39098918|FG000|Overall Study|Physician Decision|0|||
16169682|NCT00600171|39098919|FG001|Overall Study|Physician Decision|1|||
16169683|NCT00600171|39098920|FG002|Overall Study|Physician Decision|0|||
16169684|NCT00600171|39098921|FG003|Overall Study|Physician Decision|1|||
16169685|NCT00600171|39098922|FG004|Overall Study|Physician Decision|0|||
16169686|NCT00600171|39098923|FG005|Overall Study|Physician Decision|2|||
16169687|NCT00600171|39098918|FG000|Overall Study|Lost to Follow-up|0|||
16464105|NCT01569464|40178561|FG000|Overall Study|Other|1|||
16464106|NCT01569464|40178562|FG001|Overall Study|Other|1|||
16464107|NCT01904773|40178563|FG000|Screen|Screen failure|3|||
16464108|NCT01904773|40178564|FG001|Screen|Screen failure|0|||
16464109|NCT01904773|40178565|FG002|Screen|Screen failure|0|||
16464110|NCT01904773|40178566|FG003|Screen|Screen failure|0|||
16464111|NCT01904773|40178567|FG004|Screen|Screen failure|0|||
16464112|NCT01904773|40178568|FG005|Screen|Screen failure|0|||
16464113|NCT01904773|40178569|FG006|Screen|Screen failure|0|||
16464114|NCT01904773|40178570|FG007|Screen|Screen failure|0|||
16464115|NCT01904773|40178571|FG008|Screen|Screen failure|0|||
16464116|NCT01904773|40178563|FG000|Screen|Withdrawal by Subject|1|||
16464117|NCT01904773|40178564|FG001|Screen|Withdrawal by Subject|0|||
16464118|NCT01904773|40178565|FG002|Screen|Withdrawal by Subject|0|||
16464119|NCT01904773|40178566|FG003|Screen|Withdrawal by Subject|0|||
16464120|NCT01904773|40178567|FG004|Screen|Withdrawal by Subject|0|||
16464121|NCT01904773|40178568|FG005|Screen|Withdrawal by Subject|0|||
16464122|NCT01904773|40178569|FG006|Screen|Withdrawal by Subject|0|||
16464123|NCT01904773|40178570|FG007|Screen|Withdrawal by Subject|0|||
16464124|NCT01904773|40178571|FG008|Screen|Withdrawal by Subject|0|||
16464125|NCT01904773|40178563|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
16464126|NCT01904773|40178564|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16464127|NCT01904773|40178565|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16464128|NCT01904773|40178566|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16464129|NCT01904773|40178567|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16464130|NCT01904773|40178568|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16464131|NCT01904773|40178569|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16464132|NCT01904773|40178570|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16464133|NCT01904773|40178571|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
16464134|NCT01904773|40178563|FG000|First Intervention|Adverse Event|0|||
16464135|NCT01904773|40178564|FG001|First Intervention|Adverse Event|0|||
16464136|NCT01904773|40178565|FG002|First Intervention|Adverse Event|0|||
16464137|NCT01904773|40178566|FG003|First Intervention|Adverse Event|0|||
16464138|NCT01904773|40178567|FG004|First Intervention|Adverse Event|0|||
16464139|NCT01904773|40178568|FG005|First Intervention|Adverse Event|0|||
16464140|NCT01904773|40178569|FG006|First Intervention|Adverse Event|1|||
16464141|NCT01904773|40178570|FG007|First Intervention|Adverse Event|0|||
16464142|NCT01904773|40178571|FG008|First Intervention|Adverse Event|0|||
16464143|NCT01904773|40178563|FG000|Placebo Washout First Intervention|Condition worsened|0|||
16464144|NCT01904773|40178564|FG001|Placebo Washout First Intervention|Condition worsened|1|||
16464145|NCT01904773|40178565|FG002|Placebo Washout First Intervention|Condition worsened|0|||
16464146|NCT01904773|40178566|FG003|Placebo Washout First Intervention|Condition worsened|0|||
16464147|NCT01904773|40178567|FG004|Placebo Washout First Intervention|Condition worsened|0|||
16464148|NCT01904773|40178568|FG005|Placebo Washout First Intervention|Condition worsened|0|||
16464149|NCT01904773|40178569|FG006|Placebo Washout First Intervention|Condition worsened|0|||
16464150|NCT01904773|40178570|FG007|Placebo Washout First Intervention|Condition worsened|0|||
16464151|NCT01904773|40178571|FG008|Placebo Washout First Intervention|Condition worsened|0|||
16464152|NCT01904773|40178563|FG000|Fifth Intervention|Adverse Event|0|||
16464153|NCT01904773|40178564|FG001|Fifth Intervention|Adverse Event|0|||
16464154|NCT01904773|40178565|FG002|Fifth Intervention|Adverse Event|0|||
16464155|NCT01904773|40178566|FG003|Fifth Intervention|Adverse Event|0|||
16464156|NCT01904773|40178567|FG004|Fifth Intervention|Adverse Event|0|||
16464157|NCT01904773|40178568|FG005|Fifth Intervention|Adverse Event|0|||
16464158|NCT01904773|40178569|FG006|Fifth Intervention|Adverse Event|0|||
16464159|NCT01904773|40178570|FG007|Fifth Intervention|Adverse Event|1|||
16464160|NCT01904773|40178571|FG008|Fifth Intervention|Adverse Event|0|||
16464161|NCT01904773|40178563|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16464162|NCT01904773|40178564|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
16464163|NCT01904773|40178565|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16464164|NCT01904773|40178566|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16464165|NCT01904773|40178567|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16464166|NCT01904773|40178568|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16464167|NCT01904773|40178569|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16464168|NCT01904773|40178570|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16464169|NCT01904773|40178571|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
16464170|NCT00510653|40178573|FG000|Overall Study|Withdrawal by Subject|8|||
16464171|NCT00510653|40178573|FG000|Overall Study|Monetary|3|||
16464172|NCT02456103|40178574|FG000|Overall Study|Study Closure|207|||
16464173|NCT02456103|40178574|FG000|Overall Study|Physician Decision|1|||
16464174|NCT02456103|40178574|FG000|Overall Study|Required prohibited medications|5|||
16464175|NCT02456103|40178574|FG000|Overall Study|Protocol Violation|1|||
16464176|NCT02456103|40178574|FG000|Overall Study|Adverse Event|5|||
16464177|NCT02456103|40178574|FG000|Overall Study|Abnormal Laboratory Value|2|||
16464178|NCT02456103|40178574|FG000|Overall Study|Lost to Follow-up|1|||
16464179|NCT02456103|40178574|FG000|Overall Study|Withdrawal by Subject|24|||
16464180|NCT03603509|40178575|FG000|Overall Study|Lost to Follow-up|3|||
16464181|NCT03603509|40178576|FG001|Overall Study|Lost to Follow-up|4|||
16464182|NCT00890045|40178577|FG000|Overall Study|Death|0|||
16464183|NCT00890045|40178578|FG001|Overall Study|Death|1|||
16464184|NCT00890045|40178577|FG000|Overall Study|Did not receive HeRO Graft|0|||
16464185|NCT00890045|40178578|FG001|Overall Study|Did not receive HeRO Graft|2|||
16464186|NCT00890045|40178577|FG000|Overall Study|Lost to Follow-up|5|||
16464187|NCT00890045|40178578|FG001|Overall Study|Lost to Follow-up|7|||
16464188|NCT02518464|40178586|FG000|Overall Study|Adverse Event|2|||
16464189|NCT00725842|40178590|FG000|Overall Study|Lost to Follow-up|19|||
16464190|NCT00725842|40178590|FG000|Overall Study|Death|1|||
16464191|NCT00725842|40178590|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
16464192|NCT00725842|40178590|FG000|Overall Study|Consent date prior to study start date|5|||
16464193|NCT00725842|40178590|FG000|Overall Study|Inclusion criterion not met|1|||
16464194|NCT00725842|40178590|FG000|Overall Study|No Visit 1 data|1|||
16464195|NCT01527357|40178594|FG000|Overall Study|Death|8|||
16464196|NCT01527357|40178595|FG001|Overall Study|Death|2|||
16464197|NCT01527357|40178594|FG000|Overall Study|Lost to Follow-up|6|||
16464198|NCT01527357|40178595|FG001|Overall Study|Lost to Follow-up|4|||
16464199|NCT01527357|40178594|FG000|Overall Study|Withdrew Consent|1|||
16464200|NCT01527357|40178595|FG001|Overall Study|Withdrew Consent|1|||
16464201|NCT01527357|40178594|FG000|Overall Study|Non-compliance|0|||
16464202|NCT01527357|40178595|FG001|Overall Study|Non-compliance|1|||
16464203|NCT01527357|40178594|FG000|Overall Study|No Day 29 Visit|0|||
16464204|NCT01527357|40178595|FG001|Overall Study|No Day 29 Visit|1|||
16464205|NCT01527357|40178594|FG000|Overall Study|Did Not Receive Treatment|2|||
16464206|NCT01527357|40178595|FG001|Overall Study|Did Not Receive Treatment|0|||
16464207|NCT00686634|40178596|FG000|Overall Study|Protocol Violation|6|||
16464208|NCT00265148|40178601|FG000|Overall Study|Adverse Event|2|||
16464209|NCT00265148|40178602|FG001|Overall Study|Adverse Event|2|||
16464210|NCT00265148|40178601|FG000|Overall Study|Lack of Efficacy|0|||
16464211|NCT00265148|40178602|FG001|Overall Study|Lack of Efficacy|2|||
16464212|NCT00265148|40178601|FG000|Overall Study|Protocol Violation|3|||
16464213|NCT00265148|40178602|FG001|Overall Study|Protocol Violation|2|||
16464214|NCT00265148|40178601|FG000|Overall Study|Lost to Follow-up|0|||
16464215|NCT00265148|40178602|FG001|Overall Study|Lost to Follow-up|1|||
16464216|NCT00265148|40178601|FG000|Overall Study|Withdrawal by Subject|2|||
16464217|NCT00265148|40178602|FG001|Overall Study|Withdrawal by Subject|1|||
16464218|NCT00265148|40178601|FG000|Overall Study|Physician Decision|1|||
16464219|NCT00265148|40178602|FG001|Overall Study|Physician Decision|0|||
16464220|NCT00265148|40178601|FG000|Overall Study|Increasing frailty|0|||
16464221|NCT00265148|40178602|FG001|Overall Study|Increasing frailty|1|||
16464222|NCT00265148|40178601|FG000|Overall Study|Subject chose to change of the dose|1|||
16464223|NCT00265148|40178602|FG001|Overall Study|Subject chose to change of the dose|0|||
16464224|NCT02248675|40178603|FG000|Overall Study|Lost to Follow-up|3|||
16464225|NCT02248675|40178604|FG001|Overall Study|Lost to Follow-up|1|||
16464226|NCT01561898|40178607|FG000|Overall Study|Withdrawal by Subject|0|||
16464227|NCT01561898|40178608|FG001|Overall Study|Withdrawal by Subject|8|||
16464228|NCT01561898|40178609|FG002|Overall Study|Withdrawal by Subject|12|||
16464229|NCT01561898|40178610|FG003|Overall Study|Withdrawal by Subject|5|||
16464230|NCT01561898|40178607|FG000|Overall Study|Lack of Efficacy|0|||
16464231|NCT01561898|40178608|FG001|Overall Study|Lack of Efficacy|8|||
16464232|NCT01561898|40178609|FG002|Overall Study|Lack of Efficacy|10|||
16464233|NCT01561898|40178610|FG003|Overall Study|Lack of Efficacy|5|||
16464234|NCT01561898|40178607|FG000|Overall Study|Worsening of complications|0|||
16464235|NCT01561898|40178608|FG001|Overall Study|Worsening of complications|1|||
16464236|NCT01561898|40178609|FG002|Overall Study|Worsening of complications|0|||
16464237|NCT01561898|40178610|FG003|Overall Study|Worsening of complications|0|||
16464238|NCT01561898|40178607|FG000|Overall Study|Lost to Follow-up|0|||
16464239|NCT01561898|40178608|FG001|Overall Study|Lost to Follow-up|0|||
16464240|NCT01561898|40178609|FG002|Overall Study|Lost to Follow-up|1|||
16464241|NCT01561898|40178610|FG003|Overall Study|Lost to Follow-up|0|||
16464242|NCT01561898|40178607|FG000|Overall Study|Adverse Event|1|||
16464243|NCT01561898|40178608|FG001|Overall Study|Adverse Event|19|||
16464244|NCT01561898|40178609|FG002|Overall Study|Adverse Event|14|||
16464245|NCT01561898|40178610|FG003|Overall Study|Adverse Event|9|||
16464246|NCT01561898|40178607|FG000|Overall Study|Physician Decision|1|||
16464247|NCT01561898|40178608|FG001|Overall Study|Physician Decision|5|||
16464248|NCT01561898|40178609|FG002|Overall Study|Physician Decision|7|||
16464249|NCT01561898|40178610|FG003|Overall Study|Physician Decision|1|||
16464250|NCT03007888|40178616|FG000|First Intervention (14 Days)|Adverse Event|1|||
16464251|NCT03007888|40178617|FG001|First Intervention (14 Days)|Adverse Event|0|||
16464252|NCT00722371|40178620|FG000|Overall Study|Adverse Event|6|||
16464253|NCT00722371|40178621|FG001|Overall Study|Adverse Event|13|||
16464254|NCT00722371|40178622|FG002|Overall Study|Adverse Event|9|||
16169688|NCT00600171|39098919|FG001|Overall Study|Lost to Follow-up|0|||
16169689|NCT00600171|39098920|FG002|Overall Study|Lost to Follow-up|0|||
16169690|NCT00600171|39098921|FG003|Overall Study|Lost to Follow-up|1|||
16169691|NCT00600171|39098922|FG004|Overall Study|Lost to Follow-up|0|||
16169692|NCT00600171|39098923|FG005|Overall Study|Lost to Follow-up|0|||
16169693|NCT00158184|39098924|FG000|Overall Study|personal issues|3|||
16169694|NCT00158184|39098925|FG001|Overall Study|personal issues|1|||
16169695|NCT00158184|39098924|FG000|Overall Study|failed for follow unit/study rules|2|||
16169696|NCT00158184|39098925|FG001|Overall Study|failed for follow unit/study rules|0|||
16169697|NCT00158184|39098924|FG000|Overall Study|Adverse Event|1|||
16464255|NCT00722371|40178623|FG003|Overall Study|Adverse Event|10|||
16464256|NCT00722371|40178624|FG004|Overall Study|Adverse Event|6|||
16464257|NCT00722371|40178625|FG005|Overall Study|Adverse Event|8|||
16464258|NCT00722371|40178626|FG006|Overall Study|Adverse Event|4|||
16464259|NCT00722371|40178620|FG000|Overall Study|Contraindication|0|||
16464260|NCT00722371|40178621|FG001|Overall Study|Contraindication|0|||
16169698|NCT00158184|39098925|FG001|Overall Study|Adverse Event|1|||
16464261|NCT00722371|40178622|FG002|Overall Study|Contraindication|1|||
16464262|NCT00722371|40178623|FG003|Overall Study|Contraindication|0|||
16169699|NCT02804763|39098938|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
16169700|NCT02804763|39098939|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
16169701|NCT02804763|39098940|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
16169702|NCT02804763|39098941|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
16169703|NCT02804763|39098938|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
16169704|NCT02804763|39098939|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
16169705|NCT02804763|39098940|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
16169706|NCT02804763|39098941|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
16169707|NCT02804763|39098938|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
16169708|NCT02804763|39098939|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
16169709|NCT02804763|39098940|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
16169710|NCT02804763|39098941|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
16169711|NCT02804763|39098938|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
16169712|NCT02804763|39098939|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
16169713|NCT02804763|39098940|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
16169714|NCT02804763|39098941|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
16169715|NCT02804763|39098938|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
16169716|NCT02804763|39098939|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
16169717|NCT02804763|39098940|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
16169718|NCT02804763|39098941|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
16169719|NCT02804763|39098938|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
16169720|NCT02804763|39098939|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
16464263|NCT00722371|40178624|FG004|Overall Study|Contraindication|0|||
16464264|NCT00722371|40178625|FG005|Overall Study|Contraindication|0|||
16464265|NCT00722371|40178626|FG006|Overall Study|Contraindication|0|||
16464266|NCT00722371|40178620|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
16464267|NCT00722371|40178621|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
16464268|NCT00722371|40178622|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
16464269|NCT00722371|40178623|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
16464270|NCT00722371|40178624|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
16464271|NCT00722371|40178625|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
16464272|NCT00722371|40178626|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
16464273|NCT00722371|40178620|FG000|Overall Study|Excluded medication|0|||
16464274|NCT00722371|40178621|FG001|Overall Study|Excluded medication|1|||
16464275|NCT00722371|40178622|FG002|Overall Study|Excluded medication|1|||
16464276|NCT00722371|40178623|FG003|Overall Study|Excluded medication|0|||
16464277|NCT00722371|40178624|FG004|Overall Study|Excluded medication|0|||
16464278|NCT00722371|40178625|FG005|Overall Study|Excluded medication|0|||
16464279|NCT00722371|40178626|FG006|Overall Study|Excluded medication|1|||
16464280|NCT00722371|40178620|FG000|Overall Study|Hyperglycemia|2|||
16464281|NCT00722371|40178621|FG001|Overall Study|Hyperglycemia|6|||
16464282|NCT00722371|40178622|FG002|Overall Study|Hyperglycemia|4|||
16464283|NCT00722371|40178623|FG003|Overall Study|Hyperglycemia|2|||
16464284|NCT00722371|40178624|FG004|Overall Study|Hyperglycemia|5|||
16464285|NCT00722371|40178625|FG005|Overall Study|Hyperglycemia|1|||
16464286|NCT00722371|40178626|FG006|Overall Study|Hyperglycemia|1|||
16464287|NCT00722371|40178620|FG000|Overall Study|Hypoglycemia|1|||
16464288|NCT00722371|40178621|FG001|Overall Study|Hypoglycemia|0|||
16464289|NCT00722371|40178622|FG002|Overall Study|Hypoglycemia|0|||
16464290|NCT00722371|40178623|FG003|Overall Study|Hypoglycemia|0|||
16464291|NCT00722371|40178624|FG004|Overall Study|Hypoglycemia|0|||
16464292|NCT00722371|40178625|FG005|Overall Study|Hypoglycemia|0|||
16464293|NCT00722371|40178626|FG006|Overall Study|Hypoglycemia|0|||
16464294|NCT00722371|40178620|FG000|Overall Study|Lack of Efficacy|4|||
16464295|NCT00722371|40178621|FG001|Overall Study|Lack of Efficacy|6|||
16464296|NCT00722371|40178622|FG002|Overall Study|Lack of Efficacy|6|||
16464297|NCT00722371|40178623|FG003|Overall Study|Lack of Efficacy|6|||
16464298|NCT00722371|40178624|FG004|Overall Study|Lack of Efficacy|2|||
16464299|NCT00722371|40178625|FG005|Overall Study|Lack of Efficacy|3|||
16269273|NCT04089553|39471049|FG001|Overall Study|Withdrawal by Subject|3|||
16464300|NCT00722371|40178626|FG006|Overall Study|Lack of Efficacy|0|||
16464301|NCT00722371|40178620|FG000|Overall Study|Lost to Follow-up|11|||
16464302|NCT00722371|40178621|FG001|Overall Study|Lost to Follow-up|14|||
16464303|NCT00722371|40178622|FG002|Overall Study|Lost to Follow-up|21|||
16464304|NCT00722371|40178623|FG003|Overall Study|Lost to Follow-up|13|||
16464305|NCT00722371|40178624|FG004|Overall Study|Lost to Follow-up|8|||
16464306|NCT00722371|40178625|FG005|Overall Study|Lost to Follow-up|16|||
16464307|NCT00722371|40178626|FG006|Overall Study|Lost to Follow-up|13|||
16464308|NCT00722371|40178620|FG000|Overall Study|Physician Decision|5|||
16464309|NCT00722371|40178621|FG001|Overall Study|Physician Decision|2|||
16464310|NCT00722371|40178622|FG002|Overall Study|Physician Decision|2|||
16464311|NCT00722371|40178623|FG003|Overall Study|Physician Decision|5|||
16464312|NCT00722371|40178624|FG004|Overall Study|Physician Decision|2|||
16464313|NCT00722371|40178625|FG005|Overall Study|Physician Decision|3|||
16464314|NCT00722371|40178626|FG006|Overall Study|Physician Decision|4|||
16169721|NCT02804763|39098940|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
16169722|NCT02804763|39098941|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
16169723|NCT01268293|39098942|FG000|Overall Study|Disease progression|7|||
16464315|NCT00722371|40178620|FG000|Overall Study|Pregnancy|1|||
16464316|NCT00722371|40178621|FG001|Overall Study|Pregnancy|1|||
16464317|NCT00722371|40178622|FG002|Overall Study|Pregnancy|0|||
16464318|NCT00722371|40178623|FG003|Overall Study|Pregnancy|0|||
16464319|NCT00722371|40178624|FG004|Overall Study|Pregnancy|0|||
16464320|NCT00722371|40178625|FG005|Overall Study|Pregnancy|1|||
16464321|NCT00722371|40178626|FG006|Overall Study|Pregnancy|0|||
16464322|NCT00722371|40178620|FG000|Overall Study|Protocol Violation|6|||
16464323|NCT00722371|40178621|FG001|Overall Study|Protocol Violation|1|||
16464324|NCT00722371|40178622|FG002|Overall Study|Protocol Violation|0|||
16464325|NCT00722371|40178623|FG003|Overall Study|Protocol Violation|1|||
16169724|NCT01268293|39098942|FG000|Overall Study|Adverse Event|1|||
16169725|NCT01268293|39098942|FG000|Overall Study|Subject choice|1|||
16169726|NCT03219164|39098947|FG000|Overall Study|Study Terminated by Sponsor|16|||
16169727|NCT03219164|39098948|FG001|Overall Study|Study Terminated by Sponsor|12|||
16169728|NCT03219164|39098947|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
16169729|NCT03219164|39098948|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
16169730|NCT03219164|39098947|FG000|Overall Study|Lost to Follow-up|1|||
16169731|NCT03219164|39098948|FG001|Overall Study|Lost to Follow-up|1|||
16169732|NCT03219164|39098947|FG000|Overall Study|Adverse Event|1|||
16169733|NCT03219164|39098948|FG001|Overall Study|Adverse Event|0|||
16169734|NCT03219164|39098947|FG000|Overall Study|Non-Compliance with Study Drug|1|||
16169735|NCT03219164|39098948|FG001|Overall Study|Non-Compliance with Study Drug|0|||
16169736|NCT03219164|39098947|FG000|Overall Study|Protocol Violation|0|||
16169737|NCT03219164|39098948|FG001|Overall Study|Protocol Violation|1|||
16169738|NCT03219164|39098947|FG000|Overall Study|Withdrew Assent|1|||
16169739|NCT03219164|39098948|FG001|Overall Study|Withdrew Assent|0|||
16169740|NCT00103012|39098949|FG000|Overall Study|Withdrawal by Subject|2|||
16169741|NCT00103012|39098950|FG001|Overall Study|Withdrawal by Subject|1|||
16169742|NCT00103012|39098951|FG002|Overall Study|Withdrawal by Subject|2|||
16169743|NCT00103012|39098949|FG000|Overall Study|Pregnancy|1|||
16169744|NCT00103012|39098950|FG001|Overall Study|Pregnancy|0|||
16169745|NCT00103012|39098951|FG002|Overall Study|Pregnancy|0|||
16169746|NCT00103012|39098949|FG000|Overall Study|Adverse Event|0|||
16169747|NCT00103012|39098950|FG001|Overall Study|Adverse Event|0|||
16169748|NCT00103012|39098951|FG002|Overall Study|Adverse Event|1|||
16169749|NCT00103012|39098949|FG000|Overall Study|Subject non-compliant with medications|0|||
16169750|NCT00103012|39098950|FG001|Overall Study|Subject non-compliant with medications|0|||
16169751|NCT00103012|39098951|FG002|Overall Study|Subject non-compliant with medications|1|||
16169752|NCT00988247|39098954|FG000|Overall Study|Adverse Event|17|||
16169753|NCT00988247|39098955|FG001|Overall Study|Adverse Event|3|||
16169754|NCT00988247|39098954|FG000|Overall Study|Withdrawal by Subject|44|||
16169755|NCT00988247|39098955|FG001|Overall Study|Withdrawal by Subject|13|||
16169756|NCT00988247|39098954|FG000|Overall Study|Pregnancy|1|||
16169757|NCT00988247|39098955|FG001|Overall Study|Pregnancy|2|||
16169758|NCT00988247|39098954|FG000|Overall Study|Lost to Follow-up|11|||
16169759|NCT00988247|39098955|FG001|Overall Study|Lost to Follow-up|2|||
16169760|NCT00988247|39098954|FG000|Overall Study|Protocol Violation|4|||
16169761|NCT00988247|39098955|FG001|Overall Study|Protocol Violation|5|||
16169762|NCT00988247|39098954|FG000|Overall Study|Sponsor requested withdrawal|3|||
16169763|NCT00988247|39098955|FG001|Overall Study|Sponsor requested withdrawal|1|||
16169764|NCT00988247|39098954|FG000|Overall Study|Other|3|||
16169765|NCT00988247|39098955|FG001|Overall Study|Other|0|||
16169766|NCT03468309|39098959|FG000|Overall Study|Lost to Follow-up|4|||
16169767|NCT03468309|39098959|FG000|Overall Study|Withdrawal by Subject|2|||
16169768|NCT01023789|39098967|FG000|3 - Year Visit|Death|29|||
16169769|NCT01023789|39098967|FG000|3 - Year Visit|Withdrawal of consent|1|||
16169770|NCT01023789|39098967|FG000|3 - Year Visit|Lost to Follow-up|13|||
16169771|NCT01961544|39098968|FG000|Overall Study|Protocol Violation|1|||
16169772|NCT01961544|39098968|FG000|Overall Study|Withdrawal by Subject|7|||
16169773|NCT01961544|39098968|FG000|Overall Study|Adverse Event|1|||
16464326|NCT00722371|40178624|FG004|Overall Study|Protocol Violation|4|||
16464327|NCT00722371|40178625|FG005|Overall Study|Protocol Violation|2|||
16169774|NCT01961544|39098968|FG000|Overall Study|Physician Decision|2|||
16169775|NCT01961544|39098968|FG000|Overall Study|Poor Tolerance|1|||
16169776|NCT01961544|39098968|FG000|Overall Study|Aggravation of Steral Pain|1|||
16169777|NCT03474679|39098969|FG000|Overall Study|Death|7|||
16169778|NCT03474679|39098969|FG000|Overall Study|Withdrawal by Subject|1|||
16169779|NCT04003610|39098972|FG000|Overall Study|Lost to Follow-up|0|||
16169780|NCT04003610|39098973|FG001|Overall Study|Lost to Follow-up|1|||
16169781|NCT04003610|39098974|FG002|Overall Study|Lost to Follow-up|0|||
16464328|NCT00722371|40178626|FG006|Overall Study|Protocol Violation|1|||
16464329|NCT00722371|40178620|FG000|Overall Study|Withdrawal by Subject|18|||
16464330|NCT00722371|40178621|FG001|Overall Study|Withdrawal by Subject|27|||
16169782|NCT04003610|39098972|FG000|Overall Study|Death|0|||
16169783|NCT04003610|39098973|FG001|Overall Study|Death|0|||
16464331|NCT00722371|40178622|FG002|Overall Study|Withdrawal by Subject|19|||
16464332|NCT00722371|40178623|FG003|Overall Study|Withdrawal by Subject|23|||
16464333|NCT00722371|40178624|FG004|Overall Study|Withdrawal by Subject|19|||
16464334|NCT00722371|40178625|FG005|Overall Study|Withdrawal by Subject|18|||
16464335|NCT00722371|40178626|FG006|Overall Study|Withdrawal by Subject|26|||
16464336|NCT01547780|40178632|FG000|Baseline PET Scan|Physician Decision|1|||
16464337|NCT01547780|40178633|FG001|Baseline PET Scan|Physician Decision|0|||
16464338|NCT01547780|40178634|FG002|Baseline PET Scan|Physician Decision|1|||
16464339|NCT01547780|40178635|FG003|Baseline PET Scan|Physician Decision|0|||
16464340|NCT01547780|40178632|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
16464341|NCT01547780|40178633|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
16169784|NCT04003610|39098974|FG002|Overall Study|Death|3|||
16169785|NCT04003610|39098972|FG000|Overall Study|Study Terminated by Sponsor|0|||
16169786|NCT04003610|39098973|FG001|Overall Study|Study Terminated by Sponsor|0|||
16169787|NCT04003610|39098974|FG002|Overall Study|Study Terminated by Sponsor|3|||
16169788|NCT01291017|39098978|FG000|Overall Study|Lost to Follow-up|2|||
16169789|NCT01291017|39098978|FG000|Overall Study|Withdrawal by Subject|3|||
16169790|NCT02440581|39098979|FG000|Overall Study|Death|0|||
16169791|NCT02440581|39098980|FG001|Overall Study|Death|0|||
16169792|NCT02440581|39098981|FG002|Overall Study|Death|7|||
16169793|NCT02440581|39098982|FG003|Overall Study|Death|5|||
16169794|NCT02440581|39098979|FG000|Overall Study|Transplanted|1|||
16169795|NCT02440581|39098980|FG001|Overall Study|Transplanted|0|||
16169796|NCT02440581|39098981|FG002|Overall Study|Transplanted|3|||
16169797|NCT02440581|39098982|FG003|Overall Study|Transplanted|2|||
16169798|NCT02440581|39098979|FG000|Overall Study|Withdrawal by Subject|4|||
16169799|NCT02440581|39098980|FG001|Overall Study|Withdrawal by Subject|11|||
16169800|NCT02440581|39098981|FG002|Overall Study|Withdrawal by Subject|3|||
16464342|NCT01547780|40178634|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
16464343|NCT01547780|40178635|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
16464344|NCT01238588|40178636|FG000|Overall Study|Withdrawal by Subject|1|||
16464345|NCT01238588|40178636|FG000|Overall Study|Physician Decision|2|||
16464346|NCT02674854|40178642|FG000|Overall Study|Adverse Event|17|||
16464347|NCT02674854|40178643|FG001|Overall Study|Adverse Event|15|||
16464348|NCT02674854|40178644|FG002|Overall Study|Adverse Event|5|||
16464349|NCT02674854|40178642|FG000|Overall Study|Withdrawal by Subject|1|||
16464350|NCT02674854|40178643|FG001|Overall Study|Withdrawal by Subject|5|||
16464351|NCT02674854|40178644|FG002|Overall Study|Withdrawal by Subject|4|||
16464352|NCT02674854|40178642|FG000|Overall Study|No-compliant subject|1|||
16464353|NCT02674854|40178643|FG001|Overall Study|No-compliant subject|0|||
16464354|NCT02674854|40178644|FG002|Overall Study|No-compliant subject|1|||
16464355|NCT02674854|40178642|FG000|Overall Study|Lost to Follow-up|1|||
16169801|NCT02440581|39098982|FG003|Overall Study|Withdrawal by Subject|7|||
16169802|NCT04173741|39098987|FG000|Overall Study|IVC measurement cannot be done|1|||
16169803|NCT04173741|39098988|FG001|Overall Study|IVC measurement cannot be done|1|||
16169804|NCT03038308|39098989|FG000|Overall Study|Surgical resection|1|||
16169805|NCT03038308|39098989|FG000|Overall Study|Withdrawal by Subject|2|||
16169806|NCT03038308|39098989|FG000|Overall Study|Lost to Follow-up|1|||
16169807|NCT01552902|39098990|FG000|Overall Study|Adverse Event|1|||
16169808|NCT01552902|39098991|FG001|Overall Study|Adverse Event|15|||
16169809|NCT01552902|39098992|FG002|Overall Study|Adverse Event|14|||
16169810|NCT01552902|39098990|FG000|Overall Study|Protocol Violation|3|||
16169811|NCT01552902|39098991|FG001|Overall Study|Protocol Violation|3|||
16169812|NCT01552902|39098992|FG002|Overall Study|Protocol Violation|3|||
16169813|NCT01552902|39098990|FG000|Overall Study|Lack of Efficacy|4|||
16169814|NCT01552902|39098991|FG001|Overall Study|Lack of Efficacy|3|||
16169815|NCT01552902|39098992|FG002|Overall Study|Lack of Efficacy|1|||
16169816|NCT01552902|39098990|FG000|Overall Study|Withdrawal by Subject|1|||
16169817|NCT01552902|39098991|FG001|Overall Study|Withdrawal by Subject|9|||
16169818|NCT01552902|39098992|FG002|Overall Study|Withdrawal by Subject|6|||
16169819|NCT01552902|39098990|FG000|Overall Study|Lost to Follow-up|1|||
16169820|NCT01552902|39098991|FG001|Overall Study|Lost to Follow-up|3|||
16169821|NCT01552902|39098992|FG002|Overall Study|Lost to Follow-up|6|||
16169822|NCT01552902|39098990|FG000|Overall Study|Other|3|||
16169823|NCT01552902|39098991|FG001|Overall Study|Other|4|||
16169824|NCT01552902|39098992|FG002|Overall Study|Other|3|||
16464356|NCT02674854|40178643|FG001|Overall Study|Lost to Follow-up|0|||
16464357|NCT02674854|40178644|FG002|Overall Study|Lost to Follow-up|2|||
16464358|NCT02674854|40178642|FG000|Overall Study|Lack of Efficacy|0|||
16464359|NCT02674854|40178643|FG001|Overall Study|Lack of Efficacy|3|||
16169825|NCT02582658|39098993|FG000|Overall Study|Failure to Return|10|||
16169826|NCT02582658|39098993|FG000|Overall Study|Insufficient Virological Response|2|||
16169827|NCT02582658|39098993|FG000|Overall Study|Withdrawn Consent|1|||
16169828|NCT02582658|39098993|FG000|Overall Study|Death|1|||
16169829|NCT02582658|39098993|FG000|Overall Study|Not further specified|11|||
16169830|NCT05340504|39098994|FG000|Overall Study|Withdrawal by Subject|1|||
16169831|NCT05340504|39098995|FG001|Overall Study|Withdrawal by Subject|0|||
16169832|NCT03371355|39098996|FG000|Overall Study|Investigator judgment|0|||
16169833|NCT03371355|39098997|FG001|Overall Study|Investigator judgment|0|||
16169834|NCT03371355|39098998|FG002|Overall Study|Investigator judgment|1|||
16169835|NCT03371355|39098999|FG003|Overall Study|Investigator judgment|1|||
16169836|NCT03371355|39098996|FG000|Overall Study|Voluntary withdrawal|1|||
16169837|NCT03371355|39098997|FG001|Overall Study|Voluntary withdrawal|0|||
16169838|NCT03371355|39098998|FG002|Overall Study|Voluntary withdrawal|1|||
16169839|NCT03371355|39098999|FG003|Overall Study|Voluntary withdrawal|2|||
16169840|NCT03371355|39098996|FG000|Overall Study|Adverse Event|0|||
16169841|NCT03371355|39098997|FG001|Overall Study|Adverse Event|1|||
16169842|NCT03371355|39098998|FG002|Overall Study|Adverse Event|2|||
16169843|NCT03371355|39098999|FG003|Overall Study|Adverse Event|3|||
16169844|NCT03371355|39098996|FG000|Overall Study|Reason not Specified|0|||
16169845|NCT03371355|39098997|FG001|Overall Study|Reason not Specified|1|||
16169846|NCT03371355|39098998|FG002|Overall Study|Reason not Specified|0|||
16169847|NCT03371355|39098999|FG003|Overall Study|Reason not Specified|1|||
16169848|NCT00929240|39099003|FG000|Initial Treatment Phase|Adverse Event|31|||
16169849|NCT00929240|39099004|FG001|Initial Treatment Phase|Adverse Event|0|||
16169850|NCT00929240|39099005|FG002|Initial Treatment Phase|Adverse Event|0|||
16169851|NCT00929240|39099003|FG000|Initial Treatment Phase|Disease progression|41|||
16169852|NCT00929240|39099004|FG001|Initial Treatment Phase|Disease progression|0|||
16169853|NCT00929240|39099005|FG002|Initial Treatment Phase|Disease progression|0|||
16169854|NCT00929240|39099003|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
16169855|NCT00929240|39099004|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
16169856|NCT00929240|39099005|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
16169857|NCT00929240|39099003|FG000|Initial Treatment Phase|Protocol Violation|5|||
16169858|NCT00929240|39099004|FG001|Initial Treatment Phase|Protocol Violation|0|||
16169859|NCT00929240|39099005|FG002|Initial Treatment Phase|Protocol Violation|0|||
16169860|NCT00929240|39099003|FG000|Initial Treatment Phase|Death|2|||
16169861|NCT00929240|39099004|FG001|Initial Treatment Phase|Death|0|||
16169862|NCT00929240|39099005|FG002|Initial Treatment Phase|Death|0|||
16169863|NCT00929240|39099003|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
16169864|NCT00929240|39099004|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
16169865|NCT00929240|39099005|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
16169866|NCT00929240|39099003|FG000|Initial Treatment Phase|Physician Decision|4|||
16169867|NCT00929240|39099004|FG001|Initial Treatment Phase|Physician Decision|0|||
16169868|NCT00929240|39099005|FG002|Initial Treatment Phase|Physician Decision|0|||
16169869|NCT00929240|39099003|FG000|Maintenance Phase|Disease progression|0|||
16169870|NCT00929240|39099004|FG001|Maintenance Phase|Disease progression|73|||
16169871|NCT00929240|39099005|FG002|Maintenance Phase|Disease progression|60|||
16464360|NCT02674854|40178644|FG002|Overall Study|Lack of Efficacy|0|||
16464361|NCT02674854|40178642|FG000|Overall Study|Disallowed Concurrent Medication|2|||
16464362|NCT02674854|40178643|FG001|Overall Study|Disallowed Concurrent Medication|2|||
16464363|NCT02674854|40178644|FG002|Overall Study|Disallowed Concurrent Medication|0|||
16464364|NCT02674854|40178642|FG000|Overall Study|Protocol Violation|1|||
16464365|NCT02674854|40178643|FG001|Overall Study|Protocol Violation|1|||
16464366|NCT02674854|40178644|FG002|Overall Study|Protocol Violation|2|||
16464367|NCT02674854|40178642|FG000|Overall Study|Death|0|||
16464368|NCT02674854|40178643|FG001|Overall Study|Death|1|||
16464369|NCT02674854|40178644|FG002|Overall Study|Death|0|||
16464370|NCT02674854|40178642|FG000|Overall Study|Subject missed V6.2|1|||
16464371|NCT02674854|40178643|FG001|Overall Study|Subject missed V6.2|0|||
16464372|NCT02674854|40178644|FG002|Overall Study|Subject missed V6.2|0|||
16464373|NCT01185301|40178645|FG000|Overall Study|Adverse Event|3|||
16464374|NCT01185301|40178646|FG001|Overall Study|Adverse Event|0|||
16464375|NCT01185301|40178647|FG002|Overall Study|Adverse Event|2|||
16464376|NCT01185301|40178648|FG003|Overall Study|Adverse Event|3|||
16464377|NCT01185301|40178645|FG000|Overall Study|Withdrawal by Subject|7|||
16464378|NCT01185301|40178646|FG001|Overall Study|Withdrawal by Subject|5|||
16464379|NCT01185301|40178647|FG002|Overall Study|Withdrawal by Subject|2|||
16464380|NCT01185301|40178648|FG003|Overall Study|Withdrawal by Subject|3|||
16464381|NCT01185301|40178645|FG000|Overall Study|Lost to Follow-up|2|||
16464382|NCT01185301|40178646|FG001|Overall Study|Lost to Follow-up|0|||
16464383|NCT01185301|40178647|FG002|Overall Study|Lost to Follow-up|0|||
16464384|NCT01185301|40178648|FG003|Overall Study|Lost to Follow-up|1|||
16464385|NCT01185301|40178645|FG000|Overall Study|Other Reason|3|||
16464386|NCT01185301|40178646|FG001|Overall Study|Other Reason|2|||
16464387|NCT01185301|40178647|FG002|Overall Study|Other Reason|2|||
16464388|NCT01185301|40178648|FG003|Overall Study|Other Reason|2|||
16464389|NCT03412565|40178652|FG000|Overall Study|Lost to Follow-up|0|||
16169872|NCT00929240|39099003|FG000|Maintenance Phase|Adverse Event|0|||
16169873|NCT00929240|39099004|FG001|Maintenance Phase|Adverse Event|9|||
16169874|NCT00929240|39099005|FG002|Maintenance Phase|Adverse Event|12|||
16169875|NCT00929240|39099003|FG000|Maintenance Phase|Withdrawal by Subject|0|||
16169876|NCT00929240|39099004|FG001|Maintenance Phase|Withdrawal by Subject|2|||
16169877|NCT00929240|39099005|FG002|Maintenance Phase|Withdrawal by Subject|6|||
16169878|NCT00929240|39099003|FG000|Maintenance Phase|Protocol Violation|0|||
16169879|NCT00929240|39099004|FG001|Maintenance Phase|Protocol Violation|1|||
16464390|NCT03412565|40178653|FG001|Overall Study|Lost to Follow-up|0|||
16464391|NCT03412565|40178654|FG002|Overall Study|Lost to Follow-up|1|||
16464392|NCT03412565|40178655|FG003|Overall Study|Lost to Follow-up|0|||
16464393|NCT03412565|40178652|FG000|Overall Study|Physician Decision|0|||
16464394|NCT03412565|40178653|FG001|Overall Study|Physician Decision|0|||
16464395|NCT03412565|40178654|FG002|Overall Study|Physician Decision|0|||
16464396|NCT03412565|40178655|FG003|Overall Study|Physician Decision|1|||
16464397|NCT03412565|40178652|FG000|Overall Study|Withdrawal by Subject|0|||
16464398|NCT03412565|40178653|FG001|Overall Study|Withdrawal by Subject|4|||
16464399|NCT03412565|40178654|FG002|Overall Study|Withdrawal by Subject|5|||
16464400|NCT03412565|40178655|FG003|Overall Study|Withdrawal by Subject|5|||
16464401|NCT03412565|40178652|FG000|Overall Study|Death|1|||
16464402|NCT03412565|40178653|FG001|Overall Study|Death|3|||
16169880|NCT00929240|39099005|FG002|Maintenance Phase|Protocol Violation|0|||
16169881|NCT00929240|39099003|FG000|Maintenance Phase|Health authority/Study termination|0|||
16169882|NCT00929240|39099004|FG001|Maintenance Phase|Health authority/Study termination|1|||
16169883|NCT00929240|39099005|FG002|Maintenance Phase|Health authority/Study termination|2|||
16169884|NCT00929240|39099003|FG000|Maintenance Phase|Physician Decision|0|||
16169885|NCT00929240|39099004|FG001|Maintenance Phase|Physician Decision|2|||
16169886|NCT00929240|39099005|FG002|Maintenance Phase|Physician Decision|1|||
16169887|NCT00929240|39099003|FG000|Maintenance Phase|Change of treatment|0|||
16169888|NCT00929240|39099004|FG001|Maintenance Phase|Change of treatment|4|||
16169889|NCT00929240|39099005|FG002|Maintenance Phase|Change of treatment|0|||
16464403|NCT03412565|40178654|FG002|Overall Study|Death|4|||
16464404|NCT03412565|40178655|FG003|Overall Study|Death|5|||
16464405|NCT03412565|40178652|FG000|Overall Study|Data collection ended|0|||
16464406|NCT03412565|40178653|FG001|Overall Study|Data collection ended|41|||
16464407|NCT03412565|40178654|FG002|Overall Study|Data collection ended|41|||
16464408|NCT03412565|40178655|FG003|Overall Study|Data collection ended|40|||
16464409|NCT03005873|40178660|FG000|Overall Study|Prohibited medication use post radnomization|1|||
16464410|NCT03005873|40178661|FG001|Overall Study|Prohibited medication use post radnomization|1|||
16464411|NCT03005873|40178662|FG002|Overall Study|Prohibited medication use post radnomization|1|||
16464412|NCT03005873|40178660|FG000|Overall Study|Withdrew consent|0|||
16464413|NCT03005873|40178661|FG001|Overall Study|Withdrew consent|1|||
16464414|NCT03005873|40178662|FG002|Overall Study|Withdrew consent|2|||
16464415|NCT03005873|40178660|FG000|Overall Study|Lost to Follow-up|0|||
16464416|NCT03005873|40178661|FG001|Overall Study|Lost to Follow-up|1|||
16464417|NCT03005873|40178662|FG002|Overall Study|Lost to Follow-up|0|||
16464418|NCT03005873|40178660|FG000|Overall Study|Ineligible post randomization|0|||
16464419|NCT03005873|40178661|FG001|Overall Study|Ineligible post randomization|0|||
16464420|NCT03005873|40178662|FG002|Overall Study|Ineligible post randomization|1|||
16464421|NCT03234881|40178663|FG000|Overall Study|Lost to Follow-up|9|||
16464422|NCT03234881|40178664|FG001|Overall Study|Lost to Follow-up|3|||
16464423|NCT04214288|40178665|FG000|Overall Study|Ongoing in the study|41|||
16464424|NCT04214288|40178666|FG001|Overall Study|Ongoing in the study|51|||
16464425|NCT04214288|40178667|FG002|Overall Study|Ongoing in the study|12|||
16464426|NCT04214288|40178668|FG003|Overall Study|Ongoing in the study|39|||
16464427|NCT04214288|40178665|FG000|Overall Study|Adverse Event|1|||
16169890|NCT00929240|39099003|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
16169891|NCT00929240|39099004|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
16169892|NCT00929240|39099005|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
16169893|NCT00929240|39099003|FG000|Maintenance Phase|Participant not treated|0|||
16169894|NCT00929240|39099004|FG001|Maintenance Phase|Participant not treated|2|||
16169895|NCT00929240|39099005|FG002|Maintenance Phase|Participant not treated|0|||
16464428|NCT04214288|40178666|FG001|Overall Study|Adverse Event|0|||
16169896|NCT01628926|39099006|FG000|Overall Study|Adverse Event|13|||
16169897|NCT01628926|39099007|FG001|Overall Study|Adverse Event|11|||
16169898|NCT01628926|39099008|FG002|Overall Study|Adverse Event|9|||
16169899|NCT01628926|39099006|FG000|Overall Study|Lack of Efficacy|2|||
16169900|NCT01628926|39099007|FG001|Overall Study|Lack of Efficacy|1|||
16169901|NCT01628926|39099008|FG002|Overall Study|Lack of Efficacy|5|||
16169902|NCT01628926|39099006|FG000|Overall Study|Withdrawal by Subject|6|||
16169903|NCT01628926|39099007|FG001|Overall Study|Withdrawal by Subject|4|||
16464429|NCT04214288|40178667|FG002|Overall Study|Adverse Event|0|||
16464430|NCT04214288|40178668|FG003|Overall Study|Adverse Event|0|||
16464431|NCT04214288|40178665|FG000|Overall Study|Death|22|||
16464432|NCT04214288|40178666|FG001|Overall Study|Death|13|||
16464433|NCT04214288|40178667|FG002|Overall Study|Death|7|||
16169904|NCT01628926|39099008|FG002|Overall Study|Withdrawal by Subject|2|||
16169905|NCT01628926|39099006|FG000|Overall Study|Protocol Violation|0|||
16169906|NCT01628926|39099007|FG001|Overall Study|Protocol Violation|1|||
16169907|NCT01628926|39099008|FG002|Overall Study|Protocol Violation|0|||
16169908|NCT01628926|39099006|FG000|Overall Study|Discontinuation criteria|3|||
16464434|NCT04214288|40178668|FG003|Overall Study|Death|19|||
16464435|NCT04214288|40178665|FG000|Overall Study|Lost to Follow-up|1|||
16169909|NCT01628926|39099007|FG001|Overall Study|Discontinuation criteria|4|||
16169910|NCT01628926|39099008|FG002|Overall Study|Discontinuation criteria|0|||
16169911|NCT01628926|39099006|FG000|Overall Study|Physician Decision|2|||
16464436|NCT04214288|40178666|FG001|Overall Study|Lost to Follow-up|2|||
16464437|NCT04214288|40178667|FG002|Overall Study|Lost to Follow-up|1|||
16464438|NCT04214288|40178668|FG003|Overall Study|Lost to Follow-up|0|||
16464439|NCT04214288|40178665|FG000|Overall Study|Other|1|||
16464440|NCT04214288|40178666|FG001|Overall Study|Other|2|||
16464441|NCT04214288|40178667|FG002|Overall Study|Other|0|||
16464442|NCT04214288|40178668|FG003|Overall Study|Other|6|||
16464443|NCT04214288|40178665|FG000|Overall Study|Protocol Violation|0|||
16464444|NCT04214288|40178666|FG001|Overall Study|Protocol Violation|1|||
16464445|NCT04214288|40178667|FG002|Overall Study|Protocol Violation|0|||
16464446|NCT04214288|40178668|FG003|Overall Study|Protocol Violation|0|||
16464447|NCT04214288|40178665|FG000|Overall Study|Withdrawal by Subject|8|||
16464448|NCT04214288|40178666|FG001|Overall Study|Withdrawal by Subject|4|||
16464449|NCT04214288|40178667|FG002|Overall Study|Withdrawal by Subject|0|||
16464450|NCT04214288|40178668|FG003|Overall Study|Withdrawal by Subject|9|||
16464451|NCT01077375|40178670|FG000|Overall Study|Adverse Event|2|||
16464452|NCT01077375|40178671|FG001|Overall Study|Adverse Event|15|||
16464453|NCT01077375|40178670|FG000|Overall Study|Lack of Efficacy|6|||
16464454|NCT01077375|40178671|FG001|Overall Study|Lack of Efficacy|8|||
16464455|NCT01077375|40178670|FG000|Overall Study|Withdrawal by Subject|0|||
16464456|NCT01077375|40178671|FG001|Overall Study|Withdrawal by Subject|6|||
16464457|NCT01077375|40178670|FG000|Overall Study|Lost to Follow-up|2|||
16464458|NCT01077375|40178671|FG001|Overall Study|Lost to Follow-up|5|||
16464459|NCT01077375|40178670|FG000|Overall Study|Other Reason|0|||
16464460|NCT01077375|40178671|FG001|Overall Study|Other Reason|1|||
16464461|NCT00412373|40178672|FG000|Overall Study|Adverse Event|8|||
16464462|NCT00412373|40178673|FG001|Overall Study|Adverse Event|13|||
16464463|NCT00412373|40178672|FG000|Overall Study|Lack of Efficacy|16|||
16169912|NCT01628926|39099007|FG001|Overall Study|Physician Decision|2|||
16169913|NCT01628926|39099008|FG002|Overall Study|Physician Decision|1|||
16169914|NCT00364182|39099009|FG000|First Intervention|Secondary prophylaxis|1|||
16169915|NCT00364182|39099010|FG001|First Intervention|Secondary prophylaxis|0|||
16169916|NCT00364182|39099011|FG002|First Intervention|Secondary prophylaxis|0|||
16169917|NCT00364182|39099009|FG000|First Intervention|Withdrawal by Subject|2|||
16169918|NCT00364182|39099010|FG001|First Intervention|Withdrawal by Subject|0|||
16169919|NCT00364182|39099011|FG002|First Intervention|Withdrawal by Subject|0|||
16169920|NCT00364182|39099009|FG000|Second Intervention|non-compliance|0|||
16169921|NCT00364182|39099010|FG001|Second Intervention|non-compliance|1|||
16169922|NCT00364182|39099011|FG002|Second Intervention|non-compliance|1|||
16169923|NCT00364182|39099009|FG000|Second Intervention|Protocol Violation|0|||
16169924|NCT00364182|39099010|FG001|Second Intervention|Protocol Violation|1|||
16169925|NCT00364182|39099011|FG002|Second Intervention|Protocol Violation|0|||
16464464|NCT00412373|40178673|FG001|Overall Study|Lack of Efficacy|22|||
16464465|NCT00412373|40178672|FG000|Overall Study|Lost to Follow-up|7|||
16464466|NCT00412373|40178673|FG001|Overall Study|Lost to Follow-up|13|||
16464467|NCT00412373|40178672|FG000|Overall Study|Withdrawal by Subject|8|||
16464468|NCT00412373|40178673|FG001|Overall Study|Withdrawal by Subject|27|||
16464469|NCT00412373|40178672|FG000|Overall Study|Other|2|||
16464470|NCT00412373|40178673|FG001|Overall Study|Other|2|||
16464471|NCT03467152|40178674|FG000|Overall Study|Adverse Event|4|||
16464472|NCT03467152|40178675|FG001|Overall Study|Adverse Event|5|||
16464473|NCT03467152|40178676|FG002|Overall Study|Adverse Event|0|||
16464474|NCT03467152|40178674|FG000|Overall Study|Subject Choice|1|||
16464475|NCT03467152|40178675|FG001|Overall Study|Subject Choice|3|||
16169926|NCT00364182|39099009|FG000|Second Intervention|Adverse Event|0|||
16169927|NCT00364182|39099010|FG001|Second Intervention|Adverse Event|0|||
16464476|NCT03467152|40178676|FG002|Overall Study|Subject Choice|0|||
16464477|NCT03467152|40178674|FG000|Overall Study|Lost to Follow-up|1|||
16464478|NCT03467152|40178675|FG001|Overall Study|Lost to Follow-up|0|||
16464479|NCT03467152|40178676|FG002|Overall Study|Lost to Follow-up|0|||
16464480|NCT03467152|40178674|FG000|Overall Study|Withdrawal by Subject|4|||
16464481|NCT03467152|40178675|FG001|Overall Study|Withdrawal by Subject|2|||
16169928|NCT00364182|39099011|FG002|Second Intervention|Adverse Event|1|||
16169929|NCT00364182|39099009|FG000|Third Intervention|non-compliance|0|||
16169930|NCT00364182|39099010|FG001|Third Intervention|non-compliance|1|||
16169931|NCT00364182|39099011|FG002|Third Intervention|non-compliance|0|||
16169932|NCT00364182|39099009|FG000|Third Intervention|Lost to Follow-up|0|||
16169933|NCT00364182|39099010|FG001|Third Intervention|Lost to Follow-up|0|||
16169934|NCT00364182|39099011|FG002|Third Intervention|Lost to Follow-up|1|||
16169935|NCT00862251|39099012|FG000|Overall Study|Adverse Event|8|||
16464482|NCT03467152|40178676|FG002|Overall Study|Withdrawal by Subject|0|||
16464483|NCT03467152|40178674|FG000|Overall Study|Others|3|||
16169936|NCT00862251|39099013|FG001|Overall Study|Adverse Event|3|||
16169937|NCT00862251|39099014|FG002|Overall Study|Adverse Event|1|||
16169938|NCT00862251|39099012|FG000|Overall Study|Lost to Follow-up|0|||
16169939|NCT00862251|39099013|FG001|Overall Study|Lost to Follow-up|0|||
16464484|NCT03467152|40178675|FG001|Overall Study|Others|0|||
16464485|NCT03467152|40178676|FG002|Overall Study|Others|0|||
16464486|NCT03467152|40178674|FG000|Overall Study|Not treated|3|||
16169940|NCT00862251|39099014|FG002|Overall Study|Lost to Follow-up|1|||
16169941|NCT00862251|39099012|FG000|Overall Study|Protocol Violation|2|||
16464487|NCT03467152|40178675|FG001|Overall Study|Not treated|1|||
16169942|NCT00862251|39099013|FG001|Overall Study|Protocol Violation|0|||
16169943|NCT00862251|39099014|FG002|Overall Study|Protocol Violation|1|||
16169944|NCT00862251|39099012|FG000|Overall Study|Withdrawal by Subject|9|||
16169945|NCT00862251|39099013|FG001|Overall Study|Withdrawal by Subject|2|||
16169946|NCT00862251|39099014|FG002|Overall Study|Withdrawal by Subject|6|||
16169947|NCT01354132|39099027|FG000|Randomization|Physician Decision|1|||
16169948|NCT01354132|39099028|FG001|Randomization|Physician Decision|0|||
16169949|NCT01354132|39099027|FG000|Randomization|Withdrawal by Subject|0|||
16169950|NCT01354132|39099028|FG001|Randomization|Withdrawal by Subject|1|||
16169951|NCT01354132|39099027|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
16169952|NCT01354132|39099028|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
16169953|NCT01354132|39099027|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
16169954|NCT01354132|39099028|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
16169955|NCT01354132|39099027|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
16169956|NCT01354132|39099028|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
16169957|NCT01275222|39099029|FG000|Phase l by Treatment|Adverse Event|1|||
16169958|NCT01275222|39099030|FG001|Phase l by Treatment|Adverse Event|4|||
16169959|NCT01275222|39099031|FG002|Phase l by Treatment|Adverse Event|2|||
16464488|NCT03467152|40178676|FG002|Overall Study|Not treated|6|||
16464489|NCT05277337|40178680|FG000|Overall Study|Lost to Follow-up|2|||
16464490|NCT05277337|40178681|FG001|Overall Study|Lost to Follow-up|0|||
16464491|NCT05277337|40178680|FG000|Overall Study|Withdrawal by Subject|1|||
16464492|NCT05277337|40178681|FG001|Overall Study|Withdrawal by Subject|0|||
16464493|NCT00734747|40178684|FG000|SRS Procedure|No staples placed|3|||
16464494|NCT00734747|40178684|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
16464495|NCT00814879|40178687|FG000|By Week 24|Cancer Diagnosis|1|||
16464496|NCT00814879|40178688|FG001|By Week 24|Cancer Diagnosis|0|||
16464497|NCT00814879|40178687|FG000|By Week 24|Incarceration|0|||
16169960|NCT01275222|39099032|FG003|Phase l by Treatment|Adverse Event|3|||
16169961|NCT01275222|39099033|FG004|Phase l by Treatment|Adverse Event|0|||
16169962|NCT01275222|39099034|FG005|Phase l by Treatment|Adverse Event|0|||
16169963|NCT01275222|39099029|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
16169964|NCT01275222|39099030|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
16169965|NCT01275222|39099031|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
16169966|NCT01275222|39099032|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
16169967|NCT01275222|39099033|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
16169968|NCT01275222|39099034|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
16464498|NCT00814879|40178688|FG001|By Week 24|Incarceration|1|||
16464499|NCT00814879|40178687|FG000|By Week 48|Lost to Follow-up|2|||
16464500|NCT00814879|40178688|FG001|By Week 48|Lost to Follow-up|2|||
16464501|NCT00814879|40178687|FG000|By Week 48|Death|0|||
16464502|NCT00814879|40178688|FG001|By Week 48|Death|1|||
16464503|NCT01892384|40178689|FG000|Overall Study|Withdrawal by Subject|1|||
16464504|NCT01892384|40178690|FG001|Overall Study|Withdrawal by Subject|1|||
16464505|NCT01892384|40178691|FG002|Overall Study|Withdrawal by Subject|0|||
16464506|NCT01892384|40178692|FG003|Overall Study|Withdrawal by Subject|0|||
16464507|NCT01262352|40178693|FG000|Period 1|Illness after randomization|1|||
16464508|NCT01262352|40178694|FG001|Period 1|Illness after randomization|0|||
16464509|NCT01262352|40178693|FG000|Washout|Adverse Event|1|||
16464510|NCT01262352|40178694|FG001|Washout|Adverse Event|1|||
16464511|NCT01262352|40178693|FG000|Washout|Extended Washout|0|||
16464512|NCT01262352|40178694|FG001|Washout|Extended Washout|1|||
16464513|NCT00220779|40178699|FG000|Overall Study|Adverse Event|1|||
16464514|NCT00220779|40178700|FG001|Overall Study|Adverse Event|0|||
16464515|NCT00220779|40178701|FG002|Overall Study|Adverse Event|0|||
16464516|NCT00220779|40178699|FG000|Overall Study|Withdrawal by Subject|1|||
16464517|NCT00220779|40178700|FG001|Overall Study|Withdrawal by Subject|4|||
16169969|NCT01275222|39099029|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
16169970|NCT01275222|39099030|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
16169971|NCT01275222|39099031|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
16169972|NCT01275222|39099032|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
16169973|NCT01275222|39099033|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
16169974|NCT01275222|39099034|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
16169975|NCT01275222|39099029|FG000|Phase l by Treatment|Disease progression|12|||
16169976|NCT01275222|39099030|FG001|Phase l by Treatment|Disease progression|8|||
16269274|NCT04089553|39471048|FG000|Overall Study|Physician Decision|1|||
16464518|NCT00220779|40178701|FG002|Overall Study|Withdrawal by Subject|1|||
16464519|NCT00220779|40178699|FG000|Overall Study|Non-compliance|1|||
16072703|NCT01959412|38759143|FG005|Overall Study|Protocol deviation|0|||
16269275|NCT04089553|39471049|FG001|Overall Study|Physician Decision|0|||
16464520|NCT00220779|40178700|FG001|Overall Study|Non-compliance|0|||
16464521|NCT00220779|40178701|FG002|Overall Study|Non-compliance|0|||
16464522|NCT00220779|40178699|FG000|Overall Study|Too time consuming|1|||
16464523|NCT00220779|40178700|FG001|Overall Study|Too time consuming|0|||
16464524|NCT00220779|40178701|FG002|Overall Study|Too time consuming|0|||
16464525|NCT00220779|40178699|FG000|Overall Study|Pregnancy|0|||
16464526|NCT00220779|40178700|FG001|Overall Study|Pregnancy|0|||
16464527|NCT00220779|40178701|FG002|Overall Study|Pregnancy|2|||
16464528|NCT00220779|40178699|FG000|Overall Study|Lack of Efficacy|3|||
16464529|NCT00220779|40178700|FG001|Overall Study|Lack of Efficacy|0|||
16464530|NCT00220779|40178701|FG002|Overall Study|Lack of Efficacy|1|||
16464531|NCT00938886|40178702|FG000|Overall Study|Death|0|||
16464532|NCT00938886|40178703|FG001|Overall Study|Death|1|||
16464533|NCT00938886|40178702|FG000|Overall Study|Withdrawal by Subject|4|||
16464534|NCT00938886|40178703|FG001|Overall Study|Withdrawal by Subject|7|||
16464535|NCT00938886|40178702|FG000|Overall Study|Lost to Follow-up|3|||
16464536|NCT00938886|40178703|FG001|Overall Study|Lost to Follow-up|2|||
16464537|NCT01511055|40178706|FG000|Overall Study|Withdrawal by Subject|6|||
16464538|NCT01129583|40178707|FG000|Overall Study|Death|1|||
16464539|NCT01129583|40178708|FG001|Overall Study|Death|0|||
16464540|NCT01129583|40178707|FG000|Overall Study|Lost to Follow-up|1|||
16464541|NCT01129583|40178708|FG001|Overall Study|Lost to Follow-up|1|||
16464542|NCT01129583|40178707|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
16464543|NCT01129583|40178708|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
16464544|NCT00608569|40178716|FG000|Overall Study|Death|4|||
16464545|NCT00608569|40178717|FG001|Overall Study|Death|3|||
16464546|NCT00608569|40178716|FG000|Overall Study|Lost to Follow-up|4|||
16464547|NCT00608569|40178717|FG001|Overall Study|Lost to Follow-up|5|||
16464548|NCT00608569|40178716|FG000|Overall Study|Withdrawal by Subject|1|||
16464549|NCT00608569|40178717|FG001|Overall Study|Withdrawal by Subject|0|||
16464550|NCT00608569|40178716|FG000|Overall Study|Adverse Event|1|||
16464551|NCT00608569|40178717|FG001|Overall Study|Adverse Event|0|||
16464552|NCT00608569|40178716|FG000|Overall Study|Unable to adhere with study requirements|0|||
16464553|NCT00608569|40178717|FG001|Overall Study|Unable to adhere with study requirements|1|||
16464554|NCT01566214|40178718|FG000|Overall Study|Lost to Follow-up|3|||
16464555|NCT01566214|40178719|FG001|Overall Study|Lost to Follow-up|0|||
16464556|NCT04518995|40178720|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
16464557|NCT04518995|40178721|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
16464558|NCT04518995|40178722|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
16464559|NCT04518995|40178720|FG000|Overall Study|Lack of Efficacy|2|||
16464560|NCT04518995|40178721|FG001|Overall Study|Lack of Efficacy|1|||
16464561|NCT04518995|40178722|FG002|Overall Study|Lack of Efficacy|0|||
16464562|NCT04518995|40178720|FG000|Overall Study|Non-compliance With Study Drug|0|||
16464563|NCT04518995|40178721|FG001|Overall Study|Non-compliance With Study Drug|3|||
16464564|NCT04518995|40178722|FG002|Overall Study|Non-compliance With Study Drug|2|||
16464565|NCT04518995|40178720|FG000|Overall Study|Pregnancy|0|||
16464566|NCT04518995|40178721|FG001|Overall Study|Pregnancy|0|||
16464567|NCT04518995|40178722|FG002|Overall Study|Pregnancy|1|||
16464568|NCT04518995|40178720|FG000|Overall Study|Protocol Violation|2|||
16464569|NCT04518995|40178721|FG001|Overall Study|Protocol Violation|0|||
16464570|NCT04518995|40178722|FG002|Overall Study|Protocol Violation|1|||
16464571|NCT04518995|40178720|FG000|Overall Study|Reason not Specified|4|||
16464572|NCT04518995|40178721|FG001|Overall Study|Reason not Specified|11|||
16464573|NCT04518995|40178722|FG002|Overall Study|Reason not Specified|2|||
16464574|NCT04518995|40178720|FG000|Overall Study|Lost to Follow-up|1|||
16464575|NCT04518995|40178721|FG001|Overall Study|Lost to Follow-up|10|||
16464576|NCT04518995|40178722|FG002|Overall Study|Lost to Follow-up|6|||
16464577|NCT02483533|40178723|FG000|Overall Study|Lack of Efficacy|50|||
16464578|NCT02483533|40178724|FG001|Overall Study|Lack of Efficacy|50|||
16464579|NCT03433456|40178729|FG000|Overall Study|Death|1|||
16464580|NCT03433456|40178730|FG001|Overall Study|Death|1|||
16464581|NCT03433456|40178729|FG000|Overall Study|Lost to Follow-up|14|||
16169977|NCT01275222|39099031|FG002|Phase l by Treatment|Disease progression|2|||
16169978|NCT01275222|39099032|FG003|Phase l by Treatment|Disease progression|5|||
16169979|NCT01275222|39099033|FG004|Phase l by Treatment|Disease progression|0|||
16169980|NCT01275222|39099034|FG005|Phase l by Treatment|Disease progression|0|||
16169981|NCT01275222|39099029|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
16464582|NCT03433456|40178730|FG001|Overall Study|Lost to Follow-up|11|||
16464583|NCT03433456|40178729|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
16464584|NCT03433456|40178730|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
16464585|NCT01009840|40178731|FG000|Overall Study|Lost to Follow-up|1|||
16464586|NCT01009840|40178731|FG000|Overall Study|Adverse Event|4|||
16464587|NCT01009840|40178731|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
16464588|NCT01009840|40178731|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
16464589|NCT01009840|40178731|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
16464590|NCT01215916|40178732|FG000|Overall Study|Progressive Disease|0|||
16464591|NCT01215916|40178733|FG001|Overall Study|Progressive Disease|2|||
16464592|NCT01215916|40178734|FG002|Overall Study|Progressive Disease|1|||
16464593|NCT01215916|40178735|FG003|Overall Study|Progressive Disease|2|||
16464594|NCT01215916|40178736|FG004|Overall Study|Progressive Disease|5|||
16169982|NCT01275222|39099030|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
16169983|NCT01275222|39099031|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
16169984|NCT01275222|39099032|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
16169985|NCT01275222|39099033|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
16169986|NCT01275222|39099034|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
16169987|NCT01275222|39099029|FG000|Phase l by Treatment|Death|0|||
16169988|NCT01275222|39099030|FG001|Phase l by Treatment|Death|1|||
16169989|NCT01275222|39099031|FG002|Phase l by Treatment|Death|0|||
16169990|NCT01275222|39099032|FG003|Phase l by Treatment|Death|1|||
16169991|NCT01275222|39099033|FG004|Phase l by Treatment|Death|0|||
16169992|NCT01275222|39099034|FG005|Phase l by Treatment|Death|0|||
16169993|NCT01275222|39099029|FG000|Phase ll by Stratum|Adverse Event|0|||
16169994|NCT01275222|39099030|FG001|Phase ll by Stratum|Adverse Event|0|||
16169995|NCT01275222|39099031|FG002|Phase ll by Stratum|Adverse Event|0|||
16169996|NCT01275222|39099032|FG003|Phase ll by Stratum|Adverse Event|0|||
16169997|NCT01275222|39099033|FG004|Phase ll by Stratum|Adverse Event|2|||
16169998|NCT01275222|39099034|FG005|Phase ll by Stratum|Adverse Event|10|||
16169999|NCT01275222|39099029|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
16170000|NCT01275222|39099030|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
16170001|NCT01275222|39099031|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
16170002|NCT01275222|39099032|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
16170003|NCT01275222|39099033|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
16170004|NCT01275222|39099034|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
16170005|NCT01275222|39099029|FG000|Phase ll by Stratum|Disease progression|0|||
16464595|NCT01215916|40178737|FG005|Overall Study|Progressive Disease|4|||
16464596|NCT01215916|40178738|FG006|Overall Study|Progressive Disease|5|||
16464597|NCT01215916|40178739|FG007|Overall Study|Progressive Disease|3|||
16464598|NCT01215916|40178740|FG008|Overall Study|Progressive Disease|1|||
16464599|NCT01215916|40178732|FG000|Overall Study|Adverse Event|1|||
16464600|NCT01215916|40178733|FG001|Overall Study|Adverse Event|1|||
16464601|NCT01215916|40178734|FG002|Overall Study|Adverse Event|0|||
16170006|NCT01275222|39099030|FG001|Phase ll by Stratum|Disease progression|0|||
16170007|NCT01275222|39099031|FG002|Phase ll by Stratum|Disease progression|0|||
16170008|NCT01275222|39099032|FG003|Phase ll by Stratum|Disease progression|0|||
16464602|NCT01215916|40178735|FG003|Overall Study|Adverse Event|1|||
16464603|NCT01215916|40178736|FG004|Overall Study|Adverse Event|0|||
16464604|NCT01215916|40178737|FG005|Overall Study|Adverse Event|0|||
16464605|NCT01215916|40178738|FG006|Overall Study|Adverse Event|3|||
16464606|NCT01215916|40178739|FG007|Overall Study|Adverse Event|0|||
16464607|NCT01215916|40178740|FG008|Overall Study|Adverse Event|0|||
16464608|NCT01215916|40178732|FG000|Overall Study|Withdrawal by Subject|0|||
16464609|NCT01215916|40178733|FG001|Overall Study|Withdrawal by Subject|1|||
16464610|NCT01215916|40178734|FG002|Overall Study|Withdrawal by Subject|1|||
16464611|NCT01215916|40178735|FG003|Overall Study|Withdrawal by Subject|2|||
16464612|NCT01215916|40178736|FG004|Overall Study|Withdrawal by Subject|0|||
16464613|NCT01215916|40178737|FG005|Overall Study|Withdrawal by Subject|0|||
16464614|NCT01215916|40178738|FG006|Overall Study|Withdrawal by Subject|1|||
16464615|NCT01215916|40178739|FG007|Overall Study|Withdrawal by Subject|0|||
16464616|NCT01215916|40178740|FG008|Overall Study|Withdrawal by Subject|0|||
16464617|NCT01215916|40178732|FG000|Overall Study|Death|0|||
16464618|NCT01215916|40178733|FG001|Overall Study|Death|1|||
16464619|NCT01215916|40178734|FG002|Overall Study|Death|0|||
16464620|NCT01215916|40178735|FG003|Overall Study|Death|0|||
16464621|NCT01215916|40178736|FG004|Overall Study|Death|1|||
16464622|NCT01215916|40178737|FG005|Overall Study|Death|0|||
16464623|NCT01215916|40178738|FG006|Overall Study|Death|0|||
16464624|NCT01215916|40178739|FG007|Overall Study|Death|0|||
16464625|NCT01215916|40178740|FG008|Overall Study|Death|1|||
16464626|NCT01215916|40178732|FG000|Overall Study|Physician Decision|0|||
16464627|NCT01215916|40178733|FG001|Overall Study|Physician Decision|0|||
16464628|NCT01215916|40178734|FG002|Overall Study|Physician Decision|1|||
16464629|NCT01215916|40178735|FG003|Overall Study|Physician Decision|1|||
16464630|NCT01215916|40178736|FG004|Overall Study|Physician Decision|0|||
16464631|NCT01215916|40178737|FG005|Overall Study|Physician Decision|0|||
16464632|NCT01215916|40178738|FG006|Overall Study|Physician Decision|0|||
16464633|NCT01215916|40178739|FG007|Overall Study|Physician Decision|0|||
16170009|NCT01275222|39099033|FG004|Phase ll by Stratum|Disease progression|23|||
16170010|NCT01275222|39099034|FG005|Phase ll by Stratum|Disease progression|31|||
16170011|NCT01275222|39099029|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
16170012|NCT01275222|39099030|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
16464634|NCT01215916|40178740|FG008|Overall Study|Physician Decision|0|||
16464635|NCT01853839|40178741|FG000|Overall Study|Violated inclusion criteria|2|||
16464636|NCT01853839|40178741|FG000|Overall Study|Not meet ITT population definition|58|||
16464637|NCT01853839|40178741|FG000|Overall Study|End of treatment visit too early|33|||
16464638|NCT01853839|40178741|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
16464639|NCT01001299|40178744|FG000|Overall Study|Insufficient Therapeutic Response|20|||
16464640|NCT01001299|40178744|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
16464641|NCT01001299|40178744|FG000|Overall Study|Death|1|||
16170013|NCT01275222|39099031|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
16170014|NCT01275222|39099032|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
16170015|NCT01275222|39099033|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
16170016|NCT01275222|39099034|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
16170017|NCT01275222|39099029|FG000|Phase ll by Stratum|Death|0|||
16170018|NCT01275222|39099030|FG001|Phase ll by Stratum|Death|0|||
16170019|NCT01275222|39099031|FG002|Phase ll by Stratum|Death|0|||
16170020|NCT01275222|39099032|FG003|Phase ll by Stratum|Death|0|||
16170021|NCT01275222|39099033|FG004|Phase ll by Stratum|Death|1|||
16170022|NCT01275222|39099034|FG005|Phase ll by Stratum|Death|1|||
16170023|NCT01032629|39099035|FG000|Overall Study|Closed Site|21|||
16170024|NCT01032629|39099036|FG001|Overall Study|Closed Site|18|||
16170025|NCT01032629|39099037|FG002|Overall Study|Closed Site|16|||
16170026|NCT01032629|39099035|FG000|Overall Study|Withdrawal by Subject|50|||
16170027|NCT01032629|39099036|FG001|Overall Study|Withdrawal by Subject|36|||
16170028|NCT01032629|39099037|FG002|Overall Study|Withdrawal by Subject|35|||
16170029|NCT01032629|39099035|FG000|Overall Study|Lost to Follow-up|74|||
16170030|NCT01032629|39099036|FG001|Overall Study|Lost to Follow-up|47|||
16170031|NCT01032629|39099037|FG002|Overall Study|Lost to Follow-up|37|||
16170032|NCT02949830|39099040|FG000|Overall Study|Adverse Event|1|||
16170033|NCT02949830|39099040|FG000|Overall Study|Withdrawal by Subject|1|||
16170034|NCT02775435|39099042|FG000|Overall Study|Adverse Event|48|||
16170035|NCT02775435|39099043|FG001|Overall Study|Adverse Event|25|||
16170036|NCT02775435|39099042|FG000|Overall Study|Lost to Follow-up|0|||
16170037|NCT02775435|39099043|FG001|Overall Study|Lost to Follow-up|2|||
16170038|NCT02775435|39099042|FG000|Overall Study|Physician Decision|5|||
16170039|NCT02775435|39099043|FG001|Overall Study|Physician Decision|6|||
16170040|NCT02775435|39099042|FG000|Overall Study|Withdrawal by Subject|5|||
16170041|NCT02775435|39099043|FG001|Overall Study|Withdrawal by Subject|9|||
16170042|NCT02775435|39099042|FG000|Overall Study|Progressive Disease|86|||
16170043|NCT02775435|39099043|FG001|Overall Study|Progressive Disease|140|||
16170044|NCT02775435|39099042|FG000|Overall Study|Clinical Progression|13|||
16170045|NCT02775435|39099043|FG001|Overall Study|Clinical Progression|26|||
16170046|NCT02775435|39099042|FG000|Overall Study|Ongoing in Study|121|||
16170047|NCT02775435|39099043|FG001|Overall Study|Ongoing in Study|72|||
16170048|NCT02775435|39099042|FG000|Overall Study|Not Treated|0|||
16170049|NCT02775435|39099043|FG001|Overall Study|Not Treated|1|||
16170050|NCT01162421|39099045|FG000|Overall Study|Did not receive study drug|2|||
16170051|NCT01162421|39099046|FG001|Overall Study|Did not receive study drug|1|||
16170052|NCT01162421|39099045|FG000|Overall Study|Adverse Event|2|||
16170053|NCT01162421|39099046|FG001|Overall Study|Adverse Event|5|||
16170054|NCT01162421|39099045|FG000|Overall Study|Lost to Follow-up|0|||
16170055|NCT01162421|39099046|FG001|Overall Study|Lost to Follow-up|2|||
16170056|NCT01162421|39099045|FG000|Overall Study|Lack of Efficacy|2|||
16170057|NCT01162421|39099046|FG001|Overall Study|Lack of Efficacy|2|||
16170058|NCT01162421|39099045|FG000|Overall Study|Other|2|||
16170059|NCT01162421|39099046|FG001|Overall Study|Other|3|||
16170060|NCT01279057|39099051|FG000|Overall Study|Adverse Event|1|||
16170061|NCT01279057|39099052|FG001|Overall Study|Adverse Event|0|||
16170062|NCT01279057|39099053|FG002|Overall Study|Adverse Event|1|||
16170063|NCT01279057|39099051|FG000|Overall Study|Insufficient therapeutic response|0|||
16464642|NCT01001299|40178744|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
16464643|NCT01001299|40178744|FG000|Overall Study|Withdrew Consent|1|||
16170064|NCT01279057|39099052|FG001|Overall Study|Insufficient therapeutic response|0|||
16170065|NCT01279057|39099053|FG002|Overall Study|Insufficient therapeutic response|1|||
16464644|NCT01463007|40178745|FG000|Overall Study|Physician Decision|1|||
16464645|NCT00584740|40178747|FG000|Overall Study|Adverse Event|1|||
16464646|NCT00584740|40178748|FG001|Overall Study|Adverse Event|1|||
16464647|NCT00584740|40178747|FG000|Overall Study|Lack of Efficacy|8|||
16464648|NCT00584740|40178748|FG001|Overall Study|Lack of Efficacy|2|||
16170066|NCT01279057|39099051|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
16170067|NCT01279057|39099052|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
16464649|NCT00584740|40178747|FG000|Overall Study|Withdrawal by Subject|3|||
16170068|NCT01279057|39099053|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
16170069|NCT01279057|39099051|FG000|Overall Study|Withdrew consent|2|||
16170070|NCT01279057|39099052|FG001|Overall Study|Withdrew consent|0|||
16170071|NCT01279057|39099053|FG002|Overall Study|Withdrew consent|1|||
16170072|NCT01279057|39099051|FG000|Overall Study|Pregnancy|0|||
16170073|NCT01279057|39099052|FG001|Overall Study|Pregnancy|1|||
16170074|NCT01279057|39099053|FG002|Overall Study|Pregnancy|0|||
16170075|NCT01279057|39099051|FG000|Overall Study|Other|3|||
16170076|NCT01279057|39099052|FG001|Overall Study|Other|3|||
16170077|NCT01279057|39099053|FG002|Overall Study|Other|0|||
16170078|NCT04373460|39099054|FG000|Overall Study|Did not receive tranfusion|18|||
16170079|NCT04373460|39099055|FG001|Overall Study|Did not receive tranfusion|26|||
16170080|NCT02468648|39099057|FG000|Overall Study|Death|1|||
16170081|NCT00388947|39099064|FG000|Overall Study|Protocol Violation|47|||
16464650|NCT00584740|40178748|FG001|Overall Study|Withdrawal by Subject|2|||
16170082|NCT00404092|39099065|FG000|Overall Study|Death|1|||
16170083|NCT00404092|39099066|FG001|Overall Study|Death|0|||
16170084|NCT00404092|39099067|FG002|Overall Study|Death|0|||
16170085|NCT00404092|39099068|FG003|Overall Study|Death|0|||
16170086|NCT00404092|39099065|FG000|Overall Study|Adverse Event|0|||
16170087|NCT00404092|39099066|FG001|Overall Study|Adverse Event|0|||
16170088|NCT00404092|39099067|FG002|Overall Study|Adverse Event|1|||
16170089|NCT00404092|39099068|FG003|Overall Study|Adverse Event|0|||
16170090|NCT03136107|39099069|FG000|Overall Study|Other (Not specified)|1|||
16170091|NCT00500266|39099074|FG000|Overall Study|Death|3|||
16170092|NCT00500266|39099074|FG000|Overall Study|Lost to Follow-up|3|||
16170093|NCT00500266|39099074|FG000|Overall Study|Withdrawal by Subject|3|||
16170094|NCT00500266|39099074|FG000|Overall Study|Assigned, not treated|4|||
16170095|NCT00584233|39099078|FG000|Overall Study|Withdrawal by Subject|5|||
16170096|NCT00584233|39099078|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
16170097|NCT02620020|39099079|FG000|Overall Study|Adverse Event|8|||
16170098|NCT02620020|39099080|FG001|Overall Study|Adverse Event|4|||
16170099|NCT02620020|39099081|FG002|Overall Study|Adverse Event|3|||
16170100|NCT02620020|39099082|FG003|Overall Study|Adverse Event|5|||
16170101|NCT02620020|39099079|FG000|Overall Study|Lost to Follow-up|4|||
16170102|NCT02620020|39099080|FG001|Overall Study|Lost to Follow-up|8|||
16170103|NCT02620020|39099081|FG002|Overall Study|Lost to Follow-up|1|||
16170104|NCT02620020|39099082|FG003|Overall Study|Lost to Follow-up|4|||
16170105|NCT02620020|39099079|FG000|Overall Study|Physician Decision|7|||
16170106|NCT02620020|39099080|FG001|Overall Study|Physician Decision|4|||
16170107|NCT02620020|39099081|FG002|Overall Study|Physician Decision|3|||
16170108|NCT02620020|39099082|FG003|Overall Study|Physician Decision|4|||
16170109|NCT02620020|39099079|FG000|Overall Study|Protocol Violation|5|||
16170110|NCT02620020|39099080|FG001|Overall Study|Protocol Violation|2|||
16170111|NCT02620020|39099081|FG002|Overall Study|Protocol Violation|1|||
16170112|NCT02620020|39099082|FG003|Overall Study|Protocol Violation|1|||
16170113|NCT02620020|39099079|FG000|Overall Study|Withdrawal by Subject|20|||
16170114|NCT02620020|39099080|FG001|Overall Study|Withdrawal by Subject|16|||
16170115|NCT02620020|39099081|FG002|Overall Study|Withdrawal by Subject|17|||
16170116|NCT02620020|39099082|FG003|Overall Study|Withdrawal by Subject|12|||
16464651|NCT00584740|40178747|FG000|Overall Study|Lost to Follow-up|0|||
16269276|NCT04089553|39471048|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
16269277|NCT04089553|39471049|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
16269278|NCT04089553|39471048|FG000|Overall Study|Other|1|||
16464652|NCT00584740|40178748|FG001|Overall Study|Lost to Follow-up|1|||
16464653|NCT04575597|40178749|FG000|Overall Study|Death|0|||
16464654|NCT04575597|40178750|FG001|Overall Study|Death|0|||
16464655|NCT04575597|40178751|FG002|Overall Study|Death|0|||
16464656|NCT04575597|40178752|FG003|Overall Study|Death|1|||
16464657|NCT04575597|40178753|FG004|Overall Study|Death|3|||
16464658|NCT04575597|40178754|FG005|Overall Study|Death|14|||
16464659|NCT04575597|40178749|FG000|Overall Study|Lost to Follow-up|2|||
16464660|NCT04575597|40178750|FG001|Overall Study|Lost to Follow-up|1|||
16464661|NCT04575597|40178751|FG002|Overall Study|Lost to Follow-up|1|||
16464662|NCT04575597|40178752|FG003|Overall Study|Lost to Follow-up|2|||
16464663|NCT04575597|40178753|FG004|Overall Study|Lost to Follow-up|10|||
16464664|NCT04575597|40178754|FG005|Overall Study|Lost to Follow-up|8|||
16464665|NCT04575597|40178749|FG000|Overall Study|Withdrawal by Subject|2|||
16170117|NCT02620020|39099079|FG000|Overall Study|Death|0|||
16170118|NCT02620020|39099080|FG001|Overall Study|Death|1|||
16170119|NCT02620020|39099081|FG002|Overall Study|Death|0|||
16170120|NCT02620020|39099082|FG003|Overall Study|Death|0|||
16170121|NCT02116621|39099083|FG000|Baseline|Withdrawal by Subject|0|||
16170122|NCT02116621|39099084|FG001|Baseline|Withdrawal by Subject|4|||
16170123|NCT02116621|39099083|FG000|Three Month Follow-up|Death|1|||
16170124|NCT02116621|39099084|FG001|Three Month Follow-up|Death|1|||
16170125|NCT02116621|39099083|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
16170126|NCT02116621|39099084|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
16170127|NCT02116621|39099083|FG000|Three Month Follow-up|Lost to Follow-up|0|||
16170128|NCT02116621|39099084|FG001|Three Month Follow-up|Lost to Follow-up|1|||
16170129|NCT02116621|39099083|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
16170130|NCT02116621|39099084|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
16170131|NCT02116621|39099083|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
16170132|NCT02116621|39099084|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
16170133|NCT02116621|39099083|FG000|Six Month Follow-up|Lost to Follow-up|2|||
16170134|NCT02116621|39099084|FG001|Six Month Follow-up|Lost to Follow-up|1|||
16170135|NCT02116621|39099083|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
16170136|NCT02116621|39099084|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
16170137|NCT02116621|39099083|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
16170138|NCT02116621|39099084|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
16464666|NCT04575597|40178750|FG001|Overall Study|Withdrawal by Subject|2|||
16464667|NCT04575597|40178751|FG002|Overall Study|Withdrawal by Subject|4|||
16464668|NCT04575597|40178752|FG003|Overall Study|Withdrawal by Subject|2|||
16464669|NCT04575597|40178753|FG004|Overall Study|Withdrawal by Subject|25|||
16170139|NCT02116621|39099083|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
16464670|NCT04575597|40178754|FG005|Overall Study|Withdrawal by Subject|28|||
16464671|NCT04575597|40178749|FG000|Overall Study|Not Recorded|0|||
16464672|NCT04575597|40178750|FG001|Overall Study|Not Recorded|0|||
16464673|NCT04575597|40178751|FG002|Overall Study|Not Recorded|0|||
16464674|NCT04575597|40178752|FG003|Overall Study|Not Recorded|0|||
16170140|NCT02116621|39099084|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
16170141|NCT02116621|39099083|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
16170142|NCT02116621|39099084|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
16170143|NCT02116621|39099083|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
16170144|NCT02116621|39099084|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
16170145|NCT01246206|39099085|FG000|Overall Study|Patient did not receive study regiments.|1|||
16170146|NCT02809833|39099088|FG000|Overall Study|Death|3|||
16170147|NCT02809833|39099088|FG000|Overall Study|Intolerance|54|||
16170148|NCT02809833|39099088|FG000|Overall Study|Lack of Efficacy|89|||
16170149|NCT02809833|39099088|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
16170150|NCT02809833|39099088|FG000|Overall Study|Noncompliance|1|||
16170151|NCT02809833|39099088|FG000|Overall Study|Withdrawal by Subject|34|||
16170152|NCT02809833|39099088|FG000|Overall Study|Lost to Follow-up|35|||
16170153|NCT02809833|39099088|FG000|Overall Study|Adverse Event (AE)|24|||
16170154|NCT02809833|39099088|FG000|Overall Study|Other|5|||
16170155|NCT02809833|39099088|FG000|Overall Study|Missing Information|52|||
16170156|NCT00699348|39099089|FG000|Overall Study|Death|6|||
16464675|NCT04575597|40178753|FG004|Overall Study|Not Recorded|0|||
16464676|NCT04575597|40178754|FG005|Overall Study|Not Recorded|2|||
16464677|NCT04575597|40178749|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16464678|NCT04575597|40178750|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16464679|NCT04575597|40178751|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16464680|NCT04575597|40178752|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
16464681|NCT04575597|40178753|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
16464682|NCT04575597|40178754|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
16464683|NCT00567255|40178757|FG000|Overall Study|Adverse Event|241|||
16464684|NCT00567255|40178758|FG001|Overall Study|Adverse Event|68|||
16464685|NCT00567255|40178757|FG000|Overall Study|Lost to Follow-up|77|||
16464686|NCT00567255|40178758|FG001|Overall Study|Lost to Follow-up|48|||
16464687|NCT00567255|40178757|FG000|Overall Study|Withdrawal by Subject|75|||
16464688|NCT00567255|40178758|FG001|Overall Study|Withdrawal by Subject|56|||
16464689|NCT00567255|40178757|FG000|Overall Study|Lack of Efficacy|19|||
16464690|NCT00567255|40178758|FG001|Overall Study|Lack of Efficacy|33|||
16464691|NCT00567255|40178757|FG000|Overall Study|Protocol Violation|20|||
16464692|NCT00567255|40178758|FG001|Overall Study|Protocol Violation|8|||
16464693|NCT00567255|40178757|FG000|Overall Study|Pregnancy|6|||
16464694|NCT00567255|40178758|FG001|Overall Study|Pregnancy|0|||
16464695|NCT00567255|40178757|FG000|Overall Study|Drug noncompliance,moved,other|25|||
16464696|NCT00567255|40178758|FG001|Overall Study|Drug noncompliance,moved,other|15|||
16464697|NCT02650921|40178759|FG000|Overall Study|Withdrawal by Subject|4|||
16464698|NCT02650921|40178759|FG000|Overall Study|Lost to Follow-up|2|||
16170157|NCT00699348|39099089|FG000|Overall Study|Adverse Event|15|||
16170158|NCT00699348|39099089|FG000|Overall Study|Withdrawal by Subject|11|||
16170159|NCT00699348|39099089|FG000|Overall Study|Protocol Violation|10|||
16170160|NCT00699348|39099089|FG000|Overall Study|Lack of Efficacy|8|||
16464699|NCT02650921|40178759|FG000|Overall Study|Adverse Event|1|||
16170161|NCT00699348|39099089|FG000|Overall Study|Failure to return|1|||
16170162|NCT00699348|39099089|FG000|Overall Study|Blood transfusion|24|||
16170163|NCT00699348|39099089|FG000|Overall Study|Renal transplantation|10|||
16170164|NCT00699348|39099089|FG000|Overall Study|Other|5|||
16170165|NCT00469612|39099090|FG000|Overall Study|Study terminated before data collected|2|||
16170166|NCT00469612|39099091|FG001|Overall Study|Study terminated before data collected|0|||
16170167|NCT00473876|39099095|FG000|Overall Study|Lost to Follow-up|3|||
16170168|NCT00473876|39099096|FG001|Overall Study|Lost to Follow-up|1|||
16170169|NCT00122135|39099097|FG000|Overall Study|Withdrawal by Subject|3|||
16170170|NCT00122135|39099098|FG001|Overall Study|Withdrawal by Subject|0|||
16170171|NCT02689492|39099100|FG000|Overall Study|Lost to Follow-up|61|||
16170172|NCT02689492|39099100|FG000|Overall Study|Withdrawal by Subject|11|||
16464700|NCT02650921|40178759|FG000|Overall Study|Due to Medical Condition|1|||
16170173|NCT02689492|39099100|FG000|Overall Study|Death|9|||
16170174|NCT02689492|39099100|FG000|Overall Study|Physician Decision|2|||
16170175|NCT02689492|39099100|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
16170176|NCT02689492|39099100|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
16170177|NCT02689492|39099100|FG000|Overall Study|Other than listed|1|||
16170178|NCT01587989|39099112|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
16170179|NCT01587989|39099113|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
16170180|NCT01587989|39099114|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
16464701|NCT01120067|40178778|FG000|Overall Study|Lost to Follow-up|3|||
16464702|NCT01120067|40178779|FG001|Overall Study|Lost to Follow-up|1|||
16464703|NCT01120067|40178778|FG000|Overall Study|fail to engage >3 sessions|2|||
16464704|NCT01120067|40178779|FG001|Overall Study|fail to engage >3 sessions|0|||
16464705|NCT01989468|40178793|FG000|Overall Study|Adverse Event|10|||
16464706|NCT01989468|40178794|FG001|Overall Study|Adverse Event|15|||
16170181|NCT01587989|39099112|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
16464707|NCT01989468|40178795|FG002|Overall Study|Adverse Event|4|||
16464708|NCT01989468|40178796|FG003|Overall Study|Adverse Event|5|||
16464709|NCT01989468|40178797|FG004|Overall Study|Adverse Event|4|||
16464710|NCT01989468|40178793|FG000|Overall Study|Lack of Efficacy|11|||
16464711|NCT01989468|40178794|FG001|Overall Study|Lack of Efficacy|11|||
16464712|NCT01989468|40178795|FG002|Overall Study|Lack of Efficacy|7|||
16464713|NCT01989468|40178796|FG003|Overall Study|Lack of Efficacy|4|||
16464714|NCT01989468|40178797|FG004|Overall Study|Lack of Efficacy|2|||
16464715|NCT01989468|40178793|FG000|Overall Study|Lost to Follow-up|5|||
16464716|NCT01989468|40178794|FG001|Overall Study|Lost to Follow-up|2|||
16464717|NCT01989468|40178795|FG002|Overall Study|Lost to Follow-up|0|||
16464718|NCT01989468|40178796|FG003|Overall Study|Lost to Follow-up|1|||
16464719|NCT01989468|40178797|FG004|Overall Study|Lost to Follow-up|1|||
16464720|NCT01989468|40178793|FG000|Overall Study|Physician Decision|4|||
16464721|NCT01989468|40178794|FG001|Overall Study|Physician Decision|1|||
16464722|NCT01989468|40178795|FG002|Overall Study|Physician Decision|0|||
16464723|NCT01989468|40178796|FG003|Overall Study|Physician Decision|1|||
16464724|NCT01989468|40178797|FG004|Overall Study|Physician Decision|0|||
16464725|NCT01989468|40178793|FG000|Overall Study|Pregnancy|0|||
16464726|NCT01989468|40178794|FG001|Overall Study|Pregnancy|1|||
16464727|NCT01989468|40178795|FG002|Overall Study|Pregnancy|0|||
16464728|NCT01989468|40178796|FG003|Overall Study|Pregnancy|0|||
16464729|NCT01989468|40178797|FG004|Overall Study|Pregnancy|0|||
16464730|NCT01989468|40178793|FG000|Overall Study|Technical Problems|3|||
16464731|NCT01989468|40178794|FG001|Overall Study|Technical Problems|1|||
16464732|NCT01989468|40178795|FG002|Overall Study|Technical Problems|3|||
16464733|NCT01989468|40178796|FG003|Overall Study|Technical Problems|1|||
16464734|NCT01989468|40178797|FG004|Overall Study|Technical Problems|0|||
16464735|NCT01989468|40178793|FG000|Overall Study|Subject Guardian Decision|11|||
16464736|NCT01989468|40178794|FG001|Overall Study|Subject Guardian Decision|6|||
16464737|NCT01989468|40178795|FG002|Overall Study|Subject Guardian Decision|4|||
16464738|NCT01989468|40178796|FG003|Overall Study|Subject Guardian Decision|4|||
16464739|NCT01989468|40178797|FG004|Overall Study|Subject Guardian Decision|1|||
16464740|NCT01989468|40178793|FG000|Overall Study|Death|3|||
16464741|NCT01989468|40178794|FG001|Overall Study|Death|0|||
16464742|NCT01989468|40178795|FG002|Overall Study|Death|1|||
16464743|NCT01989468|40178796|FG003|Overall Study|Death|0|||
16464744|NCT01989468|40178797|FG004|Overall Study|Death|0|||
16464745|NCT04439253|40178802|FG000|Overall Study|Adverse Event|1|||
16464746|NCT04439253|40178802|FG000|Overall Study|Disease progression|2|||
16464747|NCT04439253|40178802|FG000|Overall Study|Complicating disease|1|||
16464748|NCT01227629|40181930|FG000|Overall Study|Adverse Event|2|||
16464749|NCT01227629|40181931|FG001|Overall Study|Adverse Event|2|||
16464750|NCT01227629|40181932|FG002|Overall Study|Adverse Event|1|||
16464751|NCT01227629|40181933|FG003|Overall Study|Adverse Event|6|||
16464752|NCT01227629|40181934|FG004|Overall Study|Adverse Event|1|||
16464753|NCT01227629|40181935|FG005|Overall Study|Adverse Event|1|||
16464754|NCT01227629|40181936|FG006|Overall Study|Adverse Event|6|||
16464755|NCT01227629|40181937|FG007|Overall Study|Adverse Event|6|||
16464756|NCT01227629|40181938|FG008|Overall Study|Adverse Event|4|||
16464757|NCT01227629|40181939|FG009|Overall Study|Adverse Event|0|||
16464758|NCT01227629|40181930|FG000|Overall Study|Protocol Violation|0|||
16464759|NCT01227629|40181931|FG001|Overall Study|Protocol Violation|0|||
16464760|NCT01227629|40181932|FG002|Overall Study|Protocol Violation|0|||
16464761|NCT01227629|40181933|FG003|Overall Study|Protocol Violation|1|||
16464762|NCT01227629|40181934|FG004|Overall Study|Protocol Violation|0|||
16464763|NCT01227629|40181935|FG005|Overall Study|Protocol Violation|0|||
16464764|NCT01227629|40181936|FG006|Overall Study|Protocol Violation|0|||
16464765|NCT01227629|40181937|FG007|Overall Study|Protocol Violation|0|||
16464766|NCT01227629|40181938|FG008|Overall Study|Protocol Violation|0|||
16464767|NCT01227629|40181939|FG009|Overall Study|Protocol Violation|0|||
16464768|NCT01227629|40181930|FG000|Overall Study|Lost to Follow-up|0|||
16464769|NCT01227629|40181931|FG001|Overall Study|Lost to Follow-up|0|||
16464770|NCT01227629|40181932|FG002|Overall Study|Lost to Follow-up|0|||
16464771|NCT01227629|40181933|FG003|Overall Study|Lost to Follow-up|0|||
16464772|NCT01227629|40181934|FG004|Overall Study|Lost to Follow-up|1|||
16464773|NCT01227629|40181935|FG005|Overall Study|Lost to Follow-up|0|||
16464774|NCT01227629|40181936|FG006|Overall Study|Lost to Follow-up|0|||
16464775|NCT01227629|40181937|FG007|Overall Study|Lost to Follow-up|0|||
16464776|NCT01227629|40181938|FG008|Overall Study|Lost to Follow-up|0|||
16464777|NCT01227629|40181939|FG009|Overall Study|Lost to Follow-up|0|||
16464778|NCT01227629|40181930|FG000|Overall Study|Withdrawal by Subject|0|||
16464779|NCT01227629|40181931|FG001|Overall Study|Withdrawal by Subject|0|||
16464780|NCT01227629|40181932|FG002|Overall Study|Withdrawal by Subject|0|||
16464781|NCT01227629|40181933|FG003|Overall Study|Withdrawal by Subject|0|||
16464782|NCT01227629|40181934|FG004|Overall Study|Withdrawal by Subject|0|||
16464783|NCT01227629|40181935|FG005|Overall Study|Withdrawal by Subject|0|||
16464784|NCT01227629|40181936|FG006|Overall Study|Withdrawal by Subject|2|||
16464785|NCT01227629|40181937|FG007|Overall Study|Withdrawal by Subject|0|||
16464786|NCT01227629|40181938|FG008|Overall Study|Withdrawal by Subject|0|||
16464787|NCT01227629|40181939|FG009|Overall Study|Withdrawal by Subject|1|||
16464788|NCT01227629|40181930|FG000|Overall Study|Other|0|||
16464789|NCT01227629|40181931|FG001|Overall Study|Other|0|||
16464790|NCT01227629|40181932|FG002|Overall Study|Other|0|||
16464791|NCT01227629|40181933|FG003|Overall Study|Other|1|||
16464792|NCT01227629|40181934|FG004|Overall Study|Other|0|||
16464793|NCT01227629|40181935|FG005|Overall Study|Other|0|||
16464794|NCT01227629|40181936|FG006|Overall Study|Other|0|||
16464795|NCT01227629|40181937|FG007|Overall Study|Other|0|||
16464796|NCT01227629|40181938|FG008|Overall Study|Other|2|||
16464797|NCT01227629|40181939|FG009|Overall Study|Other|1|||
16464798|NCT02342418|40181940|FG000|Overall Study|Adverse Event|0|||
16464799|NCT02342418|40181941|FG001|Overall Study|Adverse Event|1|||
16464800|NCT01465191|40181942|FG000|Overall Study|Protocol Violation|6|||
16464801|NCT01465191|40181943|FG001|Overall Study|Protocol Violation|3|||
16464802|NCT01465191|40181944|FG002|Overall Study|Protocol Violation|3|||
16464803|NCT01465191|40181942|FG000|Overall Study|Lost to Follow-up|3|||
16464804|NCT01465191|40181943|FG001|Overall Study|Lost to Follow-up|6|||
16464805|NCT01465191|40181944|FG002|Overall Study|Lost to Follow-up|4|||
16464806|NCT01030666|40181945|FG000|Overall Study|Lost to Follow-up|3|||
16464807|NCT01030666|40181946|FG001|Overall Study|Lost to Follow-up|2|||
16464808|NCT02015221|40181951|FG000|Overall Study|Withdrawal by Subject|8|||
16464809|NCT02015221|40181952|FG001|Overall Study|Withdrawal by Subject|6|||
16464810|NCT02015221|40181951|FG000|Overall Study|Lost to Follow-up|1|||
16464811|NCT02015221|40181952|FG001|Overall Study|Lost to Follow-up|0|||
16464812|NCT02742246|40181953|FG000|Overall Study|Never initiated treatment|5|||
16464813|NCT02742246|40181954|FG001|Overall Study|Never initiated treatment|3|||
16464814|NCT02742246|40181955|FG002|Overall Study|Never initiated treatment|1|||
16464815|NCT02742246|40181953|FG000|Overall Study|dropped out during treatment|7|||
16464816|NCT02742246|40181954|FG001|Overall Study|dropped out during treatment|13|||
16464817|NCT02742246|40181955|FG002|Overall Study|dropped out during treatment|10|||
16464818|NCT02742246|40181953|FG000|Overall Study|Death|1|||
16464819|NCT02742246|40181954|FG001|Overall Study|Death|0|||
16464820|NCT02742246|40181955|FG002|Overall Study|Death|0|||
16464821|NCT03338959|40181956|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
16464822|NCT03338959|40181956|FG000|Overall Study|Physician Decision|1|||
16464823|NCT00731042|40181957|FG000|Second Intervention|Did not meet inclusion criteria|0|||
16464824|NCT00731042|40181958|FG001|Second Intervention|Did not meet inclusion criteria|2|||
16464825|NCT01375075|40181959|FG000|Overall Study|Adverse Event|0|||
16464826|NCT01375075|40181960|FG001|Overall Study|Adverse Event|0|||
16464827|NCT01375075|40181961|FG002|Overall Study|Adverse Event|3|||
16464828|NCT01375075|40181962|FG003|Overall Study|Adverse Event|1|||
16464829|NCT01375075|40181963|FG004|Overall Study|Adverse Event|0|||
16464830|NCT01375075|40181964|FG005|Overall Study|Adverse Event|1|||
16464831|NCT01375075|40181959|FG000|Overall Study|Entry Criterion Not Met|1|||
16464832|NCT01375075|40181960|FG001|Overall Study|Entry Criterion Not Met|0|||
16464833|NCT01375075|40181961|FG002|Overall Study|Entry Criterion Not Met|0|||
16464834|NCT01375075|40181962|FG003|Overall Study|Entry Criterion Not Met|0|||
16464835|NCT01375075|40181963|FG004|Overall Study|Entry Criterion Not Met|0|||
16464836|NCT01375075|40181964|FG005|Overall Study|Entry Criterion Not Met|1|||
16464837|NCT01375075|40181959|FG000|Overall Study|Withdrawal by Subject|0|||
16464838|NCT01375075|40181960|FG001|Overall Study|Withdrawal by Subject|1|||
16464839|NCT01375075|40181961|FG002|Overall Study|Withdrawal by Subject|0|||
16464840|NCT01375075|40181962|FG003|Overall Study|Withdrawal by Subject|0|||
16464841|NCT01375075|40181963|FG004|Overall Study|Withdrawal by Subject|0|||
16464842|NCT01375075|40181964|FG005|Overall Study|Withdrawal by Subject|1|||
16464843|NCT00527488|40181966|FG000|Overall Study|Withdrawn prior to dosing|0|||
16464844|NCT00527488|40181967|FG001|Overall Study|Withdrawn prior to dosing|1|||
16464845|NCT00527488|40181968|FG002|Overall Study|Withdrawn prior to dosing|1|||
16464846|NCT00527488|40181969|FG003|Overall Study|Withdrawn prior to dosing|0|||
16464847|NCT01075191|40181971|FG000|Overall Study|Death|1|||
16464848|NCT01075191|40181971|FG000|Overall Study|Intensification|3|||
16464849|NCT01075191|40181971|FG000|Overall Study|Co-morbidities|1|||
16464850|NCT01075191|40181971|FG000|Overall Study|Adverse Event|4|||
16464851|NCT01075191|40181971|FG000|Overall Study|Noncompliance|3|||
16464852|NCT01075191|40181971|FG000|Overall Study|Therapy Break|3|||
16464853|NCT01075191|40181971|FG000|Overall Study|Patient's Wish|2|||
16464854|NCT01075191|40181971|FG000|Overall Study|Unknown Reasons|1|||
16464855|NCT01743001|40181974|FG000|Overall Study|Physician Decision|1|||
16464856|NCT01743001|40181975|FG001|Overall Study|Physician Decision|0|||
16464857|NCT01743001|40181974|FG000|Overall Study|Pregnancy|1|||
16464858|NCT01743001|40181975|FG001|Overall Study|Pregnancy|0|||
16464859|NCT01743001|40181974|FG000|Overall Study|Death|1|||
16464860|NCT01743001|40181975|FG001|Overall Study|Death|0|||
16464861|NCT00592774|40181976|FG000|Overall Study|Adverse Event|5|||
16464862|NCT00592774|40181977|FG001|Overall Study|Adverse Event|19|||
16464863|NCT00592774|40181978|FG002|Overall Study|Adverse Event|2|||
16464864|NCT00592774|40181979|FG003|Overall Study|Adverse Event|14|||
16464865|NCT00592774|40181980|FG004|Overall Study|Adverse Event|8|||
16464866|NCT00592774|40181976|FG000|Overall Study|Protocol Violation|0|||
16464867|NCT00592774|40181977|FG001|Overall Study|Protocol Violation|1|||
16464868|NCT00592774|40181978|FG002|Overall Study|Protocol Violation|0|||
16170182|NCT01587989|39099113|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
16170183|NCT01587989|39099114|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
16170184|NCT01587989|39099112|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
16170185|NCT01587989|39099113|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
16170186|NCT01587989|39099114|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
16170187|NCT01587989|39099112|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
16170188|NCT01587989|39099113|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
16170189|NCT01587989|39099114|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
16170190|NCT01587989|39099112|FG000|Randomized Study Treatment|Screening failure|0|||
16170191|NCT01587989|39099113|FG001|Randomized Study Treatment|Screening failure|1|||
16170192|NCT01587989|39099114|FG002|Randomized Study Treatment|Screening failure|0|||
16170193|NCT01587989|39099112|FG000|Randomized Study Treatment|Physician Decision|0|||
16170194|NCT01587989|39099113|FG001|Randomized Study Treatment|Physician Decision|0|||
16464869|NCT00592774|40181979|FG003|Overall Study|Protocol Violation|0|||
16464870|NCT00592774|40181980|FG004|Overall Study|Protocol Violation|1|||
16464871|NCT00592774|40181976|FG000|Overall Study|Withdrawal by Subject|3|||
16464872|NCT00592774|40181977|FG001|Overall Study|Withdrawal by Subject|7|||
16464873|NCT00592774|40181978|FG002|Overall Study|Withdrawal by Subject|0|||
16464874|NCT00592774|40181979|FG003|Overall Study|Withdrawal by Subject|0|||
16464875|NCT00592774|40181980|FG004|Overall Study|Withdrawal by Subject|0|||
16464876|NCT00592774|40181976|FG000|Overall Study|Lack of Efficacy|3|||
16464877|NCT00592774|40181977|FG001|Overall Study|Lack of Efficacy|3|||
16464878|NCT00592774|40181978|FG002|Overall Study|Lack of Efficacy|0|||
16464879|NCT00592774|40181979|FG003|Overall Study|Lack of Efficacy|0|||
16464880|NCT00592774|40181980|FG004|Overall Study|Lack of Efficacy|2|||
16464881|NCT00592774|40181976|FG000|Overall Study|Physician Decision|0|||
16464882|NCT00592774|40181977|FG001|Overall Study|Physician Decision|1|||
16464883|NCT00592774|40181978|FG002|Overall Study|Physician Decision|1|||
16464884|NCT00592774|40181979|FG003|Overall Study|Physician Decision|0|||
16464885|NCT00592774|40181980|FG004|Overall Study|Physician Decision|1|||
16464886|NCT00592774|40181976|FG000|Overall Study|Other|0|||
16464887|NCT00592774|40181977|FG001|Overall Study|Other|1|||
16464888|NCT00592774|40181978|FG002|Overall Study|Other|1|||
16464889|NCT00592774|40181979|FG003|Overall Study|Other|0|||
16464890|NCT00592774|40181980|FG004|Overall Study|Other|2|||
16464891|NCT00711516|40181981|FG000|Overall Study|Adverse Event|1|||
16464892|NCT00711516|40181982|FG001|Overall Study|Adverse Event|1|||
16464893|NCT00711516|40181981|FG000|Overall Study|Withdrawal by Subject|0|||
16464894|NCT00711516|40181982|FG001|Overall Study|Withdrawal by Subject|1|||
16464895|NCT00711516|40181981|FG000|Overall Study|Protocol Violation|0|||
16464896|NCT00711516|40181982|FG001|Overall Study|Protocol Violation|1|||
16464897|NCT03761797|40181984|FG000|Overall Study|Changing hospital|11|||
16464898|NCT03761797|40181984|FG000|Overall Study|Improvement/remission|6|||
16464899|NCT03761797|40181984|FG000|Overall Study|Withdrawal by Subject|19|||
16464900|NCT03761797|40181984|FG000|Overall Study|Lost to Follow-up|33|||
16464901|NCT03761797|40181984|FG000|Overall Study|Adverse Event|37|||
16464902|NCT03761797|40181984|FG000|Overall Study|Case report form (CRF) not collected|5|||
16464903|NCT03761797|40181984|FG000|Overall Study|No patient visit after entry|13|||
16464904|NCT03761797|40181984|FG000|Overall Study|Switch to other diabetes medication|10|||
16464905|NCT03761797|40181984|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
16464906|NCT03761797|40181984|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
16464907|NCT03761797|40181984|FG000|Overall Study|Insufficient effectives|2|||
16464908|NCT03761797|40181984|FG000|Overall Study|Excessive alcohol intake|1|||
16464909|NCT01101191|40181985|FG000|Period 1|Withdrawal by Subject|1|||
16464910|NCT01101191|40181986|FG001|Period 1|Withdrawal by Subject|0|||
16464911|NCT01101191|40181985|FG000|Period 1|Adverse Event|1|||
16464912|NCT01101191|40181986|FG001|Period 1|Adverse Event|2|||
16464913|NCT00409175|40181999|FG000|Overall Study|Adverse Event|4|||
16464914|NCT00409175|40182000|FG001|Overall Study|Adverse Event|3|||
16464915|NCT00409175|40181999|FG000|Overall Study|Withdrawal by Subject|1|||
16464916|NCT00409175|40182000|FG001|Overall Study|Withdrawal by Subject|2|||
16464917|NCT00409175|40181999|FG000|Overall Study|Negative genotype|0|||
16170195|NCT01587989|39099114|FG002|Randomized Study Treatment|Physician Decision|1|||
16170196|NCT00667576|39099115|FG000|Overall Study|Withdrawal by Subject|1|||
16464918|NCT00409175|40182000|FG001|Overall Study|Negative genotype|1|||
16464919|NCT00409175|40181999|FG000|Overall Study|Liver transplantation|13|||
16464920|NCT00409175|40182000|FG001|Overall Study|Liver transplantation|13|||
16464921|NCT02068768|40182001|FG000|Overall Study|Lost to Follow-up|5|||
16464922|NCT02068768|40182001|FG000|Overall Study|Early Termination by Sponsor|2|||
16464923|NCT04604132|40182002|FG000|Overall Study|Adverse Event|2|||
16464924|NCT04604132|40182003|FG001|Overall Study|Adverse Event|0|||
16464925|NCT04604132|40182004|FG002|Overall Study|Adverse Event|0|||
16464926|NCT04604132|40182005|FG003|Overall Study|Adverse Event|1|||
16464927|NCT04604132|40182006|FG004|Overall Study|Adverse Event|2|||
16464928|NCT04604132|40182002|FG000|Overall Study|Study terminated by sponsor|0|||
16464929|NCT04604132|40182003|FG001|Overall Study|Study terminated by sponsor|0|||
16464930|NCT04604132|40182004|FG002|Overall Study|Study terminated by sponsor|0|||
16464931|NCT04604132|40182005|FG003|Overall Study|Study terminated by sponsor|0|||
16464932|NCT04604132|40182006|FG004|Overall Study|Study terminated by sponsor|1|||
16464933|NCT04604132|40182002|FG000|Overall Study|Progressive disease: Clinical progression|0|||
16464934|NCT04604132|40182003|FG001|Overall Study|Progressive disease: Clinical progression|0|||
16464935|NCT04604132|40182004|FG002|Overall Study|Progressive disease: Clinical progression|1|||
16464936|NCT04604132|40182005|FG003|Overall Study|Progressive disease: Clinical progression|0|||
16464937|NCT04604132|40182006|FG004|Overall Study|Progressive disease: Clinical progression|0|||
16464938|NCT04604132|40182002|FG000|Overall Study|Progressive disease: Radiological progression|8|||
16464939|NCT04604132|40182003|FG001|Overall Study|Progressive disease: Radiological progression|7|||
16464940|NCT04604132|40182004|FG002|Overall Study|Progressive disease: Radiological progression|10|||
16464941|NCT04604132|40182005|FG003|Overall Study|Progressive disease: Radiological progression|4|||
16464942|NCT04604132|40182006|FG004|Overall Study|Progressive disease: Radiological progression|3|||
16464943|NCT04604132|40182002|FG000|Overall Study|Death|3|||
16464944|NCT04604132|40182003|FG001|Overall Study|Death|1|||
16464945|NCT04604132|40182004|FG002|Overall Study|Death|2|||
16464946|NCT04604132|40182005|FG003|Overall Study|Death|1|||
16464947|NCT04604132|40182006|FG004|Overall Study|Death|0|||
16464948|NCT01038869|40182007|FG000|Overall Study|Withdrawal by Subject|1|||
16464949|NCT01038869|40182007|FG000|Overall Study|Lost to Follow-up|6|||
16464950|NCT02522871|40182012|FG000|Overall Study|Protocol Violation|1|||
16464951|NCT02522871|40182013|FG001|Overall Study|Protocol Violation|4|||
16464952|NCT02522871|40182012|FG000|Overall Study|Treated without randomization|1|||
16464953|NCT02522871|40182013|FG001|Overall Study|Treated without randomization|0|||
16464954|NCT02522871|40182012|FG000|Overall Study|Death|9|||
16464955|NCT02522871|40182013|FG001|Overall Study|Death|9|||
16464956|NCT02522871|40182012|FG000|Overall Study|Died in operating room prior to transplant|0|||
16464957|NCT02522871|40182013|FG001|Overall Study|Died in operating room prior to transplant|1|||
16464958|NCT01998984|40182015|FG000|Overall Study|Adverse Event|0|||
16464959|NCT01998984|40182016|FG001|Overall Study|Adverse Event|0|||
16464960|NCT01998984|40182017|FG002|Overall Study|Adverse Event|0|||
16464961|NCT01998984|40182018|FG003|Overall Study|Adverse Event|1|||
16464962|NCT01998984|40182015|FG000|Overall Study|Lost to Follow-up|0|||
16464963|NCT01998984|40182016|FG001|Overall Study|Lost to Follow-up|1|||
16464964|NCT01998984|40182017|FG002|Overall Study|Lost to Follow-up|0|||
16464965|NCT01998984|40182018|FG003|Overall Study|Lost to Follow-up|1|||
16464966|NCT01998984|40182015|FG000|Overall Study|Withdrawal by Subject|0|||
16464967|NCT01998984|40182016|FG001|Overall Study|Withdrawal by Subject|0|||
16464968|NCT01998984|40182017|FG002|Overall Study|Withdrawal by Subject|1|||
16464969|NCT01998984|40182018|FG003|Overall Study|Withdrawal by Subject|0|||
16464970|NCT01998984|40182015|FG000|Overall Study|Other|0|||
16464971|NCT01998984|40182016|FG001|Overall Study|Other|0|||
16464972|NCT01998984|40182017|FG002|Overall Study|Other|0|||
16464973|NCT01998984|40182018|FG003|Overall Study|Other|1|||
16464974|NCT02969408|40182019|FG000|Overall Study|Adverse Event|2|||
16464975|NCT02969408|40182019|FG000|Overall Study|Withdrawal by Subject|8|||
16464976|NCT02969408|40182019|FG000|Overall Study|Lost to Follow-up|4|||
16464977|NCT02969408|40182019|FG000|Overall Study|Protocol Violation|1|||
16464978|NCT02969408|40182019|FG000|Overall Study|Other than specified|1|||
16464979|NCT04136444|40182020|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
16464980|NCT04136444|40182021|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
16464981|NCT02101112|40182022|FG000|Overall Study|Adverse Event|0|||
16464982|NCT02101112|40182023|FG001|Overall Study|Adverse Event|0|||
16464983|NCT02101112|40182024|FG002|Overall Study|Adverse Event|1|||
16464984|NCT02101112|40182025|FG003|Overall Study|Adverse Event|0|||
16464985|NCT02101112|40182026|FG004|Overall Study|Adverse Event|0|||
16464986|NCT02101112|40182027|FG005|Overall Study|Adverse Event|0|||
16464987|NCT02101112|40182022|FG000|Overall Study|Withdrawal by Subject|0|||
16464988|NCT02101112|40182023|FG001|Overall Study|Withdrawal by Subject|0|||
16464989|NCT02101112|40182024|FG002|Overall Study|Withdrawal by Subject|0|||
16464990|NCT02101112|40182025|FG003|Overall Study|Withdrawal by Subject|0|||
16464991|NCT02101112|40182026|FG004|Overall Study|Withdrawal by Subject|1|||
16464992|NCT02101112|40182027|FG005|Overall Study|Withdrawal by Subject|0|||
16464993|NCT00706849|40182032|FG000|Treatment Period|Adverse Event|0|||
16269279|NCT04089553|39471049|FG001|Overall Study|Other|0|||
16269280|NCT04089553|39471048|FG000|Overall Study|Adverse Event|1|||
16464994|NCT00706849|40182033|FG001|Treatment Period|Adverse Event|9|||
16464995|NCT00706849|40182032|FG000|Treatment Period|Other|0|||
16464996|NCT00706849|40182033|FG001|Treatment Period|Other|1|||
16464997|NCT00706849|40182032|FG000|Follow-up Period|Withdrawal by Subject|0|||
16464998|NCT00706849|40182033|FG001|Follow-up Period|Withdrawal by Subject|2|||
16464999|NCT00706849|40182032|FG000|Follow-up Period|Protocol non-compliance|0|||
16465000|NCT00706849|40182033|FG001|Follow-up Period|Protocol non-compliance|1|||
16170197|NCT00667576|39099116|FG001|Overall Study|Withdrawal by Subject|0|||
16170198|NCT00667576|39099117|FG002|Overall Study|Withdrawal by Subject|1|||
16170199|NCT00667576|39099118|FG003|Overall Study|Withdrawal by Subject|1|||
16170200|NCT00667576|39099119|FG004|Overall Study|Withdrawal by Subject|1|||
16170201|NCT00667576|39099115|FG000|Overall Study|Adverse Event|1|||
16170202|NCT00667576|39099116|FG001|Overall Study|Adverse Event|1|||
16170203|NCT00667576|39099117|FG002|Overall Study|Adverse Event|0|||
16170204|NCT00667576|39099118|FG003|Overall Study|Adverse Event|0|||
16465001|NCT01470989|40182034|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
16465002|NCT01470989|40182035|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
16465003|NCT01470989|40182034|FG000|Overall Study|Adverse Event|2|||
16465004|NCT01470989|40182035|FG001|Overall Study|Adverse Event|5|||
16465005|NCT01470989|40182034|FG000|Overall Study|Abnormal laboratory value|1|||
16465006|NCT01470989|40182035|FG001|Overall Study|Abnormal laboratory value|1|||
16465007|NCT01470989|40182034|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
16465008|NCT01470989|40182035|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
16465009|NCT01470989|40182034|FG000|Overall Study|Withdrawal by Subject|19|||
16465010|NCT01470989|40182035|FG001|Overall Study|Withdrawal by Subject|17|||
16465011|NCT01470989|40182034|FG000|Overall Study|Lost to Follow-up|18|||
16465012|NCT01470989|40182035|FG001|Overall Study|Lost to Follow-up|13|||
16170205|NCT00667576|39099119|FG004|Overall Study|Adverse Event|0|||
16170206|NCT00667576|39099115|FG000|Overall Study|Lost to Follow-up|0|||
16170207|NCT00667576|39099116|FG001|Overall Study|Lost to Follow-up|0|||
16170208|NCT00667576|39099117|FG002|Overall Study|Lost to Follow-up|1|||
16170209|NCT00667576|39099118|FG003|Overall Study|Lost to Follow-up|0|||
16170210|NCT00667576|39099119|FG004|Overall Study|Lost to Follow-up|0|||
16170211|NCT00667576|39099115|FG000|Overall Study|Protocol Violation|0|||
16170212|NCT00667576|39099116|FG001|Overall Study|Protocol Violation|0|||
16465013|NCT01470989|40182034|FG000|Overall Study|Administrative problems|2|||
16465014|NCT01470989|40182035|FG001|Overall Study|Administrative problems|4|||
16465015|NCT01470989|40182034|FG000|Overall Study|Death|2|||
16465016|NCT01470989|40182035|FG001|Overall Study|Death|2|||
16465017|NCT01470989|40182034|FG000|Overall Study|Protocol deviation|1|||
16465018|NCT01470989|40182035|FG001|Overall Study|Protocol deviation|2|||
16465019|NCT01461057|40182036|FG000|Overall Study|Death|10|||
16465020|NCT01461057|40182037|FG001|Overall Study|Death|9|||
16465021|NCT01461057|40182036|FG000|Overall Study|Withdrawal by Subject|2|||
16465022|NCT01461057|40182037|FG001|Overall Study|Withdrawal by Subject|3|||
16465023|NCT01461057|40182036|FG000|Overall Study|Physician Decision|0|||
16465024|NCT01461057|40182037|FG001|Overall Study|Physician Decision|2|||
16465025|NCT01461057|40182036|FG000|Overall Study|Adverse Event|0|||
16465026|NCT01461057|40182037|FG001|Overall Study|Adverse Event|1|||
16465027|NCT01461057|40182036|FG000|Overall Study|Progression of Disease|1|||
16465028|NCT01461057|40182037|FG001|Overall Study|Progression of Disease|0|||
16465029|NCT01461057|40182036|FG000|Overall Study|Study Terminated by Sponsor|2|||
16465030|NCT01461057|40182037|FG001|Overall Study|Study Terminated by Sponsor|0|||
16465031|NCT02095132|40182038|FG000|Overall Study|Adverse Event|0|||
16465032|NCT02095132|40182039|FG001|Overall Study|Adverse Event|0|||
16465033|NCT02095132|40182040|FG002|Overall Study|Adverse Event|0|||
16465034|NCT02095132|40182041|FG003|Overall Study|Adverse Event|0|||
16465035|NCT02095132|40182042|FG004|Overall Study|Adverse Event|1|||
16465036|NCT02095132|40182043|FG005|Overall Study|Adverse Event|0|||
16465037|NCT02095132|40182044|FG006|Overall Study|Adverse Event|1|||
16465038|NCT02095132|40182045|FG007|Overall Study|Adverse Event|0|||
16465039|NCT02095132|40182046|FG008|Overall Study|Adverse Event|0|||
16465040|NCT02095132|40182038|FG000|Overall Study|Death|0|||
16465041|NCT02095132|40182039|FG001|Overall Study|Death|0|||
16465042|NCT02095132|40182040|FG002|Overall Study|Death|0|||
16465043|NCT02095132|40182041|FG003|Overall Study|Death|0|||
16465044|NCT02095132|40182042|FG004|Overall Study|Death|0|||
16465045|NCT02095132|40182043|FG005|Overall Study|Death|0|||
16465046|NCT02095132|40182044|FG006|Overall Study|Death|1|||
16465047|NCT02095132|40182045|FG007|Overall Study|Death|0|||
16465048|NCT02095132|40182046|FG008|Overall Study|Death|0|||
16072704|NCT01959412|38759138|FG000|Overall Study|Adverse Event|0|||
16170213|NCT00667576|39099117|FG002|Overall Study|Protocol Violation|0|||
16170214|NCT00667576|39099118|FG003|Overall Study|Protocol Violation|1|||
16170215|NCT00667576|39099119|FG004|Overall Study|Protocol Violation|0|||
16170216|NCT00667576|39099115|FG000|Overall Study|Physician Decision|0|||
16170217|NCT00667576|39099116|FG001|Overall Study|Physician Decision|0|||
16170218|NCT00667576|39099117|FG002|Overall Study|Physician Decision|0|||
16465049|NCT02095132|40182038|FG000|Overall Study|Lack of Efficacy|3|||
16465050|NCT02095132|40182039|FG001|Overall Study|Lack of Efficacy|5|||
16465051|NCT02095132|40182040|FG002|Overall Study|Lack of Efficacy|2|||
16465052|NCT02095132|40182041|FG003|Overall Study|Lack of Efficacy|8|||
16465053|NCT02095132|40182042|FG004|Overall Study|Lack of Efficacy|3|||
16465054|NCT02095132|40182043|FG005|Overall Study|Lack of Efficacy|6|||
16465055|NCT02095132|40182044|FG006|Overall Study|Lack of Efficacy|10|||
16465056|NCT02095132|40182045|FG007|Overall Study|Lack of Efficacy|9|||
16465057|NCT02095132|40182046|FG008|Overall Study|Lack of Efficacy|8|||
16465058|NCT02095132|40182038|FG000|Overall Study|Physician Decision|1|||
16465059|NCT02095132|40182039|FG001|Overall Study|Physician Decision|0|||
16465060|NCT02095132|40182040|FG002|Overall Study|Physician Decision|0|||
16465061|NCT02095132|40182041|FG003|Overall Study|Physician Decision|0|||
16465062|NCT02095132|40182042|FG004|Overall Study|Physician Decision|0|||
16465063|NCT02095132|40182043|FG005|Overall Study|Physician Decision|0|||
16465064|NCT02095132|40182044|FG006|Overall Study|Physician Decision|1|||
16465065|NCT02095132|40182045|FG007|Overall Study|Physician Decision|0|||
16465066|NCT02095132|40182046|FG008|Overall Study|Physician Decision|2|||
16465067|NCT02095132|40182038|FG000|Overall Study|Withdrawal by Subject|0|||
16465068|NCT02095132|40182039|FG001|Overall Study|Withdrawal by Subject|0|||
16465069|NCT02095132|40182040|FG002|Overall Study|Withdrawal by Subject|2|||
16465070|NCT02095132|40182041|FG003|Overall Study|Withdrawal by Subject|2|||
16465071|NCT02095132|40182042|FG004|Overall Study|Withdrawal by Subject|3|||
16465072|NCT02095132|40182043|FG005|Overall Study|Withdrawal by Subject|0|||
16465073|NCT02095132|40182044|FG006|Overall Study|Withdrawal by Subject|5|||
16465074|NCT02095132|40182045|FG007|Overall Study|Withdrawal by Subject|0|||
16465075|NCT02095132|40182046|FG008|Overall Study|Withdrawal by Subject|0|||
16465076|NCT03874429|40182050|FG000|Overall Study|Adverse Event|2|||
16465077|NCT03874429|40182051|FG001|Overall Study|Adverse Event|2|||
16465078|NCT03874429|40182050|FG000|Overall Study|Lack of Efficacy|0|||
16465079|NCT03874429|40182051|FG001|Overall Study|Lack of Efficacy|1|||
16465080|NCT03874429|40182050|FG000|Overall Study|Covid-19 pandemic|4|||
16465081|NCT03874429|40182051|FG001|Overall Study|Covid-19 pandemic|2|||
16465082|NCT00266864|40182052|FG000|Overall Study|Lost to Follow-up|4|||
16465083|NCT00266864|40182053|FG001|Overall Study|Lost to Follow-up|1|||
16465084|NCT00266864|40182052|FG000|Overall Study|Withdrawal by Subject|1|||
16465085|NCT00266864|40182053|FG001|Overall Study|Withdrawal by Subject|1|||
16465086|NCT01307020|40182054|FG000|Overall Study|Lost to Follow-up|0|||
16465087|NCT01307020|40182055|FG001|Overall Study|Lost to Follow-up|0|||
16465088|NCT01307020|40182056|FG002|Overall Study|Lost to Follow-up|1|||
16465089|NCT01307020|40182057|FG003|Overall Study|Lost to Follow-up|1|||
16465090|NCT01307020|40182058|FG004|Overall Study|Lost to Follow-up|0|||
16465091|NCT01307020|40182059|FG005|Overall Study|Lost to Follow-up|0|||
16465092|NCT01307020|40182060|FG006|Overall Study|Lost to Follow-up|1|||
16465093|NCT01307020|40182061|FG007|Overall Study|Lost to Follow-up|0|||
16465094|NCT01307020|40182062|FG008|Overall Study|Lost to Follow-up|0|||
16465095|NCT01307020|40182063|FG009|Overall Study|Lost to Follow-up|0|||
16465096|NCT01307020|40182054|FG000|Overall Study|Electronic data capture failure|0|||
16465097|NCT01307020|40182055|FG001|Overall Study|Electronic data capture failure|1|||
16465098|NCT01307020|40182056|FG002|Overall Study|Electronic data capture failure|0|||
16465099|NCT01307020|40182057|FG003|Overall Study|Electronic data capture failure|0|||
16465100|NCT01307020|40182058|FG004|Overall Study|Electronic data capture failure|0|||
16465101|NCT01307020|40182059|FG005|Overall Study|Electronic data capture failure|0|||
16465102|NCT01307020|40182060|FG006|Overall Study|Electronic data capture failure|0|||
16465103|NCT01307020|40182061|FG007|Overall Study|Electronic data capture failure|0|||
16465104|NCT01307020|40182062|FG008|Overall Study|Electronic data capture failure|0|||
16465105|NCT01307020|40182063|FG009|Overall Study|Electronic data capture failure|0|||
16465106|NCT00621621|40182064|FG000|Overall Study|Subjects were exited at EP study|30|||
16465107|NCT00621621|40182065|FG001|Overall Study|Subjects were exited at EP study|0|||
16465108|NCT00137839|40182066|FG000|Overall Study|Adverse Event|7|||
16465109|NCT00137839|40182066|FG000|Overall Study|Physician Decision|7|||
16465110|NCT00137839|40182066|FG000|Overall Study|Death|8|||
16465111|NCT00137839|40182066|FG000|Overall Study|Disease Progression|60|||
16465112|NCT00137839|40182066|FG000|Overall Study|Not Start Treatment|1|||
16465113|NCT00137839|40182066|FG000|Overall Study|Prolonged Treatment Delay|1|||
16465114|NCT00397943|40182069|FG000|Overall Study|Unspecified reasons|12|||
16465115|NCT00397943|40182070|FG001|Overall Study|Unspecified reasons|9|||
16465116|NCT00397943|40182071|FG002|Overall Study|Unspecified reasons|0|||
16465117|NCT00397943|40182072|FG003|Overall Study|Unspecified reasons|0|||
16465118|NCT00397943|40182073|FG004|Overall Study|Unspecified reasons|0|||
16465119|NCT00719264|40182074|FG000|Overall Study|Adverse Event|41|||
16465120|NCT00719264|40182075|FG001|Overall Study|Adverse Event|49|||
16269281|NCT04089553|39471049|FG001|Overall Study|Adverse Event|1|||
16465121|NCT00719264|40182074|FG000|Overall Study|Death|13|||
16465122|NCT00719264|40182075|FG001|Overall Study|Death|10|||
16465123|NCT00719264|40182074|FG000|Overall Study|Administrative Problems|6|||
16465124|NCT00719264|40182075|FG001|Overall Study|Administrative Problems|4|||
16465125|NCT00719264|40182074|FG000|Overall Study|Lost to Follow-up|1|||
16465126|NCT00719264|40182075|FG001|Overall Study|Lost to Follow-up|1|||
16465127|NCT00719264|40182074|FG000|Overall Study|Withdrawal by Subject|12|||
16465128|NCT00719264|40182075|FG001|Overall Study|Withdrawal by Subject|7|||
16465129|NCT00719264|40182074|FG000|Overall Study|Protocol Deviation|1|||
16465130|NCT00719264|40182075|FG001|Overall Study|Protocol Deviation|3|||
16465131|NCT00719264|40182074|FG000|Overall Study|New Cancer Therapy|4|||
16465132|NCT00719264|40182075|FG001|Overall Study|New Cancer Therapy|2|||
16465133|NCT00719264|40182074|FG000|Overall Study|Disease Progression|104|||
16465134|NCT00719264|40182075|FG001|Overall Study|Disease Progression|107|||
16465135|NCT00816023|40182076|FG000|Overall Study|Lost to Follow-up|1|||
16465136|NCT00816023|40182077|FG001|Overall Study|Lost to Follow-up|1|||
16465137|NCT00816023|40182078|FG002|Overall Study|Lost to Follow-up|0|||
16465138|NCT00816023|40182079|FG003|Overall Study|Lost to Follow-up|0|||
16465139|NCT00816023|40182076|FG000|Overall Study|Withdrawal by Subject|1|||
16465140|NCT00816023|40182077|FG001|Overall Study|Withdrawal by Subject|0|||
16465141|NCT00816023|40182078|FG002|Overall Study|Withdrawal by Subject|0|||
16465142|NCT00816023|40182079|FG003|Overall Study|Withdrawal by Subject|0|||
16465143|NCT00816023|40182076|FG000|Overall Study|Physician Decision|0|||
16465144|NCT00816023|40182077|FG001|Overall Study|Physician Decision|0|||
16465145|NCT00816023|40182078|FG002|Overall Study|Physician Decision|1|||
16465146|NCT00816023|40182079|FG003|Overall Study|Physician Decision|0|||
16465147|NCT00816023|40182076|FG000|Overall Study|assessments complete prior to window|1|||
16465148|NCT00816023|40182077|FG001|Overall Study|assessments complete prior to window|1|||
16465149|NCT00816023|40182078|FG002|Overall Study|assessments complete prior to window|2|||
16465150|NCT00816023|40182079|FG003|Overall Study|assessments complete prior to window|1|||
16465151|NCT00816023|40182076|FG000|Overall Study|Randomized Not Treated|6|||
16465152|NCT00816023|40182077|FG001|Overall Study|Randomized Not Treated|4|||
16465153|NCT00816023|40182078|FG002|Overall Study|Randomized Not Treated|6|||
16465154|NCT00816023|40182079|FG003|Overall Study|Randomized Not Treated|11|||
16465155|NCT02158364|40182080|FG000|Overall Study|Case report forms uncollected|10|||
16465156|NCT02158364|40182080|FG000|Overall Study|Protocol Deviation|50|||
16465157|NCT04381988|40182081|FG000|Overall Study|The study was terminated|4|||
16465158|NCT04381988|40182082|FG001|Overall Study|The study was terminated|0|||
16465159|NCT00393042|40182083|FG000|First Intervention|Withdrawal by Subject|1|||
16465160|NCT00393042|40182084|FG001|First Intervention|Withdrawal by Subject|2|||
16465161|NCT00393042|40182083|FG000|First Intervention|Lost to Follow-up|3|||
16465162|NCT00393042|40182084|FG001|First Intervention|Lost to Follow-up|3|||
16465163|NCT00393042|40182083|FG000|First Intervention|Protocol Violation|1|||
16465164|NCT00393042|40182084|FG001|First Intervention|Protocol Violation|0|||
16465165|NCT00393042|40182083|FG000|First Intervention|Adverse Event|0|||
16465166|NCT00393042|40182084|FG001|First Intervention|Adverse Event|1|||
16465167|NCT00393042|40182083|FG000|Second Intervetion|Adverse Event|0|||
16465168|NCT00393042|40182084|FG001|Second Intervetion|Adverse Event|3|||
16465169|NCT00393042|40182083|FG000|Second Intervetion|Withdrawal by Subject|0|||
16465170|NCT00393042|40182084|FG001|Second Intervetion|Withdrawal by Subject|2|||
16465171|NCT00393042|40182083|FG000|Second Intervetion|Lack of Efficacy|1|||
16465172|NCT00393042|40182084|FG001|Second Intervetion|Lack of Efficacy|0|||
16465173|NCT00393042|40182083|FG000|Second Intervetion|Lost to Follow-up|0|||
16465174|NCT00393042|40182084|FG001|Second Intervetion|Lost to Follow-up|2|||
16465175|NCT00393042|40182083|FG000|Second Intervetion|Protocol Violation|1|||
16465176|NCT00393042|40182084|FG001|Second Intervetion|Protocol Violation|1|||
16465177|NCT00797966|40182085|FG000|Phase A|Lost to Follow-up|0|||
16465178|NCT00797966|40182086|FG001|Phase A|Lost to Follow-up|0|||
16465179|NCT00797966|40182087|FG002|Phase A|Lost to Follow-up|0|||
16465180|NCT00797966|40182088|FG003|Phase A|Lost to Follow-up|0|||
16465181|NCT00797966|40182089|FG004|Phase A|Lost to Follow-up|33|||
16465182|NCT00797966|40182090|FG005|Phase A|Lost to Follow-up|0|||
16465183|NCT00797966|40182085|FG000|Phase A|Adverse Event|0|||
16465184|NCT00797966|40182086|FG001|Phase A|Adverse Event|0|||
16465185|NCT00797966|40182087|FG002|Phase A|Adverse Event|0|||
16465186|NCT00797966|40182088|FG003|Phase A|Adverse Event|0|||
16465187|NCT00797966|40182089|FG004|Phase A|Adverse Event|46|||
16465188|NCT00797966|40182090|FG005|Phase A|Adverse Event|0|||
16465189|NCT00797966|40182085|FG000|Phase A|Met withdrawal criteria|0|||
16465190|NCT00797966|40182086|FG001|Phase A|Met withdrawal criteria|0|||
16465191|NCT00797966|40182087|FG002|Phase A|Met withdrawal criteria|0|||
16465192|NCT00797966|40182088|FG003|Phase A|Met withdrawal criteria|0|||
16465193|NCT00797966|40182089|FG004|Phase A|Met withdrawal criteria|4|||
16465194|NCT00797966|40182090|FG005|Phase A|Met withdrawal criteria|0|||
16465195|NCT00797966|40182085|FG000|Phase A|Physician Decision|0|||
16465196|NCT00797966|40182086|FG001|Phase A|Physician Decision|0|||
16465197|NCT00797966|40182087|FG002|Phase A|Physician Decision|0|||
16465198|NCT00797966|40182088|FG003|Phase A|Physician Decision|0|||
16465199|NCT00797966|40182089|FG004|Phase A|Physician Decision|13|||
16465200|NCT00797966|40182090|FG005|Phase A|Physician Decision|0|||
16465201|NCT00797966|40182085|FG000|Phase A|Withdrawal by Subject|0|||
16465202|NCT00797966|40182086|FG001|Phase A|Withdrawal by Subject|0|||
16465203|NCT00797966|40182087|FG002|Phase A|Withdrawal by Subject|0|||
16465204|NCT00797966|40182088|FG003|Phase A|Withdrawal by Subject|0|||
16465205|NCT00797966|40182089|FG004|Phase A|Withdrawal by Subject|33|||
16465206|NCT00797966|40182090|FG005|Phase A|Withdrawal by Subject|0|||
16465207|NCT00797966|40182085|FG000|Phase A|Protocol deviation|0|||
16465208|NCT00797966|40182086|FG001|Phase A|Protocol deviation|0|||
16465209|NCT00797966|40182087|FG002|Phase A|Protocol deviation|0|||
16072705|NCT01959412|38759139|FG001|Overall Study|Adverse Event|0|||
16465210|NCT00797966|40182088|FG003|Phase A|Protocol deviation|0|||
16465211|NCT00797966|40182089|FG004|Phase A|Protocol deviation|56|||
16465212|NCT00797966|40182090|FG005|Phase A|Protocol deviation|0|||
16465213|NCT00797966|40182085|FG000|Phase B|Lost to Follow-up|0|||
16465214|NCT00797966|40182086|FG001|Phase B|Lost to Follow-up|1|||
16465215|NCT00797966|40182087|FG002|Phase B|Lost to Follow-up|3|||
16465216|NCT00797966|40182088|FG003|Phase B|Lost to Follow-up|0|||
16465217|NCT00797966|40182089|FG004|Phase B|Lost to Follow-up|0|||
16465218|NCT00797966|40182090|FG005|Phase B|Lost to Follow-up|0|||
16465219|NCT00797966|40182085|FG000|Phase B|Adverse Event|2|||
16465220|NCT00797966|40182086|FG001|Phase B|Adverse Event|1|||
16465221|NCT00797966|40182087|FG002|Phase B|Adverse Event|3|||
16465222|NCT00797966|40182088|FG003|Phase B|Adverse Event|1|||
16465223|NCT00797966|40182089|FG004|Phase B|Adverse Event|0|||
16465224|NCT00797966|40182090|FG005|Phase B|Adverse Event|0|||
16465225|NCT00797966|40182085|FG000|Phase B|Met Withdrawal Criteria|3|||
16465226|NCT00797966|40182086|FG001|Phase B|Met Withdrawal Criteria|3|||
16465227|NCT00797966|40182087|FG002|Phase B|Met Withdrawal Criteria|6|||
16465228|NCT00797966|40182088|FG003|Phase B|Met Withdrawal Criteria|1|||
16465229|NCT00797966|40182089|FG004|Phase B|Met Withdrawal Criteria|0|||
16465230|NCT00797966|40182090|FG005|Phase B|Met Withdrawal Criteria|0|||
16465231|NCT00797966|40182085|FG000|Phase B|Physician Decision|1|||
16465232|NCT00797966|40182086|FG001|Phase B|Physician Decision|0|||
16465233|NCT00797966|40182087|FG002|Phase B|Physician Decision|3|||
16465234|NCT00797966|40182088|FG003|Phase B|Physician Decision|1|||
16465235|NCT00797966|40182089|FG004|Phase B|Physician Decision|0|||
16465236|NCT00797966|40182090|FG005|Phase B|Physician Decision|0|||
16465237|NCT00797966|40182085|FG000|Phase B|Withdrawal by Subject|1|||
16465238|NCT00797966|40182086|FG001|Phase B|Withdrawal by Subject|4|||
16465239|NCT00797966|40182087|FG002|Phase B|Withdrawal by Subject|3|||
16465240|NCT00797966|40182088|FG003|Phase B|Withdrawal by Subject|3|||
16465241|NCT00797966|40182089|FG004|Phase B|Withdrawal by Subject|0|||
16465242|NCT00797966|40182090|FG005|Phase B|Withdrawal by Subject|0|||
16465243|NCT00797966|40182085|FG000|Phase B|Protocol Deviation|4|||
16465244|NCT00797966|40182086|FG001|Phase B|Protocol Deviation|8|||
16465245|NCT00797966|40182087|FG002|Phase B|Protocol Deviation|2|||
16465246|NCT00797966|40182088|FG003|Phase B|Protocol Deviation|6|||
16465247|NCT00797966|40182089|FG004|Phase B|Protocol Deviation|0|||
16465248|NCT00797966|40182090|FG005|Phase B|Protocol Deviation|0|||
16465249|NCT00797966|40182085|FG000|Phase B|Lack of Efficacy|0|||
16465250|NCT00797966|40182086|FG001|Phase B|Lack of Efficacy|1|||
16465251|NCT00797966|40182087|FG002|Phase B|Lack of Efficacy|1|||
16465252|NCT00797966|40182088|FG003|Phase B|Lack of Efficacy|4|||
16465253|NCT00797966|40182089|FG004|Phase B|Lack of Efficacy|0|||
16465254|NCT00797966|40182090|FG005|Phase B|Lack of Efficacy|0|||
16465255|NCT00797966|40182085|FG000|Phase A+|Lost to Follow-up|0|||
16465256|NCT00797966|40182086|FG001|Phase A+|Lost to Follow-up|0|||
16465257|NCT00797966|40182087|FG002|Phase A+|Lost to Follow-up|0|||
16465258|NCT00797966|40182088|FG003|Phase A+|Lost to Follow-up|0|||
16465259|NCT00797966|40182089|FG004|Phase A+|Lost to Follow-up|0|||
16465260|NCT00797966|40182090|FG005|Phase A+|Lost to Follow-up|9|||
16465261|NCT00797966|40182085|FG000|Phase A+|Met withdrawal criteria|0|||
16465262|NCT00797966|40182086|FG001|Phase A+|Met withdrawal criteria|0|||
16465263|NCT00797966|40182087|FG002|Phase A+|Met withdrawal criteria|0|||
16465264|NCT00797966|40182088|FG003|Phase A+|Met withdrawal criteria|0|||
16465265|NCT00797966|40182089|FG004|Phase A+|Met withdrawal criteria|0|||
16269282|NCT00295490|39471053|FG000|Overall Study|Protocol Violation|0|||
16465266|NCT00797966|40182090|FG005|Phase A+|Met withdrawal criteria|5|||
16465267|NCT00797966|40182085|FG000|Phase A+|Withdrawal by Subject|0|||
16465268|NCT00797966|40182086|FG001|Phase A+|Withdrawal by Subject|0|||
16465269|NCT00797966|40182087|FG002|Phase A+|Withdrawal by Subject|0|||
16465270|NCT00797966|40182088|FG003|Phase A+|Withdrawal by Subject|0|||
16465271|NCT00797966|40182089|FG004|Phase A+|Withdrawal by Subject|0|||
16465272|NCT00797966|40182090|FG005|Phase A+|Withdrawal by Subject|6|||
16465273|NCT00797966|40182085|FG000|Phase A+|Adverse Event|0|||
16465274|NCT00797966|40182086|FG001|Phase A+|Adverse Event|0|||
16465275|NCT00797966|40182087|FG002|Phase A+|Adverse Event|0|||
16465276|NCT00797966|40182088|FG003|Phase A+|Adverse Event|0|||
16465277|NCT00797966|40182089|FG004|Phase A+|Adverse Event|0|||
16465278|NCT00797966|40182090|FG005|Phase A+|Adverse Event|4|||
16465279|NCT00797966|40182085|FG000|Phase A+|Protocol deviation|0|||
16465280|NCT00797966|40182086|FG001|Phase A+|Protocol deviation|0|||
16465281|NCT00797966|40182087|FG002|Phase A+|Protocol deviation|0|||
16465282|NCT00797966|40182088|FG003|Phase A+|Protocol deviation|0|||
16465283|NCT00797966|40182089|FG004|Phase A+|Protocol deviation|0|||
16465284|NCT00797966|40182090|FG005|Phase A+|Protocol deviation|4|||
16465285|NCT02425644|40182091|FG000|Overall Study|Lost to Follow-up|2|||
16465286|NCT02425644|40182092|FG001|Overall Study|Lost to Follow-up|3|||
16465287|NCT02425644|40182091|FG000|Overall Study|Withdrawal by Subject|41|||
16465288|NCT02425644|40182092|FG001|Overall Study|Withdrawal by Subject|36|||
16465289|NCT02425644|40182091|FG000|Overall Study|Lack of Efficacy|3|||
16465290|NCT02425644|40182092|FG001|Overall Study|Lack of Efficacy|10|||
16465291|NCT02425644|40182091|FG000|Overall Study|Adverse Event|13|||
16465292|NCT02425644|40182092|FG001|Overall Study|Adverse Event|3|||
16465293|NCT02425644|40182091|FG000|Overall Study|Death|0|||
16465294|NCT02425644|40182092|FG001|Overall Study|Death|2|||
16465295|NCT02425644|40182091|FG000|Overall Study|Other|18|||
16465296|NCT02425644|40182092|FG001|Overall Study|Other|17|||
16465297|NCT01133990|40182093|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
16465298|NCT01133990|40182094|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16465299|NCT01133990|40182095|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16465300|NCT01133990|40182096|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16465301|NCT01133990|40182097|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16465302|NCT01133990|40182098|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
16465303|NCT01133990|40182093|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
16465304|NCT01133990|40182094|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
16465305|NCT01133990|40182095|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
16465306|NCT01133990|40182096|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
16465307|NCT01133990|40182097|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
16465308|NCT01133990|40182098|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
16465309|NCT01133990|40182093|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
16465310|NCT01133990|40182094|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16465311|NCT01133990|40182095|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16465312|NCT01133990|40182096|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16465313|NCT01133990|40182097|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16465314|NCT01133990|40182098|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
16465315|NCT01133990|40182093|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
16465316|NCT01133990|40182094|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
16465317|NCT01133990|40182095|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
16465318|NCT01133990|40182096|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
16465319|NCT01133990|40182097|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
16465320|NCT01133990|40182098|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
16465321|NCT00538785|40182105|FG000|Overall Study|Death|9|||
16465322|NCT00538785|40182106|FG001|Overall Study|Death|10|||
16465323|NCT00538785|40182105|FG000|Overall Study|Withdrawal of consent|9|||
16465324|NCT00538785|40182106|FG001|Overall Study|Withdrawal of consent|7|||
16465325|NCT00538785|40182105|FG000|Overall Study|Lost to Follow-up|1|||
16465326|NCT00538785|40182106|FG001|Overall Study|Lost to Follow-up|0|||
16465327|NCT00791076|40182107|FG000|Overall Study|Study was terminated,PI left institution|8|||
16465328|NCT04905498|40182108|FG000|Overall Study|Lost to Follow-up|0|||
16465329|NCT04905498|40182109|FG001|Overall Study|Lost to Follow-up|2|||
16465330|NCT04905498|40182108|FG000|Overall Study|COVID lockdown|1|||
16465331|NCT04905498|40182109|FG001|Overall Study|COVID lockdown|0|||
16465332|NCT00913692|40182116|FG000|Screening (4 Months)|Physician Decision|3|||
16465333|NCT00913692|40182116|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
16465334|NCT00913692|40182116|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
16465335|NCT00528970|40182117|FG000|Overall Study|Adverse Event|6|||
16465336|NCT00528970|40182118|FG001|Overall Study|Adverse Event|8|||
16465337|NCT00528970|40182119|FG002|Overall Study|Adverse Event|5|||
16465338|NCT00528970|40182117|FG000|Overall Study|Lost to Follow-up|0|||
16465339|NCT00528970|40182118|FG001|Overall Study|Lost to Follow-up|0|||
16465340|NCT00528970|40182119|FG002|Overall Study|Lost to Follow-up|1|||
16465341|NCT00528970|40182117|FG000|Overall Study|Other than specified|2|||
16465342|NCT00528970|40182118|FG001|Overall Study|Other than specified|3|||
16465343|NCT00528970|40182119|FG002|Overall Study|Other than specified|3|||
16465344|NCT00528970|40182117|FG000|Overall Study|Protocol Violation|2|||
16465345|NCT00528970|40182118|FG001|Overall Study|Protocol Violation|1|||
16465346|NCT00528970|40182119|FG002|Overall Study|Protocol Violation|4|||
16465347|NCT00528970|40182117|FG000|Overall Study|Lack of Efficacy|0|||
16465348|NCT00528970|40182118|FG001|Overall Study|Lack of Efficacy|0|||
16465349|NCT00528970|40182119|FG002|Overall Study|Lack of Efficacy|1|||
16465350|NCT00528970|40182117|FG000|Overall Study|Withdrawal by Subject|4|||
16465351|NCT00528970|40182118|FG001|Overall Study|Withdrawal by Subject|3|||
16465352|NCT00528970|40182119|FG002|Overall Study|Withdrawal by Subject|5|||
16465353|NCT00528970|40182117|FG000|Overall Study|Randomized but not treated|0|||
16465354|NCT00528970|40182118|FG001|Overall Study|Randomized but not treated|0|||
16465355|NCT00528970|40182119|FG002|Overall Study|Randomized but not treated|1|||
16465356|NCT02617485|40182122|FG000|Treatment and Observation Period|Adverse Event|9|||
16465357|NCT02617485|40182123|FG001|Treatment and Observation Period|Adverse Event|1|||
16465358|NCT02617485|40182122|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
16465359|NCT02617485|40182123|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
16465360|NCT02617485|40182122|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
16465361|NCT02617485|40182123|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
16465362|NCT02617485|40182122|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
16465363|NCT02617485|40182123|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
16072706|NCT01959412|38759140|FG002|Overall Study|Adverse Event|0|||
16465364|NCT02617485|40182122|FG000|Treatment and Observation Period|Physician Decision|0|||
16465365|NCT02617485|40182123|FG001|Treatment and Observation Period|Physician Decision|1|||
16465366|NCT02617485|40182122|FG000|Follow-up Period|Adverse Event|1|||
16465367|NCT02617485|40182123|FG001|Follow-up Period|Adverse Event|0|||
16465368|NCT02617485|40182122|FG000|Follow-up Period|Withdrawal by Subject|1|||
16170219|NCT00667576|39099118|FG003|Overall Study|Physician Decision|1|||
16170220|NCT00667576|39099119|FG004|Overall Study|Physician Decision|0|||
16170221|NCT00667576|39099115|FG000|Overall Study|Missed Visit|0|||
16170222|NCT00667576|39099116|FG001|Overall Study|Missed Visit|0|||
16170223|NCT00667576|39099117|FG002|Overall Study|Missed Visit|0|||
16170224|NCT00667576|39099118|FG003|Overall Study|Missed Visit|1|||
16170225|NCT00667576|39099119|FG004|Overall Study|Missed Visit|0|||
16170226|NCT00289913|39099122|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170227|NCT00289913|39099123|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
16170228|NCT00289913|39099124|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170229|NCT00289913|39099125|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170230|NCT00289913|39099126|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170231|NCT00289913|39099122|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
16170232|NCT00289913|39099123|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
16170233|NCT00289913|39099124|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
16465369|NCT02617485|40182123|FG001|Follow-up Period|Withdrawal by Subject|0|||
16465370|NCT02617485|40182122|FG000|Follow-up Period|Disease progression|2|||
16465371|NCT02617485|40182123|FG001|Follow-up Period|Disease progression|1|||
16465372|NCT02617485|40182122|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
16465373|NCT02617485|40182123|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
16465374|NCT02617485|40182122|FG000|Follow-up Period|Patient needed radiotherapy|9|||
16465375|NCT02617485|40182123|FG001|Follow-up Period|Patient needed radiotherapy|5|||
16465376|NCT02617485|40182122|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
16465377|NCT02617485|40182123|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
16465378|NCT03699475|40182128|FG000|Overall Study|Death|1|||
16465379|NCT00991952|40182131|FG000|Overall Study|Adverse Event|0|||
16465380|NCT00991952|40182132|FG001|Overall Study|Adverse Event|1|||
16465381|NCT00727532|40182134|FG000|Overall Study|Adverse Event|1|||
16465382|NCT00727532|40182134|FG000|Overall Study|Withdrawal by Subject|1|||
16465383|NCT00327470|40182135|FG000|Overall Study|Randomized, but not treated|0|||
16465384|NCT00327470|40182136|FG001|Overall Study|Randomized, but not treated|2|||
16465385|NCT00327470|40182135|FG000|Overall Study|Adverse Event|9|||
16465386|NCT00327470|40182136|FG001|Overall Study|Adverse Event|14|||
16465387|NCT00327470|40182135|FG000|Overall Study|Lack of Efficacy|7|||
16465388|NCT00327470|40182136|FG001|Overall Study|Lack of Efficacy|19|||
16465389|NCT00327470|40182135|FG000|Overall Study|Other|5|||
16465390|NCT00327470|40182136|FG001|Overall Study|Other|9|||
16465391|NCT00327470|40182135|FG000|Overall Study|Lost to Follow-up|1|||
16465392|NCT00327470|40182136|FG001|Overall Study|Lost to Follow-up|3|||
16465393|NCT00327470|40182135|FG000|Overall Study|Withdrawal by Subject|6|||
16465394|NCT00327470|40182136|FG001|Overall Study|Withdrawal by Subject|12|||
16465395|NCT00327470|40182135|FG000|Overall Study|Death|1|||
16465396|NCT00327470|40182136|FG001|Overall Study|Death|4|||
16465397|NCT00281658|40182137|FG000|Randomized Phase|Adverse Event|0|||
16465398|NCT00281658|40182138|FG001|Randomized Phase|Adverse Event|2|||
16465399|NCT00281658|40182139|FG002|Randomized Phase|Adverse Event|0|||
16465400|NCT00281658|40182140|FG003|Randomized Phase|Adverse Event|0|||
16465401|NCT00281658|40182137|FG000|Randomized Phase|Lost to Follow-up|34|||
16465402|NCT00281658|40182138|FG001|Randomized Phase|Lost to Follow-up|27|||
16465403|NCT00281658|40182139|FG002|Randomized Phase|Lost to Follow-up|0|||
16465404|NCT00281658|40182140|FG003|Randomized Phase|Lost to Follow-up|0|||
16465405|NCT00281658|40182137|FG000|Randomized Phase|Withdrawal by Subject|8|||
16465406|NCT00281658|40182138|FG001|Randomized Phase|Withdrawal by Subject|7|||
16465407|NCT00281658|40182139|FG002|Randomized Phase|Withdrawal by Subject|0|||
16465408|NCT00281658|40182140|FG003|Randomized Phase|Withdrawal by Subject|0|||
16465409|NCT00281658|40182137|FG000|Randomized Phase|Study closed/terminated|1|||
16170234|NCT00289913|39099125|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
16269283|NCT00295490|39471054|FG001|Overall Study|Protocol Violation|0|||
16465410|NCT00281658|40182138|FG001|Randomized Phase|Study closed/terminated|1|||
16170235|NCT00289913|39099126|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
16465411|NCT00281658|40182139|FG002|Randomized Phase|Study closed/terminated|0|||
16465412|NCT00281658|40182140|FG003|Randomized Phase|Study closed/terminated|0|||
16465413|NCT00281658|40182137|FG000|Randomized Phase|Disease progression|36|||
16465414|NCT00281658|40182138|FG001|Randomized Phase|Disease progression|27|||
16465415|NCT00281658|40182139|FG002|Randomized Phase|Disease progression|0|||
16465416|NCT00281658|40182140|FG003|Randomized Phase|Disease progression|0|||
16465417|NCT00281658|40182137|FG000|Randomized Phase|Physician Decision|1|||
16465418|NCT00281658|40182138|FG001|Randomized Phase|Physician Decision|1|||
16465419|NCT00281658|40182139|FG002|Randomized Phase|Physician Decision|0|||
16465420|NCT00281658|40182140|FG003|Randomized Phase|Physician Decision|0|||
16465421|NCT00281658|40182137|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
16465422|NCT00281658|40182138|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
16465423|NCT00281658|40182139|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
16465424|NCT00281658|40182140|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
16465425|NCT00281658|40182137|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
16465426|NCT00281658|40182138|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
16465427|NCT00281658|40182139|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
16465428|NCT00281658|40182140|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
16465429|NCT00281658|40182137|FG000|Randomized Phase|Treatment ongoing|1|||
16170236|NCT00289913|39099122|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
16170237|NCT00289913|39099123|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
16170238|NCT00289913|39099124|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
16170239|NCT00289913|39099125|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
16465430|NCT00281658|40182138|FG001|Randomized Phase|Treatment ongoing|0|||
16465431|NCT00281658|40182139|FG002|Randomized Phase|Treatment ongoing|0|||
16465432|NCT00281658|40182140|FG003|Randomized Phase|Treatment ongoing|0|||
16465433|NCT00281658|40182137|FG000|Open Label Phase|Adverse Event|0|||
16465434|NCT00281658|40182138|FG001|Open Label Phase|Adverse Event|0|||
16465435|NCT00281658|40182139|FG002|Open Label Phase|Adverse Event|1|||
16465436|NCT00281658|40182140|FG003|Open Label Phase|Adverse Event|0|||
16465437|NCT00281658|40182137|FG000|Open Label Phase|Lost to Follow-up|0|||
16465438|NCT00281658|40182138|FG001|Open Label Phase|Lost to Follow-up|0|||
16465439|NCT00281658|40182139|FG002|Open Label Phase|Lost to Follow-up|16|||
16465440|NCT00281658|40182140|FG003|Open Label Phase|Lost to Follow-up|2|||
16465441|NCT00281658|40182137|FG000|Open Label Phase|Withdrawal by Subject|0|||
16465442|NCT00281658|40182138|FG001|Open Label Phase|Withdrawal by Subject|0|||
16465443|NCT00281658|40182139|FG002|Open Label Phase|Withdrawal by Subject|3|||
16465444|NCT00281658|40182140|FG003|Open Label Phase|Withdrawal by Subject|2|||
16465445|NCT00281658|40182137|FG000|Open Label Phase|Disease progression|0|||
16465446|NCT00281658|40182138|FG001|Open Label Phase|Disease progression|0|||
16465447|NCT00281658|40182139|FG002|Open Label Phase|Disease progression|18|||
16465448|NCT00281658|40182140|FG003|Open Label Phase|Disease progression|0|||
16465449|NCT00281658|40182137|FG000|Open Label Phase|Physician Decision|0|||
16465450|NCT00281658|40182138|FG001|Open Label Phase|Physician Decision|0|||
16465451|NCT00281658|40182139|FG002|Open Label Phase|Physician Decision|1|||
16465452|NCT00281658|40182140|FG003|Open Label Phase|Physician Decision|0|||
16465453|NCT00281658|40182137|FG000|Open Label Phase|Relocation of patient|0|||
16465454|NCT00281658|40182138|FG001|Open Label Phase|Relocation of patient|0|||
16465455|NCT00281658|40182139|FG002|Open Label Phase|Relocation of patient|1|||
16465456|NCT00281658|40182140|FG003|Open Label Phase|Relocation of patient|0|||
16465457|NCT00281658|40182137|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
16465458|NCT00281658|40182138|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
16465459|NCT00281658|40182139|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
16465460|NCT00281658|40182140|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
16465461|NCT00523367|40182141|FG000|Overall Study|19 screen failures|19|||
16465462|NCT00523367|40182141|FG000|Overall Study|4 Withdrawn by PI|4|||
16465463|NCT02446171|40182142|FG000|Overall Study|Withdrawal by Subject|0|||
16465464|NCT02446171|40182143|FG001|Overall Study|Withdrawal by Subject|0|||
16465465|NCT02446171|40182144|FG002|Overall Study|Withdrawal by Subject|2|||
16465466|NCT02446171|40182145|FG003|Overall Study|Withdrawal by Subject|0|||
16465467|NCT01974765|40182146|FG000|Overall Study|Withdrawal by Subject|1|||
16465468|NCT01974765|40182146|FG000|Overall Study|Death|1|||
16465469|NCT01974765|40182146|FG000|Overall Study|Adverse Event|2|||
16465470|NCT00662532|40182152|FG000|Overall Study|Adverse Event|0|||
16465471|NCT00662532|40182153|FG001|Overall Study|Adverse Event|1|||
16465472|NCT00662532|40182152|FG000|Overall Study|Lost to Follow-up|0|||
16170240|NCT00289913|39099126|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
16170241|NCT00289913|39099122|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
16170242|NCT00289913|39099123|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
16269284|NCT00295490|39471055|FG002|Overall Study|Protocol Violation|3|||
16465473|NCT00662532|40182153|FG001|Overall Study|Lost to Follow-up|1|||
16465474|NCT00246571|40182154|FG000|Overall Study|Adverse Event|7|||
16465475|NCT00246571|40182155|FG001|Overall Study|Adverse Event|0|||
16465476|NCT00246571|40182154|FG000|Overall Study|Protocol Violation|0|||
16465477|NCT00246571|40182155|FG001|Overall Study|Protocol Violation|1|||
16465478|NCT00246571|40182154|FG000|Overall Study|Withdrawal by Subject|2|||
16465479|NCT00246571|40182155|FG001|Overall Study|Withdrawal by Subject|3|||
16465480|NCT00246571|40182154|FG000|Overall Study|Lack of Efficacy|84|||
16465481|NCT00246571|40182155|FG001|Overall Study|Lack of Efficacy|21|||
16465482|NCT00246571|40182154|FG000|Overall Study|Death|17|||
16465483|NCT00246571|40182155|FG001|Overall Study|Death|3|||
16465484|NCT00246571|40182154|FG000|Overall Study|Sponsor|0|||
16465485|NCT00246571|40182155|FG001|Overall Study|Sponsor|1|||
16465486|NCT00246571|40182154|FG000|Overall Study|Did not meet entrance criteria|2|||
16465487|NCT00246571|40182155|FG001|Overall Study|Did not meet entrance criteria|1|||
16465488|NCT00246571|40182154|FG000|Overall Study|Laboratory abnormalities|1|||
16465489|NCT00246571|40182155|FG001|Overall Study|Laboratory abnormalities|0|||
16465490|NCT00246571|40182154|FG000|Overall Study|Crossover participants|0|||
16465491|NCT00246571|40182155|FG001|Overall Study|Crossover participants|74|||
16465492|NCT04022733|40182161|FG000|Overall Study|conversion to open surgery|3|||
16465493|NCT04022733|40182162|FG001|Overall Study|conversion to open surgery|2|||
16170243|NCT00289913|39099124|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
16170244|NCT00289913|39099125|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
16170245|NCT00289913|39099126|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
16170246|NCT00289913|39099122|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16170247|NCT00289913|39099123|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16269285|NCT00295490|39471056|FG003|Overall Study|Protocol Violation|3|||
16465494|NCT04022733|40182161|FG000|Overall Study|bradycardia|0|||
16465495|NCT04022733|40182162|FG001|Overall Study|bradycardia|1|||
16465496|NCT02273739|40182166|FG000|Overall Study|Progression of Disease|3|||
16465497|NCT02273739|40182167|FG001|Overall Study|Progression of Disease|4|||
16465498|NCT02273739|40182168|FG002|Overall Study|Progression of Disease|5|||
16465499|NCT02273739|40182169|FG003|Overall Study|Progression of Disease|2|||
16465500|NCT02273739|40182166|FG000|Overall Study|Death|0|||
16465501|NCT02273739|40182167|FG001|Overall Study|Death|0|||
16465502|NCT02273739|40182168|FG002|Overall Study|Death|0|||
16465503|NCT02273739|40182169|FG003|Overall Study|Death|2|||
16465504|NCT02273739|40182166|FG000|Overall Study|Adverse Event|0|||
16465505|NCT02273739|40182167|FG001|Overall Study|Adverse Event|0|||
16465506|NCT02273739|40182168|FG002|Overall Study|Adverse Event|0|||
16465507|NCT02273739|40182169|FG003|Overall Study|Adverse Event|1|||
16465508|NCT02273739|40182166|FG000|Overall Study|Withdrawal by Subject|0|||
16465509|NCT02273739|40182167|FG001|Overall Study|Withdrawal by Subject|0|||
16465510|NCT02273739|40182168|FG002|Overall Study|Withdrawal by Subject|2|||
16465511|NCT02273739|40182169|FG003|Overall Study|Withdrawal by Subject|1|||
16465512|NCT02273739|40182166|FG000|Overall Study|Physician Decision|0|||
16465513|NCT02273739|40182167|FG001|Overall Study|Physician Decision|0|||
16465514|NCT02273739|40182168|FG002|Overall Study|Physician Decision|0|||
16465515|NCT02273739|40182169|FG003|Overall Study|Physician Decision|1|||
16465516|NCT02616601|40182177|FG000|Overall Study|Withdrawal by Subject|4|||
16465517|NCT02616601|40182178|FG001|Overall Study|Withdrawal by Subject|4|||
16465518|NCT02616601|40182179|FG002|Overall Study|Withdrawal by Subject|3|||
16465519|NCT02616601|40182177|FG000|Overall Study|Adverse Event|2|||
16465520|NCT02616601|40182178|FG001|Overall Study|Adverse Event|0|||
16465521|NCT02616601|40182179|FG002|Overall Study|Adverse Event|2|||
16465522|NCT02616601|40182177|FG000|Overall Study|Death|1|||
16465523|NCT02616601|40182178|FG001|Overall Study|Death|0|||
16465524|NCT02616601|40182179|FG002|Overall Study|Death|0|||
16465525|NCT02616601|40182177|FG000|Overall Study|Lost to Follow-up|1|||
16465526|NCT02616601|40182178|FG001|Overall Study|Lost to Follow-up|0|||
16465527|NCT02616601|40182179|FG002|Overall Study|Lost to Follow-up|1|||
16465528|NCT02616601|40182177|FG000|Overall Study|Non-Compliance with Test Article|1|||
16465529|NCT02616601|40182178|FG001|Overall Study|Non-Compliance with Test Article|0|||
16465530|NCT02616601|40182179|FG002|Overall Study|Non-Compliance with Test Article|1|||
16465531|NCT04322539|40182180|FG000|Overall Study|Withdrawal of consent|14|||
16465532|NCT04322539|40182181|FG001|Overall Study|Withdrawal of consent|8|||
16465533|NCT04322539|40182180|FG000|Overall Study|Death|317|||
16465534|NCT04322539|40182181|FG001|Overall Study|Death|173|||
16465535|NCT04322539|40182180|FG000|Overall Study|Adverse Event|1|||
16465536|NCT04322539|40182181|FG001|Overall Study|Adverse Event|0|||
16465537|NCT04322539|40182180|FG000|Overall Study|Lost to Follow-up|3|||
16465538|NCT04322539|40182181|FG001|Overall Study|Lost to Follow-up|0|||
16465539|NCT04322539|40182180|FG000|Overall Study|Other|2|||
16465540|NCT04322539|40182181|FG001|Overall Study|Other|3|||
16465541|NCT04322539|40182180|FG000|Overall Study|Ongoing|124|||
16465542|NCT04322539|40182181|FG001|Overall Study|Ongoing|46|||
16465543|NCT00813943|40182182|FG000|Overall Study|Ongoing at cut-off date|5|||
16465544|NCT00813943|40182183|FG001|Overall Study|Ongoing at cut-off date|5|||
16170248|NCT00289913|39099124|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16465545|NCT00813943|40182184|FG002|Overall Study|Ongoing at cut-off date|3|||
16465546|NCT00409331|40182185|FG000|Overall Study|Physician Decision|1|||
16465547|NCT01829243|40182186|FG000|First Intervention|Screen Failure|4|||
16465548|NCT01829243|40182187|FG001|First Intervention|Screen Failure|2|||
16465549|NCT01436162|40182188|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
16465550|NCT01436162|40182189|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
16465551|NCT01436162|40182190|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
16465552|NCT01436162|40182188|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
16465553|NCT01436162|40182189|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
16465554|NCT01436162|40182190|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
16465555|NCT01436162|40182188|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
16465556|NCT01436162|40182189|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
16465557|NCT01436162|40182190|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
16465558|NCT01436162|40182188|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
16465559|NCT01436162|40182189|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
16465560|NCT01436162|40182190|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
16465561|NCT01436162|40182188|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
16465562|NCT01436162|40182189|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16465563|NCT01436162|40182190|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
16465564|NCT01436162|40182188|FG000|Single-blind Lead-in Phase|Other|107|||
16465565|NCT01436162|40182189|FG001|Single-blind Lead-in Phase|Other|0|||
16465566|NCT01436162|40182190|FG002|Single-blind Lead-in Phase|Other|0|||
16465567|NCT01436162|40182188|FG000|Randomized Phase|Adverse Event|1|||
16465568|NCT01436162|40182189|FG001|Randomized Phase|Adverse Event|5|||
16465569|NCT01436162|40182190|FG002|Randomized Phase|Adverse Event|6|||
16465570|NCT01436162|40182188|FG000|Randomized Phase|Protocol Violation|4|||
16465571|NCT01436162|40182189|FG001|Randomized Phase|Protocol Violation|4|||
16465572|NCT01436162|40182190|FG002|Randomized Phase|Protocol Violation|2|||
16465573|NCT01436162|40182188|FG000|Randomized Phase|Withdrawal by Subject|16|||
16465574|NCT01436162|40182189|FG001|Randomized Phase|Withdrawal by Subject|9|||
16465575|NCT01436162|40182190|FG002|Randomized Phase|Withdrawal by Subject|8|||
16465576|NCT01436162|40182188|FG000|Randomized Phase|Lost to Follow-up|17|||
16465577|NCT01436162|40182189|FG001|Randomized Phase|Lost to Follow-up|5|||
16465578|NCT01436162|40182190|FG002|Randomized Phase|Lost to Follow-up|4|||
16465579|NCT01436162|40182188|FG000|Randomized Phase|Lack of Efficacy|0|||
16465580|NCT01436162|40182189|FG001|Randomized Phase|Lack of Efficacy|1|||
16465581|NCT01436162|40182190|FG002|Randomized Phase|Lack of Efficacy|1|||
16465582|NCT01436162|40182188|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
16465583|NCT01436162|40182189|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
16170249|NCT00289913|39099125|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
16170250|NCT00289913|39099126|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16170251|NCT00289913|39099122|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
16170252|NCT00289913|39099123|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
16170253|NCT00289913|39099124|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
16170254|NCT00289913|39099125|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
16170255|NCT00289913|39099126|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
16170256|NCT00289913|39099122|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
16170257|NCT00289913|39099123|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
16170258|NCT00289913|39099124|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
16170259|NCT00289913|39099125|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
16170260|NCT00289913|39099126|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
16170261|NCT00289913|39099122|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
16170262|NCT00289913|39099123|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
16170263|NCT00289913|39099124|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
16170264|NCT00289913|39099125|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
16170265|NCT00289913|39099126|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
16170266|NCT00289913|39099122|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
16170267|NCT00289913|39099123|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
16170268|NCT00289913|39099124|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
16170269|NCT00289913|39099125|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
16170270|NCT00289913|39099126|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
16170271|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170272|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170273|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
16170274|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170275|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170276|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
16170277|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
16170278|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
16170279|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
16170280|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
16170281|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
16170282|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
16465584|NCT01436162|40182190|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
16465585|NCT01436162|40182188|FG000|Randomized Phase|Other|2|||
16465586|NCT01436162|40182189|FG001|Randomized Phase|Other|5|||
16465587|NCT01436162|40182190|FG002|Randomized Phase|Other|4|||
16465588|NCT00924781|40182191|FG000|Overall Study|Study terminated by sponsor|12|||
16170283|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
16170284|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
16170285|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
16170286|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
16170287|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
16170288|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
16170289|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
16170290|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
16170291|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
16170292|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16465589|NCT00924781|40182192|FG001|Overall Study|Study terminated by sponsor|10|||
16465590|NCT02232880|40182193|FG000|Overall Study|study stopped prior to randomization|1|||
16465591|NCT02217527|40182195|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
16465592|NCT02217527|40182196|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
16465593|NCT02217527|40182195|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
16465594|NCT02217527|40182196|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
16465595|NCT04966910|40182201|FG000|Baseline|Participant did not complete measure|0|||
16465596|NCT04966910|40182202|FG001|Baseline|Participant did not complete measure|0|||
16465597|NCT04966910|40182203|FG002|Baseline|Participant did not complete measure|1|||
16465598|NCT04966910|40182204|FG003|Baseline|Participant did not complete measure|0|||
16465599|NCT04966910|40182201|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
16465600|NCT04966910|40182202|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
16465601|NCT04966910|40182203|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
16465602|NCT04966910|40182204|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
16465603|NCT04966910|40182201|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
16465604|NCT04966910|40182202|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
16465605|NCT04966910|40182203|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
16465606|NCT04966910|40182204|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
16465607|NCT04966910|40182201|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
16465608|NCT04966910|40182202|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
16465609|NCT04966910|40182203|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
16465610|NCT04966910|40182204|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
16465611|NCT01604278|40182206|FG000|Overall Study|Lack of Efficacy|0|||
16465612|NCT01604278|40182207|FG001|Overall Study|Lack of Efficacy|1|||
16465613|NCT01604278|40182206|FG000|Overall Study|Lost to Follow-up|1|||
16465614|NCT01604278|40182207|FG001|Overall Study|Lost to Follow-up|0|||
16170293|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
16170294|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16170295|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16170296|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
16170297|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
16170298|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
16170299|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
16170300|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
16465615|NCT01604278|40182206|FG000|Overall Study|Administrative problems|2|||
16465616|NCT01604278|40182207|FG001|Overall Study|Administrative problems|1|||
16465617|NCT01604278|40182206|FG000|Overall Study|Withdrawal by Subject|3|||
16465618|NCT01604278|40182207|FG001|Overall Study|Withdrawal by Subject|3|||
16465619|NCT01604278|40182206|FG000|Overall Study|Adverse Event|3|||
16465620|NCT01604278|40182207|FG001|Overall Study|Adverse Event|5|||
16465621|NCT01604278|40182206|FG000|Overall Study|Protocol Deviation|5|||
16465622|NCT01604278|40182207|FG001|Overall Study|Protocol Deviation|3|||
16465623|NCT00674154|40182208|FG000|Overall Study|Withdrawal by Subject|3|||
16465624|NCT00674154|40182209|FG001|Overall Study|Withdrawal by Subject|1|||
16465625|NCT00674154|40182208|FG000|Overall Study|Did not want parathyroidectomy|0|||
16465626|NCT00674154|40182209|FG001|Overall Study|Did not want parathyroidectomy|2|||
16465627|NCT02882152|40182212|FG000|Overall Study|Lost to Follow-up|1|||
16465628|NCT02882152|40182213|FG001|Overall Study|Lost to Follow-up|0|||
16465629|NCT03149848|40182218|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
16465630|NCT03149848|40182218|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
16465631|NCT03915860|40182220|FG000|Overall Study|Adverse Event|3|||
16465632|NCT03915860|40182220|FG000|Overall Study|Withdrawal by Subject|6|||
16465633|NCT03915860|40182220|FG000|Overall Study|Lost to Follow-up|2|||
16465634|NCT03915860|40182220|FG000|Overall Study|Other than specified|3|||
16465635|NCT00770146|40182225|FG000|Treatment Period|Withdrawal by Subject|6|||
16465636|NCT00770146|40182226|FG001|Treatment Period|Withdrawal by Subject|13|||
16465637|NCT00770146|40182225|FG000|Treatment Period|Adverse Event|2|||
16465638|NCT00770146|40182226|FG001|Treatment Period|Adverse Event|26|||
16465639|NCT00770146|40182225|FG000|Treatment Period|Other|1|||
16465640|NCT00770146|40182226|FG001|Treatment Period|Other|5|||
16465641|NCT00770146|40182225|FG000|Treatment Period|Protocol non-compliance|0|||
16465642|NCT00770146|40182226|FG001|Treatment Period|Protocol non-compliance|1|||
16465643|NCT00770146|40182225|FG000|Follow-up Period|Withdrawal by Subject|7|||
16465644|NCT00770146|40182226|FG001|Follow-up Period|Withdrawal by Subject|13|||
16465645|NCT00770146|40182225|FG000|Follow-up Period|Adverse Event|0|||
16465646|NCT00770146|40182226|FG001|Follow-up Period|Adverse Event|2|||
16465647|NCT00770146|40182225|FG000|Follow-up Period|Other|4|||
16465648|NCT00770146|40182226|FG001|Follow-up Period|Other|5|||
16465649|NCT03452527|40182230|FG000|Overall Study|Withdrawal by Subject|1|||
16465650|NCT03452527|40182231|FG001|Overall Study|Withdrawal by Subject|1|||
16465651|NCT03452527|40182230|FG000|Overall Study|Study Terminated|2|||
16465652|NCT03452527|40182231|FG001|Overall Study|Study Terminated|3|||
16465653|NCT00859638|40182232|FG000|Overall Study|Lost to Follow-up|6|||
16465654|NCT00859638|40182233|FG001|Overall Study|Lost to Follow-up|1|||
16465655|NCT00859638|40182232|FG000|Overall Study|Withdrawal by Subject|3|||
16465656|NCT00859638|40182233|FG001|Overall Study|Withdrawal by Subject|2|||
16465657|NCT00859638|40182232|FG000|Overall Study|Ill health|1|||
16465658|NCT00859638|40182233|FG001|Overall Study|Ill health|1|||
16465659|NCT03104816|40182234|FG000|Overall Study|Lack of Efficacy|0|||
16170301|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
16170302|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
16170303|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
16170304|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
16170305|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
16170306|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
16170307|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
16170308|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
16170309|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
16170310|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
16170311|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
16170312|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
16170313|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
16170314|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
16170315|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
16170316|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
16170317|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
16170318|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
16170319|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
16170320|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
16170321|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
16170322|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
16170323|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
16170324|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
16170325|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
16170326|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
16170327|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
16269286|NCT00295490|39471053|FG000|Overall Study|Withdrawal by Subject|0|||
16269287|NCT00295490|39471054|FG001|Overall Study|Withdrawal by Subject|2|||
16465660|NCT03104816|40182235|FG001|Overall Study|Lack of Efficacy|2|||
16465661|NCT03104816|40182236|FG002|Overall Study|Lack of Efficacy|0|||
16465662|NCT03104816|40182234|FG000|Overall Study|Protocol Violation|2|||
16465663|NCT03104816|40182235|FG001|Overall Study|Protocol Violation|0|||
16465664|NCT03104816|40182236|FG002|Overall Study|Protocol Violation|2|||
16465665|NCT00129311|40182237|FG000|Overall Study|Withdrawal by Subject|12|||
16465666|NCT00129311|40182238|FG001|Overall Study|Withdrawal by Subject|19|||
16465667|NCT01658813|40182239|FG000|Overall Study|Disease progression|3|||
16465668|NCT01104376|40182240|FG000|Overall Study|Withdrawal by Subject|15|||
16465669|NCT01104376|40182240|FG000|Overall Study|Consented but excluded after labs|13|||
16465670|NCT00322621|40182241|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
16465671|NCT00322621|40182242|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
16465672|NCT00322621|40182243|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
16465673|NCT00322621|40182241|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
16465674|NCT00322621|40182242|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
16465675|NCT00322621|40182243|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
16465676|NCT00322621|40182241|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
16465677|NCT00322621|40182242|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
16465678|NCT00322621|40182243|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
16465679|NCT00322621|40182241|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
16072707|NCT01959412|38759141|FG003|Overall Study|Adverse Event|1|||
16465680|NCT00322621|40182242|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
16465681|NCT00322621|40182243|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
16465682|NCT00322621|40182241|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
16465683|NCT00322621|40182242|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
16465684|NCT00322621|40182243|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
16465685|NCT00322621|40182241|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
16465686|NCT00322621|40182242|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
16465687|NCT00322621|40182243|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
16465688|NCT00322621|40182241|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
16465689|NCT00322621|40182242|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
16465690|NCT00322621|40182243|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
16465691|NCT00322621|40182241|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
16465692|NCT00322621|40182242|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
16465693|NCT00322621|40182243|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
16465694|NCT00322621|40182241|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
16465695|NCT00322621|40182242|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
16465696|NCT00322621|40182243|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
16465697|NCT00322621|40182241|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
16465698|NCT00322621|40182242|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
16465699|NCT00322621|40182243|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
16465700|NCT00322621|40182241|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
16465701|NCT00322621|40182242|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
16465702|NCT00322621|40182243|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
16465703|NCT01975831|40182246|FG000|Overall Study|Adverse Event|1|||
16465704|NCT01975831|40182247|FG001|Overall Study|Adverse Event|2|||
16465705|NCT01975831|40182248|FG002|Overall Study|Adverse Event|2|||
16465706|NCT01975831|40182249|FG003|Overall Study|Adverse Event|0|||
16465707|NCT01975831|40182250|FG004|Overall Study|Adverse Event|1|||
16465708|NCT01975831|40182251|FG005|Overall Study|Adverse Event|1|||
16465709|NCT01975831|40182252|FG006|Overall Study|Adverse Event|3|||
16465710|NCT01975831|40182253|FG007|Overall Study|Adverse Event|4|||
16465711|NCT01975831|40182254|FG008|Overall Study|Adverse Event|1|||
16465712|NCT01975831|40182246|FG000|Overall Study|Death|1|||
16465713|NCT01975831|40182247|FG001|Overall Study|Death|1|||
16465714|NCT01975831|40182248|FG002|Overall Study|Death|0|||
16465715|NCT01975831|40182249|FG003|Overall Study|Death|0|||
16465716|NCT01975831|40182250|FG004|Overall Study|Death|1|||
16465717|NCT01975831|40182251|FG005|Overall Study|Death|0|||
16465718|NCT01975831|40182252|FG006|Overall Study|Death|1|||
16465719|NCT01975831|40182253|FG007|Overall Study|Death|0|||
16465720|NCT01975831|40182254|FG008|Overall Study|Death|0|||
16465721|NCT01975831|40182246|FG000|Overall Study|Progressive Disease|1|||
16465722|NCT01975831|40182247|FG001|Overall Study|Progressive Disease|3|||
16465723|NCT01975831|40182248|FG002|Overall Study|Progressive Disease|2|||
16465724|NCT01975831|40182249|FG003|Overall Study|Progressive Disease|4|||
16465725|NCT01975831|40182250|FG004|Overall Study|Progressive Disease|13|||
16465726|NCT01975831|40182251|FG005|Overall Study|Progressive Disease|9|||
16465727|NCT01975831|40182252|FG006|Overall Study|Progressive Disease|10|||
16465728|NCT01975831|40182253|FG007|Overall Study|Progressive Disease|8|||
16465729|NCT01975831|40182254|FG008|Overall Study|Progressive Disease|10|||
16465730|NCT01975831|40182246|FG000|Overall Study|Withdrawal by Subject|0|||
16465731|NCT01975831|40182247|FG001|Overall Study|Withdrawal by Subject|3|||
16465732|NCT01975831|40182248|FG002|Overall Study|Withdrawal by Subject|0|||
16465733|NCT01975831|40182249|FG003|Overall Study|Withdrawal by Subject|0|||
16465734|NCT01975831|40182250|FG004|Overall Study|Withdrawal by Subject|3|||
16465735|NCT01975831|40182251|FG005|Overall Study|Withdrawal by Subject|1|||
16465736|NCT01975831|40182252|FG006|Overall Study|Withdrawal by Subject|1|||
16465737|NCT01975831|40182253|FG007|Overall Study|Withdrawal by Subject|0|||
16465738|NCT01975831|40182254|FG008|Overall Study|Withdrawal by Subject|0|||
16465739|NCT01975831|40182246|FG000|Overall Study|Physician Decision|0|||
16465740|NCT01975831|40182247|FG001|Overall Study|Physician Decision|0|||
16465741|NCT01975831|40182248|FG002|Overall Study|Physician Decision|0|||
16465742|NCT01975831|40182249|FG003|Overall Study|Physician Decision|0|||
16465743|NCT01975831|40182250|FG004|Overall Study|Physician Decision|0|||
16465744|NCT01975831|40182251|FG005|Overall Study|Physician Decision|1|||
16465745|NCT01975831|40182252|FG006|Overall Study|Physician Decision|0|||
16465746|NCT01975831|40182253|FG007|Overall Study|Physician Decision|1|||
16465747|NCT01975831|40182254|FG008|Overall Study|Physician Decision|0|||
16465748|NCT01975831|40182246|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
16465749|NCT01975831|40182247|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
16465750|NCT01975831|40182248|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
16465751|NCT01975831|40182249|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
16465752|NCT01975831|40182250|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
16465753|NCT01975831|40182251|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
16072708|NCT01959412|38759142|FG004|Overall Study|Adverse Event|0|||
16465754|NCT01975831|40182252|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
16465755|NCT01975831|40182253|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
16465756|NCT01975831|40182254|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
16465757|NCT01975831|40182246|FG000|Overall Study|Entered Hospice|0|||
16465758|NCT01975831|40182247|FG001|Overall Study|Entered Hospice|0|||
16465759|NCT01975831|40182248|FG002|Overall Study|Entered Hospice|0|||
16465760|NCT01975831|40182249|FG003|Overall Study|Entered Hospice|0|||
16465761|NCT01975831|40182250|FG004|Overall Study|Entered Hospice|0|||
16465762|NCT01975831|40182251|FG005|Overall Study|Entered Hospice|1|||
16465763|NCT01975831|40182252|FG006|Overall Study|Entered Hospice|0|||
16465764|NCT01975831|40182253|FG007|Overall Study|Entered Hospice|0|||
16465765|NCT01975831|40182254|FG008|Overall Study|Entered Hospice|0|||
16465766|NCT01975831|40182246|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
16465767|NCT01975831|40182247|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
16465768|NCT01975831|40182248|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
16465769|NCT01975831|40182249|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
16465770|NCT01975831|40182250|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
16465771|NCT01975831|40182251|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
16465772|NCT01975831|40182252|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
16465773|NCT01975831|40182253|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
16465774|NCT01975831|40182254|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
16465775|NCT02635646|40182255|FG000|Overall Study|Lost to Follow-up|24|||
16465776|NCT02635646|40182256|FG001|Overall Study|Lost to Follow-up|25|||
16465777|NCT02635646|40182255|FG000|Overall Study|Pregnancy|1|||
16465778|NCT02635646|40182256|FG001|Overall Study|Pregnancy|1|||
16465779|NCT00617669|40182258|FG000|Overall Study|Withdrawal by Subject|71|||
16465780|NCT00617669|40182259|FG001|Overall Study|Withdrawal by Subject|77|||
16465781|NCT00617669|40182258|FG000|Overall Study|Lost to Follow-up|3|||
16465782|NCT00617669|40182259|FG001|Overall Study|Lost to Follow-up|2|||
16465783|NCT00617669|40182258|FG000|Overall Study|Adverse Event|87|||
16465784|NCT00617669|40182259|FG001|Overall Study|Adverse Event|76|||
16465785|NCT00617669|40182258|FG000|Overall Study|Protocol Violation|2|||
16465786|NCT00617669|40182259|FG001|Overall Study|Protocol Violation|3|||
16465787|NCT00617669|40182258|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
16465788|NCT00617669|40182259|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
16465789|NCT00617669|40182258|FG000|Overall Study|Patients randomized but not treated|2|||
16465790|NCT00617669|40182259|FG001|Overall Study|Patients randomized but not treated|3|||
16465791|NCT02216812|40182260|FG000|Overall Study|Lost to Follow-up|10|||
16465792|NCT02216812|40182261|FG001|Overall Study|Lost to Follow-up|5|||
16465793|NCT03739242|40182262|FG000|Overall Study|Withdrawal by Subject|1|||
16465794|NCT03739242|40182263|FG001|Overall Study|Withdrawal by Subject|1|||
16465795|NCT03739242|40182262|FG000|Overall Study|Protocol Violation|0|||
16465796|NCT03739242|40182263|FG001|Overall Study|Protocol Violation|1|||
16465797|NCT01185834|40182264|FG000|Overall Study|Lost to Follow-up|2|||
16465798|NCT01185834|40182264|FG000|Overall Study|Discomfort|4|||
16465799|NCT01185834|40182264|FG000|Overall Study|Biomicroscopy|4|||
16465800|NCT01185834|40182264|FG000|Overall Study|Time/Job Conflict|2|||
16465801|NCT01185834|40182264|FG000|Overall Study|Early exit - Site error|2|||
16465802|NCT00331552|40185143|FG000|Period 3: Phase II|Neurological Symptoms|1|||
16465803|NCT00331552|40185144|FG001|Period 3: Phase II|Neurological Symptoms|0|||
16465804|NCT00331552|40185143|FG000|Period 3: Phase II|Severe Nausea|1|||
16465805|NCT00331552|40185144|FG001|Period 3: Phase II|Severe Nausea|0|||
16465806|NCT01487577|40185145|FG000|Overall Study|Became ineligible after signing consent|1|||
16465807|NCT00934843|40185146|FG000|Overall Study|Protocol Violation|0|||
16170328|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
16170329|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
16170330|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
16170331|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
16170332|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
16170333|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
16170334|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
16170335|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
16170336|NCT00289913|39099122|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
16170337|NCT00289913|39099123|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
16170338|NCT00289913|39099124|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
16170339|NCT00289913|39099125|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
16170340|NCT00289913|39099126|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
16269288|NCT00295490|39471055|FG002|Overall Study|Withdrawal by Subject|0|||
16465808|NCT00934843|40185147|FG001|Overall Study|Protocol Violation|1|||
16465809|NCT03189381|40185148|FG000|Overall Study|Death|1|||
16465810|NCT03189381|40185149|FG001|Overall Study|Death|0|||
16465811|NCT02195011|40185152|FG000|Overall Study|Adverse Event|4|||
16465812|NCT02195011|40185153|FG001|Overall Study|Adverse Event|0|||
16465813|NCT02195011|40185152|FG000|Overall Study|Progressive Disease|18|||
16170341|NCT00289913|39099122|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16465814|NCT02195011|40185153|FG001|Overall Study|Progressive Disease|1|||
16465815|NCT02195011|40185152|FG000|Overall Study|Withdrawal by Subject|3|||
16465816|NCT02195011|40185153|FG001|Overall Study|Withdrawal by Subject|0|||
16465817|NCT03400956|40185154|FG000|Treatment Period 1|Adverse Event|0|||
16465818|NCT03400956|40185155|FG001|Treatment Period 1|Adverse Event|1|||
16465819|NCT03400956|40185156|FG002|Treatment Period 1|Adverse Event|0|||
16465820|NCT03400956|40185154|FG000|Treatment Period 1|Lost to Follow-up|0|||
16465821|NCT03400956|40185155|FG001|Treatment Period 1|Lost to Follow-up|0|||
16465822|NCT03400956|40185156|FG002|Treatment Period 1|Lost to Follow-up|1|||
16465823|NCT03400956|40185154|FG000|Treatment Period 1|Protocol Violation|0|||
16465824|NCT03400956|40185155|FG001|Treatment Period 1|Protocol Violation|2|||
16465825|NCT03400956|40185156|FG002|Treatment Period 1|Protocol Violation|0|||
16465826|NCT03400956|40185154|FG000|Treatment Period 1|Study terminated by sponsor|3|||
16465827|NCT03400956|40185155|FG001|Treatment Period 1|Study terminated by sponsor|1|||
16465828|NCT03400956|40185156|FG002|Treatment Period 1|Study terminated by sponsor|1|||
16465829|NCT03400956|40185154|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16465830|NCT03400956|40185155|FG001|Treatment Period 1|Withdrawal by Subject|2|||
16465831|NCT03400956|40185156|FG002|Treatment Period 1|Withdrawal by Subject|4|||
16465832|NCT03400956|40185154|FG000|Treatment Period 1|Other|1|||
16465833|NCT03400956|40185155|FG001|Treatment Period 1|Other|2|||
16465834|NCT03400956|40185156|FG002|Treatment Period 1|Other|3|||
16465835|NCT03400956|40185154|FG000|Post-treatment Period 1|Adverse Event|0|||
16465836|NCT03400956|40185155|FG001|Post-treatment Period 1|Adverse Event|0|||
16465837|NCT03400956|40185156|FG002|Post-treatment Period 1|Adverse Event|1|||
16465838|NCT03400956|40185154|FG000|Post-treatment Period 1|Physician Decision|2|||
16465839|NCT03400956|40185155|FG001|Post-treatment Period 1|Physician Decision|3|||
16465840|NCT03400956|40185156|FG002|Post-treatment Period 1|Physician Decision|0|||
16465841|NCT03400956|40185154|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
16465842|NCT03400956|40185155|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
16465843|NCT03400956|40185156|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
16465844|NCT03400956|40185154|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
16465845|NCT03400956|40185155|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
16465846|NCT03400956|40185156|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
16465847|NCT03400956|40185154|FG000|Post-treatment Period 1|Other|4|||
16465848|NCT03400956|40185155|FG001|Post-treatment Period 1|Other|3|||
16465849|NCT03400956|40185156|FG002|Post-treatment Period 1|Other|4|||
16465850|NCT03400956|40185154|FG000|Treatment Period 2|Adverse Event|2|||
16465851|NCT03400956|40185155|FG001|Treatment Period 2|Adverse Event|1|||
16465852|NCT03400956|40185156|FG002|Treatment Period 2|Adverse Event|1|||
16465853|NCT03400956|40185154|FG000|Treatment Period 2|Lost to Follow-up|1|||
16465854|NCT03400956|40185155|FG001|Treatment Period 2|Lost to Follow-up|1|||
16465855|NCT03400956|40185156|FG002|Treatment Period 2|Lost to Follow-up|0|||
16465856|NCT03400956|40185154|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16465857|NCT03400956|40185155|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16465858|NCT03400956|40185156|FG002|Treatment Period 2|Withdrawal by Subject|3|||
16465859|NCT03400956|40185154|FG000|Treatment Period 2|Other|1|||
16465860|NCT03400956|40185155|FG001|Treatment Period 2|Other|1|||
16465861|NCT03400956|40185156|FG002|Treatment Period 2|Other|0|||
16465862|NCT03400956|40185154|FG000|Follow-up Period|Withdrawal by Subject|0|||
16465863|NCT03400956|40185155|FG001|Follow-up Period|Withdrawal by Subject|0|||
16465864|NCT03400956|40185156|FG002|Follow-up Period|Withdrawal by Subject|1|||
16465865|NCT03400956|40185154|FG000|Follow-up Period|Other|0|||
16465866|NCT03400956|40185155|FG001|Follow-up Period|Other|0|||
16465867|NCT03400956|40185156|FG002|Follow-up Period|Other|1|||
16465868|NCT03044574|40185158|FG000|Overall Study|Lost to Follow-up|37|||
16465869|NCT03044574|40185159|FG001|Overall Study|Lost to Follow-up|45|||
16465870|NCT04267562|40185162|FG000|Assessed for Eligibility|Screen Failure|64|||
16465871|NCT04267562|40185162|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
16465872|NCT04267562|40185162|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
16465873|NCT04267562|40185162|FG000|Assessed for Eligibility|Site closure|6|||
16465874|NCT04267562|40185162|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
16465875|NCT04267562|40185162|FG000|Assessed for Eligibility|Physician Decision|1|||
16465876|NCT01107379|40185163|FG000|Overall Study|Withdrawal by Subject|18|||
16465877|NCT01107379|40185163|FG000|Overall Study|Lost to Follow-up|3|||
16465878|NCT02045303|40185167|FG000|Overall Study|Protocol Violation|2|||
16465879|NCT02045303|40185168|FG001|Overall Study|Protocol Violation|1|||
16465880|NCT02045303|40185169|FG002|Overall Study|Protocol Violation|0|||
16465881|NCT02045303|40185167|FG000|Overall Study|Withdrawal by Subject|0|||
16465882|NCT02045303|40185168|FG001|Overall Study|Withdrawal by Subject|2|||
16465883|NCT02045303|40185169|FG002|Overall Study|Withdrawal by Subject|0|||
16465884|NCT01028378|40185172|FG000|Overall Study|Lost to Follow-up|12|||
16465885|NCT01028378|40185172|FG000|Overall Study|Withdrawal by Subject|1|||
16170342|NCT00289913|39099123|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
16465886|NCT01028378|40185172|FG000|Overall Study|Adminstrative Reasons|4|||
16465887|NCT00206076|40185183|FG000|Overall Study|Physician Decision|2|||
16465888|NCT00206076|40185184|FG001|Overall Study|Physician Decision|0|||
16465889|NCT00206076|40185183|FG000|Overall Study|Withdrawal by Subject|1|||
16465890|NCT00206076|40185184|FG001|Overall Study|Withdrawal by Subject|1|||
16465891|NCT00667446|40185187|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
16465892|NCT00667446|40185188|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
16465893|NCT00667446|40185187|FG000|Treatment Period (36 Months)|Other|2|||
16465894|NCT00667446|40185188|FG001|Treatment Period (36 Months)|Other|2|||
16465895|NCT00667446|40185187|FG000|Treatment Period (36 Months)|Personal reasons|2|||
16465896|NCT00667446|40185188|FG001|Treatment Period (36 Months)|Personal reasons|2|||
16465897|NCT00667446|40185187|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
16465898|NCT00667446|40185188|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
16465899|NCT00667446|40185187|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
16465900|NCT00667446|40185188|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
16465901|NCT00667446|40185187|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
16465902|NCT00667446|40185188|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
16465903|NCT00667446|40185187|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
16465904|NCT00667446|40185188|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
16465905|NCT00667446|40185187|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
16465906|NCT00667446|40185188|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
16465907|NCT00667446|40185187|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
16465908|NCT00667446|40185188|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
16465909|NCT01534182|40185189|FG000|Overall Study|Administrative problems|1|||
16465910|NCT01534182|40185190|FG001|Overall Study|Administrative problems|0|||
16465911|NCT01534182|40185189|FG000|Overall Study|Withdrawal by Subject|4|||
16465912|NCT01534182|40185190|FG001|Overall Study|Withdrawal by Subject|7|||
16465913|NCT01534182|40185189|FG000|Overall Study|Adverse Event|7|||
16465914|NCT01534182|40185190|FG001|Overall Study|Adverse Event|3|||
16465915|NCT02815280|40185191|FG000|Double-Blind Phase|Adverse Event|1|||
16465916|NCT02815280|40185192|FG001|Double-Blind Phase|Adverse Event|1|||
16465917|NCT02815280|40185191|FG000|Double-Blind Phase|Lost to Follow-up|10|||
16465918|NCT02815280|40185192|FG001|Double-Blind Phase|Lost to Follow-up|9|||
16465919|NCT02815280|40185191|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
16465920|NCT02815280|40185192|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
16465921|NCT02815280|40185191|FG000|Double-Blind Phase|Protocol Violation|2|||
16465922|NCT02815280|40185192|FG001|Double-Blind Phase|Protocol Violation|2|||
16465923|NCT02815280|40185191|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
16465924|NCT02815280|40185192|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
16465925|NCT02815280|40185191|FG000|Open-Label Phase|Adverse Event|2|||
16465926|NCT02815280|40185192|FG001|Open-Label Phase|Adverse Event|3|||
16465927|NCT02815280|40185191|FG000|Open-Label Phase|Lost to Follow-up|18|||
16465928|NCT02815280|40185192|FG001|Open-Label Phase|Lost to Follow-up|9|||
16465929|NCT02815280|40185191|FG000|Open-Label Phase|Withdrawal by Subject|33|||
16465930|NCT02815280|40185192|FG001|Open-Label Phase|Withdrawal by Subject|18|||
16465931|NCT02815280|40185191|FG000|Open-Label Phase|Protocol Violation|3|||
16465932|NCT02815280|40185192|FG001|Open-Label Phase|Protocol Violation|0|||
16465933|NCT02815280|40185191|FG000|Open-Label Phase|Administrative|26|||
16465934|NCT02815280|40185192|FG001|Open-Label Phase|Administrative|12|||
16465935|NCT02815280|40185191|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
16465936|NCT02815280|40185192|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
16170343|NCT00289913|39099124|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170344|NCT00289913|39099125|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170345|NCT00289913|39099126|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
16170346|NCT00289913|39099122|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
16170347|NCT00289913|39099123|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
16170348|NCT00289913|39099124|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
16170349|NCT00289913|39099125|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
16170350|NCT00289913|39099126|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
16170351|NCT00289913|39099122|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
16170352|NCT00289913|39099123|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
16170353|NCT00289913|39099124|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
16170354|NCT00289913|39099125|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
16170355|NCT00289913|39099126|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
16170356|NCT00289913|39099122|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16170357|NCT00289913|39099123|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16170358|NCT00289913|39099124|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16170359|NCT00289913|39099125|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
16170360|NCT00289913|39099126|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
16170361|NCT00289913|39099122|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
16170362|NCT00289913|39099123|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
16170363|NCT00289913|39099124|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
16170364|NCT00289913|39099125|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
16170365|NCT00289913|39099126|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
16170366|NCT00289913|39099122|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
16170367|NCT00289913|39099123|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
16170368|NCT00289913|39099124|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
16170369|NCT00289913|39099125|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
16170370|NCT00289913|39099126|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
16170371|NCT00289913|39099122|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
16170372|NCT00289913|39099123|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
16170373|NCT00289913|39099124|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
16170374|NCT00289913|39099125|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
16170375|NCT00289913|39099126|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
16170376|NCT00289913|39099122|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
16170377|NCT00289913|39099123|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
16170378|NCT00289913|39099124|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
16170379|NCT00289913|39099125|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
16170380|NCT00289913|39099126|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
16170381|NCT01573910|39099127|FG000|Overall Study|Adverse Event|4|||
16170382|NCT01573910|39099128|FG001|Overall Study|Adverse Event|4|||
16170383|NCT01573910|39099127|FG000|Overall Study|Lost to Follow-up|2|||
16170384|NCT01573910|39099128|FG001|Overall Study|Lost to Follow-up|1|||
16170385|NCT01573910|39099127|FG000|Overall Study|Withdrawal by Subject|0|||
16170386|NCT01573910|39099128|FG001|Overall Study|Withdrawal by Subject|1|||
16170387|NCT01573910|39099127|FG000|Overall Study|Protocol Violation|3|||
16170388|NCT01573910|39099128|FG001|Overall Study|Protocol Violation|0|||
16170389|NCT01573910|39099127|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
16170390|NCT01573910|39099128|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
16173410|NCT01607892|39111207|FG002|Overall Study|Investigator discretion|4|||
16173411|NCT01607892|39111208|FG003|Overall Study|Investigator discretion|8|||
16173412|NCT01607892|39111209|FG004|Overall Study|Investigator discretion|0|||
16173413|NCT01607892|39111205|FG000|Overall Study|Other treatments became available|1|||
16465937|NCT02984943|40185193|FG000|Overall Study|Withdrawal by Subject|3|||
16173414|NCT01607892|39111206|FG001|Overall Study|Other treatments became available|1|||
16173415|NCT01607892|39111207|FG002|Overall Study|Other treatments became available|0|||
16173416|NCT01607892|39111208|FG003|Overall Study|Other treatments became available|0|||
16173417|NCT01607892|39111209|FG004|Overall Study|Other treatments became available|2|||
16173418|NCT01607892|39111205|FG000|Overall Study|Intercurrent illness|1|||
16465938|NCT02984943|40185193|FG000|Overall Study|Physician Decision|1|||
16465939|NCT00251004|40185201|FG000|Overall Study|Withdrawal by Subject|23|||
16465940|NCT00251004|40185202|FG001|Overall Study|Withdrawal by Subject|16|||
16465941|NCT00251004|40185203|FG002|Overall Study|Withdrawal by Subject|14|||
16465942|NCT00251004|40185201|FG000|Overall Study|Death|9|||
16173419|NCT01607892|39111206|FG001|Overall Study|Intercurrent illness|0|||
16173420|NCT01607892|39111207|FG002|Overall Study|Intercurrent illness|0|||
16173421|NCT01607892|39111208|FG003|Overall Study|Intercurrent illness|3|||
16173422|NCT01607892|39111209|FG004|Overall Study|Intercurrent illness|0|||
16173423|NCT01607892|39111205|FG000|Overall Study|Non-Compliance with study procedures|0|||
16173424|NCT01607892|39111206|FG001|Overall Study|Non-Compliance with study procedures|0|||
16173425|NCT01607892|39111207|FG002|Overall Study|Non-Compliance with study procedures|1|||
16173426|NCT01607892|39111208|FG003|Overall Study|Non-Compliance with study procedures|0|||
16173427|NCT01607892|39111209|FG004|Overall Study|Non-Compliance with study procedures|0|||
16173428|NCT01607892|39111205|FG000|Overall Study|Consent withdrawn by participant|9|||
16173429|NCT01607892|39111206|FG001|Overall Study|Consent withdrawn by participant|4|||
16173430|NCT01607892|39111207|FG002|Overall Study|Consent withdrawn by participant|24|||
16465943|NCT00251004|40185202|FG001|Overall Study|Death|10|||
16465944|NCT00251004|40185203|FG002|Overall Study|Death|8|||
16465945|NCT00251004|40185201|FG000|Overall Study|Lost to Follow-up|1|||
16465946|NCT00251004|40185202|FG001|Overall Study|Lost to Follow-up|2|||
16465947|NCT00251004|40185203|FG002|Overall Study|Lost to Follow-up|1|||
16465948|NCT00251004|40185201|FG000|Overall Study|Graft Loss|12|||
16465949|NCT00251004|40185202|FG001|Overall Study|Graft Loss|13|||
16173431|NCT01607892|39111208|FG003|Overall Study|Consent withdrawn by participant|14|||
16173432|NCT01607892|39111209|FG004|Overall Study|Consent withdrawn by participant|4|||
16173433|NCT01607892|39111205|FG000|Overall Study|Disease progression|38|||
16173434|NCT01607892|39111206|FG001|Overall Study|Disease progression|13|||
16465950|NCT00251004|40185203|FG002|Overall Study|Graft Loss|8|||
16465951|NCT01850602|40185204|FG000|Overall Study|Adverse Event|7|||
16465952|NCT01850602|40185205|FG001|Overall Study|Adverse Event|10|||
16465953|NCT01850602|40185204|FG000|Overall Study|Physician Decision|2|||
16465954|NCT01850602|40185205|FG001|Overall Study|Physician Decision|1|||
16465955|NCT01850602|40185204|FG000|Overall Study|Withdrawal by Subject|2|||
16465956|NCT01850602|40185205|FG001|Overall Study|Withdrawal by Subject|4|||
16465957|NCT01850602|40185204|FG000|Overall Study|Decrease in serum calcium|2|||
16465958|NCT01850602|40185205|FG001|Overall Study|Decrease in serum calcium|3|||
16465959|NCT01850602|40185204|FG000|Overall Study|Increase in serum ferritin|1|||
16465960|NCT01850602|40185205|FG001|Overall Study|Increase in serum ferritin|0|||
16465961|NCT01673282|40185208|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
16465962|NCT01673282|40185209|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
16465963|NCT01673282|40185208|FG000|Overall Study|Lack of Efficacy|9|||
16465964|NCT01673282|40185209|FG001|Overall Study|Lack of Efficacy|2|||
16465965|NCT01673282|40185208|FG000|Overall Study|Lost to Follow-up|11|||
16465966|NCT01673282|40185209|FG001|Overall Study|Lost to Follow-up|10|||
16465967|NCT01673282|40185208|FG000|Overall Study|Withdrawal by Subject|3|||
16465968|NCT01673282|40185209|FG001|Overall Study|Withdrawal by Subject|3|||
16465969|NCT01673282|40185208|FG000|Overall Study|Other|1|||
16465970|NCT01673282|40185209|FG001|Overall Study|Other|6|||
16465971|NCT05093790|40185217|FG000|Overall Study|Failure to meet continuation criteria|0|||
16465972|NCT05093790|40185218|FG001|Overall Study|Failure to meet continuation criteria|0|||
16465973|NCT05093790|40185219|FG002|Overall Study|Failure to meet continuation criteria|1|||
16465974|NCT05093790|40185220|FG003|Overall Study|Failure to meet continuation criteria|0|||
16465975|NCT05093790|40185217|FG000|Overall Study|Adverse Event|1|||
16465976|NCT05093790|40185218|FG001|Overall Study|Adverse Event|0|||
16465977|NCT05093790|40185219|FG002|Overall Study|Adverse Event|0|||
16465978|NCT05093790|40185220|FG003|Overall Study|Adverse Event|0|||
16465979|NCT03860935|40185221|FG000|Overall Study|Withdrawal of Consent|15|||
16465980|NCT03860935|40185222|FG001|Overall Study|Withdrawal of Consent|6|||
16465981|NCT03860935|40185221|FG000|Overall Study|Death|75|||
16465982|NCT03860935|40185222|FG001|Overall Study|Death|51|||
16465983|NCT01611454|40185223|FG000|Overall Study|Lack of Efficacy|18|||
16465984|NCT01611454|40185224|FG001|Overall Study|Lack of Efficacy|10|||
16465985|NCT01585584|40185225|FG000|Overall Study|Lack of Efficacy|1|||
16465986|NCT01585584|40185225|FG000|Overall Study|Withdrawal by Subject|1|||
16465987|NCT01585584|40185225|FG000|Overall Study|Physician Decision|2|||
16465988|NCT00783302|40185228|FG000|Overall Study|Lost to Follow-up|17|||
16465989|NCT00783302|40185228|FG000|Overall Study|Technical Problems|11|||
16465990|NCT00783302|40185228|FG000|Overall Study|Protocol Violation|3|||
16465991|NCT00783302|40185228|FG000|Overall Study|Physician Decision|1|||
16465992|NCT00783302|40185228|FG000|Overall Study|Withdrawal by Subject|3|||
16465993|NCT04369924|40185229|FG000|Overall Study|Lost to Follow-up|302|||
16465994|NCT04369924|40185230|FG001|Overall Study|Lost to Follow-up|339|||
16465995|NCT00130442|40185233|FG000|Overall Study|Withdrawal by Subject|0|||
16465996|NCT00130442|40185234|FG001|Overall Study|Withdrawal by Subject|1|||
16465997|NCT00130442|40185233|FG000|Overall Study|did not meet criteria|1|||
16465998|NCT00130442|40185234|FG001|Overall Study|did not meet criteria|1|||
16465999|NCT03614975|40185236|FG000|Overall Study|Physician Decision|7|||
16466000|NCT03614975|40185237|FG001|Overall Study|Physician Decision|5|||
16466001|NCT03614975|40185236|FG000|Overall Study|Withdrawal by Subject|2|||
16466002|NCT03614975|40185237|FG001|Overall Study|Withdrawal by Subject|2|||
16466003|NCT03614975|40185236|FG000|Overall Study|Specimens not in lab batch shipment|1|||
16466004|NCT03614975|40185237|FG001|Overall Study|Specimens not in lab batch shipment|1|||
16466005|NCT02186301|40185238|FG000|Overall Study|Progressive Disease|7|||
16466006|NCT02186301|40185239|FG001|Overall Study|Progressive Disease|22|||
16170391|NCT02582671|39102915|FG000|Overall Study|Failure to return|1|||
16170392|NCT02582671|39102915|FG000|Overall Study|Other, not specified|1|||
16170393|NCT00960076|39102924|FG000|Overall Study|Adverse Event|1|||
16170394|NCT00960076|39102925|FG001|Overall Study|Adverse Event|7|||
16170395|NCT00960076|39102924|FG000|Overall Study|No longer met study criteria|1|||
16170396|NCT00960076|39102925|FG001|Overall Study|No longer met study criteria|5|||
16170397|NCT00960076|39102924|FG000|Overall Study|Withdrawal by Subject|1|||
16170398|NCT00960076|39102925|FG001|Overall Study|Withdrawal by Subject|2|||
16170399|NCT00960076|39102924|FG000|Overall Study|Lost to Follow-up|3|||
16170400|NCT00960076|39102925|FG001|Overall Study|Lost to Follow-up|3|||
16170401|NCT00960076|39102924|FG000|Overall Study|Severe non-compliance to protocol|1|||
16466007|NCT02186301|40185240|FG002|Overall Study|Progressive Disease|27|||
16466008|NCT02186301|40185238|FG000|Overall Study|Adverse Event|5|||
16466009|NCT02186301|40185239|FG001|Overall Study|Adverse Event|5|||
16466010|NCT02186301|40185240|FG002|Overall Study|Adverse Event|5|||
16466011|NCT02186301|40185238|FG000|Overall Study|Death|1|||
16466012|NCT02186301|40185239|FG001|Overall Study|Death|0|||
16466013|NCT02186301|40185240|FG002|Overall Study|Death|0|||
16466014|NCT02186301|40185238|FG000|Overall Study|Withdrawal by Subject|5|||
16466015|NCT02186301|40185239|FG001|Overall Study|Withdrawal by Subject|1|||
16466016|NCT02186301|40185240|FG002|Overall Study|Withdrawal by Subject|3|||
16466017|NCT02186301|40185238|FG000|Overall Study|Physician Decision|1|||
16170402|NCT00960076|39102925|FG001|Overall Study|Severe non-compliance to protocol|2|||
16170403|NCT00960076|39102924|FG000|Overall Study|Hyperglycemia|1|||
16170404|NCT00960076|39102925|FG001|Overall Study|Hyperglycemia|5|||
16466018|NCT02186301|40185239|FG001|Overall Study|Physician Decision|0|||
16170405|NCT00960076|39102924|FG000|Overall Study|Did not attend the termination visit|0|||
16170406|NCT00960076|39102925|FG001|Overall Study|Did not attend the termination visit|1|||
16170407|NCT01914679|39102926|FG000|Overall Study|Lack of Efficacy|1|||
16170408|NCT01914679|39102926|FG000|Overall Study|Sponsor terminated study|4|||
16170409|NCT00934102|39102927|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
16170410|NCT00934102|39102928|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
16170411|NCT00934102|39102929|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
16170412|NCT00828451|39102930|FG000|Overall Study|Death|2|||
16170413|NCT00828451|39102930|FG000|Overall Study|Lack of intravenous line|7|||
16170414|NCT00828451|39102930|FG000|Overall Study|Withdrawal by Subject|1|||
16170415|NCT00828451|39102930|FG000|Overall Study|Deterioration in clinical status|1|||
16170416|NCT00442598|39102931|FG000|Overall Study|Adverse Event|1|||
16170417|NCT00442598|39102932|FG001|Overall Study|Adverse Event|0|||
16170418|NCT00442598|39102933|FG002|Overall Study|Adverse Event|0|||
16170419|NCT00442598|39102931|FG000|Overall Study|Tumor progression|3|||
16170420|NCT00442598|39102932|FG001|Overall Study|Tumor progression|4|||
16170421|NCT00442598|39102933|FG002|Overall Study|Tumor progression|0|||
16170422|NCT00442598|39102931|FG000|Overall Study|Clinical deterioration|1|||
16170423|NCT00442598|39102932|FG001|Overall Study|Clinical deterioration|2|||
16170424|NCT00442598|39102933|FG002|Overall Study|Clinical deterioration|0|||
16170425|NCT00442598|39102931|FG000|Overall Study|CA125 progression|0|||
16269289|NCT00295490|39471056|FG003|Overall Study|Withdrawal by Subject|1|||
16466019|NCT02186301|40185240|FG002|Overall Study|Physician Decision|1|||
16466020|NCT02186301|40185238|FG000|Overall Study|Study Terminated by Sponsor|1|||
16466021|NCT02186301|40185239|FG001|Overall Study|Study Terminated by Sponsor|0|||
16466022|NCT02186301|40185240|FG002|Overall Study|Study Terminated by Sponsor|11|||
16466023|NCT02186301|40185238|FG000|Overall Study|Protocol Deviation|0|||
16466024|NCT02186301|40185239|FG001|Overall Study|Protocol Deviation|2|||
16466025|NCT02186301|40185240|FG002|Overall Study|Protocol Deviation|0|||
16466026|NCT02186301|40185238|FG000|Overall Study|Missing|0|||
16466027|NCT02186301|40185239|FG001|Overall Study|Missing|0|||
16466028|NCT02186301|40185240|FG002|Overall Study|Missing|2|||
16466029|NCT02186301|40185238|FG000|Overall Study|Other|0|||
16466030|NCT02186301|40185239|FG001|Overall Study|Other|0|||
16466031|NCT02186301|40185240|FG002|Overall Study|Other|1|||
16466032|NCT02021656|40185241|FG000|Overall Study|Adverse Event|1|||
16466033|NCT02021656|40185241|FG000|Overall Study|Lack of Efficacy|2|||
16466034|NCT02021656|40185241|FG000|Overall Study|Lost to Follow-up|1|||
16466035|NCT02021656|40185241|FG000|Overall Study|Withdrew Consent|2|||
16466036|NCT00136604|40185246|FG000|Overall Study|Lost to Follow-up|1|||
16466037|NCT00136604|40185247|FG001|Overall Study|Lost to Follow-up|0|||
16466038|NCT00136604|40185248|FG002|Overall Study|Lost to Follow-up|0|||
16466039|NCT00136604|40185249|FG003|Overall Study|Lost to Follow-up|0|||
16466040|NCT00136604|40185250|FG004|Overall Study|Lost to Follow-up|1|||
16466041|NCT00136604|40185246|FG000|Overall Study|Migrated/moved from study area|0|||
16466042|NCT00136604|40185247|FG001|Overall Study|Migrated/moved from study area|1|||
16466043|NCT00136604|40185248|FG002|Overall Study|Migrated/moved from study area|0|||
16466044|NCT00136604|40185249|FG003|Overall Study|Migrated/moved from study area|0|||
16466045|NCT00136604|40185250|FG004|Overall Study|Migrated/moved from study area|0|||
16466046|NCT01923168|40185251|FG000|Overall Study|Protocol Violation|1|||
16466047|NCT01923168|40185252|FG001|Overall Study|Protocol Violation|1|||
16466048|NCT01923168|40185253|FG002|Overall Study|Protocol Violation|0|||
16466049|NCT01923168|40185251|FG000|Overall Study|Subject/guardian decision|14|||
16466050|NCT01923168|40185252|FG001|Overall Study|Subject/guardian decision|14|||
16466051|NCT01923168|40185253|FG002|Overall Study|Subject/guardian decision|4|||
16466052|NCT01923168|40185251|FG000|Overall Study|Adverse Event|12|||
16466053|NCT01923168|40185252|FG001|Overall Study|Adverse Event|12|||
16466054|NCT01923168|40185253|FG002|Overall Study|Adverse Event|0|||
16466055|NCT01923168|40185251|FG000|Overall Study|Physician Decision|6|||
16466056|NCT01923168|40185252|FG001|Overall Study|Physician Decision|9|||
16466057|NCT01923168|40185253|FG002|Overall Study|Physician Decision|5|||
16466058|NCT01923168|40185251|FG000|Overall Study|Progressive disease|4|||
16466059|NCT01923168|40185252|FG001|Overall Study|Progressive disease|3|||
16466060|NCT01923168|40185253|FG002|Overall Study|Progressive disease|7|||
16466061|NCT01923168|40185251|FG000|Overall Study|Death|0|||
16466062|NCT01923168|40185252|FG001|Overall Study|Death|0|||
16466063|NCT01923168|40185253|FG002|Overall Study|Death|1|||
16466064|NCT02925793|40185256|FG000|Overall Study|Adverse Event|3|||
16466065|NCT02925793|40185257|FG001|Overall Study|Adverse Event|3|||
16170426|NCT00442598|39102932|FG001|Overall Study|CA125 progression|1|||
16170427|NCT00442598|39102933|FG002|Overall Study|CA125 progression|0|||
16170428|NCT00442598|39102931|FG000|Overall Study|Reduced creatinine clearance|1|||
16466066|NCT02925793|40185258|FG002|Overall Study|Adverse Event|6|||
16170429|NCT00442598|39102932|FG001|Overall Study|Reduced creatinine clearance|0|||
16170430|NCT00442598|39102933|FG002|Overall Study|Reduced creatinine clearance|0|||
16466067|NCT02925793|40185256|FG000|Overall Study|Withdrawal by Subject|16|||
16466068|NCT02925793|40185257|FG001|Overall Study|Withdrawal by Subject|15|||
16466069|NCT02925793|40185258|FG002|Overall Study|Withdrawal by Subject|13|||
16466070|NCT02925793|40185256|FG000|Overall Study|Investigator Discretion|0|||
16466071|NCT02925793|40185257|FG001|Overall Study|Investigator Discretion|1|||
16466072|NCT02925793|40185258|FG002|Overall Study|Investigator Discretion|1|||
16466073|NCT02925793|40185256|FG000|Overall Study|Lost to Follow-up|2|||
16466074|NCT02925793|40185257|FG001|Overall Study|Lost to Follow-up|3|||
16466075|NCT02925793|40185258|FG002|Overall Study|Lost to Follow-up|1|||
16466076|NCT02925793|40185256|FG000|Overall Study|Lack of Efficacy|2|||
16466077|NCT02925793|40185257|FG001|Overall Study|Lack of Efficacy|6|||
16466078|NCT02925793|40185258|FG002|Overall Study|Lack of Efficacy|4|||
16466079|NCT02925793|40185256|FG000|Overall Study|Other:|2|||
16466080|NCT02925793|40185257|FG001|Overall Study|Other:|1|||
16466081|NCT02925793|40185258|FG002|Overall Study|Other:|3|||
16466082|NCT01576159|40185259|FG000|Overall Study|Withdrawal by Subject|0|||
16466083|NCT01576159|40185260|FG001|Overall Study|Withdrawal by Subject|1|||
16466084|NCT01576159|40185261|FG002|Overall Study|Withdrawal by Subject|0|||
16466085|NCT01576159|40185262|FG003|Overall Study|Withdrawal by Subject|0|||
16466086|NCT01576159|40185259|FG000|Overall Study|Physician Decision|0|||
16466087|NCT01576159|40185260|FG001|Overall Study|Physician Decision|0|||
16466088|NCT01576159|40185261|FG002|Overall Study|Physician Decision|1|||
16466089|NCT01576159|40185262|FG003|Overall Study|Physician Decision|0|||
16466090|NCT01576159|40185259|FG000|Overall Study|Lost to Follow-up|0|||
16466091|NCT01576159|40185260|FG001|Overall Study|Lost to Follow-up|0|||
16466092|NCT01576159|40185261|FG002|Overall Study|Lost to Follow-up|0|||
16466093|NCT01576159|40185262|FG003|Overall Study|Lost to Follow-up|1|||
16466094|NCT01576159|40185259|FG000|Overall Study|Protocol Violation|1|||
16466095|NCT01576159|40185260|FG001|Overall Study|Protocol Violation|0|||
16466096|NCT01576159|40185261|FG002|Overall Study|Protocol Violation|0|||
16466097|NCT01576159|40185262|FG003|Overall Study|Protocol Violation|0|||
16466098|NCT00821509|40185263|FG000|Overall Study|Withdrawal by Subject|12|||
16466099|NCT00821509|40185264|FG001|Overall Study|Withdrawal by Subject|11|||
16466100|NCT00821509|40185265|FG002|Overall Study|Withdrawal by Subject|34|||
16466101|NCT03059446|40185266|FG000|Overall Study|Adverse Event|11|||
16466102|NCT03059446|40185266|FG000|Overall Study|Withdrawal of Consent|16|||
16466103|NCT03059446|40185266|FG000|Overall Study|Lost to Follow-up|3|||
16466104|NCT03059446|40185266|FG000|Overall Study|Protocol Violation|1|||
16466105|NCT03059446|40185266|FG000|Overall Study|Study Terminated by Sponsor|131|||
16466106|NCT03059446|40185266|FG000|Overall Study|Reason not Specified|5|||
16466107|NCT00064298|40185267|FG000|Overall Study|Withdrawal by Subject|2|||
16466108|NCT00064298|40185268|FG001|Overall Study|Withdrawal by Subject|1|||
16466109|NCT00064298|40185267|FG000|Overall Study|Lost to Follow-up|2|||
16466110|NCT00064298|40185268|FG001|Overall Study|Lost to Follow-up|2|||
16466111|NCT00064298|40185267|FG000|Overall Study|Death|0|||
16466112|NCT00064298|40185268|FG001|Overall Study|Death|1|||
16466113|NCT00064298|40185267|FG000|Overall Study|Disease Progression|2|||
16466114|NCT00064298|40185268|FG001|Overall Study|Disease Progression|1|||
16466115|NCT00775203|40185269|FG000|Overall Study|Adverse Event|25|||
16466116|NCT00775203|40185270|FG001|Overall Study|Adverse Event|6|||
16466117|NCT00775203|40185269|FG000|Overall Study|Lack of Efficacy|8|||
16466118|NCT00775203|40185270|FG001|Overall Study|Lack of Efficacy|9|||
16466119|NCT00775203|40185269|FG000|Overall Study|Withdrawal by Subject|11|||
16466120|NCT00775203|40185270|FG001|Overall Study|Withdrawal by Subject|9|||
16466121|NCT00775203|40185269|FG000|Overall Study|Lost to Follow-up|11|||
16466122|NCT00775203|40185270|FG001|Overall Study|Lost to Follow-up|15|||
16466123|NCT00775203|40185269|FG000|Overall Study|Administrative reason|2|||
16466124|NCT00775203|40185270|FG001|Overall Study|Administrative reason|0|||
16466125|NCT00775203|40185269|FG000|Overall Study|Noncompliance|4|||
16466126|NCT00775203|40185270|FG001|Overall Study|Noncompliance|2|||
16466127|NCT00775203|40185269|FG000|Overall Study|Protocol Violation|0|||
16466128|NCT00775203|40185270|FG001|Overall Study|Protocol Violation|1|||
16466129|NCT00775203|40185269|FG000|Overall Study|Entered other study|1|||
16466130|NCT00775203|40185270|FG001|Overall Study|Entered other study|0|||
16466131|NCT00775203|40185269|FG000|Overall Study|Physician Decision|0|||
16466132|NCT00775203|40185270|FG001|Overall Study|Physician Decision|1|||
16466133|NCT00998764|40185273|FG000|Overall Study|Lack of Efficacy|3|||
16466134|NCT00998764|40185274|FG001|Overall Study|Lack of Efficacy|6|||
16466135|NCT00998764|40185273|FG000|Overall Study|Adverse Event|17|||
16466136|NCT00998764|40185274|FG001|Overall Study|Adverse Event|12|||
16466137|NCT00998764|40185273|FG000|Overall Study|Withdrawal by Subject|19|||
16466138|NCT00998764|40185274|FG001|Overall Study|Withdrawal by Subject|25|||
16466139|NCT00998764|40185273|FG000|Overall Study|Physician Decision|3|||
16466140|NCT00998764|40185274|FG001|Overall Study|Physician Decision|3|||
16466141|NCT00998764|40185273|FG000|Overall Study|Death|3|||
16466142|NCT00998764|40185274|FG001|Overall Study|Death|1|||
16466143|NCT00998764|40185273|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
16466144|NCT00998764|40185274|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
16466145|NCT00998764|40185273|FG000|Overall Study|Protocol Violation|0|||
16466146|NCT00998764|40185274|FG001|Overall Study|Protocol Violation|1|||
16466147|NCT00998764|40185273|FG000|Overall Study|Failed to Return|1|||
16466148|NCT00998764|40185274|FG001|Overall Study|Failed to Return|1|||
16466149|NCT00998764|40185273|FG000|Overall Study|Lost to Follow-up|1|||
16466150|NCT00998764|40185274|FG001|Overall Study|Lost to Follow-up|1|||
16466151|NCT00998764|40185273|FG000|Overall Study|Loss of Caregiver|0|||
16466152|NCT00998764|40185274|FG001|Overall Study|Loss of Caregiver|3|||
16466153|NCT00998764|40185273|FG000|Overall Study|Other|4|||
16466154|NCT00998764|40185274|FG001|Overall Study|Other|4|||
16466155|NCT00998764|40185273|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
16466156|NCT00998764|40185274|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
16466157|NCT01475071|40185276|FG000|Overall Study|Physician Decision|1|||
16466158|NCT01475071|40185276|FG000|Overall Study|Withdrawal by Subject|6|||
16466159|NCT01475071|40185276|FG000|Overall Study|Lost to Follow-up|1|||
16466160|NCT01099709|40185277|FG000|Period 1|Withdrawal by Subject|0|||
16466161|NCT01099709|40185278|FG001|Period 1|Withdrawal by Subject|1|||
16466162|NCT01099709|40185277|FG000|Period 1|Positive cotinine test|0|||
16466163|NCT01099709|40185278|FG001|Period 1|Positive cotinine test|1|||
16466164|NCT01099709|40185277|FG000|Period 1|Adverse Event|1|||
16466165|NCT01099709|40185278|FG001|Period 1|Adverse Event|0|||
16466166|NCT02195687|40185279|FG000|Overall Study|Personal Reasons|1|||
16466167|NCT02195687|40185280|FG001|Overall Study|Personal Reasons|1|||
16466168|NCT02195687|40185279|FG000|Overall Study|Lost to Follow-up|4|||
16466169|NCT02195687|40185280|FG001|Overall Study|Lost to Follow-up|1|||
16466170|NCT02093026|40185281|FG000|Overall Study|Adverse Event|26|||
16466171|NCT02093026|40185281|FG000|Overall Study|Death|10|||
16466172|NCT02093026|40185281|FG000|Overall Study|Other|157|||
16466173|NCT04010539|40185282|FG000|Overall Study|Withdrawal by Subject|4|||
16466174|NCT04010539|40185283|FG001|Overall Study|Withdrawal by Subject|1|||
16466175|NCT04010539|40185282|FG000|Overall Study|Physician Decision|0|||
16466176|NCT04010539|40185283|FG001|Overall Study|Physician Decision|2|||
16466177|NCT04010539|40185282|FG000|Overall Study|Lost to Follow-up|10|||
16466178|NCT04010539|40185283|FG001|Overall Study|Lost to Follow-up|14|||
16466179|NCT04010539|40185282|FG000|Overall Study|Adverse Event|3|||
16466180|NCT04010539|40185283|FG001|Overall Study|Adverse Event|0|||
16170431|NCT00442598|39102931|FG000|Overall Study|Death|0|||
16170432|NCT00442598|39102932|FG001|Overall Study|Death|1|||
16170433|NCT00442598|39102933|FG002|Overall Study|Death|0|||
16170434|NCT02251912|39102934|FG000|Overall Study|Withdrawal by Subject|2|||
16170435|NCT02251912|39102935|FG001|Overall Study|Withdrawal by Subject|3|||
16170436|NCT02251912|39102934|FG000|Overall Study|Adverse Event|0|||
16170437|NCT02251912|39102935|FG001|Overall Study|Adverse Event|2|||
16170438|NCT00441792|39102937|FG000|Overall Study|Lost to Follow-up|0|||
16170439|NCT00441792|39102938|FG001|Overall Study|Lost to Follow-up|2|||
16170440|NCT00619502|39102945|FG000|Overall Study|Lost to Follow-up|8|||
16170441|NCT00619502|39102946|FG001|Overall Study|Lost to Follow-up|10|||
16170442|NCT01381094|39102947|FG000|Overall Study|Adverse Event|1|||
16170443|NCT01381094|39102948|FG001|Overall Study|Adverse Event|2|||
16170444|NCT01381094|39102949|FG002|Overall Study|Adverse Event|0|||
16170445|NCT01381094|39102950|FG003|Overall Study|Adverse Event|1|||
16466181|NCT04010539|40185282|FG000|Overall Study|Participant Did Not Receive IP|0|||
16466182|NCT04010539|40185283|FG001|Overall Study|Participant Did Not Receive IP|1|||
16466183|NCT04010539|40185282|FG000|Overall Study|Protocol Deviation|0|||
16466184|NCT04010539|40185283|FG001|Overall Study|Protocol Deviation|1|||
16466185|NCT04010539|40185282|FG000|Overall Study|Randomized in Error/ Mistake|2|||
16466186|NCT04010539|40185283|FG001|Overall Study|Randomized in Error/ Mistake|0|||
16466187|NCT04010539|40185282|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
16466188|NCT04010539|40185283|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
16466189|NCT03780400|40185284|FG000|Overall Study|Lost to Follow-up|5|||
16466190|NCT03780400|40185284|FG000|Overall Study|Withdrawal by Subject|2|||
16170446|NCT01381094|39102951|FG004|Overall Study|Adverse Event|0|||
16170447|NCT01381094|39102947|FG000|Overall Study|Lost to Follow-up|0|||
16170448|NCT01381094|39102948|FG001|Overall Study|Lost to Follow-up|0|||
16170449|NCT01381094|39102949|FG002|Overall Study|Lost to Follow-up|0|||
16170450|NCT01381094|39102950|FG003|Overall Study|Lost to Follow-up|0|||
16466191|NCT01074047|40185285|FG000|Treatment Phase|Adverse Event|89|||
16466192|NCT01074047|40185286|FG001|Treatment Phase|Adverse Event|66|||
16466193|NCT01074047|40185285|FG000|Treatment Phase|Disease Progression|16|||
16466194|NCT01074047|40185286|FG001|Treatment Phase|Disease Progression|21|||
16466195|NCT01074047|40185285|FG000|Treatment Phase|Withdrawal by Subject|27|||
16072709|NCT01959412|38759143|FG005|Overall Study|Adverse Event|0|||
16170451|NCT01381094|39102951|FG004|Overall Study|Lost to Follow-up|1|||
16170452|NCT01381094|39102947|FG000|Overall Study|Withdrawal of informed consent|0|||
16170453|NCT01381094|39102948|FG001|Overall Study|Withdrawal of informed consent|1|||
16170454|NCT01381094|39102949|FG002|Overall Study|Withdrawal of informed consent|0|||
16170455|NCT01381094|39102950|FG003|Overall Study|Withdrawal of informed consent|0|||
16173435|NCT01607892|39111207|FG002|Overall Study|Disease progression|37|||
16466196|NCT01074047|40185286|FG001|Treatment Phase|Withdrawal by Subject|48|||
16466197|NCT01074047|40185285|FG000|Treatment Phase|Death|53|||
16466198|NCT01074047|40185286|FG001|Treatment Phase|Death|58|||
16466199|NCT01074047|40185285|FG000|Treatment Phase|Lost to Follow-up|0|||
16466200|NCT01074047|40185286|FG001|Treatment Phase|Lost to Follow-up|1|||
16466201|NCT01074047|40185285|FG000|Treatment Phase|Protocol Violation|0|||
16466202|NCT01074047|40185286|FG001|Treatment Phase|Protocol Violation|1|||
16466203|NCT01074047|40185285|FG000|Treatment Phase|Miscellaneous|32|||
16466204|NCT01074047|40185286|FG001|Treatment Phase|Miscellaneous|39|||
16466205|NCT01074047|40185285|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
16466206|NCT01074047|40185286|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
16466207|NCT01074047|40185285|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
16466208|NCT01074047|40185286|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
16466209|NCT01074047|40185285|FG000|Survival Follow-Up Phase|Death|116|||
16466210|NCT01074047|40185286|FG001|Survival Follow-Up Phase|Death|124|||
16466211|NCT01074047|40185285|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
16466212|NCT01074047|40185286|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
16466213|NCT01074047|40185285|FG000|Extension Phase|Physician Decision|1|||
16466214|NCT01074047|40185286|FG001|Extension Phase|Physician Decision|0|||
16466215|NCT01074047|40185285|FG000|Extension Phase|Adverse Event|5|||
16466216|NCT01074047|40185286|FG001|Extension Phase|Adverse Event|0|||
16466217|NCT01074047|40185285|FG000|Extension Phase|Disease Progression|9|||
16466218|NCT01074047|40185286|FG001|Extension Phase|Disease Progression|0|||
16466219|NCT01074047|40185285|FG000|Extension Phase|Withdrawal by Subject|2|||
16466220|NCT01074047|40185286|FG001|Extension Phase|Withdrawal by Subject|0|||
16466221|NCT01074047|40185285|FG000|Extension Phase|Death|5|||
16466222|NCT01074047|40185286|FG001|Extension Phase|Death|0|||
16466223|NCT01565343|40185287|FG000|Overall Study|Administrative decision/technical issues|1|||
16170456|NCT01381094|39102951|FG004|Overall Study|Withdrawal of informed consent|0|||
16170457|NCT01381094|39102947|FG000|Overall Study|Participant given Aranesp injection|1|||
16170458|NCT01381094|39102948|FG001|Overall Study|Participant given Aranesp injection|0|||
16170459|NCT01381094|39102949|FG002|Overall Study|Participant given Aranesp injection|0|||
16170460|NCT01381094|39102950|FG003|Overall Study|Participant given Aranesp injection|0|||
16170461|NCT01381094|39102951|FG004|Overall Study|Participant given Aranesp injection|0|||
16170462|NCT02054702|39102952|FG000|Overall Study|Lost to Follow-up|3|||
16170463|NCT02054702|39102953|FG001|Overall Study|Lost to Follow-up|5|||
16170464|NCT02054702|39102952|FG000|Overall Study|Adverse Event|3|||
16170465|NCT02054702|39102953|FG001|Overall Study|Adverse Event|1|||
16170466|NCT02054702|39102952|FG000|Overall Study|Met Withdrawal Criteria|4|||
16170467|NCT02054702|39102953|FG001|Overall Study|Met Withdrawal Criteria|1|||
16170468|NCT02054702|39102952|FG000|Overall Study|Physician Decision|0|||
16170469|NCT02054702|39102953|FG001|Overall Study|Physician Decision|1|||
16170470|NCT02054702|39102952|FG000|Overall Study|Withdrawal by Subject|14|||
16170471|NCT02054702|39102953|FG001|Overall Study|Withdrawal by Subject|4|||
16170472|NCT01169779|39102954|FG000|Overall Study|Adverse Event|3|||
16170473|NCT01169779|39102955|FG001|Overall Study|Adverse Event|11|||
16170474|NCT01169779|39102954|FG000|Overall Study|Lack of Efficacy|1|||
16170475|NCT01169779|39102955|FG001|Overall Study|Lack of Efficacy|0|||
16170476|NCT01169779|39102954|FG000|Overall Study|Protocol Violation|1|||
16170477|NCT01169779|39102955|FG001|Overall Study|Protocol Violation|1|||
16170478|NCT01169779|39102954|FG000|Overall Study|Withdrawal by Subject|3|||
16170479|NCT01169779|39102955|FG001|Overall Study|Withdrawal by Subject|2|||
16170480|NCT01169779|39102954|FG000|Overall Study|Familial and personal reasons|3|||
16170481|NCT01169779|39102955|FG001|Overall Study|Familial and personal reasons|3|||
16170482|NCT01955707|39102956|FG000|Overall Study|Adverse Event|1|||
16170483|NCT01955707|39102957|FG001|Overall Study|Adverse Event|2|||
16170484|NCT01955707|39102956|FG000|Overall Study|Lost to Follow-up|2|||
16170485|NCT01955707|39102957|FG001|Overall Study|Lost to Follow-up|1|||
16170486|NCT01955707|39102956|FG000|Overall Study|Withdrawal by Subject|0|||
16170487|NCT01955707|39102957|FG001|Overall Study|Withdrawal by Subject|3|||
16170488|NCT01955707|39102956|FG000|Overall Study|Death|13|||
16170489|NCT01955707|39102957|FG001|Overall Study|Death|14|||
16170490|NCT01955707|39102956|FG000|Overall Study|Other|4|||
16170491|NCT01955707|39102957|FG001|Overall Study|Other|2|||
16170492|NCT04574999|39102961|FG000|Overall Study|Adverse Event|1|||
16170493|NCT04574999|39102962|FG001|Overall Study|Adverse Event|0|||
16170494|NCT04574999|39102961|FG000|Overall Study|Lack of Efficacy|2|||
16170495|NCT04574999|39102962|FG001|Overall Study|Lack of Efficacy|3|||
16170496|NCT04574999|39102961|FG000|Overall Study|Protocol Violation|1|||
16170497|NCT04574999|39102962|FG001|Overall Study|Protocol Violation|0|||
16170498|NCT04574999|39102961|FG000|Overall Study|Withdrawal by Subject|2|||
16170499|NCT04574999|39102962|FG001|Overall Study|Withdrawal by Subject|2|||
16170500|NCT04574999|39102961|FG000|Overall Study|Lost to Follow-up|1|||
16170501|NCT04574999|39102962|FG001|Overall Study|Lost to Follow-up|0|||
16170502|NCT04574999|39102961|FG000|Overall Study|Personal problems|1|||
16170503|NCT04574999|39102962|FG001|Overall Study|Personal problems|0|||
16466224|NCT01565343|40185288|FG001|Overall Study|Administrative decision/technical issues|0|||
16466225|NCT01565343|40185289|FG002|Overall Study|Administrative decision/technical issues|0|||
16466226|NCT02915874|40185294|FG000|Overall Study|Lost to Follow-up|5|||
16466227|NCT02915874|40185295|FG001|Overall Study|Lost to Follow-up|4|||
16466228|NCT02915874|40185294|FG000|Overall Study|Withdrawal by Subject|1|||
16466229|NCT02915874|40185295|FG001|Overall Study|Withdrawal by Subject|1|||
16466230|NCT02915874|40185294|FG000|Overall Study|Started New Anxiety Medication|0|||
16466231|NCT02915874|40185295|FG001|Overall Study|Started New Anxiety Medication|1|||
16466232|NCT00869778|40185296|FG000|Overall Study|Adverse Event|2|||
16466233|NCT00869778|40185297|FG001|Overall Study|Adverse Event|0|||
16466234|NCT00869778|40185298|FG002|Overall Study|Adverse Event|0|||
16466235|NCT00869778|40185296|FG000|Overall Study|Withdrawal by Subject|3|||
16466236|NCT00869778|40185297|FG001|Overall Study|Withdrawal by Subject|4|||
16466237|NCT00869778|40185298|FG002|Overall Study|Withdrawal by Subject|5|||
16466238|NCT00869778|40185296|FG000|Overall Study|Pregnancy|1|||
16466239|NCT00869778|40185297|FG001|Overall Study|Pregnancy|0|||
16466240|NCT00869778|40185298|FG002|Overall Study|Pregnancy|0|||
16466241|NCT00869778|40185296|FG000|Overall Study|Protocol Violation|5|||
16466242|NCT00869778|40185297|FG001|Overall Study|Protocol Violation|3|||
16466243|NCT00869778|40185298|FG002|Overall Study|Protocol Violation|5|||
16466244|NCT00869778|40185296|FG000|Overall Study|Unblinding|1|||
16466245|NCT00869778|40185297|FG001|Overall Study|Unblinding|0|||
16466246|NCT00869778|40185298|FG002|Overall Study|Unblinding|0|||
16466247|NCT02694718|40185299|FG000|Overall Study|Death|1|||
16466248|NCT02694718|40185299|FG000|Overall Study|Withdrawal by Subject|1|||
16466249|NCT01244490|40185310|FG000|Overall Study|Lack of Efficacy|14|||
16466250|NCT01244490|40185311|FG001|Overall Study|Lack of Efficacy|5|||
16466251|NCT01244490|40185312|FG002|Overall Study|Lack of Efficacy|5|||
16466252|NCT01244490|40185310|FG000|Overall Study|Withdrawal by Subject|4|||
16466253|NCT01244490|40185311|FG001|Overall Study|Withdrawal by Subject|4|||
16466254|NCT01244490|40185312|FG002|Overall Study|Withdrawal by Subject|9|||
16466255|NCT01244490|40185310|FG000|Overall Study|Adverse Event|1|||
16072710|NCT05136443|38759147|FG000|Overall Study|Lost to Follow-up|2|||
16072711|NCT05136443|38759147|FG000|Overall Study|Adverse Event|2|||
16072712|NCT00798096|38759150|FG000|Overall Study|Ongoing|2|||
16072713|NCT00831415|38759157|FG000|Overall Study|Adverse Event|14|||
16072714|NCT00831415|38759157|FG000|Overall Study|Failed to return|3|||
16170504|NCT04574999|39102961|FG000|Overall Study|Previous planned surgery|1|||
16170505|NCT04574999|39102962|FG001|Overall Study|Previous planned surgery|0|||
16170506|NCT01446809|39102964|FG000|Overall Study|Adverse Event|0|||
16170507|NCT01446809|39102965|FG001|Overall Study|Adverse Event|0|||
16170508|NCT01446809|39102966|FG002|Overall Study|Adverse Event|1|||
16170509|NCT01446809|39102964|FG000|Overall Study|Failure to complete study procedures|0|||
16170510|NCT01446809|39102965|FG001|Overall Study|Failure to complete study procedures|0|||
16170511|NCT01446809|39102966|FG002|Overall Study|Failure to complete study procedures|1|||
16170512|NCT02370121|39102967|FG000|Overall Study|Lost to Follow-up|1|||
16170513|NCT02370121|39102968|FG001|Overall Study|Lost to Follow-up|1|||
16170514|NCT02197377|39102969|FG000|Overall Study|Insertion Failure|0|||
16170515|NCT02197377|39102970|FG001|Overall Study|Insertion Failure|3|||
16170516|NCT00430755|39102971|FG000|Overall Study|Withdrawal by Subject|53|||
16170517|NCT01596257|39102972|FG000|Overall Study|Inadequate Collection|23|||
16170518|NCT01596257|39102973|FG001|Overall Study|Inadequate Collection|19|||
16170519|NCT01427309|39102974|FG000|Overall Study|Lost to Follow-up|130|||
16170520|NCT01427309|39102975|FG001|Overall Study|Lost to Follow-up|145|||
16170521|NCT01427309|39102976|FG002|Overall Study|Lost to Follow-up|122|||
16170522|NCT01427309|39102977|FG003|Overall Study|Lost to Follow-up|135|||
16170523|NCT01427309|39102974|FG000|Overall Study|Protocol Violation|42|||
16170524|NCT01427309|39102975|FG001|Overall Study|Protocol Violation|69|||
16170525|NCT01427309|39102976|FG002|Overall Study|Protocol Violation|125|||
16170526|NCT01427309|39102977|FG003|Overall Study|Protocol Violation|124|||
16170527|NCT01427309|39102974|FG000|Overall Study|Adverse Event|0|||
16170528|NCT01427309|39102975|FG001|Overall Study|Adverse Event|0|||
16170529|NCT01427309|39102976|FG002|Overall Study|Adverse Event|3|||
16170530|NCT01427309|39102977|FG003|Overall Study|Adverse Event|1|||
16170531|NCT01427309|39102974|FG000|Overall Study|Serious adverse event|52|||
16170532|NCT01427309|39102975|FG001|Overall Study|Serious adverse event|45|||
16466256|NCT01244490|40185311|FG001|Overall Study|Adverse Event|9|||
16466257|NCT01244490|40185312|FG002|Overall Study|Adverse Event|5|||
16466258|NCT01244490|40185310|FG000|Overall Study|Lost to Follow-up|0|||
16072715|NCT00831415|38759157|FG000|Overall Study|Physician Decision|6|||
16072716|NCT00831415|38759157|FG000|Overall Study|Lost to Follow-up|9|||
16072717|NCT00831415|38759157|FG000|Overall Study|Protocol Violation|3|||
16072718|NCT00831415|38759157|FG000|Overall Study|Withdrawal by Subject|35|||
16466259|NCT01244490|40185311|FG001|Overall Study|Lost to Follow-up|6|||
16466260|NCT01244490|40185312|FG002|Overall Study|Lost to Follow-up|3|||
16466261|NCT01244490|40185310|FG000|Overall Study|Other|0|||
16466262|NCT01244490|40185311|FG001|Overall Study|Other|0|||
16466263|NCT01244490|40185312|FG002|Overall Study|Other|1|||
16466264|NCT02276027|40185313|FG000|Overall Study|Death|1|||
16466265|NCT02276027|40185314|FG001|Overall Study|Death|0|||
16466266|NCT02276027|40185315|FG002|Overall Study|Death|0|||
16466267|NCT02276027|40185316|FG003|Overall Study|Death|2|||
16466268|NCT02276027|40185313|FG000|Overall Study|Physician Decision|0|||
16466269|NCT02276027|40185314|FG001|Overall Study|Physician Decision|0|||
16466270|NCT02276027|40185315|FG002|Overall Study|Physician Decision|0|||
16466271|NCT02276027|40185316|FG003|Overall Study|Physician Decision|1|||
16466272|NCT02276027|40185313|FG000|Overall Study|Progressive disease|1|||
16466273|NCT02276027|40185314|FG001|Overall Study|Progressive disease|13|||
16466274|NCT02276027|40185315|FG002|Overall Study|Progressive disease|12|||
16466275|NCT02276027|40185316|FG003|Overall Study|Progressive disease|14|||
16466276|NCT02276027|40185313|FG000|Overall Study|Subject/guardian decision|0|||
16466277|NCT02276027|40185314|FG001|Overall Study|Subject/guardian decision|1|||
16466278|NCT02276027|40185315|FG002|Overall Study|Subject/guardian decision|0|||
16466279|NCT02276027|40185316|FG003|Overall Study|Subject/guardian decision|3|||
16466280|NCT02276027|40185313|FG000|Overall Study|Adverse Event|0|||
16466281|NCT02276027|40185314|FG001|Overall Study|Adverse Event|2|||
16466282|NCT02276027|40185315|FG002|Overall Study|Adverse Event|8|||
16466283|NCT02276027|40185316|FG003|Overall Study|Adverse Event|2|||
16466284|NCT03025789|40185317|FG000|Overall Study|Lack of Efficacy|6|||
16466285|NCT03025789|40185318|FG001|Overall Study|Lack of Efficacy|1|||
16466286|NCT03025789|40185317|FG000|Overall Study|Death|1|||
16466287|NCT03025789|40185318|FG001|Overall Study|Death|0|||
16466288|NCT03025789|40185317|FG000|Overall Study|Withdrawal by Subject|0|||
16466289|NCT03025789|40185318|FG001|Overall Study|Withdrawal by Subject|2|||
16466290|NCT02412488|40185319|FG000|Overall Study|Lost to Follow-up|10|||
16466291|NCT02412488|40185319|FG000|Overall Study|Withdrawal by Subject|5|||
16466292|NCT02412488|40185319|FG000|Overall Study|Physician Decision|1|||
16466293|NCT02412488|40185319|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
16466294|NCT02412488|40185319|FG000|Overall Study|Reveal LINQ explant|1|||
16466295|NCT01027273|40185322|FG000|Overall Study|Lost to Follow-up|57|||
16466296|NCT01027273|40185323|FG001|Overall Study|Lost to Follow-up|31|||
16466297|NCT01027273|40185322|FG000|Overall Study|Death|2|||
16466298|NCT01027273|40185323|FG001|Overall Study|Death|2|||
16466299|NCT01029405|40185324|FG000|Overall Study|Withdrawal by Subject|0|||
16466300|NCT01029405|40185325|FG001|Overall Study|Withdrawal by Subject|1|||
16466301|NCT01029405|40185326|FG002|Overall Study|Withdrawal by Subject|2|||
16466302|NCT01029405|40185327|FG003|Overall Study|Withdrawal by Subject|0|||
16466303|NCT01029405|40185324|FG000|Overall Study|Protocol Violation|0|||
16466304|NCT01029405|40185325|FG001|Overall Study|Protocol Violation|0|||
16466305|NCT01029405|40185326|FG002|Overall Study|Protocol Violation|0|||
16466306|NCT01029405|40185327|FG003|Overall Study|Protocol Violation|1|||
16466307|NCT01029405|40185324|FG000|Overall Study|Adverse Event|0|||
16466308|NCT01029405|40185325|FG001|Overall Study|Adverse Event|0|||
16466309|NCT01029405|40185326|FG002|Overall Study|Adverse Event|1|||
16466310|NCT01029405|40185327|FG003|Overall Study|Adverse Event|1|||
16466311|NCT01029405|40185324|FG000|Overall Study|Lost to Follow-up|2|||
16466312|NCT01029405|40185325|FG001|Overall Study|Lost to Follow-up|1|||
16466313|NCT01029405|40185326|FG002|Overall Study|Lost to Follow-up|1|||
16466314|NCT01029405|40185327|FG003|Overall Study|Lost to Follow-up|2|||
16466315|NCT01029405|40185324|FG000|Overall Study|Other|0|||
16466316|NCT01029405|40185325|FG001|Overall Study|Other|1|||
16466317|NCT01029405|40185326|FG002|Overall Study|Other|0|||
16466318|NCT01029405|40185327|FG003|Overall Study|Other|1|||
16466319|NCT03309046|40185329|FG000|Overall Study|Withdrawal by Subject|4|||
16170533|NCT01427309|39102976|FG002|Overall Study|Serious adverse event|50|||
16170534|NCT01427309|39102977|FG003|Overall Study|Serious adverse event|61|||
16170535|NCT01427309|39102974|FG000|Overall Study|Withdrawal by Subject|148|||
16170536|NCT01427309|39102975|FG001|Overall Study|Withdrawal by Subject|148|||
16170537|NCT01427309|39102976|FG002|Overall Study|Withdrawal by Subject|61|||
16170538|NCT01427309|39102977|FG003|Overall Study|Withdrawal by Subject|55|||
16170539|NCT03636906|39102978|FG000|Overall Study|Adverse Event|0|||
16466320|NCT03309046|40185330|FG001|Overall Study|Withdrawal by Subject|17|||
16466321|NCT01403948|40185334|FG000|Overall Study|Progressive disease|0|||
16466322|NCT01403948|40185335|FG001|Overall Study|Progressive disease|2|||
16466323|NCT01403948|40185336|FG002|Overall Study|Progressive disease|2|||
16170540|NCT03636906|39102979|FG001|Overall Study|Adverse Event|0|||
16170541|NCT03636906|39102980|FG002|Overall Study|Adverse Event|1|||
16170542|NCT03636906|39102978|FG000|Overall Study|Lost to Follow-up|1|||
16466324|NCT01403948|40185337|FG003|Overall Study|Progressive disease|4|||
16466325|NCT01403948|40185338|FG004|Overall Study|Progressive disease|2|||
16466326|NCT01403948|40185339|FG005|Overall Study|Progressive disease|6|||
16466327|NCT01403948|40185340|FG006|Overall Study|Progressive disease|2|||
16466328|NCT01403948|40185341|FG007|Overall Study|Progressive disease|4|||
16466329|NCT01403948|40185342|FG008|Overall Study|Progressive disease|5|||
16466330|NCT01403948|40185343|FG009|Overall Study|Progressive disease|5|||
16466331|NCT01403948|40185334|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
16466332|NCT01403948|40185335|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
16466333|NCT01403948|40185336|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
16466334|NCT01403948|40185337|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
16466335|NCT01403948|40185338|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
16466336|NCT01403948|40185339|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
16466337|NCT01403948|40185340|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
16466338|NCT01403948|40185341|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
16466339|NCT01403948|40185342|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
16170543|NCT03636906|39102979|FG001|Overall Study|Lost to Follow-up|0|||
16170544|NCT03636906|39102980|FG002|Overall Study|Lost to Follow-up|0|||
16170545|NCT03636906|39102978|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
16170546|NCT03636906|39102979|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
16170547|NCT03636906|39102980|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
16170548|NCT03636906|39102978|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
16170549|NCT03636906|39102979|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
16170550|NCT03636906|39102980|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
16466340|NCT01403948|40185343|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
16466341|NCT01403948|40185334|FG000|Overall Study|Lost to Follow-up|0|||
16466342|NCT01403948|40185335|FG001|Overall Study|Lost to Follow-up|0|||
16466343|NCT01403948|40185336|FG002|Overall Study|Lost to Follow-up|0|||
16466344|NCT01403948|40185337|FG003|Overall Study|Lost to Follow-up|0|||
16466345|NCT01403948|40185338|FG004|Overall Study|Lost to Follow-up|0|||
16466346|NCT01403948|40185339|FG005|Overall Study|Lost to Follow-up|0|||
16466347|NCT01403948|40185340|FG006|Overall Study|Lost to Follow-up|0|||
16466348|NCT01403948|40185341|FG007|Overall Study|Lost to Follow-up|0|||
16466349|NCT01403948|40185342|FG008|Overall Study|Lost to Follow-up|0|||
16466350|NCT01403948|40185343|FG009|Overall Study|Lost to Follow-up|1|||
16466351|NCT01403948|40185334|FG000|Overall Study|Refused cont. medication|0|||
16466352|NCT01403948|40185335|FG001|Overall Study|Refused cont. medication|0|||
16466353|NCT01403948|40185336|FG002|Overall Study|Refused cont. medication|0|||
16466354|NCT01403948|40185337|FG003|Overall Study|Refused cont. medication|0|||
16466355|NCT01403948|40185338|FG004|Overall Study|Refused cont. medication|1|||
16466356|NCT01403948|40185339|FG005|Overall Study|Refused cont. medication|0|||
16466357|NCT01403948|40185340|FG006|Overall Study|Refused cont. medication|0|||
16466358|NCT01403948|40185341|FG007|Overall Study|Refused cont. medication|0|||
16466359|NCT01403948|40185342|FG008|Overall Study|Refused cont. medication|0|||
16466360|NCT01403948|40185343|FG009|Overall Study|Refused cont. medication|1|||
16466361|NCT01403948|40185334|FG000|Overall Study|other than above|1|||
16466362|NCT01403948|40185335|FG001|Overall Study|other than above|2|||
16466363|NCT01403948|40185336|FG002|Overall Study|other than above|1|||
16466364|NCT01403948|40185337|FG003|Overall Study|other than above|0|||
16466365|NCT01403948|40185338|FG004|Overall Study|other than above|1|||
16466366|NCT01403948|40185339|FG005|Overall Study|other than above|1|||
16466367|NCT01403948|40185340|FG006|Overall Study|other than above|2|||
16466368|NCT01403948|40185341|FG007|Overall Study|other than above|0|||
16466369|NCT01403948|40185342|FG008|Overall Study|other than above|0|||
16466370|NCT01403948|40185343|FG009|Overall Study|other than above|0|||
16466371|NCT01115803|40185344|FG000|Overall Study|Withdrawal by Subject|0|||
16466372|NCT01115803|40185345|FG001|Overall Study|Withdrawal by Subject|0|||
16466373|NCT01115803|40185346|FG002|Overall Study|Withdrawal by Subject|0|||
16466374|NCT01115803|40185347|FG003|Overall Study|Withdrawal by Subject|0|||
16466375|NCT01115803|40185348|FG004|Overall Study|Withdrawal by Subject|0|||
16466376|NCT01115803|40185349|FG005|Overall Study|Withdrawal by Subject|0|||
16466377|NCT01115803|40185350|FG006|Overall Study|Withdrawal by Subject|1|||
16466378|NCT01115803|40185344|FG000|Overall Study|Lost to Follow-up|0|||
16466379|NCT01115803|40185345|FG001|Overall Study|Lost to Follow-up|0|||
16466380|NCT01115803|40185346|FG002|Overall Study|Lost to Follow-up|1|||
16466381|NCT01115803|40185347|FG003|Overall Study|Lost to Follow-up|0|||
16466382|NCT01115803|40185348|FG004|Overall Study|Lost to Follow-up|0|||
16466383|NCT01115803|40185349|FG005|Overall Study|Lost to Follow-up|0|||
16466384|NCT01115803|40185350|FG006|Overall Study|Lost to Follow-up|0|||
16466385|NCT01115803|40185344|FG000|Overall Study|Progressive Disease during Cycle1|0|||
16466386|NCT01115803|40185345|FG001|Overall Study|Progressive Disease during Cycle1|0|||
16466387|NCT01115803|40185346|FG002|Overall Study|Progressive Disease during Cycle1|0|||
16170551|NCT03636906|39102978|FG000|Overall Study|Other|0|||
16466388|NCT01115803|40185347|FG003|Overall Study|Progressive Disease during Cycle1|0|||
16466389|NCT01115803|40185348|FG004|Overall Study|Progressive Disease during Cycle1|0|||
16466390|NCT01115803|40185349|FG005|Overall Study|Progressive Disease during Cycle1|0|||
16466391|NCT01115803|40185350|FG006|Overall Study|Progressive Disease during Cycle1|1|||
16466392|NCT01713933|40185351|FG000|Overall Study|Lost to Follow-up|2|||
16466393|NCT01713933|40185351|FG000|Overall Study|Withdrawal by Subject|3|||
16466394|NCT01713933|40185351|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
16466395|NCT03985878|40185352|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
16466396|NCT03985878|40185352|FG000|Overall Study|Study Terminated by Sponsor|12|||
16466397|NCT03985878|40185352|FG000|Overall Study|Withdrawal by Subject|1|||
16466398|NCT03828370|40185354|FG000|3 Month Follow-up|Lost to Follow-up|4|||
16466399|NCT03828370|40185355|FG001|3 Month Follow-up|Lost to Follow-up|12|||
16466400|NCT03828370|40185354|FG000|9 Month Follow up|Lost to Follow-up|12|||
16466401|NCT03828370|40185355|FG001|9 Month Follow up|Lost to Follow-up|20|||
16466402|NCT02152631|40185356|FG000|Overall Study|Adverse Event|32|||
16466403|NCT02152631|40185357|FG001|Overall Study|Adverse Event|4|||
16466404|NCT02152631|40185356|FG000|Overall Study|Withdrawal by Subject|13|||
16466405|NCT02152631|40185357|FG001|Overall Study|Withdrawal by Subject|16|||
16466406|NCT02152631|40185356|FG000|Overall Study|Noncompliance with study drug|1|||
16466407|NCT02152631|40185357|FG001|Overall Study|Noncompliance with study drug|0|||
16466408|NCT02152631|40185356|FG000|Overall Study|Physician Decision|1|||
16466409|NCT02152631|40185357|FG001|Overall Study|Physician Decision|2|||
16466410|NCT02152631|40185356|FG000|Overall Study|Lost to Follow-up|0|||
16466411|NCT02152631|40185357|FG001|Overall Study|Lost to Follow-up|1|||
16466412|NCT02152631|40185356|FG000|Overall Study|On Treatment|19|||
16466413|NCT02152631|40185357|FG001|Overall Study|On Treatment|3|||
16466414|NCT03680742|40185358|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
16466415|NCT00323869|40185360|FG000|Overall Study|Death|1|||
16466416|NCT02220998|40185363|FG000|Overall Study|Randomized but Never Treated|1|||
16466417|NCT02220998|40185364|FG001|Overall Study|Randomized but Never Treated|2|||
16466418|NCT02220998|40185363|FG000|Overall Study|Death|2|||
16466419|NCT02220998|40185364|FG001|Overall Study|Death|0|||
16466420|NCT02220998|40185363|FG000|Overall Study|Lack of Efficacy|0|||
16466421|NCT02220998|40185364|FG001|Overall Study|Lack of Efficacy|5|||
16466422|NCT02220998|40185363|FG000|Overall Study|Lost to Follow-up|4|||
16466423|NCT02220998|40185364|FG001|Overall Study|Lost to Follow-up|4|||
16466424|NCT03584373|40185365|FG000|Overall Study|Lost to Follow-up|7|||
16466425|NCT03584373|40185366|FG001|Overall Study|Lost to Follow-up|8|||
16466426|NCT01343901|40185367|FG000|Overall Study|Death|85|||
16466427|NCT01343901|40185367|FG000|Overall Study|Physician Decision|4|||
16466428|NCT01343901|40185367|FG000|Overall Study|Lost to Follow-up|12|||
16466429|NCT01343901|40185367|FG000|Overall Study|Management by another medical team|11|||
16466430|NCT01343901|40185367|FG000|Overall Study|Participant decision|1|||
16466431|NCT00348933|40185368|FG000|Overall Study|Withdrawal by Subject|10|||
16466432|NCT00348933|40185368|FG000|Overall Study|Lost to Follow-up|6|||
16466433|NCT00348933|40185368|FG000|Overall Study|Protocol Violation|2|||
16466434|NCT00348933|40185368|FG000|Overall Study|Adverse Event|7|||
16466435|NCT01445548|40185369|FG000|Overall Study|Adverse Event|1|||
16466436|NCT04590248|40185370|FG000|Overall Study|Lost to Follow-up|1|||
16466437|NCT04590248|40185370|FG000|Overall Study|Withdrawal by Subject|16|||
16466438|NCT04590248|40185370|FG000|Overall Study|Other|2|||
16466439|NCT02296138|40185371|FG000|Overall Study|Adverse Event|348|||
16466440|NCT02296138|40185372|FG001|Overall Study|Adverse Event|259|||
16466441|NCT02296138|40185371|FG000|Overall Study|Lack of Efficacy|59|||
16466442|NCT02296138|40185372|FG001|Overall Study|Lack of Efficacy|37|||
16466443|NCT02296138|40185371|FG000|Overall Study|Protocol Violation|35|||
16466444|NCT02296138|40185372|FG001|Overall Study|Protocol Violation|36|||
16466445|NCT02296138|40185371|FG000|Overall Study|Lost to Follow-up|9|||
16466446|NCT02296138|40185372|FG001|Overall Study|Lost to Follow-up|12|||
16466447|NCT02296138|40185371|FG000|Overall Study|Withdrawal by Subject|184|||
16466448|NCT02296138|40185372|FG001|Overall Study|Withdrawal by Subject|131|||
16466449|NCT02296138|40185371|FG000|Overall Study|Not Treated|1|||
16466450|NCT02296138|40185372|FG001|Overall Study|Not Treated|1|||
16466451|NCT02296138|40185371|FG000|Overall Study|Patients with data irregularities|10|||
16466452|NCT02296138|40185372|FG001|Overall Study|Patients with data irregularities|11|||
16466453|NCT02296138|40185371|FG000|Overall Study|Other than specified|15|||
16466454|NCT02296138|40185372|FG001|Overall Study|Other than specified|13|||
16466455|NCT01625260|40185373|FG000|Overall Study|Adverse Event|3|||
16466456|NCT01625260|40185374|FG001|Overall Study|Adverse Event|0|||
16466457|NCT01625260|40185373|FG000|Overall Study|Study Terminated by Investigator|2|||
16466458|NCT01625260|40185374|FG001|Overall Study|Study Terminated by Investigator|0|||
16466459|NCT01625260|40185373|FG000|Overall Study|Disease Progression|2|||
16466460|NCT01625260|40185374|FG001|Overall Study|Disease Progression|0|||
16466461|NCT01625260|40185373|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
16466462|NCT01625260|40185374|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
16466463|NCT01673347|40185375|FG000|Overall Study|failure of allograft|7|||
16466464|NCT02047318|40185378|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
16466465|NCT02047318|40185378|FG000|Core Study Period|Adverse Event|1|||
16170552|NCT03636906|39102979|FG001|Overall Study|Other|0|||
16269290|NCT00295490|39471053|FG000|Overall Study|Lost to Follow-up|0|||
16269291|NCT00295490|39471054|FG001|Overall Study|Lost to Follow-up|0|||
16466466|NCT02047318|40185378|FG000|Core Study Period|Withdrawal by caregiver|3|||
16466467|NCT02047318|40185378|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
16466468|NCT05672667|40185379|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
16466469|NCT02380690|40185383|FG000|Overall Study|Lost to Follow-up|14|||
16466470|NCT02380690|40185384|FG001|Overall Study|Lost to Follow-up|4|||
16466471|NCT02380690|40185383|FG000|Overall Study|Withdrawal by Subject|20|||
16466472|NCT02380690|40185384|FG001|Overall Study|Withdrawal by Subject|8|||
16466473|NCT03729362|40185385|FG000|Overall Study|Withdrawal by Subject|2|||
16466474|NCT03729362|40185386|FG001|Overall Study|Withdrawal by Subject|0|||
16466475|NCT03729362|40185385|FG000|Overall Study|Physician Decision|1|||
16466476|NCT03729362|40185386|FG001|Overall Study|Physician Decision|0|||
16466477|NCT03729362|40185385|FG000|Overall Study|COVID-19 Pandemic|1|||
16466478|NCT03729362|40185386|FG001|Overall Study|COVID-19 Pandemic|0|||
16466479|NCT03729362|40185385|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
16466480|NCT03729362|40185386|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
16170553|NCT03636906|39102980|FG002|Overall Study|Other|1|||
16170554|NCT02185521|39102981|FG000|Overall Study|Withdrawal by Subject|1|||
16170555|NCT02185521|39102981|FG000|Overall Study|Protocol Violation|1|||
16170556|NCT01658514|39102983|FG000|Overall Study|Protocol Violation|1|||
16170557|NCT01658514|39102984|FG001|Overall Study|Protocol Violation|0|||
16170558|NCT01658514|39102985|FG002|Overall Study|Protocol Violation|2|||
16170559|NCT02162862|39102986|FG000|Overall Study|Lost to Follow-up|0|||
16170560|NCT02162862|39102987|FG001|Overall Study|Lost to Follow-up|11|||
16170561|NCT02162862|39102988|FG002|Overall Study|Lost to Follow-up|0|||
16170562|NCT02162862|39102986|FG000|Overall Study|Subject did not feel the med was needed|0|||
16170563|NCT02162862|39102987|FG001|Overall Study|Subject did not feel the med was needed|0|||
16170564|NCT02162862|39102988|FG002|Overall Study|Subject did not feel the med was needed|4|||
16170565|NCT02207907|39102989|FG000|Overall Study|Lost to Follow-up|3|||
16170566|NCT02207907|39102990|FG001|Overall Study|Lost to Follow-up|1|||
16170567|NCT02207907|39102989|FG000|Overall Study|Withdrawal by Subject|5|||
16170568|NCT02207907|39102990|FG001|Overall Study|Withdrawal by Subject|6|||
16170569|NCT02207907|39102989|FG000|Overall Study|Did not meet study criteria|3|||
16170570|NCT02207907|39102990|FG001|Overall Study|Did not meet study criteria|0|||
16170571|NCT02207907|39102989|FG000|Overall Study|Pregnancy|0|||
16170572|NCT02207907|39102990|FG001|Overall Study|Pregnancy|1|||
16170573|NCT02690701|39102991|FG000|Treatment Period 1|Adverse Event|2|||
16170574|NCT02690701|39102992|FG001|Treatment Period 1|Adverse Event|2|||
16170575|NCT02690701|39102991|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16170576|NCT02690701|39102992|FG001|Treatment Period 1|Withdrawal by Subject|1|||
16170577|NCT02690701|39102991|FG000|Treatment Period 2|Adverse Event|2|||
16170578|NCT02690701|39102992|FG001|Treatment Period 2|Adverse Event|0|||
16170579|NCT02690701|39102991|FG000|Treatment Period 2|Lack of Efficacy|1|||
16170580|NCT02690701|39102992|FG001|Treatment Period 2|Lack of Efficacy|0|||
16170581|NCT02690701|39102991|FG000|Treatment Period 2|Lost to Follow-up|0|||
16170582|NCT02690701|39102992|FG001|Treatment Period 2|Lost to Follow-up|2|||
16170583|NCT02690701|39102991|FG000|Treatment Period 2|Withdrawal by Subject|0|||
16170584|NCT02690701|39102992|FG001|Treatment Period 2|Withdrawal by Subject|2|||
16170585|NCT02690701|39102991|FG000|Treatment Period 2|Protocol Violation|0|||
16170586|NCT02690701|39102992|FG001|Treatment Period 2|Protocol Violation|1|||
16170587|NCT01795547|39102995|FG000|Overall Study|Adverse Event|16|||
16170588|NCT01795547|39102996|FG001|Overall Study|Adverse Event|27|||
16170589|NCT01795547|39102995|FG000|Overall Study|Lack of Efficacy|8|||
16170590|NCT01795547|39102996|FG001|Overall Study|Lack of Efficacy|3|||
16170591|NCT01795547|39102995|FG000|Overall Study|Protocol Violation|6|||
16170592|NCT01795547|39102996|FG001|Overall Study|Protocol Violation|4|||
16170593|NCT01795547|39102995|FG000|Overall Study|Lost to Follow-up|2|||
16170594|NCT01795547|39102996|FG001|Overall Study|Lost to Follow-up|5|||
16170595|NCT01795547|39102995|FG000|Overall Study|Withdrawal of consent|7|||
16170596|NCT01795547|39102996|FG001|Overall Study|Withdrawal of consent|12|||
16170597|NCT01795547|39102995|FG000|Overall Study|Not Treated|4|||
16170598|NCT01795547|39102996|FG001|Overall Study|Not Treated|10|||
16170599|NCT01795547|39102995|FG000|Overall Study|Non-compliance with IMP|1|||
16170600|NCT01795547|39102996|FG001|Overall Study|Non-compliance with IMP|1|||
16170601|NCT01795547|39102995|FG000|Overall Study|Others|4|||
16170602|NCT01795547|39102996|FG001|Overall Study|Others|1|||
16170603|NCT01795547|39102995|FG000|Overall Study|Not stated|0|||
16170604|NCT01795547|39102996|FG001|Overall Study|Not stated|1|||
16170605|NCT03502330|39102997|FG000|Overall Study|Adverse Event|2|||
16170606|NCT03502330|39102998|FG001|Overall Study|Adverse Event|1|||
16170607|NCT03502330|39102999|FG002|Overall Study|Adverse Event|0|||
16466481|NCT03729362|40185385|FG000|Overall Study|Adverse Event|0|||
16466482|NCT03729362|40185386|FG001|Overall Study|Adverse Event|1|||
16466483|NCT03729362|40185385|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
16466484|NCT03729362|40185386|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
16466485|NCT01653132|40185387|FG000|First Intervention|Protocol Violation|1|||
16466486|NCT01653132|40185388|FG001|First Intervention|Protocol Violation|0|||
16466487|NCT00830869|40185389|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
16466488|NCT00830869|40185390|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
16170608|NCT03502330|39103000|FG003|Overall Study|Adverse Event|0|||
16170609|NCT03502330|39103001|FG004|Overall Study|Adverse Event|1|||
16170610|NCT03502330|39103002|FG005|Overall Study|Adverse Event|0|||
16170611|NCT03502330|39103003|FG006|Overall Study|Adverse Event|1|||
16170612|NCT03502330|39103004|FG007|Overall Study|Adverse Event|1|||
16170613|NCT03502330|39103005|FG008|Overall Study|Adverse Event|0|||
16170614|NCT03502330|39102997|FG000|Overall Study|Lack of Efficacy|1|||
16170615|NCT03502330|39102998|FG001|Overall Study|Lack of Efficacy|5|||
16170616|NCT03502330|39102999|FG002|Overall Study|Lack of Efficacy|3|||
16170617|NCT03502330|39103000|FG003|Overall Study|Lack of Efficacy|5|||
16170618|NCT03502330|39103001|FG004|Overall Study|Lack of Efficacy|1|||
16170619|NCT03502330|39103002|FG005|Overall Study|Lack of Efficacy|5|||
16170620|NCT03502330|39103003|FG006|Overall Study|Lack of Efficacy|5|||
16466489|NCT00830869|40185391|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
16170621|NCT03502330|39103004|FG007|Overall Study|Lack of Efficacy|6|||
16170622|NCT03502330|39103005|FG008|Overall Study|Lack of Efficacy|0|||
16170623|NCT03502330|39102997|FG000|Overall Study|Physician Decision|0|||
16170624|NCT03502330|39102998|FG001|Overall Study|Physician Decision|0|||
16170625|NCT03502330|39102999|FG002|Overall Study|Physician Decision|0|||
16170626|NCT03502330|39103000|FG003|Overall Study|Physician Decision|0|||
16170627|NCT03502330|39103001|FG004|Overall Study|Physician Decision|1|||
16170628|NCT03502330|39103002|FG005|Overall Study|Physician Decision|0|||
16170629|NCT03502330|39103003|FG006|Overall Study|Physician Decision|0|||
16170630|NCT03502330|39103004|FG007|Overall Study|Physician Decision|0|||
16170631|NCT03502330|39103005|FG008|Overall Study|Physician Decision|0|||
16170632|NCT03502330|39102997|FG000|Overall Study|Withdrawal by Subject|0|||
16170633|NCT03502330|39102998|FG001|Overall Study|Withdrawal by Subject|0|||
16170634|NCT03502330|39102999|FG002|Overall Study|Withdrawal by Subject|0|||
16170635|NCT03502330|39103000|FG003|Overall Study|Withdrawal by Subject|0|||
16170636|NCT03502330|39103001|FG004|Overall Study|Withdrawal by Subject|0|||
16170637|NCT03502330|39103002|FG005|Overall Study|Withdrawal by Subject|1|||
16170638|NCT03502330|39103003|FG006|Overall Study|Withdrawal by Subject|0|||
16170639|NCT03502330|39103004|FG007|Overall Study|Withdrawal by Subject|1|||
16170640|NCT03502330|39103005|FG008|Overall Study|Withdrawal by Subject|0|||
16170641|NCT03502330|39102997|FG000|Overall Study|Death|0|||
16170642|NCT03502330|39102998|FG001|Overall Study|Death|0|||
16170643|NCT03502330|39102999|FG002|Overall Study|Death|0|||
16170644|NCT03502330|39103000|FG003|Overall Study|Death|0|||
16170645|NCT03502330|39103001|FG004|Overall Study|Death|0|||
16170646|NCT03502330|39103002|FG005|Overall Study|Death|0|||
16170647|NCT03502330|39103003|FG006|Overall Study|Death|2|||
16170648|NCT03502330|39103004|FG007|Overall Study|Death|0|||
16170649|NCT03502330|39103005|FG008|Overall Study|Death|0|||
16170650|NCT01818726|39103007|FG000|Overall Study|Administrative reasons|5|||
16170651|NCT01818726|39103008|FG001|Overall Study|Administrative reasons|1|||
16170652|NCT01818726|39103007|FG000|Overall Study|Withdrawal by Subject|0|||
16170653|NCT01818726|39103008|FG001|Overall Study|Withdrawal by Subject|1|||
16170654|NCT01818726|39103007|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
16170655|NCT01818726|39103008|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
16170656|NCT02654002|39103009|FG000|Overall Study|Adverse Event|0|||
16170657|NCT02654002|39103010|FG001|Overall Study|Adverse Event|0|||
16170658|NCT02654002|39103011|FG002|Overall Study|Adverse Event|0|||
16170659|NCT02654002|39103012|FG003|Overall Study|Adverse Event|0|||
16170660|NCT02654002|39103013|FG004|Overall Study|Adverse Event|0|||
16170661|NCT02654002|39103014|FG005|Overall Study|Adverse Event|0|||
16170662|NCT02654002|39103015|FG006|Overall Study|Adverse Event|1|||
16170663|NCT02654002|39103016|FG007|Overall Study|Adverse Event|0|||
16170664|NCT02654002|39103017|FG008|Overall Study|Adverse Event|0|||
16170665|NCT02654002|39103009|FG000|Overall Study|Withdrew Consent|0|||
16170666|NCT02654002|39103010|FG001|Overall Study|Withdrew Consent|0|||
16170667|NCT02654002|39103011|FG002|Overall Study|Withdrew Consent|0|||
16170668|NCT02654002|39103012|FG003|Overall Study|Withdrew Consent|0|||
16170669|NCT02654002|39103013|FG004|Overall Study|Withdrew Consent|0|||
16170670|NCT02654002|39103014|FG005|Overall Study|Withdrew Consent|1|||
16170671|NCT02654002|39103015|FG006|Overall Study|Withdrew Consent|0|||
16170672|NCT02654002|39103016|FG007|Overall Study|Withdrew Consent|1|||
16170673|NCT02654002|39103017|FG008|Overall Study|Withdrew Consent|0|||
16170674|NCT02700451|39103018|FG000|Overall Study|Protocol Violation|2|||
16170675|NCT02700451|39103019|FG001|Overall Study|Protocol Violation|2|||
16170676|NCT02700451|39103020|FG002|Overall Study|Protocol Violation|3|||
16170677|NCT02700451|39103018|FG000|Overall Study|Discontinued intervention|14|||
16170678|NCT02700451|39103019|FG001|Overall Study|Discontinued intervention|15|||
16170679|NCT02700451|39103020|FG002|Overall Study|Discontinued intervention|14|||
16170680|NCT00700804|39103021|FG000|Overall Study|Withdrawal by Subject|1|||
16170681|NCT00700804|39103022|FG001|Overall Study|Withdrawal by Subject|2|||
16170682|NCT00700804|39103021|FG000|Overall Study|Protocol Violation|1|||
16170683|NCT00700804|39103022|FG001|Overall Study|Protocol Violation|1|||
16170684|NCT00700804|39103021|FG000|Overall Study|Loose Stools|1|||
16170685|NCT00700804|39103022|FG001|Overall Study|Loose Stools|1|||
16170686|NCT02118792|39103023|FG000|Overall Study|Withdrawal by Subject|6|||
16170687|NCT02118792|39103024|FG001|Overall Study|Withdrawal by Subject|3|||
16170688|NCT02118792|39103023|FG000|Overall Study|Lost to Follow-up|4|||
16170689|NCT02118792|39103024|FG001|Overall Study|Lost to Follow-up|4|||
16170690|NCT02118792|39103023|FG000|Overall Study|Adverse Event|5|||
16170691|NCT02118792|39103024|FG001|Overall Study|Adverse Event|4|||
16170692|NCT02118792|39103023|FG000|Overall Study|Withdrawal by parent/guardian|14|||
16170693|NCT02118792|39103024|FG001|Overall Study|Withdrawal by parent/guardian|20|||
16170694|NCT02118792|39103023|FG000|Overall Study|Other|1|||
16170695|NCT02118792|39103024|FG001|Overall Study|Other|6|||
16170696|NCT02118792|39103023|FG000|Overall Study|Randomised but not treated|1|||
16170697|NCT02118792|39103024|FG001|Overall Study|Randomised but not treated|0|||
16170698|NCT00846742|39103028|FG000|Overall Study|Withdrawal by Subject|1|||
16170699|NCT01817790|39103029|FG000|Overall Study|Adverse Event|0|||
16170700|NCT01817790|39103030|FG001|Overall Study|Adverse Event|2|||
16170701|NCT01817790|39103029|FG000|Overall Study|Lost to Follow-up|0|||
16170702|NCT01817790|39103030|FG001|Overall Study|Lost to Follow-up|1|||
16170703|NCT01817790|39103029|FG000|Overall Study|Protocol Violation|2|||
16170704|NCT01817790|39103030|FG001|Overall Study|Protocol Violation|1|||
16170705|NCT01817790|39103029|FG000|Overall Study|Withdrawal by Subject|1|||
16170706|NCT01817790|39103030|FG001|Overall Study|Withdrawal by Subject|3|||
16170707|NCT01817790|39103029|FG000|Overall Study|Other: Could not attend appointment|1|||
16170708|NCT01817790|39103030|FG001|Overall Study|Other: Could not attend appointment|1|||
16170709|NCT00510276|39103031|FG000|Acute Double-Blind Phase|Adverse Event|21|||
16170710|NCT00510276|39103032|FG001|Acute Double-Blind Phase|Adverse Event|6|||
16170711|NCT00510276|39103031|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
16170712|NCT00510276|39103032|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
16170713|NCT00510276|39103031|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
16170714|NCT00510276|39103032|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
16170715|NCT00510276|39103031|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
16170716|NCT00510276|39103032|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
16170717|NCT00510276|39103031|FG000|Acute Double-Blind Phase|Physician Decision|0|||
16170718|NCT00510276|39103032|FG001|Acute Double-Blind Phase|Physician Decision|3|||
16170719|NCT00510276|39103031|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
16170720|NCT00510276|39103032|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
16170721|NCT00510276|39103031|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
16170722|NCT00510276|39103032|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
16170723|NCT00510276|39103031|FG000|Acute Double-Blind Phase|Subject Decision|26|||
16170724|NCT00510276|39103032|FG001|Acute Double-Blind Phase|Subject Decision|28|||
16170725|NCT00510276|39103031|FG000|Extension Open-Label Phase|Adverse Event|9|||
16170726|NCT00510276|39103032|FG001|Extension Open-Label Phase|Adverse Event|18|||
16170727|NCT00510276|39103031|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
16170728|NCT00510276|39103032|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
16170729|NCT00510276|39103031|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
16170730|NCT00510276|39103032|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
16170731|NCT00510276|39103031|FG000|Extension Open-Label Phase|Physician Decision|2|||
16170732|NCT00510276|39103032|FG001|Extension Open-Label Phase|Physician Decision|3|||
16170733|NCT00510276|39103031|FG000|Extension Open-Label Phase|Protocol Violation|0|||
16170734|NCT00510276|39103032|FG001|Extension Open-Label Phase|Protocol Violation|1|||
16170735|NCT00510276|39103031|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
16170736|NCT00510276|39103032|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
16170737|NCT00510276|39103031|FG000|Extension Open-Label Phase|Subject Decision|7|||
16170738|NCT00510276|39103032|FG001|Extension Open-Label Phase|Subject Decision|9|||
16170739|NCT03486392|39103033|FG000|Overall Study|Lost to Follow-up|0|||
16170740|NCT03486392|39103034|FG001|Overall Study|Lost to Follow-up|0|||
16170741|NCT03486392|39103035|FG002|Overall Study|Lost to Follow-up|8|||
16170742|NCT03486392|39103036|FG003|Overall Study|Lost to Follow-up|5|||
16170743|NCT03486392|39103037|FG004|Overall Study|Lost to Follow-up|2|||
16170744|NCT03486392|39103033|FG000|Overall Study|Withdrawal by Subject|3|||
16170745|NCT03486392|39103034|FG001|Overall Study|Withdrawal by Subject|0|||
16170746|NCT03486392|39103035|FG002|Overall Study|Withdrawal by Subject|6|||
16170747|NCT03486392|39103036|FG003|Overall Study|Withdrawal by Subject|4|||
16170748|NCT03486392|39103037|FG004|Overall Study|Withdrawal by Subject|1|||
16170749|NCT03486392|39103033|FG000|Overall Study|Death|0|||
16170750|NCT03486392|39103034|FG001|Overall Study|Death|0|||
16170751|NCT03486392|39103035|FG002|Overall Study|Death|0|||
16170752|NCT03486392|39103036|FG003|Overall Study|Death|0|||
16170753|NCT03486392|39103037|FG004|Overall Study|Death|1|||
16170754|NCT04223609|39103038|FG000|Overall Study|Adverse Event|0|||
16170755|NCT04223609|39103039|FG001|Overall Study|Adverse Event|1|||
16170756|NCT04223609|39103038|FG000|Overall Study|Missed last visit|0|||
16170757|NCT04223609|39103039|FG001|Overall Study|Missed last visit|1|||
16170758|NCT00618748|39103050|FG000|Overall Study|Adverse Event|4|||
16170759|NCT00618748|39103051|FG001|Overall Study|Adverse Event|3|||
16170760|NCT00618748|39103052|FG002|Overall Study|Adverse Event|8|||
16269292|NCT00295490|39471055|FG002|Overall Study|Lost to Follow-up|1|||
16269293|NCT00295490|39471056|FG003|Overall Study|Lost to Follow-up|0|||
16170761|NCT00618748|39103050|FG000|Overall Study|Physician Decision|3|||
16170762|NCT00618748|39103051|FG001|Overall Study|Physician Decision|1|||
16170763|NCT00618748|39103052|FG002|Overall Study|Physician Decision|1|||
16170764|NCT00618748|39103050|FG000|Overall Study|Withdrawal by Subject|4|||
16170765|NCT00618748|39103051|FG001|Overall Study|Withdrawal by Subject|1|||
16170766|NCT00618748|39103052|FG002|Overall Study|Withdrawal by Subject|5|||
16269294|NCT00295490|39471053|FG000|Overall Study|Adverse Event|1|||
16170767|NCT01553149|39103053|FG000|Overall Study|Adverse Event|0|||
16170768|NCT01553149|39103054|FG001|Overall Study|Adverse Event|9|||
16170769|NCT01553149|39103053|FG000|Overall Study|Physician Decision|5|||
16170770|NCT01553149|39103054|FG001|Overall Study|Physician Decision|10|||
16170771|NCT01553149|39103053|FG000|Overall Study|Ineligible|0|||
16170772|NCT01553149|39103054|FG001|Overall Study|Ineligible|1|||
16170773|NCT01228747|39103059|FG000|Overall Study|Adverse Event|8|||
16170774|NCT01228747|39103060|FG001|Overall Study|Adverse Event|4|||
16170775|NCT01228747|39103059|FG000|Overall Study|Lack of Efficacy|40|||
16170776|NCT01228747|39103060|FG001|Overall Study|Lack of Efficacy|27|||
16170777|NCT01228747|39103059|FG000|Overall Study|Protocol Violation|6|||
16170778|NCT01228747|39103060|FG001|Overall Study|Protocol Violation|5|||
16170779|NCT01228747|39103059|FG000|Overall Study|Lost to Follow-up|4|||
16170780|NCT01228747|39103060|FG001|Overall Study|Lost to Follow-up|3|||
16170781|NCT01228747|39103059|FG000|Overall Study|Withdrawal by Subject|5|||
16170782|NCT01228747|39103060|FG001|Overall Study|Withdrawal by Subject|1|||
16170783|NCT01228747|39103059|FG000|Overall Study|Other Reason|2|||
16170784|NCT01228747|39103060|FG001|Overall Study|Other Reason|5|||
16170785|NCT01672957|39103061|FG000|Overall Study|Protocol Violation|48|||
16170786|NCT01672957|39103061|FG000|Overall Study|Death|2|||
16170787|NCT01672957|39103061|FG000|Overall Study|ICF Signed After Transplantation|5|||
16466490|NCT00830869|40185392|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
16170788|NCT00522392|39103062|FG000|Overall Study|Disease progression|0|||
16170789|NCT00522392|39103063|FG001|Overall Study|Disease progression|3|||
16170790|NCT00522392|39103062|FG000|Overall Study|Adverse Event|7|||
16170791|NCT00522392|39103063|FG001|Overall Study|Adverse Event|7|||
16170792|NCT00522392|39103062|FG000|Overall Study|Withdrawal by Subject|1|||
16170793|NCT00522392|39103063|FG001|Overall Study|Withdrawal by Subject|1|||
16170794|NCT00522392|39103062|FG000|Overall Study|Physician Decision|0|||
16170795|NCT00522392|39103063|FG001|Overall Study|Physician Decision|1|||
16170796|NCT00522392|39103062|FG000|Overall Study|Non-compliance|0|||
16170797|NCT00522392|39103063|FG001|Overall Study|Non-compliance|1|||
16170798|NCT03093402|39103064|FG000|Overall Study|Lost to Follow-up|1|||
16170799|NCT03093402|39103065|FG001|Overall Study|Lost to Follow-up|0|||
16170800|NCT03093402|39103066|FG002|Overall Study|Lost to Follow-up|0|||
16170801|NCT03093402|39103067|FG003|Overall Study|Lost to Follow-up|0|||
16170802|NCT03093402|39103064|FG000|Overall Study|Withdrawal by Subject|3|||
16170803|NCT03093402|39103065|FG001|Overall Study|Withdrawal by Subject|3|||
16170804|NCT03093402|39103066|FG002|Overall Study|Withdrawal by Subject|0|||
16170805|NCT03093402|39103067|FG003|Overall Study|Withdrawal by Subject|1|||
16170806|NCT03093402|39103064|FG000|Overall Study|Withdrew prior to dosing|2|||
16170807|NCT03093402|39103065|FG001|Overall Study|Withdrew prior to dosing|1|||
16170808|NCT03093402|39103066|FG002|Overall Study|Withdrew prior to dosing|2|||
16170809|NCT03093402|39103067|FG003|Overall Study|Withdrew prior to dosing|3|||
16170810|NCT03093402|39103064|FG000|Overall Study|Ineligible for study|1|||
16170811|NCT03093402|39103065|FG001|Overall Study|Ineligible for study|0|||
16170812|NCT03093402|39103066|FG002|Overall Study|Ineligible for study|0|||
16170813|NCT03093402|39103067|FG003|Overall Study|Ineligible for study|0|||
16170814|NCT03093402|39103064|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
16170815|NCT03093402|39103065|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
16170816|NCT03093402|39103066|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
16170817|NCT03093402|39103067|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
16170818|NCT00688909|39103068|FG000|Overall Study|Adverse Event|28|||
16170819|NCT00688909|39103068|FG000|Overall Study|Patient withdrew consent|2|||
16466491|NCT00830869|40185393|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
16170820|NCT00688909|39103068|FG000|Overall Study|Administrative problems|1|||
16170821|NCT00688909|39103068|FG000|Overall Study|Protocol Violation|2|||
16466492|NCT00830869|40185394|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
16466493|NCT00830869|40185395|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
16466494|NCT00830869|40185396|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
16466495|NCT00830869|40185397|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
16466496|NCT00830869|40185398|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
16466497|NCT00830869|40185399|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
16466498|NCT00830869|40185400|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
16466499|NCT00830869|40185389|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
16466500|NCT00830869|40185390|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
16466501|NCT00830869|40185391|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
16466502|NCT00830869|40185392|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
16170822|NCT02502864|39103069|FG000|Overall Study|Withdrawal by Subject|1|||
16170823|NCT02494596|39103070|FG000|Overall Study|Insufficient Therapeutic Response|3|||
16269295|NCT00295490|39471054|FG001|Overall Study|Adverse Event|0|||
16170824|NCT02494596|39103071|FG001|Overall Study|Insufficient Therapeutic Response|3|||
16170825|NCT02494596|39103072|FG002|Overall Study|Insufficient Therapeutic Response|1|||
16170826|NCT02494596|39103070|FG000|Overall Study|Adverse Event|0|||
16170827|NCT02494596|39103071|FG001|Overall Study|Adverse Event|1|||
16170828|NCT02494596|39103072|FG002|Overall Study|Adverse Event|0|||
16170829|NCT02494596|39103070|FG000|Overall Study|Refused Treatment|0|||
16170830|NCT02494596|39103071|FG001|Overall Study|Refused Treatment|1|||
16170831|NCT02494596|39103072|FG002|Overall Study|Refused Treatment|0|||
16170832|NCT00840827|39103073|FG000|Overall Study|Adverse Event|1|||
16170833|NCT00840827|39103073|FG000|Overall Study|Lack of Efficacy|4|||
16170834|NCT00840827|39103073|FG000|Overall Study|Physician Decision|1|||
16466503|NCT00830869|40185393|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
16170835|NCT00961961|39103074|FG000|Phase I|Withdrawal by Subject|7|||
16170836|NCT00961961|39103075|FG001|Phase I|Withdrawal by Subject|0|||
16170837|NCT00961961|39103076|FG002|Phase I|Withdrawal by Subject|0|||
16170838|NCT00961961|39103077|FG003|Phase I|Withdrawal by Subject|0|||
16170839|NCT00961961|39103074|FG000|Phase I|Lost to Follow-up|10|||
16170840|NCT00961961|39103075|FG001|Phase I|Lost to Follow-up|0|||
16170841|NCT00961961|39103076|FG002|Phase I|Lost to Follow-up|0|||
16170842|NCT00961961|39103077|FG003|Phase I|Lost to Follow-up|0|||
16170843|NCT00961961|39103074|FG000|Phase I|Lack of Efficacy|94|||
16170844|NCT00961961|39103075|FG001|Phase I|Lack of Efficacy|0|||
16466504|NCT00830869|40185394|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
16466505|NCT00830869|40185395|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
16466506|NCT00830869|40185396|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
16466507|NCT00830869|40185397|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
16466508|NCT00830869|40185398|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
16466509|NCT00830869|40185399|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
16466510|NCT00830869|40185400|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
16466511|NCT00830869|40185389|FG000|Period 1: Part 1|Adverse Event|0|||
16466512|NCT00830869|40185390|FG001|Period 1: Part 1|Adverse Event|0|||
16466513|NCT00830869|40185391|FG002|Period 1: Part 1|Adverse Event|0|||
16466514|NCT00830869|40185392|FG003|Period 1: Part 1|Adverse Event|0|||
16466515|NCT00830869|40185393|FG004|Period 1: Part 1|Adverse Event|0|||
16466516|NCT00830869|40185394|FG005|Period 1: Part 1|Adverse Event|1|||
16466517|NCT00830869|40185395|FG006|Period 1: Part 1|Adverse Event|1|||
16466518|NCT00830869|40185396|FG007|Period 1: Part 1|Adverse Event|0|||
16466519|NCT00830869|40185397|FG008|Period 1: Part 1|Adverse Event|0|||
16466520|NCT00830869|40185398|FG009|Period 1: Part 1|Adverse Event|0|||
16466521|NCT00830869|40185399|FG010|Period 1: Part 1|Adverse Event|0|||
16466522|NCT00830869|40185400|FG011|Period 1: Part 1|Adverse Event|0|||
16466523|NCT00830869|40185389|FG000|Period 1: Part 1|Progressive disease|1|||
16466524|NCT00830869|40185390|FG001|Period 1: Part 1|Progressive disease|0|||
16466525|NCT00830869|40185391|FG002|Period 1: Part 1|Progressive disease|1|||
16466526|NCT00830869|40185392|FG003|Period 1: Part 1|Progressive disease|6|||
16466527|NCT00830869|40185393|FG004|Period 1: Part 1|Progressive disease|4|||
16466528|NCT00830869|40185394|FG005|Period 1: Part 1|Progressive disease|4|||
16466529|NCT00830869|40185395|FG006|Period 1: Part 1|Progressive disease|1|||
16466530|NCT00830869|40185396|FG007|Period 1: Part 1|Progressive disease|0|||
16466531|NCT00830869|40185397|FG008|Period 1: Part 1|Progressive disease|0|||
16466532|NCT00830869|40185398|FG009|Period 1: Part 1|Progressive disease|0|||
16466533|NCT00830869|40185399|FG010|Period 1: Part 1|Progressive disease|0|||
16466534|NCT00830869|40185400|FG011|Period 1: Part 1|Progressive disease|0|||
16466535|NCT00830869|40185389|FG000|Period 2: Part 2|Protocol Violation|0|||
16170845|NCT00961961|39103076|FG002|Phase I|Lack of Efficacy|0|||
16170846|NCT00961961|39103077|FG003|Phase I|Lack of Efficacy|0|||
16170847|NCT00961961|39103074|FG000|Phase I|Adverse Event|7|||
16170848|NCT00961961|39103075|FG001|Phase I|Adverse Event|0|||
16170849|NCT00961961|39103076|FG002|Phase I|Adverse Event|0|||
16170850|NCT00961961|39103077|FG003|Phase I|Adverse Event|0|||
16170851|NCT00961961|39103074|FG000|Phase I|Physician Decision|8|||
16170852|NCT00961961|39103075|FG001|Phase I|Physician Decision|0|||
16170853|NCT00961961|39103076|FG002|Phase I|Physician Decision|0|||
16170854|NCT00961961|39103077|FG003|Phase I|Physician Decision|0|||
16170855|NCT00961961|39103074|FG000|Phase II|Lost to Follow-up|0|||
16170856|NCT00961961|39103075|FG001|Phase II|Lost to Follow-up|0|||
16170857|NCT00961961|39103076|FG002|Phase II|Lost to Follow-up|10|||
16170858|NCT00961961|39103077|FG003|Phase II|Lost to Follow-up|7|||
16170859|NCT00961961|39103074|FG000|Phase II|Adverse Event|0|||
16170860|NCT00961961|39103075|FG001|Phase II|Adverse Event|0|||
16170861|NCT00961961|39103076|FG002|Phase II|Adverse Event|0|||
16170862|NCT00961961|39103077|FG003|Phase II|Adverse Event|1|||
16170863|NCT00961961|39103074|FG000|Phase II|Physician Decision|0|||
16170864|NCT00961961|39103075|FG001|Phase II|Physician Decision|0|||
16170865|NCT00961961|39103076|FG002|Phase II|Physician Decision|1|||
16170866|NCT00961961|39103077|FG003|Phase II|Physician Decision|0|||
16170867|NCT00961961|39103074|FG000|Phase II|Withdrawal by Subject|0|||
16170868|NCT00961961|39103075|FG001|Phase II|Withdrawal by Subject|0|||
16170869|NCT00961961|39103076|FG002|Phase II|Withdrawal by Subject|1|||
16170870|NCT00961961|39103077|FG003|Phase II|Withdrawal by Subject|0|||
16170871|NCT04167345|39103078|FG000|Overall Study|Other|1|||
16170872|NCT04167345|39103079|FG001|Overall Study|Other|1|||
16170873|NCT04167345|39103080|FG002|Overall Study|Other|0|||
16170874|NCT04167345|39103081|FG003|Overall Study|Other|0|||
16170875|NCT04167345|39103082|FG004|Overall Study|Other|0|||
16466536|NCT00830869|40185390|FG001|Period 2: Part 2|Protocol Violation|0|||
16466537|NCT00830869|40185391|FG002|Period 2: Part 2|Protocol Violation|0|||
16466538|NCT00830869|40185392|FG003|Period 2: Part 2|Protocol Violation|0|||
16466539|NCT00830869|40185393|FG004|Period 2: Part 2|Protocol Violation|0|||
16170876|NCT00716976|39103085|FG000|Overall Study|Adverse Event|2|||
16170877|NCT00716976|39103086|FG001|Overall Study|Adverse Event|0|||
16170878|NCT00716976|39103085|FG000|Overall Study|Death|1|||
16170879|NCT00716976|39103086|FG001|Overall Study|Death|0|||
16466540|NCT00830869|40185394|FG005|Period 2: Part 2|Protocol Violation|0|||
16466541|NCT00830869|40185395|FG006|Period 2: Part 2|Protocol Violation|0|||
16466542|NCT00830869|40185396|FG007|Period 2: Part 2|Protocol Violation|1|||
16466543|NCT00830869|40185397|FG008|Period 2: Part 2|Protocol Violation|0|||
16170880|NCT00716976|39103085|FG000|Overall Study|Physician Decision|2|||
16170881|NCT00716976|39103086|FG001|Overall Study|Physician Decision|2|||
16170882|NCT00716976|39103085|FG000|Overall Study|Withdrawal by Subject|5|||
16170883|NCT00716976|39103086|FG001|Overall Study|Withdrawal by Subject|1|||
16170884|NCT00716976|39103085|FG000|Overall Study|Premature discontinuation cisplatin|5|||
16170885|NCT00716976|39103086|FG001|Overall Study|Premature discontinuation cisplatin|4|||
16170886|NCT00716976|39103085|FG000|Overall Study|Radiation during protocol|1|||
16170887|NCT00716976|39103086|FG001|Overall Study|Radiation during protocol|0|||
16170888|NCT00716976|39103085|FG000|Overall Study|Ineligibles|4|||
16170889|NCT00716976|39103086|FG001|Overall Study|Ineligibles|2|||
16170890|NCT01220414|39103088|FG000|Overall Study|Withdrawal by Subject|1|||
16170891|NCT01220414|39103089|FG001|Overall Study|Withdrawal by Subject|0|||
16170892|NCT01220414|39103090|FG002|Overall Study|Withdrawal by Subject|0|||
16170893|NCT01220414|39103091|FG003|Overall Study|Withdrawal by Subject|1|||
16170894|NCT02435914|39103092|FG000|Overall Study|Ocular Adverse Event|1|||
16170895|NCT02435914|39103093|FG001|Overall Study|Ocular Adverse Event|0|||
16170896|NCT02435914|39103094|FG002|Overall Study|Ocular Adverse Event|0|||
16170897|NCT02435914|39103095|FG003|Overall Study|Ocular Adverse Event|0|||
16170898|NCT02435914|39103092|FG000|Overall Study|Withdrawal by Subject|0|||
16170899|NCT02435914|39103093|FG001|Overall Study|Withdrawal by Subject|1|||
16170900|NCT02435914|39103094|FG002|Overall Study|Withdrawal by Subject|0|||
16170901|NCT02435914|39103095|FG003|Overall Study|Withdrawal by Subject|0|||
16170902|NCT02435914|39103092|FG000|Overall Study|Other Miscellaneous Reason|0|||
16170903|NCT02435914|39103093|FG001|Overall Study|Other Miscellaneous Reason|0|||
16170904|NCT02435914|39103094|FG002|Overall Study|Other Miscellaneous Reason|1|||
16170905|NCT02435914|39103095|FG003|Overall Study|Other Miscellaneous Reason|0|||
16170906|NCT00619957|39103101|FG000|Month 24 Double-Blind|Adverse Event|9|||
16170907|NCT00619957|39103102|FG001|Month 24 Double-Blind|Adverse Event|7|||
16170908|NCT00619957|39103101|FG000|Month 24 Double-Blind|Protocol Violation|1|||
16170909|NCT00619957|39103102|FG001|Month 24 Double-Blind|Protocol Violation|0|||
16466544|NCT00830869|40185398|FG009|Period 2: Part 2|Protocol Violation|1|||
16466545|NCT00830869|40185399|FG010|Period 2: Part 2|Protocol Violation|0|||
16466546|NCT00830869|40185400|FG011|Period 2: Part 2|Protocol Violation|0|||
16466547|NCT00830869|40185389|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
16466548|NCT00830869|40185390|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
16466549|NCT00830869|40185391|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
16466550|NCT00830869|40185392|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
16466551|NCT00830869|40185393|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
16466552|NCT00830869|40185394|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
16466553|NCT00830869|40185395|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
16466554|NCT00830869|40185396|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
16466555|NCT00830869|40185397|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
16466556|NCT00830869|40185398|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
16466557|NCT00830869|40185399|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
16466558|NCT00830869|40185400|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
16466559|NCT00830869|40185389|FG000|Period 2: Part 2|Adverse Event|0|||
16466560|NCT00830869|40185390|FG001|Period 2: Part 2|Adverse Event|0|||
16170910|NCT00619957|39103101|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
16170911|NCT00619957|39103102|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
16170912|NCT00619957|39103101|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
16170913|NCT00619957|39103102|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
16170914|NCT00619957|39103101|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
16170915|NCT00619957|39103102|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
16170916|NCT00619957|39103101|FG000|Month 48 Open-Label|Adverse Event|4|||
16170917|NCT00619957|39103102|FG001|Month 48 Open-Label|Adverse Event|4|||
16170918|NCT00619957|39103101|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
16170919|NCT00619957|39103102|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
16170920|NCT00619957|39103101|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
16170921|NCT00619957|39103102|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
16170922|NCT00331006|39103105|FG000|Screening Phase|Withdrawal by Subject|1|||
16170923|NCT00331006|39103105|FG000|Screening Phase|enrollment halted|1|||
16170924|NCT00331006|39103105|FG000|Screening Phase|Lost to Follow-up|1|||
16170925|NCT00331006|39103105|FG000|Screening Phase|Ineligible for treatment phase|4|||
16170926|NCT00331006|39103105|FG000|Treatment Phase|Withdrawal by Subject|1|||
16466561|NCT00830869|40185391|FG002|Period 2: Part 2|Adverse Event|0|||
16170927|NCT00331006|39103105|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
16170928|NCT00331006|39103105|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
16170929|NCT02472847|39103106|FG000|Overall Study|Withdrawal by Subject|1|||
16170930|NCT02472847|39103107|FG001|Overall Study|Withdrawal by Subject|5|||
16170931|NCT05032950|39103111|FG000|Overall Study|Adverse Event|0|||
16466562|NCT00830869|40185392|FG003|Period 2: Part 2|Adverse Event|0|||
16466563|NCT00830869|40185393|FG004|Period 2: Part 2|Adverse Event|0|||
16170932|NCT05032950|39103112|FG001|Overall Study|Adverse Event|0|||
16170933|NCT05032950|39103113|FG002|Overall Study|Adverse Event|1|||
16170934|NCT05032950|39103114|FG003|Overall Study|Adverse Event|1|||
16170935|NCT05032950|39103115|FG004|Overall Study|Adverse Event|0|||
16170936|NCT05032950|39103116|FG005|Overall Study|Adverse Event|0|||
16170937|NCT01889602|39103118|FG000|First Intervention|Adverse Event|1|||
16170938|NCT01889602|39103119|FG001|First Intervention|Adverse Event|1|||
16170939|NCT01889602|39103120|FG002|First Intervention|Adverse Event|1|||
16170940|NCT01889602|39103118|FG000|First Intervention|Protocol Violation|0|||
16170941|NCT01889602|39103119|FG001|First Intervention|Protocol Violation|1|||
16170942|NCT01889602|39103120|FG002|First Intervention|Protocol Violation|1|||
16170943|NCT01889602|39103118|FG000|First Intervention|Study ending|0|||
16170944|NCT01889602|39103119|FG001|First Intervention|Study ending|1|||
16170945|NCT01889602|39103120|FG002|First Intervention|Study ending|0|||
16170946|NCT01889602|39103118|FG000|Second Intervention|Adverse Event|0|||
16170947|NCT01889602|39103119|FG001|Second Intervention|Adverse Event|0|||
16170948|NCT01889602|39103120|FG002|Second Intervention|Adverse Event|1|||
16170949|NCT01889602|39103118|FG000|Second Intervention|Study ending|1|||
16170950|NCT01889602|39103119|FG001|Second Intervention|Study ending|0|||
16170951|NCT01889602|39103120|FG002|Second Intervention|Study ending|0|||
16170952|NCT01889602|39103118|FG000|Second Intervention|Withdrawal by Subject|0|||
16170953|NCT01889602|39103119|FG001|Second Intervention|Withdrawal by Subject|0|||
16170954|NCT01889602|39103120|FG002|Second Intervention|Withdrawal by Subject|1|||
16170955|NCT01889602|39103118|FG000|Third Intervention|Protocol Violation|1|||
16170956|NCT01889602|39103119|FG001|Third Intervention|Protocol Violation|0|||
16170957|NCT01889602|39103120|FG002|Third Intervention|Protocol Violation|0|||
16170958|NCT01889602|39103118|FG000|Third Intervention|Withdrawal by Subject|2|||
16170959|NCT01889602|39103119|FG001|Third Intervention|Withdrawal by Subject|2|||
16170960|NCT01889602|39103120|FG002|Third Intervention|Withdrawal by Subject|0|||
16170961|NCT00206726|39103121|FG000|Overall Study|Delayed recovery of blood counts|1|||
16466564|NCT00830869|40185394|FG005|Period 2: Part 2|Adverse Event|0|||
16466565|NCT00830869|40185395|FG006|Period 2: Part 2|Adverse Event|0|||
16466566|NCT00830869|40185396|FG007|Period 2: Part 2|Adverse Event|4|||
16466567|NCT00830869|40185397|FG008|Period 2: Part 2|Adverse Event|3|||
16466568|NCT00830869|40185398|FG009|Period 2: Part 2|Adverse Event|2|||
16466569|NCT00830869|40185399|FG010|Period 2: Part 2|Adverse Event|2|||
16466570|NCT00830869|40185400|FG011|Period 2: Part 2|Adverse Event|0|||
16466571|NCT00830869|40185389|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
16466572|NCT00830869|40185390|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
16466573|NCT00830869|40185391|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
16466574|NCT00830869|40185392|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
16466575|NCT00830869|40185393|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
16466576|NCT00830869|40185394|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
16466577|NCT00830869|40185395|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
16466578|NCT00830869|40185396|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
16466579|NCT00830869|40185397|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
16466580|NCT00830869|40185398|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
16466581|NCT00830869|40185399|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
16466582|NCT00830869|40185400|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
16466583|NCT00830869|40185389|FG000|Period 2: Part 2|Progressive disease|0|||
16466584|NCT00830869|40185390|FG001|Period 2: Part 2|Progressive disease|0|||
16466585|NCT00830869|40185391|FG002|Period 2: Part 2|Progressive disease|0|||
16466586|NCT00830869|40185392|FG003|Period 2: Part 2|Progressive disease|0|||
16466587|NCT00830869|40185393|FG004|Period 2: Part 2|Progressive disease|0|||
16466588|NCT00830869|40185394|FG005|Period 2: Part 2|Progressive disease|0|||
16466589|NCT00830869|40185395|FG006|Period 2: Part 2|Progressive disease|0|||
16466590|NCT00830869|40185396|FG007|Period 2: Part 2|Progressive disease|14|||
16466591|NCT00830869|40185397|FG008|Period 2: Part 2|Progressive disease|11|||
16466592|NCT00830869|40185398|FG009|Period 2: Part 2|Progressive disease|12|||
16466593|NCT00830869|40185399|FG010|Period 2: Part 2|Progressive disease|8|||
16466594|NCT00830869|40185400|FG011|Period 2: Part 2|Progressive disease|15|||
16466595|NCT00830869|40185389|FG000|Period 2: Part 2|Other|0|||
16466596|NCT00830869|40185390|FG001|Period 2: Part 2|Other|0|||
16466597|NCT00830869|40185391|FG002|Period 2: Part 2|Other|0|||
16466598|NCT00830869|40185392|FG003|Period 2: Part 2|Other|0|||
16466599|NCT00830869|40185393|FG004|Period 2: Part 2|Other|0|||
16466600|NCT00830869|40185394|FG005|Period 2: Part 2|Other|0|||
16170962|NCT00206726|39103121|FG000|Overall Study|Progressive disease or relapsed disease|18|||
16170963|NCT00206726|39103121|FG000|Overall Study|Placed on new protocol|1|||
16466601|NCT00830869|40185395|FG006|Period 2: Part 2|Other|0|||
16466602|NCT00830869|40185396|FG007|Period 2: Part 2|Other|0|||
16466603|NCT00830869|40185397|FG008|Period 2: Part 2|Other|0|||
16173436|NCT01607892|39111208|FG003|Overall Study|Disease progression|57|||
16466604|NCT00830869|40185398|FG009|Period 2: Part 2|Other|1|||
16466605|NCT00830869|40185399|FG010|Period 2: Part 2|Other|0|||
16466606|NCT00830869|40185400|FG011|Period 2: Part 2|Other|0|||
16466607|NCT00266877|40185406|FG000|Overall Study|Death|1|||
16466608|NCT00266877|40185407|FG001|Overall Study|Death|1|||
16466609|NCT00266877|40185408|FG002|Overall Study|Death|1|||
16466610|NCT00266877|40185406|FG000|Overall Study|Adverse Event|6|||
16466611|NCT00266877|40185407|FG001|Overall Study|Adverse Event|4|||
16466612|NCT00266877|40185408|FG002|Overall Study|Adverse Event|1|||
16466613|NCT00266877|40185406|FG000|Overall Study|Physician Decision|2|||
16466614|NCT00266877|40185407|FG001|Overall Study|Physician Decision|1|||
16466615|NCT00266877|40185408|FG002|Overall Study|Physician Decision|1|||
16466616|NCT00266877|40185406|FG000|Overall Study|Withdrawal by Subject|3|||
16466617|NCT00266877|40185407|FG001|Overall Study|Withdrawal by Subject|1|||
16466618|NCT00266877|40185408|FG002|Overall Study|Withdrawal by Subject|1|||
16466619|NCT00266877|40185406|FG000|Overall Study|Disease Progression|72|||
16466620|NCT00266877|40185407|FG001|Overall Study|Disease Progression|37|||
16466621|NCT00266877|40185408|FG002|Overall Study|Disease Progression|23|||
16466622|NCT00266877|40185406|FG000|Overall Study|Symptomatic Deterioration|6|||
16466623|NCT00266877|40185407|FG001|Overall Study|Symptomatic Deterioration|3|||
16170964|NCT00206726|39103121|FG000|Overall Study|Bone marrow transplant|1|||
16170965|NCT00206726|39103121|FG000|Overall Study|Adverse Event|17|||
16170966|NCT00206726|39103121|FG000|Overall Study|Death|4|||
16170967|NCT00206726|39103121|FG000|Overall Study|Protocol Violation|1|||
16170968|NCT00206726|39103121|FG000|Overall Study|Withdrawal by Subject|8|||
16170969|NCT01523873|39103126|FG000|Overall Study|Protocol Violation|422|||
16170970|NCT01431287|39103133|FG000|Overall Study|not treated|0|||
16466624|NCT00266877|40185408|FG002|Overall Study|Symptomatic Deterioration|1|||
16466625|NCT00266877|40185406|FG000|Overall Study|Hospitalization|1|||
16466626|NCT00266877|40185407|FG001|Overall Study|Hospitalization|0|||
16466627|NCT00266877|40185408|FG002|Overall Study|Hospitalization|0|||
16466628|NCT00266877|40185406|FG000|Overall Study|Concomitant Radiotherapy|0|||
16466629|NCT00266877|40185407|FG001|Overall Study|Concomitant Radiotherapy|1|||
16466630|NCT00266877|40185408|FG002|Overall Study|Concomitant Radiotherapy|0|||
16466631|NCT00588952|40185413|FG000|Overall Study|Adverse Event|0|||
16466632|NCT00588952|40185414|FG001|Overall Study|Adverse Event|2|||
16466633|NCT00588952|40185413|FG000|Overall Study|Withdrawal by Subject|3|||
16466634|NCT00588952|40185414|FG001|Overall Study|Withdrawal by Subject|5|||
16466635|NCT00984620|40185417|FG000|Overall Study|Adverse Event|5|||
16466636|NCT00984620|40185418|FG001|Overall Study|Adverse Event|5|||
16466637|NCT00984620|40185417|FG000|Overall Study|Lost to Follow-up|1|||
16466638|NCT00984620|40185418|FG001|Overall Study|Lost to Follow-up|1|||
16170971|NCT01431287|39103134|FG001|Overall Study|not treated|0|||
16170972|NCT01431287|39103135|FG002|Overall Study|not treated|1|||
16170973|NCT01431287|39103136|FG003|Overall Study|not treated|0|||
16170974|NCT01431287|39103137|FG004|Overall Study|not treated|0|||
16170975|NCT01431287|39103133|FG000|Overall Study|Adverse Event|59|||
16170976|NCT01431287|39103134|FG001|Overall Study|Adverse Event|57|||
16170977|NCT01431287|39103135|FG002|Overall Study|Adverse Event|53|||
16170978|NCT01431287|39103136|FG003|Overall Study|Adverse Event|33|||
16170979|NCT01431287|39103137|FG004|Overall Study|Adverse Event|41|||
16170980|NCT01431287|39103133|FG000|Overall Study|Non compliant with protocol|6|||
16170981|NCT01431287|39103134|FG001|Overall Study|Non compliant with protocol|6|||
16170982|NCT01431287|39103135|FG002|Overall Study|Non compliant with protocol|5|||
16170983|NCT01431287|39103136|FG003|Overall Study|Non compliant with protocol|6|||
16170984|NCT01431287|39103137|FG004|Overall Study|Non compliant with protocol|5|||
16170985|NCT01431287|39103133|FG000|Overall Study|Lost to Follow-up|0|||
16170986|NCT01431287|39103134|FG001|Overall Study|Lost to Follow-up|3|||
16170987|NCT01431287|39103135|FG002|Overall Study|Lost to Follow-up|2|||
16170988|NCT01431287|39103136|FG003|Overall Study|Lost to Follow-up|3|||
16170989|NCT01431287|39103137|FG004|Overall Study|Lost to Follow-up|1|||
16170990|NCT01431287|39103133|FG000|Overall Study|Consent withdrawn not due to AE|29|||
16170991|NCT01431287|39103134|FG001|Overall Study|Consent withdrawn not due to AE|30|||
16170992|NCT01431287|39103135|FG002|Overall Study|Consent withdrawn not due to AE|34|||
16170993|NCT01431287|39103136|FG003|Overall Study|Consent withdrawn not due to AE|19|||
16170994|NCT01431287|39103137|FG004|Overall Study|Consent withdrawn not due to AE|29|||
16170995|NCT01431287|39103133|FG000|Overall Study|not stated above|4|||
16170996|NCT01431287|39103134|FG001|Overall Study|not stated above|2|||
16466639|NCT00984620|40185417|FG000|Overall Study|Withdrawal by Subject|0|||
16466640|NCT00984620|40185418|FG001|Overall Study|Withdrawal by Subject|2|||
16466641|NCT00984620|40185417|FG000|Overall Study|reason other than listed above|0|||
16466642|NCT00984620|40185418|FG001|Overall Study|reason other than listed above|4|||
16466643|NCT02992132|40185419|FG000|Overall Study|Adverse Event|4|||
16466644|NCT02992132|40185420|FG001|Overall Study|Adverse Event|1|||
16466645|NCT02992132|40185421|FG002|Overall Study|Adverse Event|3|||
16170997|NCT01431287|39103135|FG002|Overall Study|not stated above|2|||
16466646|NCT02992132|40185419|FG000|Overall Study|Lack of Efficacy|2|||
16170998|NCT01431287|39103136|FG003|Overall Study|not stated above|2|||
16170999|NCT01431287|39103137|FG004|Overall Study|not stated above|1|||
16171000|NCT00680836|39103139|FG000|Overall Study|Withdrawal by Subject|3|||
16171001|NCT00680836|39103140|FG001|Overall Study|Withdrawal by Subject|0|||
16171002|NCT00680836|39103139|FG000|Overall Study|Lost to Follow-up|3|||
16171003|NCT00680836|39103140|FG001|Overall Study|Lost to Follow-up|1|||
16466647|NCT02992132|40185420|FG001|Overall Study|Lack of Efficacy|0|||
16466648|NCT02992132|40185421|FG002|Overall Study|Lack of Efficacy|0|||
16466649|NCT02992132|40185419|FG000|Overall Study|Non-compliance with study drug|2|||
16466650|NCT02992132|40185420|FG001|Overall Study|Non-compliance with study drug|0|||
16466651|NCT02992132|40185421|FG002|Overall Study|Non-compliance with study drug|0|||
16466652|NCT02992132|40185419|FG000|Overall Study|Progressive disease|1|||
16466653|NCT02992132|40185420|FG001|Overall Study|Progressive disease|0|||
16466654|NCT02992132|40185421|FG002|Overall Study|Progressive disease|0|||
16466655|NCT02992132|40185419|FG000|Overall Study|Protocol Violation|2|||
16466656|NCT02992132|40185420|FG001|Overall Study|Protocol Violation|2|||
16466657|NCT02992132|40185421|FG002|Overall Study|Protocol Violation|0|||
16466658|NCT02992132|40185419|FG000|Overall Study|Caregiver withdrew consent|2|||
16466659|NCT02992132|40185420|FG001|Overall Study|Caregiver withdrew consent|3|||
16466660|NCT02992132|40185421|FG002|Overall Study|Caregiver withdrew consent|2|||
16466661|NCT02992132|40185419|FG000|Overall Study|Withdrawal by Subject|0|||
16466662|NCT02992132|40185420|FG001|Overall Study|Withdrawal by Subject|2|||
16466663|NCT02992132|40185421|FG002|Overall Study|Withdrawal by Subject|1|||
16466664|NCT02992132|40185419|FG000|Overall Study|Physician Decision|0|||
16466665|NCT02992132|40185420|FG001|Overall Study|Physician Decision|0|||
16466666|NCT02992132|40185421|FG002|Overall Study|Physician Decision|1|||
16466667|NCT00906971|40185422|FG000|Overall Study|Withdrawal by Subject|8|||
16466668|NCT00906971|40185423|FG001|Overall Study|Withdrawal by Subject|2|||
16466669|NCT00906971|40185422|FG000|Overall Study|Lost to Follow-up|0|||
16466670|NCT00906971|40185423|FG001|Overall Study|Lost to Follow-up|1|||
16466671|NCT01423604|40185425|FG000|Safety Run-In|Adverse Event|3|||
16466672|NCT01423604|40185426|FG001|Safety Run-In|Adverse Event|0|||
16466673|NCT01423604|40185425|FG000|Safety Run-In|Death|1|||
16466674|NCT01423604|40185426|FG001|Safety Run-In|Death|0|||
16466675|NCT01423604|40185425|FG000|Safety Run-In|Physician Decision|1|||
16466676|NCT01423604|40185426|FG001|Safety Run-In|Physician Decision|0|||
16466677|NCT01423604|40185425|FG000|Safety Run-In|Disease progression|3|||
16466678|NCT01423604|40185426|FG001|Safety Run-In|Disease progression|0|||
16466679|NCT01423604|40185425|FG000|Safety Run-In|Patient decision|1|||
16466680|NCT01423604|40185426|FG001|Safety Run-In|Patient decision|0|||
16466681|NCT01423604|40185425|FG000|Randomized|Adverse Event|4|||
16466682|NCT01423604|40185426|FG001|Randomized|Adverse Event|10|||
16466683|NCT01423604|40185425|FG000|Randomized|Death|1|||
16466684|NCT01423604|40185426|FG001|Randomized|Death|0|||
16466685|NCT01423604|40185425|FG000|Randomized|Physician Decision|16|||
16466686|NCT01423604|40185426|FG001|Randomized|Physician Decision|13|||
16466687|NCT01423604|40185425|FG000|Randomized|Other - unspecified|37|||
16466688|NCT01423604|40185426|FG001|Randomized|Other - unspecified|31|||
16466689|NCT01423604|40185425|FG000|Randomized|Patient decision|5|||
16466690|NCT01423604|40185426|FG001|Randomized|Patient decision|9|||
16466691|NCT04559529|40185427|FG000|First Intervention (1 Day)|Adverse Event|0|||
16466692|NCT04559529|40185428|FG001|First Intervention (1 Day)|Adverse Event|0|||
16466693|NCT04559529|40185429|FG002|First Intervention (1 Day)|Adverse Event|0|||
16466694|NCT04559529|40185430|FG003|First Intervention (1 Day)|Adverse Event|1|||
16466695|NCT04559529|40185427|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
16466696|NCT04559529|40185428|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
16466697|NCT04559529|40185429|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
16466698|NCT04559529|40185430|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
16466699|NCT04559529|40185427|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
16466700|NCT04559529|40185428|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
16466701|NCT04559529|40185429|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
16466702|NCT04559529|40185430|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
16466703|NCT02106923|40185431|FG000|Overall Study|Protocol Violation|0|||
16466704|NCT02106923|40185432|FG001|Overall Study|Protocol Violation|0|||
16466705|NCT02106923|40185433|FG002|Overall Study|Protocol Violation|0|||
16466706|NCT02106923|40185434|FG003|Overall Study|Protocol Violation|0|||
16466707|NCT02106923|40185435|FG004|Overall Study|Protocol Violation|0|||
16466708|NCT02106923|40185436|FG005|Overall Study|Protocol Violation|1|||
16466709|NCT00760084|40188209|FG000|Overall Study|Physician Decision|5|||
16466710|NCT00760084|40188209|FG000|Overall Study|Withdrawal by Subject|2|||
16466711|NCT00760084|40188209|FG000|Overall Study|Progressive Disease|3|||
16466712|NCT03533686|40188210|FG000|Overall Study|Withdrawal by Subject|1|||
16466713|NCT03533686|40188211|FG001|Overall Study|Withdrawal by Subject|0|||
16466714|NCT03533686|40188212|FG002|Overall Study|Withdrawal by Subject|0|||
16466715|NCT03533686|40188213|FG003|Overall Study|Withdrawal by Subject|3|||
16466716|NCT03533686|40188214|FG004|Overall Study|Withdrawal by Subject|5|||
16466717|NCT03533686|40188215|FG005|Overall Study|Withdrawal by Subject|1|||
16466718|NCT03533686|40188210|FG000|Overall Study|Lost to Follow-up|0|||
16466719|NCT03533686|40188211|FG001|Overall Study|Lost to Follow-up|1|||
16466720|NCT03533686|40188212|FG002|Overall Study|Lost to Follow-up|0|||
16466721|NCT03533686|40188213|FG003|Overall Study|Lost to Follow-up|0|||
16466722|NCT03533686|40188214|FG004|Overall Study|Lost to Follow-up|2|||
16466723|NCT03533686|40188215|FG005|Overall Study|Lost to Follow-up|0|||
16466724|NCT03533686|40188210|FG000|Overall Study|Screen Failure|0|||
16466725|NCT03533686|40188211|FG001|Overall Study|Screen Failure|0|||
16171004|NCT00680836|39103139|FG000|Overall Study|Physician Decision|2|||
16466726|NCT03533686|40188212|FG002|Overall Study|Screen Failure|0|||
16466727|NCT03533686|40188213|FG003|Overall Study|Screen Failure|2|||
16466728|NCT03533686|40188214|FG004|Overall Study|Screen Failure|0|||
16466729|NCT03533686|40188215|FG005|Overall Study|Screen Failure|0|||
16466730|NCT01298193|40188219|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
16466731|NCT01298193|40188219|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
16466732|NCT01298193|40188219|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
16466733|NCT01298193|40188219|FG000|Efficacy Phase (Second Cycle)|Death|1|||
16466734|NCT00829933|40188220|FG000|Overall Study|Adverse Event|2|||
16466735|NCT00829933|40188221|FG001|Overall Study|Adverse Event|3|||
16466736|NCT00829933|40188222|FG002|Overall Study|Adverse Event|2|||
16466737|NCT00829933|40188223|FG003|Overall Study|Adverse Event|1|||
16466738|NCT00829933|40188220|FG000|Overall Study|Death|0|||
16466739|NCT00829933|40188221|FG001|Overall Study|Death|0|||
16466740|NCT00829933|40188222|FG002|Overall Study|Death|1|||
16466741|NCT00829933|40188223|FG003|Overall Study|Death|1|||
16466742|NCT00829933|40188220|FG000|Overall Study|Lack of Efficacy|0|||
16466743|NCT00829933|40188221|FG001|Overall Study|Lack of Efficacy|1|||
16466744|NCT00829933|40188222|FG002|Overall Study|Lack of Efficacy|0|||
16466745|NCT00829933|40188223|FG003|Overall Study|Lack of Efficacy|0|||
16466746|NCT00829933|40188220|FG000|Overall Study|Physician Decision|5|||
16466747|NCT00829933|40188221|FG001|Overall Study|Physician Decision|7|||
16466748|NCT00829933|40188222|FG002|Overall Study|Physician Decision|8|||
16466749|NCT00829933|40188223|FG003|Overall Study|Physician Decision|1|||
16466750|NCT00829933|40188220|FG000|Overall Study|Pregnancy|0|||
16466751|NCT00829933|40188221|FG001|Overall Study|Pregnancy|0|||
16466752|NCT00829933|40188222|FG002|Overall Study|Pregnancy|0|||
16466753|NCT00829933|40188223|FG003|Overall Study|Pregnancy|2|||
16466754|NCT00829933|40188220|FG000|Overall Study|Protocol Violation|2|||
16466755|NCT00829933|40188221|FG001|Overall Study|Protocol Violation|1|||
16466756|NCT00829933|40188222|FG002|Overall Study|Protocol Violation|0|||
16466757|NCT00829933|40188223|FG003|Overall Study|Protocol Violation|0|||
16466758|NCT00829933|40188220|FG000|Overall Study|withdrew before treatment started|5|||
16466759|NCT00829933|40188221|FG001|Overall Study|withdrew before treatment started|1|||
16171005|NCT00680836|39103140|FG001|Overall Study|Physician Decision|1|||
16171006|NCT00709202|39103143|FG000|Overall Study|Withdrawal by Subject|6|||
16171007|NCT00709202|39103144|FG001|Overall Study|Withdrawal by Subject|6|||
16171008|NCT01805180|39103147|FG000|Lead-in Donor Phase|screen failure|1|||
16466760|NCT00829933|40188222|FG002|Overall Study|withdrew before treatment started|2|||
16466761|NCT00829933|40188223|FG003|Overall Study|withdrew before treatment started|9|||
16466762|NCT00708201|40188224|FG000|Overall Study|Adverse Event|4|||
16466763|NCT00708201|40188225|FG001|Overall Study|Adverse Event|4|||
16466764|NCT00708201|40188224|FG000|Overall Study|Withdrawal by Subject|1|||
16466765|NCT00708201|40188225|FG001|Overall Study|Withdrawal by Subject|1|||
16466766|NCT00708201|40188224|FG000|Overall Study|Lost to Follow-up|2|||
16466767|NCT00708201|40188225|FG001|Overall Study|Lost to Follow-up|0|||
16466768|NCT00708201|40188224|FG000|Overall Study|Protocol Violation|0|||
16466769|NCT00708201|40188225|FG001|Overall Study|Protocol Violation|1|||
16466770|NCT01142128|40188226|FG000|Overall Study|Physician Decision|1|||
16466771|NCT01142128|40188226|FG000|Overall Study|Lost to Follow-up|1|||
16466772|NCT01142128|40188226|FG000|Overall Study|Withdrawal by Subject|2|||
16466773|NCT01854944|40188230|FG000|Overall Study|Withdrawal by Subject|0|||
16466774|NCT01854944|40188231|FG001|Overall Study|Withdrawal by Subject|0|||
16466775|NCT01854944|40188232|FG002|Overall Study|Withdrawal by Subject|1|||
16466776|NCT02239120|40188233|FG000|Overall Study|Death|56|||
16466777|NCT02239120|40188234|FG001|Overall Study|Death|58|||
16466778|NCT02239120|40188233|FG000|Overall Study|Lost to Follow-up|19|||
16466779|NCT02239120|40188234|FG001|Overall Study|Lost to Follow-up|14|||
16466780|NCT01924429|40188237|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
16466781|NCT01924429|40188238|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
16171009|NCT01805180|39103148|FG001|Lead-in Donor Phase|screen failure|0|||
16171010|NCT01805180|39103149|FG002|Lead-in Donor Phase|screen failure|0|||
16171011|NCT00420511|39103150|FG000|Overall Study|Adverse Event|1|||
16171012|NCT00420511|39103151|FG001|Overall Study|Adverse Event|1|||
16171013|NCT00420511|39103150|FG000|Overall Study|Lost to Follow-up|1|||
16171014|NCT00420511|39103151|FG001|Overall Study|Lost to Follow-up|0|||
16171015|NCT01661790|39103163|FG000|Overall Study|Lost to Follow-up|0|||
16171016|NCT01661790|39103164|FG001|Overall Study|Lost to Follow-up|2|||
16171017|NCT01802281|39103165|FG000|Overall Study|Death|1|||
16171018|NCT01802281|39103166|FG001|Overall Study|Death|2|||
16171019|NCT01802281|39103165|FG000|Overall Study|Withdrawal by Subject|2|||
16171020|NCT01802281|39103166|FG001|Overall Study|Withdrawal by Subject|1|||
16171021|NCT01802281|39103165|FG000|Overall Study|Ineligible|5|||
16466782|NCT00256282|40188240|FG000|Overall Study|Disease progression, relapse during acti|12|||
16466783|NCT00256282|40188240|FG000|Overall Study|Adverse Event|3|||
16466784|NCT00256282|40188240|FG000|Overall Study|Physician Decision|1|||
16466785|NCT01565499|40188250|FG000|Overall Study|Physician Decision|1|||
16466786|NCT01565499|40188250|FG000|Overall Study|Adverse Event|5|||
16466787|NCT01565499|40188250|FG000|Overall Study|Withdrawal by Subject|2|||
16466788|NCT02937584|40188251|FG000|Period 1|Adverse Event|1|||
16466789|NCT02937584|40188252|FG001|Period 1|Adverse Event|2|||
16466790|NCT02937584|40188251|FG000|Washout|Adverse Event|0|||
16171022|NCT01802281|39103166|FG001|Overall Study|Ineligible|3|||
16171023|NCT01267955|39103167|FG000|Stage 1 (6 Months)|Death|3|||
16466791|NCT02937584|40188252|FG001|Washout|Adverse Event|1|||
16466792|NCT01479985|40188253|FG000|Overall Study|Tablet malfunction, no data saved|1|||
16466793|NCT01479985|40188254|FG001|Overall Study|Tablet malfunction, no data saved|1|||
16466794|NCT01479985|40188253|FG000|Overall Study|No decisional conflict scale responses|0|||
16466795|NCT01479985|40188254|FG001|Overall Study|No decisional conflict scale responses|2|||
16466796|NCT01479985|40188253|FG000|Overall Study|No post-visit survey|5|||
16466797|NCT01479985|40188254|FG001|Overall Study|No post-visit survey|3|||
16466798|NCT01117051|40188255|FG000|Overall Study|Withdrawal by Subject|5|||
16466799|NCT01117051|40188256|FG001|Overall Study|Withdrawal by Subject|3|||
16466800|NCT01117051|40188255|FG000|Overall Study|Adverse Event|4|||
16466801|NCT01117051|40188256|FG001|Overall Study|Adverse Event|3|||
16466802|NCT01117051|40188255|FG000|Overall Study|Lost to Follow-up|0|||
16466803|NCT01117051|40188256|FG001|Overall Study|Lost to Follow-up|1|||
16466804|NCT01117051|40188255|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
16466805|NCT01117051|40188256|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
16466806|NCT01117051|40188255|FG000|Overall Study|Sponsor's decision|3|||
16466807|NCT01117051|40188256|FG001|Overall Study|Sponsor's decision|1|||
16466808|NCT01117051|40188255|FG000|Overall Study|Surgical procedure|0|||
16466809|NCT01117051|40188256|FG001|Overall Study|Surgical procedure|1|||
16466810|NCT01117051|40188255|FG000|Overall Study|Randomized by mistake|0|||
16466811|NCT01117051|40188256|FG001|Overall Study|Randomized by mistake|1|||
16466812|NCT01117051|40188255|FG000|Overall Study|Convenience issue|1|||
16466813|NCT01117051|40188256|FG001|Overall Study|Convenience issue|0|||
16466814|NCT03390101|40188257|FG000|Weeks 0-12|Withdrawal by Subject|0|||
16466815|NCT03390101|40188258|FG001|Weeks 0-12|Withdrawal by Subject|1|||
16466816|NCT03390101|40188259|FG002|Weeks 0-12|Withdrawal by Subject|1|||
16466817|NCT03390101|40188257|FG000|Weeks 0-12|Lost to Follow-up|0|||
16466818|NCT03390101|40188258|FG001|Weeks 0-12|Lost to Follow-up|1|||
16466819|NCT03390101|40188259|FG002|Weeks 0-12|Lost to Follow-up|0|||
16466820|NCT03390101|40188257|FG000|Weeks 12-54|Withdrawal by Subject|0|||
16466821|NCT03390101|40188258|FG001|Weeks 12-54|Withdrawal by Subject|3|||
16466822|NCT03390101|40188259|FG002|Weeks 12-54|Withdrawal by Subject|1|||
16466823|NCT03390101|40188257|FG000|Weeks 12-54|Pregnancy|1|||
16466824|NCT03390101|40188258|FG001|Weeks 12-54|Pregnancy|0|||
16466825|NCT03390101|40188259|FG002|Weeks 12-54|Pregnancy|0|||
16466826|NCT03390101|40188257|FG000|Weeks 12-54|Adverse Event|2|||
16466827|NCT03390101|40188258|FG001|Weeks 12-54|Adverse Event|1|||
16466828|NCT03390101|40188259|FG002|Weeks 12-54|Adverse Event|1|||
16466829|NCT00400153|40188260|FG000|Overall Study|AE due to study disease worsening|14|||
16466830|NCT00400153|40188261|FG001|Overall Study|AE due to study disease worsening|19|||
16466831|NCT00400153|40188262|FG002|Overall Study|AE due to study disease worsening|20|||
16466832|NCT00400153|40188260|FG000|Overall Study|AE due to other disease worsening|2|||
16466833|NCT00400153|40188261|FG001|Overall Study|AE due to other disease worsening|1|||
16466834|NCT00400153|40188262|FG002|Overall Study|AE due to other disease worsening|0|||
16466835|NCT00400153|40188260|FG000|Overall Study|AE due to other condition|3|||
16466836|NCT00400153|40188261|FG001|Overall Study|AE due to other condition|14|||
16466837|NCT00400153|40188262|FG002|Overall Study|AE due to other condition|15|||
16466838|NCT00400153|40188260|FG000|Overall Study|Protocol Violation|7|||
16466839|NCT00400153|40188261|FG001|Overall Study|Protocol Violation|4|||
16466840|NCT00400153|40188262|FG002|Overall Study|Protocol Violation|9|||
16466841|NCT00400153|40188260|FG000|Overall Study|Lost to Follow-up|2|||
16466842|NCT00400153|40188261|FG001|Overall Study|Lost to Follow-up|1|||
16466843|NCT00400153|40188262|FG002|Overall Study|Lost to Follow-up|4|||
16466844|NCT00400153|40188260|FG000|Overall Study|Withdrawal by Subject|12|||
16466845|NCT00400153|40188261|FG001|Overall Study|Withdrawal by Subject|11|||
16466846|NCT00400153|40188262|FG002|Overall Study|Withdrawal by Subject|10|||
16466847|NCT00400153|40188260|FG000|Overall Study|Other reasons - not mentioned above|8|||
16466848|NCT00400153|40188261|FG001|Overall Study|Other reasons - not mentioned above|5|||
16466849|NCT00400153|40188262|FG002|Overall Study|Other reasons - not mentioned above|3|||
16466850|NCT00371761|40188274|FG000|Overall Study|Adverse Event|1|||
16171024|NCT01267955|39103167|FG000|Stage 2 (6 Months)|Death|5|||
16171025|NCT01267955|39103167|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
16171026|NCT01264939|39103170|FG000|Overall Study|Adverse Event|1|||
16171027|NCT01264939|39103171|FG001|Overall Study|Adverse Event|3|||
16466851|NCT00371761|40188275|FG001|Overall Study|Adverse Event|1|||
16466852|NCT00371761|40188274|FG000|Overall Study|Withdrawal by Subject|1|||
16466853|NCT00371761|40188275|FG001|Overall Study|Withdrawal by Subject|3|||
16466854|NCT00371761|40188274|FG000|Overall Study|Investigator Judgment|2|||
16466855|NCT00371761|40188275|FG001|Overall Study|Investigator Judgment|3|||
16466856|NCT00371761|40188274|FG000|Overall Study|Study termination|4|||
16171028|NCT01264939|39103170|FG000|Overall Study|Lost to Follow-up|0|||
16466857|NCT00371761|40188275|FG001|Overall Study|Study termination|3|||
16466858|NCT01246466|40188276|FG000|Overall Study|Death|1|||
16466859|NCT01246466|40188276|FG000|Overall Study|Withdrawal by Subject|1|||
16466860|NCT02314143|40188277|FG000|Overall Study|Adverse Event|0|||
16466861|NCT02314143|40188278|FG001|Overall Study|Adverse Event|6|||
16466862|NCT02314143|40188279|FG002|Overall Study|Adverse Event|4|||
16466863|NCT02314143|40188277|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
16466864|NCT02314143|40188278|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
16466865|NCT02314143|40188279|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
16466866|NCT02314143|40188277|FG000|Overall Study|Physician Decision|2|||
16466867|NCT02314143|40188278|FG001|Overall Study|Physician Decision|1|||
16466868|NCT02314143|40188279|FG002|Overall Study|Physician Decision|0|||
16466869|NCT02314143|40188277|FG000|Overall Study|Withdrawal by Subject|1|||
16466870|NCT02314143|40188278|FG001|Overall Study|Withdrawal by Subject|0|||
16466871|NCT02314143|40188279|FG002|Overall Study|Withdrawal by Subject|1|||
16466872|NCT01235598|40188280|FG000|Overall Study|Adverse Event|0|||
16466873|NCT01235598|40188281|FG001|Overall Study|Adverse Event|3|||
16466874|NCT01235598|40188280|FG000|Overall Study|Lack of Efficacy|0|||
16466875|NCT01235598|40188281|FG001|Overall Study|Lack of Efficacy|1|||
16466876|NCT01235598|40188280|FG000|Overall Study|Withdrawal by Subject|1|||
16466877|NCT01235598|40188281|FG001|Overall Study|Withdrawal by Subject|0|||
16466878|NCT00545129|40188284|FG000|Overall Study|Lack of Efficacy|2|||
16466879|NCT00545129|40188285|FG001|Overall Study|Lack of Efficacy|5|||
16171029|NCT01264939|39103171|FG001|Overall Study|Lost to Follow-up|3|||
16171030|NCT01264939|39103170|FG000|Overall Study|Physician Decision|1|||
16466880|NCT00545129|40188284|FG000|Overall Study|Death|2|||
16466881|NCT00545129|40188285|FG001|Overall Study|Death|1|||
16466882|NCT00545129|40188284|FG000|Overall Study|Adverse Event|1|||
16466883|NCT00545129|40188285|FG001|Overall Study|Adverse Event|1|||
16466884|NCT00545129|40188284|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
16466885|NCT00545129|40188285|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
16466886|NCT00545129|40188284|FG000|Overall Study|Other|3|||
16466887|NCT00545129|40188285|FG001|Overall Study|Other|3|||
16466888|NCT02946931|40188286|FG000|Overall Study|Did not require collection of CRFs|588|||
16466889|NCT02946931|40188286|FG000|Overall Study|Other than listed|37|||
16466890|NCT02946931|40188286|FG000|Overall Study|Discharge from hospital|118|||
16466891|NCT02946931|40188286|FG000|Overall Study|Adverse Event|81|||
16466892|NCT02946931|40188286|FG000|Overall Study|CRFs not valid|1|||
16466893|NCT02946931|40188286|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
16466894|NCT03911843|40188287|FG000|Overall Study|Adverse Event|2|||
16171031|NCT01264939|39103171|FG001|Overall Study|Physician Decision|1|||
16171032|NCT01264939|39103170|FG000|Overall Study|Patient/Guardian Decision|8|||
16171033|NCT01264939|39103171|FG001|Overall Study|Patient/Guardian Decision|10|||
16466895|NCT03911843|40188288|FG001|Overall Study|Adverse Event|0|||
16466896|NCT03911843|40188287|FG000|Overall Study|Protocol Violation|2|||
16466897|NCT03911843|40188288|FG001|Overall Study|Protocol Violation|0|||
16466898|NCT03911843|40188287|FG000|Overall Study|Lost to Follow-up|0|||
16466899|NCT03911843|40188288|FG001|Overall Study|Lost to Follow-up|1|||
16466900|NCT04738318|40188289|FG000|Overall Study|Protocol Violation|1|||
16466901|NCT04738318|40188290|FG001|Overall Study|Protocol Violation|0|||
16466902|NCT01879579|40188291|FG000|Overall Study|Phone incompatible with texting platform|3|||
16466903|NCT01879579|40188292|FG001|Overall Study|Phone incompatible with texting platform|0|||
16466904|NCT01879579|40188291|FG000|Overall Study|Did not enroll in texting platform|1|||
16466905|NCT01879579|40188292|FG001|Overall Study|Did not enroll in texting platform|0|||
16466906|NCT01879579|40188291|FG000|Overall Study|Did not initiate insulin treatment|1|||
16466907|NCT01879579|40188292|FG001|Overall Study|Did not initiate insulin treatment|0|||
16466908|NCT01879579|40188291|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
16466909|NCT01879579|40188292|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
16466910|NCT01879579|40188291|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
16466911|NCT01879579|40188292|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
16466912|NCT00217464|40188293|FG000|Overall Study|Progression|15|||
16466913|NCT00217464|40188293|FG000|Overall Study|Other|2|||
16466914|NCT01343823|40188295|FG000|Overall Study|Study Terminated|1|||
16466915|NCT01343823|40188296|FG001|Overall Study|Study Terminated|0|||
16466916|NCT01343823|40188297|FG002|Overall Study|Study Terminated|0|||
16171034|NCT01264939|39103170|FG000|Overall Study|Disease Progression|8|||
16171035|NCT01264939|39103171|FG001|Overall Study|Disease Progression|11|||
16269296|NCT00295490|39471055|FG002|Overall Study|Adverse Event|0|||
16466917|NCT01343823|40188298|FG003|Overall Study|Study Terminated|1|||
16466918|NCT01343823|40188295|FG000|Overall Study|Withdrawal by Subject|1|||
16466919|NCT01343823|40188296|FG001|Overall Study|Withdrawal by Subject|0|||
16466920|NCT01343823|40188297|FG002|Overall Study|Withdrawal by Subject|0|||
16466921|NCT01343823|40188298|FG003|Overall Study|Withdrawal by Subject|0|||
16466922|NCT00509262|40188299|FG000|Overall Study|Adverse Event|16|||
16466923|NCT00509262|40188300|FG001|Overall Study|Adverse Event|18|||
16171036|NCT04401267|39103172|FG000|Overall Study|Death|0|||
16171037|NCT04401267|39103173|FG001|Overall Study|Death|1|||
16466924|NCT00509262|40188299|FG000|Overall Study|Other|2|||
16466925|NCT00509262|40188300|FG001|Overall Study|Other|2|||
16171038|NCT04401267|39103172|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
16171039|NCT04401267|39103173|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
16466926|NCT00509262|40188299|FG000|Overall Study|Lack of Efficacy|1|||
16466927|NCT00509262|40188300|FG001|Overall Study|Lack of Efficacy|0|||
16466928|NCT00509262|40188299|FG000|Overall Study|Lost to Follow-up|1|||
16466929|NCT00509262|40188300|FG001|Overall Study|Lost to Follow-up|6|||
16466930|NCT00509262|40188299|FG000|Overall Study|Physician Decision|1|||
16466931|NCT00509262|40188300|FG001|Overall Study|Physician Decision|3|||
16466932|NCT00509262|40188299|FG000|Overall Study|Protocol Violation|2|||
16466933|NCT00509262|40188300|FG001|Overall Study|Protocol Violation|2|||
16466934|NCT00509262|40188299|FG000|Overall Study|Withdrawal by Subject|24|||
16466935|NCT00509262|40188300|FG001|Overall Study|Withdrawal by Subject|11|||
16466936|NCT01214174|40188301|FG000|Overall Study|Withdrawal by Subject|0|||
16466937|NCT01214174|40188302|FG001|Overall Study|Withdrawal by Subject|0|||
16466938|NCT01214174|40188303|FG002|Overall Study|Withdrawal by Subject|1|||
16466939|NCT02692651|40188309|FG000|Study Treatment|Death|7|||
16466940|NCT02692651|40188310|FG001|Study Treatment|Death|3|||
16466941|NCT02692651|40188309|FG000|Study Treatment|comfort care|1|||
16466942|NCT02692651|40188310|FG001|Study Treatment|comfort care|1|||
16466943|NCT02692651|40188309|FG000|Study Treatment|Protocol violation per treating team preference|8|||
16466944|NCT02692651|40188310|FG001|Study Treatment|Protocol violation per treating team preference|6|||
16466945|NCT02692651|40188309|FG000|Post Study Treatment Follow-up|Death|4|||
16466946|NCT02692651|40188310|FG001|Post Study Treatment Follow-up|Death|4|||
16466947|NCT01653782|40188311|FG000|Overall Study|Withdrawal by Subject|9|||
16466948|NCT01653782|40188312|FG001|Overall Study|Withdrawal by Subject|15|||
16466949|NCT01653782|40188313|FG002|Overall Study|Withdrawal by Subject|4|||
16466950|NCT01653782|40188311|FG000|Overall Study|Lost to Follow-up|7|||
16466951|NCT01653782|40188312|FG001|Overall Study|Lost to Follow-up|3|||
16466952|NCT01653782|40188313|FG002|Overall Study|Lost to Follow-up|2|||
16466953|NCT00887744|40188314|FG000|Overall Study|Adverse Event|3|||
16466954|NCT00887744|40188314|FG000|Overall Study|Death|1|||
16466955|NCT00887744|40188314|FG000|Overall Study|Lost to Follow-up|3|||
16466956|NCT00887744|40188314|FG000|Overall Study|Withdrawal by Subject|18|||
16466957|NCT00887744|40188314|FG000|Overall Study|Various reasons|9|||
16466958|NCT03269552|40188315|FG000|Overall Study|Adverse Event|2|||
16466959|NCT01751802|40188316|FG000|Overall Study|Adverse Event|4|||
16466960|NCT01751802|40188317|FG001|Overall Study|Adverse Event|2|||
16466961|NCT01958827|40188324|FG000|Overall Study|Adverse Event|3|||
16466962|NCT01958827|40188324|FG000|Overall Study|Lack of Efficacy|6|||
16466963|NCT01958827|40188324|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
16466964|NCT03745820|40188325|FG000|Overall Study|Adverse Event|0|||
16466965|NCT03745820|40188326|FG001|Overall Study|Adverse Event|3|||
16466966|NCT03745820|40188327|FG002|Overall Study|Adverse Event|2|||
16466967|NCT03745820|40188325|FG000|Overall Study|Non-Compliance with Study Drug|4|||
16466968|NCT03745820|40188326|FG001|Overall Study|Non-Compliance with Study Drug|3|||
16466969|NCT03745820|40188327|FG002|Overall Study|Non-Compliance with Study Drug|0|||
16466970|NCT03745820|40188325|FG000|Overall Study|Withdrawal by Subject|4|||
16466971|NCT03745820|40188326|FG001|Overall Study|Withdrawal by Subject|4|||
16466972|NCT03745820|40188327|FG002|Overall Study|Withdrawal by Subject|4|||
16466973|NCT03745820|40188325|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
16466974|NCT03745820|40188326|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
16466975|NCT03745820|40188327|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
16466976|NCT03745820|40188325|FG000|Overall Study|Lost to Follow-up|2|||
16466977|NCT03745820|40188326|FG001|Overall Study|Lost to Follow-up|0|||
16466978|NCT03745820|40188327|FG002|Overall Study|Lost to Follow-up|3|||
16466979|NCT03745820|40188325|FG000|Overall Study|Reason not Specified|2|||
16466980|NCT03745820|40188326|FG001|Overall Study|Reason not Specified|4|||
16466981|NCT03745820|40188327|FG002|Overall Study|Reason not Specified|1|||
16466982|NCT03345342|40188329|FG000|Open-Label Phase|Adverse Event|30|||
16466983|NCT03345342|40188330|FG001|Open-Label Phase|Adverse Event|0|||
16466984|NCT03345342|40188331|FG002|Open-Label Phase|Adverse Event|0|||
16466985|NCT03345342|40188332|FG003|Open-Label Phase|Adverse Event|0|||
16466986|NCT03345342|40188333|FG004|Open-Label Phase|Adverse Event|0|||
16466987|NCT03345342|40188329|FG000|Open-Label Phase|Death|1|||
16466988|NCT03345342|40188330|FG001|Open-Label Phase|Death|0|||
16466989|NCT03345342|40188331|FG002|Open-Label Phase|Death|0|||
16466990|NCT03345342|40188332|FG003|Open-Label Phase|Death|0|||
16171040|NCT04401267|39103172|FG000|Overall Study|Found to be Ineligible|1|||
16466991|NCT03345342|40188333|FG004|Open-Label Phase|Death|0|||
16466992|NCT03345342|40188329|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
16466993|NCT03345342|40188330|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
16466994|NCT03345342|40188331|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
16466995|NCT03345342|40188332|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
16466996|NCT03345342|40188333|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
16466997|NCT03345342|40188329|FG000|Open-Label Phase|Lack of Efficacy|6|||
16466998|NCT03345342|40188330|FG001|Open-Label Phase|Lack of Efficacy|0|||
16466999|NCT03345342|40188331|FG002|Open-Label Phase|Lack of Efficacy|0|||
16467000|NCT03345342|40188332|FG003|Open-Label Phase|Lack of Efficacy|0|||
16467001|NCT03345342|40188333|FG004|Open-Label Phase|Lack of Efficacy|0|||
16467002|NCT03345342|40188329|FG000|Open-Label Phase|Lost to Follow-up|9|||
16467003|NCT03345342|40188330|FG001|Open-Label Phase|Lost to Follow-up|0|||
16467004|NCT03345342|40188331|FG002|Open-Label Phase|Lost to Follow-up|0|||
16467005|NCT03345342|40188332|FG003|Open-Label Phase|Lost to Follow-up|0|||
16467006|NCT03345342|40188333|FG004|Open-Label Phase|Lost to Follow-up|0|||
16467007|NCT03345342|40188329|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
16467008|NCT03345342|40188330|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
16467009|NCT03345342|40188331|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
16467010|NCT03345342|40188332|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
16467011|NCT03345342|40188333|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
16467012|NCT03345342|40188329|FG000|Open-Label Phase|Physician Decision|4|||
16467013|NCT03345342|40188330|FG001|Open-Label Phase|Physician Decision|0|||
16467014|NCT03345342|40188331|FG002|Open-Label Phase|Physician Decision|0|||
16467015|NCT03345342|40188332|FG003|Open-Label Phase|Physician Decision|0|||
16467016|NCT03345342|40188333|FG004|Open-Label Phase|Physician Decision|0|||
16467017|NCT03345342|40188329|FG000|Open-Label Phase|Protocol Violation|8|||
16467018|NCT03345342|40188330|FG001|Open-Label Phase|Protocol Violation|0|||
16467019|NCT03345342|40188331|FG002|Open-Label Phase|Protocol Violation|0|||
16467020|NCT03345342|40188332|FG003|Open-Label Phase|Protocol Violation|0|||
16467021|NCT03345342|40188333|FG004|Open-Label Phase|Protocol Violation|0|||
16467022|NCT03345342|40188329|FG000|Open-Label Phase|Withdrawal by Subject|57|||
16467023|NCT03345342|40188330|FG001|Open-Label Phase|Withdrawal by Subject|0|||
16467024|NCT03345342|40188331|FG002|Open-Label Phase|Withdrawal by Subject|0|||
16467025|NCT03345342|40188332|FG003|Open-Label Phase|Withdrawal by Subject|0|||
16467026|NCT03345342|40188333|FG004|Open-Label Phase|Withdrawal by Subject|0|||
16467027|NCT03345342|40188329|FG000|Open-Label Phase|Other|15|||
16467028|NCT03345342|40188330|FG001|Open-Label Phase|Other|0|||
16467029|NCT03345342|40188331|FG002|Open-Label Phase|Other|0|||
16467030|NCT03345342|40188332|FG003|Open-Label Phase|Other|0|||
16467031|NCT03345342|40188333|FG004|Open-Label Phase|Other|0|||
16467032|NCT03345342|40188329|FG000|Double-Blind Phase|Adverse Event|0|||
16467033|NCT03345342|40188330|FG001|Double-Blind Phase|Adverse Event|1|||
16467034|NCT03345342|40188331|FG002|Double-Blind Phase|Adverse Event|6|||
16467035|NCT03345342|40188332|FG003|Double-Blind Phase|Adverse Event|0|||
16467036|NCT03345342|40188333|FG004|Double-Blind Phase|Adverse Event|0|||
16467037|NCT03345342|40188329|FG000|Double-Blind Phase|Death|0|||
16467038|NCT03345342|40188330|FG001|Double-Blind Phase|Death|2|||
16467039|NCT03345342|40188331|FG002|Double-Blind Phase|Death|1|||
16467040|NCT03345342|40188332|FG003|Double-Blind Phase|Death|0|||
16467041|NCT03345342|40188333|FG004|Double-Blind Phase|Death|0|||
16467042|NCT03345342|40188329|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
16467043|NCT03345342|40188330|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
16467044|NCT03345342|40188331|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
16467045|NCT03345342|40188332|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
16467046|NCT03345342|40188333|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
16467047|NCT03345342|40188329|FG000|Double-Blind Phase|Lost to Follow-up|0|||
16467048|NCT03345342|40188330|FG001|Double-Blind Phase|Lost to Follow-up|1|||
16467049|NCT03345342|40188331|FG002|Double-Blind Phase|Lost to Follow-up|7|||
16467050|NCT03345342|40188332|FG003|Double-Blind Phase|Lost to Follow-up|0|||
16467051|NCT03345342|40188333|FG004|Double-Blind Phase|Lost to Follow-up|0|||
16467052|NCT03345342|40188329|FG000|Double-Blind Phase|Physician Decision|0|||
16467053|NCT03345342|40188330|FG001|Double-Blind Phase|Physician Decision|1|||
16467054|NCT03345342|40188331|FG002|Double-Blind Phase|Physician Decision|4|||
16467055|NCT03345342|40188332|FG003|Double-Blind Phase|Physician Decision|0|||
16467056|NCT03345342|40188333|FG004|Double-Blind Phase|Physician Decision|0|||
16467057|NCT03345342|40188329|FG000|Double-Blind Phase|Protocol Violation|0|||
16467058|NCT03345342|40188330|FG001|Double-Blind Phase|Protocol Violation|0|||
16467059|NCT03345342|40188331|FG002|Double-Blind Phase|Protocol Violation|1|||
16467060|NCT03345342|40188332|FG003|Double-Blind Phase|Protocol Violation|0|||
16467061|NCT03345342|40188333|FG004|Double-Blind Phase|Protocol Violation|0|||
16467062|NCT03345342|40188329|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
16467063|NCT03345342|40188330|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
16467064|NCT03345342|40188331|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
16467065|NCT03345342|40188332|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
16467066|NCT03345342|40188333|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
16467067|NCT03345342|40188329|FG000|Double-Blind Phase|Other|0|||
16467068|NCT03345342|40188330|FG001|Double-Blind Phase|Other|1|||
16467069|NCT03345342|40188331|FG002|Double-Blind Phase|Other|3|||
16467070|NCT03345342|40188332|FG003|Double-Blind Phase|Other|0|||
16467071|NCT03345342|40188333|FG004|Double-Blind Phase|Other|0|||
16467072|NCT03345342|40188329|FG000|Follow-Up Phase|Adverse Event|0|||
16467073|NCT03345342|40188330|FG001|Follow-Up Phase|Adverse Event|0|||
16467074|NCT03345342|40188331|FG002|Follow-Up Phase|Adverse Event|0|||
16467075|NCT03345342|40188332|FG003|Follow-Up Phase|Adverse Event|0|||
16467076|NCT03345342|40188333|FG004|Follow-Up Phase|Adverse Event|4|||
16467077|NCT03345342|40188329|FG000|Follow-Up Phase|Lost to Follow-up|0|||
16467078|NCT03345342|40188330|FG001|Follow-Up Phase|Lost to Follow-up|0|||
16467079|NCT03345342|40188331|FG002|Follow-Up Phase|Lost to Follow-up|0|||
16467080|NCT03345342|40188332|FG003|Follow-Up Phase|Lost to Follow-up|0|||
16467081|NCT03345342|40188333|FG004|Follow-Up Phase|Lost to Follow-up|6|||
16467082|NCT03345342|40188329|FG000|Follow-Up Phase|Physician Decision|0|||
16467083|NCT03345342|40188330|FG001|Follow-Up Phase|Physician Decision|0|||
16467084|NCT03345342|40188331|FG002|Follow-Up Phase|Physician Decision|0|||
16467085|NCT03345342|40188332|FG003|Follow-Up Phase|Physician Decision|0|||
16467086|NCT03345342|40188333|FG004|Follow-Up Phase|Physician Decision|5|||
16467087|NCT03345342|40188329|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
16467088|NCT03345342|40188330|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
16467089|NCT03345342|40188331|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
16467090|NCT03345342|40188332|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
16467091|NCT03345342|40188333|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
16467092|NCT03345342|40188329|FG000|Follow-Up Phase|Other|0|||
16467093|NCT03345342|40188330|FG001|Follow-Up Phase|Other|0|||
16467094|NCT03345342|40188331|FG002|Follow-Up Phase|Other|0|||
16467095|NCT03345342|40188332|FG003|Follow-Up Phase|Other|3|||
16467096|NCT03345342|40188333|FG004|Follow-Up Phase|Other|1|||
16467097|NCT00645788|40188334|FG000|Overall Study|Did not receive study drug|1|||
16467098|NCT00645788|40188335|FG001|Overall Study|Did not receive study drug|1|||
16467099|NCT00645788|40188336|FG002|Overall Study|Did not receive study drug|0|||
16467100|NCT00645788|40188337|FG003|Overall Study|Did not receive study drug|0|||
16467101|NCT00645788|40188334|FG000|Overall Study|Adverse Event|4|||
16467102|NCT00645788|40188335|FG001|Overall Study|Adverse Event|9|||
16467103|NCT00645788|40188336|FG002|Overall Study|Adverse Event|5|||
16467104|NCT00645788|40188337|FG003|Overall Study|Adverse Event|3|||
16467105|NCT00645788|40188334|FG000|Overall Study|Lost to Follow-up|1|||
16467106|NCT00645788|40188335|FG001|Overall Study|Lost to Follow-up|0|||
16467107|NCT00645788|40188336|FG002|Overall Study|Lost to Follow-up|0|||
16467108|NCT00645788|40188337|FG003|Overall Study|Lost to Follow-up|0|||
16467109|NCT00645788|40188334|FG000|Overall Study|Protocol Violation|1|||
16467110|NCT00645788|40188335|FG001|Overall Study|Protocol Violation|0|||
16467111|NCT00645788|40188336|FG002|Overall Study|Protocol Violation|2|||
16467112|NCT00645788|40188337|FG003|Overall Study|Protocol Violation|0|||
16467113|NCT00645788|40188334|FG000|Overall Study|Withdrawal by Subject|0|||
16467114|NCT00645788|40188335|FG001|Overall Study|Withdrawal by Subject|1|||
16467115|NCT00645788|40188336|FG002|Overall Study|Withdrawal by Subject|0|||
16467116|NCT00645788|40188337|FG003|Overall Study|Withdrawal by Subject|2|||
16467117|NCT00645788|40188334|FG000|Overall Study|Pulmonary exacerbation|13|||
16467118|NCT00645788|40188335|FG001|Overall Study|Pulmonary exacerbation|16|||
16467119|NCT00645788|40188336|FG002|Overall Study|Pulmonary exacerbation|11|||
16467120|NCT00645788|40188337|FG003|Overall Study|Pulmonary exacerbation|9|||
16467121|NCT01752036|40188341|FG000|Overall Study|Death|2|||
16467122|NCT01209832|40188354|FG000|Period 1|Sponsor Decision and was not dosed|1|||
16467123|NCT01209832|40188354|FG000|Period 2|Sponsor Decision|1|||
16467124|NCT00807573|40188357|FG000|Overall Study|Withdrawal by Subject|1|||
16467125|NCT00807573|40188357|FG000|Overall Study|Adverse Event|1|||
16467126|NCT00973349|40188358|FG000|Overall Study|Adverse Event|0|||
16467127|NCT00973349|40188359|FG001|Overall Study|Adverse Event|0|||
16467128|NCT00973349|40188360|FG002|Overall Study|Adverse Event|0|||
16467129|NCT00973349|40188361|FG003|Overall Study|Adverse Event|0|||
16467130|NCT00973349|40188362|FG004|Overall Study|Adverse Event|1|||
16467131|NCT00973349|40188363|FG005|Overall Study|Adverse Event|0|||
16467132|NCT00973349|40188364|FG006|Overall Study|Adverse Event|0|||
16467133|NCT00973349|40188365|FG007|Overall Study|Adverse Event|0|||
16467134|NCT00973349|40188366|FG008|Overall Study|Adverse Event|1|||
16467135|NCT00973349|40188367|FG009|Overall Study|Adverse Event|0|||
16467136|NCT00973349|40188368|FG010|Overall Study|Adverse Event|0|||
16467137|NCT00973349|40188369|FG011|Overall Study|Adverse Event|0|||
16467138|NCT00973349|40188370|FG012|Overall Study|Adverse Event|0|||
16467139|NCT00973349|40188371|FG013|Overall Study|Adverse Event|0|||
16467140|NCT00973349|40188372|FG014|Overall Study|Adverse Event|1|||
16467141|NCT00973349|40188373|FG015|Overall Study|Adverse Event|0|||
16467142|NCT00973349|40188358|FG000|Overall Study|Withdrawal by Subject|1|||
16467143|NCT00973349|40188359|FG001|Overall Study|Withdrawal by Subject|2|||
16467144|NCT00973349|40188360|FG002|Overall Study|Withdrawal by Subject|2|||
16467145|NCT00973349|40188361|FG003|Overall Study|Withdrawal by Subject|3|||
16467146|NCT00973349|40188362|FG004|Overall Study|Withdrawal by Subject|2|||
16467147|NCT00973349|40188363|FG005|Overall Study|Withdrawal by Subject|0|||
16467148|NCT00973349|40188364|FG006|Overall Study|Withdrawal by Subject|2|||
16467149|NCT00973349|40188365|FG007|Overall Study|Withdrawal by Subject|2|||
16467150|NCT00973349|40188366|FG008|Overall Study|Withdrawal by Subject|0|||
16467151|NCT00973349|40188367|FG009|Overall Study|Withdrawal by Subject|2|||
16467152|NCT00973349|40188368|FG010|Overall Study|Withdrawal by Subject|0|||
16467153|NCT00973349|40188369|FG011|Overall Study|Withdrawal by Subject|1|||
16467154|NCT00973349|40188370|FG012|Overall Study|Withdrawal by Subject|0|||
16467155|NCT00973349|40188371|FG013|Overall Study|Withdrawal by Subject|0|||
16467156|NCT00973349|40188372|FG014|Overall Study|Withdrawal by Subject|0|||
16467157|NCT00973349|40188373|FG015|Overall Study|Withdrawal by Subject|0|||
16467158|NCT00973349|40188358|FG000|Overall Study|Lost to Follow-up|3|||
16467159|NCT00973349|40188359|FG001|Overall Study|Lost to Follow-up|1|||
16467160|NCT00973349|40188360|FG002|Overall Study|Lost to Follow-up|2|||
16467161|NCT00973349|40188361|FG003|Overall Study|Lost to Follow-up|2|||
16467162|NCT00973349|40188362|FG004|Overall Study|Lost to Follow-up|1|||
16467163|NCT00973349|40188363|FG005|Overall Study|Lost to Follow-up|3|||
16467164|NCT00973349|40188364|FG006|Overall Study|Lost to Follow-up|0|||
16467165|NCT00973349|40188365|FG007|Overall Study|Lost to Follow-up|1|||
16467166|NCT00973349|40188366|FG008|Overall Study|Lost to Follow-up|2|||
16467167|NCT00973349|40188367|FG009|Overall Study|Lost to Follow-up|1|||
16467168|NCT00973349|40188368|FG010|Overall Study|Lost to Follow-up|0|||
16467169|NCT00973349|40188369|FG011|Overall Study|Lost to Follow-up|1|||
16467170|NCT00973349|40188370|FG012|Overall Study|Lost to Follow-up|0|||
16467171|NCT00973349|40188371|FG013|Overall Study|Lost to Follow-up|0|||
16467172|NCT00973349|40188372|FG014|Overall Study|Lost to Follow-up|0|||
16467173|NCT00973349|40188373|FG015|Overall Study|Lost to Follow-up|1|||
16171041|NCT04401267|39103173|FG001|Overall Study|Found to be Ineligible|0|||
16171042|NCT02853760|39103176|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
16171043|NCT02853760|39103177|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
16171044|NCT02853760|39103178|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
16171045|NCT02853760|39103179|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
16171046|NCT02853760|39103180|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
16171047|NCT02853760|39103181|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
16171048|NCT02304926|39103183|FG000|Overall Study|Lost to Follow-up|2|||
16171049|NCT02304926|39103184|FG001|Overall Study|Lost to Follow-up|1|||
16171050|NCT05172544|39103185|FG000|Overall Study|Withdrawal by Subject|1|||
16171051|NCT05172544|39103186|FG001|Overall Study|Withdrawal by Subject|0|||
16171052|NCT05172544|39103187|FG002|Overall Study|Withdrawal by Subject|0|||
16171053|NCT05172544|39103185|FG000|Overall Study|Physician Decision|0|||
16171054|NCT05172544|39103186|FG001|Overall Study|Physician Decision|0|||
16171055|NCT05172544|39103187|FG002|Overall Study|Physician Decision|1|||
16171056|NCT04025632|39103188|FG000|Overall Study|Adverse Event|1|||
16171057|NCT04025632|39103189|FG001|Overall Study|Adverse Event|1|||
16171058|NCT04025632|39103188|FG000|Overall Study|Withdrawal by Subject|1|||
16171059|NCT04025632|39103189|FG001|Overall Study|Withdrawal by Subject|1|||
16171060|NCT04025632|39103188|FG000|Overall Study|Study Terminated by Sponsor|10|||
16171061|NCT04025632|39103189|FG001|Overall Study|Study Terminated by Sponsor|9|||
16171062|NCT04025632|39103188|FG000|Overall Study|Physician Decision|3|||
16171063|NCT04025632|39103189|FG001|Overall Study|Physician Decision|1|||
16467174|NCT00973349|40188358|FG000|Overall Study|Inappropriate enrolment|0|||
16467175|NCT00973349|40188359|FG001|Overall Study|Inappropriate enrolment|0|||
16467176|NCT00973349|40188360|FG002|Overall Study|Inappropriate enrolment|1|||
16467177|NCT00973349|40188361|FG003|Overall Study|Inappropriate enrolment|0|||
16467178|NCT00973349|40188362|FG004|Overall Study|Inappropriate enrolment|0|||
16467179|NCT00973349|40188363|FG005|Overall Study|Inappropriate enrolment|0|||
16467180|NCT00973349|40188364|FG006|Overall Study|Inappropriate enrolment|0|||
16467181|NCT00973349|40188365|FG007|Overall Study|Inappropriate enrolment|0|||
16467182|NCT00973349|40188366|FG008|Overall Study|Inappropriate enrolment|0|||
16467183|NCT00973349|40188367|FG009|Overall Study|Inappropriate enrolment|2|||
16467184|NCT00973349|40188368|FG010|Overall Study|Inappropriate enrolment|0|||
16467185|NCT00973349|40188369|FG011|Overall Study|Inappropriate enrolment|0|||
16467186|NCT00973349|40188370|FG012|Overall Study|Inappropriate enrolment|1|||
16467187|NCT00973349|40188371|FG013|Overall Study|Inappropriate enrolment|0|||
16467188|NCT00973349|40188372|FG014|Overall Study|Inappropriate enrolment|1|||
16467189|NCT00973349|40188373|FG015|Overall Study|Inappropriate enrolment|1|||
16467190|NCT00973349|40188358|FG000|Overall Study|Protocol Violation|0|||
16467191|NCT00973349|40188359|FG001|Overall Study|Protocol Violation|0|||
16467192|NCT00973349|40188360|FG002|Overall Study|Protocol Violation|0|||
16467193|NCT00973349|40188361|FG003|Overall Study|Protocol Violation|0|||
16467194|NCT00973349|40188362|FG004|Overall Study|Protocol Violation|0|||
16467195|NCT00973349|40188363|FG005|Overall Study|Protocol Violation|0|||
16467196|NCT00973349|40188364|FG006|Overall Study|Protocol Violation|0|||
16467197|NCT00973349|40188365|FG007|Overall Study|Protocol Violation|0|||
16467198|NCT00973349|40188366|FG008|Overall Study|Protocol Violation|1|||
16467199|NCT00973349|40188367|FG009|Overall Study|Protocol Violation|0|||
16171064|NCT00727402|39103190|FG000|Overall Study|Physician Decision|116|||
16467200|NCT00973349|40188368|FG010|Overall Study|Protocol Violation|0|||
16467201|NCT00973349|40188369|FG011|Overall Study|Protocol Violation|0|||
16467202|NCT00973349|40188370|FG012|Overall Study|Protocol Violation|0|||
16467203|NCT00973349|40188371|FG013|Overall Study|Protocol Violation|0|||
16467204|NCT00973349|40188372|FG014|Overall Study|Protocol Violation|0|||
16467205|NCT00973349|40188373|FG015|Overall Study|Protocol Violation|0|||
16467206|NCT00973349|40188358|FG000|Overall Study|Unable to classify|0|||
16467207|NCT00973349|40188359|FG001|Overall Study|Unable to classify|0|||
16467208|NCT00973349|40188360|FG002|Overall Study|Unable to classify|0|||
16467209|NCT00973349|40188361|FG003|Overall Study|Unable to classify|0|||
16467210|NCT00973349|40188362|FG004|Overall Study|Unable to classify|1|||
16467211|NCT00973349|40188363|FG005|Overall Study|Unable to classify|1|||
16467212|NCT00973349|40188364|FG006|Overall Study|Unable to classify|0|||
16467213|NCT00973349|40188365|FG007|Overall Study|Unable to classify|0|||
16467214|NCT00973349|40188366|FG008|Overall Study|Unable to classify|0|||
16467215|NCT00973349|40188367|FG009|Overall Study|Unable to classify|1|||
16467216|NCT00973349|40188368|FG010|Overall Study|Unable to classify|0|||
16467217|NCT00973349|40188369|FG011|Overall Study|Unable to classify|0|||
16467218|NCT00973349|40188370|FG012|Overall Study|Unable to classify|0|||
16467219|NCT00973349|40188371|FG013|Overall Study|Unable to classify|0|||
16467220|NCT00973349|40188372|FG014|Overall Study|Unable to classify|0|||
16467221|NCT00973349|40188373|FG015|Overall Study|Unable to classify|0|||
16467222|NCT01002820|40188380|FG000|Overall Study|Adverse Event|1|||
16467223|NCT01002820|40188380|FG000|Overall Study|Withdrawal by Subject|2|||
16467224|NCT01002820|40188380|FG000|Overall Study|Lack of Efficacy|1|||
16467225|NCT00870233|40188383|FG000|Overall Study|Withdrawal by Subject|18|||
16467226|NCT00870233|40188383|FG000|Overall Study|Did not undergo laparotomy|3|||
16467227|NCT00870233|40188383|FG000|Overall Study|Incompatible internet browser|2|||
16467228|NCT00870233|40188383|FG000|Overall Study|Death|1|||
16171065|NCT00331760|39103199|FG000|Overall Study|Ineligible / no protocol treatment|15|||
16171066|NCT00331760|39103200|FG001|Overall Study|Ineligible / no protocol treatment|8|||
16171067|NCT03437447|39103203|FG000|Treatment Period 1|Withdrawal by Subject|0|||
16467229|NCT02478398|40188384|FG000|Overall Study|Adverse Event|20|||
16467230|NCT02478398|40188385|FG001|Overall Study|Adverse Event|5|||
16467231|NCT02478398|40188384|FG000|Overall Study|Lost to Follow-up|5|||
16467232|NCT02478398|40188385|FG001|Overall Study|Lost to Follow-up|4|||
16467233|NCT02478398|40188384|FG000|Overall Study|Non-Compliance With Study Drug|5|||
16467234|NCT02478398|40188385|FG001|Overall Study|Non-Compliance With Study Drug|1|||
16072719|NCT00831415|38759157|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
16072720|NCT00831415|38759157|FG000|Overall Study|Death|1|||
16072721|NCT01787760|38759158|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
16072722|NCT01787760|38759159|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
16072723|NCT01787760|38759160|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
16072724|NCT01787760|38759158|FG000|Overall Study|Decompensated on left exotropia|0|||
16072725|NCT01787760|38759159|FG001|Overall Study|Decompensated on left exotropia|0|||
16072726|NCT01787760|38759160|FG002|Overall Study|Decompensated on left exotropia|1|||
16171068|NCT03437447|39103204|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16171069|NCT03437447|39103205|FG002|Treatment Period 1|Withdrawal by Subject|1|||
16171070|NCT00490542|39103206|FG000|Overall Study|Lost to Follow-up|3|||
16171071|NCT00490542|39103207|FG001|Overall Study|Lost to Follow-up|0|||
16171072|NCT00490542|39103206|FG000|Overall Study|Adverse Event|3|||
16171073|NCT00490542|39103207|FG001|Overall Study|Adverse Event|3|||
16171074|NCT00490542|39103206|FG000|Overall Study|Lack of Efficacy|1|||
16171075|NCT00490542|39103207|FG001|Overall Study|Lack of Efficacy|1|||
16171076|NCT00611247|39103208|FG000|Overall Study|Death|1|||
16171077|NCT00611247|39103209|FG001|Overall Study|Death|5|||
16171078|NCT00611247|39103208|FG000|Overall Study|Lack of Efficacy|1|||
16171079|NCT00611247|39103209|FG001|Overall Study|Lack of Efficacy|16|||
16171080|NCT00607048|39103210|FG000|Overall Study|Adverse Event|0|||
16171081|NCT00607048|39103211|FG001|Overall Study|Adverse Event|1|||
16171082|NCT00607048|39103212|FG002|Overall Study|Adverse Event|0|||
16171083|NCT00607048|39103213|FG003|Overall Study|Adverse Event|0|||
16171084|NCT00607048|39103214|FG004|Overall Study|Adverse Event|4|||
16171085|NCT00607048|39103215|FG005|Overall Study|Adverse Event|0|||
16171086|NCT00607048|39103210|FG000|Overall Study|Global deterioration of health|1|||
16171087|NCT00607048|39103211|FG001|Overall Study|Global deterioration of health|0|||
16171088|NCT00607048|39103212|FG002|Overall Study|Global deterioration of health|0|||
16171089|NCT00607048|39103213|FG003|Overall Study|Global deterioration of health|0|||
16072727|NCT01787760|38759158|FG000|Overall Study|Dryness|0|||
16072728|NCT01787760|38759159|FG001|Overall Study|Dryness|1|||
16072729|NCT01787760|38759160|FG002|Overall Study|Dryness|0|||
16072730|NCT01787760|38759158|FG000|Overall Study|Relocation|1|||
16072731|NCT01787760|38759159|FG001|Overall Study|Relocation|1|||
16072732|NCT01787760|38759160|FG002|Overall Study|Relocation|0|||
16072733|NCT01787760|38759158|FG000|Overall Study|Lens discomfort|3|||
16072734|NCT01787760|38759159|FG001|Overall Study|Lens discomfort|0|||
16171090|NCT00607048|39103214|FG004|Overall Study|Global deterioration of health|0|||
16171091|NCT00607048|39103215|FG005|Overall Study|Global deterioration of health|0|||
16171092|NCT00607048|39103210|FG000|Overall Study|Objective disease progression - relapse|1|||
16171093|NCT00607048|39103211|FG001|Overall Study|Objective disease progression - relapse|2|||
16171094|NCT00607048|39103212|FG002|Overall Study|Objective disease progression - relapse|4|||
16072735|NCT01787760|38759160|FG002|Overall Study|Lens discomfort|0|||
16072736|NCT01787760|38759158|FG000|Overall Study|Lens handling difficulty|1|||
16072737|NCT01787760|38759159|FG001|Overall Study|Lens handling difficulty|2|||
16171095|NCT00607048|39103213|FG003|Overall Study|Objective disease progression - relapse|2|||
16072738|NCT01787760|38759160|FG002|Overall Study|Lens handling difficulty|0|||
16467235|NCT02478398|40188384|FG000|Overall Study|Protocol Violation|3|||
16467236|NCT02478398|40188385|FG001|Overall Study|Protocol Violation|1|||
16467237|NCT02478398|40188384|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
16467238|NCT02478398|40188385|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
16467239|NCT02478398|40188384|FG000|Overall Study|Withdrawal By Participant|10|||
16467240|NCT02478398|40188385|FG001|Overall Study|Withdrawal By Participant|4|||
16467241|NCT00384111|40188386|FG000|Overall Study|Disease Progression|3|||
16467242|NCT00384111|40188386|FG000|Overall Study|Adverse Event|1|||
16171096|NCT00607048|39103214|FG004|Overall Study|Objective disease progression - relapse|2|||
16171097|NCT00607048|39103215|FG005|Overall Study|Objective disease progression - relapse|2|||
16171098|NCT00607048|39103210|FG000|Overall Study|Withdrawal by Subject|0|||
16171099|NCT00607048|39103211|FG001|Overall Study|Withdrawal by Subject|0|||
16171100|NCT00607048|39103212|FG002|Overall Study|Withdrawal by Subject|0|||
16171101|NCT00607048|39103213|FG003|Overall Study|Withdrawal by Subject|1|||
16467243|NCT00384111|40188386|FG000|Overall Study|Investigator Decision|3|||
16467244|NCT00384111|40188386|FG000|Overall Study|Study Terminated by the Sponsor|19|||
16467245|NCT01369485|40188391|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
16467246|NCT01369485|40188392|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
16467247|NCT01369485|40188391|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
16467248|NCT01369485|40188392|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
16467249|NCT01369485|40188391|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
16467250|NCT01369485|40188392|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
16467251|NCT01369485|40188391|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
16467252|NCT01369485|40188392|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
16467253|NCT01369485|40188391|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
16467254|NCT01369485|40188392|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
16467255|NCT01369485|40188391|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
16467256|NCT01369485|40188392|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
16467257|NCT01369485|40188391|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
16467258|NCT01369485|40188392|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
16467259|NCT01369485|40188391|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
16467260|NCT01369485|40188392|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
16467261|NCT01369485|40188391|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
16467262|NCT01369485|40188392|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
16467263|NCT01369485|40188391|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
16467264|NCT01369485|40188392|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
16467265|NCT01856023|40188395|FG000|Overall Study|Death|1|||
16467266|NCT01856023|40188396|FG001|Overall Study|Death|2|||
16467267|NCT01856023|40188395|FG000|Overall Study|Adverse Event|2|||
16467268|NCT01856023|40188396|FG001|Overall Study|Adverse Event|1|||
16467269|NCT01856023|40188395|FG000|Overall Study|Lack of Efficacy|5|||
16467270|NCT01856023|40188396|FG001|Overall Study|Lack of Efficacy|5|||
16467271|NCT01856023|40188395|FG000|Overall Study|non compliance, study closure|1|||
16467272|NCT01856023|40188396|FG001|Overall Study|non compliance, study closure|3|||
16467273|NCT01856023|40188395|FG000|Overall Study|Withdrawal by Subject|1|||
16467274|NCT01856023|40188396|FG001|Overall Study|Withdrawal by Subject|1|||
16467275|NCT02519855|40188397|FG000|Overall Study|Adverse Event|0|||
16467276|NCT02519855|40188398|FG001|Overall Study|Adverse Event|1|||
16467277|NCT02519855|40188397|FG000|Overall Study|Lost to Follow-up|3|||
16467278|NCT02519855|40188398|FG001|Overall Study|Lost to Follow-up|3|||
16467279|NCT03312751|40188399|FG000|Overall Study|Death|7|||
16467280|NCT03312751|40188400|FG001|Overall Study|Death|9|||
16467281|NCT03312751|40188399|FG000|Overall Study|Study discontinuation due to other reason|0|||
16467282|NCT03312751|40188400|FG001|Overall Study|Study discontinuation due to other reason|1|||
16467283|NCT02448680|40188402|FG000|Overall Study|Physician Decision|1|||
16467284|NCT02448680|40188403|FG001|Overall Study|Physician Decision|1|||
16467285|NCT02448680|40188402|FG000|Overall Study|Withdrawal by Subject|0|||
16467286|NCT02448680|40188403|FG001|Overall Study|Withdrawal by Subject|2|||
16467287|NCT01150474|40188404|FG000|Overall Study|Withdrawal by Subject|5|||
16467288|NCT01150474|40188405|FG001|Overall Study|Withdrawal by Subject|2|||
16467289|NCT01150474|40188404|FG000|Overall Study|Cancer found|1|||
16467290|NCT01150474|40188405|FG001|Overall Study|Cancer found|0|||
16467291|NCT01150474|40188404|FG000|Overall Study|Multiple Studies|0|||
16467292|NCT01150474|40188405|FG001|Overall Study|Multiple Studies|1|||
16467293|NCT01150474|40188404|FG000|Overall Study|Rectotomy|1|||
16467294|NCT01150474|40188405|FG001|Overall Study|Rectotomy|0|||
16467295|NCT01150474|40188404|FG000|Overall Study|Drug did not arrive in time|1|||
16467296|NCT01150474|40188405|FG001|Overall Study|Drug did not arrive in time|0|||
16171102|NCT00607048|39103214|FG004|Overall Study|Withdrawal by Subject|0|||
16467297|NCT01150474|40188404|FG000|Overall Study|Drug not administered|1|||
16467298|NCT01150474|40188405|FG001|Overall Study|Drug not administered|0|||
16467299|NCT01150474|40188404|FG000|Overall Study|Surgery Changed|1|||
16467300|NCT01150474|40188405|FG001|Overall Study|Surgery Changed|0|||
16467301|NCT01860846|40188406|FG000|Overall Study|Lost to Follow-up|33|||
16467302|NCT01277042|40188407|FG000|Overall Study|Adverse Event|4|||
16467303|NCT01277042|40188408|FG001|Overall Study|Adverse Event|3|||
16467304|NCT01277042|40188407|FG000|Overall Study|Lost to Follow-up|2|||
16467305|NCT01277042|40188408|FG001|Overall Study|Lost to Follow-up|2|||
16467306|NCT01277042|40188407|FG000|Overall Study|Withdrawal by Subject|2|||
16467307|NCT01277042|40188408|FG001|Overall Study|Withdrawal by Subject|0|||
16467308|NCT02213133|40188411|FG000|Overall Study|Participant discontinued study therapy|2|||
16171103|NCT00607048|39103215|FG005|Overall Study|Withdrawal by Subject|2|||
16171104|NCT00607048|39103210|FG000|Overall Study|Other|1|||
16171105|NCT00607048|39103211|FG001|Overall Study|Other|1|||
16171106|NCT00607048|39103212|FG002|Overall Study|Other|0|||
16171107|NCT00607048|39103213|FG003|Overall Study|Other|0|||
16171108|NCT00607048|39103214|FG004|Overall Study|Other|0|||
16171109|NCT00607048|39103215|FG005|Overall Study|Other|1|||
16171110|NCT00723957|39103216|FG000|Overall Study|Adverse event unrelated to study drug|1|||
16171111|NCT00723957|39103217|FG001|Overall Study|Adverse event unrelated to study drug|4|||
16171112|NCT00723957|39103216|FG000|Overall Study|Death|3|||
16171113|NCT00723957|39103217|FG001|Overall Study|Death|4|||
16171114|NCT00723957|39103216|FG000|Overall Study|Disease progression|27|||
16171115|NCT00723957|39103217|FG001|Overall Study|Disease progression|25|||
16171116|NCT00723957|39103216|FG000|Overall Study|Maximum clinical benefit|4|||
16171117|NCT00723957|39103217|FG001|Overall Study|Maximum clinical benefit|5|||
16171118|NCT00723957|39103216|FG000|Overall Study|Investigator decision|1|||
16171119|NCT00723957|39103217|FG001|Overall Study|Investigator decision|1|||
16171120|NCT00723957|39103216|FG000|Overall Study|Study drug toxicity|4|||
16171121|NCT00723957|39103217|FG001|Overall Study|Study drug toxicity|6|||
16171122|NCT00723957|39103216|FG000|Overall Study|Withdrawal by Subject|7|||
16171123|NCT00723957|39103217|FG001|Overall Study|Withdrawal by Subject|5|||
16171124|NCT00723957|39103216|FG000|Overall Study|Reason not analyzed|1|||
16171125|NCT00723957|39103217|FG001|Overall Study|Reason not analyzed|0|||
16171126|NCT00723957|39103216|FG000|Overall Study|Never received treatment|3|||
16171127|NCT00723957|39103217|FG001|Overall Study|Never received treatment|3|||
16171128|NCT00868790|39103224|FG000|Period 1|Adverse Event|1|||
16171129|NCT00868790|39103225|FG001|Period 1|Adverse Event|0|||
16171130|NCT00868790|39103226|FG002|Period 1|Adverse Event|0|||
16467309|NCT02213133|40188412|FG001|Overall Study|Participant discontinued study therapy|0|||
16467310|NCT02213133|40188413|FG002|Overall Study|Participant discontinued study therapy|0|||
16467311|NCT02213133|40188411|FG000|Overall Study|Participant withdrew informed consent|2|||
16467312|NCT02213133|40188412|FG001|Overall Study|Participant withdrew informed consent|1|||
16467313|NCT02213133|40188413|FG002|Overall Study|Participant withdrew informed consent|2|||
16467314|NCT02213133|40188411|FG000|Overall Study|Disease progression|11|||
16467315|NCT02213133|40188412|FG001|Overall Study|Disease progression|2|||
16467316|NCT02213133|40188413|FG002|Overall Study|Disease progression|0|||
16467317|NCT02213133|40188411|FG000|Overall Study|Adverse Event (AE)|1|||
16467318|NCT02213133|40188412|FG001|Overall Study|Adverse Event (AE)|0|||
16467319|NCT02213133|40188413|FG002|Overall Study|Adverse Event (AE)|0|||
16467320|NCT02213133|40188411|FG000|Overall Study|Death|16|||
16467321|NCT02213133|40188412|FG001|Overall Study|Death|2|||
16467322|NCT02213133|40188413|FG002|Overall Study|Death|1|||
16467323|NCT02213133|40188411|FG000|Overall Study|Other|5|||
16467324|NCT02213133|40188412|FG001|Overall Study|Other|0|||
16467325|NCT02213133|40188413|FG002|Overall Study|Other|0|||
16467326|NCT01006603|40188414|FG000|Overall Study|Withdrawal by Subject|17|||
16467327|NCT01006603|40188415|FG001|Overall Study|Withdrawal by Subject|19|||
16467328|NCT01006603|40188414|FG000|Overall Study|Lost to Follow-up|0|||
16467329|NCT01006603|40188415|FG001|Overall Study|Lost to Follow-up|1|||
16467330|NCT01006603|40188414|FG000|Overall Study|Safety reason|1|||
16467331|NCT01006603|40188415|FG001|Overall Study|Safety reason|1|||
16467332|NCT01006603|40188414|FG000|Overall Study|Protocol Violation|1|||
16467333|NCT01006603|40188415|FG001|Overall Study|Protocol Violation|3|||
16467334|NCT01006603|40188414|FG000|Overall Study|Incorrect enrolment|0|||
16467335|NCT01006603|40188415|FG001|Overall Study|Incorrect enrolment|2|||
16467336|NCT01006603|40188414|FG000|Overall Study|Adverse Event|15|||
16171131|NCT00868790|39103227|FG003|Period 1|Adverse Event|0|||
16171132|NCT00868790|39103228|FG004|Period 1|Adverse Event|0|||
16171133|NCT00868790|39103229|FG005|Period 1|Adverse Event|0|||
16171134|NCT00868790|39103230|FG006|Period 1|Adverse Event|0|||
16171135|NCT00868790|39103231|FG007|Period 1|Adverse Event|3|||
16171136|NCT00868790|39103232|FG008|Period 1|Adverse Event|1|||
16171137|NCT00868790|39103233|FG009|Period 1|Adverse Event|0|||
16171138|NCT00868790|39103234|FG010|Period 1|Adverse Event|0|||
16171139|NCT00868790|39103235|FG011|Period 1|Adverse Event|0|||
16467337|NCT01006603|40188415|FG001|Overall Study|Adverse Event|7|||
16467338|NCT01006603|40188414|FG000|Overall Study|Death|1|||
16467339|NCT01006603|40188415|FG001|Overall Study|Death|1|||
16467340|NCT01006603|40188414|FG000|Overall Study|Study specific discontinuation criteria|33|||
16467341|NCT01006603|40188415|FG001|Overall Study|Study specific discontinuation criteria|34|||
16171140|NCT00868790|39103236|FG012|Period 1|Adverse Event|0|||
16171141|NCT00868790|39103237|FG013|Period 1|Adverse Event|1|||
16467342|NCT01006603|40188414|FG000|Overall Study|Other|3|||
16467343|NCT01006603|40188415|FG001|Overall Study|Other|7|||
16467344|NCT00877773|40188416|FG000|Overall Study|Disease Progression|44|||
16467345|NCT00829283|40188423|FG000|Overall Study|Lost to Follow-up|7|||
16467346|NCT00829283|40188424|FG001|Overall Study|Lost to Follow-up|25|||
16467347|NCT02609503|40188431|FG000|Overall Study|Adverse Event|1|||
16467348|NCT02609503|40188431|FG000|Overall Study|Death|1|||
16467349|NCT02609503|40188431|FG000|Overall Study|Withdrawal by Subject|1|||
16467350|NCT02609503|40188431|FG000|Overall Study|Disease progression|1|||
16467351|NCT02661178|40188432|FG000|Part 1|Protocol Violation|1|||
16467352|NCT02661178|40188433|FG001|Part 1|Protocol Violation|0|||
16467353|NCT02661178|40188434|FG002|Part 1|Protocol Violation|0|||
16467354|NCT02661178|40188435|FG003|Part 1|Protocol Violation|0|||
16467355|NCT02661178|40188436|FG004|Part 1|Protocol Violation|0|||
16171142|NCT00868790|39103224|FG000|Period 1|Protocol Violation|1|||
16171143|NCT00868790|39103225|FG001|Period 1|Protocol Violation|0|||
16171144|NCT00868790|39103226|FG002|Period 1|Protocol Violation|0|||
16171145|NCT00868790|39103227|FG003|Period 1|Protocol Violation|0|||
16171146|NCT00868790|39103228|FG004|Period 1|Protocol Violation|0|||
16467356|NCT02661178|40188437|FG005|Part 1|Protocol Violation|0|||
16171147|NCT00868790|39103229|FG005|Period 1|Protocol Violation|0|||
16171148|NCT00868790|39103230|FG006|Period 1|Protocol Violation|0|||
16171149|NCT00868790|39103231|FG007|Period 1|Protocol Violation|0|||
16467357|NCT02661178|40188438|FG006|Part 1|Protocol Violation|0|||
16467358|NCT02661178|40188439|FG007|Part 1|Protocol Violation|0|||
16467359|NCT02661178|40188440|FG008|Part 1|Protocol Violation|0|||
16467360|NCT02661178|40188441|FG009|Part 1|Protocol Violation|0|||
16467361|NCT02661178|40188442|FG010|Part 1|Protocol Violation|0|||
16467362|NCT02661178|40188443|FG011|Part 1|Protocol Violation|0|||
16467363|NCT02661178|40188444|FG012|Part 1|Protocol Violation|0|||
16171150|NCT00868790|39103232|FG008|Period 1|Protocol Violation|0|||
16171151|NCT00868790|39103233|FG009|Period 1|Protocol Violation|0|||
16171152|NCT00868790|39103234|FG010|Period 1|Protocol Violation|0|||
16171153|NCT00868790|39103235|FG011|Period 1|Protocol Violation|0|||
16171154|NCT00868790|39103236|FG012|Period 1|Protocol Violation|0|||
16171155|NCT00868790|39103237|FG013|Period 1|Protocol Violation|0|||
16171156|NCT00868790|39103224|FG000|Period 1|Withdrawal by Subject|0|||
16171157|NCT00868790|39103225|FG001|Period 1|Withdrawal by Subject|1|||
16171158|NCT00868790|39103226|FG002|Period 1|Withdrawal by Subject|0|||
16171159|NCT00868790|39103227|FG003|Period 1|Withdrawal by Subject|0|||
16171160|NCT00868790|39103228|FG004|Period 1|Withdrawal by Subject|0|||
16171161|NCT00868790|39103229|FG005|Period 1|Withdrawal by Subject|0|||
16171162|NCT00868790|39103230|FG006|Period 1|Withdrawal by Subject|0|||
16171163|NCT00868790|39103231|FG007|Period 1|Withdrawal by Subject|0|||
16171164|NCT00868790|39103232|FG008|Period 1|Withdrawal by Subject|0|||
16171165|NCT00868790|39103233|FG009|Period 1|Withdrawal by Subject|0|||
16171166|NCT00868790|39103234|FG010|Period 1|Withdrawal by Subject|0|||
16171167|NCT00868790|39103235|FG011|Period 1|Withdrawal by Subject|0|||
16171168|NCT00868790|39103236|FG012|Period 1|Withdrawal by Subject|0|||
16171169|NCT00868790|39103237|FG013|Period 1|Withdrawal by Subject|1|||
16171170|NCT00868790|39103224|FG000|Period 1|Abnormal Triglycerides|0|||
16171171|NCT00868790|39103225|FG001|Period 1|Abnormal Triglycerides|0|||
16171172|NCT00868790|39103226|FG002|Period 1|Abnormal Triglycerides|0|||
16171173|NCT00868790|39103227|FG003|Period 1|Abnormal Triglycerides|0|||
16171174|NCT00868790|39103228|FG004|Period 1|Abnormal Triglycerides|1|||
16171175|NCT00868790|39103229|FG005|Period 1|Abnormal Triglycerides|0|||
16171176|NCT00868790|39103230|FG006|Period 1|Abnormal Triglycerides|0|||
16171177|NCT00868790|39103231|FG007|Period 1|Abnormal Triglycerides|0|||
16171178|NCT00868790|39103232|FG008|Period 1|Abnormal Triglycerides|0|||
16171179|NCT00868790|39103233|FG009|Period 1|Abnormal Triglycerides|0|||
16171180|NCT00868790|39103234|FG010|Period 1|Abnormal Triglycerides|0|||
16171181|NCT00868790|39103235|FG011|Period 1|Abnormal Triglycerides|0|||
16171182|NCT00868790|39103236|FG012|Period 1|Abnormal Triglycerides|0|||
16171183|NCT00868790|39103237|FG013|Period 1|Abnormal Triglycerides|0|||
16171184|NCT00868790|39103224|FG000|Period 1|Lost to Follow-up|0|||
16171185|NCT00868790|39103225|FG001|Period 1|Lost to Follow-up|0|||
16171186|NCT00868790|39103226|FG002|Period 1|Lost to Follow-up|0|||
16467364|NCT02661178|40188445|FG013|Part 1|Protocol Violation|0|||
16467365|NCT02661178|40188446|FG014|Part 1|Protocol Violation|0|||
16171187|NCT00868790|39103227|FG003|Period 1|Lost to Follow-up|0|||
16171188|NCT00868790|39103228|FG004|Period 1|Lost to Follow-up|0|||
16171189|NCT00868790|39103229|FG005|Period 1|Lost to Follow-up|1|||
16171190|NCT00868790|39103230|FG006|Period 1|Lost to Follow-up|0|||
16171191|NCT00868790|39103231|FG007|Period 1|Lost to Follow-up|0|||
16171192|NCT00868790|39103232|FG008|Period 1|Lost to Follow-up|0|||
16171193|NCT00868790|39103233|FG009|Period 1|Lost to Follow-up|0|||
16467366|NCT00895011|40188447|FG000|Overall Study|Withdrawal by Subject|14|||
16467367|NCT00895011|40188448|FG001|Overall Study|Withdrawal by Subject|7|||
16171194|NCT00868790|39103234|FG010|Period 1|Lost to Follow-up|0|||
16171195|NCT00868790|39103235|FG011|Period 1|Lost to Follow-up|0|||
16171196|NCT00868790|39103236|FG012|Period 1|Lost to Follow-up|0|||
16467368|NCT00895011|40188449|FG002|Overall Study|Withdrawal by Subject|2|||
16171197|NCT00868790|39103237|FG013|Period 1|Lost to Follow-up|0|||
16171198|NCT00868790|39103224|FG000|Period 2|Adverse Event|0|||
16171199|NCT00868790|39103225|FG001|Period 2|Adverse Event|0|||
16171200|NCT00868790|39103226|FG002|Period 2|Adverse Event|0|||
16171201|NCT00868790|39103227|FG003|Period 2|Adverse Event|0|||
16171202|NCT00868790|39103228|FG004|Period 2|Adverse Event|0|||
16171203|NCT00868790|39103229|FG005|Period 2|Adverse Event|0|||
16171204|NCT00868790|39103230|FG006|Period 2|Adverse Event|0|||
16171205|NCT00868790|39103231|FG007|Period 2|Adverse Event|0|||
16171206|NCT00868790|39103232|FG008|Period 2|Adverse Event|1|||
16171207|NCT00868790|39103233|FG009|Period 2|Adverse Event|0|||
16171208|NCT00868790|39103234|FG010|Period 2|Adverse Event|0|||
16171209|NCT00868790|39103235|FG011|Period 2|Adverse Event|0|||
16171210|NCT00868790|39103236|FG012|Period 2|Adverse Event|0|||
16171211|NCT00868790|39103237|FG013|Period 2|Adverse Event|0|||
16467369|NCT00895011|40188447|FG000|Overall Study|Lost to Follow-up|5|||
16467370|NCT00895011|40188448|FG001|Overall Study|Lost to Follow-up|4|||
16467371|NCT00895011|40188449|FG002|Overall Study|Lost to Follow-up|1|||
16467372|NCT00895011|40188447|FG000|Overall Study|Protocol Violation|3|||
16171212|NCT00868790|39103224|FG000|Period 2|Lost to Follow-up|0|||
16171213|NCT00868790|39103225|FG001|Period 2|Lost to Follow-up|1|||
16171214|NCT00868790|39103226|FG002|Period 2|Lost to Follow-up|0|||
16171215|NCT00868790|39103227|FG003|Period 2|Lost to Follow-up|0|||
16171216|NCT00868790|39103228|FG004|Period 2|Lost to Follow-up|0|||
16171217|NCT00868790|39103229|FG005|Period 2|Lost to Follow-up|1|||
16269297|NCT00295490|39471056|FG003|Overall Study|Adverse Event|0|||
16269298|NCT00295490|39471053|FG000|Overall Study|Other|0|||
16269299|NCT00295490|39471054|FG001|Overall Study|Other|2|||
16269300|NCT00295490|39471055|FG002|Overall Study|Other|0|||
16269301|NCT00295490|39471056|FG003|Overall Study|Other|1|||
16269302|NCT02905435|39471059|FG000|Overall Study|Death|2|||
16269303|NCT02905435|39471059|FG000|Overall Study|Physician Decision|1|||
16269304|NCT02905435|39471059|FG000|Overall Study|Lost to Follow-up|4|||
16269305|NCT02294981|39471060|FG000|Overall Study|Lost to Follow-up|1|||
16269306|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
16269307|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
16269308|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
16269309|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
16269310|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
16269311|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
16269312|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
16269313|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
16269314|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
16269315|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
16269316|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
16269317|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
16269318|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
16269319|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
16269320|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
16269321|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
16269322|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
16269323|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
16269324|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
16269325|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
16269326|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
16269327|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
16269328|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
16467373|NCT00895011|40188448|FG001|Overall Study|Protocol Violation|1|||
16467374|NCT00895011|40188449|FG002|Overall Study|Protocol Violation|3|||
16467375|NCT00895011|40188447|FG000|Overall Study|Adverse Event|1|||
16467376|NCT00895011|40188448|FG001|Overall Study|Adverse Event|2|||
16467377|NCT00895011|40188449|FG002|Overall Study|Adverse Event|2|||
16467378|NCT00895011|40188447|FG000|Overall Study|schedule conflict|1|||
16467379|NCT00895011|40188448|FG001|Overall Study|schedule conflict|0|||
16467380|NCT00895011|40188449|FG002|Overall Study|schedule conflict|0|||
16467381|NCT01288976|40188452|FG000|Overall Study|Withdrawal by Subject|58|||
16467382|NCT01288976|40188453|FG001|Overall Study|Withdrawal by Subject|12|||
16467383|NCT01288976|40188454|FG002|Overall Study|Withdrawal by Subject|9|||
16467384|NCT01288976|40188452|FG000|Overall Study|Death|98|||
16467385|NCT01288976|40188453|FG001|Overall Study|Death|6|||
16467386|NCT01288976|40188454|FG002|Overall Study|Death|4|||
16467387|NCT01288976|40188452|FG000|Overall Study|Data unavailable|22|||
16467388|NCT01288976|40188453|FG001|Overall Study|Data unavailable|9|||
16171218|NCT00868790|39103230|FG006|Period 2|Lost to Follow-up|0|||
16171219|NCT00868790|39103231|FG007|Period 2|Lost to Follow-up|0|||
16171220|NCT00868790|39103232|FG008|Period 2|Lost to Follow-up|0|||
16171221|NCT00868790|39103233|FG009|Period 2|Lost to Follow-up|0|||
16467389|NCT01288976|40188454|FG002|Overall Study|Data unavailable|7|||
16467390|NCT04761627|40188455|FG000|Run-in Period|Death|1|||
16467391|NCT04761627|40188456|FG001|Run-in Period|Death|0|||
16467392|NCT04761627|40188457|FG002|Run-in Period|Death|0|||
16467393|NCT04761627|40188455|FG000|Run-in Period|Required alternative therapy|2|||
16467394|NCT04761627|40188456|FG001|Run-in Period|Required alternative therapy|0|||
16467395|NCT04761627|40188457|FG002|Run-in Period|Required alternative therapy|0|||
16467396|NCT04761627|40188455|FG000|Run-in Period|Lost to Follow-up|2|||
16467397|NCT04761627|40188456|FG001|Run-in Period|Lost to Follow-up|0|||
16467398|NCT04761627|40188457|FG002|Run-in Period|Lost to Follow-up|0|||
16467399|NCT04761627|40188455|FG000|Run-in Period|Protocol Violation|3|||
16467400|NCT04761627|40188456|FG001|Run-in Period|Protocol Violation|0|||
16467401|NCT04761627|40188457|FG002|Run-in Period|Protocol Violation|0|||
16467402|NCT04761627|40188455|FG000|Run-in Period|Abnormal liver function|1|||
16171222|NCT00868790|39103234|FG010|Period 2|Lost to Follow-up|0|||
16171223|NCT00868790|39103235|FG011|Period 2|Lost to Follow-up|0|||
16171224|NCT00868790|39103236|FG012|Period 2|Lost to Follow-up|0|||
16171225|NCT00868790|39103237|FG013|Period 2|Lost to Follow-up|0|||
16171226|NCT00868790|39103224|FG000|Period 2|Withdrawal by Subject|0|||
16171227|NCT00868790|39103225|FG001|Period 2|Withdrawal by Subject|0|||
16171228|NCT00868790|39103226|FG002|Period 2|Withdrawal by Subject|0|||
16171229|NCT00868790|39103227|FG003|Period 2|Withdrawal by Subject|0|||
16171230|NCT00868790|39103228|FG004|Period 2|Withdrawal by Subject|0|||
16171231|NCT00868790|39103229|FG005|Period 2|Withdrawal by Subject|0|||
16171232|NCT00868790|39103230|FG006|Period 2|Withdrawal by Subject|0|||
16171233|NCT00868790|39103231|FG007|Period 2|Withdrawal by Subject|0|||
16171234|NCT00868790|39103232|FG008|Period 2|Withdrawal by Subject|1|||
16171235|NCT00868790|39103233|FG009|Period 2|Withdrawal by Subject|0|||
16171236|NCT00868790|39103234|FG010|Period 2|Withdrawal by Subject|0|||
16171237|NCT00868790|39103235|FG011|Period 2|Withdrawal by Subject|0|||
16467403|NCT04761627|40188456|FG001|Run-in Period|Abnormal liver function|0|||
16467404|NCT04761627|40188457|FG002|Run-in Period|Abnormal liver function|0|||
16467405|NCT04761627|40188455|FG000|Run-in Period|Adverse Event|6|||
16467406|NCT04761627|40188456|FG001|Run-in Period|Adverse Event|0|||
16467407|NCT04761627|40188457|FG002|Run-in Period|Adverse Event|0|||
16467408|NCT04761627|40188455|FG000|Run-in Period|Withdrawal by Subject|7|||
16467409|NCT04761627|40188456|FG001|Run-in Period|Withdrawal by Subject|0|||
16467410|NCT04761627|40188457|FG002|Run-in Period|Withdrawal by Subject|0|||
16467411|NCT04761627|40188455|FG000|Run-in Period|Did not meet PASI 50|15|||
16467412|NCT04761627|40188456|FG001|Run-in Period|Did not meet PASI 50|0|||
16467413|NCT04761627|40188457|FG002|Run-in Period|Did not meet PASI 50|0|||
16467414|NCT04761627|40188455|FG000|Run-in Period|Study site closure|2|||
16467415|NCT04761627|40188456|FG001|Run-in Period|Study site closure|0|||
16467416|NCT04761627|40188457|FG002|Run-in Period|Study site closure|0|||
16467417|NCT04761627|40188455|FG000|Run-in Period|Pregnancy|2|||
16467418|NCT04761627|40188456|FG001|Run-in Period|Pregnancy|0|||
16467419|NCT04761627|40188457|FG002|Run-in Period|Pregnancy|0|||
16467420|NCT04761627|40188455|FG000|Post-randomization Period|Military service|0|||
16467421|NCT04761627|40188456|FG001|Post-randomization Period|Military service|1|||
16467422|NCT04761627|40188457|FG002|Post-randomization Period|Military service|0|||
16467423|NCT04761627|40188455|FG000|Post-randomization Period|Adverse Event|0|||
16467424|NCT04761627|40188456|FG001|Post-randomization Period|Adverse Event|4|||
16467425|NCT04761627|40188457|FG002|Post-randomization Period|Adverse Event|2|||
16467426|NCT04761627|40188455|FG000|Post-randomization Period|Lost to Follow-up|0|||
16467427|NCT04761627|40188456|FG001|Post-randomization Period|Lost to Follow-up|6|||
16467428|NCT04761627|40188457|FG002|Post-randomization Period|Lost to Follow-up|6|||
16467429|NCT04761627|40188455|FG000|Post-randomization Period|Withdrawal by Subject|0|||
16467430|NCT04761627|40188456|FG001|Post-randomization Period|Withdrawal by Subject|7|||
16171238|NCT00868790|39103236|FG012|Period 2|Withdrawal by Subject|0|||
16171239|NCT00868790|39103237|FG013|Period 2|Withdrawal by Subject|1|||
16171240|NCT00868790|39103224|FG000|Period 3|Adverse Event|0|||
16171241|NCT00868790|39103225|FG001|Period 3|Adverse Event|0|||
16171242|NCT00868790|39103226|FG002|Period 3|Adverse Event|0|||
16467431|NCT04761627|40188457|FG002|Post-randomization Period|Withdrawal by Subject|6|||
16467432|NCT04761627|40188455|FG000|Post-randomization Period|Pregnancy|0|||
16467433|NCT04761627|40188456|FG001|Post-randomization Period|Pregnancy|0|||
16467434|NCT04761627|40188457|FG002|Post-randomization Period|Pregnancy|1|||
16467435|NCT04761627|40188455|FG000|Post-randomization Period|Study site closure|0|||
16467436|NCT04761627|40188456|FG001|Post-randomization Period|Study site closure|0|||
16467437|NCT04761627|40188457|FG002|Post-randomization Period|Study site closure|1|||
16467438|NCT04761627|40188455|FG000|Post-randomization Period|Family planning|0|||
16171243|NCT00868790|39103227|FG003|Period 3|Adverse Event|0|||
16171244|NCT00868790|39103228|FG004|Period 3|Adverse Event|0|||
16171245|NCT00868790|39103229|FG005|Period 3|Adverse Event|0|||
16171246|NCT00868790|39103230|FG006|Period 3|Adverse Event|0|||
16171247|NCT00868790|39103231|FG007|Period 3|Adverse Event|0|||
16171248|NCT00868790|39103232|FG008|Period 3|Adverse Event|0|||
16171249|NCT00868790|39103233|FG009|Period 3|Adverse Event|1|||
16467439|NCT04761627|40188456|FG001|Post-randomization Period|Family planning|1|||
16171250|NCT00868790|39103234|FG010|Period 3|Adverse Event|0|||
16171251|NCT00868790|39103235|FG011|Period 3|Adverse Event|0|||
16171252|NCT00868790|39103236|FG012|Period 3|Adverse Event|0|||
16171253|NCT00868790|39103237|FG013|Period 3|Adverse Event|0|||
16171254|NCT00868790|39103224|FG000|Period 3|Protocol Violation|0|||
16171255|NCT00868790|39103225|FG001|Period 3|Protocol Violation|0|||
16171256|NCT00868790|39103226|FG002|Period 3|Protocol Violation|0|||
16171257|NCT00868790|39103227|FG003|Period 3|Protocol Violation|0|||
16171258|NCT00868790|39103228|FG004|Period 3|Protocol Violation|0|||
16171259|NCT00868790|39103229|FG005|Period 3|Protocol Violation|0|||
16171260|NCT00868790|39103230|FG006|Period 3|Protocol Violation|0|||
16467440|NCT04761627|40188457|FG002|Post-randomization Period|Family planning|0|||
16467441|NCT02312687|40188458|FG000|Overall Study|Other, Not Specified|1|||
16467442|NCT03442764|40188459|FG000|Overall Study|Adverse Event|1|||
16467443|NCT03442764|40188460|FG001|Overall Study|Adverse Event|0|||
16467444|NCT03442764|40188461|FG002|Overall Study|Adverse Event|0|||
16467445|NCT02140775|40188462|FG000|Overall Study|Withdrawal by Subject|30|||
16467446|NCT02140775|40188463|FG001|Overall Study|Withdrawal by Subject|7|||
16467447|NCT00089674|40188464|FG000|Overall Study|Physician Decision|4|||
16467448|NCT00089674|40188465|FG001|Overall Study|Physician Decision|2|||
16467449|NCT00089674|40188464|FG000|Overall Study|Adverse Event|23|||
16467450|NCT00089674|40188465|FG001|Overall Study|Adverse Event|29|||
16467451|NCT00089674|40188464|FG000|Overall Study|Withdrawal by Subject|143|||
16467452|NCT00089674|40188465|FG001|Overall Study|Withdrawal by Subject|127|||
16467453|NCT00089674|40188464|FG000|Overall Study|Death|43|||
16467454|NCT00089674|40188465|FG001|Overall Study|Death|43|||
16467455|NCT00089674|40188464|FG000|Overall Study|Disease progression|21|||
16467456|NCT00089674|40188465|FG001|Overall Study|Disease progression|23|||
16467457|NCT00089674|40188464|FG000|Overall Study|Ineligibility determined|8|||
16467458|NCT00089674|40188465|FG001|Overall Study|Ineligibility determined|10|||
16467459|NCT00089674|40188464|FG000|Overall Study|Lost to Follow-up|21|||
16467460|NCT00089674|40188465|FG001|Overall Study|Lost to Follow-up|17|||
16467461|NCT00089674|40188464|FG000|Overall Study|Noncompliance|7|||
16467462|NCT00089674|40188465|FG001|Overall Study|Noncompliance|3|||
16467463|NCT00089674|40188464|FG000|Overall Study|Other|5|||
16467464|NCT00089674|40188465|FG001|Overall Study|Other|9|||
16467465|NCT00089674|40188464|FG000|Overall Study|Requirement for alternative therapy|14|||
16467466|NCT00089674|40188465|FG001|Overall Study|Requirement for alternative therapy|4|||
16467467|NCT00510952|40188466|FG000|Overall Study|Adverse Event|1|||
16467468|NCT00510952|40188467|FG001|Overall Study|Adverse Event|0|||
16467469|NCT00510952|40188466|FG000|Overall Study|Entry Criteria Not Met|3|||
16467470|NCT00510952|40188467|FG001|Overall Study|Entry Criteria Not Met|1|||
16467471|NCT00510952|40188466|FG000|Overall Study|Lost to Follow-up|5|||
16467472|NCT00510952|40188467|FG001|Overall Study|Lost to Follow-up|3|||
16467473|NCT00510952|40188466|FG000|Overall Study|Physician Decision|1|||
16467474|NCT00510952|40188467|FG001|Overall Study|Physician Decision|1|||
16467475|NCT00510952|40188466|FG000|Overall Study|Protocol Violation|7|||
16467476|NCT00510952|40188467|FG001|Overall Study|Protocol Violation|4|||
16467477|NCT00510952|40188466|FG000|Overall Study|Sponsor Decision|1|||
16467478|NCT00510952|40188467|FG001|Overall Study|Sponsor Decision|0|||
16467479|NCT00510952|40188466|FG000|Overall Study|Withdrawal by Subject|6|||
16467480|NCT00510952|40188467|FG001|Overall Study|Withdrawal by Subject|7|||
16467481|NCT00510952|40188466|FG000|Overall Study|Did Not Receive Study Drug|2|||
16467482|NCT00510952|40188467|FG001|Overall Study|Did Not Receive Study Drug|0|||
16467483|NCT00249288|40188468|FG000|Overall Study|Lost to Follow-up|3|||
16467484|NCT00249288|40188469|FG001|Overall Study|Lost to Follow-up|3|||
16467485|NCT00249288|40188468|FG000|Overall Study|Withdrawal by Subject|2|||
16467486|NCT00249288|40188469|FG001|Overall Study|Withdrawal by Subject|2|||
16467487|NCT03339297|40188474|FG000|Overall Study|Relapse of Hematologic Disease|1|||
16467488|NCT03339297|40188475|FG001|Overall Study|Relapse of Hematologic Disease|0|||
16467489|NCT03339297|40188474|FG000|Overall Study|Death|10|||
16467490|NCT03339297|40188475|FG001|Overall Study|Death|7|||
16467491|NCT03339297|40188474|FG000|Overall Study|Hepatic Candidosis|1|||
16467492|NCT03339297|40188475|FG001|Overall Study|Hepatic Candidosis|0|||
16269329|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
16467493|NCT03339297|40188474|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
16467494|NCT03339297|40188475|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
16467495|NCT03339297|40188474|FG000|Overall Study|Consent Withdrawn by Participant|3|||
16467496|NCT03339297|40188475|FG001|Overall Study|Consent Withdrawn by Participant|3|||
16467497|NCT03339297|40188474|FG000|Overall Study|Disease Relapse|2|||
16467498|NCT03339297|40188475|FG001|Overall Study|Disease Relapse|0|||
16467499|NCT03339297|40188474|FG000|Overall Study|Physician Decision|1|||
16467500|NCT03339297|40188475|FG001|Overall Study|Physician Decision|1|||
16467501|NCT03339297|40188474|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
16467502|NCT03339297|40188475|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
16467503|NCT03339297|40188474|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
16467504|NCT03339297|40188475|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
16171261|NCT00868790|39103231|FG007|Period 3|Protocol Violation|0|||
16467505|NCT03339297|40188474|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
16467506|NCT03339297|40188475|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
16467507|NCT03339297|40188474|FG000|Overall Study|Adverse Event, Non-fatal|1|||
16467508|NCT03339297|40188475|FG001|Overall Study|Adverse Event, Non-fatal|0|||
16467509|NCT03339297|40188474|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
16467510|NCT03339297|40188475|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
16467511|NCT03339297|40188474|FG000|Overall Study|Patient Was Not Eligible|1|||
16467512|NCT03339297|40188475|FG001|Overall Study|Patient Was Not Eligible|0|||
16467513|NCT00424255|40188479|FG000|Overall Study|Death|115|||
16467514|NCT00424255|40188480|FG001|Overall Study|Death|111|||
16467515|NCT00424255|40188479|FG000|Overall Study|Lost to Follow-up|26|||
16467516|NCT00424255|40188480|FG001|Overall Study|Lost to Follow-up|20|||
16467517|NCT00424255|40188479|FG000|Overall Study|Protocol Violation|0|||
16467518|NCT00424255|40188480|FG001|Overall Study|Protocol Violation|1|||
16467519|NCT00424255|40188479|FG000|Overall Study|Withdrawal by Subject|34|||
16467520|NCT00424255|40188480|FG001|Overall Study|Withdrawal by Subject|38|||
16467521|NCT00424255|40188479|FG000|Overall Study|Physician Decision|3|||
16467522|NCT00424255|40188480|FG001|Overall Study|Physician Decision|7|||
16467523|NCT00424255|40188479|FG000|Overall Study|Cognitive Disturbance|1|||
16467524|NCT00424255|40188480|FG001|Overall Study|Cognitive Disturbance|0|||
16467525|NCT00424255|40188479|FG000|Overall Study|Non-compliance by Participants|1|||
16467526|NCT00424255|40188480|FG001|Overall Study|Non-compliance by Participants|0|||
16467527|NCT00424255|40188479|FG000|Overall Study|Fatigue|1|||
16467528|NCT00424255|40188480|FG001|Overall Study|Fatigue|0|||
16467529|NCT00424255|40188479|FG000|Overall Study|Disease Progression|0|||
16467530|NCT00424255|40188480|FG001|Overall Study|Disease Progression|2|||
16467531|NCT00424255|40188479|FG000|Overall Study|Sponsor Terminated Study|161|||
16467532|NCT00424255|40188480|FG001|Overall Study|Sponsor Terminated Study|167|||
16467533|NCT02829944|40192340|FG000|Overall Study|Physician Decision|0|||
16467534|NCT02829944|40192341|FG001|Overall Study|Physician Decision|1|||
16467535|NCT02829944|40192340|FG000|Overall Study|Screen Failure|2|||
16467536|NCT02829944|40192341|FG001|Overall Study|Screen Failure|2|||
16467537|NCT02829944|40192340|FG000|Overall Study|Inadequate Neuraxial Block|1|||
16467538|NCT02829944|40192341|FG001|Overall Study|Inadequate Neuraxial Block|1|||
16467539|NCT02829944|40192340|FG000|Overall Study|Withdrawal by Subject|2|||
16467540|NCT02829944|40192341|FG001|Overall Study|Withdrawal by Subject|1|||
16467541|NCT02829944|40192340|FG000|Overall Study|Catheter Displacement|1|||
16467542|NCT02829944|40192341|FG001|Overall Study|Catheter Displacement|0|||
16467543|NCT02829944|40192340|FG000|Overall Study|Catheter broke|0|||
16467544|NCT02829944|40192341|FG001|Overall Study|Catheter broke|1|||
16467545|NCT02829944|40192340|FG000|Overall Study|Staff unavailable|0|||
16467546|NCT02829944|40192341|FG001|Overall Study|Staff unavailable|1|||
16467547|NCT01390220|40192342|FG000|Test Dose Phase|Adverse Event|17|||
16467548|NCT01390220|40192343|FG001|Test Dose Phase|Adverse Event|0|||
16467549|NCT01390220|40192344|FG002|Test Dose Phase|Adverse Event|0|||
16467550|NCT01390220|40192342|FG000|Test Dose Phase|Withdrawal by Subject|8|||
16467551|NCT01390220|40192343|FG001|Test Dose Phase|Withdrawal by Subject|0|||
16467552|NCT01390220|40192344|FG002|Test Dose Phase|Withdrawal by Subject|0|||
16467553|NCT01390220|40192342|FG000|Test Dose Phase|Lost to Follow-up|2|||
16467554|NCT01390220|40192343|FG001|Test Dose Phase|Lost to Follow-up|0|||
16467555|NCT01390220|40192344|FG002|Test Dose Phase|Lost to Follow-up|0|||
16467556|NCT01390220|40192342|FG000|Test Dose Phase|Protocol Violation|8|||
16467557|NCT01390220|40192343|FG001|Test Dose Phase|Protocol Violation|0|||
16467558|NCT01390220|40192344|FG002|Test Dose Phase|Protocol Violation|0|||
16467559|NCT01390220|40192342|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
16467560|NCT01390220|40192343|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
16467561|NCT01390220|40192344|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
16467562|NCT01390220|40192342|FG000|Test Dose Phase|Study/Site closure|6|||
16467563|NCT01390220|40192343|FG001|Test Dose Phase|Study/Site closure|0|||
16467564|NCT01390220|40192344|FG002|Test Dose Phase|Study/Site closure|0|||
16467565|NCT01390220|40192342|FG000|Test Dose Phase|Caregiver no longer available|5|||
16467566|NCT01390220|40192343|FG001|Test Dose Phase|Caregiver no longer available|0|||
16467567|NCT01390220|40192344|FG002|Test Dose Phase|Caregiver no longer available|0|||
16467568|NCT01390220|40192342|FG000|Test Dose Phase|Noncompliance|2|||
16467569|NCT01390220|40192343|FG001|Test Dose Phase|Noncompliance|0|||
16467570|NCT01390220|40192344|FG002|Test Dose Phase|Noncompliance|0|||
16467571|NCT01390220|40192342|FG000|Test Dose Phase|Logistical|6|||
16467572|NCT01390220|40192343|FG001|Test Dose Phase|Logistical|0|||
16467573|NCT01390220|40192344|FG002|Test Dose Phase|Logistical|0|||
16467574|NCT01390220|40192342|FG000|Comparative Phase|Withdrawal by Subject|0|||
16467575|NCT01390220|40192343|FG001|Comparative Phase|Withdrawal by Subject|1|||
16467576|NCT01390220|40192344|FG002|Comparative Phase|Withdrawal by Subject|0|||
16467577|NCT02353143|40192345|FG000|Overall Study|Withdrawal by Subject|1|||
16467578|NCT02353143|40192346|FG001|Overall Study|Withdrawal by Subject|0|||
16467579|NCT02353143|40192347|FG002|Overall Study|Withdrawal by Subject|0|||
16467580|NCT02353143|40192348|FG003|Overall Study|Withdrawal by Subject|0|||
16467581|NCT02353143|40192349|FG004|Overall Study|Withdrawal by Subject|1|||
16467582|NCT02353143|40192350|FG005|Overall Study|Withdrawal by Subject|0|||
16467583|NCT02353143|40192351|FG006|Overall Study|Withdrawal by Subject|0|||
16467584|NCT02353143|40192352|FG007|Overall Study|Withdrawal by Subject|1|||
16467585|NCT02353143|40192353|FG008|Overall Study|Withdrawal by Subject|1|||
16467586|NCT02353143|40192345|FG000|Overall Study|Lack of Efficacy|2|||
16467587|NCT02353143|40192346|FG001|Overall Study|Lack of Efficacy|1|||
16467588|NCT02353143|40192347|FG002|Overall Study|Lack of Efficacy|2|||
16467589|NCT02353143|40192348|FG003|Overall Study|Lack of Efficacy|4|||
16467590|NCT02353143|40192349|FG004|Overall Study|Lack of Efficacy|13|||
16467591|NCT02353143|40192350|FG005|Overall Study|Lack of Efficacy|2|||
16467592|NCT02353143|40192351|FG006|Overall Study|Lack of Efficacy|2|||
16467593|NCT02353143|40192352|FG007|Overall Study|Lack of Efficacy|2|||
16467594|NCT02353143|40192353|FG008|Overall Study|Lack of Efficacy|1|||
16467595|NCT02353143|40192345|FG000|Overall Study|reason not specified|1|||
16467596|NCT02353143|40192346|FG001|Overall Study|reason not specified|2|||
16467597|NCT02353143|40192347|FG002|Overall Study|reason not specified|0|||
16467598|NCT02353143|40192348|FG003|Overall Study|reason not specified|0|||
16467599|NCT02353143|40192349|FG004|Overall Study|reason not specified|6|||
16467600|NCT02353143|40192350|FG005|Overall Study|reason not specified|1|||
16467601|NCT02353143|40192351|FG006|Overall Study|reason not specified|0|||
16467602|NCT02353143|40192352|FG007|Overall Study|reason not specified|3|||
16467603|NCT02353143|40192353|FG008|Overall Study|reason not specified|1|||
16467604|NCT02353143|40192345|FG000|Overall Study|Physician Decision|0|||
16467605|NCT02353143|40192346|FG001|Overall Study|Physician Decision|4|||
16467606|NCT02353143|40192347|FG002|Overall Study|Physician Decision|2|||
16467607|NCT02353143|40192348|FG003|Overall Study|Physician Decision|3|||
16467608|NCT02353143|40192349|FG004|Overall Study|Physician Decision|4|||
16467609|NCT02353143|40192350|FG005|Overall Study|Physician Decision|0|||
16467610|NCT02353143|40192351|FG006|Overall Study|Physician Decision|1|||
16467611|NCT02353143|40192352|FG007|Overall Study|Physician Decision|2|||
16467612|NCT02353143|40192353|FG008|Overall Study|Physician Decision|0|||
16467613|NCT02353143|40192345|FG000|Overall Study|Adverse Event|0|||
16467614|NCT02353143|40192346|FG001|Overall Study|Adverse Event|0|||
16467615|NCT02353143|40192347|FG002|Overall Study|Adverse Event|1|||
16467616|NCT02353143|40192348|FG003|Overall Study|Adverse Event|0|||
16467617|NCT02353143|40192349|FG004|Overall Study|Adverse Event|1|||
16467618|NCT02353143|40192350|FG005|Overall Study|Adverse Event|1|||
16467619|NCT02353143|40192351|FG006|Overall Study|Adverse Event|0|||
16467620|NCT02353143|40192352|FG007|Overall Study|Adverse Event|0|||
16467621|NCT02353143|40192353|FG008|Overall Study|Adverse Event|0|||
16467622|NCT02353143|40192345|FG000|Overall Study|patient receiving other treatment for AML|0|||
16467623|NCT02353143|40192346|FG001|Overall Study|patient receiving other treatment for AML|0|||
16467624|NCT02353143|40192347|FG002|Overall Study|patient receiving other treatment for AML|1|||
16467625|NCT02353143|40192348|FG003|Overall Study|patient receiving other treatment for AML|0|||
16467626|NCT02353143|40192349|FG004|Overall Study|patient receiving other treatment for AML|0|||
16467627|NCT02353143|40192350|FG005|Overall Study|patient receiving other treatment for AML|0|||
16467628|NCT02353143|40192351|FG006|Overall Study|patient receiving other treatment for AML|0|||
16467629|NCT02353143|40192352|FG007|Overall Study|patient receiving other treatment for AML|0|||
16467630|NCT02353143|40192353|FG008|Overall Study|patient receiving other treatment for AML|0|||
16467631|NCT02353143|40192345|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
16467632|NCT02353143|40192346|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
16467633|NCT02353143|40192347|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
16467634|NCT02353143|40192348|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
16467635|NCT02353143|40192349|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
16467636|NCT02353143|40192350|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
16467637|NCT02353143|40192351|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
16467638|NCT02353143|40192352|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
16467639|NCT02353143|40192353|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
16467640|NCT03194490|40192354|FG000|Overall Study|Lost to Follow-up|1|||
16467641|NCT03194490|40192355|FG001|Overall Study|Lost to Follow-up|3|||
16467642|NCT03194490|40192354|FG000|Overall Study|participant developed specific neck pain|1|||
16467643|NCT03194490|40192355|FG001|Overall Study|participant developed specific neck pain|0|||
16467644|NCT00591578|40192358|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
16467645|NCT00591578|40192359|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
16467646|NCT00591578|40192360|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
16467647|NCT00591578|40192358|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
16467648|NCT00591578|40192359|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
16467649|NCT00591578|40192360|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
16467650|NCT00591578|40192358|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
16467651|NCT00591578|40192359|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
16467652|NCT00591578|40192360|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
16467653|NCT00591578|40192358|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
16467654|NCT00591578|40192359|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
16467655|NCT00591578|40192360|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
16467656|NCT00591578|40192358|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
16467657|NCT00591578|40192359|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
16467658|NCT00591578|40192360|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
16171262|NCT00868790|39103232|FG008|Period 3|Protocol Violation|0|||
16171263|NCT00868790|39103233|FG009|Period 3|Protocol Violation|0|||
16467659|NCT00591578|40192358|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
16467660|NCT00591578|40192359|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
16467661|NCT00591578|40192360|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
16467662|NCT00591578|40192358|FG000|Double-Blind Treatment Phase|Other|4|||
16467663|NCT00591578|40192359|FG001|Double-Blind Treatment Phase|Other|9|||
16467664|NCT00591578|40192360|FG002|Double-Blind Treatment Phase|Other|4|||
16467665|NCT00591578|40192358|FG000|Open-Label Extension Phase|Adverse Event|3|||
16467666|NCT00591578|40192359|FG001|Open-Label Extension Phase|Adverse Event|5|||
16467667|NCT00591578|40192360|FG002|Open-Label Extension Phase|Adverse Event|0|||
16467668|NCT00591578|40192358|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
16467669|NCT00591578|40192359|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
16467670|NCT00591578|40192360|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
16467671|NCT00591578|40192358|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
16467672|NCT00591578|40192359|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
16467673|NCT00591578|40192360|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
16467674|NCT00591578|40192358|FG000|Open-Label Extension Phase|Other|1|||
16467675|NCT00591578|40192359|FG001|Open-Label Extension Phase|Other|0|||
16467676|NCT00591578|40192360|FG002|Open-Label Extension Phase|Other|0|||
16467677|NCT00504582|40192365|FG000|Overall Study|Lost to Follow-up|1|||
16467678|NCT00504582|40192366|FG001|Overall Study|Lost to Follow-up|0|||
16171264|NCT00868790|39103234|FG010|Period 3|Protocol Violation|1|||
16171265|NCT00868790|39103235|FG011|Period 3|Protocol Violation|0|||
16171266|NCT00868790|39103236|FG012|Period 3|Protocol Violation|0|||
16171267|NCT00868790|39103237|FG013|Period 3|Protocol Violation|0|||
16171268|NCT00868790|39103224|FG000|Period 3|Study Terminated by Sponsor|0|||
16171269|NCT00868790|39103225|FG001|Period 3|Study Terminated by Sponsor|0|||
16171270|NCT00868790|39103226|FG002|Period 3|Study Terminated by Sponsor|0|||
16171271|NCT00868790|39103227|FG003|Period 3|Study Terminated by Sponsor|1|||
16171272|NCT00868790|39103228|FG004|Period 3|Study Terminated by Sponsor|0|||
16171273|NCT00868790|39103229|FG005|Period 3|Study Terminated by Sponsor|0|||
16171274|NCT00868790|39103230|FG006|Period 3|Study Terminated by Sponsor|0|||
16171275|NCT00868790|39103231|FG007|Period 3|Study Terminated by Sponsor|0|||
16171276|NCT00868790|39103232|FG008|Period 3|Study Terminated by Sponsor|0|||
16171277|NCT00868790|39103233|FG009|Period 3|Study Terminated by Sponsor|0|||
16171278|NCT00868790|39103234|FG010|Period 3|Study Terminated by Sponsor|0|||
16171279|NCT00868790|39103235|FG011|Period 3|Study Terminated by Sponsor|0|||
16171280|NCT00868790|39103236|FG012|Period 3|Study Terminated by Sponsor|0|||
16171281|NCT00868790|39103237|FG013|Period 3|Study Terminated by Sponsor|0|||
16171282|NCT00868790|39103224|FG000|Period 4|Adverse Event|0|||
16171283|NCT00868790|39103225|FG001|Period 4|Adverse Event|0|||
16171284|NCT00868790|39103226|FG002|Period 4|Adverse Event|0|||
16171285|NCT00868790|39103227|FG003|Period 4|Adverse Event|0|||
16171286|NCT00868790|39103228|FG004|Period 4|Adverse Event|0|||
16171287|NCT00868790|39103229|FG005|Period 4|Adverse Event|0|||
16171288|NCT00868790|39103230|FG006|Period 4|Adverse Event|0|||
16171289|NCT00868790|39103231|FG007|Period 4|Adverse Event|1|||
16171290|NCT00868790|39103232|FG008|Period 4|Adverse Event|0|||
16171291|NCT00868790|39103233|FG009|Period 4|Adverse Event|0|||
16171292|NCT00868790|39103234|FG010|Period 4|Adverse Event|1|||
16171293|NCT00868790|39103235|FG011|Period 4|Adverse Event|0|||
16171294|NCT00868790|39103236|FG012|Period 4|Adverse Event|1|||
16171295|NCT00868790|39103237|FG013|Period 4|Adverse Event|0|||
16171296|NCT00868790|39103224|FG000|Period 4|Lost to Follow-up|0|||
16171297|NCT00868790|39103225|FG001|Period 4|Lost to Follow-up|0|||
16171298|NCT00868790|39103226|FG002|Period 4|Lost to Follow-up|0|||
16171299|NCT00868790|39103227|FG003|Period 4|Lost to Follow-up|0|||
16467679|NCT00504582|40192367|FG002|Overall Study|Lost to Follow-up|0|||
16467680|NCT01309893|40192370|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
16171300|NCT00868790|39103228|FG004|Period 4|Lost to Follow-up|0|||
16467681|NCT01309893|40192371|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
16467682|NCT01309893|40192370|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
16171301|NCT00868790|39103229|FG005|Period 4|Lost to Follow-up|0|||
16171302|NCT00868790|39103230|FG006|Period 4|Lost to Follow-up|0|||
16171303|NCT00868790|39103231|FG007|Period 4|Lost to Follow-up|1|||
16171304|NCT00868790|39103232|FG008|Period 4|Lost to Follow-up|0|||
16171305|NCT00868790|39103233|FG009|Period 4|Lost to Follow-up|0|||
16171306|NCT00868790|39103234|FG010|Period 4|Lost to Follow-up|0|||
16171307|NCT00868790|39103235|FG011|Period 4|Lost to Follow-up|0|||
16467683|NCT01309893|40192371|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
16467684|NCT00322153|40192372|FG000|Overall Study|Adverse Event|21|||
16467685|NCT00322153|40192373|FG001|Overall Study|Adverse Event|34|||
16467686|NCT00322153|40192372|FG000|Overall Study|Protocol Violation|6|||
16171308|NCT00868790|39103236|FG012|Period 4|Lost to Follow-up|0|||
16171309|NCT00868790|39103237|FG013|Period 4|Lost to Follow-up|0|||
16171310|NCT00868790|39103224|FG000|Period 4|Study Terminated by Sponsor|2|||
16171311|NCT00868790|39103225|FG001|Period 4|Study Terminated by Sponsor|0|||
16171312|NCT00868790|39103226|FG002|Period 4|Study Terminated by Sponsor|0|||
16171313|NCT00868790|39103227|FG003|Period 4|Study Terminated by Sponsor|0|||
16171314|NCT00868790|39103228|FG004|Period 4|Study Terminated by Sponsor|0|||
16467687|NCT00322153|40192373|FG001|Overall Study|Protocol Violation|14|||
16467688|NCT00322153|40192372|FG000|Overall Study|Withdrawal by Subject|18|||
16467689|NCT00322153|40192373|FG001|Overall Study|Withdrawal by Subject|10|||
16467690|NCT00322153|40192372|FG000|Overall Study|Lack of Efficacy|8|||
16467691|NCT00322153|40192373|FG001|Overall Study|Lack of Efficacy|3|||
16467692|NCT00322153|40192372|FG000|Overall Study|Lost to Follow-up|5|||
16467693|NCT00322153|40192373|FG001|Overall Study|Lost to Follow-up|4|||
16467694|NCT00322153|40192372|FG000|Overall Study|Withdrawn for other reasons|5|||
16467695|NCT00322153|40192373|FG001|Overall Study|Withdrawn for other reasons|4|||
16467696|NCT02889562|40192375|FG000|Overall Study|Physician Decision|0|||
16467697|NCT02889562|40192376|FG001|Overall Study|Physician Decision|1|||
16467698|NCT02889562|40192375|FG000|Overall Study|Withdrawal by Subject|0|||
16467699|NCT02889562|40192376|FG001|Overall Study|Withdrawal by Subject|1|||
16467700|NCT01323920|40192377|FG000|Overall Study|Death|5|||
16467701|NCT01323920|40192377|FG000|Overall Study|Withdrawal by Subject|1|||
16467702|NCT00378079|40192378|FG000|Overall Study|Lost to Follow-up|6|||
16467703|NCT00378079|40192379|FG001|Overall Study|Lost to Follow-up|1|||
16467704|NCT00378079|40192380|FG002|Overall Study|Lost to Follow-up|0|||
16467705|NCT03361176|40192381|FG000|Overall Study|Lost to Follow-up|1|||
16467706|NCT03361176|40192382|FG001|Overall Study|Lost to Follow-up|2|||
16467707|NCT03361176|40192381|FG000|Overall Study|Adverse Event|0|||
16467708|NCT03361176|40192382|FG001|Overall Study|Adverse Event|2|||
16467709|NCT03361176|40192381|FG000|Overall Study|Withdrawal by Subject|0|||
16467710|NCT03361176|40192382|FG001|Overall Study|Withdrawal by Subject|1|||
16467711|NCT01275339|40192383|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
16467712|NCT01275339|40192384|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
16467713|NCT01275339|40192385|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
16467714|NCT01275339|40192386|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
16467715|NCT01275339|40192383|FG000|Overall Study|Withdrawal by Subject|0|||
16467716|NCT01275339|40192384|FG001|Overall Study|Withdrawal by Subject|0|||
16467717|NCT01275339|40192385|FG002|Overall Study|Withdrawal by Subject|1|||
16467718|NCT01275339|40192386|FG003|Overall Study|Withdrawal by Subject|0|||
16171315|NCT00868790|39103229|FG005|Period 4|Study Terminated by Sponsor|0|||
16171316|NCT00868790|39103230|FG006|Period 4|Study Terminated by Sponsor|0|||
16171317|NCT00868790|39103231|FG007|Period 4|Study Terminated by Sponsor|1|||
16171318|NCT00868790|39103232|FG008|Period 4|Study Terminated by Sponsor|2|||
16171319|NCT00868790|39103233|FG009|Period 4|Study Terminated by Sponsor|0|||
16171320|NCT00868790|39103234|FG010|Period 4|Study Terminated by Sponsor|2|||
16171321|NCT00868790|39103235|FG011|Period 4|Study Terminated by Sponsor|1|||
16171322|NCT00868790|39103236|FG012|Period 4|Study Terminated by Sponsor|0|||
16171323|NCT00868790|39103237|FG013|Period 4|Study Terminated by Sponsor|1|||
16171324|NCT00868790|39103224|FG000|Period 4|Abnormal ALT/AST|0|||
16171325|NCT00868790|39103225|FG001|Period 4|Abnormal ALT/AST|0|||
16171326|NCT00868790|39103226|FG002|Period 4|Abnormal ALT/AST|1|||
16171327|NCT00868790|39103227|FG003|Period 4|Abnormal ALT/AST|0|||
16171328|NCT00868790|39103228|FG004|Period 4|Abnormal ALT/AST|0|||
16171329|NCT00868790|39103229|FG005|Period 4|Abnormal ALT/AST|0|||
16171330|NCT00868790|39103230|FG006|Period 4|Abnormal ALT/AST|0|||
16171331|NCT00868790|39103231|FG007|Period 4|Abnormal ALT/AST|0|||
16171332|NCT00868790|39103232|FG008|Period 4|Abnormal ALT/AST|0|||
16171333|NCT00868790|39103233|FG009|Period 4|Abnormal ALT/AST|0|||
16171334|NCT00868790|39103234|FG010|Period 4|Abnormal ALT/AST|0|||
16171335|NCT00868790|39103235|FG011|Period 4|Abnormal ALT/AST|0|||
16171336|NCT00868790|39103236|FG012|Period 4|Abnormal ALT/AST|0|||
16171337|NCT00868790|39103237|FG013|Period 4|Abnormal ALT/AST|0|||
16171338|NCT00868790|39103224|FG000|Post-study|Withdrawal by Subject|0|||
16171339|NCT00868790|39103225|FG001|Post-study|Withdrawal by Subject|0|||
16171340|NCT00868790|39103226|FG002|Post-study|Withdrawal by Subject|0|||
16171341|NCT00868790|39103227|FG003|Post-study|Withdrawal by Subject|0|||
16171342|NCT00868790|39103228|FG004|Post-study|Withdrawal by Subject|1|||
16171343|NCT00868790|39103229|FG005|Post-study|Withdrawal by Subject|0|||
16171344|NCT00868790|39103230|FG006|Post-study|Withdrawal by Subject|0|||
16171345|NCT00868790|39103231|FG007|Post-study|Withdrawal by Subject|0|||
16171346|NCT00868790|39103232|FG008|Post-study|Withdrawal by Subject|0|||
16171347|NCT00868790|39103233|FG009|Post-study|Withdrawal by Subject|0|||
16171348|NCT00868790|39103234|FG010|Post-study|Withdrawal by Subject|0|||
16171349|NCT00868790|39103235|FG011|Post-study|Withdrawal by Subject|0|||
16171350|NCT00868790|39103236|FG012|Post-study|Withdrawal by Subject|0|||
16467719|NCT02414139|40192388|FG000|Treatment Period|Adverse Event|11|||
16467720|NCT02414139|40192389|FG001|Treatment Period|Adverse Event|6|||
16467721|NCT02414139|40192390|FG002|Treatment Period|Adverse Event|8|||
16467722|NCT02414139|40192391|FG003|Treatment Period|Adverse Event|5|||
16171351|NCT00868790|39103237|FG013|Post-study|Withdrawal by Subject|0|||
16171352|NCT00868790|39103224|FG000|Post-study|Excluded Medication|0|||
16171353|NCT00868790|39103225|FG001|Post-study|Excluded Medication|0|||
16171354|NCT00868790|39103226|FG002|Post-study|Excluded Medication|0|||
16467723|NCT02414139|40192392|FG004|Treatment Period|Adverse Event|14|||
16467724|NCT02414139|40192393|FG005|Treatment Period|Adverse Event|3|||
16467725|NCT02414139|40192394|FG006|Treatment Period|Adverse Event|6|||
16467726|NCT02414139|40192395|FG007|Treatment Period|Adverse Event|1|||
16467727|NCT02414139|40192396|FG008|Treatment Period|Adverse Event|6|||
16467728|NCT02414139|40192397|FG009|Treatment Period|Adverse Event|8|||
16467729|NCT02414139|40192388|FG000|Treatment Period|Death|0|||
16467730|NCT02414139|40192389|FG001|Treatment Period|Death|0|||
16467731|NCT02414139|40192390|FG002|Treatment Period|Death|1|||
16467732|NCT02414139|40192391|FG003|Treatment Period|Death|1|||
16467733|NCT02414139|40192392|FG004|Treatment Period|Death|0|||
16467734|NCT02414139|40192393|FG005|Treatment Period|Death|0|||
16467735|NCT02414139|40192394|FG006|Treatment Period|Death|0|||
16467736|NCT02414139|40192395|FG007|Treatment Period|Death|0|||
16467737|NCT02414139|40192396|FG008|Treatment Period|Death|0|||
16467738|NCT02414139|40192397|FG009|Treatment Period|Death|1|||
16467739|NCT02414139|40192388|FG000|Treatment Period|Physician Decision|5|||
16467740|NCT02414139|40192389|FG001|Treatment Period|Physician Decision|4|||
16467741|NCT02414139|40192390|FG002|Treatment Period|Physician Decision|6|||
16467742|NCT02414139|40192391|FG003|Treatment Period|Physician Decision|1|||
16467743|NCT02414139|40192392|FG004|Treatment Period|Physician Decision|4|||
16467744|NCT02414139|40192393|FG005|Treatment Period|Physician Decision|0|||
16467745|NCT02414139|40192394|FG006|Treatment Period|Physician Decision|2|||
16467746|NCT02414139|40192395|FG007|Treatment Period|Physician Decision|0|||
16467747|NCT02414139|40192396|FG008|Treatment Period|Physician Decision|1|||
16467748|NCT02414139|40192397|FG009|Treatment Period|Physician Decision|4|||
16467749|NCT02414139|40192388|FG000|Treatment Period|Progressive disease|48|||
16467750|NCT02414139|40192389|FG001|Treatment Period|Progressive disease|31|||
16467751|NCT02414139|40192390|FG002|Treatment Period|Progressive disease|37|||
16467752|NCT02414139|40192391|FG003|Treatment Period|Progressive disease|21|||
16467753|NCT02414139|40192392|FG004|Treatment Period|Progressive disease|43|||
16467754|NCT02414139|40192393|FG005|Treatment Period|Progressive disease|12|||
16467755|NCT02414139|40192394|FG006|Treatment Period|Progressive disease|16|||
16467756|NCT02414139|40192395|FG007|Treatment Period|Progressive disease|2|||
16467757|NCT02414139|40192396|FG008|Treatment Period|Progressive disease|20|||
16467758|NCT02414139|40192397|FG009|Treatment Period|Progressive disease|14|||
16467759|NCT02414139|40192388|FG000|Treatment Period|Protocol deviation|0|||
16467760|NCT02414139|40192389|FG001|Treatment Period|Protocol deviation|0|||
16467761|NCT02414139|40192390|FG002|Treatment Period|Protocol deviation|1|||
16467762|NCT02414139|40192391|FG003|Treatment Period|Protocol deviation|0|||
16467763|NCT02414139|40192392|FG004|Treatment Period|Protocol deviation|0|||
16467764|NCT02414139|40192393|FG005|Treatment Period|Protocol deviation|0|||
16467765|NCT02414139|40192394|FG006|Treatment Period|Protocol deviation|0|||
16467766|NCT02414139|40192395|FG007|Treatment Period|Protocol deviation|0|||
16467767|NCT02414139|40192396|FG008|Treatment Period|Protocol deviation|0|||
16467768|NCT02414139|40192397|FG009|Treatment Period|Protocol deviation|0|||
16467769|NCT02414139|40192388|FG000|Treatment Period|Subject/Guardian decision|5|||
16467770|NCT02414139|40192389|FG001|Treatment Period|Subject/Guardian decision|1|||
16467771|NCT02414139|40192390|FG002|Treatment Period|Subject/Guardian decision|1|||
16467772|NCT02414139|40192391|FG003|Treatment Period|Subject/Guardian decision|2|||
16467773|NCT02414139|40192392|FG004|Treatment Period|Subject/Guardian decision|5|||
16467774|NCT02414139|40192393|FG005|Treatment Period|Subject/Guardian decision|0|||
16467775|NCT02414139|40192394|FG006|Treatment Period|Subject/Guardian decision|2|||
16467776|NCT02414139|40192395|FG007|Treatment Period|Subject/Guardian decision|0|||
16467777|NCT02414139|40192396|FG008|Treatment Period|Subject/Guardian decision|1|||
16467778|NCT02414139|40192397|FG009|Treatment Period|Subject/Guardian decision|1|||
16467779|NCT02414139|40192388|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
16467780|NCT02414139|40192389|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
16467781|NCT02414139|40192390|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
16467782|NCT02414139|40192391|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
16467783|NCT02414139|40192392|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
16467784|NCT02414139|40192393|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
16467785|NCT02414139|40192394|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
16467786|NCT02414139|40192395|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
16467787|NCT02414139|40192396|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
16467788|NCT02414139|40192397|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
16467789|NCT02414139|40192388|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
16171355|NCT00868790|39103227|FG003|Post-study|Excluded Medication|0|||
16171356|NCT00868790|39103228|FG004|Post-study|Excluded Medication|0|||
16467790|NCT02414139|40192389|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
16467791|NCT02414139|40192390|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
16467792|NCT02414139|40192391|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
16467793|NCT02414139|40192392|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
16467794|NCT02414139|40192393|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
16467795|NCT02414139|40192394|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
16467796|NCT02414139|40192395|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
16467797|NCT02414139|40192396|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
16467798|NCT02414139|40192397|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
16467799|NCT02414139|40192388|FG000|Post-treatment Efficacy Follow-up|Death|0|||
16467800|NCT02414139|40192389|FG001|Post-treatment Efficacy Follow-up|Death|1|||
16467801|NCT02414139|40192390|FG002|Post-treatment Efficacy Follow-up|Death|0|||
16467802|NCT02414139|40192391|FG003|Post-treatment Efficacy Follow-up|Death|0|||
16467803|NCT02414139|40192392|FG004|Post-treatment Efficacy Follow-up|Death|1|||
16467804|NCT02414139|40192393|FG005|Post-treatment Efficacy Follow-up|Death|0|||
16467805|NCT02414139|40192394|FG006|Post-treatment Efficacy Follow-up|Death|0|||
16467806|NCT02414139|40192395|FG007|Post-treatment Efficacy Follow-up|Death|0|||
16467807|NCT02414139|40192396|FG008|Post-treatment Efficacy Follow-up|Death|0|||
16467808|NCT02414139|40192397|FG009|Post-treatment Efficacy Follow-up|Death|1|||
16467809|NCT02414139|40192388|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
16467810|NCT02414139|40192389|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
16467811|NCT02414139|40192390|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
16467812|NCT02414139|40192391|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
16467813|NCT02414139|40192392|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
16467814|NCT02414139|40192393|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
16467815|NCT02414139|40192394|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
16467816|NCT02414139|40192395|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
16467817|NCT02414139|40192396|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
16467818|NCT02414139|40192397|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
16467819|NCT02414139|40192388|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
16467820|NCT02414139|40192389|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
16467821|NCT02414139|40192390|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
16467822|NCT02414139|40192391|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
16467823|NCT02414139|40192392|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
16467824|NCT02414139|40192393|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
16467825|NCT02414139|40192394|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
16467826|NCT02414139|40192395|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
16467827|NCT02414139|40192396|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
16467828|NCT02414139|40192397|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
16467829|NCT02414139|40192388|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
16467830|NCT02414139|40192389|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
16467831|NCT02414139|40192390|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
16467832|NCT02414139|40192391|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
16467833|NCT02414139|40192392|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
16467834|NCT02414139|40192393|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
16467835|NCT02414139|40192394|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
16467836|NCT02414139|40192395|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
16467837|NCT02414139|40192396|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
16467838|NCT02414139|40192397|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
16467839|NCT02414139|40192388|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
16467840|NCT02414139|40192389|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
16467841|NCT02414139|40192390|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
16467842|NCT02414139|40192391|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
16467843|NCT02414139|40192392|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
16467844|NCT02414139|40192393|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
16467845|NCT02414139|40192394|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
16467846|NCT02414139|40192395|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
16467847|NCT02414139|40192396|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
16467848|NCT02414139|40192397|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
16467849|NCT02414139|40192388|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
16467850|NCT02414139|40192389|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
16467851|NCT02414139|40192390|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
16467852|NCT02414139|40192391|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
16467853|NCT02414139|40192392|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
16467854|NCT02414139|40192393|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
16467855|NCT02414139|40192394|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
16467856|NCT02414139|40192395|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
16467857|NCT02414139|40192396|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
16467858|NCT02414139|40192397|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
16467859|NCT00879879|40192398|FG000|Overall Study|Death|1|||
16467860|NCT00879879|40192398|FG000|Overall Study|Withdrawal by Subject|1|||
16171357|NCT00868790|39103229|FG005|Post-study|Excluded Medication|0|||
16467861|NCT00879879|40192398|FG000|Overall Study|Physician Decision|1|||
16467862|NCT02108262|40192399|FG000|Overall Study|Non-compliance|0|||
16467863|NCT02108262|40192400|FG001|Overall Study|Non-compliance|2|||
16467864|NCT02108262|40192401|FG002|Overall Study|Non-compliance|1|||
16467865|NCT02108262|40192402|FG003|Overall Study|Non-compliance|1|||
16467866|NCT02108262|40192399|FG000|Overall Study|Randomized by error/screen failure|0|||
16467867|NCT02108262|40192400|FG001|Overall Study|Randomized by error/screen failure|0|||
16467868|NCT02108262|40192401|FG002|Overall Study|Randomized by error/screen failure|1|||
16467869|NCT02108262|40192402|FG003|Overall Study|Randomized by error/screen failure|0|||
16467870|NCT02108262|40192399|FG000|Overall Study|Distance to center|0|||
16467871|NCT02108262|40192400|FG001|Overall Study|Distance to center|1|||
16467872|NCT02108262|40192401|FG002|Overall Study|Distance to center|1|||
16467873|NCT02108262|40192402|FG003|Overall Study|Distance to center|0|||
16467874|NCT02108262|40192399|FG000|Overall Study|Adverse Event|0|||
16467875|NCT02108262|40192400|FG001|Overall Study|Adverse Event|11|||
16467876|NCT02108262|40192401|FG002|Overall Study|Adverse Event|6|||
16171358|NCT00868790|39103230|FG006|Post-study|Excluded Medication|0|||
16171359|NCT00868790|39103231|FG007|Post-study|Excluded Medication|2|||
16171360|NCT00868790|39103232|FG008|Post-study|Excluded Medication|0|||
16171361|NCT00868790|39103233|FG009|Post-study|Excluded Medication|1|||
16269330|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
16467877|NCT02108262|40192402|FG003|Overall Study|Adverse Event|12|||
16467878|NCT02108262|40192399|FG000|Overall Study|Death|0|||
16467879|NCT02108262|40192400|FG001|Overall Study|Death|2|||
16467880|NCT02108262|40192401|FG002|Overall Study|Death|2|||
16467881|NCT02108262|40192402|FG003|Overall Study|Death|1|||
16467882|NCT02108262|40192399|FG000|Overall Study|Lost to Follow-up|0|||
16467883|NCT02108262|40192400|FG001|Overall Study|Lost to Follow-up|0|||
16467884|NCT02108262|40192401|FG002|Overall Study|Lost to Follow-up|1|||
16467885|NCT02108262|40192402|FG003|Overall Study|Lost to Follow-up|0|||
16467886|NCT02108262|40192399|FG000|Overall Study|Physician Decision|0|||
16467887|NCT02108262|40192400|FG001|Overall Study|Physician Decision|0|||
16467888|NCT02108262|40192401|FG002|Overall Study|Physician Decision|2|||
16467889|NCT02108262|40192402|FG003|Overall Study|Physician Decision|0|||
16467890|NCT02108262|40192399|FG000|Overall Study|Withdrawal by Subject|0|||
16467891|NCT02108262|40192400|FG001|Overall Study|Withdrawal by Subject|7|||
16467892|NCT02108262|40192401|FG002|Overall Study|Withdrawal by Subject|3|||
16467893|NCT02108262|40192402|FG003|Overall Study|Withdrawal by Subject|4|||
16467894|NCT02108262|40192399|FG000|Overall Study|Due to key hepatic values|0|||
16467895|NCT02108262|40192400|FG001|Overall Study|Due to key hepatic values|1|||
16467896|NCT02108262|40192401|FG002|Overall Study|Due to key hepatic values|0|||
16467897|NCT02108262|40192402|FG003|Overall Study|Due to key hepatic values|0|||
16467898|NCT02108262|40192399|FG000|Overall Study|Unable to contact patient|0|||
16467899|NCT02108262|40192400|FG001|Overall Study|Unable to contact patient|3|||
16467900|NCT02108262|40192401|FG002|Overall Study|Unable to contact patient|1|||
16467901|NCT02108262|40192402|FG003|Overall Study|Unable to contact patient|2|||
16467902|NCT02108262|40192399|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
16467903|NCT02108262|40192400|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
16467904|NCT02108262|40192401|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
16467905|NCT02108262|40192402|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
16467906|NCT02108262|40192399|FG000|Overall Study|Patient did not want another infusion|0|||
16467907|NCT02108262|40192400|FG001|Overall Study|Patient did not want another infusion|3|||
16467908|NCT02108262|40192401|FG002|Overall Study|Patient did not want another infusion|3|||
16467909|NCT02108262|40192402|FG003|Overall Study|Patient did not want another infusion|2|||
16467910|NCT02108262|40192399|FG000|Overall Study|Vacation|0|||
16467911|NCT02108262|40192400|FG001|Overall Study|Vacation|1|||
16467912|NCT02108262|40192401|FG002|Overall Study|Vacation|0|||
16467913|NCT02108262|40192402|FG003|Overall Study|Vacation|0|||
16467914|NCT02108262|40192399|FG000|Overall Study|Patient decision|0|||
16467915|NCT02108262|40192400|FG001|Overall Study|Patient decision|7|||
16467916|NCT02108262|40192401|FG002|Overall Study|Patient decision|9|||
16467917|NCT02108262|40192402|FG003|Overall Study|Patient decision|14|||
16467918|NCT02108262|40192399|FG000|Overall Study|Missed IV due to pharmacy error|0|||
16467919|NCT02108262|40192400|FG001|Overall Study|Missed IV due to pharmacy error|0|||
16467920|NCT02108262|40192401|FG002|Overall Study|Missed IV due to pharmacy error|1|||
16467921|NCT02108262|40192402|FG003|Overall Study|Missed IV due to pharmacy error|0|||
16467922|NCT03490981|40192403|FG000|Overall Study|Lost to Follow-up|1|||
16467923|NCT03490981|40192404|FG001|Overall Study|Lost to Follow-up|2|||
16467924|NCT00910247|40192405|FG000|Overall Study|Adverse Event|15|||
16467925|NCT00910247|40192405|FG000|Overall Study|Death|2|||
16171362|NCT00868790|39103234|FG010|Post-study|Excluded Medication|0|||
16467926|NCT00910247|40192405|FG000|Overall Study|Lost to Follow-up|10|||
16467927|NCT00910247|40192405|FG000|Overall Study|Physician Decision|3|||
16467928|NCT00910247|40192405|FG000|Overall Study|Protocol Violation|10|||
16467929|NCT00910247|40192405|FG000|Overall Study|Withdrawal by Subject|25|||
16467930|NCT00910247|40192405|FG000|Overall Study|Not collected|4|||
16467931|NCT03560739|40192406|FG000|Overall Study|Adverse Event|0|||
16467932|NCT03560739|40192407|FG001|Overall Study|Adverse Event|1|||
16467933|NCT03560739|40192408|FG002|Overall Study|Adverse Event|0|||
16467934|NCT03560739|40192409|FG003|Overall Study|Adverse Event|0|||
16467935|NCT00920907|40192410|FG000|Induction Period|Adverse Event|0|||
16467936|NCT00920907|40192411|FG001|Induction Period|Adverse Event|2|||
16467937|NCT00920907|40192410|FG000|Induction Period|Death|1|||
16467938|NCT00920907|40192411|FG001|Induction Period|Death|1|||
16467939|NCT00920907|40192410|FG000|Induction Period|Disease Progression|12|||
16467940|NCT00920907|40192411|FG001|Induction Period|Disease Progression|11|||
16467941|NCT00920907|40192410|FG000|Induction Period|Study Drug Toxicity|8|||
16467942|NCT00920907|40192411|FG001|Induction Period|Study Drug Toxicity|6|||
16467943|NCT00920907|40192410|FG000|Induction Period|No longer meets study criteria|0|||
16467944|NCT00920907|40192411|FG001|Induction Period|No longer meets study criteria|1|||
16467945|NCT00920907|40192410|FG000|Induction Period|Withdrawal by Subject|1|||
16467946|NCT00920907|40192411|FG001|Induction Period|Withdrawal by Subject|1|||
16467947|NCT00920907|40192410|FG000|Maintenance Period|Disease Progression|3|||
16467948|NCT00920907|40192411|FG001|Maintenance Period|Disease Progression|7|||
16467949|NCT00920907|40192410|FG000|Maintenance Period|Administrative (study closure)|7|||
16467950|NCT00920907|40192411|FG001|Maintenance Period|Administrative (study closure)|2|||
16171363|NCT00868790|39103235|FG011|Post-study|Excluded Medication|0|||
16171364|NCT00868790|39103236|FG012|Post-study|Excluded Medication|0|||
16171365|NCT00868790|39103237|FG013|Post-study|Excluded Medication|0|||
16171366|NCT00424398|39103244|FG000|Overall Study|Withdrawal by Subject|2|||
16171367|NCT00424398|39103245|FG001|Overall Study|Withdrawal by Subject|1|||
16171368|NCT00424398|39103246|FG002|Overall Study|Withdrawal by Subject|0|||
16171369|NCT00424398|39103244|FG000|Overall Study|Subject met exclusion criteria|1|||
16171370|NCT00424398|39103245|FG001|Overall Study|Subject met exclusion criteria|0|||
16171371|NCT00424398|39103246|FG002|Overall Study|Subject met exclusion criteria|0|||
16171372|NCT03772327|39103247|FG000|Overall Study|Lost to Follow-up|3|||
16171373|NCT03772327|39103248|FG001|Overall Study|Lost to Follow-up|4|||
16171374|NCT03772327|39103247|FG000|Overall Study|Withdrawal by Subject|2|||
16467951|NCT00920907|40192410|FG000|Maintenance Period|Study Drug Toxicity|0|||
16467952|NCT00920907|40192411|FG001|Maintenance Period|Study Drug Toxicity|2|||
16467953|NCT00920907|40192410|FG000|Maintenance Period|Death|1|||
16467954|NCT00920907|40192411|FG001|Maintenance Period|Death|1|||
16467955|NCT00920907|40192410|FG000|Maintenance Period|Withdrawal by Subject|1|||
16467956|NCT00920907|40192411|FG001|Maintenance Period|Withdrawal by Subject|0|||
16467957|NCT00920907|40192410|FG000|Maintenance Period|Adverse Event|0|||
16467958|NCT00920907|40192411|FG001|Maintenance Period|Adverse Event|1|||
16467959|NCT00366340|40192412|FG000|Infant Series|Protocol Violation|3|||
16467960|NCT00366340|40192413|FG001|Infant Series|Protocol Violation|4|||
16467961|NCT00366340|40192412|FG000|Infant Series|Withdrawal by Subject|3|||
16171375|NCT03772327|39103248|FG001|Overall Study|Withdrawal by Subject|3|||
16171376|NCT00483327|39103249|FG000|Overall Study|Adverse Event|1|||
16171377|NCT00483327|39103249|FG000|Overall Study|Withdrawal by Subject|3|||
16171378|NCT00483327|39103249|FG000|Overall Study|Lost to Follow-up|4|||
16171379|NCT00483327|39103249|FG000|Overall Study|Patient Non Compliance|2|||
16171380|NCT02357420|39103252|FG000|Overall Study|Adverse Event|3|||
16171381|NCT02357420|39103253|FG001|Overall Study|Adverse Event|3|||
16171382|NCT02357420|39103254|FG002|Overall Study|Adverse Event|8|||
16171383|NCT02357420|39103255|FG003|Overall Study|Adverse Event|9|||
16171384|NCT02357420|39103252|FG000|Overall Study|Investigator Decision|1|||
16171385|NCT02357420|39103253|FG001|Overall Study|Investigator Decision|0|||
16171386|NCT02357420|39103254|FG002|Overall Study|Investigator Decision|0|||
16467962|NCT00366340|40192413|FG001|Infant Series|Withdrawal by Subject|3|||
16467963|NCT00366340|40192412|FG000|Infant Series|Adverse Event|0|||
16467964|NCT00366340|40192413|FG001|Infant Series|Adverse Event|2|||
16467965|NCT00366340|40192412|FG000|Infant Series|Lost to Follow-up|1|||
16467966|NCT00366340|40192413|FG001|Infant Series|Lost to Follow-up|1|||
16467967|NCT00366340|40192412|FG000|Infant Series|Failure to return|1|||
16467968|NCT00366340|40192413|FG001|Infant Series|Failure to return|0|||
16467969|NCT00366340|40192412|FG000|After the Infant Series|Parent/legal guardian request|1|||
16467970|NCT00366340|40192413|FG001|After the Infant Series|Parent/legal guardian request|1|||
16467971|NCT00366340|40192412|FG000|After the Infant Series|Failed to return|0|||
16467972|NCT00366340|40192413|FG001|After the Infant Series|Failed to return|1|||
16467973|NCT00366340|40192412|FG000|After the Infant Series|Protocol Violation|2|||
16467974|NCT00366340|40192413|FG001|After the Infant Series|Protocol Violation|2|||
16467975|NCT00366340|40192412|FG000|After the Infant Series|Adverse Event|0|||
16467976|NCT00366340|40192413|FG001|After the Infant Series|Adverse Event|1|||
16467977|NCT00366340|40192412|FG000|After the Infant Series|Lost to Follow-up|0|||
16171387|NCT02357420|39103255|FG003|Overall Study|Investigator Decision|0|||
16467978|NCT00366340|40192413|FG001|After the Infant Series|Lost to Follow-up|1|||
16467979|NCT00366340|40192412|FG000|Toddler Dose|Failed to return|1|||
16467980|NCT00366340|40192413|FG001|Toddler Dose|Failed to return|0|||
16467981|NCT00366340|40192412|FG000|Toddler Dose|Parent/legal guardian request|0|||
16467982|NCT00366340|40192413|FG001|Toddler Dose|Parent/legal guardian request|1|||
16467983|NCT03631355|40192414|FG000|Overall Study|Lost to Follow-up|1|||
16467984|NCT03631355|40192415|FG001|Overall Study|Lost to Follow-up|2|||
16467985|NCT01142089|40192420|FG000|Overall Study|Physician Decision|1|||
16467986|NCT01142089|40192421|FG001|Overall Study|Physician Decision|0|||
16467987|NCT01142089|40192420|FG000|Overall Study|Withdrawal by Subject|1|||
16467988|NCT01142089|40192421|FG001|Overall Study|Withdrawal by Subject|2|||
16467989|NCT01142089|40192420|FG000|Overall Study|Use of prohibited medications|0|||
16171388|NCT02357420|39103252|FG000|Overall Study|Prohibited Medication|1|||
16171389|NCT02357420|39103253|FG001|Overall Study|Prohibited Medication|1|||
16171390|NCT02357420|39103254|FG002|Overall Study|Prohibited Medication|0|||
16171391|NCT02357420|39103255|FG003|Overall Study|Prohibited Medication|0|||
16171392|NCT02357420|39103252|FG000|Overall Study|Protocol Non-compliance|0|||
16171393|NCT02357420|39103253|FG001|Overall Study|Protocol Non-compliance|0|||
16171394|NCT02357420|39103254|FG002|Overall Study|Protocol Non-compliance|0|||
16171395|NCT02357420|39103255|FG003|Overall Study|Protocol Non-compliance|1|||
16171396|NCT02357420|39103252|FG000|Overall Study|Withdrawn Consent|4|||
16171397|NCT02357420|39103253|FG001|Overall Study|Withdrawn Consent|8|||
16171398|NCT02357420|39103254|FG002|Overall Study|Withdrawn Consent|6|||
16171399|NCT02357420|39103255|FG003|Overall Study|Withdrawn Consent|6|||
16467990|NCT01142089|40192421|FG001|Overall Study|Use of prohibited medications|1|||
16467991|NCT01142089|40192420|FG000|Overall Study|Noncompliance with study procedures|2|||
16467992|NCT01142089|40192421|FG001|Overall Study|Noncompliance with study procedures|1|||
16467993|NCT01142089|40192420|FG000|Overall Study|Patient required rescue medication|8|||
16467994|NCT01142089|40192421|FG001|Overall Study|Patient required rescue medication|17|||
16467995|NCT02017171|40192424|FG000|Overall Study|Death|10|||
16467996|NCT02017171|40192425|FG001|Overall Study|Death|4|||
16467997|NCT02017171|40192424|FG000|Overall Study|Withdrawal by Subject|23|||
16467998|NCT02017171|40192425|FG001|Overall Study|Withdrawal by Subject|17|||
16467999|NCT02017171|40192424|FG000|Overall Study|Lost to Follow-up|21|||
16468000|NCT02017171|40192425|FG001|Overall Study|Lost to Follow-up|20|||
16468001|NCT02017171|40192424|FG000|Overall Study|ESKD|6|||
16468002|NCT02017171|40192425|FG001|Overall Study|ESKD|2|||
16468003|NCT02017171|40192424|FG000|Overall Study|Miscellaneous|2|||
16468004|NCT02017171|40192425|FG001|Overall Study|Miscellaneous|3|||
16468005|NCT00718081|40192427|FG000|Overall Study|Adverse Event|0|||
16171400|NCT02357420|39103252|FG000|Overall Study|Lost to Follow-up|3|||
16171401|NCT02357420|39103253|FG001|Overall Study|Lost to Follow-up|0|||
16468006|NCT00718081|40192428|FG001|Overall Study|Adverse Event|1|||
16468007|NCT00718081|40192429|FG002|Overall Study|Adverse Event|0|||
16468008|NCT00718081|40192427|FG000|Overall Study|Lack of Efficacy|7|||
16468009|NCT00718081|40192428|FG001|Overall Study|Lack of Efficacy|3|||
16468010|NCT00718081|40192429|FG002|Overall Study|Lack of Efficacy|21|||
16468011|NCT02469038|40192430|FG000|Overall Study|Physician Decision|4|||
16468012|NCT02469038|40192431|FG001|Overall Study|Physician Decision|5|||
16468013|NCT01562873|40192432|FG000|Overall Study|Disease Progression per RECIST|10|||
16468014|NCT01562873|40192433|FG001|Overall Study|Disease Progression per RECIST|0|||
16468015|NCT01562873|40192432|FG000|Overall Study|Adverse Event|1|||
16468016|NCT01562873|40192433|FG001|Overall Study|Adverse Event|0|||
16468017|NCT01562873|40192432|FG000|Overall Study|Clinical Disease Progression|9|||
16468018|NCT01562873|40192433|FG001|Overall Study|Clinical Disease Progression|0|||
16468019|NCT01562873|40192432|FG000|Overall Study|Clinical PD and adverse event|1|||
16468020|NCT01562873|40192433|FG001|Overall Study|Clinical PD and adverse event|0|||
16468021|NCT02652767|40192434|FG000|Overall Study|Death|2|||
16468022|NCT02652767|40192434|FG000|Overall Study|Lost to Follow-up|1|||
16468023|NCT02652767|40192434|FG000|Overall Study|Withdrawal by Subject|1|||
16468024|NCT00169442|40192435|FG000|Overall Study|Withdrawal by Subject|0|||
16468025|NCT00169442|40192436|FG001|Overall Study|Withdrawal by Subject|0|||
16468026|NCT00169442|40192437|FG002|Overall Study|Withdrawal by Subject|1|||
16468027|NCT00169442|40192438|FG003|Overall Study|Withdrawal by Subject|0|||
16171402|NCT02357420|39103254|FG002|Overall Study|Lost to Follow-up|2|||
16468028|NCT00169442|40192439|FG004|Overall Study|Withdrawal by Subject|0|||
16468029|NCT00169442|40192440|FG005|Overall Study|Withdrawal by Subject|0|||
16468030|NCT00169442|40192435|FG000|Overall Study|Migrated/moved from study area|0|||
16468031|NCT00169442|40192436|FG001|Overall Study|Migrated/moved from study area|0|||
16468032|NCT00169442|40192437|FG002|Overall Study|Migrated/moved from study area|0|||
16468033|NCT00169442|40192438|FG003|Overall Study|Migrated/moved from study area|0|||
16468034|NCT00169442|40192439|FG004|Overall Study|Migrated/moved from study area|0|||
16468035|NCT00169442|40192440|FG005|Overall Study|Migrated/moved from study area|2|||
16468036|NCT00169442|40192435|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
16468037|NCT00169442|40192436|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
16468038|NCT00169442|40192437|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
16468039|NCT00169442|40192438|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
16468040|NCT00169442|40192439|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
16468041|NCT00169442|40192440|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
16468042|NCT00169442|40192435|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
16468043|NCT00169442|40192436|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
16468044|NCT00169442|40192437|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
16468045|NCT00169442|40192438|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
16468046|NCT00169442|40192439|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
16468047|NCT00169442|40192440|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
16468048|NCT03687970|40192441|FG000|Overall Study|visit scheduling conflicts|2|||
16468049|NCT03687970|40192442|FG001|Overall Study|visit scheduling conflicts|0|||
16468050|NCT02446743|40192448|FG000|Overall Study|Withdrawal by Subject|1|||
16468051|NCT02446743|40192449|FG001|Overall Study|Withdrawal by Subject|1|||
16468052|NCT02446743|40192448|FG000|Overall Study|Lost to Follow-up|1|||
16468053|NCT02446743|40192449|FG001|Overall Study|Lost to Follow-up|0|||
16468054|NCT02446743|40192448|FG000|Overall Study|Adverse Event|1|||
16468055|NCT02446743|40192449|FG001|Overall Study|Adverse Event|1|||
16468056|NCT02446743|40192448|FG000|Overall Study|Other|2|||
16468057|NCT02446743|40192449|FG001|Overall Study|Other|3|||
16468058|NCT01268579|40192451|FG000|Overall Study|Adverse Event|1|||
16468059|NCT01268579|40192451|FG000|Overall Study|Withdrawal by Subject|2|||
16468060|NCT00761150|40192452|FG000|Open-label Period|Adverse Event|36|||
16468061|NCT00761150|40192453|FG001|Open-label Period|Adverse Event|0|||
16468062|NCT00761150|40192454|FG002|Open-label Period|Adverse Event|0|||
16468063|NCT00761150|40192452|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
16468064|NCT00761150|40192453|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
16468065|NCT00761150|40192454|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
16468066|NCT00761150|40192452|FG000|Open-label Period|Lost to Follow-up|7|||
16468067|NCT00761150|40192453|FG001|Open-label Period|Lost to Follow-up|0|||
16468068|NCT00761150|40192454|FG002|Open-label Period|Lost to Follow-up|0|||
16468069|NCT00761150|40192452|FG000|Open-label Period|Lack of Efficacy|4|||
16468070|NCT00761150|40192453|FG001|Open-label Period|Lack of Efficacy|0|||
16468071|NCT00761150|40192454|FG002|Open-label Period|Lack of Efficacy|0|||
16468072|NCT00761150|40192452|FG000|Open-label Period|Withdrawal by Subject|5|||
16468073|NCT00761150|40192453|FG001|Open-label Period|Withdrawal by Subject|0|||
16468074|NCT00761150|40192454|FG002|Open-label Period|Withdrawal by Subject|0|||
16468075|NCT00761150|40192452|FG000|Open-label Period|Noncompliance|2|||
16468076|NCT00761150|40192453|FG001|Open-label Period|Noncompliance|0|||
16468077|NCT00761150|40192454|FG002|Open-label Period|Noncompliance|0|||
16468078|NCT00761150|40192452|FG000|Open-label Period|Other|5|||
16468079|NCT00761150|40192453|FG001|Open-label Period|Other|0|||
16468080|NCT00761150|40192454|FG002|Open-label Period|Other|0|||
16468081|NCT00761150|40192452|FG000|Double-blind Period|Lack of Efficacy|0|||
16468082|NCT00761150|40192453|FG001|Double-blind Period|Lack of Efficacy|2|||
16468083|NCT00761150|40192454|FG002|Double-blind Period|Lack of Efficacy|19|||
16468084|NCT00761150|40192452|FG000|Double-blind Period|Adverse Event|0|||
16468085|NCT00761150|40192453|FG001|Double-blind Period|Adverse Event|3|||
16468086|NCT00761150|40192454|FG002|Double-blind Period|Adverse Event|3|||
16468087|NCT00761150|40192452|FG000|Double-blind Period|Withdrawal by Subject|0|||
16468088|NCT00761150|40192453|FG001|Double-blind Period|Withdrawal by Subject|3|||
16468089|NCT00761150|40192454|FG002|Double-blind Period|Withdrawal by Subject|2|||
16468090|NCT00761150|40192452|FG000|Double-blind Period|Lost to Follow-up|0|||
16468091|NCT00761150|40192453|FG001|Double-blind Period|Lost to Follow-up|2|||
16468092|NCT00761150|40192454|FG002|Double-blind Period|Lost to Follow-up|1|||
16468093|NCT00761150|40192452|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
16468094|NCT00761150|40192453|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
16468095|NCT00761150|40192454|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
16468096|NCT00761150|40192452|FG000|Double-blind Period|Noncompliance|0|||
16468097|NCT00761150|40192453|FG001|Double-blind Period|Noncompliance|1|||
16468098|NCT00761150|40192454|FG002|Double-blind Period|Noncompliance|0|||
16468099|NCT00761150|40192452|FG000|Double-blind Period|Other|0|||
16468100|NCT00761150|40192453|FG001|Double-blind Period|Other|3|||
16468101|NCT00761150|40192454|FG002|Double-blind Period|Other|3|||
16468102|NCT00880165|40192455|FG000|Overall Study|Withdrawal by Subject|27|||
16468103|NCT00880165|40192456|FG001|Overall Study|Withdrawal by Subject|23|||
16468104|NCT00880165|40192455|FG000|Overall Study|Not diagnosed with OSA|14|||
16468105|NCT00880165|40192456|FG001|Overall Study|Not diagnosed with OSA|8|||
16171403|NCT02357420|39103255|FG003|Overall Study|Lost to Follow-up|3|||
16171404|NCT03182738|39103259|FG000|Overall Study|Lost to Follow-up|9|||
16171405|NCT03182738|39103260|FG001|Overall Study|Lost to Follow-up|3|||
16468106|NCT00880165|40192455|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
16468107|NCT00880165|40192456|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
16468108|NCT00880165|40192455|FG000|Overall Study|Lost to follow|9|||
16468109|NCT00880165|40192456|FG001|Overall Study|Lost to follow|15|||
16468110|NCT01634178|40192457|FG000|Treatment Period 1|Adverse Event|0|||
16171406|NCT03182738|39103259|FG000|Overall Study|Pregnancy|0|||
16171407|NCT03182738|39103260|FG001|Overall Study|Pregnancy|1|||
16171408|NCT03182738|39103259|FG000|Overall Study|Withdrawal by Subject|0|||
16171409|NCT03182738|39103260|FG001|Overall Study|Withdrawal by Subject|1|||
16171410|NCT00474240|39107117|FG000|Overall Study|Withdrawal by Subject|1|||
16171411|NCT00474240|39107118|FG001|Overall Study|Withdrawal by Subject|1|||
16171412|NCT00474240|39107119|FG002|Overall Study|Withdrawal by Subject|0|||
16171413|NCT00474240|39107120|FG003|Overall Study|Withdrawal by Subject|2|||
16468111|NCT01634178|40192458|FG001|Treatment Period 1|Adverse Event|1|||
16468112|NCT01634178|40192457|FG000|Treatment Period 2|Adverse Event|1|||
16468113|NCT01634178|40192458|FG001|Treatment Period 2|Adverse Event|0|||
16468114|NCT03678870|40192463|FG000|Overall Study|prescribed non- protocol medications|10|||
16468115|NCT03678870|40192464|FG001|Overall Study|prescribed non- protocol medications|6|||
16468116|NCT03678870|40192463|FG000|Overall Study|Lost to Follow-up|3|||
16468117|NCT03678870|40192464|FG001|Overall Study|Lost to Follow-up|2|||
16468118|NCT02793128|40192465|FG000|Overall Study|Death|4|||
16468119|NCT02793128|40192465|FG000|Overall Study|Withdrawal by Subject|2|||
16468120|NCT02793128|40192465|FG000|Overall Study|Physician Decision|1|||
16468121|NCT02793128|40192465|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
16468122|NCT02793128|40192465|FG000|Overall Study|Patient elected nephroureterectomy|1|||
16468123|NCT02125604|40192466|FG000|Overall Study|Other|4|||
16468124|NCT02125604|40192466|FG000|Overall Study|Investigator Decision|1|||
16468125|NCT02125604|40192466|FG000|Overall Study|Lost to Follow-up|2|||
16468126|NCT02125604|40192466|FG000|Overall Study|Consent Withdrawn|4|||
16468127|NCT02125604|40192466|FG000|Overall Study|Adverse Event|20|||
16468128|NCT04473482|40192473|FG000|Overall Study|Death|0|||
16468129|NCT04473482|40192474|FG001|Overall Study|Death|3|||
16468130|NCT04473482|40192473|FG000|Overall Study|Lost to Follow-up|9|||
16468131|NCT04473482|40192474|FG001|Overall Study|Lost to Follow-up|7|||
16468132|NCT04473482|40192473|FG000|Overall Study|Withdrawal by Subject|2|||
16468133|NCT04473482|40192474|FG001|Overall Study|Withdrawal by Subject|1|||
16468134|NCT00923364|40192475|FG000|Overall Study|Death|3|||
16468135|NCT00923364|40192476|FG001|Overall Study|Death|0|||
16468136|NCT00923364|40192475|FG000|Overall Study|Did not go to transplant|1|||
16468137|NCT00923364|40192476|FG001|Overall Study|Did not go to transplant|0|||
16171414|NCT00474240|39107121|FG004|Overall Study|Withdrawal by Subject|3|||
16171415|NCT00474240|39107122|FG005|Overall Study|Withdrawal by Subject|1|||
16468138|NCT02764190|40192477|FG000|Overall Study|Lost to Follow-up|17|||
16468139|NCT02764190|40192478|FG001|Overall Study|Lost to Follow-up|13|||
16468140|NCT02292784|40192479|FG000|Overall Study|Lost to Follow-up|1|||
16171416|NCT00474240|39107117|FG000|Overall Study|Adverse Event|0|||
16171417|NCT00474240|39107118|FG001|Overall Study|Adverse Event|0|||
16171418|NCT00474240|39107119|FG002|Overall Study|Adverse Event|9|||
16171419|NCT00474240|39107120|FG003|Overall Study|Adverse Event|14|||
16171420|NCT00474240|39107121|FG004|Overall Study|Adverse Event|5|||
16171421|NCT00474240|39107122|FG005|Overall Study|Adverse Event|16|||
16468141|NCT02292784|40192480|FG001|Overall Study|Lost to Follow-up|17|||
16468142|NCT02292784|40192481|FG002|Overall Study|Lost to Follow-up|18|||
16468143|NCT02292784|40192479|FG000|Overall Study|Withdrawal by Subject|0|||
16468144|NCT02292784|40192480|FG001|Overall Study|Withdrawal by Subject|3|||
16468145|NCT02292784|40192481|FG002|Overall Study|Withdrawal by Subject|3|||
16468146|NCT03222492|40192482|FG000|Overall Study|Withdrawal by Subject|0|||
16468147|NCT03222492|40192483|FG001|Overall Study|Withdrawal by Subject|0|||
16171422|NCT00474240|39107117|FG000|Overall Study|Removed due to lab value|0|||
16171423|NCT00474240|39107118|FG001|Overall Study|Removed due to lab value|0|||
16171424|NCT00474240|39107119|FG002|Overall Study|Removed due to lab value|0|||
16171425|NCT00474240|39107120|FG003|Overall Study|Removed due to lab value|0|||
16171426|NCT00474240|39107121|FG004|Overall Study|Removed due to lab value|0|||
16171427|NCT00474240|39107122|FG005|Overall Study|Removed due to lab value|1|||
16171428|NCT02601573|39107123|FG000|Overall Study|Lost to Follow-up|0|||
16171429|NCT02601573|39107124|FG001|Overall Study|Lost to Follow-up|3|||
16171430|NCT02601573|39107125|FG002|Overall Study|Lost to Follow-up|1|||
16171431|NCT02601573|39107126|FG003|Overall Study|Lost to Follow-up|0|||
16171432|NCT02601573|39107127|FG004|Overall Study|Lost to Follow-up|2|||
16171433|NCT02601573|39107123|FG000|Overall Study|Withdrawal by Subject|0|||
16171434|NCT02601573|39107124|FG001|Overall Study|Withdrawal by Subject|1|||
16468148|NCT03222492|40192484|FG002|Overall Study|Withdrawal by Subject|1|||
16468149|NCT03222492|40192485|FG003|Overall Study|Withdrawal by Subject|0|||
16468150|NCT03222492|40192482|FG000|Overall Study|COVID-19 related|0|||
16171435|NCT02601573|39107125|FG002|Overall Study|Withdrawal by Subject|0|||
16171436|NCT02601573|39107126|FG003|Overall Study|Withdrawal by Subject|1|||
16171437|NCT02601573|39107127|FG004|Overall Study|Withdrawal by Subject|0|||
16468151|NCT03222492|40192483|FG001|Overall Study|COVID-19 related|0|||
16468152|NCT03222492|40192484|FG002|Overall Study|COVID-19 related|1|||
16171438|NCT01151137|39107128|FG000|Overall Study|Death|15|||
16468153|NCT03222492|40192485|FG003|Overall Study|COVID-19 related|0|||
16468154|NCT01858636|40192486|FG000|Overall Study|No Device Deployment Attempted|24|||
16468155|NCT01858636|40192486|FG000|Overall Study|Physician Decision|1|||
16468156|NCT01858636|40192486|FG000|Overall Study|Death|1|||
16468157|NCT01858636|40192486|FG000|Overall Study|Lost to Follow-up|1|||
16468158|NCT01858636|40192486|FG000|Overall Study|Withdrawal by Subject|1|||
16468159|NCT01894568|40192488|FG000|Overall Study|Adverse Event|2|||
16468160|NCT01894568|40192489|FG001|Overall Study|Adverse Event|3|||
16468161|NCT01894568|40192488|FG000|Overall Study|Protocol required discontinuation|2|||
16468162|NCT01894568|40192489|FG001|Overall Study|Protocol required discontinuation|1|||
16468163|NCT01894568|40192488|FG000|Overall Study|Withdrawal by Subject|5|||
16468164|NCT01894568|40192489|FG001|Overall Study|Withdrawal by Subject|5|||
16468165|NCT01894568|40192488|FG000|Overall Study|Physician Decision|1|||
16468166|NCT01894568|40192489|FG001|Overall Study|Physician Decision|0|||
16468167|NCT01894568|40192488|FG000|Overall Study|Lost to Follow-up|0|||
16468168|NCT01894568|40192489|FG001|Overall Study|Lost to Follow-up|1|||
16468169|NCT00548405|40192490|FG000|Overall Study|Adverse Event|6|||
16468170|NCT00548405|40192491|FG001|Overall Study|Adverse Event|2|||
16468171|NCT00548405|40192492|FG002|Overall Study|Adverse Event|0|||
16468172|NCT00548405|40192490|FG000|Overall Study|Lack of Efficacy|6|||
16468173|NCT00548405|40192491|FG001|Overall Study|Lack of Efficacy|0|||
16468174|NCT00548405|40192492|FG002|Overall Study|Lack of Efficacy|0|||
16468175|NCT00548405|40192490|FG000|Overall Study|Physician Decision|3|||
16468176|NCT00548405|40192491|FG001|Overall Study|Physician Decision|4|||
16468177|NCT00548405|40192492|FG002|Overall Study|Physician Decision|1|||
16468178|NCT00548405|40192490|FG000|Overall Study|Pregnancy|1|||
16468179|NCT00548405|40192491|FG001|Overall Study|Pregnancy|0|||
16468180|NCT00548405|40192492|FG002|Overall Study|Pregnancy|0|||
16468181|NCT00548405|40192490|FG000|Overall Study|Protocol Violation|1|||
16468182|NCT00548405|40192491|FG001|Overall Study|Protocol Violation|0|||
16468183|NCT00548405|40192492|FG002|Overall Study|Protocol Violation|0|||
16468184|NCT00548405|40192490|FG000|Overall Study|Withdrawal by Subject|36|||
16468185|NCT00548405|40192491|FG001|Overall Study|Withdrawal by Subject|12|||
16468186|NCT00548405|40192492|FG002|Overall Study|Withdrawal by Subject|5|||
16468187|NCT00548405|40192490|FG000|Overall Study|Lost to Follow-up|1|||
16468188|NCT00548405|40192491|FG001|Overall Study|Lost to Follow-up|1|||
16468189|NCT00548405|40192492|FG002|Overall Study|Lost to Follow-up|2|||
16468190|NCT00548405|40192490|FG000|Overall Study|Death|0|||
16468191|NCT00548405|40192491|FG001|Overall Study|Death|1|||
16468192|NCT00548405|40192492|FG002|Overall Study|Death|1|||
16468193|NCT00548405|40192490|FG000|Overall Study|Sponsor decision|1|||
16468194|NCT00548405|40192491|FG001|Overall Study|Sponsor decision|0|||
16468195|NCT00548405|40192492|FG002|Overall Study|Sponsor decision|0|||
16468196|NCT00548405|40192490|FG000|Overall Study|Randomized but not treated|1|||
16468197|NCT00548405|40192491|FG001|Overall Study|Randomized but not treated|0|||
16468198|NCT00548405|40192492|FG002|Overall Study|Randomized but not treated|0|||
16468199|NCT02360605|40192493|FG000|Overall Study|Withdrawal by Subject|4|||
16468200|NCT02360605|40192494|FG001|Overall Study|Withdrawal by Subject|9|||
16468201|NCT02360605|40192493|FG000|Overall Study|Lost to Follow-up|7|||
16468202|NCT02360605|40192494|FG001|Overall Study|Lost to Follow-up|8|||
16468203|NCT02360605|40192493|FG000|Overall Study|Death|0|||
16468204|NCT02360605|40192494|FG001|Overall Study|Death|1|||
16468205|NCT03418571|40192499|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
16468206|NCT03418571|40192500|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
16468207|NCT03718299|40192503|FG000|Overall Study|Adverse Event|1|||
16468208|NCT03718299|40192503|FG000|Overall Study|Withdrawal by Subject|6|||
16468209|NCT03718299|40192503|FG000|Overall Study|Physician Decision|2|||
16468210|NCT03718299|40192503|FG000|Overall Study|Lost to Follow-up|1|||
16468211|NCT02480712|40192504|FG000|Overall Study|Enrolled but Never Treated|1|||
16468212|NCT02480712|40192504|FG000|Overall Study|Lost to Follow-up|5|||
16468213|NCT02480712|40192504|FG000|Overall Study|Withdrew Consent|3|||
16468214|NCT02480712|40192504|FG000|Overall Study|Death|1|||
16468215|NCT02480712|40192504|FG000|Overall Study|Lack of Efficacy|1|||
16468216|NCT03433339|40192507|FG000|Overall Study|Lost to Follow-up|2|||
16468217|NCT03433339|40192508|FG001|Overall Study|Lost to Follow-up|0|||
16468218|NCT03433339|40192507|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
16468219|NCT03433339|40192508|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
16468220|NCT03433339|40192507|FG000|Overall Study|Withdrawal by Subject|0|||
16468221|NCT03433339|40192508|FG001|Overall Study|Withdrawal by Subject|2|||
16468222|NCT03036800|40192511|FG000|Overall Study|Protocol Violation|1|||
16468223|NCT03036800|40192512|FG001|Overall Study|Protocol Violation|0|||
16468224|NCT03036800|40192511|FG000|Overall Study|Non-compliance|1|||
16468225|NCT03036800|40192512|FG001|Overall Study|Non-compliance|0|||
16468226|NCT03036800|40192511|FG000|Overall Study|Lost to Follow-up|1|||
16468227|NCT03036800|40192512|FG001|Overall Study|Lost to Follow-up|0|||
16468228|NCT03036800|40192511|FG000|Overall Study|Death|1|||
16468229|NCT03036800|40192512|FG001|Overall Study|Death|0|||
16468230|NCT03036800|40192511|FG000|Overall Study|Tolerance|5|||
16468231|NCT03036800|40192512|FG001|Overall Study|Tolerance|0|||
16468232|NCT03036800|40192511|FG000|Overall Study|Unknown/no reason given|50|||
16468233|NCT03036800|40192512|FG001|Overall Study|Unknown/no reason given|39|||
16468234|NCT02632838|40192516|FG000|Overall Study|Withdrawal by Subject|3|||
16468235|NCT02632838|40192517|FG001|Overall Study|Withdrawal by Subject|0|||
16468236|NCT02632838|40192516|FG000|Overall Study|Lost to Follow-up|0|||
16171439|NCT01151137|39107129|FG001|Overall Study|Death|27|||
16171440|NCT01151137|39107128|FG000|Overall Study|Lost to Follow-up|1|||
16171441|NCT01151137|39107129|FG001|Overall Study|Lost to Follow-up|1|||
16171442|NCT01290887|39107136|FG000|Overall Study|Adverse Event|6|||
16171443|NCT01290887|39107137|FG001|Overall Study|Adverse Event|11|||
16171444|NCT01290887|39107136|FG000|Overall Study|Lack of Efficacy|4|||
16171445|NCT01290887|39107137|FG001|Overall Study|Lack of Efficacy|5|||
16171446|NCT01290887|39107136|FG000|Overall Study|Withdrawal by Subject|26|||
16171447|NCT01290887|39107137|FG001|Overall Study|Withdrawal by Subject|32|||
16171448|NCT01290887|39107136|FG000|Overall Study|Protocol Violation|2|||
16171449|NCT01290887|39107137|FG001|Overall Study|Protocol Violation|1|||
16171450|NCT01290887|39107136|FG000|Overall Study|Lost to Follow-up|4|||
16171451|NCT01290887|39107137|FG001|Overall Study|Lost to Follow-up|4|||
16171452|NCT01290887|39107136|FG000|Overall Study|Non-compliance to study procedures|0|||
16171453|NCT01290887|39107137|FG001|Overall Study|Non-compliance to study procedures|1|||
16171454|NCT01290887|39107136|FG000|Overall Study|Non-compliance to study medications|1|||
16171455|NCT01290887|39107137|FG001|Overall Study|Non-compliance to study medications|0|||
16171456|NCT01290887|39107136|FG000|Overall Study|Sponsor closure of study|420|||
16171457|NCT01290887|39107137|FG001|Overall Study|Sponsor closure of study|476|||
16171458|NCT01290887|39107136|FG000|Overall Study|Other|3|||
16171459|NCT01290887|39107137|FG001|Overall Study|Other|6|||
16171460|NCT01147497|39107138|FG000|Overall Study|failed insertion|2|||
16171461|NCT01147497|39107139|FG001|Overall Study|failed insertion|0|||
16171462|NCT01389245|39107144|FG000|Overall Study|Protocol Violation|10|||
16171463|NCT01389245|39107144|FG000|Overall Study|Lost to Follow-up|3|||
16171464|NCT01389245|39107144|FG000|Overall Study|Withdrawal by Subject|2|||
16171465|NCT01993888|39107147|FG000|Overall Study|Death|1|||
16171466|NCT01993888|39107148|FG001|Overall Study|Death|1|||
16171467|NCT01993888|39107147|FG000|Overall Study|Lost to Follow-up|1|||
16171468|NCT01993888|39107148|FG001|Overall Study|Lost to Follow-up|1|||
16171469|NCT01993888|39107147|FG000|Overall Study|Withdrawal by Subject|0|||
16171470|NCT01993888|39107148|FG001|Overall Study|Withdrawal by Subject|1|||
16171471|NCT02932267|39107152|FG000|Overall Study|Withdrawal by Subject|3|||
16468237|NCT02632838|40192517|FG001|Overall Study|Lost to Follow-up|2|||
16468238|NCT02274038|40192518|FG000|Overall Study|Death|1|||
16468239|NCT02431247|40192519|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
16468240|NCT02431247|40192520|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
16468241|NCT02431247|40192521|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
16468242|NCT02431247|40192519|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
16468243|NCT02431247|40192520|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
16468244|NCT02431247|40192521|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
16468245|NCT02431247|40192519|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
16468246|NCT02431247|40192520|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
16468247|NCT02431247|40192521|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
16468248|NCT02431247|40192519|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
16468249|NCT02431247|40192520|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
16468250|NCT02431247|40192521|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
16468251|NCT02431247|40192519|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
16468252|NCT02431247|40192520|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
16468253|NCT02431247|40192521|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
16468254|NCT02431247|40192519|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
16468255|NCT02431247|40192520|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
16468256|NCT02431247|40192521|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
16468257|NCT02431247|40192519|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
16468258|NCT02431247|40192520|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
16468259|NCT02431247|40192521|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
16468260|NCT02431247|40192519|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
16468261|NCT02431247|40192520|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
16468262|NCT02431247|40192521|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
16468263|NCT02431247|40192519|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
16468264|NCT02431247|40192520|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
16468265|NCT02431247|40192521|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
16468266|NCT02431247|40192519|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
16468267|NCT02431247|40192520|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
16468268|NCT02431247|40192521|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
16468269|NCT02431247|40192519|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
16171472|NCT02932267|39107152|FG000|Overall Study|Lost to Follow-up|4|||
16171473|NCT02932267|39107152|FG000|Overall Study|Pregnancy|1|||
16072739|NCT01787760|38759158|FG000|Overall Study|Protocol Violation|6|||
16072740|NCT01787760|38759159|FG001|Overall Study|Protocol Violation|0|||
16072741|NCT01787760|38759160|FG002|Overall Study|Protocol Violation|1|||
16072742|NCT01787760|38759158|FG000|Overall Study|Withdrawal by Subject|5|||
16468270|NCT02431247|40192520|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
16468271|NCT02431247|40192521|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
16468272|NCT02431247|40192519|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
16468273|NCT02431247|40192520|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
16468274|NCT02431247|40192521|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
16468275|NCT02431247|40192519|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
16468276|NCT02431247|40192520|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
16468277|NCT02431247|40192521|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
16468278|NCT02431247|40192519|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
16468279|NCT02431247|40192520|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
16468280|NCT02431247|40192521|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
16468281|NCT01895361|40192522|FG000|Overall Study|Adverse Event|1|||
16171474|NCT01485614|39107155|FG000|Randomization|Not Treated|1|||
16468282|NCT01895361|40192523|FG001|Overall Study|Adverse Event|1|||
16468283|NCT01895361|40192524|FG002|Overall Study|Adverse Event|3|||
16468284|NCT01895361|40192522|FG000|Overall Study|Death|2|||
16468285|NCT01895361|40192523|FG001|Overall Study|Death|1|||
16468286|NCT01895361|40192524|FG002|Overall Study|Death|2|||
16468287|NCT01895361|40192522|FG000|Overall Study|Lost to Follow-up|4|||
16171475|NCT01485614|39107156|FG001|Randomization|Not Treated|0|||
16171476|NCT01485614|39107157|FG002|Randomization|Not Treated|0|||
16171477|NCT01485614|39107158|FG003|Randomization|Not Treated|0|||
16171478|NCT01485614|39107155|FG000|Weeks 0-20|Lost to Follow-up|2|||
16171479|NCT01485614|39107156|FG001|Weeks 0-20|Lost to Follow-up|0|||
16171480|NCT01485614|39107157|FG002|Weeks 0-20|Lost to Follow-up|0|||
16171481|NCT01485614|39107158|FG003|Weeks 0-20|Lost to Follow-up|0|||
16171482|NCT01485614|39107155|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
16171483|NCT01485614|39107156|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
16171484|NCT01485614|39107157|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
16171485|NCT01485614|39107158|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
16171486|NCT01485614|39107155|FG000|Weeks 0-20|Withdrawal by Subject|3|||
16171487|NCT01485614|39107156|FG001|Weeks 0-20|Withdrawal by Subject|2|||
16171488|NCT01485614|39107157|FG002|Weeks 0-20|Withdrawal by Subject|1|||
16171489|NCT01485614|39107158|FG003|Weeks 0-20|Withdrawal by Subject|0|||
16171490|NCT01485614|39107155|FG000|Weeks 20-54|Lost to Follow-up|4|||
16171491|NCT01485614|39107156|FG001|Weeks 20-54|Lost to Follow-up|3|||
16171492|NCT01485614|39107157|FG002|Weeks 20-54|Lost to Follow-up|1|||
16171493|NCT01485614|39107158|FG003|Weeks 20-54|Lost to Follow-up|0|||
16171494|NCT01485614|39107155|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
16171495|NCT01485614|39107156|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
16171496|NCT01485614|39107157|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
16171497|NCT01485614|39107158|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
16468288|NCT01895361|40192523|FG001|Overall Study|Lost to Follow-up|4|||
16468289|NCT01895361|40192524|FG002|Overall Study|Lost to Follow-up|6|||
16468290|NCT01895361|40192522|FG000|Overall Study|Non-compliance with study|1|||
16468291|NCT01895361|40192523|FG001|Overall Study|Non-compliance with study|3|||
16468292|NCT01895361|40192524|FG002|Overall Study|Non-compliance with study|1|||
16468293|NCT01895361|40192522|FG000|Overall Study|Physician Decision|2|||
16468294|NCT01895361|40192523|FG001|Overall Study|Physician Decision|2|||
16468295|NCT01895361|40192524|FG002|Overall Study|Physician Decision|2|||
16468296|NCT01895361|40192522|FG000|Overall Study|Withdrawal by Subject|7|||
16468297|NCT01895361|40192523|FG001|Overall Study|Withdrawal by Subject|6|||
16468298|NCT01895361|40192524|FG002|Overall Study|Withdrawal by Subject|6|||
16468299|NCT01895361|40192522|FG000|Overall Study|Lack of Efficacy|0|||
16468300|NCT01895361|40192523|FG001|Overall Study|Lack of Efficacy|1|||
16468301|NCT01895361|40192524|FG002|Overall Study|Lack of Efficacy|0|||
16468302|NCT01895361|40192522|FG000|Overall Study|Reasons different from categories above|7|||
16468303|NCT01895361|40192523|FG001|Overall Study|Reasons different from categories above|3|||
16171498|NCT01485614|39107155|FG000|Weeks 20-54|Withdrawal by Subject|5|||
16171499|NCT01485614|39107156|FG001|Weeks 20-54|Withdrawal by Subject|3|||
16171500|NCT01485614|39107157|FG002|Weeks 20-54|Withdrawal by Subject|0|||
16171501|NCT01485614|39107158|FG003|Weeks 20-54|Withdrawal by Subject|0|||
16171502|NCT03521791|39107159|FG000|Overall Study|Protocol Violation|7|||
16171503|NCT03521791|39107160|FG001|Overall Study|Protocol Violation|17|||
16171504|NCT02034123|39107161|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171505|NCT02034123|39107162|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16468304|NCT01895361|40192524|FG002|Overall Study|Reasons different from categories above|4|||
16468305|NCT00589784|40192525|FG000|Overall Study|Withdrawal by Subject|0|||
16468306|NCT00589784|40192526|FG001|Overall Study|Withdrawal by Subject|6|||
16468307|NCT00589784|40192525|FG000|Overall Study|Patient inevaluable|1|||
16468308|NCT00589784|40192526|FG001|Overall Study|Patient inevaluable|0|||
16468309|NCT00589784|40192525|FG000|Overall Study|Adverse Event|0|||
16468310|NCT00589784|40192526|FG001|Overall Study|Adverse Event|4|||
16171506|NCT02034123|39107163|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171507|NCT02034123|39107164|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171508|NCT02034123|39107165|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
16468311|NCT02052414|40192527|FG000|Overall Study|Adverse Event|12|||
16468312|NCT02052414|40192527|FG000|Overall Study|Lack of Efficacy|2|||
16468313|NCT02052414|40192527|FG000|Overall Study|Withdrawal by Subject|3|||
16468314|NCT00282464|40192531|FG000|Overall Study|Adverse Event|26|||
16468315|NCT00282464|40192532|FG001|Overall Study|Adverse Event|20|||
16468316|NCT00282464|40192531|FG000|Overall Study|Lack of Efficacy|8|||
16468317|NCT00282464|40192532|FG001|Overall Study|Lack of Efficacy|8|||
16468318|NCT00282464|40192531|FG000|Overall Study|Lost to Follow-up|10|||
16468319|NCT00282464|40192532|FG001|Overall Study|Lost to Follow-up|10|||
16468320|NCT00282464|40192531|FG000|Overall Study|Withdrawal by Subject|24|||
16468321|NCT00282464|40192532|FG001|Overall Study|Withdrawal by Subject|10|||
16468322|NCT00282464|40192531|FG000|Overall Study|laboratory abnormality|1|||
16468323|NCT00282464|40192532|FG001|Overall Study|laboratory abnormality|2|||
16468324|NCT00282464|40192531|FG000|Overall Study|Protocol Violation|0|||
16468325|NCT00282464|40192532|FG001|Overall Study|Protocol Violation|7|||
16468326|NCT00282464|40192531|FG000|Overall Study|Patient moved|1|||
16468327|NCT00282464|40192532|FG001|Overall Study|Patient moved|0|||
16468328|NCT00282464|40192531|FG000|Overall Study|patient non-compliant|3|||
16468329|NCT00282464|40192532|FG001|Overall Study|patient non-compliant|0|||
16468330|NCT00282464|40192531|FG000|Overall Study|patient no show|0|||
16468331|NCT00282464|40192532|FG001|Overall Study|patient no show|1|||
16468332|NCT00282464|40192531|FG000|Overall Study|patient incarcerated|0|||
16468333|NCT00282464|40192532|FG001|Overall Study|patient incarcerated|1|||
16468334|NCT00282464|40192531|FG000|Overall Study|family crisis|0|||
16468335|NCT00282464|40192532|FG001|Overall Study|family crisis|1|||
16468336|NCT00282464|40192531|FG000|Overall Study|dispensed wrong kit|0|||
16468337|NCT00282464|40192532|FG001|Overall Study|dispensed wrong kit|1|||
16468338|NCT00282464|40192531|FG000|Overall Study|dropped due to missed visits|0|||
16468339|NCT00282464|40192532|FG001|Overall Study|dropped due to missed visits|1|||
16468340|NCT00704522|40192533|FG000|Overall Study|Lack of Efficacy|65|||
16468341|NCT00704522|40192534|FG001|Overall Study|Lack of Efficacy|17|||
16468342|NCT00704522|40192533|FG000|Overall Study|Failure to appear again at hospital|56|||
16468343|NCT00704522|40192534|FG001|Overall Study|Failure to appear again at hospital|10|||
16468344|NCT00704522|40192533|FG000|Overall Study|Withdrawal by Subject|17|||
16468345|NCT00704522|40192534|FG001|Overall Study|Withdrawal by Subject|8|||
16468346|NCT00704522|40192533|FG000|Overall Study|Adverse Event|9|||
16468347|NCT00704522|40192534|FG001|Overall Study|Adverse Event|1|||
16468348|NCT00704522|40192533|FG000|Overall Study|Undefined causes|9|||
16468349|NCT00704522|40192534|FG001|Overall Study|Undefined causes|7|||
16468350|NCT00704522|40192533|FG000|Overall Study|No information on therapy end|27|||
16468351|NCT00704522|40192534|FG001|Overall Study|No information on therapy end|2|||
16468352|NCT03963401|40192535|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
16468353|NCT03963401|40192536|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
16468354|NCT03963401|40192537|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
16468355|NCT03963401|40192538|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
16468356|NCT03963401|40192539|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
16468357|NCT03963401|40192540|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
16468358|NCT03963401|40192535|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
16468359|NCT03963401|40192536|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
16468360|NCT03963401|40192537|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
16468361|NCT03963401|40192538|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
16468362|NCT03963401|40192539|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
16468363|NCT03963401|40192540|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
16468364|NCT03963401|40192535|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
16468365|NCT03963401|40192536|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
16468366|NCT03963401|40192537|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
16468367|NCT03963401|40192538|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
16468368|NCT03963401|40192539|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
16468369|NCT03963401|40192540|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
16468370|NCT03963401|40192535|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
16468371|NCT03963401|40192536|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
16468372|NCT03963401|40192537|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
16468373|NCT03963401|40192538|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
16468374|NCT03963401|40192539|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
16468375|NCT03963401|40192540|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
16468376|NCT03963401|40192535|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
16468377|NCT03963401|40192536|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
16468378|NCT03963401|40192537|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
16468379|NCT03963401|40192538|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
16468380|NCT03963401|40192539|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
16468381|NCT03963401|40192540|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
16468382|NCT03963401|40192535|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
16468383|NCT03963401|40192536|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
16468384|NCT03963401|40192537|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
16468385|NCT03963401|40192538|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
16468386|NCT03963401|40192539|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
16468387|NCT03963401|40192540|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
16468388|NCT03963401|40192535|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
16468389|NCT03963401|40192536|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
16468390|NCT03963401|40192537|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
16468391|NCT03963401|40192538|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
16468392|NCT03963401|40192539|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
16468393|NCT03963401|40192540|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
16468394|NCT03963401|40192535|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
16468395|NCT03963401|40192536|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
16468396|NCT03963401|40192537|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
16468397|NCT03963401|40192538|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
16468398|NCT03963401|40192539|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
16468399|NCT03963401|40192540|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
16468400|NCT03963401|40192535|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
16468401|NCT03963401|40192536|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
16468402|NCT03963401|40192537|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
16468403|NCT03963401|40192538|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
16468404|NCT03963401|40192539|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
16468405|NCT03963401|40192540|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
16468406|NCT03963401|40192535|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
16468407|NCT03963401|40192536|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
16468408|NCT03963401|40192537|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
16468409|NCT03963401|40192538|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
16468410|NCT03963401|40192539|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
16468411|NCT03963401|40192540|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
16468412|NCT03963401|40192535|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
16468413|NCT03963401|40192536|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
16468414|NCT03963401|40192537|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
16468415|NCT03963401|40192538|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
16468416|NCT03963401|40192539|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
16468417|NCT03963401|40192540|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
16468418|NCT02536833|40192544|FG000|Overall Study|Discontinued Before Treatment|0|||
16468419|NCT02536833|40192545|FG001|Overall Study|Discontinued Before Treatment|0|||
16468420|NCT02536833|40192546|FG002|Overall Study|Discontinued Before Treatment|1|||
16468421|NCT02536833|40192547|FG003|Overall Study|Discontinued Before Treatment|2|||
16468422|NCT02536833|40192544|FG000|Overall Study|Adverse Event|1|||
16468423|NCT02536833|40192545|FG001|Overall Study|Adverse Event|3|||
16468424|NCT02536833|40192546|FG002|Overall Study|Adverse Event|4|||
16468425|NCT02536833|40192547|FG003|Overall Study|Adverse Event|1|||
16468426|NCT02536833|40192544|FG000|Overall Study|Lost to Follow-up|2|||
16468427|NCT02536833|40192545|FG001|Overall Study|Lost to Follow-up|1|||
16468428|NCT02536833|40192546|FG002|Overall Study|Lost to Follow-up|2|||
16468429|NCT02536833|40192547|FG003|Overall Study|Lost to Follow-up|2|||
16468430|NCT02536833|40192544|FG000|Overall Study|Physician Decision|0|||
16468431|NCT02536833|40192545|FG001|Overall Study|Physician Decision|0|||
16468432|NCT02536833|40192546|FG002|Overall Study|Physician Decision|0|||
16468433|NCT02536833|40192547|FG003|Overall Study|Physician Decision|1|||
16468434|NCT02536833|40192544|FG000|Overall Study|Site Terminated by Sponsor|2|||
16468435|NCT02536833|40192545|FG001|Overall Study|Site Terminated by Sponsor|2|||
16468436|NCT02536833|40192546|FG002|Overall Study|Site Terminated by Sponsor|2|||
16171509|NCT02034123|39107166|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171510|NCT02034123|39107167|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171511|NCT02034123|39107168|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
16171512|NCT02034123|39107169|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
16171513|NCT02034123|39107170|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171514|NCT02034123|39107171|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171515|NCT02034123|39107172|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171516|NCT02034123|39107173|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171517|NCT02034123|39107174|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171518|NCT02034123|39107175|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171519|NCT02034123|39107176|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16468437|NCT02536833|40192547|FG003|Overall Study|Site Terminated by Sponsor|2|||
16468438|NCT02536833|40192544|FG000|Overall Study|Subject Non-Compliance|0|||
16468439|NCT02536833|40192545|FG001|Overall Study|Subject Non-Compliance|1|||
16171520|NCT02034123|39107177|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171521|NCT02034123|39107178|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
16171522|NCT02034123|39107161|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171523|NCT02034123|39107162|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16468440|NCT02536833|40192546|FG002|Overall Study|Subject Non-Compliance|1|||
16468441|NCT02536833|40192547|FG003|Overall Study|Subject Non-Compliance|0|||
16468442|NCT02536833|40192544|FG000|Overall Study|Withdrawal by Subject|4|||
16468443|NCT02536833|40192545|FG001|Overall Study|Withdrawal by Subject|3|||
16468444|NCT02536833|40192546|FG002|Overall Study|Withdrawal by Subject|5|||
16468445|NCT02536833|40192547|FG003|Overall Study|Withdrawal by Subject|11|||
16468446|NCT05463198|40192549|FG000|Overall Study|Withdrawal by Subject|19|||
16468447|NCT05463198|40192549|FG000|Overall Study|Procedure Notes Missing|18|||
16468448|NCT01233687|40192551|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
16468449|NCT01233687|40192551|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
16468450|NCT01233687|40192551|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
16468451|NCT00290407|40192557|FG000|Overall Study|Physician Decision|2|||
16468452|NCT02233946|40192558|FG000|Baseline|Withdrawal by Subject|2|||
16468453|NCT02233946|40192559|FG001|Baseline|Withdrawal by Subject|0|||
16468454|NCT02233946|40192558|FG000|3-months Follow-up|Lost to Follow-up|53|||
16468455|NCT02233946|40192559|FG001|3-months Follow-up|Lost to Follow-up|29|||
16468456|NCT02233946|40192558|FG000|6-months Follow-up|Lost to Follow-up|21|||
16468457|NCT02233946|40192559|FG001|6-months Follow-up|Lost to Follow-up|2|||
16468458|NCT02233946|40192558|FG000|9-month Follow-up|Lost to Follow-up|20|||
16468459|NCT02233946|40192559|FG001|9-month Follow-up|Lost to Follow-up|11|||
16468460|NCT02233946|40192558|FG000|12-month Follow-up|Lost to Follow-up|28|||
16468461|NCT02233946|40192559|FG001|12-month Follow-up|Lost to Follow-up|11|||
16468462|NCT00476047|40192560|FG000|Overall Study|Lost to Follow-up|1|||
16468463|NCT01315236|40192562|FG000|Double-blind Phase|Death|1|||
16468464|NCT01315236|40192563|FG001|Double-blind Phase|Death|0|||
16468465|NCT01315236|40192562|FG000|Double-blind Phase|Adverse Event|1|||
16468466|NCT01315236|40192563|FG001|Double-blind Phase|Adverse Event|0|||
16468467|NCT01315236|40192562|FG000|Double-blind Phase|Withdrawal of Consent|1|||
16468468|NCT01315236|40192563|FG001|Double-blind Phase|Withdrawal of Consent|0|||
16468469|NCT01315236|40192562|FG000|Double-blind Phase|Lost to Follow-up|1|||
16468470|NCT01315236|40192563|FG001|Double-blind Phase|Lost to Follow-up|0|||
16468471|NCT01315236|40192562|FG000|Open-label Phase|Death|1|||
16468472|NCT01315236|40192563|FG001|Open-label Phase|Death|0|||
16468473|NCT01315236|40192562|FG000|Open-label Phase|Adverse Event|0|||
16171524|NCT02034123|39107163|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171525|NCT02034123|39107164|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
16171526|NCT02034123|39107165|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171527|NCT02034123|39107166|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171528|NCT02034123|39107167|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171529|NCT02034123|39107168|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171530|NCT02034123|39107169|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171531|NCT02034123|39107170|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171532|NCT02034123|39107171|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171533|NCT02034123|39107172|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171534|NCT02034123|39107173|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171535|NCT02034123|39107174|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171536|NCT02034123|39107175|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171537|NCT02034123|39107176|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171538|NCT02034123|39107177|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171539|NCT02034123|39107178|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
16171540|NCT02034123|39107161|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171541|NCT02034123|39107162|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171542|NCT02034123|39107163|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171543|NCT02034123|39107164|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16468474|NCT01315236|40192563|FG001|Open-label Phase|Adverse Event|1|||
16468475|NCT01315236|40192562|FG000|Open-label Phase|Other|0|||
16468476|NCT01315236|40192563|FG001|Open-label Phase|Other|1|||
16171544|NCT02034123|39107165|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171545|NCT02034123|39107166|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171546|NCT02034123|39107167|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171547|NCT02034123|39107168|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171548|NCT02034123|39107169|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
16171549|NCT02034123|39107170|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16173437|NCT01607892|39111209|FG004|Overall Study|Disease progression|9|||
16468477|NCT01315236|40192562|FG000|12-Month Follow-up Period|Death|0|||
16468478|NCT01315236|40192563|FG001|12-Month Follow-up Period|Death|1|||
16171550|NCT02034123|39107171|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171551|NCT02034123|39107172|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171552|NCT02034123|39107173|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16468479|NCT01315236|40192562|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
16468480|NCT01315236|40192563|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
16468481|NCT00669409|40192564|FG000|Part 2|Withdrawal by Subject|0|||
16468482|NCT00669409|40192565|FG001|Part 2|Withdrawal by Subject|0|||
16468483|NCT00669409|40192566|FG002|Part 2|Withdrawal by Subject|0|||
16468484|NCT00669409|40192567|FG003|Part 2|Withdrawal by Subject|0|||
16468485|NCT00669409|40192568|FG004|Part 2|Withdrawal by Subject|0|||
16468486|NCT00669409|40192569|FG005|Part 2|Withdrawal by Subject|0|||
16468487|NCT00669409|40192570|FG006|Part 2|Withdrawal by Subject|0|||
16468488|NCT00669409|40192571|FG007|Part 2|Withdrawal by Subject|0|||
16468489|NCT00669409|40192572|FG008|Part 2|Withdrawal by Subject|0|||
16468490|NCT00669409|40192573|FG009|Part 2|Withdrawal by Subject|1|||
16468491|NCT00669409|40192574|FG010|Part 2|Withdrawal by Subject|0|||
16468492|NCT02554279|40192576|FG000|Overall Study|Adverse Event|2|||
16468493|NCT02554279|40192577|FG001|Overall Study|Adverse Event|5|||
16468494|NCT02554279|40192576|FG000|Overall Study|Lost to Follow-up|3|||
16468495|NCT02554279|40192577|FG001|Overall Study|Lost to Follow-up|2|||
16468496|NCT02554279|40192576|FG000|Overall Study|Withdrawal by Subject|6|||
16468497|NCT02554279|40192577|FG001|Overall Study|Withdrawal by Subject|4|||
16468498|NCT02554279|40192576|FG000|Overall Study|Protocol Violation|2|||
16468499|NCT02554279|40192577|FG001|Overall Study|Protocol Violation|1|||
16171553|NCT02034123|39107174|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171554|NCT02034123|39107175|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171555|NCT02034123|39107176|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16468500|NCT02554279|40192576|FG000|Overall Study|Other reason|19|||
16468501|NCT02554279|40192577|FG001|Overall Study|Other reason|6|||
16468502|NCT00214500|40192584|FG000|Treatment Period|Adverse Event|1|||
16468503|NCT00214500|40192584|FG000|Extension Period|Withdrawal by Subject|2|||
16468504|NCT04285580|40192586|FG000|Overall Study|Protocol Violation|0|||
16468505|NCT04285580|40192587|FG001|Overall Study|Protocol Violation|1|||
16468506|NCT01426789|40192588|FG000|Part 1|Protocol deviation|0|||
16468507|NCT01426789|40192589|FG001|Part 1|Protocol deviation|1|||
16468508|NCT01426789|40192590|FG002|Part 1|Protocol deviation|0|||
16468509|NCT01426789|40192591|FG003|Part 1|Protocol deviation|0|||
16468510|NCT01426789|40192592|FG004|Part 1|Protocol deviation|0|||
16468511|NCT01426789|40192593|FG005|Part 1|Protocol deviation|0|||
16468512|NCT01426789|40192588|FG000|Part 1|Lost to Follow-up|1|||
16468513|NCT01426789|40192589|FG001|Part 1|Lost to Follow-up|2|||
16468514|NCT01426789|40192590|FG002|Part 1|Lost to Follow-up|0|||
16468515|NCT01426789|40192591|FG003|Part 1|Lost to Follow-up|0|||
16468516|NCT01426789|40192592|FG004|Part 1|Lost to Follow-up|0|||
16468517|NCT01426789|40192593|FG005|Part 1|Lost to Follow-up|0|||
16171556|NCT02034123|39107177|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171557|NCT02034123|39107178|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
16171558|NCT02034123|39107161|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171559|NCT02034123|39107162|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171560|NCT02034123|39107163|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171561|NCT02034123|39107164|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
16171562|NCT02034123|39107165|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
16468518|NCT01426789|40192588|FG000|Part 1|Lack of Efficacy|2|||
16468519|NCT01426789|40192589|FG001|Part 1|Lack of Efficacy|1|||
16468520|NCT01426789|40192590|FG002|Part 1|Lack of Efficacy|0|||
16468521|NCT01426789|40192591|FG003|Part 1|Lack of Efficacy|0|||
16468522|NCT01426789|40192592|FG004|Part 1|Lack of Efficacy|0|||
16468523|NCT01426789|40192593|FG005|Part 1|Lack of Efficacy|0|||
16468524|NCT01426789|40192588|FG000|Part 1|Adverse Event|3|||
16468525|NCT01426789|40192589|FG001|Part 1|Adverse Event|0|||
16468526|NCT01426789|40192590|FG002|Part 1|Adverse Event|0|||
16468527|NCT01426789|40192591|FG003|Part 1|Adverse Event|0|||
16468528|NCT01426789|40192592|FG004|Part 1|Adverse Event|0|||
16468529|NCT01426789|40192593|FG005|Part 1|Adverse Event|0|||
16468530|NCT01426789|40192588|FG000|Part 2|Protocol deviation|0|||
16468531|NCT01426789|40192589|FG001|Part 2|Protocol deviation|0|||
16468532|NCT01426789|40192590|FG002|Part 2|Protocol deviation|1|||
16171563|NCT02034123|39107166|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171564|NCT02034123|39107167|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171565|NCT02034123|39107168|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16468533|NCT01426789|40192591|FG003|Part 2|Protocol deviation|0|||
16468534|NCT01426789|40192592|FG004|Part 2|Protocol deviation|0|||
16468535|NCT01426789|40192593|FG005|Part 2|Protocol deviation|0|||
16468536|NCT01426789|40192588|FG000|Part 2|Death|0|||
16468537|NCT01426789|40192589|FG001|Part 2|Death|0|||
16468538|NCT01426789|40192590|FG002|Part 2|Death|1|||
16468539|NCT01426789|40192591|FG003|Part 2|Death|0|||
16468540|NCT01426789|40192592|FG004|Part 2|Death|1|||
16171566|NCT02034123|39107169|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171567|NCT02034123|39107170|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171568|NCT02034123|39107171|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171569|NCT02034123|39107172|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171570|NCT02034123|39107173|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171571|NCT02034123|39107174|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171572|NCT02034123|39107175|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171573|NCT02034123|39107176|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171574|NCT02034123|39107177|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171575|NCT02034123|39107178|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
16171576|NCT01475734|39107188|FG000|Overall Study|Withdrawal by Subject|1|||
16171577|NCT01475734|39107189|FG001|Overall Study|Withdrawal by Subject|0|||
16171578|NCT01475734|39107188|FG000|Overall Study|Protocol Violation|1|||
16171579|NCT01475734|39107189|FG001|Overall Study|Protocol Violation|0|||
16171580|NCT01475734|39107188|FG000|Overall Study|Physician Decision|0|||
16171581|NCT01475734|39107189|FG001|Overall Study|Physician Decision|1|||
16171582|NCT01946178|39107190|FG000|Overall Study|Pregnancy|1|||
16171583|NCT01946178|39107190|FG000|Overall Study|Lost to Follow-up|1|||
16171584|NCT00100048|39107191|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
16171585|NCT00100048|39107192|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
16468541|NCT01426789|40192593|FG005|Part 2|Death|0|||
16468542|NCT01426789|40192588|FG000|Part 2|Administrative problems|0|||
16468543|NCT01426789|40192589|FG001|Part 2|Administrative problems|0|||
16468544|NCT01426789|40192590|FG002|Part 2|Administrative problems|2|||
16468545|NCT01426789|40192591|FG003|Part 2|Administrative problems|0|||
16468546|NCT01426789|40192592|FG004|Part 2|Administrative problems|1|||
16468547|NCT01426789|40192593|FG005|Part 2|Administrative problems|0|||
16468548|NCT01426789|40192588|FG000|Part 2|Lost to Follow-up|0|||
16468549|NCT01426789|40192589|FG001|Part 2|Lost to Follow-up|0|||
16468550|NCT01426789|40192590|FG002|Part 2|Lost to Follow-up|4|||
16468551|NCT01426789|40192591|FG003|Part 2|Lost to Follow-up|0|||
16468552|NCT01426789|40192592|FG004|Part 2|Lost to Follow-up|1|||
16468553|NCT01426789|40192593|FG005|Part 2|Lost to Follow-up|0|||
16468554|NCT01426789|40192588|FG000|Part 2|Withdrawal by Subject|0|||
16468555|NCT01426789|40192589|FG001|Part 2|Withdrawal by Subject|0|||
16468556|NCT01426789|40192590|FG002|Part 2|Withdrawal by Subject|0|||
16468557|NCT01426789|40192591|FG003|Part 2|Withdrawal by Subject|1|||
16468558|NCT01426789|40192592|FG004|Part 2|Withdrawal by Subject|2|||
16468559|NCT01426789|40192593|FG005|Part 2|Withdrawal by Subject|0|||
16468560|NCT01426789|40192588|FG000|Part 2|Lack of Efficacy|0|||
16468561|NCT01426789|40192589|FG001|Part 2|Lack of Efficacy|0|||
16468562|NCT01426789|40192590|FG002|Part 2|Lack of Efficacy|5|||
16468563|NCT01426789|40192591|FG003|Part 2|Lack of Efficacy|0|||
16468564|NCT01426789|40192592|FG004|Part 2|Lack of Efficacy|2|||
16468565|NCT01426789|40192593|FG005|Part 2|Lack of Efficacy|0|||
16468566|NCT01426789|40192588|FG000|Part 2|Adverse Event|0|||
16468567|NCT01426789|40192589|FG001|Part 2|Adverse Event|0|||
16468568|NCT01426789|40192590|FG002|Part 2|Adverse Event|2|||
16468569|NCT01426789|40192591|FG003|Part 2|Adverse Event|0|||
16468570|NCT01426789|40192592|FG004|Part 2|Adverse Event|1|||
16468571|NCT01426789|40192593|FG005|Part 2|Adverse Event|0|||
16468572|NCT02290431|40192594|FG000|Overall Study|Adverse Event|20|||
16468573|NCT02290431|40192594|FG000|Overall Study|Progressive disease|4|||
16468574|NCT02290431|40192594|FG000|Overall Study|Study terminated by Sponsor|1|||
16468575|NCT02290431|40192594|FG000|Overall Study|Physician Decision|2|||
16468576|NCT00769483|40192595|FG000|Overall Study|Withdrawal by Subject|0|||
16468577|NCT00769483|40192596|FG001|Overall Study|Withdrawal by Subject|1|||
16468578|NCT00769483|40192597|FG002|Overall Study|Withdrawal by Subject|0|||
16468579|NCT00769483|40192598|FG003|Overall Study|Withdrawal by Subject|0|||
16468580|NCT00769483|40192599|FG004|Overall Study|Withdrawal by Subject|1|||
16468581|NCT00769483|40192600|FG005|Overall Study|Withdrawal by Subject|0|||
16468582|NCT02582255|40192601|FG000|Overall Study|Protocol Violation|0|||
16468583|NCT02582255|40192602|FG001|Overall Study|Protocol Violation|3|||
16468584|NCT03324581|40192603|FG000|Overall Study|Adverse Event|18|||
16171586|NCT00100048|39107193|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
16171587|NCT00100048|39107194|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
16171588|NCT00100048|39107195|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
16171589|NCT00100048|39107196|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
16171590|NCT00100048|39107191|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
16173594|NCT02764541|39111270|FG004|Overall Study|Disease progression|0|||
16468585|NCT03324581|40192604|FG001|Overall Study|Adverse Event|11|||
16468586|NCT03324581|40192605|FG002|Overall Study|Adverse Event|7|||
16468587|NCT03324581|40192603|FG000|Overall Study|Lack of Efficacy|0|||
16468588|NCT03324581|40192604|FG001|Overall Study|Lack of Efficacy|1|||
16468589|NCT03324581|40192605|FG002|Overall Study|Lack of Efficacy|0|||
16468590|NCT03324581|40192603|FG000|Overall Study|Lost to Follow-up|5|||
16468591|NCT03324581|40192604|FG001|Overall Study|Lost to Follow-up|3|||
16468592|NCT03324581|40192605|FG002|Overall Study|Lost to Follow-up|6|||
16468593|NCT03324581|40192603|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
16468594|NCT03324581|40192604|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
16468595|NCT03324581|40192605|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
16468596|NCT03324581|40192603|FG000|Overall Study|Physician Decision|0|||
16468597|NCT03324581|40192604|FG001|Overall Study|Physician Decision|1|||
16468598|NCT03324581|40192605|FG002|Overall Study|Physician Decision|2|||
16468599|NCT03324581|40192603|FG000|Overall Study|Protocol Deviation|8|||
16468600|NCT03324581|40192604|FG001|Overall Study|Protocol Deviation|9|||
16468601|NCT03324581|40192605|FG002|Overall Study|Protocol Deviation|4|||
16468602|NCT03324581|40192603|FG000|Overall Study|Withdrawal by Subject|6|||
16468603|NCT03324581|40192604|FG001|Overall Study|Withdrawal by Subject|8|||
16468604|NCT03324581|40192605|FG002|Overall Study|Withdrawal by Subject|6|||
16468605|NCT03324581|40192603|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
16468606|NCT03324581|40192604|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
16468607|NCT03324581|40192605|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
16468608|NCT03328182|40192606|FG000|Overall Study|Withdrawal by Subject|1|||
16468609|NCT03328182|40192606|FG000|Overall Study|Protocol Violation|2|||
16468610|NCT03328182|40192606|FG000|Overall Study|No Product Evaluated|1|||
16468611|NCT03021564|40192607|FG000|Overall Study|Death|84|||
16468612|NCT03021564|40192608|FG001|Overall Study|Death|466|||
16468613|NCT03021564|40192607|FG000|Overall Study|Lost to Follow-up|0|||
16468614|NCT03021564|40192608|FG001|Overall Study|Lost to Follow-up|2|||
16171591|NCT00100048|39107192|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
16171592|NCT00100048|39107193|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
16171593|NCT00100048|39107194|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
16171594|NCT00100048|39107195|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
16171595|NCT00100048|39107196|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
16171596|NCT00100048|39107191|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
16171597|NCT00100048|39107192|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
16171598|NCT00100048|39107193|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
16171599|NCT00100048|39107194|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
16171600|NCT00100048|39107195|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
16171601|NCT00100048|39107196|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
16171602|NCT00100048|39107191|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
16171603|NCT00100048|39107192|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
16171604|NCT00100048|39107193|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
16171605|NCT00100048|39107194|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
16171606|NCT00100048|39107195|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
16171607|NCT00100048|39107196|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
16171608|NCT00100048|39107191|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
16171609|NCT00100048|39107192|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
16171610|NCT00100048|39107193|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
16171611|NCT00100048|39107194|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
16171612|NCT00100048|39107195|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
16171613|NCT00100048|39107196|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
16468615|NCT04449029|40192609|FG000|Overall Study|Adverse Event|0|||
16468616|NCT04449029|40192610|FG001|Overall Study|Adverse Event|1|||
16468617|NCT04449029|40192611|FG002|Overall Study|Adverse Event|1|||
16468618|NCT04449029|40192612|FG003|Overall Study|Adverse Event|0|||
16468619|NCT04449029|40192613|FG004|Overall Study|Adverse Event|1|||
16468620|NCT04449029|40192614|FG005|Overall Study|Adverse Event|0|||
16468621|NCT04449029|40192615|FG006|Overall Study|Adverse Event|1|||
16468622|NCT04449029|40192616|FG007|Overall Study|Adverse Event|0|||
16468623|NCT04449029|40192609|FG000|Overall Study|Lost to Follow-up|0|||
16468624|NCT04449029|40192610|FG001|Overall Study|Lost to Follow-up|1|||
16468625|NCT04449029|40192611|FG002|Overall Study|Lost to Follow-up|0|||
16468626|NCT04449029|40192612|FG003|Overall Study|Lost to Follow-up|0|||
16468627|NCT04449029|40192613|FG004|Overall Study|Lost to Follow-up|0|||
16468628|NCT04449029|40192614|FG005|Overall Study|Lost to Follow-up|0|||
16468629|NCT04449029|40192615|FG006|Overall Study|Lost to Follow-up|0|||
16468630|NCT04449029|40192616|FG007|Overall Study|Lost to Follow-up|0|||
16468631|NCT04449029|40192609|FG000|Overall Study|Protocol Violation|0|||
16468632|NCT04449029|40192610|FG001|Overall Study|Protocol Violation|1|||
16468633|NCT04449029|40192611|FG002|Overall Study|Protocol Violation|0|||
16468634|NCT04449029|40192612|FG003|Overall Study|Protocol Violation|0|||
16468635|NCT04449029|40192613|FG004|Overall Study|Protocol Violation|0|||
16468636|NCT04449029|40192614|FG005|Overall Study|Protocol Violation|0|||
16468637|NCT04449029|40192615|FG006|Overall Study|Protocol Violation|0|||
16468638|NCT04449029|40192616|FG007|Overall Study|Protocol Violation|0|||
16468639|NCT04449029|40192609|FG000|Overall Study|Physician Decision|0|||
16468640|NCT04449029|40192610|FG001|Overall Study|Physician Decision|0|||
16468641|NCT04449029|40192611|FG002|Overall Study|Physician Decision|0|||
16468642|NCT04449029|40192612|FG003|Overall Study|Physician Decision|0|||
16468643|NCT04449029|40192613|FG004|Overall Study|Physician Decision|0|||
16468644|NCT04449029|40192614|FG005|Overall Study|Physician Decision|1|||
16468645|NCT04449029|40192615|FG006|Overall Study|Physician Decision|0|||
16468646|NCT04449029|40192616|FG007|Overall Study|Physician Decision|0|||
16468647|NCT04449029|40192609|FG000|Overall Study|Withdrawal by Subject|3|||
16468648|NCT04449029|40192610|FG001|Overall Study|Withdrawal by Subject|0|||
16468649|NCT04449029|40192611|FG002|Overall Study|Withdrawal by Subject|1|||
16468650|NCT04449029|40192612|FG003|Overall Study|Withdrawal by Subject|1|||
16468651|NCT04449029|40192613|FG004|Overall Study|Withdrawal by Subject|5|||
16468652|NCT04449029|40192614|FG005|Overall Study|Withdrawal by Subject|1|||
16468653|NCT04449029|40192615|FG006|Overall Study|Withdrawal by Subject|4|||
16468654|NCT04449029|40192616|FG007|Overall Study|Withdrawal by Subject|0|||
16468655|NCT02677324|40192622|FG000|Overall Study|Disease Progression|6|||
16468656|NCT02677324|40192622|FG000|Overall Study|Inability to Swallow pills|1|||
16468657|NCT02677324|40192622|FG000|Overall Study|Non-compliance|1|||
16468658|NCT02677324|40192622|FG000|Overall Study|Lack of Efficacy|1|||
16468659|NCT02677324|40192622|FG000|Overall Study|Medical insurance coverage|1|||
16468660|NCT02677324|40192622|FG000|Overall Study|Adverse Event|1|||
16468661|NCT02677324|40192622|FG000|Overall Study|IgM Myeloma diagnosis|1|||
16468662|NCT02927067|40192623|FG000|Overall Study|Withdrawn Consent|20|||
16468663|NCT02927067|40192624|FG001|Overall Study|Withdrawn Consent|12|||
16468664|NCT02927067|40192623|FG000|Overall Study|Death|18|||
16468665|NCT02927067|40192624|FG001|Overall Study|Death|31|||
16468666|NCT02927067|40192623|FG000|Overall Study|Adverse Event|13|||
16468667|NCT02927067|40192624|FG001|Overall Study|Adverse Event|10|||
16468668|NCT02927067|40192623|FG000|Overall Study|Noncompliance|5|||
16468669|NCT02927067|40192624|FG001|Overall Study|Noncompliance|2|||
16468670|NCT02927067|40192623|FG000|Overall Study|Reason not Specified|4|||
16468671|NCT02927067|40192624|FG001|Overall Study|Reason not Specified|6|||
16468672|NCT00924170|40192625|FG000|Overall Study|Refused further treatment|0|||
16468673|NCT00924170|40192626|FG001|Overall Study|Refused further treatment|1|||
16468674|NCT00924170|40192625|FG000|Overall Study|Physician Decision|0|||
16468675|NCT00924170|40192626|FG001|Overall Study|Physician Decision|1|||
16468676|NCT00924170|40192625|FG000|Overall Study|Progressive disease|3|||
16468677|NCT00924170|40192626|FG001|Overall Study|Progressive disease|6|||
16468678|NCT00924170|40192625|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
16468679|NCT00924170|40192626|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
16468680|NCT00924170|40192625|FG000|Overall Study|Death|1|||
16468681|NCT00924170|40192626|FG001|Overall Study|Death|0|||
16468682|NCT04389970|40196295|FG000|Overall Study|Lost to Follow-up|1|||
16468683|NCT00873860|40196296|FG000|Overall Study|Lost to Follow-up|1|||
16468684|NCT00873860|40196297|FG001|Overall Study|Lost to Follow-up|0|||
16468685|NCT00873860|40196298|FG002|Overall Study|Lost to Follow-up|0|||
16468686|NCT00873860|40196299|FG003|Overall Study|Lost to Follow-up|1|||
16468687|NCT00873860|40196296|FG000|Overall Study|Withdrawal by Subject|1|||
16468688|NCT00873860|40196297|FG001|Overall Study|Withdrawal by Subject|0|||
16468689|NCT00873860|40196298|FG002|Overall Study|Withdrawal by Subject|2|||
16468690|NCT00873860|40196299|FG003|Overall Study|Withdrawal by Subject|0|||
16468691|NCT00873860|40196296|FG000|Overall Study|Death|1|||
16468692|NCT00873860|40196297|FG001|Overall Study|Death|0|||
16468693|NCT00873860|40196298|FG002|Overall Study|Death|0|||
16468694|NCT00873860|40196299|FG003|Overall Study|Death|0|||
16468695|NCT00873860|40196296|FG000|Overall Study|Other|1|||
16468696|NCT00873860|40196297|FG001|Overall Study|Other|0|||
16468697|NCT00873860|40196298|FG002|Overall Study|Other|1|||
16468698|NCT00873860|40196299|FG003|Overall Study|Other|0|||
16468699|NCT00821327|40196300|FG000|Overall Study|Adverse Event|13|||
16468700|NCT00821327|40196300|FG000|Overall Study|Patient Request|1|||
16468701|NCT00821327|40196300|FG000|Overall Study|Investigator Request|2|||
16468702|NCT00821327|40196300|FG000|Overall Study|Sponsor Request|1|||
16468703|NCT00821327|40196300|FG000|Overall Study|Disease Progression|13|||
16468704|NCT00821327|40196300|FG000|Overall Study|Other/Unknown|5|||
16468705|NCT00450112|40196301|FG000|Overall Study|Other Treatment Required|5|||
16468706|NCT00450112|40196302|FG001|Overall Study|Other Treatment Required|1|||
16468707|NCT00450112|40196301|FG000|Overall Study|Withdrawal by Subject|4|||
16468708|NCT00450112|40196302|FG001|Overall Study|Withdrawal by Subject|1|||
16468709|NCT00450112|40196301|FG000|Overall Study|Lost to Follow-up|2|||
16468710|NCT00450112|40196302|FG001|Overall Study|Lost to Follow-up|1|||
16468711|NCT00450112|40196301|FG000|Overall Study|Others|2|||
16468712|NCT00450112|40196302|FG001|Overall Study|Others|3|||
16468713|NCT01155479|40196303|FG000|Part I|Adverse Event|13|||
16468714|NCT01155479|40196304|FG001|Part I|Adverse Event|8|||
16468715|NCT01155479|40196305|FG002|Part I|Adverse Event|18|||
16468716|NCT01155479|40196306|FG003|Part I|Adverse Event|7|||
16468717|NCT01155479|40196307|FG004|Part I|Adverse Event|6|||
16468718|NCT01155479|40196303|FG000|Part I|Administrative|2|||
16468719|NCT01155479|40196304|FG001|Part I|Administrative|2|||
16468720|NCT01155479|40196305|FG002|Part I|Administrative|2|||
16468721|NCT01155479|40196306|FG003|Part I|Administrative|0|||
16468722|NCT01155479|40196307|FG004|Part I|Administrative|0|||
16468723|NCT01155479|40196303|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
16468724|NCT01155479|40196304|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
16468725|NCT01155479|40196305|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
16468726|NCT01155479|40196306|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
16468727|NCT01155479|40196307|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
16468728|NCT01155479|40196303|FG000|Part I|Withdrawal by Subject|11|||
16468729|NCT01155479|40196304|FG001|Part I|Withdrawal by Subject|13|||
16468730|NCT01155479|40196305|FG002|Part I|Withdrawal by Subject|8|||
16468731|NCT01155479|40196306|FG003|Part I|Withdrawal by Subject|8|||
16468732|NCT01155479|40196307|FG004|Part I|Withdrawal by Subject|9|||
16468733|NCT01155479|40196303|FG000|Part I|Lost to Follow-up|0|||
16468734|NCT01155479|40196304|FG001|Part I|Lost to Follow-up|0|||
16468735|NCT01155479|40196305|FG002|Part I|Lost to Follow-up|1|||
16468736|NCT01155479|40196306|FG003|Part I|Lost to Follow-up|1|||
16468737|NCT01155479|40196307|FG004|Part I|Lost to Follow-up|0|||
16468738|NCT01155479|40196303|FG000|Part I|Treatment Failure|3|||
16468739|NCT01155479|40196304|FG001|Part I|Treatment Failure|0|||
16468740|NCT01155479|40196305|FG002|Part I|Treatment Failure|3|||
16468741|NCT01155479|40196306|FG003|Part I|Treatment Failure|1|||
16468742|NCT01155479|40196307|FG004|Part I|Treatment Failure|2|||
16468743|NCT01155479|40196303|FG000|Part I|Did Not Receive Treatment|4|||
16468744|NCT01155479|40196304|FG001|Part I|Did Not Receive Treatment|2|||
16468745|NCT01155479|40196305|FG002|Part I|Did Not Receive Treatment|2|||
16468746|NCT01155479|40196306|FG003|Part I|Did Not Receive Treatment|6|||
16468747|NCT01155479|40196307|FG004|Part I|Did Not Receive Treatment|1|||
16468748|NCT01155479|40196303|FG000|Part I|Non-Compliance with Protocol|2|||
16468749|NCT01155479|40196304|FG001|Part I|Non-Compliance with Protocol|1|||
16468750|NCT01155479|40196305|FG002|Part I|Non-Compliance with Protocol|3|||
16468751|NCT01155479|40196306|FG003|Part I|Non-Compliance with Protocol|3|||
16468752|NCT01155479|40196307|FG004|Part I|Non-Compliance with Protocol|2|||
16468753|NCT01155479|40196303|FG000|Part II|Adverse Event|7|||
16468754|NCT01155479|40196304|FG001|Part II|Adverse Event|6|||
16468755|NCT01155479|40196305|FG002|Part II|Adverse Event|8|||
16171614|NCT00100048|39107191|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
16171615|NCT00100048|39107192|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
16171616|NCT00100048|39107193|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
16171617|NCT00100048|39107194|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
16171618|NCT00100048|39107195|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
16171619|NCT00100048|39107196|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
16171620|NCT00100048|39107191|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
16171621|NCT00100048|39107192|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
16171622|NCT00100048|39107193|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
16468756|NCT01155479|40196306|FG003|Part II|Adverse Event|3|||
16468757|NCT01155479|40196307|FG004|Part II|Adverse Event|4|||
16468758|NCT01155479|40196303|FG000|Part II|Administrative|43|||
16468759|NCT01155479|40196304|FG001|Part II|Administrative|49|||
16468760|NCT01155479|40196305|FG002|Part II|Administrative|36|||
16468761|NCT01155479|40196306|FG003|Part II|Administrative|38|||
16468762|NCT01155479|40196307|FG004|Part II|Administrative|46|||
16468763|NCT01155479|40196303|FG000|Part II|Withdrawal by Subject|8|||
16468764|NCT01155479|40196304|FG001|Part II|Withdrawal by Subject|4|||
16468765|NCT01155479|40196305|FG002|Part II|Withdrawal by Subject|12|||
16468766|NCT01155479|40196306|FG003|Part II|Withdrawal by Subject|7|||
16468767|NCT01155479|40196307|FG004|Part II|Withdrawal by Subject|3|||
16468768|NCT01155479|40196303|FG000|Part II|Lost to Follow-up|1|||
16468769|NCT01155479|40196304|FG001|Part II|Lost to Follow-up|0|||
16468770|NCT01155479|40196305|FG002|Part II|Lost to Follow-up|0|||
16468771|NCT01155479|40196306|FG003|Part II|Lost to Follow-up|0|||
16468772|NCT01155479|40196307|FG004|Part II|Lost to Follow-up|1|||
16468773|NCT01155479|40196303|FG000|Part II|Treatment Failure|0|||
16468774|NCT01155479|40196304|FG001|Part II|Treatment Failure|1|||
16468775|NCT01155479|40196305|FG002|Part II|Treatment Failure|2|||
16468776|NCT01155479|40196306|FG003|Part II|Treatment Failure|0|||
16468777|NCT01155479|40196307|FG004|Part II|Treatment Failure|1|||
16468778|NCT01155479|40196303|FG000|Part II|Non-Compliance with Protocol|0|||
16468779|NCT01155479|40196304|FG001|Part II|Non-Compliance with Protocol|1|||
16468780|NCT01155479|40196305|FG002|Part II|Non-Compliance with Protocol|0|||
16468781|NCT01155479|40196306|FG003|Part II|Non-Compliance with Protocol|2|||
16468782|NCT01155479|40196307|FG004|Part II|Non-Compliance with Protocol|0|||
16468783|NCT00622739|40196308|FG000|Overall Study|Physician Decision|1|||
16468784|NCT00622739|40196309|FG001|Overall Study|Physician Decision|0|||
16468785|NCT00622739|40196308|FG000|Overall Study|Adverse Event|1|||
16468786|NCT00622739|40196309|FG001|Overall Study|Adverse Event|2|||
16468787|NCT00622739|40196308|FG000|Overall Study|Lack of Efficacy|0|||
16468788|NCT00622739|40196309|FG001|Overall Study|Lack of Efficacy|2|||
16468789|NCT00622739|40196308|FG000|Overall Study|Withdrawal by Subject|0|||
16468790|NCT00622739|40196309|FG001|Overall Study|Withdrawal by Subject|1|||
16468791|NCT00622739|40196308|FG000|Overall Study|Lost to Follow-up|0|||
16468792|NCT00622739|40196309|FG001|Overall Study|Lost to Follow-up|1|||
16468793|NCT01624870|40196310|FG000|Overall Study|Death|19|||
16468794|NCT01624870|40196310|FG000|Overall Study|Withdrawal by Subject|1|||
16468795|NCT01624870|40196310|FG000|Overall Study|CoreValve not implanted|6|||
16468796|NCT01624870|40196310|FG000|Overall Study|Lost to follow up|1|||
16468797|NCT01172275|40196311|FG000|Overall Study|Lost to Follow-up|1|||
16468798|NCT01172275|40196312|FG001|Overall Study|Lost to Follow-up|0|||
16468799|NCT01172275|40196311|FG000|Overall Study|Protocol Violation|1|||
16468800|NCT01172275|40196312|FG001|Overall Study|Protocol Violation|0|||
16468801|NCT01439347|40196318|FG000|Overall Study|Death|10|||
16468802|NCT01439347|40196319|FG001|Overall Study|Death|9|||
16468803|NCT01439347|40196318|FG000|Overall Study|Withdrawal by Subject|0|||
16468804|NCT01439347|40196319|FG001|Overall Study|Withdrawal by Subject|1|||
16468805|NCT01439347|40196318|FG000|Overall Study|Physician Decision|1|||
16468806|NCT01439347|40196319|FG001|Overall Study|Physician Decision|0|||
16468807|NCT01439347|40196318|FG000|Overall Study|Sponsor Terminated Study|2|||
16468808|NCT01439347|40196319|FG001|Overall Study|Sponsor Terminated Study|3|||
16468809|NCT01226121|40196320|FG000|Overall Study|Lost to Follow-up|2|||
16468810|NCT01226121|40196321|FG001|Overall Study|Lost to Follow-up|0|||
16468811|NCT01226121|40196322|FG002|Overall Study|Lost to Follow-up|1|||
16468812|NCT03475875|40196324|FG000|Period 1|Lost to Follow-up|1|||
16468813|NCT03475875|40196325|FG001|Period 1|Lost to Follow-up|0|||
16468814|NCT03475875|40196324|FG000|Period 1|Adverse Event|2|||
16468815|NCT03475875|40196325|FG001|Period 1|Adverse Event|1|||
16171623|NCT00100048|39107194|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
16171624|NCT00100048|39107195|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
16171625|NCT00100048|39107196|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
16171626|NCT00100048|39107191|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
16171627|NCT00100048|39107192|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
16171628|NCT00100048|39107193|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
16171629|NCT00100048|39107194|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
16171630|NCT00100048|39107195|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
16171631|NCT00100048|39107196|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
16171632|NCT01107444|39107197|FG000|Overall Study|Withdrawal by Subject|8|||
16171633|NCT01107444|39107198|FG001|Overall Study|Withdrawal by Subject|12|||
16171634|NCT01107444|39107197|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
16171635|NCT01107444|39107198|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
16171636|NCT02921425|39107201|FG000|Overall Study|Protocol Violation|9|||
16171637|NCT01934504|39107204|FG000|Overall Study|Protocol Deviation|0|||
16171638|NCT01934504|39107205|FG001|Overall Study|Protocol Deviation|0|||
16171639|NCT01934504|39107206|FG002|Overall Study|Protocol Deviation|0|||
16171640|NCT01934504|39107207|FG003|Overall Study|Protocol Deviation|2|||
16171641|NCT01934504|39107204|FG000|Overall Study|Study Terminated by Sponsor|1|||
16171642|NCT01934504|39107205|FG001|Overall Study|Study Terminated by Sponsor|0|||
16171643|NCT01934504|39107206|FG002|Overall Study|Study Terminated by Sponsor|5|||
16171644|NCT01934504|39107207|FG003|Overall Study|Study Terminated by Sponsor|5|||
16171645|NCT00486603|39107210|FG000|Overall Study|Withdrawal by Subject|1|||
16171646|NCT00486603|39107211|FG001|Overall Study|Withdrawal by Subject|0|||
16171647|NCT00486603|39107212|FG002|Overall Study|Withdrawal by Subject|0|||
16171648|NCT00486603|39107213|FG003|Overall Study|Withdrawal by Subject|0|||
16171649|NCT00486603|39107214|FG004|Overall Study|Withdrawal by Subject|0|||
16171650|NCT00486603|39107210|FG000|Overall Study|Physician Decision|0|||
16171651|NCT00486603|39107211|FG001|Overall Study|Physician Decision|1|||
16171652|NCT00486603|39107212|FG002|Overall Study|Physician Decision|0|||
16171653|NCT00486603|39107213|FG003|Overall Study|Physician Decision|0|||
16171654|NCT00486603|39107214|FG004|Overall Study|Physician Decision|0|||
16171655|NCT02347631|39107215|FG000|First Intervention (2 Months)|Adverse Event|1|||
16171656|NCT02347631|39107216|FG001|First Intervention (2 Months)|Adverse Event|1|||
16468816|NCT03475875|40196324|FG000|Period 2|Adverse Event|3|||
16468817|NCT03475875|40196325|FG001|Period 2|Adverse Event|0|||
16468818|NCT03475875|40196324|FG000|Period 2|Protocol Violation|0|||
16468819|NCT03475875|40196325|FG001|Period 2|Protocol Violation|1|||
16468820|NCT01888003|40196326|FG000|Overall Study|Study Terminated|5|||
16468821|NCT01888003|40196327|FG001|Overall Study|Study Terminated|6|||
16468822|NCT01888003|40196328|FG002|Overall Study|Study Terminated|40|||
16468823|NCT01362595|40196331|FG000|Overall Study|Screen failure|10|||
16468824|NCT01362595|40196331|FG000|Overall Study|Withdrawal by Subject|2|||
16468825|NCT00609362|40196332|FG000|Overall Study|Withdrawal by Subject|2|||
16468826|NCT00609362|40196333|FG001|Overall Study|Withdrawal by Subject|1|||
16468827|NCT00609362|40196332|FG000|Overall Study|Adverse Event|1|||
16468828|NCT00609362|40196333|FG001|Overall Study|Adverse Event|0|||
16468829|NCT03123185|40196334|FG000|Overall Study|Withdrawal by Subject|0|||
16468830|NCT03123185|40196335|FG001|Overall Study|Withdrawal by Subject|0|||
16468831|NCT03123185|40196336|FG002|Overall Study|Withdrawal by Subject|0|||
16468832|NCT03123185|40196337|FG003|Overall Study|Withdrawal by Subject|0|||
16468833|NCT03123185|40196338|FG004|Overall Study|Withdrawal by Subject|0|||
16468834|NCT03123185|40196339|FG005|Overall Study|Withdrawal by Subject|0|||
16468835|NCT03123185|40196340|FG006|Overall Study|Withdrawal by Subject|0|||
16468836|NCT03123185|40196341|FG007|Overall Study|Withdrawal by Subject|0|||
16468837|NCT03123185|40196342|FG008|Overall Study|Withdrawal by Subject|0|||
16468838|NCT03123185|40196343|FG009|Overall Study|Withdrawal by Subject|0|||
16468839|NCT03123185|40196344|FG010|Overall Study|Withdrawal by Subject|0|||
16468840|NCT03123185|40196345|FG011|Overall Study|Withdrawal by Subject|0|||
16468841|NCT03123185|40196346|FG012|Overall Study|Withdrawal by Subject|1|||
16468842|NCT03123185|40196347|FG013|Overall Study|Withdrawal by Subject|0|||
16468843|NCT03370289|40196350|FG000|Overall Study|Screen Failure|1|||
16468844|NCT03370289|40196350|FG000|Overall Study|Sample Size Sufficient|4|||
16468845|NCT02160002|40196351|FG000|Overall Study|Withdrawal by Subject|2|||
16468846|NCT02160002|40196352|FG001|Overall Study|Withdrawal by Subject|1|||
16468847|NCT00761748|40196353|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
16468848|NCT00761748|40196354|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
16468849|NCT00761748|40196353|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
16468850|NCT00761748|40196354|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
16468851|NCT00586326|40196355|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
16468852|NCT00586326|40196355|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
16468853|NCT00586326|40196355|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
16468854|NCT00586326|40196355|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
16468855|NCT00586326|40196355|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
16468856|NCT00586326|40196355|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
16468857|NCT00586326|40196355|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
16468858|NCT00586326|40196355|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
16468859|NCT00586326|40196355|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
16468860|NCT00586326|40196355|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
16468861|NCT00586326|40196355|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
16468862|NCT00586326|40196355|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
16468863|NCT00586326|40196355|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
16468864|NCT00586326|40196355|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
16468865|NCT00586326|40196355|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
16468866|NCT00586326|40196355|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
16468867|NCT00586326|40196355|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
16468868|NCT02230527|40196356|FG000|Overall Study|Withdrawal by Subject|1|||
16468869|NCT02230527|40196357|FG001|Overall Study|Withdrawal by Subject|1|||
16468870|NCT02230527|40196356|FG000|Overall Study|Death|1|||
16468871|NCT02230527|40196357|FG001|Overall Study|Death|0|||
16468872|NCT02230527|40196356|FG000|Overall Study|Lost to Follow-up|2|||
16468873|NCT02230527|40196357|FG001|Overall Study|Lost to Follow-up|1|||
16468874|NCT02230527|40196356|FG000|Overall Study|Other|1|||
16468875|NCT02230527|40196357|FG001|Overall Study|Other|0|||
16468876|NCT01009281|40196360|FG000|Overall Study|Administrative problems|7|||
16468877|NCT01011478|40196363|FG000|Overall Study|No follow up data|12|||
16468878|NCT01011478|40196364|FG001|Overall Study|No follow up data|7|||
16468879|NCT00381381|40196365|FG000|Overall Study|Adverse Event|3|||
16468880|NCT00381381|40196365|FG000|Overall Study|Lost to Follow-up|52|||
16468881|NCT00381381|40196365|FG000|Overall Study|Withdrawal by Subject|9|||
16468882|NCT03891667|40196366|FG000|Overall Study|Physician Decision|1|||
16468883|NCT03891667|40196367|FG001|Overall Study|Physician Decision|0|||
16468884|NCT03891667|40196366|FG000|Overall Study|COVID related pause|1|||
16468885|NCT03891667|40196367|FG001|Overall Study|COVID related pause|1|||
16468886|NCT03891667|40196366|FG000|Overall Study|Withdrawal by Subject|0|||
16468887|NCT03891667|40196367|FG001|Overall Study|Withdrawal by Subject|1|||
16468888|NCT03891667|40196366|FG000|Overall Study|Adverse Event|0|||
16468889|NCT03891667|40196367|FG001|Overall Study|Adverse Event|1|||
16468890|NCT04854642|40196368|FG000|Overall Study|Adverse Event|1|||
16468891|NCT04854642|40196369|FG001|Overall Study|Adverse Event|2|||
16468892|NCT04854642|40196368|FG000|Overall Study|Withdrawal by Subject|0|||
16468893|NCT04854642|40196369|FG001|Overall Study|Withdrawal by Subject|1|||
16171657|NCT02347631|39107215|FG000|First Intervention (2 Months)|Pregnancy|1|||
16171658|NCT02347631|39107216|FG001|First Intervention (2 Months)|Pregnancy|0|||
16171659|NCT02347631|39107215|FG000|First Intervention (2 Months)|Moved out of area|0|||
16171660|NCT02347631|39107216|FG001|First Intervention (2 Months)|Moved out of area|2|||
16171661|NCT02347631|39107215|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
16171662|NCT02347631|39107216|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
16171663|NCT02347631|39107215|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
16468894|NCT01609478|40196372|FG000|Overall Study|Adverse Event|3|||
16171664|NCT02347631|39107216|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
16468895|NCT01609478|40196373|FG001|Overall Study|Adverse Event|1|||
16468896|NCT01609478|40196374|FG002|Overall Study|Adverse Event|5|||
16468897|NCT01609478|40196372|FG000|Overall Study|Protocol Deviation|0|||
16468898|NCT01609478|40196373|FG001|Overall Study|Protocol Deviation|1|||
16468899|NCT01609478|40196374|FG002|Overall Study|Protocol Deviation|1|||
16468900|NCT01609478|40196372|FG000|Overall Study|Non-Compliance with study treatment|1|||
16468901|NCT01609478|40196373|FG001|Overall Study|Non-Compliance with study treatment|0|||
16468902|NCT01609478|40196374|FG002|Overall Study|Non-Compliance with study treatment|0|||
16468903|NCT01609478|40196372|FG000|Overall Study|Physician Decision|1|||
16468904|NCT01609478|40196373|FG001|Overall Study|Physician Decision|0|||
16171665|NCT02347631|39107215|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
16171666|NCT02347631|39107216|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
16468905|NCT01609478|40196374|FG002|Overall Study|Physician Decision|1|||
16468906|NCT01609478|40196372|FG000|Overall Study|Withdrawal by Subject|2|||
16468907|NCT01609478|40196373|FG001|Overall Study|Withdrawal by Subject|0|||
16468908|NCT01609478|40196374|FG002|Overall Study|Withdrawal by Subject|2|||
16468909|NCT01857310|40196375|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
16468910|NCT01857310|40196376|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
16468911|NCT01306877|40196377|FG000|Overall Study|Lost to Follow-up|3|||
16468912|NCT01306877|40196378|FG001|Overall Study|Lost to Follow-up|3|||
16468913|NCT01306877|40196377|FG000|Overall Study|Physician Decision|0|||
16468914|NCT01306877|40196378|FG001|Overall Study|Physician Decision|1|||
16468915|NCT00427960|40196379|FG000|Overall Study|Adverse Event|2|||
16468916|NCT00427960|40196380|FG001|Overall Study|Adverse Event|0|||
16468917|NCT00427960|40196379|FG000|Overall Study|Withdrawal by Subject|0|||
16468918|NCT00427960|40196380|FG001|Overall Study|Withdrawal by Subject|3|||
16171667|NCT02347631|39107215|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
16171668|NCT02347631|39107216|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
16171669|NCT02347631|39107215|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
16171670|NCT02347631|39107216|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
16171671|NCT02945657|39107217|FG000|Overall Study|Adverse Event|1|||
16171672|NCT02945657|39107217|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
16171673|NCT02970929|39107218|FG000|Overall Study|Adverse Event|18|||
16171674|NCT02970929|39107218|FG000|Overall Study|Lack of Efficacy|8|||
16171675|NCT02970929|39107218|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
16171676|NCT02970929|39107218|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
16171677|NCT02970929|39107218|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
16171678|NCT02970929|39107218|FG000|Overall Study|LOST TO FOLLOWUP|6|||
16171679|NCT02970929|39107218|FG000|Overall Study|MOVED OUT OF STATE|1|||
16171680|NCT02970929|39107218|FG000|Overall Study|Withdrawal by Subject|16|||
16171681|NCT03403400|39107220|FG000|Overall Study|Lost to Follow-up|1|||
16171682|NCT03403400|39107221|FG001|Overall Study|Lost to Follow-up|0|||
16171683|NCT03403400|39107222|FG002|Overall Study|Lost to Follow-up|1|||
16171684|NCT03403400|39107220|FG000|Overall Study|Hospitalization|1|||
16171685|NCT03403400|39107221|FG001|Overall Study|Hospitalization|0|||
16171686|NCT03403400|39107222|FG002|Overall Study|Hospitalization|0|||
16171687|NCT03403400|39107220|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
16171688|NCT03403400|39107221|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
16171689|NCT03403400|39107222|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
16171690|NCT00642642|39107225|FG000|Treatment & Follow Up|Adverse Event|2|||
16171691|NCT00642642|39107225|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
16171692|NCT00642642|39107225|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
16171693|NCT01731002|39107245|FG000|Overall Study|Adverse Event|0|||
16171694|NCT01731002|39107246|FG001|Overall Study|Adverse Event|2|||
16171695|NCT01731002|39107247|FG002|Overall Study|Adverse Event|2|||
16171696|NCT01731002|39107245|FG000|Overall Study|Non-Compliant|0|||
16171697|NCT01731002|39107246|FG001|Overall Study|Non-Compliant|1|||
16171698|NCT01731002|39107247|FG002|Overall Study|Non-Compliant|0|||
16171699|NCT01731002|39107245|FG000|Overall Study|Lost to Follow-up|1|||
16171700|NCT01731002|39107246|FG001|Overall Study|Lost to Follow-up|0|||
16171701|NCT01731002|39107247|FG002|Overall Study|Lost to Follow-up|0|||
16171702|NCT01731002|39107245|FG000|Overall Study|Test Agent Discontinuation|0|||
16171703|NCT01731002|39107246|FG001|Overall Study|Test Agent Discontinuation|1|||
16171704|NCT01731002|39107247|FG002|Overall Study|Test Agent Discontinuation|0|||
16171705|NCT01731002|39107245|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
16171706|NCT01731002|39107246|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
16171707|NCT01731002|39107247|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
16171708|NCT01731002|39107245|FG000|Overall Study|Elevated IOP|1|||
16171709|NCT01731002|39107246|FG001|Overall Study|Elevated IOP|0|||
16171710|NCT01731002|39107247|FG002|Overall Study|Elevated IOP|0|||
16171711|NCT01731002|39107245|FG000|Overall Study|Inappropriate use of study medications|0|||
16171712|NCT01731002|39107246|FG001|Overall Study|Inappropriate use of study medications|0|||
16171713|NCT01731002|39107247|FG002|Overall Study|Inappropriate use of study medications|1|||
16171714|NCT00496366|39107248|FG000|Overall Study|Death|1|||
16269331|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
16468919|NCT00427960|40196379|FG000|Overall Study|Other|0|||
16171715|NCT04398732|39107249|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
16171716|NCT00855439|39107250|FG000|Overall Study|Withdrawal by Subject|2|||
16468920|NCT00427960|40196380|FG001|Overall Study|Other|1|||
16171717|NCT00855439|39107251|FG001|Overall Study|Withdrawal by Subject|0|||
16171718|NCT00855439|39107250|FG000|Overall Study|Pregnancy|1|||
16171719|NCT00855439|39107251|FG001|Overall Study|Pregnancy|0|||
16171720|NCT01614964|39107252|FG000|Overall Study|Withdrawal by Subject|2|||
16171721|NCT01614964|39107253|FG001|Overall Study|Withdrawal by Subject|0|||
16171722|NCT01614964|39107252|FG000|Overall Study|Lost to Follow-up|3|||
16171723|NCT01614964|39107253|FG001|Overall Study|Lost to Follow-up|0|||
16171724|NCT00888355|39107254|FG000|Overall Study|Adverse Event|10|||
16171725|NCT00888355|39107255|FG001|Overall Study|Adverse Event|0|||
16171726|NCT00888355|39107256|FG002|Overall Study|Adverse Event|3|||
16171727|NCT00888355|39107257|FG003|Overall Study|Adverse Event|3|||
16171728|NCT00888355|39107254|FG000|Overall Study|Lack of Efficacy|9|||
16171729|NCT00888355|39107255|FG001|Overall Study|Lack of Efficacy|2|||
16171730|NCT00888355|39107256|FG002|Overall Study|Lack of Efficacy|5|||
16171731|NCT00888355|39107257|FG003|Overall Study|Lack of Efficacy|2|||
16171732|NCT00888355|39107254|FG000|Overall Study|Lost to Follow-up|0|||
16171733|NCT00888355|39107255|FG001|Overall Study|Lost to Follow-up|2|||
16171734|NCT00888355|39107256|FG002|Overall Study|Lost to Follow-up|2|||
16171735|NCT00888355|39107257|FG003|Overall Study|Lost to Follow-up|0|||
16171736|NCT00888355|39107254|FG000|Overall Study|Protocol Violation|3|||
16171737|NCT00888355|39107255|FG001|Overall Study|Protocol Violation|2|||
16171738|NCT00888355|39107256|FG002|Overall Study|Protocol Violation|1|||
16171739|NCT00888355|39107257|FG003|Overall Study|Protocol Violation|2|||
16171740|NCT00888355|39107254|FG000|Overall Study|Withdrawal by Subject|0|||
16171741|NCT00888355|39107255|FG001|Overall Study|Withdrawal by Subject|3|||
16171742|NCT00888355|39107256|FG002|Overall Study|Withdrawal by Subject|1|||
16171743|NCT00888355|39107257|FG003|Overall Study|Withdrawal by Subject|3|||
16171744|NCT00833092|39107264|FG000|Overall Study|Withdrawal by Subject|2|||
16171745|NCT00833092|39107265|FG001|Overall Study|Withdrawal by Subject|3|||
16171746|NCT00833092|39107264|FG000|Overall Study|Protocol Violation|2|||
16171747|NCT00833092|39107265|FG001|Overall Study|Protocol Violation|1|||
16171748|NCT00833092|39107264|FG000|Overall Study|Diarrhea|0|||
16171749|NCT00833092|39107265|FG001|Overall Study|Diarrhea|2|||
16171750|NCT00833092|39107264|FG000|Overall Study|constipation|0|||
16171751|NCT00833092|39107265|FG001|Overall Study|constipation|1|||
16171752|NCT03569202|39107272|FG000|Part 3|Physician Decision|1|||
16171753|NCT03569202|39107273|FG001|Part 3|Physician Decision|0|||
16171754|NCT03569202|39107272|FG000|Part 3|Other|1|||
16171755|NCT03569202|39107273|FG001|Part 3|Other|1|||
16171756|NCT03812510|39107277|FG000|Overall Study|Lost to Follow-up|39|||
16171757|NCT03812510|39107277|FG000|Overall Study|Withdrawal by Subject|42|||
16171758|NCT03812510|39107277|FG000|Overall Study|Physician Decision|2|||
16171759|NCT03812510|39107277|FG000|Overall Study|Study Terminated by Sponsor|9|||
16171760|NCT03812510|39107277|FG000|Overall Study|Did Not Start Study Medication|55|||
16171761|NCT03812510|39107277|FG000|Overall Study|Adverse Event|5|||
16171762|NCT01413958|39107278|FG000|Overall Study|Lost to Follow-up|0|||
16171763|NCT01413958|39107279|FG001|Overall Study|Lost to Follow-up|1|||
16171764|NCT00755079|39107280|FG000|Overall Study|Lost to Follow-up|1|||
16171765|NCT00755079|39107281|FG001|Overall Study|Lost to Follow-up|3|||
16171766|NCT00755079|39107280|FG000|Overall Study|Adverse Event|0|||
16171767|NCT00755079|39107281|FG001|Overall Study|Adverse Event|1|||
16171768|NCT00755079|39107280|FG000|Overall Study|Withdrawal by Subject|0|||
16171769|NCT00755079|39107281|FG001|Overall Study|Withdrawal by Subject|2|||
16171770|NCT01850615|39107285|FG000|Overall Study|Protocol Violation|4|||
16171771|NCT01850615|39107286|FG001|Overall Study|Protocol Violation|1|||
16171772|NCT01850615|39107285|FG000|Overall Study|Adverse Event|2|||
16171773|NCT01850615|39107286|FG001|Overall Study|Adverse Event|1|||
16171774|NCT01850615|39107285|FG000|Overall Study|Withdrawal by Subject|3|||
16171775|NCT01850615|39107286|FG001|Overall Study|Withdrawal by Subject|1|||
16171776|NCT01850615|39107285|FG000|Overall Study|Lost to Follow-up|0|||
16171777|NCT01850615|39107286|FG001|Overall Study|Lost to Follow-up|1|||
16171778|NCT01850615|39107285|FG000|Overall Study|Unclassified|0|||
16171779|NCT01850615|39107286|FG001|Overall Study|Unclassified|1|||
16171780|NCT00548548|39107287|FG000|Overall Study|Death|345|||
16171781|NCT00548548|39107288|FG001|Overall Study|Death|348|||
16171782|NCT00548548|39107287|FG000|Overall Study|Lost to Follow-up|17|||
16171783|NCT00548548|39107288|FG001|Overall Study|Lost to Follow-up|18|||
16171784|NCT01309737|39107289|FG000|Week 0 to 16|Death|1|||
16171785|NCT01309737|39107290|FG001|Week 0 to 16|Death|0|||
16171786|NCT01309737|39107291|FG002|Week 0 to 16|Death|1|||
16171787|NCT01309737|39107292|FG003|Week 0 to 16|Death|0|||
16171788|NCT01309737|39107293|FG004|Week 0 to 16|Death|0|||
16171789|NCT01309737|39107289|FG000|Week 0 to 16|Adverse Event|11|||
16171790|NCT01309737|39107290|FG001|Week 0 to 16|Adverse Event|10|||
16171791|NCT01309737|39107291|FG002|Week 0 to 16|Adverse Event|5|||
16171792|NCT01309737|39107292|FG003|Week 0 to 16|Adverse Event|0|||
16171793|NCT01309737|39107293|FG004|Week 0 to 16|Adverse Event|0|||
16171794|NCT01309737|39107289|FG000|Week 0 to 16|Lack of Efficacy|15|||
16171795|NCT01309737|39107290|FG001|Week 0 to 16|Lack of Efficacy|2|||
16171796|NCT01309737|39107291|FG002|Week 0 to 16|Lack of Efficacy|24|||
16171797|NCT01309737|39107292|FG003|Week 0 to 16|Lack of Efficacy|0|||
16171798|NCT01309737|39107293|FG004|Week 0 to 16|Lack of Efficacy|0|||
16171799|NCT01309737|39107289|FG000|Week 0 to 16|Lost to Follow-up|7|||
16171800|NCT01309737|39107290|FG001|Week 0 to 16|Lost to Follow-up|8|||
16171801|NCT01309737|39107291|FG002|Week 0 to 16|Lost to Follow-up|3|||
16171802|NCT01309737|39107292|FG003|Week 0 to 16|Lost to Follow-up|0|||
16171803|NCT01309737|39107293|FG004|Week 0 to 16|Lost to Follow-up|0|||
16171804|NCT01309737|39107289|FG000|Week 0 to 16|Withdrawal by Subject|7|||
16171805|NCT01309737|39107290|FG001|Week 0 to 16|Withdrawal by Subject|6|||
16171806|NCT01309737|39107291|FG002|Week 0 to 16|Withdrawal by Subject|7|||
16171807|NCT01309737|39107292|FG003|Week 0 to 16|Withdrawal by Subject|0|||
16171808|NCT01309737|39107293|FG004|Week 0 to 16|Withdrawal by Subject|0|||
16171809|NCT01309737|39107289|FG000|Week 0 to 16|Other|10|||
16171810|NCT01309737|39107290|FG001|Week 0 to 16|Other|14|||
16171811|NCT01309737|39107291|FG002|Week 0 to 16|Other|4|||
16171812|NCT01309737|39107292|FG003|Week 0 to 16|Other|0|||
16171813|NCT01309737|39107293|FG004|Week 0 to 16|Other|0|||
16171814|NCT01309737|39107289|FG000|Week 0 to 16|Randomized, but not treated|1|||
16171815|NCT01309737|39107290|FG001|Week 0 to 16|Randomized, but not treated|0|||
16171816|NCT01309737|39107291|FG002|Week 0 to 16|Randomized, but not treated|0|||
16171817|NCT01309737|39107292|FG003|Week 0 to 16|Randomized, but not treated|0|||
16171818|NCT01309737|39107293|FG004|Week 0 to 16|Randomized, but not treated|0|||
16171819|NCT01309737|39107289|FG000|Week 16 to 52|Death|0|||
16171820|NCT01309737|39107290|FG001|Week 16 to 52|Death|0|||
16171821|NCT01309737|39107291|FG002|Week 16 to 52|Death|0|||
16171822|NCT01309737|39107292|FG003|Week 16 to 52|Death|0|||
16171823|NCT01309737|39107293|FG004|Week 16 to 52|Death|1|||
16171824|NCT01309737|39107289|FG000|Week 16 to 52|Adverse Event|7|||
16171825|NCT01309737|39107290|FG001|Week 16 to 52|Adverse Event|7|||
16171826|NCT01309737|39107291|FG002|Week 16 to 52|Adverse Event|0|||
16171827|NCT01309737|39107292|FG003|Week 16 to 52|Adverse Event|6|||
16171828|NCT01309737|39107293|FG004|Week 16 to 52|Adverse Event|5|||
16171829|NCT01309737|39107289|FG000|Week 16 to 52|Lack of Efficacy|107|||
16171830|NCT01309737|39107290|FG001|Week 16 to 52|Lack of Efficacy|76|||
16171831|NCT01309737|39107291|FG002|Week 16 to 52|Lack of Efficacy|0|||
16171832|NCT01309737|39107292|FG003|Week 16 to 52|Lack of Efficacy|25|||
16171833|NCT01309737|39107293|FG004|Week 16 to 52|Lack of Efficacy|21|||
16171834|NCT01309737|39107289|FG000|Week 16 to 52|Lost to Follow-up|4|||
16171835|NCT01309737|39107290|FG001|Week 16 to 52|Lost to Follow-up|2|||
16171836|NCT01309737|39107291|FG002|Week 16 to 52|Lost to Follow-up|0|||
16171837|NCT01309737|39107292|FG003|Week 16 to 52|Lost to Follow-up|1|||
16171838|NCT01309737|39107293|FG004|Week 16 to 52|Lost to Follow-up|4|||
16171839|NCT01309737|39107289|FG000|Week 16 to 52|Withdrawal by Subject|5|||
16171840|NCT01309737|39107290|FG001|Week 16 to 52|Withdrawal by Subject|6|||
16171841|NCT01309737|39107291|FG002|Week 16 to 52|Withdrawal by Subject|0|||
16171842|NCT01309737|39107292|FG003|Week 16 to 52|Withdrawal by Subject|0|||
16171843|NCT01309737|39107293|FG004|Week 16 to 52|Withdrawal by Subject|2|||
16171844|NCT01309737|39107289|FG000|Week 16 to 52|Other|10|||
16171845|NCT01309737|39107290|FG001|Week 16 to 52|Other|12|||
16171846|NCT01309737|39107291|FG002|Week 16 to 52|Other|0|||
16171847|NCT01309737|39107292|FG003|Week 16 to 52|Other|2|||
16171848|NCT01309737|39107293|FG004|Week 16 to 52|Other|0|||
16171849|NCT03539432|39107295|FG000|Overall Study|Lost to Follow-up|0|||
16171850|NCT03539432|39107296|FG001|Overall Study|Lost to Follow-up|1|||
16171851|NCT00403260|39107297|FG000|Overall Study|Adverse Event|5|||
16171852|NCT00403260|39107298|FG001|Overall Study|Adverse Event|4|||
16171853|NCT00403260|39107297|FG000|Overall Study|Withdrawal by Subject|5|||
16171854|NCT00403260|39107298|FG001|Overall Study|Withdrawal by Subject|6|||
16171855|NCT00403260|39107297|FG000|Overall Study|Lost to Follow-up|49|||
16171856|NCT00403260|39107298|FG001|Overall Study|Lost to Follow-up|25|||
16171857|NCT00403260|39107297|FG000|Overall Study|Re-appearance of P. falciparum|34|||
16171858|NCT00403260|39107298|FG001|Overall Study|Re-appearance of P. falciparum|25|||
16171859|NCT00403260|39107297|FG000|Overall Study|P. vivax infection|26|||
16171860|NCT00403260|39107298|FG001|Overall Study|P. vivax infection|4|||
16171861|NCT00403260|39107297|FG000|Overall Study|Mixed infection with P. vivax|2|||
16171862|NCT00403260|39107298|FG001|Overall Study|Mixed infection with P. vivax|0|||
16171863|NCT00403260|39107297|FG000|Overall Study|Mixed infection with P. falciparum|1|||
16171864|NCT00403260|39107298|FG001|Overall Study|Mixed infection with P. falciparum|0|||
16171865|NCT00403260|39107297|FG000|Overall Study|P. vivax infection at screening|1|||
16171866|NCT00403260|39107298|FG001|Overall Study|P. vivax infection at screening|0|||
16171867|NCT00403260|39107297|FG000|Overall Study|P. ovale infection|1|||
16171868|NCT00403260|39107298|FG001|Overall Study|P. ovale infection|0|||
16171869|NCT00403260|39107297|FG000|Overall Study|Gametocyte re-appearance|1|||
16171870|NCT00403260|39107298|FG001|Overall Study|Gametocyte re-appearance|1|||
16171871|NCT00403260|39107297|FG000|Overall Study|Withdrawn from study accidentally|0|||
16171872|NCT00403260|39107298|FG001|Overall Study|Withdrawn from study accidentally|1|||
16171873|NCT01335971|39107299|FG000|Overall Study|Withdrawal by Subject|1|||
16171874|NCT01335971|39107300|FG001|Overall Study|Withdrawal by Subject|0|||
16171875|NCT01335971|39107301|FG002|Overall Study|Withdrawal by Subject|0|||
16171876|NCT01335971|39107299|FG000|Overall Study|Did not complete bronchoscopy|1|||
16171877|NCT01335971|39107300|FG001|Overall Study|Did not complete bronchoscopy|1|||
16171878|NCT01335971|39107301|FG002|Overall Study|Did not complete bronchoscopy|1|||
16171879|NCT02266433|39107304|FG000|Overall Study|Lost to Follow-up|54|||
16171880|NCT02266433|39107305|FG001|Overall Study|Lost to Follow-up|46|||
16171881|NCT02266433|39107304|FG000|Overall Study|Withdrawal by Subject|5|||
16171882|NCT02266433|39107305|FG001|Overall Study|Withdrawal by Subject|7|||
16171883|NCT01449708|39107306|FG000|Overall Study|Protocol Violation|0|||
16171884|NCT01449708|39107307|FG001|Overall Study|Protocol Violation|1|||
16171885|NCT01449708|39107306|FG000|Overall Study|surgical complication|1|||
16171886|NCT01449708|39107307|FG001|Overall Study|surgical complication|2|||
16171887|NCT01449708|39107306|FG000|Overall Study|respiratory failure|1|||
16171888|NCT01449708|39107307|FG001|Overall Study|respiratory failure|0|||
16171889|NCT02407457|39107308|FG000|1 Month|Death|3|||
16171890|NCT02407457|39107309|FG001|1 Month|Death|0|||
16171891|NCT02407457|39107308|FG000|1 Month|Lost to Follow-up|1|||
16171892|NCT02407457|39107309|FG001|1 Month|Lost to Follow-up|1|||
16171893|NCT02407457|39107308|FG000|1 Month|missed visit|2|||
16171894|NCT02407457|39107309|FG001|1 Month|missed visit|6|||
16171895|NCT02407457|39107308|FG000|6-Month|Death|2|||
16171896|NCT02407457|39107309|FG001|6-Month|Death|8|||
16171897|NCT02407457|39107308|FG000|6-Month|Lost to Follow-up|2|||
16171898|NCT02407457|39107309|FG001|6-Month|Lost to Follow-up|2|||
16171899|NCT02407457|39107308|FG000|6-Month|missed visit|15|||
16171900|NCT02407457|39107309|FG001|6-Month|missed visit|12|||
16171901|NCT02407457|39107308|FG000|6-Month|Over Due|1|||
16171902|NCT02407457|39107309|FG001|6-Month|Over Due|2|||
16171903|NCT02407457|39107308|FG000|6-Month|Open Repair|0|||
16171904|NCT02407457|39107309|FG001|6-Month|Open Repair|1|||
16171905|NCT02407457|39107308|FG000|1 Year|Death|6|||
16171906|NCT02407457|39107309|FG001|1 Year|Death|11|||
16171907|NCT02407457|39107308|FG000|1 Year|Lost to Follow-up|3|||
16171908|NCT02407457|39107309|FG001|1 Year|Lost to Follow-up|2|||
16171909|NCT02407457|39107308|FG000|1 Year|Missed Visit|18|||
16171910|NCT02407457|39107309|FG001|1 Year|Missed Visit|10|||
16171911|NCT02407457|39107308|FG000|1 Year|Over Due|6|||
16171912|NCT02407457|39107309|FG001|1 Year|Over Due|4|||
16171913|NCT02407457|39107308|FG000|1 Year|Open Repair|0|||
16171914|NCT02407457|39107309|FG001|1 Year|Open Repair|1|||
16171915|NCT02407457|39107308|FG000|2-year|Death|14|||
16171916|NCT02407457|39107309|FG001|2-year|Death|8|||
16171917|NCT02407457|39107308|FG000|2-year|Lost to Follow-up|6|||
16171918|NCT02407457|39107309|FG001|2-year|Lost to Follow-up|9|||
16171919|NCT02407457|39107308|FG000|2-year|Missed Visit|13|||
16171920|NCT02407457|39107309|FG001|2-year|Missed Visit|11|||
16171921|NCT02407457|39107308|FG000|2-year|Over Due|1|||
16171922|NCT02407457|39107309|FG001|2-year|Over Due|5|||
16171923|NCT02407457|39107308|FG000|2-year|Open Repair|0|||
16171924|NCT02407457|39107309|FG001|2-year|Open Repair|2|||
16171925|NCT02407457|39107308|FG000|3-year|Death|11|||
16171926|NCT02407457|39107309|FG001|3-year|Death|10|||
16171927|NCT02407457|39107308|FG000|3-year|Lost to Follow-up|6|||
16171928|NCT02407457|39107309|FG001|3-year|Lost to Follow-up|9|||
16171929|NCT02407457|39107308|FG000|3-year|Missed Visit|21|||
16171930|NCT02407457|39107309|FG001|3-year|Missed Visit|16|||
16171931|NCT02407457|39107308|FG000|3-year|Over Due|4|||
16171932|NCT02407457|39107309|FG001|3-year|Over Due|3|||
16171933|NCT02407457|39107308|FG000|4-year|Death|14|||
16171934|NCT02407457|39107309|FG001|4-year|Death|7|||
16171935|NCT02407457|39107308|FG000|4-year|Lost to Follow-up|9|||
16171936|NCT02407457|39107309|FG001|4-year|Lost to Follow-up|12|||
16171937|NCT02407457|39107308|FG000|4-year|Over Due|10|||
16171938|NCT02407457|39107309|FG001|4-year|Over Due|5|||
16171939|NCT02407457|39107308|FG000|4-year|Missed Visit|13|||
16171940|NCT02407457|39107309|FG001|4-year|Missed Visit|13|||
16171941|NCT02407457|39107308|FG000|4-year|Pending visit|19|||
16171942|NCT02407457|39107309|FG001|4-year|Pending visit|14|||
16171943|NCT02407457|39107308|FG000|4-year|Not Due|16|||
16468921|NCT03091777|40196386|FG000|Overall Study|Pregnancy|2|||
16171944|NCT02407457|39107309|FG001|4-year|Not Due|10|||
16171945|NCT02407457|39107308|FG000|5-year|Death|6|||
16171946|NCT02407457|39107309|FG001|5-year|Death|1|||
16171947|NCT02407457|39107308|FG000|5-year|Lost to Follow-up|4|||
16171948|NCT02407457|39107309|FG001|5-year|Lost to Follow-up|4|||
16468922|NCT03091777|40196387|FG001|Overall Study|Pregnancy|1|||
16171949|NCT02407457|39107308|FG000|5-year|Missed Visit|10|||
16171950|NCT02407457|39107309|FG001|5-year|Missed Visit|9|||
16171951|NCT02407457|39107308|FG000|5-year|Pending Visit|18|||
16171952|NCT02407457|39107309|FG001|5-year|Pending Visit|17|||
16171953|NCT02407457|39107308|FG000|5-year|Not Due|54|||
16171954|NCT02407457|39107309|FG001|5-year|Not Due|46|||
16171955|NCT01769105|39107310|FG000|First Intervention|Protocol Violation|2|||
16171956|NCT01769105|39107311|FG001|First Intervention|Protocol Violation|2|||
16171957|NCT01769105|39107310|FG000|Cross-over|Lost to Follow-up|5|||
16171958|NCT01769105|39107311|FG001|Cross-over|Lost to Follow-up|0|||
16171959|NCT01361711|39107312|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
16171960|NCT01361711|39107312|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
16171961|NCT01361711|39107312|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
16171962|NCT01361711|39107312|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
16171963|NCT01361711|39107312|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
16171964|NCT01361711|39107312|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
16171965|NCT01361711|39107312|FG000|Completed Week 18 of Treatment|Other|9|||
16171966|NCT01361711|39107312|FG000|10 Year Follow-up|Still in follow-up|22|||
16171967|NCT01361711|39107312|FG000|10 Year Follow-up|Death|7|||
16171968|NCT01361711|39107312|FG000|10 Year Follow-up|Developed new cancer|1|||
16171969|NCT01361711|39107312|FG000|10 Year Follow-up|Lost to Follow-up|2|||
16171970|NCT01361711|39107312|FG000|10 Year Follow-up|New treatment started|6|||
16171971|NCT01361711|39107312|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
16171972|NCT01361711|39107312|FG000|10 Year Follow-up|Progressive Disease|1|||
16171973|NCT02720757|39107313|FG000|Overall Study|Other reason|5|||
16171974|NCT02720757|39107313|FG000|Overall Study|Loss of contact|4|||
16171975|NCT02720757|39107313|FG000|Overall Study|Informed consent withdrawal|1|||
16171976|NCT02720757|39107313|FG000|Overall Study|Patients wish to withdraw|2|||
16171977|NCT02720757|39107313|FG000|Overall Study|Missing|3|||
16171978|NCT02720757|39107313|FG000|Overall Study|General exclusion|3|||
16171979|NCT00348140|39107314|FG000|Overall Study|Adverse Event|46|||
16171980|NCT00348140|39107315|FG001|Overall Study|Adverse Event|49|||
16171981|NCT00348140|39107316|FG002|Overall Study|Adverse Event|78|||
16171982|NCT00348140|39107314|FG000|Overall Study|Lost to Follow-up|4|||
16171983|NCT00348140|39107315|FG001|Overall Study|Lost to Follow-up|4|||
16171984|NCT00348140|39107316|FG002|Overall Study|Lost to Follow-up|4|||
16171985|NCT00348140|39107314|FG000|Overall Study|Protocol Violation|12|||
16171986|NCT00348140|39107315|FG001|Overall Study|Protocol Violation|13|||
16171987|NCT00348140|39107316|FG002|Overall Study|Protocol Violation|14|||
16171988|NCT00348140|39107314|FG000|Overall Study|Withdrawal by Subject|32|||
16171989|NCT00348140|39107315|FG001|Overall Study|Withdrawal by Subject|40|||
16171990|NCT00348140|39107316|FG002|Overall Study|Withdrawal by Subject|40|||
16171991|NCT00348140|39107314|FG000|Overall Study|Non-compliance|8|||
16171992|NCT00348140|39107315|FG001|Overall Study|Non-compliance|13|||
16171993|NCT00348140|39107316|FG002|Overall Study|Non-compliance|5|||
16171994|NCT00348140|39107314|FG000|Overall Study|Participant at risk due to study drug|2|||
16171995|NCT00348140|39107315|FG001|Overall Study|Participant at risk due to study drug|0|||
16171996|NCT00348140|39107316|FG002|Overall Study|Participant at risk due to study drug|0|||
16171997|NCT00348140|39107314|FG000|Overall Study|Conditional medication increased dose|1|||
16171998|NCT00348140|39107315|FG001|Overall Study|Conditional medication increased dose|0|||
16171999|NCT00348140|39107316|FG002|Overall Study|Conditional medication increased dose|0|||
16172000|NCT00348140|39107314|FG000|Overall Study|Caregiver related|4|||
16172001|NCT00348140|39107315|FG001|Overall Study|Caregiver related|7|||
16172002|NCT00348140|39107316|FG002|Overall Study|Caregiver related|3|||
16172003|NCT00348140|39107314|FG000|Overall Study|Participant hospitalised|3|||
16172004|NCT00348140|39107315|FG001|Overall Study|Participant hospitalised|0|||
16172005|NCT00348140|39107316|FG002|Overall Study|Participant hospitalised|0|||
16172006|NCT00348140|39107314|FG000|Overall Study|Efficacy related|1|||
16172007|NCT00348140|39107315|FG001|Overall Study|Efficacy related|1|||
16172008|NCT00348140|39107316|FG002|Overall Study|Efficacy related|0|||
16172009|NCT00348140|39107314|FG000|Overall Study|Administration related|3|||
16172010|NCT00348140|39107315|FG001|Overall Study|Administration related|1|||
16172011|NCT00348140|39107316|FG002|Overall Study|Administration related|1|||
16172012|NCT00348140|39107314|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
16172013|NCT00348140|39107315|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
16172014|NCT00348140|39107316|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
16172015|NCT00348140|39107314|FG000|Overall Study|Participant unwell|1|||
16172016|NCT00348140|39107315|FG001|Overall Study|Participant unwell|0|||
16172017|NCT00348140|39107316|FG002|Overall Study|Participant unwell|0|||
16172018|NCT00348140|39107314|FG000|Overall Study|Screen failure|1|||
16172019|NCT00348140|39107315|FG001|Overall Study|Screen failure|0|||
16172020|NCT00348140|39107316|FG002|Overall Study|Screen failure|0|||
16172021|NCT00348140|39107314|FG000|Overall Study|Investigator decided to discontinue|4|||
16172022|NCT00348140|39107315|FG001|Overall Study|Investigator decided to discontinue|1|||
16172023|NCT00348140|39107316|FG002|Overall Study|Investigator decided to discontinue|4|||
16172024|NCT00348140|39107314|FG000|Overall Study|Decided to discontinue on their own|1|||
16172025|NCT00348140|39107315|FG001|Overall Study|Decided to discontinue on their own|4|||
16172026|NCT00348140|39107316|FG002|Overall Study|Decided to discontinue on their own|1|||
16172027|NCT00348140|39107314|FG000|Overall Study|Use of prohibited drug|1|||
16172028|NCT00348140|39107315|FG001|Overall Study|Use of prohibited drug|0|||
16172029|NCT00348140|39107316|FG002|Overall Study|Use of prohibited drug|2|||
16172030|NCT00348140|39107314|FG000|Overall Study|Disease progression|1|||
16172031|NCT00348140|39107315|FG001|Overall Study|Disease progression|2|||
16172032|NCT00348140|39107316|FG002|Overall Study|Disease progression|5|||
16172033|NCT00348140|39107314|FG000|Overall Study|Increased risk of cardiac infarction|0|||
16172034|NCT00348140|39107315|FG001|Overall Study|Increased risk of cardiac infarction|1|||
16172035|NCT00348140|39107316|FG002|Overall Study|Increased risk of cardiac infarction|0|||
16172036|NCT00348140|39107314|FG000|Overall Study|Serious adverse event|0|||
16172037|NCT00348140|39107315|FG001|Overall Study|Serious adverse event|1|||
16172038|NCT00348140|39107316|FG002|Overall Study|Serious adverse event|0|||
16172039|NCT00348140|39107314|FG000|Overall Study|Abnormal ECG|0|||
16172040|NCT00348140|39107315|FG001|Overall Study|Abnormal ECG|1|||
16172041|NCT00348140|39107316|FG002|Overall Study|Abnormal ECG|3|||
16172042|NCT00348140|39107314|FG000|Overall Study|Participant died|0|||
16172043|NCT00348140|39107315|FG001|Overall Study|Participant died|1|||
16172044|NCT00348140|39107316|FG002|Overall Study|Participant died|0|||
16172045|NCT00348140|39107314|FG000|Overall Study|Exclusion criteria met|0|||
16172046|NCT00348140|39107315|FG001|Overall Study|Exclusion criteria met|0|||
16172047|NCT00348140|39107316|FG002|Overall Study|Exclusion criteria met|1|||
16172048|NCT00348140|39107314|FG000|Overall Study|Memory declined|0|||
16172049|NCT00348140|39107315|FG001|Overall Study|Memory declined|0|||
16172050|NCT00348140|39107316|FG002|Overall Study|Memory declined|1|||
16172051|NCT01727258|39107317|FG000|Overall Study|Adverse Event|0|||
16172052|NCT01727258|39107318|FG001|Overall Study|Adverse Event|2|||
16172053|NCT01727258|39107319|FG002|Overall Study|Adverse Event|0|||
16172054|NCT01727258|39107317|FG000|Overall Study|Noncompliance with Study Drug|0|||
16172055|NCT01727258|39107318|FG001|Overall Study|Noncompliance with Study Drug|0|||
16172056|NCT01727258|39107319|FG002|Overall Study|Noncompliance with Study Drug|1|||
16172057|NCT01727258|39107317|FG000|Overall Study|Withdrawal by Subject|1|||
16172058|NCT01727258|39107318|FG001|Overall Study|Withdrawal by Subject|1|||
16172059|NCT01727258|39107319|FG002|Overall Study|Withdrawal by Subject|0|||
16172060|NCT01727258|39107317|FG000|Overall Study|Lost to Follow-up|1|||
16172061|NCT01727258|39107318|FG001|Overall Study|Lost to Follow-up|0|||
16172062|NCT01727258|39107319|FG002|Overall Study|Lost to Follow-up|0|||
16172063|NCT01763164|39107320|FG000|Treatment Phase|Participant/Guardian decision|26|||
16172064|NCT01763164|39107321|FG001|Treatment Phase|Participant/Guardian decision|14|||
16172065|NCT01763164|39107320|FG000|Treatment Phase|Protocol Violation|1|||
16172066|NCT01763164|39107321|FG001|Treatment Phase|Protocol Violation|1|||
16172067|NCT01763164|39107320|FG000|Treatment Phase|Progressive Disease|142|||
16172068|NCT01763164|39107321|FG001|Treatment Phase|Progressive Disease|76|||
16172069|NCT01763164|39107320|FG000|Treatment Phase|Physician Decision|24|||
16172070|NCT01763164|39107321|FG001|Treatment Phase|Physician Decision|13|||
16172071|NCT01763164|39107320|FG000|Treatment Phase|Death|10|||
16172072|NCT01763164|39107321|FG001|Treatment Phase|Death|1|||
16172073|NCT01763164|39107320|FG000|Treatment Phase|Adverse Event|66|||
16172074|NCT01763164|39107321|FG001|Treatment Phase|Adverse Event|8|||
16172075|NCT01763164|39107320|FG000|Treatment Phase|Randomized but not Treated|0|||
16172076|NCT01763164|39107321|FG001|Treatment Phase|Randomized but not Treated|19|||
16172077|NCT01763164|39107320|FG000|Treatment Phase|Other|0|||
16172078|NCT01763164|39107321|FG001|Treatment Phase|Other|1|||
16172079|NCT01763164|39107320|FG000|Follow up Phase|New therapy for study indication|12|||
16172080|NCT01763164|39107321|FG001|Follow up Phase|New therapy for study indication|3|||
16172081|NCT01763164|39107320|FG000|Follow up Phase|Death|21|||
16172082|NCT01763164|39107321|FG001|Follow up Phase|Death|4|||
16172083|NCT01763164|39107320|FG000|Follow up Phase|Subject/guardian decision|9|||
16172084|NCT01763164|39107321|FG001|Follow up Phase|Subject/guardian decision|2|||
16172085|NCT01763164|39107320|FG000|Follow up Phase|Progressive disease|127|||
16172086|NCT01763164|39107321|FG001|Follow up Phase|Progressive disease|62|||
16172087|NCT01763164|39107320|FG000|Follow up Phase|Physician Decision|10|||
16172088|NCT01763164|39107321|FG001|Follow up Phase|Physician Decision|3|||
16172089|NCT01763164|39107320|FG000|Follow up Phase|Lost to Follow-up|1|||
16172090|NCT01763164|39107321|FG001|Follow up Phase|Lost to Follow-up|0|||
16172091|NCT01763164|39107320|FG000|Follow up Phase|Adverse Event|17|||
16172092|NCT01763164|39107321|FG001|Follow up Phase|Adverse Event|1|||
16269332|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
16269333|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
16269334|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
16269335|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
16269336|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
16269337|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
16269338|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
16269339|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
16269340|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
16269341|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
16269342|NCT04194801|39471061|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
16269343|NCT04194801|39471062|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
16269344|NCT04194801|39471063|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
16269345|NCT04194801|39471061|FG000|Part Ib/II End of Study|Death|2|||
16269346|NCT04194801|39471062|FG001|Part Ib/II End of Study|Death|3|||
16269347|NCT04194801|39471063|FG002|Part Ib/II End of Study|Death|3|||
16172093|NCT00809133|39107324|FG000|Overall Study|Progressive disease|2|||
16172094|NCT00809133|39107325|FG001|Overall Study|Progressive disease|5|||
16269348|NCT04194801|39471061|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
16269349|NCT04194801|39471062|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
16269350|NCT04194801|39471063|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
16269351|NCT04194801|39471061|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
16269352|NCT04194801|39471062|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
16269353|NCT04194801|39471063|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
16269354|NCT04194801|39471061|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
16269355|NCT04194801|39471062|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
16269356|NCT04194801|39471063|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
16269357|NCT04194801|39471061|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
16269358|NCT04194801|39471062|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
16269359|NCT04194801|39471063|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
16269360|NCT03801707|39471064|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
16269361|NCT05616728|39471071|FG000|Overall Study|Lost to Follow-up|0|||
16172095|NCT00809133|39107326|FG002|Overall Study|Progressive disease|5|||
16172096|NCT00809133|39107327|FG003|Overall Study|Progressive disease|3|||
16172097|NCT00809133|39107328|FG004|Overall Study|Progressive disease|4|||
16172098|NCT00809133|39107329|FG005|Overall Study|Progressive disease|1|||
16172099|NCT00809133|39107330|FG006|Overall Study|Progressive disease|3|||
16172100|NCT00809133|39107331|FG007|Overall Study|Progressive disease|3|||
16172101|NCT00809133|39107332|FG008|Overall Study|Progressive disease|3|||
16172102|NCT00809133|39107333|FG009|Overall Study|Progressive disease|9|||
16172103|NCT00809133|39107334|FG010|Overall Study|Progressive disease|5|||
16172104|NCT00809133|39107335|FG011|Overall Study|Progressive disease|7|||
16172105|NCT00809133|39107336|FG012|Overall Study|Progressive disease|5|||
16172106|NCT00809133|39107337|FG013|Overall Study|Progressive disease|4|||
16172107|NCT00809133|39107324|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16172108|NCT00809133|39107325|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16172109|NCT00809133|39107326|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16172110|NCT00809133|39107327|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16172111|NCT00809133|39107328|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16172112|NCT00809133|39107329|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
16172113|NCT00809133|39107330|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
16172114|NCT00809133|39107331|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
16172115|NCT00809133|39107332|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16172116|NCT00809133|39107333|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16172117|NCT00809133|39107334|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16172118|NCT00809133|39107335|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16172119|NCT00809133|39107336|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
16269362|NCT05616728|39471072|FG001|Overall Study|Lost to Follow-up|0|||
16269363|NCT05616728|39471073|FG002|Overall Study|Lost to Follow-up|1|||
16269364|NCT05616728|39471071|FG000|Overall Study|Withdrawal by Subject|1|||
16269365|NCT05616728|39471072|FG001|Overall Study|Withdrawal by Subject|1|||
16269366|NCT05616728|39471073|FG002|Overall Study|Withdrawal by Subject|0|||
16269367|NCT05616728|39471071|FG000|Overall Study|Physician Decision|1|||
16269368|NCT05616728|39471072|FG001|Overall Study|Physician Decision|1|||
16269369|NCT05616728|39471073|FG002|Overall Study|Physician Decision|1|||
16269370|NCT05616728|39471071|FG000|Overall Study|Other|0|||
16269371|NCT05616728|39471072|FG001|Overall Study|Other|2|||
16269372|NCT05616728|39471073|FG002|Overall Study|Other|0|||
16269373|NCT04203667|39471074|FG000|Overall Study|Withdrawal by Subject|1|||
16269374|NCT04203667|39471074|FG000|Overall Study|Lost to Follow-up|1|||
16269375|NCT04203667|39471074|FG000|Overall Study|Death|1|||
16269376|NCT04203667|39471074|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
16269377|NCT03679598|39471075|FG000|Overall Study|Adverse Event|2|||
16269378|NCT03679598|39471076|FG001|Overall Study|Adverse Event|0|||
16269379|NCT01958294|39471079|FG000|Overall Study|Clinical Circumstances|2|||
16269380|NCT00828321|39471088|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
16269381|NCT00828321|39471089|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
16269382|NCT00828321|39471088|FG000|Second Intervention|Protocol Violation|0|||
16269383|NCT00828321|39471089|FG001|Second Intervention|Protocol Violation|1|||
16269384|NCT02820350|39471090|FG000|Overall Study|Withdrawal by Subject|3|||
16269385|NCT02820350|39471090|FG000|Overall Study|Death|4|||
16269386|NCT01183884|39471093|FG000|Overall Study|Progressive Disease|26|||
16269387|NCT01183884|39471093|FG000|Overall Study|Adverse Event|3|||
16269388|NCT01183884|39471093|FG000|Overall Study|Withdrawal by Subject|1|||
16269389|NCT01183884|39471093|FG000|Overall Study|Other Complicating Disease|3|||
16269390|NCT01183884|39471093|FG000|Overall Study|Not Treated|1|||
16269391|NCT01183884|39471093|FG000|Overall Study|Other|4|||
16269392|NCT00663234|39471094|FG000|Overall Study|Not willing to adhere to requirements|1|||
16269393|NCT01415986|39471095|FG000|Overall Study|Lost to Follow-up|1|||
16269394|NCT00402103|39471096|FG000|Overall Study|Adverse Event|60|||
16269395|NCT00402103|39471097|FG001|Overall Study|Adverse Event|7|||
16269396|NCT00402103|39471096|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
16269397|NCT00402103|39471097|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
16269398|NCT00402103|39471096|FG000|Overall Study|Condition no longer requires study drug|2|||
16269399|NCT00402103|39471097|FG001|Overall Study|Condition no longer requires study drug|0|||
16269400|NCT00402103|39471096|FG000|Overall Study|Protocol Deviation|8|||
16269401|NCT00402103|39471097|FG001|Overall Study|Protocol Deviation|0|||
16269402|NCT00402103|39471096|FG000|Overall Study|Patient withdrew consent|12|||
16269403|NCT00402103|39471097|FG001|Overall Study|Patient withdrew consent|1|||
16269404|NCT00402103|39471096|FG000|Overall Study|Lost to Follow-up|6|||
16269405|NCT00402103|39471097|FG001|Overall Study|Lost to Follow-up|3|||
16269406|NCT00402103|39471096|FG000|Overall Study|Administrative problems|2|||
16269407|NCT00402103|39471097|FG001|Overall Study|Administrative problems|0|||
16269408|NCT03193021|39471103|FG000|Overall Study|Lost to Follow-up|1|||
16269409|NCT03193021|39471104|FG001|Overall Study|Lost to Follow-up|1|||
16269410|NCT00573443|39471105|FG000|Double-Blind Phase|Lost to Follow-up|1|||
16269411|NCT00573443|39471106|FG001|Double-Blind Phase|Lost to Follow-up|3|||
16269412|NCT00573443|39471107|FG002|Double-Blind Phase|Lost to Follow-up|2|||
16269413|NCT00573443|39471105|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
16269414|NCT00573443|39471106|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
16269415|NCT00573443|39471107|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
16269416|NCT00573443|39471105|FG000|Double-Blind Phase|Adverse Event|1|||
16269417|NCT00573443|39471106|FG001|Double-Blind Phase|Adverse Event|5|||
16269418|NCT00573443|39471107|FG002|Double-Blind Phase|Adverse Event|0|||
16269419|NCT00573443|39471105|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
16269420|NCT00573443|39471106|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
16269421|NCT00573443|39471107|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
16269422|NCT00573443|39471105|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
16269423|NCT00573443|39471106|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
16269424|NCT00573443|39471107|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
16269425|NCT00573443|39471105|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
16269426|NCT00573443|39471106|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
16269427|NCT00573443|39471107|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
16269428|NCT00573443|39471105|FG000|Double-Blind Phase|Protocol Violation|0|||
16269429|NCT00573443|39471106|FG001|Double-Blind Phase|Protocol Violation|2|||
16269430|NCT00573443|39471107|FG002|Double-Blind Phase|Protocol Violation|1|||
16269431|NCT00573443|39471105|FG000|Double-Blind Phase|Other|0|||
16172120|NCT00809133|39107337|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
16172121|NCT00809133|39107324|FG000|Overall Study|Other adverse event|1|||
16172122|NCT00809133|39107325|FG001|Overall Study|Other adverse event|1|||
16172123|NCT00809133|39107326|FG002|Overall Study|Other adverse event|1|||
16172124|NCT00809133|39107327|FG003|Overall Study|Other adverse event|0|||
16172125|NCT00809133|39107328|FG004|Overall Study|Other adverse event|0|||
16172126|NCT00809133|39107329|FG005|Overall Study|Other adverse event|3|||
16172127|NCT00809133|39107330|FG006|Overall Study|Other adverse event|2|||
16172128|NCT00809133|39107331|FG007|Overall Study|Other adverse event|4|||
16172129|NCT00809133|39107332|FG008|Overall Study|Other adverse event|0|||
16172130|NCT00809133|39107333|FG009|Overall Study|Other adverse event|0|||
16172131|NCT00809133|39107334|FG010|Overall Study|Other adverse event|1|||
16269432|NCT00573443|39471106|FG001|Double-Blind Phase|Other|2|||
16269433|NCT00573443|39471107|FG002|Double-Blind Phase|Other|3|||
16172132|NCT00809133|39107335|FG011|Overall Study|Other adverse event|1|||
16172133|NCT00809133|39107336|FG012|Overall Study|Other adverse event|0|||
16172134|NCT00809133|39107337|FG013|Overall Study|Other adverse event|1|||
16172135|NCT00809133|39107324|FG000|Overall Study|Lost to Follow-up|0|||
16172136|NCT00809133|39107325|FG001|Overall Study|Lost to Follow-up|0|||
16172137|NCT00809133|39107326|FG002|Overall Study|Lost to Follow-up|0|||
16172138|NCT00809133|39107327|FG003|Overall Study|Lost to Follow-up|0|||
16172139|NCT00809133|39107328|FG004|Overall Study|Lost to Follow-up|0|||
16172140|NCT00809133|39107329|FG005|Overall Study|Lost to Follow-up|1|||
16172141|NCT00809133|39107330|FG006|Overall Study|Lost to Follow-up|0|||
16172142|NCT00809133|39107331|FG007|Overall Study|Lost to Follow-up|0|||
16172143|NCT00809133|39107332|FG008|Overall Study|Lost to Follow-up|0|||
16172144|NCT00809133|39107333|FG009|Overall Study|Lost to Follow-up|0|||
16172145|NCT00809133|39107334|FG010|Overall Study|Lost to Follow-up|0|||
16172146|NCT00809133|39107335|FG011|Overall Study|Lost to Follow-up|0|||
16468923|NCT03091777|40196388|FG002|Overall Study|Pregnancy|0|||
16468924|NCT03091777|40196386|FG000|Overall Study|Adverse Event|2|||
16172147|NCT00809133|39107336|FG012|Overall Study|Lost to Follow-up|0|||
16172148|NCT00809133|39107337|FG013|Overall Study|Lost to Follow-up|0|||
16172149|NCT00809133|39107324|FG000|Overall Study|Consent withdrawn|0|||
16172150|NCT00809133|39107325|FG001|Overall Study|Consent withdrawn|0|||
16172151|NCT00809133|39107326|FG002|Overall Study|Consent withdrawn|0|||
16172152|NCT00809133|39107327|FG003|Overall Study|Consent withdrawn|0|||
16172153|NCT00809133|39107328|FG004|Overall Study|Consent withdrawn|1|||
16172154|NCT00809133|39107329|FG005|Overall Study|Consent withdrawn|0|||
16269434|NCT00573443|39471105|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
16269435|NCT00573443|39471106|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
16269436|NCT00573443|39471107|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
16468925|NCT03091777|40196387|FG001|Overall Study|Adverse Event|1|||
16172155|NCT00809133|39107330|FG006|Overall Study|Consent withdrawn|0|||
16172156|NCT00809133|39107331|FG007|Overall Study|Consent withdrawn|0|||
16172157|NCT00809133|39107332|FG008|Overall Study|Consent withdrawn|0|||
16172158|NCT00809133|39107333|FG009|Overall Study|Consent withdrawn|0|||
16172159|NCT00809133|39107334|FG010|Overall Study|Consent withdrawn|0|||
16172160|NCT00809133|39107335|FG011|Overall Study|Consent withdrawn|0|||
16172161|NCT00809133|39107336|FG012|Overall Study|Consent withdrawn|0|||
16172162|NCT00809133|39107337|FG013|Overall Study|Consent withdrawn|0|||
16172163|NCT00809133|39107324|FG000|Overall Study|Other not mentioned above|0|||
16172164|NCT00809133|39107325|FG001|Overall Study|Other not mentioned above|1|||
16172165|NCT00809133|39107326|FG002|Overall Study|Other not mentioned above|0|||
16172166|NCT00809133|39107327|FG003|Overall Study|Other not mentioned above|0|||
16172167|NCT00809133|39107328|FG004|Overall Study|Other not mentioned above|0|||
16172168|NCT00809133|39107329|FG005|Overall Study|Other not mentioned above|1|||
16172169|NCT00809133|39107330|FG006|Overall Study|Other not mentioned above|0|||
16172170|NCT00809133|39107331|FG007|Overall Study|Other not mentioned above|0|||
16172171|NCT00809133|39107332|FG008|Overall Study|Other not mentioned above|0|||
16172172|NCT00809133|39107333|FG009|Overall Study|Other not mentioned above|0|||
16172173|NCT00809133|39107334|FG010|Overall Study|Other not mentioned above|0|||
16172174|NCT00809133|39107335|FG011|Overall Study|Other not mentioned above|0|||
16172175|NCT00809133|39107336|FG012|Overall Study|Other not mentioned above|0|||
16172176|NCT00809133|39107337|FG013|Overall Study|Other not mentioned above|0|||
16172177|NCT00087438|39107340|FG000|Overall Study|Ineligible / No protocol treatment|4|||
16172178|NCT01053429|39107344|FG000|Overall Study|Adverse Event|64|||
16269437|NCT00573443|39471105|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
16269438|NCT00573443|39471106|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
16269439|NCT00573443|39471107|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
16269440|NCT00573443|39471105|FG000|Open-Label Extension Phase|Adverse Event|3|||
16269441|NCT00573443|39471106|FG001|Open-Label Extension Phase|Adverse Event|0|||
16269442|NCT00573443|39471107|FG002|Open-Label Extension Phase|Adverse Event|0|||
16269443|NCT00573443|39471105|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
16269444|NCT00573443|39471106|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
16269445|NCT00573443|39471107|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
16269446|NCT00573443|39471105|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
16269447|NCT00573443|39471106|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
16269448|NCT00573443|39471107|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
16269449|NCT00573443|39471105|FG000|Open-Label Extension Phase|Protocol Violation|2|||
16269450|NCT00573443|39471106|FG001|Open-Label Extension Phase|Protocol Violation|0|||
16269451|NCT00573443|39471107|FG002|Open-Label Extension Phase|Protocol Violation|0|||
16269452|NCT00573443|39471105|FG000|Open-Label Extension Phase|Other|2|||
16269453|NCT00573443|39471106|FG001|Open-Label Extension Phase|Other|0|||
16269454|NCT00573443|39471107|FG002|Open-Label Extension Phase|Other|0|||
16269455|NCT01010503|39471112|FG000|Overall Study|Adverse Event|1|||
16269456|NCT01010503|39471112|FG000|Overall Study|Death|1|||
16269457|NCT00835692|39471113|FG000|First Intervention|Withdrawal by Subject|1|||
16269458|NCT00835692|39471114|FG001|First Intervention|Withdrawal by Subject|0|||
16269459|NCT01200810|39471119|FG000|Overall Study|Physician Decision|1|||
16269460|NCT01200810|39471120|FG001|Overall Study|Physician Decision|0|||
16269461|NCT01200810|39471119|FG000|Overall Study|Withdrawal by Subject|1|||
16269462|NCT01200810|39471120|FG001|Overall Study|Withdrawal by Subject|2|||
16269463|NCT01200810|39471119|FG000|Overall Study|Sponsor stopped making study drug|3|||
16269464|NCT01200810|39471120|FG001|Overall Study|Sponsor stopped making study drug|3|||
16269465|NCT00218257|39471125|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
16269466|NCT00218257|39471126|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
16269467|NCT00274651|39471127|FG000|Overall Study|Adverse Event|6|||
16269468|NCT00274651|39471128|FG001|Overall Study|Adverse Event|3|||
16269469|NCT00274651|39471127|FG000|Overall Study|Lack of Efficacy|13|||
16269470|NCT00274651|39471128|FG001|Overall Study|Lack of Efficacy|6|||
16269471|NCT00274651|39471127|FG000|Overall Study|Death|1|||
16269472|NCT00274651|39471128|FG001|Overall Study|Death|3|||
16269473|NCT00274651|39471127|FG000|Overall Study|Withdrawal by Subject|0|||
16269474|NCT00274651|39471128|FG001|Overall Study|Withdrawal by Subject|1|||
16269475|NCT00274651|39471127|FG000|Overall Study|Physician Decision|8|||
16468926|NCT03091777|40196388|FG002|Overall Study|Adverse Event|4|||
16269476|NCT00274651|39471128|FG001|Overall Study|Physician Decision|7|||
16269477|NCT01046084|39471131|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
16269478|NCT01046084|39471132|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
16269479|NCT00838539|39471133|FG000|Overall Study|Disease Progression|2|||
16269480|NCT00838539|39471134|FG001|Overall Study|Disease Progression|4|||
16269481|NCT00838539|39471135|FG002|Overall Study|Disease Progression|3|||
16269482|NCT00838539|39471136|FG003|Overall Study|Disease Progression|2|||
16269483|NCT00838539|39471137|FG004|Overall Study|Disease Progression|4|||
16269484|NCT00838539|39471138|FG005|Overall Study|Disease Progression|2|||
16269485|NCT00838539|39471139|FG006|Overall Study|Disease Progression|3|||
16269486|NCT00838539|39471140|FG007|Overall Study|Disease Progression|4|||
16269487|NCT00838539|39471141|FG008|Overall Study|Disease Progression|4|||
16172179|NCT01053429|39107344|FG000|Overall Study|Other|309|||
16269488|NCT00838539|39471142|FG009|Overall Study|Disease Progression|5|||
16269489|NCT00838539|39471143|FG010|Overall Study|Disease Progression|1|||
16269490|NCT00838539|39471144|FG011|Overall Study|Disease Progression|4|||
16269491|NCT00838539|39471133|FG000|Overall Study|Adverse Event|1|||
16269492|NCT00838539|39471134|FG001|Overall Study|Adverse Event|1|||
16269493|NCT00838539|39471135|FG002|Overall Study|Adverse Event|1|||
16269494|NCT00838539|39471136|FG003|Overall Study|Adverse Event|1|||
16269495|NCT00838539|39471137|FG004|Overall Study|Adverse Event|2|||
16269496|NCT00838539|39471138|FG005|Overall Study|Adverse Event|1|||
16269497|NCT00838539|39471139|FG006|Overall Study|Adverse Event|0|||
16269498|NCT00838539|39471140|FG007|Overall Study|Adverse Event|2|||
16269499|NCT00838539|39471141|FG008|Overall Study|Adverse Event|0|||
16269500|NCT00838539|39471142|FG009|Overall Study|Adverse Event|1|||
16269501|NCT00838539|39471143|FG010|Overall Study|Adverse Event|2|||
16172180|NCT02731742|39107347|FG000|Overall Study|Death|1|||
16172181|NCT02731742|39107348|FG001|Overall Study|Death|2|||
16172182|NCT02731742|39107349|FG002|Overall Study|Death|5|||
16172183|NCT02731742|39107350|FG003|Overall Study|Death|0|||
16172184|NCT02731742|39107347|FG000|Overall Study|Physician Decision|0|||
16172185|NCT02731742|39107348|FG001|Overall Study|Physician Decision|0|||
16172186|NCT02731742|39107349|FG002|Overall Study|Physician Decision|0|||
16172187|NCT02731742|39107350|FG003|Overall Study|Physician Decision|1|||
16172188|NCT02731742|39107347|FG000|Overall Study|Study Terminated by Sponsor|2|||
16172189|NCT02731742|39107348|FG001|Overall Study|Study Terminated by Sponsor|1|||
16172190|NCT02731742|39107349|FG002|Overall Study|Study Terminated by Sponsor|1|||
16269502|NCT00838539|39471144|FG011|Overall Study|Adverse Event|0|||
16269503|NCT00838539|39471133|FG000|Overall Study|Withdrawal by Subject|0|||
16269504|NCT00838539|39471134|FG001|Overall Study|Withdrawal by Subject|1|||
16269505|NCT00838539|39471135|FG002|Overall Study|Withdrawal by Subject|0|||
16269506|NCT00838539|39471136|FG003|Overall Study|Withdrawal by Subject|0|||
16269507|NCT00838539|39471137|FG004|Overall Study|Withdrawal by Subject|0|||
16269508|NCT00838539|39471138|FG005|Overall Study|Withdrawal by Subject|0|||
16269509|NCT00838539|39471139|FG006|Overall Study|Withdrawal by Subject|0|||
16269510|NCT00838539|39471140|FG007|Overall Study|Withdrawal by Subject|0|||
16269511|NCT00838539|39471141|FG008|Overall Study|Withdrawal by Subject|0|||
16269512|NCT00838539|39471142|FG009|Overall Study|Withdrawal by Subject|1|||
16269513|NCT00838539|39471143|FG010|Overall Study|Withdrawal by Subject|2|||
16269514|NCT00838539|39471144|FG011|Overall Study|Withdrawal by Subject|0|||
16269515|NCT00838539|39471133|FG000|Overall Study|Death|0|||
16269516|NCT00838539|39471134|FG001|Overall Study|Death|0|||
16269517|NCT00838539|39471135|FG002|Overall Study|Death|0|||
16269518|NCT00838539|39471136|FG003|Overall Study|Death|0|||
16269519|NCT00838539|39471137|FG004|Overall Study|Death|0|||
16269520|NCT00838539|39471138|FG005|Overall Study|Death|0|||
16269521|NCT00838539|39471139|FG006|Overall Study|Death|1|||
16269522|NCT00838539|39471140|FG007|Overall Study|Death|0|||
16269523|NCT00838539|39471141|FG008|Overall Study|Death|0|||
16269524|NCT00838539|39471142|FG009|Overall Study|Death|0|||
16269525|NCT00838539|39471143|FG010|Overall Study|Death|0|||
16269526|NCT00838539|39471144|FG011|Overall Study|Death|0|||
16269527|NCT00838539|39471133|FG000|Overall Study|Physician Decision|0|||
16269528|NCT00838539|39471134|FG001|Overall Study|Physician Decision|0|||
16269529|NCT00838539|39471135|FG002|Overall Study|Physician Decision|0|||
16269530|NCT00838539|39471136|FG003|Overall Study|Physician Decision|0|||
16269531|NCT00838539|39471137|FG004|Overall Study|Physician Decision|0|||
16269532|NCT00838539|39471138|FG005|Overall Study|Physician Decision|0|||
16269533|NCT00838539|39471139|FG006|Overall Study|Physician Decision|0|||
16269534|NCT00838539|39471140|FG007|Overall Study|Physician Decision|0|||
16269535|NCT00838539|39471141|FG008|Overall Study|Physician Decision|1|||
16269536|NCT00838539|39471142|FG009|Overall Study|Physician Decision|0|||
16269537|NCT00838539|39471143|FG010|Overall Study|Physician Decision|0|||
16269538|NCT00838539|39471144|FG011|Overall Study|Physician Decision|0|||
16269539|NCT00838539|39471133|FG000|Overall Study|Clinical Progression|0|||
16269540|NCT00838539|39471134|FG001|Overall Study|Clinical Progression|0|||
16269541|NCT00838539|39471135|FG002|Overall Study|Clinical Progression|0|||
16269542|NCT00838539|39471136|FG003|Overall Study|Clinical Progression|0|||
16269543|NCT00838539|39471137|FG004|Overall Study|Clinical Progression|0|||
16269544|NCT00838539|39471138|FG005|Overall Study|Clinical Progression|0|||
16269545|NCT00838539|39471139|FG006|Overall Study|Clinical Progression|1|||
16269546|NCT00838539|39471140|FG007|Overall Study|Clinical Progression|0|||
16269547|NCT00838539|39471141|FG008|Overall Study|Clinical Progression|0|||
16269548|NCT00838539|39471142|FG009|Overall Study|Clinical Progression|0|||
16269549|NCT00838539|39471143|FG010|Overall Study|Clinical Progression|0|||
16269550|NCT00838539|39471144|FG011|Overall Study|Clinical Progression|0|||
16269551|NCT00838539|39471133|FG000|Overall Study|Symptomatic Deterioration|0|||
16269552|NCT00838539|39471134|FG001|Overall Study|Symptomatic Deterioration|0|||
16269553|NCT00838539|39471135|FG002|Overall Study|Symptomatic Deterioration|1|||
16172191|NCT02731742|39107350|FG003|Overall Study|Study Terminated by Sponsor|1|||
16269554|NCT00838539|39471136|FG003|Overall Study|Symptomatic Deterioration|1|||
16269555|NCT00838539|39471137|FG004|Overall Study|Symptomatic Deterioration|0|||
16269556|NCT00838539|39471138|FG005|Overall Study|Symptomatic Deterioration|1|||
16269557|NCT00838539|39471139|FG006|Overall Study|Symptomatic Deterioration|0|||
16269558|NCT00838539|39471140|FG007|Overall Study|Symptomatic Deterioration|0|||
16269559|NCT00838539|39471141|FG008|Overall Study|Symptomatic Deterioration|0|||
16269560|NCT00838539|39471142|FG009|Overall Study|Symptomatic Deterioration|1|||
16269561|NCT00838539|39471143|FG010|Overall Study|Symptomatic Deterioration|0|||
16269562|NCT00838539|39471144|FG011|Overall Study|Symptomatic Deterioration|0|||
16269563|NCT00902538|39471145|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
16269564|NCT00902538|39471146|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
16269565|NCT00902538|39471147|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
16269566|NCT00902538|39471148|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
16269567|NCT00902538|39471149|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
16269568|NCT00902538|39471150|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
16269569|NCT00902538|39471145|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
16269570|NCT00902538|39471146|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
16269571|NCT00902538|39471147|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
16269572|NCT00902538|39471148|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
16269573|NCT00902538|39471149|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
16269574|NCT00902538|39471150|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
16269575|NCT00902538|39471145|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
16269576|NCT00902538|39471146|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
16269577|NCT00902538|39471147|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
16269578|NCT00902538|39471148|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
16269579|NCT00902538|39471149|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
16269580|NCT00902538|39471150|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
16269581|NCT00902538|39471145|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
16269582|NCT00902538|39471146|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
16269583|NCT00902538|39471147|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
16269584|NCT00902538|39471148|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
16269585|NCT00902538|39471149|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
16269586|NCT00902538|39471150|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
16269587|NCT00902538|39471145|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
16269588|NCT00902538|39471146|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
16269589|NCT00902538|39471147|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
16269590|NCT00902538|39471148|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
16269591|NCT00902538|39471149|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
16269592|NCT00902538|39471150|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
16269593|NCT00902538|39471145|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
16269594|NCT00902538|39471146|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
16269595|NCT00902538|39471147|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
16269596|NCT00902538|39471148|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
16269597|NCT00902538|39471149|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
16269598|NCT00902538|39471150|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
16269599|NCT00902538|39471145|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
16269600|NCT00902538|39471146|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
16269601|NCT00902538|39471147|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
16269602|NCT00902538|39471148|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
16269603|NCT00902538|39471149|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
16269604|NCT00902538|39471150|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
16269605|NCT00902538|39471145|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
16269606|NCT00902538|39471146|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
16269607|NCT00902538|39471147|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
16269608|NCT00902538|39471148|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
16269609|NCT00902538|39471149|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
16269610|NCT00902538|39471150|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
16269611|NCT00902538|39471145|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
16269612|NCT00902538|39471146|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
16269613|NCT00902538|39471147|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
16269614|NCT00902538|39471148|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
16269615|NCT00902538|39471149|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
16269616|NCT00902538|39471150|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
16269617|NCT00902538|39471145|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
16269618|NCT00902538|39471146|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
16269619|NCT00902538|39471147|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
16269620|NCT00902538|39471148|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
16269621|NCT00902538|39471149|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
16269622|NCT00902538|39471150|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
16269623|NCT00902538|39471145|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
16269624|NCT00902538|39471146|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
16269625|NCT00902538|39471147|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
16269626|NCT00902538|39471148|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
16269627|NCT00902538|39471149|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
16269628|NCT00902538|39471150|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
16269629|NCT00902538|39471145|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
16269630|NCT00902538|39471146|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
16269631|NCT00902538|39471147|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
16269632|NCT00902538|39471148|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
16269633|NCT00902538|39471149|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
16269634|NCT00902538|39471150|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
16269635|NCT00902538|39471145|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
16269636|NCT00902538|39471146|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
16269637|NCT00902538|39471147|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
16269638|NCT00902538|39471148|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
16269639|NCT00902538|39471149|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
16269640|NCT00902538|39471150|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
16269641|NCT00902538|39471145|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
16269642|NCT00902538|39471146|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
16269643|NCT00902538|39471147|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
16269644|NCT00902538|39471148|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
16269645|NCT00902538|39471149|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
16269646|NCT00902538|39471150|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
16269647|NCT00902538|39471145|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
16269648|NCT00902538|39471146|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
16269649|NCT00902538|39471147|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
16269650|NCT00902538|39471148|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
16269651|NCT00902538|39471149|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
16269652|NCT00902538|39471150|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
16269653|NCT00902538|39471145|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
16269654|NCT00902538|39471146|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
16269655|NCT00902538|39471147|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
16269656|NCT00902538|39471148|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
16269657|NCT00902538|39471149|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
16269658|NCT00902538|39471150|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
16269659|NCT00902538|39471145|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
16269660|NCT00902538|39471146|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
16269661|NCT00902538|39471147|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
16269662|NCT00902538|39471148|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
16269663|NCT00902538|39471149|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
16269664|NCT00902538|39471150|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
16269665|NCT01811953|39471152|FG000|Overall Study|Adverse Event|0|||
16269666|NCT01811953|39471153|FG001|Overall Study|Adverse Event|0|||
16269667|NCT01811953|39471154|FG002|Overall Study|Adverse Event|0|||
16269668|NCT01811953|39471155|FG003|Overall Study|Adverse Event|1|||
16269669|NCT01811953|39471156|FG004|Overall Study|Adverse Event|0|||
16269670|NCT01811953|39471157|FG005|Overall Study|Adverse Event|1|||
16269671|NCT01811953|39471152|FG000|Overall Study|Protocol Violation|0|||
16269672|NCT01811953|39471153|FG001|Overall Study|Protocol Violation|0|||
16269673|NCT01811953|39471154|FG002|Overall Study|Protocol Violation|0|||
16269674|NCT01811953|39471155|FG003|Overall Study|Protocol Violation|0|||
16269675|NCT01811953|39471156|FG004|Overall Study|Protocol Violation|1|||
16269676|NCT01811953|39471157|FG005|Overall Study|Protocol Violation|0|||
16269677|NCT01034358|39471158|FG000|Overall Study|Withdrawal by Subject|1|||
16269678|NCT01034358|39471158|FG000|Overall Study|Protocol Violation|1|||
16269679|NCT00521586|39471159|FG000|Initial Vaccination (Year 0)|Subject request|8|||
16269680|NCT00521586|39471160|FG001|Initial Vaccination (Year 0)|Subject request|11|||
16269681|NCT00521586|39471159|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
16269682|NCT00521586|39471160|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
16269683|NCT00521586|39471159|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
16269684|NCT00521586|39471160|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
16269685|NCT00521586|39471159|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
16269686|NCT00521586|39471160|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
16269687|NCT00521586|39471159|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
16269688|NCT00521586|39471160|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
16269689|NCT00521586|39471159|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
16269690|NCT00521586|39471160|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
16269691|NCT00521586|39471159|FG000|Initial Vaccination (Year 0)|Death|1|||
16269692|NCT00521586|39471160|FG001|Initial Vaccination (Year 0)|Death|0|||
16269693|NCT00521586|39471159|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
16269694|NCT00521586|39471160|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
16269695|NCT00521586|39471159|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
16269696|NCT00521586|39471160|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
16269697|NCT00521586|39471159|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
16269698|NCT00521586|39471160|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
16269699|NCT00521586|39471159|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
16269700|NCT00521586|39471160|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
16269701|NCT00521586|39471159|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
16269702|NCT00521586|39471160|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
16269703|NCT00521586|39471159|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
16269704|NCT00521586|39471160|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
16269705|NCT00521586|39471159|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
16269706|NCT00521586|39471160|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
16269707|NCT00521586|39471159|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
16269708|NCT00521586|39471160|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
16269709|NCT00521586|39471159|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
16269710|NCT00521586|39471160|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
16269711|NCT00521586|39471159|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
16269712|NCT00521586|39471160|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
16269713|NCT00521586|39471159|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
16269714|NCT00521586|39471160|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
16269715|NCT00521586|39471159|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
16269716|NCT00521586|39471160|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
16269717|NCT01906372|39471161|FG000|Overall Study|Withdrawal by Subject|2|||
16269718|NCT01559363|39471162|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
16269719|NCT01559363|39471163|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
16269720|NCT01559363|39471164|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
16269721|NCT01559363|39471165|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
16269722|NCT01559363|39471166|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
16269723|NCT01559363|39471167|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
16269724|NCT01559363|39471162|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
16269725|NCT01559363|39471163|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
16269726|NCT01559363|39471164|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
16269727|NCT01559363|39471165|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
16269728|NCT01559363|39471166|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
16269729|NCT01559363|39471167|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
16269730|NCT01559363|39471162|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
16269731|NCT01559363|39471163|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
16269732|NCT01559363|39471164|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
16269733|NCT01559363|39471165|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
16269734|NCT01559363|39471166|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
16269735|NCT01559363|39471167|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
16269736|NCT01559363|39471162|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
16269737|NCT01559363|39471163|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
16269738|NCT01559363|39471164|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
16269739|NCT01559363|39471165|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
16269740|NCT01559363|39471166|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
16269741|NCT01559363|39471167|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
16269742|NCT01559363|39471162|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
16269743|NCT01559363|39471163|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
16269744|NCT01559363|39471164|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
16269745|NCT01559363|39471165|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
16269746|NCT01559363|39471166|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
16269747|NCT01559363|39471167|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
16269748|NCT01559363|39471162|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
16269749|NCT01559363|39471163|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
16269750|NCT01559363|39471164|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
16269751|NCT01559363|39471165|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
16269752|NCT01559363|39471166|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
16269753|NCT01559363|39471167|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
16269754|NCT01559363|39471162|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
16269755|NCT01559363|39471163|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
16269756|NCT01559363|39471164|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
16269757|NCT01559363|39471165|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
16269758|NCT01559363|39471166|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
16269759|NCT01559363|39471167|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
16269760|NCT02286466|39471170|FG000|Overall Study|Death|1|||
16269761|NCT02286466|39471171|FG001|Overall Study|Death|3|||
16269762|NCT02286466|39471170|FG000|Overall Study|Withdrawal by Subject|5|||
16269763|NCT02286466|39471171|FG001|Overall Study|Withdrawal by Subject|2|||
16269764|NCT02286466|39471170|FG000|Overall Study|Lost to Follow-up|1|||
16269765|NCT02286466|39471171|FG001|Overall Study|Lost to Follow-up|4|||
16269766|NCT02286466|39471170|FG000|Overall Study|Declined Clinician Assessment|0|||
16269767|NCT02286466|39471171|FG001|Overall Study|Declined Clinician Assessment|1|||
16269768|NCT03552484|39471175|FG000|Overall Study|Death|6|||
16269769|NCT03552484|39471176|FG001|Overall Study|Death|4|||
16269770|NCT03552484|39471175|FG000|Overall Study|Lost to Follow-up|0|||
16269771|NCT03552484|39471176|FG001|Overall Study|Lost to Follow-up|16|||
16269772|NCT01175135|39471179|FG000|Overall Study|Adverse Event|2|||
16269773|NCT01175135|39471180|FG001|Overall Study|Adverse Event|5|||
16269774|NCT01175135|39471181|FG002|Overall Study|Adverse Event|3|||
16269775|NCT01175135|39471182|FG003|Overall Study|Adverse Event|4|||
16269776|NCT01175135|39471179|FG000|Overall Study|Death|1|||
16269777|NCT01175135|39471180|FG001|Overall Study|Death|0|||
16269778|NCT01175135|39471181|FG002|Overall Study|Death|0|||
16269779|NCT01175135|39471182|FG003|Overall Study|Death|0|||
16269780|NCT01175135|39471179|FG000|Overall Study|Lack of Efficacy|4|||
16269781|NCT01175135|39471180|FG001|Overall Study|Lack of Efficacy|5|||
16269782|NCT01175135|39471181|FG002|Overall Study|Lack of Efficacy|0|||
16269783|NCT01175135|39471182|FG003|Overall Study|Lack of Efficacy|5|||
16269784|NCT01175135|39471179|FG000|Overall Study|Lost to Follow-up|1|||
16269785|NCT01175135|39471180|FG001|Overall Study|Lost to Follow-up|2|||
16269786|NCT01175135|39471181|FG002|Overall Study|Lost to Follow-up|0|||
16269787|NCT01175135|39471182|FG003|Overall Study|Lost to Follow-up|0|||
16269788|NCT01175135|39471179|FG000|Overall Study|Protocol Violation|1|||
16269789|NCT01175135|39471180|FG001|Overall Study|Protocol Violation|1|||
16269790|NCT01175135|39471181|FG002|Overall Study|Protocol Violation|0|||
16269791|NCT01175135|39471182|FG003|Overall Study|Protocol Violation|0|||
16269792|NCT01175135|39471179|FG000|Overall Study|Withdrawal by Subject|4|||
16269793|NCT01175135|39471180|FG001|Overall Study|Withdrawal by Subject|8|||
16269794|NCT01175135|39471181|FG002|Overall Study|Withdrawal by Subject|5|||
16269795|NCT01175135|39471182|FG003|Overall Study|Withdrawal by Subject|5|||
16269796|NCT01175135|39471179|FG000|Overall Study|Other|3|||
16269797|NCT01175135|39471180|FG001|Overall Study|Other|1|||
16269798|NCT01175135|39471181|FG002|Overall Study|Other|3|||
16269799|NCT01175135|39471182|FG003|Overall Study|Other|0|||
16269800|NCT01175135|39471179|FG000|Overall Study|Randomized But Not Treated|0|||
16269801|NCT01175135|39471180|FG001|Overall Study|Randomized But Not Treated|0|||
16269802|NCT01175135|39471181|FG002|Overall Study|Randomized But Not Treated|1|||
16269803|NCT01175135|39471182|FG003|Overall Study|Randomized But Not Treated|0|||
16269804|NCT03888235|39471185|FG000|Overall Study|Lost to Follow-up|1|||
16269805|NCT03888235|39471186|FG001|Overall Study|Lost to Follow-up|1|||
16269806|NCT03888235|39471187|FG002|Overall Study|Lost to Follow-up|0|||
16269807|NCT03499353|39471188|FG000|Treatment|Adverse Event|3|||
16269808|NCT03499353|39471188|FG000|Treatment|Progressive Disease|10|||
16269809|NCT03499353|39471188|FG000|Treatment|Other|1|||
16269810|NCT03499353|39471188|FG000|Treatment|Withdrawal by Subject|2|||
16269811|NCT03499353|39471188|FG000|Long-Term Follow-up|Death|2|||
16269812|NCT03499353|39471188|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
16269813|NCT03499353|39471188|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
16269814|NCT02911792|39471189|FG000|Overall Study|Lost to Follow-up|3|||
16269815|NCT02911792|39471190|FG001|Overall Study|Lost to Follow-up|3|||
16269816|NCT02911792|39471191|FG002|Overall Study|Lost to Follow-up|3|||
16269817|NCT02911792|39471192|FG003|Overall Study|Lost to Follow-up|3|||
16269818|NCT03049748|39471195|FG000|Overall Study|Lost to Follow-up|1|||
16269819|NCT03049748|39471196|FG001|Overall Study|Lost to Follow-up|0|||
16269820|NCT03049748|39471195|FG000|Overall Study|Death|3|||
16269821|NCT03049748|39471196|FG001|Overall Study|Death|0|||
16269822|NCT03049748|39471195|FG000|Overall Study|Withdrawal by Subject|0|||
16269823|NCT03049748|39471196|FG001|Overall Study|Withdrawal by Subject|3|||
16468927|NCT03091777|40196386|FG000|Overall Study|Withdrawal by Subject|4|||
16269824|NCT03049748|39471195|FG000|Overall Study|Protocol Violation|0|||
16269825|NCT03049748|39471196|FG001|Overall Study|Protocol Violation|2|||
16269826|NCT03049748|39471195|FG000|Overall Study|Moved out of state (relocation)|0|||
16269827|NCT03049748|39471196|FG001|Overall Study|Moved out of state (relocation)|1|||
16269828|NCT01442376|39471197|FG000|Overall Study|Adverse Event|0|||
16269829|NCT01442376|39471198|FG001|Overall Study|Adverse Event|3|||
16269830|NCT01442376|39471199|FG002|Overall Study|Adverse Event|2|||
16269831|NCT01442376|39471197|FG000|Overall Study|Death|0|||
16269832|NCT01442376|39471198|FG001|Overall Study|Death|1|||
16269833|NCT01442376|39471199|FG002|Overall Study|Death|1|||
16269834|NCT01442376|39471197|FG000|Overall Study|Withdrawal of consent|0|||
16269835|NCT01442376|39471198|FG001|Overall Study|Withdrawal of consent|0|||
16269836|NCT01442376|39471199|FG002|Overall Study|Withdrawal of consent|1|||
16269837|NCT01442376|39471197|FG000|Overall Study|Patients not treated|2|||
16269838|NCT01442376|39471198|FG001|Overall Study|Patients not treated|3|||
16269839|NCT01442376|39471199|FG002|Overall Study|Patients not treated|1|||
16269840|NCT01442376|39471197|FG000|Overall Study|Not eligible for subsequent cycles|1|||
16269841|NCT01442376|39471198|FG001|Overall Study|Not eligible for subsequent cycles|2|||
16269842|NCT01442376|39471199|FG002|Overall Study|Not eligible for subsequent cycles|0|||
16269843|NCT00455312|39471200|FG000|Overall Study|Death|0|||
16269844|NCT00455312|39471201|FG001|Overall Study|Death|1|||
16269845|NCT03364192|39471202|FG000|Overall Study|Ineligible|10|||
16269846|NCT03364192|39471202|FG000|Overall Study|Withdrawal by Subject|5|||
16269847|NCT03364192|39471202|FG000|Overall Study|Lost to Follow-up|1|||
16269848|NCT01796171|39471209|FG000|Enrolled|Death|0|||
16269849|NCT01796171|39471210|FG001|Enrolled|Death|0|||
16269850|NCT01796171|39471211|FG002|Enrolled|Death|0|||
16269851|NCT01796171|39471212|FG003|Enrolled|Death|0|||
16269852|NCT01796171|39471213|FG004|Enrolled|Death|0|||
16269853|NCT01796171|39471214|FG005|Enrolled|Death|0|||
16269854|NCT01796171|39471215|FG006|Enrolled|Death|0|||
16269855|NCT01796171|39471216|FG007|Enrolled|Death|0|||
16269856|NCT01796171|39471217|FG008|Enrolled|Death|0|||
16269857|NCT01796171|39471218|FG009|Enrolled|Death|0|||
16269858|NCT01796171|39471219|FG010|Enrolled|Death|0|||
16269859|NCT01796171|39471220|FG011|Enrolled|Death|0|||
16269860|NCT01796171|39471221|FG012|Enrolled|Death|0|||
16269861|NCT01796171|39471222|FG013|Enrolled|Death|0|||
16269862|NCT01796171|39471223|FG014|Enrolled|Death|1|||
16269863|NCT01796171|39471209|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
16269864|NCT01796171|39471210|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
16269865|NCT01796171|39471211|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
16269866|NCT01796171|39471212|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
16269867|NCT01796171|39471213|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
16269868|NCT01796171|39471214|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
16269869|NCT01796171|39471215|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
16269870|NCT01796171|39471216|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
16269871|NCT01796171|39471217|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
16269872|NCT01796171|39471218|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
16269873|NCT01796171|39471219|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
16269874|NCT01796171|39471220|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
16269875|NCT01796171|39471221|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
16269876|NCT01796171|39471222|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
16269877|NCT01796171|39471223|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
16269878|NCT01796171|39471209|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269879|NCT01796171|39471210|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269880|NCT01796171|39471211|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269881|NCT01796171|39471212|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269882|NCT01796171|39471213|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269883|NCT01796171|39471214|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269884|NCT01796171|39471215|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269885|NCT01796171|39471216|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269886|NCT01796171|39471217|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269887|NCT01796171|39471218|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269888|NCT01796171|39471219|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269889|NCT01796171|39471220|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269890|NCT01796171|39471221|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269891|NCT01796171|39471222|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
16269892|NCT01796171|39471223|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
16269893|NCT01796171|39471209|FG000|Treatment Period With Betalutin|Progressive disease|0|||
16269894|NCT01796171|39471210|FG001|Treatment Period With Betalutin|Progressive disease|1|||
16269895|NCT01796171|39471211|FG002|Treatment Period With Betalutin|Progressive disease|0|||
16269896|NCT01796171|39471212|FG003|Treatment Period With Betalutin|Progressive disease|0|||
16269897|NCT01796171|39471213|FG004|Treatment Period With Betalutin|Progressive disease|0|||
16269898|NCT01796171|39471214|FG005|Treatment Period With Betalutin|Progressive disease|0|||
16269899|NCT01796171|39471215|FG006|Treatment Period With Betalutin|Progressive disease|0|||
16269900|NCT01796171|39471216|FG007|Treatment Period With Betalutin|Progressive disease|0|||
16269901|NCT01796171|39471217|FG008|Treatment Period With Betalutin|Progressive disease|0|||
16269902|NCT01796171|39471218|FG009|Treatment Period With Betalutin|Progressive disease|0|||
16269903|NCT01796171|39471219|FG010|Treatment Period With Betalutin|Progressive disease|0|||
16269904|NCT01796171|39471220|FG011|Treatment Period With Betalutin|Progressive disease|0|||
16269905|NCT01796171|39471221|FG012|Treatment Period With Betalutin|Progressive disease|0|||
16269906|NCT01796171|39471222|FG013|Treatment Period With Betalutin|Progressive disease|0|||
16269907|NCT01796171|39471223|FG014|Treatment Period With Betalutin|Progressive disease|0|||
16269908|NCT01796171|39471209|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269909|NCT01796171|39471210|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269910|NCT01796171|39471211|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269911|NCT01796171|39471212|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269912|NCT01796171|39471213|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269913|NCT01796171|39471214|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269914|NCT01796171|39471215|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269915|NCT01796171|39471216|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269916|NCT01796171|39471217|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
16269917|NCT01796171|39471218|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269918|NCT01796171|39471219|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
16269919|NCT01796171|39471220|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
16269920|NCT01796171|39471221|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269921|NCT01796171|39471222|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269922|NCT01796171|39471223|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
16269923|NCT01796171|39471209|FG000|Treatment Period With Betalutin|Physician Decision|0|||
16269924|NCT01796171|39471210|FG001|Treatment Period With Betalutin|Physician Decision|0|||
16269925|NCT01796171|39471211|FG002|Treatment Period With Betalutin|Physician Decision|0|||
16269926|NCT01796171|39471212|FG003|Treatment Period With Betalutin|Physician Decision|0|||
16269927|NCT01796171|39471213|FG004|Treatment Period With Betalutin|Physician Decision|0|||
16269928|NCT01796171|39471214|FG005|Treatment Period With Betalutin|Physician Decision|0|||
16269929|NCT01796171|39471215|FG006|Treatment Period With Betalutin|Physician Decision|0|||
16269930|NCT01796171|39471216|FG007|Treatment Period With Betalutin|Physician Decision|0|||
16269931|NCT01796171|39471217|FG008|Treatment Period With Betalutin|Physician Decision|0|||
16269932|NCT01796171|39471218|FG009|Treatment Period With Betalutin|Physician Decision|0|||
16269933|NCT01796171|39471219|FG010|Treatment Period With Betalutin|Physician Decision|5|||
16269934|NCT01796171|39471220|FG011|Treatment Period With Betalutin|Physician Decision|1|||
16269935|NCT01796171|39471221|FG012|Treatment Period With Betalutin|Physician Decision|1|||
16269936|NCT01796171|39471222|FG013|Treatment Period With Betalutin|Physician Decision|0|||
16269937|NCT01796171|39471223|FG014|Treatment Period With Betalutin|Physician Decision|0|||
16269938|NCT01796171|39471209|FG000|Treatment Period With Betalutin|Death|0|||
16269939|NCT01796171|39471210|FG001|Treatment Period With Betalutin|Death|0|||
16269940|NCT01796171|39471211|FG002|Treatment Period With Betalutin|Death|0|||
16269941|NCT01796171|39471212|FG003|Treatment Period With Betalutin|Death|0|||
16269942|NCT01796171|39471213|FG004|Treatment Period With Betalutin|Death|0|||
16269943|NCT01796171|39471214|FG005|Treatment Period With Betalutin|Death|0|||
16269944|NCT01796171|39471215|FG006|Treatment Period With Betalutin|Death|0|||
16269945|NCT01796171|39471216|FG007|Treatment Period With Betalutin|Death|0|||
16269946|NCT01796171|39471217|FG008|Treatment Period With Betalutin|Death|0|||
16269947|NCT01796171|39471218|FG009|Treatment Period With Betalutin|Death|0|||
16269948|NCT01796171|39471219|FG010|Treatment Period With Betalutin|Death|2|||
16269949|NCT01796171|39471220|FG011|Treatment Period With Betalutin|Death|0|||
16269950|NCT01796171|39471221|FG012|Treatment Period With Betalutin|Death|0|||
16269951|NCT01796171|39471222|FG013|Treatment Period With Betalutin|Death|0|||
16269952|NCT01796171|39471223|FG014|Treatment Period With Betalutin|Death|0|||
16269953|NCT01796171|39471209|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
16269954|NCT01796171|39471210|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
16269955|NCT01796171|39471211|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
16269956|NCT01796171|39471212|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
16269957|NCT01796171|39471213|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
16269958|NCT01796171|39471214|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
16269959|NCT01796171|39471215|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
16269960|NCT01796171|39471216|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
16269961|NCT01796171|39471217|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
16269962|NCT01796171|39471218|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
16269963|NCT01796171|39471219|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
16269964|NCT01796171|39471220|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
16269965|NCT01796171|39471221|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
16269966|NCT01796171|39471222|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
16269967|NCT01796171|39471223|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
16269968|NCT01796171|39471209|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269969|NCT01796171|39471210|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269970|NCT01796171|39471211|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269971|NCT01796171|39471212|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269972|NCT01796171|39471213|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269973|NCT01796171|39471214|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269974|NCT01796171|39471215|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269975|NCT01796171|39471216|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269976|NCT01796171|39471217|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269977|NCT01796171|39471218|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269978|NCT01796171|39471219|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
16269979|NCT01796171|39471220|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
16269980|NCT01796171|39471221|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269981|NCT01796171|39471222|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269982|NCT01796171|39471223|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
16269983|NCT01796171|39471209|FG000|Follow-up Period|Start of further anticancer therapy|4|||
16269984|NCT01796171|39471210|FG001|Follow-up Period|Start of further anticancer therapy|25|||
16269985|NCT01796171|39471211|FG002|Follow-up Period|Start of further anticancer therapy|2|||
16269986|NCT01796171|39471212|FG003|Follow-up Period|Start of further anticancer therapy|1|||
16269987|NCT01796171|39471213|FG004|Follow-up Period|Start of further anticancer therapy|2|||
16269988|NCT01796171|39471214|FG005|Follow-up Period|Start of further anticancer therapy|2|||
16269989|NCT01796171|39471215|FG006|Follow-up Period|Start of further anticancer therapy|1|||
16269990|NCT01796171|39471216|FG007|Follow-up Period|Start of further anticancer therapy|15|||
16269991|NCT01796171|39471217|FG008|Follow-up Period|Start of further anticancer therapy|2|||
16269992|NCT01796171|39471218|FG009|Follow-up Period|Start of further anticancer therapy|0|||
16269993|NCT01796171|39471219|FG010|Follow-up Period|Start of further anticancer therapy|0|||
16269994|NCT01796171|39471220|FG011|Follow-up Period|Start of further anticancer therapy|0|||
16269995|NCT01796171|39471221|FG012|Follow-up Period|Start of further anticancer therapy|0|||
16269996|NCT01796171|39471222|FG013|Follow-up Period|Start of further anticancer therapy|0|||
16269997|NCT01796171|39471223|FG014|Follow-up Period|Start of further anticancer therapy|0|||
16269998|NCT01796171|39471209|FG000|Follow-up Period|Progressive disease|0|||
16269999|NCT01796171|39471210|FG001|Follow-up Period|Progressive disease|1|||
16270000|NCT01796171|39471211|FG002|Follow-up Period|Progressive disease|0|||
16270001|NCT01796171|39471212|FG003|Follow-up Period|Progressive disease|0|||
16270002|NCT01796171|39471213|FG004|Follow-up Period|Progressive disease|0|||
16270003|NCT01796171|39471214|FG005|Follow-up Period|Progressive disease|0|||
16270004|NCT01796171|39471215|FG006|Follow-up Period|Progressive disease|0|||
16270005|NCT01796171|39471216|FG007|Follow-up Period|Progressive disease|3|||
16270006|NCT01796171|39471217|FG008|Follow-up Period|Progressive disease|0|||
16270007|NCT01796171|39471218|FG009|Follow-up Period|Progressive disease|0|||
16270008|NCT01796171|39471219|FG010|Follow-up Period|Progressive disease|0|||
16270009|NCT01796171|39471220|FG011|Follow-up Period|Progressive disease|0|||
16270010|NCT01796171|39471221|FG012|Follow-up Period|Progressive disease|0|||
16270011|NCT01796171|39471222|FG013|Follow-up Period|Progressive disease|0|||
16270012|NCT01796171|39471223|FG014|Follow-up Period|Progressive disease|0|||
16270013|NCT01796171|39471209|FG000|Follow-up Period|Physician Decision|0|||
16270014|NCT01796171|39471210|FG001|Follow-up Period|Physician Decision|2|||
16270015|NCT01796171|39471211|FG002|Follow-up Period|Physician Decision|0|||
16270016|NCT01796171|39471212|FG003|Follow-up Period|Physician Decision|0|||
16270017|NCT01796171|39471213|FG004|Follow-up Period|Physician Decision|0|||
16270018|NCT01796171|39471214|FG005|Follow-up Period|Physician Decision|0|||
16270019|NCT01796171|39471215|FG006|Follow-up Period|Physician Decision|0|||
16270020|NCT01796171|39471216|FG007|Follow-up Period|Physician Decision|0|||
16270021|NCT01796171|39471217|FG008|Follow-up Period|Physician Decision|0|||
16270022|NCT01796171|39471218|FG009|Follow-up Period|Physician Decision|0|||
16270023|NCT01796171|39471219|FG010|Follow-up Period|Physician Decision|5|||
16270024|NCT01796171|39471220|FG011|Follow-up Period|Physician Decision|0|||
16270025|NCT01796171|39471221|FG012|Follow-up Period|Physician Decision|0|||
16270026|NCT01796171|39471222|FG013|Follow-up Period|Physician Decision|0|||
16270027|NCT01796171|39471223|FG014|Follow-up Period|Physician Decision|0|||
16270028|NCT01796171|39471209|FG000|Follow-up Period|Withdrawal by Subject|0|||
16270029|NCT01796171|39471210|FG001|Follow-up Period|Withdrawal by Subject|1|||
16270030|NCT01796171|39471211|FG002|Follow-up Period|Withdrawal by Subject|0|||
16270031|NCT01796171|39471212|FG003|Follow-up Period|Withdrawal by Subject|0|||
16270032|NCT01796171|39471213|FG004|Follow-up Period|Withdrawal by Subject|0|||
16270033|NCT01796171|39471214|FG005|Follow-up Period|Withdrawal by Subject|1|||
16270034|NCT01796171|39471215|FG006|Follow-up Period|Withdrawal by Subject|0|||
16270035|NCT01796171|39471216|FG007|Follow-up Period|Withdrawal by Subject|0|||
16270036|NCT01796171|39471217|FG008|Follow-up Period|Withdrawal by Subject|0|||
16270037|NCT01796171|39471218|FG009|Follow-up Period|Withdrawal by Subject|0|||
16270038|NCT01796171|39471219|FG010|Follow-up Period|Withdrawal by Subject|3|||
16270039|NCT01796171|39471220|FG011|Follow-up Period|Withdrawal by Subject|1|||
16270040|NCT01796171|39471221|FG012|Follow-up Period|Withdrawal by Subject|0|||
16270041|NCT01796171|39471222|FG013|Follow-up Period|Withdrawal by Subject|0|||
16270042|NCT01796171|39471223|FG014|Follow-up Period|Withdrawal by Subject|0|||
16270043|NCT01796171|39471209|FG000|Follow-up Period|Death|0|||
16270044|NCT01796171|39471210|FG001|Follow-up Period|Death|0|||
16270045|NCT01796171|39471211|FG002|Follow-up Period|Death|0|||
16270046|NCT01796171|39471212|FG003|Follow-up Period|Death|0|||
16270047|NCT01796171|39471213|FG004|Follow-up Period|Death|0|||
16270048|NCT01796171|39471214|FG005|Follow-up Period|Death|0|||
16270049|NCT01796171|39471215|FG006|Follow-up Period|Death|1|||
16270050|NCT01796171|39471216|FG007|Follow-up Period|Death|0|||
16270051|NCT01796171|39471217|FG008|Follow-up Period|Death|0|||
16270052|NCT01796171|39471218|FG009|Follow-up Period|Death|0|||
16270053|NCT01796171|39471219|FG010|Follow-up Period|Death|17|||
16270054|NCT01796171|39471220|FG011|Follow-up Period|Death|9|||
16270055|NCT01796171|39471221|FG012|Follow-up Period|Death|1|||
16270056|NCT01796171|39471222|FG013|Follow-up Period|Death|0|||
16270057|NCT01796171|39471223|FG014|Follow-up Period|Death|0|||
16270058|NCT01796171|39471209|FG000|Follow-up Period|Patient transferred to other hospital|0|||
16270059|NCT01796171|39471210|FG001|Follow-up Period|Patient transferred to other hospital|1|||
16270060|NCT01796171|39471211|FG002|Follow-up Period|Patient transferred to other hospital|0|||
16270061|NCT01796171|39471212|FG003|Follow-up Period|Patient transferred to other hospital|0|||
16270062|NCT01796171|39471213|FG004|Follow-up Period|Patient transferred to other hospital|0|||
16270063|NCT01796171|39471214|FG005|Follow-up Period|Patient transferred to other hospital|0|||
16270064|NCT01796171|39471215|FG006|Follow-up Period|Patient transferred to other hospital|0|||
16270065|NCT01796171|39471216|FG007|Follow-up Period|Patient transferred to other hospital|0|||
16270066|NCT01796171|39471217|FG008|Follow-up Period|Patient transferred to other hospital|0|||
16270067|NCT01796171|39471218|FG009|Follow-up Period|Patient transferred to other hospital|0|||
16270068|NCT01796171|39471219|FG010|Follow-up Period|Patient transferred to other hospital|0|||
16270069|NCT01796171|39471220|FG011|Follow-up Period|Patient transferred to other hospital|0|||
16270070|NCT01796171|39471221|FG012|Follow-up Period|Patient transferred to other hospital|0|||
16270071|NCT01796171|39471222|FG013|Follow-up Period|Patient transferred to other hospital|0|||
16270072|NCT01796171|39471223|FG014|Follow-up Period|Patient transferred to other hospital|0|||
16270073|NCT01796171|39471209|FG000|Follow-up Period|Sponsor Decision|0|||
16270074|NCT01796171|39471210|FG001|Follow-up Period|Sponsor Decision|0|||
16270075|NCT01796171|39471211|FG002|Follow-up Period|Sponsor Decision|0|||
16270076|NCT01796171|39471212|FG003|Follow-up Period|Sponsor Decision|0|||
16270077|NCT01796171|39471213|FG004|Follow-up Period|Sponsor Decision|0|||
16270078|NCT01796171|39471214|FG005|Follow-up Period|Sponsor Decision|0|||
16270079|NCT01796171|39471215|FG006|Follow-up Period|Sponsor Decision|0|||
16270080|NCT01796171|39471216|FG007|Follow-up Period|Sponsor Decision|0|||
16270081|NCT01796171|39471217|FG008|Follow-up Period|Sponsor Decision|0|||
16270082|NCT01796171|39471218|FG009|Follow-up Period|Sponsor Decision|0|||
16270083|NCT01796171|39471219|FG010|Follow-up Period|Sponsor Decision|40|||
16270084|NCT01796171|39471220|FG011|Follow-up Period|Sponsor Decision|15|||
16270085|NCT01796171|39471221|FG012|Follow-up Period|Sponsor Decision|7|||
16270086|NCT01796171|39471222|FG013|Follow-up Period|Sponsor Decision|0|||
16270087|NCT01796171|39471223|FG014|Follow-up Period|Sponsor Decision|0|||
16270088|NCT04723693|39471224|FG000|Overall Study|Withdrawal by Subject|2|||
16270089|NCT02654145|39471227|FG000|Overall Study|Lack of Efficacy|1|||
16270090|NCT02654145|39471227|FG000|Overall Study|Protocol Violation|1|||
16270091|NCT02654145|39471227|FG000|Overall Study|Withdrawal by Subject|5|||
16270092|NCT02627963|39471228|FG000|Overall Study|Randomized but not treated|2|||
16270093|NCT02627963|39471229|FG001|Overall Study|Randomized but not treated|6|||
16270094|NCT01309672|39471230|FG000|Overall Study|Lack of Efficacy|20|||
16270095|NCT01309672|39471230|FG000|Overall Study|Other|9|||
16270096|NCT01309672|39471230|FG000|Overall Study|Adverse Event|5|||
16270097|NCT01309672|39471230|FG000|Overall Study|Withdrawal by Subject|3|||
16270098|NCT00354835|39471231|FG000|Overall Study|Death|1|||
16270099|NCT00354835|39471232|FG001|Overall Study|Death|1|||
16270100|NCT00354835|39471231|FG000|Overall Study|Physician Decision|8|||
16270101|NCT00354835|39471232|FG001|Overall Study|Physician Decision|13|||
16270102|NCT00354835|39471231|FG000|Overall Study|Withdrawal by Subject|2|||
16270103|NCT00354835|39471232|FG001|Overall Study|Withdrawal by Subject|1|||
16270104|NCT00354835|39471231|FG000|Overall Study|Ineligible|17|||
16270105|NCT00354835|39471232|FG001|Overall Study|Ineligible|16|||
16270106|NCT00354835|39471231|FG000|Overall Study|Disease progression or relapse|15|||
16270107|NCT00354835|39471232|FG001|Overall Study|Disease progression or relapse|22|||
16270108|NCT00354835|39471231|FG000|Overall Study|Adverse Event|6|||
16270109|NCT00354835|39471232|FG001|Overall Study|Adverse Event|0|||
16270110|NCT00354835|39471231|FG000|Overall Study|Refusal of further therapy|3|||
16270111|NCT00354835|39471232|FG001|Overall Study|Refusal of further therapy|8|||
16270112|NCT00191815|39471234|FG000|Overall Study|Adverse Event|2|||
16270113|NCT00191815|39471234|FG000|Overall Study|Disease progression or relapse|24|||
16270114|NCT00191815|39471234|FG000|Overall Study|Death|2|||
16270115|NCT00191815|39471234|FG000|Overall Study|Protocol Violation|3|||
16270116|NCT00191815|39471234|FG000|Overall Study|Physician Decision|2|||
16270117|NCT00191815|39471234|FG000|Overall Study|Withdrawal by Subject|7|||
16270118|NCT00319696|39471235|FG000|Overall Study|Adverse Event|36|||
16270119|NCT00319696|39471235|FG000|Overall Study|withdrawal of consent|14|||
16270120|NCT00319696|39471235|FG000|Overall Study|administrative|7|||
16270121|NCT00319696|39471235|FG000|Overall Study|Lost to Follow-up|3|||
16270122|NCT02566850|39471238|FG000|Overall Study|Protocol Violation|1|||
16270123|NCT02440711|39471239|FG000|Second Intervention|Lost to Follow-up|1|||
16270124|NCT02440711|39471240|FG001|Second Intervention|Lost to Follow-up|0|||
16270125|NCT00829712|39471241|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
16270126|NCT00829712|39471242|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
16270127|NCT02039908|39471243|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
16270128|NCT02039908|39471244|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
16270129|NCT02039908|39471245|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
16270130|NCT02039908|39471246|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
16270131|NCT02039908|39471243|FG000|Phase 1-Summer|Protocol Violation|6|||
16270132|NCT02039908|39471244|FG001|Phase 1-Summer|Protocol Violation|0|||
16270133|NCT02039908|39471245|FG002|Phase 1-Summer|Protocol Violation|0|||
16270134|NCT02039908|39471246|FG003|Phase 1-Summer|Protocol Violation|0|||
16270135|NCT02039908|39471243|FG000|Phase 2-School Year|Lost to Follow-up|0|||
16270136|NCT02039908|39471244|FG001|Phase 2-School Year|Lost to Follow-up|0|||
16270137|NCT02039908|39471245|FG002|Phase 2-School Year|Lost to Follow-up|1|||
16270138|NCT02039908|39471246|FG003|Phase 2-School Year|Lost to Follow-up|3|||
16270139|NCT02039908|39471243|FG000|Phase 2-School Year|Protocol Violation|0|||
16270140|NCT02039908|39471244|FG001|Phase 2-School Year|Protocol Violation|0|||
16270141|NCT02039908|39471245|FG002|Phase 2-School Year|Protocol Violation|3|||
16270142|NCT02039908|39471246|FG003|Phase 2-School Year|Protocol Violation|0|||
16270143|NCT02039908|39471243|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
16270144|NCT02039908|39471244|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
16270145|NCT02039908|39471245|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
16270146|NCT02039908|39471246|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
16270147|NCT02854800|39474220|FG000|Overall Study|Protocol Violation|16|||
16270148|NCT02854800|39474221|FG001|Overall Study|Protocol Violation|11|||
16270149|NCT02854800|39474222|FG002|Overall Study|Protocol Violation|3|||
16270150|NCT02854800|39474220|FG000|Overall Study|Withdrawal by Subject|4|||
16270151|NCT02854800|39474221|FG001|Overall Study|Withdrawal by Subject|2|||
16270152|NCT02854800|39474222|FG002|Overall Study|Withdrawal by Subject|3|||
16270153|NCT03199469|39474223|FG000|Overall Study|Randomized, not treated|0|||
16270154|NCT03199469|39474224|FG001|Overall Study|Randomized, not treated|3|||
16270155|NCT03199469|39474223|FG000|Overall Study|Withdrawal by Subject|1|||
16270156|NCT03199469|39474224|FG001|Overall Study|Withdrawal by Subject|0|||
16270157|NCT03199469|39474223|FG000|Overall Study|Death|1|||
16270158|NCT03199469|39474224|FG001|Overall Study|Death|3|||
16270159|NCT03199469|39474223|FG000|Overall Study|Ongoing|5|||
16270160|NCT03199469|39474224|FG001|Overall Study|Ongoing|14|||
16270161|NCT01539239|39474225|FG000|Overall Study|Death|5|||
16270162|NCT01539239|39474226|FG001|Overall Study|Death|5|||
16270163|NCT01539239|39474225|FG000|Overall Study|Lost to Follow-up|7|||
16270164|NCT01539239|39474226|FG001|Overall Study|Lost to Follow-up|12|||
16270165|NCT00583453|39474227|FG000|Overall Study|discontinued intervention|0|||
16270166|NCT00583453|39474228|FG001|Overall Study|discontinued intervention|2|||
16270167|NCT01196390|39474229|FG000|Overall Study|Protocol Violation|4|||
16270168|NCT01196390|39474230|FG001|Overall Study|Protocol Violation|5|||
16270169|NCT02272803|39474231|FG000|Overall Study|Disease progression|16|||
16270170|NCT02272803|39474232|FG001|Overall Study|Disease progression|8|||
16270171|NCT02272803|39474231|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
16270172|NCT02272803|39474232|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
16270173|NCT02272803|39474231|FG000|Overall Study|Study drug toxicity|4|||
16270174|NCT02272803|39474232|FG001|Overall Study|Study drug toxicity|9|||
16270175|NCT02272803|39474231|FG000|Overall Study|Participant request to discontinue study treatment|3|||
16270176|NCT02272803|39474232|FG001|Overall Study|Participant request to discontinue study treatment|7|||
16270177|NCT02272803|39474231|FG000|Overall Study|Maximum clinical benefit|4|||
16270178|NCT02272803|39474232|FG001|Overall Study|Maximum clinical benefit|2|||
16270179|NCT02272803|39474231|FG000|Overall Study|Poor/non-compliance|2|||
16270180|NCT02272803|39474232|FG001|Overall Study|Poor/non-compliance|2|||
16270181|NCT02272803|39474231|FG000|Overall Study|Withdrawal by Subject|2|||
16270182|NCT02272803|39474232|FG001|Overall Study|Withdrawal by Subject|1|||
16270183|NCT02272803|39474231|FG000|Overall Study|Death|0|||
16270184|NCT02272803|39474232|FG001|Overall Study|Death|1|||
16270185|NCT02272803|39474231|FG000|Overall Study|Other reasons|1|||
16270186|NCT02272803|39474232|FG001|Overall Study|Other reasons|3|||
16270187|NCT02272803|39474231|FG000|Overall Study|Administrative reason by sponsor|5|||
16270188|NCT02272803|39474232|FG001|Overall Study|Administrative reason by sponsor|4|||
16270189|NCT01015703|39474233|FG000|Overall Study|Withdrawal by Subject|0|||
16270190|NCT01015703|39474234|FG001|Overall Study|Withdrawal by Subject|1|||
16270191|NCT01015703|39474235|FG002|Overall Study|Withdrawal by Subject|0|||
16270192|NCT01015703|39474236|FG003|Overall Study|Withdrawal by Subject|0|||
16270193|NCT01015703|39474237|FG004|Overall Study|Withdrawal by Subject|0|||
16270194|NCT01015703|39474233|FG000|Overall Study|Adverse Event|1|||
16270195|NCT01015703|39474234|FG001|Overall Study|Adverse Event|0|||
16270196|NCT01015703|39474235|FG002|Overall Study|Adverse Event|0|||
16270197|NCT01015703|39474236|FG003|Overall Study|Adverse Event|0|||
16270198|NCT01015703|39474237|FG004|Overall Study|Adverse Event|0|||
16270199|NCT01015703|39474233|FG000|Overall Study|Protocol Violation|1|||
16270200|NCT01015703|39474234|FG001|Overall Study|Protocol Violation|0|||
16270201|NCT01015703|39474235|FG002|Overall Study|Protocol Violation|0|||
16270202|NCT01015703|39474236|FG003|Overall Study|Protocol Violation|0|||
16270203|NCT01015703|39474237|FG004|Overall Study|Protocol Violation|0|||
16270204|NCT01531894|39474241|FG000|Overall Study|Physician Decision|8|||
16270205|NCT01531894|39474241|FG000|Overall Study|Death|1|||
16270206|NCT01484912|39474242|FG000|Overall Study|Withdrawal by Subject|1|||
16270207|NCT01484912|39474243|FG001|Overall Study|Withdrawal by Subject|0|||
16270208|NCT01484912|39474242|FG000|Overall Study|Physician Decision|0|||
16270209|NCT01484912|39474243|FG001|Overall Study|Physician Decision|1|||
16270210|NCT01794845|39474244|FG000|Overall Study|Withdrawal by Subject|1|||
16270211|NCT00467597|39474245|FG000|Overall Study|Withdrawal by Subject|2|||
16270212|NCT00467597|39474246|FG001|Overall Study|Withdrawal by Subject|0|||
16270213|NCT00834431|39474247|FG000|First Intervention|Adverse Event|0|||
16270214|NCT00834431|39474248|FG001|First Intervention|Adverse Event|1|||
16270215|NCT00834431|39474247|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
16270216|NCT00834431|39474248|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
16270217|NCT00268203|39474249|FG000|Overall Study|Lost to Follow-up|92|||
16270218|NCT00268203|39474249|FG000|Overall Study|Withdrawal by Subject|9|||
16270219|NCT00268203|39474249|FG000|Overall Study|Received Other NHL Therapy|7|||
16270220|NCT00268203|39474249|FG000|Overall Study|Progressive Disease|359|||
16270221|NCT00268203|39474249|FG000|Overall Study|Death|84|||
16270222|NCT00268203|39474249|FG000|Overall Study|Reason Not Specified|34|||
16270223|NCT00268203|39474249|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
16270224|NCT02426918|39474250|FG000|Overall Study|Adverse Event|2|||
16270225|NCT02426918|39474251|FG001|Overall Study|Adverse Event|2|||
16270226|NCT02426918|39474252|FG002|Overall Study|Adverse Event|0|||
16270227|NCT02426918|39474250|FG000|Overall Study|Physician Decision|1|||
16270228|NCT02426918|39474251|FG001|Overall Study|Physician Decision|1|||
16270229|NCT02426918|39474252|FG002|Overall Study|Physician Decision|1|||
16270230|NCT02426918|39474250|FG000|Overall Study|Withdrawal by Subject|5|||
16270231|NCT02426918|39474251|FG001|Overall Study|Withdrawal by Subject|5|||
16270232|NCT02426918|39474252|FG002|Overall Study|Withdrawal by Subject|4|||
16270233|NCT02426918|39474250|FG000|Overall Study|Other|9|||
16270234|NCT02426918|39474251|FG001|Overall Study|Other|11|||
16270235|NCT02426918|39474252|FG002|Overall Study|Other|9|||
16270236|NCT01675596|39474256|FG000|Overall Study|Death|6|||
16270237|NCT01675596|39474256|FG000|Overall Study|Exit with other reason|1|||
16270238|NCT01675596|39474256|FG000|Overall Study|Missed Visit|1|||
16270239|NCT01597791|39474257|FG000|Overall Study|Physician Decision|2|||
16270240|NCT01597791|39474258|FG001|Overall Study|Physician Decision|1|||
16270241|NCT01597791|39474257|FG000|Overall Study|Cesarean Section|6|||
16270242|NCT01597791|39474258|FG001|Overall Study|Cesarean Section|7|||
16270243|NCT01597791|39474257|FG000|Overall Study|Subject withdrawal|0|||
16270244|NCT01597791|39474258|FG001|Overall Study|Subject withdrawal|1|||
16270245|NCT01597791|39474257|FG000|Overall Study|Protocol Violation|0|||
16270246|NCT01597791|39474258|FG001|Overall Study|Protocol Violation|1|||
16270247|NCT00857454|39474260|FG000|Overall Study|Withdrawal by Subject|2|||
16270248|NCT00857454|39474260|FG000|Overall Study|Lost to Follow-up|1|||
16270249|NCT00857454|39474260|FG000|Overall Study|Adverse Event|2|||
16270250|NCT00857454|39474260|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
16270251|NCT00857454|39474260|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
16270252|NCT00857454|39474260|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
16270253|NCT02761915|39474263|FG000|Overall Study|Death|3|||
16270254|NCT02761915|39474264|FG001|Overall Study|Death|1|||
16270255|NCT02761915|39474265|FG002|Overall Study|Death|1|||
16270256|NCT02761915|39474266|FG003|Overall Study|Death|1|||
16270257|NCT02761915|39474267|FG004|Overall Study|Death|0|||
16270258|NCT02761915|39474268|FG005|Overall Study|Death|1|||
16270259|NCT02761915|39474263|FG000|Overall Study|Withdrawal by Subject|1|||
16270260|NCT02761915|39474264|FG001|Overall Study|Withdrawal by Subject|0|||
16270261|NCT02761915|39474265|FG002|Overall Study|Withdrawal by Subject|0|||
16270262|NCT02761915|39474266|FG003|Overall Study|Withdrawal by Subject|0|||
16270263|NCT02761915|39474267|FG004|Overall Study|Withdrawal by Subject|1|||
16270264|NCT02761915|39474268|FG005|Overall Study|Withdrawal by Subject|2|||
16270265|NCT02761915|39474263|FG000|Overall Study|Disease Progression|0|||
16270266|NCT02761915|39474264|FG001|Overall Study|Disease Progression|0|||
16270267|NCT02761915|39474265|FG002|Overall Study|Disease Progression|0|||
16270268|NCT02761915|39474266|FG003|Overall Study|Disease Progression|2|||
16270269|NCT02761915|39474267|FG004|Overall Study|Disease Progression|2|||
16270270|NCT02761915|39474268|FG005|Overall Study|Disease Progression|2|||
16270271|NCT00830024|39474269|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
16270272|NCT00830024|39474270|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
16270273|NCT00474058|39474271|FG000|Overall Study|Adverse Event|11|||
16270274|NCT00474058|39474272|FG001|Overall Study|Adverse Event|6|||
16270275|NCT00474058|39474271|FG000|Overall Study|Lack of Efficacy|0|||
16270276|NCT00474058|39474272|FG001|Overall Study|Lack of Efficacy|4|||
16270277|NCT00474058|39474271|FG000|Overall Study|Withdrawal by Subject|11|||
16270278|NCT00474058|39474272|FG001|Overall Study|Withdrawal by Subject|7|||
16270279|NCT00474058|39474271|FG000|Overall Study|Other|2|||
16270280|NCT00474058|39474272|FG001|Overall Study|Other|0|||
16270281|NCT02316223|39474280|FG000|Overall Study|Lack of Efficacy|0|||
16270282|NCT02316223|39474281|FG001|Overall Study|Lack of Efficacy|1|||
16270283|NCT02316223|39474282|FG002|Overall Study|Lack of Efficacy|1|||
16270284|NCT02316223|39474280|FG000|Overall Study|Lost to Follow-up|27|||
16270285|NCT02316223|39474281|FG001|Overall Study|Lost to Follow-up|34|||
16270286|NCT02316223|39474282|FG002|Overall Study|Lost to Follow-up|36|||
16270287|NCT02316223|39474280|FG000|Overall Study|COPD Diagnosis|3|||
16270288|NCT02316223|39474281|FG001|Overall Study|COPD Diagnosis|2|||
16270289|NCT02316223|39474282|FG002|Overall Study|COPD Diagnosis|3|||
16270290|NCT02316223|39474280|FG000|Overall Study|Reside outside study area|1|||
16270291|NCT02316223|39474281|FG001|Overall Study|Reside outside study area|1|||
16270292|NCT02316223|39474282|FG002|Overall Study|Reside outside study area|1|||
16270293|NCT02316223|39474280|FG000|Overall Study|No asthma|2|||
16270294|NCT02316223|39474281|FG001|Overall Study|No asthma|0|||
16270295|NCT02316223|39474282|FG002|Overall Study|No asthma|0|||
16270296|NCT02316223|39474280|FG000|Overall Study|Discontinued by PI|11|||
16270297|NCT02316223|39474281|FG001|Overall Study|Discontinued by PI|19|||
16270298|NCT02316223|39474282|FG002|Overall Study|Discontinued by PI|3|||
16270299|NCT00406393|39474283|FG000|Overall Study|Did not undergo transplantation|2|||
16270300|NCT00406393|39474284|FG001|Overall Study|Did not undergo transplantation|1|||
16270301|NCT05274763|39474290|FG000|Overall Study|Lost to Follow-up|1|||
16270302|NCT03214588|39474291|FG000|Overall Study|Adverse Event|1|||
16270303|NCT03214588|39474292|FG001|Overall Study|Adverse Event|0|||
16270304|NCT03214588|39474293|FG002|Overall Study|Adverse Event|2|||
16270305|NCT03214588|39474291|FG000|Overall Study|Reason Not Specified|0|||
16270306|NCT03214588|39474292|FG001|Overall Study|Reason Not Specified|1|||
16270307|NCT03214588|39474293|FG002|Overall Study|Reason Not Specified|0|||
16270308|NCT01494532|39474295|FG000|Overall Study|Adverse Event|4|||
16270309|NCT01494532|39474296|FG001|Overall Study|Adverse Event|1|||
16270310|NCT01494532|39474297|FG002|Overall Study|Adverse Event|8|||
16270311|NCT01494532|39474298|FG003|Overall Study|Adverse Event|6|||
16270312|NCT01494532|39474299|FG004|Overall Study|Adverse Event|5|||
16270313|NCT01494532|39474300|FG005|Overall Study|Adverse Event|0|||
16270314|NCT01494532|39474295|FG000|Overall Study|Lack of Efficacy|0|||
16270315|NCT01494532|39474296|FG001|Overall Study|Lack of Efficacy|0|||
16270316|NCT01494532|39474297|FG002|Overall Study|Lack of Efficacy|0|||
16270317|NCT01494532|39474298|FG003|Overall Study|Lack of Efficacy|0|||
16270318|NCT01494532|39474299|FG004|Overall Study|Lack of Efficacy|2|||
16270319|NCT01494532|39474300|FG005|Overall Study|Lack of Efficacy|0|||
16270320|NCT01494532|39474295|FG000|Overall Study|Protocol deviation|2|||
16270321|NCT01494532|39474296|FG001|Overall Study|Protocol deviation|1|||
16270322|NCT01494532|39474297|FG002|Overall Study|Protocol deviation|3|||
16270323|NCT01494532|39474298|FG003|Overall Study|Protocol deviation|2|||
16270324|NCT01494532|39474299|FG004|Overall Study|Protocol deviation|3|||
16270325|NCT01494532|39474300|FG005|Overall Study|Protocol deviation|0|||
16270326|NCT01494532|39474295|FG000|Overall Study|Protocol-defined stopping criteria|0|||
16270327|NCT01494532|39474296|FG001|Overall Study|Protocol-defined stopping criteria|0|||
16270328|NCT01494532|39474297|FG002|Overall Study|Protocol-defined stopping criteria|1|||
16270329|NCT01494532|39474298|FG003|Overall Study|Protocol-defined stopping criteria|0|||
16270330|NCT01494532|39474299|FG004|Overall Study|Protocol-defined stopping criteria|0|||
16270331|NCT01494532|39474300|FG005|Overall Study|Protocol-defined stopping criteria|0|||
16270332|NCT01494532|39474295|FG000|Overall Study|Lost to Follow-up|1|||
16270333|NCT01494532|39474296|FG001|Overall Study|Lost to Follow-up|0|||
16270334|NCT01494532|39474297|FG002|Overall Study|Lost to Follow-up|0|||
16270335|NCT01494532|39474298|FG003|Overall Study|Lost to Follow-up|2|||
16270336|NCT01494532|39474299|FG004|Overall Study|Lost to Follow-up|0|||
16270337|NCT01494532|39474300|FG005|Overall Study|Lost to Follow-up|0|||
16270338|NCT01494532|39474295|FG000|Overall Study|Physician Decision|0|||
16270339|NCT01494532|39474296|FG001|Overall Study|Physician Decision|1|||
16270340|NCT01494532|39474297|FG002|Overall Study|Physician Decision|1|||
16270341|NCT01494532|39474298|FG003|Overall Study|Physician Decision|2|||
16270342|NCT01494532|39474299|FG004|Overall Study|Physician Decision|0|||
16270343|NCT01494532|39474300|FG005|Overall Study|Physician Decision|0|||
16270344|NCT01494532|39474295|FG000|Overall Study|Withdrawal by Subject|3|||
16270345|NCT01494532|39474296|FG001|Overall Study|Withdrawal by Subject|1|||
16270346|NCT01494532|39474297|FG002|Overall Study|Withdrawal by Subject|4|||
16270347|NCT01494532|39474298|FG003|Overall Study|Withdrawal by Subject|3|||
16270348|NCT01494532|39474299|FG004|Overall Study|Withdrawal by Subject|2|||
16270349|NCT01494532|39474300|FG005|Overall Study|Withdrawal by Subject|0|||
16270350|NCT03025087|39474303|FG000|Overall Study|Physician Decision|3|||
16270351|NCT03025087|39474304|FG001|Overall Study|Physician Decision|3|||
16270352|NCT03025087|39474305|FG002|Overall Study|Physician Decision|0|||
16468928|NCT03091777|40196387|FG001|Overall Study|Withdrawal by Subject|2|||
16270353|NCT03025087|39474306|FG003|Overall Study|Physician Decision|0|||
16270354|NCT03025087|39474307|FG004|Overall Study|Physician Decision|0|||
16270355|NCT03025087|39474303|FG000|Overall Study|Withdrawal by Subject|1|||
16270356|NCT03025087|39474304|FG001|Overall Study|Withdrawal by Subject|1|||
16270357|NCT03025087|39474305|FG002|Overall Study|Withdrawal by Subject|0|||
16270358|NCT03025087|39474306|FG003|Overall Study|Withdrawal by Subject|0|||
16270359|NCT03025087|39474307|FG004|Overall Study|Withdrawal by Subject|0|||
16270360|NCT03025087|39474303|FG000|Overall Study|Unable to complete MRI|2|||
16270361|NCT03025087|39474304|FG001|Overall Study|Unable to complete MRI|2|||
16270362|NCT03025087|39474305|FG002|Overall Study|Unable to complete MRI|0|||
16270363|NCT03025087|39474306|FG003|Overall Study|Unable to complete MRI|0|||
16270364|NCT03025087|39474307|FG004|Overall Study|Unable to complete MRI|0|||
16270365|NCT00918645|39474308|FG000|Overall Study|Withdrawal by Subject|1|||
16270366|NCT02005276|39474313|FG000|Overall Study|No longer interested|5|||
16270367|NCT02005276|39474314|FG001|Overall Study|No longer interested|2|||
16270368|NCT02005276|39474315|FG002|Overall Study|No longer interested|3|||
16270369|NCT02005276|39474316|FG003|Overall Study|No longer interested|3|||
16270370|NCT03497130|39474317|FG000|Overall Study|Lost to Follow-up|1|||
16270371|NCT03497130|39474318|FG001|Overall Study|Lost to Follow-up|1|||
16270372|NCT02167594|39474321|FG000|Overall Study|Withdrawal by Subject|2|||
16270373|NCT02167594|39474322|FG001|Overall Study|Withdrawal by Subject|0|||
16270374|NCT02167594|39474323|FG002|Overall Study|Withdrawal by Subject|0|||
16270375|NCT02167594|39474321|FG000|Overall Study|Death|0|||
16270376|NCT02167594|39474322|FG001|Overall Study|Death|1|||
16270377|NCT02167594|39474323|FG002|Overall Study|Death|0|||
16270378|NCT02653664|39474329|FG000|Post-Treatment|Withdrawal by Subject|6|||
16270379|NCT02653664|39474330|FG001|Post-Treatment|Withdrawal by Subject|5|||
16270380|NCT02653664|39474331|FG002|Post-Treatment|Withdrawal by Subject|7|||
16270381|NCT02653664|39474329|FG000|Post-Treatment|Lost to Follow-up|8|||
16270382|NCT02653664|39474330|FG001|Post-Treatment|Lost to Follow-up|1|||
16270383|NCT02653664|39474331|FG002|Post-Treatment|Lost to Follow-up|7|||
16270384|NCT02653664|39474329|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
16270385|NCT02653664|39474330|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
16270386|NCT02653664|39474331|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
16270387|NCT02653664|39474329|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
16270388|NCT02653664|39474330|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
16270389|NCT02653664|39474331|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
16270390|NCT02653664|39474329|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
16270391|NCT02653664|39474330|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
16270392|NCT02653664|39474331|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
16270393|NCT02653664|39474329|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
16270394|NCT02653664|39474330|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
16270395|NCT02653664|39474331|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
16270396|NCT02653664|39474329|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
16270397|NCT02653664|39474330|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
16270398|NCT02653664|39474331|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
16270399|NCT02653664|39474329|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
16270400|NCT02653664|39474330|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
16270401|NCT02653664|39474331|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
16270402|NCT02653664|39474329|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
16270403|NCT02653664|39474330|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
16270404|NCT02653664|39474331|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
16270405|NCT02653664|39474329|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
16270406|NCT02653664|39474330|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
16270407|NCT02653664|39474331|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
16270408|NCT04183335|39474335|FG000|Overall Study|Adverse Event|1|||
16270409|NCT04183335|39474336|FG001|Overall Study|Adverse Event|0|||
16270410|NCT04183335|39474335|FG000|Overall Study|Withdrawal by Subject|12|||
16270411|NCT04183335|39474336|FG001|Overall Study|Withdrawal by Subject|3|||
16270412|NCT02452463|39474337|FG000|Overall Study|Death|1|||
16270413|NCT02452463|39474338|FG001|Overall Study|Death|0|||
16270414|NCT02452463|39474339|FG002|Overall Study|Death|0|||
16270415|NCT02452463|39474337|FG000|Overall Study|Study Suspended|1|||
16270416|NCT02452463|39474338|FG001|Overall Study|Study Suspended|0|||
16270417|NCT02452463|39474339|FG002|Overall Study|Study Suspended|0|||
16270418|NCT02452463|39474337|FG000|Overall Study|Recommended by DSMB|0|||
16270419|NCT02452463|39474338|FG001|Overall Study|Recommended by DSMB|1|||
16270420|NCT02452463|39474339|FG002|Overall Study|Recommended by DSMB|0|||
16270421|NCT02452463|39474337|FG000|Overall Study|Withdrawal by Subject|0|||
16270422|NCT02452463|39474338|FG001|Overall Study|Withdrawal by Subject|1|||
16270423|NCT02452463|39474339|FG002|Overall Study|Withdrawal by Subject|0|||
16270424|NCT00377260|39474340|FG000|Overall Study|Lost to Follow-up|0|||
16270425|NCT00377260|39474341|FG001|Overall Study|Lost to Follow-up|1|||
16270426|NCT00377260|39474340|FG000|Overall Study|Withdrawal by Subject|2|||
16270427|NCT00377260|39474341|FG001|Overall Study|Withdrawal by Subject|4|||
16270428|NCT01609257|39474344|FG000|Overall Study|Lost to Follow-up|2|||
16270429|NCT01609257|39474345|FG001|Overall Study|Lost to Follow-up|1|||
16270430|NCT01609257|39474344|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
16270431|NCT01609257|39474345|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
16270432|NCT01609257|39474344|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
16270433|NCT01609257|39474345|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
16270434|NCT00918684|39474346|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
16270435|NCT00918684|39474346|FG000|Treatment Phase|Lack of Efficacy|6|||
16270436|NCT00918684|39474346|FG000|Treatment Phase|Lost to Follow-up|2|||
16270437|NCT00918684|39474346|FG000|Treatment Phase|Physician Decision|8|||
16270438|NCT00918684|39474346|FG000|Treatment Phase|Protocol Violation|1|||
16270439|NCT00918684|39474346|FG000|Treatment Phase|Withdrawal by Subject|8|||
16270440|NCT01378962|39474349|FG000|Overall Study|Death|14|||
16270441|NCT01378962|39474349|FG000|Overall Study|Lost to Follow-up|1|||
16270442|NCT01378962|39474349|FG000|Overall Study|Other|2|||
16270443|NCT02488239|39474350|FG000|Overall Study|Death|3|||
16270444|NCT02488239|39474350|FG000|Overall Study|Withdrawal by Subject|3|||
16270445|NCT02488239|39474350|FG000|Overall Study|Physician Decision|2|||
16270446|NCT02488239|39474350|FG000|Overall Study|Consent ineligible|1|||
16270447|NCT02488239|39474350|FG000|Overall Study|Did not undergo implant procedure|1|||
16270448|NCT02313558|39474353|FG000|Overall Study|Withdrawal by Subject|2|||
16270449|NCT02313558|39474354|FG001|Overall Study|Withdrawal by Subject|0|||
16270450|NCT02313558|39474353|FG000|Overall Study|Lost to Follow-up|4|||
16270451|NCT02313558|39474354|FG001|Overall Study|Lost to Follow-up|4|||
16270452|NCT03930732|39474355|FG000|Overall Study|Adverse Event|9|||
16270453|NCT03930732|39474356|FG001|Overall Study|Adverse Event|7|||
16270454|NCT03930732|39474355|FG000|Overall Study|Poor compliance to protocol|0|||
16270455|NCT03930732|39474356|FG001|Overall Study|Poor compliance to protocol|1|||
16270456|NCT03930732|39474355|FG000|Overall Study|Withdrawal by Subject|23|||
16270457|NCT03930732|39474356|FG001|Overall Study|Withdrawal by Subject|11|||
16270458|NCT03930732|39474355|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
16270459|NCT03930732|39474356|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
16270460|NCT03930732|39474355|FG000|Overall Study|Other reason not related to COVID-19|5|||
16270461|NCT03930732|39474356|FG001|Overall Study|Other reason not related to COVID-19|8|||
16270462|NCT02222818|39474361|FG000|Period 1|Eligibility criteria not met|0|||
16270463|NCT02222818|39474362|FG001|Period 1|Eligibility criteria not met|3|||
16270464|NCT00867360|39474363|FG000|Overall Study|Withdrawal by Subject|1|||
16270465|NCT00867360|39474364|FG001|Overall Study|Withdrawal by Subject|0|||
16270466|NCT00867360|39474363|FG000|Overall Study|Physician Decision|0|||
16270467|NCT00867360|39474364|FG001|Overall Study|Physician Decision|1|||
16270468|NCT01566435|39474367|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
16270469|NCT01519947|39474369|FG000|Overall Study|Death|0|||
16270470|NCT01519947|39474370|FG001|Overall Study|Death|0|||
16270471|NCT01519947|39474371|FG002|Overall Study|Death|0|||
16270472|NCT01519947|39474372|FG003|Overall Study|Death|1|||
16270473|NCT01519947|39474369|FG000|Overall Study|Protocol Violation|0|||
16270474|NCT01519947|39474370|FG001|Overall Study|Protocol Violation|0|||
16270475|NCT01519947|39474371|FG002|Overall Study|Protocol Violation|2|||
16270476|NCT01519947|39474372|FG003|Overall Study|Protocol Violation|1|||
16270477|NCT01519947|39474369|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
16270478|NCT01519947|39474370|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
16270479|NCT01519947|39474371|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
16270480|NCT01519947|39474372|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
16270481|NCT01519947|39474369|FG000|Overall Study|Development of Anemia|0|||
16270482|NCT01519947|39474370|FG001|Overall Study|Development of Anemia|1|||
16270483|NCT01519947|39474371|FG002|Overall Study|Development of Anemia|0|||
16270484|NCT01519947|39474372|FG003|Overall Study|Development of Anemia|1|||
16270485|NCT01519947|39474369|FG000|Overall Study|Blood Transfusion|0|||
16270486|NCT01519947|39474370|FG001|Overall Study|Blood Transfusion|1|||
16270487|NCT01519947|39474371|FG002|Overall Study|Blood Transfusion|1|||
16270488|NCT01519947|39474372|FG003|Overall Study|Blood Transfusion|0|||
16270489|NCT01519947|39474369|FG000|Overall Study|Withdrawal by Subject|0|||
16270490|NCT01519947|39474370|FG001|Overall Study|Withdrawal by Subject|1|||
16270491|NCT01519947|39474371|FG002|Overall Study|Withdrawal by Subject|0|||
16270492|NCT01519947|39474372|FG003|Overall Study|Withdrawal by Subject|1|||
16270493|NCT01519947|39474369|FG000|Overall Study|Lost to Follow-up|0|||
16270494|NCT01519947|39474370|FG001|Overall Study|Lost to Follow-up|0|||
16270495|NCT01519947|39474371|FG002|Overall Study|Lost to Follow-up|3|||
16270496|NCT01519947|39474372|FG003|Overall Study|Lost to Follow-up|2|||
16270497|NCT01519947|39474369|FG000|Overall Study|Poor Response|1|||
16270498|NCT01519947|39474370|FG001|Overall Study|Poor Response|0|||
16270499|NCT01519947|39474371|FG002|Overall Study|Poor Response|0|||
16270500|NCT01519947|39474372|FG003|Overall Study|Poor Response|1|||
16270501|NCT01519947|39474369|FG000|Overall Study|Adverse Event|1|||
16270502|NCT01519947|39474370|FG001|Overall Study|Adverse Event|0|||
16270503|NCT01519947|39474371|FG002|Overall Study|Adverse Event|1|||
16270504|NCT01519947|39474372|FG003|Overall Study|Adverse Event|1|||
16270505|NCT00594035|39474377|FG000|Overall Study|Lost to Follow-up|1|||
16270506|NCT00594035|39474378|FG001|Overall Study|Lost to Follow-up|1|||
16468929|NCT03091777|40196388|FG002|Overall Study|Withdrawal by Subject|6|||
16468930|NCT03091777|40196386|FG000|Overall Study|Protocol Violation|2|||
16270507|NCT00594035|39474377|FG000|Overall Study|Withdrawal by Subject|1|||
16270508|NCT00594035|39474378|FG001|Overall Study|Withdrawal by Subject|0|||
16270509|NCT00594035|39474377|FG000|Overall Study|Subject transferred to nursing home|0|||
16270510|NCT00594035|39474378|FG001|Overall Study|Subject transferred to nursing home|1|||
16270511|NCT00594035|39474377|FG000|Overall Study|Subject couldn't return due to job|0|||
16270512|NCT00594035|39474378|FG001|Overall Study|Subject couldn't return due to job|1|||
16270513|NCT00585286|39474383|FG000|Overall Study|Lost to Follow-up|1|||
16270514|NCT02258074|39474384|FG000|Overall Study|Withdrawal by Subject|1|||
16270515|NCT02258074|39474385|FG001|Overall Study|Withdrawal by Subject|0|||
16270516|NCT02258074|39474386|FG002|Overall Study|Withdrawal by Subject|0|||
16270517|NCT02258074|39474387|FG003|Overall Study|Withdrawal by Subject|0|||
16270518|NCT04968925|39474389|FG000|Phase I- Period 1|COVID-19 related|0|||
16270519|NCT04968925|39474390|FG001|Phase I- Period 1|COVID-19 related|1|||
16270520|NCT04968925|39474391|FG002|Phase I- Period 1|COVID-19 related|0|||
16270521|NCT04968925|39474392|FG003|Phase I- Period 1|COVID-19 related|0|||
16270522|NCT04968925|39474389|FG000|Phase I- Period 1|Subject enrolled in error|1|||
16270523|NCT04968925|39474390|FG001|Phase I- Period 1|Subject enrolled in error|1|||
16270524|NCT04968925|39474391|FG002|Phase I- Period 1|Subject enrolled in error|0|||
16270525|NCT04968925|39474392|FG003|Phase I- Period 1|Subject enrolled in error|0|||
16270526|NCT04968925|39474389|FG000|Phase II- Period 1|COVID-19 Related|0|||
16270527|NCT04968925|39474390|FG001|Phase II- Period 1|COVID-19 Related|0|||
16270528|NCT04968925|39474391|FG002|Phase II- Period 1|COVID-19 Related|6|||
16270529|NCT04968925|39474392|FG003|Phase II- Period 1|COVID-19 Related|6|||
16270530|NCT04968925|39474389|FG000|Phase II- Period 1|Subject enrolled in error|0|||
16270531|NCT04968925|39474390|FG001|Phase II- Period 1|Subject enrolled in error|0|||
16270532|NCT04968925|39474391|FG002|Phase II- Period 1|Subject enrolled in error|1|||
16270533|NCT04968925|39474392|FG003|Phase II- Period 1|Subject enrolled in error|0|||
16270534|NCT04968925|39474389|FG000|Phase II -Period 2|COVID-19 related|0|||
16270535|NCT04968925|39474390|FG001|Phase II -Period 2|COVID-19 related|0|||
16270536|NCT04968925|39474391|FG002|Phase II -Period 2|COVID-19 related|4|||
16270537|NCT04968925|39474392|FG003|Phase II -Period 2|COVID-19 related|3|||
16270538|NCT04968925|39474389|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
16270539|NCT04968925|39474390|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
16270540|NCT04968925|39474391|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
16270541|NCT04968925|39474392|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
16270542|NCT04535986|39474396|FG000|Overall Study|Death|4|||
16270543|NCT04535986|39474397|FG001|Overall Study|Death|5|||
16270544|NCT04535986|39474396|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
16270545|NCT04535986|39474397|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
16270546|NCT04535986|39474396|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
16270547|NCT04535986|39474397|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
16270548|NCT04535986|39474396|FG000|Overall Study|Adverse Event|10|||
16270549|NCT04535986|39474397|FG001|Overall Study|Adverse Event|1|||
16270550|NCT04535986|39474396|FG000|Overall Study|Lack of Efficacy|3|||
16270551|NCT04535986|39474397|FG001|Overall Study|Lack of Efficacy|2|||
16270552|NCT04535986|39474396|FG000|Overall Study|Investigator discretion|3|||
16270553|NCT04535986|39474397|FG001|Overall Study|Investigator discretion|0|||
16270554|NCT04535986|39474396|FG000|Overall Study|Withdrawal by Subject|32|||
16270555|NCT04535986|39474397|FG001|Overall Study|Withdrawal by Subject|14|||
16270556|NCT04535986|39474396|FG000|Overall Study|Lost to Follow-up|5|||
16270557|NCT04535986|39474397|FG001|Overall Study|Lost to Follow-up|3|||
16270558|NCT04535986|39474396|FG000|Overall Study|Other|7|||
16270559|NCT04535986|39474397|FG001|Overall Study|Other|3|||
16270560|NCT00654186|39474400|FG000|Overall Study|Withdrawal by Subject|5|||
16270561|NCT01302548|39474403|FG000|Overall Study|Lost to Follow-up|2|||
16270562|NCT01302548|39474404|FG001|Overall Study|Lost to Follow-up|1|||
16270563|NCT00705666|39474405|FG000|Overall Study|No post-treatment questionnaire|279|||
16270564|NCT00705666|39474405|FG000|Overall Study|Withdrawal by Subject|21|||
16270565|NCT00705666|39474405|FG000|Overall Study|Physician Decision|7|||
16270566|NCT00705666|39474405|FG000|Overall Study|Lost to Follow-up|5|||
16270567|NCT00705666|39474405|FG000|Overall Study|Death|1|||
16270568|NCT00705666|39474405|FG000|Overall Study|Adverse Event|4|||
16270569|NCT00705666|39474405|FG000|Overall Study|Other|12|||
16270570|NCT00705666|39474405|FG000|Overall Study|Other|2|||
16270571|NCT00705666|39474405|FG000|Overall Study|Lack of data|3|||
16270572|NCT00705666|39474405|FG000|Overall Study|Untreated|5|||
16270573|NCT00858780|39474409|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
16270574|NCT00858780|39474410|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
16270575|NCT00858780|39474411|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
16270576|NCT00858780|39474412|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
16270577|NCT00858780|39474413|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
16270578|NCT00858780|39474409|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
16270579|NCT00858780|39474410|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
16270580|NCT00858780|39474411|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
16270581|NCT00858780|39474412|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
16270582|NCT00858780|39474413|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
16270583|NCT00858780|39474409|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
16270584|NCT00858780|39474410|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
16270585|NCT00858780|39474411|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
16270586|NCT00858780|39474412|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
16270587|NCT00858780|39474413|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
16270588|NCT00858780|39474409|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
16270589|NCT00858780|39474410|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
16270590|NCT00858780|39474411|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
16270591|NCT00858780|39474412|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
16270592|NCT00858780|39474413|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
16270593|NCT00858780|39474409|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
16270594|NCT00858780|39474410|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
16270595|NCT00858780|39474411|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
16270596|NCT00858780|39474412|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
16270597|NCT00858780|39474413|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
16270598|NCT00858780|39474409|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
16270599|NCT00858780|39474410|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
16270600|NCT00858780|39474411|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
16270601|NCT00858780|39474412|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
16270602|NCT00858780|39474413|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
16270603|NCT03196284|39474414|FG000|Main Part|Withdrawal by Subject|0|||
16270604|NCT03196284|39474415|FG001|Main Part|Withdrawal by Subject|1|||
16270605|NCT03196284|39474416|FG002|Main Part|Withdrawal by Subject|0|||
16270606|NCT03196284|39474414|FG000|Extension Part|Lack of Efficacy|0|||
16270607|NCT03196284|39474415|FG001|Extension Part|Lack of Efficacy|0|||
16270608|NCT03196284|39474416|FG002|Extension Part|Lack of Efficacy|1|||
16270609|NCT03196284|39474414|FG000|Extension Part|Withdrawal by Subject|0|||
16270610|NCT03196284|39474415|FG001|Extension Part|Withdrawal by Subject|0|||
16270611|NCT03196284|39474416|FG002|Extension Part|Withdrawal by Subject|1|||
16270612|NCT03196284|39474414|FG000|Extension Part|Physician Decision|0|||
16270613|NCT03196284|39474415|FG001|Extension Part|Physician Decision|0|||
16270614|NCT03196284|39474416|FG002|Extension Part|Physician Decision|1|||
16270615|NCT03246503|39474417|FG000|Overall Study|Lost to Follow-up|23|||
16270616|NCT03246503|39474417|FG000|Overall Study|Withdrawal by Subject|20|||
16270617|NCT03246503|39474417|FG000|Overall Study|Physician Decision|5|||
16270618|NCT03246503|39474417|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
16270619|NCT01410227|39474418|FG000|Overall Study|Adverse Event|1|||
16270620|NCT01410227|39474419|FG001|Overall Study|Adverse Event|0|||
16270621|NCT01410227|39474420|FG002|Overall Study|Adverse Event|0|||
16270622|NCT01410227|39474421|FG003|Overall Study|Adverse Event|0|||
16270623|NCT01410227|39474418|FG000|Overall Study|Withdrawal by Subject|3|||
16270624|NCT01410227|39474419|FG001|Overall Study|Withdrawal by Subject|0|||
16270625|NCT01410227|39474420|FG002|Overall Study|Withdrawal by Subject|1|||
16270626|NCT01410227|39474421|FG003|Overall Study|Withdrawal by Subject|0|||
16270627|NCT01410227|39474418|FG000|Overall Study|Pregnancy|0|||
16270628|NCT01410227|39474419|FG001|Overall Study|Pregnancy|0|||
16270629|NCT01410227|39474420|FG002|Overall Study|Pregnancy|0|||
16270630|NCT01410227|39474421|FG003|Overall Study|Pregnancy|1|||
16270631|NCT01410227|39474418|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
16270632|NCT01410227|39474419|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
16270633|NCT01410227|39474420|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
16270634|NCT01410227|39474421|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
16270635|NCT00421304|39474422|FG000|Overall Study|Lost to Follow-up|5|||
16270636|NCT00421304|39474423|FG001|Overall Study|Lost to Follow-up|2|||
16270637|NCT00421304|39474424|FG002|Overall Study|Lost to Follow-up|5|||
16270638|NCT00421304|39474422|FG000|Overall Study|Withdrawal by Subject|2|||
16270639|NCT00421304|39474423|FG001|Overall Study|Withdrawal by Subject|2|||
16270640|NCT00421304|39474424|FG002|Overall Study|Withdrawal by Subject|2|||
16270641|NCT00421304|39474422|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
16270642|NCT00421304|39474423|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
16270643|NCT00421304|39474424|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
16270644|NCT00421304|39474422|FG000|Overall Study|Did not attend Day 360 visit|0|||
16270645|NCT00421304|39474423|FG001|Overall Study|Did not attend Day 360 visit|0|||
16270646|NCT00421304|39474424|FG002|Overall Study|Did not attend Day 360 visit|1|||
16270647|NCT04299087|39474427|FG000|Overall Study|Lost to Follow-up|2|||
16270648|NCT04299087|39474428|FG001|Overall Study|Lost to Follow-up|1|||
16270649|NCT01709903|39474429|FG000|Overall Study|administrative problems|2|||
16270650|NCT01709903|39474430|FG001|Overall Study|administrative problems|6|||
16270651|NCT01709903|39474429|FG000|Overall Study|Abnormal test procedure results|1|||
16270652|NCT01709903|39474430|FG001|Overall Study|Abnormal test procedure results|0|||
16270653|NCT01709903|39474429|FG000|Overall Study|In ability to use device|1|||
16270654|NCT01709903|39474430|FG001|Overall Study|In ability to use device|1|||
16270655|NCT01709903|39474429|FG000|Overall Study|no longer needed study drug|0|||
16270656|NCT01709903|39474430|FG001|Overall Study|no longer needed study drug|1|||
16270657|NCT01709903|39474429|FG000|Overall Study|Lost to Follow-up|0|||
16270658|NCT01709903|39474430|FG001|Overall Study|Lost to Follow-up|2|||
16270659|NCT01709903|39474429|FG000|Overall Study|Death|2|||
16270660|NCT01709903|39474430|FG001|Overall Study|Death|0|||
16270661|NCT01709903|39474429|FG000|Overall Study|Protocol Violation|3|||
16270662|NCT01709903|39474430|FG001|Overall Study|Protocol Violation|2|||
16270663|NCT01709903|39474429|FG000|Overall Study|Lack of Efficacy|3|||
16270664|NCT01709903|39474430|FG001|Overall Study|Lack of Efficacy|3|||
16270665|NCT01709903|39474429|FG000|Overall Study|Withdrawal by Subject|6|||
16270666|NCT01709903|39474430|FG001|Overall Study|Withdrawal by Subject|6|||
16270667|NCT01709903|39474429|FG000|Overall Study|Adverse Event|11|||
16270668|NCT01709903|39474430|FG001|Overall Study|Adverse Event|18|||
16270669|NCT00243347|39474431|FG000|Overall Study|Lack of Efficacy|4|||
16270670|NCT00243347|39474431|FG000|Overall Study|Adverse Event|2|||
16270671|NCT00243347|39474431|FG000|Overall Study|Death|1|||
16270672|NCT00243347|39474431|FG000|Overall Study|Withdrawal by Subject|5|||
16270673|NCT00243347|39474431|FG000|Overall Study|Condition worsened|7|||
16270674|NCT00425308|39474432|FG000|Overall Study|Adverse Event|2|||
16270675|NCT00425308|39474433|FG001|Overall Study|Adverse Event|1|||
16270676|NCT00425308|39474432|FG000|Overall Study|Withdrawal by Subject|1|||
16270677|NCT00425308|39474433|FG001|Overall Study|Withdrawal by Subject|0|||
16270678|NCT00425308|39474432|FG000|Overall Study|Death|1|||
16270679|NCT00425308|39474433|FG001|Overall Study|Death|0|||
16270680|NCT01075516|39474434|FG000|Overall Study|Death|5|||
16270681|NCT01075516|39474435|FG001|Overall Study|Death|9|||
16270682|NCT01075516|39474434|FG000|Overall Study|Lost to Follow-up|10|||
16270683|NCT01075516|39474435|FG001|Overall Study|Lost to Follow-up|2|||
16270684|NCT01075516|39474434|FG000|Overall Study|Withdrawal by Subject|3|||
16270685|NCT01075516|39474435|FG001|Overall Study|Withdrawal by Subject|5|||
16270686|NCT02054715|39474436|FG000|Baseline/Follow-up 1|Refused|1|||
16270687|NCT02054715|39474437|FG001|Baseline/Follow-up 1|Refused|3|||
16270688|NCT02054715|39474436|FG000|Baseline/Follow-up 1|Medical|0|||
16270689|NCT02054715|39474437|FG001|Baseline/Follow-up 1|Medical|1|||
16270690|NCT02054715|39474436|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
16270691|NCT02054715|39474437|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
16270692|NCT02054715|39474436|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
16270693|NCT02054715|39474437|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
16270694|NCT02054715|39474436|FG000|Baseline/Follow-up 1|No Reason|0|||
16270695|NCT02054715|39474437|FG001|Baseline/Follow-up 1|No Reason|1|||
16270696|NCT02054715|39474436|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
16270697|NCT02054715|39474437|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
16270698|NCT02054715|39474436|FG000|Baseline/Follow-up 1|Ineligible|3|||
16270699|NCT02054715|39474437|FG001|Baseline/Follow-up 1|Ineligible|0|||
16270700|NCT02054715|39474436|FG000|Baseline/Follow-up 1|Hospitalization|1|||
16270701|NCT02054715|39474437|FG001|Baseline/Follow-up 1|Hospitalization|0|||
16270702|NCT02054715|39474436|FG000|Baseline/Follow-up 1|Changed Mind|1|||
16270703|NCT02054715|39474437|FG001|Baseline/Follow-up 1|Changed Mind|0|||
16270704|NCT02054715|39474436|FG000|Follow-up 2|Lost to Followup|3|||
16270705|NCT02054715|39474437|FG001|Follow-up 2|Lost to Followup|1|||
16270706|NCT02054715|39474436|FG000|Follow-up 2|Refused|3|||
16270707|NCT02054715|39474437|FG001|Follow-up 2|Refused|2|||
16270708|NCT02054715|39474436|FG000|Follow-up 2|Followup Not Completed|3|||
16270709|NCT02054715|39474437|FG001|Follow-up 2|Followup Not Completed|4|||
16270710|NCT02054715|39474436|FG000|Follow-up 2|Ineligible|4|||
16270711|NCT02054715|39474437|FG001|Follow-up 2|Ineligible|5|||
16270712|NCT02054715|39474436|FG000|Follow-up 2|Death|3|||
16270713|NCT02054715|39474437|FG001|Follow-up 2|Death|3|||
16270714|NCT02054715|39474436|FG000|Follow-up 2|Hospitalization|0|||
16270715|NCT02054715|39474437|FG001|Follow-up 2|Hospitalization|2|||
16270716|NCT02054715|39474436|FG000|Follow-up 2|Changed MD/Facility|0|||
16270717|NCT02054715|39474437|FG001|Follow-up 2|Changed MD/Facility|1|||
16270718|NCT02054715|39474436|FG000|Follow-up 2|Changed Mind|0|||
16270719|NCT02054715|39474437|FG001|Follow-up 2|Changed Mind|1|||
16270720|NCT02054715|39474436|FG000|Follow-up 2|No Reason|2|||
16270721|NCT02054715|39474437|FG001|Follow-up 2|No Reason|0|||
16270722|NCT02054715|39474436|FG000|Follow-up 2|Treatment Change or Delay|1|||
16270723|NCT02054715|39474437|FG001|Follow-up 2|Treatment Change or Delay|0|||
16270724|NCT01490190|39474441|FG000|Overall Study|Withdrawal by Subject|9|||
16270725|NCT01490190|39474441|FG000|Overall Study|Adverse Event|17|||
16270726|NCT01490190|39474441|FG000|Overall Study|Protocol Violation|5|||
16270727|NCT01490190|39474441|FG000|Overall Study|Lost to Follow-up|13|||
16270728|NCT01490190|39474441|FG000|Overall Study|Relocation|1|||
16270729|NCT01490190|39474441|FG000|Overall Study|Inconvenience|1|||
16270730|NCT01490190|39474441|FG000|Overall Study|Ring expulsion|2|||
16270731|NCT00950300|39474444|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
16270732|NCT00950300|39474445|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
16270733|NCT00950300|39474444|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
16270734|NCT00950300|39474445|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
16270735|NCT00950300|39474444|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
16270736|NCT00950300|39474445|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
16270737|NCT00950300|39474444|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
16270738|NCT00950300|39474445|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
16270739|NCT00950300|39474444|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
16270740|NCT00950300|39474445|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
16270741|NCT00950300|39474444|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
16270742|NCT00950300|39474445|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
16270743|NCT00950300|39474444|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
16270744|NCT00950300|39474445|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
16270745|NCT00950300|39474444|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
16270746|NCT00950300|39474445|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
16270747|NCT00950300|39474444|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
16270748|NCT00950300|39474445|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
16270749|NCT00950300|39474444|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
16270750|NCT00950300|39474445|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
16270751|NCT00950300|39474444|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
16270752|NCT00950300|39474445|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
16270753|NCT00950300|39474444|FG000|TFFU Period|Death|4|||
16270754|NCT00950300|39474445|FG001|TFFU Period|Death|1|||
16270755|NCT00950300|39474444|FG000|TFFU Period|Refused Treatment|10|||
16270756|NCT00950300|39474445|FG001|TFFU Period|Refused Treatment|11|||
16270757|NCT00950300|39474444|FG000|TFFU Period|Failure to Return|16|||
16270758|NCT00950300|39474445|FG001|TFFU Period|Failure to Return|16|||
16270759|NCT00950300|39474444|FG000|TFFU Period|Recurrence of Disease|63|||
16270760|NCT00950300|39474445|FG001|TFFU Period|Recurrence of Disease|72|||
16270761|NCT00950300|39474444|FG000|TFFU Period|Other|4|||
16270762|NCT00950300|39474445|FG001|TFFU Period|Other|3|||
16270763|NCT00950300|39474444|FG000|SFU Period|Death|44|||
16270764|NCT00950300|39474445|FG001|SFU Period|Death|42|||
16270765|NCT00950300|39474444|FG000|SFU Period|Lost to Follow-up|30|||
16270766|NCT00950300|39474445|FG001|SFU Period|Lost to Follow-up|28|||
16270767|NCT00950300|39474444|FG000|SFU Period|Withdrawal by Subject|4|||
16270768|NCT00950300|39474445|FG001|SFU Period|Withdrawal by Subject|8|||
16270769|NCT03415308|39474446|FG000|Overall Study|Lost to Follow-up|0|||
16270770|NCT03415308|39474447|FG001|Overall Study|Lost to Follow-up|0|||
16270771|NCT03415308|39474448|FG002|Overall Study|Lost to Follow-up|1|||
16270772|NCT03415308|39474446|FG000|Overall Study|Scheduling Conflicts|0|||
16270773|NCT03415308|39474447|FG001|Overall Study|Scheduling Conflicts|0|||
16270774|NCT03415308|39474448|FG002|Overall Study|Scheduling Conflicts|7|||
16270775|NCT00292227|39474451|FG000|Patch Period|Adverse Event|1|||
16270776|NCT00292227|39474452|FG001|Patch Period|Adverse Event|0|||
16270777|NCT00292227|39474453|FG002|Patch Period|Adverse Event|2|||
16270778|NCT00292227|39474451|FG000|Patch Period|Withdrawal by Subject|0|||
16270779|NCT00292227|39474452|FG001|Patch Period|Withdrawal by Subject|0|||
16270780|NCT00292227|39474453|FG002|Patch Period|Withdrawal by Subject|1|||
16270781|NCT00999687|39474454|FG000|First Intervention|Withdrawal by Subject|1|||
16270782|NCT00999687|39474454|FG000|Second Intervention|Withdrawal by Subject|2|||
16270783|NCT00999687|39474454|FG000|Second Intervention|Lack of Efficacy|1|||
16270784|NCT00556673|39474455|FG000|Overall Study|Protocol deviation|3|||
16270785|NCT00556673|39474456|FG001|Overall Study|Protocol deviation|2|||
16270786|NCT00736190|39474458|FG000|Overall Study|Pregnancy|1|||
16270787|NCT00736190|39474458|FG000|Overall Study|Withdrawal by Subject|1|||
16270788|NCT00736190|39474458|FG000|Overall Study|Adverse Event|1|||
16270789|NCT01528735|39474459|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
16270790|NCT01528735|39474460|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
16270791|NCT01528735|39474459|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
16270792|NCT01528735|39474460|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
16270793|NCT03504085|39474463|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
16270794|NCT03504085|39474464|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
16270795|NCT03504085|39474463|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
16270796|NCT03504085|39474464|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
16270797|NCT04547192|39474465|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
16270798|NCT04547192|39474466|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
16270799|NCT04547192|39474467|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
16270800|NCT04547192|39474468|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
16270801|NCT04547192|39474465|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
16270802|NCT04547192|39474466|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
16270803|NCT04547192|39474467|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
16270804|NCT04547192|39474468|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
16270805|NCT04547192|39474465|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
16270806|NCT04547192|39474466|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
16270807|NCT04547192|39474467|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
16270808|NCT04547192|39474468|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
16270809|NCT04547192|39474465|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
16270810|NCT04547192|39474466|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
16270811|NCT04547192|39474467|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
16468931|NCT03091777|40196387|FG001|Overall Study|Protocol Violation|1|||
16270812|NCT04547192|39474468|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
16270813|NCT04547192|39474465|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
16270814|NCT04547192|39474466|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
16270815|NCT04547192|39474467|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
16270816|NCT04547192|39474468|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
16270817|NCT02658487|39474469|FG000|Overall Study|Death|2|||
16270818|NCT02658487|39474469|FG000|Overall Study|Disease progression|10|||
16270819|NCT02658487|39474469|FG000|Overall Study|Alternative therapy|1|||
16270820|NCT02658487|39474469|FG000|Overall Study|Adverse Event|1|||
16270821|NCT02658487|39474469|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
16270822|NCT02658487|39474469|FG000|Overall Study|Refractory AML|1|||
16270823|NCT03681470|39474470|FG000|Overall Study|Lack of Efficacy|3|||
16270824|NCT03681470|39474470|FG000|Overall Study|Lost to Follow-up|1|||
16270825|NCT03681470|39474470|FG000|Overall Study|Protocol Violation|3|||
16270826|NCT03681470|39474470|FG000|Overall Study|Withdrawal by Subject|1|||
16270827|NCT03694197|39474471|FG000|Overall Study|Adverse Event|9|||
16270828|NCT03694197|39474471|FG000|Overall Study|Protocol became inconvenient to participate|1|||
16270829|NCT03694197|39474471|FG000|Overall Study|Physician Decision|4|||
16270830|NCT03694197|39474471|FG000|Overall Study|Study terminated by sponsor|1350|||
16270831|NCT03694197|39474471|FG000|Overall Study|Participant moved|5|||
16270832|NCT03694197|39474471|FG000|Overall Study|Participant withdrew consent|10|||
16270833|NCT03694197|39474471|FG000|Overall Study|Related to IMP administration|1|||
16270834|NCT03694197|39474471|FG000|Overall Study|Not disclosed|5|||
16270835|NCT04112823|39474474|FG000|Overall Study|Lost to Follow-up|2|||
16270836|NCT04112823|39474475|FG001|Overall Study|Lost to Follow-up|3|||
16270837|NCT03789110|39474476|FG000|Overall Study|Adverse Event|2|||
16270838|NCT03789110|39474476|FG000|Overall Study|Physician Decision|1|||
16270839|NCT03789110|39474476|FG000|Overall Study|Withdrawal by Subject|2|||
16270840|NCT03789110|39474476|FG000|Overall Study|Lack of Efficacy|22|||
16270841|NCT03789110|39474476|FG000|Overall Study|still on treatment|3|||
16270842|NCT03502811|39474477|FG000|Overall Study|Death|157|||
16270843|NCT03502811|39474477|FG000|Overall Study|Withdrawal by Subject|105|||
16270844|NCT03502811|39474477|FG000|Overall Study|Lost to Follow-up|26|||
16270845|NCT03502811|39474477|FG000|Overall Study|No Visits (Missed)|31|||
16270846|NCT00798603|39474478|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
16270847|NCT00798603|39474478|FG000|Overall Study|Withdrawal by Subject|10|||
16270848|NCT00798603|39474478|FG000|Overall Study|Adverse Event|22|||
16270849|NCT00798603|39474478|FG000|Overall Study|Physician Decision|1|||
16270850|NCT00798603|39474478|FG000|Overall Study|Lack of insurance coverage|1|||
16270851|NCT00463684|39474479|FG000|Overall Study|Withdrawal by Subject|1|||
16270852|NCT00463684|39474479|FG000|Overall Study|Lost to Follow-up|3|||
16270853|NCT03131895|39474480|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
16270854|NCT03131895|39474481|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
16270855|NCT03131895|39474482|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
16270856|NCT03131895|39474483|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
16270857|NCT03131895|39474480|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
16270858|NCT03131895|39474481|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
16270859|NCT03131895|39474482|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
16270860|NCT03131895|39474483|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
16270861|NCT03131895|39474480|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16270862|NCT03131895|39474481|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
16270863|NCT03131895|39474482|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
16270864|NCT03131895|39474483|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
16270865|NCT03131895|39474480|FG000|Washout Period (at Least 5 Days)|Other|0|||
16270866|NCT03131895|39474481|FG001|Washout Period (at Least 5 Days)|Other|0|||
16270867|NCT03131895|39474482|FG002|Washout Period (at Least 5 Days)|Other|2|||
16270868|NCT03131895|39474483|FG003|Washout Period (at Least 5 Days)|Other|0|||
16270869|NCT03131895|39474480|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
16270870|NCT03131895|39474481|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
16270871|NCT03131895|39474482|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
16270872|NCT03131895|39474483|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
16270873|NCT03131895|39474480|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
16270874|NCT03131895|39474481|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
16270875|NCT03131895|39474482|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
16270876|NCT03131895|39474483|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
16270877|NCT01983969|39474484|FG000|Overall Study|Disease Progression|0|||
16270878|NCT01983969|39474485|FG001|Overall Study|Disease Progression|1|||
16270879|NCT01983969|39474486|FG002|Overall Study|Disease Progression|0|||
16270880|NCT00101439|39474488|FG000|Period 2|Withdrawal by Subject|0|||
16270881|NCT00101439|39474489|FG001|Period 2|Withdrawal by Subject|2|||
16270882|NCT03480763|39474490|FG000|Overall Study|Withdrawal by Subject|18|||
16270883|NCT03480763|39474491|FG001|Overall Study|Withdrawal by Subject|10|||
16270884|NCT03480763|39474490|FG000|Overall Study|Lost to Follow-up|4|||
16270885|NCT03480763|39474491|FG001|Overall Study|Lost to Follow-up|7|||
16270886|NCT03480763|39474490|FG000|Overall Study|non-study pneumococcal vaccine|1|||
16270887|NCT03480763|39474491|FG001|Overall Study|non-study pneumococcal vaccine|0|||
16270888|NCT03480763|39474490|FG000|Overall Study|oncological treatment|0|||
16270889|NCT03480763|39474491|FG001|Overall Study|oncological treatment|2|||
16270890|NCT03480763|39474490|FG000|Overall Study|pain with vaccination|1|||
16270891|NCT03480763|39474491|FG001|Overall Study|pain with vaccination|0|||
16270892|NCT02179190|39474492|FG000|Enrollment|Exit Prior to Device Attempt|11|||
16270893|NCT02179190|39474492|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
16270894|NCT02179190|39474492|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
16270895|NCT02179190|39474492|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
16270896|NCT02179190|39474492|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
16270897|NCT02179190|39474492|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
16270898|NCT00438633|39474493|FG000|Overall Study|Withdrawal by Subject|1|||
16270899|NCT00438633|39474494|FG001|Overall Study|Withdrawal by Subject|0|||
16270900|NCT00438633|39474493|FG000|Overall Study|Lost to Follow-up|15|||
16270901|NCT00438633|39474494|FG001|Overall Study|Lost to Follow-up|17|||
16270902|NCT02003391|39474495|FG000|Overall Study|Withdrawal by Subject|2|||
16270903|NCT02003391|39474496|FG001|Overall Study|Withdrawal by Subject|1|||
16270904|NCT02003391|39474495|FG000|Overall Study|Protocol Violation|0|||
16270905|NCT02003391|39474496|FG001|Overall Study|Protocol Violation|1|||
16270906|NCT02003391|39474495|FG000|Overall Study|Adverse Event|1|||
16270907|NCT02003391|39474496|FG001|Overall Study|Adverse Event|0|||
16270908|NCT01215721|39474499|FG000|Overall Study|Adverse Event|2|||
16273197|NCT02699866|39484451|FG000|Overall Study|Withdrawal by Subject|3|||
16273198|NCT02699866|39484451|FG000|Overall Study|Physician Decision|2|||
16273199|NCT02699866|39484451|FG000|Overall Study|Adverse Event|3|||
16273200|NCT00198133|39484453|FG000|Overall Study|Disease progression|2|||
16273201|NCT00198133|39484454|FG001|Overall Study|Disease progression|5|||
16273202|NCT00198133|39484453|FG000|Overall Study|Adverse Event|1|||
16273203|NCT00198133|39484454|FG001|Overall Study|Adverse Event|3|||
16273204|NCT00198133|39484453|FG000|Overall Study|Withdrawal by Subject|1|||
16273205|NCT00198133|39484454|FG001|Overall Study|Withdrawal by Subject|0|||
16273206|NCT00198133|39484453|FG000|Overall Study|Physician Decision|1|||
16273207|NCT00198133|39484454|FG001|Overall Study|Physician Decision|0|||
16273208|NCT02611362|39484455|FG000|Overall Study|Withdrawal by Subject|7|||
16273209|NCT02611362|39484456|FG001|Overall Study|Withdrawal by Subject|2|||
16273210|NCT02611362|39484455|FG000|Overall Study|Lost to Follow-up|2|||
16273211|NCT02611362|39484456|FG001|Overall Study|Lost to Follow-up|4|||
16273212|NCT01374451|39484457|FG000|Overall Study|Administrative problems|1|||
16273213|NCT01374451|39484458|FG001|Overall Study|Administrative problems|0|||
16273214|NCT02336074|39484459|FG000|Overall Study|Adverse Event|0|||
16273215|NCT02336074|39484460|FG001|Overall Study|Adverse Event|2|||
16273216|NCT01532908|39484461|FG000|Overall Study|Not Transplanted|1|||
16273217|NCT01532908|39484462|FG001|Overall Study|Not Transplanted|0|||
16273218|NCT00372996|39484465|FG000|Overall Study|Death|11|||
16273219|NCT00372996|39484466|FG001|Overall Study|Death|4|||
16273220|NCT00372996|39484467|FG002|Overall Study|Death|8|||
16273221|NCT00372996|39484468|FG003|Overall Study|Death|7|||
16273222|NCT00372996|39484465|FG000|Overall Study|Lost to Follow-up|0|||
16273223|NCT00372996|39484466|FG001|Overall Study|Lost to Follow-up|2|||
16273224|NCT00372996|39484467|FG002|Overall Study|Lost to Follow-up|0|||
16273225|NCT00372996|39484468|FG003|Overall Study|Lost to Follow-up|1|||
16273226|NCT00372996|39484465|FG000|Overall Study|Withdrawal by Subject|12|||
16273227|NCT00372996|39484466|FG001|Overall Study|Withdrawal by Subject|6|||
16273228|NCT00372996|39484467|FG002|Overall Study|Withdrawal by Subject|9|||
16273229|NCT00372996|39484468|FG003|Overall Study|Withdrawal by Subject|5|||
16273230|NCT00372996|39484465|FG000|Overall Study|Study Terminated by Sponsor|4|||
16273231|NCT00372996|39484466|FG001|Overall Study|Study Terminated by Sponsor|0|||
16273232|NCT00372996|39484467|FG002|Overall Study|Study Terminated by Sponsor|4|||
16273233|NCT00372996|39484468|FG003|Overall Study|Study Terminated by Sponsor|0|||
16273234|NCT00372996|39484465|FG000|Overall Study|Other|10|||
16273235|NCT00372996|39484466|FG001|Overall Study|Other|2|||
16273236|NCT00372996|39484467|FG002|Overall Study|Other|7|||
16273237|NCT00372996|39484468|FG003|Overall Study|Other|7|||
16273238|NCT01968551|39484473|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
16273239|NCT01968551|39484474|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
16273240|NCT01968551|39484475|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
16273241|NCT01968551|39484473|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
16273242|NCT01968551|39484474|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
16273243|NCT01968551|39484475|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
16273244|NCT01968551|39484473|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
16273245|NCT01968551|39484474|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
16273246|NCT01968551|39484475|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
16273247|NCT01968551|39484473|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
16273248|NCT01968551|39484474|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
16273249|NCT01968551|39484475|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
16273250|NCT01968551|39484473|FG000|Extension Phase|Adverse Event|0|||
16270909|NCT00635648|39476836|FG000|Overall Study|Adverse Event|12|||
16270910|NCT00635648|39476836|FG000|Overall Study|Withdrawal by Subject|9|||
16270911|NCT00635648|39476836|FG000|Overall Study|Physician Decision|4|||
16270912|NCT00635648|39476836|FG000|Overall Study|Rapid progression of baseline disease|4|||
16270913|NCT00635648|39476836|FG000|Overall Study|Use of other antifungal agent needed|1|||
16172192|NCT00950170|39107351|FG000|Overall Study|Parent/Legal Guardian Request|1|||
16172193|NCT00950170|39107351|FG000|Overall Study|Adverse Event|2|||
16270914|NCT00635648|39476836|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
16270915|NCT00635648|39476836|FG000|Overall Study|Noncompliance with protocol|1|||
16270916|NCT00635648|39476836|FG000|Overall Study|Other reason|2|||
16270917|NCT00836056|39476837|FG000|First Intervention|Adverse Event|1|||
16270918|NCT00836056|39476838|FG001|First Intervention|Adverse Event|0|||
16270919|NCT01558635|39476839|FG000|Overall Study|Death|1|||
16270920|NCT01558635|39476839|FG000|Overall Study|Withdrawal by Subject|2|||
16270921|NCT01558635|39476839|FG000|Overall Study|Physician Decision|1|||
16270922|NCT01558635|39476839|FG000|Overall Study|Subject received other treatment|1|||
16270923|NCT01558635|39476839|FG000|Overall Study|Reveal XT was explanted|1|||
16270924|NCT01438060|39476844|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
16270925|NCT01438060|39476845|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
16270926|NCT01438060|39476844|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
16270927|NCT01438060|39476845|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
16270928|NCT01438060|39476844|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
16270929|NCT01438060|39476845|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
16270930|NCT01438060|39476844|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
16270931|NCT01438060|39476845|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
16270932|NCT01438060|39476844|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
16270933|NCT01438060|39476845|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
16270934|NCT01438060|39476844|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
16270935|NCT01438060|39476845|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
16270936|NCT01438060|39476844|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
16270937|NCT01438060|39476845|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
16270938|NCT01438060|39476844|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
16270939|NCT01438060|39476845|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
16270940|NCT01438060|39476844|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
16270941|NCT01438060|39476845|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
16270942|NCT01438060|39476844|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
16270943|NCT01438060|39476845|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
16270944|NCT01438060|39476844|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
16270945|NCT01438060|39476845|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
16270946|NCT01438060|39476844|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
16270947|NCT01438060|39476845|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
16270948|NCT01438060|39476844|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
16270949|NCT01438060|39476845|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
16270950|NCT01438060|39476844|FG000|On Study Beyond Week 140|Adverse Event|0|||
16270951|NCT01438060|39476845|FG001|On Study Beyond Week 140|Adverse Event|2|||
16270952|NCT01438060|39476844|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
16270953|NCT01438060|39476845|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
16270954|NCT01438060|39476844|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
16270955|NCT01438060|39476845|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
16270956|NCT01438060|39476844|FG000|On Study Beyond Week 140|Death|0|||
16270957|NCT01438060|39476845|FG001|On Study Beyond Week 140|Death|1|||
16270958|NCT01438060|39476844|FG000|On Study Beyond Week 140|Other Reason|0|||
16270959|NCT01438060|39476845|FG001|On Study Beyond Week 140|Other Reason|3|||
16270960|NCT02648438|39476846|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
16270961|NCT02648438|39476847|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
16270962|NCT02648438|39476848|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
16270963|NCT02648438|39476846|FG000|Overall Study|Protocol Violation|2|||
16270964|NCT02648438|39476847|FG001|Overall Study|Protocol Violation|0|||
16270965|NCT02648438|39476848|FG002|Overall Study|Protocol Violation|0|||
16270966|NCT02648438|39476846|FG000|Overall Study|Withdrawal by Subject|1|||
16270967|NCT02648438|39476847|FG001|Overall Study|Withdrawal by Subject|1|||
16270968|NCT02648438|39476848|FG002|Overall Study|Withdrawal by Subject|0|||
16270969|NCT00730691|39476851|FG000|Overall Study|Adverse Event|4|||
16172194|NCT00950170|39107351|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
16172195|NCT02965378|39107352|FG000|Overall Study|Progression|16|||
16172196|NCT02965378|39107353|FG001|Overall Study|Progression|4|||
16172197|NCT02965378|39107352|FG000|Overall Study|Adverse Event|5|||
16172198|NCT02965378|39107353|FG001|Overall Study|Adverse Event|2|||
16172199|NCT02965378|39107352|FG000|Overall Study|Death|2|||
16172200|NCT02965378|39107353|FG001|Overall Study|Death|0|||
16172201|NCT02965378|39107352|FG000|Overall Study|Refusal|2|||
16172202|NCT02965378|39107353|FG001|Overall Study|Refusal|1|||
16172203|NCT02965378|39107352|FG000|Overall Study|Not protocol specified|0|||
16270970|NCT00730691|39476852|FG001|Overall Study|Adverse Event|8|||
16270971|NCT00730691|39476853|FG002|Overall Study|Adverse Event|11|||
16270972|NCT00730691|39476854|FG003|Overall Study|Adverse Event|11|||
16270973|NCT00730691|39476855|FG004|Overall Study|Adverse Event|23|||
16270974|NCT00730691|39476851|FG000|Overall Study|Lack of Efficacy|4|||
16270975|NCT00730691|39476852|FG001|Overall Study|Lack of Efficacy|4|||
16270976|NCT00730691|39476853|FG002|Overall Study|Lack of Efficacy|2|||
16270977|NCT00730691|39476854|FG003|Overall Study|Lack of Efficacy|1|||
16270978|NCT00730691|39476855|FG004|Overall Study|Lack of Efficacy|1|||
16270979|NCT00730691|39476851|FG000|Overall Study|Non-compliance with Study Drug|6|||
16270980|NCT00730691|39476852|FG001|Overall Study|Non-compliance with Study Drug|1|||
16270981|NCT00730691|39476853|FG002|Overall Study|Non-compliance with Study Drug|6|||
16270982|NCT00730691|39476854|FG003|Overall Study|Non-compliance with Study Drug|3|||
16270983|NCT00730691|39476855|FG004|Overall Study|Non-compliance with Study Drug|3|||
16270984|NCT00730691|39476851|FG000|Overall Study|Protocol Deviations|3|||
16270985|NCT00730691|39476852|FG001|Overall Study|Protocol Deviations|5|||
16270986|NCT00730691|39476853|FG002|Overall Study|Protocol Deviations|3|||
16270987|NCT00730691|39476854|FG003|Overall Study|Protocol Deviations|7|||
16270988|NCT00730691|39476855|FG004|Overall Study|Protocol Deviations|5|||
16270989|NCT00730691|39476851|FG000|Overall Study|Withdrawal of Consent|7|||
16270990|NCT00730691|39476852|FG001|Overall Study|Withdrawal of Consent|9|||
16270991|NCT00730691|39476853|FG002|Overall Study|Withdrawal of Consent|3|||
16270992|NCT00730691|39476854|FG003|Overall Study|Withdrawal of Consent|6|||
16270993|NCT00730691|39476855|FG004|Overall Study|Withdrawal of Consent|3|||
16270994|NCT00730691|39476851|FG000|Overall Study|Lost to Follow-up|11|||
16270995|NCT00730691|39476852|FG001|Overall Study|Lost to Follow-up|8|||
16270996|NCT00730691|39476853|FG002|Overall Study|Lost to Follow-up|13|||
16270997|NCT00730691|39476854|FG003|Overall Study|Lost to Follow-up|15|||
16270998|NCT00730691|39476855|FG004|Overall Study|Lost to Follow-up|13|||
16270999|NCT00730691|39476851|FG000|Overall Study|Other|1|||
16271000|NCT00730691|39476852|FG001|Overall Study|Other|1|||
16271001|NCT00730691|39476853|FG002|Overall Study|Other|1|||
16271002|NCT00730691|39476854|FG003|Overall Study|Other|2|||
16271003|NCT00730691|39476855|FG004|Overall Study|Other|2|||
16271004|NCT03950674|39476856|FG000|Overall Study|Death|16|||
16271005|NCT03950674|39476857|FG001|Overall Study|Death|15|||
16271006|NCT03950674|39476856|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
16271007|NCT03950674|39476857|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
16271008|NCT03541252|39476858|FG000|Overall Study|Withdrawal by Subject|1|||
16271009|NCT00834613|39476864|FG000|First Intervention|Protocol Violation|1|||
16271010|NCT00834613|39476865|FG001|First Intervention|Protocol Violation|0|||
16271011|NCT04435782|39476866|FG000|Overall Study|Study terminated by sponsor|4|||
16271012|NCT02300103|39476867|FG000|Overall Study|Lack of Efficacy|3|||
16271013|NCT02300103|39476867|FG000|Overall Study|Protocol Violation|1|||
16271014|NCT02300103|39476867|FG000|Overall Study|Withdrew Consent|2|||
16271015|NCT04364763|39476868|FG000|Overall Study|Death|1|||
16271016|NCT04364763|39476869|FG001|Overall Study|Death|2|||
16271017|NCT04364763|39476868|FG000|Overall Study|Lost to Follow-up|1|||
16271018|NCT04364763|39476869|FG001|Overall Study|Lost to Follow-up|0|||
16271019|NCT00081653|39476870|FG000|Overall Study|Adverse Event|23|||
16271020|NCT00081653|39476871|FG001|Overall Study|Adverse Event|17|||
16271021|NCT00081653|39476870|FG000|Overall Study|Lost to Follow-up|2|||
16271022|NCT00081653|39476871|FG001|Overall Study|Lost to Follow-up|4|||
16271023|NCT00081653|39476870|FG000|Overall Study|Refused Treatment|18|||
16271024|NCT00081653|39476871|FG001|Overall Study|Refused Treatment|14|||
16271025|NCT00081653|39476870|FG000|Overall Study|Low bone mineral density|1|||
16271026|NCT00081653|39476871|FG001|Overall Study|Low bone mineral density|0|||
16271027|NCT00081653|39476870|FG000|Overall Study|Bone loss|2|||
16271028|NCT00081653|39476871|FG001|Overall Study|Bone loss|0|||
16271029|NCT00081653|39476870|FG000|Overall Study|Participant leaving country|1|||
16271030|NCT00081653|39476871|FG001|Overall Study|Participant leaving country|0|||
16271031|NCT00081653|39476870|FG000|Overall Study|Loss of bone mass|0|||
16271032|NCT00081653|39476871|FG001|Overall Study|Loss of bone mass|2|||
16271033|NCT02280863|39476874|FG000|Integrated Platform|Met stopping criteria|0|||
16271034|NCT02280863|39476875|FG001|Integrated Platform|Met stopping criteria|1|||
16271035|NCT00608322|39476876|FG000|Overall Study|Death|2|||
16271036|NCT00608322|39476877|FG001|Overall Study|Death|1|||
16271037|NCT02264977|39476878|FG000|Overall Study|Death|3|||
16271038|NCT02264977|39476878|FG000|Overall Study|Physician Decision|1|||
16271039|NCT02264977|39476878|FG000|Overall Study|Refuse to return|1|||
16271040|NCT00446966|39476879|FG000|Overall Study|Lost to Follow-up|10|||
16271041|NCT00446966|39476880|FG001|Overall Study|Lost to Follow-up|7|||
16271042|NCT02436200|39476881|FG000|Overall Study|Significant outlier|1|||
16271043|NCT00466167|39476884|FG000|Overall Study|Adverse Event|8|||
16271044|NCT00466167|39476885|FG001|Overall Study|Adverse Event|8|||
16271045|NCT00466167|39476886|FG002|Overall Study|Adverse Event|7|||
16271046|NCT00466167|39476884|FG000|Overall Study|Lack of Efficacy|2|||
16271047|NCT00466167|39476885|FG001|Overall Study|Lack of Efficacy|0|||
16271048|NCT00466167|39476886|FG002|Overall Study|Lack of Efficacy|3|||
16271049|NCT00466167|39476884|FG000|Overall Study|Protocol Violation|1|||
16271050|NCT00466167|39476885|FG001|Overall Study|Protocol Violation|1|||
16271051|NCT00466167|39476886|FG002|Overall Study|Protocol Violation|2|||
16271052|NCT00466167|39476884|FG000|Overall Study|Lost to Follow-up|3|||
16271053|NCT00466167|39476885|FG001|Overall Study|Lost to Follow-up|2|||
16271054|NCT00466167|39476886|FG002|Overall Study|Lost to Follow-up|2|||
16271055|NCT00466167|39476884|FG000|Overall Study|Withdrawal by Subject|4|||
16271056|NCT00466167|39476885|FG001|Overall Study|Withdrawal by Subject|1|||
16271057|NCT00466167|39476886|FG002|Overall Study|Withdrawal by Subject|6|||
16271058|NCT00466167|39476884|FG000|Overall Study|patient did not meet inclusion criteria|1|||
16271059|NCT00466167|39476885|FG001|Overall Study|patient did not meet inclusion criteria|0|||
16271060|NCT00466167|39476886|FG002|Overall Study|patient did not meet inclusion criteria|1|||
16271061|NCT00466167|39476884|FG000|Overall Study|Not treated|1|||
16271062|NCT00466167|39476885|FG001|Overall Study|Not treated|0|||
16271063|NCT00466167|39476886|FG002|Overall Study|Not treated|0|||
16271064|NCT03889639|39476887|FG000|Overall Study|Withdrawal by Subject|0|||
16271065|NCT03889639|39476888|FG001|Overall Study|Withdrawal by Subject|0|||
16271066|NCT03889639|39476889|FG002|Overall Study|Withdrawal by Subject|0|||
16271067|NCT03889639|39476890|FG003|Overall Study|Withdrawal by Subject|0|||
16271068|NCT03889639|39476891|FG004|Overall Study|Withdrawal by Subject|0|||
16271069|NCT03889639|39476892|FG005|Overall Study|Withdrawal by Subject|0|||
16271070|NCT03889639|39476893|FG006|Overall Study|Withdrawal by Subject|0|||
16271071|NCT03889639|39476894|FG007|Overall Study|Withdrawal by Subject|1|||
16271072|NCT03419403|39476895|FG000|Overall Study|Withdrawal by Subject|5|||
16271073|NCT03419403|39476896|FG001|Overall Study|Withdrawal by Subject|2|||
16271074|NCT03419403|39476897|FG002|Overall Study|Withdrawal by Subject|5|||
16271075|NCT03419403|39476898|FG003|Overall Study|Withdrawal by Subject|1|||
16271076|NCT03419403|39476895|FG000|Overall Study|Progressive disease (per protocol)|0|||
16271077|NCT03419403|39476896|FG001|Overall Study|Progressive disease (per protocol)|2|||
16271078|NCT03419403|39476897|FG002|Overall Study|Progressive disease (per protocol)|2|||
16172204|NCT02965378|39107353|FG001|Overall Study|Not protocol specified|2|||
16172205|NCT04026568|39107354|FG000|Overall Study|study terminated|0|||
16172206|NCT04026568|39107355|FG001|Overall Study|study terminated|1|||
16172207|NCT00686543|39107356|FG000|Overall Study|Adverse Event|9|||
16172208|NCT00686543|39107357|FG001|Overall Study|Adverse Event|1|||
16172209|NCT00686543|39107358|FG002|Overall Study|Adverse Event|3|||
16172210|NCT00686543|39107359|FG003|Overall Study|Adverse Event|2|||
16172211|NCT00686543|39107356|FG000|Overall Study|Withdrawal by Subject|2|||
16172212|NCT00686543|39107357|FG001|Overall Study|Withdrawal by Subject|0|||
16172213|NCT00686543|39107358|FG002|Overall Study|Withdrawal by Subject|0|||
16172214|NCT00686543|39107359|FG003|Overall Study|Withdrawal by Subject|0|||
16172215|NCT00686543|39107356|FG000|Overall Study|Protocol Violation|3|||
16172216|NCT00686543|39107357|FG001|Overall Study|Protocol Violation|0|||
16172217|NCT00686543|39107358|FG002|Overall Study|Protocol Violation|2|||
16172218|NCT00686543|39107359|FG003|Overall Study|Protocol Violation|1|||
16172219|NCT01324830|39107362|FG000|Overall Study|Progressive Disease|3|||
16172220|NCT01324830|39107363|FG001|Overall Study|Progressive Disease|2|||
16172221|NCT01324830|39107364|FG002|Overall Study|Progressive Disease|3|||
16172222|NCT01324830|39107365|FG003|Overall Study|Progressive Disease|3|||
16172223|NCT01324830|39107366|FG004|Overall Study|Progressive Disease|6|||
16172224|NCT01324830|39107367|FG005|Overall Study|Progressive Disease|6|||
16172225|NCT01324830|39107368|FG006|Overall Study|Progressive Disease|3|||
16172226|NCT01324830|39107369|FG007|Overall Study|Progressive Disease|3|||
16172227|NCT01324830|39107370|FG008|Overall Study|Progressive Disease|3|||
16172228|NCT01324830|39107371|FG009|Overall Study|Progressive Disease|6|||
16172229|NCT01324830|39107372|FG010|Overall Study|Progressive Disease|2|||
16172230|NCT01324830|39107373|FG011|Overall Study|Progressive Disease|1|||
16172231|NCT01324830|39107374|FG012|Overall Study|Progressive Disease|1|||
16172232|NCT01324830|39107375|FG013|Overall Study|Progressive Disease|1|||
16172233|NCT01324830|39107376|FG014|Overall Study|Progressive Disease|1|||
16172234|NCT01324830|39107377|FG015|Overall Study|Progressive Disease|3|||
16172235|NCT01324830|39107378|FG016|Overall Study|Progressive Disease|2|||
16172236|NCT01324830|39107379|FG017|Overall Study|Progressive Disease|3|||
16172237|NCT01324830|39107380|FG018|Overall Study|Progressive Disease|4|||
16172238|NCT01324830|39107362|FG000|Overall Study|Dose limiting toxicity|0|||
16172239|NCT01324830|39107363|FG001|Overall Study|Dose limiting toxicity|0|||
16172240|NCT01324830|39107364|FG002|Overall Study|Dose limiting toxicity|0|||
16172241|NCT01324830|39107365|FG003|Overall Study|Dose limiting toxicity|0|||
16172242|NCT01324830|39107366|FG004|Overall Study|Dose limiting toxicity|1|||
16172243|NCT01324830|39107367|FG005|Overall Study|Dose limiting toxicity|0|||
16172244|NCT01324830|39107368|FG006|Overall Study|Dose limiting toxicity|0|||
16172245|NCT01324830|39107369|FG007|Overall Study|Dose limiting toxicity|0|||
16172246|NCT01324830|39107370|FG008|Overall Study|Dose limiting toxicity|0|||
16172247|NCT01324830|39107371|FG009|Overall Study|Dose limiting toxicity|0|||
16172248|NCT01324830|39107372|FG010|Overall Study|Dose limiting toxicity|0|||
16172249|NCT01324830|39107373|FG011|Overall Study|Dose limiting toxicity|0|||
16271079|NCT03419403|39476898|FG003|Overall Study|Progressive disease (per protocol)|0|||
16271080|NCT03419403|39476895|FG000|Overall Study|Other, not specified|6|||
16271081|NCT03419403|39476896|FG001|Overall Study|Other, not specified|4|||
16271082|NCT03419403|39476897|FG002|Overall Study|Other, not specified|5|||
16271083|NCT03419403|39476898|FG003|Overall Study|Other, not specified|1|||
16271084|NCT03419403|39476895|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
16271085|NCT03419403|39476896|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
16271086|NCT03419403|39476897|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
16271087|NCT03419403|39476898|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
16271088|NCT01624233|39476902|FG000|Period 2 - Induction|Adverse Event|1|||
16271089|NCT01624233|39476902|FG000|Period 3 - Maintenance|Adverse Event|2|||
16271090|NCT01624233|39476902|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
16271091|NCT01624233|39476902|FG000|Period 3 - Maintenance|Physician Decision|2|||
16271092|NCT01624233|39476902|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
16271093|NCT01624233|39476902|FG000|Period 4 - Drug Free Period|Relapsed|61|||
16271094|NCT01624233|39476902|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
16271095|NCT01624233|39476902|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
16271096|NCT01624233|39476902|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
16271097|NCT01624233|39476902|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
16271098|NCT01624233|39476902|FG000|Period 6: Follow-up|Adverse Event|3|||
16271099|NCT01624233|39476902|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
16271100|NCT01624233|39476902|FG000|Period 6: Follow-up|Physician Decision|1|||
16271101|NCT01624233|39476902|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
16271102|NCT03167606|39476903|FG000|Overall Study|Lost to Follow-up|73|||
16271103|NCT03167606|39476904|FG001|Overall Study|Lost to Follow-up|64|||
16271104|NCT03167606|39476903|FG000|Overall Study|Withdrawal by Subject|6|||
16271105|NCT03167606|39476904|FG001|Overall Study|Withdrawal by Subject|5|||
16271106|NCT03167606|39476903|FG000|Overall Study|Withdrawal by Investigator|0|||
16271107|NCT03167606|39476904|FG001|Overall Study|Withdrawal by Investigator|2|||
16271108|NCT00849797|39476915|FG000|First Intervention|bad veins|1|||
16271109|NCT00849797|39476916|FG001|First Intervention|bad veins|0|||
16271110|NCT00849797|39476915|FG000|First Intervention|Adverse Event|0|||
16271111|NCT00849797|39476916|FG001|First Intervention|Adverse Event|1|||
16271112|NCT00849797|39476915|FG000|Washout: One Week|Withdrawal by Subject|0|||
16271113|NCT00849797|39476916|FG001|Washout: One Week|Withdrawal by Subject|2|||
16271114|NCT00691704|39476917|FG000|Induction Therapy|Disease Progression|1|||
16271115|NCT00691704|39476917|FG000|Induction Therapy|Active Hepatitis|1|||
16271116|NCT00691704|39476917|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
16271117|NCT00691704|39476917|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
16271118|NCT00691704|39476917|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
16271119|NCT04567329|39476918|FG000|Overall Study|Withdrawal by Subject|5|||
16271120|NCT04567329|39476919|FG001|Overall Study|Withdrawal by Subject|6|||
16271121|NCT04567329|39476918|FG000|Overall Study|Protocol Violation|2|||
16271122|NCT04567329|39476919|FG001|Overall Study|Protocol Violation|3|||
16271123|NCT04567329|39476918|FG000|Overall Study|Discontinued|2|||
16271124|NCT04567329|39476919|FG001|Overall Study|Discontinued|2|||
16271125|NCT04567329|39476918|FG000|Overall Study|Lost to Follow-up|0|||
16271126|NCT04567329|39476919|FG001|Overall Study|Lost to Follow-up|1|||
16271127|NCT04567329|39476918|FG000|Overall Study|Lack of Efficacy|0|||
16271128|NCT04567329|39476919|FG001|Overall Study|Lack of Efficacy|1|||
16271129|NCT03123094|39476920|FG000|Overall Study|Withdrawal by Subject|0|||
16271130|NCT03123094|39476921|FG001|Overall Study|Withdrawal by Subject|2|||
16271131|NCT03123094|39476922|FG002|Overall Study|Withdrawal by Subject|1|||
16271132|NCT03123094|39476923|FG003|Overall Study|Withdrawal by Subject|0|||
16271133|NCT03123094|39476924|FG004|Overall Study|Withdrawal by Subject|1|||
16271134|NCT00725322|39476930|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
16271135|NCT00725322|39476931|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
16271136|NCT00725322|39476930|FG000|Washout (28 Days)|Protocol Violation|0|||
16271137|NCT00725322|39476931|FG001|Washout (28 Days)|Protocol Violation|1|||
16271138|NCT00695110|39476932|FG000|Treatment Period 1|Adverse Event|1|||
16271139|NCT00695110|39476932|FG000|Treatment Period 1|Withdrawal by Subject|2|||
16271140|NCT00695110|39476932|FG000|Treatment Period 3|Withdrawal by Subject|1|||
16271141|NCT00695110|39476932|FG000|Treatment Period 4|Adverse Event|1|||
16271142|NCT02473393|39476933|FG000|Overall Study|Adverse Event|0|||
16271143|NCT02473393|39476934|FG001|Overall Study|Adverse Event|0|||
16271144|NCT02473393|39476935|FG002|Overall Study|Adverse Event|1|||
16271145|NCT02473393|39476936|FG003|Overall Study|Adverse Event|0|||
16271146|NCT02473393|39476933|FG000|Overall Study|Withdrawal by Subject|0|||
16271147|NCT02473393|39476934|FG001|Overall Study|Withdrawal by Subject|0|||
16271148|NCT02473393|39476935|FG002|Overall Study|Withdrawal by Subject|1|||
16271149|NCT02473393|39476936|FG003|Overall Study|Withdrawal by Subject|1|||
16271150|NCT01590563|39476937|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
16271151|NCT01018862|39476938|FG000|Overall Study|Adverse Event|2|||
16271152|NCT01018862|39476939|FG001|Overall Study|Adverse Event|0|||
16271153|NCT01018862|39476940|FG002|Overall Study|Adverse Event|6|||
16271154|NCT01018862|39476938|FG000|Overall Study|Lack of Efficacy|1|||
16271155|NCT01018862|39476939|FG001|Overall Study|Lack of Efficacy|0|||
16271156|NCT01018862|39476940|FG002|Overall Study|Lack of Efficacy|2|||
16271157|NCT01018862|39476938|FG000|Overall Study|Lost to Follow-up|3|||
16271158|NCT01018862|39476939|FG001|Overall Study|Lost to Follow-up|1|||
16271159|NCT01018862|39476940|FG002|Overall Study|Lost to Follow-up|0|||
16271160|NCT01018862|39476938|FG000|Overall Study|Protocol Violation|1|||
16271161|NCT01018862|39476939|FG001|Overall Study|Protocol Violation|3|||
16271162|NCT01018862|39476940|FG002|Overall Study|Protocol Violation|3|||
16271163|NCT01018862|39476938|FG000|Overall Study|Withdrawal by Subject|1|||
16271164|NCT01018862|39476939|FG001|Overall Study|Withdrawal by Subject|2|||
16271165|NCT01018862|39476940|FG002|Overall Study|Withdrawal by Subject|1|||
16271166|NCT01018862|39476938|FG000|Overall Study|administrative problems|5|||
16271167|NCT01018862|39476939|FG001|Overall Study|administrative problems|4|||
16271168|NCT01018862|39476940|FG002|Overall Study|administrative problems|4|||
16271169|NCT04697173|39476944|FG000|Overall Study|Withdrawal by Subject|34|||
16271170|NCT04697173|39476945|FG001|Overall Study|Withdrawal by Subject|38|||
16271171|NCT00924638|39476946|FG000|Overall Study|Death|3|||
16271172|NCT00924638|39476947|FG001|Overall Study|Death|2|||
16271173|NCT00924638|39476946|FG000|Overall Study|Lost to Follow-up|1|||
16271174|NCT00924638|39476947|FG001|Overall Study|Lost to Follow-up|1|||
16271175|NCT00924638|39476946|FG000|Overall Study|Withdrawal by Subject|5|||
16271176|NCT00924638|39476947|FG001|Overall Study|Withdrawal by Subject|7|||
16271177|NCT00924638|39476946|FG000|Overall Study|Physician Decision|3|||
16271178|NCT00924638|39476947|FG001|Overall Study|Physician Decision|3|||
16271179|NCT01158118|39476950|FG000|Overall Study|Screen failure|1|||
16271180|NCT01158118|39476951|FG001|Overall Study|Screen failure|0|||
16271181|NCT01158118|39476950|FG000|Overall Study|Donor match was a screen failure|0|||
16271182|NCT01158118|39476951|FG001|Overall Study|Donor match was a screen failure|1|||
16271183|NCT01158118|39476950|FG000|Overall Study|Suffered stroke prior to transplant|0|||
16271184|NCT01158118|39476951|FG001|Overall Study|Suffered stroke prior to transplant|1|||
16271185|NCT01158118|39476950|FG000|Overall Study|Death|0|||
16271186|NCT01158118|39476951|FG001|Overall Study|Death|1|||
16271187|NCT02663349|39476952|FG000|Overall Study|Withdrawal by Subject|6|||
16271188|NCT00847535|39476953|FG000|Overall Study|Withdrawal by Subject|2|||
16271189|NCT00847535|39476954|FG001|Overall Study|Withdrawal by Subject|1|||
16271190|NCT00847535|39476955|FG002|Overall Study|Withdrawal by Subject|1|||
16271191|NCT00847535|39476953|FG000|Overall Study|Lost to Follow-up|0|||
16271192|NCT00847535|39476954|FG001|Overall Study|Lost to Follow-up|1|||
16271193|NCT00847535|39476955|FG002|Overall Study|Lost to Follow-up|0|||
16271194|NCT02057835|39476964|FG000|Overall Study|Withdrawal by Subject|0|||
16271195|NCT02057835|39476965|FG001|Overall Study|Withdrawal by Subject|2|||
16271196|NCT02057835|39476966|FG002|Overall Study|Withdrawal by Subject|0|||
16271197|NCT02057835|39476967|FG003|Overall Study|Withdrawal by Subject|0|||
16271198|NCT02057835|39476968|FG004|Overall Study|Withdrawal by Subject|0|||
16271199|NCT02057835|39476969|FG005|Overall Study|Withdrawal by Subject|0|||
16271200|NCT02057835|39476970|FG006|Overall Study|Withdrawal by Subject|0|||
16271201|NCT02057835|39476971|FG007|Overall Study|Withdrawal by Subject|0|||
16271202|NCT02057835|39476972|FG008|Overall Study|Withdrawal by Subject|0|||
16271203|NCT02057835|39476973|FG009|Overall Study|Withdrawal by Subject|0|||
16271204|NCT02387762|39476975|FG000|Overall Study|Withdrawal by Subject|1|||
16271205|NCT02387762|39476976|FG001|Overall Study|Withdrawal by Subject|0|||
16271206|NCT04878211|39476977|FG000|Overall Study|Lost to Follow-up|0|||
16271207|NCT04878211|39476978|FG001|Overall Study|Lost to Follow-up|0|||
16271208|NCT04878211|39476979|FG002|Overall Study|Lost to Follow-up|0|||
16271209|NCT04878211|39476980|FG003|Overall Study|Lost to Follow-up|1|||
16271210|NCT04878211|39476981|FG004|Overall Study|Lost to Follow-up|0|||
16271211|NCT04878211|39476982|FG005|Overall Study|Lost to Follow-up|1|||
16271212|NCT04878211|39476977|FG000|Overall Study|Protocol deviation|1|||
16271213|NCT04878211|39476978|FG001|Overall Study|Protocol deviation|0|||
16271214|NCT04878211|39476979|FG002|Overall Study|Protocol deviation|0|||
16271215|NCT04878211|39476980|FG003|Overall Study|Protocol deviation|0|||
16271216|NCT04878211|39476981|FG004|Overall Study|Protocol deviation|0|||
16271217|NCT04878211|39476982|FG005|Overall Study|Protocol deviation|0|||
16271218|NCT04878211|39476977|FG000|Overall Study|Study terminated by sponsor|0|||
16271219|NCT04878211|39476978|FG001|Overall Study|Study terminated by sponsor|0|||
16271220|NCT04878211|39476979|FG002|Overall Study|Study terminated by sponsor|0|||
16271221|NCT04878211|39476980|FG003|Overall Study|Study terminated by sponsor|0|||
16271222|NCT04878211|39476981|FG004|Overall Study|Study terminated by sponsor|9|||
16271223|NCT04878211|39476982|FG005|Overall Study|Study terminated by sponsor|4|||
16271224|NCT04878211|39476977|FG000|Overall Study|Subject decision|0|||
16271225|NCT04878211|39476978|FG001|Overall Study|Subject decision|0|||
16271226|NCT04878211|39476979|FG002|Overall Study|Subject decision|0|||
16271227|NCT04878211|39476980|FG003|Overall Study|Subject decision|0|||
16271228|NCT04878211|39476981|FG004|Overall Study|Subject decision|1|||
16271229|NCT04878211|39476982|FG005|Overall Study|Subject decision|0|||
16271230|NCT03086460|39476987|FG000|Study Participants|Lost to Follow-up|2|||
16271231|NCT03086460|39476987|FG000|Study Participants|Protocol Violation|1|||
16271232|NCT03086460|39476987|FG000|Study Participants|Withdrawal by Subject|6|||
16271233|NCT03086460|39476987|FG000|Treatment A|Lost to Follow-up|1|||
16271234|NCT03086460|39476987|FG000|Treatment A|Protocol Violation|1|||
16271235|NCT03086460|39476987|FG000|Treatment A|Withdrawal by Subject|2|||
16271236|NCT03086460|39476987|FG000|Treatment C|Withdrawal by Subject|2|||
16271237|NCT03086460|39476987|FG000|Treatment E|Lost to Follow-up|1|||
16271238|NCT03086460|39476987|FG000|Treatment E|Withdrawal by Subject|3|||
16271239|NCT00387153|39476991|FG000|Overall Study|Adverse Event|1|||
16271240|NCT00387153|39476991|FG000|Overall Study|Disease Progression|3|||
16271241|NCT00387153|39476991|FG000|Overall Study|Lack of Response|4|||
16271242|NCT00216736|39476996|FG000|Overall Study|Lost to Follow-up|1|||
16271243|NCT00216736|39476997|FG001|Overall Study|Lost to Follow-up|1|||
16271244|NCT03629054|39476998|FG000|Period 2 (4 Days)|Not treated|0|||
16271245|NCT03629054|39476999|FG001|Period 2 (4 Days)|Not treated|1|||
16271246|NCT03314857|39477004|FG000|Overall Study|Death|4|||
16271247|NCT03314857|39477004|FG000|Overall Study|Physician Decision|1|||
16271248|NCT02121184|39477006|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
16271249|NCT02121184|39477007|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
16271250|NCT02121184|39477006|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
16271251|NCT02121184|39477007|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
16271252|NCT02121184|39477006|FG000|Overall Study|Emergency cesarean section required|0|||
16271253|NCT02121184|39477007|FG001|Overall Study|Emergency cesarean section required|2|||
16271254|NCT02121184|39477006|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
16271255|NCT02121184|39477007|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
16271256|NCT00715676|39477008|FG000|Overall Study|Adverse Event|3|||
16271257|NCT00715676|39477009|FG001|Overall Study|Adverse Event|5|||
16271258|NCT00715676|39477010|FG002|Overall Study|Adverse Event|21|||
16271259|NCT00715676|39477008|FG000|Overall Study|Withdrawal by Subject|1|||
16271260|NCT00715676|39477009|FG001|Overall Study|Withdrawal by Subject|3|||
16271261|NCT00715676|39477010|FG002|Overall Study|Withdrawal by Subject|8|||
16271262|NCT00715676|39477008|FG000|Overall Study|Lost to Follow-up|1|||
16271263|NCT00715676|39477009|FG001|Overall Study|Lost to Follow-up|2|||
16271264|NCT00715676|39477010|FG002|Overall Study|Lost to Follow-up|1|||
16271265|NCT00715676|39477008|FG000|Overall Study|Terminated by Sponsor|1|||
16271266|NCT00715676|39477009|FG001|Overall Study|Terminated by Sponsor|0|||
16271267|NCT00715676|39477010|FG002|Overall Study|Terminated by Sponsor|0|||
16271268|NCT00715676|39477008|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
16271269|NCT00715676|39477009|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
16271270|NCT00715676|39477010|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
16271271|NCT00715676|39477008|FG000|Overall Study|Use of Exclusionary Medication|0|||
16271272|NCT00715676|39477009|FG001|Overall Study|Use of Exclusionary Medication|0|||
16271273|NCT00715676|39477010|FG002|Overall Study|Use of Exclusionary Medication|1|||
16271274|NCT00715676|39477008|FG000|Overall Study|Elevated Blood Glucose|0|||
16271275|NCT00715676|39477009|FG001|Overall Study|Elevated Blood Glucose|1|||
16271276|NCT00715676|39477010|FG002|Overall Study|Elevated Blood Glucose|0|||
16271277|NCT00487695|39477011|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
16271278|NCT00487695|39477012|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
16271279|NCT00487695|39477011|FG000|First Procedure|active wheezing (did not have procedure)|1|||
16271280|NCT00487695|39477012|FG001|First Procedure|active wheezing (did not have procedure)|0|||
16271281|NCT00487695|39477011|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
16271282|NCT00487695|39477012|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
16271283|NCT00487695|39477011|FG000|Second Procedure|active wheezing|0|||
16271284|NCT00487695|39477012|FG001|Second Procedure|active wheezing|1|||
16271285|NCT00487695|39477011|FG000|Second Procedure|Withdrawal by Subject|1|||
16271286|NCT00487695|39477012|FG001|Second Procedure|Withdrawal by Subject|2|||
16271287|NCT00537095|39477013|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
16271288|NCT00537095|39477014|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
16271289|NCT00537095|39477013|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
16271290|NCT00537095|39477014|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
16271291|NCT00537095|39477013|FG000|Randomized Treatment Period (433 Days)|Death|3|||
16271292|NCT00537095|39477014|FG001|Randomized Treatment Period (433 Days)|Death|1|||
16271293|NCT00537095|39477013|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
16271294|NCT00537095|39477014|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
16271295|NCT00537095|39477013|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
16271296|NCT00537095|39477014|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
16271297|NCT00537095|39477013|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
16271298|NCT00537095|39477014|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
16271299|NCT00537095|39477013|FG000|Open-label Period (590 Days)|Adverse Event|2|||
16271300|NCT00537095|39477014|FG001|Open-label Period (590 Days)|Adverse Event|11|||
16271301|NCT00537095|39477013|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
16271302|NCT00537095|39477014|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
16271303|NCT00537095|39477013|FG000|Open-label Period (590 Days)|Death|2|||
16271304|NCT00537095|39477014|FG001|Open-label Period (590 Days)|Death|2|||
16271305|NCT00537095|39477013|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
16271306|NCT00537095|39477014|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
16271307|NCT00537095|39477013|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
16271308|NCT00537095|39477014|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
16271309|NCT02535923|39477015|FG000|Overall Study|Lost to Follow-up|5|||
16271310|NCT02535923|39477016|FG001|Overall Study|Lost to Follow-up|5|||
16271311|NCT02535923|39477015|FG000|Overall Study|Withdrawal by Subject|4|||
16271312|NCT02535923|39477016|FG001|Overall Study|Withdrawal by Subject|3|||
16271313|NCT00472212|39477025|FG000|Overall Study|Lost to Follow-up|6|||
16271314|NCT00472212|39477026|FG001|Overall Study|Lost to Follow-up|4|||
16271315|NCT03602339|39477027|FG000|Overall Study|Withdrawal by Subject|9|||
16271316|NCT03602339|39477027|FG000|Overall Study|Physician Decision|2|||
16271317|NCT03602339|39477027|FG000|Overall Study|Other reason|4|||
16271318|NCT01277510|39477031|FG000|Double-blind Phase|Non-compliance|0|||
16271319|NCT01277510|39477032|FG001|Double-blind Phase|Non-compliance|1|||
16271320|NCT01277510|39477031|FG000|Double-blind Phase|Adverse Event|1|||
16271321|NCT01277510|39477032|FG001|Double-blind Phase|Adverse Event|0|||
16271322|NCT01277510|39477031|FG000|Double-blind Phase|Withdrawal by Subject|2|||
16271323|NCT01277510|39477032|FG001|Double-blind Phase|Withdrawal by Subject|0|||
16271324|NCT01277510|39477031|FG000|Double-blind Phase|Administrative decision|7|||
16271325|NCT01277510|39477032|FG001|Double-blind Phase|Administrative decision|9|||
16271326|NCT01277510|39477031|FG000|Double-blind Phase|Death|0|||
16271327|NCT01277510|39477032|FG001|Double-blind Phase|Death|1|||
16271328|NCT01277510|39477031|FG000|Double-blind Phase|Protocol-specified criteria|2|||
16271329|NCT01277510|39477032|FG001|Double-blind Phase|Protocol-specified criteria|6|||
16271330|NCT01277510|39477031|FG000|Double-blind Phase|Other|1|||
16271331|NCT01277510|39477032|FG001|Double-blind Phase|Other|1|||
16271332|NCT01277510|39477031|FG000|Open-label Phase|Administrative decision|4|||
16271333|NCT01277510|39477032|FG001|Open-label Phase|Administrative decision|3|||
16271334|NCT01277510|39477031|FG000|Open-label Phase|Protocol-specified criteria|1|||
16271335|NCT01277510|39477032|FG001|Open-label Phase|Protocol-specified criteria|0|||
16271336|NCT01277510|39477031|FG000|Open-label Phase|Never received investigational product|2|||
16271337|NCT01277510|39477032|FG001|Open-label Phase|Never received investigational product|0|||
16271338|NCT04768114|39477036|FG000|Overall Study|Lost to Follow-up|5|||
16271339|NCT04768114|39477037|FG001|Overall Study|Lost to Follow-up|10|||
16271340|NCT04768114|39477036|FG000|Overall Study|Withdrawal by Subject|0|||
16271341|NCT04768114|39477037|FG001|Overall Study|Withdrawal by Subject|1|||
16271342|NCT03644550|39477038|FG000|Overall Study|Withdrawal by Subject|3|||
16271343|NCT03644550|39477038|FG000|Overall Study|Progressive disease|15|||
16271344|NCT04002648|39477039|FG000|Overall Study|Lost to Follow-up|2|||
16271345|NCT04002648|39477040|FG001|Overall Study|Lost to Follow-up|0|||
16271346|NCT00573313|39477041|FG000|Overall Study|Protocol Violation|5|||
16271347|NCT00573313|39477042|FG001|Overall Study|Protocol Violation|0|||
16271348|NCT00573313|39477043|FG002|Overall Study|Protocol Violation|6|||
16271349|NCT00573313|39477044|FG003|Overall Study|Protocol Violation|0|||
16271350|NCT00429416|39477048|FG000|Overall Study|Death|1|||
16271351|NCT02125461|39477053|FG000|Overall Study|Withdrawal by Subject|30|||
16271352|NCT02125461|39477054|FG001|Overall Study|Withdrawal by Subject|16|||
16271353|NCT02125461|39477053|FG000|Overall Study|Lost to Follow-up|8|||
16271354|NCT02125461|39477054|FG001|Overall Study|Lost to Follow-up|3|||
16271355|NCT02125461|39477053|FG000|Overall Study|Death|260|||
16271356|NCT02125461|39477054|FG001|Overall Study|Death|149|||
16271357|NCT02125461|39477053|FG000|Overall Study|Missing Termination Reason|0|||
16271358|NCT02125461|39477054|FG001|Overall Study|Missing Termination Reason|1|||
16271359|NCT01456221|39477056|FG000|Overall Study|Withdrawal by Subject|56|||
16271360|NCT01456221|39477057|FG001|Overall Study|Withdrawal by Subject|49|||
16271361|NCT01456221|39477056|FG000|Overall Study|Lost to Follow-up|1|||
16271362|NCT01456221|39477057|FG001|Overall Study|Lost to Follow-up|4|||
16271363|NCT01456221|39477056|FG000|Overall Study|Received medication|3|||
16271364|NCT01456221|39477057|FG001|Overall Study|Received medication|2|||
16271365|NCT01456221|39477056|FG000|Overall Study|Incomplete data|4|||
16271366|NCT01456221|39477057|FG001|Overall Study|Incomplete data|2|||
16271367|NCT00487435|39477058|FG000|Overall Study|Adverse Event|146|||
16271368|NCT00487435|39477058|FG000|Overall Study|Death|2|||
16271369|NCT00487435|39477058|FG000|Overall Study|Lack of Efficacy|33|||
16271370|NCT00487435|39477058|FG000|Overall Study|Lost to Follow-up|54|||
16271371|NCT00487435|39477058|FG000|Overall Study|Pregnancy|2|||
16271372|NCT00487435|39477058|FG000|Overall Study|Withdrawal by Subject|132|||
16271373|NCT00487435|39477058|FG000|Overall Study|Resolution Of Pain|1|||
16271374|NCT00487435|39477058|FG000|Overall Study|Study Medication Non-Compliant|32|||
16271375|NCT00487435|39477058|FG000|Overall Study|Other|83|||
16271376|NCT04060251|39477063|FG000|Overall Study|Study terminated due to low enrollment.|7|||
16271377|NCT04060251|39477064|FG001|Overall Study|Study terminated due to low enrollment.|5|||
16271378|NCT04060251|39477065|FG002|Overall Study|Study terminated due to low enrollment.|7|||
16271379|NCT04060251|39477063|FG000|Overall Study|Adverse Event|1|||
16271380|NCT04060251|39477064|FG001|Overall Study|Adverse Event|1|||
16271381|NCT04060251|39477065|FG002|Overall Study|Adverse Event|0|||
16271382|NCT02450539|39477066|FG000|Overall Study|Withdrawal by Subject|12|||
16271383|NCT02450539|39477067|FG001|Overall Study|Withdrawal by Subject|6|||
16271384|NCT02450539|39477066|FG000|Overall Study|Lost to Follow-up|4|||
16271385|NCT02450539|39477067|FG001|Overall Study|Lost to Follow-up|1|||
16271386|NCT03366428|39477068|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
16271387|NCT03366428|39477068|FG000|Overall Study|Adverse Event|12|||
16271388|NCT03366428|39477068|FG000|Overall Study|Clinical progression|2|||
16271389|NCT03366428|39477068|FG000|Overall Study|Withdrawal by Subject|4|||
16271390|NCT00840658|39477069|FG000|Overall Study|Death|2|||
16271391|NCT00840658|39477070|FG001|Overall Study|Death|2|||
16271392|NCT00840658|39477071|FG002|Overall Study|Death|3|||
16271393|NCT00840658|39477072|FG003|Overall Study|Death|3|||
16271394|NCT00840658|39477069|FG000|Overall Study|Lost to Follow-up|3|||
16271395|NCT00840658|39477070|FG001|Overall Study|Lost to Follow-up|1|||
16271396|NCT00840658|39477071|FG002|Overall Study|Lost to Follow-up|2|||
16271397|NCT00840658|39477072|FG003|Overall Study|Lost to Follow-up|1|||
16271398|NCT01741545|39477073|FG000|Treatment Period|Lack of Efficacy|0|||
16271399|NCT01741545|39477074|FG001|Treatment Period|Lack of Efficacy|1|||
16271400|NCT01741545|39477073|FG000|Treatment Period|Adverse event, non-fatal|1|||
16271401|NCT01741545|39477074|FG001|Treatment Period|Adverse event, non-fatal|3|||
16271402|NCT01741545|39477073|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
16271403|NCT01741545|39477074|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
16271404|NCT01741545|39477073|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
16271405|NCT01741545|39477074|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
16271406|NCT03261167|39477075|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
16271407|NCT03261167|39477076|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
16271408|NCT03261167|39477075|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
16271409|NCT03261167|39477076|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
16271410|NCT03261167|39477075|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
16271411|NCT03261167|39477076|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
16271412|NCT03261167|39477075|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
16271413|NCT03261167|39477076|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
16271414|NCT03261167|39477075|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
16271415|NCT03261167|39477076|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
16271416|NCT02451358|39477078|FG000|Overall Study|Withdrawal by Subject|1|||
16271417|NCT02451358|39477079|FG001|Overall Study|Withdrawal by Subject|1|||
16271418|NCT02451358|39477080|FG002|Overall Study|Withdrawal by Subject|0|||
16271419|NCT02451358|39477081|FG003|Overall Study|Withdrawal by Subject|0|||
16271420|NCT02451358|39477078|FG000|Overall Study|Protocol Violation|0|||
16271421|NCT02451358|39477079|FG001|Overall Study|Protocol Violation|1|||
16271422|NCT02451358|39477080|FG002|Overall Study|Protocol Violation|1|||
16271423|NCT02451358|39477081|FG003|Overall Study|Protocol Violation|0|||
16271424|NCT00562718|39477082|FG000|Overall Study|Death|1|||
16271425|NCT00562718|39477082|FG000|Overall Study|Withdrawal by Subject|3|||
16271426|NCT00562718|39477082|FG000|Overall Study|Adverse Event|4|||
16271427|NCT00562718|39477082|FG000|Overall Study|Lack of Efficacy|2|||
16271428|NCT00562718|39477082|FG000|Overall Study|not stated|1|||
16271429|NCT00903877|39477084|FG000|Overall Study|Did not meet study criteria|33|||
16271430|NCT00903877|39477084|FG000|Overall Study|Withdrawal by Subject|3|||
16271431|NCT00903877|39477084|FG000|Overall Study|Adverse Event|2|||
16271432|NCT00903877|39477084|FG000|Overall Study|Lost to Follow-up|1|||
16271433|NCT00903877|39477084|FG000|Overall Study|Participation put on hold|4|||
16271434|NCT00540423|39477088|FG000|Double-Blind Treatment Period|Adverse Event|0|||
16271435|NCT00540423|39477089|FG001|Double-Blind Treatment Period|Adverse Event|1|||
16271436|NCT00540423|39477090|FG002|Double-Blind Treatment Period|Adverse Event|0|||
16271437|NCT00540423|39477088|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
16271438|NCT00540423|39477089|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
16271439|NCT00540423|39477090|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
16271440|NCT03599362|39477091|FG000|Overall Study|Screen Failure|3|||
16271441|NCT04750239|39477092|FG000|Overall Study|Withdrawal by Subject|2|||
16271442|NCT04750239|39477092|FG000|Overall Study|Trial terminated by sponsor|1|||
16271443|NCT01103713|39477095|FG000|Overall Study|Lost to Follow-up|2|||
16271444|NCT01103713|39477095|FG000|Overall Study|Withdrawal by Subject|8|||
16271445|NCT01103713|39477095|FG000|Overall Study|Study terminated by sponsor|2|||
16271446|NCT01103713|39477095|FG000|Overall Study|Other|1|||
16271447|NCT02255149|39477096|FG000|Overall Study|Lost to Follow-up|2|||
16271448|NCT02255149|39477096|FG000|Overall Study|Withdrawal by Subject|1|||
16271449|NCT02255149|39477096|FG000|Overall Study|Withdrawal by PI|1|||
16271450|NCT02255149|39477096|FG000|Overall Study|Implant Failure|1|||
16271451|NCT01583530|39480204|FG000|Overall Study|Adverse Event|0|||
16271452|NCT01583530|39480205|FG001|Overall Study|Adverse Event|0|||
16271453|NCT01583530|39480206|FG002|Overall Study|Adverse Event|0|||
16271454|NCT01583530|39480207|FG003|Overall Study|Adverse Event|0|||
16271455|NCT01583530|39480208|FG004|Overall Study|Adverse Event|0|||
16271456|NCT01583530|39480209|FG005|Overall Study|Adverse Event|1|||
16271457|NCT01583530|39480204|FG000|Overall Study|Withdrawal by Subject|0|||
16271458|NCT01583530|39480205|FG001|Overall Study|Withdrawal by Subject|3|||
16271459|NCT01583530|39480206|FG002|Overall Study|Withdrawal by Subject|0|||
16271460|NCT01583530|39480207|FG003|Overall Study|Withdrawal by Subject|1|||
16271461|NCT01583530|39480208|FG004|Overall Study|Withdrawal by Subject|1|||
16271462|NCT01583530|39480209|FG005|Overall Study|Withdrawal by Subject|2|||
16271463|NCT01583530|39480204|FG000|Overall Study|Lost to Follow-up|0|||
16271464|NCT01583530|39480205|FG001|Overall Study|Lost to Follow-up|0|||
16271465|NCT01583530|39480206|FG002|Overall Study|Lost to Follow-up|0|||
16271466|NCT01583530|39480207|FG003|Overall Study|Lost to Follow-up|0|||
16271467|NCT01583530|39480208|FG004|Overall Study|Lost to Follow-up|3|||
16271468|NCT01583530|39480209|FG005|Overall Study|Lost to Follow-up|0|||
16271469|NCT01583530|39480204|FG000|Overall Study|Lack of compliance|0|||
16271470|NCT01583530|39480205|FG001|Overall Study|Lack of compliance|0|||
16271471|NCT01583530|39480206|FG002|Overall Study|Lack of compliance|0|||
16271472|NCT01583530|39480207|FG003|Overall Study|Lack of compliance|0|||
16271473|NCT01583530|39480208|FG004|Overall Study|Lack of compliance|1|||
16271474|NCT01583530|39480209|FG005|Overall Study|Lack of compliance|0|||
16271475|NCT01576705|39480214|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
16271476|NCT01576705|39480215|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
16271477|NCT01576705|39480216|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
16271478|NCT01576705|39480217|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
16271479|NCT01576705|39480214|FG000|Overall Study|invalid ICF|0|||
16271480|NCT01576705|39480215|FG001|Overall Study|invalid ICF|1|||
16271481|NCT01576705|39480216|FG002|Overall Study|invalid ICF|0|||
16271482|NCT01576705|39480217|FG003|Overall Study|invalid ICF|0|||
16271483|NCT04277507|39480218|FG000|Overall Study|Lost to Follow-up|17|||
16271484|NCT04277507|39480218|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
16271485|NCT04277507|39480218|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
16271486|NCT04277507|39480218|FG000|Overall Study|Withdrawal by Subject|3|||
16271487|NCT04277507|39480218|FG000|Overall Study|Death due to COVID-19|1|||
16271488|NCT04277507|39480218|FG000|Overall Study|Data missing for full evaluation|5|||
16271489|NCT04892147|39480221|FG000|Overall Study|Withdrawal by Subject|2|||
16271490|NCT04892147|39480222|FG001|Overall Study|Withdrawal by Subject|0|||
16271491|NCT01174186|39480224|FG000|Overall Study|Lost to Follow-up|0|||
16271492|NCT01174186|39480225|FG001|Overall Study|Lost to Follow-up|1|||
16271493|NCT01174186|39480224|FG000|Overall Study|Withdrawal by Subject|0|||
16271494|NCT01174186|39480225|FG001|Overall Study|Withdrawal by Subject|2|||
16271495|NCT01205035|39480234|FG000|Overall Study|Withdrawal by Subject|1|||
16271496|NCT01205035|39480235|FG001|Overall Study|Withdrawal by Subject|0|||
16271497|NCT01205035|39480234|FG000|Overall Study|Physician Decision|1|||
16271498|NCT01205035|39480235|FG001|Overall Study|Physician Decision|0|||
16271499|NCT00484679|39480240|FG000|Overall Study|Withdrawal by Subject|3|||
16271500|NCT03827395|39480241|FG000|Overall Study|Lost to Follow-up|1|||
16271501|NCT03827395|39480242|FG001|Overall Study|Lost to Follow-up|0|||
16271502|NCT03827395|39480241|FG000|Overall Study|Protocol Violation|1|||
16271503|NCT03827395|39480242|FG001|Overall Study|Protocol Violation|0|||
16271504|NCT03827395|39480241|FG000|Overall Study|Became ineligible after enrollment|1|||
16271505|NCT03827395|39480242|FG001|Overall Study|Became ineligible after enrollment|2|||
16271506|NCT03666143|39480243|FG000|Overall Study|Death|158|||
16271507|NCT03666143|39480243|FG000|Overall Study|Sponsor Decision|31|||
16271508|NCT03666143|39480243|FG000|Overall Study|Withdrawal by Subject|11|||
16271509|NCT03666143|39480243|FG000|Overall Study|Lost to Follow-up|5|||
16271510|NCT03666143|39480243|FG000|Overall Study|Physician Decision|1|||
16271511|NCT03666143|39480243|FG000|Overall Study|Rolled into extension study|9|||
16271512|NCT03666143|39480243|FG000|Overall Study|Progressive Disease|1|||
16271513|NCT00533507|39480244|FG000|Overall Study|Withdrawal by Subject|1|||
16271514|NCT02637141|39480245|FG000|Overall Study|Adverse Event|1|||
16271515|NCT02637141|39480246|FG001|Overall Study|Adverse Event|1|||
16271516|NCT02637141|39480247|FG002|Overall Study|Adverse Event|0|||
16271517|NCT02637141|39480245|FG000|Overall Study|Withdrawal by Subject|1|||
16271518|NCT02637141|39480246|FG001|Overall Study|Withdrawal by Subject|1|||
16271519|NCT02637141|39480247|FG002|Overall Study|Withdrawal by Subject|1|||
16271520|NCT01320722|39480248|FG000|Overall Study|Did not Receive Intervention|3|||
16271521|NCT01320722|39480249|FG001|Overall Study|Did not Receive Intervention|2|||
16271522|NCT01320722|39480250|FG002|Overall Study|Did not Receive Intervention|1|||
16271523|NCT01320722|39480251|FG003|Overall Study|Did not Receive Intervention|1|||
16271524|NCT01320722|39480252|FG004|Overall Study|Did not Receive Intervention|2|||
16271525|NCT01320722|39480248|FG000|Overall Study|Lost to Follow-up|0|||
16271526|NCT01320722|39480249|FG001|Overall Study|Lost to Follow-up|1|||
16271527|NCT01320722|39480250|FG002|Overall Study|Lost to Follow-up|0|||
16271528|NCT01320722|39480251|FG003|Overall Study|Lost to Follow-up|1|||
16271529|NCT01320722|39480252|FG004|Overall Study|Lost to Follow-up|3|||
16271530|NCT01320722|39480248|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
16271531|NCT01320722|39480249|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
16271532|NCT01320722|39480250|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
16271533|NCT01320722|39480251|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
16271534|NCT01320722|39480252|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
16271535|NCT01320722|39480248|FG000|Overall Study|Participant Developed a Rash|0|||
16271536|NCT01320722|39480249|FG001|Overall Study|Participant Developed a Rash|0|||
16271537|NCT01320722|39480250|FG002|Overall Study|Participant Developed a Rash|2|||
16271538|NCT01320722|39480251|FG003|Overall Study|Participant Developed a Rash|1|||
16271539|NCT01320722|39480252|FG004|Overall Study|Participant Developed a Rash|1|||
16271540|NCT01320722|39480248|FG000|Overall Study|Non-compliant with Medication|0|||
16271541|NCT01320722|39480249|FG001|Overall Study|Non-compliant with Medication|0|||
16271542|NCT01320722|39480250|FG002|Overall Study|Non-compliant with Medication|1|||
16271543|NCT01320722|39480251|FG003|Overall Study|Non-compliant with Medication|0|||
16271544|NCT01320722|39480252|FG004|Overall Study|Non-compliant with Medication|0|||
16271545|NCT01320722|39480248|FG000|Overall Study|Adverse Event|0|||
16271546|NCT01320722|39480249|FG001|Overall Study|Adverse Event|0|||
16271547|NCT01320722|39480250|FG002|Overall Study|Adverse Event|3|||
16271548|NCT01320722|39480251|FG003|Overall Study|Adverse Event|6|||
16271549|NCT01320722|39480252|FG004|Overall Study|Adverse Event|0|||
16271550|NCT01320722|39480248|FG000|Overall Study|Not Compliant with Study Procedures|0|||
16271551|NCT01320722|39480249|FG001|Overall Study|Not Compliant with Study Procedures|0|||
16271552|NCT01320722|39480250|FG002|Overall Study|Not Compliant with Study Procedures|0|||
16271553|NCT01320722|39480251|FG003|Overall Study|Not Compliant with Study Procedures|4|||
16271554|NCT01320722|39480252|FG004|Overall Study|Not Compliant with Study Procedures|0|||
16271555|NCT01320722|39480248|FG000|Overall Study|Pregnancy|0|||
16271556|NCT01320722|39480249|FG001|Overall Study|Pregnancy|0|||
16271557|NCT01320722|39480250|FG002|Overall Study|Pregnancy|0|||
16271558|NCT01320722|39480251|FG003|Overall Study|Pregnancy|1|||
16271559|NCT01320722|39480252|FG004|Overall Study|Pregnancy|0|||
16271560|NCT01320722|39480248|FG000|Overall Study|Started an Exclusionary Medication|0|||
16271561|NCT01320722|39480249|FG001|Overall Study|Started an Exclusionary Medication|0|||
16271562|NCT01320722|39480250|FG002|Overall Study|Started an Exclusionary Medication|0|||
16271563|NCT01320722|39480251|FG003|Overall Study|Started an Exclusionary Medication|0|||
16271564|NCT01320722|39480252|FG004|Overall Study|Started an Exclusionary Medication|1|||
16271565|NCT01320722|39480248|FG000|Overall Study|Withdrew due to Health Condition|0|||
16271566|NCT01320722|39480249|FG001|Overall Study|Withdrew due to Health Condition|0|||
16271567|NCT01320722|39480250|FG002|Overall Study|Withdrew due to Health Condition|0|||
16271568|NCT01320722|39480251|FG003|Overall Study|Withdrew due to Health Condition|0|||
16271569|NCT01320722|39480252|FG004|Overall Study|Withdrew due to Health Condition|1|||
16271570|NCT01604941|39480255|FG000|Overall Study|Adverse Event|1|||
16271571|NCT01604941|39480256|FG001|Overall Study|Adverse Event|2|||
16271572|NCT01604941|39480257|FG002|Overall Study|Adverse Event|0|||
16271573|NCT01604941|39480258|FG003|Overall Study|Adverse Event|0|||
16271574|NCT01604941|39480259|FG004|Overall Study|Adverse Event|1|||
16271575|NCT01604941|39480260|FG005|Overall Study|Adverse Event|5|||
16271576|NCT01604941|39480255|FG000|Overall Study|Non-compliance|1|||
16271577|NCT01604941|39480256|FG001|Overall Study|Non-compliance|0|||
16271578|NCT01604941|39480257|FG002|Overall Study|Non-compliance|0|||
16271579|NCT01604941|39480258|FG003|Overall Study|Non-compliance|0|||
16271580|NCT01604941|39480259|FG004|Overall Study|Non-compliance|0|||
16271581|NCT01604941|39480260|FG005|Overall Study|Non-compliance|0|||
16271582|NCT01604941|39480255|FG000|Overall Study|Participant Decision|0|||
16271583|NCT01604941|39480256|FG001|Overall Study|Participant Decision|0|||
16271584|NCT01604941|39480257|FG002|Overall Study|Participant Decision|0|||
16271585|NCT01604941|39480258|FG003|Overall Study|Participant Decision|0|||
16271586|NCT01604941|39480259|FG004|Overall Study|Participant Decision|0|||
16271587|NCT01604941|39480260|FG005|Overall Study|Participant Decision|2|||
16271588|NCT01604941|39480255|FG000|Overall Study|Early Study Termination|9|||
16271589|NCT01604941|39480256|FG001|Overall Study|Early Study Termination|2|||
16271590|NCT01604941|39480257|FG002|Overall Study|Early Study Termination|3|||
16271591|NCT01604941|39480258|FG003|Overall Study|Early Study Termination|3|||
16271592|NCT01604941|39480259|FG004|Overall Study|Early Study Termination|0|||
16271593|NCT01604941|39480260|FG005|Overall Study|Early Study Termination|0|||
16271594|NCT01091363|39480261|FG000|Overall Study|Withdrawal by Subject|11|||
16271595|NCT01091363|39480262|FG001|Overall Study|Withdrawal by Subject|15|||
16271596|NCT01091363|39480261|FG000|Overall Study|Lost to Follow-up|2|||
16271597|NCT01091363|39480262|FG001|Overall Study|Lost to Follow-up|2|||
16271598|NCT00700739|39480263|FG000|Overall Study|Lost to Follow-up|4|||
16271599|NCT00700739|39480264|FG001|Overall Study|Lost to Follow-up|4|||
16271600|NCT04561115|39480265|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
16271601|NCT04561115|39480266|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
16271602|NCT04561115|39480265|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
16271603|NCT04561115|39480266|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
16271604|NCT04561115|39480265|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
16271605|NCT04561115|39480266|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
16271606|NCT03366792|39480267|FG000|Overall Study|Withdrawal by Subject|7|||
16271607|NCT03366792|39480267|FG000|Overall Study|Lost to Follow-up|2|||
16271608|NCT03366792|39480267|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
16271609|NCT03366792|39480267|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
16271610|NCT03980522|39480268|FG000|Treatment Period|Adverse Event|1|||
16271611|NCT03980522|39480269|FG001|Treatment Period|Adverse Event|0|||
16271612|NCT03980522|39480270|FG002|Treatment Period|Adverse Event|0|||
16271613|NCT03980522|39480271|FG003|Treatment Period|Adverse Event|0|||
16271614|NCT03980522|39480272|FG004|Treatment Period|Adverse Event|0|||
16271615|NCT01993186|39480277|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
16271616|NCT01993186|39480278|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
16271617|NCT01993186|39480277|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
16271618|NCT01993186|39480278|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
16271619|NCT01993186|39480277|FG000|Open-Label Extension Period|Other, Not Specified|0|||
16271620|NCT01993186|39480278|FG001|Open-Label Extension Period|Other, Not Specified|1|||
16271621|NCT01993186|39480277|FG000|Open-Label Extension Period|Adverse Event|1|||
16271622|NCT01993186|39480278|FG001|Open-Label Extension Period|Adverse Event|0|||
16271623|NCT01993186|39480277|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
16271624|NCT01993186|39480278|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
16271625|NCT01993186|39480277|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
16271626|NCT01993186|39480278|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
16271627|NCT01993186|39480277|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
16271628|NCT01993186|39480278|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
16271629|NCT00205777|39480279|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
16271630|NCT00205777|39480280|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
16271631|NCT00205777|39480281|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
16271632|NCT00205777|39480282|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
16271633|NCT00205777|39480283|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
16271634|NCT00205777|39480284|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
16271635|NCT00205777|39480279|FG000|Core Study (Up to 3 Years)|Death|9|||
16271636|NCT00205777|39480280|FG001|Core Study (Up to 3 Years)|Death|7|||
16271637|NCT00205777|39480281|FG002|Core Study (Up to 3 Years)|Death|14|||
16271638|NCT00205777|39480282|FG003|Core Study (Up to 3 Years)|Death|7|||
16271639|NCT00205777|39480283|FG004|Core Study (Up to 3 Years)|Death|0|||
16271640|NCT00205777|39480284|FG005|Core Study (Up to 3 Years)|Death|0|||
16271641|NCT00205777|39480279|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
16271642|NCT00205777|39480280|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
16271643|NCT00205777|39480281|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
16271644|NCT00205777|39480282|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
16271645|NCT00205777|39480283|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
16271646|NCT00205777|39480284|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
16271647|NCT00205777|39480279|FG000|Core Study (Up to 3 Years)|Other Event|49|||
16271648|NCT00205777|39480280|FG001|Core Study (Up to 3 Years)|Other Event|52|||
16271649|NCT00205777|39480281|FG002|Core Study (Up to 3 Years)|Other Event|41|||
16271650|NCT00205777|39480282|FG003|Core Study (Up to 3 Years)|Other Event|58|||
16271651|NCT00205777|39480283|FG004|Core Study (Up to 3 Years)|Other Event|0|||
16271652|NCT00205777|39480284|FG005|Core Study (Up to 3 Years)|Other Event|0|||
16271653|NCT00205777|39480279|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
16271654|NCT00205777|39480280|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
16271655|NCT00205777|39480281|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
16271656|NCT00205777|39480282|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
16271657|NCT00205777|39480283|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
16271658|NCT00205777|39480284|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
16271659|NCT00205777|39480279|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
16271660|NCT00205777|39480280|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
16271661|NCT00205777|39480281|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
16271662|NCT00205777|39480282|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
16271663|NCT00205777|39480283|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
16271664|NCT00205777|39480284|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
16271665|NCT00205777|39480279|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
16271666|NCT00205777|39480280|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
16271667|NCT00205777|39480281|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
16271668|NCT00205777|39480282|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
16271669|NCT00205777|39480283|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
16271670|NCT00205777|39480284|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
16271671|NCT00205777|39480279|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
16271672|NCT00205777|39480280|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
16271673|NCT00205777|39480281|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
16271674|NCT00205777|39480282|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
16273251|NCT01968551|39484474|FG001|Extension Phase|Adverse Event|0|||
16271675|NCT00205777|39480283|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
16271676|NCT00205777|39480284|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
16271677|NCT00205777|39480279|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
16271678|NCT00205777|39480280|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
16271679|NCT00205777|39480281|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
16271680|NCT00205777|39480282|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
16271681|NCT00205777|39480283|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
16271682|NCT00205777|39480284|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
16271683|NCT00205777|39480279|FG000|Completed Core Study, Entered SE I|Other Event|52|||
16271684|NCT00205777|39480280|FG001|Completed Core Study, Entered SE I|Other Event|46|||
16271685|NCT00205777|39480281|FG002|Completed Core Study, Entered SE I|Other Event|47|||
16271686|NCT00205777|39480282|FG003|Completed Core Study, Entered SE I|Other Event|50|||
16271687|NCT00205777|39480283|FG004|Completed Core Study, Entered SE I|Other Event|0|||
16271688|NCT00205777|39480284|FG005|Completed Core Study, Entered SE I|Other Event|0|||
16271689|NCT00205777|39480279|FG000|Study Extension I|Adverse Event|57|||
16271690|NCT00205777|39480280|FG001|Study Extension I|Adverse Event|0|||
16271691|NCT00205777|39480281|FG002|Study Extension I|Adverse Event|0|||
16271692|NCT00205777|39480282|FG003|Study Extension I|Adverse Event|61|||
16271693|NCT00205777|39480283|FG004|Study Extension I|Adverse Event|58|||
16271694|NCT00205777|39480284|FG005|Study Extension I|Adverse Event|0|||
16271695|NCT00205777|39480279|FG000|Study Extension I|Death|5|||
16271696|NCT00205777|39480280|FG001|Study Extension I|Death|0|||
16271697|NCT00205777|39480281|FG002|Study Extension I|Death|0|||
16271698|NCT00205777|39480282|FG003|Study Extension I|Death|1|||
16271699|NCT00205777|39480283|FG004|Study Extension I|Death|2|||
16271700|NCT00205777|39480284|FG005|Study Extension I|Death|0|||
16271701|NCT00205777|39480279|FG000|Study Extension I|Withdrawal by Subject|99|||
16271702|NCT00205777|39480280|FG001|Study Extension I|Withdrawal by Subject|0|||
16271703|NCT00205777|39480281|FG002|Study Extension I|Withdrawal by Subject|0|||
16271704|NCT00205777|39480282|FG003|Study Extension I|Withdrawal by Subject|106|||
16271705|NCT00205777|39480283|FG004|Study Extension I|Withdrawal by Subject|89|||
16271706|NCT00205777|39480284|FG005|Study Extension I|Withdrawal by Subject|0|||
16271707|NCT00205777|39480279|FG000|Study Extension I|Protocol Violation|4|||
16271708|NCT00205777|39480280|FG001|Study Extension I|Protocol Violation|0|||
16271709|NCT00205777|39480281|FG002|Study Extension I|Protocol Violation|0|||
16271710|NCT00205777|39480282|FG003|Study Extension I|Protocol Violation|8|||
16271711|NCT00205777|39480283|FG004|Study Extension I|Protocol Violation|8|||
16271712|NCT00205777|39480284|FG005|Study Extension I|Protocol Violation|0|||
16271713|NCT00205777|39480279|FG000|Study Extension I|Lack of Efficacy|0|||
16271714|NCT00205777|39480280|FG001|Study Extension I|Lack of Efficacy|0|||
16271715|NCT00205777|39480281|FG002|Study Extension I|Lack of Efficacy|0|||
16271716|NCT00205777|39480282|FG003|Study Extension I|Lack of Efficacy|1|||
16271717|NCT00205777|39480283|FG004|Study Extension I|Lack of Efficacy|2|||
16271718|NCT00205777|39480284|FG005|Study Extension I|Lack of Efficacy|0|||
16271719|NCT00205777|39480279|FG000|Study Extension I|Failed to return|15|||
16271720|NCT00205777|39480280|FG001|Study Extension I|Failed to return|0|||
16271721|NCT00205777|39480281|FG002|Study Extension I|Failed to return|0|||
16271722|NCT00205777|39480282|FG003|Study Extension I|Failed to return|17|||
16271723|NCT00205777|39480283|FG004|Study Extension I|Failed to return|13|||
16271724|NCT00205777|39480284|FG005|Study Extension I|Failed to return|0|||
16271725|NCT00205777|39480279|FG000|Study Extension I|Other Event|34|||
16271726|NCT00205777|39480280|FG001|Study Extension I|Other Event|0|||
16271727|NCT00205777|39480281|FG002|Study Extension I|Other Event|0|||
16271728|NCT00205777|39480282|FG003|Study Extension I|Other Event|34|||
16271729|NCT00205777|39480283|FG004|Study Extension I|Other Event|29|||
16271730|NCT00205777|39480284|FG005|Study Extension I|Other Event|0|||
16271731|NCT00205777|39480279|FG000|Study Extension I|Withdrawn as per protocol|0|||
16271732|NCT00205777|39480280|FG001|Study Extension I|Withdrawn as per protocol|0|||
16271733|NCT00205777|39480281|FG002|Study Extension I|Withdrawn as per protocol|1070|||
16271734|NCT00205777|39480282|FG003|Study Extension I|Withdrawn as per protocol|0|||
16271735|NCT00205777|39480283|FG004|Study Extension I|Withdrawn as per protocol|0|||
16271736|NCT00205777|39480284|FG005|Study Extension I|Withdrawn as per protocol|0|||
16271737|NCT00205777|39480279|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
16271738|NCT00205777|39480280|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
16271739|NCT00205777|39480281|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
16271740|NCT00205777|39480282|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
16271741|NCT00205777|39480283|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
16271742|NCT00205777|39480284|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
16271743|NCT00205777|39480279|FG000|Study Extension II|Adverse Event|0|||
16271744|NCT00205777|39480280|FG001|Study Extension II|Adverse Event|0|||
16271745|NCT00205777|39480281|FG002|Study Extension II|Adverse Event|0|||
16271746|NCT00205777|39480282|FG003|Study Extension II|Adverse Event|14|||
16271747|NCT00205777|39480283|FG004|Study Extension II|Adverse Event|0|||
16271748|NCT00205777|39480284|FG005|Study Extension II|Adverse Event|30|||
16271749|NCT00205777|39480279|FG000|Study Extension II|Death|0|||
16271750|NCT00205777|39480280|FG001|Study Extension II|Death|0|||
16271751|NCT00205777|39480281|FG002|Study Extension II|Death|0|||
16271752|NCT00205777|39480282|FG003|Study Extension II|Death|2|||
16271753|NCT00205777|39480283|FG004|Study Extension II|Death|0|||
16271754|NCT00205777|39480284|FG005|Study Extension II|Death|5|||
16271755|NCT00205777|39480279|FG000|Study Extension II|Withdrawal by Subject|0|||
16271756|NCT00205777|39480280|FG001|Study Extension II|Withdrawal by Subject|0|||
16271757|NCT00205777|39480281|FG002|Study Extension II|Withdrawal by Subject|0|||
16271758|NCT00205777|39480282|FG003|Study Extension II|Withdrawal by Subject|35|||
16271759|NCT00205777|39480283|FG004|Study Extension II|Withdrawal by Subject|0|||
16271760|NCT00205777|39480284|FG005|Study Extension II|Withdrawal by Subject|59|||
16271761|NCT00205777|39480279|FG000|Study Extension II|Protocol Violation|0|||
16271762|NCT00205777|39480280|FG001|Study Extension II|Protocol Violation|0|||
16271763|NCT00205777|39480281|FG002|Study Extension II|Protocol Violation|0|||
16271764|NCT00205777|39480282|FG003|Study Extension II|Protocol Violation|1|||
16271765|NCT00205777|39480283|FG004|Study Extension II|Protocol Violation|0|||
16271766|NCT00205777|39480284|FG005|Study Extension II|Protocol Violation|10|||
16271767|NCT00205777|39480279|FG000|Study Extension II|Lack of Efficacy|0|||
16271768|NCT00205777|39480280|FG001|Study Extension II|Lack of Efficacy|0|||
16271769|NCT00205777|39480281|FG002|Study Extension II|Lack of Efficacy|0|||
16271770|NCT00205777|39480282|FG003|Study Extension II|Lack of Efficacy|0|||
16271771|NCT00205777|39480283|FG004|Study Extension II|Lack of Efficacy|0|||
16271772|NCT00205777|39480284|FG005|Study Extension II|Lack of Efficacy|1|||
16271773|NCT00205777|39480279|FG000|Study Extension II|Failed to return|0|||
16271774|NCT00205777|39480280|FG001|Study Extension II|Failed to return|0|||
16271775|NCT00205777|39480281|FG002|Study Extension II|Failed to return|0|||
16271776|NCT00205777|39480282|FG003|Study Extension II|Failed to return|14|||
16271777|NCT00205777|39480283|FG004|Study Extension II|Failed to return|0|||
16271778|NCT00205777|39480284|FG005|Study Extension II|Failed to return|26|||
16271779|NCT00205777|39480279|FG000|Study Extension II|Other Event|0|||
16271780|NCT00205777|39480280|FG001|Study Extension II|Other Event|0|||
16271781|NCT00205777|39480281|FG002|Study Extension II|Other Event|0|||
16271782|NCT00205777|39480282|FG003|Study Extension II|Other Event|12|||
16271783|NCT00205777|39480283|FG004|Study Extension II|Other Event|0|||
16271784|NCT00205777|39480284|FG005|Study Extension II|Other Event|20|||
16271785|NCT00205777|39480279|FG000|Study Extension II|Enrolled but not treated|0|||
16271786|NCT00205777|39480280|FG001|Study Extension II|Enrolled but not treated|0|||
16271787|NCT00205777|39480281|FG002|Study Extension II|Enrolled but not treated|0|||
16271788|NCT00205777|39480282|FG003|Study Extension II|Enrolled but not treated|71|||
16271789|NCT00205777|39480283|FG004|Study Extension II|Enrolled but not treated|0|||
16271790|NCT00205777|39480284|FG005|Study Extension II|Enrolled but not treated|131|||
16271791|NCT01058668|39480285|FG000|Double-blind Treatment Phase|Adverse Event|8|||
16271792|NCT01058668|39480286|FG001|Double-blind Treatment Phase|Adverse Event|15|||
16271793|NCT01058668|39480287|FG002|Double-blind Treatment Phase|Adverse Event|25|||
16271794|NCT01058668|39480285|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
16271795|NCT01058668|39480286|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
16271796|NCT01058668|39480287|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
16271797|NCT01058668|39480285|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
16271798|NCT01058668|39480286|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
16271799|NCT01058668|39480287|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
16271800|NCT01058668|39480285|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
16271801|NCT01058668|39480286|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
16271802|NCT01058668|39480287|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
16271803|NCT01058668|39480285|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
16271804|NCT01058668|39480286|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
16271805|NCT01058668|39480287|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
16271806|NCT01058668|39480285|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
16271807|NCT01058668|39480286|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
16271808|NCT01058668|39480287|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
16271809|NCT00371839|39480289|FG000|Overall Study|Death|4|||
16271810|NCT00371839|39480290|FG001|Overall Study|Death|0|||
16271811|NCT00371839|39480291|FG002|Overall Study|Death|0|||
16271812|NCT00371839|39480289|FG000|Overall Study|Withdrawal by Subject|7|||
16271813|NCT00371839|39480290|FG001|Overall Study|Withdrawal by Subject|4|||
16271814|NCT00371839|39480291|FG002|Overall Study|Withdrawal by Subject|0|||
16271815|NCT00371839|39480289|FG000|Overall Study|Lost to Follow-up|6|||
16271816|NCT00371839|39480290|FG001|Overall Study|Lost to Follow-up|3|||
16271817|NCT00371839|39480291|FG002|Overall Study|Lost to Follow-up|2|||
16271818|NCT01492439|39480292|FG000|Overall Study|Withdrew from RTE|4|||
16271819|NCT01492439|39480293|FG001|Overall Study|Withdrew from RTE|9|||
16271820|NCT04388787|39480294|FG000|Blinded Period|Patient could not follow instructions|1|||
16271821|NCT04388787|39480294|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
16271822|NCT02471807|39480301|FG000|Overall Study|Death|14|||
16271823|NCT02471807|39480301|FG000|Overall Study|Withdrawal by Subject|2|||
16271824|NCT02471807|39480301|FG000|Overall Study|Explant|5|||
16271825|NCT02471807|39480301|FG000|Overall Study|Lost to Follow-up|1|||
16271826|NCT00627016|39480305|FG000|Overall Study|Adverse Event|1|||
16271827|NCT00627016|39480306|FG001|Overall Study|Adverse Event|1|||
16271828|NCT00627016|39480305|FG000|Overall Study|Protocol Violation|0|||
16271829|NCT00627016|39480306|FG001|Overall Study|Protocol Violation|2|||
16271830|NCT00627016|39480305|FG000|Overall Study|Lost to Follow-up|0|||
16271831|NCT00627016|39480306|FG001|Overall Study|Lost to Follow-up|1|||
16271832|NCT00627016|39480305|FG000|Overall Study|Withdrawal by Subject|2|||
16271833|NCT00627016|39480306|FG001|Overall Study|Withdrawal by Subject|1|||
16271834|NCT00627016|39480305|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
16271835|NCT00627016|39480306|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
16271836|NCT00627016|39480305|FG000|Overall Study|Lack of Efficacy|1|||
16271837|NCT00627016|39480306|FG001|Overall Study|Lack of Efficacy|0|||
16271838|NCT00627016|39480305|FG000|Overall Study|Placed on Excluded Drugs|1|||
16271839|NCT00627016|39480306|FG001|Overall Study|Placed on Excluded Drugs|0|||
16271840|NCT00627016|39480305|FG000|Overall Study|Pregnancy|1|||
16271841|NCT00627016|39480306|FG001|Overall Study|Pregnancy|0|||
16271842|NCT03234907|39480307|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
16271843|NCT03234907|39480308|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
16271844|NCT03234907|39480309|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
16271845|NCT03234907|39480310|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
16271846|NCT03234907|39480311|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
16271847|NCT03234907|39480312|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
16271848|NCT03234907|39480307|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
16271849|NCT03234907|39480308|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
16271850|NCT03234907|39480309|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
16271851|NCT03234907|39480310|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
16271852|NCT03234907|39480311|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
16271853|NCT03234907|39480312|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
16271854|NCT03234907|39480307|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
16271855|NCT03234907|39480308|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
16271856|NCT03234907|39480309|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
16271857|NCT03234907|39480310|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
16271858|NCT03234907|39480311|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
16271859|NCT03234907|39480312|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
16271860|NCT03234907|39480307|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
16271861|NCT03234907|39480308|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
16271862|NCT03234907|39480309|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
16271863|NCT03234907|39480310|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
16271864|NCT03234907|39480311|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
16271865|NCT03234907|39480312|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
16271866|NCT03234907|39480307|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
16271867|NCT03234907|39480308|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
16271868|NCT03234907|39480309|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
16271869|NCT03234907|39480310|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
16271870|NCT03234907|39480311|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
16271871|NCT03234907|39480312|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
16271872|NCT03234907|39480307|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
16271873|NCT03234907|39480308|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
16271874|NCT03234907|39480309|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
16271875|NCT03234907|39480310|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
16271876|NCT03234907|39480311|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
16271877|NCT03234907|39480312|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
16271878|NCT03234907|39480307|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
16271879|NCT03234907|39480308|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
16271880|NCT03234907|39480309|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
16271881|NCT03234907|39480310|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
16271882|NCT03234907|39480311|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
16271883|NCT03234907|39480312|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
16271884|NCT04610580|39480313|FG000|Two-way Crossover Period|Adverse Event|1|||
16271885|NCT04610580|39480314|FG001|Two-way Crossover Period|Adverse Event|0|||
16271886|NCT04610580|39480315|FG002|Two-way Crossover Period|Adverse Event|0|||
16271887|NCT04610580|39480316|FG003|Two-way Crossover Period|Adverse Event|0|||
16271888|NCT04610580|39480317|FG004|Two-way Crossover Period|Adverse Event|0|||
16271889|NCT04610580|39480318|FG005|Two-way Crossover Period|Adverse Event|0|||
16271890|NCT04610580|39480313|FG000|Two-way Crossover Period|Physician Decision|1|||
16271891|NCT04610580|39480314|FG001|Two-way Crossover Period|Physician Decision|0|||
16271892|NCT04610580|39480315|FG002|Two-way Crossover Period|Physician Decision|0|||
16271893|NCT04610580|39480316|FG003|Two-way Crossover Period|Physician Decision|0|||
16271894|NCT04610580|39480317|FG004|Two-way Crossover Period|Physician Decision|0|||
16271895|NCT04610580|39480318|FG005|Two-way Crossover Period|Physician Decision|0|||
16271896|NCT04610580|39480313|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
16271897|NCT04610580|39480314|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
16271898|NCT04610580|39480315|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
16271899|NCT04610580|39480316|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
16271900|NCT04610580|39480317|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
16271901|NCT04610580|39480318|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
16271902|NCT04610580|39480313|FG000|Two-way Crossover Period|Other than specified|0|||
16271903|NCT04610580|39480314|FG001|Two-way Crossover Period|Other than specified|1|||
16271904|NCT04610580|39480315|FG002|Two-way Crossover Period|Other than specified|0|||
16271905|NCT04610580|39480316|FG003|Two-way Crossover Period|Other than specified|0|||
16271906|NCT04610580|39480317|FG004|Two-way Crossover Period|Other than specified|0|||
16271907|NCT04610580|39480318|FG005|Two-way Crossover Period|Other than specified|0|||
16271908|NCT04610580|39480313|FG000|Washout Before Extension Period|Other than specified|0|||
16271909|NCT04610580|39480314|FG001|Washout Before Extension Period|Other than specified|1|||
16271910|NCT04610580|39480315|FG002|Washout Before Extension Period|Other than specified|0|||
16271911|NCT04610580|39480316|FG003|Washout Before Extension Period|Other than specified|0|||
16271912|NCT04610580|39480317|FG004|Washout Before Extension Period|Other than specified|0|||
16271913|NCT04610580|39480318|FG005|Washout Before Extension Period|Other than specified|0|||
16271914|NCT04610580|39480313|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
16271915|NCT04610580|39480314|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
16271916|NCT04610580|39480315|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
16271917|NCT04610580|39480316|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
16271918|NCT04610580|39480317|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
16271919|NCT04610580|39480318|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
16271920|NCT04610580|39480313|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
16271921|NCT04610580|39480314|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
16271922|NCT04610580|39480315|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
16271923|NCT04610580|39480316|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
16271924|NCT04610580|39480317|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
16271925|NCT04610580|39480318|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
16271926|NCT02030535|39480327|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
16271927|NCT00787605|39480328|FG000|Overall Study|Administrative Problems|3|||
16271928|NCT00787605|39480329|FG001|Overall Study|Administrative Problems|0|||
16271929|NCT00787605|39480328|FG000|Overall Study|Adverse Event|14|||
16271930|NCT00787605|39480329|FG001|Overall Study|Adverse Event|25|||
16271931|NCT00787605|39480328|FG000|Overall Study|Lost to Follow-up|3|||
16271932|NCT00787605|39480329|FG001|Overall Study|Lost to Follow-up|6|||
16271933|NCT00787605|39480328|FG000|Overall Study|Protocol Violation|7|||
16271934|NCT00787605|39480329|FG001|Overall Study|Protocol Violation|3|||
16271935|NCT00787605|39480328|FG000|Overall Study|Withdrawal by Subject|6|||
16271936|NCT00787605|39480329|FG001|Overall Study|Withdrawal by Subject|13|||
16271937|NCT00787605|39480328|FG000|Overall Study|Lack of Efficacy|13|||
16271938|NCT00787605|39480329|FG001|Overall Study|Lack of Efficacy|9|||
16271939|NCT01160640|39480330|FG000|Overall Study|Physician Decision|3|||
16271940|NCT01160640|39480331|FG001|Overall Study|Physician Decision|3|||
16271941|NCT01160640|39480330|FG000|Overall Study|Incarceration|1|||
16271942|NCT01160640|39480331|FG001|Overall Study|Incarceration|0|||
16271943|NCT01160640|39480330|FG000|Overall Study|Withdrawal by Subject|0|||
16271944|NCT01160640|39480331|FG001|Overall Study|Withdrawal by Subject|3|||
16271945|NCT00516295|39480332|FG000|Overall Study|Lack of Efficacy|2|||
16271946|NCT00516295|39480333|FG001|Overall Study|Lack of Efficacy|0|||
16271947|NCT00516295|39480334|FG002|Overall Study|Lack of Efficacy|0|||
16271948|NCT00516295|39480332|FG000|Overall Study|Ineligible|1|||
16271949|NCT00516295|39480333|FG001|Overall Study|Ineligible|0|||
16271950|NCT00516295|39480334|FG002|Overall Study|Ineligible|0|||
16271951|NCT00965757|39480337|FG000|Double-blind Phase|Progression of concomitant disease|1|||
16271952|NCT00965757|39480338|FG001|Double-blind Phase|Progression of concomitant disease|2|||
16468932|NCT03091777|40196388|FG002|Overall Study|Protocol Violation|1|||
16271953|NCT00965757|39480339|FG002|Double-blind Phase|Progression of concomitant disease|0|||
16271954|NCT00965757|39480340|FG003|Double-blind Phase|Progression of concomitant disease|0|||
16271955|NCT00965757|39480337|FG000|Double-blind Phase|Adverse drug reaction|2|||
16271956|NCT00965757|39480338|FG001|Double-blind Phase|Adverse drug reaction|1|||
16271957|NCT00965757|39480339|FG002|Double-blind Phase|Adverse drug reaction|0|||
16271958|NCT00965757|39480340|FG003|Double-blind Phase|Adverse drug reaction|0|||
16271959|NCT00965757|39480337|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
16271960|NCT00965757|39480338|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
16271961|NCT00965757|39480339|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
16271962|NCT00965757|39480340|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
16271963|NCT00965757|39480337|FG000|Double-blind Phase|Lack of Efficacy|7|||
16271964|NCT00965757|39480338|FG001|Double-blind Phase|Lack of Efficacy|11|||
16271965|NCT00965757|39480339|FG002|Double-blind Phase|Lack of Efficacy|0|||
16271966|NCT00965757|39480340|FG003|Double-blind Phase|Lack of Efficacy|0|||
16271967|NCT00965757|39480337|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
16271968|NCT00965757|39480338|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
16271969|NCT00965757|39480339|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
16271970|NCT00965757|39480340|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
16271971|NCT00965757|39480337|FG000|Double-blind Phase|Lost to Follow-up|0|||
16271972|NCT00965757|39480338|FG001|Double-blind Phase|Lost to Follow-up|1|||
16271973|NCT00965757|39480339|FG002|Double-blind Phase|Lost to Follow-up|0|||
16271974|NCT00965757|39480340|FG003|Double-blind Phase|Lost to Follow-up|0|||
16271975|NCT00965757|39480337|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
16271976|NCT00965757|39480338|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
16271977|NCT00965757|39480339|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
16271978|NCT00965757|39480340|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
16271979|NCT00965757|39480337|FG000|Double-blind Phase|Other|1|||
16271980|NCT00965757|39480338|FG001|Double-blind Phase|Other|0|||
16271981|NCT00965757|39480339|FG002|Double-blind Phase|Other|0|||
16271982|NCT00965757|39480340|FG003|Double-blind Phase|Other|0|||
16271983|NCT00965757|39480337|FG000|Extension Phase|Progression of concomitant disease|0|||
16271984|NCT00965757|39480338|FG001|Extension Phase|Progression of concomitant disease|0|||
16271985|NCT00965757|39480339|FG002|Extension Phase|Progression of concomitant disease|4|||
16271986|NCT00965757|39480340|FG003|Extension Phase|Progression of concomitant disease|2|||
16271987|NCT00965757|39480337|FG000|Extension Phase|Adverse drug reaction|0|||
16271988|NCT00965757|39480338|FG001|Extension Phase|Adverse drug reaction|0|||
16271989|NCT00965757|39480339|FG002|Extension Phase|Adverse drug reaction|6|||
16271990|NCT00965757|39480340|FG003|Extension Phase|Adverse drug reaction|3|||
16271991|NCT00965757|39480337|FG000|Extension Phase|Abnormal Laboratory Value|0|||
16271992|NCT00965757|39480338|FG001|Extension Phase|Abnormal Laboratory Value|0|||
16271993|NCT00965757|39480339|FG002|Extension Phase|Abnormal Laboratory Value|6|||
16271994|NCT00965757|39480340|FG003|Extension Phase|Abnormal Laboratory Value|1|||
16271995|NCT00965757|39480337|FG000|Extension Phase|Lack of Efficacy|0|||
16271996|NCT00965757|39480338|FG001|Extension Phase|Lack of Efficacy|0|||
16271997|NCT00965757|39480339|FG002|Extension Phase|Lack of Efficacy|8|||
16271998|NCT00965757|39480340|FG003|Extension Phase|Lack of Efficacy|12|||
16271999|NCT00965757|39480337|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
16272000|NCT00965757|39480338|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
16272001|NCT00965757|39480339|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
16272002|NCT00965757|39480340|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
16272003|NCT00965757|39480337|FG000|Extension Phase|Lost to Follow-up|0|||
16272004|NCT00965757|39480338|FG001|Extension Phase|Lost to Follow-up|0|||
16272005|NCT00965757|39480339|FG002|Extension Phase|Lost to Follow-up|0|||
16272006|NCT00965757|39480340|FG003|Extension Phase|Lost to Follow-up|1|||
16272007|NCT00965757|39480337|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
16272008|NCT00965757|39480338|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
16272009|NCT00965757|39480339|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
16272010|NCT00965757|39480340|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
16272011|NCT00965757|39480337|FG000|Extension Phase|Protocol Violation|0|||
16272012|NCT00965757|39480338|FG001|Extension Phase|Protocol Violation|0|||
16272013|NCT00965757|39480339|FG002|Extension Phase|Protocol Violation|0|||
16272014|NCT00965757|39480340|FG003|Extension Phase|Protocol Violation|1|||
16272015|NCT00965757|39480337|FG000|Extension Phase|Other|0|||
16272016|NCT00965757|39480338|FG001|Extension Phase|Other|0|||
16272017|NCT00965757|39480339|FG002|Extension Phase|Other|2|||
16272018|NCT00965757|39480340|FG003|Extension Phase|Other|1|||
16272019|NCT01024855|39480349|FG000|Overall Study|Inclusion/exclusion criteria|1|||
16272020|NCT02105272|39480350|FG000|Overall Study|Adverse Event|1|||
16272021|NCT02105272|39480351|FG001|Overall Study|Adverse Event|2|||
16272022|NCT02105272|39480350|FG000|Overall Study|Physician Decision|0|||
16272023|NCT02105272|39480351|FG001|Overall Study|Physician Decision|1|||
16272024|NCT02105272|39480350|FG000|Overall Study|Protocol Violation|2|||
16272025|NCT02105272|39480351|FG001|Overall Study|Protocol Violation|0|||
16272026|NCT02105272|39480350|FG000|Overall Study|Withdrawal by Subject|2|||
16272027|NCT02105272|39480351|FG001|Overall Study|Withdrawal by Subject|0|||
16272028|NCT00731939|39480352|FG000|Overall Study|Adverse Event|6|||
16272029|NCT00731939|39480352|FG000|Overall Study|Lost to Follow-up|15|||
16272030|NCT00731939|39480352|FG000|Overall Study|Not implanted with study device|9|||
16272031|NCT00731939|39480352|FG000|Overall Study|Withdrawal by Subject|2|||
16272032|NCT00731939|39480352|FG000|Overall Study|Did not meet enrollment criteria|2|||
16272033|NCT00239005|39480353|FG000|Overall Study|Adverse Event|6|||
16272034|NCT00239005|39480354|FG001|Overall Study|Adverse Event|6|||
16272035|NCT00239005|39480353|FG000|Overall Study|Withdrawal by Subject|3|||
16272036|NCT00239005|39480354|FG001|Overall Study|Withdrawal by Subject|4|||
16272037|NCT00239005|39480353|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
16272038|NCT00239005|39480354|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
16272039|NCT00239005|39480353|FG000|Overall Study|Protocol Violation|1|||
16272040|NCT00239005|39480354|FG001|Overall Study|Protocol Violation|0|||
16272041|NCT00239005|39480353|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
16272042|NCT00239005|39480354|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
16272043|NCT00239005|39480353|FG000|Overall Study|Lost to Follow-up|0|||
16272044|NCT00239005|39480354|FG001|Overall Study|Lost to Follow-up|1|||
16272045|NCT00506831|39480357|FG000|Overall Study|Death|1|||
16272046|NCT00506831|39480357|FG000|Overall Study|Withdrawal by Subject|1|||
16272047|NCT03382041|39480358|FG000|Overall Study|Consent Form Lost|2|||
16272048|NCT03382041|39480359|FG001|Overall Study|Consent Form Lost|1|||
16272049|NCT03382041|39480358|FG000|Overall Study|Withdrawal by Subject|1|||
16272050|NCT03382041|39480359|FG001|Overall Study|Withdrawal by Subject|4|||
16272051|NCT03382041|39480358|FG000|Overall Study|Lost to Follow-up|1|||
16272052|NCT03382041|39480359|FG001|Overall Study|Lost to Follow-up|4|||
16272053|NCT02252016|39480360|FG000|Overall Study|Lost to Follow-up|2|||
16272054|NCT02252016|39480361|FG001|Overall Study|Lost to Follow-up|1|||
16272055|NCT02252016|39480360|FG000|Overall Study|Physician Decision|1|||
16272056|NCT02252016|39480361|FG001|Overall Study|Physician Decision|0|||
16272057|NCT02252016|39480360|FG000|Overall Study|Withdrawal by Subject|0|||
16272058|NCT02252016|39480361|FG001|Overall Study|Withdrawal by Subject|2|||
16272059|NCT05740098|39480362|FG000|Overall Study|Lost to Follow-up|26|||
16272060|NCT05740098|39480363|FG001|Overall Study|Lost to Follow-up|17|||
16272061|NCT05740098|39480364|FG002|Overall Study|Lost to Follow-up|21|||
16272062|NCT02340780|39480365|FG000|Overall Study|Ineligible|1|||
16272063|NCT02358538|39480366|FG000|Through Week 26|Adverse Event|0|||
16272064|NCT02358538|39480367|FG001|Through Week 26|Adverse Event|1|||
16272065|NCT02358538|39480368|FG002|Through Week 26|Adverse Event|1|||
16272066|NCT02358538|39480369|FG003|Through Week 26|Adverse Event|2|||
16272067|NCT02358538|39480366|FG000|Through Week 26|Lack of Efficacy|1|||
16272068|NCT02358538|39480367|FG001|Through Week 26|Lack of Efficacy|1|||
16272069|NCT02358538|39480368|FG002|Through Week 26|Lack of Efficacy|3|||
16272070|NCT02358538|39480369|FG003|Through Week 26|Lack of Efficacy|3|||
16272071|NCT02358538|39480366|FG000|Through Week 26|Withdrawal by Subject|1|||
16272072|NCT02358538|39480367|FG001|Through Week 26|Withdrawal by Subject|0|||
16272073|NCT02358538|39480368|FG002|Through Week 26|Withdrawal by Subject|0|||
16272074|NCT02358538|39480369|FG003|Through Week 26|Withdrawal by Subject|0|||
16272075|NCT02358538|39480366|FG000|Through Week 26|Non-Compliance|0|||
16272076|NCT02358538|39480367|FG001|Through Week 26|Non-Compliance|0|||
16272077|NCT02358538|39480368|FG002|Through Week 26|Non-Compliance|1|||
16272078|NCT02358538|39480369|FG003|Through Week 26|Non-Compliance|0|||
16272079|NCT02358538|39480366|FG000|Through Week 26|Family did not see benefit from IP|1|||
16272080|NCT02358538|39480367|FG001|Through Week 26|Family did not see benefit from IP|0|||
16272081|NCT02358538|39480368|FG002|Through Week 26|Family did not see benefit from IP|0|||
16272082|NCT02358538|39480369|FG003|Through Week 26|Family did not see benefit from IP|0|||
16272083|NCT02358538|39480366|FG000|52 Week Extension Period|Lack of Efficacy|0|||
16272084|NCT02358538|39480367|FG001|52 Week Extension Period|Lack of Efficacy|0|||
16272085|NCT02358538|39480368|FG002|52 Week Extension Period|Lack of Efficacy|2|||
16272086|NCT02358538|39480369|FG003|52 Week Extension Period|Lack of Efficacy|4|||
16272087|NCT00660660|39480374|FG000|Overall Study|Adverse Event|1|||
16272088|NCT00660660|39480375|FG001|Overall Study|Adverse Event|0|||
16272089|NCT00660660|39480374|FG000|Overall Study|Lost to Follow-up|0|||
16272090|NCT00660660|39480375|FG001|Overall Study|Lost to Follow-up|6|||
16272091|NCT00660660|39480374|FG000|Overall Study|Lack of Efficacy|0|||
16272092|NCT00660660|39480375|FG001|Overall Study|Lack of Efficacy|2|||
16272093|NCT00660660|39480374|FG000|Overall Study|Withdrawal by Subject|3|||
16272094|NCT00660660|39480375|FG001|Overall Study|Withdrawal by Subject|0|||
16272095|NCT00660660|39480374|FG000|Overall Study|Incorrect enrollment and other|0|||
16272096|NCT00660660|39480375|FG001|Overall Study|Incorrect enrollment and other|1|||
16272097|NCT00660660|39480374|FG000|Overall Study|New medication after randomization|1|||
16272098|NCT00660660|39480375|FG001|Overall Study|New medication after randomization|0|||
16272099|NCT04198363|39480376|FG000|Overall Study|Adverse Event|1|||
16272100|NCT04198363|39480377|FG001|Overall Study|Adverse Event|1|||
16272101|NCT04198363|39480376|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
16272102|NCT04198363|39480377|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
16272103|NCT04198363|39480376|FG000|Overall Study|Reason not Specified|1|||
16272104|NCT04198363|39480377|FG001|Overall Study|Reason not Specified|0|||
16272105|NCT03807440|39480380|FG000|Overall Study|No documentation of index date 2|320|||
16272106|NCT03807440|39480380|FG000|Overall Study|No informed consent for index date 2|117|||
16272107|NCT01499043|39480381|FG000|Overall Study|Progressive disease (radiographic)|2|||
16272108|NCT01499043|39480381|FG000|Overall Study|Progressive disease (clinical)|1|||
16272109|NCT01499043|39480381|FG000|Overall Study|Withdrawal by Subject|2|||
16272110|NCT01499043|39480381|FG000|Overall Study|Adverse Event|1|||
16272111|NCT03306277|39480385|FG000|Overall Study|Death|1|||
16272112|NCT03306277|39480385|FG000|Overall Study|Adverse Event|1|||
16273252|NCT01968551|39484475|FG002|Extension Phase|Adverse Event|2|||
16272113|NCT03306277|39480385|FG000|Overall Study|Withdrawal by Subject|1|||
16272114|NCT04133311|39480391|FG000|Period 1 Double Masked Treatment Period|Death|1|||
16272115|NCT04133311|39480392|FG001|Period 1 Double Masked Treatment Period|Death|0|||
16272116|NCT04133311|39480393|FG002|Period 1 Double Masked Treatment Period|Death|0|||
16272117|NCT04133311|39480394|FG003|Period 1 Double Masked Treatment Period|Death|0|||
16272118|NCT04133311|39480391|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
16272119|NCT04133311|39480392|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
16272120|NCT04133311|39480393|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
16272121|NCT04133311|39480394|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
16272122|NCT04133311|39480391|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
16272123|NCT04133311|39480392|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
16272124|NCT04133311|39480393|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
16272125|NCT04133311|39480394|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
16272126|NCT04133311|39480391|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
16272127|NCT04133311|39480392|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
16272128|NCT04133311|39480393|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
16272129|NCT04133311|39480394|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
16272130|NCT04133311|39480391|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
16272131|NCT04133311|39480392|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
16272132|NCT04133311|39480393|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
16272133|NCT04133311|39480394|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
16272134|NCT04133311|39480391|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
16272135|NCT04133311|39480392|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
16272136|NCT04133311|39480393|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
16272137|NCT04133311|39480394|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
16272138|NCT04133311|39480391|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
16272139|NCT04133311|39480392|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
16272140|NCT04133311|39480393|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
16272141|NCT04133311|39480394|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
16272142|NCT04133311|39480391|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
16272143|NCT04133311|39480392|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
16272144|NCT04133311|39480393|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
16272145|NCT04133311|39480394|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
16272146|NCT00323258|39480395|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
16272147|NCT00323258|39480396|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
16272148|NCT00323258|39480395|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
16272149|NCT00323258|39480396|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
16272150|NCT00323258|39480395|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
16272151|NCT00323258|39480396|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
16272152|NCT00323258|39480395|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
16272153|NCT00323258|39480396|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
16272154|NCT00323258|39480395|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
16272155|NCT00323258|39480396|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
16272156|NCT00323258|39480395|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
16272157|NCT00323258|39480396|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
16272158|NCT00323258|39480395|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
16272159|NCT00323258|39480396|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
16272160|NCT02462837|39480397|FG000|Overall Study|pt developed hives|1|||
16272161|NCT02462837|39480398|FG001|Overall Study|pt developed hives|0|||
16272162|NCT02462837|39480397|FG000|Overall Study|Withdrawal by Subject|1|||
16272163|NCT02462837|39480398|FG001|Overall Study|Withdrawal by Subject|0|||
16272164|NCT01513239|39480399|FG000|Period 1: Main Phase|Adverse Event|1|||
16272165|NCT01513239|39480400|FG001|Period 1: Main Phase|Adverse Event|1|||
16272166|NCT01513239|39480401|FG002|Period 1: Main Phase|Adverse Event|2|||
16272167|NCT01513239|39480402|FG003|Period 1: Main Phase|Adverse Event|0|||
16272168|NCT01513239|39480403|FG004|Period 1: Main Phase|Adverse Event|0|||
16272169|NCT01513239|39480404|FG005|Period 1: Main Phase|Adverse Event|0|||
16272170|NCT01513239|39480399|FG000|Period 1: Main Phase|Death|29|||
16272171|NCT01513239|39480400|FG001|Period 1: Main Phase|Death|22|||
16272172|NCT01513239|39480401|FG002|Period 1: Main Phase|Death|32|||
16272173|NCT01513239|39480402|FG003|Period 1: Main Phase|Death|0|||
16272174|NCT01513239|39480403|FG004|Period 1: Main Phase|Death|0|||
16272175|NCT01513239|39480404|FG005|Period 1: Main Phase|Death|0|||
16272176|NCT01513239|39480399|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
16272177|NCT01513239|39480400|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
16272178|NCT01513239|39480401|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
16272179|NCT01513239|39480402|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
16272180|NCT01513239|39480403|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
16272181|NCT01513239|39480404|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
16272182|NCT01513239|39480399|FG000|Period 1: Main Phase|Physician Decision|4|||
16272183|NCT01513239|39480400|FG001|Period 1: Main Phase|Physician Decision|4|||
16272184|NCT01513239|39480401|FG002|Period 1: Main Phase|Physician Decision|4|||
16272185|NCT01513239|39480402|FG003|Period 1: Main Phase|Physician Decision|0|||
16272186|NCT01513239|39480403|FG004|Period 1: Main Phase|Physician Decision|0|||
16272187|NCT01513239|39480404|FG005|Period 1: Main Phase|Physician Decision|0|||
16272188|NCT01513239|39480399|FG000|Period 1: Main Phase|Protocol Violation|2|||
16272189|NCT01513239|39480400|FG001|Period 1: Main Phase|Protocol Violation|2|||
16272190|NCT01513239|39480401|FG002|Period 1: Main Phase|Protocol Violation|2|||
16272191|NCT01513239|39480402|FG003|Period 1: Main Phase|Protocol Violation|0|||
16272192|NCT01513239|39480403|FG004|Period 1: Main Phase|Protocol Violation|0|||
16272193|NCT01513239|39480404|FG005|Period 1: Main Phase|Protocol Violation|0|||
16272194|NCT01513239|39480399|FG000|Period 1: Main Phase|Technical Problems|1|||
16272195|NCT01513239|39480400|FG001|Period 1: Main Phase|Technical Problems|2|||
16272196|NCT01513239|39480401|FG002|Period 1: Main Phase|Technical Problems|0|||
16272197|NCT01513239|39480402|FG003|Period 1: Main Phase|Technical Problems|0|||
16272198|NCT01513239|39480403|FG004|Period 1: Main Phase|Technical Problems|0|||
16272199|NCT01513239|39480404|FG005|Period 1: Main Phase|Technical Problems|0|||
16272200|NCT01513239|39480399|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
16272201|NCT01513239|39480400|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
16272202|NCT01513239|39480401|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
16272203|NCT01513239|39480402|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
16272204|NCT01513239|39480403|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
16272205|NCT01513239|39480404|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
16272206|NCT01513239|39480399|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
16272207|NCT01513239|39480400|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
16272208|NCT01513239|39480401|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
16272209|NCT01513239|39480402|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
16272210|NCT01513239|39480403|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
16272211|NCT01513239|39480404|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
16272212|NCT01513239|39480399|FG000|Period 2: 9 Month Extension Phase|Death|0|||
16272213|NCT01513239|39480400|FG001|Period 2: 9 Month Extension Phase|Death|0|||
16272214|NCT01513239|39480401|FG002|Period 2: 9 Month Extension Phase|Death|0|||
16272215|NCT01513239|39480402|FG003|Period 2: 9 Month Extension Phase|Death|2|||
16272216|NCT01513239|39480403|FG004|Period 2: 9 Month Extension Phase|Death|5|||
16272217|NCT01513239|39480404|FG005|Period 2: 9 Month Extension Phase|Death|2|||
16272218|NCT01513239|39480399|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
16272219|NCT01513239|39480400|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
16272220|NCT01513239|39480401|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
16272221|NCT01513239|39480402|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
16272222|NCT01513239|39480403|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
16272223|NCT01513239|39480404|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
16272224|NCT01513239|39480399|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
16272225|NCT01513239|39480400|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
16272226|NCT01513239|39480401|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
16272227|NCT01513239|39480402|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
16272228|NCT01513239|39480403|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
16272229|NCT01513239|39480404|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
16272230|NCT01513239|39480399|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
16272231|NCT01513239|39480400|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
16272232|NCT01513239|39480401|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
16272233|NCT01513239|39480402|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
16272234|NCT01513239|39480403|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
16272235|NCT01513239|39480404|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
16272236|NCT02420353|39480405|FG000|Overall Study|Withdrawal by Subject|0|||
16272237|NCT02420353|39480406|FG001|Overall Study|Withdrawal by Subject|1|||
16272238|NCT02957331|39480407|FG000|Overall Study|Protocol Violation|1|||
16272239|NCT02957331|39480408|FG001|Overall Study|Protocol Violation|0|||
16272240|NCT01977456|39480409|FG000|Overall Study|Death|5|||
16272241|NCT03707587|39480410|FG000|Overall Study|Death|0|||
16272242|NCT03707587|39480411|FG001|Overall Study|Death|1|||
16272243|NCT02385708|39480412|FG000|Overall Study|Withdrawal by Subject|0|||
16272244|NCT02385708|39480413|FG001|Overall Study|Withdrawal by Subject|2|||
16272245|NCT02385708|39480412|FG000|Overall Study|Withdrawn - surgery canceled|2|||
16272246|NCT02385708|39480413|FG001|Overall Study|Withdrawn - surgery canceled|5|||
16272247|NCT02385708|39480412|FG000|Overall Study|Investigator decision|5|||
16272248|NCT02385708|39480413|FG001|Overall Study|Investigator decision|7|||
16272249|NCT02385708|39480412|FG000|Overall Study|Protocol Violation|1|||
16272250|NCT02385708|39480413|FG001|Overall Study|Protocol Violation|1|||
16272251|NCT00796562|39480414|FG000|Overall Study|Death|49|||
16272252|NCT00087529|39480415|FG000|Overall Study|Death|1|||
16272253|NCT00087529|39480416|FG001|Overall Study|Death|0|||
16272254|NCT00087529|39480415|FG000|Overall Study|Adverse Event|0|||
16272255|NCT00087529|39480416|FG001|Overall Study|Adverse Event|8|||
16272256|NCT00087529|39480415|FG000|Overall Study|Pregnancy|0|||
16272257|NCT00087529|39480416|FG001|Overall Study|Pregnancy|1|||
16272258|NCT00087529|39480415|FG000|Overall Study|Lost to Follow-up|2|||
16272259|NCT00087529|39480416|FG001|Overall Study|Lost to Follow-up|3|||
16272260|NCT00087529|39480415|FG000|Overall Study|Participant Decision|14|||
16272261|NCT00087529|39480416|FG001|Overall Study|Participant Decision|37|||
16272262|NCT00087529|39480415|FG000|Overall Study|Physician Decision|4|||
16272263|NCT00087529|39480416|FG001|Overall Study|Physician Decision|8|||
16272264|NCT00087529|39480415|FG000|Overall Study|Initiation of Excluded Therapy|0|||
16272265|NCT00087529|39480416|FG001|Overall Study|Initiation of Excluded Therapy|1|||
16272266|NCT00087529|39480415|FG000|Overall Study|Participant Noncompliance|0|||
16272267|NCT00087529|39480416|FG001|Overall Study|Participant Noncompliance|1|||
16272268|NCT00087529|39480415|FG000|Overall Study|Disease Progression|5|||
16272269|NCT00087529|39480416|FG001|Overall Study|Disease Progression|4|||
16272270|NCT00087529|39480415|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
16272271|NCT00087529|39480416|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
16272272|NCT01963260|39480417|FG000|Overall Study|Withdrawal by Subject|2|||
16272273|NCT01963260|39480418|FG001|Overall Study|Withdrawal by Subject|0|||
16272274|NCT01963260|39480419|FG002|Overall Study|Withdrawal by Subject|0|||
16272275|NCT01963260|39480420|FG003|Overall Study|Withdrawal by Subject|1|||
16272276|NCT01963260|39480421|FG004|Overall Study|Withdrawal by Subject|2|||
16272277|NCT01963260|39480422|FG005|Overall Study|Withdrawal by Subject|0|||
16272278|NCT01963260|39480423|FG006|Overall Study|Withdrawal by Subject|0|||
16272279|NCT01963260|39480424|FG007|Overall Study|Withdrawal by Subject|0|||
16272280|NCT01963260|39480425|FG008|Overall Study|Withdrawal by Subject|0|||
16272281|NCT01963260|39480426|FG009|Overall Study|Withdrawal by Subject|0|||
16272282|NCT01297504|39480427|FG000|Overall Study|Invalid Consent|1|||
16272283|NCT01297504|39480427|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
16272284|NCT01297504|39480427|FG000|Overall Study|No Study Visits|4|||
16272285|NCT01297504|39480427|FG000|Overall Study|Death|3|||
16272286|NCT01297504|39480427|FG000|Overall Study|Lost to Follow-up|43|||
16272287|NCT01297504|39480427|FG000|Overall Study|Withdrawal by Subject|9|||
16272288|NCT01297504|39480427|FG000|Overall Study|Site Closure|3|||
16272289|NCT01297504|39480427|FG000|Overall Study|Protocol Violation|3|||
16272290|NCT01685008|39480428|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
16272291|NCT01685008|39480429|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
16272292|NCT01685008|39480430|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
16272293|NCT01685008|39480431|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
16272294|NCT01685008|39480428|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
16272295|NCT01685008|39480429|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
16272296|NCT01685008|39480430|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
16272297|NCT01685008|39480431|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
16272298|NCT01685008|39480428|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
16272299|NCT01685008|39480429|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
16272300|NCT01685008|39480430|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
16272301|NCT01685008|39480431|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
16272302|NCT01685008|39480428|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
16272303|NCT01685008|39480429|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
16272304|NCT01685008|39480430|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
16272305|NCT01685008|39480431|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
16272306|NCT01685008|39480428|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
16272307|NCT01685008|39480429|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
16272308|NCT01685008|39480430|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
16272309|NCT01685008|39480431|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
16272310|NCT05755282|39480432|FG000|Overall Study|Protocol Violation|0|||
16272311|NCT05755282|39480433|FG001|Overall Study|Protocol Violation|1|||
16272312|NCT01695239|39480434|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
16272313|NCT01695239|39480435|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
16272314|NCT01695239|39480436|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
16272315|NCT01695239|39480437|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
16272316|NCT01695239|39480438|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16272317|NCT01695239|39480439|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16272318|NCT01695239|39480440|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16272319|NCT01695239|39480441|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16272320|NCT01695239|39480442|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16272321|NCT01695239|39480443|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16272322|NCT01695239|39480444|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16272323|NCT01695239|39480445|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16273253|NCT01968551|39484473|FG000|Extension Phase|Death|0|||
16272324|NCT01695239|39480446|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16272325|NCT01695239|39480447|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
16272326|NCT01695239|39480434|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
16272327|NCT01695239|39480435|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
16272328|NCT01695239|39480436|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
16272329|NCT01695239|39480437|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
16272330|NCT01695239|39480438|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16272331|NCT01695239|39480439|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16272332|NCT01695239|39480440|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16272333|NCT01695239|39480441|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16272334|NCT01695239|39480442|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16272335|NCT01695239|39480443|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16468933|NCT03091777|40196386|FG000|Overall Study|Lost to Follow-up|12|||
16468934|NCT03091777|40196387|FG001|Overall Study|Lost to Follow-up|14|||
16468935|NCT03091777|40196388|FG002|Overall Study|Lost to Follow-up|7|||
16468936|NCT03091777|40196386|FG000|Overall Study|Lack of Efficacy|0|||
16468937|NCT03091777|40196387|FG001|Overall Study|Lack of Efficacy|0|||
16468938|NCT03091777|40196388|FG002|Overall Study|Lack of Efficacy|5|||
16468939|NCT03091777|40196386|FG000|Overall Study|Noncompliance with study drug|2|||
16468940|NCT03091777|40196387|FG001|Overall Study|Noncompliance with study drug|3|||
16468941|NCT03091777|40196388|FG002|Overall Study|Noncompliance with study drug|1|||
16468942|NCT03091777|40196386|FG000|Overall Study|Physician Decision|1|||
16468943|NCT03091777|40196387|FG001|Overall Study|Physician Decision|0|||
16468944|NCT03091777|40196388|FG002|Overall Study|Physician Decision|1|||
16468945|NCT03091777|40196386|FG000|Overall Study|Abnormal Laboratory Value|7|||
16072743|NCT01787760|38759159|FG001|Overall Study|Withdrawal by Subject|1|||
16072744|NCT01787760|38759160|FG002|Overall Study|Withdrawal by Subject|2|||
16072745|NCT01787760|38759158|FG000|Overall Study|Lost to Follow-up|1|||
16072746|NCT01787760|38759159|FG001|Overall Study|Lost to Follow-up|0|||
16072747|NCT01787760|38759160|FG002|Overall Study|Lost to Follow-up|1|||
16072748|NCT01787760|38759158|FG000|Overall Study|Stroke|1|||
16072749|NCT01787760|38759159|FG001|Overall Study|Stroke|0|||
16072750|NCT01787760|38759160|FG002|Overall Study|Stroke|0|||
16072751|NCT01787760|38759158|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
16072752|NCT01787760|38759159|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
16072753|NCT01787760|38759160|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
16072754|NCT01787760|38759158|FG000|Overall Study|Unsatisfactory physiological response|2|||
16072755|NCT01787760|38759159|FG001|Overall Study|Unsatisfactory physiological response|4|||
16072756|NCT01787760|38759160|FG002|Overall Study|Unsatisfactory physiological response|0|||
16072757|NCT01787760|38759158|FG000|Overall Study|Unsatisfactory visual response|1|||
16173595|NCT02764541|39111271|FG005|Overall Study|Disease progression|0|||
16468946|NCT03091777|40196387|FG001|Overall Study|Abnormal Laboratory Value|11|||
16468947|NCT03091777|40196388|FG002|Overall Study|Abnormal Laboratory Value|12|||
16468948|NCT01466595|40196397|FG000|Overall Study|Withdrawal by Subject|0|||
16468949|NCT01466595|40196398|FG001|Overall Study|Withdrawal by Subject|1|||
16468950|NCT03355664|40196399|FG000|Overall Study|Adverse Event|1|||
16468951|NCT03355664|40196400|FG001|Overall Study|Adverse Event|2|||
16468952|NCT03355664|40196399|FG000|Overall Study|Lost to Follow-up|11|||
16072758|NCT01787760|38759159|FG001|Overall Study|Unsatisfactory visual response|1|||
16173596|NCT02764541|39111272|FG006|Overall Study|Disease progression|0|||
16173597|NCT02764541|39111273|FG007|Overall Study|Disease progression|1|||
16173598|NCT02764541|39111266|FG000|Overall Study|Protocol Violation|0|||
16173599|NCT02764541|39111267|FG001|Overall Study|Protocol Violation|0|||
16173600|NCT02764541|39111268|FG002|Overall Study|Protocol Violation|0|||
16173601|NCT02764541|39111269|FG003|Overall Study|Protocol Violation|1|||
16173602|NCT02764541|39111270|FG004|Overall Study|Protocol Violation|0|||
16173603|NCT02764541|39111271|FG005|Overall Study|Protocol Violation|1|||
16173604|NCT02764541|39111272|FG006|Overall Study|Protocol Violation|0|||
16173605|NCT02764541|39111273|FG007|Overall Study|Protocol Violation|0|||
16173606|NCT02764541|39111266|FG000|Overall Study|Physician Decision|0|||
16173607|NCT02764541|39111267|FG001|Overall Study|Physician Decision|0|||
16173608|NCT02764541|39111268|FG002|Overall Study|Physician Decision|0|||
16173609|NCT02764541|39111269|FG003|Overall Study|Physician Decision|1|||
16173610|NCT02764541|39111270|FG004|Overall Study|Physician Decision|0|||
16173611|NCT02764541|39111271|FG005|Overall Study|Physician Decision|0|||
16173612|NCT02764541|39111272|FG006|Overall Study|Physician Decision|0|||
16173613|NCT02764541|39111273|FG007|Overall Study|Physician Decision|1|||
16173614|NCT02764541|39111266|FG000|Overall Study|Three Cycles completed before surgery|0|||
16173615|NCT02764541|39111267|FG001|Overall Study|Three Cycles completed before surgery|0|||
16173616|NCT02764541|39111268|FG002|Overall Study|Three Cycles completed before surgery|0|||
16173617|NCT02764541|39111269|FG003|Overall Study|Three Cycles completed before surgery|1|||
16173618|NCT02764541|39111270|FG004|Overall Study|Three Cycles completed before surgery|0|||
16173619|NCT02764541|39111271|FG005|Overall Study|Three Cycles completed before surgery|0|||
16173620|NCT02764541|39111272|FG006|Overall Study|Three Cycles completed before surgery|0|||
16468953|NCT03355664|40196400|FG001|Overall Study|Lost to Follow-up|7|||
16468954|NCT03355664|40196399|FG000|Overall Study|Protocol Violation|1|||
16468955|NCT03355664|40196400|FG001|Overall Study|Protocol Violation|2|||
16468956|NCT03355664|40196399|FG000|Overall Study|Withdrawal by Subject|2|||
16468957|NCT03355664|40196400|FG001|Overall Study|Withdrawal by Subject|1|||
16468958|NCT01255787|40196401|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
16468959|NCT01255787|40196402|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
16468960|NCT01255787|40196403|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
16468961|NCT01255787|40196404|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
16468962|NCT01255787|40196401|FG000|Overall Study|Major Protocol Deviation|1|||
16468963|NCT01255787|40196402|FG001|Overall Study|Major Protocol Deviation|1|||
16468964|NCT01255787|40196403|FG002|Overall Study|Major Protocol Deviation|0|||
16272336|NCT01695239|39480444|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16272337|NCT01695239|39480445|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16272338|NCT01695239|39480446|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16272339|NCT01695239|39480447|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
16272340|NCT01695239|39480434|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
16272341|NCT01695239|39480435|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16272342|NCT01695239|39480436|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
16272343|NCT01695239|39480437|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16272344|NCT01695239|39480438|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16272345|NCT01695239|39480439|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16272346|NCT01695239|39480440|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16272347|NCT01695239|39480441|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16272348|NCT01695239|39480442|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16272349|NCT01695239|39480443|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16272350|NCT01695239|39480444|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16272351|NCT01695239|39480445|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16468965|NCT01255787|40196404|FG003|Overall Study|Major Protocol Deviation|4|||
16468966|NCT01255787|40196401|FG000|Overall Study|Lost to Follow-up|1|||
16468967|NCT01255787|40196402|FG001|Overall Study|Lost to Follow-up|2|||
16468968|NCT01255787|40196403|FG002|Overall Study|Lost to Follow-up|4|||
16468969|NCT01255787|40196404|FG003|Overall Study|Lost to Follow-up|2|||
16468970|NCT01255787|40196401|FG000|Overall Study|Withdrawal of Consent|3|||
16468971|NCT01255787|40196402|FG001|Overall Study|Withdrawal of Consent|9|||
16468972|NCT01255787|40196403|FG002|Overall Study|Withdrawal of Consent|3|||
16468973|NCT01255787|40196404|FG003|Overall Study|Withdrawal of Consent|4|||
16468974|NCT01255787|40196401|FG000|Overall Study|Pregnancy|0|||
16468975|NCT01255787|40196402|FG001|Overall Study|Pregnancy|0|||
16468976|NCT01255787|40196403|FG002|Overall Study|Pregnancy|0|||
16468977|NCT01255787|40196404|FG003|Overall Study|Pregnancy|1|||
16468978|NCT01255787|40196401|FG000|Overall Study|Lack of Efficacy|2|||
16272352|NCT01695239|39480446|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16272353|NCT01695239|39480447|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
16468979|NCT01255787|40196402|FG001|Overall Study|Lack of Efficacy|2|||
16468980|NCT01255787|40196403|FG002|Overall Study|Lack of Efficacy|2|||
16468981|NCT01255787|40196404|FG003|Overall Study|Lack of Efficacy|2|||
16468982|NCT01255787|40196401|FG000|Overall Study|Noncompliance with Study Drug|3|||
16468983|NCT01255787|40196402|FG001|Overall Study|Noncompliance with Study Drug|1|||
16468984|NCT01255787|40196403|FG002|Overall Study|Noncompliance with Study Drug|0|||
16468985|NCT01255787|40196404|FG003|Overall Study|Noncompliance with Study Drug|0|||
16468986|NCT00745615|40196405|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
16468987|NCT00745615|40196406|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
16468988|NCT00745615|40196407|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
16468989|NCT00745615|40196408|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
16468990|NCT00745615|40196409|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
16468991|NCT00745615|40196410|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
16468992|NCT00745615|40196405|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
16468993|NCT00745615|40196406|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
16468994|NCT00745615|40196407|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
16468995|NCT00745615|40196408|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
16468996|NCT00745615|40196409|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
16468997|NCT00745615|40196410|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
16468998|NCT00745615|40196405|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
16468999|NCT00745615|40196406|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
16469000|NCT00745615|40196407|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
16469001|NCT00745615|40196408|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
16469002|NCT00745615|40196409|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
16469003|NCT00745615|40196410|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
16469004|NCT00745615|40196405|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
16469005|NCT00745615|40196406|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
16072759|NCT01787760|38759160|FG002|Overall Study|Unsatisfactory visual response|0|||
16072760|NCT01787760|38759158|FG000|Overall Study|Near vision blur|1|||
16072761|NCT01787760|38759159|FG001|Overall Study|Near vision blur|0|||
16072762|NCT01787760|38759160|FG002|Overall Study|Near vision blur|0|||
16072763|NCT00004124|38759161|FG000|Overall Study|Received no protocol therapy|12|||
16072764|NCT00004124|38759162|FG001|Overall Study|Received no protocol therapy|20|||
16072765|NCT01560949|38759163|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
16072766|NCT01560949|38759163|FG000|Surgery Phase|Physician Decision|3|||
16072767|NCT00517933|38759165|FG000|Period 1|Death|2|||
16072768|NCT00517933|38759166|FG001|Period 1|Death|1|||
16072769|NCT00517933|38759165|FG000|Period 1|Adverse Event|4|||
16072770|NCT00517933|38759166|FG001|Period 1|Adverse Event|4|||
16072771|NCT00517933|38759165|FG000|Period 1|Lost to Follow-up|2|||
16072772|NCT00517933|38759166|FG001|Period 1|Lost to Follow-up|0|||
16072773|NCT00517933|38759165|FG000|Period 1|Underwent lung transplant|0|||
16072774|NCT00517933|38759166|FG001|Period 1|Underwent lung transplant|1|||
16072775|NCT00517933|38759165|FG000|Period 2|Death|2|||
16072776|NCT00517933|38759166|FG001|Period 2|Death|4|||
16072777|NCT00517933|38759165|FG000|Period 2|Adverse Event|2|||
16072778|NCT00517933|38759166|FG001|Period 2|Adverse Event|4|||
16072779|NCT00517933|38759165|FG000|Period 2|Physician Decision|1|||
16072780|NCT00517933|38759166|FG001|Period 2|Physician Decision|0|||
16072781|NCT00517933|38759165|FG000|Period 2|Withdrawal by Subject|1|||
16072782|NCT00517933|38759166|FG001|Period 2|Withdrawal by Subject|3|||
16072783|NCT00517933|38759165|FG000|Period 2|Underwent lung transplant|0|||
16072784|NCT00517933|38759166|FG001|Period 2|Underwent lung transplant|2|||
16072785|NCT00079183|38759167|FG000|Overall Study|Withdrawal by Subject|4|||
16072786|NCT00079183|38759167|FG000|Overall Study|Study medication non-compliance|2|||
16072787|NCT00079183|38759167|FG000|Overall Study|Specimen collection non-compliance|1|||
16072788|NCT03923491|38759168|FG000|Overall Study|Lost to Follow-up|5|||
16072789|NCT03923491|38759169|FG001|Overall Study|Lost to Follow-up|8|||
16072790|NCT03923491|38759168|FG000|Overall Study|Withdrawal by Subject|4|||
16072791|NCT03923491|38759169|FG001|Overall Study|Withdrawal by Subject|6|||
16272354|NCT01695239|39480434|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
16272355|NCT01695239|39480435|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
16272356|NCT01695239|39480436|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
16272357|NCT01695239|39480437|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272358|NCT01695239|39480438|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272359|NCT01695239|39480439|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272360|NCT01695239|39480440|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272361|NCT01695239|39480441|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272362|NCT01695239|39480442|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272363|NCT01695239|39480443|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272364|NCT01695239|39480444|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272365|NCT01695239|39480445|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272366|NCT01695239|39480446|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272367|NCT01695239|39480447|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
16272368|NCT01695239|39480434|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
16272369|NCT01695239|39480435|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272370|NCT01695239|39480436|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
16272371|NCT01695239|39480437|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272372|NCT01695239|39480438|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272373|NCT01695239|39480439|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272374|NCT01695239|39480440|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272375|NCT01695239|39480441|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272376|NCT01695239|39480442|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272377|NCT01695239|39480443|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272378|NCT01695239|39480444|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272379|NCT01695239|39480445|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272380|NCT01695239|39480446|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272381|NCT01695239|39480447|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
16272382|NCT01695239|39480434|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
16272383|NCT01695239|39480435|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272384|NCT01695239|39480436|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
16272385|NCT01695239|39480437|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272386|NCT01695239|39480438|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272387|NCT01695239|39480439|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272388|NCT01695239|39480440|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272389|NCT01695239|39480441|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272390|NCT01695239|39480442|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272391|NCT01695239|39480443|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16469006|NCT00745615|40196407|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
16469007|NCT00745615|40196408|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
16469008|NCT00745615|40196409|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
16469009|NCT00745615|40196410|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
16469010|NCT00745615|40196405|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
16469011|NCT00745615|40196406|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
16469012|NCT00745615|40196407|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
16469013|NCT00745615|40196408|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
16469014|NCT00745615|40196409|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
16469015|NCT00745615|40196410|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
16469016|NCT00745615|40196405|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
16469017|NCT00745615|40196406|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
16469018|NCT00745615|40196407|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
16469019|NCT00745615|40196408|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
16469020|NCT00745615|40196409|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
16469021|NCT00745615|40196410|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
16469022|NCT00745615|40196405|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
16469023|NCT00745615|40196406|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
16469024|NCT00745615|40196407|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
16469025|NCT00745615|40196408|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
16469026|NCT00745615|40196409|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
16469027|NCT00745615|40196410|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
16469028|NCT00745615|40196405|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
16469029|NCT00745615|40196406|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
16469030|NCT00745615|40196407|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
16469031|NCT00745615|40196408|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
16469032|NCT00745615|40196409|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
16469033|NCT00745615|40196410|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
16469034|NCT00745615|40196405|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
16469035|NCT00745615|40196406|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
16469036|NCT00745615|40196407|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
16469037|NCT00745615|40196408|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
16469038|NCT00745615|40196409|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
16469039|NCT00745615|40196410|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
16469040|NCT00745615|40196405|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
16469041|NCT00745615|40196406|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
16469042|NCT00745615|40196407|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
16469043|NCT00745615|40196408|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
16469044|NCT00745615|40196409|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
16469045|NCT00745615|40196410|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
16469046|NCT00745615|40196405|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
16469047|NCT00745615|40196406|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
16469048|NCT00745615|40196407|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
16469049|NCT00745615|40196408|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
16469050|NCT00745615|40196409|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
16469051|NCT00745615|40196410|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
16469052|NCT00745615|40196405|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
16469053|NCT00745615|40196406|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
16469054|NCT00745615|40196407|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
16469055|NCT00745615|40196408|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
16469056|NCT00745615|40196409|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
16469057|NCT00745615|40196410|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
16469058|NCT00745615|40196405|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
16469059|NCT00745615|40196406|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
16469060|NCT00745615|40196407|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
16469061|NCT00745615|40196408|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
16469062|NCT00745615|40196409|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
16469063|NCT00745615|40196410|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
16469064|NCT00745615|40196405|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
16469065|NCT00745615|40196406|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
16469066|NCT00745615|40196407|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
16469067|NCT00745615|40196408|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
16469068|NCT00745615|40196409|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
16469069|NCT00745615|40196410|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
16469070|NCT00604214|40196411|FG000|Baseline to Day 28|Death|223|||
16469071|NCT00604214|40196412|FG001|Baseline to Day 28|Death|202|||
16469072|NCT00604214|40196411|FG000|Baseline to Day 28|Lost to Follow-up|2|||
16469073|NCT00604214|40196412|FG001|Baseline to Day 28|Lost to Follow-up|4|||
16469074|NCT00604214|40196411|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
16469075|NCT00604214|40196412|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
16469076|NCT00604214|40196411|FG000|Day 29 to Day 90|Death|64|||
16469077|NCT00604214|40196412|FG001|Day 29 to Day 90|Death|67|||
16469078|NCT00604214|40196411|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
16469079|NCT00604214|40196412|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
16469080|NCT00604214|40196411|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
16469081|NCT00604214|40196412|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
16469082|NCT00604214|40196411|FG000|Day 91 to Day 180|Death|19|||
16469083|NCT00604214|40196412|FG001|Day 91 to Day 180|Death|23|||
16469084|NCT00604214|40196411|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
16469085|NCT00604214|40196412|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
16469086|NCT00604214|40196411|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
16469087|NCT00604214|40196412|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
16469088|NCT05070546|40196413|FG000|Overall Study|Death|0|||
16469089|NCT05070546|40196414|FG001|Overall Study|Death|0|||
16469090|NCT05070546|40196415|FG002|Overall Study|Death|0|||
16469091|NCT05070546|40196416|FG003|Overall Study|Death|0|||
16469092|NCT05070546|40196417|FG004|Overall Study|Death|0|||
16469093|NCT05070546|40196418|FG005|Overall Study|Death|1|||
16469094|NCT05070546|40196413|FG000|Overall Study|Lost to Follow-up|8|||
16469095|NCT05070546|40196414|FG001|Overall Study|Lost to Follow-up|2|||
16469096|NCT05070546|40196415|FG002|Overall Study|Lost to Follow-up|7|||
16469097|NCT05070546|40196416|FG003|Overall Study|Lost to Follow-up|1|||
16469098|NCT05070546|40196417|FG004|Overall Study|Lost to Follow-up|2|||
16469099|NCT05070546|40196418|FG005|Overall Study|Lost to Follow-up|0|||
16469100|NCT05070546|40196413|FG000|Overall Study|Withdrawal by Subject|1|||
16469101|NCT05070546|40196414|FG001|Overall Study|Withdrawal by Subject|1|||
16272392|NCT01695239|39480444|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272393|NCT01695239|39480445|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272394|NCT01695239|39480446|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272395|NCT01695239|39480447|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
16272396|NCT01695239|39480434|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
16272397|NCT01695239|39480435|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272398|NCT01695239|39480436|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272399|NCT01695239|39480437|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272400|NCT01695239|39480438|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272401|NCT01695239|39480439|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272402|NCT01695239|39480440|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272403|NCT01695239|39480441|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272404|NCT01695239|39480442|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272405|NCT01695239|39480443|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272406|NCT01695239|39480444|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272407|NCT01695239|39480445|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272408|NCT01695239|39480446|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272409|NCT01695239|39480447|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
16272410|NCT01695239|39480434|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272411|NCT01695239|39480435|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272412|NCT01695239|39480436|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272413|NCT01695239|39480437|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272414|NCT01695239|39480438|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272415|NCT01695239|39480439|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272416|NCT01695239|39480440|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272417|NCT01695239|39480441|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
16272418|NCT01695239|39480442|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272419|NCT01695239|39480443|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272420|NCT01695239|39480444|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272421|NCT01695239|39480445|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272422|NCT01695239|39480446|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272423|NCT01695239|39480447|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
16272424|NCT01695239|39480434|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272425|NCT01695239|39480435|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272426|NCT01695239|39480436|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272427|NCT01695239|39480437|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272428|NCT01695239|39480438|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272429|NCT01695239|39480439|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272430|NCT01695239|39480440|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16469102|NCT05070546|40196415|FG002|Overall Study|Withdrawal by Subject|3|||
16469103|NCT05070546|40196416|FG003|Overall Study|Withdrawal by Subject|0|||
16469104|NCT05070546|40196417|FG004|Overall Study|Withdrawal by Subject|0|||
16469105|NCT05070546|40196418|FG005|Overall Study|Withdrawal by Subject|0|||
16469106|NCT05070546|40196413|FG000|Overall Study|Other|0|||
16469107|NCT05070546|40196414|FG001|Overall Study|Other|0|||
16469108|NCT05070546|40196415|FG002|Overall Study|Other|0|||
16469109|NCT05070546|40196416|FG003|Overall Study|Other|0|||
16469110|NCT05070546|40196417|FG004|Overall Study|Other|3|||
16469111|NCT05070546|40196418|FG005|Overall Study|Other|0|||
16469112|NCT05070546|40196413|FG000|Overall Study|Randomized but not vaccinated|1|||
16469113|NCT05070546|40196414|FG001|Overall Study|Randomized but not vaccinated|0|||
16469114|NCT05070546|40196415|FG002|Overall Study|Randomized but not vaccinated|1|||
16469115|NCT05070546|40196416|FG003|Overall Study|Randomized but not vaccinated|1|||
16469116|NCT05070546|40196417|FG004|Overall Study|Randomized but not vaccinated|3|||
16469117|NCT05070546|40196418|FG005|Overall Study|Randomized but not vaccinated|0|||
16469118|NCT00219544|40196419|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
16469119|NCT00219544|40196420|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
16469120|NCT00219544|40196419|FG000|Single Blind Treatment Period|Adverse Event|9|||
16469121|NCT00219544|40196420|FG001|Single Blind Treatment Period|Adverse Event|0|||
16469122|NCT00219544|40196419|FG000|Single Blind Treatment Period|Protocol Violation|4|||
16469123|NCT00219544|40196420|FG001|Single Blind Treatment Period|Protocol Violation|0|||
16469124|NCT00219544|40196419|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
16469125|NCT00219544|40196420|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
16469126|NCT00219544|40196419|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
16469127|NCT00219544|40196420|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
16469128|NCT00219544|40196419|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
16469129|NCT00219544|40196420|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
16469130|NCT02376829|40196421|FG000|Overall Study|Withdrawal by Subject|27|||
16469131|NCT02376829|40196422|FG001|Overall Study|Withdrawal by Subject|44|||
16469132|NCT02581943|40196425|FG000|Overall Study|Death|5|||
16469133|NCT02581943|40196426|FG001|Overall Study|Death|2|||
16469134|NCT02581943|40196425|FG000|Overall Study|Disease Progression|12|||
16469135|NCT02581943|40196426|FG001|Overall Study|Disease Progression|15|||
16469136|NCT02581943|40196425|FG000|Overall Study|Withdrawal by Subject|1|||
16469137|NCT02581943|40196426|FG001|Overall Study|Withdrawal by Subject|2|||
16469138|NCT02862600|40196427|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
16469139|NCT02862600|40196427|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
16469140|NCT02862600|40196427|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
16469141|NCT02862600|40196427|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
16469142|NCT00999921|40196428|FG000|Overall Study|Lost to Follow-up|10|||
16469143|NCT00999921|40196429|FG001|Overall Study|Lost to Follow-up|19|||
16469144|NCT01758289|40196430|FG000|Overall Study|Premature Study Termination|44|||
16469145|NCT01758289|40196430|FG000|Overall Study|Adverse Event|9|||
16469146|NCT02119676|40196434|FG000|Overall Study|Adverse Event|9|||
16469147|NCT02119676|40196435|FG001|Overall Study|Adverse Event|17|||
16469148|NCT02119676|40196436|FG002|Overall Study|Adverse Event|10|||
16469149|NCT02119676|40196437|FG003|Overall Study|Adverse Event|10|||
16469150|NCT02119676|40196434|FG000|Overall Study|Disease progression|53|||
16469151|NCT02119676|40196435|FG001|Overall Study|Disease progression|55|||
16469152|NCT02119676|40196436|FG002|Overall Study|Disease progression|68|||
16469153|NCT02119676|40196437|FG003|Overall Study|Disease progression|73|||
16469154|NCT02119676|40196434|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
16469155|NCT02119676|40196435|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
16469156|NCT02119676|40196436|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
16469157|NCT02119676|40196437|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
16469158|NCT02119676|40196434|FG000|Overall Study|Physician Decision|4|||
16469159|NCT02119676|40196435|FG001|Overall Study|Physician Decision|2|||
16469160|NCT02119676|40196436|FG002|Overall Study|Physician Decision|3|||
16469161|NCT02119676|40196437|FG003|Overall Study|Physician Decision|2|||
16469162|NCT02119676|40196434|FG000|Overall Study|Death|9|||
16469163|NCT02119676|40196435|FG001|Overall Study|Death|3|||
16469164|NCT02119676|40196436|FG002|Overall Study|Death|2|||
16469165|NCT02119676|40196437|FG003|Overall Study|Death|1|||
16469166|NCT02119676|40196434|FG000|Overall Study|Noncompliance|0|||
16469167|NCT02119676|40196435|FG001|Overall Study|Noncompliance|1|||
16469168|NCT02119676|40196436|FG002|Overall Study|Noncompliance|0|||
16469169|NCT02119676|40196437|FG003|Overall Study|Noncompliance|0|||
16469170|NCT02119676|40196434|FG000|Overall Study|Lost to Follow-up|0|||
16469171|NCT02119676|40196435|FG001|Overall Study|Lost to Follow-up|0|||
16469172|NCT02119676|40196436|FG002|Overall Study|Lost to Follow-up|1|||
16469173|NCT02119676|40196437|FG003|Overall Study|Lost to Follow-up|0|||
16469174|NCT02119676|40196434|FG000|Overall Study|Protocol deviation|0|||
16469175|NCT02119676|40196435|FG001|Overall Study|Protocol deviation|0|||
16469176|NCT02119676|40196436|FG002|Overall Study|Protocol deviation|1|||
16469177|NCT02119676|40196437|FG003|Overall Study|Protocol deviation|0|||
16469178|NCT02119676|40196434|FG000|Overall Study|Other, unspecified|2|||
16469179|NCT02119676|40196435|FG001|Overall Study|Other, unspecified|1|||
16469180|NCT02119676|40196436|FG002|Overall Study|Other, unspecified|3|||
16469181|NCT02119676|40196437|FG003|Overall Study|Other, unspecified|4|||
16469182|NCT02119676|40196434|FG000|Overall Study|Did not receive study med|2|||
16469183|NCT02119676|40196435|FG001|Overall Study|Did not receive study med|2|||
16469184|NCT02119676|40196436|FG002|Overall Study|Did not receive study med|4|||
16469185|NCT02119676|40196437|FG003|Overall Study|Did not receive study med|5|||
16469186|NCT03945175|40196440|FG000|Overall Study|Did not meet inclusion criteria|31|||
16469187|NCT03945175|40196440|FG000|Overall Study|Withdrew consent|2|||
16469188|NCT03945175|40196440|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
16469189|NCT03945175|40196440|FG000|Overall Study|Early termination during Mydayis treatment|1|||
16469190|NCT02718300|40196441|FG000|Overall Study|Death|4|||
16469191|NCT02718300|40196442|FG001|Overall Study|Death|5|||
16469192|NCT02718300|40196443|FG002|Overall Study|Death|17|||
16469193|NCT02718300|40196441|FG000|Overall Study|Lost to Follow-up|1|||
16469194|NCT02718300|40196442|FG001|Overall Study|Lost to Follow-up|0|||
16469195|NCT02718300|40196443|FG002|Overall Study|Lost to Follow-up|2|||
16469196|NCT02718300|40196441|FG000|Overall Study|Physician Decision|1|||
16469197|NCT02718300|40196442|FG001|Overall Study|Physician Decision|0|||
16469198|NCT02718300|40196443|FG002|Overall Study|Physician Decision|2|||
16469199|NCT02718300|40196441|FG000|Overall Study|Study Terminated by Sponsor|6|||
16469200|NCT02718300|40196442|FG001|Overall Study|Study Terminated by Sponsor|3|||
16469201|NCT02718300|40196443|FG002|Overall Study|Study Terminated by Sponsor|4|||
16469202|NCT02718300|40196441|FG000|Overall Study|Withdrawal by Subject|0|||
16469203|NCT02718300|40196442|FG001|Overall Study|Withdrawal by Subject|4|||
16469204|NCT02718300|40196443|FG002|Overall Study|Withdrawal by Subject|3|||
16469205|NCT02718300|40196441|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
16469206|NCT02718300|40196442|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
16469207|NCT02718300|40196443|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
16469208|NCT00636987|40196446|FG000|Overall Study|Death|44|||
16469209|NCT00636987|40196446|FG000|Overall Study|Explanted|13|||
16469210|NCT00636987|40196446|FG000|Overall Study|Lost to Follow-up|63|||
16469211|NCT00636987|40196446|FG000|Overall Study|5 year visit window not complete|69|||
16469212|NCT01251146|40196447|FG000|Overall Study|Lost to Follow-up|3|||
16469213|NCT01251146|40196448|FG001|Overall Study|Lost to Follow-up|10|||
16469214|NCT01925989|40196449|FG000|Period 1|Sponsor Decision|1|||
16469215|NCT01925989|40196450|FG001|Period 1|Sponsor Decision|1|||
16469216|NCT01925989|40196451|FG002|Period 1|Sponsor Decision|0|||
16469217|NCT01925989|40196449|FG000|Period 1|Withdrawal by Subject|0|||
16469218|NCT01925989|40196450|FG001|Period 1|Withdrawal by Subject|1|||
16469219|NCT01925989|40196451|FG002|Period 1|Withdrawal by Subject|0|||
16469220|NCT02898116|40196452|FG000|Overall Study|Adverse Event|1|||
16469221|NCT02898116|40196452|FG000|Overall Study|Progressive disease|1|||
16469222|NCT04352127|40196453|FG000|Overall Study|Unable to obtain readings|4|||
16469223|NCT04352127|40196454|FG001|Overall Study|Unable to obtain readings|1|||
16469224|NCT01725308|40196455|FG000|Treatment Period I|Did Not Receive Drug|1|||
16469225|NCT01725308|40196456|FG001|Treatment Period I|Did Not Receive Drug|0|||
16469226|NCT01725308|40196457|FG002|Treatment Period I|Did Not Receive Drug|0|||
16469227|NCT01725308|40196455|FG000|Treatment Period I|Adverse Event|5|||
16469228|NCT01725308|40196456|FG001|Treatment Period I|Adverse Event|4|||
16469229|NCT01725308|40196457|FG002|Treatment Period I|Adverse Event|21|||
16469230|NCT01725308|40196455|FG000|Treatment Period I|Insufficient Response|7|||
16469231|NCT01725308|40196456|FG001|Treatment Period I|Insufficient Response|0|||
16469232|NCT01725308|40196457|FG002|Treatment Period I|Insufficient Response|5|||
16469233|NCT01725308|40196455|FG000|Treatment Period I|Worsening of the Target Disease|8|||
16469234|NCT01725308|40196456|FG001|Treatment Period I|Worsening of the Target Disease|0|||
16469235|NCT01725308|40196457|FG002|Treatment Period I|Worsening of the Target Disease|2|||
16469236|NCT01725308|40196455|FG000|Treatment Period I|Changes in the Episodes|3|||
16469237|NCT01725308|40196456|FG001|Treatment Period I|Changes in the Episodes|0|||
16469238|NCT01725308|40196457|FG002|Treatment Period I|Changes in the Episodes|2|||
16469239|NCT01725308|40196455|FG000|Treatment Period I|Withdrawal of Consent|12|||
16469240|NCT01725308|40196456|FG001|Treatment Period I|Withdrawal of Consent|7|||
16469241|NCT01725308|40196457|FG002|Treatment Period I|Withdrawal of Consent|5|||
16469242|NCT01725308|40196455|FG000|Treatment Period I|Lost to Follow-up|3|||
16469243|NCT01725308|40196456|FG001|Treatment Period I|Lost to Follow-up|2|||
16469244|NCT01725308|40196457|FG002|Treatment Period I|Lost to Follow-up|2|||
16469245|NCT01725308|40196455|FG000|Treatment Period I|Protocol Deviations|3|||
16469246|NCT01725308|40196456|FG001|Treatment Period I|Protocol Deviations|1|||
16469247|NCT01725308|40196457|FG002|Treatment Period I|Protocol Deviations|1|||
16469248|NCT01725308|40196455|FG000|Treatment Period I|Miscellaneous|2|||
16469249|NCT01725308|40196456|FG001|Treatment Period I|Miscellaneous|0|||
16469250|NCT01725308|40196457|FG002|Treatment Period I|Miscellaneous|3|||
16469251|NCT01725308|40196455|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
16469252|NCT01725308|40196456|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
16469253|NCT01725308|40196457|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
16469254|NCT01725308|40196455|FG000|Treatment Period II|Did Not Receive Drug|4|||
16469255|NCT01725308|40196456|FG001|Treatment Period II|Did Not Receive Drug|0|||
16469256|NCT01725308|40196457|FG002|Treatment Period II|Did Not Receive Drug|0|||
16469257|NCT01725308|40196455|FG000|Treatment Period II|Adverse Event|13|||
16469258|NCT01725308|40196456|FG001|Treatment Period II|Adverse Event|8|||
16469259|NCT01725308|40196457|FG002|Treatment Period II|Adverse Event|20|||
16469260|NCT01725308|40196455|FG000|Treatment Period II|Insufficient Response|2|||
16469261|NCT01725308|40196456|FG001|Treatment Period II|Insufficient Response|4|||
16469262|NCT01725308|40196457|FG002|Treatment Period II|Insufficient Response|6|||
16469263|NCT01725308|40196455|FG000|Treatment Period II|Worsening of the Target Disease|1|||
16469264|NCT01725308|40196456|FG001|Treatment Period II|Worsening of the Target Disease|4|||
16469265|NCT01725308|40196457|FG002|Treatment Period II|Worsening of the Target Disease|2|||
16469266|NCT01725308|40196455|FG000|Treatment Period II|Changes in the Episodes|1|||
16469267|NCT01725308|40196456|FG001|Treatment Period II|Changes in the Episodes|0|||
16469268|NCT01725308|40196457|FG002|Treatment Period II|Changes in the Episodes|5|||
16469269|NCT01725308|40196455|FG000|Treatment Period II|Withdrawal of Consent|28|||
16469270|NCT01725308|40196456|FG001|Treatment Period II|Withdrawal of Consent|2|||
16469271|NCT01725308|40196457|FG002|Treatment Period II|Withdrawal of Consent|16|||
16469272|NCT01725308|40196455|FG000|Treatment Period II|Lost to Follow-up|1|||
16469273|NCT01725308|40196456|FG001|Treatment Period II|Lost to Follow-up|5|||
16469274|NCT01725308|40196457|FG002|Treatment Period II|Lost to Follow-up|3|||
16469275|NCT01725308|40196455|FG000|Treatment Period II|Protocol Deviations|0|||
16469276|NCT01725308|40196456|FG001|Treatment Period II|Protocol Deviations|0|||
16469277|NCT01725308|40196457|FG002|Treatment Period II|Protocol Deviations|1|||
16469278|NCT01725308|40196455|FG000|Treatment Period II|Miscellaneous|5|||
16469279|NCT01725308|40196456|FG001|Treatment Period II|Miscellaneous|3|||
16469280|NCT01725308|40196457|FG002|Treatment Period II|Miscellaneous|7|||
16469281|NCT01484938|40196458|FG000|Overall Study|Adverse Event|2|||
16469282|NCT01484938|40196458|FG000|Overall Study|Lost to Follow-up|1|||
16469283|NCT01484938|40196458|FG000|Overall Study|Noncompliance|1|||
16469284|NCT02716896|40196459|FG000|Overall Study|Physician Decision|0|||
16469285|NCT02716896|40196460|FG001|Overall Study|Physician Decision|1|||
16469286|NCT00989573|40196462|FG000|Overall Study|Adverse Event|8|||
16469287|NCT00989573|40196463|FG001|Overall Study|Adverse Event|12|||
16469288|NCT00989573|40196464|FG002|Overall Study|Adverse Event|4|||
16469289|NCT00989573|40196462|FG000|Overall Study|Physician Decision|0|||
16469290|NCT00989573|40196463|FG001|Overall Study|Physician Decision|2|||
16469291|NCT00989573|40196464|FG002|Overall Study|Physician Decision|0|||
16469292|NCT00989573|40196462|FG000|Overall Study|Protocol Violation|1|||
16469293|NCT00989573|40196463|FG001|Overall Study|Protocol Violation|1|||
16469294|NCT00989573|40196464|FG002|Overall Study|Protocol Violation|1|||
16469295|NCT00989573|40196462|FG000|Overall Study|Withdrawal by Subject|4|||
16469296|NCT00989573|40196463|FG001|Overall Study|Withdrawal by Subject|7|||
16469297|NCT00989573|40196464|FG002|Overall Study|Withdrawal by Subject|3|||
16469298|NCT01056380|40196465|FG000|Overall Study|Lost to Follow-up|2|||
16469299|NCT01056380|40196466|FG001|Overall Study|Lost to Follow-up|3|||
16469300|NCT02359851|40196467|FG000|Overall Study|Death|1|||
16469301|NCT02359851|40196467|FG000|Overall Study|Disease progression|1|||
16469302|NCT01268683|40196468|FG000|Overall Study|Lost to Follow-up|1|||
16469303|NCT01268683|40196468|FG000|Overall Study|Death|1|||
16469304|NCT00367770|40196469|FG000|Overall Study|Adverse Event|1|||
16469305|NCT00367770|40196469|FG000|Overall Study|Withdrawal by Subject|1|||
16469306|NCT02605837|40196470|FG000|Overall Study|Adverse Event|3|||
16469307|NCT02605837|40196471|FG001|Overall Study|Adverse Event|1|||
16469308|NCT02605837|40196470|FG000|Overall Study|Non-Compliance with Study Drug|0|||
16469309|NCT02605837|40196471|FG001|Overall Study|Non-Compliance with Study Drug|1|||
16469310|NCT02605837|40196470|FG000|Overall Study|Withdrawal by Subject|8|||
16469311|NCT02605837|40196471|FG001|Overall Study|Withdrawal by Subject|8|||
16469312|NCT02605837|40196470|FG000|Overall Study|Physician Decision|0|||
16469313|NCT02605837|40196471|FG001|Overall Study|Physician Decision|1|||
16469314|NCT04085367|40196482|FG000|Overall Study|Adverse Event|1|||
16469315|NCT04085367|40196483|FG001|Overall Study|Adverse Event|1|||
16469316|NCT04085367|40196482|FG000|Overall Study|Withdrawal by Subject|13|||
16469317|NCT04085367|40196483|FG001|Overall Study|Withdrawal by Subject|4|||
16469318|NCT04085367|40196482|FG000|Overall Study|Lost to Follow-up|3|||
16469319|NCT04085367|40196483|FG001|Overall Study|Lost to Follow-up|1|||
16469320|NCT04085367|40196482|FG000|Overall Study|Other unspecified|2|||
16469321|NCT04085367|40196483|FG001|Overall Study|Other unspecified|1|||
16469322|NCT04085367|40196482|FG000|Overall Study|Status Unknown|1|||
16469323|NCT04085367|40196483|FG001|Overall Study|Status Unknown|1|||
16469324|NCT00938964|40196484|FG000|Overall Study|Death|3|||
16469325|NCT00938964|40196485|FG001|Overall Study|Death|3|||
16469326|NCT00938964|40196484|FG000|Overall Study|Lost to Follow-up|2|||
16469327|NCT00938964|40196485|FG001|Overall Study|Lost to Follow-up|3|||
16469328|NCT00938964|40196484|FG000|Overall Study|Withdrawal by Subject|22|||
16469329|NCT00938964|40196485|FG001|Overall Study|Withdrawal by Subject|18|||
16469330|NCT00938964|40196484|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
16469331|NCT00938964|40196485|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
16469332|NCT04054947|40196488|FG000|Overall Study|Withdrawal by Subject|1|||
16469333|NCT04054947|40196489|FG001|Overall Study|Withdrawal by Subject|0|||
16469334|NCT04054947|40196488|FG000|Overall Study|Lost to Follow-up|2|||
16469335|NCT04054947|40196489|FG001|Overall Study|Lost to Follow-up|5|||
16469336|NCT01736657|40196492|FG000|Overall Study|insufficient vascular access|1|||
16469337|NCT00570232|40196496|FG000|Overall Study|Adverse Event|10|||
16469338|NCT00570232|40196496|FG000|Overall Study|discontinued due to medical condition|3|||
16469339|NCT00570232|40196496|FG000|Overall Study|discontinued due to recurrence|8|||
16469340|NCT00570232|40196496|FG000|Overall Study|discontinued due to noncompliance|2|||
16469341|NCT00321893|40196497|FG000|Overall Study|Non-Compliance/Refusal|16|||
16469342|NCT00321893|40196498|FG001|Overall Study|Non-Compliance/Refusal|10|||
16469343|NCT00321893|40196497|FG000|Overall Study|Lost to Follow-up|2|||
16469344|NCT00321893|40196498|FG001|Overall Study|Lost to Follow-up|1|||
16469345|NCT00321893|40196497|FG000|Overall Study|Adverse Event|6|||
16469346|NCT00321893|40196498|FG001|Overall Study|Adverse Event|3|||
16469347|NCT00976508|40196499|FG000|Overall Study|Death|7|||
16469348|NCT00976508|40196500|FG001|Overall Study|Death|1|||
16469349|NCT00976508|40196499|FG000|Overall Study|Lost to Follow-up|1|||
16469350|NCT00976508|40196500|FG001|Overall Study|Lost to Follow-up|0|||
16469351|NCT00976508|40196499|FG000|Overall Study|Withdrawal by Subject|1|||
16469352|NCT00976508|40196500|FG001|Overall Study|Withdrawal by Subject|0|||
16469353|NCT00976508|40196499|FG000|Overall Study|Disease Progression|4|||
16469354|NCT00976508|40196500|FG001|Overall Study|Disease Progression|4|||
16469355|NCT00976508|40196499|FG000|Overall Study|Subject Enrolled in Hospice|1|||
16469356|NCT00976508|40196500|FG001|Overall Study|Subject Enrolled in Hospice|0|||
16469357|NCT00976508|40196499|FG000|Overall Study|Terminated by the Sponsor|0|||
16469358|NCT00976508|40196500|FG001|Overall Study|Terminated by the Sponsor|1|||
16469359|NCT00134784|40196501|FG000|Overall Study|Withdrawal by Subject|2|||
16469360|NCT00134784|40196502|FG001|Overall Study|Withdrawal by Subject|2|||
16469361|NCT00134784|40196503|FG002|Overall Study|Withdrawal by Subject|2|||
16469362|NCT00134784|40196504|FG003|Overall Study|Withdrawal by Subject|1|||
16469363|NCT03170232|40196506|FG000|Overall Study|Adverse Event|0|||
16469364|NCT03170232|40196507|FG001|Overall Study|Adverse Event|1|||
16469365|NCT03170232|40196506|FG000|Overall Study|Protocol Violation|0|||
16469366|NCT03170232|40196507|FG001|Overall Study|Protocol Violation|1|||
16469367|NCT03170232|40196506|FG000|Overall Study|Lack of Efficacy|0|||
16469368|NCT03170232|40196507|FG001|Overall Study|Lack of Efficacy|1|||
16469369|NCT03170232|40196506|FG000|Overall Study|Study closed/terminated|26|||
16469370|NCT03170232|40196507|FG001|Overall Study|Study closed/terminated|23|||
16469371|NCT03170232|40196506|FG000|Overall Study|Lost to Follow-up|1|||
16469372|NCT03170232|40196507|FG001|Overall Study|Lost to Follow-up|0|||
16469373|NCT03170232|40196506|FG000|Overall Study|Withdrawal by Subject|0|||
16469374|NCT03170232|40196507|FG001|Overall Study|Withdrawal by Subject|1|||
16469375|NCT01227564|40196508|FG000|Overall Study|No Longer Willing to Participate|4|||
16469376|NCT01227564|40196509|FG001|Overall Study|No Longer Willing to Participate|2|||
16469377|NCT01227564|40196510|FG002|Overall Study|No Longer Willing to Participate|5|||
16469378|NCT01227564|40196508|FG000|Overall Study|Participant moved to another town|0|||
16469379|NCT01227564|40196509|FG001|Overall Study|Participant moved to another town|0|||
16469380|NCT01227564|40196510|FG002|Overall Study|Participant moved to another town|1|||
16469381|NCT03726996|40196512|FG000|Overall Study|Parent's decision|2|||
16469382|NCT03726996|40196512|FG000|Overall Study|Study early termination|2|||
16469383|NCT02054481|40196515|FG000|Overall Study|Adverse Event|1|||
16469384|NCT02054481|40196516|FG001|Overall Study|Adverse Event|1|||
16469385|NCT02054481|40196517|FG002|Overall Study|Adverse Event|0|||
16469386|NCT02054481|40196518|FG003|Overall Study|Adverse Event|1|||
16469387|NCT02054481|40196515|FG000|Overall Study|Lost to Follow-up|1|||
16469388|NCT02054481|40196516|FG001|Overall Study|Lost to Follow-up|0|||
16469389|NCT02054481|40196517|FG002|Overall Study|Lost to Follow-up|0|||
16469390|NCT02054481|40196518|FG003|Overall Study|Lost to Follow-up|0|||
16469391|NCT02054481|40196515|FG000|Overall Study|Other reason|2|||
16469392|NCT02054481|40196516|FG001|Overall Study|Other reason|1|||
16469393|NCT02054481|40196517|FG002|Overall Study|Other reason|2|||
16469394|NCT02054481|40196518|FG003|Overall Study|Other reason|0|||
16469395|NCT00466687|40196519|FG000|Overall Study|Adverse Event|1|||
16469396|NCT00466687|40196519|FG000|Overall Study|Other complicating illness|3|||
16469397|NCT00466687|40196519|FG000|Overall Study|Withdrawal by Subject|1|||
16469398|NCT00466687|40196519|FG000|Overall Study|Disease progression|29|||
16469399|NCT04461600|40196520|FG000|Overall Study|Death|6|||
16469400|NCT04461600|40196521|FG001|Overall Study|Death|5|||
16469401|NCT04461600|40196520|FG000|Overall Study|Withdrawal by Subject|0|||
16469402|NCT04461600|40196521|FG001|Overall Study|Withdrawal by Subject|1|||
16469403|NCT04050371|40196524|FG000|Overall Study|Withdrawal by Subject|1|||
16469404|NCT04050371|40196525|FG001|Overall Study|Withdrawal by Subject|0|||
16469405|NCT01489111|40196526|FG000|Overall Study|Withdrawal criterion|1|||
16469406|NCT02711345|40196536|FG000|Overall Study|Adverse Event|0|||
16469407|NCT02711345|40196537|FG001|Overall Study|Adverse Event|0|||
16469408|NCT02711345|40196538|FG002|Overall Study|Adverse Event|0|||
16469409|NCT02711345|40196539|FG003|Overall Study|Adverse Event|1|||
16469410|NCT02711345|40196540|FG004|Overall Study|Adverse Event|1|||
16469411|NCT02711345|40196541|FG005|Overall Study|Adverse Event|2|||
16469412|NCT02711345|40196542|FG006|Overall Study|Adverse Event|1|||
16469413|NCT02711345|40196543|FG007|Overall Study|Adverse Event|0|||
16469414|NCT02711345|40196544|FG008|Overall Study|Adverse Event|0|||
16469415|NCT02711345|40196545|FG009|Overall Study|Adverse Event|2|||
16469416|NCT02711345|40196536|FG000|Overall Study|Physician Decision|0|||
16469417|NCT02711345|40196537|FG001|Overall Study|Physician Decision|0|||
16469418|NCT02711345|40196538|FG002|Overall Study|Physician Decision|1|||
16469419|NCT02711345|40196539|FG003|Overall Study|Physician Decision|0|||
16469420|NCT02711345|40196540|FG004|Overall Study|Physician Decision|0|||
16469421|NCT02711345|40196541|FG005|Overall Study|Physician Decision|0|||
16469422|NCT02711345|40196542|FG006|Overall Study|Physician Decision|0|||
16469423|NCT02711345|40196543|FG007|Overall Study|Physician Decision|0|||
16469424|NCT02711345|40196544|FG008|Overall Study|Physician Decision|1|||
16469425|NCT02711345|40196545|FG009|Overall Study|Physician Decision|0|||
16469426|NCT02711345|40196536|FG000|Overall Study|Progressive disease|1|||
16469427|NCT02711345|40196537|FG001|Overall Study|Progressive disease|3|||
16469428|NCT02711345|40196538|FG002|Overall Study|Progressive disease|5|||
16469429|NCT02711345|40196539|FG003|Overall Study|Progressive disease|3|||
16469430|NCT02711345|40196540|FG004|Overall Study|Progressive disease|7|||
16469431|NCT02711345|40196541|FG005|Overall Study|Progressive disease|2|||
16469432|NCT02711345|40196542|FG006|Overall Study|Progressive disease|8|||
16469433|NCT02711345|40196543|FG007|Overall Study|Progressive disease|4|||
16469434|NCT02711345|40196544|FG008|Overall Study|Progressive disease|5|||
16469435|NCT02711345|40196545|FG009|Overall Study|Progressive disease|6|||
16469436|NCT02711345|40196536|FG000|Overall Study|Subject/guardian decision|0|||
16469437|NCT02711345|40196537|FG001|Overall Study|Subject/guardian decision|0|||
16469438|NCT02711345|40196538|FG002|Overall Study|Subject/guardian decision|0|||
16469439|NCT02711345|40196539|FG003|Overall Study|Subject/guardian decision|0|||
16469440|NCT02711345|40196540|FG004|Overall Study|Subject/guardian decision|0|||
16469441|NCT02711345|40196541|FG005|Overall Study|Subject/guardian decision|2|||
16469442|NCT02711345|40196542|FG006|Overall Study|Subject/guardian decision|3|||
16469443|NCT02711345|40196543|FG007|Overall Study|Subject/guardian decision|1|||
16469444|NCT02711345|40196544|FG008|Overall Study|Subject/guardian decision|0|||
16469445|NCT02711345|40196545|FG009|Overall Study|Subject/guardian decision|4|||
16469446|NCT02711345|40196536|FG000|Overall Study|Death|1|||
16469447|NCT02711345|40196537|FG001|Overall Study|Death|0|||
16469448|NCT02711345|40196538|FG002|Overall Study|Death|0|||
16469449|NCT02711345|40196539|FG003|Overall Study|Death|0|||
16469450|NCT02711345|40196540|FG004|Overall Study|Death|0|||
16469451|NCT02711345|40196541|FG005|Overall Study|Death|0|||
16469452|NCT02711345|40196542|FG006|Overall Study|Death|0|||
16469453|NCT02711345|40196543|FG007|Overall Study|Death|1|||
16469454|NCT02711345|40196544|FG008|Overall Study|Death|0|||
16469455|NCT02711345|40196545|FG009|Overall Study|Death|0|||
16469456|NCT01347580|40196546|FG000|Overall Study|Withdrawal by Subject|13|||
16469457|NCT01347580|40196547|FG001|Overall Study|Withdrawal by Subject|23|||
16469458|NCT01347580|40196546|FG000|Overall Study|Death|30|||
16469459|NCT01347580|40196547|FG001|Overall Study|Death|19|||
16469460|NCT01347580|40196546|FG000|Overall Study|Protocol Violation|10|||
16469461|NCT01347580|40196547|FG001|Overall Study|Protocol Violation|7|||
16469462|NCT01347580|40196546|FG000|Overall Study|Lost to Follow-up|3|||
16469463|NCT01347580|40196547|FG001|Overall Study|Lost to Follow-up|1|||
16469464|NCT01347580|40196546|FG000|Overall Study|Had other reason|9|||
16469465|NCT01347580|40196547|FG001|Overall Study|Had other reason|6|||
16469466|NCT01992159|40196550|FG000|Overall Study|Withdrawal by Subject|4|||
16469467|NCT01992159|40196551|FG001|Overall Study|Withdrawal by Subject|7|||
16469468|NCT01992159|40196552|FG002|Overall Study|Withdrawal by Subject|0|||
16469469|NCT01992159|40196553|FG003|Overall Study|Withdrawal by Subject|3|||
16469470|NCT01992159|40196550|FG000|Overall Study|Adverse Event|0|||
16469471|NCT01992159|40196551|FG001|Overall Study|Adverse Event|1|||
16469472|NCT01992159|40196552|FG002|Overall Study|Adverse Event|0|||
16469473|NCT01992159|40196553|FG003|Overall Study|Adverse Event|1|||
16469474|NCT01992159|40196550|FG000|Overall Study|Death|0|||
16469475|NCT01992159|40196551|FG001|Overall Study|Death|0|||
16469476|NCT01992159|40196552|FG002|Overall Study|Death|1|||
16469477|NCT01992159|40196553|FG003|Overall Study|Death|0|||
16469478|NCT01606878|40196555|FG000|Overall Study|Adverse Event|1|||
16469479|NCT01606878|40196556|FG001|Overall Study|Adverse Event|1|||
16469480|NCT01606878|40196557|FG002|Overall Study|Adverse Event|0|||
16469481|NCT01606878|40196558|FG003|Overall Study|Adverse Event|0|||
16469482|NCT01606878|40196559|FG004|Overall Study|Adverse Event|0|||
16469483|NCT01606878|40196560|FG005|Overall Study|Adverse Event|0|||
16469484|NCT01606878|40196561|FG006|Overall Study|Adverse Event|1|||
16469485|NCT01606878|40196562|FG007|Overall Study|Adverse Event|0|||
16469486|NCT01606878|40196563|FG008|Overall Study|Adverse Event|1|||
16469487|NCT01606878|40196564|FG009|Overall Study|Adverse Event|3|||
16469488|NCT01606878|40196565|FG010|Overall Study|Adverse Event|0|||
16469489|NCT01606878|40196555|FG000|Overall Study|Lack of Efficacy|1|||
16469490|NCT01606878|40196556|FG001|Overall Study|Lack of Efficacy|1|||
16469491|NCT01606878|40196557|FG002|Overall Study|Lack of Efficacy|1|||
16469492|NCT01606878|40196558|FG003|Overall Study|Lack of Efficacy|2|||
16469493|NCT01606878|40196559|FG004|Overall Study|Lack of Efficacy|1|||
16469494|NCT01606878|40196560|FG005|Overall Study|Lack of Efficacy|2|||
16469495|NCT01606878|40196561|FG006|Overall Study|Lack of Efficacy|1|||
16469496|NCT01606878|40196562|FG007|Overall Study|Lack of Efficacy|2|||
16469497|NCT01606878|40196563|FG008|Overall Study|Lack of Efficacy|2|||
16469498|NCT01606878|40196564|FG009|Overall Study|Lack of Efficacy|0|||
16469499|NCT01606878|40196565|FG010|Overall Study|Lack of Efficacy|1|||
16469500|NCT01606878|40196555|FG000|Overall Study|Physician Decision|1|||
16469501|NCT01606878|40196556|FG001|Overall Study|Physician Decision|0|||
16469502|NCT01606878|40196557|FG002|Overall Study|Physician Decision|2|||
16469503|NCT01606878|40196558|FG003|Overall Study|Physician Decision|1|||
16469504|NCT01606878|40196559|FG004|Overall Study|Physician Decision|1|||
16469505|NCT01606878|40196560|FG005|Overall Study|Physician Decision|1|||
16469506|NCT01606878|40196561|FG006|Overall Study|Physician Decision|2|||
16469507|NCT01606878|40196562|FG007|Overall Study|Physician Decision|0|||
16469508|NCT01606878|40196563|FG008|Overall Study|Physician Decision|1|||
16469509|NCT01606878|40196564|FG009|Overall Study|Physician Decision|0|||
16469510|NCT01606878|40196565|FG010|Overall Study|Physician Decision|0|||
16469511|NCT01606878|40196555|FG000|Overall Study|Withdrawal by Subject|3|||
16469512|NCT01606878|40196556|FG001|Overall Study|Withdrawal by Subject|2|||
16469513|NCT01606878|40196557|FG002|Overall Study|Withdrawal by Subject|2|||
16469514|NCT01606878|40196558|FG003|Overall Study|Withdrawal by Subject|0|||
16469515|NCT01606878|40196559|FG004|Overall Study|Withdrawal by Subject|1|||
16469516|NCT01606878|40196560|FG005|Overall Study|Withdrawal by Subject|1|||
16469517|NCT01606878|40196561|FG006|Overall Study|Withdrawal by Subject|2|||
16469518|NCT01606878|40196562|FG007|Overall Study|Withdrawal by Subject|1|||
16469519|NCT01606878|40196563|FG008|Overall Study|Withdrawal by Subject|2|||
16469520|NCT01606878|40196564|FG009|Overall Study|Withdrawal by Subject|0|||
16469521|NCT01606878|40196565|FG010|Overall Study|Withdrawal by Subject|2|||
16469522|NCT03505710|40196567|FG000|Overall Study|Progressive Disease|22|||
16469523|NCT03505710|40196568|FG001|Overall Study|Progressive Disease|9|||
16469524|NCT03505710|40196569|FG002|Overall Study|Progressive Disease|34|||
16469525|NCT03505710|40196567|FG000|Overall Study|Clinical Progression|6|||
16469526|NCT03505710|40196568|FG001|Overall Study|Clinical Progression|6|||
16469527|NCT03505710|40196569|FG002|Overall Study|Clinical Progression|3|||
16469528|NCT03505710|40196567|FG000|Overall Study|Adverse Event|12|||
16469529|NCT03505710|40196568|FG001|Overall Study|Adverse Event|5|||
16469530|NCT03505710|40196569|FG002|Overall Study|Adverse Event|27|||
16469531|NCT03505710|40196567|FG000|Overall Study|Withdrawal by Subject|1|||
16469532|NCT03505710|40196568|FG001|Overall Study|Withdrawal by Subject|3|||
16469533|NCT03505710|40196569|FG002|Overall Study|Withdrawal by Subject|3|||
16469534|NCT03505710|40196567|FG000|Overall Study|Physician Decision|1|||
16469535|NCT03505710|40196568|FG001|Overall Study|Physician Decision|0|||
16469536|NCT03505710|40196569|FG002|Overall Study|Physician Decision|2|||
16469537|NCT03505710|40196567|FG000|Overall Study|Death|4|||
16469538|NCT03505710|40196568|FG001|Overall Study|Death|3|||
16469539|NCT03505710|40196569|FG002|Overall Study|Death|6|||
16469540|NCT03505710|40196567|FG000|Overall Study|Other Reasons|1|||
16469541|NCT03505710|40196568|FG001|Overall Study|Other Reasons|1|||
16469542|NCT03505710|40196569|FG002|Overall Study|Other Reasons|1|||
16469543|NCT03213691|40196570|FG000|Overall Study|Adverse Event|2|||
16469544|NCT03213691|40196570|FG000|Overall Study|Death|3|||
16469545|NCT03213691|40196570|FG000|Overall Study|Physician Decision|1|||
16469546|NCT03213691|40196570|FG000|Overall Study|Progressive Disease|14|||
16469547|NCT03213691|40196570|FG000|Overall Study|Ineligible|1|||
16469548|NCT01445886|40196571|FG000|Overall Study|Lost to Follow-up|2|||
16469549|NCT01445886|40196571|FG000|Overall Study|Protocol Violation|3|||
16469550|NCT03435640|40196572|FG000|Overall Study|Withdrawal by Subject|0|||
16469551|NCT03435640|40196573|FG001|Overall Study|Withdrawal by Subject|1|||
16469552|NCT03435640|40196574|FG002|Overall Study|Withdrawal by Subject|0|||
16469553|NCT03435640|40196575|FG003|Overall Study|Withdrawal by Subject|2|||
16469554|NCT03435640|40196576|FG004|Overall Study|Withdrawal by Subject|0|||
16469555|NCT03435640|40196577|FG005|Overall Study|Withdrawal by Subject|0|||
16469556|NCT03435640|40196578|FG006|Overall Study|Withdrawal by Subject|3|||
16469557|NCT03435640|40196579|FG007|Overall Study|Withdrawal by Subject|0|||
16469558|NCT03435640|40196580|FG008|Overall Study|Withdrawal by Subject|0|||
16469559|NCT03435640|40196581|FG009|Overall Study|Withdrawal by Subject|2|||
16469560|NCT03435640|40196582|FG010|Overall Study|Withdrawal by Subject|3|||
16469561|NCT03435640|40196572|FG000|Overall Study|Lost to Follow-up|0|||
16469562|NCT03435640|40196573|FG001|Overall Study|Lost to Follow-up|0|||
16469563|NCT03435640|40196574|FG002|Overall Study|Lost to Follow-up|1|||
16469564|NCT03435640|40196575|FG003|Overall Study|Lost to Follow-up|0|||
16469565|NCT03435640|40196576|FG004|Overall Study|Lost to Follow-up|0|||
16469566|NCT03435640|40196577|FG005|Overall Study|Lost to Follow-up|0|||
16469567|NCT03435640|40196578|FG006|Overall Study|Lost to Follow-up|0|||
16469568|NCT03435640|40196579|FG007|Overall Study|Lost to Follow-up|0|||
16469569|NCT03435640|40196580|FG008|Overall Study|Lost to Follow-up|0|||
16469570|NCT03435640|40196581|FG009|Overall Study|Lost to Follow-up|0|||
16469571|NCT03435640|40196582|FG010|Overall Study|Lost to Follow-up|0|||
16469572|NCT00475423|40196585|FG000|Overall Study|Protocol Violation|5|||
16469573|NCT00475423|40196585|FG000|Overall Study|Adverse Event|4|||
16469574|NCT00475423|40196585|FG000|Overall Study|Withdrawal by Subject|6|||
16469575|NCT00475423|40196585|FG000|Overall Study|Lack of Efficacy|8|||
16469576|NCT00475423|40196585|FG000|Overall Study|Death|1|||
16469577|NCT00475423|40196585|FG000|Overall Study|Reason not specified|1|||
16469578|NCT00475423|40196585|FG000|Overall Study|Lost to Follow-up|7|||
16469579|NCT00473746|40196588|FG000|Period 1 (Phase 1)|Adverse Event|1|||
16469580|NCT00473746|40196589|FG001|Period 1 (Phase 1)|Adverse Event|0|||
16469581|NCT00473746|40196590|FG002|Period 1 (Phase 1)|Adverse Event|0|||
16469582|NCT00473746|40196591|FG003|Period 1 (Phase 1)|Adverse Event|0|||
16469583|NCT00473746|40196592|FG004|Period 1 (Phase 1)|Adverse Event|0|||
16469584|NCT00473746|40196588|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
16469585|NCT00473746|40196589|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
16469586|NCT00473746|40196590|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
16469587|NCT00473746|40196591|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
16469588|NCT00473746|40196592|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
16469589|NCT00473746|40196588|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
16469590|NCT00473746|40196589|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
16469591|NCT00473746|40196590|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
16469592|NCT00473746|40196591|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
16469593|NCT00473746|40196592|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
16469594|NCT00473746|40196588|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
16469595|NCT00473746|40196589|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
16469596|NCT00473746|40196590|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
16469597|NCT00473746|40196591|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
16469598|NCT00473746|40196592|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
16469599|NCT00473746|40196588|FG000|Period 1 (Phase 1)|Reason not specified|0|||
16469600|NCT00473746|40196589|FG001|Period 1 (Phase 1)|Reason not specified|1|||
16469601|NCT00473746|40196590|FG002|Period 1 (Phase 1)|Reason not specified|0|||
16469602|NCT00473746|40196591|FG003|Period 1 (Phase 1)|Reason not specified|0|||
16469603|NCT00473746|40196592|FG004|Period 1 (Phase 1)|Reason not specified|0|||
16469604|NCT00473746|40196588|FG000|Period 2 (Phase 2)|Adverse Event|0|||
16469605|NCT00473746|40196589|FG001|Period 2 (Phase 2)|Adverse Event|0|||
16469606|NCT00473746|40196590|FG002|Period 2 (Phase 2)|Adverse Event|0|||
16469607|NCT00473746|40196591|FG003|Period 2 (Phase 2)|Adverse Event|0|||
16469608|NCT00473746|40196592|FG004|Period 2 (Phase 2)|Adverse Event|3|||
16469609|NCT00473746|40196588|FG000|Period 2 (Phase 2)|Death|0|||
16469610|NCT00473746|40196589|FG001|Period 2 (Phase 2)|Death|0|||
16469611|NCT00473746|40196590|FG002|Period 2 (Phase 2)|Death|0|||
16469612|NCT00473746|40196591|FG003|Period 2 (Phase 2)|Death|0|||
16469613|NCT00473746|40196592|FG004|Period 2 (Phase 2)|Death|1|||
16469614|NCT00473746|40196588|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
16469615|NCT00473746|40196589|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
16469616|NCT00473746|40196590|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
16469617|NCT00473746|40196591|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
16469618|NCT00473746|40196592|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
16469619|NCT00473746|40196588|FG000|Period 2 (Phase 2)|Reason not specified|0|||
16469620|NCT00473746|40196589|FG001|Period 2 (Phase 2)|Reason not specified|0|||
16469621|NCT00473746|40196590|FG002|Period 2 (Phase 2)|Reason not specified|0|||
16469622|NCT00473746|40196591|FG003|Period 2 (Phase 2)|Reason not specified|0|||
16469623|NCT00473746|40196592|FG004|Period 2 (Phase 2)|Reason not specified|3|||
16469624|NCT03119701|40196593|FG000|6-day Dosing|Death|4|||
16469625|NCT03119701|40196594|FG001|6-day Dosing|Death|1|||
16469626|NCT03119701|40196593|FG000|6-day Dosing|Adverse Event|3|||
16469627|NCT03119701|40196594|FG001|6-day Dosing|Adverse Event|0|||
16469628|NCT03119701|40196593|FG000|6-day Dosing|Physician Decision|0|||
16469629|NCT03119701|40196594|FG001|6-day Dosing|Physician Decision|1|||
16469630|NCT03119701|40196593|FG000|6-day Dosing|Withdrawal by Subject|0|||
16469631|NCT03119701|40196594|FG001|6-day Dosing|Withdrawal by Subject|1|||
16469632|NCT03119701|40196593|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
16469633|NCT03119701|40196594|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
16469634|NCT02567552|40196595|FG000|Overall Study|Adverse Event|0|||
16469635|NCT02567552|40196596|FG001|Overall Study|Adverse Event|1|||
16469636|NCT00608543|40196597|FG000|Overall Study|Adverse Event|4|||
16469637|NCT00459979|40196600|FG000|Overall Study|Withdrawal by Subject|1|||
16469638|NCT00459979|40196600|FG000|Overall Study|Protocol Violation|1|||
16469639|NCT01931670|40196601|FG000|Treatment Period|Exclusionary Medication Received|1|||
16469640|NCT01931670|40196602|FG001|Treatment Period|Exclusionary Medication Received|1|||
16469641|NCT01931670|40196603|FG002|Treatment Period|Exclusionary Medication Received|1|||
16469642|NCT01931670|40196601|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
16469643|NCT01931670|40196602|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
16469644|NCT01931670|40196603|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
16469645|NCT01931670|40196601|FG000|Treatment Period|Subject Noncompliant|4|||
16469646|NCT01931670|40196602|FG001|Treatment Period|Subject Noncompliant|9|||
16469647|NCT01931670|40196603|FG002|Treatment Period|Subject Noncompliant|5|||
16469648|NCT01931670|40196601|FG000|Treatment Period|Adverse Event|19|||
16469649|NCT01931670|40196602|FG001|Treatment Period|Adverse Event|8|||
16469650|NCT01931670|40196603|FG002|Treatment Period|Adverse Event|21|||
16469651|NCT01931670|40196601|FG000|Treatment Period|Lack of Efficacy|11|||
16469652|NCT01931670|40196602|FG001|Treatment Period|Lack of Efficacy|2|||
16469653|NCT01931670|40196603|FG002|Treatment Period|Lack of Efficacy|2|||
16469654|NCT01931670|40196601|FG000|Treatment Period|Pregnancy|7|||
16469655|NCT01931670|40196602|FG001|Treatment Period|Pregnancy|2|||
16469656|NCT01931670|40196603|FG002|Treatment Period|Pregnancy|0|||
16469657|NCT01931670|40196601|FG000|Treatment Period|Other|8|||
16469658|NCT01931670|40196602|FG001|Treatment Period|Other|7|||
16469659|NCT01931670|40196603|FG002|Treatment Period|Other|2|||
16469660|NCT01931670|40196601|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
16469661|NCT01931670|40196602|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
16469662|NCT01931670|40196603|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
16469663|NCT01931670|40196601|FG000|Treatment Period|Lost to Follow-up|19|||
16469664|NCT01931670|40196602|FG001|Treatment Period|Lost to Follow-up|5|||
16469665|NCT01931670|40196603|FG002|Treatment Period|Lost to Follow-up|7|||
16469666|NCT01931670|40196601|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
16469667|NCT01931670|40196602|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
16469668|NCT01931670|40196603|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
16469669|NCT01931670|40196601|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
16469670|NCT01931670|40196602|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
16469671|NCT01931670|40196603|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
16469672|NCT01931670|40196601|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
16469673|NCT01931670|40196602|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
16469674|NCT01931670|40196603|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
16469675|NCT01931670|40196601|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
16469676|NCT01931670|40196602|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
16469677|NCT01931670|40196603|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
16469678|NCT01931670|40196601|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
16469679|NCT01931670|40196602|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
16469680|NCT01931670|40196603|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
16469681|NCT01931670|40196601|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
16469682|NCT01931670|40196602|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
16469683|NCT01931670|40196603|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
16469684|NCT05498701|40196604|FG000|Period 3|Adverse Event|1|||
16469685|NCT05498701|40196605|FG001|Period 3|Adverse Event|0|||
16469686|NCT01933789|40196608|FG000|Overall Study|Death|0|||
16469687|NCT01933789|40196609|FG001|Overall Study|Death|0|||
16469688|NCT01933789|40196610|FG002|Overall Study|Death|0|||
16469689|NCT01933789|40196611|FG003|Overall Study|Death|0|||
16469690|NCT01933789|40196612|FG004|Overall Study|Death|21|||
16469691|NCT01933789|40196613|FG005|Overall Study|Death|32|||
16469692|NCT01933789|40196614|FG006|Overall Study|Death|0|||
16469693|NCT01933789|40196615|FG007|Overall Study|Death|0|||
16469694|NCT01933789|40196616|FG008|Overall Study|Death|0|||
16469695|NCT01933789|40196608|FG000|Overall Study|Lost to Follow-up|0|||
16469696|NCT01933789|40196609|FG001|Overall Study|Lost to Follow-up|0|||
16469697|NCT01933789|40196610|FG002|Overall Study|Lost to Follow-up|0|||
16469698|NCT01933789|40196611|FG003|Overall Study|Lost to Follow-up|1|||
16469699|NCT01933789|40196612|FG004|Overall Study|Lost to Follow-up|8|||
16469700|NCT01933789|40196613|FG005|Overall Study|Lost to Follow-up|9|||
16469701|NCT01933789|40196614|FG006|Overall Study|Lost to Follow-up|1|||
16469702|NCT01933789|40196615|FG007|Overall Study|Lost to Follow-up|4|||
16469703|NCT01933789|40196616|FG008|Overall Study|Lost to Follow-up|0|||
16469704|NCT01933789|40196608|FG000|Overall Study|Withdrawal by Subject|2|||
16469705|NCT01933789|40196609|FG001|Overall Study|Withdrawal by Subject|1|||
16469706|NCT01933789|40196610|FG002|Overall Study|Withdrawal by Subject|0|||
16469707|NCT01933789|40196611|FG003|Overall Study|Withdrawal by Subject|0|||
16469708|NCT01933789|40196612|FG004|Overall Study|Withdrawal by Subject|17|||
16469709|NCT01933789|40196613|FG005|Overall Study|Withdrawal by Subject|16|||
16469710|NCT01933789|40196614|FG006|Overall Study|Withdrawal by Subject|1|||
16469711|NCT01933789|40196615|FG007|Overall Study|Withdrawal by Subject|4|||
16469712|NCT01933789|40196616|FG008|Overall Study|Withdrawal by Subject|0|||
16469713|NCT01933789|40196608|FG000|Overall Study|Became Ineligible|4|||
16469714|NCT01933789|40196609|FG001|Overall Study|Became Ineligible|0|||
16469715|NCT01933789|40196610|FG002|Overall Study|Became Ineligible|0|||
16469716|NCT01933789|40196611|FG003|Overall Study|Became Ineligible|0|||
16469717|NCT01933789|40196612|FG004|Overall Study|Became Ineligible|13|||
16469718|NCT01933789|40196613|FG005|Overall Study|Became Ineligible|10|||
16469719|NCT01933789|40196614|FG006|Overall Study|Became Ineligible|13|||
16469720|NCT01933789|40196615|FG007|Overall Study|Became Ineligible|6|||
16469721|NCT01933789|40196616|FG008|Overall Study|Became Ineligible|0|||
16469722|NCT00772070|40198905|FG000|Overall Study|Lost to Follow-up|0|||
16469723|NCT00772070|40198906|FG001|Overall Study|Lost to Follow-up|8|||
16469724|NCT00772070|40198905|FG000|Overall Study|Withdrawal by Subject|0|||
16469725|NCT00772070|40198906|FG001|Overall Study|Withdrawal by Subject|2|||
16469726|NCT00772070|40198905|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
16469727|NCT00772070|40198906|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
16469728|NCT00739596|40198913|FG000|Overall Study|Adverse Event|12|||
16469729|NCT00739596|40198914|FG001|Overall Study|Adverse Event|6|||
16469730|NCT00739596|40198913|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
16469731|NCT00739596|40198914|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
16469732|NCT00739596|40198913|FG000|Overall Study|Patient Withdrew Consent|8|||
16469733|NCT00739596|40198914|FG001|Overall Study|Patient Withdrew Consent|8|||
16469734|NCT00739596|40198913|FG000|Overall Study|Lost to Follow-up|0|||
16469735|NCT00739596|40198914|FG001|Overall Study|Lost to Follow-up|2|||
16469736|NCT00739596|40198913|FG000|Overall Study|Protocol Deviation|1|||
16469737|NCT00739596|40198914|FG001|Overall Study|Protocol Deviation|1|||
16469738|NCT00245583|40198918|FG000|Overall Study|Lost to Follow-up|1|||
16469739|NCT00245583|40198919|FG001|Overall Study|Lost to Follow-up|5|||
16469740|NCT00245583|40198918|FG000|Overall Study|Adverse Event|2|||
16469741|NCT00245583|40198919|FG001|Overall Study|Adverse Event|1|||
16469742|NCT00245583|40198918|FG000|Overall Study|Lack of Efficacy|1|||
16469743|NCT00245583|40198919|FG001|Overall Study|Lack of Efficacy|0|||
16469744|NCT00245583|40198918|FG000|Overall Study|Withdrawal by Subject|2|||
16469745|NCT00245583|40198919|FG001|Overall Study|Withdrawal by Subject|3|||
16469746|NCT01920555|40198928|FG000|Overall Study|Physician Decision|1|||
16469747|NCT01920555|40198929|FG001|Overall Study|Physician Decision|2|||
16469748|NCT01920555|40198930|FG002|Overall Study|Physician Decision|1|||
16469749|NCT01920555|40198931|FG003|Overall Study|Physician Decision|2|||
16469750|NCT01920555|40198932|FG004|Overall Study|Physician Decision|0|||
16469751|NCT01920555|40198928|FG000|Overall Study|Lack of Efficacy|2|||
16469752|NCT01920555|40198929|FG001|Overall Study|Lack of Efficacy|0|||
16469753|NCT01920555|40198930|FG002|Overall Study|Lack of Efficacy|0|||
16469754|NCT01920555|40198931|FG003|Overall Study|Lack of Efficacy|0|||
16469755|NCT01920555|40198932|FG004|Overall Study|Lack of Efficacy|0|||
16469756|NCT01920555|40198928|FG000|Overall Study|Travel Difficulties|1|||
16469757|NCT01920555|40198929|FG001|Overall Study|Travel Difficulties|1|||
16469758|NCT01920555|40198930|FG002|Overall Study|Travel Difficulties|0|||
16469759|NCT01920555|40198931|FG003|Overall Study|Travel Difficulties|0|||
16469760|NCT01920555|40198932|FG004|Overall Study|Travel Difficulties|1|||
16469761|NCT01920555|40198928|FG000|Overall Study|Lost to Follow-up|0|||
16469762|NCT01920555|40198929|FG001|Overall Study|Lost to Follow-up|1|||
16469763|NCT01920555|40198930|FG002|Overall Study|Lost to Follow-up|0|||
16469764|NCT01920555|40198931|FG003|Overall Study|Lost to Follow-up|1|||
16469765|NCT01920555|40198932|FG004|Overall Study|Lost to Follow-up|0|||
16469766|NCT00827931|40198935|FG000|Overall Study|Death|3|||
16469767|NCT00827931|40198936|FG001|Overall Study|Death|5|||
16469768|NCT00827931|40198935|FG000|Overall Study|Adverse Event|1|||
16469769|NCT00827931|40198936|FG001|Overall Study|Adverse Event|0|||
16469770|NCT00827931|40198935|FG000|Overall Study|Lost to Follow-up|1|||
16469771|NCT00827931|40198936|FG001|Overall Study|Lost to Follow-up|0|||
16469772|NCT00827931|40198935|FG000|Overall Study|Withdrawal by Subject|0|||
16469773|NCT00827931|40198936|FG001|Overall Study|Withdrawal by Subject|1|||
16469774|NCT00827931|40198935|FG000|Overall Study|Other|1|||
16469775|NCT00827931|40198936|FG001|Overall Study|Other|0|||
16469776|NCT00969280|40198937|FG000|Overall Study|Protocol Violation|2|||
16469777|NCT00969280|40198938|FG001|Overall Study|Protocol Violation|1|||
16469778|NCT00969280|40198937|FG000|Overall Study|Withdrawal by Subject|0|||
16469779|NCT00969280|40198938|FG001|Overall Study|Withdrawal by Subject|1|||
16469780|NCT00969280|40198937|FG000|Overall Study|infection of influenza A(H1N1)|0|||
16469781|NCT00969280|40198938|FG001|Overall Study|infection of influenza A(H1N1)|1|||
16469782|NCT03026088|40198941|FG000|Overall Study|Study termination|20|||
16469783|NCT03523000|40198942|FG000|Overall Study|Withdrawal by Subject|3|||
16469784|NCT03523000|40198943|FG001|Overall Study|Withdrawal by Subject|0|||
16469785|NCT03523000|40198942|FG000|Overall Study|Unsuccessful trial|2|||
16469786|NCT03523000|40198943|FG001|Overall Study|Unsuccessful trial|0|||
16469787|NCT02942576|40198944|FG000|Overall Study|Adverse Event|28|||
16469788|NCT02942576|40198945|FG001|Overall Study|Adverse Event|6|||
16469789|NCT02942576|40198944|FG000|Overall Study|Withdrawal by Subject|7|||
16469790|NCT02942576|40198945|FG001|Overall Study|Withdrawal by Subject|5|||
16469791|NCT02942576|40198944|FG000|Overall Study|Physician Decision|1|||
16469792|NCT02942576|40198945|FG001|Overall Study|Physician Decision|4|||
16469793|NCT02942576|40198944|FG000|Overall Study|Other|10|||
16469794|NCT02942576|40198945|FG001|Overall Study|Other|8|||
16469795|NCT04073368|40198947|FG000|Overall Study|Adverse Event|2|||
16469796|NCT04073368|40198948|FG001|Overall Study|Adverse Event|0|||
16469797|NCT04073368|40198949|FG002|Overall Study|Adverse Event|1|||
16469798|NCT04073368|40198950|FG003|Overall Study|Adverse Event|1|||
16469799|NCT04073368|40198947|FG000|Overall Study|Withdrawal by Subject|2|||
16469800|NCT04073368|40198948|FG001|Overall Study|Withdrawal by Subject|2|||
16469801|NCT04073368|40198949|FG002|Overall Study|Withdrawal by Subject|1|||
16469802|NCT04073368|40198950|FG003|Overall Study|Withdrawal by Subject|1|||
16469803|NCT04073368|40198947|FG000|Overall Study|Lost to Follow-up|1|||
16469804|NCT04073368|40198948|FG001|Overall Study|Lost to Follow-up|1|||
16469805|NCT04073368|40198949|FG002|Overall Study|Lost to Follow-up|1|||
16469806|NCT04073368|40198950|FG003|Overall Study|Lost to Follow-up|0|||
16469807|NCT04073368|40198947|FG000|Overall Study|Protocol Violation|0|||
16469808|NCT04073368|40198948|FG001|Overall Study|Protocol Violation|1|||
16469809|NCT04073368|40198949|FG002|Overall Study|Protocol Violation|0|||
16469810|NCT04073368|40198950|FG003|Overall Study|Protocol Violation|0|||
16469811|NCT04073368|40198947|FG000|Overall Study|Subject noncompliance|7|||
16469812|NCT04073368|40198948|FG001|Overall Study|Subject noncompliance|4|||
16469813|NCT04073368|40198949|FG002|Overall Study|Subject noncompliance|0|||
16469814|NCT04073368|40198950|FG003|Overall Study|Subject noncompliance|0|||
16469815|NCT00278915|40198951|FG000|Overall Study|Disease progression|1|||
16469816|NCT03112590|40198952|FG000|Overall Study|Adverse Event|0|||
16469817|NCT03112590|40198953|FG001|Overall Study|Adverse Event|1|||
16469818|NCT03112590|40198954|FG002|Overall Study|Adverse Event|0|||
16469819|NCT00900601|40198955|FG000|Overall Study|Physician Decision|1|||
16469820|NCT02734433|40198968|FG000|Overall Study|Disease progression|1|||
16469821|NCT02734433|40198969|FG001|Overall Study|Disease progression|5|||
16469822|NCT02734433|40198968|FG000|Overall Study|Clinical progression|0|||
16469823|NCT02734433|40198969|FG001|Overall Study|Clinical progression|1|||
16469824|NCT02734433|40198968|FG000|Overall Study|Withdrawal by Subject|1|||
16469825|NCT02734433|40198969|FG001|Overall Study|Withdrawal by Subject|2|||
16469826|NCT01574079|40198972|FG000|Overall Study|Physician Decision|0|||
16469827|NCT01574079|40198973|FG001|Overall Study|Physician Decision|2|||
16469828|NCT01574079|40198972|FG000|Overall Study|Lost to Follow-up|1|||
16469829|NCT01574079|40198973|FG001|Overall Study|Lost to Follow-up|0|||
16469830|NCT02628769|40198974|FG000|First Intervention|Adverse Event|1|||
16469831|NCT02628769|40198975|FG001|First Intervention|Adverse Event|0|||
16469832|NCT02628769|40198974|FG000|First Intervention|Withdrawal by Subject|0|||
16469833|NCT02628769|40198975|FG001|First Intervention|Withdrawal by Subject|1|||
16469834|NCT02628769|40198974|FG000|Second Intervention|Adverse Event|2|||
16469835|NCT02628769|40198975|FG001|Second Intervention|Adverse Event|0|||
16469836|NCT02628769|40198974|FG000|Second Intervention|Physician Decision|0|||
16469837|NCT02628769|40198975|FG001|Second Intervention|Physician Decision|1|||
16469838|NCT01525901|40198976|FG000|Period 2: 12 Weeks|Adverse Event|0|||
16469839|NCT01525901|40198977|FG001|Period 2: 12 Weeks|Adverse Event|1|||
16469840|NCT01525901|40198978|FG002|Period 2: 12 Weeks|Adverse Event|0|||
16469841|NCT01525901|40198979|FG003|Period 2: 12 Weeks|Adverse Event|0|||
16469842|NCT00174291|40198982|FG000|Overall Study|Lost to Follow-up|1|||
16469843|NCT00174291|40198983|FG001|Overall Study|Lost to Follow-up|1|||
16469844|NCT00174291|40198982|FG000|Overall Study|Protocol Violation|0|||
16469845|NCT00174291|40198983|FG001|Overall Study|Protocol Violation|2|||
16469846|NCT00174291|40198982|FG000|Overall Study|Study terminated by sponsor|1|||
16469847|NCT00174291|40198983|FG001|Overall Study|Study terminated by sponsor|0|||
16469848|NCT00174291|40198982|FG000|Overall Study|Withdrawal by Subject|3|||
16469849|NCT00174291|40198983|FG001|Overall Study|Withdrawal by Subject|3|||
16469850|NCT03783702|40198987|FG000|Overall Study|Lost to Follow-up|6|||
16469851|NCT03783702|40198988|FG001|Overall Study|Lost to Follow-up|8|||
16469852|NCT03783702|40198987|FG000|Overall Study|Protocol Violation|1|||
16469853|NCT03783702|40198988|FG001|Overall Study|Protocol Violation|3|||
16469854|NCT01249118|40198989|FG000|First Washout Period|Physician Decision|0|||
16469855|NCT01249118|40198990|FG001|First Washout Period|Physician Decision|1|||
16469856|NCT01249118|40198991|FG002|First Washout Period|Physician Decision|0|||
16469857|NCT00470184|40198992|FG000|Overall Study|Not Treated(became ineligible)|4|||
16469858|NCT00470184|40198992|FG000|Overall Study|Not treated (other)|1|||
16469859|NCT00470184|40198992|FG000|Overall Study|disease Progression|4|||
16469860|NCT00470184|40198992|FG000|Overall Study|Adverse Event|3|||
16469861|NCT00470184|40198992|FG000|Overall Study|Withdrawal by Subject|4|||
16469862|NCT00470184|40198992|FG000|Overall Study|other|5|||
16469863|NCT00470184|40198992|FG000|Overall Study|recurrence|1|||
16469864|NCT03612856|40198993|FG000|Pre-dose Period|Physician Decision|0|||
16469865|NCT03612856|40198994|FG001|Pre-dose Period|Physician Decision|1|||
16469866|NCT03612856|40198995|FG002|Pre-dose Period|Physician Decision|1|||
16469867|NCT03612856|40198993|FG000|Pre-dose Period|Withdrawal by Subject|0|||
16469868|NCT03612856|40198994|FG001|Pre-dose Period|Withdrawal by Subject|1|||
16469869|NCT03612856|40198995|FG002|Pre-dose Period|Withdrawal by Subject|0|||
16469870|NCT03350984|40199001|FG000|Overall Study|Death|1|||
16469871|NCT03350984|40199002|FG001|Overall Study|Death|0|||
16469872|NCT03350984|40199001|FG000|Overall Study|Lost to Follow-up|5|||
16469873|NCT03350984|40199002|FG001|Overall Study|Lost to Follow-up|6|||
16469874|NCT03350984|40199001|FG000|Overall Study|Protocol Violation|1|||
16469875|NCT03350984|40199002|FG001|Overall Study|Protocol Violation|2|||
16469876|NCT03350984|40199001|FG000|Overall Study|Physician Decision|1|||
16469877|NCT03350984|40199002|FG001|Overall Study|Physician Decision|0|||
16469878|NCT01205581|40199004|FG000|Overall Study|Withdrawal by Subject|1|||
16469879|NCT01205581|40199005|FG001|Overall Study|Withdrawal by Subject|0|||
16469880|NCT01205581|40199006|FG002|Overall Study|Withdrawal by Subject|0|||
16469881|NCT01205581|40199007|FG003|Overall Study|Withdrawal by Subject|0|||
16469882|NCT01205581|40199008|FG004|Overall Study|Withdrawal by Subject|0|||
16469883|NCT01205581|40199009|FG005|Overall Study|Withdrawal by Subject|0|||
16469884|NCT01017575|40199017|FG000|Overall Study|Lack of Efficacy|0|||
16469885|NCT01017575|40199018|FG001|Overall Study|Lack of Efficacy|1|||
16469886|NCT01017575|40199019|FG002|Overall Study|Lack of Efficacy|0|||
16469887|NCT01017575|40199020|FG003|Overall Study|Lack of Efficacy|1|||
16469888|NCT01017575|40199021|FG004|Overall Study|Lack of Efficacy|1|||
16469889|NCT01017575|40199017|FG000|Overall Study|Adverse Event|0|||
16469890|NCT01017575|40199018|FG001|Overall Study|Adverse Event|1|||
16469891|NCT01017575|40199019|FG002|Overall Study|Adverse Event|0|||
16469892|NCT01017575|40199020|FG003|Overall Study|Adverse Event|0|||
16469893|NCT01017575|40199021|FG004|Overall Study|Adverse Event|2|||
16469894|NCT01017575|40199017|FG000|Overall Study|Withdrawal by Subject|1|||
16469895|NCT01017575|40199018|FG001|Overall Study|Withdrawal by Subject|0|||
16469896|NCT01017575|40199019|FG002|Overall Study|Withdrawal by Subject|0|||
16469897|NCT01017575|40199020|FG003|Overall Study|Withdrawal by Subject|0|||
16469898|NCT01017575|40199021|FG004|Overall Study|Withdrawal by Subject|0|||
16469899|NCT01551420|40199024|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
16469900|NCT01551420|40199025|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
16469901|NCT01551420|40199024|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
16469902|NCT01551420|40199025|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
16469903|NCT01551420|40199024|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
16469904|NCT01551420|40199025|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
16469905|NCT01551420|40199024|FG000|Screened for Part B Eligibility|Declined participation|8|||
16469906|NCT01551420|40199025|FG001|Screened for Part B Eligibility|Declined participation|1|||
16469907|NCT01551420|40199024|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
16469908|NCT01551420|40199025|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
16469909|NCT01551420|40199024|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
16469910|NCT01551420|40199025|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
16469911|NCT01551420|40199024|FG000|Home Use (Part B)|Withdrawal by staff|0|||
16469912|NCT01551420|40199025|FG001|Home Use (Part B)|Withdrawal by staff|1|||
16469913|NCT02663687|40199028|FG000|Overall Study|Adverse Event|1|||
16469914|NCT02663687|40199029|FG001|Overall Study|Adverse Event|0|||
16469915|NCT02663687|40199030|FG002|Overall Study|Adverse Event|0|||
16469916|NCT02663687|40199031|FG003|Overall Study|Adverse Event|0|||
16469917|NCT02663687|40199032|FG004|Overall Study|Adverse Event|0|||
16469918|NCT02663687|40199028|FG000|Overall Study|Other|1|||
16469919|NCT02663687|40199029|FG001|Overall Study|Other|0|||
16469920|NCT02663687|40199030|FG002|Overall Study|Other|1|||
16469921|NCT02663687|40199031|FG003|Overall Study|Other|0|||
16469922|NCT02663687|40199032|FG004|Overall Study|Other|0|||
16469923|NCT00908011|40199034|FG000|Overall Study|Withdrawal by Subject|2|||
16469924|NCT00908011|40199035|FG001|Overall Study|Withdrawal by Subject|2|||
16469925|NCT01505647|40199036|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
16469926|NCT01505647|40199037|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
16469927|NCT01505647|40199036|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
16469928|NCT01505647|40199037|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
16469929|NCT01505647|40199036|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
16469930|NCT01505647|40199037|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
16469931|NCT01505647|40199036|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
16469932|NCT01505647|40199037|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
16469933|NCT01505647|40199036|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
16469934|NCT01505647|40199037|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
16469935|NCT01514370|40199038|FG000|Overall Study|Protocol Violation|2|||
16469936|NCT01514370|40199039|FG001|Overall Study|Protocol Violation|3|||
16469937|NCT01514370|40199038|FG000|Overall Study|Lost to Follow-up|0|||
16469938|NCT01514370|40199039|FG001|Overall Study|Lost to Follow-up|2|||
16469939|NCT01514370|40199038|FG000|Overall Study|Withdrawal by Subject|2|||
16469940|NCT01514370|40199039|FG001|Overall Study|Withdrawal by Subject|1|||
16469941|NCT01514370|40199038|FG000|Overall Study|Adverse Event|1|||
16469942|NCT01514370|40199039|FG001|Overall Study|Adverse Event|3|||
16469943|NCT01514370|40199038|FG000|Overall Study|Other|6|||
16469944|NCT01514370|40199039|FG001|Overall Study|Other|7|||
16469945|NCT02117414|40199040|FG000|Overall Study|Death|5|||
16469946|NCT02117414|40199041|FG001|Overall Study|Death|2|||
16469947|NCT02117414|40199040|FG000|Overall Study|Withdrawal by Subject|10|||
16469948|NCT02117414|40199041|FG001|Overall Study|Withdrawal by Subject|4|||
16469949|NCT00145600|40199042|FG000|Overall Study|Death|1|||
16469950|NCT00145600|40199043|FG001|Overall Study|Death|2|||
16469951|NCT00145600|40199044|FG002|Overall Study|Death|2|||
16469952|NCT00145600|40199045|FG003|Overall Study|Death|6|||
16469953|NCT00145600|40199042|FG000|Overall Study|Ineligible|3|||
16469954|NCT00145600|40199043|FG001|Overall Study|Ineligible|0|||
16469955|NCT00145600|40199044|FG002|Overall Study|Ineligible|1|||
16469956|NCT00145600|40199045|FG003|Overall Study|Ineligible|5|||
16469957|NCT00145600|40199042|FG000|Overall Study|Lost to Follow-up|2|||
16469958|NCT00145600|40199043|FG001|Overall Study|Lost to Follow-up|6|||
16469959|NCT00145600|40199044|FG002|Overall Study|Lost to Follow-up|2|||
16469960|NCT00145600|40199045|FG003|Overall Study|Lost to Follow-up|4|||
16469961|NCT00145600|40199042|FG000|Overall Study|Noncompliance|1|||
16469962|NCT00145600|40199043|FG001|Overall Study|Noncompliance|0|||
16469963|NCT00145600|40199044|FG002|Overall Study|Noncompliance|0|||
16469964|NCT00145600|40199045|FG003|Overall Study|Noncompliance|0|||
16469965|NCT00145600|40199042|FG000|Overall Study|Withdrawal by Subject|1|||
16469966|NCT00145600|40199043|FG001|Overall Study|Withdrawal by Subject|2|||
16469967|NCT00145600|40199044|FG002|Overall Study|Withdrawal by Subject|0|||
16469968|NCT00145600|40199045|FG003|Overall Study|Withdrawal by Subject|1|||
16469969|NCT01916967|40199047|FG000|Overall Study|Adverse Event|0|||
16469970|NCT01916967|40199048|FG001|Overall Study|Adverse Event|0|||
16469971|NCT01916967|40199049|FG002|Overall Study|Adverse Event|2|||
16469972|NCT01916967|40199047|FG000|Overall Study|Lack of Efficacy|0|||
16469973|NCT01916967|40199048|FG001|Overall Study|Lack of Efficacy|0|||
16469974|NCT01916967|40199049|FG002|Overall Study|Lack of Efficacy|6|||
16469975|NCT01916967|40199047|FG000|Overall Study|Physician Decision|0|||
16469976|NCT01916967|40199048|FG001|Overall Study|Physician Decision|0|||
16469977|NCT01916967|40199049|FG002|Overall Study|Physician Decision|1|||
16469978|NCT01916967|40199047|FG000|Overall Study|Protocol Violation|0|||
16469979|NCT01916967|40199048|FG001|Overall Study|Protocol Violation|1|||
16469980|NCT01916967|40199049|FG002|Overall Study|Protocol Violation|0|||
16469981|NCT04041700|40199050|FG000|Overall Study|Pregnancy|1|||
16469982|NCT04041700|40199050|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
16469983|NCT00768469|40199052|FG000|Overall Study|Adverse Event|0|||
16469984|NCT00768469|40199053|FG001|Overall Study|Adverse Event|2|||
16469985|NCT00768469|40199052|FG000|Overall Study|Disease Progression|3|||
16469986|NCT00768469|40199053|FG001|Overall Study|Disease Progression|4|||
16469987|NCT00768469|40199052|FG000|Overall Study|Withdrawal by Subject|0|||
16469988|NCT00768469|40199053|FG001|Overall Study|Withdrawal by Subject|1|||
16469989|NCT02117427|40199054|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
16469990|NCT02117427|40199055|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
16469991|NCT02117427|40199056|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
16469992|NCT02117427|40199054|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
16469993|NCT02117427|40199055|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
16469994|NCT02117427|40199056|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
16469995|NCT02117427|40199054|FG000|Overall Study|Physician Decision|0|||
16469996|NCT02117427|40199055|FG001|Overall Study|Physician Decision|2|||
16469997|NCT02117427|40199056|FG002|Overall Study|Physician Decision|0|||
16469998|NCT02117427|40199054|FG000|Overall Study|No longer meets inclusion criteria|0|||
16469999|NCT02117427|40199055|FG001|Overall Study|No longer meets inclusion criteria|1|||
16470000|NCT02117427|40199056|FG002|Overall Study|No longer meets inclusion criteria|0|||
16470001|NCT02117427|40199054|FG000|Overall Study|Death|0|||
16470002|NCT02117427|40199055|FG001|Overall Study|Death|1|||
16470003|NCT02117427|40199056|FG002|Overall Study|Death|0|||
16470004|NCT00046891|40199057|FG000|Overall Study|Cancels|5|||
16470005|NCT00046891|40199058|FG001|Overall Study|Cancels|9|||
16470006|NCT00046891|40199057|FG000|Overall Study|Ineligible|1|||
16470007|NCT00046891|40199058|FG001|Overall Study|Ineligible|1|||
16470008|NCT00046891|40199057|FG000|Overall Study|Withdrawal by Subject|18|||
16470009|NCT00046891|40199058|FG001|Overall Study|Withdrawal by Subject|15|||
16470010|NCT00046891|40199057|FG000|Overall Study|Adverse Event|5|||
16470011|NCT00046891|40199058|FG001|Overall Study|Adverse Event|5|||
16470012|NCT01727700|40199059|FG000|Overall Study|Adverse Event|0|||
16470013|NCT01727700|40199060|FG001|Overall Study|Adverse Event|7|||
16470014|NCT01727700|40199061|FG002|Overall Study|Adverse Event|1|||
16470015|NCT01727700|40199059|FG000|Overall Study|Particpant withdrew consent|0|||
16470016|NCT01727700|40199060|FG001|Overall Study|Particpant withdrew consent|3|||
16470017|NCT01727700|40199061|FG002|Overall Study|Particpant withdrew consent|1|||
16470018|NCT01727700|40199059|FG000|Overall Study|Protocol Violation|2|||
16470019|NCT01727700|40199060|FG001|Overall Study|Protocol Violation|0|||
16470020|NCT01727700|40199061|FG002|Overall Study|Protocol Violation|0|||
16470021|NCT00442468|40199062|FG000|Overall Study|Adverse Event|4|||
16470022|NCT00442468|40199062|FG000|Overall Study|Withdrawal by Subject|91|||
16470023|NCT00442468|40199062|FG000|Overall Study|Did not complete all study procedures|88|||
16470024|NCT04099251|40199063|FG000|Pre-Treatment|Other reasons|1|||
16470025|NCT04099251|40199064|FG001|Pre-Treatment|Other reasons|0|||
16470026|NCT04099251|40199063|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
16470027|NCT04099251|40199064|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
16470028|NCT04099251|40199063|FG000|Blinded Treatment Phase|Other reasons|16|||
16470029|NCT04099251|40199064|FG001|Blinded Treatment Phase|Other reasons|7|||
16470030|NCT04099251|40199063|FG000|Blinded Treatment Phase|Disease recurrence|26|||
16470031|NCT04099251|40199064|FG001|Blinded Treatment Phase|Disease recurrence|41|||
16470032|NCT04099251|40199063|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
16470033|NCT04099251|40199064|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
16470034|NCT04099251|40199063|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
16470035|NCT04099251|40199064|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
16470036|NCT04099251|40199063|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
16470037|NCT04099251|40199064|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
16470038|NCT04099251|40199063|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
16470039|NCT04099251|40199064|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
16470040|NCT04099251|40199063|FG000|Blinded Treatment Phase|Death|6|||
16470041|NCT04099251|40199064|FG001|Blinded Treatment Phase|Death|2|||
16470042|NCT04099251|40199063|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
16470043|NCT04099251|40199064|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
16470044|NCT04099251|40199063|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
16470045|NCT04099251|40199064|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
16470046|NCT04099251|40199063|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
16470047|NCT04099251|40199064|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
16470048|NCT04099251|40199063|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
16470049|NCT04099251|40199064|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
16470050|NCT04099251|40199063|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
16470051|NCT04099251|40199064|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
16470052|NCT04099251|40199063|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
16470053|NCT04099251|40199064|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
16470054|NCT04099251|40199063|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
16470055|NCT04099251|40199064|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
16470056|NCT04099251|40199063|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
16470057|NCT04099251|40199064|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
16470058|NCT04099251|40199063|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
16470059|NCT04099251|40199064|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
16470060|NCT01739400|40199065|FG000|Overall Study|Physician Decision|3|||
16470061|NCT01739400|40199066|FG001|Overall Study|Physician Decision|0|||
16470062|NCT01739400|40199065|FG000|Overall Study|Lost to Follow-up|2|||
16470063|NCT01739400|40199066|FG001|Overall Study|Lost to Follow-up|0|||
16470064|NCT01739400|40199065|FG000|Overall Study|Death|5|||
16470065|NCT01739400|40199066|FG001|Overall Study|Death|2|||
16470066|NCT01739400|40199065|FG000|Overall Study|Withdrawal by Subject|7|||
16470067|NCT01739400|40199066|FG001|Overall Study|Withdrawal by Subject|7|||
16470068|NCT00812487|40199070|FG000|Overall Study|Lost to Follow-up|2|||
16470069|NCT00812487|40199071|FG001|Overall Study|Lost to Follow-up|0|||
16470070|NCT00812487|40199070|FG000|Overall Study|Withdrawal by Subject|3|||
16470071|NCT00812487|40199071|FG001|Overall Study|Withdrawal by Subject|2|||
16470072|NCT00812487|40199070|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
16470073|NCT00812487|40199071|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
16470074|NCT00812487|40199070|FG000|Overall Study|Protocol Violation|0|||
16470075|NCT00812487|40199071|FG001|Overall Study|Protocol Violation|1|||
16470076|NCT03055858|40199075|FG000|Overall Study|Death|9|||
16470077|NCT03055858|40199075|FG000|Overall Study|Withdrawal by Subject|11|||
16470078|NCT03055858|40199075|FG000|Overall Study|Lost to Follow-up|6|||
16470079|NCT03055858|40199075|FG000|Overall Study|Missed Follow-Up Visits|18|||
16470080|NCT01222403|40199081|FG000|Overall Study|Inappropriate enrollment|0|||
16470081|NCT01222403|40199082|FG001|Overall Study|Inappropriate enrollment|2|||
16470082|NCT01089361|40199083|FG000|Overall Study|Death|1|||
16470083|NCT01089361|40199084|FG001|Overall Study|Death|0|||
16470084|NCT01117792|40199092|FG000|Overall Study|Death|1|||
16470085|NCT01117792|40199092|FG000|Overall Study|Adverse Event|3|||
16470086|NCT04163718|40199095|FG000|Overall Study|Study terminated|12|||
16470087|NCT00993044|40199097|FG000|Irinotecan 50 mg|Physician Decision|1|||
16470088|NCT03455764|40199100|FG000|Overall Study|Adverse Event|1|||
16470089|NCT03455764|40199101|FG001|Overall Study|Adverse Event|0|||
16470090|NCT03455764|40199102|FG002|Overall Study|Adverse Event|0|||
16470091|NCT03455764|40199103|FG003|Overall Study|Adverse Event|0|||
16470092|NCT03455764|40199104|FG004|Overall Study|Adverse Event|0|||
16470093|NCT03455764|40199100|FG000|Overall Study|Disease Progression|4|||
16470094|NCT03455764|40199101|FG001|Overall Study|Disease Progression|0|||
16470095|NCT03455764|40199102|FG002|Overall Study|Disease Progression|0|||
16470096|NCT03455764|40199103|FG003|Overall Study|Disease Progression|0|||
16470097|NCT03455764|40199104|FG004|Overall Study|Disease Progression|0|||
16470098|NCT03455764|40199100|FG000|Overall Study|On Treatment|1|||
16470099|NCT03455764|40199101|FG001|Overall Study|On Treatment|0|||
16470100|NCT03455764|40199102|FG002|Overall Study|On Treatment|0|||
16470101|NCT03455764|40199103|FG003|Overall Study|On Treatment|0|||
16470102|NCT03455764|40199104|FG004|Overall Study|On Treatment|0|||
16470103|NCT00562627|40199110|FG000|Overall Study|Protocol Violation|1|||
16470104|NCT00562627|40199111|FG001|Overall Study|Protocol Violation|1|||
16470105|NCT00562627|40199112|FG002|Overall Study|Protocol Violation|1|||
16470106|NCT02775903|40199113|FG000|Overall Study|Death|7|||
16470107|NCT02775903|40199114|FG001|Overall Study|Death|11|||
16470108|NCT02775903|40199115|FG002|Overall Study|Death|12|||
16470109|NCT02775903|40199116|FG003|Overall Study|Death|11|||
16470110|NCT02775903|40199113|FG000|Overall Study|Adverse Event|0|||
16470111|NCT02775903|40199114|FG001|Overall Study|Adverse Event|1|||
16470112|NCT02775903|40199115|FG002|Overall Study|Adverse Event|12|||
16470113|NCT02775903|40199116|FG003|Overall Study|Adverse Event|3|||
16470114|NCT02775903|40199113|FG000|Overall Study|Progressive disease|15|||
16470115|NCT02775903|40199114|FG001|Overall Study|Progressive disease|14|||
16470116|NCT02775903|40199115|FG002|Overall Study|Progressive disease|30|||
16470117|NCT02775903|40199116|FG003|Overall Study|Progressive disease|20|||
16470118|NCT02775903|40199113|FG000|Overall Study|Lack of Efficacy|2|||
16470119|NCT02775903|40199114|FG001|Overall Study|Lack of Efficacy|2|||
16470120|NCT02775903|40199115|FG002|Overall Study|Lack of Efficacy|2|||
16470121|NCT02775903|40199116|FG003|Overall Study|Lack of Efficacy|6|||
16470122|NCT02775903|40199113|FG000|Overall Study|Withdrawal by Subject|7|||
16470123|NCT02775903|40199114|FG001|Overall Study|Withdrawal by Subject|5|||
16470124|NCT02775903|40199115|FG002|Overall Study|Withdrawal by Subject|5|||
16470125|NCT02775903|40199116|FG003|Overall Study|Withdrawal by Subject|8|||
16470126|NCT02775903|40199113|FG000|Overall Study|Other reasons|7|||
16470127|NCT02775903|40199114|FG001|Overall Study|Other reasons|8|||
16470128|NCT02775903|40199115|FG002|Overall Study|Other reasons|2|||
16470129|NCT02775903|40199116|FG003|Overall Study|Other reasons|12|||
16470130|NCT03116347|40199120|FG000|Overall Study|Withdrawal by Subject|1|||
16470131|NCT03116347|40199121|FG001|Overall Study|Withdrawal by Subject|2|||
16470132|NCT01721577|40201357|FG000|Overall Study|Lack of Efficacy|1|||
16470133|NCT01721577|40201358|FG001|Overall Study|Lack of Efficacy|0|||
16470134|NCT01721577|40201357|FG000|Overall Study|Death|1|||
16470135|NCT01721577|40201358|FG001|Overall Study|Death|0|||
16470136|NCT01721577|40201357|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
16470137|NCT01721577|40201358|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
16470138|NCT01721577|40201357|FG000|Overall Study|Adverse Event|0|||
16470139|NCT01721577|40201358|FG001|Overall Study|Adverse Event|2|||
16470140|NCT00107952|40201359|FG000|Overall Study|Death|75|||
16470141|NCT00107952|40201360|FG001|Overall Study|Death|61|||
16470142|NCT00107952|40201359|FG000|Overall Study|Lost to Follow-up|0|||
16470143|NCT00107952|40201360|FG001|Overall Study|Lost to Follow-up|3|||
16470144|NCT00107952|40201359|FG000|Overall Study|Withdrawal by Subject|9|||
16470145|NCT00107952|40201360|FG001|Overall Study|Withdrawal by Subject|6|||
16470146|NCT00107952|40201359|FG000|Overall Study|Other|2|||
16470147|NCT00107952|40201360|FG001|Overall Study|Other|5|||
16470148|NCT00107952|40201359|FG000|Overall Study|Never received study treatment|9|||
16470149|NCT00107952|40201360|FG001|Overall Study|Never received study treatment|6|||
16470150|NCT01314911|40201371|FG000|Overall Study|Lost to Follow-up|3|||
16470151|NCT01314911|40201372|FG001|Overall Study|Lost to Follow-up|2|||
16470152|NCT01314911|40201371|FG000|Overall Study|Withdrawal by Subject|1|||
16470153|NCT01314911|40201372|FG001|Overall Study|Withdrawal by Subject|3|||
16470154|NCT01314911|40201371|FG000|Overall Study|Received Non-randomized Study Drug|0|||
16470155|NCT01314911|40201372|FG001|Overall Study|Received Non-randomized Study Drug|1|||
16470156|NCT01314911|40201371|FG000|Overall Study|Never Started Treatment|1|||
16470157|NCT01314911|40201372|FG001|Overall Study|Never Started Treatment|0|||
16470158|NCT00640835|40201373|FG000|Overall Study|Adverse Event|5|||
16470159|NCT00640835|40201374|FG001|Overall Study|Adverse Event|3|||
16470160|NCT00640835|40201373|FG000|Overall Study|Withdrawal by Subject|12|||
16470161|NCT00640835|40201374|FG001|Overall Study|Withdrawal by Subject|14|||
16470162|NCT00640835|40201373|FG000|Overall Study|Physician Decision|10|||
16470163|NCT00640835|40201374|FG001|Overall Study|Physician Decision|14|||
16470164|NCT00640835|40201373|FG000|Overall Study|Sponsor's Decision|11|||
16470165|NCT00640835|40201374|FG001|Overall Study|Sponsor's Decision|7|||
16470166|NCT00640835|40201373|FG000|Overall Study|Protocol Violation|2|||
16470167|NCT00640835|40201374|FG001|Overall Study|Protocol Violation|2|||
16470168|NCT00640835|40201373|FG000|Overall Study|Lost to Follow-up|17|||
16470169|NCT00640835|40201374|FG001|Overall Study|Lost to Follow-up|13|||
16470170|NCT00640835|40201373|FG000|Overall Study|Other Reason|19|||
16470171|NCT00640835|40201374|FG001|Overall Study|Other Reason|4|||
16470172|NCT00843726|40201376|FG000|Overall Study|Death|1|||
16470173|NCT00843726|40201377|FG001|Overall Study|Death|0|||
16470174|NCT00843726|40201376|FG000|Overall Study|Withdrawal by Subject|0|||
16470175|NCT00843726|40201377|FG001|Overall Study|Withdrawal by Subject|1|||
16470176|NCT00122278|40201378|FG000|Overall Study|Lost to Follow-up|2|||
16470177|NCT00122278|40201379|FG001|Overall Study|Lost to Follow-up|0|||
16470178|NCT02497976|40201380|FG000|Overall Study|Withdrawal by Subject|2|||
16470179|NCT02497976|40201381|FG001|Overall Study|Withdrawal by Subject|0|||
16470180|NCT02497976|40201380|FG000|Overall Study|Moved out of area|0|||
16470181|NCT02497976|40201381|FG001|Overall Study|Moved out of area|1|||
16470182|NCT01898494|40201382|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
16470183|NCT01898494|40201383|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
16470184|NCT01898494|40201384|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
16470185|NCT01898494|40201385|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
16273254|NCT01968551|39484474|FG001|Extension Phase|Death|1|||
16470186|NCT01898494|40201386|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
16470187|NCT01898494|40201382|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
16470188|NCT01898494|40201383|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
16470189|NCT01898494|40201384|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
16470190|NCT01898494|40201385|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
16470191|NCT01898494|40201386|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
16470192|NCT01898494|40201382|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
16470193|NCT01898494|40201383|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
16470194|NCT01898494|40201384|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
16470195|NCT01898494|40201385|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
16470196|NCT01898494|40201386|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
16470197|NCT01898494|40201382|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
16470198|NCT01898494|40201383|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
16470199|NCT01898494|40201384|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
16470200|NCT01898494|40201385|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
16470201|NCT01898494|40201386|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
16470202|NCT01898494|40201382|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
16470203|NCT01898494|40201383|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
16470204|NCT01898494|40201384|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
16470205|NCT01898494|40201385|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
16470206|NCT01898494|40201386|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
16470207|NCT01898494|40201382|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
16470208|NCT01898494|40201383|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
16470209|NCT01898494|40201384|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
16470210|NCT01898494|40201385|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
16470211|NCT01898494|40201386|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
16470212|NCT01898494|40201382|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
16470213|NCT01898494|40201383|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
16470214|NCT01898494|40201384|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
16470215|NCT01898494|40201385|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
16470216|NCT01898494|40201386|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
16470217|NCT01898494|40201382|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
16470218|NCT01898494|40201383|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
16470219|NCT01898494|40201384|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
16470220|NCT01898494|40201385|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
16470221|NCT01898494|40201386|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
16470222|NCT01898494|40201382|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
16470223|NCT01898494|40201383|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
16470224|NCT01898494|40201384|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
16470225|NCT01898494|40201385|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
16470226|NCT01898494|40201386|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
16470227|NCT01898494|40201382|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
16470228|NCT01898494|40201383|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
16470229|NCT01898494|40201384|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
16470230|NCT01898494|40201385|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
16470231|NCT01898494|40201386|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
16470232|NCT01898494|40201382|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
16470233|NCT01898494|40201383|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
16470234|NCT01898494|40201384|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
16470235|NCT01898494|40201385|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
16470236|NCT01898494|40201386|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
16470237|NCT01898494|40201382|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
16470238|NCT01898494|40201383|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
16470239|NCT01898494|40201384|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
16470240|NCT01898494|40201385|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
16470241|NCT01898494|40201386|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
16470242|NCT01898494|40201382|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
16470243|NCT01898494|40201383|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
16470244|NCT01898494|40201384|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
16470245|NCT01898494|40201385|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
16470246|NCT01898494|40201386|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
16470247|NCT01898494|40201382|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
16470248|NCT01898494|40201383|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
16470249|NCT01898494|40201384|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
16470250|NCT01898494|40201385|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
16470251|NCT01898494|40201386|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
16470252|NCT02320903|40201387|FG000|Overall Study|Withdrawal by Subject|0|||
16470253|NCT02320903|40201388|FG001|Overall Study|Withdrawal by Subject|9|||
16470254|NCT02320903|40201389|FG002|Overall Study|Withdrawal by Subject|9|||
16470255|NCT02320903|40201387|FG000|Overall Study|Exited therapy; no longer eligible|8|||
16470256|NCT02320903|40201388|FG001|Overall Study|Exited therapy; no longer eligible|2|||
16470257|NCT02320903|40201389|FG002|Overall Study|Exited therapy; no longer eligible|2|||
16470258|NCT02320903|40201387|FG000|Overall Study|Lost to Follow-up|0|||
16470259|NCT02320903|40201388|FG001|Overall Study|Lost to Follow-up|5|||
16470260|NCT02320903|40201389|FG002|Overall Study|Lost to Follow-up|5|||
16470261|NCT01629706|40201390|FG000|Phase 1 PureVision|Screen Failure|4|||
16470262|NCT01629706|40201390|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
16470263|NCT01629706|40201390|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
16470264|NCT01629706|40201390|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
16470265|NCT01629706|40201390|FG000|Phase 2 Habitual|Screen Failure|6|||
16470266|NCT01629706|40201390|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
16470267|NCT01629706|40201390|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
16470268|NCT01629706|40201390|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
16470269|NCT01629706|40201390|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
16470270|NCT00568685|40201398|FG000|Overall Study|Adverse Event|2|||
16470271|NCT00568685|40201399|FG001|Overall Study|Adverse Event|3|||
16470272|NCT00568685|40201400|FG002|Overall Study|Adverse Event|3|||
16470273|NCT00568685|40201398|FG000|Overall Study|Withdrawal by Subject|7|||
16470274|NCT00568685|40201399|FG001|Overall Study|Withdrawal by Subject|2|||
16470275|NCT00568685|40201400|FG002|Overall Study|Withdrawal by Subject|2|||
16470276|NCT00568685|40201398|FG000|Overall Study|Protocol Violation|1|||
16470277|NCT00568685|40201399|FG001|Overall Study|Protocol Violation|0|||
16470278|NCT00568685|40201400|FG002|Overall Study|Protocol Violation|0|||
16470279|NCT01437878|40201401|FG000|Overall Study|Withdrawal by Subject|1|||
16470280|NCT01437878|40201402|FG001|Overall Study|Withdrawal by Subject|0|||
16470281|NCT01931202|40201405|FG000|Overall Study|Withdrawal by Subject|0|||
16470282|NCT01931202|40201406|FG001|Overall Study|Withdrawal by Subject|0|||
16470283|NCT01931202|40201407|FG002|Overall Study|Withdrawal by Subject|2|||
16470284|NCT01931202|40201405|FG000|Overall Study|Lost to Follow-up|0|||
16470285|NCT01931202|40201406|FG001|Overall Study|Lost to Follow-up|5|||
16470286|NCT01931202|40201407|FG002|Overall Study|Lost to Follow-up|2|||
16470287|NCT01484132|40201408|FG000|Overall Study|Lost to Follow-up|8|||
16470288|NCT01484132|40201408|FG000|Overall Study|Difficulty with time commitment|2|||
16470289|NCT01484132|40201408|FG000|Overall Study|Ineligible|1|||
16470290|NCT01484132|40201408|FG000|Overall Study|No pre-treatment urine sample collected|1|||
16470291|NCT01484132|40201408|FG000|Overall Study|No post-treatment urine sample collected|10|||
16470292|NCT01143207|40201409|FG000|Overall Study|Lost to Follow-up|2|||
16470293|NCT02537574|40201411|FG000|Overall Study|Adverse Event|1|||
16470294|NCT02537574|40201412|FG001|Overall Study|Adverse Event|3|||
16470295|NCT02537574|40201413|FG002|Overall Study|Adverse Event|2|||
16470296|NCT02537574|40201411|FG000|Overall Study|Lost to Follow-up|40|||
16470297|NCT02537574|40201412|FG001|Overall Study|Lost to Follow-up|51|||
16470298|NCT02537574|40201413|FG002|Overall Study|Lost to Follow-up|55|||
16470299|NCT02537574|40201411|FG000|Overall Study|Noncompliance with study drug|0|||
16470300|NCT02537574|40201412|FG001|Overall Study|Noncompliance with study drug|1|||
16470301|NCT02537574|40201413|FG002|Overall Study|Noncompliance with study drug|1|||
16470302|NCT02537574|40201411|FG000|Overall Study|Physician Decision|2|||
16470303|NCT02537574|40201412|FG001|Overall Study|Physician Decision|0|||
16470304|NCT02537574|40201413|FG002|Overall Study|Physician Decision|0|||
16470305|NCT02537574|40201411|FG000|Overall Study|Protocol Violation|4|||
16470306|NCT02537574|40201412|FG001|Overall Study|Protocol Violation|2|||
16470307|NCT02537574|40201413|FG002|Overall Study|Protocol Violation|3|||
16470308|NCT02537574|40201411|FG000|Overall Study|Withdrawal by Subject|37|||
16470309|NCT02537574|40201412|FG001|Overall Study|Withdrawal by Subject|27|||
16470310|NCT02537574|40201413|FG002|Overall Study|Withdrawal by Subject|29|||
16470311|NCT02537574|40201411|FG000|Overall Study|Lack of Efficacy|14|||
16470312|NCT02537574|40201412|FG001|Overall Study|Lack of Efficacy|16|||
16470313|NCT02537574|40201413|FG002|Overall Study|Lack of Efficacy|15|||
16470314|NCT02537574|40201411|FG000|Overall Study|Duplicate Patient|1|||
16470315|NCT02537574|40201412|FG001|Overall Study|Duplicate Patient|0|||
16470316|NCT02537574|40201413|FG002|Overall Study|Duplicate Patient|0|||
16470317|NCT02537574|40201411|FG000|Overall Study|Patient not Stable|0|||
16470318|NCT02537574|40201412|FG001|Overall Study|Patient not Stable|1|||
16470319|NCT02537574|40201413|FG002|Overall Study|Patient not Stable|0|||
16470320|NCT02537574|40201411|FG000|Overall Study|Incarceration|0|||
16470321|NCT02537574|40201412|FG001|Overall Study|Incarceration|1|||
16470322|NCT02537574|40201413|FG002|Overall Study|Incarceration|0|||
16470323|NCT02537574|40201411|FG000|Overall Study|Failed Naloxone Challenge|0|||
16470324|NCT02537574|40201412|FG001|Overall Study|Failed Naloxone Challenge|1|||
16470325|NCT02537574|40201413|FG002|Overall Study|Failed Naloxone Challenge|0|||
16470326|NCT02537574|40201411|FG000|Overall Study|Transportation Issues|0|||
16470327|NCT02537574|40201412|FG001|Overall Study|Transportation Issues|0|||
16470328|NCT02537574|40201413|FG002|Overall Study|Transportation Issues|1|||
16272431|NCT01695239|39480441|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
16470329|NCT02537574|40201411|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
16470330|NCT02537574|40201412|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
16470331|NCT02537574|40201413|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
16470332|NCT02537574|40201411|FG000|Overall Study|Noncompliance with Protocol|0|||
16470333|NCT02537574|40201412|FG001|Overall Study|Noncompliance with Protocol|0|||
16470334|NCT02537574|40201413|FG002|Overall Study|Noncompliance with Protocol|1|||
16470335|NCT00596362|40201414|FG000|Overall Study|Progressive Disease|1|||
16470336|NCT02961218|40201415|FG000|Overall Study|Lost to Follow-up|0|||
16470337|NCT02961218|40201416|FG001|Overall Study|Lost to Follow-up|2|||
16470338|NCT02961218|40201415|FG000|Overall Study|Physician Decision|0|||
16470339|NCT02961218|40201416|FG001|Overall Study|Physician Decision|2|||
16470340|NCT02961218|40201415|FG000|Overall Study|Subject/Guardian Decision|3|||
16470341|NCT02961218|40201416|FG001|Overall Study|Subject/Guardian Decision|1|||
16470342|NCT02059005|40201419|FG000|Overall Study|Death|1|||
16470343|NCT02059005|40201420|FG001|Overall Study|Death|3|||
16470344|NCT02059005|40201419|FG000|Overall Study|Lost to Follow-up|19|||
16470345|NCT02059005|40201420|FG001|Overall Study|Lost to Follow-up|19|||
16470346|NCT02059005|40201419|FG000|Overall Study|Incarceration|0|||
16470347|NCT02059005|40201420|FG001|Overall Study|Incarceration|1|||
16470348|NCT02059005|40201419|FG000|Overall Study|Inpatient|0|||
16470349|NCT02059005|40201420|FG001|Overall Study|Inpatient|1|||
16470350|NCT00510874|40201423|FG000|Overall Study|Withdrawal by Subject|1|||
16470351|NCT00510874|40201424|FG001|Overall Study|Withdrawal by Subject|1|||
16470352|NCT00510874|40201425|FG002|Overall Study|Withdrawal by Subject|0|||
16470353|NCT00510874|40201426|FG003|Overall Study|Withdrawal by Subject|0|||
16470354|NCT00510874|40201427|FG004|Overall Study|Withdrawal by Subject|3|||
16470355|NCT00510874|40201428|FG005|Overall Study|Withdrawal by Subject|0|||
16470356|NCT00510874|40201429|FG006|Overall Study|Withdrawal by Subject|0|||
16470357|NCT00510874|40201423|FG000|Overall Study|Lost to Follow-up|2|||
16470358|NCT00510874|40201424|FG001|Overall Study|Lost to Follow-up|3|||
16470359|NCT00510874|40201425|FG002|Overall Study|Lost to Follow-up|1|||
16470360|NCT00510874|40201426|FG003|Overall Study|Lost to Follow-up|3|||
16470361|NCT00510874|40201427|FG004|Overall Study|Lost to Follow-up|4|||
16470362|NCT00510874|40201428|FG005|Overall Study|Lost to Follow-up|0|||
16470363|NCT00510874|40201429|FG006|Overall Study|Lost to Follow-up|1|||
16470364|NCT01756300|40201432|FG000|Overall Study|Death|1|||
16470365|NCT01756300|40201432|FG000|Overall Study|Withdrawal by Subject|1|||
16470366|NCT00920829|40201436|FG000|Allocation|No post randomization data|3|||
16470367|NCT00920829|40201437|FG001|Allocation|No post randomization data|1|||
16470368|NCT00920829|40201438|FG002|Allocation|No post randomization data|0|||
16470369|NCT00920829|40201439|FG003|Allocation|No post randomization data|2|||
16470370|NCT00920829|40201436|FG000|Available for Analysis|Withdrawal by Subject|6|||
16470371|NCT00920829|40201437|FG001|Available for Analysis|Withdrawal by Subject|6|||
16470372|NCT00920829|40201438|FG002|Available for Analysis|Withdrawal by Subject|6|||
16470373|NCT00920829|40201439|FG003|Available for Analysis|Withdrawal by Subject|10|||
16470374|NCT00920829|40201436|FG000|Available for Analysis|Required Medical Treatment|0|||
16470375|NCT00920829|40201437|FG001|Available for Analysis|Required Medical Treatment|1|||
16470376|NCT00920829|40201438|FG002|Available for Analysis|Required Medical Treatment|2|||
16470377|NCT00920829|40201439|FG003|Available for Analysis|Required Medical Treatment|0|||
16470378|NCT00920829|40201436|FG000|Available for Analysis|Adverse Event|1|||
16470379|NCT00920829|40201437|FG001|Available for Analysis|Adverse Event|2|||
16470380|NCT00920829|40201438|FG002|Available for Analysis|Adverse Event|1|||
16470381|NCT00920829|40201439|FG003|Available for Analysis|Adverse Event|0|||
16470382|NCT00920829|40201436|FG000|Available for Analysis|Death|1|||
16470383|NCT00920829|40201437|FG001|Available for Analysis|Death|0|||
16470384|NCT00920829|40201438|FG002|Available for Analysis|Death|0|||
16470385|NCT00920829|40201439|FG003|Available for Analysis|Death|0|||
16470386|NCT00920829|40201436|FG000|Available for Analysis|Protocol Violation|0|||
16470387|NCT00920829|40201437|FG001|Available for Analysis|Protocol Violation|0|||
16470388|NCT00920829|40201438|FG002|Available for Analysis|Protocol Violation|1|||
16470389|NCT00920829|40201439|FG003|Available for Analysis|Protocol Violation|0|||
16470390|NCT00920829|40201436|FG000|Available for Analysis|Required more treatment|0|||
16470391|NCT00920829|40201437|FG001|Available for Analysis|Required more treatment|2|||
16470392|NCT00920829|40201438|FG002|Available for Analysis|Required more treatment|0|||
16470393|NCT00920829|40201439|FG003|Available for Analysis|Required more treatment|1|||
16470394|NCT02496676|40201444|FG000|Phase 1 - Period 1|Adverse Event|0|||
16470395|NCT02496676|40201445|FG001|Phase 1 - Period 1|Adverse Event|1|||
16470396|NCT02496676|40201444|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
16470397|NCT02496676|40201445|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
16470398|NCT02038452|40201453|FG000|Overall Study|Withdrawal by Subject|7|||
16470399|NCT02038452|40201454|FG001|Overall Study|Withdrawal by Subject|9|||
16470400|NCT02038452|40201453|FG000|Overall Study|Lost to Follow-up|31|||
16470401|NCT02038452|40201454|FG001|Overall Study|Lost to Follow-up|28|||
16470402|NCT01711879|40201455|FG000|Overall Study|Death|1|||
16470403|NCT01711879|40201456|FG001|Overall Study|Death|0|||
16470404|NCT05867342|40201457|FG000|Overall Study|Investigator Decision|3|||
16470405|NCT05867342|40201458|FG001|Overall Study|Investigator Decision|3|||
16470406|NCT04271280|40201459|FG000|Overall Study|Lost to Follow-up|300|||
16470407|NCT04271280|40201459|FG000|Overall Study|Death|153|||
16470408|NCT04271280|40201459|FG000|Overall Study|Withdrawal of consent by patient|59|||
16470409|NCT04271280|40201459|FG000|Overall Study|Other|51|||
16470410|NCT04271280|40201459|FG000|Overall Study|No end of study information|42|||
16470411|NCT02923427|40201466|FG000|Overall Study|convert to laparatomy|2|||
16470412|NCT02923427|40201467|FG001|Overall Study|convert to laparatomy|2|||
16470413|NCT02923427|40201466|FG000|Overall Study|destaturation|1|||
16470414|NCT02923427|40201467|FG001|Overall Study|destaturation|0|||
16470415|NCT02923427|40201466|FG000|Overall Study|can not replace LMA|1|||
16470416|NCT02923427|40201467|FG001|Overall Study|can not replace LMA|0|||
16470417|NCT02730208|40201468|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
16470418|NCT02730208|40201469|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
16470419|NCT01070043|40201474|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
16470420|NCT01070043|40201475|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
16470421|NCT01070043|40201476|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
16470422|NCT01070043|40201474|FG000|Double-Blind Treatment|Adverse Event|0|||
16470423|NCT01070043|40201475|FG001|Double-Blind Treatment|Adverse Event|0|||
16470424|NCT01070043|40201476|FG002|Double-Blind Treatment|Adverse Event|2|||
16470425|NCT00686998|40201477|FG000|Overall Study|Adverse Event|3|||
16470426|NCT00686998|40201478|FG001|Overall Study|Adverse Event|2|||
16470427|NCT00686998|40201479|FG002|Overall Study|Adverse Event|1|||
16470428|NCT00686998|40201477|FG000|Overall Study|Withdrawal by Subject|2|||
16470429|NCT00686998|40201478|FG001|Overall Study|Withdrawal by Subject|1|||
16470430|NCT00686998|40201479|FG002|Overall Study|Withdrawal by Subject|2|||
16470431|NCT00686998|40201477|FG000|Overall Study|Lack of Efficacy|7|||
16470432|NCT00686998|40201478|FG001|Overall Study|Lack of Efficacy|5|||
16272432|NCT01695239|39480442|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272433|NCT01695239|39480443|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272434|NCT01695239|39480444|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272435|NCT01695239|39480445|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272436|NCT01695239|39480446|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272437|NCT01695239|39480447|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
16272438|NCT01695239|39480434|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272439|NCT01695239|39480435|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272440|NCT01695239|39480436|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272441|NCT01695239|39480437|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272442|NCT01695239|39480438|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272443|NCT01695239|39480439|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272444|NCT01695239|39480440|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272445|NCT01695239|39480441|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
16272446|NCT01695239|39480442|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272447|NCT01695239|39480443|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272448|NCT01695239|39480444|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272449|NCT01695239|39480445|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272450|NCT01695239|39480446|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272451|NCT01695239|39480447|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
16272452|NCT01695239|39480434|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272453|NCT01695239|39480435|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272454|NCT01695239|39480436|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272455|NCT01695239|39480437|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272456|NCT01695239|39480438|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272457|NCT01695239|39480439|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272458|NCT01695239|39480440|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272459|NCT01695239|39480441|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272460|NCT01695239|39480442|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
16272461|NCT01695239|39480443|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
16272462|NCT01695239|39480444|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272463|NCT01695239|39480445|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272464|NCT01695239|39480446|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272465|NCT01695239|39480447|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
16272466|NCT01695239|39480434|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
16272467|NCT01695239|39480435|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
16272468|NCT01695239|39480436|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
16272469|NCT01695239|39480437|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
16272470|NCT01695239|39480438|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
16470433|NCT00686998|40201479|FG002|Overall Study|Lack of Efficacy|0|||
16470434|NCT00686998|40201477|FG000|Overall Study|Other|0|||
16470435|NCT00686998|40201478|FG001|Overall Study|Other|0|||
16470436|NCT00686998|40201479|FG002|Overall Study|Other|1|||
16272471|NCT01695239|39480439|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
16272472|NCT01695239|39480440|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
16272473|NCT01695239|39480441|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
16272474|NCT01695239|39480442|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
16272475|NCT01695239|39480443|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
16272476|NCT01695239|39480444|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
16272477|NCT01695239|39480445|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
16272478|NCT01695239|39480446|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
16272479|NCT01695239|39480447|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
16272480|NCT01695239|39480434|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272481|NCT01695239|39480435|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272482|NCT01695239|39480436|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272483|NCT01695239|39480437|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272484|NCT01695239|39480438|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272485|NCT01695239|39480439|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272486|NCT01695239|39480440|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272487|NCT01695239|39480441|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272488|NCT01695239|39480442|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
16272489|NCT01695239|39480443|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
16272490|NCT01695239|39480444|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272491|NCT01695239|39480445|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272492|NCT01695239|39480446|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272493|NCT01695239|39480447|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
16272494|NCT01695239|39480434|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
16272495|NCT01695239|39480435|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
16272496|NCT01695239|39480436|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
16272497|NCT01695239|39480437|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
16272498|NCT01695239|39480438|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
16272499|NCT01695239|39480439|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
16272500|NCT01695239|39480440|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
16272501|NCT01695239|39480441|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
16272502|NCT01695239|39480442|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
16272503|NCT01695239|39480443|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
16272504|NCT01695239|39480444|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
16272505|NCT01695239|39480445|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
16272506|NCT01695239|39480446|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
16272507|NCT01695239|39480447|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
16272508|NCT01695239|39480434|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272509|NCT01695239|39480435|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272510|NCT01695239|39480436|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272511|NCT01695239|39480437|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272512|NCT01695239|39480438|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272513|NCT01695239|39480439|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272514|NCT01695239|39480440|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272515|NCT01695239|39480441|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272516|NCT01695239|39480442|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
16272517|NCT01695239|39480443|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
16272518|NCT01695239|39480444|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272519|NCT01695239|39480445|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272520|NCT01695239|39480446|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272521|NCT01695239|39480447|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
16272522|NCT01695239|39480434|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272523|NCT01695239|39480435|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272524|NCT01695239|39480436|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272525|NCT01695239|39480437|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272526|NCT01695239|39480438|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272527|NCT01695239|39480439|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272528|NCT01695239|39480440|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272529|NCT01695239|39480441|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272530|NCT01695239|39480442|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
16272531|NCT01695239|39480443|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
16272532|NCT01695239|39480444|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272533|NCT01695239|39480445|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16470437|NCT00686998|40201477|FG000|Overall Study|Safety Reasons|1|||
16470438|NCT00686998|40201478|FG001|Overall Study|Safety Reasons|0|||
16272534|NCT01695239|39480446|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272535|NCT01695239|39480447|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
16272536|NCT01695239|39480434|FG000|Extension Long-Term Extension Periods|Death|0|||
16272537|NCT01695239|39480435|FG001|Extension Long-Term Extension Periods|Death|0|||
16272538|NCT01695239|39480436|FG002|Extension Long-Term Extension Periods|Death|0|||
16272539|NCT01695239|39480437|FG003|Extension Long-Term Extension Periods|Death|0|||
16272540|NCT01695239|39480438|FG004|Extension Long-Term Extension Periods|Death|0|||
16272541|NCT01695239|39480439|FG005|Extension Long-Term Extension Periods|Death|0|||
16272542|NCT01695239|39480440|FG006|Extension Long-Term Extension Periods|Death|0|||
16272543|NCT01695239|39480441|FG007|Extension Long-Term Extension Periods|Death|0|||
16272544|NCT01695239|39480442|FG008|Extension Long-Term Extension Periods|Death|1|||
16272545|NCT01695239|39480443|FG009|Extension Long-Term Extension Periods|Death|0|||
16272546|NCT01695239|39480444|FG010|Extension Long-Term Extension Periods|Death|0|||
16272547|NCT01695239|39480445|FG011|Extension Long-Term Extension Periods|Death|0|||
16272548|NCT01695239|39480446|FG012|Extension Long-Term Extension Periods|Death|0|||
16272549|NCT01695239|39480447|FG013|Extension Long-Term Extension Periods|Death|0|||
16272550|NCT01695239|39480434|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272551|NCT01695239|39480435|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272552|NCT01695239|39480436|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272553|NCT01695239|39480437|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272554|NCT01695239|39480438|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272555|NCT01695239|39480439|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272556|NCT01695239|39480440|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272557|NCT01695239|39480441|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272558|NCT01695239|39480442|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272559|NCT01695239|39480443|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272560|NCT01695239|39480444|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
16272561|NCT01695239|39480445|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
16272562|NCT01695239|39480446|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
16272563|NCT01695239|39480447|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
16272564|NCT01695239|39480434|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272565|NCT01695239|39480435|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272566|NCT01695239|39480436|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272567|NCT01695239|39480437|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272568|NCT01695239|39480438|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272569|NCT01695239|39480439|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272570|NCT01695239|39480440|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272571|NCT01695239|39480441|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272572|NCT01695239|39480442|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272573|NCT01695239|39480443|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272574|NCT01695239|39480444|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272575|NCT01695239|39480445|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
16272576|NCT01695239|39480446|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
16272577|NCT01695239|39480447|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
16272578|NCT01695239|39480434|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272579|NCT01695239|39480435|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272580|NCT01695239|39480436|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272581|NCT01695239|39480437|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272582|NCT01695239|39480438|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272583|NCT01695239|39480439|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272584|NCT01695239|39480440|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272585|NCT01695239|39480441|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272586|NCT01695239|39480442|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272587|NCT01695239|39480443|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272588|NCT01695239|39480444|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272589|NCT01695239|39480445|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272590|NCT01695239|39480446|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
16272591|NCT01695239|39480447|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
16272592|NCT01695239|39480434|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272593|NCT01695239|39480435|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272594|NCT01695239|39480436|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272595|NCT01695239|39480437|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16470439|NCT00686998|40201479|FG002|Overall Study|Safety Reasons|0|||
16272596|NCT01695239|39480438|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272597|NCT01695239|39480439|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272598|NCT01695239|39480440|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272599|NCT01695239|39480441|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16273255|NCT01968551|39484475|FG002|Extension Phase|Death|0|||
16470440|NCT00433654|40201480|FG000|Overall Study|Death|4|||
16470441|NCT00433654|40201481|FG001|Overall Study|Death|0|||
16470442|NCT00433654|40201480|FG000|Overall Study|Missed visit|6|||
16470443|NCT00433654|40201481|FG001|Overall Study|Missed visit|3|||
16470444|NCT00433654|40201480|FG000|Overall Study|Subject not yet due for visit|4|||
16470445|NCT00433654|40201481|FG001|Overall Study|Subject not yet due for visit|0|||
16470446|NCT00433654|40201480|FG000|Overall Study|Withdrawal by Subject|1|||
16470447|NCT00433654|40201481|FG001|Overall Study|Withdrawal by Subject|2|||
16470448|NCT00058539|40201482|FG000|Overall Study|Disease progression|24|||
16470449|NCT00058539|40201482|FG000|Overall Study|Adverse Event|3|||
16470450|NCT00058539|40201482|FG000|Overall Study|Withdrawal by Subject|5|||
16470451|NCT00058539|40201482|FG000|Overall Study|Physician Decision|9|||
16470452|NCT00058539|40201482|FG000|Overall Study|Death|1|||
16470453|NCT00267189|40201487|FG000|Overall Study|Patient withdrew consent|1|||
16470454|NCT00267189|40201488|FG001|Overall Study|Patient withdrew consent|1|||
16470455|NCT00267189|40201487|FG000|Overall Study|Death|1|||
16470456|NCT00267189|40201488|FG001|Overall Study|Death|0|||
16470457|NCT00267189|40201487|FG000|Overall Study|Missing|3|||
16470458|NCT00267189|40201488|FG001|Overall Study|Missing|0|||
16470459|NCT03052764|40201489|FG000|Double-Blind Treatment Period|Adverse Event|2|||
16470460|NCT03052764|40201490|FG001|Double-Blind Treatment Period|Adverse Event|0|||
16470461|NCT03052764|40201489|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
16470462|NCT03052764|40201490|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
16470463|NCT03052764|40201489|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
16470464|NCT03052764|40201490|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
16470465|NCT03052764|40201489|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
16470466|NCT03052764|40201490|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
16470467|NCT03052764|40201489|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
16470468|NCT03052764|40201490|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
16470469|NCT02278471|40201492|FG000|Overall Study|Lost to Follow-up|6|||
16470470|NCT02278471|40201493|FG001|Overall Study|Lost to Follow-up|15|||
16470471|NCT02278471|40201492|FG000|Overall Study|Death|2|||
16470472|NCT02278471|40201493|FG001|Overall Study|Death|2|||
16470473|NCT02278471|40201492|FG000|Overall Study|Withdrawal by Subject|0|||
16470474|NCT02278471|40201493|FG001|Overall Study|Withdrawal by Subject|3|||
16470475|NCT04179890|40201494|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
16470476|NCT04179890|40201495|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
16470477|NCT04179890|40201494|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
16470478|NCT04179890|40201495|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
16470479|NCT04179890|40201494|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
16470480|NCT04179890|40201495|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
16470481|NCT04179890|40201494|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
16470482|NCT04179890|40201495|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
16470483|NCT04179890|40201494|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
16470484|NCT04179890|40201495|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
16470485|NCT04179890|40201494|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
16470486|NCT04179890|40201495|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
16470487|NCT04179890|40201494|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
16470488|NCT04179890|40201495|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
16470489|NCT04179890|40201494|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
16470490|NCT04179890|40201495|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
16470491|NCT04179890|40201494|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
16470492|NCT04179890|40201495|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
16470493|NCT00761579|40201499|FG000|Overall Study|Adverse Event|10|||
16470494|NCT00761579|40201499|FG000|Overall Study|Death|2|||
16470495|NCT00761579|40201499|FG000|Overall Study|Lack of Efficacy|21|||
16470496|NCT00761579|40201499|FG000|Overall Study|Lost to Follow-up|16|||
16470497|NCT00761579|40201499|FG000|Overall Study|Pregnancy|1|||
16470498|NCT00761579|40201499|FG000|Overall Study|Withdrawal by Subject|34|||
16470499|NCT00761579|40201499|FG000|Overall Study|Lack of compliance|2|||
16470500|NCT00761579|40201499|FG000|Overall Study|Protocol deviation|1|||
16470501|NCT00761579|40201499|FG000|Overall Study|Drug overdose|1|||
16470502|NCT00761579|40201499|FG000|Overall Study|Aggravation of depression|1|||
16470503|NCT00761579|40201499|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
16470504|NCT00761579|40201499|FG000|Overall Study|Lost survey form|1|||
16470505|NCT00761579|40201499|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
16470506|NCT01757691|40201502|FG000|Overall Study|Administrative problems|2|||
16470507|NCT01757691|40201503|FG001|Overall Study|Administrative problems|0|||
16470508|NCT02011893|40201504|FG000|Enrollment to Randomization|Adverse Event|2|||
16470509|NCT02011893|40201505|FG001|Enrollment to Randomization|Adverse Event|0|||
16470510|NCT02011893|40201506|FG002|Enrollment to Randomization|Adverse Event|0|||
16470511|NCT02011893|40201504|FG000|Enrollment to Randomization|Physician Decision|10|||
16470512|NCT02011893|40201505|FG001|Enrollment to Randomization|Physician Decision|0|||
16470513|NCT02011893|40201506|FG002|Enrollment to Randomization|Physician Decision|0|||
16470514|NCT02011893|40201504|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
16470515|NCT02011893|40201505|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
16470516|NCT02011893|40201506|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
16470517|NCT02011893|40201504|FG000|Enrollment to Randomization|Screening Failure|29|||
16470518|NCT02011893|40201505|FG001|Enrollment to Randomization|Screening Failure|0|||
16470519|NCT02011893|40201506|FG002|Enrollment to Randomization|Screening Failure|0|||
16470520|NCT02011893|40201504|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
16470521|NCT02011893|40201505|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
16470522|NCT02011893|40201506|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
16470523|NCT02011893|40201504|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
16470524|NCT02011893|40201505|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
16470525|NCT02011893|40201506|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
16470526|NCT02011893|40201504|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
16470527|NCT02011893|40201505|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
16470528|NCT02011893|40201506|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
16470529|NCT02011893|40201504|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
16470530|NCT02011893|40201505|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
16470531|NCT02011893|40201506|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
16470532|NCT02011893|40201504|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
16470533|NCT02011893|40201505|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
16470534|NCT02011893|40201506|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
16470535|NCT00006389|40201516|FG000|Overall Study|Adverse Event|1|||
16470536|NCT00740051|40201523|FG000|Overall Study|Lack of Efficacy|2|||
16470537|NCT00740051|40201524|FG001|Overall Study|Lack of Efficacy|5|||
16470538|NCT00740051|40201523|FG000|Overall Study|Adverse Event|1|||
16470539|NCT00740051|40201524|FG001|Overall Study|Adverse Event|4|||
16470540|NCT00740051|40201523|FG000|Overall Study|Protocol Violation|2|||
16470541|NCT00740051|40201524|FG001|Overall Study|Protocol Violation|6|||
16470542|NCT00740051|40201523|FG000|Overall Study|Lost to Follow-up|3|||
16470543|NCT00740051|40201524|FG001|Overall Study|Lost to Follow-up|8|||
16470544|NCT00740051|40201523|FG000|Overall Study|Withdrawal by Subject|6|||
16272600|NCT01695239|39480442|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272601|NCT01695239|39480443|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272602|NCT01695239|39480444|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272603|NCT01695239|39480445|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272604|NCT01695239|39480446|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
16272605|NCT01695239|39480447|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
16272606|NCT02651987|39480452|FG000|Overall Study|Adverse Event|2|||
16272607|NCT02651987|39480453|FG001|Overall Study|Adverse Event|2|||
16272608|NCT02651987|39480452|FG000|Overall Study|Consent Withdrawn|2|||
16272609|NCT02651987|39480453|FG001|Overall Study|Consent Withdrawn|0|||
16272610|NCT02651987|39480452|FG000|Overall Study|Local PD|0|||
16272611|NCT02651987|39480453|FG001|Overall Study|Local PD|2|||
16272612|NCT02651987|39480452|FG000|Overall Study|Investigator Decision|1|||
16272613|NCT02651987|39480453|FG001|Overall Study|Investigator Decision|1|||
16272614|NCT00503867|39480454|FG000|Overall Study|Lost to Follow-up|1|||
16272615|NCT00503867|39480454|FG000|Overall Study|Adverse Event|1|||
16272616|NCT02817828|39480457|FG000|Overall Study|Lost to Follow-up|41|||
16272617|NCT02817828|39480457|FG000|Overall Study|Adverse event not related to bleeding|104|||
16272618|NCT02817828|39480457|FG000|Overall Study|Adverse event related to bleeding|53|||
16272619|NCT02817828|39480457|FG000|Overall Study|Protocol Violation|11|||
16272620|NCT02817828|39480457|FG000|Overall Study|Pregnancy|7|||
16272621|NCT02817828|39480457|FG000|Overall Study|Pregnancy wish|15|||
16272622|NCT02817828|39480457|FG000|Overall Study|Withdrawal by Subject|78|||
16272623|NCT02817828|39480457|FG000|Overall Study|Other|26|||
16272624|NCT00633022|39480460|FG000|Overall Study|Adverse Event|1|||
16272625|NCT00633022|39480461|FG001|Overall Study|Adverse Event|0|||
16272626|NCT00633022|39480462|FG002|Overall Study|Adverse Event|5|||
16272627|NCT00633022|39480460|FG000|Overall Study|Physician Decision|0|||
16272628|NCT00633022|39480461|FG001|Overall Study|Physician Decision|1|||
16272629|NCT00633022|39480462|FG002|Overall Study|Physician Decision|0|||
16272630|NCT01962298|39480466|FG000|Overall Study|Protocol Violation|1|||
16272631|NCT01962298|39480467|FG001|Overall Study|Protocol Violation|0|||
16272632|NCT01962298|39480468|FG002|Overall Study|Protocol Violation|1|||
16272633|NCT01962298|39480469|FG003|Overall Study|Protocol Violation|1|||
16272634|NCT01962298|39480470|FG004|Overall Study|Protocol Violation|0|||
16470545|NCT00740051|40201524|FG001|Overall Study|Withdrawal by Subject|8|||
16272635|NCT01962298|39480466|FG000|Overall Study|Data quality insufficient|2|||
16272636|NCT01962298|39480467|FG001|Overall Study|Data quality insufficient|0|||
16272637|NCT01962298|39480468|FG002|Overall Study|Data quality insufficient|3|||
16272638|NCT01962298|39480469|FG003|Overall Study|Data quality insufficient|1|||
16272639|NCT01962298|39480470|FG004|Overall Study|Data quality insufficient|4|||
16272640|NCT01962298|39480466|FG000|Overall Study|Insufficient data|0|||
16272641|NCT01962298|39480467|FG001|Overall Study|Insufficient data|2|||
16272642|NCT01962298|39480468|FG002|Overall Study|Insufficient data|1|||
16272643|NCT01962298|39480469|FG003|Overall Study|Insufficient data|0|||
16272644|NCT01962298|39480470|FG004|Overall Study|Insufficient data|1|||
16272645|NCT01962298|39480466|FG000|Overall Study|Incorrect data recorded|0|||
16272646|NCT01962298|39480467|FG001|Overall Study|Incorrect data recorded|1|||
16272647|NCT01962298|39480468|FG002|Overall Study|Incorrect data recorded|0|||
16272648|NCT01962298|39480469|FG003|Overall Study|Incorrect data recorded|0|||
16272649|NCT01962298|39480470|FG004|Overall Study|Incorrect data recorded|0|||
16272650|NCT01962298|39480466|FG000|Overall Study|Physician Decision|0|||
16272651|NCT01962298|39480467|FG001|Overall Study|Physician Decision|1|||
16272652|NCT01962298|39480468|FG002|Overall Study|Physician Decision|0|||
16272653|NCT01962298|39480469|FG003|Overall Study|Physician Decision|0|||
16272654|NCT01962298|39480470|FG004|Overall Study|Physician Decision|1|||
16272655|NCT01919112|39480473|FG000|Secondary Analysis-day 30|Death|1|||
16272656|NCT01919112|39480474|FG001|Secondary Analysis-day 30|Death|1|||
16272657|NCT01919112|39480475|FG002|Secondary Analysis-day 30|Death|1|||
16272658|NCT01919112|39480473|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
16272659|NCT01919112|39480474|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
16272660|NCT01919112|39480475|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
16272661|NCT02911701|39480479|FG000|Overall Study|Withdrawal by Subject|2|||
16272662|NCT02911701|39480480|FG001|Overall Study|Withdrawal by Subject|4|||
16272663|NCT02911701|39480479|FG000|Overall Study|Adverse Event|1|||
16272664|NCT02911701|39480480|FG001|Overall Study|Adverse Event|0|||
16272665|NCT03101358|39480487|FG000|Overall Study|Non-compliance with study schedule|1|||
16272666|NCT03101358|39480488|FG001|Overall Study|Non-compliance with study schedule|0|||
16272667|NCT03101358|39480489|FG002|Overall Study|Non-compliance with study schedule|0|||
16272668|NCT03101358|39480490|FG003|Overall Study|Non-compliance with study schedule|1|||
16272669|NCT03101358|39480487|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
16272670|NCT03101358|39480488|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
16272671|NCT03101358|39480489|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
16272672|NCT03101358|39480490|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
16272673|NCT03101358|39480487|FG000|Overall Study|Physician Decision|1|||
16272674|NCT03101358|39480488|FG001|Overall Study|Physician Decision|0|||
16272675|NCT03101358|39480489|FG002|Overall Study|Physician Decision|0|||
16272676|NCT03101358|39480490|FG003|Overall Study|Physician Decision|3|||
16272677|NCT03101358|39480487|FG000|Overall Study|Adverse Event|0|||
16272678|NCT03101358|39480488|FG001|Overall Study|Adverse Event|0|||
16272679|NCT03101358|39480489|FG002|Overall Study|Adverse Event|1|||
16272680|NCT03101358|39480490|FG003|Overall Study|Adverse Event|0|||
16272681|NCT03101358|39480487|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
16272682|NCT03101358|39480488|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
16272683|NCT03101358|39480489|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
16272684|NCT03101358|39480490|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
16272685|NCT03101358|39480487|FG000|Overall Study|Lost to Follow-up|1|||
16272686|NCT03101358|39480488|FG001|Overall Study|Lost to Follow-up|0|||
16272687|NCT03101358|39480489|FG002|Overall Study|Lost to Follow-up|0|||
16272688|NCT03101358|39480490|FG003|Overall Study|Lost to Follow-up|1|||
16272689|NCT02241551|39480494|FG000|Overall Study|Adverse Event|1|||
16272690|NCT02241551|39480495|FG001|Overall Study|Adverse Event|0|||
16272691|NCT03676634|39480496|FG000|Overall Study|Red blood cell loss|1|||
16272692|NCT03676634|39480496|FG000|Overall Study|Out-of-limit pulse|2|||
16272693|NCT02072096|39480497|FG000|Overall Study|Lack of Efficacy|18|||
16272694|NCT02072096|39480498|FG001|Overall Study|Lack of Efficacy|29|||
16272695|NCT02072096|39480497|FG000|Overall Study|Protocol Violation|7|||
16272696|NCT02072096|39480498|FG001|Overall Study|Protocol Violation|7|||
16272697|NCT02072096|39480497|FG000|Overall Study|Withdrawal by Subject|5|||
16272698|NCT02072096|39480498|FG001|Overall Study|Withdrawal by Subject|7|||
16272699|NCT02072096|39480497|FG000|Overall Study|Adverse Event|5|||
16272700|NCT02072096|39480498|FG001|Overall Study|Adverse Event|2|||
16272701|NCT02072096|39480497|FG000|Overall Study|No Reason Provided|4|||
16272702|NCT02072096|39480498|FG001|Overall Study|No Reason Provided|2|||
16272703|NCT02072096|39480497|FG000|Overall Study|Death|2|||
16272704|NCT02072096|39480498|FG001|Overall Study|Death|0|||
16272705|NCT02072096|39480497|FG000|Overall Study|Physician Decision|0|||
16272706|NCT02072096|39480498|FG001|Overall Study|Physician Decision|1|||
16272707|NCT02072096|39480497|FG000|Overall Study|Study Terminated by Sponsor|43|||
16272708|NCT02072096|39480498|FG001|Overall Study|Study Terminated by Sponsor|30|||
16272709|NCT02072096|39480497|FG000|Overall Study|Lost to Follow-up|1|||
16272710|NCT02072096|39480498|FG001|Overall Study|Lost to Follow-up|0|||
16272711|NCT01120028|39480503|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
16272712|NCT01120028|39480504|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
16272713|NCT01120028|39480505|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
16272714|NCT01120028|39480506|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
16272715|NCT01120028|39480503|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
16272716|NCT01120028|39480504|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
16272717|NCT01120028|39480505|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
16272718|NCT01120028|39480506|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
16272719|NCT03439085|39480507|FG000|Overall Study|Death|2|||
16272720|NCT03439085|39480507|FG000|Overall Study|Screen Failure|20|||
16272721|NCT04692155|39484279|FG000|Overall Study|Death|1|||
16272722|NCT01841060|39484280|FG000|Overall Study|Protocol Violation|10|||
16272723|NCT03119662|39484285|FG000|Overall Study|Withdrawal by Subject|0|||
16272724|NCT03119662|39484286|FG001|Overall Study|Withdrawal by Subject|1|||
16272725|NCT00515216|39484290|FG000|Overall Study|Withdrawal by Subject|1|||
16272726|NCT01051349|39484291|FG000|Overall Study|Adverse Event|88|||
16272727|NCT01051349|39484291|FG000|Overall Study|Consent Withdrawn|54|||
16272728|NCT01051349|39484291|FG000|Overall Study|Investigator Decision|6|||
16272729|NCT01051349|39484291|FG000|Overall Study|Lost to Follow-up|6|||
16272730|NCT01051349|39484291|FG000|Overall Study|Subject non-compliance|7|||
16272731|NCT01051349|39484291|FG000|Overall Study|Reason not Specified|12|||
16272732|NCT00003470|39484301|FG000|Overall Study|Not evaluable|6|||
16272733|NCT04583423|39484304|FG000|Overall Study|Lost to Follow-up|0|||
16272734|NCT04583423|39484305|FG001|Overall Study|Lost to Follow-up|1|||
16272735|NCT04583423|39484306|FG002|Overall Study|Lost to Follow-up|0|||
16272736|NCT04583423|39484307|FG003|Overall Study|Lost to Follow-up|2|||
16272737|NCT04583423|39484304|FG000|Overall Study|Study Terminated by Sponsor|32|||
16272738|NCT04583423|39484305|FG001|Overall Study|Study Terminated by Sponsor|35|||
16272739|NCT04583423|39484306|FG002|Overall Study|Study Terminated by Sponsor|36|||
16272740|NCT04583423|39484307|FG003|Overall Study|Study Terminated by Sponsor|33|||
16272741|NCT04583423|39484304|FG000|Overall Study|Withdrawal by Subject|3|||
16272742|NCT04583423|39484305|FG001|Overall Study|Withdrawal by Subject|1|||
16272743|NCT04583423|39484306|FG002|Overall Study|Withdrawal by Subject|2|||
16272744|NCT04583423|39484307|FG003|Overall Study|Withdrawal by Subject|1|||
16272745|NCT04411680|39484308|FG000|Treatment Period|Adverse Event|3|||
16272746|NCT04411680|39484309|FG001|Treatment Period|Adverse Event|0|||
16272747|NCT04411680|39484308|FG000|Treatment Period|Discharged from hospital|18|||
16272748|NCT04411680|39484309|FG001|Treatment Period|Discharged from hospital|7|||
16272749|NCT04411680|39484308|FG000|Treatment Period|Missed 1 or more doses|8|||
16272750|NCT04411680|39484309|FG001|Treatment Period|Missed 1 or more doses|0|||
16272751|NCT04411680|39484308|FG000|Treatment Period|Transferred to another hospital|0|||
16272752|NCT04411680|39484309|FG001|Treatment Period|Transferred to another hospital|1|||
16272753|NCT04411680|39484308|FG000|Follow up Period|Withdrawal by Subject|2|||
16272754|NCT04411680|39484309|FG001|Follow up Period|Withdrawal by Subject|0|||
16272755|NCT04411680|39484308|FG000|Follow up Period|Lost to Follow-up|5|||
16272756|NCT04411680|39484309|FG001|Follow up Period|Lost to Follow-up|6|||
16272757|NCT04411680|39484308|FG000|Follow up Period|Death|11|||
16272758|NCT04411680|39484309|FG001|Follow up Period|Death|8|||
16272759|NCT01049581|39484310|FG000|Overall Study|Lost to Follow-up|2|||
16272760|NCT01049581|39484311|FG001|Overall Study|Lost to Follow-up|1|||
16272761|NCT01169558|39484312|FG000|Overall Study|Disease progression|98|||
16272762|NCT01169558|39484312|FG000|Overall Study|Adverse Event|25|||
16272763|NCT01169558|39484312|FG000|Overall Study|Withdrawal of Consent|8|||
16272764|NCT01169558|39484312|FG000|Overall Study|Medical Decision|7|||
16272765|NCT01169558|39484312|FG000|Overall Study|Stable Disease|4|||
16272766|NCT01169558|39484312|FG000|Overall Study|Lost to Follow-up|4|||
16272767|NCT01169558|39484312|FG000|Overall Study|Need for Surgery|4|||
16272768|NCT01169558|39484312|FG000|Overall Study|Non-compliance|2|||
16272769|NCT01169558|39484312|FG000|Overall Study|Protocol Violation|2|||
16272770|NCT01169558|39484312|FG000|Overall Study|Partial response|2|||
16272771|NCT01686438|39484313|FG000|Overall Study|Lost to Follow-up|8|||
16272772|NCT01686438|39484314|FG001|Overall Study|Lost to Follow-up|9|||
16272773|NCT01686438|39484315|FG002|Overall Study|Lost to Follow-up|10|||
16272774|NCT01686438|39484313|FG000|Overall Study|Adverse Event|0|||
16272775|NCT01686438|39484314|FG001|Overall Study|Adverse Event|0|||
16272776|NCT01686438|39484315|FG002|Overall Study|Adverse Event|1|||
16272777|NCT01686438|39484313|FG000|Overall Study|Protocol Violation|0|||
16272778|NCT01686438|39484314|FG001|Overall Study|Protocol Violation|0|||
16272779|NCT01686438|39484315|FG002|Overall Study|Protocol Violation|1|||
16272780|NCT01686438|39484313|FG000|Overall Study|Withdrawal by Subject|0|||
16272781|NCT01686438|39484314|FG001|Overall Study|Withdrawal by Subject|0|||
16272782|NCT01686438|39484315|FG002|Overall Study|Withdrawal by Subject|1|||
16272783|NCT01083693|39484316|FG000|Overall Study|Adverse Event|1|||
16272784|NCT01083693|39484317|FG001|Overall Study|Adverse Event|1|||
16272785|NCT01083693|39484318|FG002|Overall Study|Adverse Event|0|||
16272786|NCT01083693|39484316|FG000|Overall Study|Lost to Follow-up|2|||
16272787|NCT01083693|39484317|FG001|Overall Study|Lost to Follow-up|0|||
16272788|NCT01083693|39484318|FG002|Overall Study|Lost to Follow-up|2|||
16272789|NCT01083693|39484316|FG000|Overall Study|Lack of effectiveness|13|||
16272790|NCT01083693|39484317|FG001|Overall Study|Lack of effectiveness|2|||
16272791|NCT01083693|39484318|FG002|Overall Study|Lack of effectiveness|2|||
16272792|NCT01083693|39484316|FG000|Overall Study|Patient Moved|0|||
16272793|NCT01083693|39484317|FG001|Overall Study|Patient Moved|1|||
16272794|NCT01083693|39484318|FG002|Overall Study|Patient Moved|0|||
16272795|NCT01083693|39484316|FG000|Overall Study|Complete remission|0|||
16272796|NCT01083693|39484317|FG001|Overall Study|Complete remission|1|||
16272797|NCT01083693|39484318|FG002|Overall Study|Complete remission|0|||
16272798|NCT01083693|39484316|FG000|Overall Study|Other medical condition/surgery|1|||
16272799|NCT01083693|39484317|FG001|Overall Study|Other medical condition/surgery|1|||
16272800|NCT01083693|39484318|FG002|Overall Study|Other medical condition/surgery|0|||
16272801|NCT01083693|39484316|FG000|Overall Study|Withdrawal by Subject|3|||
16272802|NCT01083693|39484317|FG001|Overall Study|Withdrawal by Subject|0|||
16272803|NCT01083693|39484318|FG002|Overall Study|Withdrawal by Subject|2|||
16272804|NCT01083693|39484316|FG000|Overall Study|Reason unknown|0|||
16272805|NCT01083693|39484317|FG001|Overall Study|Reason unknown|0|||
16272806|NCT01083693|39484318|FG002|Overall Study|Reason unknown|1|||
16272807|NCT01450800|39484319|FG000|Overall Study|Protocol Violation|1|||
16272808|NCT01450800|39484320|FG001|Overall Study|Protocol Violation|3|||
16272809|NCT00965731|39484323|FG000|Overall Study|Death|0|||
16272810|NCT00965731|39484324|FG001|Overall Study|Death|4|||
16272811|NCT00965731|39484323|FG000|Overall Study|Withdrawal by Subject|0|||
16272812|NCT00965731|39484324|FG001|Overall Study|Withdrawal by Subject|1|||
16272813|NCT00965731|39484323|FG000|Overall Study|Other|7|||
16272814|NCT00965731|39484324|FG001|Overall Study|Other|15|||
16272815|NCT01155531|39484325|FG000|Overall Study|Adverse Event|0|||
16272816|NCT01155531|39484326|FG001|Overall Study|Adverse Event|0|||
16272817|NCT01155531|39484327|FG002|Overall Study|Adverse Event|1|||
16272818|NCT01155531|39484328|FG003|Overall Study|Adverse Event|0|||
16272819|NCT01155531|39484325|FG000|Overall Study|Lost to Follow-up|0|||
16272820|NCT01155531|39484326|FG001|Overall Study|Lost to Follow-up|0|||
16272821|NCT01155531|39484327|FG002|Overall Study|Lost to Follow-up|0|||
16272822|NCT01155531|39484328|FG003|Overall Study|Lost to Follow-up|1|||
16272823|NCT01155531|39484325|FG000|Overall Study|Withdrawal by Subject|1|||
16272824|NCT01155531|39484326|FG001|Overall Study|Withdrawal by Subject|0|||
16272825|NCT01155531|39484327|FG002|Overall Study|Withdrawal by Subject|1|||
16272826|NCT01155531|39484328|FG003|Overall Study|Withdrawal by Subject|0|||
16272827|NCT01717313|39484332|FG000|Phase A (Weeks 0 to 24)|Death|0|||
16272828|NCT01717313|39484333|FG001|Phase A (Weeks 0 to 24)|Death|1|||
16272829|NCT01717313|39484332|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
16272830|NCT01717313|39484333|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
16272831|NCT01717313|39484332|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
16470546|NCT00740051|40201523|FG000|Overall Study|Other reason (not specified)|4|||
16470547|NCT00740051|40201524|FG001|Overall Study|Other reason (not specified)|1|||
16470548|NCT01321073|40201525|FG000|Overall Study|Did not attempt implant|4|||
16470549|NCT01321073|40201525|FG000|Overall Study|Death|3|||
16470550|NCT02375555|40201526|FG000|Induction Period|Adverse Event|7|||
16470551|NCT02375555|40201526|FG000|Induction Period|Withdrawal by Subject|2|||
16470552|NCT02375555|40201526|FG000|Induction Period|Other|1|||
16470553|NCT02375555|40201526|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
16470554|NCT02375555|40201526|FG000|Maintenance Period|Adverse Event|2|||
16470555|NCT02375555|40201526|FG000|Maintenance Period|Withdrawal by Subject|4|||
16470556|NCT02375555|40201526|FG000|Maintenance Period|Death|1|||
16470557|NCT02375555|40201526|FG000|Maintenance Period|Disease Progression|5|||
16272832|NCT01717313|39484333|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
16272833|NCT01717313|39484332|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
16272834|NCT01717313|39484333|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
16272835|NCT01717313|39484332|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
16272836|NCT01717313|39484333|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
16272837|NCT01717313|39484332|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
16272838|NCT01717313|39484333|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
16272839|NCT01717313|39484332|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
16272840|NCT01717313|39484333|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
16272841|NCT01717313|39484332|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
16272842|NCT01717313|39484333|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
16272843|NCT01717313|39484332|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
16272844|NCT01717313|39484333|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
16272845|NCT01923740|39484335|FG000|Overall Study|Lost to Follow-up|4|||
16272846|NCT01923740|39484336|FG001|Overall Study|Lost to Follow-up|9|||
16272847|NCT01923740|39484335|FG000|Overall Study|Withdrawal by Subject|2|||
16272848|NCT01923740|39484336|FG001|Overall Study|Withdrawal by Subject|0|||
16272849|NCT03750695|39484337|FG000|Overall Study|Lost to Follow-up|0|||
16470558|NCT02375555|40201526|FG000|Maintenance Period|Patient Non-compliance|1|||
16470559|NCT02375555|40201526|FG000|Maintenance Period|Still on maintenance|16|||
16470560|NCT00586664|40201529|FG000|Overall Study|Withdrawal by Subject|3|||
16470561|NCT00586664|40201530|FG001|Overall Study|Withdrawal by Subject|7|||
16470562|NCT00586664|40201531|FG002|Overall Study|Withdrawal by Subject|1|||
16470563|NCT00586664|40201529|FG000|Overall Study|Exclusion criteria met|2|||
16470564|NCT00586664|40201530|FG001|Overall Study|Exclusion criteria met|0|||
16470565|NCT00586664|40201531|FG002|Overall Study|Exclusion criteria met|0|||
16470566|NCT01082640|40201534|FG000|Overall Study|Adverse Event|9|||
16470567|NCT01082640|40201535|FG001|Overall Study|Adverse Event|5|||
16470568|NCT01082640|40201536|FG002|Overall Study|Adverse Event|3|||
16470569|NCT01082640|40201534|FG000|Overall Study|Withdrawal by Subject|3|||
16470570|NCT01082640|40201535|FG001|Overall Study|Withdrawal by Subject|3|||
16470571|NCT01082640|40201536|FG002|Overall Study|Withdrawal by Subject|2|||
16470572|NCT01082640|40201534|FG000|Overall Study|Major protocol deviation|3|||
16470573|NCT01082640|40201535|FG001|Overall Study|Major protocol deviation|3|||
16470574|NCT01082640|40201536|FG002|Overall Study|Major protocol deviation|0|||
16470575|NCT01082640|40201534|FG000|Overall Study|Lost to Follow-up|0|||
16470576|NCT01082640|40201535|FG001|Overall Study|Lost to Follow-up|3|||
16470577|NCT01082640|40201536|FG002|Overall Study|Lost to Follow-up|0|||
16470578|NCT01082640|40201534|FG000|Overall Study|Other|2|||
16470579|NCT01082640|40201535|FG001|Overall Study|Other|1|||
16470580|NCT01082640|40201536|FG002|Overall Study|Other|3|||
16470581|NCT00470158|40201541|FG000|Overall Study|Death|0|||
16470582|NCT00470158|40201542|FG001|Overall Study|Death|0|||
16470583|NCT00470158|40201543|FG002|Overall Study|Death|0|||
16470584|NCT00470158|40201544|FG003|Overall Study|Death|0|||
16470585|NCT00470158|40201545|FG004|Overall Study|Death|2|||
16470586|NCT00470158|40201541|FG000|Overall Study|Lost to Follow-up|7|||
16470587|NCT00470158|40201542|FG001|Overall Study|Lost to Follow-up|8|||
16470588|NCT00470158|40201543|FG002|Overall Study|Lost to Follow-up|8|||
16470589|NCT00470158|40201544|FG003|Overall Study|Lost to Follow-up|5|||
16470590|NCT00470158|40201545|FG004|Overall Study|Lost to Follow-up|4|||
16470591|NCT00470158|40201541|FG000|Overall Study|Protocol Violation|1|||
16470592|NCT00470158|40201542|FG001|Overall Study|Protocol Violation|0|||
16470593|NCT00470158|40201543|FG002|Overall Study|Protocol Violation|0|||
16470594|NCT00470158|40201544|FG003|Overall Study|Protocol Violation|0|||
16470595|NCT00470158|40201545|FG004|Overall Study|Protocol Violation|0|||
16470596|NCT00625742|40201546|FG000|Overall Study|Disease Progression|2|||
16470597|NCT00625742|40201546|FG000|Overall Study|Withdrawal by Subject|1|||
16470598|NCT00625742|40201546|FG000|Overall Study|Adverse Event|4|||
16470599|NCT00625742|40201546|FG000|Overall Study|Lost to Follow-up|4|||
16470600|NCT00625742|40201546|FG000|Overall Study|Ineligible|1|||
16470601|NCT00751621|40201547|FG000|Overall Study|Adverse Event|1|||
16470602|NCT00751621|40201547|FG000|Overall Study|Withdrawal by Subject|1|||
16470603|NCT00751621|40201547|FG000|Overall Study|Subject moved to another country|1|||
16470604|NCT00751621|40201547|FG000|Overall Study|Poor adherence to asthma treatment|1|||
16470605|NCT01055496|40201548|FG000|Overall Study|Withdrawal by Subject|2|||
16470606|NCT01055496|40201549|FG001|Overall Study|Withdrawal by Subject|4|||
16470607|NCT01055496|40201548|FG000|Overall Study|Death|13|||
16470608|NCT01055496|40201549|FG001|Overall Study|Death|23|||
16470609|NCT01055496|40201548|FG000|Overall Study|Lost to Follow-up|0|||
16470610|NCT01055496|40201549|FG001|Overall Study|Lost to Follow-up|2|||
16470611|NCT01055496|40201548|FG000|Overall Study|Other - Unspecified|0|||
16470612|NCT01055496|40201549|FG001|Overall Study|Other - Unspecified|1|||
16470613|NCT00543855|40201553|FG000|Overall Study|Adverse Event|3|||
16470614|NCT00543855|40201554|FG001|Overall Study|Adverse Event|1|||
16470615|NCT00543855|40201555|FG002|Overall Study|Adverse Event|3|||
16470616|NCT00543855|40201556|FG003|Overall Study|Adverse Event|4|||
16470617|NCT00543855|40201553|FG000|Overall Study|Lost to Follow-up|0|||
16470618|NCT00543855|40201554|FG001|Overall Study|Lost to Follow-up|0|||
16470619|NCT00543855|40201555|FG002|Overall Study|Lost to Follow-up|1|||
16470620|NCT00543855|40201556|FG003|Overall Study|Lost to Follow-up|0|||
16470621|NCT00543855|40201553|FG000|Overall Study|Withdrawal by Subject|0|||
16470622|NCT00543855|40201554|FG001|Overall Study|Withdrawal by Subject|1|||
16470623|NCT00543855|40201555|FG002|Overall Study|Withdrawal by Subject|2|||
16470624|NCT00543855|40201556|FG003|Overall Study|Withdrawal by Subject|0|||
16470625|NCT00543855|40201553|FG000|Overall Study|Protocol Violation|1|||
16470626|NCT00543855|40201554|FG001|Overall Study|Protocol Violation|0|||
16470627|NCT00543855|40201555|FG002|Overall Study|Protocol Violation|0|||
16470628|NCT00543855|40201556|FG003|Overall Study|Protocol Violation|0|||
16470629|NCT03023046|40201557|FG000|Overall Study|Withdrawal by Subject|1|||
16470630|NCT02284178|40201558|FG000|Overall Study|Met exclusion criteria|49|||
16470631|NCT02284178|40201559|FG001|Overall Study|Met exclusion criteria|54|||
16470632|NCT00667420|40201564|FG000|Overall Study|Adverse Event|2|||
16470633|NCT00667420|40201564|FG000|Overall Study|Lack of Efficacy|5|||
16470634|NCT00667420|40201564|FG000|Overall Study|Physician Decision|1|||
16470635|NCT00667420|40201564|FG000|Overall Study|Withdrawal by Subject|2|||
16470636|NCT01076075|40201565|FG000|Overall Study|Adverse Event|3|||
16470637|NCT01076075|40201566|FG001|Overall Study|Adverse Event|9|||
16470638|NCT01076075|40201565|FG000|Overall Study|Lack of Efficacy|5|||
16470639|NCT01076075|40201566|FG001|Overall Study|Lack of Efficacy|4|||
16470640|NCT01076075|40201565|FG000|Overall Study|Lost to Follow-up|6|||
16470641|NCT01076075|40201566|FG001|Overall Study|Lost to Follow-up|5|||
16470642|NCT01076075|40201565|FG000|Overall Study|other|19|||
16470643|NCT01076075|40201566|FG001|Overall Study|other|9|||
16470644|NCT01076075|40201565|FG000|Overall Study|Protocol Violation|0|||
16470645|NCT01076075|40201566|FG001|Overall Study|Protocol Violation|1|||
16470646|NCT01076075|40201565|FG000|Overall Study|Withdrawal by Subject|8|||
16470647|NCT01076075|40201566|FG001|Overall Study|Withdrawal by Subject|19|||
16470648|NCT00076024|40201568|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
16470649|NCT00076024|40201569|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
16470650|NCT00076024|40201570|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
16470651|NCT00076024|40201571|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
16470652|NCT00076024|40201568|FG000|Phase 1, Lead-in|Adverse Event|1|||
16470653|NCT00076024|40201569|FG001|Phase 1, Lead-in|Adverse Event|0|||
16470654|NCT00076024|40201570|FG002|Phase 1, Lead-in|Adverse Event|0|||
16470655|NCT00076024|40201571|FG003|Phase 1, Lead-in|Adverse Event|0|||
16470656|NCT00076024|40201568|FG000|Phase 1, Lead-in|Clinical progression|1|||
16470657|NCT00076024|40201569|FG001|Phase 1, Lead-in|Clinical progression|0|||
16470658|NCT00076024|40201570|FG002|Phase 1, Lead-in|Clinical progression|0|||
16470659|NCT00076024|40201571|FG003|Phase 1, Lead-in|Clinical progression|0|||
16470660|NCT00076024|40201568|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
16470661|NCT00076024|40201569|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
16470662|NCT00076024|40201570|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
16470663|NCT00076024|40201571|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
16470664|NCT00076024|40201568|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
16470665|NCT00076024|40201569|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
16470666|NCT00076024|40201570|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
16470667|NCT00076024|40201571|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
16470668|NCT00076024|40201568|FG000|Phase 2, Double-blind|Adverse Event|0|||
16470669|NCT00076024|40201569|FG001|Phase 2, Double-blind|Adverse Event|25|||
16470670|NCT00076024|40201570|FG002|Phase 2, Double-blind|Adverse Event|6|||
16470671|NCT00076024|40201571|FG003|Phase 2, Double-blind|Adverse Event|0|||
16470672|NCT00076024|40201568|FG000|Phase 2, Double-blind|Un-specified|0|||
16470673|NCT00076024|40201569|FG001|Phase 2, Double-blind|Un-specified|14|||
16470674|NCT00076024|40201570|FG002|Phase 2, Double-blind|Un-specified|6|||
16470675|NCT00076024|40201571|FG003|Phase 2, Double-blind|Un-specified|0|||
16470676|NCT00076024|40201568|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
16470677|NCT00076024|40201569|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
16470678|NCT00076024|40201570|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
16470679|NCT00076024|40201571|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
16470680|NCT00076024|40201568|FG000|Phase 2, Open-label|Adverse Event|0|||
16470681|NCT00076024|40201569|FG001|Phase 2, Open-label|Adverse Event|0|||
16470682|NCT00076024|40201570|FG002|Phase 2, Open-label|Adverse Event|0|||
16470683|NCT00076024|40201571|FG003|Phase 2, Open-label|Adverse Event|2|||
16470684|NCT00076024|40201568|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
16470685|NCT00076024|40201569|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
16470686|NCT00076024|40201570|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
16470687|NCT00076024|40201571|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
16470688|NCT00076024|40201568|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
16470689|NCT00076024|40201569|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
16470690|NCT00076024|40201570|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
16470691|NCT00076024|40201571|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
16470692|NCT00076024|40201568|FG000|Phase 2, Open-label|Other|0|||
16470693|NCT00076024|40201569|FG001|Phase 2, Open-label|Other|0|||
16470694|NCT00076024|40201570|FG002|Phase 2, Open-label|Other|0|||
16470695|NCT00076024|40201571|FG003|Phase 2, Open-label|Other|2|||
16470696|NCT01224782|40201572|FG000|Overall Study|Lost to Follow-up|177|||
16470697|NCT01224782|40201572|FG000|Overall Study|Withdrawal by Subject|16|||
16470698|NCT01224782|40201572|FG000|Overall Study|Death|14|||
16470699|NCT01224782|40201572|FG000|Overall Study|Improvement|13|||
16470700|NCT01224782|40201572|FG000|Overall Study|Adverse Event|12|||
16470701|NCT01224782|40201572|FG000|Overall Study|Adverse Reaction|11|||
16470702|NCT01224782|40201572|FG000|Overall Study|Noncompliance|10|||
16470703|NCT01224782|40201572|FG000|Overall Study|Other|4|||
16470704|NCT01224782|40201572|FG000|Overall Study|Start of Dialysis|3|||
16470705|NCT01224782|40201572|FG000|Overall Study|Change of Treatment|1|||
16470706|NCT01224782|40201572|FG000|Overall Study|Financial Reasons|1|||
16470707|NCT01224782|40201572|FG000|Overall Study|Deterioration|1|||
16470708|NCT01224782|40201572|FG000|Overall Study|Transplantation|1|||
16470709|NCT04571515|40201573|FG000|Overall Study|Physician Decision|0|||
16272850|NCT03750695|39484338|FG001|Overall Study|Lost to Follow-up|1|||
16470710|NCT04571515|40201574|FG001|Overall Study|Physician Decision|0|||
16470711|NCT04571515|40201575|FG002|Overall Study|Physician Decision|0|||
16470712|NCT04571515|40201576|FG003|Overall Study|Physician Decision|0|||
16470713|NCT04571515|40201577|FG004|Overall Study|Physician Decision|1|||
16470714|NCT04571515|40201573|FG000|Overall Study|Withdrawal by Subject|0|||
16470715|NCT04571515|40201574|FG001|Overall Study|Withdrawal by Subject|0|||
16470716|NCT04571515|40201575|FG002|Overall Study|Withdrawal by Subject|0|||
16470717|NCT04571515|40201576|FG003|Overall Study|Withdrawal by Subject|0|||
16470718|NCT04571515|40201577|FG004|Overall Study|Withdrawal by Subject|1|||
16470719|NCT04571515|40201573|FG000|Overall Study|insufficient pain|1|||
16470720|NCT04571515|40201574|FG001|Overall Study|insufficient pain|0|||
16470721|NCT04571515|40201575|FG002|Overall Study|insufficient pain|0|||
16470722|NCT04571515|40201576|FG003|Overall Study|insufficient pain|0|||
16470723|NCT04571515|40201577|FG004|Overall Study|insufficient pain|1|||
16470724|NCT05342532|40201578|FG000|Overall Study|Adverse Event|5|||
16470725|NCT05342532|40201579|FG001|Overall Study|Adverse Event|20|||
16470726|NCT05342532|40201578|FG000|Overall Study|Lost to Follow-up|10|||
16470727|NCT05342532|40201579|FG001|Overall Study|Lost to Follow-up|15|||
16470728|NCT04706416|40201584|FG000|Overall Study|Lost to Follow-up|2|||
16470729|NCT04706416|40201585|FG001|Overall Study|Lost to Follow-up|0|||
16470730|NCT01559935|40201588|FG000|Car Phase|Toxicity|4|||
16470731|NCT01559935|40201588|FG000|Car Phase|Death|1|||
16470732|NCT01559935|40201588|FG000|Car Phase|Lack of Efficacy|2|||
16470733|NCT01559935|40201588|FG000|Car Phase|Lost to Follow-up|1|||
16470734|NCT01559935|40201588|FG000|Car Phase|Physician Decision|1|||
16470735|NCT01559935|40201588|FG000|Car Phase|Withdrawal by Subject|2|||
16470736|NCT01559935|40201588|FG000|Car Phase|Per protocol|1|||
16470737|NCT01559935|40201588|FG000|Car Phase|Insurance|1|||
16470738|NCT01559935|40201588|FG000|Car Phase|non-compliance|1|||
16470739|NCT01559935|40201588|FG000|BiRD Phase|Toxicity|1|||
16470740|NCT01559935|40201588|FG000|BiRD Phase|Lack of Efficacy|1|||
16470741|NCT01559935|40201588|FG000|BiRD Phase|Withdrawal by Subject|2|||
16470742|NCT01559935|40201588|FG000|Maintenance Phase|Remains on study|28|||
16470743|NCT01559935|40201588|FG000|Maintenance Phase|Toxicity|1|||
16470744|NCT01559935|40201588|FG000|Maintenance Phase|Lack of Efficacy|18|||
16470745|NCT01559935|40201588|FG000|Maintenance Phase|Withdrawal by Subject|5|||
16470746|NCT01559935|40201588|FG000|Maintenance Phase|Non-compliance|2|||
16470747|NCT01007253|40201589|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
16470748|NCT01007253|40201590|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
16470749|NCT01007253|40201591|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
16470750|NCT01007253|40201592|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
16470751|NCT00521001|40201593|FG000|Overall Study|Ineligible|1|||
16470752|NCT00817479|40201594|FG000|Overall Study|Physician Decision|1|||
16470753|NCT00817479|40201595|FG001|Overall Study|Physician Decision|1|||
16470754|NCT00194675|40201598|FG000|Overall Study|Lost to Follow-up|1|||
16470755|NCT00194675|40201599|FG001|Overall Study|Lost to Follow-up|1|||
16470756|NCT00194675|40201598|FG000|Overall Study|lack of interest|1|||
16470757|NCT00194675|40201599|FG001|Overall Study|lack of interest|1|||
16470758|NCT00194675|40201598|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
16470759|NCT00194675|40201599|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
16470760|NCT00194675|40201598|FG000|Overall Study|Protocol Violation|1|||
16470761|NCT00194675|40201599|FG001|Overall Study|Protocol Violation|0|||
16470762|NCT00194675|40201598|FG000|Overall Study|Death|1|||
16470763|NCT00194675|40201599|FG001|Overall Study|Death|0|||
16470764|NCT03489551|40201603|FG000|Overall Study|Withdrawal by Subject|2|||
16470765|NCT02025556|40201611|FG000|Overall Study|Adverse Event|0|||
16470766|NCT02025556|40201612|FG001|Overall Study|Adverse Event|4|||
16470767|NCT02025556|40201613|FG002|Overall Study|Adverse Event|2|||
16470768|NCT02025556|40201611|FG000|Overall Study|Lack of Efficacy|2|||
16470769|NCT02025556|40201612|FG001|Overall Study|Lack of Efficacy|1|||
16470770|NCT02025556|40201613|FG002|Overall Study|Lack of Efficacy|0|||
16470771|NCT02025556|40201611|FG000|Overall Study|Protocol Violation|2|||
16470772|NCT02025556|40201612|FG001|Overall Study|Protocol Violation|1|||
16470773|NCT02025556|40201613|FG002|Overall Study|Protocol Violation|0|||
16470774|NCT02025556|40201611|FG000|Overall Study|Withdrawal by Subject|0|||
16470775|NCT02025556|40201612|FG001|Overall Study|Withdrawal by Subject|3|||
16470776|NCT02025556|40201613|FG002|Overall Study|Withdrawal by Subject|6|||
16470777|NCT02025556|40201611|FG000|Overall Study|Lost to Follow-up|2|||
16470778|NCT02025556|40201612|FG001|Overall Study|Lost to Follow-up|4|||
16470779|NCT02025556|40201613|FG002|Overall Study|Lost to Follow-up|0|||
16470780|NCT02025556|40201611|FG000|Overall Study|Reason not reported|0|||
16470781|NCT02025556|40201612|FG001|Overall Study|Reason not reported|0|||
16470782|NCT02025556|40201613|FG002|Overall Study|Reason not reported|1|||
16470783|NCT00095628|40201614|FG000|Overall Study|Disease progression prior to treatment|1|||
16470784|NCT01869725|40204156|FG000|Overall Study|ineligible after registration|1|||
16470785|NCT01869725|40204156|FG000|Overall Study|Death|1|||
16470786|NCT01869725|40204156|FG000|Overall Study|Lost to Follow-up|2|||
16470787|NCT02788474|40204157|FG000|Double Blind Treatment Period|Not treated|1|||
16470788|NCT02788474|40204158|FG001|Double Blind Treatment Period|Not treated|0|||
16470789|NCT02788474|40204157|FG000|Double Blind Treatment Period|Patient's refusal|3|||
16470790|NCT02788474|40204158|FG001|Double Blind Treatment Period|Patient's refusal|0|||
16470791|NCT02788474|40204157|FG000|Double Blind Treatment Period|Adverse Event|6|||
16470792|NCT02788474|40204158|FG001|Double Blind Treatment Period|Adverse Event|4|||
16470793|NCT02788474|40204157|FG000|Open Label Treatment Period|Adverse Event|29|||
16470794|NCT02788474|40204158|FG001|Open Label Treatment Period|Adverse Event|9|||
16470795|NCT02788474|40204157|FG000|Open Label Treatment Period|Other than reason specified|1|||
16470796|NCT02788474|40204158|FG001|Open Label Treatment Period|Other than reason specified|0|||
16470797|NCT02788474|40204157|FG000|Open Label Treatment Period|Patient's refusal|1|||
16470798|NCT02788474|40204158|FG001|Open Label Treatment Period|Patient's refusal|3|||
16470799|NCT02788474|40204157|FG000|Open Label Treatment Period|Non-compliance|1|||
16470800|NCT02788474|40204158|FG001|Open Label Treatment Period|Non-compliance|0|||
16470801|NCT00084838|40204161|FG000|Overall Study|Death|1|||
16470802|NCT00084838|40204161|FG000|Overall Study|Adverse Event|2|||
16470803|NCT00084838|40204161|FG000|Overall Study|Withdrawal by Subject|1|||
16470804|NCT00084838|40204161|FG000|Overall Study|Progressive Disease|4|||
16470805|NCT00084838|40204161|FG000|Overall Study|Pt Non-Compliance|1|||
16470806|NCT00084838|40204161|FG000|Overall Study|Ineligible|4|||
16470807|NCT03430843|40204168|FG000|Overall Study|Death|233|||
16470808|NCT03430843|40204169|FG001|Overall Study|Death|233|||
16470809|NCT03430843|40204168|FG000|Overall Study|Sponsor Decision|17|||
16470810|NCT03430843|40204169|FG001|Overall Study|Sponsor Decision|6|||
16470811|NCT03430843|40204168|FG000|Overall Study|Withdrawal by Subject|5|||
16470812|NCT03430843|40204169|FG001|Overall Study|Withdrawal by Subject|14|||
16470813|NCT03430843|40204168|FG000|Overall Study|Lost to Follow-up|1|||
16470814|NCT03430843|40204169|FG001|Overall Study|Lost to Follow-up|3|||
16470815|NCT00814801|40204170|FG000|Overall Study|Adverse Event|15|||
16470816|NCT00814801|40204171|FG001|Overall Study|Adverse Event|16|||
16470817|NCT00814801|40204172|FG002|Overall Study|Adverse Event|19|||
16470818|NCT00814801|40204170|FG000|Overall Study|Withdrawal by Subject|9|||
16470819|NCT00814801|40204171|FG001|Overall Study|Withdrawal by Subject|11|||
16470820|NCT00814801|40204172|FG002|Overall Study|Withdrawal by Subject|14|||
16470821|NCT00814801|40204170|FG000|Overall Study|Inappropriate as a subject|1|||
16470822|NCT00814801|40204171|FG001|Overall Study|Inappropriate as a subject|1|||
16470823|NCT00814801|40204172|FG002|Overall Study|Inappropriate as a subject|1|||
16470824|NCT00814801|40204170|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
16470825|NCT00814801|40204171|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
16470826|NCT00814801|40204172|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
16470827|NCT00814801|40204170|FG000|Overall Study|Missing or change of caregiver|6|||
16470828|NCT00814801|40204171|FG001|Overall Study|Missing or change of caregiver|2|||
16470829|NCT00814801|40204172|FG002|Overall Study|Missing or change of caregiver|4|||
16470830|NCT00814801|40204170|FG000|Overall Study|Non-compliance|0|||
16470831|NCT00814801|40204171|FG001|Overall Study|Non-compliance|1|||
16470832|NCT00814801|40204172|FG002|Overall Study|Non-compliance|1|||
16470833|NCT00814801|40204170|FG000|Overall Study|Other|2|||
16470834|NCT00814801|40204171|FG001|Overall Study|Other|6|||
16470835|NCT00814801|40204172|FG002|Overall Study|Other|4|||
16470836|NCT01107418|40204178|FG000|Overall Study|Disease Progression|45|||
16470837|NCT01107418|40204178|FG000|Overall Study|Adverse Event|3|||
16470838|NCT01107418|40204178|FG000|Overall Study|Withdrawal by Subject|1|||
16470839|NCT01107418|40204178|FG000|Overall Study|Study Closing|1|||
16470840|NCT01107418|40204178|FG000|Overall Study|Started Other Therapy|1|||
16470841|NCT01107418|40204178|FG000|Overall Study|Entered Extension Study|1|||
16470842|NCT01709578|40204180|FG000|Overall Study|Rescued and entered in long term safety|63|||
16470843|NCT01709578|40204181|FG001|Overall Study|Rescued and entered in long term safety|25|||
16470844|NCT01709578|40204182|FG002|Overall Study|Rescued and entered in long term safety|26|||
16470845|NCT01709578|40204180|FG000|Overall Study|Adverse Event|9|||
16470846|NCT01709578|40204181|FG001|Overall Study|Adverse Event|18|||
16470847|NCT01709578|40204182|FG002|Overall Study|Adverse Event|17|||
16470848|NCT01709578|40204180|FG000|Overall Study|Lack of Efficacy|5|||
16470849|NCT01709578|40204181|FG001|Overall Study|Lack of Efficacy|4|||
16470850|NCT01709578|40204182|FG002|Overall Study|Lack of Efficacy|2|||
16470851|NCT01709578|40204180|FG000|Overall Study|Poor compliance to protocol|1|||
16470852|NCT01709578|40204181|FG001|Overall Study|Poor compliance to protocol|2|||
16470853|NCT01709578|40204182|FG002|Overall Study|Poor compliance to protocol|1|||
16470854|NCT01709578|40204180|FG000|Overall Study|Other, not related to safety or efficacy|2|||
16470855|NCT01709578|40204181|FG001|Overall Study|Other, not related to safety or efficacy|7|||
16470856|NCT01709578|40204182|FG002|Overall Study|Other, not related to safety or efficacy|5|||
16470857|NCT01962922|40204183|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
16470858|NCT01962922|40204184|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
16470859|NCT01962922|40204183|FG000|PK Portion Day 7|non-compliance|1|||
16470860|NCT01962922|40204184|FG001|PK Portion Day 7|non-compliance|0|||
16470861|NCT01962922|40204183|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
16470862|NCT01962922|40204184|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
16470863|NCT01962922|40204183|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
16470864|NCT01962922|40204184|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
16470865|NCT03901456|40204185|FG000|Overall Study|Withdrawal by Subject|0|||
16470866|NCT03901456|40204186|FG001|Overall Study|Withdrawal by Subject|0|||
16470867|NCT03901456|40204187|FG002|Overall Study|Withdrawal by Subject|1|||
16470868|NCT03901456|40204185|FG000|Overall Study|Lost to Follow-up|0|||
16470869|NCT03901456|40204186|FG001|Overall Study|Lost to Follow-up|1|||
16470870|NCT03901456|40204187|FG002|Overall Study|Lost to Follow-up|0|||
16470871|NCT00426231|40204188|FG000|Overall Study|Withdrawal by Subject|9|||
16470872|NCT00426231|40204189|FG001|Overall Study|Withdrawal by Subject|12|||
16470873|NCT01467427|40204190|FG000|Overall Study|Withdrawal by Subject|1|||
16470874|NCT01467427|40204191|FG001|Overall Study|Withdrawal by Subject|0|||
16470875|NCT01467427|40204190|FG000|Overall Study|Entered extension phase|11|||
16470876|NCT01467427|40204191|FG001|Overall Study|Entered extension phase|11|||
16470877|NCT01467427|40204190|FG000|Overall Study|Not continuing in extension phase|0|||
16470878|NCT01467427|40204191|FG001|Overall Study|Not continuing in extension phase|2|||
16470879|NCT02283177|40204210|FG000|Overall Study|Withdrawal by Subject|1|||
16470880|NCT02283177|40204211|FG001|Overall Study|Withdrawal by Subject|1|||
16470881|NCT01631812|40204212|FG000|Overall Study|Adverse Event|25|||
16470882|NCT01631812|40204212|FG000|Overall Study|Lack of Efficacy|5|||
16470883|NCT01631812|40204212|FG000|Overall Study|Withdrawal by Subject|4|||
16470884|NCT01631812|40204212|FG000|Overall Study|Physician Decision|3|||
16470885|NCT00586066|40204213|FG000|Overall Study|Lost to Follow-up|6|||
16470886|NCT00586066|40204214|FG001|Overall Study|Lost to Follow-up|3|||
16470887|NCT00586066|40204213|FG000|Overall Study|Lack of Efficacy|5|||
16470888|NCT00586066|40204214|FG001|Overall Study|Lack of Efficacy|3|||
16470889|NCT00586066|40204213|FG000|Overall Study|Adverse Event|2|||
16470890|NCT00586066|40204214|FG001|Overall Study|Adverse Event|2|||
16470891|NCT00586066|40204213|FG000|Overall Study|Physician Decision|1|||
16470892|NCT00586066|40204214|FG001|Overall Study|Physician Decision|0|||
16470893|NCT00586066|40204213|FG000|Overall Study|Withdrawal of consent|4|||
16470894|NCT00586066|40204214|FG001|Overall Study|Withdrawal of consent|2|||
16470895|NCT00723203|40204219|FG000|Overall Study|Withdrawal by Subject|3|||
16470896|NCT02821910|40204222|FG000|Overall Study|Withdrawal by Subject|0|||
16470897|NCT02821910|40204223|FG001|Overall Study|Withdrawal by Subject|0|||
16470898|NCT02821910|40204224|FG002|Overall Study|Withdrawal by Subject|1|||
16470899|NCT02821910|40204225|FG003|Overall Study|Withdrawal by Subject|0|||
16470900|NCT02821910|40204226|FG004|Overall Study|Withdrawal by Subject|0|||
16470901|NCT02821910|40204227|FG005|Overall Study|Withdrawal by Subject|1|||
16470902|NCT02821910|40204222|FG000|Overall Study|Other than specified|1|||
16470903|NCT02821910|40204223|FG001|Overall Study|Other than specified|0|||
16470904|NCT02821910|40204224|FG002|Overall Study|Other than specified|1|||
16470905|NCT02821910|40204225|FG003|Overall Study|Other than specified|0|||
16470906|NCT02821910|40204226|FG004|Overall Study|Other than specified|0|||
16470907|NCT02821910|40204227|FG005|Overall Study|Other than specified|0|||
16470908|NCT05128773|40204229|FG000|Overall Study|Sponsor decision to terminate study|3|||
16470909|NCT01476644|40204230|FG000|Overall Study|Death|5|||
16470910|NCT01476644|40204230|FG000|Overall Study|moved to another state|2|||
16470911|NCT01476644|40204230|FG000|Overall Study|Lost to Follow-up|19|||
16470912|NCT01476644|40204230|FG000|Overall Study|Withdrawal by Subject|13|||
16470913|NCT04738734|40204231|FG000|Overall Study|Withdrawal by Subject|2|||
16470914|NCT04738734|40204232|FG001|Overall Study|Withdrawal by Subject|4|||
16470915|NCT04738734|40204231|FG000|Overall Study|Lost to Follow-up|5|||
16470916|NCT04738734|40204232|FG001|Overall Study|Lost to Follow-up|2|||
16470917|NCT04738734|40204231|FG000|Overall Study|Physician Decision|0|||
16470918|NCT04738734|40204232|FG001|Overall Study|Physician Decision|1|||
16072792|NCT01194258|38759170|FG000|Titration Period|Withdrawal by Subject|6|||
16072793|NCT01194258|38759171|FG001|Titration Period|Withdrawal by Subject|0|||
16072794|NCT01194258|38759172|FG002|Titration Period|Withdrawal by Subject|0|||
16072795|NCT01194258|38759173|FG003|Titration Period|Withdrawal by Subject|0|||
16072796|NCT01194258|38759174|FG004|Titration Period|Withdrawal by Subject|0|||
16072797|NCT01194258|38759170|FG000|Titration Period|Lost to Follow-up|2|||
16072798|NCT01194258|38759171|FG001|Titration Period|Lost to Follow-up|0|||
16072799|NCT01194258|38759172|FG002|Titration Period|Lost to Follow-up|0|||
16072800|NCT01194258|38759173|FG003|Titration Period|Lost to Follow-up|0|||
16072801|NCT01194258|38759174|FG004|Titration Period|Lost to Follow-up|0|||
16072802|NCT01194258|38759170|FG000|Titration Period|Titration failure|3|||
16072803|NCT01194258|38759171|FG001|Titration Period|Titration failure|0|||
16072804|NCT01194258|38759172|FG002|Titration Period|Titration failure|0|||
16072805|NCT01194258|38759173|FG003|Titration Period|Titration failure|0|||
16072806|NCT01194258|38759174|FG004|Titration Period|Titration failure|0|||
16072807|NCT01194258|38759170|FG000|Period 1 (12 Weeks)|Death|0|||
16072808|NCT01194258|38759171|FG001|Period 1 (12 Weeks)|Death|0|||
16072809|NCT01194258|38759172|FG002|Period 1 (12 Weeks)|Death|0|||
16072810|NCT01194258|38759173|FG003|Period 1 (12 Weeks)|Death|0|||
16072811|NCT01194258|38759174|FG004|Period 1 (12 Weeks)|Death|1|||
16072812|NCT01194258|38759170|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16072813|NCT01194258|38759171|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16072814|NCT01194258|38759172|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16470919|NCT04738734|40204231|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
16470920|NCT04738734|40204232|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
16470921|NCT02305888|40204233|FG000|Overall Study|Lost to Follow-up|0|||
16470922|NCT02305888|40204234|FG001|Overall Study|Lost to Follow-up|0|||
16470923|NCT02305888|40204235|FG002|Overall Study|Lost to Follow-up|1|||
16470924|NCT02305888|40204233|FG000|Overall Study|Adverse Event|0|||
16470925|NCT02305888|40204234|FG001|Overall Study|Adverse Event|1|||
16470926|NCT02305888|40204235|FG002|Overall Study|Adverse Event|0|||
16470927|NCT04533880|40204239|FG000|Overall Study|Lost to Follow-up|0|||
16470928|NCT04533880|40204240|FG001|Overall Study|Lost to Follow-up|1|||
16470929|NCT04533880|40204241|FG002|Overall Study|Lost to Follow-up|1|||
16470930|NCT01272661|40204244|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
16470931|NCT01272661|40204245|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
16470932|NCT01272661|40204246|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
16470933|NCT01912963|40204249|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
16470934|NCT01912963|40204250|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
16470935|NCT01912963|40204251|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
16470936|NCT01912963|40204249|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
16470937|NCT01912963|40204250|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
16470938|NCT01912963|40204251|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
16470939|NCT01912963|40204249|FG000|Overall Study|Adverse Event|0|||
16470940|NCT01912963|40204250|FG001|Overall Study|Adverse Event|1|||
16470941|NCT01912963|40204251|FG002|Overall Study|Adverse Event|1|||
16470942|NCT01912963|40204249|FG000|Overall Study|Withdrawal by Subject|0|||
16470943|NCT01912963|40204250|FG001|Overall Study|Withdrawal by Subject|1|||
16470944|NCT01912963|40204251|FG002|Overall Study|Withdrawal by Subject|0|||
16470945|NCT01912963|40204249|FG000|Overall Study|Sought treatment locally|0|||
16470946|NCT01912963|40204250|FG001|Overall Study|Sought treatment locally|1|||
16470947|NCT01912963|40204251|FG002|Overall Study|Sought treatment locally|0|||
16470948|NCT01982331|40204253|FG000|Received Vaccination 2|Adverse Event|1|||
16470949|NCT01982331|40204254|FG001|Received Vaccination 2|Adverse Event|2|||
16470950|NCT01982331|40204253|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
16470951|NCT01982331|40204254|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
16470952|NCT01982331|40204253|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
16470953|NCT01982331|40204254|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
16470954|NCT00171054|40204259|FG000|Overall Study|Protocol Violation|1|||
16470955|NCT00171054|40204260|FG001|Overall Study|Protocol Violation|2|||
16470956|NCT00171054|40204259|FG000|Overall Study|Patient withdrew consent|1|||
16470957|NCT00171054|40204260|FG001|Overall Study|Patient withdrew consent|0|||
16470958|NCT00171054|40204259|FG000|Overall Study|Lost to Follow-up|0|||
16470959|NCT00171054|40204260|FG001|Overall Study|Lost to Follow-up|1|||
16470960|NCT00171054|40204259|FG000|Overall Study|Adverse Event|8|||
16470961|NCT00171054|40204260|FG001|Overall Study|Adverse Event|8|||
16470962|NCT00171054|40204259|FG000|Overall Study|Condition no longer required study drug|0|||
16470963|NCT00171054|40204260|FG001|Overall Study|Condition no longer required study drug|1|||
16470964|NCT03224546|40204267|FG000|Overall Study|Lost to Follow-up|9|||
16470965|NCT03224546|40204268|FG001|Overall Study|Lost to Follow-up|8|||
16470966|NCT03224546|40204269|FG002|Overall Study|Lost to Follow-up|3|||
16470967|NCT03224546|40204267|FG000|Overall Study|Withdrawal by Subject|7|||
16470968|NCT03224546|40204268|FG001|Overall Study|Withdrawal by Subject|14|||
16470969|NCT03224546|40204269|FG002|Overall Study|Withdrawal by Subject|12|||
16470970|NCT01539317|40204270|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
16470971|NCT01539317|40204271|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
16470972|NCT00591344|40204272|FG000|Overall Study|Transportation issues|1|||
16470973|NCT00591344|40204273|FG001|Overall Study|Transportation issues|0|||
16470974|NCT00591344|40204272|FG000|Overall Study|Moved out of state|1|||
16470975|NCT00591344|40204273|FG001|Overall Study|Moved out of state|0|||
16470976|NCT00591344|40204272|FG000|Overall Study|Medical complications|1|||
16470977|NCT00591344|40204273|FG001|Overall Study|Medical complications|3|||
16470978|NCT00591344|40204272|FG000|Overall Study|Underwent DBS|2|||
16470979|NCT00591344|40204273|FG001|Overall Study|Underwent DBS|2|||
16470980|NCT00591344|40204272|FG000|Overall Study|Death|0|||
16470981|NCT00591344|40204273|FG001|Overall Study|Death|1|||
16470982|NCT00591344|40204272|FG000|Overall Study|Lost to Follow-up|0|||
16470983|NCT00591344|40204273|FG001|Overall Study|Lost to Follow-up|1|||
16470984|NCT00591344|40204272|FG000|Overall Study|Did not want to come off medication|0|||
16470985|NCT00591344|40204273|FG001|Overall Study|Did not want to come off medication|1|||
16470986|NCT03611010|40204274|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
16470987|NCT03611010|40204275|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
16470988|NCT03611010|40204276|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
16470989|NCT03611010|40204277|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
16470990|NCT01676727|40204278|FG000|Overall Study|Death|18|||
16470991|NCT01676727|40204278|FG000|Overall Study|Withdrawal by Subject|6|||
16470992|NCT01676727|40204278|FG000|Overall Study|Screening failure|5|||
16470993|NCT01676727|40204278|FG000|Overall Study|Not willing to attend 1-year visit|2|||
16470994|NCT01676727|40204278|FG000|Overall Study|Valve explanted|1|||
16470995|NCT01002482|40204279|FG000|Overall Study|Withdrawal by Subject|14|||
16470996|NCT01002482|40204280|FG001|Overall Study|Withdrawal by Subject|21|||
16470997|NCT01002482|40204279|FG000|Overall Study|Included twice|1|||
16470998|NCT01002482|40204280|FG001|Overall Study|Included twice|0|||
16470999|NCT00560885|40204281|FG000|Overall Study|Death|7|||
16471000|NCT00560885|40204281|FG000|Overall Study|Withdrawal by Subject|1|||
16471001|NCT02750943|40204284|FG000|Overall Study|Lost to Follow-up|1|||
16471002|NCT02750943|40204285|FG001|Overall Study|Lost to Follow-up|2|||
16471003|NCT02750943|40204284|FG000|Overall Study|Withdrawal by Subject|5|||
16471004|NCT02750943|40204285|FG001|Overall Study|Withdrawal by Subject|7|||
16471005|NCT00287079|40204287|FG000|Overall Study|Qualifying relapse|12|||
16471006|NCT00287079|40204288|FG001|Overall Study|Qualifying relapse|1|||
16471007|NCT00287079|40204287|FG000|Overall Study|Non-qualifying relapse|1|||
16471008|NCT00287079|40204288|FG001|Overall Study|Non-qualifying relapse|0|||
16471009|NCT00287079|40204287|FG000|Overall Study|Adverse Event|5|||
16471010|NCT00287079|40204288|FG001|Overall Study|Adverse Event|0|||
16471011|NCT00287079|40204287|FG000|Overall Study|Protocol Violation|1|||
16471012|NCT00287079|40204288|FG001|Overall Study|Protocol Violation|0|||
16471013|NCT00287079|40204287|FG000|Overall Study|Other|3|||
16471014|NCT00287079|40204288|FG001|Overall Study|Other|0|||
16471015|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
16471016|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
16471017|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
16471018|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
16471019|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
16471020|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
16471021|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
16471022|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
16471023|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
16471024|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
16471025|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
16471026|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
16471027|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
16471028|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
16471029|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
16471030|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
16471031|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Program Termination|3|||
16471032|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Program Termination|0|||
16471033|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Program Termination|1|||
16471034|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Program Termination|1|||
16471035|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
16471036|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
16471037|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
16471038|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
16471039|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
16471040|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
16471041|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
16471042|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
16471043|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
16471044|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
16471045|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
16471046|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
16471047|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
16471048|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
16471049|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
16471050|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
16471051|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
16471052|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
16471053|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
16471054|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
16471055|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
16471056|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
16471057|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
16471058|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
16471059|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
16471060|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
16471061|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
16471062|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
16471063|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
16471064|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
16471065|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
16471066|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
16471067|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
16272851|NCT01460628|39484339|FG000|Overall Study|Adverse Event|3|||
16471068|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
16471069|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
16471070|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
16471071|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
16471072|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
16471073|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
16471074|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
16471075|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
16471076|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
16471077|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
16471078|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
16471079|NCT03739840|40204296|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
16471080|NCT03739840|40204297|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
16471081|NCT03739840|40204298|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
16471082|NCT03739840|40204299|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
16471083|NCT03739840|40204296|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
16471084|NCT03739840|40204297|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
16471085|NCT03739840|40204298|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
16471086|NCT03739840|40204299|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
16471087|NCT03739840|40204296|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
16471088|NCT03739840|40204297|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
16471089|NCT03739840|40204298|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
16471090|NCT03739840|40204299|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
16471091|NCT03739840|40204296|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
16471092|NCT03739840|40204297|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
16471093|NCT03739840|40204298|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
16471094|NCT03739840|40204299|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
16471095|NCT03739840|40204296|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
16471096|NCT03739840|40204297|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
16471097|NCT03739840|40204298|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
16471098|NCT03739840|40204299|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
16471099|NCT03739840|40204296|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
16471100|NCT03739840|40204297|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
16471101|NCT03739840|40204298|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
16471102|NCT03739840|40204299|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
16471103|NCT03739840|40204296|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
16471104|NCT03739840|40204297|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
16471105|NCT03739840|40204298|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
16471106|NCT03739840|40204299|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
16471107|NCT03739840|40204296|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
16471108|NCT03739840|40204297|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
16471109|NCT03739840|40204298|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
16471110|NCT03739840|40204299|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
16471111|NCT03739840|40204296|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
16471112|NCT03739840|40204297|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
16471113|NCT03739840|40204298|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
16471114|NCT03739840|40204299|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
16471115|NCT02486627|40204301|FG000|Overall Study|Death|1|||
16471116|NCT02486627|40204302|FG001|Overall Study|Death|0|||
16471117|NCT02486627|40204301|FG000|Overall Study|Other Unspecified|0|||
16471118|NCT02486627|40204302|FG001|Overall Study|Other Unspecified|2|||
16471119|NCT02486627|40204301|FG000|Overall Study|Consent Withdrawn by Participant|4|||
16471120|NCT02486627|40204302|FG001|Overall Study|Consent Withdrawn by Participant|3|||
16471121|NCT02486627|40204301|FG000|Overall Study|Significant Participant Noncompliance|1|||
16471122|NCT02486627|40204302|FG001|Overall Study|Significant Participant Noncompliance|1|||
16471123|NCT02486627|40204301|FG000|Overall Study|Lost to Follow-up|1|||
16471124|NCT02486627|40204302|FG001|Overall Study|Lost to Follow-up|3|||
16471125|NCT01229397|40204303|FG000|Overall Study|Withdrawal by Subject|3|||
16471126|NCT01229397|40204304|FG001|Overall Study|Withdrawal by Subject|3|||
16471127|NCT01229397|40204303|FG000|Overall Study|Lost to Follow-up|7|||
16471128|NCT01229397|40204304|FG001|Overall Study|Lost to Follow-up|6|||
16471129|NCT01229397|40204303|FG000|Overall Study|Migrated/moved from study area|1|||
16471130|NCT01229397|40204304|FG001|Overall Study|Migrated/moved from study area|0|||
16471131|NCT03882008|40204305|FG000|Overall Study|Withdrawal by Subject|1|||
16471132|NCT03882008|40204305|FG000|Overall Study|Lost to Follow-up|1|||
16471133|NCT00072176|40204308|FG000|Overall Study|Withdrawal by Subject|1|||
16471134|NCT00072176|40204309|FG001|Overall Study|Withdrawal by Subject|0|||
16471135|NCT00072176|40204308|FG000|Overall Study|Protocol Violation|0|||
16471136|NCT00072176|40204309|FG001|Overall Study|Protocol Violation|1|||
16471137|NCT01865084|40204310|FG000|Double Blind Period (DB)|Adverse Event|2|||
16471138|NCT01865084|40204311|FG001|Double Blind Period (DB)|Adverse Event|2|||
16471139|NCT01865084|40204312|FG002|Double Blind Period (DB)|Adverse Event|1|||
16471140|NCT01865084|40204310|FG000|Double Blind Period (DB)|Protocol Violation|0|||
16471141|NCT01865084|40204311|FG001|Double Blind Period (DB)|Protocol Violation|0|||
16471142|NCT01865084|40204312|FG002|Double Blind Period (DB)|Protocol Violation|1|||
16471143|NCT01865084|40204310|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
16471144|NCT01865084|40204311|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
16471145|NCT01865084|40204312|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
16471146|NCT01865084|40204310|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
16471147|NCT01865084|40204311|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
16471148|NCT01865084|40204312|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
16471149|NCT01865084|40204310|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
16471150|NCT01865084|40204311|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
16471151|NCT01865084|40204312|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
16471152|NCT01865084|40204310|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
16471153|NCT01865084|40204311|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
16471154|NCT01865084|40204312|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
16471155|NCT01865084|40204310|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
16471156|NCT01865084|40204311|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
16471157|NCT01865084|40204312|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
16471158|NCT01865084|40204310|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
16471159|NCT01865084|40204311|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
16471160|NCT01865084|40204312|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
16471161|NCT01865084|40204310|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
16471162|NCT01865084|40204311|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
16471163|NCT01865084|40204312|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
16471164|NCT00542451|40204317|FG000|Overall Study|Adverse Event|31|||
16471165|NCT00542451|40204317|FG000|Overall Study|Withdrawal by Subject|30|||
16471166|NCT00542451|40204317|FG000|Overall Study|Physician Decision|4|||
16471167|NCT00542451|40204317|FG000|Overall Study|Recurrent disease|1|||
16471168|NCT00542451|40204317|FG000|Overall Study|unknown reason|1|||
16471169|NCT00542451|40204317|FG000|Overall Study|Death|2|||
16471170|NCT00542451|40204317|FG000|Overall Study|Lost to Follow-up|10|||
16471171|NCT00880685|40204323|FG000|Memantine 10mg|Lost to Follow-up|2|||
16471172|NCT00880685|40204323|FG000|Memantine 20mg|Withdrawal by Subject|1|||
16471173|NCT02294773|40204324|FG000|Overall Study|Withdrawal by Subject|0|||
16471174|NCT02294773|40204325|FG001|Overall Study|Withdrawal by Subject|2|||
16471175|NCT01309308|40204329|FG000|Overall Study|Lost to Follow-up|6|||
16471176|NCT01309308|40204330|FG001|Overall Study|Lost to Follow-up|4|||
16471177|NCT02445391|40204336|FG000|Overall Study|No active protocol treatment|3|||
16471178|NCT02445391|40204337|FG001|Overall Study|No active protocol treatment|0|||
16471179|NCT02445391|40204338|FG002|Overall Study|No active protocol treatment|0|||
16471180|NCT02445391|40204336|FG000|Overall Study|Adverse Event|0|||
16471181|NCT02445391|40204337|FG001|Overall Study|Adverse Event|21|||
16471182|NCT02445391|40204338|FG002|Overall Study|Adverse Event|12|||
16471183|NCT02445391|40204336|FG000|Overall Study|Alternative therapy|0|||
16471184|NCT02445391|40204337|FG001|Overall Study|Alternative therapy|0|||
16471185|NCT02445391|40204338|FG002|Overall Study|Alternative therapy|1|||
16471186|NCT02445391|40204336|FG000|Overall Study|Disease progression|0|||
16471187|NCT02445391|40204337|FG001|Overall Study|Disease progression|7|||
16471188|NCT02445391|40204338|FG002|Overall Study|Disease progression|22|||
16471189|NCT02445391|40204336|FG000|Overall Study|Complicating disease|0|||
16471190|NCT02445391|40204337|FG001|Overall Study|Complicating disease|2|||
16471191|NCT02445391|40204338|FG002|Overall Study|Complicating disease|1|||
16471192|NCT02445391|40204336|FG000|Overall Study|Withdrawal by Subject|0|||
16471193|NCT02445391|40204337|FG001|Overall Study|Withdrawal by Subject|4|||
16471194|NCT02445391|40204338|FG002|Overall Study|Withdrawal by Subject|9|||
16471195|NCT02445391|40204336|FG000|Overall Study|Financial issue|0|||
16471196|NCT02445391|40204337|FG001|Overall Study|Financial issue|0|||
16471197|NCT02445391|40204338|FG002|Overall Study|Financial issue|2|||
16471198|NCT02445391|40204336|FG000|Overall Study|Still on treatment|0|||
16471199|NCT02445391|40204337|FG001|Overall Study|Still on treatment|7|||
16471200|NCT02445391|40204338|FG002|Overall Study|Still on treatment|16|||
16471201|NCT02445391|40204336|FG000|Overall Study|Not start protocol therapy|0|||
16471202|NCT02445391|40204337|FG001|Overall Study|Not start protocol therapy|12|||
16471203|NCT02445391|40204338|FG002|Overall Study|Not start protocol therapy|9|||
16471204|NCT03799211|40204339|FG000|Overall Study|Lost to Follow-up|2|||
16471205|NCT03799211|40204340|FG001|Overall Study|Lost to Follow-up|13|||
16471206|NCT03799211|40204339|FG000|Overall Study|Withdrawal by Subject|2|||
16471207|NCT03799211|40204340|FG001|Overall Study|Withdrawal by Subject|0|||
16273256|NCT01968551|39484473|FG000|Extension Phase|Withdrew Consent|0|||
16471208|NCT02180724|40204344|FG000|Overall Study|Death|26|||
16471209|NCT02180724|40204345|FG001|Overall Study|Death|1|||
16471210|NCT02180724|40204344|FG000|Overall Study|Lost to Follow-up|3|||
16471211|NCT02180724|40204345|FG001|Overall Study|Lost to Follow-up|1|||
16471212|NCT02180724|40204344|FG000|Overall Study|Withdrawal by Subject|4|||
16471213|NCT02180724|40204345|FG001|Overall Study|Withdrawal by Subject|2|||
16471214|NCT02180724|40204344|FG000|Overall Study|PI Decision|5|||
16471215|NCT02180724|40204345|FG001|Overall Study|PI Decision|2|||
16471216|NCT02180724|40204344|FG000|Overall Study|Study terminated by sponsor|54|||
16471217|NCT02180724|40204345|FG001|Overall Study|Study terminated by sponsor|8|||
16471218|NCT04068610|40204346|FG000|Overall Study|Death|4|||
16471219|NCT04068610|40204347|FG001|Overall Study|Death|8|||
16471220|NCT04068610|40204348|FG002|Overall Study|Death|13|||
16471221|NCT04068610|40204346|FG000|Overall Study|Lost to Follow-up|0|||
16471222|NCT04068610|40204347|FG001|Overall Study|Lost to Follow-up|2|||
16471223|NCT04068610|40204348|FG002|Overall Study|Lost to Follow-up|0|||
16471224|NCT04068610|40204346|FG000|Overall Study|Withdrawal by Subject|0|||
16471225|NCT04068610|40204347|FG001|Overall Study|Withdrawal by Subject|4|||
16471226|NCT04068610|40204348|FG002|Overall Study|Withdrawal by Subject|2|||
16471227|NCT04068610|40204346|FG000|Overall Study|Other|3|||
16471228|NCT04068610|40204347|FG001|Overall Study|Other|12|||
16471229|NCT04068610|40204348|FG002|Overall Study|Other|11|||
16471230|NCT02398227|40204349|FG000|Overall Study|Lost to Follow-up|21|||
16471231|NCT02398227|40204350|FG001|Overall Study|Lost to Follow-up|12|||
16471232|NCT02398227|40204349|FG000|Overall Study|Withdrawal by Subject|5|||
16471233|NCT02398227|40204350|FG001|Overall Study|Withdrawal by Subject|6|||
16471234|NCT02398227|40204349|FG000|Overall Study|Removed from treatment and dropped out|1|||
16471235|NCT02398227|40204350|FG001|Overall Study|Removed from treatment and dropped out|0|||
16471236|NCT01484054|40204351|FG000|Period 1|Withdrawal by Subject|0|||
16471237|NCT01484054|40204352|FG001|Period 1|Withdrawal by Subject|1|||
16471238|NCT00976573|40204353|FG000|Overall Study|Ineligible|0|||
16471239|NCT00976573|40204354|FG001|Overall Study|Ineligible|1|||
16471240|NCT00976573|40204353|FG000|Overall Study|Cancel prior to receiving treatment|4|||
16471241|NCT00976573|40204354|FG001|Overall Study|Cancel prior to receiving treatment|2|||
16471242|NCT00301821|40204355|FG000|Overall Study|Ineligible|25|||
16471243|NCT00301821|40204355|FG000|Overall Study|Cancel|1|||
16471244|NCT00117286|40204356|FG000|Overall Study|Adverse Event|12|||
16471245|NCT00117286|40204357|FG001|Overall Study|Adverse Event|6|||
16471246|NCT00117286|40204356|FG000|Overall Study|Lost to Follow-up|2|||
16471247|NCT00117286|40204357|FG001|Overall Study|Lost to Follow-up|0|||
16471248|NCT00117286|40204356|FG000|Overall Study|Protocol Violation|3|||
16471249|NCT00117286|40204357|FG001|Overall Study|Protocol Violation|3|||
16471250|NCT00117286|40204356|FG000|Overall Study|Withdrawal by Subject|6|||
16471251|NCT00117286|40204357|FG001|Overall Study|Withdrawal by Subject|2|||
16471252|NCT00117286|40204356|FG000|Overall Study|Physician Decision|3|||
16471253|NCT00117286|40204357|FG001|Overall Study|Physician Decision|7|||
16471254|NCT00117286|40204356|FG000|Overall Study|Lack of Efficacy|2|||
16471255|NCT00117286|40204357|FG001|Overall Study|Lack of Efficacy|1|||
16471256|NCT00117286|40204356|FG000|Overall Study|Research site closing|0|||
16471257|NCT00117286|40204357|FG001|Overall Study|Research site closing|2|||
16471258|NCT01280955|40204360|FG000|Overall Study|Death|2|||
16471259|NCT01280955|40204360|FG000|Overall Study|Withdrawal by Subject|1|||
16471260|NCT00597701|40204361|FG000|Overall Study|Withdrawal by Subject|5|||
16471261|NCT00597701|40204362|FG001|Overall Study|Withdrawal by Subject|5|||
16471262|NCT00597701|40204361|FG000|Overall Study|Death|0|||
16471263|NCT00597701|40204362|FG001|Overall Study|Death|1|||
16471264|NCT00597701|40204361|FG000|Overall Study|Physician Decision|2|||
16471265|NCT00597701|40204362|FG001|Overall Study|Physician Decision|0|||
16471266|NCT00597701|40204361|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
16471267|NCT00597701|40204362|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
16471268|NCT03875118|40204363|FG000|Overall Study|Withdrawal by Subject|4|||
16471269|NCT03875118|40204364|FG001|Overall Study|Withdrawal by Subject|4|||
16471270|NCT01325623|40204369|FG000|Overall Study|Withdrawal by Subject|3|||
16471271|NCT01697358|40204372|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
16471272|NCT01697358|40204373|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
16471273|NCT01697358|40204372|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
16471274|NCT01697358|40204373|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
16471275|NCT01697358|40204372|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
16471276|NCT01697358|40204373|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
16471277|NCT01697358|40204372|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
16471278|NCT01697358|40204373|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
16471279|NCT01697358|40204372|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
16471280|NCT01697358|40204373|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
16471281|NCT01697358|40204372|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
16471282|NCT01697358|40204373|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
16471283|NCT01697358|40204372|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
16471284|NCT01697358|40204373|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
16471285|NCT01697358|40204372|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
16471286|NCT01697358|40204373|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
16471287|NCT01697358|40204372|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
16471288|NCT01697358|40204373|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
16471289|NCT01697358|40204372|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
16471290|NCT01697358|40204373|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
16471291|NCT05442775|40204374|FG000|Overall Study|Trial terminated|61|||
16471292|NCT05442775|40204374|FG000|Overall Study|Lack of Efficacy|4|||
16471293|NCT05442775|40204374|FG000|Overall Study|Withdrawal by Subject|4|||
16471294|NCT05442775|40204374|FG000|Overall Study|Death|1|||
16471295|NCT05442775|40204374|FG000|Overall Study|Participant removed at Sponsor request|1|||
16471296|NCT02435069|40204381|FG000|Dose Response - First Intervention|Adverse Event|0|||
16471297|NCT02435069|40204382|FG001|Dose Response - First Intervention|Adverse Event|1|||
16471298|NCT02435069|40204383|FG002|Dose Response - First Intervention|Adverse Event|1|||
16471299|NCT02435069|40204384|FG003|Dose Response - First Intervention|Adverse Event|0|||
16471300|NCT02435069|40204385|FG004|Dose Response - First Intervention|Adverse Event|0|||
16471301|NCT02435069|40204381|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
16471302|NCT02435069|40204382|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
16471303|NCT02435069|40204383|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
16471304|NCT02435069|40204384|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
16471305|NCT02435069|40204385|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
16471306|NCT01151098|40204388|FG000|Overall Study|Adverse Event|82|||
16471307|NCT01151098|40204388|FG000|Overall Study|Lost to Follow-up|6|||
16471308|NCT01151098|40204388|FG000|Overall Study|Lack of Efficacy|15|||
16471309|NCT01151098|40204388|FG000|Overall Study|Protocol Violation|1|||
16471310|NCT01151098|40204388|FG000|Overall Study|Miscellaneous|13|||
16471311|NCT00417482|40204389|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
16471312|NCT00417482|40204390|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
16471313|NCT00417482|40204391|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
16471314|NCT00417482|40204389|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
16471315|NCT00417482|40204390|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
16471316|NCT00417482|40204391|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
16471317|NCT00417482|40204389|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
16471318|NCT00417482|40204390|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
16471319|NCT00417482|40204391|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
16471320|NCT00417482|40204389|FG000|Phase B 1st 16 Weeks|Death|1|||
16471321|NCT00417482|40204390|FG001|Phase B 1st 16 Weeks|Death|0|||
16471322|NCT00417482|40204391|FG002|Phase B 1st 16 Weeks|Death|0|||
16471323|NCT00417482|40204389|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
16471324|NCT00417482|40204390|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
16471325|NCT00417482|40204391|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
16471326|NCT00417482|40204389|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
16471327|NCT00417482|40204390|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
16471328|NCT00417482|40204391|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
16471329|NCT00417482|40204389|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
16471330|NCT00417482|40204390|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
16471331|NCT00417482|40204391|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
16471332|NCT00417482|40204389|FG000|Phase B 2nd 16 Weeks|Death|1|||
16471333|NCT00417482|40204390|FG001|Phase B 2nd 16 Weeks|Death|1|||
16471334|NCT00417482|40204391|FG002|Phase B 2nd 16 Weeks|Death|0|||
16471335|NCT02460458|40204392|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
16471336|NCT02460458|40204392|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
16471337|NCT02460458|40204392|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
16471338|NCT02460458|40204392|FG000|First Prospective Phase|Lost to Follow-up|16|||
16471339|NCT02460458|40204392|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
16471340|NCT01903525|40204393|FG000|Overall Study|Lost to Follow-up|5|||
16471341|NCT01903525|40204394|FG001|Overall Study|Lost to Follow-up|9|||
16471342|NCT01903525|40204393|FG000|Overall Study|Adverse Event|0|||
16471343|NCT01903525|40204394|FG001|Overall Study|Adverse Event|1|||
16471344|NCT00116168|40204395|FG000|Overall Study|Lost to Follow-up|6|||
16471345|NCT00116168|40204396|FG001|Overall Study|Lost to Follow-up|5|||
16471346|NCT00116168|40204397|FG002|Overall Study|Lost to Follow-up|0|||
16471347|NCT00116168|40204398|FG003|Overall Study|Lost to Follow-up|0|||
16471348|NCT01155219|40204401|FG000|Overall Study|Adverse Event|3|||
16471349|NCT01155219|40204402|FG001|Overall Study|Adverse Event|1|||
16471350|NCT01155219|40204401|FG000|Overall Study|non-medical reason|1|||
16471351|NCT01155219|40204402|FG001|Overall Study|non-medical reason|2|||
16471352|NCT00773383|40204403|FG000|Overall Study|Adverse Event|4|||
16471353|NCT00773383|40204403|FG000|Overall Study|Death|1|||
16471354|NCT00773383|40204403|FG000|Overall Study|Progression of Disease|23|||
16471355|NCT00773383|40204403|FG000|Overall Study|Other|2|||
16471356|NCT00773383|40204403|FG000|Overall Study|No study dose received|1|||
16471357|NCT01285960|40204404|FG000|Overall Study|Withdrawal by Subject|2|||
16471358|NCT01285960|40204404|FG000|Overall Study|Lost to Follow-up|2|||
16471359|NCT01285960|40204404|FG000|Overall Study|2 subjects received less 10 sonications|2|||
16471360|NCT01104155|40207587|FG000|Overall Study|Adverse Event|15|||
16471361|NCT01104155|40207588|FG001|Overall Study|Adverse Event|8|||
16471362|NCT01104155|40207587|FG000|Overall Study|Participant choice|6|||
16471363|NCT01104155|40207588|FG001|Overall Study|Participant choice|5|||
16471364|NCT01104155|40207587|FG000|Overall Study|Withdrawal of consent|1|||
16471365|NCT01104155|40207588|FG001|Overall Study|Withdrawal of consent|1|||
16471366|NCT01104155|40207587|FG000|Overall Study|Other|3|||
16471367|NCT01104155|40207588|FG001|Overall Study|Other|4|||
16471368|NCT02028871|40207591|FG000|Overall Study|Positive urine drug screen|1|||
16471369|NCT02028871|40207592|FG001|Overall Study|Positive urine drug screen|1|||
16471370|NCT02028871|40207591|FG000|Overall Study|Withdrawal by Subject|1|||
16471371|NCT02028871|40207592|FG001|Overall Study|Withdrawal by Subject|2|||
16471372|NCT02028871|40207591|FG000|Overall Study|IV placement difficulty|1|||
16471373|NCT02028871|40207592|FG001|Overall Study|IV placement difficulty|0|||
16471374|NCT02028871|40207591|FG000|Overall Study|Current Illness|1|||
16471375|NCT02028871|40207592|FG001|Overall Study|Current Illness|0|||
16471376|NCT01462227|40207595|FG000|Second Assignment|Lost to Follow-up|1|||
16471377|NCT01462227|40207596|FG001|Second Assignment|Lost to Follow-up|0|||
16471378|NCT01462227|40207597|FG002|Second Assignment|Lost to Follow-up|0|||
16471379|NCT01462227|40207598|FG003|Second Assignment|Lost to Follow-up|0|||
16471380|NCT01462227|40207595|FG000|Second Assignment|Protocol Violation|0|||
16471381|NCT01462227|40207596|FG001|Second Assignment|Protocol Violation|1|||
16471382|NCT01462227|40207597|FG002|Second Assignment|Protocol Violation|1|||
16471383|NCT01462227|40207598|FG003|Second Assignment|Protocol Violation|0|||
16471384|NCT01539642|40207605|FG000|Overall Study|Lack of Efficacy|20|||
16471385|NCT01539642|40207606|FG001|Overall Study|Lack of Efficacy|18|||
16471386|NCT01539642|40207605|FG000|Overall Study|Patient ready for early discharge|8|||
16471387|NCT01539642|40207606|FG001|Overall Study|Patient ready for early discharge|7|||
16471388|NCT01539642|40207605|FG000|Overall Study|Adverse Event|6|||
16471389|NCT01539642|40207606|FG001|Overall Study|Adverse Event|4|||
16471390|NCT01539642|40207605|FG000|Overall Study|Withdrawal by Subject|2|||
16471391|NCT01539642|40207606|FG001|Overall Study|Withdrawal by Subject|2|||
16471392|NCT03150485|40207609|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
16471393|NCT03150485|40207610|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
16471394|NCT03150485|40207611|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
16471395|NCT03150485|40207612|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
16471396|NCT03150485|40207613|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
16471397|NCT03150485|40207614|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
16471398|NCT01528215|40207615|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
16471399|NCT01528215|40207616|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
16471400|NCT01528215|40207615|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
16471401|NCT01528215|40207616|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
16471402|NCT01528215|40207615|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
16471403|NCT01528215|40207616|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
16471404|NCT01528215|40207615|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
16471405|NCT01528215|40207616|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
16471406|NCT00744471|40207617|FG000|Overall Study|Randomized but not treated|1|||
16471407|NCT00744471|40207618|FG001|Overall Study|Randomized but not treated|1|||
16471408|NCT00744471|40207619|FG002|Overall Study|Randomized but not treated|4|||
16471409|NCT00744471|40207620|FG003|Overall Study|Randomized but not treated|0|||
16471410|NCT00744471|40207617|FG000|Overall Study|Death|0|||
16471411|NCT00744471|40207618|FG001|Overall Study|Death|0|||
16471412|NCT00744471|40207619|FG002|Overall Study|Death|0|||
16471413|NCT00744471|40207620|FG003|Overall Study|Death|1|||
16471414|NCT00744471|40207617|FG000|Overall Study|Adverse Event|6|||
16471415|NCT00744471|40207618|FG001|Overall Study|Adverse Event|7|||
16471416|NCT00744471|40207619|FG002|Overall Study|Adverse Event|5|||
16471417|NCT00744471|40207620|FG003|Overall Study|Adverse Event|9|||
16471418|NCT00744471|40207617|FG000|Overall Study|Withdrawal by Subject|9|||
16471419|NCT00744471|40207618|FG001|Overall Study|Withdrawal by Subject|9|||
16471420|NCT00744471|40207619|FG002|Overall Study|Withdrawal by Subject|15|||
16471421|NCT00744471|40207620|FG003|Overall Study|Withdrawal by Subject|12|||
16471422|NCT00744471|40207617|FG000|Overall Study|Protocol Violation|1|||
16471423|NCT00744471|40207618|FG001|Overall Study|Protocol Violation|4|||
16471424|NCT00744471|40207619|FG002|Overall Study|Protocol Violation|1|||
16471425|NCT00744471|40207620|FG003|Overall Study|Protocol Violation|2|||
16471426|NCT00744471|40207617|FG000|Overall Study|Entered extension study|41|||
16471427|NCT00744471|40207618|FG001|Overall Study|Entered extension study|84|||
16471428|NCT00744471|40207619|FG002|Overall Study|Entered extension study|100|||
16471429|NCT00744471|40207620|FG003|Overall Study|Entered extension study|91|||
16471430|NCT00744471|40207617|FG000|Overall Study|Other|2|||
16471431|NCT00744471|40207618|FG001|Overall Study|Other|3|||
16471432|NCT00744471|40207619|FG002|Overall Study|Other|6|||
16471433|NCT00744471|40207620|FG003|Overall Study|Other|2|||
16471434|NCT00744471|40207617|FG000|Overall Study|Lack of Efficacy|83|||
16471435|NCT00744471|40207618|FG001|Overall Study|Lack of Efficacy|37|||
16471436|NCT00744471|40207619|FG002|Overall Study|Lack of Efficacy|19|||
16471437|NCT00744471|40207620|FG003|Overall Study|Lack of Efficacy|31|||
16471438|NCT00744471|40207617|FG000|Overall Study|Lost to Follow-up|0|||
16471439|NCT00744471|40207618|FG001|Overall Study|Lost to Follow-up|0|||
16471440|NCT00744471|40207619|FG002|Overall Study|Lost to Follow-up|2|||
16471441|NCT00744471|40207620|FG003|Overall Study|Lost to Follow-up|0|||
16471442|NCT03384693|40207621|FG000|Overall Study|Adverse Event|3|||
16471443|NCT03468543|40207622|FG000|Overall Study|Protocol stopping rules met|3|||
16471444|NCT03053271|40207623|FG000|Overall Study|Did not meet randomization criteria|3|||
16471445|NCT03053271|40207623|FG000|Overall Study|Withdrawal by Subject|1|||
16471446|NCT03953183|40207629|FG000|Overall Study|Physician Decision|0|||
16471447|NCT03953183|40207630|FG001|Overall Study|Physician Decision|1|||
16471448|NCT03953183|40207629|FG000|Overall Study|Withdrawal by Subject|0|||
16471449|NCT03953183|40207630|FG001|Overall Study|Withdrawal by Subject|1|||
16471450|NCT03181893|40207634|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
16471451|NCT03181893|40207635|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
16471452|NCT03181893|40207636|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
16471453|NCT03181893|40207637|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
16471454|NCT03181893|40207638|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
16471455|NCT03181893|40207639|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
16471456|NCT03181893|40207640|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
16471457|NCT03181893|40207641|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
16471458|NCT03181893|40207642|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
16471459|NCT03181893|40207643|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
16471460|NCT03181893|40207644|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
16471461|NCT03181893|40207634|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
16471462|NCT03181893|40207635|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
16471463|NCT03181893|40207636|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
16471464|NCT03181893|40207637|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
16471465|NCT03181893|40207638|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
16471466|NCT03181893|40207639|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
16471467|NCT03181893|40207640|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
16471468|NCT03181893|40207641|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
16471469|NCT03181893|40207642|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
16471470|NCT03181893|40207643|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
16471471|NCT03181893|40207644|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
16471472|NCT03181893|40207634|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
16471473|NCT03181893|40207635|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
16471474|NCT03181893|40207636|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
16471475|NCT03181893|40207637|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
16471476|NCT03181893|40207638|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
16471477|NCT03181893|40207639|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
16471478|NCT03181893|40207640|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
16471479|NCT03181893|40207641|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
16471480|NCT03181893|40207642|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
16471481|NCT03181893|40207643|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
16471482|NCT03181893|40207644|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
16471483|NCT03181893|40207634|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
16471484|NCT03181893|40207635|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
16471485|NCT03181893|40207636|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
16471486|NCT03181893|40207637|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
16471487|NCT03181893|40207638|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
16471488|NCT03181893|40207639|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
16471489|NCT03181893|40207640|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
16471490|NCT03181893|40207641|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
16471491|NCT03181893|40207642|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
16471492|NCT03181893|40207643|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
16471493|NCT03181893|40207644|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
16471494|NCT03181893|40207634|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
16471495|NCT03181893|40207635|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
16471496|NCT03181893|40207636|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
16471497|NCT03181893|40207637|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
16471498|NCT03181893|40207638|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
16471499|NCT03181893|40207639|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
16471500|NCT03181893|40207640|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
16471501|NCT03181893|40207641|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
16471502|NCT03181893|40207642|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
16471503|NCT03181893|40207643|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
16471504|NCT03181893|40207644|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
16471505|NCT02787005|40207645|FG000|Overall Study|Adverse Event|24|||
16471506|NCT02787005|40207646|FG001|Overall Study|Adverse Event|9|||
16471507|NCT02787005|40207647|FG002|Overall Study|Adverse Event|9|||
16471508|NCT02787005|40207648|FG003|Overall Study|Adverse Event|7|||
16471509|NCT02787005|40207649|FG004|Overall Study|Adverse Event|2|||
16471510|NCT02787005|40207645|FG000|Overall Study|Death|100|||
16471511|NCT02787005|40207646|FG001|Overall Study|Death|53|||
16471512|NCT02787005|40207647|FG002|Overall Study|Death|48|||
16471513|NCT02787005|40207648|FG003|Overall Study|Death|69|||
16471514|NCT02787005|40207649|FG004|Overall Study|Death|38|||
16471515|NCT02787005|40207645|FG000|Overall Study|Sponsor Decision|7|||
16471516|NCT02787005|40207646|FG001|Overall Study|Sponsor Decision|4|||
16471517|NCT02787005|40207647|FG002|Overall Study|Sponsor Decision|0|||
16471518|NCT02787005|40207648|FG003|Overall Study|Sponsor Decision|4|||
16471519|NCT02787005|40207649|FG004|Overall Study|Sponsor Decision|5|||
16471520|NCT02787005|40207645|FG000|Overall Study|Withdrawal by Subject|2|||
16471521|NCT02787005|40207646|FG001|Overall Study|Withdrawal by Subject|1|||
16471522|NCT02787005|40207647|FG002|Overall Study|Withdrawal by Subject|1|||
16471523|NCT02787005|40207648|FG003|Overall Study|Withdrawal by Subject|0|||
16471524|NCT02787005|40207649|FG004|Overall Study|Withdrawal by Subject|1|||
16471525|NCT02787005|40207645|FG000|Overall Study|Screen Failure|0|||
16471526|NCT02787005|40207646|FG001|Overall Study|Screen Failure|2|||
16471527|NCT02787005|40207647|FG002|Overall Study|Screen Failure|0|||
16471528|NCT02787005|40207648|FG003|Overall Study|Screen Failure|0|||
16471529|NCT02787005|40207649|FG004|Overall Study|Screen Failure|1|||
16471530|NCT02787005|40207645|FG000|Overall Study|Lost to Follow-up|0|||
16471531|NCT02787005|40207646|FG001|Overall Study|Lost to Follow-up|0|||
16471532|NCT02787005|40207647|FG002|Overall Study|Lost to Follow-up|0|||
16471533|NCT02787005|40207648|FG003|Overall Study|Lost to Follow-up|1|||
16471534|NCT02787005|40207649|FG004|Overall Study|Lost to Follow-up|0|||
16471535|NCT04447755|40207650|FG000|Overall Study|Death|8|||
16471536|NCT04447755|40207651|FG001|Overall Study|Death|14|||
16471537|NCT04447755|40207652|FG002|Overall Study|Death|8|||
16471538|NCT04447755|40207653|FG003|Overall Study|Death|9|||
16471539|NCT04447755|40207654|FG004|Overall Study|Death|7|||
16471540|NCT04447755|40207655|FG005|Overall Study|Death|7|||
16471541|NCT04447755|40207656|FG006|Overall Study|Death|40|||
16471542|NCT04447755|40207650|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
16471543|NCT04447755|40207651|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
16471544|NCT04447755|40207652|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
16471545|NCT04447755|40207653|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
16471546|NCT04447755|40207654|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
16471547|NCT04447755|40207655|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
16471548|NCT04447755|40207656|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
16471549|NCT04447755|40207650|FG000|Overall Study|Ongoing in Study|1|||
16471550|NCT04447755|40207651|FG001|Overall Study|Ongoing in Study|2|||
16471551|NCT04447755|40207652|FG002|Overall Study|Ongoing in Study|0|||
16471552|NCT04447755|40207653|FG003|Overall Study|Ongoing in Study|0|||
16471553|NCT04447755|40207654|FG004|Overall Study|Ongoing in Study|2|||
16471554|NCT04447755|40207655|FG005|Overall Study|Ongoing in Study|2|||
16471555|NCT04447755|40207656|FG006|Overall Study|Ongoing in Study|26|||
16471556|NCT01741012|40207669|FG000|Overall Study|Lost to Follow-up|1|||
16471557|NCT01741012|40207669|FG000|Overall Study|Withdrawal by Subject|2|||
16471558|NCT00815516|40207673|FG000|Overall Study|Death|3|||
16471559|NCT00815516|40207674|FG001|Overall Study|Death|1|||
16471560|NCT00815516|40207673|FG000|Overall Study|Physician Decision|1|||
16471561|NCT00815516|40207674|FG001|Overall Study|Physician Decision|0|||
16471562|NCT02435147|40207675|FG000|Overall Study|non-evaluable DXA scan|11|||
16471563|NCT00591266|40207682|FG000|Overall Study|Adverse Event|2|||
16471564|NCT00591266|40207683|FG001|Overall Study|Adverse Event|2|||
16471565|NCT00591266|40207684|FG002|Overall Study|Adverse Event|3|||
16471566|NCT00591266|40207682|FG000|Overall Study|Lost to Follow-up|0|||
16471567|NCT00591266|40207683|FG001|Overall Study|Lost to Follow-up|1|||
16471568|NCT00591266|40207684|FG002|Overall Study|Lost to Follow-up|0|||
16471569|NCT00591266|40207682|FG000|Overall Study|Protocol Violation|0|||
16471570|NCT00591266|40207683|FG001|Overall Study|Protocol Violation|0|||
16471571|NCT00591266|40207684|FG002|Overall Study|Protocol Violation|1|||
16471572|NCT00591266|40207682|FG000|Overall Study|Withdrawal by Subject|6|||
16471573|NCT00591266|40207683|FG001|Overall Study|Withdrawal by Subject|2|||
16471574|NCT00591266|40207684|FG002|Overall Study|Withdrawal by Subject|5|||
16471575|NCT00591266|40207682|FG000|Overall Study|Lack of Efficacy|0|||
16471576|NCT00591266|40207683|FG001|Overall Study|Lack of Efficacy|2|||
16471577|NCT00591266|40207684|FG002|Overall Study|Lack of Efficacy|0|||
16471578|NCT00591266|40207682|FG000|Overall Study|Other|1|||
16471579|NCT00591266|40207683|FG001|Overall Study|Other|4|||
16471580|NCT00591266|40207684|FG002|Overall Study|Other|5|||
16471581|NCT01442038|40207685|FG000|Overall Study|Death|35|||
16471582|NCT01442038|40207686|FG001|Overall Study|Death|29|||
16471583|NCT01442038|40207685|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
16471584|NCT01442038|40207686|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
16471585|NCT01442038|40207685|FG000|Overall Study|Participant Withdrew Consent|137|||
16471586|NCT01442038|40207686|FG001|Overall Study|Participant Withdrew Consent|102|||
16471587|NCT01442038|40207685|FG000|Overall Study|Lost to Follow-up|37|||
16471588|NCT01442038|40207686|FG001|Overall Study|Lost to Follow-up|51|||
16471589|NCT01442038|40207685|FG000|Overall Study|Adverse Event|26|||
16471590|NCT01442038|40207686|FG001|Overall Study|Adverse Event|15|||
16471591|NCT01442038|40207685|FG000|Overall Study|Protocol Deviation|9|||
16471592|NCT01442038|40207686|FG001|Overall Study|Protocol Deviation|20|||
16471593|NCT01442038|40207685|FG000|Overall Study|Investigator's Discretion|13|||
16471594|NCT01442038|40207686|FG001|Overall Study|Investigator's Discretion|16|||
16471595|NCT01442038|40207685|FG000|Overall Study|Study Terminated By Sponsor|2|||
16471596|NCT01442038|40207686|FG001|Overall Study|Study Terminated By Sponsor|3|||
16471597|NCT00925990|40207689|FG000|Overall Study|Adverse Event|1|||
16471598|NCT00925990|40207690|FG001|Overall Study|Adverse Event|3|||
16471599|NCT00925990|40207689|FG000|Overall Study|Withdrawal by Subject|2|||
16471600|NCT00925990|40207690|FG001|Overall Study|Withdrawal by Subject|2|||
16471601|NCT00925990|40207689|FG000|Overall Study|Lost to Follow-up|1|||
16471602|NCT00925990|40207690|FG001|Overall Study|Lost to Follow-up|3|||
16471603|NCT00925990|40207689|FG000|Overall Study|Physician Decision|1|||
16471604|NCT00925990|40207690|FG001|Overall Study|Physician Decision|1|||
16471605|NCT00925990|40207689|FG000|Overall Study|moved out of state, missed medication|0|||
16471606|NCT00925990|40207690|FG001|Overall Study|moved out of state, missed medication|2|||
16471607|NCT04072575|40207695|FG000|Overall Study|Physician Decision|1|||
16471608|NCT04072575|40207695|FG000|Overall Study|Adverse Event|7|||
16471609|NCT04072575|40207695|FG000|Overall Study|Withdrawal by Subject|14|||
16471610|NCT04072575|40207695|FG000|Overall Study|Other|2|||
16072815|NCT01194258|38759173|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
16072816|NCT01194258|38759174|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
16072817|NCT01194258|38759170|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
16072818|NCT01194258|38759171|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
16072819|NCT01194258|38759172|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
16072820|NCT01194258|38759173|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
16072821|NCT01194258|38759174|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
16072822|NCT01194258|38759170|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16072823|NCT01194258|38759171|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16072824|NCT01194258|38759172|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
16072825|NCT01194258|38759173|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16072826|NCT01194258|38759174|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
16072827|NCT03192046|38759177|FG000|Overall Study|Withdrawal by Subject|1|||
16471611|NCT01367119|40207698|FG000|Overall Study|Adverse Event|1|||
16471612|NCT01367119|40207699|FG001|Overall Study|Adverse Event|0|||
16471613|NCT01367119|40207698|FG000|Overall Study|Withdrawal by Subject|1|||
16471614|NCT01367119|40207699|FG001|Overall Study|Withdrawal by Subject|1|||
16471615|NCT02963831|40207700|FG000|Overall Study|Progressive Disease|3|||
16471616|NCT02963831|40207701|FG001|Overall Study|Progressive Disease|3|||
16471617|NCT02963831|40207702|FG002|Overall Study|Progressive Disease|16|||
16471618|NCT02963831|40207703|FG003|Overall Study|Progressive Disease|27|||
16471619|NCT02963831|40207700|FG000|Overall Study|Withdrawal by Subject|1|||
16471620|NCT02963831|40207701|FG001|Overall Study|Withdrawal by Subject|0|||
16471621|NCT02963831|40207702|FG002|Overall Study|Withdrawal by Subject|2|||
16471622|NCT02963831|40207703|FG003|Overall Study|Withdrawal by Subject|4|||
16471623|NCT02963831|40207700|FG000|Overall Study|Adverse Event|0|||
16471624|NCT02963831|40207701|FG001|Overall Study|Adverse Event|1|||
16471625|NCT02963831|40207702|FG002|Overall Study|Adverse Event|1|||
16471626|NCT02963831|40207703|FG003|Overall Study|Adverse Event|2|||
16471627|NCT02963831|40207700|FG000|Overall Study|Death|0|||
16471628|NCT02963831|40207701|FG001|Overall Study|Death|0|||
16471629|NCT02963831|40207702|FG002|Overall Study|Death|0|||
16471630|NCT02963831|40207703|FG003|Overall Study|Death|2|||
16471631|NCT03183778|40207704|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
16471632|NCT02063880|40207705|FG000|Overall Study|Death|21|||
16471633|NCT02063880|40207706|FG001|Overall Study|Death|18|||
16471634|NCT02063880|40207705|FG000|Overall Study|Lost to Follow-up|7|||
16471635|NCT02063880|40207706|FG001|Overall Study|Lost to Follow-up|7|||
16471636|NCT02063880|40207705|FG000|Overall Study|Ineligible|0|||
16471637|NCT02063880|40207706|FG001|Overall Study|Ineligible|2|||
16471638|NCT01086423|40207707|FG000|Overall Study|Protocol Violation|0|||
16471639|NCT01086423|40207708|FG001|Overall Study|Protocol Violation|0|||
16471640|NCT01086423|40207709|FG002|Overall Study|Protocol Violation|1|||
16471641|NCT01086423|40207707|FG000|Overall Study|Migrated/moved from study area|2|||
16471642|NCT01086423|40207708|FG001|Overall Study|Migrated/moved from study area|0|||
16471643|NCT01086423|40207709|FG002|Overall Study|Migrated/moved from study area|4|||
16471644|NCT01086423|40207707|FG000|Overall Study|Adverse event, fatal|1|||
16471645|NCT01086423|40207708|FG001|Overall Study|Adverse event, fatal|1|||
16471646|NCT01086423|40207709|FG002|Overall Study|Adverse event, fatal|0|||
16471647|NCT01086423|40207707|FG000|Overall Study|Adverse event, non-fatal|2|||
16471648|NCT01086423|40207708|FG001|Overall Study|Adverse event, non-fatal|1|||
16471649|NCT01086423|40207709|FG002|Overall Study|Adverse event, non-fatal|0|||
16471650|NCT01086423|40207707|FG000|Overall Study|Withdrawal by Subject|5|||
16471651|NCT01086423|40207708|FG001|Overall Study|Withdrawal by Subject|1|||
16471652|NCT01086423|40207709|FG002|Overall Study|Withdrawal by Subject|3|||
16471653|NCT01086423|40207707|FG000|Overall Study|Lost to Follow-up|0|||
16471654|NCT01086423|40207708|FG001|Overall Study|Lost to Follow-up|0|||
16471655|NCT01086423|40207709|FG002|Overall Study|Lost to Follow-up|1|||
16471656|NCT00096954|40207712|FG000|Overall Study|Adverse Event|3|||
16471657|NCT00096954|40207713|FG001|Overall Study|Adverse Event|1|||
16471658|NCT00096954|40207712|FG000|Overall Study|Withdrawal by Subject|9|||
16471659|NCT00096954|40207713|FG001|Overall Study|Withdrawal by Subject|8|||
16471660|NCT00096954|40207712|FG000|Overall Study|Physician Decision|1|||
16471661|NCT00096954|40207713|FG001|Overall Study|Physician Decision|1|||
16471662|NCT00096954|40207712|FG000|Overall Study|Sponsors Decision|1|||
16471663|NCT00096954|40207713|FG001|Overall Study|Sponsors Decision|1|||
16471664|NCT00096954|40207712|FG000|Overall Study|Pregnancy|1|||
16471665|NCT00096954|40207713|FG001|Overall Study|Pregnancy|1|||
16471666|NCT00096954|40207712|FG000|Overall Study|Initiation of immunotherapy|1|||
16471667|NCT00096954|40207713|FG001|Overall Study|Initiation of immunotherapy|0|||
16471668|NCT00096954|40207712|FG000|Overall Study|Non-compliance|0|||
16471669|NCT00096954|40207713|FG001|Overall Study|Non-compliance|3|||
16471670|NCT00096954|40207712|FG000|Overall Study|Lost to Follow-up|8|||
16471671|NCT00096954|40207713|FG001|Overall Study|Lost to Follow-up|5|||
16471672|NCT01986140|40207714|FG000|Overall Study|Withdrawal by Subject|31|||
16471673|NCT01986140|40207715|FG001|Overall Study|Withdrawal by Subject|25|||
16471674|NCT01986140|40207714|FG000|Overall Study|alternative treatment|1|||
16471675|NCT01986140|40207715|FG001|Overall Study|alternative treatment|1|||
16471676|NCT01986140|40207714|FG000|Overall Study|found not eligible|3|||
16471677|NCT01986140|40207715|FG001|Overall Study|found not eligible|0|||
16471678|NCT01986140|40207714|FG000|Overall Study|Adverse Event|0|||
16471679|NCT01986140|40207715|FG001|Overall Study|Adverse Event|1|||
16471680|NCT01986140|40207714|FG000|Overall Study|progression disease|0|||
16471681|NCT01986140|40207715|FG001|Overall Study|progression disease|1|||
16471682|NCT01675427|40207716|FG000|Overall Study|Withdrawal by Subject|7|||
16471683|NCT01675427|40207716|FG000|Overall Study|Participant Refused Sample Collection|18|||
16471684|NCT01675427|40207716|FG000|Overall Study|Sample not Collected by Mistake|2|||
16471685|NCT01675427|40207716|FG000|Overall Study|Lost to Follow-up|5|||
16471686|NCT01675427|40207716|FG000|Overall Study|Other|2|||
16471687|NCT04137224|40207717|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
16471688|NCT04137224|40207718|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
16471689|NCT04137224|40207717|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
16471690|NCT04137224|40207718|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
16471691|NCT04137224|40207717|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
16471692|NCT04137224|40207718|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
16471693|NCT01236118|40207721|FG000|Overall Study|Adverse Event|2|||
16471694|NCT01236118|40207722|FG001|Overall Study|Adverse Event|0|||
16471695|NCT01236118|40207723|FG002|Overall Study|Adverse Event|2|||
16471696|NCT01236118|40207721|FG000|Overall Study|Physician Decision|0|||
16471697|NCT01236118|40207722|FG001|Overall Study|Physician Decision|1|||
16471698|NCT01236118|40207723|FG002|Overall Study|Physician Decision|0|||
16471699|NCT01236118|40207721|FG000|Overall Study|Withdrawal by Subject|0|||
16471700|NCT01236118|40207722|FG001|Overall Study|Withdrawal by Subject|0|||
16471701|NCT01236118|40207723|FG002|Overall Study|Withdrawal by Subject|1|||
16471702|NCT00237185|40207724|FG000|Core|Adverse Event|3|||
16471703|NCT00237185|40207725|FG001|Core|Adverse Event|4|||
16471704|NCT00237185|40207724|FG000|Core|Abnormal laboratory value|0|||
16471705|NCT00237185|40207725|FG001|Core|Abnormal laboratory value|4|||
16471706|NCT00237185|40207724|FG000|Core|Abnormal test procedure results|1|||
16471707|NCT00237185|40207725|FG001|Core|Abnormal test procedure results|0|||
16471708|NCT00237185|40207724|FG000|Core|Lack of Efficacy|30|||
16471709|NCT00237185|40207725|FG001|Core|Lack of Efficacy|23|||
16471710|NCT00237185|40207724|FG000|Core|Protocol Violation|1|||
16471711|NCT00237185|40207725|FG001|Core|Protocol Violation|1|||
16471712|NCT00237185|40207724|FG000|Core|Withdrawal by Subject|4|||
16471713|NCT00237185|40207725|FG001|Core|Withdrawal by Subject|4|||
16471714|NCT00237185|40207724|FG000|Core|Administrative problems|0|||
16471715|NCT00237185|40207725|FG001|Core|Administrative problems|1|||
16471716|NCT00237185|40207724|FG000|Core|Death|4|||
16471717|NCT00237185|40207725|FG001|Core|Death|0|||
16471718|NCT00237185|40207724|FG000|Core|Determined ineligible post randomization|1|||
16471719|NCT00237185|40207725|FG001|Core|Determined ineligible post randomization|0|||
16471720|NCT00237185|40207724|FG000|Extension|Adverse Event|1|||
16471721|NCT00237185|40207725|FG001|Extension|Adverse Event|0|||
16471722|NCT00237185|40207724|FG000|Extension|Abnormal laboratory value|0|||
16471723|NCT00237185|40207725|FG001|Extension|Abnormal laboratory value|1|||
16471724|NCT00237185|40207724|FG000|Extension|Lack of Efficacy|9|||
16471725|NCT00237185|40207725|FG001|Extension|Lack of Efficacy|14|||
16471726|NCT00237185|40207724|FG000|Extension|Condition no longer required study drug|0|||
16471727|NCT00237185|40207725|FG001|Extension|Condition no longer required study drug|1|||
16471728|NCT00237185|40207724|FG000|Extension|Withdrawal by Subject|3|||
16471729|NCT00237185|40207725|FG001|Extension|Withdrawal by Subject|2|||
16471730|NCT00237185|40207724|FG000|Extension|Lost to Follow-up|1|||
16471731|NCT00237185|40207725|FG001|Extension|Lost to Follow-up|0|||
16471732|NCT00237185|40207724|FG000|Extension|Administrative problems|1|||
16471733|NCT00237185|40207725|FG001|Extension|Administrative problems|0|||
16471734|NCT00237185|40207724|FG000|Extension|Death|1|||
16471735|NCT00237185|40207725|FG001|Extension|Death|1|||
16471736|NCT02393690|40207726|FG000|Overall Study|Ineligible|0|||
16471737|NCT02393690|40207727|FG001|Overall Study|Ineligible|1|||
16471738|NCT01180647|40207728|FG000|Overall Study|Lost to Follow-up|5|||
16471739|NCT01180647|40207729|FG001|Overall Study|Lost to Follow-up|6|||
16471740|NCT04618770|40207730|FG000|Overall Study|Censored from Analysis|12|||
16471741|NCT04618770|40207730|FG000|Overall Study|Early Termination|25|||
16471742|NCT03190369|40207731|FG000|Overall Study|Poor compliance to protocol|0|||
16471743|NCT03190369|40207732|FG001|Overall Study|Poor compliance to protocol|1|||
16471744|NCT03190369|40207731|FG000|Overall Study|Withdraw before treatment|1|||
16471745|NCT03190369|40207732|FG001|Overall Study|Withdraw before treatment|5|||
16471746|NCT03190369|40207731|FG000|Overall Study|Randomized but not treated|0|||
16471747|NCT03190369|40207732|FG001|Overall Study|Randomized but not treated|2|||
16471748|NCT00764491|40207733|FG000|Overall Study|Lost to Follow-up|35|||
16471749|NCT00764491|40207734|FG001|Overall Study|Lost to Follow-up|17|||
16471750|NCT00995865|40207736|FG000|Overall Study|Protocol Violation|2|||
16471751|NCT00995865|40207737|FG001|Overall Study|Protocol Violation|0|||
16471752|NCT00995865|40207738|FG002|Overall Study|Protocol Violation|0|||
16471753|NCT00995865|40207736|FG000|Overall Study|Lost to Follow-up|0|||
16471754|NCT00995865|40207737|FG001|Overall Study|Lost to Follow-up|0|||
16471755|NCT00995865|40207738|FG002|Overall Study|Lost to Follow-up|1|||
16471756|NCT00930982|40207739|FG000|Overall Study|Adverse Event|19|||
16471757|NCT00930982|40207740|FG001|Overall Study|Adverse Event|23|||
16471758|NCT00930982|40207739|FG000|Overall Study|Protocol Violation|1|||
16471759|NCT00930982|40207740|FG001|Overall Study|Protocol Violation|5|||
16471760|NCT00930982|40207739|FG000|Overall Study|Withdrawal by Subject|1|||
16471761|NCT00930982|40207740|FG001|Overall Study|Withdrawal by Subject|1|||
16471762|NCT01606254|40207741|FG000|Overall Study|Withdrawal by Subject|1|||
16471763|NCT01606254|40207742|FG001|Overall Study|Withdrawal by Subject|3|||
16471764|NCT01606254|40207743|FG002|Overall Study|Withdrawal by Subject|0|||
16471765|NCT01606254|40207744|FG003|Overall Study|Withdrawal by Subject|2|||
16471766|NCT01606254|40207741|FG000|Overall Study|Adverse Event|1|||
16471767|NCT01606254|40207742|FG001|Overall Study|Adverse Event|1|||
16471768|NCT01606254|40207743|FG002|Overall Study|Adverse Event|0|||
16471769|NCT01606254|40207744|FG003|Overall Study|Adverse Event|1|||
16471770|NCT03500679|40207746|FG000|Overall Study|Lost to Follow-up|6|||
16471771|NCT03500679|40207747|FG001|Overall Study|Lost to Follow-up|3|||
16471772|NCT03500679|40207746|FG000|Overall Study|Withdrawal by Subject|3|||
16471773|NCT03500679|40207747|FG001|Overall Study|Withdrawal by Subject|0|||
16471774|NCT01058265|40207748|FG000|Overall Study|Lost to Follow-up|11|||
16471775|NCT01058265|40207749|FG001|Overall Study|Lost to Follow-up|12|||
16471776|NCT00730028|40207756|FG000|Overall Study|Adverse Event|23|||
16471777|NCT00730028|40207757|FG001|Overall Study|Adverse Event|26|||
16471778|NCT00730028|40207758|FG002|Overall Study|Adverse Event|16|||
16471779|NCT00730028|40207759|FG003|Overall Study|Adverse Event|20|||
16471780|NCT00730028|40207760|FG004|Overall Study|Adverse Event|43|||
16471781|NCT00730028|40207756|FG000|Overall Study|Lost to Follow-up|13|||
16471782|NCT00730028|40207757|FG001|Overall Study|Lost to Follow-up|26|||
16471783|NCT00730028|40207758|FG002|Overall Study|Lost to Follow-up|22|||
16471784|NCT00730028|40207759|FG003|Overall Study|Lost to Follow-up|26|||
16471785|NCT00730028|40207760|FG004|Overall Study|Lost to Follow-up|25|||
16471786|NCT00730028|40207756|FG000|Overall Study|Protocol Violation|6|||
16471787|NCT00730028|40207757|FG001|Overall Study|Protocol Violation|1|||
16471788|NCT00730028|40207758|FG002|Overall Study|Protocol Violation|1|||
16471789|NCT00730028|40207759|FG003|Overall Study|Protocol Violation|2|||
16471790|NCT00730028|40207760|FG004|Overall Study|Protocol Violation|0|||
16471791|NCT00730028|40207756|FG000|Overall Study|Withdrawal by Subject|9|||
16471792|NCT00730028|40207757|FG001|Overall Study|Withdrawal by Subject|5|||
16471793|NCT00730028|40207758|FG002|Overall Study|Withdrawal by Subject|4|||
16471794|NCT00730028|40207759|FG003|Overall Study|Withdrawal by Subject|5|||
16471795|NCT00730028|40207760|FG004|Overall Study|Withdrawal by Subject|9|||
16471796|NCT00730028|40207756|FG000|Overall Study|Physician Decision|3|||
16471797|NCT00730028|40207757|FG001|Overall Study|Physician Decision|3|||
16471798|NCT00730028|40207758|FG002|Overall Study|Physician Decision|2|||
16471799|NCT00730028|40207759|FG003|Overall Study|Physician Decision|3|||
16471800|NCT00730028|40207760|FG004|Overall Study|Physician Decision|2|||
16471801|NCT00730028|40207756|FG000|Overall Study|Treatment Failure|5|||
16471802|NCT00730028|40207757|FG001|Overall Study|Treatment Failure|5|||
16471803|NCT00730028|40207758|FG002|Overall Study|Treatment Failure|0|||
16471804|NCT00730028|40207759|FG003|Overall Study|Treatment Failure|0|||
16471805|NCT00730028|40207760|FG004|Overall Study|Treatment Failure|1|||
16471806|NCT00730028|40207756|FG000|Overall Study|Randomization Error|1|||
16471807|NCT00730028|40207757|FG001|Overall Study|Randomization Error|0|||
16471808|NCT00730028|40207758|FG002|Overall Study|Randomization Error|0|||
16471809|NCT00730028|40207759|FG003|Overall Study|Randomization Error|0|||
16471810|NCT00730028|40207760|FG004|Overall Study|Randomization Error|2|||
16471811|NCT02280473|40207761|FG000|Overall Study|Adverse Event|1|||
16471812|NCT02280473|40207762|FG001|Overall Study|Adverse Event|1|||
16471813|NCT02280473|40207761|FG000|Overall Study|Lack of Efficacy|0|||
16471814|NCT02280473|40207762|FG001|Overall Study|Lack of Efficacy|1|||
16471815|NCT02280473|40207761|FG000|Overall Study|Lost to Follow-up|0|||
16471816|NCT02280473|40207762|FG001|Overall Study|Lost to Follow-up|1|||
16471817|NCT03911154|40207765|FG000|Overall Study|Withdrawal by Subject|1|||
16471818|NCT02301988|40207766|FG000|Overall Study|Withdrawal by Subject|2|||
16471819|NCT02301988|40207767|FG001|Overall Study|Withdrawal by Subject|1|||
16471820|NCT02301988|40207766|FG000|Overall Study|Physician Decision|2|||
16471821|NCT02301988|40207767|FG001|Overall Study|Physician Decision|2|||
16471822|NCT02301988|40207766|FG000|Overall Study|Unknown Reason|1|||
16471823|NCT02301988|40207767|FG001|Overall Study|Unknown Reason|3|||
16471824|NCT02301988|40207766|FG000|Overall Study|Lack of Efficacy|3|||
16471825|NCT02301988|40207767|FG001|Overall Study|Lack of Efficacy|2|||
16471826|NCT02301988|40207766|FG000|Overall Study|Death|1|||
16471827|NCT02301988|40207767|FG001|Overall Study|Death|0|||
16471828|NCT02301988|40207766|FG000|Overall Study|Adverse Event|1|||
16471829|NCT02301988|40207767|FG001|Overall Study|Adverse Event|1|||
16471830|NCT03481660|40207768|FG000|Overall Study|Adverse Event|5|||
16471831|NCT03481660|40207769|FG001|Overall Study|Adverse Event|4|||
16471832|NCT03481660|40207768|FG000|Overall Study|Death|13|||
16471833|NCT03481660|40207769|FG001|Overall Study|Death|9|||
16471834|NCT03481660|40207768|FG000|Overall Study|Lost to Follow-up|2|||
16471835|NCT03481660|40207769|FG001|Overall Study|Lost to Follow-up|2|||
16471836|NCT03481660|40207768|FG000|Overall Study|Physician Decision|2|||
16471837|NCT03481660|40207769|FG001|Overall Study|Physician Decision|3|||
16471838|NCT03481660|40207768|FG000|Overall Study|Withdrawal by Subject|14|||
16471839|NCT03481660|40207769|FG001|Overall Study|Withdrawal by Subject|7|||
16471840|NCT03698331|40207770|FG000|Overall Study|Adverse Event|2|||
16471841|NCT03698331|40207771|FG001|Overall Study|Adverse Event|3|||
16471842|NCT03698331|40207770|FG000|Overall Study|Withdrawal by Subject|1|||
16471843|NCT03698331|40207771|FG001|Overall Study|Withdrawal by Subject|1|||
16471844|NCT03698331|40207770|FG000|Overall Study|Lost to Follow-up|0|||
16471845|NCT03698331|40207771|FG001|Overall Study|Lost to Follow-up|2|||
16471846|NCT03698331|40207770|FG000|Overall Study|Non-compliance with study drug|1|||
16471847|NCT03698331|40207771|FG001|Overall Study|Non-compliance with study drug|0|||
16471848|NCT04123665|40207772|FG000|Overall Study|Withdrawal by Subject|7|||
16471849|NCT04123665|40207773|FG001|Overall Study|Withdrawal by Subject|0|||
16471850|NCT04123665|40207772|FG000|Overall Study|Lost to Follow-up|1|||
16471851|NCT04123665|40207773|FG001|Overall Study|Lost to Follow-up|0|||
16471852|NCT03505671|40207774|FG000|Overall Study|Withdrawal by Subject|2|||
16471853|NCT03505671|40207775|FG001|Overall Study|Withdrawal by Subject|1|||
16471854|NCT03505671|40207774|FG000|Overall Study|Lost to Follow-up|1|||
16471855|NCT03505671|40207775|FG001|Overall Study|Lost to Follow-up|0|||
16471856|NCT01570868|40207776|FG000|Overall Study|Adverse Event|8|||
16471857|NCT01570868|40207777|FG001|Overall Study|Adverse Event|1|||
16471858|NCT01570868|40207776|FG000|Overall Study|FDA Recommendation|23|||
16471859|NCT01570868|40207777|FG001|Overall Study|FDA Recommendation|3|||
16471860|NCT01570868|40207776|FG000|Overall Study|Physician Decision|10|||
16471861|NCT01570868|40207777|FG001|Overall Study|Physician Decision|4|||
16471862|NCT01570868|40207776|FG000|Overall Study|Lost to Follow-up|1|||
16471863|NCT01570868|40207777|FG001|Overall Study|Lost to Follow-up|0|||
16471864|NCT01570868|40207776|FG000|Overall Study|Withdrawal by Subject|1|||
16471865|NCT01570868|40207777|FG001|Overall Study|Withdrawal by Subject|0|||
16471866|NCT00777205|40207783|FG000|Overall Study|Lost to Follow-up|25|||
16471867|NCT00777205|40207784|FG001|Overall Study|Lost to Follow-up|9|||
16471868|NCT00777205|40207783|FG000|Overall Study|Withdrawal by Subject|6|||
16471869|NCT00777205|40207784|FG001|Overall Study|Withdrawal by Subject|4|||
16471870|NCT00777205|40207783|FG000|Overall Study|Death|0|||
16471871|NCT00777205|40207784|FG001|Overall Study|Death|2|||
16471872|NCT00777205|40207783|FG000|Overall Study|Protocol Violation|0|||
16471873|NCT00777205|40207784|FG001|Overall Study|Protocol Violation|56|||
16471874|NCT03488927|40207785|FG000|Overall Study|Withdrawal by Subject|44|||
16471875|NCT03488927|40207786|FG001|Overall Study|Withdrawal by Subject|118|||
16471876|NCT03488927|40207787|FG002|Overall Study|Withdrawal by Subject|217|||
16471877|NCT02787551|40207788|FG000|Core Period: 26 Weeks|Adverse Event|10|||
16471878|NCT02787551|40207789|FG001|Core Period: 26 Weeks|Adverse Event|0|||
16471879|NCT02787551|40207788|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
16471880|NCT02787551|40207789|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
16471881|NCT02787551|40207788|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
16471882|NCT02787551|40207789|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
16471883|NCT02787551|40207788|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
16471884|NCT02787551|40207789|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
16471885|NCT02787551|40207788|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
16471886|NCT02787551|40207789|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
16471887|NCT02787551|40207788|FG000|Core Period: 26 Weeks|Other than specified|3|||
16471888|NCT02787551|40207789|FG001|Core Period: 26 Weeks|Other than specified|1|||
16471889|NCT02787551|40207788|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
16471890|NCT02787551|40207789|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
16471891|NCT02787551|40207788|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
16471892|NCT02787551|40207789|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
16471893|NCT02787551|40207788|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
16471894|NCT02787551|40207789|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
16471895|NCT00364130|40207790|FG000|Intervention Period|Lost to Follow-up|4|||
16471896|NCT00364130|40207791|FG001|Intervention Period|Lost to Follow-up|3|||
16471897|NCT00364130|40207790|FG000|Intervention Period|Pregnancy|1|||
16471898|NCT00364130|40207791|FG001|Intervention Period|Pregnancy|0|||
16471899|NCT00364130|40207790|FG000|Intervention Period|Withdrawal by Subject|4|||
16471900|NCT00364130|40207791|FG001|Intervention Period|Withdrawal by Subject|5|||
16471901|NCT00364130|40207790|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
16471902|NCT00364130|40207791|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
16471903|NCT00620464|40207796|FG000|Overall Study|Adverse Event|15|||
16471904|NCT00620464|40207797|FG001|Overall Study|Adverse Event|17|||
16471905|NCT00620464|40207796|FG000|Overall Study|Lost to Follow-up|1|||
16471906|NCT00620464|40207797|FG001|Overall Study|Lost to Follow-up|1|||
16471907|NCT00620464|40207796|FG000|Overall Study|Planning Pregnancy|1|||
16471908|NCT00620464|40207797|FG001|Overall Study|Planning Pregnancy|4|||
16471909|NCT00620464|40207796|FG000|Overall Study|Personal|2|||
16471910|NCT00620464|40207797|FG001|Overall Study|Personal|2|||
16471911|NCT00620464|40207796|FG000|Overall Study|Used prohibited medication|1|||
16471912|NCT00620464|40207797|FG001|Overall Study|Used prohibited medication|0|||
16471913|NCT00945555|40207799|FG000|Overall Study|Referred to another hospital|5|||
16471914|NCT00945555|40207799|FG000|Overall Study|Worsening condition, intensive care unit|1|||
16471915|NCT00945555|40207799|FG000|Overall Study|Withdrawal by Subject|2|||
16471916|NCT00945555|40207799|FG000|Overall Study|Participant continued treatment at home|1|||
16471917|NCT00945555|40207799|FG000|Overall Study|Death|18|||
16471918|NCT00945555|40207799|FG000|Overall Study|Other|1|||
16471919|NCT02038829|40207800|FG000|Washout Period 1|Death|0|||
16471920|NCT02038829|40207801|FG001|Washout Period 1|Death|0|||
16471921|NCT02038829|40207802|FG002|Washout Period 1|Death|0|||
16471922|NCT02038829|40207803|FG003|Washout Period 1|Death|0|||
16471923|NCT02038829|40207804|FG004|Washout Period 1|Death|1|||
16471924|NCT02038829|40207805|FG005|Washout Period 1|Death|0|||
16471925|NCT02038829|40207806|FG006|Washout Period 1|Death|0|||
16471926|NCT02038829|40207807|FG007|Washout Period 1|Death|0|||
16471927|NCT02038829|40207808|FG008|Washout Period 1|Death|0|||
16471928|NCT02038829|40207809|FG009|Washout Period 1|Death|0|||
16471929|NCT02038829|40207810|FG010|Washout Period 1|Death|0|||
16471930|NCT02038829|40207811|FG011|Washout Period 1|Death|0|||
16471931|NCT02038829|40207800|FG000|Treatment Period 2|Adverse Event|0|||
16471932|NCT02038829|40207801|FG001|Treatment Period 2|Adverse Event|0|||
16471933|NCT02038829|40207802|FG002|Treatment Period 2|Adverse Event|0|||
16471934|NCT02038829|40207803|FG003|Treatment Period 2|Adverse Event|0|||
16471935|NCT02038829|40207804|FG004|Treatment Period 2|Adverse Event|0|||
16471936|NCT02038829|40207805|FG005|Treatment Period 2|Adverse Event|0|||
16471937|NCT02038829|40207806|FG006|Treatment Period 2|Adverse Event|0|||
16471938|NCT02038829|40207807|FG007|Treatment Period 2|Adverse Event|0|||
16471939|NCT02038829|40207808|FG008|Treatment Period 2|Adverse Event|0|||
16471940|NCT02038829|40207809|FG009|Treatment Period 2|Adverse Event|0|||
16471941|NCT02038829|40207810|FG010|Treatment Period 2|Adverse Event|1|||
16471942|NCT02038829|40207811|FG011|Treatment Period 2|Adverse Event|0|||
16471943|NCT02038829|40207800|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16471944|NCT02038829|40207801|FG001|Treatment Period 2|Withdrawal by Subject|0|||
16471945|NCT02038829|40207802|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16471946|NCT02038829|40207803|FG003|Treatment Period 2|Withdrawal by Subject|0|||
16471947|NCT02038829|40207804|FG004|Treatment Period 2|Withdrawal by Subject|0|||
16471948|NCT02038829|40207805|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16471949|NCT02038829|40207806|FG006|Treatment Period 2|Withdrawal by Subject|0|||
16471950|NCT02038829|40207807|FG007|Treatment Period 2|Withdrawal by Subject|0|||
16471951|NCT02038829|40207808|FG008|Treatment Period 2|Withdrawal by Subject|0|||
16471952|NCT02038829|40207809|FG009|Treatment Period 2|Withdrawal by Subject|0|||
16471953|NCT02038829|40207810|FG010|Treatment Period 2|Withdrawal by Subject|0|||
16471954|NCT02038829|40207811|FG011|Treatment Period 2|Withdrawal by Subject|0|||
16471955|NCT02038829|40207800|FG000|Washout Period 2|Adverse Event|0|||
16471956|NCT02038829|40207801|FG001|Washout Period 2|Adverse Event|0|||
16471957|NCT02038829|40207802|FG002|Washout Period 2|Adverse Event|0|||
16471958|NCT02038829|40207803|FG003|Washout Period 2|Adverse Event|0|||
16471959|NCT02038829|40207804|FG004|Washout Period 2|Adverse Event|0|||
16471960|NCT02038829|40207805|FG005|Washout Period 2|Adverse Event|0|||
16471961|NCT02038829|40207806|FG006|Washout Period 2|Adverse Event|0|||
16471962|NCT02038829|40207807|FG007|Washout Period 2|Adverse Event|0|||
16471963|NCT02038829|40207808|FG008|Washout Period 2|Adverse Event|1|||
16471964|NCT02038829|40207809|FG009|Washout Period 2|Adverse Event|0|||
16471965|NCT02038829|40207810|FG010|Washout Period 2|Adverse Event|0|||
16471966|NCT02038829|40207811|FG011|Washout Period 2|Adverse Event|0|||
16471967|NCT02038829|40207800|FG000|Washout Period 2|Withdrawal by Subject|0|||
16471968|NCT02038829|40207801|FG001|Washout Period 2|Withdrawal by Subject|0|||
16471969|NCT02038829|40207802|FG002|Washout Period 2|Withdrawal by Subject|0|||
16471970|NCT02038829|40207803|FG003|Washout Period 2|Withdrawal by Subject|0|||
16471971|NCT02038829|40207804|FG004|Washout Period 2|Withdrawal by Subject|0|||
16471972|NCT02038829|40207805|FG005|Washout Period 2|Withdrawal by Subject|1|||
16471973|NCT02038829|40207806|FG006|Washout Period 2|Withdrawal by Subject|0|||
16471974|NCT02038829|40207807|FG007|Washout Period 2|Withdrawal by Subject|0|||
16172250|NCT01324830|39107374|FG012|Overall Study|Dose limiting toxicity|0|||
16172251|NCT01324830|39107375|FG013|Overall Study|Dose limiting toxicity|0|||
16172252|NCT01324830|39107376|FG014|Overall Study|Dose limiting toxicity|0|||
16172253|NCT01324830|39107377|FG015|Overall Study|Dose limiting toxicity|0|||
16172254|NCT01324830|39107378|FG016|Overall Study|Dose limiting toxicity|1|||
16172255|NCT01324830|39107379|FG017|Overall Study|Dose limiting toxicity|1|||
16471975|NCT02038829|40207808|FG008|Washout Period 2|Withdrawal by Subject|0|||
16471976|NCT02038829|40207809|FG009|Washout Period 2|Withdrawal by Subject|0|||
16471977|NCT02038829|40207810|FG010|Washout Period 2|Withdrawal by Subject|0|||
16471978|NCT02038829|40207811|FG011|Washout Period 2|Withdrawal by Subject|0|||
16471979|NCT02038829|40207800|FG000|Treatment Period 4|Adverse Event|0|||
16471980|NCT02038829|40207801|FG001|Treatment Period 4|Adverse Event|1|||
16471981|NCT02038829|40207802|FG002|Treatment Period 4|Adverse Event|0|||
16471982|NCT02038829|40207803|FG003|Treatment Period 4|Adverse Event|0|||
16471983|NCT02038829|40207804|FG004|Treatment Period 4|Adverse Event|0|||
16471984|NCT02038829|40207805|FG005|Treatment Period 4|Adverse Event|0|||
16471985|NCT02038829|40207806|FG006|Treatment Period 4|Adverse Event|0|||
16471986|NCT02038829|40207807|FG007|Treatment Period 4|Adverse Event|0|||
16471987|NCT02038829|40207808|FG008|Treatment Period 4|Adverse Event|0|||
16471988|NCT02038829|40207809|FG009|Treatment Period 4|Adverse Event|0|||
16471989|NCT02038829|40207810|FG010|Treatment Period 4|Adverse Event|0|||
16471990|NCT02038829|40207811|FG011|Treatment Period 4|Adverse Event|0|||
16471991|NCT02038829|40207800|FG000|Washout Period 4|Adverse Event|0|||
16471992|NCT02038829|40207801|FG001|Washout Period 4|Adverse Event|0|||
16471993|NCT02038829|40207802|FG002|Washout Period 4|Adverse Event|0|||
16471994|NCT02038829|40207803|FG003|Washout Period 4|Adverse Event|0|||
16471995|NCT02038829|40207804|FG004|Washout Period 4|Adverse Event|0|||
16471996|NCT02038829|40207805|FG005|Washout Period 4|Adverse Event|0|||
16471997|NCT02038829|40207806|FG006|Washout Period 4|Adverse Event|1|||
16471998|NCT02038829|40207807|FG007|Washout Period 4|Adverse Event|0|||
16471999|NCT02038829|40207808|FG008|Washout Period 4|Adverse Event|0|||
16472000|NCT02038829|40207809|FG009|Washout Period 4|Adverse Event|0|||
16472001|NCT02038829|40207810|FG010|Washout Period 4|Adverse Event|0|||
16472002|NCT02038829|40207811|FG011|Washout Period 4|Adverse Event|0|||
16472003|NCT02038829|40207800|FG000|Treatment Period 6|Adverse Event|0|||
16472004|NCT02038829|40207801|FG001|Treatment Period 6|Adverse Event|0|||
16472005|NCT02038829|40207802|FG002|Treatment Period 6|Adverse Event|1|||
16472006|NCT02038829|40207803|FG003|Treatment Period 6|Adverse Event|0|||
16472007|NCT02038829|40207804|FG004|Treatment Period 6|Adverse Event|0|||
16472008|NCT02038829|40207805|FG005|Treatment Period 6|Adverse Event|0|||
16472009|NCT02038829|40207806|FG006|Treatment Period 6|Adverse Event|0|||
16472010|NCT02038829|40207807|FG007|Treatment Period 6|Adverse Event|0|||
16472011|NCT02038829|40207808|FG008|Treatment Period 6|Adverse Event|0|||
16472012|NCT02038829|40207809|FG009|Treatment Period 6|Adverse Event|0|||
16472013|NCT02038829|40207810|FG010|Treatment Period 6|Adverse Event|0|||
16472014|NCT02038829|40207811|FG011|Treatment Period 6|Adverse Event|0|||
16472015|NCT01336569|40207812|FG000|Overall Study|Lost to Follow-up|4|||
16472016|NCT05036369|40207813|FG000|Overall Study|Run In non compliance|1|||
16472017|NCT05036369|40207814|FG001|Overall Study|Run In non compliance|2|||
16472018|NCT05036369|40207813|FG000|Overall Study|Change in eligibility criteria|0|||
16472019|NCT05036369|40207814|FG001|Overall Study|Change in eligibility criteria|1|||
16472020|NCT01369615|40207815|FG000|Overall Study|Withdrawal by Subject|0|||
16472021|NCT01369615|40207816|FG001|Overall Study|Withdrawal by Subject|1|||
16472022|NCT01369615|40207815|FG000|Overall Study|Lost to Follow-up|0|||
16472023|NCT01369615|40207816|FG001|Overall Study|Lost to Follow-up|1|||
16472024|NCT02239224|40207819|FG000|Overall Study|Administrative|0|||
16472025|NCT02239224|40207820|FG001|Overall Study|Administrative|0|||
16472026|NCT02239224|40207821|FG002|Overall Study|Administrative|3|||
16472027|NCT02239224|40207822|FG003|Overall Study|Administrative|1|||
16472028|NCT05080660|40207823|FG000|Overall Study|Adverse Event|4|||
16472029|NCT05080660|40207824|FG001|Overall Study|Adverse Event|0|||
16472030|NCT05080660|40207823|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
16472031|NCT05080660|40207824|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
16472032|NCT05080660|40207823|FG000|Overall Study|Physician Decision|1|||
16472033|NCT05080660|40207824|FG001|Overall Study|Physician Decision|0|||
16472034|NCT05080660|40207823|FG000|Overall Study|Protocol Deviation|2|||
16472035|NCT05080660|40207824|FG001|Overall Study|Protocol Deviation|0|||
16472036|NCT05080660|40207823|FG000|Overall Study|Withdrawal by Subject|5|||
16472037|NCT05080660|40207824|FG001|Overall Study|Withdrawal by Subject|2|||
16472038|NCT00997438|40207825|FG000|Overall Study|Blood draw difficulty|2|||
16472039|NCT00997438|40207826|FG001|Overall Study|Blood draw difficulty|0|||
16472040|NCT00997438|40207827|FG002|Overall Study|Blood draw difficulty|1|||
16472041|NCT00997438|40207825|FG000|Overall Study|Withdrawal by Subject|1|||
16472042|NCT00997438|40207826|FG001|Overall Study|Withdrawal by Subject|1|||
16472043|NCT00997438|40207827|FG002|Overall Study|Withdrawal by Subject|0|||
16072828|NCT03192046|38759178|FG001|Overall Study|Withdrawal by Subject|1|||
16072829|NCT02371746|38759179|FG000|Overall Study|Consent withdrawn|0|||
16072830|NCT02371746|38759180|FG001|Overall Study|Consent withdrawn|0|||
16072831|NCT02371746|38759181|FG002|Overall Study|Consent withdrawn|0|||
16072832|NCT02371746|38759182|FG003|Overall Study|Consent withdrawn|0|||
16072833|NCT02371746|38759183|FG004|Overall Study|Consent withdrawn|0|||
16072834|NCT02371746|38759184|FG005|Overall Study|Consent withdrawn|0|||
16072835|NCT02371746|38759185|FG006|Overall Study|Consent withdrawn|1|||
16072836|NCT01456936|38759203|FG000|Overall Study|Other reason|41|||
16072837|NCT01456936|38759204|FG001|Overall Study|Other reason|30|||
16072838|NCT01456936|38759205|FG002|Overall Study|Other reason|36|||
16072839|NCT01456936|38759206|FG003|Overall Study|Other reason|33|||
16072840|NCT01456936|38759203|FG000|Overall Study|No longer meets eligibility criteria|4|||
16072841|NCT01456936|38759204|FG001|Overall Study|No longer meets eligibility criteria|8|||
16072842|NCT01456936|38759205|FG002|Overall Study|No longer meets eligibility criteria|6|||
16072843|NCT01456936|38759206|FG003|Overall Study|No longer meets eligibility criteria|5|||
16072844|NCT01456936|38759203|FG000|Overall Study|Protocol Violation|4|||
16072845|NCT01456936|38759204|FG001|Overall Study|Protocol Violation|2|||
16072846|NCT01456936|38759205|FG002|Overall Study|Protocol Violation|5|||
16072847|NCT01456936|38759206|FG003|Overall Study|Protocol Violation|5|||
16072848|NCT01456936|38759203|FG000|Overall Study|Pregnancy|1|||
16072849|NCT01456936|38759204|FG001|Overall Study|Pregnancy|0|||
16072850|NCT01456936|38759205|FG002|Overall Study|Pregnancy|0|||
16072851|NCT01456936|38759206|FG003|Overall Study|Pregnancy|1|||
16072852|NCT01456936|38759203|FG000|Overall Study|Insufficient clinical response|4|||
16072853|NCT01456936|38759204|FG001|Overall Study|Insufficient clinical response|4|||
16072854|NCT01456936|38759205|FG002|Overall Study|Insufficient clinical response|14|||
16072855|NCT01456936|38759206|FG003|Overall Study|Insufficient clinical response|13|||
16072856|NCT01456936|38759203|FG000|Overall Study|No longer willing to participate|195|||
16072857|NCT01456936|38759204|FG001|Overall Study|No longer willing to participate|218|||
16072858|NCT01456936|38759205|FG002|Overall Study|No longer willing to participate|224|||
16072859|NCT01456936|38759206|FG003|Overall Study|No longer willing to participate|248|||
16072860|NCT01456936|38759203|FG000|Overall Study|Lost to Follow-up|135|||
16072861|NCT01456936|38759204|FG001|Overall Study|Lost to Follow-up|126|||
16072862|NCT01456936|38759205|FG002|Overall Study|Lost to Follow-up|144|||
16072863|NCT01456936|38759206|FG003|Overall Study|Lost to Follow-up|127|||
16072864|NCT01456936|38759203|FG000|Overall Study|Medication error|0|||
16072865|NCT01456936|38759204|FG001|Overall Study|Medication error|1|||
16072866|NCT01456936|38759205|FG002|Overall Study|Medication error|0|||
16072867|NCT01456936|38759206|FG003|Overall Study|Medication error|1|||
16072868|NCT01456936|38759203|FG000|Overall Study|Adverse event (study drug)|25|||
16072869|NCT01456936|38759204|FG001|Overall Study|Adverse event (study drug)|21|||
16072870|NCT01456936|38759205|FG002|Overall Study|Adverse event (study drug)|26|||
16072871|NCT01456936|38759206|FG003|Overall Study|Adverse event (study drug)|17|||
16072872|NCT01456936|38759203|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
16072873|NCT01456936|38759204|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
16072874|NCT01456936|38759205|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
16072875|NCT01456936|38759206|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
16072876|NCT01456936|38759203|FG000|Overall Study|Death|0|||
16072877|NCT01456936|38759204|FG001|Overall Study|Death|3|||
16072878|NCT01456936|38759205|FG002|Overall Study|Death|1|||
16072879|NCT01456936|38759206|FG003|Overall Study|Death|3|||
16072880|NCT01456936|38759203|FG000|Overall Study|Randomized but not treated|21|||
16072881|NCT01456936|38759204|FG001|Overall Study|Randomized but not treated|28|||
16072882|NCT01456936|38759205|FG002|Overall Study|Randomized but not treated|16|||
16072883|NCT01456936|38759206|FG003|Overall Study|Randomized but not treated|21|||
16072884|NCT01212991|38759207|FG000|Double-blind|Lost to Follow-up|8|||
16072885|NCT01212991|38759208|FG001|Double-blind|Lost to Follow-up|4|||
16072886|NCT01212991|38759209|FG002|Double-blind|Lost to Follow-up|0|||
16072887|NCT01212991|38759207|FG000|Double-blind|Death|699|||
16072888|NCT01212991|38759208|FG001|Double-blind|Death|550|||
16072889|NCT01212991|38759209|FG002|Double-blind|Death|0|||
16072890|NCT01212991|38759207|FG000|Double-blind|Withdrawal by Subject|16|||
16072891|NCT01212991|38759208|FG001|Double-blind|Withdrawal by Subject|19|||
16072892|NCT01212991|38759209|FG002|Double-blind|Withdrawal by Subject|0|||
16072893|NCT01212991|38759207|FG000|Double-blind|Other|7|||
16072894|NCT01212991|38759208|FG001|Double-blind|Other|0|||
16072895|NCT01212991|38759209|FG002|Double-blind|Other|0|||
16072896|NCT01212991|38759207|FG000|Double-blind|Sponsor decision|142|||
16072897|NCT01212991|38759208|FG001|Double-blind|Sponsor decision|38|||
16072898|NCT01212991|38759209|FG002|Double-blind|Sponsor decision|0|||
16072899|NCT01212991|38759207|FG000|Open-label|Death|0|||
16072900|NCT01212991|38759208|FG001|Open-label|Death|0|||
16072901|NCT01212991|38759209|FG002|Open-label|Death|166|||
16072902|NCT01212991|38759207|FG000|Open-label|Lost to Follow-up|0|||
16072903|NCT01212991|38759208|FG001|Open-label|Lost to Follow-up|0|||
16072904|NCT01212991|38759209|FG002|Open-label|Lost to Follow-up|5|||
16072905|NCT01212991|38759207|FG000|Open-label|Withdrawal by Subject|0|||
16072906|NCT01212991|38759208|FG001|Open-label|Withdrawal by Subject|0|||
16072907|NCT01212991|38759209|FG002|Open-label|Withdrawal by Subject|7|||
16072908|NCT01212991|38759207|FG000|Open-label|Sponsor decision|0|||
16072909|NCT01212991|38759208|FG001|Open-label|Sponsor decision|0|||
16072910|NCT01212991|38759209|FG002|Open-label|Sponsor decision|53|||
16072911|NCT01212991|38759207|FG000|Open-label|Other|0|||
16072912|NCT01212991|38759208|FG001|Open-label|Other|0|||
16072913|NCT01212991|38759209|FG002|Open-label|Other|3|||
16072914|NCT00843193|38759210|FG000|Overall Study|Adverse Event|2|||
16072915|NCT00843193|38759211|FG001|Overall Study|Adverse Event|4|||
16072916|NCT00843193|38759210|FG000|Overall Study|Lack of Efficacy|1|||
16072917|NCT00843193|38759211|FG001|Overall Study|Lack of Efficacy|1|||
16072918|NCT00843193|38759210|FG000|Overall Study|Protocol Violation|1|||
16072919|NCT00843193|38759211|FG001|Overall Study|Protocol Violation|2|||
16072920|NCT00843193|38759210|FG000|Overall Study|Lost to Follow-up|1|||
16072921|NCT00843193|38759211|FG001|Overall Study|Lost to Follow-up|0|||
16072922|NCT00843193|38759210|FG000|Overall Study|Physician Decision|0|||
16072923|NCT00843193|38759211|FG001|Overall Study|Physician Decision|1|||
16072924|NCT00843193|38759210|FG000|Overall Study|Withdrawal by Subject|3|||
16072925|NCT00843193|38759211|FG001|Overall Study|Withdrawal by Subject|3|||
16072926|NCT00559949|38759213|FG000|Overall Study|Progressive Disease during cycle 1|1|||
16072927|NCT00559949|38759213|FG000|Overall Study|Adverse Event|1|||
16072928|NCT00559949|38759213|FG000|Overall Study|Withdrawal by Subject|4|||
16072929|NCT00559949|38759213|FG000|Overall Study|No disease evaluation per protocol|1|||
16072930|NCT01360840|38759214|FG000|Overall Study|Ongoing at data cut-off|10|||
16072931|NCT01360840|38759215|FG001|Overall Study|Ongoing at data cut-off|10|||
16072932|NCT01360840|38759216|FG002|Overall Study|Ongoing at data cut-off|9|||
16072933|NCT00828672|38759222|FG000|Study Treatment|Lost to Follow-up|1|||
16072934|NCT00828672|38759223|FG001|Study Treatment|Lost to Follow-up|0|||
16072935|NCT00828672|38759222|FG000|Study Treatment|Adverse Event|0|||
16072936|NCT00828672|38759223|FG001|Study Treatment|Adverse Event|1|||
16072937|NCT00828672|38759222|FG000|Study Treatment|Complete response, no surgery|1|||
16072938|NCT00828672|38759223|FG001|Study Treatment|Complete response, no surgery|1|||
16072939|NCT00828672|38759222|FG000|Post-surgery (<30 Days)|No central review materials|0|||
16072940|NCT00828672|38759223|FG001|Post-surgery (<30 Days)|No central review materials|1|||
16072941|NCT04678830|38759224|FG000|Overall Study|Lack of Efficacy|2|||
16072942|NCT04678830|38759225|FG001|Overall Study|Lack of Efficacy|0|||
16072943|NCT04678830|38759224|FG000|Overall Study|Withdrawal by Subject|0|||
16072944|NCT04678830|38759225|FG001|Overall Study|Withdrawal by Subject|1|||
16072945|NCT00003656|38759226|FG000|Overall Study|Adverse Event|0|||
16072946|NCT00003656|38759227|FG001|Overall Study|Adverse Event|1|||
16072947|NCT00344019|38759228|FG000|Overall Study|did not meet final inclusion criteria|0|||
16072948|NCT00344019|38759229|FG001|Overall Study|did not meet final inclusion criteria|0|||
16072949|NCT00344019|38759230|FG002|Overall Study|did not meet final inclusion criteria|74|||
16072950|NCT02873754|38759234|FG000|Overall Study|Lost to Follow-up|5|||
16072951|NCT02873754|38759234|FG000|Overall Study|Couldn't complete study procedures|1|||
16072952|NCT00324038|38759235|FG000|Overall Study|Adverse Event|38|||
16072953|NCT00324038|38759236|FG001|Overall Study|Adverse Event|23|||
16072954|NCT00324038|38759235|FG000|Overall Study|Lack of Efficacy|5|||
16072955|NCT00324038|38759236|FG001|Overall Study|Lack of Efficacy|13|||
16072956|NCT00324038|38759235|FG000|Overall Study|Lost to Follow-up|0|||
16072957|NCT00324038|38759236|FG001|Overall Study|Lost to Follow-up|2|||
16072958|NCT00324038|38759235|FG000|Overall Study|Other|6|||
16072959|NCT00324038|38759236|FG001|Overall Study|Other|13|||
16072960|NCT01835899|38759237|FG000|Overall Study|Adverse Event|0|||
16072961|NCT01835899|38759238|FG001|Overall Study|Adverse Event|0|||
16072962|NCT01835899|38759239|FG002|Overall Study|Adverse Event|1|||
16072963|NCT01835899|38759237|FG000|Overall Study|Other than stated above|0|||
16072964|NCT01835899|38759238|FG001|Overall Study|Other than stated above|1|||
16072965|NCT01835899|38759239|FG002|Overall Study|Other than stated above|0|||
16072966|NCT00708032|38759240|FG000|Overall Study|Adverse Event|0|||
16072967|NCT00708032|38759241|FG001|Overall Study|Adverse Event|2|||
16072968|NCT00708032|38759240|FG000|Overall Study|Lost to Follow-up|1|||
16072969|NCT00708032|38759241|FG001|Overall Study|Lost to Follow-up|2|||
16072970|NCT00708032|38759240|FG000|Overall Study|Pregnancy|0|||
16072971|NCT00708032|38759241|FG001|Overall Study|Pregnancy|1|||
16072972|NCT00708032|38759240|FG000|Overall Study|Poor vision|0|||
16072973|NCT00708032|38759241|FG001|Overall Study|Poor vision|6|||
16072974|NCT00708032|38759240|FG000|Overall Study|Visit out of range at month 12|4|||
16072975|NCT00708032|38759241|FG001|Overall Study|Visit out of range at month 12|1|||
16072976|NCT00708032|38759240|FG000|Overall Study|Did not meet protocol criteria|1|||
16072977|NCT00708032|38759241|FG001|Overall Study|Did not meet protocol criteria|2|||
16072978|NCT00708032|38759240|FG000|Overall Study|Protocol Violation|4|||
16072979|NCT00708032|38759241|FG001|Overall Study|Protocol Violation|1|||
16072980|NCT00708032|38759240|FG000|Overall Study|Withdrawal by Subject|0|||
16072981|NCT00708032|38759241|FG001|Overall Study|Withdrawal by Subject|1|||
16072982|NCT00753012|38759253|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
16072983|NCT00753012|38759254|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
16072984|NCT00753012|38759253|FG000|Overall Study|Adverse Event|2|||
16072985|NCT00753012|38759254|FG001|Overall Study|Adverse Event|0|||
16072986|NCT00753012|38759253|FG000|Overall Study|Withdrawal by Subject|0|||
16072987|NCT00753012|38759254|FG001|Overall Study|Withdrawal by Subject|1|||
16072988|NCT00753012|38759253|FG000|Overall Study|Lost to Follow-up|4|||
16072989|NCT00753012|38759254|FG001|Overall Study|Lost to Follow-up|0|||
16072990|NCT00753012|38759253|FG000|Overall Study|Confounded endpoint data|1|||
16072991|NCT00753012|38759254|FG001|Overall Study|Confounded endpoint data|0|||
16072992|NCT03837028|38759259|FG000|Overall Study|Lost to Follow-up|4|||
16072993|NCT03837028|38759260|FG001|Overall Study|Lost to Follow-up|0|||
16072994|NCT03837028|38759261|FG002|Overall Study|Lost to Follow-up|2|||
16072995|NCT03837028|38759262|FG003|Overall Study|Lost to Follow-up|0|||
16072996|NCT03837028|38759259|FG000|Overall Study|Withdrawal by Subject|12|||
16072997|NCT03837028|38759260|FG001|Overall Study|Withdrawal by Subject|11|||
16072998|NCT03837028|38759261|FG002|Overall Study|Withdrawal by Subject|11|||
16072999|NCT03837028|38759262|FG003|Overall Study|Withdrawal by Subject|7|||
16073000|NCT02281318|38759263|FG000|Overall Study|Adverse Event|2|||
16073001|NCT02281318|38759264|FG001|Overall Study|Adverse Event|2|||
16073002|NCT02281318|38759263|FG000|Overall Study|Lack of Efficacy|2|||
16073003|NCT02281318|38759264|FG001|Overall Study|Lack of Efficacy|0|||
16073004|NCT02281318|38759263|FG000|Overall Study|Lost to Follow-up|2|||
16073005|NCT02281318|38759264|FG001|Overall Study|Lost to Follow-up|1|||
16073006|NCT02281318|38759263|FG000|Overall Study|Physician Decision|2|||
16073007|NCT02281318|38759264|FG001|Overall Study|Physician Decision|0|||
16073008|NCT02281318|38759263|FG000|Overall Study|Withdrawal by Subject|6|||
16073009|NCT02281318|38759264|FG001|Overall Study|Withdrawal by Subject|2|||
16073010|NCT00494442|38759266|FG000|Overall Study|Death|1|||
16073011|NCT00494442|38759267|FG001|Overall Study|Death|1|||
16073012|NCT00494442|38759266|FG000|Overall Study|Lack of Efficacy|16|||
16073013|NCT00494442|38759267|FG001|Overall Study|Lack of Efficacy|10|||
16073014|NCT00494442|38759266|FG000|Overall Study|Adverse Event|0|||
16073015|NCT00494442|38759267|FG001|Overall Study|Adverse Event|2|||
16073016|NCT00494442|38759266|FG000|Overall Study|Physician Decision|0|||
16073017|NCT00494442|38759267|FG001|Overall Study|Physician Decision|1|||
16073018|NCT00494442|38759266|FG000|Overall Study|Non-compliance|0|||
16073019|NCT00494442|38759267|FG001|Overall Study|Non-compliance|1|||
16073020|NCT00494442|38759266|FG000|Overall Study|Intercurrent illness|0|||
16073021|NCT00494442|38759267|FG001|Overall Study|Intercurrent illness|1|||
16073022|NCT00544440|38759268|FG000|Overall Study|Other|1|||
16073023|NCT00544440|38759268|FG000|Overall Study|Adverse Event|1|||
16073024|NCT00544440|38759268|FG000|Overall Study|Withdrawal by Subject|2|||
16073025|NCT00544440|38759268|FG000|Overall Study|Subject Non-compliance|1|||
16073026|NCT00544440|38759268|FG000|Overall Study|Progressive Disease|47|||
16073027|NCT00544440|38759268|FG000|Overall Study|Other|5|||
16073028|NCT01020838|38759271|FG000|Overall Study|Death|90|||
16073029|NCT01020838|38759271|FG000|Overall Study|Adverse Event|1|||
16073030|NCT01020838|38759271|FG000|Overall Study|Withdrawal by Subject|9|||
16073031|NCT01020838|38759271|FG000|Overall Study|Lost to Follow-up|6|||
16073032|NCT01020838|38759271|FG000|Overall Study|Most common: Study ended by sponsor|77|||
16073033|NCT01190007|38759272|FG000|Overall Study|Withdrawal by Subject|4|||
16073034|NCT01190007|38759272|FG000|Overall Study|Adverse Event|8|||
16073035|NCT01190007|38759272|FG000|Overall Study|Difficulty of visit for complications|1|||
16073036|NCT01190007|38759272|FG000|Overall Study|Participant was arrested|1|||
16073037|NCT02393716|38759273|FG000|Overall Study|Death|29|||
16073038|NCT02393716|38759273|FG000|Overall Study|Withdrawal by Subject|8|||
16073039|NCT02393716|38759273|FG000|Overall Study|Device Explanted|8|||
16073040|NCT02393716|38759273|FG000|Overall Study|Missed visit|16|||
16073041|NCT02148133|38759278|FG000|Overall Study|Investigator discretion|1|||
16073042|NCT02148133|38759278|FG000|Overall Study|Lack of Efficacy|1|||
16073043|NCT02148133|38759278|FG000|Overall Study|Protocol deviation|1|||
16073044|NCT02148133|38759278|FG000|Overall Study|Protocol-defined stopping criteria|2|||
16073045|NCT00732381|38759279|FG000|Overall Study|Adverse Event|1|||
16073046|NCT00732381|38759280|FG001|Overall Study|Adverse Event|0|||
16073047|NCT00732381|38759279|FG000|Overall Study|Treatment Failure|1|||
16073048|NCT00732381|38759280|FG001|Overall Study|Treatment Failure|1|||
16073049|NCT05308004|38759288|FG000|Overall Study|Not seen by Palliative Care NP|0|||
16073050|NCT05308004|38759289|FG001|Overall Study|Not seen by Palliative Care NP|1|||
16073051|NCT02385669|38759292|FG000|Overall Study|Adverse Event|2|||
16073052|NCT00001575|38759293|FG000|Overall Study|Screening failures-Ph I portion|22|||
16073053|NCT00001575|38759293|FG000|Overall Study|Withdrawn/deaths|23|||
16073054|NCT00420316|38759296|FG000|Overall Study|Withdrawal by Subject|0|||
16073055|NCT00420316|38759297|FG001|Overall Study|Withdrawal by Subject|1|||
16073056|NCT00420316|38759296|FG000|Overall Study|Lost to Follow-up|12|||
16073057|NCT00420316|38759297|FG001|Overall Study|Lost to Follow-up|8|||
16073058|NCT01072357|38759300|FG000|Overall Study|Lost to Follow-up|0|||
16073059|NCT01072357|38759301|FG001|Overall Study|Lost to Follow-up|1|||
16073060|NCT01693614|38759302|FG000|Overall Study|Adverse Event|7|||
16073061|NCT01693614|38759303|FG001|Overall Study|Adverse Event|11|||
16073062|NCT01693614|38759304|FG002|Overall Study|Adverse Event|5|||
16073063|NCT01693614|38759302|FG000|Overall Study|Disease progression|11|||
16073064|NCT01693614|38759303|FG001|Overall Study|Disease progression|8|||
16073065|NCT01693614|38759304|FG002|Overall Study|Disease progression|7|||
16073066|NCT01693614|38759302|FG000|Overall Study|Protocol Violation|5|||
16073067|NCT01693614|38759303|FG001|Overall Study|Protocol Violation|2|||
16073068|NCT01693614|38759304|FG002|Overall Study|Protocol Violation|1|||
16073069|NCT01693614|38759302|FG000|Overall Study|Death|1|||
16073070|NCT01693614|38759303|FG001|Overall Study|Death|0|||
16073071|NCT01693614|38759304|FG002|Overall Study|Death|0|||
16073072|NCT01693614|38759302|FG000|Overall Study|Physician Decision|1|||
16073073|NCT01693614|38759303|FG001|Overall Study|Physician Decision|1|||
16073074|NCT01693614|38759304|FG002|Overall Study|Physician Decision|4|||
16073075|NCT01693614|38759302|FG000|Overall Study|Withdrawal by subject/guardian|0|||
16073076|NCT01693614|38759303|FG001|Overall Study|Withdrawal by subject/guardian|0|||
16073077|NCT01693614|38759304|FG002|Overall Study|Withdrawal by subject/guardian|2|||
16073078|NCT01693614|38759302|FG000|Overall Study|Withdrawal by Subject|1|||
16073079|NCT01693614|38759303|FG001|Overall Study|Withdrawal by Subject|0|||
16073080|NCT01693614|38759304|FG002|Overall Study|Withdrawal by Subject|5|||
16073081|NCT01212757|38759305|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
16073082|NCT01212757|38759306|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
16073083|NCT01212757|38759307|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
16073084|NCT01212757|38759308|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16073085|NCT01212757|38759309|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16073086|NCT01212757|38759310|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16073087|NCT01212757|38759311|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16073088|NCT01212757|38759312|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16073089|NCT01212757|38759313|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
16073090|NCT01212757|38759305|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
16073091|NCT01212757|38759306|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
16073092|NCT01212757|38759307|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
16073093|NCT01212757|38759308|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16073094|NCT01212757|38759309|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16073095|NCT01212757|38759310|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16073096|NCT01212757|38759311|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16073097|NCT01212757|38759312|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16073098|NCT01212757|38759313|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
16073099|NCT01212757|38759305|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
16073100|NCT01212757|38759306|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
16073101|NCT01212757|38759307|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
16073102|NCT01212757|38759308|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16073103|NCT01212757|38759309|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16073104|NCT01212757|38759310|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16073105|NCT01212757|38759311|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16073106|NCT01212757|38759312|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16073107|NCT01212757|38759313|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
16073108|NCT01212757|38759305|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
16073109|NCT01212757|38759306|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16073110|NCT01212757|38759307|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
16073111|NCT01212757|38759308|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16073112|NCT01212757|38759309|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16073113|NCT01212757|38759310|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16073114|NCT01212757|38759311|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16073115|NCT01212757|38759312|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16073116|NCT01212757|38759313|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
16073117|NCT01212757|38759305|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
16073118|NCT01212757|38759306|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
16073119|NCT01212757|38759307|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
16073120|NCT01212757|38759308|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16073121|NCT01212757|38759309|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16073122|NCT01212757|38759310|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16172256|NCT01324830|39107380|FG018|Overall Study|Dose limiting toxicity|1|||
16073123|NCT01212757|38759311|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16073124|NCT01212757|38759312|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16073125|NCT01212757|38759313|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
16073126|NCT01212757|38759305|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16073127|NCT01212757|38759306|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
16073128|NCT01212757|38759307|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
16073129|NCT01212757|38759308|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16073130|NCT01212757|38759309|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16073131|NCT01212757|38759310|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16073132|NCT01212757|38759311|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16073133|NCT01212757|38759312|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16073134|NCT01212757|38759313|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
16073135|NCT01212757|38759305|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
16073136|NCT01212757|38759306|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
16073137|NCT01212757|38759307|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16073138|NCT01212757|38759308|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16073139|NCT01212757|38759309|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16073140|NCT01212757|38759310|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16073141|NCT01212757|38759311|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16073142|NCT01212757|38759312|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16073143|NCT01212757|38759313|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
16073144|NCT01212757|38759305|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
16073145|NCT01212757|38759306|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
16073146|NCT01212757|38759307|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
16073147|NCT01212757|38759308|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
16073148|NCT01212757|38759309|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
16073149|NCT01212757|38759310|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
16073150|NCT01212757|38759311|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
16073151|NCT01212757|38759312|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
16073152|NCT01212757|38759313|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
16073153|NCT01212757|38759305|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
16073154|NCT01212757|38759306|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
16073155|NCT01212757|38759307|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
16073156|NCT01212757|38759308|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
16073157|NCT01212757|38759309|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
16073158|NCT01212757|38759310|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
16073159|NCT01212757|38759311|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
16073160|NCT01212757|38759312|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
16073161|NCT01212757|38759313|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
16073162|NCT01212757|38759305|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16073163|NCT01212757|38759306|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16073164|NCT01212757|38759307|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
16073165|NCT01212757|38759308|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16073166|NCT01212757|38759309|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16073167|NCT01212757|38759310|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16073168|NCT01212757|38759311|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16073169|NCT01212757|38759312|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16073170|NCT01212757|38759313|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
16073171|NCT01212757|38759305|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16073172|NCT01212757|38759306|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
16073173|NCT01212757|38759307|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
16073174|NCT01212757|38759308|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
16073175|NCT01212757|38759309|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
16073176|NCT01212757|38759310|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
16073177|NCT01212757|38759311|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16073178|NCT01212757|38759312|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16073179|NCT01212757|38759313|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
16073180|NCT01212757|38759305|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16073181|NCT01212757|38759306|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
16073182|NCT01212757|38759307|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16073183|NCT01212757|38759308|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16073184|NCT01212757|38759309|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
16073185|NCT01212757|38759310|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16073186|NCT01212757|38759311|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16073187|NCT01212757|38759312|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16073188|NCT01212757|38759313|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
16073189|NCT01212757|38759305|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16073190|NCT01212757|38759306|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
16073191|NCT01212757|38759307|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
16073192|NCT01212757|38759308|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16073193|NCT01212757|38759309|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16073194|NCT01212757|38759310|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16073195|NCT01212757|38759311|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16073196|NCT01212757|38759312|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16073197|NCT01212757|38759313|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
16073198|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16073199|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16073200|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16073201|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16073202|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16073203|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16073204|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16073205|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
16073206|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
16073207|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
16073208|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
16073209|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
16073210|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
16073211|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
16073212|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
16073213|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
16073214|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
16073215|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
16073216|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16073217|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
16073218|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
16073219|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16073220|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16073221|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16073222|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16073223|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
16073224|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
16073225|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16073226|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
16073227|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
16073228|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16073229|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16073230|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16073231|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
16073232|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
16073233|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
16073234|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16073235|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16073236|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
16073237|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16073238|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16073239|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16073240|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16073241|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16073242|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
16073243|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16073244|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
16073245|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
16073246|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16073247|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16073248|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16073249|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16073250|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
16073251|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
16073252|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
16073253|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
16073254|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
16073255|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
16073256|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
16073257|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
16073258|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
16073259|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
16073260|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
16073261|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16073262|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16073263|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
16073264|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16073265|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16073266|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16073267|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16073268|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16073269|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
16073270|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16073271|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
16073272|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
16073273|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16073274|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16073275|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16073276|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
16073277|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
16073278|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
16073279|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16073280|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16073281|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16073282|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16073283|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16073284|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16073285|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16073286|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
16073287|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
16073288|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16073289|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
16073290|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16073291|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16073292|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16073293|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16073294|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16073295|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16073296|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
16073297|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16073298|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16073299|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
16073300|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16073301|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16073302|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16073303|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16073304|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
16073305|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
16073306|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16073307|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
16073308|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16073309|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16073310|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16073311|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16073312|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16073313|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
16073314|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
16073315|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
16073316|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
16073317|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
16073318|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
16073319|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
16073320|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
16073321|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
16073322|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
16273257|NCT01968551|39484474|FG001|Extension Phase|Withdrew Consent|0|||
16073323|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
16073324|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
16073325|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
16073326|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
16073327|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
16073328|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
16073329|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
16073330|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
16073331|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
16073332|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
16073333|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16073334|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
16073335|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
16073336|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16073337|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16073338|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16073339|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
16073340|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
16073341|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
16073342|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
16073343|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
16073344|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
16073345|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
16073346|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
16073347|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
16073348|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
16073349|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
16073350|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
16073351|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16073352|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16073353|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16073354|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16073355|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16073356|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16073357|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16073358|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
16073359|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
16073360|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16073361|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
16073362|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
16073363|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16073364|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16073365|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16073366|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
16073367|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
16073368|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
16073369|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16073370|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
16073371|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
16073372|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16073373|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16073374|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16073375|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16073376|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
16073377|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
16073378|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
16073379|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
16073380|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
16073381|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
16073382|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
16073383|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
16073384|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
16073385|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
16073386|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
16073387|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16073388|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
16073389|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16073390|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16073391|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16073392|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16073393|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16073394|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16073395|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
16073396|NCT01212757|38759305|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16073397|NCT01212757|38759306|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
16073398|NCT01212757|38759307|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
16073399|NCT01212757|38759308|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16073400|NCT01212757|38759309|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16073401|NCT01212757|38759310|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16073402|NCT01212757|38759311|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16073403|NCT01212757|38759312|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16073404|NCT01212757|38759313|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
16073405|NCT01595321|38759317|FG000|Overall Study|Adverse Event|1|||
16073406|NCT01595321|38759318|FG001|Overall Study|Adverse Event|1|||
16073407|NCT01595321|38759319|FG002|Overall Study|Adverse Event|1|||
16073408|NCT01595321|38759317|FG000|Overall Study|Lack of Efficacy|0|||
16073409|NCT01595321|38759318|FG001|Overall Study|Lack of Efficacy|0|||
16073410|NCT01595321|38759319|FG002|Overall Study|Lack of Efficacy|4|||
16073411|NCT00509769|38759320|FG000|Overall Study|Progressive disease|77|||
16073412|NCT00509769|38759320|FG000|Overall Study|Adverse Event|4|||
16073413|NCT00509769|38759320|FG000|Overall Study|Patient's decision|1|||
16073414|NCT00509769|38759320|FG000|Overall Study|Physician Decision|8|||
16073415|NCT00509769|38759320|FG000|Overall Study|Use of prohibited therapies during study|1|||
16073416|NCT03808883|38759324|FG000|Overall Study|Withdrawal by Subject|2|||
16073417|NCT03808883|38759325|FG001|Overall Study|Withdrawal by Subject|0|||
16073418|NCT03808883|38759324|FG000|Overall Study|Did not complete pre test or post test survey|4|||
16073419|NCT03808883|38759325|FG001|Overall Study|Did not complete pre test or post test survey|3|||
16073420|NCT01391130|38759326|FG000|Overall Study|Withdrawal by Subject|3|||
16073421|NCT01391130|38759327|FG001|Overall Study|Withdrawal by Subject|2|||
16073422|NCT01391130|38759326|FG000|Overall Study|Physician Decision|2|||
16073423|NCT01391130|38759327|FG001|Overall Study|Physician Decision|3|||
16073424|NCT01391130|38759326|FG000|Overall Study|Did not Receive Drug|1|||
16073425|NCT01391130|38759327|FG001|Overall Study|Did not Receive Drug|1|||
16073426|NCT03478956|38759329|FG000|Overall Study|Adverse Event|1|||
16073427|NCT03478956|38759330|FG001|Overall Study|Adverse Event|0|||
16073428|NCT03478956|38759329|FG000|Overall Study|Withdrawal by Subject|0|||
16073429|NCT03478956|38759330|FG001|Overall Study|Withdrawal by Subject|1|||
16073430|NCT03478956|38759329|FG000|Overall Study|Ongoing in the Study|11|||
16073431|NCT03478956|38759330|FG001|Overall Study|Ongoing in the Study|11|||
16073432|NCT01981850|38759336|FG000|Main Phase Stage 1|Death|2|||
16073433|NCT01981850|38759337|FG001|Main Phase Stage 1|Death|0|||
16073434|NCT01981850|38759338|FG002|Main Phase Stage 1|Death|0|||
16073435|NCT01981850|38759339|FG003|Main Phase Stage 1|Death|0|||
16073436|NCT01981850|38759340|FG004|Main Phase Stage 1|Death|0|||
16073437|NCT01981850|38759341|FG005|Main Phase Stage 1|Death|0|||
16073438|NCT01981850|38759342|FG006|Main Phase Stage 1|Death|0|||
16073439|NCT01981850|38759343|FG007|Main Phase Stage 1|Death|0|||
16073440|NCT01981850|38759344|FG008|Main Phase Stage 1|Death|0|||
16073441|NCT01981850|38759345|FG009|Main Phase Stage 1|Death|0|||
16073442|NCT01981850|38759336|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
16073443|NCT01981850|38759337|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
16073444|NCT01981850|38759338|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
16073445|NCT01981850|38759339|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
16073446|NCT01981850|38759340|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
16073447|NCT01981850|38759341|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
16073448|NCT01981850|38759342|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
16073449|NCT01981850|38759343|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
16073450|NCT01981850|38759344|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
16073451|NCT01981850|38759345|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
16073452|NCT01981850|38759336|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
16073453|NCT01981850|38759337|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
16073454|NCT01981850|38759338|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
16073455|NCT01981850|38759339|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
16073456|NCT01981850|38759340|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
16073457|NCT01981850|38759341|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
16073458|NCT01981850|38759342|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
16073459|NCT01981850|38759343|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
16073460|NCT01981850|38759344|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
16073461|NCT01981850|38759345|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
16073462|NCT01981850|38759336|FG000|Main Phase Stage 1|Various reasons|0|||
16073463|NCT01981850|38759337|FG001|Main Phase Stage 1|Various reasons|0|||
16073464|NCT01981850|38759338|FG002|Main Phase Stage 1|Various reasons|2|||
16073465|NCT01981850|38759339|FG003|Main Phase Stage 1|Various reasons|0|||
16172257|NCT01324830|39107362|FG000|Overall Study|Reason not mentioned above|0|||
16073466|NCT01981850|38759340|FG004|Main Phase Stage 1|Various reasons|0|||
16073467|NCT01981850|38759341|FG005|Main Phase Stage 1|Various reasons|0|||
16073468|NCT01981850|38759342|FG006|Main Phase Stage 1|Various reasons|0|||
16073469|NCT01981850|38759343|FG007|Main Phase Stage 1|Various reasons|0|||
16073470|NCT01981850|38759344|FG008|Main Phase Stage 1|Various reasons|0|||
16073471|NCT01981850|38759345|FG009|Main Phase Stage 1|Various reasons|0|||
16073472|NCT01981850|38759336|FG000|Main Phase Stage 2|Adverse Event|0|||
16073473|NCT01981850|38759337|FG001|Main Phase Stage 2|Adverse Event|0|||
16073474|NCT01981850|38759338|FG002|Main Phase Stage 2|Adverse Event|0|||
16073475|NCT01981850|38759339|FG003|Main Phase Stage 2|Adverse Event|0|||
16073476|NCT01981850|38759340|FG004|Main Phase Stage 2|Adverse Event|6|||
16073477|NCT01981850|38759341|FG005|Main Phase Stage 2|Adverse Event|5|||
16073478|NCT01981850|38759342|FG006|Main Phase Stage 2|Adverse Event|7|||
16073479|NCT01981850|38759343|FG007|Main Phase Stage 2|Adverse Event|0|||
16073480|NCT01981850|38759344|FG008|Main Phase Stage 2|Adverse Event|0|||
16073481|NCT01981850|38759345|FG009|Main Phase Stage 2|Adverse Event|0|||
16073482|NCT01981850|38759336|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
16073483|NCT01981850|38759337|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
16073484|NCT01981850|38759338|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
16073485|NCT01981850|38759339|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
16073486|NCT01981850|38759340|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
16073487|NCT01981850|38759341|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
16073488|NCT01981850|38759342|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
16073489|NCT01981850|38759343|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
16073490|NCT01981850|38759344|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
16073491|NCT01981850|38759345|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
16073492|NCT01981850|38759336|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
16073493|NCT01981850|38759337|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
16073494|NCT01981850|38759338|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
16073495|NCT01981850|38759339|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
16073496|NCT01981850|38759340|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
16073497|NCT01981850|38759341|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
16073498|NCT01981850|38759342|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
16073499|NCT01981850|38759343|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
16073500|NCT01981850|38759344|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
16073501|NCT01981850|38759345|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
16073502|NCT01981850|38759336|FG000|Main Phase Stage 2|Various reasons|0|||
16073503|NCT01981850|38759337|FG001|Main Phase Stage 2|Various reasons|0|||
16073504|NCT01981850|38759338|FG002|Main Phase Stage 2|Various reasons|0|||
16073505|NCT01981850|38759339|FG003|Main Phase Stage 2|Various reasons|0|||
16073506|NCT01981850|38759340|FG004|Main Phase Stage 2|Various reasons|2|||
16073507|NCT01981850|38759341|FG005|Main Phase Stage 2|Various reasons|0|||
16073508|NCT01981850|38759342|FG006|Main Phase Stage 2|Various reasons|1|||
16073509|NCT01981850|38759343|FG007|Main Phase Stage 2|Various reasons|0|||
16073510|NCT01981850|38759344|FG008|Main Phase Stage 2|Various reasons|0|||
16073511|NCT01981850|38759345|FG009|Main Phase Stage 2|Various reasons|0|||
16073512|NCT01981850|38759336|FG000|Main Phase Stage 2|Progressive Disease|0|||
16073513|NCT01981850|38759337|FG001|Main Phase Stage 2|Progressive Disease|0|||
16073514|NCT01981850|38759338|FG002|Main Phase Stage 2|Progressive Disease|0|||
16073515|NCT01981850|38759339|FG003|Main Phase Stage 2|Progressive Disease|0|||
16073516|NCT01981850|38759340|FG004|Main Phase Stage 2|Progressive Disease|0|||
16073517|NCT01981850|38759341|FG005|Main Phase Stage 2|Progressive Disease|6|||
16073518|NCT01981850|38759342|FG006|Main Phase Stage 2|Progressive Disease|6|||
16073519|NCT01981850|38759343|FG007|Main Phase Stage 2|Progressive Disease|0|||
16073520|NCT01981850|38759344|FG008|Main Phase Stage 2|Progressive Disease|0|||
16073521|NCT01981850|38759345|FG009|Main Phase Stage 2|Progressive Disease|0|||
16073522|NCT01981850|38759336|FG000|Open Label Extension (OLE)|Adverse Event|0|||
16073523|NCT01981850|38759337|FG001|Open Label Extension (OLE)|Adverse Event|0|||
16073524|NCT01981850|38759338|FG002|Open Label Extension (OLE)|Adverse Event|0|||
16073525|NCT01981850|38759339|FG003|Open Label Extension (OLE)|Adverse Event|0|||
16073526|NCT01981850|38759340|FG004|Open Label Extension (OLE)|Adverse Event|0|||
16073527|NCT01981850|38759341|FG005|Open Label Extension (OLE)|Adverse Event|0|||
16073528|NCT01981850|38759342|FG006|Open Label Extension (OLE)|Adverse Event|0|||
16073529|NCT01981850|38759343|FG007|Open Label Extension (OLE)|Adverse Event|2|||
16073530|NCT01981850|38759344|FG008|Open Label Extension (OLE)|Adverse Event|1|||
16073531|NCT01981850|38759345|FG009|Open Label Extension (OLE)|Adverse Event|8|||
16073532|NCT01981850|38759336|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
16073533|NCT01981850|38759337|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
16073534|NCT01981850|38759338|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
16073535|NCT01981850|38759339|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
16073536|NCT01981850|38759340|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
16073537|NCT01981850|38759341|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
16073538|NCT01981850|38759342|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
16073539|NCT01981850|38759343|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
16273258|NCT01968551|39484475|FG002|Extension Phase|Withdrew Consent|1|||
16073540|NCT01981850|38759344|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
16073541|NCT01981850|38759345|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
16073542|NCT01981850|38759336|FG000|Open Label Extension (OLE)|Various reasons|0|||
16073543|NCT01981850|38759337|FG001|Open Label Extension (OLE)|Various reasons|0|||
16073544|NCT01981850|38759338|FG002|Open Label Extension (OLE)|Various reasons|0|||
16073545|NCT01981850|38759339|FG003|Open Label Extension (OLE)|Various reasons|0|||
16073546|NCT01981850|38759340|FG004|Open Label Extension (OLE)|Various reasons|0|||
16073547|NCT01981850|38759341|FG005|Open Label Extension (OLE)|Various reasons|0|||
16073548|NCT01981850|38759342|FG006|Open Label Extension (OLE)|Various reasons|0|||
16073549|NCT01981850|38759343|FG007|Open Label Extension (OLE)|Various reasons|3|||
16073550|NCT01981850|38759344|FG008|Open Label Extension (OLE)|Various reasons|1|||
16073551|NCT01981850|38759345|FG009|Open Label Extension (OLE)|Various reasons|3|||
16073552|NCT01981850|38759336|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
16073553|NCT01981850|38759337|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
16073554|NCT01981850|38759338|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
16073555|NCT01981850|38759339|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
16073556|NCT01981850|38759340|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
16073557|NCT01981850|38759341|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
16073558|NCT01981850|38759342|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
16073559|NCT01981850|38759343|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
16073560|NCT01981850|38759344|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
16073561|NCT01981850|38759345|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
16073562|NCT01981850|38759336|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
16073563|NCT01981850|38759337|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
16073564|NCT01981850|38759338|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
16073565|NCT01981850|38759339|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
16073566|NCT01981850|38759340|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
16073567|NCT01981850|38759341|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
16073568|NCT01981850|38759342|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
16073569|NCT01981850|38759343|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
16073570|NCT01981850|38759344|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
16073571|NCT01981850|38759345|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
16073572|NCT01981850|38759336|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
16073573|NCT01981850|38759337|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
16073574|NCT01981850|38759338|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
16073575|NCT01981850|38759339|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
16073576|NCT01981850|38759340|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
16073577|NCT01981850|38759341|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
16073578|NCT01981850|38759342|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
16073579|NCT01981850|38759343|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
16073580|NCT01981850|38759344|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
16073581|NCT01981850|38759345|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
16073582|NCT00395018|38759346|FG000|On-Treatment|Death|4|||
16073583|NCT00395018|38759346|FG000|On-Treatment|Other Reason|2|||
16073584|NCT00395018|38759346|FG000|On-Treatment|Poor/non-compliance|2|||
16073585|NCT00395018|38759346|FG000|On-Treatment|Subject no longer meets study criteria|2|||
16073586|NCT00395018|38759346|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
16073587|NCT00395018|38759346|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
16073588|NCT00395018|38759346|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
16073589|NCT04340362|38759347|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
16073590|NCT00811057|38759348|FG000|Overall Study|Protocol Violation|5|||
16073591|NCT00811057|38759349|FG001|Overall Study|Protocol Violation|10|||
16073592|NCT00811057|38759350|FG002|Overall Study|Protocol Violation|10|||
16073593|NCT05193318|38759351|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
16073594|NCT05193318|38759351|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
16073595|NCT01289119|38759352|FG000|Overall Study|Adverse Event|2|||
16073596|NCT01289119|38759353|FG001|Overall Study|Adverse Event|1|||
16073597|NCT01289119|38759354|FG002|Overall Study|Adverse Event|0|||
16073598|NCT01289119|38759355|FG003|Overall Study|Adverse Event|2|||
16073599|NCT01289119|38759356|FG004|Overall Study|Adverse Event|1|||
16073600|NCT01289119|38759357|FG005|Overall Study|Adverse Event|0|||
16073601|NCT01289119|38759352|FG000|Overall Study|Major Protocol Deviation|2|||
16073602|NCT01289119|38759353|FG001|Overall Study|Major Protocol Deviation|1|||
16073603|NCT01289119|38759354|FG002|Overall Study|Major Protocol Deviation|3|||
16272852|NCT01460628|39484339|FG000|Overall Study|Withdrawal by Subject|2|||
16272853|NCT01243151|39484340|FG000|Overall Study|Adverse Event|0|||
16272854|NCT01243151|39484341|FG001|Overall Study|Adverse Event|1|||
16272855|NCT01243151|39484342|FG002|Overall Study|Adverse Event|0|||
16272856|NCT01243151|39484343|FG003|Overall Study|Adverse Event|0|||
16272857|NCT01243151|39484344|FG004|Overall Study|Adverse Event|0|||
16272858|NCT01243151|39484340|FG000|Overall Study|Protocol Violation|0|||
16272859|NCT01243151|39484341|FG001|Overall Study|Protocol Violation|0|||
16272860|NCT01243151|39484342|FG002|Overall Study|Protocol Violation|1|||
16272861|NCT01243151|39484343|FG003|Overall Study|Protocol Violation|0|||
16272862|NCT01243151|39484344|FG004|Overall Study|Protocol Violation|0|||
16272863|NCT01243151|39484340|FG000|Overall Study|Other|0|||
16272864|NCT01243151|39484341|FG001|Overall Study|Other|0|||
16272865|NCT01243151|39484342|FG002|Overall Study|Other|0|||
16272866|NCT01243151|39484343|FG003|Overall Study|Other|1|||
16272867|NCT01243151|39484344|FG004|Overall Study|Other|0|||
16272868|NCT01243151|39484340|FG000|Overall Study|Randomized but not treated|0|||
16272869|NCT01243151|39484341|FG001|Overall Study|Randomized but not treated|0|||
16272870|NCT01243151|39484342|FG002|Overall Study|Randomized but not treated|0|||
16272871|NCT01243151|39484343|FG003|Overall Study|Randomized but not treated|1|||
16272872|NCT01243151|39484344|FG004|Overall Study|Randomized but not treated|0|||
16272873|NCT02472639|39484345|FG000|Overall Study|Physician Decision|4|||
16272874|NCT02472639|39484346|FG001|Overall Study|Physician Decision|3|||
16272875|NCT01972841|39484347|FG000|Overall Study|Randomized but Never Received Treatment|2|||
16272876|NCT01972841|39484348|FG001|Overall Study|Randomized but Never Received Treatment|5|||
16272877|NCT01972841|39484349|FG002|Overall Study|Randomized but Never Received Treatment|4|||
16272878|NCT01972841|39484350|FG003|Overall Study|Randomized but Never Received Treatment|2|||
16272879|NCT01972841|39484351|FG004|Overall Study|Randomized but Never Received Treatment|6|||
16272880|NCT01972841|39484352|FG005|Overall Study|Randomized but Never Received Treatment|13|||
16272881|NCT01972841|39484347|FG000|Overall Study|Adverse Event|13|||
16272882|NCT01972841|39484348|FG001|Overall Study|Adverse Event|8|||
16272883|NCT01972841|39484349|FG002|Overall Study|Adverse Event|12|||
16272884|NCT01972841|39484350|FG003|Overall Study|Adverse Event|9|||
16272885|NCT01972841|39484351|FG004|Overall Study|Adverse Event|21|||
16272886|NCT01972841|39484352|FG005|Overall Study|Adverse Event|26|||
16272887|NCT01972841|39484347|FG000|Overall Study|Lack of Efficacy|1|||
16272888|NCT01972841|39484348|FG001|Overall Study|Lack of Efficacy|0|||
16272889|NCT01972841|39484349|FG002|Overall Study|Lack of Efficacy|0|||
16272890|NCT01972841|39484350|FG003|Overall Study|Lack of Efficacy|2|||
16272891|NCT01972841|39484351|FG004|Overall Study|Lack of Efficacy|4|||
16272892|NCT01972841|39484352|FG005|Overall Study|Lack of Efficacy|1|||
16272893|NCT01972841|39484347|FG000|Overall Study|Lost to Follow-up|4|||
16272894|NCT01972841|39484348|FG001|Overall Study|Lost to Follow-up|2|||
16272895|NCT01972841|39484349|FG002|Overall Study|Lost to Follow-up|4|||
16272896|NCT01972841|39484350|FG003|Overall Study|Lost to Follow-up|2|||
16272897|NCT01972841|39484351|FG004|Overall Study|Lost to Follow-up|9|||
16272898|NCT01972841|39484352|FG005|Overall Study|Lost to Follow-up|3|||
16272899|NCT01972841|39484347|FG000|Overall Study|Protocol Violation|2|||
16272900|NCT01972841|39484348|FG001|Overall Study|Protocol Violation|2|||
16272901|NCT01972841|39484349|FG002|Overall Study|Protocol Violation|3|||
16272902|NCT01972841|39484350|FG003|Overall Study|Protocol Violation|5|||
16272903|NCT01972841|39484351|FG004|Overall Study|Protocol Violation|9|||
16272904|NCT01972841|39484352|FG005|Overall Study|Protocol Violation|4|||
16272905|NCT01972841|39484347|FG000|Overall Study|Withdrawal by participants|21|||
16472044|NCT00997438|40207825|FG000|Overall Study|Exclusion criteria at visit 1|2|||
16472045|NCT00997438|40207826|FG001|Overall Study|Exclusion criteria at visit 1|2|||
16472046|NCT00997438|40207827|FG002|Overall Study|Exclusion criteria at visit 1|3|||
16472047|NCT02545075|40207829|FG000|Randomization|Lost to Follow-up|0|||
16472048|NCT02545075|40207830|FG001|Randomization|Lost to Follow-up|1|||
16472049|NCT02545075|40207829|FG000|Randomization|Withdrawal by Subject|0|||
16472050|NCT02545075|40207830|FG001|Randomization|Withdrawal by Subject|6|||
16472051|NCT02545075|40207829|FG000|Treatment|Disease progression|71|||
16472052|NCT02545075|40207830|FG001|Treatment|Disease progression|32|||
16472053|NCT02545075|40207829|FG000|Treatment|Participant dicontinued study treatment|7|||
16472054|NCT02545075|40207830|FG001|Treatment|Participant dicontinued study treatment|9|||
16472055|NCT02545075|40207829|FG000|Treatment|Withdrawal by Subject|1|||
16472056|NCT02545075|40207830|FG001|Treatment|Withdrawal by Subject|0|||
16472057|NCT02545075|40207829|FG000|Treatment|Adverse event not related to study drug|1|||
16472058|NCT02545075|40207830|FG001|Treatment|Adverse event not related to study drug|0|||
16472059|NCT02545075|40207829|FG000|Treatment|Death|1|||
16472060|NCT02545075|40207830|FG001|Treatment|Death|0|||
16472061|NCT02545075|40207829|FG000|Treatment|Participant drug toxicity|1|||
16472062|NCT02545075|40207830|FG001|Treatment|Participant drug toxicity|0|||
16472063|NCT02545075|40207829|FG000|Treatment|Completed treatment|40|||
16472064|NCT02545075|40207830|FG001|Treatment|Completed treatment|12|||
16472065|NCT01610271|40207831|FG000|Overall Study|Surgery not complete|0|||
16472066|NCT01610271|40207832|FG001|Overall Study|Surgery not complete|1|||
16472067|NCT01610271|40207831|FG000|Overall Study|Prosthesis not implanted|2|||
16472068|NCT01610271|40207832|FG001|Overall Study|Prosthesis not implanted|3|||
16472069|NCT01163266|40207835|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
16472070|NCT01163266|40207836|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
16472071|NCT01163266|40207837|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
16272906|NCT01972841|39484348|FG001|Overall Study|Withdrawal by participants|27|||
16272907|NCT01972841|39484349|FG002|Overall Study|Withdrawal by participants|23|||
16272908|NCT01972841|39484350|FG003|Overall Study|Withdrawal by participants|16|||
16472072|NCT01163266|40207835|FG000|Overall Study|Lack of Efficacy|1|||
16472073|NCT01163266|40207836|FG001|Overall Study|Lack of Efficacy|3|||
16472074|NCT01163266|40207837|FG002|Overall Study|Lack of Efficacy|1|||
16472075|NCT01163266|40207835|FG000|Overall Study|Noncompliance with Study Drug|0|||
16472076|NCT01163266|40207836|FG001|Overall Study|Noncompliance with Study Drug|2|||
16472077|NCT01163266|40207837|FG002|Overall Study|Noncompliance with Study Drug|0|||
16472078|NCT01163266|40207835|FG000|Overall Study|Protocol Deviations|2|||
16472079|NCT01163266|40207836|FG001|Overall Study|Protocol Deviations|2|||
16472080|NCT01163266|40207837|FG002|Overall Study|Protocol Deviations|5|||
16472081|NCT01163266|40207835|FG000|Overall Study|Withdrawal of Consent|5|||
16472082|NCT01163266|40207836|FG001|Overall Study|Withdrawal of Consent|7|||
16472083|NCT01163266|40207837|FG002|Overall Study|Withdrawal of Consent|3|||
16472084|NCT01163266|40207835|FG000|Overall Study|Lost to Follow-up|7|||
16472085|NCT01163266|40207836|FG001|Overall Study|Lost to Follow-up|7|||
16472086|NCT01163266|40207837|FG002|Overall Study|Lost to Follow-up|10|||
16472087|NCT01163266|40207835|FG000|Overall Study|Other|1|||
16472088|NCT01163266|40207836|FG001|Overall Study|Other|1|||
16472089|NCT01163266|40207837|FG002|Overall Study|Other|2|||
16472090|NCT01467583|40207840|FG000|Overall Study|Death|1|||
16472091|NCT01467583|40207841|FG001|Overall Study|Death|1|||
16472092|NCT01467583|40207842|FG002|Overall Study|Death|0|||
16472093|NCT01467583|40207840|FG000|Overall Study|Withdrawal by Subject|1|||
16472094|NCT01467583|40207841|FG001|Overall Study|Withdrawal by Subject|0|||
16472095|NCT01467583|40207842|FG002|Overall Study|Withdrawal by Subject|0|||
16472096|NCT01467583|40207840|FG000|Overall Study|Protocol Violation|0|||
16472097|NCT01467583|40207841|FG001|Overall Study|Protocol Violation|0|||
16472098|NCT01467583|40207842|FG002|Overall Study|Protocol Violation|2|||
16472099|NCT00495131|40207845|FG000|Overall Study|Adverse Event|6|||
16472100|NCT00495131|40207846|FG001|Overall Study|Adverse Event|2|||
16472101|NCT00495131|40207845|FG000|Overall Study|Lack of Efficacy|0|||
16472102|NCT00495131|40207846|FG001|Overall Study|Lack of Efficacy|2|||
16472103|NCT00495131|40207845|FG000|Overall Study|Lost to Follow-up|0|||
16472104|NCT00495131|40207846|FG001|Overall Study|Lost to Follow-up|2|||
16472105|NCT00495131|40207845|FG000|Overall Study|Withdrawal by Subject|1|||
16472106|NCT00495131|40207846|FG001|Overall Study|Withdrawal by Subject|0|||
16472107|NCT04209348|40207849|FG000|Overall Study|Lost to Follow-up|1|||
16472108|NCT04209348|40207850|FG001|Overall Study|Lost to Follow-up|0|||
16472109|NCT02939079|40207853|FG000|Overall Study|Adverse Event|2|||
16472110|NCT02939079|40207854|FG001|Overall Study|Adverse Event|1|||
16472111|NCT02939079|40207853|FG000|Overall Study|Lost to Follow-up|0|||
16472112|NCT02939079|40207854|FG001|Overall Study|Lost to Follow-up|2|||
16472113|NCT02939079|40207853|FG000|Overall Study|Protocol Violation|1|||
16472114|NCT02939079|40207854|FG001|Overall Study|Protocol Violation|0|||
16472115|NCT02939079|40207853|FG000|Overall Study|Withdrawal by Subject|0|||
16472116|NCT02939079|40207854|FG001|Overall Study|Withdrawal by Subject|1|||
16472117|NCT02939079|40207853|FG000|Overall Study|relapse during the study|1|||
16472118|NCT02939079|40207854|FG001|Overall Study|relapse during the study|1|||
16472119|NCT03960554|40207859|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
16472120|NCT03960554|40207860|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
16472121|NCT02319837|40207861|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
16472122|NCT02319837|40207862|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
16472123|NCT02319837|40207863|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
16472124|NCT02319837|40207861|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
16472125|NCT02319837|40207862|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
16472126|NCT02319837|40207863|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
16472127|NCT02319837|40207861|FG000|Study Treatment Phase|Adverse Event|73|||
16472128|NCT02319837|40207862|FG001|Study Treatment Phase|Adverse Event|36|||
16472129|NCT02319837|40207863|FG002|Study Treatment Phase|Adverse Event|63|||
16472130|NCT02319837|40207861|FG000|Study Treatment Phase|Development of castration resistance|0|||
16472131|NCT02319837|40207862|FG001|Study Treatment Phase|Development of castration resistance|2|||
16472132|NCT02319837|40207863|FG002|Study Treatment Phase|Development of castration resistance|0|||
16472133|NCT02319837|40207861|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
16472134|NCT02319837|40207862|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
16472135|NCT02319837|40207863|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
16472136|NCT02319837|40207861|FG000|Study Treatment Phase|Protocol Violation|2|||
16472137|NCT02319837|40207862|FG001|Study Treatment Phase|Protocol Violation|2|||
16472138|NCT02319837|40207863|FG002|Study Treatment Phase|Protocol Violation|1|||
16472139|NCT02319837|40207861|FG000|Study Treatment Phase|Lost to Follow-up|0|||
16472140|NCT02319837|40207862|FG001|Study Treatment Phase|Lost to Follow-up|1|||
16472141|NCT02319837|40207863|FG002|Study Treatment Phase|Lost to Follow-up|0|||
16472142|NCT02319837|40207861|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
16472143|NCT02319837|40207862|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
16472144|NCT02319837|40207863|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
16472145|NCT02319837|40207861|FG000|Study Treatment Phase|Other|0|||
16472146|NCT02319837|40207862|FG001|Study Treatment Phase|Other|1|||
16472147|NCT02319837|40207863|FG002|Study Treatment Phase|Other|0|||
16472148|NCT02319837|40207861|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
16472149|NCT02319837|40207862|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
16472150|NCT02319837|40207863|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
16472151|NCT02319837|40207861|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
16472152|NCT02319837|40207862|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
16472153|NCT02319837|40207863|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
16472154|NCT02319837|40207861|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
16472155|NCT02319837|40207862|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
16472156|NCT02319837|40207863|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
16472157|NCT02319837|40207861|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
16472158|NCT02319837|40207862|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
16472159|NCT02319837|40207863|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
16472160|NCT02319837|40207861|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
16472161|NCT02319837|40207862|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
16472162|NCT02319837|40207863|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
16472163|NCT02319837|40207861|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
16472164|NCT02319837|40207862|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
16472165|NCT02319837|40207863|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
16472166|NCT02319837|40207861|FG000|Long-Term Follow-Up Phase|Death|33|||
16472167|NCT02319837|40207862|FG001|Long-Term Follow-Up Phase|Death|54|||
16472168|NCT02319837|40207863|FG002|Long-Term Follow-Up Phase|Death|42|||
16472169|NCT03332771|40207864|FG000|Overall Study|Adverse Event|6|||
16472170|NCT03332771|40207865|FG001|Overall Study|Adverse Event|4|||
16472171|NCT03332771|40207866|FG002|Overall Study|Adverse Event|1|||
16472172|NCT03332771|40207867|FG003|Overall Study|Adverse Event|3|||
16472173|NCT03332771|40207864|FG000|Overall Study|Poor Compliance to Protocol|0|||
16472174|NCT03332771|40207865|FG001|Overall Study|Poor Compliance to Protocol|1|||
16472175|NCT03332771|40207866|FG002|Overall Study|Poor Compliance to Protocol|0|||
16472176|NCT03332771|40207867|FG003|Overall Study|Poor Compliance to Protocol|1|||
16472177|NCT03332771|40207864|FG000|Overall Study|Lost to Follow-up|2|||
16472178|NCT03332771|40207865|FG001|Overall Study|Lost to Follow-up|2|||
16472179|NCT03332771|40207866|FG002|Overall Study|Lost to Follow-up|1|||
16472180|NCT03332771|40207867|FG003|Overall Study|Lost to Follow-up|2|||
16472181|NCT03332771|40207864|FG000|Overall Study|At the Participant's own request|20|||
16472182|NCT03332771|40207865|FG001|Overall Study|At the Participant's own request|26|||
16472183|NCT03332771|40207866|FG002|Overall Study|At the Participant's own request|14|||
16472184|NCT03332771|40207867|FG003|Overall Study|At the Participant's own request|23|||
16472185|NCT03332771|40207864|FG000|Overall Study|Reason Not Specified|6|||
16472186|NCT03332771|40207865|FG001|Overall Study|Reason Not Specified|18|||
16472187|NCT03332771|40207866|FG002|Overall Study|Reason Not Specified|16|||
16472188|NCT03332771|40207867|FG003|Overall Study|Reason Not Specified|19|||
16472189|NCT04597918|40207869|FG000|Overall Study|Withdrawal by Subject|6|||
16472190|NCT04597918|40207869|FG000|Overall Study|Lost to Follow-up|3|||
16472191|NCT04597918|40207869|FG000|Overall Study|Death|1|||
16472192|NCT04223232|40207873|FG000|Overall Study|Withdrawal by Subject|1|||
16472193|NCT00598702|40207874|FG000|Overall Study|Other|0|||
16472194|NCT00598702|40207875|FG001|Overall Study|Other|2|||
16472195|NCT00598702|40207876|FG002|Overall Study|Other|0|||
16472196|NCT00598702|40207877|FG003|Overall Study|Other|0|||
16472197|NCT00598702|40207878|FG004|Overall Study|Other|0|||
16472198|NCT00598702|40207879|FG005|Overall Study|Other|1|||
16472199|NCT00598702|40207880|FG006|Overall Study|Other|0|||
16472200|NCT00598702|40207881|FG007|Overall Study|Other|0|||
16472201|NCT00598702|40207874|FG000|Overall Study|Early discharge from hospital|0|||
16472202|NCT00598702|40207875|FG001|Overall Study|Early discharge from hospital|0|||
16472203|NCT00598702|40207876|FG002|Overall Study|Early discharge from hospital|2|||
16472204|NCT00598702|40207877|FG003|Overall Study|Early discharge from hospital|5|||
16472205|NCT00598702|40207878|FG004|Overall Study|Early discharge from hospital|0|||
16472206|NCT00598702|40207879|FG005|Overall Study|Early discharge from hospital|10|||
16472207|NCT00598702|40207880|FG006|Overall Study|Early discharge from hospital|1|||
16472208|NCT00598702|40207881|FG007|Overall Study|Early discharge from hospital|0|||
16472209|NCT00598702|40207874|FG000|Overall Study|Adverse Event|0|||
16472210|NCT00598702|40207875|FG001|Overall Study|Adverse Event|0|||
16472211|NCT00598702|40207876|FG002|Overall Study|Adverse Event|0|||
16472212|NCT00598702|40207877|FG003|Overall Study|Adverse Event|1|||
16472213|NCT00598702|40207878|FG004|Overall Study|Adverse Event|0|||
16472214|NCT00598702|40207879|FG005|Overall Study|Adverse Event|0|||
16472215|NCT00598702|40207880|FG006|Overall Study|Adverse Event|0|||
16472216|NCT00598702|40207881|FG007|Overall Study|Adverse Event|0|||
16472217|NCT00598702|40207874|FG000|Overall Study|Withdrawal by Subject|0|||
16472218|NCT00598702|40207875|FG001|Overall Study|Withdrawal by Subject|0|||
16472219|NCT00598702|40207876|FG002|Overall Study|Withdrawal by Subject|0|||
16472220|NCT00598702|40207877|FG003|Overall Study|Withdrawal by Subject|1|||
16472221|NCT00598702|40207878|FG004|Overall Study|Withdrawal by Subject|1|||
16472222|NCT00598702|40207879|FG005|Overall Study|Withdrawal by Subject|0|||
16472223|NCT00598702|40207880|FG006|Overall Study|Withdrawal by Subject|0|||
16472224|NCT00598702|40207881|FG007|Overall Study|Withdrawal by Subject|0|||
16472225|NCT00598702|40207874|FG000|Overall Study|Physician Decision|0|||
16472226|NCT00598702|40207875|FG001|Overall Study|Physician Decision|0|||
16472227|NCT00598702|40207876|FG002|Overall Study|Physician Decision|0|||
16472228|NCT00598702|40207877|FG003|Overall Study|Physician Decision|0|||
16472229|NCT00598702|40207878|FG004|Overall Study|Physician Decision|1|||
16472230|NCT00598702|40207879|FG005|Overall Study|Physician Decision|0|||
16472231|NCT00598702|40207880|FG006|Overall Study|Physician Decision|0|||
16472232|NCT00598702|40207881|FG007|Overall Study|Physician Decision|0|||
16472233|NCT00598702|40207874|FG000|Overall Study|Dose limiting toxicity|0|||
16472234|NCT00598702|40207875|FG001|Overall Study|Dose limiting toxicity|0|||
16472235|NCT00598702|40207876|FG002|Overall Study|Dose limiting toxicity|0|||
16472236|NCT00598702|40207877|FG003|Overall Study|Dose limiting toxicity|1|||
16472237|NCT00598702|40207878|FG004|Overall Study|Dose limiting toxicity|1|||
16472238|NCT00598702|40207879|FG005|Overall Study|Dose limiting toxicity|1|||
16472239|NCT00598702|40207880|FG006|Overall Study|Dose limiting toxicity|0|||
16472240|NCT00598702|40207881|FG007|Overall Study|Dose limiting toxicity|0|||
16472241|NCT01672736|40207882|FG000|Overall Study|Available drug expired on 31 May 16|3|||
16472242|NCT00679055|40207885|FG000|Overall Study|Adverse Event|0|||
16472243|NCT00679055|40207886|FG001|Overall Study|Adverse Event|1|||
16472244|NCT00679055|40207885|FG000|Overall Study|Other|0|||
16472245|NCT00679055|40207886|FG001|Overall Study|Other|3|||
16472246|NCT00679055|40207885|FG000|Overall Study|Study Terminated|2|||
16472247|NCT00679055|40207886|FG001|Overall Study|Study Terminated|1|||
16472248|NCT02579928|40207887|FG000|Overall Study|Withdrawal by Subject|1|||
16472249|NCT02579928|40207888|FG001|Overall Study|Withdrawal by Subject|0|||
16472250|NCT00700570|40207889|FG000|Overall Study|Adverse Event|2|||
16472251|NCT00700570|40207890|FG001|Overall Study|Adverse Event|6|||
16472252|NCT00700570|40207889|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
16472253|NCT00700570|40207890|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
16472254|NCT00700570|40207889|FG000|Overall Study|Disease Progression|8|||
16472255|NCT00700570|40207890|FG001|Overall Study|Disease Progression|11|||
16472256|NCT00700570|40207889|FG000|Overall Study|Withdrawal by Subject|1|||
16472257|NCT00700570|40207890|FG001|Overall Study|Withdrawal by Subject|6|||
16472258|NCT02987660|40207892|FG000|Overall Study|Study terminated by sponsor|10|||
16472259|NCT02987660|40207893|FG001|Overall Study|Study terminated by sponsor|10|||
16472260|NCT04228783|40207894|FG000|Overall Study|Adverse Event|1|||
16472261|NCT04228783|40207895|FG001|Overall Study|Adverse Event|0|||
16472262|NCT04228783|40207896|FG002|Overall Study|Adverse Event|2|||
16472263|NCT04228783|40207897|FG003|Overall Study|Adverse Event|0|||
16472264|NCT04228783|40207898|FG004|Overall Study|Adverse Event|0|||
16472265|NCT04228783|40207899|FG005|Overall Study|Adverse Event|1|||
16472266|NCT04228783|40207894|FG000|Overall Study|Death|0|||
16472267|NCT04228783|40207895|FG001|Overall Study|Death|0|||
16472268|NCT04228783|40207896|FG002|Overall Study|Death|0|||
16472269|NCT04228783|40207897|FG003|Overall Study|Death|0|||
16472270|NCT04228783|40207898|FG004|Overall Study|Death|1|||
16472271|NCT04228783|40207899|FG005|Overall Study|Death|0|||
16472272|NCT04228783|40207894|FG000|Overall Study|Lost to Follow-up|36|||
16472273|NCT04228783|40207895|FG001|Overall Study|Lost to Follow-up|36|||
16472274|NCT04228783|40207896|FG002|Overall Study|Lost to Follow-up|28|||
16472275|NCT04228783|40207897|FG003|Overall Study|Lost to Follow-up|6|||
16472276|NCT04228783|40207898|FG004|Overall Study|Lost to Follow-up|14|||
16472277|NCT04228783|40207899|FG005|Overall Study|Lost to Follow-up|3|||
16472278|NCT04228783|40207894|FG000|Overall Study|Physician Decision|1|||
16472279|NCT04228783|40207895|FG001|Overall Study|Physician Decision|2|||
16472280|NCT04228783|40207896|FG002|Overall Study|Physician Decision|0|||
16472281|NCT04228783|40207897|FG003|Overall Study|Physician Decision|0|||
16472282|NCT04228783|40207898|FG004|Overall Study|Physician Decision|0|||
16472283|NCT04228783|40207899|FG005|Overall Study|Physician Decision|0|||
16472284|NCT04228783|40207894|FG000|Overall Study|Protocol Violation|0|||
16472285|NCT04228783|40207895|FG001|Overall Study|Protocol Violation|0|||
16472286|NCT04228783|40207896|FG002|Overall Study|Protocol Violation|0|||
16472287|NCT04228783|40207897|FG003|Overall Study|Protocol Violation|1|||
16472288|NCT04228783|40207898|FG004|Overall Study|Protocol Violation|0|||
16472289|NCT04228783|40207899|FG005|Overall Study|Protocol Violation|0|||
16472290|NCT04228783|40207894|FG000|Overall Study|Withdrawal by Subject|6|||
16472291|NCT04228783|40207895|FG001|Overall Study|Withdrawal by Subject|10|||
16472292|NCT04228783|40207896|FG002|Overall Study|Withdrawal by Subject|19|||
16472293|NCT04228783|40207897|FG003|Overall Study|Withdrawal by Subject|1|||
16472294|NCT04228783|40207898|FG004|Overall Study|Withdrawal by Subject|2|||
16472295|NCT04228783|40207899|FG005|Overall Study|Withdrawal by Subject|0|||
16472296|NCT04228783|40207894|FG000|Overall Study|Other|4|||
16472297|NCT04228783|40207895|FG001|Overall Study|Other|3|||
16472298|NCT04228783|40207896|FG002|Overall Study|Other|2|||
16472299|NCT04228783|40207897|FG003|Overall Study|Other|1|||
16472300|NCT04228783|40207898|FG004|Overall Study|Other|0|||
16472301|NCT04228783|40207899|FG005|Overall Study|Other|0|||
16472302|NCT01859143|40210469|FG000|Overall Study|Lost to Follow-up|2|||
16472303|NCT01859143|40210470|FG001|Overall Study|Lost to Follow-up|0|||
16472304|NCT01199731|40210471|FG000|Overall Study|Adverse Event|0|||
16472305|NCT01199731|40210472|FG001|Overall Study|Adverse Event|1|||
16472306|NCT01199731|40210473|FG002|Overall Study|Adverse Event|0|||
16472307|NCT01199731|40210471|FG000|Overall Study|Study closed/terminated|7|||
16472308|NCT01199731|40210472|FG001|Overall Study|Study closed/terminated|9|||
16472309|NCT01199731|40210473|FG002|Overall Study|Study closed/terminated|7|||
16472310|NCT01199731|40210471|FG000|Overall Study|Lost to Follow-up|0|||
16472311|NCT01199731|40210472|FG001|Overall Study|Lost to Follow-up|0|||
16472312|NCT01199731|40210473|FG002|Overall Study|Lost to Follow-up|2|||
16472313|NCT01199731|40210471|FG000|Overall Study|Physician Decision|0|||
16472314|NCT01199731|40210472|FG001|Overall Study|Physician Decision|1|||
16472315|NCT01199731|40210473|FG002|Overall Study|Physician Decision|1|||
16472316|NCT01199731|40210471|FG000|Overall Study|Withdrawal by Subject|2|||
16472317|NCT01199731|40210472|FG001|Overall Study|Withdrawal by Subject|0|||
16472318|NCT01199731|40210473|FG002|Overall Study|Withdrawal by Subject|0|||
16472319|NCT03823378|40210474|FG000|Overall Study|Adverse Event|2|||
16472320|NCT03823378|40210475|FG001|Overall Study|Adverse Event|2|||
16472321|NCT03823378|40210476|FG002|Overall Study|Adverse Event|0|||
16472322|NCT03823378|40210477|FG003|Overall Study|Adverse Event|0|||
16472323|NCT03823378|40210478|FG004|Overall Study|Adverse Event|0|||
16472324|NCT03823378|40210479|FG005|Overall Study|Adverse Event|0|||
16472325|NCT03823378|40210474|FG000|Overall Study|Lost to Follow-up|0|||
16472326|NCT03823378|40210475|FG001|Overall Study|Lost to Follow-up|1|||
16472327|NCT03823378|40210476|FG002|Overall Study|Lost to Follow-up|0|||
16472328|NCT03823378|40210477|FG003|Overall Study|Lost to Follow-up|0|||
16472329|NCT03823378|40210478|FG004|Overall Study|Lost to Follow-up|1|||
16472330|NCT03823378|40210479|FG005|Overall Study|Lost to Follow-up|0|||
16472331|NCT03823378|40210474|FG000|Overall Study|Withdrawal by Subject|0|||
16472332|NCT03823378|40210475|FG001|Overall Study|Withdrawal by Subject|1|||
16472333|NCT03823378|40210476|FG002|Overall Study|Withdrawal by Subject|4|||
16472334|NCT03823378|40210477|FG003|Overall Study|Withdrawal by Subject|2|||
16472335|NCT03823378|40210478|FG004|Overall Study|Withdrawal by Subject|0|||
16472336|NCT03823378|40210479|FG005|Overall Study|Withdrawal by Subject|1|||
16472337|NCT03823378|40210474|FG000|Overall Study|Other, not specified|19|||
16472338|NCT03823378|40210475|FG001|Overall Study|Other, not specified|12|||
16472339|NCT03823378|40210476|FG002|Overall Study|Other, not specified|6|||
16472340|NCT03823378|40210477|FG003|Overall Study|Other, not specified|8|||
16472341|NCT03823378|40210478|FG004|Overall Study|Other, not specified|17|||
16472342|NCT03823378|40210479|FG005|Overall Study|Other, not specified|7|||
16472343|NCT02808650|40210480|FG000|Overall Study|Death|0|||
16472344|NCT02808650|40210481|FG001|Overall Study|Death|0|||
16472345|NCT02808650|40210482|FG002|Overall Study|Death|0|||
16472346|NCT02808650|40210483|FG003|Overall Study|Death|0|||
16472347|NCT02808650|40210484|FG004|Overall Study|Death|1|||
16472348|NCT02808650|40210480|FG000|Overall Study|Lack of Efficacy|5|||
16472349|NCT02808650|40210481|FG001|Overall Study|Lack of Efficacy|5|||
16472350|NCT02808650|40210482|FG002|Overall Study|Lack of Efficacy|6|||
16472351|NCT02808650|40210483|FG003|Overall Study|Lack of Efficacy|5|||
16472352|NCT02808650|40210484|FG004|Overall Study|Lack of Efficacy|4|||
16472353|NCT02808650|40210480|FG000|Overall Study|Physician Decision|1|||
16472354|NCT02808650|40210481|FG001|Overall Study|Physician Decision|1|||
16472355|NCT02808650|40210482|FG002|Overall Study|Physician Decision|0|||
16472356|NCT02808650|40210483|FG003|Overall Study|Physician Decision|0|||
16472357|NCT02808650|40210484|FG004|Overall Study|Physician Decision|0|||
16472358|NCT02808650|40210480|FG000|Overall Study|Withdrawal by Subject|0|||
16472359|NCT02808650|40210481|FG001|Overall Study|Withdrawal by Subject|0|||
16472360|NCT02808650|40210482|FG002|Overall Study|Withdrawal by Subject|0|||
16472361|NCT02808650|40210483|FG003|Overall Study|Withdrawal by Subject|1|||
16472362|NCT02808650|40210484|FG004|Overall Study|Withdrawal by Subject|1|||
16472363|NCT00749580|40210487|FG000|Overall Study|Lost to Follow-up|4|||
16472364|NCT00749580|40210488|FG001|Overall Study|Lost to Follow-up|8|||
16472365|NCT00749580|40210487|FG000|Overall Study|Adverse Event|0|||
16472366|NCT00749580|40210488|FG001|Overall Study|Adverse Event|1|||
16472367|NCT03204812|40210491|FG000|Overall Study|Adverse Event|3|||
16472368|NCT01243671|40210492|FG000|Overall Study|Adverse Event|3|||
16472369|NCT01243671|40210492|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
16472370|NCT01243671|40210492|FG000|Overall Study|Other|1|||
16472371|NCT00704808|40210493|FG000|Overall Study|Discontinued prior to starting treatment|14|||
16472372|NCT00704808|40210493|FG000|Overall Study|Death|7|||
16472373|NCT00704808|40210493|FG000|Overall Study|Tumor progression|80|||
16472374|NCT00704808|40210493|FG000|Overall Study|Patient's decision|11|||
16472375|NCT00704808|40210493|FG000|Overall Study|Early therapy discontinuation|16|||
16472376|NCT00704808|40210493|FG000|Overall Study|Adverse Event|1|||
16472377|NCT00704808|40210493|FG000|Overall Study|Lost to Follow-up|1|||
16472378|NCT00704808|40210493|FG000|Overall Study|Treatment change|1|||
16472379|NCT00423670|40210494|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
16472380|NCT00423670|40210495|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
16472381|NCT00423670|40210496|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
16472382|NCT00423670|40210497|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
16472383|NCT00423670|40210498|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
16472384|NCT00423670|40210499|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
16472385|NCT00423670|40210500|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
16472386|NCT00423670|40210501|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
16472387|NCT00423670|40210494|FG000|Treatment Period|Adverse Event|8|||
16472388|NCT00423670|40210495|FG001|Treatment Period|Adverse Event|12|||
16472389|NCT00423670|40210496|FG002|Treatment Period|Adverse Event|15|||
16472390|NCT00423670|40210497|FG003|Treatment Period|Adverse Event|20|||
16472391|NCT00423670|40210498|FG004|Treatment Period|Adverse Event|9|||
16472392|NCT00423670|40210499|FG005|Treatment Period|Adverse Event|4|||
16472393|NCT00423670|40210500|FG006|Treatment Period|Adverse Event|7|||
16472394|NCT00423670|40210501|FG007|Treatment Period|Adverse Event|2|||
16472395|NCT00423670|40210494|FG000|Treatment Period|Protocol-defined clinical event|0|||
16472396|NCT00423670|40210495|FG001|Treatment Period|Protocol-defined clinical event|7|||
16472397|NCT00423670|40210496|FG002|Treatment Period|Protocol-defined clinical event|4|||
16472398|NCT00423670|40210497|FG003|Treatment Period|Protocol-defined clinical event|12|||
16472399|NCT00423670|40210498|FG004|Treatment Period|Protocol-defined clinical event|5|||
16472400|NCT00423670|40210499|FG005|Treatment Period|Protocol-defined clinical event|4|||
16472401|NCT00423670|40210500|FG006|Treatment Period|Protocol-defined clinical event|16|||
16472402|NCT00423670|40210501|FG007|Treatment Period|Protocol-defined clinical event|15|||
16472403|NCT00423670|40210494|FG000|Treatment Period|Lost to Follow-up|2|||
16472404|NCT00423670|40210495|FG001|Treatment Period|Lost to Follow-up|1|||
16472405|NCT00423670|40210496|FG002|Treatment Period|Lost to Follow-up|3|||
16472406|NCT00423670|40210497|FG003|Treatment Period|Lost to Follow-up|1|||
16472407|NCT00423670|40210498|FG004|Treatment Period|Lost to Follow-up|6|||
16472408|NCT00423670|40210499|FG005|Treatment Period|Lost to Follow-up|0|||
16472409|NCT00423670|40210500|FG006|Treatment Period|Lost to Follow-up|3|||
16472410|NCT00423670|40210501|FG007|Treatment Period|Lost to Follow-up|1|||
16472411|NCT00423670|40210494|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
16472412|NCT00423670|40210495|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
16472413|NCT00423670|40210496|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
16472414|NCT00423670|40210497|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
16472415|NCT00423670|40210498|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
16472416|NCT00423670|40210499|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
16472417|NCT00423670|40210500|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
16472418|NCT00423670|40210501|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
16472419|NCT00423670|40210494|FG000|Treatment Period|Investigator decision|0|||
16472420|NCT00423670|40210495|FG001|Treatment Period|Investigator decision|0|||
16472421|NCT00423670|40210496|FG002|Treatment Period|Investigator decision|0|||
16472422|NCT00423670|40210497|FG003|Treatment Period|Investigator decision|0|||
16472423|NCT00423670|40210498|FG004|Treatment Period|Investigator decision|0|||
16472424|NCT00423670|40210499|FG005|Treatment Period|Investigator decision|0|||
16472425|NCT00423670|40210500|FG006|Treatment Period|Investigator decision|0|||
16472426|NCT00423670|40210501|FG007|Treatment Period|Investigator decision|1|||
16472427|NCT00423670|40210494|FG000|Treatment Period|Non-compliance with protocol|3|||
16472428|NCT00423670|40210495|FG001|Treatment Period|Non-compliance with protocol|1|||
16472429|NCT00423670|40210496|FG002|Treatment Period|Non-compliance with protocol|1|||
16472430|NCT00423670|40210497|FG003|Treatment Period|Non-compliance with protocol|3|||
16472431|NCT00423670|40210498|FG004|Treatment Period|Non-compliance with protocol|2|||
16472432|NCT00423670|40210499|FG005|Treatment Period|Non-compliance with protocol|0|||
16472433|NCT00423670|40210500|FG006|Treatment Period|Non-compliance with protocol|2|||
16472434|NCT00423670|40210501|FG007|Treatment Period|Non-compliance with protocol|2|||
16472435|NCT00423670|40210494|FG000|Follow-up Period|Lost to Follow-up|0|||
16472436|NCT00423670|40210495|FG001|Follow-up Period|Lost to Follow-up|12|||
16472437|NCT00423670|40210496|FG002|Follow-up Period|Lost to Follow-up|8|||
16472438|NCT00423670|40210497|FG003|Follow-up Period|Lost to Follow-up|3|||
16472439|NCT00423670|40210498|FG004|Follow-up Period|Lost to Follow-up|1|||
16472440|NCT00423670|40210499|FG005|Follow-up Period|Lost to Follow-up|0|||
16472441|NCT00423670|40210500|FG006|Follow-up Period|Lost to Follow-up|5|||
16472442|NCT00423670|40210501|FG007|Follow-up Period|Lost to Follow-up|0|||
16472443|NCT00423670|40210494|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
16472444|NCT00423670|40210495|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
16472445|NCT00423670|40210496|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
16472446|NCT00423670|40210497|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
16472447|NCT00423670|40210498|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
16472448|NCT00423670|40210499|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
16472449|NCT00423670|40210500|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
16472450|NCT00423670|40210501|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
16472451|NCT00423670|40210494|FG000|Follow-up Period|Non-compliance with protocol|2|||
16472452|NCT00423670|40210495|FG001|Follow-up Period|Non-compliance with protocol|0|||
16472453|NCT00423670|40210496|FG002|Follow-up Period|Non-compliance with protocol|1|||
16472454|NCT00423670|40210497|FG003|Follow-up Period|Non-compliance with protocol|1|||
16472455|NCT00423670|40210498|FG004|Follow-up Period|Non-compliance with protocol|0|||
16472456|NCT00423670|40210499|FG005|Follow-up Period|Non-compliance with protocol|0|||
16472457|NCT00423670|40210500|FG006|Follow-up Period|Non-compliance with protocol|3|||
16472458|NCT00423670|40210501|FG007|Follow-up Period|Non-compliance with protocol|2|||
16472459|NCT03416374|40210506|FG000|Between Treatment Period I and II|Other|0|||
16472460|NCT03416374|40210507|FG001|Between Treatment Period I and II|Other|9|||
16472461|NCT03416374|40210506|FG000|Treatment Period II|Lack of Efficacy|3|||
16472462|NCT03416374|40210507|FG001|Treatment Period II|Lack of Efficacy|11|||
16472463|NCT03416374|40210506|FG000|Treatment Period II|Adverse Event|1|||
16472464|NCT03416374|40210507|FG001|Treatment Period II|Adverse Event|4|||
16472465|NCT03416374|40210506|FG000|Treatment Period II|Death|0|||
16472466|NCT03416374|40210507|FG001|Treatment Period II|Death|1|||
16472467|NCT03416374|40210506|FG000|Treatment Period II|Other|0|||
16472468|NCT03416374|40210507|FG001|Treatment Period II|Other|2|||
16472469|NCT00567593|40210508|FG000|Overall Study|Adverse Event|1|||
16472470|NCT00567593|40210508|FG000|Overall Study|Physician Decision|1|||
16472471|NCT00978432|40210510|FG000|Overall Study|Withdrawal by Subject|0|||
16472472|NCT00978432|40210511|FG001|Overall Study|Withdrawal by Subject|0|||
16472473|NCT00978432|40210512|FG002|Overall Study|Withdrawal by Subject|1|||
16472474|NCT00978432|40210510|FG000|Overall Study|Lack of Efficacy|1|||
16472475|NCT00978432|40210511|FG001|Overall Study|Lack of Efficacy|1|||
16472476|NCT00978432|40210512|FG002|Overall Study|Lack of Efficacy|3|||
16472477|NCT00978432|40210510|FG000|Overall Study|Adverse Event|2|||
16472478|NCT00978432|40210511|FG001|Overall Study|Adverse Event|0|||
16472479|NCT00978432|40210512|FG002|Overall Study|Adverse Event|1|||
16472480|NCT01994590|40210513|FG000|Overall Study|Adverse Event|1|||
16472481|NCT01994590|40210513|FG000|Overall Study|Trial Terminated|1|||
16472482|NCT01795638|40210514|FG000|Overall Study|Death|0|||
16472483|NCT01795638|40210515|FG001|Overall Study|Death|3|||
16472484|NCT01795638|40210514|FG000|Overall Study|transferred to quaternary hospital|2|||
16472485|NCT01795638|40210515|FG001|Overall Study|transferred to quaternary hospital|3|||
16472486|NCT01795638|40210514|FG000|Overall Study|Protocol Violation|3|||
16472487|NCT01795638|40210515|FG001|Overall Study|Protocol Violation|0|||
16472488|NCT01795638|40210514|FG000|Overall Study|discharged from hospital|7|||
16472489|NCT01795638|40210515|FG001|Overall Study|discharged from hospital|5|||
16472490|NCT01795638|40210514|FG000|Overall Study|Withdrawal by Subject|1|||
16472491|NCT01795638|40210515|FG001|Overall Study|Withdrawal by Subject|0|||
16472492|NCT00857415|40210516|FG000|Overall Study|Image acquisition failure|2|||
16472493|NCT00857415|40210517|FG001|Overall Study|Image acquisition failure|0|||
16472494|NCT00857415|40210516|FG000|Overall Study|Invalid image or not imaged|3|||
16472495|NCT00857415|40210517|FG001|Overall Study|Invalid image or not imaged|0|||
16472496|NCT00857415|40210516|FG000|Overall Study|Subject still living at end of study|110|||
16472497|NCT00857415|40210517|FG001|Overall Study|Subject still living at end of study|0|||
16472498|NCT00857415|40210516|FG000|Overall Study|Deceased with no autopsy|2|||
16472499|NCT00857415|40210517|FG001|Overall Study|Deceased with no autopsy|0|||
16472500|NCT04239027|40210530|FG000|Overall Study|Adverse Event|4|||
16472501|NCT04239027|40210530|FG000|Overall Study|Withdrawal by Subject|9|||
16472502|NCT04239027|40210530|FG000|Overall Study|Death|1|||
16472503|NCT04239027|40210530|FG000|Overall Study|Physician Decision|9|||
16472504|NCT04239027|40210530|FG000|Overall Study|Lost to Follow-up|2|||
16472505|NCT04239027|40210530|FG000|Overall Study|Lack of Efficacy|1|||
16472506|NCT00958789|40210531|FG000|Overall Study|Death|5|||
16472507|NCT00958789|40210531|FG000|Overall Study|Lost to Follow-up|14|||
16472508|NCT00958789|40210531|FG000|Overall Study|Withdrawal by Subject|17|||
16472509|NCT00958789|40210531|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
16472510|NCT00958789|40210531|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
16472511|NCT00958789|40210531|FG000|Overall Study|Subject terminated|2|||
16472512|NCT00958789|40210531|FG000|Overall Study|Revision|7|||
16472513|NCT02966873|40210532|FG000|Overall Study|Lost to Follow-up|16|||
16472514|NCT02966873|40210533|FG001|Overall Study|Lost to Follow-up|15|||
16472515|NCT03387150|40210536|FG000|Overall Study|Withdrawal by Subject|3|||
16472516|NCT03387150|40210537|FG001|Overall Study|Withdrawal by Subject|0|||
16472517|NCT03387150|40210538|FG002|Overall Study|Withdrawal by Subject|3|||
16472518|NCT03387150|40210539|FG003|Overall Study|Withdrawal by Subject|4|||
16472519|NCT03387150|40210540|FG004|Overall Study|Withdrawal by Subject|1|||
16472520|NCT03387150|40210541|FG005|Overall Study|Withdrawal by Subject|2|||
16472521|NCT03387150|40210542|FG006|Overall Study|Withdrawal by Subject|0|||
16472522|NCT03387150|40210536|FG000|Overall Study|Lost to Follow-up|3|||
16472523|NCT03387150|40210537|FG001|Overall Study|Lost to Follow-up|2|||
16472524|NCT03387150|40210538|FG002|Overall Study|Lost to Follow-up|2|||
16472525|NCT03387150|40210539|FG003|Overall Study|Lost to Follow-up|3|||
16472526|NCT03387150|40210540|FG004|Overall Study|Lost to Follow-up|3|||
16472527|NCT03387150|40210541|FG005|Overall Study|Lost to Follow-up|3|||
16472528|NCT03387150|40210542|FG006|Overall Study|Lost to Follow-up|0|||
16472529|NCT03387150|40210536|FG000|Overall Study|Participant unable to adhere to visit|0|||
16472530|NCT03387150|40210537|FG001|Overall Study|Participant unable to adhere to visit|1|||
16472531|NCT03387150|40210538|FG002|Overall Study|Participant unable to adhere to visit|0|||
16472532|NCT03387150|40210539|FG003|Overall Study|Participant unable to adhere to visit|0|||
16472533|NCT03387150|40210540|FG004|Overall Study|Participant unable to adhere to visit|2|||
16472534|NCT03387150|40210541|FG005|Overall Study|Participant unable to adhere to visit|2|||
16472535|NCT03387150|40210542|FG006|Overall Study|Participant unable to adhere to visit|0|||
16472536|NCT00432965|40210545|FG000|Overall Study|Lost to Follow-up|22|||
16472537|NCT00432965|40210546|FG001|Overall Study|Lost to Follow-up|19|||
16472538|NCT00432965|40210545|FG000|Overall Study|Withdrawal by Subject|13|||
16472539|NCT00432965|40210546|FG001|Overall Study|Withdrawal by Subject|13|||
16472540|NCT00432965|40210545|FG000|Overall Study|Physician Decision|14|||
16472541|NCT00432965|40210546|FG001|Overall Study|Physician Decision|13|||
16472542|NCT00432965|40210545|FG000|Overall Study|Lack of Efficacy|8|||
16472543|NCT00432965|40210546|FG001|Overall Study|Lack of Efficacy|13|||
16472544|NCT00432965|40210545|FG000|Overall Study|Non-compliance|7|||
16472545|NCT00432965|40210546|FG001|Overall Study|Non-compliance|0|||
16472546|NCT00432965|40210545|FG000|Overall Study|Adverse Event|22|||
16472547|NCT00432965|40210546|FG001|Overall Study|Adverse Event|19|||
16472548|NCT00432965|40210545|FG000|Overall Study|Death|3|||
16472549|NCT00432965|40210546|FG001|Overall Study|Death|4|||
16472550|NCT00432965|40210545|FG000|Overall Study|Exclusionary Methods|1|||
16472551|NCT00432965|40210546|FG001|Overall Study|Exclusionary Methods|2|||
16472552|NCT00432965|40210545|FG000|Overall Study|Incomplete Data|4|||
16472553|NCT00432965|40210546|FG001|Overall Study|Incomplete Data|3|||
16472554|NCT03238196|40210547|FG000|Overall Study|Adverse Event|3|||
16472555|NCT03238196|40210548|FG001|Overall Study|Adverse Event|0|||
16472556|NCT03238196|40210549|FG002|Overall Study|Adverse Event|2|||
16472557|NCT03238196|40210550|FG003|Overall Study|Adverse Event|2|||
16472558|NCT03238196|40210547|FG000|Overall Study|Withdrawal by Subject|4|||
16472559|NCT03238196|40210548|FG001|Overall Study|Withdrawal by Subject|1|||
16472560|NCT03238196|40210549|FG002|Overall Study|Withdrawal by Subject|1|||
16472561|NCT03238196|40210550|FG003|Overall Study|Withdrawal by Subject|0|||
16472562|NCT03238196|40210547|FG000|Overall Study|Disease progression|14|||
16472563|NCT03238196|40210548|FG001|Overall Study|Disease progression|2|||
16472564|NCT03238196|40210549|FG002|Overall Study|Disease progression|3|||
16472565|NCT03238196|40210550|FG003|Overall Study|Disease progression|2|||
16472566|NCT03238196|40210547|FG000|Overall Study|Still on treatment|1|||
16472567|NCT03238196|40210548|FG001|Overall Study|Still on treatment|0|||
16472568|NCT03238196|40210549|FG002|Overall Study|Still on treatment|0|||
16472569|NCT03238196|40210550|FG003|Overall Study|Still on treatment|0|||
16472570|NCT01323946|40210551|FG000|Overall Study|Lost to Follow-up|0|||
16472571|NCT01323946|40210552|FG001|Overall Study|Lost to Follow-up|1|||
16472572|NCT01323946|40210553|FG002|Overall Study|Lost to Follow-up|0|||
16472573|NCT01323946|40210551|FG000|Overall Study|Parents refused the last blood draw|1|||
16472574|NCT01323946|40210552|FG001|Overall Study|Parents refused the last blood draw|0|||
16472575|NCT01323946|40210553|FG002|Overall Study|Parents refused the last blood draw|0|||
16472576|NCT01323946|40210551|FG000|Overall Study|Withdrawal by Subject|2|||
16472577|NCT01323946|40210552|FG001|Overall Study|Withdrawal by Subject|2|||
16472578|NCT01323946|40210553|FG002|Overall Study|Withdrawal by Subject|0|||
16472579|NCT03766685|40210554|FG000|Overall Study|Lost to Follow-up|1|||
16472580|NCT03766685|40210555|FG001|Overall Study|Lost to Follow-up|1|||
16472581|NCT03766685|40210556|FG002|Overall Study|Lost to Follow-up|0|||
16472582|NCT03766685|40210557|FG003|Overall Study|Lost to Follow-up|0|||
16472583|NCT03766685|40210554|FG000|Overall Study|Adverse Event, not fatal|0|||
16472584|NCT03766685|40210555|FG001|Overall Study|Adverse Event, not fatal|1|||
16472585|NCT03766685|40210556|FG002|Overall Study|Adverse Event, not fatal|0|||
16472586|NCT03766685|40210557|FG003|Overall Study|Adverse Event, not fatal|1|||
16472587|NCT03766685|40210554|FG000|Overall Study|Withdrawal by Subject|0|||
16472588|NCT03766685|40210555|FG001|Overall Study|Withdrawal by Subject|2|||
16472589|NCT03766685|40210556|FG002|Overall Study|Withdrawal by Subject|0|||
16472590|NCT03766685|40210557|FG003|Overall Study|Withdrawal by Subject|0|||
16472591|NCT03766685|40210554|FG000|Overall Study|Protocol Violation|0|||
16472592|NCT03766685|40210555|FG001|Overall Study|Protocol Violation|1|||
16472593|NCT03766685|40210556|FG002|Overall Study|Protocol Violation|0|||
16472594|NCT03766685|40210557|FG003|Overall Study|Protocol Violation|0|||
16472595|NCT03766685|40210554|FG000|Overall Study|Non-compliance|0|||
16472596|NCT03766685|40210555|FG001|Overall Study|Non-compliance|2|||
16472597|NCT03766685|40210556|FG002|Overall Study|Non-compliance|0|||
16472598|NCT03766685|40210557|FG003|Overall Study|Non-compliance|0|||
16472599|NCT00053365|40210558|FG000|Overall Study|Incorrect cell type|1|||
16472600|NCT00053365|40210558|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
16472601|NCT00053365|40210558|FG000|Overall Study|Never treated|4|||
16472602|NCT00518973|40210565|FG000|Overall Study|Withdrawal by Subject|3|||
16472603|NCT00518973|40210566|FG001|Overall Study|Withdrawal by Subject|2|||
16472604|NCT02676466|40210567|FG000|Overall Study|Death|0|||
16472605|NCT02676466|40210568|FG001|Overall Study|Death|2|||
16472606|NCT02676466|40210569|FG002|Overall Study|Death|1|||
16472607|NCT02676466|40210570|FG003|Overall Study|Death|0|||
16472608|NCT02676466|40210571|FG004|Overall Study|Death|0|||
16472609|NCT02676466|40210572|FG005|Overall Study|Death|0|||
16472610|NCT02676466|40210573|FG006|Overall Study|Death|0|||
16472611|NCT02676466|40210574|FG007|Overall Study|Death|0|||
16472612|NCT02676466|40210567|FG000|Overall Study|Withdrawal by Subject|4|||
16472613|NCT02676466|40210568|FG001|Overall Study|Withdrawal by Subject|3|||
16472614|NCT02676466|40210569|FG002|Overall Study|Withdrawal by Subject|1|||
16472615|NCT02676466|40210570|FG003|Overall Study|Withdrawal by Subject|0|||
16472616|NCT02676466|40210571|FG004|Overall Study|Withdrawal by Subject|3|||
16472617|NCT02676466|40210572|FG005|Overall Study|Withdrawal by Subject|1|||
16472618|NCT02676466|40210573|FG006|Overall Study|Withdrawal by Subject|1|||
16472619|NCT02676466|40210574|FG007|Overall Study|Withdrawal by Subject|1|||
16472620|NCT00116428|40210576|FG000|Overall Study|Withdrawal by Subject|2|||
16472621|NCT00116428|40210577|FG001|Overall Study|Withdrawal by Subject|5|||
16472622|NCT00116428|40210576|FG000|Overall Study|Did not meet inclusion criteria|1|||
16472623|NCT00116428|40210577|FG001|Overall Study|Did not meet inclusion criteria|0|||
16472624|NCT00611533|40210578|FG000|First Intervention (6 Weeks)|Never started study|0|||
16472625|NCT00611533|40210579|FG001|First Intervention (6 Weeks)|Never started study|1|||
16472626|NCT00611533|40210578|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
16472627|NCT00611533|40210579|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
16472628|NCT00611533|40210578|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
16472629|NCT00611533|40210579|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
16472630|NCT04502979|40210586|FG000|Overall Study|Lost to Follow-up|1|||
16472631|NCT04502979|40210587|FG001|Overall Study|Lost to Follow-up|3|||
16472632|NCT04502979|40210586|FG000|Overall Study|Withdrawal by Subject|2|||
16472633|NCT04502979|40210587|FG001|Overall Study|Withdrawal by Subject|1|||
16472634|NCT02237911|40210592|FG000|Overall Study|Withdrawal by Subject|4|||
16472635|NCT02237911|40210593|FG001|Overall Study|Withdrawal by Subject|7|||
16472636|NCT02237911|40210594|FG002|Overall Study|Withdrawal by Subject|2|||
16472637|NCT02237911|40210592|FG000|Overall Study|Lost to Follow-up|3|||
16472638|NCT02237911|40210593|FG001|Overall Study|Lost to Follow-up|1|||
16472639|NCT02237911|40210594|FG002|Overall Study|Lost to Follow-up|1|||
16472640|NCT01466179|40210595|FG000|Overall Study|Ongoing in core study|2|||
16472641|NCT01466179|40210595|FG000|Overall Study|Physician Decision|46|||
16472642|NCT01466179|40210595|FG000|Overall Study|Progressive disease|43|||
16472643|NCT01466179|40210595|FG000|Overall Study|Adverse Event|32|||
16472644|NCT01466179|40210595|FG000|Overall Study|Disease relapse|23|||
16472645|NCT01466179|40210595|FG000|Overall Study|Lack of Efficacy|14|||
16472646|NCT01466179|40210595|FG000|Overall Study|Death|7|||
16472647|NCT01466179|40210595|FG000|Overall Study|Withdrawal by Subject|7|||
16472648|NCT01466179|40210595|FG000|Overall Study|Protocol Violation|2|||
16472649|NCT01466179|40210595|FG000|Overall Study|Other|3|||
16472650|NCT01400815|40210598|FG000|Overall Study|Adverse Event|3|||
16472651|NCT01400815|40210599|FG001|Overall Study|Adverse Event|0|||
16472652|NCT01400815|40210598|FG000|Overall Study|Death|0|||
16472653|NCT01400815|40210599|FG001|Overall Study|Death|1|||
16472654|NCT01400815|40210598|FG000|Overall Study|Lost to Follow-up|18|||
16472655|NCT01400815|40210599|FG001|Overall Study|Lost to Follow-up|11|||
16472656|NCT01400815|40210598|FG000|Overall Study|Protocol Violation|0|||
16472657|NCT01400815|40210599|FG001|Overall Study|Protocol Violation|1|||
16472658|NCT01400815|40210598|FG000|Overall Study|Physician Decision|1|||
16472659|NCT01400815|40210599|FG001|Overall Study|Physician Decision|0|||
16472660|NCT01400815|40210598|FG000|Overall Study|Withdrawal by Subject|15|||
16472661|NCT01400815|40210599|FG001|Overall Study|Withdrawal by Subject|8|||
16472662|NCT01400815|40210598|FG000|Overall Study|Subject in jail|1|||
16472663|NCT01400815|40210599|FG001|Overall Study|Subject in jail|0|||
16472664|NCT03911713|40210602|FG000|Overall Study|Lost to Follow-up|0|||
16472665|NCT03911713|40210603|FG001|Overall Study|Lost to Follow-up|2|||
16472666|NCT03911713|40210604|FG002|Overall Study|Lost to Follow-up|0|||
16472667|NCT03911713|40210605|FG003|Overall Study|Lost to Follow-up|0|||
16472668|NCT03911713|40210606|FG004|Overall Study|Lost to Follow-up|0|||
16472669|NCT03911713|40210602|FG000|Overall Study|Other|0|||
16472670|NCT03911713|40210603|FG001|Overall Study|Other|0|||
16472671|NCT03911713|40210604|FG002|Overall Study|Other|0|||
16472672|NCT03911713|40210605|FG003|Overall Study|Other|1|||
16472673|NCT03911713|40210606|FG004|Overall Study|Other|0|||
16472674|NCT03911713|40210602|FG000|Overall Study|Randomized, Never Dosed|1|||
16472675|NCT03911713|40210603|FG001|Overall Study|Randomized, Never Dosed|0|||
16472676|NCT03911713|40210604|FG002|Overall Study|Randomized, Never Dosed|0|||
16273259|NCT01968551|39484473|FG000|Extension Phase|Lost to Follow-up|1|||
16472677|NCT03911713|40210605|FG003|Overall Study|Randomized, Never Dosed|1|||
16472678|NCT03911713|40210606|FG004|Overall Study|Randomized, Never Dosed|0|||
16472679|NCT01282203|40210609|FG000|Overall Study|Adverse Event|1|||
16472680|NCT01439568|40210611|FG000|Overall Study|Lost to Follow-up|1|||
16472681|NCT01439568|40210612|FG001|Overall Study|Lost to Follow-up|0|||
16472682|NCT01439568|40210611|FG000|Overall Study|Withdrawal by Subject|2|||
16472683|NCT01439568|40210612|FG001|Overall Study|Withdrawal by Subject|2|||
16472684|NCT01241240|40210614|FG000|Overall Study|Adverse Event|5|||
16472685|NCT01241240|40210615|FG001|Overall Study|Adverse Event|4|||
16472686|NCT01241240|40210614|FG000|Overall Study|Lost to Follow-up|2|||
16472687|NCT01241240|40210615|FG001|Overall Study|Lost to Follow-up|4|||
16472688|NCT01241240|40210614|FG000|Overall Study|Personal Reasons|1|||
16472689|NCT01241240|40210615|FG001|Overall Study|Personal Reasons|1|||
16472690|NCT01069627|40210620|FG000|Overall Study|Disease progression|7|||
16472691|NCT01069627|40210620|FG000|Overall Study|Adverse Event|12|||
16472692|NCT01069627|40210620|FG000|Overall Study|Protocol Violation|1|||
16472693|NCT01134731|40210623|FG000|Overall Study|Adverse Event|3|||
16472694|NCT01134731|40210624|FG001|Overall Study|Adverse Event|2|||
16472695|NCT01134731|40210625|FG002|Overall Study|Adverse Event|1|||
16472696|NCT01134731|40210623|FG000|Overall Study|Physician Decision|2|||
16472697|NCT01134731|40210624|FG001|Overall Study|Physician Decision|2|||
16472698|NCT01134731|40210625|FG002|Overall Study|Physician Decision|2|||
16472699|NCT01134731|40210623|FG000|Overall Study|Lack of Efficacy|0|||
16472700|NCT01134731|40210624|FG001|Overall Study|Lack of Efficacy|0|||
16472701|NCT01134731|40210625|FG002|Overall Study|Lack of Efficacy|1|||
16472702|NCT01134731|40210623|FG000|Overall Study|Withdrawal by Subject|3|||
16472703|NCT01134731|40210624|FG001|Overall Study|Withdrawal by Subject|3|||
16472704|NCT01134731|40210625|FG002|Overall Study|Withdrawal by Subject|1|||
16472705|NCT01134731|40210623|FG000|Overall Study|Lost to Follow-up|5|||
16472706|NCT01134731|40210624|FG001|Overall Study|Lost to Follow-up|4|||
16472707|NCT01134731|40210625|FG002|Overall Study|Lost to Follow-up|3|||
16472708|NCT02131532|40210629|FG000|Overall Study|Withdrawal by Subject|1|||
16472709|NCT02131532|40210629|FG000|Overall Study|Physician Decision|1|||
16472710|NCT02131532|40210629|FG000|Overall Study|Other health conditions|2|||
16472711|NCT01163032|40210632|FG000|Randomization Phase|Withdrawal by Subject|2|||
16472712|NCT01163032|40210633|FG001|Randomization Phase|Withdrawal by Subject|3|||
16472713|NCT01163032|40210634|FG002|Randomization Phase|Withdrawal by Subject|0|||
16472714|NCT01163032|40210632|FG000|Randomization Phase|Adverse Event|3|||
16472715|NCT01163032|40210633|FG001|Randomization Phase|Adverse Event|3|||
16472716|NCT01163032|40210634|FG002|Randomization Phase|Adverse Event|0|||
16472717|NCT01163032|40210632|FG000|Randomization Phase|Protocol Violation|0|||
16472718|NCT01163032|40210633|FG001|Randomization Phase|Protocol Violation|1|||
16472719|NCT01163032|40210634|FG002|Randomization Phase|Protocol Violation|0|||
16472720|NCT01163032|40210632|FG000|Randomization Phase|Various*|5|||
16472721|NCT01163032|40210633|FG001|Randomization Phase|Various*|4|||
16472722|NCT01163032|40210634|FG002|Randomization Phase|Various*|0|||
16472723|NCT01163032|40210632|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
16472724|NCT01163032|40210633|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
16472725|NCT01163032|40210634|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
16472726|NCT01163032|40210632|FG000|Open Label Extension Phase|Adverse Event|0|||
16472727|NCT01163032|40210633|FG001|Open Label Extension Phase|Adverse Event|0|||
16472728|NCT01163032|40210634|FG002|Open Label Extension Phase|Adverse Event|3|||
16472729|NCT01163032|40210632|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
16472730|NCT01163032|40210633|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
16472731|NCT01163032|40210634|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
16472732|NCT01163032|40210632|FG000|Open Label Extension Phase|Protocol Violation|0|||
16472733|NCT01163032|40210633|FG001|Open Label Extension Phase|Protocol Violation|0|||
16472734|NCT01163032|40210634|FG002|Open Label Extension Phase|Protocol Violation|1|||
16472735|NCT01163032|40210632|FG000|Open Label Extension Phase|Study Termination|0|||
16472736|NCT01163032|40210633|FG001|Open Label Extension Phase|Study Termination|0|||
16472737|NCT01163032|40210634|FG002|Open Label Extension Phase|Study Termination|7|||
16472738|NCT01163032|40210632|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
16472739|NCT01163032|40210633|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
16472740|NCT01163032|40210634|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
16472741|NCT03538431|40210635|FG000|Overall Study|Physician Decision|0|||
16472742|NCT03538431|40210636|FG001|Overall Study|Physician Decision|1|||
16472743|NCT03538431|40210635|FG000|Overall Study|Withdrawal by Subject|1|||
16472744|NCT03538431|40210636|FG001|Overall Study|Withdrawal by Subject|0|||
16472745|NCT00901927|40210637|FG000|Overall Study|Lack of Efficacy|1|||
16472746|NCT00901927|40210637|FG000|Overall Study|Protocol Violation|3|||
16472747|NCT00901927|40210637|FG000|Overall Study|Withdrawal by Subject|2|||
16472748|NCT03463031|40210638|FG000|Overall Study|Withdrawal by Subject|4|||
16472749|NCT03463031|40210639|FG001|Overall Study|Withdrawal by Subject|2|||
16472750|NCT03463031|40210638|FG000|Overall Study|Investigator/Sponsor Decision|0|||
16472751|NCT03463031|40210639|FG001|Overall Study|Investigator/Sponsor Decision|1|||
16472752|NCT03463031|40210638|FG000|Overall Study|Lost to Follow-up|1|||
16472753|NCT03463031|40210639|FG001|Overall Study|Lost to Follow-up|1|||
16472754|NCT03463031|40210638|FG000|Overall Study|Adverse Event|4|||
16472755|NCT03463031|40210639|FG001|Overall Study|Adverse Event|1|||
16472756|NCT03463031|40210638|FG000|Overall Study|Use of prohibited medication by subject|1|||
16472757|NCT03463031|40210639|FG001|Overall Study|Use of prohibited medication by subject|0|||
16472758|NCT01674634|40210640|FG000|Overall Study|Withdrawal by Subject|3|||
16472759|NCT01674634|40210640|FG000|Overall Study|Lost to Follow-up|3|||
16472760|NCT03139279|40210641|FG000|Overall Study|Physician Decision|2|||
16472761|NCT03139279|40210642|FG001|Overall Study|Physician Decision|0|||
16472762|NCT03139279|40210641|FG000|Overall Study|Protocol Violation|5|||
16472763|NCT03139279|40210642|FG001|Overall Study|Protocol Violation|4|||
16472764|NCT03139279|40210641|FG000|Overall Study|Withdrawal by Subject|0|||
16472765|NCT03139279|40210642|FG001|Overall Study|Withdrawal by Subject|2|||
16472766|NCT01230710|40210643|FG000|Overall Study|Disease Progression|41|||
16472767|NCT01230710|40210643|FG000|Overall Study|Lost to Follow-up|3|||
16472768|NCT01230710|40210643|FG000|Overall Study|Death|4|||
16472769|NCT01230710|40210643|FG000|Overall Study|Withdrawal of Consent|1|||
16472770|NCT03179761|40210649|FG000|Overall Study|Death|2|||
16472771|NCT03179761|40210650|FG001|Overall Study|Death|5|||
16472772|NCT03179761|40210649|FG000|Overall Study|Lost to Follow-up|2|||
16472773|NCT03179761|40210650|FG001|Overall Study|Lost to Follow-up|2|||
16472774|NCT03179761|40210649|FG000|Overall Study|Protocol Violation|1|||
16472775|NCT03179761|40210650|FG001|Overall Study|Protocol Violation|0|||
16472776|NCT03179761|40210649|FG000|Overall Study|Withdrawal by Subject|1|||
16472777|NCT03179761|40210650|FG001|Overall Study|Withdrawal by Subject|4|||
16472778|NCT03179761|40210649|FG000|Overall Study|Investigator Request|0|||
16472779|NCT03179761|40210650|FG001|Overall Study|Investigator Request|2|||
16472780|NCT01067976|40210651|FG000|Overall Study|Study drug never administered|20|||
16472781|NCT01067976|40210651|FG000|Overall Study|Study prematurely discontinued|2|||
16472782|NCT00586846|40210652|FG000|Overall Study|Physician Decision|1|||
16472783|NCT00586846|40210652|FG000|Overall Study|Death|1|||
16472784|NCT00586846|40210652|FG000|Overall Study|Evaluable for Toxicity Only|4|||
16472785|NCT00395538|40210653|FG000|Overall Study|Did not re-consent to revised protocol|1|||
16472786|NCT00395538|40210654|FG001|Overall Study|Did not re-consent to revised protocol|10|||
16472787|NCT00395538|40210655|FG002|Overall Study|Did not re-consent to revised protocol|0|||
16472788|NCT00395538|40210653|FG000|Overall Study|FDA partial hold on PTH|0|||
16472789|NCT00395538|40210654|FG001|Overall Study|FDA partial hold on PTH|0|||
16472790|NCT00395538|40210655|FG002|Overall Study|FDA partial hold on PTH|11|||
16472791|NCT00395538|40210653|FG000|Overall Study|Failed screening|0|||
16472792|NCT00395538|40210654|FG001|Overall Study|Failed screening|0|||
16472793|NCT00395538|40210655|FG002|Overall Study|Failed screening|4|||
16472794|NCT00395538|40210653|FG000|Overall Study|Switch to Natpara|0|||
16472795|NCT00395538|40210654|FG001|Overall Study|Switch to Natpara|0|||
16472796|NCT00395538|40210655|FG002|Overall Study|Switch to Natpara|3|||
16472797|NCT00395538|40210653|FG000|Overall Study|Adverse Event|1|||
16472798|NCT00395538|40210654|FG001|Overall Study|Adverse Event|0|||
16472799|NCT00395538|40210655|FG002|Overall Study|Adverse Event|2|||
16472800|NCT00395538|40210653|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
16472801|NCT00395538|40210654|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
16472802|NCT00395538|40210655|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
16472803|NCT00395538|40210653|FG000|Overall Study|Non-compliance with study protocol|0|||
16472804|NCT00395538|40210654|FG001|Overall Study|Non-compliance with study protocol|1|||
16472805|NCT00395538|40210655|FG002|Overall Study|Non-compliance with study protocol|0|||
16472806|NCT00395538|40210653|FG000|Overall Study|PTH resistance|0|||
16472807|NCT00395538|40210654|FG001|Overall Study|PTH resistance|0|||
16472808|NCT00395538|40210655|FG002|Overall Study|PTH resistance|1|||
16472809|NCT00395538|40210653|FG000|Overall Study|Pregnancy|1|||
16472810|NCT00395538|40210654|FG001|Overall Study|Pregnancy|0|||
16472811|NCT00395538|40210655|FG002|Overall Study|Pregnancy|0|||
16472812|NCT00395538|40210653|FG000|Overall Study|Partial recovery of parathyroid function|0|||
16472813|NCT00395538|40210654|FG001|Overall Study|Partial recovery of parathyroid function|0|||
16472814|NCT00395538|40210655|FG002|Overall Study|Partial recovery of parathyroid function|1|||
16472815|NCT00395538|40210653|FG000|Overall Study|Participant elected to discontinue|0|||
16472816|NCT00395538|40210654|FG001|Overall Study|Participant elected to discontinue|0|||
16472817|NCT00395538|40210655|FG002|Overall Study|Participant elected to discontinue|1|||
16472818|NCT00932737|40210656|FG000|Overall Study|Not treated in second episode|1|||
16472819|NCT00932737|40210657|FG001|Overall Study|Not treated in second episode|0|||
16472820|NCT00932737|40210656|FG000|Overall Study|Adverse Event|0|||
16472821|NCT00932737|40210657|FG001|Overall Study|Adverse Event|1|||
16472822|NCT00923936|40210658|FG000|Overall Study|progressive disease on study|2|||
16472823|NCT00923936|40210659|FG001|Overall Study|progressive disease on study|1|||
16472824|NCT00923936|40210658|FG000|Overall Study|Adverse Event|2|||
16472825|NCT00923936|40210659|FG001|Overall Study|Adverse Event|1|||
16472826|NCT00923936|40210658|FG000|Overall Study|Lost to follow up|2|||
16472827|NCT00923936|40210659|FG001|Overall Study|Lost to follow up|0|||
16472828|NCT00923936|40210658|FG000|Overall Study|Continuing in follow up period|2|||
16472829|NCT00923936|40210659|FG001|Overall Study|Continuing in follow up period|1|||
16472830|NCT03666624|40210660|FG000|Overall Study|participant grieving over recent death of parent|1|||
16472831|NCT03666624|40210661|FG001|Overall Study|participant grieving over recent death of parent|0|||
16472832|NCT01483690|40210664|FG000|Overall Study|Adverse Event|1|||
16472833|NCT01483690|40210665|FG001|Overall Study|Adverse Event|2|||
16472834|NCT01483690|40210664|FG000|Overall Study|clinical deterioration|1|||
16472835|NCT01483690|40210665|FG001|Overall Study|clinical deterioration|0|||
16472836|NCT01483690|40210664|FG000|Overall Study|Physician Decision|0|||
16472837|NCT01483690|40210665|FG001|Overall Study|Physician Decision|2|||
16472838|NCT01483690|40210664|FG000|Overall Study|exclusionary procedure|0|||
16472839|NCT01483690|40210665|FG001|Overall Study|exclusionary procedure|1|||
16472840|NCT00478881|40210666|FG000|Overall Study|Adverse Event|31|||
16472841|NCT00478881|40210667|FG001|Overall Study|Adverse Event|12|||
16472842|NCT00478881|40210666|FG000|Overall Study|Lack of Efficacy|0|||
16472843|NCT00478881|40210667|FG001|Overall Study|Lack of Efficacy|3|||
16472844|NCT00478881|40210666|FG000|Overall Study|Lost to Follow-up|0|||
16472845|NCT00478881|40210667|FG001|Overall Study|Lost to Follow-up|1|||
16472846|NCT00478881|40210666|FG000|Overall Study|Protocol Violation|2|||
16472847|NCT00478881|40210667|FG001|Overall Study|Protocol Violation|2|||
16472848|NCT00478881|40210666|FG000|Overall Study|Withdrawal by Subject|6|||
16472849|NCT00478881|40210667|FG001|Overall Study|Withdrawal by Subject|2|||
16472850|NCT00478881|40210666|FG000|Overall Study|Non-Compliance with Study Medication|0|||
16472851|NCT00478881|40210667|FG001|Overall Study|Non-Compliance with Study Medication|2|||
16472852|NCT03977454|40210668|FG000|Overall Study|immediate postoperative revision|2|||
16472853|NCT03977454|40210669|FG001|Overall Study|immediate postoperative revision|2|||
16472854|NCT05055128|40210670|FG000|Overall Study|Adverse Event|0|||
16472855|NCT05055128|40210671|FG001|Overall Study|Adverse Event|0|||
16472856|NCT05055128|40210672|FG002|Overall Study|Adverse Event|0|||
16472857|NCT05055128|40210673|FG003|Overall Study|Adverse Event|1|||
16472858|NCT05055128|40210674|FG004|Overall Study|Adverse Event|1|||
16472859|NCT05055128|40210670|FG000|Overall Study|Protocol Violation|0|||
16472860|NCT05055128|40210671|FG001|Overall Study|Protocol Violation|0|||
16472861|NCT05055128|40210672|FG002|Overall Study|Protocol Violation|0|||
16472862|NCT05055128|40210673|FG003|Overall Study|Protocol Violation|1|||
16472863|NCT05055128|40210674|FG004|Overall Study|Protocol Violation|0|||
16472864|NCT05055128|40210670|FG000|Overall Study|Withdrawal by Subject|5|||
16472865|NCT05055128|40210671|FG001|Overall Study|Withdrawal by Subject|2|||
16472866|NCT05055128|40210672|FG002|Overall Study|Withdrawal by Subject|2|||
16472867|NCT05055128|40210673|FG003|Overall Study|Withdrawal by Subject|4|||
16472868|NCT05055128|40210674|FG004|Overall Study|Withdrawal by Subject|2|||
16472869|NCT05055128|40210670|FG000|Overall Study|Randomized By Mistake|0|||
16472870|NCT05055128|40210671|FG001|Overall Study|Randomized By Mistake|1|||
16472871|NCT05055128|40210672|FG002|Overall Study|Randomized By Mistake|0|||
16472872|NCT05055128|40210673|FG003|Overall Study|Randomized By Mistake|0|||
16472873|NCT05055128|40210674|FG004|Overall Study|Randomized By Mistake|0|||
16472874|NCT05055128|40210670|FG000|Overall Study|Other|1|||
16472875|NCT05055128|40210671|FG001|Overall Study|Other|0|||
16472876|NCT05055128|40210672|FG002|Overall Study|Other|0|||
16472877|NCT05055128|40210673|FG003|Overall Study|Other|0|||
16472878|NCT05055128|40210674|FG004|Overall Study|Other|0|||
16472879|NCT01394718|40210675|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
16472880|NCT01394718|40210676|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
16472881|NCT00055471|40210679|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
16472882|NCT00055471|40210680|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
16472883|NCT00055471|40210681|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
16472884|NCT00055471|40210679|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
16472885|NCT00055471|40210680|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
16472886|NCT00055471|40210681|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
16472887|NCT00055471|40210679|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
16472888|NCT00055471|40210680|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
16472889|NCT00055471|40210681|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
16472890|NCT00566501|40210684|FG000|Overall Study|Adverse Event|68|||
16472891|NCT00566501|40210685|FG001|Overall Study|Adverse Event|59|||
16472892|NCT00566501|40210684|FG000|Overall Study|Medication Non-compliance|5|||
16472893|NCT00566501|40210685|FG001|Overall Study|Medication Non-compliance|0|||
16472894|NCT00566501|40210684|FG000|Overall Study|Protocol Violation|2|||
16472895|NCT00566501|40210685|FG001|Overall Study|Protocol Violation|2|||
16472896|NCT00566501|40210684|FG000|Overall Study|Request of Investigator or Sponsor|6|||
16472897|NCT00566501|40210685|FG001|Overall Study|Request of Investigator or Sponsor|7|||
16472898|NCT00566501|40210684|FG000|Overall Study|Withdrawal by Subject|33|||
16472899|NCT00566501|40210685|FG001|Overall Study|Withdrawal by Subject|30|||
16472900|NCT00566501|40210684|FG000|Overall Study|Lack of Efficacy|8|||
16472901|NCT00566501|40210685|FG001|Overall Study|Lack of Efficacy|3|||
16472902|NCT00566501|40210684|FG000|Overall Study|Other|25|||
16472903|NCT00566501|40210685|FG001|Overall Study|Other|21|||
16472904|NCT04365257|40210687|FG000|Overall Study|Physician Decision|1|||
16472905|NCT04365257|40210688|FG001|Overall Study|Physician Decision|0|||
16472906|NCT04365257|40210687|FG000|Overall Study|Patient Noncompliance|1|||
16472907|NCT04365257|40210688|FG001|Overall Study|Patient Noncompliance|0|||
16472908|NCT04365257|40210687|FG000|Overall Study|Withdrawal by Subject|0|||
16472909|NCT04365257|40210688|FG001|Overall Study|Withdrawal by Subject|1|||
16472910|NCT02514473|40210689|FG000|Overall Study|Adverse Event|0|||
16472911|NCT02514473|40210690|FG001|Overall Study|Adverse Event|2|||
16472912|NCT02514473|40210689|FG000|Overall Study|Withdrawal by Subject|2|||
16472913|NCT02514473|40210690|FG001|Overall Study|Withdrawal by Subject|1|||
16472914|NCT02514473|40210689|FG000|Overall Study|Lost to Follow-up|0|||
16472915|NCT02514473|40210690|FG001|Overall Study|Lost to Follow-up|1|||
16472916|NCT02514473|40210689|FG000|Overall Study|Other|1|||
16472917|NCT02514473|40210690|FG001|Overall Study|Other|1|||
16472918|NCT01638819|40210692|FG000|Overall Study|Lost to Follow-up|1|||
16472919|NCT01638819|40210693|FG001|Overall Study|Lost to Follow-up|0|||
16472920|NCT03422627|40210698|FG000|Overall Study|Protocol-specified Criteria|1|||
16472921|NCT03422627|40210699|FG001|Overall Study|Protocol-specified Criteria|1|||
16472922|NCT03422627|40210700|FG002|Overall Study|Protocol-specified Criteria|0|||
16472923|NCT03422627|40210701|FG003|Overall Study|Protocol-specified Criteria|0|||
16472924|NCT03422627|40210702|FG004|Overall Study|Protocol-specified Criteria|2|||
16472925|NCT03422627|40210698|FG000|Overall Study|Requirement for Alternative Therapy|1|||
16472926|NCT03422627|40210699|FG001|Overall Study|Requirement for Alternative Therapy|1|||
16472927|NCT03422627|40210700|FG002|Overall Study|Requirement for Alternative Therapy|2|||
16472928|NCT03422627|40210701|FG003|Overall Study|Requirement for Alternative Therapy|0|||
16472929|NCT03422627|40210702|FG004|Overall Study|Requirement for Alternative Therapy|0|||
16472930|NCT03422627|40210698|FG000|Overall Study|Disease Progression|1|||
16472931|NCT03422627|40210699|FG001|Overall Study|Disease Progression|0|||
16472932|NCT03422627|40210700|FG002|Overall Study|Disease Progression|1|||
16472933|NCT03422627|40210701|FG003|Overall Study|Disease Progression|2|||
16472934|NCT03422627|40210702|FG004|Overall Study|Disease Progression|0|||
16472935|NCT03422627|40210698|FG000|Overall Study|Adverse Event|2|||
16472936|NCT03422627|40210699|FG001|Overall Study|Adverse Event|1|||
16472937|NCT03422627|40210700|FG002|Overall Study|Adverse Event|0|||
16472938|NCT03422627|40210701|FG003|Overall Study|Adverse Event|0|||
16472939|NCT03422627|40210702|FG004|Overall Study|Adverse Event|2|||
16472940|NCT03422627|40210698|FG000|Overall Study|Ineligibility Determined|0|||
16472941|NCT03422627|40210699|FG001|Overall Study|Ineligibility Determined|1|||
16472942|NCT03422627|40210700|FG002|Overall Study|Ineligibility Determined|0|||
16472943|NCT03422627|40210701|FG003|Overall Study|Ineligibility Determined|0|||
16472944|NCT03422627|40210702|FG004|Overall Study|Ineligibility Determined|0|||
16472945|NCT03422627|40210698|FG000|Overall Study|Death|0|||
16472946|NCT03422627|40210699|FG001|Overall Study|Death|1|||
16472947|NCT03422627|40210700|FG002|Overall Study|Death|1|||
16472948|NCT03422627|40210701|FG003|Overall Study|Death|0|||
16472949|NCT03422627|40210702|FG004|Overall Study|Death|0|||
16472950|NCT03422627|40210698|FG000|Overall Study|Withdrawal by Subject|0|||
16472951|NCT03422627|40210699|FG001|Overall Study|Withdrawal by Subject|0|||
16472952|NCT03422627|40210700|FG002|Overall Study|Withdrawal by Subject|0|||
16472953|NCT03422627|40210701|FG003|Overall Study|Withdrawal by Subject|1|||
16472954|NCT03422627|40210702|FG004|Overall Study|Withdrawal by Subject|0|||
16472955|NCT00950911|40210703|FG000|Overall Study|Adverse Event|0|||
16472956|NCT00950911|40210704|FG001|Overall Study|Adverse Event|2|||
16472957|NCT00950911|40210703|FG000|Overall Study|Death|4|||
16472958|NCT00950911|40210704|FG001|Overall Study|Death|6|||
16472959|NCT00950911|40210703|FG000|Overall Study|Disease progression|2|||
16472960|NCT00950911|40210704|FG001|Overall Study|Disease progression|2|||
16472961|NCT00950911|40210703|FG000|Overall Study|Consent withdrawn|1|||
16472962|NCT00950911|40210704|FG001|Overall Study|Consent withdrawn|3|||
16472963|NCT00950911|40210703|FG000|Overall Study|Administrative decision|3|||
16472964|NCT00950911|40210704|FG001|Overall Study|Administrative decision|1|||
16472965|NCT00950911|40210703|FG000|Overall Study|Ineligibility determined|1|||
16472966|NCT00950911|40210704|FG001|Overall Study|Ineligibility determined|0|||
16472967|NCT00950911|40210703|FG000|Overall Study|Noncompliance|1|||
16472968|NCT00950911|40210704|FG001|Overall Study|Noncompliance|0|||
16472969|NCT00950911|40210703|FG000|Overall Study|Poor performance status|0|||
16472970|NCT00950911|40210704|FG001|Overall Study|Poor performance status|1|||
16472971|NCT04128371|40210711|FG000|Overall Study|Lack of Efficacy|1|||
16472972|NCT00642473|40210712|FG000|Overall Study|Withdrawal by Subject|0|||
16472973|NCT00642473|40210713|FG001|Overall Study|Withdrawal by Subject|5|||
16472974|NCT00642473|40210712|FG000|Overall Study|Progression or death|2|||
16472975|NCT00642473|40210713|FG001|Overall Study|Progression or death|4|||
16472976|NCT00642473|40210712|FG000|Overall Study|Other|2|||
16472977|NCT00642473|40210713|FG001|Overall Study|Other|2|||
16472978|NCT04399837|40210716|FG000|Overall Study|Other than listed|0|||
16472979|NCT04399837|40210717|FG001|Overall Study|Other than listed|2|||
16472980|NCT04399837|40210718|FG002|Overall Study|Other than listed|2|||
16472981|NCT04399837|40210719|FG003|Overall Study|Other than listed|3|||
16273260|NCT01968551|39484474|FG001|Extension Phase|Lost to Follow-up|0|||
16472982|NCT04399837|40210716|FG000|Overall Study|Withdrawal by Subject|1|||
16472983|NCT04399837|40210717|FG001|Overall Study|Withdrawal by Subject|2|||
16472984|NCT04399837|40210718|FG002|Overall Study|Withdrawal by Subject|1|||
16472985|NCT04399837|40210719|FG003|Overall Study|Withdrawal by Subject|1|||
16073604|NCT01289119|38759355|FG003|Overall Study|Major Protocol Deviation|0|||
16073605|NCT01289119|38759356|FG004|Overall Study|Major Protocol Deviation|2|||
16073606|NCT01289119|38759357|FG005|Overall Study|Major Protocol Deviation|1|||
16073607|NCT01289119|38759352|FG000|Overall Study|Lost to Follow-up|0|||
16073608|NCT01289119|38759353|FG001|Overall Study|Lost to Follow-up|3|||
16073609|NCT01289119|38759354|FG002|Overall Study|Lost to Follow-up|0|||
16472986|NCT04250714|40210720|FG000|Overall Study|Treatment - withdrawal by subject|14|||
16472987|NCT04250714|40210720|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
16472988|NCT04250714|40210720|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
16472989|NCT04250714|40210720|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
16472990|NCT04250714|40210720|FG000|Overall Study|Treatment - Death|1|||
16472991|NCT04250714|40210720|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
16472992|NCT04250714|40210720|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
16472993|NCT04250714|40210720|FG000|Overall Study|Attempt|2|||
16472994|NCT04250714|40210720|FG000|Overall Study|Intent|7|||
16472995|NCT03161093|40210725|FG000|Overall Study|Protocol Violation|11|||
16472996|NCT03161093|40210726|FG001|Overall Study|Protocol Violation|14|||
16472997|NCT03161093|40210727|FG002|Overall Study|Protocol Violation|6|||
16472998|NCT03161093|40210728|FG003|Overall Study|Protocol Violation|13|||
16472999|NCT03161093|40210729|FG004|Overall Study|Protocol Violation|1|||
16473000|NCT03161093|40210730|FG005|Overall Study|Protocol Violation|0|||
16473001|NCT03161093|40210725|FG000|Overall Study|Adverse Event|5|||
16473002|NCT03161093|40210726|FG001|Overall Study|Adverse Event|21|||
16473003|NCT03161093|40210727|FG002|Overall Study|Adverse Event|16|||
16473004|NCT03161093|40210728|FG003|Overall Study|Adverse Event|35|||
16473005|NCT03161093|40210729|FG004|Overall Study|Adverse Event|2|||
16473006|NCT03161093|40210730|FG005|Overall Study|Adverse Event|1|||
16473007|NCT03161093|40210725|FG000|Overall Study|Lack of Efficacy|9|||
16473008|NCT03161093|40210726|FG001|Overall Study|Lack of Efficacy|13|||
16473009|NCT03161093|40210727|FG002|Overall Study|Lack of Efficacy|9|||
16473010|NCT03161093|40210728|FG003|Overall Study|Lack of Efficacy|24|||
16473011|NCT03161093|40210729|FG004|Overall Study|Lack of Efficacy|4|||
16473012|NCT03161093|40210730|FG005|Overall Study|Lack of Efficacy|1|||
16473013|NCT03161093|40210725|FG000|Overall Study|Physician Decision|0|||
16473014|NCT03161093|40210726|FG001|Overall Study|Physician Decision|1|||
16473015|NCT03161093|40210727|FG002|Overall Study|Physician Decision|0|||
16473016|NCT03161093|40210728|FG003|Overall Study|Physician Decision|2|||
16473017|NCT03161093|40210729|FG004|Overall Study|Physician Decision|17|||
16473018|NCT03161093|40210730|FG005|Overall Study|Physician Decision|15|||
16473019|NCT03161093|40210725|FG000|Overall Study|Withdrawal by Subject|24|||
16473020|NCT03161093|40210726|FG001|Overall Study|Withdrawal by Subject|73|||
16473021|NCT03161093|40210727|FG002|Overall Study|Withdrawal by Subject|44|||
16473022|NCT03161093|40210728|FG003|Overall Study|Withdrawal by Subject|97|||
16473023|NCT03161093|40210729|FG004|Overall Study|Withdrawal by Subject|11|||
16473024|NCT03161093|40210730|FG005|Overall Study|Withdrawal by Subject|10|||
16473025|NCT03161093|40210725|FG000|Overall Study|Lost to Follow-up|3|||
16473026|NCT03161093|40210726|FG001|Overall Study|Lost to Follow-up|12|||
16473027|NCT03161093|40210727|FG002|Overall Study|Lost to Follow-up|4|||
16473028|NCT03161093|40210728|FG003|Overall Study|Lost to Follow-up|7|||
16473029|NCT03161093|40210729|FG004|Overall Study|Lost to Follow-up|8|||
16473030|NCT03161093|40210730|FG005|Overall Study|Lost to Follow-up|13|||
16473031|NCT03161093|40210725|FG000|Overall Study|Death|3|||
16473032|NCT03161093|40210726|FG001|Overall Study|Death|9|||
16473033|NCT03161093|40210727|FG002|Overall Study|Death|7|||
16473034|NCT03161093|40210728|FG003|Overall Study|Death|9|||
16473035|NCT03161093|40210729|FG004|Overall Study|Death|0|||
16473036|NCT03161093|40210730|FG005|Overall Study|Death|0|||
16473037|NCT03161093|40210725|FG000|Overall Study|Unknown - Not reported|0|||
16473038|NCT03161093|40210726|FG001|Overall Study|Unknown - Not reported|1|||
16473039|NCT03161093|40210727|FG002|Overall Study|Unknown - Not reported|0|||
16473040|NCT03161093|40210728|FG003|Overall Study|Unknown - Not reported|0|||
16473041|NCT03161093|40210729|FG004|Overall Study|Unknown - Not reported|0|||
16473042|NCT03161093|40210730|FG005|Overall Study|Unknown - Not reported|1|||
16473043|NCT01886716|40210735|FG000|Week 1|Lost to Follow-up|0|||
16473044|NCT01886716|40210736|FG001|Week 1|Lost to Follow-up|0|||
16473045|NCT01886716|40210737|FG002|Week 1|Lost to Follow-up|2|||
16473046|NCT01886716|40210738|FG003|Week 1|Lost to Follow-up|2|||
16473047|NCT01886716|40210735|FG000|Week 2|Lost to Follow-up|3|||
16473048|NCT01886716|40210736|FG001|Week 2|Lost to Follow-up|2|||
16473049|NCT01886716|40210737|FG002|Week 2|Lost to Follow-up|1|||
16473050|NCT01886716|40210738|FG003|Week 2|Lost to Follow-up|3|||
16473051|NCT01886716|40210735|FG000|Week 3|Lost to Follow-up|1|||
16473052|NCT01886716|40210736|FG001|Week 3|Lost to Follow-up|1|||
16473053|NCT01886716|40210737|FG002|Week 3|Lost to Follow-up|0|||
16473054|NCT01886716|40210738|FG003|Week 3|Lost to Follow-up|1|||
16473055|NCT00098475|40210740|FG000|Step 1|Progressive disease|33|||
16073610|NCT01289119|38759355|FG003|Overall Study|Lost to Follow-up|0|||
16073611|NCT01289119|38759356|FG004|Overall Study|Lost to Follow-up|0|||
16073612|NCT01289119|38759357|FG005|Overall Study|Lost to Follow-up|1|||
16073613|NCT01289119|38759352|FG000|Overall Study|Withdrawal by Subject|4|||
16073614|NCT01289119|38759353|FG001|Overall Study|Withdrawal by Subject|2|||
16073615|NCT01289119|38759354|FG002|Overall Study|Withdrawal by Subject|4|||
16073616|NCT01289119|38759355|FG003|Overall Study|Withdrawal by Subject|3|||
16073617|NCT01289119|38759356|FG004|Overall Study|Withdrawal by Subject|1|||
16073618|NCT01289119|38759357|FG005|Overall Study|Withdrawal by Subject|1|||
16073619|NCT01289119|38759352|FG000|Overall Study|Pregnancy|0|||
16073620|NCT01289119|38759353|FG001|Overall Study|Pregnancy|1|||
16073621|NCT01289119|38759354|FG002|Overall Study|Pregnancy|0|||
16073622|NCT01289119|38759355|FG003|Overall Study|Pregnancy|0|||
16073623|NCT01289119|38759356|FG004|Overall Study|Pregnancy|0|||
16073624|NCT01289119|38759357|FG005|Overall Study|Pregnancy|0|||
16073625|NCT01289119|38759352|FG000|Overall Study|Lack of Efficacy|0|||
16073626|NCT01289119|38759353|FG001|Overall Study|Lack of Efficacy|1|||
16073627|NCT01289119|38759354|FG002|Overall Study|Lack of Efficacy|1|||
16073628|NCT01289119|38759355|FG003|Overall Study|Lack of Efficacy|1|||
16073629|NCT01289119|38759356|FG004|Overall Study|Lack of Efficacy|1|||
16073630|NCT01289119|38759357|FG005|Overall Study|Lack of Efficacy|1|||
16073631|NCT01289119|38759352|FG000|Overall Study|Other|1|||
16073632|NCT01289119|38759353|FG001|Overall Study|Other|0|||
16073633|NCT01289119|38759354|FG002|Overall Study|Other|1|||
16073634|NCT01289119|38759355|FG003|Overall Study|Other|0|||
16073635|NCT01289119|38759356|FG004|Overall Study|Other|0|||
16073636|NCT01289119|38759357|FG005|Overall Study|Other|0|||
16073637|NCT01930045|38759362|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
16073638|NCT01930045|38759363|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
16073639|NCT01930045|38759364|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
16073640|NCT01930045|38759365|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
16073641|NCT01930045|38759366|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
16073642|NCT01930045|38759367|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
16073643|NCT01930045|38759362|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
16073644|NCT01930045|38759363|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
16073645|NCT01930045|38759364|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
16073646|NCT01930045|38759365|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
16073647|NCT01930045|38759366|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
16073648|NCT01930045|38759367|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
16073649|NCT02299336|38759368|FG000|Overall Study|Withdrawal by Subject|11|||
16073650|NCT02299336|38759368|FG000|Overall Study|Adverse Event|1|||
16073651|NCT02299336|38759368|FG000|Overall Study|Death|1|||
16073652|NCT02299336|38759368|FG000|Overall Study|Lost to Follow-up|1|||
16073653|NCT01091454|38759369|FG000|Overall Study|Ineligible|1|||
16073654|NCT03999554|38759370|FG000|Overall Study|Lost to Follow-up|4|||
16073655|NCT03999554|38759371|FG001|Overall Study|Lost to Follow-up|5|||
16073656|NCT03999554|38759372|FG002|Overall Study|Lost to Follow-up|4|||
16073657|NCT03999554|38759373|FG003|Overall Study|Lost to Follow-up|5|||
16073658|NCT03999554|38759374|FG004|Overall Study|Lost to Follow-up|8|||
16073659|NCT03999554|38759370|FG000|Overall Study|Protocol Violation|0|||
16073660|NCT03999554|38759371|FG001|Overall Study|Protocol Violation|0|||
16073661|NCT03999554|38759372|FG002|Overall Study|Protocol Violation|5|||
16073662|NCT03999554|38759373|FG003|Overall Study|Protocol Violation|0|||
16073663|NCT03999554|38759374|FG004|Overall Study|Protocol Violation|0|||
16073664|NCT03999554|38759370|FG000|Overall Study|Pregnancy|0|||
16073665|NCT03999554|38759371|FG001|Overall Study|Pregnancy|0|||
16073666|NCT03999554|38759372|FG002|Overall Study|Pregnancy|1|||
16073667|NCT03999554|38759373|FG003|Overall Study|Pregnancy|0|||
16073668|NCT03999554|38759374|FG004|Overall Study|Pregnancy|0|||
16073669|NCT03999554|38759370|FG000|Overall Study|Withdrawal by Subject|2|||
16073670|NCT03999554|38759371|FG001|Overall Study|Withdrawal by Subject|2|||
16073671|NCT03999554|38759372|FG002|Overall Study|Withdrawal by Subject|2|||
16073672|NCT03999554|38759373|FG003|Overall Study|Withdrawal by Subject|1|||
16073673|NCT03999554|38759374|FG004|Overall Study|Withdrawal by Subject|1|||
16073674|NCT03999554|38759370|FG000|Overall Study|failure to comply with protocol requirements|0|||
16073675|NCT03999554|38759371|FG001|Overall Study|failure to comply with protocol requirements|0|||
16073676|NCT03999554|38759372|FG002|Overall Study|failure to comply with protocol requirements|0|||
16073677|NCT03999554|38759373|FG003|Overall Study|failure to comply with protocol requirements|1|||
16073678|NCT03999554|38759374|FG004|Overall Study|failure to comply with protocol requirements|0|||
16073679|NCT03743246|38759377|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
16073680|NCT03743246|38759378|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
16073681|NCT03743246|38759379|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
16073682|NCT03743246|38759380|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
16073683|NCT03743246|38759377|FG000|Pre-Treatment Period|Death|0|||
16073684|NCT03743246|38759378|FG001|Pre-Treatment Period|Death|1|||
16073685|NCT03743246|38759379|FG002|Pre-Treatment Period|Death|0|||
16073686|NCT03743246|38759380|FG003|Pre-Treatment Period|Death|1|||
16073687|NCT03743246|38759377|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
16073688|NCT03743246|38759378|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
16073689|NCT03743246|38759379|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
16073690|NCT03743246|38759380|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
16073691|NCT03743246|38759377|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
16073692|NCT03743246|38759378|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
16073693|NCT03743246|38759379|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
16073694|NCT03743246|38759380|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
16073695|NCT03743246|38759377|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
16073696|NCT03743246|38759378|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
16073697|NCT03743246|38759379|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
16073698|NCT03743246|38759380|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
16073699|NCT03743246|38759377|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
16073700|NCT03743246|38759378|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
16073701|NCT03743246|38759379|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
16073702|NCT03743246|38759380|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
16073703|NCT03743246|38759377|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
16073704|NCT03743246|38759378|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
16073705|NCT03743246|38759379|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
16073706|NCT03743246|38759380|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
16073707|NCT03743246|38759377|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
16073708|NCT03743246|38759378|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
16073709|NCT03743246|38759379|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
16073710|NCT03743246|38759380|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
16073711|NCT03743246|38759377|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
16073712|NCT03743246|38759378|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
16073713|NCT03743246|38759379|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
16073714|NCT03743246|38759380|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
16073715|NCT02954848|38759381|FG000|Overall Study|Randomized but Not Treated|0|||
16073716|NCT02954848|38759382|FG001|Overall Study|Randomized but Not Treated|1|||
16073717|NCT02954848|38759381|FG000|Overall Study|Adverse Event|2|||
16073718|NCT02954848|38759382|FG001|Overall Study|Adverse Event|3|||
16073719|NCT02954848|38759381|FG000|Overall Study|Withdrawal by Participant|0|||
16073720|NCT02954848|38759382|FG001|Overall Study|Withdrawal by Participant|1|||
16073721|NCT04148937|38759383|FG000|Overall Study|Withdrawal by Subject|0|||
16073722|NCT04148937|38759384|FG001|Overall Study|Withdrawal by Subject|0|||
16073723|NCT04148937|38759385|FG002|Overall Study|Withdrawal by Subject|0|||
16073724|NCT04148937|38759386|FG003|Overall Study|Withdrawal by Subject|1|||
16073725|NCT04148937|38759387|FG004|Overall Study|Withdrawal by Subject|0|||
16073726|NCT04148937|38759388|FG005|Overall Study|Withdrawal by Subject|1|||
16073727|NCT04148937|38759389|FG006|Overall Study|Withdrawal by Subject|1|||
16073728|NCT04148937|38759390|FG007|Overall Study|Withdrawal by Subject|0|||
16073729|NCT04148937|38759383|FG000|Overall Study|Lost to Follow-up|0|||
16073730|NCT04148937|38759384|FG001|Overall Study|Lost to Follow-up|0|||
16073731|NCT04148937|38759385|FG002|Overall Study|Lost to Follow-up|1|||
16073732|NCT04148937|38759386|FG003|Overall Study|Lost to Follow-up|0|||
16073733|NCT04148937|38759387|FG004|Overall Study|Lost to Follow-up|0|||
16073734|NCT04148937|38759388|FG005|Overall Study|Lost to Follow-up|2|||
16073735|NCT04148937|38759389|FG006|Overall Study|Lost to Follow-up|0|||
16073736|NCT04148937|38759390|FG007|Overall Study|Lost to Follow-up|0|||
16073737|NCT00346333|38759391|FG000|Overall Study|Death|1|||
16073738|NCT00346333|38759392|FG001|Overall Study|Death|0|||
16073739|NCT00346333|38759391|FG000|Overall Study|unwilling or unable to continue|4|||
16073740|NCT00346333|38759392|FG001|Overall Study|unwilling or unable to continue|8|||
16073741|NCT03257813|38759393|FG000|Overall Study|Protocol Violation|6|||
16073742|NCT03257813|38759394|FG001|Overall Study|Protocol Violation|3|||
16073743|NCT02314117|38759397|FG000|Overall Study|Lost to Follow-up|9|||
16073744|NCT02314117|38759398|FG001|Overall Study|Lost to Follow-up|14|||
16073745|NCT02314117|38759397|FG000|Overall Study|Withdrawal by Subject|3|||
16073746|NCT02314117|38759398|FG001|Overall Study|Withdrawal by Subject|2|||
16073747|NCT00751036|38759400|FG000|Overall Study|Disease Progression|28|||
16073748|NCT00751036|38759401|FG001|Overall Study|Disease Progression|29|||
16073749|NCT00751036|38759400|FG000|Overall Study|Adverse Event|6|||
16073750|NCT00751036|38759401|FG001|Overall Study|Adverse Event|4|||
16073751|NCT00751036|38759400|FG000|Overall Study|Administrative Problems|3|||
16073752|NCT00751036|38759401|FG001|Overall Study|Administrative Problems|4|||
16073753|NCT00751036|38759400|FG000|Overall Study|Withdrawal by Subject|5|||
16073754|NCT00751036|38759401|FG001|Overall Study|Withdrawal by Subject|2|||
16073755|NCT00751036|38759400|FG000|Overall Study|Death|3|||
16073756|NCT00751036|38759401|FG001|Overall Study|Death|3|||
16073757|NCT00751036|38759400|FG000|Overall Study|Lost to Follow-up|0|||
16073758|NCT00751036|38759401|FG001|Overall Study|Lost to Follow-up|1|||
16073759|NCT00751036|38759400|FG000|Overall Study|Protocol Violation|1|||
16073760|NCT00751036|38759401|FG001|Overall Study|Protocol Violation|0|||
16073761|NCT00751036|38759400|FG000|Overall Study|Missing end of Treatment Page|2|||
16073762|NCT00751036|38759401|FG001|Overall Study|Missing end of Treatment Page|3|||
16073763|NCT04364269|38759408|FG000|Overall Study|Adverse Event|1|||
16073764|NCT04364269|38759409|FG001|Overall Study|Adverse Event|0|||
16073765|NCT04364269|38759410|FG002|Overall Study|Adverse Event|0|||
16073766|NCT04364269|38759408|FG000|Overall Study|Withdrawal by Subject|0|||
16073767|NCT04364269|38759409|FG001|Overall Study|Withdrawal by Subject|1|||
16073768|NCT04364269|38759410|FG002|Overall Study|Withdrawal by Subject|0|||
16073769|NCT03885596|38759411|FG000|Overall Study|Withdrawal by Subject|2|||
16073770|NCT03885596|38759412|FG001|Overall Study|Withdrawal by Subject|1|||
16073771|NCT03885596|38759413|FG002|Overall Study|Withdrawal by Subject|0|||
16073772|NCT03885596|38759414|FG003|Overall Study|Withdrawal by Subject|0|||
16073773|NCT00770965|38759415|FG000|Safety Set|Withdrawal by Subject|0|||
16073774|NCT00770965|38759416|FG001|Safety Set|Withdrawal by Subject|0|||
16073775|NCT00770965|38759417|FG002|Safety Set|Withdrawal by Subject|0|||
16073776|NCT00770965|38759418|FG003|Safety Set|Withdrawal by Subject|1|||
16073777|NCT00770965|38759415|FG000|Safety Set|Protocol deviation|0|||
16073778|NCT00770965|38759416|FG001|Safety Set|Protocol deviation|0|||
16073779|NCT00770965|38759417|FG002|Safety Set|Protocol deviation|1|||
16073780|NCT00770965|38759418|FG003|Safety Set|Protocol deviation|0|||
16073781|NCT00770965|38759415|FG000|Excluded Set|Administrative problems|14|||
16073782|NCT00770965|38759416|FG001|Excluded Set|Administrative problems|12|||
16073783|NCT00770965|38759417|FG002|Excluded Set|Administrative problems|12|||
16073784|NCT00770965|38759418|FG003|Excluded Set|Administrative problems|10|||
16073785|NCT00770965|38759415|FG000|Excluded Set|Withdrawal by Subject|1|||
16073786|NCT00770965|38759416|FG001|Excluded Set|Withdrawal by Subject|1|||
16073787|NCT00770965|38759417|FG002|Excluded Set|Withdrawal by Subject|2|||
16073788|NCT00770965|38759418|FG003|Excluded Set|Withdrawal by Subject|3|||
16073789|NCT04581824|38759430|FG000|Overall Study|Ongoing|75|||
16073790|NCT04581824|38759431|FG001|Overall Study|Ongoing|69|||
16073791|NCT04581824|38759430|FG000|Overall Study|Withdrawal by Subject|3|||
16073792|NCT04581824|38759431|FG001|Overall Study|Withdrawal by Subject|5|||
16073793|NCT04581824|38759430|FG000|Overall Study|Lost to Follow-up|1|||
16073794|NCT04581824|38759431|FG001|Overall Study|Lost to Follow-up|0|||
16073795|NCT00606580|38759432|FG000|Overall Study|Lost to Follow-up|1|||
16073796|NCT00606580|38759433|FG001|Overall Study|Lost to Follow-up|1|||
16073797|NCT00606580|38759434|FG002|Overall Study|Lost to Follow-up|4|||
16073798|NCT00606580|38759432|FG000|Overall Study|Clinical failures|1|||
16073799|NCT00606580|38759433|FG001|Overall Study|Clinical failures|0|||
16073800|NCT00606580|38759434|FG002|Overall Study|Clinical failures|12|||
16073801|NCT00606580|38759432|FG000|Overall Study|Withdrawal by investigator|0|||
16073802|NCT00606580|38759433|FG001|Overall Study|Withdrawal by investigator|1|||
16073803|NCT00606580|38759434|FG002|Overall Study|Withdrawal by investigator|6|||
16073804|NCT00606580|38759432|FG000|Overall Study|Withdrawal by Subject|0|||
16073805|NCT00606580|38759433|FG001|Overall Study|Withdrawal by Subject|1|||
16073806|NCT00606580|38759434|FG002|Overall Study|Withdrawal by Subject|0|||
16073807|NCT02596035|38759435|FG000|Overall Study|Disease Progression|64|||
16073808|NCT02596035|38759436|FG001|Overall Study|Disease Progression|32|||
16073809|NCT02596035|38759437|FG002|Overall Study|Disease Progression|1|||
16073810|NCT02596035|38759435|FG000|Overall Study|study drug toxicity|12|||
16073811|NCT02596035|38759436|FG001|Overall Study|study drug toxicity|3|||
16073812|NCT02596035|38759437|FG002|Overall Study|study drug toxicity|0|||
16073813|NCT02596035|38759435|FG000|Overall Study|AE unrelated to study drug|5|||
16073814|NCT02596035|38759436|FG001|Overall Study|AE unrelated to study drug|2|||
16073815|NCT02596035|38759437|FG002|Overall Study|AE unrelated to study drug|0|||
16073816|NCT02596035|38759435|FG000|Overall Study|participant request to discontinue study treatment|2|||
16073817|NCT02596035|38759436|FG001|Overall Study|participant request to discontinue study treatment|0|||
16073818|NCT02596035|38759437|FG002|Overall Study|participant request to discontinue study treatment|0|||
16073819|NCT02596035|38759435|FG000|Overall Study|participant withdrew consent|2|||
16073820|NCT02596035|38759436|FG001|Overall Study|participant withdrew consent|2|||
16073821|NCT02596035|38759437|FG002|Overall Study|participant withdrew consent|0|||
16073822|NCT02596035|38759435|FG000|Overall Study|Poor/Non Comlpiance|0|||
16073823|NCT02596035|38759436|FG001|Overall Study|Poor/Non Comlpiance|1|||
16073824|NCT02596035|38759437|FG002|Overall Study|Poor/Non Comlpiance|0|||
16073825|NCT02596035|38759435|FG000|Overall Study|participant no longer meets study criteria|1|||
16073826|NCT02596035|38759436|FG001|Overall Study|participant no longer meets study criteria|0|||
16073827|NCT02596035|38759437|FG002|Overall Study|participant no longer meets study criteria|0|||
16073828|NCT02596035|38759435|FG000|Overall Study|other reasons|11|||
16073829|NCT02596035|38759436|FG001|Overall Study|other reasons|4|||
16073830|NCT02596035|38759437|FG002|Overall Study|other reasons|0|||
16172258|NCT01324830|39107363|FG001|Overall Study|Reason not mentioned above|0|||
16172259|NCT01324830|39107364|FG002|Overall Study|Reason not mentioned above|0|||
16172260|NCT01324830|39107365|FG003|Overall Study|Reason not mentioned above|0|||
16172261|NCT01324830|39107366|FG004|Overall Study|Reason not mentioned above|0|||
16172262|NCT01324830|39107367|FG005|Overall Study|Reason not mentioned above|0|||
16172263|NCT01324830|39107368|FG006|Overall Study|Reason not mentioned above|0|||
16172264|NCT01324830|39107369|FG007|Overall Study|Reason not mentioned above|0|||
16172265|NCT01324830|39107370|FG008|Overall Study|Reason not mentioned above|0|||
16172266|NCT01324830|39107371|FG009|Overall Study|Reason not mentioned above|0|||
16172267|NCT01324830|39107372|FG010|Overall Study|Reason not mentioned above|0|||
16172268|NCT01324830|39107373|FG011|Overall Study|Reason not mentioned above|0|||
16172269|NCT01324830|39107374|FG012|Overall Study|Reason not mentioned above|0|||
16172270|NCT01324830|39107375|FG013|Overall Study|Reason not mentioned above|0|||
16172271|NCT01324830|39107376|FG014|Overall Study|Reason not mentioned above|0|||
16172272|NCT01324830|39107377|FG015|Overall Study|Reason not mentioned above|0|||
16172273|NCT01324830|39107378|FG016|Overall Study|Reason not mentioned above|0|||
16172274|NCT01324830|39107379|FG017|Overall Study|Reason not mentioned above|1|||
16172275|NCT01324830|39107380|FG018|Overall Study|Reason not mentioned above|0|||
16172276|NCT01324830|39107362|FG000|Overall Study|Adverse Event, serious fatal|0|||
16172277|NCT01324830|39107363|FG001|Overall Study|Adverse Event, serious fatal|1|||
16172278|NCT01324830|39107364|FG002|Overall Study|Adverse Event, serious fatal|0|||
16172279|NCT01324830|39107365|FG003|Overall Study|Adverse Event, serious fatal|0|||
16172280|NCT01324830|39107366|FG004|Overall Study|Adverse Event, serious fatal|0|||
16172281|NCT01324830|39107367|FG005|Overall Study|Adverse Event, serious fatal|0|||
16172282|NCT01324830|39107368|FG006|Overall Study|Adverse Event, serious fatal|0|||
16172283|NCT01324830|39107369|FG007|Overall Study|Adverse Event, serious fatal|0|||
16172284|NCT01324830|39107370|FG008|Overall Study|Adverse Event, serious fatal|0|||
16172285|NCT01324830|39107371|FG009|Overall Study|Adverse Event, serious fatal|0|||
16172286|NCT01324830|39107372|FG010|Overall Study|Adverse Event, serious fatal|0|||
16172287|NCT01324830|39107373|FG011|Overall Study|Adverse Event, serious fatal|0|||
16172288|NCT01324830|39107374|FG012|Overall Study|Adverse Event, serious fatal|0|||
16172289|NCT01324830|39107375|FG013|Overall Study|Adverse Event, serious fatal|0|||
16172290|NCT01324830|39107376|FG014|Overall Study|Adverse Event, serious fatal|0|||
16172291|NCT01324830|39107377|FG015|Overall Study|Adverse Event, serious fatal|0|||
16172292|NCT01324830|39107378|FG016|Overall Study|Adverse Event, serious fatal|0|||
16172293|NCT01324830|39107379|FG017|Overall Study|Adverse Event, serious fatal|0|||
16172294|NCT01324830|39107380|FG018|Overall Study|Adverse Event, serious fatal|0|||
16172295|NCT01324830|39107362|FG000|Overall Study|Adverse Event, non-fatal|0|||
16172296|NCT01324830|39107363|FG001|Overall Study|Adverse Event, non-fatal|0|||
16172297|NCT01324830|39107364|FG002|Overall Study|Adverse Event, non-fatal|0|||
16172298|NCT01324830|39107365|FG003|Overall Study|Adverse Event, non-fatal|0|||
16172299|NCT01324830|39107366|FG004|Overall Study|Adverse Event, non-fatal|0|||
16172300|NCT01324830|39107367|FG005|Overall Study|Adverse Event, non-fatal|0|||
16172301|NCT01324830|39107368|FG006|Overall Study|Adverse Event, non-fatal|0|||
16172302|NCT01324830|39107369|FG007|Overall Study|Adverse Event, non-fatal|0|||
16172303|NCT01324830|39107370|FG008|Overall Study|Adverse Event, non-fatal|2|||
16172304|NCT01324830|39107371|FG009|Overall Study|Adverse Event, non-fatal|0|||
16172305|NCT01324830|39107372|FG010|Overall Study|Adverse Event, non-fatal|1|||
16172306|NCT01324830|39107373|FG011|Overall Study|Adverse Event, non-fatal|0|||
16172307|NCT01324830|39107374|FG012|Overall Study|Adverse Event, non-fatal|0|||
16172308|NCT01324830|39107375|FG013|Overall Study|Adverse Event, non-fatal|0|||
16172309|NCT01324830|39107376|FG014|Overall Study|Adverse Event, non-fatal|0|||
16172310|NCT01324830|39107377|FG015|Overall Study|Adverse Event, non-fatal|0|||
16172311|NCT01324830|39107378|FG016|Overall Study|Adverse Event, non-fatal|0|||
16172312|NCT01324830|39107379|FG017|Overall Study|Adverse Event, non-fatal|1|||
16172313|NCT01324830|39107380|FG018|Overall Study|Adverse Event, non-fatal|0|||
16172314|NCT01324830|39107362|FG000|Overall Study|Withdrawal by Subject|0|||
16172315|NCT01324830|39107363|FG001|Overall Study|Withdrawal by Subject|0|||
16172316|NCT01324830|39107364|FG002|Overall Study|Withdrawal by Subject|0|||
16172317|NCT01324830|39107365|FG003|Overall Study|Withdrawal by Subject|0|||
16172318|NCT01324830|39107366|FG004|Overall Study|Withdrawal by Subject|0|||
16172319|NCT01324830|39107367|FG005|Overall Study|Withdrawal by Subject|1|||
16172320|NCT01324830|39107368|FG006|Overall Study|Withdrawal by Subject|0|||
16172321|NCT01324830|39107369|FG007|Overall Study|Withdrawal by Subject|0|||
16172322|NCT01324830|39107370|FG008|Overall Study|Withdrawal by Subject|0|||
16172323|NCT01324830|39107371|FG009|Overall Study|Withdrawal by Subject|0|||
16172324|NCT01324830|39107372|FG010|Overall Study|Withdrawal by Subject|1|||
16172325|NCT01324830|39107373|FG011|Overall Study|Withdrawal by Subject|0|||
16172326|NCT01324830|39107374|FG012|Overall Study|Withdrawal by Subject|0|||
16172327|NCT01324830|39107375|FG013|Overall Study|Withdrawal by Subject|0|||
16172328|NCT01324830|39107376|FG014|Overall Study|Withdrawal by Subject|0|||
16172329|NCT01324830|39107377|FG015|Overall Study|Withdrawal by Subject|0|||
16172330|NCT01324830|39107378|FG016|Overall Study|Withdrawal by Subject|0|||
16172331|NCT01324830|39107379|FG017|Overall Study|Withdrawal by Subject|0|||
16172332|NCT01324830|39107380|FG018|Overall Study|Withdrawal by Subject|1|||
16172333|NCT01285349|39107384|FG000|Overall Study|Lost to Follow-up|27|||
16172334|NCT01285349|39107385|FG001|Overall Study|Lost to Follow-up|20|||
16172335|NCT01285349|39107386|FG002|Overall Study|Lost to Follow-up|27|||
16172336|NCT02209506|39107387|FG000|Overall Study|Withdrawal by Subject|0|||
16172337|NCT02209506|39107388|FG001|Overall Study|Withdrawal by Subject|0|||
16172338|NCT02209506|39107389|FG002|Overall Study|Withdrawal by Subject|0|||
16172339|NCT02209506|39107390|FG003|Overall Study|Withdrawal by Subject|0|||
16172340|NCT02209506|39107391|FG004|Overall Study|Withdrawal by Subject|1|||
16172341|NCT03367871|39107392|FG000|Overall Study|Lost to Follow-up|1|||
16172342|NCT01859403|39107393|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
16172343|NCT01859403|39107394|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
16172344|NCT01859403|39107393|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
16172345|NCT01859403|39107394|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
16172346|NCT01859403|39107393|FG000|Primary Endpoint Measure|Physician Decision|0|||
16172347|NCT01859403|39107394|FG001|Primary Endpoint Measure|Physician Decision|1|||
16172348|NCT01859403|39107393|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
16172349|NCT01859403|39107394|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
16172350|NCT03617705|39107395|FG000|Overall Study|Withdrawal by Subject|2|||
16172351|NCT03617705|39107395|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
16172352|NCT03617705|39107395|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
16172353|NCT01384292|39107396|FG000|Part B|Severe non-compliance to protocol|1|||
16172354|NCT01384292|39107397|FG001|Part B|Severe non-compliance to protocol|0|||
16172355|NCT01384292|39107398|FG002|Part B|Severe non-compliance to protocol|0|||
16172356|NCT01111604|39107399|FG000|Overall Study|Lost to Follow-up|0|||
16172357|NCT01111604|39107400|FG001|Overall Study|Lost to Follow-up|0|||
16172358|NCT01111604|39107401|FG002|Overall Study|Lost to Follow-up|1|||
16172359|NCT01111604|39107399|FG000|Overall Study|Withdrew Consent|3|||
16172360|NCT01111604|39107400|FG001|Overall Study|Withdrew Consent|0|||
16172361|NCT01111604|39107401|FG002|Overall Study|Withdrew Consent|2|||
16172362|NCT01111604|39107399|FG000|Overall Study|Withdrawal by Subject|2|||
16172363|NCT01111604|39107400|FG001|Overall Study|Withdrawal by Subject|0|||
16172364|NCT01111604|39107401|FG002|Overall Study|Withdrawal by Subject|0|||
16172365|NCT01111604|39107399|FG000|Overall Study|Death|1|||
16172366|NCT01111604|39107400|FG001|Overall Study|Death|0|||
16172367|NCT01111604|39107401|FG002|Overall Study|Death|0|||
16172368|NCT01111604|39107399|FG000|Overall Study|Met Exclusion Criteria|2|||
16172369|NCT01111604|39107400|FG001|Overall Study|Met Exclusion Criteria|0|||
16172370|NCT01111604|39107401|FG002|Overall Study|Met Exclusion Criteria|0|||
16172371|NCT01562028|39107404|FG000|Overall Study|Withdrawal by Subject|1|||
16172372|NCT01562028|39107405|FG001|Overall Study|Withdrawal by Subject|1|||
16172373|NCT01562028|39107404|FG000|Overall Study|Lost to Follow-up|2|||
16172374|NCT01562028|39107405|FG001|Overall Study|Lost to Follow-up|1|||
16172375|NCT02320487|39107407|FG000|Overall Study|Reason not Specified|1|||
16172376|NCT02320487|39107407|FG000|Overall Study|Physician Decision|5|||
16172377|NCT02320487|39107407|FG000|Overall Study|Withdrawal by Subject|1|||
16172378|NCT02320487|39107407|FG000|Overall Study|Death|3|||
16172379|NCT02320487|39107407|FG000|Overall Study|Adverse Event|11|||
16172380|NCT02115308|39107408|FG000|Overall Study|Safety Screening|2|||
16172381|NCT02115308|39107409|FG001|Overall Study|Safety Screening|2|||
16172382|NCT00365989|39107410|FG000|Overall Study|Withdrawal by Subject|1|||
16172383|NCT00365989|39107410|FG000|Overall Study|Non-compliance|1|||
16172384|NCT02629159|39107411|FG000|Overall Study|Adverse Event|17|||
16172385|NCT02629159|39107412|FG001|Overall Study|Adverse Event|20|||
16172386|NCT02629159|39107413|FG002|Overall Study|Adverse Event|22|||
16172387|NCT02629159|39107411|FG000|Overall Study|Withdrawal by Subject|22|||
16172388|NCT02629159|39107412|FG001|Overall Study|Withdrawal by Subject|11|||
16172389|NCT02629159|39107413|FG002|Overall Study|Withdrawal by Subject|15|||
16172390|NCT02629159|39107411|FG000|Overall Study|Lost to Follow-up|7|||
16172391|NCT02629159|39107412|FG001|Overall Study|Lost to Follow-up|4|||
16172392|NCT02629159|39107413|FG002|Overall Study|Lost to Follow-up|5|||
16172393|NCT02629159|39107411|FG000|Overall Study|Lack of Efficacy|4|||
16172394|NCT02629159|39107412|FG001|Overall Study|Lack of Efficacy|0|||
16172395|NCT02629159|39107413|FG002|Overall Study|Lack of Efficacy|1|||
16172396|NCT02629159|39107411|FG000|Overall Study|Other|6|||
16172397|NCT02629159|39107412|FG001|Overall Study|Other|4|||
16172398|NCT02629159|39107413|FG002|Overall Study|Other|8|||
16172399|NCT03440944|39107416|FG000|Overall Study|Physician Decision|1|||
16172400|NCT03440944|39107417|FG001|Overall Study|Physician Decision|0|||
16172401|NCT03440944|39107416|FG000|Overall Study|No Acceptable Vasculature|0|||
16172402|NCT03440944|39107417|FG001|Overall Study|No Acceptable Vasculature|1|||
16172403|NCT01929083|39107418|FG000|Intervention 1|Lost to Follow-up|2|||
16172404|NCT01929083|39107419|FG001|Intervention 1|Lost to Follow-up|0|||
16172405|NCT01929083|39107418|FG000|Intervention 1|Nonadherent to study medications|1|||
16172406|NCT01929083|39107419|FG001|Intervention 1|Nonadherent to study medications|0|||
16172407|NCT01929083|39107418|FG000|Intervention 2|Adverse Event|0|||
16172408|NCT01929083|39107419|FG001|Intervention 2|Adverse Event|1|||
16172409|NCT03446456|39107420|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
16172410|NCT03446456|39107421|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
16172411|NCT03446456|39107420|FG000|Overall Study|Lost to Follow-up|1|||
16172412|NCT03446456|39107421|FG001|Overall Study|Lost to Follow-up|3|||
16172413|NCT03446456|39107420|FG000|Overall Study|Participant failed the toxicology test|1|||
16172414|NCT03446456|39107421|FG001|Overall Study|Participant failed the toxicology test|0|||
16172415|NCT03446456|39107420|FG000|Overall Study|Break down of the experimental equipment|1|||
16172416|NCT03446456|39107421|FG001|Overall Study|Break down of the experimental equipment|0|||
16172417|NCT00432237|39107422|FG000|Overall Study|Adverse Event|0|||
16172418|NCT00432237|39107423|FG001|Overall Study|Adverse Event|0|||
16172419|NCT00432237|39107424|FG002|Overall Study|Adverse Event|0|||
16172420|NCT00432237|39107425|FG003|Overall Study|Adverse Event|1|||
16172421|NCT00432237|39107422|FG000|Overall Study|Lack of Efficacy|0|||
16172422|NCT00432237|39107423|FG001|Overall Study|Lack of Efficacy|0|||
16172423|NCT00432237|39107424|FG002|Overall Study|Lack of Efficacy|0|||
16172424|NCT00432237|39107425|FG003|Overall Study|Lack of Efficacy|1|||
16172425|NCT00432237|39107422|FG000|Overall Study|Lost to Follow-up|10|||
16172426|NCT00432237|39107423|FG001|Overall Study|Lost to Follow-up|10|||
16172427|NCT00432237|39107424|FG002|Overall Study|Lost to Follow-up|18|||
16172428|NCT00432237|39107425|FG003|Overall Study|Lost to Follow-up|18|||
16172429|NCT00432237|39107422|FG000|Overall Study|Physician Decision|1|||
16172430|NCT00432237|39107423|FG001|Overall Study|Physician Decision|3|||
16172431|NCT00432237|39107424|FG002|Overall Study|Physician Decision|2|||
16172432|NCT00432237|39107425|FG003|Overall Study|Physician Decision|1|||
16172433|NCT00432237|39107422|FG000|Overall Study|Pregnancy|0|||
16172434|NCT00432237|39107423|FG001|Overall Study|Pregnancy|1|||
16172435|NCT00432237|39107424|FG002|Overall Study|Pregnancy|0|||
16172436|NCT00432237|39107425|FG003|Overall Study|Pregnancy|0|||
16172437|NCT00432237|39107422|FG000|Overall Study|Protocol Violation|13|||
16172438|NCT00432237|39107423|FG001|Overall Study|Protocol Violation|10|||
16172439|NCT00432237|39107424|FG002|Overall Study|Protocol Violation|11|||
16172440|NCT00432237|39107425|FG003|Overall Study|Protocol Violation|8|||
16172441|NCT00432237|39107422|FG000|Overall Study|Withdrawal by Subject|5|||
16172442|NCT00432237|39107423|FG001|Overall Study|Withdrawal by Subject|6|||
16172443|NCT00432237|39107424|FG002|Overall Study|Withdrawal by Subject|9|||
16172444|NCT00432237|39107425|FG003|Overall Study|Withdrawal by Subject|11|||
16172445|NCT00432237|39107422|FG000|Overall Study|Lack of Qualifying Event|38|||
16172446|NCT00432237|39107423|FG001|Overall Study|Lack of Qualifying Event|71|||
16172447|NCT00432237|39107424|FG002|Overall Study|Lack of Qualifying Event|69|||
16172448|NCT00432237|39107425|FG003|Overall Study|Lack of Qualifying Event|84|||
16172449|NCT03665038|39107426|FG000|Overall Study|Lost to Follow-up|0|||
16172450|NCT03665038|39107427|FG001|Overall Study|Lost to Follow-up|0|||
16172451|NCT03665038|39107428|FG002|Overall Study|Lost to Follow-up|1|||
16172452|NCT00792298|39107429|FG000|Treatment Period 1|Adverse Event|0|||
16172453|NCT00792298|39107430|FG001|Treatment Period 1|Adverse Event|1|||
16172454|NCT00792298|39107431|FG002|Treatment Period 1|Adverse Event|0|||
16172455|NCT00792298|39107432|FG003|Treatment Period 1|Adverse Event|1|||
16172456|NCT00792298|39107433|FG004|Treatment Period 1|Adverse Event|0|||
16172457|NCT00792298|39107434|FG005|Treatment Period 1|Adverse Event|1|||
16172458|NCT00792298|39107435|FG006|Treatment Period 1|Adverse Event|1|||
16172459|NCT00792298|39107436|FG007|Treatment Period 1|Adverse Event|0|||
16172460|NCT00792298|39107429|FG000|Treatment Period 1|Lack of Efficacy|0|||
16172461|NCT00792298|39107430|FG001|Treatment Period 1|Lack of Efficacy|0|||
16172462|NCT00792298|39107431|FG002|Treatment Period 1|Lack of Efficacy|1|||
16172463|NCT00792298|39107432|FG003|Treatment Period 1|Lack of Efficacy|0|||
16172464|NCT00792298|39107433|FG004|Treatment Period 1|Lack of Efficacy|0|||
16172465|NCT00792298|39107434|FG005|Treatment Period 1|Lack of Efficacy|0|||
16172466|NCT00792298|39107435|FG006|Treatment Period 1|Lack of Efficacy|0|||
16172467|NCT00792298|39107436|FG007|Treatment Period 1|Lack of Efficacy|0|||
16172468|NCT00792298|39107429|FG000|Treatment Period 1|Withdrawal by Subject|1|||
16172469|NCT00792298|39107430|FG001|Treatment Period 1|Withdrawal by Subject|0|||
16172470|NCT00792298|39107431|FG002|Treatment Period 1|Withdrawal by Subject|1|||
16172471|NCT00792298|39107432|FG003|Treatment Period 1|Withdrawal by Subject|2|||
16172472|NCT00792298|39107433|FG004|Treatment Period 1|Withdrawal by Subject|0|||
16172473|NCT00792298|39107434|FG005|Treatment Period 1|Withdrawal by Subject|2|||
16172474|NCT00792298|39107435|FG006|Treatment Period 1|Withdrawal by Subject|1|||
16172475|NCT00792298|39107436|FG007|Treatment Period 1|Withdrawal by Subject|0|||
16172476|NCT00792298|39107429|FG000|Treatment Period 1|Lost to Follow-up|0|||
16172477|NCT00792298|39107430|FG001|Treatment Period 1|Lost to Follow-up|0|||
16172478|NCT00792298|39107431|FG002|Treatment Period 1|Lost to Follow-up|0|||
16172479|NCT00792298|39107432|FG003|Treatment Period 1|Lost to Follow-up|0|||
16172480|NCT00792298|39107433|FG004|Treatment Period 1|Lost to Follow-up|0|||
16172481|NCT00792298|39107434|FG005|Treatment Period 1|Lost to Follow-up|0|||
16172482|NCT00792298|39107435|FG006|Treatment Period 1|Lost to Follow-up|1|||
16172483|NCT00792298|39107436|FG007|Treatment Period 1|Lost to Follow-up|0|||
16172484|NCT00792298|39107429|FG000|Treatment Period 1|Physician Decision|0|||
16172485|NCT00792298|39107430|FG001|Treatment Period 1|Physician Decision|0|||
16172486|NCT00792298|39107431|FG002|Treatment Period 1|Physician Decision|0|||
16172487|NCT00792298|39107432|FG003|Treatment Period 1|Physician Decision|1|||
16172488|NCT00792298|39107433|FG004|Treatment Period 1|Physician Decision|0|||
16172489|NCT00792298|39107434|FG005|Treatment Period 1|Physician Decision|0|||
16172490|NCT00792298|39107435|FG006|Treatment Period 1|Physician Decision|1|||
16172491|NCT00792298|39107436|FG007|Treatment Period 1|Physician Decision|0|||
16172492|NCT00792298|39107429|FG000|Treatment Period 1|Protocol Violation|0|||
16172493|NCT00792298|39107430|FG001|Treatment Period 1|Protocol Violation|0|||
16172494|NCT00792298|39107431|FG002|Treatment Period 1|Protocol Violation|0|||
16172495|NCT00792298|39107432|FG003|Treatment Period 1|Protocol Violation|0|||
16172496|NCT00792298|39107433|FG004|Treatment Period 1|Protocol Violation|0|||
16172497|NCT00792298|39107434|FG005|Treatment Period 1|Protocol Violation|0|||
16172498|NCT00792298|39107435|FG006|Treatment Period 1|Protocol Violation|0|||
16172499|NCT00792298|39107436|FG007|Treatment Period 1|Protocol Violation|1|||
16172500|NCT00792298|39107429|FG000|Washout|Adverse Event|0|||
16172501|NCT00792298|39107430|FG001|Washout|Adverse Event|0|||
16172502|NCT00792298|39107431|FG002|Washout|Adverse Event|0|||
16172503|NCT00792298|39107432|FG003|Washout|Adverse Event|0|||
16172504|NCT00792298|39107433|FG004|Washout|Adverse Event|0|||
16172505|NCT00792298|39107434|FG005|Washout|Adverse Event|1|||
16172506|NCT00792298|39107435|FG006|Washout|Adverse Event|0|||
16172507|NCT00792298|39107436|FG007|Washout|Adverse Event|0|||
16172508|NCT00792298|39107429|FG000|Washout|Withdrawal by Subject|0|||
16172509|NCT00792298|39107430|FG001|Washout|Withdrawal by Subject|0|||
16172510|NCT00792298|39107431|FG002|Washout|Withdrawal by Subject|1|||
16172511|NCT00792298|39107432|FG003|Washout|Withdrawal by Subject|0|||
16172512|NCT00792298|39107433|FG004|Washout|Withdrawal by Subject|0|||
16172513|NCT00792298|39107434|FG005|Washout|Withdrawal by Subject|1|||
16172514|NCT00792298|39107435|FG006|Washout|Withdrawal by Subject|0|||
16172515|NCT00792298|39107436|FG007|Washout|Withdrawal by Subject|0|||
16172516|NCT00792298|39107429|FG000|Treatment Period 2|Lack of Efficacy|0|||
16172517|NCT00792298|39107430|FG001|Treatment Period 2|Lack of Efficacy|0|||
16172518|NCT00792298|39107431|FG002|Treatment Period 2|Lack of Efficacy|0|||
16172519|NCT00792298|39107432|FG003|Treatment Period 2|Lack of Efficacy|0|||
16172520|NCT00792298|39107433|FG004|Treatment Period 2|Lack of Efficacy|1|||
16172521|NCT00792298|39107434|FG005|Treatment Period 2|Lack of Efficacy|0|||
16172522|NCT00792298|39107435|FG006|Treatment Period 2|Lack of Efficacy|0|||
16172523|NCT00792298|39107436|FG007|Treatment Period 2|Lack of Efficacy|0|||
16172524|NCT00792298|39107429|FG000|Treatment Period 2|Physician Decision|0|||
16172525|NCT00792298|39107430|FG001|Treatment Period 2|Physician Decision|0|||
16172526|NCT00792298|39107431|FG002|Treatment Period 2|Physician Decision|0|||
16172527|NCT00792298|39107432|FG003|Treatment Period 2|Physician Decision|0|||
16172528|NCT00792298|39107433|FG004|Treatment Period 2|Physician Decision|0|||
16172529|NCT00792298|39107434|FG005|Treatment Period 2|Physician Decision|0|||
16172530|NCT00792298|39107435|FG006|Treatment Period 2|Physician Decision|1|||
16172531|NCT00792298|39107436|FG007|Treatment Period 2|Physician Decision|0|||
16172532|NCT00792298|39107429|FG000|Treatment Period 2|Pregnancy|0|||
16172533|NCT00792298|39107430|FG001|Treatment Period 2|Pregnancy|0|||
16172534|NCT00792298|39107431|FG002|Treatment Period 2|Pregnancy|1|||
16172535|NCT00792298|39107432|FG003|Treatment Period 2|Pregnancy|0|||
16172536|NCT00792298|39107433|FG004|Treatment Period 2|Pregnancy|0|||
16172537|NCT00792298|39107434|FG005|Treatment Period 2|Pregnancy|0|||
16172538|NCT00792298|39107435|FG006|Treatment Period 2|Pregnancy|0|||
16172539|NCT00792298|39107436|FG007|Treatment Period 2|Pregnancy|0|||
16172540|NCT00792298|39107429|FG000|Treatment Period 2|Withdrawal by Subject|1|||
16172541|NCT00792298|39107430|FG001|Treatment Period 2|Withdrawal by Subject|1|||
16172542|NCT00792298|39107431|FG002|Treatment Period 2|Withdrawal by Subject|0|||
16172543|NCT00792298|39107432|FG003|Treatment Period 2|Withdrawal by Subject|2|||
16172544|NCT00792298|39107433|FG004|Treatment Period 2|Withdrawal by Subject|1|||
16172545|NCT00792298|39107434|FG005|Treatment Period 2|Withdrawal by Subject|0|||
16172546|NCT00792298|39107435|FG006|Treatment Period 2|Withdrawal by Subject|0|||
16172547|NCT00792298|39107436|FG007|Treatment Period 2|Withdrawal by Subject|2|||
16172548|NCT01950819|39107437|FG000|Overall Study|Graft Loss|35|||
16172549|NCT01950819|39107438|FG001|Overall Study|Graft Loss|30|||
16172550|NCT01950819|39107437|FG000|Overall Study|Death|29|||
16172551|NCT01950819|39107438|FG001|Overall Study|Death|34|||
16172552|NCT01950819|39107437|FG000|Overall Study|Subject / Gardian decision|54|||
16172553|NCT01950819|39107438|FG001|Overall Study|Subject / Gardian decision|51|||
16172554|NCT01950819|39107437|FG000|Overall Study|technical problems|2|||
16172555|NCT01950819|39107438|FG001|Overall Study|technical problems|0|||
16172556|NCT01950819|39107437|FG000|Overall Study|Pregnancy|0|||
16172557|NCT01950819|39107438|FG001|Overall Study|Pregnancy|2|||
16172558|NCT01950819|39107437|FG000|Overall Study|Lost to Follow-up|9|||
16172559|NCT01950819|39107438|FG001|Overall Study|Lost to Follow-up|17|||
16172560|NCT00974220|39107439|FG000|Treatment Period 1|Adverse Event|2|||
16172561|NCT00974220|39107440|FG001|Treatment Period 1|Adverse Event|1|||
16172562|NCT00974220|39107439|FG000|Treatment Period 1|noncompliant subjects|0|||
16172563|NCT00974220|39107440|FG001|Treatment Period 1|noncompliant subjects|1|||
16172564|NCT04258579|39107442|FG000|Overall Study|Withdrawal by Subject|7|||
16172565|NCT04258579|39107442|FG000|Overall Study|Lost to Follow-up|3|||
16172566|NCT04258579|39107442|FG000|Overall Study|Protocol Violation|2|||
16172567|NCT04258579|39107442|FG000|Overall Study|Adverse Event|1|||
16172568|NCT01707030|39107443|FG000|Overall Study|Death|1|||
16172569|NCT01707030|39107444|FG001|Overall Study|Death|1|||
16172570|NCT01707030|39107443|FG000|Overall Study|Withdrawal by Subject|2|||
16172571|NCT01707030|39107444|FG001|Overall Study|Withdrawal by Subject|3|||
16172572|NCT01707030|39107443|FG000|Overall Study|Lost to Follow-up|8|||
16172573|NCT01707030|39107444|FG001|Overall Study|Lost to Follow-up|13|||
16172574|NCT01276288|39107445|FG000|Overall Study|Adverse Event|1|||
16172575|NCT01276288|39107446|FG001|Overall Study|Adverse Event|1|||
16172576|NCT01276288|39107447|FG002|Overall Study|Adverse Event|0|||
16172577|NCT01276288|39107448|FG003|Overall Study|Adverse Event|0|||
16172578|NCT01276288|39107445|FG000|Overall Study|not treated|1|||
16172579|NCT01276288|39107446|FG001|Overall Study|not treated|0|||
16172580|NCT01276288|39107447|FG002|Overall Study|not treated|0|||
16172581|NCT01276288|39107448|FG003|Overall Study|not treated|0|||
16172582|NCT00706628|39107449|FG000|Overall Study|Other Adverse Event|16|||
16172583|NCT00706628|39107450|FG001|Overall Study|Other Adverse Event|5|||
16172584|NCT00706628|39107451|FG002|Overall Study|Other Adverse Event|5|||
16172585|NCT00706628|39107452|FG003|Overall Study|Other Adverse Event|2|||
16172586|NCT00706628|39107449|FG000|Overall Study|Non compliant with protocol|0|||
16172587|NCT00706628|39107450|FG001|Overall Study|Non compliant with protocol|1|||
16172588|NCT00706628|39107451|FG002|Overall Study|Non compliant with protocol|0|||
16172589|NCT00706628|39107452|FG003|Overall Study|Non compliant with protocol|0|||
16172590|NCT00706628|39107449|FG000|Overall Study|Consent withdrawn|6|||
16172591|NCT00706628|39107450|FG001|Overall Study|Consent withdrawn|1|||
16172592|NCT00706628|39107451|FG002|Overall Study|Consent withdrawn|3|||
16172593|NCT00706628|39107452|FG003|Overall Study|Consent withdrawn|0|||
16172594|NCT00706628|39107449|FG000|Overall Study|Progressive disease|20|||
16172595|NCT00706628|39107450|FG001|Overall Study|Progressive disease|13|||
16172596|NCT00706628|39107451|FG002|Overall Study|Progressive disease|8|||
16172597|NCT00706628|39107452|FG003|Overall Study|Progressive disease|1|||
16172598|NCT00706628|39107449|FG000|Overall Study|Other than those stated above|4|||
16172599|NCT00706628|39107450|FG001|Overall Study|Other than those stated above|0|||
16172600|NCT00706628|39107451|FG002|Overall Study|Other than those stated above|0|||
16172601|NCT00706628|39107452|FG003|Overall Study|Other than those stated above|0|||
16172602|NCT00706628|39107449|FG000|Overall Study|Not treated|1|||
16172603|NCT00706628|39107450|FG001|Overall Study|Not treated|1|||
16172604|NCT00706628|39107451|FG002|Overall Study|Not treated|0|||
16172605|NCT00706628|39107452|FG003|Overall Study|Not treated|0|||
16172606|NCT01551745|39107453|FG000|Overall Study|Withdrawal by Subject|1|||
16172607|NCT01551745|39107453|FG000|Overall Study|Disease Progression|2|||
16172608|NCT02210780|39107456|FG000|Overall Study|Adverse Event|0|||
16172609|NCT02210780|39107457|FG001|Overall Study|Adverse Event|5|||
16172610|NCT02210780|39107456|FG000|Overall Study|Lost to Follow-up|2|||
16172611|NCT02210780|39107457|FG001|Overall Study|Lost to Follow-up|1|||
16172612|NCT02210780|39107456|FG000|Overall Study|Withdrawal by Subject|1|||
16172613|NCT02210780|39107457|FG001|Overall Study|Withdrawal by Subject|1|||
16172614|NCT02210780|39107456|FG000|Overall Study|Physician Decision|1|||
16172615|NCT02210780|39107457|FG001|Overall Study|Physician Decision|0|||
16172616|NCT02210780|39107456|FG000|Overall Study|Protocol Violation|1|||
16172617|NCT02210780|39107457|FG001|Overall Study|Protocol Violation|0|||
16172618|NCT02210780|39107456|FG000|Overall Study|Other than specified above|0|||
16172619|NCT02210780|39107457|FG001|Overall Study|Other than specified above|1|||
16172620|NCT00670007|39110946|FG000|Overall Study|Drug abuse|1|||
16172621|NCT00670007|39110946|FG000|Overall Study|Lung transplant|1|||
16172622|NCT00670007|39110946|FG000|Overall Study|Travel/Vacation|1|||
16172623|NCT00670007|39110946|FG000|Overall Study|Adverse event, serious fatal|1|||
16172624|NCT00670007|39110946|FG000|Overall Study|Adverse Event|1|||
16172625|NCT00670007|39110946|FG000|Overall Study|Withdrawal by Subject|4|||
16172626|NCT00609622|39110947|FG000|Overall Study|Adverse Event|14|||
16172627|NCT00609622|39110948|FG001|Overall Study|Adverse Event|10|||
16172628|NCT00609622|39110947|FG000|Overall Study|Withdrawal by Subject|4|||
16172629|NCT00609622|39110948|FG001|Overall Study|Withdrawal by Subject|20|||
16172630|NCT00609622|39110947|FG000|Overall Study|Death|1|||
16172631|NCT00609622|39110948|FG001|Overall Study|Death|4|||
16172632|NCT00609622|39110947|FG000|Overall Study|Protocol Violation|1|||
16172633|NCT00609622|39110948|FG001|Overall Study|Protocol Violation|1|||
16172634|NCT00609622|39110947|FG000|Overall Study|Objective progression or relapse|47|||
16172635|NCT00609622|39110948|FG001|Overall Study|Objective progression or relapse|41|||
16172636|NCT00609622|39110947|FG000|Overall Study|Study terminated by sponsor|16|||
16172637|NCT00609622|39110948|FG001|Overall Study|Study terminated by sponsor|3|||
16172638|NCT00609622|39110947|FG000|Overall Study|Other|7|||
16172639|NCT00609622|39110948|FG001|Overall Study|Other|14|||
16172640|NCT00609622|39110947|FG000|Overall Study|Global deterioration of health status|6|||
16172641|NCT00609622|39110948|FG001|Overall Study|Global deterioration of health status|2|||
16172642|NCT01990261|39110949|FG000|Overall Study|Death Before Treatment Start|2|||
16172643|NCT01990261|39110949|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
16172644|NCT01990261|39110949|FG000|Overall Study|Death From other Causes|1|||
16172645|NCT01990261|39110949|FG000|Overall Study|Disease Progression (PD)|8|||
16172646|NCT01990261|39110949|FG000|Overall Study|PD Before Treatment Start|1|||
16172647|NCT01990261|39110949|FG000|Overall Study|Dossier not Approved|1|||
16172648|NCT01990261|39110949|FG000|Overall Study|Lost to Follow-up|2|||
16172649|NCT00254566|39110950|FG000|Overall Study|Death|1|||
16172650|NCT00254566|39110951|FG001|Overall Study|Death|0|||
16172651|NCT00254566|39110950|FG000|Overall Study|Adverse Event|5|||
16172652|NCT00254566|39110951|FG001|Overall Study|Adverse Event|4|||
16172653|NCT00254566|39110950|FG000|Overall Study|Lack of Efficacy|12|||
16172654|NCT00254566|39110951|FG001|Overall Study|Lack of Efficacy|9|||
16172655|NCT00254566|39110950|FG000|Overall Study|Other|1|||
16172656|NCT00254566|39110951|FG001|Overall Study|Other|5|||
16172657|NCT00254566|39110950|FG000|Overall Study|Withdrawal by Subject|5|||
16172658|NCT00254566|39110951|FG001|Overall Study|Withdrawal by Subject|6|||
16172659|NCT00254566|39110950|FG000|Overall Study|Lost to Follow-up|7|||
16172660|NCT00254566|39110951|FG001|Overall Study|Lost to Follow-up|2|||
16172661|NCT00771472|39110956|FG000|Overall Study|Physician Decision|2|||
16172662|NCT00771472|39110957|FG001|Overall Study|Physician Decision|3|||
16172663|NCT00771472|39110956|FG000|Overall Study|Progressive Disease|3|||
16172664|NCT00771472|39110957|FG001|Overall Study|Progressive Disease|1|||
16172665|NCT00771472|39110956|FG000|Overall Study|Protocol Violation|1|||
16172666|NCT00771472|39110957|FG001|Overall Study|Protocol Violation|0|||
16172667|NCT04348851|39110961|FG000|Post-Test 1|Withdrawal by Subject|0|||
16172668|NCT04348851|39110962|FG001|Post-Test 1|Withdrawal by Subject|1|||
16172669|NCT04348851|39110963|FG002|Post-Test 1|Withdrawal by Subject|0|||
16172670|NCT04348851|39110964|FG003|Post-Test 1|Withdrawal by Subject|0|||
16172671|NCT04348851|39110961|FG000|Post-Test 1|Lost to Follow-up|0|||
16172672|NCT04348851|39110962|FG001|Post-Test 1|Lost to Follow-up|1|||
16172673|NCT04348851|39110963|FG002|Post-Test 1|Lost to Follow-up|0|||
16172674|NCT04348851|39110964|FG003|Post-Test 1|Lost to Follow-up|0|||
16172675|NCT04348851|39110961|FG000|Post-Test 2|Stroke survivor death|0|||
16172676|NCT04348851|39110962|FG001|Post-Test 2|Stroke survivor death|1|||
16172677|NCT04348851|39110963|FG002|Post-Test 2|Stroke survivor death|0|||
16172678|NCT04348851|39110964|FG003|Post-Test 2|Stroke survivor death|1|||
16172679|NCT02337387|39110966|FG000|Overall Study|Adverse Event|0|||
16172680|NCT02337387|39110967|FG001|Overall Study|Adverse Event|1|||
16172681|NCT02337387|39110968|FG002|Overall Study|Adverse Event|0|||
16172682|NCT02337387|39110969|FG003|Overall Study|Adverse Event|0|||
16172683|NCT02337387|39110966|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
16172684|NCT02337387|39110967|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
16172685|NCT02337387|39110968|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
16172686|NCT02337387|39110969|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
16172687|NCT00191854|39110970|FG000|Overall Study|Death|26|||
16172688|NCT00191854|39110971|FG001|Overall Study|Death|23|||
16172689|NCT00191854|39110972|FG002|Overall Study|Death|29|||
16172690|NCT00191854|39110970|FG000|Overall Study|Lost to Follow-up|7|||
16172691|NCT00191854|39110971|FG001|Overall Study|Lost to Follow-up|5|||
16172692|NCT00191854|39110972|FG002|Overall Study|Lost to Follow-up|5|||
16172693|NCT00191854|39110970|FG000|Overall Study|Withdrawal by Subject|4|||
16172694|NCT00191854|39110971|FG001|Overall Study|Withdrawal by Subject|2|||
16172695|NCT00191854|39110972|FG002|Overall Study|Withdrawal by Subject|3|||
16172696|NCT00191854|39110970|FG000|Overall Study|Sponsor Decision|0|||
16172697|NCT00191854|39110971|FG001|Overall Study|Sponsor Decision|0|||
16172698|NCT00191854|39110972|FG002|Overall Study|Sponsor Decision|1|||
16172699|NCT00191854|39110970|FG000|Overall Study|Screen Failure|0|||
16172700|NCT00191854|39110971|FG001|Overall Study|Screen Failure|0|||
16172701|NCT00191854|39110972|FG002|Overall Study|Screen Failure|1|||
16172702|NCT01705691|39110973|FG000|Overall Study|Death|1|||
16172703|NCT01705691|39110974|FG001|Overall Study|Death|2|||
16172704|NCT01705691|39110973|FG000|Overall Study|Withdrawal by Subject|1|||
16172705|NCT01705691|39110974|FG001|Overall Study|Withdrawal by Subject|2|||
16172706|NCT01705691|39110973|FG000|Overall Study|Lost to Follow-up|1|||
16172707|NCT01705691|39110974|FG001|Overall Study|Lost to Follow-up|1|||
16172708|NCT01705691|39110973|FG000|Overall Study|Other|0|||
16172709|NCT01705691|39110974|FG001|Overall Study|Other|1|||
16172710|NCT00749203|39110975|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
16172711|NCT00749203|39110976|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
16172712|NCT00749203|39110975|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
16172713|NCT00749203|39110976|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
16172714|NCT00749203|39110975|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
16172715|NCT00749203|39110976|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
16172716|NCT00749203|39110975|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
16172717|NCT00749203|39110976|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
16172718|NCT00749203|39110975|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
16172719|NCT00749203|39110976|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
16172720|NCT00749203|39110975|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
16172721|NCT00749203|39110976|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
16172722|NCT04325503|39110977|FG000|Overall Study|Withdrawal by Subject|1|||
16172723|NCT04325503|39110977|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
16172724|NCT00502840|39110979|FG000|Overall Study|Adverse Event|5|||
16172725|NCT00502840|39110979|FG000|Overall Study|Additional or changed therapy|48|||
16172726|NCT00502840|39110979|FG000|Overall Study|Lack of Efficacy|11|||
16172727|NCT00502840|39110979|FG000|Overall Study|Protocol Violation|4|||
16172728|NCT00502840|39110979|FG000|Overall Study|Withdrawal by Subject|5|||
16172729|NCT00502840|39110979|FG000|Overall Study|Lost to Follow-up|6|||
16172730|NCT00502840|39110979|FG000|Overall Study|Administrative problems|1|||
16172731|NCT00502840|39110979|FG000|Overall Study|Other|20|||
16172732|NCT03377634|39110980|FG000|Study Period|Adverse Event|1|||
16172733|NCT03377634|39110981|FG001|Study Period|Adverse Event|0|||
16172734|NCT03377634|39110980|FG000|Study Period|Withdrawal by Subject|1|||
16172735|NCT03377634|39110981|FG001|Study Period|Withdrawal by Subject|0|||
16172736|NCT02500537|39110982|FG000|Overall Study|Death|2|||
16172737|NCT02500537|39110983|FG001|Overall Study|Death|0|||
16172738|NCT02500537|39110982|FG000|Overall Study|Lost to Follow-up|0|||
16172739|NCT02500537|39110983|FG001|Overall Study|Lost to Follow-up|1|||
16172740|NCT02500537|39110982|FG000|Overall Study|Withdrawal by Subject|1|||
16172741|NCT02500537|39110983|FG001|Overall Study|Withdrawal by Subject|0|||
16172742|NCT04525703|39110984|FG000|Overall Study|Lost to Follow-up|6|||
16172743|NCT04525703|39110985|FG001|Overall Study|Lost to Follow-up|15|||
16172744|NCT04525703|39110986|FG002|Overall Study|Lost to Follow-up|8|||
16172745|NCT01976806|39110987|FG000|Overall Study|Lost to Follow-up|1|||
16172746|NCT01976806|39110988|FG001|Overall Study|Lost to Follow-up|4|||
16172747|NCT01976806|39110987|FG000|Overall Study|Adverse Event|1|||
16172748|NCT01976806|39110988|FG001|Overall Study|Adverse Event|1|||
16172749|NCT01976806|39110987|FG000|Overall Study|Withdrawal by Subject|1|||
16172750|NCT01976806|39110988|FG001|Overall Study|Withdrawal by Subject|1|||
16172751|NCT00345605|39110989|FG000|Arm 1|Adverse Event|0|||
16172752|NCT00345605|39110990|FG001|Arm 1|Adverse Event|1|||
16172753|NCT00345605|39110989|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
16172754|NCT00345605|39110990|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
16172755|NCT03168867|39110992|FG000|Overall Study|Withdrawal by Subject|1|||
16172756|NCT03168867|39110993|FG001|Overall Study|Withdrawal by Subject|5|||
16172757|NCT02076165|39110994|FG000|Overall Study|Lost to Follow-up|7|||
16172758|NCT02076165|39110995|FG001|Overall Study|Lost to Follow-up|5|||
16172759|NCT02076165|39110994|FG000|Overall Study|Refused follow-up assessment|1|||
16172760|NCT02076165|39110995|FG001|Overall Study|Refused follow-up assessment|1|||
16172761|NCT02006576|39110996|FG000|Overall Study|Withdrawal by Subject|4|||
16172762|NCT02006576|39110997|FG001|Overall Study|Withdrawal by Subject|6|||
16172763|NCT02006576|39110998|FG002|Overall Study|Withdrawal by Subject|2|||
16172764|NCT02006576|39110996|FG000|Overall Study|Death|0|||
16172765|NCT02006576|39110997|FG001|Overall Study|Death|0|||
16172766|NCT02006576|39110998|FG002|Overall Study|Death|1|||
16172767|NCT02006576|39110996|FG000|Overall Study|Lost to Follow-up|1|||
16172768|NCT02006576|39110997|FG001|Overall Study|Lost to Follow-up|0|||
16172769|NCT02006576|39110998|FG002|Overall Study|Lost to Follow-up|1|||
16172770|NCT02006576|39110996|FG000|Overall Study|Screen Failure, too sick, other|13|||
16172771|NCT02006576|39110997|FG001|Overall Study|Screen Failure, too sick, other|1|||
16172772|NCT02006576|39110998|FG002|Overall Study|Screen Failure, too sick, other|13|||
16172773|NCT00008385|39110999|FG000|Overall Study|Off treatment reasons not reported|79|||
16172774|NCT00008385|39111000|FG001|Overall Study|Off treatment reasons not reported|70|||
16172775|NCT00008385|39110999|FG000|Overall Study|Progressive disease|52|||
16172776|NCT00008385|39111000|FG001|Overall Study|Progressive disease|117|||
16172777|NCT00008385|39110999|FG000|Overall Study|Adverse Event|8|||
16172778|NCT00008385|39111000|FG001|Overall Study|Adverse Event|20|||
16172779|NCT00008385|39110999|FG000|Overall Study|Death|12|||
16172780|NCT00008385|39111000|FG001|Overall Study|Death|18|||
16172781|NCT00008385|39110999|FG000|Overall Study|Withdrawal by Subject|67|||
16172782|NCT00008385|39111000|FG001|Overall Study|Withdrawal by Subject|157|||
16172783|NCT00008385|39110999|FG000|Overall Study|Start non-protocol therapy|3|||
16172784|NCT00008385|39111000|FG001|Overall Study|Start non-protocol therapy|1|||
16172785|NCT00008385|39110999|FG000|Overall Study|Other complicating disease|17|||
16172786|NCT00008385|39111000|FG001|Overall Study|Other complicating disease|30|||
16172787|NCT00008385|39110999|FG000|Overall Study|Maximum dose reached|0|||
16172788|NCT00008385|39111000|FG001|Overall Study|Maximum dose reached|2|||
16172789|NCT00008385|39110999|FG000|Overall Study|Other|105|||
16172790|NCT00008385|39111000|FG001|Overall Study|Other|212|||
16172791|NCT00008385|39110999|FG000|Overall Study|Not start protocol therapy|44|||
16172792|NCT00008385|39111000|FG001|Overall Study|Not start protocol therapy|175|||
16172793|NCT00355121|39111001|FG000|Overall Study|Did not receive study vaccine|1|||
16172794|NCT00355121|39111002|FG001|Overall Study|Did not receive study vaccine|0|||
16172795|NCT00355121|39111003|FG002|Overall Study|Did not receive study vaccine|1|||
16172796|NCT00355121|39111001|FG000|Overall Study|Adverse Event|0|||
16172797|NCT00355121|39111002|FG001|Overall Study|Adverse Event|1|||
16172798|NCT00355121|39111003|FG002|Overall Study|Adverse Event|0|||
16172799|NCT00355121|39111001|FG000|Overall Study|Protocol Violation|7|||
16172800|NCT00355121|39111002|FG001|Overall Study|Protocol Violation|9|||
16172801|NCT00355121|39111003|FG002|Overall Study|Protocol Violation|1|||
16172802|NCT00355121|39111001|FG000|Overall Study|Lost to Follow-up|4|||
16172803|NCT00355121|39111002|FG001|Overall Study|Lost to Follow-up|7|||
16172804|NCT00355121|39111003|FG002|Overall Study|Lost to Follow-up|1|||
16172805|NCT00355121|39111001|FG000|Overall Study|Withdrawal by Subject|9|||
16172806|NCT00355121|39111002|FG001|Overall Study|Withdrawal by Subject|10|||
16172807|NCT00355121|39111003|FG002|Overall Study|Withdrawal by Subject|2|||
16172808|NCT00355121|39111001|FG000|Overall Study|Serious adverse events|0|||
16172809|NCT00355121|39111002|FG001|Overall Study|Serious adverse events|2|||
16172810|NCT00355121|39111003|FG002|Overall Study|Serious adverse events|0|||
16172811|NCT00591734|39111004|FG000|Overall Study|Lack of Efficacy|35|||
16172812|NCT00591734|39111004|FG000|Overall Study|Adverse Event|5|||
16172813|NCT00591734|39111004|FG000|Overall Study|Physician Decision|5|||
16172814|NCT00591734|39111004|FG000|Overall Study|Intercurrent Illness|8|||
16172815|NCT01974323|39111007|FG000|Overall Study|Other Reasons|25|||
16172816|NCT01974323|39111008|FG001|Overall Study|Other Reasons|28|||
16172817|NCT01974323|39111007|FG000|Overall Study|Protocol Violation|2|||
16172818|NCT01974323|39111008|FG001|Overall Study|Protocol Violation|2|||
16172819|NCT01974323|39111007|FG000|Overall Study|Personal Reasons|15|||
16172820|NCT01974323|39111008|FG001|Overall Study|Personal Reasons|19|||
16172821|NCT01974323|39111007|FG000|Overall Study|Lost to Follow-up|45|||
16172822|NCT01974323|39111008|FG001|Overall Study|Lost to Follow-up|40|||
16172823|NCT01974323|39111007|FG000|Overall Study|Pregnancy|2|||
16172824|NCT01974323|39111008|FG001|Overall Study|Pregnancy|1|||
16172825|NCT01974323|39111007|FG000|Overall Study|Lack of Efficacy|1|||
16172826|NCT01974323|39111008|FG001|Overall Study|Lack of Efficacy|1|||
16172827|NCT01974323|39111007|FG000|Overall Study|Adverse Event|2|||
16172828|NCT01974323|39111008|FG001|Overall Study|Adverse Event|2|||
16172829|NCT00582556|39111012|FG000|Overall Study|Withdrawal by Subject|0|||
16172830|NCT00582556|39111013|FG001|Overall Study|Withdrawal by Subject|1|||
16172831|NCT00582556|39111014|FG002|Overall Study|Withdrawal by Subject|1|||
16172832|NCT00582556|39111012|FG000|Overall Study|Physician Decision|0|||
16172833|NCT00582556|39111013|FG001|Overall Study|Physician Decision|0|||
16172834|NCT00582556|39111014|FG002|Overall Study|Physician Decision|1|||
16172835|NCT01147926|39111015|FG000|Overall Study|Subject Withdrew Consent|9|||
16172836|NCT01147926|39111016|FG001|Overall Study|Subject Withdrew Consent|10|||
16172837|NCT01147926|39111015|FG000|Overall Study|Adverse Event|7|||
16172838|NCT01147926|39111016|FG001|Overall Study|Adverse Event|6|||
16172839|NCT01147926|39111015|FG000|Overall Study|Subject Non-Compliant|5|||
16172840|NCT01147926|39111016|FG001|Overall Study|Subject Non-Compliant|4|||
16172841|NCT01147926|39111015|FG000|Overall Study|Principal investigator left hospital|1|||
16172842|NCT01147926|39111016|FG001|Overall Study|Principal investigator left hospital|3|||
16172843|NCT01147926|39111015|FG000|Overall Study|Selection criteria not met|3|||
16172844|NCT01147926|39111016|FG001|Overall Study|Selection criteria not met|1|||
16172845|NCT01147926|39111015|FG000|Overall Study|Lost to Follow-up|0|||
16172846|NCT01147926|39111016|FG001|Overall Study|Lost to Follow-up|2|||
16172847|NCT01147926|39111015|FG000|Overall Study|Sponsor's Decision|0|||
16172848|NCT01147926|39111016|FG001|Overall Study|Sponsor's Decision|1|||
16172849|NCT01147926|39111015|FG000|Overall Study|Lack of Efficacy|1|||
16172850|NCT01147926|39111016|FG001|Overall Study|Lack of Efficacy|0|||
16172851|NCT01147926|39111015|FG000|Overall Study|Too busy, no time for study|1|||
16172852|NCT01147926|39111016|FG001|Overall Study|Too busy, no time for study|0|||
16172853|NCT01147926|39111015|FG000|Overall Study|Went on holiday|0|||
16172854|NCT01147926|39111016|FG001|Overall Study|Went on holiday|1|||
16172855|NCT01147926|39111015|FG000|Overall Study|Colonoscopy result|0|||
16172856|NCT01147926|39111016|FG001|Overall Study|Colonoscopy result|1|||
16172857|NCT00669617|39111017|FG000|Period 1|Withdrawal by Subject|0|||
16172858|NCT00669617|39111018|FG001|Period 1|Withdrawal by Subject|0|||
16172859|NCT00669617|39111019|FG002|Period 1|Withdrawal by Subject|1|||
16172860|NCT00669617|39111020|FG003|Period 1|Withdrawal by Subject|0|||
16172861|NCT00669617|39111021|FG004|Period 1|Withdrawal by Subject|0|||
16172862|NCT00669617|39111017|FG000|Period 1|Protocol Deviation|0|||
16172863|NCT00669617|39111018|FG001|Period 1|Protocol Deviation|0|||
16172864|NCT00669617|39111019|FG002|Period 1|Protocol Deviation|0|||
16172865|NCT00669617|39111020|FG003|Period 1|Protocol Deviation|0|||
16172866|NCT00669617|39111021|FG004|Period 1|Protocol Deviation|1|||
16172867|NCT00669617|39111017|FG000|Period 3|Lost to Follow-up|1|||
16172868|NCT00669617|39111018|FG001|Period 3|Lost to Follow-up|0|||
16172869|NCT00669617|39111019|FG002|Period 3|Lost to Follow-up|0|||
16172870|NCT00669617|39111020|FG003|Period 3|Lost to Follow-up|0|||
16172871|NCT00669617|39111021|FG004|Period 3|Lost to Follow-up|0|||
16172872|NCT00900796|39111022|FG000|Phase 1|Lacked sufficient information|4|||
16172873|NCT00900796|39111022|FG000|Phase 1|Missing information at Week 16|7|||
16172874|NCT00900796|39111022|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
16172875|NCT00900796|39111022|FG000|Phase 2|Lost to Follow-up|5|||
16172876|NCT00733902|39111023|FG000|Overall Study|Death|0|||
16172877|NCT00733902|39111024|FG001|Overall Study|Death|0|||
16172878|NCT00733902|39111025|FG002|Overall Study|Death|0|||
16172879|NCT00733902|39111026|FG003|Overall Study|Death|1|||
16172880|NCT00733902|39111023|FG000|Overall Study|Adverse Event|3|||
16172881|NCT00733902|39111024|FG001|Overall Study|Adverse Event|4|||
16172882|NCT00733902|39111025|FG002|Overall Study|Adverse Event|7|||
16172883|NCT00733902|39111026|FG003|Overall Study|Adverse Event|11|||
16172884|NCT00733902|39111023|FG000|Overall Study|Lack of Efficacy|56|||
16172885|NCT00733902|39111024|FG001|Overall Study|Lack of Efficacy|21|||
16172886|NCT00733902|39111025|FG002|Overall Study|Lack of Efficacy|34|||
16172887|NCT00733902|39111026|FG003|Overall Study|Lack of Efficacy|23|||
16172888|NCT00733902|39111023|FG000|Overall Study|Protocol Violation|4|||
16172889|NCT00733902|39111024|FG001|Overall Study|Protocol Violation|6|||
16172890|NCT00733902|39111025|FG002|Overall Study|Protocol Violation|3|||
16172891|NCT00733902|39111026|FG003|Overall Study|Protocol Violation|3|||
16172892|NCT00733902|39111023|FG000|Overall Study|Withdrawal by Subject|10|||
16172893|NCT00733902|39111024|FG001|Overall Study|Withdrawal by Subject|5|||
16172894|NCT00733902|39111025|FG002|Overall Study|Withdrawal by Subject|4|||
16172895|NCT00733902|39111026|FG003|Overall Study|Withdrawal by Subject|16|||
16172896|NCT00733902|39111023|FG000|Overall Study|Entered extension study|89|||
16172897|NCT00733902|39111024|FG001|Overall Study|Entered extension study|124|||
16172898|NCT00733902|39111025|FG002|Overall Study|Entered extension study|111|||
16172899|NCT00733902|39111026|FG003|Overall Study|Entered extension study|109|||
16172900|NCT00733902|39111023|FG000|Overall Study|Randomized but not treated|2|||
16172901|NCT00733902|39111024|FG001|Overall Study|Randomized but not treated|2|||
16172902|NCT00733902|39111025|FG002|Overall Study|Randomized but not treated|2|||
16172903|NCT00733902|39111026|FG003|Overall Study|Randomized but not treated|1|||
16172904|NCT02029976|39111027|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
16172905|NCT02029976|39111028|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
16172906|NCT02029976|39111027|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
16172907|NCT02029976|39111028|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
16172908|NCT02029976|39111027|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
16172909|NCT02029976|39111028|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
16172910|NCT02029976|39111027|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
16172911|NCT02029976|39111028|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
16172912|NCT02698189|39111029|FG000|Overall Study|Physician Decision|3|||
16172913|NCT02698189|39111030|FG001|Overall Study|Physician Decision|0|||
16172914|NCT02698189|39111029|FG000|Overall Study|Progressive disease|0|||
16172915|NCT02698189|39111030|FG001|Overall Study|Progressive disease|5|||
16172916|NCT02698189|39111029|FG000|Overall Study|Study terminated by sponsor|0|||
16172917|NCT02698189|39111030|FG001|Overall Study|Study terminated by sponsor|1|||
16172918|NCT02388295|39111031|FG000|Dose Escalation Week 1|Adverse Event|1|||
16172919|NCT02388295|39111032|FG001|Dose Escalation Week 1|Adverse Event|2|||
16172920|NCT02388295|39111033|FG002|Dose Escalation Week 1|Adverse Event|1|||
16172921|NCT02388295|39111031|FG000|Dose Escalation Week 1|Determined not eligible|1|||
16172922|NCT02388295|39111032|FG001|Dose Escalation Week 1|Determined not eligible|1|||
16172923|NCT02388295|39111033|FG002|Dose Escalation Week 1|Determined not eligible|1|||
16172924|NCT02388295|39111031|FG000|Dose Escalation Week 2|Protocol Violation|0|||
16172925|NCT02388295|39111032|FG001|Dose Escalation Week 2|Protocol Violation|1|||
16172926|NCT02388295|39111033|FG002|Dose Escalation Week 2|Protocol Violation|0|||
16172927|NCT02388295|39111031|FG000|Dose Escalation Week 2|Determined not eligible|1|||
16172928|NCT02388295|39111032|FG001|Dose Escalation Week 2|Determined not eligible|1|||
16172929|NCT02388295|39111033|FG002|Dose Escalation Week 2|Determined not eligible|1|||
16172930|NCT02388295|39111031|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
16172931|NCT02388295|39111032|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
16172932|NCT02388295|39111033|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
16172933|NCT02983604|39111036|FG000|Overall Study|Enrolled but not Treated|0|||
16172934|NCT02983604|39111037|FG001|Overall Study|Enrolled but not Treated|0|||
16172935|NCT02983604|39111038|FG002|Overall Study|Enrolled but not Treated|1|||
16172936|NCT02983604|39111039|FG003|Overall Study|Enrolled but not Treated|0|||
16172937|NCT02393209|39111040|FG000|Overall Study|Study Terminated by Sponsor|1|||
16172938|NCT02393209|39111041|FG001|Overall Study|Study Terminated by Sponsor|1|||
16172939|NCT02393209|39111042|FG002|Overall Study|Study Terminated by Sponsor|0|||
16172940|NCT02393209|39111043|FG003|Overall Study|Study Terminated by Sponsor|0|||
16172941|NCT02393209|39111040|FG000|Overall Study|Withdrawal by Patient|1|||
16172942|NCT02393209|39111041|FG001|Overall Study|Withdrawal by Patient|0|||
16172943|NCT02393209|39111042|FG002|Overall Study|Withdrawal by Patient|0|||
16172944|NCT02393209|39111043|FG003|Overall Study|Withdrawal by Patient|0|||
16172945|NCT02393209|39111040|FG000|Overall Study|Death|2|||
16172946|NCT02393209|39111041|FG001|Overall Study|Death|2|||
16172947|NCT02393209|39111042|FG002|Overall Study|Death|0|||
16172948|NCT02393209|39111043|FG003|Overall Study|Death|0|||
16172949|NCT02393209|39111040|FG000|Overall Study|Death due to Disease Progression|2|||
16172950|NCT02393209|39111041|FG001|Overall Study|Death due to Disease Progression|2|||
16172951|NCT02393209|39111042|FG002|Overall Study|Death due to Disease Progression|0|||
16172952|NCT02393209|39111043|FG003|Overall Study|Death due to Disease Progression|0|||
16172953|NCT02393209|39111040|FG000|Overall Study|Death from Legionella Infection|0|||
16172954|NCT02393209|39111041|FG001|Overall Study|Death from Legionella Infection|1|||
16172955|NCT02393209|39111042|FG002|Overall Study|Death from Legionella Infection|0|||
16172956|NCT02393209|39111043|FG003|Overall Study|Death from Legionella Infection|0|||
16172957|NCT02393209|39111040|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
16172958|NCT02393209|39111041|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
16172959|NCT02393209|39111042|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
16273261|NCT01968551|39484475|FG002|Extension Phase|Lost to Follow-up|1|||
16172960|NCT02393209|39111043|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
16172961|NCT02393209|39111040|FG000|Overall Study|Lost to Follow-up|0|||
16172962|NCT02393209|39111041|FG001|Overall Study|Lost to Follow-up|1|||
16172963|NCT02393209|39111042|FG002|Overall Study|Lost to Follow-up|0|||
16172964|NCT02393209|39111043|FG003|Overall Study|Lost to Follow-up|0|||
16172965|NCT03837899|39111044|FG000|Overall Study|Death|6|||
16172966|NCT03837899|39111045|FG001|Overall Study|Death|8|||
16172967|NCT03837899|39111046|FG002|Overall Study|Death|3|||
16172968|NCT03837899|39111047|FG003|Overall Study|Death|7|||
16172969|NCT03837899|39111048|FG004|Overall Study|Death|8|||
16172970|NCT03837899|39111049|FG005|Overall Study|Death|7|||
16172971|NCT03837899|39111044|FG000|Overall Study|Moved to post-trial access program|0|||
16172972|NCT03837899|39111045|FG001|Overall Study|Moved to post-trial access program|1|||
16172973|NCT03837899|39111046|FG002|Overall Study|Moved to post-trial access program|0|||
16172974|NCT03837899|39111047|FG003|Overall Study|Moved to post-trial access program|0|||
16172975|NCT03837899|39111048|FG004|Overall Study|Moved to post-trial access program|0|||
16172976|NCT03837899|39111049|FG005|Overall Study|Moved to post-trial access program|0|||
16172977|NCT03837899|39111044|FG000|Overall Study|Other|0|||
16172978|NCT03837899|39111045|FG001|Overall Study|Other|0|||
16172979|NCT03837899|39111046|FG002|Overall Study|Other|0|||
16172980|NCT03837899|39111047|FG003|Overall Study|Other|0|||
16172981|NCT03837899|39111048|FG004|Overall Study|Other|0|||
16172982|NCT03837899|39111049|FG005|Overall Study|Other|2|||
16172983|NCT03837899|39111044|FG000|Overall Study|Lost to Follow-up|0|||
16172984|NCT03837899|39111045|FG001|Overall Study|Lost to Follow-up|1|||
16172985|NCT03837899|39111046|FG002|Overall Study|Lost to Follow-up|0|||
16172986|NCT03837899|39111047|FG003|Overall Study|Lost to Follow-up|0|||
16172987|NCT03837899|39111048|FG004|Overall Study|Lost to Follow-up|0|||
16172988|NCT03837899|39111049|FG005|Overall Study|Lost to Follow-up|0|||
16172989|NCT03837899|39111044|FG000|Overall Study|Withdrawal by Subject|0|||
16172990|NCT03837899|39111045|FG001|Overall Study|Withdrawal by Subject|0|||
16172991|NCT03837899|39111046|FG002|Overall Study|Withdrawal by Subject|0|||
16172992|NCT03837899|39111047|FG003|Overall Study|Withdrawal by Subject|1|||
16172993|NCT03837899|39111048|FG004|Overall Study|Withdrawal by Subject|0|||
16172994|NCT03837899|39111049|FG005|Overall Study|Withdrawal by Subject|0|||
16172995|NCT03837899|39111044|FG000|Overall Study|Study specific discontinuation criteria|0|||
16172996|NCT03837899|39111045|FG001|Overall Study|Study specific discontinuation criteria|1|||
16172997|NCT03837899|39111046|FG002|Overall Study|Study specific discontinuation criteria|0|||
16172998|NCT03837899|39111047|FG003|Overall Study|Study specific discontinuation criteria|0|||
16172999|NCT03837899|39111048|FG004|Overall Study|Study specific discontinuation criteria|3|||
16173000|NCT03837899|39111049|FG005|Overall Study|Study specific discontinuation criteria|1|||
16173001|NCT05148884|39111050|FG000|Overall Study|Withdrawal by Subject|3|||
16173002|NCT05148884|39111051|FG001|Overall Study|Withdrawal by Subject|0|||
16173003|NCT05148884|39111050|FG000|Overall Study|Deep brain stimulation operation|0|||
16173004|NCT05148884|39111051|FG001|Overall Study|Deep brain stimulation operation|1|||
16173005|NCT04007159|39111052|FG000|Induction Phase|(missed study visits)|16|||
16173006|NCT04007159|39111052|FG000|Induction Phase|Withdrawal by Subject|4|||
16173007|NCT04007159|39111052|FG000|Induction Phase|Adverse Event|2|||
16173008|NCT04007159|39111052|FG000|Challenge Phase|missed study visits|3|||
16173009|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
16173010|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
16173011|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
16173012|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
16173013|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
16173014|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
16173015|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
16173016|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
16173017|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
16173018|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
16173019|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
16173020|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
16173021|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
16173022|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
16173023|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
16173024|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
16173025|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
16173026|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
16173027|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
16173028|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
16173029|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
16173030|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
16173031|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
16173032|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
16173033|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
16173034|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
16173035|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
16173036|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
16173037|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
16173038|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
16173039|NCT00849017|39111053|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
16173040|NCT00849017|39111054|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
16173041|NCT00849017|39111055|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
16173042|NCT00849017|39111053|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
16173043|NCT00849017|39111054|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
16173044|NCT00849017|39111055|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
16173045|NCT00849017|39111053|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
16173046|NCT00849017|39111054|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
16173047|NCT00849017|39111055|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
16173048|NCT00849017|39111053|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
16173049|NCT00849017|39111054|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
16173050|NCT00849017|39111055|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
16173051|NCT00849017|39111053|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
16173052|NCT00849017|39111054|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
16173053|NCT00849017|39111055|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
16173054|NCT00849017|39111053|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
16173055|NCT00849017|39111054|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
16173056|NCT00849017|39111055|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
16173057|NCT00849017|39111053|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
16173058|NCT00849017|39111054|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
16173059|NCT00849017|39111055|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
16173060|NCT00849017|39111053|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
16173061|NCT00849017|39111054|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
16173062|NCT00849017|39111055|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
16173063|NCT00849017|39111053|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
16173064|NCT00849017|39111054|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
16173065|NCT00849017|39111055|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
16173066|NCT00384956|39111058|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
16173067|NCT00749190|39111059|FG000|Overall Study|Adverse Event|0|||
16173068|NCT00749190|39111060|FG001|Overall Study|Adverse Event|2|||
16173069|NCT00749190|39111061|FG002|Overall Study|Adverse Event|0|||
16173070|NCT00749190|39111062|FG003|Overall Study|Adverse Event|4|||
16173071|NCT00749190|39111063|FG004|Overall Study|Adverse Event|0|||
16173072|NCT00749190|39111064|FG005|Overall Study|Adverse Event|3|||
16173073|NCT00749190|39111065|FG006|Overall Study|Adverse Event|0|||
16173074|NCT00749190|39111059|FG000|Overall Study|Lack of Efficacy|3|||
16173075|NCT00749190|39111060|FG001|Overall Study|Lack of Efficacy|1|||
16173076|NCT00749190|39111061|FG002|Overall Study|Lack of Efficacy|1|||
16173077|NCT00749190|39111062|FG003|Overall Study|Lack of Efficacy|0|||
16173078|NCT00749190|39111063|FG004|Overall Study|Lack of Efficacy|0|||
16173079|NCT00749190|39111064|FG005|Overall Study|Lack of Efficacy|1|||
16173080|NCT00749190|39111065|FG006|Overall Study|Lack of Efficacy|0|||
16173081|NCT00749190|39111059|FG000|Overall Study|Withdrawal by Subject|2|||
16173082|NCT00749190|39111060|FG001|Overall Study|Withdrawal by Subject|1|||
16173083|NCT00749190|39111061|FG002|Overall Study|Withdrawal by Subject|0|||
16173084|NCT00749190|39111062|FG003|Overall Study|Withdrawal by Subject|0|||
16173085|NCT00749190|39111063|FG004|Overall Study|Withdrawal by Subject|0|||
16173086|NCT00749190|39111064|FG005|Overall Study|Withdrawal by Subject|1|||
16173087|NCT00749190|39111065|FG006|Overall Study|Withdrawal by Subject|0|||
16173088|NCT00749190|39111059|FG000|Overall Study|Protocol Violation|0|||
16173089|NCT00749190|39111060|FG001|Overall Study|Protocol Violation|1|||
16173090|NCT00749190|39111061|FG002|Overall Study|Protocol Violation|0|||
16173091|NCT00749190|39111062|FG003|Overall Study|Protocol Violation|0|||
16173092|NCT00749190|39111063|FG004|Overall Study|Protocol Violation|0|||
16173093|NCT00749190|39111064|FG005|Overall Study|Protocol Violation|0|||
16173094|NCT00749190|39111065|FG006|Overall Study|Protocol Violation|1|||
16173095|NCT00749190|39111059|FG000|Overall Study|Other reason not defined above|0|||
16173096|NCT00749190|39111060|FG001|Overall Study|Other reason not defined above|0|||
16173097|NCT00749190|39111061|FG002|Overall Study|Other reason not defined above|0|||
16173098|NCT00749190|39111062|FG003|Overall Study|Other reason not defined above|1|||
16173099|NCT00749190|39111063|FG004|Overall Study|Other reason not defined above|0|||
16173100|NCT00749190|39111064|FG005|Overall Study|Other reason not defined above|0|||
16173101|NCT00749190|39111065|FG006|Overall Study|Other reason not defined above|0|||
16173102|NCT00699192|39111066|FG000|Overall Study|Missing|1|||
16173103|NCT00699192|39111067|FG001|Overall Study|Missing|1|||
16173104|NCT00699192|39111068|FG002|Overall Study|Missing|1|||
16272909|NCT01972841|39484351|FG004|Overall Study|Withdrawal by participants|33|||
16173105|NCT00699192|39111066|FG000|Overall Study|Adverse Event|9|||
16173106|NCT00699192|39111067|FG001|Overall Study|Adverse Event|4|||
16173107|NCT00699192|39111068|FG002|Overall Study|Adverse Event|3|||
16173108|NCT00699192|39111066|FG000|Overall Study|Abnormal test procedure result(s)|0|||
16173109|NCT00699192|39111067|FG001|Overall Study|Abnormal test procedure result(s)|0|||
16173110|NCT00699192|39111068|FG002|Overall Study|Abnormal test procedure result(s)|1|||
16173111|NCT00699192|39111066|FG000|Overall Study|Lack of Efficacy|0|||
16173112|NCT00699192|39111067|FG001|Overall Study|Lack of Efficacy|0|||
16173113|NCT00699192|39111068|FG002|Overall Study|Lack of Efficacy|1|||
16173114|NCT00699192|39111066|FG000|Overall Study|Withdrawal by Subject|3|||
16173115|NCT00699192|39111067|FG001|Overall Study|Withdrawal by Subject|2|||
16173116|NCT00699192|39111068|FG002|Overall Study|Withdrawal by Subject|4|||
16173117|NCT00699192|39111066|FG000|Overall Study|Administrative problems|1|||
16173118|NCT00699192|39111067|FG001|Overall Study|Administrative problems|3|||
16173119|NCT00699192|39111068|FG002|Overall Study|Administrative problems|1|||
16173120|NCT00699192|39111066|FG000|Overall Study|Protocol Violation|2|||
16173121|NCT00699192|39111067|FG001|Overall Study|Protocol Violation|2|||
16173122|NCT00699192|39111068|FG002|Overall Study|Protocol Violation|0|||
16173123|NCT04125680|39111069|FG000|Overall Study|Lost to Follow-up|15|||
16173124|NCT01708057|39111073|FG000|Overall Study|Withdrawal due to study termination.|1|||
16173125|NCT01708057|39111074|FG001|Overall Study|Withdrawal due to study termination.|1|||
16173126|NCT01708057|39111075|FG002|Overall Study|Withdrawal due to study termination.|1|||
16173127|NCT02563002|39111076|FG000|Overall Study|Death|72|||
16173128|NCT02563002|39111077|FG001|Overall Study|Death|87|||
16173129|NCT02563002|39111076|FG000|Overall Study|Lost to Follow-up|5|||
16173130|NCT02563002|39111077|FG001|Overall Study|Lost to Follow-up|0|||
16173131|NCT02563002|39111076|FG000|Overall Study|Physician Decision|0|||
16173132|NCT02563002|39111077|FG001|Overall Study|Physician Decision|2|||
16173133|NCT02563002|39111076|FG000|Overall Study|Withdrawal by Subject|2|||
16173134|NCT02563002|39111077|FG001|Overall Study|Withdrawal by Subject|10|||
16173135|NCT02563002|39111076|FG000|Overall Study|Sponsor decision|74|||
16173136|NCT02563002|39111077|FG001|Overall Study|Sponsor decision|55|||
16173137|NCT02599402|39111080|FG000|Overall Study|Disease progression|153|||
16173138|NCT02599402|39111080|FG000|Overall Study|Study drug toxicity|201|||
16173139|NCT02599402|39111080|FG000|Overall Study|Death|26|||
16173140|NCT02599402|39111080|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
16173141|NCT02599402|39111080|FG000|Overall Study|Participant request to discontinue study treatment|13|||
16173142|NCT02599402|39111080|FG000|Overall Study|Participant withdrew consent|5|||
16173143|NCT02599402|39111080|FG000|Overall Study|Lost to Follow-up|1|||
16173144|NCT02599402|39111080|FG000|Overall Study|Maximum Clinical Benefit|7|||
16272910|NCT01972841|39484352|FG005|Overall Study|Withdrawal by participants|34|||
16272911|NCT01972841|39484347|FG000|Overall Study|Miscellaneous|0|||
16272912|NCT01972841|39484348|FG001|Overall Study|Miscellaneous|0|||
16272913|NCT01972841|39484349|FG002|Overall Study|Miscellaneous|4|||
16272914|NCT01972841|39484350|FG003|Overall Study|Miscellaneous|1|||
16272915|NCT01972841|39484351|FG004|Overall Study|Miscellaneous|0|||
16272916|NCT01972841|39484352|FG005|Overall Study|Miscellaneous|4|||
16272917|NCT01972841|39484347|FG000|Overall Study|Did not have end of treatment page|0|||
16272918|NCT01972841|39484348|FG001|Overall Study|Did not have end of treatment page|0|||
16272919|NCT01972841|39484349|FG002|Overall Study|Did not have end of treatment page|0|||
16272920|NCT01972841|39484350|FG003|Overall Study|Did not have end of treatment page|0|||
16272921|NCT01972841|39484351|FG004|Overall Study|Did not have end of treatment page|1|||
16272922|NCT01972841|39484352|FG005|Overall Study|Did not have end of treatment page|0|||
16272923|NCT01139762|39484353|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
16272924|NCT01139762|39484354|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
16272925|NCT01139762|39484355|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
16272926|NCT01139762|39484353|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
16272927|NCT01139762|39484354|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
16272928|NCT01139762|39484355|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
16272929|NCT01139762|39484353|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
16272930|NCT01139762|39484354|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
16272931|NCT01139762|39484355|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
16272932|NCT01139762|39484353|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
16272933|NCT01139762|39484354|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
16272934|NCT01139762|39484355|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
16272935|NCT01139762|39484353|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
16272936|NCT01139762|39484354|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
16272937|NCT01139762|39484355|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
16272938|NCT01139762|39484353|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
16272939|NCT01139762|39484354|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
16173145|NCT02599402|39111080|FG000|Overall Study|Poor/non-compliance|1|||
16173146|NCT02599402|39111080|FG000|Overall Study|Pregnancy|1|||
16173147|NCT02599402|39111080|FG000|Overall Study|Participant no longer met study criteria|7|||
16173148|NCT02599402|39111080|FG000|Overall Study|Other Reasons|95|||
16272940|NCT01139762|39484355|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
16272941|NCT01139762|39484353|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
16272942|NCT01139762|39484354|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
16272943|NCT01139762|39484355|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
16272944|NCT01139762|39484353|FG000|Double-Blind Randomized Active Treatment|Death|0|||
16272945|NCT01139762|39484354|FG001|Double-Blind Randomized Active Treatment|Death|1|||
16272946|NCT01139762|39484355|FG002|Double-Blind Randomized Active Treatment|Death|1|||
16272947|NCT01139762|39484353|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
16272948|NCT01139762|39484354|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
16272949|NCT01139762|39484355|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
16272950|NCT01139762|39484353|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
16272951|NCT01139762|39484354|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
16272952|NCT01139762|39484355|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
16272953|NCT01139762|39484353|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
16272954|NCT01139762|39484354|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
16272955|NCT01139762|39484355|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
16272956|NCT01139762|39484353|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
16272957|NCT01139762|39484354|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
16272958|NCT01139762|39484355|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
16272959|NCT01139762|39484353|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
16272960|NCT01139762|39484354|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
16272961|NCT01139762|39484355|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
16272962|NCT01139762|39484353|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
16272963|NCT01139762|39484354|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
16272964|NCT01139762|39484355|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
16272965|NCT01139762|39484353|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
16272966|NCT01139762|39484354|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
16272967|NCT01139762|39484355|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
16272968|NCT00660387|39484356|FG000|Overall Study|Adverse Event|1|||
16272969|NCT00660387|39484357|FG001|Overall Study|Adverse Event|2|||
16272970|NCT00660387|39484356|FG000|Overall Study|Lack of Efficacy|0|||
16272971|NCT00660387|39484357|FG001|Overall Study|Lack of Efficacy|1|||
16272972|NCT00660387|39484356|FG000|Overall Study|Protocol Violation|1|||
16272973|NCT00660387|39484357|FG001|Overall Study|Protocol Violation|0|||
16272974|NCT03255733|39484360|FG000|Overall Study|Lost to Follow-up|4|||
16272975|NCT00160524|39484365|FG000|Overall Study|Adverse Event|119|||
16272976|NCT00160524|39484365|FG000|Overall Study|Adverse Event and Other|94|||
16272977|NCT00160524|39484365|FG000|Overall Study|Protocol Violation|16|||
16272978|NCT00160524|39484365|FG000|Overall Study|Protocol Violation and Other|2|||
16272979|NCT00160524|39484365|FG000|Overall Study|Withdrawal by Subject|141|||
16272980|NCT00160524|39484365|FG000|Overall Study|Withdrawal by Subject and Other|17|||
16272981|NCT00160524|39484365|FG000|Overall Study|Physician Decision|27|||
16272982|NCT00160524|39484365|FG000|Overall Study|Physician Decision and Other|6|||
16272983|NCT00160524|39484365|FG000|Overall Study|Lost to Follow-up|13|||
16272984|NCT00160524|39484365|FG000|Overall Study|Lost to Follow-up and Other|1|||
16272985|NCT00160524|39484365|FG000|Overall Study|Lack of Efficacy|21|||
16272986|NCT00160524|39484365|FG000|Overall Study|Lack of Efficacy and Other|1|||
16272987|NCT00160524|39484365|FG000|Overall Study|Other|20|||
16272988|NCT00848536|39484366|FG000|Overall Study|Adverse Event|2|||
16272989|NCT00848536|39484367|FG001|Overall Study|Adverse Event|2|||
16272990|NCT00848536|39484366|FG000|Overall Study|Withdrawal by Subject|0|||
16272991|NCT00848536|39484367|FG001|Overall Study|Withdrawal by Subject|1|||
16272992|NCT00848536|39484366|FG000|Overall Study|Protocol Violation|0|||
16272993|NCT00848536|39484367|FG001|Overall Study|Protocol Violation|1|||
16272994|NCT00848536|39484366|FG000|Overall Study|Noncompliance|1|||
16272995|NCT00848536|39484367|FG001|Overall Study|Noncompliance|0|||
16272996|NCT00848536|39484366|FG000|Overall Study|Inadequate Control of IOP|1|||
16272997|NCT00848536|39484367|FG001|Overall Study|Inadequate Control of IOP|1|||
16272998|NCT00848536|39484366|FG000|Overall Study|Patient Moved|0|||
16272999|NCT00848536|39484367|FG001|Overall Study|Patient Moved|2|||
16273000|NCT01944722|39484368|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
16273001|NCT01944722|39484368|FG000|Overall Study|Specimen Shipping Issues|34|||
16273002|NCT01944722|39484368|FG000|Overall Study|Improper Storage/Transport|5|||
16273003|NCT01944722|39484368|FG000|Overall Study|Insufficient Volume for Test|1|||
16273004|NCT01944722|39484368|FG000|Overall Study|Missing Specimens|3|||
16273005|NCT01944722|39484368|FG000|Overall Study|Specimens Mislabeled|2|||
16273006|NCT01944722|39484368|FG000|Overall Study|Withdrawal by Subject|8|||
16273007|NCT01944722|39484368|FG000|Overall Study|NILM Subjects <30 years old|8106|||
16273008|NCT01944722|39484368|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
16273009|NCT01944722|39484368|FG000|Overall Study|>ASCUS Cytology|1122|||
16273010|NCT01252953|39484369|FG000|Overall Study|Withdrawal by Subject|16|||
16273011|NCT01252953|39484370|FG001|Overall Study|Withdrawal by Subject|17|||
16273012|NCT01252953|39484369|FG000|Overall Study|Lost to Follow-up|22|||
16273013|NCT01252953|39484370|FG001|Overall Study|Lost to Follow-up|21|||
16273014|NCT03684928|39484373|FG000|First Intervention|Lost to Follow-up|0|||
16273015|NCT03684928|39484374|FG001|First Intervention|Lost to Follow-up|1|||
16273016|NCT03684928|39484373|FG000|First Intervention|Withdrawal by Subject|0|||
16273017|NCT03684928|39484374|FG001|First Intervention|Withdrawal by Subject|2|||
16273018|NCT03684928|39484373|FG000|Second Intervention|Soft Tissue Injury|1|||
16273019|NCT03684928|39484374|FG001|Second Intervention|Soft Tissue Injury|0|||
16273020|NCT00714051|39484380|FG000|Overall Study|Withdrawal by Subject|1|||
16273021|NCT00714051|39484381|FG001|Overall Study|Withdrawal by Subject|0|||
16273022|NCT00714051|39484380|FG000|Overall Study|Death|0|||
16273023|NCT00714051|39484381|FG001|Overall Study|Death|1|||
16273024|NCT00127166|39484384|FG000|Period I|Protocol Violation|0|||
16273025|NCT00127166|39484385|FG001|Period I|Protocol Violation|2|||
16273026|NCT00127166|39484384|FG000|Period I|Withdrawal by Subject|2|||
16273027|NCT00127166|39484385|FG001|Period I|Withdrawal by Subject|0|||
16273028|NCT00127166|39484384|FG000|Period I|Patient did not meet inclusion criteria|1|||
16273029|NCT00127166|39484385|FG001|Period I|Patient did not meet inclusion criteria|0|||
16273030|NCT00127166|39484384|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
16273031|NCT00127166|39484385|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
16273032|NCT00127166|39484384|FG000|Period II|Withdrawal by Subject|2|||
16273033|NCT00127166|39484385|FG001|Period II|Withdrawal by Subject|0|||
16273034|NCT00127166|39484384|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
16273035|NCT00127166|39484385|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
16273036|NCT01266902|39484386|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
16273037|NCT01266902|39484387|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
16273038|NCT01266902|39484388|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
16273039|NCT01266902|39484386|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
16273040|NCT01266902|39484387|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
16273041|NCT01266902|39484388|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
16273042|NCT01266902|39484386|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
16273043|NCT01266902|39484387|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
16273044|NCT01266902|39484388|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
16273045|NCT01266902|39484386|FG000|Period 1 (Main Study)|Adverse Event|3|||
16273046|NCT01266902|39484387|FG001|Period 1 (Main Study)|Adverse Event|11|||
16273047|NCT01266902|39484388|FG002|Period 1 (Main Study)|Adverse Event|0|||
16273048|NCT01266902|39484386|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
16273049|NCT01266902|39484387|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
16273050|NCT01266902|39484388|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
16273051|NCT01266902|39484386|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
16273052|NCT01266902|39484387|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
16273053|NCT01266902|39484388|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
16273054|NCT01266902|39484386|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
16273055|NCT01266902|39484387|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
16273056|NCT01266902|39484388|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
16273057|NCT01266902|39484386|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
16273058|NCT01266902|39484387|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
16273059|NCT01266902|39484388|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
16273060|NCT01266902|39484386|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
16273061|NCT01266902|39484387|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
16273062|NCT01266902|39484388|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
16273063|NCT01266902|39484386|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
16273064|NCT01266902|39484387|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
16273065|NCT01266902|39484388|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
16273066|NCT02997176|39484389|FG000|Overall Study|Adverse Event|0|||
16273067|NCT02997176|39484390|FG001|Overall Study|Adverse Event|0|||
16273068|NCT02997176|39484391|FG002|Overall Study|Adverse Event|0|||
16273069|NCT02997176|39484392|FG003|Overall Study|Adverse Event|8|||
16273070|NCT02997176|39484389|FG000|Overall Study|Progressive Disease|1|||
16273071|NCT02997176|39484390|FG001|Overall Study|Progressive Disease|0|||
16273072|NCT02997176|39484391|FG002|Overall Study|Progressive Disease|1|||
16273073|NCT02997176|39484392|FG003|Overall Study|Progressive Disease|1|||
16273074|NCT02997176|39484389|FG000|Overall Study|Death|0|||
16273075|NCT02997176|39484390|FG001|Overall Study|Death|0|||
16273076|NCT02997176|39484391|FG002|Overall Study|Death|1|||
16273077|NCT02997176|39484392|FG003|Overall Study|Death|1|||
16273078|NCT02997176|39484389|FG000|Overall Study|Withdrawal by Subject|0|||
16273079|NCT02997176|39484390|FG001|Overall Study|Withdrawal by Subject|2|||
16273080|NCT02997176|39484391|FG002|Overall Study|Withdrawal by Subject|0|||
16273081|NCT02997176|39484392|FG003|Overall Study|Withdrawal by Subject|1|||
16273082|NCT02218216|39484393|FG000|Overall Study|Study terminated before completed|6|||
16273083|NCT02218216|39484394|FG001|Overall Study|Study terminated before completed|0|||
16273084|NCT02218216|39484395|FG002|Overall Study|Study terminated before completed|0|||
16273085|NCT00702507|39484396|FG000|Initial Treatment Phase|Adverse Event|2|||
16273086|NCT00702507|39484396|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
16273087|NCT00702507|39484396|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
16273088|NCT00702507|39484396|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
16273089|NCT00702507|39484396|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
16273090|NCT00702507|39484396|FG000|Follow-up Phase|Protocol Violation|2|||
16273091|NCT00702507|39484396|FG000|Follow-up Phase|Lost to Follow-up|23|||
16273092|NCT00702507|39484396|FG000|Follow-up Phase|Late Enrollment|1|||
16273093|NCT04474405|39484397|FG000|Overall Study|Withdrawal by Subject|0|||
16273094|NCT04474405|39484398|FG001|Overall Study|Withdrawal by Subject|0|||
16273095|NCT04474405|39484399|FG002|Overall Study|Withdrawal by Subject|1|||
16273096|NCT04474405|39484400|FG003|Overall Study|Withdrawal by Subject|0|||
16273097|NCT04474405|39484401|FG004|Overall Study|Withdrawal by Subject|1|||
16273098|NCT04474405|39484402|FG005|Overall Study|Withdrawal by Subject|0|||
16273099|NCT04474405|39484397|FG000|Overall Study|Other|0|||
16273100|NCT04474405|39484398|FG001|Overall Study|Other|0|||
16273101|NCT04474405|39484399|FG002|Overall Study|Other|0|||
16273102|NCT04474405|39484400|FG003|Overall Study|Other|0|||
16273103|NCT04474405|39484401|FG004|Overall Study|Other|3|||
16273104|NCT04474405|39484402|FG005|Overall Study|Other|0|||
16273105|NCT02096705|39484403|FG000|Treatment|Adverse Event|6|||
16473056|NCT00098475|40210741|FG001|Step 1|Progressive disease|35|||
16473057|NCT00098475|40210742|FG002|Step 1|Progressive disease|2|||
16473058|NCT00098475|40210743|FG003|Step 1|Progressive disease|1|||
16473059|NCT00098475|40210740|FG000|Step 1|Adverse Event|56|||
16473060|NCT00098475|40210741|FG001|Step 1|Adverse Event|37|||
16473061|NCT00098475|40210742|FG002|Step 1|Adverse Event|0|||
16473062|NCT00098475|40210743|FG003|Step 1|Adverse Event|1|||
16473063|NCT00098475|40210740|FG000|Step 1|Death|8|||
16473064|NCT00098475|40210741|FG001|Step 1|Death|5|||
16473065|NCT00098475|40210742|FG002|Step 1|Death|0|||
16473066|NCT00098475|40210743|FG003|Step 1|Death|1|||
16473067|NCT00098475|40210740|FG000|Step 1|Withdrawal by Subject|14|||
16473068|NCT00098475|40210741|FG001|Step 1|Withdrawal by Subject|11|||
16473069|NCT00098475|40210742|FG002|Step 1|Withdrawal by Subject|0|||
16473070|NCT00098475|40210743|FG003|Step 1|Withdrawal by Subject|0|||
16473071|NCT00098475|40210740|FG000|Step 1|Physician Decision|5|||
16473072|NCT00098475|40210741|FG001|Step 1|Physician Decision|2|||
16473073|NCT00098475|40210742|FG002|Step 1|Physician Decision|0|||
16473074|NCT00098475|40210743|FG003|Step 1|Physician Decision|0|||
16473075|NCT00098475|40210740|FG000|Step 1|Alternative therapy|31|||
16473076|NCT00098475|40210741|FG001|Step 1|Alternative therapy|43|||
16473077|NCT00098475|40210742|FG002|Step 1|Alternative therapy|1|||
16473078|NCT00098475|40210743|FG003|Step 1|Alternative therapy|0|||
16473079|NCT00098475|40210740|FG000|Step 1|Other disease|2|||
16473080|NCT00098475|40210741|FG001|Step 1|Other disease|1|||
16173149|NCT00374556|39111083|FG000|Overall Study|Lost to Follow-up|1|||
16173150|NCT00374556|39111084|FG001|Overall Study|Lost to Follow-up|0|||
16173151|NCT00374556|39111083|FG000|Overall Study|Removed at baseline due to medical cond|0|||
16173152|NCT00374556|39111084|FG001|Overall Study|Removed at baseline due to medical cond|1|||
16173153|NCT00246259|39111085|FG000|Overall Study|Other|3|||
16173154|NCT00246259|39111086|FG001|Overall Study|Other|3|||
16173155|NCT00246259|39111085|FG000|Overall Study|Not stable by Week 18|2|||
16173156|NCT00246259|39111086|FG001|Overall Study|Not stable by Week 18|1|||
16173157|NCT00246259|39111085|FG000|Overall Study|Participant non-compliant|4|||
16173158|NCT00246259|39111086|FG001|Overall Study|Participant non-compliant|9|||
16173159|NCT00246259|39111085|FG000|Overall Study|Lack of Efficacy|2|||
16173160|NCT00246259|39111086|FG001|Overall Study|Lack of Efficacy|2|||
16173161|NCT00246259|39111085|FG000|Overall Study|Investigator withdrew participant|2|||
16173162|NCT00246259|39111086|FG001|Overall Study|Investigator withdrew participant|0|||
16173163|NCT00246259|39111085|FG000|Overall Study|Adverse Event|5|||
16173164|NCT00246259|39111086|FG001|Overall Study|Adverse Event|0|||
16173165|NCT00246259|39111085|FG000|Overall Study|Lost to Follow-up|3|||
16173166|NCT00246259|39111086|FG001|Overall Study|Lost to Follow-up|4|||
16173167|NCT00246259|39111085|FG000|Overall Study|Withdrawal by Subject|5|||
16173168|NCT00246259|39111086|FG001|Overall Study|Withdrawal by Subject|1|||
16173169|NCT00246259|39111085|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
16173170|NCT00246259|39111086|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
16173171|NCT01128387|39111091|FG000|Overall Study|Physician Decision|0|||
16173172|NCT01128387|39111092|FG001|Overall Study|Physician Decision|1|||
16173173|NCT00501228|39111104|FG000|Overall Study|Withdrawal by Subject|1|||
16173174|NCT00214461|39111105|FG000|Overall Study|Adverse Event|0|||
16173175|NCT00214461|39111106|FG001|Overall Study|Adverse Event|0|||
16173176|NCT00214461|39111107|FG002|Overall Study|Adverse Event|1|||
16173177|NCT00214461|39111108|FG003|Overall Study|Adverse Event|1|||
16173178|NCT00214461|39111105|FG000|Overall Study|Withdrawal by Subject|0|||
16473081|NCT00098475|40210742|FG002|Step 1|Other disease|1|||
16473082|NCT00098475|40210743|FG003|Step 1|Other disease|0|||
16473083|NCT00098475|40210740|FG000|Step 1|Never started treatment|0|||
16173438|NCT01607892|39111205|FG000|Overall Study|Incidence or severity of Adverse events|3|||
16173439|NCT01607892|39111206|FG001|Overall Study|Incidence or severity of Adverse events|3|||
16173440|NCT01607892|39111207|FG002|Overall Study|Incidence or severity of Adverse events|7|||
16173441|NCT01607892|39111208|FG003|Overall Study|Incidence or severity of Adverse events|2|||
16173442|NCT01607892|39111209|FG004|Overall Study|Incidence or severity of Adverse events|6|||
16173443|NCT00398112|39111219|FG000|Overall Study|Adverse Event|4|||
16173444|NCT00398112|39111219|FG000|Overall Study|Disease progression|9|||
16173445|NCT00398112|39111219|FG000|Overall Study|Alternative treatment|1|||
16173446|NCT00398112|39111219|FG000|Overall Study|Withdrawal by Subject|3|||
16173447|NCT00398112|39111219|FG000|Overall Study|Death|1|||
16173448|NCT00883493|39111220|FG000|Overall Study|Adverse Event|11|||
16173449|NCT00883493|39111221|FG001|Overall Study|Adverse Event|12|||
16173450|NCT00883493|39111220|FG000|Overall Study|Lack of Efficacy|4|||
16173451|NCT00883493|39111221|FG001|Overall Study|Lack of Efficacy|3|||
16173452|NCT00883493|39111220|FG000|Overall Study|Lost to Follow-up|7|||
16173453|NCT00883493|39111221|FG001|Overall Study|Lost to Follow-up|6|||
16173454|NCT00883493|39111220|FG000|Overall Study|Withdrawal by Subject|11|||
16173455|NCT00883493|39111221|FG001|Overall Study|Withdrawal by Subject|20|||
16173456|NCT00883493|39111220|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
16173457|NCT00883493|39111221|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
16173458|NCT00883493|39111220|FG000|Overall Study|Study specific disc. criteria|2|||
16173459|NCT00883493|39111221|FG001|Overall Study|Study specific disc. criteria|0|||
16173460|NCT00883493|39111220|FG000|Overall Study|Other|5|||
16173461|NCT00883493|39111221|FG001|Overall Study|Other|3|||
16173462|NCT01392183|39111223|FG000|First Drug Administration|Adverse Event|3|||
16173463|NCT01392183|39111224|FG001|First Drug Administration|Adverse Event|2|||
16173464|NCT01392183|39111223|FG000|First Drug Administration|Death|1|||
16173465|NCT01392183|39111224|FG001|First Drug Administration|Death|0|||
16173466|NCT01392183|39111223|FG000|First Drug Administration|Withdrawal by Subject|10|||
16173467|NCT01392183|39111224|FG001|First Drug Administration|Withdrawal by Subject|17|||
16173468|NCT03068715|39111228|FG000|Overall Study|No longer met inclusion criteria|1|||
16173469|NCT03068715|39111229|FG001|Overall Study|No longer met inclusion criteria|0|||
16173470|NCT02586805|39111230|FG000|Overall Study|Withdrawal by Subject|3|||
16173471|NCT02586805|39111231|FG001|Overall Study|Withdrawal by Subject|1|||
16173472|NCT02586805|39111232|FG002|Overall Study|Withdrawal by Subject|1|||
16173473|NCT02586805|39111233|FG003|Overall Study|Withdrawal by Subject|2|||
16173474|NCT02586805|39111230|FG000|Overall Study|Adverse Event|2|||
16173475|NCT02586805|39111231|FG001|Overall Study|Adverse Event|0|||
16173476|NCT02586805|39111232|FG002|Overall Study|Adverse Event|1|||
16173477|NCT02586805|39111233|FG003|Overall Study|Adverse Event|0|||
16173478|NCT02586805|39111230|FG000|Overall Study|Lost to Follow-up|0|||
16173479|NCT02586805|39111231|FG001|Overall Study|Lost to Follow-up|0|||
16173480|NCT02586805|39111232|FG002|Overall Study|Lost to Follow-up|1|||
16173481|NCT02586805|39111233|FG003|Overall Study|Lost to Follow-up|0|||
16173482|NCT02586805|39111230|FG000|Overall Study|Physician Decision|1|||
16173483|NCT02586805|39111231|FG001|Overall Study|Physician Decision|0|||
16173484|NCT02586805|39111232|FG002|Overall Study|Physician Decision|0|||
16173485|NCT02586805|39111233|FG003|Overall Study|Physician Decision|0|||
16173486|NCT01289015|39111234|FG000|Overall Study|Protocol Violation|12|||
16173487|NCT01289015|39111235|FG001|Overall Study|Protocol Violation|9|||
16173488|NCT01289015|39111234|FG000|Overall Study|Adverse Event|3|||
16173489|NCT01289015|39111235|FG001|Overall Study|Adverse Event|0|||
16173490|NCT01289015|39111234|FG000|Overall Study|Lost to Follow-up|33|||
16173491|NCT01289015|39111235|FG001|Overall Study|Lost to Follow-up|17|||
16173492|NCT01289015|39111234|FG000|Overall Study|Withdrawal by Subject|17|||
16173493|NCT01289015|39111235|FG001|Overall Study|Withdrawal by Subject|8|||
16173494|NCT01289015|39111234|FG000|Overall Study|Disease progression|1|||
16173495|NCT01289015|39111235|FG001|Overall Study|Disease progression|0|||
16173496|NCT01289015|39111234|FG000|Overall Study|Negative baseline culture and others|33|||
16173497|NCT01289015|39111235|FG001|Overall Study|Negative baseline culture and others|20|||
16173498|NCT05499520|39111237|FG000|Overall Study|Lost to Follow-up|0|||
16173499|NCT05499520|39111238|FG001|Overall Study|Lost to Follow-up|0|||
16173500|NCT05499520|39111239|FG002|Overall Study|Lost to Follow-up|38|||
16173501|NCT05499520|39111240|FG003|Overall Study|Lost to Follow-up|41|||
16173502|NCT05499520|39111241|FG004|Overall Study|Lost to Follow-up|46|||
16173503|NCT05499520|39111242|FG005|Overall Study|Lost to Follow-up|0|||
16173504|NCT05499520|39111243|FG006|Overall Study|Lost to Follow-up|31|||
16173505|NCT05499520|39111244|FG007|Overall Study|Lost to Follow-up|45|||
16173506|NCT05499520|39111245|FG008|Overall Study|Lost to Follow-up|42|||
16173507|NCT05499520|39111246|FG009|Overall Study|Lost to Follow-up|0|||
16173508|NCT05499520|39111247|FG010|Overall Study|Lost to Follow-up|0|||
16173509|NCT05499520|39111248|FG011|Overall Study|Lost to Follow-up|37|||
16173510|NCT05499520|39111249|FG012|Overall Study|Lost to Follow-up|53|||
16173511|NCT05499520|39111250|FG013|Overall Study|Lost to Follow-up|49|||
16173512|NCT05499520|39111251|FG014|Overall Study|Lost to Follow-up|0|||
16173513|NCT05499520|39111252|FG015|Overall Study|Lost to Follow-up|36|||
16173514|NCT05499520|39111253|FG016|Overall Study|Lost to Follow-up|58|||
16173515|NCT05499520|39111254|FG017|Overall Study|Lost to Follow-up|53|||
16173516|NCT00618722|39111256|FG000|Overall Study|Refusal of Treatment|0|||
16173517|NCT00618722|39111257|FG001|Overall Study|Refusal of Treatment|0|||
16173518|NCT00618722|39111258|FG002|Overall Study|Refusal of Treatment|1|||
16173519|NCT00618722|39111259|FG003|Overall Study|Refusal of Treatment|0|||
16173520|NCT00618722|39111256|FG000|Overall Study|Patient Request|1|||
16173521|NCT00618722|39111257|FG001|Overall Study|Patient Request|1|||
16173522|NCT00618722|39111258|FG002|Overall Study|Patient Request|1|||
16173523|NCT00618722|39111259|FG003|Overall Study|Patient Request|1|||
16173524|NCT00618722|39111256|FG000|Overall Study|Inability to Complete Study Procedure|0|||
16173525|NCT00618722|39111257|FG001|Overall Study|Inability to Complete Study Procedure|1|||
16173526|NCT00618722|39111258|FG002|Overall Study|Inability to Complete Study Procedure|0|||
16173527|NCT00618722|39111259|FG003|Overall Study|Inability to Complete Study Procedure|0|||
16173528|NCT00618722|39111256|FG000|Overall Study|Lost to Follow-up|2|||
16173529|NCT00618722|39111257|FG001|Overall Study|Lost to Follow-up|0|||
16173530|NCT00618722|39111258|FG002|Overall Study|Lost to Follow-up|0|||
16173531|NCT00618722|39111259|FG003|Overall Study|Lost to Follow-up|2|||
16173532|NCT00618722|39111256|FG000|Overall Study|Miscellaneous Reasons|0|||
16173533|NCT00618722|39111257|FG001|Overall Study|Miscellaneous Reasons|0|||
16173534|NCT00618722|39111258|FG002|Overall Study|Miscellaneous Reasons|1|||
16173535|NCT00618722|39111259|FG003|Overall Study|Miscellaneous Reasons|1|||
16173536|NCT02344576|39111260|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
16173537|NCT02344576|39111261|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
16173538|NCT02344576|39111262|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
16173539|NCT02344576|39111263|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
16173540|NCT02344576|39111260|FG000|1-Month Follow-Up|Death|13|||
16173541|NCT02344576|39111261|FG001|1-Month Follow-Up|Death|8|||
16173542|NCT02344576|39111262|FG002|1-Month Follow-Up|Death|0|||
16173543|NCT02344576|39111263|FG003|1-Month Follow-Up|Death|0|||
16173544|NCT02344576|39111260|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
16173545|NCT02344576|39111261|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
16173546|NCT02344576|39111262|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
16173547|NCT02344576|39111263|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
16173548|NCT02344576|39111260|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
16173549|NCT02344576|39111261|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
16173550|NCT02344576|39111262|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
16173551|NCT02344576|39111263|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
16173552|NCT02344576|39111260|FG000|6-Month Follow-Up|Death|14|||
16173553|NCT02344576|39111261|FG001|6-Month Follow-Up|Death|14|||
16173554|NCT02344576|39111262|FG002|6-Month Follow-Up|Death|0|||
16173555|NCT02344576|39111263|FG003|6-Month Follow-Up|Death|0|||
16173556|NCT02344576|39111260|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
16173557|NCT02344576|39111261|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
16173558|NCT02344576|39111262|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
16173559|NCT02344576|39111263|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
16173560|NCT02344576|39111260|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
16173561|NCT02344576|39111261|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
16173562|NCT02344576|39111262|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
16173563|NCT02344576|39111263|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
16173564|NCT00628355|39111264|FG000|Overall Study|Withdrawal by Subject|1|||
16173565|NCT00628355|39111265|FG001|Overall Study|Withdrawal by Subject|1|||
16173566|NCT02764541|39111266|FG000|Overall Study|Withdrawal by Subject|0|||
16173567|NCT02764541|39111267|FG001|Overall Study|Withdrawal by Subject|0|||
16173568|NCT02764541|39111268|FG002|Overall Study|Withdrawal by Subject|0|||
16173569|NCT02764541|39111269|FG003|Overall Study|Withdrawal by Subject|0|||
16173570|NCT02764541|39111270|FG004|Overall Study|Withdrawal by Subject|1|||
16173571|NCT02764541|39111271|FG005|Overall Study|Withdrawal by Subject|1|||
16173572|NCT02764541|39111272|FG006|Overall Study|Withdrawal by Subject|0|||
16173573|NCT02764541|39111273|FG007|Overall Study|Withdrawal by Subject|1|||
16173574|NCT02764541|39111266|FG000|Overall Study|Adverse Event|1|||
16173575|NCT02764541|39111267|FG001|Overall Study|Adverse Event|0|||
16173576|NCT02764541|39111268|FG002|Overall Study|Adverse Event|0|||
16173577|NCT02764541|39111269|FG003|Overall Study|Adverse Event|0|||
16173578|NCT02764541|39111270|FG004|Overall Study|Adverse Event|0|||
16173579|NCT02764541|39111271|FG005|Overall Study|Adverse Event|0|||
16173580|NCT02764541|39111272|FG006|Overall Study|Adverse Event|1|||
16173581|NCT02764541|39111273|FG007|Overall Study|Adverse Event|0|||
16173582|NCT02764541|39111266|FG000|Overall Study|Metastasis|1|||
16173583|NCT02764541|39111267|FG001|Overall Study|Metastasis|0|||
16173584|NCT02764541|39111268|FG002|Overall Study|Metastasis|0|||
16173585|NCT02764541|39111269|FG003|Overall Study|Metastasis|0|||
16173586|NCT02764541|39111270|FG004|Overall Study|Metastasis|0|||
16173587|NCT02764541|39111271|FG005|Overall Study|Metastasis|0|||
16173588|NCT02764541|39111272|FG006|Overall Study|Metastasis|0|||
16173589|NCT02764541|39111273|FG007|Overall Study|Metastasis|0|||
16173590|NCT02764541|39111266|FG000|Overall Study|Disease progression|1|||
16173591|NCT02764541|39111267|FG001|Overall Study|Disease progression|1|||
16173592|NCT02764541|39111268|FG002|Overall Study|Disease progression|0|||
16173593|NCT02764541|39111269|FG003|Overall Study|Disease progression|0|||
16173621|NCT02764541|39111273|FG007|Overall Study|Three Cycles completed before surgery|0|||
16173622|NCT02764541|39111266|FG000|Overall Study|Patient Compliance|0|||
16173623|NCT02764541|39111267|FG001|Overall Study|Patient Compliance|0|||
16173624|NCT02764541|39111268|FG002|Overall Study|Patient Compliance|1|||
16173625|NCT02764541|39111269|FG003|Overall Study|Patient Compliance|0|||
16173626|NCT02764541|39111270|FG004|Overall Study|Patient Compliance|0|||
16173627|NCT02764541|39111271|FG005|Overall Study|Patient Compliance|0|||
16173628|NCT02764541|39111272|FG006|Overall Study|Patient Compliance|0|||
16173629|NCT02764541|39111273|FG007|Overall Study|Patient Compliance|0|||
16173630|NCT02764541|39111266|FG000|Overall Study|Death|0|||
16173631|NCT02764541|39111267|FG001|Overall Study|Death|0|||
16173632|NCT02764541|39111268|FG002|Overall Study|Death|0|||
16173633|NCT02764541|39111269|FG003|Overall Study|Death|0|||
16173634|NCT02764541|39111270|FG004|Overall Study|Death|0|||
16173635|NCT02764541|39111271|FG005|Overall Study|Death|0|||
16173636|NCT02764541|39111272|FG006|Overall Study|Death|1|||
16173637|NCT02764541|39111273|FG007|Overall Study|Death|0|||
16173638|NCT02764541|39111266|FG000|Overall Study|Insurance reasons|0|||
16173639|NCT02764541|39111267|FG001|Overall Study|Insurance reasons|0|||
16173640|NCT02764541|39111268|FG002|Overall Study|Insurance reasons|0|||
16173641|NCT02764541|39111269|FG003|Overall Study|Insurance reasons|0|||
16173642|NCT02764541|39111270|FG004|Overall Study|Insurance reasons|0|||
16173643|NCT02764541|39111271|FG005|Overall Study|Insurance reasons|0|||
16173644|NCT02764541|39111272|FG006|Overall Study|Insurance reasons|1|||
16173645|NCT02764541|39111273|FG007|Overall Study|Insurance reasons|0|||
16173646|NCT01454076|39111274|FG000|Overall Study|Other|2|||
16173647|NCT01454076|39111275|FG001|Overall Study|Other|0|||
16173648|NCT01454076|39111276|FG002|Overall Study|Other|0|||
16173649|NCT01454076|39111277|FG003|Overall Study|Other|1|||
16173650|NCT01454076|39111278|FG004|Overall Study|Other|2|||
16173651|NCT01454076|39111274|FG000|Overall Study|Withdrawal by Subject|3|||
16173652|NCT01454076|39111275|FG001|Overall Study|Withdrawal by Subject|4|||
16173653|NCT01454076|39111276|FG002|Overall Study|Withdrawal by Subject|2|||
16173654|NCT01454076|39111277|FG003|Overall Study|Withdrawal by Subject|1|||
16173655|NCT01454076|39111278|FG004|Overall Study|Withdrawal by Subject|2|||
16173656|NCT01454076|39111274|FG000|Overall Study|Adverse Event|8|||
16173657|NCT01454076|39111275|FG001|Overall Study|Adverse Event|2|||
16173658|NCT01454076|39111276|FG002|Overall Study|Adverse Event|7|||
16173659|NCT01454076|39111277|FG003|Overall Study|Adverse Event|0|||
16173660|NCT01454076|39111278|FG004|Overall Study|Adverse Event|2|||
16173661|NCT00389207|39111279|FG000|Overall Study|Adverse Event|26|||
16173662|NCT00389207|39111280|FG001|Overall Study|Adverse Event|32|||
16173663|NCT00389207|39111281|FG002|Overall Study|Adverse Event|10|||
16173664|NCT00389207|39111279|FG000|Overall Study|Protocol Violation|3|||
16173665|NCT00389207|39111280|FG001|Overall Study|Protocol Violation|1|||
16173666|NCT00389207|39111281|FG002|Overall Study|Protocol Violation|4|||
16173667|NCT00389207|39111279|FG000|Overall Study|Lost to Follow-up|12|||
16173668|NCT00389207|39111280|FG001|Overall Study|Lost to Follow-up|9|||
16173669|NCT00389207|39111281|FG002|Overall Study|Lost to Follow-up|7|||
16173670|NCT00389207|39111279|FG000|Overall Study|Withdrawal by Subject|5|||
16173671|NCT00389207|39111280|FG001|Overall Study|Withdrawal by Subject|7|||
16173672|NCT00389207|39111281|FG002|Overall Study|Withdrawal by Subject|11|||
16173673|NCT00389207|39111279|FG000|Overall Study|Other|17|||
16173674|NCT00389207|39111280|FG001|Overall Study|Other|23|||
16173675|NCT00389207|39111281|FG002|Overall Study|Other|9|||
16173676|NCT00619229|39111287|FG000|Overall Study|Withdrawal by Subject|1|||
16173677|NCT00619229|39111288|FG001|Overall Study|Withdrawal by Subject|1|||
16173678|NCT00619229|39111287|FG000|Overall Study|Lost to Follow-up|1|||
16173679|NCT00619229|39111288|FG001|Overall Study|Lost to Follow-up|0|||
16173680|NCT00619229|39111287|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
16173681|NCT00619229|39111288|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
16173682|NCT00619229|39111287|FG000|Overall Study|Investigator planned Cataract Operation|1|||
16173683|NCT00619229|39111288|FG001|Overall Study|Investigator planned Cataract Operation|0|||
16273106|NCT02096705|39484404|FG001|Treatment|Adverse Event|3|||
16273107|NCT02096705|39484403|FG000|Treatment|Subject request to discontinue treatment|1|||
16273108|NCT02096705|39484404|FG001|Treatment|Subject request to discontinue treatment|1|||
16273109|NCT02096705|39484403|FG000|Treatment|Withdrawal by Subject|1|||
16273110|NCT02096705|39484404|FG001|Treatment|Withdrawal by Subject|0|||
16273111|NCT02096705|39484403|FG000|Treatment|Other|1|||
16273112|NCT02096705|39484404|FG001|Treatment|Other|1|||
16273113|NCT02096705|39484403|FG000|Follow-up|Withdrawal by Subject|1|||
16273114|NCT02096705|39484404|FG001|Follow-up|Withdrawal by Subject|0|||
16273115|NCT02096705|39484403|FG000|Follow-up|Adverse Event|2|||
16273116|NCT02096705|39484404|FG001|Follow-up|Adverse Event|2|||
16273117|NCT02096705|39484403|FG000|Follow-up|Subjects not reporting status|1|||
16273118|NCT02096705|39484404|FG001|Follow-up|Subjects not reporting status|2|||
16273119|NCT02694536|39484413|FG000|Overall Study|Progressive Disease|40|||
16273120|NCT02694536|39484413|FG000|Overall Study|Lost to Follow-up|1|||
16273121|NCT02694536|39484413|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
16273122|NCT02694536|39484413|FG000|Overall Study|Withdrawal by Subject|8|||
16273264|NCT01541215|39484476|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
16273265|NCT01541215|39484477|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
16273266|NCT01541215|39484476|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
16273267|NCT01541215|39484477|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
16273268|NCT01541215|39484476|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
16273269|NCT01541215|39484477|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
16273270|NCT01541215|39484476|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
16273271|NCT01541215|39484477|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
16273272|NCT01541215|39484476|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
16273273|NCT01541215|39484477|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
16273274|NCT01456962|39484478|FG000|Overall Study|Lost to Follow-up|2|||
16273275|NCT01456962|39484479|FG001|Overall Study|Lost to Follow-up|1|||
16273276|NCT01617096|39484480|FG000|Overall Study|Withdrawal by Subject|96|||
16273277|NCT01617096|39484481|FG001|Overall Study|Withdrawal by Subject|81|||
16273278|NCT01617096|39484480|FG000|Overall Study|Lost to Follow-up|37|||
16273279|NCT01617096|39484481|FG001|Overall Study|Lost to Follow-up|32|||
16273280|NCT01617096|39484480|FG000|Overall Study|Physician Decision|10|||
16273281|NCT01617096|39484481|FG001|Overall Study|Physician Decision|18|||
16273282|NCT01617096|39484480|FG000|Overall Study|Death|4|||
16273283|NCT01617096|39484481|FG001|Overall Study|Death|3|||
16273284|NCT01617096|39484480|FG000|Overall Study|Other|1|||
16273285|NCT01617096|39484481|FG001|Overall Study|Other|3|||
16273286|NCT01547728|39484484|FG000|Overall Study|Change in procedure and equipment|1|||
16273287|NCT01547728|39484484|FG000|Overall Study|Drug not ready for subject|1|||
16273288|NCT01547728|39484484|FG000|Overall Study|Screen failure|39|||
16273289|NCT03218787|39484485|FG000|Overall Study|Lost to Follow-up|12|||
16273290|NCT03218787|39484485|FG000|Overall Study|Withdrawal by Subject|72|||
16273291|NCT03218787|39484485|FG000|Overall Study|Physician Decision|11|||
16273292|NCT03218787|39484485|FG000|Overall Study|Death|111|||
16273293|NCT03920280|39484486|FG000|Overall Study|Adverse Event|2|||
16273294|NCT03920280|39484487|FG001|Overall Study|Adverse Event|3|||
16273295|NCT03920280|39484486|FG000|Overall Study|Lost to Follow-up|0|||
16273296|NCT03920280|39484487|FG001|Overall Study|Lost to Follow-up|1|||
16273297|NCT03920280|39484486|FG000|Overall Study|Withdrawal by Subject|1|||
16273298|NCT03920280|39484487|FG001|Overall Study|Withdrawal by Subject|1|||
16273299|NCT03920280|39484486|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
16273300|NCT03920280|39484487|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
16273301|NCT00452348|39484490|FG000|Overall Study|Adverse Event|6|||
16273302|NCT00452348|39484491|FG001|Overall Study|Adverse Event|9|||
16273303|NCT00452348|39484490|FG000|Overall Study|Lack of Efficacy|10|||
16273304|NCT00452348|39484491|FG001|Overall Study|Lack of Efficacy|9|||
16273305|NCT00452348|39484490|FG000|Overall Study|Lost to Follow-up|14|||
16273306|NCT00452348|39484491|FG001|Overall Study|Lost to Follow-up|8|||
16273307|NCT00452348|39484490|FG000|Overall Study|Protocol Violation|22|||
16273308|NCT00452348|39484491|FG001|Overall Study|Protocol Violation|28|||
16273309|NCT00452348|39484490|FG000|Overall Study|Withdrawal by Subject|18|||
16273310|NCT00452348|39484491|FG001|Overall Study|Withdrawal by Subject|21|||
16273311|NCT00452348|39484490|FG000|Overall Study|Other|9|||
16273312|NCT00452348|39484491|FG001|Overall Study|Other|9|||
16273313|NCT00113919|39484492|FG000|Overall Study|Physician Decision|8|||
16273314|NCT00113919|39484492|FG000|Overall Study|Death|6|||
16273315|NCT01960296|39484496|FG000|Overall Study|Postponed surgery|1|||
16273316|NCT01960296|39484497|FG001|Overall Study|Postponed surgery|0|||
16273317|NCT01960296|39484496|FG000|Overall Study|Received different procedure|1|||
16273318|NCT01960296|39484497|FG001|Overall Study|Received different procedure|3|||
16273319|NCT00070291|39484504|FG000|Step 1|Withdrawal by Subject|1|||
16273320|NCT00070291|39484504|FG000|Step 1|Adverse Event|1|||
16273321|NCT00070291|39484504|FG000|Step 2|Adverse Event|1|||
16273322|NCT02250651|39484507|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
16273323|NCT02250651|39484508|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
16273324|NCT02250651|39484509|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
16273325|NCT02250651|39484507|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
16273326|NCT02250651|39484508|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
16273327|NCT02250651|39484509|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
16273328|NCT02250651|39484507|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
16273329|NCT02250651|39484508|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
16273330|NCT02250651|39484509|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
16273331|NCT02250651|39484507|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
16273332|NCT02250651|39484508|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
16273333|NCT02250651|39484509|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
16273334|NCT02250651|39484507|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
16273335|NCT02250651|39484508|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
16273336|NCT02250651|39484509|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
16273337|NCT02250651|39484507|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
16273338|NCT02250651|39484508|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
16273339|NCT02250651|39484509|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
16273340|NCT02250651|39484507|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
16273341|NCT02250651|39484508|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
16273342|NCT02250651|39484509|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
16273343|NCT02250651|39484507|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
16273344|NCT02250651|39484508|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
16273345|NCT02250651|39484509|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
16273346|NCT02250651|39484507|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
16273347|NCT02250651|39484508|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
16273348|NCT02250651|39484509|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
16273349|NCT02250651|39484507|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
16273350|NCT02250651|39484508|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
16273351|NCT02250651|39484509|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
16273352|NCT02250651|39484507|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
16273353|NCT02250651|39484508|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
16273354|NCT02250651|39484509|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
16273355|NCT02250651|39484507|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
16273356|NCT02250651|39484508|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
16273357|NCT02250651|39484509|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
16273358|NCT02250651|39484507|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
16273359|NCT02250651|39484508|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
16273360|NCT02250651|39484509|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
16273361|NCT02250651|39484507|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
16273362|NCT02250651|39484508|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
16273363|NCT02250651|39484509|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
16273364|NCT02250651|39484507|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
16273365|NCT02250651|39484508|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
16273366|NCT02250651|39484509|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
16273367|NCT02911025|39484512|FG000|Overall Study|Lost to Follow-up|3|||
16273368|NCT01567527|39484513|FG000|Conversion Phase.|Protocol deviation|3|||
16273369|NCT01567527|39484514|FG001|Conversion Phase.|Protocol deviation|0|||
16273370|NCT01567527|39484515|FG002|Conversion Phase.|Protocol deviation|0|||
16273371|NCT01567527|39484516|FG003|Conversion Phase.|Protocol deviation|0|||
16273372|NCT01567527|39484517|FG004|Conversion Phase.|Protocol deviation|0|||
16273373|NCT01567527|39484513|FG000|Conversion Phase.|Met withdrawal criteria|10|||
16273374|NCT01567527|39484514|FG001|Conversion Phase.|Met withdrawal criteria|0|||
16273375|NCT01567527|39484515|FG002|Conversion Phase.|Met withdrawal criteria|0|||
16273376|NCT01567527|39484516|FG003|Conversion Phase.|Met withdrawal criteria|0|||
16273377|NCT01567527|39484517|FG004|Conversion Phase.|Met withdrawal criteria|0|||
16273378|NCT01567527|39484513|FG000|Conversion Phase.|Withdrawal by Subject|32|||
16273379|NCT01567527|39484514|FG001|Conversion Phase.|Withdrawal by Subject|0|||
16273380|NCT01567527|39484515|FG002|Conversion Phase.|Withdrawal by Subject|0|||
16273381|NCT01567527|39484516|FG003|Conversion Phase.|Withdrawal by Subject|0|||
16273382|NCT01567527|39484517|FG004|Conversion Phase.|Withdrawal by Subject|0|||
16273383|NCT01567527|39484513|FG000|Conversion Phase.|Lost to Follow-up|16|||
16273384|NCT01567527|39484514|FG001|Conversion Phase.|Lost to Follow-up|0|||
16273385|NCT01567527|39484515|FG002|Conversion Phase.|Lost to Follow-up|0|||
16273386|NCT01567527|39484516|FG003|Conversion Phase.|Lost to Follow-up|0|||
16273387|NCT01567527|39484517|FG004|Conversion Phase.|Lost to Follow-up|0|||
16273388|NCT01567527|39484513|FG000|Conversion Phase.|Lack of Efficacy|2|||
16273389|NCT01567527|39484514|FG001|Conversion Phase.|Lack of Efficacy|0|||
16273390|NCT01567527|39484515|FG002|Conversion Phase.|Lack of Efficacy|0|||
16273391|NCT01567527|39484516|FG003|Conversion Phase.|Lack of Efficacy|0|||
16273392|NCT01567527|39484517|FG004|Conversion Phase.|Lack of Efficacy|0|||
16273393|NCT01567527|39484513|FG000|Conversion Phase.|Adverse Event|33|||
16273394|NCT01567527|39484514|FG001|Conversion Phase.|Adverse Event|0|||
16273395|NCT01567527|39484515|FG002|Conversion Phase.|Adverse Event|0|||
16273396|NCT01567527|39484516|FG003|Conversion Phase.|Adverse Event|0|||
16273397|NCT01567527|39484517|FG004|Conversion Phase.|Adverse Event|0|||
16273398|NCT01567527|39484513|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
16273399|NCT01567527|39484514|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
16273400|NCT01567527|39484515|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
16273401|NCT01567527|39484516|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
16273402|NCT01567527|39484517|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
16273403|NCT01567527|39484513|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
16273404|NCT01567527|39484514|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
16273405|NCT01567527|39484515|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
16273406|NCT01567527|39484516|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
16273407|NCT01567527|39484517|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
16273408|NCT01567527|39484513|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
16273409|NCT01567527|39484514|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
16273410|NCT01567527|39484515|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
16273411|NCT01567527|39484516|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
16273412|NCT01567527|39484517|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
16273413|NCT01567527|39484513|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
16273414|NCT01567527|39484514|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
16273415|NCT01567527|39484515|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
16273416|NCT01567527|39484516|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
16273417|NCT01567527|39484517|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
16273418|NCT01567527|39484513|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
16273419|NCT01567527|39484514|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
16273420|NCT01567527|39484515|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
16273421|NCT01567527|39484516|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
16273422|NCT01567527|39484517|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
16273423|NCT01567527|39484513|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
16273424|NCT01567527|39484514|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
16273425|NCT01567527|39484515|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
16273426|NCT01567527|39484516|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
16273427|NCT01567527|39484517|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
16273428|NCT01567527|39484513|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
16273429|NCT01567527|39484514|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
16273430|NCT01567527|39484515|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
16273431|NCT01567527|39484516|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
16273432|NCT01567527|39484517|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
16273433|NCT01567527|39484513|FG000|IM Depot Stabilization.|Protocol deviation|0|||
16273434|NCT01567527|39484514|FG001|IM Depot Stabilization.|Protocol deviation|0|||
16273435|NCT01567527|39484515|FG002|IM Depot Stabilization.|Protocol deviation|5|||
16273436|NCT01567527|39484516|FG003|IM Depot Stabilization.|Protocol deviation|0|||
16273437|NCT01567527|39484517|FG004|IM Depot Stabilization.|Protocol deviation|0|||
16273438|NCT01567527|39484513|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
16273439|NCT01567527|39484514|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
16273440|NCT01567527|39484515|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
16273441|NCT01567527|39484516|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
16273442|NCT01567527|39484517|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
16273443|NCT01567527|39484513|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
16273444|NCT01567527|39484514|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
16273445|NCT01567527|39484515|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
16273446|NCT01567527|39484516|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
16273447|NCT01567527|39484517|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
16273448|NCT01567527|39484513|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
16273449|NCT01567527|39484514|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
16273450|NCT01567527|39484515|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
16273451|NCT01567527|39484516|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
16273452|NCT01567527|39484517|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
16273453|NCT01567527|39484513|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
16273454|NCT01567527|39484514|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
16273455|NCT01567527|39484515|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
16273456|NCT01567527|39484516|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
16273457|NCT01567527|39484517|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
16273458|NCT01567527|39484513|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
16273459|NCT01567527|39484514|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
16273460|NCT01567527|39484515|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
16273461|NCT01567527|39484516|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
16273462|NCT01567527|39484517|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
16273463|NCT01567527|39484513|FG000|IM Depot Stabilization.|Adverse Event|0|||
16273464|NCT01567527|39484514|FG001|IM Depot Stabilization.|Adverse Event|0|||
16273465|NCT01567527|39484515|FG002|IM Depot Stabilization.|Adverse Event|37|||
16273466|NCT01567527|39484516|FG003|IM Depot Stabilization.|Adverse Event|0|||
16273467|NCT01567527|39484517|FG004|IM Depot Stabilization.|Adverse Event|0|||
16273468|NCT01567527|39484513|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
16273469|NCT01567527|39484514|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
16273470|NCT01567527|39484515|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
16273471|NCT01567527|39484516|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
16273472|NCT01567527|39484517|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
16273473|NCT01567527|39484513|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
16273474|NCT01567527|39484514|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
16473084|NCT00098475|40210741|FG001|Step 1|Never started treatment|2|||
16273475|NCT01567527|39484515|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
16273476|NCT01567527|39484516|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
16273477|NCT01567527|39484517|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
16273478|NCT01567527|39484513|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
16273479|NCT01567527|39484514|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
16273480|NCT01567527|39484515|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
16273481|NCT01567527|39484516|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
16273482|NCT01567527|39484517|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
16273483|NCT01567527|39484513|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
16273484|NCT01567527|39484514|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
16273485|NCT01567527|39484515|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
16273486|NCT01567527|39484516|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
16273487|NCT01567527|39484517|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
16273488|NCT01567527|39484513|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
16273489|NCT01567527|39484514|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
16273490|NCT01567527|39484515|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
16273491|NCT01567527|39484516|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
16273492|NCT01567527|39484517|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
16273493|NCT01567527|39484513|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16273494|NCT01567527|39484514|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16273495|NCT01567527|39484515|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
16273496|NCT01567527|39484516|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
16273497|NCT01567527|39484517|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
16273498|NCT01567527|39484513|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
16273499|NCT01567527|39484514|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
16273500|NCT01567527|39484515|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
16273501|NCT01567527|39484516|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
16273502|NCT01567527|39484517|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
16273503|NCT01567527|39484513|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
16273504|NCT01567527|39484514|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
16273505|NCT01567527|39484515|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
16273506|NCT01567527|39484516|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
16273507|NCT01567527|39484517|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
16273508|NCT01567527|39484513|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16273509|NCT01567527|39484514|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16273510|NCT01567527|39484515|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
16273511|NCT01567527|39484516|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
16273512|NCT01567527|39484517|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
16273513|NCT04422431|39484518|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
16273514|NCT04422431|39484518|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
16273515|NCT04422431|39484518|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
16273516|NCT04422431|39484518|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
16273517|NCT04422431|39484518|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
16273518|NCT04422431|39484518|FG000|Extension Period (48 Weeks)|Other than specified|2|||
16273519|NCT05776901|39484522|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
16273520|NCT01929681|39484523|FG000|Overall Study|Withdrawal by Subject|1|||
16273521|NCT01929681|39484524|FG001|Overall Study|Withdrawal by Subject|0|||
16273522|NCT01929681|39484523|FG000|Overall Study|Physician Decision|1|||
16273523|NCT01929681|39484524|FG001|Overall Study|Physician Decision|1|||
16273524|NCT01986647|39484527|FG000|Overall Study|Lost to Follow-up|4|||
16273525|NCT01986647|39484528|FG001|Overall Study|Lost to Follow-up|1|||
16273526|NCT01986647|39484529|FG002|Overall Study|Lost to Follow-up|4|||
16273527|NCT01986647|39484530|FG003|Overall Study|Lost to Follow-up|4|||
16273528|NCT01986647|39484527|FG000|Overall Study|Withdrawal by Subject|1|||
16273529|NCT01986647|39484528|FG001|Overall Study|Withdrawal by Subject|3|||
16273530|NCT01986647|39484529|FG002|Overall Study|Withdrawal by Subject|2|||
16273531|NCT01986647|39484530|FG003|Overall Study|Withdrawal by Subject|3|||
16273532|NCT01986647|39484527|FG000|Overall Study|Health|5|||
16273533|NCT01986647|39484528|FG001|Overall Study|Health|3|||
16273534|NCT01986647|39484529|FG002|Overall Study|Health|6|||
16273535|NCT01986647|39484530|FG003|Overall Study|Health|4|||
16273536|NCT00288704|39484531|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
16273537|NCT00288704|39484532|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
16273538|NCT00288704|39484533|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
16273539|NCT00288704|39484531|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
16273540|NCT00288704|39484532|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
16273541|NCT00288704|39484533|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
16273542|NCT00288704|39484531|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
16273543|NCT00288704|39484532|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
16273544|NCT00288704|39484533|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
16273545|NCT00288704|39484531|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
16273546|NCT00288704|39484532|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
16273547|NCT00288704|39484533|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
16273548|NCT00288704|39484531|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
16273549|NCT00288704|39484532|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
16273550|NCT00288704|39484533|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
16273551|NCT00288704|39484531|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
16273552|NCT00288704|39484532|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
16273553|NCT00288704|39484533|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
16273554|NCT00288704|39484531|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
16273555|NCT00288704|39484532|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
16273556|NCT00288704|39484533|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
16273557|NCT03234608|39484534|FG000|Overall Study|Lost to Follow-up|23|||
16273558|NCT03234608|39484535|FG001|Overall Study|Lost to Follow-up|21|||
16273559|NCT04194008|39484536|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
16273560|NCT04194008|39484536|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
16273561|NCT04194008|39484536|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
16273562|NCT04194008|39484536|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
16273563|NCT04194008|39484536|FG000|Treatment Phase With Nerivio|Missing data|4|||
16273564|NCT04194008|39484536|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
16273565|NCT03073798|39484537|FG000|Overall Study|Adverse Event|1|||
16273566|NCT03073798|39484537|FG000|Overall Study|Withdrawal by Subject|1|||
16273567|NCT00807495|39484538|FG000|Overall Study|Adverse Event|6|||
16273568|NCT00807495|39484539|FG001|Overall Study|Adverse Event|3|||
16273569|NCT00807495|39484540|FG002|Overall Study|Adverse Event|1|||
16273570|NCT00807495|39484541|FG003|Overall Study|Adverse Event|1|||
16273571|NCT00807495|39484542|FG004|Overall Study|Adverse Event|2|||
16273572|NCT00807495|39484538|FG000|Overall Study|Withdrawal by Patient|2|||
16273573|NCT00807495|39484539|FG001|Overall Study|Withdrawal by Patient|0|||
16273574|NCT00807495|39484540|FG002|Overall Study|Withdrawal by Patient|1|||
16273575|NCT00807495|39484541|FG003|Overall Study|Withdrawal by Patient|0|||
16273576|NCT00807495|39484542|FG004|Overall Study|Withdrawal by Patient|0|||
16273577|NCT00807495|39484538|FG000|Overall Study|Reason Not Specified|0|||
16273578|NCT00807495|39484539|FG001|Overall Study|Reason Not Specified|3|||
16273579|NCT00807495|39484540|FG002|Overall Study|Reason Not Specified|2|||
16273580|NCT00807495|39484541|FG003|Overall Study|Reason Not Specified|0|||
16273581|NCT00807495|39484542|FG004|Overall Study|Reason Not Specified|3|||
16273582|NCT01638013|39484550|FG000|Overall Study|Adverse Event|36|||
16273583|NCT01638013|39484551|FG001|Overall Study|Adverse Event|29|||
16273584|NCT01638013|39484552|FG002|Overall Study|Adverse Event|48|||
16273585|NCT01638013|39484550|FG000|Overall Study|Lack of Efficacy|39|||
16273586|NCT01638013|39484551|FG001|Overall Study|Lack of Efficacy|11|||
16273587|NCT01638013|39484552|FG002|Overall Study|Lack of Efficacy|14|||
16273588|NCT01638013|39484550|FG000|Overall Study|Protocol Violation|10|||
16273589|NCT01638013|39484551|FG001|Overall Study|Protocol Violation|7|||
16273590|NCT01638013|39484552|FG002|Overall Study|Protocol Violation|11|||
16273591|NCT01638013|39484550|FG000|Overall Study|Met discontinuation criteria|4|||
16273592|NCT01638013|39484551|FG001|Overall Study|Met discontinuation criteria|0|||
16273593|NCT01638013|39484552|FG002|Overall Study|Met discontinuation criteria|7|||
16273594|NCT01638013|39484550|FG000|Overall Study|Subject Lost to Follow up|1|||
16273595|NCT01638013|39484551|FG001|Overall Study|Subject Lost to Follow up|0|||
16273596|NCT01638013|39484552|FG002|Overall Study|Subject Lost to Follow up|1|||
16273597|NCT01638013|39484550|FG000|Overall Study|Miscellaneous|25|||
16273598|NCT01638013|39484551|FG001|Overall Study|Miscellaneous|19|||
16273599|NCT01638013|39484552|FG002|Overall Study|Miscellaneous|23|||
16273600|NCT01638013|39484550|FG000|Overall Study|Withdrawal of Consent|16|||
16273601|NCT01638013|39484551|FG001|Overall Study|Withdrawal of Consent|12|||
16273602|NCT01638013|39484552|FG002|Overall Study|Withdrawal of Consent|16|||
16273603|NCT01638013|39484550|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
16273604|NCT01638013|39484551|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
16273605|NCT01638013|39484552|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
16273606|NCT00874276|39484553|FG000|Overall Study|Withdrawal by Subject|1|||
16273607|NCT00874276|39484554|FG001|Overall Study|Withdrawal by Subject|1|||
16473085|NCT00098475|40210742|FG002|Step 1|Never started treatment|0|||
16473086|NCT00098475|40210743|FG003|Step 1|Never started treatment|0|||
16473087|NCT00098475|40210740|FG000|Step 1|Still on treatment as of this analysis|14|||
16473088|NCT00098475|40210741|FG001|Step 1|Still on treatment as of this analysis|27|||
16473089|NCT00098475|40210742|FG002|Step 1|Still on treatment as of this analysis|0|||
